<SEC-DOCUMENT>0000875045-15-000024.txt : 20150724
<SEC-HEADER>0000875045-15-000024.hdr.sgml : 20150724
<ACCEPTANCE-DATETIME>20150724162545
ACCESSION NUMBER:		0000875045-15-000024
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		33
CONFORMED PERIOD OF REPORT:	20150630
FILED AS OF DATE:		20150724
DATE AS OF CHANGE:		20150724

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOGEN INC.
		CENTRAL INDEX KEY:			0000875045
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				330112644
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19311
		FILM NUMBER:		151004879

	BUSINESS ADDRESS:	
		STREET 1:		225 BINNEY STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		7814642000

	MAIL ADDRESS:	
		STREET 1:		225 BINNEY STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOGEN IDEC INC.
		DATE OF NAME CHANGE:	20070427

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOGEN IDEC INC
		DATE OF NAME CHANGE:	20031112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IDEC PHARMACEUTICALS CORP / DE
		DATE OF NAME CHANGE:	19970530
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>biib-2015630x10q.htm
<DESCRIPTION>10-Q
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2015 Workiva -->
		<title>BIIB-2015.6.30-10Q</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s8CF6E565C1E3D4EA53539B203CC86DD2"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:14pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:14pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:14pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;font-weight:bold;">Washington,&#160;D.C. 20549</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:18pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:18pt;font-weight:bold;">Form&#160;10-Q</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="6%"></td><td width="94%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Wingdings;font-size:12pt;">x</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;font-weight:bold;">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:6px;padding-left:48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">For the quarterly period ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">OR</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="6%"></td><td width="94%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Wingdings;font-size:12pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">Commission File Number 0-19311</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><img src="biogenlogostandard.jpg" style="height:56px;width:173px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:24pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:24pt;font-weight:bold;">BIOGEN INC.</font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-style:italic;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="49%"></td><td width="4%"></td><td width="47%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">Delaware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">33-0112644</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-style:italic;">(State or other jurisdiction of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-style:italic;">incorporation or organization)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-style:italic;">(I.R.S. Employer</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-style:italic;">Identification No.)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">225 Binney Street, Cambridge, MA 02142</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">(617)&#160;679-2000</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-style:italic;">(Address, including zip code, and telephone number, including</font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-style:italic;">area code, of registrant&#8217;s principal executive offices)</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days:&#160;&#160;&#160;&#160;Yes</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">x</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">No</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule&#160;405 of Regulation&#160;S-T during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit and post such files):&#160;&#160;&#160;&#160;Yes</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">x</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">No</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act (Check One):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="42%"></td><td width="19%"></td><td width="39%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Large&#160;accelerated&#160;filer</font><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:Wingdings;font-size:10pt;">x</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accelerated filer</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-accelerated&#160;filer</font><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Smaller&#160;reporting&#160;company</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(Do not check if a smaller reporting company)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act):&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;No&#160;</font><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:Wingdings;font-size:10pt;">x</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The number of shares of the issuer&#8217;s Common Stock, $0.0005&#160;par value, outstanding as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">July&#160;17, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">235,169,225</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;shares.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><br><div></div><hr style="page-break-after:always"><a name="sD7FEAB285F05C019C5249B203D1AEE60"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">BIOGEN INC.</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">FORM&#160;10-Q &#8212; Quarterly Report</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">For the Quarterly Period Ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">&#32;</font></div><div style="line-height:120%;padding-top:18px;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">TABLE OF CONTENTS</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="9%"></td><td width="81%"></td><td width="10%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Page</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;vertical-align:top;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;vertical-align:top;">PART&#160;I&#160;&#8212; </font><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;vertical-align:top;" href="#s874B6CC8B0444DCF6D439B203D6D183D"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;vertical-align:top;">FINANCIAL INFORMATION</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 1.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Financial Statements (unaudited)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#sFEEB121F9D8AE3B7E5C09B1F3FA845A8"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Condensed Consolidated Statements of Income&#160;&#8212; For the Three and Six Months Ended June 30, 2015 and 2014</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#sFEEB121F9D8AE3B7E5C09B1F3FA845A8">4</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s982C3AD7F95196087A399B1F3EB01E18"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Condensed Consolidated Statements of Comprehensive Income &#8212; For the Three and Six Months Ended June 30, 2015 and 2014</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#s982C3AD7F95196087A399B1F3EB01E18">5</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s35041FE8386EDDF34AFE9B1F3F480255"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Condensed Consolidated Balance Sheets&#160;&#8212; As of June 30, 2015 and December&#160;31, 2014</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#s35041FE8386EDDF34AFE9B1F3F480255">6</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s8907D203F214ECCAB6BB9B1F3F2886DD"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Condensed Consolidated Statements of Cash Flows&#160;&#8212; For the Six Months Ended June 30, 2015 and 2014</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#s8907D203F214ECCAB6BB9B1F3F2886DD">7</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s5F35084703B8B1A86F129B203EBD2982"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Notes to Condensed Consolidated Financial Statements</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#s5F35084703B8B1A86F129B203EBD2982">8</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 2.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#s867191548312672671029B2042F7AA2C"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#s867191548312672671029B2042F7AA2C">31</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 3.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#sD897585BCD8E1F9DB8269B2046DF9037"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;">Quantitative and Qualitative Disclosures About Market Risk</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#sD897585BCD8E1F9DB8269B2046DF9037">53</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 4.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#sBA1B63BCA25D7E070F739B2046FFB0D8"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;">Controls and Procedures</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#sBA1B63BCA25D7E070F739B2046FFB0D8">53</a></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;vertical-align:top;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;vertical-align:top;">PART&#160;II&#160;&#8212; </font><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;vertical-align:top;" href="#s3F02126B27BF04460C5E9B204732F2A0"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;vertical-align:top;">OTHER INFORMATION</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 1.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#sF6A22B14F5B4A27EEF0E9B20475432F2"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;">Legal Proceedings</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#sF6A22B14F5B4A27EEF0E9B20475432F2">54</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item&#160;1A.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#s026B95792BCF8A7D20849B204786810F"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;">Risk Factors</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#s026B95792BCF8A7D20849B204786810F">54</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 2.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#s01E7C57A8D89FF0739029B1FF3FE6F3A"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;">Unregistered Sales of Equity Securities and Use of Proceeds</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#s01E7C57A8D89FF0739029B1FF3FE6F3A">65</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 6.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#sC2779DA73CA048CEA9469B2047D9FCB3"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;">Exhibits</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#sC2779DA73CA048CEA9469B2047D9FCB3">65</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#sFA440BC99160E6BD61119B2047FAFD58"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;">Signatures</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;vertical-align:top;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;vertical-align:top;" href="#sFA440BC99160E6BD61119B2047FAFD58">66</a></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2</font></div></div><hr style="page-break-after:always"><a name="sF249D1F543F80E039EA29B203D3DD0E6"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">NOTE&#160;REGARDING FORWARD-LOOKING STATEMENTS</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">This report contains forward-looking statements that are being made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995 (the &#8220;Act&#8221;) with the intention of obtaining the benefits of the &#8220;Safe Harbor&#8221; provisions of the Act. These forward-looking statements may be accompanied by such words as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;project,&#8221; &#8220;target,&#8221; &#8220;will&#8221; and other words and terms of similar meaning. Reference is made in particular to forward-looking statements regarding:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">the anticipated amount, timing and accounting of revenues, contingent payments, milestone, royalty and other payments under licensing, collaboration or acquisition agreements, tax positions and contingencies, collectability of receivables, pre-approval inventory, cost of sales, research and development costs, compensation and other expenses, amortization of intangible assets, foreign currency exchange risk, estimated fair value of assets and liabilities, and impairment assessments;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">expectations relating to sales, growth and pricing of our marketed products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">the potential impact of increased product competition in the markets in which we compete;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">the timing, outcome and impact of administrative, regulatory, legal and other proceedings related to patents and other proprietary and intellectual property rights, tax audits, assessments and settlements, pricing matters, sales and promotional practices, product liability and other matters;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">the costs and timing of potential trials, filing and approvals, and the potential therapeutic scope of the development and commercialization of our and our collaborators' pipeline products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">our intent to commit resources for research and development opportunities, and expectations relating to selling, general and administrative expense;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">the impact of the continued uncertainty of the credit and economic conditions in certain countries in Europe and our collection of accounts receivable in such countries;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">expectations relating to the timing and execution of our stock repurchase programs;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">expected timing of the closing of our proposed collaboration with Applied Genetic Technologies Corporation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">plans and timing relating to the expansion of our manufacturing capabilities, including anticipated investments in Solothurn, Switzerland and Research Triangle Park, North Carolina;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">our ability to finance our operations and business initiatives and obtain funding for such activities; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">the impact of new laws and accounting standards.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">These forward-looking statements involve risks and uncertainties, including those that are described in the &#8220;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Risk Factors</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8221; section of this report and elsewhere within this report that could cause actual results to differ materially from those reflected in such statements. You should not place undue reliance on these statements. Forward-looking statements speak only as of the date of this report. We do not undertake any obligation to publicly update any forward-looking statements.</font></div><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">NOTE REGARDING COMPANY AND PRODUCT REFERENCES</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Throughout this report, &#8220;Biogen,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Biogen Inc. (formerly Biogen Idec Inc.) and its consolidated subsidiaries. References to &#8220;RITUXAN&#8221; refer to both RITUXAN (the trade name for rituximab in the U.S., Canada and Japan) and MabThera (the trade name for rituximab outside the U.S., Canada and Japan), and &#8220;ANGIOMAX&#8221; refers to both ANGIOMAX (the trade name for bivalirudin in the U.S., Canada and Latin America) and ANGIOX (the trade name for bivalirudin in Europe).</font></div><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">NOTE&#160;REGARDING TRADEMARKS</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ALPROLIX</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">,</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt"> </sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">AVONEX</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, ELOCTATE</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, PLEGRIDY</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">,</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt"> </sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">RITUXAN</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, TECFIDERA</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and TYSABRI</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;are registered trademarks of Biogen. BENEPALI</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">TM</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, ELOCTA</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">TM</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, FUMADERM</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">TM</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and ZINBRYTA</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">TM</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;are trademarks of Biogen. The following are trademarks of the respective companies listed: ANGIOMAX</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and ANGIOX</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;&#8212;&#160;The Medicines Company; BETASERON</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;&#160;Bayer Pharma AG; EXTAVIA</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;&#8212;&#160;Novartis AG; FAMPYRA</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">TM</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;&#8212;&#160;Acorda Therapeutics, Inc.; GAZYVA</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;&#8212;&#160; Genentech, Inc.; and REBIF</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;&#8212;&#160;Ares Trading S.A.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3</font></div></div><hr style="page-break-after:always"><a name="s874B6CC8B0444DCF6D439B203D6D183D"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">PART&#160;I FINANCIAL INFORMATION</font></div><a name="sCDC07B25DC79E5142F9D9B203D90BB8E"></a><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><a name="sFEEB121F9D8AE3B7E5C09B1F3FA845A8"></a><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF INCOME</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">(unaudited, in thousands, except per share amounts)</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="45%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Product, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,198,566</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,056,292</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,370,888</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,799,057</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unconsolidated joint business</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">337,510</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">303,296</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">668,121</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">600,181</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">55,566</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">61,864</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">107,596</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">151,965</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total revenues</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,591,642</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,421,452</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5,146,605</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,551,203</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cost and expenses:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cost of sales, excluding amortization of acquired intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">286,120</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">291,887</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">598,551</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">571,132</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">490,728</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">447,273</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">951,277</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">976,157</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">491,895</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">576,622</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,052,256</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,088,296</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amortization of acquired intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">92,004</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">116,826</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">187,907</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">260,084</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(Gain) loss on fair value remeasurement of contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2,201</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,019</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5,643</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,220</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total cost and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,358,546</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,436,627</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,795,634</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,898,889</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gain on sale of rights</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,900</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7,759</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income from operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,233,096</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">988,725</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,350,971</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,660,073</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense), net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(10,889</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,861</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(25,875</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(740</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income before income tax expense and equity in loss of investee, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,222,207</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">993,586</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,325,096</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,659,333</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">292,501</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">268,521</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">574,382</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">446,935</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Equity in loss of investee, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,881</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,933</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5,715</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9,538</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">924,825</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">723,132</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,744,999</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,202,860</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net&#160;income (loss) attributable to noncontrolling interests, net&#160;of&#160;tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2,451</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8,626</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4,818</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8,398</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income attributable to Biogen Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">927,276</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">714,506</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,749,817</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,194,462</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income per share:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Basic earnings per share attributable to Biogen Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3.94</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.02</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.44</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.05</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Diluted earnings per share attributable to Biogen Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3.93</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.01</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.42</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.03</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted-average shares used in calculating:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Basic earnings per share attributable to Biogen Inc.</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235,286</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">236,661</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235,122</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">236,729</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Diluted earnings per share attributable to Biogen Inc.</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235,718</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">237,401</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235,671</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">237,634</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">See accompanying notes to these unaudited condensed consolidated financial statements.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4</font></div></div><hr style="page-break-after:always"><a name="s982C3AD7F95196087A399B1F3EB01E18"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">(unaudited, in thousands)</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="45%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income attributable to Biogen Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">927,276</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">714,506</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,749,817</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,194,462</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unrealized gains (losses) on securities available for sale, net of tax of $(145) and $(4,029) for the three months ended June 30, 2015 and 2014, respectively; and $621 and $(3,015) for the six months ended June 30, 2015 and 2014, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(214</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(6,865</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,085</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5,140</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unrealized gains (losses) on foreign currency forward contracts, net of tax of $(454) and $(260) for the three months ended June 30, 2015 and 2014, respectively; and $(42) and $5 for the six months ended June 30, 2015 and 2014, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(96,159</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10,760</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(8,913</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">16,551</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unrealized gains (losses) on pension benefit obligation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,851</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(170</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,109</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">646</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Currency translation adjustment</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">63,035</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(8,047</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(37,818</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(10,991</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total other comprehensive income (loss), net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(30,487</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(4,322</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(41,537</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,066</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Comprehensive income attributable to Biogen Inc.</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">896,789</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">710,184</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,708,280</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,195,528</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Comprehensive income (loss) attributable to noncontrolling interests, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2,266</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8,626</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4,533</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8,398</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Comprehensive income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">894,523</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">718,810</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,703,747</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,203,926</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">See accompanying notes to these unaudited condensed consolidated financial statements.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5</font></div></div><hr style="page-break-after:always"><a name="s35041FE8386EDDF34AFE9B1F3F480255"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">CONDENSED CONSOLIDATED BALANCE SHEETS</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">(unaudited, in thousands, except per share amounts)</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td width="68%"></td><td width="1%"></td><td width="14%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="13%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, <br>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, <br>2014</font></div></td></tr><tr><td colspan="8" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">ASSETS</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,282,078</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,204,924</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,086,595</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">640,460</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts receivable, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,310,821</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,292,445</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due from unconsolidated joint business, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">323,714</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">283,360</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">865,738</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">804,022</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">750,039</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">447,462</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5,618,985</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,672,673</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,101,796</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,470,652</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Property, plant and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,837,670</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,765,683</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Intangible assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,294,791</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,028,507</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,154,341</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,760,249</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Investments and other assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">751,588</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">618,795</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">16,759,171</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">14,316,559</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td colspan="8" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">LIABILITIES AND EQUITY</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current portion of notes payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,262</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,136</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Taxes payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">457,769</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">168,058</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">282,702</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">229,178</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,812,099</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,819,334</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,555,832</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,219,706</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Notes payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">576,207</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">582,061</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Long-term deferred tax liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">138,403</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">50,656</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other long-term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">915,731</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">650,096</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,186,173</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,502,519</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Commitments and contingencies</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Equity:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Biogen Inc. shareholders&#8217; equity</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Preferred stock, par value $0.001 per share</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Common stock, par value $0.0005 per share</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">129</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">129</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Additional paid-in capital</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,251,443</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,196,156</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accumulated other comprehensive loss</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(101,025</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(59,488</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Retained earnings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">11,033,736</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9,283,919</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Treasury stock, at cost</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2,611,706</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2,611,706</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total Biogen Inc. shareholders&#8217; equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">12,572,577</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10,809,010</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">421</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5,030</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total equity</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">12,572,998</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10,814,040</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total liabilities and equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">16,759,171</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">14,316,559</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:18px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:18px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:18px;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">See accompanying notes to these unaudited condensed consolidated financial statements.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6</font></div></div><hr style="page-break-after:always"><a name="s8907D203F214ECCAB6BB9B1F3F2886DD"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">(unaudited, in thousands)</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td width="73%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash flows from operating activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,744,999</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,202,860</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adjustments to reconcile net income to net cash flows from operating activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">292,523</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">355,102</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">93,677</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">83,856</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(90,647</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(146,506</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5,808</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(64,213</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Changes in operating assets and liabilities, net:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(38,907</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(188,961</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(81,294</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(72,689</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(169,929</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(30,299</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current taxes payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">102,017</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">31,113</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other changes in operating assets and liabilities, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(66,374</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(75,044</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net cash flows provided by operating activities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,780,257</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,095,219</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash flows from investing activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Proceeds from sales and maturities of marketable securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">975,517</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,317,525</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Purchases of marketable securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2,045,046</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1,787,606</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquisitions of business, net of cash acquired</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(198,798</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Purchases of property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(227,688</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(118,308</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration related to Fumapharm AG acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(250,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(25,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(10,119</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(10,745</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net cash flows used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1,756,134</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(624,134</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash flows from financing activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Purchase of treasury stock</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(42,193</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(336,905</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Proceeds from issuance of stock for share-based compensation arrangements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">34,727</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">33,477</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Excess tax benefit from stock options</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">69,690</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">83,940</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">14,995</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">12,003</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net cash flows provided by (used in) financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">77,219</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(207,485</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net increase in cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">101,342</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">263,600</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Effect of exchange rate changes on cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(24,188</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2,965</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash and cash equivalents, beginning of the period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,204,924</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">602,562</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash and cash equivalents, end of the period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,282,078</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">863,197</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">See accompanying notes to these unaudited condensed consolidated financial statements.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7</font></div></div><hr style="page-break-after:always"><a name="s5F35084703B8B1A86F129B203EBD2982"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited)</font></div></div><br><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><a name="s5FA0781F10053CE640D19B1F3EB958CD"></a><div style="line-height:120%;padding-top:12px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">1.&#160;&#160;&#160;&#160;Summary of Significant Accounting Policies</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Business Overview</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Biogen is a global biopharmaceutical company focused on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. Our principal marketed products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI, and FAMPYRA for multiple sclerosis (MS), ALPROLIX for hemophilia B and ELOCTATE for hemophilia A. We also collaborate with Genentech, Inc., a wholly-owned member of the Roche Group, on the development and commercialization of RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and other conditions and share profits and losses for GAZYVA, which is approved for the treatment of chronic lymphocytic leukemia.  </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of our financial statements for interim periods in accordance with accounting principles generally accepted in the United States (U.S.&#160;GAAP). The information included in this quarterly report on Form&#160;10-Q should be read in conjunction with our consolidated financial statements and the accompanying notes included in our Annual Report on Form&#160;10-K for the year ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;(</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form&#160;10-K). Our accounting policies are described in the &#8220;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Notes to Consolidated Financial Statements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8221; in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form&#160;10-K and updated, as necessary, in this Form&#160;10-Q. The year-end condensed consolidated balance sheet data presented for comparative purposes was derived from our audited financial statements, but does not include all disclosures required by U.S.&#160;GAAP. The results of operations for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, are not necessarily indicative of the operating results for the full year or for any other subsequent interim period. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Consolidation</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our condensed consolidated financial statements reflect our financial statements, those of our wholly-owned subsidiaries and those of certain variable interest entities where we are the primary beneficiary. For consolidated entities where we own or are exposed to less than </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">100%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;of the economics, we record net income (loss) attributable to noncontrolling interests in our condensed consolidated statements of income equal to the percentage of the economic or ownership interest retained in such entities by the respective noncontrolling parties. Intercompany balances and transactions are eliminated in consolidation. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In determining whether we are the primary beneficiary of an entity and therefore required to consolidate, we apply a qualitative approach that determines whether we have both (1) the power to direct the economically significant activities of the entity and (2) the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to that entity. These considerations impact the way we account for our existing collaborative relationships and other arrangements. We continuously assess whether we are the primary beneficiary of a variable interest entity as changes to existing relationships or future transactions may result in us consolidating or deconsolidating one or more of our collaborators or partners.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We operate as </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">one</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;operating segment, which is focused on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The preparation of our condensed consolidated financial statements requires us to make estimates, judgments, and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and judgments and methodologies. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited)</font></div></div><br><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Accounts Receivable</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our accounts receivable primarily arise from product sales in the U.S.&#160;and Europe and mainly represent amounts due from our wholesale distributors, public hospitals and other government entities. Concentrations of credit risk with respect to our accounts receivable, which are typically unsecured, are limited due to the wide variety of customers and markets using our products, as well as their dispersion across many different geographic areas. The majority of our accounts receivable require payment within </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">30 to 90 days</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. We monitor the financial performance and credit worthiness of our customers so that we can properly assess and respond to changes in their credit profile. We provide reserves against trade receivables for estimated losses that may result from a customer&#8217;s inability to pay. Amounts determined to be uncollectible are charged or written-off against the reserve. To date, our historical reserves and write-offs of accounts receivable have not been significant.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In countries where we have experienced a pattern of payments extending beyond our contractual payment term and we expect to collect receivables greater than one year after the time of sale, we have discounted our receivables and reduced related revenues over the period of time that we estimate those amounts will be paid using the country&#8217;s market-based borrowing rate for such period. The related receivables are classified at the time of sale as non-current assets. We accrete interest income on these receivables, which is recognized as a component of other income (expense), net within our condensed consolidated statement of income.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Property, Plant and Equipment</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Property, plant and equipment are recorded at cost, net of accumulated depreciation. Accumulated depreciation on property, plant and equipment was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1,274.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1,186.4 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">New Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard setting bodies that we adopt as of the specified effective date. Unless otherwise discussed, we do not believe that the impact of recently issued standards that are not yet effective will have a material impact on our financial position or results of operations upon adoption.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes all existing revenue recognition requirements, including most industry-specific guidance. The new standard requires a company to recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. In July 2015, the FASB decided to delay the effective date of the new revenue standard by one year. The new standard will be effective for us on January 1, 2018. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. We are currently evaluating the method of adoption and the potential impact that Topic 606 may have on our financial position and results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In June 2014, the FASB issued ASU No. 2014-11, Transfers and Servicing (Topic 860): Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosure. The new standard expanded secured borrowing accounting to include repurchase-to-maturity transactions and repurchase financings and set forth new disclosure requirements for repurchase agreements, securities lending transactions, and repurchase-to-maturity transactions that are accounted for as secured borrowings. We adopted this standard on April 1, 2015 and expanded our disclosures presented within Note 7, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Financial Instruments</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to these condensed consolidated financial statements. The adoption of this standard did not have an impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In April 2015, the FASB issued ASU No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The new standard requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The new standard will be effective for us on January 1, 2016. The adoption of this standard is not expected to have an impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In April 2015, the FASB issued ASU No. 2015-05, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Fees Paid in a Cloud Computing Arrangement. Under this standard, if a cloud computing arrangement includes a software license, the software license element of the arrangement should be accounted for consistent with the acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the arrangement should be accounted for as a service contract. The new standard </font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited)</font></div></div><br><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">will be effective for us on January 1, 2016. The adoption of this standard is not expected to have an impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2015, the FASB issued ASU No. 2015-07, Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent). The new standard removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient. The new standard will be effective for us on January 1, 2016. Early application is permitted. We maintain investments in certain venture capital funds which primarily invest in small, privately-owned, venture-backed biotechnology companies. The value of our investments in these venture capital funds is estimated using the net asset value of the fund and has been included in the fair value hierarchy disclosure as a Level 3 measurement. These venture capital investments are not material to our financial position or results of operations. We have elected to apply this standard as of June 30, 2015 and our investments in venture capital funds will no longer be included in our disclosures reflected within Note 6, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Fair Value Measurements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to these condensed consolidated financial statements.</font></div><a name="s948E812DF684E7C7AF709B1F3ED3DEB3"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">2.&#160;&#160;&#160;&#160;Acquisitions</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Convergence Pharmaceuticals</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On February 12, 2015, we completed our acquisition of all of the outstanding stock of Convergence Pharmaceuticals (Convergence), a clinical-stage biopharmaceutical company with a focus on developing product candidates for neuropathic pain. Convergence&#8217;s lead candidate is its Phase 2 clinical candidate (CNV1014802), which has demonstrated clinical activity in proof-of-concept studies for trigeminal neuralgia (TGN), a chronic orphan disease. Additionally, CNV1014802 has potential applicability in several other neuropathic pain states. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The purchase price consisted of a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$200.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;cash payment at closing, plus contingent consideration in the form of development and approval milestones up to a maximum of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$450.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, of which </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$350.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;is associated with the development and approval of CNV1014802 for the treatment of TGN. The acquisition was funded from our existing cash on hand and has been accounted for as the acquisition of a business. In addition to obtaining the rights to CNV1014802 and additional product candidates in preclinical development, we retained the services of key employees of Convergence.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In connection with our acquisition of Convergence, we recorded a liability of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$274.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;representing the fair value of the contingent consideration.&#160;This amount was estimated through a valuation model that incorporates industry-based probability adjusted assumptions relating to the achievement of these milestones and thus the likelihood of making the contingent payments. This fair value measurement is based upon significant inputs not observable in the market and therefore represents a Level 3 measurement. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The purchase price, as adjusted, consisted of the following:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td width="87%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash portion of consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">200.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">274.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase price</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">474.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Subsequent changes in the fair value of the contingent consideration obligation will be recognized as adjustments to contingent consideration and reflected within our condensed consolidated statements of income. For additional information related to the fair value of this obligation, please read Note 6,&#160;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Fair Value Measurements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;to these condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We adjusted our preliminary estimate of the fair value of the separately identifiable assets acquired and contingent consideration as of the date of acquisition to reflect revised estimates to our initial clinical development plans, resulting probabilities of success and the timing of certain milestone payments. The primary effects of these revised estimates resulted in an increase in the value of our estimated contingent consideration and goodwill by </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$36.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, as compared with March 31, 2015. Our revised purchase price allocation is reflected in the chart below. Our purchase price allocation is substantially complete.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the estimated fair values of the separately identifiable assets acquired and liabilities assumed as of February&#160;12, 2015, as adjusted:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td width="87%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In-process research and development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">424.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">128.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(84.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase price</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">474.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our estimate of the fair value of the IPR&amp;D programs acquired was determined through a probability adjusted cash flow analysis based on probability weighted net cash flows utilizing a discount rate of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">11%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. This valuation was primarily driven by the value associated with the lead candidate, CNV1014802, which is in development for the treatment of TGN and is expected to be completed no earlier than 2020, at a remaining cost of approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$145.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. The fair value associated with CNV1014802 for the treatment of TGN was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$200.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. We have recorded additional IPR&amp;D assets related to the use of CNV1014802 in two additional neuropathic pain indications, with a total estimated value of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$220.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. The remaining cost of development for these two indications is approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$415.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, with an expected completion date of no earlier than 2021. These fair value measurements were based on significant inputs not observable in the market and thus represent Level 3 fair value measurements.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have attributed the goodwill recognized to the Convergence workforce's expertise in chronic pain research and clinical development and to establishing a deferred tax liability for the acquired IPR&amp;D intangible assets which has no tax basis. The goodwill is not tax deductible.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Pro forma results of operations would not be materially different as a result of the acquisition of Convergence and therefore are not presented. Subsequent to the acquisition date, our results of operations include the results of operations of Convergence.</font></div><a name="sF7F8D43C3224AF2202699B1F3F109A39"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">3.&#160;&#160;&#160;&#160;Reserves for Discounts and Allowances</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">An analysis of the change in reserves for discounts and allowances is summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="45%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Discounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Contractual</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Returns</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">47.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">387.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">49.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">483.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current provisions relating to sales in current year</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">209.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">854.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">19.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,082.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adjustments relating to prior years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(19.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(8.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(27.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments/credits relating to sales in current year</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(158.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(483.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(642.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments/credits relating to sales in prior years</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(43.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(254.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(7.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(305.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">55.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">483.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">51.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">590.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The total reserves above, included in our condensed consolidated balance sheets, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td width="73%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br>June 30, <br>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br>December 31, <br>2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Reduction of accounts receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">143.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">124.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Component of accrued expenses and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">446.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">359.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total reserves</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">590.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">483.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">11</font></div></div><hr style="page-break-after:always"><a name="sD44BCA8286C8FC5A41439B1F3EA436A3"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">4.&#160;&#160;&#160;&#160;Inventory</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The components of inventory are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td width="73%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br>June 30, <br>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br>December 31, <br>2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">173.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">128.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">516.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">511.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">175.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">164.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total inventory</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">865.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">804.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, our inventory included </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$35.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;associated with our ZINBRYTA and biosimilar programs, which have been capitalized in advance of regulatory approval. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, our inventory included </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$6.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;associated with our ZINBRYTA program, which had been capitalized in advance of regulatory approval.</font></div><a name="s8F99803D8EDD7815865F9B1F3EB71C97"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">5.&#160;&#160;&#160;&#160;Intangible Assets and Goodwill</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Intangible Assets</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Intangible assets, net of accumulated amortization, impairment charges and adjustments, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26"></td></tr><tr><td width="21%"></td><td width="17%"></td><td width="1%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="8%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="8%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Life</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Out-licensed patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">13-23 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">543.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(493.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">49.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">543.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(481.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">61.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Developed&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">15-23&#160;years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,005.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2,492.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">513.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,005.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2,396.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">608.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In-process research and development</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Indefinite until commercialization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">752.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">752.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">314.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">314.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Trademarks&#160;and&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">tradenames</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Indefinite</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">64.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">64.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">64.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">64.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired and in-licensed&#160;rights&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">and&#160;patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3-17 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,296.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(380.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,916.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,280.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(300.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,980.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7,661.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(3,366.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,294.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7,207.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3,178.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,028.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, amortization of acquired intangible assets totaled </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$92.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$187.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, as compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$116.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$260.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in the prior year comparative periods. For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in amortization of acquired intangible assets was primarily driven by a decrease in AVONEX and TYSABRI revenues during the comparative periods and higher expected lifetime revenues of TYSABRI as discussed below. Amortization of acquired intangible assets during the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;also includes a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$34.7 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;impairment charge related to one of our out-licensed patents. </font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Developed Technology</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Developed technology primarily relates to our AVONEX product, which was recorded in connection with the merger of Biogen, Inc. and IDEC Pharmaceuticals Corporation in 2003. The net book value of this asset as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$504.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. </font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">12</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">In-process Research and Development (IPR&amp;D)</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">IPR&amp;D represents the fair value assigned to research and development assets that we acquire that have not reached technological feasibility at the date of acquisition. Upon commercialization, we will determine the estimated useful life. In connection with our acquisition of Convergence in February 2015, we acquired IPR&amp;D programs with an estimated fair value of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$424.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. This amount will be adjusted for foreign exchange rate fluctuations. For a more detailed description of this transaction, please read Note 2, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Acquisitions</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to these condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Acquired and In-licensed Rights and Patents</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired and in-licensed rights and patents primarily relate to our acquisition of the TYSABRI rights from Elan Corporation plc (Elan). Elan was acquired by Perrigo Company plc (Perrigo) in December 2013. The net book value of this asset as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$2,851.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Estimated Future Amortization of Intangible Assets </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our amortization expense is based on the economic consumption of intangible assets. Our most significant intangible assets are related to our AVONEX and TYSABRI products. Annually, during our long-range planning cycle, we perform an analysis of anticipated lifetime revenues of AVONEX and TYSABRI. This analysis is also updated whenever events or changes in circumstances would significantly affect the anticipated lifetime revenues of either product.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our most recent long range planning cycle was updated in the third quarter of 2014. Our analysis included an increase in the expected future product revenues of TYSABRI, resulting in a decrease in the rate of amortization expense as compared to prior quarters. Our analysis also included a decrease in the expected future product revenues of AVONEX. The results of our TYSABRI and AVONEX analyses were impacted by changes in the estimated impact of TECFIDERA, as well as other existing and potential oral and alternative MS formulations, including PLEGRIDY, that may compete with TYSABRI and AVONEX. Based upon this recent analysis, the estimated future amortization for acquired intangible assets is expected to be as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td width="87%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br>June 30, <br>2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015 (remaining six months)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">185.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">312.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">285.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">281.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">270.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">263.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,599.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">13</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table provides a roll forward of the changes in our goodwill balance:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td width="87%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,760.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increase to goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">390.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,154.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The increase in goodwill during the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;was related to a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$300.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;contingent payment achieved (exclusive of a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$38.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;tax benefit) and to be paid to former shareholders of Fumapharm AG or holders of their rights and our acquisition of Convergence. Other includes changes related to foreign exchange. For additional information related to future contingent payments to the former shareholders of Fumapharm AG or holders of their rights, please read Note 18, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Commitments and Contingencies</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to these condensed consolidated financial statements. For additional information related to our acquisition of Convergence, please read Note 2, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Acquisitions</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to these condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we had </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">no</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;accumulated impairment losses related to goodwill.</font></div><a name="s2A5B37F1E6B5C156FE789B1F3EF17EB7"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">6.&#160;&#160;&#160;&#160;Fair Value Measurements</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The tables below present information about our assets and liabilities that are regularly measured and carried at fair value and indicate the level within the fair value hierarchy of the valuation techniques we utilized to determine such fair value:</font></div><div style="line-height:120%;padding-top:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="41%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of June 30, 2015 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Quoted&#160;Prices</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">in Active</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant&#160;Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Observable&#160;Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">974.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">974.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable debt securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,198.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,198.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,700.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,700.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">290.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">290.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">100.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">100.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Plan assets for deferred compensation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,310.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,303.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">27.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">27.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">523.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">27.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">14</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="41%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2014 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Quoted&#160;Prices</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">in Active</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">716.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">716.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable debt securities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,063.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,063.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">849.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">849.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">198.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">198.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">72.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">72.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Plan assets for deferred compensation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,943.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,937.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">215.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">215.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">220.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">215.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">There have been </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">no</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;material impairments of our assets measured and carried at fair value during the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. In addition, there were </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">no</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;changes in valuation techniques or inputs utilized or transfers between fair value measurement levels during the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. The fair value of Level 2 instruments classified as cash equivalents and marketable debt securities was determined through third party pricing services. For a description of our validation procedures related to prices provided by third party pricing services, refer to Note 1, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Summary of Significant Accounting Policies: Fair Value Measurements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form 10-K. For additional information related to our decision to no longer reflect our investments in venture capital funds within the fair value hierarchy, refer to Note 1, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Summary of Significant Accounting Policies: New Accounting Pronouncements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, to these condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Debt Instruments</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The fair and carrying values of our debt instruments, which are Level&#160;2 liabilities, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="45%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Notes payable to Fumedica</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">10.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">9.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">11.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.875% Senior Notes due March&#160;1, 2018</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">621.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">570.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">634.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">573.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">631.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">579.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">647.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">585.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The fair value of our notes payable to Fumedica was estimated using market observable inputs, including current interest and foreign currency exchange rates. The fair value of our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.875%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Senior Notes was determined through market, observable, and corroborated sources. For additional information related to our debt instruments, please read Note 12, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Indebtedness</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form 10-K.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">15</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Contingent Consideration Obligations</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table provides a roll forward of the fair values of our contingent consideration obligations which includes Level 3 measurements:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="45%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value, beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">461.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">275.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">215.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">280.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Additions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">36.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">274.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Changes in fair value</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">279.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">279.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$302.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$200.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, of the fair value of our total contingent consideration obligations were reflected as components of other long-term liabilities within our condensed consolidated balance sheets with the remaining balances reflected as a component of accrued expenses and other. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In connection with our acquisition of Convergence, we recorded a liability of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$274.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, representing the fair value of the contingent consideration. This valuation was based on probability weighted net cash outflow projections of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$450.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, discounted using a rate of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, which is the estimated cost of debt financing for market participants. This liability reflects the revised estimate from the date of acquisition for our initial clinical development plans, resulting probabilities of success and the timing of certain milestone payments. For a more detailed description of this transaction, please read Note 2, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Acquisitions</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to these condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Acquired IPR&amp;D</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In connection with our acquisition of Convergence, we also allocated </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$424.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;of the total purchase price to acquired IPR&amp;D, which was capitalized as an intangible asset. The amount allocated to acquired IPR&amp;D was based on significant inputs not observable in the market and thus represented a Level 3 fair value measurement. This estimate was also adjusted from our preliminary estimate as of the date of acquisition to reflect revised estimates to our initial clinical development plans, resulting probabilities of success and the timing of certain milestone payments. These assets will be tested for impairment annually until commercialization, after which time the IPR&amp;D will be amortized over its estimated useful life. For a more detailed description of this transaction, please read Note 2, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Acquisitions</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to these condensed consolidated financial statements.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">16</font></div></div><hr style="page-break-after:always"><a name="s610CA0EF2883FC25818E9B1F3F137178"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">7.&#160;&#160;&#160;&#160;Financial Instruments</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Marketable Securities</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following tables summarize our marketable debt and equity securities:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="41%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of June 30, 2015 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Available-for-sale:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">375.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">375.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">822.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">823.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">710.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">710.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">989.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">989.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">289.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">289.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total marketable debt securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,188.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,188.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities, non-current</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="41%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2014 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Available-for-sale:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">370.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">370.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">692.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">693.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">269.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">270.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">579.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">580.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">198.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">198.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total marketable debt securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,111.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,112.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities, non-current</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes our financial assets with maturities of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">less than 90&#160;days</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;from the date of purchase included within cash and cash equivalents on the accompanying condensed consolidated balance sheet:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td width="73%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br>June 30, <br>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br>December 31, <br>2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Commercial paper</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">38.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">54.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Overnight reverse repurchase agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">185.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">305.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Money market funds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">740.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">321.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Short-term debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">10.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">974.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">716.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The carrying values of our commercial paper, including accrued interest, overnight reverse repurchase agreements, money market funds and our short-term debt securities approximate fair value due to their short term maturities. Our overnight reverse repurchase agreements are collateralized with agency-guaranteed mortgage securities and represent approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.1%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;of total assets as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">17</font></div></div><hr style="page-break-after:always"><a name="s610CA0EF2883FC25818E9B1F3F137178"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Summary of Contractual Maturities: Available-for-Sale Securities</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The estimated fair value and amortized cost of our marketable debt securities available-for-sale by contractual maturity are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="45%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due in one year or less</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,086.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,086.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">640.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">640.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due after one year through five years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,954.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,954.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,343.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,345.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due after five years</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">147.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">147.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">126.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">126.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,188.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,188.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,111.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,112.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The average maturity of our marketable debt securities available-for-sale as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;was approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">17 months</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">15 months</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Proceeds from Marketable Debt Securities</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The proceeds from maturities and sales of marketable debt securities and resulting realized gains and losses are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="45%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Proceeds from maturities and sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">601.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">560.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">975.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,317.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Realized gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Realized losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Strategic Investments</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, our strategic investment portfolio was comprised of investments totaling </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$45.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$47.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, which are included in investments and other assets in our accompanying condensed consolidated balance sheets. Our strategic investment portfolio includes investments in equity securities of certain biotechnology companies and investments in venture capital funds where the underlying investments are in equity securities of biotechnology companies. </font></div><a name="s7DD5BEFF4020EDAA1F6F9B1F3EBE7719"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">8.&#160;&#160;&#160;&#160;Derivative Instruments</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Foreign Currency Forward Contracts - Hedging Instruments</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due to the global nature of our operations, portions of our revenues are earned in currencies other than the U.S.&#160;dollar. The value of revenues measured in U.S.&#160;dollars is therefore subject to changes in foreign currency exchange rates. In order to mitigate these changes we use foreign currency forward contracts to lock in exchange rates associated with a portion of our forecasted international revenues.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Foreign currency forward contracts in effect as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;had durations of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">18 months</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">15 months</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. These contracts have been designated as cash flow hedges and accordingly, to the extent effective, any unrealized gains or losses on these foreign currency forward contracts are reported in accumulated other comprehensive income (loss) (referred to as AOCI in the tables below). Realized gains and losses for the effective portion of such contracts are recognized in revenue when the sale of product in the currency being hedged is recognized. To the extent ineffective, hedge transaction gains and losses are reported in other income (expense), net.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">18</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The notional value of foreign currency forward contracts that were entered into to hedge forecasted revenues is summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td width="69%"></td><td width="1%"></td><td width="13%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="13%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Notional Amount</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Foreign Currency: (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br>June 30, <br>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br>December 31, <br>2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Euro</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,437.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,174.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Canadian dollar</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">32.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">56.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">British pound sterling</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">21.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">34.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Japanese yen</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">15.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">16.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Australian dollar</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">10.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">19.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,517.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,302.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The portion of the fair value of these foreign currency forward contracts that was included in accumulated other comprehensive income (loss) within total equity reflected gains of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$63.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$72.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. We expect all contracts to be settled over the next </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">18</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months and any amounts in accumulated other comprehensive income (loss) to be reported as an adjustment to revenue. We consider the impact of our and our counterparties&#8217; credit risk on the fair value of the contracts as well as the ability of each party to execute its contractual obligations. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, credit risk did not change the fair value of our foreign currency forward contracts.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the effect of derivatives designated as hedging instruments on our condensed consolidated statements of income:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19"></td></tr><tr><td width="20%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="19%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td></tr><tr><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months Ended June 30,</font></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Reclassified from AOCI into Operating Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Recognized into Net Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Ineffective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="19"></td></tr><tr><td width="20%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="19%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td></tr><tr><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months Ended June 30,</font></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Reclassified from AOCI into Operating Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Recognized into Net Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Ineffective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">75.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(10.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Foreign Currency Forward Contracts - Other Derivatives</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We also enter into other foreign currency forward contracts, usually with one month durations, to mitigate the foreign currency risk related to certain balance sheet positions. We have not elected hedge accounting for these transactions.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The aggregate notional amount of these outstanding foreign currency contracts was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$472.4 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$365.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. Net gains of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$13.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$3.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;related to these contracts were recognized as a component of other income (expense), net, for </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, as compared to net losses of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$2.4 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$3.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in the prior year comparative periods.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">19</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Summary of Derivatives</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">While certain of our derivatives are subject to netting arrangements with our counterparties, we do not offset derivative assets and liabilities within our condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the fair value and presentation in our condensed consolidated balance sheets of our outstanding derivatives including those designated as hedging instruments:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="43%"></td><td width="42%"></td><td width="1%"></td><td width="13%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Balance Sheet Location</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">Fair Value As of June 30, 2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Hedging Instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">92.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">17.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Other Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Balance Sheet Location</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair Value As of December 31, 2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Hedging Instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">69.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Investments and other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Other Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><a name="s7D4B94C787F08050DA969B1F3EE868FD"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">9.&#160;&#160;&#160;&#160;Equity</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total equity as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;increased </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1,759.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. This increase was driven by net income attributable to Biogen Inc. and an increase in additional paid in capital resulting from our share-based compensation arrangements, partially offset by other comprehensive losses and a reduction in additional paid-in-capital resulting from the repurchase and retirement of common stock as described below. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Share Repurchases</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2015, our Board of Directors authorized a program to repurchase up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$5.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;of our common stock (2015 Share Repurchase Program). This authorization does not have an expiration date. We expect that purchases will be executed within a period of up to five years and that repurchased shares will be retired. The 2015 Share Repurchase Program is in addition to the approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;shares remaining under our February 2011 Share Repurchase Program (2011 Share Repurchase Program), which has been used principally to offset common stock issuances under our share-based compensation plans.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we repurchased and retired approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;shares of common stock at a cost of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$42.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;under our 2015 Share Repurchase Program and did not repurchase any shares of common stock under our 2011 Share Repurchase Program. During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we purchased approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;shares of common stock at a cost of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$336.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;under our 2011 Share Repurchase Program. </font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">20</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Noncontrolling Interests</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table reconciles equity attributable to noncontrolling interests (NCI):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="45%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">NCI, beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) attributable to NCI, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of net assets and liabilities acquired and assigned to NCI</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Distribution to NCI</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(9.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(9.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Translation adjustment and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">NCI, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><a name="sF7E5B3869F19F2B56A4A9B1F3EDD7DFA"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">10.&#160;&#160;&#160;&#160;Accumulated Other Comprehensive Income (Loss)</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the changes in accumulated other comprehensive income (loss), net of tax by component:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td width="31%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Securities Available for Sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Foreign Currency Forward Contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unfunded Status of Postretirement Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Translation Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">71.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(31.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(99.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(59.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">66.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(37.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">33.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(75.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(74.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net current period other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(8.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(37.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(41.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">62.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(27.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(137.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(101.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td width="31%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Securities Available for Sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Foreign Currency Forward Contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unfunded Status of Postretirement Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Translation Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(23.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(19.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(27.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(11.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(6.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net current period other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">16.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(11.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(7.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(19.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(26.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">21</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the amounts reclassified from accumulated other comprehensive income:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td width="24%"></td><td width="21%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Income Statement Location</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amounts Reclassified from Accumulated Other Comprehensive Income</font></div></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gains (losses) on securities available for sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax benefit (expense)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gains (losses) on foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenues</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">75.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(10.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax benefit (expense)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total reclassifications, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">74.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div><a name="s733352DF53DD766FA1519B1F3ECED94F"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">11.&#160;&#160;&#160;&#160;Earnings&#160;per Share</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Basic and diluted earnings per share are calculated as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="45%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income attributable to Biogen Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">927.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">714.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,749.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,194.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted average number of common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">236.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">236.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Effect of dilutive securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Stock options and employee stock purchase plan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Time-vested restricted stock units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market stock units</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Dilutive potential common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Shares used in calculating diluted earnings per share</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">237.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">237.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts excluded from the calculation of net income per diluted share because their effects were anti-dilutive were not significant.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">22</font></div></div><hr style="page-break-after:always"><a name="s7EDFDC95DE5694F967679B1F3ED8D77A"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">12. &#160;&#160;&#160;&#160;Share-based Payments</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Share-based Compensation Expense</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes share-based compensation expense included within our condensed consolidated statements of income:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="45%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">22.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">57.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">53.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">26.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">33.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">81.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">80.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Subtotal</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">48.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">58.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">139.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">134.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Capitalized share-based compensation costs </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation expense included in total cost and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">46.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">55.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">133.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">129.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax effect</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(12.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(16.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(39.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(38.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation expense included in net income attributable to Biogen Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">33.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">39.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">94.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">90.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="45%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">9.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">26.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">23.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Time-vested restricted stock units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">31.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">29.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">63.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">58.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash settled performance units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">14.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">27.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Performance units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">14.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee stock purchase plan</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">8.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Subtotal</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">48.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">58.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">139.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">134.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Capitalized share-based compensation costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation expense included in total cost and expenses</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">46.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">55.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">133.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">129.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Grants Under Share-based Compensation Plans</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes our equity grants to employees, officers and directors under our current stock plans:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td width="73%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market stock units</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">179,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">222,000</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash settled performance shares</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">115,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">180,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Performance units</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">89,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">50,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Time-vested restricted stock units</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">375,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">418,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Employee Stock Purchase Plan (ESPP)</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In June 2015, our stockholders approved the Biogen Inc. 2015 Employee Stock Purchase Plan (ESPP). The ESPP, which became effective on July 1, 2015, replaced the Biogen Idec Inc. 1995 ESPP (1995 ESPP), which expired on June&#160;30, 2015. The maximum aggregate number of shares of our common stock that may be purchased under the ESPP is </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6,200,000</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">98,000</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;shares were issued under our 1995 ESPP compared to approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">112,000</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;shares issued in the prior year comparative period.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">23</font></div></div><hr style="page-break-after:always"><a name="s65DAA035B08AD44A27F89B1F3EC15C50"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">13.&#160;&#160;&#160;&#160;Income Taxes</font></div><div style="line-height:120%;padding-top:6px;text-indent:24px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, our effective tax rate was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">23.9%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24.7%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, as compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">27.0%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">26.9%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in the prior year comparative periods.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">A reconciliation between the U.S.&#160;federal statutory tax rate and our effective tax rate is summarized as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td width="45%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Statutory rate</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State taxes</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Taxes on foreign earnings</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(11.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(8.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(9.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(8.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Credits and net operating loss utilization</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Purchased intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Manufacturing deduction</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other permanent items</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Effective tax rate</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">23.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">27.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">24.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">26.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in our effective income tax rate is due to lower anticipated taxes on foreign earnings.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in our income tax rate was due to a benefit resulting from the remeasurement of one of our uncertain tax positions, described below, and lower anticipated taxes on foreign earnings.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Accounting for Uncertainty in Income Taxes</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We and our subsidiaries are routinely examined by various taxing authorities. We file income tax returns in the U.S.&#160;federal jurisdiction, various U.S. states, and foreign jurisdictions. With few exceptions, including the proposed disallowance we discuss below, we are no longer subject to U.S.&#160;federal tax examination for years before 2013 or state, local, or non-U.S.&#160;income tax examinations for years before 2004. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In March 2015, we received a final assessment from the Danish Tax Authority (SKAT) for fiscal 2009, regarding withholding taxes and the treatment of certain intercompany transactions involving our Danish affiliate and another of our affiliates.&#160;The audits of our tax filings for 2010 through 2013 are not completed but have been prepared in a manner consistent with prior filings, with similar transactions, which may result in an assessment for those years.&#160;The total amount assessed for 2009 is </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$48.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, including interest.&#160;For all periods potentially under dispute, we believe that positions taken in our tax filings are valid and we are contesting the assessment vigorously.  </font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Federal Uncertain Tax Positions</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the net effect of adjustments to our uncertain tax positions was a net benefit of approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$24.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;primarily related to the state impact of a federal uncertain tax item. It is reasonably possible that we will adjust the value of our uncertain tax positions related to our unconsolidated joint business and certain transfer pricing issues as we receive additional information from various taxing authorities, including reaching settlements with the authorities. In addition, the Internal Revenue Service (IRS) and other national tax authorities routinely examine our intercompany transfer pricing with respect to intellectual property related transactions and it is possible that they may disagree with one or more positions we have taken with respect to such valuations.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In October 2011, in conjunction with our examination, the IRS proposed a disallowance of approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$130.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;in deductions for tax years 2007, 2008 and 2009 related to payments for services provided by our wholly owned Danish subsidiary located in Hiller&#248;d, Denmark. We believe that these items represent valid deductible business expenses and are vigorously defending our position. We have initiated a mutual agreement procedure between the IRS and SKAT for the years 2001 through 2009, in an attempt to reach agreement on the issue. In addition, we have applied for a bilateral advanced pricing agreement for the years 2010 through 2014 to resolve similar issues for the subsequent years.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24</font></div></div><hr style="page-break-after:always"><a name="sC21A88ED9064F56831309B1F3F5C1495"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">14.&#160;&#160;&#160;&#160;Other Consolidated Financial Statement Detail</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Other Income (Expense), Net</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Components of other income (expense), net, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="45%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(7.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(12.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(14.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gain (loss) on investments, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">13.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">16.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Foreign exchange gains (losses), net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(14.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(4.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(8.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total other income (expense), net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(10.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(25.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Other Current Assets</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets includes prepaid taxes totaling approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$280.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$57.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Accrued Expenses and Other</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other consists of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td width="73%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br>June 30, <br>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br>December 31, <br>2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current portion of contingent consideration obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">493.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">265.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue-related rebates</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">446.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">359.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee compensation and benefits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">214.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">393.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Royalties and licensing fees</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">161.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">172.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">62.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">120.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">433.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">507.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total accrued expenses and other</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,812.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,819.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Other Long-Term Liabilities</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other long-term liabilities consist of the following:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td width="73%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br>June 30, <br>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br>December 31, <br>2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">302.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">200.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee compensation and benefits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">224.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">200.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">389.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">249.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total other long-term liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">915.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">650.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Pricing of TYSABRI in Italy - AIFA</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the fourth quarter of 2011, Biogen Italia SRL (formerly Biogen Idec Italia SRL), our Italian subsidiary,&#160;received notice from the Italian National Medicines Agency (Agenzia Italiana del Farmaco or AIFA) that sales of TYSABRI after mid-February 2009 exceeded a reimbursement limit established pursuant to a Price Determination Resolution granted by AIFA in December 2006. In December 2011, we filed an appeal against AIFA in administrative court in Rome, Italy seeking a ruling that the reimbursement limit is unenforceable. That appeal is pending. </font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">25</font></div></div><hr style="page-break-after:always"><a name="sC21A88ED9064F56831309B1F3F5C1495"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In June 2014, AIFA approved a resolution, effective for a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;month term, setting the price for TYSABRI in Italy.&#160;This resolution also eliminated the reimbursement limit from February 2013 going forward. As a result, in June 2014, we recognized </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$53.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;of TYSABRI revenues related to the periods beginning February 2013 that were previously deferred. In October 2014, we proposed a settlement to resolve all of AIFA's claims relating to sales of TYSABRI in excess of the reimbursement limit for the period from mid-February 2009 through January 2013 for an aggregate lump sum repayment of EUR</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. The settlement agreement was sent to the Avvocatura Generale dello Stata (Attorney General) for its opinion. In June 2015, the Attorney General chose not to approve the settlement. AIFA and Biogen Italia SRL continue to discuss a possible resolution for this period. We have approximately EUR</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">75 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;recorded as accrued expenses and deferred revenue included within our long-term liabilities within our condensed consolidated balance sheets for this matter.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For additional information relating to our agreement with AIFA relating to sales of TYSABRI in Italy, please read Note 4, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Accounts Receivable</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form 10-K.</font></div><a name="s859D5014A0C9E2D86EF49B1F3F0A65B6"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">15.&#160;&#160;&#160;&#160;Investments in Variable Interest Entities</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Consolidated Variable Interest Entities</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our condensed consolidated financial statements include the financial results of variable interest entities in which we are the primary beneficiary.</font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Neurimmune SubOne AG</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In 2007, we entered into a collaboration agreement with Neurimmune SubOne AG (Neurimmune), a subsidiary of Neurimmune AG, for the development and commercialization of antibodies for the treatment of Alzheimer&#8217;s disease. Neurimmune conducts research to identify potential therapeutic antibodies and we are responsible for the development, manufacturing and commercialization of all products. Our anti-amyloid beta antibody, aducanumab (BIIB037), for the treatment of Alzheimer&#8217;s disease resulted from this collaboration. In December 2014, we reported positive interim data from the Phase 1b trial of aducanumab. Based upon our current development plans, we may pay Neurimmune up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$335.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;in remaining milestone payments, of which </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$60.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;is payable upon dosing of the first patient in a Phase 3 trial for aducanumab. We may also pay royalties in the low-to-mid-teens on sales of any resulting commercial products.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts that are incurred by Neurimmune for research and development expenses in support of the collaboration that we reimburse are reflected in research and development expense in our condensed consolidated statements of income. Future milestone payments, if any, will be reflected within our condensed consolidated statements of income as a charge to noncontrolling interest, net of tax, when such milestones are achieved.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the collaboration incurred expenses totaling </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$35.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$47.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, which is included in total costs and expenses within our condensed consolidated statements of income, as compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$10.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$21.7 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in the prior year comparative periods. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The assets and liabilities of Neurimmune are not significant to our financial position or results of operations as it is a research and development organization. We have provided no financing to Neurimmune other than contractually required amounts.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Unconsolidated Variable Interest Entities</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have relationships with other variable interest entities that we do not consolidate as we lack the power to direct the activities that significantly impact the economic success of these entities. These relationships include investments in certain biotechnology companies and research collaboration agreements. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the total carrying value of our investments in biotechnology companies totaled </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$8.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$7.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. Our maximum exposure to losses related to these variable interest entities is limited to the carrying value of our investments.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">26</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have entered into research collaboration agreements with certain variable interest entities where we are required to fund certain development activities. These development activities are included in research and development expense within our condensed consolidated statements of income, as they are incurred. We have provided no financing to these variable interest entities other than previously contractually required amounts. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For additional information related to our investments in variable interest entities, please read Note 19, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Investments in Variable Interest Entities</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form 10-K.</font></div><a name="sED0A47F989BFC135433B9B1F3EC710C2"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">16.&#160;&#160;&#160;&#160;Collaborative and Other Relationships</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Samsung Bioepis</font></div><div style="line-height:120%;padding-top:6px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Joint Venture Agreement</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In February 2012, we entered into a joint venture agreement with Samsung BioLogics Co. Ltd. (Samsung Biologics), establishing an entity, Samsung Bioepis, to develop, manufacture and market biosimilar pharmaceuticals.&#160;Samsung Biologics contributed </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">280.5 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;South Korean won (approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$250.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">) for an </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">85%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;stake in Samsung Bioepis and we contributed approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">49.5 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;South Korean won (approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$45.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">) for the remaining </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">15%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;ownership interest.&#160;Under the joint venture agreement, we have no obligation to provide any additional funding and our ownership interest may be diluted due to financings in which we do not participate. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, our ownership interest is approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, which reflects our additional contribution of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.3 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;South Korean won (approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$5.7 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">) in the first quarter of 2015 and the effect of additional equity financings in which we did not participate. We maintain an option to purchase additional stock in Samsung Bioepis that would allow us to increase our ownership percentage up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">49.9%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">.&#160;The exercise of this option is within our control and is based on paying for </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">49.9%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;of the total investment made by Samsung Biologics into Samsung Bioepis in excess of what we have already contributed under the agreement plus interest.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the carrying value of our investment in Samsung Bioepis totaled </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7.5 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9.1 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;South Korean won (approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$6.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$8.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">), respectively, which is classified as a component of investments and other assets within our condensed consolidated balance sheets. Based on our level of influence over Samsung Bioepis, we account for this investment under the equity method of accounting and we recognize our share of the results of operations related to our investment in Samsung Bioepis one quarter in arrears when the results of the entity become available, which is reflected as equity in loss of investee, net of tax within our condensed consolidated statements of income. During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we recognized a loss on our investment of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$4.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$5.7 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, as compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$9.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in the prior year comparative periods.</font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Commercial Agreement</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On December 17, 2013, pursuant to our rights under the joint venture agreement with Samsung Biologics, we entered into an agreement with Samsung Bioepis to commercialize anti-tumor necrosis factor (TNF) biosimilar product candidates in Europe and, in the case of one anti-TNF biosimilar candidate, Japan.&#160;Under the terms of this agreement, we have paid </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$46.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, which has been recorded as a research and development expense within our condensed consolidated statements of income as the programs they relate to have not achieved regulatory approval. Samsung Bioepis is eligible to receive an additional </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$75.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;in additional milestones related to clinical development and regulatory approval of the product candidates. Upon commercialization, there will be a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">50%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;profit share with Samsung Bioepis.</font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Other Services</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Simultaneous with the formation of Samsung Bioepis, we also entered into a license agreement, a technical development services agreement and a manufacturing agreement with Samsung Bioepis. For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we recognized </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$17.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$36.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in other revenues in relation to these services, as compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$12.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$36.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in the prior year comparative periods. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For additional information related to our other significant collaboration arrangements, please read Note 20, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Collaborative and Other Relationships</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form 10-K.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">27</font></div></div><hr style="page-break-after:always"><a name="s87E4C9517D2F060D47B49B1F3EE05D4F"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">17.&#160;&#160;&#160;&#160;Litigation</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">&#32;&#8217;755 Patent Litigation</font></div><div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On May&#160;28, 2010, Biogen MA Inc. (formerly Biogen Idec MA Inc.) filed a complaint in the U.S.&#160;District Court for the District of New Jersey alleging infringement by Bayer Healthcare Pharmaceuticals Inc. (Bayer) (manufacturer, marketer and seller of BETASERON and manufacturer of EXTAVIA), EMD Serono, Inc. (manufacturer, marketer and seller of REBIF), Pfizer Inc. (co-marketer of REBIF), and Novartis Pharmaceuticals Corp. (marketer and seller of EXTAVIA) of our U.S. Patent No. 7,588,755 (&#8217;755 Patent), which claims the use of interferon beta for immunomodulation or treating a viral condition, viral disease, cancers or tumors. The complaint seeks monetary damages, including lost profits and royalties. Bayer had previously filed a complaint against us in the same court, on May 27, 2010, seeking a declaratory judgment that it does not infringe the &#8217;755 Patent and that the patent is invalid, and seeking monetary relief in the form of attorneys' fees, costs and expenses. The court has consolidated the two lawsuits, and we refer to the two actions as the &#8220;Consolidated &#8217;755 Patent Actions.&#8221;</font></div><div style="line-height:120%;padding-top:12px;text-align:left;padding-left:12px;text-indent:17px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Bayer, Pfizer, Novartis and EMD Serono have all filed counterclaims in the Consolidated &#8217;755 Patent Actions seeking declaratory judgments of patent invalidity and non-infringement, and seeking monetary relief in the form of costs and attorneys' fees, and EMD Serono and Bayer have each filed a counterclaim seeking a declaratory judgment that the &#8217;755 Patent is unenforceable based on alleged inequitable conduct. Bayer has also amended its complaint to seek such a declaration. No trial date has been set.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Italian National Medicines Agency</font></div><div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the fourth quarter of 2011, Biogen Italia SRL&#160;received notice from the Italian National Medicines Agency (Agenzia Italiana del Farmaco or AIFA) that sales of TYSABRI after mid-February 2009 exceeded a reimbursement limit established pursuant to a Price Determination Resolution (Price Resolution) granted by AIFA in December 2006. On December&#160;23, 2011, we filed an appeal in the Regional Administrative Tribunal of Lazio (Il Tribunale Amministrativo Regionale per il Lazio) in Rome, Italy seeking a ruling that the reimbursement limit in the Price Resolution should apply as written to only &#8220;the first </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months&#8221; of TYSABRI sales, which ended in mid-February 2009. The appeal is still pending. In June 2014, AIFA approved a resolution affirming that there is no reimbursement limit from and after February 2013. AIFA and Biogen Italia SRL are discussing a possible resolution for the period from mid-February 2009 through January 2013.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Government Matters</font></div><div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have learned that state and federal governmental authorities are investigating our sales and promotional practices and have received related subpoenas. We have also received a subpoena from the federal government for documents relating to our relationship with certain pharmacy benefit managers. We are cooperating with the government in these matters.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Qui Tam Litigation</font></div><div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On July 6, 2015, four qui tam actions filed against us by relators suing on behalf of the United States and certain states were unsealed by the U.S. District Court for the District of Massachusetts. The actions, which have been administratively consolidated, allege sales and promotional activities in violation of the federal False Claims Act and state law counterparts, and seek single and treble damages, civil penalties, interest, attorneys&#8217; fees and costs. The United States has declined to intervene in two of the actions and has not made an intervention decision in the other two actions. We have not been served with any of the complaints. We have not formed an opinion that an unfavorable outcome in any of the actions is either &#8220;probable&#8221; or &#8220;remote&#8221; and are unable to estimate the magnitude or range of any potential loss.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Forward Pharma Litigation</font></div><div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On November 18, 2014 Forward Pharma A/S (Forward Pharma) filed suit against us in the Regional Court of Dusseldorf, Germany alleging that TECFIDERA infringes German Utility Model DE&#160;20 2005 022 112&#160;U1, which was issued in April 2014 and expires in October 2015. Forward Pharma subsequently&#160;extended its allegations&#160;to assert that TECFIDERA infringes Forward Pharma's European Patent No. 2,801,355, which was issued in May 2015 and expires in October 2025. Forward Pharma seeks declarations of infringement and damages. A hearing has been scheduled for early 2016.&#160;We have not formed an opinion that an unfavorable outcome is either &#8220;probable&#8221; or &#8220;remote&#8221; and are unable to estimate the magnitude or range of any potential loss.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">28</font></div></div><hr style="page-break-after:always"><a name="s87E4C9517D2F060D47B49B1F3EE05D4F"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160; </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Product Liability and Other Legal Proceedings</font></div><div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We are also involved in product liability claims and other legal proceedings generally incidental to our normal business activities. While the outcome of any of these proceedings cannot be accurately predicted, we do not believe the ultimate resolution of any of these existing matters would have a material adverse effect on our business or financial condition.</font></div><a name="sF6E99D26CBBC4C6843C19B1F3EE40F59"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">18.&#160;&#160;&#160;&#160;Commitments and Contingencies</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Fumapharm AG</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In 2006, we acquired Fumapharm AG. As part of this acquisition we acquired FUMADERM and TECFIDERA (together, Fumapharm Products). We paid </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$220.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;upon the closing of the transaction and agreed to pay an additional </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$15.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;if a Fumapharm Product was approved for MS in the U.S.&#160;or E.U. In the second quarter of 2013, we paid this </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$15.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;contingent payment as TECFIDERA was approved in the U.S. for MS by the U.S. Food and Drug Administration (FDA). We are also required to make additional contingent payments to former shareholders of Fumapharm AG or holders of their rights based on the attainment of certain cumulative sales levels of Fumapharm Products and the level of total net sales of Fumapharm Products in the prior twelve month period, as defined in the acquisition agreement. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we paid a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$250.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;contingent payment as we reached the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$4.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;cumulative sales level related to the Fumapharm Products in the fourth quarter of 2014 and accrued </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$300.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;upon reaching </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$5.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;in total cumulative sales of Fumapharm Products in the second quarter of 2015.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We will owe an additional </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$300.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;contingent payment for every additional </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;in cumulative sales level of Fumapharm Products reached if the prior 12 months sales of the Fumapharm Products exceed </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$3.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, until such time as the cumulative sales level reaches </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$20.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, at which time no further contingent payments shall be due. These payments will be accounted for as an increase to goodwill as incurred, in accordance with the accounting standard applicable to business combinations when we acquired Fumapharm. Any portion of the payment which is tax deductible will be recorded as a reduction to goodwill. Payments are due within 60&#160;days following the end of the quarter in which the applicable cumulative sales level has been reached. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Solothurn, Switzerland Facility</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On June 30, 2015, we signed an agreement to purchase land in Solothurn, Switzerland for </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">65.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Swiss Francs. The contract also includes certain environmental remediation costs. Our obligation to purchase the land under the contract is subject to customary closing conditions as well as a condition that no material adverse changes in our business such as a decision to discontinue our aducanumab program have occurred during the period. </font></div><a name="s5cf544087a784566aab3fe3c8ad2658f"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">19.&#160;&#160;&#160;&#160;Subsequent Events</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Applied Genetic Technologies Corporation</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On July 2, 2015, we announced a collaboration and license agreement to develop gene-based therapies for multiple ophthalmic diseases with Applied Genetic Technologies Corporation (AGTC). The collaboration will focus on the development of a portfolio of AGTC&#8217;s therapeutic programs, including both a clinical stage candidate for X-linked Retinoschisis (XLRS) and a pre-clinical candidate for the treatment of X-Linked Retinitis Pigmentosa (XLRP). The agreement also includes options for early stage discovery programs in two ophthalmic diseases and one non-ophthalmic condition, as well as an equity investment in AGTC by Biogen and a license agreement for manufacturing rights.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Upon closing, we will make an upfront payment in the amount of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$124.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to AGTC, which includes a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$30.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;equity investment in AGTC, prepaid research and development expenditures of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$58.4 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and total licensing and other fees of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$35.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. We will be granted a license to the XLRS and XLRP programs and the option to license discovery programs for three additional indications at the time of clinical candidate selection.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">29</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">BIOGEN INC. AND SUBSIDIARIES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">NOTES&#160;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1c5a7d;font-weight:bold;">(unaudited, continued)</font></div></div><br><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Under the collaboration, AGTC is eligible to receive upfront and milestone payments aggregating in excess of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. This includes up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$472.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;collectively for the two lead programs, which also will carry royalties in the high single digit to mid-teen percentages of annual net sales. In addition, we will make payments up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$592.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;across the discovery programs, along with royalties in the mid-single digits to low-teen percentages of annual net sales.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We will be granted worldwide commercialization rights for the XLRS and XLRP programs. AGTC has an option to share development costs and profits after the initial clinical trial data are available, and an option to co-promote the second of these products to be approved in the U.S. AGTC will lead the clinical development programs of XLRS through product approval and of XLRP through the completion of first-in-human trials. We will support the clinical development costs, subject to certain conditions, following the first-in-human study for XLRS and IND-enabling studies for XLRP. Under the manufacturing license, we will receive an exclusive license to use AGTC&#8217;s proprietary technology platform to make AAV vectors for up to six genes, three of which are in AGTC&#8217;s discretion, in exchange for payment of milestones and royalties.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The transaction is subject to customary closing conditions, including the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in the U.S., and is expected to close in the third quarter of 2015.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Research Triangle Park Facility Purchase</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On July 15, 2015, we entered into an arrangement with Eisai, Inc. (Eisai) to purchase their manufacturing facility in Research Triangle Park, North Carolina, including a drug product facility and supporting infrastructure.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Currently, we are leasing a portion of this facility in order to manufacture our and Eisai's oral solid dose products under a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;year lease. We have committed to buy that portion of the facility upon Eisai&#8217;s completion of certain transition activities.&#160; </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The transaction is subject to customary closing conditions, including the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in the U.S., and is expected to close in the third quarter of 2015.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Swedish Orphan Biovitrum AB</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On July 16, 2015, Swedish Orphan Biovitrum AB (Sobi) exercised its option to assume development and commercialization of ALPROLIX in Europe, Russia, Turkey and certain markets in the Middle East and paid us </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$10.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, which will be held in escrow pending E.U. regulatory approval.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We collaborate with Sobi to jointly develop and commercialize Factor VIII and Factor IX hemophilia products, including ELOCTATE and ALPROLIX. For more information about our agreement with Sobi, please read Note 20, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Collaborative and Other Relationships</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form 10-K.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">30</font></div></div><hr style="page-break-after:always"><a name="s867191548312672671029B2042F7AA2C"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">Item&#160;2.&#160;&#160;&#160;&#160;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-style:italic;font-weight:bold;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following discussion should be read in conjunction with our condensed consolidated financial statements and accompanying notes beginning on page&#160;4 of this quarterly report on Form&#160;10-Q and our audited consolidated financial statements and related notes included in our Annual Report on Form&#160;10-K for the year ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;(</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form&#160;10-K). Certain totals may not sum due to rounding.</font></div><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Executive Summary</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Introduction</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Biogen is a global biopharmaceutical company focused on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. Our principal products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI and FAMPYRA for multiple sclerosis (MS), ALPROLIX for hemophilia B and ELOCTATE for hemophilia A. We also collaborate with Genentech, Inc., a wholly-owned member of the Roche Group, on the development and commercialization of RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and other conditions and share profits and losses for GAZYVA, which is approved for the treatment of chronic lymphocytic leukemia.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our current revenues depend upon continued sales of our principal products. We may be substantially dependent on sales from our principal products for many years, including an increasing reliance on sales and growth of TECFIDERA as we continue to expand into additional markets. In the longer term, our revenue growth will be dependent upon the successful clinical development, regulatory approval and launch of new commercial products as well as additional indications for our existing products, our ability to obtain and maintain patents and other rights related to our marketed products and assets originating from our research and development efforts, and successful execution of external business development opportunities. As part of our ongoing research and development efforts, we have devoted significant resources to conducting clinical studies to advance the development of new pharmaceutical products and to explore the utility of our existing products in treating disorders beyond those currently approved in their labels.</font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><a name="s050D468FCA498D68E46F9B204318D7AA"></a><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Financial Highlights</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;"><img src="biib-2015630_highlightschart.jpg" style="height:426px;width:317px;"></div><a name="s97E43A2B2CB1DDA47EE39B20434AE23D"></a><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, diluted earnings per share attributable to Biogen Inc. was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$3.93</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, as compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$3.01</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, in the prior year comparative period.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As described below under </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">&#8220;Results of Operations,&#8221;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;our operating results for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;reflect the following:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Product revenues, net totaled </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">$2,198.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;in the </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">second</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;quarter of </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, representing an increase of 6.9% over the same period in </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. This increase was driven by a 26.1% increase in worldwide TECFIDERA revenues as well as revenue increases from PLEGRIDY, ALPROLIX and ELOCTATE, which are recent product additions, offset by a decrease in worldwide AVONEX and TYSABRI revenues.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our share of RITUXAN and GAZYVA operating profits totaled </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">$337.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;in the </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">second</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;quarter of </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, representing an increase of 11.3% over the same period in </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">.</font></div></td></tr></table></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">31</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other revenues totaled $55.6 million in the </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">second</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;quarter of </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, representing a decrease of 10.2% from the same period in </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. This decrease was driven by a 78.7% decrease in royalty revenue primarily due to the expiration of U.S. patent rights that gave rise to royalty payments related to ANGIOMAX, partially offset by a 118.3% increase in corporate partner revenue.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total cost and expenses totaled </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">$1,358.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;in the </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">second</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;quarter of </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, representing a decrease of </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">5.4%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;compared to the same period in </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. This decrease was driven by a </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">21.2%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;decrease in the amortization of acquired intangible assets and a </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">14.7%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;decrease in selling, general and administrative expense, partially offset by a </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">9.7%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;increase in research and development expense. In addition, total costs and expenses in the </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">second</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;quarter of </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;compared to the same period in </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, were positively impacted by foreign currency translation totaling $36.2 million.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We generated </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1,780.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;of net cash flows from operations for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, which were primarily driven by earnings. Cash, cash equivalents and marketable securities totaled approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$4,470.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Acquisitions</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On February 12, 2015, we completed our acquisition of all of the outstanding stock of Convergence Pharmaceuticals (Convergence), a clinical-stage biopharmaceutical company with a focus on developing product candidates for the treatment of neuropathic pain. For additional information related to this transaction, please read Note 2, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Acquisitions</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our condensed consolidated financial statements included within this report.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Business Environment</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The biopharmaceutical industry and the markets in which we operate are intensely competitive. Many of our competitors are working to develop or have commercialized products similar to those we market or are developing. In addition, the commercialization of certain of our own approved MS products, products of our collaborators and pipeline product candidates may negatively impact future sales of our existing MS products. Our products may also face increased competitive pressures from the introduction of generic versions, related prodrug derivatives or biosimilars of existing products and other technologies, such as gene therapies.</font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Key Pipeline and Product Developments</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">ZINBRYTA</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In March 2015, the European Medicines Agency (EMA) validated our Marketing Authorization Application (MAA) for ZINBRYTA for the treatment of relapsing forms of MS in the E.U.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In April 2015, the U.S. Food and Drug Administration (FDA) accepted our Biologics License Application (BLA) for ZINBRYTA for the treatment of relapsing forms of MS in the U.S.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We collaborate with AbbVie Biotherapeutics, Inc. (AbbVie) on the development and commercialization of ZINBRYTA. For additional information about this collaboration, please read Note 20, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Collaborative and Other Relationships</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form 10-K.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">ALPROLIX</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In February 2015, we and Swedish Orphan Biovitrum AB announced positive top-line results of the Kids B-LONG Phase 3 clinical study that evaluated the safety, efficacy and pharmacokinetics of ALPROLIX in children under age 12 with severe hemophilia B. This data was required as part of our MAA for ALPROLIX for the treatment of hemophilia B in the E.U., which was submitted to the EMA. The EMA validated our MAA for ALPROLIX in June 2015.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">GAZYVA</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In February 2015, the Roche Group announced positive results from the Phase 3 GADOLIN study in non-Hodgkin&#8217;s lymphoma.&#160;At a pre-planned interim analysis, an independent data monitoring committee determined that the study met its primary endpoint early, showing that people lived significantly longer without disease worsening or death (progression-free survival) when treated with GAZYVA plus bendamustine followed by GAZYVA alone, compared to bendamustine alone.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Ocrelizumab</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In June 2015, the Roche Group announced positive results from two Phase 3 studies evaluating ocrelizumab compared with interferon beta-1a in people with relapsing forms of MS. Treatment with ocrelizumab compared with interferon beta-1a significantly reduced the annualized relapse rate over a two-year period; significantly reduced the progression of clinical disability; and led to a significant reduction in the number of lesions in the brain as measured by MRI. The Roche Group plans to submit the data for review to U.S. and E.U. regulatory authorities in the first quarter of 2016.</font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">32</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Biosimilars</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In January 2015, the EMA validated and accepted Samsung Bioepis&#8217; MAA for BENEPALI, its etanercept biosimilar candidate.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In March 2015, the EMA validated and accepted Samsung Bioepis&#8217; MAA for its infliximab biosimilar candidate.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Neublastin</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In June 2015, the results of our Phase 2 trial investigating Neublastin in neuropathic pain did not meet its primary endpoint or its efficacy criteria. Based on these results, we have discontinued development of Neublastin in neuropathic pain.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">TYSABRI</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In July 2015, the results of our Phase 2 trial investigating TYSABRI in acute ischemic stroke did not demonstrate an impact on change in infarct volume, the primary endpoint. However, exploratory clinical endpoints suggested that TYSABRI did have a beneficial impact on patient functional deficits. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">ISIS-SMN</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;"><sub style="vertical-align:bottom;line-height:120%;font-size:pt">Rx</sub>&#160;</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In June 2015, Isis Pharmaceuticals, Inc. (Isis) announced additional data from two Phase 2 studies of ISIS-SMN</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sub style="vertical-align:bottom;line-height:120%;font-size:pt">Rx</sub></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;for the treatment of spinal muscular atrophy in infants and children. There are two Phase 3 studies that are active and currently enrolling patients.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Aducanumab (BIIB037)</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In March 2015, we announced data from a pre-specified interim analysis of PRIME, the Phase 1b study of aducanumab, in which aducanumab demonstrated an acceptable safety profile and positive results on radiologic and clinical measurements in patients with prodromal or mild </font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Alzheimer&#8217;s disease.&#160;Based on results from our Phase 1b study, we advanced the aducanumab clinical program to Phase 3. In June 2015, we began initiating the clinical sites for two global Phase 3 studies, ENGAGE and EMERGE, to assess the efficacy and safety of aducanumab in people with early Alzheimer's disease. In July 2015, we announced new results from a pre-specified interim analysis of PRIME in patients with prodromal or mild Alzheimer&#8217;s disease. In this analysis, which included patients treated up to 54 weeks with the 6 mg/kg dose, aducanumab demonstrated acceptable safety and tolerability, and the findings reinforced the previously reported results from PRIME.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Anti-LINGO</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In January 2015, we announced positive top-line results from the Phase 2 acute optic neuritis (AON) RENEW trial in which treatment with anti-LINGO-1 showed evidence of biological repair of the visual system. Anti-LINGO-1 demonstrated an improvement in the study&#8217;s primary endpoint, recovery of optic nerve latency (time for a signal to travel from the retina to the visual cortex) relative to placebo. The study showed no effect on secondary endpoints, including change in thickness of the retinal layers (optic nerve neurons and axons) and visual function. Anti-LINGO-1 is also being studied in people with MS through a Phase 2 study, SYNERGY.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Results in our early stage trials for aducanumab and anti-LINGO-1 may not be indicative of results in later stage trials, which, in some cases, may take several years to enroll and complete and may result in the incurrence of significant costs and investment without the assurance of success.&#160;Development of biopharmaceutical products is subject to the risks and uncertainties described in our risk factors. </font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">33</font></div></div><hr style="page-break-after:always"><a name="s100C59338BCCCCBC02479B1F44C5921F"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Results of Operations</font></div><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Revenues</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenues are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="28"></td></tr><tr><td width="21%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="1%"></td><td width="8%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="1%"></td><td width="8%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="1%"></td><td width="8%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="1%"></td><td width="8%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions, except percentages)</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Product revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,565.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">60.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,343.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">55.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,099.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">60.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,513.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">55.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Rest of world</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">633.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">24.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">713.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">29.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,271.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">24.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,285.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">28.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total product revenues</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,198.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">84.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,056.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">84.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,370.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">84.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,799.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">83.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unconsolidated joint business</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">337.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">303.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">12.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">668.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">600.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">13.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other revenues</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">55.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">61.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">107.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">151.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,591.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,421.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5,146.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,551.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Product Revenues</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Product revenues are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="28"></td></tr><tr><td width="21%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="1%"></td><td width="8%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="1%"></td><td width="8%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="1%"></td><td width="8%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="1%"></td><td width="8%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions, except percentages)</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Multiple Sclerosis:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">TECFIDERA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">883.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">700.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">34.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,708.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">39.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,206.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">31.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interferon</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">689.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">31.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">773.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,444.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">33.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,535.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">40.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">TYSABRI</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">463.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">21.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">533.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">25.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">925.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">21.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">974.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">25.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">FAMPYRA</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">21.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">22.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">41.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">41.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Hemophilia:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ALPROLIX</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">54.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">97.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ELOCTATE</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">74.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">127.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">12.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">16.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">26.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">31.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total product revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,198.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,056.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,370.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,799.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr></table></div></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">34</font></div></div><hr style="page-break-after:always"><a name="s602E4AF3E6E7C3359DAF9B20439EBDBD"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Multiple Sclerosis (MS)</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">TECFIDERA</font><img src="biib-2015630_tecchart.jpg" style="height:310px;width:317px;"></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the increase in U.S. TECFIDERA revenues was primarily due to increases in unit sales volume of 14% and 24%, respectively, as TECFIDERA continued its penetration into the U.S. market, and to price increases.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the increase in rest of world TECFIDERA revenues was primarily due to increases in unit sales volume experienced in existing markets and in additional markets as we continue to expand our presence around the world. These increases were partially offset by pricing reductions in Germany as described below. &#160;</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Rest of world TECFIDERA revenues for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, were negatively impacted by foreign currency exchange losses totaling $21.2 million and $28.8 million, respectively.&#160;These foreign currency exchange losses were partially offset by comparative net gains recognized under our foreign currency hedging program totaling $11.0 million and $20.9 million, respectively.</font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In 2011, the German government implemented new legislation to manage pricing related to new drug products introduced within the German market. For the first 12 months after launch, pricing is unregulated. We launched TECFIDERA in Germany in February 2014. During the first quarter of 2015, our unregulated pricing ended and we recognized revenue at the fixed price that was established through negotiations with the German authorities. The negotiated annual price is fixed for three years at EUR12,800. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">TECFIDERA&#8217;s launch disrupted the historical market dynamics which benefited our results throughout 2014. While we continue to see strong uptake in newly launched markets, total market growth and switch rates are returning to historical averages in our maturing markets, such as the U.S. and Germany. During 2015, TECFIDERA's U.S. patient growth versus prior quarters has moderated primarily due to changing physician prescribing patterns and intense competition. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Interferon</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">PLEGRIDY</font></div><div style="line-height:120%;text-align:left;"><img src="biib-2015630_plegchart.jpg" style="height:310px;width:317px;"></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Sales of PLEGRIDY began in the E.U. and the U.S. in the third and fourth quarters of 2014, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We expect that PLEGRIDY revenues will increase as PLEGRIDY becomes commercially available in additional markets.</font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35</font></div></div><hr style="page-break-after:always"><a name="s602E4AF3E6E7C3359DAF9B20439EBDBD"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">AVONEX</font></div><div style="line-height:120%;text-align:left;"><img src="biib-2015630_avxchart.jpg" style="height:310px;width:317px;"></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in U.S. AVONEX revenues was primarily due to decreases in unit sales volume of 27% and 19%, respectively, which was attributable in part to patients transitioning to PLEGRIDY and oral MS therapies, including TECFIDERA, partially offset by price increases. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in rest of world AVONEX revenues was primarily due to decreases in unit sales volume of 18% and 16%, respectively, primarily in Europe, attributable to patients transitioning to PLEGRIDY and oral MS therapies, including TECFIDERA. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Rest of world AVONEX revenues for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, were negatively impacted by foreign currency exchange losses totaling $47.1 million and $90.4 million, respectively. These foreign currency exchange losses were partially offset by comparative net gains recognized under our foreign currency hedging program totaling $18.7 million and $35.0 million, respectively.</font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">TYSABRI</font></div><div style="line-height:120%;"><img src="biib-2015630_tyschart.jpg" style="height:310px;width:317px;"></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the increase in U.S. TYSABRI revenues was primarily due to increases in unit sales volume of 4% and 9%, respectively, which includes an additional shipping week over the six month prior year comparative period, and price increases. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in rest of world TYSABRI revenues was primarily due to the prior year recognition of $53.5 million of revenues previously deferred in Italy relating to the pricing agreement with the Italian National Medicines Agency (Agenzia Italiana del Farmaco, or AIFA), as discussed below, and pricing reductions in some countries, partially offset by increases in unit sales volume of 5% and 4%, respectively, primarily in our emerging markets. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Rest of world TYSABRI revenues for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, were negatively impacted by foreign currency exchange losses totaling $48.0 million and $78.4 million, respectively. These foreign currency exchange losses were partially offset by comparative net gains recognized under our foreign currency hedging program totaling $12.8 million and $23.4 million respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We remain in discussions with AIFA about a resolution relating to a claim that sales of TYSABRI in Italy exceeded a reimbursement limit established pursuant to a Price Determination Resolution granted by AIFA in December 2006 for the period from mid-February 2009 through January 2013. If AIFA agrees to our current proposal, we could recognize approximately EUR40 million in revenue related to this matter. For information relating to our agreement with </font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">36</font></div></div><hr style="page-break-after:always"><a name="s602E4AF3E6E7C3359DAF9B20439EBDBD"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">AIFA relating to sales of TYSABRI in Italy, please read Note 14, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Other Consolidated Financial Statement Detail</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our condensed consolidated financial statements included within this report.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Hemophilia</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">ALPROLIX</font></div><div style="line-height:120%;"><img src="biib-2015630_alpchart.jpg" style="height:310px;width:317px;"></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Sales of ALPROLIX in the U.S. and Japan began in the second and fourth quarters of 2014, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">ELOCTATE</font></div><div style="line-height:120%;"><img src="biib-2015630_elochart.jpg" style="height:310px;width:317px;"></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Sales of ELOCTATE in the U.S. and Japan began in the third quarter of 2014 and in the first quarter of 2015, respectively. </font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have a relatively limited product history for ALPROLIX and ELOCTATE. Therefore, it remains difficult to estimate trends of future product sales of these products.</font></div><a name="s8F55EDAD3850B53B6B169B1FF8A53D43"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Unconsolidated Joint Business Revenues</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We collaborate with Genentech, Inc., a wholly-owned member of the Roche Group, on the development and commercialization of RITUXAN. In addition, in the U.S. we share operating profits and losses relating to GAZYVA with Genentech. The Roche Group and its sub-licensees maintain sole responsibility for the development, manufacturing and commercialization of GAZYVA in the U.S. For additional information related to this collaboration, including information regarding the pre-tax profit sharing formula and its impact on future unconsolidated joint business revenues, please read Note&#160;20, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Collaborative and Other Relationships</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form&#160;10-K.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenues from unconsolidated joint business are summarized as follows:</font></div><div style="line-height:120%;"><img src="biib-2015630_ujbchart.jpg" style="height:517px;width:317px;"></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Biogen&#8217;s Share of Pre-tax Profits in the U.S. for RITUXAN and GAZYVA</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following tables provide a summary of amounts comprising our share of pre-tax profits on RITUXAN and GAZYVA in the U.S.:</font></div><div style="line-height:120%;padding-top:6px;text-align:center;"><img src="biib-2015630_3mosujbchart.jpg" style="height:517px;width:317px;"></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;text-align:center;"><img src="biib-2015630_6mosujbchart.jpg" style="height:517px;width:317px;"></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the increase in U.S.&#160;product revenues was primarily due to price increases and increases in RITUXAN unit sales volume of 5% for both periods, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Collaboration costs and expenses for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, were relatively consistent. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Revenue on Sales in the Rest of World for RITUXAN</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue on sales in the rest of world for RITUXAN consists of our share of pre-tax co-promotion profits on RITUXAN in Canada and royalty revenue on sales outside the U.S.&#160;and Canada. For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, revenue on sales in the rest of world for RITUXAN decreased as a result of patent expirations. </font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">38</font></div></div><hr style="page-break-after:always"><a name="s1A350128C5B1C40996069B2043F0AC00"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Other Revenues</font></div><div style="line-height:120%;"><img src="biib-2015630_otherrevchart.jpg" style="height:386px;width:317px;"></div><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Royalty Revenues</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We receive royalties from net sales on products related to patents that we have out-licensed. Our most significant source of royalty revenue had been derived from net worldwide sales of ANGIOMAX, which was out-licensed to The Medicines Company. Our royalty revenues from U.S. sales of ANGIOMAX ceased as of December 15, 2014 upon patent expiry. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, royalty revenues decreased primarily due to the expiration of U.S. patent rights that gave rise to royalty payments related to ANGIOMAX.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Corporate Partner Revenues</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our corporate partner revenues include amounts earned under contract manufacturing agreements, which includes revenues related to our arrangement with Samsung Bioepis, and revenues covering products previously included within our product line that we have sold or exclusively licensed to third parties.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the increase in corporate partner revenues was primarily due to higher contract manufacturing revenue.</font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For additional information on our relationship with Samsung Bioepis, please read Note 16, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Collaborative and Other Relationships</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our condensed consolidated financial statements included within this report. </font></div><a name="sC17ADDC08DA90CAC5C739B1F6C9C5302"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Reserves for Discounts and Allowances</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenues from product sales are recorded net of applicable discounts, allowances and other governmental allowances including those associated with the implementation of pricing actions in certain international markets where we operate.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Reserves established for these discounts and allowances are classified as reductions of accounts receivable (if the amount is payable to our customer) or a liability (if the amount is payable to a party other than our customer). These reserves are based on estimates of the amounts earned or to be claimed on the related sales. Our estimates take into consideration our historical experience, current contractual and statutory requirements, specific known market events and trends, and forecasted customer buying and payment patterns. Actual amounts may ultimately differ from our estimates. If actual results vary, we adjust these estimates, which will have an effect on earnings in the period of adjustment. To date, such adjustments have not been significant.</font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">39</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Reserves for discounts, contractual adjustments and returns that reduced gross product revenues are summarized as follows:</font></div><div style="line-height:120%;text-align:center;"><img src="biib-2015630_reserveschart.jpg" style="height:425px;width:317px;"></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Discounts include trade term discounts and wholesaler incentives. For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the increase in discounts was primarily driven by our recent product additions. </font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contractual adjustments relate to Medicaid and managed care rebates, Veterans Administration, Public Health Service discounts, specialty pharmacy program fees and other government rebates or applicable allowances. For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the increase in contractual adjustments was primarily due to our recent product additions, higher Medicaid and governmental rebates and allowances as a result of price increases and an increase in governmental rebates in certain international markets.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Product return reserves are established for returns made by wholesalers. In accordance with contractual terms, wholesalers are permitted to return product for reasons such as damaged or expired product. The majority of wholesaler returns are due to product expiration. Reserves for product returns are recorded in the period the related revenue is recognized, resulting in a reduction to product sales. For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, return reserves decreased primarily due to a reduction in return rates based on recent experiences of returned products.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For additional information related to our reserves, please read Note 3, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Reserves for Discounts and Allowances</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our condensed consolidated financial statements included within this report.</font></div></div></div><br><a name="sB2DFA5CD09AA63637EAD9B1F53E5F65B"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Cost and Expenses</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">A summary of total cost and expenses is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td width="29%"></td><td width="1%"></td><td width="9%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="9%"></td><td width="1%"></td><td width="1%"></td><td width="10%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="9%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="9%"></td><td width="1%"></td><td width="1%"></td><td width="10%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions, except percentages)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Change&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Change&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cost of sales, excluding amortization of acquired intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">286.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">291.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">598.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">571.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">490.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">447.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">951.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">976.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">491.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">576.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(14.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,052.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,088.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amortization of acquired intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">92.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">116.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(21.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">187.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">260.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(27.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(Gain) loss on fair value remeasurement of contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(154.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">75.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total cost and expenses</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,358.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,436.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,795.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,898.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)%</font></div></td></tr></table></div></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">40</font></div></div><hr style="page-break-after:always"><a name="s8869F65B54BCD2D9B1179B204466698B"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Cost of Sales, Excluding Amortization of Acquired Intangible Assets</font></div><div style="line-height:120%;"><img src="biib-2015630_coschart.jpg" style="height:310px;width:317px;"></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the increase in product cost of sales was driven primarily by higher unit sales volume, partially offset by a reduction in charges related to inventory write-downs and lower costs related to our biosimilars arrangements. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the increase in product cost of sales was driven primarily by higher unit sales volume and higher AVONEX production costs, partially offset by lower costs related to our biosimilars arrangements and a reduction in charges related to inventory write-downs. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory amounts written down as a result of  excess, obsolescence, unmarketable or other reasons are included in product cost of sales. For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, inventory write-downs totaled $7.8 million and $11.4 million, respectively, compared to $15.1 million and $20.9 million, respectively, in the prior year comparative periods. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in royalty cost of sales was driven by the expiration of third party royalties related to TYSABRI.</font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the increase in royalty cost of sales was driven by an increase in the contractual rate on TYSABRI contingent payments due to Perrigo Company plc (Perrigo), which is based on the expected level of annual worldwide net sales of TYSABRI, partially offset by the expiration of third party royalties related to TYSABRI. Perrigo acquired Elan in December 2013. Following that acquisition, we began making our TYSABRI contingent payments to Perrigo. For additional information on the contingent payments due to Perrigo, please read Note 2, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Acquisitions</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form 10-K.</font></div><a name="s6413EEECB1EED546A81C9B2044976577"></a><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Research and Development</font></div><div style="line-height:120%;"><img src="biib-2015630_rdchart.jpg" style="height:616px;width:317px;"></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">41</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development expense incurred in support of our marketed products includes costs associated with product lifecycle management activities including, if applicable, costs associated with the development of new indications for existing products. Late stage programs are programs in Phase 3 development or in registration stage. Early stage programs are programs in Phase 1 or Phase 2 development. Research and discovery represents costs incurred to support our discovery research and translational science efforts. Other research and development costs consist of indirect costs incurred in support of overall research and development activities and non-specific programs, including activities that benefit multiple programs, such as management costs as well as depreciation and other facility-based expenses. For several of our programs, the research and development activities are part of our collaborative and other relationships. Our costs reflect our share of the total costs incurred.</font></div><div style="line-height:120%;text-align:center;"><img src="biib-2015630_15rdpiechart.jpg" style="height:305px;width:317px;"></div><div style="line-height:120%;text-align:center;"><img src="biib-2015630_14rdpiechart.jpg" style="height:305px;width:317px;"></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the increase in research and development expense was primarily related to increases in costs incurred in connection with our research and discovery, late stage programs and early stage programs, partially offset by decreases in upfront and milestone expenses.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in research and development expense was primarily related to decreases in upfront and milestone expenses and costs incurred in connection with our late stage programs, partially offset by increases in costs incurred in connection with research and discovery and our early stage programs. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development expense related to our early stage programs increased over the prior year comparative periods primarily due to costs incurred to advance our aducanumab and BAN2401 programs for Alzheimer&#8217;s disease and our CNV1014802 program for trigeminal neuralgia. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The increase in spending associated with our late stage product candidates for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, was driven by costs incurred in the development of ISIS-SMN</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sub style="vertical-align:bottom;line-height:120%;font-size:pt">Rx</sub></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;for the treatment of spinal muscular atrophy, partially offset by the recent approval of PLEGRIDY in 2014.  </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The decrease in spending associated with our late stage product candidates for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;was driven by the recent approvals of ELOCTATE and PLEGRIDY in 2014, partially offset by costs incurred in the development of ISIS-SMN</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sub style="vertical-align:bottom;line-height:120%;font-size:pt">Rx</sub></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The decrease in spending associated with milestones and upfront expenses was driven by amounts paid to Eisai Co., Ltd. (Eisai) and Sangamo BioSciences, Inc. (Sangamo) during the first </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. Research and development expense for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;included charges of $117.7 million recorded upon entering into the collaboration agreement with Eisai, $21.6 million as Eisai exercised its option in the collaboration agreement to expand the joint development and commercialization activities to include Japan and $20.0 million related to an upfront payment made to Sangamo upon entering into an exclusive worldwide collaboration and license agreement. This decrease in spending was partially offset by payments of $16.0 million to AbbVie related to milestones for the development of ZINBRYTA as a result of filing with the FDA and EMA in 2015. For additional information about these transactions, please read Note 20, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Collaborative and Other Relationships</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form 10-K.</font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">42</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We intend to continue committing significant resources to targeted research and development opportunities where there is a significant unmet need and where the drug candidate has the potential to be highly differentiated. Specifically, we intend to continue to invest in our MS pipeline, including our anti-LINGO-1 and TYSABRI in secondary progressive MS programs, aducanumab program and in pursuing additional therapies for autoimmune disorders, neurodegenerative diseases and hematologic conditions.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Selling, General and Administrative</font></div><div style="line-height:120%;"><img src="biib-2015630_sgachart.jpg" style="height:240px;width:317px;"></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in selling, general and administrative expenses was driven by a decrease in corporate giving, partially offset by increased cost related to the Branded Pharmaceutical Drug Fee. As our recent product additions evolve out of launch phase, we expect our future spend on sales and marketing activities in support of these products will moderate.</font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><a name="sBD270FB653C963208E2E9B2044B8EA47"></a><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Amortization of Acquired Intangible Assets</font></div><div style="line-height:120%;"><img src="biib-2015630_amortchart.jpg" style="height:240px;width:317px;"></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in amortization of acquired intangible assets was primarily driven by a decrease in AVONEX and TYSABRI revenues during the comparative periods and higher expected lifetime revenues of TYSABRI as discussed below. Amortization of acquired intangible assets during the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;also includes a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$34.7 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;impairment charge related to one of our out-licensed patents. For additional information related to the amortization of acquired intangible assets, please read Note 5, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Intangible Assets and Goodwill</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our condensed consolidated financial statements included within this report.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our amortization expense is based on the economic consumption of intangible assets. Our most significant intangible assets are related to our AVONEX and TYSABRI products. Annually, during our long-range planning cycle, we perform an analysis of anticipated lifetime revenues of AVONEX and TYSABRI. This analysis is also updated whenever events or changes in circumstances would significantly affect the anticipated lifetime revenues of either product.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our most recent long range planning cycle was updated in the third quarter of 2014. Our analysis included an increase in the expected future product revenues of TYSABRI, resulting in a decrease in the rate of amortization expense as compared to prior quarters. Our analysis also included a decrease in the expected future product revenues of AVONEX. The results of our TYSABRI and AVONEX analyses were impacted by changes in the estimated impact of TECFIDERA, as well as other existing and potential oral and alternative MS formulations, including PLEGRIDY, that may compete with TYSABRI and AVONEX. </font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">43</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We monitor events and expectations regarding product performance. If there are any indications that the assumptions underlying our most recent analysis would be different than those utilized within our current estimates, our analysis would be updated and may result in a significant change in the anticipated lifetime revenues of the relevant process. The occurrence of an adverse event could substantially increase the amount of amortization expense associated with our acquired intangible assets as compared to previous periods or our current expectations, which may result in a significant negative impact on our future results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">In-process Research and Development (IPR&amp;D)</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Overall, the value of our acquired IPR&amp;D assets is dependent upon a number of variables, including estimates of future revenues and the effects of competition, the level of anticipated development costs and the probability and timing of successfully advancing a particular research program from a clinical trial phase to the next. We are continually reevaluating our estimates concerning these variables and evaluating industry data regarding the productivity of clinical research and the development process. Changes in our estimates of items may result in a significant change in our valuation of these assets.</font></div><a name="sE1F913A36DF6376ED5419B2044EB1CA4"></a><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">(Gain) Loss on Fair Value Remeasurement of Contingent Consideration</font></div><div style="line-height:120%;"><img src="biib-2015630_gainlosschart.jpg" style="height:240px;width:317px;"></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The consideration for certain of our business combinations includes future payments that are contingent upon the occurrence of a particular factor or factors. We record an obligation for such contingent consideration payments at fair value on the acquisition date. We revalue our contingent consideration obligations each reporting period. Changes in the fair value of our contingent consideration obligations, other than changes due to payments, are recognized as a (gain) loss on fair value remeasurement of contingent consideration within our condensed consolidated statements of income. </font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The change in fair value remeasurement of contingent consideration for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, was primarily due to changes in the expected timing related to the achievement of certain developmental milestones and changes in the discount rate.</font></div><a name="s26A3B28AF6411AF5D70A9B1F4881B621"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Other Income (Expense), Net</font></div><div style="line-height:120%;"><img src="biib-2015630_oiechart.jpg" style="height:240px;width:317px;"></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the change in other income (expense), net was primarily due to a gain recognized on the sale of a strategic investment during the second quarter of 2014.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the change in other income (expense), net was primarily due to a gain recognized on the sale of a strategic investment during the second quarter of 2014 and higher foreign exchange losses. </font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">44</font></div></div><hr style="page-break-after:always"><a name="s2EEB95761A328D7B52699B1F7E38284A"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Income Tax Provision</font></div><div style="line-height:120%;"><img src="biib-2015630_taxchart.jpg" style="height:338px;width:317px;"></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our effective tax rate fluctuates from year to year due to the global nature of our operations. The factors that most significantly impact our effective tax rate include variability in the allocation of our taxable earnings among multiple jurisdictions, changes in tax laws, the amount and characterization of our research and development expenses, the levels of certain deductions and credits, acquisitions, and licensing transactions.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in our effective income tax rate is due to lower anticipated taxes on foreign earnings.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in our income tax rate was due to a benefit resulting from the remeasurement of one of our uncertain tax positions and lower anticipated taxes on foreign earnings.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For more information on our uncertain tax positions and income tax rate reconciliation for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, please read Note 13, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our condensed consolidated financial statements included within this report.</font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><a name="s9C570B2461B9E03E17179B1F53E3F96B"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Equity in Loss of Investee, Net of Tax</font></div><div style="line-height:120%;"><img src="biib-2015630_investeechart.jpg" style="height:240px;width:317px;"></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In February 2012, we entered into an agreement with Samsung BioLogics Co. Ltd. (Samsung Biologics), establishing an entity, Samsung Bioepis, to develop, manufacture and market biosimilar pharmaceuticals. We account for this investment under the equity method of accounting. We recognize our share of the results of operations related to our investment in Samsung Bioepis one quarter in arrears. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the increase in our equity in loss of investee, net of tax, was due to our recognition of a gain in the second quarter of 2014 as Samsung Bioepis secured an additional equity financing in which we did not participate. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in our equity in loss of investee, net of tax, was due to decreases in the joint venture's clinical activity and a decrease in our ownership interest. For additional information related to this transaction, please read Note 16, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Collaborative and Other Relationships</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our condensed consolidated financial statements included within this report.</font></div><a name="sA79522613BC1EBA0ED159B204592BD43"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Market Risk</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We conduct business globally. As a result, our operations are subject to certain risks which may affect our results of operations, including volatility in foreign currency exchange rates or weak economic conditions in the foreign markets in which we operate, and pricing pressures worldwide. In addition, our results of operations and the fair value of our assets and liabilities may be impacted by interest rate movements. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Foreign Currency Exchange Risk</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our results of operations are subject to foreign currency exchange rate fluctuations due to the global nature of our operations. We have operations or maintain distribution relationships in the U.S., Europe, </font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">45</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Canada, Switzerland, Australia, New Zealand, Japan and Central and South America. In addition, we receive royalty revenues based on sales of RITUXAN outside the U.S. and Canada. As a result, our financial position, results of operations and cash flows can be affected by market fluctuations in foreign exchange rates, primarily with respect to the Euro, Canadian dollar, Swiss franc, Danish krone, Japanese yen, Australian dollar and British pound.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">While the financial results of our global activities are reported in U.S. dollars, the functional currency for most of our foreign subsidiaries is their respective local currency. Fluctuations in the foreign currency exchange rates of the countries in which we do business will affect our operating results, often in ways that are difficult to predict. In particular, as the U.S. dollar strengthens versus other currencies, the value of the non-U.S. revenue will decline when reported in U.S. dollars. The impact to net income as a result of a strengthening U.S. dollar will be partially mitigated by the value of non-U.S. expense which will also decline when reported in U.S. dollars. As the U.S. dollar weakens versus other currencies, the value of the non-U.S. revenue and expenses will increase when reported in U.S. dollars.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have established revenue hedging and balance sheet risk management programs to protect against volatility of future foreign currency cash flows and changes in fair value caused by volatility in foreign exchange rates.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Revenue Hedging Program</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our foreign currency hedging program is designed to mitigate, over time, a portion of the impact resulting from volatility in exchange rate changes on revenues. We use foreign currency forward contracts to manage foreign currency risk, with the majority of our forward contracts used to hedge certain forecasted revenue transactions denominated in foreign currencies in the next </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">18 months</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. We do not engage in currency speculation. For a more detailed disclosure of our revenue hedging program, please read Note 8, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Derivative Instruments</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our condensed consolidated financial statements included in this report. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our ability to mitigate the impact of exchange rate changes on revenues and net income diminishes as significant exchange rate fluctuations are sustained over extended periods of time. In particular, devaluation or significant deterioration of foreign currency exchange rates are difficult to mitigate and likely to negatively impact earnings. The cash flows from these contracts are reported as operating activities in our condensed consolidated statements of cash flows.</font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Balance Sheet Risk Management Hedging Program</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We also use forward contracts to mitigate the foreign currency exposure related to certain balance sheet items. The primary objective of our balance sheet risk management program is to mitigate the exposure of foreign currency denominated net monetary assets of foreign affiliates. In these instances, we principally utilize currency forward contracts. We have not elected hedge accounting for the balance sheet related items. The cash flows from these contracts are reported as operating activities in our condensed consolidated statement of cash flows.</font></div><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Quantitative and Qualitative Disclosures About Market Risk</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following quantitative information includes the impact of currency movements on forward contracts used in both our revenue and balance sheet hedging programs. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, a hypothetical adverse 10% movement in foreign currency rates compared to the U.S. dollar across all maturities would result in a hypothetical decrease in the fair value of forward contracts of approximately $192.0 million and $160.0 million, respectively. The estimated fair value change was determined by measuring the impact of the hypothetical exchange rate movement on outstanding forward contracts. Our use of this methodology to quantify the market risk of such instruments is subject to assumptions and actual impact could be significantly different. The quantitative information about market risk is limited because it does not take into account all foreign currency operating transactions. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Interest Rate Risk</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our investment portfolio includes cash equivalents and short-term investments. The fair value of our marketable securities is subject to change as a result of potential changes in market interest rates. The potential change in fair value for interest rate sensitive instruments has been assessed on a hypothetical 100 basis point adverse movement across all maturities. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we estimate that such hypothetical 100 basis point adverse movement would result in a hypothetical loss in fair value of approximately $28.0 million and $14.5 million, respectively, to our interest rate sensitive instruments. The fair values of our investments were determined using a combination of pricing and duration models.</font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">46</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Pricing Pressure</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Governments in some international markets in which we operate have implemented measures aimed at reducing healthcare costs to constrain the overall level of government expenditures. These implemented measures vary by country and include, among other things, mandatory rebates and discounts, prospective and possible retroactive price reductions and suspensions on price increases of pharmaceuticals. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In addition, certain countries set prices by reference to the prices in other countries where our products are marketed. Thus, our inability to secure favorable prices in a particular country may impair our ability to obtain acceptable prices in existing and potential new markets and limit market growth. The continued implementation of pricing actions throughout Europe may also lead to higher levels of parallel trade.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the U.S., federal and state legislatures, health agencies and third-party payors continue to focus on containing the cost of health care. Legislative and regulatory proposals and enactments to reform health care insurance programs could significantly influence the manner in which our products are prescribed and purchased. It is possible that additional federal health care reform measures will be adopted in the future, which could result in increased pricing pressure and reduced reimbursement for our products and otherwise have an adverse impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">There is also significant economic pressure on state budgets that may result in states increasingly seeking to achieve budget savings through mechanisms that limit coverage or payment for our drugs. Managed care organizations are also continuing to seek price discounts and, in some cases, to impose restrictions on the coverage of particular drugs.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Credit Risk</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We are subject to credit risk from our accounts receivable related to our product sales. The majority of our accounts receivable arise from product sales in the U.S.&#160;and Europe with concentrations of credit risk limited due to the wide variety of customers and markets using our products, as well as their dispersion across many different geographic areas. Our accounts receivable are primarily due from wholesale distributors, public hospitals and other government entities. We monitor the financial performance and creditworthiness of our large </font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">customers so that we can properly assess and respond to changes in their credit profile. We operate in certain countries where weakness in economic conditions can result in extended collection periods. We continue to monitor these conditions, including the volatility associated with international economies and the relevant financial markets, and assess their possible impact on our business. Our historical write-offs of accounts receivable have not been significant.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Credit and economic conditions within the E.U. continue to remain uncertain, which has generally led to long collection periods for our accounts receivable and greater collection risk within certain countries. </font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our accounts receivable in Portugal continue to be subject to significant payment delays due to government funding and reimbursement practices, although Portugal has introduced various programs periodically to pay down significantly overdue payables. Our net accounts receivable balance from product sales in Portugal totaled $21.4 million and $22.7 million as of </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, of which $10.2 million and $7.6 million were classified as non-current and included within investments and other assets within our condensed consolidated balance sheets. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our accounts receivable collection efforts in Spain have improved during the </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. All of our accounts receivable in Spain are expected to be collected within one year and are included within accounts receivable, net within our condensed consolidated balance sheets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our only accounts receivable in Greece are due from our distributor, which totaled approximately $2.0 million&#160;as of&#160;</font><font style="font-family:Franklin Gothic Book;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. There were no outstanding accounts receivables in Greece as of </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. In addition, we maintain no investment holdings backed by the Greek government.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We believe that our allowance for doubtful accounts was adequate as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. However, if significant changes occur in the availability of government funding or the reimbursement practices of these or other governments, we may not be able to collect on amounts due to us from customers in such countries and our results of operations could be adversely affected.</font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">47</font></div></div><hr style="page-break-after:always"><a name="s6219E084653A36CF02E29B1F43539BC8"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Financial Condition, Liquidity and Capital Resources</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our financial condition is summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.875%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td width="56%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="13%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions, except percentages)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br>June 30, <br>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br>December 31, <br>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Change&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Financial assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,282.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,204.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable securities &#8212; current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,086.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">640.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">69.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable securities &#8212; non-current</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,101.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,470.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">42.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total cash, cash equivalents and marketable securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,470.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,316.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">34.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Borrowings:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current portion of notes payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Notes payable</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">576.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">582.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total borrowings</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">579.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">585.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Working capital:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5,619.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,672.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">20.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2,555.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2,219.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">15.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total working capital</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,063.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,453.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><a name="s0E8163BB2E0AB3A165AA9B2045E5C7C0"></a><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, certain significant cash flows were as follows:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:67px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:43px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$520.9 million in total payments for income taxes;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:67px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:43px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book;font-size:10pt;">$250.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;in contingent payments made to former shareholders of Fumapharm AG and holders of their rights;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:67px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:43px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book;font-size:10pt;">$227.7 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;used for purchases of property, plant and equipment;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:67px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:43px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book;font-size:10pt;">$198.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;net cash paid for the acquisition of Convergence; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:67px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:43px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book;font-size:10pt;text-transform:default;">$42.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;used for share repurchases.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, certain significant cash flows were as follows:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:67px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:43px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$476.6 million in total payments for income taxes;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:67px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:43px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book;font-size:10pt;text-transform:default;">$336.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;used for share repurchases;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:67px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:43px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$155.0 million used for upfront and milestone payments in collaborative arrangements; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:67px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:43px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book;font-size:10pt;">$118.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;used for purchases of property, plant and equipment.</font></div></td></tr></table></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Overview</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have historically financed our operating and capital expenditures primarily through cash flows earned through our operations. We expect to continue funding our current and planned operating requirements principally through our cash flows from operations, as well as our existing cash resources. We believe that our existing funds, when combined with cash generated from operations and our access to additional financing resources, if needed, are sufficient to satisfy our operating, working capital, strategic alliance, milestone payment, capital expenditure and debt service requirements for the foreseeable future. In addition, we may choose to opportunistically return cash to shareholders and pursue other business initiatives, including acquisition and licensing activities. We may, from time to time, also seek additional funding through a combination of new collaborative agreements, strategic alliances and additional equity and debt financings or from other sources should we identify a significant new opportunity.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The undistributed cumulative foreign earnings of certain of our foreign subsidiaries, exclusive of earnings that would result in little or no net income tax expense under current U.S. tax law or which has already been subject to tax under U.S. tax law, are invested indefinitely outside the U.S. </font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">48</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Of the total cash, cash equivalents and marketable securities at </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, approximately $2,409 million was generated in foreign jurisdictions and is primarily intended for use in our foreign operations or in connection with business development transactions outside of the U.S. In managing our day-to-day liquidity in the U.S., we do not rely on the unrepatriated earnings as a source of funds and we have not provided for U.S.&#160;federal or state income taxes on these undistributed foreign earnings. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For additional information related to certain risks that could negatively impact our financial position or future results of operations, please read the &#8220;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Risk Factors</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8221; and &#8220;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Quantitative and Qualitative Disclosures About Market Risk</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8221; sections of this report.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Share Repurchase Programs</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2015, our Board of Directors authorized a program to repurchase up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$5.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;of our common stock (2015 Share Repurchase Program). This authorization does not have an expiration date. We expect that purchases will be executed within a period of up to five years and that repurchased shares will be retired. The 2015 Share Repurchase Program is in addition to the approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;shares remaining under our February 2011 Share Repurchase Program (2011 Share Repurchase Program), which has been used principally to offset common stock issuances under our share-based compensation plans.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we repurchased and retired approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;shares of common stock at a cost of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$42.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;under our 2015 Share Repurchase Program and did not repurchase any shares of common stock under our 2011 Share Repurchase Program. During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we purchased approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;shares of common stock at a cost of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$336.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;under our 2011 Share Repurchase Program. </font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Cash, Cash Equivalents and Marketable Securities</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Until required for another use in our business, we typically invest our cash reserves in bank deposits, certificates of deposit, commercial paper, corporate notes, U.S.&#160;and foreign government instruments and other interest bearing marketable debt instruments in accordance with our investment policy. It is our policy to mitigate credit risk in our cash reserves and marketable securities by maintaining a well-diversified portfolio that limits the amount of exposure as to institution, maturity, and investment type. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The increase in cash, cash equivalents and marketable securities from </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, is primarily due to net cash flows provided by operating activities, partially offset by net purchases of marketable securities, contingent payments made to former shareholders of Fumapharm AG and holders of their rights, the acquisition of Convergence and net purchases of property, plant and equipment.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Borrowings</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have $550.0 million aggregate principal amount of 6.875% Senior Notes due March&#160;1, 2018 that were originally priced at 99.184% of par. The discount is amortized as additional interest expense over the period from issuance through maturity.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In connection with our 2006 distribution agreement with Fumedica, we issued notes totaling 61.4&#160;million Swiss Francs which were payable to Fumedica in varying amounts from June 2008 through June 2018. Our remaining note payable to Fumedica had a carrying value of 8.7&#160;million Swiss Francs ($9.4&#160;million) and 11.6&#160;million Swiss Francs ($11.7 million) as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For a summary of the fair and carrying values of our outstanding borrowings as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, please read Note&#160;6, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Fair Value Measurements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our condensed consolidated financial statements included within this report.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Working Capital</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We define working capital as current assets less current liabilities. The increase in working capital from </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;reflects an increase in total current assets of $946.3 million, partially offset by an increase in current liabilities of $336.1 million. The increase in total current assets was primarily driven by an increase in marketable securities and prepaid taxes. The increase in total current liabilities primarily resulted from an increase in taxes payable. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">49</font></div></div><hr style="page-break-after:always"><a name="sFDDDAA93D6989892AF9A9B1F642C6A31"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Cash Flows</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes our cash flow activity:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.65625%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td width="55%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="13%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions, except percentages)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">%&#160;Change</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net cash flows provided by operating activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,780.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,095.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">62.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net cash flows used in investing activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1,756.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(624.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">181.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net cash flows provided by (used in) financing activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">77.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(207.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">137.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</font></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><a name="sE186132606EED7AC3FF59B2046394AC4"></a><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Operating Activities</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash flows from operating activities represent the cash receipts and disbursements related to all of our activities other than investing and financing activities. We expect cash provided from operating activities will continue to be our primary source of funds to finance operating needs and capital expenditures for the foreseeable future.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating cash flow is derived by adjusting our net income for:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-cash operating items such as depreciation and amortization, impairment charges and share-based compensation charges;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Changes in operating assets and liabilities which reflect timing differences between the receipt and payment of cash associated with transactions and when they are recognized in results of operations;&#160;and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Changes associated with the fair value of contingent payments associated with our acquisitions of businesses and payments related to collaborations.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the increase in cash provided by operating activities is primarily driven by higher net income, a decrease in the comparative growth in outstanding accounts receivable balances due to collection efforts, partially offset by a decrease in accrued expenses and other current liabilities.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Investing Activities</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the increase in net cash flows used in investing activities is primarily due to an increase in net purchases of marketable securities, an increase in the total amount of contingent consideration paid to the former shareholders of Fumapharm AG, an increase in purchases of property, plant and equipment and cash paid for the acquisition of Convergence.</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Financing Activities</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the change in net cash flows used in financing activities is primarily due to a decrease in the amount of common stock we repurchased.</font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><a name="s45D5FD5F4B27C7E084C79B204659E832"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Contractual Obligations and Off-Balance Sheet Arrangements</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Contractual Obligations</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our contractual obligations primarily consist of our obligations under non-cancellable operating leases, notes payable, and defined benefit and other purchase obligations, excluding amounts related to uncertain tax positions, amounts payable to tax authorities, funding commitments, contingent development, regulatory and commercial milestone payments, TYSABRI contingent payments and contingent consideration related to our business combinations, as described below.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In March 2015, we signed a lease for additional laboratory space in Cambridge, Massachusetts through June 2025. We are subject to future minimum rental commitments related to this lease in the amount of approximately $55.5 million over the term of the lease.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">There have been no other material changes in our contractual obligations since </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Tax Related Obligations</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We exclude liabilities pertaining to uncertain tax positions from our summary of contractual obligations as we cannot make a reliable estimate of the period of cash settlement with the respective taxing authorities. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we have approximately $50.0 million of liabilities associated with uncertain tax positions.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Other Funding Commitments</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we have several on-going clinical studies in various clinical trial stages. Our most significant clinical trial expenditures are to contract research organizations (CROs). The contracts with CROs are generally cancellable, with notice, at our option. We have recorded accrued expenses of approximately $30.0 million on our condensed consolidated balance sheet for expenditures incurred by CROs as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. We have approximately $700.0 million in cancellable future commitments based on existing CRO contracts as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we have planned clinical trials for our ISIS-SMN</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sub style="vertical-align:bottom;line-height:120%;font-size:pt">Rx</sub></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;and ISIS-DMPK</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sub style="vertical-align:bottom;line-height:120%;font-size:pt">Rx</sub></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;programs which are managed by Isis Pharmaceuticals, Inc. (Isis). We have agreed to pay up to approximately $150 million in payments to Isis as the trials for these programs proceed. If these trials advance and we continue with our Isis programs, it is possible that we could make a significant amount of additional development payments in the future.</font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">50</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Contingent Development, Regulatory and Commercial Milestone Payments</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Based on our development plans as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we could make potential future milestone payments to third parties of up to approximately $2.9 billion as part of our various collaborations, including licensing and development programs. Payments under these agreements generally become due and payable upon achievement of certain development, regulatory or commercial milestones. Because the achievement of these milestones had not occurred as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, such contingencies have not been recorded in our financial statements. Amounts related to contingent milestone payments are not considered contractual obligations as they are contingent on the successful achievement of certain development, regulatory approval and commercial milestones.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We anticipate that we may pay approximately $60.3 million of milestone payments during the remainder of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, provided various development, regulatory or commercial milestones are achieved, including $60.0 million due to Neurimmune in connection with dosing of the first patient in a Phase 3 trial for aducanumab.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">TYSABRI Contingent Payments</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In 2013, we acquired from Elan full ownership of all remaining rights to TYSABRI that we did not already own or control. Under the terms of the acquisition agreement, we are obligated to make contingent payments to Elan of 18% on annual worldwide net sales up to $2.0 billion and 25% on annual worldwide net sales that exceed $2.0 billion. Royalty payments to Elan and other third parties are recognized as cost of sales within our condensed consolidated statements of income. Elan was acquired by Perrigo in December 2013. Following that acquisition, we began making these royalty payments to Perrigo.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Contingent Consideration related to Business Combinations</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In connection with our purchase of the noncontrolling interests in our joint venture investments in Biogen Domp&#233; SRL and Biogen Domp&#233; Switzerland GmbH and our acquisitions of Convergence, Stromedix, Inc. (Stromedix), Biogen International Neuroscience GmbH (formerly Biogen Idec International Neuroscience GmbH) (BIN) and Biogen Hemophilia Inc. (formerly Biogen Idec Hemophilia Inc.) (BIH), we may pay up to approximately $1.3 billion in remaining milestones based upon the achievement of certain events. These milestones may not be achieved.  </font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As the acquisitions of the noncontrolling interests in our joint venture investments and our acquisitions of Convergence, Stromedix and BIN, formerly Panima Pharmaceuticals AG, occurred after January&#160;1, 2009, we record contingent consideration liabilities at their fair value on the acquisition date and revalue these obligations each reporting period. For additional information related to our acquisition of Convergence, please read Note 2, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Acquisitions</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, to our condensed consolidated financial statements included within this report. For additional information related to our acquisition of Stromedix, please read Note 2, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Acquisitions</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form 10-K.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">BIH</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In connection with our acquisition of BIH, formerly Syntonix, in January 2007, we agreed to pay up to an additional $80.0 million if certain milestone events associated with the development of BIH&#8217;s lead product, ALPROLIX are achieved. The first $40.0 million contingent payment was achieved in the first quarter of 2010. We paid an additional $20.0 million during the second quarter of 2014 as ALPROLIX was approved for the treatment of hemophilia B. A second $20.0 million contingent payment will occur if prior to the tenth anniversary of the closing date, a marketing authorization is granted by the EMA for ALPROLIX. This payment will be accounted for as an increase to intangible assets if achieved.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Fumapharm AG</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In 2006, we acquired Fumapharm AG. As part of this acquisition we acquired FUMADERM and TECFIDERA (together, Fumapharm Products). We paid </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$220.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;upon the closing of the transaction and agreed to pay an additional </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$15.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;if a Fumapharm Product was approved for MS in the U.S.&#160;or E.U. In the second quarter of 2013, we paid this </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$15.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;contingent payment as TECFIDERA was approved in the U.S. for MS by the FDA. We are also required to make additional contingent payments to former shareholders of Fumapharm AG or holders of their rights based on the attainment of certain cumulative sales levels of Fumapharm Products and the level of total net sales of Fumapharm Products in the prior twelve month period, as defined in the acquisition agreement. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we paid a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$250.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;contingent payment as we reached the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$4.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;cumulative sales level related to the Fumapharm Products in the fourth quarter of 2014 and accrued </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$300.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;upon reaching </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$5.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;in total cumulative sales of Fumapharm Products in the second quarter of 2015.</font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">51</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We will owe an additional </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$300.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;contingent payment for every additional </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;in cumulative sales level of Fumapharm Products reached if the prior 12 months sales of the Fumapharm Products exceed </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$3.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, until such time as the cumulative sales level reaches </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$20.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, at which time no further contingent payments shall be due. These payments will be accounted for as an increase to goodwill as incurred, in accordance with the accounting standard applicable to business combinations when we acquired Fumapharm. Any portion of the payment which is tax deductible will be recorded as a reduction to goodwill. Payments are due within 60&#160;days following the end of the quarter in which the applicable cumulative sales level has been reached. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Other Off-Balance Sheet Arrangements</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We do not have any relationships with entities often referred to as structured finance or special purpose entities that were established for the purpose of facilitating off-balance sheet arrangements. As such, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships. We consolidate variable interest entities if we are the primary beneficiary.</font></div></div><div id='pagebreak' style='width:4%; float:left;'>&nbsp;</div><div style='float:right; width:48%;'><a name="s1579521DCC03F86098F09B20468B0465"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">New Accounting Standards</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For a discussion of new accounting standards please read Note&#160;1, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Summary of Significant Accounting Policies - New Accounting Pronouncements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our condensed consolidated financial statements included within this report.</font></div><a name="s19BACC935BFB7EA416F89B2046ADDD10"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Critical Accounting Estimates</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The preparation of our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the U.S.&#160;(U.S.&#160;GAAP), requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and judgments and methodologies. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For a discussion of our critical accounting estimates, please read Part&#160;II, Item&#160;7 &#8220;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8221; of our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form&#160;10-K. There have been no material changes to these critical accounting estimates since our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;Form&#160;10-K.</font></div></div></div><br><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">52</font></div></div><hr style="page-break-after:always"><a name="sD897585BCD8E1F9DB8269B2046DF9037"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">Item&#160;3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The information required by this Item is incorporated by reference to the discussion under </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">&#8220;Market Risk&#8221;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;in Item 2. </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">&#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221;</font></div><a name="sBA1B63BCA25D7E070F739B2046FFB0D8"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">Item&#160;4.&#160;&#160;&#160;&#160;Controls and Procedures</font></div><div style="line-height:120%;padding-top:12px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Disclosure Controls and Procedures and Internal Control over Financial Reporting</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Controls and Procedures</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules&#160;13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended), as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in ensuring that (a)&#160;the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities Exchange Commission&#8217;s rules and forms, and (b)&#160;such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Changes in Internal Control over Financial Reporting</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">There were no changes in our internal control over financial reporting during the quarter ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">53</font></div></div><hr style="page-break-after:always"><a name="s3F02126B27BF04460C5E9B204732F2A0"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;padding-top:18px;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">Part&#160;II&#160;&#8212; OTHER INFORMATION</font></div><a name="sF6A22B14F5B4A27EEF0E9B20475432F2"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">Item&#160;1.&#160;&#160;&#160;&#160;Legal Proceedings</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Please refer to Note&#160;17, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Litigation</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;to our condensed consolidated financial statements included within this report, which is incorporated into this item by reference.</font></div><a name="s026B95792BCF8A7D20849B204786810F"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">Item&#160;1A.&#160;&#160;&#160;&#160;Risk Factors</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">We are substantially dependent on revenues from our principal products. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our current revenues depend upon continued sales of our principal products. We may be substantially dependent on sales from our principal products for many years, including an increasing reliance on sales and growth of TECFIDERA as we continue to expand into additional markets. Any of the following negative developments relating to any of our principal products, may adversely affect our revenues and results of operations or could cause a decline in our stock price: </font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">safety or efficacy issues; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">the introduction or greater acceptance of competing products; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">constraints and additional pressures on product pricing or price increases, due to a number of factors, including governmental or regulatory requirements, increased competition, or changes in reimbursement policies and practices of payors and other third parties; or </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">adverse legal, administrative, regulatory or legislative developments. </font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">If we fail to compete effectively, our business and market position would suffer.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The biopharmaceutical industry and the markets in which we operate are intensely competitive. We compete in the marketing and sale of our products, the development of new products and processes, the acquisition of rights to new products with commercial potential and the hiring and retention of personnel. We compete with biotechnology and pharmaceutical companies that have a greater number of products on the market and in the product pipeline, greater financial and other resources and other technological or competitive advantages. One or more of our competitors may benefit from significantly greater sales and marketing capabilities, may develop products that are accepted more widely than ours or may receive patent protection that dominates, blocks or adversely affects our product development or business.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our products are also susceptible to competition from generics and biosimilars in many markets.&#160;Generic versions of drugs and biosimilars are likely to be sold at substantially lower prices than branded products.&#160;Accordingly, the introduction of generic or biosimilar versions of our marketed products likely would significantly reduce both the price that we receive for such marketed products and the volume of products that we sell, which may have an adverse impact on our results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the MS market, we face intense competition as the number of products and competitors continues to expand. Due to our significant reliance on sales of our MS products, our business may be harmed if we are unable to successfully compete in the MS market. More specifically, our ability to compete, maintain and grow our share in the MS market may be adversely affected due to a number of factors, including:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">the introduction of more efficacious, safer, less expensive or more convenient alternatives to our MS products, including our own products and products of our collaborators; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">the introduction of lower-cost biosimilars, follow-on products or generic versions of branded MS products sold by our competitors, and the possibility of future competition from generic versions or related prodrug derivatives or from off-label use by physicians of therapies indicated for other conditions to treat MS patients; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">patient dynamics, including the size of the patient population and our ability to attract new patients to our therapies; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">damage to physician and patient confidence in any of our MS products or to our sales and reputation as a result of label changes or adverse experiences or events that may occur with patients treated with our MS products; </font></div></td></tr></table><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">54</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">inability to obtain appropriate pricing and reimbursement for our MS products compared to our competitors in key international markets; or </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">our ability to obtain and maintain patent, data or market exclusivity for our MS products.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Similarly, the hemophilia treatment market is highly competitive, with current treatments marketed by companies that have substantially greater financial resources and marketing expertise. Our ability to successfully compete in the hemophilia market and gain share in this market may be adversely affected due to a number of reasons, including:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">difficulty in penetrating this market if our therapies are not regarded as offering substantial benefits over current treatments;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">the introduction by other companies of longer-lasting or more efficacious, safer, less expensive or more convenient treatments than our therapies; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">our limited marketing experience within the hemophilia treatment market, which may impact our ability to develop well-established relationships with the associated medical and scientific community; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">if one of several companies that are working to develop additional treatments for hemophilia obtains marketing approval of its treatment in the E.U. before we do, our applications with the EMA could be barred under operation of the EMA&#8217;s Orphan Medicines Regulation.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">If we are unable to obtain and maintain adequate protection for our data, intellectual property and other proprietary rights, our business may be harmed. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our success depends in part on our ability to obtain and defend patent and other intellectual property rights that are important to the commercialization of our products and product candidates. The degree of patent protection that will be afforded to our products and processes in the U.S. and in other important markets remains uncertain and is dependent upon the scope of protection decided upon by the patent offices, courts and lawmakers in these countries. We can provide no assurance that we will successfully obtain or preserve patent protection for the technologies incorporated into our products and processes, or that the protection obtained will be of sufficient breadth and degree to protect our commercial interests in all countries where we conduct business. If we cannot prevent others from exploiting our inventions, we will not derive the benefit from them that we currently expect. Furthermore, we can provide no assurance that our products will not infringe patents or other intellectual property rights held by third parties.  </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We also rely on regulatory exclusivity for protection of our products. Implementation and enforcement of regulatory exclusivity, which may consist of regulatory data protection and market protection, varies widely from country to country.&#160;Failure to qualify for regulatory exclusivity, or failure to obtain or maintain the extent or duration of such protections that we expect in each of the markets for our products, could affect our revenue for our products or our decision on whether to market our products in a particular country or countries or could otherwise have an adverse impact on our results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Litigation, interferences, oppositions, inter partes reviews or other proceedings are, have been and may in the future be necessary in some instances to determine the validity and scope of certain of our proprietary rights, and in other instances to determine the validity, scope or non-infringement of certain patent rights claimed by third parties to be pertinent to the manufacture, use or sale of our products.&#160;We may also face challenges to our patent and regulatory protections covering our products by manufacturers of generics and biosimilars that may choose to launch or attempt to launch their products before the expiration of our patent or regulatory exclusivity.&#160;Litigation, interference, oppositions or other similar types of proceedings are unpredictable and may be protracted, expensive and distracting to management. The outcome of such proceedings could adversely affect the validity and scope of our patent or other proprietary rights, hinder our ability to manufacture and market our products, require us to seek a license for the infringed product or technology or result in the assessment of significant monetary damages against us that may exceed amounts, if any, accrued in our financial statements. An adverse determination in a judicial or administrative proceeding or a failure to obtain necessary licenses could prevent us from manufacturing or selling our products.  Furthermore, payments under any licenses that we are able to obtain would reduce our profits derived from the covered products and services.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">55</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Our long-term success depends upon the successful development of new products and additional indications for existing products. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our long-term viability and growth will depend upon successful development of additional indications for our existing products as well as successful development of new products and technologies resulting from our research and development activities, our biosimilars joint venture with Samsung Biologics or licenses or acquisitions from third parties. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Product development is very expensive and involves a high degree of risk. Only a small number of research and development programs result in the commercialization of a product. Clinical trials may indicate that our product candidates lack efficacy, have harmful side effects or raise other concerns that may significantly reduce the likelihood of regulatory approval. This may result in significant restrictions on use and safety warnings in an approved label, adverse placement within the treatment paradigm, or significant reduction in the commercial potential of the product candidate.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Clinical trials and the development of biopharmaceutical products is a lengthy and complex process. If we fail to adequately manage our clinical activities, our clinical trials or potential regulatory approvals may be delayed or denied. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Conducting clinical trials is a complex, time-consuming and expensive process. Our ability to complete clinical trials in a timely fashion depends in large part on a number of key factors. These factors include protocol design, regulatory and institutional review board approval, patient enrollment rates, and compliance with extensive current Good Clinical Practices. If we or our third party clinical trial providers or third party contract research organizations, or CROs, do not successfully carry out these clinical activities, our clinical trials or the potential regulatory approval of a product candidate may be delayed or be unsuccessful.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have opened clinical sites and are enrolling patients in a number of countries where our experience is more limited. In most cases, we use the services of third parties to carry out our clinical trial related activities and rely on such parties to accurately report their results. Our reliance on third parties for these activities may impact our ability to control the timing, conduct, expense and quality of our clinical trials. One CRO has responsibility for substantially all of our clinical trial related activities and reporting. If this CRO does not adequately perform, many of our trials may be affected. We may need to replace our CROs. Although we believe there are a number of other CROs we could engage to continue these activities, the replacement of an existing CRO may result in the delay of the affected trials or otherwise adversely affect our efforts to obtain regulatory approvals and commercialize our product candidates.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Successful preclinical work or early stage clinical trials does not ensure success in later stage trials, regulatory approval or commercial viability of a product.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Positive results in a trial may not be replicated in subsequent or confirmatory trials. Additionally, success in preclinical work or early stage clinical trials does not ensure that later stage or larger scale clinical trials will be successful or that regulatory approval will be obtained. In addition, even if later stage clinical trials are successful regulatory authorities may delay or decline approval of our product candidates. Regulatory authorities may disagree with our view of the data, require additional studies or disagree with our trial design or endpoints. Regulatory authorities may also fail to approve the facilities or the processes used to manufacture a product candidate, our dosing or delivery methods or companion devices. Regulatory authorities may grant marketing approval that is more restricted than anticipated. These restrictions may include limiting indications to narrow patient populations and the imposition of safety monitoring, educational requirements and risk evaluation and mitigation strategies. The occurrence of any of these events could result in significant costs and expenses, have an adverse effect on our business, financial condition and results of operations and cause our stock price to decline or experience periods of volatility.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Even if we are able to successfully develop new products or indications, sales of new products or products with additional indications may not meet investor expectations.  We may also make a strategic decision to discontinue development of a product or indication if, for example, we believe commercialization will be difficult relative to the standard of care or other opportunities in our pipeline.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">56</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Adverse safety events or restrictions on use and safety warnings for our products can negatively affect our business, product sales and stock price.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adverse safety events involving our marketed products may have a negative impact on our business. Discovery of safety issues with our products could create product liability and could cause additional regulatory scrutiny and requirements for additional labeling, withdrawal of products from the market, and the imposition of fines or criminal penalties. Adverse safety events may also damage physician and patient confidence in our products and our reputation. Any of these could result in liabilities, loss of revenue, material write-offs of inventory, material impairments of intangible assets, goodwill and fixed assets, material restructuring charges and other adverse impacts on our results of operations. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Regulatory authorities are making greater amounts of stand-alone safety information directly available to the public through periodic safety update reports, patient registries and other reporting requirements. The reporting of adverse safety events involving our products or products similar to ours and public rumors about such events may increase claims against us and may also cause our product sales or stock price to decline or experience periods of volatility. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Restrictions on use or significant safety warnings that may be required to be included in the label of our products, such as the risk of developing progressive multifocal leukoencephalopathy (PML), a serious brain infection, in the label for TYSABRI and in the U.S. label for TECFIDERA, may significantly reduce expected revenues for those products and require significant expense and management time. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Sales of our products depend, to a significant extent, on adequate coverage, pricing and reimbursement from third party payors, which are subject to increasing and intense pressure from political, social, competitive and other sources. Our inability to maintain adequate coverage, or a reduction in pricing or reimbursement, could have an adverse effect on our business, revenues and results of operations, and could cause a decline in our stock price.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Sales of our products are dependent, in large part, on the availability and extent of coverage, pricing and reimbursement from government health administration authorities, private health insurers and other organizations. Drug prices are under significant scrutiny in the markets where our products are prescribed.  In addition, when a new pharmaceutical product is approved, the availability of government and private reimbursement for that product may be uncertain, as is the pricing and amount for which that product will be reimbursed. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Pricing and reimbursement for our products may be adversely affected by a number of factors, including: </font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">changes in government regulations or private third-party payors' reimbursement policies; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">pressure by employers on private health insurance plans to reduce costs; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">payors, including managed care organizations, health insurers, pharmacy benefit managers, government health administration authorities, private health insurers and other organizations, seeking price discounts or rebates in connection with the placement of our products on their formularies and, in some cases, the imposition of restrictions on access or coverage of particular drugs or pricing determined based on perceived value.&#160; </font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our ability to set the price for our products can vary significantly from country to country and as a result so can the price of our products.  Certain countries set prices by reference to the prices in other countries where our products are marketed. Thus, our inability to secure adequate prices in a particular country may not only limit the marketing of our products within that country, but may also adversely affect our ability to obtain acceptable prices in other markets. This may create the opportunity for third party cross-border trade or influence our decision to sell or not to sell a product, thus adversely affecting our geographic expansion plans and revenues.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our failure to maintain adequate coverage, pricing, or reimbursement for our products would have an adverse effect on our business, revenues and results of operation, could curtail or eliminate our ability to adequately fund research and development programs for the discovery and commercialization of new products, and could cause a decline in our stock price.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">57</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Our results of operations may be adversely affected by current and potential future healthcare reforms.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the U.S., federal and state legislatures, health agencies and third-party payors continue to focus on containing the cost of health care. Legislative and regulatory proposals and enactments to reform health care insurance programs could significantly influence the manner in which our products are prescribed and purchased. For example, provisions of the Patient Protection and Affordable Care Act (PPACA) have resulted in changes in the way health care is paid for by both governmental and private insurers, including increased rebates owed by manufacturers under the Medicaid Drug Rebate Program, annual fees and taxes on manufacturers of certain branded prescription drugs, the requirement that manufacturers participate in a discount program for certain outpatient drugs under Medicare Part D and the expansion of the number of hospitals eligible for discounts under Section 340B of the Public Health Service Act. These changes have had and are expected to continue to have a significant impact on our business.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">There is also significant economic pressure on state budgets that may result in states increasingly seeking to achieve budget savings through mechanisms that limit coverage or payment for our drugs. In recent years, some states have considered legislation that would control the prices of drugs, including laws to allow importation of pharmaceutical products from lower cost jurisdictions outside the U.S. State Medicaid programs are increasingly requesting manufacturers to pay supplemental rebates and requiring prior authorization by the state program for use of any drug for which supplemental rebates are not being paid. Government efforts to reduce Medicaid expenses may lead to increased use of managed care organizations by Medicaid programs. This may result in managed care organizations influencing prescription decisions for a larger segment of the population and a corresponding constraint on prices and reimbursement for our products. In addition, under the PPACA, as states implement their health care marketplaces or operate under the federal exchange, the impact on drug manufacturers, including us, will depend in part on the formulary and benefit design decisions made by insurance sponsors or plans participating in these programs. It is possible that we may need to provide discounts or rebates to such plans in order to maintain favorable formulary access for our products for this patient population, which could have an adverse impact on our sales and results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the European Union and some other international markets, the government provides health care at low cost to consumers and regulates pharmaceutical prices, patient eligibility or reimbursement levels to control costs for the government-sponsored health care system. Many countries have announced or implemented measures to reduce health care costs to constrain their overall level of government expenditures. These measures vary by country and may include, among other things, patient access restrictions, suspensions on price increases, prospective and possibly retroactive price reductions and other recoupments and increased mandatory discounts or rebates, recoveries of past price increases, and greater importation of drugs from lower-cost countries to higher-cost countries. These measures have negatively impacted our revenues, and may continue to adversely affect our revenues and results of operations in the future.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">We depend on relationships with collaborators and other third-parties for revenue, and the development, commercialization and marketing of certain products, which are outside of our full control.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We rely on a number of significant collaborative relationships for revenue, and the development, commercialization, and marketing of certain of our products and product candidates. Reliance on collaborative relationships subjects us to a number of risks, including:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:29px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">we may be unable to control the resources our collaborator devotes to our programs or products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:29px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">disputes may arise with respect to ownership of rights to technology developed with our collaborator, and the underlying contract with our collaborator may fail to provide significant protection or may fail to be effectively enforced if the collaborator fails to perform; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:29px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">our collaborator&#8217;s interests may not always be aligned with our interests and may not market a product in the same manner or to the same extent that we would, which could adversely affect our revenues; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:29px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">collaborations often require the parties to cooperate, and failure to do so effectively could adversely affect product sales by our collaborator or the clinical development or regulatory approvals of products under joint control or could result in termination of the research, development or commercialization of product candidates or result in litigation or arbitration; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:29px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">any failure on the part of our collaborator to comply with applicable laws and regulatory requirements in the marketing, sale and maintenance of the market authorization of our products or to fulfill any responsibilities our </font></div></td></tr></table><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">58</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;padding-left:29px;padding-top:12px;text-align:left;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">collaborator may have to protect and enforce any intellectual property rights underlying our products could have an adverse effect on our revenues as well as involve us in possible legal proceedings.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Given these risks, there is considerable uncertainty regarding the success of our current and future collaborative efforts. If these efforts fail, our product development or commercialization of new products could be delayed or revenues from products could decline.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Manufacturing issues could substantially increase our costs, limit supply of our products and reduce our revenues.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The process of manufacturing our products is complex, highly regulated and subject to numerous risks, including:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:29px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Risk of Product Loss.</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;The manufacturing process for our products is extremely susceptible to product loss due to contamination, oxidation, equipment failure or improper installation or operation of equipment, or vendor or operator error. Even minor deviations from normal manufacturing processes could result in reduced production yields, product defects and other supply disruptions. If microbial, viral or other contaminations are discovered in our products or manufacturing facilities, we may need to close our manufacturing facilities for an extended period of time to investigate and remediate the contaminant. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:29px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Risks of Reliance on Third Parties and Single Source Providers.</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;We rely on third party suppliers and manufacturers for, among other things: manufacturing of RITUXAN and GAZYVA; the majority of our clinical and commercial requirements for TECFIDERA and other small molecule products and product candidates; raw materials and supplies for production of products we manufacture; delivery devices such as syringes and auto-injectors; drug product and fill-finish operations; the majority of our final product storage; and a substantial portion of our packaging operations. In addition, due to the unique manner in which our products are manufactured, we rely on single source providers of several raw materials and manufacturing supplies. These third parties are independent entities subject to their own unique operational and financial risks that are outside of our control. These third parties may not perform their obligations in a timely and cost-effective manner or in compliance with applicable regulations, and they may be unable or unwilling to increase production capacity commensurate with demand for our existing or future products. Finding alternative providers could take a significant amount of time and involve significant expense due to the specialized nature of the services and the need to obtain regulatory approval of any significant changes to our suppliers or manufacturing methods. We cannot be certain that we could reach agreement with alternative providers or that the FDA or other regulatory authorities would approve our use of such alternatives. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:29px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Global Bulk Supply Risks.</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;We rely on our manufacturing facilities in Cambridge, Massachusetts, RTP, North Carolina and Hiller&#248;d, Denmark for the production of drug substance for certain of our large molecule products and product candidates, including AVONEX, TYSABRI, PLEGRIDY, ZINBRYTA, ALPROLIX and ELOCTATE. Our global bulk supply of these products and product candidates depends on the uninterrupted and efficient operation of these facilities, which could be adversely affected by equipment failures, labor shortages, natural disasters, power failures and numerous other factors.   </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:29px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Risks Relating to Compliance with Current Good Manufacturing Practices.</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;We and our third party providers are generally required to maintain compliance with current Good Manufacturing Practices and other stringent requirements and are subject to inspections by the FDA and comparable agencies in other jurisdictions to confirm such compliance. Any delay, interruption or other issues that arise in the manufacture, fill-finish, packaging, or storage of our products as a result of a failure of our facilities or the facilities or operations of third parties to pass any regulatory agency inspection could significantly impair our ability to develop and commercialize our products. Significant noncompliance could also result in the imposition of monetary penalties or other civil or criminal sanctions and damage our reputation.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Any adverse developments affecting our manufacturing operations or the operations of our third-party suppliers and manufacturers may result in shipment delays, inventory shortages, lot failures, product withdrawals or recalls, or other interruptions in the commercial supply of our products. We may also have to take inventory write-offs and incur other charges and expenses for products that fail to meet specifications, undertake costly remediation efforts or seek more costly manufacturing alternatives. Such developments could increase our manufacturing costs, cause us to lose revenue or market share as patients and physicians turn to competing therapeutics, diminish our profitability or damage our reputation. </font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">59</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Our business may be adversely affected if we do not manage our current growth and do not successfully execute our growth initiatives.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have experienced significant growth in our headcount and operations, which has placed, and will continue to place, significant demands on our management and our operational and financial infrastructure. We anticipate further growth through both internal development projects as well as external opportunities, which may include the acquisition, partnering and in-licensing of products, technologies and companies or the entry into strategic alliances and collaborations. The availability of high quality development opportunities is limited and competitive, and we are not certain that we will be able to identify candidates that we and our shareholders consider suitable or complete transactions on terms that are acceptable to us and our shareholders. In order to pursue such opportunities, we may require significant additional financing, which may not be available to us on favorable terms, if at all. Even if we are able to successfully identify and complete acquisitions and other strategic alliances and collaborations, we may face unanticipated costs or liabilities in connection with the transaction or we may not be able to integrate them or take full advantage of them or otherwise realize the benefits that we expect.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">To manage our current and future potential growth effectively, we need to continue to enhance our operational, financial and management processes and to expand, train and manage our employee base. Our growth is also dependent upon our ability to attract and retain qualified scientific, information technology, manufacturing, sales and marketing and executive personnel and to develop and maintain relationships with qualified clinical researchers and key distributors in a highly competitive environment. Supporting our growth initiatives and the further development of our existing products and potential new products in our pipeline will require significant capital expenditures and management resources, including investments in research and development, sales and marketing, manufacturing capabilities and other areas of our business. If we do not successfully manage our current growth and do not successfully execute our growth initiatives, then our business and financial results may be adversely affected and we may incur asset impairment or restructuring charges.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">If we fail to comply with the extensive legal and regulatory requirements affecting the health care industry, we could face increased costs, penalties and a loss of business.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our activities, and the activities of our collaborators, distributors and other third party providers, are subject to extensive government regulation and oversight both in the U.S.&#160;and in foreign jurisdictions. The FDA and comparable agencies in other jurisdictions directly regulate many of our most critical business activities, including the conduct of preclinical and clinical studies, product manufacturing, advertising and promotion, product distribution, adverse event reporting and product risk management. Our interactions in the U.S.&#160;or abroad with physicians and other health care providers that prescribe or purchase our products are also subject to government regulation designed to prevent fraud and abuse in the sale and use of the products and place greater restrictions on the marketing practices of health care companies. Health care companies such as ours are facing heightened scrutiny of their relationships with health care providers from anti-corruption enforcement officials. In addition, we along with many other pharmaceutical and biotechnology companies have been the target of lawsuits and investigations alleging violations of government regulation, including claims asserting submission of incorrect pricing information, impermissible off-label promotion of pharmaceutical products, payments intended to influence the referral of health care business, submission of false claims for government reimbursement, antitrust violations, or violations related to environmental matters. These risks may be heightened as we continue to expand our global operations and introduce additional products to the market.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Regulations governing the health care industry are subject to change, with possibly retroactive effect, including:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:29px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">new laws, regulations or judicial decisions, or new interpretations of existing laws, regulations or decisions, related to health care availability, pricing or marketing practices, compliance with wage and hour laws and other employment practices, method of delivery, payment for health care products and services, compliance with health information and data privacy and security laws and regulations, tracking and reporting payments and other transfers of value made to physicians and teaching hospitals, extensive anti-bribery and anti-corruption prohibitions, product serialization and labeling requirements, and used product take-back requirements; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:29px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">changes in the FDA and foreign regulatory approval processes that may delay or prevent the approval of new products and result in lost market opportunity; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:29px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">requirements that provide for increased transparency of clinical trial results and quality data, such as the EMA&#8217;s recently enacted clinical transparency policy, which could impact our ability to protect trade secrets and competitively-sensitive information contained in approval applications or could be misinterpreted leading to reputational damage, misperception or legal action which could harm our business; and</font></div></td></tr></table><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">60</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:29px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">changes in FDA and foreign regulations that may require additional safety monitoring, labeling changes, restrictions on product distribution or use, or other measures after the introduction of our products to market, which could increase our costs of doing business, adversely affect the future permitted uses of approved products, or otherwise adversely affect the market for our products.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Examples of previously enacted and possible future changes in laws that could adversely affect our business include the enactment in the U.S.&#160;of health care reform, regulatory pathways easing the entry of competing biosimilars in the marketplace, new legislation or implementation of existing statutory provisions on importation of lower-cost competing drugs from other jurisdictions, enhanced penalties for and investigations into non-compliance with U.S.&#160;fraud and abuse laws, and compliance with the Physician Payment Sunshine Act in the U.S. and similar foreign rules and regulations that require collection and reporting of payments or other transfers of value made to physicians and teaching hospitals.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Violations of governmental regulation may be punishable by criminal and civil sanctions against us, including fines and civil monetary penalties and exclusion from participation in government programs, including Medicare and Medicaid, as well as against executives overseeing our business. In addition to penalties for violation of laws and regulations, we could be required to repay amounts we received from government payors, or pay additional rebates and interest if we are found to have miscalculated the pricing information we have submitted to the government. Whether or not we have complied with the law, an investigation into alleged unlawful conduct could increase our expenses, damage our reputation, divert management time and attention and adversely affect our business.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">A breakdown or breach of our technology systems could subject us to liability or interrupt the operation of our business.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We are increasingly dependent upon technology systems and data. Our computer systems continue to increase in multitude and complexity due to the growth in our business, making them potentially vulnerable to breakdown, malicious intrusion and random attack.&#160;Likewise, data privacy or security breaches by individuals authorized to access our technology systems or others may pose a risk that sensitive data, including intellectual property, trade secrets or personal information belonging to us, our patients, customers or other business partners, may be exposed to unauthorized persons or to the public. Cyber-attacks are increasing in their frequency, sophistication and intensity. While we continue to build and improve our systems and infrastructure and believe we have taken appropriate security measures to minimize these risks to our data and information technology systems, there can be no assurance that our efforts will prevent breakdowns or breaches in our systems that could adversely affect our business and operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Our sales and operations are subject to the risks of doing business internationally.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We are increasing our presence in international markets, particularly emerging markets, subjecting us to many risks that could adversely affect our business and revenues, such as:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">the inability to obtain necessary foreign regulatory or pricing approvals of products in a timely manner; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">collectability of accounts receivable; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">fluctuations in foreign currency exchange rates, in particular the recent strength of the U.S. dollar versus foreign currencies which has adversely impacted our revenues and net income; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">difficulties in staffing and managing international operations; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">the imposition of governmental controls; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">less favorable intellectual property or other applicable laws; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">increasingly complex standards for complying with foreign laws and regulations that may differ substantially from country to country and may conflict with corresponding U.S. laws and regulations; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">the far-reaching anti-bribery and anti-corruption legislation in the U.K., including the U.K. Bribery Act 2010, and elsewhere and escalation of investigations and prosecutions pursuant to such laws; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">compliance with complex import and export control laws;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">restrictions on direct investments by foreign entities and trade restrictions; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">greater political or economic instability; and </font></div></td></tr></table><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">61</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">changes in tax laws and tariffs.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In addition, our international operations are subject to regulation under U.S. law. For example, the Foreign Corrupt Practices Act prohibits U.S. companies and their representatives from offering, promising, authorizing or making payments to foreign officials for the purpose of obtaining or retaining business abroad. In many countries, the health care professionals we regularly interact with may meet the definition of a foreign government official for purposes of the Foreign Corrupt Practices Act. Failure to comply with domestic or foreign laws could result in various adverse consequences, including: possible delay in approval or refusal to approve a product; recalls, seizures or withdrawal of an approved product from the market; disruption in the supply or availability of our products or suspension of export or import privileges; the imposition of civil or criminal sanctions; the prosecution of executives overseeing our international operations; and damage to our reputation.  Any significant impairment of our ability to sell products outside of the U.S. could adversely impact our business and financial results.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Our effective tax rate may fluctuate and we may incur obligations in tax jurisdictions in excess of accrued amounts.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As a global biopharmaceutical company, we are subject to taxation in numerous countries, states and other jurisdictions. As a result, our effective tax rate is derived from a combination of applicable tax rates in the various places that we operate. In preparing our financial statements, we estimate the amount of tax that will become payable in each of such places. Our effective tax rate, however, may be different than experienced in the past due to numerous factors, including changes in the mix of our profitability from country to country, the results of examinations and audits of our tax filings, adjustments to the value of our uncertain tax positions, changes in accounting for income taxes and changes in tax laws. Any of these factors could cause us to experience an effective tax rate significantly different from previous periods or our current expectations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In addition, our inability to secure or sustain acceptable arrangements with tax authorities and previously enacted or future changes in the tax laws, among other things, may result in tax obligations in excess of amounts accrued in our financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the U.S., there are several proposals under consideration to reform tax law, including proposals that may reduce or eliminate the deferral of U.S.&#160;income tax on our unrepatriated earnings, penalize certain transfer pricing structures, and reduce or eliminate certain foreign or domestic tax credits or deductions. Our future reported financial results may be adversely affected by tax law changes which restrict or eliminate certain foreign tax credits or our ability to deduct expenses attributable to foreign earnings, or otherwise affect the treatment of our unrepatriated earnings.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In addition to U.S. tax reform proposals, the adoption of some or all of the recommendations set forth in the Organization for Economic Co-operation and Development&#8217;s project on &#8220;Base Erosion and Profit Shifting&#8221; (BEPS) by tax authorities in the countries in which we operate, could negatively impact our effective tax rate.&#160;These recommendations focus on payments from affiliates in high tax jurisdictions to affiliates in lower tax jurisdictions and the activities that give rise to a taxable presence in a particular country.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Our operating results are subject to significant fluctuations.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our quarterly revenues, expenses and net income (loss) have fluctuated in the past and are likely to fluctuate significantly in the future due to the risks described in these </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">&#8220;Risk Factors&#8221;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;as well as the timing of charges and expenses that we may take. We have recorded, or may be required to record, charges that include:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">the cost of restructurings; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">impairments with respect to investments, fixed assets and long-lived assets, including in-process R&amp;D and other intangible assets; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">inventory write-downs for failed quality specifications, charges for excess or obsolete inventory and charges for inventory write downs relating to product suspensions, expirations or recalls; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">changes in the fair value of contingent consideration;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">bad debt expenses and increased bad debt reserves; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">outcomes of litigation and other legal or administrative proceedings, regulatory matters and tax matters;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">milestone payments under license and collaboration agreements; and </font></div></td></tr></table><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">62</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">payments in connection with acquisitions and other business development activities.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our revenues are also subject to foreign exchange rate fluctuations due to the global nature of our operations. Although we have foreign currency forward contracts to hedge specific forecasted transactions denominated in foreign currencies, our efforts to mitigate the impact of fluctuating currency exchange rates may not be successful. As a result, currency fluctuations among our reporting currency, the U.S.&#160;dollar, and the currencies in which we do business will affect our operating results, often in unpredictable ways. Our net income may also fluctuate due to the impact of charges we may be required to take with respect to foreign currency hedge transactions. In particular, we may incur higher than expected charges from hedge ineffectiveness or from the termination of a hedge relationship.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our operating results during any one period do not necessarily suggest the anticipated results of future periods.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">We are pursuing opportunities to expand our manufacturing capacity for future clinical and commercial requirements for product candidates, which would result in the incurrence of significant investment with no assurance that such investment will be recouped.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">While we believe we currently have sufficient manufacturing capacity to meet our near-term manufacturing requirements, it is probable that we would need additional manufacturing capacity to support future clinical and commercial manufacturing requirements for product candidates in our pipeline, if such candidates are successful and approved. Due to the long lead times necessary for the expansion of manufacturing capacity, we expect to incur significant investment to build or acquire additional facilities or obtain third party contract manufacturers with no assurance that such investment will be recouped. If we are unable to adequately and timely manufacture and supply our products and product candidates or if we do not fully utilize our manufacturing facilities, our business may be harmed.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Our investments in properties may not be fully realized.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We own or lease real estate primarily consisting of buildings that contain research laboratories, office space, and manufacturing operations. For strategic or other operational reasons, we may decide to further consolidate or co-locate certain aspects of our business operations or dispose of one or more of our properties, some of which may be located in markets that are experiencing high vacancy rates and decreasing property values. If we determine that the fair value of any of our owned properties is lower than their book value we may not realize the full investment in these properties and incur significant impairment charges. If we decide to fully or partially vacate a leased property, such as we did following our 2013 relocation of our corporate headquarters from Weston, Massachusetts to Cambridge, Massachusetts, we may incur significant cost, including lease termination fees, rent expense in excess of sublease income and impairment of leasehold improvements. Any of these events may have an adverse impact on our results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Our portfolio of marketable securities is subject to market, interest and credit risk that may reduce its value.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We maintain a portfolio of marketable securities for investment of our cash. Changes in the value of our portfolio of marketable securities could adversely affect our earnings. In particular, the value of our investments may decline due to increases in interest rates, downgrades of the bonds and other securities included in our portfolio, instability in the global financial markets that reduces the liquidity of securities included in our portfolio, declines in the value of collateral underlying the securities included in our portfolio, and other factors. Each of these events may cause us to record charges to reduce the carrying value of our investment portfolio or sell investments for less than our acquisition cost. Although we attempt to mitigate these risks through diversification of our investments and continuous monitoring of our portfolio's overall risk profile, the value of our investments may nevertheless decline.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">There can be no assurance that we will continue to repurchase stock or that we will repurchase stock at favorable prices.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our Board of Directors has approved stock repurchase programs. The amount and timing of such stock repurchases are subject to capital availability and determinations by our Board of Directors that stock repurchases are in the best interest of our stockholders and are in compliance with all respective laws and our agreements applicable to the repurchase of stock. Our ability to repurchase stock will depend upon, among other factors, our cash balances and potential future capital requirements for strategic transactions, results of operations, financial condition, our ability to obtain debt financing, and other factors beyond our control that our Board of Directors may deem relevant. A reduction in or elimination of our stock repurchase program could have a negative effect on our stock price. We can provide no assurance that we will repurchase stock at favorable prices, if at all.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">63</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">We may not be able to access the capital and credit markets on terms that are favorable to us.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We may seek access to the capital markets to supplement our existing funds and cash generated from operations for working capital, capital expenditure and debt service requirements, and other business initiatives. The capital and credit markets have experienced extreme volatility and disruption which leads to uncertainty and liquidity issues for both borrowers and investors. In the event of adverse capital and credit market conditions, we may be unable to obtain capital market financing on favorable terms. Changes in credit ratings issued by nationally recognized credit rating agencies could also adversely affect our cost of financing and the market price of our securities.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Our business involves environmental risks, which include the cost of compliance and the risk of contamination or injury.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our business and the business of several of our strategic partners involve the controlled use of hazardous materials, chemicals, biologics and radioactive compounds. Although we believe that our safety procedures for handling and disposing of such materials comply with state and federal standards, there will always be the risk of accidental contamination or injury. If we were to become liable for an accident, or if we were to suffer an extended facility shutdown, we could incur significant costs, damages and penalties that could harm our business. Manufacturing of our products and product candidates also requires permits from government agencies for water supply and wastewater discharge. If we do not obtain appropriate permits, or permits for sufficient quantities of water and wastewater, we could incur significant costs and limits on our manufacturing volumes that could harm our business.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">The illegal distribution and sale by third parties of counterfeit versions of our products or stolen products could have a negative impact on our reputation and business.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Third parties might illegally distribute and sell counterfeit or unfit versions of our products, which do not meet our rigorous manufacturing, distribution and testing standards. A patient who receives a counterfeit or unfit drug may be at risk for a number of dangerous health consequences. Our reputation and business could suffer harm as a result of counterfeit or unfit drugs sold under our brand name. In addition, thefts of inventory at warehouses, plants or while in-transit, which are not properly stored and which are sold through unauthorized channels, could adversely impact patient safety, our reputation and our business.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">The increasing use of social media platforms presents new risks and challenges.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Social media is increasingly being used to communicate about our products and the diseases our therapies are designed to treat. Social media practices in the biopharmaceutical industry continue to evolve and regulations relating to such use are not always clear. This evolution creates uncertainty and risk of noncompliance with regulations applicable to our business. For example, patients may use social media channels to comment on the effectiveness of a product or to report an alleged adverse event. When such disclosures occur, there is a risk that we fail to monitor and comply with applicable adverse event reporting obligations or we may not be able to defend the company or the public's legitimate interests in the face of the political and market pressures generated by social media due to restrictions on what we may say about our products. There is also a risk of inappropriate disclosure of sensitive information or negative or inaccurate posts or comments about us on any social networking website. If any of these events were to occur or we otherwise fail to comply with applicable regulations, we could incur liability, face overly restrictive regulatory actions or incur other harm to our business.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Some of our collaboration agreements contain change in control provisions that may discourage a third party from attempting to acquire us.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Some of our collaboration agreements include change in control provisions that could reduce the potential acquisition price an acquirer is willing to pay or discourage a takeover attempt that could be viewed as beneficial to shareholders. &#160;Upon a change in control, some of these provisions could trigger reduced milestone, profit or royalty payments to us or give our collaboration partner rights to terminate our collaboration agreement, acquire operational control or force the purchase or sale of the programs that are the subject of the collaboration.&#160; </font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">64</font></div></div><hr style="page-break-after:always"><a name="s01E7C57A8D89FF0739029B1FF3FE6F3A"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">Item&#160;2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</font></div><div style="line-height:120%;padding-top:12px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Issuer Purchases of Equity Securities</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes our common stock repurchase activity under our 2015 Share Repurchase Program during the second quarter of 2015:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td width="17%"></td><td width="19%"></td><td width="1%"></td><td width="1%"></td><td width="19%"></td><td width="1%"></td><td width="1%"></td><td width="19%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="18%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total&#160;Number&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Shares&#160;Purchased</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(#)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Average&#160;Price</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Paid&#160;per&#160;Share</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total&#160;Number&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Shares&#160;Purchased</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">as&#160;Part&#160;of&#160;Publicly</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Announced&#160; Programs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(#)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Maximum</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Approximate Dollar Value</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">of Shares That May Yet Be</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Purchased Under</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Our Programs ($ in millions)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">April&#160;2015</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">May&#160;2015</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">24,110</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">396.79</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">24,110</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,990</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;2015</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">82,961</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">393.28</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">82,961</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,958</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">107,071</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">394.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes our common stock repurchase activity under our 2011 Share Repurchase Program during the second quarter of 2015:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td width="17%"></td><td width="19%"></td><td width="1%"></td><td width="1%"></td><td width="19%"></td><td width="1%"></td><td width="1%"></td><td width="19%"></td><td width="1%"></td><td width="1%"></td><td width="19%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total&#160;Number&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Shares&#160;Purchased</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(#)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Average&#160;Price</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Paid&#160;per&#160;Share</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total&#160;Number&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Shares&#160;Purchased</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">as&#160;Part&#160;of&#160;Publicly</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Announced&#160; Programs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(#)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Maximum</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Number&#160;of&#160;Shares</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">That May Yet Be</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Purchased Under</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Our Programs (#)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">April&#160;2015</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,264,156</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">May&#160;2015</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,264,156</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;2015</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,264,156</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2015, our Board of Directors authorized a program to repurchase up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$5.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;of our common stock (2015 Share Repurchase Program). This authorization does not have an expiration date. We expect that purchases will be executed within a period of up to five years and that repurchased shares will be retired. The 2015 Share Repurchase Program is in addition to the approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;shares remaining under our February 2011 Share Repurchase Program (2011 Share Repurchase Program), which has been used principally to offset common stock issuances under our share-based compensation plans.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we repurchased and retired approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;shares of common stock at a cost of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$42.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;under our 2015 Share Repurchase Program and did not repurchase any shares of common stock under our 2011 Share Repurchase Program. During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we purchased approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;shares of common stock at a cost of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$336.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;under our 2011 Share Repurchase Program. </font></div><a name="sC2779DA73CA048CEA9469B2047D9FCB3"></a><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">Item&#160;6.&#160;&#160;&#160;&#160;Exhibits</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The exhibits listed on the Exhibit&#160;Index immediately preceding such exhibits, which is incorporated herein by reference, are filed or furnished as part of this Quarterly Report on Form&#160;10-Q.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">65</font></div></div><hr style="page-break-after:always"><a name="sFA440BC99160E6BD61119B2047FAFD58"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;padding-top:18px;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</font></div><div style="line-height:120%;padding-left:492px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:27.34375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">BIOGEN INC.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">/s/&#160;&#160;&#160;&#160;Paul J. Clancy</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Paul J. Clancy</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Executive Vice President and</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(principal financial officer)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">July&#160;24, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">66</font></div></div><hr style="page-break-after:always"><a name="sDF719D34E2D7391DE35D9B20482B775D"></a><div><div style="line-height:120%;font-size:8pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;" href="#sD7FEAB285F05C019C5249B203D1AEE60"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Table of Contents</font></a></div></div><br><div style="line-height:120%;padding-top:18px;text-align:center;padding-left:0px;text-indent:0px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#1c5a7d;font-weight:bold;">EXHIBIT&#160;INDEX&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="17%"></td><td width="5%"></td><td width="78%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Exhibit</font></div><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;text-decoration:underline;">Number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;text-decoration:underline;">Description of Exhibit</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Biogen Inc. 2015 Employee Stock Purchase Plan. Filed as Appendix A to Biogen's Definitive Proxy Statement on Schedule 14A filed on April 30, 2015.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">31.1+</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Certification of the Chief Executive Officer Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">31.2+</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Certification of the Chief Financial Officer Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">32.1++</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Certification Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">101++</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following materials from Biogen Inc.&#8217;s Quarterly Report on Form&#160;10-Q for the quarter ended June&#160;30, 2015, formatted in XBRL (Extensible Business Reporting Language): (i)&#160;the Condensed Consolidated Statements of Income, (ii)&#160;the Condensed Consolidated Statements of  Comprehensive Income, (iii) the Condensed Consolidated Balance Sheets, (iv)&#160;the Condensed Consolidated Statements of Cash Flows, and (v)&#160;Notes to Condensed Consolidated Financial Statements.</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#32;&#32;&#32;+&#160;&#160;&#160;&#160;Filed herewith </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">++&#160;&#160;&#160;&#160;Furnished herewith</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">67</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>biib-2015630xex311.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2015 Workiva -->
		<title>BIIB-2015.6.30-EX31.1</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s25ADDFA62E9A851482189B2034F8F6AD"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;font-weight:bold;">Exhibit 31.1</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;font-weight:bold;">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;font-weight:bold;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">I, George A. Scangos, certify that:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1. I have reviewed this quarterly report of Biogen Inc.;</font></div><div style="line-height:120%;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div><div style="line-height:120%;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div><div style="line-height:120%;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a&#8211;15(e) and 15d&#8211;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#8211;15(f) and 15d&#8211;15(f)) for the registrant and have:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="52%"></td><td width="3%"></td><td width="45%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Date: July&#160;24, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">/s/ George A. Scangos</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">George A. Scangos</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Chief Executive Officer</font></div></td></tr></table></div></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>biib-2015630xex312.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2015 Workiva -->
		<title>BIIB-2015.6.30-EX31.2</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s3512D8369EAB6C8E3B179B20359D21D2"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;font-weight:bold;">Exhibit 31.2</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;font-weight:bold;">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;font-weight:bold;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">I, Paul J. Clancy, certify that:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1. I have reviewed this quarterly report of Biogen Inc.;</font></div><div style="line-height:120%;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div><div style="line-height:120%;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div><div style="line-height:120%;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a&#8211;15(e) and 15d&#8211;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#8211;15(f) and 15d&#8211;15(f)) for the registrant and have:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;padding-left:40px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="52%"></td><td width="3%"></td><td width="45%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Date: July&#160;24, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">/s/ Paul J. Clancy</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Paul J. Clancy</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Executive Vice President and</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Chief Financial Officer</font></div></td></tr></table></div></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>biib-2015630xex321.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2015 Workiva -->
		<title>BIIB-2015.6.30-EX32.1</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s432DE4764FA8AA5FC9F69B2036454644"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;font-weight:bold;">Exhibit 32.1</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;font-weight:bold;">CERTIFICATION</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;font-weight:bold;">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Biogen Inc., a Delaware corporation (the &#8220;Company&#8221;), does hereby certify, to such officer&#8217;s knowledge, that:</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2015 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="52%"></td><td width="3%"></td><td width="45%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Dated: July&#160;24, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">/s/ George A. Scangos</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">George A. Scangos</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Chief Executive Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">[principal executive officer]</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="52%"></td><td width="3%"></td><td width="45%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Dated: July&#160;24, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">/s/ Paul J. Clancy</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Paul J. Clancy</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Executive Vice President and</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">[principal financial officer]</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>5
<FILENAME>biib-20150630.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:8c86bd93117441a08fdb5b023b4a185b,x:1e94d1eaa2d34462b4dae07be75a54d8-->
<xbrli:xbrl xmlns:biib="http://www.biogenidec.com/20150630" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2015-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2015-01-31" xmlns:us-roles="http://fasb.org/us-roles/2015-01-31" xmlns:us-types="http://fasb.org/us-types/2015-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
	<link:schemaRef xlink:href="biib-20150630.xsd" xlink:type="simple" />
	<xbrli:context id="FD2015Q2YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2015Q2SharesOutstanding">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-07-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q2">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2013Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2013-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2015Q1ConvergencePharma_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:ConvergencePharmaceuticalsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-02-12</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2015Q1ConvergencePharma_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember_us-gaap_ProductOrServiceAxis_biib_CNV1014802Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:ConvergencePharmaceuticalsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">biib:CNV1014802Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-02-12</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2015Q1ConvergencePharma_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember_us-gaap_ProductOrServiceAxis_biib_NeuropathicpainindicationsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:ConvergencePharmaceuticalsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">biib:NeuropathicpainindicationsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-02-12</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:ConvergencePharmaceuticalsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2015Q1_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:ConvergencePharmaceuticalsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-02-01</xbrli:startDate>
			<xbrli:endDate>2015-02-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2015Q1_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember_us-gaap_ProductOrServiceAxis_biib_CNV1014802Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:ConvergencePharmaceuticalsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">biib:CNV1014802Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-02-01</xbrli:startDate>
			<xbrli:endDate>2015-02-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_BalanceSheetLocationAxis_us-gaap_AccountsReceivableMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccountsReceivableMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ReserveForCashDiscountMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ReserveForCashDiscountMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_biib_ContractualAdjustmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">biib:ContractualAdjustmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_biib_ContractualAdjustmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">biib:ContractualAdjustmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ReserveForCashDiscountMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ReserveForCashDiscountMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_ValuationAllowancesAndReservesTypeAxis_biib_ContractualAdjustmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">biib:ContractualAdjustmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ReserveForCashDiscountMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ReserveForCashDiscountMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_BusinessAcquisitionAxis_biib_TysabriProductMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_InLicensedPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:TysabriProductMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">biib:InLicensedPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_us-gaap_ProductOrServiceAxis_biib_AVONEXMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">biib:AVONEXMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_OutLicensedPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">biib:OutLicensedPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember_us-gaap_ProductOrServiceAxis_biib_TecfideraMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:FumapharmAgMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">biib:TecfideraMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_OutLicensedPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">biib:OutLicensedPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_InLicensedPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">biib:InLicensedPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_InLicensedPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">biib:InLicensedPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_OutLicensedPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">biib:OutLicensedPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_InLicensedPatentsMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">biib:InLicensedPatentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_InLicensedPatentsMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">biib:InLicensedPatentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_OutLicensedPatentsMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">biib:OutLicensedPatentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_OutLicensedPatentsMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">biib:OutLicensedPatentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_DebtInstrumentAxis_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">biib:SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_DebtInstrumentAxis_biib_NotesPayableToFumedicaMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">biib:NotesPayableToFumedicaMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_DebtInstrumentAxis_biib_NotesPayableToFumedicaMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">biib:NotesPayableToFumedicaMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_DebtInstrumentAxis_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">biib:SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2013Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2013-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q2_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">biib:MortgageAndOtherAssetBackedSecuritiesNonCurrentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_EquitySecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesNonCurrentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">biib:GovernmentSecuritiesNonCurrentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesCurrentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">biib:CorporateDebtSecuritiesCurrentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesNonCurrentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">biib:CorporateDebtSecuritiesNonCurrentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">biib:MortgageAndOtherAssetBackedSecuritiesCurrentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesCurrentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">biib:GovernmentSecuritiesCurrentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_StrategicInvestmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">biib:StrategicInvestmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_StrategicInvestmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">biib:StrategicInvestmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_InvestmentTypeAxis_us-gaap_DebtSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_InvestmentTypeAxis_us-gaap_MoneyMarketFundsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_InvestmentTypeAxis_us-gaap_RepurchaseAgreementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RepurchaseAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_InvestmentTypeAxis_us-gaap_MoneyMarketFundsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_InvestmentTypeAxis_us-gaap_CommercialPaperMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_InvestmentTypeAxis_us-gaap_RepurchaseAgreementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RepurchaseAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_InvestmentTypeAxis_us-gaap_CommercialPaperMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_InvestmentTypeAxis_us-gaap_DebtSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesCurrentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">biib:GovernmentSecuritiesCurrentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesNonCurrentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">biib:CorporateDebtSecuritiesNonCurrentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesNonCurrentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">biib:GovernmentSecuritiesNonCurrentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">biib:MortgageAndOtherAssetBackedSecuritiesCurrentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_EquitySecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">biib:MortgageAndOtherAssetBackedSecuritiesNonCurrentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesCurrentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">biib:CorporateDebtSecuritiesCurrentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherInvestmentsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_CurrencyAxis_currency_EUR_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_CurrencyAxis_currency_JPY_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_CurrencyAxis_currency_AUD_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:AUD</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_CurrencyAxis_currency_AUD_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:AUD</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_CurrencyAxis_currency_EUR_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_CurrencyAxis_currency_GBP_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_CurrencyAxis_currency_GBP_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_CurrencyAxis_currency_CAD_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_CurrencyAxis_currency_JPY_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_CurrencyAxis_currency_CAD_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2013Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2013-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2013Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2013-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2013Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2013-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2013Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2013-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_MarketStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">biib:MarketStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_TimeVestedRestrictedStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">biib:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_MarketStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">biib:MarketStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_StockOptionsAndEmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">biib:StockOptionsAndEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_TimeVestedRestrictedStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">biib:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_TimeVestedRestrictedStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">biib:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_StockOptionsAndEmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">biib:StockOptionsAndEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_MarketStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">biib:MarketStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_StockOptionsAndEmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">biib:StockOptionsAndEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_TimeVestedRestrictedStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">biib:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_StockOptionsAndEmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">biib:StockOptionsAndEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_MarketStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">biib:MarketStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_PlanNameAxis_biib_MarketStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:MarketStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_PlanNameAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_PlanNameAxis_biib_CashSettledPerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_PlanNameAxis_biib_TimeVestedRestrictedStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_PlanNameAxis_biib_CashSettledPerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_PlanNameAxis_biib_MarketStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:MarketStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_PlanNameAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_PlanNameAxis_biib_TimeVestedRestrictedStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_PlanNameAxis_biib_EmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_PlanNameAxis_biib_MarketStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:MarketStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_PlanNameAxis_biib_CashSettledPerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_PlanNameAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_PlanNameAxis_biib_EmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_PlanNameAxis_biib_CashSettledPerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_PlanNameAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_PlanNameAxis_biib_MarketStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:MarketStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_PlanNameAxis_biib_TimeVestedRestrictedStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_PlanNameAxis_biib_EmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_PlanNameAxis_biib_TimeVestedRestrictedStockUnitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_PlanNameAxis_biib_EmployeeStockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">biib:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ParentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ParentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ParentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ParentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ParentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ParentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ParentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ParentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2011Q4Oct_us-gaap_TaxPeriodAxis_us-gaap_TaxYear2009Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2009Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2011-10-01</xbrli:startDate>
			<xbrli:endDate>2011-10-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2011Q4Oct_us-gaap_TaxPeriodAxis_us-gaap_TaxYear2007Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2007Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2011-10-01</xbrli:startDate>
			<xbrli:endDate>2011-10-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2011Q4Oct_us-gaap_TaxPeriodAxis_us-gaap_TaxYear2008Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2008Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2011-10-01</xbrli:startDate>
			<xbrli:endDate>2011-10-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_StatementGeographicalAxis_country_IT">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_StatementGeographicalAxis_country_IT">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_StatementGeographicalAxis_country_IT">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_biib_NeurimmuneMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:VariableInterestEntitiesByClassificationOfEntityAxis">biib:NeurimmuneMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_biib_NeurimmuneMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:VariableInterestEntitiesByClassificationOfEntityAxis">biib:NeurimmuneMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_biib_NeurimmuneMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:VariableInterestEntitiesByClassificationOfEntityAxis">biib:NeurimmuneMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_biib_NeurimmuneMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:VariableInterestEntitiesByClassificationOfEntityAxis">biib:NeurimmuneMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2013Q4_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">biib:SamsungBiosimilarAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2013-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2QTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">biib:SamsungBiosimilarAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-04-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">biib:SamsungBiosimilarAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2012Q1SD2_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">biib:SamsungBiosimilarAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2012-02-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">biib:SamsungBiosimilarAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2012Q1Feb_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">biib:SamsungBiosimilarAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2012-02-01</xbrli:startDate>
			<xbrli:endDate>2012-02-29</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2QTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">biib:SamsungBiosimilarAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-04-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2014Q2YTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">biib:SamsungBiosimilarAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-01-01</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2013Q4QTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">biib:SamsungBiosimilarAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2013-10-01</xbrli:startDate>
			<xbrli:endDate>2013-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q4_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">biib:SamsungBiosimilarAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_biib_CumulativeSalesLevelAxis_biib_FourbillionMember_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="biib:CumulativeSalesLevelAxis">biib:FourbillionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:FumapharmAgMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_biib_CumulativeSalesLevelAxis_biib_FourbillionMember_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="biib:CumulativeSalesLevelAxis">biib:FourbillionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:FumapharmAgMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_biib_CumulativeSalesLevelAxis_biib_OneBillionMember_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="biib:CumulativeSalesLevelAxis">biib:OneBillionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:FumapharmAgMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2013Q2_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember_us-gaap_ProductOrServiceAxis_biib_TecfideraMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:FumapharmAgMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">biib:TecfideraMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2013-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2006Q4YTD_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:FumapharmAgMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2006-01-01</xbrli:startDate>
			<xbrli:endDate>2006-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_biib_CumulativeSalesLevelAxis_biib_FivebillionMember_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="biib:CumulativeSalesLevelAxis">biib:FivebillionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:FumapharmAgMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_biib_CumulativeSalesLevelAxis_biib_ThreeBillionMember_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="biib:CumulativeSalesLevelAxis">biib:ThreeBillionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:FumapharmAgMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q2YTD_biib_CumulativeSalesLevelAxis_biib_FivebillionMember_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="biib:CumulativeSalesLevelAxis">biib:FivebillionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:FumapharmAgMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-01-01</xbrli:startDate>
			<xbrli:endDate>2015-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_biib_CumulativeSalesLevelAxis_biib_EachAdditionalOneBillionUpToTwentyBillionMember_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="biib:CumulativeSalesLevelAxis">biib:EachAdditionalOneBillionUpToTwentyBillionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">biib:FumapharmAgMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q2_us-gaap_StatementGeographicalAxis_country_CH">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2015Q2Sobi_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_biib_SwedishOrphanBiovitrumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">biib:SwedishOrphanBiovitrumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-07-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2015Q3_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_biib_AGTCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">biib:AGTCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-07-02</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2015Q1Eisai_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_biib_EisaiMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">biib:EisaiMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-07-15</xbrli:startDate>
			<xbrli:endDate>2015-07-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2015Q3_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_biib_AGTCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">biib:AGTCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-07-01</xbrli:startDate>
			<xbrli:endDate>2015-07-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2015Q3_us-gaap_ProductOrServiceAxis_biib_DiscoveryprogramsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_biib_AGTCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">biib:DiscoveryprogramsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">biib:AGTCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-07-02</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2015Q3_us-gaap_ProductOrServiceAxis_biib_LeadprogramsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_biib_AGTCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">biib:LeadprogramsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">biib:AGTCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-07-02</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:unit id="number">
		<xbrli:measure>xbrli:pure</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="segment">
		<xbrli:measure>biib:segment</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="shares">
		<xbrli:measure>xbrli:shares</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="usdPerShare">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit>
	<xbrli:unit id="usd">
		<xbrli:measure>iso4217:USD</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="EUR">
		<xbrli:measure>iso4217:EUR</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="KRW">
		<xbrli:measure>iso4217:KRW</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="chf">
		<xbrli:measure>iso4217:CHF</xbrli:measure>
	</xbrli:unit>
	<biib:AdditionalMilestonePayment contextRef="FI2013Q4_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-5" id="Fact-EDF3FAFAC20635362944D4ECA972A0F5" unitRef="usd">75000000</biib:AdditionalMilestonePayment>
	<biib:AdditionalMilestonePayment contextRef="I2015Q2Sobi_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_biib_SwedishOrphanBiovitrumMember" decimals="-5" id="Fact-48D02B033EBE58DA6538B74576DC6AEC" unitRef="usd">10000000</biib:AdditionalMilestonePayment>
	<biib:AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears contextRef="FD2015Q2YTD" decimals="-5" id="Fact-DA0B3E13881D9B15DD0CD4ECA9A7A4D4" unitRef="usd">27500000</biib:AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears>
	<biib:AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears contextRef="FD2015Q2YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_biib_ContractualAdjustmentsMember" decimals="-5" id="Fact-69A79C36D3857DC61ED1D4ECA9A73DCF" unitRef="usd">19800000</biib:AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears>
	<biib:AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears contextRef="FD2015Q2YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ReserveForCashDiscountMember" decimals="-5" id="Fact-F8FA082AF255D1B606ACD4ECA9A9B422" unitRef="usd">-400000</biib:AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears>
	<biib:AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears contextRef="FD2015Q2YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" decimals="-5" id="Fact-3C1D2A5C2C53AC4C6C91D4ECA9A9D9A0" unitRef="usd">8100000</biib:AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears>
	<biib:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost contextRef="FI2014Q4" decimals="-5" id="Fact-7DA5D3983DA4BCCE822BD4ECA98DB4C9" unitRef="usd">126800000</biib:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost>
	<biib:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost contextRef="FI2015Q2" decimals="-5" id="Fact-B4D4FC3B02D7DB651968D4ECA98C3BE0" unitRef="usd">147400000</biib:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost>
	<biib:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue contextRef="FI2014Q4" decimals="-5" id="Fact-757FA575FF5EDB95638CD4ECA98D751A" unitRef="usd">126900000</biib:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue>
	<biib:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue contextRef="FI2015Q2" decimals="-5" id="Fact-78078FE2AA4490565DCED4ECA98C0BDF" unitRef="usd">147400000</biib:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue>
	<biib:AverageMaturityOfMarketableSecurities contextRef="FD2014Q4YTD" id="Fact-14A88849F5F1132722D4B1DD3D7BE042">P15M</biib:AverageMaturityOfMarketableSecurities>
	<biib:AverageMaturityOfMarketableSecurities contextRef="FD2015Q2YTD" id="Fact-5830B6BAFEBA49B83C7FD4ECA97563C3">P17M</biib:AverageMaturityOfMarketableSecurities>
	<biib:CumulativeSalesLevel contextRef="FI2015Q2_biib_CumulativeSalesLevelAxis_biib_EachAdditionalOneBillionUpToTwentyBillionMember_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember" decimals="-8" id="Fact-F5D52D67075F66E8645AD4ECA9AFFF5A" unitRef="usd">20000000000</biib:CumulativeSalesLevel>
	<biib:CumulativeSalesLevel contextRef="FI2015Q2_biib_CumulativeSalesLevelAxis_biib_FivebillionMember_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember" decimals="-8" id="Fact-A920E8522EDE855DD6B5D4ECA9AFF18E" unitRef="usd">5000000000</biib:CumulativeSalesLevel>
	<biib:CumulativeSalesLevel contextRef="FI2015Q2_biib_CumulativeSalesLevelAxis_biib_FourbillionMember_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember" decimals="-8" id="Fact-5428201D270D99640005D4ECA9A963AD" unitRef="usd">4000000000</biib:CumulativeSalesLevel>
	<biib:CumulativeSalesLevel contextRef="FI2015Q2_biib_CumulativeSalesLevelAxis_biib_OneBillionMember_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember" decimals="-8" id="Fact-3487FBB838CE2BE06E16D4ECA999DC60" unitRef="usd">1000000000</biib:CumulativeSalesLevel>
	<biib:CumulativeSalesLevel contextRef="FI2015Q2_biib_CumulativeSalesLevelAxis_biib_ThreeBillionMember_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember" decimals="-8" id="Fact-E54C4055EDD8DF6F82ABD4ECA9993CEA" unitRef="usd">3000000000</biib:CumulativeSalesLevel>
	<biib:CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear contextRef="FD2015Q2YTD" decimals="-5" id="Fact-1BF63D65456C556D51DBD4ECA9A88E5F" unitRef="usd">1082700000</biib:CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear>
	<biib:CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear contextRef="FD2015Q2YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_biib_ContractualAdjustmentsMember" decimals="-5" id="Fact-3FD79A5F10FB364E69D0D4ECA9A9055F" unitRef="usd">854400000</biib:CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear>
	<biib:CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear contextRef="FD2015Q2YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ReserveForCashDiscountMember" decimals="-5" id="Fact-3057F4F0BC10E0172A2FD4ECA9A9D8FC" unitRef="usd">209200000</biib:CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear>
	<biib:CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear contextRef="FD2015Q2YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" decimals="-5" id="Fact-E3939D8E27B9CF4C105BD4ECA9A8FBC0" unitRef="usd">19100000</biib:CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear>
	<biib:DueFromUnconsolidatedJointBusiness contextRef="FI2014Q4" decimals="-3" id="Fact-C5A85D802391FF61048AD4ECA9A3D177" unitRef="usd">283360000</biib:DueFromUnconsolidatedJointBusiness>
	<biib:DueFromUnconsolidatedJointBusiness contextRef="FI2015Q2" decimals="-3" id="Fact-A2CF381DE012070585EAD4ECA9A5E1ED" unitRef="usd">323714000</biib:DueFromUnconsolidatedJointBusiness>
	<biib:EffectiveIncomeTaxRateReconciliationManufacturingDeduction contextRef="FD2014Q2QTD" decimals="3" id="Fact-6C18A810B1157DD81F11D4ECA999D82C" unitRef="number">-0.017</biib:EffectiveIncomeTaxRateReconciliationManufacturingDeduction>
	<biib:EffectiveIncomeTaxRateReconciliationManufacturingDeduction contextRef="FD2014Q2YTD" decimals="3" id="Fact-A11FD3087E77E72FDA8AD4ECA9992A02" unitRef="number">-0.018</biib:EffectiveIncomeTaxRateReconciliationManufacturingDeduction>
	<biib:EffectiveIncomeTaxRateReconciliationManufacturingDeduction contextRef="FD2015Q2QTD" decimals="3" id="Fact-AAFDE4D25D0F6B03C504D4ECA99B97E6" unitRef="number">-0.021</biib:EffectiveIncomeTaxRateReconciliationManufacturingDeduction>
	<biib:EffectiveIncomeTaxRateReconciliationManufacturingDeduction contextRef="FD2015Q2YTD" decimals="3" id="Fact-5408556F54809EA58C2BD4ECA9755BC3" unitRef="number">-0.018</biib:EffectiveIncomeTaxRateReconciliationManufacturingDeduction>
	<biib:Employeerelatedliabilitiesnoncurrent contextRef="FI2014Q4" decimals="-5" id="Fact-930F5D284340F6CCD840D4ECA99B6703" unitRef="usd">200700000</biib:Employeerelatedliabilitiesnoncurrent>
	<biib:Employeerelatedliabilitiesnoncurrent contextRef="FI2015Q2" decimals="-5" id="Fact-BD079944E9A4C95C673FD4ECA99B951F" unitRef="usd">224500000</biib:Employeerelatedliabilitiesnoncurrent>
	<biib:Employeestockpurchaseplanmaximumshares contextRef="FI2015Q2" decimals="0" id="Fact-95E07C6CA43BEEB9E0907434A55C6556" unitRef="shares">6200000</biib:Employeestockpurchaseplanmaximumshares>
	<biib:EquityMethodInvestmentOwnershipPercentageMaximum contextRef="D2012Q1Feb_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="INF" id="Fact-73B75B3391F737C57087D4ECA9755EEC" unitRef="number">0.499</biib:EquityMethodInvestmentOwnershipPercentageMaximum>
	<biib:EquityMethodInvestmentsExpectedProfitShare contextRef="FD2013Q4QTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="INF" id="Fact-FB4484177A09C154A877D4ECA994B264" unitRef="number">0.5</biib:EquityMethodInvestmentsExpectedProfitShare>
	<biib:Expectedmilestonepaymentforinitiationofalatestageclinicaltrial contextRef="FD2015Q2YTD_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_biib_NeurimmuneMember" decimals="-5" id="Fact-3647F9ABB0AC014416E4D4ECA9A19EBB" unitRef="usd">60000000</biib:Expectedmilestonepaymentforinitiationofalatestageclinicaltrial>
	<biib:Finitelivedintangibleassetsfutureamortization contextRef="FI2015Q2" decimals="-5" id="Fact-7101A946BB9A02AA578ED4ECA9B11C0C" unitRef="usd">1599800000</biib:Finitelivedintangibleassetsfutureamortization>
	<biib:GainOnSaleOfRights contextRef="FD2014Q2QTD" decimals="-3" id="Fact-BA4A887CA54CEE1EA86FD4ECA9A7A367" unitRef="usd">3900000</biib:GainOnSaleOfRights>
	<biib:GainOnSaleOfRights contextRef="FD2014Q2YTD" decimals="-3" id="Fact-33A82EF194741552569AD4ECA983538B" unitRef="usd">7759000</biib:GainOnSaleOfRights>
	<biib:GainOnSaleOfRights contextRef="FD2015Q2QTD" decimals="-3" id="Fact-7F6CCE93BA378BAE788DD4ECA98E2259" unitRef="usd">0</biib:GainOnSaleOfRights>
	<biib:GainOnSaleOfRights contextRef="FD2015Q2YTD" decimals="-3" id="Fact-003133068B3297B1AF5FD4ECA997ED27" unitRef="usd">0</biib:GainOnSaleOfRights>
	<biib:IndefiniteLivedIntangibleAssetsUsefulLife contextRef="FD2015Q2YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" id="Fact-B7E77B1E631786AE4326D4ECA98CC317">Indefinite until commercialization</biib:IndefiniteLivedIntangibleAssetsUsefulLife>
	<biib:IndefiniteLivedIntangibleAssetsUsefulLife contextRef="FD2015Q2YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" id="Fact-8744EC72DA6488A1B45BD4ECA98C4492">Indefinite</biib:IndefiniteLivedIntangibleAssetsUsefulLife>
	<biib:InterestInSubsidiary contextRef="FD2015Q2YTD" decimals="INF" id="Fact-7A633DC0F76DBCBD1D8AD4ECA9AFA172" unitRef="number">1.00</biib:InterestInSubsidiary>
	<biib:InventoryVariousProgramsGross contextRef="FI2014Q4" decimals="-5" id="Fact-B92C35BD2DFE16158052B1D56BBDD5A9" unitRef="usd">6300000</biib:InventoryVariousProgramsGross>
	<biib:InventoryVariousProgramsGross contextRef="FI2015Q2" decimals="-5" id="Fact-ABC6CAFE6D57DDF2F6B2B1D5C76A9B8D" unitRef="usd">35800000</biib:InventoryVariousProgramsGross>
	<biib:InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities contextRef="FI2014Q4" decimals="-5" id="Fact-F726D78493976D677483D4ECA97495BE" unitRef="usd">7900000</biib:InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities>
	<biib:InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities contextRef="FI2015Q2" decimals="-5" id="Fact-0680F6FB4ECBBAD13A16D4ECA9A6A7D7" unitRef="usd">8500000</biib:InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities>
	<biib:InvestmentsByThirdPartyInJointVentureAsPerAgreement contextRef="I2012Q1SD2_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-8" id="Fact-63BE82FB4BF2B3F0E6A5D4ECA9994ADE" unitRef="KRW">280500000000</biib:InvestmentsByThirdPartyInJointVentureAsPerAgreement>
	<biib:InvestmentsByThirdPartyInJointVentureAsPerAgreement contextRef="I2012Q1SD2_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-5" id="Fact-BB62CE57AAB4191425FCD4ECA98604CE" unitRef="usd">250000000</biib:InvestmentsByThirdPartyInJointVentureAsPerAgreement>
	<biib:JointVentureOwnerShipPercentageByThirdParty contextRef="D2012Q1Feb_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="INF" id="Fact-4A7E4279E62051725EF9D4ECA97D377E" unitRef="number">0.85</biib:JointVentureOwnerShipPercentageByThirdParty>
	<biib:MaximumTermForAccountsReceivable contextRef="FD2015Q2YTD" id="Fact-AAB1B992B9B7C4A8FCA1D4ECA99BB1A8">P90D</biib:MaximumTermForAccountsReceivable>
	<biib:MinimumTermForAccountsReceivable contextRef="FD2015Q2YTD" id="Fact-511F1855F106246A05CCD4ECA9AF19C8">P30D</biib:MinimumTermForAccountsReceivable>
	<biib:Noncontrollinginterestincreasedecreaseother contextRef="FD2014Q2QTD" decimals="-5" id="Fact-1B9B49580352B38EAEEAD4ECA9827454" unitRef="usd">0</biib:Noncontrollinginterestincreasedecreaseother>
	<biib:Noncontrollinginterestincreasedecreaseother contextRef="FD2014Q2YTD" decimals="-5" id="Fact-7F44B42D844117DE5B0CD4ECA972A044" unitRef="usd">0</biib:Noncontrollinginterestincreasedecreaseother>
	<biib:Noncontrollinginterestincreasedecreaseother contextRef="FD2015Q2QTD" decimals="-5" id="Fact-3EDDE7DDAAA0B68CC848D4ECA982DB3E" unitRef="usd">200000</biib:Noncontrollinginterestincreasedecreaseother>
	<biib:Noncontrollinginterestincreasedecreaseother contextRef="FD2015Q2YTD" decimals="-5" id="Fact-B053D19551C325C01F91D4ECA973205D" unitRef="usd">200000</biib:Noncontrollinginterestincreasedecreaseother>
	<biib:Overnightreverserepurchaseagreementspercentoftotalassets contextRef="FI2014Q4" decimals="3" id="Fact-DE4E819F98EA71A07B62D4ECA9AEDBA8" unitRef="number">0.021</biib:Overnightreverserepurchaseagreementspercentoftotalassets>
	<biib:Overnightreverserepurchaseagreementspercentoftotalassets contextRef="FI2015Q2" decimals="3" id="Fact-2B75C4C9FB16F1BF0116D4ECA9A7780E" unitRef="number">0.011</biib:Overnightreverserepurchaseagreementspercentoftotalassets>
	<biib:PaymentTermsOfAccountsReceivable contextRef="FD2015Q2YTD" id="Fact-BC9790677553762427C5D4ECA9A97C9F">30 to 90 days</biib:PaymentTermsOfAccountsReceivable>
	<biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear contextRef="FD2015Q2YTD" decimals="-5" id="Fact-8161C548387609B08F45D4ECA9A7D0E9" unitRef="usd">642800000</biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear>
	<biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear contextRef="FD2015Q2YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_biib_ContractualAdjustmentsMember" decimals="-5" id="Fact-689962B7A29DDBAE028BD4ECA9A8628F" unitRef="usd">483900000</biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear>
	<biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear contextRef="FD2015Q2YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ReserveForCashDiscountMember" decimals="-5" id="Fact-A18F58C1CEFBA4AD32D2D4ECA9A85132" unitRef="usd">158000000</biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear>
	<biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear contextRef="FD2015Q2YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" decimals="-5" id="Fact-51A75F9A587CC3351531D4ECA9A7F456" unitRef="usd">900000</biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear>
	<biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear contextRef="FD2015Q2YTD" decimals="-5" id="Fact-E9F1EECAA20E310E866AD4ECA9A74FD1" unitRef="usd">305800000</biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear>
	<biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear contextRef="FD2015Q2YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_biib_ContractualAdjustmentsMember" decimals="-5" id="Fact-9C3FC32708C2BF9B929DD4ECA9A65C8D" unitRef="usd">254700000</biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear>
	<biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear contextRef="FD2015Q2YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ReserveForCashDiscountMember" decimals="-5" id="Fact-180A184E1DD676C55B4DD4ECA9A7AD77" unitRef="usd">43300000</biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear>
	<biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear contextRef="FD2015Q2YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" decimals="-5" id="Fact-20D0E9C6A3800C0F6BC6D4ECA9A972B0" unitRef="usd">7800000</biib:PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear>
	<biib:PlanAssetsForDeferredCompensationFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-32C60AF1A0047406B09BD4ECA982D669" unitRef="usd">0</biib:PlanAssetsForDeferredCompensationFairValueDisclosure>
	<biib:PlanAssetsForDeferredCompensationFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-7D76115405FEC782BA70D4ECA983061B" unitRef="usd">36900000</biib:PlanAssetsForDeferredCompensationFairValueDisclosure>
	<biib:PlanAssetsForDeferredCompensationFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-6F20AF426284220EC253D4ECA982EE09" unitRef="usd">0</biib:PlanAssetsForDeferredCompensationFairValueDisclosure>
	<biib:PlanAssetsForDeferredCompensationFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-C25A147B0628800DA5C1D4ECA982DEB1" unitRef="usd">36900000</biib:PlanAssetsForDeferredCompensationFairValueDisclosure>
	<biib:PlanAssetsForDeferredCompensationFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-4636A3B5843267FEAEB5D4ECA9AF6CE8" unitRef="usd">0</biib:PlanAssetsForDeferredCompensationFairValueDisclosure>
	<biib:PlanAssetsForDeferredCompensationFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-0B21B7DF2B86CBDC742FD4ECA9B295DA" unitRef="usd">40700000</biib:PlanAssetsForDeferredCompensationFairValueDisclosure>
	<biib:PlanAssetsForDeferredCompensationFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-6395DAD6038910DEDB04D4ECA9AED6D3" unitRef="usd">0</biib:PlanAssetsForDeferredCompensationFairValueDisclosure>
	<biib:PlanAssetsForDeferredCompensationFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-BF07D278B8D8D4C67C16D4ECA9AE3BF6" unitRef="usd">40700000</biib:PlanAssetsForDeferredCompensationFairValueDisclosure>
	<biib:PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately contextRef="I2015Q1ConvergencePharma_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember" decimals="-5" id="Fact-C3EE706D29480E3B0E5DD4ECA97D8818" unitRef="usd">450000000</biib:PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately>
	<biib:PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately contextRef="I2015Q1ConvergencePharma_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember_us-gaap_ProductOrServiceAxis_biib_CNV1014802Member" decimals="-5" id="Fact-A491A08A25EDAC368372D4ECA99AA1CF" unitRef="usd">350000000</biib:PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately>
	<biib:PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately contextRef="I2015Q3_us-gaap_ProductOrServiceAxis_biib_DiscoveryprogramsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_biib_AGTCMember" decimals="-5" id="Fact-6E4D08721214E78F3DD374A2D7DF8BA5" unitRef="usd">592500000</biib:PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately>
	<biib:PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately contextRef="I2015Q3_us-gaap_ProductOrServiceAxis_biib_LeadprogramsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_biib_AGTCMember" decimals="-5" id="Fact-13528D22DFE4BE1BC90E74A2C5F01E18" unitRef="usd">472500000</biib:PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately>
	<biib:PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately contextRef="I2015Q3_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_biib_AGTCMember" decimals="-8" id="Fact-F9E1F3ABC12F76DB62DE74A1CA0BF0A8" unitRef="usd">1000000000</biib:PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately>
	<biib:ProposedDisallowanceByTaxAuthoritiesForPaymentForServices contextRef="D2011Q4Oct_us-gaap_TaxPeriodAxis_us-gaap_TaxYear2007Member" decimals="-5" id="Fact-7891F2EBF7131E217971D4ECA999ABAF" unitRef="usd">130000000</biib:ProposedDisallowanceByTaxAuthoritiesForPaymentForServices>
	<biib:ProposedDisallowanceByTaxAuthoritiesForPaymentForServices contextRef="D2011Q4Oct_us-gaap_TaxPeriodAxis_us-gaap_TaxYear2008Member" decimals="-5" id="Fact-E59C70F0CB9E073E7CD1D4ECA971684C" unitRef="usd">130000000</biib:ProposedDisallowanceByTaxAuthoritiesForPaymentForServices>
	<biib:ProposedDisallowanceByTaxAuthoritiesForPaymentForServices contextRef="D2011Q4Oct_us-gaap_TaxPeriodAxis_us-gaap_TaxYear2009Member" decimals="-5" id="Fact-5FD63F059AFF5E39D6D9D4ECA974636A" unitRef="usd">130000000</biib:ProposedDisallowanceByTaxAuthoritiesForPaymentForServices>
	<biib:Purchaseofcommonstock contextRef="D2015Q3_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_biib_AGTCMember" decimals="-5" id="Fact-AF6208875B95A282A196749B3B29F188" unitRef="usd">30000000</biib:Purchaseofcommonstock>
	<biib:ReimbursementLimitStatedInResolution contextRef="FD2014Q2QTD_us-gaap_StatementGeographicalAxis_country_IT" id="Fact-9FB161C965E4D0BAAFE3D4ECA9A71167">P24M</biib:ReimbursementLimitStatedInResolution>
	<biib:RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement contextRef="FD2015Q2YTD_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_biib_NeurimmuneMember" decimals="-5" id="Fact-E84217718F6B13126DA9D4ECA9A5A1A2" unitRef="usd">335000000</biib:RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement>
	<biib:ShareBasedCompensationExpenseIncludedInCostsAndExpenses contextRef="FD2014Q2QTD" decimals="-5" id="Fact-A8170A2781DC88713EB5D4ECA9AF12F2" unitRef="usd">55500000</biib:ShareBasedCompensationExpenseIncludedInCostsAndExpenses>
	<biib:ShareBasedCompensationExpenseIncludedInCostsAndExpenses contextRef="FD2014Q2YTD" decimals="-5" id="Fact-33C92FD7B1288968325ED4ECA99A07E7" unitRef="usd">129500000</biib:ShareBasedCompensationExpenseIncludedInCostsAndExpenses>
	<biib:ShareBasedCompensationExpenseIncludedInCostsAndExpenses contextRef="FD2015Q2QTD" decimals="-5" id="Fact-1B8F649654C8A52D6FB7D4ECA9AF8F3D" unitRef="usd">46100000</biib:ShareBasedCompensationExpenseIncludedInCostsAndExpenses>
	<biib:ShareBasedCompensationExpenseIncludedInCostsAndExpenses contextRef="FD2015Q2YTD" decimals="-5" id="Fact-FB8978D6C6B2E1E5AFD5D4ECA971A95A" unitRef="usd">133700000</biib:ShareBasedCompensationExpenseIncludedInCostsAndExpenses>
	<biib:StrategicInvestmentPortfolio contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_StrategicInvestmentsMember" decimals="-5" id="Fact-822AD3C2904478B72014D4ECA973BDEB" unitRef="usd">47800000</biib:StrategicInvestmentPortfolio>
	<biib:StrategicInvestmentPortfolio contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_StrategicInvestmentsMember" decimals="-5" id="Fact-6378FAC7EA38367D3CF6D4ECA9732AAE" unitRef="usd">45300000</biib:StrategicInvestmentPortfolio>
	<biib:TermOfLease contextRef="D2015Q1Eisai_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_biib_EisaiMember" id="Fact-2C2659A0AA5FF27EDCE9B74BA9825C0A">P10Y</biib:TermOfLease>
	<biib:UnconsolidatedJointBusiness contextRef="FD2014Q2QTD" decimals="-3" id="Fact-1789B9B79B29CE4970D9D4ECA985CE8F" unitRef="usd">303296000</biib:UnconsolidatedJointBusiness>
	<biib:UnconsolidatedJointBusiness contextRef="FD2014Q2YTD" decimals="-3" id="Fact-BA3232BA4F5B3FB3E7EAD4ECA982FC6A" unitRef="usd">600181000</biib:UnconsolidatedJointBusiness>
	<biib:UnconsolidatedJointBusiness contextRef="FD2015Q2QTD" decimals="-3" id="Fact-B9E779723742E8421D99D4ECA99792A9" unitRef="usd">337510000</biib:UnconsolidatedJointBusiness>
	<biib:UnconsolidatedJointBusiness contextRef="FD2015Q2YTD" decimals="-3" id="Fact-4A9B1EFCD0D7A8955AEDD4ECA973DD8B" unitRef="usd">668121000</biib:UnconsolidatedJointBusiness>
	<biib:UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax contextRef="FI2014Q4" decimals="-5" id="Fact-6FBCC63B96AA5899E690D4ECA99BCD36" unitRef="usd">72100000</biib:UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax>
	<biib:UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax contextRef="FI2015Q2" decimals="-5" id="Fact-96B39D2E6B6B97808E1DD4ECA9A704D2" unitRef="usd">63100000</biib:UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax>
	<dei:AmendmentFlag contextRef="FD2015Q2YTD" id="Fact-33848EC5882C21B95A5CD4ECA99A9E8A">false</dei:AmendmentFlag>
	<dei:CurrentFiscalYearEndDate contextRef="FD2015Q2YTD" id="Fact-37EC8C2916E64F9EFBA6D4ECA99BA076">--12-31</dei:CurrentFiscalYearEndDate>
	<dei:DocumentFiscalPeriodFocus contextRef="FD2015Q2YTD" id="Fact-DE48A0FBF83FB19E9B7AD4ECA99B96F5">Q2</dei:DocumentFiscalPeriodFocus>
	<dei:DocumentFiscalYearFocus contextRef="FD2015Q2YTD" id="Fact-9BBE0C98EFB925039B2DD4ECA99B0DE7">2015</dei:DocumentFiscalYearFocus>
	<dei:DocumentPeriodEndDate contextRef="FD2015Q2YTD" id="Fact-2A2417332C21FCE18780D4ECA99A09A4">2015-06-30</dei:DocumentPeriodEndDate>
	<dei:DocumentType contextRef="FD2015Q2YTD" id="Fact-9823BC416349AD02B22ED4ECA99AB5DA">10-Q</dei:DocumentType>
	<dei:EntityCentralIndexKey contextRef="FD2015Q2YTD" id="Fact-057B2FD3B3A0F2624466D4ECA99A6B8C">0000875045</dei:EntityCentralIndexKey>
	<dei:EntityCommonStockSharesOutstanding contextRef="I2015Q2SharesOutstanding" decimals="INF" id="Fact-C6408299C6CB056ABF20D4ECA9996687" unitRef="shares">235169225</dei:EntityCommonStockSharesOutstanding>
	<dei:EntityFilerCategory contextRef="FD2015Q2YTD" id="Fact-DADB984967D662FB07EDD4ECA99A941C">Large Accelerated Filer</dei:EntityFilerCategory>
	<dei:EntityRegistrantName contextRef="FD2015Q2YTD" id="Fact-606DCBD3A69A231C18BBD4ECA9A47ACC">BIOGEN INC.</dei:EntityRegistrantName>
	<invest:DerivativeNotionalAmount contextRef="FI2014Q4_us-gaap_CurrencyAxis_currency_AUD_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-AEADBCFECF3E9F23C314D4ECA9800BE7" unitRef="usd">19900000</invest:DerivativeNotionalAmount>
	<invest:DerivativeNotionalAmount contextRef="FI2014Q4_us-gaap_CurrencyAxis_currency_CAD_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-12E7BD1A34B28EEBD222D4ECA97D7855" unitRef="usd">56700000</invest:DerivativeNotionalAmount>
	<invest:DerivativeNotionalAmount contextRef="FI2014Q4_us-gaap_CurrencyAxis_currency_EUR_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-7FC6D6D31C11D0C96886D4ECA971E95E" unitRef="usd">1174600000</invest:DerivativeNotionalAmount>
	<invest:DerivativeNotionalAmount contextRef="FI2014Q4_us-gaap_CurrencyAxis_currency_GBP_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-776436CC57CE60C2A98AD4ECA97F2240" unitRef="usd">34500000</invest:DerivativeNotionalAmount>
	<invest:DerivativeNotionalAmount contextRef="FI2014Q4_us-gaap_CurrencyAxis_currency_JPY_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-BA26199111C90F7E1161D4ECA97D3370" unitRef="usd">16600000</invest:DerivativeNotionalAmount>
	<invest:DerivativeNotionalAmount contextRef="FI2014Q4_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-1EFA63C9E6A7657C3B9FD4ECA9721192" unitRef="usd">1302300000</invest:DerivativeNotionalAmount>
	<invest:DerivativeNotionalAmount contextRef="FI2014Q4_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" decimals="-5" id="Fact-671205C7117F2362F5E7D4ECA97337D6" unitRef="usd">365200000</invest:DerivativeNotionalAmount>
	<invest:DerivativeNotionalAmount contextRef="FI2015Q2_us-gaap_CurrencyAxis_currency_AUD_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-F252C5A2747DE7DF59C8D4ECA980E2F9" unitRef="usd">10300000</invest:DerivativeNotionalAmount>
	<invest:DerivativeNotionalAmount contextRef="FI2015Q2_us-gaap_CurrencyAxis_currency_CAD_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-7E87E39D4957C7AF2ADED4ECA97E0204" unitRef="usd">32100000</invest:DerivativeNotionalAmount>
	<invest:DerivativeNotionalAmount contextRef="FI2015Q2_us-gaap_CurrencyAxis_currency_EUR_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-DE8F0D373DB515860CB2D4ECA97FCA6F" unitRef="usd">1437200000</invest:DerivativeNotionalAmount>
	<invest:DerivativeNotionalAmount contextRef="FI2015Q2_us-gaap_CurrencyAxis_currency_GBP_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-F6BFA3BC8377E53D78A3D4ECA97FE9D8" unitRef="usd">21900000</invest:DerivativeNotionalAmount>
	<invest:DerivativeNotionalAmount contextRef="FI2015Q2_us-gaap_CurrencyAxis_currency_JPY_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-DC135FF578BE6C5174EED4ECA9976A95" unitRef="usd">15500000</invest:DerivativeNotionalAmount>
	<invest:DerivativeNotionalAmount contextRef="FI2015Q2_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-9A2CE8C13B233E7D162DD4ECA97F73C7" unitRef="usd">1517000000</invest:DerivativeNotionalAmount>
	<invest:DerivativeNotionalAmount contextRef="FI2015Q2_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" decimals="-5" id="Fact-E036D950F09C783CD746D4ECA99AB7D4" unitRef="usd">472400000</invest:DerivativeNotionalAmount>
	<us-gaap:AccountsPayableCurrent contextRef="FI2014Q4" decimals="-3" id="Fact-637C59356F97ABE7440ED4ECA9A5EFA9" unitRef="usd">229178000</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccountsPayableCurrent contextRef="FI2015Q2" decimals="-3" id="Fact-0DD43A9DDDA2A222DEC3D4ECA99B8FE0" unitRef="usd">282702000</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccountsReceivableNetCurrent contextRef="FI2014Q4" decimals="-3" id="Fact-368695C5823D01304C3DD4ECA9A33FAA" unitRef="usd">1292445000</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:AccountsReceivableNetCurrent contextRef="FI2015Q2" decimals="-3" id="Fact-1579F9FA879B17748061D4ECA9A3A96B" unitRef="usd">1310821000</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:AccruedRoyaltiesCurrent contextRef="FI2014Q4" decimals="-5" id="Fact-02C95421331D7F10CD4DD4ECA974B327" unitRef="usd">172400000</us-gaap:AccruedRoyaltiesCurrent>
	<us-gaap:AccruedRoyaltiesCurrent contextRef="FI2015Q2" decimals="-5" id="Fact-A9A60825E595966A6425D4ECA98CAE9E" unitRef="usd">161900000</us-gaap:AccruedRoyaltiesCurrent>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="FI2014Q4" decimals="-5" id="Fact-6BE7AC0B04D1434F571FD4ECA99994D4" unitRef="usd">1186400000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="FI2015Q2" decimals="-5" id="Fact-9B3AF5A883A3851DB646D4ECA99A6231" unitRef="usd">1274200000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2013Q4" decimals="-5" id="Fact-E6F0FBA6ABB6FAE55EC1D4ECA9733308" unitRef="usd">-27700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2013Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-5614686417D286A458EBD4ECA973CCBD" unitRef="usd">-19600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2013Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-38A5309D84B16D40E505D4ECA9759882" unitRef="usd">-23700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2013Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-1039EDC98C6BDE3C78D3D4ECA974C7ED" unitRef="usd">5600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2013Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-8FDBF3D0D2F15705EB9CD4ECA97347DB" unitRef="usd">10000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2014Q2" decimals="-5" id="Fact-E8B920B68881BC4FB22ED4ECA9754D1E" unitRef="usd">-26700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2014Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-96F22A950B7817FDC8C8D4ECA973384B" unitRef="usd">-19000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2014Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-89B77C71975067E15574D4ECA973FDF3" unitRef="usd">-7100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2014Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-EDF2282381DD8C527F6BD4ECA975A648" unitRef="usd">400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2014Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-7882D8A7430FFBD821F8D4ECA9801160" unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2014Q4" decimals="-3" id="Fact-DC9931F07EB11F830C6CD4ECA9A3C5B7" unitRef="usd">-59488000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2014Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-D354326C5C176B286122D4ECA98D21A0" unitRef="usd">-31600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2014Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-83A32EB44E69B91BC408D4ECA98E6DA4" unitRef="usd">71700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2014Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-54E8CD5279404F974A59D4ECA9A58B03" unitRef="usd">-400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2014Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-CFA6A30059C9ABB5F164D4ECA9AF6A87" unitRef="usd">-99200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2015Q2" decimals="-3" id="Fact-854B3438BCE596BBE935D4ECA99AB04D" unitRef="usd">-101025000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2015Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-7950FA67DD3E1305DCCFD4ECA9A598F6" unitRef="usd">-27500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2015Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-E5AC1618A39E58217344D4ECA9961FF1" unitRef="usd">62800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2015Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-D9889448D42A18D53188D4ECA98CFB06" unitRef="usd">700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2015Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-AC499FAE9F21A493AC0CD4ECA98CB79E" unitRef="usd">-137000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AdditionalPaidInCapital contextRef="FI2014Q4" decimals="-3" id="Fact-2B56C70168B013A65C7ED4ECA99AA077" unitRef="usd">4196156000</us-gaap:AdditionalPaidInCapital>
	<us-gaap:AdditionalPaidInCapital contextRef="FI2015Q2" decimals="-3" id="Fact-40531422424D0F324F53D4ECA99BAD9D" unitRef="usd">4251443000</us-gaap:AdditionalPaidInCapital>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ParentMember" decimals="-5" id="Fact-34CE03AA6180C67E951AD4ECA98ED91C" unitRef="usd">39000000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" decimals="-5" id="Fact-C69852A01D79A2324F76D4ECA9953116" unitRef="usd">24500000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember" decimals="-5" id="Fact-6DFC71D91862C37835D4D4ECA98D8017" unitRef="usd">33600000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2QTD_us-gaap_PlanNameAxis_biib_CashSettledPerformanceSharesMember" decimals="-5" id="Fact-116A98A7EDD10F8E8B77D4ECA9AF3A78" unitRef="usd">14000000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2QTD_us-gaap_PlanNameAxis_biib_EmployeeStockPurchasePlanMember" decimals="-5" id="Fact-A5A73020ED668314FCBFD4ECA9AE9BA9" unitRef="usd">2700000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2QTD_us-gaap_PlanNameAxis_biib_MarketStockUnitsMember" decimals="-5" id="Fact-D199C8C948A8BBFF0C5ED4ECA9AF775A" unitRef="usd">8200000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2QTD_us-gaap_PlanNameAxis_biib_TimeVestedRestrictedStockUnitsMember" decimals="-5" id="Fact-6BA1F198E31CB9AD329AD4ECA9AFF2CC" unitRef="usd">29200000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2QTD_us-gaap_PlanNameAxis_us-gaap_PerformanceSharesMember" decimals="-5" id="Fact-E2315EA57DFB444EFE01D4ECA9AECDA8" unitRef="usd">4000000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ParentMember" decimals="-5" id="Fact-506721FCE24A5E4418B4D4ECA9850D7C" unitRef="usd">90700000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" decimals="-5" id="Fact-EE59AA5FD5656BA72BE5D4ECA98DFE9A" unitRef="usd">53900000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember" decimals="-5" id="Fact-FE01502AC258EA1A1781D4ECA9AF31AF" unitRef="usd">80800000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2YTD_us-gaap_PlanNameAxis_biib_CashSettledPerformanceSharesMember" decimals="-5" id="Fact-3EF3A30BDA99A365892AD4ECA999B2E3" unitRef="usd">35400000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2YTD_us-gaap_PlanNameAxis_biib_EmployeeStockPurchasePlanMember" decimals="-5" id="Fact-D5CC5A71A85E0E136FC0D4ECA97DE112" unitRef="usd">7500000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2YTD_us-gaap_PlanNameAxis_biib_MarketStockUnitsMember" decimals="-5" id="Fact-EE52AE5E3424C1A85ED8D4ECA9A4664F" unitRef="usd">23100000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2YTD_us-gaap_PlanNameAxis_biib_TimeVestedRestrictedStockUnitsMember" decimals="-5" id="Fact-BC40D34F0CF5DCA814A8D4ECA972BA35" unitRef="usd">58400000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2014Q2YTD_us-gaap_PlanNameAxis_us-gaap_PerformanceSharesMember" decimals="-5" id="Fact-6D3DC311574FAC025798D4ECA99726D5" unitRef="usd">10300000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ParentMember" decimals="-5" id="Fact-14AEF838E7EA1FDBBFDAD4ECA98E075C" unitRef="usd">33200000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" decimals="-5" id="Fact-08BF2154938FDA434E3BD4ECA98D40E0" unitRef="usd">22100000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember" decimals="-5" id="Fact-191DFFE85F8BABBBEFD7D4ECA98DE68F" unitRef="usd">26200000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2QTD_us-gaap_PlanNameAxis_biib_CashSettledPerformanceSharesMember" decimals="-5" id="Fact-BE0106E0E16C58957040D4ECA9AE162C" unitRef="usd">3200000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2QTD_us-gaap_PlanNameAxis_biib_EmployeeStockPurchasePlanMember" decimals="-5" id="Fact-918F3879AA65C5264487D4ECA9AF8D98" unitRef="usd">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2QTD_us-gaap_PlanNameAxis_biib_MarketStockUnitsMember" decimals="-5" id="Fact-39F6734722AE72507740D4ECA9AEF557" unitRef="usd">9100000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2QTD_us-gaap_PlanNameAxis_biib_TimeVestedRestrictedStockUnitsMember" decimals="-5" id="Fact-834CB2730C701F8E8DEBD4ECA9AEC988" unitRef="usd">31800000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2QTD_us-gaap_PlanNameAxis_us-gaap_PerformanceSharesMember" decimals="-5" id="Fact-129F37B9658F31147800D4ECA9AF64FD" unitRef="usd">1200000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ParentMember" decimals="-5" id="Fact-C83599766D18CC332D2CD4ECA98DE9B3" unitRef="usd">94100000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" decimals="-5" id="Fact-F7A434921972443E6FAFD4ECA97336CA" unitRef="usd">57500000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember" decimals="-5" id="Fact-52377B4B1B0EE76F001DD4ECA997A2EF" unitRef="usd">81800000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2YTD_us-gaap_PlanNameAxis_biib_CashSettledPerformanceSharesMember" decimals="-5" id="Fact-29BD8BC642B55E1A8B58D4ECA974EF1A" unitRef="usd">27000000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2YTD_us-gaap_PlanNameAxis_biib_EmployeeStockPurchasePlanMember" decimals="-5" id="Fact-3442466E1CDA41EE7469D4ECA99B04D9" unitRef="usd">8100000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2YTD_us-gaap_PlanNameAxis_biib_MarketStockUnitsMember" decimals="-5" id="Fact-3F99B3D33069FFCBF13AD4ECA97FDA23" unitRef="usd">26100000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2YTD_us-gaap_PlanNameAxis_biib_TimeVestedRestrictedStockUnitsMember" decimals="-5" id="Fact-48661AA3505EE67EAC77D4ECA9735833" unitRef="usd">63700000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2015Q2YTD_us-gaap_PlanNameAxis_us-gaap_PerformanceSharesMember" decimals="-5" id="Fact-D5559148FE787D45B434D4ECA97B3E6D" unitRef="usd">14400000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="FD2014Q2QTD" decimals="-5" id="Fact-AA9D7528AC7537709C51D4ECA9AF15C9" unitRef="usd">58100000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
	<us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="FD2014Q2YTD" decimals="-5" id="Fact-DF8E6FF027BA90CAD74CD4ECA97B04A1" unitRef="usd">134700000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
	<us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="FD2015Q2QTD" decimals="-5" id="Fact-F202CEC665E5F6605624D4ECA9AFB342" unitRef="usd">48300000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
	<us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="FD2015Q2YTD" decimals="-5" id="Fact-66D11ED40B0DE2C79429D4ECA99A9D50" unitRef="usd">139300000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2014Q2QTD" decimals="-3" id="Fact-300A9614EAEF9A0BF15AD4ECA983898F" unitRef="usd">116826000</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2014Q2YTD" decimals="-3" id="Fact-8E976E71F67320D70C52D4ECA98D6531" unitRef="usd">260084000</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2015Q2QTD" decimals="-3" id="Fact-E84AE53CA38B527928F3D4ECA9B1C7D5" unitRef="usd">92004000</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2015Q2YTD" decimals="-3" id="Fact-31AD06D47EADBFC6F75ED4ECA98C05E5" unitRef="usd">187907000</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AssetImpairmentCharges contextRef="FD2015Q2YTD" decimals="-6" id="Fact-E48889E76141F2D786D6D4ECA98C4BF1" unitRef="usd">0</us-gaap:AssetImpairmentCharges>
	<us-gaap:Assets contextRef="FI2014Q4" decimals="-3" id="Fact-71E89B865BA75AB3B96BD4ECA9A16751" unitRef="usd">14316559000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2015Q2" decimals="-3" id="Fact-701E3CC9C821602696DDD4ECA98C7249" unitRef="usd">16759171000</us-gaap:Assets>
	<us-gaap:AssetsCurrent contextRef="FI2014Q4" decimals="-3" id="Fact-16D23D466612763B2538D4ECA9A47D7D" unitRef="usd">4672673000</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent contextRef="FI2015Q2" decimals="-3" id="Fact-CDDA88F0CBF1F5151DCDD4ECA99A4435" unitRef="usd">5618985000</us-gaap:AssetsCurrent>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-63646E5BAAD38125BA89D4ECA982F415" unitRef="usd">6900000</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-7FB7BE2AD955362A0EDCD4ECA97F044B" unitRef="usd">2937000000</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-B65928C44C98C674D45FD4ECA9A630E4" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-4C2A4F3E57292B988D27D4ECA98205A1" unitRef="usd">2943900000</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-4BD676899A73E4C871DDD4ECA9B20137" unitRef="usd">6800000</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-3C47B996F7F6FDE1E0E8D4ECA9A9C8B8" unitRef="usd">4303600000</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-7A838DA1F7F7DF363914D4ECA9B1FF3B" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-3704A522B40F5CE95803D4ECA9AF67FA" unitRef="usd">4310400000</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="FI2014Q4" decimals="-5" id="Fact-0707B5CE6A38DCDBA8A6D4ECA98C756A" unitRef="usd">2112800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
	<us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="FI2015Q2" decimals="-5" id="Fact-6B453E6E215B85BC97FED4ECA98CC764" unitRef="usd">3188500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4" decimals="-5" id="Fact-BEF6AD3903FCCA6BA855D4ECA98B5CA2" unitRef="usd">2111100000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-F3D4526A4AEFA3C353ACD4ECA97EE578" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-79A79A27DC68F07FBF2FD4ECA97D045C" unitRef="usd">198300000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-1C3E75D63C9B54EC3773D4ECA97E3AED" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-0BD4C2D2C3F767C6719FD4ECA97F6B09" unitRef="usd">198300000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-4D8D99C9DBA3A67CF0D3D4ECA9800210" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-2F15593B62AB2D854188D4ECA97CD071" unitRef="usd">1063000000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-C2A2BF161065119FEC0FD4ECA97FCE1E" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-7501F229A078EB41F12BD4ECA97D6E67" unitRef="usd">1063000000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-0BD51D26679FF838990CD4ECA97F5056" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-F3455C5E045A8BDB12F7D4ECA9A7EDBE" unitRef="usd">849800000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-1CD73E39CCB9792C285ED4ECA97D336F" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-8AC0B72FCE665C2FD35DD4ECA97F19CE" unitRef="usd">849800000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesCurrentMember" decimals="-5" id="Fact-AA75C1916E969EAEE5B3D4ECA98CF690" unitRef="usd">370400000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesNonCurrentMember" decimals="-5" id="Fact-34C5665BB3DA56586651D4ECA98D8425" unitRef="usd">692600000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesCurrentMember" decimals="-5" id="Fact-90B33EE7C1025062547FD4ECA98BCE0D" unitRef="usd">269900000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesNonCurrentMember" decimals="-5" id="Fact-3C2732D95FC1FFDAD250D4ECA9864A58" unitRef="usd">579900000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember" decimals="-5" id="Fact-480C34DB247FBBEE4264D4ECA98C0B71" unitRef="usd">200000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember" decimals="-5" id="Fact-3CAC9318253A88BF9EBBD4ECA98CE7BD" unitRef="usd">198100000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_EquitySecuritiesMember" decimals="-5" id="Fact-6736AE2469B4343272DFD4ECA98D8D99" unitRef="usd">6900000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2" decimals="-5" id="Fact-E8326B67EF35C458FBF6D4ECA9A39B72" unitRef="usd">3188400000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-268AC63F96CA2F8348D9D4ECA9AF253D" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-5B25A8146599FF0C448FD4ECA9B09B65" unitRef="usd">290000000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-0E51746395D74C51904DD4ECA9B1D4BF" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_AssetBackedSecuritiesMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-2410C5B4337E904EBD64D4ECA9AF0723" unitRef="usd">290000000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-1C47A617FAF6ACF1F08AD4ECA9A9D23D" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-B8561B0D3D351733786ED4ECA9A97C5A" unitRef="usd">1198100000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-D82C09466039B80EC748D4ECA9AF6F76" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_CorporateDebtSecuritiesMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-E33B806879C46D3966F0D4ECA9AE5206" unitRef="usd">1198100000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-CFA520FACC3C4B8EE774D4ECA9AF0A50" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-527954FACF92A5653CE2D4ECA9715BF9" unitRef="usd">1700300000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-B8BE0F9AC0DFC60E8A24D4ECA9B082CE" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_FairValueByAssetClassAxis_us-gaap_USTreasuryAndGovernmentMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-5C4B4F2486FB21F9468DD4ECA9A8478A" unitRef="usd">1700300000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesCurrentMember" decimals="-5" id="Fact-47FB36942BE6D5DEAC00D4ECA99BE7E8" unitRef="usd">375900000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesNonCurrentMember" decimals="-5" id="Fact-16DC248FAA6D92116072D4ECA99B3E42" unitRef="usd">822200000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesCurrentMember" decimals="-5" id="Fact-5B9D5D5E8B749D856152D4ECA99AB525" unitRef="usd">710500000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesNonCurrentMember" decimals="-5" id="Fact-DBCF9B1A88C3009C45A8D4ECA99A7BEE" unitRef="usd">989800000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember" decimals="-5" id="Fact-15EBCCF893FC34ED5352D4ECA99A0A3F" unitRef="usd">200000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember" decimals="-5" id="Fact-6D4C9C22BBE907B43E3DD4ECA98BBF89" unitRef="usd">289800000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_EquitySecuritiesMember" decimals="-5" id="Fact-E6A565090B03213D0F87D4ECA99B4F7E" unitRef="usd">6800000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2014Q4" decimals="-5" id="Fact-152A5D16CE6108F9D228D4ECA98BD5EE" unitRef="usd">700000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesCurrentMember" decimals="-5" id="Fact-CFEB707D6A287C1888BAD4ECA98D8F52" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesNonCurrentMember" decimals="-5" id="Fact-4BDDB33C5077D345117CD4ECA98B1D1F" unitRef="usd">200000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesCurrentMember" decimals="-5" id="Fact-766E484109B0999D3BCCD4ECA98D04AE" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesNonCurrentMember" decimals="-5" id="Fact-670861E5EEE329835D82D4ECA98DE8D1" unitRef="usd">300000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember" decimals="-5" id="Fact-4FFAF119B398FAEA7E3CD4ECA98B74B4" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember" decimals="-5" id="Fact-23418703EA4E338AFC0DD4ECA98D1A3C" unitRef="usd">200000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_EquitySecuritiesMember" decimals="-5" id="Fact-437F59FBA0FDA3F5E03DD4ECA98D948A" unitRef="usd">1200000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2015Q2" decimals="-5" id="Fact-705D5A62F55DE41B4768D4ECA99BBC6B" unitRef="usd">1700000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesCurrentMember" decimals="-5" id="Fact-78B3685A5738D00FCE2AD4ECA98D2561" unitRef="usd">100000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesNonCurrentMember" decimals="-5" id="Fact-47CB16C3D3B148C71638D4ECA9A36F38" unitRef="usd">400000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesCurrentMember" decimals="-5" id="Fact-6FA79A335CF13CA47A95D4ECA99B00D3" unitRef="usd">100000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesNonCurrentMember" decimals="-5" id="Fact-61D3B56904B1077C1F00D4ECA99A1A87" unitRef="usd">900000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember" decimals="-5" id="Fact-D7F06407618C70312153D4ECA99B323F" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember" decimals="-5" id="Fact-EDE0E1E42E96CC20C4B4D4ECA99B0BD6" unitRef="usd">200000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_EquitySecuritiesMember" decimals="-5" id="Fact-81E8B301AF7345556842D4ECA99B7A09" unitRef="usd">1100000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2014Q4" decimals="-5" id="Fact-C4EDBC4EDD78152CEABBD4ECA98CFE6D" unitRef="usd">2400000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesCurrentMember" decimals="-5" id="Fact-89DD12993FBB6E41A804D4ECA98CCAB0" unitRef="usd">200000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesNonCurrentMember" decimals="-5" id="Fact-DD096B96BBDA02F7A095D4ECA98CD0AE" unitRef="usd">1500000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesCurrentMember" decimals="-5" id="Fact-7FD8DE4D5C6000E602A5D4ECA98DDC8B" unitRef="usd">100000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesNonCurrentMember" decimals="-5" id="Fact-89836568B09BE1EAA17FD4ECA98CAFC1" unitRef="usd">400000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember" decimals="-5" id="Fact-4F1E5619EA463344D063D4ECA98D38D6" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember" decimals="-5" id="Fact-D38F043F5DD311066E8ED4ECA98C18A1" unitRef="usd">200000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_EquitySecuritiesMember" decimals="-5" id="Fact-85D745CD5EB55820DC6BD4ECA98CDCF5" unitRef="usd">200000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2015Q2" decimals="-5" id="Fact-0B5E78106D53161F09C4D4ECA9A4F27E" unitRef="usd">1800000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesCurrentMember" decimals="-5" id="Fact-CD2B11E750132A2256A2D4ECA99BA69B" unitRef="usd">100000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesNonCurrentMember" decimals="-5" id="Fact-2339F024F98C0B78C453D4ECA9A3A2C0" unitRef="usd">1200000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesCurrentMember" decimals="-5" id="Fact-40100F68D31967503D9FD4ECA99ACA76" unitRef="usd">100000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesNonCurrentMember" decimals="-5" id="Fact-1B3107A0DD5FF04CD45BD4ECA99A0741" unitRef="usd">100000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember" decimals="-5" id="Fact-C2C035BC5700FB5F6DF7D4ECA99B1B95" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember" decimals="-5" id="Fact-7E33F8DF430900BD9B77D4ECA99A53B6" unitRef="usd">300000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_EquitySecuritiesMember" decimals="-5" id="Fact-E80D053C5F678AA39039D4ECA9857096" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2014Q4" decimals="-5" id="Fact-D0A264E06A252FCE7DB6D4ECA9852302" unitRef="usd">2112800000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesCurrentMember" decimals="-5" id="Fact-C4BC31555520ED260531D4ECA98B682B" unitRef="usd">370600000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesNonCurrentMember" decimals="-5" id="Fact-805DE76CE02AC1A834C4D4ECA98CCD89" unitRef="usd">693900000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesCurrentMember" decimals="-5" id="Fact-DCE0177F2B78C880D854D4ECA98C23AD" unitRef="usd">270000000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesNonCurrentMember" decimals="-5" id="Fact-55E588E5E41D2187B57AD4ECA9862E2F" unitRef="usd">580000000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember" decimals="-5" id="Fact-91B1D9BB5D036F938648D4ECA98B7AFD" unitRef="usd">200000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember" decimals="-5" id="Fact-AD8EF3DFFB88E89D57A7D4ECA98BC9CB" unitRef="usd">198100000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2014Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_EquitySecuritiesMember" decimals="-5" id="Fact-00309E913F58F7A84D4ED4ECA98D650B" unitRef="usd">5900000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2015Q2" decimals="-5" id="Fact-577DFD8D7248702E3A06D4ECA99B8BE3" unitRef="usd">3188500000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesCurrentMember" decimals="-5" id="Fact-4195307A9E2F6C8D788CD4ECA99A4858" unitRef="usd">375900000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_CorporateDebtSecuritiesNonCurrentMember" decimals="-5" id="Fact-ED2F10432D002D9CE496D4ECA99994AF" unitRef="usd">823000000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesCurrentMember" decimals="-5" id="Fact-D18B6A662F364F49AC70D4ECA98C6C97" unitRef="usd">710500000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_GovernmentSecuritiesNonCurrentMember" decimals="-5" id="Fact-FD23F01A1054B24D1C8DD4ECA99B80A2" unitRef="usd">989000000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember" decimals="-5" id="Fact-FF0C7D1C80F19C7B56F9D4ECA99AB4AE" unitRef="usd">200000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember" decimals="-5" id="Fact-1FD7AA3701076DE5110BD4ECA98BF173" unitRef="usd">289900000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="FI2015Q2_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_EquitySecuritiesMember" decimals="-5" id="Fact-BE19B00EB482F52948B6D4ECA99ADECF" unitRef="usd">5700000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesCurrent contextRef="FI2014Q4" decimals="-3" id="Fact-2C3A1062AFAE59006682D4ECA9A3B5E4" unitRef="usd">640460000</us-gaap:AvailableForSaleSecuritiesCurrent>
	<us-gaap:AvailableForSaleSecuritiesCurrent contextRef="FI2015Q2" decimals="-3" id="Fact-218F8357ECE09E2D0775D4ECA99AE872" unitRef="usd">1086595000</us-gaap:AvailableForSaleSecuritiesCurrent>
	<us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost contextRef="FI2014Q4" decimals="-5" id="Fact-D1F534336121EC2ED739D4ECA98CE0DA" unitRef="usd">1345200000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost contextRef="FI2015Q2" decimals="-5" id="Fact-2E387866C12E2E2D71CAD4ECA98CFC33" unitRef="usd">1954500000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue contextRef="FI2014Q4" decimals="-5" id="Fact-E14075D356EFCC27CACCD4ECA98CA98D" unitRef="usd">1343700000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
	<us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue contextRef="FI2015Q2" decimals="-5" id="Fact-8B4F8E9951B1A5BD033DD4ECA98C8390" unitRef="usd">1954400000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
	<us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost contextRef="FI2014Q4" decimals="-5" id="Fact-33B5FEF81DCEBB3AD8F8D4ECA98C33BF" unitRef="usd">640800000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost contextRef="FI2015Q2" decimals="-5" id="Fact-CCDA56B60F825B64D04DD4ECA98CAEB8" unitRef="usd">1086600000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="FI2014Q4" decimals="-5" id="Fact-4AFEF765F332F6136FB4D4ECA98E9DAB" unitRef="usd">640500000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
	<us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="FI2015Q2" decimals="-5" id="Fact-DE7945DA60B29486E2BBD4ECA98C576F" unitRef="usd">1086600000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
	<us-gaap:AvailableForSaleSecuritiesGrossRealizedGains contextRef="FD2014Q2QTD" decimals="-5" id="Fact-63082E2DAA1B00EB284DD4ECA9A3EE87" unitRef="usd">200000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGains>
	<us-gaap:AvailableForSaleSecuritiesGrossRealizedGains contextRef="FD2014Q2YTD" decimals="-5" id="Fact-AE73DC338FFE3551650CD4ECA98C8621" unitRef="usd">400000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGains>
	<us-gaap:AvailableForSaleSecuritiesGrossRealizedGains contextRef="FD2015Q2QTD" decimals="-5" id="Fact-51157A970B28A24D4E8AD4ECA9A4812A" unitRef="usd">300000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGains>
	<us-gaap:AvailableForSaleSecuritiesGrossRealizedGains contextRef="FD2015Q2YTD" decimals="-5" id="Fact-2955C4A95D21361E9C09D4ECA973F3C8" unitRef="usd">500000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGains>
	<us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses contextRef="FD2014Q2QTD" decimals="-5" id="Fact-BD8BA60EC232042F4216D4ECA9A347DC" unitRef="usd">100000</us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses>
	<us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses contextRef="FD2014Q2YTD" decimals="-5" id="Fact-3ACF79FA41B5D5497586D4ECA996142F" unitRef="usd">200000</us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses>
	<us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses contextRef="FD2015Q2QTD" decimals="-5" id="Fact-656DBE1A29A79FE84389D4ECA9A4D47F" unitRef="usd">500000</us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses>
	<us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses contextRef="FD2015Q2YTD" decimals="-5" id="Fact-A1E2B64E32FB9365475ED4ECA984E229" unitRef="usd">800000</us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses>
	<us-gaap:AvailableForSaleSecuritiesNoncurrent contextRef="FI2014Q4" decimals="-3" id="Fact-783AA38BF8E34389FAB8D4ECA99AA47D" unitRef="usd">1470652000</us-gaap:AvailableForSaleSecuritiesNoncurrent>
	<us-gaap:AvailableForSaleSecuritiesNoncurrent contextRef="FI2015Q2" decimals="-3" id="Fact-4D4D4862B4B06C180A58D4ECA999F9E5" unitRef="usd">2101796000</us-gaap:AvailableForSaleSecuritiesNoncurrent>
	<us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="D2015Q1_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember" decimals="-5" id="Fact-1D0DF8CBB38C417013B1D4ECA986E337" unitRef="usd">474600000</us-gaap:BusinessCombinationConsiderationTransferred1>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="FD2015Q2QTD_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember" decimals="-5" id="Fact-D91B442DEB0130B6A0A1B1CE805B2812" unitRef="usd">36000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="FI2013Q2_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember_us-gaap_ProductOrServiceAxis_biib_TecfideraMember" decimals="-5" id="Fact-E4C8A404AA79DEF08EAFD4ECA995DFED" unitRef="usd">15000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="I2015Q1ConvergencePharma_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember_us-gaap_ProductOrServiceAxis_biib_CNV1014802Member" decimals="-5" id="Fact-AE6A1D56E0B25DB4AF2ED4ECA9749214" unitRef="usd">145000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="I2015Q1ConvergencePharma_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember_us-gaap_ProductOrServiceAxis_biib_NeuropathicpainindicationsMember" decimals="-5" id="Fact-8CB6DAE7A129018BE5D2D4ECA995FF5D" unitRef="usd">415000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2013Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-D701BADB0D9081A4EFB5D4ECA9757E14" unitRef="usd">280900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2014Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-4DC9C99EA51A51A6F623D4ECA97F6A98" unitRef="usd">275100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2014Q2_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-A4C06406BB490A99CCF1D4ECA980FD35" unitRef="usd">279100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-B420E4CF64D5331AFF44D4ECA97F5C24" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-30B2E6776EA26721A9A9D4ECA982F173" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-956EE4202BD70680188ED4ECA97EA4E1" unitRef="usd">215500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2014Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-EA88BF4CF0C7259BE4E9D4ECA97D29AC" unitRef="usd">215500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2015Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-8F3374B23344C131EE74D4ECA97F2FD8" unitRef="usd">461800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-413B47F4E763E8C25DAAD4ECA9711698" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-328AE9213F604EE818CDD4ECA9A97F9B" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-1DC2921105B6C0451F9DD4ECA9A9EAB6" unitRef="usd">495600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2015Q2_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-315E72827C22E8BF52DBD4ECA997C289" unitRef="usd">495600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="FI2014Q4" decimals="-5" id="Fact-55656828E6DCF2B3ACE3D4ECA98BD20B" unitRef="usd">265500000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="FI2015Q2" decimals="-5" id="Fact-669A4545439168B0B29FD4ECA983C893" unitRef="usd">493500000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="FI2014Q4" decimals="-5" id="Fact-56D1046FFF3F2B31C688D4ECA98C039D" unitRef="usd">200000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="FI2015Q2" decimals="-5" id="Fact-CB89B291D916E94D61A8D4ECA98608F4" unitRef="usd">302200000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent contextRef="I2015Q1ConvergencePharma_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember" decimals="-5" id="Fact-9CB78E237770E5DC67BED4ECA99B9F71" unitRef="usd">84900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets contextRef="I2015Q1ConvergencePharma_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember" decimals="-5" id="Fact-9F8EA5E981FA1C987043D4ECA9A61408" unitRef="usd">424600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets contextRef="I2015Q1ConvergencePharma_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember_us-gaap_ProductOrServiceAxis_biib_CNV1014802Member" decimals="-5" id="Fact-9F7817BAB0E221243B07D4ECA99AF5D6" unitRef="usd">200000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets contextRef="I2015Q1ConvergencePharma_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember_us-gaap_ProductOrServiceAxis_biib_NeuropathicpainindicationsMember" decimals="-5" id="Fact-7A1D2B82AA8F862D6832741D7F239AD1" unitRef="usd">220000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="I2015Q1ConvergencePharma_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember" decimals="-5" id="Fact-390008D8E42674B32034D4ECA9A49B0A" unitRef="usd">7600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="I2015Q1ConvergencePharma_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember" decimals="-5" id="Fact-293B7770653ADC4CD835D4ECA9A77347" unitRef="usd">474600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets contextRef="I2015Q1ConvergencePharma_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember" decimals="-5" id="Fact-161EFB7C74BE4EDE43D5D4ECA9B0AE2D" unitRef="usd">-1000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2013Q4" decimals="-3" id="Fact-9A05138E5FC3C0BC4807D4ECA9A5CEE3" unitRef="usd">602562000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2014Q2" decimals="-3" id="Fact-B4F053858A03E7295274D4ECA97F5CB3" unitRef="usd">863197000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2014Q4" decimals="-3" id="Fact-A4032070D241A828C47CD4ECA9A2F70A" unitRef="usd">1204924000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2015Q2" decimals="-3" id="Fact-71DD44FEEF19DA031AE2D4ECA9A49004" unitRef="usd">1282078000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-2C96CC94E9870F2FF5A4D4ECA97D6D2A" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-77C9EAB3C655891D87B5D4ECA97D2953" unitRef="usd">716300000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-55A85233945C60A4C18CD4ECA97DA42C" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-9AE6C57973E86033E849D4ECA9A65040" unitRef="usd">716300000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-2EAA856D76A64B3B3D7DD4ECA9AFD1F3" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-B713A982716EC0C933B9D4ECA9B19348" unitRef="usd">974000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-CC1F557F549CD3F60AC9D4ECA9AF1365" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-66F714C885D10D62DE0FD4ECA9A94731" unitRef="usd">974000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="FD2014Q2YTD" decimals="-3" id="Fact-15C6807F37CAE397DB4BD4ECA98EB858" unitRef="usd">263600000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="FD2015Q2YTD" decimals="-3" id="Fact-EAF6600F93FF7EFDC0F3D4ECA99A736A" unitRef="usd">101342000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashEquivalentsAtCarryingValue contextRef="FI2014Q4" decimals="-5" id="Fact-6AD545C57C0D648DF12ED4ECA99B7C49" unitRef="usd">716300000</us-gaap:CashEquivalentsAtCarryingValue>
	<us-gaap:CashEquivalentsAtCarryingValue contextRef="FI2014Q4_us-gaap_InvestmentTypeAxis_us-gaap_CommercialPaperMember" decimals="-5" id="Fact-B9A36505F6B229275291D4ECA9A325B9" unitRef="usd">54200000</us-gaap:CashEquivalentsAtCarryingValue>
	<us-gaap:CashEquivalentsAtCarryingValue contextRef="FI2014Q4_us-gaap_InvestmentTypeAxis_us-gaap_DebtSecuritiesMember" decimals="-5" id="Fact-F4C8CF885892D13DDE10D4ECA99B8A49" unitRef="usd">35900000</us-gaap:CashEquivalentsAtCarryingValue>
	<us-gaap:CashEquivalentsAtCarryingValue contextRef="FI2014Q4_us-gaap_InvestmentTypeAxis_us-gaap_MoneyMarketFundsMember" decimals="-5" id="Fact-6F4E3754DFF10B8FB006D4ECA9A4EDBB" unitRef="usd">321200000</us-gaap:CashEquivalentsAtCarryingValue>
	<us-gaap:CashEquivalentsAtCarryingValue contextRef="FI2014Q4_us-gaap_InvestmentTypeAxis_us-gaap_RepurchaseAgreementsMember" decimals="-5" id="Fact-DACB380FFB7630A62E3ED4ECA9A5B9F1" unitRef="usd">305000000</us-gaap:CashEquivalentsAtCarryingValue>
	<us-gaap:CashEquivalentsAtCarryingValue contextRef="FI2015Q2" decimals="-5" id="Fact-397EF31A29034757E8FAD4ECA9A44C71" unitRef="usd">974000000</us-gaap:CashEquivalentsAtCarryingValue>
	<us-gaap:CashEquivalentsAtCarryingValue contextRef="FI2015Q2_us-gaap_InvestmentTypeAxis_us-gaap_CommercialPaperMember" decimals="-5" id="Fact-20CE5EC3D48184524190D4ECA9A3F8D9" unitRef="usd">38800000</us-gaap:CashEquivalentsAtCarryingValue>
	<us-gaap:CashEquivalentsAtCarryingValue contextRef="FI2015Q2_us-gaap_InvestmentTypeAxis_us-gaap_DebtSecuritiesMember" decimals="-5" id="Fact-FA4CE0350C3E84EEE6FED4ECA9A655C5" unitRef="usd">10000000</us-gaap:CashEquivalentsAtCarryingValue>
	<us-gaap:CashEquivalentsAtCarryingValue contextRef="FI2015Q2_us-gaap_InvestmentTypeAxis_us-gaap_MoneyMarketFundsMember" decimals="-5" id="Fact-A7CE038AC6075D999504D4ECA9A5AB52" unitRef="usd">740200000</us-gaap:CashEquivalentsAtCarryingValue>
	<us-gaap:CashEquivalentsAtCarryingValue contextRef="FI2015Q2_us-gaap_InvestmentTypeAxis_us-gaap_RepurchaseAgreementsMember" decimals="-5" id="Fact-88B707C181C929336C0AD4ECA9A1F90C" unitRef="usd">185000000</us-gaap:CashEquivalentsAtCarryingValue>
	<us-gaap:CommitmentsAndContingencies contextRef="FI2014Q4" id="Fact-7D08877E18A2834433B8D4ECA99A90E8" unitRef="usd" xsi:nil="true" />
	<us-gaap:CommitmentsAndContingencies contextRef="FI2015Q2" id="Fact-934D0A594CB6B7FD1083D4ECA99B2612" unitRef="usd" xsi:nil="true" />
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="FI2014Q4" decimals="INF" id="Fact-9F39697F25EC0F670FFCD4ECA993B146" unitRef="usdPerShare">0.0005</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="FI2015Q2" decimals="INF" id="Fact-C04DF202AAFA124DADC6D4ECA9B1DC98" unitRef="usdPerShare">0.0005</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockValue contextRef="FI2014Q4" decimals="-3" id="Fact-4584DA210C33D087A2FDD4ECA999F344" unitRef="usd">129000</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue contextRef="FI2015Q2" decimals="-3" id="Fact-CD40723BAA8637AA5D55D4ECA98556EE" unitRef="usd">129000</us-gaap:CommonStockValue>
	<us-gaap:ComprehensiveIncomeNetOfTax contextRef="FD2014Q2QTD" decimals="-3" id="Fact-1400556A5735AACA2419D4ECA9804AAF" unitRef="usd">710184000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ComprehensiveIncomeNetOfTax contextRef="FD2014Q2YTD" decimals="-3" id="Fact-D6475E6A87B7380456ACD4ECA999DABF" unitRef="usd">1195528000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ComprehensiveIncomeNetOfTax contextRef="FD2015Q2QTD" decimals="-3" id="Fact-EF0DE8184F93D0F1A028D4ECA980C2D6" unitRef="usd">896789000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ComprehensiveIncomeNetOfTax contextRef="FD2015Q2YTD" decimals="-3" id="Fact-88430677D9036E502973D4ECA99AA936" unitRef="usd">1708280000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="FD2014Q2QTD" decimals="-3" id="Fact-F878CD5F2767C2E4BE85D4ECA97583C7" unitRef="usd">-8626000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
	<us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="FD2014Q2YTD" decimals="-3" id="Fact-307710B426BBD1BCECD1D4ECA9A4AFE0" unitRef="usd">-8398000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
	<us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="FD2015Q2QTD" decimals="-3" id="Fact-93F276FF12962AFB95E8D4ECA9AE599B" unitRef="usd">2266000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
	<us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="FD2015Q2YTD" decimals="-3" id="Fact-E81AFCC501F3C8D04B24D4ECA99B862F" unitRef="usd">4533000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
	<us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="FD2014Q2QTD" decimals="-3" id="Fact-4F605D484258B523909FD4ECA97DFB63" unitRef="usd">718810000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="FD2014Q2YTD" decimals="-3" id="Fact-04B49757B21C493081A7D4ECA9A9229B" unitRef="usd">1203926000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="FD2015Q2QTD" decimals="-3" id="Fact-F35649F76C4DB8A00741D4ECA9A7DCB3" unitRef="usd">894523000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="FD2015Q2YTD" decimals="-3" id="Fact-140B4617BDA28F66E32ED4ECA99A9CBE" unitRef="usd">1703747000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:CostOfGoodsSold contextRef="FD2014Q2QTD" decimals="-3" id="Fact-8E470DDB30BD17E74EC7D4ECA9A94F04" unitRef="usd">291887000</us-gaap:CostOfGoodsSold>
	<us-gaap:CostOfGoodsSold contextRef="FD2014Q2YTD" decimals="-3" id="Fact-08A7434DCB75427A8A1FD4ECA999AA9B" unitRef="usd">571132000</us-gaap:CostOfGoodsSold>
	<us-gaap:CostOfGoodsSold contextRef="FD2015Q2QTD" decimals="-3" id="Fact-E64D22C93D54DC961621D4ECA9A940E4" unitRef="usd">286120000</us-gaap:CostOfGoodsSold>
	<us-gaap:CostOfGoodsSold contextRef="FD2015Q2YTD" decimals="-3" id="Fact-C55C186D938524DA3E8DD4ECA97D252B" unitRef="usd">598551000</us-gaap:CostOfGoodsSold>
	<us-gaap:CostsAndExpenses contextRef="FD2014Q2QTD" decimals="-3" id="Fact-ADCB38AA711C38B54B49D4ECA9841679" unitRef="usd">1436627000</us-gaap:CostsAndExpenses>
	<us-gaap:CostsAndExpenses contextRef="FD2014Q2YTD" decimals="-3" id="Fact-FEB4E132B703E990675ED4ECA97A497F" unitRef="usd">2898889000</us-gaap:CostsAndExpenses>
	<us-gaap:CostsAndExpenses contextRef="FD2015Q2QTD" decimals="-3" id="Fact-DDAA55F6EC9A8CEDD72BD4ECA9966838" unitRef="usd">1358546000</us-gaap:CostsAndExpenses>
	<us-gaap:CostsAndExpenses contextRef="FD2015Q2YTD" decimals="-3" id="Fact-2141FE6516351B853E93D4ECA997405B" unitRef="usd">2795634000</us-gaap:CostsAndExpenses>
	<us-gaap:DebtCurrent contextRef="FI2014Q4" decimals="-3" id="Fact-D4749C4AF2CB5CADE6C4D4ECA9A5DA04" unitRef="usd">3136000</us-gaap:DebtCurrent>
	<us-gaap:DebtCurrent contextRef="FI2015Q2" decimals="-3" id="Fact-7BFA9071074258BE7606D4ECA99AC8CA" unitRef="usd">3262000</us-gaap:DebtCurrent>
	<us-gaap:DebtInstrumentFairValue contextRef="FI2014Q4" decimals="-5" id="Fact-48DE556194ADF3AC95EBD4ECA9AEBCA4" unitRef="usd">647200000</us-gaap:DebtInstrumentFairValue>
	<us-gaap:DebtInstrumentFairValue contextRef="FI2015Q2" decimals="-5" id="Fact-89B49FEF4776C39447B9D4ECA98EFFC4" unitRef="usd">631500000</us-gaap:DebtInstrumentFairValue>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="FI2015Q2_us-gaap_DebtInstrumentAxis_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember" decimals="INF" id="Fact-2AD44F9F18EC31646545D4ECA98BFF43" unitRef="number">0.06875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentMaturityDateDescription contextRef="FD2015Q2YTD" id="Fact-A697443B13F537F84579D4ECA9716DA9">less than 90&#160;days</us-gaap:DebtInstrumentMaturityDateDescription>
	<us-gaap:DeferredCreditsAndOtherLiabilitiesCurrent contextRef="FI2015Q2_us-gaap_StatementGeographicalAxis_country_IT" decimals="-6" id="Fact-ADD9376AEC9DB3F53EECD4ECA9AF3E2A" unitRef="EUR">75000000</us-gaap:DeferredCreditsAndOtherLiabilitiesCurrent>
	<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="FD2014Q2YTD" decimals="-3" id="Fact-2AC2B0E09C36D35AD53CD4ECA97B8695" unitRef="usd">-146506000</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="FD2015Q2YTD" decimals="-3" id="Fact-C69670D4B4B3E6568440D4ECA9AF964E" unitRef="usd">-90647000</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredRevenueCurrent contextRef="FI2014Q4" decimals="-5" id="Fact-2EDD632128EFE4563F02D4ECA9809CC9" unitRef="usd">120900000</us-gaap:DeferredRevenueCurrent>
	<us-gaap:DeferredRevenueCurrent contextRef="FI2015Q2" decimals="-5" id="Fact-77D4EDAFCB34CBCB122DD4ECA983C822" unitRef="usd">62500000</us-gaap:DeferredRevenueCurrent>
	<us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="FI2014Q4" decimals="-3" id="Fact-7993E14420282F5ADFD8D4ECA99B60C9" unitRef="usd">50656000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
	<us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="FI2015Q2" decimals="-3" id="Fact-D622E6BBAA2B640C296DD4ECA999BFB8" unitRef="usd">138403000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
	<us-gaap:DepreciationDepletionAndAmortization contextRef="FD2014Q2YTD" decimals="-3" id="Fact-122BCD3F465C7EAD41F5D4ECA98BD886" unitRef="usd">355102000</us-gaap:DepreciationDepletionAndAmortization>
	<us-gaap:DepreciationDepletionAndAmortization contextRef="FD2015Q2YTD" decimals="-3" id="Fact-569AF85B769868831415D4ECA9724AD8" unitRef="usd">292523000</us-gaap:DepreciationDepletionAndAmortization>
	<us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="FI2014Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-1995567C15DD342A68C1D4ECA9829FE1" unitRef="usd">69500000</us-gaap:DerivativeFairValueOfDerivativeAsset>
	<us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="FI2014Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" decimals="-5" id="Fact-EC7FDEA4C0B27BF77C6ED4ECA9801811" unitRef="usd">1300000</us-gaap:DerivativeFairValueOfDerivativeAsset>
	<us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="FI2014Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherInvestmentsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-4E9CC97A17935AC23BC5D4ECA97472E3" unitRef="usd">1900000</us-gaap:DerivativeFairValueOfDerivativeAsset>
	<us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="FI2015Q2_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-CFE403C3CCE07CE1DDA8D4ECA9814248" unitRef="usd">92800000</us-gaap:DerivativeFairValueOfDerivativeAsset>
	<us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="FI2015Q2_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" decimals="-5" id="Fact-0F7F742F10FCF0AB77BAD4ECA97EC4F5" unitRef="usd">7700000</us-gaap:DerivativeFairValueOfDerivativeAsset>
	<us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="FI2014Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" decimals="-5" id="Fact-F27F0155EAD31F787B35D4ECA98CFD77" unitRef="usd">5400000</us-gaap:DerivativeFairValueOfDerivativeLiability>
	<us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="FI2015Q2_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-A05E1EC01A09F4C0C9B2D4ECA985D3CB" unitRef="usd">9800000</us-gaap:DerivativeFairValueOfDerivativeLiability>
	<us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="FI2015Q2_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" decimals="-5" id="Fact-9103FDB0B99FCB4200DAD4ECA97FC5D3" unitRef="usd">700000</us-gaap:DerivativeFairValueOfDerivativeLiability>
	<us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="FI2015Q2_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-37268FA787CECF517B86D4ECA982EA13" unitRef="usd">17200000</us-gaap:DerivativeFairValueOfDerivativeLiability>
	<us-gaap:DerivativeHigherRemainingMaturityRange1 contextRef="FD2014Q4YTD" id="Fact-5BEF46603F059467E9CAD4ECA9753DD5">P15M</us-gaap:DerivativeHigherRemainingMaturityRange1>
	<us-gaap:DerivativeHigherRemainingMaturityRange1 contextRef="FD2015Q2YTD" id="Fact-AE250097AB02D427D300D4ECA985A064">P18M</us-gaap:DerivativeHigherRemainingMaturityRange1>
	<us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="FD2014Q2QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember" decimals="-5" id="Fact-C5CC9FD906C9A07FB905D4ECA9AFBEAE" unitRef="usd">-5200000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
	<us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="FD2014Q2YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember" decimals="-5" id="Fact-BA02B747B04CD93D6878D4ECA99A4907" unitRef="usd">-10000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
	<us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="FD2015Q2QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember" decimals="-5" id="Fact-AC57E782E4DAB87E8F82D4ECA9AF48CE" unitRef="usd">40400000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
	<us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="FD2015Q2YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember" decimals="-5" id="Fact-343E05191859009BA0B8D4ECA9AFE645" unitRef="usd">75400000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
	<us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet contextRef="FD2014Q2QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember" decimals="-5" id="Fact-CCD5F36CD1882810DB13D4ECA9AFBEB8" unitRef="usd">-1000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet>
	<us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet contextRef="FD2014Q2YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember" decimals="-5" id="Fact-80AC444F0B5CBF4F2D01D4ECA99AE86E" unitRef="usd">-1200000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet>
	<us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet contextRef="FD2015Q2QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember" decimals="-5" id="Fact-CB03FF6B5AC4B3796F24D4ECA9AF256B" unitRef="usd">1200000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet>
	<us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet contextRef="FD2015Q2YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember" decimals="-5" id="Fact-CBDADE6F471806B8EE6DD4ECA9999AF1" unitRef="usd">3400000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet>
	<us-gaap:DerivativeLowerRemainingMaturityRange1 contextRef="FD2014Q4YTD" id="Fact-1950108CDB6CA193382CD4ECA985CBD8">P1M</us-gaap:DerivativeLowerRemainingMaturityRange1>
	<us-gaap:DerivativeLowerRemainingMaturityRange1 contextRef="FD2015Q2YTD" id="Fact-8E956D1414692A998A3AD4ECA9859988">P1M</us-gaap:DerivativeLowerRemainingMaturityRange1>
	<us-gaap:EarningsPerShareBasic contextRef="FD2014Q2QTD" decimals="2" id="Fact-AFE2A71D86E2F7F2F97BD4ECA98C2990" unitRef="usdPerShare">3.02</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2014Q2YTD" decimals="2" id="Fact-7873AA958CC6E46C5AF6D4ECA9A567B9" unitRef="usdPerShare">5.05</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2015Q2QTD" decimals="2" id="Fact-827D6F15E06DB67A1BD2D4ECA98C03A4" unitRef="usdPerShare">3.94</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2015Q2YTD" decimals="2" id="Fact-8F97BD2E7C45A559AA77D4ECA994FFC3" unitRef="usdPerShare">7.44</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2014Q2QTD" decimals="2" id="Fact-DEC6C0AB1034931FC72ED4ECA98492CC" unitRef="usdPerShare">3.01</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2014Q2YTD" decimals="2" id="Fact-8BA198F23A630F896313D4ECA975D0F5" unitRef="usdPerShare">5.03</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2015Q2QTD" decimals="2" id="Fact-5693B5D449256A91F4C2D4ECA9960431" unitRef="usdPerShare">3.93</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2015Q2YTD" decimals="2" id="Fact-ADB09A08B56D7D74B195D4ECA975B6A0" unitRef="usdPerShare">7.42</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="FD2014Q2YTD" decimals="-3" id="Fact-02B4B5B56A423A0B0070D4ECA98DCC54" unitRef="usd">-2965000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="FD2015Q2YTD" decimals="-3" id="Fact-3FC320D234B56C0E9C50D4ECA99B6B28" unitRef="usd">-24188000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="FD2014Q2QTD" decimals="3" id="Fact-2965A50B1900B599D62ED4ECA97B5631" unitRef="number">0.270</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
	<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="FD2014Q2YTD" decimals="3" id="Fact-01A159C07075D42ED925D4ECA98D482A" unitRef="number">0.269</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
	<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="FD2015Q2QTD" decimals="3" id="Fact-5DCCCFFB73087BFEF8F1D4ECA971D79E" unitRef="number">0.239</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
	<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="FD2015Q2YTD" decimals="3" id="Fact-78B3B98A381AC666DC31D4ECA9A9070D" unitRef="number">0.247</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
	<us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="FD2014Q2QTD" decimals="INF" id="Fact-B23C747921E4B9012952D4ECA9971309" unitRef="number">0.35</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
	<us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="FD2014Q2YTD" decimals="3" id="Fact-4A28E265286FA461DBF6D4ECA9AFB2AF" unitRef="number">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
	<us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="FD2015Q2QTD" decimals="INF" id="Fact-981B810BF226C23A228BD4ECA9A2B811" unitRef="number">0.35</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
	<us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="FD2015Q2YTD" decimals="3" id="Fact-4D78DA6702226D948178D4ECA9A742FC" unitRef="number">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
	<us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="FD2014Q2QTD" decimals="3" id="Fact-54851CC35DC5BB9C23E8D4ECA983B60B" unitRef="number">-0.087</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
	<us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="FD2014Q2YTD" decimals="3" id="Fact-F30BE5E0C0C53D5FF944D4ECA99B4CCA" unitRef="number">-0.085</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
	<us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="FD2015Q2QTD" decimals="3" id="Fact-317F2D2017934BF1DEB3D4ECA9B22A1B" unitRef="number">-0.111</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
	<us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="FD2015Q2YTD" decimals="3" id="Fact-6F47FC5735DDE4AF3A49D4ECA999FF38" unitRef="number">-0.098</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
	<us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization contextRef="FD2014Q2QTD" decimals="3" id="Fact-D7B5C7629CF4C3F1459BD4ECA98D9E0C" unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization>
	<us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization contextRef="FD2014Q2YTD" decimals="3" id="Fact-C42F2AFA56E32723B1ABD4ECA9A5C450" unitRef="number">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization>
	<us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization contextRef="FD2015Q2QTD" decimals="3" id="Fact-4842D6814018693E6CEFD4ECA99A01CB" unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization>
	<us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization contextRef="FD2015Q2YTD" decimals="3" id="Fact-29011F5BAF0B31258BAED4ECA98D0565" unitRef="number">0.010</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization>
	<us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther contextRef="FD2014Q2QTD" decimals="3" id="Fact-EFA63696D6058ED991CCD4ECA9B08448" unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
	<us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther contextRef="FD2014Q2YTD" decimals="3" id="Fact-BC7088EA4D9DD76BD66AD4ECA99A1424" unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
	<us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther contextRef="FD2015Q2QTD" decimals="3" id="Fact-F97478A955C2A2D6B83AD4ECA9AF8789" unitRef="number">0.009</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
	<us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther contextRef="FD2015Q2YTD" decimals="3" id="Fact-D7CC40788911BE43FF44D4ECA98C14AE" unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
	<us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="FD2014Q2QTD" decimals="3" id="Fact-98D84E72BD22ED62B53FD4ECA9971F9A" unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
	<us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="FD2014Q2YTD" decimals="3" id="Fact-91DC9524084391E6432BD4ECA997D4B0" unitRef="number">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
	<us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="FD2015Q2QTD" decimals="3" id="Fact-98F7C0E1E07E752CEEEFD4ECA99962C9" unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
	<us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="FD2015Q2YTD" decimals="3" id="Fact-B70F6274F355425CA233D4ECA9AE329C" unitRef="number">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
	<us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="FD2014Q2QTD" decimals="3" id="Fact-4A6C20DBD2E7A69AB1CED4ECA985CE50" unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
	<us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="FD2014Q2YTD" decimals="3" id="Fact-91B3108240EA82F76CF1D4ECA9AFED47" unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
	<us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="FD2015Q2QTD" decimals="3" id="Fact-8E8C18F9D10C59008D56D4ECA9735014" unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
	<us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="FD2015Q2YTD" decimals="3" id="Fact-7A3138BE8138CB84380BD4ECA98EEFD8" unitRef="number">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
	<us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="FD2014Q2QTD" decimals="3" id="Fact-A73030AC708107ED11C0D4ECA98B12E5" unitRef="number">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
	<us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="FD2014Q2YTD" decimals="3" id="Fact-D8AB6FAFBFBB86261893D4ECA973EFB3" unitRef="number">-0.009</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
	<us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="FD2015Q2QTD" decimals="3" id="Fact-43CC8C3139A3DD77BA55D4ECA9AF6033" unitRef="number">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
	<us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="FD2015Q2YTD" decimals="3" id="Fact-F39A53D5DE07DB22E7FFD4ECA997CDE4" unitRef="number">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
	<us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="FI2014Q4" decimals="-5" id="Fact-905BEF9B742CAC0BEA04D4ECA97BFBFB" unitRef="usd">393800000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
	<us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="FI2015Q2" decimals="-5" id="Fact-6F17BAD98650DD8EFDAAD4ECA996368C" unitRef="usd">214400000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
	<us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount contextRef="FD2014Q2QTD" decimals="-5" id="Fact-8964CA48AB8E8E459BDED4ECA9AFB3D0" unitRef="usd">2600000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
	<us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount contextRef="FD2014Q2YTD" decimals="-5" id="Fact-651D0257B600CCB5D774D4ECA983E859" unitRef="usd">5200000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
	<us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount contextRef="FD2015Q2QTD" decimals="-5" id="Fact-5B484AB3BFCCDDA6FADBD4ECA9AE80D1" unitRef="usd">2200000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
	<us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount contextRef="FD2015Q2YTD" decimals="-5" id="Fact-188AE686F212F078278CD4ECA9994570" unitRef="usd">5600000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
	<us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="FD2014Q2QTD" decimals="-5" id="Fact-EFD6ADD266AA524B223CD4ECA98D2A61" unitRef="usd">16500000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
	<us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="FD2014Q2YTD" decimals="-5" id="Fact-760B2264A4F3215D7FBDD4ECA975021E" unitRef="usd">38800000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
	<us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="FD2015Q2QTD" decimals="-5" id="Fact-1974E4F4B0E2E318B6A7D4ECA98E65CB" unitRef="usd">12900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
	<us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="FD2015Q2YTD" decimals="-5" id="Fact-F6E1DFD458B9B9225A7FD4ECA999D6BD" unitRef="usd">39600000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
	<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="FI2015Q2_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="INF" id="Fact-A40BC0B29960A7CE2CECD4ECA98BDD0A" unitRef="number">0.1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
	<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="I2012Q1SD2_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="INF" id="Fact-D5667B0646884A526DBBD4ECA9A31BA6" unitRef="number">0.15</us-gaap:EquityMethodInvestmentOwnershipPercentage>
	<us-gaap:EquityMethodInvestments contextRef="FI2014Q4_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-5" id="Fact-876226ADBF7DD71BD814D4ECA9A5BD48" unitRef="usd">8600000</us-gaap:EquityMethodInvestments>
	<us-gaap:EquityMethodInvestments contextRef="FI2014Q4_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-8" id="Fact-5EF81928422923418855D4ECA995F9A9" unitRef="KRW">9100000000</us-gaap:EquityMethodInvestments>
	<us-gaap:EquityMethodInvestments contextRef="FI2015Q2_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-5" id="Fact-99B252CF7BF752027B4FD4ECA98EFBD0" unitRef="usd">6800000</us-gaap:EquityMethodInvestments>
	<us-gaap:EquityMethodInvestments contextRef="FI2015Q2_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-8" id="Fact-7C4ABC7DF98762F89755D4ECA98E3731" unitRef="KRW">7500000000</us-gaap:EquityMethodInvestments>
	<us-gaap:EquityMethodInvestments contextRef="I2012Q1SD2_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-8" id="Fact-6E4EAB24354E3AA1BC77D4ECA98E923C" unitRef="KRW">49500000000</us-gaap:EquityMethodInvestments>
	<us-gaap:EquityMethodInvestments contextRef="I2012Q1SD2_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-5" id="Fact-88FDB0B70633290C3C74D4ECA9962E05" unitRef="usd">45000000</us-gaap:EquityMethodInvestments>
	<us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities contextRef="FD2014Q2YTD" decimals="-3" id="Fact-C6FE2E3B21B2A9685CA7D4ECA97FE3F5" unitRef="usd">83940000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
	<us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities contextRef="FD2015Q2YTD" decimals="-3" id="Fact-9CC2358F075F3800E4F4D4ECA98B1D69" unitRef="usd">69690000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
	<us-gaap:FairValueInputsDiscountRate contextRef="D2015Q1_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember" decimals="INF" id="Fact-F1676D2507D1FF631555D4ECA98B3EB6" unitRef="number">0.02</us-gaap:FairValueInputsDiscountRate>
	<us-gaap:FairValueInputsDiscountRate contextRef="D2015Q1_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember_us-gaap_ProductOrServiceAxis_biib_CNV1014802Member" decimals="2" id="Fact-7BADF4054C6837936C56D4ECA99B2CDE" unitRef="number">0.11</us-gaap:FairValueInputsDiscountRate>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2014Q2QTD" decimals="-3" id="Fact-AC88A844F7514DDC09F3D4ECA98C3DEA" unitRef="usd">-4019000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2014Q2YTD" decimals="-3" id="Fact-08A22DAD6D5BD5087F4BD4ECA996C041" unitRef="usd">-3220000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2015Q2QTD" decimals="-3" id="Fact-DCB8B71211C1AC9D9EE5D4ECA98DEF48" unitRef="usd">2201000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2015Q2YTD" decimals="-3" id="Fact-740B7C020CC108DDB031D4ECA97EE81E" unitRef="usd">-5643000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases contextRef="D2015Q1_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember" decimals="-5" id="Fact-B3002874FFE514090BB4D4ECA98D98A8" unitRef="usd">274500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases contextRef="FD2014Q2QTD" decimals="-5" id="Fact-C4C22C8251DD6D2D7A28D4ECA981EFB5" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases contextRef="FD2014Q2YTD" decimals="-5" id="Fact-DC14462C64991C0BE223D4ECA98D3281" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases contextRef="FD2015Q2QTD" decimals="-5" id="Fact-A37D5C0D089C2F277C27D4ECA97FF2E2" unitRef="usd">36000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases contextRef="FD2015Q2YTD" decimals="-5" id="Fact-AB260502EE15FBD77EBBD4ECA986FB66" unitRef="usd">274500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="FD2014Q2QTD" decimals="-5" id="Fact-ACFD34E8FE2A5FA07492D4ECA982EBAB" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="FD2014Q2YTD" decimals="-5" id="Fact-873111EEB4D1A1A47576D4ECA9AF2C7B" unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="FD2015Q2QTD" decimals="-5" id="Fact-8B1069CF3A7DCCAAD11AD4ECA97F8116" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="FD2015Q2YTD" decimals="-5" id="Fact-4EA6922521E7D3198F35D4ECA9978652" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
	<us-gaap:FairValueMeasurementsChangesInValuationTechniques contextRef="FD2015Q2YTD" id="Fact-9BF42B585CCCDEBFD87BD4ECA985C32B">0</us-gaap:FairValueMeasurementsChangesInValuationTechniques>
	<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="FD2015Q2YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_InLicensedPatentsMember_us-gaap_RangeAxis_us-gaap_MaximumMember" id="Fact-E352C9B6C544DB40BAB4D4ECA98DBEE7">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
	<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="FD2015Q2YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_InLicensedPatentsMember_us-gaap_RangeAxis_us-gaap_MinimumMember" id="Fact-B6E56517A5D3EF0DA8D3D4ECA98C7619">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
	<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="FD2015Q2YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_OutLicensedPatentsMember_us-gaap_RangeAxis_us-gaap_MaximumMember" id="Fact-78047A47D5478392BA9ED4ECA99A2C89">P23Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
	<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="FD2015Q2YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_OutLicensedPatentsMember_us-gaap_RangeAxis_us-gaap_MinimumMember" id="Fact-125D8C5576FEF6BB2472D4ECA9735B52">P13Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
	<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="FD2015Q2YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_us-gaap_RangeAxis_us-gaap_MaximumMember" id="Fact-B78E9C5D092A592C434CD4ECA9808E1C">P23Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
	<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="FD2015Q2YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_us-gaap_RangeAxis_us-gaap_MinimumMember" id="Fact-6EEACB7DA66A7F797F82D4ECA98CC38E">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2014Q4" decimals="-5" id="Fact-B85ED02E18D77C98B28AD4ECA9736650" unitRef="usd">3178600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2014Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_InLicensedPatentsMember" decimals="-5" id="Fact-271CEC8AC2C251EB302FD4ECA98EAA58" unitRef="usd">300100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2014Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_OutLicensedPatentsMember" decimals="-5" id="Fact-B362F42F6644C5CDE6A1D4ECA9715917" unitRef="usd">481700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2014Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-5" id="Fact-DE793E3C8A48925F9E87D4ECA9974768" unitRef="usd">2396800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2014Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" decimals="-5" id="Fact-DF814D9AA2D0E4ED1D09D4ECA9A7EB5E" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2014Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" decimals="-5" id="Fact-1B1C7D350ECFD6C98CF9D4ECA98DC75B" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2015Q2" decimals="-5" id="Fact-14A78C550350648A1ACED4ECA98D6865" unitRef="usd">3366500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2015Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_InLicensedPatentsMember" decimals="-5" id="Fact-99883D84FAD1DF307780D4ECA9716AAB" unitRef="usd">380500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2015Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_OutLicensedPatentsMember" decimals="-5" id="Fact-F17DD406506C691E46E7D4ECA98D7F7B" unitRef="usd">493900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2015Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-5" id="Fact-9004818D4D049464D1A8D4ECA971ABD1" unitRef="usd">2492100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2015Q2_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" decimals="-5" id="Fact-C784911905F20A942E7CD4ECA9AEB930" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2015Q2_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" decimals="-5" id="Fact-B63FC68D888FB48C3E9CD4ECA973F660" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="FI2015Q2" decimals="-5" id="Fact-E30C16BCB264E1891EF4D4ECA9B10CCF" unitRef="usd">312500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear contextRef="FI2015Q2" decimals="-5" id="Fact-77D19527221A6E0232DFD4ECA9846061" unitRef="usd">185500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="FI2015Q2" decimals="-5" id="Fact-EF76EEB8FB37796498C0D4ECA9B117BD" unitRef="usd">263800000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="FI2015Q2" decimals="-5" id="Fact-33BD28016F02B33EA508D4ECA9714177" unitRef="usd">270600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="FI2015Q2" decimals="-5" id="Fact-D53520186C1441A19E35D4ECA984088C" unitRef="usd">281600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="FI2015Q2" decimals="-5" id="Fact-1B8615E40C2F502DC042D4ECA9B206A0" unitRef="usd">285800000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2014Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_InLicensedPatentsMember" decimals="-5" id="Fact-EC8B1F6CE5B86F8382E7D4ECA9B1FDC4" unitRef="usd">3280400000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2014Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_OutLicensedPatentsMember" decimals="-5" id="Fact-FD6461A8EAC75D29BFCAD4ECA975D80A" unitRef="usd">543300000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2014Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-5" id="Fact-F8E248134FABA396A02AD4ECA9713239" unitRef="usd">3005300000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2015Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_InLicensedPatentsMember" decimals="-5" id="Fact-ABA4F55323ED8C3D25ACD4ECA9AEE95C" unitRef="usd">3296700000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2015Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_OutLicensedPatentsMember" decimals="-5" id="Fact-3F496DBF79E028AD0F53D4ECA98E9AF8" unitRef="usd">543300000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2015Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-5" id="Fact-262DAF05ED3663C205E4D4ECA9804350" unitRef="usd">3005300000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2014Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_InLicensedPatentsMember" decimals="-5" id="Fact-081DEF270565F3D9B255D4ECA973A130" unitRef="usd">2980300000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2014Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_OutLicensedPatentsMember" decimals="-5" id="Fact-3DACD9ACBB8341184B6ED4ECA9B123F0" unitRef="usd">61600000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2014Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-5" id="Fact-8C4C701FFE2B220EAE88D4ECA999C892" unitRef="usd">608500000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2015Q2_us-gaap_BusinessAcquisitionAxis_biib_TysabriProductMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_InLicensedPatentsMember" decimals="-5" id="Fact-7AB6CDA56009207828E1D4ECA99AE2D1" unitRef="usd">2851900000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2015Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_InLicensedPatentsMember" decimals="-5" id="Fact-E1A41B4D9A5EE30800ABD4ECA97107A8" unitRef="usd">2916200000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2015Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_OutLicensedPatentsMember" decimals="-5" id="Fact-0130584E52895A65A50ED4ECA99A40D0" unitRef="usd">49400000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2015Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-5" id="Fact-714F39410D2020AD4BDED4ECA9AFCB7C" unitRef="usd">513200000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2015Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_us-gaap_ProductOrServiceAxis_biib_AVONEXMember" decimals="-5" id="Fact-3BA93D2D2AC68B16783DD4ECA999C381" unitRef="usd">504300000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-8EDEAA48A869F8CC2051D4ECA97B7437" unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-463D7772ABFE46708817D4ECA97FCF7F" unitRef="usd">72700000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-DEE2DE88DFA33B98213DD4ECA98266E4" unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-C68D6530A04E1FD13F7FD4ECA97DD549" unitRef="usd">72700000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-497568CA27B6CFC94B05D4ECA9AE4609" unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-C8DFFBDC36DE07C72665D4ECA9A9C157" unitRef="usd">100500000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-8E5F5DC9E39A87F63312D4ECA9AED105" unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-207E129BAC2E598665BED4ECA9AF4FD4" unitRef="usd">100500000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-BBE54642B3DB15C7A497D4ECA9828811" unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-182B280FA77023973265D4ECA9A7BA62" unitRef="usd">5400000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-7EEC09A3A43672A1741BD4ECA97D6C35" unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-5AA3D71D70BC0FE7A9A4D4ECA982FC8C" unitRef="usd">5400000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-B2E63271E3241B461B8DD4ECA9A874C0" unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-49591EB0BB8080428535D4ECA9AF921C" unitRef="usd">27700000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-46BE6FD68034728B8100D4ECA9A8898B" unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-68C2EA64B3458D9083E6D4ECA971937B" unitRef="usd">27700000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
	<us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="FD2014Q2QTD" decimals="-5" id="Fact-493A98FA8D6C6E8A238DD4ECA9999C3F" unitRef="usd">-1400000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
	<us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="FD2014Q2YTD" decimals="-5" id="Fact-BA04301C51F2D23CF515D4ECA98BF378" unitRef="usd">-4700000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
	<us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="FD2015Q2QTD" decimals="-5" id="Fact-331B87D1F0C9A5E80E5FD4ECA9A3A652" unitRef="usd">-1500000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
	<us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="FD2015Q2YTD" decimals="-5" id="Fact-0A40F839BCE63C8AABA8D4ECA9A56A0F" unitRef="usd">-14500000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
	<us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments contextRef="FD2014Q2QTD" decimals="-5" id="Fact-A82BF6773C74B702D78DD4ECA985467A" unitRef="usd">2400000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
	<us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments contextRef="FD2014Q2YTD" decimals="-5" id="Fact-B9A232F8D1DC3E591B65D4ECA98BBB46" unitRef="usd">3800000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
	<us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments contextRef="FD2015Q2QTD" decimals="-5" id="Fact-618F3D220AC745910EE4D4ECA97453D1" unitRef="usd">13600000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
	<us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments contextRef="FD2015Q2YTD" decimals="-5" id="Fact-140F2D4CFA318802CE66D4ECA999A97D" unitRef="usd">3900000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
	<us-gaap:GainLossOnSaleOfInvestments contextRef="FD2014Q2QTD" decimals="-5" id="Fact-24A39252197116BB2DCAD4ECA98EA44E" unitRef="usd">13600000</us-gaap:GainLossOnSaleOfInvestments>
	<us-gaap:GainLossOnSaleOfInvestments contextRef="FD2014Q2YTD" decimals="-5" id="Fact-1F749D2EDB761A2526F5D4ECA9B25C7F" unitRef="usd">16600000</us-gaap:GainLossOnSaleOfInvestments>
	<us-gaap:GainLossOnSaleOfInvestments contextRef="FD2015Q2QTD" decimals="-5" id="Fact-582810F483DB491BE357D4ECA98E4614" unitRef="usd">300000</us-gaap:GainLossOnSaleOfInvestments>
	<us-gaap:GainLossOnSaleOfInvestments contextRef="FD2015Q2YTD" decimals="-5" id="Fact-C849E65C38C26BAD9CEED4ECA9AF725D" unitRef="usd">-1400000</us-gaap:GainLossOnSaleOfInvestments>
	<us-gaap:Goodwill contextRef="FI2014Q4" decimals="-3" id="Fact-2A22C6820631CCF5AC2AD4ECA9A53082" unitRef="usd">1760249000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2015Q2" decimals="-3" id="Fact-DB74B466D544F4D202E6D4ECA9A4818C" unitRef="usd">2154341000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="I2015Q1ConvergencePharma_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember" decimals="-5" id="Fact-2C3EF383DADC71591345D4ECA97FFEE8" unitRef="usd">128300000</us-gaap:Goodwill>
	<us-gaap:GoodwillAcquiredDuringPeriod contextRef="FD2015Q2YTD" decimals="-5" id="Fact-533906B78AC21D07CE27D4ECA9751AD9" unitRef="usd">390000000</us-gaap:GoodwillAcquiredDuringPeriod>
	<us-gaap:GoodwillAcquiredDuringPeriod contextRef="FD2015Q2YTD_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember_us-gaap_ProductOrServiceAxis_biib_TecfideraMember" decimals="-5" id="Fact-202C6205F592E4CEC080D4ECA97D8C12" unitRef="usd">300000000</us-gaap:GoodwillAcquiredDuringPeriod>
	<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="FI2015Q2" decimals="-6" id="Fact-9342ADCB3C1091EDA1F5D4ECA99A607E" unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
	<us-gaap:GoodwillOtherChanges contextRef="FD2015Q2YTD" decimals="-5" id="Fact-2CF6C9CAFEFBAE988E34D4ECA981CBAE" unitRef="usd">4100000</us-gaap:GoodwillOtherChanges>
	<us-gaap:GoodwillPeriodIncreaseDecrease contextRef="FD2015Q2QTD_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember" decimals="-5" id="Fact-2E6A2AE9F60490D129DB741B900100F4" unitRef="usd">36000000</us-gaap:GoodwillPeriodIncreaseDecrease>
	<us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="FD2014Q2QTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_biib_OutLicensedPatentsMember" decimals="-5" id="Fact-541FF1A7199CB4AA46A3D4ECA99AF35B" unitRef="usd">34700000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2014Q2QTD" decimals="-3" id="Fact-3B011F65337BD723110AD4ECA9A9CBE1" unitRef="usd">993586000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2014Q2YTD" decimals="-3" id="Fact-A631789F7B82EC5AAEF3D4ECA97D9C92" unitRef="usd">1659333000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2015Q2QTD" decimals="-3" id="Fact-3C585C20EB77A0F47479D4ECA975C154" unitRef="usd">1222207000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2015Q2YTD" decimals="-3" id="Fact-1C80D4F5B4CE9B321A46D4ECA98DC7E0" unitRef="usd">2325096000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromEquityMethodInvestments contextRef="FD2014Q2QTD" decimals="-3" id="Fact-987EF65C5BAB8EFBEB7ED4ECA9A64A52" unitRef="usd">-1933000</us-gaap:IncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromEquityMethodInvestments contextRef="FD2014Q2QTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-5" id="Fact-7B1702CC38AB396909FFD4ECA985EBDB" unitRef="usd">-1900000</us-gaap:IncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromEquityMethodInvestments contextRef="FD2014Q2YTD" decimals="-3" id="Fact-83EA80A694DC4FF0DA83D4ECA985832C" unitRef="usd">-9538000</us-gaap:IncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromEquityMethodInvestments contextRef="FD2014Q2YTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-5" id="Fact-DCB5B620AB6E273E75B0D4ECA9960154" unitRef="usd">-9500000</us-gaap:IncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromEquityMethodInvestments contextRef="FD2015Q2QTD" decimals="-3" id="Fact-D2EE9439F59D6BD35B2AD4ECA9A7574F" unitRef="usd">-4881000</us-gaap:IncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromEquityMethodInvestments contextRef="FD2015Q2QTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-5" id="Fact-B052C9A91191BC047E95D4ECA999FB9E" unitRef="usd">-4900000</us-gaap:IncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromEquityMethodInvestments contextRef="FD2015Q2YTD" decimals="-3" id="Fact-E3E17E987DDF1DEDB87FD4ECA97378D6" unitRef="usd">-5715000</us-gaap:IncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromEquityMethodInvestments contextRef="FD2015Q2YTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-5" id="Fact-BF2FED6B11844F1620EED4ECA99A4198" unitRef="usd">-5700000</us-gaap:IncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="FI2015Q1" decimals="-5" id="Fact-6E17512353EC6AED1582D4ECA972B60C" unitRef="usd">48300000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2014Q2QTD" decimals="-3" id="Fact-4C0C45373EC0CF2ED558D4ECA98C1BCA" unitRef="usd">268521000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2014Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-920C87351B3D9F293AD5D4ECA98D5A1B" unitRef="usd">-500000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2014Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-CCA36696FCF6E34803F3D4ECA98D3EB4" unitRef="usd">-3600000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2014Q2YTD" decimals="-3" id="Fact-E4562CE1E7D6E0AE3530D4ECA97F1024" unitRef="usd">446935000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2014Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-E959495D928BA2783F21D4ECA999C4D6" unitRef="usd">-100000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2014Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-1E7DA52225DAFB80E426D4ECA9A5F66A" unitRef="usd">-3600000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2015Q2QTD" decimals="-3" id="Fact-939888F240180DF6E1A6D4ECA9B17EF6" unitRef="usd">292501000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2015Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-37350AD7C361A47E7F36D4ECA98D26F0" unitRef="usd">-200000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2015Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-980C4066FC1A11611B1AD4ECA98D76B0" unitRef="usd">100000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2015Q2YTD" decimals="-3" id="Fact-0BFE880462A3C0B37AA6D4ECA97E6269" unitRef="usd">574382000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2015Q2YTD_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember_us-gaap_ProductOrServiceAxis_biib_TecfideraMember" decimals="-5" id="Fact-1382D342115367411B2AD4ECA974938E" unitRef="usd">38300000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2015Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-AE79523B05272711225AD4ECA9A4AEB3" unitRef="usd">-400000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2015Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-B347A8EF57843A72CF37D4ECA9995B61" unitRef="usd">100000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="FD2014Q2YTD" decimals="-3" id="Fact-4838A8329B23521B2EDDD4ECA97E1393" unitRef="usd">188961000</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="FD2015Q2YTD" decimals="-3" id="Fact-7F9C5C580D7C7B00FE29D4ECA999AE6A" unitRef="usd">38907000</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="FD2014Q2YTD" decimals="-3" id="Fact-613C3F7D91147F98DD66D4ECA98D361E" unitRef="usd">31113000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
	<us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="FD2015Q2YTD" decimals="-3" id="Fact-4565314C824F0796B3C9D4ECA974BC43" unitRef="usd">102017000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="FD2014Q2YTD" decimals="-3" id="Fact-85C85A514D992AA17DFDD4ECA9A526EC" unitRef="usd">-30299000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="FD2015Q2YTD" decimals="-3" id="Fact-ABB2C12B0613A5922037D4ECA999B5FE" unitRef="usd">-169929000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInInventories contextRef="FD2014Q2YTD" decimals="-3" id="Fact-4B5ACB5EDFF0A8D2B62AD4ECA973AE62" unitRef="usd">72689000</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInInventories contextRef="FD2015Q2YTD" decimals="-3" id="Fact-82B672F81FFE88720C66D4ECA975C79D" unitRef="usd">81294000</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="FD2014Q2YTD" decimals="-3" id="Fact-A3A183F60BBA24A75FBBD4ECA97E25EB" unitRef="usd">75044000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
	<us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="FD2015Q2YTD" decimals="-3" id="Fact-2D8EF8E76540C19A8ADBD4ECA99ADC21" unitRef="usd">66374000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2014Q2QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_MarketStockUnitsMember" decimals="-5" id="Fact-732D634D288EA90B02BFD4ECA999DF54" unitRef="shares">200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2014Q2QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_StockOptionsAndEmployeeStockPurchasePlanMember" decimals="-5" id="Fact-00F8DE4B35B237CD84A8D4ECA99A68A1" unitRef="shares">100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2014Q2QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_TimeVestedRestrictedStockUnitsMember" decimals="-5" id="Fact-77B671FE4F0039C96E8FD4ECA99BD42A" unitRef="shares">400000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2014Q2YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_MarketStockUnitsMember" decimals="-5" id="Fact-D6B39B036249F1563A28D4ECA9A35F4C" unitRef="shares">300000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2014Q2YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_StockOptionsAndEmployeeStockPurchasePlanMember" decimals="-5" id="Fact-ABAF3A4DFD79F244B515D4ECA9990097" unitRef="shares">100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2014Q2YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_TimeVestedRestrictedStockUnitsMember" decimals="-5" id="Fact-31B36C56073664A60FD1D4ECA9B1E258" unitRef="shares">500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2015Q2QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_MarketStockUnitsMember" decimals="-5" id="Fact-E6B24D2017716AA9B7EBD4ECA99946E4" unitRef="shares">100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2015Q2QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_StockOptionsAndEmployeeStockPurchasePlanMember" decimals="-5" id="Fact-C6451E883874D3C262E7D4ECA99ACE35" unitRef="shares">100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2015Q2QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_TimeVestedRestrictedStockUnitsMember" decimals="-5" id="Fact-8DD7DA87E2E7965766A2D4ECA99A36D3" unitRef="shares">200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2015Q2YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_MarketStockUnitsMember" decimals="-5" id="Fact-375DDBE133682CA4B576D4ECA974C21D" unitRef="shares">200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2015Q2YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_StockOptionsAndEmployeeStockPurchasePlanMember" decimals="-5" id="Fact-8CA8AAF120D24CFDD4C2D4ECA99B4A95" unitRef="shares">100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2015Q2YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_biib_TimeVestedRestrictedStockUnitsMember" decimals="-5" id="Fact-90B740C1A9D713B2938BD4ECA98B2BFB" unitRef="shares">300000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="FI2014Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" decimals="-5" id="Fact-860415A5D6BD98E91764D4ECA999CF1D" unitRef="usd">314100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
	<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="FI2014Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" decimals="-5" id="Fact-E1F0DF16E387F86BCF42D4ECA9744D63" unitRef="usd">64000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
	<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="FI2015Q2_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" decimals="-5" id="Fact-3C94C27B4A1C5805AAD1D4ECA9B04F00" unitRef="usd">752000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
	<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="FI2015Q2_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" decimals="-5" id="Fact-517643EA232A441A4ED5D4ECA973A01E" unitRef="usd">64000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
	<us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="FI2014Q4" decimals="-5" id="Fact-C143BC21CE1747A076B9D4ECA9AF22DC" unitRef="usd">7207100000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
	<us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="FI2015Q2" decimals="-5" id="Fact-87CABFB13F9FF084C2E0D4ECA997F373" unitRef="usd">7661300000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="FI2014Q4" decimals="-3" id="Fact-468EE22E28CFA0A5B0A8D4ECA99B3EB1" unitRef="usd">4028507000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="FI2015Q2" decimals="-3" id="Fact-24B55D77E2D3D6AE4B6DD4ECA9A385C5" unitRef="usd">4294791000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:InterestExpense contextRef="FD2014Q2QTD" decimals="-5" id="Fact-5BD65ACD2F4AA15E3101D4ECA9A3C791" unitRef="usd">7100000</us-gaap:InterestExpense>
	<us-gaap:InterestExpense contextRef="FD2014Q2YTD" decimals="-5" id="Fact-2FD78FBB703C38670297D4ECA97D30E8" unitRef="usd">14700000</us-gaap:InterestExpense>
	<us-gaap:InterestExpense contextRef="FD2015Q2QTD" decimals="-5" id="Fact-D35E9ACBBE302E841131D4ECA999368F" unitRef="usd">5800000</us-gaap:InterestExpense>
	<us-gaap:InterestExpense contextRef="FD2015Q2YTD" decimals="-5" id="Fact-F0E272A3158E1BFCDBAAD4ECA983CACD" unitRef="usd">12500000</us-gaap:InterestExpense>
	<us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="FI2014Q4" decimals="-5" id="Fact-B539AD434F20CD98FA70D4ECA9B02DA7" unitRef="usd">164200000</us-gaap:InventoryFinishedGoodsNetOfReserves>
	<us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="FI2015Q2" decimals="-5" id="Fact-D8CEE9254A587EF78837D4ECA9B0DEC5" unitRef="usd">175800000</us-gaap:InventoryFinishedGoodsNetOfReserves>
	<us-gaap:InventoryNet contextRef="FI2014Q4" decimals="-3" id="Fact-E0079DE2FE7D53FF447FD4ECA9855517" unitRef="usd">804022000</us-gaap:InventoryNet>
	<us-gaap:InventoryNet contextRef="FI2015Q2" decimals="-3" id="Fact-19B6C8DDF6CDAFA6A88AD4ECA9A559B0" unitRef="usd">865738000</us-gaap:InventoryNet>
	<us-gaap:InventoryRawMaterialsNetOfReserves contextRef="FI2014Q4" decimals="-5" id="Fact-717E39909579C2312C1FD4ECA9B06059" unitRef="usd">128300000</us-gaap:InventoryRawMaterialsNetOfReserves>
	<us-gaap:InventoryRawMaterialsNetOfReserves contextRef="FI2015Q2" decimals="-5" id="Fact-093D188EDFD2D5378924D4ECA9B14053" unitRef="usd">173200000</us-gaap:InventoryRawMaterialsNetOfReserves>
	<us-gaap:InventoryWorkInProcessNetOfReserves contextRef="FI2014Q4" decimals="-5" id="Fact-8C50D34E88A49690B11BD4ECA9AFAC04" unitRef="usd">511500000</us-gaap:InventoryWorkInProcessNetOfReserves>
	<us-gaap:InventoryWorkInProcessNetOfReserves contextRef="FI2015Q2" decimals="-5" id="Fact-5D3BEC72141157B332C6D4ECA9B1272D" unitRef="usd">516700000</us-gaap:InventoryWorkInProcessNetOfReserves>
	<us-gaap:InvestmentIncomeInterest contextRef="FD2014Q2QTD" decimals="-5" id="Fact-D7247B9AC73329A90CC7D4ECA98C1756" unitRef="usd">2400000</us-gaap:InvestmentIncomeInterest>
	<us-gaap:InvestmentIncomeInterest contextRef="FD2014Q2YTD" decimals="-5" id="Fact-69D64A62E78CCD40927FD4ECA98E2F12" unitRef="usd">5100000</us-gaap:InvestmentIncomeInterest>
	<us-gaap:InvestmentIncomeInterest contextRef="FD2015Q2QTD" decimals="-5" id="Fact-D5CD0E2E6FE6828216E9D4ECA999A14B" unitRef="usd">4300000</us-gaap:InvestmentIncomeInterest>
	<us-gaap:InvestmentIncomeInterest contextRef="FD2015Q2YTD" decimals="-5" id="Fact-FA16BFA3C0681C580F4BD4ECA9758BD5" unitRef="usd">7600000</us-gaap:InvestmentIncomeInterest>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-4D6AF70AF0991A7A0B5CD4ECA97D0216" unitRef="usd">6900000</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-F8A2029BDE5F55C73D2ED4ECA97F5BC7" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-28A9D70478714124813FD4ECA98072AB" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-B30B45123785B643A230D4ECA9A6A7A8" unitRef="usd">6900000</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-5B863156EE618425D539D4ECA9A8CE41" unitRef="usd">6800000</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-19C3CEF662FDFD0E6BEAD4ECA9AF0F9D" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-96D197496A8E8F1AFFD3D4ECA9AEC38B" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-495F2287C138E3D6CA6DD4ECA9A8B997" unitRef="usd">6800000</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:Land contextRef="FI2015Q2_us-gaap_StatementGeographicalAxis_country_CH" decimals="-5" id="Fact-5DA24C88335D3032998B745390AD5358" unitRef="chf">65100000</us-gaap:Land>
	<us-gaap:Liabilities contextRef="FI2014Q4" decimals="-3" id="Fact-E9472F6B01F0EDCBBC22D4ECA9A52286" unitRef="usd">3502519000</us-gaap:Liabilities>
	<us-gaap:Liabilities contextRef="FI2015Q2" decimals="-3" id="Fact-7DF6A1A0F3076C149266D4ECA99B3E5C" unitRef="usd">4186173000</us-gaap:Liabilities>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="FI2014Q4" decimals="-3" id="Fact-59362CFC1E42F5FE4374D4ECA98CDD65" unitRef="usd">14316559000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="FI2015Q2" decimals="-3" id="Fact-400C83AF099DF4F800D4D4ECA9A4BD8B" unitRef="usd">16759171000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesCurrent contextRef="FI2014Q4" decimals="-3" id="Fact-E5B9452376C202FCE8DED4ECA98CE303" unitRef="usd">2219706000</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent contextRef="FI2015Q2" decimals="-3" id="Fact-889D61B07DC7DA8C8459D4ECA99A0202" unitRef="usd">2555832000</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-AB78C9CE32F19CE8A71DD4ECA982CE20" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-5FD113E6F04841F5BA8DD4ECA982DB27" unitRef="usd">5400000</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-711413BF71FDD64B8F54D4ECA9827304" unitRef="usd">215500000</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2014Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-02A7DC04849524A5B49FD4ECA97D257B" unitRef="usd">220900000</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-A9096115A49AC61D1818D4ECA9AFFB70" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-B5E57DFCE1FBE813386DD4ECA9AFD207" unitRef="usd">27700000</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-810BDEB1A5FA737099F3D4ECA9AEFB1E" unitRef="usd">495600000</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2015Q2_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-5" id="Fact-2939754171F7AC9C03E1D4ECA9B13E4D" unitRef="usd">523300000</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LicenseCosts contextRef="D2015Q3_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_biib_AGTCMember" decimals="-5" id="Fact-AC87623D9EF82524D0ED74A09AB57833" unitRef="usd">35600000</us-gaap:LicenseCosts>
	<us-gaap:LongTermDebt contextRef="FI2014Q4" decimals="-3" id="Fact-43A4D495BF3671434F5BD4ECA985403F" unitRef="usd">582061000</us-gaap:LongTermDebt>
	<us-gaap:LongTermDebt contextRef="FI2015Q2" decimals="-3" id="Fact-6A0FD08A7A5B19F4D273D4ECA9A3C442" unitRef="usd">576207000</us-gaap:LongTermDebt>
	<us-gaap:LossContingencyEstimateOfPossibleLoss contextRef="FI2014Q4_us-gaap_StatementGeographicalAxis_country_IT" decimals="-5" id="Fact-7C8649C7E7C66F539AE7D4ECA9990C25" unitRef="EUR">35600000</us-gaap:LossContingencyEstimateOfPossibleLoss>
	<us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1 contextRef="FD2015Q2YTD" id="Fact-C461F845ECBA8B3C3076D4ECA99A3D37">P18M</us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1>
	<us-gaap:MinorityInterest contextRef="FI2013Q4" decimals="-5" id="Fact-BDFC67D234025A6EAE97D4ECA9AF574D" unitRef="usd">600000</us-gaap:MinorityInterest>
	<us-gaap:MinorityInterest contextRef="FI2014Q1" decimals="-5" id="Fact-D702564815410853DD72D4ECA97FCB33" unitRef="usd">4400000</us-gaap:MinorityInterest>
	<us-gaap:MinorityInterest contextRef="FI2014Q2" decimals="-5" id="Fact-C23711A4146051D484B6D4ECA98B1A04" unitRef="usd">3900000</us-gaap:MinorityInterest>
	<us-gaap:MinorityInterest contextRef="FI2014Q4" decimals="-3" id="Fact-62D395056C6DA7EA3359D4ECA9999D2D" unitRef="usd">5030000</us-gaap:MinorityInterest>
	<us-gaap:MinorityInterest contextRef="FI2015Q1" decimals="-5" id="Fact-925226A062293EA4EAA0D4ECA9809101" unitRef="usd">2700000</us-gaap:MinorityInterest>
	<us-gaap:MinorityInterest contextRef="FI2015Q2" decimals="-3" id="Fact-FE3769D4E1DBF822ADEAD4ECA9994516" unitRef="usd">421000</us-gaap:MinorityInterest>
	<us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="FD2014Q2QTD" decimals="-5" id="Fact-989A9B447EF2AB3B261BD4ECA99BA17E" unitRef="usd">9100000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
	<us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="FD2014Q2YTD" decimals="-5" id="Fact-0E6BAE65E6B816F752B6D4ECA99A4746" unitRef="usd">9100000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2014Q2YTD" decimals="-3" id="Fact-1CDC94923A53E57D1B40D4ECA9A10896" unitRef="usd">-207485000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2015Q2YTD" decimals="-3" id="Fact-C89E80A547D7908B54ADD4ECA97BD344" unitRef="usd">77219000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2014Q2YTD" decimals="-3" id="Fact-FBBD520095A8DACDCD9BD4ECA996CB79" unitRef="usd">-624134000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2015Q2YTD" decimals="-3" id="Fact-5FF1898B986312D1F8E8D4ECA98B3007" unitRef="usd">-1756134000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2014Q2YTD" decimals="-3" id="Fact-2CCC97FC6851724F9C85D4ECA9A4E70E" unitRef="usd">1095219000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2015Q2YTD" decimals="-3" id="Fact-22C65893C4BF97374EB1D4ECA97DAE29" unitRef="usd">1780257000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetIncomeLoss contextRef="FD2014Q2QTD" decimals="-3" id="Fact-D052E24CA44E45F7C97BD4ECA98EBC47" unitRef="usd">714506000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2014Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" decimals="-5" id="Fact-ABD9754AB72CEDE28A06D4ECA98D14D7" unitRef="usd">700000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2014Q2YTD" decimals="-3" id="Fact-91D80186983BBF5C6A8AD4ECA98D7ED9" unitRef="usd">1194462000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2014Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" decimals="-5" id="Fact-B6A1114893F97F62DF67D4ECA99A7461" unitRef="usd">-3500000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2015Q2QTD" decimals="-3" id="Fact-C6B3AC97E65C5A094461D4ECA98C83A4" unitRef="usd">927276000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2015Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" decimals="-5" id="Fact-53FBE262316D020E3417D4ECA98D6CC8" unitRef="usd">40100000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2015Q2YTD" decimals="-3" id="Fact-3B3D30430EB534CE3B40D4ECA98368F5" unitRef="usd">1749817000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2015Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" decimals="-5" id="Fact-4565471C2AF3521C3E6CD4ECA9A5EAA9" unitRef="usd">74800000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="FD2014Q2QTD" decimals="-3" id="Fact-B36F2495D98F5B27280ED4ECA9AFBEEF" unitRef="usd">8626000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
	<us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="FD2014Q2YTD" decimals="-3" id="Fact-3BF5BF4DD3085F24205BD4ECA98C1589" unitRef="usd">8398000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
	<us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="FD2015Q2QTD" decimals="-3" id="Fact-EA1B96569D97EC3451ACD4ECA9AF7BBB" unitRef="usd">-2451000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
	<us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="FD2015Q2YTD" decimals="-3" id="Fact-F3CEBB0FB508EB3D93E4D4ECA9744E99" unitRef="usd">-4818000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
	<us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination contextRef="FD2014Q2QTD" decimals="-5" id="Fact-5AEA4C24EFC3AF2CE288D4ECA982B5D6" unitRef="usd">0</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
	<us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination contextRef="FD2014Q2YTD" decimals="-5" id="Fact-447CF605CA3903F3CC4FD4ECA9A888E8" unitRef="usd">4000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
	<us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination contextRef="FD2015Q2QTD" decimals="-5" id="Fact-51CBE70A215BDD98C22ED4ECA97FBCB6" unitRef="usd">0</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
	<us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination contextRef="FD2015Q2YTD" decimals="-5" id="Fact-1B4B47FD6578E02C132DD4ECA9A11DA1" unitRef="usd">0</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
	<us-gaap:NonoperatingIncomeExpense contextRef="FD2014Q2QTD" decimals="-3" id="Fact-93674B70C657360B6DEDD4ECA9B210BF" unitRef="usd">4861000</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:NonoperatingIncomeExpense contextRef="FD2014Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-AEBBDFCBD12F6F0D6980D4ECA98D8B06" unitRef="usd">10100000</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:NonoperatingIncomeExpense contextRef="FD2014Q2YTD" decimals="-3" id="Fact-E2C11649DEA2977F1495D4ECA998D785" unitRef="usd">-740000</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:NonoperatingIncomeExpense contextRef="FD2014Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-C35CB2E06AB771FDCD8DD4ECA99BF19E" unitRef="usd">10200000</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:NonoperatingIncomeExpense contextRef="FD2015Q2QTD" decimals="-3" id="Fact-F43594BFA2CD49C30942D4ECA9AF924E" unitRef="usd">-10889000</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:NonoperatingIncomeExpense contextRef="FD2015Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-0D5E0DA580F4D6AB9441D4ECA98DA360" unitRef="usd">-200000</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:NonoperatingIncomeExpense contextRef="FD2015Q2YTD" decimals="-3" id="Fact-8991B462A4BE49598E42D4ECA98E4022" unitRef="usd">-25875000</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:NonoperatingIncomeExpense contextRef="FD2015Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-2395C7C4D88CAA455DCFD4ECA9A698B6" unitRef="usd">-300000</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:NotesPayable contextRef="FI2014Q4" decimals="-5" id="Fact-50B883218A59A9ED6ED1D4ECA98E237D" unitRef="usd">585200000</us-gaap:NotesPayable>
	<us-gaap:NotesPayable contextRef="FI2014Q4_us-gaap_DebtInstrumentAxis_biib_NotesPayableToFumedicaMember" decimals="-5" id="Fact-720ACF83605E48F1FC10D4ECA9A94A5F" unitRef="usd">11700000</us-gaap:NotesPayable>
	<us-gaap:NotesPayable contextRef="FI2014Q4_us-gaap_DebtInstrumentAxis_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember" decimals="-5" id="Fact-12DC32FC588815749619D4ECA9A81BF4" unitRef="usd">573500000</us-gaap:NotesPayable>
	<us-gaap:NotesPayable contextRef="FI2015Q2" decimals="-5" id="Fact-D134B197CEA8041663D1D4ECA9951E5A" unitRef="usd">579500000</us-gaap:NotesPayable>
	<us-gaap:NotesPayable contextRef="FI2015Q2_us-gaap_DebtInstrumentAxis_biib_NotesPayableToFumedicaMember" decimals="-5" id="Fact-D6CD4F98A5ED78312110D4ECA9AF6994" unitRef="usd">9400000</us-gaap:NotesPayable>
	<us-gaap:NotesPayable contextRef="FI2015Q2_us-gaap_DebtInstrumentAxis_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember" decimals="-5" id="Fact-ECEE6270A8F941395823D4ECA9A9CD0E" unitRef="usd">570100000</us-gaap:NotesPayable>
	<us-gaap:NotesPayableFairValueDisclosure contextRef="FI2014Q4_us-gaap_DebtInstrumentAxis_biib_NotesPayableToFumedicaMember" decimals="-5" id="Fact-76319BF336EB7250CB78D4ECA9959695" unitRef="usd">12600000</us-gaap:NotesPayableFairValueDisclosure>
	<us-gaap:NotesPayableFairValueDisclosure contextRef="FI2014Q4_us-gaap_DebtInstrumentAxis_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember" decimals="-5" id="Fact-96CBCE6A0CE3AFFB5C41D4ECA98DB49E" unitRef="usd">634600000</us-gaap:NotesPayableFairValueDisclosure>
	<us-gaap:NotesPayableFairValueDisclosure contextRef="FI2015Q2_us-gaap_DebtInstrumentAxis_biib_NotesPayableToFumedicaMember" decimals="-5" id="Fact-23F2373287828F521C13D4ECA9AE7173" unitRef="usd">10000000</us-gaap:NotesPayableFairValueDisclosure>
	<us-gaap:NotesPayableFairValueDisclosure contextRef="FI2015Q2_us-gaap_DebtInstrumentAxis_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember" decimals="-5" id="Fact-A8B2288AD05FA8D3A48BD4ECA9A9C059" unitRef="usd">621500000</us-gaap:NotesPayableFairValueDisclosure>
	<us-gaap:NumberOfReportableSegments contextRef="FD2015Q2YTD" decimals="0" id="Fact-D914E938AC419EB2C208D4ECA9A7E5D4" unitRef="segment">1</us-gaap:NumberOfReportableSegments>
	<us-gaap:OperatingIncomeLoss contextRef="FD2014Q2QTD" decimals="-3" id="Fact-58A00503528CA16CAACED4ECA98494C5" unitRef="usd">988725000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2014Q2YTD" decimals="-3" id="Fact-6846E53FCF1A806F7802D4ECA98E230F" unitRef="usd">1660073000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2015Q2QTD" decimals="-3" id="Fact-6991E8448BF835F4E2D7D4ECA9B15C9B" unitRef="usd">1233096000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2015Q2YTD" decimals="-3" id="Fact-CAC88B0CEBD779B7B8B1D4ECA9713514" unitRef="usd">2350971000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OtherAccruedLiabilitiesCurrent contextRef="FI2014Q4" decimals="-5" id="Fact-78FF8DE3087BDF665EEFD4ECA99AAEC4" unitRef="usd">507500000</us-gaap:OtherAccruedLiabilitiesCurrent>
	<us-gaap:OtherAccruedLiabilitiesCurrent contextRef="FI2015Q2" decimals="-5" id="Fact-DAD26531F1B4553E0356D4ECA97E1604" unitRef="usd">433300000</us-gaap:OtherAccruedLiabilitiesCurrent>
	<us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="FI2014Q4" decimals="-5" id="Fact-6DC008CD7497750A4132D4ECA99BC952" unitRef="usd">249400000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
	<us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="FI2015Q2" decimals="-5" id="Fact-38882FF67315CBAC5B83D4ECA99B365D" unitRef="usd">389000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
	<us-gaap:OtherAssetsCurrent contextRef="FI2014Q4" decimals="-3" id="Fact-C60302D6E736F11DB776D4ECA99AA951" unitRef="usd">447462000</us-gaap:OtherAssetsCurrent>
	<us-gaap:OtherAssetsCurrent contextRef="FI2015Q2" decimals="-3" id="Fact-2CDD4A7B0B2AEA1D5414D4ECA9A4FC49" unitRef="usd">750039000</us-gaap:OtherAssetsCurrent>
	<us-gaap:OtherAssetsNoncurrent contextRef="FI2014Q4" decimals="-3" id="Fact-FFD932A55B01F98BD266D4ECA99A7B98" unitRef="usd">618795000</us-gaap:OtherAssetsNoncurrent>
	<us-gaap:OtherAssetsNoncurrent contextRef="FI2015Q2" decimals="-3" id="Fact-7B9277AED95EF07CBA7DD4ECA99BD785" unitRef="usd">751588000</us-gaap:OtherAssetsNoncurrent>
	<us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="FD2014Q2QTD" decimals="-3" id="Fact-3C964DB7B79D1A2197FBD4ECA997AB40" unitRef="usd">-6865000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="FD2014Q2YTD" decimals="-3" id="Fact-E78466B6A53DB75393F5D4ECA9A71642" unitRef="usd">-5140000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="FD2015Q2QTD" decimals="-3" id="Fact-01FB33D694369F5D293AD4ECA999D6E9" unitRef="usd">-214000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="FD2015Q2YTD" decimals="-3" id="Fact-E051338352A2CEABD3E4D4ECA973E0A4" unitRef="usd">1085000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax contextRef="FD2014Q2QTD" decimals="-3" id="Fact-AA761B931A8D79DBF649D4ECA99AD118" unitRef="usd">4029000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
	<us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax contextRef="FD2014Q2YTD" decimals="-3" id="Fact-109B63FD01AA66B1F417D4ECA99BE32B" unitRef="usd">3015000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
	<us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax contextRef="FD2015Q2QTD" decimals="-3" id="Fact-D361DF13E13895AB7406D4ECA99A51E1" unitRef="usd">145000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
	<us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax contextRef="FD2015Q2YTD" decimals="-3" id="Fact-5CC6C9CE3C26D8CBCC90D4ECA99BBAC7" unitRef="usd">621000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="FD2014Q2YTD" decimals="-5" id="Fact-DB0D411CC4FA3C002DDBD4ECA973B365" unitRef="usd">-2500000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-0A1D566F7BC2E3BABD47D4ECA972BC3B" unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-F5049993C657BBA7AD26D4ECA9730DD9" unitRef="usd">6500000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-190DEF4596036EFD4777D4ECA984786B" unitRef="usd">1400000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-2D5F686CEFA9CD33B826D4ECA9752F20" unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="FD2015Q2YTD" decimals="-5" id="Fact-DA8F52B5AA3C9FBC477ED4ECA982CE30" unitRef="usd">33300000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-CF3954913EB7E003394ED4ECA98CDF08" unitRef="usd">4100000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-97596921E78D1930D2C3D4ECA9AFA8AC" unitRef="usd">66100000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-43F29B657910869CBF1FD4ECA974BC49" unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-A271B9EF25E12CB1296AD4ECA98DAAC5" unitRef="usd">-37800000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax contextRef="FD2014Q2QTD" decimals="-3" id="Fact-CDE96A6D7EFDE0FBA0E7D4ECA97D377F" unitRef="usd">10760000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax contextRef="FD2014Q2YTD" decimals="-3" id="Fact-FF2FB6FD109CCB9FF932D4ECA9A32666" unitRef="usd">16551000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax contextRef="FD2015Q2QTD" decimals="-3" id="Fact-5BD5F5B43BBA7D33070ED4ECA98D18E4" unitRef="usd">-96159000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax contextRef="FD2015Q2YTD" decimals="-3" id="Fact-6FF8EF9EE2AF973E7645D4ECA97EBFE8" unitRef="usd">-8913000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="FD2014Q2QTD" decimals="-3" id="Fact-C5B4866057D909703EBDD4ECA99B7226" unitRef="usd">260000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="FD2014Q2YTD" decimals="-3" id="Fact-5222A62D4E9A1A11E063D4ECA98D386B" unitRef="usd">5000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="FD2015Q2QTD" decimals="-3" id="Fact-94EFAED9083896576A34D4ECA99A512D" unitRef="usd">454000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="FD2015Q2YTD" decimals="-3" id="Fact-4782C169E584B6131323D4ECA996C120" unitRef="usd">42000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="FD2014Q2QTD" decimals="-3" id="Fact-DCF4172E5B8447E65F10D4ECA9A72B6C" unitRef="usd">-8047000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="FD2014Q2YTD" decimals="-3" id="Fact-ADEB09C5A6DC54D9D40FD4ECA9AFB9BF" unitRef="usd">-10991000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="FD2015Q2QTD" decimals="-3" id="Fact-B00D02E1031CC7F76D4FD4ECA9B08EB0" unitRef="usd">63035000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="FD2015Q2YTD" decimals="-3" id="Fact-3DCCC05BC5CE0B93326CD4ECA97392ED" unitRef="usd">-37818000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2014Q2QTD" decimals="-3" id="Fact-78D12DB58A7D4D56F9D6D4ECA98C8942" unitRef="usd">-4322000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2014Q2YTD" decimals="-3" id="Fact-7A092ECAC152BA4B47D3D4ECA98C4450" unitRef="usd">1066000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-B9205170FFAA7D40C72FD4ECA97365AB" unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-93255D0F9569431B3DB6D4ECA9724AF8" unitRef="usd">16600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-BDA538F28DCC52868C83D4ECA984FC37" unitRef="usd">-5200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-FEF2611826E03FEE41D8D4ECA9A98E31" unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2015Q2QTD" decimals="-3" id="Fact-91980D8712915D85169CD4ECA9834371" unitRef="usd">-30487000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2015Q2YTD" decimals="-3" id="Fact-1DB6C61676A95AD1AC9ED4ECA9A342DA" unitRef="usd">-41537000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-32A44ADEE7F8986FD424D4ECA9961BC9" unitRef="usd">4100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-827B74F64A4DD474CA97D4ECA99B0C65" unitRef="usd">-8900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-D92760DF3FD9E0F680E5D4ECA98B7447" unitRef="usd">1100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-F01287DF8891B6603844D4ECA9969E47" unitRef="usd">-37800000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="FD2014Q2QTD" decimals="-3" id="Fact-F653D0534458BBE84959D4ECA97D2CE3" unitRef="usd">170000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="FD2014Q2YTD" decimals="-3" id="Fact-E8E39A10FDFD6B20E5DDD4ECA99A01EF" unitRef="usd">-646000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="FD2015Q2QTD" decimals="-3" id="Fact-7B99AAD71E621D85B14BD4ECA9B031ED" unitRef="usd">-2851000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="FD2015Q2YTD" decimals="-3" id="Fact-680771104F84D91558C8D4ECA9833353" unitRef="usd">-4109000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
	<us-gaap:OtherLiabilitiesCurrent contextRef="FI2014Q4" decimals="-3" id="Fact-896C3DD2749D7A948477D4ECA985C873" unitRef="usd">1819334000</us-gaap:OtherLiabilitiesCurrent>
	<us-gaap:OtherLiabilitiesCurrent contextRef="FI2015Q2" decimals="-3" id="Fact-B580319824EF71BF81D7D4ECA99A3DD6" unitRef="usd">1812099000</us-gaap:OtherLiabilitiesCurrent>
	<us-gaap:OtherLiabilitiesNoncurrent contextRef="FI2014Q4" decimals="-3" id="Fact-1BFE0A7CF7C35E9C6404D4ECA99A7665" unitRef="usd">650096000</us-gaap:OtherLiabilitiesNoncurrent>
	<us-gaap:OtherLiabilitiesNoncurrent contextRef="FI2015Q2" decimals="-3" id="Fact-1D0B401743C22F04A9E2D4ECA9A569E8" unitRef="usd">915731000</us-gaap:OtherLiabilitiesNoncurrent>
	<us-gaap:OtherNoncashIncomeExpense contextRef="FD2014Q2YTD" decimals="-3" id="Fact-D21A4FCC9E8BD2696467D4ECA97D997B" unitRef="usd">64213000</us-gaap:OtherNoncashIncomeExpense>
	<us-gaap:OtherNoncashIncomeExpense contextRef="FD2015Q2YTD" decimals="-3" id="Fact-103FF03E22F85EA49229D4ECA9A89641" unitRef="usd">5808000</us-gaap:OtherNoncashIncomeExpense>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2014Q2QTD" decimals="-5" id="Fact-CC989084202ED9CC3AA9D4ECA997129F" unitRef="usd">-2600000</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2014Q2YTD" decimals="-5" id="Fact-38A4063FF9FE9A4AD9AAD4ECA9B03D46" unitRef="usd">-3000000</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2015Q2QTD" decimals="-5" id="Fact-767F1744253F2A53431ED4ECA9A791DA" unitRef="usd">-8200000</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2015Q2YTD" decimals="-5" id="Fact-23819F926502646FB9A8D4ECA9AE2499" unitRef="usd">-5100000</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:OtherSalesRevenueNet contextRef="FD2014Q2QTD" decimals="-3" id="Fact-990C90D1944BBA592E58D4ECA9B1DB5E" unitRef="usd">61864000</us-gaap:OtherSalesRevenueNet>
	<us-gaap:OtherSalesRevenueNet contextRef="FD2014Q2QTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-5" id="Fact-57540819DA97B1B60729D4ECA973779B" unitRef="usd">12300000</us-gaap:OtherSalesRevenueNet>
	<us-gaap:OtherSalesRevenueNet contextRef="FD2014Q2YTD" decimals="-3" id="Fact-A5CA2B8BD1857BFDBD3FD4ECA985E9D4" unitRef="usd">151965000</us-gaap:OtherSalesRevenueNet>
	<us-gaap:OtherSalesRevenueNet contextRef="FD2014Q2YTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-5" id="Fact-B15EB87C21E34AB5C122D4ECA9983A18" unitRef="usd">36500000</us-gaap:OtherSalesRevenueNet>
	<us-gaap:OtherSalesRevenueNet contextRef="FD2015Q2QTD" decimals="-3" id="Fact-ED4B8D7007C1344314CED4ECA9AF203D" unitRef="usd">55566000</us-gaap:OtherSalesRevenueNet>
	<us-gaap:OtherSalesRevenueNet contextRef="FD2015Q2QTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-5" id="Fact-F3CF17ACC411CB4D1CFCD4ECA9A1FF4D" unitRef="usd">17200000</us-gaap:OtherSalesRevenueNet>
	<us-gaap:OtherSalesRevenueNet contextRef="FD2015Q2YTD" decimals="-3" id="Fact-A91028F9FC46A4339D61D4ECA98E8DD8" unitRef="usd">107596000</us-gaap:OtherSalesRevenueNet>
	<us-gaap:OtherSalesRevenueNet contextRef="FD2015Q2YTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-5" id="Fact-566264024C774E36B107D4ECA971853D" unitRef="usd">36100000</us-gaap:OtherSalesRevenueNet>
	<us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="FD2014Q2YTD" decimals="-3" id="Fact-0D1807CB9E99B16CF0ECD4ECA97D5DE3" unitRef="usd">10745000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
	<us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="FD2015Q2YTD" decimals="-3" id="Fact-A860A566A1DD2CDF35AAD4ECA9AEBE07" unitRef="usd">10119000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
	<us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="FD2014Q2YTD" decimals="-3" id="Fact-D1F3B8892520E8D0ACFFD4ECA9A5620E" unitRef="usd">336905000</us-gaap:PaymentsForRepurchaseOfCommonStock>
	<us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="FD2015Q2YTD" decimals="-3" id="Fact-FEA7D72BC23E14472768D4ECA98C80AF" unitRef="usd">42193000</us-gaap:PaymentsForRepurchaseOfCommonStock>
	<us-gaap:PaymentsToAcquireAvailableForSaleSecurities contextRef="FD2014Q2YTD" decimals="-3" id="Fact-4D0DD0055BAB608E3117D4ECA97DF910" unitRef="usd">1787606000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
	<us-gaap:PaymentsToAcquireAvailableForSaleSecurities contextRef="FD2015Q2YTD" decimals="-3" id="Fact-1E073B039B89BC90D288D4ECA98C17C9" unitRef="usd">2045046000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
	<us-gaap:PaymentsToAcquireBusinessesGross contextRef="D2006Q4YTD_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember" decimals="-5" id="Fact-E2FC5EF6308A539E1D6AD4ECA9AF3C02" unitRef="usd">220000000</us-gaap:PaymentsToAcquireBusinessesGross>
	<us-gaap:PaymentsToAcquireBusinessesGross contextRef="D2015Q1_us-gaap_BusinessAcquisitionAxis_biib_ConvergencePharmaceuticalsMember" decimals="-5" id="Fact-81AD2FE3ACCDA098B9CDD4ECA98C3332" unitRef="usd">200100000</us-gaap:PaymentsToAcquireBusinessesGross>
	<us-gaap:PaymentsToAcquireBusinessesGross contextRef="FD2015Q2YTD_biib_CumulativeSalesLevelAxis_biib_FivebillionMember_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember" decimals="-5" id="Fact-227D64EF4EE41D00F707D4ECA9AFA4E7" unitRef="usd">300000000</us-gaap:PaymentsToAcquireBusinessesGross>
	<us-gaap:PaymentsToAcquireBusinessesGross contextRef="FD2015Q2YTD_biib_CumulativeSalesLevelAxis_biib_FourbillionMember_us-gaap_BusinessAcquisitionAxis_biib_FumapharmAgMember" decimals="-5" id="Fact-20549D62412FEBD29C3CD4ECA9A67831" unitRef="usd">250000000</us-gaap:PaymentsToAcquireBusinessesGross>
	<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="FD2014Q2YTD" decimals="-3" id="Fact-0E725758E0B1C801F313D4ECA98CD649" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
	<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="FD2015Q2YTD" decimals="-3" id="Fact-59C48DFBF7695757B4BDD4ECA98599EE" unitRef="usd">198798000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
	<us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="FD2015Q2YTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-8" id="Fact-530331B9682D1F2B8E95D4ECA98529A9" unitRef="KRW">6300000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
	<us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="FD2015Q2YTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-5" id="Fact-298EE1319CEA3B048613D4ECA99B87D1" unitRef="usd">5700000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
	<us-gaap:PaymentsToAcquireOtherProductiveAssets contextRef="FD2014Q2YTD" decimals="-3" id="Fact-E6603A812E580D343C89D4ECA975507C" unitRef="usd">25000000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
	<us-gaap:PaymentsToAcquireOtherProductiveAssets contextRef="FD2015Q2YTD" decimals="-3" id="Fact-45B6D8A5BD72D67520D2D4ECA97D06F1" unitRef="usd">250000000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2014Q2YTD" decimals="-3" id="Fact-3E274D5FE4EF94AD5E67D4ECA99B7E0C" unitRef="usd">118308000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2015Q2YTD" decimals="-3" id="Fact-49B53AFC70CE9EDFEB7DD4ECA98CDC64" unitRef="usd">227688000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="FI2014Q4" decimals="INF" id="Fact-41FA6B749BC84DBE7C1DD4ECA974DB9E" unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="FI2015Q2" decimals="INF" id="Fact-E205E8F7563291A6B61DD4ECA9A5F14E" unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockValue contextRef="FI2014Q4" decimals="-3" id="Fact-96F06971A5C5636ADD26D4ECA9A43FB1" unitRef="usd">0</us-gaap:PreferredStockValue>
	<us-gaap:PreferredStockValue contextRef="FI2015Q2" decimals="-3" id="Fact-477A12BD3C3DFB45AB62D4ECA98BA402" unitRef="usd">0</us-gaap:PreferredStockValue>
	<us-gaap:PrepaidExpenseAndOtherAssets contextRef="I2015Q3_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_biib_AGTCMember" decimals="-5" id="Fact-F2E5C8638210EAE95955749F3D6368B5" unitRef="usd">58400000</us-gaap:PrepaidExpenseAndOtherAssets>
	<us-gaap:PrepaidTaxes contextRef="FI2014Q4" decimals="-5" id="Fact-BF58F2B62EB8B8FEA0D8B733DEB344EF" unitRef="usd">57600000</us-gaap:PrepaidTaxes>
	<us-gaap:PrepaidTaxes contextRef="FI2015Q2" decimals="-5" id="Fact-E873372B17AC55428BE0B7338FD5FB04" unitRef="usd">280500000</us-gaap:PrepaidTaxes>
	<us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="FD2014Q2YTD" decimals="-3" id="Fact-FE6153F895656DE8E956D4ECA9721CF7" unitRef="usd">33477000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
	<us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="FD2015Q2YTD" decimals="-3" id="Fact-46AC769AF014D42D5CAAD4ECA99AFB9A" unitRef="usd">34727000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
	<us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="FD2014Q2YTD" decimals="-3" id="Fact-381BA688034135088853D4ECA97BB601" unitRef="usd">12003000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
	<us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="FD2015Q2YTD" decimals="-3" id="Fact-49D70724F91ADEB402D8D4ECA97DEC56" unitRef="usd">14995000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
	<us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="FD2014Q2QTD" decimals="-5" id="Fact-F0FD74936E36F293EA7BD4ECA9A57D48" unitRef="usd">560100000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
	<us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="FD2014Q2YTD" decimals="-3" id="Fact-BEF1B619923A18B62B7CD4ECA9831D73" unitRef="usd">1317525000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
	<us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="FD2015Q2QTD" decimals="-5" id="Fact-C9F62FA4C596D2ABC955D4ECA9A302C7" unitRef="usd">601900000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
	<us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="FD2015Q2YTD" decimals="-3" id="Fact-7182BE891E61FF610265D4ECA9805C27" unitRef="usd">975517000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
	<us-gaap:ProfitLoss contextRef="FD2014Q2QTD" decimals="-3" id="Fact-ACE00B61922D2B3D257AD4ECA9A7D7C5" unitRef="usd">723132000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2014Q2YTD" decimals="-3" id="Fact-74905EA784052D96926BD4ECA971B9C5" unitRef="usd">1202860000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2015Q2QTD" decimals="-3" id="Fact-14329BF87280F02A37A7D4ECA9AF7769" unitRef="usd">924825000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2015Q2YTD" decimals="-3" id="Fact-570EC164BD304578C336D4ECA98C53A0" unitRef="usd">1744999000</us-gaap:ProfitLoss>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="FI2014Q4" decimals="-3" id="Fact-0C2133F8B5152FEFC026D4ECA9A194E3" unitRef="usd">1765683000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="FI2015Q2" decimals="-3" id="Fact-DD9FDF782671BD110752D4ECA9993C17" unitRef="usd">1837670000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2014Q2YTD" decimals="-5" id="Fact-ECA7B0364038F428DCC9D4ECA984A7E2" unitRef="usd">3500000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-F50813F363A77037DF96D4ECA9745807" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-19596932C90146D993B4D4ECA97346AF" unitRef="usd">10100000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-87F1A0947B9509F07B83D4ECA9826C38" unitRef="usd">-6600000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2014Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-E51F3F8A575312A352DDD4ECA97507D0" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2015Q2YTD" decimals="-5" id="Fact-CE7049368A80FB8F77B3D4ECA9823B36" unitRef="usd">-74800000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-F63D8C80EC4BF59A49DCD4ECA98DE1FF" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-B8CE9115E1F32FE73700D4ECA9832ADD" unitRef="usd">-75000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-3B4550226AF529F2719ED4ECA9965404" unitRef="usd">200000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2015Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-EA7F9FD6FCC29ADC1770D4ECA98C6CA8" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="D2015Q3_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_biib_AGTCMember" decimals="-5" id="Fact-34494B206A765E24ED1F749578A7194C" unitRef="usd">124000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
	<us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="FD2013Q4QTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_biib_SamsungBiosimilarAgreementMember" decimals="-5" id="Fact-9D2BFE4F579914178F2FD4ECA9A59225" unitRef="usd">46000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
	<us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="FD2014Q2QTD" decimals="-3" id="Fact-F8119396B102D32E9E8ED4ECA98EBBB5" unitRef="usd">447273000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
	<us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="FD2014Q2QTD_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_biib_NeurimmuneMember" decimals="-5" id="Fact-EF1437EA510475DAFE74D4ECA9A511E7" unitRef="usd">10600000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
	<us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="FD2014Q2YTD" decimals="-3" id="Fact-A4BCFC4E294C25414D90D4ECA982ABFC" unitRef="usd">976157000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
	<us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="FD2014Q2YTD_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_biib_NeurimmuneMember" decimals="-5" id="Fact-2D4144A5490993987C8BD4ECA97E484F" unitRef="usd">21700000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
	<us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="FD2015Q2QTD" decimals="-3" id="Fact-F87CDE8F480F4B2A3243D4ECA9AE6F6F" unitRef="usd">490728000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
	<us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="FD2015Q2QTD_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_biib_NeurimmuneMember" decimals="-5" id="Fact-9ACB028BBABA8A4AA876D4ECA9A316C8" unitRef="usd">35000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
	<us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="FD2015Q2YTD" decimals="-3" id="Fact-69C160859EF8B02ADEE6D4ECA98CFBBD" unitRef="usd">951277000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
	<us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="FD2015Q2YTD_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_biib_NeurimmuneMember" decimals="-5" id="Fact-028520FDECC311DBCD1DD4ECA99A9A3D" unitRef="usd">47800000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="FI2014Q4" decimals="-3" id="Fact-7C735F52E4C0CF624FF6D4ECA9A4B14A" unitRef="usd">9283919000</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="FI2015Q2" decimals="-3" id="Fact-1BA96C71F9A4CBE10AC6D4ECA9A49A3F" unitRef="usd">11033736000</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:Revenues contextRef="FD2014Q2QTD" decimals="-3" id="Fact-99F1DA95FD524819A7D1D4ECA9715977" unitRef="usd">2421452000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2014Q2YTD" decimals="-3" id="Fact-8E8168591FFFA99A7F93D4ECA98E5F5D" unitRef="usd">4551203000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2015Q2QTD" decimals="-3" id="Fact-FC91E24DC8812CFD14F4D4ECA9AEA42E" unitRef="usd">2591642000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2015Q2YTD" decimals="-3" id="Fact-D959917448A6A2DAF508D4ECA98B8695" unitRef="usd">5146605000</us-gaap:Revenues>
	<us-gaap:SalesRevenueGoodsNet contextRef="FD2014Q2QTD" decimals="-3" id="Fact-3B949BB37F15E32048CDD4ECA99771F3" unitRef="usd">2056292000</us-gaap:SalesRevenueGoodsNet>
	<us-gaap:SalesRevenueGoodsNet contextRef="FD2014Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-747928FEAB8E74F9AA3AD4ECA98DF75B" unitRef="usd">5300000</us-gaap:SalesRevenueGoodsNet>
	<us-gaap:SalesRevenueGoodsNet contextRef="FD2014Q2QTD_us-gaap_StatementGeographicalAxis_country_IT" decimals="-5" id="Fact-CCA3B7B55E5C2E3C9C8ED4ECA9AF73A3" unitRef="usd">53500000</us-gaap:SalesRevenueGoodsNet>
	<us-gaap:SalesRevenueGoodsNet contextRef="FD2014Q2YTD" decimals="-3" id="Fact-C8533A606C33D8BF18D2D4ECA9737D2B" unitRef="usd">3799057000</us-gaap:SalesRevenueGoodsNet>
	<us-gaap:SalesRevenueGoodsNet contextRef="FD2014Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-C959B861F39B0879A4AED4ECA9A3EEAB" unitRef="usd">10000000</us-gaap:SalesRevenueGoodsNet>
	<us-gaap:SalesRevenueGoodsNet contextRef="FD2015Q2QTD" decimals="-3" id="Fact-7E655DF3DC936FFAC9FFD4ECA9B19455" unitRef="usd">2198566000</us-gaap:SalesRevenueGoodsNet>
	<us-gaap:SalesRevenueGoodsNet contextRef="FD2015Q2QTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-8E18DE7F5DB6D53E138ED4ECA98DAD51" unitRef="usd">40400000</us-gaap:SalesRevenueGoodsNet>
	<us-gaap:SalesRevenueGoodsNet contextRef="FD2015Q2YTD" decimals="-3" id="Fact-314626B153B198D864EDD4ECA97F551D" unitRef="usd">4370888000</us-gaap:SalesRevenueGoodsNet>
	<us-gaap:SalesRevenueGoodsNet contextRef="FD2015Q2YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-5F3CDB7E869739034503D4ECA99A829B" unitRef="usd">75400000</us-gaap:SalesRevenueGoodsNet>
	<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="FD2014Q2QTD" decimals="-3" id="Fact-6760DDCAB97981E102F3D4ECA9A73FD4" unitRef="usd">576622000</us-gaap:SellingGeneralAndAdministrativeExpense>
	<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="FD2014Q2YTD" decimals="-3" id="Fact-6B1AD896735AAB1E0296D4ECA9720989" unitRef="usd">1088296000</us-gaap:SellingGeneralAndAdministrativeExpense>
	<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="FD2015Q2QTD" decimals="-3" id="Fact-963416693C87D91DAF35D4ECA9AFA057" unitRef="usd">491895000</us-gaap:SellingGeneralAndAdministrativeExpense>
	<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="FD2015Q2YTD" decimals="-3" id="Fact-FEB338C1288ABEEABD85D4ECA9974D44" unitRef="usd">1052256000</us-gaap:SellingGeneralAndAdministrativeExpense>
	<us-gaap:ShareBasedCompensation contextRef="FD2014Q2YTD" decimals="-3" id="Fact-CEA190B1CEC294259F2ED4ECA98C6129" unitRef="usd">83856000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2015Q2YTD" decimals="-3" id="Fact-5A829B81651287F3F1FCD4ECA97DCA84" unitRef="usd">93677000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2014Q2YTD_us-gaap_PlanNameAxis_biib_CashSettledPerformanceSharesMember" decimals="0" id="Fact-0645F6D3A5DD4B74103CD4ECA9B15A04" unitRef="shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2014Q2YTD_us-gaap_PlanNameAxis_biib_MarketStockUnitsMember" decimals="0" id="Fact-9CFF6B911419123B7F95D4ECA99BB945" unitRef="shares">222000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2014Q2YTD_us-gaap_PlanNameAxis_biib_TimeVestedRestrictedStockUnitsMember" decimals="0" id="Fact-EA70B7900133F20E62FED4ECA99A977F" unitRef="shares">418000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2014Q2YTD_us-gaap_PlanNameAxis_us-gaap_PerformanceSharesMember" decimals="0" id="Fact-92FDA5CAE6BA5A5B7005D4ECA972932C" unitRef="shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2015Q2YTD_us-gaap_PlanNameAxis_biib_CashSettledPerformanceSharesMember" decimals="0" id="Fact-0CE92D154312217F4BBAD4ECA99A2C24" unitRef="shares">115000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2015Q2YTD_us-gaap_PlanNameAxis_biib_MarketStockUnitsMember" decimals="0" id="Fact-D65466FA1BF09E074D1ED4ECA974E180" unitRef="shares">179000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2015Q2YTD_us-gaap_PlanNameAxis_biib_TimeVestedRestrictedStockUnitsMember" decimals="0" id="Fact-F09E4FE49ED349653541D4ECA98E814C" unitRef="shares">375000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2015Q2YTD_us-gaap_PlanNameAxis_us-gaap_PerformanceSharesMember" decimals="0" id="Fact-C936381D194FF512C47ED4ECA99A94CC" unitRef="shares">89000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="FD2014Q2YTD" decimals="INF" id="Fact-B298D156C4149914731CD4ECA97317AE" unitRef="shares">112000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
	<us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="FD2015Q2YTD" decimals="INF" id="Fact-B1FDBE84C48773553447D4ECA9999C33" unitRef="shares">98000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
	<us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="FI2015Q2" decimals="-8" id="Fact-9203B998EAF60807C9A2D4ECA9953E5D" unitRef="usd">5000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
	<us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased contextRef="FI2015Q2" decimals="-5" id="Fact-96B2E6686DC1ABFAA921D4ECA97D8418" unitRef="shares">1300000</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
	<us-gaap:StockholdersEquity contextRef="FI2014Q4" decimals="-3" id="Fact-74BAE1580A002B2F6D90D4ECA9A45758" unitRef="usd">10809010000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2015Q2" decimals="-3" id="Fact-9BE2729839E5BE29B4CED4ECA9AEECAF" unitRef="usd">12572577000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2014Q4" decimals="-3" id="Fact-031F55D5FE6B49B82BDCD4ECA9A1E734" unitRef="usd">10814040000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2015Q2" decimals="-3" id="Fact-55CF164B6F9B7233A01BD4ECA98C31E8" unitRef="usd">12572998000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityPeriodIncreaseDecrease contextRef="FD2015Q2YTD" decimals="-5" id="Fact-2F0DEAEF1222717F5B16D4ECA973E6F6" unitRef="usd">1759000000</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
	<us-gaap:TaxesPayableCurrent contextRef="FI2014Q4" decimals="-3" id="Fact-EA67C56E3F51D14D3AFFD4ECA9A4C8C1" unitRef="usd">168058000</us-gaap:TaxesPayableCurrent>
	<us-gaap:TaxesPayableCurrent contextRef="FI2015Q2" decimals="-3" id="Fact-5F268A6A07448E5E32BFD4ECA9A1ACD2" unitRef="usd">457769000</us-gaap:TaxesPayableCurrent>
	<us-gaap:TreasuryStockSharesAcquired contextRef="FD2014Q2YTD" decimals="-5" id="Fact-1AC07EE4E34334980EC3D4ECA99BD711" unitRef="shares">1200000</us-gaap:TreasuryStockSharesAcquired>
	<us-gaap:TreasuryStockSharesAcquired contextRef="FD2015Q2YTD" decimals="-5" id="Fact-C58F77E21BF71E3BA162D4ECA999FD39" unitRef="shares">100000</us-gaap:TreasuryStockSharesAcquired>
	<us-gaap:TreasuryStockValue contextRef="FI2014Q4" decimals="-3" id="Fact-A786B1EA94152D0AC9F6D4ECA99AA243" unitRef="usd">2611706000</us-gaap:TreasuryStockValue>
	<us-gaap:TreasuryStockValue contextRef="FI2015Q2" decimals="-3" id="Fact-CFB491099C194821C10ED4ECA9A31482" unitRef="usd">2611706000</us-gaap:TreasuryStockValue>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2015Q2" decimals="-5" id="Fact-387DFC3A5294719CFFE7D4ECA983F4CA" unitRef="usd">24000000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2014Q4" decimals="-5" id="Fact-5B52C192231FA3671295D4ECA9963208" unitRef="usd">483800000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2014Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccountsReceivableMember" decimals="-5" id="Fact-627045ECEFA9F0A11420D4ECA98CE3EA" unitRef="usd">124600000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2014Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember" decimals="-5" id="Fact-3E7A650945481217EBBFD4ECA9867AC2" unitRef="usd">359200000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2014Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_biib_ContractualAdjustmentsMember" decimals="-5" id="Fact-1DD4A86453C82D86FF55D4ECA9A93929" unitRef="usd">387100000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2014Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ReserveForCashDiscountMember" decimals="-5" id="Fact-18F156E1183C9575D58CD4ECA9A65B23" unitRef="usd">47600000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2014Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" decimals="-5" id="Fact-C2C70976AB337EB28F0DD4ECA9A9B5F8" unitRef="usd">49100000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2015Q2" decimals="-5" id="Fact-D183E2C29BDD84BBBFB6D4ECA98DCAC5" unitRef="usd">590400000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2015Q2_us-gaap_BalanceSheetLocationAxis_us-gaap_AccountsReceivableMember" decimals="-5" id="Fact-E77C5337865809E4EC79D4ECA9A3D83A" unitRef="usd">143900000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2015Q2_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember" decimals="-5" id="Fact-A138609E5CA463A57773D4ECA98C82CA" unitRef="usd">446500000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2015Q2_us-gaap_ValuationAllowancesAndReservesTypeAxis_biib_ContractualAdjustmentsMember" decimals="-5" id="Fact-BEEFD689ACA3F368D445D4ECA9A70BE8" unitRef="usd">483100000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2015Q2_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ReserveForCashDiscountMember" decimals="-5" id="Fact-C00465CFAD031FAAF82ED4ECA9A8076F" unitRef="usd">55900000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2015Q2_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" decimals="-5" id="Fact-F77C9398B0D560BAA5E0D4ECA9A68547" unitRef="usd">51400000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="FD2014Q2QTD" decimals="-5" id="Fact-9A06D57E9D18C4680D09D4ECA99AE69B" unitRef="shares">700000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
	<us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="FD2014Q2YTD" decimals="-5" id="Fact-29B2338BBB9972B16995D4ECA9990CB8" unitRef="shares">900000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
	<us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="FD2015Q2QTD" decimals="-5" id="Fact-1B175DFDB83EA3152F49D4ECA999A1BD" unitRef="shares">400000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
	<us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="FD2015Q2YTD" decimals="-5" id="Fact-DCF415E731F18C4F66E9D4ECA99BA103" unitRef="shares">600000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2014Q2QTD" decimals="-3" id="Fact-47F1B7E31C92EE7A8C91D4ECA9B13D3B" unitRef="shares">237401000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2014Q2YTD" decimals="-3" id="Fact-C04484636B25DD45996ED4ECA972E3E9" unitRef="shares">237634000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2015Q2QTD" decimals="-3" id="Fact-64575ADB67AA3098BB7AD4ECA9B1D875" unitRef="shares">235718000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2015Q2YTD" decimals="-3" id="Fact-8567BC9585A569BF9E92D4ECA98C36F2" unitRef="shares">235671000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2014Q2QTD" decimals="-3" id="Fact-8369251DE5D04F4D3177D4ECA9AF60A3" unitRef="shares">236661000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2014Q2YTD" decimals="-3" id="Fact-FAF5633F9FC14A91C1A7D4ECA98B19BF" unitRef="shares">236729000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2015Q2QTD" decimals="-3" id="Fact-FCA1C69E4E911B8EFBB7D4ECA9A67084" unitRef="shares">235286000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2015Q2YTD" decimals="-3" id="Fact-D139227B61A241D8D102D4ECA98D9CE4" unitRef="shares">235122000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<biib:AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock contextRef="FD2015Q2YTD" id="Fact-D770F40804FBFA7589EFD4ECA9A7A865">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;An analysis of the change in reserves for discounts and allowances is summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Discounts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Contractual&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Returns&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of December 31, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;47.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;387.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;49.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;483.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current provisions relating to sales in current year&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;209.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;854.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;19.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,082.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Adjustments relating to prior years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(19.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(8.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(27.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Payments/credits relating to sales in current year&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(158.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(483.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(642.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Payments/credits relating to sales in prior years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(43.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(254.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(7.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(305.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of June 30, 2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;55.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;483.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;51.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;590.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</biib:AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock>
	<biib:BusinessOverviewPolicyTextBlock contextRef="FD2015Q2YTD" id="Fact-E9E055B0BB6DF1D41412D4ECA985B795">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Biogen is a global biopharmaceutical company focused on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. Our principal marketed products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI, and FAMPYRA for multiple sclerosis (MS), ALPROLIX for hemophilia B and ELOCTATE for hemophilia A. We also collaborate with Genentech, Inc., a wholly-owned member of the Roche Group, on the development and commercialization of RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and other conditions and share profits and losses for GAZYVA, which is approved for the treatment of chronic lymphocytic leukemia.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</biib:BusinessOverviewPolicyTextBlock>
	<biib:IntangibleAssetsExcludingGoodwillTableTextBlock contextRef="FD2015Q2YTD" id="Fact-0C26EB934EBE77426E16D4ECA99AAE33">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Intangible assets, net of accumulated amortization, impairment charges and adjustments, are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="26" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="21%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="17%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="7%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="8%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="7%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="7%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="8%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="7%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of June 30, 2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of December 31, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Life&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Out-licensed patents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;13-23 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;543.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(493.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;49.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;543.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(481.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;61.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Developed&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;technology&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;15-23&amp;#160;years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3,005.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(2,492.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;513.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3,005.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(2,396.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;608.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In-process research and development&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Indefinite until commercialization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;752.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;752.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;314.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;314.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Trademarks&amp;#160;and&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;tradenames&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Indefinite&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;64.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;64.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;64.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;64.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquired and in-licensed&amp;#160;rights&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;and&amp;#160;patents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3-17 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3,296.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(380.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;2,916.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3,280.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(300.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2,980.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;7,661.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(3,366.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;4,294.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;7,207.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(3,178.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;4,028.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</biib:IntangibleAssetsExcludingGoodwillTableTextBlock>
	<biib:ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock contextRef="FD2015Q2YTD" id="Fact-01453EC737E6102D0C6DD4ECA97DA64C">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table reconciles equity attributable to noncontrolling interests (NCI):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;NCI, beginning of period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;2.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;4.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;5.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income (loss) attributable to NCI, net of tax&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(2.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;8.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(4.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;8.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of net assets and liabilities acquired and assigned to NCI&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;4.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Distribution to NCI&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(9.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(9.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Translation adjustment and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;NCI, end of period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</biib:ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock>
	<biib:ScheduleOfRestrictedStockUnitGrantsTableTextBlock contextRef="FD2015Q2YTD" id="Fact-012202FFD519C64A00A4D4ECA9A74880">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes our equity grants to employees, officers and directors under our current stock plans:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="73%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Market stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;179,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;222,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash settled performance shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;115,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;180,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Performance units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;89,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;50,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Time-vested restricted stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;375,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;418,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</biib:ScheduleOfRestrictedStockUnitGrantsTableTextBlock>
	<biib:SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock contextRef="FD2015Q2YTD" id="Fact-DE3305C1DF65FCE15BD8D4ECA9A77CBA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The total reserves above, included in our condensed consolidated balance sheets, are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="73%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;June 30, &lt;br clear="none"/&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;December 31, &lt;br clear="none"/&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Reduction of accounts receivable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;143.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;124.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Component of accrued expenses and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;446.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;359.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total reserves&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;590.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;483.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</biib:SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock>
	<us-gaap:AdditionalFinancialInformationDisclosureTextBlock contextRef="FD2015Q2YTD" id="Fact-7F57279FE13259FEF76ED4ECA9B139D3">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Other Consolidated Financial Statement Detail&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Other Income (Expense), Net&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Components of other income (expense), net, are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;4.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;7.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;5.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(5.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(7.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(12.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(14.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Gain (loss) on investments, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;13.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(1.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;16.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Foreign exchange gains (losses), net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(1.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(1.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(14.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(4.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(8.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(5.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(3.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total other income (expense), net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(10.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;4.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(25.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Other Current Assets&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other current assets includes prepaid taxes totaling approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$280.5 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$57.6 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; as of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Accrued Expenses and Other&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accrued expenses and other consists of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="73%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;June 30, &lt;br clear="none"/&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;December 31, &lt;br clear="none"/&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current portion of contingent consideration obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;493.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;265.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenue-related rebates&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;446.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;359.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Employee compensation and benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;214.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;393.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Royalties and licensing fees&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;161.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;172.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;62.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;120.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;433.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;507.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total accrued expenses and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,812.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,819.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Other Long-Term Liabilities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other long-term liabilities consist of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="73%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;June 30, &lt;br clear="none"/&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;December 31, &lt;br clear="none"/&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Contingent consideration obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;302.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;200.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Employee compensation and benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;224.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;200.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;389.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;249.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total other long-term liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;915.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;650.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Pricing of TYSABRI in Italy - AIFA&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In the fourth quarter of 2011, Biogen Italia SRL (formerly Biogen Idec Italia SRL), our Italian subsidiary,&amp;#160;received notice from the Italian National Medicines Agency (Agenzia Italiana del Farmaco or AIFA) that sales of TYSABRI after mid-February 2009 exceeded a reimbursement limit established pursuant to a Price Determination Resolution granted by AIFA in December 2006. In December 2011, we filed an appeal against AIFA in administrative court in Rome, Italy seeking a ruling that the reimbursement limit is unenforceable. That appeal is pending. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In June 2014, AIFA approved a resolution, effective for a &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;24&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; month term, setting the price for TYSABRI in Italy.&amp;#160;This resolution also eliminated the reimbursement limit from February 2013 going forward. As a result, in June 2014, we recognized &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$53.5 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; of TYSABRI revenues related to the periods beginning February 2013 that were previously deferred. In October 2014, we proposed a settlement to resolve all of AIFA's claims relating to sales of TYSABRI in excess of the reimbursement limit for the period from mid-February 2009 through January 2013 for an aggregate lump sum repayment of EUR&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;35.6 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. The settlement agreement was sent to the Avvocatura Generale dello Stata (Attorney General) for its opinion. In June 2015, the Attorney General chose not to approve the settlement. AIFA and Biogen Italia SRL continue to discuss a possible resolution for this period. We have approximately EUR&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;75 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; recorded as accrued expenses and deferred revenue included within our long-term liabilities within our condensed consolidated balance sheets for this matter.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;For additional information relating to our agreement with AIFA relating to sales of TYSABRI in Italy, please read Note 4, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Accounts Receivable&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to our consolidated financial statements included within our &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; Form 10-K.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
	<us-gaap:AvailableForSaleSecuritiesTextBlock contextRef="FD2015Q2YTD" id="Fact-6584290A0EB02F0AAB68D4ECA973DEDD">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following tables summarize our marketable debt and equity securities:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="41%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of June 30, 2015 (In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Gains&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Available-for-sale:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Corporate debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;375.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;375.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;822.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;823.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Government securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;710.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;710.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;989.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;989.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Mortgage and other asset backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;289.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;289.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total marketable debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3,188.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(1.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3,188.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Marketable equity securities, non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;6.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;5.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="41%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of December 31, 2014 (In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Gains&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Available-for-sale:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Corporate debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;370.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;370.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;692.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(1.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;693.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Government securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;269.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;270.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;579.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;580.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Mortgage and other asset backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;198.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;198.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total marketable debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2,111.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(2.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2,112.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Marketable equity securities, non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;6.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;5.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:AvailableForSaleSecuritiesTextBlock>
	<us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="FD2015Q2YTD" id="Fact-4BF0F0847D1DCACCF78FD4ECA9829716">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of our financial statements for interim periods in accordance with accounting principles generally accepted in the United States (U.S.&amp;#160;GAAP). The information included in this quarterly report on Form&amp;#160;10-Q should be read in conjunction with our consolidated financial statements and the accompanying notes included in our Annual Report on Form&amp;#160;10-K for the year ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; (&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; Form&amp;#160;10-K). Our accounting policies are described in the &amp;#8220;&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Notes to Consolidated Financial Statements&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8221; in our &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; Form&amp;#160;10-K and updated, as necessary, in this Form&amp;#160;10-Q. The year-end condensed consolidated balance sheet data presented for comparative purposes was derived from our audited financial statements, but does not include all disclosures required by U.S.&amp;#160;GAAP. The results of operations for the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;three and six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, are not necessarily indicative of the operating results for the full year or for any other subsequent interim period. &lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
	<us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock contextRef="FD2015Q2YTD" id="Fact-660F1DFEF27072A61378D4ECA973B426">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Financial Instruments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Marketable Securities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following tables summarize our marketable debt and equity securities:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="41%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of June 30, 2015 (In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Gains&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Available-for-sale:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Corporate debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;375.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;375.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;822.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;823.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Government securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;710.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;710.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;989.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;989.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Mortgage and other asset backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;289.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;289.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total marketable debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3,188.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(1.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3,188.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Marketable equity securities, non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;6.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;5.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="41%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of December 31, 2014 (In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Gains&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Available-for-sale:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Corporate debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;370.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;370.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;692.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(1.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;693.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Government securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;269.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;270.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;579.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;580.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Mortgage and other asset backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;198.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;198.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total marketable debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2,111.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(2.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2,112.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Marketable equity securities, non-current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;6.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;5.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes our financial assets with maturities of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;less than 90&amp;#160;days&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; from the date of purchase included within cash and cash equivalents on the accompanying condensed consolidated balance sheet:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="73%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;June 30, &lt;br clear="none"/&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;December 31, &lt;br clear="none"/&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Commercial paper&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;38.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;54.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Overnight reverse repurchase agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;185.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;305.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Money market funds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;740.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;321.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Short-term debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;10.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;35.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;974.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;716.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The carrying values of our commercial paper, including accrued interest, overnight reverse repurchase agreements, money market funds and our short-term debt securities approximate fair value due to their short term maturities. Our overnight reverse repurchase agreements are collateralized with agency-guaranteed mortgage securities and represent approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.1%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2.1%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; of total assets as of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Summary of Contractual Maturities: Available-for-Sale Securities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The estimated fair value and amortized cost of our marketable debt securities available-for-sale by contractual maturity are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of June 30, 2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of December 31, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Fair Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Fair Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Due in one year or less&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,086.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,086.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;640.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;640.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Due after one year through five years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,954.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,954.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,343.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,345.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Due after five years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;147.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;147.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;126.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;126.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total available-for-sale securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3,188.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3,188.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2,111.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2,112.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The average maturity of our marketable debt securities available-for-sale as of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; was approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;17 months&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;15 months&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Proceeds from Marketable Debt Securities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The proceeds from maturities and sales of marketable debt securities and resulting realized gains and losses are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Proceeds from maturities and sales&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;601.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;560.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;975.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,317.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Realized gains&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Realized losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Strategic Investments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, our strategic investment portfolio was comprised of investments totaling &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$45.3 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$47.8 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively, which are included in investments and other assets in our accompanying condensed consolidated balance sheets. Our strategic investment portfolio includes investments in equity securities of certain biotechnology companies and investments in venture capital funds where the underlying investments are in equity securities of biotechnology companies.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
	<us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="FD2015Q2YTD" id="Fact-9A6499FBC0D45066790ED4ECA9992DA6">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Collaborative and Other Relationships&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Samsung Bioepis&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:18px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;"&gt;Joint Venture Agreement&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In February 2012, we entered into a joint venture agreement with Samsung BioLogics Co. Ltd. (Samsung Biologics), establishing an entity, Samsung Bioepis, to develop, manufacture and market biosimilar pharmaceuticals.&amp;#160;Samsung Biologics contributed &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;280.5 billion&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; South Korean won (approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$250.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;) for an &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;85%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; stake in Samsung Bioepis and we contributed approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;49.5 billion&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; South Korean won (approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$45.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;) for the remaining &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;15%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; ownership interest.&amp;#160;Under the joint venture agreement, we have no obligation to provide any additional funding and our ownership interest may be diluted due to financings in which we do not participate. As of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, our ownership interest is approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;10%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, which reflects our additional contribution of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;6.3 billion&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; South Korean won (approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$5.7 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;) in the first quarter of 2015 and the effect of additional equity financings in which we did not participate. We maintain an option to purchase additional stock in Samsung Bioepis that would allow us to increase our ownership percentage up to &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;49.9%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;.&amp;#160;The exercise of this option is within our control and is based on paying for &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;49.9%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; of the total investment made by Samsung Biologics into Samsung Bioepis in excess of what we have already contributed under the agreement plus interest.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, the carrying value of our investment in Samsung Bioepis totaled &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;7.5 billion&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;9.1 billion&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; South Korean won (approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$6.8 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$8.6 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;), respectively, which is classified as a component of investments and other assets within our condensed consolidated balance sheets. Based on our level of influence over Samsung Bioepis, we account for this investment under the equity method of accounting and we recognize our share of the results of operations related to our investment in Samsung Bioepis one quarter in arrears when the results of the entity become available, which is reflected as equity in loss of investee, net of tax within our condensed consolidated statements of income. During the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;three and six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, we recognized a loss on our investment of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$4.9 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$5.7 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively, as compared to &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$1.9 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$9.5 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively, in the prior year comparative periods.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;"&gt;Commercial Agreement&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;On December 17, 2013, pursuant to our rights under the joint venture agreement with Samsung Biologics, we entered into an agreement with Samsung Bioepis to commercialize anti-tumor necrosis factor (TNF) biosimilar product candidates in Europe and, in the case of one anti-TNF biosimilar candidate, Japan.&amp;#160;Under the terms of this agreement, we have paid &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$46.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, which has been recorded as a research and development expense within our condensed consolidated statements of income as the programs they relate to have not achieved regulatory approval. Samsung Bioepis is eligible to receive an additional &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$75.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; in additional milestones related to clinical development and regulatory approval of the product candidates. Upon commercialization, there will be a &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;50%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; profit share with Samsung Bioepis.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;"&gt;Other Services&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Simultaneous with the formation of Samsung Bioepis, we also entered into a license agreement, a technical development services agreement and a manufacturing agreement with Samsung Bioepis. For the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;three and six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, we recognized &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$17.2 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$36.1 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively, in other revenues in relation to these services, as compared to &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$12.3 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$36.5 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively, in the prior year comparative periods. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;For additional information related to our other significant collaboration arrangements, please read Note 20, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Collaborative and Other Relationships&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to our consolidated financial statements included within our &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; Form 10-K.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
	<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="FD2015Q2YTD" id="Fact-EA748DC557728E08D78ED4ECA9A690B8">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Commitments and Contingencies&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Fumapharm AG&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In 2006, we acquired Fumapharm AG. As part of this acquisition we acquired FUMADERM and TECFIDERA (together, Fumapharm Products). We paid &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$220.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; upon the closing of the transaction and agreed to pay an additional &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$15.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; if a Fumapharm Product was approved for MS in the U.S.&amp;#160;or E.U. In the second quarter of 2013, we paid this &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$15.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; contingent payment as TECFIDERA was approved in the U.S. for MS by the U.S. Food and Drug Administration (FDA). We are also required to make additional contingent payments to former shareholders of Fumapharm AG or holders of their rights based on the attainment of certain cumulative sales levels of Fumapharm Products and the level of total net sales of Fumapharm Products in the prior twelve month period, as defined in the acquisition agreement. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;During the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, we paid a &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$250.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; contingent payment as we reached the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$4.0 billion&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; cumulative sales level related to the Fumapharm Products in the fourth quarter of 2014 and accrued &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$300.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; upon reaching &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$5.0 billion&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; in total cumulative sales of Fumapharm Products in the second quarter of 2015.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;We will owe an additional &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$300.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; contingent payment for every additional &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$1.0 billion&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; in cumulative sales level of Fumapharm Products reached if the prior 12 months sales of the Fumapharm Products exceed &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$3.0 billion&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, until such time as the cumulative sales level reaches &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$20.0 billion&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, at which time no further contingent payments shall be due. These payments will be accounted for as an increase to goodwill as incurred, in accordance with the accounting standard applicable to business combinations when we acquired Fumapharm. Any portion of the payment which is tax deductible will be recorded as a reduction to goodwill. Payments are due within 60&amp;#160;days following the end of the quarter in which the applicable cumulative sales level has been reached. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Solothurn, Switzerland Facility&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;On June 30, 2015, we signed an agreement to purchase land in Solothurn, Switzerland for &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;65.1 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; Swiss Francs. The contract also includes certain environmental remediation costs. Our obligation to purchase the land under the contract is subject to customary closing conditions as well as a condition that no material adverse changes in our business such as a decision to discontinue our aducanumab program have occurred during the period.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
	<us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="FD2015Q2YTD" id="Fact-2E01009CE337B624F060D4ECA99A55B6">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes the changes in accumulated other comprehensive income (loss), net of tax by component:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="20" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="31%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized Gains (Losses) on Securities Available for Sale&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized Gains (Losses) on Foreign Currency Forward Contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unfunded Status of Postretirement Benefit Plans&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Translation Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of December 31, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;71.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(31.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(99.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(59.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other comprehensive income (loss) before reclassifications&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;66.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;4.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(37.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;33.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(75.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(74.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net current period other comprehensive income (loss)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(8.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;4.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(37.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(41.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of June 30, 2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;62.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(27.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(137.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(101.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="20" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="31%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized Gains (Losses) on Securities Available for Sale&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized Gains (Losses) on Foreign Currency Forward Contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unfunded Status of Postretirement Benefit Plans&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Translation Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of December 31, 2013&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;5.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(23.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(19.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;10.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(27.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other comprehensive income (loss) before reclassifications&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;6.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(11.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(2.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(6.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;10.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net current period other comprehensive income (loss)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(5.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;16.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(11.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of June 30, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(7.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(19.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(1.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(26.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes the amounts reclassified from accumulated other comprehensive income:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="24%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="21%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Income Statement Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Amounts Reclassified from Accumulated Other Comprehensive Income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Gains (losses) on securities available for sale&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other income (expense)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;10.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;10.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Income tax benefit (expense)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(3.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(3.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Gains (losses) on foreign currency forward contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenues&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;40.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(5.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;75.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(10.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Income tax benefit (expense)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total reclassifications, net of tax&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;40.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;74.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(3.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
	<us-gaap:ConsolidationPolicyTextBlock contextRef="FD2015Q2YTD" id="Fact-67E3D5A275B1230D38FED4ECA99A893C">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Our condensed consolidated financial statements reflect our financial statements, those of our wholly-owned subsidiaries and those of certain variable interest entities where we are the primary beneficiary. For consolidated entities where we own or are exposed to less than &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; of the economics, we record net income (loss) attributable to noncontrolling interests in our condensed consolidated statements of income equal to the percentage of the economic or ownership interest retained in such entities by the respective noncontrolling parties. Intercompany balances and transactions are eliminated in consolidation. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In determining whether we are the primary beneficiary of an entity and therefore required to consolidate, we apply a qualitative approach that determines whether we have both (1) the power to direct the economically significant activities of the entity and (2) the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to that entity. These considerations impact the way we account for our existing collaborative relationships and other arrangements. We continuously assess whether we are the primary beneficiary of a variable interest entity as changes to existing relationships or future transactions may result in us consolidating or deconsolidating one or more of our collaborators or partners.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;We operate as &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; operating segment, which is focused on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
	<us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="FD2015Q2YTD" id="Fact-617F84ACB85A0D3BBA6FD4ECA97DF6DA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Derivative Instruments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Foreign Currency Forward Contracts - Hedging Instruments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Due to the global nature of our operations, portions of our revenues are earned in currencies other than the U.S.&amp;#160;dollar. The value of revenues measured in U.S.&amp;#160;dollars is therefore subject to changes in foreign currency exchange rates. In order to mitigate these changes we use foreign currency forward contracts to lock in exchange rates associated with a portion of our forecasted international revenues.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Foreign currency forward contracts in effect as of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; had durations of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;18 months&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;15 months&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively. These contracts have been designated as cash flow hedges and accordingly, to the extent effective, any unrealized gains or losses on these foreign currency forward contracts are reported in accumulated other comprehensive income (loss) (referred to as AOCI in the tables below). Realized gains and losses for the effective portion of such contracts are recognized in revenue when the sale of product in the currency being hedged is recognized. To the extent ineffective, hedge transaction gains and losses are reported in other income (expense), net.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The notional value of foreign currency forward contracts that were entered into to hedge forecasted revenues is summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="69%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="13%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="13%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Notional Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Foreign Currency: (In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;June 30, &lt;br clear="none"/&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;December 31, &lt;br clear="none"/&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Euro&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,437.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,174.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Canadian dollar&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;32.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;56.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;British pound sterling&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;21.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;34.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Japanese yen&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;15.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;16.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Australian dollar&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;10.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;19.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total foreign currency forward contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,517.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,302.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The portion of the fair value of these foreign currency forward contracts that was included in accumulated other comprehensive income (loss) within total equity reflected gains of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$63.1 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$72.1 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; as of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively. We expect all contracts to be settled over the next &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;18&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months and any amounts in accumulated other comprehensive income (loss) to be reported as an adjustment to revenue. We consider the impact of our and our counterparties&amp;#8217; credit risk on the fair value of the contracts as well as the ability of each party to execute its contractual obligations. As of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, credit risk did not change the fair value of our foreign currency forward contracts.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes the effect of derivatives designated as hedging instruments on our condensed consolidated statements of income:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="19" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="20%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="19%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Net Gains/(Losses)&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Reclassified from AOCI into Operating Income&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;"&gt;(Effective Portion)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Net Gains/(Losses)&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Recognized into Net Income&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;"&gt;(Ineffective Portion)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;40.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(5.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other income (expense)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(1.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="19" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="20%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="19%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Net Gains/(Losses)&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Reclassified from AOCI into Operating Income&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;"&gt;(Effective Portion)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Net Gains/(Losses)&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Recognized into Net Income&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;"&gt;(Ineffective Portion)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;75.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(10.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other income (expense)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Foreign Currency Forward Contracts - Other Derivatives&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;We also enter into other foreign currency forward contracts, usually with one month durations, to mitigate the foreign currency risk related to certain balance sheet positions. We have not elected hedge accounting for these transactions.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The aggregate notional amount of these outstanding foreign currency contracts was &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$472.4 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$365.2 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; as of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively. Net gains of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$13.6 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$3.9 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; related to these contracts were recognized as a component of other income (expense), net, for &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;three and six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively, as compared to net losses of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$2.4 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$3.8 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively, in the prior year comparative periods.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Summary of Derivatives&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;While certain of our derivatives are subject to netting arrangements with our counterparties, we do not offset derivative assets and liabilities within our condensed consolidated balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes the fair value and presentation in our condensed consolidated balance sheets of our outstanding derivatives including those designated as hedging instruments:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="43%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="42%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="13%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Balance Sheet Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;Fair Value As of June 30, 2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Hedging Instruments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Asset derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;92.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Liability derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accrued expenses and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;9.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other long-term liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;17.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Other Derivatives:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Asset derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;7.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Liability derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accrued expenses and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Balance Sheet Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Fair Value As of December 31, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Hedging Instruments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Asset derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;69.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Investments and other assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Other Derivatives:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Asset derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Liability derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accrued expenses and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;5.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
	<us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="FD2015Q2YTD" id="Fact-52EC7892B4CD2D480F40D4ECA9A5F032">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Share-based Payments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Share-based Compensation Expense&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes share-based compensation expense included within our condensed consolidated statements of income:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Research and development &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;22.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;24.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;57.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;53.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Selling, general and administrative&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;26.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;33.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;81.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;80.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Subtotal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;48.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;58.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;139.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;134.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Capitalized share-based compensation costs &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(5.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(5.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Share-based compensation expense included in total cost and expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;46.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;55.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;133.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;129.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Income tax effect&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(12.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(16.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(39.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(38.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Share-based compensation expense included in net income attributable to Biogen Inc.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;33.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;39.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;94.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;90.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Market stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;9.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;8.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;26.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;23.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Time-vested restricted stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;31.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;29.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;63.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;58.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash settled performance units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;14.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;27.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;35.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Performance units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;4.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;14.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;10.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Employee stock purchase plan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;8.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;7.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Subtotal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;48.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;58.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;139.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;134.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Capitalized share-based compensation costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(5.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(5.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Share-based compensation expense included in total cost and expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;46.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;55.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;133.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;129.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Grants Under Share-based Compensation Plans&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes our equity grants to employees, officers and directors under our current stock plans:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="73%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Market stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;179,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;222,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash settled performance shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;115,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;180,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Performance units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;89,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;50,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Time-vested restricted stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;375,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;418,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Employee Stock Purchase Plan (ESPP)&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In June 2015, our stockholders approved the Biogen Inc. 2015 Employee Stock Purchase Plan (ESPP). The ESPP, which became effective on July 1, 2015, replaced the Biogen Idec Inc. 1995 ESPP (1995 ESPP), which expired on June&amp;#160;30, 2015. The maximum aggregate number of shares of our common stock that may be purchased under the ESPP is &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;6,200,000&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;For the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;98,000&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; shares were issued under our 1995 ESPP compared to approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;112,000&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#160;shares issued in the prior year comparative period.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
	<us-gaap:EarningsPerShareTextBlock contextRef="FD2015Q2YTD" id="Fact-FAD7BBB10EC9987A40B7D4ECA9AF196F">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Earnings&amp;#160;per Share&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Basic and diluted earnings per share are calculated as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Numerator:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income attributable to Biogen Inc.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;927.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;714.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,749.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,194.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Denominator:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Weighted average number of common shares outstanding&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;235.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;236.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;235.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;236.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Effect of dilutive securities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Stock options and employee stock purchase plan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Time-vested restricted stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Market stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Dilutive potential common shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Shares used in calculating diluted earnings per share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;235.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;237.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;235.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;237.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Amounts excluded from the calculation of net income per diluted share because their effects were anti-dilutive were not significant.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
	<us-gaap:FairValueDisclosuresTextBlock contextRef="FD2015Q2YTD" id="Fact-2CE56BBC8995B4445903D4ECA98B6920">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Fair Value Measurements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The tables below present information about our assets and liabilities that are regularly measured and carried at fair value and indicate the level within the fair value hierarchy of the valuation techniques we utilized to determine such fair value:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:4px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="41%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of June 30, 2015 (In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Quoted&amp;#160;Prices&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;in Active&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Markets&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(Level 1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Significant&amp;#160;Other&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Observable&amp;#160;Inputs&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(Level 2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Significant&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unobservable&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Inputs&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash equivalents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;974.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;974.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Marketable debt securities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Corporate debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,198.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,198.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Government securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,700.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,700.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Mortgage and other asset backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;290.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;290.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Marketable equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;6.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;6.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Derivative contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;100.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;100.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Plan assets for deferred compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;40.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;40.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;4,310.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;6.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;4,303.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Derivative contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;27.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;27.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Contingent consideration obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;495.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;495.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;523.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;27.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;495.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="41%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of December 31, 2014 (In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Quoted&amp;#160;Prices&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;in Active&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Markets&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(Level 1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Significant&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Observable&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Inputs&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(Level 2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Significant&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unobservable&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Inputs&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash equivalents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;716.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;716.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Marketable debt securities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Corporate debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,063.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,063.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Government securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;849.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;849.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Mortgage and other asset backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;198.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;198.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Marketable equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;6.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;6.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Derivative contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;72.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;72.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Plan assets for deferred compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;36.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;36.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2,943.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;6.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2,937.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Derivative contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;5.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;5.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Contingent consideration obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;215.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;215.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;220.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;5.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;215.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;There have been &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; material impairments of our assets measured and carried at fair value during the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;three and six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. In addition, there were &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; changes in valuation techniques or inputs utilized or transfers between fair value measurement levels during the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;three and six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. The fair value of Level 2 instruments classified as cash equivalents and marketable debt securities was determined through third party pricing services. For a description of our validation procedures related to prices provided by third party pricing services, refer to Note 1, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Summary of Significant Accounting Policies: Fair Value Measurements&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, to our consolidated financial statements included within our &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; Form 10-K. For additional information related to our decision to no longer reflect our investments in venture capital funds within the fair value hierarchy, refer to Note 1, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Summary of Significant Accounting Policies: New Accounting Pronouncements&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, to these condensed consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Debt Instruments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The fair and carrying values of our debt instruments, which are Level&amp;#160;2 liabilities, are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of June 30, 2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of December 31, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Notes payable to Fumedica&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;10.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;9.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;12.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;11.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;6.875% Senior Notes due March&amp;#160;1, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;621.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;570.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;634.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;573.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;631.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;579.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;647.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;585.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The fair value of our notes payable to Fumedica was estimated using market observable inputs, including current interest and foreign currency exchange rates. The fair value of our &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;6.875%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; Senior Notes was determined through market, observable, and corroborated sources. For additional information related to our debt instruments, please read Note 12, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Indebtedness&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to our consolidated financial statements included within our &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; Form 10-K.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Contingent Consideration Obligations&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table provides a roll forward of the fair values of our contingent consideration obligations which includes Level 3 measurements:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value, beginning of period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;461.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;275.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;215.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;280.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Additions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;36.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;274.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Changes in fair value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;4.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;5.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(5.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value, end of period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;495.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;279.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;495.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;279.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$302.2 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$200.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively, of the fair value of our total contingent consideration obligations were reflected as components of other long-term liabilities within our condensed consolidated balance sheets with the remaining balances reflected as a component of accrued expenses and other. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In connection with our acquisition of Convergence, we recorded a liability of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$274.5 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, representing the fair value of the contingent consideration. This valuation was based on probability weighted net cash outflow projections of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$450.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, discounted using a rate of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, which is the estimated cost of debt financing for market participants. This liability reflects the revised estimate from the date of acquisition for our initial clinical development plans, resulting probabilities of success and the timing of certain milestone payments. For a more detailed description of this transaction, please read Note 2, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Acquisitions&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to these condensed consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Acquired IPR&amp;amp;D&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In connection with our acquisition of Convergence, we also allocated &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$424.6 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; of the total purchase price to acquired IPR&amp;amp;D, which was capitalized as an intangible asset. The amount allocated to acquired IPR&amp;amp;D was based on significant inputs not observable in the market and thus represented a Level 3 fair value measurement. This estimate was also adjusted from our preliminary estimate as of the date of acquisition to reflect revised estimates to our initial clinical development plans, resulting probabilities of success and the timing of certain milestone payments. These assets will be tested for impairment annually until commercialization, after which time the IPR&amp;amp;D will be amortized over its estimated useful life. For a more detailed description of this transaction, please read Note 2, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Acquisitions&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to these condensed consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="FD2015Q2YTD" id="Fact-A85881369E4F45FE6156D4ECA98CE8F2">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table provides a roll forward of the fair values of our contingent consideration obligations which includes Level 3 measurements:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value, beginning of period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;461.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;275.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;215.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;280.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Additions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;36.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;274.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Changes in fair value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;4.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;5.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(5.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value, end of period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;495.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;279.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;495.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;279.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
	<us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="FD2015Q2YTD" id="Fact-E2FB2E0FA289919A200ED4ECA99B78B6">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Intangible Assets and Goodwill&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Intangible Assets&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Intangible assets, net of accumulated amortization, impairment charges and adjustments, are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="26" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="21%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="17%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="7%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="8%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="7%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="7%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="8%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="7%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of June 30, 2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of December 31, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Life&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Out-licensed patents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;13-23 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;543.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(493.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;49.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;543.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(481.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;61.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Developed&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;technology&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;15-23&amp;#160;years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3,005.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(2,492.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;513.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3,005.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(2,396.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;608.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In-process research and development&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Indefinite until commercialization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;752.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;752.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;314.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;314.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Trademarks&amp;#160;and&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;tradenames&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Indefinite&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;64.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;64.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;64.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;64.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquired and in-licensed&amp;#160;rights&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;and&amp;#160;patents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3-17 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3,296.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(380.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;2,916.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3,280.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(300.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2,980.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;7,661.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(3,366.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;4,294.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;7,207.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(3,178.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;4,028.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;For the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;three and six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, amortization of acquired intangible assets totaled &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$92.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$187.9 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively, as compared to &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$116.8 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$260.1 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively, in the prior year comparative periods. For the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;three and six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, compared to the same periods in &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, the decrease in amortization of acquired intangible assets was primarily driven by a decrease in AVONEX and TYSABRI revenues during the comparative periods and higher expected lifetime revenues of TYSABRI as discussed below. Amortization of acquired intangible assets during the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; also includes a &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$34.7 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; impairment charge related to one of our out-licensed patents. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;"&gt;Developed Technology&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Developed technology primarily relates to our AVONEX product, which was recorded in connection with the merger of Biogen, Inc. and IDEC Pharmaceuticals Corporation in 2003. The net book value of this asset as of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$504.3 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;"&gt;In-process Research and Development (IPR&amp;amp;D)&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;IPR&amp;amp;D represents the fair value assigned to research and development assets that we acquire that have not reached technological feasibility at the date of acquisition. Upon commercialization, we will determine the estimated useful life. In connection with our acquisition of Convergence in February 2015, we acquired IPR&amp;amp;D programs with an estimated fair value of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$424.6 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. This amount will be adjusted for foreign exchange rate fluctuations. For a more detailed description of this transaction, please read Note 2, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Acquisitions&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to these condensed consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;"&gt;Acquired and In-licensed Rights and Patents&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquired and in-licensed rights and patents primarily relate to our acquisition of the TYSABRI rights from Elan Corporation plc (Elan). Elan was acquired by Perrigo Company plc (Perrigo) in December 2013. The net book value of this asset as of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$2,851.9 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;"&gt;Estimated Future Amortization of Intangible Assets &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Our amortization expense is based on the economic consumption of intangible assets. Our most significant intangible assets are related to our AVONEX and TYSABRI products. Annually, during our long-range planning cycle, we perform an analysis of anticipated lifetime revenues of AVONEX and TYSABRI. This analysis is also updated whenever events or changes in circumstances would significantly affect the anticipated lifetime revenues of either product.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Our most recent long range planning cycle was updated in the third quarter of 2014. Our analysis included an increase in the expected future product revenues of TYSABRI, resulting in a decrease in the rate of amortization expense as compared to prior quarters. Our analysis also included a decrease in the expected future product revenues of AVONEX. The results of our TYSABRI and AVONEX analyses were impacted by changes in the estimated impact of TECFIDERA, as well as other existing and potential oral and alternative MS formulations, including PLEGRIDY, that may compete with TYSABRI and AVONEX. Based upon this recent analysis, the estimated future amortization for acquired intangible assets is expected to be as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="87%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;June 30, &lt;br clear="none"/&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2015 (remaining six months)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;185.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;312.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;285.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;281.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;270.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;263.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,599.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table provides a roll forward of the changes in our goodwill balance:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="87%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of December 31, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,760.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Increase to goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;390.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;4.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of June 30, 2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;2,154.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The increase in goodwill during the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; was related to a &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$300.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; contingent payment achieved (exclusive of a &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$38.3 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; tax benefit) and to be paid to former shareholders of Fumapharm AG or holders of their rights and our acquisition of Convergence. Other includes changes related to foreign exchange. For additional information related to future contingent payments to the former shareholders of Fumapharm AG or holders of their rights, please read Note 18, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Commitments and Contingencies&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to these condensed consolidated financial statements. For additional information related to our acquisition of Convergence, please read Note 2, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Acquisitions&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to these condensed consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, we had &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; accumulated impairment losses related to goodwill.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
	<us-gaap:IncomeTaxDisclosureTextBlock contextRef="FD2015Q2YTD" id="Fact-0E409DAF0A8DE1C6FA2BD4ECA9726FEA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Income Taxes&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:24px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;For the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;three and six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, our effective tax rate was &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;23.9%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;24.7%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively, as compared to &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;27.0%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;26.9%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively, in the prior year comparative periods.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;A reconciliation between the U.S.&amp;#160;federal statutory tax rate and our effective tax rate is summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Statutory rate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;35.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;35.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;35.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;35.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;State taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Taxes on foreign earnings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(11.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(8.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(9.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(8.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Credits and net operating loss utilization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Purchased intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Manufacturing deduction&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(2.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(1.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(1.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(1.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other permanent items&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Effective tax rate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;23.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;27.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;24.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;26.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;For the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, compared to the same period in &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, the decrease in our effective income tax rate is due to lower anticipated taxes on foreign earnings.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;For the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, compared to the same period in &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, the decrease in our income tax rate was due to a benefit resulting from the remeasurement of one of our uncertain tax positions, described below, and lower anticipated taxes on foreign earnings.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Accounting for Uncertainty in Income Taxes&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;We and our subsidiaries are routinely examined by various taxing authorities. We file income tax returns in the U.S.&amp;#160;federal jurisdiction, various U.S. states, and foreign jurisdictions. With few exceptions, including the proposed disallowance we discuss below, we are no longer subject to U.S.&amp;#160;federal tax examination for years before 2013 or state, local, or non-U.S.&amp;#160;income tax examinations for years before 2004. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In March 2015, we received a final assessment from the Danish Tax Authority (SKAT) for fiscal 2009, regarding withholding taxes and the treatment of certain intercompany transactions involving our Danish affiliate and another of our affiliates.&amp;#160;The audits of our tax filings for 2010 through 2013 are not completed but have been prepared in a manner consistent with prior filings, with similar transactions, which may result in an assessment for those years.&amp;#160;The total amount assessed for 2009 is &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$48.3 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, including interest.&amp;#160;For all periods potentially under dispute, we believe that positions taken in our tax filings are valid and we are contesting the assessment vigorously.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;"&gt;Federal Uncertain Tax Positions&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;During the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, the net effect of adjustments to our uncertain tax positions was a net benefit of approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$24.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; primarily related to the state impact of a federal uncertain tax item. It is reasonably possible that we will adjust the value of our uncertain tax positions related to our unconsolidated joint business and certain transfer pricing issues as we receive additional information from various taxing authorities, including reaching settlements with the authorities. In addition, the Internal Revenue Service (IRS) and other national tax authorities routinely examine our intercompany transfer pricing with respect to intellectual property related transactions and it is possible that they may disagree with one or more positions we have taken with respect to such valuations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In October 2011, in conjunction with our examination, the IRS proposed a disallowance of approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$130.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; in deductions for tax years 2007, 2008 and 2009 related to payments for services provided by our wholly owned Danish subsidiary located in Hiller&amp;#248;d, Denmark. We believe that these items represent valid deductible business expenses and are vigorously defending our position. We have initiated a mutual agreement procedure between the IRS and SKAT for the years 2001 through 2009, in an attempt to reach agreement on the issue. In addition, we have applied for a bilateral advanced pricing agreement for the years 2010 through 2014 to resolve similar issues for the subsequent years.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
	<us-gaap:InventoryDisclosureTextBlock contextRef="FD2015Q2YTD" id="Fact-C5474FB9A415C603296BD4ECA9A5F913">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Inventory&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The components of inventory are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="73%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;June 30, &lt;br clear="none"/&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;December 31, &lt;br clear="none"/&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Raw materials&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;173.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;128.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Work in process&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;516.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;511.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Finished goods&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;175.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;164.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total inventory&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;865.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;804.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, our inventory included &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$35.8 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; associated with our ZINBRYTA and biosimilar programs, which have been capitalized in advance of regulatory approval. As of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, our inventory included &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$6.3 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; associated with our ZINBRYTA program, which had been capitalized in advance of regulatory approval.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
	<us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="FD2015Q2YTD" id="Fact-F420E0C816E885C75A72D4ECA973DB7B">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The estimated fair value and amortized cost of our marketable debt securities available-for-sale by contractual maturity are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of June 30, 2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of December 31, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Fair Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Fair Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Due in one year or less&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,086.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,086.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;640.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;640.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Due after one year through five years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,954.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,954.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,343.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,345.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Due after five years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;147.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;147.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;126.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;126.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total available-for-sale securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3,188.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3,188.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2,111.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2,112.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
	<us-gaap:LegalMattersAndContingenciesTextBlock contextRef="FD2015Q2YTD" id="Fact-7192AC57ED3363699571D4ECA98EAC92">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Litigation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt; &amp;#8217;755 Patent Litigation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;On May&amp;#160;28, 2010, Biogen MA Inc. (formerly Biogen Idec MA Inc.) filed a complaint in the U.S.&amp;#160;District Court for the District of New Jersey alleging infringement by Bayer Healthcare Pharmaceuticals Inc. (Bayer) (manufacturer, marketer and seller of BETASERON and manufacturer of EXTAVIA), EMD Serono, Inc. (manufacturer, marketer and seller of REBIF), Pfizer Inc. (co-marketer of REBIF), and Novartis Pharmaceuticals Corp. (marketer and seller of EXTAVIA) of our U.S. Patent No. 7,588,755 (&amp;#8217;755 Patent), which claims the use of interferon beta for immunomodulation or treating a viral condition, viral disease, cancers or tumors. The complaint seeks monetary damages, including lost profits and royalties. Bayer had previously filed a complaint against us in the same court, on May 27, 2010, seeking a declaratory judgment that it does not infringe the &amp;#8217;755 Patent and that the patent is invalid, and seeking monetary relief in the form of attorneys' fees, costs and expenses. The court has consolidated the two lawsuits, and we refer to the two actions as the &amp;#8220;Consolidated &amp;#8217;755 Patent Actions.&amp;#8221;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;padding-left:12px;text-indent:17px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Bayer, Pfizer, Novartis and EMD Serono have all filed counterclaims in the Consolidated &amp;#8217;755 Patent Actions seeking declaratory judgments of patent invalidity and non-infringement, and seeking monetary relief in the form of costs and attorneys' fees, and EMD Serono and Bayer have each filed a counterclaim seeking a declaratory judgment that the &amp;#8217;755 Patent is unenforceable based on alleged inequitable conduct. Bayer has also amended its complaint to seek such a declaration. No trial date has been set.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Italian National Medicines Agency&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In the fourth quarter of 2011, Biogen Italia SRL&amp;#160;received notice from the Italian National Medicines Agency (Agenzia Italiana del Farmaco or AIFA) that sales of TYSABRI after mid-February 2009 exceeded a reimbursement limit established pursuant to a Price Determination Resolution (Price Resolution) granted by AIFA in December 2006. On December&amp;#160;23, 2011, we filed an appeal in the Regional Administrative Tribunal of Lazio (Il Tribunale Amministrativo Regionale per il Lazio) in Rome, Italy seeking a ruling that the reimbursement limit in the Price Resolution should apply as written to only &amp;#8220;the first &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;24&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months&amp;#8221; of TYSABRI sales, which ended in mid-February 2009. The appeal is still pending. In June 2014, AIFA approved a resolution affirming that there is no reimbursement limit from and after February 2013. AIFA and Biogen Italia SRL are discussing a possible resolution for the period from mid-February 2009 through January 2013.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Government Matters&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;We have learned that state and federal governmental authorities are investigating our sales and promotional practices and have received related subpoenas. We have also received a subpoena from the federal government for documents relating to our relationship with certain pharmacy benefit managers. We are cooperating with the government in these matters.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Qui Tam Litigation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;On July 6, 2015, four qui tam actions filed against us by relators suing on behalf of the United States and certain states were unsealed by the U.S. District Court for the District of Massachusetts. The actions, which have been administratively consolidated, allege sales and promotional activities in violation of the federal False Claims Act and state law counterparts, and seek single and treble damages, civil penalties, interest, attorneys&amp;#8217; fees and costs. The United States has declined to intervene in two of the actions and has not made an intervention decision in the other two actions. We have not been served with any of the complaints. We have not formed an opinion that an unfavorable outcome in any of the actions is either &amp;#8220;probable&amp;#8221; or &amp;#8220;remote&amp;#8221; and are unable to estimate the magnitude or range of any potential loss.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Forward Pharma Litigation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;On November 18, 2014 Forward Pharma A/S (Forward Pharma) filed suit against us in the Regional Court of Dusseldorf, Germany alleging that TECFIDERA infringes German Utility Model DE&amp;#160;20 2005 022 112&amp;#160;U1, which was issued in April 2014 and expires in October 2015. Forward Pharma subsequently&amp;#160;extended its allegations&amp;#160;to assert that TECFIDERA infringes Forward Pharma's European Patent No. 2,801,355, which was issued in May 2015 and expires in October 2025. Forward Pharma seeks declarations of infringement and damages. A hearing has been scheduled for early 2016.&amp;#160;We have not formed an opinion that an unfavorable outcome is either &amp;#8220;probable&amp;#8221; or &amp;#8220;remote&amp;#8221; and are unable to estimate the magnitude or range of any potential loss.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Product Liability and Other Legal Proceedings&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;We are also involved in product liability claims and other legal proceedings generally incidental to our normal business activities. While the outcome of any of these proceedings cannot be accurately predicted, we do not believe the ultimate resolution of any of these existing matters would have a material adverse effect on our business or financial condition.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
	<us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock contextRef="FD2015Q2YTD" id="Fact-C3ABC832FEA6F01F2308D4ECA9A5F60D">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Acquisitions&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Convergence Pharmaceuticals&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;On February 12, 2015, we completed our acquisition of all of the outstanding stock of Convergence Pharmaceuticals (Convergence), a clinical-stage biopharmaceutical company with a focus on developing product candidates for neuropathic pain. Convergence&amp;#8217;s lead candidate is its Phase 2 clinical candidate (CNV1014802), which has demonstrated clinical activity in proof-of-concept studies for trigeminal neuralgia (TGN), a chronic orphan disease. Additionally, CNV1014802 has potential applicability in several other neuropathic pain states. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The purchase price consisted of a &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$200.1 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; cash payment at closing, plus contingent consideration in the form of development and approval milestones up to a maximum of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$450.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, of which &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$350.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; is associated with the development and approval of CNV1014802 for the treatment of TGN. The acquisition was funded from our existing cash on hand and has been accounted for as the acquisition of a business. In addition to obtaining the rights to CNV1014802 and additional product candidates in preclinical development, we retained the services of key employees of Convergence.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In connection with our acquisition of Convergence, we recorded a liability of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$274.5 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; representing the fair value of the contingent consideration.&amp;#160;This amount was estimated through a valuation model that incorporates industry-based probability adjusted assumptions relating to the achievement of these milestones and thus the likelihood of making the contingent payments. This fair value measurement is based upon significant inputs not observable in the market and therefore represents a Level 3 measurement. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The purchase price, as adjusted, consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="87%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash portion of consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;200.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;274.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total purchase price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;474.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Subsequent changes in the fair value of the contingent consideration obligation will be recognized as adjustments to contingent consideration and reflected within our condensed consolidated statements of income. For additional information related to the fair value of this obligation, please read Note 6,&amp;#160;&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Fair Value Measurements&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#160;to these condensed consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;We adjusted our preliminary estimate of the fair value of the separately identifiable assets acquired and contingent consideration as of the date of acquisition to reflect revised estimates to our initial clinical development plans, resulting probabilities of success and the timing of certain milestone payments. The primary effects of these revised estimates resulted in an increase in the value of our estimated contingent consideration and goodwill by &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$36.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively, as compared with March 31, 2015. Our revised purchase price allocation is reflected in the chart below. Our purchase price allocation is substantially complete.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes the estimated fair values of the separately identifiable assets acquired and liabilities assumed as of February&amp;#160;12, 2015, as adjusted:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="87%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In-process research and development&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;424.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;7.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;128.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred tax liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(84.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(1.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total purchase price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;474.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Our estimate of the fair value of the IPR&amp;amp;D programs acquired was determined through a probability adjusted cash flow analysis based on probability weighted net cash flows utilizing a discount rate of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;11%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. This valuation was primarily driven by the value associated with the lead candidate, CNV1014802, which is in development for the treatment of TGN and is expected to be completed no earlier than 2020, at a remaining cost of approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$145.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. The fair value associated with CNV1014802 for the treatment of TGN was &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$200.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. We have recorded additional IPR&amp;amp;D assets related to the use of CNV1014802 in two additional neuropathic pain indications, with a total estimated value of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$220.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. The remaining cost of development for these two indications is approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$415.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, with an expected completion date of no earlier than 2021. These fair value measurements were based on significant inputs not observable in the market and thus represent Level 3 fair value measurements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;We have attributed the goodwill recognized to the Convergence workforce's expertise in chronic pain research and clinical development and to establishing a deferred tax liability for the acquired IPR&amp;amp;D intangible assets which has no tax basis. The goodwill is not tax deductible.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Pro forma results of operations would not be materially different as a result of the acquisition of Convergence and therefore are not presented. Subsequent to the acquisition date, our results of operations include the results of operations of Convergence.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
	<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="FD2015Q2YTD" id="Fact-FD9542E3377FBA191341D4ECA98CAF0E">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard setting bodies that we adopt as of the specified effective date. Unless otherwise discussed, we do not believe that the impact of recently issued standards that are not yet effective will have a material impact on our financial position or results of operations upon adoption.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes all existing revenue recognition requirements, including most industry-specific guidance. The new standard requires a company to recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. In July 2015, the FASB decided to delay the effective date of the new revenue standard by one year. The new standard will be effective for us on January 1, 2018. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. We are currently evaluating the method of adoption and the potential impact that Topic 606 may have on our financial position and results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In June 2014, the FASB issued ASU No. 2014-11, Transfers and Servicing (Topic 860): Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosure. The new standard expanded secured borrowing accounting to include repurchase-to-maturity transactions and repurchase financings and set forth new disclosure requirements for repurchase agreements, securities lending transactions, and repurchase-to-maturity transactions that are accounted for as secured borrowings. We adopted this standard on April 1, 2015 and expanded our disclosures presented within Note 7, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Financial Instruments&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to these condensed consolidated financial statements. The adoption of this standard did not have an impact on our financial position or results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In April 2015, the FASB issued ASU No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The new standard requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The new standard will be effective for us on January 1, 2016. The adoption of this standard is not expected to have an impact on our financial position or results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In April 2015, the FASB issued ASU No. 2015-05, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Fees Paid in a Cloud Computing Arrangement. Under this standard, if a cloud computing arrangement includes a software license, the software license element of the arrangement should be accounted for consistent with the acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the arrangement should be accounted for as a service contract. The new standard will be effective for us on January 1, 2016. The adoption of this standard is not expected to have an impact on our financial position or results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In May 2015, the FASB issued ASU No. 2015-07, Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent). The new standard removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient. The new standard will be effective for us on January 1, 2016. Early application is permitted. We maintain investments in certain venture capital funds which primarily invest in small, privately-owned, venture-backed biotechnology companies. The value of our investments in these venture capital funds is estimated using the net asset value of the fund and has been included in the fair value hierarchy disclosure as a Level 3 measurement. These venture capital investments are not material to our financial position or results of operations. We have elected to apply this standard as of June 30, 2015 and our investments in venture capital funds will no longer be included in our disclosures reflected within Note 6, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Fair Value Measurements&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to these condensed consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
	<us-gaap:OtherNoncurrentLiabilitiesTableTextBlock contextRef="FD2015Q2YTD" id="Fact-C7A8DB9507CC400ECC73D4ECA9B19895">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other long-term liabilities consist of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="73%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;June 30, &lt;br clear="none"/&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;December 31, &lt;br clear="none"/&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Contingent consideration obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;302.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;200.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Employee compensation and benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;224.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;200.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;389.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;249.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total other long-term liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;915.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;650.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
	<us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="FD2015Q2YTD" id="Fact-9B017EBBDF5D747260E0D4ECA97B899B">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Property, plant and equipment are recorded at cost, net of accumulated depreciation. Accumulated depreciation on property, plant and equipment was &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$1,274.2 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$1,186.4 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; as of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
	<us-gaap:RealizedGainLossOnInvestmentsTableTextBlock contextRef="FD2015Q2YTD" id="Fact-B94FC939C66F7D3633E6D4ECA9969458">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The proceeds from maturities and sales of marketable debt securities and resulting realized gains and losses are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Proceeds from maturities and sales&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;601.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;560.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;975.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,317.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Realized gains&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Realized losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RealizedGainLossOnInvestmentsTableTextBlock>
	<us-gaap:ReceivablesPolicyTextBlock contextRef="FD2015Q2YTD" id="Fact-B732036CB03505A43D9974094C83E29E">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Our accounts receivable primarily arise from product sales in the U.S.&amp;#160;and Europe and mainly represent amounts due from our wholesale distributors, public hospitals and other government entities. Concentrations of credit risk with respect to our accounts receivable, which are typically unsecured, are limited due to the wide variety of customers and markets using our products, as well as their dispersion across many different geographic areas. The majority of our accounts receivable require payment within &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;30 to 90 days&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. We monitor the financial performance and credit worthiness of our customers so that we can properly assess and respond to changes in their credit profile. We provide reserves against trade receivables for estimated losses that may result from a customer&amp;#8217;s inability to pay. Amounts determined to be uncollectible are charged or written-off against the reserve. To date, our historical reserves and write-offs of accounts receivable have not been significant.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In countries where we have experienced a pattern of payments extending beyond our contractual payment term and we expect to collect receivables greater than one year after the time of sale, we have discounted our receivables and reduced related revenues over the period of time that we estimate those amounts will be paid using the country&amp;#8217;s market-based borrowing rate for such period. The related receivables are classified at the time of sale as non-current assets. We accrete interest income on these receivables, which is recognized as a component of other income (expense), net within our condensed consolidated statement of income.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
	<us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock contextRef="FD2015Q2YTD" id="Fact-09FB2122B50483CE452FD4ECA99A2BF0">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes the amounts reclassified from accumulated other comprehensive income:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="24%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="21%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Income Statement Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Amounts Reclassified from Accumulated Other Comprehensive Income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Gains (losses) on securities available for sale&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other income (expense)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;10.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;10.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Income tax benefit (expense)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(3.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(3.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Gains (losses) on foreign currency forward contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenues&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;40.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(5.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;75.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(10.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Income tax benefit (expense)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total reclassifications, net of tax&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;40.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;74.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(3.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
	<us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="FD2015Q2YTD" id="Fact-F858621DED7B8F68E42FD4ECA9B01F88">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accrued expenses and other consists of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="73%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;June 30, &lt;br clear="none"/&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;December 31, &lt;br clear="none"/&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current portion of contingent consideration obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;493.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;265.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenue-related rebates&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;446.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;359.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Employee compensation and benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;214.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;393.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Royalties and licensing fees&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;161.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;172.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;62.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;120.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;433.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;507.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total accrued expenses and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,812.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,819.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
	<us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="FD2015Q2YTD" id="Fact-8AB6AF2CDF9DE93B568AD4ECA99A031F">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes the changes in accumulated other comprehensive income (loss), net of tax by component:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="20" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="31%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized Gains (Losses) on Securities Available for Sale&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized Gains (Losses) on Foreign Currency Forward Contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unfunded Status of Postretirement Benefit Plans&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Translation Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of December 31, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;71.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(31.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(99.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(59.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other comprehensive income (loss) before reclassifications&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;66.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;4.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(37.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;33.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(75.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(74.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net current period other comprehensive income (loss)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(8.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;4.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(37.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(41.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of June 30, 2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;62.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(27.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(137.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(101.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="20" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="31%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized Gains (Losses) on Securities Available for Sale&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unrealized Gains (Losses) on Foreign Currency Forward Contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unfunded Status of Postretirement Benefit Plans&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Translation Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of December 31, 2013&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;5.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(23.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(19.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;10.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(27.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other comprehensive income (loss) before reclassifications&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;6.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(11.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(2.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(6.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;10.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net current period other comprehensive income (loss)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(5.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;16.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(11.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of June 30, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(7.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(19.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(1.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(26.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
	<us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="FD2015Q2YTD" id="Fact-12F9B9F117A676285AD0D4ECA9756270">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;he purchase price, as adjusted, consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="87%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash portion of consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;200.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;274.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total purchase price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;474.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
	<us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock contextRef="FD2015Q2YTD" id="Fact-FB281FCC4FECD2E7C4BDD4ECA98C4707">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The fair and carrying values of our debt instruments, which are Level&amp;#160;2 liabilities, are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of June 30, 2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of December 31, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Notes payable to Fumedica&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;10.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;9.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;12.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;11.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;6.875% Senior Notes due March&amp;#160;1, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;621.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;570.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;634.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;573.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;631.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;579.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;647.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;585.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
	<us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="FD2015Q2YTD" id="Fact-84259EE203021869AF2CD4ECA9730B97">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes our financial assets with maturities of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;less than 90&amp;#160;days&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; from the date of purchase included within cash and cash equivalents on the accompanying condensed consolidated balance sheet:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="73%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;June 30, &lt;br clear="none"/&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;December 31, &lt;br clear="none"/&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Commercial paper&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;38.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;54.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Overnight reverse repurchase agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;185.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;305.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Money market funds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;740.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;321.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Short-term debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;10.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;35.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;974.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;716.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
	<us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock contextRef="FD2015Q2YTD" id="Fact-F53F35647CD80B807651D4ECA9AFB6A9">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Market stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;9.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;8.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;26.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;23.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Time-vested restricted stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;31.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;29.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;63.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;58.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash settled performance units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;14.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;27.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;35.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Performance units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;4.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;14.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;10.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Employee stock purchase plan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;8.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;7.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Subtotal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;48.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;58.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;139.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;134.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Capitalized share-based compensation costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(5.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(5.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Share-based compensation expense included in total cost and expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;46.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;55.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;133.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;129.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
	<us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock contextRef="FD2015Q2YTD" id="Fact-677E1CDC00ED20F12DB8D4ECA97D8230">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes the effect of derivatives designated as hedging instruments on our condensed consolidated statements of income:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="19" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="20%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="19%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Net Gains/(Losses)&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Reclassified from AOCI into Operating Income&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;"&gt;(Effective Portion)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Net Gains/(Losses)&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Recognized into Net Income&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;"&gt;(Ineffective Portion)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;40.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(5.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other income (expense)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(1.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="19" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="20%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="19%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Net Gains/(Losses)&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Reclassified from AOCI into Operating Income&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;"&gt;(Effective Portion)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Net Gains/(Losses)&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Recognized into Net Income&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;"&gt;(Ineffective Portion)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;75.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(10.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other income (expense)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;3.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
	<us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="FD2015Q2YTD" id="Fact-DE3DD6E03B2A926F8B66D4ECA9979D20">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes the fair value and presentation in our condensed consolidated balance sheets of our outstanding derivatives including those designated as hedging instruments:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="43%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="42%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="13%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Balance Sheet Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;Fair Value As of June 30, 2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Hedging Instruments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Asset derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;92.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Liability derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accrued expenses and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;9.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other long-term liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;17.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Other Derivatives:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Asset derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;7.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Liability derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accrued expenses and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Balance Sheet Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Fair Value As of December 31, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Hedging Instruments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Asset derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;69.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Investments and other assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Other Derivatives:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Asset derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Liability derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accrued expenses and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;5.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
	<us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="FD2015Q2YTD" id="Fact-A68FD6AC17D8F8FC8E5DD4ECA9A5CEC7">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Basic and diluted earnings per share are calculated as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Numerator:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income attributable to Biogen Inc.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;927.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;714.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,749.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,194.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Denominator:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Weighted average number of common shares outstanding&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;235.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;236.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;235.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;236.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Effect of dilutive securities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Stock options and employee stock purchase plan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Time-vested restricted stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Market stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Dilutive potential common shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Shares used in calculating diluted earnings per share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;235.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;237.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;235.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;237.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
	<us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="FD2015Q2YTD" id="Fact-B95089CE6B18BD814789D4ECA9733D12">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;A reconciliation between the U.S.&amp;#160;federal statutory tax rate and our effective tax rate is summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Statutory rate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;35.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;35.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;35.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;35.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;State taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Taxes on foreign earnings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(11.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(8.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(9.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(8.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Credits and net operating loss utilization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Purchased intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Manufacturing deduction&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(2.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(1.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(1.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(1.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other permanent items&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Effective tax rate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;23.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;27.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;24.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;26.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#160;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
	<us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="FD2015Q2YTD" id="Fact-86BFF32ABAFD48F5C504D4ECA98EB3ED">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table summarizes share-based compensation expense included within our condensed consolidated statements of income:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Research and development &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;22.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;24.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;57.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;53.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Selling, general and administrative&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;26.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;33.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;81.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;80.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Subtotal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;48.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;58.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;139.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;134.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Capitalized share-based compensation costs &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(5.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(5.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Share-based compensation expense included in total cost and expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;46.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;55.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;133.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;129.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Income tax effect&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(12.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(16.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(39.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(38.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Share-based compensation expense included in net income attributable to Biogen Inc.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;33.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;39.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;94.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;90.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
	<us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="FD2015Q2YTD" id="Fact-A4EC15926D79A5F3C516D4ECA9866FEA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The tables below present information about our assets and liabilities that are regularly measured and carried at fair value and indicate the level within the fair value hierarchy of the valuation techniques we utilized to determine such fair value:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:4px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="41%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of June 30, 2015 (In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Quoted&amp;#160;Prices&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;in Active&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Markets&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(Level 1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Significant&amp;#160;Other&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Observable&amp;#160;Inputs&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(Level 2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Significant&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unobservable&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Inputs&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash equivalents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;974.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;974.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Marketable debt securities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Corporate debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,198.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,198.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Government securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,700.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,700.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Mortgage and other asset backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;290.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;290.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Marketable equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;6.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;6.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Derivative contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;100.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;100.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Plan assets for deferred compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;40.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;40.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;4,310.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;6.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;4,303.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Derivative contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;27.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;27.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Contingent consideration obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;495.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;495.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;523.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;27.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;495.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="41%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="12%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of December 31, 2014 (In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Quoted&amp;#160;Prices&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;in Active&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Markets&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(Level 1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Significant&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Observable&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Inputs&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(Level 2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Significant&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Unobservable&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Inputs&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash equivalents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;716.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;716.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Marketable debt securities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Corporate debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,063.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,063.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Government securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;849.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;849.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Mortgage and other asset backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;198.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;198.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Marketable equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;6.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;6.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Derivative contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;72.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;72.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Plan assets for deferred compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;36.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;36.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2,943.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;6.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2,937.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Derivative contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;5.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;5.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Contingent consideration obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;215.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;215.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;220.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;5.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;215.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
	<us-gaap:ScheduleOfGoodwillTextBlock contextRef="FD2015Q2YTD" id="Fact-6FEA3348DE6E0CCAC557D4ECA9B1EA5C">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table provides a roll forward of the changes in our goodwill balance:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="87%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of December 31, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,760.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Increase to goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;390.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;4.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of June 30, 2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;2,154.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
	<us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="FD2015Q2YTD" id="Fact-C546E38D722BAFD67E75D4ECA9A5BEC1">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The components of inventory are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="73%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;June 30, &lt;br clear="none"/&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;December 31, &lt;br clear="none"/&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Raw materials&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;173.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;128.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Work in process&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;516.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;511.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Finished goods&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;175.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;164.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total inventory&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;865.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;804.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
	<us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock contextRef="FD2015Q2YTD" id="Fact-F7CA17E919266904936DD4ECA983D78F">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The notional value of foreign currency forward contracts that were entered into to hedge forecasted revenues is summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="69%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="13%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="13%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Notional Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Foreign Currency: (In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;June 30, &lt;br clear="none"/&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;December 31, &lt;br clear="none"/&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Euro&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,437.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,174.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Canadian dollar&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;32.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;56.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;British pound sterling&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;21.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;34.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Japanese yen&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;15.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;16.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Australian dollar&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;10.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;19.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total foreign currency forward contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,517.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1,302.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
	<us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock contextRef="FD2015Q2YTD" id="Fact-3E135BB8DDE85FE27E7FD4ECA9B05124">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Components of other income (expense), net, are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;4.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;7.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;5.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(5.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(7.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(12.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(14.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Gain (loss) on investments, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;13.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(1.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;16.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Foreign exchange gains (losses), net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(1.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(1.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(14.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(4.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(8.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(5.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(3.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total other income (expense), net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(10.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;4.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(25.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
	<us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="FD2015Q2YTD" id="Fact-AEB99086C3600866A3C5D4ECA9A5B060">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;he following table summarizes the estimated fair values of the separately identifiable assets acquired and liabilities assumed as of February&amp;#160;12, 2015, as adjusted:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="87%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In-process research and development&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;424.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;7.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;128.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred tax liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(84.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(1.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total purchase price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;474.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
	<us-gaap:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="FD2015Q2YTD" id="Fact-6F6DC53AD23AF089C4E2D4ECA9B19599">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Reserves for Discounts and Allowances&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;An analysis of the change in reserves for discounts and allowances is summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Discounts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Contractual&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Returns&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of December 31, 2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;47.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;387.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;49.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;483.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current provisions relating to sales in current year&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;209.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;854.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;19.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,082.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Adjustments relating to prior years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(19.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(8.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(27.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Payments/credits relating to sales in current year&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(158.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(483.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(0.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(642.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Payments/credits relating to sales in prior years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(43.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(254.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(7.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(305.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, as of June 30, 2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;55.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;483.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;51.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;590.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The total reserves above, included in our condensed consolidated balance sheets, are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="73%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;June 30, &lt;br clear="none"/&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;December 31, &lt;br clear="none"/&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Reduction of accounts receivable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;143.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;124.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Component of accrued expenses and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;446.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;359.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total reserves&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;590.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;483.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
	<us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="FD2015Q2YTD" id="Fact-4466F0D38F9019EAC5C8D4ECA99605F3">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Based upon this recent analysis, the estimated future amortization for acquired intangible assets is expected to be as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="87%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;As of &lt;br clear="none"/&gt;June 30, &lt;br clear="none"/&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2015 (remaining six months)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;185.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;312.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;285.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;281.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;270.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;263.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;1,599.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
	<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="FD2015Q2YTD" id="Fact-833B3E102333E6345BEDD4ECA9B18D78">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Summary of Significant Accounting Policies&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Business Overview&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Biogen is a global biopharmaceutical company focused on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. Our principal marketed products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI, and FAMPYRA for multiple sclerosis (MS), ALPROLIX for hemophilia B and ELOCTATE for hemophilia A. We also collaborate with Genentech, Inc., a wholly-owned member of the Roche Group, on the development and commercialization of RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and other conditions and share profits and losses for GAZYVA, which is approved for the treatment of chronic lymphocytic leukemia.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Basis of Presentation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of our financial statements for interim periods in accordance with accounting principles generally accepted in the United States (U.S.&amp;#160;GAAP). The information included in this quarterly report on Form&amp;#160;10-Q should be read in conjunction with our consolidated financial statements and the accompanying notes included in our Annual Report on Form&amp;#160;10-K for the year ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; (&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; Form&amp;#160;10-K). Our accounting policies are described in the &amp;#8220;&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Notes to Consolidated Financial Statements&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8221; in our &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; Form&amp;#160;10-K and updated, as necessary, in this Form&amp;#160;10-Q. The year-end condensed consolidated balance sheet data presented for comparative purposes was derived from our audited financial statements, but does not include all disclosures required by U.S.&amp;#160;GAAP. The results of operations for the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;three and six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, are not necessarily indicative of the operating results for the full year or for any other subsequent interim period. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Consolidation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Our condensed consolidated financial statements reflect our financial statements, those of our wholly-owned subsidiaries and those of certain variable interest entities where we are the primary beneficiary. For consolidated entities where we own or are exposed to less than &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; of the economics, we record net income (loss) attributable to noncontrolling interests in our condensed consolidated statements of income equal to the percentage of the economic or ownership interest retained in such entities by the respective noncontrolling parties. Intercompany balances and transactions are eliminated in consolidation. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In determining whether we are the primary beneficiary of an entity and therefore required to consolidate, we apply a qualitative approach that determines whether we have both (1) the power to direct the economically significant activities of the entity and (2) the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to that entity. These considerations impact the way we account for our existing collaborative relationships and other arrangements. We continuously assess whether we are the primary beneficiary of a variable interest entity as changes to existing relationships or future transactions may result in us consolidating or deconsolidating one or more of our collaborators or partners.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;We operate as &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; operating segment, which is focused on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Use of Estimates&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The preparation of our condensed consolidated financial statements requires us to make estimates, judgments, and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and judgments and methodologies. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Accounts Receivable&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Our accounts receivable primarily arise from product sales in the U.S.&amp;#160;and Europe and mainly represent amounts due from our wholesale distributors, public hospitals and other government entities. Concentrations of credit risk with respect to our accounts receivable, which are typically unsecured, are limited due to the wide variety of customers and markets using our products, as well as their dispersion across many different geographic areas. The majority of our accounts receivable require payment within &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;30 to 90 days&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. We monitor the financial performance and credit worthiness of our customers so that we can properly assess and respond to changes in their credit profile. We provide reserves against trade receivables for estimated losses that may result from a customer&amp;#8217;s inability to pay. Amounts determined to be uncollectible are charged or written-off against the reserve. To date, our historical reserves and write-offs of accounts receivable have not been significant.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In countries where we have experienced a pattern of payments extending beyond our contractual payment term and we expect to collect receivables greater than one year after the time of sale, we have discounted our receivables and reduced related revenues over the period of time that we estimate those amounts will be paid using the country&amp;#8217;s market-based borrowing rate for such period. The related receivables are classified at the time of sale as non-current assets. We accrete interest income on these receivables, which is recognized as a component of other income (expense), net within our condensed consolidated statement of income.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Property, Plant and Equipment&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Property, plant and equipment are recorded at cost, net of accumulated depreciation. Accumulated depreciation on property, plant and equipment was &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$1,274.2 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$1,186.4 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; as of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;New Accounting Pronouncements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard setting bodies that we adopt as of the specified effective date. Unless otherwise discussed, we do not believe that the impact of recently issued standards that are not yet effective will have a material impact on our financial position or results of operations upon adoption.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes all existing revenue recognition requirements, including most industry-specific guidance. The new standard requires a company to recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. In July 2015, the FASB decided to delay the effective date of the new revenue standard by one year. The new standard will be effective for us on January 1, 2018. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. We are currently evaluating the method of adoption and the potential impact that Topic 606 may have on our financial position and results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In June 2014, the FASB issued ASU No. 2014-11, Transfers and Servicing (Topic 860): Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosure. The new standard expanded secured borrowing accounting to include repurchase-to-maturity transactions and repurchase financings and set forth new disclosure requirements for repurchase agreements, securities lending transactions, and repurchase-to-maturity transactions that are accounted for as secured borrowings. We adopted this standard on April 1, 2015 and expanded our disclosures presented within Note 7, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Financial Instruments&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to these condensed consolidated financial statements. The adoption of this standard did not have an impact on our financial position or results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In April 2015, the FASB issued ASU No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The new standard requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The new standard will be effective for us on January 1, 2016. The adoption of this standard is not expected to have an impact on our financial position or results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In April 2015, the FASB issued ASU No. 2015-05, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Fees Paid in a Cloud Computing Arrangement. Under this standard, if a cloud computing arrangement includes a software license, the software license element of the arrangement should be accounted for consistent with the acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the arrangement should be accounted for as a service contract. The new standard will be effective for us on January 1, 2016. The adoption of this standard is not expected to have an impact on our financial position or results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In May 2015, the FASB issued ASU No. 2015-07, Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent). The new standard removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient. The new standard will be effective for us on January 1, 2016. Early application is permitted. We maintain investments in certain venture capital funds which primarily invest in small, privately-owned, venture-backed biotechnology companies. The value of our investments in these venture capital funds is estimated using the net asset value of the fund and has been included in the fair value hierarchy disclosure as a Level 3 measurement. These venture capital investments are not material to our financial position or results of operations. We have elected to apply this standard as of June 30, 2015 and our investments in venture capital funds will no longer be included in our disclosures reflected within Note 6, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Fair Value Measurements&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to these condensed consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
	<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="FD2015Q2YTD" id="Fact-C2F491C26F94638A61EED4ECA97360CA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Equity&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total equity as of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; increased &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$1,759.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; compared to &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. This increase was driven by net income attributable to Biogen Inc. and an increase in additional paid in capital resulting from our share-based compensation arrangements, partially offset by other comprehensive losses and a reduction in additional paid-in-capital resulting from the repurchase and retirement of common stock as described below. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Share Repurchases&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In May 2015, our Board of Directors authorized a program to repurchase up to &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$5.0 billion&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; of our common stock (2015 Share Repurchase Program). This authorization does not have an expiration date. We expect that purchases will be executed within a period of up to five years and that repurchased shares will be retired. The 2015 Share Repurchase Program is in addition to the approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.3 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; shares remaining under our February 2011 Share Repurchase Program (2011 Share Repurchase Program), which has been used principally to offset common stock issuances under our share-based compensation plans.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;During the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, we repurchased and retired approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.1 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; shares of common stock at a cost of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$42.2 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; under our 2015 Share Repurchase Program and did not repurchase any shares of common stock under our 2011 Share Repurchase Program. During the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, we purchased approximately &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.2 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; shares of common stock at a cost of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$336.9 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; under our 2011 Share Repurchase Program. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Noncontrolling Interests&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The following table reconciles equity attributable to noncontrolling interests (NCI):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td width="45%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="11%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td width="1%" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Three Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;For the Six Months &lt;br clear="none"/&gt;Ended June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;(In millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;"&gt;2015&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;"&gt;2014&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;NCI, beginning of period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;2.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;4.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;5.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income (loss) attributable to NCI, net of tax&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(2.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;8.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;(4.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;8.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of net assets and liabilities acquired and assigned to NCI&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;4.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Distribution to NCI&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(9.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;(9.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Translation adjustment and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;NCI, end of period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
	<us-gaap:SubsequentEventsTextBlock contextRef="FD2015Q2YTD" id="Fact-778B39D1CABAF26573DE7488F9B50A67">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Subsequent Events&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Applied Genetic Technologies Corporation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;On July 2, 2015, we announced a collaboration and license agreement to develop gene-based therapies for multiple ophthalmic diseases with Applied Genetic Technologies Corporation (AGTC). The collaboration will focus on the development of a portfolio of AGTC&amp;#8217;s therapeutic programs, including both a clinical stage candidate for X-linked Retinoschisis (XLRS) and a pre-clinical candidate for the treatment of X-Linked Retinitis Pigmentosa (XLRP). The agreement also includes options for early stage discovery programs in two ophthalmic diseases and one non-ophthalmic condition, as well as an equity investment in AGTC by Biogen and a license agreement for manufacturing rights.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Upon closing, we will make an upfront payment in the amount of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$124.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to AGTC, which includes a &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$30.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; equity investment in AGTC, prepaid research and development expenditures of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$58.4 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and total licensing and other fees of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$35.6 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. We will be granted a license to the XLRS and XLRP programs and the option to license discovery programs for three additional indications at the time of clinical candidate selection.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Under the collaboration, AGTC is eligible to receive upfront and milestone payments aggregating in excess of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$1.0 billion&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;. This includes up to &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$472.5 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; collectively for the two lead programs, which also will carry royalties in the high single digit to mid-teen percentages of annual net sales. In addition, we will make payments up to &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$592.5 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; across the discovery programs, along with royalties in the mid-single digits to low-teen percentages of annual net sales.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;We will be granted worldwide commercialization rights for the XLRS and XLRP programs. AGTC has an option to share development costs and profits after the initial clinical trial data are available, and an option to co-promote the second of these products to be approved in the U.S. AGTC will lead the clinical development programs of XLRS through product approval and of XLRP through the completion of first-in-human trials. We will support the clinical development costs, subject to certain conditions, following the first-in-human study for XLRS and IND-enabling studies for XLRP. Under the manufacturing license, we will receive an exclusive license to use AGTC&amp;#8217;s proprietary technology platform to make AAV vectors for up to six genes, three of which are in AGTC&amp;#8217;s discretion, in exchange for payment of milestones and royalties.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The transaction is subject to customary closing conditions, including the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in the U.S., and is expected to close in the third quarter of 2015.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Research Triangle Park Facility Purchase&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;On July 15, 2015, we entered into an arrangement with Eisai, Inc. (Eisai) to purchase their manufacturing facility in Research Triangle Park, North Carolina, including a drug product facility and supporting infrastructure.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Currently, we are leasing a portion of this facility in order to manufacture our and Eisai's oral solid dose products under a &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;10&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; year lease. We have committed to buy that portion of the facility upon Eisai&amp;#8217;s completion of certain transition activities.&amp;#160; &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The transaction is subject to customary closing conditions, including the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in the U.S., and is expected to close in the third quarter of 2015.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Swedish Orphan Biovitrum AB&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;On July 16, 2015, Swedish Orphan Biovitrum AB (Sobi) exercised its option to assume development and commercialization of ALPROLIX in Europe, Russia, Turkey and certain markets in the Middle East and paid us &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$10.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, which will be held in escrow pending E.U. regulatory approval.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;We collaborate with Sobi to jointly develop and commercialize Factor VIII and Factor IX hemophilia products, including ELOCTATE and ALPROLIX. For more information about our agreement with Sobi, please read Note 20, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Collaborative and Other Relationships&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to our consolidated financial statements included within our &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; Form 10-K.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
	<us-gaap:UseOfEstimates contextRef="FD2015Q2YTD" id="Fact-3D7F51FF3F8B07684952D4ECA9A9A3B4">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The preparation of our condensed consolidated financial statements requires us to make estimates, judgments, and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and judgments and methodologies. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
	<us-gaap:VariableInterestEntityDisclosureTextBlock contextRef="FD2015Q2YTD" id="Fact-4823C58A3E3D05E74C9BD4ECA999F60D">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:12pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;"&gt;Investments in Variable Interest Entities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Consolidated Variable Interest Entities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Our condensed consolidated financial statements include the financial results of variable interest entities in which we are the primary beneficiary.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;"&gt;Neurimmune SubOne AG&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;In 2007, we entered into a collaboration agreement with Neurimmune SubOne AG (Neurimmune), a subsidiary of Neurimmune AG, for the development and commercialization of antibodies for the treatment of Alzheimer&amp;#8217;s disease. Neurimmune conducts research to identify potential therapeutic antibodies and we are responsible for the development, manufacturing and commercialization of all products. Our anti-amyloid beta antibody, aducanumab (BIIB037), for the treatment of Alzheimer&amp;#8217;s disease resulted from this collaboration. In December 2014, we reported positive interim data from the Phase 1b trial of aducanumab. Based upon our current development plans, we may pay Neurimmune up to &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$335.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; in remaining milestone payments, of which &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$60.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; is payable upon dosing of the first patient in a Phase 3 trial for aducanumab. We may also pay royalties in the low-to-mid-teens on sales of any resulting commercial products.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Amounts that are incurred by Neurimmune for research and development expenses in support of the collaboration that we reimburse are reflected in research and development expense in our condensed consolidated statements of income. Future milestone payments, if any, will be reflected within our condensed consolidated statements of income as a charge to noncontrolling interest, net of tax, when such milestones are achieved.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;For the &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;three and six&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, the collaboration incurred expenses totaling &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$35.0 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$47.8 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively, which is included in total costs and expenses within our condensed consolidated statements of income, as compared to &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$10.6 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$21.7 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively, in the prior year comparative periods. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;The assets and liabilities of Neurimmune are not significant to our financial position or results of operations as it is a research and development organization. We have provided no financing to Neurimmune other than contractually required amounts.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"&gt;Unconsolidated Variable Interest Entities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;We have relationships with other variable interest entities that we do not consolidate as we lack the power to direct the activities that significantly impact the economic success of these entities. These relationships include investments in certain biotechnology companies and research collaboration agreements. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;June&amp;#160;30, 2015&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December&amp;#160;31, 2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, the total carrying value of our investments in biotechnology companies totaled &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$8.5 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$7.9 million&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;, respectively. Our maximum exposure to losses related to these variable interest entities is limited to the carrying value of our investments.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;We have entered into research collaboration agreements with certain variable interest entities where we are required to fund certain development activities. These development activities are included in research and development expense within our condensed consolidated statements of income, as they are incurred. We have provided no financing to these variable interest entities other than previously contractually required amounts. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;For additional information related to our investments in variable interest entities, please read Note 19, &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"&gt;Investments in Variable Interest Entities&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; to our consolidated financial statements included within our &lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2014&lt;/font&gt;&lt;font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt; Form 10-K.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:VariableInterestEntityDisclosureTextBlock>
	<link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
	</link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>biib-20150630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.biogenidec.com/20150630" xmlns:biib="http://www.biogenidec.com/20150630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2015-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/us-gaap/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-roles-2015-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-types-2015-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2013-01-31" schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2014-01-31" schemaLocation="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2015-01-31" schemaLocation="http://xbrl.sec.gov/exch/2015/exch-2015-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="biib-20150630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="biib-20150630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="biib-20150630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="biib-20150630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLoss" roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLoss">
        <link:definition>2115100 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2415402 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails1" roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails1">
        <link:definition>2415403 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables" roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables">
        <link:definition>2315301 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAcquisitions" roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitions">
        <link:definition>2104100 - Disclosure - Acquisitions Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAcquisitionsDetails" roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails">
        <link:definition>2404402 - Disclosure - Acquisitions  Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAcquisitionsDetails1" roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails1">
        <link:definition>2404403 - Disclosure - Acquisitions Acquisitions (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAcquisitionsDetailsTextual" roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetailsTextual">
        <link:definition>2404404 - Disclosure - Acquisitions Acquisitions (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAcquisitionsTables" roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsTables">
        <link:definition>2304301 - Disclosure - Acquisitions Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeAndOtherRelationships" roleURI="http://www.biogenidec.com/role/CollaborativeAndOtherRelationships">
        <link:definition>2121100 - Disclosure - Collaborative and Other Relationships</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsEquityMethodInvestmentsDetails" roleURI="http://www.biogenidec.com/role/CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsEquityMethodInvestmentsDetails">
        <link:definition>2421401 - Disclosure - Collaborative and Other Relationships Collaborative and Other Relationships - Equity Method Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingencesDetails" roleURI="http://www.biogenidec.com/role/CommitmentsAndContingencesDetails">
        <link:definition>2423401 - Disclosure - Commitments and Contingences (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingencies" roleURI="http://www.biogenidec.com/role/CommitmentsAndContingencies">
        <link:definition>2123100 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingenciesCommitmentsAndContingenciesDetails1" roleURI="http://www.biogenidec.com/role/CommitmentsAndContingenciesCommitmentsAndContingenciesDetails1">
        <link:definition>2423402 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>1003000 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>1003501 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfCashFlowsUnaudited" roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited">
        <link:definition>1004000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited">
        <link:definition>1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical" roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical">
        <link:definition>1002501 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfIncomeUnaudited" roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited">
        <link:definition>1001000 - Statement - Condensed Consolidated Statements of Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstruments" roleURI="http://www.biogenidec.com/role/DerivativeInstruments">
        <link:definition>2112100 - Disclosure - Derivative Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsDetails" roleURI="http://www.biogenidec.com/role/DerivativeInstrumentsDetails">
        <link:definition>2412402 - Disclosure - Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsTables" roleURI="http://www.biogenidec.com/role/DerivativeInstrumentsTables">
        <link:definition>2312301 - Disclosure - Derivative Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DocumentAndEntityInformation" roleURI="http://www.biogenidec.com/role/DocumentAndEntityInformation">
        <link:definition>0001000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.biogenidec.com/role/EarningsPerShare">
        <link:definition>2116100 - Disclosure - Earnings per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.biogenidec.com/role/EarningsPerShareDetails">
        <link:definition>2416402 - Disclosure - Earnings per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.biogenidec.com/role/EarningsPerShareTables">
        <link:definition>2316301 - Disclosure - Earnings per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Equity" roleURI="http://www.biogenidec.com/role/Equity">
        <link:definition>2114100 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityDetails" roleURI="http://www.biogenidec.com/role/EquityDetails">
        <link:definition>2414402 - Disclosure - Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityDetailsTextual" roleURI="http://www.biogenidec.com/role/EquityDetailsTextual">
        <link:definition>2414403 - Disclosure - Equity (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityTables" roleURI="http://www.biogenidec.com/role/EquityTables">
        <link:definition>2314301 - Disclosure - Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.biogenidec.com/role/FairValueMeasurements">
        <link:definition>2109100 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetails">
        <link:definition>2409402 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails1" roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetails1">
        <link:definition>2409403 - Disclosure - Fair Value Measurements (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails2" roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetails2">
        <link:definition>2409404 - Disclosure - Fair Value Measurements (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetailsTextual" roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetailsTextual">
        <link:definition>2409405 - Disclosure - Fair Value Measurements (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.biogenidec.com/role/FairValueMeasurementsTables">
        <link:definition>2309301 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.biogenidec.com/role/FinancialInstruments">
        <link:definition>2110100 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsDetails" roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails">
        <link:definition>2410402 - Disclosure - Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsDetails1" roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails1">
        <link:definition>2410403 - Disclosure - Financial Instruments (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsDetails2" roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails2">
        <link:definition>2410404 - Disclosure - Financial Instruments (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsDetails3" roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails3">
        <link:definition>2410405 - Disclosure - Financial Instruments (Details 3)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsDetailsTextual" roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetailsTextual">
        <link:definition>2410406 - Disclosure - Financial Instruments (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsFinancialInstrumentsDetailsTextual2" roleURI="http://www.biogenidec.com/role/FinancialInstrumentsFinancialInstrumentsDetailsTextual2">
        <link:definition>2410407 - Disclosure - Financial Instruments Financial Instruments (Details Textual 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.biogenidec.com/role/FinancialInstrumentsTables">
        <link:definition>2310301 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.biogenidec.com/role/IncomeTaxes">
        <link:definition>2118100 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.biogenidec.com/role/IncomeTaxesDetails">
        <link:definition>2418402 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetailsTextual" roleURI="http://www.biogenidec.com/role/IncomeTaxesDetailsTextual">
        <link:definition>2418403 - Disclosure - Income Taxes (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.biogenidec.com/role/IncomeTaxesTables">
        <link:definition>2318301 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAndGoodwill" roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwill">
        <link:definition>2108100 - Disclosure - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAndGoodwillDetails" roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails">
        <link:definition>2408402 - Disclosure - Intangible Assets and Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAndGoodwillDetails1" roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails1">
        <link:definition>2408403 - Disclosure - Intangible Assets and Goodwill (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAndGoodwillTables" roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillTables">
        <link:definition>2308301 - Disclosure - Intangible Assets and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventory" roleURI="http://www.biogenidec.com/role/Inventory">
        <link:definition>2107100 - Disclosure - Inventory</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryDetails" roleURI="http://www.biogenidec.com/role/InventoryDetails">
        <link:definition>2407402 - Disclosure - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryInventoryDetailsTextual" roleURI="http://www.biogenidec.com/role/InventoryInventoryDetailsTextual">
        <link:definition>2407403 - Disclosure - Inventory Inventory (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryTables" roleURI="http://www.biogenidec.com/role/InventoryTables">
        <link:definition>2307301 - Disclosure - Inventory (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsInVariableInterestEntities" roleURI="http://www.biogenidec.com/role/InvestmentsInVariableInterestEntities">
        <link:definition>2120100 - Disclosure - Investments in Variable Interest Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsInVariableInterestEntitiesDetails" roleURI="http://www.biogenidec.com/role/InvestmentsInVariableInterestEntitiesDetails">
        <link:definition>2420401 - Disclosure - Investments in Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Litigation" roleURI="http://www.biogenidec.com/role/Litigation">
        <link:definition>2122100 - Disclosure - Litigation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationDetails" roleURI="http://www.biogenidec.com/role/LitigationDetails">
        <link:definition>2422401 - Disclosure - Litigation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherConsolidatedFinancialStatementDetail" roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetail">
        <link:definition>2119100 - Disclosure - Other Consolidated Financial Statement Detail</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherConsolidatedFinancialStatementDetailDetails" roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailDetails">
        <link:definition>2419402 - Disclosure - Other Consolidated Financial Statement Detail (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherConsolidatedFinancialStatementDetailOtherConsolidatedFinancialStatementDetailsTextual" roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailOtherConsolidatedFinancialStatementDetailsTextual">
        <link:definition>2419403 - Disclosure - Other Consolidated Financial Statement Detail Other Consolidated Financial Statement (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherConsolidatedFinancialStatementDetailTables" roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailTables">
        <link:definition>2319301 - Disclosure - Other Consolidated Financial Statement Detail (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesForDiscountsAndAllowances" roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowances">
        <link:definition>2106100 - Disclosure - Reserves for Discounts and Allowances</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesForDiscountsAndAllowancesDetails" roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails">
        <link:definition>2406402 - Disclosure - Reserves for Discounts and Allowances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesForDiscountsAndAllowancesDetails1" roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails1">
        <link:definition>2406403 - Disclosure - Reserves for Discounts and Allowances (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesForDiscountsAndAllowancesDetails1Calc2" roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails1Calc2">
        <link:definition>2406403 - Disclosure - Reserves for Discounts and Allowances (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesForDiscountsAndAllowancesTables" roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesTables">
        <link:definition>2306301 - Disclosure - Reserves for Discounts and Allowances (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPayments" roleURI="http://www.biogenidec.com/role/ShareBasedPayments">
        <link:definition>2117100 - Disclosure - Share-based Payments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsDetails" roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetails">
        <link:definition>2417402 - Disclosure - Share-Based Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsDetails1" roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetails1">
        <link:definition>2417403 - Disclosure - Share-Based Payments (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsDetails2" roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetails2">
        <link:definition>2417404 - Disclosure - Share-Based Payments (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsDetailsTextual" roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetailsTextual">
        <link:definition>2417405 - Disclosure - Share-Based Payments (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsTables" roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsTables">
        <link:definition>2317301 - Disclosure - Share-Based Payments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsSubsequentEvents" roleURI="http://www.biogenidec.com/role/SubsequentEventsSubsequentEvents">
        <link:definition>2124100 - Disclosure - Subsequent Events Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsSubsequentEventsDetails" roleURI="http://www.biogenidec.com/role/SubsequentEventsSubsequentEventsDetails">
        <link:definition>2424401 - Disclosure - Subsequent Events Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPolicies" roleURI="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPolicies">
        <link:definition>2101100 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesDetails" roleURI="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesDetails">
        <link:definition>2401402 - Disclosure - Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>2201201 - Disclosure - Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="biib_AGTCMember" name="AGTCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_AVONEXMember" name="AVONEXMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_AdditionalMilestonePayment" name="AdditionalMilestonePayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears" name="AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract" name="AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock" name="AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost" name="AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue" name="AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="biib_AverageMaturityOfMarketableSecurities" name="AverageMaturityOfMarketableSecurities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_BasicAndDilutedEarningsPerShareAbstract" name="BasicAndDilutedEarningsPerShareAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_BusinessOverviewPolicyTextBlock" name="BusinessOverviewPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_CNV1014802Member" name="CNV1014802Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_CashSettledPerformanceSharesMember" name="CashSettledPerformanceSharesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_ContractualAdjustmentsMember" name="ContractualAdjustmentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_ConvergencePharmaceuticalsMember" name="ConvergencePharmaceuticalsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_CorporateDebtSecuritiesCurrentMember" name="CorporateDebtSecuritiesCurrentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_CorporateDebtSecuritiesNonCurrentMember" name="CorporateDebtSecuritiesNonCurrentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_CumulativeSalesLevel" name="CumulativeSalesLevel" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="biib_CumulativeSalesLevelAxis" name="CumulativeSalesLevelAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_CumulativeSalesLevelDomain" name="CumulativeSalesLevelDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear" name="CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_DerivativeInstrumentsTextualAbstract" name="DerivativeInstrumentsTextualAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_DiscoveryprogramsMember" name="DiscoveryprogramsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_DueFromUnconsolidatedJointBusiness" name="DueFromUnconsolidatedJointBusiness" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="biib_EachAdditionalOneBillionUpToTwentyBillionMember" name="EachAdditionalOneBillionUpToTwentyBillionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction" name="EffectiveIncomeTaxRateReconciliationManufacturingDeduction" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_EisaiMember" name="EisaiMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_EmployeeStockPurchasePlanMember" name="EmployeeStockPurchasePlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_Employeerelatedliabilitiesnoncurrent" name="Employeerelatedliabilitiesnoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="biib_Employeestockpurchaseplanmaximumshares" name="Employeestockpurchaseplanmaximumshares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant" />
  <xsd:element id="biib_EquityMethodInvestmentOwnershipPercentageMaximum" name="EquityMethodInvestmentOwnershipPercentageMaximum" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_EquityMethodInvestmentsExpectedProfitShare" name="EquityMethodInvestmentsExpectedProfitShare" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_EquityTextualAbstract" name="EquityTextualAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial" name="Expectedmilestonepaymentforinitiationofalatestageclinicaltrial" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="biib_Finitelivedintangibleassetsfutureamortization" name="Finitelivedintangibleassetsfutureamortization" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="biib_FivebillionMember" name="FivebillionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_FourbillionMember" name="FourbillionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_FumapharmAgMember" name="FumapharmAgMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_GainOnSaleOfRights" name="GainOnSaleOfRights" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_GovernmentSecuritiesCurrentMember" name="GovernmentSecuritiesCurrentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_GovernmentSecuritiesNonCurrentMember" name="GovernmentSecuritiesNonCurrentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_InLicensedPatentsMember" name="InLicensedPatentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_IndefiniteLivedIntangibleAssetsUsefulLife" name="IndefiniteLivedIntangibleAssetsUsefulLife" nillable="true" substitutionGroup="xbrli:item" type="us-types:durationStringItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_IntangibleAssetsExcludingGoodwillTableTextBlock" name="IntangibleAssetsExcludingGoodwillTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_InterestInSubsidiary" name="InterestInSubsidiary" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_InventoryVariousProgramsGross" name="InventoryVariousProgramsGross" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities" name="InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="biib_InvestmentInVariableInterestEntitiesTextualAbstract" name="InvestmentInVariableInterestEntitiesTextualAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement" name="InvestmentsByThirdPartyInJointVentureAsPerAgreement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="biib_InvestmentsInVariableInterestEntitiesAbstract" name="InvestmentsInVariableInterestEntitiesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_JointVentureOwnerShipPercentageByThirdParty" name="JointVentureOwnerShipPercentageByThirdParty" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_LeadprogramsMember" name="LeadprogramsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_MarketStockUnitsMember" name="MarketStockUnitsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_MaximumTermForAccountsReceivable" name="MaximumTermForAccountsReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_MinimumTermForAccountsReceivable" name="MinimumTermForAccountsReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember" name="MortgageAndOtherAssetBackedSecuritiesCurrentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember" name="MortgageAndOtherAssetBackedSecuritiesNonCurrentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_NeurimmuneMember" name="NeurimmuneMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_NeuropathicpainindicationsMember" name="NeuropathicpainindicationsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_Noncontrollinginterestincreasedecreaseother" name="Noncontrollinginterestincreasedecreaseother" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_NotesPayableToFumedicaMember" name="NotesPayableToFumedicaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_OneBillionMember" name="OneBillionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_OutLicensedPatentsMember" name="OutLicensedPatentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_Overnightreverserepurchaseagreementspercentoftotalassets" name="Overnightreverserepurchaseagreementspercentoftotalassets" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element id="biib_PaymentTermsOfAccountsReceivable" name="PaymentTermsOfAccountsReceivable" nillable="true" substitutionGroup="xbrli:item" type="us-types:durationStringItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear" name="PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear" name="PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="biib_PlanAssetsForDeferredCompensationFairValueDisclosure" name="PlanAssetsForDeferredCompensationFairValueDisclosure" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately" name="PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices" name="ProposedDisallowanceByTaxAuthoritiesForPaymentForServices" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="biib_Purchaseofcommonstock" name="Purchaseofcommonstock" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract" name="ReconciliationOfEquityAttributableToNonControllingInterestsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock" name="ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_ReimbursementLimitStatedInResolution" name="ReimbursementLimitStatedInResolution" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement" name="RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_SamsungBiosimilarAgreementMember" name="SamsungBiosimilarAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock" name="ScheduleOfRestrictedStockUnitGrantsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_ScheduleOfStockOptionGrantsAbstract" name="ScheduleOfStockOptionGrantsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember" name="SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses" name="ShareBasedCompensationExpenseIncludedInCostsAndExpenses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_StockOptionsAndEmployeeStockPurchasePlanMember" name="StockOptionsAndEmployeeStockPurchasePlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_StrategicInvestmentPortfolio" name="StrategicInvestmentPortfolio" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="biib_StrategicInvestmentsMember" name="StrategicInvestmentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract" name="SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock" name="SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract" name="SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_SwedishOrphanBiovitrumMember" name="SwedishOrphanBiovitrumMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_TecfideraMember" name="TecfideraMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_TermOfLease" name="TermOfLease" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_ThreeBillionMember" name="ThreeBillionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_TimeVestedRestrictedStockUnitsMember" name="TimeVestedRestrictedStockUnitsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="biib_TysabriProductMember" name="TysabriProductMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="biib_UnconsolidatedJointBusiness" name="UnconsolidatedJointBusiness" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax" name="UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>biib-20150630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <roleRef roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLoss" xlink:href="biib-20150630.xsd#AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="biib-20150630.xsd#AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails1" xlink:href="biib-20150630.xsd#AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables" xlink:href="biib-20150630.xsd#AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitions" xlink:href="biib-20150630.xsd#AcquisitionsAcquisitions" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails" xlink:href="biib-20150630.xsd#AcquisitionsAcquisitionsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails1" xlink:href="biib-20150630.xsd#AcquisitionsAcquisitionsDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetailsTextual" xlink:href="biib-20150630.xsd#AcquisitionsAcquisitionsDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsTables" xlink:href="biib-20150630.xsd#AcquisitionsAcquisitionsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CollaborativeAndOtherRelationships" xlink:href="biib-20150630.xsd#CollaborativeAndOtherRelationships" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsEquityMethodInvestmentsDetails" xlink:href="biib-20150630.xsd#CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsEquityMethodInvestmentsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CommitmentsAndContingencesDetails" xlink:href="biib-20150630.xsd#CommitmentsAndContingencesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CommitmentsAndContingencies" xlink:href="biib-20150630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CommitmentsAndContingenciesCommitmentsAndContingenciesDetails1" xlink:href="biib-20150630.xsd#CommitmentsAndContingenciesCommitmentsAndContingenciesDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:href="biib-20150630.xsd#CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:href="biib-20150630.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="biib-20150630.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" xlink:href="biib-20150630.xsd#CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical" xlink:href="biib-20150630.xsd#CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited" xlink:href="biib-20150630.xsd#CondensedConsolidatedStatementsOfIncomeUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/DerivativeInstruments" xlink:href="biib-20150630.xsd#DerivativeInstruments" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/DerivativeInstrumentsDetails" xlink:href="biib-20150630.xsd#DerivativeInstrumentsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/DerivativeInstrumentsTables" xlink:href="biib-20150630.xsd#DerivativeInstrumentsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/DocumentAndEntityInformation" xlink:href="biib-20150630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EarningsPerShare" xlink:href="biib-20150630.xsd#EarningsPerShare" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EarningsPerShareDetails" xlink:href="biib-20150630.xsd#EarningsPerShareDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EarningsPerShareTables" xlink:href="biib-20150630.xsd#EarningsPerShareTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/Equity" xlink:href="biib-20150630.xsd#Equity" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EquityDetails" xlink:href="biib-20150630.xsd#EquityDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EquityDetailsTextual" xlink:href="biib-20150630.xsd#EquityDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EquityTables" xlink:href="biib-20150630.xsd#EquityTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurements" xlink:href="biib-20150630.xsd#FairValueMeasurements" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetails" xlink:href="biib-20150630.xsd#FairValueMeasurementsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetails1" xlink:href="biib-20150630.xsd#FairValueMeasurementsDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetails2" xlink:href="biib-20150630.xsd#FairValueMeasurementsDetails2" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetailsTextual" xlink:href="biib-20150630.xsd#FairValueMeasurementsDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurementsTables" xlink:href="biib-20150630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstruments" xlink:href="biib-20150630.xsd#FinancialInstruments" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails" xlink:href="biib-20150630.xsd#FinancialInstrumentsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails1" xlink:href="biib-20150630.xsd#FinancialInstrumentsDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails2" xlink:href="biib-20150630.xsd#FinancialInstrumentsDetails2" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails3" xlink:href="biib-20150630.xsd#FinancialInstrumentsDetails3" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetailsTextual" xlink:href="biib-20150630.xsd#FinancialInstrumentsDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsFinancialInstrumentsDetailsTextual2" xlink:href="biib-20150630.xsd#FinancialInstrumentsFinancialInstrumentsDetailsTextual2" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsTables" xlink:href="biib-20150630.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IncomeTaxes" xlink:href="biib-20150630.xsd#IncomeTaxes" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IncomeTaxesDetails" xlink:href="biib-20150630.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IncomeTaxesDetailsTextual" xlink:href="biib-20150630.xsd#IncomeTaxesDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IncomeTaxesTables" xlink:href="biib-20150630.xsd#IncomeTaxesTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwill" xlink:href="biib-20150630.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails" xlink:href="biib-20150630.xsd#IntangibleAssetsAndGoodwillDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails1" xlink:href="biib-20150630.xsd#IntangibleAssetsAndGoodwillDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillTables" xlink:href="biib-20150630.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/Inventory" xlink:href="biib-20150630.xsd#Inventory" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/InventoryDetails" xlink:href="biib-20150630.xsd#InventoryDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/InventoryInventoryDetailsTextual" xlink:href="biib-20150630.xsd#InventoryInventoryDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/InventoryTables" xlink:href="biib-20150630.xsd#InventoryTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/InvestmentsInVariableInterestEntities" xlink:href="biib-20150630.xsd#InvestmentsInVariableInterestEntities" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/InvestmentsInVariableInterestEntitiesDetails" xlink:href="biib-20150630.xsd#InvestmentsInVariableInterestEntitiesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/Litigation" xlink:href="biib-20150630.xsd#Litigation" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/LitigationDetails" xlink:href="biib-20150630.xsd#LitigationDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetail" xlink:href="biib-20150630.xsd#OtherConsolidatedFinancialStatementDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailDetails" xlink:href="biib-20150630.xsd#OtherConsolidatedFinancialStatementDetailDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailOtherConsolidatedFinancialStatementDetailsTextual" xlink:href="biib-20150630.xsd#OtherConsolidatedFinancialStatementDetailOtherConsolidatedFinancialStatementDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailTables" xlink:href="biib-20150630.xsd#OtherConsolidatedFinancialStatementDetailTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowances" xlink:href="biib-20150630.xsd#ReservesForDiscountsAndAllowances" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails" xlink:href="biib-20150630.xsd#ReservesForDiscountsAndAllowancesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails1" xlink:href="biib-20150630.xsd#ReservesForDiscountsAndAllowancesDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails1Calc2" xlink:href="biib-20150630.xsd#ReservesForDiscountsAndAllowancesDetails1Calc2" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesTables" xlink:href="biib-20150630.xsd#ReservesForDiscountsAndAllowancesTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPayments" xlink:href="biib-20150630.xsd#ShareBasedPayments" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetails" xlink:href="biib-20150630.xsd#ShareBasedPaymentsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetails1" xlink:href="biib-20150630.xsd#ShareBasedPaymentsDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetails2" xlink:href="biib-20150630.xsd#ShareBasedPaymentsDetails2" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetailsTextual" xlink:href="biib-20150630.xsd#ShareBasedPaymentsDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsTables" xlink:href="biib-20150630.xsd#ShareBasedPaymentsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/SubsequentEventsSubsequentEvents" xlink:href="biib-20150630.xsd#SubsequentEventsSubsequentEvents" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/SubsequentEventsSubsequentEventsDetails" xlink:href="biib-20150630.xsd#SubsequentEventsSubsequentEventsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="biib-20150630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesDetails" xlink:href="biib-20150630.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="biib-20150630.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails1" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/AcquisitionsAcquisitions" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7482f468-ad2c-9a86-91bc-7630d59b2e7f" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_109615d2-1833-125a-1bfc-cb072e58e440" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7482f468-ad2c-9a86-91bc-7630d59b2e7f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_109615d2-1833-125a-1bfc-cb072e58e440" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_606e9f3e-262e-f1b7-9864-37b9aab5c800" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7482f468-ad2c-9a86-91bc-7630d59b2e7f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_606e9f3e-262e-f1b7-9864-37b9aab5c800" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8e82af62-5d0c-8a44-003d-d4557b49ee76" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_3a587fe4-d426-9267-7729-fe8f09d606cf" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8e82af62-5d0c-8a44-003d-d4557b49ee76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_3a587fe4-d426-9267-7729-fe8f09d606cf" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_b108d604-1348-4e65-3817-2944b734c65a" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8e82af62-5d0c-8a44-003d-d4557b49ee76" xlink:to="loc_us-gaap_Goodwill_b108d604-1348-4e65-3817-2944b734c65a" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_b0419091-032e-c384-ce03-ca388d51379a" xlink:type="locator" />
    <calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8e82af62-5d0c-8a44-003d-d4557b49ee76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_b0419091-032e-c384-ce03-ca388d51379a" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_b00c3cef-b479-982f-a9af-358785626dd3" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8e82af62-5d0c-8a44-003d-d4557b49ee76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_b00c3cef-b479-982f-a9af-358785626dd3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_38b908d0-3ddf-2ab7-5076-d76b2cb8c9a7" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8e82af62-5d0c-8a44-003d-d4557b49ee76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_38b908d0-3ddf-2ab7-5076-d76b2cb8c9a7" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetailsTextual" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/AcquisitionsAcquisitionsTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/CollaborativeAndOtherRelationships" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsEquityMethodInvestmentsDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/CommitmentsAndContingencesDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/CommitmentsAndContingencies" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/CommitmentsAndContingenciesCommitmentsAndContingenciesDetails1" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4a314f0d-c6fa-5cf2-0be1-add747465af3" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a5c5aff-ee63-a4f2-571a-3515b5d26a3b" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4a314f0d-c6fa-5cf2-0be1-add747465af3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a5c5aff-ee63-a4f2-571a-3515b5d26a3b" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_d0f349aa-18e3-6323-86ad-665f8773c064" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a5c5aff-ee63-a4f2-571a-3515b5d26a3b" xlink:to="loc_us-gaap_StockholdersEquity_d0f349aa-18e3-6323-86ad-665f8773c064" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_359b0ac4-80ce-a291-f73b-cff103b81eae" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d0f349aa-18e3-6323-86ad-665f8773c064" xlink:to="loc_us-gaap_PreferredStockValue_359b0ac4-80ce-a291-f73b-cff103b81eae" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_ce40a301-9b6b-9fc3-bfb6-dfbb8fcdf29b" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d0f349aa-18e3-6323-86ad-665f8773c064" xlink:to="loc_us-gaap_CommonStockValue_ce40a301-9b6b-9fc3-bfb6-dfbb8fcdf29b" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_9158c8ad-1189-2464-9c41-553e6a22df6c" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d0f349aa-18e3-6323-86ad-665f8773c064" xlink:to="loc_us-gaap_AdditionalPaidInCapital_9158c8ad-1189-2464-9c41-553e6a22df6c" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dd6b7206-c19f-4dd5-339b-1369c57cfe0f" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d0f349aa-18e3-6323-86ad-665f8773c064" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dd6b7206-c19f-4dd5-339b-1369c57cfe0f" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1d565cd0-d7bf-de89-4dbe-a484007b1fe8" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d0f349aa-18e3-6323-86ad-665f8773c064" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1d565cd0-d7bf-de89-4dbe-a484007b1fe8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_0b2a392d-b5d5-0c30-4a0c-bcaab86d8160" xlink:type="locator" />
    <calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d0f349aa-18e3-6323-86ad-665f8773c064" xlink:to="loc_us-gaap_TreasuryStockValue_0b2a392d-b5d5-0c30-4a0c-bcaab86d8160" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_be52b263-dda5-21e0-250c-b71c8efa5893" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a5c5aff-ee63-a4f2-571a-3515b5d26a3b" xlink:to="loc_us-gaap_MinorityInterest_be52b263-dda5-21e0-250c-b71c8efa5893" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_4e70462c-e5f6-e2d9-0cf5-7f1332ddbc05" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4a314f0d-c6fa-5cf2-0be1-add747465af3" xlink:to="loc_us-gaap_Liabilities_4e70462c-e5f6-e2d9-0cf5-7f1332ddbc05" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_1de50dbc-01a9-6657-f83f-d1e74edfdf18" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4e70462c-e5f6-e2d9-0cf5-7f1332ddbc05" xlink:to="loc_us-gaap_LiabilitiesCurrent_1de50dbc-01a9-6657-f83f-d1e74edfdf18" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_22caddf9-3843-6329-6e39-dc458323b572" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1de50dbc-01a9-6657-f83f-d1e74edfdf18" xlink:to="loc_us-gaap_AccountsPayableCurrent_22caddf9-3843-6329-6e39-dc458323b572" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaap_TaxesPayableCurrent_7432ef68-60ae-faca-f534-19eb617f5674" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1de50dbc-01a9-6657-f83f-d1e74edfdf18" xlink:to="loc_us-gaap_TaxesPayableCurrent_7432ef68-60ae-faca-f534-19eb617f5674" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_0d8009a1-9f3a-b52e-6afc-03d7b3b4df06" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1de50dbc-01a9-6657-f83f-d1e74edfdf18" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_0d8009a1-9f3a-b52e-6afc-03d7b3b4df06" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaap_DebtCurrent_e290f5d1-6cff-e2db-d278-97a30e8ccd78" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1de50dbc-01a9-6657-f83f-d1e74edfdf18" xlink:to="loc_us-gaap_DebtCurrent_e290f5d1-6cff-e2db-d278-97a30e8ccd78" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_9210187e-cdda-2312-446f-000237db141c" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4e70462c-e5f6-e2d9-0cf5-7f1332ddbc05" xlink:to="loc_us-gaap_LongTermDebt_9210187e-cdda-2312-446f-000237db141c" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_d3900b70-6aae-8c94-5a39-4a06f81c5d62" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4e70462c-e5f6-e2d9-0cf5-7f1332ddbc05" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_d3900b70-6aae-8c94-5a39-4a06f81c5d62" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7f5c7cfd-4659-429c-35ab-266d67961421" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4e70462c-e5f6-e2d9-0cf5-7f1332ddbc05" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7f5c7cfd-4659-429c-35ab-266d67961421" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_53d4115f-c3d1-6e9c-3f23-fd144b27061e" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4a314f0d-c6fa-5cf2-0be1-add747465af3" xlink:to="loc_us-gaap_CommitmentsAndContingencies_53d4115f-c3d1-6e9c-3f23-fd144b27061e" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_effc14df-fd72-eec8-ede9-64e0071b91bc" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_39eaeb62-7ee3-5503-48f5-08c2dff05e50" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_effc14df-fd72-eec8-ede9-64e0071b91bc" xlink:to="loc_us-gaap_AssetsCurrent_39eaeb62-7ee3-5503-48f5-08c2dff05e50" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_eae794c2-73ec-cd91-efb3-99a2ff1f24cf" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_39eaeb62-7ee3-5503-48f5-08c2dff05e50" xlink:to="loc_us-gaap_InventoryNet_eae794c2-73ec-cd91-efb3-99a2ff1f24cf" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cd34decb-53b6-e0a9-28d5-0a9741c4b0f8" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_39eaeb62-7ee3-5503-48f5-08c2dff05e50" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cd34decb-53b6-e0a9-28d5-0a9741c4b0f8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesCurrent_222b5a74-9526-7448-da46-fccf1775d7c0" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_39eaeb62-7ee3-5503-48f5-08c2dff05e50" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesCurrent_222b5a74-9526-7448-da46-fccf1775d7c0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4d24e56f-a5cb-07ba-0508-f5f1533ae24e" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_39eaeb62-7ee3-5503-48f5-08c2dff05e50" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4d24e56f-a5cb-07ba-0508-f5f1533ae24e" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_DueFromUnconsolidatedJointBusiness" xlink:label="loc_biib_DueFromUnconsolidatedJointBusiness_cf573ba9-04a8-7ac8-507a-d4ecccd56637" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_39eaeb62-7ee3-5503-48f5-08c2dff05e50" xlink:to="loc_biib_DueFromUnconsolidatedJointBusiness_cf573ba9-04a8-7ac8-507a-d4ecccd56637" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_33278e4f-d71c-924a-f185-bd5aaa288d0b" xlink:type="locator" />
    <calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_39eaeb62-7ee3-5503-48f5-08c2dff05e50" xlink:to="loc_us-gaap_OtherAssetsCurrent_33278e4f-d71c-924a-f185-bd5aaa288d0b" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesNoncurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesNoncurrent_392a46ef-05fd-68f8-e487-35e85a8f15a1" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_effc14df-fd72-eec8-ede9-64e0071b91bc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesNoncurrent_392a46ef-05fd-68f8-e487-35e85a8f15a1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7ce178a4-245f-fa78-36a1-552609a67554" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_effc14df-fd72-eec8-ede9-64e0071b91bc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7ce178a4-245f-fa78-36a1-552609a67554" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_894a128f-2068-d267-1e3e-64c93d0ed5ca" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_effc14df-fd72-eec8-ede9-64e0071b91bc" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_894a128f-2068-d267-1e3e-64c93d0ed5ca" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_b108d604-1348-4e65-3817-2944b734c65a" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_effc14df-fd72-eec8-ede9-64e0071b91bc" xlink:to="loc_us-gaap_Goodwill_b108d604-1348-4e65-3817-2944b734c65a" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9b98e689-e6db-3e5b-e5c3-3324fffb4edf" xlink:type="locator" />
    <calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_effc14df-fd72-eec8-ede9-64e0071b91bc" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9b98e689-e6db-3e5b-e5c3-3324fffb4edf" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ff5db18e-7b91-5a5d-e914-0527b02a8012" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ff5db18e-7b91-5a5d-e914-0527b02a8012" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_bfab8b08-4541-18e9-28b5-5802fef422a3" xlink:type="locator" />
    <calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_bfab8b08-4541-18e9-28b5-5802fef422a3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_91d80b53-6368-7466-a11d-02030d33de5c" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_91d80b53-6368-7466-a11d-02030d33de5c" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_5f8983ec-dfa4-10d0-f53d-c0676300a16f" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_ProfitLoss_5f8983ec-dfa4-10d0-f53d-c0676300a16f" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_783b94c5-664a-4bc7-f813-8c258cc934b7" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_783b94c5-664a-4bc7-f813-8c258cc934b7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_d4c99b59-c44a-c4ac-309f-0bddfdb944a5" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_ShareBasedCompensation_d4c99b59-c44a-c4ac-309f-0bddfdb944a5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8b437d2d-6bbf-1f71-a341-6d3ac2b36703" xlink:type="locator" />
    <calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8b437d2d-6bbf-1f71-a341-6d3ac2b36703" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_8a9fbf97-3c14-4351-6d6b-553e136a9df1" xlink:type="locator" />
    <calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_8a9fbf97-3c14-4351-6d6b-553e136a9df1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_59947135-2495-391e-9e35-ed6effebb894" xlink:type="locator" />
    <calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_59947135-2495-391e-9e35-ed6effebb894" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1ea297cc-8653-7155-6fa9-a3af7df49950" xlink:type="locator" />
    <calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1ea297cc-8653-7155-6fa9-a3af7df49950" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_3eb22aca-47ee-3290-8d2e-e73a1c67010e" xlink:type="locator" />
    <calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_3eb22aca-47ee-3290-8d2e-e73a1c67010e" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_58a5bd26-e5f4-de8f-6118-f713733148b8" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ff5db18e-7b91-5a5d-e914-0527b02a8012" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_58a5bd26-e5f4-de8f-6118-f713733148b8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0ff68e79-9d67-8dd3-0a29-1b2e1239e793" xlink:type="locator" />
    <calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_58a5bd26-e5f4-de8f-6118-f713733148b8" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0ff68e79-9d67-8dd3-0a29-1b2e1239e793" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_11bab1ef-563b-9c08-d855-5223ff2c6591" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_58a5bd26-e5f4-de8f-6118-f713733148b8" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_11bab1ef-563b-9c08-d855-5223ff2c6591" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_198988d2-2f05-3f47-d4f0-bce81f98eaf0" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_58a5bd26-e5f4-de8f-6118-f713733148b8" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_198988d2-2f05-3f47-d4f0-bce81f98eaf0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_386292ff-155c-0309-455a-2b91b395b3da" xlink:type="locator" />
    <calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_58a5bd26-e5f4-de8f-6118-f713733148b8" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_386292ff-155c-0309-455a-2b91b395b3da" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4852d3ee-c33e-1b07-798c-41e651367343" xlink:type="locator" />
    <calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_58a5bd26-e5f4-de8f-6118-f713733148b8" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4852d3ee-c33e-1b07-798c-41e651367343" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_b6ed717f-2ece-aa81-6051-41cf1a876a59" xlink:type="locator" />
    <calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_58a5bd26-e5f4-de8f-6118-f713733148b8" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_b6ed717f-2ece-aa81-6051-41cf1a876a59" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ff5db18e-7b91-5a5d-e914-0527b02a8012" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_03b01b21-9333-5ba7-dbad-c8702c225fae" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_03b01b21-9333-5ba7-dbad-c8702c225fae" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_fdef3cb2-ec10-67c4-c0cc-b6e268faa4f7" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_fdef3cb2-ec10-67c4-c0cc-b6e268faa4f7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_9dbeb004-67a9-1b19-c357-8b5cbf0013ee" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_9dbeb004-67a9-1b19-c357-8b5cbf0013ee" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4c2e87e5-41d0-b35b-6dfd-e3ab5b253709" xlink:type="locator" />
    <calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4c2e87e5-41d0-b35b-6dfd-e3ab5b253709" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_038f4602-9abc-1f60-05a2-6f69306a77ae" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_640557c9-9806-6bef-9084-9cc792948f77" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_038f4602-9abc-1f60-05a2-6f69306a77ae" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_640557c9-9806-6bef-9084-9cc792948f77" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e716acb8-9d7f-1564-a267-c0491db420a5" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_640557c9-9806-6bef-9084-9cc792948f77" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e716acb8-9d7f-1564-a267-c0491db420a5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_8449f638-e094-e8fc-6726-9e09a5f21c54" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e716acb8-9d7f-1564-a267-c0491db420a5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_8449f638-e094-e8fc-6726-9e09a5f21c54" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_7443b8c0-35a8-1f56-7e6b-5e71bdbce930" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e716acb8-9d7f-1564-a267-c0491db420a5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_7443b8c0-35a8-1f56-7e6b-5e71bdbce930" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a8fa6c6f-a6dd-0012-f55c-e82fc2a06223" xlink:type="locator" />
    <calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e716acb8-9d7f-1564-a267-c0491db420a5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a8fa6c6f-a6dd-0012-f55c-e82fc2a06223" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fbd5cad0-09ca-a68e-f9d5-77ff2ba61ae4" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e716acb8-9d7f-1564-a267-c0491db420a5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fbd5cad0-09ca-a68e-f9d5-77ff2ba61ae4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_640557c9-9806-6bef-9084-9cc792948f77" xlink:to="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_560dfcb1-0fb6-5ffa-6e3b-8257ed923a94" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_038f4602-9abc-1f60-05a2-6f69306a77ae" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_560dfcb1-0fb6-5ffa-6e3b-8257ed923a94" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_5f8983ec-dfa4-10d0-f53d-c0676300a16f" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:to="loc_us-gaap_ProfitLoss_5f8983ec-dfa4-10d0-f53d-c0676300a16f" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f0ea1b66-a9f7-f42c-6882-4cca5faefea1" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_5f8983ec-dfa4-10d0-f53d-c0676300a16f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f0ea1b66-a9f7-f42c-6882-4cca5faefea1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_0ea1551e-1643-5e21-4c6e-6431fd87aa68" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f0ea1b66-a9f7-f42c-6882-4cca5faefea1" xlink:to="loc_us-gaap_OperatingIncomeLoss_0ea1551e-1643-5e21-4c6e-6431fd87aa68" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_ba59260a-e348-d7f8-5375-fde11baf79c1" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0ea1551e-1643-5e21-4c6e-6431fd87aa68" xlink:to="loc_us-gaap_Revenues_ba59260a-e348-d7f8-5375-fde11baf79c1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_ca646ab3-5159-77d2-80af-f70eebc0f27d" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_ba59260a-e348-d7f8-5375-fde11baf79c1" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_ca646ab3-5159-77d2-80af-f70eebc0f27d" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_UnconsolidatedJointBusiness" xlink:label="loc_biib_UnconsolidatedJointBusiness_9d7213e3-e33d-5fcd-5a5d-d4ecccc4667d" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_ba59260a-e348-d7f8-5375-fde11baf79c1" xlink:to="loc_biib_UnconsolidatedJointBusiness_9d7213e3-e33d-5fcd-5a5d-d4ecccc4667d" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="loc_us-gaap_OtherSalesRevenueNet_104a708e-80a2-fec9-83a4-0bfbe74de8c9" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_ba59260a-e348-d7f8-5375-fde11baf79c1" xlink:to="loc_us-gaap_OtherSalesRevenueNet_104a708e-80a2-fec9-83a4-0bfbe74de8c9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses_8281466b-86c7-ec9c-c7fc-3723705ba526" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0ea1551e-1643-5e21-4c6e-6431fd87aa68" xlink:to="loc_us-gaap_CostsAndExpenses_8281466b-86c7-ec9c-c7fc-3723705ba526" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaap_CostOfGoodsSold_47bf16bc-113d-838a-56d3-e154f0f2a154" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8281466b-86c7-ec9c-c7fc-3723705ba526" xlink:to="loc_us-gaap_CostOfGoodsSold_47bf16bc-113d-838a-56d3-e154f0f2a154" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_ec32a100-932a-145a-1c30-859c3cf9ce96" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8281466b-86c7-ec9c-c7fc-3723705ba526" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_ec32a100-932a-145a-1c30-859c3cf9ce96" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_37d23128-e0be-7b8b-d6c6-f3d1ac14cac9" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8281466b-86c7-ec9c-c7fc-3723705ba526" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_37d23128-e0be-7b8b-d6c6-f3d1ac14cac9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_682e13ed-74ef-f976-16fa-3796f1bc898f" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8281466b-86c7-ec9c-c7fc-3723705ba526" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_682e13ed-74ef-f976-16fa-3796f1bc898f" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_8d928bd0-3555-e21c-4646-ebe154fbdd5d" xlink:type="locator" />
    <calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8281466b-86c7-ec9c-c7fc-3723705ba526" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_8d928bd0-3555-e21c-4646-ebe154fbdd5d" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_GainOnSaleOfRights" xlink:label="loc_biib_GainOnSaleOfRights_c3d7f6e7-1c4d-b587-6955-d4ecccf10a0d" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0ea1551e-1643-5e21-4c6e-6431fd87aa68" xlink:to="loc_biib_GainOnSaleOfRights_c3d7f6e7-1c4d-b587-6955-d4ecccf10a0d" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_915682f7-b9cc-2ed3-6852-178ddfcb101f" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f0ea1b66-a9f7-f42c-6882-4cca5faefea1" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_915682f7-b9cc-2ed3-6852-178ddfcb101f" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b8dcf191-083d-828d-7b9f-e2d2969b89f4" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_5f8983ec-dfa4-10d0-f53d-c0676300a16f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b8dcf191-083d-828d-7b9f-e2d2969b89f4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b71b86f8-adb0-6f61-c3a9-37e1e67b4d68" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_5f8983ec-dfa4-10d0-f53d-c0676300a16f" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b71b86f8-adb0-6f61-c3a9-37e1e67b4d68" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6e1329dd-9911-a537-956e-8ca9c6805be6" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6e1329dd-9911-a537-956e-8ca9c6805be6" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.biogenidec.com/role/DerivativeInstruments" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/DerivativeInstrumentsDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/DerivativeInstrumentsTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/EarningsPerShare" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/EarningsPerShareDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ca9bebe4-4073-b721-7b75-1a0086593d58" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8afbf9ec-40f2-ac04-dde9-64f96fdfbf74" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ca9bebe4-4073-b721-7b75-1a0086593d58" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8afbf9ec-40f2-ac04-dde9-64f96fdfbf74" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_58a1745d-db2b-3ff9-104d-4b3f9664d3ce" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ca9bebe4-4073-b721-7b75-1a0086593d58" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_58a1745d-db2b-3ff9-104d-4b3f9664d3ce" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0449447d-2475-b5e7-892e-ced6d0229840" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_58a1745d-db2b-3ff9-104d-4b3f9664d3ce" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0449447d-2475-b5e7-892e-ced6d0229840" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.biogenidec.com/role/EarningsPerShareTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/Equity" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/EquityDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/EquityDetailsTextual" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/EquityTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurements" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_190f7f5c-4b8c-bf2f-74c0-cab5f1deb02f" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0fe5317b-bdcf-7a27-121f-55fe035264d7" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_190f7f5c-4b8c-bf2f-74c0-cab5f1deb02f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0fe5317b-bdcf-7a27-121f-55fe035264d7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_72dfc996-2bdc-a5c2-43c9-885b6330f5bb" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_190f7f5c-4b8c-bf2f-74c0-cab5f1deb02f" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_72dfc996-2bdc-a5c2-43c9-885b6330f5bb" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurementsDetails1" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurementsDetails2" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurementsDetailsTextual" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/FinancialInstruments" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAmortizedCost_fc1c6482-bc06-c49d-f5fe-3b9e6e37b9c3" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_a6e76a34-fa42-d66f-a2a4-5865ce92446b" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAmortizedCost_fc1c6482-bc06-c49d-f5fe-3b9e6e37b9c3" xlink:to="loc_us-gaap_AvailableForSaleSecurities_a6e76a34-fa42-d66f-a2a4-5865ce92446b" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d5cbedb3-d62c-f015-a49f-ef377e438819" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAmortizedCost_fc1c6482-bc06-c49d-f5fe-3b9e6e37b9c3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d5cbedb3-d62c-f015-a49f-ef377e438819" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_258c41aa-2b09-923b-df97-cb86ef48f935" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAmortizedCost_fc1c6482-bc06-c49d-f5fe-3b9e6e37b9c3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_258c41aa-2b09-923b-df97-cb86ef48f935" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsDetails1" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsDetails2" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9361d00b-bf28-09e2-175e-2f8c5c8d39ac" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0c84ece3-1f8c-2bb3-6d4d-e7a215e4c9c1" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9361d00b-bf28-09e2-175e-2f8c5c8d39ac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0c84ece3-1f8c-2bb3-6d4d-e7a215e4c9c1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0936fe34-b1c6-5f4e-1eee-fa338ed8b930" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9361d00b-bf28-09e2-175e-2f8c5c8d39ac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0936fe34-b1c6-5f4e-1eee-fa338ed8b930" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost" xlink:label="loc_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost_a142b19a-8793-4b19-f90e-d4ecccce4f97" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9361d00b-bf28-09e2-175e-2f8c5c8d39ac" xlink:to="loc_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost_a142b19a-8793-4b19-f90e-d4ecccce4f97" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_a6e76a34-fa42-d66f-a2a4-5865ce92446b" xlink:type="locator" />
    <loc xlink:href="biib-20150630.xsd#biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue" xlink:label="loc_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue_bf13782d-1724-0c45-a352-d4ecccf5eb0b" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecurities_a6e76a34-fa42-d66f-a2a4-5865ce92446b" xlink:to="loc_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue_bf13782d-1724-0c45-a352-d4ecccf5eb0b" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_73b022da-9054-5e1b-96dd-04e339313a48" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecurities_a6e76a34-fa42-d66f-a2a4-5865ce92446b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_73b022da-9054-5e1b-96dd-04e339313a48" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_465ba6e6-2b33-45fe-3e73-c5293643fc38" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecurities_a6e76a34-fa42-d66f-a2a4-5865ce92446b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_465ba6e6-2b33-45fe-3e73-c5293643fc38" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsDetails3" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsDetailsTextual" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsFinancialInstrumentsDetailsTextual2" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/IncomeTaxes" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/IncomeTaxesDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_037594ef-c95d-7169-0f2c-0d9bf9c6587e" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization_9c55f220-92b5-d322-b264-8565d6f98283" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_037594ef-c95d-7169-0f2c-0d9bf9c6587e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization_9c55f220-92b5-d322-b264-8565d6f98283" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_decf3e7b-8400-73a7-9168-2d6d4804b247" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_037594ef-c95d-7169-0f2c-0d9bf9c6587e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_decf3e7b-8400-73a7-9168-2d6d4804b247" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_acf5d13d-61d7-58c0-7f7b-a5c0f7cb7066" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_037594ef-c95d-7169-0f2c-0d9bf9c6587e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_acf5d13d-61d7-58c0-7f7b-a5c0f7cb7066" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_4b3be44f-5687-e783-ac34-c53c5c3f10e0" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_037594ef-c95d-7169-0f2c-0d9bf9c6587e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_4b3be44f-5687-e783-ac34-c53c5c3f10e0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_79b52493-ed4b-fb62-5daf-e1982275e67b" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_037594ef-c95d-7169-0f2c-0d9bf9c6587e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_79b52493-ed4b-fb62-5daf-e1982275e67b" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_b7dc579f-e75c-078b-3163-aa7cbf10455d" xlink:type="locator" />
    <calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_037594ef-c95d-7169-0f2c-0d9bf9c6587e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_b7dc579f-e75c-078b-3163-aa7cbf10455d" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_750737d4-a9f6-ddcb-7238-bbe8eadd7390" xlink:type="locator" />
    <calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_037594ef-c95d-7169-0f2c-0d9bf9c6587e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_750737d4-a9f6-ddcb-7238-bbe8eadd7390" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction" xlink:label="loc_biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction_827805f6-6e2a-818b-c1dc-d4eccd3a9153" xlink:type="locator" />
    <calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_037594ef-c95d-7169-0f2c-0d9bf9c6587e" xlink:to="loc_biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction_827805f6-6e2a-818b-c1dc-d4eccd3a9153" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.biogenidec.com/role/IncomeTaxesDetailsTextual" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/IncomeTaxesTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwill" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d1f67248-e9b5-f4cc-7b0f-6057f1a3d17a" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_37242da4-8bd9-8845-4f04-4d33ee3aa769" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d1f67248-e9b5-f4cc-7b0f-6057f1a3d17a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_37242da4-8bd9-8845-4f04-4d33ee3aa769" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5fad788a-33b8-6ace-c3c4-7d91cd9f63e4" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d1f67248-e9b5-f4cc-7b0f-6057f1a3d17a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5fad788a-33b8-6ace-c3c4-7d91cd9f63e4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0b66a991-68b5-43d2-3cb3-4ea68bba2b7e" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d1f67248-e9b5-f4cc-7b0f-6057f1a3d17a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0b66a991-68b5-43d2-3cb3-4ea68bba2b7e" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_894a128f-2068-d267-1e3e-64c93d0ed5ca" xlink:type="locator" />
    <calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_894a128f-2068-d267-1e3e-64c93d0ed5ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5fad788a-33b8-6ace-c3c4-7d91cd9f63e4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ba3ee58c-a1d2-0b1b-d8ba-aeea5e112c4e" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_894a128f-2068-d267-1e3e-64c93d0ed5ca" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ba3ee58c-a1d2-0b1b-d8ba-aeea5e112c4e" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_Finitelivedintangibleassetsfutureamortization" xlink:label="loc_biib_Finitelivedintangibleassetsfutureamortization_7f8164a6-3307-f223-f76d-d4ecccfc5814" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_d2ae3101-f749-ffd5-b93e-6f07027013ae" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_biib_Finitelivedintangibleassetsfutureamortization_7f8164a6-3307-f223-f76d-d4ecccfc5814" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_d2ae3101-f749-ffd5-b93e-6f07027013ae" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2249ecdd-108d-3264-e1fb-82dc2f8b7f93" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_biib_Finitelivedintangibleassetsfutureamortization_7f8164a6-3307-f223-f76d-d4ecccfc5814" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2249ecdd-108d-3264-e1fb-82dc2f8b7f93" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0395a918-3975-df2b-2aff-c690ea9ff6a6" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_biib_Finitelivedintangibleassetsfutureamortization_7f8164a6-3307-f223-f76d-d4ecccfc5814" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0395a918-3975-df2b-2aff-c690ea9ff6a6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_522cf592-49df-8430-14fb-ace2b07d08a6" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_biib_Finitelivedintangibleassetsfutureamortization_7f8164a6-3307-f223-f76d-d4ecccfc5814" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_522cf592-49df-8430-14fb-ace2b07d08a6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f9536b4e-5267-6ef8-a509-7c8008810f55" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_biib_Finitelivedintangibleassetsfutureamortization_7f8164a6-3307-f223-f76d-d4ecccfc5814" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f9536b4e-5267-6ef8-a509-7c8008810f55" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1435205b-5a1f-afbc-0b39-6d638729472e" xlink:type="locator" />
    <calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_biib_Finitelivedintangibleassetsfutureamortization_7f8164a6-3307-f223-f76d-d4ecccfc5814" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1435205b-5a1f-afbc-0b39-6d638729472e" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails1" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/Inventory" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/InventoryDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_eae794c2-73ec-cd91-efb3-99a2ff1f24cf" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_52e0aebe-a03f-09bd-b0a5-024dc9cc6bc5" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_eae794c2-73ec-cd91-efb3-99a2ff1f24cf" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_52e0aebe-a03f-09bd-b0a5-024dc9cc6bc5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8162f0c6-3901-3410-efb8-4a460fb9898c" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_eae794c2-73ec-cd91-efb3-99a2ff1f24cf" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8162f0c6-3901-3410-efb8-4a460fb9898c" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_67158a47-96e7-9b0f-c6d4-8e2f09cc69df" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_eae794c2-73ec-cd91-efb3-99a2ff1f24cf" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_67158a47-96e7-9b0f-c6d4-8e2f09cc69df" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.biogenidec.com/role/InventoryInventoryDetailsTextual" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/InventoryTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/InvestmentsInVariableInterestEntities" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/InvestmentsInVariableInterestEntitiesDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/Litigation" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/LitigationDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_915682f7-b9cc-2ed3-6852-178ddfcb101f" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_f41ffc72-ebad-5797-e151-38939dd37877" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_915682f7-b9cc-2ed3-6852-178ddfcb101f" xlink:to="loc_us-gaap_InvestmentIncomeInterest_f41ffc72-ebad-5797-e151-38939dd37877" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_8d3aa4ad-dbea-9eba-4578-5d3b83ba3bc6" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_915682f7-b9cc-2ed3-6852-178ddfcb101f" xlink:to="loc_us-gaap_InterestExpense_8d3aa4ad-dbea-9eba-4578-5d3b83ba3bc6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_a9b00820-766d-4f93-08eb-06a6be9e0e6b" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_915682f7-b9cc-2ed3-6852-178ddfcb101f" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_a9b00820-766d-4f93-08eb-06a6be9e0e6b" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_7d95006c-ae0a-39bc-bb82-9715342e9a83" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_915682f7-b9cc-2ed3-6852-178ddfcb101f" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_7d95006c-ae0a-39bc-bb82-9715342e9a83" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_51486ac3-3cfb-dff4-43ca-0d3980775a1d" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_915682f7-b9cc-2ed3-6852-178ddfcb101f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_51486ac3-3cfb-dff4-43ca-0d3980775a1d" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7f5c7cfd-4659-429c-35ab-266d67961421" xlink:type="locator" />
    <loc xlink:href="biib-20150630.xsd#biib_Employeerelatedliabilitiesnoncurrent" xlink:label="loc_biib_Employeerelatedliabilitiesnoncurrent_f92e99ca-128a-38fa-2b71-d4ecccd8d600" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_7f5c7cfd-4659-429c-35ab-266d67961421" xlink:to="loc_biib_Employeerelatedliabilitiesnoncurrent_f92e99ca-128a-38fa-2b71-d4ecccd8d600" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_966acde3-4f37-c9e4-23af-34b57d61d82f" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_7f5c7cfd-4659-429c-35ab-266d67961421" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_966acde3-4f37-c9e4-23af-34b57d61d82f" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_c1cdcecb-6358-aee2-3913-b09d3829a3a8" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_7f5c7cfd-4659-429c-35ab-266d67961421" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_c1cdcecb-6358-aee2-3913-b09d3829a3a8" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailOtherConsolidatedFinancialStatementDetailsTextual" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowances" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails1" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails1Calc2" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/ShareBasedPayments" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/ShareBasedPaymentsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_ed55a377-3e01-611f-cd7f-0fbe24ab1ea8" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_7668125b-8e16-a6bf-5206-b61c4942c5e3" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_ed55a377-3e01-611f-cd7f-0fbe24ab1ea8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_7668125b-8e16-a6bf-5206-b61c4942c5e3" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses" xlink:label="loc_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_33deb27f-5bc5-f719-f29b-d4eccd282105" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_ed55a377-3e01-611f-cd7f-0fbe24ab1ea8" xlink:to="loc_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_33deb27f-5bc5-f719-f29b-d4eccd282105" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.biogenidec.com/role/ShareBasedPaymentsDetails1" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/ShareBasedPaymentsDetails2" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/ShareBasedPaymentsDetailsTextual" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/ShareBasedPaymentsTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/SubsequentEventsSubsequentEvents" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/SubsequentEventsSubsequentEventsDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>biib-20150630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <roleRef roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLoss" xlink:href="biib-20150630.xsd#AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="biib-20150630.xsd#AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails1" xlink:href="biib-20150630.xsd#AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables" xlink:href="biib-20150630.xsd#AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitions" xlink:href="biib-20150630.xsd#AcquisitionsAcquisitions" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails" xlink:href="biib-20150630.xsd#AcquisitionsAcquisitionsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails1" xlink:href="biib-20150630.xsd#AcquisitionsAcquisitionsDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetailsTextual" xlink:href="biib-20150630.xsd#AcquisitionsAcquisitionsDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsTables" xlink:href="biib-20150630.xsd#AcquisitionsAcquisitionsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CollaborativeAndOtherRelationships" xlink:href="biib-20150630.xsd#CollaborativeAndOtherRelationships" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsEquityMethodInvestmentsDetails" xlink:href="biib-20150630.xsd#CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsEquityMethodInvestmentsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CommitmentsAndContingencesDetails" xlink:href="biib-20150630.xsd#CommitmentsAndContingencesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CommitmentsAndContingencies" xlink:href="biib-20150630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CommitmentsAndContingenciesCommitmentsAndContingenciesDetails1" xlink:href="biib-20150630.xsd#CommitmentsAndContingenciesCommitmentsAndContingenciesDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:href="biib-20150630.xsd#CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:href="biib-20150630.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="biib-20150630.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" xlink:href="biib-20150630.xsd#CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical" xlink:href="biib-20150630.xsd#CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited" xlink:href="biib-20150630.xsd#CondensedConsolidatedStatementsOfIncomeUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/DerivativeInstruments" xlink:href="biib-20150630.xsd#DerivativeInstruments" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/DerivativeInstrumentsDetails" xlink:href="biib-20150630.xsd#DerivativeInstrumentsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/DerivativeInstrumentsTables" xlink:href="biib-20150630.xsd#DerivativeInstrumentsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/DocumentAndEntityInformation" xlink:href="biib-20150630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EarningsPerShare" xlink:href="biib-20150630.xsd#EarningsPerShare" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EarningsPerShareDetails" xlink:href="biib-20150630.xsd#EarningsPerShareDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EarningsPerShareTables" xlink:href="biib-20150630.xsd#EarningsPerShareTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/Equity" xlink:href="biib-20150630.xsd#Equity" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EquityDetails" xlink:href="biib-20150630.xsd#EquityDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EquityDetailsTextual" xlink:href="biib-20150630.xsd#EquityDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EquityTables" xlink:href="biib-20150630.xsd#EquityTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurements" xlink:href="biib-20150630.xsd#FairValueMeasurements" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetails" xlink:href="biib-20150630.xsd#FairValueMeasurementsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetails1" xlink:href="biib-20150630.xsd#FairValueMeasurementsDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetails2" xlink:href="biib-20150630.xsd#FairValueMeasurementsDetails2" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetailsTextual" xlink:href="biib-20150630.xsd#FairValueMeasurementsDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurementsTables" xlink:href="biib-20150630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstruments" xlink:href="biib-20150630.xsd#FinancialInstruments" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails" xlink:href="biib-20150630.xsd#FinancialInstrumentsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails1" xlink:href="biib-20150630.xsd#FinancialInstrumentsDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails2" xlink:href="biib-20150630.xsd#FinancialInstrumentsDetails2" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails3" xlink:href="biib-20150630.xsd#FinancialInstrumentsDetails3" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetailsTextual" xlink:href="biib-20150630.xsd#FinancialInstrumentsDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsFinancialInstrumentsDetailsTextual2" xlink:href="biib-20150630.xsd#FinancialInstrumentsFinancialInstrumentsDetailsTextual2" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsTables" xlink:href="biib-20150630.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IncomeTaxes" xlink:href="biib-20150630.xsd#IncomeTaxes" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IncomeTaxesDetails" xlink:href="biib-20150630.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IncomeTaxesDetailsTextual" xlink:href="biib-20150630.xsd#IncomeTaxesDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IncomeTaxesTables" xlink:href="biib-20150630.xsd#IncomeTaxesTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwill" xlink:href="biib-20150630.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails" xlink:href="biib-20150630.xsd#IntangibleAssetsAndGoodwillDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails1" xlink:href="biib-20150630.xsd#IntangibleAssetsAndGoodwillDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillTables" xlink:href="biib-20150630.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/Inventory" xlink:href="biib-20150630.xsd#Inventory" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/InventoryDetails" xlink:href="biib-20150630.xsd#InventoryDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/InventoryInventoryDetailsTextual" xlink:href="biib-20150630.xsd#InventoryInventoryDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/InventoryTables" xlink:href="biib-20150630.xsd#InventoryTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/InvestmentsInVariableInterestEntities" xlink:href="biib-20150630.xsd#InvestmentsInVariableInterestEntities" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/InvestmentsInVariableInterestEntitiesDetails" xlink:href="biib-20150630.xsd#InvestmentsInVariableInterestEntitiesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/Litigation" xlink:href="biib-20150630.xsd#Litigation" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/LitigationDetails" xlink:href="biib-20150630.xsd#LitigationDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetail" xlink:href="biib-20150630.xsd#OtherConsolidatedFinancialStatementDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailDetails" xlink:href="biib-20150630.xsd#OtherConsolidatedFinancialStatementDetailDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailOtherConsolidatedFinancialStatementDetailsTextual" xlink:href="biib-20150630.xsd#OtherConsolidatedFinancialStatementDetailOtherConsolidatedFinancialStatementDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailTables" xlink:href="biib-20150630.xsd#OtherConsolidatedFinancialStatementDetailTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowances" xlink:href="biib-20150630.xsd#ReservesForDiscountsAndAllowances" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails" xlink:href="biib-20150630.xsd#ReservesForDiscountsAndAllowancesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails1" xlink:href="biib-20150630.xsd#ReservesForDiscountsAndAllowancesDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesTables" xlink:href="biib-20150630.xsd#ReservesForDiscountsAndAllowancesTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPayments" xlink:href="biib-20150630.xsd#ShareBasedPayments" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetails" xlink:href="biib-20150630.xsd#ShareBasedPaymentsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetails1" xlink:href="biib-20150630.xsd#ShareBasedPaymentsDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetails2" xlink:href="biib-20150630.xsd#ShareBasedPaymentsDetails2" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetailsTextual" xlink:href="biib-20150630.xsd#ShareBasedPaymentsDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsTables" xlink:href="biib-20150630.xsd#ShareBasedPaymentsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/SubsequentEventsSubsequentEvents" xlink:href="biib-20150630.xsd#SubsequentEventsSubsequentEvents" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/SubsequentEventsSubsequentEventsDetails" xlink:href="biib-20150630.xsd#SubsequentEventsSubsequentEventsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="biib-20150630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesDetails" xlink:href="biib-20150630.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="biib-20150630.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C65D719F9A07D12C96ADEC340EC2393" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_75543205564E67591B93DEC340EB16DA" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C65D719F9A07D12C96ADEC340EC2393" xlink:to="loc_us-gaap_StatementTable_75543205564E67591B93DEC340EB16DA" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3CED4FA8DB247515A8DADEC340EBB317" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_75543205564E67591B93DEC340EB16DA" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3CED4FA8DB247515A8DADEC340EBB317" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_6DCA3C5514C9AA145344DEC340EBAF3A_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3CED4FA8DB247515A8DADEC340EBB317" xlink:to="loc_us-gaap_EquityComponentDomain_6DCA3C5514C9AA145344DEC340EBAF3A_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_6DCA3C5514C9AA145344DEC340EBAF3A" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3CED4FA8DB247515A8DADEC340EBB317" xlink:to="loc_us-gaap_EquityComponentDomain_6DCA3C5514C9AA145344DEC340EBAF3A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_2EC98A35F2EB6E592425DEC340EB9491" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6DCA3C5514C9AA145344DEC340EBAF3A" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_2EC98A35F2EB6E592425DEC340EB9491" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_A83B8C0D86B5F019333DDEC340EB99CC" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6DCA3C5514C9AA145344DEC340EBAF3A" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_A83B8C0D86B5F019333DDEC340EB99CC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_A1565EC83CDAC888340CDEC340EC5B64" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6DCA3C5514C9AA145344DEC340EBAF3A" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_A1565EC83CDAC888340CDEC340EC5B64" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_DDAFD3CDAF31EDD53E78DEC340EC7DFA" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6DCA3C5514C9AA145344DEC340EBAF3A" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_DDAFD3CDAF31EDD53E78DEC340EC7DFA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9868D94022B94C2C9C96DEC340EC70F7" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C65D719F9A07D12C96ADEC340EC2393" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9868D94022B94C2C9C96DEC340EC70F7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4F54429D1294DE7171C9DEC340EC7F2D" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C65D719F9A07D12C96ADEC340EC2393" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4F54429D1294DE7171C9DEC340EC7F2D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_F2B8BB15C7B40F7DFC87DEC340EC4D17" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C65D719F9A07D12C96ADEC340EC2393" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_F2B8BB15C7B40F7DFC87DEC340EC4D17" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_30ED53B9CEEB06B028E2DEC340ECA6D0" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C65D719F9A07D12C96ADEC340EC2393" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_30ED53B9CEEB06B028E2DEC340ECA6D0" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_AC50B0FD4C13A43D5C12DEC3995B2281" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_150AB93CA86027479AD2DEC3995B284E" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_AC50B0FD4C13A43D5C12DEC3995B2281" xlink:to="loc_us-gaap_StatementTable_150AB93CA86027479AD2DEC3995B284E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9E9D6B1FE36019F6AFFBDEC3995B201E" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_150AB93CA86027479AD2DEC3995B284E" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9E9D6B1FE36019F6AFFBDEC3995B201E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_B61F13C57E7D51DAAAA0DEC3995BB9C4_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9E9D6B1FE36019F6AFFBDEC3995B201E" xlink:to="loc_us-gaap_EquityComponentDomain_B61F13C57E7D51DAAAA0DEC3995BB9C4_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_B61F13C57E7D51DAAAA0DEC3995BB9C4" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9E9D6B1FE36019F6AFFBDEC3995B201E" xlink:to="loc_us-gaap_EquityComponentDomain_B61F13C57E7D51DAAAA0DEC3995BB9C4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C12C206E3554B0DFCF1DEC3995B10B2" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_B61F13C57E7D51DAAAA0DEC3995BB9C4" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C12C206E3554B0DFCF1DEC3995B10B2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_E58D18D7CCD8F62CADA4DEC3995B1F3B" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_B61F13C57E7D51DAAAA0DEC3995BB9C4" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_E58D18D7CCD8F62CADA4DEC3995B1F3B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_D6ECAD56BC8DF7F75E8ADEC3995B45EE" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_150AB93CA86027479AD2DEC3995B284E" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_D6ECAD56BC8DF7F75E8ADEC3995B45EE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_92C179A5FAB899AA90F7DEC3995B8A40_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_D6ECAD56BC8DF7F75E8ADEC3995B45EE" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_92C179A5FAB899AA90F7DEC3995B8A40_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_92C179A5FAB899AA90F7DEC3995B8A40" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_D6ECAD56BC8DF7F75E8ADEC3995B45EE" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_92C179A5FAB899AA90F7DEC3995B8A40" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_464CB587FAAE36323B6CDEC3995B47D0" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_92C179A5FAB899AA90F7DEC3995B8A40" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_464CB587FAAE36323B6CDEC3995B47D0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5CAC7CE0C2960FC425F8DEC3995B345B" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_AC50B0FD4C13A43D5C12DEC3995B2281" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_5CAC7CE0C2960FC425F8DEC3995B345B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_E283839255A3E467249DDEC3995B5EB4" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_AC50B0FD4C13A43D5C12DEC3995B2281" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_E283839255A3E467249DDEC3995B5EB4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_7B970EEA650E6905CD6ADEC3995B15FD" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_AC50B0FD4C13A43D5C12DEC3995B2281" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_7B970EEA650E6905CD6ADEC3995B15FD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_FAEF36A4CB4983D5A270DEC3995B346A" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_AC50B0FD4C13A43D5C12DEC3995B2281" xlink:to="loc_us-gaap_NetIncomeLoss_FAEF36A4CB4983D5A270DEC3995B346A" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/AcquisitionsAcquisitions" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_CD7D903FE2D8F342517BDE109A95A9F3" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E508BCD5A4931DDDD185DE109A952F63" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_CD7D903FE2D8F342517BDE109A95A9F3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E508BCD5A4931DDDD185DE109A952F63" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6110A94010430F6B1736DE109A95437E" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E508BCD5A4931DDDD185DE109A952F63" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6110A94010430F6B1736DE109A95437E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2F1902BE056C1E8D24C2DE109A9531CB_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6110A94010430F6B1736DE109A95437E" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2F1902BE056C1E8D24C2DE109A9531CB_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2F1902BE056C1E8D24C2DE109A9531CB" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6110A94010430F6B1736DE109A95437E" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2F1902BE056C1E8D24C2DE109A9531CB" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ConvergencePharmaceuticalsMember" xlink:label="loc_biib_ConvergencePharmaceuticalsMember_F872C69C9A3E71B8199DDE109A958828" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2F1902BE056C1E8D24C2DE109A9531CB" xlink:to="loc_biib_ConvergencePharmaceuticalsMember_F872C69C9A3E71B8199DDE109A958828" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_05D3D5AD02AB5B286FA9DE109A9645CD" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_CD7D903FE2D8F342517BDE109A95A9F3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_05D3D5AD02AB5B286FA9DE109A9645CD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_EFECA8E22F29B7DC1E19DE11E2B31134" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_CD7D903FE2D8F342517BDE109A95A9F3" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_EFECA8E22F29B7DC1E19DE11E2B31134" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3FD7CE1D8201E1D5A2B4DE126779B083" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_CD7D903FE2D8F342517BDE109A95A9F3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3FD7CE1D8201E1D5A2B4DE126779B083" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_25E04F9B1B1467677092DE0CFBE3F9DD" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1B17148B2DCED5B2EE7EDE0CFBE371A6" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_25E04F9B1B1467677092DE0CFBE3F9DD" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1B17148B2DCED5B2EE7EDE0CFBE371A6" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_025643EEECB0AED14F42DE0CFBE3B750" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1B17148B2DCED5B2EE7EDE0CFBE371A6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_025643EEECB0AED14F42DE0CFBE3B750" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7CADEAEE1715B85FA1A3DE0CFBE3A4E6_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_025643EEECB0AED14F42DE0CFBE3B750" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7CADEAEE1715B85FA1A3DE0CFBE3A4E6_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7CADEAEE1715B85FA1A3DE0CFBE3A4E6" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_025643EEECB0AED14F42DE0CFBE3B750" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7CADEAEE1715B85FA1A3DE0CFBE3A4E6" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ConvergencePharmaceuticalsMember" xlink:label="loc_biib_ConvergencePharmaceuticalsMember_7E60A65A6B24E8A78A1ADE0CFBE3AD81" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7CADEAEE1715B85FA1A3DE0CFBE3A4E6" xlink:to="loc_biib_ConvergencePharmaceuticalsMember_7E60A65A6B24E8A78A1ADE0CFBE3AD81" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_E719472F3D1E6015822BDE0CFBE383E9" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_25E04F9B1B1467677092DE0CFBE3F9DD" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_E719472F3D1E6015822BDE0CFBE383E9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4C26DBF7067F1C0E1CD3DE0CFBE3649E" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_25E04F9B1B1467677092DE0CFBE3F9DD" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4C26DBF7067F1C0E1CD3DE0CFBE3649E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_F2D8773964007BAE81CCDE0CFBE343CF" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_25E04F9B1B1467677092DE0CFBE3F9DD" xlink:to="loc_us-gaap_Goodwill_F2D8773964007BAE81CCDE0CFBE343CF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_3037A293A4F0278615FDDE0CFBE3CDE0" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_25E04F9B1B1467677092DE0CFBE3F9DD" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_3037A293A4F0278615FDDE0CFBE3CDE0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_9B4B298C8DA91EE8A0C7DE0CFBE3155E" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_25E04F9B1B1467677092DE0CFBE3F9DD" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_9B4B298C8DA91EE8A0C7DE0CFBE3155E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_E219109129DD541FD7D3DE0CFBE3068E" xlink:type="locator" />
    <definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_25E04F9B1B1467677092DE0CFBE3F9DD" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_E219109129DD541FD7D3DE0CFBE3068E" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetailsTextual" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_AAC428C2F76C073EC7B2B1CA3927502D" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_AAC428C2F76C073EC7B2B1CA3927502D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4C497D984F16C1F83CCBB1CA3927AA3F_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_AAC428C2F76C073EC7B2B1CA3927502D" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4C497D984F16C1F83CCBB1CA3927AA3F_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4C497D984F16C1F83CCBB1CA3927AA3F" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_AAC428C2F76C073EC7B2B1CA3927502D" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4C497D984F16C1F83CCBB1CA3927AA3F" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ConvergencePharmaceuticalsMember" xlink:label="loc_biib_ConvergencePharmaceuticalsMember_EF694B669BBF78DF74D0B1CA3927DF4C" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4C497D984F16C1F83CCBB1CA3927AA3F" xlink:to="loc_biib_ConvergencePharmaceuticalsMember_EF694B669BBF78DF74D0B1CA3927DF4C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_D968A86CB6C7DE41BF8AB1CA39272213" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF" xlink:to="loc_us-gaap_ProductOrServiceAxis_D968A86CB6C7DE41BF8AB1CA39272213" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ProductOrServiceAxis_D968A86CB6C7DE41BF8AB1CA39272213" xlink:to="loc_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ProductOrServiceAxis_D968A86CB6C7DE41BF8AB1CA39272213" xlink:to="loc_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CNV1014802Member" xlink:label="loc_biib_CNV1014802Member_24751951D13CCC35C0AEB1CA392894C1" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346" xlink:to="loc_biib_CNV1014802Member_24751951D13CCC35C0AEB1CA392894C1" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_NeuropathicpainindicationsMember" xlink:label="loc_biib_NeuropathicpainindicationsMember_5F69208B988FC50DEE81B1CA3928FEA0" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346" xlink:to="loc_biib_NeuropathicpainindicationsMember_5F69208B988FC50DEE81B1CA3928FEA0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_18921EF4090E639A71CBB1CA39284500" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_18921EF4090E639A71CBB1CA39284500" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately" xlink:label="loc_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_FCC8C2F678E99AC85E9DB1CA39287F25" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_FCC8C2F678E99AC85E9DB1CA39287F25" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_05E070147C53310323AAB1CA39284BCB" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_05E070147C53310323AAB1CA39284BCB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_DED23CEFF460E961F8B5B1CA39282659" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_DED23CEFF460E961F8B5B1CA39282659" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_1780E4C2D0AEAC688FB7B1CA3928F1B5" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_1780E4C2D0AEAC688FB7B1CA3928F1B5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="loc_us-gaap_FairValueInputsDiscountRate_F9B59BB108C41D1AF07CB1CA3928E42E" xlink:type="locator" />
    <definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_us-gaap_FairValueInputsDiscountRate_F9B59BB108C41D1AF07CB1CA3928E42E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_F60C74BF72260371A776B1CA392816A3" xlink:type="locator" />
    <definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_F60C74BF72260371A776B1CA392816A3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_99C882F2F9E2A020BFCEB1CA39285788" xlink:type="locator" />
    <definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_99C882F2F9E2A020BFCEB1CA39285788" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/AcquisitionsAcquisitionsTables" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/CollaborativeAndOtherRelationships" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsEquityMethodInvestmentsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ED6E2379A512B8611EBED4ED4BD7475C" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ED6E2379A512B8611EBED4ED4BD7475C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_A1C8C4EEC60462059522D4ED4BD7942C" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ED6E2379A512B8611EBED4ED4BD7475C" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_A1C8C4EEC60462059522D4ED4BD7942C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityMethodInvesteeNameDomain" xlink:label="loc_us-gaap_EquityMethodInvesteeNameDomain_EC4107E0F0AF5B20FCC1D4ED4BD89CA0_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_A1C8C4EEC60462059522D4ED4BD7942C" xlink:to="loc_us-gaap_EquityMethodInvesteeNameDomain_EC4107E0F0AF5B20FCC1D4ED4BD89CA0_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityMethodInvesteeNameDomain" xlink:label="loc_us-gaap_EquityMethodInvesteeNameDomain_EC4107E0F0AF5B20FCC1D4ED4BD89CA0" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_A1C8C4EEC60462059522D4ED4BD7942C" xlink:to="loc_us-gaap_EquityMethodInvesteeNameDomain_EC4107E0F0AF5B20FCC1D4ED4BD89CA0" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_SamsungBiosimilarAgreementMember" xlink:label="loc_biib_SamsungBiosimilarAgreementMember_9DEB65368349330C1533D4ED4BD841E4" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvesteeNameDomain_EC4107E0F0AF5B20FCC1D4ED4BD89CA0" xlink:to="loc_biib_SamsungBiosimilarAgreementMember_9DEB65368349330C1533D4ED4BD841E4" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement" xlink:label="loc_biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement_207324B535E16D8A4B16D4ED4BD89551" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement_207324B535E16D8A4B16D4ED4BD89551" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_JointVentureOwnerShipPercentageByThirdParty" xlink:label="loc_biib_JointVentureOwnerShipPercentageByThirdParty_071DDB63F6E7B0DF79B5D4ED4BD88D58" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_biib_JointVentureOwnerShipPercentageByThirdParty_071DDB63F6E7B0DF79B5D4ED4BD88D58" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_2F7A3840C8B916FBAA87D4ED4BD8CC26" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_us-gaap_EquityMethodInvestments_2F7A3840C8B916FBAA87D4ED4BD8CC26" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1913B942AF6AB95931D5D4ED4BD853A3" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1913B942AF6AB95931D5D4ED4BD853A3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_DA1249D14801BC1FFF4FD4ED4BD8063D" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_DA1249D14801BC1FFF4FD4ED4BD8063D" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_EquityMethodInvestmentOwnershipPercentageMaximum" xlink:label="loc_biib_EquityMethodInvestmentOwnershipPercentageMaximum_872A902C54EEF6BA240AD4ED4BD8B377" xlink:type="locator" />
    <definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_biib_EquityMethodInvestmentOwnershipPercentageMaximum_872A902C54EEF6BA240AD4ED4BD8B377" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_739CF25652D8C9789EF0D4ED4BD802D7" xlink:type="locator" />
    <definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_739CF25652D8C9789EF0D4ED4BD802D7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_17854409963FD1E9A121D4ED4BD83E8A" xlink:type="locator" />
    <definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_17854409963FD1E9A121D4ED4BD83E8A" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AdditionalMilestonePayment" xlink:label="loc_biib_AdditionalMilestonePayment_1397FC60E3C7EEB0EE26D4ED4BD8F8D1" xlink:type="locator" />
    <definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_biib_AdditionalMilestonePayment_1397FC60E3C7EEB0EE26D4ED4BD8F8D1" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_EquityMethodInvestmentsExpectedProfitShare" xlink:label="loc_biib_EquityMethodInvestmentsExpectedProfitShare_74B56CFA3A39E42C0271D4ED4BD8E289" xlink:type="locator" />
    <definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_biib_EquityMethodInvestmentsExpectedProfitShare_74B56CFA3A39E42C0271D4ED4BD8E289" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="loc_us-gaap_OtherSalesRevenueNet_EB10FFC494F06650D3F2D4ED4BD8A06E" xlink:type="locator" />
    <definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_us-gaap_OtherSalesRevenueNet_EB10FFC494F06650D3F2D4ED4BD8A06E" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/CommitmentsAndContingencesDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="biib-20150630.xsd#biib_CumulativeSalesLevelAxis" xlink:label="loc_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:to="loc_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CumulativeSalesLevelDomain" xlink:label="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881" xlink:to="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD_default" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CumulativeSalesLevelDomain" xlink:label="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881" xlink:to="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_FourbillionMember" xlink:label="loc_biib_FourbillionMember_692FB14EC0F32391BFABD4ED4BB5111C" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:to="loc_biib_FourbillionMember_692FB14EC0F32391BFABD4ED4BB5111C" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_FivebillionMember" xlink:label="loc_biib_FivebillionMember_332481569C77EB7D7323D4ED4BB5B70F" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:to="loc_biib_FivebillionMember_332481569C77EB7D7323D4ED4BB5B70F" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_EachAdditionalOneBillionUpToTwentyBillionMember" xlink:label="loc_biib_EachAdditionalOneBillionUpToTwentyBillionMember_3E9BE8D5592079C75DEBD4ED4BB5040F" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:to="loc_biib_EachAdditionalOneBillionUpToTwentyBillionMember_3E9BE8D5592079C75DEBD4ED4BB5040F" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_OneBillionMember" xlink:label="loc_biib_OneBillionMember_BA01B70086152E91BFC6D4ED4BB50D16" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:to="loc_biib_OneBillionMember_BA01B70086152E91BFC6D4ED4BB50D16" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ThreeBillionMember" xlink:label="loc_biib_ThreeBillionMember_75C9CF7606AC472AC4FDD4ED4BB542A4" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:to="loc_biib_ThreeBillionMember_75C9CF7606AC472AC4FDD4ED4BB542A4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_628B331AF83EABE34839D4ED4BB52444" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_628B331AF83EABE34839D4ED4BB52444" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D815669C360FD0C1DD8AD4ED4BB5509E_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_628B331AF83EABE34839D4ED4BB52444" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D815669C360FD0C1DD8AD4ED4BB5509E_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D815669C360FD0C1DD8AD4ED4BB5509E" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_628B331AF83EABE34839D4ED4BB52444" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D815669C360FD0C1DD8AD4ED4BB5509E" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_FumapharmAgMember" xlink:label="loc_biib_FumapharmAgMember_6BE43698FB1DB4771027D4ED4BB58A30" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D815669C360FD0C1DD8AD4ED4BB5509E" xlink:to="loc_biib_FumapharmAgMember_6BE43698FB1DB4771027D4ED4BB58A30" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_1ABEE423828310DFC227D4ED4BB5EB73" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:to="loc_us-gaap_ProductOrServiceAxis_1ABEE423828310DFC227D4ED4BB5EB73" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_5AC405D6250550F86CD7D4ED4BB5E3F8_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ProductOrServiceAxis_1ABEE423828310DFC227D4ED4BB5EB73" xlink:to="loc_us-gaap_ProductsAndServicesDomain_5AC405D6250550F86CD7D4ED4BB5E3F8_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_5AC405D6250550F86CD7D4ED4BB5E3F8" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ProductOrServiceAxis_1ABEE423828310DFC227D4ED4BB5EB73" xlink:to="loc_us-gaap_ProductsAndServicesDomain_5AC405D6250550F86CD7D4ED4BB5E3F8" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_TecfideraMember" xlink:label="loc_biib_TecfideraMember_E4A5BDBDFCB2F7CAA570D4ED4BB59E8A" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_5AC405D6250550F86CD7D4ED4BB5E3F8" xlink:to="loc_biib_TecfideraMember_E4A5BDBDFCB2F7CAA570D4ED4BB59E8A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_15DDB72EE31BAF65D26AD4ED4BB61808" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_15DDB72EE31BAF65D26AD4ED4BB61808" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5992331E1F873CE806AD4ED4BB6CDA9" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5992331E1F873CE806AD4ED4BB6CDA9" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CumulativeSalesLevel" xlink:label="loc_biib_CumulativeSalesLevel_54168BA36403C369CC05D4ED4BB6924F" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741" xlink:to="loc_biib_CumulativeSalesLevel_54168BA36403C369CC05D4ED4BB6924F" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/CommitmentsAndContingencies" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/CommitmentsAndContingenciesCommitmentsAndContingenciesDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_367E393CFC108D310DAAB7340A8C1CE6" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_FC24B9B0169C0F9730ACB7340A8B4672" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_367E393CFC108D310DAAB7340A8C1CE6" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_FC24B9B0169C0F9730ACB7340A8B4672" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaap_StatementGeographicalAxis_F60F8373872558F4EF2FB7340A8BBA15" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_FC24B9B0169C0F9730ACB7340A8B4672" xlink:to="loc_us-gaap_StatementGeographicalAxis_F60F8373872558F4EF2FB7340A8BBA15" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_5C124D06AAA900802881B7340A8C763C_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementGeographicalAxis_F60F8373872558F4EF2FB7340A8BBA15" xlink:to="loc_us-gaap_SegmentGeographicalDomain_5C124D06AAA900802881B7340A8C763C_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_5C124D06AAA900802881B7340A8C763C" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementGeographicalAxis_F60F8373872558F4EF2FB7340A8BBA15" xlink:to="loc_us-gaap_SegmentGeographicalDomain_5C124D06AAA900802881B7340A8C763C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_CH" xlink:label="loc_country_CH_B97B099DEC6B69C1BED7B7340A8C2A03" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentGeographicalDomain_5C124D06AAA900802881B7340A8C763C" xlink:to="loc_country_CH_B97B099DEC6B69C1BED7B7340A8C2A03" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Land" xlink:label="loc_us-gaap_Land_4C393239BA1E6618117FB7340A8C87F8" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_367E393CFC108D310DAAB7340A8C1CE6" xlink:to="loc_us-gaap_Land_4C393239BA1E6618117FB7340A8C87F8" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/DerivativeInstruments" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/DerivativeInstrumentsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_787295BE833F77FC8631D4ED4B5BFA8D" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_787295BE833F77FC8631D4ED4B5BFA8D" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaap_CurrencyAxis_E5D344CE45838575B240D4ED4B5AB366" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:to="loc_us-gaap_CurrencyAxis_E5D344CE45838575B240D4ED4B5AB366" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CurrencyAxis_E5D344CE45838575B240D4ED4B5AB366" xlink:to="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CurrencyAxis_E5D344CE45838575B240D4ED4B5AB366" xlink:to="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_EUR" xlink:label="loc_currency_EUR_63B3E7E36C2123A215EFD4ED4B5A5543" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:to="loc_currency_EUR_63B3E7E36C2123A215EFD4ED4B5A5543" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_CAD" xlink:label="loc_currency_CAD_D0A32D57F9C92B650C91D4ED4B5A3239" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:to="loc_currency_CAD_D0A32D57F9C92B650C91D4ED4B5A3239" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_GBP" xlink:label="loc_currency_GBP_325FE05DF2BD342E256FD4ED4B5A3D60" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:to="loc_currency_GBP_325FE05DF2BD342E256FD4ED4B5A3D60" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_JPY" xlink:label="loc_currency_JPY_C0FA5024E47989BEEA2DD4ED4B5A3D1A" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:to="loc_currency_JPY_C0FA5024E47989BEEA2DD4ED4B5A3D1A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_AUD" xlink:label="loc_currency_AUD_37A046259A976EAE74DFD4ED4B5ABB8E" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:to="loc_currency_AUD_37A046259A976EAE74DFD4ED4B5ABB8E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4D57C11CD6BF825AF0CDD4ED4B5A0FE7" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4D57C11CD6BF825AF0CDD4ED4B5A0FE7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4D57C11CD6BF825AF0CDD4ED4B5A0FE7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4D57C11CD6BF825AF0CDD4ED4B5A0FE7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaap_SalesMember_CBA265A100FC2D384608D4ED4B5A74F3" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363" xlink:to="loc_us-gaap_SalesMember_CBA265A100FC2D384608D4ED4B5A74F3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_10DEF585FBA44B140919D4ED4B5A76E0" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_10DEF585FBA44B140919D4ED4B5A76E0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8F2AC0A40395954C3566D4ED4B5A5A61" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8F2AC0A40395954C3566D4ED4B5A5A61" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9F29738DF6A88650056AD4ED4B5A3CD6_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8F2AC0A40395954C3566D4ED4B5A5A61" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9F29738DF6A88650056AD4ED4B5A3CD6_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9F29738DF6A88650056AD4ED4B5A3CD6" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8F2AC0A40395954C3566D4ED4B5A5A61" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9F29738DF6A88650056AD4ED4B5A3CD6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_55DB65EE47E17BCC71BAD4ED4B5BDFAA" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9F29738DF6A88650056AD4ED4B5A3CD6" xlink:to="loc_us-gaap_ForeignExchangeContractMember_55DB65EE47E17BCC71BAD4ED4B5BDFAA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_B728CC373CE1D50C7177D4ED4B5BEA02" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_B728CC373CE1D50C7177D4ED4B5BEA02" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_BC52ABFA2B6ED560D76CD4ED4B5BC63E_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_B728CC373CE1D50C7177D4ED4B5BEA02" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_BC52ABFA2B6ED560D76CD4ED4B5BC63E_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_BC52ABFA2B6ED560D76CD4ED4B5BC63E" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_B728CC373CE1D50C7177D4ED4B5BEA02" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_BC52ABFA2B6ED560D76CD4ED4B5BC63E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherCurrentAssetsMember" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_2BD715A360241BDF7E68D4ED4B5B1696" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_BC52ABFA2B6ED560D76CD4ED4B5BC63E" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_2BD715A360241BDF7E68D4ED4B5B1696" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherInvestmentsMember" xlink:label="loc_us-gaap_OtherInvestmentsMember_FBF2DB0CA630B09B7321D4ED4B5B66FB" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_BC52ABFA2B6ED560D76CD4ED4B5BC63E" xlink:to="loc_us-gaap_OtherInvestmentsMember_FBF2DB0CA630B09B7321D4ED4B5B66FB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesMember" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_8C75C9C62E4C905B70CAD4ED4B5BF177" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_BC52ABFA2B6ED560D76CD4ED4B5BC63E" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_8C75C9C62E4C905B70CAD4ED4B5BF177" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_D8E8381E227F65503630D4ED4B5B522F" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_BC52ABFA2B6ED560D76CD4ED4B5BC63E" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_D8E8381E227F65503630D4ED4B5B522F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_3724493CC8DA8F9E9D49D4ED4B5BD24D" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:to="loc_us-gaap_HedgingDesignationAxis_3724493CC8DA8F9E9D49D4ED4B5BD24D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_3724493CC8DA8F9E9D49D4ED4B5BD24D" xlink:to="loc_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_3724493CC8DA8F9E9D49D4ED4B5BD24D" xlink:to="loc_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4435752E4D7397598BA9D4ED4B5B1F56" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4435752E4D7397598BA9D4ED4B5B1F56" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_41D6C827586978CCE3CFD4ED4B5B1780" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33" xlink:to="loc_us-gaap_NondesignatedMember_41D6C827586978CCE3CFD4ED4B5B1780" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeAssetFairValueNetAbstract" xlink:label="loc_us-gaap_DerivativeAssetFairValueNetAbstract_CCC7F6D95BC9CAE4389FD4ED4B5B0F10" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_787295BE833F77FC8631D4ED4B5BFA8D" xlink:to="loc_us-gaap_DerivativeAssetFairValueNetAbstract_CCC7F6D95BC9CAE4389FD4ED4B5B0F10" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_FFC1E2F2CA1451D76B8ED4ED4B5BF90F" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetFairValueNetAbstract_CCC7F6D95BC9CAE4389FD4ED4B5B0F10" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_FFC1E2F2CA1451D76B8ED4ED4B5BF90F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5F671231BB164232B337D4ED4B5C0453" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetFairValueNetAbstract_CCC7F6D95BC9CAE4389FD4ED4B5B0F10" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5F671231BB164232B337D4ED4B5C0453" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_DerivativeInstrumentsTextualAbstract" xlink:label="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_787295BE833F77FC8631D4ED4B5BFA8D" xlink:to="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeLowerRemainingMaturityRange1" xlink:label="loc_us-gaap_DerivativeLowerRemainingMaturityRange1_26AFBEBBEA296AF40D02D4ED4B5CBEE4" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_us-gaap_DerivativeLowerRemainingMaturityRange1_26AFBEBBEA296AF40D02D4ED4B5CBEE4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeHigherRemainingMaturityRange1" xlink:label="loc_us-gaap_DerivativeHigherRemainingMaturityRange1_4709E1E1B875A9894E1FD4ED4B5CCF78" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_us-gaap_DerivativeHigherRemainingMaturityRange1_4709E1E1B875A9894E1FD4ED4B5CCF78" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="loc_invest_DerivativeNotionalAmount_3F1C2437A7D213ACEFA3D4ED4B5C7AB2" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_invest_DerivativeNotionalAmount_3F1C2437A7D213ACEFA3D4ED4B5C7AB2" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax" xlink:label="loc_biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax_4F715EEFEF835B84273AD4ED4B5CCE85" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax_4F715EEFEF835B84273AD4ED4B5CCE85" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_8F00757D094CEE3704E8D4ED4B5C50C3" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_8F00757D094CEE3704E8D4ED4B5C50C3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_A7133ECB602F912EC3F0D4ED4B5C74FE" xlink:type="locator" />
    <definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_A7133ECB602F912EC3F0D4ED4B5C74FE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_D2E9352C84A1DF8CE207D4ED4B5CD2ED" xlink:type="locator" />
    <definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_D2E9352C84A1DF8CE207D4ED4B5CD2ED" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_D2E39B9A13F28980A6F0D4ED4B5C92AA" xlink:type="locator" />
    <definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_D2E39B9A13F28980A6F0D4ED4B5C92AA" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/DerivativeInstrumentsTables" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/EarningsPerShare" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/EarningsPerShareDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5376DD131B7A3DBE1DF6DEA10B9EDEA7" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5A64CC1EA7D82DD9971EDEA10B9EA550" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5376DD131B7A3DBE1DF6DEA10B9EDEA7" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5A64CC1EA7D82DD9971EDEA10B9EA550" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_AD64938197DE562A882FDEA10B9ECC34" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5A64CC1EA7D82DD9971EDEA10B9EA550" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_AD64938197DE562A882FDEA10B9ECC34" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_AD64938197DE562A882FDEA10B9ECC34" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_AD64938197DE562A882FDEA10B9ECC34" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_StockOptionsAndEmployeeStockPurchasePlanMember" xlink:label="loc_biib_StockOptionsAndEmployeeStockPurchasePlanMember_2E2DE22F4266CCE288DEDEA10B9E5E38" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0" xlink:to="loc_biib_StockOptionsAndEmployeeStockPurchasePlanMember_2E2DE22F4266CCE288DEDEA10B9E5E38" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_TimeVestedRestrictedStockUnitsMember" xlink:label="loc_biib_TimeVestedRestrictedStockUnitsMember_5C5BC22231CF9323CFFCDEA10B9EA7F5" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0" xlink:to="loc_biib_TimeVestedRestrictedStockUnitsMember_5C5BC22231CF9323CFFCDEA10B9EA7F5" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_MarketStockUnitsMember" xlink:label="loc_biib_MarketStockUnitsMember_5ED63919E84E581DB0C6DEA10B9E2084" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0" xlink:to="loc_biib_MarketStockUnitsMember_5ED63919E84E581DB0C6DEA10B9E2084" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_BasicAndDilutedEarningsPerShareAbstract" xlink:label="loc_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5376DD131B7A3DBE1DF6DEA10B9EDEA7" xlink:to="loc_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="loc_us-gaap_NetIncomeLossAbstract_B74946F5CF3FE72EEDD3DEC797A68E08" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19" xlink:to="loc_us-gaap_NetIncomeLossAbstract_B74946F5CF3FE72EEDD3DEC797A68E08" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_AB5B1CC24EF7C4FAEA9FDEC797A99CD8" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAbstract_B74946F5CF3FE72EEDD3DEC797A68E08" xlink:to="loc_us-gaap_NetIncomeLoss_AB5B1CC24EF7C4FAEA9FDEC797A99CD8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C002BB61CC6F0E4F89BCDEC808B322E8" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C002BB61CC6F0E4F89BCDEC808B322E8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_A080341C35CFB7223A4DDEC808B33CC0" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_A080341C35CFB7223A4DDEC808B33CC0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0ED2255CC06966555136DEC808B4EC4C" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_A080341C35CFB7223A4DDEC808B33CC0" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0ED2255CC06966555136DEC808B4EC4C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_47149D148DB513F40DADDEC808B4DCCE" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_A080341C35CFB7223A4DDEC808B33CC0" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_47149D148DB513F40DADDEC808B4DCCE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06A7C143CD3119B21E03DEC808B4CD8C" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06A7C143CD3119B21E03DEC808B4CD8C" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/EarningsPerShareTables" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/Equity" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/EquityDetails" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/EquityDetailsTextual" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/EquityTables" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurements" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BFE2BE4A3569F036496D4ED4B79E07D" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BFE2BE4A3569F036496D4ED4B79E07D" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3F420A63E1A6BD51BBBFD4ED4B77EC41" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3F420A63E1A6BD51BBBFD4ED4B77EC41" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3F420A63E1A6BD51BBBFD4ED4B77EC41" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3F420A63E1A6BD51BBBFD4ED4B77EC41" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_C73C572BBB2E22D4A1E1D4ED4B78AD1E" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_C73C572BBB2E22D4A1E1D4ED4B78AD1E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_CF59A14D69696973B8BED4ED4B78697E" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_CF59A14D69696973B8BED4ED4B78697E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_B2D9EE9CB62507CE22F4D4ED4B7839C3" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_B2D9EE9CB62507CE22F4D4ED4B7839C3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A57E86007D93D16CF343D4ED4B78E337" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A57E86007D93D16CF343D4ED4B78E337" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_727944FED3607E8BF378D4ED4B78EBC5_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A57E86007D93D16CF343D4ED4B78E337" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_727944FED3607E8BF378D4ED4B78EBC5_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_727944FED3607E8BF378D4ED4B78EBC5" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A57E86007D93D16CF343D4ED4B78E337" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_727944FED3607E8BF378D4ED4B78EBC5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_406890C909979751E0F6D4ED4B782705" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_727944FED3607E8BF378D4ED4B78EBC5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_406890C909979751E0F6D4ED4B782705" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_ABD0E6126B5F12975143D4ED4B7895E0" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_ABD0E6126B5F12975143D4ED4B7895E0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_ABD0E6126B5F12975143D4ED4B7895E0" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_ABD0E6126B5F12975143D4ED4B7895E0" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_11CA350A2A4AF10B7B0BD4ED4B78B81D" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_11CA350A2A4AF10B7B0BD4ED4B78B81D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_FFF75F698D9DC9D5AD10D4ED4B78124F" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_FFF75F698D9DC9D5AD10D4ED4B78124F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetBackedSecuritiesMember" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_162C69580FD5FDC6F6D0D4ED4B79F01E" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_162C69580FD5FDC6F6D0D4ED4B79F01E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_7539103107ECE2935B80D4ED4B790708" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BFE2BE4A3569F036496D4ED4B79E07D" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_7539103107ECE2935B80D4ED4B790708" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_7539103107ECE2935B80D4ED4B790708" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_92A3263B6F6D5335A841D4ED4B79CBD8" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_92A3263B6F6D5335A841D4ED4B79CBD8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_A9BA9FAE24BCD64FFC4DD4ED4B79FFC5" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:to="loc_us-gaap_AvailableForSaleSecurities_A9BA9FAE24BCD64FFC4DD4ED4B79FFC5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_8C9079D0621322E80590D4ED4B79B4F6" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_8C9079D0621322E80590D4ED4B79B4F6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_B2ED7F7E4A7C40506320D4ED4B79FBD9" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_B2ED7F7E4A7C40506320D4ED4B79FBD9" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_PlanAssetsForDeferredCompensationFairValueDisclosure" xlink:label="loc_biib_PlanAssetsForDeferredCompensationFairValueDisclosure_EFC1DD2764FF6F26EB51D4ED4B79BDF2" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:to="loc_biib_PlanAssetsForDeferredCompensationFairValueDisclosure_EFC1DD2764FF6F26EB51D4ED4B79BDF2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6600961CA4F8EA1CF787D4ED4B79AD64" xlink:type="locator" />
    <definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_6600961CA4F8EA1CF787D4ED4B79AD64" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_7539103107ECE2935B80D4ED4B790708" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_AA0886088669242687CFD4ED4B79B967" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_AA0886088669242687CFD4ED4B79B967" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_A92EA42202FFE95C114FD4ED4B799938" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_A92EA42202FFE95C114FD4ED4B799938" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_5013B0A407E147FD684DD4ED4B79282E" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_5013B0A407E147FD684DD4ED4B79282E" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurementsDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_41E3DFD6AD1E19F0CE89DEA10BF4A08E" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3" xlink:to="loc_us-gaap_DebtInstrumentTable_41E3DFD6AD1E19F0CE89DEA10BF4A08E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_DD3A001412E321779155DEA10BF451E0" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_41E3DFD6AD1E19F0CE89DEA10BF4A08E" xlink:to="loc_us-gaap_DebtInstrumentAxis_DD3A001412E321779155DEA10BF451E0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_DD3A001412E321779155DEA10BF451E0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_DD3A001412E321779155DEA10BF451E0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_NotesPayableToFumedicaMember" xlink:label="loc_biib_NotesPayableToFumedicaMember_61B81A0B8DDA9CAFAADDDEA10BF43017" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5" xlink:to="loc_biib_NotesPayableToFumedicaMember_61B81A0B8DDA9CAFAADDDEA10BF43017" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember" xlink:label="loc_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_2ACCD89813F0A541CB7EDEA10BF452A2" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5" xlink:to="loc_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_2ACCD89813F0A541CB7EDEA10BF452A2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayableFairValueDisclosure" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_08D52D231F57E3A7849EDEA5E62671F1" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3" xlink:to="loc_us-gaap_NotesPayableFairValueDisclosure_08D52D231F57E3A7849EDEA5E62671F1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable_54DF43BE375928F10D7DDEA5E628ABD4" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3" xlink:to="loc_us-gaap_NotesPayable_54DF43BE375928F10D7DDEA5E628ABD4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_54E889FD84A1E79D75C7DEA5E62AD0DD" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3" xlink:to="loc_us-gaap_DebtInstrumentFairValue_54E889FD84A1E79D75C7DEA5E62AD0DD" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurementsDetails2" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_BFE1A62CD2E031B931A7D4ED4B9E325B" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5776A1E721148908E34AD4ED4B9EC173" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_BFE1A62CD2E031B931A7D4ED4B9E325B" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5776A1E721148908E34AD4ED4B9EC173" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_050BB8F03D6370CA971ED4ED4B9E6205" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5776A1E721148908E34AD4ED4B9EC173" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_050BB8F03D6370CA971ED4ED4B9E6205" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_CDAA4148C51380907065D4ED4B9ED497_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_050BB8F03D6370CA971ED4ED4B9E6205" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_CDAA4148C51380907065D4ED4B9ED497_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_CDAA4148C51380907065D4ED4B9ED497" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_050BB8F03D6370CA971ED4ED4B9E6205" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_CDAA4148C51380907065D4ED4B9ED497" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_AC2366FAC469CBA31A90D4ED4B9E683F" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_CDAA4148C51380907065D4ED4B9ED497" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_AC2366FAC469CBA31A90D4ED4B9E683F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_79BEDD1D329223FB9444D4ED4B9EB371" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_BFE1A62CD2E031B931A7D4ED4B9E325B" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_79BEDD1D329223FB9444D4ED4B9EB371" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_78E838D2DB339FA78B23D4ED4B9F777D" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_BFE1A62CD2E031B931A7D4ED4B9E325B" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_78E838D2DB339FA78B23D4ED4B9F777D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AB818D1AED385C99FC95D4ED4B9FC558" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_BFE1A62CD2E031B931A7D4ED4B9E325B" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AB818D1AED385C99FC95D4ED4B9FC558" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_351C0CDD58C4FC47837FD4ED4B9F930D" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_BFE1A62CD2E031B931A7D4ED4B9E325B" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_351C0CDD58C4FC47837FD4ED4B9F930D" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurementsDetailsTextual" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8404BA6810FED2430816D4ED4AEEB552" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8404BA6810FED2430816D4ED4AEEB552" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_F78A024BE4691D006B5DD4ED4AEE3730" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8404BA6810FED2430816D4ED4AEEB552" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_F78A024BE4691D006B5DD4ED4AEE3730" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_485B838AD3814EB2CD72D4ED4AEF4FDF_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_F78A024BE4691D006B5DD4ED4AEE3730" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_485B838AD3814EB2CD72D4ED4AEF4FDF_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_485B838AD3814EB2CD72D4ED4AEF4FDF" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_F78A024BE4691D006B5DD4ED4AEE3730" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_485B838AD3814EB2CD72D4ED4AEF4FDF" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ConvergencePharmaceuticalsMember" xlink:label="loc_biib_ConvergencePharmaceuticalsMember_E6B0B0DD38457CACDA3DD4ED4AEF2FFC" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_485B838AD3814EB2CD72D4ED4AEF4FDF" xlink:to="loc_biib_ConvergencePharmaceuticalsMember_E6B0B0DD38457CACDA3DD4ED4AEF2FFC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_14CB2C95999FA69FE911D4ED4AEF7569" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8404BA6810FED2430816D4ED4AEEB552" xlink:to="loc_us-gaap_DebtInstrumentAxis_14CB2C95999FA69FE911D4ED4AEF7569" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_960568CFD75525F2670ED4ED4AEF9960_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_14CB2C95999FA69FE911D4ED4AEF7569" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_960568CFD75525F2670ED4ED4AEF9960_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_960568CFD75525F2670ED4ED4AEF9960" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_14CB2C95999FA69FE911D4ED4AEF7569" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_960568CFD75525F2670ED4ED4AEF9960" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember" xlink:label="loc_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_C7BDB378E29D80BD1A51D4ED4AEF727C" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_960568CFD75525F2670ED4ED4AEF9960" xlink:to="loc_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_C7BDB378E29D80BD1A51D4ED4AEF727C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_05231476781940512275D4ED4AEFF04B" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_us-gaap_AssetImpairmentCharges_05231476781940512275D4ED4AEFF04B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsChangesInValuationTechniques" xlink:label="loc_us-gaap_FairValueMeasurementsChangesInValuationTechniques_DF6854000D7B6A94C92DD4ED4AEFAA16" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_us-gaap_FairValueMeasurementsChangesInValuationTechniques_DF6854000D7B6A94C92DD4ED4AEFAA16" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1E6F980D15FFB430E648D4ED4AEF1532" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1E6F980D15FFB430E648D4ED4AEF1532" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_B60452F849ED23D73A81D4ED4AEFE03D" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_B60452F849ED23D73A81D4ED4AEFE03D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_64029F3D755DD17F4A1CD4ED4AEF47E8" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_64029F3D755DD17F4A1CD4ED4AEF47E8" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately" xlink:label="loc_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_31FB46AA4D466E0C7F19D4ED4AEFA66F" xlink:type="locator" />
    <definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_31FB46AA4D466E0C7F19D4ED4AEFA66F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="loc_us-gaap_FairValueInputsDiscountRate_584A15A0FDB52B67FC6CD4ED4AEF4B67" xlink:type="locator" />
    <definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_us-gaap_FairValueInputsDiscountRate_584A15A0FDB52B67FC6CD4ED4AEF4B67" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_AACE4F1AB1916E954C7DD4ED4AF0D4AC" xlink:type="locator" />
    <definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_AACE4F1AB1916E954C7DD4ED4AF0D4AC" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/FinancialInstruments" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_AC53FEF10D44A426955ADEB09F62E454" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_68EEF0132F6A3E66A9DDDEB09F61826A" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_AC53FEF10D44A426955ADEB09F62E454" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_68EEF0132F6A3E66A9DDDEB09F61826A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_75B0BB3E90F78B8AA7BBDEB09F6132F9" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_68EEF0132F6A3E66A9DDDEB09F61826A" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_75B0BB3E90F78B8AA7BBDEB09F6132F9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_75B0BB3E90F78B8AA7BBDEB09F6132F9" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_75B0BB3E90F78B8AA7BBDEB09F6132F9" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CorporateDebtSecuritiesCurrentMember" xlink:label="loc_biib_CorporateDebtSecuritiesCurrentMember_005AAC744B4863231CCDDEB09F62927D" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E" xlink:to="loc_biib_CorporateDebtSecuritiesCurrentMember_005AAC744B4863231CCDDEB09F62927D" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CorporateDebtSecuritiesNonCurrentMember" xlink:label="loc_biib_CorporateDebtSecuritiesNonCurrentMember_8414B333287A942AE461DEB09F62619F" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E" xlink:to="loc_biib_CorporateDebtSecuritiesNonCurrentMember_8414B333287A942AE461DEB09F62619F" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_GovernmentSecuritiesCurrentMember" xlink:label="loc_biib_GovernmentSecuritiesCurrentMember_99C9E29B49DF7D5C91C4DEB09F62D876" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E" xlink:to="loc_biib_GovernmentSecuritiesCurrentMember_99C9E29B49DF7D5C91C4DEB09F62D876" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_GovernmentSecuritiesNonCurrentMember" xlink:label="loc_biib_GovernmentSecuritiesNonCurrentMember_E370437F5FE692E3D17CDEB09F629114" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E" xlink:to="loc_biib_GovernmentSecuritiesNonCurrentMember_E370437F5FE692E3D17CDEB09F629114" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember" xlink:label="loc_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember_50D7BC74C8A96D9C0513DEB09F62C0BC" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E" xlink:to="loc_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember_50D7BC74C8A96D9C0513DEB09F62C0BC" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember" xlink:label="loc_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember_67190E498F3ED90BE787DEB09F62E09E" xlink:type="locator" />
    <definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E" xlink:to="loc_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember_67190E498F3ED90BE787DEB09F62E09E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaap_EquitySecuritiesMember_13528845E57A1DF731A7DEB1C5EA18C3" xlink:type="locator" />
    <definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E" xlink:to="loc_us-gaap_EquitySecuritiesMember_13528845E57A1DF731A7DEB1C5EA18C3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_D4AC48FB6950BF028E5DDEB09F62C7F9" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_AC53FEF10D44A426955ADEB09F62E454" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_D4AC48FB6950BF028E5DDEB09F62C7F9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_4DE8D504198BA2B31805DEB09F6271D1" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_D4AC48FB6950BF028E5DDEB09F62C7F9" xlink:to="loc_us-gaap_AvailableForSaleSecurities_4DE8D504198BA2B31805DEB09F6271D1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5E5887901989C7F701FBDEB09F624F6B" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_D4AC48FB6950BF028E5DDEB09F62C7F9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5E5887901989C7F701FBDEB09F624F6B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8100521E5030A14AED33DEB09F628BCF" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_D4AC48FB6950BF028E5DDEB09F62C7F9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8100521E5030A14AED33DEB09F628BCF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAmortizedCost_76245FD28CBC6692A881DEB09F62BFA3" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_D4AC48FB6950BF028E5DDEB09F62C7F9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAmortizedCost_76245FD28CBC6692A881DEB09F62BFA3" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_1CCF7866EB3AF7177FABDEB33F8BB4D4" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_DA3E64E7C16170C6AC53DEB33F8B8D44" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_1CCF7866EB3AF7177FABDEB33F8BB4D4" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_DA3E64E7C16170C6AC53DEB33F8B8D44" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_7563379A79B07CE5D39ADEB33F8B2942" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_DA3E64E7C16170C6AC53DEB33F8B8D44" xlink:to="loc_us-gaap_InvestmentTypeAxis_7563379A79B07CE5D39ADEB33F8B2942" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_3F4A3C31B8221811B42CDEB33F8BEA06_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_7563379A79B07CE5D39ADEB33F8B2942" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_3F4A3C31B8221811B42CDEB33F8BEA06_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_3F4A3C31B8221811B42CDEB33F8BEA06" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_7563379A79B07CE5D39ADEB33F8B2942" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_3F4A3C31B8221811B42CDEB33F8BEA06" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_121DB734F849BE9C3EB7DEB33F8B7715" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3F4A3C31B8221811B42CDEB33F8BEA06" xlink:to="loc_us-gaap_CommercialPaperMember_121DB734F849BE9C3EB7DEB33F8B7715" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RepurchaseAgreementsMember" xlink:label="loc_us-gaap_RepurchaseAgreementsMember_0319BF09A3EC6D2175A6DEB33F8BDC72" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3F4A3C31B8221811B42CDEB33F8BEA06" xlink:to="loc_us-gaap_RepurchaseAgreementsMember_0319BF09A3EC6D2175A6DEB33F8BDC72" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_2F663803CD132EF79482DEB33F8BED58" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3F4A3C31B8221811B42CDEB33F8BEA06" xlink:to="loc_us-gaap_MoneyMarketFundsMember_2F663803CD132EF79482DEB33F8BED58" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtSecuritiesMember" xlink:label="loc_us-gaap_DebtSecuritiesMember_CA87AC919FA9BFB20C78DEB33F8B5104" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3F4A3C31B8221811B42CDEB33F8BEA06" xlink:to="loc_us-gaap_DebtSecuritiesMember_CA87AC919FA9BFB20C78DEB33F8B5104" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValueAbstract" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_D0E69D6962470577CFF0DEB33F8BC507" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_1CCF7866EB3AF7177FABDEB33F8BB4D4" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_D0E69D6962470577CFF0DEB33F8BC507" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_52FA7B74D0B68020C02FDEB33F8B842B" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_D0E69D6962470577CFF0DEB33F8BC507" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_52FA7B74D0B68020C02FDEB33F8B842B" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsDetails2" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsDetails3" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsDetailsTextual" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsFinancialInstrumentsDetailsTextual2" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_D501520B817CDFEFC172B1DCEA1FFC9F" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8419B024564E8404BFEBB1DCEA1E59DE" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D501520B817CDFEFC172B1DCEA1FFC9F" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8419B024564E8404BFEBB1DCEA1E59DE" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_4624EFB02A7EC078D15EB1DCEA1E464C" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8419B024564E8404BFEBB1DCEA1E59DE" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_4624EFB02A7EC078D15EB1DCEA1E464C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_D536225E4CAB547BD3C8B1DCEA1F6B42_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_4624EFB02A7EC078D15EB1DCEA1E464C" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_D536225E4CAB547BD3C8B1DCEA1F6B42_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_D536225E4CAB547BD3C8B1DCEA1F6B42" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_4624EFB02A7EC078D15EB1DCEA1E464C" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_D536225E4CAB547BD3C8B1DCEA1F6B42" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_StrategicInvestmentsMember" xlink:label="loc_biib_StrategicInvestmentsMember_048890608606B482A22EB1DCEA1FBF6C" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_D536225E4CAB547BD3C8B1DCEA1F6B42" xlink:to="loc_biib_StrategicInvestmentsMember_048890608606B482A22EB1DCEA1FBF6C" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_StrategicInvestmentPortfolio" xlink:label="loc_biib_StrategicInvestmentPortfolio_41E6DACE672C81ADF8A3B1DCEA208FAE" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D501520B817CDFEFC172B1DCEA1FFC9F" xlink:to="loc_biib_StrategicInvestmentPortfolio_41E6DACE672C81ADF8A3B1DCEA208FAE" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsTables" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/IncomeTaxes" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/IncomeTaxesDetails" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/IncomeTaxesDetailsTextual" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_159C68ED76735566F9C4DEA10B7727AA" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_159C68ED76735566F9C4DEA10B7727AA" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaap_TaxPeriodAxis_860746713351A6F05094DEA10B77973A" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_159C68ED76735566F9C4DEA10B7727AA" xlink:to="loc_us-gaap_TaxPeriodAxis_860746713351A6F05094DEA10B77973A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_860746713351A6F05094DEA10B77973A" xlink:to="loc_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_860746713351A6F05094DEA10B77973A" xlink:to="loc_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxYear2007Member" xlink:label="loc_us-gaap_TaxYear2007Member_7CE988422CD297CD9237DEA10B77223C" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476" xlink:to="loc_us-gaap_TaxYear2007Member_7CE988422CD297CD9237DEA10B77223C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxYear2008Member" xlink:label="loc_us-gaap_TaxYear2008Member_7E5D11CD969DBB792824DEA10B773ABD" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476" xlink:to="loc_us-gaap_TaxYear2008Member_7E5D11CD969DBB792824DEA10B773ABD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxYear2009Member" xlink:label="loc_us-gaap_TaxYear2009Member_47B581C8941FDEB9FEEADEA10B773C04" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476" xlink:to="loc_us-gaap_TaxYear2009Member_47B581C8941FDEB9FEEADEA10B773C04" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_713DB3C0DD8246480B77DEA10B774641" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_713DB3C0DD8246480B77DEA10B774641" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_88955348035C5F9B0D96DEA10B7778F5" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_88955348035C5F9B0D96DEA10B7778F5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_BD956E1149970342B8EDDECA941EB691" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_BD956E1149970342B8EDDECA941EB691" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices" xlink:label="loc_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices_8165E761FCCB4D382E7ADEA10B78CAE7" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:to="loc_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices_8165E761FCCB4D382E7ADEA10B78CAE7" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/IncomeTaxesTables" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwill" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_086420AD222AAC6BCFE7DE9E115B17E7" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_086420AD222AAC6BCFE7DE9E115B17E7" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_DB7B50C2D001774BBE72DE9E115A010A" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_DB7B50C2D001774BBE72DE9E115A010A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_51460370DCE44187EAAFDE9E115A3B04_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_DB7B50C2D001774BBE72DE9E115A010A" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_51460370DCE44187EAAFDE9E115A3B04_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_51460370DCE44187EAAFDE9E115A3B04" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_DB7B50C2D001774BBE72DE9E115A010A" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_51460370DCE44187EAAFDE9E115A3B04" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ConvergencePharmaceuticalsMember" xlink:label="loc_biib_ConvergencePharmaceuticalsMember_1E71D81D323BB1790DF0DE9E115A56C7" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_51460370DCE44187EAAFDE9E115A3B04" xlink:to="loc_biib_ConvergencePharmaceuticalsMember_1E71D81D323BB1790DF0DE9E115A56C7" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_TysabriProductMember" xlink:label="loc_biib_TysabriProductMember_2B88A407CFA08F2F2481DE9E115A5A80" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_51460370DCE44187EAAFDE9E115A3B04" xlink:to="loc_biib_TysabriProductMember_2B88A407CFA08F2F2481DE9E115A5A80" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_36BD7858FFBDDD05BD39DE9E115A8000" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_36BD7858FFBDDD05BD39DE9E115A8000" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_36BD7858FFBDDD05BD39DE9E115A8000" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_36BD7858FFBDDD05BD39DE9E115A8000" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_18786B135B7CEAB6586BDE9E115A5EDB" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_18786B135B7CEAB6586BDE9E115A5EDB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_E906066BA6020A5543B0DE9E115A1CC4" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_E906066BA6020A5543B0DE9E115A1CC4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86813380AE43BC1E5BE6DE9E115A141D" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86813380AE43BC1E5BE6DE9E115A141D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86813380AE43BC1E5BE6DE9E115A141D" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86813380AE43BC1E5BE6DE9E115A141D" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_OutLicensedPatentsMember" xlink:label="loc_biib_OutLicensedPatentsMember_CFDB88EF086B018518C1DE9E115A6258" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949" xlink:to="loc_biib_OutLicensedPatentsMember_CFDB88EF086B018518C1DE9E115A6258" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_0F7EECD74927743E0C01DE9E115BD98C" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_0F7EECD74927743E0C01DE9E115BD98C" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_InLicensedPatentsMember" xlink:label="loc_biib_InLicensedPatentsMember_B2D0F1D290209CC6140BDE9E115BB096" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949" xlink:to="loc_biib_InLicensedPatentsMember_B2D0F1D290209CC6140BDE9E115BB096" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_F404217FB9318C7EB26FDE9E115B3AD7" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:to="loc_us-gaap_ProductOrServiceAxis_F404217FB9318C7EB26FDE9E115B3AD7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_EB345572BC0783236773DE9E115B9826_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ProductOrServiceAxis_F404217FB9318C7EB26FDE9E115B3AD7" xlink:to="loc_us-gaap_ProductsAndServicesDomain_EB345572BC0783236773DE9E115B9826_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_EB345572BC0783236773DE9E115B9826" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ProductOrServiceAxis_F404217FB9318C7EB26FDE9E115B3AD7" xlink:to="loc_us-gaap_ProductsAndServicesDomain_EB345572BC0783236773DE9E115B9826" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AVONEXMember" xlink:label="loc_biib_AVONEXMember_B8E9A51DB32D533C6B8EDE9E115BE1D2" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_EB345572BC0783236773DE9E115B9826" xlink:to="loc_biib_AVONEXMember_B8E9A51DB32D533C6B8EDE9E115BE1D2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_B29DEC769A323C35E6F8DE9E115B6B87" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:to="loc_us-gaap_RangeAxis_B29DEC769A323C35E6F8DE9E115B6B87" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_B29DEC769A323C35E6F8DE9E115B6B87" xlink:to="loc_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_B29DEC769A323C35E6F8DE9E115B6B87" xlink:to="loc_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_BC27783AAFA599DE9C41DE9E115BCA7C" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6" xlink:to="loc_us-gaap_MinimumMember_BC27783AAFA599DE9C41DE9E115BCA7C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_940809A63466F53766C7DE9E115BA2B1" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6" xlink:to="loc_us-gaap_MaximumMember_940809A63466F53766C7DE9E115BA2B1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_086420AD222AAC6BCFE7DE9E115B17E7" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0FBB889D181BE481BD60DE9E115BFF56" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0FBB889D181BE481BD60DE9E115BFF56" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_IndefiniteLivedIntangibleAssetsUsefulLife" xlink:label="loc_biib_IndefiniteLivedIntangibleAssetsUsefulLife_4A16125F74B672195EDDDE9E115BDF8C" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_biib_IndefiniteLivedIntangibleAssetsUsefulLife_4A16125F74B672195EDDDE9E115BDF8C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_86352CB02A79941AC242DE9E115B1A44" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_86352CB02A79941AC242DE9E115B1A44" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_D600447D01DF423BECD7DE9E115B2388" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_D600447D01DF423BECD7DE9E115B2388" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_155615B5CBD8A104E981DE9E115B19F0" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_155615B5CBD8A104E981DE9E115B19F0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_CA84C7805842F890007ADE9E115BF008" xlink:type="locator" />
    <definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_CA84C7805842F890007ADE9E115BF008" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_11BBDA22B795A4CBF251DE9E115B0B58" xlink:type="locator" />
    <definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_11BBDA22B795A4CBF251DE9E115B0B58" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_F452C9E4D9BF2E43FF08DE9E115C9679" xlink:type="locator" />
    <definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_F452C9E4D9BF2E43FF08DE9E115C9679" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_AD6204E90CA602702129DE9E115C228D" xlink:type="locator" />
    <definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_AD6204E90CA602702129DE9E115C228D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_67F52D1B2FE76FC2F2CADE9E115C181E" xlink:type="locator" />
    <definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_67F52D1B2FE76FC2F2CADE9E115C181E" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_97460C1B5E636C717AE8D4ED4B0074B6" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_97460C1B5E636C717AE8D4ED4B0074B6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_F0C91D7BB46709636CADD4ED4AFF4C74" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C" xlink:to="loc_us-gaap_ProductOrServiceAxis_F0C91D7BB46709636CADD4ED4AFF4C74" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_C2DD840C42E3E9C2B658D4ED4AFFC1E3_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ProductOrServiceAxis_F0C91D7BB46709636CADD4ED4AFF4C74" xlink:to="loc_us-gaap_ProductsAndServicesDomain_C2DD840C42E3E9C2B658D4ED4AFFC1E3_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_C2DD840C42E3E9C2B658D4ED4AFFC1E3" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ProductOrServiceAxis_F0C91D7BB46709636CADD4ED4AFF4C74" xlink:to="loc_us-gaap_ProductsAndServicesDomain_C2DD840C42E3E9C2B658D4ED4AFFC1E3" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_TecfideraMember" xlink:label="loc_biib_TecfideraMember_6318475A6D1FD28E75E5D4ED4AFF1668" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_C2DD840C42E3E9C2B658D4ED4AFFC1E3" xlink:to="loc_biib_TecfideraMember_6318475A6D1FD28E75E5D4ED4AFF1668" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_BD53C95A653021AE1C8BD4ED4AFFD733" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_BD53C95A653021AE1C8BD4ED4AFFD733" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6EA0124CAD039623783ED4ED4B0054C4_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_BD53C95A653021AE1C8BD4ED4AFFD733" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6EA0124CAD039623783ED4ED4B0054C4_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6EA0124CAD039623783ED4ED4B0054C4" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_BD53C95A653021AE1C8BD4ED4AFFD733" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6EA0124CAD039623783ED4ED4B0054C4" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_FumapharmAgMember" xlink:label="loc_biib_FumapharmAgMember_54DC52B995468C4DCB56D4ED4B005FDA" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6EA0124CAD039623783ED4ED4B0054C4" xlink:to="loc_biib_FumapharmAgMember_54DC52B995468C4DCB56D4ED4B005FDA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3089A30B005844353A94D4ED4B008AB9" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_97460C1B5E636C717AE8D4ED4B0074B6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3089A30B005844353A94D4ED4B008AB9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_B0C69B6257F12125CF68D4ED4B00E433" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_97460C1B5E636C717AE8D4ED4B0074B6" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_B0C69B6257F12125CF68D4ED4B00E433" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillTables" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/Inventory" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/InventoryDetails" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/InventoryInventoryDetailsTextual" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/InventoryTables" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/InvestmentsInVariableInterestEntities" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/InvestmentsInVariableInterestEntitiesDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_A429BC3F88778D836AF9D4ED4B32DDBA" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_59E826147670AEB69CA5D4ED4B320FA1" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_A429BC3F88778D836AF9D4ED4B32DDBA" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_59E826147670AEB69CA5D4ED4B320FA1" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis" xlink:label="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_4B1FAE014283FFEAF24AD4ED4B329118" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_59E826147670AEB69CA5D4ED4B320FA1" xlink:to="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_4B1FAE014283FFEAF24AD4ED4B329118" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassificationOfVariableInterestEntityDomain" xlink:label="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_443E92945B877EFF859DD4ED4B320E1F_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_4B1FAE014283FFEAF24AD4ED4B329118" xlink:to="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_443E92945B877EFF859DD4ED4B320E1F_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassificationOfVariableInterestEntityDomain" xlink:label="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_443E92945B877EFF859DD4ED4B320E1F" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_4B1FAE014283FFEAF24AD4ED4B329118" xlink:to="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_443E92945B877EFF859DD4ED4B320E1F" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_NeurimmuneMember" xlink:label="loc_biib_NeurimmuneMember_B1289199A8826B12494BD4ED4B32BCCF" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_443E92945B877EFF859DD4ED4B320E1F" xlink:to="loc_biib_NeurimmuneMember_B1289199A8826B12494BD4ED4B32BCCF" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_InvestmentInVariableInterestEntitiesTextualAbstract" xlink:label="loc_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_A429BC3F88778D836AF9D4ED4B32DDBA" xlink:to="loc_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement" xlink:label="loc_biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement_2653690F8A44554ED4F0D4ED4B32CB3E" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:to="loc_biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement_2653690F8A44554ED4F0D4ED4B32CB3E" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial" xlink:label="loc_biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial_EDB9A001105B082F9DD4D4ED4B323A29" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:to="loc_biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial_EDB9A001105B082F9DD4D4ED4B323A29" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_AE52B00D8CBBF7248DCCD4ED4B3288E1" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_AE52B00D8CBBF7248DCCD4ED4B3288E1" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities" xlink:label="loc_biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities_96EDC688ED36480F5E33D4ED4B32864C" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:to="loc_biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities_96EDC688ED36480F5E33D4ED4B32864C" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/Litigation" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/LitigationDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_912D53441D564E5D1B367489D2EA4F6B" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_B0B5BFF64CC42197BC5B7489D2E99E52" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_912D53441D564E5D1B367489D2EA4F6B" xlink:to="loc_us-gaap_LossContingenciesTable_B0B5BFF64CC42197BC5B7489D2E99E52" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaap_StatementGeographicalAxis_392E7D606883CD05ADD27489D2E91B0A" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_B0B5BFF64CC42197BC5B7489D2E99E52" xlink:to="loc_us-gaap_StatementGeographicalAxis_392E7D606883CD05ADD27489D2E91B0A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_47C3F688F9D27C1E700E7489D2EA27C1_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementGeographicalAxis_392E7D606883CD05ADD27489D2E91B0A" xlink:to="loc_us-gaap_SegmentGeographicalDomain_47C3F688F9D27C1E700E7489D2EA27C1_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_47C3F688F9D27C1E700E7489D2EA27C1" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementGeographicalAxis_392E7D606883CD05ADD27489D2E91B0A" xlink:to="loc_us-gaap_SegmentGeographicalDomain_47C3F688F9D27C1E700E7489D2EA27C1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_IT" xlink:label="loc_country_IT_22E43D11B9274F01F4247489D2EA0773" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentGeographicalDomain_47C3F688F9D27C1E700E7489D2EA27C1" xlink:to="loc_country_IT_22E43D11B9274F01F4247489D2EA0773" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ReimbursementLimitStatedInResolution" xlink:label="loc_biib_ReimbursementLimitStatedInResolution_CD91E94EDA3FAFCB3E077489D2EAEFC3" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_912D53441D564E5D1B367489D2EA4F6B" xlink:to="loc_biib_ReimbursementLimitStatedInResolution_CD91E94EDA3FAFCB3E077489D2EAEFC3" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetail" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_9189AB37DEB782C4A2B4B72E3D713F32" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_FF4458DB49BF131E0267B72E3D6B4730" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9189AB37DEB782C4A2B4B72E3D713F32" xlink:to="loc_us-gaap_StatementTable_FF4458DB49BF131E0267B72E3D6B4730" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_F9CBCEE3D80C9FE0A070B72E3D6B812A" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_FF4458DB49BF131E0267B72E3D6B4730" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_F9CBCEE3D80C9FE0A070B72E3D6B812A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3981BCAFC69B727C7197B72E3D7161D8_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_F9CBCEE3D80C9FE0A070B72E3D6B812A" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3981BCAFC69B727C7197B72E3D7161D8_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3981BCAFC69B727C7197B72E3D7161D8" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_F9CBCEE3D80C9FE0A070B72E3D6B812A" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3981BCAFC69B727C7197B72E3D7161D8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_F15E93BB90651EDAFEB0B72E3D7157BF" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3981BCAFC69B727C7197B72E3D7161D8" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_F15E93BB90651EDAFEB0B72E3D7157BF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaap_PrepaidTaxes_26B1F8067FBA9E49362AB7338FB5AD8B" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9189AB37DEB782C4A2B4B72E3D713F32" xlink:to="loc_us-gaap_PrepaidTaxes_26B1F8067FBA9E49362AB7338FB5AD8B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_49F0CA153F80C32DD115B72E3D775F85" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DB3AF38B044E46309EFAB72E3D7742CA" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49F0CA153F80C32DD115B72E3D775F85" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DB3AF38B044E46309EFAB72E3D7742CA" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_94A969339FD6E292613BB72E3D77840E" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DB3AF38B044E46309EFAB72E3D7742CA" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_94A969339FD6E292613BB72E3D77840E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ACDF43FB2BDF09F691EB72E3D77B2A0_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_94A969339FD6E292613BB72E3D77840E" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ACDF43FB2BDF09F691EB72E3D77B2A0_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ACDF43FB2BDF09F691EB72E3D77B2A0" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_94A969339FD6E292613BB72E3D77840E" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ACDF43FB2BDF09F691EB72E3D77B2A0" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ConvergencePharmaceuticalsMember" xlink:label="loc_biib_ConvergencePharmaceuticalsMember_C428ADDF907E34E1DCFFB72E3D770D39" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ACDF43FB2BDF09F691EB72E3D77B2A0" xlink:to="loc_biib_ConvergencePharmaceuticalsMember_C428ADDF907E34E1DCFFB72E3D770D39" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1179F0E20E13DDB76F0BB72E3D77A01C" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49F0CA153F80C32DD115B72E3D775F85" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_1179F0E20E13DDB76F0BB72E3D77A01C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_7B2F9BB1CA1551377346B72E3D77985A" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49F0CA153F80C32DD115B72E3D775F85" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_7B2F9BB1CA1551377346B72E3D77985A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_937F22AD636C7478A3C5B72E3D773ED6" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49F0CA153F80C32DD115B72E3D775F85" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_937F22AD636C7478A3C5B72E3D773ED6" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailOtherConsolidatedFinancialStatementDetailsTextual" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductLiabilityContingencyTable" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_DCE0203777C31D2F0F177489D32F9A9E" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_DCE0203777C31D2F0F177489D32F9A9E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaap_StatementGeographicalAxis_1DB64EE5F84B675C67997489D32FBDBA" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_DCE0203777C31D2F0F177489D32F9A9E" xlink:to="loc_us-gaap_StatementGeographicalAxis_1DB64EE5F84B675C67997489D32FBDBA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_3F451AAB1383E94A7E6A7489D3340BE1_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementGeographicalAxis_1DB64EE5F84B675C67997489D32FBDBA" xlink:to="loc_us-gaap_SegmentGeographicalDomain_3F451AAB1383E94A7E6A7489D3340BE1_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_3F451AAB1383E94A7E6A7489D3340BE1" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementGeographicalAxis_1DB64EE5F84B675C67997489D32FBDBA" xlink:to="loc_us-gaap_SegmentGeographicalDomain_3F451AAB1383E94A7E6A7489D3340BE1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_IT" xlink:label="loc_country_IT_0D2D8066ADD644296BA57489D33412C4" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentGeographicalDomain_3F451AAB1383E94A7E6A7489D3340BE1" xlink:to="loc_country_IT_0D2D8066ADD644296BA57489D33412C4" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ReimbursementLimitStatedInResolution" xlink:label="loc_biib_ReimbursementLimitStatedInResolution_205553BF9148DCA2ACFA7489D334BCF8" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:to="loc_biib_ReimbursementLimitStatedInResolution_205553BF9148DCA2ACFA7489D334BCF8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_1DE57D75A39C5BC0078F7489D334471D" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_1DE57D75A39C5BC0078F7489D334471D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_F4E17687C59353D30B327489D33449F9" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_F4E17687C59353D30B327489D33449F9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent" xlink:label="loc_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_CBAA6412D5F0515B8C2E7489D334EA22" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:to="loc_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_CBAA6412D5F0515B8C2E7489D334EA22" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailTables" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowances" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_69EAC835A9D3EAE5E835DE175DDDB529" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_45191AF2AE2F19CF8451DE175DDDEF7C" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_69EAC835A9D3EAE5E835DE175DDDB529" xlink:to="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_45191AF2AE2F19CF8451DE175DDDEF7C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_DCEC228DEB62D65467A1DE175DDD2D48" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_45191AF2AE2F19CF8451DE175DDDEF7C" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_DCEC228DEB62D65467A1DE175DDD2D48" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_D6C8579C41D21FF9AA46DE175DDDB01B_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_DCEC228DEB62D65467A1DE175DDD2D48" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_D6C8579C41D21FF9AA46DE175DDDB01B_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_D6C8579C41D21FF9AA46DE175DDDB01B" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_DCEC228DEB62D65467A1DE175DDD2D48" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_D6C8579C41D21FF9AA46DE175DDDB01B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReserveForCashDiscountMember" xlink:label="loc_us-gaap_ReserveForCashDiscountMember_8FA010C82D125F34B469DE175DDD0AD7" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_D6C8579C41D21FF9AA46DE175DDDB01B" xlink:to="loc_us-gaap_ReserveForCashDiscountMember_8FA010C82D125F34B469DE175DDD0AD7" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ContractualAdjustmentsMember" xlink:label="loc_biib_ContractualAdjustmentsMember_4C733E000A386C42D48DDE175DDDDB16" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_D6C8579C41D21FF9AA46DE175DDDB01B" xlink:to="loc_biib_ContractualAdjustmentsMember_4C733E000A386C42D48DDE175DDDDB16" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesReturnsAndAllowancesMember" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember_D385ECD612A17AE95DFDDE175DDDF11D" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_D6C8579C41D21FF9AA46DE175DDDB01B" xlink:to="loc_us-gaap_SalesReturnsAndAllowancesMember_D385ECD612A17AE95DFDDE175DDDF11D" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract" xlink:label="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_69EAC835A9D3EAE5E835DE175DDDB529" xlink:to="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_3164B1E35283559DACF6DE175DDEFB2F" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_3164B1E35283559DACF6DE175DDEFB2F" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear" xlink:label="loc_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear_98AB5F007D6ACEEF14FEDE175DDE863D" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF" xlink:to="loc_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear_98AB5F007D6ACEEF14FEDE175DDE863D" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears" xlink:label="loc_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears_C784A5B777626B2A0EBEDE175DDEE96C" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF" xlink:to="loc_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears_C784A5B777626B2A0EBEDE175DDEE96C" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear" xlink:label="loc_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear_3BEA06C0033D3CAFFFD9DE175DDE2636" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF" xlink:to="loc_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear_3BEA06C0033D3CAFFFD9DE175DDE2636" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear" xlink:label="loc_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear_28E7837D78E3D8D3FB8BDE175DDEA668" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF" xlink:to="loc_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear_28E7837D78E3D8D3FB8BDE175DDEA668" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_E8720FFF918777470F31DE183B2A9D11" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_55326C6BB9992A8E1AAEDE183B2A5BFC" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_E8720FFF918777470F31DE183B2A9D11" xlink:to="loc_us-gaap_StatementTable_55326C6BB9992A8E1AAEDE183B2A5BFC" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_A7E14808A7A82B491566DE183B2AE56F" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_55326C6BB9992A8E1AAEDE183B2A5BFC" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_A7E14808A7A82B491566DE183B2AE56F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_454E13EF8C0299F3FD0EDE183B2A6ACC_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_A7E14808A7A82B491566DE183B2AE56F" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_454E13EF8C0299F3FD0EDE183B2A6ACC_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_454E13EF8C0299F3FD0EDE183B2A6ACC" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_A7E14808A7A82B491566DE183B2AE56F" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_454E13EF8C0299F3FD0EDE183B2A6ACC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_860A49C6DA8D1F43C997DE183B2AA15F" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_454E13EF8C0299F3FD0EDE183B2A6ACC" xlink:to="loc_us-gaap_AccountsReceivableMember_860A49C6DA8D1F43C997DE183B2AA15F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_963254416FAFEB86E734DE183B2A16C3" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_454E13EF8C0299F3FD0EDE183B2A6ACC" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_963254416FAFEB86E734DE183B2A16C3" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract" xlink:label="loc_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract_CF092EEECA0DC1159FE3DE183B2A6B2C" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_E8720FFF918777470F31DE183B2A9D11" xlink:to="loc_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract_CF092EEECA0DC1159FE3DE183B2A6B2C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_F669D93EB8C9CA6C4377DE183B2AF952" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract_CF092EEECA0DC1159FE3DE183B2A6B2C" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_F669D93EB8C9CA6C4377DE183B2AF952" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesTables" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/ShareBasedPayments" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/ShareBasedPaymentsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_27064A8B9F7391BD7E27D4ED4B36D684" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_C5DDB6F8D1528FA5E509D4ED4B36D28A" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_27064A8B9F7391BD7E27D4ED4B36D684" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_C5DDB6F8D1528FA5E509D4ED4B36D28A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_D6367ADBD1B79E1C4D5BD4ED4B36F9CC" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_C5DDB6F8D1528FA5E509D4ED4B36D28A" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_D6367ADBD1B79E1C4D5BD4ED4B36F9CC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_CFE44C5C3B819804F9C9D4ED4B36E5F3_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_D6367ADBD1B79E1C4D5BD4ED4B36F9CC" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_CFE44C5C3B819804F9C9D4ED4B36E5F3_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_CFE44C5C3B819804F9C9D4ED4B36E5F3" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_D6367ADBD1B79E1C4D5BD4ED4B36F9CC" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_CFE44C5C3B819804F9C9D4ED4B36E5F3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_0A16BFDD56F2FCFA0726D4ED4B369DD4" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_CFE44C5C3B819804F9C9D4ED4B36E5F3" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_0A16BFDD56F2FCFA0726D4ED4B369DD4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6423EC869C881A512F9ED4ED4B36F45E" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_CFE44C5C3B819804F9C9D4ED4B36E5F3" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6423EC869C881A512F9ED4ED4B36F45E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ParentMember" xlink:label="loc_us-gaap_ParentMember_98D90735A12C2A73862FD4ED4B3618CE" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_CFE44C5C3B819804F9C9D4ED4B36E5F3" xlink:to="loc_us-gaap_ParentMember_98D90735A12C2A73862FD4ED4B3618CE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_27064A8B9F7391BD7E27D4ED4B36D684" xlink:to="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2F3B66D9779A4379C7FAD4ED4B373018" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2F3B66D9779A4379C7FAD4ED4B373018" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_20E102D74AA5F0A174FED4ED4B3749CB" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_20E102D74AA5F0A174FED4ED4B3749CB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_B590D976E8B20ED0FBB4D4ED4B379445" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_B590D976E8B20ED0FBB4D4ED4B379445" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses" xlink:label="loc_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_4F5AF64204B06EEC48A6D4ED4B37879C" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:to="loc_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_4F5AF64204B06EEC48A6D4ED4B37879C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_D814D5899BCC573DEF17D4ED4B37D109" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_D814D5899BCC573DEF17D4ED4B37D109" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/ShareBasedPaymentsDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1464EA0C1384DE90337FD4ED4BAFC978" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8C75F8E989239EBD5EBFD4ED4BAE047B" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1464EA0C1384DE90337FD4ED4BAFC978" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8C75F8E989239EBD5EBFD4ED4BAE047B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_3764085253B8C5FC42A8D4ED4BAF9AC0" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8C75F8E989239EBD5EBFD4ED4BAE047B" xlink:to="loc_us-gaap_PlanNameAxis_3764085253B8C5FC42A8D4ED4BAF9AC0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3764085253B8C5FC42A8D4ED4BAF9AC0" xlink:to="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3764085253B8C5FC42A8D4ED4BAF9AC0" xlink:to="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_MarketStockUnitsMember" xlink:label="loc_biib_MarketStockUnitsMember_21355C156AAF67F86D98D4ED4BAFAD6F" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E" xlink:to="loc_biib_MarketStockUnitsMember_21355C156AAF67F86D98D4ED4BAFAD6F" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_TimeVestedRestrictedStockUnitsMember" xlink:label="loc_biib_TimeVestedRestrictedStockUnitsMember_3F1A89D305B572546718D4ED4BAF81B8" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E" xlink:to="loc_biib_TimeVestedRestrictedStockUnitsMember_3F1A89D305B572546718D4ED4BAF81B8" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CashSettledPerformanceSharesMember" xlink:label="loc_biib_CashSettledPerformanceSharesMember_2C7CD7036EED1BA54A0FD4ED4BAF558F" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E" xlink:to="loc_biib_CashSettledPerformanceSharesMember_2C7CD7036EED1BA54A0FD4ED4BAF558F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_91AD475A5C81E8F4FC69D4ED4BAF07E6" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E" xlink:to="loc_us-gaap_PerformanceSharesMember_91AD475A5C81E8F4FC69D4ED4BAF07E6" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_EmployeeStockPurchasePlanMember" xlink:label="loc_biib_EmployeeStockPurchasePlanMember_C580B0D0FD7098B99E71D4ED4BAF39CB" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E" xlink:to="loc_biib_EmployeeStockPurchasePlanMember_C580B0D0FD7098B99E71D4ED4BAF39CB" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract" xlink:label="loc_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1464EA0C1384DE90337FD4ED4BAFC978" xlink:to="loc_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_602FE9224655D2D0D2A9D4ED4BAF8E09" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_602FE9224655D2D0D2A9D4ED4BAF8E09" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_44E64F2C5534611F7AB3D4ED4BAF24AD" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_44E64F2C5534611F7AB3D4ED4BAF24AD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_CCAA7FD886AF5D443486D4ED4BAFF74C" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_CCAA7FD886AF5D443486D4ED4BAFF74C" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses" xlink:label="loc_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_C748C22FC4113452038ED4ED4BAF02C4" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:to="loc_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_C748C22FC4113452038ED4ED4BAF02C4" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/ShareBasedPaymentsDetails2" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B8CBBCA1A4D053D375CED4ED4AD0BBFA" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_58661BA7D073C9063C05D4ED4ACF8EBF" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B8CBBCA1A4D053D375CED4ED4AD0BBFA" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_58661BA7D073C9063C05D4ED4ACF8EBF" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_AB106E479BE91712B682D4ED4ACF92D5" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_58661BA7D073C9063C05D4ED4ACF8EBF" xlink:to="loc_us-gaap_PlanNameAxis_AB106E479BE91712B682D4ED4ACF92D5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_AB106E479BE91712B682D4ED4ACF92D5" xlink:to="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_AB106E479BE91712B682D4ED4ACF92D5" xlink:to="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_MarketStockUnitsMember" xlink:label="loc_biib_MarketStockUnitsMember_BFE8CD48F7B66C524FC8D4ED4ACF00B9" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:to="loc_biib_MarketStockUnitsMember_BFE8CD48F7B66C524FC8D4ED4ACF00B9" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CashSettledPerformanceSharesMember" xlink:label="loc_biib_CashSettledPerformanceSharesMember_D1B572FA74FCD42CC965D4ED4AD0DC9B" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:to="loc_biib_CashSettledPerformanceSharesMember_D1B572FA74FCD42CC965D4ED4AD0DC9B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_CB8E6DA6F2EA4EBC89C9D4ED4AD01D06" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:to="loc_us-gaap_PerformanceSharesMember_CB8E6DA6F2EA4EBC89C9D4ED4AD01D06" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_TimeVestedRestrictedStockUnitsMember" xlink:label="loc_biib_TimeVestedRestrictedStockUnitsMember_82BD6DF4361E1931E2CFD4ED4AD00290" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:to="loc_biib_TimeVestedRestrictedStockUnitsMember_82BD6DF4361E1931E2CFD4ED4AD00290" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ScheduleOfStockOptionGrantsAbstract" xlink:label="loc_biib_ScheduleOfStockOptionGrantsAbstract_1BA6DAAB68C13E083D0BD4ED4AD073D0" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B8CBBCA1A4D053D375CED4ED4AD0BBFA" xlink:to="loc_biib_ScheduleOfStockOptionGrantsAbstract_1BA6DAAB68C13E083D0BD4ED4AD073D0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F825C80AEBCE6521E97D4ED4AD078A3" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_biib_ScheduleOfStockOptionGrantsAbstract_1BA6DAAB68C13E083D0BD4ED4AD073D0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F825C80AEBCE6521E97D4ED4AD078A3" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/ShareBasedPaymentsDetailsTextual" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/ShareBasedPaymentsTables" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/SubsequentEventsSubsequentEvents" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/SubsequentEventsSubsequentEventsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="loc_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_771D440E33CF0CFB17FAB7340A86F17F" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:to="loc_us-gaap_ProductOrServiceAxis_771D440E33CF0CFB17FAB7340A86F17F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_D3372953B801B4BB457DB7340A864789_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ProductOrServiceAxis_771D440E33CF0CFB17FAB7340A86F17F" xlink:to="loc_us-gaap_ProductsAndServicesDomain_D3372953B801B4BB457DB7340A864789_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_D3372953B801B4BB457DB7340A864789" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ProductOrServiceAxis_771D440E33CF0CFB17FAB7340A86F17F" xlink:to="loc_us-gaap_ProductsAndServicesDomain_D3372953B801B4BB457DB7340A864789" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_LeadprogramsMember" xlink:label="loc_biib_LeadprogramsMember_13AD78A278696FC050C7B7340A86D93A" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_D3372953B801B4BB457DB7340A864789" xlink:to="loc_biib_LeadprogramsMember_13AD78A278696FC050C7B7340A86D93A" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_DiscoveryprogramsMember" xlink:label="loc_biib_DiscoveryprogramsMember_9F1C5329C9C3B7466A3AB7340A86A9F8" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_D3372953B801B4BB457DB7340A864789" xlink:to="loc_biib_DiscoveryprogramsMember_9F1C5329C9C3B7466A3AB7340A86A9F8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_3213F345859D56084D8AB7340A86F713" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:to="loc_us-gaap_TypeOfArrangementAxis_3213F345859D56084D8AB7340A86F713" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_3213F345859D56084D8AB7340A86F713" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_3213F345859D56084D8AB7340A86F713" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AGTCMember" xlink:label="loc_biib_AGTCMember_5F66FF87C17C2F6EAD60B7340A860704" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF" xlink:to="loc_biib_AGTCMember_5F66FF87C17C2F6EAD60B7340A860704" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_EisaiMember" xlink:label="loc_biib_EisaiMember_214CD51B8CA2FEB6DFD9B74CEBBE076E" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF" xlink:to="loc_biib_EisaiMember_214CD51B8CA2FEB6DFD9B74CEBBE076E" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_SwedishOrphanBiovitrumMember" xlink:label="loc_biib_SwedishOrphanBiovitrumMember_4CD6B22F4232245CFBACB747240DB15D" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF" xlink:to="loc_biib_SwedishOrphanBiovitrumMember_4CD6B22F4232245CFBACB747240DB15D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2B04F499DD14AAADCA3FB7340A87E7B5" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2B04F499DD14AAADCA3FB7340A87E7B5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8FA32BABB4D1D8814B03B7340A878038_default" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2B04F499DD14AAADCA3FB7340A87E7B5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8FA32BABB4D1D8814B03B7340A878038_default" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8FA32BABB4D1D8814B03B7340A878038" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2B04F499DD14AAADCA3FB7340A87E7B5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8FA32BABB4D1D8814B03B7340A878038" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_62B67C6D09D421E1E0D6B7340A87C6B5" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8FA32BABB4D1D8814B03B7340A878038" xlink:to="loc_us-gaap_SubsequentEventMember_62B67C6D09D421E1E0D6B7340A87C6B5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_45C387DE7D408819095BB7340A875AF8" xlink:type="locator" />
    <definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_45C387DE7D408819095BB7340A875AF8" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_Purchaseofcommonstock" xlink:label="loc_biib_Purchaseofcommonstock_788FE33F878812B5527DB7340A877A3B" xlink:type="locator" />
    <definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="loc_biib_Purchaseofcommonstock_788FE33F878812B5527DB7340A877A3B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_7F962168BB59A771C190B7340A87B4C2" xlink:type="locator" />
    <definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssets_7F962168BB59A771C190B7340A87B4C2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LicenseCosts" xlink:label="loc_us-gaap_LicenseCosts_623EBA60EEB10186FB46B7340A87988B" xlink:type="locator" />
    <definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="loc_us-gaap_LicenseCosts_623EBA60EEB10186FB46B7340A87988B" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately" xlink:label="loc_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_B9E228840EDB6B118514B7340A872FFD" xlink:type="locator" />
    <definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="loc_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_B9E228840EDB6B118514B7340A872FFD" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_TermOfLease" xlink:label="loc_biib_TermOfLease_041B1AD828D88D5E7DE1B74BA968471C" xlink:type="locator" />
    <definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="loc_biib_TermOfLease_041B1AD828D88D5E7DE1B74BA968471C" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AdditionalMilestonePayment" xlink:label="loc_biib_AdditionalMilestonePayment_F700C0105EAA54DA6889B74576C2D9D1" xlink:type="locator" />
    <definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="loc_biib_AdditionalMilestonePayment_F700C0105EAA54DA6889B74576C2D9D1" xlink:type="arc" />
  </definitionLink>
  <definitionLink xlink:role="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesDetails" xlink:type="extended" />
  <definitionLink xlink:role="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>biib-20150630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_EquityAbstract_6D663FA4EAB950614723B7291AF7438F_label_en-US" xlink:label="lab_us-gaap_EquityAbstract_6D663FA4EAB950614723B7291AF7438F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_6D663FA4EAB950614723B7291AF7438F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract_6D663FA4EAB950614723B7291AF7438F" xlink:to="lab_us-gaap_EquityAbstract_6D663FA4EAB950614723B7291AF7438F" xlink:type="arc" />
    <link:label id="lab_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31_verboseLabel_en-US" xlink:label="lab_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of equity attributable to non-controlling interests</link:label>
    <link:label id="lab_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31_label_en-US" xlink:label="lab_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation Of Equity Attributable To Non Controlling Interests [Abstract]</link:label>
    <link:label id="lab_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31_documentation_en-US" xlink:label="lab_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reconciliation of equity attributable to non-controlling interests.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract" xlink:label="loc_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31" xlink:to="lab_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterest_19445903D07ACCB89687B7291AFBC8BB_periodStartLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest_19445903D07ACCB89687B7291AFBC8BB" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">NCI, beginning of period</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_19445903D07ACCB89687B7291AFBC8BB_label_en-US" xlink:label="lab_us-gaap_MinorityInterest_19445903D07ACCB89687B7291AFBC8BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_19445903D07ACCB89687B7291AFBC8BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest_19445903D07ACCB89687B7291AFBC8BB" xlink:to="lab_us-gaap_MinorityInterest_19445903D07ACCB89687B7291AFBC8BB" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_CF40AD7BC69E6073B8D1B7291AFB8C65_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_CF40AD7BC69E6073B8D1B7291AFB8C65" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) attributable to NCI, net of tax</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_CF40AD7BC69E6073B8D1B7291AFB8C65_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_CF40AD7BC69E6073B8D1B7291AFB8C65" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_CF40AD7BC69E6073B8D1B7291AFB8C65" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_CF40AD7BC69E6073B8D1B7291AFB8C65" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_CF40AD7BC69E6073B8D1B7291AFB8C65" xlink:type="arc" />
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8D367119D69B1B9673B7B7291AFB7E78_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8D367119D69B1B9673B7B7291AFB7E78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of net assets and liabilities acquired and assigned to NCI</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8D367119D69B1B9673B7B7291AFB7E78_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8D367119D69B1B9673B7B7291AFB7E78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8D367119D69B1B9673B7B7291AFB7E78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8D367119D69B1B9673B7B7291AFB7E78" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8D367119D69B1B9673B7B7291AFB7E78" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93933BA76E23E7B88FD6B7291AFBEBAC_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93933BA76E23E7B88FD6B7291AFBEBAC" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Distribution to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93933BA76E23E7B88FD6B7291AFBEBAC_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93933BA76E23E7B88FD6B7291AFBEBAC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93933BA76E23E7B88FD6B7291AFBEBAC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93933BA76E23E7B88FD6B7291AFBEBAC" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93933BA76E23E7B88FD6B7291AFBEBAC" xlink:type="arc" />
    <link:label id="lab_biib_Noncontrollinginterestincreasedecreaseother_495E8A503936DFC90BB3B7291AFBD213_terseLabel_en-US" xlink:label="lab_biib_Noncontrollinginterestincreasedecreaseother_495E8A503936DFC90BB3B7291AFBD213" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Translation adjustment and other</link:label>
    <link:label id="lab_biib_Noncontrollinginterestincreasedecreaseother_495E8A503936DFC90BB3B7291AFBD213_label_en-US" xlink:label="lab_biib_Noncontrollinginterestincreasedecreaseother_495E8A503936DFC90BB3B7291AFBD213" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling interest, increase (decrease) other</link:label>
    <link:label id="lab_biib_Noncontrollinginterestincreasedecreaseother_495E8A503936DFC90BB3B7291AFBD213_documentation_en-US" xlink:label="lab_biib_Noncontrollinginterestincreasedecreaseother_495E8A503936DFC90BB3B7291AFBD213" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Noncontrolling interest, increase (decrease) other</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_Noncontrollinginterestincreasedecreaseother" xlink:label="loc_biib_Noncontrollinginterestincreasedecreaseother_495E8A503936DFC90BB3B7291AFBD213" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_Noncontrollinginterestincreasedecreaseother_495E8A503936DFC90BB3B7291AFBD213" xlink:to="lab_biib_Noncontrollinginterestincreasedecreaseother_495E8A503936DFC90BB3B7291AFBD213" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterest_15C3E7A75C9C09199EA4B7291AFBB1F0_periodEndLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest_15C3E7A75C9C09199EA4B7291AFBB1F0" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">NCI, end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_15C3E7A75C9C09199EA4B7291AFBB1F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest_15C3E7A75C9C09199EA4B7291AFBB1F0" xlink:to="lab_us-gaap_MinorityInterest_15C3E7A75C9C09199EA4B7291AFBB1F0" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_3D90C639609931F0FB477489D2E98657_label_en-US" xlink:label="lab_us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_3D90C639609931F0FB477489D2E98657" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Information about Litigation Matters [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyInformationAboutLitigationMattersAbstract" xlink:label="loc_us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_3D90C639609931F0FB477489D2E98657" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_3D90C639609931F0FB477489D2E98657" xlink:to="lab_us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_3D90C639609931F0FB477489D2E98657" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesTable_B0B5BFF64CC42197BC5B7489D2E99E52_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_B0B5BFF64CC42197BC5B7489D2E99E52" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_B0B5BFF64CC42197BC5B7489D2E99E52_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_B0B5BFF64CC42197BC5B7489D2E99E52" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_B0B5BFF64CC42197BC5B7489D2E99E52" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable_B0B5BFF64CC42197BC5B7489D2E99E52" xlink:to="lab_us-gaap_LossContingenciesTable_B0B5BFF64CC42197BC5B7489D2E99E52" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementGeographicalAxis_392E7D606883CD05ADD27489D2E91B0A_terseLabel_en-US" xlink:label="lab_us-gaap_StatementGeographicalAxis_392E7D606883CD05ADD27489D2E91B0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementGeographicalAxis_392E7D606883CD05ADD27489D2E91B0A_label_en-US" xlink:label="lab_us-gaap_StatementGeographicalAxis_392E7D606883CD05ADD27489D2E91B0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaap_StatementGeographicalAxis_392E7D606883CD05ADD27489D2E91B0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementGeographicalAxis_392E7D606883CD05ADD27489D2E91B0A" xlink:to="lab_us-gaap_StatementGeographicalAxis_392E7D606883CD05ADD27489D2E91B0A" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentGeographicalDomain_47C3F688F9D27C1E700E7489D2EA27C1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentGeographicalDomain_47C3F688F9D27C1E700E7489D2EA27C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentGeographicalDomain_47C3F688F9D27C1E700E7489D2EA27C1_label_en-US" xlink:label="lab_us-gaap_SegmentGeographicalDomain_47C3F688F9D27C1E700E7489D2EA27C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_47C3F688F9D27C1E700E7489D2EA27C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentGeographicalDomain_47C3F688F9D27C1E700E7489D2EA27C1" xlink:to="lab_us-gaap_SegmentGeographicalDomain_47C3F688F9D27C1E700E7489D2EA27C1" xlink:type="arc" />
    <link:label id="lab_country_IT_22E43D11B9274F01F4247489D2EA0773_terseLabel_en-US" xlink:label="lab_country_IT_22E43D11B9274F01F4247489D2EA0773" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Italy</link:label>
    <link:label id="lab_country_IT_22E43D11B9274F01F4247489D2EA0773_label_en-US" xlink:label="lab_country_IT_22E43D11B9274F01F4247489D2EA0773" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ITALY</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_IT" xlink:label="loc_country_IT_22E43D11B9274F01F4247489D2EA0773" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IT_22E43D11B9274F01F4247489D2EA0773" xlink:to="lab_country_IT_22E43D11B9274F01F4247489D2EA0773" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesLineItems_912D53441D564E5D1B367489D2EA4F6B_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems_912D53441D564E5D1B367489D2EA4F6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_912D53441D564E5D1B367489D2EA4F6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems_912D53441D564E5D1B367489D2EA4F6B" xlink:to="lab_us-gaap_LossContingenciesLineItems_912D53441D564E5D1B367489D2EA4F6B" xlink:type="arc" />
    <link:label id="lab_biib_ReimbursementLimitStatedInResolution_CD91E94EDA3FAFCB3E077489D2EAEFC3_terseLabel_en-US" xlink:label="lab_biib_ReimbursementLimitStatedInResolution_CD91E94EDA3FAFCB3E077489D2EAEFC3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reimbursement limit stated in the resolution</link:label>
    <link:label id="lab_biib_ReimbursementLimitStatedInResolution_CD91E94EDA3FAFCB3E077489D2EAEFC3_label_en-US" xlink:label="lab_biib_ReimbursementLimitStatedInResolution_CD91E94EDA3FAFCB3E077489D2EAEFC3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reimbursement Limit Stated In Resolution</link:label>
    <link:label id="lab_biib_ReimbursementLimitStatedInResolution_CD91E94EDA3FAFCB3E077489D2EAEFC3_documentation_en-US" xlink:label="lab_biib_ReimbursementLimitStatedInResolution_CD91E94EDA3FAFCB3E077489D2EAEFC3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reimbursement limit stated in the resolution.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_ReimbursementLimitStatedInResolution" xlink:label="loc_biib_ReimbursementLimitStatedInResolution_CD91E94EDA3FAFCB3E077489D2EAEFC3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_ReimbursementLimitStatedInResolution_CD91E94EDA3FAFCB3E077489D2EAEFC3" xlink:to="lab_biib_ReimbursementLimitStatedInResolution_CD91E94EDA3FAFCB3E077489D2EAEFC3" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_86ECECBC0B453339B9BFD4ED4B8F0EC7_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_86ECECBC0B453339B9BFD4ED4B8F0EC7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_86ECECBC0B453339B9BFD4ED4B8F0EC7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_86ECECBC0B453339B9BFD4ED4B8F0EC7" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_86ECECBC0B453339B9BFD4ED4B8F0EC7" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_B6679C3211A76D1E2190D4ED4B8F6C3B_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare_B6679C3211A76D1E2190D4ED4B8F6C3B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_B6679C3211A76D1E2190D4ED4B8F6C3B_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare_B6679C3211A76D1E2190D4ED4B8F6C3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_B6679C3211A76D1E2190D4ED4B8F6C3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare_B6679C3211A76D1E2190D4ED4B8F6C3B" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare_B6679C3211A76D1E2190D4ED4B8F6C3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_05FAB23A63EF7DC0FF99D4ED4B8FB1DF_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_05FAB23A63EF7DC0FF99D4ED4B8FB1DF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_05FAB23A63EF7DC0FF99D4ED4B8FB1DF_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_05FAB23A63EF7DC0FF99D4ED4B8FB1DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_05FAB23A63EF7DC0FF99D4ED4B8FB1DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_05FAB23A63EF7DC0FF99D4ED4B8FB1DF" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_05FAB23A63EF7DC0FF99D4ED4B8FB1DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4190F6C7FB6063F44F34D4ED4B93D6E0_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4190F6C7FB6063F44F34D4ED4B93D6E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4190F6C7FB6063F44F34D4ED4B93D6E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4190F6C7FB6063F44F34D4ED4B93D6E0" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4190F6C7FB6063F44F34D4ED4B93D6E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_17D5904237133F4CBA0BD4ED4B933D53_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_17D5904237133F4CBA0BD4ED4B933D53" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_17D5904237133F4CBA0BD4ED4B933D53_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_17D5904237133F4CBA0BD4ED4B933D53" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_17D5904237133F4CBA0BD4ED4B933D53" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_17D5904237133F4CBA0BD4ED4B933D53" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_17D5904237133F4CBA0BD4ED4B933D53" xlink:type="arc" />
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_B0EB9CEBD831128D4E06D4ED4BC0E24F_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_B0EB9CEBD831128D4E06D4ED4BC0E24F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_B0EB9CEBD831128D4E06D4ED4BC0E24F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_B0EB9CEBD831128D4E06D4ED4BC0E24F" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_B0EB9CEBD831128D4E06D4ED4BC0E24F" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_7963524F0370193265C4D4ED4BC02559_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_7963524F0370193265C4D4ED4BC02559" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other Consolidated Financial Statement Detail</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_7963524F0370193265C4D4ED4BC02559_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_7963524F0370193265C4D4ED4BC02559" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_7963524F0370193265C4D4ED4BC02559" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_7963524F0370193265C4D4ED4BC02559" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_7963524F0370193265C4D4ED4BC02559" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_7E4F3FBF08C11391E78FB1CA3925D16D_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract_7E4F3FBF08C11391E78FB1CA3925D16D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7E4F3FBF08C11391E78FB1CA3925D16D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7E4F3FBF08C11391E78FB1CA3925D16D" xlink:to="lab_us-gaap_BusinessCombinationsAbstract_7E4F3FBF08C11391E78FB1CA3925D16D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_AAC428C2F76C073EC7B2B1CA3927502D_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_AAC428C2F76C073EC7B2B1CA3927502D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_AAC428C2F76C073EC7B2B1CA3927502D_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_AAC428C2F76C073EC7B2B1CA3927502D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_AAC428C2F76C073EC7B2B1CA3927502D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_AAC428C2F76C073EC7B2B1CA3927502D" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_AAC428C2F76C073EC7B2B1CA3927502D" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_4C497D984F16C1F83CCBB1CA3927AA3F_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_4C497D984F16C1F83CCBB1CA3927AA3F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_4C497D984F16C1F83CCBB1CA3927AA3F_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_4C497D984F16C1F83CCBB1CA3927AA3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4C497D984F16C1F83CCBB1CA3927AA3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4C497D984F16C1F83CCBB1CA3927AA3F" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain_4C497D984F16C1F83CCBB1CA3927AA3F" xlink:type="arc" />
    <link:label id="lab_biib_ConvergencePharmaceuticalsMember_EF694B669BBF78DF74D0B1CA3927DF4C_terseLabel_en-US" xlink:label="lab_biib_ConvergencePharmaceuticalsMember_EF694B669BBF78DF74D0B1CA3927DF4C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convergence Pharmaceuticals</link:label>
    <link:label id="lab_biib_ConvergencePharmaceuticalsMember_EF694B669BBF78DF74D0B1CA3927DF4C_label_en-US" xlink:label="lab_biib_ConvergencePharmaceuticalsMember_EF694B669BBF78DF74D0B1CA3927DF4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convergence Pharmaceuticals [Member]</link:label>
    <link:label id="lab_biib_ConvergencePharmaceuticalsMember_EF694B669BBF78DF74D0B1CA3927DF4C_documentation_en-US" xlink:label="lab_biib_ConvergencePharmaceuticalsMember_EF694B669BBF78DF74D0B1CA3927DF4C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convergence Pharmaceuticals [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_ConvergencePharmaceuticalsMember" xlink:label="loc_biib_ConvergencePharmaceuticalsMember_EF694B669BBF78DF74D0B1CA3927DF4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_ConvergencePharmaceuticalsMember_EF694B669BBF78DF74D0B1CA3927DF4C" xlink:to="lab_biib_ConvergencePharmaceuticalsMember_EF694B669BBF78DF74D0B1CA3927DF4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProductOrServiceAxis_D968A86CB6C7DE41BF8AB1CA39272213_terseLabel_en-US" xlink:label="lab_us-gaap_ProductOrServiceAxis_D968A86CB6C7DE41BF8AB1CA39272213" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Products and Services [Axis]</link:label>
    <link:label id="lab_us-gaap_ProductOrServiceAxis_D968A86CB6C7DE41BF8AB1CA39272213_label_en-US" xlink:label="lab_us-gaap_ProductOrServiceAxis_D968A86CB6C7DE41BF8AB1CA39272213" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Products and Services [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_D968A86CB6C7DE41BF8AB1CA39272213" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductOrServiceAxis_D968A86CB6C7DE41BF8AB1CA39272213" xlink:to="lab_us-gaap_ProductOrServiceAxis_D968A86CB6C7DE41BF8AB1CA39272213" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346_terseLabel_en-US" xlink:label="lab_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Products and Services [Domain]</link:label>
    <link:label id="lab_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346_label_en-US" xlink:label="lab_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Products and Services [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346" xlink:to="lab_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346" xlink:type="arc" />
    <link:label id="lab_biib_CNV1014802Member_24751951D13CCC35C0AEB1CA392894C1_terseLabel_en-US" xlink:label="lab_biib_CNV1014802Member_24751951D13CCC35C0AEB1CA392894C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CNV1014802</link:label>
    <link:label id="lab_biib_CNV1014802Member_24751951D13CCC35C0AEB1CA392894C1_label_en-US" xlink:label="lab_biib_CNV1014802Member_24751951D13CCC35C0AEB1CA392894C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CNV1014802 [Member]</link:label>
    <link:label id="lab_biib_CNV1014802Member_24751951D13CCC35C0AEB1CA392894C1_documentation_en-US" xlink:label="lab_biib_CNV1014802Member_24751951D13CCC35C0AEB1CA392894C1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CNV1014802 [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_CNV1014802Member" xlink:label="loc_biib_CNV1014802Member_24751951D13CCC35C0AEB1CA392894C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_CNV1014802Member_24751951D13CCC35C0AEB1CA392894C1" xlink:to="lab_biib_CNV1014802Member_24751951D13CCC35C0AEB1CA392894C1" xlink:type="arc" />
    <link:label id="lab_biib_NeuropathicpainindicationsMember_5F69208B988FC50DEE81B1CA3928FEA0_terseLabel_en-US" xlink:label="lab_biib_NeuropathicpainindicationsMember_5F69208B988FC50DEE81B1CA3928FEA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Neuropathic pain indications</link:label>
    <link:label id="lab_biib_NeuropathicpainindicationsMember_5F69208B988FC50DEE81B1CA3928FEA0_label_en-US" xlink:label="lab_biib_NeuropathicpainindicationsMember_5F69208B988FC50DEE81B1CA3928FEA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Neuropathic pain indications [Member]</link:label>
    <link:label id="lab_biib_NeuropathicpainindicationsMember_5F69208B988FC50DEE81B1CA3928FEA0_documentation_en-US" xlink:label="lab_biib_NeuropathicpainindicationsMember_5F69208B988FC50DEE81B1CA3928FEA0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Neuropathic pain indications [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_NeuropathicpainindicationsMember" xlink:label="loc_biib_NeuropathicpainindicationsMember_5F69208B988FC50DEE81B1CA3928FEA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_NeuropathicpainindicationsMember_5F69208B988FC50DEE81B1CA3928FEA0" xlink:to="lab_biib_NeuropathicpainindicationsMember_5F69208B988FC50DEE81B1CA3928FEA0" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_18921EF4090E639A71CBB1CA39284500_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_18921EF4090E639A71CBB1CA39284500" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash portion of consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_18921EF4090E639A71CBB1CA39284500_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_18921EF4090E639A71CBB1CA39284500" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_18921EF4090E639A71CBB1CA39284500" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross_18921EF4090E639A71CBB1CA39284500" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross_18921EF4090E639A71CBB1CA39284500" xlink:type="arc" />
    <link:label id="lab_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_FCC8C2F678E99AC85E9DB1CA39287F25_terseLabel_en-US" xlink:label="lab_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_FCC8C2F678E99AC85E9DB1CA39287F25" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential future milestone payments</link:label>
    <link:label id="lab_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_FCC8C2F678E99AC85E9DB1CA39287F25_label_en-US" xlink:label="lab_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_FCC8C2F678E99AC85E9DB1CA39287F25" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential Future Milestone Payments Commitment To Third Party Approximately</link:label>
    <link:label id="lab_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_FCC8C2F678E99AC85E9DB1CA39287F25_documentation_en-US" xlink:label="lab_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_FCC8C2F678E99AC85E9DB1CA39287F25" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Potential future milestone payments commitment to third party approximately.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately" xlink:label="loc_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_FCC8C2F678E99AC85E9DB1CA39287F25" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_FCC8C2F678E99AC85E9DB1CA39287F25" xlink:to="lab_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_FCC8C2F678E99AC85E9DB1CA39287F25" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_05E070147C53310323AAB1CA39284BCB_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_05E070147C53310323AAB1CA39284BCB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_05E070147C53310323AAB1CA39284BCB_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_05E070147C53310323AAB1CA39284BCB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_05E070147C53310323AAB1CA39284BCB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_05E070147C53310323AAB1CA39284BCB" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_05E070147C53310323AAB1CA39284BCB" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_DED23CEFF460E961F8B5B1CA39282659_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_DED23CEFF460E961F8B5B1CA39282659" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in the value of our estimated contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_DED23CEFF460E961F8B5B1CA39282659_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_DED23CEFF460E961F8B5B1CA39282659" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_DED23CEFF460E961F8B5B1CA39282659" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_DED23CEFF460E961F8B5B1CA39282659" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_DED23CEFF460E961F8B5B1CA39282659" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_1780E4C2D0AEAC688FB7B1CA3928F1B5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease_1780E4C2D0AEAC688FB7B1CA3928F1B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_1780E4C2D0AEAC688FB7B1CA3928F1B5_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease_1780E4C2D0AEAC688FB7B1CA3928F1B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_1780E4C2D0AEAC688FB7B1CA3928F1B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease_1780E4C2D0AEAC688FB7B1CA3928F1B5" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease_1780E4C2D0AEAC688FB7B1CA3928F1B5" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsDiscountRate_F9B59BB108C41D1AF07CB1CA3928E42E_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsDiscountRate_F9B59BB108C41D1AF07CB1CA3928E42E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_FairValueInputsDiscountRate_F9B59BB108C41D1AF07CB1CA3928E42E_label_en-US" xlink:label="lab_us-gaap_FairValueInputsDiscountRate_F9B59BB108C41D1AF07CB1CA3928E42E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Inputs, Discount Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="loc_us-gaap_FairValueInputsDiscountRate_F9B59BB108C41D1AF07CB1CA3928E42E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsDiscountRate_F9B59BB108C41D1AF07CB1CA3928E42E" xlink:to="lab_us-gaap_FairValueInputsDiscountRate_F9B59BB108C41D1AF07CB1CA3928E42E" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_F60C74BF72260371A776B1CA392816A3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_F60C74BF72260371A776B1CA392816A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining cost to complete CNV1014802</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_F60C74BF72260371A776B1CA392816A3_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_F60C74BF72260371A776B1CA392816A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_F60C74BF72260371A776B1CA392816A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_F60C74BF72260371A776B1CA392816A3" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_F60C74BF72260371A776B1CA392816A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_99C882F2F9E2A020BFCEB1CA39285788_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_99C882F2F9E2A020BFCEB1CA39285788" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In-process research and development and other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_99C882F2F9E2A020BFCEB1CA39285788_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_99C882F2F9E2A020BFCEB1CA39285788" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_99C882F2F9E2A020BFCEB1CA39285788" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_99C882F2F9E2A020BFCEB1CA39285788" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_99C882F2F9E2A020BFCEB1CA39285788" xlink:type="arc" />
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_0311D79977BA34FEDFC0D4ED4B05470F_verboseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock_0311D79977BA34FEDFC0D4ED4B05470F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Litigation</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_0311D79977BA34FEDFC0D4ED4B05470F_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock_0311D79977BA34FEDFC0D4ED4B05470F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_0311D79977BA34FEDFC0D4ED4B05470F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock_0311D79977BA34FEDFC0D4ED4B05470F" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock_0311D79977BA34FEDFC0D4ED4B05470F" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2D96CB6CE7AA80EC5455DEC2ED0CA0A6_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2D96CB6CE7AA80EC5455DEC2ED0CA0A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2D96CB6CE7AA80EC5455DEC2ED0CA0A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2D96CB6CE7AA80EC5455DEC2ED0CA0A6" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2D96CB6CE7AA80EC5455DEC2ED0CA0A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_EB4DC49F0D944A42FA04DEC2ED13F810_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_EB4DC49F0D944A42FA04DEC2ED13F810" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_EB4DC49F0D944A42FA04DEC2ED13F810_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_EB4DC49F0D944A42FA04DEC2ED13F810" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_EB4DC49F0D944A42FA04DEC2ED13F810" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_EB4DC49F0D944A42FA04DEC2ED13F810" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_EB4DC49F0D944A42FA04DEC2ED13F810" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_998EE3A5D8BAFA1F4954DEC2ED13CE9B_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_998EE3A5D8BAFA1F4954DEC2ED13CE9B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_998EE3A5D8BAFA1F4954DEC2ED13CE9B_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_998EE3A5D8BAFA1F4954DEC2ED13CE9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_998EE3A5D8BAFA1F4954DEC2ED13CE9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_998EE3A5D8BAFA1F4954DEC2ED13CE9B" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_998EE3A5D8BAFA1F4954DEC2ED13CE9B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_68AF0F96E859B5C20FABDEC299DF2F6C_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_68AF0F96E859B5C20FABDEC299DF2F6C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_68AF0F96E859B5C20FABDEC299DF2F6C_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_68AF0F96E859B5C20FABDEC299DF2F6C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_68AF0F96E859B5C20FABDEC299DF2F6C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_68AF0F96E859B5C20FABDEC299DF2F6C" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_68AF0F96E859B5C20FABDEC299DF2F6C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ED6E2379A512B8611EBED4ED4BD7475C_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ED6E2379A512B8611EBED4ED4BD7475C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ED6E2379A512B8611EBED4ED4BD7475C_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ED6E2379A512B8611EBED4ED4BD7475C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ED6E2379A512B8611EBED4ED4BD7475C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ED6E2379A512B8611EBED4ED4BD7475C" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ED6E2379A512B8611EBED4ED4BD7475C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_A1C8C4EEC60462059522D4ED4BD7942C_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_A1C8C4EEC60462059522D4ED4BD7942C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Method Investee, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_A1C8C4EEC60462059522D4ED4BD7942C_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_A1C8C4EEC60462059522D4ED4BD7942C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_A1C8C4EEC60462059522D4ED4BD7942C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_A1C8C4EEC60462059522D4ED4BD7942C" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_A1C8C4EEC60462059522D4ED4BD7942C" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityMethodInvesteeNameDomain_EC4107E0F0AF5B20FCC1D4ED4BD89CA0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeNameDomain_EC4107E0F0AF5B20FCC1D4ED4BD89CA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Method Investee, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvesteeNameDomain_EC4107E0F0AF5B20FCC1D4ED4BD89CA0_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeNameDomain_EC4107E0F0AF5B20FCC1D4ED4BD89CA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityMethodInvesteeNameDomain" xlink:label="loc_us-gaap_EquityMethodInvesteeNameDomain_EC4107E0F0AF5B20FCC1D4ED4BD89CA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvesteeNameDomain_EC4107E0F0AF5B20FCC1D4ED4BD89CA0" xlink:to="lab_us-gaap_EquityMethodInvesteeNameDomain_EC4107E0F0AF5B20FCC1D4ED4BD89CA0" xlink:type="arc" />
    <link:label id="lab_biib_SamsungBiosimilarAgreementMember_9DEB65368349330C1533D4ED4BD841E4_terseLabel_en-US" xlink:label="lab_biib_SamsungBiosimilarAgreementMember_9DEB65368349330C1533D4ED4BD841E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Samsung Biosimilar Agreement [Member]</link:label>
    <link:label id="lab_biib_SamsungBiosimilarAgreementMember_9DEB65368349330C1533D4ED4BD841E4_label_en-US" xlink:label="lab_biib_SamsungBiosimilarAgreementMember_9DEB65368349330C1533D4ED4BD841E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Samsung Biosimilar Agreement [Member]</link:label>
    <link:label id="lab_biib_SamsungBiosimilarAgreementMember_9DEB65368349330C1533D4ED4BD841E4_documentation_en-US" xlink:label="lab_biib_SamsungBiosimilarAgreementMember_9DEB65368349330C1533D4ED4BD841E4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Samsung bio-similar agreement.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_SamsungBiosimilarAgreementMember" xlink:label="loc_biib_SamsungBiosimilarAgreementMember_9DEB65368349330C1533D4ED4BD841E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_SamsungBiosimilarAgreementMember_9DEB65368349330C1533D4ED4BD841E4" xlink:to="lab_biib_SamsungBiosimilarAgreementMember_9DEB65368349330C1533D4ED4BD841E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:type="arc" />
    <link:label id="lab_biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement_207324B535E16D8A4B16D4ED4BD89551_verboseLabel_en-US" xlink:label="lab_biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement_207324B535E16D8A4B16D4ED4BD89551" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contribution from Samsung to develop, manufacture and market biosimilar pharmaceuticals</link:label>
    <link:label id="lab_biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement_207324B535E16D8A4B16D4ED4BD89551_label_en-US" xlink:label="lab_biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement_207324B535E16D8A4B16D4ED4BD89551" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments By Third Party In Joint Venture As Per Agreement.</link:label>
    <link:label id="lab_biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement_207324B535E16D8A4B16D4ED4BD89551_documentation_en-US" xlink:label="lab_biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement_207324B535E16D8A4B16D4ED4BD89551" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investments by third party in joint venture as per agreement</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement" xlink:label="loc_biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement_207324B535E16D8A4B16D4ED4BD89551" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement_207324B535E16D8A4B16D4ED4BD89551" xlink:to="lab_biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement_207324B535E16D8A4B16D4ED4BD89551" xlink:type="arc" />
    <link:label id="lab_biib_JointVentureOwnerShipPercentageByThirdParty_071DDB63F6E7B0DF79B5D4ED4BD88D58_verboseLabel_en-US" xlink:label="lab_biib_JointVentureOwnerShipPercentageByThirdParty_071DDB63F6E7B0DF79B5D4ED4BD88D58" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Variable interest entity, qualitative or quantitative information, ownership percentage</link:label>
    <link:label id="lab_biib_JointVentureOwnerShipPercentageByThirdParty_071DDB63F6E7B0DF79B5D4ED4BD88D58_label_en-US" xlink:label="lab_biib_JointVentureOwnerShipPercentageByThirdParty_071DDB63F6E7B0DF79B5D4ED4BD88D58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Joint Venture Owner Ship Percentage By Third Party.</link:label>
    <link:label id="lab_biib_JointVentureOwnerShipPercentageByThirdParty_071DDB63F6E7B0DF79B5D4ED4BD88D58_documentation_en-US" xlink:label="lab_biib_JointVentureOwnerShipPercentageByThirdParty_071DDB63F6E7B0DF79B5D4ED4BD88D58" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Joint venture owner ship percentage by third party.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_JointVentureOwnerShipPercentageByThirdParty" xlink:label="loc_biib_JointVentureOwnerShipPercentageByThirdParty_071DDB63F6E7B0DF79B5D4ED4BD88D58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_JointVentureOwnerShipPercentageByThirdParty_071DDB63F6E7B0DF79B5D4ED4BD88D58" xlink:to="lab_biib_JointVentureOwnerShipPercentageByThirdParty_071DDB63F6E7B0DF79B5D4ED4BD88D58" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityMethodInvestments_2F7A3840C8B916FBAA87D4ED4BD8CC26_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments_2F7A3840C8B916FBAA87D4ED4BD8CC26" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contribution from Biogen to develop, manufacture and market biosimilar pharmaceuticals</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_2F7A3840C8B916FBAA87D4ED4BD8CC26_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments_2F7A3840C8B916FBAA87D4ED4BD8CC26" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_2F7A3840C8B916FBAA87D4ED4BD8CC26" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments_2F7A3840C8B916FBAA87D4ED4BD8CC26" xlink:to="lab_us-gaap_EquityMethodInvestments_2F7A3840C8B916FBAA87D4ED4BD8CC26" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_1913B942AF6AB95931D5D4ED4BD853A3_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_1913B942AF6AB95931D5D4ED4BD853A3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Percentage of stake in entity minimum</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_1913B942AF6AB95931D5D4ED4BD853A3_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_1913B942AF6AB95931D5D4ED4BD853A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1913B942AF6AB95931D5D4ED4BD853A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1913B942AF6AB95931D5D4ED4BD853A3" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_1913B942AF6AB95931D5D4ED4BD853A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_DA1249D14801BC1FFF4FD4ED4BD8063D_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_DA1249D14801BC1FFF4FD4ED4BD8063D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional contribution made to Samsung Bioepis</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_DA1249D14801BC1FFF4FD4ED4BD8063D_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_DA1249D14801BC1FFF4FD4ED4BD8063D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_DA1249D14801BC1FFF4FD4ED4BD8063D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_DA1249D14801BC1FFF4FD4ED4BD8063D" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_DA1249D14801BC1FFF4FD4ED4BD8063D" xlink:type="arc" />
    <link:label id="lab_biib_EquityMethodInvestmentOwnershipPercentageMaximum_872A902C54EEF6BA240AD4ED4BD8B377_verboseLabel_en-US" xlink:label="lab_biib_EquityMethodInvestmentOwnershipPercentageMaximum_872A902C54EEF6BA240AD4ED4BD8B377" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Percentage of stake in entity maximum</link:label>
    <link:label id="lab_biib_EquityMethodInvestmentOwnershipPercentageMaximum_872A902C54EEF6BA240AD4ED4BD8B377_label_en-US" xlink:label="lab_biib_EquityMethodInvestmentOwnershipPercentageMaximum_872A902C54EEF6BA240AD4ED4BD8B377" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment Ownership Percentage Maximum</link:label>
    <link:label id="lab_biib_EquityMethodInvestmentOwnershipPercentageMaximum_872A902C54EEF6BA240AD4ED4BD8B377_documentation_en-US" xlink:label="lab_biib_EquityMethodInvestmentOwnershipPercentageMaximum_872A902C54EEF6BA240AD4ED4BD8B377" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity method investment ownership percentage maximum.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_EquityMethodInvestmentOwnershipPercentageMaximum" xlink:label="loc_biib_EquityMethodInvestmentOwnershipPercentageMaximum_872A902C54EEF6BA240AD4ED4BD8B377" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_EquityMethodInvestmentOwnershipPercentageMaximum_872A902C54EEF6BA240AD4ED4BD8B377" xlink:to="lab_biib_EquityMethodInvestmentOwnershipPercentageMaximum_872A902C54EEF6BA240AD4ED4BD8B377" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_739CF25652D8C9789EF0D4ED4BD802D7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments_739CF25652D8C9789EF0D4ED4BD802D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recognized loss</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_739CF25652D8C9789EF0D4ED4BD802D7_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments_739CF25652D8C9789EF0D4ED4BD802D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_739CF25652D8C9789EF0D4ED4BD802D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments_739CF25652D8C9789EF0D4ED4BD802D7" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments_739CF25652D8C9789EF0D4ED4BD802D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_17854409963FD1E9A121D4ED4BD83E8A_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_17854409963FD1E9A121D4ED4BD83E8A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_17854409963FD1E9A121D4ED4BD83E8A_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_17854409963FD1E9A121D4ED4BD83E8A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_17854409963FD1E9A121D4ED4BD83E8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_17854409963FD1E9A121D4ED4BD83E8A" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_17854409963FD1E9A121D4ED4BD83E8A" xlink:type="arc" />
    <link:label id="lab_biib_AdditionalMilestonePayment_1397FC60E3C7EEB0EE26D4ED4BD8F8D1_terseLabel_en-US" xlink:label="lab_biib_AdditionalMilestonePayment_1397FC60E3C7EEB0EE26D4ED4BD8F8D1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional milestone payment</link:label>
    <link:label id="lab_biib_AdditionalMilestonePayment_1397FC60E3C7EEB0EE26D4ED4BD8F8D1_label_en-US" xlink:label="lab_biib_AdditionalMilestonePayment_1397FC60E3C7EEB0EE26D4ED4BD8F8D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Milestone Payment</link:label>
    <link:label id="lab_biib_AdditionalMilestonePayment_1397FC60E3C7EEB0EE26D4ED4BD8F8D1_documentation_en-US" xlink:label="lab_biib_AdditionalMilestonePayment_1397FC60E3C7EEB0EE26D4ED4BD8F8D1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Additional milestone payment.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_AdditionalMilestonePayment" xlink:label="loc_biib_AdditionalMilestonePayment_1397FC60E3C7EEB0EE26D4ED4BD8F8D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_AdditionalMilestonePayment_1397FC60E3C7EEB0EE26D4ED4BD8F8D1" xlink:to="lab_biib_AdditionalMilestonePayment_1397FC60E3C7EEB0EE26D4ED4BD8F8D1" xlink:type="arc" />
    <link:label id="lab_biib_EquityMethodInvestmentsExpectedProfitShare_74B56CFA3A39E42C0271D4ED4BD8E289_terseLabel_en-US" xlink:label="lab_biib_EquityMethodInvestmentsExpectedProfitShare_74B56CFA3A39E42C0271D4ED4BD8E289" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected profit share with Samsung Bioepis</link:label>
    <link:label id="lab_biib_EquityMethodInvestmentsExpectedProfitShare_74B56CFA3A39E42C0271D4ED4BD8E289_label_en-US" xlink:label="lab_biib_EquityMethodInvestmentsExpectedProfitShare_74B56CFA3A39E42C0271D4ED4BD8E289" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments, Expected Profit Share</link:label>
    <link:label id="lab_biib_EquityMethodInvestmentsExpectedProfitShare_74B56CFA3A39E42C0271D4ED4BD8E289_documentation_en-US" xlink:label="lab_biib_EquityMethodInvestmentsExpectedProfitShare_74B56CFA3A39E42C0271D4ED4BD8E289" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Method Investments, Expected Profit Share</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_EquityMethodInvestmentsExpectedProfitShare" xlink:label="loc_biib_EquityMethodInvestmentsExpectedProfitShare_74B56CFA3A39E42C0271D4ED4BD8E289" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_EquityMethodInvestmentsExpectedProfitShare_74B56CFA3A39E42C0271D4ED4BD8E289" xlink:to="lab_biib_EquityMethodInvestmentsExpectedProfitShare_74B56CFA3A39E42C0271D4ED4BD8E289" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherSalesRevenueNet_EB10FFC494F06650D3F2D4ED4BD8A06E_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSalesRevenueNet_EB10FFC494F06650D3F2D4ED4BD8A06E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue related to technical development and technology transfer services</link:label>
    <link:label id="lab_us-gaap_OtherSalesRevenueNet_EB10FFC494F06650D3F2D4ED4BD8A06E_label_en-US" xlink:label="lab_us-gaap_OtherSalesRevenueNet_EB10FFC494F06650D3F2D4ED4BD8A06E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Revenue, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="loc_us-gaap_OtherSalesRevenueNet_EB10FFC494F06650D3F2D4ED4BD8A06E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSalesRevenueNet_EB10FFC494F06650D3F2D4ED4BD8A06E" xlink:to="lab_us-gaap_OtherSalesRevenueNet_EB10FFC494F06650D3F2D4ED4BD8A06E" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_7EBF7A93C5A4A774F06DD4ED4B90ADAB_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_7EBF7A93C5A4A774F06DD4ED4B90ADAB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7EBF7A93C5A4A774F06DD4ED4B90ADAB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7EBF7A93C5A4A774F06DD4ED4B90ADAB" xlink:to="lab_us-gaap_EarningsPerShareAbstract_7EBF7A93C5A4A774F06DD4ED4B90ADAB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EA6F173D10171822C2B0D4ED4B90A812_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EA6F173D10171822C2B0D4ED4B90A812" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic and diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EA6F173D10171822C2B0D4ED4B90A812_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EA6F173D10171822C2B0D4ED4B90A812" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EA6F173D10171822C2B0D4ED4B90A812" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EA6F173D10171822C2B0D4ED4B90A812" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EA6F173D10171822C2B0D4ED4B90A812" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_260260A54BFEC084A09A740CBB499B3C_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_260260A54BFEC084A09A740CBB499B3C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_260260A54BFEC084A09A740CBB499B3C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_260260A54BFEC084A09A740CBB499B3C" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_260260A54BFEC084A09A740CBB499B3C" xlink:type="arc" />
    <link:label id="lab_biib_Employeestockpurchaseplanmaximumshares_22C1100CD9AACE4516147434A5516DF0_terseLabel_en-US" xlink:label="lab_biib_Employeestockpurchaseplanmaximumshares_22C1100CD9AACE4516147434A5516DF0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee stock purchase plan maximum shares</link:label>
    <link:label id="lab_biib_Employeestockpurchaseplanmaximumshares_22C1100CD9AACE4516147434A5516DF0_label_en-US" xlink:label="lab_biib_Employeestockpurchaseplanmaximumshares_22C1100CD9AACE4516147434A5516DF0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee stock purchase plan maximum shares</link:label>
    <link:label id="lab_biib_Employeestockpurchaseplanmaximumshares_22C1100CD9AACE4516147434A5516DF0_documentation_en-US" xlink:label="lab_biib_Employeestockpurchaseplanmaximumshares_22C1100CD9AACE4516147434A5516DF0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee stock purchase plan maximum shares</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_Employeestockpurchaseplanmaximumshares" xlink:label="loc_biib_Employeestockpurchaseplanmaximumshares_22C1100CD9AACE4516147434A5516DF0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_Employeestockpurchaseplanmaximumshares_22C1100CD9AACE4516147434A5516DF0" xlink:to="lab_biib_Employeestockpurchaseplanmaximumshares_22C1100CD9AACE4516147434A5516DF0" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6DB273C76E0DA1448CDA740CBB4E7BD6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6DB273C76E0DA1448CDA740CBB4E7BD6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued under ESPP</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6DB273C76E0DA1448CDA740CBB4E7BD6_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6DB273C76E0DA1448CDA740CBB4E7BD6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6DB273C76E0DA1448CDA740CBB4E7BD6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6DB273C76E0DA1448CDA740CBB4E7BD6" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6DB273C76E0DA1448CDA740CBB4E7BD6" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_A7268D31D616174B8528D4ED4B0FB960_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract_A7268D31D616174B8528D4ED4B0FB960" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_A7268D31D616174B8528D4ED4B0FB960" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_A7268D31D616174B8528D4ED4B0FB960" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract_A7268D31D616174B8528D4ED4B0FB960" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_71901E9F58E99655025ED4ED4B0FB4D8_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock_71901E9F58E99655025ED4ED4B0FB4D8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_71901E9F58E99655025ED4ED4B0FB4D8_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock_71901E9F58E99655025ED4ED4B0FB4D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_71901E9F58E99655025ED4ED4B0FB4D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock_71901E9F58E99655025ED4ED4B0FB4D8" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock_71901E9F58E99655025ED4ED4B0FB4D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_5C4408D646FFE8F4C361D4ED4BDAD968_verboseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_5C4408D646FFE8F4C361D4ED4BDAD968" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Collaborative and Other Relationships</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_5C4408D646FFE8F4C361D4ED4BDAD968_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_5C4408D646FFE8F4C361D4ED4BDAD968" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_5C4408D646FFE8F4C361D4ED4BDAD968" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_5C4408D646FFE8F4C361D4ED4BDAD968" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_5C4408D646FFE8F4C361D4ED4BDAD968" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9BE69D5AC794E37E8D4EDEB3A57BF945_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9BE69D5AC794E37E8D4EDEB3A57BF945" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9BE69D5AC794E37E8D4EDEB3A57BF945" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9BE69D5AC794E37E8D4EDEB3A57BF945" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9BE69D5AC794E37E8D4EDEB3A57BF945" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_1F02BAD6A7D02B458C1CDEB3A57D37B6_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_1F02BAD6A7D02B458C1CDEB3A57D37B6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Contractual Maturities: Available-for-Sale Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_1F02BAD6A7D02B458C1CDEB3A57D37B6_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_1F02BAD6A7D02B458C1CDEB3A57D37B6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities, Debt Maturities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_1F02BAD6A7D02B458C1CDEB3A57D37B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_1F02BAD6A7D02B458C1CDEB3A57D37B6" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_1F02BAD6A7D02B458C1CDEB3A57D37B6" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0194C5F9F70B05A40928DEB3A57D39C4_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0194C5F9F70B05A40928DEB3A57D39C4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Due in one year or less, estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0194C5F9F70B05A40928DEB3A57D39C4_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0194C5F9F70B05A40928DEB3A57D39C4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0194C5F9F70B05A40928DEB3A57D39C4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0194C5F9F70B05A40928DEB3A57D39C4" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0194C5F9F70B05A40928DEB3A57D39C4" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_663E5A73D06E9BB58080DEB3A57DD6EC_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_663E5A73D06E9BB58080DEB3A57DD6EC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Due in one year or less, amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_663E5A73D06E9BB58080DEB3A57DD6EC_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_663E5A73D06E9BB58080DEB3A57DD6EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities, Debt Maturities, Next Twelve Months, Amortized Cost Basis</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_663E5A73D06E9BB58080DEB3A57DD6EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_663E5A73D06E9BB58080DEB3A57DD6EC" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_663E5A73D06E9BB58080DEB3A57DD6EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0ACB1E0BB26E1807EFBADEB3A57D3244_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0ACB1E0BB26E1807EFBADEB3A57D3244" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Due after one year through five years, Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0ACB1E0BB26E1807EFBADEB3A57D3244_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0ACB1E0BB26E1807EFBADEB3A57D3244" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities, Debt Maturities, Year Two Through Five, Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0ACB1E0BB26E1807EFBADEB3A57D3244" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0ACB1E0BB26E1807EFBADEB3A57D3244" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0ACB1E0BB26E1807EFBADEB3A57D3244" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_98F3E6E5537EAC010D3CDEB3A57D1078_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_98F3E6E5537EAC010D3CDEB3A57D1078" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Due after one year through five years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_98F3E6E5537EAC010D3CDEB3A57D1078_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_98F3E6E5537EAC010D3CDEB3A57D1078" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities, Debt Maturities, Year Two Through Five, Amortized Cost Basis</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_98F3E6E5537EAC010D3CDEB3A57D1078" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_98F3E6E5537EAC010D3CDEB3A57D1078" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_98F3E6E5537EAC010D3CDEB3A57D1078" xlink:type="arc" />
    <link:label id="lab_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue_7E991D9393375755F28FDEB3A57D99CE_verboseLabel_en-US" xlink:label="lab_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue_7E991D9393375755F28FDEB3A57D99CE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Due after five years, estimated fair value</link:label>
    <link:label id="lab_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue_7E991D9393375755F28FDEB3A57D99CE_label_en-US" xlink:label="lab_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue_7E991D9393375755F28FDEB3A57D99CE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available For Sale Securities Debt Maturities After Five Years Fair Value</link:label>
    <link:label id="lab_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue_7E991D9393375755F28FDEB3A57D99CE_documentation_en-US" xlink:label="lab_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue_7E991D9393375755F28FDEB3A57D99CE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">This item represents the fair value of debt securities, which are expected to mature after five years from the balance sheet date and which are categorized neither as held-to-maturity nor trading securities.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue" xlink:label="loc_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue_7E991D9393375755F28FDEB3A57D99CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue_7E991D9393375755F28FDEB3A57D99CE" xlink:to="lab_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue_7E991D9393375755F28FDEB3A57D99CE" xlink:type="arc" />
    <link:label id="lab_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost_0153A0B3D052D25003C7DEB3A57D6449_verboseLabel_en-US" xlink:label="lab_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost_0153A0B3D052D25003C7DEB3A57D6449" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Due after five years, amortized cost</link:label>
    <link:label id="lab_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost_0153A0B3D052D25003C7DEB3A57D6449_label_en-US" xlink:label="lab_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost_0153A0B3D052D25003C7DEB3A57D6449" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available For Sale Securities Debt Maturities After Five Years Amortized Cost</link:label>
    <link:label id="lab_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost_0153A0B3D052D25003C7DEB3A57D6449_documentation_en-US" xlink:label="lab_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost_0153A0B3D052D25003C7DEB3A57D6449" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">This item represents debt securities, at cost, net of adjustments made for accretion, amortization, other-than-temporary impairments, and hedging, if any, which are expected to mature after five years from the balance sheet date and which are categorized neither as held-to-maturity nor trading securities.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost" xlink:label="loc_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost_0153A0B3D052D25003C7DEB3A57D6449" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost_0153A0B3D052D25003C7DEB3A57D6449" xlink:to="lab_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost_0153A0B3D052D25003C7DEB3A57D6449" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecurities_F6230D9A165A4866084BDEB3A57D58B4_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecurities_F6230D9A165A4866084BDEB3A57D58B4" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total available-for-sale securities, Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecurities_F6230D9A165A4866084BDEB3A57D58B4_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecurities_F6230D9A165A4866084BDEB3A57D58B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_F6230D9A165A4866084BDEB3A57D58B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecurities_F6230D9A165A4866084BDEB3A57D58B4" xlink:to="lab_us-gaap_AvailableForSaleSecurities_F6230D9A165A4866084BDEB3A57D58B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C14CE60D3436C452A693DEB3A57DC0DD_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C14CE60D3436C452A693DEB3A57DC0DD" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total available-for-sale securities, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C14CE60D3436C452A693DEB3A57DC0DD_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C14CE60D3436C452A693DEB3A57DC0DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Debt Securities, Amortized Cost Basis</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C14CE60D3436C452A693DEB3A57DC0DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C14CE60D3436C452A693DEB3A57DC0DD" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C14CE60D3436C452A693DEB3A57DC0DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementTable_150AB93CA86027479AD2DEC3995B284E_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable_150AB93CA86027479AD2DEC3995B284E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_150AB93CA86027479AD2DEC3995B284E_label_en-US" xlink:label="lab_us-gaap_StatementTable_150AB93CA86027479AD2DEC3995B284E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_150AB93CA86027479AD2DEC3995B284E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_150AB93CA86027479AD2DEC3995B284E" xlink:to="lab_us-gaap_StatementTable_150AB93CA86027479AD2DEC3995B284E" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_9E9D6B1FE36019F6AFFBDEC3995B201E_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_9E9D6B1FE36019F6AFFBDEC3995B201E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_9E9D6B1FE36019F6AFFBDEC3995B201E_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_9E9D6B1FE36019F6AFFBDEC3995B201E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9E9D6B1FE36019F6AFFBDEC3995B201E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9E9D6B1FE36019F6AFFBDEC3995B201E" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_9E9D6B1FE36019F6AFFBDEC3995B201E" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityComponentDomain_B61F13C57E7D51DAAAA0DEC3995BB9C4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_B61F13C57E7D51DAAAA0DEC3995BB9C4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_B61F13C57E7D51DAAAA0DEC3995BB9C4_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_B61F13C57E7D51DAAAA0DEC3995BB9C4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_B61F13C57E7D51DAAAA0DEC3995BB9C4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_B61F13C57E7D51DAAAA0DEC3995BB9C4" xlink:to="lab_us-gaap_EquityComponentDomain_B61F13C57E7D51DAAAA0DEC3995BB9C4" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C12C206E3554B0DFCF1DEC3995B10B2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C12C206E3554B0DFCF1DEC3995B10B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Net Unrealized Investment Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C12C206E3554B0DFCF1DEC3995B10B2_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C12C206E3554B0DFCF1DEC3995B10B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Net Investment Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C12C206E3554B0DFCF1DEC3995B10B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C12C206E3554B0DFCF1DEC3995B10B2" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C12C206E3554B0DFCF1DEC3995B10B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_E58D18D7CCD8F62CADA4DEC3995B1F3B_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_E58D18D7CCD8F62CADA4DEC3995B1F3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_E58D18D7CCD8F62CADA4DEC3995B1F3B_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_E58D18D7CCD8F62CADA4DEC3995B1F3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_E58D18D7CCD8F62CADA4DEC3995B1F3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_E58D18D7CCD8F62CADA4DEC3995B1F3B" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_E58D18D7CCD8F62CADA4DEC3995B1F3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_D6ECAD56BC8DF7F75E8ADEC3995B45EE_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_D6ECAD56BC8DF7F75E8ADEC3995B45EE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_D6ECAD56BC8DF7F75E8ADEC3995B45EE_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_D6ECAD56BC8DF7F75E8ADEC3995B45EE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_D6ECAD56BC8DF7F75E8ADEC3995B45EE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_D6ECAD56BC8DF7F75E8ADEC3995B45EE" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_D6ECAD56BC8DF7F75E8ADEC3995B45EE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_92C179A5FAB899AA90F7DEC3995B8A40_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_92C179A5FAB899AA90F7DEC3995B8A40" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_92C179A5FAB899AA90F7DEC3995B8A40_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_92C179A5FAB899AA90F7DEC3995B8A40" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_92C179A5FAB899AA90F7DEC3995B8A40" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_92C179A5FAB899AA90F7DEC3995B8A40" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_92C179A5FAB899AA90F7DEC3995B8A40" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_464CB587FAAE36323B6CDEC3995B47D0_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_464CB587FAAE36323B6CDEC3995B47D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_464CB587FAAE36323B6CDEC3995B47D0_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_464CB587FAAE36323B6CDEC3995B47D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_464CB587FAAE36323B6CDEC3995B47D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_464CB587FAAE36323B6CDEC3995B47D0" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_464CB587FAAE36323B6CDEC3995B47D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_AC50B0FD4C13A43D5C12DEC3995B2281_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_AC50B0FD4C13A43D5C12DEC3995B2281" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_AC50B0FD4C13A43D5C12DEC3995B2281_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_AC50B0FD4C13A43D5C12DEC3995B2281" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_AC50B0FD4C13A43D5C12DEC3995B2281" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_AC50B0FD4C13A43D5C12DEC3995B2281" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_AC50B0FD4C13A43D5C12DEC3995B2281" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_5CAC7CE0C2960FC425F8DEC3995B345B_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_5CAC7CE0C2960FC425F8DEC3995B345B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_5CAC7CE0C2960FC425F8DEC3995B345B_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_5CAC7CE0C2960FC425F8DEC3995B345B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5CAC7CE0C2960FC425F8DEC3995B345B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5CAC7CE0C2960FC425F8DEC3995B345B" xlink:to="lab_us-gaap_NonoperatingIncomeExpense_5CAC7CE0C2960FC425F8DEC3995B345B" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_E283839255A3E467249DDEC3995B5EB4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_E283839255A3E467249DDEC3995B5EB4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_E283839255A3E467249DDEC3995B5EB4_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_E283839255A3E467249DDEC3995B5EB4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_E283839255A3E467249DDEC3995B5EB4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_E283839255A3E467249DDEC3995B5EB4" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_E283839255A3E467249DDEC3995B5EB4" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesRevenueGoodsNet_7B970EEA650E6905CD6ADEC3995B15FD_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueGoodsNet_7B970EEA650E6905CD6ADEC3995B15FD" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Product, net</link:label>
    <link:label id="lab_us-gaap_SalesRevenueGoodsNet_7B970EEA650E6905CD6ADEC3995B15FD_label_en-US" xlink:label="lab_us-gaap_SalesRevenueGoodsNet_7B970EEA650E6905CD6ADEC3995B15FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Revenue, Goods, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_7B970EEA650E6905CD6ADEC3995B15FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueGoodsNet_7B970EEA650E6905CD6ADEC3995B15FD" xlink:to="lab_us-gaap_SalesRevenueGoodsNet_7B970EEA650E6905CD6ADEC3995B15FD" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_FAEF36A4CB4983D5A270DEC3995B346A_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_FAEF36A4CB4983D5A270DEC3995B346A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income attributable to Biogen Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_FAEF36A4CB4983D5A270DEC3995B346A_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_FAEF36A4CB4983D5A270DEC3995B346A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_FAEF36A4CB4983D5A270DEC3995B346A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_FAEF36A4CB4983D5A270DEC3995B346A" xlink:to="lab_us-gaap_NetIncomeLoss_FAEF36A4CB4983D5A270DEC3995B346A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:type="arc" />
    <link:label id="lab_biib_TysabriProductMember_2B88A407CFA08F2F2481DE9E115A5A80_terseLabel_en-US" xlink:label="lab_biib_TysabriProductMember_2B88A407CFA08F2F2481DE9E115A5A80" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">TYSABRI product</link:label>
    <link:label id="lab_biib_TysabriProductMember_2B88A407CFA08F2F2481DE9E115A5A80_label_en-US" xlink:label="lab_biib_TysabriProductMember_2B88A407CFA08F2F2481DE9E115A5A80" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">TYSABRI product [Member]</link:label>
    <link:label id="lab_biib_TysabriProductMember_2B88A407CFA08F2F2481DE9E115A5A80_documentation_en-US" xlink:label="lab_biib_TysabriProductMember_2B88A407CFA08F2F2481DE9E115A5A80" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">TYSABRI product [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_TysabriProductMember" xlink:label="loc_biib_TysabriProductMember_2B88A407CFA08F2F2481DE9E115A5A80" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_TysabriProductMember_2B88A407CFA08F2F2481DE9E115A5A80" xlink:to="lab_biib_TysabriProductMember_2B88A407CFA08F2F2481DE9E115A5A80" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_36BD7858FFBDDD05BD39DE9E115A8000_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_36BD7858FFBDDD05BD39DE9E115A8000" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_36BD7858FFBDDD05BD39DE9E115A8000_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_36BD7858FFBDDD05BD39DE9E115A8000" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_36BD7858FFBDDD05BD39DE9E115A8000" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_36BD7858FFBDDD05BD39DE9E115A8000" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_36BD7858FFBDDD05BD39DE9E115A8000" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4" xlink:type="arc" />
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_18786B135B7CEAB6586BDE9E115A5EDB_verboseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember_18786B135B7CEAB6586BDE9E115A5EDB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_18786B135B7CEAB6586BDE9E115A5EDB_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember_18786B135B7CEAB6586BDE9E115A5EDB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_18786B135B7CEAB6586BDE9E115A5EDB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember_18786B135B7CEAB6586BDE9E115A5EDB" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember_18786B135B7CEAB6586BDE9E115A5EDB" xlink:type="arc" />
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_E906066BA6020A5543B0DE9E115A1CC4_verboseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember_E906066BA6020A5543B0DE9E115A1CC4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Trademarks and trade names</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_E906066BA6020A5543B0DE9E115A1CC4_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember_E906066BA6020A5543B0DE9E115A1CC4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_E906066BA6020A5543B0DE9E115A1CC4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember_E906066BA6020A5543B0DE9E115A1CC4" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember_E906066BA6020A5543B0DE9E115A1CC4" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86813380AE43BC1E5BE6DE9E115A141D_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86813380AE43BC1E5BE6DE9E115A141D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86813380AE43BC1E5BE6DE9E115A141D_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86813380AE43BC1E5BE6DE9E115A141D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86813380AE43BC1E5BE6DE9E115A141D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86813380AE43BC1E5BE6DE9E115A141D" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86813380AE43BC1E5BE6DE9E115A141D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949" xlink:type="arc" />
    <link:label id="lab_biib_OutLicensedPatentsMember_CFDB88EF086B018518C1DE9E115A6258_terseLabel_en-US" xlink:label="lab_biib_OutLicensedPatentsMember_CFDB88EF086B018518C1DE9E115A6258" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Out-licensed patents</link:label>
    <link:label id="lab_biib_OutLicensedPatentsMember_CFDB88EF086B018518C1DE9E115A6258_label_en-US" xlink:label="lab_biib_OutLicensedPatentsMember_CFDB88EF086B018518C1DE9E115A6258" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Out Licensed Patents [Member]</link:label>
    <link:label id="lab_biib_OutLicensedPatentsMember_CFDB88EF086B018518C1DE9E115A6258_documentation_en-US" xlink:label="lab_biib_OutLicensedPatentsMember_CFDB88EF086B018518C1DE9E115A6258" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Out-licensed patents.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_OutLicensedPatentsMember" xlink:label="loc_biib_OutLicensedPatentsMember_CFDB88EF086B018518C1DE9E115A6258" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_OutLicensedPatentsMember_CFDB88EF086B018518C1DE9E115A6258" xlink:to="lab_biib_OutLicensedPatentsMember_CFDB88EF086B018518C1DE9E115A6258" xlink:type="arc" />
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_0F7EECD74927743E0C01DE9E115BD98C_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_0F7EECD74927743E0C01DE9E115BD98C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_0F7EECD74927743E0C01DE9E115BD98C_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_0F7EECD74927743E0C01DE9E115BD98C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_0F7EECD74927743E0C01DE9E115BD98C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember_0F7EECD74927743E0C01DE9E115BD98C" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember_0F7EECD74927743E0C01DE9E115BD98C" xlink:type="arc" />
    <link:label id="lab_biib_InLicensedPatentsMember_B2D0F1D290209CC6140BDE9E115BB096_terseLabel_en-US" xlink:label="lab_biib_InLicensedPatentsMember_B2D0F1D290209CC6140BDE9E115BB096" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired and in-licensed rights and patents</link:label>
    <link:label id="lab_biib_InLicensedPatentsMember_B2D0F1D290209CC6140BDE9E115BB096_label_en-US" xlink:label="lab_biib_InLicensedPatentsMember_B2D0F1D290209CC6140BDE9E115BB096" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Licensed Patents [Member]</link:label>
    <link:label id="lab_biib_InLicensedPatentsMember_B2D0F1D290209CC6140BDE9E115BB096_documentation_en-US" xlink:label="lab_biib_InLicensedPatentsMember_B2D0F1D290209CC6140BDE9E115BB096" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">In-licensed patents.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_InLicensedPatentsMember" xlink:label="loc_biib_InLicensedPatentsMember_B2D0F1D290209CC6140BDE9E115BB096" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_InLicensedPatentsMember_B2D0F1D290209CC6140BDE9E115BB096" xlink:to="lab_biib_InLicensedPatentsMember_B2D0F1D290209CC6140BDE9E115BB096" xlink:type="arc" />
    <link:label id="lab_biib_AVONEXMember_B8E9A51DB32D533C6B8EDE9E115BE1D2_terseLabel_en-US" xlink:label="lab_biib_AVONEXMember_B8E9A51DB32D533C6B8EDE9E115BE1D2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AVONEX</link:label>
    <link:label id="lab_biib_AVONEXMember_B8E9A51DB32D533C6B8EDE9E115BE1D2_label_en-US" xlink:label="lab_biib_AVONEXMember_B8E9A51DB32D533C6B8EDE9E115BE1D2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AVONEX [Member]</link:label>
    <link:label id="lab_biib_AVONEXMember_B8E9A51DB32D533C6B8EDE9E115BE1D2_documentation_en-US" xlink:label="lab_biib_AVONEXMember_B8E9A51DB32D533C6B8EDE9E115BE1D2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AVONEX</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_AVONEXMember" xlink:label="loc_biib_AVONEXMember_B8E9A51DB32D533C6B8EDE9E115BE1D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_AVONEXMember_B8E9A51DB32D533C6B8EDE9E115BE1D2" xlink:to="lab_biib_AVONEXMember_B8E9A51DB32D533C6B8EDE9E115BE1D2" xlink:type="arc" />
    <link:label id="lab_us-gaap_RangeAxis_B29DEC769A323C35E6F8DE9E115B6B87_terseLabel_en-US" xlink:label="lab_us-gaap_RangeAxis_B29DEC769A323C35E6F8DE9E115B6B87" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_us-gaap_RangeAxis_B29DEC769A323C35E6F8DE9E115B6B87_label_en-US" xlink:label="lab_us-gaap_RangeAxis_B29DEC769A323C35E6F8DE9E115B6B87" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_B29DEC769A323C35E6F8DE9E115B6B87" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RangeAxis_B29DEC769A323C35E6F8DE9E115B6B87" xlink:to="lab_us-gaap_RangeAxis_B29DEC769A323C35E6F8DE9E115B6B87" xlink:type="arc" />
    <link:label id="lab_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6_terseLabel_en-US" xlink:label="lab_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6_label_en-US" xlink:label="lab_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6" xlink:to="lab_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinimumMember_BC27783AAFA599DE9C41DE9E115BCA7C_verboseLabel_en-US" xlink:label="lab_us-gaap_MinimumMember_BC27783AAFA599DE9C41DE9E115BCA7C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_us-gaap_MinimumMember_BC27783AAFA599DE9C41DE9E115BCA7C_label_en-US" xlink:label="lab_us-gaap_MinimumMember_BC27783AAFA599DE9C41DE9E115BCA7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_BC27783AAFA599DE9C41DE9E115BCA7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinimumMember_BC27783AAFA599DE9C41DE9E115BCA7C" xlink:to="lab_us-gaap_MinimumMember_BC27783AAFA599DE9C41DE9E115BCA7C" xlink:type="arc" />
    <link:label id="lab_us-gaap_MaximumMember_940809A63466F53766C7DE9E115BA2B1_verboseLabel_en-US" xlink:label="lab_us-gaap_MaximumMember_940809A63466F53766C7DE9E115BA2B1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_us-gaap_MaximumMember_940809A63466F53766C7DE9E115BA2B1_label_en-US" xlink:label="lab_us-gaap_MaximumMember_940809A63466F53766C7DE9E115BA2B1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_940809A63466F53766C7DE9E115BA2B1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumMember_940809A63466F53766C7DE9E115BA2B1" xlink:to="lab_us-gaap_MaximumMember_940809A63466F53766C7DE9E115BA2B1" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_086420AD222AAC6BCFE7DE9E115B17E7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_086420AD222AAC6BCFE7DE9E115B17E7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_086420AD222AAC6BCFE7DE9E115B17E7_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_086420AD222AAC6BCFE7DE9E115B17E7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_086420AD222AAC6BCFE7DE9E115B17E7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_086420AD222AAC6BCFE7DE9E115B17E7" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_086420AD222AAC6BCFE7DE9E115B17E7" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0FBB889D181BE481BD60DE9E115BFF56_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0FBB889D181BE481BD60DE9E115BFF56" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Estimated life, (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0FBB889D181BE481BD60DE9E115BFF56_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0FBB889D181BE481BD60DE9E115BFF56" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0FBB889D181BE481BD60DE9E115BFF56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0FBB889D181BE481BD60DE9E115BFF56" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0FBB889D181BE481BD60DE9E115BFF56" xlink:type="arc" />
    <link:label id="lab_biib_IndefiniteLivedIntangibleAssetsUsefulLife_4A16125F74B672195EDDDE9E115BDF8C_terseLabel_en-US" xlink:label="lab_biib_IndefiniteLivedIntangibleAssetsUsefulLife_4A16125F74B672195EDDDE9E115BDF8C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite lived intangible assets useful life</link:label>
    <link:label id="lab_biib_IndefiniteLivedIntangibleAssetsUsefulLife_4A16125F74B672195EDDDE9E115BDF8C_label_en-US" xlink:label="lab_biib_IndefiniteLivedIntangibleAssetsUsefulLife_4A16125F74B672195EDDDE9E115BDF8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite Lived Intangible Assets Useful Life</link:label>
    <link:label id="lab_biib_IndefiniteLivedIntangibleAssetsUsefulLife_4A16125F74B672195EDDDE9E115BDF8C_documentation_en-US" xlink:label="lab_biib_IndefiniteLivedIntangibleAssetsUsefulLife_4A16125F74B672195EDDDE9E115BDF8C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Indefinite lived intangible assets useful life.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_IndefiniteLivedIntangibleAssetsUsefulLife" xlink:label="loc_biib_IndefiniteLivedIntangibleAssetsUsefulLife_4A16125F74B672195EDDDE9E115BDF8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_IndefiniteLivedIntangibleAssetsUsefulLife_4A16125F74B672195EDDDE9E115BDF8C" xlink:to="lab_biib_IndefiniteLivedIntangibleAssetsUsefulLife_4A16125F74B672195EDDDE9E115BDF8C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_86352CB02A79941AC242DE9E115B1A44_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_86352CB02A79941AC242DE9E115B1A44" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_86352CB02A79941AC242DE9E115B1A44_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_86352CB02A79941AC242DE9E115B1A44" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_86352CB02A79941AC242DE9E115B1A44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross_86352CB02A79941AC242DE9E115B1A44" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross_86352CB02A79941AC242DE9E115B1A44" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_D600447D01DF423BECD7DE9E115B2388_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_D600447D01DF423BECD7DE9E115B2388" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost and Net</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_D600447D01DF423BECD7DE9E115B2388_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_D600447D01DF423BECD7DE9E115B2388" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_D600447D01DF423BECD7DE9E115B2388" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_D600447D01DF423BECD7DE9E115B2388" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_D600447D01DF423BECD7DE9E115B2388" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_155615B5CBD8A104E981DE9E115B19F0_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_155615B5CBD8A104E981DE9E115B19F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_155615B5CBD8A104E981DE9E115B19F0_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_155615B5CBD8A104E981DE9E115B19F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_155615B5CBD8A104E981DE9E115B19F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_155615B5CBD8A104E981DE9E115B19F0" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_155615B5CBD8A104E981DE9E115B19F0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_CA84C7805842F890007ADE9E115BF008_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_CA84C7805842F890007ADE9E115BF008" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_CA84C7805842F890007ADE9E115BF008_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_CA84C7805842F890007ADE9E115BF008" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_CA84C7805842F890007ADE9E115BF008" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_CA84C7805842F890007ADE9E115BF008" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_CA84C7805842F890007ADE9E115BF008" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_11BBDA22B795A4CBF251DE9E115B0B58_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_11BBDA22B795A4CBF251DE9E115B0B58" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_11BBDA22B795A4CBF251DE9E115B0B58_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_11BBDA22B795A4CBF251DE9E115B0B58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_11BBDA22B795A4CBF251DE9E115B0B58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_11BBDA22B795A4CBF251DE9E115B0B58" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_11BBDA22B795A4CBF251DE9E115B0B58" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_F452C9E4D9BF2E43FF08DE9E115C9679_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_F452C9E4D9BF2E43FF08DE9E115C9679" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_F452C9E4D9BF2E43FF08DE9E115C9679_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_F452C9E4D9BF2E43FF08DE9E115C9679" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_F452C9E4D9BF2E43FF08DE9E115C9679" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_F452C9E4D9BF2E43FF08DE9E115C9679" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_F452C9E4D9BF2E43FF08DE9E115C9679" xlink:type="arc" />
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_AD6204E90CA602702129DE9E115C228D_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_AD6204E90CA602702129DE9E115C228D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of out-licensed patent</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_AD6204E90CA602702129DE9E115C228D_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_AD6204E90CA602702129DE9E115C228D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_AD6204E90CA602702129DE9E115C228D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_AD6204E90CA602702129DE9E115C228D" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_AD6204E90CA602702129DE9E115C228D" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_DFB3492C84D00504071FDEA0EE5A320A_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_DFB3492C84D00504071FDEA0EE5A320A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets and Goodwill (Textual) [Abstract]</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_DFB3492C84D00504071FDEA0EE5A320A_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_DFB3492C84D00504071FDEA0EE5A320A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Including Goodwill) [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_DFB3492C84D00504071FDEA0EE5A320A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_DFB3492C84D00504071FDEA0EE5A320A" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_DFB3492C84D00504071FDEA0EE5A320A" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_72C1004350B4E0C3B390DEA0EE5E4760_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_72C1004350B4E0C3B390DEA0EE5E4760" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_72C1004350B4E0C3B390DEA0EE5E4760_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_72C1004350B4E0C3B390DEA0EE5E4760" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_72C1004350B4E0C3B390DEA0EE5E4760" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_72C1004350B4E0C3B390DEA0EE5E4760" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_72C1004350B4E0C3B390DEA0EE5E4760" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_DD0B1159857B97EC7527DEA0EE5E9BC2_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_DD0B1159857B97EC7527DEA0EE5E9BC2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated impairment losses related to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_DD0B1159857B97EC7527DEA0EE5E9BC2_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_DD0B1159857B97EC7527DEA0EE5E9BC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_DD0B1159857B97EC7527DEA0EE5E9BC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_DD0B1159857B97EC7527DEA0EE5E9BC2" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_DD0B1159857B97EC7527DEA0EE5E9BC2" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_82DAD1DA83485B57BC56DEA14B66F97D_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_82DAD1DA83485B57BC56DEA14B66F97D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected future amortization expense, 2015 (remaining six months)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_82DAD1DA83485B57BC56DEA14B66F97D_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_82DAD1DA83485B57BC56DEA14B66F97D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_82DAD1DA83485B57BC56DEA14B66F97D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_82DAD1DA83485B57BC56DEA14B66F97D" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_82DAD1DA83485B57BC56DEA14B66F97D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5929276452A2E3E7D3CFDEA14B680096_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5929276452A2E3E7D3CFDEA14B680096" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected future amortization expense, 2016</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5929276452A2E3E7D3CFDEA14B680096_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5929276452A2E3E7D3CFDEA14B680096" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5929276452A2E3E7D3CFDEA14B680096" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5929276452A2E3E7D3CFDEA14B680096" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5929276452A2E3E7D3CFDEA14B680096" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6C3B7B97454B5445ED04DEA14B696CB5_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6C3B7B97454B5445ED04DEA14B696CB5" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected future amortization expense, 2017</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6C3B7B97454B5445ED04DEA14B696CB5_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6C3B7B97454B5445ED04DEA14B696CB5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6C3B7B97454B5445ED04DEA14B696CB5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6C3B7B97454B5445ED04DEA14B696CB5" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6C3B7B97454B5445ED04DEA14B696CB5" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8AE03D585E97EE367D1BDEA14B6B28B9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8AE03D585E97EE367D1BDEA14B6B28B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected future amortization expense, 2018</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8AE03D585E97EE367D1BDEA14B6B28B9_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8AE03D585E97EE367D1BDEA14B6B28B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8AE03D585E97EE367D1BDEA14B6B28B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8AE03D585E97EE367D1BDEA14B6B28B9" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8AE03D585E97EE367D1BDEA14B6B28B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4646E044289B7821E0EADEA14B6C3B33_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4646E044289B7821E0EADEA14B6C3B33" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected future amortization expense, 2019</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4646E044289B7821E0EADEA14B6C3B33_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4646E044289B7821E0EADEA14B6C3B33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4646E044289B7821E0EADEA14B6C3B33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4646E044289B7821E0EADEA14B6C3B33" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4646E044289B7821E0EADEA14B6C3B33" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_358464443D7390E9FFA0DEA14B6DB4AB_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_358464443D7390E9FFA0DEA14B6DB4AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected future amortization expense, 2020</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_358464443D7390E9FFA0DEA14B6DB4AB_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_358464443D7390E9FFA0DEA14B6DB4AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_358464443D7390E9FFA0DEA14B6DB4AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_358464443D7390E9FFA0DEA14B6DB4AB" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_358464443D7390E9FFA0DEA14B6DB4AB" xlink:type="arc" />
    <link:label id="lab_biib_Finitelivedintangibleassetsfutureamortization_50EFEB80DD4222340C5CDEA14B6F2C40_totalLabel_en-US" xlink:label="lab_biib_Finitelivedintangibleassetsfutureamortization_50EFEB80DD4222340C5CDEA14B6F2C40" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_biib_Finitelivedintangibleassetsfutureamortization_50EFEB80DD4222340C5CDEA14B6F2C40_label_en-US" xlink:label="lab_biib_Finitelivedintangibleassetsfutureamortization_50EFEB80DD4222340C5CDEA14B6F2C40" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">FiniteLivedIntangibleAssetsFutureAmortization</link:label>
    <link:label id="lab_biib_Finitelivedintangibleassetsfutureamortization_50EFEB80DD4222340C5CDEA14B6F2C40_documentation_en-US" xlink:label="lab_biib_Finitelivedintangibleassetsfutureamortization_50EFEB80DD4222340C5CDEA14B6F2C40" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">FiniteLivedIntangibleAssetsFutureAmortization</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_Finitelivedintangibleassetsfutureamortization" xlink:label="loc_biib_Finitelivedintangibleassetsfutureamortization_50EFEB80DD4222340C5CDEA14B6F2C40" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_Finitelivedintangibleassetsfutureamortization_50EFEB80DD4222340C5CDEA14B6F2C40" xlink:to="lab_biib_Finitelivedintangibleassetsfutureamortization_50EFEB80DD4222340C5CDEA14B6F2C40" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract_1B5D803E4A3C0565A452DE175DD8EF33_label_en-US" xlink:label="lab_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract_1B5D803E4A3C0565A452DE175DD8EF33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Discounts, Returns and Allowances, Goods [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract" xlink:label="loc_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract_1B5D803E4A3C0565A452DE175DD8EF33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract_1B5D803E4A3C0565A452DE175DD8EF33" xlink:to="lab_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract_1B5D803E4A3C0565A452DE175DD8EF33" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_45191AF2AE2F19CF8451DE175DDDEF7C_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_45191AF2AE2F19CF8451DE175DDDEF7C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_45191AF2AE2F19CF8451DE175DDDEF7C_label_en-US" xlink:label="lab_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_45191AF2AE2F19CF8451DE175DDDEF7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_45191AF2AE2F19CF8451DE175DDDEF7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_45191AF2AE2F19CF8451DE175DDDEF7C" xlink:to="lab_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_45191AF2AE2F19CF8451DE175DDDEF7C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_DCEC228DEB62D65467A1DE175DDD2D48_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_DCEC228DEB62D65467A1DE175DDD2D48" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_DCEC228DEB62D65467A1DE175DDD2D48_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_DCEC228DEB62D65467A1DE175DDD2D48" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_DCEC228DEB62D65467A1DE175DDD2D48" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_DCEC228DEB62D65467A1DE175DDD2D48" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_DCEC228DEB62D65467A1DE175DDD2D48" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_D6C8579C41D21FF9AA46DE175DDDB01B_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain_D6C8579C41D21FF9AA46DE175DDDB01B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_D6C8579C41D21FF9AA46DE175DDDB01B_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain_D6C8579C41D21FF9AA46DE175DDDB01B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_D6C8579C41D21FF9AA46DE175DDDB01B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_D6C8579C41D21FF9AA46DE175DDDB01B" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain_D6C8579C41D21FF9AA46DE175DDDB01B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReserveForCashDiscountMember_8FA010C82D125F34B469DE175DDD0AD7_verboseLabel_en-US" xlink:label="lab_us-gaap_ReserveForCashDiscountMember_8FA010C82D125F34B469DE175DDD0AD7" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Discounts</link:label>
    <link:label id="lab_us-gaap_ReserveForCashDiscountMember_8FA010C82D125F34B469DE175DDD0AD7_label_en-US" xlink:label="lab_us-gaap_ReserveForCashDiscountMember_8FA010C82D125F34B469DE175DDD0AD7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reserve for Cash Discount [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReserveForCashDiscountMember" xlink:label="loc_us-gaap_ReserveForCashDiscountMember_8FA010C82D125F34B469DE175DDD0AD7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReserveForCashDiscountMember_8FA010C82D125F34B469DE175DDD0AD7" xlink:to="lab_us-gaap_ReserveForCashDiscountMember_8FA010C82D125F34B469DE175DDD0AD7" xlink:type="arc" />
    <link:label id="lab_biib_ContractualAdjustmentsMember_4C733E000A386C42D48DDE175DDDDB16_verboseLabel_en-US" xlink:label="lab_biib_ContractualAdjustmentsMember_4C733E000A386C42D48DDE175DDDDB16" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contractual Adjustments</link:label>
    <link:label id="lab_biib_ContractualAdjustmentsMember_4C733E000A386C42D48DDE175DDDDB16_label_en-US" xlink:label="lab_biib_ContractualAdjustmentsMember_4C733E000A386C42D48DDE175DDDDB16" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Adjustments [Member]</link:label>
    <link:label id="lab_biib_ContractualAdjustmentsMember_4C733E000A386C42D48DDE175DDDDB16_documentation_en-US" xlink:label="lab_biib_ContractualAdjustmentsMember_4C733E000A386C42D48DDE175DDDDB16" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contractual adjustments.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_ContractualAdjustmentsMember" xlink:label="loc_biib_ContractualAdjustmentsMember_4C733E000A386C42D48DDE175DDDDB16" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_ContractualAdjustmentsMember_4C733E000A386C42D48DDE175DDDDB16" xlink:to="lab_biib_ContractualAdjustmentsMember_4C733E000A386C42D48DDE175DDDDB16" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesReturnsAndAllowancesMember_D385ECD612A17AE95DFDDE175DDDF11D_verboseLabel_en-US" xlink:label="lab_us-gaap_SalesReturnsAndAllowancesMember_D385ECD612A17AE95DFDDE175DDDF11D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Returns</link:label>
    <link:label id="lab_us-gaap_SalesReturnsAndAllowancesMember_D385ECD612A17AE95DFDDE175DDDF11D_label_en-US" xlink:label="lab_us-gaap_SalesReturnsAndAllowancesMember_D385ECD612A17AE95DFDDE175DDDF11D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Returns and Allowances [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesReturnsAndAllowancesMember" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember_D385ECD612A17AE95DFDDE175DDDF11D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesReturnsAndAllowancesMember_D385ECD612A17AE95DFDDE175DDDF11D" xlink:to="lab_us-gaap_SalesReturnsAndAllowancesMember_D385ECD612A17AE95DFDDE175DDDF11D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_69EAC835A9D3EAE5E835DE175DDDB529_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_69EAC835A9D3EAE5E835DE175DDDB529" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_69EAC835A9D3EAE5E835DE175DDDB529_label_en-US" xlink:label="lab_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_69EAC835A9D3EAE5E835DE175DDDB529" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_69EAC835A9D3EAE5E835DE175DDDB529" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_69EAC835A9D3EAE5E835DE175DDDB529" xlink:to="lab_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_69EAC835A9D3EAE5E835DE175DDDB529" xlink:type="arc" />
    <link:label id="lab_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF_verboseLabel_en-US" xlink:label="lab_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Analysis of the amount of, and change in, reserves</link:label>
    <link:label id="lab_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF_label_en-US" xlink:label="lab_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Analysis Of Amount Of And Change In Product Revenue Reserves [Abstract]</link:label>
    <link:label id="lab_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF_documentation_en-US" xlink:label="lab_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Analysis of the amount of, and change in product revenue reserves.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract" xlink:label="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF" xlink:to="lab_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_4A5A5326D5D64EF480BCDE175DDD3ECF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_3164B1E35283559DACF6DE175DDEFB2F_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_3164B1E35283559DACF6DE175DDEFB2F" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance as of December 31, 2014</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_3164B1E35283559DACF6DE175DDEFB2F_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_3164B1E35283559DACF6DE175DDEFB2F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowances and Reserves, Balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_3164B1E35283559DACF6DE175DDEFB2F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance_3164B1E35283559DACF6DE175DDEFB2F" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance_3164B1E35283559DACF6DE175DDEFB2F" xlink:type="arc" />
    <link:label id="lab_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear_98AB5F007D6ACEEF14FEDE175DDE863D_verboseLabel_en-US" xlink:label="lab_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear_98AB5F007D6ACEEF14FEDE175DDE863D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current provisions relating to sales in current year</link:label>
    <link:label id="lab_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear_98AB5F007D6ACEEF14FEDE175DDE863D_label_en-US" xlink:label="lab_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear_98AB5F007D6ACEEF14FEDE175DDE863D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Provisions To Product Revenue Reserves Relating To Sales In Current Year</link:label>
    <link:label id="lab_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear_98AB5F007D6ACEEF14FEDE175DDE863D_documentation_en-US" xlink:label="lab_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear_98AB5F007D6ACEEF14FEDE175DDE863D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current provisions to product revenue reserves relating to sales in current year.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear" xlink:label="loc_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear_98AB5F007D6ACEEF14FEDE175DDE863D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear_98AB5F007D6ACEEF14FEDE175DDE863D" xlink:to="lab_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear_98AB5F007D6ACEEF14FEDE175DDE863D" xlink:type="arc" />
    <link:label id="lab_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears_C784A5B777626B2A0EBEDE175DDEE96C_negatedLabel_en-US" xlink:label="lab_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears_C784A5B777626B2A0EBEDE175DDEE96C" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Adjustments relating to prior years</link:label>
    <link:label id="lab_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears_C784A5B777626B2A0EBEDE175DDEE96C_label_en-US" xlink:label="lab_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears_C784A5B777626B2A0EBEDE175DDEE96C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments To Product Revenue Reserves Relating To Sales In Prior Years</link:label>
    <link:label id="lab_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears_C784A5B777626B2A0EBEDE175DDEE96C_documentation_en-US" xlink:label="lab_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears_C784A5B777626B2A0EBEDE175DDEE96C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments to product revenue reserves relating to sales in prior years.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears" xlink:label="loc_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears_C784A5B777626B2A0EBEDE175DDEE96C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears_C784A5B777626B2A0EBEDE175DDEE96C" xlink:to="lab_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears_C784A5B777626B2A0EBEDE175DDEE96C" xlink:type="arc" />
    <link:label id="lab_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear_3BEA06C0033D3CAFFFD9DE175DDE2636_negatedLabel_en-US" xlink:label="lab_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear_3BEA06C0033D3CAFFFD9DE175DDE2636" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments/credits relating to sales in current year</link:label>
    <link:label id="lab_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear_3BEA06C0033D3CAFFFD9DE175DDE2636_label_en-US" xlink:label="lab_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear_3BEA06C0033D3CAFFFD9DE175DDE2636" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments Returns Applied Against Product Revenue Reserves Relating To Current Year</link:label>
    <link:label id="lab_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear_3BEA06C0033D3CAFFFD9DE175DDE2636_documentation_en-US" xlink:label="lab_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear_3BEA06C0033D3CAFFFD9DE175DDE2636" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments/ returns applied against product revenue reserves relating to current year.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear" xlink:label="loc_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear_3BEA06C0033D3CAFFFD9DE175DDE2636" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear_3BEA06C0033D3CAFFFD9DE175DDE2636" xlink:to="lab_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear_3BEA06C0033D3CAFFFD9DE175DDE2636" xlink:type="arc" />
    <link:label id="lab_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear_28E7837D78E3D8D3FB8BDE175DDEA668_negatedLabel_en-US" xlink:label="lab_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear_28E7837D78E3D8D3FB8BDE175DDEA668" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments/credits relating to sales in prior years</link:label>
    <link:label id="lab_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear_28E7837D78E3D8D3FB8BDE175DDEA668_label_en-US" xlink:label="lab_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear_28E7837D78E3D8D3FB8BDE175DDEA668" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year</link:label>
    <link:label id="lab_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear_28E7837D78E3D8D3FB8BDE175DDEA668_documentation_en-US" xlink:label="lab_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear_28E7837D78E3D8D3FB8BDE175DDEA668" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments/ returns applied against product revenue reserves relating to prior year.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear" xlink:label="loc_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear_28E7837D78E3D8D3FB8BDE175DDEA668" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear_28E7837D78E3D8D3FB8BDE175DDEA668" xlink:to="lab_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear_28E7837D78E3D8D3FB8BDE175DDEA668" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_6F2FA8128C5BA33CE51FDE175DDEECAD_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_6F2FA8128C5BA33CE51FDE175DDEECAD" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance as of June 30, 2015</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_6F2FA8128C5BA33CE51FDE175DDEECAD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance_6F2FA8128C5BA33CE51FDE175DDEECAD" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance_6F2FA8128C5BA33CE51FDE175DDEECAD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_C68EE605C474E309BF67D4ED4AD3FDA8_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_C68EE605C474E309BF67D4ED4AD3FDA8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_C68EE605C474E309BF67D4ED4AD3FDA8_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_C68EE605C474E309BF67D4ED4AD3FDA8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_C68EE605C474E309BF67D4ED4AD3FDA8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_C68EE605C474E309BF67D4ED4AD3FDA8" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_C68EE605C474E309BF67D4ED4AD3FDA8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_D63834B8CF8B870AE25CD4ED4AD3BF17_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_D63834B8CF8B870AE25CD4ED4AD3BF17" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_D63834B8CF8B870AE25CD4ED4AD3BF17_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_D63834B8CF8B870AE25CD4ED4AD3BF17" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_D63834B8CF8B870AE25CD4ED4AD3BF17" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_D63834B8CF8B870AE25CD4ED4AD3BF17" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_D63834B8CF8B870AE25CD4ED4AD3BF17" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_C586B5DABF695027AC19D4ED4AD3E838_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_C586B5DABF695027AC19D4ED4AD3E838" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_C586B5DABF695027AC19D4ED4AD3E838_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_C586B5DABF695027AC19D4ED4AD3E838" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_C586B5DABF695027AC19D4ED4AD3E838" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_C586B5DABF695027AC19D4ED4AD3E838" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_C586B5DABF695027AC19D4ED4AD3E838" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_3FD7CE1D8201E1D5A2B4DE126779B083_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_3FD7CE1D8201E1D5A2B4DE126779B083" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_3FD7CE1D8201E1D5A2B4DE126779B083_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_3FD7CE1D8201E1D5A2B4DE126779B083" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3FD7CE1D8201E1D5A2B4DE126779B083" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3FD7CE1D8201E1D5A2B4DE126779B083" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1_3FD7CE1D8201E1D5A2B4DE126779B083" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_259FA3E6DEDCCA4EC6A1748A06B19270_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract_259FA3E6DEDCCA4EC6A1748A06B19270" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_259FA3E6DEDCCA4EC6A1748A06B19270" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract_259FA3E6DEDCCA4EC6A1748A06B19270" xlink:to="lab_us-gaap_SubsequentEventsAbstract_259FA3E6DEDCCA4EC6A1748A06B19270" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_CB8CC84A5E9815FD54AE748A06B6AF16_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock_CB8CC84A5E9815FD54AE748A06B6AF16" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_CB8CC84A5E9815FD54AE748A06B6AF16_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock_CB8CC84A5E9815FD54AE748A06B6AF16" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_CB8CC84A5E9815FD54AE748A06B6AF16" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock_CB8CC84A5E9815FD54AE748A06B6AF16" xlink:to="lab_us-gaap_SubsequentEventsTextBlock_CB8CC84A5E9815FD54AE748A06B6AF16" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_3F420A63E1A6BD51BBBFD4ED4B77EC41_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_3F420A63E1A6BD51BBBFD4ED4B77EC41" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Hierarchy [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_3F420A63E1A6BD51BBBFD4ED4B77EC41_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_3F420A63E1A6BD51BBBFD4ED4B77EC41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Hierarchy [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3F420A63E1A6BD51BBBFD4ED4B77EC41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3F420A63E1A6BD51BBBFD4ED4B77EC41" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_3F420A63E1A6BD51BBBFD4ED4B77EC41" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_C73C572BBB2E22D4A1E1D4ED4B78AD1E_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_C73C572BBB2E22D4A1E1D4ED4B78AD1E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Quoted Prices in Active Markets, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_C73C572BBB2E22D4A1E1D4ED4B78AD1E_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_C73C572BBB2E22D4A1E1D4ED4B78AD1E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_C73C572BBB2E22D4A1E1D4ED4B78AD1E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member_C73C572BBB2E22D4A1E1D4ED4B78AD1E" xlink:to="lab_us-gaap_FairValueInputsLevel1Member_C73C572BBB2E22D4A1E1D4ED4B78AD1E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_CF59A14D69696973B8BED4ED4B78697E_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_CF59A14D69696973B8BED4ED4B78697E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Significant Other Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_CF59A14D69696973B8BED4ED4B78697E_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_CF59A14D69696973B8BED4ED4B78697E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_CF59A14D69696973B8BED4ED4B78697E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member_CF59A14D69696973B8BED4ED4B78697E" xlink:to="lab_us-gaap_FairValueInputsLevel2Member_CF59A14D69696973B8BED4ED4B78697E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_B2D9EE9CB62507CE22F4D4ED4B7839C3_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_B2D9EE9CB62507CE22F4D4ED4B7839C3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Significant Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_B2D9EE9CB62507CE22F4D4ED4B7839C3_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_B2D9EE9CB62507CE22F4D4ED4B7839C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_B2D9EE9CB62507CE22F4D4ED4B7839C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member_B2D9EE9CB62507CE22F4D4ED4B7839C3" xlink:to="lab_us-gaap_FairValueInputsLevel3Member_B2D9EE9CB62507CE22F4D4ED4B7839C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_A57E86007D93D16CF343D4ED4B78E337_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_A57E86007D93D16CF343D4ED4B78E337" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_A57E86007D93D16CF343D4ED4B78E337_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_A57E86007D93D16CF343D4ED4B78E337" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A57E86007D93D16CF343D4ED4B78E337" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A57E86007D93D16CF343D4ED4B78E337" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis_A57E86007D93D16CF343D4ED4B78E337" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_727944FED3607E8BF378D4ED4B78EBC5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_727944FED3607E8BF378D4ED4B78EBC5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_727944FED3607E8BF378D4ED4B78EBC5_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_727944FED3607E8BF378D4ED4B78EBC5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_727944FED3607E8BF378D4ED4B78EBC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_727944FED3607E8BF378D4ED4B78EBC5" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain_727944FED3607E8BF378D4ED4B78EBC5" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_406890C909979751E0F6D4ED4B782705_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_406890C909979751E0F6D4ED4B782705" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_406890C909979751E0F6D4ED4B782705_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_406890C909979751E0F6D4ED4B782705" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurements, Recurring [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_406890C909979751E0F6D4ED4B782705" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember_406890C909979751E0F6D4ED4B782705" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember_406890C909979751E0F6D4ED4B782705" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_ABD0E6126B5F12975143D4ED4B7895E0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis_ABD0E6126B5F12975143D4ED4B7895E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_ABD0E6126B5F12975143D4ED4B7895E0_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis_ABD0E6126B5F12975143D4ED4B7895E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_ABD0E6126B5F12975143D4ED4B7895E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_ABD0E6126B5F12975143D4ED4B7895E0" xlink:to="lab_us-gaap_FairValueByAssetClassAxis_ABD0E6126B5F12975143D4ED4B7895E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_11CA350A2A4AF10B7B0BD4ED4B78B81D_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember_11CA350A2A4AF10B7B0BD4ED4B78B81D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_11CA350A2A4AF10B7B0BD4ED4B78B81D_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember_11CA350A2A4AF10B7B0BD4ED4B78B81D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_11CA350A2A4AF10B7B0BD4ED4B78B81D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember_11CA350A2A4AF10B7B0BD4ED4B78B81D" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember_11CA350A2A4AF10B7B0BD4ED4B78B81D" xlink:type="arc" />
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_FFF75F698D9DC9D5AD10D4ED4B78124F_verboseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember_FFF75F698D9DC9D5AD10D4ED4B78124F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Government securities</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_FFF75F698D9DC9D5AD10D4ED4B78124F_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember_FFF75F698D9DC9D5AD10D4ED4B78124F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_FFF75F698D9DC9D5AD10D4ED4B78124F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember_FFF75F698D9DC9D5AD10D4ED4B78124F" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember_FFF75F698D9DC9D5AD10D4ED4B78124F" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_162C69580FD5FDC6F6D0D4ED4B79F01E_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember_162C69580FD5FDC6F6D0D4ED4B79F01E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Mortgage and other asset backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_162C69580FD5FDC6F6D0D4ED4B79F01E_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember_162C69580FD5FDC6F6D0D4ED4B79F01E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetBackedSecuritiesMember" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_162C69580FD5FDC6F6D0D4ED4B79F01E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember_162C69580FD5FDC6F6D0D4ED4B79F01E" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember_162C69580FD5FDC6F6D0D4ED4B79F01E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BFE2BE4A3569F036496D4ED4B79E07D_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BFE2BE4A3569F036496D4ED4B79E07D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BFE2BE4A3569F036496D4ED4B79E07D_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BFE2BE4A3569F036496D4ED4B79E07D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BFE2BE4A3569F036496D4ED4B79E07D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BFE2BE4A3569F036496D4ED4B79E07D" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BFE2BE4A3569F036496D4ED4B79E07D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_7539103107ECE2935B80D4ED4B790708_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_7539103107ECE2935B80D4ED4B790708" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of assets and liabilities recorded at fair value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_7539103107ECE2935B80D4ED4B790708_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_7539103107ECE2935B80D4ED4B790708" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets, Liabilities and Stockholders' Equity Measured on Recurring Basis [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_7539103107ECE2935B80D4ED4B790708" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_7539103107ECE2935B80D4ED4B790708" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_7539103107ECE2935B80D4ED4B790708" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_92A3263B6F6D5335A841D4ED4B79CBD8_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_92A3263B6F6D5335A841D4ED4B79CBD8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_92A3263B6F6D5335A841D4ED4B79CBD8_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_92A3263B6F6D5335A841D4ED4B79CBD8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_92A3263B6F6D5335A841D4ED4B79CBD8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_92A3263B6F6D5335A841D4ED4B79CBD8" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_92A3263B6F6D5335A841D4ED4B79CBD8" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecurities_A9BA9FAE24BCD64FFC4DD4ED4B79FFC5_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecurities_A9BA9FAE24BCD64FFC4DD4ED4B79FFC5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable debt securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_A9BA9FAE24BCD64FFC4DD4ED4B79FFC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecurities_A9BA9FAE24BCD64FFC4DD4ED4B79FFC5" xlink:to="lab_us-gaap_AvailableForSaleSecurities_A9BA9FAE24BCD64FFC4DD4ED4B79FFC5" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_8C9079D0621322E80590D4ED4B79B4F6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_8C9079D0621322E80590D4ED4B79B4F6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_8C9079D0621322E80590D4ED4B79B4F6_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_8C9079D0621322E80590D4ED4B79B4F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_8C9079D0621322E80590D4ED4B79B4F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure_8C9079D0621322E80590D4ED4B79B4F6" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure_8C9079D0621322E80590D4ED4B79B4F6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_B2ED7F7E4A7C40506320D4ED4B79FBD9_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_B2ED7F7E4A7C40506320D4ED4B79FBD9" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Derivative contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_B2ED7F7E4A7C40506320D4ED4B79FBD9_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_B2ED7F7E4A7C40506320D4ED4B79FBD9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_B2ED7F7E4A7C40506320D4ED4B79FBD9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_B2ED7F7E4A7C40506320D4ED4B79FBD9" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_B2ED7F7E4A7C40506320D4ED4B79FBD9" xlink:type="arc" />
    <link:label id="lab_biib_PlanAssetsForDeferredCompensationFairValueDisclosure_EFC1DD2764FF6F26EB51D4ED4B79BDF2_verboseLabel_en-US" xlink:label="lab_biib_PlanAssetsForDeferredCompensationFairValueDisclosure_EFC1DD2764FF6F26EB51D4ED4B79BDF2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Plan assets for deferred compensation</link:label>
    <link:label id="lab_biib_PlanAssetsForDeferredCompensationFairValueDisclosure_EFC1DD2764FF6F26EB51D4ED4B79BDF2_label_en-US" xlink:label="lab_biib_PlanAssetsForDeferredCompensationFairValueDisclosure_EFC1DD2764FF6F26EB51D4ED4B79BDF2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Assets For Deferred Compensation Fair Value Disclosure</link:label>
    <link:label id="lab_biib_PlanAssetsForDeferredCompensationFairValueDisclosure_EFC1DD2764FF6F26EB51D4ED4B79BDF2_documentation_en-US" xlink:label="lab_biib_PlanAssetsForDeferredCompensationFairValueDisclosure_EFC1DD2764FF6F26EB51D4ED4B79BDF2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair values as of the balance sheet date of all assets of deferred compensation plans.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_PlanAssetsForDeferredCompensationFairValueDisclosure" xlink:label="loc_biib_PlanAssetsForDeferredCompensationFairValueDisclosure_EFC1DD2764FF6F26EB51D4ED4B79BDF2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_PlanAssetsForDeferredCompensationFairValueDisclosure_EFC1DD2764FF6F26EB51D4ED4B79BDF2" xlink:to="lab_biib_PlanAssetsForDeferredCompensationFairValueDisclosure_EFC1DD2764FF6F26EB51D4ED4B79BDF2" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_6600961CA4F8EA1CF787D4ED4B79AD64_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure_6600961CA4F8EA1CF787D4ED4B79AD64" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_6600961CA4F8EA1CF787D4ED4B79AD64_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure_6600961CA4F8EA1CF787D4ED4B79AD64" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6600961CA4F8EA1CF787D4ED4B79AD64" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_6600961CA4F8EA1CF787D4ED4B79AD64" xlink:to="lab_us-gaap_AssetsFairValueDisclosure_6600961CA4F8EA1CF787D4ED4B79AD64" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_AA0886088669242687CFD4ED4B79B967_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_AA0886088669242687CFD4ED4B79B967" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Derivative contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_AA0886088669242687CFD4ED4B79B967_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_AA0886088669242687CFD4ED4B79B967" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_AA0886088669242687CFD4ED4B79B967" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_AA0886088669242687CFD4ED4B79B967" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_AA0886088669242687CFD4ED4B79B967" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_A92EA42202FFE95C114FD4ED4B799938_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_A92EA42202FFE95C114FD4ED4B799938" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_A92EA42202FFE95C114FD4ED4B799938_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_A92EA42202FFE95C114FD4ED4B799938" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_A92EA42202FFE95C114FD4ED4B799938" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_A92EA42202FFE95C114FD4ED4B799938" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_A92EA42202FFE95C114FD4ED4B799938" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_5013B0A407E147FD684DD4ED4B79282E_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure_5013B0A407E147FD684DD4ED4B79282E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_5013B0A407E147FD684DD4ED4B79282E_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure_5013B0A407E147FD684DD4ED4B79282E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_5013B0A407E147FD684DD4ED4B79282E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_5013B0A407E147FD684DD4ED4B79282E" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure_5013B0A407E147FD684DD4ED4B79282E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_68EEF0132F6A3E66A9DDDEB09F61826A_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_68EEF0132F6A3E66A9DDDEB09F61826A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_68EEF0132F6A3E66A9DDDEB09F61826A_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_68EEF0132F6A3E66A9DDDEB09F61826A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_68EEF0132F6A3E66A9DDDEB09F61826A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_68EEF0132F6A3E66A9DDDEB09F61826A" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_68EEF0132F6A3E66A9DDDEB09F61826A" xlink:type="arc" />
    <link:label id="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_75B0BB3E90F78B8AA7BBDEB09F6132F9_terseLabel_en-US" xlink:label="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_75B0BB3E90F78B8AA7BBDEB09F6132F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major Types of Debt and Equity Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_75B0BB3E90F78B8AA7BBDEB09F6132F9_label_en-US" xlink:label="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_75B0BB3E90F78B8AA7BBDEB09F6132F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Types of Debt and Equity Securities [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_75B0BB3E90F78B8AA7BBDEB09F6132F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_75B0BB3E90F78B8AA7BBDEB09F6132F9" xlink:to="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_75B0BB3E90F78B8AA7BBDEB09F6132F9" xlink:type="arc" />
    <link:label id="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E_terseLabel_en-US" xlink:label="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major Types of Debt and Equity Securities [Domain]</link:label>
    <link:label id="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E_label_en-US" xlink:label="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Types of Debt and Equity Securities [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E" xlink:to="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_32FE82E8A943A4E6F55BDEB09F61BB3E" xlink:type="arc" />
    <link:label id="lab_biib_CorporateDebtSecuritiesCurrentMember_005AAC744B4863231CCDDEB09F62927D_verboseLabel_en-US" xlink:label="lab_biib_CorporateDebtSecuritiesCurrentMember_005AAC744B4863231CCDDEB09F62927D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Corporate debt securities Current</link:label>
    <link:label id="lab_biib_CorporateDebtSecuritiesCurrentMember_005AAC744B4863231CCDDEB09F62927D_label_en-US" xlink:label="lab_biib_CorporateDebtSecuritiesCurrentMember_005AAC744B4863231CCDDEB09F62927D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Debt Securities Current [Member]</link:label>
    <link:label id="lab_biib_CorporateDebtSecuritiesCurrentMember_005AAC744B4863231CCDDEB09F62927D_documentation_en-US" xlink:label="lab_biib_CorporateDebtSecuritiesCurrentMember_005AAC744B4863231CCDDEB09F62927D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Corporate debt securities Current.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_CorporateDebtSecuritiesCurrentMember" xlink:label="loc_biib_CorporateDebtSecuritiesCurrentMember_005AAC744B4863231CCDDEB09F62927D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_CorporateDebtSecuritiesCurrentMember_005AAC744B4863231CCDDEB09F62927D" xlink:to="lab_biib_CorporateDebtSecuritiesCurrentMember_005AAC744B4863231CCDDEB09F62927D" xlink:type="arc" />
    <link:label id="lab_biib_CorporateDebtSecuritiesNonCurrentMember_8414B333287A942AE461DEB09F62619F_verboseLabel_en-US" xlink:label="lab_biib_CorporateDebtSecuritiesNonCurrentMember_8414B333287A942AE461DEB09F62619F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Corporate debt securities Non-current</link:label>
    <link:label id="lab_biib_CorporateDebtSecuritiesNonCurrentMember_8414B333287A942AE461DEB09F62619F_label_en-US" xlink:label="lab_biib_CorporateDebtSecuritiesNonCurrentMember_8414B333287A942AE461DEB09F62619F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Debt Securities Non Current [Member]</link:label>
    <link:label id="lab_biib_CorporateDebtSecuritiesNonCurrentMember_8414B333287A942AE461DEB09F62619F_documentation_en-US" xlink:label="lab_biib_CorporateDebtSecuritiesNonCurrentMember_8414B333287A942AE461DEB09F62619F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Corporate Debt Securities Non Current.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_CorporateDebtSecuritiesNonCurrentMember" xlink:label="loc_biib_CorporateDebtSecuritiesNonCurrentMember_8414B333287A942AE461DEB09F62619F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_CorporateDebtSecuritiesNonCurrentMember_8414B333287A942AE461DEB09F62619F" xlink:to="lab_biib_CorporateDebtSecuritiesNonCurrentMember_8414B333287A942AE461DEB09F62619F" xlink:type="arc" />
    <link:label id="lab_biib_GovernmentSecuritiesCurrentMember_99C9E29B49DF7D5C91C4DEB09F62D876_verboseLabel_en-US" xlink:label="lab_biib_GovernmentSecuritiesCurrentMember_99C9E29B49DF7D5C91C4DEB09F62D876" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Government securities Current</link:label>
    <link:label id="lab_biib_GovernmentSecuritiesCurrentMember_99C9E29B49DF7D5C91C4DEB09F62D876_label_en-US" xlink:label="lab_biib_GovernmentSecuritiesCurrentMember_99C9E29B49DF7D5C91C4DEB09F62D876" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Securities Current [Member]</link:label>
    <link:label id="lab_biib_GovernmentSecuritiesCurrentMember_99C9E29B49DF7D5C91C4DEB09F62D876_documentation_en-US" xlink:label="lab_biib_GovernmentSecuritiesCurrentMember_99C9E29B49DF7D5C91C4DEB09F62D876" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Government securities Current.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_GovernmentSecuritiesCurrentMember" xlink:label="loc_biib_GovernmentSecuritiesCurrentMember_99C9E29B49DF7D5C91C4DEB09F62D876" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_GovernmentSecuritiesCurrentMember_99C9E29B49DF7D5C91C4DEB09F62D876" xlink:to="lab_biib_GovernmentSecuritiesCurrentMember_99C9E29B49DF7D5C91C4DEB09F62D876" xlink:type="arc" />
    <link:label id="lab_biib_GovernmentSecuritiesNonCurrentMember_E370437F5FE692E3D17CDEB09F629114_verboseLabel_en-US" xlink:label="lab_biib_GovernmentSecuritiesNonCurrentMember_E370437F5FE692E3D17CDEB09F629114" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Government securities Non-current</link:label>
    <link:label id="lab_biib_GovernmentSecuritiesNonCurrentMember_E370437F5FE692E3D17CDEB09F629114_label_en-US" xlink:label="lab_biib_GovernmentSecuritiesNonCurrentMember_E370437F5FE692E3D17CDEB09F629114" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Securities Non-current [Member]</link:label>
    <link:label id="lab_biib_GovernmentSecuritiesNonCurrentMember_E370437F5FE692E3D17CDEB09F629114_documentation_en-US" xlink:label="lab_biib_GovernmentSecuritiesNonCurrentMember_E370437F5FE692E3D17CDEB09F629114" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Government Securities Non Current.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_GovernmentSecuritiesNonCurrentMember" xlink:label="loc_biib_GovernmentSecuritiesNonCurrentMember_E370437F5FE692E3D17CDEB09F629114" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_GovernmentSecuritiesNonCurrentMember_E370437F5FE692E3D17CDEB09F629114" xlink:to="lab_biib_GovernmentSecuritiesNonCurrentMember_E370437F5FE692E3D17CDEB09F629114" xlink:type="arc" />
    <link:label id="lab_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember_50D7BC74C8A96D9C0513DEB09F62C0BC_verboseLabel_en-US" xlink:label="lab_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember_50D7BC74C8A96D9C0513DEB09F62C0BC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Mortgage and other asset backed securities Current</link:label>
    <link:label id="lab_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember_50D7BC74C8A96D9C0513DEB09F62C0BC_label_en-US" xlink:label="lab_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember_50D7BC74C8A96D9C0513DEB09F62C0BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mortgage And Other Asset Backed Securities Current [Member]</link:label>
    <link:label id="lab_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember_50D7BC74C8A96D9C0513DEB09F62C0BC_documentation_en-US" xlink:label="lab_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember_50D7BC74C8A96D9C0513DEB09F62C0BC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mortgage and other asset backed securities Current.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember" xlink:label="loc_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember_50D7BC74C8A96D9C0513DEB09F62C0BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember_50D7BC74C8A96D9C0513DEB09F62C0BC" xlink:to="lab_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember_50D7BC74C8A96D9C0513DEB09F62C0BC" xlink:type="arc" />
    <link:label id="lab_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember_67190E498F3ED90BE787DEB09F62E09E_verboseLabel_en-US" xlink:label="lab_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember_67190E498F3ED90BE787DEB09F62E09E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Mortgage and other asset backed securities Non-current</link:label>
    <link:label id="lab_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember_67190E498F3ED90BE787DEB09F62E09E_label_en-US" xlink:label="lab_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember_67190E498F3ED90BE787DEB09F62E09E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mortgage And Other Asset Backed Securities Non Current [Member]</link:label>
    <link:label id="lab_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember_67190E498F3ED90BE787DEB09F62E09E_documentation_en-US" xlink:label="lab_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember_67190E498F3ED90BE787DEB09F62E09E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mortgage And Other Asset Backed Securities Non Current.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember" xlink:label="loc_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember_67190E498F3ED90BE787DEB09F62E09E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember_67190E498F3ED90BE787DEB09F62E09E" xlink:to="lab_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember_67190E498F3ED90BE787DEB09F62E09E" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquitySecuritiesMember_13528845E57A1DF731A7DEB1C5EA18C3_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember_13528845E57A1DF731A7DEB1C5EA18C3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Marketable equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_13528845E57A1DF731A7DEB1C5EA18C3_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember_13528845E57A1DF731A7DEB1C5EA18C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaap_EquitySecuritiesMember_13528845E57A1DF731A7DEB1C5EA18C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember_13528845E57A1DF731A7DEB1C5EA18C3" xlink:to="lab_us-gaap_EquitySecuritiesMember_13528845E57A1DF731A7DEB1C5EA18C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_AC53FEF10D44A426955ADEB09F62E454_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_AC53FEF10D44A426955ADEB09F62E454" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Available-for-sale Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_AC53FEF10D44A426955ADEB09F62E454_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_AC53FEF10D44A426955ADEB09F62E454" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Available-for-sale Securities [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_AC53FEF10D44A426955ADEB09F62E454" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_AC53FEF10D44A426955ADEB09F62E454" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_AC53FEF10D44A426955ADEB09F62E454" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_D4AC48FB6950BF028E5DDEB09F62C7F9_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract_D4AC48FB6950BF028E5DDEB09F62C7F9" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Marketable Debt and Equity Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_D4AC48FB6950BF028E5DDEB09F62C7F9_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract_D4AC48FB6950BF028E5DDEB09F62C7F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_D4AC48FB6950BF028E5DDEB09F62C7F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_D4AC48FB6950BF028E5DDEB09F62C7F9" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract_D4AC48FB6950BF028E5DDEB09F62C7F9" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecurities_4DE8D504198BA2B31805DEB09F6271D1_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecurities_4DE8D504198BA2B31805DEB09F6271D1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_4DE8D504198BA2B31805DEB09F6271D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecurities_4DE8D504198BA2B31805DEB09F6271D1" xlink:to="lab_us-gaap_AvailableForSaleSecurities_4DE8D504198BA2B31805DEB09F6271D1" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5E5887901989C7F701FBDEB09F624F6B_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5E5887901989C7F701FBDEB09F624F6B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5E5887901989C7F701FBDEB09F624F6B_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5E5887901989C7F701FBDEB09F624F6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5E5887901989C7F701FBDEB09F624F6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5E5887901989C7F701FBDEB09F624F6B" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5E5887901989C7F701FBDEB09F624F6B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8100521E5030A14AED33DEB09F628BCF_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8100521E5030A14AED33DEB09F628BCF" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8100521E5030A14AED33DEB09F628BCF_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8100521E5030A14AED33DEB09F628BCF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8100521E5030A14AED33DEB09F628BCF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8100521E5030A14AED33DEB09F628BCF" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8100521E5030A14AED33DEB09F628BCF" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAmortizedCost_76245FD28CBC6692A881DEB09F62BFA3_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAmortizedCost_76245FD28CBC6692A881DEB09F62BFA3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAmortizedCost_76245FD28CBC6692A881DEB09F62BFA3_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAmortizedCost_76245FD28CBC6692A881DEB09F62BFA3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities, Amortized Cost Basis</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAmortizedCost_76245FD28CBC6692A881DEB09F62BFA3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAmortizedCost_76245FD28CBC6692A881DEB09F62BFA3" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAmortizedCost_76245FD28CBC6692A881DEB09F62BFA3" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_35B81540F91726BFA863D4ED4BB5037E_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_35B81540F91726BFA863D4ED4BB5037E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_35B81540F91726BFA863D4ED4BB5037E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_35B81540F91726BFA863D4ED4BB5037E" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_35B81540F91726BFA863D4ED4BB5037E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:type="arc" />
    <link:label id="lab_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881_terseLabel_en-US" xlink:label="lab_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative sales level [Axis]</link:label>
    <link:label id="lab_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881_label_en-US" xlink:label="lab_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative sales level [Axis]</link:label>
    <link:label id="lab_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881_documentation_en-US" xlink:label="lab_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cumulative sales level [Axis]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_CumulativeSalesLevelAxis" xlink:label="loc_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881" xlink:to="lab_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881" xlink:type="arc" />
    <link:label id="lab_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD_terseLabel_en-US" xlink:label="lab_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative sales level [Domain]</link:label>
    <link:label id="lab_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD_label_en-US" xlink:label="lab_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative sales level [Domain]</link:label>
    <link:label id="lab_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD_documentation_en-US" xlink:label="lab_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Cumulative sales level [Axis]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_CumulativeSalesLevelDomain" xlink:label="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:to="lab_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:type="arc" />
    <link:label id="lab_biib_FourbillionMember_692FB14EC0F32391BFABD4ED4BB5111C_terseLabel_en-US" xlink:label="lab_biib_FourbillionMember_692FB14EC0F32391BFABD4ED4BB5111C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Four billion</link:label>
    <link:label id="lab_biib_FourbillionMember_692FB14EC0F32391BFABD4ED4BB5111C_label_en-US" xlink:label="lab_biib_FourbillionMember_692FB14EC0F32391BFABD4ED4BB5111C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Four billion [Member]</link:label>
    <link:label id="lab_biib_FourbillionMember_692FB14EC0F32391BFABD4ED4BB5111C_documentation_en-US" xlink:label="lab_biib_FourbillionMember_692FB14EC0F32391BFABD4ED4BB5111C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Four billion [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_FourbillionMember" xlink:label="loc_biib_FourbillionMember_692FB14EC0F32391BFABD4ED4BB5111C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_FourbillionMember_692FB14EC0F32391BFABD4ED4BB5111C" xlink:to="lab_biib_FourbillionMember_692FB14EC0F32391BFABD4ED4BB5111C" xlink:type="arc" />
    <link:label id="lab_biib_FivebillionMember_332481569C77EB7D7323D4ED4BB5B70F_terseLabel_en-US" xlink:label="lab_biib_FivebillionMember_332481569C77EB7D7323D4ED4BB5B70F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Five billion</link:label>
    <link:label id="lab_biib_FivebillionMember_332481569C77EB7D7323D4ED4BB5B70F_label_en-US" xlink:label="lab_biib_FivebillionMember_332481569C77EB7D7323D4ED4BB5B70F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Five billion [Member]</link:label>
    <link:label id="lab_biib_FivebillionMember_332481569C77EB7D7323D4ED4BB5B70F_documentation_en-US" xlink:label="lab_biib_FivebillionMember_332481569C77EB7D7323D4ED4BB5B70F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Five billion [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_FivebillionMember" xlink:label="loc_biib_FivebillionMember_332481569C77EB7D7323D4ED4BB5B70F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_FivebillionMember_332481569C77EB7D7323D4ED4BB5B70F" xlink:to="lab_biib_FivebillionMember_332481569C77EB7D7323D4ED4BB5B70F" xlink:type="arc" />
    <link:label id="lab_biib_EachAdditionalOneBillionUpToTwentyBillionMember_3E9BE8D5592079C75DEBD4ED4BB5040F_terseLabel_en-US" xlink:label="lab_biib_EachAdditionalOneBillionUpToTwentyBillionMember_3E9BE8D5592079C75DEBD4ED4BB5040F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Each additional one billion up to twenty billion</link:label>
    <link:label id="lab_biib_EachAdditionalOneBillionUpToTwentyBillionMember_3E9BE8D5592079C75DEBD4ED4BB5040F_label_en-US" xlink:label="lab_biib_EachAdditionalOneBillionUpToTwentyBillionMember_3E9BE8D5592079C75DEBD4ED4BB5040F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Each additional one billion up to twenty billion [Member]</link:label>
    <link:label id="lab_biib_EachAdditionalOneBillionUpToTwentyBillionMember_3E9BE8D5592079C75DEBD4ED4BB5040F_documentation_en-US" xlink:label="lab_biib_EachAdditionalOneBillionUpToTwentyBillionMember_3E9BE8D5592079C75DEBD4ED4BB5040F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Each additional one billion up to twenty billion [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_EachAdditionalOneBillionUpToTwentyBillionMember" xlink:label="loc_biib_EachAdditionalOneBillionUpToTwentyBillionMember_3E9BE8D5592079C75DEBD4ED4BB5040F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_EachAdditionalOneBillionUpToTwentyBillionMember_3E9BE8D5592079C75DEBD4ED4BB5040F" xlink:to="lab_biib_EachAdditionalOneBillionUpToTwentyBillionMember_3E9BE8D5592079C75DEBD4ED4BB5040F" xlink:type="arc" />
    <link:label id="lab_biib_OneBillionMember_BA01B70086152E91BFC6D4ED4BB50D16_terseLabel_en-US" xlink:label="lab_biib_OneBillionMember_BA01B70086152E91BFC6D4ED4BB50D16" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">One billion</link:label>
    <link:label id="lab_biib_OneBillionMember_BA01B70086152E91BFC6D4ED4BB50D16_label_en-US" xlink:label="lab_biib_OneBillionMember_BA01B70086152E91BFC6D4ED4BB50D16" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">One billion [Member]</link:label>
    <link:label id="lab_biib_OneBillionMember_BA01B70086152E91BFC6D4ED4BB50D16_documentation_en-US" xlink:label="lab_biib_OneBillionMember_BA01B70086152E91BFC6D4ED4BB50D16" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">One billion [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_OneBillionMember" xlink:label="loc_biib_OneBillionMember_BA01B70086152E91BFC6D4ED4BB50D16" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_OneBillionMember_BA01B70086152E91BFC6D4ED4BB50D16" xlink:to="lab_biib_OneBillionMember_BA01B70086152E91BFC6D4ED4BB50D16" xlink:type="arc" />
    <link:label id="lab_biib_ThreeBillionMember_75C9CF7606AC472AC4FDD4ED4BB542A4_terseLabel_en-US" xlink:label="lab_biib_ThreeBillionMember_75C9CF7606AC472AC4FDD4ED4BB542A4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Three billion</link:label>
    <link:label id="lab_biib_ThreeBillionMember_75C9CF7606AC472AC4FDD4ED4BB542A4_label_en-US" xlink:label="lab_biib_ThreeBillionMember_75C9CF7606AC472AC4FDD4ED4BB542A4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Three billion [Member]</link:label>
    <link:label id="lab_biib_ThreeBillionMember_75C9CF7606AC472AC4FDD4ED4BB542A4_documentation_en-US" xlink:label="lab_biib_ThreeBillionMember_75C9CF7606AC472AC4FDD4ED4BB542A4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Three billion [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_ThreeBillionMember" xlink:label="loc_biib_ThreeBillionMember_75C9CF7606AC472AC4FDD4ED4BB542A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_ThreeBillionMember_75C9CF7606AC472AC4FDD4ED4BB542A4" xlink:to="lab_biib_ThreeBillionMember_75C9CF7606AC472AC4FDD4ED4BB542A4" xlink:type="arc" />
    <link:label id="lab_biib_FumapharmAgMember_6BE43698FB1DB4771027D4ED4BB58A30_terseLabel_en-US" xlink:label="lab_biib_FumapharmAgMember_6BE43698FB1DB4771027D4ED4BB58A30" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fumapharm AG</link:label>
    <link:label id="lab_biib_FumapharmAgMember_6BE43698FB1DB4771027D4ED4BB58A30_label_en-US" xlink:label="lab_biib_FumapharmAgMember_6BE43698FB1DB4771027D4ED4BB58A30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fumapharm AG [Member]</link:label>
    <link:label id="lab_biib_FumapharmAgMember_6BE43698FB1DB4771027D4ED4BB58A30_documentation_en-US" xlink:label="lab_biib_FumapharmAgMember_6BE43698FB1DB4771027D4ED4BB58A30" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fumapharm AG [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_FumapharmAgMember" xlink:label="loc_biib_FumapharmAgMember_6BE43698FB1DB4771027D4ED4BB58A30" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_FumapharmAgMember_6BE43698FB1DB4771027D4ED4BB58A30" xlink:to="lab_biib_FumapharmAgMember_6BE43698FB1DB4771027D4ED4BB58A30" xlink:type="arc" />
    <link:label id="lab_biib_TecfideraMember_E4A5BDBDFCB2F7CAA570D4ED4BB59E8A_terseLabel_en-US" xlink:label="lab_biib_TecfideraMember_E4A5BDBDFCB2F7CAA570D4ED4BB59E8A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">TECFIDERA</link:label>
    <link:label id="lab_biib_TecfideraMember_E4A5BDBDFCB2F7CAA570D4ED4BB59E8A_label_en-US" xlink:label="lab_biib_TecfideraMember_E4A5BDBDFCB2F7CAA570D4ED4BB59E8A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">TECFIDERA [Member]</link:label>
    <link:label id="lab_biib_TecfideraMember_E4A5BDBDFCB2F7CAA570D4ED4BB59E8A_documentation_en-US" xlink:label="lab_biib_TecfideraMember_E4A5BDBDFCB2F7CAA570D4ED4BB59E8A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">TECFIDERA [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_TecfideraMember" xlink:label="loc_biib_TecfideraMember_E4A5BDBDFCB2F7CAA570D4ED4BB59E8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_TecfideraMember_E4A5BDBDFCB2F7CAA570D4ED4BB59E8A" xlink:to="lab_biib_TecfideraMember_E4A5BDBDFCB2F7CAA570D4ED4BB59E8A" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5992331E1F873CE806AD4ED4BB6CDA9_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5992331E1F873CE806AD4ED4BB6CDA9" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Maximum contingent consideration in the form of development and approval milestones</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5992331E1F873CE806AD4ED4BB6CDA9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5992331E1F873CE806AD4ED4BB6CDA9" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5992331E1F873CE806AD4ED4BB6CDA9" xlink:type="arc" />
    <link:label id="lab_biib_CumulativeSalesLevel_54168BA36403C369CC05D4ED4BB6924F_terseLabel_en-US" xlink:label="lab_biib_CumulativeSalesLevel_54168BA36403C369CC05D4ED4BB6924F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative sales level</link:label>
    <link:label id="lab_biib_CumulativeSalesLevel_54168BA36403C369CC05D4ED4BB6924F_label_en-US" xlink:label="lab_biib_CumulativeSalesLevel_54168BA36403C369CC05D4ED4BB6924F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative sales level</link:label>
    <link:label id="lab_biib_CumulativeSalesLevel_54168BA36403C369CC05D4ED4BB6924F_documentation_en-US" xlink:label="lab_biib_CumulativeSalesLevel_54168BA36403C369CC05D4ED4BB6924F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cumulative sales level</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_CumulativeSalesLevel" xlink:label="loc_biib_CumulativeSalesLevel_54168BA36403C369CC05D4ED4BB6924F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_CumulativeSalesLevel_54168BA36403C369CC05D4ED4BB6924F" xlink:to="lab_biib_CumulativeSalesLevel_54168BA36403C369CC05D4ED4BB6924F" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_F9CBCEE3D80C9FE0A070B72E3D6B812A_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_F9CBCEE3D80C9FE0A070B72E3D6B812A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_F9CBCEE3D80C9FE0A070B72E3D6B812A_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_F9CBCEE3D80C9FE0A070B72E3D6B812A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_F9CBCEE3D80C9FE0A070B72E3D6B812A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_F9CBCEE3D80C9FE0A070B72E3D6B812A" xlink:to="lab_us-gaap_BalanceSheetLocationAxis_F9CBCEE3D80C9FE0A070B72E3D6B812A" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_3981BCAFC69B727C7197B72E3D7161D8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_3981BCAFC69B727C7197B72E3D7161D8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_3981BCAFC69B727C7197B72E3D7161D8_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_3981BCAFC69B727C7197B72E3D7161D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3981BCAFC69B727C7197B72E3D7161D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3981BCAFC69B727C7197B72E3D7161D8" xlink:to="lab_us-gaap_BalanceSheetLocationDomain_3981BCAFC69B727C7197B72E3D7161D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_F15E93BB90651EDAFEB0B72E3D7157BF_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember_F15E93BB90651EDAFEB0B72E3D7157BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Component of accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_F15E93BB90651EDAFEB0B72E3D7157BF_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember_F15E93BB90651EDAFEB0B72E3D7157BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_F15E93BB90651EDAFEB0B72E3D7157BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember_F15E93BB90651EDAFEB0B72E3D7157BF" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember_F15E93BB90651EDAFEB0B72E3D7157BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementLineItems_9189AB37DEB782C4A2B4B72E3D713F32_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems_9189AB37DEB782C4A2B4B72E3D713F32" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_9189AB37DEB782C4A2B4B72E3D713F32_label_en-US" xlink:label="lab_us-gaap_StatementLineItems_9189AB37DEB782C4A2B4B72E3D713F32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_9189AB37DEB782C4A2B4B72E3D713F32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_9189AB37DEB782C4A2B4B72E3D713F32" xlink:to="lab_us-gaap_StatementLineItems_9189AB37DEB782C4A2B4B72E3D713F32" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidTaxes_26B1F8067FBA9E49362AB7338FB5AD8B_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes_26B1F8067FBA9E49362AB7338FB5AD8B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_26B1F8067FBA9E49362AB7338FB5AD8B_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes_26B1F8067FBA9E49362AB7338FB5AD8B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaap_PrepaidTaxes_26B1F8067FBA9E49362AB7338FB5AD8B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes_26B1F8067FBA9E49362AB7338FB5AD8B" xlink:to="lab_us-gaap_PrepaidTaxes_26B1F8067FBA9E49362AB7338FB5AD8B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued Expenses and Other</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_19BF44223268C01DA66CB72E3D71C49D_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_19BF44223268C01DA66CB72E3D71C49D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current portion of contingent consideration obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_19BF44223268C01DA66CB72E3D71C49D_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_19BF44223268C01DA66CB72E3D71C49D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_19BF44223268C01DA66CB72E3D71C49D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_19BF44223268C01DA66CB72E3D71C49D" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_19BF44223268C01DA66CB72E3D71C49D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_E480C55D8D316361A64FB72E3D71A4A7_verboseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_E480C55D8D316361A64FB72E3D71A4A7" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenue-related rebates</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_E480C55D8D316361A64FB72E3D71A4A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance_E480C55D8D316361A64FB72E3D71A4A7" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance_E480C55D8D316361A64FB72E3D71A4A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_B5DA761C4CDC6912FA9FB72E3D712FCC_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_B5DA761C4CDC6912FA9FB72E3D712FCC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_B5DA761C4CDC6912FA9FB72E3D712FCC_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_B5DA761C4CDC6912FA9FB72E3D712FCC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_B5DA761C4CDC6912FA9FB72E3D712FCC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_B5DA761C4CDC6912FA9FB72E3D712FCC" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_B5DA761C4CDC6912FA9FB72E3D712FCC" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_B9F2C5E3B91B389E6373B72E3D711D1B_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent_B9F2C5E3B91B389E6373B72E3D711D1B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Royalties and licensing fees</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_B9F2C5E3B91B389E6373B72E3D711D1B_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent_B9F2C5E3B91B389E6373B72E3D711D1B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_B9F2C5E3B91B389E6373B72E3D711D1B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent_B9F2C5E3B91B389E6373B72E3D711D1B" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent_B9F2C5E3B91B389E6373B72E3D711D1B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_D77658B2090FE8B11F0EB72E3D71D302_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent_D77658B2090FE8B11F0EB72E3D71D302" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_D77658B2090FE8B11F0EB72E3D71D302_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent_D77658B2090FE8B11F0EB72E3D71D302" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_D77658B2090FE8B11F0EB72E3D71D302" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent_D77658B2090FE8B11F0EB72E3D71D302" xlink:to="lab_us-gaap_DeferredRevenueCurrent_D77658B2090FE8B11F0EB72E3D71D302" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_E0D40DECFEC0FF9F4C90B72E3D717BFE_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_E0D40DECFEC0FF9F4C90B72E3D717BFE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_E0D40DECFEC0FF9F4C90B72E3D717BFE_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_E0D40DECFEC0FF9F4C90B72E3D717BFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_E0D40DECFEC0FF9F4C90B72E3D717BFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_E0D40DECFEC0FF9F4C90B72E3D717BFE" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent_E0D40DECFEC0FF9F4C90B72E3D717BFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_F16712D972F5D71F6CEBB72E3D718DB5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent_F16712D972F5D71F6CEBB72E3D718DB5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_F16712D972F5D71F6CEBB72E3D718DB5_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent_F16712D972F5D71F6CEBB72E3D718DB5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_F16712D972F5D71F6CEBB72E3D718DB5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_F16712D972F5D71F6CEBB72E3D718DB5" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent_F16712D972F5D71F6CEBB72E3D718DB5" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other Income (Expense), Net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income (Expense), Net [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestIncomeExpenseNetAbstract" xlink:label="loc_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB" xlink:to="lab_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_A64F0EE8ACBD876F1750B72E3D765479_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest_A64F0EE8ACBD876F1750B72E3D765479" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_A64F0EE8ACBD876F1750B72E3D765479_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest_A64F0EE8ACBD876F1750B72E3D765479" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_A64F0EE8ACBD876F1750B72E3D765479" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest_A64F0EE8ACBD876F1750B72E3D765479" xlink:to="lab_us-gaap_InvestmentIncomeInterest_A64F0EE8ACBD876F1750B72E3D765479" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpense_EA34B5FFAAF17263CB9CB72E3D77E2B2_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense_EA34B5FFAAF17263CB9CB72E3D77E2B2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_EA34B5FFAAF17263CB9CB72E3D77E2B2_label_en-US" xlink:label="lab_us-gaap_InterestExpense_EA34B5FFAAF17263CB9CB72E3D77E2B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_EA34B5FFAAF17263CB9CB72E3D77E2B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense_EA34B5FFAAF17263CB9CB72E3D77E2B2" xlink:to="lab_us-gaap_InterestExpense_EA34B5FFAAF17263CB9CB72E3D77E2B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_763F3899CF456D371620B72E3D779466_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments_763F3899CF456D371620B72E3D779466" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gain (loss) on sales of investments, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_763F3899CF456D371620B72E3D779466_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments_763F3899CF456D371620B72E3D779466" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_763F3899CF456D371620B72E3D779466" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfInvestments_763F3899CF456D371620B72E3D779466" xlink:to="lab_us-gaap_GainLossOnSaleOfInvestments_763F3899CF456D371620B72E3D779466" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_C767B20458B5759DF426B72E3D777B91_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_C767B20458B5759DF426B72E3D777B91" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange gains (losses), net</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_C767B20458B5759DF426B72E3D777B91_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_C767B20458B5759DF426B72E3D777B91" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_C767B20458B5759DF426B72E3D777B91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_C767B20458B5759DF426B72E3D777B91" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_C767B20458B5759DF426B72E3D777B91" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_EEEED57C699F6C1EDC6AB72E3D77DE57_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_EEEED57C699F6C1EDC6AB72E3D77DE57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_EEEED57C699F6C1EDC6AB72E3D77DE57_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_EEEED57C699F6C1EDC6AB72E3D77DE57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_EEEED57C699F6C1EDC6AB72E3D77DE57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_EEEED57C699F6C1EDC6AB72E3D77DE57" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense_EEEED57C699F6C1EDC6AB72E3D77DE57" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_937F22AD636C7478A3C5B72E3D773ED6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_937F22AD636C7478A3C5B72E3D773ED6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total purchase price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_937F22AD636C7478A3C5B72E3D773ED6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_937F22AD636C7478A3C5B72E3D773ED6" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1_937F22AD636C7478A3C5B72E3D773ED6" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_C8EAE4AFC41EDE4359C9B72E3D776FFC_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_C8EAE4AFC41EDE4359C9B72E3D776FFC" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other income (expense), net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_C8EAE4AFC41EDE4359C9B72E3D776FFC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_C8EAE4AFC41EDE4359C9B72E3D776FFC" xlink:to="lab_us-gaap_NonoperatingIncomeExpense_C8EAE4AFC41EDE4359C9B72E3D776FFC" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_D4A2FC0E47D1F8576ECCB72E3D7CDBEC_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract_D4A2FC0E47D1F8576ECCB72E3D7CDBEC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_D4A2FC0E47D1F8576ECCB72E3D7CDBEC_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract_D4A2FC0E47D1F8576ECCB72E3D7CDBEC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_D4A2FC0E47D1F8576ECCB72E3D7CDBEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_D4A2FC0E47D1F8576ECCB72E3D7CDBEC" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract_D4A2FC0E47D1F8576ECCB72E3D7CDBEC" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_77CEDF849467CFFB086EB72E3D7D3C7F_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_77CEDF849467CFFB086EB72E3D7D3C7F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_77CEDF849467CFFB086EB72E3D7D3C7F_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_77CEDF849467CFFB086EB72E3D7D3C7F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_77CEDF849467CFFB086EB72E3D7D3C7F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_77CEDF849467CFFB086EB72E3D7D3C7F" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_77CEDF849467CFFB086EB72E3D7D3C7F" xlink:type="arc" />
    <link:label id="lab_biib_Employeerelatedliabilitiesnoncurrent_2458FB3210728DEDDB10B72E3D7D6CB8_terseLabel_en-US" xlink:label="lab_biib_Employeerelatedliabilitiesnoncurrent_2458FB3210728DEDDB10B72E3D7D6CB8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee related liabilities noncurrent</link:label>
    <link:label id="lab_biib_Employeerelatedliabilitiesnoncurrent_2458FB3210728DEDDB10B72E3D7D6CB8_label_en-US" xlink:label="lab_biib_Employeerelatedliabilitiesnoncurrent_2458FB3210728DEDDB10B72E3D7D6CB8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee related liabilities noncurrent</link:label>
    <link:label id="lab_biib_Employeerelatedliabilitiesnoncurrent_2458FB3210728DEDDB10B72E3D7D6CB8_documentation_en-US" xlink:label="lab_biib_Employeerelatedliabilitiesnoncurrent_2458FB3210728DEDDB10B72E3D7D6CB8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee related liabilities noncurrent</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_Employeerelatedliabilitiesnoncurrent" xlink:label="loc_biib_Employeerelatedliabilitiesnoncurrent_2458FB3210728DEDDB10B72E3D7D6CB8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_Employeerelatedliabilitiesnoncurrent_2458FB3210728DEDDB10B72E3D7D6CB8" xlink:to="lab_biib_Employeerelatedliabilitiesnoncurrent_2458FB3210728DEDDB10B72E3D7D6CB8" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_8F4A923DCD6CDF1CD4ECB72E3D7DA1E8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_8F4A923DCD6CDF1CD4ECB72E3D7DA1E8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_8F4A923DCD6CDF1CD4ECB72E3D7DA1E8_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_8F4A923DCD6CDF1CD4ECB72E3D7DA1E8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_8F4A923DCD6CDF1CD4ECB72E3D7DA1E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_8F4A923DCD6CDF1CD4ECB72E3D7DA1E8" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_8F4A923DCD6CDF1CD4ECB72E3D7DA1E8" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6F36475C28F4477743E5B72E3D7D929B_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_6F36475C28F4477743E5B72E3D7D929B" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6F36475C28F4477743E5B72E3D7D929B_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_6F36475C28F4477743E5B72E3D7D929B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_6F36475C28F4477743E5B72E3D7D929B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_6F36475C28F4477743E5B72E3D7D929B" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent_6F36475C28F4477743E5B72E3D7D929B" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7DA9C00337F4857AE12AB7340BB82B6A_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7DA9C00337F4857AE12AB7340BB82B6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7DA9C00337F4857AE12AB7340BB82B6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7DA9C00337F4857AE12AB7340BB82B6A" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7DA9C00337F4857AE12AB7340BB82B6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_CC97A280609EB733738CB7340BB8A7F1_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_CC97A280609EB733738CB7340BB8A7F1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gains (losses) on securities available for sale, net of tax of $(145) and $(4,029) for the three months ended June 30, 2015 and 2014, respectively; and $621 and $(3,015) for the six months ended June 30, 2015 and 2014, respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_CC97A280609EB733738CB7340BB8A7F1_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_CC97A280609EB733738CB7340BB8A7F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_CC97A280609EB733738CB7340BB8A7F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_CC97A280609EB733738CB7340BB8A7F1" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_CC97A280609EB733738CB7340BB8A7F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_B2C935DF5FFC169E4AF4B7340BB8DDB1_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_B2C935DF5FFC169E4AF4B7340BB8DDB1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gains (losses) on foreign currency forward contracts, net of tax of $(454) and $(260) for the three months ended June 30, 2015 and 2014, respectively; and $(42) and $5 for the six months ended June 30, 2015 and 2014, respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_B2C935DF5FFC169E4AF4B7340BB8DDB1_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_B2C935DF5FFC169E4AF4B7340BB8DDB1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_B2C935DF5FFC169E4AF4B7340BB8DDB1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_B2C935DF5FFC169E4AF4B7340BB8DDB1" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_B2C935DF5FFC169E4AF4B7340BB8DDB1" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3AAA15E5D899746ED538B7340BB94E7D_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3AAA15E5D899746ED538B7340BB94E7D" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Unrealized gains (losses) on pension benefit obligation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3AAA15E5D899746ED538B7340BB94E7D_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3AAA15E5D899746ED538B7340BB94E7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3AAA15E5D899746ED538B7340BB94E7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3AAA15E5D899746ED538B7340BB94E7D" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3AAA15E5D899746ED538B7340BB94E7D" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3839C3C43456624D937FB7340BB9F9BA_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3839C3C43456624D937FB7340BB9F9BA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3839C3C43456624D937FB7340BB9F9BA_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3839C3C43456624D937FB7340BB9F9BA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3839C3C43456624D937FB7340BB9F9BA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3839C3C43456624D937FB7340BB9F9BA" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3839C3C43456624D937FB7340BB9F9BA" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_47D29268AE990EDD6C4BB7340BB9042B_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_47D29268AE990EDD6C4BB7340BB9042B" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_47D29268AE990EDD6C4BB7340BB9042B_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_47D29268AE990EDD6C4BB7340BB9042B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_47D29268AE990EDD6C4BB7340BB9042B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_47D29268AE990EDD6C4BB7340BB9042B" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_47D29268AE990EDD6C4BB7340BB9042B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_9538FFB7AC540FBAFFFFB7340BB9C8D9_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_9538FFB7AC540FBAFFFFB7340BB9C8D9" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income attributable to Biogen Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_9538FFB7AC540FBAFFFFB7340BB9C8D9_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_9538FFB7AC540FBAFFFFB7340BB9C8D9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_9538FFB7AC540FBAFFFFB7340BB9C8D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_9538FFB7AC540FBAFFFFB7340BB9C8D9" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_9538FFB7AC540FBAFFFFB7340BB9C8D9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2C92C298B25CED1603E5B7340BB90423_negatedLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2C92C298B25CED1603E5B7340BB90423" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income (loss) attributable to noncontrolling interests, net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2C92C298B25CED1603E5B7340BB90423_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2C92C298B25CED1603E5B7340BB90423" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2C92C298B25CED1603E5B7340BB90423" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2C92C298B25CED1603E5B7340BB90423" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2C92C298B25CED1603E5B7340BB90423" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D32CFB7AD08150D9858DB7340BB96C3F_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D32CFB7AD08150D9858DB7340BB96C3F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D32CFB7AD08150D9858DB7340BB96C3F_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D32CFB7AD08150D9858DB7340BB96C3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D32CFB7AD08150D9858DB7340BB96C3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D32CFB7AD08150D9858DB7340BB96C3F" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D32CFB7AD08150D9858DB7340BB96C3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6AA031A8D3D70976E04AD4ED4B59CD72_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6AA031A8D3D70976E04AD4ED4B59CD72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6AA031A8D3D70976E04AD4ED4B59CD72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6AA031A8D3D70976E04AD4ED4B59CD72" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6AA031A8D3D70976E04AD4ED4B59CD72" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrencyAxis_E5D344CE45838575B240D4ED4B5AB366_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencyAxis_E5D344CE45838575B240D4ED4B5AB366" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_us-gaap_CurrencyAxis_E5D344CE45838575B240D4ED4B5AB366_label_en-US" xlink:label="lab_us-gaap_CurrencyAxis_E5D344CE45838575B240D4ED4B5AB366" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaap_CurrencyAxis_E5D344CE45838575B240D4ED4B5AB366" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencyAxis_E5D344CE45838575B240D4ED4B5AB366" xlink:to="lab_us-gaap_CurrencyAxis_E5D344CE45838575B240D4ED4B5AB366" xlink:type="arc" />
    <link:label id="lab_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:to="lab_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:type="arc" />
    <link:label id="lab_currency_EUR_63B3E7E36C2123A215EFD4ED4B5A5543_verboseLabel_en-US" xlink:label="lab_currency_EUR_63B3E7E36C2123A215EFD4ED4B5A5543" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Euro</link:label>
    <link:label id="lab_currency_EUR_63B3E7E36C2123A215EFD4ED4B5A5543_label_en-US" xlink:label="lab_currency_EUR_63B3E7E36C2123A215EFD4ED4B5A5543" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_EUR" xlink:label="loc_currency_EUR_63B3E7E36C2123A215EFD4ED4B5A5543" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR_63B3E7E36C2123A215EFD4ED4B5A5543" xlink:to="lab_currency_EUR_63B3E7E36C2123A215EFD4ED4B5A5543" xlink:type="arc" />
    <link:label id="lab_currency_CAD_D0A32D57F9C92B650C91D4ED4B5A3239_verboseLabel_en-US" xlink:label="lab_currency_CAD_D0A32D57F9C92B650C91D4ED4B5A3239" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Canadian Dollar</link:label>
    <link:label id="lab_currency_CAD_D0A32D57F9C92B650C91D4ED4B5A3239_label_en-US" xlink:label="lab_currency_CAD_D0A32D57F9C92B650C91D4ED4B5A3239" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Canada, Dollars</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_CAD" xlink:label="loc_currency_CAD_D0A32D57F9C92B650C91D4ED4B5A3239" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CAD_D0A32D57F9C92B650C91D4ED4B5A3239" xlink:to="lab_currency_CAD_D0A32D57F9C92B650C91D4ED4B5A3239" xlink:type="arc" />
    <link:label id="lab_currency_GBP_325FE05DF2BD342E256FD4ED4B5A3D60_terseLabel_en-US" xlink:label="lab_currency_GBP_325FE05DF2BD342E256FD4ED4B5A3D60" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">British Pound Sterling</link:label>
    <link:label id="lab_currency_GBP_325FE05DF2BD342E256FD4ED4B5A3D60_label_en-US" xlink:label="lab_currency_GBP_325FE05DF2BD342E256FD4ED4B5A3D60" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">United Kingdom, Pounds</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_GBP" xlink:label="loc_currency_GBP_325FE05DF2BD342E256FD4ED4B5A3D60" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_GBP_325FE05DF2BD342E256FD4ED4B5A3D60" xlink:to="lab_currency_GBP_325FE05DF2BD342E256FD4ED4B5A3D60" xlink:type="arc" />
    <link:label id="lab_currency_JPY_C0FA5024E47989BEEA2DD4ED4B5A3D1A_terseLabel_en-US" xlink:label="lab_currency_JPY_C0FA5024E47989BEEA2DD4ED4B5A3D1A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Japanese Yen</link:label>
    <link:label id="lab_currency_JPY_C0FA5024E47989BEEA2DD4ED4B5A3D1A_label_en-US" xlink:label="lab_currency_JPY_C0FA5024E47989BEEA2DD4ED4B5A3D1A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_JPY" xlink:label="loc_currency_JPY_C0FA5024E47989BEEA2DD4ED4B5A3D1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY_C0FA5024E47989BEEA2DD4ED4B5A3D1A" xlink:to="lab_currency_JPY_C0FA5024E47989BEEA2DD4ED4B5A3D1A" xlink:type="arc" />
    <link:label id="lab_currency_AUD_37A046259A976EAE74DFD4ED4B5ABB8E_terseLabel_en-US" xlink:label="lab_currency_AUD_37A046259A976EAE74DFD4ED4B5ABB8E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Australian Dollar</link:label>
    <link:label id="lab_currency_AUD_37A046259A976EAE74DFD4ED4B5ABB8E_label_en-US" xlink:label="lab_currency_AUD_37A046259A976EAE74DFD4ED4B5ABB8E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Australia, Dollars</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_AUD" xlink:label="loc_currency_AUD_37A046259A976EAE74DFD4ED4B5ABB8E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AUD_37A046259A976EAE74DFD4ED4B5ABB8E" xlink:to="lab_currency_AUD_37A046259A976EAE74DFD4ED4B5ABB8E" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_4D57C11CD6BF825AF0CDD4ED4B5A0FE7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_4D57C11CD6BF825AF0CDD4ED4B5A0FE7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_4D57C11CD6BF825AF0CDD4ED4B5A0FE7_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_4D57C11CD6BF825AF0CDD4ED4B5A0FE7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4D57C11CD6BF825AF0CDD4ED4B5A0FE7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4D57C11CD6BF825AF0CDD4ED4B5A0FE7" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_4D57C11CD6BF825AF0CDD4ED4B5A0FE7" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363" xlink:to="lab_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesMember_CBA265A100FC2D384608D4ED4B5A74F3_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember_CBA265A100FC2D384608D4ED4B5A74F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesMember_CBA265A100FC2D384608D4ED4B5A74F3_label_en-US" xlink:label="lab_us-gaap_SalesMember_CBA265A100FC2D384608D4ED4B5A74F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaap_SalesMember_CBA265A100FC2D384608D4ED4B5A74F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember_CBA265A100FC2D384608D4ED4B5A74F3" xlink:to="lab_us-gaap_SalesMember_CBA265A100FC2D384608D4ED4B5A74F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_10DEF585FBA44B140919D4ED4B5A76E0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_10DEF585FBA44B140919D4ED4B5A76E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_10DEF585FBA44B140919D4ED4B5A76E0_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_10DEF585FBA44B140919D4ED4B5A76E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_10DEF585FBA44B140919D4ED4B5A76E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_10DEF585FBA44B140919D4ED4B5A76E0" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_10DEF585FBA44B140919D4ED4B5A76E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_8F2AC0A40395954C3566D4ED4B5A5A61_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_8F2AC0A40395954C3566D4ED4B5A5A61" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument Risk [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_8F2AC0A40395954C3566D4ED4B5A5A61_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_8F2AC0A40395954C3566D4ED4B5A5A61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8F2AC0A40395954C3566D4ED4B5A5A61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8F2AC0A40395954C3566D4ED4B5A5A61" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis_8F2AC0A40395954C3566D4ED4B5A5A61" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_9F29738DF6A88650056AD4ED4B5A3CD6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_9F29738DF6A88650056AD4ED4B5A3CD6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_9F29738DF6A88650056AD4ED4B5A3CD6_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_9F29738DF6A88650056AD4ED4B5A3CD6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9F29738DF6A88650056AD4ED4B5A3CD6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9F29738DF6A88650056AD4ED4B5A3CD6" xlink:to="lab_us-gaap_DerivativeContractTypeDomain_9F29738DF6A88650056AD4ED4B5A3CD6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_55DB65EE47E17BCC71BAD4ED4B5BDFAA_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember_55DB65EE47E17BCC71BAD4ED4B5BDFAA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_55DB65EE47E17BCC71BAD4ED4B5BDFAA_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember_55DB65EE47E17BCC71BAD4ED4B5BDFAA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_55DB65EE47E17BCC71BAD4ED4B5BDFAA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember_55DB65EE47E17BCC71BAD4ED4B5BDFAA" xlink:to="lab_us-gaap_ForeignExchangeContractMember_55DB65EE47E17BCC71BAD4ED4B5BDFAA" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_2BD715A360241BDF7E68D4ED4B5B1696_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember_2BD715A360241BDF7E68D4ED4B5B1696" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_2BD715A360241BDF7E68D4ED4B5B1696_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember_2BD715A360241BDF7E68D4ED4B5B1696" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherCurrentAssetsMember" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_2BD715A360241BDF7E68D4ED4B5B1696" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember_2BD715A360241BDF7E68D4ED4B5B1696" xlink:to="lab_us-gaap_OtherCurrentAssetsMember_2BD715A360241BDF7E68D4ED4B5B1696" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherInvestmentsMember_FBF2DB0CA630B09B7321D4ED4B5B66FB_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember_FBF2DB0CA630B09B7321D4ED4B5B66FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments and other assets</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_FBF2DB0CA630B09B7321D4ED4B5B66FB_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember_FBF2DB0CA630B09B7321D4ED4B5B66FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherInvestmentsMember" xlink:label="loc_us-gaap_OtherInvestmentsMember_FBF2DB0CA630B09B7321D4ED4B5B66FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentsMember_FBF2DB0CA630B09B7321D4ED4B5B66FB" xlink:to="lab_us-gaap_OtherInvestmentsMember_FBF2DB0CA630B09B7321D4ED4B5B66FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_8C75C9C62E4C905B70CAD4ED4B5BF177_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember_8C75C9C62E4C905B70CAD4ED4B5BF177" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_8C75C9C62E4C905B70CAD4ED4B5BF177_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember_8C75C9C62E4C905B70CAD4ED4B5BF177" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesMember" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_8C75C9C62E4C905B70CAD4ED4B5BF177" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember_8C75C9C62E4C905B70CAD4ED4B5BF177" xlink:to="lab_us-gaap_AccruedLiabilitiesMember_8C75C9C62E4C905B70CAD4ED4B5BF177" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_D8E8381E227F65503630D4ED4B5B522F_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember_D8E8381E227F65503630D4ED4B5B522F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_D8E8381E227F65503630D4ED4B5B522F_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember_D8E8381E227F65503630D4ED4B5B522F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_D8E8381E227F65503630D4ED4B5B522F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember_D8E8381E227F65503630D4ED4B5B522F" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember_D8E8381E227F65503630D4ED4B5B522F" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationAxis_3724493CC8DA8F9E9D49D4ED4B5BD24D_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_3724493CC8DA8F9E9D49D4ED4B5BD24D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_3724493CC8DA8F9E9D49D4ED4B5BD24D_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_3724493CC8DA8F9E9D49D4ED4B5BD24D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_3724493CC8DA8F9E9D49D4ED4B5BD24D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis_3724493CC8DA8F9E9D49D4ED4B5BD24D" xlink:to="lab_us-gaap_HedgingDesignationAxis_3724493CC8DA8F9E9D49D4ED4B5BD24D" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33" xlink:to="lab_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33" xlink:type="arc" />
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_4435752E4D7397598BA9D4ED4B5B1F56_verboseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember_4435752E4D7397598BA9D4ED4B5B1F56" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Designated as hedging instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_4435752E4D7397598BA9D4ED4B5B1F56_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember_4435752E4D7397598BA9D4ED4B5B1F56" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4435752E4D7397598BA9D4ED4B5B1F56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4435752E4D7397598BA9D4ED4B5B1F56" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember_4435752E4D7397598BA9D4ED4B5B1F56" xlink:type="arc" />
    <link:label id="lab_us-gaap_NondesignatedMember_41D6C827586978CCE3CFD4ED4B5B1780_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember_41D6C827586978CCE3CFD4ED4B5B1780" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Not designated as hedging instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_41D6C827586978CCE3CFD4ED4B5B1780_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember_41D6C827586978CCE3CFD4ED4B5B1780" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_41D6C827586978CCE3CFD4ED4B5B1780" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember_41D6C827586978CCE3CFD4ED4B5B1780" xlink:to="lab_us-gaap_NondesignatedMember_41D6C827586978CCE3CFD4ED4B5B1780" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_787295BE833F77FC8631D4ED4B5BFA8D_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems_787295BE833F77FC8631D4ED4B5BFA8D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_787295BE833F77FC8631D4ED4B5BFA8D_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems_787295BE833F77FC8631D4ED4B5BFA8D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_787295BE833F77FC8631D4ED4B5BFA8D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_787295BE833F77FC8631D4ED4B5BFA8D" xlink:to="lab_us-gaap_DerivativesFairValueLineItems_787295BE833F77FC8631D4ED4B5BFA8D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeAssetFairValueNetAbstract_CCC7F6D95BC9CAE4389FD4ED4B5B0F10_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueNetAbstract_CCC7F6D95BC9CAE4389FD4ED4B5B0F10" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Derivatives designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueNetAbstract_CCC7F6D95BC9CAE4389FD4ED4B5B0F10_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueNetAbstract_CCC7F6D95BC9CAE4389FD4ED4B5B0F10" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Fair Value, Amount Not Offset Against Collateral [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeAssetFairValueNetAbstract" xlink:label="loc_us-gaap_DerivativeAssetFairValueNetAbstract_CCC7F6D95BC9CAE4389FD4ED4B5B0F10" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetFairValueNetAbstract_CCC7F6D95BC9CAE4389FD4ED4B5B0F10" xlink:to="lab_us-gaap_DerivativeAssetFairValueNetAbstract_CCC7F6D95BC9CAE4389FD4ED4B5B0F10" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_FFC1E2F2CA1451D76B8ED4ED4B5BF90F_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_FFC1E2F2CA1451D76B8ED4ED4B5BF90F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative asset, fair value, net</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_FFC1E2F2CA1451D76B8ED4ED4B5BF90F_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_FFC1E2F2CA1451D76B8ED4ED4B5BF90F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_FFC1E2F2CA1451D76B8ED4ED4B5BF90F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_FFC1E2F2CA1451D76B8ED4ED4B5BF90F" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_FFC1E2F2CA1451D76B8ED4ED4B5BF90F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_5F671231BB164232B337D4ED4B5C0453_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_5F671231BB164232B337D4ED4B5C0453" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative liability, fair value, net</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_5F671231BB164232B337D4ED4B5C0453_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_5F671231BB164232B337D4ED4B5C0453" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5F671231BB164232B337D4ED4B5C0453" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5F671231BB164232B337D4ED4B5C0453" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_5F671231BB164232B337D4ED4B5C0453" xlink:type="arc" />
    <link:label id="lab_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F_verboseLabel_en-US" xlink:label="lab_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments (Textual) [Abstract]</link:label>
    <link:label id="lab_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F_label_en-US" xlink:label="lab_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments (Textual) [Abstract]</link:label>
    <link:label id="lab_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F_documentation_en-US" xlink:label="lab_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Derivative Instruments.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_DerivativeInstrumentsTextualAbstract" xlink:label="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="lab_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeLowerRemainingMaturityRange1_26AFBEBBEA296AF40D02D4ED4B5CBEE4_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLowerRemainingMaturityRange1_26AFBEBBEA296AF40D02D4ED4B5CBEE4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Lower range of durations of foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeLowerRemainingMaturityRange1_26AFBEBBEA296AF40D02D4ED4B5CBEE4_label_en-US" xlink:label="lab_us-gaap_DerivativeLowerRemainingMaturityRange1_26AFBEBBEA296AF40D02D4ED4B5CBEE4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Lower Remaining Maturity Range</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeLowerRemainingMaturityRange1" xlink:label="loc_us-gaap_DerivativeLowerRemainingMaturityRange1_26AFBEBBEA296AF40D02D4ED4B5CBEE4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLowerRemainingMaturityRange1_26AFBEBBEA296AF40D02D4ED4B5CBEE4" xlink:to="lab_us-gaap_DerivativeLowerRemainingMaturityRange1_26AFBEBBEA296AF40D02D4ED4B5CBEE4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeHigherRemainingMaturityRange1_4709E1E1B875A9894E1FD4ED4B5CCF78_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeHigherRemainingMaturityRange1_4709E1E1B875A9894E1FD4ED4B5CCF78" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Higher range of durations of foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeHigherRemainingMaturityRange1_4709E1E1B875A9894E1FD4ED4B5CCF78_label_en-US" xlink:label="lab_us-gaap_DerivativeHigherRemainingMaturityRange1_4709E1E1B875A9894E1FD4ED4B5CCF78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Higher Remaining Maturity Range</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeHigherRemainingMaturityRange1" xlink:label="loc_us-gaap_DerivativeHigherRemainingMaturityRange1_4709E1E1B875A9894E1FD4ED4B5CCF78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeHigherRemainingMaturityRange1_4709E1E1B875A9894E1FD4ED4B5CCF78" xlink:to="lab_us-gaap_DerivativeHigherRemainingMaturityRange1_4709E1E1B875A9894E1FD4ED4B5CCF78" xlink:type="arc" />
    <link:label id="lab_invest_DerivativeNotionalAmount_3F1C2437A7D213ACEFA3D4ED4B5C7AB2_terseLabel_en-US" xlink:label="lab_invest_DerivativeNotionalAmount_3F1C2437A7D213ACEFA3D4ED4B5C7AB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate notional amount</link:label>
    <link:label id="lab_invest_DerivativeNotionalAmount_3F1C2437A7D213ACEFA3D4ED4B5C7AB2_label_en-US" xlink:label="lab_invest_DerivativeNotionalAmount_3F1C2437A7D213ACEFA3D4ED4B5C7AB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="loc_invest_DerivativeNotionalAmount_3F1C2437A7D213ACEFA3D4ED4B5C7AB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_invest_DerivativeNotionalAmount_3F1C2437A7D213ACEFA3D4ED4B5C7AB2" xlink:to="lab_invest_DerivativeNotionalAmount_3F1C2437A7D213ACEFA3D4ED4B5C7AB2" xlink:type="arc" />
    <link:label id="lab_biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax_4F715EEFEF835B84273AD4ED4B5CCE85_verboseLabel_en-US" xlink:label="lab_biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax_4F715EEFEF835B84273AD4ED4B5CCE85" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gain/Loss on fair value of foreign currency forward contracts</link:label>
    <link:label id="lab_biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax_4F715EEFEF835B84273AD4ED4B5CCE85_label_en-US" xlink:label="lab_biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax_4F715EEFEF835B84273AD4ED4B5CCE85" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrealized Gain (Losses) on Foreign Currency Derivatives, Net, before Tax</link:label>
    <link:label id="lab_biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax_4F715EEFEF835B84273AD4ED4B5CCE85_documentation_en-US" xlink:label="lab_biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax_4F715EEFEF835B84273AD4ED4B5CCE85" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax" xlink:label="loc_biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax_4F715EEFEF835B84273AD4ED4B5CCE85" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax_4F715EEFEF835B84273AD4ED4B5CCE85" xlink:to="lab_biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax_4F715EEFEF835B84273AD4ED4B5CCE85" xlink:type="arc" />
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_8F00757D094CEE3704E8D4ED4B5C50C3_verboseLabel_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_8F00757D094CEE3704E8D4ED4B5C50C3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected settlement time for contracts, in months</link:label>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_8F00757D094CEE3704E8D4ED4B5C50C3_label_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_8F00757D094CEE3704E8D4ED4B5C50C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Remaining Maturity of Foreign Currency Derivatives</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_8F00757D094CEE3704E8D4ED4B5C50C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_8F00757D094CEE3704E8D4ED4B5C50C3" xlink:to="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_8F00757D094CEE3704E8D4ED4B5C50C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_A7133ECB602F912EC3F0D4ED4B5C74FE_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_A7133ECB602F912EC3F0D4ED4B5C74FE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net gains (losses) in product revenue for the settlement of certain effective cash flow hedge instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_A7133ECB602F912EC3F0D4ED4B5C74FE_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_A7133ECB602F912EC3F0D4ED4B5C74FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_A7133ECB602F912EC3F0D4ED4B5C74FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_A7133ECB602F912EC3F0D4ED4B5C74FE" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_A7133ECB602F912EC3F0D4ED4B5C74FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_D2E9352C84A1DF8CE207D4ED4B5CD2ED_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_D2E9352C84A1DF8CE207D4ED4B5CD2ED" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net gains (losses) in earnings of Foreign currency forward contracts due to hedge ineffectiveness</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_D2E9352C84A1DF8CE207D4ED4B5CD2ED_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_D2E9352C84A1DF8CE207D4ED4B5CD2ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_D2E9352C84A1DF8CE207D4ED4B5CD2ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_D2E9352C84A1DF8CE207D4ED4B5CD2ED" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_D2E9352C84A1DF8CE207D4ED4B5CD2ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_D2E39B9A13F28980A6F0D4ED4B5C92AA_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_D2E39B9A13F28980A6F0D4ED4B5C92AA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net gains (losses) of other income (expense) related to foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_D2E39B9A13F28980A6F0D4ED4B5C92AA_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_D2E39B9A13F28980A6F0D4ED4B5C92AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_D2E39B9A13F28980A6F0D4ED4B5C92AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_D2E39B9A13F28980A6F0D4ED4B5C92AA" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_D2E39B9A13F28980A6F0D4ED4B5C92AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_770358B767FF418DA490DE012AF114F5_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_770358B767FF418DA490DE012AF114F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_770358B767FF418DA490DE012AF114F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_770358B767FF418DA490DE012AF114F5" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_770358B767FF418DA490DE012AF114F5" xlink:type="arc" />
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_C42BDD88C1DB4FB2314CDE02D917999F_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_C42BDD88C1DB4FB2314CDE02D917999F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of significant accounting policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_C42BDD88C1DB4FB2314CDE02D917999F_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_C42BDD88C1DB4FB2314CDE02D917999F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_C42BDD88C1DB4FB2314CDE02D917999F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock_C42BDD88C1DB4FB2314CDE02D917999F" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock_C42BDD88C1DB4FB2314CDE02D917999F" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_1BF8A58589E6045F9DEFD4ED4ADDCD49_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract_1BF8A58589E6045F9DEFD4ED4ADDCD49" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_1BF8A58589E6045F9DEFD4ED4ADDCD49" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_1BF8A58589E6045F9DEFD4ED4ADDCD49" xlink:to="lab_us-gaap_InventoryDisclosureAbstract_1BF8A58589E6045F9DEFD4ED4ADDCD49" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_CFC0122DBDAC29294D95D4ED4ADD72D1_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock_CFC0122DBDAC29294D95D4ED4ADD72D1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_CFC0122DBDAC29294D95D4ED4ADD72D1_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock_CFC0122DBDAC29294D95D4ED4ADD72D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_CFC0122DBDAC29294D95D4ED4ADD72D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock_CFC0122DBDAC29294D95D4ED4ADD72D1" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock_CFC0122DBDAC29294D95D4ED4ADD72D1" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_C5D64AEB4C7063995BCCDEAB5A8519C7_verboseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_C5D64AEB4C7063995BCCDEAB5A8519C7" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_C5D64AEB4C7063995BCCDEAB5A8519C7_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_C5D64AEB4C7063995BCCDEAB5A8519C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_C5D64AEB4C7063995BCCDEAB5A8519C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_C5D64AEB4C7063995BCCDEAB5A8519C7" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_C5D64AEB4C7063995BCCDEAB5A8519C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:to="lab_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:type="arc" />
    <link:label id="lab_biib_LeadprogramsMember_13AD78A278696FC050C7B7340A86D93A_terseLabel_en-US" xlink:label="lab_biib_LeadprogramsMember_13AD78A278696FC050C7B7340A86D93A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lead programs</link:label>
    <link:label id="lab_biib_LeadprogramsMember_13AD78A278696FC050C7B7340A86D93A_label_en-US" xlink:label="lab_biib_LeadprogramsMember_13AD78A278696FC050C7B7340A86D93A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lead programs [Member]</link:label>
    <link:label id="lab_biib_LeadprogramsMember_13AD78A278696FC050C7B7340A86D93A_documentation_en-US" xlink:label="lab_biib_LeadprogramsMember_13AD78A278696FC050C7B7340A86D93A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lead programs [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_LeadprogramsMember" xlink:label="loc_biib_LeadprogramsMember_13AD78A278696FC050C7B7340A86D93A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_LeadprogramsMember_13AD78A278696FC050C7B7340A86D93A" xlink:to="lab_biib_LeadprogramsMember_13AD78A278696FC050C7B7340A86D93A" xlink:type="arc" />
    <link:label id="lab_biib_DiscoveryprogramsMember_9F1C5329C9C3B7466A3AB7340A86A9F8_terseLabel_en-US" xlink:label="lab_biib_DiscoveryprogramsMember_9F1C5329C9C3B7466A3AB7340A86A9F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discovery programs</link:label>
    <link:label id="lab_biib_DiscoveryprogramsMember_9F1C5329C9C3B7466A3AB7340A86A9F8_label_en-US" xlink:label="lab_biib_DiscoveryprogramsMember_9F1C5329C9C3B7466A3AB7340A86A9F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discovery programs [Member]</link:label>
    <link:label id="lab_biib_DiscoveryprogramsMember_9F1C5329C9C3B7466A3AB7340A86A9F8_documentation_en-US" xlink:label="lab_biib_DiscoveryprogramsMember_9F1C5329C9C3B7466A3AB7340A86A9F8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Discovery programs [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_DiscoveryprogramsMember" xlink:label="loc_biib_DiscoveryprogramsMember_9F1C5329C9C3B7466A3AB7340A86A9F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_DiscoveryprogramsMember_9F1C5329C9C3B7466A3AB7340A86A9F8" xlink:to="lab_biib_DiscoveryprogramsMember_9F1C5329C9C3B7466A3AB7340A86A9F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_3213F345859D56084D8AB7340A86F713_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis_3213F345859D56084D8AB7340A86F713" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_3213F345859D56084D8AB7340A86F713_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis_3213F345859D56084D8AB7340A86F713" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_3213F345859D56084D8AB7340A86F713" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis_3213F345859D56084D8AB7340A86F713" xlink:to="lab_us-gaap_TypeOfArrangementAxis_3213F345859D56084D8AB7340A86F713" xlink:type="arc" />
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangements and Non-arrangement Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Arrangements and Non-arrangement Transactions [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF" xlink:type="arc" />
    <link:label id="lab_biib_AGTCMember_5F66FF87C17C2F6EAD60B7340A860704_terseLabel_en-US" xlink:label="lab_biib_AGTCMember_5F66FF87C17C2F6EAD60B7340A860704" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AGTC</link:label>
    <link:label id="lab_biib_AGTCMember_5F66FF87C17C2F6EAD60B7340A860704_label_en-US" xlink:label="lab_biib_AGTCMember_5F66FF87C17C2F6EAD60B7340A860704" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AGTC [Member]</link:label>
    <link:label id="lab_biib_AGTCMember_5F66FF87C17C2F6EAD60B7340A860704_documentation_en-US" xlink:label="lab_biib_AGTCMember_5F66FF87C17C2F6EAD60B7340A860704" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AGTC [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_AGTCMember" xlink:label="loc_biib_AGTCMember_5F66FF87C17C2F6EAD60B7340A860704" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_AGTCMember_5F66FF87C17C2F6EAD60B7340A860704" xlink:to="lab_biib_AGTCMember_5F66FF87C17C2F6EAD60B7340A860704" xlink:type="arc" />
    <link:label id="lab_biib_EisaiMember_214CD51B8CA2FEB6DFD9B74CEBBE076E_terseLabel_en-US" xlink:label="lab_biib_EisaiMember_214CD51B8CA2FEB6DFD9B74CEBBE076E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Eisai</link:label>
    <link:label id="lab_biib_EisaiMember_214CD51B8CA2FEB6DFD9B74CEBBE076E_label_en-US" xlink:label="lab_biib_EisaiMember_214CD51B8CA2FEB6DFD9B74CEBBE076E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Eisai [Member]</link:label>
    <link:label id="lab_biib_EisaiMember_214CD51B8CA2FEB6DFD9B74CEBBE076E_documentation_en-US" xlink:label="lab_biib_EisaiMember_214CD51B8CA2FEB6DFD9B74CEBBE076E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Eisai [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_EisaiMember" xlink:label="loc_biib_EisaiMember_214CD51B8CA2FEB6DFD9B74CEBBE076E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_EisaiMember_214CD51B8CA2FEB6DFD9B74CEBBE076E" xlink:to="lab_biib_EisaiMember_214CD51B8CA2FEB6DFD9B74CEBBE076E" xlink:type="arc" />
    <link:label id="lab_biib_SwedishOrphanBiovitrumMember_4CD6B22F4232245CFBACB747240DB15D_terseLabel_en-US" xlink:label="lab_biib_SwedishOrphanBiovitrumMember_4CD6B22F4232245CFBACB747240DB15D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Swedish Orphan Biovitrum</link:label>
    <link:label id="lab_biib_SwedishOrphanBiovitrumMember_4CD6B22F4232245CFBACB747240DB15D_label_en-US" xlink:label="lab_biib_SwedishOrphanBiovitrumMember_4CD6B22F4232245CFBACB747240DB15D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Swedish Orphan Biovitrum [Member]</link:label>
    <link:label id="lab_biib_SwedishOrphanBiovitrumMember_4CD6B22F4232245CFBACB747240DB15D_documentation_en-US" xlink:label="lab_biib_SwedishOrphanBiovitrumMember_4CD6B22F4232245CFBACB747240DB15D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Swedish orphan biovitrum.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_SwedishOrphanBiovitrumMember" xlink:label="loc_biib_SwedishOrphanBiovitrumMember_4CD6B22F4232245CFBACB747240DB15D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_SwedishOrphanBiovitrumMember_4CD6B22F4232245CFBACB747240DB15D" xlink:to="lab_biib_SwedishOrphanBiovitrumMember_4CD6B22F4232245CFBACB747240DB15D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_2B04F499DD14AAADCA3FB7340A87E7B5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_2B04F499DD14AAADCA3FB7340A87E7B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_2B04F499DD14AAADCA3FB7340A87E7B5_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_2B04F499DD14AAADCA3FB7340A87E7B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2B04F499DD14AAADCA3FB7340A87E7B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2B04F499DD14AAADCA3FB7340A87E7B5" xlink:to="lab_us-gaap_SubsequentEventTypeAxis_2B04F499DD14AAADCA3FB7340A87E7B5" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_8FA32BABB4D1D8814B03B7340A878038_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_8FA32BABB4D1D8814B03B7340A878038" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_8FA32BABB4D1D8814B03B7340A878038_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_8FA32BABB4D1D8814B03B7340A878038" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8FA32BABB4D1D8814B03B7340A878038" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8FA32BABB4D1D8814B03B7340A878038" xlink:to="lab_us-gaap_SubsequentEventTypeDomain_8FA32BABB4D1D8814B03B7340A878038" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventMember_62B67C6D09D421E1E0D6B7340A87C6B5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_62B67C6D09D421E1E0D6B7340A87C6B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_62B67C6D09D421E1E0D6B7340A87C6B5_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_62B67C6D09D421E1E0D6B7340A87C6B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_62B67C6D09D421E1E0D6B7340A87C6B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_62B67C6D09D421E1E0D6B7340A87C6B5" xlink:to="lab_us-gaap_SubsequentEventMember_62B67C6D09D421E1E0D6B7340A87C6B5" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="lab_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:type="arc" />
    <link:label id="lab_biib_Purchaseofcommonstock_788FE33F878812B5527DB7340A877A3B_terseLabel_en-US" xlink:label="lab_biib_Purchaseofcommonstock_788FE33F878812B5527DB7340A877A3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase of common stock</link:label>
    <link:label id="lab_biib_Purchaseofcommonstock_788FE33F878812B5527DB7340A877A3B_label_en-US" xlink:label="lab_biib_Purchaseofcommonstock_788FE33F878812B5527DB7340A877A3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of common stock</link:label>
    <link:label id="lab_biib_Purchaseofcommonstock_788FE33F878812B5527DB7340A877A3B_documentation_en-US" xlink:label="lab_biib_Purchaseofcommonstock_788FE33F878812B5527DB7340A877A3B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase of common stock</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_Purchaseofcommonstock" xlink:label="loc_biib_Purchaseofcommonstock_788FE33F878812B5527DB7340A877A3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_Purchaseofcommonstock_788FE33F878812B5527DB7340A877A3B" xlink:to="lab_biib_Purchaseofcommonstock_788FE33F878812B5527DB7340A877A3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssets_7F962168BB59A771C190B7340A87B4C2_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssets_7F962168BB59A771C190B7340A87B4C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid research and development</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssets_7F962168BB59A771C190B7340A87B4C2_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssets_7F962168BB59A771C190B7340A87B4C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_7F962168BB59A771C190B7340A87B4C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_7F962168BB59A771C190B7340A87B4C2" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssets_7F962168BB59A771C190B7340A87B4C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_LicenseCosts_623EBA60EEB10186FB46B7340A87988B_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseCosts_623EBA60EEB10186FB46B7340A87988B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total licensing and fees</link:label>
    <link:label id="lab_us-gaap_LicenseCosts_623EBA60EEB10186FB46B7340A87988B_label_en-US" xlink:label="lab_us-gaap_LicenseCosts_623EBA60EEB10186FB46B7340A87988B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LicenseCosts" xlink:label="loc_us-gaap_LicenseCosts_623EBA60EEB10186FB46B7340A87988B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseCosts_623EBA60EEB10186FB46B7340A87988B" xlink:to="lab_us-gaap_LicenseCosts_623EBA60EEB10186FB46B7340A87988B" xlink:type="arc" />
    <link:label id="lab_biib_TermOfLease_041B1AD828D88D5E7DE1B74BA968471C_terseLabel_en-US" xlink:label="lab_biib_TermOfLease_041B1AD828D88D5E7DE1B74BA968471C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of lease</link:label>
    <link:label id="lab_biib_TermOfLease_041B1AD828D88D5E7DE1B74BA968471C_label_en-US" xlink:label="lab_biib_TermOfLease_041B1AD828D88D5E7DE1B74BA968471C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Of Lease</link:label>
    <link:label id="lab_biib_TermOfLease_041B1AD828D88D5E7DE1B74BA968471C_documentation_en-US" xlink:label="lab_biib_TermOfLease_041B1AD828D88D5E7DE1B74BA968471C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Of Lease.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_TermOfLease" xlink:label="loc_biib_TermOfLease_041B1AD828D88D5E7DE1B74BA968471C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_TermOfLease_041B1AD828D88D5E7DE1B74BA968471C" xlink:to="lab_biib_TermOfLease_041B1AD828D88D5E7DE1B74BA968471C" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTable_FC24B9B0169C0F9730ACB7340A8B4672_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTable_FC24B9B0169C0F9730ACB7340A8B4672" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment [Table]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTable_FC24B9B0169C0F9730ACB7340A8B4672_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTable_FC24B9B0169C0F9730ACB7340A8B4672" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_FC24B9B0169C0F9730ACB7340A8B4672" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_FC24B9B0169C0F9730ACB7340A8B4672" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentTable_FC24B9B0169C0F9730ACB7340A8B4672" xlink:type="arc" />
    <link:label id="lab_country_CH_B97B099DEC6B69C1BED7B7340A8C2A03_terseLabel_en-US" xlink:label="lab_country_CH_B97B099DEC6B69C1BED7B7340A8C2A03" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Switzerland</link:label>
    <link:label id="lab_country_CH_B97B099DEC6B69C1BED7B7340A8C2A03_label_en-US" xlink:label="lab_country_CH_B97B099DEC6B69C1BED7B7340A8C2A03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SWITZERLAND</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_CH" xlink:label="loc_country_CH_B97B099DEC6B69C1BED7B7340A8C2A03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CH_B97B099DEC6B69C1BED7B7340A8C2A03" xlink:to="lab_country_CH_B97B099DEC6B69C1BED7B7340A8C2A03" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_367E393CFC108D310DAAB7340A8C1CE6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems_367E393CFC108D310DAAB7340A8C1CE6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_367E393CFC108D310DAAB7340A8C1CE6_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems_367E393CFC108D310DAAB7340A8C1CE6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_367E393CFC108D310DAAB7340A8C1CE6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_367E393CFC108D310DAAB7340A8C1CE6" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentLineItems_367E393CFC108D310DAAB7340A8C1CE6" xlink:type="arc" />
    <link:label id="lab_us-gaap_Land_4C393239BA1E6618117FB7340A8C87F8_terseLabel_en-US" xlink:label="lab_us-gaap_Land_4C393239BA1E6618117FB7340A8C87F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_4C393239BA1E6618117FB7340A8C87F8_label_en-US" xlink:label="lab_us-gaap_Land_4C393239BA1E6618117FB7340A8C87F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Land" xlink:label="loc_us-gaap_Land_4C393239BA1E6618117FB7340A8C87F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land_4C393239BA1E6618117FB7340A8C87F8" xlink:to="lab_us-gaap_Land_4C393239BA1E6618117FB7340A8C87F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_79BEDD1D329223FB9444D4ED4B9EB371_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_79BEDD1D329223FB9444D4ED4B9EB371" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Fair value, beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_79BEDD1D329223FB9444D4ED4B9EB371" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_79BEDD1D329223FB9444D4ED4B9EB371" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_79BEDD1D329223FB9444D4ED4B9EB371" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_78E838D2DB339FA78B23D4ED4B9F777D_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_78E838D2DB339FA78B23D4ED4B9F777D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_78E838D2DB339FA78B23D4ED4B9F777D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_78E838D2DB339FA78B23D4ED4B9F777D" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_78E838D2DB339FA78B23D4ED4B9F777D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AB818D1AED385C99FC95D4ED4B9FC558_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AB818D1AED385C99FC95D4ED4B9FC558" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Changes in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AB818D1AED385C99FC95D4ED4B9FC558_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AB818D1AED385C99FC95D4ED4B9FC558" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AB818D1AED385C99FC95D4ED4B9FC558" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AB818D1AED385C99FC95D4ED4B9FC558" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AB818D1AED385C99FC95D4ED4B9FC558" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_351C0CDD58C4FC47837FD4ED4B9F930D_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_351C0CDD58C4FC47837FD4ED4B9F930D" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_351C0CDD58C4FC47837FD4ED4B9F930D_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_351C0CDD58C4FC47837FD4ED4B9F930D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_351C0CDD58C4FC47837FD4ED4B9F930D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_351C0CDD58C4FC47837FD4ED4B9F930D" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_351C0CDD58C4FC47837FD4ED4B9F930D" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_EB3F5BCD6489E8C3D4A8D4ED4B9F0BF6_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_EB3F5BCD6489E8C3D4A8D4ED4B9F0BF6" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Fair value, end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_EB3F5BCD6489E8C3D4A8D4ED4B9F0BF6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_EB3F5BCD6489E8C3D4A8D4ED4B9F0BF6" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_EB3F5BCD6489E8C3D4A8D4ED4B9F0BF6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_29BC8F698B8F6C97A77CD4ED4B7BE39D_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_29BC8F698B8F6C97A77CD4ED4B7BE39D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency forward contracts that were entered into to hedge forecasted revenue</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_29BC8F698B8F6C97A77CD4ED4B7BE39D_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_29BC8F698B8F6C97A77CD4ED4B7BE39D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_29BC8F698B8F6C97A77CD4ED4B7BE39D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_29BC8F698B8F6C97A77CD4ED4B7BE39D" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_29BC8F698B8F6C97A77CD4ED4B7BE39D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_0C4D52FD218996B40BD0D4ED4B7C32AD_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_0C4D52FD218996B40BD0D4ED4B7C32AD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of the effect of derivatives designated as hedging instruments on the condensed consolidated statements of income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_0C4D52FD218996B40BD0D4ED4B7C32AD_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_0C4D52FD218996B40BD0D4ED4B7C32AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_0C4D52FD218996B40BD0D4ED4B7C32AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_0C4D52FD218996B40BD0D4ED4B7C32AD" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_0C4D52FD218996B40BD0D4ED4B7C32AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_EB563DE5D1259105BA0BD4ED4B7C8623_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_EB563DE5D1259105BA0BD4ED4B7C8623" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of fair value and presentation of derivatives</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_EB563DE5D1259105BA0BD4ED4B7C8623_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_EB563DE5D1259105BA0BD4ED4B7C8623" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_EB563DE5D1259105BA0BD4ED4B7C8623" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_EB563DE5D1259105BA0BD4ED4B7C8623" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_EB563DE5D1259105BA0BD4ED4B7C8623" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2480CECFFA65CF9877F4DEA10C01C873_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2480CECFFA65CF9877F4DEA10C01C873" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of assets and liabilities recorded at fair value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2480CECFFA65CF9877F4DEA10C01C873_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2480CECFFA65CF9877F4DEA10C01C873" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2480CECFFA65CF9877F4DEA10C01C873" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2480CECFFA65CF9877F4DEA10C01C873" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2480CECFFA65CF9877F4DEA10C01C873" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_E7A9ADB6C440655DDB74DEA49CA08605_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_E7A9ADB6C440655DDB74DEA49CA08605" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of fair and carrying value of debt instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_E7A9ADB6C440655DDB74DEA49CA08605_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_E7A9ADB6C440655DDB74DEA49CA08605" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_E7A9ADB6C440655DDB74DEA49CA08605" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_E7A9ADB6C440655DDB74DEA49CA08605" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_E7A9ADB6C440655DDB74DEA49CA08605" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9C5DAC3D80B3EF38B729DEA10C0164F9_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9C5DAC3D80B3EF38B729DEA10C0164F9" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value of contingent consideration obligations</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9C5DAC3D80B3EF38B729DEA10C0164F9_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9C5DAC3D80B3EF38B729DEA10C0164F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9C5DAC3D80B3EF38B729DEA10C0164F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9C5DAC3D80B3EF38B729DEA10C0164F9" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9C5DAC3D80B3EF38B729DEA10C0164F9" xlink:type="arc" />
    <link:label id="lab_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock_B039A285BBB9835B20ECDE162410DB5B_verboseLabel_en-US" xlink:label="lab_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock_B039A285BBB9835B20ECDE162410DB5B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Analysis of the changes in reserves</link:label>
    <link:label id="lab_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock_B039A285BBB9835B20ECDE162410DB5B_label_en-US" xlink:label="lab_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock_B039A285BBB9835B20ECDE162410DB5B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Analysis Of Amount Of And Change In Product Revenue Reserves [Table Text Block]</link:label>
    <link:label id="lab_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock_B039A285BBB9835B20ECDE162410DB5B_documentation_en-US" xlink:label="lab_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock_B039A285BBB9835B20ECDE162410DB5B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Analysis of amount of and change in product revenue reserves.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock" xlink:label="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock_B039A285BBB9835B20ECDE162410DB5B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock_B039A285BBB9835B20ECDE162410DB5B" xlink:to="lab_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock_B039A285BBB9835B20ECDE162410DB5B" xlink:type="arc" />
    <link:label id="lab_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock_BCD1142F818D4DD5461ADE1624109422_verboseLabel_en-US" xlink:label="lab_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock_BCD1142F818D4DD5461ADE1624109422" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total reserves included in condensed consolidated balance sheets</link:label>
    <link:label id="lab_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock_BCD1142F818D4DD5461ADE1624109422_label_en-US" xlink:label="lab_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock_BCD1142F818D4DD5461ADE1624109422" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary Of Product Revenue Reserves Included In Consolidated Balance Sheets [Table Text Block]</link:label>
    <link:label id="lab_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock_BCD1142F818D4DD5461ADE1624109422_documentation_en-US" xlink:label="lab_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock_BCD1142F818D4DD5461ADE1624109422" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Summary of total product revenue reserves included in consolidated balance sheets.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock" xlink:label="loc_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock_BCD1142F818D4DD5461ADE1624109422" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock_BCD1142F818D4DD5461ADE1624109422" xlink:to="lab_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock_BCD1142F818D4DD5461ADE1624109422" xlink:type="arc" />
    <link:label id="lab_biib_InvestmentsInVariableInterestEntitiesAbstract_77288AEDC527CE8F408BD4ED4BA34C05_label_en-US" xlink:label="lab_biib_InvestmentsInVariableInterestEntitiesAbstract_77288AEDC527CE8F408BD4ED4BA34C05" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in Variable Interest Entities [Abstract]</link:label>
    <link:label id="lab_biib_InvestmentsInVariableInterestEntitiesAbstract_77288AEDC527CE8F408BD4ED4BA34C05_documentation_en-US" xlink:label="lab_biib_InvestmentsInVariableInterestEntitiesAbstract_77288AEDC527CE8F408BD4ED4BA34C05" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investments In Variable Interest Entities.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_InvestmentsInVariableInterestEntitiesAbstract" xlink:label="loc_biib_InvestmentsInVariableInterestEntitiesAbstract_77288AEDC527CE8F408BD4ED4BA34C05" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_InvestmentsInVariableInterestEntitiesAbstract_77288AEDC527CE8F408BD4ED4BA34C05" xlink:to="lab_biib_InvestmentsInVariableInterestEntitiesAbstract_77288AEDC527CE8F408BD4ED4BA34C05" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_098ADB033466B5A94B7CD4ED4BA37932_verboseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_098ADB033466B5A94B7CD4ED4BA37932" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Investments in Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_098ADB033466B5A94B7CD4ED4BA37932_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_098ADB033466B5A94B7CD4ED4BA37932" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_098ADB033466B5A94B7CD4ED4BA37932" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_098ADB033466B5A94B7CD4ED4BA37932" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_098ADB033466B5A94B7CD4ED4BA37932" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentTable_41E3DFD6AD1E19F0CE89DEA10BF4A08E_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_41E3DFD6AD1E19F0CE89DEA10BF4A08E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_41E3DFD6AD1E19F0CE89DEA10BF4A08E_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_41E3DFD6AD1E19F0CE89DEA10BF4A08E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_41E3DFD6AD1E19F0CE89DEA10BF4A08E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable_41E3DFD6AD1E19F0CE89DEA10BF4A08E" xlink:to="lab_us-gaap_DebtInstrumentTable_41E3DFD6AD1E19F0CE89DEA10BF4A08E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentAxis_DD3A001412E321779155DEA10BF451E0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_DD3A001412E321779155DEA10BF451E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_DD3A001412E321779155DEA10BF451E0_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_DD3A001412E321779155DEA10BF451E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_DD3A001412E321779155DEA10BF451E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis_DD3A001412E321779155DEA10BF451E0" xlink:to="lab_us-gaap_DebtInstrumentAxis_DD3A001412E321779155DEA10BF451E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5" xlink:type="arc" />
    <link:label id="lab_biib_NotesPayableToFumedicaMember_61B81A0B8DDA9CAFAADDDEA10BF43017_verboseLabel_en-US" xlink:label="lab_biib_NotesPayableToFumedicaMember_61B81A0B8DDA9CAFAADDDEA10BF43017" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable to Fumedica</link:label>
    <link:label id="lab_biib_NotesPayableToFumedicaMember_61B81A0B8DDA9CAFAADDDEA10BF43017_label_en-US" xlink:label="lab_biib_NotesPayableToFumedicaMember_61B81A0B8DDA9CAFAADDDEA10BF43017" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable To Fumedica [Member]</link:label>
    <link:label id="lab_biib_NotesPayableToFumedicaMember_61B81A0B8DDA9CAFAADDDEA10BF43017_documentation_en-US" xlink:label="lab_biib_NotesPayableToFumedicaMember_61B81A0B8DDA9CAFAADDDEA10BF43017" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes payable.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_NotesPayableToFumedicaMember" xlink:label="loc_biib_NotesPayableToFumedicaMember_61B81A0B8DDA9CAFAADDDEA10BF43017" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_NotesPayableToFumedicaMember_61B81A0B8DDA9CAFAADDDEA10BF43017" xlink:to="lab_biib_NotesPayableToFumedicaMember_61B81A0B8DDA9CAFAADDDEA10BF43017" xlink:type="arc" />
    <link:label id="lab_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_2ACCD89813F0A541CB7EDEA10BF452A2_verboseLabel_en-US" xlink:label="lab_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_2ACCD89813F0A541CB7EDEA10BF452A2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">6.875% Senior Notes due 2018</link:label>
    <link:label id="lab_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_2ACCD89813F0A541CB7EDEA10BF452A2_label_en-US" xlink:label="lab_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_2ACCD89813F0A541CB7EDEA10BF452A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes Six Point Eight Seven Five Percent Due Twenty Eighteen [Member]</link:label>
    <link:label id="lab_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_2ACCD89813F0A541CB7EDEA10BF452A2_documentation_en-US" xlink:label="lab_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_2ACCD89813F0A541CB7EDEA10BF452A2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Notes Six Point Eight Seven Five Percent Due Twenty Eighteen.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember" xlink:label="loc_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_2ACCD89813F0A541CB7EDEA10BF452A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_2ACCD89813F0A541CB7EDEA10BF452A2" xlink:to="lab_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_2ACCD89813F0A541CB7EDEA10BF452A2" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3" xlink:to="lab_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_NotesPayableFairValueDisclosure_08D52D231F57E3A7849EDEA5E62671F1_verboseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableFairValueDisclosure_08D52D231F57E3A7849EDEA5E62671F1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Notes payable, fair value</link:label>
    <link:label id="lab_us-gaap_NotesPayableFairValueDisclosure_08D52D231F57E3A7849EDEA5E62671F1_label_en-US" xlink:label="lab_us-gaap_NotesPayableFairValueDisclosure_08D52D231F57E3A7849EDEA5E62671F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayableFairValueDisclosure" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_08D52D231F57E3A7849EDEA5E62671F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableFairValueDisclosure_08D52D231F57E3A7849EDEA5E62671F1" xlink:to="lab_us-gaap_NotesPayableFairValueDisclosure_08D52D231F57E3A7849EDEA5E62671F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_NotesPayable_54DF43BE375928F10D7DDEA5E628ABD4_verboseLabel_en-US" xlink:label="lab_us-gaap_NotesPayable_54DF43BE375928F10D7DDEA5E628ABD4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Notes payable, carrying value</link:label>
    <link:label id="lab_us-gaap_NotesPayable_54DF43BE375928F10D7DDEA5E628ABD4_label_en-US" xlink:label="lab_us-gaap_NotesPayable_54DF43BE375928F10D7DDEA5E628ABD4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable_54DF43BE375928F10D7DDEA5E628ABD4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayable_54DF43BE375928F10D7DDEA5E628ABD4" xlink:to="lab_us-gaap_NotesPayable_54DF43BE375928F10D7DDEA5E628ABD4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_54E889FD84A1E79D75C7DEA5E62AD0DD_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_54E889FD84A1E79D75C7DEA5E62AD0DD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Debt instruments, fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_54E889FD84A1E79D75C7DEA5E62AD0DD_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_54E889FD84A1E79D75C7DEA5E62AD0DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_54E889FD84A1E79D75C7DEA5E62AD0DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue_54E889FD84A1E79D75C7DEA5E62AD0DD" xlink:to="lab_us-gaap_DebtInstrumentFairValue_54E889FD84A1E79D75C7DEA5E62AD0DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5A64CC1EA7D82DD9971EDEA10B9EA550_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5A64CC1EA7D82DD9971EDEA10B9EA550" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5A64CC1EA7D82DD9971EDEA10B9EA550_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5A64CC1EA7D82DD9971EDEA10B9EA550" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5A64CC1EA7D82DD9971EDEA10B9EA550" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5A64CC1EA7D82DD9971EDEA10B9EA550" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5A64CC1EA7D82DD9971EDEA10B9EA550" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_AD64938197DE562A882FDEA10B9ECC34_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_AD64938197DE562A882FDEA10B9ECC34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_AD64938197DE562A882FDEA10B9ECC34_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_AD64938197DE562A882FDEA10B9ECC34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_AD64938197DE562A882FDEA10B9ECC34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_AD64938197DE562A882FDEA10B9ECC34" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_AD64938197DE562A882FDEA10B9ECC34" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0" xlink:type="arc" />
    <link:label id="lab_biib_StockOptionsAndEmployeeStockPurchasePlanMember_2E2DE22F4266CCE288DEDEA10B9E5E38_verboseLabel_en-US" xlink:label="lab_biib_StockOptionsAndEmployeeStockPurchasePlanMember_2E2DE22F4266CCE288DEDEA10B9E5E38" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock options and employee stock purchase plan</link:label>
    <link:label id="lab_biib_StockOptionsAndEmployeeStockPurchasePlanMember_2E2DE22F4266CCE288DEDEA10B9E5E38_label_en-US" xlink:label="lab_biib_StockOptionsAndEmployeeStockPurchasePlanMember_2E2DE22F4266CCE288DEDEA10B9E5E38" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock options and employee stock purchase plan [Member]</link:label>
    <link:label id="lab_biib_StockOptionsAndEmployeeStockPurchasePlanMember_2E2DE22F4266CCE288DEDEA10B9E5E38_documentation_en-US" xlink:label="lab_biib_StockOptionsAndEmployeeStockPurchasePlanMember_2E2DE22F4266CCE288DEDEA10B9E5E38" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock options and employee stock purchase plan.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_StockOptionsAndEmployeeStockPurchasePlanMember" xlink:label="loc_biib_StockOptionsAndEmployeeStockPurchasePlanMember_2E2DE22F4266CCE288DEDEA10B9E5E38" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_StockOptionsAndEmployeeStockPurchasePlanMember_2E2DE22F4266CCE288DEDEA10B9E5E38" xlink:to="lab_biib_StockOptionsAndEmployeeStockPurchasePlanMember_2E2DE22F4266CCE288DEDEA10B9E5E38" xlink:type="arc" />
    <link:label id="lab_biib_TimeVestedRestrictedStockUnitsMember_5C5BC22231CF9323CFFCDEA10B9EA7F5_verboseLabel_en-US" xlink:label="lab_biib_TimeVestedRestrictedStockUnitsMember_5C5BC22231CF9323CFFCDEA10B9EA7F5" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Time-vested restricted stock units</link:label>
    <link:label id="lab_biib_TimeVestedRestrictedStockUnitsMember_5C5BC22231CF9323CFFCDEA10B9EA7F5_label_en-US" xlink:label="lab_biib_TimeVestedRestrictedStockUnitsMember_5C5BC22231CF9323CFFCDEA10B9EA7F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Time Vested Restricted Stock Units [Member]</link:label>
    <link:label id="lab_biib_TimeVestedRestrictedStockUnitsMember_5C5BC22231CF9323CFFCDEA10B9EA7F5_documentation_en-US" xlink:label="lab_biib_TimeVestedRestrictedStockUnitsMember_5C5BC22231CF9323CFFCDEA10B9EA7F5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Time vested restricted stock units.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_TimeVestedRestrictedStockUnitsMember" xlink:label="loc_biib_TimeVestedRestrictedStockUnitsMember_5C5BC22231CF9323CFFCDEA10B9EA7F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_TimeVestedRestrictedStockUnitsMember_5C5BC22231CF9323CFFCDEA10B9EA7F5" xlink:to="lab_biib_TimeVestedRestrictedStockUnitsMember_5C5BC22231CF9323CFFCDEA10B9EA7F5" xlink:type="arc" />
    <link:label id="lab_biib_MarketStockUnitsMember_5ED63919E84E581DB0C6DEA10B9E2084_verboseLabel_en-US" xlink:label="lab_biib_MarketStockUnitsMember_5ED63919E84E581DB0C6DEA10B9E2084" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Market stock units</link:label>
    <link:label id="lab_biib_MarketStockUnitsMember_5ED63919E84E581DB0C6DEA10B9E2084_label_en-US" xlink:label="lab_biib_MarketStockUnitsMember_5ED63919E84E581DB0C6DEA10B9E2084" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Stock Units [Member]</link:label>
    <link:label id="lab_biib_MarketStockUnitsMember_5ED63919E84E581DB0C6DEA10B9E2084_documentation_en-US" xlink:label="lab_biib_MarketStockUnitsMember_5ED63919E84E581DB0C6DEA10B9E2084" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market stock units.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_MarketStockUnitsMember" xlink:label="loc_biib_MarketStockUnitsMember_5ED63919E84E581DB0C6DEA10B9E2084" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_MarketStockUnitsMember_5ED63919E84E581DB0C6DEA10B9E2084" xlink:to="lab_biib_MarketStockUnitsMember_5ED63919E84E581DB0C6DEA10B9E2084" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5376DD131B7A3DBE1DF6DEA10B9EDEA7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5376DD131B7A3DBE1DF6DEA10B9EDEA7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5376DD131B7A3DBE1DF6DEA10B9EDEA7_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5376DD131B7A3DBE1DF6DEA10B9EDEA7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5376DD131B7A3DBE1DF6DEA10B9EDEA7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5376DD131B7A3DBE1DF6DEA10B9EDEA7" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5376DD131B7A3DBE1DF6DEA10B9EDEA7" xlink:type="arc" />
    <link:label id="lab_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19_verboseLabel_en-US" xlink:label="lab_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic and diluted earnings per share</link:label>
    <link:label id="lab_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19_label_en-US" xlink:label="lab_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic And Diluted Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19_documentation_en-US" xlink:label="lab_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Basic and diluted earnings per share.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_BasicAndDilutedEarningsPerShareAbstract" xlink:label="loc_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19" xlink:to="lab_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_B74946F5CF3FE72EEDD3DEC797A68E08_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract_B74946F5CF3FE72EEDD3DEC797A68E08" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_B74946F5CF3FE72EEDD3DEC797A68E08_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract_B74946F5CF3FE72EEDD3DEC797A68E08" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="loc_us-gaap_NetIncomeLossAbstract_B74946F5CF3FE72EEDD3DEC797A68E08" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract_B74946F5CF3FE72EEDD3DEC797A68E08" xlink:to="lab_us-gaap_NetIncomeLossAbstract_B74946F5CF3FE72EEDD3DEC797A68E08" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_AB5B1CC24EF7C4FAEA9FDEC797A99CD8_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_AB5B1CC24EF7C4FAEA9FDEC797A99CD8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income attributable to Biogen Inc</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_AB5B1CC24EF7C4FAEA9FDEC797A99CD8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_AB5B1CC24EF7C4FAEA9FDEC797A99CD8" xlink:to="lab_us-gaap_NetIncomeLoss_AB5B1CC24EF7C4FAEA9FDEC797A99CD8" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares used in calculating:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C002BB61CC6F0E4F89BCDEC808B322E8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C002BB61CC6F0E4F89BCDEC808B322E8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average number of common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C002BB61CC6F0E4F89BCDEC808B322E8_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C002BB61CC6F0E4F89BCDEC808B322E8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C002BB61CC6F0E4F89BCDEC808B322E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C002BB61CC6F0E4F89BCDEC808B322E8" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C002BB61CC6F0E4F89BCDEC808B322E8" xlink:type="arc" />
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_A080341C35CFB7223A4DDEC808B33CC0_verboseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract_A080341C35CFB7223A4DDEC808B33CC0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_A080341C35CFB7223A4DDEC808B33CC0_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract_A080341C35CFB7223A4DDEC808B33CC0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_A080341C35CFB7223A4DDEC808B33CC0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_A080341C35CFB7223A4DDEC808B33CC0" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract_A080341C35CFB7223A4DDEC808B33CC0" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0ED2255CC06966555136DEC808B4EC4C_verboseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0ED2255CC06966555136DEC808B4EC4C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock units</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0ED2255CC06966555136DEC808B4EC4C_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0ED2255CC06966555136DEC808B4EC4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0ED2255CC06966555136DEC808B4EC4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0ED2255CC06966555136DEC808B4EC4C" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0ED2255CC06966555136DEC808B4EC4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_47149D148DB513F40DADDEC808B4DCCE_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_47149D148DB513F40DADDEC808B4DCCE" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Dilutive potential common shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_47149D148DB513F40DADDEC808B4DCCE_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_47149D148DB513F40DADDEC808B4DCCE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_47149D148DB513F40DADDEC808B4DCCE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_47149D148DB513F40DADDEC808B4DCCE" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_47149D148DB513F40DADDEC808B4DCCE" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06A7C143CD3119B21E03DEC808B4CD8C_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06A7C143CD3119B21E03DEC808B4CD8C" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Shares used in calculating diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06A7C143CD3119B21E03DEC808B4CD8C_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06A7C143CD3119B21E03DEC808B4CD8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06A7C143CD3119B21E03DEC808B4CD8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06A7C143CD3119B21E03DEC808B4CD8C" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06A7C143CD3119B21E03DEC808B4CD8C" xlink:type="arc" />
    <link:label id="lab_biib_BusinessOverviewPolicyTextBlock_8DAACEDB22F1E0E0A8617404CF70E79C_verboseLabel_en-US" xlink:label="lab_biib_BusinessOverviewPolicyTextBlock_8DAACEDB22F1E0E0A8617404CF70E79C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Overview</link:label>
    <link:label id="lab_biib_BusinessOverviewPolicyTextBlock_8DAACEDB22F1E0E0A8617404CF70E79C_label_en-US" xlink:label="lab_biib_BusinessOverviewPolicyTextBlock_8DAACEDB22F1E0E0A8617404CF70E79C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Overview [Policy Text Block]</link:label>
    <link:label id="lab_biib_BusinessOverviewPolicyTextBlock_8DAACEDB22F1E0E0A8617404CF70E79C_documentation_en-US" xlink:label="lab_biib_BusinessOverviewPolicyTextBlock_8DAACEDB22F1E0E0A8617404CF70E79C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Describes an overview of the company and its operations.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_BusinessOverviewPolicyTextBlock" xlink:label="loc_biib_BusinessOverviewPolicyTextBlock_8DAACEDB22F1E0E0A8617404CF70E79C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_BusinessOverviewPolicyTextBlock_8DAACEDB22F1E0E0A8617404CF70E79C" xlink:to="lab_biib_BusinessOverviewPolicyTextBlock_8DAACEDB22F1E0E0A8617404CF70E79C" xlink:type="arc" />
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_39C0ABC7EA2FC1613C727404CF706345_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_39C0ABC7EA2FC1613C727404CF706345" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basis of presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_39C0ABC7EA2FC1613C727404CF706345_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_39C0ABC7EA2FC1613C727404CF706345" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_39C0ABC7EA2FC1613C727404CF706345" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_39C0ABC7EA2FC1613C727404CF706345" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_39C0ABC7EA2FC1613C727404CF706345" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_B15BFC0E03792E1D85CF7404CF70DBE9_verboseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock_B15BFC0E03792E1D85CF7404CF70DBE9" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_B15BFC0E03792E1D85CF7404CF70DBE9_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock_B15BFC0E03792E1D85CF7404CF70DBE9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_B15BFC0E03792E1D85CF7404CF70DBE9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock_B15BFC0E03792E1D85CF7404CF70DBE9" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock_B15BFC0E03792E1D85CF7404CF70DBE9" xlink:type="arc" />
    <link:label id="lab_us-gaap_UseOfEstimates_AAA9CD515958EB4CF63D7404CF70F93F_verboseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates_AAA9CD515958EB4CF63D7404CF70F93F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Use of estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_AAA9CD515958EB4CF63D7404CF70F93F_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates_AAA9CD515958EB4CF63D7404CF70F93F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_AAA9CD515958EB4CF63D7404CF70F93F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates_AAA9CD515958EB4CF63D7404CF70F93F" xlink:to="lab_us-gaap_UseOfEstimates_AAA9CD515958EB4CF63D7404CF70F93F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_FDF7570131AD269511AD74094C4F122F_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock_FDF7570131AD269511AD74094C4F122F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_FDF7570131AD269511AD74094C4F122F_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock_FDF7570131AD269511AD74094C4F122F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_FDF7570131AD269511AD74094C4F122F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock_FDF7570131AD269511AD74094C4F122F" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock_FDF7570131AD269511AD74094C4F122F" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1158D5373526D49BEF9C7404CF70D7F0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1158D5373526D49BEF9C7404CF70D7F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1158D5373526D49BEF9C7404CF70D7F0_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1158D5373526D49BEF9C7404CF70D7F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1158D5373526D49BEF9C7404CF70D7F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1158D5373526D49BEF9C7404CF70D7F0" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1158D5373526D49BEF9C7404CF70D7F0" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8FBF9F8207D6C9FA12E37404CF70BB9F_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8FBF9F8207D6C9FA12E37404CF70BB9F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New accounting pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8FBF9F8207D6C9FA12E37404CF70BB9F_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8FBF9F8207D6C9FA12E37404CF70BB9F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8FBF9F8207D6C9FA12E37404CF70BB9F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8FBF9F8207D6C9FA12E37404CF70BB9F" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8FBF9F8207D6C9FA12E37404CF70BB9F" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_D43D41004B9ABFE7749CD4ED4B94CF3A_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_D43D41004B9ABFE7749CD4ED4B94CF3A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_D43D41004B9ABFE7749CD4ED4B94CF3A_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_D43D41004B9ABFE7749CD4ED4B94CF3A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_D43D41004B9ABFE7749CD4ED4B94CF3A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_D43D41004B9ABFE7749CD4ED4B94CF3A" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_D43D41004B9ABFE7749CD4ED4B94CF3A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1B4B8FA4EDD814130BA1D4ED4B860532_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1B4B8FA4EDD814130BA1D4ED4B860532" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Tax effect on net unrealized gains (losses) recognized on securities available for sale</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1B4B8FA4EDD814130BA1D4ED4B860532_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1B4B8FA4EDD814130BA1D4ED4B860532" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities, Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1B4B8FA4EDD814130BA1D4ED4B860532" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1B4B8FA4EDD814130BA1D4ED4B860532" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1B4B8FA4EDD814130BA1D4ED4B860532" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_7C7D8CCD6848916914E8D4ED4B867A49_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_7C7D8CCD6848916914E8D4ED4B867A49" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Tax effect of net unrealized gains (losses) recognized on foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_7C7D8CCD6848916914E8D4ED4B867A49_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_7C7D8CCD6848916914E8D4ED4B867A49" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_7C7D8CCD6848916914E8D4ED4B867A49" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_7C7D8CCD6848916914E8D4ED4B867A49" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_7C7D8CCD6848916914E8D4ED4B867A49" xlink:type="arc" />
    <link:label id="lab_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA_verboseLabel_en-US" xlink:label="lab_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equity (Textual) [Abstract]</link:label>
    <link:label id="lab_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA_label_en-US" xlink:label="lab_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity (Textual) [Abstract]</link:label>
    <link:label id="lab_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA_documentation_en-US" xlink:label="lab_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_EquityTextualAbstract" xlink:label="loc_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA" xlink:to="lab_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_F7FBA8DEFDEBF406E4AAB7291AFF54FC_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_F7FBA8DEFDEBF406E4AAB7291AFF54FC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equity increase during the period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_F7FBA8DEFDEBF406E4AAB7291AFF54FC_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_F7FBA8DEFDEBF406E4AAB7291AFF54FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Period Increase (Decrease)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_F7FBA8DEFDEBF406E4AAB7291AFF54FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_F7FBA8DEFDEBF406E4AAB7291AFF54FC" xlink:to="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_F7FBA8DEFDEBF406E4AAB7291AFF54FC" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2BCB1C9457F8F56AC41BB7291AFF33DF_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2BCB1C9457F8F56AC41BB7291AFF33DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock value authorized for repurchase</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2BCB1C9457F8F56AC41BB7291AFF33DF_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2BCB1C9457F8F56AC41BB7291AFF33DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2BCB1C9457F8F56AC41BB7291AFF33DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2BCB1C9457F8F56AC41BB7291AFF33DF" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2BCB1C9457F8F56AC41BB7291AFF33DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_C224A0ACEC5BCD15F9BDB7291AFFFF95_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_C224A0ACEC5BCD15F9BDB7291AFFFF95" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock shares authorized remaining or repurchase</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_C224A0ACEC5BCD15F9BDB7291AFFFF95_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_C224A0ACEC5BCD15F9BDB7291AFFFF95" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_C224A0ACEC5BCD15F9BDB7291AFFFF95" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_C224A0ACEC5BCD15F9BDB7291AFFFF95" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_C224A0ACEC5BCD15F9BDB7291AFFFF95" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_31B3915C8AF7A061015CB7291AFF1EA6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_31B3915C8AF7A061015CB7291AFF1EA6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_31B3915C8AF7A061015CB7291AFF1EA6_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_31B3915C8AF7A061015CB7291AFF1EA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_31B3915C8AF7A061015CB7291AFF1EA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_31B3915C8AF7A061015CB7291AFF1EA6" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired_31B3915C8AF7A061015CB7291AFF1EA6" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1F0ABFF15CC83C36FA8CB7291AFFB1B2_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1F0ABFF15CC83C36FA8CB7291AFFB1B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1F0ABFF15CC83C36FA8CB7291AFFB1B2_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1F0ABFF15CC83C36FA8CB7291AFFB1B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1F0ABFF15CC83C36FA8CB7291AFFB1B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1F0ABFF15CC83C36FA8CB7291AFFB1B2" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1F0ABFF15CC83C36FA8CB7291AFFB1B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNetAbstract_E5641F783A6A935932ACB1CFCCAC97ED_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract_E5641F783A6A935932ACB1CFCCAC97ED" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Components of inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_E5641F783A6A935932ACB1CFCCAC97ED_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract_E5641F783A6A935932ACB1CFCCAC97ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNetAbstract" xlink:label="loc_us-gaap_InventoryNetAbstract_E5641F783A6A935932ACB1CFCCAC97ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract_E5641F783A6A935932ACB1CFCCAC97ED" xlink:to="lab_us-gaap_InventoryNetAbstract_E5641F783A6A935932ACB1CFCCAC97ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_497895B2A99A5B0A93D1B1CFCCACCE6D_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves_497895B2A99A5B0A93D1B1CFCCACCE6D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_497895B2A99A5B0A93D1B1CFCCACCE6D_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves_497895B2A99A5B0A93D1B1CFCCACCE6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_497895B2A99A5B0A93D1B1CFCCACCE6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves_497895B2A99A5B0A93D1B1CFCCACCE6D" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves_497895B2A99A5B0A93D1B1CFCCACCE6D" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_005EB676F920D96DDEFBB1CFCCAC9A78_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves_005EB676F920D96DDEFBB1CFCCAC9A78" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_005EB676F920D96DDEFBB1CFCCAC9A78_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves_005EB676F920D96DDEFBB1CFCCAC9A78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_005EB676F920D96DDEFBB1CFCCAC9A78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves_005EB676F920D96DDEFBB1CFCCAC9A78" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves_005EB676F920D96DDEFBB1CFCCAC9A78" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_DD5D7D591014BC37A2FDB1CFCCACDC60_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_DD5D7D591014BC37A2FDB1CFCCACDC60" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_DD5D7D591014BC37A2FDB1CFCCACDC60_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_DD5D7D591014BC37A2FDB1CFCCACDC60" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_DD5D7D591014BC37A2FDB1CFCCACDC60" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_DD5D7D591014BC37A2FDB1CFCCACDC60" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_DD5D7D591014BC37A2FDB1CFCCACDC60" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_7843651C2FA7387FAADFB1CFCCACF9F8_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_7843651C2FA7387FAADFB1CFCCACF9F8" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_7843651C2FA7387FAADFB1CFCCACF9F8_label_en-US" xlink:label="lab_us-gaap_InventoryNet_7843651C2FA7387FAADFB1CFCCACF9F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_7843651C2FA7387FAADFB1CFCCACF9F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_7843651C2FA7387FAADFB1CFCCACF9F8" xlink:to="lab_us-gaap_InventoryNet_7843651C2FA7387FAADFB1CFCCACF9F8" xlink:type="arc" />
    <link:label id="lab_biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock_2AD1885248E116AD87ABD4ED4B6B9EBD_verboseLabel_en-US" xlink:label="lab_biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock_2AD1885248E116AD87ABD4ED4B6B9EBD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of equity attributable to noncontrolling interests</link:label>
    <link:label id="lab_biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock_2AD1885248E116AD87ABD4ED4B6B9EBD_label_en-US" xlink:label="lab_biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock_2AD1885248E116AD87ABD4ED4B6B9EBD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation Of Equity Attributable To Noncontrolling Interests [Table Text Block]</link:label>
    <link:label id="lab_biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock_2AD1885248E116AD87ABD4ED4B6B9EBD_documentation_en-US" xlink:label="lab_biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock_2AD1885248E116AD87ABD4ED4B6B9EBD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reconciliation of equity attributable to noncontrolling interests.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock" xlink:label="loc_biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock_2AD1885248E116AD87ABD4ED4B6B9EBD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock_2AD1885248E116AD87ABD4ED4B6B9EBD" xlink:to="lab_biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock_2AD1885248E116AD87ABD4ED4B6B9EBD" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_FDDF17E232B13CADA63ED4ED4B851DB7_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_FDDF17E232B13CADA63ED4ED4B851DB7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_FDDF17E232B13CADA63ED4ED4B851DB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_FDDF17E232B13CADA63ED4ED4B851DB7" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_FDDF17E232B13CADA63ED4ED4B851DB7" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_EBE57A57562B85A8D1B2D4ED4B85DB8A_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_EBE57A57562B85A8D1B2D4ED4B85DB8A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_EBE57A57562B85A8D1B2D4ED4B85DB8A_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_EBE57A57562B85A8D1B2D4ED4B85DB8A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_EBE57A57562B85A8D1B2D4ED4B85DB8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_EBE57A57562B85A8D1B2D4ED4B85DB8A" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_EBE57A57562B85A8D1B2D4ED4B85DB8A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDateDescription_721941F433104AA2560AB1DDA874C9FF_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDateDescription_721941F433104AA2560AB1DDA874C9FF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Original maturities of commercial paper and short-term debt securities</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDateDescription_721941F433104AA2560AB1DDA874C9FF_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDateDescription_721941F433104AA2560AB1DDA874C9FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Maturity Date, Description</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_721941F433104AA2560AB1DDA874C9FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDateDescription_721941F433104AA2560AB1DDA874C9FF" xlink:to="lab_us-gaap_DebtInstrumentMaturityDateDescription_721941F433104AA2560AB1DDA874C9FF" xlink:type="arc" />
    <link:label id="lab_biib_Overnightreverserepurchaseagreementspercentoftotalassets_3063314270AECCB9B66EB1DDA875CC54_terseLabel_en-US" xlink:label="lab_biib_Overnightreverserepurchaseagreementspercentoftotalassets_3063314270AECCB9B66EB1DDA875CC54" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Overnight reverse repurchase agreements, percent of total assets</link:label>
    <link:label id="lab_biib_Overnightreverserepurchaseagreementspercentoftotalassets_3063314270AECCB9B66EB1DDA875CC54_label_en-US" xlink:label="lab_biib_Overnightreverserepurchaseagreementspercentoftotalassets_3063314270AECCB9B66EB1DDA875CC54" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Overnight reverse repurchase agreements, percent of total assets</link:label>
    <link:label id="lab_biib_Overnightreverserepurchaseagreementspercentoftotalassets_3063314270AECCB9B66EB1DDA875CC54_documentation_en-US" xlink:label="lab_biib_Overnightreverserepurchaseagreementspercentoftotalassets_3063314270AECCB9B66EB1DDA875CC54" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Overnight reverse repurchase agreements, percent of total assets</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_Overnightreverserepurchaseagreementspercentoftotalassets" xlink:label="loc_biib_Overnightreverserepurchaseagreementspercentoftotalassets_3063314270AECCB9B66EB1DDA875CC54" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_Overnightreverserepurchaseagreementspercentoftotalassets_3063314270AECCB9B66EB1DDA875CC54" xlink:to="lab_biib_Overnightreverserepurchaseagreementspercentoftotalassets_3063314270AECCB9B66EB1DDA875CC54" xlink:type="arc" />
    <link:label id="lab_biib_AverageMaturityOfMarketableSecurities_775DD57A2DA8CE927C2CB1DDA87526AF_verboseLabel_en-US" xlink:label="lab_biib_AverageMaturityOfMarketableSecurities_775DD57A2DA8CE927C2CB1DDA87526AF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Average maturity of marketable securities, months</link:label>
    <link:label id="lab_biib_AverageMaturityOfMarketableSecurities_775DD57A2DA8CE927C2CB1DDA87526AF_label_en-US" xlink:label="lab_biib_AverageMaturityOfMarketableSecurities_775DD57A2DA8CE927C2CB1DDA87526AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average Maturity Of Marketable Securities</link:label>
    <link:label id="lab_biib_AverageMaturityOfMarketableSecurities_775DD57A2DA8CE927C2CB1DDA87526AF_documentation_en-US" xlink:label="lab_biib_AverageMaturityOfMarketableSecurities_775DD57A2DA8CE927C2CB1DDA87526AF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Average remaining time to maturity of marketable debt securities, available-for-sale securities.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_AverageMaturityOfMarketableSecurities" xlink:label="loc_biib_AverageMaturityOfMarketableSecurities_775DD57A2DA8CE927C2CB1DDA87526AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_AverageMaturityOfMarketableSecurities_775DD57A2DA8CE927C2CB1DDA87526AF" xlink:to="lab_biib_AverageMaturityOfMarketableSecurities_775DD57A2DA8CE927C2CB1DDA87526AF" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_A1565EC83CDAC888340CDEC340EC5B64_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_A1565EC83CDAC888340CDEC340EC5B64" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_A1565EC83CDAC888340CDEC340EC5B64_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_A1565EC83CDAC888340CDEC340EC5B64" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_A1565EC83CDAC888340CDEC340EC5B64" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_A1565EC83CDAC888340CDEC340EC5B64" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_A1565EC83CDAC888340CDEC340EC5B64" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_DDAFD3CDAF31EDD53E78DEC340EC7DFA_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember_DDAFD3CDAF31EDD53E78DEC340EC7DFA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Translation Adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_DDAFD3CDAF31EDD53E78DEC340EC7DFA_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember_DDAFD3CDAF31EDD53E78DEC340EC7DFA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_DDAFD3CDAF31EDD53E78DEC340EC7DFA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember_DDAFD3CDAF31EDD53E78DEC340EC7DFA" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember_DDAFD3CDAF31EDD53E78DEC340EC7DFA" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C65D719F9A07D12C96ADEC340EC2393_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C65D719F9A07D12C96ADEC340EC2393" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C65D719F9A07D12C96ADEC340EC2393_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C65D719F9A07D12C96ADEC340EC2393" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C65D719F9A07D12C96ADEC340EC2393" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C65D719F9A07D12C96ADEC340EC2393" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C65D719F9A07D12C96ADEC340EC2393" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9868D94022B94C2C9C96DEC340EC70F7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9868D94022B94C2C9C96DEC340EC70F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9868D94022B94C2C9C96DEC340EC70F7_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9868D94022B94C2C9C96DEC340EC70F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9868D94022B94C2C9C96DEC340EC70F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9868D94022B94C2C9C96DEC340EC70F7" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9868D94022B94C2C9C96DEC340EC70F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4F54429D1294DE7171C9DEC340EC7F2D_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4F54429D1294DE7171C9DEC340EC7F2D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income loss before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4F54429D1294DE7171C9DEC340EC7F2D_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4F54429D1294DE7171C9DEC340EC7F2D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4F54429D1294DE7171C9DEC340EC7F2D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4F54429D1294DE7171C9DEC340EC7F2D" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4F54429D1294DE7171C9DEC340EC7F2D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_F2B8BB15C7B40F7DFC87DEC340EC4D17_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_F2B8BB15C7B40F7DFC87DEC340EC4D17" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_F2B8BB15C7B40F7DFC87DEC340EC4D17_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_F2B8BB15C7B40F7DFC87DEC340EC4D17" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_F2B8BB15C7B40F7DFC87DEC340EC4D17" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_F2B8BB15C7B40F7DFC87DEC340EC4D17" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_F2B8BB15C7B40F7DFC87DEC340EC4D17" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_30ED53B9CEEB06B028E2DEC340ECA6D0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_30ED53B9CEEB06B028E2DEC340ECA6D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net current period other comprehensive income loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_30ED53B9CEEB06B028E2DEC340ECA6D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_30ED53B9CEEB06B028E2DEC340ECA6D0" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_30ED53B9CEEB06B028E2DEC340ECA6D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_DA3E64E7C16170C6AC53DEB33F8B8D44_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_DA3E64E7C16170C6AC53DEB33F8B8D44" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_DA3E64E7C16170C6AC53DEB33F8B8D44_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_DA3E64E7C16170C6AC53DEB33F8B8D44" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_DA3E64E7C16170C6AC53DEB33F8B8D44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_DA3E64E7C16170C6AC53DEB33F8B8D44" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_DA3E64E7C16170C6AC53DEB33F8B8D44" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentTypeAxis_7563379A79B07CE5D39ADEB33F8B2942_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis_7563379A79B07CE5D39ADEB33F8B2942" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_7563379A79B07CE5D39ADEB33F8B2942_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis_7563379A79B07CE5D39ADEB33F8B2942" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_7563379A79B07CE5D39ADEB33F8B2942" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis_7563379A79B07CE5D39ADEB33F8B2942" xlink:to="lab_us-gaap_InvestmentTypeAxis_7563379A79B07CE5D39ADEB33F8B2942" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_3F4A3C31B8221811B42CDEB33F8BEA06_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember_3F4A3C31B8221811B42CDEB33F8BEA06" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment Type Categorization [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_3F4A3C31B8221811B42CDEB33F8BEA06_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember_3F4A3C31B8221811B42CDEB33F8BEA06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_3F4A3C31B8221811B42CDEB33F8BEA06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3F4A3C31B8221811B42CDEB33F8BEA06" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember_3F4A3C31B8221811B42CDEB33F8BEA06" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommercialPaperMember_121DB734F849BE9C3EB7DEB33F8B7715_verboseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember_121DB734F849BE9C3EB7DEB33F8B7715" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_121DB734F849BE9C3EB7DEB33F8B7715_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember_121DB734F849BE9C3EB7DEB33F8B7715" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_121DB734F849BE9C3EB7DEB33F8B7715" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember_121DB734F849BE9C3EB7DEB33F8B7715" xlink:to="lab_us-gaap_CommercialPaperMember_121DB734F849BE9C3EB7DEB33F8B7715" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepurchaseAgreementsMember_0319BF09A3EC6D2175A6DEB33F8BDC72_verboseLabel_en-US" xlink:label="lab_us-gaap_RepurchaseAgreementsMember_0319BF09A3EC6D2175A6DEB33F8BDC72" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Overnight reverse repurchase agreements</link:label>
    <link:label id="lab_us-gaap_RepurchaseAgreementsMember_0319BF09A3EC6D2175A6DEB33F8BDC72_label_en-US" xlink:label="lab_us-gaap_RepurchaseAgreementsMember_0319BF09A3EC6D2175A6DEB33F8BDC72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repurchase Agreements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RepurchaseAgreementsMember" xlink:label="loc_us-gaap_RepurchaseAgreementsMember_0319BF09A3EC6D2175A6DEB33F8BDC72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepurchaseAgreementsMember_0319BF09A3EC6D2175A6DEB33F8BDC72" xlink:to="lab_us-gaap_RepurchaseAgreementsMember_0319BF09A3EC6D2175A6DEB33F8BDC72" xlink:type="arc" />
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_2F663803CD132EF79482DEB33F8BED58_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember_2F663803CD132EF79482DEB33F8BED58" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_2F663803CD132EF79482DEB33F8BED58_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember_2F663803CD132EF79482DEB33F8BED58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_2F663803CD132EF79482DEB33F8BED58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember_2F663803CD132EF79482DEB33F8BED58" xlink:to="lab_us-gaap_MoneyMarketFundsMember_2F663803CD132EF79482DEB33F8BED58" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtSecuritiesMember_CA87AC919FA9BFB20C78DEB33F8B5104_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember_CA87AC919FA9BFB20C78DEB33F8B5104" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Short-term debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_CA87AC919FA9BFB20C78DEB33F8B5104_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember_CA87AC919FA9BFB20C78DEB33F8B5104" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtSecuritiesMember" xlink:label="loc_us-gaap_DebtSecuritiesMember_CA87AC919FA9BFB20C78DEB33F8B5104" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember_CA87AC919FA9BFB20C78DEB33F8B5104" xlink:to="lab_us-gaap_DebtSecuritiesMember_CA87AC919FA9BFB20C78DEB33F8B5104" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_1CCF7866EB3AF7177FABDEB33F8BB4D4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems_1CCF7866EB3AF7177FABDEB33F8BB4D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_1CCF7866EB3AF7177FABDEB33F8BB4D4_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems_1CCF7866EB3AF7177FABDEB33F8BB4D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_1CCF7866EB3AF7177FABDEB33F8BB4D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_1CCF7866EB3AF7177FABDEB33F8BB4D4" xlink:to="lab_us-gaap_CashAndCashEquivalentsLineItems_1CCF7866EB3AF7177FABDEB33F8BB4D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract_D0E69D6962470577CFF0DEB33F8BC507_verboseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract_D0E69D6962470577CFF0DEB33F8BC507" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of financial assets with original maturities of less than 90 days included within cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract_D0E69D6962470577CFF0DEB33F8BC507_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract_D0E69D6962470577CFF0DEB33F8BC507" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Equivalents, at Carrying Value [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValueAbstract" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_D0E69D6962470577CFF0DEB33F8BC507" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_D0E69D6962470577CFF0DEB33F8BC507" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract_D0E69D6962470577CFF0DEB33F8BC507" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_52FA7B74D0B68020C02FDEB33F8B842B_verboseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue_52FA7B74D0B68020C02FDEB33F8B842B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_52FA7B74D0B68020C02FDEB33F8B842B_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue_52FA7B74D0B68020C02FDEB33F8B842B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_52FA7B74D0B68020C02FDEB33F8B842B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue_52FA7B74D0B68020C02FDEB33F8B842B" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue_52FA7B74D0B68020C02FDEB33F8B842B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_F5AA27735534EB5D0407DEABFF5FFD0F_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_F5AA27735534EB5D0407DEABFF5FFD0F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Marketable debt and equity securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_F5AA27735534EB5D0407DEABFF5FFD0F_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_F5AA27735534EB5D0407DEABFF5FFD0F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_F5AA27735534EB5D0407DEABFF5FFD0F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_F5AA27735534EB5D0407DEABFF5FFD0F" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_F5AA27735534EB5D0407DEABFF5FFD0F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_4FCE4DD1C15E6C58547DDEABFF5FD639_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_4FCE4DD1C15E6C58547DDEABFF5FD639" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of financial assets with maturities of less than 90 days included within cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_4FCE4DD1C15E6C58547DDEABFF5FD639_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_4FCE4DD1C15E6C58547DDEABFF5FD639" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_4FCE4DD1C15E6C58547DDEABFF5FD639" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_4FCE4DD1C15E6C58547DDEABFF5FD639" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_4FCE4DD1C15E6C58547DDEABFF5FD639" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_DD48AAFC135731A0DA9BDEABFF5F1D75_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_DD48AAFC135731A0DA9BDEABFF5F1D75" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of contractual maturities: available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_DD48AAFC135731A0DA9BDEABFF5F1D75_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_DD48AAFC135731A0DA9BDEABFF5F1D75" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_DD48AAFC135731A0DA9BDEABFF5F1D75" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_DD48AAFC135731A0DA9BDEABFF5F1D75" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_DD48AAFC135731A0DA9BDEABFF5F1D75" xlink:type="arc" />
    <link:label id="lab_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_226C24F4AFBF24F8DFB8DEABFF5FED37_verboseLabel_en-US" xlink:label="lab_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_226C24F4AFBF24F8DFB8DEABFF5FED37" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from marketable debt securities</link:label>
    <link:label id="lab_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_226C24F4AFBF24F8DFB8DEABFF5FED37_label_en-US" xlink:label="lab_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_226C24F4AFBF24F8DFB8DEABFF5FED37" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Realized Gain (Loss) on Investments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RealizedGainLossOnInvestmentsTableTextBlock" xlink:label="loc_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_226C24F4AFBF24F8DFB8DEABFF5FED37" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_226C24F4AFBF24F8DFB8DEABFF5FED37" xlink:to="lab_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_226C24F4AFBF24F8DFB8DEABFF5FED37" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2B8239A3C265BA0469F1D4ED4BBB7723_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2B8239A3C265BA0469F1D4ED4BBB7723" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payments</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2B8239A3C265BA0469F1D4ED4BBB7723_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2B8239A3C265BA0469F1D4ED4BBB7723" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2B8239A3C265BA0469F1D4ED4BBB7723" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2B8239A3C265BA0469F1D4ED4BBB7723" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2B8239A3C265BA0469F1D4ED4BBB7723" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4C26DBF7067F1C0E1CD3DE0CFBE3649E_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4C26DBF7067F1C0E1CD3DE0CFBE3649E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4C26DBF7067F1C0E1CD3DE0CFBE3649E_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4C26DBF7067F1C0E1CD3DE0CFBE3649E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4C26DBF7067F1C0E1CD3DE0CFBE3649E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4C26DBF7067F1C0E1CD3DE0CFBE3649E" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4C26DBF7067F1C0E1CD3DE0CFBE3649E" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_F2D8773964007BAE81CCDE0CFBE343CF_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_F2D8773964007BAE81CCDE0CFBE343CF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_F2D8773964007BAE81CCDE0CFBE343CF_label_en-US" xlink:label="lab_us-gaap_Goodwill_F2D8773964007BAE81CCDE0CFBE343CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_F2D8773964007BAE81CCDE0CFBE343CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_F2D8773964007BAE81CCDE0CFBE343CF" xlink:to="lab_us-gaap_Goodwill_F2D8773964007BAE81CCDE0CFBE343CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_3037A293A4F0278615FDDE0CFBE3CDE0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_3037A293A4F0278615FDDE0CFBE3CDE0" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_3037A293A4F0278615FDDE0CFBE3CDE0_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_3037A293A4F0278615FDDE0CFBE3CDE0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_3037A293A4F0278615FDDE0CFBE3CDE0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_3037A293A4F0278615FDDE0CFBE3CDE0" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_3037A293A4F0278615FDDE0CFBE3CDE0" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_9B4B298C8DA91EE8A0C7DE0CFBE3155E_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_9B4B298C8DA91EE8A0C7DE0CFBE3155E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_9B4B298C8DA91EE8A0C7DE0CFBE3155E_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_9B4B298C8DA91EE8A0C7DE0CFBE3155E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_9B4B298C8DA91EE8A0C7DE0CFBE3155E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_9B4B298C8DA91EE8A0C7DE0CFBE3155E" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_9B4B298C8DA91EE8A0C7DE0CFBE3155E" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_E219109129DD541FD7D3DE0CFBE3068E_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_E219109129DD541FD7D3DE0CFBE3068E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_E219109129DD541FD7D3DE0CFBE3068E_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_E219109129DD541FD7D3DE0CFBE3068E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_E219109129DD541FD7D3DE0CFBE3068E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_E219109129DD541FD7D3DE0CFBE3068E" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_E219109129DD541FD7D3DE0CFBE3068E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_58661BA7D073C9063C05D4ED4ACF8EBF_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_58661BA7D073C9063C05D4ED4ACF8EBF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_58661BA7D073C9063C05D4ED4ACF8EBF_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_58661BA7D073C9063C05D4ED4ACF8EBF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_58661BA7D073C9063C05D4ED4ACF8EBF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_58661BA7D073C9063C05D4ED4ACF8EBF" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_58661BA7D073C9063C05D4ED4ACF8EBF" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameAxis_AB106E479BE91712B682D4ED4ACF92D5_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis_AB106E479BE91712B682D4ED4ACF92D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_AB106E479BE91712B682D4ED4ACF92D5_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis_AB106E479BE91712B682D4ED4ACF92D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_AB106E479BE91712B682D4ED4ACF92D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis_AB106E479BE91712B682D4ED4ACF92D5" xlink:to="lab_us-gaap_PlanNameAxis_AB106E479BE91712B682D4ED4ACF92D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:to="lab_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:type="arc" />
    <link:label id="lab_biib_CashSettledPerformanceSharesMember_D1B572FA74FCD42CC965D4ED4AD0DC9B_terseLabel_en-US" xlink:label="lab_biib_CashSettledPerformanceSharesMember_D1B572FA74FCD42CC965D4ED4AD0DC9B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash settled performance shares</link:label>
    <link:label id="lab_biib_CashSettledPerformanceSharesMember_D1B572FA74FCD42CC965D4ED4AD0DC9B_label_en-US" xlink:label="lab_biib_CashSettledPerformanceSharesMember_D1B572FA74FCD42CC965D4ED4AD0DC9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash settled performance shares [Member]</link:label>
    <link:label id="lab_biib_CashSettledPerformanceSharesMember_D1B572FA74FCD42CC965D4ED4AD0DC9B_documentation_en-US" xlink:label="lab_biib_CashSettledPerformanceSharesMember_D1B572FA74FCD42CC965D4ED4AD0DC9B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash settled performance shares [Member]</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_CashSettledPerformanceSharesMember" xlink:label="loc_biib_CashSettledPerformanceSharesMember_D1B572FA74FCD42CC965D4ED4AD0DC9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_CashSettledPerformanceSharesMember_D1B572FA74FCD42CC965D4ED4AD0DC9B" xlink:to="lab_biib_CashSettledPerformanceSharesMember_D1B572FA74FCD42CC965D4ED4AD0DC9B" xlink:type="arc" />
    <link:label id="lab_us-gaap_PerformanceSharesMember_CB8E6DA6F2EA4EBC89C9D4ED4AD01D06_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_CB8E6DA6F2EA4EBC89C9D4ED4AD01D06" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_CB8E6DA6F2EA4EBC89C9D4ED4AD01D06_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_CB8E6DA6F2EA4EBC89C9D4ED4AD01D06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_CB8E6DA6F2EA4EBC89C9D4ED4AD01D06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember_CB8E6DA6F2EA4EBC89C9D4ED4AD01D06" xlink:to="lab_us-gaap_PerformanceSharesMember_CB8E6DA6F2EA4EBC89C9D4ED4AD01D06" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B8CBBCA1A4D053D375CED4ED4AD0BBFA_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B8CBBCA1A4D053D375CED4ED4AD0BBFA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B8CBBCA1A4D053D375CED4ED4AD0BBFA_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B8CBBCA1A4D053D375CED4ED4AD0BBFA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B8CBBCA1A4D053D375CED4ED4AD0BBFA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B8CBBCA1A4D053D375CED4ED4AD0BBFA" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B8CBBCA1A4D053D375CED4ED4AD0BBFA" xlink:type="arc" />
    <link:label id="lab_biib_ScheduleOfStockOptionGrantsAbstract_1BA6DAAB68C13E083D0BD4ED4AD073D0_verboseLabel_en-US" xlink:label="lab_biib_ScheduleOfStockOptionGrantsAbstract_1BA6DAAB68C13E083D0BD4ED4AD073D0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of stock option grants</link:label>
    <link:label id="lab_biib_ScheduleOfStockOptionGrantsAbstract_1BA6DAAB68C13E083D0BD4ED4AD073D0_label_en-US" xlink:label="lab_biib_ScheduleOfStockOptionGrantsAbstract_1BA6DAAB68C13E083D0BD4ED4AD073D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Stock Option Grants [Abstract]</link:label>
    <link:label id="lab_biib_ScheduleOfStockOptionGrantsAbstract_1BA6DAAB68C13E083D0BD4ED4AD073D0_documentation_en-US" xlink:label="lab_biib_ScheduleOfStockOptionGrantsAbstract_1BA6DAAB68C13E083D0BD4ED4AD073D0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of stock option grants.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_ScheduleOfStockOptionGrantsAbstract" xlink:label="loc_biib_ScheduleOfStockOptionGrantsAbstract_1BA6DAAB68C13E083D0BD4ED4AD073D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_ScheduleOfStockOptionGrantsAbstract_1BA6DAAB68C13E083D0BD4ED4AD073D0" xlink:to="lab_biib_ScheduleOfStockOptionGrantsAbstract_1BA6DAAB68C13E083D0BD4ED4AD073D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F825C80AEBCE6521E97D4ED4AD078A3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F825C80AEBCE6521E97D4ED4AD078A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F825C80AEBCE6521E97D4ED4AD078A3_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F825C80AEBCE6521E97D4ED4AD078A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F825C80AEBCE6521E97D4ED4AD078A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F825C80AEBCE6521E97D4ED4AD078A3" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F825C80AEBCE6521E97D4ED4AD078A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_A13224685B313195E39ED4ED4B081EAC_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_A13224685B313195E39ED4ED4B081EAC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_A13224685B313195E39ED4ED4B081EAC_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_A13224685B313195E39ED4ED4B081EAC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_A13224685B313195E39ED4ED4B081EAC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_A13224685B313195E39ED4ED4B081EAC" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_A13224685B313195E39ED4ED4B081EAC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillLineItems_97460C1B5E636C717AE8D4ED4B0074B6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_97460C1B5E636C717AE8D4ED4B0074B6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_97460C1B5E636C717AE8D4ED4B0074B6_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_97460C1B5E636C717AE8D4ED4B0074B6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_97460C1B5E636C717AE8D4ED4B0074B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems_97460C1B5E636C717AE8D4ED4B0074B6" xlink:to="lab_us-gaap_GoodwillLineItems_97460C1B5E636C717AE8D4ED4B0074B6" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_B0C69B6257F12125CF68D4ED4B00E433_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod_B0C69B6257F12125CF68D4ED4B00E433" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_B0C69B6257F12125CF68D4ED4B00E433_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod_B0C69B6257F12125CF68D4ED4B00E433" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_B0C69B6257F12125CF68D4ED4B00E433" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod_B0C69B6257F12125CF68D4ED4B00E433" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod_B0C69B6257F12125CF68D4ED4B00E433" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillRollForward_D142836F18365A42FF0AD4ED4B008AB4_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_D142836F18365A42FF0AD4ED4B008AB4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of roll forward of the changes in goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_D142836F18365A42FF0AD4ED4B008AB4_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_D142836F18365A42FF0AD4ED4B008AB4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_D142836F18365A42FF0AD4ED4B008AB4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward_D142836F18365A42FF0AD4ED4B008AB4" xlink:to="lab_us-gaap_GoodwillRollForward_D142836F18365A42FF0AD4ED4B008AB4" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_6688FF1201135E2E9F80D4ED4B00B1DF_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill_6688FF1201135E2E9F80D4ED4B00B1DF" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Goodwill, beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_6688FF1201135E2E9F80D4ED4B00B1DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_6688FF1201135E2E9F80D4ED4B00B1DF" xlink:to="lab_us-gaap_Goodwill_6688FF1201135E2E9F80D4ED4B00B1DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillOtherChanges_57CA5DC8F45A94682FCAD4ED4B00C30A_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillOtherChanges_57CA5DC8F45A94682FCAD4ED4B00C30A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_GoodwillOtherChanges_57CA5DC8F45A94682FCAD4ED4B00C30A_label_en-US" xlink:label="lab_us-gaap_GoodwillOtherChanges_57CA5DC8F45A94682FCAD4ED4B00C30A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Other Changes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillOtherChanges" xlink:label="loc_us-gaap_GoodwillOtherChanges_57CA5DC8F45A94682FCAD4ED4B00C30A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillOtherChanges_57CA5DC8F45A94682FCAD4ED4B00C30A" xlink:to="lab_us-gaap_GoodwillOtherChanges_57CA5DC8F45A94682FCAD4ED4B00C30A" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_0DD6BA9C1CEE8FEE7CF5D4ED4B00402C_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill_0DD6BA9C1CEE8FEE7CF5D4ED4B00402C" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Goodwill, end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_0DD6BA9C1CEE8FEE7CF5D4ED4B00402C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_0DD6BA9C1CEE8FEE7CF5D4ED4B00402C" xlink:to="lab_us-gaap_Goodwill_0DD6BA9C1CEE8FEE7CF5D4ED4B00402C" xlink:type="arc" />
    <link:label id="lab_biib_IntangibleAssetsExcludingGoodwillTableTextBlock_A5F6F8AABD2963C6B5EDD4ED4B0EA3D1_verboseLabel_en-US" xlink:label="lab_biib_IntangibleAssetsExcludingGoodwillTableTextBlock_A5F6F8AABD2963C6B5EDD4ED4B0EA3D1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_biib_IntangibleAssetsExcludingGoodwillTableTextBlock_A5F6F8AABD2963C6B5EDD4ED4B0EA3D1_label_en-US" xlink:label="lab_biib_IntangibleAssetsExcludingGoodwillTableTextBlock_A5F6F8AABD2963C6B5EDD4ED4B0EA3D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets Excluding Goodwill [Table Text Block]</link:label>
    <link:label id="lab_biib_IntangibleAssetsExcludingGoodwillTableTextBlock_A5F6F8AABD2963C6B5EDD4ED4B0EA3D1_documentation_en-US" xlink:label="lab_biib_IntangibleAssetsExcludingGoodwillTableTextBlock_A5F6F8AABD2963C6B5EDD4ED4B0EA3D1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Intangible assets excluding goodwill.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_IntangibleAssetsExcludingGoodwillTableTextBlock" xlink:label="loc_biib_IntangibleAssetsExcludingGoodwillTableTextBlock_A5F6F8AABD2963C6B5EDD4ED4B0EA3D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_IntangibleAssetsExcludingGoodwillTableTextBlock_A5F6F8AABD2963C6B5EDD4ED4B0EA3D1" xlink:to="lab_biib_IntangibleAssetsExcludingGoodwillTableTextBlock_A5F6F8AABD2963C6B5EDD4ED4B0EA3D1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_226F9F16FD5C521B4ACCD4ED4B0E4099_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_226F9F16FD5C521B4ACCD4ED4B0E4099" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated future amortization for acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_226F9F16FD5C521B4ACCD4ED4B0E4099_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_226F9F16FD5C521B4ACCD4ED4B0E4099" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_226F9F16FD5C521B4ACCD4ED4B0E4099" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_226F9F16FD5C521B4ACCD4ED4B0E4099" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_226F9F16FD5C521B4ACCD4ED4B0E4099" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_DADB28D732604B9F7A57D4ED4B0E9C74_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_DADB28D732604B9F7A57D4ED4B0E9C74" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of roll forward of the changes in goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_DADB28D732604B9F7A57D4ED4B0E9C74_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_DADB28D732604B9F7A57D4ED4B0E9C74" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_DADB28D732604B9F7A57D4ED4B0E9C74" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock_DADB28D732604B9F7A57D4ED4B0E9C74" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock_DADB28D732604B9F7A57D4ED4B0E9C74" xlink:type="arc" />
    <link:label id="lab_biib_InterestInSubsidiary_E423FAD582B7DBAF7FA0C096EDBB409B_verboseLabel_en-US" xlink:label="lab_biib_InterestInSubsidiary_E423FAD582B7DBAF7FA0C096EDBB409B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest in subsidiary (less than given percentage)</link:label>
    <link:label id="lab_biib_InterestInSubsidiary_E423FAD582B7DBAF7FA0C096EDBB409B_label_en-US" xlink:label="lab_biib_InterestInSubsidiary_E423FAD582B7DBAF7FA0C096EDBB409B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest In Subsidiary</link:label>
    <link:label id="lab_biib_InterestInSubsidiary_E423FAD582B7DBAF7FA0C096EDBB409B_documentation_en-US" xlink:label="lab_biib_InterestInSubsidiary_E423FAD582B7DBAF7FA0C096EDBB409B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest in subsidiary.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_InterestInSubsidiary" xlink:label="loc_biib_InterestInSubsidiary_E423FAD582B7DBAF7FA0C096EDBB409B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_InterestInSubsidiary_E423FAD582B7DBAF7FA0C096EDBB409B" xlink:to="lab_biib_InterestInSubsidiary_E423FAD582B7DBAF7FA0C096EDBB409B" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfReportableSegments_869AA79829AA07D6F441C096EDBB95F1_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_869AA79829AA07D6F441C096EDBB95F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_869AA79829AA07D6F441C096EDBB95F1_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_869AA79829AA07D6F441C096EDBB95F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_869AA79829AA07D6F441C096EDBB95F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments_869AA79829AA07D6F441C096EDBB95F1" xlink:to="lab_us-gaap_NumberOfReportableSegments_869AA79829AA07D6F441C096EDBB95F1" xlink:type="arc" />
    <link:label id="lab_biib_PaymentTermsOfAccountsReceivable_5FCF183EA47EC64B164BC096EDBBE4F0_verboseLabel_en-US" xlink:label="lab_biib_PaymentTermsOfAccountsReceivable_5FCF183EA47EC64B164BC096EDBBE4F0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Payment terms of accounts receivable arising from product sales</link:label>
    <link:label id="lab_biib_PaymentTermsOfAccountsReceivable_5FCF183EA47EC64B164BC096EDBBE4F0_label_en-US" xlink:label="lab_biib_PaymentTermsOfAccountsReceivable_5FCF183EA47EC64B164BC096EDBBE4F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment Terms Of Accounts Receivable</link:label>
    <link:label id="lab_biib_PaymentTermsOfAccountsReceivable_5FCF183EA47EC64B164BC096EDBBE4F0_documentation_en-US" xlink:label="lab_biib_PaymentTermsOfAccountsReceivable_5FCF183EA47EC64B164BC096EDBBE4F0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment  terms of accounts receivable.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_PaymentTermsOfAccountsReceivable" xlink:label="loc_biib_PaymentTermsOfAccountsReceivable_5FCF183EA47EC64B164BC096EDBBE4F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_PaymentTermsOfAccountsReceivable_5FCF183EA47EC64B164BC096EDBBE4F0" xlink:to="lab_biib_PaymentTermsOfAccountsReceivable_5FCF183EA47EC64B164BC096EDBBE4F0" xlink:type="arc" />
    <link:label id="lab_biib_MinimumTermForAccountsReceivable_6D30D53593E660C49F74C096EDBB2E06_verboseLabel_en-US" xlink:label="lab_biib_MinimumTermForAccountsReceivable_6D30D53593E660C49F74C096EDBB2E06" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Minimum term for accounts receivable</link:label>
    <link:label id="lab_biib_MinimumTermForAccountsReceivable_6D30D53593E660C49F74C096EDBB2E06_label_en-US" xlink:label="lab_biib_MinimumTermForAccountsReceivable_6D30D53593E660C49F74C096EDBB2E06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum Term For Accounts Receivable</link:label>
    <link:label id="lab_biib_MinimumTermForAccountsReceivable_6D30D53593E660C49F74C096EDBB2E06_documentation_en-US" xlink:label="lab_biib_MinimumTermForAccountsReceivable_6D30D53593E660C49F74C096EDBB2E06" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Minimum term for accounts receivable.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_MinimumTermForAccountsReceivable" xlink:label="loc_biib_MinimumTermForAccountsReceivable_6D30D53593E660C49F74C096EDBB2E06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_MinimumTermForAccountsReceivable_6D30D53593E660C49F74C096EDBB2E06" xlink:to="lab_biib_MinimumTermForAccountsReceivable_6D30D53593E660C49F74C096EDBB2E06" xlink:type="arc" />
    <link:label id="lab_biib_MaximumTermForAccountsReceivable_6B33B9D9D8C8D84FB2D2C096EDC045A0_verboseLabel_en-US" xlink:label="lab_biib_MaximumTermForAccountsReceivable_6B33B9D9D8C8D84FB2D2C096EDC045A0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Maximum term for accounts receivable</link:label>
    <link:label id="lab_biib_MaximumTermForAccountsReceivable_6B33B9D9D8C8D84FB2D2C096EDC045A0_label_en-US" xlink:label="lab_biib_MaximumTermForAccountsReceivable_6B33B9D9D8C8D84FB2D2C096EDC045A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Term For Accounts Receivable</link:label>
    <link:label id="lab_biib_MaximumTermForAccountsReceivable_6B33B9D9D8C8D84FB2D2C096EDC045A0_documentation_en-US" xlink:label="lab_biib_MaximumTermForAccountsReceivable_6B33B9D9D8C8D84FB2D2C096EDC045A0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum term for accounts receivable.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_MaximumTermForAccountsReceivable" xlink:label="loc_biib_MaximumTermForAccountsReceivable_6B33B9D9D8C8D84FB2D2C096EDC045A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_MaximumTermForAccountsReceivable_6B33B9D9D8C8D84FB2D2C096EDC045A0" xlink:to="lab_biib_MaximumTermForAccountsReceivable_6B33B9D9D8C8D84FB2D2C096EDC045A0" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3A6D9E79C7A0B5C39717C096EDC02E53_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3A6D9E79C7A0B5C39717C096EDC02E53" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3A6D9E79C7A0B5C39717C096EDC02E53_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3A6D9E79C7A0B5C39717C096EDC02E53" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3A6D9E79C7A0B5C39717C096EDC02E53" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3A6D9E79C7A0B5C39717C096EDC02E53" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3A6D9E79C7A0B5C39717C096EDC02E53" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_59E826147670AEB69CA5D4ED4B320FA1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_59E826147670AEB69CA5D4ED4B320FA1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_59E826147670AEB69CA5D4ED4B320FA1_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_59E826147670AEB69CA5D4ED4B320FA1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_59E826147670AEB69CA5D4ED4B320FA1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_59E826147670AEB69CA5D4ED4B320FA1" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_59E826147670AEB69CA5D4ED4B320FA1" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_4B1FAE014283FFEAF24AD4ED4B329118_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_4B1FAE014283FFEAF24AD4ED4B329118" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entities by Classification of Entity [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_4B1FAE014283FFEAF24AD4ED4B329118_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_4B1FAE014283FFEAF24AD4ED4B329118" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entities [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis" xlink:label="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_4B1FAE014283FFEAF24AD4ED4B329118" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_4B1FAE014283FFEAF24AD4ED4B329118" xlink:to="lab_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_4B1FAE014283FFEAF24AD4ED4B329118" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassificationOfVariableInterestEntityDomain_443E92945B877EFF859DD4ED4B320E1F_terseLabel_en-US" xlink:label="lab_us-gaap_ClassificationOfVariableInterestEntityDomain_443E92945B877EFF859DD4ED4B320E1F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassificationOfVariableInterestEntityDomain_443E92945B877EFF859DD4ED4B320E1F_label_en-US" xlink:label="lab_us-gaap_ClassificationOfVariableInterestEntityDomain_443E92945B877EFF859DD4ED4B320E1F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Classification [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassificationOfVariableInterestEntityDomain" xlink:label="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_443E92945B877EFF859DD4ED4B320E1F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_443E92945B877EFF859DD4ED4B320E1F" xlink:to="lab_us-gaap_ClassificationOfVariableInterestEntityDomain_443E92945B877EFF859DD4ED4B320E1F" xlink:type="arc" />
    <link:label id="lab_biib_NeurimmuneMember_B1289199A8826B12494BD4ED4B32BCCF_verboseLabel_en-US" xlink:label="lab_biib_NeurimmuneMember_B1289199A8826B12494BD4ED4B32BCCF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Neurimmune</link:label>
    <link:label id="lab_biib_NeurimmuneMember_B1289199A8826B12494BD4ED4B32BCCF_label_en-US" xlink:label="lab_biib_NeurimmuneMember_B1289199A8826B12494BD4ED4B32BCCF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Neurimmune [Member]</link:label>
    <link:label id="lab_biib_NeurimmuneMember_B1289199A8826B12494BD4ED4B32BCCF_documentation_en-US" xlink:label="lab_biib_NeurimmuneMember_B1289199A8826B12494BD4ED4B32BCCF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Neurimmune.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_NeurimmuneMember" xlink:label="loc_biib_NeurimmuneMember_B1289199A8826B12494BD4ED4B32BCCF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_NeurimmuneMember_B1289199A8826B12494BD4ED4B32BCCF" xlink:to="lab_biib_NeurimmuneMember_B1289199A8826B12494BD4ED4B32BCCF" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_A429BC3F88778D836AF9D4ED4B32DDBA_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems_A429BC3F88778D836AF9D4ED4B32DDBA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_A429BC3F88778D836AF9D4ED4B32DDBA_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems_A429BC3F88778D836AF9D4ED4B32DDBA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_A429BC3F88778D836AF9D4ED4B32DDBA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_A429BC3F88778D836AF9D4ED4B32DDBA" xlink:to="lab_us-gaap_VariableInterestEntityLineItems_A429BC3F88778D836AF9D4ED4B32DDBA" xlink:type="arc" />
    <link:label id="lab_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D_verboseLabel_en-US" xlink:label="lab_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Investment in Variable Interest Entities (Textual) [Abstract]</link:label>
    <link:label id="lab_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D_label_en-US" xlink:label="lab_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment in Variable Interest Entities (Textual) [Abstract]</link:label>
    <link:label id="lab_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D_documentation_en-US" xlink:label="lab_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investment in Variable Interest Entities.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_InvestmentInVariableInterestEntitiesTextualAbstract" xlink:label="loc_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:to="lab_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:type="arc" />
    <link:label id="lab_biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement_2653690F8A44554ED4F0D4ED4B32CB3E_verboseLabel_en-US" xlink:label="lab_biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement_2653690F8A44554ED4F0D4ED4B32CB3E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Remaining potential development milestone payments and royalties on commercial sales under the terms of collaboration agreement</link:label>
    <link:label id="lab_biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement_2653690F8A44554ED4F0D4ED4B32CB3E_label_en-US" xlink:label="lab_biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement_2653690F8A44554ED4F0D4ED4B32CB3E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remaining Potential Development Milestone Payments And Royalties On Commercial Sales Under Terms Of Collaboration Agreement</link:label>
    <link:label id="lab_biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement_2653690F8A44554ED4F0D4ED4B32CB3E_documentation_en-US" xlink:label="lab_biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement_2653690F8A44554ED4F0D4ED4B32CB3E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expected total payments including upfront and milestone payments as well as the greater of an annual maintenance fee or usage-based royalty payments under the terms of collaboration agreement.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement" xlink:label="loc_biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement_2653690F8A44554ED4F0D4ED4B32CB3E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement_2653690F8A44554ED4F0D4ED4B32CB3E" xlink:to="lab_biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement_2653690F8A44554ED4F0D4ED4B32CB3E" xlink:type="arc" />
    <link:label id="lab_biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial_EDB9A001105B082F9DD4D4ED4B323A29_terseLabel_en-US" xlink:label="lab_biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial_EDB9A001105B082F9DD4D4ED4B323A29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected milestone payment for initiation of a late stage clinical trial</link:label>
    <link:label id="lab_biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial_EDB9A001105B082F9DD4D4ED4B323A29_label_en-US" xlink:label="lab_biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial_EDB9A001105B082F9DD4D4ED4B323A29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected milestone payment for initiation of a late stage clinical trial</link:label>
    <link:label id="lab_biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial_EDB9A001105B082F9DD4D4ED4B323A29_documentation_en-US" xlink:label="lab_biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial_EDB9A001105B082F9DD4D4ED4B323A29" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expected milestone payment for initiation of a late stage clinical trial</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial" xlink:label="loc_biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial_EDB9A001105B082F9DD4D4ED4B323A29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial_EDB9A001105B082F9DD4D4ED4B323A29" xlink:to="lab_biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial_EDB9A001105B082F9DD4D4ED4B323A29" xlink:type="arc" />
    <link:label id="lab_biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities_96EDC688ED36480F5E33D4ED4B32864C_verboseLabel_en-US" xlink:label="lab_biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities_96EDC688ED36480F5E33D4ED4B32864C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Investment in biotechnology companies that are determined to be unconsolidated variable interest entities</link:label>
    <link:label id="lab_biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities_96EDC688ED36480F5E33D4ED4B32864C_label_en-US" xlink:label="lab_biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities_96EDC688ED36480F5E33D4ED4B32864C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment in biotechnology companies that are determined to be unconsolidated variable interest entities</link:label>
    <link:label id="lab_biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities_96EDC688ED36480F5E33D4ED4B32864C_documentation_en-US" xlink:label="lab_biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities_96EDC688ED36480F5E33D4ED4B32864C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investment in biotechnology companies that are determined to be unconsolidated variable interest entities.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities" xlink:label="loc_biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities_96EDC688ED36480F5E33D4ED4B32864C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities_96EDC688ED36480F5E33D4ED4B32864C" xlink:to="lab_biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities_96EDC688ED36480F5E33D4ED4B32864C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_FAA9B51A2A4D3A6DF1D6DE15CF1877D9_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_FAA9B51A2A4D3A6DF1D6DE15CF1877D9" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Reserves for discounts and allowances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_FAA9B51A2A4D3A6DF1D6DE15CF1877D9_label_en-US" xlink:label="lab_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_FAA9B51A2A4D3A6DF1D6DE15CF1877D9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_FAA9B51A2A4D3A6DF1D6DE15CF1877D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_FAA9B51A2A4D3A6DF1D6DE15CF1877D9" xlink:to="lab_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_FAA9B51A2A4D3A6DF1D6DE15CF1877D9" xlink:type="arc" />
    <link:label id="lab_biib_InventoryVariousProgramsGross_21D2BE92F1209BD56E6DB1D56BB6B999_terseLabel_en-US" xlink:label="lab_biib_InventoryVariousProgramsGross_21D2BE92F1209BD56E6DB1D56BB6B999" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory, Various Programs, Gross</link:label>
    <link:label id="lab_biib_InventoryVariousProgramsGross_21D2BE92F1209BD56E6DB1D56BB6B999_label_en-US" xlink:label="lab_biib_InventoryVariousProgramsGross_21D2BE92F1209BD56E6DB1D56BB6B999" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Various Programs, Gross</link:label>
    <link:label id="lab_biib_InventoryVariousProgramsGross_21D2BE92F1209BD56E6DB1D56BB6B999_documentation_en-US" xlink:label="lab_biib_InventoryVariousProgramsGross_21D2BE92F1209BD56E6DB1D56BB6B999" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gross inventory of various programs which have been capitalized in advance of regulatory approval.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_InventoryVariousProgramsGross" xlink:label="loc_biib_InventoryVariousProgramsGross_21D2BE92F1209BD56E6DB1D56BB6B999" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_InventoryVariousProgramsGross_21D2BE92F1209BD56E6DB1D56BB6B999" xlink:to="lab_biib_InventoryVariousProgramsGross_21D2BE92F1209BD56E6DB1D56BB6B999" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8F253C91D5F057DB6CA8D4ED4B071C48_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8F253C91D5F057DB6CA8D4ED4B071C48" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation between the U.S. federal statutory tax rate and effective tax rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8F253C91D5F057DB6CA8D4ED4B071C48_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8F253C91D5F057DB6CA8D4ED4B071C48" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8F253C91D5F057DB6CA8D4ED4B071C48" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8F253C91D5F057DB6CA8D4ED4B071C48" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8F253C91D5F057DB6CA8D4ED4B071C48" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:to="lab_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenuesAbstract_E2DB06742CFC93AF4061DDE4D5B10406_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract_E2DB06742CFC93AF4061DDE4D5B10406" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_E2DB06742CFC93AF4061DDE4D5B10406_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract_E2DB06742CFC93AF4061DDE4D5B10406" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_E2DB06742CFC93AF4061DDE4D5B10406" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract_E2DB06742CFC93AF4061DDE4D5B10406" xlink:to="lab_us-gaap_RevenuesAbstract_E2DB06742CFC93AF4061DDE4D5B10406" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesRevenueGoodsNet_E6A7411617529E4ABE6ADDE4D5B15A45_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueGoodsNet_E6A7411617529E4ABE6ADDE4D5B15A45" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_E6A7411617529E4ABE6ADDE4D5B15A45" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueGoodsNet_E6A7411617529E4ABE6ADDE4D5B15A45" xlink:to="lab_us-gaap_SalesRevenueGoodsNet_E6A7411617529E4ABE6ADDE4D5B15A45" xlink:type="arc" />
    <link:label id="lab_biib_UnconsolidatedJointBusiness_6038F0C85E178B10F6C7DDE4D5B2E244_verboseLabel_en-US" xlink:label="lab_biib_UnconsolidatedJointBusiness_6038F0C85E178B10F6C7DDE4D5B2E244" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unconsolidated joint business</link:label>
    <link:label id="lab_biib_UnconsolidatedJointBusiness_6038F0C85E178B10F6C7DDE4D5B2E244_label_en-US" xlink:label="lab_biib_UnconsolidatedJointBusiness_6038F0C85E178B10F6C7DDE4D5B2E244" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unconsolidated Joint Business</link:label>
    <link:label id="lab_biib_UnconsolidatedJointBusiness_6038F0C85E178B10F6C7DDE4D5B2E244_documentation_en-US" xlink:label="lab_biib_UnconsolidatedJointBusiness_6038F0C85E178B10F6C7DDE4D5B2E244" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenues from unconsolidated joint business consists of our share of pre-tax co-promotion profits in the U.S.; reimbursement of selling and development expense in the U.S.; and revenue on sales of RITUXAN outside the U.S., which consist of our share of pre-tax co-promotion profits in Canada.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_UnconsolidatedJointBusiness" xlink:label="loc_biib_UnconsolidatedJointBusiness_6038F0C85E178B10F6C7DDE4D5B2E244" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_UnconsolidatedJointBusiness_6038F0C85E178B10F6C7DDE4D5B2E244" xlink:to="lab_biib_UnconsolidatedJointBusiness_6038F0C85E178B10F6C7DDE4D5B2E244" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherSalesRevenueNet_8BB3D79CD4ADC62745F3DDE4D5B23829_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherSalesRevenueNet_8BB3D79CD4ADC62745F3DDE4D5B23829" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="loc_us-gaap_OtherSalesRevenueNet_8BB3D79CD4ADC62745F3DDE4D5B23829" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSalesRevenueNet_8BB3D79CD4ADC62745F3DDE4D5B23829" xlink:to="lab_us-gaap_OtherSalesRevenueNet_8BB3D79CD4ADC62745F3DDE4D5B23829" xlink:type="arc" />
    <link:label id="lab_us-gaap_Revenues_F81FE90DCA537EF10F71DDE4D5B2D534_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues_F81FE90DCA537EF10F71DDE4D5B2D534" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_F81FE90DCA537EF10F71DDE4D5B2D534_label_en-US" xlink:label="lab_us-gaap_Revenues_F81FE90DCA537EF10F71DDE4D5B2D534" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_F81FE90DCA537EF10F71DDE4D5B2D534" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_F81FE90DCA537EF10F71DDE4D5B2D534" xlink:to="lab_us-gaap_Revenues_F81FE90DCA537EF10F71DDE4D5B2D534" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_8A9D137E188AE7B3E8BDDDE4D5B231F9_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract_8A9D137E188AE7B3E8BDDDE4D5B231F9" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_8A9D137E188AE7B3E8BDDDE4D5B231F9_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract_8A9D137E188AE7B3E8BDDDE4D5B231F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_8A9D137E188AE7B3E8BDDDE4D5B231F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8A9D137E188AE7B3E8BDDDE4D5B231F9" xlink:to="lab_us-gaap_CostsAndExpensesAbstract_8A9D137E188AE7B3E8BDDDE4D5B231F9" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfGoodsSold_E95B8D9B933DB22EDA12DDE4D5B2B151_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsSold_E95B8D9B933DB22EDA12DDE4D5B2B151" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales, excluding amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsSold_E95B8D9B933DB22EDA12DDE4D5B2B151_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsSold_E95B8D9B933DB22EDA12DDE4D5B2B151" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods Sold</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaap_CostOfGoodsSold_E95B8D9B933DB22EDA12DDE4D5B2B151" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsSold_E95B8D9B933DB22EDA12DDE4D5B2B151" xlink:to="lab_us-gaap_CostOfGoodsSold_E95B8D9B933DB22EDA12DDE4D5B2B151" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_BEEA16ED9B8F96D4C0A4DDE4D5B268A2_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_BEEA16ED9B8F96D4C0A4DDE4D5B268A2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_BEEA16ED9B8F96D4C0A4DDE4D5B268A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_BEEA16ED9B8F96D4C0A4DDE4D5B268A2" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_BEEA16ED9B8F96D4C0A4DDE4D5B268A2" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_14BDB77A98DF7C56EE6BDDE4D5B2DD9B_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_14BDB77A98DF7C56EE6BDDE4D5B2DD9B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_14BDB77A98DF7C56EE6BDDE4D5B2DD9B_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_14BDB77A98DF7C56EE6BDDE4D5B2DD9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_14BDB77A98DF7C56EE6BDDE4D5B2DD9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_14BDB77A98DF7C56EE6BDDE4D5B2DD9B" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense_14BDB77A98DF7C56EE6BDDE4D5B2DD9B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_5FF0E208DF570F21EAA0DDE4D5B3BA96_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_5FF0E208DF570F21EAA0DDE4D5B3BA96" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">(Gain) loss on fair value remeasurement of contingent consideration</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_5FF0E208DF570F21EAA0DDE4D5B3BA96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_5FF0E208DF570F21EAA0DDE4D5B3BA96" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_5FF0E208DF570F21EAA0DDE4D5B3BA96" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostsAndExpenses_694816FA976C2F063E4BDDE4D5B3DEDD_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses_694816FA976C2F063E4BDDE4D5B3DEDD" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cost and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_694816FA976C2F063E4BDDE4D5B3DEDD_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses_694816FA976C2F063E4BDDE4D5B3DEDD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses_694816FA976C2F063E4BDDE4D5B3DEDD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses_694816FA976C2F063E4BDDE4D5B3DEDD" xlink:to="lab_us-gaap_CostsAndExpenses_694816FA976C2F063E4BDDE4D5B3DEDD" xlink:type="arc" />
    <link:label id="lab_biib_GainOnSaleOfRights_4284A26B734ED32B4644DDE4D5B31AA2_terseLabel_en-US" xlink:label="lab_biib_GainOnSaleOfRights_4284A26B734ED32B4644DDE4D5B31AA2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on sale of rights</link:label>
    <link:label id="lab_biib_GainOnSaleOfRights_4284A26B734ED32B4644DDE4D5B31AA2_label_en-US" xlink:label="lab_biib_GainOnSaleOfRights_4284A26B734ED32B4644DDE4D5B31AA2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain on sale of rights</link:label>
    <link:label id="lab_biib_GainOnSaleOfRights_4284A26B734ED32B4644DDE4D5B31AA2_documentation_en-US" xlink:label="lab_biib_GainOnSaleOfRights_4284A26B734ED32B4644DDE4D5B31AA2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain on sale of our royalty and other rights related to future sales of BENLYSTA recognized in our consolidated statement of income.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_GainOnSaleOfRights" xlink:label="loc_biib_GainOnSaleOfRights_4284A26B734ED32B4644DDE4D5B31AA2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_GainOnSaleOfRights_4284A26B734ED32B4644DDE4D5B31AA2" xlink:to="lab_biib_GainOnSaleOfRights_4284A26B734ED32B4644DDE4D5B31AA2" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_35443F082FE10A87D714DDE4D5B324BD_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_35443F082FE10A87D714DDE4D5B324BD" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_35443F082FE10A87D714DDE4D5B324BD_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_35443F082FE10A87D714DDE4D5B324BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_35443F082FE10A87D714DDE4D5B324BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_35443F082FE10A87D714DDE4D5B324BD" xlink:to="lab_us-gaap_OperatingIncomeLoss_35443F082FE10A87D714DDE4D5B324BD" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_4AACBDB43406482F36E8DDEC7A491AA6_verboseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_4AACBDB43406482F36E8DDEC7A491AA6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense), net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4AACBDB43406482F36E8DDEC7A491AA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_4AACBDB43406482F36E8DDEC7A491AA6" xlink:to="lab_us-gaap_NonoperatingIncomeExpense_4AACBDB43406482F36E8DDEC7A491AA6" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_313652D7125B48DD29A7DDE4D5B34155_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_313652D7125B48DD29A7DDE4D5B34155" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before income tax expense and equity in loss of investee, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_313652D7125B48DD29A7DDE4D5B34155_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_313652D7125B48DD29A7DDE4D5B34155" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_313652D7125B48DD29A7DDE4D5B34155" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_313652D7125B48DD29A7DDE4D5B34155" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_313652D7125B48DD29A7DDE4D5B34155" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_7032B2CE78A30F08D6B0DDE4D5B35477_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_7032B2CE78A30F08D6B0DDE4D5B35477" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7032B2CE78A30F08D6B0DDE4D5B35477" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_7032B2CE78A30F08D6B0DDE4D5B35477" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_7032B2CE78A30F08D6B0DDE4D5B35477" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_FF103291E6BAEB1D70E1DDE4D5B3F5B8_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments_FF103291E6BAEB1D70E1DDE4D5B3F5B8" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Equity in loss of investee, net of tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_FF103291E6BAEB1D70E1DDE4D5B3F5B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments_FF103291E6BAEB1D70E1DDE4D5B3F5B8" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments_FF103291E6BAEB1D70E1DDE4D5B3F5B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_48E961954B6AA89AD738DDE4D5B391EC_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_48E961954B6AA89AD738DDE4D5B391EC" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_48E961954B6AA89AD738DDE4D5B391EC_label_en-US" xlink:label="lab_us-gaap_ProfitLoss_48E961954B6AA89AD738DDE4D5B391EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_48E961954B6AA89AD738DDE4D5B391EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_48E961954B6AA89AD738DDE4D5B391EC" xlink:to="lab_us-gaap_ProfitLoss_48E961954B6AA89AD738DDE4D5B391EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_A52056BE83473006C68CDDE4D5B3D453_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_A52056BE83473006C68CDDE4D5B3D453" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) attributable to noncontrolling interests, net of tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_A52056BE83473006C68CDDE4D5B3D453" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_A52056BE83473006C68CDDE4D5B3D453" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_A52056BE83473006C68CDDE4D5B3D453" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_99841B6A4F1F120C4AFBDDE4D5B32EE1_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_99841B6A4F1F120C4AFBDDE4D5B32EE1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income attributable to Biogen Inc.</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_99841B6A4F1F120C4AFBDDE4D5B32EE1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_99841B6A4F1F120C4AFBDDE4D5B32EE1" xlink:to="lab_us-gaap_NetIncomeLoss_99841B6A4F1F120C4AFBDDE4D5B32EE1" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_98251E59A7A8FF417F04DDE4D5B33B28_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_98251E59A7A8FF417F04DDE4D5B33B28" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income per share:</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_98251E59A7A8FF417F04DDE4D5B33B28" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_98251E59A7A8FF417F04DDE4D5B33B28" xlink:to="lab_us-gaap_EarningsPerShareAbstract_98251E59A7A8FF417F04DDE4D5B33B28" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasic_5DD5192785D92F45CB56DDE4D5B3BE50_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_5DD5192785D92F45CB56DDE4D5B3BE50" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic earnings per share attributable to Biogen Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_5DD5192785D92F45CB56DDE4D5B3BE50_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_5DD5192785D92F45CB56DDE4D5B3BE50" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_5DD5192785D92F45CB56DDE4D5B3BE50" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_5DD5192785D92F45CB56DDE4D5B3BE50" xlink:to="lab_us-gaap_EarningsPerShareBasic_5DD5192785D92F45CB56DDE4D5B3BE50" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_2E555A6B6DD95672C888DDE4D5B3BD2A_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_2E555A6B6DD95672C888DDE4D5B3BD2A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted earnings per share attributable to Biogen Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_2E555A6B6DD95672C888DDE4D5B3BD2A_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_2E555A6B6DD95672C888DDE4D5B3BD2A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2E555A6B6DD95672C888DDE4D5B3BD2A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_2E555A6B6DD95672C888DDE4D5B3BD2A" xlink:to="lab_us-gaap_EarningsPerShareDiluted_2E555A6B6DD95672C888DDE4D5B3BD2A" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_A0CE885C5B3CA5DC2698DDE4D5B46315_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_A0CE885C5B3CA5DC2698DDE4D5B46315" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic earnings per share attributable to Biogen Inc.</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_A0CE885C5B3CA5DC2698DDE4D5B46315" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_A0CE885C5B3CA5DC2698DDE4D5B46315" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_A0CE885C5B3CA5DC2698DDE4D5B46315" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_CE19B9CA2CF6EE698DADDDE4D5B42AEF_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_CE19B9CA2CF6EE698DADDDE4D5B42AEF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted earnings per share attributable to Biogen Inc.</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_CE19B9CA2CF6EE698DADDDE4D5B42AEF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_CE19B9CA2CF6EE698DADDDE4D5B42AEF" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_CE19B9CA2CF6EE698DADDDE4D5B42AEF" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_8AB36378C0991D61FF98B7340BA3A24D_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_8AB36378C0991D61FF98B7340BA3A24D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_8AB36378C0991D61FF98B7340BA3A24D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8AB36378C0991D61FF98B7340BA3A24D" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_8AB36378C0991D61FF98B7340BA3A24D" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_61D054E60378165C5FB2B7340BA3D337_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_61D054E60378165C5FB2B7340BA3D337" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_61D054E60378165C5FB2B7340BA3D337_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_61D054E60378165C5FB2B7340BA3D337" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_61D054E60378165C5FB2B7340BA3D337" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_61D054E60378165C5FB2B7340BA3D337" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_61D054E60378165C5FB2B7340BA3D337" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_501A641FCE364D386195B7340BA3C411_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_501A641FCE364D386195B7340BA3C411" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_501A641FCE364D386195B7340BA3C411" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_501A641FCE364D386195B7340BA3C411" xlink:to="lab_us-gaap_ProfitLoss_501A641FCE364D386195B7340BA3C411" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6DFF729F46D10F85856CB7340BA330BB_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6DFF729F46D10F85856CB7340BA330BB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net income to net cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6DFF729F46D10F85856CB7340BA330BB_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6DFF729F46D10F85856CB7340BA330BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6DFF729F46D10F85856CB7340BA330BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6DFF729F46D10F85856CB7340BA330BB" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6DFF729F46D10F85856CB7340BA330BB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_0F5077E38B6472DBF754B7340BA39231_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_0F5077E38B6472DBF754B7340BA39231" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_0F5077E38B6472DBF754B7340BA39231_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_0F5077E38B6472DBF754B7340BA39231" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0F5077E38B6472DBF754B7340BA39231" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_0F5077E38B6472DBF754B7340BA39231" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_0F5077E38B6472DBF754B7340BA39231" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensation_B8AC070B86F533971100B7340BA32323_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_B8AC070B86F533971100B7340BA32323" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_B8AC070B86F533971100B7340BA32323_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_B8AC070B86F533971100B7340BA32323" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_B8AC070B86F533971100B7340BA32323" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_B8AC070B86F533971100B7340BA32323" xlink:to="lab_us-gaap_ShareBasedCompensation_B8AC070B86F533971100B7340BA32323" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_E1D2C3B45AD89D54F254B7340BA337B2_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_E1D2C3B45AD89D54F254B7340BA337B2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_E1D2C3B45AD89D54F254B7340BA337B2_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_E1D2C3B45AD89D54F254B7340BA337B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_E1D2C3B45AD89D54F254B7340BA337B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_E1D2C3B45AD89D54F254B7340BA337B2" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_E1D2C3B45AD89D54F254B7340BA337B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_C87CFED2F0AC65D1FF70B7340BA3C243_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense_C87CFED2F0AC65D1FF70B7340BA3C243" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_C87CFED2F0AC65D1FF70B7340BA3C243_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense_C87CFED2F0AC65D1FF70B7340BA3C243" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_C87CFED2F0AC65D1FF70B7340BA3C243" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense_C87CFED2F0AC65D1FF70B7340BA3C243" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense_C87CFED2F0AC65D1FF70B7340BA3C243" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_BEF253C8BEEFC19421D5B7340BA4C733_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_BEF253C8BEEFC19421D5B7340BA4C733" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities, net:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_BEF253C8BEEFC19421D5B7340BA4C733_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_BEF253C8BEEFC19421D5B7340BA4C733" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_BEF253C8BEEFC19421D5B7340BA4C733" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_BEF253C8BEEFC19421D5B7340BA4C733" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_BEF253C8BEEFC19421D5B7340BA4C733" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_0073D962EE35BDA37EF0B7340BA4587B_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_0073D962EE35BDA37EF0B7340BA4587B" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_0073D962EE35BDA37EF0B7340BA4587B_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_0073D962EE35BDA37EF0B7340BA4587B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0073D962EE35BDA37EF0B7340BA4587B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0073D962EE35BDA37EF0B7340BA4587B" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_0073D962EE35BDA37EF0B7340BA4587B" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_7E4743A160ABB38E45D4B7340BA457F5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_7E4743A160ABB38E45D4B7340BA457F5" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_7E4743A160ABB38E45D4B7340BA457F5_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_7E4743A160ABB38E45D4B7340BA457F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_7E4743A160ABB38E45D4B7340BA457F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories_7E4743A160ABB38E45D4B7340BA457F5" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories_7E4743A160ABB38E45D4B7340BA457F5" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_9D0E7D96FA1F6D1CDA6CB7340BA495C2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_9D0E7D96FA1F6D1CDA6CB7340BA495C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_9D0E7D96FA1F6D1CDA6CB7340BA495C2_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_9D0E7D96FA1F6D1CDA6CB7340BA495C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9D0E7D96FA1F6D1CDA6CB7340BA495C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9D0E7D96FA1F6D1CDA6CB7340BA495C2" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_9D0E7D96FA1F6D1CDA6CB7340BA495C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_04D2537A4308DE065B3AB7340BA40219_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_04D2537A4308DE065B3AB7340BA40219" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_04D2537A4308DE065B3AB7340BA40219_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_04D2537A4308DE065B3AB7340BA40219" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_04D2537A4308DE065B3AB7340BA40219" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_04D2537A4308DE065B3AB7340BA40219" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_04D2537A4308DE065B3AB7340BA40219" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_474D8B5AFDC3D473CD34B7340BA4F08F_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_474D8B5AFDC3D473CD34B7340BA4F08F" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other changes in operating assets and liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_474D8B5AFDC3D473CD34B7340BA4F08F_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_474D8B5AFDC3D473CD34B7340BA4F08F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_474D8B5AFDC3D473CD34B7340BA4F08F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_474D8B5AFDC3D473CD34B7340BA4F08F" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_474D8B5AFDC3D473CD34B7340BA4F08F" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0E219B0314E4D676D758B7340BA4D2F3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0E219B0314E4D676D758B7340BA4D2F3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash flows provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0E219B0314E4D676D758B7340BA4D2F3_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0E219B0314E4D676D758B7340BA4D2F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0E219B0314E4D676D758B7340BA4D2F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0E219B0314E4D676D758B7340BA4D2F3" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0E219B0314E4D676D758B7340BA4D2F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_0380351FC6D306BF23ADB7340BA417C3_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_0380351FC6D306BF23ADB7340BA417C3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sales and maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_0380351FC6D306BF23ADB7340BA417C3_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_0380351FC6D306BF23ADB7340BA417C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Maturity of Available-for-sale Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_0380351FC6D306BF23ADB7340BA417C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_0380351FC6D306BF23ADB7340BA417C3" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_0380351FC6D306BF23ADB7340BA417C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_F3E015F2E5FAD5102C8CB7340BA4A1C0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_F3E015F2E5FAD5102C8CB7340BA4A1C0" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_F3E015F2E5FAD5102C8CB7340BA4A1C0_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_F3E015F2E5FAD5102C8CB7340BA4A1C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Available-for-sale Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_F3E015F2E5FAD5102C8CB7340BA4A1C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_F3E015F2E5FAD5102C8CB7340BA4A1C0" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_F3E015F2E5FAD5102C8CB7340BA4A1C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_CB54E9489C31061FF24FB7340BA4DD9B_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_CB54E9489C31061FF24FB7340BA4DD9B" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions of business, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_CB54E9489C31061FF24FB7340BA4DD9B_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_CB54E9489C31061FF24FB7340BA4DD9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_CB54E9489C31061FF24FB7340BA4DD9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_CB54E9489C31061FF24FB7340BA4DD9B" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_CB54E9489C31061FF24FB7340BA4DD9B" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A6AC6CB78E2178F5FD46B7340BA41C7C_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A6AC6CB78E2178F5FD46B7340BA41C7C" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A6AC6CB78E2178F5FD46B7340BA41C7C_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A6AC6CB78E2178F5FD46B7340BA41C7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A6AC6CB78E2178F5FD46B7340BA41C7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A6AC6CB78E2178F5FD46B7340BA41C7C" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A6AC6CB78E2178F5FD46B7340BA41C7C" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_33BBD557EFA5106B9EFEB7340BA413E3_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_33BBD557EFA5106B9EFEB7340BA413E3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration related to Fumapharm AG acquisition</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_33BBD557EFA5106B9EFEB7340BA413E3_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_33BBD557EFA5106B9EFEB7340BA413E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Other Productive Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_33BBD557EFA5106B9EFEB7340BA413E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_33BBD557EFA5106B9EFEB7340BA413E3" xlink:to="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_33BBD557EFA5106B9EFEB7340BA413E3" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_55A63AFC2781DC18F588B7340BA519CB_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_55A63AFC2781DC18F588B7340BA519CB" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_55A63AFC2781DC18F588B7340BA519CB_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_55A63AFC2781DC18F588B7340BA519CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_55A63AFC2781DC18F588B7340BA519CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_55A63AFC2781DC18F588B7340BA519CB" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_55A63AFC2781DC18F588B7340BA519CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_E77E8754DAADC5E9C0E3B7340BA53E50_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_E77E8754DAADC5E9C0E3B7340BA53E50" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash flows used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_E77E8754DAADC5E9C0E3B7340BA53E50_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_E77E8754DAADC5E9C0E3B7340BA53E50" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_E77E8754DAADC5E9C0E3B7340BA53E50" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_E77E8754DAADC5E9C0E3B7340BA53E50" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_E77E8754DAADC5E9C0E3B7340BA53E50" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5AE538973693F4F095C1B7340BA59730_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5AE538973693F4F095C1B7340BA59730" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5AE538973693F4F095C1B7340BA59730_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5AE538973693F4F095C1B7340BA59730" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5AE538973693F4F095C1B7340BA59730" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5AE538973693F4F095C1B7340BA59730" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5AE538973693F4F095C1B7340BA59730" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_F1A4F724513566CE5EB9B7340BA5F69E_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_F1A4F724513566CE5EB9B7340BA5F69E" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_F1A4F724513566CE5EB9B7340BA5F69E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_F1A4F724513566CE5EB9B7340BA5F69E" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_F1A4F724513566CE5EB9B7340BA5F69E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_4BD14FEEEFB41C24E77BB7340BA50FA5_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_4BD14FEEEFB41C24E77BB7340BA50FA5" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of stock for share-based compensation arrangements</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_4BD14FEEEFB41C24E77BB7340BA50FA5_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_4BD14FEEEFB41C24E77BB7340BA50FA5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_4BD14FEEEFB41C24E77BB7340BA50FA5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_4BD14FEEEFB41C24E77BB7340BA50FA5" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_4BD14FEEEFB41C24E77BB7340BA50FA5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_359192A9C3B2DBEEF53CB7340BA5778B_terseLabel_en-US" xlink:label="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_359192A9C3B2DBEEF53CB7340BA5778B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Excess tax benefit from stock options</link:label>
    <link:label id="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_359192A9C3B2DBEEF53CB7340BA5778B_label_en-US" xlink:label="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_359192A9C3B2DBEEF53CB7340BA5778B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Excess Tax Benefit from Share-based Compensation, Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_359192A9C3B2DBEEF53CB7340BA5778B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_359192A9C3B2DBEEF53CB7340BA5778B" xlink:to="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_359192A9C3B2DBEEF53CB7340BA5778B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A4D603B1E56C94C62BD6B7340BA5FF28_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A4D603B1E56C94C62BD6B7340BA5FF28" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A4D603B1E56C94C62BD6B7340BA5FF28_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A4D603B1E56C94C62BD6B7340BA5FF28" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A4D603B1E56C94C62BD6B7340BA5FF28" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A4D603B1E56C94C62BD6B7340BA5FF28" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A4D603B1E56C94C62BD6B7340BA5FF28" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_A47416892AF1A629AC7AB7340BA5F7F6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_A47416892AF1A629AC7AB7340BA5F7F6" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash flows provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_A47416892AF1A629AC7AB7340BA5F7F6_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_A47416892AF1A629AC7AB7340BA5F7F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_A47416892AF1A629AC7AB7340BA5F7F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_A47416892AF1A629AC7AB7340BA5F7F6" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_A47416892AF1A629AC7AB7340BA5F7F6" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_90AED62FFA1AD67E0B00B7340BA5C9C6_totalLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_90AED62FFA1AD67E0B00B7340BA5C9C6" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_90AED62FFA1AD67E0B00B7340BA5C9C6_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_90AED62FFA1AD67E0B00B7340BA5C9C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_90AED62FFA1AD67E0B00B7340BA5C9C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_90AED62FFA1AD67E0B00B7340BA5C9C6" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_90AED62FFA1AD67E0B00B7340BA5C9C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F32526A3EF4D30EB9853B7340BA5BE59_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F32526A3EF4D30EB9853B7340BA5BE59" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F32526A3EF4D30EB9853B7340BA5BE59_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F32526A3EF4D30EB9853B7340BA5BE59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F32526A3EF4D30EB9853B7340BA5BE59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F32526A3EF4D30EB9853B7340BA5BE59" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F32526A3EF4D30EB9853B7340BA5BE59" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1D24C5900A1E290C92AAB7340BA5D76E_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1D24C5900A1E290C92AAB7340BA5D76E" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1D24C5900A1E290C92AAB7340BA5D76E_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1D24C5900A1E290C92AAB7340BA5D76E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1D24C5900A1E290C92AAB7340BA5D76E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1D24C5900A1E290C92AAB7340BA5D76E" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1D24C5900A1E290C92AAB7340BA5D76E" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_D230DC08BED4D6A12C1EB7340BA5F337_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_D230DC08BED4D6A12C1EB7340BA5F337" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, end of the period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_D230DC08BED4D6A12C1EB7340BA5F337" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_D230DC08BED4D6A12C1EB7340BA5F337" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_D230DC08BED4D6A12C1EB7340BA5F337" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1341767895013DC36F8ED4ED4AE0490D_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1341767895013DC36F8ED4ED4AE0490D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1341767895013DC36F8ED4ED4AE0490D_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1341767895013DC36F8ED4ED4AE0490D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1341767895013DC36F8ED4ED4AE0490D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1341767895013DC36F8ED4ED4AE0490D" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1341767895013DC36F8ED4ED4AE0490D" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_46E9F7E83F7FDEBAD687D4ED4B92A4B4_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_46E9F7E83F7FDEBAD687D4ED4B92A4B4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Earnings per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_46E9F7E83F7FDEBAD687D4ED4B92A4B4_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_46E9F7E83F7FDEBAD687D4ED4B92A4B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_46E9F7E83F7FDEBAD687D4ED4B92A4B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_46E9F7E83F7FDEBAD687D4ED4B92A4B4" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_46E9F7E83F7FDEBAD687D4ED4B92A4B4" xlink:type="arc" />
    <link:label id="lab_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6_label_en-US" xlink:label="lab_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6_documentation_en-US" xlink:label="lab_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Document and Entity Information.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_DocumentAndEntityInformationAbstract" xlink:label="loc_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:to="lab_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_943BD0DB5E96077E2409D4ED4B833781_label_en-US" xlink:label="lab_dei_EntityRegistrantName_943BD0DB5E96077E2409D4ED4B833781" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_943BD0DB5E96077E2409D4ED4B833781" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_943BD0DB5E96077E2409D4ED4B833781" xlink:to="lab_dei_EntityRegistrantName_943BD0DB5E96077E2409D4ED4B833781" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_7930E4CFA52B545E80E4D4ED4B8317ED_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_7930E4CFA52B545E80E4D4ED4B8317ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_7930E4CFA52B545E80E4D4ED4B8317ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_7930E4CFA52B545E80E4D4ED4B8317ED" xlink:to="lab_dei_EntityCentralIndexKey_7930E4CFA52B545E80E4D4ED4B8317ED" xlink:type="arc" />
    <link:label id="lab_dei_CurrentFiscalYearEndDate_CE4C795F3063A981019CD4ED4B835CF8_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_CE4C795F3063A981019CD4ED4B835CF8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_CE4C795F3063A981019CD4ED4B835CF8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_CE4C795F3063A981019CD4ED4B835CF8" xlink:to="lab_dei_CurrentFiscalYearEndDate_CE4C795F3063A981019CD4ED4B835CF8" xlink:type="arc" />
    <link:label id="lab_dei_EntityFilerCategory_7140091D220BA565C5B3D4ED4B83CE06_label_en-US" xlink:label="lab_dei_EntityFilerCategory_7140091D220BA565C5B3D4ED4B83CE06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_7140091D220BA565C5B3D4ED4B83CE06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_7140091D220BA565C5B3D4ED4B83CE06" xlink:to="lab_dei_EntityFilerCategory_7140091D220BA565C5B3D4ED4B83CE06" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_9A57A9BD281955F5EDD3D4ED4B8369FF_label_en-US" xlink:label="lab_dei_DocumentType_9A57A9BD281955F5EDD3D4ED4B8369FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_9A57A9BD281955F5EDD3D4ED4B8369FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_9A57A9BD281955F5EDD3D4ED4B8369FF" xlink:to="lab_dei_DocumentType_9A57A9BD281955F5EDD3D4ED4B8369FF" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_4990BD73BF5AB22FC607D4ED4B8360D6_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_4990BD73BF5AB22FC607D4ED4B8360D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_4990BD73BF5AB22FC607D4ED4B8360D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_4990BD73BF5AB22FC607D4ED4B8360D6" xlink:to="lab_dei_DocumentPeriodEndDate_4990BD73BF5AB22FC607D4ED4B8360D6" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalYearFocus_40C1BA6EDB3FCFCD8F9BD4ED4B8383A9_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_40C1BA6EDB3FCFCD8F9BD4ED4B8383A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_40C1BA6EDB3FCFCD8F9BD4ED4B8383A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_40C1BA6EDB3FCFCD8F9BD4ED4B8383A9" xlink:to="lab_dei_DocumentFiscalYearFocus_40C1BA6EDB3FCFCD8F9BD4ED4B8383A9" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_70288413A985B6199EF4D4ED4B83F78B_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_70288413A985B6199EF4D4ED4B83F78B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_70288413A985B6199EF4D4ED4B83F78B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_70288413A985B6199EF4D4ED4B83F78B" xlink:to="lab_dei_DocumentFiscalPeriodFocus_70288413A985B6199EF4D4ED4B83F78B" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_576E9AC27B8052C5ACD8D4ED4B84BE9B_label_en-US" xlink:label="lab_dei_AmendmentFlag_576E9AC27B8052C5ACD8D4ED4B84BE9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_576E9AC27B8052C5ACD8D4ED4B84BE9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_576E9AC27B8052C5ACD8D4ED4B84BE9B" xlink:to="lab_dei_AmendmentFlag_576E9AC27B8052C5ACD8D4ED4B84BE9B" xlink:type="arc" />
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_10592DB75CB12D3CEDA5D4ED4B84A11D_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_10592DB75CB12D3CEDA5D4ED4B84A11D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_10592DB75CB12D3CEDA5D4ED4B84A11D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_10592DB75CB12D3CEDA5D4ED4B84A11D" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_10592DB75CB12D3CEDA5D4ED4B84A11D" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesAbstract_CD631A4EC5D9ABA27BE47489D32E578D_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesAbstract_CD631A4EC5D9ABA27BE47489D32E578D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesAbstract" xlink:label="loc_us-gaap_OtherLiabilitiesAbstract_CD631A4EC5D9ABA27BE47489D32E578D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesAbstract_CD631A4EC5D9ABA27BE47489D32E578D" xlink:to="lab_us-gaap_OtherLiabilitiesAbstract_CD631A4EC5D9ABA27BE47489D32E578D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProductLiabilityContingencyTable_DCE0203777C31D2F0F177489D32F9A9E_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyTable_DCE0203777C31D2F0F177489D32F9A9E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Liability Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyTable_DCE0203777C31D2F0F177489D32F9A9E_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyTable_DCE0203777C31D2F0F177489D32F9A9E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Liability Contingency [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductLiabilityContingencyTable" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_DCE0203777C31D2F0F177489D32F9A9E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_DCE0203777C31D2F0F177489D32F9A9E" xlink:to="lab_us-gaap_ProductLiabilityContingencyTable_DCE0203777C31D2F0F177489D32F9A9E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Liability Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Liability Contingency [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:to="lab_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_F4E17687C59353D30B327489D33449F9_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_F4E17687C59353D30B327489D33449F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proposed settlement</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_F4E17687C59353D30B327489D33449F9_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_F4E17687C59353D30B327489D33449F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_F4E17687C59353D30B327489D33449F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_F4E17687C59353D30B327489D33449F9" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_F4E17687C59353D30B327489D33449F9" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_CBAA6412D5F0515B8C2E7489D334EA22_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_CBAA6412D5F0515B8C2E7489D334EA22" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount reserved for this matter</link:label>
    <link:label id="lab_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_CBAA6412D5F0515B8C2E7489D334EA22_label_en-US" xlink:label="lab_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_CBAA6412D5F0515B8C2E7489D334EA22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Credits and Other Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent" xlink:label="loc_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_CBAA6412D5F0515B8C2E7489D334EA22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_CBAA6412D5F0515B8C2E7489D334EA22" xlink:to="lab_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_CBAA6412D5F0515B8C2E7489D334EA22" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD" xlink:to="lab_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67" xlink:to="lab_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_52D2490B0BACCFC8EF00D4ED4B420EAA_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_52D2490B0BACCFC8EF00D4ED4B420EAA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_52D2490B0BACCFC8EF00D4ED4B420EAA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_52D2490B0BACCFC8EF00D4ED4B420EAA" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_52D2490B0BACCFC8EF00D4ED4B420EAA" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesCurrent_1B887A82B43BED1B3EF2D4ED4B4244BE_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesCurrent_1B887A82B43BED1B3EF2D4ED4B4244BE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesCurrent_1B887A82B43BED1B3EF2D4ED4B4244BE_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesCurrent_1B887A82B43BED1B3EF2D4ED4B4244BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesCurrent_1B887A82B43BED1B3EF2D4ED4B4244BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesCurrent_1B887A82B43BED1B3EF2D4ED4B4244BE" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesCurrent_1B887A82B43BED1B3EF2D4ED4B4244BE" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_070AAFC9E0F35604553ED4ED4B4281EA_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_070AAFC9E0F35604553ED4ED4B4281EA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_070AAFC9E0F35604553ED4ED4B4281EA_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_070AAFC9E0F35604553ED4ED4B4281EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Net, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_070AAFC9E0F35604553ED4ED4B4281EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_070AAFC9E0F35604553ED4ED4B4281EA" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_070AAFC9E0F35604553ED4ED4B4281EA" xlink:type="arc" />
    <link:label id="lab_biib_DueFromUnconsolidatedJointBusiness_82BF9FE5D8E9EB979EBFD4ED4B4206BA_verboseLabel_en-US" xlink:label="lab_biib_DueFromUnconsolidatedJointBusiness_82BF9FE5D8E9EB979EBFD4ED4B4206BA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Due from unconsolidated joint business, net</link:label>
    <link:label id="lab_biib_DueFromUnconsolidatedJointBusiness_82BF9FE5D8E9EB979EBFD4ED4B4206BA_label_en-US" xlink:label="lab_biib_DueFromUnconsolidatedJointBusiness_82BF9FE5D8E9EB979EBFD4ED4B4206BA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Due from unconsolidated joint business</link:label>
    <link:label id="lab_biib_DueFromUnconsolidatedJointBusiness_82BF9FE5D8E9EB979EBFD4ED4B4206BA_documentation_en-US" xlink:label="lab_biib_DueFromUnconsolidatedJointBusiness_82BF9FE5D8E9EB979EBFD4ED4B4206BA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Receivable from unconsolidated joint business for our share of the pre-tax co-promotion profits generated from our co-promotion arrangement for sales of RITUXAN.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_DueFromUnconsolidatedJointBusiness" xlink:label="loc_biib_DueFromUnconsolidatedJointBusiness_82BF9FE5D8E9EB979EBFD4ED4B4206BA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_DueFromUnconsolidatedJointBusiness_82BF9FE5D8E9EB979EBFD4ED4B4206BA" xlink:to="lab_biib_DueFromUnconsolidatedJointBusiness_82BF9FE5D8E9EB979EBFD4ED4B4206BA" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_41BA10A5618893984C5AD4ED4B424134_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_41BA10A5618893984C5AD4ED4B424134" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_41BA10A5618893984C5AD4ED4B424134" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_41BA10A5618893984C5AD4ED4B424134" xlink:to="lab_us-gaap_InventoryNet_41BA10A5618893984C5AD4ED4B424134" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsCurrent_81392430E458F3385D0FD4ED4B42C60F_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent_81392430E458F3385D0FD4ED4B42C60F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_81392430E458F3385D0FD4ED4B42C60F_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent_81392430E458F3385D0FD4ED4B42C60F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_81392430E458F3385D0FD4ED4B42C60F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent_81392430E458F3385D0FD4ED4B42C60F" xlink:to="lab_us-gaap_OtherAssetsCurrent_81392430E458F3385D0FD4ED4B42C60F" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrent_283FD5636C04AC982649D4ED4B428C1C_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent_283FD5636C04AC982649D4ED4B428C1C" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_283FD5636C04AC982649D4ED4B428C1C_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent_283FD5636C04AC982649D4ED4B428C1C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_283FD5636C04AC982649D4ED4B428C1C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_283FD5636C04AC982649D4ED4B428C1C" xlink:to="lab_us-gaap_AssetsCurrent_283FD5636C04AC982649D4ED4B428C1C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesNoncurrent_91BBEBC271787897A465D4ED4B42D3CD_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesNoncurrent_91BBEBC271787897A465D4ED4B42D3CD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesNoncurrent_91BBEBC271787897A465D4ED4B42D3CD_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesNoncurrent_91BBEBC271787897A465D4ED4B42D3CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesNoncurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesNoncurrent_91BBEBC271787897A465D4ED4B42D3CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesNoncurrent_91BBEBC271787897A465D4ED4B42D3CD" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesNoncurrent_91BBEBC271787897A465D4ED4B42D3CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_BD776E1C1C84A36B25A7D4ED4B426AC6_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_BD776E1C1C84A36B25A7D4ED4B426AC6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_BD776E1C1C84A36B25A7D4ED4B426AC6_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_BD776E1C1C84A36B25A7D4ED4B426AC6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_BD776E1C1C84A36B25A7D4ED4B426AC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_BD776E1C1C84A36B25A7D4ED4B426AC6" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_BD776E1C1C84A36B25A7D4ED4B426AC6" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_03181078D72612927860D4ED4B42C078_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_03181078D72612927860D4ED4B42C078" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_03181078D72612927860D4ED4B42C078" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_03181078D72612927860D4ED4B42C078" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_03181078D72612927860D4ED4B42C078" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_8BA4ED9D2AC7A5B695F5D4ED4B432297_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_8BA4ED9D2AC7A5B695F5D4ED4B432297" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_8BA4ED9D2AC7A5B695F5D4ED4B432297" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_8BA4ED9D2AC7A5B695F5D4ED4B432297" xlink:to="lab_us-gaap_Goodwill_8BA4ED9D2AC7A5B695F5D4ED4B432297" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_4858DB806B8DD4222BE4D4ED4B430A0B_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_4858DB806B8DD4222BE4D4ED4B430A0B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Investments and other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_4858DB806B8DD4222BE4D4ED4B430A0B_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_4858DB806B8DD4222BE4D4ED4B430A0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4858DB806B8DD4222BE4D4ED4B430A0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_4858DB806B8DD4222BE4D4ED4B430A0B" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_4858DB806B8DD4222BE4D4ED4B430A0B" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_8D0790B28E8FF1AAF302D4ED4B4398E5_totalLabel_en-US" xlink:label="lab_us-gaap_Assets_8D0790B28E8FF1AAF302D4ED4B4398E5" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_8D0790B28E8FF1AAF302D4ED4B4398E5_label_en-US" xlink:label="lab_us-gaap_Assets_8D0790B28E8FF1AAF302D4ED4B4398E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_8D0790B28E8FF1AAF302D4ED4B4398E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_8D0790B28E8FF1AAF302D4ED4B4398E5" xlink:to="lab_us-gaap_Assets_8D0790B28E8FF1AAF302D4ED4B4398E5" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_3BD52DEC22A90DCA9B91D4ED4B430DA3_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_3BD52DEC22A90DCA9B91D4ED4B430DA3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_3BD52DEC22A90DCA9B91D4ED4B430DA3_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_3BD52DEC22A90DCA9B91D4ED4B430DA3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3BD52DEC22A90DCA9B91D4ED4B430DA3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3BD52DEC22A90DCA9B91D4ED4B430DA3" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_3BD52DEC22A90DCA9B91D4ED4B430DA3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtCurrent_B063A35B33E8D9A12A13D4ED4B43E859_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent_B063A35B33E8D9A12A13D4ED4B43E859" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current portion of notes payable</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_B063A35B33E8D9A12A13D4ED4B43E859_label_en-US" xlink:label="lab_us-gaap_DebtCurrent_B063A35B33E8D9A12A13D4ED4B43E859" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaap_DebtCurrent_B063A35B33E8D9A12A13D4ED4B43E859" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent_B063A35B33E8D9A12A13D4ED4B43E859" xlink:to="lab_us-gaap_DebtCurrent_B063A35B33E8D9A12A13D4ED4B43E859" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxesPayableCurrent_A50FE00BD1665966401FD4ED4B43C467_verboseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent_A50FE00BD1665966401FD4ED4B43C467" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_A50FE00BD1665966401FD4ED4B43C467_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent_A50FE00BD1665966401FD4ED4B43C467" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaap_TaxesPayableCurrent_A50FE00BD1665966401FD4ED4B43C467" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent_A50FE00BD1665966401FD4ED4B43C467" xlink:to="lab_us-gaap_TaxesPayableCurrent_A50FE00BD1665966401FD4ED4B43C467" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableCurrent_7DA793E7CA6C104A5622D4ED4B435ACC_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_7DA793E7CA6C104A5622D4ED4B435ACC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_7DA793E7CA6C104A5622D4ED4B435ACC_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_7DA793E7CA6C104A5622D4ED4B435ACC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_7DA793E7CA6C104A5622D4ED4B435ACC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_7DA793E7CA6C104A5622D4ED4B435ACC" xlink:to="lab_us-gaap_AccountsPayableCurrent_7DA793E7CA6C104A5622D4ED4B435ACC" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_2AF5910CC3BF9C671D5CD4ED4B43E33F_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent_2AF5910CC3BF9C671D5CD4ED4B43E33F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_2AF5910CC3BF9C671D5CD4ED4B43E33F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_2AF5910CC3BF9C671D5CD4ED4B43E33F" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent_2AF5910CC3BF9C671D5CD4ED4B43E33F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrent_F6CFD6AF868328AD95FFD4ED4B435AAE_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_F6CFD6AF868328AD95FFD4ED4B435AAE" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_F6CFD6AF868328AD95FFD4ED4B435AAE_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_F6CFD6AF868328AD95FFD4ED4B435AAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_F6CFD6AF868328AD95FFD4ED4B435AAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_F6CFD6AF868328AD95FFD4ED4B435AAE" xlink:to="lab_us-gaap_LiabilitiesCurrent_F6CFD6AF868328AD95FFD4ED4B435AAE" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebt_AF20EBB0540601A379C3D4ED4B447467_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt_AF20EBB0540601A379C3D4ED4B447467" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Notes payable</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_AF20EBB0540601A379C3D4ED4B447467_label_en-US" xlink:label="lab_us-gaap_LongTermDebt_AF20EBB0540601A379C3D4ED4B447467" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_AF20EBB0540601A379C3D4ED4B447467" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt_AF20EBB0540601A379C3D4ED4B447467" xlink:to="lab_us-gaap_LongTermDebt_AF20EBB0540601A379C3D4ED4B447467" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_404E1552EADA5BB57B61D4ED4B449F7D_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_404E1552EADA5BB57B61D4ED4B449F7D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_404E1552EADA5BB57B61D4ED4B449F7D_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_404E1552EADA5BB57B61D4ED4B449F7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Net, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_404E1552EADA5BB57B61D4ED4B449F7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_404E1552EADA5BB57B61D4ED4B449F7D" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_404E1552EADA5BB57B61D4ED4B449F7D" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6947C725EA2C1B9CB54CD4ED4B449427_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_6947C725EA2C1B9CB54CD4ED4B449427" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_6947C725EA2C1B9CB54CD4ED4B449427" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_6947C725EA2C1B9CB54CD4ED4B449427" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent_6947C725EA2C1B9CB54CD4ED4B449427" xlink:type="arc" />
    <link:label id="lab_us-gaap_Liabilities_3D921A31AD1FDA842F40D4ED4B44DAB1_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities_3D921A31AD1FDA842F40D4ED4B44DAB1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_3D921A31AD1FDA842F40D4ED4B44DAB1_label_en-US" xlink:label="lab_us-gaap_Liabilities_3D921A31AD1FDA842F40D4ED4B44DAB1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_3D921A31AD1FDA842F40D4ED4B44DAB1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_3D921A31AD1FDA842F40D4ED4B44DAB1" xlink:to="lab_us-gaap_Liabilities_3D921A31AD1FDA842F40D4ED4B44DAB1" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_21F50CD7D3997330F507D4ED4B44C4BF_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies_21F50CD7D3997330F507D4ED4B44C4BF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_21F50CD7D3997330F507D4ED4B44C4BF_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies_21F50CD7D3997330F507D4ED4B44C4BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_21F50CD7D3997330F507D4ED4B44C4BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies_21F50CD7D3997330F507D4ED4B44C4BF" xlink:to="lab_us-gaap_CommitmentsAndContingencies_21F50CD7D3997330F507D4ED4B44C4BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_C0C3471C9DDEA39D4B42D4ED4B442FC1_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_C0C3471C9DDEA39D4B42D4ED4B442FC1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_C0C3471C9DDEA39D4B42D4ED4B442FC1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_C0C3471C9DDEA39D4B42D4ED4B442FC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_C0C3471C9DDEA39D4B42D4ED4B442FC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_C0C3471C9DDEA39D4B42D4ED4B442FC1" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_C0C3471C9DDEA39D4B42D4ED4B442FC1" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Biogen Idec Inc. shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258" xlink:to="lab_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockValue_81287CD81A3B30DF5791D4ED4B442B2C_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue_81287CD81A3B30DF5791D4ED4B442B2C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value $0.001 per share</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_81287CD81A3B30DF5791D4ED4B442B2C_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue_81287CD81A3B30DF5791D4ED4B442B2C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_81287CD81A3B30DF5791D4ED4B442B2C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue_81287CD81A3B30DF5791D4ED4B442B2C" xlink:to="lab_us-gaap_PreferredStockValue_81287CD81A3B30DF5791D4ED4B442B2C" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockValue_F2E096B8C82AA64FF6CAD4ED4B441C4A_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue_F2E096B8C82AA64FF6CAD4ED4B441C4A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value $0.0005 per share</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_F2E096B8C82AA64FF6CAD4ED4B441C4A_label_en-US" xlink:label="lab_us-gaap_CommonStockValue_F2E096B8C82AA64FF6CAD4ED4B441C4A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_F2E096B8C82AA64FF6CAD4ED4B441C4A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_F2E096B8C82AA64FF6CAD4ED4B441C4A" xlink:to="lab_us-gaap_CommonStockValue_F2E096B8C82AA64FF6CAD4ED4B441C4A" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_AE596FB0D0CFD2CB4D53D4ED4B443BB4_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital_AE596FB0D0CFD2CB4D53D4ED4B443BB4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_AE596FB0D0CFD2CB4D53D4ED4B443BB4_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital_AE596FB0D0CFD2CB4D53D4ED4B443BB4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_AE596FB0D0CFD2CB4D53D4ED4B443BB4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital_AE596FB0D0CFD2CB4D53D4ED4B443BB4" xlink:to="lab_us-gaap_AdditionalPaidInCapital_AE596FB0D0CFD2CB4D53D4ED4B443BB4" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4A685C8B16DB68E0219CD4ED4B457C85_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4A685C8B16DB68E0219CD4ED4B457C85" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4A685C8B16DB68E0219CD4ED4B457C85" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4A685C8B16DB68E0219CD4ED4B457C85" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4A685C8B16DB68E0219CD4ED4B457C85" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_D6D75C097C2BECCA06C6D4ED4B45A400_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_D6D75C097C2BECCA06C6D4ED4B45A400" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_D6D75C097C2BECCA06C6D4ED4B45A400_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_D6D75C097C2BECCA06C6D4ED4B45A400" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_D6D75C097C2BECCA06C6D4ED4B45A400" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_D6D75C097C2BECCA06C6D4ED4B45A400" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_D6D75C097C2BECCA06C6D4ED4B45A400" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValue_A4761B39C93CEBDD785DD4ED4B450EDF_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_A4761B39C93CEBDD785DD4ED4B450EDF" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_A4761B39C93CEBDD785DD4ED4B450EDF_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_A4761B39C93CEBDD785DD4ED4B450EDF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_A4761B39C93CEBDD785DD4ED4B450EDF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_A4761B39C93CEBDD785DD4ED4B450EDF" xlink:to="lab_us-gaap_TreasuryStockValue_A4761B39C93CEBDD785DD4ED4B450EDF" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_F907934BF3A94BAF528DD4ED4B45CE9D_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_F907934BF3A94BAF528DD4ED4B45CE9D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Biogen Inc. shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_F907934BF3A94BAF528DD4ED4B45CE9D_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity_F907934BF3A94BAF528DD4ED4B45CE9D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_F907934BF3A94BAF528DD4ED4B45CE9D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_F907934BF3A94BAF528DD4ED4B45CE9D" xlink:to="lab_us-gaap_StockholdersEquity_F907934BF3A94BAF528DD4ED4B45CE9D" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterest_274BB6211AF6DEEEEA69D4ED4B4585C1_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest_274BB6211AF6DEEEEA69D4ED4B4585C1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_274BB6211AF6DEEEEA69D4ED4B4585C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest_274BB6211AF6DEEEEA69D4ED4B4585C1" xlink:to="lab_us-gaap_MinorityInterest_274BB6211AF6DEEEEA69D4ED4B4585C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_139B71B666404D5A45ABD4ED4B459420_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_139B71B666404D5A45ABD4ED4B459420" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_139B71B666404D5A45ABD4ED4B459420_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_139B71B666404D5A45ABD4ED4B459420" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_139B71B666404D5A45ABD4ED4B459420" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_139B71B666404D5A45ABD4ED4B459420" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_139B71B666404D5A45ABD4ED4B459420" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_2D6DAB0CC5E21A6C6095D4ED4B45540C_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_2D6DAB0CC5E21A6C6095D4ED4B45540C" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_2D6DAB0CC5E21A6C6095D4ED4B45540C_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_2D6DAB0CC5E21A6C6095D4ED4B45540C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2D6DAB0CC5E21A6C6095D4ED4B45540C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2D6DAB0CC5E21A6C6095D4ED4B45540C" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_2D6DAB0CC5E21A6C6095D4ED4B45540C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8C75F8E989239EBD5EBFD4ED4BAE047B_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8C75F8E989239EBD5EBFD4ED4BAE047B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8C75F8E989239EBD5EBFD4ED4BAE047B_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8C75F8E989239EBD5EBFD4ED4BAE047B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8C75F8E989239EBD5EBFD4ED4BAE047B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8C75F8E989239EBD5EBFD4ED4BAE047B" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8C75F8E989239EBD5EBFD4ED4BAE047B" xlink:type="arc" />
    <link:label id="lab_biib_EmployeeStockPurchasePlanMember_C580B0D0FD7098B99E71D4ED4BAF39CB_verboseLabel_en-US" xlink:label="lab_biib_EmployeeStockPurchasePlanMember_C580B0D0FD7098B99E71D4ED4BAF39CB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_biib_EmployeeStockPurchasePlanMember_C580B0D0FD7098B99E71D4ED4BAF39CB_label_en-US" xlink:label="lab_biib_EmployeeStockPurchasePlanMember_C580B0D0FD7098B99E71D4ED4BAF39CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_biib_EmployeeStockPurchasePlanMember_C580B0D0FD7098B99E71D4ED4BAF39CB_documentation_en-US" xlink:label="lab_biib_EmployeeStockPurchasePlanMember_C580B0D0FD7098B99E71D4ED4BAF39CB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee stock purchase plan.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_EmployeeStockPurchasePlanMember" xlink:label="loc_biib_EmployeeStockPurchasePlanMember_C580B0D0FD7098B99E71D4ED4BAF39CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_EmployeeStockPurchasePlanMember_C580B0D0FD7098B99E71D4ED4BAF39CB" xlink:to="lab_biib_EmployeeStockPurchasePlanMember_C580B0D0FD7098B99E71D4ED4BAF39CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1464EA0C1384DE90337FD4ED4BAFC978_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1464EA0C1384DE90337FD4ED4BAFC978" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1464EA0C1384DE90337FD4ED4BAFC978_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1464EA0C1384DE90337FD4ED4BAFC978" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1464EA0C1384DE90337FD4ED4BAFC978" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1464EA0C1384DE90337FD4ED4BAFC978" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1464EA0C1384DE90337FD4ED4BAFC978" xlink:type="arc" />
    <link:label id="lab_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64_verboseLabel_en-US" xlink:label="lab_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of share based compensation expense associated with different programs</link:label>
    <link:label id="lab_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64_label_en-US" xlink:label="lab_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary of share based compensation expense associated with different programs [Abstract]</link:label>
    <link:label id="lab_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64_documentation_en-US" xlink:label="lab_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Summary of share-based compensation expense associated with different programs.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract" xlink:label="loc_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:to="lab_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_602FE9224655D2D0D2A9D4ED4BAF8E09_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_602FE9224655D2D0D2A9D4ED4BAF8E09" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_602FE9224655D2D0D2A9D4ED4BAF8E09_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_602FE9224655D2D0D2A9D4ED4BAF8E09" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allocated Share-based Compensation Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_602FE9224655D2D0D2A9D4ED4BAF8E09" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_602FE9224655D2D0D2A9D4ED4BAF8E09" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_602FE9224655D2D0D2A9D4ED4BAF8E09" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_44E64F2C5534611F7AB3D4ED4BAF24AD_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_44E64F2C5534611F7AB3D4ED4BAF24AD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_44E64F2C5534611F7AB3D4ED4BAF24AD_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_44E64F2C5534611F7AB3D4ED4BAF24AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allocated Share-based Compensation Expense, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_44E64F2C5534611F7AB3D4ED4BAF24AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_44E64F2C5534611F7AB3D4ED4BAF24AD" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_44E64F2C5534611F7AB3D4ED4BAF24AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_CCAA7FD886AF5D443486D4ED4BAFF74C_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_CCAA7FD886AF5D443486D4ED4BAFF74C" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Capitalized share-based compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_CCAA7FD886AF5D443486D4ED4BAFF74C_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_CCAA7FD886AF5D443486D4ED4BAFF74C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Capitalized Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_CCAA7FD886AF5D443486D4ED4BAFF74C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_CCAA7FD886AF5D443486D4ED4BAFF74C" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_CCAA7FD886AF5D443486D4ED4BAFF74C" xlink:type="arc" />
    <link:label id="lab_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_C748C22FC4113452038ED4ED4BAF02C4_terseLabel_en-US" xlink:label="lab_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_C748C22FC4113452038ED4ED4BAF02C4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense included in total costs and expenses</link:label>
    <link:label id="lab_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_C748C22FC4113452038ED4ED4BAF02C4_label_en-US" xlink:label="lab_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_C748C22FC4113452038ED4ED4BAF02C4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Expense Included In Costs And Expenses</link:label>
    <link:label id="lab_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_C748C22FC4113452038ED4ED4BAF02C4_documentation_en-US" xlink:label="lab_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_C748C22FC4113452038ED4ED4BAF02C4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation expense included in costs and expenses.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses" xlink:label="loc_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_C748C22FC4113452038ED4ED4BAF02C4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_C748C22FC4113452038ED4ED4BAF02C4" xlink:to="lab_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_C748C22FC4113452038ED4ED4BAF02C4" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetImpairmentCharges_05231476781940512275D4ED4AEFF04B_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges_05231476781940512275D4ED4AEFF04B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_05231476781940512275D4ED4AEFF04B_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges_05231476781940512275D4ED4AEFF04B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_05231476781940512275D4ED4AEFF04B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges_05231476781940512275D4ED4AEFF04B" xlink:to="lab_us-gaap_AssetImpairmentCharges_05231476781940512275D4ED4AEFF04B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsChangesInValuationTechniques_DF6854000D7B6A94C92DD4ED4AEFAA16_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsChangesInValuationTechniques_DF6854000D7B6A94C92DD4ED4AEFAA16" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in valuation techniques</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsChangesInValuationTechniques_DF6854000D7B6A94C92DD4ED4AEFAA16_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsChangesInValuationTechniques_DF6854000D7B6A94C92DD4ED4AEFAA16" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Changes in Valuation Techniques</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsChangesInValuationTechniques" xlink:label="loc_us-gaap_FairValueMeasurementsChangesInValuationTechniques_DF6854000D7B6A94C92DD4ED4AEFAA16" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsChangesInValuationTechniques_DF6854000D7B6A94C92DD4ED4AEFAA16" xlink:to="lab_us-gaap_FairValueMeasurementsChangesInValuationTechniques_DF6854000D7B6A94C92DD4ED4AEFAA16" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1E6F980D15FFB430E648D4ED4AEF1532_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1E6F980D15FFB430E648D4ED4AEF1532" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stated rate on debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1E6F980D15FFB430E648D4ED4AEF1532_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1E6F980D15FFB430E648D4ED4AEF1532" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1E6F980D15FFB430E648D4ED4AEF1532" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1E6F980D15FFB430E648D4ED4AEF1532" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1E6F980D15FFB430E648D4ED4AEF1532" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_B60452F849ED23D73A81D4ED4AEFE03D_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_B60452F849ED23D73A81D4ED4AEFE03D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration obligations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_B60452F849ED23D73A81D4ED4AEFE03D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_B60452F849ED23D73A81D4ED4AEFE03D" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_B60452F849ED23D73A81D4ED4AEFE03D" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation between the U.S. federal statutory tax rate and effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_88A8BF2B79CD0321ABA4D4ED4B13BF51_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_88A8BF2B79CD0321ABA4D4ED4B13BF51" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_88A8BF2B79CD0321ABA4D4ED4B13BF51_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_88A8BF2B79CD0321ABA4D4ED4B13BF51" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_88A8BF2B79CD0321ABA4D4ED4B13BF51" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_88A8BF2B79CD0321ABA4D4ED4B13BF51" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_88A8BF2B79CD0321ABA4D4ED4B13BF51" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_BA37BC185F83115E70E0D4ED4B146CCD_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_BA37BC185F83115E70E0D4ED4B146CCD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">State taxes</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_BA37BC185F83115E70E0D4ED4B146CCD_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_BA37BC185F83115E70E0D4ED4B146CCD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_BA37BC185F83115E70E0D4ED4B146CCD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_BA37BC185F83115E70E0D4ED4B146CCD" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_BA37BC185F83115E70E0D4ED4B146CCD" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_80F161652E3E36648B53D4ED4B146AB2_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_80F161652E3E36648B53D4ED4B146AB2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Taxes on foreign earnings</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_80F161652E3E36648B53D4ED4B146AB2_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_80F161652E3E36648B53D4ED4B146AB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_80F161652E3E36648B53D4ED4B146AB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_80F161652E3E36648B53D4ED4B146AB2" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_80F161652E3E36648B53D4ED4B146AB2" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_0F0F645680741778D61FD4ED4B147324_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_0F0F645680741778D61FD4ED4B147324" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Credits and net operating loss utilization</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_0F0F645680741778D61FD4ED4B147324_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_0F0F645680741778D61FD4ED4B147324" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_0F0F645680741778D61FD4ED4B147324" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_0F0F645680741778D61FD4ED4B147324" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_0F0F645680741778D61FD4ED4B147324" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization_16A4A278DB525C5DEEA0D4ED4B14F4DC_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization_16A4A278DB525C5DEEA0D4ED4B14F4DC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Purchased intangible assets</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization_16A4A278DB525C5DEEA0D4ED4B14F4DC_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization_16A4A278DB525C5DEEA0D4ED4B14F4DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation and Amortization, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization_16A4A278DB525C5DEEA0D4ED4B14F4DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization_16A4A278DB525C5DEEA0D4ED4B14F4DC" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization_16A4A278DB525C5DEEA0D4ED4B14F4DC" xlink:type="arc" />
    <link:label id="lab_biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction_10A66FCCCCE2E5F72750D4ED4B14501E_terseLabel_en-US" xlink:label="lab_biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction_10A66FCCCCE2E5F72750D4ED4B14501E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Manufacturing deduction</link:label>
    <link:label id="lab_biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction_10A66FCCCCE2E5F72750D4ED4B14501E_label_en-US" xlink:label="lab_biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction_10A66FCCCCE2E5F72750D4ED4B14501E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective income tax rate reconciliation manufacturing deduction</link:label>
    <link:label id="lab_biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction_10A66FCCCCE2E5F72750D4ED4B14501E_documentation_en-US" xlink:label="lab_biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction_10A66FCCCCE2E5F72750D4ED4B14501E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective income tax rate reconciliation manufacturing deduction</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction" xlink:label="loc_biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction_10A66FCCCCE2E5F72750D4ED4B14501E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction_10A66FCCCCE2E5F72750D4ED4B14501E" xlink:to="lab_biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction_10A66FCCCCE2E5F72750D4ED4B14501E" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_D9DAD6DD5F6AE7FED1A6D4ED4B147733_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_D9DAD6DD5F6AE7FED1A6D4ED4B147733" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Permanent items</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_D9DAD6DD5F6AE7FED1A6D4ED4B147733_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_D9DAD6DD5F6AE7FED1A6D4ED4B147733" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_D9DAD6DD5F6AE7FED1A6D4ED4B147733" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_D9DAD6DD5F6AE7FED1A6D4ED4B147733" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_D9DAD6DD5F6AE7FED1A6D4ED4B147733" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1B18056E66DEACC55D8FD4ED4B14CD4D_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1B18056E66DEACC55D8FD4ED4B14CD4D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1B18056E66DEACC55D8FD4ED4B14CD4D_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1B18056E66DEACC55D8FD4ED4B14CD4D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1B18056E66DEACC55D8FD4ED4B14CD4D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1B18056E66DEACC55D8FD4ED4B14CD4D" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1B18056E66DEACC55D8FD4ED4B14CD4D" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_C2CB11A4456DDE353CDAD4ED4B1421CD_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_C2CB11A4456DDE353CDAD4ED4B1421CD" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_C2CB11A4456DDE353CDAD4ED4B1421CD_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_C2CB11A4456DDE353CDAD4ED4B1421CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_C2CB11A4456DDE353CDAD4ED4B1421CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_C2CB11A4456DDE353CDAD4ED4B1421CD" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_C2CB11A4456DDE353CDAD4ED4B1421CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_159C68ED76735566F9C4DEA10B7727AA_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable_159C68ED76735566F9C4DEA10B7727AA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_159C68ED76735566F9C4DEA10B7727AA_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable_159C68ED76735566F9C4DEA10B7727AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_159C68ED76735566F9C4DEA10B7727AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_159C68ED76735566F9C4DEA10B7727AA" xlink:to="lab_us-gaap_IncomeTaxContingencyTable_159C68ED76735566F9C4DEA10B7727AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxPeriodAxis_860746713351A6F05094DEA10B77973A_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis_860746713351A6F05094DEA10B77973A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_860746713351A6F05094DEA10B77973A_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis_860746713351A6F05094DEA10B77973A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaap_TaxPeriodAxis_860746713351A6F05094DEA10B77973A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis_860746713351A6F05094DEA10B77973A" xlink:to="lab_us-gaap_TaxPeriodAxis_860746713351A6F05094DEA10B77973A" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476" xlink:to="lab_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxYear2007Member_7CE988422CD297CD9237DEA10B77223C_terseLabel_en-US" xlink:label="lab_us-gaap_TaxYear2007Member_7CE988422CD297CD9237DEA10B77223C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Year 2007</link:label>
    <link:label id="lab_us-gaap_TaxYear2007Member_7CE988422CD297CD9237DEA10B77223C_label_en-US" xlink:label="lab_us-gaap_TaxYear2007Member_7CE988422CD297CD9237DEA10B77223C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Year 2007 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxYear2007Member" xlink:label="loc_us-gaap_TaxYear2007Member_7CE988422CD297CD9237DEA10B77223C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxYear2007Member_7CE988422CD297CD9237DEA10B77223C" xlink:to="lab_us-gaap_TaxYear2007Member_7CE988422CD297CD9237DEA10B77223C" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxYear2008Member_7E5D11CD969DBB792824DEA10B773ABD_terseLabel_en-US" xlink:label="lab_us-gaap_TaxYear2008Member_7E5D11CD969DBB792824DEA10B773ABD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Year 2008</link:label>
    <link:label id="lab_us-gaap_TaxYear2008Member_7E5D11CD969DBB792824DEA10B773ABD_label_en-US" xlink:label="lab_us-gaap_TaxYear2008Member_7E5D11CD969DBB792824DEA10B773ABD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Year 2008 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxYear2008Member" xlink:label="loc_us-gaap_TaxYear2008Member_7E5D11CD969DBB792824DEA10B773ABD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxYear2008Member_7E5D11CD969DBB792824DEA10B773ABD" xlink:to="lab_us-gaap_TaxYear2008Member_7E5D11CD969DBB792824DEA10B773ABD" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxYear2009Member_47B581C8941FDEB9FEEADEA10B773C04_terseLabel_en-US" xlink:label="lab_us-gaap_TaxYear2009Member_47B581C8941FDEB9FEEADEA10B773C04" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Year 2009</link:label>
    <link:label id="lab_us-gaap_TaxYear2009Member_47B581C8941FDEB9FEEADEA10B773C04_label_en-US" xlink:label="lab_us-gaap_TaxYear2009Member_47B581C8941FDEB9FEEADEA10B773C04" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Year 2009 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxYear2009Member" xlink:label="loc_us-gaap_TaxYear2009Member_47B581C8941FDEB9FEEADEA10B773C04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxYear2009Member_47B581C8941FDEB9FEEADEA10B773C04" xlink:to="lab_us-gaap_TaxYear2009Member_47B581C8941FDEB9FEEADEA10B773C04" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_713DB3C0DD8246480B77DEA10B774641_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_713DB3C0DD8246480B77DEA10B774641" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Effective tax rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_713DB3C0DD8246480B77DEA10B774641" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_713DB3C0DD8246480B77DEA10B774641" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_713DB3C0DD8246480B77DEA10B774641" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_88955348035C5F9B0D96DEA10B7778F5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_88955348035C5F9B0D96DEA10B7778F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notice of assessment of corporate withholding tax including penalties and interest</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_88955348035C5F9B0D96DEA10B7778F5_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_88955348035C5F9B0D96DEA10B7778F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_88955348035C5F9B0D96DEA10B7778F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_88955348035C5F9B0D96DEA10B7778F5" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_88955348035C5F9B0D96DEA10B7778F5" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_BD956E1149970342B8EDDECA941EB691_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_BD956E1149970342B8EDDECA941EB691" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net benefit for a previously unrecognized position</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_BD956E1149970342B8EDDECA941EB691_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_BD956E1149970342B8EDDECA941EB691" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_BD956E1149970342B8EDDECA941EB691" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_BD956E1149970342B8EDDECA941EB691" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_BD956E1149970342B8EDDECA941EB691" xlink:type="arc" />
    <link:label id="lab_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices_8165E761FCCB4D382E7ADEA10B78CAE7_verboseLabel_en-US" xlink:label="lab_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices_8165E761FCCB4D382E7ADEA10B78CAE7" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proposed deduction disallowance by tax authorities</link:label>
    <link:label id="lab_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices_8165E761FCCB4D382E7ADEA10B78CAE7_label_en-US" xlink:label="lab_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices_8165E761FCCB4D382E7ADEA10B78CAE7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proposed Disallowance By Tax Authorities For Payment For Services</link:label>
    <link:label id="lab_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices_8165E761FCCB4D382E7ADEA10B78CAE7_documentation_en-US" xlink:label="lab_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices_8165E761FCCB4D382E7ADEA10B78CAE7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proposed disallowance by tax authorities for payment for services.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices" xlink:label="loc_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices_8165E761FCCB4D382E7ADEA10B78CAE7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices_8165E761FCCB4D382E7ADEA10B78CAE7" xlink:to="lab_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices_8165E761FCCB4D382E7ADEA10B78CAE7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_156BF6E3915EEB914749D4ED4ADF6320_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_156BF6E3915EEB914749D4ED4ADF6320" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense included in condensed consolidated statements of income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_156BF6E3915EEB914749D4ED4ADF6320_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_156BF6E3915EEB914749D4ED4ADF6320" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_156BF6E3915EEB914749D4ED4ADF6320" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_156BF6E3915EEB914749D4ED4ADF6320" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_156BF6E3915EEB914749D4ED4ADF6320" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_2BAA43E05048730B88D4D4ED4ADFA2F6_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_2BAA43E05048730B88D4D4ED4ADFA2F6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of share-based compensation expense associated with each of our share-based compensating programs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_2BAA43E05048730B88D4D4ED4ADFA2F6_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_2BAA43E05048730B88D4D4ED4ADFA2F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_2BAA43E05048730B88D4D4ED4ADFA2F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_2BAA43E05048730B88D4D4ED4ADFA2F6" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_2BAA43E05048730B88D4D4ED4ADFA2F6" xlink:type="arc" />
    <link:label id="lab_biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock_34AB5389A6FE696B2343D4ED4ADF4E52_verboseLabel_en-US" xlink:label="lab_biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock_34AB5389A6FE696B2343D4ED4ADF4E52" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of equity grants to employees, officers and directors under our current stock plans</link:label>
    <link:label id="lab_biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock_34AB5389A6FE696B2343D4ED4ADF4E52_label_en-US" xlink:label="lab_biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock_34AB5389A6FE696B2343D4ED4ADF4E52" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Restricted Stock Unit Grants [Table Text Block]</link:label>
    <link:label id="lab_biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock_34AB5389A6FE696B2343D4ED4ADF4E52_documentation_en-US" xlink:label="lab_biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock_34AB5389A6FE696B2343D4ED4ADF4E52" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of restricted stock unit grants.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock" xlink:label="loc_biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock_34AB5389A6FE696B2343D4ED4ADF4E52" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock_34AB5389A6FE696B2343D4ED4ADF4E52" xlink:to="lab_biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock_34AB5389A6FE696B2343D4ED4ADF4E52" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_0A16BFDD56F2FCFA0726D4ED4B369DD4_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember_0A16BFDD56F2FCFA0726D4ED4B369DD4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_0A16BFDD56F2FCFA0726D4ED4B369DD4_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember_0A16BFDD56F2FCFA0726D4ED4B369DD4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_0A16BFDD56F2FCFA0726D4ED4B369DD4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember_0A16BFDD56F2FCFA0726D4ED4B369DD4" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember_0A16BFDD56F2FCFA0726D4ED4B369DD4" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6423EC869C881A512F9ED4ED4B36F45E_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6423EC869C881A512F9ED4ED4B36F45E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6423EC869C881A512F9ED4ED4B36F45E_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6423EC869C881A512F9ED4ED4B36F45E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6423EC869C881A512F9ED4ED4B36F45E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6423EC869C881A512F9ED4ED4B36F45E" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6423EC869C881A512F9ED4ED4B36F45E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ParentMember_98D90735A12C2A73862FD4ED4B3618CE_verboseLabel_en-US" xlink:label="lab_us-gaap_ParentMember_98D90735A12C2A73862FD4ED4B3618CE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total share-based compensation expense, net of tax</link:label>
    <link:label id="lab_us-gaap_ParentMember_98D90735A12C2A73862FD4ED4B3618CE_label_en-US" xlink:label="lab_us-gaap_ParentMember_98D90735A12C2A73862FD4ED4B3618CE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ParentMember" xlink:label="loc_us-gaap_ParentMember_98D90735A12C2A73862FD4ED4B3618CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember_98D90735A12C2A73862FD4ED4B3618CE" xlink:to="lab_us-gaap_ParentMember_98D90735A12C2A73862FD4ED4B3618CE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Expense included in consolidated statements of income</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:to="lab_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_20E102D74AA5F0A174FED4ED4B3749CB_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_20E102D74AA5F0A174FED4ED4B3749CB" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Subtotal</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_20E102D74AA5F0A174FED4ED4B3749CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_20E102D74AA5F0A174FED4ED4B3749CB" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_20E102D74AA5F0A174FED4ED4B3749CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_D814D5899BCC573DEF17D4ED4B37D109_negatedLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_D814D5899BCC573DEF17D4ED4B37D109" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Income tax effect</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_D814D5899BCC573DEF17D4ED4B37D109_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_D814D5899BCC573DEF17D4ED4B37D109" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Tax Benefit from Compensation Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_D814D5899BCC573DEF17D4ED4B37D109" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_D814D5899BCC573DEF17D4ED4B37D109" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_D814D5899BCC573DEF17D4ED4B37D109" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableMember_860A49C6DA8D1F43C997DE183B2AA15F_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember_860A49C6DA8D1F43C997DE183B2AA15F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reduction of accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_860A49C6DA8D1F43C997DE183B2AA15F_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember_860A49C6DA8D1F43C997DE183B2AA15F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_860A49C6DA8D1F43C997DE183B2AA15F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember_860A49C6DA8D1F43C997DE183B2AA15F" xlink:to="lab_us-gaap_AccountsReceivableMember_860A49C6DA8D1F43C997DE183B2AA15F" xlink:type="arc" />
    <link:label id="lab_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract_CF092EEECA0DC1159FE3DE183B2A6B2C_verboseLabel_en-US" xlink:label="lab_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract_CF092EEECA0DC1159FE3DE183B2A6B2C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of total product revenue reserves included in consolidated balance sheets</link:label>
    <link:label id="lab_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract_CF092EEECA0DC1159FE3DE183B2A6B2C_label_en-US" xlink:label="lab_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract_CF092EEECA0DC1159FE3DE183B2A6B2C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary Of Product Revenue Reserves Included In Consolidated Balance Sheets [Abstract]</link:label>
    <link:label id="lab_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract_CF092EEECA0DC1159FE3DE183B2A6B2C_documentation_en-US" xlink:label="lab_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract_CF092EEECA0DC1159FE3DE183B2A6B2C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Summary of product revenue reserves included in consolidated balance sheets.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract" xlink:label="loc_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract_CF092EEECA0DC1159FE3DE183B2A6B2C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract_CF092EEECA0DC1159FE3DE183B2A6B2C" xlink:to="lab_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract_CF092EEECA0DC1159FE3DE183B2A6B2C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_F669D93EB8C9CA6C4377DE183B2AF952_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_F669D93EB8C9CA6C4377DE183B2AF952" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_F669D93EB8C9CA6C4377DE183B2AF952" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance_F669D93EB8C9CA6C4377DE183B2AF952" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance_F669D93EB8C9CA6C4377DE183B2AF952" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_44CA8DF6BF75050CC32EB1DCEA1EDA06_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_44CA8DF6BF75050CC32EB1DCEA1EDA06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_44CA8DF6BF75050CC32EB1DCEA1EDA06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_44CA8DF6BF75050CC32EB1DCEA1EDA06" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_44CA8DF6BF75050CC32EB1DCEA1EDA06" xlink:type="arc" />
    <link:label id="lab_biib_StrategicInvestmentsMember_048890608606B482A22EB1DCEA1FBF6C_terseLabel_en-US" xlink:label="lab_biib_StrategicInvestmentsMember_048890608606B482A22EB1DCEA1FBF6C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Strategic Investments</link:label>
    <link:label id="lab_biib_StrategicInvestmentsMember_048890608606B482A22EB1DCEA1FBF6C_label_en-US" xlink:label="lab_biib_StrategicInvestmentsMember_048890608606B482A22EB1DCEA1FBF6C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Strategic Investments [Member]</link:label>
    <link:label id="lab_biib_StrategicInvestmentsMember_048890608606B482A22EB1DCEA1FBF6C_documentation_en-US" xlink:label="lab_biib_StrategicInvestmentsMember_048890608606B482A22EB1DCEA1FBF6C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Strategic investments.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_StrategicInvestmentsMember" xlink:label="loc_biib_StrategicInvestmentsMember_048890608606B482A22EB1DCEA1FBF6C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_StrategicInvestmentsMember_048890608606B482A22EB1DCEA1FBF6C" xlink:to="lab_biib_StrategicInvestmentsMember_048890608606B482A22EB1DCEA1FBF6C" xlink:type="arc" />
    <link:label id="lab_biib_StrategicInvestmentPortfolio_41E6DACE672C81ADF8A3B1DCEA208FAE_verboseLabel_en-US" xlink:label="lab_biib_StrategicInvestmentPortfolio_41E6DACE672C81ADF8A3B1DCEA208FAE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Strategic investment portfolio</link:label>
    <link:label id="lab_biib_StrategicInvestmentPortfolio_41E6DACE672C81ADF8A3B1DCEA208FAE_label_en-US" xlink:label="lab_biib_StrategicInvestmentPortfolio_41E6DACE672C81ADF8A3B1DCEA208FAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Strategic Investment Portfolio</link:label>
    <link:label id="lab_biib_StrategicInvestmentPortfolio_41E6DACE672C81ADF8A3B1DCEA208FAE_documentation_en-US" xlink:label="lab_biib_StrategicInvestmentPortfolio_41E6DACE672C81ADF8A3B1DCEA208FAE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Strategic investment portfolio.</link:label>
    <link:loc xlink:href="biib-20150630.xsd#biib_StrategicInvestmentPortfolio" xlink:label="loc_biib_StrategicInvestmentPortfolio_41E6DACE672C81ADF8A3B1DCEA208FAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_biib_StrategicInvestmentPortfolio_41E6DACE672C81ADF8A3B1DCEA208FAE" xlink:to="lab_biib_StrategicInvestmentPortfolio_41E6DACE672C81ADF8A3B1DCEA208FAE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_D2C959C3598E34A2D833DEB4FB38B0E8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_D2C959C3598E34A2D833DEB4FB38B0E8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from maturities and sales</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_D2C959C3598E34A2D833DEB4FB38B0E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_D2C959C3598E34A2D833DEB4FB38B0E8" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_D2C959C3598E34A2D833DEB4FB38B0E8" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedGains_4EAC1A384101EE049848DEB4FB4007AE_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedGains_4EAC1A384101EE049848DEB4FB4007AE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Realized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedGains_4EAC1A384101EE049848DEB4FB4007AE_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedGains_4EAC1A384101EE049848DEB4FB4007AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities, Gross Realized Gains</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGains" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGains_4EAC1A384101EE049848DEB4FB4007AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGains_4EAC1A384101EE049848DEB4FB4007AE" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedGains_4EAC1A384101EE049848DEB4FB4007AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses_E641CF635B7AF4438ACCDEB4FB431466_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses_E641CF635B7AF4438ACCDEB4FB431466" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Realized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses_E641CF635B7AF4438ACCDEB4FB431466_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses_E641CF635B7AF4438ACCDEB4FB431466" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities, Gross Realized Losses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses_E641CF635B7AF4438ACCDEB4FB431466" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses_E641CF635B7AF4438ACCDEB4FB431466" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses_E641CF635B7AF4438ACCDEB4FB431466" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_9D4DC9355EFE1F054048DE0B30291C58_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_9D4DC9355EFE1F054048DE0B30291C58" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase price schedule</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_9D4DC9355EFE1F054048DE0B30291C58_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_9D4DC9355EFE1F054048DE0B30291C58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_9D4DC9355EFE1F054048DE0B30291C58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_9D4DC9355EFE1F054048DE0B30291C58" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_9D4DC9355EFE1F054048DE0B30291C58" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1104E558C6E1DDEA627FDE0B302966C7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1104E558C6E1DDEA627FDE0B302966C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated fair values of the separately identifiable assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1104E558C6E1DDEA627FDE0B302966C7_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1104E558C6E1DDEA627FDE0B302966C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1104E558C6E1DDEA627FDE0B302966C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1104E558C6E1DDEA627FDE0B302966C7" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1104E558C6E1DDEA627FDE0B302966C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D2614C7AA25A1E6D2408D4ED4B65C16E_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D2614C7AA25A1E6D2408D4ED4B65C16E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Components of inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D2614C7AA25A1E6D2408D4ED4B65C16E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D2614C7AA25A1E6D2408D4ED4B65C16E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D2614C7AA25A1E6D2408D4ED4B65C16E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D2614C7AA25A1E6D2408D4ED4B65C16E" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D2614C7AA25A1E6D2408D4ED4B65C16E" xlink:type="arc" />
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_FB7DD0B042F26083E9F5DE0A9EA15DB4_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_FB7DD0B042F26083E9F5DE0A9EA15DB4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_FB7DD0B042F26083E9F5DE0A9EA15DB4_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_FB7DD0B042F26083E9F5DE0A9EA15DB4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_FB7DD0B042F26083E9F5DE0A9EA15DB4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_FB7DD0B042F26083E9F5DE0A9EA15DB4" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_FB7DD0B042F26083E9F5DE0A9EA15DB4" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>biib-20150630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <roleRef roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLoss" xlink:href="biib-20150630.xsd#AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="biib-20150630.xsd#AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails1" xlink:href="biib-20150630.xsd#AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables" xlink:href="biib-20150630.xsd#AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitions" xlink:href="biib-20150630.xsd#AcquisitionsAcquisitions" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails" xlink:href="biib-20150630.xsd#AcquisitionsAcquisitionsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails1" xlink:href="biib-20150630.xsd#AcquisitionsAcquisitionsDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetailsTextual" xlink:href="biib-20150630.xsd#AcquisitionsAcquisitionsDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/AcquisitionsAcquisitionsTables" xlink:href="biib-20150630.xsd#AcquisitionsAcquisitionsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CollaborativeAndOtherRelationships" xlink:href="biib-20150630.xsd#CollaborativeAndOtherRelationships" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsEquityMethodInvestmentsDetails" xlink:href="biib-20150630.xsd#CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsEquityMethodInvestmentsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CommitmentsAndContingencesDetails" xlink:href="biib-20150630.xsd#CommitmentsAndContingencesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CommitmentsAndContingencies" xlink:href="biib-20150630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CommitmentsAndContingenciesCommitmentsAndContingenciesDetails1" xlink:href="biib-20150630.xsd#CommitmentsAndContingenciesCommitmentsAndContingenciesDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:href="biib-20150630.xsd#CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:href="biib-20150630.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="biib-20150630.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" xlink:href="biib-20150630.xsd#CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical" xlink:href="biib-20150630.xsd#CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited" xlink:href="biib-20150630.xsd#CondensedConsolidatedStatementsOfIncomeUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/DerivativeInstruments" xlink:href="biib-20150630.xsd#DerivativeInstruments" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/DerivativeInstrumentsDetails" xlink:href="biib-20150630.xsd#DerivativeInstrumentsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/DerivativeInstrumentsTables" xlink:href="biib-20150630.xsd#DerivativeInstrumentsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/DocumentAndEntityInformation" xlink:href="biib-20150630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EarningsPerShare" xlink:href="biib-20150630.xsd#EarningsPerShare" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EarningsPerShareDetails" xlink:href="biib-20150630.xsd#EarningsPerShareDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EarningsPerShareTables" xlink:href="biib-20150630.xsd#EarningsPerShareTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/Equity" xlink:href="biib-20150630.xsd#Equity" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EquityDetails" xlink:href="biib-20150630.xsd#EquityDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EquityDetailsTextual" xlink:href="biib-20150630.xsd#EquityDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/EquityTables" xlink:href="biib-20150630.xsd#EquityTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurements" xlink:href="biib-20150630.xsd#FairValueMeasurements" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetails" xlink:href="biib-20150630.xsd#FairValueMeasurementsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetails1" xlink:href="biib-20150630.xsd#FairValueMeasurementsDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetails2" xlink:href="biib-20150630.xsd#FairValueMeasurementsDetails2" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurementsDetailsTextual" xlink:href="biib-20150630.xsd#FairValueMeasurementsDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FairValueMeasurementsTables" xlink:href="biib-20150630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstruments" xlink:href="biib-20150630.xsd#FinancialInstruments" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails" xlink:href="biib-20150630.xsd#FinancialInstrumentsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails1" xlink:href="biib-20150630.xsd#FinancialInstrumentsDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails2" xlink:href="biib-20150630.xsd#FinancialInstrumentsDetails2" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetails3" xlink:href="biib-20150630.xsd#FinancialInstrumentsDetails3" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsDetailsTextual" xlink:href="biib-20150630.xsd#FinancialInstrumentsDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsFinancialInstrumentsDetailsTextual2" xlink:href="biib-20150630.xsd#FinancialInstrumentsFinancialInstrumentsDetailsTextual2" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/FinancialInstrumentsTables" xlink:href="biib-20150630.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IncomeTaxes" xlink:href="biib-20150630.xsd#IncomeTaxes" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IncomeTaxesDetails" xlink:href="biib-20150630.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IncomeTaxesDetailsTextual" xlink:href="biib-20150630.xsd#IncomeTaxesDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IncomeTaxesTables" xlink:href="biib-20150630.xsd#IncomeTaxesTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwill" xlink:href="biib-20150630.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails" xlink:href="biib-20150630.xsd#IntangibleAssetsAndGoodwillDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails1" xlink:href="biib-20150630.xsd#IntangibleAssetsAndGoodwillDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillTables" xlink:href="biib-20150630.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/Inventory" xlink:href="biib-20150630.xsd#Inventory" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/InventoryDetails" xlink:href="biib-20150630.xsd#InventoryDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/InventoryInventoryDetailsTextual" xlink:href="biib-20150630.xsd#InventoryInventoryDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/InventoryTables" xlink:href="biib-20150630.xsd#InventoryTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/InvestmentsInVariableInterestEntities" xlink:href="biib-20150630.xsd#InvestmentsInVariableInterestEntities" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/InvestmentsInVariableInterestEntitiesDetails" xlink:href="biib-20150630.xsd#InvestmentsInVariableInterestEntitiesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/Litigation" xlink:href="biib-20150630.xsd#Litigation" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/LitigationDetails" xlink:href="biib-20150630.xsd#LitigationDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetail" xlink:href="biib-20150630.xsd#OtherConsolidatedFinancialStatementDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailDetails" xlink:href="biib-20150630.xsd#OtherConsolidatedFinancialStatementDetailDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailOtherConsolidatedFinancialStatementDetailsTextual" xlink:href="biib-20150630.xsd#OtherConsolidatedFinancialStatementDetailOtherConsolidatedFinancialStatementDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailTables" xlink:href="biib-20150630.xsd#OtherConsolidatedFinancialStatementDetailTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowances" xlink:href="biib-20150630.xsd#ReservesForDiscountsAndAllowances" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails" xlink:href="biib-20150630.xsd#ReservesForDiscountsAndAllowancesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails1" xlink:href="biib-20150630.xsd#ReservesForDiscountsAndAllowancesDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesTables" xlink:href="biib-20150630.xsd#ReservesForDiscountsAndAllowancesTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPayments" xlink:href="biib-20150630.xsd#ShareBasedPayments" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetails" xlink:href="biib-20150630.xsd#ShareBasedPaymentsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetails1" xlink:href="biib-20150630.xsd#ShareBasedPaymentsDetails1" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetails2" xlink:href="biib-20150630.xsd#ShareBasedPaymentsDetails2" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsDetailsTextual" xlink:href="biib-20150630.xsd#ShareBasedPaymentsDetailsTextual" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/ShareBasedPaymentsTables" xlink:href="biib-20150630.xsd#ShareBasedPaymentsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/SubsequentEventsSubsequentEvents" xlink:href="biib-20150630.xsd#SubsequentEventsSubsequentEvents" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/SubsequentEventsSubsequentEventsDetails" xlink:href="biib-20150630.xsd#SubsequentEventsSubsequentEventsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="biib-20150630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesDetails" xlink:href="biib-20150630.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="biib-20150630.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <presentationLink xlink:role="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_0C62161EC12EE7087433DEC299D7B5CD" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_7353B39F99FAB4081393DEA10BAE782F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_0C62161EC12EE7087433DEC299D7B5CD" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_7353B39F99FAB4081393DEA10BAE782F" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_1C093A089E8E955A1387DEC340E9ADE7" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_77BFB8F46F8D3EE0EF58DEA10BAA3D0C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_1C093A089E8E955A1387DEC340E9ADE7" xlink:to="loc_us-gaap_StatementTable_77BFB8F46F8D3EE0EF58DEA10BAA3D0C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_33E37BCF3A9C8B496172DEA10BAAC953" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_77BFB8F46F8D3EE0EF58DEA10BAA3D0C" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_33E37BCF3A9C8B496172DEA10BAAC953" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_CFF636DB1AEA74F45004DEA10BAA4833" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_33E37BCF3A9C8B496172DEA10BAAC953" xlink:to="loc_us-gaap_EquityComponentDomain_CFF636DB1AEA74F45004DEA10BAA4833" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_CCFFF8A58B8D5806DC29DEA10BAA9602" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_CFF636DB1AEA74F45004DEA10BAA4833" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_CCFFF8A58B8D5806DC29DEA10BAA9602" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_DB9FA62F2C5B9C636894DEA10BAA8F34" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_CFF636DB1AEA74F45004DEA10BAA4833" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_DB9FA62F2C5B9C636894DEA10BAA8F34" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_929DF00E6BF19CA41E45DEA10BAA2BD7" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_CFF636DB1AEA74F45004DEA10BAA4833" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_929DF00E6BF19CA41E45DEA10BAA2BD7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_422B45FE65A82B018BEFDEA10BAA75D1" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_CFF636DB1AEA74F45004DEA10BAA4833" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_422B45FE65A82B018BEFDEA10BAA75D1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8E8524A57814D5AEC49DDEA10BAB6ABC" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_77BFB8F46F8D3EE0EF58DEA10BAA3D0C" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8E8524A57814D5AEC49DDEA10BAB6ABC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3C25177E6087F52CEDCFDEA10BABD6A7" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8E8524A57814D5AEC49DDEA10BAB6ABC" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3C25177E6087F52CEDCFDEA10BABD6A7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2EA91F1A9901997B4BC5DEA10BABA112" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8E8524A57814D5AEC49DDEA10BAB6ABC" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2EA91F1A9901997B4BC5DEA10BABA112" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3B4E445CA3139E668285DEA10BABF859" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8E8524A57814D5AEC49DDEA10BAB6ABC" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3B4E445CA3139E668285DEA10BABF859" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_F93B01DD941368F834A7DEA10BAB6E37" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8E8524A57814D5AEC49DDEA10BAB6ABC" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_F93B01DD941368F834A7DEA10BAB6E37" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_D99DFBCFE7FC79AEC88ADEC399537488" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_F45E97885C828EB30486DEA10BA62607" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_D99DFBCFE7FC79AEC88ADEC399537488" xlink:to="loc_us-gaap_StatementTable_F45E97885C828EB30486DEA10BA62607" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3935CAECAFF61CDA9855DEA10BA65B38" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_F45E97885C828EB30486DEA10BA62607" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3935CAECAFF61CDA9855DEA10BA65B38" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_80D6D35018E929E32485DEA10BA629E7" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3935CAECAFF61CDA9855DEA10BA65B38" xlink:to="loc_us-gaap_EquityComponentDomain_80D6D35018E929E32485DEA10BA629E7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_FAB467DDE4E115BDF3A8DEA10BA6B87A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_80D6D35018E929E32485DEA10BA629E7" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_FAB467DDE4E115BDF3A8DEA10BA6B87A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_587374D9D106FF7F717BDEA10BA73069" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_80D6D35018E929E32485DEA10BA629E7" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_587374D9D106FF7F717BDEA10BA73069" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_BAE8C3C5A71C03332ED3DEA10BA7196A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_F45E97885C828EB30486DEA10BA62607" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_BAE8C3C5A71C03332ED3DEA10BA7196A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_CFA11124A8FE3E3C01E7DEA10BA78DB8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_BAE8C3C5A71C03332ED3DEA10BA7196A" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_CFA11124A8FE3E3C01E7DEA10BA78DB8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_D26F11DFF019935E4D3BDEA10BA7AFD9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_CFA11124A8FE3E3C01E7DEA10BA78DB8" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_D26F11DFF019935E4D3BDEA10BA7AFD9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_A78EF942E596DCCDAC8CDEA10BA7A213" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_F45E97885C828EB30486DEA10BA62607" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_A78EF942E596DCCDAC8CDEA10BA7A213" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_04B3F38B0E30FACFDFD7DEA10BA76B26" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_A78EF942E596DCCDAC8CDEA10BA7A213" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_04B3F38B0E30FACFDFD7DEA10BA76B26" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_DA690B5CA07DBF3FD693DEA10BA79DF5" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_A78EF942E596DCCDAC8CDEA10BA7A213" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_DA690B5CA07DBF3FD693DEA10BA79DF5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_AF76FB89B15DFD15CCD0DEA10BA728B6" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_A78EF942E596DCCDAC8CDEA10BA7A213" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_AF76FB89B15DFD15CCD0DEA10BA728B6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_2075A91CFF6737D5FA2DDEA10BA768C6" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_A78EF942E596DCCDAC8CDEA10BA7A213" xlink:to="loc_us-gaap_NetIncomeLoss_2075A91CFF6737D5FA2DDEA10BA768C6" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2D96CB6CE7AA80EC5455DEC2ED0CA0A6" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_87802244476B27B3CB52DEA10BAD2008" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2D96CB6CE7AA80EC5455DEC2ED0CA0A6" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_87802244476B27B3CB52DEA10BAD2008" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_E9A4212D4C5060748435DEA10BADDBF5" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2D96CB6CE7AA80EC5455DEC2ED0CA0A6" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_E9A4212D4C5060748435DEA10BADDBF5" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/AcquisitionsAcquisitions" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_19160F5CA84FAE3950E9DE0A9E9E1B06" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_7F43FD29DEAB6D491799DDF8D85E7698" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_19160F5CA84FAE3950E9DE0A9E9E1B06" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_7F43FD29DEAB6D491799DDF8D85E7698" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_CB2D7601F219C217EB60DE109A94C92C" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D35873C1F27FB5BA881DDE10307FB349" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_CB2D7601F219C217EB60DE109A94C92C" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D35873C1F27FB5BA881DDE10307FB349" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_F326ACDE6E063727EEAFDE10307F0E99" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D35873C1F27FB5BA881DDE10307FB349" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_F326ACDE6E063727EEAFDE10307F0E99" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72DB819B45BC56EBD256DE103080DA8B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_F326ACDE6E063727EEAFDE10307F0E99" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72DB819B45BC56EBD256DE103080DA8B" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ConvergencePharmaceuticalsMember" xlink:label="loc_biib_ConvergencePharmaceuticalsMember_B530E75C652A8F504E1EDE103093B6EB" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72DB819B45BC56EBD256DE103080DA8B" xlink:to="loc_biib_ConvergencePharmaceuticalsMember_B530E75C652A8F504E1EDE103093B6EB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5A14ABE1EC881A419B65DE10308010F7" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D35873C1F27FB5BA881DDE10307FB349" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5A14ABE1EC881A419B65DE10308010F7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_33FC0CD34B35BEA20AE1DE10308A8292" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5A14ABE1EC881A419B65DE10308010F7" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_33FC0CD34B35BEA20AE1DE10308A8292" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_ECBC32C3E64317E83E4BDE11E2B33B65" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5A14ABE1EC881A419B65DE10308010F7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_ECBC32C3E64317E83E4BDE11E2B33B65" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_A3E8A078F2D64397A535DE126778CF16" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5A14ABE1EC881A419B65DE10308010F7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_A3E8A078F2D64397A535DE126778CF16" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_991EE77AF425C3D78DE4DE0CFBDCD1BB" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DFEFB0DD2BF2E8B0AE95DDF8D856B271" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_991EE77AF425C3D78DE4DE0CFBDCD1BB" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DFEFB0DD2BF2E8B0AE95DDF8D856B271" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ED1E42CE490D52997283DDF8D856FB9D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DFEFB0DD2BF2E8B0AE95DDF8D856B271" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ED1E42CE490D52997283DDF8D856FB9D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D71B786F44E8ACC2CCEFDDF8D856EE71" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ED1E42CE490D52997283DDF8D856FB9D" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D71B786F44E8ACC2CCEFDDF8D856EE71" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ConvergencePharmaceuticalsMember" xlink:label="loc_biib_ConvergencePharmaceuticalsMember_F4DF5F883547E5928FE7DDF8D856E28E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D71B786F44E8ACC2CCEFDDF8D856EE71" xlink:to="loc_biib_ConvergencePharmaceuticalsMember_F4DF5F883547E5928FE7DDF8D856E28E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_B10A91F335F3748F7448DDF8D856D6B9" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DFEFB0DD2BF2E8B0AE95DDF8D856B271" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_B10A91F335F3748F7448DDF8D856D6B9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_93D3273A4399F7FFD3E5DDF8D85635D5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_B10A91F335F3748F7448DDF8D856D6B9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_93D3273A4399F7FFD3E5DDF8D85635D5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_EE730B29FF0CCDA2FEBDDDF8D857BA86" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_B10A91F335F3748F7448DDF8D856D6B9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_EE730B29FF0CCDA2FEBDDDF8D857BA86" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_E5BF3CDBF46EBE1225A8DDF8D857CA53" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_B10A91F335F3748F7448DDF8D856D6B9" xlink:to="loc_us-gaap_Goodwill_E5BF3CDBF46EBE1225A8DDF8D857CA53" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_4ED0AAB59969E4AEC44FDDF8D8574DF5" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_B10A91F335F3748F7448DDF8D856D6B9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_4ED0AAB59969E4AEC44FDDF8D8574DF5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_38DC5B65492D978F53D4DDF8D8575733" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_B10A91F335F3748F7448DDF8D856D6B9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_38DC5B65492D978F53D4DDF8D8575733" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_48B2B3AE847DD4FD52F1DDF8D8577A11" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_B10A91F335F3748F7448DDF8D856D6B9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_48B2B3AE847DD4FD52F1DDF8D8577A11" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetailsTextual" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7E4F3FBF08C11391E78FB1CA3925D16D" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7E4F3FBF08C11391E78FB1CA3925D16D" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_AAC428C2F76C073EC7B2B1CA3927502D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_AAC428C2F76C073EC7B2B1CA3927502D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4C497D984F16C1F83CCBB1CA3927AA3F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_AAC428C2F76C073EC7B2B1CA3927502D" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4C497D984F16C1F83CCBB1CA3927AA3F" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ConvergencePharmaceuticalsMember" xlink:label="loc_biib_ConvergencePharmaceuticalsMember_EF694B669BBF78DF74D0B1CA3927DF4C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4C497D984F16C1F83CCBB1CA3927AA3F" xlink:to="loc_biib_ConvergencePharmaceuticalsMember_EF694B669BBF78DF74D0B1CA3927DF4C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_D968A86CB6C7DE41BF8AB1CA39272213" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF" xlink:to="loc_us-gaap_ProductOrServiceAxis_D968A86CB6C7DE41BF8AB1CA39272213" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_D968A86CB6C7DE41BF8AB1CA39272213" xlink:to="loc_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CNV1014802Member" xlink:label="loc_biib_CNV1014802Member_24751951D13CCC35C0AEB1CA392894C1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346" xlink:to="loc_biib_CNV1014802Member_24751951D13CCC35C0AEB1CA392894C1" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_NeuropathicpainindicationsMember" xlink:label="loc_biib_NeuropathicpainindicationsMember_5F69208B988FC50DEE81B1CA3928FEA0" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_DC134550D942CA853160B1CA3927A346" xlink:to="loc_biib_NeuropathicpainindicationsMember_5F69208B988FC50DEE81B1CA3928FEA0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01B0E31AACE5C7BCF5ECB1CA3926EADF" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_18921EF4090E639A71CBB1CA39284500" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_18921EF4090E639A71CBB1CA39284500" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately" xlink:label="loc_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_FCC8C2F678E99AC85E9DB1CA39287F25" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_FCC8C2F678E99AC85E9DB1CA39287F25" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_05E070147C53310323AAB1CA39284BCB" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_05E070147C53310323AAB1CA39284BCB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_DED23CEFF460E961F8B5B1CA39282659" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_DED23CEFF460E961F8B5B1CA39282659" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_1780E4C2D0AEAC688FB7B1CA3928F1B5" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_1780E4C2D0AEAC688FB7B1CA3928F1B5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="loc_us-gaap_FairValueInputsDiscountRate_F9B59BB108C41D1AF07CB1CA3928E42E" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_us-gaap_FairValueInputsDiscountRate_F9B59BB108C41D1AF07CB1CA3928E42E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_F60C74BF72260371A776B1CA392816A3" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_F60C74BF72260371A776B1CA392816A3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_99C882F2F9E2A020BFCEB1CA39285788" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_01DA82932FC8B757CECAB1CA39289AA3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_99C882F2F9E2A020BFCEB1CA39285788" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/AcquisitionsAcquisitionsTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_EF3E4A688E22115C1F13DE0B30204C3E" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_1D398BB94349B4075C4DDDF8D85CC515" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_EF3E4A688E22115C1F13DE0B30204C3E" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_1D398BB94349B4075C4DDDF8D85CC515" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_A2DD79B84CD765848B2EDDF8D85C3B2A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_EF3E4A688E22115C1F13DE0B30204C3E" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_A2DD79B84CD765848B2EDDF8D85C3B2A" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/CollaborativeAndOtherRelationships" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36E5B2E62E90B4FD6AE0D4ED4BDA4133" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_5C4408D646FFE8F4C361D4ED4BDAD968" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36E5B2E62E90B4FD6AE0D4ED4BDA4133" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_5C4408D646FFE8F4C361D4ED4BDAD968" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsEquityMethodInvestmentsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_A462866C99565EA7626BD4ED4BD72CB2" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ED6E2379A512B8611EBED4ED4BD7475C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_A462866C99565EA7626BD4ED4BD72CB2" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ED6E2379A512B8611EBED4ED4BD7475C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_A1C8C4EEC60462059522D4ED4BD7942C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ED6E2379A512B8611EBED4ED4BD7475C" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_A1C8C4EEC60462059522D4ED4BD7942C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityMethodInvesteeNameDomain" xlink:label="loc_us-gaap_EquityMethodInvesteeNameDomain_EC4107E0F0AF5B20FCC1D4ED4BD89CA0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_A1C8C4EEC60462059522D4ED4BD7942C" xlink:to="loc_us-gaap_EquityMethodInvesteeNameDomain_EC4107E0F0AF5B20FCC1D4ED4BD89CA0" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_SamsungBiosimilarAgreementMember" xlink:label="loc_biib_SamsungBiosimilarAgreementMember_9DEB65368349330C1533D4ED4BD841E4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvesteeNameDomain_EC4107E0F0AF5B20FCC1D4ED4BD89CA0" xlink:to="loc_biib_SamsungBiosimilarAgreementMember_9DEB65368349330C1533D4ED4BD841E4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ED6E2379A512B8611EBED4ED4BD7475C" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement" xlink:label="loc_biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement_207324B535E16D8A4B16D4ED4BD89551" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement_207324B535E16D8A4B16D4ED4BD89551" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_JointVentureOwnerShipPercentageByThirdParty" xlink:label="loc_biib_JointVentureOwnerShipPercentageByThirdParty_071DDB63F6E7B0DF79B5D4ED4BD88D58" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_biib_JointVentureOwnerShipPercentageByThirdParty_071DDB63F6E7B0DF79B5D4ED4BD88D58" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_2F7A3840C8B916FBAA87D4ED4BD8CC26" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_us-gaap_EquityMethodInvestments_2F7A3840C8B916FBAA87D4ED4BD8CC26" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1913B942AF6AB95931D5D4ED4BD853A3" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1913B942AF6AB95931D5D4ED4BD853A3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_DA1249D14801BC1FFF4FD4ED4BD8063D" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_DA1249D14801BC1FFF4FD4ED4BD8063D" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_EquityMethodInvestmentOwnershipPercentageMaximum" xlink:label="loc_biib_EquityMethodInvestmentOwnershipPercentageMaximum_872A902C54EEF6BA240AD4ED4BD8B377" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_biib_EquityMethodInvestmentOwnershipPercentageMaximum_872A902C54EEF6BA240AD4ED4BD8B377" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_739CF25652D8C9789EF0D4ED4BD802D7" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_739CF25652D8C9789EF0D4ED4BD802D7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_17854409963FD1E9A121D4ED4BD83E8A" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_17854409963FD1E9A121D4ED4BD83E8A" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AdditionalMilestonePayment" xlink:label="loc_biib_AdditionalMilestonePayment_1397FC60E3C7EEB0EE26D4ED4BD8F8D1" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_biib_AdditionalMilestonePayment_1397FC60E3C7EEB0EE26D4ED4BD8F8D1" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_EquityMethodInvestmentsExpectedProfitShare" xlink:label="loc_biib_EquityMethodInvestmentsExpectedProfitShare_74B56CFA3A39E42C0271D4ED4BD8E289" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_biib_EquityMethodInvestmentsExpectedProfitShare_74B56CFA3A39E42C0271D4ED4BD8E289" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="loc_us-gaap_OtherSalesRevenueNet_EB10FFC494F06650D3F2D4ED4BD8A06E" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_64C67A50581252CB3620D4ED4BD8BB7B" xlink:to="loc_us-gaap_OtherSalesRevenueNet_EB10FFC494F06650D3F2D4ED4BD8A06E" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/CommitmentsAndContingencesDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_35B81540F91726BFA863D4ED4BB5037E" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_35B81540F91726BFA863D4ED4BB5037E" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CumulativeSalesLevelAxis" xlink:label="loc_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:to="loc_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CumulativeSalesLevelDomain" xlink:label="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_CumulativeSalesLevelAxis_C6A36F43EF745A6A7CC6D4ED4BB5B881" xlink:to="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_FourbillionMember" xlink:label="loc_biib_FourbillionMember_692FB14EC0F32391BFABD4ED4BB5111C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:to="loc_biib_FourbillionMember_692FB14EC0F32391BFABD4ED4BB5111C" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_FivebillionMember" xlink:label="loc_biib_FivebillionMember_332481569C77EB7D7323D4ED4BB5B70F" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:to="loc_biib_FivebillionMember_332481569C77EB7D7323D4ED4BB5B70F" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_EachAdditionalOneBillionUpToTwentyBillionMember" xlink:label="loc_biib_EachAdditionalOneBillionUpToTwentyBillionMember_3E9BE8D5592079C75DEBD4ED4BB5040F" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:to="loc_biib_EachAdditionalOneBillionUpToTwentyBillionMember_3E9BE8D5592079C75DEBD4ED4BB5040F" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_OneBillionMember" xlink:label="loc_biib_OneBillionMember_BA01B70086152E91BFC6D4ED4BB50D16" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:to="loc_biib_OneBillionMember_BA01B70086152E91BFC6D4ED4BB50D16" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ThreeBillionMember" xlink:label="loc_biib_ThreeBillionMember_75C9CF7606AC472AC4FDD4ED4BB542A4" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_CumulativeSalesLevelDomain_D99B9ABD3B32BAFDE8ACD4ED4BB57EDD" xlink:to="loc_biib_ThreeBillionMember_75C9CF7606AC472AC4FDD4ED4BB542A4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_628B331AF83EABE34839D4ED4BB52444" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_628B331AF83EABE34839D4ED4BB52444" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D815669C360FD0C1DD8AD4ED4BB5509E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_628B331AF83EABE34839D4ED4BB52444" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D815669C360FD0C1DD8AD4ED4BB5509E" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_FumapharmAgMember" xlink:label="loc_biib_FumapharmAgMember_6BE43698FB1DB4771027D4ED4BB58A30" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D815669C360FD0C1DD8AD4ED4BB5509E" xlink:to="loc_biib_FumapharmAgMember_6BE43698FB1DB4771027D4ED4BB58A30" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_1ABEE423828310DFC227D4ED4BB5EB73" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:to="loc_us-gaap_ProductOrServiceAxis_1ABEE423828310DFC227D4ED4BB5EB73" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_5AC405D6250550F86CD7D4ED4BB5E3F8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_1ABEE423828310DFC227D4ED4BB5EB73" xlink:to="loc_us-gaap_ProductsAndServicesDomain_5AC405D6250550F86CD7D4ED4BB5E3F8" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_TecfideraMember" xlink:label="loc_biib_TecfideraMember_E4A5BDBDFCB2F7CAA570D4ED4BB59E8A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_5AC405D6250550F86CD7D4ED4BB5E3F8" xlink:to="loc_biib_TecfideraMember_E4A5BDBDFCB2F7CAA570D4ED4BB59E8A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_C31DE997EB1DC5C110DDD4ED4BB54771" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_15DDB72EE31BAF65D26AD4ED4BB61808" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_15DDB72EE31BAF65D26AD4ED4BB61808" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5992331E1F873CE806AD4ED4BB6CDA9" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5992331E1F873CE806AD4ED4BB6CDA9" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CumulativeSalesLevel" xlink:label="loc_biib_CumulativeSalesLevel_54168BA36403C369CC05D4ED4BB6924F" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_CA5730379F77207C5A08D4ED4BB58741" xlink:to="loc_biib_CumulativeSalesLevel_54168BA36403C369CC05D4ED4BB6924F" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/CommitmentsAndContingencies" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4EFC77284E039FDBB1CED4ED4AE0E562" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1341767895013DC36F8ED4ED4AE0490D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4EFC77284E039FDBB1CED4ED4AE0E562" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1341767895013DC36F8ED4ED4AE0490D" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/CommitmentsAndContingenciesCommitmentsAndContingenciesDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_C58F6FC2743202B42010B7340A8B191D" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_FC24B9B0169C0F9730ACB7340A8B4672" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_C58F6FC2743202B42010B7340A8B191D" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_FC24B9B0169C0F9730ACB7340A8B4672" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaap_StatementGeographicalAxis_F60F8373872558F4EF2FB7340A8BBA15" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_FC24B9B0169C0F9730ACB7340A8B4672" xlink:to="loc_us-gaap_StatementGeographicalAxis_F60F8373872558F4EF2FB7340A8BBA15" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_5C124D06AAA900802881B7340A8C763C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementGeographicalAxis_F60F8373872558F4EF2FB7340A8BBA15" xlink:to="loc_us-gaap_SegmentGeographicalDomain_5C124D06AAA900802881B7340A8C763C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_CH" xlink:label="loc_country_CH_B97B099DEC6B69C1BED7B7340A8C2A03" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_5C124D06AAA900802881B7340A8C763C" xlink:to="loc_country_CH_B97B099DEC6B69C1BED7B7340A8C2A03" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_367E393CFC108D310DAAB7340A8C1CE6" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_FC24B9B0169C0F9730ACB7340A8B4672" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentLineItems_367E393CFC108D310DAAB7340A8C1CE6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Land" xlink:label="loc_us-gaap_Land_4C393239BA1E6618117FB7340A8C87F8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_367E393CFC108D310DAAB7340A8C1CE6" xlink:to="loc_us-gaap_Land_4C393239BA1E6618117FB7340A8C87F8" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2F2AFB19EB5CD72608BAD4ED4B41F8D7" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2F2AFB19EB5CD72608BAD4ED4B41F8D7" xlink:to="loc_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD" xlink:to="loc_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_52D2490B0BACCFC8EF00D4ED4B420EAA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_52D2490B0BACCFC8EF00D4ED4B420EAA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesCurrent_1B887A82B43BED1B3EF2D4ED4B4244BE" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesCurrent_1B887A82B43BED1B3EF2D4ED4B4244BE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_070AAFC9E0F35604553ED4ED4B4281EA" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_070AAFC9E0F35604553ED4ED4B4281EA" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_DueFromUnconsolidatedJointBusiness" xlink:label="loc_biib_DueFromUnconsolidatedJointBusiness_82BF9FE5D8E9EB979EBFD4ED4B4206BA" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67" xlink:to="loc_biib_DueFromUnconsolidatedJointBusiness_82BF9FE5D8E9EB979EBFD4ED4B4206BA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_41BA10A5618893984C5AD4ED4B424134" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67" xlink:to="loc_us-gaap_InventoryNet_41BA10A5618893984C5AD4ED4B424134" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_81392430E458F3385D0FD4ED4B42C60F" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67" xlink:to="loc_us-gaap_OtherAssetsCurrent_81392430E458F3385D0FD4ED4B42C60F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_283FD5636C04AC982649D4ED4B428C1C" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1D637399575D330BC080D4ED4B421A67" xlink:to="loc_us-gaap_AssetsCurrent_283FD5636C04AC982649D4ED4B428C1C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesNoncurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesNoncurrent_91BBEBC271787897A465D4ED4B42D3CD" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesNoncurrent_91BBEBC271787897A465D4ED4B42D3CD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_BD776E1C1C84A36B25A7D4ED4B426AC6" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_BD776E1C1C84A36B25A7D4ED4B426AC6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_03181078D72612927860D4ED4B42C078" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_03181078D72612927860D4ED4B42C078" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_8BA4ED9D2AC7A5B695F5D4ED4B432297" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD" xlink:to="loc_us-gaap_Goodwill_8BA4ED9D2AC7A5B695F5D4ED4B432297" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4858DB806B8DD4222BE4D4ED4B430A0B" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4858DB806B8DD4222BE4D4ED4B430A0B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_8D0790B28E8FF1AAF302D4ED4B4398E5" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_A53A36C70E848DA400B4D4ED4B421AAD" xlink:to="loc_us-gaap_Assets_8D0790B28E8FF1AAF302D4ED4B4398E5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2F2AFB19EB5CD72608BAD4ED4B41F8D7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3BD52DEC22A90DCA9B91D4ED4B430DA3" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3BD52DEC22A90DCA9B91D4ED4B430DA3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaap_DebtCurrent_B063A35B33E8D9A12A13D4ED4B43E859" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3BD52DEC22A90DCA9B91D4ED4B430DA3" xlink:to="loc_us-gaap_DebtCurrent_B063A35B33E8D9A12A13D4ED4B43E859" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaap_TaxesPayableCurrent_A50FE00BD1665966401FD4ED4B43C467" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3BD52DEC22A90DCA9B91D4ED4B430DA3" xlink:to="loc_us-gaap_TaxesPayableCurrent_A50FE00BD1665966401FD4ED4B43C467" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_7DA793E7CA6C104A5622D4ED4B435ACC" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3BD52DEC22A90DCA9B91D4ED4B430DA3" xlink:to="loc_us-gaap_AccountsPayableCurrent_7DA793E7CA6C104A5622D4ED4B435ACC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_2AF5910CC3BF9C671D5CD4ED4B43E33F" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3BD52DEC22A90DCA9B91D4ED4B430DA3" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_2AF5910CC3BF9C671D5CD4ED4B43E33F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_F6CFD6AF868328AD95FFD4ED4B435AAE" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3BD52DEC22A90DCA9B91D4ED4B430DA3" xlink:to="loc_us-gaap_LiabilitiesCurrent_F6CFD6AF868328AD95FFD4ED4B435AAE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_AF20EBB0540601A379C3D4ED4B447467" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91" xlink:to="loc_us-gaap_LongTermDebt_AF20EBB0540601A379C3D4ED4B447467" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_404E1552EADA5BB57B61D4ED4B449F7D" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_404E1552EADA5BB57B61D4ED4B449F7D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_6947C725EA2C1B9CB54CD4ED4B449427" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_6947C725EA2C1B9CB54CD4ED4B449427" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_3D921A31AD1FDA842F40D4ED4B44DAB1" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91" xlink:to="loc_us-gaap_Liabilities_3D921A31AD1FDA842F40D4ED4B44DAB1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_21F50CD7D3997330F507D4ED4B44C4BF" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91" xlink:to="loc_us-gaap_CommitmentsAndContingencies_21F50CD7D3997330F507D4ED4B44C4BF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_C0C3471C9DDEA39D4B42D4ED4B442FC1" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_C0C3471C9DDEA39D4B42D4ED4B442FC1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_C0C3471C9DDEA39D4B42D4ED4B442FC1" xlink:to="loc_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_81287CD81A3B30DF5791D4ED4B442B2C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258" xlink:to="loc_us-gaap_PreferredStockValue_81287CD81A3B30DF5791D4ED4B442B2C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_F2E096B8C82AA64FF6CAD4ED4B441C4A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258" xlink:to="loc_us-gaap_CommonStockValue_F2E096B8C82AA64FF6CAD4ED4B441C4A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_AE596FB0D0CFD2CB4D53D4ED4B443BB4" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258" xlink:to="loc_us-gaap_AdditionalPaidInCapital_AE596FB0D0CFD2CB4D53D4ED4B443BB4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4A685C8B16DB68E0219CD4ED4B457C85" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4A685C8B16DB68E0219CD4ED4B457C85" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_D6D75C097C2BECCA06C6D4ED4B45A400" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_D6D75C097C2BECCA06C6D4ED4B45A400" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_A4761B39C93CEBDD785DD4ED4B450EDF" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258" xlink:to="loc_us-gaap_TreasuryStockValue_A4761B39C93CEBDD785DD4ED4B450EDF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_F907934BF3A94BAF528DD4ED4B45CE9D" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1074F41F87DA1ADEA8E0D4ED4B44C258" xlink:to="loc_us-gaap_StockholdersEquity_F907934BF3A94BAF528DD4ED4B45CE9D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_274BB6211AF6DEEEEA69D4ED4B4585C1" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_C0C3471C9DDEA39D4B42D4ED4B442FC1" xlink:to="loc_us-gaap_MinorityInterest_274BB6211AF6DEEEEA69D4ED4B4585C1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_139B71B666404D5A45ABD4ED4B459420" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_C0C3471C9DDEA39D4B42D4ED4B442FC1" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_139B71B666404D5A45ABD4ED4B459420" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2D6DAB0CC5E21A6C6095D4ED4B45540C" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9E5245D7B7273F1F5E8AD4ED4B430F91" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_2D6DAB0CC5E21A6C6095D4ED4B45540C" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_86ECECBC0B453339B9BFD4ED4B8F0EC7" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_B6679C3211A76D1E2190D4ED4B8F6C3B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_86ECECBC0B453339B9BFD4ED4B8F0EC7" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_B6679C3211A76D1E2190D4ED4B8F6C3B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_05FAB23A63EF7DC0FF99D4ED4B8FB1DF" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_86ECECBC0B453339B9BFD4ED4B8F0EC7" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_05FAB23A63EF7DC0FF99D4ED4B8FB1DF" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_8AB36378C0991D61FF98B7340BA3A24D" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_61D054E60378165C5FB2B7340BA3D337" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8AB36378C0991D61FF98B7340BA3A24D" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_61D054E60378165C5FB2B7340BA3D337" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_501A641FCE364D386195B7340BA3C411" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_61D054E60378165C5FB2B7340BA3D337" xlink:to="loc_us-gaap_ProfitLoss_501A641FCE364D386195B7340BA3C411" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6DFF729F46D10F85856CB7340BA330BB" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_61D054E60378165C5FB2B7340BA3D337" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6DFF729F46D10F85856CB7340BA330BB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0F5077E38B6472DBF754B7340BA39231" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6DFF729F46D10F85856CB7340BA330BB" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0F5077E38B6472DBF754B7340BA39231" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_B8AC070B86F533971100B7340BA32323" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6DFF729F46D10F85856CB7340BA330BB" xlink:to="loc_us-gaap_ShareBasedCompensation_B8AC070B86F533971100B7340BA32323" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_E1D2C3B45AD89D54F254B7340BA337B2" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6DFF729F46D10F85856CB7340BA330BB" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_E1D2C3B45AD89D54F254B7340BA337B2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_C87CFED2F0AC65D1FF70B7340BA3C243" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6DFF729F46D10F85856CB7340BA330BB" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_C87CFED2F0AC65D1FF70B7340BA3C243" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_BEF253C8BEEFC19421D5B7340BA4C733" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6DFF729F46D10F85856CB7340BA330BB" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_BEF253C8BEEFC19421D5B7340BA4C733" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0073D962EE35BDA37EF0B7340BA4587B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_BEF253C8BEEFC19421D5B7340BA4C733" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0073D962EE35BDA37EF0B7340BA4587B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_7E4743A160ABB38E45D4B7340BA457F5" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_BEF253C8BEEFC19421D5B7340BA4C733" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_7E4743A160ABB38E45D4B7340BA457F5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9D0E7D96FA1F6D1CDA6CB7340BA495C2" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_BEF253C8BEEFC19421D5B7340BA4C733" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9D0E7D96FA1F6D1CDA6CB7340BA495C2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_04D2537A4308DE065B3AB7340BA40219" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_BEF253C8BEEFC19421D5B7340BA4C733" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_04D2537A4308DE065B3AB7340BA40219" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_474D8B5AFDC3D473CD34B7340BA4F08F" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_BEF253C8BEEFC19421D5B7340BA4C733" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_474D8B5AFDC3D473CD34B7340BA4F08F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0E219B0314E4D676D758B7340BA4D2F3" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6DFF729F46D10F85856CB7340BA330BB" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0E219B0314E4D676D758B7340BA4D2F3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8AB36378C0991D61FF98B7340BA3A24D" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_0380351FC6D306BF23ADB7340BA417C3" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_0380351FC6D306BF23ADB7340BA417C3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_F3E015F2E5FAD5102C8CB7340BA4A1C0" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_F3E015F2E5FAD5102C8CB7340BA4A1C0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_CB54E9489C31061FF24FB7340BA4DD9B" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_CB54E9489C31061FF24FB7340BA4DD9B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A6AC6CB78E2178F5FD46B7340BA41C7C" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A6AC6CB78E2178F5FD46B7340BA41C7C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_33BBD557EFA5106B9EFEB7340BA413E3" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_33BBD557EFA5106B9EFEB7340BA413E3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_55A63AFC2781DC18F588B7340BA519CB" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_55A63AFC2781DC18F588B7340BA519CB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_E77E8754DAADC5E9C0E3B7340BA53E50" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4E9EB11630CE2F19BE8BB7340BA497F8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_E77E8754DAADC5E9C0E3B7340BA53E50" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5AE538973693F4F095C1B7340BA59730" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8AB36378C0991D61FF98B7340BA3A24D" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5AE538973693F4F095C1B7340BA59730" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_F1A4F724513566CE5EB9B7340BA5F69E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5AE538973693F4F095C1B7340BA59730" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_F1A4F724513566CE5EB9B7340BA5F69E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_4BD14FEEEFB41C24E77BB7340BA50FA5" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5AE538973693F4F095C1B7340BA59730" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_4BD14FEEEFB41C24E77BB7340BA50FA5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_359192A9C3B2DBEEF53CB7340BA5778B" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5AE538973693F4F095C1B7340BA59730" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_359192A9C3B2DBEEF53CB7340BA5778B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A4D603B1E56C94C62BD6B7340BA5FF28" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5AE538973693F4F095C1B7340BA59730" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A4D603B1E56C94C62BD6B7340BA5FF28" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_A47416892AF1A629AC7AB7340BA5F7F6" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5AE538973693F4F095C1B7340BA59730" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_A47416892AF1A629AC7AB7340BA5F7F6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_90AED62FFA1AD67E0B00B7340BA5C9C6" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8AB36378C0991D61FF98B7340BA3A24D" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_90AED62FFA1AD67E0B00B7340BA5C9C6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F32526A3EF4D30EB9853B7340BA5BE59" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8AB36378C0991D61FF98B7340BA3A24D" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F32526A3EF4D30EB9853B7340BA5BE59" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1D24C5900A1E290C92AAB7340BA5D76E" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8AB36378C0991D61FF98B7340BA3A24D" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1D24C5900A1E290C92AAB7340BA5D76E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_D230DC08BED4D6A12C1EB7340BA5F337" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8AB36378C0991D61FF98B7340BA3A24D" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_D230DC08BED4D6A12C1EB7340BA5F337" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7DA9C00337F4857AE12AB7340BB82B6A" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_BC3F76A6255E3929A74CB7340BB88A3B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7DA9C00337F4857AE12AB7340BB82B6A" xlink:to="loc_us-gaap_NetIncomeLoss_BC3F76A6255E3929A74CB7340BB88A3B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7DA9C00337F4857AE12AB7340BB82B6A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_CC97A280609EB733738CB7340BB8A7F1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_CC97A280609EB733738CB7340BB8A7F1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_B2C935DF5FFC169E4AF4B7340BB8DDB1" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_B2C935DF5FFC169E4AF4B7340BB8DDB1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3AAA15E5D899746ED538B7340BB94E7D" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3AAA15E5D899746ED538B7340BB94E7D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3839C3C43456624D937FB7340BB9F9BA" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3839C3C43456624D937FB7340BB9F9BA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_47D29268AE990EDD6C4BB7340BB9042B" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_47D29268AE990EDD6C4BB7340BB9042B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_9538FFB7AC540FBAFFFFB7340BB9C8D9" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_9538FFB7AC540FBAFFFFB7340BB9C8D9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2C92C298B25CED1603E5B7340BB90423" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2C92C298B25CED1603E5B7340BB90423" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D32CFB7AD08150D9858DB7340BB96C3F" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6A6AB3CEA66593C426D9B7340BB89D9A" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D32CFB7AD08150D9858DB7340BB96C3F" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_25B84854186E3073616CD4ED4B86771F" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1B4B8FA4EDD814130BA1D4ED4B860532" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_25B84854186E3073616CD4ED4B86771F" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1B4B8FA4EDD814130BA1D4ED4B860532" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_7C7D8CCD6848916914E8D4ED4B867A49" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_25B84854186E3073616CD4ED4B86771F" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_7C7D8CCD6848916914E8D4ED4B867A49" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_E2DB06742CFC93AF4061DDE4D5B10406" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:to="loc_us-gaap_RevenuesAbstract_E2DB06742CFC93AF4061DDE4D5B10406" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_E6A7411617529E4ABE6ADDE4D5B15A45" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_E2DB06742CFC93AF4061DDE4D5B10406" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_E6A7411617529E4ABE6ADDE4D5B15A45" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_UnconsolidatedJointBusiness" xlink:label="loc_biib_UnconsolidatedJointBusiness_6038F0C85E178B10F6C7DDE4D5B2E244" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_E2DB06742CFC93AF4061DDE4D5B10406" xlink:to="loc_biib_UnconsolidatedJointBusiness_6038F0C85E178B10F6C7DDE4D5B2E244" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="loc_us-gaap_OtherSalesRevenueNet_8BB3D79CD4ADC62745F3DDE4D5B23829" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_E2DB06742CFC93AF4061DDE4D5B10406" xlink:to="loc_us-gaap_OtherSalesRevenueNet_8BB3D79CD4ADC62745F3DDE4D5B23829" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_F81FE90DCA537EF10F71DDE4D5B2D534" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_E2DB06742CFC93AF4061DDE4D5B10406" xlink:to="loc_us-gaap_Revenues_F81FE90DCA537EF10F71DDE4D5B2D534" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_8A9D137E188AE7B3E8BDDDE4D5B231F9" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_8A9D137E188AE7B3E8BDDDE4D5B231F9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaap_CostOfGoodsSold_E95B8D9B933DB22EDA12DDE4D5B2B151" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8A9D137E188AE7B3E8BDDDE4D5B231F9" xlink:to="loc_us-gaap_CostOfGoodsSold_E95B8D9B933DB22EDA12DDE4D5B2B151" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_BEEA16ED9B8F96D4C0A4DDE4D5B268A2" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8A9D137E188AE7B3E8BDDDE4D5B231F9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_BEEA16ED9B8F96D4C0A4DDE4D5B268A2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_14BDB77A98DF7C56EE6BDDE4D5B2DD9B" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8A9D137E188AE7B3E8BDDDE4D5B231F9" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_14BDB77A98DF7C56EE6BDDE4D5B2DD9B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_FFAA07DA7C0B0FB4414EDDE4D5B3B8CB" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8A9D137E188AE7B3E8BDDDE4D5B231F9" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_FFAA07DA7C0B0FB4414EDDE4D5B3B8CB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_5FF0E208DF570F21EAA0DDE4D5B3BA96" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8A9D137E188AE7B3E8BDDDE4D5B231F9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_5FF0E208DF570F21EAA0DDE4D5B3BA96" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses_694816FA976C2F063E4BDDE4D5B3DEDD" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8A9D137E188AE7B3E8BDDDE4D5B231F9" xlink:to="loc_us-gaap_CostsAndExpenses_694816FA976C2F063E4BDDE4D5B3DEDD" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_GainOnSaleOfRights" xlink:label="loc_biib_GainOnSaleOfRights_4284A26B734ED32B4644DDE4D5B31AA2" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:to="loc_biib_GainOnSaleOfRights_4284A26B734ED32B4644DDE4D5B31AA2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_35443F082FE10A87D714DDE4D5B324BD" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:to="loc_us-gaap_OperatingIncomeLoss_35443F082FE10A87D714DDE4D5B324BD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4AACBDB43406482F36E8DDEC7A491AA6" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_4AACBDB43406482F36E8DDEC7A491AA6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_313652D7125B48DD29A7DDE4D5B34155" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_313652D7125B48DD29A7DDE4D5B34155" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7032B2CE78A30F08D6B0DDE4D5B35477" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7032B2CE78A30F08D6B0DDE4D5B35477" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_FF103291E6BAEB1D70E1DDE4D5B3F5B8" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_FF103291E6BAEB1D70E1DDE4D5B3F5B8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_48E961954B6AA89AD738DDE4D5B391EC" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:to="loc_us-gaap_ProfitLoss_48E961954B6AA89AD738DDE4D5B391EC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_A52056BE83473006C68CDDE4D5B3D453" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_A52056BE83473006C68CDDE4D5B3D453" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_99841B6A4F1F120C4AFBDDE4D5B32EE1" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:to="loc_us-gaap_NetIncomeLoss_99841B6A4F1F120C4AFBDDE4D5B32EE1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_98251E59A7A8FF417F04DDE4D5B33B28" xlink:type="locator" />
    <presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:to="loc_us-gaap_EarningsPerShareAbstract_98251E59A7A8FF417F04DDE4D5B33B28" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_5DD5192785D92F45CB56DDE4D5B3BE50" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_98251E59A7A8FF417F04DDE4D5B33B28" xlink:to="loc_us-gaap_EarningsPerShareBasic_5DD5192785D92F45CB56DDE4D5B3BE50" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2E555A6B6DD95672C888DDE4D5B3BD2A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_98251E59A7A8FF417F04DDE4D5B33B28" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2E555A6B6DD95672C888DDE4D5B3BD2A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_AB79F6CF3E4358FF34A3DDE4D5B3B22A" xlink:type="locator" />
    <presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_95910BD633702D31882CDDE4D5B04C60" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_AB79F6CF3E4358FF34A3DDE4D5B3B22A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_A0CE885C5B3CA5DC2698DDE4D5B46315" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_AB79F6CF3E4358FF34A3DDE4D5B3B22A" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_A0CE885C5B3CA5DC2698DDE4D5B46315" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_CE19B9CA2CF6EE698DADDDE4D5B42AEF" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_AB79F6CF3E4358FF34A3DDE4D5B3B22A" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_CE19B9CA2CF6EE698DADDDE4D5B42AEF" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/DerivativeInstruments" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_74DC691924403C929AAED4ED4B084CEA" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_A13224685B313195E39ED4ED4B081EAC" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_74DC691924403C929AAED4ED4B084CEA" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_A13224685B313195E39ED4ED4B081EAC" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/DerivativeInstrumentsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6AA031A8D3D70976E04AD4ED4B59CD72" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6AA031A8D3D70976E04AD4ED4B59CD72" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaap_CurrencyAxis_E5D344CE45838575B240D4ED4B5AB366" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:to="loc_us-gaap_CurrencyAxis_E5D344CE45838575B240D4ED4B5AB366" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrencyAxis_E5D344CE45838575B240D4ED4B5AB366" xlink:to="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_EUR" xlink:label="loc_currency_EUR_63B3E7E36C2123A215EFD4ED4B5A5543" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:to="loc_currency_EUR_63B3E7E36C2123A215EFD4ED4B5A5543" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_CAD" xlink:label="loc_currency_CAD_D0A32D57F9C92B650C91D4ED4B5A3239" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:to="loc_currency_CAD_D0A32D57F9C92B650C91D4ED4B5A3239" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_GBP" xlink:label="loc_currency_GBP_325FE05DF2BD342E256FD4ED4B5A3D60" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:to="loc_currency_GBP_325FE05DF2BD342E256FD4ED4B5A3D60" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_JPY" xlink:label="loc_currency_JPY_C0FA5024E47989BEEA2DD4ED4B5A3D1A" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:to="loc_currency_JPY_C0FA5024E47989BEEA2DD4ED4B5A3D1A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_AUD" xlink:label="loc_currency_AUD_37A046259A976EAE74DFD4ED4B5ABB8E" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1C1E2FC6B398B9E14AE5D4ED4B5ABBB7" xlink:to="loc_currency_AUD_37A046259A976EAE74DFD4ED4B5ABB8E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4D57C11CD6BF825AF0CDD4ED4B5A0FE7" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4D57C11CD6BF825AF0CDD4ED4B5A0FE7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4D57C11CD6BF825AF0CDD4ED4B5A0FE7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaap_SalesMember_CBA265A100FC2D384608D4ED4B5A74F3" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363" xlink:to="loc_us-gaap_SalesMember_CBA265A100FC2D384608D4ED4B5A74F3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_10DEF585FBA44B140919D4ED4B5A76E0" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F2B9418866F2777F4C3ED4ED4B5A5363" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_10DEF585FBA44B140919D4ED4B5A76E0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8F2AC0A40395954C3566D4ED4B5A5A61" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8F2AC0A40395954C3566D4ED4B5A5A61" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9F29738DF6A88650056AD4ED4B5A3CD6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8F2AC0A40395954C3566D4ED4B5A5A61" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9F29738DF6A88650056AD4ED4B5A3CD6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_55DB65EE47E17BCC71BAD4ED4B5BDFAA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9F29738DF6A88650056AD4ED4B5A3CD6" xlink:to="loc_us-gaap_ForeignExchangeContractMember_55DB65EE47E17BCC71BAD4ED4B5BDFAA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_B728CC373CE1D50C7177D4ED4B5BEA02" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_B728CC373CE1D50C7177D4ED4B5BEA02" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_BC52ABFA2B6ED560D76CD4ED4B5BC63E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_B728CC373CE1D50C7177D4ED4B5BEA02" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_BC52ABFA2B6ED560D76CD4ED4B5BC63E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherCurrentAssetsMember" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_2BD715A360241BDF7E68D4ED4B5B1696" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_BC52ABFA2B6ED560D76CD4ED4B5BC63E" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_2BD715A360241BDF7E68D4ED4B5B1696" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherInvestmentsMember" xlink:label="loc_us-gaap_OtherInvestmentsMember_FBF2DB0CA630B09B7321D4ED4B5B66FB" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_BC52ABFA2B6ED560D76CD4ED4B5BC63E" xlink:to="loc_us-gaap_OtherInvestmentsMember_FBF2DB0CA630B09B7321D4ED4B5B66FB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesMember" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_8C75C9C62E4C905B70CAD4ED4B5BF177" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_BC52ABFA2B6ED560D76CD4ED4B5BC63E" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_8C75C9C62E4C905B70CAD4ED4B5BF177" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_D8E8381E227F65503630D4ED4B5B522F" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_BC52ABFA2B6ED560D76CD4ED4B5BC63E" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_D8E8381E227F65503630D4ED4B5B522F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_3724493CC8DA8F9E9D49D4ED4B5BD24D" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:to="loc_us-gaap_HedgingDesignationAxis_3724493CC8DA8F9E9D49D4ED4B5BD24D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_3724493CC8DA8F9E9D49D4ED4B5BD24D" xlink:to="loc_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4435752E4D7397598BA9D4ED4B5B1F56" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4435752E4D7397598BA9D4ED4B5B1F56" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_41D6C827586978CCE3CFD4ED4B5B1780" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_75CDF1EEA49FDBF88BD2D4ED4B5B9B33" xlink:to="loc_us-gaap_NondesignatedMember_41D6C827586978CCE3CFD4ED4B5B1780" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_787295BE833F77FC8631D4ED4B5BFA8D" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_B1B2F3EC25DB8B787059D4ED4B5AF57A" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_787295BE833F77FC8631D4ED4B5BFA8D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeAssetFairValueNetAbstract" xlink:label="loc_us-gaap_DerivativeAssetFairValueNetAbstract_CCC7F6D95BC9CAE4389FD4ED4B5B0F10" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_787295BE833F77FC8631D4ED4B5BFA8D" xlink:to="loc_us-gaap_DerivativeAssetFairValueNetAbstract_CCC7F6D95BC9CAE4389FD4ED4B5B0F10" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_FFC1E2F2CA1451D76B8ED4ED4B5BF90F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetFairValueNetAbstract_CCC7F6D95BC9CAE4389FD4ED4B5B0F10" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_FFC1E2F2CA1451D76B8ED4ED4B5BF90F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5F671231BB164232B337D4ED4B5C0453" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetFairValueNetAbstract_CCC7F6D95BC9CAE4389FD4ED4B5B0F10" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5F671231BB164232B337D4ED4B5C0453" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_DerivativeInstrumentsTextualAbstract" xlink:label="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_787295BE833F77FC8631D4ED4B5BFA8D" xlink:to="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeLowerRemainingMaturityRange1" xlink:label="loc_us-gaap_DerivativeLowerRemainingMaturityRange1_26AFBEBBEA296AF40D02D4ED4B5CBEE4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_us-gaap_DerivativeLowerRemainingMaturityRange1_26AFBEBBEA296AF40D02D4ED4B5CBEE4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeHigherRemainingMaturityRange1" xlink:label="loc_us-gaap_DerivativeHigherRemainingMaturityRange1_4709E1E1B875A9894E1FD4ED4B5CCF78" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_us-gaap_DerivativeHigherRemainingMaturityRange1_4709E1E1B875A9894E1FD4ED4B5CCF78" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="loc_invest_DerivativeNotionalAmount_3F1C2437A7D213ACEFA3D4ED4B5C7AB2" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_invest_DerivativeNotionalAmount_3F1C2437A7D213ACEFA3D4ED4B5C7AB2" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax" xlink:label="loc_biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax_4F715EEFEF835B84273AD4ED4B5CCE85" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax_4F715EEFEF835B84273AD4ED4B5CCE85" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_8F00757D094CEE3704E8D4ED4B5C50C3" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_8F00757D094CEE3704E8D4ED4B5C50C3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_A7133ECB602F912EC3F0D4ED4B5C74FE" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_A7133ECB602F912EC3F0D4ED4B5C74FE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_D2E9352C84A1DF8CE207D4ED4B5CD2ED" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_D2E9352C84A1DF8CE207D4ED4B5CD2ED" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_D2E39B9A13F28980A6F0D4ED4B5C92AA" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DerivativeInstrumentsTextualAbstract_D8D16AF3624915839E20D4ED4B5CCF6F" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_D2E39B9A13F28980A6F0D4ED4B5C92AA" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/DerivativeInstrumentsTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_B5865B6439874396E131D4ED4B7BB6EA" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_29BC8F698B8F6C97A77CD4ED4B7BE39D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_B5865B6439874396E131D4ED4B7BB6EA" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_29BC8F698B8F6C97A77CD4ED4B7BE39D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_0C4D52FD218996B40BD0D4ED4B7C32AD" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_B5865B6439874396E131D4ED4B7BB6EA" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_0C4D52FD218996B40BD0D4ED4B7C32AD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_EB563DE5D1259105BA0BD4ED4B7C8623" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_B5865B6439874396E131D4ED4B7BB6EA" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_EB563DE5D1259105BA0BD4ED4B7C8623" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <loc xlink:href="biib-20150630.xsd#biib_DocumentAndEntityInformationAbstract" xlink:label="loc_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:type="locator" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_943BD0DB5E96077E2409D4ED4B833781" xlink:type="locator" />
    <presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:to="loc_dei_EntityRegistrantName_943BD0DB5E96077E2409D4ED4B833781" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_7930E4CFA52B545E80E4D4ED4B8317ED" xlink:type="locator" />
    <presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:to="loc_dei_EntityCentralIndexKey_7930E4CFA52B545E80E4D4ED4B8317ED" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_CE4C795F3063A981019CD4ED4B835CF8" xlink:type="locator" />
    <presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:to="loc_dei_CurrentFiscalYearEndDate_CE4C795F3063A981019CD4ED4B835CF8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_7140091D220BA565C5B3D4ED4B83CE06" xlink:type="locator" />
    <presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:to="loc_dei_EntityFilerCategory_7140091D220BA565C5B3D4ED4B83CE06" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_9A57A9BD281955F5EDD3D4ED4B8369FF" xlink:type="locator" />
    <presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:to="loc_dei_DocumentType_9A57A9BD281955F5EDD3D4ED4B8369FF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_4990BD73BF5AB22FC607D4ED4B8360D6" xlink:type="locator" />
    <presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:to="loc_dei_DocumentPeriodEndDate_4990BD73BF5AB22FC607D4ED4B8360D6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_40C1BA6EDB3FCFCD8F9BD4ED4B8383A9" xlink:type="locator" />
    <presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:to="loc_dei_DocumentFiscalYearFocus_40C1BA6EDB3FCFCD8F9BD4ED4B8383A9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_70288413A985B6199EF4D4ED4B83F78B" xlink:type="locator" />
    <presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:to="loc_dei_DocumentFiscalPeriodFocus_70288413A985B6199EF4D4ED4B83F78B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_576E9AC27B8052C5ACD8D4ED4B84BE9B" xlink:type="locator" />
    <presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:to="loc_dei_AmendmentFlag_576E9AC27B8052C5ACD8D4ED4B84BE9B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_10592DB75CB12D3CEDA5D4ED4B84A11D" xlink:type="locator" />
    <presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_DocumentAndEntityInformationAbstract_679EF5AFC41F378A4CDBD4ED4B8325E6" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_10592DB75CB12D3CEDA5D4ED4B84A11D" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/EarningsPerShare" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_C95BE646BAD38A2EFC60D4ED4B928E47" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_46E9F7E83F7FDEBAD687D4ED4B92A4B4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_C95BE646BAD38A2EFC60D4ED4B928E47" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_46E9F7E83F7FDEBAD687D4ED4B92A4B4" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/EarningsPerShareDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_A5C97F0E70CA31D479E1DEA10B9EDEDC" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5A64CC1EA7D82DD9971EDEA10B9EA550" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_A5C97F0E70CA31D479E1DEA10B9EDEDC" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5A64CC1EA7D82DD9971EDEA10B9EA550" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_AD64938197DE562A882FDEA10B9ECC34" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5A64CC1EA7D82DD9971EDEA10B9EA550" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_AD64938197DE562A882FDEA10B9ECC34" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_AD64938197DE562A882FDEA10B9ECC34" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_StockOptionsAndEmployeeStockPurchasePlanMember" xlink:label="loc_biib_StockOptionsAndEmployeeStockPurchasePlanMember_2E2DE22F4266CCE288DEDEA10B9E5E38" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0" xlink:to="loc_biib_StockOptionsAndEmployeeStockPurchasePlanMember_2E2DE22F4266CCE288DEDEA10B9E5E38" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_TimeVestedRestrictedStockUnitsMember" xlink:label="loc_biib_TimeVestedRestrictedStockUnitsMember_5C5BC22231CF9323CFFCDEA10B9EA7F5" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0" xlink:to="loc_biib_TimeVestedRestrictedStockUnitsMember_5C5BC22231CF9323CFFCDEA10B9EA7F5" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_MarketStockUnitsMember" xlink:label="loc_biib_MarketStockUnitsMember_5ED63919E84E581DB0C6DEA10B9E2084" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1A1C9284504F37F22E41DEA10B9E86A0" xlink:to="loc_biib_MarketStockUnitsMember_5ED63919E84E581DB0C6DEA10B9E2084" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5376DD131B7A3DBE1DF6DEA10B9EDEA7" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5A64CC1EA7D82DD9971EDEA10B9EA550" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5376DD131B7A3DBE1DF6DEA10B9EDEA7" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_BasicAndDilutedEarningsPerShareAbstract" xlink:label="loc_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5376DD131B7A3DBE1DF6DEA10B9EDEA7" xlink:to="loc_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="loc_us-gaap_NetIncomeLossAbstract_B74946F5CF3FE72EEDD3DEC797A68E08" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19" xlink:to="loc_us-gaap_NetIncomeLossAbstract_B74946F5CF3FE72EEDD3DEC797A68E08" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_9CB4D395DD41609F1C4CDEA10B9E9666" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_B74946F5CF3FE72EEDD3DEC797A68E08" xlink:to="loc_us-gaap_NetIncomeLoss_9CB4D395DD41609F1C4CDEA10B9E9666" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_BasicAndDilutedEarningsPerShareAbstract_5AE4095983A00FF459BFDEA10B9E2C19" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0280810FA59633A90996DEA10B9ECE3C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0280810FA59633A90996DEA10B9ECE3C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_8F037D5DA7B8FE6A4D16DEA10B9E68C6" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_8F037D5DA7B8FE6A4D16DEA10B9E68C6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_EF2DAD1E1F4C29C0FC56DEA10B9E11D8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_8F037D5DA7B8FE6A4D16DEA10B9E68C6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_EF2DAD1E1F4C29C0FC56DEA10B9E11D8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7A625A5924EBAB18732CDEA10B9F3E62" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_8F037D5DA7B8FE6A4D16DEA10B9E68C6" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7A625A5924EBAB18732CDEA10B9F3E62" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2B695AD78AFABFA0A8ACDEA10B9F203F" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1DEC288C6BC7B1FA8B1FDEC808AB7574" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2B695AD78AFABFA0A8ACDEA10B9F203F" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/EarningsPerShareTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7EBF7A93C5A4A774F06DD4ED4B90ADAB" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EA6F173D10171822C2B0D4ED4B90A812" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7EBF7A93C5A4A774F06DD4ED4B90ADAB" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EA6F173D10171822C2B0D4ED4B90A812" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/Equity" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_188957FBFE1A57BEBFC4D4ED4B94B328" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_D43D41004B9ABFE7749CD4ED4B94CF3A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_188957FBFE1A57BEBFC4D4ED4B94B328" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_D43D41004B9ABFE7749CD4ED4B94CF3A" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/EquityDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_6D663FA4EAB950614723B7291AF7438F" xlink:type="locator" />
    <loc xlink:href="biib-20150630.xsd#biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract" xlink:label="loc_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6D663FA4EAB950614723B7291AF7438F" xlink:to="loc_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_19445903D07ACCB89687B7291AFBC8BB" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31" xlink:to="loc_us-gaap_MinorityInterest_19445903D07ACCB89687B7291AFBC8BB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_CF40AD7BC69E6073B8D1B7291AFB8C65" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_CF40AD7BC69E6073B8D1B7291AFB8C65" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8D367119D69B1B9673B7B7291AFB7E78" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8D367119D69B1B9673B7B7291AFB7E78" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93933BA76E23E7B88FD6B7291AFBEBAC" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93933BA76E23E7B88FD6B7291AFBEBAC" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_Noncontrollinginterestincreasedecreaseother" xlink:label="loc_biib_Noncontrollinginterestincreasedecreaseother_495E8A503936DFC90BB3B7291AFBD213" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31" xlink:to="loc_biib_Noncontrollinginterestincreasedecreaseother_495E8A503936DFC90BB3B7291AFBD213" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_15C3E7A75C9C09199EA4B7291AFBB1F0" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract_AD47E781D57D81873935B7291AFB0D31" xlink:to="loc_us-gaap_MinorityInterest_15C3E7A75C9C09199EA4B7291AFBB1F0" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/EquityDetailsTextual" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_8DB0328BA8438D80ED6EB7291AFF9072" xlink:type="locator" />
    <loc xlink:href="biib-20150630.xsd#biib_EquityTextualAbstract" xlink:label="loc_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8DB0328BA8438D80ED6EB7291AFF9072" xlink:to="loc_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_F7FBA8DEFDEBF406E4AAB7291AFF54FC" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_F7FBA8DEFDEBF406E4AAB7291AFF54FC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2BCB1C9457F8F56AC41BB7291AFF33DF" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2BCB1C9457F8F56AC41BB7291AFF33DF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_C224A0ACEC5BCD15F9BDB7291AFFFF95" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_C224A0ACEC5BCD15F9BDB7291AFFFF95" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_31B3915C8AF7A061015CB7291AFF1EA6" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_31B3915C8AF7A061015CB7291AFF1EA6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1F0ABFF15CC83C36FA8CB7291AFFB1B2" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_EquityTextualAbstract_DDE82D48AE6C06CDFF0DB7291AFFDBCA" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1F0ABFF15CC83C36FA8CB7291AFFB1B2" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/EquityTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_A2428234848F2EC00F9CD4ED4B6BA77F" xlink:type="locator" />
    <loc xlink:href="biib-20150630.xsd#biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock" xlink:label="loc_biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock_2AD1885248E116AD87ABD4ED4B6B9EBD" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_A2428234848F2EC00F9CD4ED4B6BA77F" xlink:to="loc_biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock_2AD1885248E116AD87ABD4ED4B6B9EBD" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurements" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_A7268D31D616174B8528D4ED4B0FB960" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_71901E9F58E99655025ED4ED4B0FB4D8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_A7268D31D616174B8528D4ED4B0FB960" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_71901E9F58E99655025ED4ED4B0FB4D8" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_DBC5CE3C655BB2CE25B4D4ED4B77CE95" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_DBC5CE3C655BB2CE25B4D4ED4B77CE95" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3F420A63E1A6BD51BBBFD4ED4B77EC41" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3F420A63E1A6BD51BBBFD4ED4B77EC41" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3F420A63E1A6BD51BBBFD4ED4B77EC41" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_C73C572BBB2E22D4A1E1D4ED4B78AD1E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_C73C572BBB2E22D4A1E1D4ED4B78AD1E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_CF59A14D69696973B8BED4ED4B78697E" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_CF59A14D69696973B8BED4ED4B78697E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_B2D9EE9CB62507CE22F4D4ED4B7839C3" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CFD51404A0FF2C97C6ADD4ED4B7831F0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_B2D9EE9CB62507CE22F4D4ED4B7839C3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A57E86007D93D16CF343D4ED4B78E337" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A57E86007D93D16CF343D4ED4B78E337" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_727944FED3607E8BF378D4ED4B78EBC5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A57E86007D93D16CF343D4ED4B78E337" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_727944FED3607E8BF378D4ED4B78EBC5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_406890C909979751E0F6D4ED4B782705" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_727944FED3607E8BF378D4ED4B78EBC5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_406890C909979751E0F6D4ED4B782705" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_ABD0E6126B5F12975143D4ED4B7895E0" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_ABD0E6126B5F12975143D4ED4B7895E0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_ABD0E6126B5F12975143D4ED4B7895E0" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_11CA350A2A4AF10B7B0BD4ED4B78B81D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_11CA350A2A4AF10B7B0BD4ED4B78B81D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_FFF75F698D9DC9D5AD10D4ED4B78124F" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_FFF75F698D9DC9D5AD10D4ED4B78124F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetBackedSecuritiesMember" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_162C69580FD5FDC6F6D0D4ED4B79F01E" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_69BDA4545D5C31B577A2D4ED4B7826E6" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_162C69580FD5FDC6F6D0D4ED4B79F01E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BFE2BE4A3569F036496D4ED4B79E07D" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5DA31CC2DCE00B38A0F3D4ED4B772339" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BFE2BE4A3569F036496D4ED4B79E07D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_7539103107ECE2935B80D4ED4B790708" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BFE2BE4A3569F036496D4ED4B79E07D" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_7539103107ECE2935B80D4ED4B790708" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_7539103107ECE2935B80D4ED4B790708" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_92A3263B6F6D5335A841D4ED4B79CBD8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_92A3263B6F6D5335A841D4ED4B79CBD8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_A9BA9FAE24BCD64FFC4DD4ED4B79FFC5" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:to="loc_us-gaap_AvailableForSaleSecurities_A9BA9FAE24BCD64FFC4DD4ED4B79FFC5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_8C9079D0621322E80590D4ED4B79B4F6" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_8C9079D0621322E80590D4ED4B79B4F6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_B2ED7F7E4A7C40506320D4ED4B79FBD9" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_B2ED7F7E4A7C40506320D4ED4B79FBD9" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_PlanAssetsForDeferredCompensationFairValueDisclosure" xlink:label="loc_biib_PlanAssetsForDeferredCompensationFairValueDisclosure_EFC1DD2764FF6F26EB51D4ED4B79BDF2" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:to="loc_biib_PlanAssetsForDeferredCompensationFairValueDisclosure_EFC1DD2764FF6F26EB51D4ED4B79BDF2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6600961CA4F8EA1CF787D4ED4B79AD64" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59056C5F926D837B07B3D4ED4B799129" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_6600961CA4F8EA1CF787D4ED4B79AD64" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_7539103107ECE2935B80D4ED4B790708" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_AA0886088669242687CFD4ED4B79B967" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_AA0886088669242687CFD4ED4B79B967" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_A92EA42202FFE95C114FD4ED4B799938" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_A92EA42202FFE95C114FD4ED4B799938" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_5013B0A407E147FD684DD4ED4B79282E" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7F2D97CDCBFA6749CE97D4ED4B79B964" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_5013B0A407E147FD684DD4ED4B79282E" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurementsDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7347DF8FE307F12A7D98DEA10BF4898C" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_41E3DFD6AD1E19F0CE89DEA10BF4A08E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7347DF8FE307F12A7D98DEA10BF4898C" xlink:to="loc_us-gaap_DebtInstrumentTable_41E3DFD6AD1E19F0CE89DEA10BF4A08E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_DD3A001412E321779155DEA10BF451E0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_41E3DFD6AD1E19F0CE89DEA10BF4A08E" xlink:to="loc_us-gaap_DebtInstrumentAxis_DD3A001412E321779155DEA10BF451E0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_DD3A001412E321779155DEA10BF451E0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_NotesPayableToFumedicaMember" xlink:label="loc_biib_NotesPayableToFumedicaMember_61B81A0B8DDA9CAFAADDDEA10BF43017" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5" xlink:to="loc_biib_NotesPayableToFumedicaMember_61B81A0B8DDA9CAFAADDDEA10BF43017" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember" xlink:label="loc_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_2ACCD89813F0A541CB7EDEA10BF452A2" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D1F4BEA2E965572D7B48DEA10BF4CFD5" xlink:to="loc_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_2ACCD89813F0A541CB7EDEA10BF452A2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_41E3DFD6AD1E19F0CE89DEA10BF4A08E" xlink:to="loc_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayableFairValueDisclosure" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_E8E18F3CD2D2173B3173DEA10BF4F079" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3" xlink:to="loc_us-gaap_NotesPayableFairValueDisclosure_E8E18F3CD2D2173B3173DEA10BF4F079" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable_BF7EA7C5E6B87B3589B1DEA10BF4E1AF" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3" xlink:to="loc_us-gaap_NotesPayable_BF7EA7C5E6B87B3589B1DEA10BF4E1AF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_868F0F220D0C41053F80DEA10BF489B0" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_333403F1FF64A6D55EF8DEA10BF4A6C3" xlink:to="loc_us-gaap_DebtInstrumentFairValue_868F0F220D0C41053F80DEA10BF489B0" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurementsDetails2" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0DE8B0D80363F158E993D4ED4B9E2E21" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5776A1E721148908E34AD4ED4B9EC173" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0DE8B0D80363F158E993D4ED4B9E2E21" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5776A1E721148908E34AD4ED4B9EC173" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_050BB8F03D6370CA971ED4ED4B9E6205" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5776A1E721148908E34AD4ED4B9EC173" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_050BB8F03D6370CA971ED4ED4B9E6205" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_CDAA4148C51380907065D4ED4B9ED497" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_050BB8F03D6370CA971ED4ED4B9E6205" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_CDAA4148C51380907065D4ED4B9ED497" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_AC2366FAC469CBA31A90D4ED4B9E683F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_CDAA4148C51380907065D4ED4B9ED497" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_AC2366FAC469CBA31A90D4ED4B9E683F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_BFE1A62CD2E031B931A7D4ED4B9E325B" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5776A1E721148908E34AD4ED4B9EC173" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_BFE1A62CD2E031B931A7D4ED4B9E325B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_79BEDD1D329223FB9444D4ED4B9EB371" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_BFE1A62CD2E031B931A7D4ED4B9E325B" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_79BEDD1D329223FB9444D4ED4B9EB371" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_78E838D2DB339FA78B23D4ED4B9F777D" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_BFE1A62CD2E031B931A7D4ED4B9E325B" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_78E838D2DB339FA78B23D4ED4B9F777D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AB818D1AED385C99FC95D4ED4B9FC558" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_BFE1A62CD2E031B931A7D4ED4B9E325B" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AB818D1AED385C99FC95D4ED4B9FC558" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_351C0CDD58C4FC47837FD4ED4B9F930D" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_BFE1A62CD2E031B931A7D4ED4B9E325B" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_351C0CDD58C4FC47837FD4ED4B9F930D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_EB3F5BCD6489E8C3D4A8D4ED4B9F0BF6" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_BFE1A62CD2E031B931A7D4ED4B9E325B" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_EB3F5BCD6489E8C3D4A8D4ED4B9F0BF6" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurementsDetailsTextual" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_891CC798594697C891CDD4ED4AEE5272" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8404BA6810FED2430816D4ED4AEEB552" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_891CC798594697C891CDD4ED4AEE5272" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8404BA6810FED2430816D4ED4AEEB552" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_F78A024BE4691D006B5DD4ED4AEE3730" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8404BA6810FED2430816D4ED4AEEB552" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_F78A024BE4691D006B5DD4ED4AEE3730" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_485B838AD3814EB2CD72D4ED4AEF4FDF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_F78A024BE4691D006B5DD4ED4AEE3730" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_485B838AD3814EB2CD72D4ED4AEF4FDF" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ConvergencePharmaceuticalsMember" xlink:label="loc_biib_ConvergencePharmaceuticalsMember_E6B0B0DD38457CACDA3DD4ED4AEF2FFC" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_485B838AD3814EB2CD72D4ED4AEF4FDF" xlink:to="loc_biib_ConvergencePharmaceuticalsMember_E6B0B0DD38457CACDA3DD4ED4AEF2FFC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_14CB2C95999FA69FE911D4ED4AEF7569" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8404BA6810FED2430816D4ED4AEEB552" xlink:to="loc_us-gaap_DebtInstrumentAxis_14CB2C95999FA69FE911D4ED4AEF7569" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_960568CFD75525F2670ED4ED4AEF9960" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_14CB2C95999FA69FE911D4ED4AEF7569" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_960568CFD75525F2670ED4ED4AEF9960" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember" xlink:label="loc_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_C7BDB378E29D80BD1A51D4ED4AEF727C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_960568CFD75525F2670ED4ED4AEF9960" xlink:to="loc_biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember_C7BDB378E29D80BD1A51D4ED4AEF727C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:type="locator" />
    <presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8404BA6810FED2430816D4ED4AEEB552" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_05231476781940512275D4ED4AEFF04B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_us-gaap_AssetImpairmentCharges_05231476781940512275D4ED4AEFF04B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsChangesInValuationTechniques" xlink:label="loc_us-gaap_FairValueMeasurementsChangesInValuationTechniques_DF6854000D7B6A94C92DD4ED4AEFAA16" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_us-gaap_FairValueMeasurementsChangesInValuationTechniques_DF6854000D7B6A94C92DD4ED4AEFAA16" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1E6F980D15FFB430E648D4ED4AEF1532" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1E6F980D15FFB430E648D4ED4AEF1532" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_B60452F849ED23D73A81D4ED4AEFE03D" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_B60452F849ED23D73A81D4ED4AEFE03D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_64029F3D755DD17F4A1CD4ED4AEF47E8" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_64029F3D755DD17F4A1CD4ED4AEF47E8" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately" xlink:label="loc_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_31FB46AA4D466E0C7F19D4ED4AEFA66F" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_31FB46AA4D466E0C7F19D4ED4AEFA66F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="loc_us-gaap_FairValueInputsDiscountRate_584A15A0FDB52B67FC6CD4ED4AEF4B67" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_us-gaap_FairValueInputsDiscountRate_584A15A0FDB52B67FC6CD4ED4AEF4B67" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_AACE4F1AB1916E954C7DD4ED4AF0D4AC" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_C4A2588A7F1655F6F80AD4ED4AEF8DA4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_AACE4F1AB1916E954C7DD4ED4AF0D4AC" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_E0AA27A4DBA210BC5D2CDEA10C005FFE" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2480CECFFA65CF9877F4DEA10C01C873" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_E0AA27A4DBA210BC5D2CDEA10C005FFE" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2480CECFFA65CF9877F4DEA10C01C873" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_E7A9ADB6C440655DDB74DEA49CA08605" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_E0AA27A4DBA210BC5D2CDEA10C005FFE" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_E7A9ADB6C440655DDB74DEA49CA08605" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9C5DAC3D80B3EF38B729DEA10C0164F9" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_E0AA27A4DBA210BC5D2CDEA10C005FFE" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9C5DAC3D80B3EF38B729DEA10C0164F9" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/FinancialInstruments" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_EC8AB591A1E296047C60DEAB5A83851F" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_097B785D89563C4890C2DEA10BE555A6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_EC8AB591A1E296047C60DEAB5A83851F" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_097B785D89563C4890C2DEA10BE555A6" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_AFF36B15981C4EE0B71EDEB09F5F32C6" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_774A07EA8900DFB11C4CDEA10BE0BC9F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_AFF36B15981C4EE0B71EDEB09F5F32C6" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_774A07EA8900DFB11C4CDEA10BE0BC9F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_7911595DFD8572A51BBCDEA10BE05BB6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_774A07EA8900DFB11C4CDEA10BE0BC9F" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_7911595DFD8572A51BBCDEA10BE05BB6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_FC8387380A0B2EDF96A7DEA10BE0A11D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_7911595DFD8572A51BBCDEA10BE05BB6" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_FC8387380A0B2EDF96A7DEA10BE0A11D" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CorporateDebtSecuritiesCurrentMember" xlink:label="loc_biib_CorporateDebtSecuritiesCurrentMember_134034B6DAABC9ACDB4EDEA10BE0748E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_FC8387380A0B2EDF96A7DEA10BE0A11D" xlink:to="loc_biib_CorporateDebtSecuritiesCurrentMember_134034B6DAABC9ACDB4EDEA10BE0748E" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CorporateDebtSecuritiesNonCurrentMember" xlink:label="loc_biib_CorporateDebtSecuritiesNonCurrentMember_22EE8E7101501F623A7CDEA10BE0A7F8" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_FC8387380A0B2EDF96A7DEA10BE0A11D" xlink:to="loc_biib_CorporateDebtSecuritiesNonCurrentMember_22EE8E7101501F623A7CDEA10BE0A7F8" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_GovernmentSecuritiesCurrentMember" xlink:label="loc_biib_GovernmentSecuritiesCurrentMember_74D5AE752D464A3EDBA2DEA10BE0AC9D" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_FC8387380A0B2EDF96A7DEA10BE0A11D" xlink:to="loc_biib_GovernmentSecuritiesCurrentMember_74D5AE752D464A3EDBA2DEA10BE0AC9D" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_GovernmentSecuritiesNonCurrentMember" xlink:label="loc_biib_GovernmentSecuritiesNonCurrentMember_CDF0A0573E6A48895F0FDEA10BE19F59" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_FC8387380A0B2EDF96A7DEA10BE0A11D" xlink:to="loc_biib_GovernmentSecuritiesNonCurrentMember_CDF0A0573E6A48895F0FDEA10BE19F59" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember" xlink:label="loc_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember_C11EBB7135178754438CDEA10BE1454B" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_FC8387380A0B2EDF96A7DEA10BE0A11D" xlink:to="loc_biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember_C11EBB7135178754438CDEA10BE1454B" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember" xlink:label="loc_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember_3A0787E3EAD0215DC021DEA10BE1F5CD" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_FC8387380A0B2EDF96A7DEA10BE0A11D" xlink:to="loc_biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember_3A0787E3EAD0215DC021DEA10BE1F5CD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaap_EquitySecuritiesMember_B2242D11979ECCF722F8DEB1C5E9C60D" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_FC8387380A0B2EDF96A7DEA10BE0A11D" xlink:to="loc_us-gaap_EquitySecuritiesMember_B2242D11979ECCF722F8DEB1C5E9C60D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_52680172CCC1D98000F1DEA10BE107D3" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_774A07EA8900DFB11C4CDEA10BE0BC9F" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_52680172CCC1D98000F1DEA10BE107D3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_5A6B9C4D5364FD86C719DEA10BE1E6D1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_52680172CCC1D98000F1DEA10BE107D3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_5A6B9C4D5364FD86C719DEA10BE1E6D1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_88789E98F1F8D19AC6AADEA10BE12DC2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_5A6B9C4D5364FD86C719DEA10BE1E6D1" xlink:to="loc_us-gaap_AvailableForSaleSecurities_88789E98F1F8D19AC6AADEA10BE12DC2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_AE187B6FFAB14F361C30DEA10BE1944B" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_5A6B9C4D5364FD86C719DEA10BE1E6D1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_AE187B6FFAB14F361C30DEA10BE1944B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_AD5B39BB3B0B9741B948DEA10BE1FFCA" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_5A6B9C4D5364FD86C719DEA10BE1E6D1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_AD5B39BB3B0B9741B948DEA10BE1FFCA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAmortizedCost_3923BCB374B48BDBEB1EDEA10BE1D079" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_5A6B9C4D5364FD86C719DEA10BE1E6D1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAmortizedCost_3923BCB374B48BDBEB1EDEA10BE1D079" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1CF937352C80ADA8D3DFDEB33F88896D" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_55A4CBF003840D4D6330DEA10BD8A58D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1CF937352C80ADA8D3DFDEB33F88896D" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_55A4CBF003840D4D6330DEA10BD8A58D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_522F9547B94AA5608CCFDEA10BD99854" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_55A4CBF003840D4D6330DEA10BD8A58D" xlink:to="loc_us-gaap_InvestmentTypeAxis_522F9547B94AA5608CCFDEA10BD99854" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_F2C40004D1764E7FD418DEA10BD9A866" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_522F9547B94AA5608CCFDEA10BD99854" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_F2C40004D1764E7FD418DEA10BD9A866" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_1B56B35E3F191A28BAFDDEA10BD9AAC4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_F2C40004D1764E7FD418DEA10BD9A866" xlink:to="loc_us-gaap_CommercialPaperMember_1B56B35E3F191A28BAFDDEA10BD9AAC4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RepurchaseAgreementsMember" xlink:label="loc_us-gaap_RepurchaseAgreementsMember_6A6C111E237CEAF01728DEA10BD99B7A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_F2C40004D1764E7FD418DEA10BD9A866" xlink:to="loc_us-gaap_RepurchaseAgreementsMember_6A6C111E237CEAF01728DEA10BD99B7A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_F3A762B10DAA1CF9EF41DEA10BD9E9CE" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_F2C40004D1764E7FD418DEA10BD9A866" xlink:to="loc_us-gaap_MoneyMarketFundsMember_F3A762B10DAA1CF9EF41DEA10BD9E9CE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtSecuritiesMember" xlink:label="loc_us-gaap_DebtSecuritiesMember_040A5D0B33FDCEC4561FDEA10BD9E6FF" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_F2C40004D1764E7FD418DEA10BD9A866" xlink:to="loc_us-gaap_DebtSecuritiesMember_040A5D0B33FDCEC4561FDEA10BD9E6FF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_3D1869D7284230490470DEA10BD9EAFF" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_55A4CBF003840D4D6330DEA10BD8A58D" xlink:to="loc_us-gaap_CashAndCashEquivalentsLineItems_3D1869D7284230490470DEA10BD9EAFF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValueAbstract" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_2E06785E9DD331737DE9DEA10BD95575" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_3D1869D7284230490470DEA10BD9EAFF" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_2E06785E9DD331737DE9DEA10BD95575" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_3AF63C5F519C6FA15C22DEA10BD9208D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_2E06785E9DD331737DE9DEA10BD95575" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_3AF63C5F519C6FA15C22DEA10BD9208D" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsDetails2" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9BE69D5AC794E37E8D4EDEB3A57BF945" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_9D371625A2AC41B7010EDEA10BD50577" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9BE69D5AC794E37E8D4EDEB3A57BF945" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_9D371625A2AC41B7010EDEA10BD50577" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_33281B47CDAD7C1B2E5DDEA10BD54589" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_9D371625A2AC41B7010EDEA10BD50577" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_33281B47CDAD7C1B2E5DDEA10BD54589" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_5192A24AB20B29D96FDADEA10BD5D1C8" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_9D371625A2AC41B7010EDEA10BD50577" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_5192A24AB20B29D96FDADEA10BD5D1C8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_804E704D8E41CC78A026DEA10BD5B05C" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_9D371625A2AC41B7010EDEA10BD50577" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_804E704D8E41CC78A026DEA10BD5B05C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_D63D723CDB06C4205F16DEA10BD5956A" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_9D371625A2AC41B7010EDEA10BD50577" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_D63D723CDB06C4205F16DEA10BD5956A" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue" xlink:label="loc_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue_8E5981292938ECA3F1C3DEA10BD63DD1" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_9D371625A2AC41B7010EDEA10BD50577" xlink:to="loc_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue_8E5981292938ECA3F1C3DEA10BD63DD1" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost" xlink:label="loc_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost_D38F7B0F8838803F6075DEA10BD669B7" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_9D371625A2AC41B7010EDEA10BD50577" xlink:to="loc_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost_D38F7B0F8838803F6075DEA10BD669B7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_9D216B024A95E3E83C3FDEA10BD60F7D" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_9D371625A2AC41B7010EDEA10BD50577" xlink:to="loc_us-gaap_AvailableForSaleSecurities_9D216B024A95E3E83C3FDEA10BD60F7D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_35F3E286881F82A181DEDEA10BD6CC43" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_9D371625A2AC41B7010EDEA10BD50577" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_35F3E286881F82A181DEDEA10BD6CC43" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsDetails3" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9E54F00FDCEA0F458315DEB49ABDEE99" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_CD9A95D91C5AB9F9A2E8DEA10BCFB820" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9E54F00FDCEA0F458315DEB49ABDEE99" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_CD9A95D91C5AB9F9A2E8DEA10BCFB820" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGains" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGains_28FBDEE101F0891957C0DEA10BCF5738" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9E54F00FDCEA0F458315DEB49ABDEE99" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGains_28FBDEE101F0891957C0DEA10BCF5738" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses_02E2339294F1DD3D4C16DEA10BCFE241" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9E54F00FDCEA0F458315DEB49ABDEE99" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses_02E2339294F1DD3D4C16DEA10BCFE241" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsDetailsTextual" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4A1F9B2C8AE80E55EA7CB1DDA8742C65" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_721941F433104AA2560AB1DDA874C9FF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4A1F9B2C8AE80E55EA7CB1DDA8742C65" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_721941F433104AA2560AB1DDA874C9FF" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_Overnightreverserepurchaseagreementspercentoftotalassets" xlink:label="loc_biib_Overnightreverserepurchaseagreementspercentoftotalassets_3063314270AECCB9B66EB1DDA875CC54" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4A1F9B2C8AE80E55EA7CB1DDA8742C65" xlink:to="loc_biib_Overnightreverserepurchaseagreementspercentoftotalassets_3063314270AECCB9B66EB1DDA875CC54" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AverageMaturityOfMarketableSecurities" xlink:label="loc_biib_AverageMaturityOfMarketableSecurities_775DD57A2DA8CE927C2CB1DDA87526AF" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4A1F9B2C8AE80E55EA7CB1DDA8742C65" xlink:to="loc_biib_AverageMaturityOfMarketableSecurities_775DD57A2DA8CE927C2CB1DDA87526AF" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsFinancialInstrumentsDetailsTextual2" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_44CA8DF6BF75050CC32EB1DCEA1EDA06" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8419B024564E8404BFEBB1DCEA1E59DE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_44CA8DF6BF75050CC32EB1DCEA1EDA06" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8419B024564E8404BFEBB1DCEA1E59DE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_4624EFB02A7EC078D15EB1DCEA1E464C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8419B024564E8404BFEBB1DCEA1E59DE" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_4624EFB02A7EC078D15EB1DCEA1E464C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_D536225E4CAB547BD3C8B1DCEA1F6B42" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_4624EFB02A7EC078D15EB1DCEA1E464C" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_D536225E4CAB547BD3C8B1DCEA1F6B42" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_StrategicInvestmentsMember" xlink:label="loc_biib_StrategicInvestmentsMember_048890608606B482A22EB1DCEA1FBF6C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_D536225E4CAB547BD3C8B1DCEA1F6B42" xlink:to="loc_biib_StrategicInvestmentsMember_048890608606B482A22EB1DCEA1FBF6C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_D501520B817CDFEFC172B1DCEA1FFC9F" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8419B024564E8404BFEBB1DCEA1E59DE" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_D501520B817CDFEFC172B1DCEA1FFC9F" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_StrategicInvestmentPortfolio" xlink:label="loc_biib_StrategicInvestmentPortfolio_41E6DACE672C81ADF8A3B1DCEA208FAE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D501520B817CDFEFC172B1DCEA1FFC9F" xlink:to="loc_biib_StrategicInvestmentPortfolio_41E6DACE672C81ADF8A3B1DCEA208FAE" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_CA225EC33F5CA6121223DEABFF5EAFC6" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_80B81A3B4123319A281BDEA10BE41819" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_CA225EC33F5CA6121223DEABFF5EAFC6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_80B81A3B4123319A281BDEA10BE41819" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_43E6993A335545E873C7DEA10BE46C4B" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_CA225EC33F5CA6121223DEABFF5EAFC6" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_43E6993A335545E873C7DEA10BE46C4B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_664D0DDBD60453936567DEA10BE40BDF" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_CA225EC33F5CA6121223DEABFF5EAFC6" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_664D0DDBD60453936567DEA10BE40BDF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RealizedGainLossOnInvestmentsTableTextBlock" xlink:label="loc_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_C2501BDAA85E7F83E9CDDEA10BE44AA0" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_CA225EC33F5CA6121223DEABFF5EAFC6" xlink:to="loc_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_C2501BDAA85E7F83E9CDDEA10BE44AA0" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/IncomeTaxes" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_FDDF17E232B13CADA63ED4ED4B851DB7" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_EBE57A57562B85A8D1B2D4ED4B85DB8A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_FDDF17E232B13CADA63ED4ED4B851DB7" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_EBE57A57562B85A8D1B2D4ED4B85DB8A" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/IncomeTaxesDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_806235B8C5927AF2B0E2D4ED4B13CF1B" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_806235B8C5927AF2B0E2D4ED4B13CF1B" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_88A8BF2B79CD0321ABA4D4ED4B13BF51" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_88A8BF2B79CD0321ABA4D4ED4B13BF51" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_BA37BC185F83115E70E0D4ED4B146CCD" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_BA37BC185F83115E70E0D4ED4B146CCD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_80F161652E3E36648B53D4ED4B146AB2" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_80F161652E3E36648B53D4ED4B146AB2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_0F0F645680741778D61FD4ED4B147324" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_0F0F645680741778D61FD4ED4B147324" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization_16A4A278DB525C5DEEA0D4ED4B14F4DC" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization_16A4A278DB525C5DEEA0D4ED4B14F4DC" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction" xlink:label="loc_biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction_10A66FCCCCE2E5F72750D4ED4B14501E" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:to="loc_biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction_10A66FCCCCE2E5F72750D4ED4B14501E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_D9DAD6DD5F6AE7FED1A6D4ED4B147733" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_D9DAD6DD5F6AE7FED1A6D4ED4B147733" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1B18056E66DEACC55D8FD4ED4B14CD4D" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1B18056E66DEACC55D8FD4ED4B14CD4D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_C2CB11A4456DDE353CDAD4ED4B1421CD" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_970FFE8E92F38B1F1B3ED4ED4B1370ED" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_C2CB11A4456DDE353CDAD4ED4B1421CD" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/IncomeTaxesDetailsTextual" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6B8A5CC72B4970BFEBECDEA10B771186" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_159C68ED76735566F9C4DEA10B7727AA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6B8A5CC72B4970BFEBECDEA10B771186" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_159C68ED76735566F9C4DEA10B7727AA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaap_TaxPeriodAxis_860746713351A6F05094DEA10B77973A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_159C68ED76735566F9C4DEA10B7727AA" xlink:to="loc_us-gaap_TaxPeriodAxis_860746713351A6F05094DEA10B77973A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_860746713351A6F05094DEA10B77973A" xlink:to="loc_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxYear2007Member" xlink:label="loc_us-gaap_TaxYear2007Member_7CE988422CD297CD9237DEA10B77223C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476" xlink:to="loc_us-gaap_TaxYear2007Member_7CE988422CD297CD9237DEA10B77223C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxYear2008Member" xlink:label="loc_us-gaap_TaxYear2008Member_7E5D11CD969DBB792824DEA10B773ABD" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476" xlink:to="loc_us-gaap_TaxYear2008Member_7E5D11CD969DBB792824DEA10B773ABD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxYear2009Member" xlink:label="loc_us-gaap_TaxYear2009Member_47B581C8941FDEB9FEEADEA10B773C04" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_7C7AD48A41C7C6B8142BDEA10B77B476" xlink:to="loc_us-gaap_TaxYear2009Member_47B581C8941FDEB9FEEADEA10B773C04" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_159C68ED76735566F9C4DEA10B7727AA" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_713DB3C0DD8246480B77DEA10B774641" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_713DB3C0DD8246480B77DEA10B774641" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_88955348035C5F9B0D96DEA10B7778F5" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_88955348035C5F9B0D96DEA10B7778F5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_BD956E1149970342B8EDDECA941EB691" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_BD956E1149970342B8EDDECA941EB691" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices" xlink:label="loc_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices_8165E761FCCB4D382E7ADEA10B78CAE7" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_FEC7BEF7761C3B0CE597DEA10B77152C" xlink:to="loc_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices_8165E761FCCB4D382E7ADEA10B78CAE7" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/IncomeTaxesTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_625075F7FCC78FDFC886D4ED4B077D65" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8F253C91D5F057DB6CA8D4ED4B071C48" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_625075F7FCC78FDFC886D4ED4B077D65" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8F253C91D5F057DB6CA8D4ED4B071C48" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwill" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4190F6C7FB6063F44F34D4ED4B93D6E0" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_17D5904237133F4CBA0BD4ED4B933D53" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4190F6C7FB6063F44F34D4ED4B93D6E0" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_17D5904237133F4CBA0BD4ED4B933D53" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_192A2192116ED1CE4585DE9E11596451" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_192A2192116ED1CE4585DE9E11596451" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_DB7B50C2D001774BBE72DE9E115A010A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_DB7B50C2D001774BBE72DE9E115A010A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_51460370DCE44187EAAFDE9E115A3B04" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_DB7B50C2D001774BBE72DE9E115A010A" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_51460370DCE44187EAAFDE9E115A3B04" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ConvergencePharmaceuticalsMember" xlink:label="loc_biib_ConvergencePharmaceuticalsMember_1E71D81D323BB1790DF0DE9E115A56C7" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_51460370DCE44187EAAFDE9E115A3B04" xlink:to="loc_biib_ConvergencePharmaceuticalsMember_1E71D81D323BB1790DF0DE9E115A56C7" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_TysabriProductMember" xlink:label="loc_biib_TysabriProductMember_2B88A407CFA08F2F2481DE9E115A5A80" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_51460370DCE44187EAAFDE9E115A3B04" xlink:to="loc_biib_TysabriProductMember_2B88A407CFA08F2F2481DE9E115A5A80" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_36BD7858FFBDDD05BD39DE9E115A8000" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_36BD7858FFBDDD05BD39DE9E115A8000" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_36BD7858FFBDDD05BD39DE9E115A8000" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_18786B135B7CEAB6586BDE9E115A5EDB" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_18786B135B7CEAB6586BDE9E115A5EDB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_E906066BA6020A5543B0DE9E115A1CC4" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6EC875536A02793DC421DE9E115A0CB4" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_E906066BA6020A5543B0DE9E115A1CC4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86813380AE43BC1E5BE6DE9E115A141D" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86813380AE43BC1E5BE6DE9E115A141D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86813380AE43BC1E5BE6DE9E115A141D" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_OutLicensedPatentsMember" xlink:label="loc_biib_OutLicensedPatentsMember_CFDB88EF086B018518C1DE9E115A6258" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949" xlink:to="loc_biib_OutLicensedPatentsMember_CFDB88EF086B018518C1DE9E115A6258" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_0F7EECD74927743E0C01DE9E115BD98C" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_0F7EECD74927743E0C01DE9E115BD98C" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_InLicensedPatentsMember" xlink:label="loc_biib_InLicensedPatentsMember_B2D0F1D290209CC6140BDE9E115BB096" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_F0550EB69D78C309F044DE9E115A4949" xlink:to="loc_biib_InLicensedPatentsMember_B2D0F1D290209CC6140BDE9E115BB096" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_F404217FB9318C7EB26FDE9E115B3AD7" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:to="loc_us-gaap_ProductOrServiceAxis_F404217FB9318C7EB26FDE9E115B3AD7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_EB345572BC0783236773DE9E115B9826" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_F404217FB9318C7EB26FDE9E115B3AD7" xlink:to="loc_us-gaap_ProductsAndServicesDomain_EB345572BC0783236773DE9E115B9826" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AVONEXMember" xlink:label="loc_biib_AVONEXMember_B8E9A51DB32D533C6B8EDE9E115BE1D2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_EB345572BC0783236773DE9E115B9826" xlink:to="loc_biib_AVONEXMember_B8E9A51DB32D533C6B8EDE9E115BE1D2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_B29DEC769A323C35E6F8DE9E115B6B87" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:to="loc_us-gaap_RangeAxis_B29DEC769A323C35E6F8DE9E115B6B87" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_B29DEC769A323C35E6F8DE9E115B6B87" xlink:to="loc_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_BC27783AAFA599DE9C41DE9E115BCA7C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6" xlink:to="loc_us-gaap_MinimumMember_BC27783AAFA599DE9C41DE9E115BCA7C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_940809A63466F53766C7DE9E115BA2B1" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_657A8B9E795A43BE985EDE9E115B68E6" xlink:to="loc_us-gaap_MaximumMember_940809A63466F53766C7DE9E115BA2B1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_086420AD222AAC6BCFE7DE9E115B17E7" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23EEA270E3198C38B7B6DE9E115AA5E8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_086420AD222AAC6BCFE7DE9E115B17E7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_086420AD222AAC6BCFE7DE9E115B17E7" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0FBB889D181BE481BD60DE9E115BFF56" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0FBB889D181BE481BD60DE9E115BFF56" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_IndefiniteLivedIntangibleAssetsUsefulLife" xlink:label="loc_biib_IndefiniteLivedIntangibleAssetsUsefulLife_4A16125F74B672195EDDDE9E115BDF8C" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_biib_IndefiniteLivedIntangibleAssetsUsefulLife_4A16125F74B672195EDDDE9E115BDF8C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_86352CB02A79941AC242DE9E115B1A44" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_86352CB02A79941AC242DE9E115B1A44" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_D600447D01DF423BECD7DE9E115B2388" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_D600447D01DF423BECD7DE9E115B2388" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_155615B5CBD8A104E981DE9E115B19F0" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_155615B5CBD8A104E981DE9E115B19F0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_CA84C7805842F890007ADE9E115BF008" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_CA84C7805842F890007ADE9E115BF008" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_11BBDA22B795A4CBF251DE9E115B0B58" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_11BBDA22B795A4CBF251DE9E115B0B58" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_F452C9E4D9BF2E43FF08DE9E115C9679" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_F452C9E4D9BF2E43FF08DE9E115C9679" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_AD6204E90CA602702129DE9E115C228D" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_AD6204E90CA602702129DE9E115C228D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_67F52D1B2FE76FC2F2CADE9E115C181E" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94C5BEB765457AB16E10DE9E115B8958" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_67F52D1B2FE76FC2F2CADE9E115C181E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_DFB3492C84D00504071FDEA0EE5A320A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_192A2192116ED1CE4585DE9E11596451" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_DFB3492C84D00504071FDEA0EE5A320A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1763E4AEE5EF84737236DE9E115C0425" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_DFB3492C84D00504071FDEA0EE5A320A" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1763E4AEE5EF84737236DE9E115C0425" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_709DEDB62E38341F6495DE9E115C7CD9" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_DFB3492C84D00504071FDEA0EE5A320A" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_709DEDB62E38341F6495DE9E115C7CD9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0CF0D085255C9597EA42DE9E115C06A9" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_192A2192116ED1CE4585DE9E11596451" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0CF0D085255C9597EA42DE9E115C06A9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_B1D477A84BBA2B5A9A99DE9E115CB6BC" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_192A2192116ED1CE4585DE9E11596451" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_B1D477A84BBA2B5A9A99DE9E115CB6BC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_615B1BCE59D8A44E4ED8DE9E115C311E" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_192A2192116ED1CE4585DE9E11596451" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_615B1BCE59D8A44E4ED8DE9E115C311E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_337EA5B1036A89D3C0DFDE9E115C7542" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_192A2192116ED1CE4585DE9E11596451" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_337EA5B1036A89D3C0DFDE9E115C7542" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_95C12D9C03605328B422DE9E115CC080" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_192A2192116ED1CE4585DE9E11596451" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_95C12D9C03605328B422DE9E115CC080" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_3E69A3D3BD0E79138649DE9E115C341A" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_192A2192116ED1CE4585DE9E11596451" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_3E69A3D3BD0E79138649DE9E115C341A" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_Finitelivedintangibleassetsfutureamortization" xlink:label="loc_biib_Finitelivedintangibleassetsfutureamortization_C4D85A6705931AFB38E4DE9E115CDE3C" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_192A2192116ED1CE4585DE9E11596451" xlink:to="loc_biib_Finitelivedintangibleassetsfutureamortization_C4D85A6705931AFB38E4DE9E115CDE3C" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4CEE3572DF7ABD03F439D4ED4AFF3CF3" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4CEE3572DF7ABD03F439D4ED4AFF3CF3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_F0C91D7BB46709636CADD4ED4AFF4C74" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C" xlink:to="loc_us-gaap_ProductOrServiceAxis_F0C91D7BB46709636CADD4ED4AFF4C74" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_C2DD840C42E3E9C2B658D4ED4AFFC1E3" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_F0C91D7BB46709636CADD4ED4AFF4C74" xlink:to="loc_us-gaap_ProductsAndServicesDomain_C2DD840C42E3E9C2B658D4ED4AFFC1E3" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_TecfideraMember" xlink:label="loc_biib_TecfideraMember_6318475A6D1FD28E75E5D4ED4AFF1668" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_C2DD840C42E3E9C2B658D4ED4AFFC1E3" xlink:to="loc_biib_TecfideraMember_6318475A6D1FD28E75E5D4ED4AFF1668" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_BD53C95A653021AE1C8BD4ED4AFFD733" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_BD53C95A653021AE1C8BD4ED4AFFD733" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6EA0124CAD039623783ED4ED4B0054C4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_BD53C95A653021AE1C8BD4ED4AFFD733" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6EA0124CAD039623783ED4ED4B0054C4" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_FumapharmAgMember" xlink:label="loc_biib_FumapharmAgMember_54DC52B995468C4DCB56D4ED4B005FDA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6EA0124CAD039623783ED4ED4B0054C4" xlink:to="loc_biib_FumapharmAgMember_54DC52B995468C4DCB56D4ED4B005FDA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_97460C1B5E636C717AE8D4ED4B0074B6" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_F6AD9D27E1586F89AE71D4ED4AFF3B8C" xlink:to="loc_us-gaap_GoodwillLineItems_97460C1B5E636C717AE8D4ED4B0074B6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3089A30B005844353A94D4ED4B008AB9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_97460C1B5E636C717AE8D4ED4B0074B6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3089A30B005844353A94D4ED4B008AB9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_B0C69B6257F12125CF68D4ED4B00E433" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_97460C1B5E636C717AE8D4ED4B0074B6" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_B0C69B6257F12125CF68D4ED4B00E433" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_D142836F18365A42FF0AD4ED4B008AB4" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4CEE3572DF7ABD03F439D4ED4AFF3CF3" xlink:to="loc_us-gaap_GoodwillRollForward_D142836F18365A42FF0AD4ED4B008AB4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_6688FF1201135E2E9F80D4ED4B00B1DF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_D142836F18365A42FF0AD4ED4B008AB4" xlink:to="loc_us-gaap_Goodwill_6688FF1201135E2E9F80D4ED4B00B1DF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillOtherChanges" xlink:label="loc_us-gaap_GoodwillOtherChanges_57CA5DC8F45A94682FCAD4ED4B00C30A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_D142836F18365A42FF0AD4ED4B008AB4" xlink:to="loc_us-gaap_GoodwillOtherChanges_57CA5DC8F45A94682FCAD4ED4B00C30A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_0DD6BA9C1CEE8FEE7CF5D4ED4B00402C" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_D142836F18365A42FF0AD4ED4B008AB4" xlink:to="loc_us-gaap_Goodwill_0DD6BA9C1CEE8FEE7CF5D4ED4B00402C" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8FF2479ABC332C4532A6D4ED4B0E777D" xlink:type="locator" />
    <loc xlink:href="biib-20150630.xsd#biib_IntangibleAssetsExcludingGoodwillTableTextBlock" xlink:label="loc_biib_IntangibleAssetsExcludingGoodwillTableTextBlock_A5F6F8AABD2963C6B5EDD4ED4B0EA3D1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8FF2479ABC332C4532A6D4ED4B0E777D" xlink:to="loc_biib_IntangibleAssetsExcludingGoodwillTableTextBlock_A5F6F8AABD2963C6B5EDD4ED4B0EA3D1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_226F9F16FD5C521B4ACCD4ED4B0E4099" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8FF2479ABC332C4532A6D4ED4B0E777D" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_226F9F16FD5C521B4ACCD4ED4B0E4099" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_DADB28D732604B9F7A57D4ED4B0E9C74" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8FF2479ABC332C4532A6D4ED4B0E777D" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_DADB28D732604B9F7A57D4ED4B0E9C74" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/Inventory" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_1BF8A58589E6045F9DEFD4ED4ADDCD49" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_CFC0122DBDAC29294D95D4ED4ADD72D1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_1BF8A58589E6045F9DEFD4ED4ADDCD49" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_CFC0122DBDAC29294D95D4ED4ADD72D1" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/InventoryDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_D91F42D0613F33FC3477B1CFCCABFAF9" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNetAbstract" xlink:label="loc_us-gaap_InventoryNetAbstract_E5641F783A6A935932ACB1CFCCAC97ED" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_D91F42D0613F33FC3477B1CFCCABFAF9" xlink:to="loc_us-gaap_InventoryNetAbstract_E5641F783A6A935932ACB1CFCCAC97ED" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_497895B2A99A5B0A93D1B1CFCCACCE6D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_E5641F783A6A935932ACB1CFCCAC97ED" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_497895B2A99A5B0A93D1B1CFCCACCE6D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_005EB676F920D96DDEFBB1CFCCAC9A78" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_E5641F783A6A935932ACB1CFCCAC97ED" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_005EB676F920D96DDEFBB1CFCCAC9A78" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_DD5D7D591014BC37A2FDB1CFCCACDC60" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_E5641F783A6A935932ACB1CFCCAC97ED" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_DD5D7D591014BC37A2FDB1CFCCACDC60" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_7843651C2FA7387FAADFB1CFCCACF9F8" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_E5641F783A6A935932ACB1CFCCAC97ED" xlink:to="loc_us-gaap_InventoryNet_7843651C2FA7387FAADFB1CFCCACF9F8" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/InventoryInventoryDetailsTextual" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_DBE114E24B08C4587446B1D4CBFA352E" xlink:type="locator" />
    <loc xlink:href="biib-20150630.xsd#biib_InventoryVariousProgramsGross" xlink:label="loc_biib_InventoryVariousProgramsGross_21D2BE92F1209BD56E6DB1D56BB6B999" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_DBE114E24B08C4587446B1D4CBFA352E" xlink:to="loc_biib_InventoryVariousProgramsGross_21D2BE92F1209BD56E6DB1D56BB6B999" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/InventoryTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_842578B8684DEEC25435D4ED4B656B4F" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D2614C7AA25A1E6D2408D4ED4B65C16E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_842578B8684DEEC25435D4ED4B656B4F" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D2614C7AA25A1E6D2408D4ED4B65C16E" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/InvestmentsInVariableInterestEntities" xlink:type="extended">
    <loc xlink:href="biib-20150630.xsd#biib_InvestmentsInVariableInterestEntitiesAbstract" xlink:label="loc_biib_InvestmentsInVariableInterestEntitiesAbstract_77288AEDC527CE8F408BD4ED4BA34C05" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_098ADB033466B5A94B7CD4ED4BA37932" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_InvestmentsInVariableInterestEntitiesAbstract_77288AEDC527CE8F408BD4ED4BA34C05" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_098ADB033466B5A94B7CD4ED4BA37932" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/InvestmentsInVariableInterestEntitiesDetails" xlink:type="extended">
    <loc xlink:href="biib-20150630.xsd#biib_InvestmentsInVariableInterestEntitiesAbstract" xlink:label="loc_biib_InvestmentsInVariableInterestEntitiesAbstract_7164C4794306D0F03FA8D4ED4B318D44" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_59E826147670AEB69CA5D4ED4B320FA1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_InvestmentsInVariableInterestEntitiesAbstract_7164C4794306D0F03FA8D4ED4B318D44" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_59E826147670AEB69CA5D4ED4B320FA1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis" xlink:label="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_4B1FAE014283FFEAF24AD4ED4B329118" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_59E826147670AEB69CA5D4ED4B320FA1" xlink:to="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_4B1FAE014283FFEAF24AD4ED4B329118" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassificationOfVariableInterestEntityDomain" xlink:label="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_443E92945B877EFF859DD4ED4B320E1F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_4B1FAE014283FFEAF24AD4ED4B329118" xlink:to="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_443E92945B877EFF859DD4ED4B320E1F" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_NeurimmuneMember" xlink:label="loc_biib_NeurimmuneMember_B1289199A8826B12494BD4ED4B32BCCF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_443E92945B877EFF859DD4ED4B320E1F" xlink:to="loc_biib_NeurimmuneMember_B1289199A8826B12494BD4ED4B32BCCF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_A429BC3F88778D836AF9D4ED4B32DDBA" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_59E826147670AEB69CA5D4ED4B320FA1" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_A429BC3F88778D836AF9D4ED4B32DDBA" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_InvestmentInVariableInterestEntitiesTextualAbstract" xlink:label="loc_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_A429BC3F88778D836AF9D4ED4B32DDBA" xlink:to="loc_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement" xlink:label="loc_biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement_2653690F8A44554ED4F0D4ED4B32CB3E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:to="loc_biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement_2653690F8A44554ED4F0D4ED4B32CB3E" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial" xlink:label="loc_biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial_EDB9A001105B082F9DD4D4ED4B323A29" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:to="loc_biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial_EDB9A001105B082F9DD4D4ED4B323A29" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_AE52B00D8CBBF7248DCCD4ED4B3288E1" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_AE52B00D8CBBF7248DCCD4ED4B3288E1" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities" xlink:label="loc_biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities_96EDC688ED36480F5E33D4ED4B32864C" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_InvestmentInVariableInterestEntitiesTextualAbstract_BB7D0F9EA314BF9679B5D4ED4B32FE9D" xlink:to="loc_biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities_96EDC688ED36480F5E33D4ED4B32864C" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/Litigation" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyInformationAboutLitigationMattersAbstract" xlink:label="loc_us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_EFE35FE6121E11F0DAC9D4ED4B05E7FF" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_0311D79977BA34FEDFC0D4ED4B05470F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_EFE35FE6121E11F0DAC9D4ED4B05E7FF" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_0311D79977BA34FEDFC0D4ED4B05470F" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/LitigationDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyInformationAboutLitigationMattersAbstract" xlink:label="loc_us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_3D90C639609931F0FB477489D2E98657" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_B0B5BFF64CC42197BC5B7489D2E99E52" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_3D90C639609931F0FB477489D2E98657" xlink:to="loc_us-gaap_LossContingenciesTable_B0B5BFF64CC42197BC5B7489D2E99E52" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaap_StatementGeographicalAxis_392E7D606883CD05ADD27489D2E91B0A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_B0B5BFF64CC42197BC5B7489D2E99E52" xlink:to="loc_us-gaap_StatementGeographicalAxis_392E7D606883CD05ADD27489D2E91B0A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_47C3F688F9D27C1E700E7489D2EA27C1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementGeographicalAxis_392E7D606883CD05ADD27489D2E91B0A" xlink:to="loc_us-gaap_SegmentGeographicalDomain_47C3F688F9D27C1E700E7489D2EA27C1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_IT" xlink:label="loc_country_IT_22E43D11B9274F01F4247489D2EA0773" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_47C3F688F9D27C1E700E7489D2EA27C1" xlink:to="loc_country_IT_22E43D11B9274F01F4247489D2EA0773" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_912D53441D564E5D1B367489D2EA4F6B" xlink:type="locator" />
    <presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_B0B5BFF64CC42197BC5B7489D2E99E52" xlink:to="loc_us-gaap_LossContingenciesLineItems_912D53441D564E5D1B367489D2EA4F6B" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ReimbursementLimitStatedInResolution" xlink:label="loc_biib_ReimbursementLimitStatedInResolution_CD91E94EDA3FAFCB3E077489D2EAEFC3" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_912D53441D564E5D1B367489D2EA4F6B" xlink:to="loc_biib_ReimbursementLimitStatedInResolution_CD91E94EDA3FAFCB3E077489D2EAEFC3" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_B0EB9CEBD831128D4E06D4ED4BC0E24F" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_7963524F0370193265C4D4ED4BC02559" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_B0EB9CEBD831128D4E06D4ED4BC0E24F" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_7963524F0370193265C4D4ED4BC02559" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_CD572858A919CE6865E6B72E3D6BDCAB" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_FF4458DB49BF131E0267B72E3D6B4730" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_CD572858A919CE6865E6B72E3D6BDCAB" xlink:to="loc_us-gaap_StatementTable_FF4458DB49BF131E0267B72E3D6B4730" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_F9CBCEE3D80C9FE0A070B72E3D6B812A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_FF4458DB49BF131E0267B72E3D6B4730" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_F9CBCEE3D80C9FE0A070B72E3D6B812A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3981BCAFC69B727C7197B72E3D7161D8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_F9CBCEE3D80C9FE0A070B72E3D6B812A" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3981BCAFC69B727C7197B72E3D7161D8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_F15E93BB90651EDAFEB0B72E3D7157BF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3981BCAFC69B727C7197B72E3D7161D8" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_F15E93BB90651EDAFEB0B72E3D7157BF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_9189AB37DEB782C4A2B4B72E3D713F32" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_FF4458DB49BF131E0267B72E3D6B4730" xlink:to="loc_us-gaap_StatementLineItems_9189AB37DEB782C4A2B4B72E3D713F32" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaap_PrepaidTaxes_26B1F8067FBA9E49362AB7338FB5AD8B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9189AB37DEB782C4A2B4B72E3D713F32" xlink:to="loc_us-gaap_PrepaidTaxes_26B1F8067FBA9E49362AB7338FB5AD8B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_CD572858A919CE6865E6B72E3D6BDCAB" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_19BF44223268C01DA66CB72E3D71C49D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_19BF44223268C01DA66CB72E3D71C49D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_E480C55D8D316361A64FB72E3D71A4A7" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_E480C55D8D316361A64FB72E3D71A4A7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_B5DA761C4CDC6912FA9FB72E3D712FCC" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_B5DA761C4CDC6912FA9FB72E3D712FCC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_B9F2C5E3B91B389E6373B72E3D711D1B" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_B9F2C5E3B91B389E6373B72E3D711D1B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_D77658B2090FE8B11F0EB72E3D71D302" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3" xlink:to="loc_us-gaap_DeferredRevenueCurrent_D77658B2090FE8B11F0EB72E3D71D302" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_E0D40DECFEC0FF9F4C90B72E3D717BFE" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_E0D40DECFEC0FF9F4C90B72E3D717BFE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_F16712D972F5D71F6CEBB72E3D718DB5" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_80575F7C4A6A0B55C9F2B72E3D71DAA3" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_F16712D972F5D71F6CEBB72E3D718DB5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestIncomeExpenseNetAbstract" xlink:label="loc_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_CD572858A919CE6865E6B72E3D6BDCAB" xlink:to="loc_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_A64F0EE8ACBD876F1750B72E3D765479" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB" xlink:to="loc_us-gaap_InvestmentIncomeInterest_A64F0EE8ACBD876F1750B72E3D765479" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_EA34B5FFAAF17263CB9CB72E3D77E2B2" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB" xlink:to="loc_us-gaap_InterestExpense_EA34B5FFAAF17263CB9CB72E3D77E2B2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_763F3899CF456D371620B72E3D779466" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_763F3899CF456D371620B72E3D779466" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_C767B20458B5759DF426B72E3D777B91" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_C767B20458B5759DF426B72E3D777B91" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_EEEED57C699F6C1EDC6AB72E3D77DE57" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_EEEED57C699F6C1EDC6AB72E3D77DE57" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_9B71A2E6810910733EEBB72E3D7781B0" xlink:type="locator" />
    <presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB" xlink:to="loc_us-gaap_BusinessCombinationsAbstract_9B71A2E6810910733EEBB72E3D7781B0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DB3AF38B044E46309EFAB72E3D7742CA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_9B71A2E6810910733EEBB72E3D7781B0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DB3AF38B044E46309EFAB72E3D7742CA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_94A969339FD6E292613BB72E3D77840E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DB3AF38B044E46309EFAB72E3D7742CA" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_94A969339FD6E292613BB72E3D77840E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ACDF43FB2BDF09F691EB72E3D77B2A0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_94A969339FD6E292613BB72E3D77840E" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ACDF43FB2BDF09F691EB72E3D77B2A0" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ConvergencePharmaceuticalsMember" xlink:label="loc_biib_ConvergencePharmaceuticalsMember_C428ADDF907E34E1DCFFB72E3D770D39" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ACDF43FB2BDF09F691EB72E3D77B2A0" xlink:to="loc_biib_ConvergencePharmaceuticalsMember_C428ADDF907E34E1DCFFB72E3D770D39" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_49F0CA153F80C32DD115B72E3D775F85" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DB3AF38B044E46309EFAB72E3D7742CA" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_49F0CA153F80C32DD115B72E3D775F85" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1179F0E20E13DDB76F0BB72E3D77A01C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49F0CA153F80C32DD115B72E3D775F85" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_1179F0E20E13DDB76F0BB72E3D77A01C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_7B2F9BB1CA1551377346B72E3D77985A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49F0CA153F80C32DD115B72E3D775F85" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_7B2F9BB1CA1551377346B72E3D77985A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_937F22AD636C7478A3C5B72E3D773ED6" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49F0CA153F80C32DD115B72E3D775F85" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_937F22AD636C7478A3C5B72E3D773ED6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_C8EAE4AFC41EDE4359C9B72E3D776FFC" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_B41E101F044D74E5F83BB72E3D711ECB" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_C8EAE4AFC41EDE4359C9B72E3D776FFC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_D4A2FC0E47D1F8576ECCB72E3D7CDBEC" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_CD572858A919CE6865E6B72E3D6BDCAB" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_D4A2FC0E47D1F8576ECCB72E3D7CDBEC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_77CEDF849467CFFB086EB72E3D7D3C7F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_D4A2FC0E47D1F8576ECCB72E3D7CDBEC" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_77CEDF849467CFFB086EB72E3D7D3C7F" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_Employeerelatedliabilitiesnoncurrent" xlink:label="loc_biib_Employeerelatedliabilitiesnoncurrent_2458FB3210728DEDDB10B72E3D7D6CB8" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_D4A2FC0E47D1F8576ECCB72E3D7CDBEC" xlink:to="loc_biib_Employeerelatedliabilitiesnoncurrent_2458FB3210728DEDDB10B72E3D7D6CB8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_8F4A923DCD6CDF1CD4ECB72E3D7DA1E8" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_D4A2FC0E47D1F8576ECCB72E3D7CDBEC" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_8F4A923DCD6CDF1CD4ECB72E3D7DA1E8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_6F36475C28F4477743E5B72E3D7D929B" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_D4A2FC0E47D1F8576ECCB72E3D7CDBEC" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_6F36475C28F4477743E5B72E3D7D929B" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailOtherConsolidatedFinancialStatementDetailsTextual" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesAbstract" xlink:label="loc_us-gaap_OtherLiabilitiesAbstract_CD631A4EC5D9ABA27BE47489D32E578D" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductLiabilityContingencyTable" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_DCE0203777C31D2F0F177489D32F9A9E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesAbstract_CD631A4EC5D9ABA27BE47489D32E578D" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_DCE0203777C31D2F0F177489D32F9A9E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaap_StatementGeographicalAxis_1DB64EE5F84B675C67997489D32FBDBA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_DCE0203777C31D2F0F177489D32F9A9E" xlink:to="loc_us-gaap_StatementGeographicalAxis_1DB64EE5F84B675C67997489D32FBDBA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_3F451AAB1383E94A7E6A7489D3340BE1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementGeographicalAxis_1DB64EE5F84B675C67997489D32FBDBA" xlink:to="loc_us-gaap_SegmentGeographicalDomain_3F451AAB1383E94A7E6A7489D3340BE1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_IT" xlink:label="loc_country_IT_0D2D8066ADD644296BA57489D33412C4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_3F451AAB1383E94A7E6A7489D3340BE1" xlink:to="loc_country_IT_0D2D8066ADD644296BA57489D33412C4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_DCE0203777C31D2F0F177489D32F9A9E" xlink:to="loc_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ReimbursementLimitStatedInResolution" xlink:label="loc_biib_ReimbursementLimitStatedInResolution_205553BF9148DCA2ACFA7489D334BCF8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:to="loc_biib_ReimbursementLimitStatedInResolution_205553BF9148DCA2ACFA7489D334BCF8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_1DE57D75A39C5BC0078F7489D334471D" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_1DE57D75A39C5BC0078F7489D334471D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_F4E17687C59353D30B327489D33449F9" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_F4E17687C59353D30B327489D33449F9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent" xlink:label="loc_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_CBAA6412D5F0515B8C2E7489D334EA22" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_E142ABB6BB4C7B36E3037489D3346775" xlink:to="loc_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_CBAA6412D5F0515B8C2E7489D334EA22" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6B844408015BF53CD6F0D4ED4AD39584" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_C68EE605C474E309BF67D4ED4AD3FDA8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6B844408015BF53CD6F0D4ED4AD39584" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_C68EE605C474E309BF67D4ED4AD3FDA8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_D63834B8CF8B870AE25CD4ED4AD3BF17" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6B844408015BF53CD6F0D4ED4AD39584" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_D63834B8CF8B870AE25CD4ED4AD3BF17" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_C586B5DABF695027AC19D4ED4AD3E838" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6B844408015BF53CD6F0D4ED4AD39584" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_C586B5DABF695027AC19D4ED4AD3E838" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowances" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract" xlink:label="loc_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract_B3FD2D63612E5FE7BC35DE15CF17EE76" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_5704A573738D623B7864DDF8D843A460" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract_B3FD2D63612E5FE7BC35DE15CF17EE76" xlink:to="loc_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_5704A573738D623B7864DDF8D843A460" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract" xlink:label="loc_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract_1B5D803E4A3C0565A452DE175DD8EF33" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_D81CE4970BCE49A14B95DDF8D83F51C3" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract_1B5D803E4A3C0565A452DE175DD8EF33" xlink:to="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_D81CE4970BCE49A14B95DDF8D83F51C3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_72F75CE2C346A463B8BFDDF8D83FDA3C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_D81CE4970BCE49A14B95DDF8D83F51C3" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_72F75CE2C346A463B8BFDDF8D83FDA3C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_A485528BB5D352E3FC07DDF8D83FDC62" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_72F75CE2C346A463B8BFDDF8D83FDA3C" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_A485528BB5D352E3FC07DDF8D83FDC62" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReserveForCashDiscountMember" xlink:label="loc_us-gaap_ReserveForCashDiscountMember_240B93ACA078B4FAD5AFDDF8D83F8D56" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_A485528BB5D352E3FC07DDF8D83FDC62" xlink:to="loc_us-gaap_ReserveForCashDiscountMember_240B93ACA078B4FAD5AFDDF8D83F8D56" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ContractualAdjustmentsMember" xlink:label="loc_biib_ContractualAdjustmentsMember_72A376A6310F947C2960DDF8D83F065A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_A485528BB5D352E3FC07DDF8D83FDC62" xlink:to="loc_biib_ContractualAdjustmentsMember_72A376A6310F947C2960DDF8D83F065A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesReturnsAndAllowancesMember" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember_51E3D2D729372903888FDDF8D83F4A9C" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_A485528BB5D352E3FC07DDF8D83FDC62" xlink:to="loc_us-gaap_SalesReturnsAndAllowancesMember_51E3D2D729372903888FDDF8D83F4A9C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_3DABBF45B1C439C8FAB8DDF8D83F099C" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_D81CE4970BCE49A14B95DDF8D83F51C3" xlink:to="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_3DABBF45B1C439C8FAB8DDF8D83F099C" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract" xlink:label="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_27B0D1DCD51D85422536DDF8D83FD7D4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_3DABBF45B1C439C8FAB8DDF8D83F099C" xlink:to="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_27B0D1DCD51D85422536DDF8D83FD7D4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_27EE13D22ADF918AE01FDDF8D83FD566" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_27B0D1DCD51D85422536DDF8D83FD7D4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_27EE13D22ADF918AE01FDDF8D83FD566" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear" xlink:label="loc_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear_1BBA54400CA4BCBB04E7DDF8D83FA6A0" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_27B0D1DCD51D85422536DDF8D83FD7D4" xlink:to="loc_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear_1BBA54400CA4BCBB04E7DDF8D83FA6A0" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears" xlink:label="loc_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears_8888434476482D2C6B0EDDF8D83F61F4" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_27B0D1DCD51D85422536DDF8D83FD7D4" xlink:to="loc_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears_8888434476482D2C6B0EDDF8D83F61F4" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear" xlink:label="loc_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear_6A14A7FB3FBE79167245DDF8D83FD872" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_27B0D1DCD51D85422536DDF8D83FD7D4" xlink:to="loc_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear_6A14A7FB3FBE79167245DDF8D83FD872" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear" xlink:label="loc_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear_DA0A52A57D8D2C7996C3DDF8D840DE7A" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_27B0D1DCD51D85422536DDF8D83FD7D4" xlink:to="loc_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear_DA0A52A57D8D2C7996C3DDF8D840DE7A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_22D49C9071BF4B41CEB1DDF8D8405487" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract_27B0D1DCD51D85422536DDF8D83FD7D4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_22D49C9071BF4B41CEB1DDF8D8405487" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract" xlink:label="loc_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract_AAE6746D9DFE8A3D6C26DE183B26DB4B" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_06FC94B0E519AFA00152DDF8D83B513E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract_AAE6746D9DFE8A3D6C26DE183B26DB4B" xlink:to="loc_us-gaap_StatementTable_06FC94B0E519AFA00152DDF8D83B513E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9CF1903E6E10469698F1DDF8D83B516B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_06FC94B0E519AFA00152DDF8D83B513E" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9CF1903E6E10469698F1DDF8D83B516B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_B1E1C53AE9D9536C49BFDDF8D83B1FB0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9CF1903E6E10469698F1DDF8D83B516B" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_B1E1C53AE9D9536C49BFDDF8D83B1FB0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_8F12071934497BFCF7B7DDF8D83BA400" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_B1E1C53AE9D9536C49BFDDF8D83B1FB0" xlink:to="loc_us-gaap_AccountsReceivableMember_8F12071934497BFCF7B7DDF8D83BA400" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_649678FC2BBEE6015C69DDF8D83BD61F" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_B1E1C53AE9D9536C49BFDDF8D83B1FB0" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_649678FC2BBEE6015C69DDF8D83BD61F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_690F09FA03A660B8A87EDDF8D83BDD81" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_06FC94B0E519AFA00152DDF8D83B513E" xlink:to="loc_us-gaap_StatementLineItems_690F09FA03A660B8A87EDDF8D83BDD81" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract" xlink:label="loc_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract_B536E0091ADB879622FEDDF8D83BBEEE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_690F09FA03A660B8A87EDDF8D83BDD81" xlink:to="loc_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract_B536E0091ADB879622FEDDF8D83BBEEE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_977A4F9C5B2E4D1CC20CDDF8D83B28D6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract_B536E0091ADB879622FEDDF8D83BBEEE" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_977A4F9C5B2E4D1CC20CDDF8D83B28D6" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract" xlink:label="loc_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract_57C41F5961136E93988CDE16240EF732" xlink:type="locator" />
    <loc xlink:href="biib-20150630.xsd#biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock" xlink:label="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock_8C06A39AC0989F3B3C3EDDF8D8426077" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract_57C41F5961136E93988CDE16240EF732" xlink:to="loc_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock_8C06A39AC0989F3B3C3EDDF8D8426077" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock" xlink:label="loc_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock_EC893ACF868D36B9F8C9DDF8D8426935" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract_57C41F5961136E93988CDE16240EF732" xlink:to="loc_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock_EC893ACF868D36B9F8C9DDF8D8426935" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/ShareBasedPayments" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_49396C472B140D268F1BD4ED4BBBEBB0" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2B8239A3C265BA0469F1D4ED4BBB7723" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_49396C472B140D268F1BD4ED4BBBEBB0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2B8239A3C265BA0469F1D4ED4BBB7723" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/ShareBasedPaymentsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BC6695367C425F6C2ECDD4ED4B36F4DB" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_C5DDB6F8D1528FA5E509D4ED4B36D28A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BC6695367C425F6C2ECDD4ED4B36F4DB" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_C5DDB6F8D1528FA5E509D4ED4B36D28A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_D6367ADBD1B79E1C4D5BD4ED4B36F9CC" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_C5DDB6F8D1528FA5E509D4ED4B36D28A" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_D6367ADBD1B79E1C4D5BD4ED4B36F9CC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_CFE44C5C3B819804F9C9D4ED4B36E5F3" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_D6367ADBD1B79E1C4D5BD4ED4B36F9CC" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_CFE44C5C3B819804F9C9D4ED4B36E5F3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_0A16BFDD56F2FCFA0726D4ED4B369DD4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_CFE44C5C3B819804F9C9D4ED4B36E5F3" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_0A16BFDD56F2FCFA0726D4ED4B369DD4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6423EC869C881A512F9ED4ED4B36F45E" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_CFE44C5C3B819804F9C9D4ED4B36E5F3" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6423EC869C881A512F9ED4ED4B36F45E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ParentMember" xlink:label="loc_us-gaap_ParentMember_98D90735A12C2A73862FD4ED4B3618CE" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_CFE44C5C3B819804F9C9D4ED4B36E5F3" xlink:to="loc_us-gaap_ParentMember_98D90735A12C2A73862FD4ED4B3618CE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_27064A8B9F7391BD7E27D4ED4B36D684" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_C5DDB6F8D1528FA5E509D4ED4B36D28A" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_27064A8B9F7391BD7E27D4ED4B36D684" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_27064A8B9F7391BD7E27D4ED4B36D684" xlink:to="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2F3B66D9779A4379C7FAD4ED4B373018" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2F3B66D9779A4379C7FAD4ED4B373018" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_20E102D74AA5F0A174FED4ED4B3749CB" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_20E102D74AA5F0A174FED4ED4B3749CB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_B590D976E8B20ED0FBB4D4ED4B379445" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_B590D976E8B20ED0FBB4D4ED4B379445" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses" xlink:label="loc_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_4F5AF64204B06EEC48A6D4ED4B37879C" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:to="loc_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_4F5AF64204B06EEC48A6D4ED4B37879C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_D814D5899BCC573DEF17D4ED4B37D109" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_DB4B2D5728F83516CDFFD4ED4B361C7D" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_D814D5899BCC573DEF17D4ED4B37D109" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/ShareBasedPaymentsDetails1" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_E05EA6DDFBBC4920DAFDD4ED4BAE85F6" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8C75F8E989239EBD5EBFD4ED4BAE047B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_E05EA6DDFBBC4920DAFDD4ED4BAE85F6" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8C75F8E989239EBD5EBFD4ED4BAE047B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_3764085253B8C5FC42A8D4ED4BAF9AC0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8C75F8E989239EBD5EBFD4ED4BAE047B" xlink:to="loc_us-gaap_PlanNameAxis_3764085253B8C5FC42A8D4ED4BAF9AC0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3764085253B8C5FC42A8D4ED4BAF9AC0" xlink:to="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_MarketStockUnitsMember" xlink:label="loc_biib_MarketStockUnitsMember_21355C156AAF67F86D98D4ED4BAFAD6F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E" xlink:to="loc_biib_MarketStockUnitsMember_21355C156AAF67F86D98D4ED4BAFAD6F" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_TimeVestedRestrictedStockUnitsMember" xlink:label="loc_biib_TimeVestedRestrictedStockUnitsMember_3F1A89D305B572546718D4ED4BAF81B8" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E" xlink:to="loc_biib_TimeVestedRestrictedStockUnitsMember_3F1A89D305B572546718D4ED4BAF81B8" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CashSettledPerformanceSharesMember" xlink:label="loc_biib_CashSettledPerformanceSharesMember_2C7CD7036EED1BA54A0FD4ED4BAF558F" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E" xlink:to="loc_biib_CashSettledPerformanceSharesMember_2C7CD7036EED1BA54A0FD4ED4BAF558F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_91AD475A5C81E8F4FC69D4ED4BAF07E6" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E" xlink:to="loc_us-gaap_PerformanceSharesMember_91AD475A5C81E8F4FC69D4ED4BAF07E6" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_EmployeeStockPurchasePlanMember" xlink:label="loc_biib_EmployeeStockPurchasePlanMember_C580B0D0FD7098B99E71D4ED4BAF39CB" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8128CE42C1BA7F45D172D4ED4BAF610E" xlink:to="loc_biib_EmployeeStockPurchasePlanMember_C580B0D0FD7098B99E71D4ED4BAF39CB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1464EA0C1384DE90337FD4ED4BAFC978" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8C75F8E989239EBD5EBFD4ED4BAE047B" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1464EA0C1384DE90337FD4ED4BAFC978" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract" xlink:label="loc_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1464EA0C1384DE90337FD4ED4BAFC978" xlink:to="loc_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_602FE9224655D2D0D2A9D4ED4BAF8E09" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_602FE9224655D2D0D2A9D4ED4BAF8E09" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_44E64F2C5534611F7AB3D4ED4BAF24AD" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_44E64F2C5534611F7AB3D4ED4BAF24AD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_CCAA7FD886AF5D443486D4ED4BAFF74C" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_CCAA7FD886AF5D443486D4ED4BAFF74C" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses" xlink:label="loc_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_C748C22FC4113452038ED4ED4BAF02C4" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract_49417568D32C800DD353D4ED4BAF5C64" xlink:to="loc_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses_C748C22FC4113452038ED4ED4BAF02C4" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/ShareBasedPaymentsDetails2" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_C4632D372889041D33F7D4ED4ACFF5FE" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_58661BA7D073C9063C05D4ED4ACF8EBF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_C4632D372889041D33F7D4ED4ACFF5FE" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_58661BA7D073C9063C05D4ED4ACF8EBF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_AB106E479BE91712B682D4ED4ACF92D5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_58661BA7D073C9063C05D4ED4ACF8EBF" xlink:to="loc_us-gaap_PlanNameAxis_AB106E479BE91712B682D4ED4ACF92D5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_AB106E479BE91712B682D4ED4ACF92D5" xlink:to="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_MarketStockUnitsMember" xlink:label="loc_biib_MarketStockUnitsMember_BFE8CD48F7B66C524FC8D4ED4ACF00B9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:to="loc_biib_MarketStockUnitsMember_BFE8CD48F7B66C524FC8D4ED4ACF00B9" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_CashSettledPerformanceSharesMember" xlink:label="loc_biib_CashSettledPerformanceSharesMember_D1B572FA74FCD42CC965D4ED4AD0DC9B" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:to="loc_biib_CashSettledPerformanceSharesMember_D1B572FA74FCD42CC965D4ED4AD0DC9B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_CB8E6DA6F2EA4EBC89C9D4ED4AD01D06" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:to="loc_us-gaap_PerformanceSharesMember_CB8E6DA6F2EA4EBC89C9D4ED4AD01D06" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_TimeVestedRestrictedStockUnitsMember" xlink:label="loc_biib_TimeVestedRestrictedStockUnitsMember_82BD6DF4361E1931E2CFD4ED4AD00290" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_573D974E03E12D491781D4ED4ACF70C2" xlink:to="loc_biib_TimeVestedRestrictedStockUnitsMember_82BD6DF4361E1931E2CFD4ED4AD00290" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B8CBBCA1A4D053D375CED4ED4AD0BBFA" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_58661BA7D073C9063C05D4ED4ACF8EBF" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B8CBBCA1A4D053D375CED4ED4AD0BBFA" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ScheduleOfStockOptionGrantsAbstract" xlink:label="loc_biib_ScheduleOfStockOptionGrantsAbstract_1BA6DAAB68C13E083D0BD4ED4AD073D0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B8CBBCA1A4D053D375CED4ED4AD0BBFA" xlink:to="loc_biib_ScheduleOfStockOptionGrantsAbstract_1BA6DAAB68C13E083D0BD4ED4AD073D0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F825C80AEBCE6521E97D4ED4AD078A3" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_biib_ScheduleOfStockOptionGrantsAbstract_1BA6DAAB68C13E083D0BD4ED4AD073D0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F825C80AEBCE6521E97D4ED4AD078A3" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/ShareBasedPaymentsDetailsTextual" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_260260A54BFEC084A09A740CBB499B3C" xlink:type="locator" />
    <loc xlink:href="biib-20150630.xsd#biib_Employeestockpurchaseplanmaximumshares" xlink:label="loc_biib_Employeestockpurchaseplanmaximumshares_22C1100CD9AACE4516147434A5516DF0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_260260A54BFEC084A09A740CBB499B3C" xlink:to="loc_biib_Employeestockpurchaseplanmaximumshares_22C1100CD9AACE4516147434A5516DF0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6DB273C76E0DA1448CDA740CBB4E7BD6" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_260260A54BFEC084A09A740CBB499B3C" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6DB273C76E0DA1448CDA740CBB4E7BD6" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/ShareBasedPaymentsTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40A010CBFE6D532E7DEBD4ED4ADF0E7A" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_156BF6E3915EEB914749D4ED4ADF6320" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40A010CBFE6D532E7DEBD4ED4ADF0E7A" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_156BF6E3915EEB914749D4ED4ADF6320" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_2BAA43E05048730B88D4D4ED4ADFA2F6" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40A010CBFE6D532E7DEBD4ED4ADF0E7A" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_2BAA43E05048730B88D4D4ED4ADFA2F6" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock" xlink:label="loc_biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock_34AB5389A6FE696B2343D4ED4ADF4E52" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40A010CBFE6D532E7DEBD4ED4ADF0E7A" xlink:to="loc_biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock_34AB5389A6FE696B2343D4ED4ADF4E52" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/SubsequentEventsSubsequentEvents" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_259FA3E6DEDCCA4EC6A1748A06B19270" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_CB8CC84A5E9815FD54AE748A06B6AF16" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_259FA3E6DEDCCA4EC6A1748A06B19270" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_CB8CC84A5E9815FD54AE748A06B6AF16" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/SubsequentEventsSubsequentEventsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_3FCA7CBE533941A946F0B7340A86B1EE" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_3FCA7CBE533941A946F0B7340A86B1EE" xlink:to="loc_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_771D440E33CF0CFB17FAB7340A86F17F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:to="loc_us-gaap_ProductOrServiceAxis_771D440E33CF0CFB17FAB7340A86F17F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_D3372953B801B4BB457DB7340A864789" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_771D440E33CF0CFB17FAB7340A86F17F" xlink:to="loc_us-gaap_ProductsAndServicesDomain_D3372953B801B4BB457DB7340A864789" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_LeadprogramsMember" xlink:label="loc_biib_LeadprogramsMember_13AD78A278696FC050C7B7340A86D93A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_D3372953B801B4BB457DB7340A864789" xlink:to="loc_biib_LeadprogramsMember_13AD78A278696FC050C7B7340A86D93A" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_DiscoveryprogramsMember" xlink:label="loc_biib_DiscoveryprogramsMember_9F1C5329C9C3B7466A3AB7340A86A9F8" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_D3372953B801B4BB457DB7340A864789" xlink:to="loc_biib_DiscoveryprogramsMember_9F1C5329C9C3B7466A3AB7340A86A9F8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_3213F345859D56084D8AB7340A86F713" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:to="loc_us-gaap_TypeOfArrangementAxis_3213F345859D56084D8AB7340A86F713" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_3213F345859D56084D8AB7340A86F713" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AGTCMember" xlink:label="loc_biib_AGTCMember_5F66FF87C17C2F6EAD60B7340A860704" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF" xlink:to="loc_biib_AGTCMember_5F66FF87C17C2F6EAD60B7340A860704" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_EisaiMember" xlink:label="loc_biib_EisaiMember_214CD51B8CA2FEB6DFD9B74CEBBE076E" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF" xlink:to="loc_biib_EisaiMember_214CD51B8CA2FEB6DFD9B74CEBBE076E" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_SwedishOrphanBiovitrumMember" xlink:label="loc_biib_SwedishOrphanBiovitrumMember_4CD6B22F4232245CFBACB747240DB15D" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_B495BF79AFF2EE18B8E0B7340A86CECF" xlink:to="loc_biib_SwedishOrphanBiovitrumMember_4CD6B22F4232245CFBACB747240DB15D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2B04F499DD14AAADCA3FB7340A87E7B5" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2B04F499DD14AAADCA3FB7340A87E7B5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8FA32BABB4D1D8814B03B7340A878038" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2B04F499DD14AAADCA3FB7340A87E7B5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8FA32BABB4D1D8814B03B7340A878038" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_62B67C6D09D421E1E0D6B7340A87C6B5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8FA32BABB4D1D8814B03B7340A878038" xlink:to="loc_us-gaap_SubsequentEventMember_62B67C6D09D421E1E0D6B7340A87C6B5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_5ECE4B421ECE0C6BE8C1B7340A86E00B" xlink:to="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_45C387DE7D408819095BB7340A875AF8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_45C387DE7D408819095BB7340A875AF8" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_Purchaseofcommonstock" xlink:label="loc_biib_Purchaseofcommonstock_788FE33F878812B5527DB7340A877A3B" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="loc_biib_Purchaseofcommonstock_788FE33F878812B5527DB7340A877A3B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_7F962168BB59A771C190B7340A87B4C2" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssets_7F962168BB59A771C190B7340A87B4C2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LicenseCosts" xlink:label="loc_us-gaap_LicenseCosts_623EBA60EEB10186FB46B7340A87988B" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="loc_us-gaap_LicenseCosts_623EBA60EEB10186FB46B7340A87988B" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately" xlink:label="loc_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_B9E228840EDB6B118514B7340A872FFD" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="loc_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately_B9E228840EDB6B118514B7340A872FFD" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_TermOfLease" xlink:label="loc_biib_TermOfLease_041B1AD828D88D5E7DE1B74BA968471C" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="loc_biib_TermOfLease_041B1AD828D88D5E7DE1B74BA968471C" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_AdditionalMilestonePayment" xlink:label="loc_biib_AdditionalMilestonePayment_F700C0105EAA54DA6889B74576C2D9D1" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_2DD4C470A53C35336C04B7340A878FB5" xlink:to="loc_biib_AdditionalMilestonePayment_F700C0105EAA54DA6889B74576C2D9D1" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_770358B767FF418DA490DE012AF114F5" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_C42BDD88C1DB4FB2314CDE02D917999F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_770358B767FF418DA490DE012AF114F5" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_C42BDD88C1DB4FB2314CDE02D917999F" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_15E8AFAFA285ABB50B85C096EDBA9B13" xlink:type="locator" />
    <loc xlink:href="biib-20150630.xsd#biib_InterestInSubsidiary" xlink:label="loc_biib_InterestInSubsidiary_E423FAD582B7DBAF7FA0C096EDBB409B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_15E8AFAFA285ABB50B85C096EDBA9B13" xlink:to="loc_biib_InterestInSubsidiary_E423FAD582B7DBAF7FA0C096EDBB409B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_869AA79829AA07D6F441C096EDBB95F1" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_15E8AFAFA285ABB50B85C096EDBA9B13" xlink:to="loc_us-gaap_NumberOfReportableSegments_869AA79829AA07D6F441C096EDBB95F1" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_PaymentTermsOfAccountsReceivable" xlink:label="loc_biib_PaymentTermsOfAccountsReceivable_5FCF183EA47EC64B164BC096EDBBE4F0" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_15E8AFAFA285ABB50B85C096EDBA9B13" xlink:to="loc_biib_PaymentTermsOfAccountsReceivable_5FCF183EA47EC64B164BC096EDBBE4F0" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_MinimumTermForAccountsReceivable" xlink:label="loc_biib_MinimumTermForAccountsReceivable_6D30D53593E660C49F74C096EDBB2E06" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_15E8AFAFA285ABB50B85C096EDBA9B13" xlink:to="loc_biib_MinimumTermForAccountsReceivable_6D30D53593E660C49F74C096EDBB2E06" xlink:type="arc" />
    <loc xlink:href="biib-20150630.xsd#biib_MaximumTermForAccountsReceivable" xlink:label="loc_biib_MaximumTermForAccountsReceivable_6B33B9D9D8C8D84FB2D2C096EDC045A0" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_15E8AFAFA285ABB50B85C096EDBA9B13" xlink:to="loc_biib_MaximumTermForAccountsReceivable_6B33B9D9D8C8D84FB2D2C096EDC045A0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3A6D9E79C7A0B5C39717C096EDC02E53" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_15E8AFAFA285ABB50B85C096EDBA9B13" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3A6D9E79C7A0B5C39717C096EDC02E53" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_56E8C672776690AD24FC7404CF699649" xlink:type="locator" />
    <loc xlink:href="biib-20150630.xsd#biib_BusinessOverviewPolicyTextBlock" xlink:label="loc_biib_BusinessOverviewPolicyTextBlock_8DAACEDB22F1E0E0A8617404CF70E79C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56E8C672776690AD24FC7404CF699649" xlink:to="loc_biib_BusinessOverviewPolicyTextBlock_8DAACEDB22F1E0E0A8617404CF70E79C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_39C0ABC7EA2FC1613C727404CF706345" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56E8C672776690AD24FC7404CF699649" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_39C0ABC7EA2FC1613C727404CF706345" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_B15BFC0E03792E1D85CF7404CF70DBE9" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56E8C672776690AD24FC7404CF699649" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_B15BFC0E03792E1D85CF7404CF70DBE9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_AAA9CD515958EB4CF63D7404CF70F93F" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56E8C672776690AD24FC7404CF699649" xlink:to="loc_us-gaap_UseOfEstimates_AAA9CD515958EB4CF63D7404CF70F93F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_FDF7570131AD269511AD74094C4F122F" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56E8C672776690AD24FC7404CF699649" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_FDF7570131AD269511AD74094C4F122F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1158D5373526D49BEF9C7404CF70D7F0" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56E8C672776690AD24FC7404CF699649" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1158D5373526D49BEF9C7404CF70D7F0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8FBF9F8207D6C9FA12E37404CF70BB9F" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56E8C672776690AD24FC7404CF699649" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8FBF9F8207D6C9FA12E37404CF70BB9F" xlink:type="arc" />
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>biib-2015630_3mosujbchart.jpg
<TEXT>
begin 644 biib-2015630_3mosujbchart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`(%`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"D8[1G&?F4?]],%
MS^&<^]+2,-PQ[J?^^6##]10!^3O[.?\`P4UTOXO:=XT\>>/IOV<?`G@#PKX[
M^(/PX;P1X(^//BCXQ_M1V?BOPY\?]9_9_P#`FE>(?V?O#/P;LM4LM3^)WB/1
MDG\/:+HNN:_K$ESKN@Z5I]EJ[7-Q>6_U]X&_;/\`V=OB1XT\+?#GP7XUU77/
M'GB_1?$'B#3O"4/P_P#B+;:[I6E>$/&OB/X;^-+CQG87_A2UF^'\G@KQ_P"%
M=6\&>,+3QROAZ[\-^)SIFB:I#;W^NZ'!J'D6C?\`!/[P7X=_9X\(_!'1?'7B
M&Q\1_#CXY>(_VB?AY\68]!\,/XET#XE:K\<_'7QPTR74-%DLVT/Q'X>L+KQ[
MK/@?4=%U((^L^#[BZ\O4-)\03P:W8ZGP"_86\-?`GXUZC\>(/B+XJ\8>-?%'
MP]\<>&/';ZUI/AS3K/Q3XP^)'QOU3XY>+O'@AT6TM1H[MJ^HP>%=`\,V2OI>
MB^$-&T>VDN=3U>*^U>_`/'/B'_P5,\"^"?B]XY^$</PB^*5Q=_#+]L'X!?LF
M^,?$FN>&/%FB:)?WOQW^&*?$?3O%GPX%IX2UJ]^(5WI0N;#1+3P5I$"ZYXG.
MH:?XBT:1O#.KZ%J6J?1NF_M[?LKZO#X7N=.^)-W=VOB:VL[RXO(?`/Q):Q\!
M6]]X_P#$/PHMG^,E\?"`L_@B\GQ0\)>*?AX+?XMS^#;A?&'ACQ+HKQ+/X=UM
MK#S3QW_P3[T#QE^T)=_'"W^*7BG0]/UG]H7X"_M0^(/`D/A_PW?6FH?%GX"?
M#J#X0Z+/:>);A(M9T[POXA^'.GZ-I>M>'O*NS!K.GR:_I6HV;ZC?6$OBFF?\
M$>_@9IGCQOB`^LZ9XDUSQ!XU\:^)_'U[\0?@Q\&?B3J>KZ;X@_:1^,7[2'A[
M1_!FI^.O"VOO\,[SP[JOQJ\3>!+_`%[0;:]N/$W@VQT.[N;'3?&>F6GBF``^
MF/VT?VD?C1^S?:_!W5/AA\*_A=\3-+^*7QI^%GP'NO\`A._BUXN^&NH:#XP^
M,GCG2?`WA#5;>W\._![XFVVJ^'-/N]1FO_$LDUYI>J6UO;+#I6GZI-,?*\T^
M&O\`P4U^#=_'\9;#XYF'X+^(/@O\3_VC_AUK$D<'CSQCX(UU/V7O!;?$3XDZ
MEH7CY/A[H6@7.OP>`M.\2>/K3X;K-)X\E\#^'[_Q#%H\T%M?1V7U9^T'\`-(
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M>$K;51H-QXU^&VN>*O#NBZ-\3?`T&N-%I,WC/P!?>(O#<=U>:4S:E]FUO1+C
M4OEK4O\`@F5\%[_X_P"F?'J3_A'[_6+F7X-ZIXUB\5_"+X3^//$.M^(_@5X=
MT#POX)UCPGX_\9>&M8\4?#*/4='\*^&;/Q=8^%I&:[.@V&J^$[[P5XEEU/7M
M1Z3]CS_@GC\*/V--6U"[^'C>')+"R\$P_#'P7]B^$'PC\'>+M,^']OJ6GZE#
MIWC?XE>$_"MAXZ^*&N1G1M"L)-=\0ZO9PZC9Z+8W^M:+JGBHW7B:X`/.O^'E
M`A\$_M]:S>?!B[B\;_L=^.O%'A/X<>!H/&\4_P#PT9IXU/6/`7PSUS2=:?PS
M#_PA+>-_C1X2\<_#+6].?3/%0\$MX7D\23WFL6=_#91>O_";_@H-\`OB'X;^
M"UQK>O2^%?&GQ:^'WP;\57GA^TT+QOXG\)>"_&'QK^%ND?%?P=\*]>^*UAX/
MM_`-AX_U_P`.:HEWX0\*ZWJVA^*O%]C/HEWIGA]9O%'AVRU+B];_`.";_@/7
M/&UIXZF^)?CZSU.U\1?M;Z]<:?I]MX<@T77A^U/J.K:Y;Z?XGL9-/F?6[?X*
M^)-<U;Q1\*Y9+F";3O$.IZAJ5ZTTMW(!SW@G_@F7X:\$Z/X,\"VGQI\?ZA\)
MM%N?V</&?C'X=7OA_P`#BV\??&/]EOX4_"GX3?#3XA7GB2'24\1>']-GTWX'
M?"7Q)XH\"Z+=KI&K>*/`VG36FH:5HVK>*]&\0@&EXV_X*L?LM:#\/?!_Q%\#
M2_$[XP:;XV\5_LJZ7H6F?#_X0_$^YUS4O`W[7'Q$T[X=_#3XOZ+I>J>#[&\\
M3_#>35;C4[)M;\,P:L-1\7:5'\-]-$OCS7-`T34;OPK_`."GG[.GBKP9XK\2
M_%/6S\%=2\(>(/VHK2_TSQ'I7CB^T?4/#7[,/[1GB']G[Q)JWAKQ@?!.FZ#X
MO\33W5OX'UW6_AQX1FUWQCX6NOB'H?AV?3]2N4:\EX-/^"5WA"T\)_"/0=,^
M,_CJUU?X(?LO_L>?L]>`O$,_AWPG?-%K?[%'QO\`"7Q^^%?Q-UK298H[/5+S
M5?&O@O1K/QCX0CEL=$U'PZ]_I^FWFDWD]OJ-IMQ_\$S/#W_"._#'2)OC)XJD
MU'X;W?[<VJ)JD_@+X9:WIVOZE^W1\2M2^)_CB/5_!GC/0/%O@R]T#PMJFJW^
MAZ3X9U;1-9TK7/#-W<Z?X@2>ZE6_C`/N#PS\>/AGXG^'?B;XJ?VMJ_A/P9X(
MA\07'C:]^)W@[QG\)=1\&0>%-*37/$=SXK\/_$SP_P"%?$&A66DZ/(NK3ZC?
MZ9%IT^ELFI65W=6,D=PWC,G[>W[,,&E:)J-WXR\5:?>>)?'6B_#;P[X0U7X0
M?&+2/B1KGC'Q3X$\9?$SP9IFE_##5/`=G\0KV'QUX)\`>+M:\$:K!X:?2?%;
M:'?Z5HU[<ZS;3Z=%SOP]_83\"^'OV<?CQ^S5XY\4:UXU\!_M%VOCC2_&^A:1
MIVG?#_P5X0\/>/OA_I?PYUSPI\%_`.C/J>B?"OPM+IFER>)3H>E3ZA9R>/M>
M\4>*G0/KDUA%YI\,O^"9_@#X<ZG\)?$%GXHT6PU_X6?M!^&OCN;CX=_`WX+?
M!W3?%TG@_P""GQM^"FA>&O$^F?#CPQH\FH&33OCEXF\4:OX@N]1O;N;Q%$(=
M`T[PSX?O[W1F`+_QP_X*>?`'X>?"=OB-\+KJ]^.&IW.G?!#7-.T'P[HGCW3-
M(M=%^.GQHT7X,^$SXW\9KX$U;1OACXCO]7N/$TFC>#/'ZZ!XIUC4_!VLZ"VF
M6%U&\\/M)_;M_9<33_%VKW'Q(GM-)\(6^H7IU6[\"?$BWTWQK8Z;XZTGX7W5
MW\(+V;P@D'QOB'Q*U_P_X`@'P@;QM)>^,/$?AC0K!+JZ\4>'/[5^.])_X)'^
M%O#OPY\3?"OPY\?OB-I/@[XCZOX.\2_%:R7PMX$O+CQOXE^&7Q[U7XY?#[54
MO+K3WN/#J6W]HV7P]\866FR20^+O!_AGP[)"_AW74UO4]=V?!7_!(WX)?#[2
MO$.D^#]:L?"CV-UX:U+X.^*/"OP<^"NA_$7X<:QX'^,/@[X[>!=5\2?$6+P=
M<>*OB_/X3\>?#[P;:6]GXUO8=(\1>$-(.E^-],\3^(+D^+80#Z^_9@_:BTG]
MIR[_`&B1H?A;5O#6F_`CX_S?`V&;7[7Q!HVN^(I+7X,_!CXKW>LZSX1\5>&O
M"_B/P-J=E>?%FX\*7GA76+&XO+>;PTVJ&\:+5HK:U\:\)?\`!23X#MX:^,NN
M_%O4?^%4W/P7O?VP_$'B+33:^)_&>[X+?L?_`+2GBO\`9M\5_%C[7H/A4(O]
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M=9U[PGXZT+P9IGBGX`:?J&M?%[PI_P`)[JOABU\%7GBOP3X<TN_\5ZAX9T_7
MKO7+KPE:7'B?2["^T:":[3VSX5_&[X>_&:R\07/@:_ULWGA35+;1_$_AOQ?X
M-\9?#?QIX<O;_2K+7M*&O>"/B'H'ACQ;I%OK6@ZC8ZUH=Y?Z-!9ZOIMP+BPG
MF$5RL'P/\1O^"4?PB^+7AC5?`WCSQ_XXU3P?XA_:1_:S_:)U_2;6R\-V<U[>
M?M8?#3XH_#K6_"=O=RV-Y':Z;X'/Q,E\2^&=0ELKVYO]7\/Z=:^(K74=)O-4
ML[GZA_9:_91\*_LQ>&?&&CZ$_@_^U/'.M6VKZ]J'P_\`@[\+_@AI+'3=(AT3
M3$MO#OPST+3HY[J*VCGOKG5=>U/7=0?5-1O_`.S9='T0:?H.G@'S#KO_``4G
MF^'FN_%K0?BA\*O"5MJOPV^%.M?$BX\,_"KX]^$OBSXR\(>(O^$^^'OPV^'?
MP6^/6G67AW0/#OP>^*OQC\1?$C1G^&]O;^*O&WA;5K31?'LDGB!;7P8^HZS]
M;_`WXZ^)/B!XW^+7P?\`B9X)T/P!\7_@XGP_UCQ)HOA'QK=?$/P=JW@OXJ:/
MK.H^!O%GASQ3J7A'P%K,L%YJ?A/QSX5U73=;\'Z-?6.O>#M1FM/[1T/4-'U2
M[^?=<_X)Y:3\2]1UJ[^.WQN^(OQ7\KX2^./@SX#U7^P/AYX%\8>'?#_CO6?A
M]XDO/&7BCQ-X1\-VL?Q%^*7A_P`2?"OP+X@\(^)=9T;3O#>B:WI,VKMX(O-3
MOI;Q/3_`?[,WQ"\">*KGXCK\==4\2_%+Q]\0/A_J/QM\:ZMX#\%:?!XT^$?P
MQ\)>,]"\)_![P[X7TZRDT[P5H\&L^*9_%ESK^F7DWB6;Q+K/BJ]CU.WT;5+7
MPUIX!3_:=_:A^)'[.EAXQ\?CX$IXG^"GPOT?P7K/CCQK??$K3/#7BWQ/+XM\
M2?V!/X6^!_P_B\.>(7^(/C30Q<Z2_P#8?BOQ%\-4\7Z_KVA^"/`5WXB\17TX
ML.3LOVY)YO']C]M^&5M9?`;7OVF?&G[('AOXIKX[ANO&%]\;O`;>*]!U7[9\
M,(O#"VMGX"U?XG>"/%/PE\/:Q#X\O/%UUXOLM*OKWP19^%]>BUC3[_QX_9-^
M+WQ?^.7@WXLZ7^TE#H7A;X=VVB7W@/X/>*_@CX4^(W@;PG\0-.N;N6_^+6FB
MZ\5>&;J_^)%S9W$.D^']>\2QZ^GP^T^&ZE\!6N@:KK>OZGJ=M/V(-&A^)*>)
M(/B7XI_X5CI?QK\5_M/>%O@O=:'X7N_#>@?M$^,+3Q`=3\9MXD:SC\5:IX5A
M\5>*O$?Q0L/`-U>1VUM\3M8FUQM=ET*STCPOIH!YOI/_``4$UO6/@C^U3\5;
M_P""L'POUK]G3]H_PY^SW:>%/C!\2]+T&UOF\8Z3^SSJWA[QO\1O$/@_0?&]
MM\.K.&T_:!TV]\2>&M'M?B!K6@VV@7-@SWOB*ZET;3_I3]G?]H%?BU\(-8^)
MWBK4OA1#)X<U7Q/9^)8?A)XR\:^/='\-1>&[*VU*ZL?$(\:?#+X7>.-#\66^
MFSKJ6H^%M6\"65_;Z?=Z3>V1U&UU:TF?P'X+_L6_&_X677[1E]?_`+8&NZIJ
M/[0WQ#M_C-?ZMX7^"'PV\%ZEX1^+-EX<^$G@VVU71Q>7WC/2-4\&WGA'X.Z%
MH>N^"]<T>ZFU2/6?$-Y!XFTR^N-.GTSVGPI^RU_9OP[_`&@/#?BKXM?$+6_B
M'^TXFM2_%#XP^%GTCX;>+M+U/4?A=HOP>T;4_A;:^&+5['X?7G@SP=X<T5_"
ME\DFNZS;>(;1_$&J:QJM[,!$`<_+_P`%!?V6+4QVNI>-?%NAZ]<>,_!7@&S\
M%>(?@Y\9O#_Q%U'Q-\3-%^(&O_#.UTWX<:SX!L?'5_:?$73_`(7>/8_!.J6O
MA^73O$6J^&=3T"QN6UVW?3AY%\?/^"HW[/OPL^"/B/XL_#FYU'XS:IH_@OPC
MXYM_"NC^'OB'HEE8Z3XR^*<WPCT:U^(_BQO`.K:=\'=<O_&.C^,M!TWPY\2;
M;P_X@O\`Q'X)\2^'_P"S(+S2K]K7S_X<_P#!)CX>>`?BGX,^,$'Q$:U\4^&?
M&/[.OC#5-.\"_"+X5?"WPGXEO/V;=,_:AT3PLVHZ%X,TFUDDU7Q+IG[3VNCQ
MEXFU+4=9\0ZG=>%M"^RWUEI1_L>SS;C_`()&^%(?AW\5/AAX>^/WQ)\.^%_C
MS+JUS\:8[7PQX$O;SQA=6W[0?Q,^/_@.YTZ[O]/EE\,2>&KKXGZE\/\`7OL!
MN!XS\#Z'X>28:#XAM[_6]1`/O?XZ?%+XM_#^*T?X8_"/PSXXL[;PYXQ\7^,/
M&'Q&^+>G_!SX<^$-'\'+I\W]EWOB4^%/'FK2^)_$T%S?W&C^=X8LO!FC:5H.
MO:SXQ\9:%';:58:W\??\/+[+6/"&H_&'PG\(KR?X'_#3X6?LW?%?]H+Q#XP\
M:6WA/XA_#/1OVD?"NA_$*QTO1_A[;^'/$&G^*=;^%7PV\2Z!X[^*=IK'C/P7
M'%I6IQZ9X&F\7^(+>ZTZ/W3]KO\`9:^(7[32^`]'T3X[#X??#SPW>ZMJOC?X
M4ZS\*/#/Q.^'_P`8=3DFT^;PLGQ'T[5=>\-:EK/AOP?/;WVH6_@6759?!7B?
M5KRSO?&VA>(8M#TFS@Y/QM^PC!\1-3UVY\4?%WQ$FB?&3PY\*-%_:N\(Z!X1
M\*:3X>^/E]\(X8(-+U2W6Y75=5^&">,-+M[?P7\0M.\.:GJL6N_#RPTGPYI5
MQX?U6P/B>X`/1OAC^U-J7Q`_:?\`VA/V=]8^$?B/X>6'P/\`AQ\*OB+I/CKQ
M9KVA"3XCZ1\1_'GQX\`3ZKIGA32WOKGPSX5T_4_@7JEYH.M^)-6MM6\6:5J\
M6LGPSH6CQZ9?:YA?LP?MCP?M,?%K]H_P'I7@&?PYX1^#<WP<U+X?>.KGQ"-0
MF^+O@3XP^"-3\6:%XZ'AK^QK"7P9I]])HU]+X;TZ\U36;_7/"5WX?\57BZ)+
MK)T.RX63]B'QSXD_:&^-WQ;^)WQ\M_'GPV_:"^$FG_L__$CX*1_!_1O"%M?_
M``7\-7_QSU+PAX8L/B3X:\:V_C?3-<LKGX]^*H?$'BVS>*]\0V5AHT%M9>'[
MBV:\/8_LU_L$_";]EKXU_';XS?#G7_B3=3_&_1?A;H%QX6\8_$KXD>/=&\*:
M;\,-!O-%M(=)N?'OC3Q5J&H2:D;F*=+K5Y)[OP_:6_\`8?AZXL=#N;NQE`/N
M.BBB@`HHHH`****`"BBB@`HHHH`***_*']HK]LSXR_"']NW]G[X(74GPU^%_
MP0^(%OJ=O<>(_BMX:\=S6'Q6NI;KX=VK)X/^+OAQ9O!7PW\4>']3\3:AX9T7
MP?XRL;J7Q9XD;2(-4O-'TWQCX1O5`/U>HK\(],_X*F_%2P@TG4-9TCX,^(O%
M/Q)^$_[8'BG3O@1!+X@^&_B_]F#XN?LW^%-5\:^$_@S^T_\`$OQ9XHU7POHU
MSXSTO0]6\/\`B;Q)KGAKX71:'XHLCJW@^R\8^`[P:W8=-X3_`&]OVB/BCX1\
M3Z?\+VM/%OBS1/&'P,L-4UZU_8G^/_A3QYX.TSXK>"?B?XYUC3M;_9+^(7Q:
MT/XB_P!B:8_A3P+X9\-_''7O'WA'X2ZUJ7C3Q'8_VE<ZA\+O$DU\`?MM17Q!
MI?[2FN0?L5_$3X[:9J_A7XE?$SX8>`_B]/JNF^*M#N/V9=$N/BS\,3XDM+KX
M>^-=%\;^*_%S?">33_$VEVOA37;_`%;Q=KFEQ@?\)+INL7>AZIIMRW*_L-?M
M9^(OVE-1^*6BZ_K&D:\W@#2OA7JYU"7X&?%3]EWQI8ZC\3-'\1>(KOPQKWP(
M^-OBCQ/\1+?1=!TVQT(^'OBH+BV\(>/+W4?$GAK0UN]8^'/B:^G`/T)HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"OC/XL_L*_!#XT?''P5\<?&[^.[N]\*P:DN
ML_#RU\>>)K?X2_$>]FG^'UWH.H_$/X?#4FT'79O#%]\,_"5Y;6D-K9:9XCET
M718O&]EXGM?#^@V^G_)/_!0/XI_$OP;^WC_P1T^'GA'Q_P",/"_@?XR?M)?M
M#>&_BKX4\/>(=2T;0_B'H/AW]EKQKXKT'2/%]EI]Q;IKFG:1XDL+36]/L[QG
MM[?4[>*[6,S1HR_K"GAO2BB$I>Y*J?\`D+ZUW`/?42?S)/O0!\KZG^PK\"?%
M>I>,;SXE#XC?%VR\4^'/%W@_3-#^*GQ3\<>-=)^'WA;Q[KFC>)O%VD_#==2U
M8:EX5EU37?#?AJ\LM?34[WQ5X8M?#NB:%X0U[0/#FG6^CK!:_L.?#2"3Q/X@
MF^('Q^O?BGXF/A&W?XVW/QI\6)\5M(T+P!-XTG\%>$-&URQ:RT6'P7H,OQ'\
M>S/X3U#PWJ>A^(;SQ5J>I^+K/Q#JJV-]9>IWGQ#\!65W=V4NF^*6EL[JXM)6
M34;LHTEM,\+E"VO*Q0LA*DJI*D$J#D"O_P`+,^'_`/T"_%?_`(,+K_Y?T`<)
M<_L/?`S4/"EKX`U5/'^L?#Z?P]\3]*\9>!]5^)/B^]\/?$[Q%\6_&'AGQ_XG
M^*'Q)CDU$:CXH^+>G^,?#*:[X*^(;ZC::]X`NM8UR/P=+HUI>06UGWOP?_9N
M\$?![Q/XQ\>VFM_$#Q[\2/'>D^&O#'B'XB?%+QIJ7C?Q9+X*\%7_`(GU7P9X
M'T^ZNH[/3](\+>&M4\:^+M4LK#2],M;B^U3Q#J>J:[>ZOJ,R74?0^%_$O@[Q
M;J;:5IUCXA@N%M9;PO>:G?I#Y4,D,;*##K4S[RTZ%1LVX#98$`'T/_A&M*_N
M7O\`X-]9_P#EC0!OT5@?\(UI7]R]_P#!OK/_`,L:/^$:TK^Y>_\`@WUG_P"6
M-`&_16!_PC6E?W+W_P`&^L__`"QH_P"$:TK^Y>_^#?6?_EC0!OT5@?\`"-:5
M_<O?_!OK/_RQH_X1K2O[E[_X-]9_^6-`&_16!_PC6E?W+W_P;ZS_`/+&C_A&
MM*_N7O\`X-]9_P#EC0!OT5@?\(UI7]R]_P#!OK/_`,L:/^$:TK^Y>_\`@WUG
M_P"6-`&_16!_PC6E?W+W_P`&^L__`"QH_P"$:TK^Y>_^#?6?_EC0!OT5@?\`
M"-:5_<O?_!OK/_RQH_X1K2O[E[_X-]9_^6-`&_16!_PC6E?W+W_P;ZS_`/+&
MC_A&M*_N7O\`X-]9_P#EC0!OT5@?\(UI7]R]_P#!OK/_`,L:/^$:TK^Y>_\`
M@WUG_P"6-`&_16!_PC6E?W+W_P`&^L__`"QH_P"$:TK^Y>_^#?6?_EC0!OT5
M@?\`"-:5_<O?_!OK/_RQH_X1K2O[E[_X-]9_^6-`&_16!_PC6E?W+W_P;ZS_
M`/+&K]CIEIIWF_91,/-V;_.N[RZ^YNV[?M=Q/L^\<^7MW<;LX&`#0HHHH`**
M**`"BBB@`HHHH`****`/Q`_X*3_\I)/^"%/_`&=;^U!_ZQS\0:_;R/\`U<?^
MXO\`Z"*_$/\`X*3_`/*23_@A3_V=;^U!_P"L<_$&OV\C_P!7'_N+_P"@B@#X
M(U__`)#VN_\`8:U;_P!.%Q636MK_`/R'M=_[#6K?^G"XK)H`]>^"?_(Y3?\`
M8#OO_2K3Z^LJ^3?@G_R.4W_8#OO_`$JT^OK*@`HHHH`****`"BBB@`HHHH`*
M^3/VWOBA\7?@Y^S3\3/B%\%-"75_&GA_0[N[_M$>'I/&L_@W18K*\FU?QU:^
M`(-6T&Z\>S^%8(4U#_A%K;6;&2[A\Z^D74;;3;C2-1^LZ\?^.OP-^'_[17PU
M\1?"SXD6>IS>'_$%I<0IJ7A_6M3\->*?#VH2V5Y8V_B#PMXDT:YM-3T/7;""
M_NTM;RWF:*:"XNM/U&VO]*OK_3[H`_%G5/\`@I7\<H?A#\`=>TGQCX1\:WU_
M\"?B;\3?C/XP^#W[,GQ4^+?C;0_'/PZU#PI;:%X5^*O[.UKXL\.^,/V>/!VM
M65_XH7QW\0?%-W)X?MO$VBPV7A[4O"NAW5KJ%QZ;XZ_X*)?%SP5XOG\1:WJ7
MPTL-`T'Q_P#L>^&]&^!OACP+XO\`B%K7Q\^#_P"TH/@!HOC;]I7X1?'+2_$-
MCX=U3X?^`O'/Q>\8Z#X6U'2O"6K>&M07X0:AIGB_4;#7/B+H!\,?:FA_\$[O
MV:?#'A/0?"WA;3/B)X2N--\+P^"_$GC;P7\7_B9X'^(_Q3\-_:+F\OK#XO>/
M/"/B?1O$7Q&EU&_OM1OEU'Q#>W&J:!+JFJ0>$+[PWI]_<63]\O[&GP&C\0>"
M-6M]"\56F@?#I?AY)X0^%=G\2OB+:_`_1]2^$=CHFF_"W6X?@K%XG7X:OJ_P
M_M/#?A]O"]R_APPV&IZ#X?\`$+VUQXD\.Z%K&G`'F7[-WQ_^-OQ#_:H_;+^#
M'Q:TGX<:'HGP1A_9\U+X<:5X$FUS6-4M="^*OAGX@ZO?KXU\5ZQ'IEOXC\1W
M$OA6PU!XM!\,:%HOAV&^_P"$=MY_$LUA/XFU/RKXG_M:_&?PKXU^./Q$T>3P
M;#\#/V:?VF?@+^S+XO\`AS>>!?$>H_$3XB2_%^T_9TNO%?Q"T3QK%XDL;7P]
M+X0;]I'PS_PAWAJV\'>(+#Q-#X,\2Q:SJT$OB[1+OPA[%H7[`'PC\/>.OC-\
M1]/^(?[3(\6?'SPCJ/@GXEZF_P"TS\7TDU/1KC0/$'AK0IM&-KXCM9?".N>`
M]+\3ZP/AYXC\*S:1KO@N^G@U31+^#4K*SNH?1M1_8\^!>K?$#2/B3J.A^)KO
MQ!IUYX`UG5+*;XB>/6\*>./%GPHM]-MOACX[^)/@O_A(O^$6^(7CWP&FD:7+
MX>\8^+-*U/78;O1_#E]>7=[>>$O"<^A@'U`IR.>O(/&!D$@X!SQD''/2EH`P
M,>G%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'X=_\`
M!2Z-Y?\`@H__`,$+(TGEMF;]JW]I[$T`A,J8_8[^(#':+B&>$[@"C;XG^5CM
MVMAA^T\>E7OEI_Q4>M?<7_ECH'H/^H%7XN_\%)_^4DG_``0I_P"SK?VH/_6.
M?B#7[>1_ZN/_`'%_]!%`'P-KBE=;UI2[2%=8U13(^P/(5OK@%W"*B!G(W,$1
M$R3M15PHRZUM?_Y#VN_]AK5O_3A<5DT`>J_!V"6X\6RQQ7ES8L-&O6\ZU6T:
M4@7-B#&1>VMW#L8D$D1!\J-K@;@WU#_95[_T,>M?]^=`_P#E%7S/\$_^1RF_
M[`=]_P"E6GU]94`8O]E7O_0QZU_WYT#_`.45-_LV[W!/^$EUG>0S!?+\/[BJ
ME0Q`_L/)"ETW$#"[ESC<N=ROYZ?VT?&R^`?^"IW[,>OS:AXP^*VL6VGZQ!X:
M^#NA>(OC5\,_BEX=L=3U7]GW1M8NO@?;:!,GPK^-O@[4DU/4?%WQ*T'7[#3-
M-N]/T+XG>%OB%\1(M.T'PAH&A@'[]#3+PDC_`(2/6^.Y@T$`_1CH(5OP)I1I
MEXW3Q'K?T,&@J?R;0@<<'!Q@]J_E7\'^-OV@M'M/B?=?"CQ+<^+?B_\`$7]F
M7]M'QII+_#WQS\0_%'[7G@SQ))-!XO\`!^C?MS^`YTO?#O@CXK>`?#6I7'@C
MX/6W@'2M-_LKXWV6C^"?#6CQ^$+N>"3[HT+XAWGA'Q%\8?#_`.P;X>^*WQE_
M9:\5Z3^RYH=WXB^!WB&7XD/\+/'^O3_'76?VB];\!ZG\4_'FBK-XOU/X0Z#\
M"]`UV#0_$VJW/@OXP_$32/B'XNT$^(X/'5OJ8!^X`TN](!'B/6^?6#00?Q!T
M($?B*!I=X<X\1ZWQ_P!,-``Z9X)T+!'N,CMUK\6_^";G[3$_A;_@F7^S]H.D
M^#O'?BS]HB+]G[XN>*OA)^SYXRUS3[;XN?%[1_A%XR709[W0[WQ9XQU";4?#
M.FZGXV\!^']1\4>(_$T>JPP:G:SW<4EY/:I<]9_P2S\4>.;_`.,?_!1?PYX[
M\._'ZRUFR_:)^$?B/5=?^-FDZ=HJ:CXH\3_L@?L\WOC"#P_HNG?$+QWIOA&U
MN_$G]H>)M*\!^')QX9\*>"]<\)V=O?7>KMJ\-L`?KS_95[_T,>M?]^=`_P#E
M%1_95[_T,>M?]^=`_P#E%6U10!B_V5>_]#'K7_?G0/\`Y14?V5>_]#'K7_?G
M0/\`Y15M44`>7>-/$J^"ETY[[5O$]X-2:Z2(6<7A@&,VJP,YD\_2(N&$Z[=N
M[E6SCC/"?\+AT[_GX\:?]^_"'_RMJQ\>_P#4^%O^NVK_`/HO3J^<Z`/H,_&+
M30"?M'C3@$_ZOPAV_P"X;7MT&GWD\$,Z^(M;59HHY0K1>']RB1`X!QH9&0#@
MX)&>AKX,?[C?[K?R-?H-IW_(/L?^O.U_]$)0!1_LJ]_Z&/6O^_.@?_**C^RK
MW_H8]:_[\Z!_\HJVJ*`,7^RKW_H8]:_[\Z!_\HJ/[*O?^ACUK_OSH'_RBK:H
MH`Q?[*O?^ACUK_OSH'_RBH_LJ]_Z&/6O^_.@?_**MJB@#%_LJ]_Z&/6O^_.@
M?_**C^RKW_H8]:_[\Z!_\HJVJ*`,7^RKW_H8]:_[\Z!_\HJNV=K/;>9YVI7N
MH;]NW[8FGIY6W=GR_L-C99WY&[S?,QM79M^;==HH`****`"BBB@`HHHH`***
M*`"BBB@#\0/^"D__`"DD_P""%/\`V=;^U!_ZQS\0:_;R/_5Q_P"XO_H(K\/O
M^"ERSM_P4?\`^"%@MY(HIC^U;^T]LDFA:>-<?L=_$`MNB2>W9\KN48F3:Q#'
M<`5;]IH[;Q#Y:8U;2,;%_P"8#=^@_P"I@H`^(]?_`.0]KO\`V&M6_P#3A<5D
MUJ:X'&MZT)&5Y!K&J!V12B,XOKC>RH7D**S9*H9'*@A2[$;CET`>O?!/_D<I
MO^P'??\`I5I]?65?(GP>2\?Q;*ME<6]M-_8UZ3)<VDEY'L^TV.Y1%%=V3!B=
MI#^<0`""C%@5^H/LWB+_`*"VD?\`@AN__F@H`VZS+C1=(NM4T_6[K2].N-9T
MJVU"RTO59[*VFU+3;/5VLFU6TL+Z2)KJRMM3;3=..HP6TL45\;"R^UI-]DM_
M+K_9O$7_`$%M(_\`!#=__-!1]G\0CKJVD=1_S`;ON<?]#!0!KK%&CNZHJO(0
M9'`PTA`"J78<N54;4+$E%^5<+Q0L4:J55%"EF<K@;2[LSNV,8W.[,[MC<[LS
ML2S$G^=;XN?\%&OVI?!OQ6^)OA#2/$?@I-)\*_$'QEX<TQ9?`%A-*NGZ)XAU
M'3;(2S2ZDTDL@MK:,/)(S.[`LS,Q)/GO_#S[]K;_`*&7P-_X;O3?_EC7ZQ0\
M&^+,11HUX5\G4*]*G6@I8O$J2A5A"<>9+!-)\L];-JZ=FUJ?F-;Q8X9H5JM"
M=#-G.C5G2DXX7#N+E3FX2<6\8FU=.UTFU:Z5]/Z:Q%&H`6-`%!4`(H`#$%@`
M`,!B`2!@$@$@X&%6-$+%$52Q!8JJJ6(``R0`3@``9SP`.@%?C-^P?^V7^T#^
MT'\:-4\#>//$'A*;1;3P!KOB.)+'P3;V$WV_3]8\-V,!,]GJT,IC$.J7.Z,N
M48[25)52/V!^S>(O^@MI'_@AN_\`YH*^%XCX=Q_"^9/*\QGAYXE4*.(;PM2=
M2ER5N;E7-4I4I<RY7S+DLM-7T^SR#/L%Q'EZS+`1Q$,.ZU2ARXF$*=7GI<O-
M[L*E6/+[RL^:[ZI&W16)]F\1?]!;2/\`P0W?_P`T%'V;Q%_T%M(_\$-W_P#-
M!7@GMFW16)]F\1?]!;2/_!#=_P#S04?9O$7_`$%M(_\`!#=__-!0!XM\>_\`
M4^%O^NVK_P#HO3J^<Z]^^-\>HQP^&OM]W9W0,VJ^5]EL)K$QD1V&_P`PRZC?
M^:&!7:%$6S:22^X!?`:`&O\`<;_=;^1K]!M._P"0?8_]>=K_`.B$K\^7^ZW^
MZ?Y&ONRPM_$!L;(KJNDJIM+;:#H5VQ"^2F`6&OJ&('!(503S@=*`.FHK$^S>
M(O\`H+:1_P""&[_^:"D:#Q`H+-K&C@`$DG0KH```DDD^(0```22>``2<`&@#
M<HK!,7B`8/\`:VE'/]WP]>OZ'DIK[`<$$>HY&12^3XAR!_:VDY(S_P`B_>X^
MA/\`;^`?8D'VYH`W:*PA!XA)(&KZ3QW.@7@![\$^(`&X[J32^1XA!"_VMI.3
M_P!2_>8_%O[?V@^@)!/&!R*`-RBL3[-XB_Z"VD?^"&[_`/F@H^S>(O\`H+:1
M_P""&[_^:"@#;HK$^S>(O^@MI'_@AN__`)H*O6<>HQ^9]ON[.ZSM\K[+8366
MS&[?O\W4+_S-V5V[?*V;3G?N&T`NT444`%%%%`!1110`4444`%%%%`'X@?\`
M!2?_`)22?\$*?^SK?VH/_6.?B#7[>1_ZN/\`W%_]!%?B'_P4G_Y22?\`!"G_
M`+.M_:@_]8Y^(-?MY'_JX_\`<7_T$4`?!&O_`/(>UW_L-:M_Z<+BLFM;7_\`
MD/:[_P!AK5O_`$X7%9-`'KWP3_Y'*;_L!WW_`*5:?7UE7R;\$_\`D<IO^P'?
M?^E6GU]94`%(>GXK_,4M(>GXK_,4`?QU?M$?\G`?'/\`[+!\2?\`U,=8KQVO
M8OVB/^3@/CG_`-E@^)/_`*F.L5X[7]]Y;_R+<N_[`,%_ZC4C^(\Q_P"1ACO^
MPS%?^GYGZ<_\$F_^3F]>_P"R0>*__4E\$U_1_7\X'_!)O_DYO7O^R0>*_P#U
M)?!-?T?U_+/C)_R6<_\`L68#\JQ_2'A-_P`DFO\`L98W\J`4445^5'Z8%%%%
M`'SW\>_]3X6_Z[:O_P"B].KYSKZ,^/?^I\+?]=M7_P#1>G5\YT`-?[C?[K?R
M-?H-IW_(/L?^O.U_]$)7Y\O]QO\`=;^1K]!M._Y!]C_UYVO_`*(2@"Y7YW_\
M%376/]B?XRR7'CF]\!::GAW57UF_;2?'-[X4UO2HO#^NS77@_P"(NK_#F]TC
MQ7X/\"^*S'%H^J^+;77=%TS2]1GT:W\27-[X;O\`5M#U?]$*J7]A9:I97>FZ
ME9VNH:??VT]E?6-[;Q75G>V=U$]O=6EW:SI)!<VMS!))!<6\T;PSPR/%*CQN
MRD`_GH\`>`OA?^TK^Q=^QEX#\3?!&YE\3?$'XGV/[-?@?QSXC\:^/_B-9:5\
M,M/\'Z[\5/BO\4_@3\0/&BZ+XU'@7Q#\,_AEXLTSX1ZAKNF:=)X+\67.B6N@
M1:GX8\,:#>:QZ!\6)G\._'7XLZ?:ZQK6F?M:^&_VM?V0/"?[&?@N'Q9\0;:6
M]_9#N],_9NL_'\7A+PE'>IX>\1_"ZZL&_:J_X7KK$^G:K9:;>:+<WGC35]-O
M/#/P]N]-_=FTLK2PM;:RL;6WL[.RABM[.TM88K>VM;>WB6""WMH(E2*"""!4
MAAAB1(XH46*-5C4*)BB%Q(5&]595;N%8J64'J%8HA91@,40L"47`!_.3^RQ\
M0M8^%7QZ^'NMW?Q)\%77A;X0?!']K'6_^"BWQOM_C7XX\?Z7\0$\"-X+U/P3
M\<OC3X:\2Z;86GP&\:6WB*Q\7W&F>`O%UI8>-O#/AZ;XD^$?!.GWOPF\#0:W
M?^K_`!8\62ZA\=OBUX@T_P`4ZE/^UQ)^UO\`LB0?L9Z#;>+?'MM'XD_9"\3Z
M7^SA=>/;WPCX5LKB+PUXA^$NLZ9>_M4WGQQUQ=(U2PTN]TRXOO%6IZ;?^%_A
MU/IO[O"*,;\*/WAS)P#O)18]SY^^VQ%3<^X[%5,[0`%,:%Q)M&]5*JW=58J6
M4'J%8HA91@,40L"47``JYP/QQU)VY.W)/.=N,YYSUIU%%`!1110`4444`%%%
M%`!1110`4444`%%%%`'X=_\`!2YID_X*/_\`!"QK>*.>8?M6_M/[(I9C;HV?
MV._B`&W3"&<IM4EAB)MQ`3Y=VX?M)'=>(?+3&CZ=]Q<?\3V0]AW&A_J!7XP?
M\%)_^4DG_!"G_LZW]J#_`-8Y^(-?MY'_`*N/_<7_`-!%`'P-KA<ZYK1=0CG6
M-4+HK^8J.;ZX+(LFU/,56R`^Q-X`;8N=HRZUM?\`^0]KO_8:U;_TX7%9-`'J
MGP>>\C\63-96T-U-_8UZ#'/=M9H$-U8;G$JVMV68$`"/RAD,6WKMPWT_]J\0
M_P#0'T[_`,'DO_RDKYJ^"?\`R.4W_8#OO_2K3Z^LJ`,+[5XA_P"@/IW_`(/)
M?_E)2&Y\0_\`0'T[J/\`F.R>H_Z@G_ZZWJ0]/Q7^8H`_CG_:$+GX^_'`RHL<
MA^+OQ',D:2>:B.?%^KET64I&9%5LJLACCW@!MB9VCR"O8OVB/^3@/CG_`-E@
M^)/_`*F.L5X[7]]Y;_R+<N_[`,%_ZC4C^(\Q_P"1ACO^PS%?^GYGZ8?\$IGN
MX_VEM=:RMH;J;_A4?BH&.>[-F@0^)/!6YQ*+6[)8$*H3R@"&+;QLVM_17]J\
M0_\`0'T[_P`'DO\`\I*_G=_X)-_\G-Z]_P!D@\5_^I+X)K^C^OY9\9/^2SG_
M`-BS`?\`N8_I#PF_Y)-?]C+&_E0,+[5XA_Z`^G?^#R7_`.4E'VKQ#_T!]._\
M'DO_`,I*W:*_*C],,+[5XA_Z`^G?^#R7_P"4E'VKQ#_T!]._\'DO_P`I*W:*
M`/FSXW2ZC)%X;^WV=M:`2ZKY1M[YKWS"8[#>'#6-GY>T!=I'F;\D$)MRW@5?
M1GQ[_P!3X6_Z[:O_`.B].KYSH`:_W6_W3_(U]UV-SX@%E9A=(T\J+6W"DZY(
M"5\I-I(_L4X)&"1DX/&3UKX4?[C?[K?R-?H-IW_(/L?^O.U_]$)0!G?:O$/_
M`$!]._\`!Y+_`/*2C[5XA_Z`^G?^#R7_`.4E;M%`'Y??\%#/VH?C7^SK!\)9
M/AW-X;T-O%UQXUCU<ZEIMOXK%RNB0>&I+$0K=P:9]A,+:E=&1HS-]I$B*PC\
MD%OS0_X>>_M;_P#0S>!__#=Z9_\`+"OKS_@L?_QZ?L]?]?GQ._\`23P37X=U
M_5/AOPQP[F/!F3XS'9)E>+Q5;^T/:XC$8+#U:U3V>:8RG#GJ3IN4N2G3A"-V
M[1BDM$K?S7X@<19]@>+<UPN"SC,L+AJ2P'LJ&'QE>E1I\^78.K/DIPFHQYJD
MI3E9:RDV]6S]!)O^"G_[7"0SNOB?P.&C@GD4_P#"N]+X:.)W4X^W\X*@X/!Z
M9&<U_1;X&U_Q9KW@KPAK=_IFES7VL>%_#VJ7DT>K-;1RW>HZ/97ES(ENFC2+
M;H\T[LL*R.(E(0.P`-?QDW'_`![77_7I=_\`I/+7]GWPI_Y)A\.O^Q$\'?\`
MJ-Z97R'C'D6391@\AGE>5X'+Y5\1F$:TL'AJ.'=6-.G@^15'2A'G4'*3BI74
M7)VM<^I\)LXS7-,5G<,RS'&XZ-'#X&5&.+Q-6NJ<IU,3&;@JDI*+DH14FK-J
M*OL=%]J\0_\`0'T[_P`'DO\`\I*/M7B'_H#Z=_X/)?\`Y25NT5^"G[687VKQ
M#_T!]._\'DO_`,I*O64NHR>;]OL[:TV[/*^SWSWOF9W;]^ZQL_+VX7&/,W[C
M]W;\U^B@`HHHH`****`"BBB@`HHJ.9WCBDD2%[AT1W2")HEDF95++%&TTD4(
M>0@(AEECC#$%Y$3+``DHKX\\0?'3XL^'=?T.RUG2/V9_#$GB77XO"7AGP!XQ
M_:1ET/XF^)/%=[IK:YIOA32X4^&UYX;N?&][H(&L6_A+2KO7?.LP+F'7)-.=
MM2B^M-+NKF^TVPO+W3KC2+RZL[:XNM*NY[*YN=.N)H4DFL;BXTVYO-/GFM9&
M:"2:RN[FTE:,R6\\L3(Y`/Q/_P""D_\`RDD_X(4_]G6_M0?^L<_$&OV\C_U<
M?^XO_H(K\/O^"ETK0_\`!1__`((62+!-<LO[5O[3^(;<1&9\_L=_$!?D\Z6&
M+Y0=S;I5PBL1N;"G]I(]8NPB#_A'=<^XO\.CCL.W]M<4`?$NO_\`(>UW_L-:
MM_Z<+BLFM37&+ZYK3%'C+:QJC&.3:)(RU]<$I($9TWH3M?8[IN!VNRX8Y=`'
MKWP3_P"1RF_[`=]_Z5:?7UE7R'\'KB2U\6321V=U?-_8MZODV8MC*`;FP)<_
M:KFUCV+C!Q*7W,N$(R5^GO[9O/\`H7=<_P"^='_^75`&]2'I^*_S%87]LWG_
M`$+NN?\`?.C_`/RZH.L7A_YEW7.H_AT?U'IK5`'\@_[1'_)P'QS_`.RP?$G_
M`-3'6*\=KU_]H1B_Q]^.#F-XB_Q=^([&*78)(RWB_5R8Y!&\D8="=K[)'3<#
MM=EPQ\@K^^\M_P"1;EW_`&`8+_U&I'\1YC_R,,=_V&8K_P!/S/TY_P""3?\`
MR<WKW_9(/%?_`*DO@FOZ/Z_FW_X)37$EM^TMKLD=G=WK'X1^*D\FS%L90#XD
M\%'S#]JN;6/8N`IQ(7W,H"$%F7^BK^V;S_H7=<_[YT?_`.75?RSXR?\`)9S_
M`.Q9@/\`W,?TAX3?\DFO^QEC?RH&]16#_;-Y_P!"[KG_`'SH_P#\NJ/[9O/^
MA=US_OG1_P#Y=5^5'Z8;U%8/]LWG_0NZY_WSH_\`\NJ/[9O/^A=US_OG1_\`
MY=4`>,_'O_4^%O\`KMJ__HO3J^<Z]]^-M[-=Q>&Q+IU]8>7+JI4WHLP)=T=A
MD1_9+V\Y3:"WF>6/F7:6^;;X%0`U_N-_NM_(U^@VG?\`(/L?^O.U_P#1"5^?
M+_=;_=/\C7W58ZO=K96:CP_K;!;6W`8+I&&`A0!ANUE3@]1E0<=0#Q0!U%%8
M/]LWG_0NZY_WSH__`,NJ/[9O/^A=US_OG1__`)=4`?C3_P`%C_\`CT_9Z_Z_
M/B=_Z2>":_#NOVU_X+!7DUW:?L_>;IU_8;+SXF;3>BS`EW6G@K(B-I>WG*8R
M_F>6,,NTMEMOXE5_8WA7_P`D'D7_`'4O_5OCS^4O$O\`Y+7.?3+O_55@2*X_
MX]KK_KTN_P#TGEK^S[X4_P#),/AU_P!B)X._]1O3*_C!G_X][KM_HEU_Z3R^
ME?V1_"W5KI/AG\/%70-:D"^!?"`#JND;6QX=TT;EW:PC%3C(W(I&<%00:^(\
M=?\`<N'?^PG,_P#TW@3[#P8_WSB#_L&R[_T[BSUJBL'^V;S_`*%W7/\`OG1_
M_EU1_;-Y_P!"[KG_`'SH_P#\NJ_G`_?3>HK!_MF\_P"A=US_`+YT?_Y=5?LK
MR:[\SS=.OK#R]FW[:+,>;NW9\O[)>W?W-OS[_+^\NW=S@`OT444`%%%%`!11
M10`4C8VG.<8.<9SC'.,<Y],<^E+2-]UL#)P>/7CI^-`'X8^-O@!K7Q'_`&M/
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M0?\`K'/Q!K]O(_\`5Q_[B_\`H(K\0_\`@I/_`,I)/^"%/_9UO[4'_K'/Q!K]
MO(_]7'_N+_Z"*`/@C7_^0]KO_8:U;_TX7%9-:VO_`/(>UW_L-:M_Z<+BLF@#
MU[X)_P#(Y3?]@.^_]*M/KZRKY-^"?_(Y3?\`8#OO_2K3Z^LJ`"D/3\5_F*6D
M/3\5_F*`/XZOVB/^3@/CG_V6#XD_^ICK%>.U[%^T1_R<!\<_^RP?$G_U,=8K
MQVO[[RW_`)%N7?\`8!@O_4:D?Q'F/_(PQW_89BO_`$_,_3G_`()-_P#)S>O?
M]D@\5_\`J2^":_H_K^<#_@DW_P`G-Z]_V2#Q7_ZDO@FOZ/Z_EGQD_P"2SG_V
M+,!^58_I#PF_Y)-?]C+&_E0"BBBORH_3`HHHH`^>_CW_`*GPM_UVU?\`]%Z=
M7SG7T9\>_P#4^%O^NVK_`/HO3J^<Z`&O]QO]UOY&OT&T[_D'V/\`UYVO_HA*
M_/E_N-_NM_(U^@VG?\@^Q_Z\[7_T0E`%RBBB@#\2_P#@L?\`\>G[/7_7Y\3O
M_23P37X=U^XG_!8__CT_9Z_Z_/B=_P"DG@FOP[K^QO"O_D@\B_[J7_JWQY_*
M7B7_`,EKG/IEW_JJP)%<?\>UU_UZ7?\`Z3RU_9]\*?\`DF'PZ_[$3P=_ZC>F
M5_&#<?\`'M=?]>EW_P"D\M?V??"G_DF'PZ_[$3P=_P"HWIE?$>.O^X\._P#8
M3F?_`*;P)]AX,?[YQ!_V#9=_Z=Q9W]%%%?S@?OH4444`%%%%`!1110`4444`
M%8OB.`77A_7+8Q-.+C1]4@,"6MU>O,);"XC,26=E>Z;>732;MBVUIJ-A<SEA
M%!>VLKI<1[55-0LK34K&\TZ_MXKJQO[2YL[RVG7=#<6MU#);W,$JC&Z*:&1X
MY!GE&84`?SN^#_`?C?Q!\9_AUXG\2?!_QPMY%XR^&*7.IR?\$]/VR_!=C:VG
MA6?PWHNE75SK%[_P4U\1^$O#ZZ5H^CV,<OB/6_!7BBQT];5]7UW0_$>R_M+_
M`/HL']3_`#/N?_K]<#I7\^FN?"WX9ZY^VQXF%A\//#<$7PI^-/PD\&:!=_"+
M_@GQXZ^.^CZ=9^&/"7PRO=*LOB#^TLTL^B>"_'^A03VMIK,.FVUAI'PM\+0^
M$[NY%_?PZEJ=W_06.GXMVQW/^<]^M`'X=_\`!2^XBM?^"CW_``0LGG8I%'^U
M;^T^68))(1N_8[^("*`D222$EF`^5#C.6PH)'[1Q^)M&$:?Z3*0$7G[#J6.@
MYYL@<?4"OQB_X*3_`/*23_@A3_V=;^U!^O['/Q!S7[>1DF-"3DE%))ZDX')H
M`^!M<=9-;UJ1#N235]3D1L,NY'OIV4[7"LN5(.UE5AT8`@BLNM;7^=?UTGK_
M`&UJW_IPN*R:`/4_@_>VUAXLFGNI#'&=&O8P5BGF)=KFP(7;!%*XX5CN*A1C
M!;<5!^GO^$FT?_GXE_\``'4O_D.OFSX)_P#(XS>^AWV?_`K3S_.OK*@#`_X2
M;1_^?B7_`,`=2_\`D.D/B;1_^?F7J/\`EQU+U'_3G704A_J/YB@#^.?]H21)
MOCY\;Y8VW1R_%WXCR1MM9=R/XOU=E;:ZHZY4@[756'1E!!`\@KV+]HCG]H'X
MYD\G_A<'Q*_]3'6*\=K^^\M_Y%N7?]@&"_\`4:D?Q'F/_(PQW_89BO\`T_,_
M2_\`X)3WMM8?M*Z[/=2&.,_"/Q5&&$4\Q+MXD\%$#;;Q2N.%8Y*A>,;MQ4'^
MBK_A)M'_`.?B7_P!U+_Y#K^=_P#X)-DC]IO7L'_FD'BO_P!27P2?Y\U_1_7\
ML^,G_)9S_P"Q9@/RK'](>$W_`"2:_P"QEC?RH&!_PDVC_P#/Q+_X`ZE_\AT?
M\)-H_P#S\2_^`.I?_(=;]%?E1^F&!_PDVC_\_$O_`(`ZE_\`(='_``DVC_\`
M/Q+_`.`.I?\`R'6_10!\U_&W5++48O#8M)6D,,NJF3=!<P8#QV`7'VB&'=G:
MV=F[&/FQD9\#KZ,^/?\`J?"W_7;5_P#T7IU?.=`#7^ZW^Z?Y&ONFP\2Z.MC9
MJ;F7*VMNIQ8ZB1E84!Y%F0>1V-?"S_<;_=;^1K]!M/YL+$GD_8[;_P!$I0!F
M?\)-H_\`S\2_^`.I?_(='_"3:/\`\_$O_@#J7_R'6_10!^'G_!8'4[/4;3]G
M_P"R2M(8;SXF>8&@N8"H>T\%[2/M$$(;=M;[A8C:=P4%<_B57[B?\%CR?L?[
M/0SQ]L^)QQVR;3P3D_C@9^@K\.Z_L;PJ_P"2#R/_`+J?_JWQY_*7B7_R6N<^
MF7?^JK`D4_\`Q[W7_7I=?^D\M?V1?"WQ'I$?PT^'D;7,FY/`WA!6Q9:B0"OA
MW3`>19E3TR"I(((P:_C=N/\`CVNO^O2[_P#2>6O[/OA22?AA\.LG/_%">#__
M`%'-,/\`,DU\1XZ_[EPY_P!A.9W_`/!>!_K]>C^P\&/]\X@_[!LN_P#3N+.@
M_P"$FT?_`)^)?_`'4O\`Y#H_X2;1_P#GXE_\`=2_^0ZWZ*_G`_?3`_X2;1_^
M?B7_`,`=2_\`D.K]CJ=GJ/F_9)6D\G9YFZ"YAV^9NVX^T0P[L[&^YNQCYL9&
M="B@`HHHH`****`"BBB@`H.,'/`QR<XX^O;ZT52U*Y:ST^^NTC29[:SNKA(9
M+F&SCE>""258WN[C]Q;)(R!&N)OW4"L99/D1J`/S1\;ZI^Q)9?M/:M:W_P`3
M/VC4^-ES\0/`Z^*?#OPL^*'[<%W\,['QW)8^&F\-:)XU\.?"'5;OX#Z%<S:-
M-X:N=?\`#WBFWL+>7P]J-C=^,;+^Q=1267].A[>I]?4YZ^_3MCIQBOQ(\-Z5
M^T]JOQ9O?CCI'A?X^_##X7>/_B)X5\=>/+#P9^V1^Q?JGP+M+?3T\/Z+K^M2
MZ8_P5UGQ#>:9?Z)H\4OBM-+\=0:[X@6*86^LVNH26EQ;?M7IVH6&K6%GJFE7
MUIJ6F:C;0WNGZC87,-Y8WUE=1K/:W=G=V[R07-K<0NDMO/"[Q2Q.DD;LC!B`
M?B;_`,%)_P#E))_P0I_[.M_:@_\`6.?B#7[>1_ZN/_<7_P!!%?B!_P`%+)8X
M?^"D'_!"N6:2.*-/VK?VGRTDLB1HN?V.OB`!N>1E49)"C)&YB%&20#^UD>M:
M0(TSJFF\(N?]/LR.`.XGP1[CB@#X;U__`)#VN_\`8:U;_P!.%Q636KKK*^NZ
MVZ,KHVLZJRNC!E96O[@JRLI*LK`@JRD@@@@D&LJ@#U[X)_\`(Y3?]@.^_P#2
MK3Z^LJ^1_@U<V]KXNFEN9X+>/^Q;U1)/-%"A9KJPPH:5T4L<$A02Q`)`P"1]
M2_VUI'_04T[_`,#K3_X]0!ITAZ?BO\Q6;_;6D?\`04T[_P`#K3_X]2'6M(_Z
M"FG=1_R_VGJ/^FU`'\?O[1'_`"<!\<_^RP?$G_U,=8KQVO8/VAF5_C]\<71E
M='^+WQ(9'1E='5O&&L%61U)5U8$%64E6!!!((->/U_?>6_\`(MR[_L`P7_J-
M2/XCS'_D88[_`+#,5_Z?F?IS_P`$F_\`DYO7O^R0>*__`%)?!-?T?U_-U_P2
MBN;>U_:7UV6YGAMXO^%1^*8_,GECAC\Q_$G@LHF^5D3>P1V5,[F5'8`A&(_H
MP_MS1O\`H+:9QDG_`(F%GP%.&/\`K^QX/H>M?RSXR?\`)9S_`.Q9@/RK'](>
M$_\`R2:_[&6-_*B:M%97]N:-_P!!;3.H'_(0L^K8('^OZD$$#J<C'6E_MS1B
M,C5=-(ZY_M"SQ@9R<^?CC!_(^E?E1^F&I166-;T<YQJNFG&,XO[,XR`1G]]W
M!!'L0:7^VM(_Z"FG?^!UI_\`'J`/#OCW_J?"W_7;5_\`T7IU?.=?07QRO;.\
MA\,BUNK:Y,<VK&06\\,Y0-'8!2_E.^T,00-V,X.,X-?/M`#7^XW^ZW\C7Z#:
M=_R#['_KSM?_`$0E?GR_W6_W3_(U]Z6&LZ2MC9*=3TX%;2W4C[=:<$0H"#^^
MZ@C!H`WJ*S/[:TC_`*"FG?\`@=:?_'J/[:TC_H*:=_X'6G_QZ@#\7O\`@L?_
M`,>G[/7_`%^?$[_TD\$U^'=?MW_P6'O;.\M/V??LMU;7/EWGQ-\P6]Q#.4W6
MG@K:7$3N4#8.TL`&(8+G:<?B)7]C>%?_`"0>1?\`=2_]6^//Y2\2_P#DM<Y]
M,N_]56!(KC_CVNO^O2[_`/2>6O[/OA3_`,DP^'7_`&(G@[_U&],K^,&?_CVN
MO^O2Z_\`2>6O[+?A7J^E)\,OAVCZGIZLO@7P@K*;ZT!4KX<TP$$&;(((.00#
M[5\1XZ_[EP[_`-A.9_\`IO`GV'@Q_OG$'_8-EW_IW%GJ%%9G]M:1_P!!33O_
M``.M/_CU']M:1_T%-._\#K3_`./5_.!^^FG169_;6D?]!33O_`ZT_P#CU6;:
M]L[S?]DNK:Y\O;YGV>>&?9NSMW^4[[=VT[=V,X.,X-`%JBBB@`HHHH`****`
M"BBB@#QB^_9S^`&I^(G\7:C\$_A/?^)Y;EKV;7[SX>>$KC59[YIQ<F_GNY=)
M>2XO_/"RB_F,EX)%1Q/N12/9@`H"J`%```````&``!P`!P`.`*6B@#\/O^"E
M2))_P4A_X(5)(B2(W[5O[4`9'574_P#&'7Q!(RK`@X(!&1P0".0#7[91Z?IY
MC0_8;/E%/%K`!T'81X'T'%?B?_P4G_Y22?\`!"G_`+.M_:@_]8Y^(-?MY'_J
MX_\`<7_T$4`?`^O`+KNN*H"JNLZJJJH"JJB_N`%50`%4`````````"LJM;7_
M`/D/:[_V&M6_].%Q630!ZU\&(8IO%\R3113)_8E\VV6-)%#"ZL,,%<,`PR0"
M!G!(S@FOJK^SM/\`^?&S_P#`:#_XBOEGX)_\CE-_V`[[_P!*M/KZRH`I_P!G
M:?\`\^-G_P"`T'_Q%(=.T_\`Y\;/J/\`EU@]1_L5=I#T_%?YB@#^.G]H=57X
M_P#QR55557XO_$E550%55'C#6`%50`%4#@```#@#%>/5[%^T1_R<!\<_^RP?
M$G_U,=8KQVO[[RW_`)%N7?\`8!@O_4:D?Q'F/_(PQW_89BO_`$_,I_LM_%R?
MX6_\%(/A5K&M>/?',O@Z/PE>>'Y_!/PE^('AS2/%NF7GC'X@_LX>%K2P\5_!
MOQ1I-W'\;O#7B_6/%5M-J.G^%GU+Q_;^#+_Q)K7@6PTG4OA9?:E>?M7+\23H
MO[2=II&F_M;^)?#GP.^+GP*_:8UVV_:"D_:"\$?&S2=3U/P[:^!O%+_%+4O`
M>O:#H_PK_9`L/V>;"X\9^'_"_B+2M%OO`&NS7&E^&_B+;6WB)="MM7^>O^"5
M?A7PQJW[7"^*-4\.Z)J/B7PI\&_B#!X7\07VF6EUK/AV'7O$/@&'6H]$U&:)
M[K35U6&TMX;XVLD;30HT181SW"S?T%77P,^"M\?';7OPB^%]V?BC;S6GQ+-S
M\/O"$Y^(5I<-OGMO')ET9SXNMYG^>6#Q#_:44C?-(C-S7\F>+&&J8;C7,'.K
M[7ZS1PN*IZS;A3J4N14GSN37(Z<E%1DX*'*H1IQM2A_3GACB88CA#`QA3]F\
M-5Q.&J:12G4A4YW47(HI\ZJ1E)N*DY<W/*I/FJS_`"@\$ZQ)XG\)?%K5M&^.
M?Q1TOX!^/O&/PSL/V3_"?Q._:>O/`'Q5^-7B?1/!/CW7/B%"/C=XIT[Q3\;/
MA?\`![XWBRT3Q+X'\,W6IZ5\1;B#X:>+?&&@6V@?#_XA0^&KOUS]EOXP:;XU
M_8V\1:;\2_VDHOAK\1--U#]JO2[[XG^*_%_P_P!8\7?#;P;\(OC+XF\+:QK_
M`(<^)7C>+^P/C'X7^`N@7_A?P8O[2.MZ+)I'BJXL-'\9>/=+TGQ)J^H^'T^Y
M]$_9E_9Q\,Z!XJ\*>'/@#\%-`\+^.FT]_&WAO1/A1X!TK0?&#Z3+<3Z6WBG1
MK#P];Z;XA;39KNZFL&UBVO&LI;FXDMC$\\I?H]5^"OP>U[3;31M<^%/PVUG2
M;#P9K'PYL=+U7P)X4U'3K/X?^(9M%N->\#6MC>:1-:VW@[6[CPWX>GU?PO#"
MFA:E-H6C2WNGSR:78M;_`)N?H!\;_L-7.K^*M8^-GBW0/%7COQ/^S-KEY\._
M^&?+'XS>--1^(GQ,NS9Z)KB_$;XH1ZGXQN-4^(_AWX7_`!4U"X\,7/PV\'_$
M'44UM7\,^*O'.F:1X?\`"OCW0=(A_0G^SM/_`.?&S_\``:#_`.(KS[X<?!3X
M.?!T:V/A+\*/AI\+QXEFL[CQ$/AWX#\*>"!KT^G?:Q83ZT/"^D:4-5FLAJ%\
M+.2_^T/;?;;OR&C^TS;_`$V@#YU^.MM;V\/ACR((8=TVK;O*B2/=B/3\;MBK
MG&3C.<9..M?/-?1GQ[_U/A;_`*[:O_Z+TZOG.@!K_=;_`'3_`"-??>GZ?8-8
M61-C9DFTMB3]F@Y)A0D_<KX$?[C?[K?R-?H-IW_(/L?^O.U_]$)0`?V=I_\`
MSXV?_@-!_P#$4?V=I_\`SXV?_@-!_P#$5<HH`_$7_@L5;V\%I^SYY$$$.Z\^
M)N[R8HXRV+3P5C<452P7)V@Y"Y;&-QS^(-?N)_P6/_X]/V>O^OSXG?\`I)X)
MK\.Z_L;PK_Y(/(O^ZE_ZM\>?REXE_P#):YSZ9=_ZJL"13_\`'M=?]>EU_P"D
M\M?V9_"JPL6^&7P[9K*T9CX%\'DDVT!))\.:822=F223U/-?Q$?%_7/%WAOX
M:^+];\#Z6-5\1:?I%U-#$+$ZK+I^GK#*=8U^WT07VEG7[CP[I8N=9BT)=2LC
MJ/V-D,LB1O:77]`GPN_:K^-^M?L'_"SXVV7[1'[/WAJU^'WPML[#X@ZYJ'P0
M^(EQX^\4?'"#PCX(N/AK\"KSX$:SXJ\.ZWX;\5>*$UJ*WU?1/"^I:KXP^)FH
M>(_`E]\%]$T7P]XGL;J?\_\`'3%4W'A[!\E3VD99CB.=PM2<)+!T^6,V[RJ1
M<;R2BU&,HWE=V/N/!C#34L^Q?-3=.4<!A^12O54XO$U.:4+6C!QE:+<KRDI6
MC97/VQ_L[3_^?&S_`/`:#_XBC^SM/_Y\;/\`\!H/_B*_$7Q9_P`%`?VD/#?Q
MF\.Z)XV\.:#\,=#TE_V0]"\::#I_P_USXG?"KPAXZ^/%CX5F^,7@/]HG]J/2
M]<L?"_[//C3X;WGB);'P#HNL:$(_$%IJWPT\3W5QXH3XI:?X7T'Z+_9S^-7Q
M[F^.T.@_M%ZW\2O#.F_%/4_C7IGP?\%^)/V>O!/@+P1J&H>!O%FJ:G9:)H/C
M[1O'_BOXC7FM:1\,-$N]=T__`(6)X3\&6'Q'T6WUSQ;X3GU"UTS[)#_/)^ZG
MZ7_V=I__`#XV?_@-!_\`$5-%;V]ON\B"&'=C=Y421[L9QNV*N<9.,YQDXZU^
M4'[8G_!0"7X2_M`?`7X,_#/QY\)-+\C]IW]G[X:_M'CQKJ>BW6MQ^'OC=;ZV
M]CX%\*:;+XFTB\\/^*M.\/G1/B3XE\4ZI97MGH?A[5_`NE6>FZC<^.Y[SP]^
ML:$LB,>I52?8D`D8[8/;M0`ZBBB@`HHHH`****`"BBB@`HHHH`_$#_@I/_RD
MD_X(4\$_\96_M0'@$G`_8Y^())P/0<GT'-?MW&<1H"""$4$%6R#@<'BOP^_X
M*76\-U_P4>_X(607$:RPR?M6_M/;XVSM;;^QW\0'7.T@_*ZJPYZ@9R,BOVD3
MPOH!1#_9<`RJG`:;`R!ZRD_F:`/B;7^-?UT'K_;6K?\`IPN*R:U-<1(];UJ.
M-0D<>KZI&B#.%1+Z=449).%4`#))P.23S670!Z]\$_\`D<9S@G&AWV<`G'^E
M:>,G'09(&?4@5]8Y'O\`D?\`"OD3X/V-IJ'BR:"]@2XA&C7L@1RP`=;FP"L-
MK*<@,PY.,,>,X(^G?^$6T#_H&0?]]2__`!R@#>R/?\C_`(4A/UZC^$^H]JPO
M^$6T#_H&0?\`?4O_`,<H_P"$7T`8(TR#J/XI?4?]-*`/Y"/VB./V@?CF""#_
M`,+@^)601@C_`(K'6."#R#[&O':]?_:$C2'X^?'"*)0D47Q=^(\<:#.$1/%^
MKJBC))PJ@`9).!R2:\@K^^\M_P"1;EW_`&`8+_U&I'\1YC_R,,=_V&8K_P!/
MS/TZ_P""30S^TWKO!Q_PJ#Q5G`)P#XE\$#)P#CD@9/<@=Z\<^.7_``75_:>^
M%_QK^,'PTT7X3_`6^T?X=_%'Q_X&TF]U6R^(9U2\TWPGXKU;0;&ZU(VGC2VM
M3?W%K8137AMK:WMS</)Y,,4>V-?6?^"4MC:7_P"TOK<%Y`EQ$/A)XID".6`#
MKXD\%*&&UE.0K,.21ACQG!'\^7[6T:0_M6?M-Q1*$BB_:#^,L<:#.$1/B)XB
M5%&23A5``R2<#DDUXO#/"7#?%OB5Q/A^(\IPV;4<'PUDE;#4\2ZJ5&K4Q.*A
M.</95*;;E!)/FOMHEU[^)N*N(>%O#_AROP_FF(RNKB^(<YI8F>'5)NK3IX;"
M3A"7M:=16C*3:LEJ]3]8O^(@_P#:Q_Z([^SM_P"`/Q+_`/F[K[Q_X)Q_\%9_
MCS^V/^TI;_!?XA?#OX1>&_#DWP^\9^+FU/P7:^-(];&H>')_#\5G;*VM^*-7
ML?L<XU><W(-F9BT</E2QC>'_`)*:_8/_`((;VEK??MW6,%W"EQ"?@M\4G\M]
MP7<MUX-P?E93D`L.O<]\$?3^(?A3X>93P-Q7F>7<*Y=A<?@<CQ^)PF)IRQ7/
M0KTJ$I4ZD.;$2CS0DDUS)J^Z/FN`?$[CW-.-.&,NS#B;,,5@L9G6`P^*P]18
M;DK4*N(IPJ4Y\M",N646T[23\]7?^U3(]_R/^%&1[_D?\*P?^$6T#_H&0?\`
M?4O_`,<H_P"$6T#_`*!D'_?4O_QRO\]S^\CQKX]',/A;K_KM7Z@C_EGI_K7S
MG7OGQMTK3]-B\-FQM8[8S2ZJ)=A<[PD=@4!W,WW2S8QCK7@=`#7^XW^ZW\C7
MZ"Z><6%B"#D6=L.A_P">*>U?GT_W6_W3_(U]TV/AC07L;-VTR`LUK;LQW3<E
MH4)/^L]30!U&1[_D?\*,CW_(_P"%8/\`PBV@?]`R#_OJ7_XY1_PBV@?]`R#_
M`+ZE_P#CE`'XU?\`!8__`(\_V>C@X^V?$X9((&1:>"<@9'.,C/ID>M?AW7[:
M_P#!8'2]/TVT_9_^PVL=MYUY\3/-*%R7"6G@O8&WNPPNYB,`<L<YXQ^)5?V-
MX5?\D'D?_=3_`/5OCS^4O$O_`)+7.?3+O_55@3EO&WA+0?'/A;6_#'B2S>\T
MK4K"Z$@ANKNPO+2YCMIFM-2TW4+">VO=/U33YB+BQO;:=)(9EVN);>2>WF_I
MH^'?_!-S]FZZ^&G[.-YI<WQG\':W\*_`%M-X<\2>!?CS\6O!VOW_`(A\9^"_
M#&B>*O'7BJ_T/Q/;#Q5\1=8T#1-,\+?\)YK$-QXETCP=:+X(\.ZAHW@YY-!?
M^;N?_CWNO^O2Z_\`2>6OZ*OVFOVV?A3^PG\'/V<]<\=?"[Q9X^3XF^';/2;&
M/PA>:):S:=/X=\%^'=4N9[\Z_JVG1O'=)J*1P"U:5EDC<RJBE6/RWBWP_CN(
M,7PGE^2Y?]>SG'5\VHX>E2]C3KUX8?#8?%SI^UK3I0Y*=.G6JI5*B2M+D7-+
M7Z+POSW!9%A>)\?F^.^I91@J&5UJ]6HJM2C0G7Q-?"PJ>SI0J3YJE2I2I-P@
MV[QYO=C=?3>K?L1_L_Z_J46HZYH_C;58;O5?!OB3QKX>N?BI\35\&?%KQ?\`
M#^Q\'Z=X4\:_&7P/;>*;?PC\5?&-E;>`?!\>H^(_&FBZIJ'B:+PYHEMXK?7;
M32K"WMK%M^Q=\![34_$&K0:?\0!=ZQH/Q'\.Z'YGQA^+<\/PPLOBW;W%O\0[
MGX*P7'C*6+X.:UXA%U.R>(?ATOA_7-"20VGAC4-$T[_0J_'[_A_I^S+_`-&S
M?&7_`,&_P^_^:RHYO^"_'[,L,,TQ_9E^,S"&&68J-7^'P+"*-I"H/_"68RP7
M`SQDC)`YK\V_X@EXIO\`YH_':_\`47E?6W_4=YK[T???\1D\-/\`HJ\'_P"$
MV8^7_4'Y_P!75_V,\<_L5?LQ?$P?#:;X@?"7PUXRUCX4^)_AYXQ\*^+/$MJ=
M:\<S^(OA;91Z?X/U'Q7XYU(7/BWQP]I;PQ?VC%XPUC6H==EC2?68[Z95<?5"
M@`!1G```SGM[GJ?4_G7GO@U/"_C/PCX6\7V>A_8K3Q3X<T/Q';6=TY:YM;?7
M=+M-5@MKAH)Y(6G@BNUBF,,CQ&1&,;LA#'M+'2]/TWS?L-K';>=L\W87._R]
MVS.YF^[O;&,=37Y=4ISI5)TJD7&I3G*$XNUXS@W&47:ZT::T;79GZ53G"K"%
M6G+FA4A&<)*Z4H32E&5FDU=-/5)]T7Z***@L****`"BBB@`HHHH`****`/Q`
M_P""D_\`RDD_X(4_]G6_M0?^L<_$&OV\C_U<?^XO_H(K\0_^"D__`"DD_P""
M%/\`V=;^U!_ZQS\0:_;R/_5Q_P"XO_H(H`^"-?\`^0]KO_8:U;_TX7%9-:VO
M_P#(>UW_`+#6K?\`IPN*R:`/(/"/[8/AKP7^U]X0_9OTSX:_$_Q_X@\0>'-2
MG\9>)_!6F:)J&A_"]+H?#K4=`N/$>E7.MVGB[6=,U#3/'&F:GKFM>%M!U32_
M!^GM!<ZG<7;#7(?#GT=8_M_?!6]O?VOU?1/BGIVA?L6^`-`^)/Q*\3:I\/M6
ML;3Q9X7UOP[\1O$4NI?"O0KAH_&/C.QTZ/X7^*-*743X<TS3O$.K6R'PC=Z_
MHTD6M2_`OCS]B'Q[^T3^V%\#_BM8?$+P1X2\*?##2M>OY?$FG^`Y-+_:&\"3
M6WB/X.:Y;:/\,?BAH6NZ;'JNA^,)?!7B;3M3MOB!I.MV/@K2?'/CW3['2?%=
MAXQM;+PU[7<_L:?M<^+OC+^V#XP\0?&'X1_#GPM^UA\//AS\/#KOPBTWXH0_
M%'X>VOP;MOB+;>#-4L-1UW5[72=5;Q7;>/9-+\>VMA=>%M1M-%AOX/!WB/2]
M8O+/7=,`/<M6_P""A/P^\(?##XP?$;Q]\+?B_P"&[WX/>"=&^(=_X`T&Q\"?
M%OQ;XM\*^*O#_C_Q1X1N/".H?!;QW\0?`LE[K.C?#3Q9=W]MXB\8>';7PE96
M-MXA\5ZCI/@S5]#\3ZI]E_#_`,;Z7\1O`'@KXB:1#=6FC^.?"7ACQEI=OJ(M
MTO;?3?%&B:?KUC#>BVGN+5;J&TU"*.Y$%Q/`LR2>5-+&%D;\G-._X)V?%KP%
M\&_VKO`GP4G_`&6O@X?VGOAUI'PA?X1?#;X>?$'P3^SGX)TRU\&?$3P)XA^,
MEMX1TGQ#=:GJ7QJ\8>'/%?@_0]<FT^'PUX?N_#?PO\&:1JLNN:C8+XAKZ<\)
M?L\?'_6OV>O!7[-7Q;\>?#O1?`A^!'BWX,?$W7?@A;_$#PY\2+J>UTSP/X2^
M&OB'X9^+_%&JZE8>$8CX1L?'<7CZPUSPOXEO+O5=5\,MX9U;3K/3-935P#^8
M;QA\:O!WQH_:"_:LF\$B_N=(\%?M!>,-#A\03BS.C^,++Q$(?'.A^*_"4]K=
MW,MYX6UC1/$%E/I6H7L5E-J,&W4;6V?3+RQNKB*N7U+X"WWP4_:9_;%O9OB5
MXN\?:=X[^.5W/HUOXK_X1H7NBZ?X&T/3/AY`M_\`\(OX2\(Z-+J<L/AJ."U;
M1-*TK0['PU!HVD6VBP75A<7ESU%?W?P]+%2R3+7C8N.(6&C%IJFFZ492CAIV
MI2G"//AE1GR\SDF[3M/F2_BW/5AHYOCUA)<U#V[:=YNU64(/$1O4C"3Y,2ZL
M;\JB[7A>'*S].O\`@DU_R<YKG_9(?%7_`*DO@FOYZ_VNO^3L/VG_`/LX;XT?
M^K&\1U_0I_P2:_Y.<US_`+)#XJ_]27P37\]?[77_`"=A^T__`-G#?&C_`-6-
MXCKU/#?_`).AQC_V2V0?^IF*/$\1O^3=<)_]E+GO_J'@CYYK]B_^"%O_`"?I
M8_\`9%/BI_Z5^#*_'2OV+_X(6_\`)^EC_P!D4^*G_I7X,K]'\4_^3<\:_P#9
M.YE_ZCR/S[PR_P"3@\'_`/9099_ZE4S^TVBBBO\`+4_TN/GOX]_ZGPM_UVU?
M_P!%Z=7SG7T9\>_]3X6_Z[:O_P"B].KYSH`\+_:0^.WA_P#9O^$'B?XK^(=)
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M=S76FMI>I8D7_!.?X\>'?V8O@%\`_A=\:_A!HEM\._C;\)?VEO$K>+OA1XZU
MWPEIWCWX3?%/X?\`Q?\`#O@#X+^$_#'Q7\'VOPX^#DVM>"YM+O-!O9_$&J!=
M=UCQ!876GZGJ$EK$`?6'B_\`;L\)>$_V@M9^!A^'_BK4D\(^-/A+\/?&7BE-
M>\"Z=?VOB?XW6GAV\\"77@[X9ZGXCM_B9\2?!=M%XGLAXP\=^$O#MSX?\/2Z
M5XTM;.77;WX=^/;;PYU7PY_:TE\6?%KPK\)_''P1^*?P<U#XH^#?'_Q!^#E_
MX]'A1KCQGX6^%^H^"M/\9'Q'X9\/^(-6\3?"[Q#;Q?$/PCK>F^&_'.GV5[<Z
M-JC6^HRZ/XKL-1\*VOS3XQ_X)S^(_B#\4+;XG>*OB-\.;OQ9JOQ5^$OQEU?X
MK/\`"/5;W]HOX8ZM\-?^$"GU+X5?LU?&B\^(PN?A3\"_%DWACQ9I4G@[4/#G
MB:ZT_P`+?%3XFZ1JMUXKN?&.H:DO5_"/]F;]L/P;XT^,?Q4^(/QJ_9O^('QF
M^(?P]\8>%_"7Q3E^!OQ5MYOA_=/-=:C\+_".A^"+WX^WOA_1_@CX0UF6RU/Q
MGX"\*W?A_P`6?%74M-AU_P`6_$6?Q*;+5]+`/SH_X+#?M*>'KSQQX"\'6?A/
MQ-<>%_A)\1+KX6?$'XH?:_#L'A;0?B9\2_#7PC\1:+X5ATB;5!XIUB#1])\>
M_#F7QEXEL=,&B>&KKX@>';(2:G/;>*#X;_,P@J2K`JP)!4C!!'!!'8@\$=C7
MZ`?\%</V6]3TK7O"%Y>>.-!O/`OQV^*-M\:OBIX.A\!O::A<_%CX<>#?@'X9
MUN[\)^(CXGGATKP5\18OA#\,[S6]!UO1?$&O:!<^'M8_L+Q.Z>+KD:+\`.[2
M.\CG<\C,[MTW.Y+,QQQDL23]:_KSPE>)_P!3,L51/ZLEBWAW+V?,ZCS;,_K$
M8>S][V$8J@X.LG5]M+$KF=&-&,?Y:\3U0_UMS%P:^L-X55U'VEO9K*\M]A*7
M/[OM6W74E2?L_91P[:55UFX+C_CVNO\`KTN__2>6OOG_`(+I_P#)O/[!_P#U
MS\0_^JR\$5\#7'_'M=?]>EW_`.D\M??/_!=/_DWG]@__`*Y^(?\`U67@BOKX
M_P#)RO"__L/XH_\`6=KGR=7_`)-YXD?]@7#7_K0X<_FKJM>_\>5]_P!>5Y_Z
M32U9JM>_\>5]_P!>5Y_Z32U_3T=UZK\S^9Y;/T?Y'^D9\"O^2*?"#_LEWP]_
M]0_1J]5KRKX%?\D4^$'_`&2[X>_^H?HU>JU_D)F?_(RQ_P#V&8G_`-/3/]7<
MN_Y%^!_[`\+_`.F(!1117"=@4444`%%%%`!1110`4444`?AU_P`%+HC/_P`%
M'O\`@A9$)IH"_P"U9^T^!+;NL<R8_8[^(#?*[QR*`V-K@H=R%E!4D,/VD31)
MBB'^W=>Y53S>6I/('4_V?R?4XY/:OQA_X*3_`/*23_@A3_V=;^U!_P"L<_$&
MOV\C_P!7'_N+_P"@B@#X&UQ=FN:TA=Y"FL:HIDD(:1]M].-\C!5#2/C<[!5!
M8DA0#@9=:VO_`/(>UW_L-:M_Z<+BLF@#U3X/VS7?BR:);J[LS_8UXWFV<L<4
MI"W5A\C-)#.IC;.2NP'<%(8;<'TB_P#BQ\'M*OKW3-2^.'AZPU'3KNXL;^QN
M_&OAR"ZL[VTE>"ZM;F"2-9(;BWFC>*:*15>.1&1@&!%<#\$_^1RF_P"P'??^
ME6GU^,GQH_Y+%\6/^RD^-_\`U)-2H`_<[_A<_P`$?^B]^%O_``NO#/\`\370
M^&?'/PZ\::B^D>$/BUI_B;58[:2^?3M"\5:'J=ZEG#+#%-=-;VD$LHMXI+B"
M.24KL5IHU9@77/\`.+7W3_P3U_Y+MJ?_`&3KQ!_Z>O#%`'Y*_M"(8_C[\<$+
MR2E/B[\1T,DK!Y9"OB_5QOE=516D?&YV"(&8DA5!P/(*]B_:(_Y.`^.?_98/
MB3_ZF.L5X[7]]Y;_`,BW+O\`L`P7_J-2/XCS'_D88[_L,Q7_`*?F?IA_P2EM
MFN_VE]<B6ZN[0_\`"I/%+^;9RQQ2D+XE\%?(S20S`QMG)4*#N52&`!#?SY?M
M;(8_VK/VFXR\DA3]H/XRH9)6#RR%?B)XB7?*ZJBM(^-SL$0,Q)"J#@?T+_\`
M!)K_`).<US_LD/BK_P!27P37\]?[77_)V'[3_P#V<-\:/_5C>(ZZ/#?_`).A
MQC_V2V0?^IF*/.\1O^3=<)_]E+GO_J'@CYYK]@_^"&]NUS^W=8Q+<W5H3\%O
MBBWG6<B13?+=^#?EWR13+M.<D;,[E0@C!!_'ROV+_P""%O\`R?I8_P#9%/BI
M_P"E?@ROT?Q3U\..-?\`LG<S_P#4>1^?>&7_`"<'@_\`[*#+/_4JF?V7?V'-
M_P!!W7?_``+M?_D"C^PYO^@[KO\`X%VO_P`@5OT5_EJ?Z7'S7\;;%[*+PV7O
M[^]\R750!>S12B/;'8$F/RK>#:6W8;=NR%7&,'/@=?1GQ[_U/A;_`*[:O_Z+
MTZOG.@!K_=;_`'3_`"-?5WBGQIX$^'-AH,OCOXE?\(FFM6[C2_[:UFRLEO6L
MH+5[M+7S+`F3[*MW;^;SE!-'DG=7RB_W&_W6_D:X+_@HR2-%^!V"1\OC+_T@
M\)4`?6__``T+\`?^B^:#_P"%/IW_`,KZ0_M#?```D_'W00`"2?\`A)].X`&2
M3_Q+^@`R:_`')]3^9J.8GR9N3_J9>Y_YYM0!]I_\%>X$33?V>;B+4KW4H+R?
MXD3P2W5Q%/'Y+V7@F2.2W\JW@`$R.K%B7#J$P%VY/XGU^U/_``5J_P"11_9;
M_P"O#QS_`.F;P%7XK5_8OA5_R0>1^N9_^KC,#^4O$O\`Y+7.?3+O_55@2*?B
MWNN_^B77!Z?\>\G6ONS_`(+DV;6W[/O["SM>WUT)D\0D1W<T4L<(_P"%:^"F
MQ"L<$)3KCYF?C//-?"=Q_P`>UU_UZ7?_`*3RU]\_\%T_^3>?V#_^N?B'_P!5
MEX(KZ:/_`"<KPO\`+'\4?^L[7/FZO_)O/$C_`+`N&O\`UH<.?S5U6O?^/*]_
MZ\KO_P!)Y:LU6O?^/*^_Z\KS_P!)I:_IZ.Z]5^9_,\MGZ/\`(_T<?@?HTLGP
M7^$3C6M<0-\+_A^0BW=ML4'PCHYPH-B2%&>A)YR<\U[!8V+V7F[[^_O?,V8^
MVS12^7LW9\ORK>#;OW?/NW9VKC&.?.O@5_R13X0?]DN^'O\`ZA^C5ZK7^0F9
MJV8X_P#[#,3_`.GIG^KN7?\`(OP/_8'A?_3$`HHHKA.P****`"BBB@`HHHH`
M****`/Q`_P""D_\`RDD_X(4_]G6_M0?^L<_$&OV\C_U<?^XO_H(K\/?^"ERS
M/_P4>_X(6+;S"WF/[5G[3^R5H5G"8_8[^(!;,3/&&W*"F=X*;MXR5"G]HTLM
M?**1KT."JD?\26`<8'87V!]!P.U`'Q/K_P#R'M=_[#6K?^G"XK)K4UP,-<UH
M.XD<:QJ@>0((P[B^N`SB,%@@=LL$#,$SM!(&:RZ`/7O@G_R.4W_8#OO_`$JT
M^OQD^-'_`"6+XL?]E)\;_P#J2:E7[(_!^*[E\63+9W2V<W]C7A,K6R78*"ZL
M-R>6\L(4MP?,#$C;MVD,2/QK^,@=?B_\55DD$LB_$;QJ))1&(A(X\1ZB'D$2
MLZQAVRPC#L$SM#,!D@'F]?=/_!/7_DNVI_\`9.O$'_IZ\,5\+5]O_L`QW4OQ
MPU-;.Z6SE_X5[KY,K6R70*#6?#.4\MY80N25;>&)&W;M(8D`'Y1?M$?\G`?'
M/_LL'Q)_]3'6*\=KU_\`:$#K\??C@LCB61?B[\1Q)((Q$)''B_5PSB)698P[
M9;RU9@F=H8@9/D%?WWEO_(MR[_L`P7_J-2/XCS'_`)&&._[#,5_Z?F?IU_P2
M:_Y.<US_`+)#XJ_]27P37\]?[77_`"=A^T__`-G#?&C_`-6-XCK^@K_@E+%=
MR_M+ZXMG=+9R_P#"I/%),K6R709!XD\%93RWEA"DDJWF!B1MV[2')'\^7[6X
M=?VK?VG%D<2R+^T'\9A)((Q$)''Q%\1!G$2LZQAVRWEJS!,[0Q`R>CPW_P"3
MH<8?]DMD'_J9BCSO$;_DW7"?_92Y[_ZAX(^?*_8O_@A;_P`GZ6/_`&13XJ?^
ME?@ROQTK]@_^"&\=S)^W=8K:7*VDW_"EOBD1,ULET-HN_!FY?*>2)<G@[M_&
MW;@ACC]'\5/^3<<:]?\`C'<S_P#4>1^?>&7_`"<'@_\`[*#+/_4JF?VJT5S_
M`-A\0?\`0>A_\$T'_P`FT?8?$'_0>A_\$T'_`,FU_EJ?Z7'C?Q[_`-3X6_Z[
M:O\`^B].KYSKWSXV0:A#%X;^W:@E\&EU7R@EE'9^41'8;R2D\WF;P5`!V[=N
M1G)QX'0`U_N-_NM_(UP/_!1K_D"_`W_=\9?^D'A*N^?[K?[I_D:\S_X*'0W\
M6D?!0WE^EXC_`/"8F!5LH[0P@6/A4L"R32^;N!0<A-NPD9W$``_,6HYO]3-_
MUQE_]%M4E1R_ZF;_`*XR_P#HMJ`/LW_@K5_R*/[+?_7AXY_],W@*OQ6K]G/^
M"KT-]%X2_9A-Y?)>*]EXX,*I91VGDC^QO`>[+)/,9=P*C!"!-N5SO('XQU_8
MOA5_R0>1^N9_^KC,#^4O$O\`Y+7.?3+O_55@2*X_X]KK_KTN_P#TGEK[Y_X+
MI_\`)O/[!_\`US\0_P#JLO!%?`T__'O=?]>EU_Z3RU]V_P#!<F&]C_9]_86:
MZO4NHW3Q#Y$:V<=L81_PK7P4>72:4R_*0OS*GKV%?31_Y.5X7:;X_BCY?\8[
M7/FZO_)O/$C_`+`N&O\`UH<.?S;U6O?^/*^_Z\KS_P!)I:LU6O?^/*]_Z\KO
M_P!)Y:_IZ.Z]5^9_,\MGZ/\`(_TC/@5_R13X0?\`9+OA[_ZA^C5ZK7AWP/L]
M=;X+_"(QZY"B'X7_``_*H='@8JI\(Z.0"WVT%L#N0#VQ@"O8;&#4(?-^W7Z7
MV[9Y6RR2T\O&[?G9/-YF_*XSMV[3C.[C_(3,_P#D8X__`+#,3_Z>G_7Y7/\`
M5W+O^1?@?^P/"_\`IB!H4445PG8%%%%`!1110`4444`%%%%`'X@?\%)_^4DG
M_!"G_LZW]J#_`-8Y^(-?MY'_`*N/_<7_`-!%?B'_`,%)_P#E))_P0I_[.M_:
M@_\`6.?B#7[>1_ZN/_<7_P!!%`'P1K__`"'M=_[#6K?^G"XK)K6U_P#Y#VN_
M]AK5O_3A<5DT`>O?!/\`Y'*;_L!WW_I5I]?C)\:/^2Q?%C_LI/C?_P!234J_
M9OX)_P#(Y3?]@.^_]*M/K\9/C1_R6+XL?]E)\;_^I)J5`'FE?=/_``3U_P"2
M[:G_`-DZ\0?^GKPQ7PM7W3_P3U_Y+MJ?_9.O$'_IZ\,4`?DQ^T1_R<!\<_\`
MLL'Q)_\`4QUBO':]B_:(_P"3@/CG_P!E@^)/_J8ZQ7CM?WWEO_(MR[_L`P7_
M`*C4C^(\Q_Y&&._[#,5_Z?F?IU_P2:_Y.<US_LD/BK_U)?!-?SU_M=?\G8?M
M/_\`9PWQH_\`5C>(Z_H4_P""37_)SFN?]DA\5?\`J2^":_GK_:Z_Y.P_:?\`
M^SAOC1_ZL;Q'71X;_P#)T.,?^R6R#_U,Q1YWB-_R;KA/_LI<]_\`4/!'SS7[
M%_\`!"W_`)/TL?\`LBGQ4_\`2OP97XZ5^Q?_``0M_P"3]+'_`+(I\5/_`$K\
M&5^C^*?_`";GC7_LG<R_]1Y'Y]X9?\G!X/\`^R@RS_U*IG]IM%%%?Y:G^EQ\
M]_'O_4^%O^NVK_\`HO3J^<Z^C/CW_J?"W_7;5_\`T7IU?.=`#7^XW^ZW\C7`
M_P#!1K_D"_`W_=\9?^D'A*N^?[C?[K?R-<#_`,%&O^0+\#?]WQE_Z0>$J`/R
MWJ.;_4S?]<9?_1;5)4<W^IF_ZXR_^BVH`^S?^"M7_(H_LM_]>'CG_P!,W@*O
MQ6K]J?\`@K5_R*/[+?\`UX>.?_3-X"K\5J_L7PJ_Y(+(_7-/_5QF!_*7B7_R
M6N<^F7?^JK`D5Q_Q[77_`%Z7?_I/+7WS_P`%T_\`DWG]@_\`ZY^(?_59>"*^
M!KC_`(]KK_KTN_\`TGEK[Y_X+I_\F\_L'_\`7/Q#_P"JR\$5]-'_`).5X7_]
MA_%'_K.USYNK_P`F\\2/^P+AK_UH<.?S5U6O?^/*^_Z\KS_TFEJS5:]_X\K[
M_KRO/_2:6OZ>CNO5?F?S/+9^C_(_TC/@5_R13X0?]DN^'O\`ZA^C5ZK7E7P*
M_P"2*?"#_LEWP]_]0_1J]5K_`"$S/_D98_\`[#,3_P"GIG^KN7?\B_`_]@>%
M_P#3$`HHHKA.P****`"BBB@`HHHH`****`/RT_X*(_L5_M"?M+?$S]BWXX?L
MS?&#X2_";XI_L=_%+XE?$C0W^,_PS\5_%'P7XDD^(OPKU+X67%A?:%X/\;^`
MM43[#I>LZG>Q2IKD/^F&RE5MMM)#<<&/AG_P72``'[6W_!-'``'_`"93^T4.
MGL/VLP/R`%?L/10!^%5W^RU_P6KO;NZO)OVN_P#@G");RYN+N41_L4_'54$M
MS,\T@13^T\Q5`[MM!9B%P"3C-5_^&4?^"U'_`$=Y_P`$Y/\`Q"KXZ?\`T3M?
MN[10!^(/AS]G3_@MOX7U!]2T[]KK_@FZ]P]K):$7'[%/Q[*"*62&5B/L_P"U
M);2!]T"`$2;=I8%3D8^;_$O_``31_P""N'BKQ'K_`(HU+]L?]@>/4?$FM:IK
MU^EI^QY\:H;1+W5[V:_NEM8G_:-F>*W6>=Q#&\LKI&%5I'(+'^DZB@#^9?\`
MX=9_\%8_^CR?V#__`!$#XT?_`$1-9/B?]G'_`(*^?L->"?'/[1&B?M5?\$__
M`!//X8\/6NF76B:A^R'\<(4O++Q!XJ\,Z6_D7%M^T;&]M<0W4UI,)6\Q6A2:
M`Q'SO,B_I^KSKXL?"SPA\:O`'B'X9^/+2\OO"GBB&Q@U>UL-2O-(NY8].U;3
M];MA#J-A)%=VQ6_TNTD=H9%,D:/"Q,<C@@'\UOB__@D#_P`%3/'/BWQ3XUUC
M]LW]AR/5O%WB37/$VJ1V'[(_QE@L8]1US4[K4KV.S@E_:!FEAM4N;F5;>*2>
M=XX@J--*1YC<]_PY8_X*=_\`1Z'[$_\`XB9\8?\`Y_M?U;@!1@=,L?Q9BQ_4
MFEKZRGQWQA2A"E3XBS.%.G"-.G"-=J,(048PBE;:,8Q2\D?+SX*X4J3G4J9#
METIU)2G.3HW<IR?-*3UW;U?FWW9_-I\`_P#@FI_P5Q_9R\:W?CWP%^V/^P1=
MZU>^'K[PS-'XC_8^^-U_8#3M0OM+U"=XXM/_`&C]*N$NA/I%JL<HNB@B:=&B
M?S`5^0OB'_P;^_\`!17XF^/_`!S\2/$/[;/[(,&O_$#QAXE\;:Y#I7[+'Q9M
M=+AU?Q5K-[KNI1:=:S?'"ZFMK".]OYEM();JYEAMQ'')/,ZF1O["**K!<>\9
M9=CL1F>!XCS3"X_%X>CA<3BZ-?EK5\/AY2G1HU)6]Z%.4I2BNC;9.,X'X1S#
M!8?+L;P_EN)P.$KU<3AL-5H<U*C7K1C&K5A&^DZD81C)WU44C^,;_B'&_;]_
MZ/>_90_\1@^*O_SZ:^C/V6O^",O_``5!_9$^*L?QA^%W[:/[$U_XJB\,Z[X4
M6W\8_LF_&75M&_LSQ#+IDU\YM=,_:`T.[^UJ^DVHMY5OQ&BM,LD,HD&W^JVB
MNS'^)O'^:8+$Y=F'%F<XS`XRC4P^*PM?$\]*O0JQY:E*I'EUA..C78X\#X<<
M"Y;C,-C\!PME&$QN#K0KX7$T</RU:%:FU*%2G+FTE%Q33\O4_'G_`(5I_P`%
MTO\`H[?_`()H_P#B%7[17_T6E'_"M/\`@NE_T=O_`,$T?_$*OVBO_HM*_8:B
MOA3[8_$_Q/\``3_@M]XM6R74_P!KG_@FT@L&G:'[-^Q3\?\`)-P(EDW_`&K]
MJBZX`A3;Y?E\YW;OEV\E_P`,H_\`!:C_`*.\_P""<G_B%7QT_P#HG:_=VB@#
M\(3^RA_P6G((/[7G_!.3!!'_`"95\=.__=SM8WQA_8S_`."S?QOM_#-MXP_;
M`_X)WVT?A0ZD=,.A_L9_'>T9_P"U8K"*Y%T+W]IW448*NG6_E+;I;*A,FX."
M@3]]Z*`/YE_^'6?_``5C_P"CR?V#_P#Q$#XT?_1$TU_^"67_``5B9'4_ME?L
M'@,C*2/V0/C1G#*0<?\`&1![$]C]#7]-5(1D$'H01^=`'\O'B;]E_P#X*[?M
MR7'B[PQXR_:M_8#\/Q_LN_%WQ9\'K&?0/V1?CA$VOW9\"?"[Q/?ZO.M[^T7>
MK!;FV\0Z;8P64:H8;BQNYQ/<0W4,=MQ__#EC_@IW_P!'H?L3_P#B)GQA_P#G
M^U_3KX#^%WA'X;W_`,1-2\+6EY:W?Q2^(.H_$[Q>]UJ-W?I=^+=5\/>&/#%Y
M=V<=U(Z:;:/I'A#1(DTZS$=I'-!/<I&)KJ=F]#KZ/`<7<397A*6!R[.\?@\)
M0Y_98>A6Y*=/VE65:IRQL[<]6<YO^])OJ?/X[A7AW,L54QN/R?!8K%UN3VM>
MM2YJD_9TX4H<SNK\M.G""[1BD?RBO_P16_X*=2))&W[:/[%`62-XVQ^R9\8,
M[9%*-C/Q\(!PQP<'GL:]4_:E_P""6O\`P5D_:[\(_"SP7\4?VROV$=/TCX0"
M\'A:3P=^R'\;-)O9_MVBZ;H,W]L2ZG^T9K<-SBRTNV:,6EO8!9S(Y#1F.*/^
MF:BM_P#7?BWZ[@<Q_M_,OKV63KU,OQ7M_P!]A)XF@\-B)496]UU:#=*;ZP=C
M'_4WA9X/&Y>\CR_ZEF,:$,=AO8_NL5##5HXBA&M&_O*E6C&I!7TFKG\8W_$.
M-^W[_P!'O?LH?^(P?%7_`.?33)/^#</]ON6*6)OVWOV4-LT4L+8_9@^*F0LL
M;1L5)^-!`8*Q*D@X;!P<8K^SRBO<_P"(N^)B_P":US[3_J+?2W]WR7W(\7_B
M%7AS_P!$=DG_`(2^G][R1^+GA?X)_P#!<3PEX:\/>%=+_:Y_X)LOIOAG0](\
M/Z>]W^Q9^T+)=/8Z+I]OIMH]U)#^U=;PR7#6]K&9GB@AC:0L8XHT*HOV[^RA
MX9_;N\.R>.C^VC\7?V9?BE#=IX;'PY3]G?X(_$?X/R:))`VN?\)6WBV3Q]\7
M?BBOB!-127PZ-#32H]#.E-9:LUZ^I#4+1;'[&HK\[G.=2<ZDY.4ZDI3G)ZN4
MY-RE)OJVVV_-GWT(1IPA3A%1A",80BMHQBE&,5Y)))>04445)04444`%%%%`
M!1110`4444`%%%%`!1110`5'--%;Q2SSRQPP0QO+--*ZQQ111J7DDDD<JD<:
M(I9W=@J*"S$`$U)7D/[07PSO/C1\!_C5\'M.UV3PM?\`Q6^$OQ)^&MCXGA22
M6?PY=^._!>M^%;;7H8XF21Y='GU:/4$2-ED<V^U"'*D`'FWAW]MK]E7Q3H?C
M?Q+I/QO\%?\`"/\`P^\-6OC7Q)K.J7.H>']-_P"$'U&^N-+TCQWH%WX@T[2X
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M?!_QT^,7CO2?%_Q2USQK_P`*AM-*\17ND>#=$\)>&=&^&GA_X2_%GXOV_AOX
M9_#SPSH=AX4\-V?B[Q--XWU>YBU3Q9XHNM4UWQ#J5XH!Z;9_M@?LSWVB?`_Q
M!;_&3P;_`&;^TGXJ_P"$)^!8N+NZL]1^)WB=5UMY=*\+Z)>6<&MW<EM'X=UF
M2\N9M.M[&Q2R9[RZ@6:U,^C:_M0_!J_^,6H_`C3M:\4:I\1=&UF+PYK5OI/P
MM^+.J^$=%U^7PI8^-UT76?B?IW@:Y^%VDZHOAC4]-U*6QU'QI;7,!U"RL9XX
M]2NH+-_BC]N7X0>/;OQK^Q]>_L^_LBZW\1!\%OVA_A?\6?&'BOX?:K^SOX&&
MF_#+P/:_%&/4?AWILGQ'^)_P]\0ZAJ,FO^,;+Q-IOA^ULAX0EEN[V_FUJUUB
M.2!]C4_@W\:)OC_:^)_A[\,OBK\+]0UC]H3P5\4O%7Q4NOVH?[;^#FH_"=O#
M7@ZV^*7@75/@+:>)I;4>-?&.D>'+SP;_`,(Y:_#;5_#FC>,9[#XJZ5\:II-,
ML].B`/U!_P`^G\Z*100H!.2``3UR<<G/&>?84M`!1110`4444`%%%%`!1110
M!X#\3OVH_@%\&_%FC^"?B9\3O#WA+Q)K%IIFI_8M0&IS6^A:-K>LOX=T/Q#X
MUU73]/O='^'WAK7?$$-SH6A>)?'FH>&]!UK6K.^TO2]1N[ZQO((&1_M3_L_R
M_%?_`(4E'\3O#[?$DZ[-X371`FJ"QD\:VV@OXJN?`$7BDZ</!\OQ%MO"\<GB
M6Y^'D?B!O&T'A^*76)M`33XWG7\V_P!LSP/\0OA=<?MQ3'PE_P`)5\/?V_\`
MX;>`O@G8?%6[U[2K#PE^SQXCOOA1XM^!M]/\:K"XCN/$T'P?M[?5;#QGX=U7
MP7HWC.[U+QYXFUSP?J>C>&9-:TOQ!J/I$/@/XW^-/VB?AOX)^(_[,WQ,TS]F
MO]GSXF:1XI^&OBWP_P"*?V<;[3/C%\5-'T2]L[?]IGXVS#XQ:9\1]*T?1M5U
MK5M:\,_#7P[\.-7\7ZYXU\GXB?$#6+B2ST7P78`'Z(ZI\8_ACH?CVX^&.L^,
M]&TKQO:?#C4?BY>:+J4LUBMG\-](UZW\,ZGXNO-5NH8M$M-)L=<NH+&Y>YU.
M*>)I//:`6B27"X?@G]HCX)?$?X+0?M%>"/B5X7\1_!"ZT#Q!XJMOB;87DG_"
M)W'AOPM=:M9:]KL.HW$$'FZ587&A:JK7R1&"XCM&GM&N()8))='XI^&_#=SX
M8\0Z]>?!JW^,NL0^'DTI?!EIIGP_N?$'BO28M9T_6%\+VEU\2-9\-^$&M_[4
MM+764M/$7B/3-(^VZ?%=-<+>1VY;\F_V:OV:OVQKO]C[X(?!/7O"/A[]GOQ/
M\&OBYXX\>>-_"7QXTSPS\:?`OQHL]6^)7Q)^)GP\LK:Z_9\_:%LM0M-'\'>(
M_$OA/Q9KNG^(KNS36_%'AG3-*ETS5/#=MJ!U4`_8'X8?$OP-\9OASX$^+?PR
M\16?BWX=_$SPCX?\=^!_%%A%>067B#PGXJTNVUG0=9M8-1M;+4((-1TV[M[J
M.&^L[2\B63R[FV@F5XE[JOBC_@G'\)OC)\"?V%OV5/@U\?H/#%G\6?AA\#?A
MUX&\8:=X2:XGTK2;_P`->'+'2DT>;49O$/B>'7-9TNWMHK+7_$.F:J=#U[68
M;W5=#LM.TNZM;&#[7H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`$P,YYR1CJ<?]\YP#[@9/<TM%%`!1110`4444`%%%%`!1110`
M4444`%%%%`"$`C!S^!*GCW4@_KSWI:**`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`***\C\5_%FU\*ZY=:)+HES>O;1VTAN(KR"%'%S`DX`C>
M)F78'VDD\D9'I0!ZY17@D/QVLI9H8AX;O5,LL408ZA;$*99%0,1Y(SC=G&><
M8%>]T`%%%<+\3_B7X&^#/PY\=?%OXG>(K/PC\.OAIX2\0>.O'/BC4([R:Q\/
M>%/"VF7&L:]K-W#I]M>W\UOIVFVEQ=2Q65I=7<BQE+>WFE9(V`.ZHKQ7X.?M
M#?"/X]6_B&7X8^*9M7O/"5UIMIXI\/:SX9\8>!O&7AI]:LFU'0YO$'@;Q_X>
M\+>,M%LM>LHI[K0=1U'0K?3];AM;Q]*NKL65V(?:"X`8X;Y>OR.2>OW0%R_3
M^$&@!U%>>_#_`.*OP_\`BG%XPF^'_B:R\3Q^`/'_`(K^%WC!["&^0:%X_P#`
M]W%8^*O#%X+RTMBVH:-=SQ0W)MQ/:NSAK:XG0%AT'BWQ=X6\!>&/$7C7QMXA
MT;PCX/\`".BZEXC\4^*?$FH6VC>'O#N@:-:2W^K:UK6L:A)!8:;I>FV,$UY?
M7UW/%;6MM#+/-(D<;L`#HJ*;N&`W.#C^%L\C/*XW`XZ@@$=#S0&!SC/'?:V#
MDXX)&"/<$C'.<<T`.HI-PR!\W/\`LL1UQR0,#\2..>E)N'/#<?[+>N...?PS
MQSTH`=132P'9NN.%8\_@#Q[]/>EW#..<^NUMO3/WL;?U]NM`"T4A(`R<_@"3
M^0!-)N''WN?]EN/][CY?^!8H`=17.>&/%_A7QI97^H^$?$6B^)K#2_$7B?PC
MJ5[H6HVNJ6MCXI\%:_J'A7Q?X=NKBSEEB@UKPOXFTG5/#WB#39&6[TC6M.OM
M,OHH+RTGA3HZ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`KXY^+O_(^ZK_UZZ5_Z015]C5R.K>`_"6N7TNI:KHT-Y?3+$DMP\]X
MC.L*".(%8KB.,;$4*,("<9.3S0!\2V?_`!^6?_7Y:?\`I1'7Z$5P2?##P'&Z
M2)X=ME>-TD1A<W^5=&#HW-WCA@#@@CCD$5WM`!7R%_P4`^%'COX[?L/?M<?!
M?X7Z9%K/Q&^*O[.7QA^'W@72I]4TW1(=0\6>+?`^L:+H%I)K&L2P:5IBSZE=
MVZ?;]2ECL+4D37;"!'KZ]HH`_*#XC?L#:Y?_`!B_9K\:R>*OB5\>#>?&Z+4_
MVH_''Q9\:>$M.U34O@WX$_9:_:C\)_";P1<>&/ASX?\`A9X5UOP#X>^./Q=T
MK7IO`^A^%'DU[6_$6I>(_%\FKZ?:7,EI\AZ1^Q'^UPN@>"(+WP#J]E#X3\,_
M"K2?VS/#3?';3]<E_P""D?C7PO\`&/POXE\;^.M*OKOQ;%:>%H=;\/:/XT\0
MX^)US\/=2\<V?C^'X!>+]/TKX::2-3M?Z&Z*`/YD==_X)^?MG:1X%_:EL_AY
M\*I=(E_:"^&7_!2WX8^!?`UA\<O#>FI\.9_VEOBE\*_BA\#O%NO:^WB00>7;
M:)X:\3>#;S_A&)=8UWP/X@CTG1M-=_`U^_BK2?I'XT?L'?%GXW?![]NOX.^,
M/@SI?B?XH_'+P%^V#IFA?M(^,/C-YO@SXCVGQ&\3R>*OV5/`5W\+K74=5O+'
M_A3FDQ^"?!L5QXI\/Z)H'PAU'X;OXF^&E]XM/CSQ`S?N[10!^<OQR^`'BGXQ
M^"_V#/"GA7X1W_PY^&OPY_:$\-^(OC/\&[OQ=X7T./PE\#]*_9Q_:`\!GP3K
M">!?%NJ^'/&&AV_C/Q-\.M,O?"'AG7M?TS5M.E62YBNM(L=42'X3^#/["?[8
MOACP_P#%*X\<>*O&FM_&71O!.K>)M-\:SZS\)="\#_'G]H[P)\<O!OQJ^$?C
MFZU+PSK>K?$SQ!:75SX%O/"!U+XMV?P_;P!X`^)/BWX:6_AKQ7X8>RNM%_H&
MHH`_!:#]C#]K[4/VB_`_Q9\5:KXQ@MO$^J_`;XI21>$-9^#VJ6O[/OC2;XFZ
MU\3OVDOA^WBWQSKTGC#2_#6M7&N-X/:^^#?A'Q?%\7_A_96OP^\3OX0TC2-%
MUB+R;4O^">/[7Y^#'@_0_#VB7.B?$#5_AC^V$_QDG?XQ127'BKQ9IO[>/P+_
M`&B?V1_"-[K+>*+N*X,OPE\(?%'P9X+UB$RZ/\+K/Q=>^&->GTK1M9U"UF_I
M"HH`_G"\??L1_MN^/?%?Q$\::OH_C31_!7Q`^.'[57Q`T3X4>'O&GP5\7^*?
M"6K?%KPM^S;:?!GXF3:C\0?&UGX$\)ZWX`L_`'Q,\,?V_P"";_Q/XP^$'B+5
M;C7_`(:^'_&]AXFU#5I/KWP?^S;^T)X'_;7T7XIV7@_6/%VDZCXST^7XE_%_
MXK^//!NOVK?#Z#]GNT\$:E)\,-9\%^(O!/Q1T34=1\<Z+HUY)^SWX[^$/C?X
M&Z?KFI>,_B=X9\8>&?$&IZ+!HW[`44`?G#^T?\-_BU^U?\.?V(]5A^&VM^#X
M(OVCO@]\6?V@/AEK/CO2-.U/PS\+!\-OBA8^-_"7B74?#^M6^F^-+>WU3Q1H
M&BZ]X:T6\U&T\26D]U$]G>Z;'>(/SD\%_L'_`+<=EXW\$S>,=<\=6OA?PMKC
M^'_@S'X0\4_![7;K]GGP5X-_;%^.OB[19SXO^(OB74_%'AG3_%_[/FN_!O3X
MKCX9^&OB'XGU[PCX=7X*?$#3=`TSP_8W<O\`1S10!^>W_!/?]FRX_97\-?M"
M?#B7X1:+\.K/7_VL?VC_`(O>'_$_A>Y\*2>&OB)X,^,GQB\;?$+X?S65EHVK
M3^(M*U+P'X#UOPW\/]=TWQ9H&@FTOM$$'AR77M"CAU5_T)HHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBOAWXT_MKZ3\&_B
M)K'P^NOA[JVOSZ1::/=-JEIK^G6,$XU?38=15$M;BQFE0P+-Y3,TA#LI=0%(
M%`'W%17YI6/_``4>T*]OK&R7X3Z]&U[?65D)&\4Z0PC-Y=0VHD*C306$9E#E
M006"D`@G-?I:#G\R/R.*`"BBLW6-9TCP[I.J:_X@U73M#T+1-.O=7UK6M8O;
M;3-)TC2=-MI;W4M4U34;V6&ST_3M/LH)[R^OKN:&VM+6&6XN)8X8W=0#2HKP
M_P"#W[1_P6^/8UM?A5XXL_$]UX>M]%O]6TR32_$/A[6K?1?$L5Y-X6\3PZ%X
MJT?0M9OO!WBR+3=3D\)^,]/L+KPIXH72M4.@:SJ/]FWWD>W;AQ][G_8;C/K\
MOR_\"Q@<GB@!U%<[X6\7^%O&^E2ZYX.\0Z-XHT:#6_$_AN75=!U&UU73X_$'
M@KQ)JW@WQ?HK7=G)-`-4\,>+=!UOPSKUCO\`M&E:]I&I:5>QPWME<0Q]`'!&
M<-CIRC@],]"H)^H&,\=>*`'45Y[\4?BM\/O@MX)U7XC?%#Q-9^#_``3HESH-
MGJOB'4H+^6RLKKQ/XBTGPGH,,RV%G>7(?4O$6NZ3I<&VW8+/>Q/,8H%DEC]`
MWK[GDCA6;D$J<X!Q@@C)XXXH`=12;A[_`(`GOCL.?;U&2.`:3>,`_-S_`+#Y
M_$;<@>Y`%`#J*;N&<<_7:V/^^L8Y[<\G@<T!U(SAOH4<'MT4KN(YY(&!WH`=
M13=PR!\W/^RQ'XG&`?4$@CO3J`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`*_!W]N$$_M)>,\`_P#((\&=O^I9LJ_>*O$/
M&?[-_P`$_B'XBO/%GC+P%I^N^(;^*S@O-2N-0UR"6:*PMDM+-&BLM4MK91!;
M1I$I2%68+ERS$L0#^>S00?[>T'@_\AW1.Q_Z"MG7]0(Z?BW\S7S;!^R!^S?;
M3P7,'PMTJ.>VGAN8)!JOB4F.>WE2:&0!M:*DI*B.`P*DJ`P(R*^D_P#/YT`%
M?.?[7GP7UC]HO]E_X]_`OP_K=MX=U[XK?"CQKX'T75[^2XCTFUU;7M$NK33E
MUW['!=7;^';N\,%CXCBM;:XN9M"NM1B@@FE=(G^C**`/RG^-_@[]I[]HG1M!
MUO7_`-F#2O"/AGPGX^^"VH_$KX.S?%GP%>?%#]HSP'HK?$*;XD_#0>-_#^LV
MW@8_"KP]XH\1?#WQ[X%\-^-O%GA<_%&]\)^+/#_CW0?`NCZ]';:O\H']C7]K
M+P[JGPH\4Z/\-KOQ9XQ\.7UM<?#O0_'7Q?\`#?C+X2?`;P'_`,-5_$SXH^$/
MAAJ>LW/B_P`&?&;X>^(?AG\%_%GA;X?:Q\4/@3JWQ;LOBM8>&?#WPW\6>!-8
M\!_#_1YO%7]`]%`'Y6?LQ?LP?$#]FC]D7]J[X%?"SX)>!/!GQ"U#XH_MJ>-/
MA/=3^([/PW\,/BU+\9_B=\5_'GP3O]2U7X9>(+?XB^#+#0?!/B;X??#3Q:\]
MKX1\5>&I_#%U'X.N[O2M.T;Q'-\0_#O]@']J)_C!X/M]?\&^(--_9=OOCQ^S
M7\2_%7PO\0>,O@YX1@TZR\/_``#_`&\?AS^T(VJ_#[X%Z[-X3OM(\8>)?B!^
MS8FI:-_PDOC[6OB%I<5OJ'C+6=7E\/ZS8:7_`$8T4`?S)ZO_`,$_/VSO$GP-
M\1_#[XB?#";XG>/[W3O@CX>^"'BG5OC=X=-A^SYX!^"G[6_B/QOK'@:<ZEXL
MDO-1;QQ\)-.\#ZYI6JZ):^(I_&*II_PV^*=_H%G\/M`GN_N__@H1^RQ^TC\<
M_BMX%\1?#W7?%FI?#;3OA%X_\'6/A?P5)\)+;7?A]\9M>\4Z-J7A_P"-%IJ'
MQ?U;3=,\.:A8>'+9])T;XE^"['Q9\2_AA>Z;+-X7\&:_:>+=;AC_`%]HH`_G
MA_;<^"/[2_P\^%W[77CK3])\3:[X3^(<OPL'PMTKP_X^U*U\7_#;QCI?[4O[
M/%K\2M4AB\&O//8V_P"V,VGK\5M6O_">E^3\(&\"W?\`;=OI]UXVUBTLLKXE
M_L(?M9^*/$NMZWX2\.^+_`/[/FM>)_C?=?#7]E?PUXK^"OBOQ!\$?$_BWPE\
M"=!\.?%:#5_B%XVF^'/A2;5?%W@/XQ^.M)U#X<:YXL\7?`Z]^)ZZUX*\-:SK
MGBOQII>B_P!&1&1CG\"0?S!!_P`XZ4M`'X7:U^Q/^U%!\0?%/Q#T:#7K_P`<
MZA^W7X>UZU^("_&E/#7B6^_9+U/_`()\^`?@E\37L=4TVY^S>#W\6?'?1=9U
MS4M(T3P?'K,?C"'3/BOI_A&:XT;PZEGX58_L-?MAP>"O#O@O0O`>K>%/@QX6
M^('PW\4^-/A[J=Q\`_%/Q?\`CA/I_P`+/BOX*UUO&/A.;XLO^RM\2-+\+>+]
M3^%GCI/%WB67X.>,?B[K=OX@\6^/?!B^*?`O@9=5_I&HH`_"L_LA_M/^%_'W
M[-WB[1O"OBSXI>.O`O@C]F7PS?>,OC1\4OA_XJ\$^$M.\#_$36=4^(D<^H^&
M-8^&/Q9^&7CG2_`WB"_TN]UCX1:7\7?`'[0=UHW@K1?BIX/72=%U2]UK]TUR
M`,XR/3TSQ^.,9[9SC(I:*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`***_-#]HW_@H_H?[//Q<\0_"B]^$VN>*;C0+'P_
M?/K=EXKTG2[:Y&OZ/;ZLD265UI=S/$ULMP('9YF$K(9%"J0*]?)<BS7B'%SP
M.3X1XW%4Z$\3.E&K0HM4*<Z=.=3FQ%6C!VG6IQY5)R?-=1:4FO+S?.LLR+#0
MQF:XI83#3K0P\:CI5JMZTX5*D8<M"G5GK"E4E=QY4HM-W:3_`$OHK\;--_X*
M_>&M1U+3=.7X$^)8FU'4M/TY9CXZT)UA;4+V"R69D71076(SB1E!!8*5!!(-
M?LF#G\R/R.*WSSAC/>&WAHYU@)8%XQ57AE*OA:WM50=-56OJU>LH\CJT_CY;
M\WNWL[89-Q'DW$"Q#RC&K&+"NDL1:CB:/LW651TO]XHTN;F]E4^#FMR^]:\;
ME%%<)\4/B9X%^#'PX\=_%OXG>(K3PE\.OAGX2\0>.O'/BB^AO;BS\/\`A/PM
MIESK&O:S<V^FVM]J,\&G:;:7%U)#8V5W>2K&8[:VFF9(V\$]L[NBO%?@[^T-
M\)/CS#XB;X9^)KK5;[PC<Z7:^*O#FO>%?&?@+QIX:;7+)]1T*?Q!X%^(7AWP
MKXRT>PU^RAN;G0=3U#0H--UN*SOFTN[NS8W@@]HWKSU&"!\P9<DG`QN`W9.`
M,9Y('<9`'45RWA#QOX0^(&@V_BGP-XFT3QAX;NK[6],MM>\-:C;:UH]QJ'AO
M7-1\->(+*'4=/DGM9+G1?$.D:IHFIPK*7LM4TZ]L9U2XMIHTZ@'/_P"H_3_/
MJ.1Q0`M%-W#)&&XR?NMCCT.,'V`.3VHWK_M?]\/Q]?EX]1G&1@C@B@!U%?,V
MB_MB?LX:]-XZ-E\3;&VTCX<:G-HWBKQGK>@^+_#7PV@U:V\>/\+[G3M'^*/B
M/P[I/PY\5WMM\1HY?`]Q;>$O%.NRP>*89]%E5+Z&6%/I<,"<8;//56`XQW(`
M[\<\\XZ&@!U%<UH_B[1-=UGQ=H.G2:@^I>!]7T_0_$*7.A:]IUK#J.J>'-'\
M5V:Z9J6I:99Z9XBM6T;7M-DGU+PW>:OIEGJ#W>B7EY;ZYIFIZ;9GBCQEX4\%
M6-AJ?B_Q'HOAC3]5\1^%O"&F7NO:E:Z5;7_BKQOXAT[PGX/\.6<UY)$EQK?B
MCQ/J^E^']`TR(M>:KK.HV6FV<4MW<Q1,`=+17!_#_P")O@7XIZ7K>M>`/$-K
MXETOPYXY^(/PUUJ]LH+Z*&P\<?"OQGK7P]^('AV0WMI:L]YX9\9^'=;T"]D@
M66TEO-.G:RN;JV,<[]??ZC9Z987NIW\ZVMCIUI<WU[<2K(%M[2S@DN;F=U5&
MD*10122-L1F(4A58\4`7:*\>\(?'WX0>/;7X.7GA'QSI>MVW[0'PWN/B]\'I
MK6#4XU\=?#BTTCP;KMQXKTL75A;M;V$6D_$'P;>M%JBZ??>5KUJHM#+'=1V_
M.:O^U5\`-"^*T?P5U7XE:/:?$-M;T'PM<Z8]EKTFD:7XP\5Z?:ZMX5\$:]XR
M@T>7P/X>\=^*=,U#2[_PQX'U[Q+IOBSQ#::QHT^CZ->)K&EF\`/H2B@'(R.A
MY%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!7\O?_!2
MQ6/[87Q&P"?^)%\.N@)_YDS3:_J$KYK^(O[('[.'Q9\6ZAXZ^(?PMTCQ-XLU
M6#3[:_UF[U3Q+;3W,&EV<=A81O#IVMV=HHMK2&.%3';HS*H:0NY+'[OP]XIP
M/".>5\SS"AB\10JY;7P488.%&=55*N)PE:,FJ]:A#D4</--J;ES.-HM-M?%\
M=\-XWBC)Z&7X&MA:%:EF-'%RGBY584G3IX?%4913HT:\^=RKQ:3@HV4KR3LG
M_)UX75AXG\,Y5A_Q4OASL?\`H.:?[5_:P.GXM_,U\>6W[`/[(%G<VUY;?!+0
M8KFSN;>\MI1K7C$M%<VD\=Q;RJ&\2,I:*:*.0!E925`964D'[$_S^=>IXD\;
M99QE/)Y9;AL?AUE\<=&LL=3P\'-XIX1T_9>PQ.(OR_5Y\_-R6O'EYKNWF^'_
M``?F/"<<U688C!5_KSP;I?4ZE>?+]76)Y_:>WP]"U_;1Y>7FO:5[:7*^0_V_
M_A/X[^._[#_[7'P6^&&G0ZO\1OBM^SG\8/A[X&TNXU33]$AO_%GB[P/K&B:#
M:R:QJTD6EZ6LVI7ENGV_49%L;7(FNCY*.#]>45^8'Z,?DE\6/^"?_B;5_B?^
MSUXML/&?Q&^,^I7_`,8;G4/VD?B/\7_%WA(:K-\*_!?[)_[5/@WX,^%+KPCX
M"\/_``O\(>(_`/A+X\_%_1/$T_@'1?"@_P"$AUK7M5\1>+7U>RMKA[;SC]AS
M]C']J_X7QW*?$;XH^.O!?B!?"/PTT#XJZUJ6D?L_>-/"7Q^\9^'M6U6[^(_C
M5=*T==?\3>(+[Q\EQ=Q7'QA^)][X3^*]]H^N1:)J7@N%]"L[V#]M**`/Y8KS
M_@FI^UEX3^`/C#]G;X4?`/PU\.KSP;X8_:UG^!?Q6^&_B_X.6CO\>OB)\8OB
M3X]^%GQ*EF\=:_K5W\,?!EGX`U'X2^%=(\:>`OAO9_M$Z=XM\->(M!U+5O#?
M@7P]X,\3:S^Q/[,7P;^.?P^^.GQ8\;_$71`?`'Q0T;4]:\":2_B^RU2Z^!OB
M./Q%92?$WPZVF6VIWVGWEI^TIXNGG_:"$_A;S[#P3K,6L>!=4F2"'PVTWZ*4
M4`?S%ZA^S?\`M/\`QWT[]MU?@_\`#[Q9X=^(]M^T?_P5*\/Z'\9];^)Q\*GQ
MY\.O'OP2^+/PY^&'[/F@:+K6KV6K:=HVJ_'7QQX`^(^B:W<:1#\+_"J_#]OB
M#I/BL>*]272J^MO%W[$7QOM?B3I]IX5\&_VA8W$W[(M_\)/B[_PLFV@MOV8;
M+P#X^7Q7^UMH6K^&=6\0+XE\8ZE\=H;OQE?ZUJGA_3O%2?&J[\?77@SXLZAH
M?A?P[IVIS?MZ!C/7DD\DGK]2<#V'`["EH`_E,L?^"0'QV3X&?$WX21?`[X>Z
M1X5UGX(23Z7\-V\;>%9?"6M_%3PM_P`%,?B-^T3HFC)IL&HSZ)9^(M<_9J?P
MAX3TGQIJ4%OIE@;_`$_PIK>KV5KI&H1V?Z4_LY_LY?&[X>_M>+\3=.^"FI^!
M_A]XMU3XJZKX_P!5^*?Q`^'OBWQ#X;\'^+-&BU#X>>`/AIXI^%/C:#Q#KEMX
M1UW3_#/AN/X._%CP#XH^&GP7\*VNM:;\%_C!K-KH^@W'B;]BJ*`/QU\;_L<_
M&?XB?M=ZUXI\9^&CXA_9Y\1_MZ6GQ:U[2;[XA(-(UGX$Q?\`!)^+]G6:VU/P
MC!K<%Q>:+<?M,VMK:7WP_EM3#J4T*^.-0TFZTEYKZ7FO%W[%_P`:?BI_P31_
M96^#/QU^'&B_&+XV_`/XJ?LL_$_Q7X`\7^)_"_BF^\3Z/\"?C_X=\1^*_"FC
M^-?$>KCPMJ'BKQ%\$--U?PAI>H^)O$5KI6LRZDVD>)?$-A#J-_JL'[7T4`?S
MA^,?^">O[8P\/:[K'P1L9?@U\4_BA\:?^"HNJ_$'Q=9?%#3+;4_^%-?M!_$;
MX@_$K]G[PIJ,NFZ_J.G0KJT]WX=L[-/#MO>W'PJ\4ZU?^*U\B?\`X2"\U/\`
M33]BO]GWQ[\-/A!\6_"'C8>,/"]CX_\`%^K7?A/P3XEL_@QI-OX!T._\`^'?
M"]]'X;\&?`F[UGX>>#=,U;7;+5?$MSH&E>+_`!,VI:W=ZGXKO;O2=1\3WVB:
M?^A%%`'XY_L__"#]IWX4>!/V7EUK]GV^O_$W[`W[$7C7X!Z-H.G_`!:^%C0?
MM,?$5?"GP-\(Z`/AIJ\^JQVWA'PQX@M/@K=ZBVO?%Z'P#>Z->^)=)TZ\\/SV
M]MJNIV>[\3O@9^TE%^T/K'CWX!^`_&'PD\2^-_C'\(/&OBWQ[H/QR\*Z_P#L
MS_$?P9HT?PT\/_$2^^/_`.SGXV>?5H?C(GPQ\)ZGX`T+Q#\%O"\>L:S-X7^%
M^OW'Q=T7^SI;+P]^M]%`'!_#7Q%XP\5^#[/6_'GP]O\`X6^)I]4\46=UX+U/
MQ)X:\6WEEIVD>*=:T?P]J\FN^$;R_P!!GB\6^';#2O%UK9V]T]YH]KKL.C:S
M';ZUI^H6\7>444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`445PGQ1^)O@7X+_#?QW\7/B=XAM?"7PZ^&?A'Q!X[\<^)[
MV"^NK3P_X3\+:9<ZQKVL7-MIEI?:E<0Z=IMI<74D%A97=Y*L9CMK:>9DC8`[
MNBOF'P#^V+^S_P#$N^.D>$O%7B2X\01Z]X1\/W?A36OA3\7_``AXSTJ?Q['X
MC?P=K&N^"_&'@'0/%6@>#/$3^$?$]KIGQ`UK1[#P)/?Z#JFG'Q(M_9RVP^G`
MZD9`;MU1P>?0%03[X''?%`#J*HV.J:=JD,EQIM]::A;PWNHZ;-/87,-[!#J&
MD:A<Z5JMA+-:O+%%>:9J=G=Z=J%J[K/97UK<VEU'%<02QIROQ*^)'@KX0?#_
M`,:_%/XCZ[%X7\`_#OPQK7C/QEXCNK34;NVT/PUX=L)M3UG59[;3+.^U"XBL
M;&WFN9(+&SNKN1(V$%O*^%(!W%%-5U;&W<00"#M8`@@,#D@#H1WZY'4$!=PS
MCG/^ZV.<_P`6-O;UXXSU%`"T5P7PP^)_@3XS?#OP7\6/ACXAMO%WP\^(GAK2
M/&'@OQ186VH067B#PUKUI'?Z1JUG#J-G97R6]]9S17$27-I!.L;J9(4)Q7=[
M@<?>Y_V6X^O''XXSQCJ*`'44@8'GD8]05/KT8`X]^G4=0:X#XG?%+P)\'/!>
MI_$#XC:ZOAWPKI-UHNGSWIT[5]6O+O5O$NNZ;X7\,Z#HFA:%I^J>(/$?B/Q-
MXFUG2/#OAKPWX>TK5-=\0:]JFG:/H^GWFH7MO;R`'H%%4[*^@O[*TO[<7`M[
MVVM[N`7%G>65R(;F%)XA<65[;V][9SB.11+:WEO!=6\F^&XABFCDC6T6`[-Q
MZ*Q_D.?PH`=17+>*?''@[P1%H<WC#Q/H7A>+Q-XGT#P5X>DU[5+32EUOQ?XI
MO!I_AOPQI1O)8OMVO:[?$6FDZ5;[[R_N,Q6\4C@@=.'!Z9]<[6`/T)&#Z\$Y
M'(XYH`=129XSS^1)ZXZ`9_3ISTI-PP#R`?56&,>N0,#W.!WH`=17FWQ4^+OP
M]^"OA%_''Q*\0#P[X>_MGP]X;M)$TK7-<U76/$GBS6;/P]X9\-^'/#?AO3-8
M\2^)O$>OZUJ%IIVD:#X>T?5-6U"YF"6UG(%D9*G@?XV?##XC7UOI'A3Q7:W7
MB*Y\,'QH/".J6.L>&/&]OX1/BC7/!D'B6_\`!'BG3=%\7:9H=[XG\-:[H^G:
MGJ.BVEIJ=SIERVGRW4`29P#U2BD#`@GG`SU4@\=>"`?IQSVS7-:!XNT3Q-=^
M*;+2)-2DN/!GB63PEKPO=!U_1XH];BT71/$#QZ9<:SI>GVWB#3_[,\0Z6ZZ[
MX>EU70GO'O-*34VU72M6LK$`Z:BN3\=^.?"GPS\$>,?B/XZUF#P[X)^'_A7Q
M#XW\8^(;R&[EL]"\*^%-(O->\0ZQ=QV=O=73V^F:1I]Y>SQVUO/<ND#)!!+,
MR1MK:#KFE>)M$T?Q'H5XFHZ)X@TO3]:T?4(4E2&_TO5;.'4-/O8EFCBE$5U9
MW$,R>;'&X5PKHC@J`#6HKR#6/CQ\+-#^(EQ\)[_Q).WQ$LK+X7ZI?^%=.\-^
M+-:U'3M'^,WB'XA>%?AQKFI-HVA:A::?H/B'Q!\*O'^FOKM[<P:1H<WARY?Q
M%>Z1!=:=->>NAP1G#=NJ.#STP"H)]P!QWQ0`ZBJ.GZIINK0S7&EZA9:C!;WV
MH:9<36%W;WD4&I:3>SZ;JNGS26TDJ17NFZA:W-CJ%I(RW%E>6\]K<QQ7$4D:
MWJ`"BBB@`HHHH`****`"BBB@`I,X]?R)_D*6OXZ_^"M_[3O[2'PV_;O^*W@_
MX=_'[XR^!/">G>&OA7/8>&?"'Q(\5^'=!LI]1\!:5>7\UII.EZG;65O+>W<D
MEU=O%"K7%P[S2EI&+'[[PYX!QGB-GN(R+!9AALMK8?+*^9RKXNG5JTY4Z&*P
M6%=)1H^\IREC8R3?NVA)/5H^&\0..<)X?Y+A\ZQN!Q.84L1F5#+51PM2E3J1
MG6P^+Q"JN57W7&,<)*+BM6YQ>R9_8GD>_P"1_P`*6O\`/F\'_MH_M@W7B_PA
M:W/[5'[0UQ;7/B[PI;7-O/\`&#QS+#<6]QXCTR"XMYHGUDI+#/#))#-&X*R1
M.Z,"K$5_H+KT/^\WZ,<5ZGB9X6YAX9U,FIX_-<'F;SF./E2>$HUZ2H_4'@U-
M5/;?%[3ZY'EY=N25]T>9X<^)F`\1H9O/`Y9C,M642P,:BQ=6C5]L\:L4X\GL
M?A]G]5ES<V_/&VS'5\@_\%`?A1XZ^.W[#O[7?P7^&&EQ:W\1?BK^S?\`&3X?
M>!M'FU?3]`CU3Q9XL\"ZSHN@V#:YJLUMIFCF[U*[MX5U34+B"RL'=;FZFBAC
M=Q]?5\Z_M>?&W7/V;/V6?VA_V@_#?@B7XD:W\$_@S\1OBGI_@F+5].T%/$$W
M@7PKJGB1K2\UC4[JT@T[2XH=.DO-8N8#=:HFE6UZ-$TS6-:.GZ3>_EI^F'Y$
M6O[(/[6FO_&;P1\0O#W@_P",O@_PQ8_&;]DW7]?U3]I/X^_#SXK_`!XMM.^$
MZ_M-#Q7?+XD\%>.O%NC:E\%O#*?%#PIJVA_"2\\4:A<:[X^U7Q5X@M/#6BQ3
MZS=Z[\T_&+X&_'[X!_![P!=>,O`__"`6-U8?LP?"_P".%GXI^+EGXK^$G[4'
MQX^&OBWQ+\2OB3^T#\=?$LOC/0?#N@?"7QEX;\*:YH-_K7QB\:_"KQ3\6?%'
MQ&\'>#?&%O;7/@KP3X:\5?HW\-?^"HDD7Q!^*VD?M"_"OQ#\+/`7AOXL?L[_
M``QT?QE9V_AC5="^&VM?'3]E3X4_''3_``_\8_$-C\1M7&K:G>>,O&'B+0+#
M7OAAH'B+PSH6DOX/7Q;=:=+J<VJO]/\`[)G[??P%_;+N]>T[X3ZC<'4M"\)>
M"_B$-/NO$?PU\0W5YX$^(,^LVWA37[E?AG\0/'T?A/4;JXT*_@U;P!X^E\*?
M$KPQ(;,>)?!VF"_M6D`/Q_\`@U^R3\:_B';?L^>*_A;KWQ>E^#7A+P-\-?AY
M\-]46+]GW0=8^#_C7X4_M#_%#6?C/\0=%USQ!J_BUK'P%\4K/4_#K>`/'_P(
MB^)VL_%3X6^&=$\$^/;VYT]X_%6J?77P'_8R^.'@;XP_![QCXF\'V(T'Q#\0
M/^"HMI^TR-0\=6?B6T\5_"3XU_M%^*?B'^R=X6UG0K_6=5M=?\.Z=X3O]/DT
M3PS96D\7PUAO=5T:XBT^35=?CU'UGQ7_`,%:_P!G'P9IVG:AKOA[Q_I,/B#Q
MO\>_!'A$>*-8^"O@!?&4O[+WQ$U;X6_'K7_#>H?$SXQ>#-*O-$\#>-K+2O#]
MG#<ZC:>(?'.J>)M(LO`.@^)#8^)I_#]O2?\`@IC\-;WQSXH\.Z!HWC[XNP^(
M/&^F>'O@QHWP[\!:#H&HZ[92?L/_``R_;5G$_B#Q_P#%;1])UD:S\//&USJ^
MDZUJ]A\-8]/U'9X#O=%N[_3;?Q1XD`.9M_V=?CAH'[?DOQH\+?#F74/"_B3X
MJ3ZWXU^(OQ(\>>%?$VF:9\+;CX(?\(=-I?PEUGP]K7A3XT^%[O\`X2C3=!6#
M]GKQ[X%^)7P)L=2N/%GQ)T3QGHGBK5=,;2(_C?\`LX_&S4?VW/"WQR^'?PZO
M/%.SQ%\!4/BWQY\0O"^K?#7PCX$\+:S+:_%!/"]K;:]X&^.GP;\72>%M4\27
MMKX5\"6OQ?\`A%\;/%">&7^*>@Z'9RZZ]OF^+O\`@JGHFL^*_P!EW0?@=\,?
M'?BH_'CQO\!O$%II/B'PUHMAX@^)'[-O[1WP#_:G^)'PO^)7PI2?XB:/8>&[
M[5?''[/#Z!K,/Q@F\(W7A'1(]6U/Q'X>LK#5-"UH>G2?\%3OV?H-'\?ZI<>$
MOC!:W/PN\)_#GQ%X]\/W?AKPS!KWAK6/'_[5/Q&_8ZO/`%_:CQE+9OXR\`?&
M/X7>*K?QLEGJ%WX;/AJ/3O$/A+Q'XIM=2M5<`_,WX=?\$]?VNO@Y\(/V=_!?
MA3X3Z-=:2_[&GP*^&W[6/@L?$CPMKUSXM^*?P]^-?@C6-0NM%T+Q7XRT[X;^
M/O'_`(6^&X\8:?X-N/'6I0_""^T":[\(^)4UK1[+PMX4EUO!G_!.S]N:;3/'
MVA7OB6X\'7NB_`#]N#P7^SCXUU/XA>%[@_#GQC\3/V@_#WC7]FFY_L#X<6>C
M>'O#6O>$/A;JWCW0-#UWPGX0BT3X./J-_I?@JTCLH=$6Z_1OQ-_P5"^#_AJP
ML=4F^%_QFGTS6_BG\=?A#X5U:_B^$?@OP_XK\6_LV?$+Q'\,_B]!HOBKXD?%
MOP5X4673/%7AJ\T_P=H6K:WI?BWXHR&\;X<>'?$MMX9\9W?ASH[C_@IE^S7!
M\?)_V=3J6I'QU9>*-/\`A]J4<NL_#6RO-/\`B;JWPVL_BGIWP_G\!ZA\0K7X
MNR7[>'-1TZRO_%MK\.;CX;:-XJU&W\):KXTM=;M]5M],`,?]B+]GKXL?"+X9
M_&?2-4NO&'PXN?&^JP2_#[POXGM/@BFF_#W4+7P'::#<^)O#_@;X'2:KX#T6
M#5/$*P:QJEF?%^NWWC#4-'?Q7K=MH&L^(M5L)/SBN?\`@FU\:OB/X1^%OAGQ
M]\"/#::3X.\4?\$])OC-X;\9_$KPW\1M/^.GQ>^"7[5/A+Q?^T9^U?;37VL:
MDJ7&L_`V/XD:"VI^)8]&^+7Q<TWX@W?A3Q7X4L$\)>&XKS]!=#_X*K_`K6-#
M\+^*9_AU\<="\+^*/A_^RK\9(]?UOPWX(@T_1_@=^V-XD/@7X,_%_6OLOQ#N
M[FW\,W/Q`AO_``CXFT"VMKOXB^')-+O_`!1=>"9/!*VWB&YYZU_X+'?LA:CH
M?Q`\1:+>>*_$^F>!]*A\2V$?@ZY^&?C+7O&W@]OC5\/_`(#7/B;1?!_A7XDZ
MQXP\*PV_CCXG>"[BTT/XL:#\.?%/B/PUKEMKGA70]:6#4;73P#C_`/@H9X!\
M4^/_`-IS]EOP7H?P3U_XZ>%=5_95_;UTW5O`.F^-S\._#B^))-?_`&.+7X;Z
MWK'B34-0T?PS::CX;U2?4-1\/R7FJP^)]$MXM<\7^`K#5_$/A=-/D^<=3_X)
M[?M=R>!_%]WXQU^]^(GCP?M4?"3Q#X[OK/5?`GB[5_VA_P!G[PE^PY\&/A?X
MFTC1_"_Q>U[3_AA9:5JO[7N@:W\;M;^'/Q&N_"UGXWO/"4?B+7KHZK<>';:?
M[6M/^"CE]XF_:N^"/[-OA#]GSQ^#XQ\8?M$?#KXT:GXL\0?#?2-:^"OC7X'^
M"/A%\0[>QN-+TGQ[KND^,=-U[P1\8_!?C.34_"NL:TT/A_Q'H]II]M=^)[?Q
M/H.@>]?$W]MOX:_#/XB>(O`-UX4^(7B6V\!:O\'/#7Q3\>^&[#PH?`OPJ\5?
MM`Z[;>'?A%X>\8WFO>,-"\037GBC4M3\//J-WX4\.>)M*\#Z1XJ\-^(_'=_X
M>\/ZA)J-H`?GU\7_`-@'XU^./V;_`-FC1O&@N?VC)O@'\</V=/C#%\`/B;%\
M&;[Q-8Z+\/?B5>ZKXW\/>&?BJUEX2\.:OXDD^'>MMX3T?P[XCUO3O`D&E:#:
M^'8/$]R4M_$5YY%8_L4_MM:U\5)_%]_X)M/`<OCWP7^TSX)^,H\+^._AO8^"
M+CQ_XW^(/@+Q1^SC\:/">MV6HZK\=O'UK\'M3T>\\=QZ]\7_`!3)X^\/ZWHL
MWACP!X&\.Z!XBG1OO7]E[]NCQEX]_8P^*W[:O[0OPUU[X?>&?"_BKXZZOHOP
MU\'^&+'Q=XSTKX8?"'Q;KW@R&UW^#_B+\0(O'?BBXO?"FL?VQK#0_#VSAU>/
M5(H_#5EX-TO3O&>NU_%W_!6#]G/P)X1\#^)/%NG:WHVH_$*?XAS^&/#DOQ&_
M9EGCU?PO\*;#P1?>.O&VA?$2#X_O\&O%NAZ;+\0_"FBZ=I/A'XD:WXXUWQ-J
M,_AW3/",FHZ-KZZ4`>2?M;^#_CAX,_X)3Z_X)U?1=<O_`(X>'O&7P7T?Q!?^
M#/$>KMJ?Q3\20?MB?#(^)/BK8:WX8;4_$'A.W^-D$FI?$W6+4H^H_#FU\7ZM
MI&I)Y'AN:5_._#W[#'[1.M?&9?$^C>'C\"?A&=#_`&W]9^#'P_O?B%IOBRQ_
M9H^(_CWPU^Q5I'P%\07?A?P]X@UCP[K]Q/\`&#X1?';]HC1_#_A^Z\1>$_AI
MJGBBW"2V?BG6&AM+OQ'_`."JGC+0OB'\0HO"MMX!O?@QH7B7XUW'ACQK#X-\
M4:_XGO/AGX"_X)0_!O\`;\\)^*$\.W/CSP7;ZWK=_P",?B-J5C=:)/?>$XM5
M\&0:5X=^V>'->-[XH'U;HO\`P4P^#D4ZV7BOPS\4[#2='\;6?PB\3_%%?!6D
M1>!?^%LS_LIZ!^U]:^&]+T#3?''B;X@W;^(?A1K$T^D)H_A_Q):6?BJT'@K4
M-8.L:AHTNJ`'YW7G_!.'XN?$*3X(?V_^SKX;\,^#/`7QD_X)^>(_&_PU\7?%
M#PU\2(]<\=?!+Q1\3;C]I_\`:9L=2GUK5;>]N/B!X,\3^$/"LMY?S67Q3^+U
MMH9U/Q]X8TG4-%T>"ZXOX>?\$SOV@_#7G>)_B!\'=3\3^/OB#^R!X]^`WB'Q
MO\/_`(Y>!/"?Q6\#:[IG[7_QI^,VGI=?$GQ.OB%K_2/B1\&_&_A/P1IEGIVE
M^+-%O6TN?X:_$RV\+>!=3O/$6F?LY^RO^V7X<_:KO?B</#G@'Q5X)L/AU8?"
MS44MO%NJ^$-4\3:W8_%CP&GQ+\.:HFF?#W7/&OAK3=-O/"6HZ%-8VTGC:\\5
M_P!JSZSIGB#PIX973-*N_$?@6G_\%;?V<+[6M<\)_P#"._$.3QUHVO?`S0XO
M`F@W_P`'?'?B?4/^&@OC!HWP(\#W,D?P[^+GB[2/#=Y8_$OQ#H>C^,/"OC/6
M/#?C'PQ9ZK::M>Z$UBE[)9`'5?L::+\=/@GX>T;X4>,O@/;>'/"?BSXH_$^^
M\,7WAW4_!N@W/PY^'5EX$\+ZWI6I?$WX?^%?B!\0OAQX:\0^*_B3)XJ\-:7X
M6^`GB&3P'8:.?#OB>XT'PWJVM>)],L_F'4?V'OCGXX_:WU;Q1\2?"<7B;]GK
M7?VQOVG_`(G:WHVJ?$>*ZT;6?A+X_P#V$_V>OA%\.X=4\(6^N17%YIDWQG\"
M>+67P=);;=$U&PM?&TUA;-=V6IMZ7\<?^"J&A:#\`?VE/&'P1^$WQ(\6?&;]
MGWX$?M)?$CQYX.UO0O"-]HGP,\5_`W4OB;X#L=.^-CZ3\3[`:SI6O_$SX7^)
M[:QM/@_KGCC5-;\%>'M=\86$UGHT5I>W'ZN:!?S:IHFD:E<+$D]_I>G7LRP;
MO)66[LH+F58MS.WEAY6$>78[`N68Y)`/YX/"W[$7[8U]^S5\0/`OQO\`A--\
M7?VE_'W[(TW@;PY\>-5_:&T^V'PVDOOV`HO@;JW[/VJ69UZ>?QK/??M`P>)_
M$>I2W%G<?"GQLWQ&D^,?BKQC;>/?"&G:6_:>(/V*?VW)[MO!O@"5O`4]]^T-
MJ_Q]T+XUI\3-+>P^'`\5?\$C=>_8TT?0K7PI9ZA-XBOM6^'7[1\&E^+[Q;#3
MSX>_L&[TCQOX7FUCQ.FIZ9H/]`5%`'\^7AC]ASX^6GQL\(?$3X??L\1?L_>!
MK7Q9_P`$Q_\`A(/!\?QQT'Q/J4MI^S/\3/VQO$?[0'B&]O=,\1ZC'JEAJ5C\
M9?`5[:P27USK?Q.9[OQ#XGTBT\6R:SIMI\K?$3]FC]HW]E']GO\`9M@\7>'C
MIFF:[^S'^Q/\-?VD(-<^*4>M?#?QC^T[\'_BA8>-O&2_M$>([_QII&@3_#2]
M^%GAWQAX)USQQXH\;>"_`_BQ-1\&_#,^,)'N?!WA/4/ZMJ0C/7/7/!(_D1Q[
M=#WH`^%?^";5MX:TS]CWX7Z!X3@\61Z-X:N_'F@QW'BO3_#5FFH7EE\0_%,N
MIWO@V[\':SXD\,Z]\,6U&ZNK;X7^(M+\3>)CK'@*UT"YU/Q)KVM_VGJMU]UT
M@&!CG\22?S))_P`XZ4M`!1110`4444`%%%%`!1110`5_(S_P5:_8I_:S^,G[
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MFD(!(1&(!.`?[V5&!_P)C^;$C]*-B?W%_P"^1_A3J]/Q(\4<V\2YY14S7+LM
MR]Y/''1HK+EBDJOU]X-U'6^M8G$.\'@X<G)R*TI<U]+>;X>^&F5>'4,UAEF8
M9CCEFTL%*M]?>%?LG@HXE0]E]6P]#X_K4^?GYOAARV]ZY7'?$/P#X3^*W@#Q
MQ\+_`![I$7B#P+\1_"'B;P%XTT">>YMH-<\)^,-$OO#OB/1Y[BRFM[R"'4]'
MU*]LI)K2X@N8EG,EO-%,J2+V-?.'[7?B'XU>%/V;/C#XA_9XTJXUGXQ:3X,O
MKKP5:6&C0>)-8ANQ<6D>IZIX=\,74-Q:^*_%6A>'Y-8USPGX4N[:ZM?%'B;3
MM)T"YM;J'47MI?S$_2#P?1O^"=O[-PTGQ'X9UO5OB#\0[G6?C/\``SXY>-;S
MQM\0?^$BUO6_&OP)\%^#_`WPUMO$WDZ=907'AV3P-X'\.:'KF@W.GQ0>+--M
M[F?5)+JYU&]NY_H+X#?LW>"?V>=-NM&\&>(?B+K&D+I7A[POX>TOQSX[U?Q;
M8>#?!GA&&YM_"W@_PM:7@A@L].T:UNY+4ZMJ$>J^,=:MH=/@\2^*-;BTG2EL
MOY];SQ-^U/X`_:(_:*\8_!'6?C=J7P-^*_Q$^")\2?M$?$3P5X\\#^/_`!-I
M_@[]E;0]'^'UG:ZAX9_8W^,6N2^'+WXD?\)?8:QXHB^`%J-4\2^%M`^&VJ>(
M=(LO$EBGBS[#^)/Q<_X*1^'O!'B[P;X*L-?\7?&^?]GWP)^U5X?\2Z;\+]9L
MO`<=]!\&-*^&/Q4^`NC6&M^!IM2C\56OQY3_`(7EX0^&NO:5=?$:]\.:I?>$
MI=(OK73_`.P4`/NF\_85^`EIHO@SP[H>M?$+P)KWASQK^T/XL\)^,/"7Q(OM
M!^(&W]IOXFZQ\:OCMX/MM::*X>]\'^+/%]_#J\FBI8277AM/#OAF^\.ZCHVI
M>';'58]>']A+X`V_Q53XQ06?C$>,(O'NH?$:*2X\=:Y?V`\1ZA^RQX<_8\N'
MF@U*6\N;RU_X4SX6TJU\N^O;J>3Q0MUXLN;J?5+N<M^.7BCQ%^VIXGN?V>_B
MAX;T;7?C#\0OAAXY_;HU;]GJ]N_"GQ*\1)'J;?\`!.KQO%X)T;Q[XO\`'W[.
MO[+H\2V&O_'2YFT'0M=E^'7AS1)KG5E^&"^)-8U30I+F+N_$7[3/QV\-?$?X
M,>%S\>_VH)?V8OB7\==(\$W7QG\7_`B#PS\>]2FE_8O_`&POBA\9_"&@^"F^
M`NBZR_A3P!X^^&GP3\21>+-/^%5_>>"_$>O^/?`]KJ6H:+X5EM?"P!^B$7_!
M,G]F6S?X.7FECXEZ+KGP!^#GP*^"WPC\2:1\2M;L->\'Z#^SCX9^,OA3X5>(
M+:\BC\K4?%^CZ-\>/B+;ZKJNL6VH6'B9-3MH?$&C:A968M)9O$'_``3+_9>\
M0Z5IFD7-G\1K:W_L6RTGQE<6?Q/\4IJ/Q8N=,^-M_P#M):5XA^*FHW5Q=W?C
M/Q-I_P`>->\7?$^'5[F6UDEU[QKXKM;R*ZT#5%T:V_./P?\`&3_@H_K,EGJ'
MC+Q!\;?#VJ:%XN_X)A^'DTF#X->'[&T\1^%OVC_C3XU^%'[0OB[Q?HMW\-)C
MIWBG1_@I+X-^+'C#1=&N=&TKX#_$YI+WQ%IMKX;LK[P@^)=?'C_@IE!XUD\&
MQ:WXJTSP_P""?'/QJ^'?P9\;>,O`'CV;4?C7KWP]_:]^.OP\T:Z^*WA_X5?L
MB?$^P\7V:_`+PM\(KFTC7Q+^SCHOC31?%VM_%W1/&&HO:WNN>!0#]=-9_8A^
M%.H?#@?"[2/%?Q@\'^&9?''Q[\<:M#X3^)NKV"^))OVE?BCXK^+GQ<\/^*M(
MO;;5/"_B;P[K'B[QCJYT*WUGP[>:MX)TYX['P9K.AM)>W%ZO@O\`86^!/PU\
M06NJ?#E?'O@;PS;Z7H5I<?#7P_\`$/Q'!\.]6U;PO\,M(^#>@>*=>T6[GN]1
MUKQ!I_PW\.^'?#LYU+6Y]%UFX\/Z-XE\0Z)J_B[3X->7\E_CAK'[>OQ+\+_&
MSP?IGBO]H.\C^+O[1?\`P4R_9?T#PCH/@G2/"UCX;^#GA3]FKX]_$/\`9W\5
M^%O$D/@*U\0:5JVK_%/P/X(\">%/BCJ7BH:%XAT7QI+X4M_MNKWV@ZS:_3/B
MWX@?M#>"O^"<?[)^I_L]ZI\1/$6I&Z^$7@[XY^.OB!IWC73?BQX.^&NE>&O$
M.F?$[6=0C7X$?$?QWHNO:;\0-#T/P#K/B.+X`^+-3\+>%]3U?QBFFVT.DMXR
MTP`^G6_X)M?LT-X)TWP!]B\<KH&D_L\_LI_LR607QUJ7VY/AA^QQ\1-1^)_P
M6A>\:!GE\06GBK4[F7Q-K\B&Y\4V/EZ??QK#&";=W_P3M_9_O_`WC#X87-]\
M4F^&?B6?P^VD>`(OB;KMOX1^'>F>'OBGX;^,MGH/P^T:W6.#1=&;QQX3T6>&
M'4CKEYH_AVW;P9X:OM#\(2MHH^7?A5\6_P!L%?%O[+S>/=7\<^(_A[XEC&E?
MM">(-#^'7B*RA\+R:G\5_B-8?LK:E8?\)C\'_AAXSOF^)^E6^G>%OVG->_X5
MIX8M-$TK3?AM\0(/"WPH\-^/=3OW^"/A3^UM_P`%"/B'^S3\$?B?\+O&/Q9^
M*D/Q`_9X_9U\6?M4>+/&_P`,;CP19_!OQ)XC\9^"+;Q#J_P-U?PG^SKXUU#7
M8_%OPRN?%NH>-[_PMX&^.<'@/P[:Z-\7+#2]-OM187P!^X9_8=^"4'Q:?XXZ
M1)XX\/\`Q/F^/&N?'^;Q-HWC&Z@DN/$'C#X7_"GX/>.O"$UA=6MYILOPW\<^
M!_@M\/;+Q%X4:T+/J.BC6])U32=6F-TFYXZ_8Y^#'Q#^*K?%?78/%D.HZGJ7
MPPUSQSX2T;QCJ^D?#[XG:_\`!/7H_$_P>UWXB^#[1Q9>(M4^'FO06-]I,ZRV
M$>L0Z5H6D^+X?$NB>']#TW3_`,B_%'Q@_P""A3>!?%6LV'COXK)J'@'_`()Y
M?M<?M"^!W\"?"K4]3L_B!\:/A-\<6?\`9M\)^(KKXE_LZ^!O%'B_6O$?PWB@
MT/Q'X=T[X9_#S5/C/H\@\6^'/#^C6^H07<NM\1_VA_V_/#7C/]H6Q^$H^+WQ
M:^(6I>'?C'??#_PM%\+-:\/>`_@_I]FEEK7@6?Q!X%\4_LUE-<O?#'AN#Q+H
MWPT\<?##X_\`QDD^/_C9O#__``D/P6\C5[C1/!(!^P/@#]F7X;?#/X#2_L[^
M#[WQWHW@.0^.9(=3TSXA>*=%\>Z?>?$#QMXC^(.MZEI'Q!\/:AHWBG1]5A\4
M>*-3O=(U+2]0M;O3(Q;6L,KPP%9/";3_`()Q?`JQOM3\66/B'XP:=\6O$/B+
M7->\6_&_2?B/<Z+\5?%MMXG\,>!O!?B/PWK>M:-I.GZ(OAO6/#/PR^'ME/8Z
M1X;TF[M=2\(:/XKTS4;#QE'<>(;C\]K[XO\`[9C?!C0?$-W\:/&VC^&D^-GB
M^QT>_P##_@3XW:EXG\5>"HOA=X-ET'1-9^/>K_\`!/F:\T>YTCXMWOB/5=`U
M/4OV1?\`A"OB#;F7X1:CX]BU/PDX\4?MS\%/$WB#QI\'OA7XO\5^'?&7A#Q1
MXH^'/@GQ!XC\*_$33M%TCQ]X<UW5_#6F7^K:)XUTKPY_Q(--\5:9?SW%IX@L
M-%"Z59ZK%=6UA'%;11Q1@'RKX\_X)N?LS_$76O&VN^(M/\>/>^/KSXBWNO?9
MOB#KR*TOQ0_9%\(?L2^*/LTERUW=IO\`@;X(T*SLI;BZNKFV\6)>>,'N+C5K
MZX+9/Q"_X)S_``IU[X:>,/"7P^\0>*?`/C+4_BE%\?/!?C>]U34/%5OX0^.6
MB?LMZ;^R;X-\67?AYK[16U[PWH7PZT/1KB^\&IK.D1ZMKMM<:U'J^G:E<K<0
M_H=10!^>'[&/['OB[]GWP1\0?AKXXU[P]>?"CQ1H>F>'-!^$?AS5?$7B;1=$
M*1>)]/\`&7BJ3QOXFT;PSXNFO_B)HFK>'M+U'PX8+C3_``ZOA2&\TS6[Z]U:
M\N$CT+_@F)^S5HE]\.M2>Y^+&N7GPGTOX+>&/A[)XA^*.NZK'X8\#_L\?&?P
M)\=/@[X$L+1X8K,>&O!WC/X=>'(0LMO)K7B#04O-,\4ZUK<MR+V+]$Z*`/SP
M\5_\$Q_V:?%EC\6]-GD^*FB6'Q[/QUL_C3;^%?BCXB\.+\3?#7[0?B3Q-XQ\
M:^#/%;Z:(Y+WPMIGBGQCXGU?P790O;7OA0:_K^CV.I2>'?$6OZ-J?Z!Z=8PZ
M9866G6QD-O86EK90&5_,E,-I!';Q&23"[Y#'$N]\#<V6P,XJY10`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`-VCW[?Q-GCWSGZ^
MO?-+@#\!C';'TZ?I2T4`)@8QR1SU).<]<Y//XYKGM7\(>%?$&J^%==UWPYH>
MLZWX%U>]\0>"M7U32[*_U/PEKNI>'M:\):AK/AJ_NH9;K0]4OO"WB3Q#X;N[
M_39;:YN-"US5])EE:QU&[@EZ*B@!,#W['J>W/KW[^O?-)M'OWSR><YX//(Y.
M%/`[`4ZB@!,#WZD]3CGU&<$>@/`["C:,8Y[\Y.1G/1L[AU(X/`X'%+10`@`'
M3/;N>QSZ]SU_O=\USWA+PAX4\`^&-!\%>!_#>A>#_!_A;2;+0?#/A7PQI5EH
M7A[P]HFFP):Z?I&AZ-ID-MI^E:98VT<<%I8V-O!;6\*)'%&BJ`.BHH`3`Z<]
M".I[_CU_VNOO1M&<X_,D@'GD`G`/)R0,G/)I:*`&[1C'/UW'/_?6=W8<9[`=
M!3J**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
=BB@`HHHH`****`"BBB@`HHHH`****`"BBB@#_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>biib-2015630_6mosujbchart.jpg
<TEXT>
begin 644 biib-2015630_6mosujbchart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`(%`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#Y_P#VK_CD
M?V8_V8OVA/VBQX:3QD?@5\%_B5\7!X3DUG_A'8_$A^'WA'5?%`T.77SIVL?V
M)%J9TS['+JW]E:E_9\<K77V"[\KR'^:_`_\`P4!^'MCX*?QA\:/'O[/EY;W_
M`/PE.IZ!-^R)\1OB/^UWI,7A+X>:5X?U3XF^*_&=[X,^#.B7G@S1/AW%XK\-
MS^+]<U#3)?#N@V7B#09-6UFRO-:TNQNOJ7]ICX(Z9^TM^SO\<?V>=:UW4O"^
MD?&_X3^/OA3JGB31K:RO-6T&P\>^&=2\-7>KZ;::DCZ?=7VGP:B]U:P7R-:2
MS1HEPIB9A7D/QV_8^L?BOX@\/^,?!/Q*\1?!7QE8?"WXC?`KQ!KW@[PSX*UE
M?$7P@^+%QX0U#Q?HHTKQ/I%[INC^*K+6?`WA[6O!OC&S@F;0+U-2@U+1/$FE
MZ@VFQ`'JG@3]I?X._%'6?B3H/PX\2:CXWO\`X27LNE^/)O#GA'QAJ.CZ3K*Z
M'H'BBVT&S\1Q:%_PCWB#7]5\+^*/#WB;1=#\.:IJNJ:QX?UK2M8T^UGT_4;*
MXN/SS^%/_!8_X*?$7_A6_B?Q!\._B;\+/A7X[_9O^-7[1&I>+?&_@_QQ+XB\
M%:+\$OC/X-^%'B67Q)X)\.>"M8NK;P#::?XKF\;:_P#%E]1A\&^%=*TB[M=4
MN/,AO[BQ^X/V7?V4_!?[*>D?%+PYX#U35+SPW\1/BC;?$33M&U&&U6'P98:9
M\)OA+\(-$\'Z5<PEKK4M+TOP[\(M$N%U+5I9M6N[R_OC=3,BP;?C?P__`,$G
MO"'A_P`*?$/P)!\:_'4WA+Q'^R7^U3^QMX'LV\,^$8M2\`_"K]I_QCI/CBZO
M)=5CC_XJ_P`5^`-9L]0@T#5M5L[&#6--U"&+Q#975]8MJ5Z`?=/AC]J?X&>,
MOB7=_"?PYXRFU'Q9;ZMXC\.VMR/"WC&V\%:]XJ\&VAO_`!GX.\)?$J\\/V_P
M[\8^,O!UBLMWXJ\*>%_%&K:[H,-EK!U"QA?P_P"($TOY[^)/[<5]X-_:AN?V
M;-)\!>"&U;3-.^$NJ6\'Q+^-N@_![QW\7K7XHZUJNF7K?LT>$?%7AN7PY\8)
M/AW!I4K>,K6[^(/@Z^_MMO\`A&=.M7OGL;K4<GX`?\$U_A!^SQ\:G^+G@]O#
M<GV76?'?B_1;:?X._"2/QW8^,OBC%J7_``G=Y=?&L^&;CXH7_AV\O-?\3WVA
M>&H]:TY]$3Q%?:#=:WK?A.TTG0+#O?VDOV-K[]I.3Q5X8\3?&WQ?:?!KXCP:
M%;>/?A3>^#_AYXMM[3^PX8+9]2^$GC#Q+H5SXE^#_B'6K>TM&U#7M$DUB^T7
M6+6+QAX!/@GQN]QXDF`.D^%G[9GPC^(,UCH5YXET6T\:ZWX_^)O@GPUX=\/6
MWCS68O$H^'7Q^^)_P%U&?0;S7?`7A&ZU>_\`#>O?#'57^*MMIFF7FC_#&9A?
M:AK^I^!M0\+>.?$^1XO_`&P(?!7[;?PW_9*UKP(T7AOXD_!K5O'MC\8CXFCC
MM-)^(<&L>+Y/#GPQU7PI+HZ>3%XL\#_#/XI>+-.\6'Q&J0WG@J3PZ^B2S:K;
M7\/`^"/^">OAKP1XF\!>-;+XI^-+CQ5\)_C#\;_BS\,]2DTS088?#:?M-?M"
M_$WXW?M!^$+^PB1H/$VB?$O0OB+9_"Z:ZUIIM2\.Z)X"\'>*?#\UGXP@U74=
M2Z?]IG]A3PG^TUK'CC6M;^(_CWP-J/C#X>?"3P+9:MX%_L2Q\0>$+KX2_%KQ
M1\4-/\4^&-;O[&]GL]:UZV\8>(O`FMJ\+VTGA#6=7M(`DVI3O0!Y)\#?^"I?
MPD^(O@_XF>+_`(F>'-;^%:>%/C[\8_A?X&\.:)IOCGXQ^,?'OPP^%7A3X>_$
M)?CG=>%/AWX`O]?\)^%KKX>?$WPAXM\6)=Z=J&B^`(->T33-5\57NI:QIT%S
M[S>?M_?LMQZUK7AS2/'VJ>+=:T?5)O#:6_@OP#\0?%6G:YXSE^"FE_M$>'?`
MGAGQ/HOA>\\)^(?&WCSX.:QI_C?X<>&=+URXU3Q]ILS0^%8-4OHGM*\?_P"'
M<UGX>\9^.?B1\*_CMXZ^%_COQM\0_C=KW]KZ-X0^'>M:?H'PX_:`\&_L_>$O
M&_PPT;P_XAT6]TN*#2;C]FGX8>)_`OBN1&U/P[K6ES6=]I^O>&KR_P!!O&>$
M?^"9'PM\!:?X;\/>$/&WB[2/"/@[]K#X+?M/^&O#C6ND7T.GQ_!#]E;X>_LH
M>'?AI)J%RAOKS0=1\'_#S3O$&J^()W_X2*3Q!>WGDR1V2P1(`<5\(?\`@KE\
M$/B/??#O4/%?A+QW\(?`/Q,_9+_9G_:BT;Q1X[\*>.3J6@0?M'?$?XG?#:PT
M'Q]HVD>";VP\$^$/#VL>!-",/QGUS7K7X;>*(O'&CZCI&J+X>-KKM_\`<_PP
M_:;^#WQC\4:]X4^'>N:_K]SH%WXWL'UYOA]\0])\!ZY>?#7QD_P\^(-MX-^)
M&M>%M/\``'C>X\%^.8KCPKXEM_"?B35Y]*UBVN89XS#"\X^"+'_@DUX8B^#_
M`(Z^#>I?'3QSJ>@^)?V//@C^Q#X=U#_A$_!]AJ7ACX.?L\^/OB#XN^&=W=+:
M*++Q)XSBTCQ[)X7\3:U<V^FV6O1:5#K,6D:7?WUY$?H_X5_L46/PT_:+\1_M
M`K\3-7O+S68?B1#)X;\-^!OA]\,+3Q6WQ+\0Z1XAN=1^,]Y\.-'\/VOQI\0^
M!VT>+2?AMXK\4:%9>)]"TR_UF?7]8\6:_K&H:Y.`=]X@_;4_9N\+Z]X\\/ZY
MX_N;.7X;V_CH^*=;'@OQ[<^"XM6^&'@C4?B1\1?!VC^/[;PQ+X'\3?$/P5X&
MTC5?$WB+X=^'/$&J>--.TS2=9>71//T/6X-.YW3?V_/V6=:M[631/'FOZQJ&
MJ:SX$T7P]X7TWX5?%RZ\=>,#\3?"GB'QWX#UKP/X"B\"MXR\;>$?$_@GP?XR
M\6Z;XV\+:)JOA%O#W@WQ?J<VM0V_AC66M/G?7O\`@E'\%]4\;?'OQ9I6I:3X
M?'QTMOVA]4N[^W^#WPAU3XE>&/'7[37@?QEX(^(^NZ7\9M8\,7?Q%F\.JOC[
MQ5XBT/P>-4L38ZMK-[HUSXBOO`;0>#H.AE_X)O:)I_Q2\(?''P=\9?&7ACXL
M_#?X:?L\?#;X>^(W\,^$=>TS1;#X(>"/CM\-M>N=5\/ZG`+;Q!%\4O!GQZUN
MWUZQENK#_A']<\+^$]<\.WD1MM3L=3`-O]FW_@I/\$OCOX!^'GB;6OM_@;Q%
MX_U2[L3H-EHOCOQIX<\(VNL?''Q_\#_A->>/?B-IO@:Q\)_#^;XR:[X$D/@/
M3/'MUX8O]7U74$T'3X;VXCM[F]Z[PI^WE\,/B1^TE\)_@)\+K/4_&6C_`!+^
M'7[2'CQOB;+I/C'PQX:0?L]>+O@OX,N8_`]SXC\'Z?H?Q5\-^(]:^*NJV7_"
M;>"?$=_H&EWG@]H89=6@URTNH/F?X8_\$=?@9\+_`!AX)\76OB"U\;:CH>KZ
M#K?BS6?B=\'/@O\`$#QGXFU+P9\5?&/Q2\*:EX?\8>(O"5W=_#/4I;CQ<OAK
MQA=^#;"`:YH^@:)JGAR#P-XOBN/$DWT!\$_V#=/^#'Q*^"_C&U^,/C?Q-X2_
M9P^&?QF^#'P.^'.L:%X/M=,\(?##XPZM\)M8FT+5?$6F:;;>(_%NJ>#Q\(?#
M>@>&_$&KW*7+^&(4M=7MK_73J?B/60#K_'?[:'@OX8?M02?L^>/M+/A_0Y/A
MC\"O%NE_$3[9J.I_VCX[_:&_:1U']F?X<_#K_A%M+T*[N;7^UO&T>B#_`(2F
M?4QIEE_;6=6@TW3M/N=5,6O?\%#?V1O#=QKEKJOQ1NTG\,6WQDU+Q*ME\//B
M=JZ>'=`_9Z^,&H_`CXW^+?$$VC>#M0AT3P3\+_B9I5[HOB_QGJCVOAC3-/2+
MQ*VJ/X:N+?59>1^)G[!FG_%WQO\`%+XH^-?BMXAF^)'B:;X&1_"K7M*\)^%=
M.T[X/:7^S9\?6_:7^$EC!H4B7D7CV>'XIBVG\:WWB>^B/BGPW8VVB6-KX:GD
MO-5N_*W_`."6'@^;0_C9I5U\:?B'=WOQQ_9^_;>^!7B/6Y]#\')>V+_MR?'?
MQ)\?_'?CBPM[2QM=.&K^$O%7BG4M.\*Z.UK'H9T9;6#4())(2[@'VKX5_:E^
M!WC3XE7OPG\-^,9[_P`66FJ>*]`MIY/"OC*P\'>(/$W@)BOCWPGX-^(VH^'[
M3X?>-_%G@8K*/&/AKPEXFUG6?#C66KQZG9P2Z#KZ:7XS^T-^U[XE^`7Q/\#>
M$;_X=>!]4\.>.?&?PP\#^&+.]^./AS1/CE\3]2^('C3P_P"$/$>H_!#X&1^'
MM8O_`![H_P`((O$VF>)/B1-KOBOP5=VWARWUW5-*M+FRTB"\U;DO@%_P3>^#
M_P"SU\;+WXN>#1X:*+KGQ&\7:%9R_![X20^.M-\5_%R]U75/'MQ?_&U?#$WQ
M3UG0)=2\1>)I_#>@-K>GR:+9:_=:!J.L>(O#MCHVE:=Z-\=_V2=7^/6OW5GX
MD^.7C:S^$6N>(?`GBKQ!\+X?"_@*ZO+#5_AYK'A;7]+B^''Q+FT2+QM\.--U
MS6/!^C:CXF2QN-8U=;]M2U/P9KG@G5+]KV(`Y#X/_MP2_$[QE\(Q??#O3M"^
M$'[2VM_&/P_^S?\`$;3O'R>(]<\9ZA\'!XAU61_&7@H>%=)MO!UI\1O`O@WQ
MG\1/AW-HGBWQNQ\-^'FL_&L7A/Q'J-EI%?4'Q:\7?%;PW%X7T[X0_"S3_B3X
MB\2ZU<V%[>>)_'$?P]\!>"=(LM'O]3G\0^,/$-KX>\:^)Y(KR\M['P_H>D>$
M_`_B34M0UK5;=[\:+H5GJ>M6?S+X5_8<A\">(M-U?PW\5O$\WA[X4?\`"ZM:
M_9@\`:CX?\(+H'P/\:?&^U\1PZYK:ZC!I+:EXXL_"-MXK\1>%_AGHWB.,:?X
M3\#^(=7T#5H_%UQ_9>J:9U'[0W[-GQA^//P7^'_PJ3]I/4_!-YIT>AQ_&G6=
M/^&WAS5=-^/MC8>'%T[7O"OBS1;?6/"]WX<\$>,/$&[7O$^@>"==T$ZUIH;P
M5?W<O@V_UO1M5`/GO2/^"E.K^.O!$7B_X7_`23Q-<^#/@!XG_:0^-VAZU\4=
M(T(^'/`/AGXC_$SX66UI\)];T[POXCTKXO:OX^UWX+?%CQ!\+-9N6\`^`O%O
M@CPUH>O7_BWPZ?&ND6]K[QX'_;-MOB'^U3X2_9_\._#'Q`G@'QW^S+XE_:0\
M$?'35M;T>RT7QUIOA_Q/\"]&_LWP=X-MS?>(+O0IM,^.FB7\GC/7IO#MM)J^
MF:AH.BZ/K26M_J]ER'B7]A75O%6@Z/;R_'/5_!GB?5O@;)^S'\8-9^%_PT\!
M^#=!^(7P(@UKQ'J/AOPMX<\%72^(M*^%.O\`@+3?%?B70/`GB?PM=WD.B6'B
MGQ')<:!J-Q-H+^&Y1^QA\0M,_:G^&_[0'A'X_6?A/P/\*?A;JWP&\'?!.P^"
MGA>XTK3_`(*^)=>^$GB/Q%X3_P"$XF\5+XC;67O_`(.>&K?P_P")Q:`:!IMQ
MJ-M_8NI3R0WD0`?L;?MI:I^U%J]_#JL/P"\/VT_@C3O'?A[PQX#^,7C?QU\2
M1I&I7]G`TNO:'XD^"_PZ\,7-GX?%_:Z+XMUKX?>+_'VB^'O&LL?A>\OQ-/;7
M4_LOB/\`;*_9^\(>,]5\!^*?%7B'P[K6EP^.#'>ZU\-/B?IGA37[[X:^$/$'
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M\`^C-+_X*"?LI:[I=GJFA_$+7-8?6?\`A6$OA/0=-^%7Q=N_&GC[3_C-X?\`
M$_BKX8:[\-_`D7@5O&/Q#\,>,?#O@?QUK6E^*?!NB:UX>33/`OC:^OM3M+7P
MGKLUE4^"O[6OB;X__LM67[0_PO\`@U=>)]?U_P")/Q1^'OA;X>1^,[71K.[A
M^'G[17CCX$Q>,?$7C#Q!H&G3^&?"[Z9X-D^)'BM!X2UCQ/X;T22_T+2/#/BW
MQ+966G:KX[!_P32T+0_&7PI^*7@WXS^,O#GQ4^!OP+_9J^"OPN\63>%_"&NV
M>CP_L^^%OV@_`&I:]K/AO4H1I_B#_A:G@3]HWQAH7BK1I)["+1;O2O#>N^%=
M1TW4K&<W'JFC_L=^+?A[^R)J_P"S!\&/VD/B'\-O$FI^+OB;XI3X]KX9\&Z_
M\1+-_B]\<O&'QI\=QVFG26ND^&[#4M3/CC7_``I8^(-'M=)U7P]9W$6O^&WT
MCQ%9:?>68!P&B_MV>-O$OB6U^"6@?![P;>?M+?\`"[OBA\&K[PQ+\99Q\%Q#
M\'/A1\/OB[XZ^(&E_%FP^&FH>*M3\.:=I?Q6^'W@6XT6/X2Q^*]%^+.LZKX-
M\0Z;IUCX4USQ$A'_`,%$[;4X?V-;SP]\#?&][HW[4_Q>B^"WB;Q-JFO^'-+\
M.?!GQU8V/QKL_%?A*[OK>34KOXB>,O#7C?X%^+O"]WI7A;3;?08],6+Q9J'B
MK38+O0M)UW2\)_L*^(?"G@3X5:;I/QETGPO\2_@+XG\9ZE\&_'OP]^"?A3PI
MH>@^%?B/H,.C?$'P3XL^'VI>)/%=IX]M?&>H&?QIX@\3ZKXDL_&&J^/;70_%
M.I:S>WUAJG]O\M\1/^">'BC4O#W[+_@WX/\`[1FI_"[PM^R[X[M_C#X?CUSX
M2^#OB=XB\<_&B6V^*EMXB^('CG7]2UGPS#.?&$WQ@\8:[X@T'0M'T6R'B>[7
M4])N=+L_^)2`#U_Q?^V;::'^V%\%OV6-`\!R^)=-^(R_%;2?&OQ.'B-=-LOA
M]X_^'WPRT?XLZ7X!M/#IT:[G\6ZKJG@O5K76/%%XFJZ+9^"K;6_!L+_VWJ'B
M*[LM#^X*_.>?_@F;\!T_:/\`@M^TUHFJ?$CPYXT^%/COXP?%#5M$TOXH_%>;
MP3X[\?\`QITF>W\6:_>^#]6^(FH^&O"T-QKUY?>(;O0_">CZ?H6N-<+H>O:?
M?Z%;06:?HQ_GU_G0`4444`%%%%`!1110`4444`%%%%`!17!?%#XH_#SX*^`/
M%7Q2^*_C#0O`7P]\$Z/=Z]XI\6>)+Z.PTG2-,LHVDEFFE?,D\\I"P65A9Q7&
MH:E>RP6&G6MU>W$%O)R5O^T?\`KKP;\-/B%!\9/AJ_@GXS>)?#/@OX3^)CXR
MT)-)^(WC'QC=O8^&O"7@RZ>\`\0^*-7NX;F"W\/::)]722RU!;FS@.GWOV<`
M]JHK@?B3\4_AU\'O"EUXX^*'C7PWX#\)VEQ964FN^*-5M=)L'U#4YQ:Z7I=J
M]PZR7VK:K=,EII>DV$=SJ6I73I;6-I<3,$/)>(?VD/@'X4^#Z?M`^(OC%\-]
M(^"$L.CW$7Q7O?%VC1^`I8O$&N6GAG13%XF6Z?3)7U/Q'?6F@V<,<[3RZQ.F
MFB,7@>%0#VNBO&]0_:&^!FE?%.R^".I_%OX>V'Q;U$6ZV/P\N_%6D0>*[FZO
M+!]7L=-CTF2Y6?\`MG4-&BGUO3M$?;K.HZ);7.LV-A<:9;S7:6_B;\=_@Q\&
M)O#-M\5_BAX%^'EQXQO9[#PS#XO\2Z7H4FLRVC6<=]-:)?7$1_L_39=2TN#5
M-6F\K2=+N-6TFWU&^M9M4T]+D`]9HH!ST_S_`)[T4`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`'P-_P4N^&_B/XF_LB_%'1_!GPX\:_$GQEIGA_Q-KOA2P^&?BC3O#G
MQ*T+7[;P+XQT[3O$/@>RUF)M&\::O'+JQT.^\":C<69\2^&M?UZ#27O?$,.C
M:1J7YK^/_A=^T/;_``"_8J/C3]DGQ[\4?C=\,OVG_@M\68?%7P^^'OP4MO'O
M@W]GOX=?'SPQ\0=8TKXGW=KXW\'>$M$^-GBCPMI4&J>.-&^%D<^C>+M:T^WM
MKVX.H"[MXOI__@H'\4_B7X-_;R_X(Y_#SPCX_P#&/A;P/\8_VDOVAO#?Q5\*
M^'?$.IZ+HGQ"T'PY^RUXU\5Z#I'BZRTZXMUUO3M'\26%GK>GV=XSP6^IV\5V
MJ&:.-E_5]?#.D2(C/'=L2H/.K:RW4`GEM1)_,D^IH`_/W]I:Z\;_`!ATOPEX
MD\!_"+]H#P[\2/V7/BO\,?BWX"UBU\(_!_Q5;WVL^.O@MXX\-^*()OAOXN^+
MGA.R\?Z;X3\&_%'Q#X)\>^'(/&?@?QGX>\5:G8>*?AMK6NS^'K;^UOR[^/?[
M!?[?_B/]C?XQ^&_">D>`O'5[\1=2_:X^+^F?!#XFZ_<V'Q&\/_$[]I3XZ>(_
M&ECJ-C+X`EO?@ROBO0/ASJ1L]&T>W\0C0/`7BCX@_%*WL_&7C,2Z-XH7^DD^
M&M)QM*7Q`X`_M;6B`/0#^T,8^E'_``C6DXQLOL>G]JZUC\O[0H`_*7QPGQ0^
M)?[0O@+X2^,_V3OB3X%^#WA#XY?!?XT?$#XF_"_P5\/]6\+_`!__`&@O"B^$
MO$>A>.[GQ=<?$+2O%/@SX+_"OQIH7A6YU[Q!X@\'7OQD^)">`M-\-?V;X7^'
M6BW-I\0V_&?PQ\;?'GB_Q[\9]._9;^)?B.Q_:'_8K\;?LH6/PH\4:I\'K3Q3
M\*O'EC\1OB;)97_Q'#>/M2\,V7PP^-FC>,M(U;7_`!%X5\1>,9=%T;P'X<C\
M2>$9=7O;#3+3]6O^$8T<G/E7F[KDZKK.<CODW_6G?\(QI.`/+O,`Y`_M;6,`
M^H_XF'!H`Y3X,>"];^&_P@^%GP]\2^(IO%_B+P+\./`O@W7O%=R9#<>)M9\+
M>%=)T'5?$,YF`E,VMW^GW&J2&55D+W3&10^X#TNL#_A&M*_N7O\`X-]9_P#E
MC1_PC6E?W+W_`,&^L_\`RQH`WZ*P/^$:TK^Y>_\`@WUG_P"6-'_"-:5_<O?_
M``;ZS_\`+&@#?HK`_P"$:TK^Y>_^#?6?_EC1_P`(UI7]R]_\&^L__+&@#?HK
M`_X1K2O[E[_X-]9_^6-'_"-:5_<O?_!OK/\`\L:`-^BL#_A&M*_N7O\`X-]9
M_P#EC1_PC6E?W+W_`,&^L_\`RQH`WZ*P/^$:TK^Y>_\`@WUG_P"6-'_"-:5_
M<O?_``;ZS_\`+&@#?HK`_P"$:TK^Y>_^#?6?_EC1_P`(UI7]R]_\&^L__+&@
M#?HK`_X1K2O[E[_X-]9_^6-'_"-:5_<O?_!OK/\`\L:`-^BL#_A&M*_N7O\`
MX-]9_P#EC1_PC6E?W+W_`,&^L_\`RQH`WZ*P/^$:TK^Y>_\`@WUG_P"6-'_"
M-:5_<O?_``;ZS_\`+&@#?HK`_P"$:TK^Y>_^#?6?_EC1_P`(UI7]R]_\&^L_
M_+&@#?HK`_X1K2O[E[_X-]9_^6-7['3+33O-^RB8>;LW^==WEU]S=MV_:[B?
M9]XY\O;NXW9P,`&A1110`4444`%%%%`!1110`4444`?B!_P4G_Y22?\`!"G_
M`+.M_:@_]8Y^(-?MY'_JX_\`<7_T$5^(?_!2?_E))_P0I_[.M_:@_P#6.?B#
M7[>1_P"KC_W%_P#010!\*Z[J6HKKNMJNHZBJKK.JJJKJ%ZJJJW]P%556<*J@
M``*H``````Q65_:FI_\`02U+_P`&-]_\D58U_P#Y#VN_]AK5O_3A<5DT`>S_
M``9O;RX\7S)<7EY.@T2^8)/=W,Z;A<V`#;)I73<`2`V,@$@'!-?5-?)OP3_Y
M'*;_`+`=]_Z5:?7UE0`4444`%%%%`!1110`4444`(3@9_P`_Y^O`[D"O@/X:
M_M_^$?B5\:_CQ\,=-^%'Q1A\#_`K1'U+5?C/I]EHOBWP]J>HZ3K'Q2T'Q3H5
MSX%\'ZKK?Q4\-ZC::K\*/$=EX3M=7\&G5/'-Q;2Q:?I5@]]X37Q;]^$9'I^&
M?S'H>_MT(/-?E#X;_8%^+OAW]M3XL?M>I\5OAM+K-]X-@T[X8RZ3\,I_!GBO
MQAJ[:#\7M#@\-?M-ZIX.US2M/^(OPY\+?\)WX4U/3[?P_IFA^(_%.O\`@3P3
MXAU&_P!`U/P2I\5`'VI^R_\`M':!^U)\,]0^)OASP=XX\"6>F_%#XR?"N\\,
M?$73M/T;QA8:Y\%OBCXI^%7B"75M'T_4M5CTDWVL>%+V_M-+O+L:QI]G<06F
MN6>G:Q%>Z=:^(:W^VQKGP\^(7Q&\.?&7X#>(_ASX$^&7PM\??&?Q)\2[;XC_
M``T\=V^G?#WPCJ<FE>'=2U+P3X3U6Y\::?J?Q/O+;5+3X=Z"=.N-3U_4?#OB
MC3H8C<:!?;>>_9=^`/[7'[/7@?QKX3UCQ]^SWXLN?&?[4'BCXX-?^'?AS\2-
M$BT_PU\>/VD/%WQI_:`\.W5MX@^*6J^?J>G^&_&>I>%_A/K=C+''8:I8:=K/
MBS0?$$4EUI[=S\3OV*/#OQH\(_MQ>"OB-XIOKO3/VR=-TCPF-1TBT:TUOX;^
M!?#OP@\,^!O#.BZ5=7-Y<PZC>>'?']OXX^*&G3A+&P.J>,KBREL=\=Y?7P!9
M\,?M6?$7QUX'\=>(?"'[,'C>[\3^"/$NEZ++X3U/XM?L_1Z?J=G?#4VU:6/X
M@>&?B/XO\%Z5XF\#/IK:?\0?`6N7^G>*/#6I7-AMM]2T74]+UR_[?X7_`+2-
M[X\_9HM_VCM8^#WQ$T..]T'Q!XGT?X:^&QHOQ/\`'/BW0[#4;^U\*:AX(3P3
M?7.D>)H?B9IMOIWB'P,\=]91W.A>(-'O]:ET6%[U[+YNTS]A7QX_@_\`:X.H
M_$?X7>#OB3^U'\%/#'P*:\^"'P<O?AC\-/">A^#=-^)FC:?X\D\$R>._$>K:
M]\3]=T_XHZS::QXFE\369TWP_H7@3PGI*26GA%=4U7ZQ^(_A#X[Q:3-H/[/G
MC+X/?#C1['X/^,_#'A:T\:?"[Q+XS'A_XH&;PE9_"?Q*D>@?$3P;8W'P[\&:
M!9^+K;Q+X`%C%JWBN_O?"LFF^,?"^G:)JUAKP!G_``/_`&B4^+7BSXE_#/Q+
M\./&'PE^*OPEM?`NK^,/!/BO4/"'B&/_`(1GXGVOB.\\!^)-$\5^`_$'B3PU
MJUEJ_P#PB/BC3+VP^VVFM:-K/A[48KS3FTBZ\/ZYKGTE7QE^QS\!OBI\#-%\
M?V_Q<U[X:>-O%WCCQ%IGB[Q!\2/"6E^/H?'7Q$\5G2$T;7/$OQ-UGQUXI\1)
M?70T_3/#^D^#]`\)VGAKP9X#\,Z=%X1\*>'-'\-Z?I&F67V;0`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110!^'?_!2Z-Y?^"C_`/P0LC2>
M6V9OVK?VGL30"$RIC]COX@,=HN(9X3N`*-OB?Y6.W:V&'[3QZ5>^6G_%1ZU]
MQ?\`ECH'H/\`J!5^+O\`P4G_`.4DG_!"G_LZW]J#_P!8Y^(-?MY'_JX_]Q?_
M`$$4`?`VN*5UO6E+M(5UC5%,C[`\A6^N`7<(J(&<C<P1$3).U%7"C+K6U_\`
MY#VN_P#8:U;_`-.%Q630!ZK\'8);CQ;+'%>7-BPT:];SK5;1I2!<V(,9%[:W
M<.QB021$'RHVN!N#?4/]E7O_`$,>M?\`?G0/_E%7S/\`!/\`Y'*;_L!WW_I5
MI]?65`&+_95[_P!#'K7_`'YT#_Y14?V5>_\`0QZU_P!^=`_^45?._P"V5\9/
M'_P$_9W^(?Q0^&OA%/%GB?PWI;3PO>:/XE\1Z)X3LG247WCOQ-X:\$V>H^-?
M$?AGPC"O]K:YH_A6RDU6YLHWDEN=*TJ'4]9TWX?TS]OSXXW?[+?['OQPT+PK
M\`_B4/C/\:OV9/A7\7_B!X*^(.NMX"\+V7QJ^._PF^#6KP^%O!MSI4/C>+XI
M1_\`"Q-1NI_`WB.[@\/?#O4_#NK0Z]XN\4-;Z/I/B$`_6C^RKW_H8]:_[\Z!
M_P#**C^RKW_H8]:_[\Z!_P#**OG7]K3XJ_$WX3_#C1-8^$NEV=_XKU[XC^!_
M!SWU_P#"[XB?&BS\/:-X@U"Y75M;E^&WPMUOPQXM\23BWLUTK38XO$_AW2;'
M5=6L=3U_6+31K2\W_G?\7_\`@IGXL^%GAKX8S7?C#X59U'P9\?M;^)?Q*U;]
MGK]H2VMM&^(OP3\4^&]*E^"FL?LZ>'/&WB?XL_!2_DTC7K^X\0_%[XE^*M7^
M&>BW?AZ&2TFU&+QEX:MY`#]FO[*O?^ACUK_OSH'_`,HJ/[*O?^ACUK_OSH'_
M`,HJ_*P_\%#O%>L_%F7PU:1_"7X>>%?A]X__`&;OA5\6;+QK9_%?QS!_PGOQ
MY\$?"WX@WFE6WQ[^%.B:U\&?A=::9I?QE\&^&?A-K'Q$MM1T7X^?$&+4-"L-
M3\`^'KW0?&&H?4?[8GQ&^/OPO\':+XG^!OBWX+:?K&K:WHO@#0/!7Q0^%WC7
MQ[J'Q#^)_C_Q!IGACX=>']#UGPI\:OA9#X2THZI>37'B_5=0TKQ3_8WANVU7
MQ.T4%GX=O;:\`/K#^RKW_H8]:_[\Z!_\HJ/[*O?^ACUK_OSH'_RBJQHPU8:3
MI@UZ;3KC6QI]D-7N-(MKFSTJXU,6T0U"?3+2\N[^[M=/FO!-)8VUU>WES!:M
M#%<75Q,CROI4`8O]E7O_`$,>M?\`?G0/_E%1_95[_P!#'K7_`'YT#_Y15M44
M`<5K-_8>'A;-K7C74=.%V95MC<IH2B8PA#*$VZ`^2@D0MG'WAC-87_":>$_^
MBDS?^43_`.9VN-^/1(A\+8./WVK_`/HO3J^=,GU/YF@#Z]/C7PF`2?B3-@#)
M_P"0)T'_`'+M=M'IMU*B21^)=99)$5T80Z!AD<!E8?\`$BZ$$$?6O@IR=C<G
M[K=SZ&OT%T[_`)!]C_UYVO\`Z(2@"C_95[_T,>M?]^=`_P#E%1_95[_T,>M?
M]^=`_P#E%6U10!B_V5>_]#'K7_?G0/\`Y14?V5>_]#'K7_?G0/\`Y15M44`8
MO]E7O_0QZU_WYT#_`.45']E7O_0QZU_WYT#_`.45;5%`&+_95[_T,>M?]^=`
M_P#E%1_95[_T,>M?]^=`_P#E%6U10!B_V5>_]#'K7_?G0/\`Y15=L[6>V\SS
MM2O=0W[=OVQ-/3RMN[/E_8;&RSOR-WF^9C:NS;\VZ[10`4444`%%%%`!1110
M`4444`%%%%`'X@?\%)_^4DG_``0I_P"SK?VH/_6.?B#7[>1_ZN/_`'%_]!%?
MA]_P4N6=O^"C_P#P0L%O)%%,?VK?VGMDDT+3QKC]COX@%MT23V[/E=RC$R;6
M(8[@"K?M-';>(?+3&K:1C8O_`#`;OT'_`%,%`'Q'K_\`R'M=_P"PUJW_`*<+
MBLFM37`XUO6A(RO(-8U0.R*41G%]<;V5"\A16;)5#(Y4$*78C<<N@#U[X)_\
MCE-_V`[[_P!*M/KZRKY$^#R7C^+95LKBWMIO[&O29+FTDO(]GVFQW*(HKNR8
M,3M(?SB``048L"OU!]F\1?\`06TC_P`$-W_\T%`'G/QW^#&@_'SX9^)/AIK^
MN^,?"L&NV%Y!9^*/`/B;5?"GBSP[J%QIU]IT.JZ3J>F7,"3M#!J%S%=:/K$&
MI>'=<L9[G2=?TG4M,N[BU?XXU'_@F3\-;KX/_#CX.:-\;?VB?!&D>!O'G@#X
MO^(O$'@_Q5X#?Q9\6OC5\,O$'PZ\5^"?BM\3==\=_#7Q]?:KXC\.^(?A;X.N
M=*TO1I]#\)P:3I-GX5N-`O/#-C8:7;?H;]F\1?\`06TC_P`$-W_\T%!M_$0_
MYBVD=O\`F`W?<X_Z&"@#Y[U3]G#5==C\01:M^T%^T")[[3_A-%X;UG1/'5AX
M;UGPGX@^&&EZQ87WC"Q@T/PU8^$M1U7XERZW/=?$KP]KWA/6/AWXEELM-_XH
MNRCM((8/,!_P3]^%6G-?:OX0^('QO\!>/_%&D:_H7Q0^*OA/X@6</Q$^+^D^
M)?$>J^+-5M?B#J^M^&-=TR:6+7-=UJ;P[J7A31/">J^![#49="\#7WAO08;+
M3+7SSQA_P4U^"G@CQ;XH\&:Q_P`)[)J_A'Q%K7AG5)+#X:6UQ8OJ.A:C<Z7>
MO9SR?$:!Y[5KFUD:WF>&)I(BCM%&25'.?\/7/@'_`,\_B1_X:ZS_`/GEU]93
MX$XQJPA5I\.YI.G4A&I"<<.W&4)I2C).^JE%IKR9\O/C7A2G.=.>?9=&<)2A
M.+KQ3C*+Y91:Z.+NFNC3['L[?\$Z_P!G2UFT?2_#MKXV\(?#"TB^":^(_@=X
M;\87-O\`"/XA7/[.6C^$?#WP5O\`QSH.H66IZYJ=WX)\/?#WX>^'YAI?B;1+
M3QKH'@7PGH?Q$M?%VE:+:V@]JLOV<_#1T[X/V?BKQG\2_B+??!3XN^+OC/X4
M\0^/?$]IK6OW_B?Q3IOQ8T2TTWQ+>6VBZ;;ZOX9\&:'\7M:T?P/I*V=I)H5C
MX>\&>9>WUSH+7-]XY\`OVW_AW^T?XWNO`/@";Q/:ZY9^'K_Q-+)XF\`1Z7IY
MT[3KW3+"X1+FV\>:C(UT9]5M3%"8`KQB9C(I0*WV7]F\1?\`06TC_P`$-W_\
MT%>%F65YCD^)^IYI@Z^!Q2IPJNAB(<E3V<[\D^5_9ERNSZV9[67YE@,UPZQ>
M78JCC,,YRI^VH34X<\+<\.9?:CS*ZZ7-L#``'88_*BL3[-XB_P"@MI'_`((;
MO_YH*/LWB+_H+:1_X(;O_P":"N`[C;HK$^S>(O\`H+:1_P""&[_^:"C[-XB_
MZ"VD?^"&[_\`F@H`\6^/?^I\+?\`7;5__1>G5\YU[]\;X]1CA\-?;[NSN@9M
M5\K[+836)C(CL-_F&74;_P`T,"NT*(MFTDE]P"^`T`-?[C?[K?R-?H-IW_(/
ML?\`KSM?_1"5^?+_`'6_W3_(U]V6%OX@-C9%=5TE5-I;;0="NV(7R4P"PU]0
MQ`X)"J"><#I0!TU%8GV;Q%_T%M(_\$-W_P#-!1]F\1?]!;2/_!#=_P#S04`;
M=%8GV;Q%_P!!;2/_``0W?_S04?9O$7_06TC_`,$-W_\`-!0!MT5B?9O$7_06
MTC_P0W?_`,T%'V;Q%_T%M(_\$-W_`/-!0!MT5B?9O$7_`$%M(_\`!#=__-!1
M]F\1?]!;2/\`P0W?_P`T%`&W16)]F\1?]!;2/_!#=_\`S05>LX]1C\S[?=V=
MUG;Y7V6PFLMF-V_?YNH7_F;LKMV^5LVG._<-H!=HHHH`****`"BBB@`HHHH`
M****`/Q`_P""D_\`RDD_X(4_]G6_M0?^L<_$&OV\C_U<?^XO_H(K\0_^"D__
M`"DD_P""%/\`V=;^U!_ZQS\0:_;R/_5Q_P"XO_H(H`^"-?\`^0]KO_8:U;_T
MX7%9-:VO_P#(>UW_`+#6K?\`IPN*R:`/7O@G_P`CE-_V`[[_`-*M/KZRKY-^
M"?\`R.4W_8#OO_2K3Z^LJ`"D/3\5_F*6D/3\5_F*`/XZOVB/^3@/CG_V6#XD
M_P#J8ZQ7CM>Q?M$?\G`?'/\`[+!\2?\`U,=8KQVO[[RW_D6Y=_V`8+_U&I'\
M1YC_`,C#'?\`89BO_3\S].?^"3?_`"<WKW_9(/%?_J2^":_H_K^<#_@DW_R<
MWKW_`&2#Q7_ZDO@FOZ/Z_EGQD_Y+.?\`V+,!^58_I#PF_P"237_8RQOY4`HH
MHK\J/TP****`/GOX]_ZGPM_UVU?_`-%Z=7SG7T9\>_\`4^%O^NVK_P#HO3J^
M<Z`&O]QO]UOY&OT&T[_D'V/_`%YVO_HA*_/E_N-_NM_(U^@VG?\`(/L?^O.U
M_P#1"4`6SD`XZ_Y_/'7'&>F1UK\>_A)^V)^TIK'[<'[1/P&^(C>`/#ZZ/X4@
MOO@;\"O&7@KQ7\/KKQ;J=H?C#J&B7?@?]I"TG\8^#O'\7C#PEX,\/>,O&-E-
MX637_#V@7.NW_ACP=%'\-/&UOK/["D9ZU\2Z'_P3]_9U\,_%?XF_&?P_I_CC
M1_&WQ)T.31[:6Q^(GBZ+2OA9>WMEXYL-<\6?!+26U.2S^%7C/Q#:_$3Q/#J'
MB/PM':WEE#J-_;>'1H=IK?B2WUH`N?L)_&GXI_'/X*>)/%7QG/@AOB%X8_:*
M_:N^$.KCX<:=J^F>$#9?!#]I'XG?"3P^='M]?U#4=:G1M"\':?\`:-3U.>WN
MM8N_M&JR:;HWVO\`LFR_//XL_P#!5_5O"_QL^)MU\.-9^#WCOX(Z'^Q_^T?\
M0?A9X>L-8LM9\;>._C1\#_C-\$_AA:>*-9U?P]XCO;K1_A/K^H_$OQ/::7HM
MEX:FUW5/"/P_UKXIVVK'1-4TJSM_T&^%7[#/PU^"WAW4O"WP_P#B%^T'::/K
M7QAT+XW:M!XC^/OQ3\82S^-;+XJ:M\9O%LEK<ZYXDEGL=,^*_CO7M:O_`(LZ
M)%))H?CRQU6^TG7-+N=.E2VCW=8_81_9$U[Q_<?$S4?V?_A@?%=[\*OB5\%]
M3N;'PCHFD6.K_#[XNW/AZX\?Z3J^EZ18V%EJ-YKL?AFPL#KMU')KMCI-UK>E
M:?J%K8>(-:@O@#Y)\5_M._M,_#SXO6W['FL>)_AKXH^+7CGQI\`=/\&?'NT^
M%NOZ#X6\/>"OC5X0_:J\8>)KC7_ADGC36M/O?&/A$?LA?$/2_!<1\>66CZDO
MCCP#/XFM;V;PWXD/BCU#3?VM?B39?LB?M4_$G4+7X;7_`,:?V7O$W[07PJCU
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M:WJ7G@'C_P"PE^TOX\^.VH_%_P`+^/K[6+G4OAQ'\,]0CM?B)\!_$W[+?QBT
M]_B)HOB#7+NT\2_`SQAXE\3:U;>"+1=.LK#P/\2X[J#2_&6M6GQ`\*6RZE>_
M#;4?$>N?H?7AWPE_9Z^'GP;U?Q;XG\-OXSU_QGXYM/#^E^*O'7Q)^(7C;XG^
M-=6T'PC<^(KOPAX8/B3QUKFN7]AX5\+7/B[Q1=:%X;TM['2+/4?$6OZP]K/K
M.MZKJ%W[C0`4444`%%%%`!1110`4444`%%%%`!1110!^'?\`P4N:9/\`@H__
M`,$+&MXHYYA^U;^T_LBEF-NC9_8[^(`;=,(9RFU26&(FW$!/EW;A^TD=UXA\
MM,:/IWW%Q_Q/9#V'<:'^H%?C!_P4G_Y22?\`!"G_`+.M_:@_]8Y^(-?MY'_J
MX_\`<7_T$4`?`VN%SKFM%U".=8U0NBOYBHYOK@LBR;4\Q5;(#[$W@!MBYVC+
MK6U__D/:[_V&M6_].%Q630!ZI\'GO(_%DS65M#=3?V->@QSW;6:!#=6&YQ*M
MK=EF!``C\H9#%MZ[<-]/_:O$/_0'T[_P>2__`"DKYJ^"?_(Y3?\`8#OO_2K3
MZ^LJ`,+[5XA_Z`^G?^#R7_Y24AN?$/\`T!].ZC_F.R>H_P"H)_\`KK>I#T_%
M?YB@#^.?]H0N?C[\<#*BQR'XN_$<R1I)YJ(Y\7ZN7192D9D56RJR&./>`&V)
MG:/(*]B_:(_Y.`^.?_98/B3_`.ICK%>.U_?>6_\`(MR[_L`P7_J-2/XCS'_D
M88[_`+#,5_Z?F?IA_P`$IGNX_P!I;76LK:&ZF_X5'XJ!CGNS9H$/B3P5N<2B
MUNR6!"J$\H`ABV\;-K?T5_:O$/\`T!]._P#!Y+_\I*_G=_X)-_\`)S>O?]D@
M\5_^I+X)K^C^OY9\9/\`DLY_]BS`?^YC^D/";_DDU_V,L;^5`POM7B'_`*`^
MG?\`@\E_^4E'VKQ#_P!`?3O_``>2_P#RDK=HK\J/TPPOM7B'_H#Z=_X/)?\`
MY24?:O$/_0'T[_P>2_\`RDK=HH`^;/C=+J,D7AO[?9VUH!+JOE&WOFO?,)CL
M-X<-8V?E[0%VD>9OR00FW+>!5]&?'O\`U/A;_KMJ_P#Z+TZOG.@!K_=;_=/\
MC7W78W/B`65F%TC3RHM;<*3KD@)7RDVDC^Q3@D8)&3@\9/6OA1_N-_NM_(U^
M@VG?\@^Q_P"O.U_]$)0!G?:O$/\`T!]._P#!Y+_\I*/M7B'_`*`^G?\`@\E_
M^4E;M%`'Q5^U1^V+:?LIQ^!Y?%/P\U/Q./'4OB&*R'A[Q'ID)LCX=BTB6X-W
M_:NGV@87`UB$0>07P8I?,VC9GY"_X?#>!O\`HB/CC_PJ_"?_`,17._\`!8__
M`(]/V>O^OSXG?^DG@FOP[K^D.`O#SA3/.$\JS3,LOJ5\;BOKOMJL<;C:2E['
M,<5AZ=J=*O"G&U*C"+Y8J[3D[MRO^`<;\=<39-Q/F66Y=CX4,'AE@O94G@\'
M5<?;8#"XBI>I5H3J2O5J3?O2=E+E5DDE^\<G_!8GP-'')(?@AXX(CCDE('BO
MPIDB-&<@?(>2%(!/`/7`R:_5[PWXDUOQ+X>T+Q%;:#9VUOKVC:5K4%O/KI:>
M"'5;"WOXH9C%HSQF6)+A8Y#&S(74E&*D$_Q<W'_'M=?]>EW_`.D\M?V??"G_
M`))A\.O^Q$\'?^HWIE?+^*O!^0<,87)JF38.>&GBZ^-A7<L3B<1SQHPPCII+
M$5JJCRNI-WC9OF]Z]D?1^&?%6=\18C-Z>;XN.)AA*&#G04</AZ#A*K/$1J-N
MA2IN7,J<-)72:;5KN_1?:O$/_0'T[_P>2_\`RDH^U>(?^@/IW_@\E_\`E)6[
M17XN?KAA?:O$/_0'T[_P>2__`"DJ]92ZC)YOV^SMK3;L\K[/?/>^9G=OW[K&
MS\O;A<8\S?N/W=OS7Z*`"BBB@`HHHH`****`"BBHYG>.*21(7N'1'=((FB62
M9E4LL4;3210AY"`B&66.,,07D1,L`"2BOCSQ!\=/BSX=U_0[+6=(_9G\,2>)
M=?B\)>&?`'C']I&70_B;XD\5WNFMKFF^%-+A3X;7GANY\;WN@@:Q;^$M*N]=
M\ZS`N8=<DTYVU*+ZTTNZN;[3;"\O=.N-(O+JSMKBZTJ[GLKFYTZXFA22:QN+
MC3;F\T^>:UD9H))K*[N;25HS);SRQ,CD`_$__@I/_P`I)/\`@A3_`-G6_M0?
M^L<_$&OV\C_U<?\`N+_Z"*_#[_@I=*T/_!1__@A9(L$URR_M6_M/XAMQ$9GS
M^QW\0%^3SI88OE!W-NE7"*Q&YL*?VDCUB["(/^$=US[B_P`.CCL.W]M<4`?$
MNO\`_(>UW_L-:M_Z<+BLFM37&+ZYK3%'C+:QJC&.3:)(RU]<$I($9TWH3M?8
M[IN!VNRX8Y=`'KWP3_Y'*;_L!WW_`*5:?7UE7R'\'KB2U\6321V=U?-_8MZO
MDV8MC*`;FP)<_:KFUCV+C!Q*7W,N$(R5^GO[9O/^A=US_OG1_P#Y=4`;U(>G
MXK_,5A?VS>?]"[KG_?.C_P#RZH.L7A_YEW7.H_AT?U'IK5`'\@_[1'_)P'QS
M_P"RP?$G_P!3'6*\=KU_]H1B_P`??C@YC>(O\7?B.QBEV"2,MXOU<F.01O)&
M'0G:^R1TW`[79<,?(*_OO+?^1;EW_8!@O_4:D?Q'F/\`R,,=_P!AF*_]/S/T
MY_X)-_\`)S>O?]D@\5_^I+X)K^C^OYM_^"4UQ);?M+:[)'9W=ZQ^$?BI/)LQ
M;&4`^)/!1\P_:KFUCV+@*<2%]S*`A!9E_HJ_MF\_Z%W7/^^='_\`EU7\L^,G
M_)9S_P"Q9@/_`',?TAX3?\DFO^QEC?RH&]16#_;-Y_T+NN?]\Z/_`/+JC^V;
MS_H7=<_[YT?_`.75?E1^F&]16#_;-Y_T+NN?]\Z/_P#+JC^V;S_H7=<_[YT?
M_P"75`'C/Q[_`-3X6_Z[:O\`^B].KYSKWWXVWLUW%X;$NG7UAY<NJE3>BS`E
MW1V&1']DO;SE-H+>9Y8^9=I;YMO@5`#7^XW^ZW\C7Z#:=_R#['_KSM?_`$0E
M?GR_W6_W3_(U]U6.KW:V5FH\/ZVP6UMP&"Z1A@(4`8;M94X/494''4`\4`=1
M16#_`&S>?]"[KG_?.C__`"ZH_MF\_P"A=US_`+YT?_Y=4`?C3_P6/_X]/V>O
M^OSXG?\`I)X)K\.Z_;7_`(+!7DUW:?L_>;IU_8;+SXF;3>BS`EW6G@K(B-I>
MWG*8R_F>6,,NTMEMOXE5_8WA7_R0>1?]U+_U;X\_E+Q+_P"2USGTR[_U58$B
MN/\`CVNO^O2[_P#2>6O[/OA3_P`DP^'7_8B>#O\`U&],K^,&?_CWNNW^B77_
M`*3R^E?V1_"W5KI/AG\/%70-:D"^!?"`#JND;6QX=TT;EW:PC%3C(W(I&<%0
M0:^(\=?]RX=_["<S_P#3>!/L/!C_`'SB#_L&R[_T[BSUJBL'^V;S_H7=<_[Y
MT?\`^75']LWG_0NZY_WSH_\`\NJ_G`_?3>HK!_MF\_Z%W7/^^='_`/EU5^RO
M)KOS/-TZ^L/+V;?MHLQYN[=GR_LE[=_<V_/O\O[R[=W.`"_1110`4444`%%%
M%`!2-C:<YQ@YQG.,<XQSGTQSZ4M(WW6P,G!X]>.GXT`?ACXV^`&M?$?]K3XO
M:KX0^%OQ[\<^"K?X[^!(/$'C*WT;]G7P?H'@;Q-/K'[*OQ2^+]SHNN_$#XN>
M&_C#XZT_4-+^!'P2T'1?&6F^!UD^'WAS3_''ASX;+XUEN]#N?#_[G*,#GU/Z
MDG/4X!Z@9X'':OP8^+_PJL[S]M7Q/\19OV?M%U+XLP_'[X+VG@?PC#^QOXR\
M5:-\7?AI&?AG%K/QP\6?M?6.EOH?A'Q+X"@U7Q5?Z:UQXR\,Z)\/&^'^F>%]
M>^'_`(QOO$%K<^*OWG7H/Q/IG)SG';/7';.*`/Q!_P""D_\`RDD_X(4_]G6_
MM0?^L<_$&OV\C_U<?^XO_H(K\0_^"D__`"DD_P""%/\`V=;^U!_ZQS\0:_;R
M/_5Q_P"XO_H(H`^"-?\`^0]KO_8:U;_TX7%9-:VO_P#(>UW_`+#6K?\`IPN*
MR:`/7O@G_P`CE-_V`[[_`-*M/KZRKY-^"?\`R.4W_8#OO_2K3Z^LJ`"D/3\5
M_F*6D/3\5_F*`/XZOVB/^3@/CG_V6#XD_P#J8ZQ7CM>Q?M$?\G`?'/\`[+!\
M2?\`U,=8KQVO[[RW_D6Y=_V`8+_U&I'\1YC_`,C#'?\`89BO_3\S].?^"3?_
M`"<WKW_9(/%?_J2^":_H_K^<#_@DW_R<WKW_`&2#Q7_ZDO@FOZ/Z_EGQD_Y+
M.?\`V+,!^58_I#PF_P"237_8RQOY4`HHHK\J/TP****`/GOX]_ZGPM_UVU?_
M`-%Z=7SG7T9\>_\`4^%O^NVK_P#HO3J^<Z`&O]QO]UOY&OT&T[_D'V/_`%YV
MO_HA*_/E_N-_NM_(U^@VG?\`(/L?^O.U_P#1"4`7****`/Q+_P""Q_\`QZ?L
M]?\`7Y\3O_23P37X=U^XG_!8_P#X]/V>O^OSXG?^DG@FOP[K^QO"O_D@\B_[
MJ7_JWQY_*7B7_P`EKG/IEW_JJP)%<?\`'M=?]>EW_P"D\M?V??"G_DF'PZ_[
M$3P=_P"HWIE?Q@W'_'M=?]>EW_Z3RU_9]\*?^28?#K_L1/!W_J-Z97Q'CK_N
M/#O_`&$YG_Z;P)]AX,?[YQ!_V#9=_P"G<6=_1117\X'[Z%%%%`!1110`4444
M`%%%%`!6+XC@%UX?URV,33BXT?5(#`EK=7KS"6PN(S$EG97NFWETTF[8MM::
MC87,Y8107MK*Z7$>U534+*TU*QO-.O[>*ZL;^TN;.\MIUW0W%K=0R6]S!*HQ
MNBFAD>.09Y1F%`'\[O@_P'XW\0?&?X=>)_$GP?\`'"WD7C+X8I<ZG)_P3T_;
M+\%V-K:>%9_#>BZ5=7.L7O\`P4U\1^$O#ZZ5H^CV,<OB/6_!7BBQT];5]7UW
M0_$>R_M+_P#HL']3_,^Y_P#K]<#I7\^FN?"WX9ZY^VQXF%A\//#<$7PI^-/P
MD\&:!=_"+_@GQXZ^.^CZ=9^&/"7PRO=*LOB#^TLTL^B>"_'^A03VMIK,.FVU
MAI'PM\+0^$[NY%_?PZEJ=W_06.GXMVQW/^<]^M`'X=_\%+[B*U_X*/?\$+)Y
MV*11_M6_M/EF"22$;OV._B`B@)$DDA)9@/E0XSEL*"1^T<?B;1A&G^DRD!%Y
M^PZECH.>;(''U`K\8O\`@I/_`,I)/^"%/_9UO[4'Z_L<_$'-?MY&28T).244
MDGJ3@<F@#X&UQUDUO6I$.Y)-7U.1&PR[D>^G93M<*RY4@[656'1@""*RZUM?
MYU_72>O]M:M_Z<+BLF@#U/X/WMM8>+)I[J0QQG1KV,%8IYB7:YL"%VP12N.%
M8[BH48P6W%0?I[_A)M'_`.?B7_P!U+_Y#KYL^"?_`".,WOH=]G_P*T\_SKZR
MH`P/^$FT?_GXE_\``'4O_D.D/B;1_P#GYEZC_EQU+U'_`$YUT%(?ZC^8H`_C
MG_:$D2;X^?&^6-MT<OQ=^(\D;;67<C^+]796VNJ.N5(.UU5AT9000/(*]B_:
M(Y_:!^.9/)_X7!\2O_4QUBO':_OO+?\`D6Y=_P!@&"_]1J1_$>8_\C#'?]AF
M*_\`3\S]+_\`@E/>VUA^TKKL]U(8XS\(_%48813S$NWB3P40-MO%*XX5CDJ%
MXQNW%0?Z*O\`A)M'_P"?B7_P!U+_`.0Z_G?_`."39(_:;U[!_P":0>*__4E\
M$G^?-?T?U_+/C)_R6<_^Q9@/RK'](>$W_))K_L98W\J!@?\`"3:/_P`_$O\`
MX`ZE_P#(='_"3:/_`,_$O_@#J7_R'6_17Y4?IA@?\)-H_P#S\2_^`.I?_(='
M_"3:/_S\2_\`@#J7_P`AUOT4`?-?QMU2RU&+PV+25I##+JIDW07,&`\=@%Q]
MHAAW9VMG9NQCYL9&?`Z^C/CW_J?"W_7;5_\`T7IU?.=`#7^ZW^Z?Y&ONFP\2
MZ.MC9J;F7*VMNIQ8ZB1E84!Y%F0>1V-?"S_<;_=;^1K]!M/YL+$GD_8[;_T2
ME`&9_P`)-H__`#\2_P#@#J7_`,AT?\)-H_\`S\2_^`.I?_(=;]%`'X>?\%@=
M3L]1M/V?_LDK2&&\^)GF!H+F`J'M/!>TC[1!"&W;6^X6(VG<%!7/XE5^XG_!
M8\G['^ST,\?;/B<<=LFT\$Y/XX&?H*_#NO[&\*O^2#R/_NI_^K?'G\I>)?\`
MR6N<^F7?^JK`D4__`![W7_7I=?\`I/+7]D7PM\1Z1'\-/AY&US)N3P-X05L6
M6HD`KX=TP'D694],@J2"",&OXW;C_CVNO^O2[_\`2>6O[/OA22?AA\.LG/\`
MQ0G@_P#]1S3#_,DU\1XZ_P"Y<.?]A.9W_P#!>!_K]>C^P\&/]\X@_P"P;+O_
M`$[BSH/^$FT?_GXE_P#`'4O_`)#H_P"$FT?_`)^)?_`'4O\`Y#K?HK^<#]],
M#_A)M'_Y^)?_``!U+_Y#J_8ZG9ZCYOV25I/)V>9N@N8=OF;MN/M$,.[.QON;
ML8^;&1G0HH`****`"BBB@`HHHH`*#C!SP,<G../KV^M%4M2N6L]/OKM(TF>V
ML[JX2&2YALXY7@@DE6-[NX_<6R2,@1KB;]U`K&63Y$:@#\T?&^J?L267[3VK
M6M_\3/VC4^-ES\0/`Z^*?#OPL^*'[<%W\,['QW)8^&F\-:)XU\.?"'5;OX#Z
M%<S:--X:N=?\/>*;>PMY?#VHV-WXQLO[%U%)9?TZ'MZGU]3GK[].V.G&*_$C
MPWI7[3VJ_%F]^..D>%_C[\,/A=X_^(GA7QUX\L/!G[9'[%^J?`NTM]/3P_HN
MOZU+IC_!76?$-YIE_HFCQ2^*TTOQU!KOB!8IA;ZS:ZA):7%M^U>G:A8:M86>
MJ:5?6FI:9J-M#>Z?J-A<PWEC?65U&L]K=V=W;O)!<VMQ"Z2V\\+O%+$Z21NR
M,&(!^)O_``4G_P"4DG_!"G_LZW]J#_UCGX@U^WD?^KC_`-Q?_017X@?\%+)8
MX?\`@I!_P0KEFDCBC3]JW]I\M)+(D:+G]CKX@`;GD95&20HR1N8A1DD`_M9'
MK6D"-,ZIIO"+G_3[,C@#N)\$>XXH`^&]?_Y#VN_]AK5O_3A<5DUJZZROKNMN
MC*Z-K.JLKHP965K^X*LK*2K*P(*LI(((()!K*H`]>^"?_(Y3?]@.^_\`2K3Z
M^LJ^1_@U<V]KXNFEN9X+>/\`L6]423S10H6:ZL,*&E=%+'!(4$L0"0,`D?4O
M]M:1_P!!33O_``.M/_CU`&G2'I^*_P`Q6;_;6D?]!33O_`ZT_P#CU(=:TC_H
M*:=U'_+_`&GJ/^FU`'\?O[1'_)P'QS_[+!\2?_4QUBO':]@_:&97^/WQQ=&5
MT?XO?$AD=&5T=6\8:P59'4E75@059258$$$@@UX_7]]Y;_R+<N_[`,%_ZC4C
M^(\Q_P"1ACO^PS%?^GYGZ<_\$F_^3F]>_P"R0>*__4E\$U_1_7\W7_!**YM[
M7]IC79+F>"WC/PB\5('GFB@0L?$G@HA0TKHI8@$A02V`S8PI(_HR_MK2/^@I
MIW_@=:?_`!ZOY9\9/^2SG_V+,!_[F/Z0\)O^237_`&,L;^5`TZ*S/[:TC_H*
M:=_X'6G_`,>H_MK2/^@IIW_@=:?_`!ZORH_3#3HK,_MK2/\`H*:=_P"!UI_\
M>H_MK2/^@IIW_@=:?_'J`/#OCW_J?"W_`%VU?_T7IU?.=?07QRO;.\A\,BUN
MK:Y,<VK&06\\,Y0-'8!2_E.^T,00-V,X.,X-?/M`#7^XW^ZW\C7Z#:=_R#['
M_KSM?_1"5^?+_=;_`'3_`"-?>EAK.DK8V2G4].!6TMU(^W6G!$*`@_ONH(P:
M`-ZBLS^VM(_Z"FG?^!UI_P#'J/[:TC_H*:=_X'6G_P`>H`_%[_@L?_QZ?L]?
M]?GQ._\`23P37X=U^W?_``6'O;.\M/V??LMU;7/EWGQ-\P6]Q#.4W6G@K:7$
M3N4#8.TL`&(8+G:<?B)7]C>%?_)!Y%_W4O\`U;X\_E+Q+_Y+7.?3+O\`U58$
MBN/^/:Z_Z]+O_P!)Y:_L^^%/_),/AU_V(G@[_P!1O3*_C!G_`./:Z_Z]+K_T
MGEK^RWX5ZOI2?#+X=H^IZ>K+X%\(*RF^M`5*^'-,!!!FR""#D$`^U?$>.O\`
MN7#O_83F?_IO`GV'@Q_OG$'_`&#9=_Z=Q9ZA169_;6D?]!33O_`ZT_\`CU']
MM:1_T%-._P#`ZT_^/5_.!^^FG169_;6D?]!33O\`P.M/_CU6;:]L[S?]DNK:
MY\O;YGV>>&?9NSMW^4[[=VT[=V,X.,X-`%JBBB@`HHHH`****`"BBB@#QB^_
M9S^`&I^(G\7:C\$_A/?^)Y;EKV;7[SX>>$KC59[YIQ<F_GNY=)>2XO\`SPLH
MOYC)>"14<3[D4CV8`*`J@!0``````!@``<``<`#@"EHH`_#[_@I4B2?\%(?^
M"%22(DB-^U;^U`&1U5U/_&'7Q!(RK`@X(!&1P0".0#7[91Z?IYC0_8;/E%/%
MK`!T'81X'T'%?B?_`,%)_P#E))_P0I_[.M_:@_\`6.?B#7[>1_ZN/_<7_P!!
M%`'P/KP"Z[KBJ`JKK.JJJJ`JJHO[@!54`!5``````````K*K6U__`)#VN_\`
M8:U;_P!.%Q630!ZU\&(8IO%\R3113)_8E\VV6-)%#"ZL,,%<,`PR0"!G!(S@
MFOJK^SM/_P"?&S_\!H/_`(BOEGX)_P#(Y3?]@.^_]*M/KZRH`I_V=I__`#XV
M?_@-!_\`$4AT[3_^?&SZC_EU@]1_L5=I#T_%?YB@#^.G]H=57X__`!R55557
MXO\`Q)554!551XPU@!54`!5`X````X`Q7CU>Q?M$?\G`?'/_`++!\2?_`%,=
M8KQVO[[RW_D6Y=_V`8+_`-1J1_$>8_\`(PQW_89BO_3\SU3]A_\`:"\;?"S_
M`(*&_#'P7=7_`,.?`_PU\=>!M>T&?6_B?X7\8WVD>/Y]4\9_!+2VTKP[\0O#
M[3^'_AYXOL-4\1WF@^&;+Q=ITND^(O$DFCZ%JEY:R^.?!\]G^S/[-?[</Q%_
M:+UGPQJN@S_"+1=*_:"^%GQ>\:_LX^!/'?P>^,/@R&_UGP9?+_PANF6WQQ2X
MUSP=\4M0TK09(M5^//A71?"G@[7?#$T]VWPPD\?:)X.\6ZQ!^9?_``3H_9F^
M%7Q=_;-T_P`9^.+/Q!J,GA3X8^(M8E\+0>*M?L?`WB[5=*\<?!G6_#5YXX\(
MVNH1:-XF7POK?@3PMK.FZ=>VQTF_U70]"OO$5CK4WAS0#IW[WZ9^P/\`LY:;
MJFKWAT3QG>Z1<:-\1M!\)>#[KXF^/4\(_";3_C!=-??$]O@WI6GZ[83?#+4?
M%UV\C#6O#-]:ZQX3LIKK0_`5]X3\/WM[I-Q_)GBO3Q5/C7,?K,W-5*6%JX:]
M3VG)A94K4Z:]RFH*$E->S4?==W*=:3E6J?TYX95,/4X0P*P\%!TZN(I8BT%!
MRQ,:EZDW[T^=SC*#YW+WE9*%&*5&G\T_#/\`:'_:/^).K?'?X?:=XG_9ZTE?
M@UJ_P_U'Q#\<OB9\#OBK\#I_"W@'Q+X5^)6N>-M8F_9I^)7CJR\7Z[I7AS7/
M!_A[1_`_Q6U+XB>"_A9XOTC7/&FI6^H:UJ?P;\1:;XM]9\)_M-^/=3_8)\=?
MM2:EX*^&4WCWPYX(^.'B3P'%J=_/\+OA9\6K+P#X@\:Z1\'OB%:W_CBYN-4^
M'W@#X]Z%H?A+Q[H=KXDU74+S0M!\:V%K)KNJQBVUF[E\=_\`!-SX*_$?0]3T
M[Q3X]_:'U#7M?\1>`-9\4>/+CXW^*;WQGXLT;X4W/C'4_AK\.?%-[JL6HZ-K
M_P`)_!OB'QWXC\7Z?\--0T&;PG?^-;P>+_$&GZUXAC74#ZS?_L@?#[Q3X3T;
MP1\3_&?QF^+_`(8T[P;XZ\%:MHWQ'^*OB+5--\8VOC;Q?X4\:V_B+Q?8:-_P
MC]AJ_CSX?ZOX.TE?A/X]BM+'Q7\-+674T\*ZI97&J7EU)^;GZ`>-?L-?M,ZS
M^T5J7Q9T#Q-<:7K4GP\L_A?J<=WK'[/?Q"_95^(=I=?$K1?$'B&ZT/Q'\`?B
M_P")_%GCVP\.Z-86.BIX7^*#7<'A;QUJ5UXM\+Z*-0U/X:^(=8U#]"/[.T__
M`)\;/_P&@_\`B*\-^#_[./@7X.>(?&'C73=5\>^-?B%X\TWPUX?\2_$+XH^.
MM>^('B^Z\(^"K[Q1J7@SP79ZEK4WV?2/"GA?4?&OB[4M-T?2;&RCFU7Q)K.L
M:K)J6K7\]\WOU`'SK\=;:WMX?#'D00P[IM6W>5$D>[$>GXW;%7.,G&<XR<=:
M^>:^C/CW_J?"W_7;5_\`T7IU?.=`#7^ZW^Z?Y&OOO3]/L&L+(FQLR3:6Q)^S
M0<DPH2?N5\"/]QO]UOY&OT&T[_D'V/\`UYVO_HA*`#^SM/\`^?&S_P#`:#_X
MBC^SM/\`^?&S_P#`:#_XBKE%`'XB_P#!8JWMX+3]GSR(((=UY\3=WDQ1QEL6
MG@K&XHJE@N3M!R%RV,;CG\0:_<3_`(+'_P#'I^SU_P!?GQ._])/!-?AW7]C>
M%?\`R0>1?]U+_P!6^//Y2\2_^2USGTR[_P!56!(I_P#CVNO^O2Z_])Y:_LS^
M%5A8M\,OAVS65HS'P+X/))MH"23X<TPDD[,DDGJ>:_B-^+'CVV^&7P^\2^-+
MG3WU--+LA##:?;+?3+,WNI.-/L)=8UB[#6FAZ%#=W$+ZQK=TKPZ?9[G$<L[P
M0R?T:^%_^"B.O^%_@#^R1K5]\/\`X'>"=5^+OP-U/Q[>W/QE_:@M_!OP^T_0
M/`EK\)-$AU'P?XT^''PF^-E[XPT[77^(J:I<W>K^&O!?_""Z1X>U>7QX-%N/
MLT4WP'CIBJ#I\/8-3OB83S#$2I\LO=HS6$IPFY\O)[TZ<XJ*DYKE;<4FF_MO
M!C#UE//L6X6H2A@</&?-'6K"6)J3CRWY_=A.#<G%1?-9-M22_7O^SM/_`.?&
MS_\``:#_`.(H_L[3_P#GQL__``&@_P#B*_/_`,2_M\:+I_QNT_X->%]!^&WB
M:ZLO$WP9\%>,+W4OV@O`O@;6;_Q;\8M*\,^*K;1O@?X9\4Z9;Q_&>3PEX#\9
M>$_'>O2S^(/``UW1?$NCZ'\.(_''CV>?PA;ZGP<_;C@^*GC+X46]Y\-SX9^%
M?[1]S\6+7]FOXE1^-K/7K[XAR_"5M3U"\'BGP3%X>TV7P'_PG7@KP_XD^(WP
MX%GXD\:'4/"&@WR>,AX'\4267ARY_G@_=S[L_L[3_P#GQL__``&@_P#B*FBM
M[>WW>1!##NQN\J)(]V,XW;%7.,G&<XR<=:^1?'W[6+>!_P!K+X#_`++S?"7Q
MG>6OQLT[XGW"_%R^N]+T/P9H^J?#GP''X^70-#T^Y-SK_CB_U#3?.AU;4--L
M]-\.^%IOLMK=ZU?ZS<MHUM]@4`%%%%`!1110`4444`%%%%`!1110!^('_!2?
M_E))_P`$*>"?^,K?VH#P"3@?L<_$$DX'H.3Z#FOV[C.(T!!!"*""K9!P.#Q7
MX??\%+K>&Z_X*/?\$+(+B-989/VK?VGM\;9VMM_8[^(#KG:0?E=58<]0,Y&1
M7[2)X7T`HA_LN`953@--@9`]92?S-`'Q-K_&OZZ#U_MK5O\`TX7%9-:FN(D>
MMZU'&H2./5]4C1!G"HE].J*,DG"J`!DDX'))YK+H`]>^"?\`R.,YP3C0[[.`
M3C_2M/&3CH,D#/J0*^L<CW_(_P"%?(GP?L;34/%DT%[`EQ"-&O9`CE@`ZW-@
M%8;64Y`9AR<88\9P1]._\(MH'_0,@_[ZE_\`CE`&]D>_Y'_"D)^O4?PGU'M6
M%_PBV@?]`R#_`+ZE_P#CE'_"+Z`,$:9!U'\4OJ/^FE`'\A'[1''[0/QS!!!_
MX7!\2L@C!'_%8ZQP0>0?8UX[7K_[0D:0_'SXX11*$BB^+OQ'CC09PB)XOU=4
M49).%4`#))P.237D%?WWEO\`R+<N_P"P#!?^HU(_B/,?^1ACO^PS%?\`I^9^
MG/\`P2;!/[3>O<'_`))!XKS@$XSXE\$C)P#@9(&?4@=Z^C/B5_P74_9D^&'Q
M&\?_``TUOX7?'B]UGX>>-?%/@;5[S2]'\`2:;=ZGX3UR^T&_N=/>[\?6EV]C
M/=6$LMHUU:VUPT#QM-;PR%HU^:O^"4MC:7_[2^MP7D"7$0^$GBF0(Y8`.OB3
MP4H8;64Y"LPY)&&/&<$?SY?M;1I#^U9^TW%$H2*+]H/XRQQH,X1$^(GB)449
M).%4`#))P.237R65\`<.<?>(_$>%XBHXJM1R_AW)<1AEAL54PLHU:V(Q-.;E
M*GK-.$4DGL[M:ZGT&;<=<0<#<!9!B>'ZV&HU<?G^;T,2\3A:>)4J='#X2I!1
M53X'S2=VMT[,_IM_XB#?V4?^B2_M#?\`@D^''_SQJ^G/V1_^"LOP(_;&^+\/
MP8^'O@'XN>'O$<WA7Q#XM74?&.F>#[;118>')=*BN[=I=$\8:W?_`&N=M6M_
MLRBP,#!)?-FB(0/_``YU^P?_``0WM+6^_;NL8+N%+B$_!;XI/Y;[@NY;KP;@
M_*RG(!8=>Y[X(]?CKP'\/<AX.XESK+L'F4,?EF3XW&8257-,15IQKT*,ITW.
MG+W9Q4DFXO1[/0\C@GQMX]SSBWAW)\?C,OG@LQS;!8/%1IY;0IU)4*]>G3J*
M%2/O0DXMVDM4V^Y_:ID>_P"1_P`*,CW_`"/^%8/_``BV@?\`0,@_[ZE_^.4?
M\(MH'_0,@_[ZE_\`CE?PT?VF>-?'HYA\+=?]=J_4$?\`+/3_`%KYSKWSXVZ5
MI^FQ>&S8VL=L9I=5$NPN=X2.P*`[F;[I9L8QUKP.@!K_`'&_W6_D:_073SBP
ML00<BSMAT/\`SQ3VK\^G^ZW^Z?Y&ONFQ\,:"]C9NVF0%FM;=F.Z;DM"A)_UG
MJ:`.HR/?\C_A1D>_Y'_"L'_A%M`_Z!D'_?4O_P`<H_X1;0/^@9!_WU+_`/'*
M`/QJ_P""Q_\`QY_L]'!Q]L^)PR00,BT\$Y`R.<9&?3(]:_#NOVU_X+`Z7I^F
MVG[/_P!AM8[;SKSXF>:4+DN$M/!>P-O=AA=S$8`Y8YSQC\2J_L;PJ_Y(/(_^
MZG_ZM\>?REXE_P#):YSZ9=_ZJL"<CX]\/7_BKP;XE\/Z9XBU'PK?:GHVJ6MO
MK6FP6%W)`UQIUW;/;WUAJ=K=V>I:-?13R6FL:<\<4US8R2?8KRPODMKR#^E;
M]F7]B#QM\%OV<_A9X7^#?[1&H^!-<UKPLNL_$^_;X/\`PS\0^#_$NM>./`OP
MXT?6-7\#^`IM/T/3OA?=:1#X&TZ30++2+O4O"NLZKJ/B'Q7\5O"7Q,\:ZW=^
M(E_G2G_X][K_`*]+K_TGEK^H;XA_M/?LQ?LE_"7X':O\?O$3^#[;QYX4T;3_
M``Y/;>%_&'B=M1OM%\):'?ZG&\?A?2]7DL_(M[V"027B013;RD+.Z.!\=XRY
M-B\VK<+4,KP.,S'-,35S6A0PF"IXC%XBM"G1PF(J*C@Z/.Y2C"G.K4G3I>T]
ME3O4;ITUR?5>$V;87*Z7$E?,L;A,ORW#TLLKUL5C*M#"T*,ZM;$8>#K8JLX*
M,9SG"G3A4J<GM*B4(J=27-YD_P#P3`^'^CQWO@WP%\1?$GA+X->-[']ERT^,
M7@6?PUX<\0^)_'\_[(&B>!/#/PCU+3?B==)8ZWX+O[OPS\,/`6@>,[BTTK69
M;BV\/)J_@-_AYXKU'5/$5WW'AG]A.\\&ZGI4OAOXU:Q9Z#\(--^.,G[)WAVZ
M^'_A:_M?@)XN^.-AKUA=>)M2N)+E#\4[;X;Z=XDUGPM\,?#VL6_ARQT[P/JN
MIZ#XMN/&6J2V/B33_'O^'N__``3-_P"BN7O_`(:GXO\`_P`R%-D_X*]?\$S(
MXY)&^+MZ$BCDE<_\*H^,!PD:,[G`\(9.%4G`Y.,#)Q7X]_Q#?Q!?_-#\6Z_]
M4]FW6W_4)YK[S]3_`.(A<!_]%GPM_P"'_*O+_J+\_P"M+^N_%#]D3X_?$3X[
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MC33336C3NB_1114E!1110`4444`%%%%`!1110!^('_!2?_E))_P0I_[.M_:@
M_P#6.?B#7[>1_P"KC_W%_P#017XA_P#!2?\`Y22?\$*?^SK?VH/_`%CGX@U^
MWD?^KC_W%_\`010!\$:__P`A[7?^PUJW_IPN*R:UM?\`^0]KO_8:U;_TX7%9
M-`'&>$OVL_@=\,_VD_!'P*\5^)=6A^(7Q#TC4+;2[;2_"'BK7?#^A7T][X*C
MT/3?''BW2-)O/#O@K4O%K>+-&/A:SUZ_M9-12ZMI[K^SK;5?#\^L_0Z?MT?L
MW?;_`!3877BSQ)I8\,^"?BI\1+74M<^&7Q,T'0_'7A#X(&)?BSJ_PIUW6O"5
MAI/Q43P,\]L-7MO`=WKMY-#=6NH:5;ZCI5Q%?M^6OCG]F7]HWQ]^W?\`!7XL
M?`VV\,?#NWT?0==3Q7\=?#_Q%\5:-K-CH-EK'P*%]X4^+OP5NM,U+P7\9DU[
MPQX;\>>$O`LUC<Z-*=-UO2U\5ZSX9F^&?A._UKZ4\2_LN_M&?%GXU^(OB+XP
M\">`/#YN?@G\=?A1X[T[7/VC_BY\0OAK\9(/B3X)T7POX6T+X9^&9="M?$?[
M*6A7M[X?TO6OB9XS^&7]@>-91!)HG]F?$:XN;;Q=I`!];2_MG_#>T\$_\)OJ
MOP]_:3T2*Y\9Z1X"T+PIK7[,?QMTWXB>+?$FL:-JGB&*W\(?#ZX\'+XL\1V5
MCH>AZUJFLZMINF2Z9HMGI5_+J=U;"W?'MFG?%SPI<_"F?XR:U;^*?`O@ZP\.
M:QXLUF/XB>#O$W@CQ/X>T/0%OIM4N?$'@[7M,MO$^DS06NG7%Y'8W.EB_N;5
MK::UMIA=6XD_,&T_9"^(<MCXTUV\_9F^'O\`PKZ_\2_"K7M+_9-N_P!J7XD7
M.FW'BWP9I7QFT;XB?&&V\>6FAP^&H?%OQ&TWXA>#O#VJ^`]<T^[\(_$#PYX*
MO-8^(^J6WBO7K>+1_I3X(^"?VI_@M\,-.^&FD^#_`(<:U)?V/Q]\;>';GQ1\
M9?%^J>&/@I?:A\0;'6_@)^SLEQ+X)OO&WCCP18^$/$&LZ'JOQ&LYM-7X?KX/
MLM&\.^!_$?AV_P!%MM*`/YIOB?\`$KPI\0_CY\?_`.P'U^SU#3?BIXKU+4_#
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M)_IU_P`$FO\`DYS7/^R0^*O_`%)?!-?SU_M=?\G8?M/_`/9PWQH_]6-XCK^A
M3_@DU_R<YKG_`&2'Q5_ZDO@FOYZ_VNO^3L/VG_\`LX;XT?\`JQO$=>IX;_\`
M)T.,?^R6R#_U,Q1XGB-_R;KA/_LI<]_]0\$?/-?L7_P0M_Y/TL?^R*?%3_TK
M\&5^.E?L7_P0M_Y/TL?^R*?%3_TK\&5^C^*?_)N>-?\`LG<R_P#4>1^?>&7_
M`"<'@_\`[*#+/_4JF?VFT445_EJ?Z7'SW\>_]3X6_P"NVK_^B].KYSKZ,^/?
M^I\+?]=M7_\`1>G5\YT`>!?M._'K2/V:O@OXM^+FL:+/XB&B1QZ?I&BKJ^D>
M&;#4?$FJVU__`&!::_XN\0W-IH/@[P[<W]FMMJGB75IFCM3/;:?IMGJOB#5-
M%T?4/:?$_P"W5XP\$?LW?#7X^:M^SEJNDZ3K_P`-[CQ_XLM/%/QL^#'A71]'
MM=.T:VUC3_"_@3Q7<>(=5L?BEXT^(6C_`&[7?A7HVEVFB66O:+I\W_"8:UX!
MUR2'0Y/+?VA/AIXC^,'P;^(/PX\*>.9/A[K?BWPKXDT*UUZ7PYHGB_1+E-;\
M-:UH4VA>+O#&NVMQ#K'A#5UU8)K4>F7&E>([!K>SUGPYK%GJNF6Z7&IX*_X)
MP>)/"'[./ASX"Z#\8_`5UX8U+1/$MUX_\*^/_P!G#P3\1?A;;>-/&EO"MYXO
M^!W@`Z_X.M_@U<>'X+C5['PQH:7WBKP<4U*ZUS7O"VI>*M3U[6-6`/6XOV_/
M#VM_&3PM\+/!_P`/;O4H]1\0?#GPEXH'B_XB_#CX5?$G1O%/Q&\$>%/B3+HG
MAGX,_$'6='\9>/[[X6>`_'G@[Q7\9[+2)M/U7PG9:S/H_AG2_'?C#0?$'AC3
M=_\`9R_;;T7]I/X@76@^"_!UB_@/4/#&J^,?"7C.S^+'PQUOQ3/X8LM8LM+\
M/>(?'?P9L]9A^)/P[T'XI65XWBGX5:O<:=XAM-7\-0!_&A^'^OZEHGA[5/'A
M_P`$R=`TW5+[2/#_`,6-3/PP\:>//V5?BI\6M/\`&/@S3?&7QG\;_$;]D;0O
MA'X;\">(]-^.\NN:1JGAQ_&.E?`KX;-\29+WPCXHUF_U>#QAX@\&ZWX+USQQ
MK&H1R?#?_@G'J?PA/@2#X<?&?0_#EC^SO\-OV@_`7[),:_!72WOOAI=?'58%
MMM3^,.HVGCJP;X]:+X`&GZ1'I/A&UM_A78^*ETNSUCQS?:[XRL='\4Z4`?#?
M_!<7X^>%_!_Q#_8X^$\%E<^(?%'C3QMXD\/ZW'I]Y;6T7@'3O'&CO-X/\0>(
M?M$4AN4\3:A\/?$^G:)HUHT>H7L6C:YJX>.PT:7[3^6`.0#ZC-??/_!9G]C#
MPK<^-OV;/BHGQ$^*]AXUU'XSR?&/XBIIWQ&\>0^!_&'BKX<?"_PK\-[:;0?A
M[<^*KSP_\.WU#1Y+&%9O#JRK8Z=:7NF"WNO[=U:]G^!B<DG`&23A0%49.<*H
MX4#LHX`X'`K^NO"/ZW_J7@/;V>'=7&O!ZT[JG]?Q2JQM",9)*NJDDZKG-N;L
MU34(K^6_%'ZM_K=C?8W]O[+!K%JT[>T6!PKI23E)Q=Z#A%JFH17(KIS<Y.*X
M_P"/:Z_Z]+O_`-)Y:^^?^"Z?_)O/[!__`%S\0_\`JLO!%?`UQ_Q[77_7I=_^
MD\M??/\`P73_`.3>?V#_`/KGXA_]5EX(K[&/_)RO"_\`[#^*/_6=KGR57_DW
MGB1_V!<-?^M#AS^:NJU[_P`>5]_UY7G_`*32U9JM>_\`'E??]>5Y_P"DTM?T
M]'=>J_,_F>6S]'^1_I&?`K_DBGP@_P"R7?#W_P!0_1J]5KRKX%?\D4^$'_9+
MOA[_`.H?HU>JU_D)F?\`R,L?_P!AF)_]/3/]7<N_Y%^!_P"P/"_^F(!1117"
M=@4444`%%%%`!1110`4444`?AU_P4NB,_P#P4>_X(61"::`O^U9^T^!+;NL<
MR8_8[^(#?*[QR*`V-K@H=R%E!4D,/VD31)BB'^W=>Y53S>6I/('4_P!G\GU.
M.3VK\8?^"D__`"DD_P""%/\`V=;^U!_ZQS\0:_;R/_5Q_P"XO_H(H`^!M<79
MKFM(7>0IK&J*9)"&D?;?3C?(P50TCXW.P506)(4`X&76MK__`"'M=_[#6K?^
MG"XK)H`]4^#]JUWXLFB6ZN[,_P!BWK>;9RQQ2D"ZL,HS20SJ8VSEEV`[E4AA
MMP?H&6[T&"66";QXT4T,CQ312^(=%CEBEC8K)')&\*NDB,"KHZAE8$,`017A
M'P3_`.1RF_[`=]_Z5:?7XP?&F&`_&/XL$P0DGXE>-R28HR23XDU+))*Y)/<G
MDT`?T)?VAX=_Z*`/_"DT/_XU5JS.E:C*;?3_`!I=7TX0R&&SUS2;J81JR*TA
MC@MI'"*SJ&8KM!902"PS_,OY$'_/"#_OS%_\17W7_P`$\XHD^.^IE(HD/_"N
M?$(RD:(<?VUX8XRJ@X]NE`'Y,?M"(8_C[\<$+R2E/B[\1T,DK!Y9"OB_5QOE
M=516D?&YV"(&8DA5!P/(*]B_:(_Y.`^.?_98/B3_`.ICK%>.U_?>6_\`(MR[
M_L`P7_J-2/XCS'_D88[_`+#,5_Z?F?IA_P`$I;9KO]I?7(ENKNT/_"I/%+^;
M9RQQ2D+XE\%?(S20S`QMG)4*#N52&`!#?SY?M;(8_P!JS]IN,O)(4_:#^,J&
M25@\LA7XB>(EWRNJHK2/C<[!$#,20J@X']"__!)K_DYS7/\`LD/BK_U)?!-?
MSU_M=?\`)V'[3_\`V<-\:/\`U8WB.NCPW_Y.AQC_`-DMD'_J9BCSO$;_`)-U
MPG_V4N>_^H>"/GFOV#_X(;V[7/[=UC$MS=6A/P6^*+>=9R)%-\MWX-^7?)%,
MNTYR1LSN5"",$'\?*_8O_@A;_P`GZ6/_`&13XJ?^E?@ROT?Q3U\..-?^R=S/
M_P!1Y'Y]X9?\G!X/_P"R@RS_`-2J9_9=_8<W_0=UW_P+M?\`Y`H_L.;_`*#N
MN_\`@7:__(%;]%?Y:G^EQ\U_&VQ>RB\-E[^_O?,EU4`7LT4HCVQV!)C\JW@V
MEMV&W;LA5QC!SX'7T9\>_P#4^%O^NVK_`/HO3J^<Z`&O]UO]T_R-?4GC+X@?
M#_X76'AZ7X@?$>Z\*IKUO*-)_M"[^6\:P@LWO$@^S:1<'_1EO+;?YA4XE3!8
M[L?+;_<;_=;^1K@O^"C)(T7X'8)'R^,O_2#PE0!]1?\`#3O[.O\`T7:V_P#`
MJZ_^9ZD/[3W[.J@L?CO;`*"Q/VJ[X"@DG_D7NP!-?@MD^I_,U',3Y,W)_P!3
M+W/_`#S:@#[2_P""O,*+IG[/%U#J5]J4%[/\1[BWENYHY4\F2Q\$R1R0!+:W
M*B5'5F+[BRA.%*G/XH5^U/\`P5J_Y%']EO\`Z\/'/_IF\!5^*U?V+X5?\D'D
M?KF?_JXS`_E+Q+_Y+7.?3+O_`%58$BGXM[KO_HEUP>G_`![R=:^[/^"Y-FUM
M^S[^PL[7M]="9/$)$=W-%+'"/^%:^"FQ"L<$)3KCYF?C//-?"=Q_Q[77_7I=
M_P#I/+7WS_P73_Y-Y_8/_P"N?B'_`-5EX(KZ:/\`R<KPO\L?Q1_ZSM<^;J_\
MF\\2/^P+AK_UH<.?S5U6O?\`CRO?^O*[_P#2>6K-5KW_`(\K[_KRO/\`TFEK
M^GH[KU7YG\SRV?H_R/\`1Q^!^C2R?!?X1.-:UQ`WPO\`A^0BW=ML4'PCHYPH
M-B2%&>A)YR<\U[!8V+V7F[[^_O?,V8^VS12^7LW9\ORK>#;OW?/NW9VKC&.?
M.O@5_P`D4^$'_9+OA[_ZA^C5ZK7^0F9JV8X__L,Q/_IZ9_J[EW_(OP/_`&!X
M7_TQ`****X3L"BBB@`HHHH`****`"BBB@#\0/^"D_P#RDD_X(4_]G6_M0?\`
MK'/Q!K]O(_\`5Q_[B_\`H(K\/?\`@I<LS_\`!1[_`((6+;S"WF/[5G[3^R5H
M5G"8_8[^(!;,3/&&W*"F=X*;MXR5"G]HTLM?**1KT."JD?\`$E@'&!V%]@?0
M<#M0!\3Z_P#\A[7?^PUJW_IPN*R:U-<##7-:#N)'&L:H'D"",.XOK@,XC!8(
M';+!`S!,[02!FLN@#U[X)_\`(Y3?]@.^_P#2K3Z_&3XT?\EB^+'_`&4GQO\`
M^I)J5?LC\'XKN7Q9,MG=+9S?V->$RM;)=@H+JPW)Y;RPA2W!\P,2-NW:0Q(_
M&OXR!U^+_P`55DD$LB_$;QJ))1&(A(X\1ZB'D$2LZQAVRPC#L$SM#,!D@'F]
M?=/_``3U_P"2[:G_`-DZ\0?^GKPQ7PM7V_\`L`QW4OQPU-;.Z6SE_P"%>Z^3
M*ULET"@UGPSE/+>6$+DE6WAB1MV[2&)`!^47[1'_`"<!\<_^RP?$G_U,=8KQ
MVO7_`-H0.OQ]^."R.)9%^+OQ'$D@C$0D<>+]7#.(E9EC#MEO+5F"9VAB!D^0
M5_?>6_\`(MR[_L`P7_J-2/XCS'_D88[_`+#,5_Z?F?IU_P`$FO\`DYS7/^R0
M^*O_`%)?!-?SU_M=?\G8?M/_`/9PWQH_]6-XCK^@K_@E+%=R_M+ZXMG=+9R_
M\*D\4DRM;)=!D'B3P5E/+>6$*22K>8&)&W;M(<D?SY?M;AU_:M_:<61Q+(O[
M0?QF$D@C$0D<?$7Q$&<1*SK&';+>6K,$SM#$#)Z/#?\`Y.AQA_V2V0?^IF*/
M.\1O^3=<)_\`92Y[_P"H>"/GROV+_P""%O\`R?I8_P#9%/BI_P"E?@ROQTK]
M@_\`@AO'<R?MW6*VERMI-_PI;XI$3-;)=#:+OP9N7RGDB7)X.[?QMVX(8X_1
M_%3_`)-QQKU_XQW,_P#U'D?GWAE_R<'@_P#[*#+/_4JF?VJT5S_V'Q!_T'H?
M_!-!_P#)M'V'Q!_T'H?_``30?_)M?Y:G^EQXW\>_]3X6_P"NVK_^B].KYSKW
MSXV0:A#%X;^W:@E\&EU7R@EE'9^41'8;R2D\WF;P5`!V[=N1G)QX'0`U_N-_
MNM_(UP/_``4:_P"0+\#?]WQE_P"D'A*N^?[K?[I_D:\S_P""AT-_%I'P4-Y?
MI>(__"8F!5LH[0P@6/A4L"R32^;N!0<A-NPD9W$``_,6HYO]3-_UQE_]%M4E
M1R_ZF;_KC+_Z+:@#[-_X*U?\BC^RW_UX>.?_`$S>`J_%:OV<_P""KT-]%X2_
M9A-Y?)>*]EXX,*I91VGDC^QO`>[+)/,9=P*C!"!-N5SO('XQU_8OA5_R0>1^
MN9_^KC,#^4O$O_DM<Y],N_\`55@2*X_X]KK_`*]+O_TGEK[Y_P""Z?\`R;S^
MP?\`]<_$/_JLO!%?`T__`![W7_7I=?\`I/+7W;_P7)AO8_V??V%FNKU+J-T\
M0^1&MG';&$?\*U\%'ETFE,ORD+\RIZ]A7TT?^3E>%VF^/XH^7_&.USYNK_R;
MSQ(_[`N&O_6APY_-O5:]_P"/*^_Z\KS_`-)I:LU6O?\`CRO?^O*[_P#2>6OZ
M>CNO5?F?S/+9^C_(_P!(SX%?\D4^$'_9+OA[_P"H?HU>JUX=\#[/76^"_P`(
MC'KD*(?A?\/RJ'1X&*J?".CD`M]M!;`[D`]L8`KV&Q@U"'S?MU^E]NV>5LLD
MM/+QNWYV3S>9ORN,[=NTXSNX_P`A,S_Y&./_`.PS$_\`IZ?]?E<_U=R[_D7X
M'_L#PO\`Z8@:%%%%<)V!1110`4444`%%%%`!1110!^('_!2?_E))_P`$*?\`
MLZW]J#_UCGX@U^WD?^KC_P!Q?_017XA_\%)_^4DG_!"G_LZW]J#_`-8Y^(-?
MMY'_`*N/_<7_`-!%`'P1K_\`R'M=_P"PUJW_`*<+BLFM;7_^0]KO_8:U;_TX
M7%9-`'KWP3_Y'*;_`+`=]_Z5:?7XR?&C_DL7Q8_[*3XW_P#4DU*OV;^"?_(Y
M3?\`8#OO_2K3Z_&3XT?\EB^+'_92?&__`*DFI4`>:5]T_P#!/7_DNVI_]DZ\
M0?\`IZ\,5\+5]T_\$]?^2[:G_P!DZ\0?^GKPQ0!^3'[1'_)P'QS_`.RP?$G_
M`-3'6*\=KV+]HC_DX#XY_P#98/B3_P"ICK%>.U_?>6_\BW+O^P#!?^HU(_B/
M,?\`D88[_L,Q7_I^9^G7_!)K_DYS7/\`LD/BK_U)?!-?SU_M=?\`)V'[3_\`
MV<-\:/\`U8WB.OZ%/^"37_)SFN?]DA\5?^I+X)K^>O\`:Z_Y.P_:?_[.&^-'
M_JQO$=='AO\`\G0XQ_[);(/_`%,Q1YWB-_R;KA/_`+*7/?\`U#P1\\U^Q?\`
MP0M_Y/TL?^R*?%3_`-*_!E?CI7[%_P#!"W_D_2Q_[(I\5/\`TK\&5^C^*?\`
MR;GC7_LG<R_]1Y'Y]X9?\G!X/_[*#+/_`%*IG]IM%%%?Y:G^EQ\]_'O_`%/A
M;_KMJ_\`Z+TZOG.OHSX]_P"I\+?]=M7_`/1>G5\YT`-?[C?[K?R-<#_P4:_Y
M`OP-_P!WQE_Z0>$J[Y_N-_NM_(UP/_!1K_D"_`W_`'?&7_I!X2H`_+>HYO\`
M4S?]<9?_`$6U25'-_J9O^N,O_HMJ`/LW_@K5_P`BC^RW_P!>'CG_`-,W@*OQ
M6K]J?^"M7_(H_LM_]>'CG_TS>`J_%:O[%\*O^2"R/US3_P!7&8'\I>)?_):Y
MSZ9=_P"JK`D5Q_Q[77_7I=_^D\M??/\`P73_`.3>?V#_`/KGXA_]5EX(KX&N
M/^/:Z_Z]+O\`])Y:^^?^"Z?_`";S^P?_`-<_$/\`ZK+P17TT?^3E>%__`&'\
M4?\`K.USYNK_`,F\\2/^P+AK_P!:'#G\U=5KW_CROO\`KRO/_2:6K-5KW_CR
MOO\`KRO/_2:6OZ>CNO5?F?S/+9^C_(_TC/@5_P`D4^$'_9+OA[_ZA^C5ZK7E
M7P*_Y(I\(/\`LEWP]_\`4/T:O5:_R$S/_D98_P#[#,3_`.GIG^KN7?\`(OP/
M_8'A?_3$`HHHKA.P****`"BBB@`HHHH`****`/RT_P""B/[%?[0G[2WQ,_8M
M^.'[,WQ@^$OPF^*?['?Q2^)7Q(T-_C/\,_%?Q1\%^))/B+\*]2^%EQ87VA>#
M_&_@+5$^PZ7K.IWL4J:Y#_IALI5;;;20W'!CX9_\%T@`!^UM_P`$T<``?\F4
M_M%#I[#]K,#\@!7[#T4`?A5=_LM?\%J[V[NKR;]KO_@G");RYN+N41_L4_'5
M4$MS,\T@13^T\Q5`[MM!9B%P"3C-5_\`AE'_`(+4?]'>?\$Y/_$*OCI_]$[7
M[NT4`?B#X<_9T_X+;^%]0?4M._:Z_P"";KW#VLEH1<?L4_'LH(I9(96(^S_M
M26T@?=`@!$FW:6!4Y&/F_P`2_P#!-'_@KAXJ\1Z_XHU+]L?]@>/4?$FM:IKU
M^EI^QY\:H;1+W5[V:_NEM8G_`&C9GBMUGG<0QO+*Z1A5:1R"Q_I.HH`_F7_X
M=9_\%8_^CR?V#_\`Q$#XT?\`T1-9/B?]G'_@KY^PUX)\<_M$:)^U5_P3_P#$
M\_ACP]:Z9=:)J'[(?QPA2\LO$'BKPSI;^1<6W[1L;VUQ#=36DPE;S%:%)H#$
M?.\R+^GZO.OBQ\+/"'QJ\`>(?AGX\M+R^\*>*(;&#5[6PU*\TB[ECT[5M/UN
MV$.HV$D5W;%;_2[21VAD4R1H\+$QR."`?S6^+_\`@D#_`,%3/'/BWQ3XUUC]
MLW]AR/5O%WB37/$VJ1V'[(_QE@L8]1US4[K4KV.S@E_:!FEAM4N;F5;>*2>=
MXX@J--*1YC<]_P`.6/\`@IW_`-'H?L3_`/B)GQA_^?[7]6X`48'3+'\68L?U
M)I:^LI\=\84H0I4^(LSA3IPC3IPC7:C"$%&,(I6VC&,4O)'R\^"N%*DYU*F0
MY=*=24ISDZ-W*<GS2D]=V]7YM]V?S:?`/_@FI_P5Q_9R\:W?CWP%^V/^P1=Z
MU>^'K[PS-'XC_8^^-U_8#3M0OM+U"=XXM/\`VC]*N$NA/I%JL<HNB@B:=&B?
MS`5^0OB'_P`&_O\`P45^)OC_`,<_$CQ#^VS^R#!K_P`0/&'B7QMKD.E?LL?%
MFUTN'5_%6LWNNZE%IUK-\<+J:VL([V_F6T@ENKF6&W$<<D\SJ9&_L(HJL%Q[
MQEEV.Q&9X'B/-,+C\7AZ.%Q.+HU^6M7P^'E*=&C4E;WH4Y2E**Z-MDXS@?A'
M,,%A\NQO#^6XG`X2O5Q.&PU6AS4J->M&,:M6$;Z3J1A&,G?512/XQO\`B'&_
M;]_Z/>_90_\`$8/BK_\`/IKZ,_9:_P"",O\`P5!_9$^*L?QA^%W[:/[$U_XJ
MB\,Z[X46W\8_LF_&75M&_LSQ#+IDU\YM=,_:`T.[^UJ^DVHMY5OQ&BM,LD,H
MD&W^JVBNS'^)O'^:8+$Y=F'%F<XS`XRC4P^*PM?$\]*O0JQY:E*I'EUA..C7
M8X\#X<<"Y;C,-C\!PME&$QN#K0KX7$T</RU:%:FU*%2G+FTE%Q33\O4_'G_A
M6G_!=+_H[?\`X)H_^(5?M%?_`$6E'_"M/^"Z7_1V_P#P31_\0J_:*_\`HM*_
M8:BOA3[8_$_Q/\!/^"WWBU;)=3_:Y_X)M(+!IVA^S?L4_'_)-P(EDW_:OVJ+
MK@"%-OE^7SG=N^7;R7_#*/\`P6H_Z.\_X)R?^(5?'3_Z)VOW=HH`_"$_LH?\
M%IR"#^UY_P`$Y,$$?\F5?'3O_P!W.UC?&']C/_@LW\;[?PS;>,/VP/\`@G?;
M1^%#J1TPZ'^QG\=[1G_M6*PBN1="]_:=U%&"KIUOY2VZ6RH3)N#@H$_?>B@#
M^9?_`(=9_P#!6/\`Z/)_8/\`_$0/C1_]$337_P""67_!6)D=3^V5^P>`R,I(
M_9`^-&<,I!Q_QD0>Q/8_0U_352$9!!Z$$?G0!_+QXF_9?_X*[?MR7'B[PQXR
M_:M_8#\/Q_LN_%WQ9\'K&?0/V1?CA$VOW9\"?"[Q/?ZO.M[^T7>K!;FV\0Z;
M8P64:H8;BQNYQ/<0W4,=MQ__``Y8_P""G?\`T>A^Q/\`^(F?&'_Y_M?TZ^`_
MA=X1^&]_\1-2\+6EY:W?Q2^(.H_$[Q>]UJ-W?I=^+=5\/>&/#%Y=V<=U(Z:;
M:/I'A#1(DTZS$=I'-!/<I&)KJ=F]#KZ/`<7<397A*6!R[.\?@\)0Y_98>A6Y
M*=/VE65:IRQL[<]6<YO^])OJ?/X[A7AW,L54QN/R?!8K%UN3VM>M2YJD_9TX
M4H<SNK\M.G""[1BD?RBO_P`$5O\`@IU(DD;?MH_L4!9(WC;'[)GQ@SMD4HV,
M_'P@'#'!P>>QKU3]J7_@EK_P5D_:[\(_"SP7\4?VROV$=/TCX0"\'A:3P=^R
M'\;-)O9_MVBZ;H,W]L2ZG^T9K<-SBRTNV:,6EO8!9S(Y#1F.*/\`IFHK?_7?
MBWZ[@<Q_M_,OKV63KU,OQ7M_WV$GB:#PV(E1E;W75H-TIOK!V,?]3>%G@\;E
M[R/+_J68QH0QV&]C^ZQ4,-6CB*$:T;^\J5:,:D%?2:N?QC?\0XW[?O\`T>]^
MRA_XC!\5?_GTTR3_`(-P_P!ON6*6)OVWOV4-LT4L+8_9@^*F0LL;1L5)^-!`
M8*Q*D@X;!P<8K^SRBO<_XB[XF+_FM<^T_P"HM]+?W?)?<CQ?^(5>'/\`T1V2
M?^$OI_>\D?BYX7^"?_!<3PEX:\/>%=+_`&N?^";+Z;X9T/2/#^GO=_L6?M"R
M73V.BZ?;Z;:/=20_M76\,EPUO:QF9XH(8VD+&.*-"J+]N_LH>&?V[O#LGCH_
MMH_%W]F7XI0W:>&Q\.4_9W^"/Q'^#\FB20-KG_"5MXMD\??%WXHKX@344E\.
MC0TTJ/0SI366K->OJ0U"T6Q^QJ*_.YSG4G.I.3E.I*4YR>KE.3<I2;ZMMMOS
M9]]"$:<(4X1480C&$(K:,8I1C%>2227D%%%%24%%%%`!1110`4444`%%%%`!
M1110`4444`%<-XC^)/@?PCXK\`>"?$GB&ST?Q-\4]3UW1/A_IE['=QGQ3K?A
MKPY?>+]9T73+Q;9M/;6+;PMI6K^((]+GNX+^^TG1=:O=/M[N#1]3:U[FOB#_
M`(**?!+X@_'K]DOXG^#O@S9W;_'738-#\9?`O6](\26/@KQ+X1^+'A/7]-U/
MPSXI\+>-+^>U@\+:UI\"ZI;?VD]U#!<Z7?ZIHM\+C3=6O;.X`-+5_P#@H%^R
MCHOQ"\'?"VY^(VLWOC3XAW^M:;X"L=`^$_QH\4Z9XTG\-:L^B>)9?"WBGPS\
M.M7\)Z]8>&M03;XCU73-<N=*T&U>'4=6O;/39X;R3I?@A^VM^S+^T7?Z1IGP
MB^*%IXCO?$NA7_BGPA%J/AKQOX,'COPOI3V*:IXG^'DOCSPOX7@^(7AK33JF
MEM?Z_P""9=?TFSBU/3I[B[B@OK667R_QU^SGXDM?VJ/V`_%7PR\):=I?P3_9
MN\$_M)>#?$$-CJVGZ=:^#='\7?#GX<^$OAEH^E:%<W:ZEJ=G(_AF[L%_LV"[
M&F16:3ZB\:W$<LGR5^QU^S]^TQ;_``P_X)H_"#XK_`O6?@HO["NG0>(?B%X[
M\3?$/X4^*)?'/B?1/V?/B/\``;3O!/PML?ACXQ\>:C/X4\13?%6^\4>)?$'C
M0^!Y+;2/!NFZ';^']4U#7O/T``_4W4_C_P#!G1-6^*^BZ[\1O#&@7GP-\-^%
M?%_Q;E\07QT+3/`7AGQK9:]J/AC6_$.MZO'9:):Z?JMEX8UVXCGCU&;R$TZ9
M;M;>1[=)N`\0?MD?L[^'?`OP>^)$OC?4M?\`"7Q]\+6OC?X07G@/X>?$_P")
M>I>.O!UYX<TCQ9#XHTGPU\.O!7BGQ1%H(\/^(-#U&?5-2T6QL[1=7TVWNY8+
MN]M[=^A^/'AG35^'WC76-(^!#?&[Q;JL'AU4\)Z#9_"Z'Q)KVJ^'[R1O"&L-
MJ7Q6\2^#/"/F>`=1O7\1:7=:KXCM[W1G@GN_#L<^K_9K:;\UO@_\$/C)IO[(
MW["O@OXI_LE_'H^/_P!FS]GS0?V??&GA?P#^UGX%^$_BK^V="^%GP=T6^\4Z
M;K/PO^-&C:!XV^&&O^*_`<LMM>:G\5O#/CGPQ?>&],UE?AAX@75%DTL`_931
M-7LO$&CZ3KVFFZ;3M:TRPU:P-]I^HZ1>FRU*TAO;4W>E:O:6&JZ9=&WGC-QI
M^IV5GJ%E+OMKVUM[F*6%-.O&OV=_#GQ0\(?`OX2^%_C3XFA\8_%?0/A_X7TG
MX@>)H+R34DUGQ58Z5;P:M>-JTMAI,NMS-<(8KG7I=)TF77KF*;69=+TZ2_:S
MA]EH`****`"BBB@`HHHH`*IZC?VVE6%[J=X9EM-/M+F^NC;VMU?3BWM()+B<
MP6=C#<WMW,(HW,5K:6\]U</MAMX99G2-KE-<95@.I!QZ@]B#V(."#V/-`'R]
MXM_;0_9I\%_#WPM\4]6^)MM?^!?&GPY'Q>\-:WX/\,^-_B"VI?"[;H+R?$#^
MR?`/ACQ-KEGX1MT\3:(UYKVH:9::?9"\/VR:`VM\+7R^R_X*9?L6ZA!X>N;;
MXMZBMKXG\!K\5--N[OX2?'#3[2W^%LM[>6%K\3M?NK_X9VUOX4^'-_<Z??C3
M/'7BF31O"NJ06-W=Z=JUU:6TTZ>/_##]CWQG\/O`_P#P4OT33?"$6FWGQO\`
M'?Q=TO\`9LT[_A*M.NK&U^#?BWX)Z-KVB>#_``]$M\;/X>>$I/VH/B/^T3XH
MM_"EZ--CTK5?&.JZHL%OX=GT"&S\F^%GPB_:J_9S^*OP8\=:?^S3XC^+L.E_
M\$M_V9_V8M9MO#'Q6^#'AS2O#GQR^$WB7QKKOB'0/&>H^-?'6DZF/"3QZ]86
MS>,/!'AKX@JT3W[6>BZA)'#;78!^LOBKXN_#;P5X=\)^+O$?C#1['PSX[\5_
M#OP1X/UV"675-+\1>)OBSXBTCPI\.=.TN\T>'4(;E?%NOZ_H]AI.H*PTN3^T
M+>ZFOH;)FN5H^'/CA\(_&'Q0^(/P7\+?$+PMXB^*7PIT+P?XD^)/@G1M4BU+
M6_`^D>/KOQ/9>#YO$\-KYL&CW6O3>#O$3V6EW<\>K"UT\7MQ8P65YI]Q=^;_
M`++?[/O_``I#]EO]GOX!>.;G1O'.J_!OX=_#3P[>ZD;4WFAGQ5X"L]-N+74?
M#,&J6T=S9Z5X>UVQB;P2T\$&HZ5INFZ,V(+RVPGQEH/P^_:$T[]MC]J+Q=\-
M/V;/$GP,\&?%S]F?P)\&OAS\=-0?]G#7_`F@?&?X>_$C]KWXBZI\9O%GPJ\'
M_&ZU^('B/PWXMUCXS>!]9LTET2#QIXKUF35K;QM8^%889M50`_1#P-\=OA'\
M2_'_`,7/A=X#\=:+XH\>?`C6?#7A[XM^'=+:[ENO!&M^+_#Z^*?#^EZK<26L
M6GR7E]HA:Z>'3KR^-C+%<6&HFSU*VN+.+UJOR8_8&_93_:>_9U_:,_:CUWXO
M7_PGU?X7^-_`G[-?A[P!XC\":/XHTO6_&&O?#;POXNT_Q3K^N0^*?B;X\UN#
M4Y=1\0ZCJ'C'5/$<;:KXZ\7>()_%-IJ$,*ZC:W'ZST`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`445Y'XK^+-KX5URZT271+F]>VCMI#<17D$*.+F!)P!&\3,NP/M))Y(R/2@
M#URBO!(?CM92S0Q#PW>J998H@QU"V(4RR*@8CR1G&[.,\XP*][H`***X7XG_
M`!+\#?!GX<^.OBW\3O$5GX1^'7PT\)>(/'7CGQ1J$=Y-8^'O"GA;3+C6->UF
M[AT^VO;^:WT[3;2XNI8K*TNKN18REO;S2LD;`'=45XK\'/VAOA'\>K?Q#+\,
M?%,VKWGA*ZTVT\4^'M9\,^,/`WC+PT^M63:CH<WB#P-X_P##WA;QEHMEKUE%
M/=:#J.HZ%;Z?K<-K>/I5U=BRNQ#[07`#'#?+U^1R3U^Z`N7Z?P@T`.HKSWX?
M_%7X?_%.+QA-\/\`Q-9>)X_`'C_Q7\+O&#V$-\@T+Q_X'NXK'Q5X8O!>6EL6
MU#1KN>*&Y-N)[5V<-;7$Z`L.@\6^+O"W@+PQXB\:^-O$.C>$?!_A'1=2\1^*
M?%/B34+;1O#WAW0-&M);_5M:UK6-0D@L--TO3;&":\OKZ[GBMK6VAEGFD2.-
MV`!T5%-W#`;G!Q_"V>1GE<;@<=00".AYH#`YQGCOM;!R<<$C!'N"1CG..:`'
M44FX9`^;G_98CKCD@8'XD<<]*3<.>&X_V6]<<<<_AGCGI0`ZBFE@.S=<<*QY
M_`'CWZ>]+N&<<Y]=K;>F?O8V_K[=:`%HI"0!DY_`$G\@":3<./O<_P"RW'^]
MQ\O_``+%`#J*YSPQXO\`"OC2RO\`4?"/B+1?$UAI?B+Q/X1U*]T+4;75+6Q\
M4^"M?U#PKXO\.W5Q9RRQ0:UX7\3:3JGA[Q!ILC+=Z1K6G7VF7T4%Y:3PIT=`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5\<_%W
M_D?=5_Z]=*_]((J^QJY'5O`?A+7+Z74M5T:&\OIEB26X>>\1G6%!'$"L5Q'&
M-B*%&$!.,G)YH`^);/\`X_+/_K\M/_2B.OT(K@D^&'@.-TD3P[;*\;I(C"YO
M\JZ,'1N;O'#`'!!''((KO:`"OD+_`(*`?"CQW\=OV'OVN/@O\+],BUGXC?%7
M]G+XP_#[P+I4^J:;HD.H>+/%O@?6-%T"TDUC6)8-*TQ9]2N[=/M^I2QV%J2)
MKMA`CU]>T4`?E!\1OV!M<O\`XQ?LU^-9/%7Q*^/!O/C=%J?[4?CCXL^-/"6G
M:IJ7P;\"?LM?M1^$_A-X(N/#'PY\/_"SPKK?@'P]\<?B[I6O3>!]#\*/)KVM
M^(M2\1^+Y-7T^TN9+3Y#TC]B/]KA=`\$07O@'5[*'PGX9^%6D_MF>&F^.VGZ
MY+_P4C\:^%_C'X7\2^-_'6E7UWXMBM/"T.M^'M'\:>(<?$ZY^'NI>.;/Q_#\
M`O%^GZ5\--)&IVO]#=%`'\R.N_\`!/S]L[2/`O[4MG\//A5+I$O[07PR_P""
MEOPQ\"^!K#XY>&]-3X<S_M+?%+X5_%#X'>+=>U]O$@@\NVT3PUXF\&WG_",2
MZQKO@?Q!'I.C::[^!K]_%6D_2/QH_8.^+/QN^#W[=?P=\8?!G2_$_P`4?CEX
M"_;!TS0OVD?&'QF\WP9\1[3XC>)Y/%7[*G@*[^%UKJ.JWEC_`,*<TF/P3X-B
MN/%/A_1-`^$.H_#=_$WPTOO%I\>>(&;]W:*`/SE^.7P`\4_&/P7^P9X4\*_"
M._\`AS\-?AS^T)X;\1?&?X-W?B[POH<?A+X'Z5^SC^T!X#/@G6$\"^+=5\.>
M,-#M_&?B;X=:9>^$/#.O:_IFK:=*LES%=:18ZHD/PG\&?V$_VQ?#'A_XI7'C
MCQ5XTUOXRZ-X)U;Q-IOC6?6?A+H7@?X\_M'>!/CEX-^-7PC\<W6I>&=;U;XF
M>(+2ZN?`MYX0.I?%NS^'[>`/`'Q)\6_#2W\->*_##V5UHO\`0-10!^"T'[&'
M[7VH?M%^!_BSXJU7QC!;>)]5^`WQ2DB\(:S\'M4M?V??&DWQ-UKXG?M)?#]O
M%OCG7I/&&E^&M:N-<;P>U]\&_"/B^+XO_#^RM?A]XG?PAI&D:+K$7DVI?\$\
M?VOS\&/!^A^'M$N=$^(&K_#']L)_C)._QBBDN/%7BS3?V\?@7^T3^R/X1O=9
M;Q1=Q7!E^$OA#XH^#/!>L0F71_A=9^+KWPQKT^E:-K.H6LW](5%`'\X7C[]B
M/]MWQ[XK^(GC35]'\::/X*^('QP_:J^(&B?"CP]XT^"OB_Q3X2U;XM>%OV;;
M3X,_$R;4?B#XVL_`GA/6_`%GX`^)GAC^W_!-_P")_&'P@\1:K<:_\-?#_C>P
M\3:AJTGU[X/_`&;?VA/`_P"VOHOQ3LO!^L>+M)U'QGI\OQ+^+_Q7\>>#=?M6
M^'T'[/=IX(U*3X8:SX+\1>"?BCHFHZCXYT71KR3]GOQW\(?&_P`#=/US4O&?
MQ.\,^,/#/B#4]%@T;]@**`/SA_:/^&_Q:_:O^'/[$>JP_#;6_!\$7[1WP>^+
M/[0'PRUGQWI&G:GX9^%@^&WQ0L?&_A+Q+J/A_6K?3?&EO;ZIXHT#1=>\-:+>
M:C:>)+2>ZB>SO=-CO$'YR>"_V#_VX[+QOX)F\8ZYXZM?"_A;7'\/_!F/PAXI
M^#VNW7[//@KP;^V+\=?%VBSGQ?\`$7Q+J?BCPSI_B_\`9\UWX-Z?%<?#/PU\
M0_$^O>$?#J_!3X@:;H&F>'[&[E_HYHH`_/;_`()[_LV7'[*_AK]H3X<2_"+1
M?AU9Z_\`M8_M'_%[P_XG\+W/A23PU\1/!GQD^,7C;XA?#^:RLM&U:?Q%I6I>
M`_`>M^&_A_KNF^+-`T$VE]H@@\.2Z]H4<.JO^A-%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`445\._&G]M?2?@W\1-8^'UU\
M/=6U^?2+31[IM4M-?TZQ@G&KZ;#J*HEK<6,TJ&!9O*9FD(=E+J`I`H`^XJ*_
M-*Q_X*/:%>WUC9+\)]>C:]OK*R$C>*=(81F\NH;42%1IH+",RARH(+!2`03F
MOTM!S^9'Y'%`!116;K&LZ1X=TG5-?\0:KIVAZ%HFG7NKZUK6L7MMIFDZ1I.F
MVTM[J6J:IJ-[+#9Z?IVGV4$]Y?7UW-#;6EK#+<7$L<,;NH!I45X?\'OVC_@M
M\>QK:_"KQQ9^)[KP];Z+?ZMIDFE^(?#VM6^B^)8KR;PMXGAT+Q5H^A:S?>#O
M%D6FZG)X3\9Z?877A3Q0NE:H=`UG4?[-OO(]NW#C[W/^PW&?7Y?E_P"!8P.3
MQ0`ZBN=\+>+_``MXWTJ77/!WB'1O%&C0:WXG\-RZKH.HVNJZ?'X@\%>)-6\&
M^+]%:[LY)H!JGACQ;H.M^&=>L=_VC2M>TC4M*O8X;VRN(8^@#@C.&QTY1P>F
M>A4$_4#&>.O%`#J*\]^*/Q6^'WP6\$ZK\1OBAXFL_!_@G1+G0;/5?$.I07\M
ME977B?Q%I/A/089EL+.\N0^I>(M=TG2X-MNP6>]B>8Q0+)+'Z!O7W/)'"LW(
M)4YP#C!!&3QQQ0`ZBDW#W_`$]\=AS[>HR1P#2;Q@'YN?]A\_B-N0/<@"@!U%
M-W#..?KM;'_?6,<]N>3P.:`ZD9PWT*.#VZ*5W$<\D#`[T`.HINX9`^;G_98C
M\3C`/J"01WIU`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%?@[^W""?VDO&>`?^01X,[?]2S95^\5>(>,_V;_@G\0_$5YX
ML\9>`M/UWQ#?Q6<%YJ5QJ&N02S16%LEI9HT5EJEM;*(+:-(E*0JS!<N68EB`
M?SV:"#_;V@\'_D.Z)V/_`$%;.OZ@1T_%OYFOFV#]D#]F^VG@N8/A;I4<]M/#
M<P2#5?$I,<]O*DT,@#:T5)25$<!@5)4!@1D5])_Y_.@`KYS_`&O/@OK'[1?[
M+_Q[^!?A_6[;P[KWQ6^%'C7P/HNKW\EQ'I-KJVO:)=6FG+KOV."ZNW\.W=X8
M+'Q'%:VUQ<S:%=:C%!!-*Z1/]&44`?E/\;_!W[3W[1.C:#K>O_LP:5X1\,^$
M_'WP6U'XE?!V;XL^`KSXH?M&>`]%;XA3?$GX:#QOX?UFV\#'X5>'O%'B+X>^
M/?`OAOQMXL\+GXHWOA/Q9X?\>Z#X%T?7H[;5_E`_L:_M9>'=4^%'BG1_AM=^
M+/&/AR^MKCX=Z'XZ^+_AOQE\)/@-X#_X:K^)GQ1\(?##4]9N?%_@SXS?#WQ#
M\,_@OXL\+?#[6/BA\"=6^+=E\5K#PSX>^&_BSP)K'@/X?Z/-XJ_H'HH`_*S]
MF+]F#X@?LT?LB_M7?`KX6?!+P)X,^(6H?%']M3QI\)[J?Q'9^&_AA\6I?C/\
M3OBOX\^"=_J6J_#+Q!;_`!%\&6&@^"?$WP^^&GBUY[7PCXJ\-3^&+J/P==W>
ME:=HWB.;XA^'?[`/[43_`!@\'V^O^#?$&F_LNWWQX_9K^)?BKX7^(/&7P<\(
MP:=9>'_@'^WC\.?VA&U7X??`O79O"=]I'C#Q+\0/V;$U+1O^$E\?:U\0M+BM
M]0\9:SJ\OA_6;#2_Z,:*`/YD]7_X)^?MG>)/@;XC^'WQ$^&$WQ.\?WNG?!'P
M]\$/%.K?&[PZ;#]GSP#\%/VM_$?C?6/`TYU+Q9)>:BWCCX2:=X'US2M5T2U\
M13^,533_`(;?%._T"S^'V@3W?W?_`,%"/V6/VD?CG\5O`OB+X>Z[XLU+X;:=
M\(O'_@ZQ\+^"I/A);:[\/OC-KWBG1M2\/_&BTU#XOZMINF>'-0L/#EL^DZ-\
M2_!=CXL^)?PPO=-EF\+^#-?M/%NMPQ_K[10!_/#^VY\$?VE_AY\+OVNO'6GZ
M3XFUWPG\0Y?A8/A;I7A_Q]J5KXO^&WC'2_VI?V>+7XE:I#%X->>>QM_VQFT]
M?BMJU_X3TOR?A`W@6[_MNWT^Z\;:Q:665\2_V$/VL_%'B76];\)>'?%_@']G
MS6O$_P`;[KX:_LK^&O%?P5\5^(/@CXG\6^$O@3H/ASXK0:O\0O&TWPY\*3:K
MXN\!_&/QUI.H?#C7/%GB[X'7OQ/76O!7AK6=<\5^--+T7^C(C(QS^!(/Y@@_
MYQTI:`/PNUK]B?\`:B@^(/BGXAZ-!KU_XYU#]NOP]KUK\0%^-*>&O$M]^R7J
M?_!/GP#\$OB:]CJFFW/V;P>_BSX[Z+K.N:EI&B>#X]9C\80Z9\5]/\(S7&C>
M'4L_"K']AK]L.#P5X=\%Z%X#U;PI\&/"WQ`^&_BGQI\/=3N/@'XI^+_QPGT_
MX6?%?P5KK>,?"<WQ9?\`96^)&E^%O%^I_"SQTGB[Q++\'/&/Q=UNW\0>+?'O
M@Q?%/@7P,NJ_TC44`?A6?V0_VG_"_C[]F[Q=HWA7Q9\4O'7@7P1^S+X9OO&7
MQH^*7P_\5>"?"6G>!_B)K.J?$2.?4?#&L?#'XL_#+QSI?@;Q!?Z7>ZQ\(M+^
M+O@#]H.ZT;P5HOQ4\'KI.BZI>ZU^Z:Y`&<9'IZ9X_'&,]LYQD4M%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%?FA^T
M;_P4?T/]GGXN>(?A1>_";7/%-QH%CX?OGUNR\5Z3I=M<C7]'M]62)+*ZTNYG
MB:V6X$#L\S"5D,BA5(%>ODN19KQ#BYX')\(\;BJ=">)G2C5H46J%.=.G.IS8
MBK1@[3K4X\JDY/FNHM*37EYOG669%AH8S-<4L)AIUH8>-1TJU6]:<*E2,.6A
M3JSUA2J2NX\J46F[M)_I?17XV:;_`,%?O#6HZEING+\"?$L3:CJ6GZ<LQ\=:
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M\*^,_`7C3PTVN63ZCH4_B#P+\0O#OA7QEH]AK]E#<W.@ZGJ&A0:;K<5G?-I=
MW=FQO!![1O7GJ,$#Y@RY).!C<!NR<`8SR0.XR`.HKEO"'C?PA\0-!M_%/@;Q
M-HGC#PW=7VMZ9;:]X:U&VUK1[C4/#>N:CX:\064.HZ?)/:R7.B^(=(U31-3A
M64O9:IIU[8SJEQ;31IU`.?\`]1^G^?4<CB@!:*;N&2,-QD_=;''H<8/L`<GM
M1O7_`&O^^'X^OR\>HSC(P1P10`ZBOF;1?VQ/V<->F\=&R^)MC;:1\.-3FT;Q
M5XSUO0?%_AKX;0:M;>/'^%]SIVC_`!1\1^'=)^'/BN]MOB-'+X'N+;PEXIUV
M6#Q3#/HLJI?0RPI]+A@3C#9YZJP'&.Y`'?CGGG'0T`.HKFM'\7:)KNL^+M!T
MZ34'U+P/J^GZ'XA2YT+7M.M8=1U3PYH_BNS73-2U+3+/3/$5JVC:]ILD^I>&
M[S5],L]0>[T2\O+?7-,U/3;,\4>,O"G@JQL-3\7^(]%\,:?JOB/PMX0TR]U[
M4K72K:_\5>-_$.G>$_!_ARSFO)(DN-;\4>)]7TOP_H&F1%KS5=9U&RTVSBEN
M[F*)@#I:*X/X?_$WP+\4]+UO6O`'B&U\2Z7X<\<_$'X:ZU>V4%]%#8>./A7X
MSUKX>_$#P[(;VTM6>\\,^,_#NMZ!>R0++:2WFG3M97-U;&.=^OO]1L],L+W4
M[^=;6QTZTN;Z]N)5D"V]I9P27-S.ZJC2%(H(I)&V(S$*0JL>*`+M%>/>$/C[
M\(/'MK\'+SPCXYTO6[;]H#X;W'Q>^#TUK!J<:^.OAQ::1X-UVX\5Z6+JPMVM
M["+2?B#X-O6BU1=/OO*UZU46AECNH[?G-7_:J^`&A?%:/X*ZK\2M'M/B&VMZ
M#X6N=,>RUZ32-+\8>*]/M=6\*^"->\90:/+X'\/>._%.F:AI=_X8\#Z]XETW
MQ9XAM-8T:?1]&O$UC2S>`'T)10#D9'0\BB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`K^7O_@I8K']L+XC8!/\`Q(OAUT!/_,F:;7]0
ME?-?Q%_9`_9P^+/BW4/'7Q#^%ND>)O%FJP:?;7^LW>J>);:>Y@TNSCL+"-X=
M.UNSM%%M:0QPJ8[=&95#2%W)8_=^'O%.!X1SROF>84,7B*%7+:^"C#!PHSJJ
MI5Q.$K1DU7K4(<BCAYIM3<N9QM%IMKXOCOAO&\49/0R_`UL+0K4LQHXN4\7*
MK"DZ=/#XJC**=&C7GSN5>+2<%&RE>2=D_P"3KPNK#Q/X9RK#_BI?#G8_]!S3
M_:O[6!T_%OYFOCRV_8!_9`L[FVO+;X):#%<V=S;WEM*-:\8EHKFTGCN+>50W
MB1E+1311R`,K*2H#*RD@_8G^?SKU/$GC;+.,IY/++<-C\.LOCCHUECJ>'@YO
M%/".G[+V&)Q%^7ZO/GYN2UX\O-=V\WP_X/S'A..:K,,1@J_UYX-TOJ=2O/E^
MKK$\_M/;X>A:_MH\O+S7M*]M+E?(?[?_`,)_'?QW_8?_`&N/@M\,-.AU?XC?
M%;]G/XP?#WP-I=QJFGZ)#?\`BSQ=X'UC1-!M9-8U:2+2]+6;4KRW3[?J,BV-
MKD371\E'!^O**_,#]&/R2^+'_!/_`,3:O\3_`-GKQ;8>,_B-\9]2O_C#<ZA^
MTC\1_B_XN\)#59OA7X+_`&3_`-JGP;\&?"EUX1\!>'_A?X0\1^`?"7QY^+^B
M>)I_`.B^%!_PD.M:]JOB+Q:^KV5M</;><?L.?L8_M7_"^.Y3XC?%'QUX+\0+
MX1^&F@?%76M2TC]G[QIX2^/WC/P]JVJW?Q'\:KI6CKK_`(F\07WCY+B[BN/C
M#\3[WPG\5[[1]<BT34O!<+Z%9WL'[:44`?RQ7G_!-3]K+PG\`?&'[.WPH^`?
MAKX=7G@WPQ^UK/\``OXK?#?Q?\'+1W^/7Q$^,7Q)\>_"SXE2S>.M?UJ[^&/@
MRS\`:C\)?"ND>-/`7PWL_P!HG3O%OAKQ%H.I:MX;\"^'O!GB;6?V)_9B^#?Q
MS^'WQT^+'C?XBZ(#X`^*&C:GK7@327\7V6J77P-\1Q^(K*3XF^'6TRVU.^T^
M\M/VE/%T\_[00G\+>?8>"=9BUCP+JDR00^&VF_12B@#^8O4/V;_VG_COIW[;
MJ_!_X?>+/#OQ'MOVC_\`@J5X?T/XSZW\3CX5/CSX=>/?@E\6?AS\,/V?-`T7
M6M7LM6T[1M5^.OCCP!\1]$UNXTB'X7^%5^'[?$'2?%8\5ZDNE5];>+OV(OC?
M:_$G3[3PKX-_M"QN)OV1;_X2?%W_`(63;06W[,-EX!\?+XK_`&MM"U?PSJWB
M!?$OC'4OCM#=^,K_`%K5/#^G>*D^-5WX^NO!GQ9U#0_"_AW3M3F_;T#&>O))
MY)/7ZDX'L.!V%+0!_*98_P#!(#X[)\#/B;\)(O@=\/=(\*ZS\$))]+^&[>-O
M"LOA+6_BIX6_X*8_$;]HG1-&338-1GT2S\1:Y^S4_A#PGI/C34H+?3+`W^G^
M%-;U>RM=(U".S_2G]G/]G+XW?#W]KQ?B;IWP4U/P/\/O%NJ?%75?'^J_%/X@
M?#WQ;XA\-^#_`!9HT6H?#SP!\-/%/PI\;0>(=<MO".NZ?X9\-Q_!WXL>`?%'
MPT^"_A6UUK3?@O\`&#6;71]!N/$W[%44`?CKXW_8Y^,_Q$_:[UKQ3XS\-'Q#
M^SSXC_;TM/BUKVDWWQ"0:1K/P)B_X)/Q?LZS6VI^$8-;@N+S1;C]IFUM;2^^
M'\MJ8=2FA7QQJ&DW6DO-?2\UXN_8O^-/Q4_X)H_LK?!GXZ_#C1?C%\;?@'\5
M/V6?B?XK\`>+_$_A?Q3?>)]'^!/Q_P##OB/Q7X4T?QKXCU<>%M0\5>(O@AIN
MK^$-+U'Q-XBM=*UF74FTCQ+XAL(=1O\`58/VOHH`_G#\8_\`!/7]L8>'M=UC
MX(V,OP:^*?Q0^-/_``5%U7X@^+K+XH:9;:G_`,*:_:#^(WQ!^)7[/WA349=-
MU_4=.A75I[OP[9V:>';>]N/A5XIUJ_\`%:^1/_PD%YJ?Z:?L5_L^^/?AI\(/
MBWX0\;#QAX7L?'_B_5KOPGX)\2V?P8TFW\`Z'?\`@'P[X7OH_#?@SX$W>L_#
MSP;IFK:[9:KXEN=`TKQ?XF;4M;N]3\5WMWI.H^)[[1-/_0BB@#\<_P!G_P"$
M'[3OPH\"?LO+K7[/M]?^)OV!OV(O&OP#T;0=/^+7PL:#]ICXBKX4^!OA'0!\
M--7GU6.V\(^&/$%I\%;O46U[XO0^`;W1KWQ+I.G7GA^>WMM5U.SW?B=\#/VD
MHOVA]8\>_`/P'XP^$GB7QO\`&/X0>-?%OCW0?CEX5U_]F?XC^#-&C^&GA_XB
M7WQ__9S\;//JT/QD3X8^$]3\`:%XA^"WA>/6-9F\+_"_7[CXNZ+_`&=+9>'O
MUOHH`X/X:^(O&'BOP?9ZWX\^'M_\+?$T^J>*+.Z\%ZGXD\->+;RRT[2/%.M:
M/X>U>37?"-Y?Z#/%XM\.V&E>+K6SM[I[S1[778=&UF.WUK3]0MXN\HHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHKA
M/BC\3?`OP7^&_COXN?$[Q#:^$OAU\,_"/B#QWXY\3WL%]=6GA_PGX6TRYUC7
MM8N;;3+2^U*XAT[3;2XNI(+"RN[R58S';6T\S)&P!W=%?,/@']L7]G_XEWQT
MCPEXJ\27'B"/7O"/A^[\*:U\*?B_X0\9Z5/X]C\1OX.UC7?!?C#P#H'BK0/!
MGB)_"/B>UTSX@:UH]AX$GO\`0=4TX^)%O[.6V'TX'4C(#=NJ.#SZ`J"??`X[
MXH`=15&QU33M4ADN--OK34+>&]U'39I["YAO8(=0TC4+G2M5L)9K5Y8HKS3-
M3L[O3M0M7=9[*^M;FTNHXKB"6-.5^)7Q(\%?"#X?^-?BG\1]=B\+^`?AWX8U
MKQGXR\1W5IJ-W;:'X:\.V$VIZSJL]MIEG?:A<16-C;S7,D%C9W5W(D;""WE?
M"D`[BBFJZMC;N((!!VL`00&!R0!T([]<CJ"`NX9QSG_=;'.?XL;>WKQQGJ*`
M%HK@OAA\3_`GQF^'?@OXL?#'Q#;>+OAY\1/#6D>,/!?BBPMM0@LO$'AK7K2.
M_P!(U:SAU&SLKY+>^LYHKB)+FT@G6-U,D*$XKN]P./O<_P"RW'UXX_'&>,=1
M0`ZBD#`\\C'J"I]>C`''OTZCJ#7`?$[XI>!/@YX+U/X@?$;75\.^%=)NM%T^
M>].G:OJUY=ZMXEUW3?"_AG0=$T+0M/U3Q!XC\1^)O$VLZ1X=\->&_#VE:IKO
MB#7M4T[1]'T^\U"]M[>0`]`HJG97T%_96E_;BX%O>VUO=P"XL[RRN1#<PI/$
M+BRO;>WO;.<1R*);6\MX+JWDWPW$,4T<D:VBP'9N/16/\AS^%`#J*Y;Q3XX\
M'>"(M#F\8>)]"\+Q>)O$^@>"O#TFO:I::4NM^+_%-X-/\-^&-*-Y+%]NU[7;
MXBTTG2K??>7]QF*WBD<$#IPX/3/KG:P!^A(P?7@G(Y''-`#J*3/&>?R)/7'0
M#/Z=.>E)N&`>0#ZJPQCUR!@>YP.]`#J*\V^*GQ=^'OP5\(OXX^)7B`>'?#W]
ML^'O#=I(FE:YKFJZQXD\6:S9^'O#/AOPYX;\-Z9K'B7Q-XCU_6M0M-.TC0?#
MVCZIJVH7,P2VLY`LC)4\#_&SX8?$:^M](\*>*[6Z\17/A@^-!X1U2QUCPQXW
MM_")\4:YX,@\2W_@CQ3INB^+M,T.]\3^&M=T?3M3U'1;2TU.YTRY;3Y;J`),
MX!ZI12!@03S@9ZJ0>.O!`/TXY[9KFM`\7:)XFN_%-EI$FI27'@SQ+)X2UX7N
M@Z_H\4>MQ:+HGB!X],N-9TO3[;Q!I_\`9GB'2W77?#TNJZ$]X]YI2:FVJZ5J
MUE8@'345R?COQSX4^&?@CQC\1_'6LP>'?!/P_P#"OB'QOXQ\0WD-W+9Z%X5\
M*:1>:]XAUB[CL[>ZNGM],TC3[R]GCMK>>Y=(&2""69DC;6T'7-*\3:)H_B/0
MKQ-1T3Q!I>GZUH^H0I*D-_I>JV<.H:?>Q+-'%*(KJSN(9D\V.-PKA71'!4`&
MM17D&L?'CX6:'\1+CX3W_B2=OB)967POU2_\*Z=X;\6:UJ.G:/\`&;Q#\0O"
MOPXUS4FT;0M0M-/T'Q#X@^%7C_37UV]N8-(T.;PY<OXBO=(@NM.FO/70X(SA
MNW5'!YZ8!4$^X`X[XH`=15'3]4TW5H9KC2]0LM1@M[[4-,N)K"[M[R*#4M)O
M9]-U73YI+:25(KW3=0M;FQU"TD9;BRO+>>UN8XKB*2-;U`!1110`4444`%%%
M%`!1110`4F<>OY$_R%+7\=?_``5O_:=_:0^&W[=_Q6\'_#OX_?&7P)X3T[PU
M\*Y[#PSX0^)'BOP[H-E/J/@+2KR_FM-)TO4[:RMY;V[DDNKMXH5:XN'>:4M(
MQ8_?>'/`.,\1L]Q&18+,,-EM;#Y97S.5?%TZM6G*G0Q6"PKI*-'WE.4L;&2;
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M_@H#\*/'7QV_8=_:[^"_PPTN+6_B+\5?V;_C)\/O`VCS:OI^@1ZIXL\6>!=9
MT70;!M<U6:VTS1S=ZE=V\*ZIJ%Q!96#NMS=310QNX^OJ^=?VO/C;KG[-G[+/
M[0_[0?AOP1+\2-;^"?P9^(WQ3T_P3%J^G:"GB";P+X5U3Q(UI>:QJ=U:0:=I
M<4.G27FL7,!NM432K:]&B:9K&M'3])O?RT_3#\B+7]D']K37_C-X(^(7A[P?
M\9?!_ABQ^,W[)NOZ_JG[2?Q]^'GQ7^/%MIWPG7]IH>*[Y?$G@KQUXMT;4O@M
MX93XH>%-6T/X27GBC4+C7?'VJ^*O$%IX:T6*?6;O7?FGXQ?`WX_?`/X/>`+K
MQEX'_P"$`L;JP_9@^%_QPL_%/Q<L_%?PD_:@^/'PU\6^)?B5\2?V@?CKXEE\
M9Z#X=T#X2^,O#?A37-!O]:^,7C7X5>*?BSXH^(W@[P;XPM[:Y\%>"?#7BK]&
M_AK_`,%1)(OB#\5M(_:%^%?B'X6>`O#?Q8_9W^&.C^,K.W\,:KH7PVUKXZ?L
MJ?"GXXZ?X?\`C'XAL?B-JXU;4[SQEXP\1:!8:]\,-`\1>&="TE_!Z^+;K3I=
M3FU5_I_]DS]OOX"_MEW>O:=\)]1N#J6A>$O!?Q"&GW7B/X:^(;J\\"?$&?6;
M;PIK]ROPS^('CZ/PGJ-U<:%?P:MX`\?2^%/B5X8D-F/$O@[3!?VK2`'X_P#P
M:_9)^-?Q#MOV?/%?PMU[XO2_!KPEX&^&OP\^&^J+%^S[H.L?!_QK\*?VA_BA
MK/QG^(.BZYX@U?Q:UCX"^*5GJ?AUO`'C_P"!$7Q.UGXJ?"WPSHG@GQ[>W.GO
M'XJU3ZZ^`_[&7QP\#?&'X/>,?$W@^Q&@^(?B!_P5%M/VF1J'CJS\2VGBOX2?
M&O\`:+\4_$/]D[PMK.A7^LZK:Z_X=T[PG?Z?)HGAFRM)XOAK#>ZKHUQ%I\FJ
MZ_'J/K/BO_@K7^SCX,T[3M0UWP]X_P!)A\0>-_CWX(\(CQ1K'P5\`+XRE_9>
M^(FK?"WX]:_X;U#XF?&+P9I5YHG@;QM9:5X?LX;G4;3Q#XYU3Q-I%EX!T'Q(
M;'Q-/X?MZ3_P4Q^&M[XY\4>'=`T;Q]\78?$'C?3/#WP8T;X=^`M!T#4==LI/
MV'_AE^VK.)_$'C_XK:/I.LC6?AYXVN=7TG6M7L/AK'I^H[/`=[HMW?Z;;^*/
M$@!S-O\`LZ_'#0/V_)?C1X6^',NH>%_$GQ4GUOQK\1?B1X\\*^)M,TSX6W'P
M0_X0Z;2_A+K/A[6O"GQI\+W?_"4:;H*P?L]>/?`OQ*^!-CJ5QXL^).B>,]$\
M5:KIC:1'\;_V<?C9J/[;GA;XY?#OX=7GBG9XB^`J'Q;X\^(7A?5OAKX1\">%
MM9EM?B@GA>UMM>\#?'3X-^+I/"VJ>)+VU\*^!+7XO_"+XV>*$\,O\4]!T.SE
MUU[?-\7?\%4]$UGQ7^R[H/P.^&/COQ4?CQXW^`WB"TTGQ#X:T6P\0?$C]FW]
MH[X!_M3_`!(^%_Q*^%*3_$31[#PW?:KXX_9X?0-9A^,$WA&Z\(Z)'JVI^(_#
MUE8:IH6M#TZ3_@J=^S]!H_C_`%2X\)?&"UN?A=X3^'/B+Q[X?N_#7AF#7O#6
ML>/_`-JGXC?L=7G@"_M1XRELW\9>`/C'\+O%5OXV2SU"[\-GPU'IWB'PEXC\
M4VNI6JN`?F;\.O\`@GK^UU\'/A!^SOX+\*?"?1KK27_8T^!7PV_:Q\%CXD>%
MM>N?%OQ3^'OQK\$:QJ%UHNA>*_&6G?#?Q]X_\+?#<>,-/\&W'CK4H?A!?:!-
M=^$?$J:UH]EX6\*2ZW@S_@G9^W--IGC[0KWQ+<>#KW1?@!^W!X+_`&<?&NI_
M$+PO<'X<^,?B9^T'X>\:_LTW/]@?#BST;P]X:U[PA\+=6\>Z!H>N^$_"$6B?
M!Q]1O]+\%6D=E#HBW7Z-^)O^"H7P?\-6%CJDWPO^,T^F:W\4_CK\(?"NK7\7
MPC\%^'_%?BW]FSXA>(_AG\7H-%\5?$CXM^"O"BRZ9XJ\-7FG^#M"U;6]+\6_
M%&0WC?#CP[XEMO#/C.[\.='<?\%,OV:X/CY/^SJ=2U(^.K+Q1I_P^U*.76?A
MK97FG_$W5OAM9_%/3OA_/X#U#XA6OQ=DOV\.:CIUE?\`BVU^'-Q\-M&\5:C;
M^$M5\:6NMV^JV^F`&/\`L1?L]?%CX1?#/XSZ1JEUXP^'%SXWU6"7X?>%_$]I
M\$4TWX>ZA:^`[30;GQ-X?\#?`Z35?`>BP:IXA6#6-4LSXOUV^\8:AH[^*];M
MM`UGQ%JMA)^<5S_P3:^-7Q'\(_"WPSX^^!'AM-)\'>*/^">DWQF\-^,_B5X;
M^(VG_'3XO?!+]JGPEXO_`&C/VK[::^UC4E2XUGX&Q_$C06U/Q+'HWQ:^+FF_
M$&[\*>*_"E@GA+PW%>?H+H?_``57^!6L:'X7\4S_``Z^..A>%_%'P_\`V5?C
M)'K^M^&_!$&GZ/\``[]L;Q(?`OP9^+^M?9?B'=W-OX9N?B!#?^$?$V@6UM=_
M$7PY)I=_XHNO!,G@E;;Q#<\]:_\`!8[]D+4=#^('B+1;SQ7XGTSP/I4/B6PC
M\'7/PS\9:]XV\'M\:OA_\!KGQ-HO@_PK\2=8\8>%8;?QQ\3O!=Q::'\6-!^'
M/BGQ'X:URVUSPKH>M+!J-KIX!Q__``4,\`^*?'_[3G[+?@O0_@GK_P`=/"NJ
M_LJ_MZZ;JW@'3?&Y^'?AQ?$DFO\`['%K\-];UCQ)J&H:/X9M-1\-ZI/J&H^'
MY+S58?$^B6\6N>+_``%8:OXA\+II\GSCJ?\`P3V_:[D\#^+[OQCK][\1/'@_
M:H^$GB'QW?6>J^!/%VK_`+0_[/WA+]ASX,?"_P`3:1H_A?XO:]I_PPLM*U7]
MKW0-;^-VM_#GXC7?A:S\;WGA*/Q%KUT=5N/#MM/]K6G_``4<OO$W[5WP1_9M
M\(?L^>/P?&/C#]HCX=?&C4_%GB#X;Z1K7P5\:_`_P1\(OB';V-QI>D^/==TG
MQCINO>"/C'X+\9R:GX5UC6FA\/\`B/1[33[:[\3V_B?0=`]Z^)O[;?PU^&?Q
M$\1>`;KPI\0O$MMX"U?X.>&OBGX]\-V'A0^!?A5XJ_:!UVV\._"+P]XQO->\
M8:%X@FO/%&I:GX>?4;OPIX<\3:5X'TCQ5X;\1^.[_P`/>']0DU&T`/SZ^+_[
M`/QK\<?LW_LT:-XT%S^T9-\`_CA^SI\88O@!\38O@S?>)K'1?A[\2KW5?&_A
M[PS\56LO"7AS5_$DGP[UMO">C^'?$>MZ=X$@TK0;7P[!XGN2EOXBO/(K']BG
M]MK6OBI/XOO_``3:>`Y?'O@O]IGP3\91X7\=_#>Q\$7'C_QO\0?`7BC]G'XT
M>$];LM1U7X[>/K7X/:GH]YX[CU[XO^*9/'WA_6]%F\,>`/`WAW0/$4Z-]Z_L
MO?MT>,O'O[&'Q6_;5_:%^&NO?#[PSX7\5?'75]%^&O@_PQ8^+O&>E?##X0^+
M=>\&0VN_P?\`$7X@1>._%%Q>^%-8_MC6&A^'MG#J\>J11^&K+P;I>G>,]=K^
M+O\`@K!^SGX$\(^!_$GBW3M;T;4?B%/\0Y_#'AR7XC?LRSQZOX7^%-AX(OO'
M7C;0OB)!\?W^#7BW0]-E^(?A31=.TGPC\2-;\<:[XFU&?P[IGA&34=&U]=*`
M/)/VM_!_QP\&?\$I]?\`!.KZ+KE_\</#WC+X+Z/X@O\`P9XCU=M3^*?B2#]L
M3X9'Q)\5;#6_##:GX@\)V_QL@DU+XFZQ:E'U'X<VOB_5M(U)/(\-S2OYWX>_
M88_:)UKXS+XGT;P\?@3\(SH?[;^L_!CX?WOQ"TWQ98_LT?$?Q[X:_8JTCX"^
M(+OPOX>\0:QX=U^XG^,'PB^.W[1&C^'_``_=>(O"?PTU3Q1;A);/Q3K#0VEW
MXC_\%5/&6A?$/XA1>%;;P#>_!C0O$OQKN/#'C6'P;XHU_P`3WGPS\!?\$H?@
MW^WYX3\4)X=N?'G@NWUO6[_QC\1M2L;K1)[[PG%JO@R#2O#OVSPYKQO?%`^K
M=%_X*8?!R*=;+Q7X9^*=AI.C^-K/X1>)_BBO@K2(O`O_``MF?]E/0/VOK7PW
MI>@:;XX\3?$&[?Q#\*-8FGTA-'\/^)+2S\56@\%:AK!UC4-&EU0`_.Z\_P""
M</Q<^(4GP0_M_P#9U\-^&?!G@+XR?\$_/$?C?X:^+OBAX:^)$>N>.O@EXH^)
MMQ^T_P#M,V.I3ZUJMO>W'Q`\&>)_"'A66\OYK+XI_%ZVT,ZGX^\,:3J&BZ/!
M=<7\//\`@F=^T'X:\[Q/\0/@[J?B?Q]\0?V0/'OP&\0^-_A_\<O`GA/XK>!M
M=TS]K_XT_&;3TNOB3XG7Q"U_I'Q(^#?C?PGX(TRST[2_%FBWK:7/\-?B9;>%
MO`NIWGB+3/V<_97_`&R_#G[5=[\3AX<\`^*O!-A\.K#X6:BEMXMU7PAJGB;6
M['XL>`T^)?AS5$TSX>ZYXU\-:;IMYX2U'0IK&VD\;7GBO^U9]9TSQ!X4\,KI
MFE7?B/P+3_\`@K;^SA?:UKGA/_A'?B')XZT;7O@9H<7@30;_`.#OCOQ/J'_#
M07Q@T;X$>![F2/X=_%SQ=I'AN\L?B7XAT/1_&'A7QGK'AOQCX8L]5M-6O=":
MQ2]DL@#JOV--%^.GP3\/:-\*/&7P'MO#GA/Q9\4?B??>&+[P[J?@W0;GX<_#
MJR\">%];TK4OB;\/_"OQ`^(7PX\->(?%?Q)D\5>&M+\+?`3Q#)X#L-'/AWQ/
M<:#X;U;6O$^F6?S#J/[#WQS\<?M;ZMXH^)/A.+Q-^SUKO[8W[3_Q.UO1M4^(
M\5UHVL_"7Q_^PG^SU\(OAW#JGA"WUR*XO-,F^,_@3Q:R^#I+;;HFHV%KXVFL
M+9KNRU-O2_CC_P`%4-"T'X`_M*>,/@C\)OB1XL^,W[/OP(_:2^)'CSP=K>A>
M$;[1/@9XK^!NI?$WP'8Z=\;'TGXGV`UG2M?^)GPO\3VUC:?!_7/'&J:WX*\/
M:[XPL)K/1HK2]N/U<T"_FU31-(U*X6))[_2].O9E@W>2LMW907,JQ;F=O+#R
ML(\NQV!<LQR2`?SP>%OV(OVQK[]FKX@>!?C?\)IOB[^TOX^_9&F\#>'/CQJO
M[0VGVP^&TE]^P%%\#=6_9^U2S.O3S^-9[[]H&#Q/XCU*6XL[CX4^-F^(TGQC
M\5>,;;Q[X0T[2W[3Q!^Q3^VY/=MX-\`2MX"GOOVAM7^/NA?&M/B9I;V'PX'B
MK_@D;KW[&FCZ%:^%+/4)O$5]JWPZ_:/@TOQ?>+8:>?#W]@W>D>-_"\VL>)TU
M/3-!_H"HH`_GR\,?L.?'RT^-GA#XB?#[]GB+]G[P-:^+/^"8_P#PD'@^/XXZ
M#XGU*6T_9G^)G[8WB/\`:`\0WM[IGB/48]4L-2L?C+X"O;6"2^N=;^)S/=^(
M?$^D6GBV36=-M/E;XB?LT?M&_LH_L]_LVP>+O#QTS3-=_9C_`&)_AK^TA!KG
MQ2CUKX;^,?VG?@_\4+#QMXR7]HCQ'?\`C32-`G^&E[\+/#OC#P3KGCCQ1XV\
M%^!_%B:CX-^&9\82/<^#O">H?U;4A&>N>N>"1_(CCVZ'O0!\*_\`!-JV\-:9
M^Q[\+]`\)P>+(]&\-7?CS08[CQ7I_AJS34+RR^(?BF74[WP;=^#M9\2>&=>^
M&+:C=75M\+_$6E^)O$QUCP%:Z!<ZGXDU[6_[3U6Z^ZZ0#`QS^))/YDD_YQTI
M:`"BBB@`HHHH`****`"BBB@`K^1G_@JU^Q3^UG\9/VX?BA\0?A7^S_\`$7QY
MX)UCPY\,+73/$_A^RTF;2KZXTCP+I>G:G#!)=ZQ:3L]E?0RVLX>W0++&P4NN
M&/\`7-32JDY*J3ZD`G\\5]WX>\>YCX=9W7SS+,%@<?B,1EM;+)4<>L0Z,:5?
M%8/%2J1^K5Z%3VD98.$8WFX\LY7BW9KXGCW@;+^/\FH9+F6,QN"H4,QHYC&K
M@705:56C0Q6'5.7UBC7A[-PQ4Y.T%+FC"TDKI_P3>$?^"<7[=]EXM\)WMW^R
MI\6[>TLO%GA>]N[B33M!\NWM;/Q!IMS=3R%?$#$1P6\4DTA`)"(Q`)P#_>RH
MP/\`@3'\V)'Z4;$_N+_WR/\`"G5Z?B1XHYMXESRBIFN79;E[R>..C167+%)5
M?K[P;J.M]:Q.(=X/!PY.3D5I2YKZ6\WP]\-,J\.H9K#+,PS''+-I8*5;Z^\*
M_9/!1Q*A[+ZMAZ'Q_6I\_/S?##EM[URN.^(?@'PG\5O`'CCX7^/=(B\0>!?B
M/X0\3>`O&F@3SW-M!KGA/QAHE]X=\1Z//<64UO>00ZGH^I7ME)-:7$%S$LYD
MMYHIE21>QKYP_:[\0_&KPI^S9\8?$/[/&E7&L_&+2?!E]=>"K2PT:#Q)K$-V
M+BTCU/5/#OABZAN+7Q7XJT+P_)K&N>$_"EW;75KXH\3:=I.@7-K=0ZB]M+^8
MGZ0>#Z-_P3M_9N&D^(_#.MZM\0?B'<ZS\9_@9\<O&MYXV^(/_"1:WK?C7X$^
M"_!_@;X:VWB;R=.LH+CP[)X&\#^'-#US0;G3XH/%FFV]S/JDEU<ZC>W<_P!!
M?`;]F[P3^SSIMUHW@SQ#\1=8TA=*\/>%_#VE^.?'>K^+;#P;X,\(PW-OX6\'
M^%K2\$,%GIVC6MW):G5M0CU7QCK5M#I\'B7Q1K<6DZ4ME_/K>>)OVI_`'[1'
M[17C'X(ZS\;M2^!OQ7^(GP1/B3]HCXB>"O'G@?Q_XFT_P=^RMH>C_#ZSM=0\
M,_L;_&+7)?#E[\2/^$OL-8\41?`"U&J>)?"V@?#;5/$.D67B2Q3Q9]A_$GXN
M?\%(_#W@CQ=X-\%6&O\`B[XWS_L^^!/VJO#_`(ETWX7ZS9>`X[Z#X,:5\,?B
MI\!=&L-;\#3:E'XJM?CRG_"\O"'PUU[2KKXC7OAS5+[PE+I%]:Z?_8*`'W3>
M?L*_`2TT7P9X=T/6OB%X$U[PYXU_:'\6>$_&'A+XD7V@_$#;^TW\3=8^-7QV
M\'VVM-%</>^#_%GB^_AU>314L)+KPVGAWPS?>'=1T;4O#MCJL>O#^PE\`;?X
MJI\8H+/QB/&$7CW4/B-%)<>.M<O[`>(]0_98\.?L>7#S0:E+>7-Y:_\`"F?"
MVE6OEWU[=3R>*%NO%ES=3ZI=SEOQR\4>(OVU/$]S^SW\4/#>C:[\8?B%\,/'
M/[=&K?L]7MWX4^)7B)(]3;_@G5XWB\$Z-X]\7^/OV=?V71XEL-?^.ES-H.A:
M[+\.O#FB37.K+\,%\2:QJFA27,7=^(OVF?CMX:^(_P`&/"Y^/?[4$O[,7Q+^
M.ND>";KXS^+_`($0>&?CWJ4TO[%_[87Q0^,_A#0?!3?`71=9?PIX`\??#3X)
M^)(O%FG_``JO[SP7XCU_Q[X'M=2U#1?"LMKX6`/T0B_X)D_LRV;_``<O-+'Q
M+T77/@#\'/@5\%OA'XDTCXE:W8:]X/T']G'PS\9?"GPJ\06UY%'Y6H^+]'T;
MX\?$6WU75=8MM0L/$R:G;0^(-&U"RLQ:2S>(/^"9?[+WB'2M,TBYL_B-;6_]
MBV6D^,KBS^)_BE-1^+%SIGQMO_VDM*\0_%34;JXN[OQGXFT_X\:]XN^)\.KW
M,MK)+KWC7Q7:WD5UH&J+HUM^<?@_XR?\%']9DL]0\9>(/C;X>U30O%W_``3#
M\/)I,'P:\/V-IXC\+?M'_&GQK\*/VA?%WB_1;OX:3'3O%.C_``4E\&_%CQAH
MNC7.C:5\!_B<TE[XBTVU\-V5]X0?$NOCQ_P4R@\:R>#8M;\5:9X?\$^.?C5\
M._@SXV\9>`/'LVH_&O7OA[^U[\=?AYHUU\5O#_PJ_9$^)]AXOLU^`7A;X17-
MI&OB7]G'1?&FB^+M;^+NB>,-1>UO=<\"@'ZZ:S^Q#\*=0^'`^%VD>*_C!X/\
M,R^./CWXXU:'PG\3=7L%\23?M*_%'Q7\7/BYX?\`%6D7MMJGA?Q-X=UCQ=XQ
MU<Z%;ZSX=O-6\$Z<\=CX,UG0VDO;B]7P7^PM\"?AKX@M=4^'*^/?`WAFWTO0
MK2X^&OA_XA^(X/AWJVK>%_AEI'P;T#Q3KVBW<]WJ.M>(-/\`AOX=\.^'9SJ6
MMSZ+K-QX?T;Q+XAT35_%VGP:\OY+_'#6/V]?B7X7^-G@_3/%?[0=Y'\7?VB_
M^"F7[+^@>$=!\$Z1X6L?#?P<\*?LU?'OXA_L[^*_"WB2'P%:^(-*U;5_BGX'
M\$>!/"GQ1U+Q4-"\0Z+XTE\*6_VW5[[0=9M?IGQ;\0/VAO!7_!./]D_4_P!G
MO5/B)XBU(W7PB\'?'/QU\0-.\:Z;\6/!WPUTKPUXATSXG:SJ$:_`CXC^.]%U
M[3?B!H>A^`=9\1Q?`'Q9J?A;POJ>K^,4TVVATEO&6F`'TZW_``3:_9H;P3IO
M@#[%XY70-)_9Y_93_9DL@OCK4OMR?##]CCXB:C\3_@M"]XT#/+X@M/%6IW,O
MB;7Y$-SXIL?+T^_C6&,$V[O_`()V_L_W_@;QA\,+F^^*3?#/Q+/X?;2/`$7Q
M-UVW\(_#O3/#WQ3\-_&6ST'X?:-;K'!HNC-XX\)Z+/##J1UR\T?P[;MX,\-7
MVA^$)6T4?+OPJ^+?[8*^+?V7F\>ZOXY\1_#WQ+&-*_:$\0:'\.O$5E#X7DU/
MXK_$:P_96U*P_P"$Q^#_`,,/&=\WQ/TJWT[PM^TYKW_"M/#%IHFE:;\-OB!!
MX6^%'AOQ[J=^_P`$?"G]K;_@H1\0_P!FGX(_$_X7>,?BS\5(?B!^SQ^SKXL_
M:H\6>-_AC<>"+/X-^)/$?C/P1;>(=7^!NK^$_P!G7QKJ&NQ^+?AE<^+=0\;W
M_A;P-\<X/`?AVUT;XN6&EZ;?:BPO@#]PS^P[\$H/BT_QQTB3QQX?^)\WQXUS
MX_S>)M&\8W4$EQX@\8?"_P"%/P>\=>$)K"ZM;S39?AOXY\#_``6^'MEXB\*-
M:%GU'11K>DZII.K3&Z3<\=?L<_!CXA_%5OBOKL'BR'4=3U+X8:YXY\):-XQU
M?2/A]\3M?^">O1^)_@]KOQ%\'VCBR\1:I\/->@L;[29UEL(]8ATK0M)\7P^)
M=$\/Z'ING_D7XH^,'_!0IO`OBK6;#QW\5DU#P#_P3R_:X_:%\#OX$^%6IZG9
M_$#XT?";XXL_[-OA/Q%=?$O]G7P-XH\7ZUXC^&\4&A^(_#NG?#/X>:I\9]'D
M'BWPYX?T:WU""[EUOB/^T/\`M^>&O&?[0MC\)1\7OBU\0M2\._&.^^'_`(6B
M^%FM>'O`?P?T^S2RUKP+/X@\"^*?V:RFN7OACPW!XET;X:>./AA\?_C))\?_
M`!LWA_\`X2'X+>1J]QHG@D`_8'P!^S+\-OAG\!I?V=_!][X[T;P'(?',D.IZ
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M[PYKNK^&M,O]6T3QKI7AS_B0:;XJTR_GN+3Q!8:*%TJSU6*ZMK".*VBCBC`/
ME7QY_P`$W/V9_B+K7C;7?$6G^/'O?'UY\1;W7OLWQ!UY%:7XH?LB^$/V)?%'
MV:2Y:[NTW_`WP1H5G92W%U=7-MXL2\\8/<7&K7UP6R?B%_P3G^%.O?#3QAX2
M^'WB#Q3X!\9:G\4HOCYX+\;WNJ:AXJM_"'QRT3]EO3?V3?!OBR[\/-?:*VO>
M&]"^'6AZ-<7W@U-9TB/5M=MKC6H]7T[4KE;B']#J*`/SP_8Q_8]\7?L^^"/B
M#\-?'&O>'KSX4>*-#TSPYH/PC\.:KXB\3:+HA2+Q/I_C+Q5)XW\3:-X9\737
M_P`1-$U;P]I>H^'#!<:?X=7PI#>:9K=]>ZM>7"1Z%_P3$_9JT2^^'6I/<_%C
M7+SX3Z7\%O#'P]D\0_%'7=5C\,>!_P!GCXS^!/CI\'?`EA:/#%9CPUX.\9_#
MKPY"%EMY-:\0:"EYIGBG6M;EN1>Q?HG10!^>'BO_`()C_LT^++'XMZ;/)\5-
M$L/CV?CK9_&FW\*_%'Q%X<7XF^&OV@_$GB;QCXU\&>*WTT1R7OA;3/%/C'Q/
MJ_@NRA>VO?"@U_7]'L=2D\.^(M?T;4_T#TZQATRPLM.MC(;>PM+6R@,K^9*8
M;2".WB,DF%WR&.)=[X&YLM@9Q5RB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`;M'OV_B;/'OG/U]>^:7`'X#&.V/IT_2EHH`3`
MQCDCGJ2<YZYR>?QS7/:OX0\*^(-5\*Z[KOAS0]9UOP+J][X@\%:OJFEV5_J?
MA+7=2\/:UX2U#6?#5_=0RW6AZI?>%O$GB'PW=W^FRVUS<:%KFKZ3+*UCJ-W!
M+T5%`"8'OV/4]N?7OW]>^:3:/?OGD\YSP>>1R<*>!V`IU%`"8'OU)ZG'/J,X
M(]`>!V%&T8QSWYR<C.>C9W#J1P>!P.*6B@!``.F>W<]CGU[GK_>[YKGO"7A#
MPIX!\,:#X*\#^&]"\'^#_"VDV6@^&?"OAC2K+0O#WA[1--@2UT_2-#T;3(;;
M3]*TRQMHXX+2QL;>"VMX42.*-%4`=%10`F!TYZ$=3W_'K_M=?>C:,YQ^9)`/
M/(!.`>3D@9.>32T4`-VC&.?KN.?^^L[NPXSV`Z"G444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
-10`4444`%%%%`'__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>biib-2015630_14rdpiechart.jpg
<TEXT>
begin 644 biib-2015630_14rdpiechart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`$Q`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*\Q^
M-GQ&_P"%/?!SXK_%G^QG\1?\*Q^&GCWXA_V!%>?V?)KG_"$^$]8\4?V/'?\`
MV6]^Q/J?]E?84N_L=W]F:<3_`&:X\OR7].KS?XQ?#JQ^+_PE^)WPGU/4;S1]
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M/[&4/_"/_LX/\,OBIXB^%WQ)_9G\!:A\,?!GQ'TSPMX0\2/JG@OQ+X%\&^`_
M&6G:_P"$O$5E/H5Q>:K!\/O!7B/2M1@>&;0?$WA;1_,36/#+:UX8UK>_9._8
MS^'W['\/Q&TKX;ZWX@OO#GCA_@[#8:1K_P!@GF\-Z;\&?V?_`(9_L_Z):1:E
M9V]J^K7&K:-\-++Q)K-_=6ML\FNZOJ26UO!8K;0H`?)7A[_@K[\']:\>:+H.
MH?#/XN>$O!LOB?\`;P\(^)/$_B;X;_%%?$NF:C^PWXV^&WA'Q!J?A_X<:+\.
MM7\3>+O#/BFU\<:OKVIZOIRQ'X;0>$[_`$KQE!;ZO_:%MI7W#X;_`&O/V?O%
M_CO2_A[X8\=OKNJ:Y>Z9H^C>(--\+^,;GX;ZMXFUGP#:_%/2_!6F_%A/#_\`
MPK.]\>W_`,-KVU\=6W@:W\5R>*I/#$Z:H-*\K<J_,FE_\$VO#&E_%;Q9X^B^
M*_BN;P[K`_;9N/#G@N?P]X>W>%]1_;UUKP-XP^-DS>)H9(KW7K.S\;^"SKW@
MFSOM.MIM%L];O=#O[_5[2TTZ>WP/V=O^"5'P5_9Q^(O@+QWX9NO#FMR>"8/"
MFM"[\0?!?X0W_P`0]2^(OAOX-^'_`(+WGB6W^,%[X<O_`(A>'?#VNZ5X?C\6
MW/@SP_J=D=,\7W^I1Z/XELO!%Y/X+D`/2_VAOVW[KX*_'C2O@;IWA#X;SZM?
M?#KPW\1-*N?BW\==#^!5Q\69?$?B_P`3>$9/AK^SP_BGPKJGA3XE_%3PVWAR
M#5/%/AO7_&/@*TTB'QA\/;>74C;>*I]7T+NO#_[;/P@G\9>/O`OBGQ+H>F^(
M_#/QE\9_!_PWI7AV#Q]XBO\`Q+KW@RV^#9O_``\\=Y\/_#]O_P`+%%U\:O"T
M[>"O"MUXPM[CPY+/XET?Q#J]AH?C4>$J_P"U'^R/JO[2^F>,?!UY\:O%7ACX
M6?%3P%_PK;XH_#&[\'>`/B%X9U+0GCUVUN?$/@5/'.C:A)\//B#>:;X@N--N
M?$=NGB#1GCTW0=23PE'K^D1:Q+Y1/_P3=\)?V_KGB72_BOX\TG5(_P!HO6/V
MJOAO-##8WA^'?QJO?"7PJ^'.E^)3)J-Q=S^-(-*^&7P[\1_#NXL/%$LR>(?#
M/Q@^)PUZ6[UC4=$U;0P#UGXQ_M=Q_![]JO\`9I_9WU3P,+WPK\?]!^(\^J?%
M5_$AL8/A[XK\/ZIX+T+X:^';[PR-"O#K%C\4?$7B:Z\+6^MKKFE_V%XF'A?3
M/[.U=?%'GZ7X[\'O^"F/PX^(&J_'Z'Q?X1U[PEI/PT_:1?X$?!__`(0_3?&_
MQD\9_M!:+_PI/PG\;[;XA^%OAQ\/O`-_XOL;*?PKK>LZY+I=CI_B.VT[P7I&
MG>+M2URUCUZ#3;;V/]IW]C#PS^TY=:OJ&K^/_&W@/5;KX)>+?A+X?U[P/)IU
MGX@\%:YK/Q/^$_Q>\)?%3POJ=[!="T\;?#CQU\'_``MK?A;[1:W.FF\C:6^A
ME$:QOY5_P[G\,^%O'>K?%#X.?%'Q+\*O'UM\1O#WC?X?ZG9>%_"_BK2/`F@Z
M=^RG\*OV1];^'R^'_$,4MGXA\/:YX%^$7A/Q-%=7<UCK.C>,]+TRYMKJZT&'
M5-!UT`]6T_\`X*"?LF:QX@TWPYH?Q1EUZZU2?X3VUMJF@^!?B/KGA9+GX[^$
M+/QO\%+:[\7:5X1N_#-A=?%G1M0L[7X=6M]JEM=>+_$]Q#X*T6&Z\72IHS?(
MWPF_X+(?!3XD0?##Q=KOP^^)/PR^%/Q$_9B^)7[2M_XL\7>#OB#<^)/`NB?#
M'XX>&_@[X@/B[P/H'@'4K[3?`6GVOB#_`(377?B[<WUOX&\.Z+:2?VC>"%;J
M^M/0O!7_``2W^%7@#0[SPOX5\?>.+;07^*G["'Q1L;?4;+0[R^MKS]A35?A]
MK7AFPNKZ.TL(M0;XE:GX"%_XUOTL;(V=WK^IMX?LK*WBLK6'F=!_X)/>!]#\
M$?$+X<)\8/&5SX3\2?L@?M*?L4>#H)?#GAQ-5\$_"']HGQDGC8W%WJ22^5XM
M\5^!+^6^T_1]6O+#2+?6M)DLEURPDU.UN=3U$`^Z/`_[4/P9^(_Q%U_X8>#-
M>U[6_$/AS5?%WA^_U6'X?_$*#X?W'B7P!>P:;XZ\+Z/\4KKPM!\-M=\3>#]0
MN([+Q#X?T?Q5>ZK87<5_;FUDETG5TL(=3_:L^!ND?$V]^$=]XKU%?%VF:LGA
MG49H/!?CF\\'6'C:?P;_`,+"L_AU>?$6T\-S^`+;XF:AX',7BK3OAU+XE7QE
M?:+=:?=6VC2'4]-CO/%/`?[#6F>"?VC;'X_1_$W5Y+C2CXCG32-`\!?#SP#K
M7C)?$_A&#P=_PCGQF\=^!M%T35OC3X(\&V=M:ZE\.=$\<Z?>>(/#.NZ9HFKZ
MGXQ\2W>CVDAYVX_X)Q_![_AI7Q=^T3IT/A6UU3QOXUN?BIKEMJ7P;^%7B3QI
M;?%"X^&ME\+7UCPQ\9O$7AR^^(_A;PS-H^E:7K\OA30]3@N8/%ME)?:'XET3
M0-5UKPWJ(!W'A[_@HK^R1XK\+0>+_#OQ'UG5=,U71/A%XE\(V-M\+OBR?$WQ
M)\/_`!W74Q\)]9^$_@]_`Z^*/BMIWC"?0O$-G:WGP]TGQ';6%YX;\10:S-IH
MT/49(.'^$'_!2SX$?$/0;_5O%<VI>!+FW^+OQW\`):0^'O'_`(KL]"\%_"']
MHOQ[^SMX?^*?Q3U?3?`MM:?!7PY\0?$?@6\:R/Q2_P"$9L]*U>/7-`_M74CX
M4U_4;/@;#_@EQX4\/2?L\:_X2^,/C#0_B!^RW^S9^SG\`/A!XPE\,^&-633+
MW]G3_A,;#3/'.M:!>%=/UF3QSX5\?^+O!_C'PQYME9KHVLR7?AW5M$UZSTW5
MK+E-._X(]_!BQ\8'QUJ'B:P\;^*_$?B[QGXE^)'B/XH_!#X&_$[6_$<?BO\`
M:!^)'[1L7_")3>,_!VK:7\,-=TSQC\5_&N@MK?A?1YK+5/!VH6=G=^'4U_0M
M`\2:6`?1VH?M[?#F\_:2^!O[/'@/2-6\9R?%GQ[^T+\/-9\<2Z3XT\,^%O#N
MN_LZ^"-5\0^,8/">O:UX+A\(_%5]-\6:3=_#SQ0O@WQ7<1>$/$EKJ-IJ4TM_
MIMSIZ[_QR_;7^'W[._QS\)_"_P"*-M_8'@GQ!\"_''QAU'XEB75M4;1=0\.?
M'C]G'X">&O"(\(Z'X?U34=0'BWQ/^T3HSG7(KR*+0_[+"WEA+8WESJ6E\-X$
M_8`T3P'\7/A)X\L/BOXPNO`WP"^(7[0?Q`^#GPHN-!\*1Z3X6G_:7T_Q?_PL
M/1M1\4VUG%XE\2Z=INN^--8U#P1)J,L=[H6E2G0M5G\1NMOK%M-\>OV!=`_:
M3\6_$[Q=\5OB?XIO+GQ#\+IOA/\`">U\/>'O#&BP_![0;GXE_"[XU7&K0R2V
MVJ7'CWQ')\5_@Q\-O$`G\2/;Z,NC^'%\.C0BNI:MJEZ`=CXL_P""A7[)W@S6
M/$7A[6?B-JTNO^%-;^,V@:]HFA?#3XI>*=6LKW]GJV^&-_\`&F==.\,>#=7O
M+O2?AWI?Q@\`ZQX@URSAGT:+1]6N]3M[ZXM=$UJ2Q]%\/?M:?`3Q9\0[3X9^
M&_&\FM:[J.HV^@Z7K6G^%_&%Q\.M6\5W/@:'XFQ>!](^*Z:!_P`*SU3Q\?AY
M/'XV;P/8>*[CQ0GAH3ZF^EK':W:P?)WAW_@F5X5TKQ;XR\=:Q\7O&?B'Q3\0
M-&_;.L_%=[-H'AS3K:ZUC]M?0?V=-'\>:K865G^[TZU\*2_L\:3/X/TA9+B.
M.U\07ECJ][J$FG6^H7,?[.__``2Q^#'[.?Q.\'?$/PS/X;UB3PB-(\017&M_
M!?X27?Q#O/B)9_";2/A)JWB%/C)=^'K[XBZ-X<UJPTN;Q6?!NAZK8MI7BK5M
M4M-.\2Q^`[C_`(0<`'J_[7'[8'B3]EN_T:]E^'?@CQ)X5U&/0(-*L]:^-V@^
M#/BW\7O%6L^(&T>\^&7[-?PE/AGQ%J?Q8^)NC6$^DZP_A[5]8\"6.M2Z]HFB
M:'JMU//JVHZ'F:9^W!<WOQ)TV"[^&^GZ=\`_$/[3OB_]CGPW\5Y?'J2^+;SX
MY>"9?%&@ZE)J/PTB\+&QT[X>:G\2O!?BCX4Z)KL7C^^\5S>+++3M0U#P38^&
M-8&K:?VG[27[)^L_M&0^*_"FJ_&_QEX<^$?Q+\)VW@CXE?#2W\*^`_$,4^B1
MF]CU*^^&_BG7]%N=?^&'BGQ'97D=AK?B&R;Q"UM_9FCZUX3L/"OBJP'B&7(M
M/V)]"LOBG:>*7^(OBR\^%&D?'/Q)^U%X?^!LVD^'&\/Z7^T%XKL]<75_%G_"
M7"P?Q5=>&!XD\3>(OB3IW@FXF%M9_$S6[KQ!+K-YHEII'A730#Z2^+/BWX@>
M%/#%E<_"_P"&Y^)_C'6?$&B:!IFCWOB>R\%^&-'@U2>0ZAXL\:^)Y[#7=2TK
MPIX>L()[J_\`^$;\*^+O$VH7DFG:3H_AZZFOWNK+X6T#]OKX@^/[R'X??#'X
M":#XJ^.&@/\`M+7GQ"\'WWQC71/`D&A?LO\`Q)T3X3^)M1^&OQ%7X=:G>^/)
M?B!XZUZ+P[\.UUCP3X(L+75O#_CG3/B'J/@[4O"4MEJ7OGQ/^!/QW^)W[,_A
M/X/0?M0^(OA]\4TTWP19?$OXW^#_``)X836O'4>CVL2^/--LM%LKGP[;>![7
MXASI+:7^K^!;[PYXD\.:7<7:>#=5\.ZG):ZG8>1Z1^PGXHT+PY\/3X9^.T/P
MU^(OP^\#>/\`X+Z;XO\`@_\`!'X<^!/#B?`?X@ZIX;UJ?X?Z=\-KZX\5Z%HN
ML^#]9\+:9K_@/QQ::C+>:1KS:C<:UHWB72M9UG1=0`-'1_V_=&\8?%[]C+P1
MX&^%/B[5?AG^V-\-O$_Q)\+_`!HUW5-#\/Z)IMIIGP<T[XRZ'H&D^&[>?6M<
M\5:S=Z#?_9?%5X!H7AOPG?>1I]KKGB75VO\`3-*Z^Q_;&@UK]M71/V4=!\!R
M:EX5U'X6?&WQ7>?&7_A(EBL%^(_P-\2?`G2?&'PTT3PTFCSKKL.BZ=\>?#C^
M)O%B>(K.VT+Q5:W?@J/2M2U73_$,FA>8>*_V"O%X^)O[*GBGX1_'Y?A9X!_8
MX\+?\(?\&?AI)\(-"\;Q6F@ZG\.-/^$_B:TU_P`7:KXPTS5=7?4?!FG00Z3,
MME:3:-JS2:G<MK:-]CKI_"/_``3>_9_^'?[2OPK_`&D_A_=?$WPSJ_PL\+_M
M`:%I_@E_C'\9/$G@C4-3_:&\7^"O&?BS76T#Q5\1M:T?2XX]:\,ZSJ$_AC2]
M*@\*Z[K'BJ7Q#K.DSZWX:\*7ND@'Z!44?Y]?YT4`%%!('4XZ#GU)P!^)X'O1
M0`4444`%%%%`!1110`4444`?&'[<7Q_U7]G[X9^#=2T#Q+IOA+7_`(A_%+0/
MAKHVN:SH/A;4]*MKC4_#_BSQ+=K=:W\0?B7\)_AMX+EDTSPI>C3_`!-X]\5S
M:0VHK;>'M*\,^+?%>O>']!N_RT\%?\%2_CCK6A_!CQUX^UCX1^!/#TESKOA_
MXA>%O#>C>%?'OQ'\1:YX+_;!^+'[-GB+7D^'^H_';P/XOO?!'BOPKX"T'7?A
M_J7[-EE^T%KMOXYU;Q(-<\,:GX4TWPIIOBW^@S4M,T[6+.;3M6L+/4]/N/+^
MT6.H6L%[9S^5*DT7G6MU'+!*(YHXY8Q)&P26-)%PZ*PJR^'M"GN+"ZFT;2I;
MK2[R\U#3+F33K-[C3K_4#(;^]L9F@,MG>7IFE^V75LT5Q=>8_GR2;VR`?EE_
MP4D_;9^('[,+6NC_``HUCP[%XVTWX)?&#XYIX6\5^&O"D6G^.(OAA_9B:;X8
MLO&/CSXN?#:VN9-6OY[C3M2\&?#'P[\0_BE=Q7NGZO9Q>%[*.Q/B7@_VX_%_
MBGXW^&?^"6-]X<\!ZCXPM?CO^T/8>(?$GP=M_C'XF^#FF>*]'U3]A3]I+XH0
M>'_$'CWPS&M]-IWA76]/TGQ/;:?=:?/9ZQK'AC3%FMH)C%/!^R%]I&E:G)9R
MZCIMA?2Z?-)<6$EY9VUT]E/-;36<L]H]Q%(UM-+:7$]K)+`8Y'MYI8&8Q2.C
M2_V?88L!]BM,:6P?3?\`1H/]`<6LMB&LOW?^B,+.>:U#6WE$6TLEN#Y,CHP!
M^"7PM_:<_:]^`WQU\!?LA>/4\,ZJ?!_CCX*^&Y+KQGX^\"ZS>^/_``+^T/\`
M$#6/$.IS>&OB#\5_C1X%^/7Q!M?V<O`OB#3OA'X%\0^%O@3X^U+XI>+/@]XJ
MNOB)>Z-=^(=GA1OP)_X*$_M'?$G2_@SK?Q'^)_[/WP:L/B-\,XOB]H-[XL^'
M/B"31?BMJ$7Q_P!=^!-S\#?`DUOX]M]9N?%6EZ3X?TSQSXHO]`TWQ!XAM]:^
M+?P_TW1O#4OAW0=6_P"$I_>R;2M,N+^SU6?3[*;4].CN8=/U"6U@DOK&*]$8
MO(K.[>-KBUCNUBB6ZCMY(TN5CC6<2!%`K_V!H@33(_[(TOR]&N6O-(C&GV83
M2[MDGC:ZTY!`%L;EH[FXC,]H(9C'<3H7*S2!@#^>SQ!_P5(_:KL_A[^UC\0(
M/`_P[\-ZK\*/AI^T=XOTWX=>+]2^%=QK_P`+=?\`@U\;O#GPS\`:#XE\->"_
MC[XL^+_B&#QCH6JW-W\0]0\>_"[X00:%X@N-&N/!!U+0[Z.VFZ7XL_M6_M(>
M$OVOOAAX1\:_'O1?"/PP_9Y_;%^+'PI^+^L>'?AC>:5X:^,OA;QA_P`$\_#W
M[6'PG\*>(_#H\;>(+Y/%.GZ]XBU[X>>#=(T"\O=6\<:]IV@:YH>CR^+;8Z;>
M?O;)X?T*6759I-&TJ2;7$MX]:E?3K-Y-7CM(S%:)JCM`6U!+6(F*V6\,ZV\9
M\N$(GRTZ[T'1+X3"]TC3+L7-_8:I<"YT^SG\_4M*:V;3-0F\V!_-OM.:RLVL
M+R3=<V36ELUK+$8(B@!_.+!_P5M^-MI8>++74/$/PMD\/:GX,_98^)^A_&2X
MT3X>RQ^$/#'QM^,OB'X9?$31X/A[X&^/_COPQ=^)O#6E6'A_7/"_@KQ]\6]!
M\8Z,^IZK'XJ/BC4H?#_AG6N[^&'_``4/_:Y?QG\%_A_XFTWX?:_JNJ:%\`-=
MU/4KWQA^SK9:-\<9_CU\6/&.B^-IO`VO1_'?PQJMEI7PJ\-66F^&_"/ASX*?
M#O\`:%N;+XB:5JG@CQ]XV\3M;#Q+??M!\5OV<OA7\8-(\-Z;XCT?4-$OO!7B
MR?QYX'\4>`->UCX>>,/!OC2ZTKQ'H=YXC\/^)/"%WI6H6M]J&D>+O$MAJL-P
MUWIVK0:U?'5+&\ED25.A^&?P7^'?PE\-Z/X9\'Z%LMM%U7Q9X@M]5UR^OO$_
MBBY\2>/-:O\`Q'XW\2:CXJ\07&HZ_?:[XMUS5+_4M>U&;4#+?RW)A8+:106T
M0!\1?MT?M6_$3X$>+-`\+>%_&OPK^#>DO\!OCM\;;;X@_&+0)/$7A_XC>.OA
M!>^`X/#?[/?AFVB\=>!GMO$7C*Q\5:MXBU-].N-9\7W&AZ.(O!VBRW$.L:CI
MWF_[`D'Q0^,7Q5_X*)_$CX\^(]=U&XUKXM?#WX1:%\+]8M=8T&_^"O@35?V0
MOV=_C/J'PF@FTWQ;+I<$WA;6_CAK?AW5]0TKP]X>\0ZAXJTG7?%NHZM+?>(%
MTK0?UKOM,T[4Q:KJ-C9WZV5Y;ZC9B\M8+H6M_:L6M;ZV$\<@M[RV9F:WNH=E
MQ`S,8I$+',T%I:VSW4EO;00/>W'VJ\>&&*)[JY\B"U^T7+1HK7$_V>VMX/.F
M+R^3!#%O\N*-5`/YR?V>/$A_9P7XF6O@CQ?I_P`)[?XF?\%*?VLOV:-6_:)^
M.?BWQK\3O`'P0^$WP@TSQSXU^%_@^/2/B'\5-'\/V%YKNL>'+3X?^"[G4==T
MZRAEU>[MYH]:UB;0M*NN!^$/_!0?]I>'QA\<?$_Q8^-V@^#]7^-6O?LEV_P/
M^%.M>#?!MAX>\(^%O&'P+\;>)/%/Q(^'UY\6OC?\/=`\+?#;XAWOP\OM;T+Q
M?\1O$.IZ2VLZ[I?A)-.\8_$?6=$T&X_IFN-!T2[LKW3;K2-+N=/U&XDNM0L9
M]/LYK.^N99DN);B\M9(&M[J:2>..9Y;B.21YD25F,B*PAU'PQX<UB4SZMH.C
M:G.UE_9S3:CI=A?2MI_VVVU$6+27=O,[68U"RM+X6K,;?[;:VUWY?VB"&1`#
M\8?^"<'[4GQ0_:G_`&D/&OCKXB[M"NY?V,OA/IFJ^"M'U:[F\&6WC+X=?MW_
M`/!1#X':[XST71H]9UK1+.^\<Z5\*?#^J7M]I=]J45S8KI=A;:WJVC:;I5Q7
MQ#\&_&/QO^&=SX0^/&F>`O$USJNM_M2?\%5-<TWX@Z+^T7\8/B#XG_:DO/@!
M\0OVQ+KP!^QOXB^!VN^%C\./`-W\0M+\+Q_\*RUO3]=\:C0M.^`S6WA[2=)\
M4ZYH,-M_45;Z9IUI/+=6MC9V]Q.ACFG@M;>&:9#=W5^5EFCC6613>WU[=E7=
M@;J[N;@@S7$TCL&CZ4([>$:;8"*TOI=2M8Q9VRQVVHS2W,\M_;HL02&]DFO+
MJ9[N()</+<W$C2EYI6<`_!/P=_P4-_:;\4_!C4_%$WB7X`:5*_C;]GW3W\:W
M_B[]G.WU-;7XK^$OB5XA\>^"?`OA_1_VJ_&/P>C\6^'[[PGX6N?AE_PO7XT_
M"_4?%'A'6_%$&N:-)XS\/^&[/QI;\'_\%-OCUX]^+/PA\+>&/#_A"Y\.:QI7
M[-5O]L\36?PK^%-O\<]1^*_Q!U_P%\8?$/@_3?'/[3MUX]TS1_AU?>']3T7P
M#!\%/#7[2/A_QCXQT+4+B7QQJ_@KQ#X<U&#]U3X7\-MINH:,V@:*VD:M-=7.
MJ:4VE6!TW4KB^E,][/J%@;?[)>S7DQ\Z[EN899+F7$DS.X#"TVBZ0USIEXVE
MZ>UWHL4\&D7+65LUQI4-S"EO<PZ;,8C+817%O''!/%:/"DT$:0R*T2*@`/YP
MO%?_``5O^/FEW7BB[\"2_#?Q[H'BOX::W\1?AUK.L^%O#GAQO"VJ^%/VN_V6
MO@2?"?BOP'X0^-?Q%\?>%D\0^!?V@-2U>ZT7XM_\(9\3-.\0>&FN/^$;T1DU
MKPIH'3_M@?M9?'JY_9P_X*%^$=:^-OPZ\&>._A/\*?VH/AQHWPKT7PWX@\#_
M`!XO5^%GP8L?%OA[]IO1?$&@>.=2U#PGX>\>:MJ,?B31[9]$M/#&F>!=:\.Z
M3I/C>[^(-O(?$/\`0:/#/AT-=-_8.C;KVZGOKQO[*L-UW>W+V4EQ>7)^SYN+
MN>33=/>:YF+SS/8V;22,UK;F.:YT'1+VXN[J[TC3+JZO]/&DWMQ<6%I//>:6
MLDDRZ;=2S0N]QIZRS2RK93-):K++)((0[NQ`/A/X,?M'_$6/Q5^W3\/OC'J7
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MT%_;[U#X87'[9G[`'A+XZ?$"'P5\'=<\*?MFZQK-MK/Q=U[X0>$]9\8^%O"W
MP-G\$2ZMJ^C^,/!D6HZGHRZIXBNM!MKS49FMGN=1O+.%)$DN(OUBF\-^'KGR
MOM&AZ//Y,VIW$/G:98R^5/K0F75YH@]NPCFU1;FX74I4`DOUFE6\:82R!HM?
M\)^%_%4=I%XF\.:#XBBT^X^U6,>NZ-IFL1V=SA1]HM4U*UNEMI\(H\Z`1R85
M1NX&`#^=OP5_P4#_`&G?A_J/A?X;^'[&U\:?#G2[_P`0>)O@;\0?B[XT^&&G
MZ_\`M2_!;Q+^UG\6?AE\*K:3QM\8/C+\,?'-S_8WP;\*>%!I_CCP#\._C=\0
M/&5]XT^%_CCQ7I.H:?XKLV\>^X_&'_@H5^T;X#75/!&E>'_#5WXF^%7QT?\`
M9X_:#\:#1_!^CV7@2\^(/B_QAXG^"OQ$M[+XH_%?X9_#K2%\6?L_>$/".LV-
MAXR^)ND>&7\=?'OX>VD^HWHM+7P[XD_<*YTC2KR?3[J[TZQNKG29GN-*N+FT
M@GN--N)('MI)]/FFC>6RGDMI)+=YK9XI&@=H68Q,5+;K1=(OH-2M;S3-/N[7
M64\O5[:YLK:XM]4C^SI:&/4898GBOHS:QQVQ2[693;HD./+15`!_.SJ'[:WQ
MYL_BQX&^,&JZWX/\.:GKW[%&A6.M9\26GC'X&>#;7Q9_P4H\"?`&]_:8\1Z/
MX(^)NK^";W3_``7\*-7G^*'BF'P_\1]:TG0[.'4O#!^(MQX2L+_Q*N_XQ_X*
M6_'?0=6\2>$$^+?[.NB6'@WX/?MJ^/O`_P`;O$/@J>?P+^TUK/[+/Q#_`&>-
M&\#:?X`TBW^*&G6L$7Q#D^+GBOX4>)H_#?B;Q!<7WCWX>:_J?PZMU^T1:'HG
M]!!T?23UTVP/_$N.D<V5L?\`B5,06TS)BS_9[;1FQS]D(`!AP!7G-S\#OA3=
M_$?PQ\6;CP9IDGCOP9\/];^%OA?5=]VEGHW@;Q#XK\%>-M3T2S\/1W"^'$+>
M*/AYX.U6QU(Z2VK:1+HL,.DWUE;7%Y#<`'X^^%/VY/VM_B;\5?#O@C3+WX:_
M#&T^)?[4?[3G[+6EZ1X@^&NH>+/$OPNU/X3?LNI^TYX>\4ZW-!\0/#]CXJU[
M1;[2-=^%/BGPHUOHNFZB+J'Q3!J^FWVDOH^I\M^S!_P5"_:2_:&^(OP)34/A
MYX#\':#\2=)_9O:Z\&7>O_"O1KSQ'X:^,_[.'@WXQ^,/BYX.'BCX\0_&_5;+
M0O%'B/6M)\`^'_#/P,\6^$];T#P!XMT[Q%X\@\2C4+SP=^^*:/I,<RW":9IZ
M3I>W.HK,ME:K,M_>6[6EW>K*(1(+RYM7:VN+H-]HGMV:&61XF*F*#P_H5M<6
M5W;Z/I<%UING-I&GW,.GV<5Q8Z4[1,^F6<T<"R6NGNT$+/8V[16KM%$S0DQI
M@`_F*\=_M\?MG?$+]G7X&ZO>?&GP%\'M?^,'P$_X)Q_MI:K\0/`OP\.EV7PS
M\$_$C]L+X*?!WXY>#=?NO$?CVYLM5^'H\+>.H_'GB7Q%J$WAV'3_``WH7C/P
MSJ\X\+Z^E]X>_I]TNZ@OM-L+VUO[75;:[LK6ZM]3L7ADLM1@N+>.:&_LY+>6
M:![6\C=;FV>&:6%H94,4LD95S5;P[H+6[6;:+I+6CZ0^@/;-IEB;=]#D4I)H
M[0FW\IM*D4E7TTK]B=25:`@XK3M[>"T@@M;6&*VMK:&*WM[>")(8(((46.&&
M&&)4CBBBC58XXXU5(T5410H``!-1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`44F1ZCMW]>GY]O6@LJ@L2``"2?0#))^@P<_0^E`'P/\`
MM;_M9>-?V<?C1^R5X8TOPWX7UCX7?%;QGXSL?CMK>K#5X_$?@?P%IT?@;PCH
M/C'PK<6=_!I44.C?$SXI>"+GQM_;NG:E;KX#C\07=D;"^LX[Q?DV3_@IO\04
M_:/^/'PPN_#_`($T?P!X4^*_PZ\"?`C4E\+^*?$'B'XDZ9K_`,`?VS?&GB*[
M\5ZFGCS0-(\,VU]\3?V1?$I\(^*-*T37+(>`U@L[OP]JNJ>*++Q-X<_1_P",
MO[.'PG_:033]0\</JNJ6'_"L_C%\,H!H&O)8V%_X/^._AW1/#7C-_M-G#/*U
M\-/T#3I_#VK6-Y!+I%^AOX#-,(3%X,G_``33_9NA\0>%_$<!^(,5[X0TOX+:
M/H\)\8K<6R6?P'^"7Q[^`?@@W;7FDW-[?7,_@?\`:.^(USXBO+J\DNM<\2/H
MVN32Q26%S!J`!Y=\!O\`@JS\#OB%:_LY^#?'NHV.B_%[XM?#K]EZ\\<P:)?^
M%+'PEX,^,'[3?PE\%_$WP;\-[3P]XC\>I\6]6;78?&^@'2]4\->"?&GAK0+7
MQ'X<MO&?C#2KZ[N##G>+_P#@JSX9G^#&E_&/X)_`#XN?%S3-5^-_[+_PIL;&
M+4OA'H,NI:/^T=\;-&^$5OX@A:7XJ7;>&?%6B7.H^4_PD^)R_#[XH:9XAU7P
MO:>._"O@KPS?ZYXI\._0/PO_`."?_P`$?@]KW@36?A[JWQ%T.R\%^'/A'H5_
MX=B\2Z8^E>/-1^!GPS\/_"#X<^+/&]ZWAL>*KCQ!IG@#PEX6T+6+;PUXE\+>
M$_&$/AS0Y?%WA?7'TNR:+F-0_P"";/P2UP^,-1\2>-/C3XF\8^(]$^&^@:!\
M1]>\=Z9>_$/P#8_![XN:'\=_AA=:'XH7PG!=>,/$7@SXK^&?#_B[3_&7QHC^
M*_C&^ETP:-KNO:MX=U#6=(U,`/B!_P`%+O@#\,=/^(GB;Q=H'Q6LOA]X`M_V
M@[:V^)4'A'2;KP;\0/&7[+/AWQ!XG^.OPV^'\\?BG^W=2\:>"=-\%^/XX#KN
M@>'/"GC'4/A[XUTWP)XI\37>@SQR9?C'_@J)^SMX`O\`4O"OC#3?''A?XH:=
MXZD\%_\`"I?%=U\)_!?C"ZM/^%9Z/\7[7QM%JWC7XL>'/AM:>$M0\`>(-&U:
MSCUCQ_IGB]M6OX_!$_A&W\>17/AJ#6\:_P#!-3X`?$/2/B/X8\7Z[\5]8\'_
M`!%TOXYK_P`(9)XULH/"_@GQE^TQX7UKPG\=_BAX!TFV\.0IH/CSXB67BKQI
M?7$UU)JWA3PKJ_CKQQ?>`O"7A,^*]:ANNB\=?\$^_@EXW^*'B_XUIJWC[PK\
M5O%^K^'=4D\;>'-6\+RZAH<&A?#&W^$5_HFA6'BKP;XJT&/0_%?@VPTV/Q)9
MZKI&KS?VYI&C>*-`NM`\0:+I>H6H!ZSXE_:E^&>B?L_>%OVEM%.J^./ACXV\
M/>!_%?A;4_#LOAG2(]2\.?$&VL+[P]K>H:W\1/$W@3P7X/T=[+4;:XU#6/'7
MBSPSI6ELZ6=[>)J,UM93_)ME_P`%;?V7]7\-GQ=X=TSXG^*O#>E_"WQ5\9O'
M.N>%M%\%:_HWPZ^'?P[^-OBG]G_XHZ[XEUC3?B%/I.KCX;_$+P?K:ZW;?#Z_
M\;W'B+PW`/%'PYC\;Z,L]S!]:_%+]F+P#\5/A_\`#'P%?ZOXU\./\%_%7@CQ
MU\+/&/AWQ#%/XS\(^,?A_I.HZ!X?\1_;O%VF>+=&\4:@NC:SK%E?CQQH'BBS
MU";4IM6N+4Z[;Z=JME\YI_P2^_9I3P_\9O#GVKXH26GQV^%'QM^$'CZ\NO';
M7VKW'A[]H'XP>-?CI\1]5L-5O]'N;NV\3WWQ#^('B34M/U>Y>]33[2XM[%+*
M6*UB:@"@_P"WZ?%?[2/[,WPH^&/@/5[[X6_&CXN_M/?"O4OB_P")M*MHO#7B
MB[_9N^&_CC5O$-U\)+_1_%]SJ$]I8_$OP;>^$KC5_&GA32]+\6:;INM:IX`;
M7-)MH_$(_2BOB[PM^PI\&_!_Q7\#?%/1M6^(L?\`PJ[Q[\6_B1\+?A[+XNCD
M^&?P]\2_';1?%&E_%I_#/AI='CO4T[Q??>,=>\1#3-4UO5;3PQK5]/%X+3PW
MH%Y?Z%=_:-`!1110`4444`%%%)N7U'YB@!:*0,IZ,#]"#2T`%%%%`!1110`4
M5\B_$_\`:WT#X6?M5?L^_LR:WX0U>=?C[X3^)&LV'Q)BU/3;?PWX3\2>#;GP
M]#X6\':[I]PJZA)>?$@ZAKUMX=U.UF^R6^K^'X=&NX7N_$&F%?)?A/\`\%)_
M@K\0G^/EQXBL=;\`Z/\`!W]H?7?@1X7OI;75/'.I?%_3]#^%W@/XJ3?%'P=X
M6\`:#KOB6W\$/X?\;Q7TUW=:;<0Z3H-K:>)M;U#3M,UO3U`!^BE%?#GQ)_X*
M`?`'P==^$='\'^*-*^+'B'Q/\6/V8OAK<:1X(U5;V+0M,_:F\9?#7PWX`\>:
MAK<=E=Z$_AV[T7XH^'?&.B^7J"OXPT87D?ARXN+BQU#[#ZJG[6_[.LNK^#M$
M@^*?A^ZO?'GDOX;>SAUF\TZYLK[QAJGP_P!!UC4-:M-*FT70/#_C#QMHNJ>%
MO`/B/Q%J.DZ!\0]=LI=.\"ZEXBN#&K@'T=17P/\`##_@I7^RA\4/!NJ^-[7Q
MAX@\':5I7Q>^-7P=EL_'W@7QEX;UN;5?@'XRO/!GQ%\8KH[:'=7MK\,M$NH+
M+4]9^(.IQ6/AGP9I^MZ19_$2_P#!WB26[T&SZ'XH?MV_!7X??%_X5_`[2M5M
M_'7Q!^(GQ\\)?`/6-*\/WK+%X%U_Q;\,O'/Q3@N-8U66PET/4=3TSPUX/LK[
M5O!NEZL_BK3-*\5^'M?U.QL-(U"RN+X`^UZ*^?/%O[57[/O@7XBV7PG\7?%#
MP[H7Q"O=1^'VE?\`"-WHU/[197OQ7U#4]&^&B:O>PZ=+I6AP>.]?TB]\,^%+
MW6M0T^QUSQ2+7POI]S-X@U#3M-NN%O/V]/V1[#PO;^,[CXX>$U\+W6KZ]HMO
MK,=OXAN+2:Y\(62:CXYNX_LVAS3/HGP[LY(YOB7XD6$^'/AL)(T\>:MX=FD2
M-@#Z]HKX0^,7_!0W]GOX3>/_`(?_``Z3Q1IGB_6_%7Q;TGX7^+)]!U(MI/PY
MBU#X+?$3X[WWB+6M<&GW.@ZM)H7@'P%%KNL^$]%U:X\4:=H7BCP]XBO[&TTC
M4;":_P#2]1_;4_9?TK3;C4[KXP>&V2'P[\(O%,-C96VOZIK>J:1\>=-\3ZU\
M(G\/^'=*T:]\0>)K_P`=Z/X+\7:OHFC>'-+U76VTOPWK6HWFG6EEI]S/&`?4
ME%?!6G?\%*/V4-2^*GQ0^%4?C758[SX7>!O@'X\E\7IX4\1ZIX"\?6/[2C:R
MOPIT/X3^(=`TW5_^%D>+?$9TJ)-*\+^%[2_UGQ'/J4=MX/L_$=SHGB^+PW]#
M>`_VC_@I\3?$'AKPMX$\?:7XEUWQ=\/-7^*>@V.G6FM$7G@CP_XOMO`&O:I)
M=W&EV]E87>B>-+I/#.K^']3N;+Q+INKQW=I>Z-`]C??9P#V^BBB@`HHHH`_(
M/]HWX]?M2?#S]IWQA\.O#M]XV3PMXQ^(?_!+>3X,V>A_#6+Q)H\GP_\`$W[6
M]SX#_;IGF\3VWA+4[*QM[;X9W_ANU\7MXCUJ'5/".DZSHNO>%AHUQJEOJ4WY
M@_&3X_\`[6_[2'[&/[0FD>%?B]\<O%>M^(O@G_P4&TCXKZ1X0^&&A:!:_#Q?
M@[^U=KGPR_9QB^'?B;3?A"+C7M4^,/@[0_$WP^\8Z%:^(_%UQXT\,6>O^)=$
MM_"-UX4U*[E_JX*JQ!(SC!')QD$,#@'!((R"1QR.A.>6\&>!?!OPZT"'PKX#
M\+Z%X.\-6^H:_JL&@^&M-M=&TF#4_%/B#5?%?B34(K"QCAMX[W7?$NN:QKVK
M7*();_5M3OKZX:2XN978`_#SP9XX_:2^&_AG5?#OB+XC_%/X:?L_>#?VYOBO
M^S+?^.?!7P8^'5EJ7P9_9A^%OP]\5ZG\(O$_A?PIX:^!FI:#%'\2/B@?"7@+
MQ%\2W\$7_@+P_P"%Y]+TSP[X?\+7UY>>,*Y[PK^T1_P4%NK#Q-XY\;ZU\2M'
MNOAG9?\`!,R[TSP!:_"#PQI&G?$?3OV@?VE_'?PB^.&M^-],U'X<:AXHT;5[
MWX#GP5\6?$G@WPS?^&KWX+>/;B7^UX;#1;&Y\)P_T&E000<\G/#,"#[$$%?P
M(XR.A-+M'OVZ$CH<C&#Q[XZ]#D4`?BO^R9JG[1_P>_X)J_M*:)X+U7XE_&_]
MKOX*^,OVUX/#_A?XU6PO/%*^.[7XM?%3Q!\*=!QIOA#0/^$JT+Q#X/N_!WC_
M`,.II=OKL'B.W\50Z=X:U)?#]YH&BZ3Y/:_M&?MOVOP:UOQ1X<\<:U\3+W2O
MB?`F@2^$O"&M^/O%>K_!F+X5W=_^T=K^IZGXL_92_91T+5O%?P5%Q;_$'X,^
M&_#'PYDEUKXNVEC^SMXHU'Q1<:S<Z3X>_H`"@9ZX/4$DCTP`20![#`]J:8T*
ME6!8$$$,S-D-D$$DDG@D#T!(&*`/YRM4_;)_;:UW4/VA+K]G;Q)XT^-'Q8^'
M_P"TE^VS\-/"GP*O?A38+\,H?@1\-O@YXA\3_"OXB3^,=*^&QUC4?&OA_P"*
M]Q\-O"NF6!\<RW'CQ_$U]\.[CP?=>(HY=:TKUCX9_%W]M7X@WWP$\&M\9M>_
MX07XE_M::I\.];^*W@?PU+XO\:V'PNB_8M^//Q%\30:OXK^)7[&_[.W@FPFT
MOXW^$O`$7AW6],^#E];>#]<U#4?AMXHUK7-8MK?0K+]L_"G@+P5X%'B(>#?"
MN@>%U\6^*]=\=>)UT'2[33!X@\9>)Y89_$7BG6%M(HQJ&OZW-;PRZGJER)+R
M]>)&GE<J*^:=#_;*\"ZW\=OC[\#8?!/Q4LKW]GKX0>'_`(Q>(/%>I^#-4M=)
M\9Z+K/BOXJ>#[ZP^&NARK_PFGC271-9^$OB*R&JV7AY/#WB>\GL[?P+J7B:-
M;B[B`/RV^#G[6?[8OB#Q'^RCX@^)'B/XB7M]XW\.?`O1/$_P1\'?"Q_!GB36
M-;U;XA>*_AS\2/&_B#3?%W[.^L>$?'/AF[L[#P]\2?B3KO@GX_\`P4O/V>_#
M=MK,L7@/6H'T^S\69WPJ_:+_`."AGB7X3_%[7/B'X]T[P+XRTWX=>"=9\>:;
M;^!/BCXTU;X'_%B\^-?@K2_%G@71].T?]AW1=/\`A[X=3X:7/CKP_/J5Y<_M
M>ZEX'LK7PM^T'-'XM\!V&O7_`(L_4S]EC]L?P_\`M/S2Q:=X#\0>#Q>?#_P=
M\6/#$]WXI\!>.;'5OA_X]FOH/#TVMZC\-_$WBC3?!_C)9+"9M3\$^(+M+^&`
MM/I&H:Y%I^M-I7*^-?V[M+^&.M7O_"R?@3\:/!?@35(_C9!\-O&FIV'AJ2]^
M(FK?`3P3XS^(?BZRM/AY!XA;Q_X2L/$O@WX?^+/$?PWUWQ5HFFZ7XGT?2$O]
M6?PK'K?A5=?`.._9"^-'B3XD7GPDMO'WQ-^.5MXKCTO]I[2-.\*>)_`OAN_^
M'_Q[\,^"O'OPO@TSXU1?%/0O@1\-S=:3X,TWQ)I?AGX3ZK<:3\"[WXJZ7XE\
M;:WJ?PP\8W?A4^)M(_1N[DU=)0+"STZXAV`E[O4;FTE$F6W*(H=+O4*!0I#F
M8,26!10H9OG?X&?M+>'OCIJ6H:+X>\/:Q::CX3MO$-K\09I+W3M2T7PIXIT3
MQQK'@BT\-0ZY93FT\3R^(CX8\0>*-#U71DELF\)6^DZK?_V?+XATVR?Z9H`Y
M[1M<?4;O5=+OK0:=J^D3Q"XM%G-S%<6%VC2:=JMG<-!;--9W@2>`EH(W@OK.
M]M)%)@$DG0D@?YY_*OG;X\_%WP)\&H=$\6Z]K$<'B2!Y8--\-62"YUKQ9HES
M+&NJZ=':(\?DVT+QQ7]IJ]^]OIMCJ=I#!)=*M[/%+^4WQG_;'^*OQ5EN],TJ
M^F\`>#I'=(]$\.WL\.JW]O\`,J_V[XAA\B]NC(AS)9:>-/T]2?+ECO0@G8`_
M6?XG?M,_!OX3F2V\3>+K6ZUJ,[3X:\.A=>\0*X)!6YLK*0Q:;TR'U:YL(SQM
M8DBOB/QE_P`%(+QI9(?A[\.((X5+B/4O&FJ.\LJY(C?^Q=!*I%Q\Q5];=N<$
M#'/Y?>O`RS%F..69B2S,>K,Q)+,<L2222:*`/KW6/VY_VC-4EE>U\3Z%H$,F
M-MMHOA/2"D.&##RY]936+HGC82\S!D)!4$Y'SW\;OVSOVHO#WPD^)/B+0_C+
MXDTO6=*\*:IJ.FWUKI_A;?97D;1&.:".;P]-`#'O8(DD4D8!`V$`8X:O&_VA
M_P#DA7Q9_P"Q'U?^<%>_PI2I5^*>&J-:G3K4:W$&2TJU&K"-2E5I5,RPT*E*
MK3FI0J4ZD).$X33C.+<9)IM'A\3U*E'AKB*M1J3I5J60YQ5I5:4Y4ZM*K3R[
M$SIU*=2#4X5(32E"<6I1DE*+329\<:+_`,%9?^"AF@W9NH/VEO$6I'?$3;^(
M/"'PTUFS80R%PAM[CP6I5)"=D_E21/+'A"ZX!'TG\._^"\7[;'A)EC\::=\'
M_BO;%AYKZWX/O?!^KLF[)$>H^"]7L-,C?'RJS^')@,9*L<Y_%ANI^I_G25_I
MAC/#3P^S&FX8K@SAMJ<4I3P^48+!5K)*W+B,%2P^(AMO"K%^9_G-@O$7CS`3
MC4PW&'$2<6VHU\VQF,I7;3UH8RK7H2VVE3DM[H_K:^"?_!P#\`/%)L]-^.7P
MP\>_"+4I3;P3Z[X<:#XF^#4D=MD]U,=/AT?QE96J<2;(_"^JR(A*^9)LWM^U
M7PF^./P@^.WAR+Q;\'OB1X.^(_A^1(VDO_"6NV.K?87D!*VVK6<$O]H:->@*
M?,L=6M+*\B(*R0*PQ7^;W78^`OB'X]^%?B:T\:?#/QIXH^'_`(NL2IMO$G@_
M6[_0-7558,()[K3YH3?6;%1YNGZ@MWI]P!LN+6:,E3^/\5_1CX4S*%2MPMCL
M9P[C/>E##5YU,TRN3T<8.->?]H4$W>]58S$J$?APTVK/]:X9^D?Q1E\Z='B7
M!83/\+[L9XFC"GEN916TIWH4U@:_*M52^JX=S?Q8B-[K_2CEEBABDFFD2*&)
M'EEED=4CCCC4N\CNQ"HB("S,Q"JH+$@`FL2V\3Z)>&W^S7AF6Z\DV\B6M\8I
MEGVF%XY3:B)HY0ZLDN_RV1@X?8=U?S!_LH?\%QM0U:WT;X7?MIV4+:'<W=E;
MZA\;O!6C3K>7.F0MNDT_Q]X&TB)U-MJ,JPQ:OXE\&1(1IWVN&3P@BSR:A%_3
MOX0\7>%?'GAG1/&'@CQ!HWBGPEXBTZ#5/#_B'P]J%KJFBZMIMPN8+O3K^RDE
MM;FW8`INBD/ENK0R!)(W1?Y$XS\/^*>`\:L)Q#ETJ-*K*4<'F6';KY9CE%)M
MX;%J,5SJ+4IX:O&CBZ47&56A",HM_P!5\(<=\-<<8-XK(<?&K5IPC+%Y?72H
MYC@G+1+$X9RDU!R]V->C*MAJDDXTJTW&27QO^U;^Q5)^TOK6I>)M.^+NN_";
MQ3#\&-2^'G@3Q3X:\.:?JVO_``\^(EM\8/A?\:?`'QBT*XU/48;*YU?P'XL^
M%VF&W\.WEB;+6[>_N[>]U"&S>XL[OPS5_P#@E_80^*?%MYX-^*]II?PW\7_$
M/1_$NH?!3Q3X`U?Q/\-9/"VB?LM?L\_LQ:+IFJZ5HGQ/\$2^*/&OA#3/@))X
MJ\!>+/$\NK>$M!O_`(B>*+?5_AGXCU&VTKQ#:]M_P4W\6^/O`'PH^%7C7P3\
M<M8^$=OH_P"T]^R%I7B+0?#L^B:-JGQ(T3QQ^V%^SUX$U_0M5\4:B[ZO8>"8
M/!OB+Q;#XKT/PW%877B6#5+2UUC7K;PY::MHGB#0^*?A#0_'?[:GP-T/PE\0
M_C+H^LG0M0_:,^)+^%?VC?CAI/P_NOA_\+]0\-^"/`7@:#X2Z/XZ3X02Z=\5
M/'GB:UU#Q3-<^#KB+Q'X7^'?C'3[PR:AXD?4X/BS[`^<_!G_``1P\'>&O@FO
MP+UWXS7_`(L\*3^+?^"=&M:Q+=>"&T>\UWPW^P!X.^#_`(+'A&_FTKQK!<I!
M\8])^%#QZW?65U:Q>%[;Q/J-A%INOV4$D5[U-O\`\$F_!UIX_P!%\3CQUH.O
M>';+3_A3X,U'PYXR\"^)M<N(?A;^S]X_\5^)O@3X1\+OI/Q=\,^"[/4O!?@_
MQ/9_#O5M=\>_#WXEV>M6?A'PKXOTG0/#'B^'6+_6*/[:7QK\:^+OC3\.OA9\
M-_&]A8_"J]_9]_:C^)TGC+0?VHI_V;/#/B'XM?`_QO\`#OP/K?A'5?CCX%T/
MQGK]AK?PIT77O%_B*7P%;Z=)X>N-?M;[4OBI:3^'?A[J.AW7D]K\?_BM8/\`
M"#XC7GQ$^*OB'X?_`!Y^''PM^*^MZ!>:I_9?Q7T'X?>/M.^'7B;X4^%?%>AM
M_P`(5\)OA!X_U6^\"?%/X>ZMXF\':OI]C\3]&UKXI>+FL=!UOP?X(TY@#T_Q
MK_P26LO%GBGQ)KK?%'PM?6&I>)/VIWT32?%WPT\=:O%IO@#]L+XV7'[17Q7\
M-:TOA/X_?#_3_%?B/2?BI?ZJ/!&OZGIR>$6\`ZG+X/\`B'\-_'MW:V/B2#V1
M/^">4^G?$+P)?>'?B[;:+\'OAU^U_'^V=X<^&?\`PK>&[\11?$/4?AUXM\`^
M*?"4WQ!'C.VM!\.[R3QAJ?B7POI5KX%M=;\*ZA(VBR:_K?A2UTK1-/\`T+\'
M>*=)\<^$O#'C30)+F70_%WA[1/$^C2WEI<6%U)I7B'3+76-.DN;&Z5+JRG>R
MO8&FM+A%GM92\$RB2-@.DH`_*;XA_L3?%;XO?M7_`+2WB76O%NC>$/V>/C)X
M!_8,T/7+2/0K?Q%XN\=-^S1\2_C?\2O$^@^'-5M/%NAWOPRNI[_Q%X+T74/$
MFKZ'XOM]1\-ZWK2>%],TCQ-80^(["QX=_P""<'B+X?\`P\^%_AWX;?'RUT#Q
MSX&^&?[4GP7\0^--;^$\7B;1?%'PV_:K^*=I\6O%W]G^!W^(.D0^&_'7A+Q/
MHV@3^#_$\VO>(-%G^RZG#XL\(>(M/U2VLM*_5&B@#\CX/^"4^A:7H_@7X3:#
M\8;^Q_9M^'OQLO?C?H/PXOO!?]K_`!"FUCQ-\`?'7P"\;^&M3^+LWC&!+KPY
MJFE>/]<\7>'9(_`5MK_ASQ+<26=UK6O>&(-+T/3Z_P`._P#@F)XT^&WBOP9\
M5-)_:.TN_P#B]\+="_9P\-?#35]2^"\W_"`:?HG[//P;_:%_9^@L_%_@:S^+
M-KK'BD^.OAA^T%K$VOW>G>//#%]I'Q`T6#Q'X<GT_P`-7S^"+;]>**`/S#^(
M'_!/?Q)XN\5^)_%D'Q@\%ZQ>_$/X6?LU^#_B/#\3_@+I/C"V\0>._P!EW7/'
M^K^!?'N@0>$/'OPSB^'4.JGXF^)9-7T_X?IX?\6>'M:T[PGKGPY^(7A!]+UB
MP\0?27[._P`#OB]\$K#PSX8\1_'Z;XH^!M'\.^/UU#1?$?@_Q!<^)Y/&GB_X
MFS^,O#]UH/Q&\5?%#QSXJLOAM\.?!U[>?#7PGX$\77'CSQ7)I,6CZKK7Q1U&
MXTK[%=?55%`!1110`4444`%%%%`!1110`4444`%?F/XF_9%_:>\9?M0_'3XQ
MWWQY^'7@OP'\;/V=X_V7%@^&'@;Q_P"&?C;\/O`?AS7OCAXJ\#>/O!7Q+O\`
MXDZMX?L?BWI&N_&9IKG5W\%'1(1X;LKG1=.TZ\N?,M_TXHH`_,3X'_L*>/O@
M#XU\4_$7X6^*OV=?A7KOB+0_A5X!O_!_P@_9X\0>`/A+XO\`"OA#XFZ=XE\;
M_$#XE^#+7XQ7MYXR^/WB#X?/XD\!>`?B-/KD*^`&UZXU#Q';?$_3=FA0=G\-
M_P!G#]I.R_:?UOXZ?&KXC?`KXK:+<R?$'PYX,M8/AO\`$O0O%'PJ^$WB*;[1
MH'P^^',%_P#%77OA_H6HW\NF>&I?C!\09O"5[XN^+%QIQAN[S1/#.E>#?"7A
M7]"**`/@'X6?L5ZS\-_B]X'^*R_%*2YGT^SO-5\?Z/I>@3Z'IWB3Q?J&D_$C
M1M2T_P`/6%MK<FE>&_AE?67CGP?"O@Z;3]5N]/@^`/P4M[+6%&A7TLW;?M/_
M`+6&C_!.V;PMX:CL_$'Q*O[7S4L99-^G>%;6>,FVU3Q`(CODN)P1)INAH\-Q
M>1C[7=36EB8WN>G_`&H_VAK+X$^#D&FFUOO'WB1;BU\*Z5,P=+58U"7?B/4H
M0"QTW2FDC$4+;?[2U%X+%66+[9-;_@MJ>IZCK6HW^KZO?76IZKJEW/?ZEJ-]
M,]Q>7]]=2&6XN[J9R6DFF<DL2=JC;'&J1(B*`:'B?Q1XB\9ZY?\`B7Q7K-_K
M^O:G()+[4]1F,UQ,5XCB0`+%;6D"_N[6RM8X;.TB`BMH(HQMK!HHH`****`"
MO&_VA_\`DA7Q9_[$?5_YP5[)7C?[0_\`R0KXL_\`8CZO_."OHN$/^2MX5_[*
M3(O_`%:80\#BO_DEN)O^R>SO_P!5F*/PD;J?J?YTE*W4_4_SI*_UECLO1?D?
MY;!1113`*^__`-A7_@H?\9/V'_%BC09KKQO\'M8O6N/&?P>U35'MM(NY)VC^
MT^(?!]W-'=1^$O&*HG-];P'2==&+;Q'97)6SU'3?@"BO+SK),JXBRW$Y1G6!
MH9CEV,AR5\-B(WC+K&<)Q<:E&M3?OT:]&=.M1FE4I5(3BI+T\GSG-,@S'#9K
MD^-KX#,,)-3H8FA)*2_FA.,E*G6HU%[M6A6A.C6@W"K"<&XO_07\#WW[(/\`
MP4&^%O@7XO/X`^%'QT\*I%J$>BQ_$WX=^#?&6M>`=:NUL?\`A)_"^H:7XJTK
M6IO"?B.VFM+"'7;"W:);U+;3KZ&?4-,DTR^E^EO#_@/P1X3328_"_@[PKX;C
MT'PU8>#-#CT#P[H^C)HWA'2I!+I?A;2DTVRMET[PYITJB2PT.S$.E6<@#VUI
M$P!K^#[]@']N/QK^P_\`&.'Q=8#4/$'PO\5M9:1\6OA_!=.L6N:)%.@@\1Z-
M;.QM8_&_A1&FN="NG2,ZE9O?>&KRXBLM22XLO[OO`/CSPC\4/!?A?XA^`]>L
M/$W@WQEHFG^(?#>O:9+YMGJ>DZG`EQ:W,>0LD3[',=S:SI'=65U'/9W<45S!
M+$G^<WBWX78SPXSF*HRK8OAS,YU)Y/F%2*]I!PM*IEV-<$H+&8>,DXU$H0QE
M&U>G"G..(P^'_P!`?"SQ+PGB%E$G6C2PG$&71IPS;`TVU3FI+EAF&#4VY/"8
MB2:E3<ISPE:]&I.<)4*]?GM0^"7P;U;PY!X/U3X3?#/4?"=MXIU'QS;>&+_P
M%X3O/#L'C76-:U'Q)JOB^'1+G1Y=+B\4:GXAU?5=>U#Q!':+J][K.IZAJEU>
M2WU[=7$O2ZMX&\%Z]#K5MKGA'PQK-OXDATNW\10:KH&DZC#KT&B2--HT.M17
MMG/'JL6DRLTNF1Z@MPEA(QDM!"Y)/545^2'ZH(`%`4``*```,``#```X``["
MEHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*Y_Q7XG
MT;P7X;UOQ7XANTL=$\/Z9=ZKJ5TV"8[6SB:5Q&I9?,GE($-O"IWS7$D4*`NZ
M@]!7P;^W2GC?Q-X-T;P)X)BCNXKF^77?%EC%>I;7][I]AN&C6%O%+Y<-W%)J
M*RZA<6SW,4K2:?9".*<.P4`_*/XN_$W6OB]X_P!?\=:V98GU2X\O2],>4RQZ
M'H=MNCTK1H#]Q1:0$R731JJ7&I7%]=XS<''FM7+_`$^_TJ[FT_5+*[TZ_MSM
MGLKZWEM;J(_[<$Z)(!Z-MV,.58@@FG0`4444`%%%%`!7C?[0_P#R0KXL_P#8
MCZO_`#@KV2O&_P!H?_DA7Q9_[$?5_P"<%?1<(?\`)6\*_P#929%_ZM,(>!Q7
M_P`DMQ-_V3V=_P#JLQ1^$C=3]3_.DI6ZGZG^=)7^LL=EZ+\C_+8****8!111
M0`5_0_\`\$+?VUW\&>-+S]CSX@ZM+_PBWQ`O=0\1?!F\O;G-OH/CI;=[WQ'X
M'@,\@%M8>,[.WN/$&CV\3)#'XHL-6B2)[OQ+'C\"_"O@CQ/XTN1;^'M*GNXE
M<)<:A)_H^E6>2`6NM0D'D(5&28HO.N21A8&)`K[%^%_P7MOA_KF@>,I=;O+K
MQEX;U73/$&@7VG2W.F6&A:]H]W#J.E:E:&%X]0O+BPO[>"YCDN);>%GBP;,H
MQ4_G7B5EV0<2<,9IPWFU6+K8N@YX)THJMB,#F-).>"QBBG'V?LJMO:*4Z;KX
M:=>@FX5I)_H/AUCL^X?XDRWB'*J4E1PU90QGM9.EA\;E]5J&,PC;3]K[6E?V
M;C"HJ&)C0KM*5*+7]]`.1D=#R**\8_9Z^+5C\<?@UX`^)]D(XI/$^A03:O9Q
MNK?V;XBL7DTWQ'IK!3E19:U:7L46X*7MQ#*%"2)GV>O\Q,7A:^"Q6)P>)@Z>
M(PE>MAJ]-[PK4*DJ52#_`,,XR5^MC_2#"XFCC,-A\7AYJIA\51I8BA46TZ5:
M$:E.:_Q0DG;=7U"BHHYX97FCCEBDDMI%BN$21'>"5HHYUCF56+1.T,L4JI(%
M8QR1R`%'5C)N7CD<G''//OCI]3QVZD5SFXM%&1SSTZ^WUI"P&<GH,D=3CZ#G
MZ<<]J`%HI,@XY'/(]?RHR.>1QUYZ?7TZ'\J`%HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`#T/./?T]Z^$_&&L-K_`(FUG4RYDBGO9HK7<<[;*V;[-:J.
MP4PQ+)@<;I&/))-?9'C#4?[*\+:_?ABKV^E7AB8'!$\L+06^#Z^?+'CWZ5\)
M`8`'H`/R&.U`'/>(_"7AKQ=:?8O$FC6.KP!2L3747^DVV[@M:7L9CO+1QV:W
MGC]P1Q7RYXR_9=/[V\\":P#]YQHFOR$'J3LL]9ACQ@`D*NH6V>`&NSG=7V+1
M0!^3'B+PIXD\)7?V+Q)HU]I$Y.(S=PD6]Q_M6EY&7L[M2#D&WGD./O!3Q7/5
M^OFH:=I^K6DMAJEC9ZE8S@B:SOK:&[MI,@@EH9T=-V"<2*!(O56!YKYO\9?L
MR^&=5$UWX0O9?#-ZVYUL+CS=0T.1R.$169M0T]2<X\F:[B4GBV"C%`'PG17?
M^,/AAXV\#.[:[HLXL%;:FL6!^WZ1)R0I-[`I%L6`SY5]':R@<%,UP'I[C(]P
M>A'M0`5XW^T/_P`D*^+/_8CZO_."O9*\;_:'_P"2%?%G_L1]7_G!7T7"'_)6
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M:\U"4"WA"]XU:2X/1('.!7U7X-_9WT#2O*O/%US_`,)'?+M?^SH1+:Z%"PP=
MLBY2]U+!&#Y[6MNQ&?LSJ:^A;2SM-/MH;*PM;>RL[=0EO:6D$5M;0J!C$4$*
MI$G'4JH+=6)/-6*_/\RXLS#&\U/#/ZC0=U:E)O$37]ZO9.'>U)0:NTY31^@9
M9PG@,%RU,2OKV(5G>K%*A!_W:%Y*33TO5E43LI1C!Z$%M:VUE;PVEG;P6EI;
MJ$@M;6&.WMX4`P%B@A5(HQ@<[$&>K9/-3T45\LVVVVVVVVVW=MO5MMZMM[L^
MI2222222222LDEHDDM$DMD?N'_P2#^*,TL'Q4^#5]=RO'9OIOQ%\-6KR!HX(
M;QET#Q7'`K-N5#>1^'[YXXUV">\N)FP\S%OVT/0_0U_*S_P3Z\6MX3_:Q^&"
MF^N-/M?%DFO>!KN>U,`D;_A(M$NWTZ+%S!<P$/KFG:2!OA<[BOEE'PP_J3M;
M"X@E6:36-3O$"L#!=+I@A)8<,QM=,M9MR=5Q*JY^\K#BOY)\8,KCE_&%7$TX
M<M/-L%AL?9*T56CSX.NEWE.>%5>;ZRK-O<_J#PJS&6.X5IX>I+FGE>,Q&!5W
M>7L7R8NC?M&$<2Z,%LHT4EM9?C1I?[0FC?`3XY_\%9/#DUI\1)OC'XT^,.A?
M$3X(^"/!7P\USQ!XR^)2:/\`\$[_`-FS3-/N?AG_`&KX;O?`GB35?^$J\#>(
MM&TZQU*_N;"Y\0Z'=Z/>V=W<*=,NOB#5_BA^UY\2OB%\,;SQW\2/C9:_L_\`
MP)_;'_8O^+J?&#P+IVM:M'K7PV^*7P[_`&I/"'Q/L_&7B/5?V4O@<_B[X>>$
MOBAX6^'6GZG#9_"*WT;P:OQ$NSK6NRV5KHL_@S^@O5/VHOV=]&^(]Q\)=6^,
M'@>P^)-KJM[H-UX-NM=6+6K?7K'P18?$>309[,CRX=<G\!:A!XOT[1Y'74M7
M\/Q7^J:3;7T&EZH]GR]C^VO^R9J,O@>&Q^/_`,,[G_A95W9VG@::/Q/`;;Q*
MVHW^FZ/I5UIE\V+1M,U?Q!K.E^%]'UF:X@TG6/%=];^$M,OKOQ&QTE?RP_23
MX?\`^"=?QF_;2^)_Q%\10_M*76G:>5^'NO:K\2?AU_9_CB6;X3?&,>.M*M-#
M\%^&YKW]EWX/>%O"_ANP\*R>)+!M`G^-'[0>M>,=/TSPI\0M"\5SZ-?ZGXA\
M3?//[3GCK]K?QQXG_;3^`?A?QU\<_%U]\0_A5^UWX+^%_AWX2^!+CP;/\,A8
M_`CQ1XA^$5[K.D^,_P!G;3;S3K/6/%6C#P!X1^.O@#]I+XB6GQ5\8>.M'L++
MP!X6:2*?X=?JW-^W%^RA;>*?&GA)_C;X*^W_``XMY;CXA:D+^<^%?`YC\?Z3
M\*TM?$WB\VX\+:5?77Q&U8>"K6Q;5FN)?$ND^)-)=(KSPQK\6GZ5G^V=^RS?
M76K6T'QO\!^9HGA77_&.JO/JL]K9VFB>$_#DOC#Q:6O+RU@L'U?PIX4AF\2>
M*?#=O/+XG\.Z'')JFMZ-8V2/,H!^*GAS]KS]H_PIJG[/Y^'7C3XP>)/AOX%\
M5_LH_#?XGS?&GPG?V%IK7P5\1^$/`>A?&[XZWVBV/[+/AB)?#7@3Q3K/B&W\
M0?$WQ?\`M!^`]4T#QA\-_&?A^\\`Z;I.F%_%'$>`/VI_VW-;^&<'CZ/XI>,K
M_P`5>-X_V6%^(VG_`!%&N?#OQ1\+OA?JF@?&K6?CA\;/AOX1T#]E?Q=H/ACX
M(^-/BI-\&_`'@[QX?@=\<?'?P]T'4O$G_"PO%NDZ):>%-9\/?NU:_M8?LC?$
M/4+;X;Q_&;X3^*KSQQXDU3X5Q^$;S7=-U&'Q%XBN?#?]MW'@R\TS4%:SNYO$
MOA2\.H:/IVH)]E\:Z%<M+X?_`+<LI6SX_P#!+XA_\$Z_AAH'C3Q[\$?%OP7\
M/:%I^I_##P7XF\2>'-3GN(K&T^)GC&V\%_!C1-*N[J2]N;3X>>,_&6K1Z-\,
M%\+>7\-]8U*2Y_X1625;6\EMP#W?]D7Q%\5/%G[._P`-_$/QHOK'4_B'J=GK
MLNJ:G8:1XFT./5-(B\6:_;>#M3N[#Q?\//A+KO\`:^H>"X?#UWKM]+\,?`5A
MJ^M2W^LZ)X4T/0]0T[3X/I&OE[]J;X[^.?V>O`LGQ#\+_".#XH>&M#TSQ#K'
MCB[F^*'A/X;MX:L=(@LVTN*SC\3V-_-XHU;Q-?W+Z-HVD:1']MN-8-CIZ+-<
MZI:1FU\7/VCX/@?^SUIWQR^(?P_\2Z9J-U#\+]-U+X=P:IX6DO\`PUXT^*7B
M'PQX.L/#WBGQM>ZOIWP]\.Z+X8\5>*+:R\9_$#5_$%EX.T/2[#4M;-_<VZ6E
MO=@'TO17YT:?_P`%&?A]!/H%MXS\%:]X.8:YJF@>/=3D\1>$?$/A?PM/I_BO
M1O!7]J>&/%.@:E=Z3\5-"MM;UVTN/$U[X,D>^\"Z-::U=^,=+TC4]$U#18ON
MOP+XDN_&/@_PWXJOO#NL>$KCQ%H]CK)\->($BBU[1HM2A6[M;'6K>%GCL]6B
MM98#J-@))&T^\::QED>6VD8@'64444`%%%%`!1110`4444`%%%%`'FWQ;G,'
M@/5P,_Z1)IUN<`=)-1M2<YZ<(1D<@D$>M?'%?7_QB_Y$6_\`^OW2_P#TNAKY
M`H`****`"BBB@!&575D959'4HZ,H9'0@@HZ,"KH02"KAE/<&O#O&7[/W@/Q3
MYUU86K^%=5DW/]JT1(UL99""-UUHSE;-@S'=(]F;&9NOF$U[E10!^;OC/X$^
M/?"'G7,=@/$>D1;F_M+04EN9(X@1A[S2BIU"U(!RQCCNX5P3]H(YKXU_:'!'
MP+^+0(P5\$:PK`]58&#*L.H8="IP0>"`:_>P$@@@D$<@@X(/J".0?<5X!\>O
MV>_!WQP^'OCKPI=:;::=XB\4^%M9T;3?$-G$MM=0ZK=6<O\`94FHI'LM]4LE
MU);7[9;WT<AFMC*@FCR&'K\/XVCEV?Y%F.)YOJ^`SG*\;B'!*4U0PF.H5ZKA
M%N*E)4Z<N6+DDW975[GDY]A*V/R+.\!AU%XC'91F6#H*3Y8NMBL%7H4E*5GR
MQ=2<5)V=E=V9_&SX<\)^(?%U\;#P]I=SJ,P?$\J+Y=G9J2<R7U])MM;1`.?W
MTBNP_P!7'(V%/U-X-_9STBP\J]\9WO\`;5T-K_V1I[36VD1MUV7-T?+OM0P1
MADC%E;L.TJGGY*\9?'+]HSX)Z_<^"]67PCI\.DW5_8P6L'@32K#39YM/N)+&
M^C\FT-O+%?V-W%)!?V\DQN(;A,RM-!)'++S/_#:WQN_YZ>"__"47_P"65?Z%
MXWQ!J9C2B\OE+"X2I%.%2E:5>I!VLW637L[[\M)1G%\T93EL?Y[X+AS+<MJ.
M.8PK8G%TI6G2K4N2C2G%J\?8\S]IUUJN49*THPCI?]:+*QLM-M(;#3K.VL+&
MW4+!9V<$=M;1*,@;(8E5`<'!<@NW5V8\U:K\E(/VV_C1$6,T'@:[#`!1+X:G
MA$9!.2IMM8A+%LX(<L!C@`DFK/\`PW#\8/\`H%^`?_!#J?\`\OJ^9>8T9-RD
MZCE)W;DKMMZMMMMMM[N[/IXXW#1BHQ4HQ2245!)))6223LDDK*Q^L5%?E1;_
M`+<WQ6C0B?P]X!N7+9#_`-G:Y;;5P!MV0:Z4;!!.\_,<X/"BI_\`ANKXG_\`
M0J^`?_`;Q%_\O*7U_#]Y_P#@#_2Z_KR9:QV'?67SCZ>?G^#/U0HK\O8OV\/'
MZQHLW@7P1+(!AY$NO$<*N<GE8OM\NP8P,>8_(SGG`?\`\-X^._\`H0?!7_@=
MXC_^2Z?U[#?S2_\``)>7E_5GY7/KV'_FE_X!+_+^K/RO^S_[/>KOH/QZ^">L
MQAF;3OBS\/)]JA&=E?Q9I5M(JB7]V2T5PX!?A2=P(8*1_8OR0?\`@0_4@5_G
M9_`+]M[Q+XB^._P/\/GX?Z'IPU[XS?";1&U"T\0ZM)=6*ZO\0_#6G->VL<^G
MM"]Q:BY,\*3*T321JL@*$U_HEKT/^\__`*$:_G?QPJ4:N/X?J4W>?U3'4YNT
MD^6%:A*"U2TO4J-6V;=]S^A/!3$QK8+/H4Y-PAB\%+5-+GG1K1E:]G=QA"^E
MG9:Z,_(BX_87^,?Q'_:(_:S\0>,_%6@^"O@=\0_VP/@O^T7X.TRU\/6^M>.?
M&5]\'/V2_@#X`\*:G8^+M+\;VI\&^&K;XN^!=3B\6>&M>\'W7B+7]&\)3V>B
M:GHVC>,AJD4FG?\`!,/7=&^%G@?X,Z3\;]/M_`VI_L@_LE_L>_M`M+\.[^;Q
M'XN\'_LGC7!HGBCX-ZK'X_M+7X0>(O&-KXO\7Z7JJZGI7C^ST07VA>(M%A_X
M2#0+F37OUUHK\+/W`_G!^%__``3[_:&^*,'Q`^'OQ;\"6WPQMO&=S-XDU'QE
MKVDV.N^'_@\UC^V3\-/VN/\`A3'P*@T#]I#Q?HGC_P"&_P`1M;T#6['Q3KL'
MP@_9_>PN-)\+>(;K15_L^U^&=K]._'K_`()3^-OCWXS\7^)_$W[1T4QO?%/[
M4NM>"M4U;P?X\USQ1H7AO]IO]FW]H+]GX?#G4DO?C,WP\C\&_"JW^-FF:AX1
M@\#_``\\$:CKFF>"+2V\57M[XBUG7?$NI_M#@<\=>OO]:*`/R;O/^"9E[<^)
M_$'B&/XPV=NFN_$O_@G+X]-I'X!9GM[/]@W^STO]",DGB=H+E?BA%9S1VTT]
MJUEX36Z>.]TWQ1`9HIN\^`7[''Q^_9ZLO$D7@K]H/P38V\^C_"7P;X.^']O\
M,_B9>?!#PKX8\$>/H]8\;:OHGPQ\5_M!>+6\`>)?&'PYO-:\`>%_#/P>\1_#
MOX.?#VZ_L/Q"OPZ\4VNCVWA^/]***`/#OCG\(;[XRZ=\.-$'BC^P-#\(_&GX
M7?%7Q/IITQM1C\9Z9\+?$:^-=)\)3$7UHMC%/XRTKPGK<E](E_$H\/\`V9["
M47?FP>4?M&?LX_$3]H:UU[PMK'Q)\&VOPQM]0^%'BCPE\.=4^&VI^(/#_BCQ
M#X/O/&LGQ!\)?M$V;_$#3M/^,OP5^(=GK'@U[?X<V%AX&GT'7?!_]KZUK_C7
M3[]/#MI]D44`?F;X(_X)[MX?^%E_\*K_`,<>$]`\+^*?C!XS^+NN>%?A%\-%
M^'W@/P"GB+P-I>C:9\.O@%X8O_%/BM_A;X%A^(NA:5\9_&-A#J5[#X\^(<_B
MRYN]-TC0_&FKZ)']7_LX?!?6?@?\./\`A"M9\:3>+;R3Q!J^NB:WM;W3M$T>
M/4ULXSI'AS3-2U77-0L-,DGLY]>O8KO5[Y[CQ+KOB"_B:WMKR"TM_H.B@`HH
MHH`****`"BBB@`HHHH`****`.!^*%N;GP)X@55+-%;P70`]+2\MKAR>#PL<;
ML1P2!U'6OBVOT!U2R74M,U#3WQMOK*ZLVW#(`N8)(<G@]-^<X.,9KX"EAEMY
M9;>=2DUO))!,IZK-"[12K^$B,/PH`CHHHH`****`"BBB@`H_,>XX(^A[&BB@
M#^;'_@J-^SWHNC?&K4M4NM*1O"/QETYO&5H\,:PMIOC"S>/3/%QT^<)BTOC?
M?8=?78,2KKDJ3))`\B'^?KQ]\/M:\`:JUGJ"-<Z=<.YTK68XBEKJ$*_-L8<B
MWOX4Q]KLF8M&?WL+2VSI)7]MG_!0SX0M\4?V=M<U?3K,W7B;X5W0\?Z.(HS)
M<SZ5:0-:>,=/B"@NPG\/R2:F(USNGT6W.,@$?S.>(/#^D>*=(NM%UJU2\T^\
M09`(62*103!=VDP!:"Z@8^9!.G*DE6#Q/)&_[]P#Q'4>5485&ZL<,UA,33;]
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M#MS<R?+ADB,;,@<NO^F0IRH([C//'7GIVZ]*_A#_`.#=WX.WGQ`_;V?XD-;*
M^B_`?X4>,?$]Q<RQK)%'XC\>1I\/?#-NF[.VYFT[4?&%Y$X!*)ILK95BAK^Q
M3]M7]I=/V0?V:_B#^T$WAG2/%W_"$77@&P31/$/C-?AYX=>7Q[\3/!GPV@U+
MQ'XW;P_XJ'ACP[H$WC&/Q!KVK?\`"/:J;;2-+O"MJS,'3^=/%S%QK<083"1:
M?U++:?M%?X:N)K5:KBUT?L50GW:DNEC^J?!#`SP_#&.QLTU_:&:U72;5E.AA
M:%"BI)[M+$/%0?2\&?5-%?$GA3]LSPSIOPTL?B)\8[_X:_8==U3QHWAK4OV4
MO$WQ5_;#\&7OA'P#'IT7BWQ7J_BGP%\"]`N?#MIX8U*[GL_%,U_H#>'_``^J
M6?VSQ(=0NYM,LN1^*W_!1_X$^"-4\):/X#OU^+]YJ?QL^!OPF\:S>$U\2MHW
M@72_CIX0TKXB^&?&/_"1V/A'6O#_`(KEO/AWXA\.^-?#'A+0M3?6/'&B:J\_
MA^20:9J36_Y4?LY^A-%>5>%_C?\`"KQEIVK:QX=\:Z/?Z/H/@WPG\0-:UO?<
M6NA:;X1\;^';OQ=X;UJZUN]M[;3$MK[PQ9R>()HS<_:=.T>6QU#4X+*VU&PD
MN?D3QW_P4U_9S\)>'_A+XFT2Q^,'CS2?B_\`&[X,?!7P_+X:^!GQD@N8W^.M
MOK5]X#^(T6FZYX!TO4]?^&&M:=H.H7FB>,?"]GK&D^*#$UKX;NM2O(KB&(`_
M1"BODS4OVXOV9=#F\60^(OB%>>%QX/\`#WB3Q5=WGBKP!\2_#.E^)-`\(>*]
M$\"^(M2^&FL:]X-T_2_B[!IOC/Q/X8\*NOPLN_&$USK_`(H\,Z9817=QXBT9
M;WF]+_X*"_LRZAI]SJEUXD\8Z%:6WB'XB:+<1:W\+/B5;:QHVF?";6-)\-?$
M;QUX\\,6OA:^\5?!_P"'7@WQ7JR^&/$/C/XTZ)\.=)TO5;2YDNWBTA[#5;X`
M^UZ*:CK(JNC!D8!E92"K*1D,I&05((*L"0P(()!!IU`!1110`45YSXJ^,'PG
M\#>)_"O@GQK\3?A_X1\9>.KA;3P3X3\3^,_#F@^)?%]TUS%9+;>&-#U74K35
M->G:\FAM%BTNUNG>[FBM4#7$L<3;M[XY\%Z;J>C:+J/B[PQI^L>(_$EQX.\/
M:5?:_I5KJ6O>+;/PWJ/C&[\+Z-8S7:76I^(K;PEI&J^*+C1+.*;4X?#NF:AK
M<EJNF6D]R@!U-%(&4XPRG.,8(YSG&/7.#CUP<=*7(_S_`)Z^W6@`HI-R^H[=
MQWSC\\''K@T;E/\`$.W<=S@$>H)X![G@<T`+13=R_P!X>O4=,XS],\9]>.M*
M649)8`#.<D#&`2<YZ<`GZ#/2@!:*Y[0O%WA3Q1/X@M?#7B;P_P"(;GPEX@N?
M"7BFWT/6-/U:;PUXILK#3=5O/#6OQ6-Q.^CZ_:Z9K&DZC<Z/J"V^H06&J:==
MR6ZV][;R2=!N7.,C/&1D<9Z`^Y[#OVH`6OCGXKZ"VB>+KN=!_HNM@ZK;MC@2
MR-LO8N`!E+E3+@?\L[B/OFOL4LH!)8``9.2!@>^>GOFO$O&\OA?XF:#XD'@_
MQ%X?\2ZU\./$5]H.OVV@ZOIVKW.@^([#3].U'6_"&NQV%Q</H_B"#2-5TG5)
MM&OU@U&**[TF>2V2&^MWD`/EVBCK@^H!'T/(_2B@`HHHH`****`"BBB@".:&
M"YAFMKJ".ZM;F&:VNK650T5U:W$;P7-M*K<-%<02202J>&CD93P37\GG[1'P
MIN/@E\:?B!\-G206&A:Y-/X<FD!'VSPGJZKJOAFZ4D#<!I-W;VDS#(^UV=RI
M.Y&`_K'K\?/^"J_P@^U:3X$^.>EVQ,VD3+\//&+QQY+:=J,MSJ7A#4IV7M::
MG_:NC%V&%&J6";L*JG[#@O,?JF:?59RM1S"'LM=EB*=YT&_.2=2DN\JL;['P
M/B'E3QV2K&TXWKY74=?17D\+6Y:>)BO*+5*O)O:%&=MV?AYKFAZ7XDTN[T;6
M;2.]T^]CV30O\K*R\Q3P2CYX+F!\26]Q&1)#(`02I96^!/B7\,M3^'VHKEI+
M_0+V1ETO5_+"DL`6-C?K&/+@U")02`,17D2F>WP1-##^B-9NKZ1INNZ==:3J
M]G#?Z=>1^7<6LX)1P"&1E92LD4L3@20SQ,DT,BAXW5A7[CEV8U<!4TO.A-KV
MM+[ESPOHJB6G137NRVC*/\Y9EEE+,*?2GB(+]U6MMUY*EM94W\W!MRBG>49?
MEC17K'Q1^%^H>`-0^T0>=?>&KZ8KIVI,H,EO*VYAINI%`%CO$4'R)\+%?Q+Y
MD0699H(_)Z^ZH5Z>(I0K4I*4)JZ:Z/K%IZJ47I)/5--/4^`KT*N&JRHUH.%2
M#LXOL]5)/:49+6,E=-:H*4`D@#DD@`>YZ4E?6/[$7[*7BG]M/]I?X:_L_P#A
MH7-K9>*-3;4?'?B"WB9T\(_#30O*O?&_B2:3B.&>+2V71]#\YXTN?%&M:#9!
MLW-3B<30P>'KXO$U(TL/AJ52O7JRVA2I1<YR?>T4W9:MZ*[:*PF$Q&/Q6&P6
M$I2K8K%UZ6'P]*/Q5*U::ITX+HKRDDV[)+5M)-G];_\`P;V_L^6WP/\`V0-3
M^,WB6*]M?%G[3OB2'QA9P2Z9?'[-\-/"`U#PW\/S&\6GNS+KLLGB3Q8KBXDA
MDL]<T[8B/&Y;]<_VMOV?+7]K?]G;QE\%%\73>!QXOOO`.MZ=XK'ANW\3C2M5
M^'?Q*\'_`!,T62\\+:K>Z-!K.G76K^#+*PU33+F_T\W.FW5W&ES#(8W'OGA+
MPMH7@;PMX;\%^%M.AT?PSX1T'1_#'AW2;;<+?2]"T#3K;2=(TZ`,S$0V6GVE
MO;IEB2L8))))/RO^WY^T-XI_97_98\>_''P;'X6?7O"7B3X.:;&_C6&^G\+6
MNF>._CA\-OAUX@U#64TV_P!,O5M=-\/>+M5U`3P7L!MI[6&Y<O%%)%)_'>=Y
MI5SK-L?FE5.,L9B)U8P;3=.BK0P])M:/V-"%.E?KR7ZG]W\/9/1R#),LR>BT
MXX#"TZ4YQ5E5KN]3$U[/;V^(G5K-=.>W0\/^)/\`P3_\8_'/2O#&G_&_XW>#
M_&EOH47Q2\/7?A6R_9P\'6?PHO\`PE\4[?PD;O6+?X4^+/&?C[PY9?&OP=?>
M&]17P%\8[R;67T'0O&?B_0Y_!>H'5YM2;F_`7_!+SPE\+/`GA/PSH_Q+\7>(
M1X`^/'[(?[0>F1RZ'H%I?ZUJG['/[,7P=_9P\,^#Y9I]4BLX8/'>E?!G3=>U
M;6)[B)M+U;7[RTB5]/M([EO`[S_@H5^TU8^/_&'@+PO#\)?C-IOPL\'_`+=O
MQ#'CGP#X1UH6G[1>E?LE>$/V/?'N@^#/A1IVG>/_`!39Z%XHUC7?VB/%OP'\
M:ZNNK>+].TSQGX)N-9TK2!JB77A.RYCQS_P4P^,W@C2HM-C^+/[-?CC0M5\0
M?`@G]I;X?>`[W7/`&@W'QE^#G[0/Q*NOA/IOP^O/CYIVG^+_`!QX=USX0^!Y
M+B\G^+?AR[TWX4?&'1?$FK^'IM7TI+_5?*/9/TO_`&-/V=-5^"'[/,W@;Q#)
MJ&@>*/&>L^-?$FH64>L:'XMOOAUH.OW5QI'PP^&.G:W+H;^'M<MO@;\(M.\`
M_"S1;N32-1T6^B\%1W#IK%G=33W_`,W:-_P2]M=&T:X%E\9WTCQ)H?Q&_9Z^
M*?PUM?"'PG\*^!?A%X6\<_LZ>)_%7B'1?&6L?`[PIKNF^#]4\8?$NU\8ZCX<
M^,6K^";OX7:?XHT/2?"<'A[0O!\_AJQF;YGT_P#X*!_M+>&+'Q'X=^(OBWX9
M>']:\$>"?V$/#LFH_P#"'^%OB/?>*_C+^UI\*-3\;>+X9/'VG_&#X*?`+2O#
M?A+5/#'B&V\'>,K[Q!X;\`>(8[[2(OMVI7D.C:3X\\KD_P""M?[4=Q\-_B=X
MSL/#?P@LK_X`_`;]I7XO^,-/U30Y]7@^)-]^R_\`MAW_`,!KG1M'U7P;\4M<
M\.^%-.^*GP]2QUJ+Q+H.O_$;2/"GB1SJ>A#QEX?N8+$`'LWQH_X)#ZXOAR_\
M7?#WQ_;?$CXLZ;X8^)/PXBUSQ;X/\">&_B;X_P#AG\:OBC\*/&_Q"U/XD?&"
M:VU'6OBE\;O"6F?#N8?"?Q+XNO\`PIX5@U)M)L9X_!-W'+XZM];P+_P2O/Q3
MT^/Q?\<O#W@'PWXOQXT\`2Q>.OA;\,/C;XN\7_"3QIKFB_$37O%'Q%_M_P`1
M_$#P18_M'ZC\4[_XD37/Q,TG7?B!HOB/P-KNCV/C_P`,^*-:LK=M&B^+/[?7
M[3'PV\3_`!D^'=SXL^`$5]\"/CE\3_!>O^,)?#/AW1_$GBWPGHO[.G[./[1O
M@VY\.?"+XG_M/?"K2]<T_P`.67QPUOPG\6+OPA\7-7^(4D'A[P=J_@KX<3/X
MMUNX\,_J#\!OBPGQ8UOQWK.G?&3X7>//#EQH?P8\3^&_AUX4\-:AX:^)?PCT
MOQ_\+])\816_Q?L]<\7ZGXCAU'XA+J,?C3P7IWB'P+\.-8T3PI=0Z9>Z=KMS
M!-K+`'T=:VUO9VT%G:11P6UI#%;6\$*+'%#!!&L4,,:*`J)%$B(B*`%50```
M!5@$'D=/\_IZ'H>HXK\7OV7_`(P65Y^UE_P4U^'6H_ME_P#"5S:=HOP`U_PA
MXJ\1?$'X<:W9_#!KSX+^+;GQYJW@#P*AA^'OAGPOX`O[6QN]7TO^P+G3EU#3
MEU3XD7OB76+[6=3U'T/_`()G?M#?#:X_9SN]%\8_M.:!\1/$<7[9_P"U_P#"
M'PWXC^(WQF\->*O'?C"[G_:Y_:&M?@]X:_M*XU=)=9U_Q+\/_"#W7@7P[HUG
M;0:CX8T&=?!>AP>&='AM;(`_5S<.>O'JK#VXR.23T`R3VI00>GU_S^5?CYX2
M_9\\.^(/B5^V;XG^$GC;Q9\,]&^&E_X?^"%M<>(_CC\:]=\)^(]=LF^&G[0W
M[0FJ^*&\7>/-=M/"FC>(-&UG0?@C8^)_"EGI^O?#71(/BAJOA^>5M<CLX/"_
M`7[>ME\!M(C3XV:5\2?BK>ZK9Z'HG@>Z7Q+IOAZ*T^'.F:#IOCWP1JS^'O%_
MB"R\17=[XJ\+?%?1M4N?&NK//JNL0167@O7A%XD^'&M>:`>K_M2_"'XK77B7
M_@H3X+M_@MXN^+>K?MK_``:^'/@']G?QYHFD:)J_A/X?ZKH'PUUKP';>%OB%
MXCU6>%OA?I'PF^*6HWO[1FG>(=6MY-+U!_%>IR>!I=6^(FG'P]+\Y:'^Q7\1
M]+_:PF\/7GA/]HA/#VM_\%5?$?[37BGXGZ7X_P#BI'X>O/@EXU_X)I_$?X36
MWBSPW\0(O%\P^'^MZI\9I=9\%^,+#P%?>%O'>@V^J^#]*\^R\*6_@.XL_OVX
M_P""G_P'D^+/A#PY8'5I/@_KWP&^./QMF^-.J^%/B%HVEZQ:_"SXI_L[_"CP
MI;?"?3+_`,%HWQDT;XH>)/CLNF>$M<^']YJ\FN:QIF@V'AC3O$$/C/1;R7WC
M1OVW/V>M73Q(K>(?$&C:SX0\(^(_%_BCPQXD\!^,?#WB_1(?".OZ#X7\0^'K
M_P`-:KHUMJ\?C73M5\8>"$3P@EO)K>HZ=X_\!:UI-M?Z+XR\/W]^`?D=^SYX
M<_X*<:EX^_9^N_C7XK^,NA_V6G[.^EZ-`W@KXC>(K>?P+X*^('B#3_C[#\9=
M6TOX\_#WX1VWC3QEX0TR%-=\2?&7X;?$CQ5J7AOQ!X8\4_!R6_\`'5AJ>B6G
MU)X/\(_M>:+_`,$EOC;--??'6[_;;\2_`O\`:&U+PZNO>*O$.L?%"P^)UM_P
MG^F_!_3_``E;:AJL]IX?OK32;'P4FBVFBQ6":O=F/6]>;5->U35=3O/7_CC_
M`,%*/A!\/_A1\4?'WPSL;_XDZ]\/;6'4O#^E:IHGC'P1X4^)FB:;\:O`GP/\
M>Z_\-?'^I>%+C0_'.@^`?%_CO3M,U_6/"#:UI\>I76BQI.^EZ_IFKS^G^+/^
M"@W[+/@23XD'Q?XVUOP_I'POT[XH:CKOBG4OAW\0K7P5K"?!+7HO#7QFL/`O
MB^;PS'X>^(.L_"O6)FL_'6B^#[_6-2T9[#7Y!;W4'A?Q/-HX!\4CX8_MJ>'/
MVT],L;+XA?&0?"#2O'_P3O/AI/<Z7\3OB5X>U;X)Q>#=$U+]H+3OB7XQNOV@
MO"WPBTSQ7XA^)<_Q+MKF;XE?"GQI\1-!T75OAV_P,BDT#PW8^&O"WSE#X<_X
M*&V7@O7?"'A.?]IC4-%.O?!35_CE\5_B?!\9[?XG7>@Z/XT\8VOQ,\%^$/A-
MH7[0NIW6J^-=4TW4/"'BCQSXW_8A^,OP_P#AMK7@O1=7\+?"_P`*Z5XAET?1
M[S]5]=_X*'_LQ>&Y[[3];UCXAV'BO2]9^(N@7_@.;X*?%L?$>TO_`(7>"_#G
MQ,\5[O`?_"&CQ5)9CX9>+-#^(FB7]OILMCXD\(7-QJ>B3WDFG:E:VD]G_P`%
M!_V6]4@N!H/BKQ/XDU2YN_AW%X4\,^'?A;\2-8\4?%'3_BWX4\5>.?AKXH^$
MV@VGA9K[XG>"?&7A+P)X\\0Z3XW\(QZEX672?!'BV^O]5L;?0[R10#\H?CMH
MO_!2&'X)Z9I7P[/[0VH?&+PO^S_X[\;_``6\=66D?%B&/Q3\28OBM\4=>\'?
M#'QQX`TK]J&#1?!_B+P;\+],^&FF)XP_:H\4_'^Z^*V@^)++1KOP%'\3-&\?
MZ'K_`*[?>"/VMX+W5?%'Q.'[8WB3X9:_^U-^WC!XJ\+_``?^(7C'2/BE:>"K
M3X@>*E_88;P+I^A^*M!OM"^$4>E:GXAN+NXT6:WM=0U?5?A1/\69KSX1>#FM
M/#/Z!7G_``4*_9.M=6T+2AX_U&^CUGPO\(/&CZUIG@#Q[J?AGPUX/^.WC3QC
M\-?AKXA\;>(;/PU+I?@33=8^(W@3Q)X!U)O%L^CS>&/%EA)H_B>#2)HKLVNC
M^S9^VAX`_:%^!GQ*^/NI^%/&OP6\$_"GXD?M!^!?&$GQAT#4/"+:;8_L[^/O
M&/@KQ=XREDU6RLHQH21^#=2U+5619'\,:A;ZOX7U>4ZWX?U-%`/SZ^#7P5_:
M=^''QYOOB9I>C?&W2O\`A8?_``5,\27GQ(TW4]?E/A#7/V7O%7[!GA_2M:\;
M>*_!/AJ^L_AEJD\GQ[\"^$(#\1-.T!]2TWQEI\^E^#=0TSP7J4VC7/5_M8K^
MVE??M0V>J?!GP[\8]$TWP1\5?V.[KP[/I%W\1_%7PV^)GP8O?BO\/X/VF[R[
MAT+XQ>`O@QX`?1?!6M^.M"UWPK\1/A3\8OBGXEMM%B\8^![O0-,;2;WPM]KM
M^WC^S\GAW3]<)^*W]J:OK]]H>D?#T?`;XS'XMZM_9OA*S\?7^OZ=\*1X'_X3
MRZ\*6G@74=.\37'BJ+1&T6"VO['1YKQ/%5Y;^'I%L_V[_P!GKQ%?ZO9?#^_\
M=?%3^R?"EGXEDUSX9?"CXD^-_"$MQK/PDL_CIX7\*?\`";Z'X6N_"UIXN\6?
M"[5-%\5^'=#U'5+.34(==T+2Q+'K^L:;I%T`?DIH7P__`."BFA?#SX"M=WO[
M5>LGQE\'?&&H_M?V]S\0?%^I?$%=,\"?MK_`Y[3P]\*7U#Q3;P_#_P"+^O\`
M[*WB#XQZ7X>E\`S>'/%'C7POI-W<)J=_\3].\(Z[!^B__!.'X:^,_AYIG[7U
M]XJ\(_$?PAI/Q,_;3^)/Q/\`AQ!\6+J^OO'.K_#7Q!\+?@CI?AK6M8OM8U'5
MM?N7FF\/ZG81?\)1J-UXLM5TTV'BIU\06FI(NI\`?^"D7P1^.W@#]GKQ3#X6
M^+GA;Q-\?/A%\*?C&?`-Q\)/B-XDU/X9^$/C/JFH^'?`&L_$G5O#7A.]TKPQ
MX3\6>)]$U[3O#'C;56L/#FNZ7HUYXO\`M%AX21]8C^UO`/CS1_B'I&IZSHFF
M>+=)M=*\7^-O!=S;^,O!7BCP)J<VJ>`O%6J^#]7O[#2?%NE:/J.I>&=0U+1K
MF\\)^++&VG\.>,_#DVF^*/"^I:IX?U33M0N`#Y]^*G@I_#FK/J]C%C1-7G>1
M`BA4L+^0&2:S8*`J13$//:8`&#+``/)0OY17WMKD6B7VD:C;:U+9C2GM9FOI
M+F>**&""-"[W#3NP6W-N%\Y;C*F%D$@8%<U\5:]X>O-%,%T;>^&C:D\[Z+J%
M[:FTEOK-'80S36Q)DLYYX0MPEM<K!<M;O'.UO#O:&(`YZBBB@`HHHH`****`
M"O-OC#\-M.^,'PN\=?#/4RB0>,?#M]I-M<N`18:N56ZT'4U)^XVFZY;:?>[Q
M@A(7'1C7I-'6KI5)T:E.M2DX5*4X5*<EO&<)*4)+S4DG\C.M2IUZ56A6BITJ
MU.=*K![3IU(N$XORE%M/U/XWM5TO4=#U34M$UBU>RU?1M1OM(U6SD4H]IJ>F
M74UCJ%LRD`@P7=O-&,@9"AAD$$T*_1'_`(*5?"$?#_X\CQUIMH(/#_Q?TP^(
MRT4>R"+QCI)@TWQ;!\H"B6^W:5K[+]YY-5NI#G:QK\[J_H#+<;#,,#A<93LE
M7HPFXIW4*EN6K3]:=13IOSB[:6/Y;S;+ZF59EC,OJW<L+7G3C)JSJ4_BHU;=
M%5I2A42Z*5BGJ&GV.JV5UINI6L-]87L+V]U:7""2&>%Q\R.IY!!PR.I62-U6
M2-DD16'P9\5/A1?^`[Q]0L%GOO"MU*!:WS#S)M-DE8A-.U1E'#Y^6TO2JQ7B
M`*Q2[5XW^_ZJWUI9W]G=66H06]U875O+#>6]TJO;36SJ?-2=7POE;02Q)&S`
MD5E958>[@,PJX"IS1]^E)KVM)O22_FCTC-+:75:--;?/9CEM',*7++W*T$_9
M5DM8O^62^U3?6-TT_>BT[W_*R*.2:2.**.6:662.**&"*2>>:::18H88((E>
M:>XGE=(;>WA1YKB>2.&%'ED1&_ON_P""*7_!.JZ_8K^!%Y\0OBEHT=E^T3\<
M[;2M6\7V=S#$U_\`#KP1:I]K\*_#+SB'>+4[>6YG\0>.!`\<,OB6\ATAUN(?
M"]C=2?#O_!(C_@C99^!O'>D?M@_M`:6LMG8QPZ[\`/A-XETT27VB7MTJS6?Q
M+\<6^H(4&HZ9$?-^'.CW%LM[I_VB+Q=K"V^MV^BPV?\`4>K*P^1@P'&00WYD
M$\^N>:^`\1^-Z69061915<\(G">98B-TJU2#4X8.#V=.C-*=>2;4ZT80B^6E
M-U/U/PI\/:V53_UDSNCR8UQG3RK"S5WAZ52+A4QU3M5KTW*GAX-)TZ$ZDYIS
MK05%U>9_%[X0?#_X[>!-0^&OQ/T1_$7@W5-7\'Z[>Z5'JFK:,TVJ>`_&GA[X
M@^%[C[?HE[I^HQC3O%?A;0]2>&.Z6"]2S:QOH[BPN;JVF],HK\>/W8Q-/\->
M'M)^P_V7H6CZ=_9<&HVNF?8=,L;0Z=:ZO=0WVJ6M@;>",V5MJ%Y;6]U>P6IB
MBN[F"&>X26:*-U\*^*7[*WPE^*;^#;^XLM=\"^(_AYJ_BG7/!7BOX6Z_>?#[
M7=`U#QU:16'C:2,Z&J:3J2>*[*".'6DUS2-4\^5([^!K;4XTO5^D*,@8!(R>
M@]>_'KQS0!Y)X"^!?PI^&WPYT[X4>%_!>CQ>!=/T:VT$Z+JUNOB%=3TZVNKR
M_6/7[K7AJ-WX@DDU'4=0U&6769KUFO;ZZG78TK"NXD\'^%)ENTE\->'Y5O[.
MZT^^631-+D6\L;ZX2[O+.Z#VC?:;2ZN8TN+FVG\R"XG1)IHWE57'1T4`<UJG
M@WPCK:31ZSX7\.ZK'<ZO9>(+B/4M#TJ_2?7=-M[:TT[6IDN[29)=6L+6SM;>
MRU.0-?6D%M!#;SQQ0QHNI;:1I5G?:EJ=IIMA:ZCK#VDFK7]O96T%[J<EA;"S
MLGU&[BB2XOGL[15MK5KN69K>W`@A*1`)6CD9`R,GH.YQUQ]**`/+K/X(_!O3
M[G4+RP^%'PTLKO5;'6=,U.YM/`/A&VN-0T[Q&&'B"POIX-&CEO++7`[#6+2Y
M>6WU0,POH[@,0;V@?"/X6>%6+^&?AOX!\/.;[2]3+Z'X+\,Z0QU+0X;VVT:_
M+:=I5J3>Z3;ZCJ$&F79/VC3X;V\BLY88[J=9/0Z*`,_^R=+\C4;7^S;#[-J[
MW,FJV_V*V\C4I+R!;:[>_B\KR[U[FW1(+AKI96GA18I2\:A12NO"_AN^N!=W
MN@:+=W:VEO8BYNM*L+BX%E:/<26MH)YK=Y1:VTEU=26]N'\F%[FX>)$::4ON
MT4`?DSJ7_!([X/>)/#?A?P%XS^)?Q$\8?#CX7?!CQ'\`_@CX'U[1OAE?Z+\+
M?AQ>_$SX"?%OP98QPWG@BZMO'VH_#SQ;^SM\/[/2+CXD6/B?3?$7A*P;PWXS
MTC7ENM8O]:]5\)?\$X_A5X4TWX*06&N3:+>_"/XQ:O\`%V_3X>?#OX0_"3PI
MX\77;3P[+J/P[U[P'\./`_A_PS:^`9/%?P^^$OC?RK6VF\777B'X5^%&U7Q;
MJ5F+^VN/T1HH`_(_2_\`@CW^S]X=\'?%'P#X4UF7PAX:\>Z1!X<T:?PM\*_@
M5H/C?PQX>7XO^#/C1-INJ_%#2OAQ9_$?XDF'Q%X(T?1=,N/'OB?5#!X:C5=:
MA\1>)X+?Q1'C_M2_\$N)_BE\$?CQX`^'7Q/U>ZNO$GAO]IJ?]GWP%XY_X1G0
M_A]\&_B)^UAKNJZ_\6?$L'B7PKX'N/&NJPS77BCQQ;>#X?$'_"16W@S3/&>N
M:?%8:TL7AZ?P]^Q%%`'YR3_\$YO"&L_%.;XU^,OBS\0_%WQ-U/4OC1=>(?$E
M[I?@+25US3_BI\%-$_9_T/1GTOPYX8TC3=/L/AS\/O#]J^A&RMDN=8\3ZEK^
MMZ]+<Q:C;Z;IWEVO_P#!(/X$>(+/X<R:GXBU'Q!KWPC^"7[+OP7^'UYX_P#`
M'PK^)OARQL?V8?!?QP^'NG:YX@^'_COPGKG@_P`47?Q`\)_'CQ/9>++._P!/
MA32[_2?#6M^"[SPYJVFM=3_K910!^:6M_P#!,7X2:KX-^(W@FT\8^*M!TKXC
M?!']EWX(7R^'?#OPW\-6NDZ1^RW\8_B3\:_#NNZ)X=\*>#_#O@[2=4\6>)_B
M=K=OXDTW2/#>E^&K:P@M/[!T;3;AKJ6;VOPU^QSX+TCX2_M*?`+Q%XF\0^,O
M@M^T=XK^/_B/4?!VJ6>@Z=>^$+/]I_Q#XT\:_&'P[H?B71-.L]2U'3]4\;_$
M/Q=KOAN]UN*\UKPS!?66D6^H7MKI5I)7V%7AG[2=YX#LO@KXW?XF^+-9\#^!
MKFVTG3?$'BC1/$7C#P=-I5OJOB#2=.MVU3QCX#4>)_!_A:\O[FTT[QGXLL;G
M3;?PYX1O=;U;5-9T72K6]U2T`/G>]_8L\4Z@W@;QC>?M4_&>Y^-WPXO_`!=:
M>$/C%/X;^$DVIZ/X$\>>$O"W@WQ;X"M_`K^`3X%73]<@\%^%?&M]K']AC6'^
M)NCP>)!,OAN6X\$3<GX=_P""9_PI\(>/_@OXH\-^-?%6D^%?@3HGP[T#P-X;
MM?#7PPMO%MKH'PV\$?\`"":=X$O/C;IO@C3OC#JGPI\4V4VHZWX_^&6L>*=5
MT'Q1XDUG5G633/#M]+X:K\B;CQ5XEO\`3Q\,=-\;?"&Q\$:%^T]\1/&D5SXS
M_:-^)MI_P2]UKPC#^S=\*;2V^#_A/]H^VN4^(NI^*-(\=>+3\2-)^'#6=WX)
MTCXEV?QE>RT3RO"6B#2ON*7]HK_A(_\`@G'\//#-C\1/&^E_%?\`X5Q^SGXY
M^-6CWWBC55^.6A?LK:Q^TOX?^&7QX^,.@7^@O>^.IOAW<_#70/BK/\-_BPLR
M>)=7\`Z;9>,7UJ'Q6EQ?1@'K]M_P2S\*#P5\"OAS??'/X@:CX3_9\\,^$/AW
M\-KR7P!\%+/XD^$/A[\-==L=4\`6'@3XOV'P]MOB5\-O&-OH^E:+X0\9^._!
MOB'2[SQUH.EVEU=:1I7B9[C7[C])/`7AOQ/X9TC5;'Q9\0-:^)%_?>,/'&OV
M.LZ[HGA70KG2/#OB7Q9J^N>&?`UI:>$='T73[G1?A]H-_8>#-#U;4;:[\3:U
MI&BV>J>*]7UKQ%=:CJMW^%ZZ7XFU#6_B5X@_9J^*=YJGP0^'_P"TEX&\!_L9
MZ'HWB3Q#\0/"OBSQYXI\%?`WXA_$:V^&/B&;7;FUU/P5X+\5>!/B#X<UR2;5
M/%'@7PS\._&_[1F@Z'#92>')/#,OZB_L/?%6Q^*GP0M+JSL?$4,WAG58-)U7
M6?$VKG7=0\6:SXD\*>%?BCJ?B*YU`0P16^N/=_$.32?'7A6",0?#KXBZ3XN^
M'-M)=6GA2VO;D`^J_P#A'M"Z_P!BZ3D$,#_9MCPRD,I_X]^H8!@>H(!'(J?5
M=(T[6[&;3=5M(KRSG'SQ2CHPSMEC<$/%,A):.:-ED1N58&M&B@#X^\;_``QU
M7PN\M[8K+JFA99A<QQEKJQ09(34(HP?D4<"]B7R6`S.ENQ`;S#]?IR/S[U^B
M!`/!`(]#SUX/Z<5Y)XJ^$6@ZXTMYI1&A:DY9W-O$'T^YD.23/9!D6)G;&Z6T
M:%B26=)3Q0!\E45V_B#X>>*_#F^2[TU[NS0G&H:9NO;;:#@-(B*+FV#$C_7P
M(@)QYC8R>(ZD@=5R&'=2.H8=5([@X(H`****`"BBB@#XG_;^^$+?%?\`9U\2
MW.G6ANO$_P`-91\0_#ZQ1E[F:WTFWE@\5:;"%!=C?>&IKVX$2@^9=:99C!95
MK^:<$$`J0RD`JPY#*>0P/<$8(/<&O[-8;.747-E#92:F9PT,EC%;R79N(IE,
M<MO+!$DA:.>-FBD5EVLCLK94FOR1\+_\$4/BUXL^*GBX^(?%OA_X8_!FW\4Z
MC+X6O$QXH\>ZOX6N;C[=IMO:>'H'MM)T26TM9SI#W>O:NT\,]H+G^PKR!U#_
M`*#PAGV%P&$Q>$Q^(C1I49?6</*7-)R52T:M*G"*E.34U&I&$%*3=2K)JT6U
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M:+E;5"#L[J,I5)1LG*$7.#[.&N`,/ELZ>-S:5/&XR%IT\/%<V$P\UJI2YTGB
M*L=&G*,:4)7<83E&%5?)_P#P4N^(GCCX1_\`!/W]L;XF?#/Q#JWA/X@>!OV=
MOBEXF\&^)-!EM8-<T3Q%I?AF]N-+U+1Y[])+*#5+:Z5'L;B\4VT-UY<MP5C5
MV'YO:+^U_P#';]GCXE>/OAQ;^%/VB-;@UOXA?`[X'^$OAE^TK>VW[0GQ=\!_
M$CQ9\,?CK\?O&/QD2;]FF^^).O>*_@AXB^%'@'2/"?@SP[8>+-9U?6_B[X4\
M=:9`?AYIGA3Q'<ZQ^ZOB;P=X>^(7@[7O!'Q+\,^&/&/A7Q5I=_H?BCPIKNE0
M:]X8\0:'J"-!=Z5K&CZQ;SVNIV%Y;L8KRRO+>6WG4E&1E.*^=_%LW[(7QF^)
M?CCX3>-/"'@/XG?$,2^$/AO\1]%UWX77WBW[(?#OA:[^/7P^\.^,]<NO"M]H
M6GVND:)XQU+QSX&?6=7M[6TUGQ!JD7ARY3Q/>W]B_P`0?HY\E)_P4+^*D.I?
M!S7?&'P8TGX1_"_Q#X7^%NI?%'Q/X_F^(NK/X9\2?$'XO^+?A/K'AV_E^'?@
MOQ7+\'8=#M_#VB>-/!/B#X]:#X2\-_%./QI8^#3K?P_UOPMXUU'1>$^&_P#P
M5)^('CSP-KGQ"O\`X%WO@;PYXN\(Z3XE^#5]XZ\,?&GP_:MX@\4?&CP7\&_!
M/PKUMH?AUJVJ?%'XD^-Y?'.E:[X>T_X(Z)K.AIXAL]3^'&O:UHFW3O'U_P#I
ME>?LR_LX:AJW@+Q!>_`;X/W.M?"S3M*T;X;:G-\,O"+7W@/2-`O)-2T'2O"4
MO]BB30-+T'4II=2T.PTT6]EHVIR/J.EPVE^S7!KR?LM?LS2K\1XY?@!\&I%^
M+[._Q3#?#+P>R_$-Y-477G;QB?[&(\0.^OJ/$#'43.S>("VNG_B<,UZ0#\KM
M&_X*R_$2>Z\4:%JWP.L[77?@II'[<GB#XY1W5QKFAZI+HW[$'AK]ECXBZTG@
M#P;/)K.I)XD^)O@O]IC2M,T+PUXCUN<>&?$VFR7>I:SJ^F1_8+[M_'_[1W[7
M^H?$_P#8C\)Z+?\`P%T?QM\3?C?X^TG5O#W@KXE:_P"*/AEK_@[7/V$?C9\:
MO!]C\2V'AJ/QI8'PKXMT#2]2TM-+@L$^(D&B:1XNTBY\-:9J-]H>D?IIX4_9
M^^`_@'4;75_!/P;^&'A'5;&Q\1:99ZCX9\!>&]&OK73_`!?IW@;2?%=G#<Z;
MID$D=KXETSX9_#NP\01!MFLVO@?PG!J/VE-`TX6\?@[]G;X!?#U?#47@/X+?
M"SP;'X-\4ZWXW\))X7\`>&=!3PSXQ\2>&+SP5KWBC0!I>EVJ:3KVK^#+^\\)
M7^JV7DWEQX7N)/#S2_V05LU`/D&Q_;MU'QG^QC^S9^T?X/\`"FB:-X[_`&G!
MX$T;P?\`#W7/^$X\97"^,O$N@^(]?U_P]X4TGX?>%[GQ!\0M0T+3_!GBO5[&
MUNI/AWIEYX8T;4/$?B7Q/X.L].NXC\:Z9_P5_P#B9KO@SQ?X]T[X%>$M.T?X
M*_`SQ%\:?C/IOB7Q?X@TS7F7X5_MC?'O]DOXH>%/"%I9Z+J5O9ZI>2_!#4?&
M_A6?Q#<3VVEM<CPMXA-])*VNZ?\`L7J?[/7P&UOX9Z/\&-7^#7PPU+X2>'AI
MAT#X:7W@7P[<>!=$.D3RW6D/HWAB;3GTC3)=,N)IIK"2PM8)K.6:5H&C,TF_
MYV\,#_@G[XO\>^./V??#7@OX$WWBK7?#?C[P!XM\'1?"[3;+0/''AWPUXWO_
M`!-\5_A_::K<^%K/P1\0H?"'Q$\?ZKK7Q.\$>'=8U^X\'^+O%>HWOC#2=*U7
M5;MY`#Y.\-?M@_'3XL_M9?L2-`-$^'_P+^-'Q"_;_P##EAX*TW7M2NO''B31
M/V;M&U/P+I,_Q7T/5O#UG:Z7K,?C3PYJ?BDZ7X<U)H_!=SJ&G^%-8FUR_%QJ
MA_9ZO@_Q7XR_8?\`@E^T%92:[\,]+\)_'7QGXU\,V5O\1M'_`&7?B3>_VOX\
M^,+0>"=$2?XV^%_A1J'@U/$'B\:G%H&J2WGC>&Y:.Y:'Q')`OFN/HOP9^T'\
M'/B$VD)X.\=:5KDNO:[<^'M&@MH-4BN-3OK;PBGCU;JRM[S3[:>XT#4/!4]E
MXKT7Q5'&WA?7_#^JZ+JVAZSJ%GKFD2WH![+1110`4444`%%%%`!1110`4444
M`%(RA@589!&"#T(/4'U!Z$=".#Q2T4`43IFG&S73S8V9L$6-%L3;0FS5(F5X
MD6T*?9PD;HKQJ(PJ.`Z!6YJSY$/FF;RH_.,:PF;8OG&)7:18S+CS"BR,SA"V
MT.Q8`,23+10!6BLK2".WBAMK>&*T_P"/2.*&...V_=M%BW1%"P#RG>/$00;'
M=,;68&2&"&W0QP11PQF264I$BQH9)I&FFD*H`N^65WEE?&Z25WD<L[LQEHH`
M****`"BBB@`KF]5\(>&-;);5-#TZ[D)R9VMUCN3Z_P"DP>5<>_,AP<FNDHH`
M\DN_@MX,N'9X1JMCG[J6VH-)&IR"2%O8KIO;!<@YR1G!K(?X$Z"23'K>LH"P
M(#+8283<"5_X]4R=F5#]CAMIQM/N5%`'B</P+\-(29M5UR9<K\JR6,/`SN!9
M;)F^88&05*XR#70V'PD\#V(&_3)=1<'(?4KRYN1P>,PH\%L?3!A(_6O2Z*`*
M-AIFG:7"+?3;&TL(``!%:6\5NG'J(D7<>Y+9)).2<U>HHH`****`/F;]L;X=
M?$[XL_LT?%SX>_!W76\/_$+Q-X9CLM%N$U^_\)R:K;0:QI5_XA\(Q^+=*!U/
MPC)X[\+V>M^!X_%NG8OO##^(EUVU9);!77\;&_8*_:*N/C-\5O&7@#X)^(O@
M=\'/B1K?Q7O-'^'/A/X\^"/`GC+PIX<UW_@FYH_[-WA33K'Q#X/U?Q_X>^'O
MB>W^+FE7:^&KOPK:>/?#_@"YN;#QG;6U[:RZHD7]%E%`'X`:!^R-^TE:V6E6
M7BK]FZQ\9_L_>'/$_P`5I-#_`&<K+QO\.?@OXTUSQCXZ^$/PVT'P3\;?&VB>
M`/BSXH_9^\,M\,_&7A+QIIVBS_";Q)HFN:5%\1;CXYZ-\+7^,.@JNM=Y\2/V
M'/CO\5_BYXRT;Q+I>L:4OCCXP6VMS_M1:9\6FU.;PQ^RI>?LUVGP[U+]F?3-
M&O==L?B+J^MZ3\3X)M9L?M_A.T\$^(]2-I^T%K7B:T^+?G:!#^X=%`'\^?Q:
M_8^_;C^,MA\/_B7\1;76;;QIXV\$_%V+XI?"SX=:W\%_$,?PW^.>H1_"[P)\
M(/BSX<UKXI>(=+\'Z1#X;^&?PUU&ZTWX@>!(]:^)/PH\6^-M7UCPAX*\27.O
M>(TC]`^('P9^,/P$M?C[\=]]M??M(ZQ^W+\.[_\`9&F\3^,H+^;XK>$/$GP(
M^"/P=UKX=K9:.UQ#HFG>,M;E^/7COQ%X:M?#VD(^L:"/B)K6CZ?HFCZ=J.D?
MN92$9Z_S(Z>N.H]0>#T/%`'RG\`_A%IWPH\;>/-(T[X5ZKI`T[X9?LZ^!_\`
MA?FJ^,=-UFX^/-O\./#7BG1[>WG\*0Z]J.L^%]2^'S7-P=5U/6M,TL>+KWQN
M]Y9WNMC3;N>V_/?]F?\`9M_;`_9HU#X=Z/I6E?$+Q=IWP)\/_M1CX@7FK?'#
MPW=_#O\`:PTSQ!J'BGQ+^SWX;^%GPQU;Q'=:+\(?BE-K^K:-?>/OB3XC\*?#
M`:=>P^*='UWQ3\6--\6-XCTO]M:*`/DO5O!OQ*^)7QZ_9T\;>+/",_AWX;?#
MKX5?$#Q]J_AVZ\4:%J<FC_M&>+X?`_A'POI&IVFE75S;:Y)X"^'NL?&:QM]?
MTT7F@2ZEXB-Y9W0FCTYY/E'PU^R_\;?A-\<]/\??!#PMI'@GP7>^)[#X<Q>'
MKKQ#I'B=]"^#7@GQ3\'=(L[S7+[Q;J&LZM:^&/&7PRT#XG6^@>&/AW<V?B'P
M;+X8_9H\+R6UEH.D_$."/]8J*`$&<#/7\,_CCC/KCC/3BEHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
$H`__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>biib-2015630_15rdpiechart.jpg
<TEXT>
begin 644 biib-2015630_15rdpiechart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`$Q`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*\Q^
M-GQ&_P"%/?!SXK_%G^QG\1?\*Q^&GCWXA_V!%>?V?)KG_"$^$]8\4?V/'?\`
MV6]^Q/J?]E?84N_L=W]F:<3_`&:X\OR7].KS?XQ?#JQ^+_PE^)WPGU/4;S1]
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M/[&4/_"/_LX/\,OBIXB^%WQ)_9G\!:A\,?!GQ'TSPMX0\2/JG@OQ+X%\&^`_
M&6G:_P"$O$5E/H5Q>:K!\/O!7B/2M1@>&;0?$WA;1_,36/#+:UX8UK>_9._8
MS^'W['\/Q&TKX;ZWX@OO#GCA_@[#8:1K_P!@GF\-Z;\&?V?_`(9_L_Z):1:E
M9V]J^K7&K:-\-++Q)K-_=6ML\FNZOJ26UO!8K;0H`?)7A[_@K[\']:\>:+H.
MH?#/XN>$O!LOB?\`;P\(^)/$_B;X;_%%?$NF:C^PWXV^&WA'Q!J?A_X<:+\.
MM7\3>+O#/BFU\<:OKVIZOIRQ'X;0>$[_`$KQE!;ZO_:%MI7W#X;_`&O/V?O%
M_CO2_A[X8\=OKNJ:Y>Z9H^C>(--\+^,;GX;ZMXFUGP#:_%/2_!6F_%A/#_\`
MPK.]\>W_`,-KVU\=6W@:W\5R>*I/#$Z:H-*\K<J_,FE_\$VO#&E_%;Q9X^B^
M*_BN;P[K`_;9N/#G@N?P]X>W>%]1_;UUKP-XP^-DS>)H9(KW7K.S\;^"SKW@
MFSOM.MIM%L];O=#O[_5[2TTZ>WP/V=O^"5'P5_9Q^(O@+QWX9NO#FMR>"8/"
MFM"[\0?!?X0W_P`0]2^(OAOX-^'_`(+WGB6W^,%[X<O_`(A>'?#VNZ5X?C\6
MW/@SP_J=D=,\7W^I1Z/XELO!%Y/X+D`/2_VAOVW[KX*_'C2O@;IWA#X;SZM?
M?#KPW\1-*N?BW\==#^!5Q\69?$?B_P`3>$9/AK^SP_BGPKJGA3XE_%3PVWAR
M#5/%/AO7_&/@*TTB'QA\/;>74C;>*I]7T+NO#_[;/P@G\9>/O`OBGQ+H>F^(
M_#/QE\9_!_PWI7AV#Q]XBO\`Q+KW@RV^#9O_``\\=Y\/_#]O_P`+%%U\:O"T
M[>"O"MUXPM[CPY+/XET?Q#J]AH?C4>$J_P"U'^R/JO[2^F>,?!UY\:O%7ACX
M6?%3P%_PK;XH_#&[\'>`/B%X9U+0GCUVUN?$/@5/'.C:A)\//B#>:;X@N--N
M?$=NGB#1GCTW0=23PE'K^D1:Q+Y1/_P3=\)?V_KGB72_BOX\TG5(_P!HO6/V
MJOAO-##8WA^'?QJO?"7PJ^'.E^)3)J-Q=S^-(-*^&7P[\1_#NXL/%$LR>(?#
M/Q@^)PUZ6[UC4=$U;0P#UGXQ_M=Q_![]JO\`9I_9WU3P,+WPK\?]!^(\^J?%
M5_$AL8/A[XK\/ZIX+T+X:^';[PR-"O#K%C\4?$7B:Z\+6^MKKFE_V%XF'A?3
M/[.U=?%'GZ7X[\'O^"F/PX^(&J_'Z'Q?X1U[PEI/PT_:1?X$?!__`(0_3?&_
MQD\9_M!:+_PI/PG\;[;XA^%OAQ\/O`-_XOL;*?PKK>LZY+I=CI_B.VT[P7I&
MG>+M2URUCUZ#3;;V/]IW]C#PS^TY=:OJ&K^/_&W@/5;KX)>+?A+X?U[P/)IU
MGX@\%:YK/Q/^$_Q>\)?%3POJ=[!="T\;?#CQU\'_``MK?A;[1:W.FF\C:6^A
ME$:QOY5_P[G\,^%O'>K?%#X.?%'Q+\*O'UM\1O#WC?X?ZG9>%_"_BK2/`F@Z
M=^RG\*OV1];^'R^'_$,4MGXA\/:YX%^$7A/Q-%=7<UCK.C>,]+TRYMKJZT&'
M5-!UT`]6T_\`X*"?LF:QX@TWPYH?Q1EUZZU2?X3VUMJF@^!?B/KGA9+GX[^$
M+/QO\%+:[\7:5X1N_#-A=?%G1M0L[7X=6M]JEM=>+_$]Q#X*T6&Z\72IHS?(
MWPF_X+(?!3XD0?##Q=KOP^^)/PR^%/Q$_9B^)7[2M_XL\7>#OB#<^)/`NB?#
M'XX>&_@[X@/B[P/H'@'4K[3?`6GVOB#_`(377?B[<WUOX&\.Z+:2?VC>"%;J
M^M/0O!7_``2W^%7@#0[SPOX5\?>.+;07^*G["'Q1L;?4;+0[R^MKS]A35?A]
MK7AFPNKZ.TL(M0;XE:GX"%_XUOTL;(V=WK^IMX?LK*WBLK6'F=!_X)/>!]#\
M$?$+X<)\8/&5SX3\2?L@?M*?L4>#H)?#GAQ-5\$_"']HGQDGC8W%WJ22^5XM
M\5^!+^6^T_1]6O+#2+?6M)DLEURPDU.UN=3U$`^Z/`_[4/P9^(_Q%U_X8>#-
M>U[6_$/AS5?%WA^_U6'X?_$*#X?W'B7P!>P:;XZ\+Z/\4KKPM!\-M=\3>#]0
MN([+Q#X?T?Q5>ZK87<5_;FUDETG5TL(=3_:L^!ND?$V]^$=]XKU%?%VF:LGA
MG49H/!?CF\\'6'C:?P;_`,+"L_AU>?$6T\-S^`+;XF:AX',7BK3OAU+XE7QE
M?:+=:?=6VC2'4]-CO/%/`?[#6F>"?VC;'X_1_$W5Y+C2CXCG32-`\!?#SP#K
M7C)?$_A&#P=_PCGQF\=^!M%T35OC3X(\&V=M:ZE\.=$\<Z?>>(/#.NZ9HFKZ
MGXQ\2W>CVDAYVX_X)Q_![_AI7Q=^T3IT/A6UU3QOXUN?BIKEMJ7P;^%7B3QI
M;?%"X^&ME\+7UCPQ\9O$7AR^^(_A;PS-H^E:7K\OA30]3@N8/%ME)?:'XET3
M0-5UKPWJ(!W'A[_@HK^R1XK\+0>+_#OQ'UG5=,U71/A%XE\(V-M\+OBR?$WQ
M)\/_`!W74Q\)]9^$_@]_`Z^*/BMIWC"?0O$-G:WGP]TGQ';6%YX;\10:S-IH
MT/49(.'^$'_!2SX$?$/0;_5O%<VI>!+FW^+OQW\`):0^'O'_`(KL]"\%_"']
MHOQ[^SMX?^*?Q3U?3?`MM:?!7PY\0?$?@6\:R/Q2_P"$9L]*U>/7-`_M74CX
M4U_4;/@;#_@EQX4\/2?L\:_X2^,/C#0_B!^RW^S9^SG\`/A!XPE\,^&-633+
MW]G3_A,;#3/'.M:!>%=/UF3QSX5\?^+O!_C'PQYME9KHVLR7?AW5M$UZSTW5
MK+E-._X(]_!BQ\8'QUJ'B:P\;^*_$?B[QGXE^)'B/XH_!#X&_$[6_$<?BO\`
M:!^)'[1L7_")3>,_!VK:7\,-=TSQC\5_&N@MK?A?1YK+5/!VH6=G=^'4U_0M
M`\2:6`?1VH?M[?#F\_:2^!O[/'@/2-6\9R?%GQ[^T+\/-9\<2Z3XT\,^%O#N
MN_LZ^"-5\0^,8/">O:UX+A\(_%5]-\6:3=_#SQ0O@WQ7<1>$/$EKJ-IJ4TM_
MIMSIZ[_QR_;7^'W[._QS\)_"_P"*-M_8'@GQ!\"_''QAU'XEB75M4;1=0\.?
M'C]G'X">&O"(\(Z'X?U34=0'BWQ/^T3HSG7(KR*+0_[+"WEA+8WESJ6E\-X$
M_8`T3P'\7/A)X\L/BOXPNO`WP"^(7[0?Q`^#GPHN-!\*1Z3X6G_:7T_Q?_PL
M/1M1\4VUG%XE\2Z=INN^--8U#P1)J,L=[H6E2G0M5G\1NMOK%M-\>OV!=`_:
M3\6_$[Q=\5OB?XIO+GQ#\+IOA/\`">U\/>'O#&BP_![0;GXE_"[XU7&K0R2V
MVJ7'CWQ')\5_@Q\-O$`G\2/;Z,NC^'%\.C0BNI:MJEZ`=CXL_P""A7[)W@S6
M/$7A[6?B-JTNO^%-;^,V@:]HFA?#3XI>*=6LKW]GJV^&-_\`&F==.\,>#=7O
M+O2?AWI?Q@\`ZQX@URSAGT:+1]6N]3M[ZXM=$UJ2Q]%\/?M:?`3Q9\0[3X9^
M&_&\FM:[J.HV^@Z7K6G^%_&%Q\.M6\5W/@:'XFQ>!](^*Z:!_P`*SU3Q\?AY
M/'XV;P/8>*[CQ0GAH3ZF^EK':W:P?)WAW_@F5X5TKQ;XR\=:Q\7O&?B'Q3\0
M-&_;.L_%=[-H'AS3K:ZUC]M?0?V=-'\>:K865G^[TZU\*2_L\:3/X/TA9+B.
M.U\07ECJ][J$FG6^H7,?[.__``2Q^#'[.?Q.\'?$/PS/X;UB3PB-(\017&M_
M!?X27?Q#O/B)9_";2/A)JWB%/C)=^'K[XBZ-X<UJPTN;Q6?!NAZK8MI7BK5M
M4M-.\2Q^`[C_`(0<`'J_[7'[8'B3]EN_T:]E^'?@CQ)X5U&/0(-*L]:^-V@^
M#/BW\7O%6L^(&T>\^&7[-?PE/AGQ%J?Q8^)NC6$^DZP_A[5]8\"6.M2Z]HFB
M:'JMU//JVHZ'F:9^W!<WOQ)TV"[^&^GZ=\`_$/[3OB_]CGPW\5Y?'J2^+;SX
MY>"9?%&@ZE)J/PTB\+&QT[X>:G\2O!?BCX4Z)KL7C^^\5S>+++3M0U#P38^&
M-8&K:?VG[27[)^L_M&0^*_"FJ_&_QEX<^$?Q+\)VW@CXE?#2W\*^`_$,4^B1
MF]CU*^^&_BG7]%N=?^&'BGQ'97D=AK?B&R;Q"UM_9FCZUX3L/"OBJP'B&7(M
M/V)]"LOBG:>*7^(OBR\^%&D?'/Q)^U%X?^!LVD^'&\/Z7^T%XKL]<75_%G_"
M7"P?Q5=>&!XD\3>(OB3IW@FXF%M9_$S6[KQ!+K-YHEII'A730#Z2^+/BWX@>
M%/#%E<_"_P"&Y^)_C'6?$&B:!IFCWOB>R\%^&-'@U2>0ZAXL\:^)Y[#7=2TK
MPIX>L()[J_\`^$;\*^+O$VH7DFG:3H_AZZFOWNK+X6T#]OKX@^/[R'X??#'X
M":#XJ^.&@/\`M+7GQ"\'WWQC71/`D&A?LO\`Q)T3X3^)M1^&OQ%7X=:G>^/)
M?B!XZUZ+P[\.UUCP3X(L+75O#_CG3/B'J/@[4O"4MEJ7OGQ/^!/QW^)W[,_A
M/X/0?M0^(OA]\4TTWP19?$OXW^#_``)X836O'4>CVL2^/--LM%LKGP[;>![7
MXASI+:7^K^!;[PYXD\.:7<7:>#=5\.ZG):ZG8>1Z1^PGXHT+PY\/3X9^.T/P
MU^(OP^\#>/\`X+Z;XO\`@_\`!'X<^!/#B?`?X@ZIX;UJ?X?Z=\-KZX\5Z%HN
ML^#]9\+:9K_@/QQ::C+>:1KS:C<:UHWB72M9UG1=0`-/1?V^M'\9_&']C#P+
MX$^%/B[5?AI^V3\./$WQ'\+?&C7M4T/P_H>FVNF_!W3OC)H.@:3X;MY]:UWQ
M7K-WH-^+7Q5=@:'X;\)WWDZ?:ZWXEU=K_3-*9\!/VTM:^,GQZ\5_"_4+3X"^
M&O#VF^(_C3X=\+V-G\7O'.K_`!D\02_"#X@ZOX$NWE\'7_P7\/\`PX;40FA7
M?B+Q?X;\+?%WQ9XB\`:5J>@_V[IQ%]+-;X'BO]@GQ=_PLW]E3Q3\)?C['\+O
MA_\`L<>%O^$.^#7PRF^#^A^.(+;P_J?PXT_X3^)[+Q#XMU7QAI>JZP=2\&:=
M#!I<RV=G/HVJM)J=P^M*WV0>[Z7^S5XEE^+GA+XA>//CEXV^(7ACX6^,_'/Q
M!^$G@/5_#G@C2AX5\3^/_#?C#P9>RZ_XNT+1[/7/&VF^%?!_C[Q9X8\#6%_%
MIDMCINJ+>>+K[QOX@T[2];LP#ZRHHHH`**"0.IQT'/J3@#\3P/>B@`HHHH`*
M***`"BBB@`HHHH`^,/VXOC_JO[/WPS\&ZEH'B73?"6O_`!#^*6@?#71M<UG0
M?"VIZ5;7&I^'_%GB6[6ZUOX@_$OX3_#;P7+)IGA2]&G^)O'OBN;2&U%;;P]I
M7AGQ;XKU[P_H-W^6G@K_`(*E_''6M#^#'CKQ]K'PC\">'I+G7?#_`,0O"WAO
M1O"OCWXC^(M<\%_M@_%C]FSQ%KR?#_4?CMX'\7WO@CQ7X5\!:#KOP_U+]FRR
M_:"UVW\<ZMXD&N>&-3\*:;X4TWQ;_09J6F:=K%G-IVK6%GJ>GW'E_:+'4+6"
M]LY_*E2:+SK6ZCE@E$<T<<L8DC8)+&DBX=%859?#VA3W%A=3:-I4MUI=Y>:A
MIES)IUF]QIU_J!D-_>V,S0&6SO+TS2_;+JV:*XNO,?SY)-[9`/RR_P""DG[;
M/Q`_9A:UT?X4:QX=B\;:;\$OC!\<T\+>*_#7A2+3_'$7PP_LQ--\,67C'QY\
M7/AM;7,FK7\]QIVI>#/ACX=^(?Q2NXKW3]7LXO"]E'8GQ+P?[<?B_P`4_&_P
MS_P2QOO#G@/4?&%K\=_VA[#Q#XD^#MO\8_$WP<TSQ7H^J?L*?M)?%"#P_P"(
M/'OAF-;Z;3O"NMZ?I/B>VT^ZT^>SUC6/#&F+-;03&*>#]D+[2-*U.2SEU'3;
M"^ET^:2XL)+RSMKI[*>:VFLY9[1[B*1K::6TN)[626`QR/;S2P,QBD=&E_L^
MPQ8#[%:8TM@^F_Z-!_H#BUEL0UE^[_T1A9SS6H:V\HBVEDMP?)D=&`/P2^%O
M[3G[7OP&^.O@+]D+QZGAG53X/\<?!7PW)=>,_'W@76;WQ_X%_:'^(&L>(=3F
M\-?$'XK_`!H\"_'KX@VO[.7@7Q!IWPC\"^(?"WP)\?:E\4O%GP>\577Q$O=&
MN_$.SPHWX$_\%"?VCOB3I?P9UOXC_$_]G[X-6'Q&^&<7Q>T&]\6?#GQ!)HOQ
M6U"+X_Z[\";GX&^!)K?Q[;ZS<^*M+TGP_IGCGQ1?Z!IOB#Q#;ZU\6_A_INC>
M&I?#N@ZM_P`)3^]DVE:9<7]GJL^GV4VIZ='<PZ?J$MK!)?6,5Z(Q>16=V\;7
M%K'=K%$MU';R1I<K'&LXD"*!7_L#1`FF1_V1I?EZ-<M>:1&-/LPFEW;)/&UU
MIR"`+8W+1W-Q&9[00S&.XG0N5FD#`'\]GB#_`(*D?M5V?P]_:Q^($'@?X=^&
M]5^%'PT_:.\7Z;\.O%^I?"NXU_X6Z_\`!KXW>'/AGX`T'Q+X:\%_'WQ9\7_$
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MFM98C!$4`/YQ8/\`@K;\;;2P\66NH>(?A;)X>U/P9^RQ\3]#^,EQHGP]EC\(
M>&/C;\9?$/PR^(FCP?#WP-\?_'?AB[\3>&M*L/#^N>%_!7C[XMZ#XQT9]3U6
M/Q4?%&I0^'_#.M=W\,/^"A_[7+^,_@O\/_$VF_#[7]5U30O@!KNIZE>^,/V=
M;+1OCC/\>OBQXQT7QM-X&UZ/X[^&-5LM*^%7AJRTWPWX1\.?!3X=_M"W-E\1
M-*U3P1X^\;>)VMAXEOOV@^*W[.7PK^,&D>&]-\1Z/J&B7W@KQ9/X\\#^*/`&
MO:Q\//&'@WQI=:5XCT.\\1^'_$GA"[TK4+6^U#2/%WB6PU6&X:[T[5H-:OCJ
MEC>2R)*G0_#/X+_#OX2^&]'\,^#]"V6VBZKXL\06^JZY?7WB?Q1<^)/'FM7_
M`(C\;^)-1\5>(+C4=?OM=\6ZYJE_J6O:C-J!EOY;DPL%M(H+:(`^(OVZ/VK?
MB)\"/%F@>%O"_C7X5_!O27^`WQV^-MM\0?C%H$GB+P_\1O'7P@O?`<'AO]GO
MPS;1>.O`SVWB+QE8^*M6\1:F^G7&L^+[C0]'$7@[19;B'6-1T[S?]@2#XH?&
M+XJ_\%$_B1\>?$>NZC<:U\6OA[\(M"^%^L6NL:#?_!7P)JO[(7[._P`9]0^$
MT$VF^+9=+@F\+:W\<-;\.ZOJ&E>'O#WB'4/%6DZ[XMU'5I;[Q`NE:#^M=]IF
MG:F+5=1L;._6RO+?4;,7EK!="UO[5BUK?6PGCD%O>6S,S6]U#LN(&9C%(A8Y
MF@M+6V>ZDM[:"![VX^U7CPPQ1/=7/D06OVBY:-%:XG^SVUO!YTQ>7R8(8M_E
MQ1JH!_.3^SQXD/[."_$RU\$>+]/^$]O\3/\`@I3^UE^S1JW[1/QS\6^-?B=X
M`^"'PF^$&F>.?&OPO\'QZ1\0_BIH_A^PO-=UCPY:?#_P7<ZCKNG64,NKW=O-
M'K6L3:%I5UP/PA_X*#_M+P^,/CCXG^+'QNT'P?J_QJU[]DNW^!_PIUKP;X-L
M/#WA'PMXP^!?C;Q)XI^)'P^O/BU\;_A[H'A;X;?$.]^'E]K>A>+_`(C>(=3T
MEM9UW2_"2:=XQ^(^LZ)H-Q_3-<:#HEW97NFW6D:7<Z?J-Q)=:A8SZ?9S6=]<
MRS)<2W%Y:R0-;W4TD\<<SRW$<DCS(DK,9$5A#J/ACPYK$IGU;0=&U.=K+^SF
MFU'2["^E;3_MMMJ(L6DN[>9VLQJ%E:7PM68V_P!MM;:[\O[1!#(@!^,/_!.#
M]J3XH?M3_M(>-?'7Q%W:%=R_L9?"?3-5\%:/JUW-X,MO&7PZ_;O_`."B'P.U
MWQGHNC1ZSK6B6=]XYTKX4^']4O;[2[[4HKFQ72["VUO5M&TW2KBOB'X-^,?C
M?\,[GPA\>-,\!>)KG5=;_:D_X*J:YIOQ!T7]HOXP?$'Q/^U)>?`#XA?MB77@
M#]C?Q%\#M=\+'X<>`;OXA:7X7C_X5EK>GZ[XU&A:=\!FMO#VDZ3XIUS08;;^
MHJWTS3K2>6ZM;&SM[B=#'-/!:V\,TR&[NK\K+-'&LLBF]OKV[*N[`W5W<W!!
MFN)I'8-'TH1V\(TVP$5I?2ZE:QBSMECMM1FEN9Y;^W18@D-[)->74SW<02X>
M6YN)&E+S2LX!^"?@[_@H;^TWXI^#&I^*)O$OP`TJ5_&W[/NGOXUO_%W[.=OJ
M:VOQ7\)?$KQ#X]\$^!?#^C_M5^,?@]'XM\/WWA/PM<_#+_A>OQI^%^H^*/".
MM^*(-<T:3QGX?\-V?C2WX/\`^"FWQZ\>_%GX0^%O#'A_PA<^'-8TK]FJW^V>
M)K/X5_"FW^.>H_%?X@Z_X"^,/B'P?IOCG]IVZ\>Z9H_PZOO#^IZ+X!@^"GAK
M]I'P_P",?&.A:A<2^.-7\%>(?#FHP?NJ?"_AMM-U#1FT#16TC5IKJYU32FTJ
MP.FZE<7TIGO9]0L#;_9+V:\F/G7<MS#+)<RXDF9W`86FT72&N=,O&TO3VN]%
MBG@TBY:RMFN-*AN84M[F'39C$9;"*XMXXX)XK1X4F@C2&16B14`!_.%XK_X*
MW_'S2[KQ1=^!)?AOX]T#Q7\--;^(OPZUG6?"WASPXWA;5?"G[7?[+7P)/A/Q
M7X#\(?&OXB^/O"R>(?`O[0&I:O=:+\6_^$,^)FG>(/#37'_"-Z(R:UX4T#I_
MVP/VLOCU<_LX?\%"_".M?&WX=>#/'?PG^%/[4'PXT;X5Z+X;\0>!_CQ>K\+/
M@Q8^+?#W[3>B^(-`\<ZEJ'A/P]X\U;48_$FCVSZ):>&-,\"ZUX=TG2?&]W\0
M;>0^(?Z#1X9\.AKIO[!T;=>W4]]>-_95ANN[VY>RDN+RY/V?-Q=SR:;I[S7,
MQ>>9[&S:21FM;<QS7.@Z)>W%W=7>D:9=75_IXTF]N+BPM)Y[S2UDDF73;J6:
M%WN-/66:65;*9I+5999)!"'=V(!\)_!C]H_XBQ^*OVZ?A]\8]2\.>(;W]DKQ
M+X:U"Q\:^"?`/B#3AJ_@_P`=_`+P[\;H=,N/A]I_B#Q?K6L:QX/N]2UC0;9]
M"U,:EXOTN#1XHM*@\0-<W.H?F3X/_P""HW[27BCQGX8^'>B:E\+M;7XD^+OV
M&+SPM\2Y?#W@G4=/T[PQ^U+\7/B9\+/'^A7'A+X5?'3XG:38ZKX/MO"OASQ/
MX9T37_B&/&>DS:A/I'C;[=;7UAJ47]%\5G:0SW5S#;6\5S?-$]Y<10Q1SW3P
M0K;P/<S(BRSO#`B0Q-*[M'$JQH510HS+?PSX<M%B6UT'1K98;DWD*P:580K%
M=M?2ZDUU&L=NHCN&U&>:_:=`LK7LLMV7-Q(\A`/YF?VH?V^/VB_'?[*G[9O@
MW6?BE\.?@WXF^#_P/_:0\(:#K^F>&M<\,^-?VH_B%\,_VE?VBOV<M<UCX(2V
M7Q/CU/P#J?@?1_@MX3\1>(=(\.+XVU71O&'Q4TJ>YGL?"-CID6M_H+^WWJ'P
MPN/VS/V`/"7QT^($/@KX.ZYX4_;-UC6;;6?B[KWP@\)ZSXQ\+>%O@;/X(EU;
M5]'\8>#(M1U/1EU3Q%=:#;7FHS-;/<ZC>6<*2))<1?K%-X;\/7/E?:-#T>?R
M9M3N(?.TRQE\J?6A,NKS1![=A'-JBW-PNI2H!)?K-*MXTPED#1:_X3\+^*H[
M2+Q-X<T'Q%%I]Q]JL8]=T;3-8CL[G"C[1:IJ5K=+;3X11YT`CDPJC=P,`'\[
M?@K_`(*!_M._#_4?"_PW\/V-KXT^'.EW_B#Q-\#?B#\7?&GPPT_7_P!J7X+>
M)?VL_BS\,OA5;2>-OC!\9?ACXYN?[&^#?A3PH-/\<>`?AW\;OB!XROO&GPO\
M<>*])U#3_%=FWCWW'XP_\%"OVC?`:ZIX(TKP_P"&KOQ-\*OCH_[/'[0?C0:/
MX/T>R\"7GQ!\7^,/$_P5^(EO9?%'XK_#/X=:0OBS]G[PAX1UFQL/&7Q-TCPR
M_CKX]_#VTGU&]%I:^'?$G[A7.D:5>3Z?=7>G6-U<Z3,]QI5Q<VD$]QIMQ)`]
MM)/I\TT;RV4\EM));O-;/%(T#M"S&)BI;=:+I%]!J5K>:9I]W:ZRGEZO;7-E
M;7%OJD?V=+0QZC#+$\5]&;6..V*7:S*;=$AQY:*H`/YV=0_;6^/-G\6/`WQ@
MU76_!_AS4]>_8HT*QUK/B2T\8_`SP;:^+/\`@I1X$^`-[^TQXCT?P1\3=7\$
MWNG^"_A1J\_Q0\4P^'_B/K6DZ'9PZEX8/Q%N/"5A?^)5W_&/_!2WX[Z#JWB3
MP@GQ;_9UT2P\&_![]M7Q]X'^-WB'P5//X%_::UG]EGXA_L\:-X&T_P``:1;_
M`!0TZU@B^(<GQ<\5_"CQ-'X;\3>(+B^\>_#S7]3^'5NOVB+0]$_H(.CZ2>NF
MV!_XEQTCFRMC_P`2IB"VF9,6?[/;:,V.?LA``,.`*\YN?@=\*;OXC^&/BS<>
M#-,D\=^#/A_K?PM\+ZKONTL]&\#>(?%?@KQMJ>B6?AZ.X7PXA;Q1\//!VJV.
MI'26U;2)=%AATF^LK:XO(;@`_'WPI^W)^UO\3?BKX=\$:9>_#7X8VGQ+_:C_
M`&G/V6M+TCQ!\-=0\6>)?A=J?PF_9=3]ISP]XIUN:#X@>'['Q5KVBWVD:[\*
M?%/A1K?1=-U$74/BF#5]-OM)?1]3Y;]F#_@J%^TE^T-\1?@2FH?#SP'X.T'X
MDZ3^S>UUX,N]?^%>C7GB/PU\9_V</!OQC\8?%SP</%'QXA^-^JV6A>*/$>M:
M3X!\/^&?@9XM\)ZWH'@#Q;IWB+QY!XE&H7G@[]\4T?28YEN$TS3TG2]N=169
M;*U69;^\MVM+N]640B07ES:NUM<70;[1/;LT,LCQ,5,4'A_0K:XLKNWT?2X+
MK3=.;2-/N8=/LXKBQTIVB9],LYHX%DM=/=H(6>QMVBM7:*)FA)C3`!_,5X[_
M`&^/VSOB%^SK\#=7O/C3X"^#VO\`Q@^`G_!./]M+5?B!X%^'ATNR^&?@GXD?
MMA?!3X._'+P;K]UXC\>W-EJOP]'A;QU'X\\2^(M0F\.PZ?X;T+QGX9U><>%]
M?2^\/?T^Z7=07VFV%[:W]KJMM=V5K=6^IV+PR66HP7%O'-#?V<EO+-`]K>1N
MMS;/#-+"T,J&*62,JYJMX=T%K=K-M%TEK1](?0'MFTRQ-N^AR*4DT=H3;^4V
ME2*2KZ:5^Q.I*M`0<5IV]O!:006MK#%;6UM#%;V]O!$D,$$$*+'####$J1Q1
M11JL<<<:JD:*J(H4```FHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBD;H?H?Y4`&Y<$[AA<[CD8&.N3VQWST[T;E/
M1@><=1UQNQ]=I!^ASTK^=7QS^V)^TCX1^&/[?_PLE^+VI6_Q9^(?C?\`;'\6
M_L8>/[RQ\.#6_AM\,/@WX_\`CU\/?BOI6@6AT>+2-73]FW2_@19>,]&N-=L]
M8U`WWQG^'^GZT^KVTUO&<C4/^"C_`,5?AQ!X!^)NOZCX]\1>&/AUXW\?:A\8
M/!]EJ&E:S=_%;2_"/_!$#X+?MCPZ+X<L[?P?#<^$+.Y^*'C<:L-,M9M;,7B:
M/6_%%QJJZ#J@\)Z*`?TA45^2,7[>_P"T1=^#)A;?LP:W%XWL_BEHO@W5-4U'
MP1^T=IGABT\*:W\,-?\`B$WBO1/A;J7P8L/VG?'G]@^)=&M/A5X@C\$?"36+
M&RGU[2_BDMV_@F'6;#2?(/"'_!1GX\:G\8OCIJMOIWP>\=_!K5_`?_!-NQ_9
MQT;PUX@\4KI]A\4OVV?%/B7X?W.H^,OB7+\/+'4KKX=Z/XOTS55\0:G<^#++
MQ#80^&=%T33O".C^*==UW2[$`_<VBOQ/\6_\%0OB[X9N_BUX;A^!_P`.]0\5
M_LW_``2_:U^,OQJFF^)?BBQ\):I:_L<^//AOI7C32/A9JZ>`;Z_UB?Q[X)^(
MUCJ7AVXU_2]-@\'^-M.UWP=XFFU.+1/[6U3W+]GS_@H/XC^/WQX/@C1?@7XY
MT[X2ZOX^^,OPVT'Q_?\`@WXJZ6VE:G\%?[:M[[Q3XK\3^(/A]H_P?N="\;ZS
MX<U_0?#WASP1\0_%'C70KJ'0;SQ#IAM]<U2+PD`?I]17YB_''_@H#JOP?_:(
MT#X;6?@+3/&OPY_X7[^SQ^S9XW\2>&A\2+[6/!?Q"_:1U/P3I'A5O%'B!_A_
M9_";PW>:'<_$7P9J=WX%/C?Q#XMU?PKK^FZ_(WAF;4M%TG5?FSP!_P`%8?BC
MXQ\,_`07WP)\#Z1XX_:[^$?P4^(O[/\`8Q_$CQ)>>&-#O/BE\5=`^$>KVOQE
MUH>`_M&@Z9H%]XCT[Q1HMQX7MM<N?$IN;;P&Z:5KEW9ZY=`'[F`@YP0<$@X.
M<$=0?<=Q2U^._P`+_P!L7XS^"OV./^"CO[1OQ"L['XE>,_V7?CU^W*OAKP7;
MZVSZ`OAWX#7DL_ASP!IOB73O#.F:DVA6<5A<6<>IWOAYM;LXIIDU&*XNK1V;
MM/%W[??Q(E_:9UO]E[X:?#/X>ZGXMG_:+UK]GSPAXD\:>/-?T7PZ]_I/[`_@
M']M5M>\20Z%X7US5(1YGBK4O!+Z-H]M=W7V6RLM?,\0DO;:W`/U3R,@9&2"0
M,\D#J0.N!D9^M+7\XW@S_@I7^TGXT^/EY\3[;PMX?D^%7C+PS_P3E^&_P6^"
MMSXWUK0K'P]XR_;OUCQUIVN^,_B3JT'@*ZD\6R>%?$G@EXM.\0Z6D5I_PKZP
MT^^\+>%CJ?BS5M_T+\2O^"JGQ%^&'PMU[XS:K\$/">L>#-9\._M12_";3-*\
M=>)+7QIJ'BC]D7X@+X!\>6OQ,T34O!<-EX'T'QQ<:;XGOO"^HZ?JNO77A.\A
M\)>&O%EO>:IXLFFT``_;2BOQGU+]M']JC5OVU/@#^SMI^A_"+PKI6A_M4_&7
MX'?M(6]GJ?B;Q1:^+/#>F_L:>"OVM/AGJW@'6M3\(:'J.B:E:^%?'T-EKUE>
M6\$=UXU\.?9X;^?PGJDJVW[,4`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`'D6H?`'X(ZJLBZG\)?AYJ'F6W
MQ9LW:]\(Z)<R?9/CSJ`U7XU6RRS6;RQV_P`5M25+[X@0QND?BNZ2.;65NWC0
MKFVO[-7[/ME<VEW:_!;X8PW%AJ=UK5I(/!>@L8-5O?A#HWP`O+]%DLGC^TW?
MP1\/:'\)[F1D;[1\/M)L/"DP?1[:.U'M]%`'S0/V-/V44\"CX9Q_L[?!R+P&
MOB9/&<7AB'P!X=ATRW\6PZ<VBV_B6U6*Q2>TUVUT%V\.VFJ6T\-[:>&V/ARV
MFBT/_B7UMZO^RU^S;K?E?VO\"OA3?10_#&/X+):R^`_#ILS\);?4;;5['X;O
MI\.GI9S>#-*U6TAU/1?#TEL^G:'J"R7VCP6-S-/+)[Y7P/\`\%"OA'\;OC!\
M+_AQH_P:NKR\L?#OQI\,^+/BYX`T^R\+:M>_%7X76'A;QMILO@I-!\=>-OAQ
MX&\46=MX\U?P+XSUCPEXO\<>&M#\3:/X3OM,N+V[F>VT35@#W^U_9@_9SL]$
M;PS:?!'X76^@3?##QI\&)M'A\$Z'%I]Q\*/B3JBZY\0OA_<VJ62QW'A7QSKD
M?]M>,-(N!)!XCUAGU/61=W\TEQ)J:!^S]\"_"WQ"O_BUX<^$?P\T/XFZEIT6
MEW_CO3/!VCV7BNZL4T^QTDPOK4-DE^S3Z3I>DZ5>SQRBZOM,TG2=.OYKBTTN
MP@M_S`\"?LW_`+3W@?Q5^SAXHU.U\::[X2^'GP\N/"OQLL?%GC[PS<>(O%=]
MKFI?%K5_A%XL31?#WB>Z\+F3]C?2_$?_``C%UHUKJVO77Q`T'XAQQZ=KOCS7
M/@/X&U/Q%\%?`G]F+]L_XJ_LJ_LT>/?`&@>/_A[X>UW]ES]B"^_:.\$^*?&7
MA;Q]XB_;#\3Z+IZ>(?%?B+2_#/C#XJZ!H5JUAX;OM%TWQ9I'Q<U[X2:G\2]-
M27X6^(+-O"O@_0GU$`_HH\0?LV?L]^*OB`?BMXE^"WPRUWXDO<^$KYO'.J>"
M-#O?%#:CX#U?2]<\%:J^LS6#WIU?PGJNAZ/=:!J[R'4](_LRQ@L[N&TMH8%R
M[C]E+]F6\\.Z=X1NO@-\*)_#.B?#9?@_H^AS>`]"?2M)^%R:_HGBJ'P'I=H]
MB8++PQ;>)_#7AWQ'9Z59B*"RU[0M(U>S$&HZ=9W$/XN^-?V&_P!L;6O`OC<Z
M;9_$36/%GAK_`()__$+0/V?Y]<^*OA+PWK'A3]K&+]I/XF?$_P""=C:Z;X4^
M(USX5\/:S\,_!&J^#?#GA#76\0>(/#7A3PS;)X-E^('B&.'5K_4>F^)O[)O[
M;>H>+?VF[?X):-XG\%:C\5X/C=>ZK\8_'7Q$\,7?B?4],\2_%/PMXYT+P'\*
M_&G@KXM:5?\`B31O$/A+2/$'PX\!Z#\;/@?X`O\`]F[POKUOX>\&?&-=-TJ\
MU#Q<`?MGX3^#OPD\">$=;\!>#?AKX(\,^!_$UQK5SXB\'Z+X3TFQ\-Z[<>)+
M2.Q\13:SH,%DNG:B^O6<26VM->VLPU2'*7WGB1]_S9XJ_P""=7[(OBO4?A8\
MGP?\(:)X:^%/B#Q?XDL_A[X?\*^%-/\``/C#5/&/P9N_@3/-X[T.70+F37GT
M/X?7,.G^'+JVOM/U#2IM.TX?;9K.V:RD_-OQ#^QW^T;<_!_PM9+X"^,?B(Z9
M\3OC-XE\+?!ZYU+X`Z/X)\!Z?XP^'GPY\->%K36/@AH'[1OA?PGINA:=XJT+
MQ=XO\$^(_AK^U##\1?@QXJ\1>(?%7AFW<>.)=)\"_JK^S5X2\3:%J7Q%UKQ[
M\%+KX9_$CQ5IOP/N?B-XWM/BE<?$?P5\6O&FB_`[P9H/B"_\!1ZQXOU[Q=H?
MA_X?ZE97?PW-YXP\/>#=?\:76@R>-;FQUM]7;Q#?@%&#P_\`L5WGQWN?@A:>
M$_@Q+\>-!\%?!_XU7/@BR\):2GB/1?!GP:\07OA;X&^,&2TTI-/TVW^&^NZG
M>Z?\.X5N8+WPTM^TVBV-K8723OE?$GX>?L)^#OB/8>%/B9\._@3I?Q,_;0U3
MQ'X`@TK6?`VA2^(?CI?:3HK_`!)\7Z)J!ATB>35[?^SO!EOXH\2SZI);:?J5
M_H6BW&KW5YK,.C(WPI\*OV7_`-NCX(?MG7_[1/BRW^%GQ]T"S_9(_:1MO$NJ
M?#O1IOA[X]^+?QJ\8?%WP3\1O!GP]L3\2?C#?:/H&JZII_@[0_"WA76M;:U^
M&O@GP3X>T[P?<ZCI$<-GJT.Q\=OV4OVT_B)^U9^S=^T#HUQ\&=6\*:7^U1\,
MO'GB/PYXE\-Z_%X]^"GP)\/_`+-'QN\#:WX#O=6MOB_-X,\7VX\=?%'Q1<:O
M+X)TE[[Q/XX\:>&M=U"WU#P-\/X;&(`^Y-*MOV+_`(VZI8^(=-T/X3^-M>\9
M?&'1_B'I^K'PU"^O:U\8?AC\,_#Q\-_$2WNKK3;;53KNB_!VW\)1^'?&ZM'9
MZE\-=3\,0:5JVH^&/$FCQZI]:7CZDAC_`+/M;&X!WF4WE]<690Y79Y8ATZ^\
MP-E]Q8Q;<+@/N.W\I?`O[,_QL^#7QTTGQM\&?!UIX4\`ZOXILOAY)H.I^(=%
M\5WGAWX.>`O%7PA\*07?B/5O$VIZCJ]KI'C?X0>%?&]UX3TOX?RKX@\-W_@K
M]FGP?XAAAT/2?'<4WZT#H.O3OC/XXXS]./2@#!TK6+B]O]6TR]LXK.\TIK%F
M^SW3W<%Q;ZA;--!/')+:V<JD20W-NZ-!MWP%DD;<RIO5R,;&W\<W2%0$U3PM
M9R@CC=)HNKWD4C'KR(]=@!)QP%`S@[>MW+ZC\Q0`M%(&4]&!^A!I:`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`H`P,>G'))/XD\GZGFBB@`P/3V_#THHHH`****`"BN6\3^,-#\)6RSZK<
MD32@FUL;<"6]NMN<F*'<NV,$8:XF:.!"0&DW$*?F/Q5\4O$?B,R6]M,^BZ8Q
M(6TL976XE0Y`^UWRA)I,@_-%"((.=K++@.0#Z3\0>/O"WAO='?ZG')=KUL+$
M"\O01U$D43;;?CO<R0KZ$U\+_'7]N'Q!\._$$/A[PEX`TVX6XTR#4K?7/$^I
MW3Q3I/+/`R1Z/I*0LIMIK=TD,FKY<LI55%6O7W))]R>I/N>YKY4_:G\/_:=`
M\-^)XDS)I.I3Z1=N!R+/5XO/MMY[*E_9%020-UUCDL!0!RFM_ML_M!ZQJ4>J
M0>)-#T&:"VN[2VBT7PMI?EV]O?36<US&KZPNL3R%WL+7#RRN5$9V!2[&O!OC
M=^V=^U%X>^$GQ)\1:'\9?$FEZSI7A35-1TV^M=/\+;[*\C:(QS01S>'IH`8]
M[!$DBDC`(&P@#'#5XW^T/_R0KXL_]B/J_P#."O?X4I4J_%/#5&M3IUJ-;B#)
M:5:C5A&I2JTJF98:%2E5IS4H5*=2$G"<)IQG%N,DTVCP^)ZE2CPUQ%6HU)TJ
MU+(<XJTJM*<J=6E5IY=B9TZE.I!J<*D)I2A.+4HR2E%II,^.-%_X*R_\%#-!
MNS=0?M+>(M2.^(FW\0>$/AIK-FPAD+A#;W'@M2J2$[)_*DB>6/"%UP"/I/X=
M_P#!>+]MCPDRQ^--.^#_`,5[8L/-?6_!][X/U=DW9(CU'P7J]AID;X^56?PY
M,!C)5CG/XL-U/U/\Z2O],,9X:>'V8TW#%<&<-M3BE*>'RC!8*M9)6Y<1@J6'
MQ$-MX58OS/\`.;!>(O'F`G&IAN,.(DXMM1KYMC,92NVGK0QE6O0EMM*G);W1
M_6U\$_\`@X!^`'BDV>F_'+X8>/?A%J4IMX)]=\.-!\3?!J2.VR>ZF.GPZ/XR
MLK5.)-D?A?59$0E?,DV;V_:KX3?''X0?';PY%XM^#WQ(\'?$?P_(D;27_A+7
M;'5OL+R`E;;5K."7^T-&O0%/F6.K6EE>1$%9(%88K_-[KL?`7Q#\>_"OQ-:>
M-/AGXT\4?#_Q=8E3;>)/!^MW^@:NJJP803W6GS0F^LV*CS=/U!;O3[@#9<6L
MT9*G\?XK^C'PIF4*E;A;'8SAW&>]*&&KSJ9IE<GHXP<:\_[0H)N]ZJQF)4(_
M#AIM6?ZUPS](_BC+YTZ/$N"PF?X7W8SQ-&%/+<RBMI3O0IK`U^5:JE]5P[F_
MBQ$;W7^E/17\P?[%W_!=^[MI-.\!_MI:6D]J1#:V7QR\%:*PFA;<J>;\0_`N
MEHP:+83)<>(_!%N2&`^T>#X81-?K_1SX1^)OACXAZ/;>)?AW=1>._"E_!:7.
ME^+/#.I:)?>&]8AN[6*[631]4.J10ZE'!'/%%=RVP>*VNS)8R.+NVNH8/Y$X
MS\/^*.`\:L)Q#E\J-*K*4<'F6';KY9CE%<S^K8M1BO:*-I3PU:-'%THN,JM"
M"E%O^J^$..^&N.,&\5D./C5JTHQEB\OKI4<QP3GHEB<*Y2:@Y7C'$495<-4D
MI1IUIN+2\2_;A^+'Q0^"7[+/Q>^)'P4@\&W'Q<T30])L_AO#\0M.U35O`[>-
M/$_BWP[X0\/_`/"5Z=HNL^'M5NM"74?$$+ZC'8:UIMR+=6>.ZC*'=\5^(?\`
M@I#XQO/C3^Q#H_@OPEH1^%WQ;\'?%;6?VE+"^LI=1^('A'QUX?\`V??CS\4/
M#'PF\%WLWBGP[H.B^,?#OBK]F_XEZ5XZ3Q;:W5M-9)H,,$VA1ZBVL#]-?BE\
M-/"?QJ^'>L^`/B%I^HQ^&=>?29]5LH-4&FWR'P]XATOQ-I\BZEID\X@5-2T.
MPN9#%,=]NLD,NT/(!\=>)OV&OV'/&OA3Q?XHU[3],O\`X>^-OBI\=OC?XUU1
M/B?J$/@W7/&?[0OPA\3_`+/GQ;U"[URWUU+*PTK5_!7B[Q#8VUAI.K:99>'_
M`!/?S:]I1L]?>6:3XL^P.-\%_P#!5_X$>/O$&E^!O"WA+QQXE^)&J_&3X?\`
MP8A\#^"/$'P8^(KIK?Q1^%/QA^,G@C5Y/&_@3XKZ_P##`:-J/A#X%_$6#5F/
MCA;WPQK.CB#6K2'3KNPU2]\6^!W_``6,^%NJ?L\0_$KXSW.@MXUT7Q6GP]\:
M+X)U3P?X2\$Z=\4?&GQL^)_@#X5?"U]:^)?Q#TG2?#GBC4/`WP\O_'GC/4_%
MOB32O"O@[1-+U"]U[6M-U/4-+\-/]H^%/V"/@/H7Q&\+?&BYOOB7XV^)WAWQ
M-\._&D'COQQ\3?$/BO5]9UOX8?#_`./?PS\#W.JF[==/N++2O!7[2?Q-TV/3
M=/L]/TNYEU#3-5EM7U33_MMUR6G?L"_LB>'O!G@7PWX=75O"MIX7O->T#P)X
MET#XE7VC^)+7QK??&CQ%\:M.U73O$%M=1OJ/C_P;\4M9^(-WX6EECO+[3+/Q
MI\2_"-_I^I^'_&'B[2+\`^<]>_X+#_#?1/&_@G77\!:C+^S#J_[+O[0?QU\:
M?&NU\7_#35G\)>,O@1\>O`GP`U+X>6=GHWC^_P!#\66]]X[\8:?X:L?%WA76
M-9\)>(-4\7^!M<\/>)+GP-_PEOB70?<?`W_!33X2?%1-%T/X5>"?&?Q-^)>J
M>)/'V@W_`,//AUXH^!_CN3P]IOPR\)?#SQIXU\;7?Q!\-?%Z^^$FN>%-&TCX
ML_#>S4^$_'VNZ_?>*/%4'@^'0TU_1_$MMHGI7C/]A']GCXJV7@2#Q?)X\\67
M7P[\-_$7X=W6O7WQ2\6:EXE\7^&/B1XDT+QKXX\,^/O$<NI7&KZJK?$CPEX.
M^(6ARVEWHVK^`/&'A#PW=>!+SPMI^FKI4FY=_L5_#+4K#PB^K>,?C?JOC/P=
MX@\3:Y8?%*]^,WC8_$RZM?&^E>'M`\;^$KSQ/;WMLD7@3Q9H7A+PO8:OX.TC
M3=)T-+WP]I'BG2[;3/&UE%XG`!XU\*?V\96_8B_8:_:1^+/@[4]=\>_M<:!^
MS7H4/A7X5:78V=F?BO\`M`^$H=6TNPT^S\9^*K./0_#/]MK-8O<:QXCN7T2U
MFAN-4O'MK:^O8<M/^"J/P/AF\66^L>`OBYH$_P`,?ACXP^)GQBBU'3/!-RWP
ML7P%\6OBK\!O$G@G7&T?QUJ4/B#QV?C%\*[GP1X<T;P/-XGM?%DGBSPKXBT7
M4I?"DNL:WI'>_%7]@GP9XM^!7[*G[._PZ\3:M\,OAU^RO\6/V>O&_A2.TNM9
MU'Q"?"/[/OVF+0/">F^);;6-)U?2]6EM3816WB>:XOS`UD?[0TW5(+FXMY.A
MT'_@GO\`LRZ-8^--/N_"FN^)XOB5\&M1^"7Q%F\6>,_$VN7_`(V\.Z]\2?B!
M\7_%'B+7=6N+]-8;X@^)?B5\3_&'B_5/'5CJ%CKL6K7UE+I$VE)HVCQV0!R"
M?\%!O#L_CBZ^"D'P.^-`_:/TK4-<_P"$F^`X?X17OBWPEX+T+P9X0\<W/Q4U
M7Q#8_%B7X<ZCX#FTKQ[X3TS3F\/>-=5\2:IXMU&Y\)V>@'4M'UF2P\!_9M_X
M*R^!_'7[/WP0\=?&#PSKNE>//%2?L7>#_B;J/AC2-*TOX?:1\0/VMOV:/#'[
M2%OXAT6+7/&5YK=A\./"/AS7IH?$3ZK+<^(=*NK*XM;.RUZ&`:C<?5=O^P)\
M$();/7?[7^+LOQ)C\2ZCXAUCXSR?%SQD/C!XKMM9\,>'/!&M>$O%'CJ&]AO=
M2\#:GX-\(>%]!D\)16]GI5A)H6G>)M&CTOQO$_BB3F="_P""9?[*'AR;X9KH
M_A;Q1:Z/\*;'X$V_ASPJ?'&OS^$;Z_\`V;_"4WP[^$_B#Q1X<GF?3?$WB'0_
MAM._P\OM2U2*4Z_X1CM-.UF&[GT[3;RT`/*?B/\`\%(?%^D>#/V;?''@#]E/
MXNZAHW[0G[1/[-OPTT*;QO??#7PU%JGPF_:+L/$VJ^'OB?X:O;3XD7^FOK:V
M'A^(W/PY\17VC^,O"[ZKI<WC70]$M=5TJ6]]5^%G_!0+PW\;=/\`B9<?"CX(
M?%_QOJOPYO-+MW\(Z7K'P+M/'6JI>_$)?`&I1:OX)U?XRV'B?X4Z[X?$&I^,
MM3\'_&K2OAWXIG\&:9<3Z1INI^)%E\,P;]O_`,$^/@+:_#Z#X=0W_P`6GT[0
M/$7PJ\2?#;6;_P"+GC/6O$GP?N?@9=7UU\';#X7ZGKM]J<'AS2?``U75K*PL
MKFPU8Z[IFJ7NF^,YO$]D\4,%J#]@SX2VNK:OXBM_'/[0D7BFX\*CP!X6\9?\
M+^^(\WC;X<?#RY^(G@SXH:]X$\!^,[C59O$^F^'/%/BKP#X97Q%'K&K:_J=[
MX=LI/"$&IV?A:YGTEP#[:!SU!')&#[$@'CL0,CV//-+2`8[D\D\G/4DX^@S@
M#L,`<"EH`****`"BBB@`HHHH`****`"BBB@`HHHH`*\M^(/Q'M?"<9TZP6*]
MUZ:/<(6;-OIT;J3'<7H4[F=^&@LU*O*O[R1HX=IET/B'XWB\'Z6/L_ES:S?A
MX].MV(*QA1B6^N%ZF"W)4*AQY\Y2$';YK)\;W%Q/=SS75U-)<7-Q*\T\\SEY
M9II&+222.Q)9F8Y)Z`850%```)]0U&^U6\FO]2NIKV\N&W2W$[;G;'"JO`6.
M)!\L<,:I%$ORQHJ\52HHH`*X7XF^'O\`A*?`/BK140/<7&D7%S8C`)_M#3<:
MC9;3V9I[58@00<2L,\G/=49P02,X(..H.#G!'<'H1W'%`'X[@Y`(&`0"!W&1
MG!S@Y&<'/>O&_P!H?_DA7Q9_[$?5_P"<%?3/Q&\/CPMXZ\4Z$J[(+/6+J2R&
M,`Z??,+^P*_[(M;J.,'I^[([5\S?M#_\D*^+/_8CZO\`S@KZ+A#_`)*WA7_L
MI,B_]6F$/`XK_P"26XF_[)[._P#U68H_"1NI^I_G24K=3]3_`#I*_P!98[+T
M7Y'^6P4444P"OO\`_86_X*'_`!D_8@\6(-!FNO''P>UB],_C+X/:IJLEMI%W
M).T?VGQ#X/NYH[J/PEXQ5$YO;>`Z3KHQ;>([*Y*V>HZ;\`45Y>=9)E7$66XG
M*,ZP-#,<NQD.2OAL1&\9=8SA.+C4HUJ;]^C7HSIUJ,TJE*I"<5)>GD^<YID&
M8X;-<GQM?`9AA)J=#$T))27\T)QDI4ZU&HO=JT*T)T:T&X583@W%_P!]GB3]
MI/\`9>_:)_8H\;?'"[M?%_Q:^`FH>#[J;QSX#\`>%/'/B_XDZ@]A<:>^K?"O
M4/AQ\-EN_&FI>)KK4'M-!USP;`DNF:YI5],NJS7?@75+R_G_`"]\`^'_``IX
MC\0>%?CQJ?PTF'P#U+]K4_$3]H']FGP;^SS\6M0\$?!O3;3]E#QA\,/@7X@O
M?`&I?"WP[!\5/$%MXR_L_P`2_&CQ?\-O`?B3PEHOCK6?`<M@NHZ1\(X/B=J7
MX@_L!?MQ>-?V'_C%#XNL!J&O_"_Q8;+2/BU\/X+J1(]<T2*=!!XCT:W=C:Q^
M-_"B--<Z%=.D9U*S>^\-7ES%9:DEQ9?W>>`?'7A#XH>"O"_Q"\!Z[8^)_!OC
M+1-/\1>&]>TV9IK/4])U.W6XM+F(MB6&38YBN;6=(KJRNHY[.[BBN8)HD_SF
M\6_"[&>'&<Q5&5;%\.9G.I/)\PJ17M(.%I5,NQK@E!8S#QDG&HE"&,HVKTX4
MYQQ&'P_^@/A9XEX3Q"RB3K1I83B#+HTX9M@:;:IS4ERPS#!J;<GA,1)-2IN4
MYX2M>C4G.$J%>O\`G;^S5XCT7X<?LRK\&?C#HGQN^'NG3>%?VD?BWX;T?2?`
M'QMT?6/AQ^RQ<_M"^+8OA%X!7QGX!T[4=0\'?$OPG\'_`!?\/]&T7X6Z%X@T
M[XNZ'HFGW$6@>'+2/P?J4^E_`G[,'PW\+_$;]AKP1X`\#^'/BUX.^)'PB^/G
M[3W@;P/X`U;X-_$SP/I^E>'OVC_VR/B=XR^&/B2X7XC^`](?2-#T#P%HW@[X
ME2?$WP_/<^(/!_@6WU_1X;F#Q+XTLK.[_H\P.G08Q@$@?D"/SZT!0/7\6)Z?
M4G_/T%?DA^J'Q5^PYXD\>:K\-=;T#QS\.-5\#7?A3Q&87U/6;?6+/5O%GB3Q
M+80>,/B)?^((]=2.XU3Q?I_C_6_$%IXO\4:(I\%>)=<EN+SP<T>DQ"TMOM:D
M``Z?Y_SZ4M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M5+4=0M-*L+O4KZ40VEE;RW-Q(<96.)2S;0?O.W"H@Y=V51RPJ[7S_P#'#Q$T
M4&G>&;>0AKK&I:B%;!-O$[1V4#@9RLMPLD[*V!_HT9((84`>&^)M?N_$VM7N
ML7>Y6N)-MO`6++:6D>5M[5/X<1)DR%0!).\TO_+2L&BB@`HHHH`****`/AW]
MJ;P_]D\2>'_$L49$6LZ7)IETX'!OM&EW0EB!]Z33[R-1DY*VW?;Q^>O[0_\`
MR0KXL_\`8CZO_."OUY_:(T#^V_AIJ-W''ON?#=Y9Z[$0/F%M&YLM2`]OL=XT
MK<](`3D+7Y#?M#_\D+^+7_8CZO\`S@KZ+A#_`)*WA7_LI,B_]6F$/`XK_P"2
M6XF_[)[._P#U68H_"1NI^I_G24K=3]3_`#I*_P!98[+T7Y'^6P4444P"BBB@
M`K^A_P#X(6_MKOX,\:7G['GQ!U:7_A%OB!>ZAXB^#-Y>W.;?0?'2V[WOB/P/
M`9Y`+:P\9V=O<>(-'MXF2&/Q18:M$D3W?B6/'\\%:V@:_KGA77=%\4>&=4NM
M#\2>&]7TW7_#VM64KPWFDZYHUY#J.DZE;2QE72:RO[:"X0@C=Y91LHS*?DN.
M>$<#QQPQF?#N.48_6Z+G@\3*/-+`YA1O/!XR%O>_<U;*K&#C*MAYU\.Y*%:=
M_J>"^*L;P9Q'EV?X)RE]5JJ&,PZE:.-R^JU'&82=WROVM*[I2DFJ6(A1KI.5
M*)_IA`Y&1T/(HKYO_9%^/VE_M/\`[./PG^-^FB&";QOX6M;CQ!IT3HW]C>,-
M,DET;QCHK*IW(--\2V&I6\'F+&TEH+:<((YD)^D*_P`K\?@<5EF.QN6XVDZ&
M,R_%8C!8NC+XJ6)PM6="O3;6C<*D)1NM':ZT/]-<#C<-F6"P>8X.JJV$Q^%H
M8S"UH_#5P^)I0K4:B\ITYQE;=7L]0HHHKD.H****`"BBB@`HHHH`****`"BB
MB@`HHHH`*\Z^+/Q4\%?!/X>^)?B=\0M3GTKPGX6M;6:_GL]-U#6M3O+O4M1L
MM$T/1-#T/2+:\U?7O$7B3Q!J>E>'?#>@:3:7>J:YKVJ:=I.G6T]Y>0QMZ+7S
MQ^U-\%]6^/?P9U?P'X;U_3_#'B_3_%OPM^)W@36]8L;W5-!L_B!\$_BGX-^,
M?@6/Q+IFGWNGWVH>%K_Q5X%TK3/$UI9745[)H5]J#6#"^CMJ`/)'_P""AG[-
M/AV;2]&^+WB;5?@!XXU7XO\`P_\`@9;_``Z^-.D1^%?%X^(GQ6TC4=?^&M@B
M:;J'B'P[?:+XTT;1]7O-(\6Z1XBU+PO%<Z/K.AZIJVG>)-&U71K/U?X*?M5?
M!+X]>#=1\:>"?&6F6UGH;^.'\1:-XEU#1M"\4>&-,\`_$+QO\,]:U_Q-H$NJ
MSWN@>'+CQ)\/?$YTG7-4%MI^HZ;8F]2:/;<0V_PK\5/V'_CK\8_'Z?M)>*)?
M@UIWQLT3X_?LA?$WPM\*['Q3XPU7X9VW@/\`9/E^+4FG^%[_`.+5_P##2R\2
MGQAXKU+X]_$SQ*WBVQ^#MK8Z.+;P;X3;1]2AT[4O%-W\Z>(/^"0?Q1UCX4_"
M+P1I_P`0/AWX2USP9I?[:<OQ$UGPE=^(M)N/B9?_`!W_`&V/A#^UG\,?">M:
MQ%X.;4-0\(3Z?\,[[P=\2+W5K&]N?#U[KJ:IX:\/^,[6TFL+P`_;VR^+GPKU
M'2_"VN:?\2O`%]HOCD*?!>KV?C/PU=:7XN5M7TSP^C>&-0@U22T\0*VO:WHV
MBJ=(FO`=7U;3-,'^G7]I!-Z'7Y,?!#_@G_XX\$_'3X"_&GQI?^$[_P#X5_=_
MM@^+/&FB:K\0/&'Q9UM?B#^T+'^S9IWA'7O#7BKQ)X`\"Z;J-SI&G?!3Q'=^
M(]2LO!?PY@M=5\31W&BZ!J-_J/B+7+W]9Z``]#SCW]/>OA/QAK#:]XFUG5-Y
M>*:]FCM2QSML[9OLUJH[!3#$LF%XW2,>22:^R/&&H_V5X6U^_#%7M]*O#$P.
M")Y86@M\'U\^6/'OTKX2`P`/0`?D,=J`%HHHH`****`"BBB@"CJ>G0:QINH:
M3=*&MM4L;O3KA6&1Y-];R6SD_P"X)=X/8J#7X6?M+6%QI?P9^,^EW:E+K3?"
M?B'3[E2,$3V5Q';2Y&!C+Q%OH01P:_>&OR!_X*%^'SH?A;XW7")LMO$7P_O-
M?@P,*9KE(;740N.,B^M)I&QWF!Y)-?1<(?\`)6\*_P#929%_ZM,(>!Q7_P`D
MMQ-_V3V=_P#JLQ1_-LW4_4_SI*5NI^I_G25_K+'9>B_(_P`M@HHI45I)%BC5
MI)7("11JTDLA)P!'$@:20D]`BL3V%.Z6[MU^2W8;["45ZEX?^#/Q#\1".6'0
MGTJTDP1>Z_*-*C*$CYX[:57U"8`'("6?S8P&KW+P]^S5H]OLF\4:]>:I)@%K
M+1H_[+L@>ZM>3BXOY0.F8X[//)XXKQL7Q!E."NJN+IU*BNO94/W]2Z^R^2\*
M;\JLX:GLX/A_-L:TZ6#J4Z;U]KB/W%.SM[R]I:<XZ[TX3/CL`EE0`L[G:B`$
MN['@*BC+.Q[*H)/85Z3X>^$?Q!\2^7)9^'KFQM)",7^MG^R+7:?XD%THNYN.
M0(+63<,8/-?=OA_P/X1\*J!H'A_3=/E``-X(/M&H/C^*34+LSWA8GDE)D7/1
M0`!75DDDDDDGJ222?J3R?QKY7&<;S=XX#!Q@NE7%2YI6_P"O-*2C%]FZTUW3
MV/J<'P1!6EC\7*3ZTL+'EC_X.J)R:Z-*E!]GU/UP_P""%FJ:UX#\._&#X#^(
M/$D>L)]OTSXI^%=.MXYDLM(6_CB\-^-+>RDNY?/ECN+ZW\-ZE*L=M;PK=75U
M<%#)<NQ_H'K^5[_@GEXS'@S]K;X6M-,T5GXJDU_P-=@.564^(]#NVTV-\<,#
MKNG:3L#`YDV8P<&OZGPP(!R.0#U]:_A3QIPDZ7&^*S*:C?/,)ALQFX4X4X.O
M%2P5>T8*,>:<L)&M4=N:4ZSG)RE)R?\`:WA#B:<N#L-EU/FY<FQ6(R^FISG4
MG[!\F+HWE-RDXPCBG1IJ[4845"*C&*BL+7/%?A?PS-H%OXD\2:!X?N/%6O6W
MA7PO!KFL:=I,WB3Q/>66HZE:>'-`BO[FW?6->NM.TC5M0MM'TY;C4)[+3-1N
MHK=H+*YDBW=R_P!Y>W<?Q?=[_P`7;U[5^=7_``4-TKQ49/V*O'GAWP'\0/B!
MI'PA_;B^&GQ)\?6'PT\%Z]\0/$VC>!K3X2_';PI?^(T\+>&+/4=?U&PT_6?%
MV@6]Z=,L+R>W2_2=H3"DKK\@_&CQ7^U_\3/CYX2\>_!GP;^TUX#\(6?QA_8[
MDL-%UWP[\;--TKQM^S?XA^('P[T+]I_5]6\-/\2OAS\-/A!K7ASPSKWQ(TS4
MO!?Q&^$?Q2^/%Q)X8M?B=X&U7PKH%]X7U7PO^2GZ@?N59W]CJ%NEW87EK>VL
MC2K'<VES#<V\C03/;SJDT#R1.89XI(90KDQS1O$X5T91:)`ZD#KU..@R?R`)
M/MS7\L/PE_9^_;Q^"7PF^&/P.^']S^T!\-?#/PWT3]HSPQ9FVTC]H/XL:J/V
MHM<_:*\1>)/!7C$:GIOQX^&ND>*/A7>?!S5_!^N^!M2\?^(?%/[+%YKLWQ'T
MOXEZ9HWCF\O5F_9+]O+0OB]JG@GX2GP1XE^-6F0Z9XOU"X\?0_!?PU\1=4T[
MQ'%)X$UNQTJR\9GX$?$_X>_M%^&]$7Q3<6NJ>']6^&-[XOT>Q\0VNG0?$OPM
MJOA"22\L@#]`HK^QFNKFRAO+66\LA;-=VL=S#)<VJWBN]H;F!',L`NDBD>W,
MJ()UC=HBX1B+.]?4'TQR3SC@#)//'`_E7\U-M\+_`-J7P-\7_BO\3M8^#?[5
M'AOQ3^U?X(_8(UGXB:QX;^)OQL^*6G?"O2?AY\&/&GAOXUV7B&'X&^,_`-]X
MU\8^&?BI:>`_#5]X3^$FL?!WQAXBT?QK?>//#M[;_#C1?B=X?N/*+?XG_M&C
M7/"WPU_:S\??%ZRTOX'2^$]8^+^L7UY\0X_#_P`./`&C_M]_&3Q1X"\0_%7X
M5^!_&WCR\^-R?M#?LH>`_A]\/9++XL^,/'47@?1U@\<Z7KWCCQK+XTEU(`_J
MNR"<`@GGC(SP<'\CP??BEK\??V#-`_;:M/C3XBU#]I3Q;XWN)5\/_%J/XJZ#
MJ?@SXF0_#6]\=ZA\5["Y^%MY\-O&'C/XS^(_AU)H^B>`(=6M_#]M^S_\*?"&
M@:EX7U41_&!=*^(>C:98W7[!4`%%%%`!7Y=?'+_@I1!\&?B;\;/AT?@YJ/B$
M?"3QG^S7\+[#6+7Q#XDO+CQI\2?VJ+"VOOAUI-CX5\$_##Q_XIM/#WA^"V\2
MZA\0];L-,U_6=,T?2M+?P9X2\=Z_KDOA[1_U%KYS^(GP'_9QDTOXU>,_B-X/
M\)6>F_$73_"OBCXR>+-;OKW2H[BV^"VE-<^#O%M_KJZG:2^%[[X;6&GC5=#\
M5:%=Z'JGANYT^'6[74K?4+*"]B`/C36/^"DGBG2_!_P]\:W'[-GB7P[X8UP_
M$J/XA>.?B9J?Q*^%WPR\%W'PT\?6/@RX@LO&7BKX"0W6GVWC'2+N;XB>!/%/
MQZ\.?LZ^`=6\$6LTVJ>+]%UJUU?2M(HZ%_P53\+^(-;^*=Q:?";Q';?"[P5!
M^T3;>&/BOK'_``L/PWX/U;6?V=?$^K>"M5D\=^,?$WP<T;X1^`O"GQ$\5:!K
M&E?#'7M"^*_Q*UC69H].L=:\):%X@U:UT&/ZD;]D3]D3XH>"/`AB^'GACQ;X
M*A\):G;^'M4T_P`1^*;JT\;^`?B3>Q^-?$&E>+M>T_Q*EW\6O!7Q#U*^'BOQ
M-HGQ#U#QAX?\9ZCJ$VN:Y9:G=W\]S-TVH?L=?LRZG?\`Q"OM6^$'A34H_B?I
M/B71_&FCZDNJ7OA:^M/&4NGW7C.YT_P?=:G+X1\-:KXNO-*TO4O%GB#PMHFA
MZ[XCU33=/U76M3O=1L[:ZC`/A_PU_P`%4+K7?B)9?!J[^`6I:/\`%&'XSZE\
M*/%%IK.N?$_P=X7\.Z99_LS:S^U3;^.XS\4OV??AS\4]4TB?X?>%O%.D3::W
MPAT^]E\6Z;96N@2Z_HFK)KMEF?$?]N3]HW7?AY^R#\3OA]\+]'^'7A_]HW]H
M_P#9(M_!,%]\0O"_BVX^(?P+_:(TGXEZM'X?^($4_@9]0^$'B^UTOP_X7U_Q
MC)X9T_Q[I^D:?J:6'@'QWXU\0:?X@T.T^R_A/^SK^QY8^.-0\:?"SPOX+UCX
MC_"?XDSV?B7Q78^*M<\8>,_#_P`6=.^$\O@2\7QSKFK>(]:UK4?'L'PA^(R:
M-?S>+[K4M=?PQXCTR6[E=3I=Q!N^&_V+/V6_"$FG2>'/@YX6TDZ/X^\'?$O0
MDM9-;\CP_P"*OAZWB:3P"WAV"75Y;?P_X>\%R^-?%\_A+P1HL=AX'\/W/B?Q
M!<:1X;M)]6OY)@#S;0/VU[;6OV2Y?VCKCP7I>A>)K+XC^+?@K??#K6O'%PFF
MR_%[P+^T#KO[-VO^&?#_`(MTKP1JWB'Q=9ZEX_\`#>IR>!HO"WPQU;Q[X[T^
M?1]/T#X=S>*]5A\.1_*-I_P5MU'6['Q/9>&OV;]2O?&GPU\&?MF^,/BKH?B7
MQQXI^'&G^'(OV*;G]G^_\<V&A#Q_\%=`^(.K3^.?!W[0WA;6/A\GBOX9>`KV
M37+231/%%CX=T*Y'C*'])+_]F;X$ZE\,-4^#=W\.=%/PYU?QOX@^)=QX>AGU
M>T^R_$3Q/\2=2^,.J^.M&UBTU*W\0>'O%P^*&KW_`(YTSQ'H&K:9JV@>))EO
M]!N],DMK98>1T;]BK]EKP^WB%](^#?A:SE\5^&/BOX0\3SI)KDEQK^@?'+3?
MAOI/Q>MM7N9]7EGU&Y^(=G\)/AX/%6KW$DFLZE=>&;74)=1&HW6IW=\`?$6I
M_M__`!)^*OQ`_9-U7X+^%8?"O[/?Q1_;K;]G'6/'.N:SI5[XV^(6D:!^S9\>
M?'_BS2[WX:ZAX1F;P'X=/C_P;HEKX>\4Z5X[O_%VJR^$=0EO-#T'PMKMK<ZM
M^P2$LB$]2JD_4@$U\E6'[)G[(_A+XC^!_%%I\-_!.C?$/2]5TSQ#\/5DUC5+
M>\MO$O@+X?GX>1^*?#/ANZU[^SY?%5A\,[B#PIXC\4Z?H\OB#5_"=OI5AXKU
M+4K#3M+%M]57<E_$L0T^TM;K[PD%S?2V0C4`;-ACL;[S">0P81[0`06R0H!P
M?Q;G,'@/5P,_Z1)IUN<`=)-1M2<YZ<(1D<@D$>M?'%?5GQ9FU=_!5\MYI]A;
MP?;-,W26^J3W<H/VV(J!"^E6BD%@`Q,ZE0=P5L8KY3H`****`"BBB@`HHHH`
M*_/#_@I?X?\`M/[-?C;Q/$A,FD^&==TB[<#)%GJZ6\UN6/7:E]9E5[!KG'4X
MK]#Z^+/^"ANI65C^QW\:+.Z,`N?$VC:5X1T5KA0\<6O^(->TZ'3;IHMRF9;$
M07-]+"&'FV]O,A(5F(]WA>M'#<3<.XF:E*&'SW*,144$G-TZ&88>K/E3<4Y<
MD'9.25]VEJ>%Q1!U.&N(J:<5*KD6;THN3M'GJY?B*<+NSLG*26S]#^1"*&:Y
MG6VMH9;BXD;;';V\4D]Q(Q/`2"%7E<GMM0UZKX>^"'Q#\0>7(VD+H5F^#]KU
M^7[`2A_BCL52;49..0#:Q`_WP.:\)TK]J?XH^`+J]T>U\,?#;3[FQN9+*\B@
M\(265RMQ:2M%<++>6FKQ7<YE="2\TT@*E9(U4-SW%K^W?\0(VS>^"/!-X#(&
M;R+CQ%8MY?&Y`S7]Z-YYQ*R,%X!B;'/^B^*\1HU(J.`PRHQ<5RUL0G5FTTK2
M5.DU3B]G9SJQ?9H_SNPG"^!IR3Q^+K5)1?O4J%/V4%).SC*I+GJ25[IVA2EY
MIGUCX?\`V:_#MF8YO$FM:AK<@VEK33T&CV!..5,NZXU"5<\8$MJ2.H&37N&A
M>$O#'AB-8]`T'3-**C!FMK5#=O\`[4E]-YMZ['@L6N#DC.*^`K/]O>_!0:A\
M+M/8;V\QK#Q9>1'R\':(UN]%F7S`?O%W*D'A01736G[>OAIMG]H?#7Q%`=K>
M8;'Q%H]V`V3L$:W-C8EU(QO9V0J<[5<`9^:Q?$6(S!M8K,*M2+_Y=VE3H]/^
M75.$*7E?EOY]3ZO!87)<#;ZK0HTI+_EY*G.=72W_`"^J*=1*]G;GMY'WSW)Z
MD]2>2?<D\D^YHKXKM/VZ/A;-C[7X9\>V1\L,VVST&^429&8E,.MPLP&21*55
M6QRBDBNGMOVS_@;.<37_`(LLC\G-SX2NW4ECAL&RN[O`CZN6"@@_N_,Y`X5B
ML._^7T.VLK=K+6WE8]18G#O_`)>P^;M^=NY]6T5\[VO[5OP#NNGCV.V_>+&/
MM^@>);/);'SY;2741+GYY&957!SP":Z:T_:$^!]Z4$'Q3\'!I&9%6YU&6Q.5
MR26%]:VVQ>#B1]J-_"QJU6HO:K3?_;\?\RE6HO:K3?\`V_'_`#/K[X`:G)HO
MQV^"^JQ/+&]C\5OA]('@\GSU67Q5I5K(8?M"20B41W#[#*C*K8;!(%?U^C0(
MR.=5U_N,_P!KW6>I&>&`!^@`'8`<5_%C\$OB/\.M>^+?PFL](^(O@^XN;_XF
M_#V"T.F^*="DOC++XTT2%&LX)+IG>X65@(8VMY-\NU1%)N"M_;8O3\6_]"/\
MNE?SGXYQIO'\/5(N+G+!XZ$FM7RPK8>4$VM+)U)V]7W1_0/@O4YL%GL%)2@L
M5@YJS32E*C6C+9Z-QA"^FMEV/&/C+\=_AE\`M+\%7OQ*U35;1?B!XXT[X8^!
M[#1_#/B3QEKGBGQ[JOA[Q-XDT?PQI6C>&-+U?5;S5M7TSPAKGV!1:[+F]@BL
M_-6XN[=9/!(_^"B?[(\D8EC^(.J,(/AYI'Q-U:-/AO\`$=KOPWX6UOQO\0?A
M?I5OXGTY/";:GX=\6WWQ9^%_B_X2V?P^U6RM?'5W\5+&T^']EX=N?$^IV&G3
M6_VT?V=?B-^T*_[+3?#?Q?IW@:_^"O[5_@?XY:]XCNC#+J5GX;\+_#?XN^%K
MA/#VF7VA:]I&NZO<:OXXT6*;1=8BT^QO=#;6MNL:=?QV,K>0Z+_P3`^%FDZ/
M\2K-_B+\1[C7?BCX$^$NF:_XN1/!]MKUO\6?A-^U#\:/VQ],^.=A!'X;;PX/
M%VH_'WXT:IXIN?#=SX?G\"6^G>']#\.V^@-I)U"&Z_!S]L.^\:_\%(?V6O`W
M@S4_%NJ:K\0+R_T&Q^)FJ>)O`&G_``?^(Y^)/@FV^$-KX3N?B%J'Q(\(:EX<
MTVZ^%FA>'1X^\`&_\:?$J?PGX'ALO'/A7Q!+XG3POJ8UR+L)OVY_@.]QXUTZ
MPC^*?B?5/ASXUU?X;>.-,\&_!'XK^.3X<^(7ANRM]4\4>#[S4_"7A+6?#\NK
M>&=)N[75M7FM=7GTN/3-0T:\M-1NX_$/AX:K^=O[1O\`P3@^-6O^/K'QAX6U
M73/C->^*+;XE>*?B#XA\5W?PT\*W7BSXW?$"S^$_A.RG^)'@+Q%\,_%?@/7?
MV=/#_P`-O@;\,O"8^'?AA8O$]\FBWMQXF_X3C4-1BUFP^EKO_@F?X;\16\>J
M^)_B/J<WB/6OVA?B%^TGXW\.W7@[P%X^^$&K^-/C#X/\&>%_B!H\7PT^)GAS
MQ)H-]I^A2>%9[WX2>*M?M=1\8^`VUC4UEN]9M]4UBQU$`]=C_P""C/[(-]?Z
M%9:5\2+[Q#%XD3X/KHVL>'?AY\1-?\/74O[0/A:7Q;\"[%]?TOPK=:99ZC\7
M+6%]$^'VEWUQ:W_B3QJT/@6QMF\77-MI$O-2?M4?L/?%SQG\+=9D\.-\2/'\
M%O%K'AS4Y_V:_'WB[QE\%DF^*/BKX0FY\=7-Q\-=1\1?`JXM_B_X$\9^!M2_
MX2@^&9M)\2^$/$DVJ_8=/T/4=5M_+?A9_P`$E_A#\)?"OA?P?X>^(WQ"N-(\
M(^*/V$?$FD_;[;PL9PO[!&N_VU\.]-G:TTNVA:W\6JL=CXMDA@@:&!`VA1Z>
M<(NEXA_X);^!]=AT^P3XN^-M.TZW^*'QG^)XO;;P7\)9/'WA/6?C1^T;XV_:
M2UV\^#OQ;N/!DGQ.^#.O1^(_&;>$[K7_``CXH=-5\(:)HYET:T\3QW'B*<`^
MT]8_:)^'/A[X7?&_XQ:S;^,]$\&?``_%9OB#=>(?`/BKPA?/;_!S3KW5?%^J
M>%K/QAI>@-XQ\.SVEA<2>%_%V@27OA+Q<H6;0-;O;4M.GC?[(_[6.M?M'ZKX
M_P!)UW0/A1HEYX1T;P'XB2R^&WQJMOBAJ^BP^/(M>FB\,?$#1;OP?X(U'1-=
MTA=$"P>*?#,/B_X6^,;E]9L/"/C6]O\`PEKELGME[\&#XU^&_P`9_A1\:O&6
MK?&+P3\9I_BGH>IZ3KFC>&?"ZZ+\)_B=87FB2?"6QF\$Z7H<NH:)X>\.ZC?Z
M+I_B367O?&6HP7)N]:UJ^OHHIU^>_`O[%/B#P)J-[XQL?VD?B3J'Q4M_!?P@
M^#?A#XD:AX-^$9O_``G\!?A/\1+;QS=?#>/PS;>"[?PCK>I?$FS;5?#7COQ]
MJ^D2^(+:SU"+4_A_;^!=4T^"64`R/$'[;_B[1?CG^TU\'?\`AG7QFT7P&_9M
M\/\`Q\\)ZI+K^D3>(/B\-7^(OQ7^'=S::%X.T6+6KO0/"D%_\,9-0TCQ#K%^
M?$WB#3;R]O[?P+96-MHT_B)?!O[:6N^/[6\CT31/A)X>O?"]]JN@>*-5^(?Q
M;G\'>%=<U[3O$>OZ;:S?#/4;OPE-?^+?#NK>$M.\+?$>SU:XL-/5/"_Q)\&(
M?M%]+J`M]W1/V1_B5I/[8_B/]K.Y_:1U?4XO$O@G3OA3>_"R7X4>`[7P^GPK
M\,^+?B#X[\&>&(O$MK<IXF&J:'XJ^(FJ75[XG:3[;KMA:6>GW5I;MYUX[=-_
M8CL_"NHMKOA#X@AO$.O>&M"TWX@ZU\0OASX.^)]UXT\4Z5K/B[Q%JGCUEUXV
M<?A[Q!XLUOQOKM_XDMM&":1<%=*MK&QL+;2X(G`/O"OR:_X*+_"SX]?$O4=8
MTCPQX:^+_P`0_ACXH_9,_:1^&_@KPE\&/'MSX#F\/_M0>.-'M])\#^,/BL(/
M'?@6#7_`UYX+N->\-Z)/K@\5^$O"^J3:\_B#PXUUXET.Y'ZRD@`D\`#)/H!7
MR/XE_;9^`?A'Q;\1_#GB/5_$]CH?PCM_$Z?$3XG+X"\6ZA\)?"WB/P7X$3XG
M>*O!.H_$#3-*OM''C+0_`,T6OWFCPB6-IY5\+VM[<^-@WAA0#\G/V>/V6_VY
M+GQA:?#SXJ>./BQ\/O#E[\.]7\$?VYX+TGQ#8>$_#/P:U']E:#X=_#;PGI?C
M#_AJV+PEX;\5?#;XDOI&OR0^#OV7;?XJVWQ4\(ZGK]UX[O?`'B2_\2Z]!\5_
MAK_P4K^)\?@?XEZP_P`5/A_<^/?`WQ"T?6OAMX#M]5\8:Y\*/C[X6'@#X=_#
M3QW;:=X/_:U_9O\`#5CX?\3V'A#QW\3_``CJ_B7Q!X^^&>A7OC^6#XH>`;>Z
MGL)8/TQN_P#@H?\``:P^Q:/=:+\8K7XFZAXO?P79_!&[^#_BZP^,\]['\/[S
MXKIJ$7@2_@M+J31;KX;:=J7BG3KV*]DDU232]6\):;:W7C_2-4\(V?G^H_\`
M!3CX6>'_`(Y_&GX.>*_AI\6-`T[X7^'_`-E>^\(^-9_".H+%\6O%_P"UK_PD
MB?#GX>>&_"NJ6VBZ]X=\52W>@R:?Y/C)=$AAU"U\4VGB:3PC+X4G74@#Y$?X
M"_M*^$OB/\:=4\6^`_COXO\`@+XU_;8^.OQ`\;>%O@#XV'PV^*'Q+&O_`+*W
M[,'@KX*_%#3-0\-_$CX?ZU%X!L_B3X*^*5GJF@6OB^R72/%]_P"#?%&KZ5+X
M5\)7&M:;X[\"K#]M?Q/\:_''@+Q=KGQO\4_M`?!?XS?L#:5XR\?Z7\3KK_A0
MO@W0#^QG^SKXF_:[\/>+/"5GX[T[1-?NOB1877BF+31:>#-=CUCXH>*M$\9>
M#I?#D^G:OJNB?N_X"^.F@_$37/#FAZ5X%^,>CKXE^'E_\1(]:\:?!_QWX(\.
M:4FE^+(_!M[X.\0ZQXHTC3;;1OB(FI&74+3P==C^T=5\+VLWBW1GU'PT;?4[
MCY[^*O[7.H^"/VM/V=/V?_!O@&P\1>'?BG\4]=^%OQ@^(EY>7FF?\(7XQ;]F
MWXM_'WP-X6\-06UC-;>*_%-QX9^$XU+QG#J%Y8VO@_PMXJ\$3-+<WOB>R@LP
M#\K]!_9]_P""@OAWX4>"-5MKC]I6[^)FA?L8_P#!-_XB7MEJ?QM\5:M]I_;8
M\,_%R]\/_M0PZIIUU\0CI.I2M\#[#2-,\?>"'/\`PJOQ+I\LVI#1M3\57EUJ
MKQWOP._X*7O\-_VCK.]\7_'"_P#B[J>@W>F7U_X-BUKP?H?BOQU?_M7_``J\
M0^'O&GPT\<>(?VKOB#826?AKX):7XZMO#5G\-?@?\#/#MCX!UR7PK\0])7Q1
MI&C^%+3]8OA;^T3\:;WX_>'/@A\:OA=\/O">J?$/X-^,?C=H^D_#_P"(5YXX
M\3_"/0_"'B_P7X3L_"WQJCFT#3=`:_\`&4OC&5O"7BOP7J=UX:U3Q%X)^(GA
MC2K?6;#PQ'XPU*]KW[3_`(\T?]LO3?V9O^%)WG_"(:Q^S=\;/C7X=\?W'BK1
M#KOC[Q+\'_%7P$T"Y\,^$_!]E)=KIWAVX_X79!IP\2^,]6T+5[WQ/I%[::?X
M67PW;P>)]8`/SJ3]E/XU:/\`MU_!GXN>)/!'QI\8?!O]GW]L3]H?P[\(;UOB
MCXS\6ZMX2^$'[0/[*W[,\OA_Q;=QZW\1IM=\2?"_3?VDK3XV:;XC/B"3Q#=^
M%[&>/3O^$?'P_LM/33OWL`P,>G%?G]^SK^V)XB^,?C+2?`'BSP3H?@/Q"D4V
MJZ^=5U74]&-S%JW@OPUXF\,>&/"6A>)K+3-?UKQEI^LZCX\\+^+K?[)]DL$^
M#?BOQ+"L&F^(O#=M'^@-`'`_%"W-SX$\0*JEFBMX+H`>EI>6UPY/!X6.-V(X
M)`ZCK7Q;7Z`ZI9+J6F:AI[XVWUE=6;;AD`7,$D.3P>F_.<'&,U\!2PRV\LMO
M.I2:WDD@F4]5FA=HI5_"1&'X4`1T444`%%%%`!1110`5^2'_``5D\:_8_!7P
ME^'4,H$GB#Q-K?C+480Y#-8>&-,31],,D8X,;ZEXANW1FR/,LSM&4)'ZWU_.
MG_P4O\;GQ3^TU?:!%,);+X<^#_#7A9$4Y$.J:A#+XJUM3V$@FUNT@DQR/LJJ
M<%2!]1P=A?K.>X>35XX6G6Q4NWNQ]E#YJK6IR2_N^1\7Q]C/JG#>*@G:>-K8
M?!P[^]/V]1>DJ-"I%^4K/<_#;]HSP8++4K+QK8PXM]69-.UH(/ECU2&+_0;M
M@,[1?6D36\AX#7%HC'YYN?F2OU`\5>';/Q9X>U;P]?86'4[5X4F(R;6Z4B6S
MO$R1A[6Z2*8'J51DZ.:_,S4M.O-(U"^TO4(C!?:==SV5W$1]RXMI&BD"],HQ
M7?&W1XF1QPP-?TYD6,]OAO83E>IAK15]W1?\-^?)K!VVBH7U9_(7$&"]ABEB
M(*U/%7D[;1K+^(O^WTU45]Y.=M$4J***]P\`****`%R1T)'XT9/J?SI**`/M
M;_@F]X0F\<_M^?L<^'H+-KW?^T/\-];NHHB$D73O!^KCQIJ=SO".RK9Z?X=N
M;ISC!2(QED#[U_TR5.5!'<9YXZ\].W7I7\(?_!N[\';SX@?M[/\`$AK97T7X
M#_"CQCXGN+F6-9(H_$?CR-/A[X9MTW9VW,VG:CXPO(G`)1--E;*L4-?W>U_.
MGBYBXUN(,)A(M/ZEEM/VBO\`#5Q-:K5<6NC]BJ$^[4ETL?U3X(8&>'X9QV-F
MFO[0S6K[)M:3H87#T**DGNTL1]9I]KP84445^5'[.%%%%`!1110`4444`%%%
M%`"$!@5(R"""/4$8(_*OAKQ7^P3\,O&%]\;],U+QM\3[7X2_M"W'C[7?B;\#
M='UCPYI?@#6/'7Q,^']I\./%_C=-1M_"O_"P([^^TFPLO$-IX?E\9W'@W3/B
M';0_$"R\.Q^(X+6XM_N:B@#\[/$G_!.OPCXRTOQ5+XQ^,GQ,\;>/?'VO^%-4
M^(/Q`\>>#OV=?'1\=:)X#\,7GA+P-X,\2?#3Q7\#M6^#DWA[PA9ZKKNO:#/8
M>`-/\0VOC7Q%K_B637)TU6YTIJ]U_P`$VOAS90O8^"OBO\7O!^E:G\#?@E\"
MO&&DW3?#/XDZ=\0]#_9VC\16GPJUOX@VGQ<^&_CJW\6:A::5XQ\4Z-XKT;48
M6\)>+K'4;&ZNM`L=;\/:#J]A^C=%`'RS^SY^RY8?LXV'AKPUX,^*GQ)U+X>^
M'?#'CC2U^&>M6_PXM_!%SXI\??$R\^)>J^.;+3_#/@#P[>>$[K2)]3U+PAX0
M\!^![[PU\)/"7@BY31]&\`V]W9VFIQ>7>/?^":_[*/CSXZ_"_P#:*E\!MX=^
M)OPS^.>I?M#'4O#>IZC8V/C;XC:C\/?%/P_;4/&NERW=Q8WT<4?B.S\1M)I4
M&D7]]KGA;P]#JEY?:`FJ:+J?WO10!^=_PJ_86\=?"FS^,*Z=^V?\?M8\2_&?
M1-=B\3?$[5?`W[,?_"UU\;ZC/$?#_P`26\:6_P`#8SK&M_#_`$S[7X<\`>$_
M$&EZG\+?"WAFY70],\!P65E9QQ=UXJ_9&\3^)OVLO!7[5B?M+_%?1KWP#X8\
M3?#WP_\`"W3_``C\$)_`2_#7Q_KWPK\3_$?P;>:CJ?PRO?']RGC#7?@_X4O'
M\0#QA'XBT".35;3P]J.GV]XB0?:U%`'QU>?L5_#?4OB'H'Q0U/7_`!EJ'B_3
M_'FH^/\`Q'J=S?Z8\WC34!X\\,_$#P?IFL3-I;7.FZ/\/+_P/X'\/^%K;PU/
MHTTO@GPO9^$M?N-9TR\U,7GV(`%`4=``!]`,4M%`!7QS\5]!;1/%UW.@_P!%
MUL'5;=L<"61ME[%P`,I<J9<#_EG<1]\U]C5YE\5?"[>(_#;SVL>_4M%,E_:*
M`"\T`3%[:KWW2PJ)8U`):>WA0#YJ`/CRBCK@^H!'T/(_2B@`HHHH`****`#,
M8(,SB.$',SG@)"O,KDD@`)&&<DD`!23P*_D6^,/C67XC_%CXE>/99'D'BWQS
MXFUJW9SEA87&J7$>E)QD!8M*ALHD`X"1J!P!7].G[3OCAOAQ^SW\8O&$4ODW
MFG>`];L]+<.$?^V/$$*^&]*$;'_EJM]J\$J`9;,1VC.*_E"5!&J1J<K&JQJ?
M544*#^(`K])X`PMHYAC6M7*EA:;MMRKVM9)^?/0;]%YGY#XH8R\\JR^+^&-?
M&58WW4W&A0DUW7)B4K])#J^0/VC/!8M;VR\;V,6(M1:/3-<V#Y5OHHL:=>/C
MI]KMHGM)6/WIK6`D[I>?K^L+Q-H%GXIT#5?#]^`+?5+22W\S&6MI^)+6[3TD
MM+E(KA2.3Y97HQK]3P&*>#Q5.MKR7Y*J7VJ4K*6G5QTG%=911^,9CA%C<)5H
M.W.USTF_LU8W<'=[*6L)/^64C\O**OZKIEYHVI7^DZA$8;[3;N>RNXR,!9[>
M0QN5]8WP)(FZ-$Z,.&%4*_0TU)*46FFDTUJFFKII]4UJC\U:<6XR34HMIIJS
M33LTUT:>C04444Q!2@$D`<DD`#W/`I*^L?V(OV4O%/[:?[2_PU_9_P##0N;6
MR\4:FVH^._$%O$SIX1^&FA>5>^-_$DTG$<,\6ELNCZ'YSQI<^*-:T&R#9N:P
MQ.)H8/#U\7B:D:6'PU*I7KU9;0I4HN<Y/O:*;LM6]%=M'1@\)B,?B\-@L)2E
M6Q.+KTL/0I0^*I6K35.G!=%>4DKO1+5M)-G]>W_!O'^S#/\`!S]CG4OC=KMO
M)!XG_:?\21>+K."9$1[3X:^#AJ'AOP"NTQB=3K<LGB/Q8I>5HY;+7M,>-%*E
MG_?C<N<;AGTR,\=>*Y[PGX6T+P-X5\->"_"VG0Z/X9\(Z#HWACP[I-MG[/I>
MA:#I]MI.D:=`&9B(;+3[2WMDRQ)6,$DDDG\6?V;_`(Z_&2*+]K']I3XS^-_V
MB)/!'P2^-W[?6C^&[KX@>/OV</"/[(WB'P_\'OVBOB3\*/AG\/['3/!WA_Q'
M^T1HM_H>A:-I&EPZYK?@VYEU#Q!HE]>6H\9W^I:+H^N?QWG>:5<ZS;'YI53C
M+&8B=6,&TW3HJT,/2;6C]C0A3I7Z\E^I_=W#N3TN'\DRS)Z+4HX#"TZ4YI65
M6N[U,37MT]OB9U:S71SLM$C]R*`0>0<CU%?CS\/O^"FOC[QQ\8?#7[.R?`.'
M3OB[J7[06E?!K6O^$BU3XG_#GPMIN@^(?V8OB!^U'HWCB"P^)_P?\*_$O;'X
M:^&/BWPG>:+J?@*P:\UZ/1K_`$O4GTS5;XZ"S_@G_P#MS_$CXJ?"C]ESP-\3
M+(>-/C1\4OA_\-/'MUXPO-4TS3IO%7PV\2>'_B=J?C7XFWVA:!X>L;+1KGP3
MXL^&U_\`#K4-%L;9M-FUGQ#X`NWU*R3Q9#;6_E'M'[$T5^?7Q1_;`^(WP^_:
M/L_@]/\`";0M#^'NHZQ\.?!FB?%WQWXB^(.F>&O%7CCXJ6KVGAS1])\1^#OA
M+XX^&7AC4[7QK=>&_`\7@CXJ?$7X>_$#QSJ7B2UNO`&B:LD_AFW\7?GC\/?^
M"L_QR\"_L._!_P#:`^-GPY\!?$OQ_!^S7?\`[3OQXT?X5R_%R\U?2_AK#XJ\
M7Z1I>K6NA>%?@AXA\+?#\:QI7@[Q+/9ZY\4?%O@WPA?ZSX6US1M"O-8M=+\1
MZ_X>`/Z$Z*_%+X@_\%4/B#X-\9?%FZMO@0NL?#'X3:Q\2?!ES#X;7XB>-?'V
MI^/-+^-OPG_9]^#NE>,SX>\"GPU\.='^,WBOXF77CKP;/X,?X\>+=7\!^$=>
ML!X,L/%>FZII]E^B?[*WQU\4?'SP)XBU_P`8_#3Q)\,?$'A/QWJW@:]L=>\,
M?$OPC8^)DT_1O#VNVGB_PGH_QA^'_P`+?B3#X;U*T\1Q:?M\5^!-!O;?7](U
MVSM?[6TJVT[7=4`/IJBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M^1OBIX*?PYJSZO8Q8T35YWD0(H5+"_D!DFLV"@*D4Q#SVF`!@RP`#R4+^45^
M@.J:99:S876F:C`MQ9WD3131MC.&'RNC8)CEC;$D4JX>.15=2"HKXQ\:^"]1
M\&ZC]GN-UQIURS'3=2"82X1>3#,!\L5[$O,L7"N/WT.8R1&`<91110`4444`
M?F5_P5.\;?V'\"O"O@F&4+<_$#Q_9/<1AL2/H_@RQFUNY.WJ8FU:ZT-6/3<%
M!Y/'X"5^GO\`P52\;C6_C9X,\#P3B2W\!>`8KN[A7!$6L^-M2EU.7=@G]ZNC
M:9HF5(!5)5Z[LU^85?M?".&^K9%A&U:>(=3%3\_:RM2?G>A&DS^=N.L9]<XE
MQZ3O#"*E@H>7L*:=:/E;$SKIKO<****^E/D#Y%_:-\%B&XLO'%C$0EVT6E:Z
M$'"W*1[=+OF`'!N(8WL9F[R06A/S2'/RS7ZC>(M"LO$VAZIH.H#-IJEG+:R/
MC+0.P#074?I+:7"17,9'.^(#H37YEZQI-[H6JZCHVHQ^5?:7>3V5TG\/FP.5
MWIZQ3+MFA(X:*1&[U]GD6,]MAWAYN]3#V4;[NB_@]>1W@^T>3N?#\08+V&)6
M)@K4\3=RLK*-9+W[]/WB]_O*7M'T,VBBD)"AF9E1$5G=W8*B(H+,[LQ"JBJ"
MS,Q`4`DD`5[I\^211R321Q11RS2RR1Q10P123SS332+%##!!$KS3W$\KI#;V
M\*/-<3R1PPH\LB(W]ZW_``1@_P""=?BC]B?X*2_$;X@:)HZ?'KXZZ?INI^.=
M&U99+36/AOX0M`U[X0^'=KJL%OJ!74(7NI];\?V/V:*&7Q+=V]A'<RQ^%;5[
MOX!_X(C?\$A=5T;4?"G[:?[4OA@6-U#;PZ[\`OA%XDTP&_L9[E$ETSXN^.-+
MOXS_`&?J<=NWVGX=^&KNV^W:49XO&.JI9ZLF@VEA_6*!CC_/^?>OP/Q+XSIX
MURX=RJLIX:G-/,\33E>%>K3DI0PE.2TE2HSBIUIIM3K1A"+4:4_:?TOX2\`5
M,O4.*<YH.GBZM-K*,)5BXSPU"K#EGCJT7K&M7IR=/#TVDZ="=2I-2E6IJE0L
MY=2D:07]E96J@*8C:ZA-?%VR=P=9=-L1&%`4JRM(6)(*IM!;Y4M_V$_V1+;Q
M9XT\9I\!_`S:U\0[KXA7OCN.XM-5N]!\6W7Q6DU.;XD3^(/"=YJ5QX0U67QK
M<ZOJE[XB-SH4AU*^OKG49A]LE-Q7UR?ZC^8K^7^\^$/[9'QN^&/[4.K_``"T
M#XQZ3\2[7XD?\%=_`2?$J^^,5G8:-\2]`G^/WQM\(?LV?"?P%X?UCXB03>&O
M$?P_\?1>&_%WAKQ)KGA3PQX<\%:!X2ULZ)XOU"/X@76F:I^-G[R?OQX)_90_
M9L^'.M^'_$G@CX+^`/#?B/PQJMMKVB^(=.T")-=M->L_!GBKX=V^NRZU*TNH
M7NMIX%\<>+/"G]K:E=7>I2Z#K^HZ?)<R6\RJF#\,OV7?A7\*_BK;^-_"%OI>
MD0^#?@_:?!GX4?#W1?#WAO1-%^$OPSU3Q'9>*_%^E^'6TVPC\1WEEX_\8>&/
M#^J:C_;6HW6EVLGA33K/0K.S=-3FOOS9^+WP-^-_PB^)?Q(\=^&="^+>F>'O
MAW\2]`^+'@+X]>&OB?JFO>%_`7[''@CX':==?&CX%-\+KKQIXM\=>,OBMXT\
M>:7\4=0TRV/PB\?1>,/&OQ$\$?$S4=:N]5\#V^C^'_A[]C;X7?$/XR0_#+1-
M`U/Q7XA\1?\`"Z_V/_&7[5T?@_XK>"_$?AR^^!WA[X&_M)^`O%NK>)?C#X*_
M:0^-&N>)/&'Q'^).L6&K_%SX57OBWPSJ(EU6T\5>'/ADT6K^/?%FH@']'FO?
MLV_`'Q1\3].^,WB#X1>`]7^*&DSZ'>6GC2^\-V<NM/J'AA@WA35KR4Q"#5M7
M\(OA_"6M:G;WVJ>%&);P_>Z83FO-KK]@W]C2_-U]M_9L^$%W!?'QDMY8W?@O
M3Y]+N;/Q]-<7?BS1[C2)D;3)=`U?4;V_UE_#;VG]A6>N:EJ>OZ5IMAK.IW^H
M7/XH:G^R]_P4@U*YU75?#G@GXA_#^;QI\/['3_BMX7T/XH>'K/2I?BWX9_;1
M_8_\>Z%XD\'>.M3^/_Q#^('Q"TRP^!.E?M$:9IGQ&\<WG@KQ'>^'H;CPW%X(
M\-C6=(\):=Z[>?L=_M@:%KOB5/!MI\;]#T"Y^._[?GP_T>[\&_M"6.C>)]'_
M`&//B1^S=XLO_@+I/@;5/%WC+7-#\/7MI^T?+HNH_#*\U_1K_7/ASXFFMKR]
M3PSX,2\N+0`^W_AW_P`$R/@[X*^(.O>*M6UW4O'GA;Q!=_%6ZUKP;XH\&^`!
M=>/4^,=SKUYXLT;XV>,].\.6?B3XT^&--EUZ0^$-$\<&6/1)='\+W][=ZUJW
MAS2]0B^J](E_9O\`V6+?X:_"32KGX>?"%OBUXXU+PW\-/!RW=GI&K?$GXAW&
MBZEXIUN#2+:XEEUKQAXIDT'0-1UO7-2N9-1U!=.TQKK5+Y88;>OA?]E[X6?%
M3PSI/@W1OBS^S5XX_L'P[^U1I/B[X37^A_$&7P-JOP]M9_@-XHT'Q)\5OBE\
M*S^UA\8?"MAX"LO$,FK^"K;X?>`O'WC72?%GBOQUIOQ/?X%^&[VRO_&4=[]O
M[PAXWU/XW_L9>._AA^R9\2_C'K_P?^/W@KXJ_$+XE?#RT^"MO?6/PG\.?#_X
M_P#A:Y^'UMK'Q"^*G@/Q)J6K1^+_`(AZ#XAB\+V=H^@3V]Y-JS:H^H63VL(!
M]WZC^TC\"=(^+6F?`O4_BKX*L?BSK#6UOIW@>YUF"+6;G4K[1KGQ)IV@@,/L
M<7B?5/#-E?>)M*\*SW<7B75/#5C>^(=.TFZT6TN+Z.'XG_M,_`+X+^(=!\*_
M%/XM>!_`OB#Q'!:WNG:9XAUN"RGBTJ^U0:%8Z]K#8>#PYX;O=>9=!L_$OB27
M2/#]WKC+HUOJ<NID6M?F-X0_9S_:L\&?M#:Q?:'9?$IK7Q9^W3K'[1]WX^U3
MQ=\-V^`3_LU^.M#T:_\`%?PV\:_#=M?O/&.L?'KPX]E_PKOP!XBM_!EYJ'A:
M;P_X&UG0/BOIOP\MO$WABX]"_:]\/?'_`/:6^"TGAC0_V;OCM\/O$_Q-^#MA
M+%HVG?$/]FG_`(1ZY\;ZKI_BB*;X#_MGV5UXGU.YNO@OX=U&73;CQ3/\$?%G
MC:3Q;X9\3^-])\.ZII6N"RM->`/T3LOCG\(]0U7Q%HEEX_\`#=SJOA7Q3H?@
MK7+&*^W7%IXI\2:_=^%-&T:-3&!?7=YXITW5_#7_`!+C>0V_B'0]?T2[EM]3
MT'6;6P]8Z]*_'SXH_LT?'/PC\5]0^+7[/?P_T^PUCPS>7$.B6LVL:3J^EZUX
M[^(/AWXI_$;Q+XQ\-:#XMUM=-\,_##3?CAX[L_#^LV,RVWC&UT'XF_M`>*O#
M$$6HZ7\.KF#]?XO-\J/S@BR[%\U8V+1B3`WB-F5&:,-D(S(K%`I958D``DHH
MHH`****`"BBB@`HHHH`****`"BBB@`K.U72=.URQFTW5;2*\LYQ\\4HZ,,[9
M(W!#Q31DYCFC99(SRK"M&B@#X^\;_#'5?"[RWMBLNJ:%EF%S'&6NK%!DA-0B
MC!^11P+V)?)8#,Z6[$!O,/U^G(_/O7Z($`\$`CT//7@_IQ7DGBKX1:#KC2WF
ME$:%J3EG<V\0?3[F0Y),]D&18F=L;I;1H6))9TE/%`'R53E1I&6-?O2,J+_O
M.P5?U(KM?$'P\\5^'-\EWIKW=FA.-0TS=>VVT'`:1$47-L&)'^O@1`3CS&QD
M^%?%7QG#\._AC\1/'<S`#P=X+\2Z^H)`/VS3M)NI-/B)R"KRZE]DB5<ABSA5
M^8BKIPE5G"E!7G4G&G!=YSDHQ7SDTB*M2%&G4K5'RTZ4)U*DOY80BY2?RBFS
M^8S]JGQP/B-^T9\8_%<4QFLKGQSJVDZ4Q.0-'\+LGA?3%3MY9M='65,<$2EN
MK&O`*5I)I6,MPYDN)29;B1B2TEQ*3)/(2<DF29G<DDDEB222:2OZ'PU".&P]
M##P^"A1I48=/=I0C"/X11_*6+Q$\7BL3BJG\3$UZV(GU]^M4E4E_Y-)V"BBE
M`)X`)/H!FMCG$KY+_:-\%A)+'QQ8Q'$IATC70@X$BJ5TJ^8#D>8BMI\[G`+)
M99.6.?M?PIX.\7^/-730/`OA+Q3XWUV1XXUT7P;X<UKQ5JV^5MD0DT[0+'4+
MN$2,"$>:&.-B&^?@X_4KX,?\$3_CW\;]*9?CI>:9\#_`NMV86\TZ[^S>)_B7
M<6DZI+$UKX=L;@Z'X>O8V59(I_$&M27FG721-<^';@I);U"SW!9%6IXK%XJE
M0@M)TW*]6K2DUSJG1A>I4:5I148M*:BW9&RX<S'B.A5PF`P5;$S=G"K&-J-&
MK'6#J5YN-&DGK%N<XWA*25V?RK>$/!OB[X@^)M%\%^!/"_B'QIXO\1WD>GZ!
MX6\*:-J'B#Q#K5[*RHEMIND:7!<WMTX9E,KI%Y%LA\ZZF@@5Y5_L2_X):_\`
M!"71OA#<:!\?OVU-(T'QA\3[9K#6?`_P0<V^N^#OAKJ$$L5Y::YXXNHI9=)\
M<>.K.5(S::1"E[X+\*7,?VJ&?Q+K,=GJ>E?LC^QU_P`$^/V7OV&_#LNE_`SP
M#%:^)]4L(+#Q7\4/$\R>(/B;XQB@E\\1:WXHF@A-KIIG"3+X<\.V>A^&(98H
MI8=&6:,3'[9KXGBSQ-Q6:PJY?DD:N7X&:<*N*G+EQV*@[7C'D;6$HRU4E"<Z
MU2%E*I3C*I1E^D\$^$6#R6I1S/B&=#,\RIVJ4,'"+GE^#J+6,Y^TC%XRO#1Q
M<Z<*%*=W&G5G"G7B@``P/\YY)]R3R3U)Y-+11GJ.>/8CWX)X/X9YXZU^4'[2
M%)@'J,YZYY_G2T4`!&?R(XX//H1R/PJK:V-E8K(EG:6UHDT\MU*EM!%`DMS.
MV^>YD6)$5[B9OFEG<-+*W+NQJUG.>O!QR"/RSU'N,C\C29&<<_D<<Y/7&.Q[
M\'`/)&0`P/0?E1@>@]>G<]32T4`)@<<#CD<=#ZB@JIZJ#]0#_.EHH`,#T]OP
M]*3`&,`#'3CI]*6B@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`KS/XE_!OX9?&#PMK?@OXC^#M)\3>&_$=JEEK5A<+<V3WUJES!>)#)?
MZ5<6&I1A;FV@F!AO(VWQKDE<J?3**J,I0E&<)2A.$E*$XMQE&46G&49)IQE%
MI-----)IW)G"%2$Z=2$:E.I&4*E.<5.$X33C*$XR3C*,HMJ46FFFTTTS\E/%
M7_!%S]C3Q!=7%UH\?Q6\#B96\JS\-_$"2_T^V=G#>9%!XQTGQ/<':H*+&]XT
M(5B3&756'D%Y_P`$*O@9(TAL/C7\9+1#<H\:7-K\/[[R[03AGMRR^&;-Y)FM
MMT,=TQ`24K</;RJI@;]RJ*]BGQ'GE))1S+$M*UO:2C5>EK7=6,V]ENW>VI\_
M5X2X;K-N>3X-7N[4HRH+7M&C.G%?)(_$&'_@AQ^SMIUKJ%UJ'Q1^-FM/!:S3
MV=LE_P"!-)C,T$,T@CGDM?!LLTD<T@A1O+DMY(U#;)5+[D^@_A=_P2?_`&'_
M``UIFE:I>?#+4_']W<V5C?I=?$/QCXCUZ+=<6T5QAM'L[O1?#[IF3&V71V4C
MJ@R0/TZ(!!!Y!!!'L>M<MIFC:UI5C8:;;ZS:O::=;6]G!YVC%KAK6U18HEEE
M358T:40(J-*L*AF'F&+DK4U<_P`ZK*T\SQ:3W5.JZ-[=_8^S_P"#U-*'"_#N
M':E3R?`W6J=6BJ]GO=>W]IJNCZ=#\5/VW?@5::5^U/\`L7_#7X$?LV?"?XAZ
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M7FE^'M"L[JT:_O\`[==Z387U7Q3^U#\%/!G[1OPG_9@O)-5N_BW\4;#QO>^'
MK;1?#%U?:!X:MO"WA:\\<ZG;^+/%:+#H_AK4_$.B:7>:AH/AXW5QX@\006<^
MJ'2DTBVDU1/)E*4Y.<Y2G.3O*4FY2D^[DVVWYMGN0A"G"-.G"-.$%:,(1481
M7:,8I**\DDC\;%_X*8_M':/X)\5VLWB/X>_$OQY>:S\)CXJ\4?#73/A-)\&_
M@3X0\8?%>_\``WCWQQ9>/M:^+^F3>%['1]-N/"^C>&?A]^V+X0^$'CG1O%FK
M7WBCQ)J?BSPUX<\4^$]!C^.?_!3C]I#X=_`>Q\<:/JWPZE^)O@SX%?&CX\VG
MA:*3X4WOA7X\>'/AE\1_B!X<\)VVD>-;3XAZY;>.O$_B3PCX`N+KQS\-/V8]
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MBR?X@^,M-UJPY_P7^TE\??A_^TQ\8?&4/C+1?$7@#XC?\%%/V)O@/XF\`WO@
M[Q59VDMA^T#_`,$__P!EJ]U?Q/X+N/%FLQ>)OAO9>'O%VIVWBK1/!]YHAF8W
MOBC3O&MO<^(-7&I:%^^S6=G+$T36UN\,DHG>)H8S%),LJS+,R%=CR"5$F61@
M7$B)*K!U5@\VML6+&"$LTT=PS&*-F:>)%CBF9BI+31HB(DI)D15558!0``?C
M'^V/^WO\3?@C^T1;^$/A]J6D:CIW@'Q7^R=IOC;X7^(M(\&^&-0\6^$_V@?C
M!X6\`>,_$?A&\UKQ1J?Q0^(\'A'PQXI_M=/$/PZ\$^'/`OP]UW1[RS\:^(/&
MC6WB#1?#WSO8_P#!0_\`:ZTWP7\(?$6N>(?AQ<VW[0O@SX]WE_XCE^%\UOH?
M[-.@_`;]NOX+_LS^)?C;KL=IXPM)O&7AC0OA%\9M1^(_C?2M7ETG2M)U?P/:
M:NE_IW@__A)X&_HCDM+6:43RVT$LRQM"LLD2/(L+213-$KLI98FE@AE:,$(T
MD44C*7C0JGV.TPJ_9K<*J31J!#&`L=RP>XC7"C"3LJM,@PLI`,@8@&@#\8/V
M9_CC\5?"_P``/^"L/QF\'ZRO[3WC#X:?M*?&3Q)\(+C3K74'\.?$B+PA^QY^
MS5K?ABS\*Z1I6KWL-QX?U76X[V>:R^'^H1Z9XEU*?6[WP;!;3ZY:P)\G>%/V
MA?'4G[>=E)I7QP\"?M.Z#XB\6_LB:'H/Q+T;0]<T[X<1ZC%^Q'_P5O\`B/K6
MI>%=!\#^*]?T6+4!XI\$>&-)\4MH">(+_P#X1>6'PQJ&D:CX_P!'L=87^E.&
MW@MX_*MX8H(\(`D,:1*!'&D,8"QA0`D44<2`#Y(XTC3"(JB*.PLH=GE6EM%Y
M;%X_+@B0QN3<$M&50%&)NKDEE(8M<3MG,TI<`_G]^'/_``4/^,_B/1/"W@[Q
M7\<?AAH5QXE\:?"NS^+/[2^G>#_A5XI^!GP$T7QK\+?C5XHNFT'X@^%/C#K'
M@NZM/'7Q2^%.C?#CX=>'_C_X<^&7Q1^'>E>,]'U+XE>&O%NI^)O#,T7IVI?M
ML?M`:O\`$+1?"GA_XH?"Z'Q/?>*?V2_AUX#^&-E\)]<L]?\`VA?`_P"T;X'\
M%WWQ#_:Z\":9XO\`$2^-]`\`?"75_%GBSQ3;^'I=(U31_#N@?`KQ]X=^(NHZ
MI?>*=(UGPS^V7]G6'E7%O]CM?(NY9)KJ'[/#Y5S-,VZ:6XBV>7/+,P#2R2J[
MRL%,C,54B<VT#3)<-#&UQ'')%'.R*94BE,;2QI(076.5HHFE16"R-'&SAF1"
M`#^?#Q[_`,%)OVG9-'^&6J:5I7A7P!X9U:+Q?\,?B=XYUQ?AIX7TSP;^TY^S
MUX2T<?&'X;G6?CIX_P#A]X%2S\0_%GQ3J_A2PLWUJ[\17GACX&_$)?!%O)KN
MIOK7A[V+0OVU_P!IJ5OVDOBYXYG\#^&_AK^R5=_LD>)OBO\`#OPGX/O_`!;?
M3?#WXJ_LZ?!;XO\`[1^I:7XLEG@UO4H_A1:^-/%_BCP4=/T:#4=;T[0KBPU>
M*Z:XL+6T_:J2SM)8S#+;02PF87!BDBC>,SK,+E9VC92AF6X59TE(,BS*)582
M`-7"_$CX6^#?BQX:N/!_C>RU"_\`#=]J>CZGJ^E:=K^O>'8/$"Z+>07D&C^)
M)/#NI:7<>(?#%^UO':^(/"NL37GA[Q+I?FZ-K^FZCI-Q/9R@'@_P'\>^./$?
MC>WT?XE?&#P$_CN\_9]^&?Q'\1?LTZ3X7L-.\:_#6?QUX[^*$]EX[U77SK\V
MM7_AK6M+L['X4Z=IUUX:LK%/$WPE\5:_;:U?W>O7VF:1]=U&(8EE:81QB9D6
M-IMB^:T:N[K&TF-Y17DD94)VJSL5`+',E`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'PE_P4,^"/QU_:/^`5Y\&?
M@AIOPDDN_$_BCX=ZYX@UWXK>/_&7@NVT&#X:?%CX=?%/3DT>Q\'_``J^)4WB
M.;7Y/!=[H%['>W'AA-%6^M=7@N-9,,VE/YW\9/@W^V1\1OVB?V/?C5I'@+]F
M6QTS]GF?XCZ_XMT74OV@OBH+_5M<^,/PNU'X:^(]'\.7-K^RY-;7.E>"?MXU
MO1-=U1=*N_''E_V9?>'_``&3_:5?IC10!\%>-?A%^U!J?Q4\(_M#^&HO@`OQ
M6^']G^TI\&M#\*ZSK_Q,A\#>(O@#\6?&G@'Q5\._$FN>(+/PO?:UHWQ6\+7W
MPB\!:YXN\-:7X8U'PMK_`/:'B_P?H_C'1X)M$\7V7B]G_P`$Z=3\%^!O@KX2
M^'VO^%+:]^`'PN^%_AC1O$\`UOP%XR^+/B_1M:M;?XE7OC;QUX7M=4\7>"-$
MU/X?VFJ^%/A[/X6U'7=8\'2^/_$=Z3._ASPNZ_J[10!QGPXT/Q+X9^'W@7PW
MXS\3R>-O%_A_P;X7T3Q5XSEM5L)?%OB32=#L+#7?$\MBC.EE)K^J6]WJKVB.
MZ6[79B5F"9KLZ**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
)HH`****`/__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>biib-2015630_alpchart.jpg
<TEXT>
begin 644 biib-2015630_alpchart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`$V`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^2OVW/VF9_V1_@!J7QG
MM=%\'ZY<0?$?X&?#F%/B'X\?X8^`M'?XU_&SP#\'1XL\:>.X_#GBR3PYX6\&
M_P#"<_\`"4Z[>IH-\S:=I%Q;C[/YWVJ'ZUKPK]H?X$Z)^T3X#T3P%X@UB_T3
M3]%^+_P%^+JW6G6ME>37>H_`;XU^`_C5I.BW$%^KVYTWQ!JG@.TT359`IN(-
M-O[J:T_TJ.&@#P'P1^W=\+H-%\)1_%WQ[\(#XE\6/I>HQZY^SGXE^(/[07P0
MT+PCXO\`'NH?#3X>>*/&/QKTSX7^'O"_@33/&'CC2-9\(V.I^-QX?T&7Q+HN
MMZ=8:S?PZ)K%W8=WJ'[:7P;E^`/QS_:+\%GQG\0/`OP%\/\`Q0U7Q+_PCW@#
MQQ#>:YJ_PB/BNR\:^$_""ZIX=M!XFUW1/$7@W6O"^MKHBZA:>'=:M9K?7+BR
M^S77D\C\;/V'/#'QC\?^+/$X\?>)O!WA+XP>$/A;\/\`]H/X=:)HWA6[TCXL
M^#/@SXO\1^,?`VDQZUJ>F3>(/`L\C>,/$_A/Q5J'AJ[:37?!FKM8V,.@^(]/
MTKQ79=[\,_V3_!?@']FKQ9^S#J&MZ[XH\%^-Y_VA1XCU2<6>CZW<6'[1GQ%^
M)GQ`\6V5H^GQO;61TR7XGZOI&CW*1O(EK965U.CW)F#`'S3\'O\`@J-\)/B3
MX[/AKQ-X4\8_#+P[JWPS_8K\=^%/$WB/POX^N'&J_MH_\)[IW@SPM\2K2V\"
M1Z;\(3;>+_"6C>!]!\0^.-;T[1/'/B7Q;I=IHMQ$DMC)J'U[\)OVH_@E\;]?
MU#PW\./%=YK&HVNE7?B+2Y-0\)^,O#.E>-/"EAK:^&[_`,9_#;7/%'A_1M&^
M)G@JQ\026^D7?B[P'?>(/#\%W?Z07U`6NN:'<ZE\8Z#_`,$O_#=IX#\=>"_$
M_P`8_%GBB?QUX;_86\'7^MMX4\,Z+)'X=_8(^*4_Q"^&D+Z;832V<^H>+M.%
MCX8\=7L;6=O.+>YUG0=/T:6\33K3U7]D7_@GU\)_V//$>JZS\/(O"RVL7A*3
MX=^$%TOX._"'P7XKT[P+)KUIX@73?&_Q*\)^$[#Q]\4=8MYM-T;2H]<\2:U;
M17FEZ)IMYKFD:SXN%[XLO0#YZ^/_`/P4/_:!_9X\9_MC6GBCX`?!?6/A]^R+
M\`_!?[1NI:_I/Q]\<V_BCQAX'^*GB?XS^%_A]I47AZ_^`46BZ#XCM;CX,ZI?
M>.?-\4ZEI6CVFKV8T&]\136UPM?7Z?MW_LS'Q%I_@Z?QIXAL/&>I^/?%_P`-
M;?P9J_PP^*>B>+H/%?@7PSX/\>>)+?5/#6M>#-/UC1-*LOAOX]\*?%!?$FL6
M=CX:N/AEJC>/X-7?PKIVJZG8\C^T!^PAX/\`V@+K]JVZUKQSXET%OVK?V>/@
M]^SQXC32]/TBX7PMHGP?\7?&3Q=IGB#1#>J3=ZKJ]S\8]4M+^VU'=900:/I[
MVP$DUUG#\1_\$[?AIXO_`&C_`!E^T)XE\5^)=5/COQ)\1=<\1>`FMM/M="N[
M'XF?LI_"?]D[7]"75;5HM;AM/^$0^%5IKT%U#-'>KK.N:A")$M+>T(`/2]._
M;M_9HU3PS?\`BJS\9>(VL8#X"?0]-G^%OQ5LO%7Q!LOBM?:KIOPNUGX3>#+W
MP7;^+/BSX>^(U[H6MQ>"_$7P[T?Q'HNO1:+J][:WWV#3;VZA]ATSX[?#+6?A
M//\`&O2];U*_^']K;ZQ+=W=GX3\87?B.UO?#VMWGAC7_``]<>`K;0)?'L7C'
M0_$^G:AX8U;P4WAG_A++#Q+8W>@W&C)JD$EJOYO:-_P1R_9^TGX8-\.VB\!7
MDWAW7/A'J_P[UD_LW?L]Z=!9+\$;3Q;IG@Y/BKH&C^"+"P^.MQK.C>-_$&D^
M.YO'%Q!9:LDUOK?A+2O`?BZ&3Q)<?6L_[&?A$?LBZC^R7H/BG4?`>A:I8WIN
M/%'PS\)_#_X;[-6U/QQ_PL+5U@\!^"O#6B?#^/PCX@UIKC0_%/@DZ&VG^+O`
M^HZSX:\47^KW&N:OK=Z`4;O_`(*%?LN6`LK2[\5^-8O$]]KOQ"\+K\/4^#'Q
MEN?BA:>)OA9X+\*_$CQUX>U+X9V?@.X\<:=K.B_#SQMX8\=K8W6AQR:IX0U6
M'Q#I!OM-2>>+A_B;_P`%(O@GX:U#X3:5\,)9_C#<?$[X[?LO?!Q]9T'3?&ME
MX!T2W_:>?P_K'AS5Q\3X_!6I_#V_\4:?\.O%&@?$B'X<2>(]/\3ZEX8UW0KV
M>/2[76+.Y?A?@_\`\$M/AI\(?BM;?%W1_&EQ;ZU)XM^)OCK5O#7A+X<_#OX;
M^`9/$?Q5_9T^$_[.OB$:!X/\$Z7IFE^&M'MM$^$ND>(["Q@%_J%QKFIZG+KN
MM:U/*U_+D?#?_@E1X2^%WA3X._#?PU\;OB`GPO\`A3\1OV7/C;=>#)?#G@DC
MQA\:OV8_"7PS\"V7C+4M?&G?VWIFC^/]`^%?AJ^\5>#]/N6LK/Q6ESKFA:C8
MZ?<7/AZX`/7/VA?VW[SX+?'72/@AI_A#X:R:IJ'PY\-?$32KKXO?'71O@3-\
M69_$?B[Q+X2D^&?[/,WBCPGJGA+XD_%7PTWAZWU3Q1X;\0>,?`=KI4/C#X>P
M27YM?%-SK.@=UX?_`&V_A!/XR\?>!?%/B70]-\1>&OC-XT^#WAO2O#MMX_\`
M$-_XDU[P9:_!LWWAQX[WP!H%NWQ&^U?&GPO<GP9X5NO%]K<^&Y+GQ-HWB'5]
M/T#QO_PB47[3_P"R/J?[2NF>,/!U[\:_%_ACX6_%/P"?AI\4_AC<>$O`'Q`\
M,:MH$D6NVEUK_@F/QWH>J/\`#SX@7VF^(+G3;OQ':+KNCRQ:?H6I#PHGB#2(
M-9?RB?\`X)N>#QK^N>)-+^*OC[2-3C_:)UC]JCX<301V%X?AW\:KWPE\*OAU
MI?B97U&:[F\90Z3\,_AUXA^'<]AXIEN$\0>%_B_\4$UZ2\U75-&U31`#USX_
M?M;-\"/VB?V3_@Q?^`_[9\)?M(7WQ'T?Q%\2!XB?3S\+M5\/7WPT\+_#I;GP
MTNA7_P#PD>G?$?XC_%#PS\/WOAK>B'P[K&LZ#,8-7BU22.S\<^&7_!2OP#XO
M^(7[3'A3Q;X,U[POH'P<^.7@WX+_``CU7PI8^,?BUXP_:(E\5_"S4?B.VN>#
M_AGX"\#:CXH@-JGA/XAW%MIVE)XHCN/`G@^;XA7VIZ7I5U-:V/OG[2O[)/A?
M]I<S/X@\6^*/"=VGP/\`C)\'M%U;PI]@@UOPKJ?Q1\6?!3QYX?\`BAX:U*\A
MN#IWCOX4^-_@5X-\6>!;AH)["/6[=+G4K>YCMHH9/`;3_@FSX9\)^,9?B3\+
MOBWXP\!_$'1/%'P@\4?#G7&\.>$?%%AX.?X6_LTW_P"RO?Z->Z'K=H;?Q1HW
MCKX<:MJ-YKJW%UI.IV/BD:=K&CZG;K936UZ`>R:7_P`%`?V4-<UO1=#T'XEW
M>O3:Y%\%)X-4T3P#\2=5\-:;!^T9<:EIWP0D\2>*;'PA/H'A/_A9?B+2;[P7
MX8B\3ZAI%Q=^/HE\"2Q0>*Y%TD?('PJ_X+*_!3XB7_AC5]>^'7Q0^&7PPUKX
M(?';XS:YXO\`&/@7XD2>(O!>G_`?]I+3?V??%%QXI\#:+\/;^_TOP%:0WS^.
MO$GQ0N[V#PGX'TZVNM&\2W%KJ>G:R=-]-\-_\$NOA?X/\-^-O"WA[XA>-X;#
MQIJ'[$6L7EU?V?AZ]U(:Y^Q=\<Y?V@K+7+J:&TL+.\U+XM^/KW6+WQTL&GZ;
MIFF#6+J/PGIFE6D-E96W,Z?_`,$H_`]AI7QP\,+\7?&;^$OBI^S;^UM^R[X8
MTH^'O#BWOP\^'W[77Q/U+XO^+KB/5][OXLUKPGXRU[78_"MUJMG8QR>'I]/T
MS7(]2O\`3Y]9U$`^X?`W[47P:^)'Q%U_X8>"]<\0:WK_`(;U;Q=X>O\`5X?A
M]\0X?A]<>)?A_?0:9XZ\+Z/\4KKPM!\-]<\3>$-0N(['7]`TGQ3=ZI97<5_;
MK;32Z3K"Z?!J?[5OP-TCXG7OPCOO%>I)XNTS5T\,:C<0>"_'%WX-L?&\_@W_
M`(6'9_#B[^(MIX<F\`6_Q,U#P,T7BK3OAY+XE7QA?:/=:?<6^CO)J>F0WGC'
M@/\`89TKP3^T78_']/B9K,UWI1\1RQZ3H7@3X<^`M:\8)XF\(V_@[_A&_C'X
M[\#:#H>N?&CP-X-LK:UU+X<:#X[M;[6O#&NZ;HNK:CXM\27>C64@Y^X_X)P_
M!T?M*>+OVB]-@\+6FJ^./&=S\4]=M]0^#OPD\2^,[?XG7'PVLOA<^L^&_C+X
MA\+W_P`3?"GAN;1M+TO7I_"NAZQ;3P>+;)[[1?$>B:%JFM>&]1`.W\.?\%$?
MV2_%O@RX\=^'OB+K&I:(WAGX/^,?#ENGPR^*D'B+XB>&_C]>3:3\&]6^%'A.
MX\%Q>)OBO:^/]>M+_P`.:*WPZTGQ*5\0:9JNDWPL[C3KKR_./A;_`,%-/@?X
MPL?'MWXYCUGX>OX.^-?Q^^&PMX_#/Q%\5S:;X#^!'Q%'PUU+XR?%.+3?`-O<
M_!#P;?:^9+'4KWXG6^@:1X>U.RUG3I]<O/\`A'O$%SI?*6?_``2Y\$Z/IWP2
MD\/_`!9\9Z7XO_9V_9H_9<^`/PG\7-H/AB_FT/6?V4?$FL>(/!7Q*U#1KN)M
M,UB^\2VGB'7_``KXS\*SK#I%WX9US4H]&O=%UL:9KFF</-_P1V^#=]XKU;QU
MKWBRT\;^,_&OBWXE:_\`$;Q+\3?@C\"_B?>:WIWQ.^)FH?%K5+/PEI_COP9K
MWA_X<ZUHGBS7O%%IH'B+0=&NHCX7\13Z-XAT'Q!>:/X:UK1@#Z=UW]O#X:K^
MT3\"_P!GOP-I^J^-=2^*WQP^+GP.\2>+/[&\::!X1\(>(O@Y\$OBI\5?%\/A
M[Q9J?@T>"/B9K.@>(/AL/AWXM\/^%?%CW7A'7-2OUU>9-1\.ZAH[:GQW_;8^
M'_[./QGTKP!\5;7_`(1_X>M^S5\6_P!HGQ-\3UDU?57\.6GPQ^+?P"^%$'AX
M>#M"\/ZIJNK#7[[XZ6M^=4L[H2Z9_8@MFTN[BU"6]T[E/"O[!>C^$OB]\+_'
MFF_%CQB?A_\`!3XZ_&_]H+X6_!]]"\(1Z%X<\:?M%^$?C#H'Q2LKKQ-:Z;;^
M)M9\/2ZW\:O&/BCPAI]W-'-X8GU"YT>XN]=TP:0-"E^.'[!7A?\`:1\4?&+Q
M!\8_B)XHUNV^('P.\6_L^>`M)T'1O#7AR/X3^`_'/B?P)X_\2WNGWRVFIWGC
M#Q9<^/\`X9>!-?L]3\3$Z-96?ARUT;_A'+B*]UB\U$`[#Q?^WW^RWX)\5^(_
M`FL^.]=NO&GA;Q;\1/`VJ^%/#7PQ^*/C+Q`WB?X3_#KX8?%KXAZ=I>D^$O!V
MM7VN+X6^'/QB\`^+-0O-'@OK%M+U._-M<SW&@:]!IW5^&_VR/V=?%_C3P_X'
M\,>/SKM[XHE\-V.@^)=-\+^,;GX;:CX@\8^`;#XJ>$_!T7Q53P__`,*W7QWX
MC^&VJ:9XXT;P1+XHC\4W_AO4M-OXM*/]HV$=S\X>"_\`@F]X?\/?%FX^-GB+
MXP>,_&'C[6_%'[0?C7Q7>77A_P`,:/INM>)?VBO@7^SW\#?%,MIINEQB/1=*
MT+2?V>]"U7PWI=O+<O#-K-]9:G?:B+6&^GY+]G;_`(),?`_]G+QM\,O%OAF\
MT+7G^'NG?#34)]0\4?!?X-:Q\0]:^(?PV^"WA+X'VWBNR^+NI>%-0^('@_1-
M>T+P=I/BC5O!OAC5+1+/QD+NX\/^(=&\-:CJGA>_`/;OVN/VP/$G[+E]HU\_
MP\\"^(_"NHIX?M])LM;^-VA>#/BY\8/%>M>(&T>[^&/[-?PF/AGQ%J7Q6^)F
MC6$^DZPV@ZQK'@:QUJ;7M$T31=4GEFU;4]#R],_;@NKSXDZ;#=_#?3M-^`7B
M+]I[Q?\`L<>&_BM+X]67Q?>?'+P3+XHT#4I=1^&L7A8V&G?#S4_B7X*\3_"G
M1-;A\?WWBN;Q59Z9J5_X+L?#.L?VGIO;_M(?LGZO^T7!XK\)ZI\</&WAOX1_
M$SPE;>!_B7\,K7PSX"U^VN]"C^VQZC=_#OQ/X@T*ZU_X8^)_$=E>)I^N>(=/
MDUU[==-TC6?"ECX5\5V"^(I,NQ_8F\/V?Q5LO%<GQ$\67GPIT?XZ>(?VH="^
M!EQIOAL^&M+^/_BJUUM-9\6CQ4E@/%UUX:_X2#Q+XC^(^G^")[P6EE\3-;N_
M$,FKW>D6FC^&-,`/HWXL^+?B#X4\,6=S\+OAN/B=XQUGQ!HF@:;I%]XHLO!?
MA?1H-4GD.H>+/&OB>:PUW4]+\*^'K"">ZOAX:\*^+?$VHWLFG:3I'A^XEOY+
MNQ^(_#/[=GQ#^(UUX>^''PQ^!/A[Q#\>Y_$/[3^F>*/"^L_&./0/A;;:+^R7
MX]\'?#/XA^)?!GQ/A^'VL:YXPT[Q1X\^(?@[PCX&-U\-O#@@UZ3Q?8>-Y/#%
MWX#U>UO/:?B3\!/CW\3/V:O#_P`'W_:F\3>`_B>Y\/I\0/C7X.\!^$[?7/&&
MDV=W<W/B;PU:Z18/X=M/!]IXNLI+?0=1\0>"+OPWXJTO2X[N?PMJWA[6;R/5
M++SO1OV)/%GA_P`+?"8>&?CG!\.OB=\&M!^(GPX\%^./A1\$?AOX)\+V'P7^
M)ESX1O=:^&B_"B[D\2^%UBT;5?`GA'Q/X4\0I?"]TKQ9X>LM1U"SUK2+_P`2
M^'O$`!0\(_\`!0?2OB)\4_V*?!_@CX1^+;KX>?MD?#SQCX[T;XL^(-;\.Z/I
M?AJ]\-?"JV^*$7@JR\/:?<Z[K'BOQ':0->Z)XTO4_L+POX6U2UCL].USQ3J,
MMW8:7;^`G[:6N?&3X]^*_A?J5K\!O#/AW3O$?QJ\.^%;&T^+'CS5OC%XAF^#
M_P`0-7\"7C2>$]1^#/A_X:RZDJ:%=^(_%_AKPI\7/%GB+P!I.I:$=<TXB]FG
MM^7UK_@GWXHT[Q_^RAKWPC_:"G^&O@']C;PQ/X3^$'P\O/A)X9\;M)INO^`K
M7X;>.)?%OB[4/$FCZGKU_P")?#=O)<17D>GZ?)IGB"[NM7E&JI(MBOT'I?[-
M7B*7XM^$_B%X[^.7CGXA>&?A=XS\<?$#X2>`]8T#P1I:>$_$_C[PWXP\&7TV
MN>+=#T2RU_QMIWA;P=X]\6>%_`MAJ2Z?)I^F:J+OQ9>^-O$&G:5K=B`=;XI_
M:B^#G@GXE:3\*O%.L>)-$\1ZWXET#P3INKW_`,._B)!\/;CQSXLTZ'5O"O@9
M?BDWA8?#D^,O$ME/%_8OAM?$[:G?7L]II*0KK%_86%SX]X;_`."CW[(?B_PE
M'XT\-_$G6-5T?4?#'PO\8^$K>'X7_%=/$'Q*\/?&?57\/_#6_P#A)X7F\$Q^
M(OBP/$OB2*Y\-K#\/-,\23Z5KEG>V&MQZ:UI-(OF_P`5?^":W@7XM?'^/X[>
M)/'^L75[8_'3X'?M">'K/4_`_P`/O$7BCPCXO^"-[X'?3O!O@_XI:YHUUX]\
M+?!O7[7P0+S4OAEH&H:=8P>*O%7C/Q)#J<T/B/4-#EXW2_\`@E3X)\.:9^S?
M+X9^+_C72O&G[*?[.GP>^!?P?\92>'O"VHS:9J_P6\56WB+0/B'J^B7<9TO5
M[G7M-;7?!WBKPN_V?3+SPSXGU9M)O]%U^#1]<TP`^B/@G^UWJ?QV^"OQO^+'
M@;X0>(==U;X6_&O]H?X->%?A[IVL0:9XB^(.H_!#XBZQ\.].NIY/'6F^#H_`
MU[XJOM+6[U;2O$MNLO@I&O;>^EU.?3VCG\LNOVZ_'VC>+?$WP-UWX*^%I?VD
M+'XQ_"/X,>%-#\+_`!<N]:^"GB#7_C#\+?''QKLKG4_BIJ7PU\/^+?#EQX#^
M%OPS\<>+O'OAB3X4:EXEBTV#P9=^'[/5[+X@Z/<V7K7@#]D_Q)\)?@-\:OA5
M\,?CSXP\-_$'XP?$+XW?%>+XXW?A#P)KOB?P9\0OCGXMO_&FO^(M&\(7VF1^
M!+\Z#K>J7TWAO2]5TB;2;>(64%_97\=HRW/E7@3]@?Q%X5^&MCX,U/X[27?B
MOP1\6M#^.WPF^)?AOX5>'_#7BCP]\6K31?$OA[QAXV^(TFI^)O&,_P`;-;^*
MVA^+?$.A_$O5O&FI0:[K>DZ[JT>GZSH^H'1M3T,`SM?_`."B5_H?ACX/Z@GP
M(UK5O$/BO]L+PW^QO\:(=-\<:(W@OX'>.]1^.&A?!'5-0G\67.FVFL>.EU"^
M\2:)XO\`AYHNC^#-.U'Q)X/U"/4O%K?#V6UN[5?4_CQ^V?:?"'X__LX?`C0/
M`X\=7/QB^+?AKX9_$7Q(GB1=%LOA##X[^'GQ<\;>`;I[4:-JO_"6>)O%$WPA
MU\)X2CN]$?2O"T4_BS5-4MDN?#.F^)/(OB5_P3Q\6^*?A]\/?`?@G]I/6?!3
M^&_V@-,_:P\>>*=5^$W@KQGXA^*'[1&B?%O3?C1I/C'5@=4\,:1X>\.VWBG3
M;?2CX*T'3$M%\(6FE>'[35+0Z=]ONNF^(?\`P32^"OQ.^(GPF^,?B#Q#\2M-
M^*G@7X]_#[]H_P`<^(/"7Q.^+/ACP[\5?B7X!^%>I?"R'4]3^'>G_$G_`(0C
MPD=1TR?1WDN/"ND6VHP:3H%MX2>]O/#FIZ[::D`?HRIW*K8QN4''7&1G%+2`
M8`&<^I/<]SZ<GL.!VXI:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`**_'C_@H-\3?B/X1_;U_X(U^`?"?C[QEX7\$
M_%K]IG]H;0OBCX4\.^)M9T30/B)H?AW]E3QUXET+1?&NEZ9>6MIXFTG2/$5K
M:Z[I^FZQ%=V5KJ]K:ZC%`+NWAEC_`%FC\-:240F*Y)**2?[3U7DD#_I^H`Z&
MBL#_`(1G2/\`GC<_^#/5?_DZC_A&=(_YXW/_`(,]5_\`DZ@#?HK`_P"$9TC_
M`)XW/_@SU7_Y.H_X1G2/^>-S_P"#/5?_`).H`WZ*P/\`A&=(_P">-S_X,]5_
M^3J/^$9TC_GC<_\`@SU7_P"3J`-^BL#_`(1G2/\`GC<_^#/5?_DZC_A&=(_Y
MXW/_`(,]5_\`DZ@#?HK`_P"$9TC_`)XW/_@SU7_Y.H_X1G2/^>-S_P"#/5?_
M`).H`WZ*P/\`A&=(_P">-S_X,]5_^3J/^$9TC_GC<_\`@SU7_P"3J`-^BL#_
M`(1G2/\`GC<_^#/5?_DZN,^(6J>#_AIX,\0>.O$-IK,^C>&[(7^H1:5=ZC=:
M@\!N(+;%K;S:M:Q2R>9<(=KW$0V!CNR`"`>I45^>9_;G_9T!(_L/XI<?]0X?
M_-G1_P`-T?LZ?]`/XI<G`_XEPY)Z#_D<^O!XH`_0RBOSQ_X;K_9QW;?[%^*&
M[IM^P+NSZ8_X3//Z4I_;H_9S&,Z'\41N.!G3@,GT'_%9\GV'-`'Z&T5^>?\`
MPW/^SI_T`OBE_P""X?\`S9U['\&/CO\`"7XZ:SK.A^#=,\:6MYH6F6^K7K^(
M%N-/MVMKF[-E&MO):^(]0:283#+(T<:B/Y@Y/RT`?5-%8'_",Z1_SQN?_!GJ
MO_R=1_PC.D?\\;G_`,&>J_\`R=0!OT5@?\(SI'_/&Y_\&>J__)U'_",Z1_SQ
MN?\`P9ZK_P#)U`&_16!_PC.D?\\;G_P9ZK_\G4?\(SI'_/&Y_P#!GJO_`,G4
M`;]%8'_",Z1_SQN?_!GJO_R=5^QTRST[S?LJ2IYVS?YES=W&=F[;C[5/-LQO
M;.S;NXW9P,`&A1110`4444`%%%%`!1110`4444`?B!_P4G_Y22?\$*?^SK?V
MH/\`UCGX@U^WD?\`JX_]Q?\`T$5^(?\`P4G_`.4DG_!"G_LZW]J#_P!8Y^(-
M?MY'_JX_]Q?_`$$4`/HHHH`****`"BBB@`HHHH`****`"BBB@`KYQ_:Y!;]G
M#XLA06)\-(`J@L2?[6TS@``D_@*^CJ_/W_@JA>WFG_\`!/S]J&]T^[N["\M_
MAY$]O>6-S/9W<#_\)/X=7?!<VTD4\+E2REHI$;:Q&<$UZ>299+.LYRC)X58X
M>>;9G@,LA7E!U(T98_%TL+&K*FI0<XTW54W!3BY*/*I1O=>;G.8QR?*,US:=
M*5>&5Y=C<QE0C-4Y5HX+#5<2Z49N,E!U%3Y%-QDHMW<96L_QN:&;)_<S=3_R
MRD]?]VOK/]G3PT=<\.^.;-?"<-Q>ZE`^F0^*=8\&V_C7PW''->^$D7P_XDM$
MN[;7/#6G+)/+K$VM:6L1N;`ZE?\`VM9?"4:#^3)_'/CC>W_%:^,?O-_S-?B#
MU/\`U$JNV7Q.^)6FQZG#IWQ$\>6,6M:;)HVKQ6OC'Q%$FIZ3-=6E[+IMZJZE
MBXLY+NQL[AH'^4RVT3'@,&_J'_B5+-6DUQGE]W;?)L0E9VOJLQ;NDW96U:LV
MD[G\V+Z3^67UX0QUM=5G%!N]M-'EZW>C=]$KV>B?].MUJ.KZ5\)9;:_@TF^/
MB/Q)J'@_06B\->'9&TS0?!0TV_U[5;#78-%BUF[N]6U35=(TBQU2?4IISI%O
MJK^8TE\DD?:?!7POKMMKUAH/BCP#J4>CZCXN?0]5:Z^%<'B>YU#5([:S@N?!
MOC'5=3$FJ?#KP]:07MOJ=WJVGZ7%JUC'>7>MQ1WPTR`V?\I3>/O'C1QQ-XZ\
M;-%$9&AB;Q?XD:*%IBIF:*)M4,<32E$,K1JK2E$,A;8N+:_$[XF*;TK\2OB*
MK:DNS4F7Q[XO5M33!&S4F&M`ZBN"1MO3.N"1C#$%_P#$J.:?]%G@?_#+7\O^
MIE_5NNEU_P`309;_`-$AC?\`P\4/+_J7>OW>9_0E<6L\-Q<0&+<8+B>`FW\R
MXMR89GB)M[C;_I%N2F8+C_EO"4F_CK]#_P#@G"DB?$7XCEXW0'P3I(!=&4$_
M\)`W`W`9_"OXT/\`A.?&XZ>-?&/_`(57B#_Y95^^W_!OSXB\0ZS\??V@(-8U
M_7-7AA^#WA>6&'5=9U/4XH96\=.C211WUU<)%(R?*SQJKE?E)(XKYGC'Z.V8
M<(<,YMQ+5XIP>.IY50I5I82GE5:A.NJN*P^&48UI8ZK&FTZZG=TYW4&K:IGT
M?"/C]@>+.(\JX=I<,XK!5,TKU*,<54S2E7A1=/#5L2Y2I1P5*4TU1<$E4C9M
M2O;0_JYHHHK^<#^@PHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/
MP_\`^"E+*O\`P4C_`."%)9@H/[5W[3R@L0!N;]COX@*JY/=F(51U+$`9)`K]
ML8]1T_RX_P#3K/[B_P#+S!_='^W7XF?\%*XXY?\`@I#_`,$*DE1)$/[5W[3Q
M*2*KJ2G['?Q`=258$$JRJRG&58!A@@$?M7'HFC^6G_$JTW[B_P#+A9^@_P"F
M-`%O^T=/_P"?ZS_\"8/_`(NC^T=/_P"?ZS_\"8/_`(NJ_P#8FC_]`K3?_`"S
M_P#C-']B:/\`]`K3?_`"S_\`C-`%C^T=/_Y_K/\`\"8/_BZ/[1T__G^L_P#P
M)@_^+JO_`&)H_P#T"M-_\`+/_P",T?V)H_\`T"M-_P#`"S_^,T`6/[1T_P#Y
M_K/_`,"8/_BZ/[1T_P#Y_K/_`,"8/_BZK_V)H_\`T"M-_P#`"S_^,T?V)H__
M`$"M-_\``"S_`/C-`%C^T=/_`.?ZS_\``F#_`.+H_M'3_P#G^L__``)@_P#B
MZK_V)H__`$"M-_\``"S_`/C-']B:/_T"M-_\`+/_`.,T`6/[1T__`)_K/_P)
M@_\`BZ/[1T__`)_K/_P)@_\`BZK_`-B:/_T"M-_\`+/_`.,T?V)H_P#T"M-_
M\`+/_P",T`6/[1T__G^L_P#P)@_^+H_M'3_^?ZS_`/`F#_XNJ_\`8FC_`/0*
MTW_P`L__`(S1_8FC_P#0*TW_`,`+/_XS0!8_M'3_`/G^L_\`P)@_^+K\^/\`
M@JO>6DW_``3U_:F2&ZMY7_X5S$=L<\3MC_A*O#:YVJQ.,D#IU('4BOO_`/L3
M1_\`H%:;_P"`%G_\9K\^O^"JNEZ;;?\`!/?]J66WL+*"5?AU%MDAM+>*0?\`
M%5>&SP\<2L.0#P>H!Z@5]5P+_P`EOP;_`-E5P]_ZM\&?,<;?\D;Q;_V36>_^
MJO%'\(3_`'V_WF_F:;3G^^W^\W\S3:_U=CLO1?D?Y?!1113`*_H#_P"#>N6*
M']H#]H1YI8XD_P"%->%OFD=47_D?6'WF('5E'7JP'4BOY_*_H`_X-[[6VNOC
M_P#M"1W-O!<)_P`*:\+?)/%',H_XKUC]V167JJGIU4'J!C\M\:_^36\8?]@.
M$_\`5KE]S],\'/\`DYO"/_8=BO\`U68X_K,_M'3_`/G^L_\`P)@_^+H_M'3_
M`/G^L_\`P)@_^+JO_8FC_P#0*TW_`,`+/_XS1_8FC_\`0*TW_P``+/\`^,U_
MF2?Z.%C^T=/_`.?ZS_\``F#_`.+H_M'3_P#G^L__``)@_P#BZK_V)H__`$"M
M-_\``"S_`/C-']B:/_T"M-_\`+/_`.,T`6/[1T__`)_K/_P)@_\`BZ/[1T__
M`)_K/_P)@_\`BZK_`-B:/_T"M-_\`+/_`.,T?V)H_P#T"M-_\`+/_P",T`6/
M[1T__G^L_P#P)@_^+J:*XM[C=Y$\,VW&[RI4DVYSC=L9L9P<9QG!QTJC_8FC
M_P#0*TW_`,`+/_XS5JVL;.SW_9+2VMO,V^9]GMX8-^W.W?Y2)NV[FV[LXR<8
MR<@%JBBB@`HHHH`****`"BBHY7>.*1XXFF=$=DB5D1I652RQJTC)&K.P"!G=
M44L"S*H)`!)17PMXM_:%^(7A#QMX9\/>(OB%^QYX0USQ?XVL/AUX8^$'B?XG
M^)T\=Z[XXU/1=/\`$VF^"XO%5O9Q6]IXNU#PYJFEZK!H\7PRU8/!K6AR6=QJ
M%KK&E7%_]M:7<7MWINGW6HV/]EZA<65K-?::+J*^%A>2PH]S9B]@5(;Q;:8O
M"MU%'&EP$$JQQA]B@'XG_P#!2?\`Y22?\$*?^SK?VH/_`%CGX@U^WD?^KC_W
M%_\`017XA_\`!2?_`)22?\$*?^SK?VH/_6.?B#7[>1_ZN/\`W%_]!%`#Z***
M`"BBB@`HHHH`****`"BBB@`HHHH`*_/3_@JW_P`H\_VIO^R=1?\`J4^'*_0N
MOST_X*M_\H\_VIO^R=1?^I3X<KZK@7_DM^#?^RJX>_\`5O@SYCC;_DC>+?\`
MLFL]_P#59BC^#1_OM_O-_,TVG/\`?;_>;^9IM?ZNQV7HOR/\O@HHHI@%?T#_
M`/!O/_R<%^T)_P!D:\+?^IX]?S\5_0/_`,&\_P#R<%^T)_V1KPM_ZGCU^6^-
M?_)K>,/^P'"?^K7+S],\'/\`DYO"/_8=B?\`U68X_K1HHHK_`#)/]'`HHHH`
M****`"BBB@`HHHH`****`"BBB@`I&`((.<$$''7&.V.<^E+2-T.`"<'@]#QT
M/7@_2@#\,O&?P=UOQY^U]\96\%_#_P")&O\`@9?C3\.+#QQ/XD^+?P:^'.F>
M'M8NM?\`V8OB_P#%/4_`?A?4O"FJ_%3Q3X5^(B?!+X*V-WK'B+7;:_CL_!'B
M;0?@_!H5AJUGXAB_<T#`_$G\R3^N<X[=*_"OXO\`P4O=3_;0\0^/YOV=$U[X
MN']H#X)7'PR2V_8I^#?B_P""?C?X-VD?PY/BOXJ_%3]JW5O@MK'CCPQ\3_!<
M"?$.^TV[N/C?X)\3>#]7\'>"=*\%_#3QO87<4_C+]U%Z?G[9Y/)&!@GJ>!R3
M0!^'O_!2R6.'_@I#_P`$*9)6")_PU?\`M.)N;.`TO['OC^)`<`XW.ZKD\#.6
M(&2/VAC\3Z'Y<?\`Q,(ON+_RSN/[H_Z85^,7_!2?_E))_P`$*?\`LZW]J#_U
MCGX@U^T5YXA\/Z2\5MJFN:1IMPT$<RP7^JV5G,T3;D658KFXBD,;,CJKA2I9
M&4$E2``+'XCT:5UCCOHV=B0JA+@9PI8\F$`8"D\GL:D.OZ2)UMOMD?G,8PJ;
M)\DRHLD>/W6WYD=6'S=#S@Y`S_\`A-/!O_0V>&__``H-*_\`DVE_X33P=G_D
M:_#?_@_TK^7VR@#>>\MH[3[<\H6U\E9_.(?;Y3J&5\!2^"K`XV;N>5SQ26EY
M;7T`N+6430EG4.H<#<A*L,.JMP1C[OTS6%_PFO@X<'Q7X;'_`''M*S_Z69_&
MC_A-?!P_YFOPU^.O:5_6\H`L?\)/H8_YB$7_`'Q<?_&*/^$GT/\`Z"$7_?NX
M_P#C%5O^$T\&_P#0U^&__!_I7_R9706MS:WMO#=V=S#=VMPBRP7-M.EQ;S1M
M]V2*:)WCD1L'#HS*<<$T`9'_``D^A_\`00B_[]W'_P`8H_X2?0_^@A%_W[N/
M_C%;V![_`)G_`!HP/?\`,_XT`8/_``D^A_\`00B_[]W'_P`8H_X2?0_^@A%_
MW[N/_C%;V![_`)G_`!HP/?\`,_XT`8/_``D^A_\`00B_[]W'_P`8H_X2?0_^
M@A%_W[N/_C%;V![_`)G_`!HP/?\`,_XT`8/_``D^A_\`00B_[]W'_P`8K\_?
M^"J.N:7>_P#!/G]J:"VNXY93\.8B$59@3GQ7X:08WQ(/O.HZYYSC`)'Z08'O
M^9_QK\]/^"K8Q_P3S_:FZ_\`).HNI)_YFGPYZFOJN!?^2WX-_P"RJX>_]6^#
M/F.-O^2-XM_[)K/?_57BK?U^1_!J_P!]O]YOYFFTY_OM_O-_,TVO]78[+T7Y
M'^7P4444P"OW]_X-\KVUL/C[^T)-=S+#'_PIKPM\S!B/^1^V]$5F^](@X!ZY
MZ`D?@%7]`_\`P;S_`/)P7[0G_9&O"W_J>/7Y;XU_\FMXP_[`<)_ZM<OO^'W>
M>Q^F>#G_`"<WA'_L.Q7_`*K,<?U9?\)/H?\`T$(O^_=Q_P#&*/\`A)]#_P"@
MA%_W[N/_`(Q6]@>_YG_&C`]_S/\`C7^9)_HX8/\`PD^A_P#00B_[]W'_`,8H
M_P"$GT/_`*"$7_?NX_\`C%;V![_F?\:,#W_,_P"-`&#_`,)/H?\`T$(O^_=Q
M_P#&*/\`A)]#_P"@A%_W[N/_`(Q6]@>_YG_&C`]_S/\`C0!@_P#"3Z'_`-!"
M+_OW<?\`QBM"QU2QU+S?L5PD_D[/,VK(NW?NVY\R-,YV-C&>ASCC-[`]_P`S
M_C2XQZ_B2?YT`%%%%`!1110`4444`%8WB.W^U^']<M3:I>BYT?5+<V<EI::A
M'=B:PN(OLTEC?W5C97B7&_R7M+N]M+6Y5S!<75O#(\R;-5KVTM;^TNK*^MK:
M]LKRVGM;NSO(([FTNK6XB>&XMKJWE5XI[>>%WBGAD1XY8G>-U96((!_.9X'^
M!'Q/U+XQ_#;Q?XS_`&3-/.L6?C3X82W_`(OUG]@+]@_1=:TO3_"]YX:TS2+T
M^*M%_P""AGBGQ/X?3POX>T?3;71]8T#P[XDU;P[IFE6$WA_1-:FL+'3KK^CL
M?U/8#J3Z9_/J>IP>*_G_`-=^#W@3Q1^VQXSU&Q^!WB>^M?AG\=/A/X5\/:]\
M!_V!_P!C3Q!\,_#>G^$?"'PIN]*TKQK\9?C#\-M0^-"^*?",,ENOB?Q/\.]=
MM-#\$>$E\*Z1\.9[#Q!X6U%;3^@`?U/7`[GT]>W<CD\YH`_$'_@I/_RDD_X(
M4_\`9UO[4'_K'/Q!K3_X*()`WQK\-F58&;_A66B`&58BV/\`A(/%&`-XSC.>
MG&<]\UF?\%)_^4DG_!"G_LZW]J#_`-8Y^(-?E7_P7WEE7]LGX?JDLJ+_`,,Z
M>#SA)9$&3X]^)7.%8#/`YQG'&<5][X;\#_\`$0>)J?#O]I_V3[3!8O%_7/J?
MUZWU50?L_J_UK!WY^>W/[9<MK\LMCX;Q"XS7`?#M3/WEW]J*&+PN%^J_7/J5
M_K,W'VGM_JN,MR6OR^Q?-?XHV/>(H+626*,0P2&26.,1PQV[32&1U01PJ58-
M,Y8)"K*5:5D4@@X/V=XH\"_#&Q_X0GQ!:^$?#EEX,T_1?$=MK5]=:3XWNM;L
M]3CTSXCW.@6'Q)\"7`BU*YO+>\\/K=:EK>E:E:P1W&C:M8ZK)IOA\:3<0?Q\
M>=/_`,_%Q_W_`)O_`(NO:M7_`&E/V@==O?A[J6J_&;XDW>I?"G2VT?X?ZD_B
M_6_M_ANTDDU`W$EM=&\:6[O[RVU*XTO4=3U$W=]J>A):Z!J,]UHUG;6,?[[7
M^BCC8RI_5N-L-5BU5]JZ^15*$H-4FZ'LXT\VQ*J*I6Y:=5RE2=&FY581KRBJ
M,OPVA]*#!RC4^L\&XBE).E[)4,\IUU-.I%5_:.IE>&=-TZ3G.DHJJJU2*I3=
M",O;+^A/QQH.EKJ7A75-$LO#U[H7C+1+'5?#\/A?P]>>&VOK=-;U'P_<V\VB
M7NI>);FVU>?5M-N[**XLM3U:PU(&SN=,>?>]N.H\::1X(O\`X=6?BKP]H7@_
M3=2L_'<OAO6K/PL?$D;^%K6ZT"XO].\+^-%\7S-/JWBP7>G:BZZUHMO%9^5I
M^I6^I,L\VGV\/\T6L_&?XN>(;OQ3?:Y\3/&VJ7GC;2=`T#Q9<7>OWC/KNA>%
M-6L=>\+Z+=+&T<<&D^'-;TW3]6T+3M.2QL]*O[."XLH875MQX[^-'Q=^*%OI
MEG\1OB9XW\;6FC3W-WIEMXC\07FH06E]>Q0V][J?E%HTNM8O8+>""]UN_%WK
M-Y##'#<W\L:[:B'T4<Q<Z2J<9X*-.3_?RADU><Z2]E3DO90EF%.-=^W=:D^>
M>&M1IT\0KSJRPU*I?2@P"C4<.$,9*:M[&,\WHPC4_>SB_;3C@*CH_N53J+V<
M,3>K.=!VA3CB*O[W+':9'[NTZC^&W]?I7]$'[+(4?L\?"`*%"CP/I&T)M"@;
M9,;0ORX^E?YU:33[T_?W'WE_Y;S>H_VZ_OJ_X)FDM^P-^R@6)8GX,>%,EB68
M_N[CDEB23ZDFOSSQ3\%GX:9/E^:OB/\`MGZ_F*R_V']D?V?[*^&KXCVOM?[3
MQW/;V/)[/V</BYN?W;/[_P`,_&!>(N:X_+/]7O['^HY<\?[?^U?K_M;8C#X=
MTO9_V;@N36OS<_M)_#R\FO,ONBBBBOPL_:@HHHH`****`"OST_X*M_\`*//]
MJ;_LG47_`*E/AROT+K\]/^"K?_*//]J;_LG47_J4^'*^JX%_Y+?@W_LJN'O_
M`%;X,^8XV_Y(WBW_`+)K/?\`U68H_@T?[[?[S?S--I93M,C<?*7/S,%7C)^9
MCPJ_WF/"C+'@5^B7C/\`8-MO"?B#X3^%9/BGJ@U;Q=X#^(7Q!\97%S\)/%QT
MK_A%_AEIGQ%\3>)O$OP;U&WN#I?Q8TZ7P_X%BM_#^B)JV@^(==N=?\.>*8X[
M3P?XA,^@_P"H^99YEF3RPM/,,1.C/%T\74HJ&'Q.(<J>`PSQ6+J26&HU7"-&
MBE)N=G.4HPIJ4W8_S2R[)LQS:&(G@*$:T,+/"4ZTI8C#4%&ICL1'"X2"^L5:
M7/*K6ERKDYE!*4ZCA!7/SLHK[)U+]EKP[HGA*T^,VM?$;Q/8_L^ZI\+O#GQ*
MT?Q4?AE$?B9J$_BCXE:]\)].\%1_#N;QS;Z"VL1^)O"OB/6)/$$'C^;PM?\`
M@O38=;TF]NKW4;;24\J\0?!K3?!'QJUCX5^/OB)H_ASP[HD(UJ;XC6VB:IJ]
MKK/A+4/!EIX_\):GX9\+I-::C?Z]XZ\.:KH4/AOPUJ&H:5'#KNLPZ=K>MZ=:
MV=YJ21AN(<IQ<J\,-B*M:>&IXJI6A#!XUU(O`O#K&453^K\\\7A98K#0KX.G
M&6+ISQ%&$J//-1-,1D.:82-&>(H4Z4,14PT*4Y8O!*G)8Q5WA*TJGUCDIX7$
MQPV)G1Q=1PPM2%"K.-9PA)KPNOZ!_P#@WG_Y."_:$_[(UX6_]3QZ_%?XO?#'
M3?ARWP[U3P_XFO?%'A/XJ_#G3OB;X2N];\.CPAXJL]%OO$/B3PNUEXG\-1:S
MXBLK*Z.J>%=1N](U+2=?U?1?$GAVYTO7=+NQ#=M;P?M1_P`&\_\`R<%^T)_V
M1KPM_P"IX]?G_C#BJ&-\)N+L1AY.=*>"P\4Y4ZE*2E3SG!4JD)TZL(5*<Z=2
M$Z<X3A&49QE&233/N_"7#5L)XI\*8?$14*L,;6DU&=.I%QJ93C*M.<*E*4Z=
M2%2G.%2$X3E&4)*2;3/ZT:***_S1/]%0HHHH`****`"BBB@`HHHH`****`"B
MBB@`I#C!STP<\XX[\]OK2U4OYIK:QO+BWBBGGAM;F:&&>:6WAFEB@DDCBEG@
MM;V:".1U5))HK.ZEB1F>.VG=5A<`_,3QQHW[#^M?M1ZUJES\.OVA?'/QLT[X
MC>!;'QAXR^%O@[]M'Q=\--`^(>G6/A6\\.:9XP\5?#5KGX'Z7<^&]&O?"][X
METS4YQI?AO1[N(^,;:S@EO8C^HH]O4^OJ<]??IVQTXQ7X=V6E?%O7/BW<?'G
M4+GP9X`\+>)?B'X0\5?$)?`/_!7;XA0?"RQ_L$^'M'U6ZC^%I_98\.>$;UO[
M%T6"'7/#-UJ/AM_&$L`TSQ%J=G).+JR_;?3-1LM8TVPU;3;A;O3M4L[?4+"Z
M0.$N;*]B2YM;B,2(D@CF@DCD0,BG8PXH`_$K_@I9)Y7_``4@_P""%3[)),?M
M7_M.+LB3>_S_`+'OC]-P4$?*F[>YS\J*S8.,'\H?^"]MU]L_;&\`2_9[JVQ^
MSMX.3R[N$P2G_BNOB0VX(6;*?/M#9^\K+_#D_K%_P4G_`.4DG_!"G_LZW]J#
M_P!8Y^(-?E1_P7Y_Y/+^'_\`V;GX._\`4]^)=?O?T;O^3F8?_L39K_Z30/PW
MZ0W_`";G$?\`8WROK_T]GTZGX>T445_H:?P2%%%%`#D^^O\`O+_,5_>M_P`$
MUM6^R_L%_LH1?V;JUQCX,>%OWEM8M-$=HNTX<2+G.S>O'*,C?Q8'\%*??7_>
M7^8K^^S_`()F`']@;]D_(!_XLQX4[?\`3.XK^8/I3_\`)(</?]E&O_59CC^D
M_HR_\E5GW_9/2_\`5E@#[*_MX_\`0'U[_P`%C?\`Q^C^WC_T!]>_\%C?_'ZW
M\#T'Y"C`]!^0K^%C^U3`_MX_]`?7O_!8W_Q^C^WC_P!`?7O_``6-_P#'ZW\#
MT'Y"C`]!^0H`P/[>/_0'U[_P6-_\?H_MX_\`0'U[_P`%C?\`Q^M_`]!^0HP/
M0?D*`,#^WC_T!]>_\%C?_'Z_/W_@JAJWVK_@GS^U+$=.U:WS\.8CYEU8M!$/
M^*K\-+@N9'P?FW'C[JL>V#^D.!Z#\A7YZ?\`!5L`?\$\_P!J;``_XMU%V_ZF
MGPY7U7`O_);\&_\`95</?^K?!GS'&W_)&\6_]DUGO_JKQ1_!L6*R;UVEDD#J
M'19$+(X90\;@I(A(`>-U9)%RCJR,RG[CU3]MBYD\/?!_PIX8^$?AGP7X:^&^
MLV?B[6?#_A7QM\4/#]CJ?C'3=2^*=SI6H_#R_P!.\8?VO\'+'3(?BIK5_:)X
M.N4U!M;BTZRU.\U?P3X>T'PK#\-O]]O]YOYFFU_J5F&3Y?FRPWU^A*NL+*I4
MH15?$4HQJ5:,Z$IN%&K3C.I&G.3HU)J4\/4:K8>5*JE-?YGX#-L?E:K_`%&M
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M1K16(P6`Q$5/#SJU,/'DK86<'0P\J]?V&&<7AJ,,3B:5*C"EB<1"IZI\9/B5
M#\6_&]YXZ.CZYI.J:M;6ZZTVO>.KOQ[<WUY:`VUF]G>7/A[PQ;:!HVFZ1%8:
M+HOA31M*MM!T+3=.MK32(+2R6.S@_:C_`(-\[K[)\??VA)?L]U<_\6:\+?N[
M2`SR?\C]M^X&7^_NZ_=5S_#@_@'7]`__``;S_P#)P7[0G_9&O"W_`*GCU\%X
MQ8:C@_"7BK"X:+IT,/EN!I4:;G4J^SI4\TR^,*:G6G4J.,8I1BI3?+%*,;))
M+[GPDQ%;%^*G"^*Q$E4KU\QQE6M-0IT^>I/+<<Y3<*4(04I2;E-QBN:3<I7E
M)M_U8_V\?^@/KW_@L;_X_1_;Q_Z`^O?^"QO_`(_6_@>@_(48'H/R%?YH'^BI
M@?V\?^@/KW_@L;_X_1_;Q_Z`^O?^"QO_`(_6_@>@_(48'H/R%`&!_;Q_Z`^O
M?^"QO_C]']O'_H#Z]_X+&_\`C];^!Z#\A1@>@_(4`8']O'_H#Z]_X+&_^/UH
M6-_]N\W_`$._M/+V?\?UJ;;S-^[_`%>7??MV_/TV[EZYXOX'H/R%+@#H`*`"
MBBB@`HHHH`****`"BBB@#SZZ^$WPNOO%,7CB]^''@*\\9PNDD/BV[\'>&[GQ
M/%)&5*/'X@FTQ]81T*(5=;T.I52&!48]!`QQ_G_/O110!^('_!2?_E))_P`$
M*?\`LZW]J#_UCGX@U^5'_!?G_D\OX?\`_9N?@[_U/?B77ZK_`/!2?_E))_P0
MI_[.M_:@_P#6.?B#7Y4?\%^?^3R_A_\`]FY^#O\`U/?B77[W]&[_`).9A_\`
ML39K_P"DT#\-^D-_R;G$?]C;*_\`T[,_#VBOJG]D+]GO2?VD/BC+X+UK7=>T
MVPTW2#K,^C>"M,TG6OB#XG1[@6'V3P?I.M:QHME=-I$L\.L>(9TDU&]M-'B/
MV+1KU[F2YTZSX!_9HTOQ7>?&*36/'>J^'O#_`,/?#?Q=D\#WFK>!KSPQXJ^(
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MZCJ&K:OIFH?$?P'X`O\`6O$6MRI::+X;TE9_',#^'K6SN-9UW7KS3=2:YL-&
MTJR6\U!T>(LHQ%&=>CB9U*<,?@\MDXX7%.2Q6/EAHX-."HN:H5_KF'E'%.*P
MT(5.>I5@H5'%5L@S2A6C0JX>$*D\#B\PBI8G"I/#8&.(EBVINMR.M0>%Q$'A
ME+ZQ.=/EITIN=-2\)3[Z_P"\O\Q7]]O_``3,_P"3!?V3_P#LC'A3_P!%W%?P
M))]]?]Y?YBO[[?\`@F9_R8+^R?\`]D8\*?\`HNXK^>_I3Z\'\//_`*J-?^JW
M''[U]&7_`)*O/O\`LGI_^K++S[IHHHK^%C^U0HHHH`****`"OST_X*M_\H\_
MVIO^R=1?^I3X<K]"Z_/3_@JW_P`H\_VIO^R=1?\`J4^'*^JX%_Y+?@W_`+*K
MA[_U;X,^8XV_Y(WBW_LFL]_]5F*/X-'^^W^\W\S3:<_WV_WF_F:;7^KL=EZ+
M\C_+X****8!7]`__``;S_P#)P7[0G_9&O"W_`*GCU_/Q7]`__!O/_P`G!?M"
M?]D:\+?^IX]?EOC7_P`FMXP_[`<)_P"K7+S],\'/^3F\(_\`8=B?_59CC^M&
MBBBO\R3_`$<"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`_#S_@I
M:95_X*0?\$*C!&DLG_#5_P"TZ`DDIA0@_L>>/PY,@BF(V(6<`1L7*A,KNW#\
MHO\`@O<]W)^V-X`:]MX;:7_AG7P<!'!=-=H4_P"$[^))W&5K:T(;>64IY9&%
M#!_FVC]8?^"D_P#RDD_X(4_]G6_M0?\`K'/Q!K\J/^"_/_)Y?P__`.S<_!W_
M`*GOQ+K][^C=_P`G,P__`&)LU_\`2:!^&_2&_P"3<XC_`+&V5_\`IV9^5/P%
M^,-I\%/'=GXNU#X=>#?B7I\6TS:)XJ@OK6^L[B"VU"&SU3PKXIT:]T_7?">L
M1'4;BVO+JQN9;35M(N+O2]3L+E6L[FP]=TG]O/\`:/TWQ-K'B.7Q1I-]#JOA
M_P`?:!:^&+CPOX=F\-^&X_B#X+;P/?77AL:EI>K>(+9])T^/3;VS@U+7]4BU
MG4-'L9/%S>(5DO\`[7\;45_>F,X>R3,,36Q>/RW"XVOB,,L'4EBZ?UB*H14U
MRTJ=5SIT)RC4E&I6H0IUJD%3C4J2C2I*'\083/LYP%"CAL#F.*P=&AB98NG'
M"U/8-UY>S?-5J4E&I7A%THRITJ\JE*E)U)4X1E5J.?TK'^TYXFM?A1_PJ;3O
M"FA:=I=_H6G>%/$^I1>*/B9=0^(O"MMXET_Q3KFEV?@K4?&EY\/O`VH^/M1T
MG2X_B)XF\">&]"UGQ-9V;6\,FD#4-7.H1^$/CUX2\(Z5\7=$A^`'@J_TSXQ1
MW.DZW9_\+#^+>EV^A>#4\=>'?B%X?\&^&ULO$KSP6?AG7?"VCQ6FO:E<ZCXD
MU73(9K/6]0O6N))S\W44WD&5.%6FJ%:G&OBUCJWL<=F%"53%QJT:\*\IT<53
MFYTJN'HRHKFY:'LXQHQA%6!9[F:G2J.O1G.AA7@J+JX'`5E3PLJ=6C.C&%;"
MS@HU*=>M"L^7FK>TDZLIR=QX(,F0-H,F0H)8*"V0H9B68*"%#,2QQEB22:_O
M6_X)JW&LI^P7^RBMKIEE<0_\*8\*[9)-6>W<@"Z"[HO[+G"DH%8@2N`6VY.T
MD_P4)]]?]Y?YBO[[?^"9G_)@O[)__9&/"G_HNXK^>/I3_P#)'\/?]E&OG_PF
M8[>_W]S]\^C-_P`E7GW_`&3T_P#U99>?9?VKQ%_T!M/_`/!X_P#\I:/M7B+_
M`*`VG_\`@\?_`.4M;U%?PL?VJ8/VKQ%_T!M/_P#!X_\`\I:/M7B+_H#:?_X/
M'_\`E+6]10!@_:O$7_0&T_\`\'C_`/REH^U>(O\`H#:?_P"#Q_\`Y2UO44`8
M/VKQ%_T!M/\`_!X__P`I:_/W_@JC/K,G_!/G]J5;O3;.V@_X5U%NEBU5[EQ_
MQ57AL?+#_9=N&(!+<RJ.,9R17Z05^>G_``5;_P"4>?[4W_9.HO\`U*?#E?5<
M"_\`);\&_P#95</?^K?!GS'&W_)&\6_]DUGO_JLQ1_!H_P!]O]YOYFFTY_OM
M_O-_,TVO]78[+T7Y'^7P4444P"OW]_X-\I+R/X^_M"-96T-S+_PIKPMF.>Z:
MT7'_``GI'$BVMWDX+$@QJ/E`!);C\`J_H'_X-Y_^3@OVA/\`LC7A;_U/'K\M
M\:_^36\8?]@.$_\`5KEY^F>#G_)S>$?^P[%?^JS'']6?VKQ%_P!`;3__``>/
M_P#*6C[5XB_Z`VG_`/@\?_Y2UO45_F2?Z.&#]J\1?]`;3_\`P>/_`/*6C[5X
MB_Z`VG_^#Q__`)2UO44`8/VKQ%_T!M/_`/!X_P#\I:/M7B+_`*`VG_\`@\?_
M`.4M;U%`&#]J\1?]`;3_`/P>/_\`*6K]C+J,OF_;[*WM-NSRO(OFO?,SNW[M
MUE9^7MPN/]9OW'[NWYK]%`!1110`4444`%%%%`!1110`4444`?B!_P`%)_\`
ME))_P0I_[.M_:@_]8Y^(-?E1_P`%^?\`D\OX?_\`9N?@[_U/?B77ZK_\%)_^
M4DG_``0I_P"SK?VH/_6.?B#7Y4?\%^?^3R_A_P#]FY^#O_4]^)=?O?T;O^3F
M8?\`[$V:_P#I-`_#?I#?\FYQ'_8VRO\`].S/P]HHHK_0T_@D****`')]]?\`
M>7^8K^^W_@F9_P`F"_LG_P#9&/"G_HNXK^!)/OK_`+R_S%?WV_\`!,S_`),%
M_9/_`.R,>%/_`$7<5_,'TI_^2/X>_P"RC7_JMQQ_2?T9?^2KS[_LGI_^K++S
MA_\`@I-^W3K_`.PE\.OASXX\/_#K1OB//XX\>W/@VXT[6?$NH>&8=.@@\+ZM
MXA%_#<Z?H^LR7,K2Z:EJ;>2&%!',THE+($;\>O\`B(C^)7_1KG@7_P`.OXE_
M^8:OI;_@X:_Y(#^S_P#]EPU'_P!5KXIK^8/X.:5X9UGXF>%+#QIH7B+Q+X2-
MQJMYXCT;PKI6N:YK-QI6E^'M9U6:Z&C^&+JQ\3:GI&DRV4.L^*+/PY?V&OS^
M%-/UQ-&O[+4C;747D>#WAGP!G_AOA.(>(.&XYIF"JYQ.O7CC<TI5JU+!8JLJ
M=.G1PV88:@ZBITHTZ:48<TK<\M7(]7Q9\1>.LC\0L3D.0\0RRS`N&44Z%&6$
MRVK1HU<9A<-*=2=;$8#$UU!U:KJ5'S3Y8WY(:*)^\P_X.(_B4>G[+G@4^F/B
MOXE.?ICP-S2_\1$7Q*.2/V7/`Q`ZG_A:_B7CZ_\`%#<5\F^+O@W\$]-_;K\"
M>%O%?P>\!ZA\//C+/X@TSP#8_#KQCXR\-_#K5-0T2\\6:-XB\4>(/!'B:SM_
M%VBZMX7NM&72H?`6@ZM8>"=4UZQM?%<.J:KHEQ?Z+<?./[-WP\^''B#PC^RQ
M8>(/A[H'Q"F_:@^.?CWX5>-O%U]<:[)KGPZT'PYI_P`.]-TL_#V\T;6].TSP
M]XHTZW\;:M\6-5UG5K#7!J6CZ)8Z;=6B>&K;5X[KZJCP!X.5<%#&K@'$1A+!
M83'1@\TS%N5.OA\ZQ5>FI+B"T*N"I\.YC3Q$,1]7E'$TZ>&Y56E4A3^7J\<^
M+=+&2P?^O-!SCC<5@G)99@%RSH8C)<-0JN+R&\Z6,GGV6SP\Z'MXNA.>(O[*
M-.53]/\`_B(C^)1Z?LN>!?\`PZ_B7_YAJ/\`B(C^)7_1KG@7_P`.OXE_^8:O
MR*_9-^!\'Q'^(%SKFM^';?XB>#OA[KO@R*Z\%#5K#19/B?J/BSQ=%X>\.Z>8
M[C6-&U(>!!9P:MXR\=:MHMP9XO#6CKX=TZYCUKQ1I4J>0?M`>"/^%;_'7XR^
M`TT?^P+/PK\4_B!H^CZ/YL$RV'AVU\6:LOAF".2WN[Z/R/\`A'CI;VZ-=2SQ
MP/''=;+E)HT]RCX3>#=?.,1DM+A/#RQ>%PE/%UO^%;.4HQFZ/[ITWG'UA3A3
MKX6K*<J*H..(IPC5E5C6IT_&J^*/BY0RG#YS5XIKPPF)Q4\+1OE>47DX*=JB
MJ+*?J[A.=#$4X1C6=;FP]24J4:3I5*G]M_\`P3@_;8UW]N?X0^,OB9K_`,/]
M(^'5UX6^)-[X$ATG1O$5]XEM[RWM?"_ACQ`NHR7FH:1H\L,SR:_):FV2WDC5
M+:.43%I61#_@JW_RCS_:F_[)U%_ZE/AROB'_`(-\O^34_BY_V<+K'_JMOAS7
MV]_P5;_Y1Y_M3?\`9.HO_4I\.5_)N:91EV0^.F$RC*,-'!Y;@..N':.$PL:E
M:K&C2^OY;/E53$5*M:?O2D[U*DY7>]K(_J/+<US#._!7%9KFF)EB\PQO!>>5
ML5B94Z5*56I]1Q\>9TZ%.E2C[L4K0IQ6FUS^#1_OM_O-_,TVG/\`?;_>;^9I
MM?Z0QV7HOR/\]0HHHI@%?T#_`/!O/_R<%^T)_P!D:\+?^IX]?S\5_0/_`,&\
M_P#R<%^T)_V1KPM_ZGCU^6^-?_)K>,/^P'"?^K7+S],\'/\`DYO"/_8=B?\`
MU68X_K`UB^;3-)U/4EC69K#3[V]6)F*+(UI:RW`C9PK%5<QA2P5BH.0"1@_R
MT)_P<2?$ID1C^RYX%&Y%;'_"U_$IQN4-C/\`P@W.,XSQGTK^HCQ9_P`BOXC_
M`.P#K/\`Z;;JO\T6'_5PY!(\N+('4_(O`]_2OYD^COP)PGQI3XMEQ/D]/-7E
MT\D6"=3%8_#>P6*6:O$)?4L7AE/VCP]!OVJGR^S7)R\T^;^C/'WC?BG@^MPM
M'AO-ZF61S"&=/&*&&P.(]L\++*/J[?US"XAP]G]9K6]FX<W/[_-RQY?Z-/\`
MB(C^)/\`T:[X%_\`#K^)?_F&I?\`B(B^)7'_`!BYX%YZ?\77\2\_3_BAJ_/B
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MA*>-PV5XFE%9=ES2CF>*IX10E..1.'M,'5J4EC*<9RJP=2$*5.M4C4A3_2`_
M\'$7Q*'!_9<\"@^A^*_B7_YAJ/\`B(B^)77_`(9<\"X/0_\`"U_$O..O_,C5
M^-'Q3\":;XDM/V:?$W@7PKX<\)>(OCY\/_[0U7P?H,]QH7@6R\36_P`7/%OP
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M?N'^R+_P6P\=?M+?M(_"?X%:I^S_`.$?"6G_`!'U[4M'NO$>G_$77=8O-*2Q
M\+Z_X@6>WTRZ\)6%O>/))HR6K1RWENJI</*'+1B-_P"A=3D`^H!_,5_!9_P2
MK_Y2$?LO?]CMX@_]5MXYK^])/N+_`+J_R%?S3](#A+AW@[BK*,OX:RR&5X/$
M</4<96H4\1B\0JF)EF.94'5<\9B,343=*A2ARQFH6@FH\SDW_1/@3Q5Q!Q;P
MSFN.XBS&>98O#Y]6P=&M.AA,.X8:&7996C24<'A\/3:56O5ES2C*?OV<N512
M=1117X0?MX4444`%%%%`!1110`4444`?F?\`\%!?V!_B%^V+XL_95^)_P<_:
MAU3]E/XP?LE?$GQS\2/A]X^T_P"#W@WXU0SWWCWX=:A\-=7LKWPEXZUG2_#[
MHNA:I?B&>\@U1%DN6=;2.YAMKN#\N?VA/^""W[9G[4_C73OB'\<?^"P_BGQ9
MXNTKPU9>$;'4K/\`8/\`V=O#<4.@:?J&J:I:6;6.@^*;&SE>.^UG493=20M<
M.LRQ/(8X8E7^G:BO0RS-LUR7%+'9/F6/RK&QA.DL7EV+KX+$JG4LJE-5\-4I
MU5":24X<W+))<R=C@S'*LLSC#/!YMEV!S3".<*CPN882AC,.ZE-MPFZ&(IU*
M;G!MN,G&\;NS1_(G_P`0P/QH_P"DL'C3_P`0N^"/_P`VU(?^#8+XT`$_\/8/
M&G`)_P"3+_@CV&?^AUK^NV@C((/0\&OI/^(C^(/_`$7/%_\`XD>;_P#S9Y?G
MW9\__P`0_P"`_P#HBN$__$>RG_YD\OS[L_BD^$/_``;O_&_XH>)?C]X?F_X*
MA>+=&3X*?&VZ^$=M=0_L??!>];Q';6_PK^$_Q'77KB*7Q9;+IT[S?$J?2#8P
M/<PB+1X;L3"6[E@A]O\`^(8'XT?])8/&G_B%WP1_^;:OZP/#/@;PGX.O_&6I
M^&M%M=)O_B#XKD\<>,;FW:X9]>\52^'O#GA236;L3SS(ETWA[PEX=TLK:K;V
M_D:5;L(!,T\LO64?\1'\0O\`HN>+O_$CS?\`^;/+^KL/^(?\!_\`1%<*?^(]
ME/\`\R?U\V?R*#_@V"^-`((_X*P>-,@Y'_&%WP1ZC_N=:_0;X7_\$S?^"I/P
M:^'WA#X6?#K_`(+<:YHG@?P)HEIX<\+Z3/\`\$Y_V5=6FL-'L0PM;:34M3UJ
MZO[UXP[`W%W/+-)U=V/-?O+17E9MQ5Q/GU&GAL\XBSS.,/1J^VHT,TS7'8^C
M2K<DJ?M:=/%5ZL(5.24H<\4I<LI*]I._IY7PSPYDE:IB,ER#)<IKU:?L:M;+
M,KP6!JU*/-&?LJE3"T*4YT^>$)N$FX\T8RM=)G\YO[1G_!&S_@H/^UCX>\.^
M%?CQ_P`%GO$?B_0_"FO2^)="M++_`()^?LS>&7M-9FTRZT>2Z>Y\/^(K">Y0
MZ=>W,'V>X>2`-()0GFHC+\I:;_P;*?'O1=0LM7T7_@KG\1]%U?3+F*]TS5]&
M_8_^#NDZMIE[`VZ"]TW4].\>6U_87D#_`#P75I<0W$+_`#1R*>:_K?HK7+^,
MN+LHP<<NRKBCB#+<!!U'#`X#.,PPF$BZTG.JXX>AB*=%.K*4I5+0]]RDY7;=
M\\?PGPMFN+EC\SX;R',<=)4U+&X[*,OQ>+DJ48QI*6(KX>I6:IQC&--.;Y(I
M1C9*Q_,2_P#P0@_;N;Q_K_Q33_@N)\<K?XA^)XK2VUKQ;:?LF_!JVUBXL]/:
M1]/T^UG3QL1I6FV#S3M9:=I*V-E;-<W+0P(;B?S/FO3/^"*_[:L_[2GQ=^`U
MO_P63^-.GVOB/X'>`?BYXX\2Z=^S)\*;!_&USXO\8_$KX6MH>N:'8>,+2P=+
M#P_X%%O_`&K'<"]OM+UF\T*Z4:8K0W/]A5<C#X#\(V_CK4/B7#H=K'XYU7PG
MH_@;4/$8>Y^VW7A30-:UWQ%I&BR(9S:"UL=:\2Z[J$3I;+<&;49A)/)$L4<:
MCQCQ9#X.)L^C^ZH4/=S;'+]QAG3>&HZ5_P"%AW1I.A3^"DZ<'347&-G+A3A>
M?Q\.9%+][6K^]E&`D_;8A5(XBLV\.VZM>-6HJU1^_552?.Y<SO\`ROZG_P`&
MU7[1FM7?A:_UC_@KY\1]5OO`VC^'_#_@R[U#]CGX*W=QX4T+PG<R7GA?2/#\
ML_C=VTK3O#UW+)<Z/:V9BBL)W:2W5&.:SM2_X-DOCMK&I:EK.J_\%:_'FH:M
MK.I:AK.K:C=_L9_!.>\U+5M6O9]1U34[V=_&QDN+[4=0NKF^O;F0M+<W5Q-/
M*S22,Q_K?HKMAXA<>T^7V?&O%<.6+C'DX@S6/+&4N>48VQ:M&4ES22T<KR:;
M;9QRX#X(G?GX.X6GS24I<V095*\HQY8R=\([M17*F]HZ;:'\Z_[.W_!'G_@H
MA^REX2UCP-\"O^"T7B+PCX8U_P`1S>+-5L+S_@GS^S)XEDN->N-,TW1Y;Q;S
MQ!XAO[J%&T_2-/A%M%*MNK0M*L8DEE9NZ^+7_!,+_@J%\<OASXL^$_Q-_P""
MVNNZ_P"`_&^FKI'B71[?_@G3^ROHTU_IZW=K?"&/4]*UNUU"T/VFSMW,MK<1
MR80INVLP/[W45\_5S;-*^9?VQ7S''5LV^L4\9_:E7%UZF8?6Z,H2HXGZY.I+
M$>WI2IPE3K>T]I!PBXR3BK>[2RO+:&7_`-DT,OP5'*_85,+_`&;2PM"G@/JU
M52C5P_U2,%A_85(SG&I2]GR34I*46I._\BA_X-@OC022?^"L'C3).3_QA=\$
M>I_[G6D_XA@?C1_TE@\:?^(7?!'_`.;:OZ[**^D_XB/X@_\`1<\7_P#B1YO_
M`/-GE^?=GS__`!#_`(#_`.B*X3_\1W*/_F3R_J[/XK?B;_P;L?&_X?>.OV>/
M!L/_``5$\6ZK'\<OBSK_`,-+K4)?V/?@O:2>&H-%^!GQA^,2:Q;6\?BV:/4Y
M;FX^%L'A]K.>6UCC@UJ?4%F::QBMKCV;_B&!^-'_`$E@\:?^(7?!'_YMJ_K#
MU_P5X7\4:OX)U[7M'MM2U?X=>([SQ;X*OIVN%E\/^(M0\(^)_`EYJMF(9HHW
MN)_"7C+Q-HCK=1W$`M=7N66);E;>>'J:/^(C^(7_`$7/%W_B1YO_`/-@O^(?
M\!_]$5PI_P"(]E/E_P!0GE^?=W_D3_XA@?C1_P!)8/&G_B%WP1_^;:OH?]G/
M_@A9^VY^R=XB\1^*_@/_`,%CO%'A#7?%FB6GAW7KN]_8*_9R\3)=Z18Z@=4M
M;9+;Q!XHO[:V:.])E,]O$DS@^6[F,!1_3+17)CN..-,SPE;`9EQ;Q+F&!Q,8
MPQ&#QN>9GBL+7C&<*D8UJ%;$SI5(QJ0A-*<9)3BI+57.K!<&<(9;BJ..R_A;
MAW`8W#R<L/B\'DN6X;$T)2BX2E1KT<-"K3DX2E!N$TW&4HMVDT_Q.N_V#_\`
M@KM?6MS977_!<K6)+:\MY[6XC'_!-G]DA"\%S$\,R!TU174M&[*&4AESD$$"
MOS#7_@V`^,ZA5'_!6#QIA0`/^,+_`((\!1@<_P#";=@*_KMHKARCB7B+A]8A
M9#GN<9*L6Z3Q2RK,L9EZQ+H>T]BZZPM:E[5TO:U53Y^;D52:C;GE?MS7A[(,
M]=!YWDF49P\*JBPSS3+L'CWAU6]FZRHO%4:OLE5]C2]IR<O/[.'-?EC;^5V/
M_@WD_:^A^'ME\)XO^"T?QD3X;:=XFA\86/@L?LF_"(^'[7Q!;K";:[AT]O'S
M0+:VUS!'J=OI.TZ1!K8;7(K%=7DDO7\I_:[_`."./[=7PL^!7BWXUZU_P6@^
M-WQ!U#X%Z8OQ`\%Z/J/[,/PCT5]-US2+P16,VB:YIGBV34?#LUNVLZA/!-I:
M((9;JZ=(M]U.9/Z^*Y'Q[X#\(_$_P?X@\`^/-#M?$GA#Q3I\FE:_H=Z]S'::
MGI\LD<LEK.]I/;7*QM)#&Q,,\3Y08<#(/6^-.+W-5'Q1Q`ZBJUJZF\WQ[FJV
M)2CB*O,Z]_:UXQC&M4OS58I1J.2T.9<(\*J#IKAK(%3=.C1<%D^7\OL<.V\/
M2M]7M[.@VW1A\--MN"BVV?S`:[_P;M?M:^*Y?&,_B3_@M!\8]=;Q_9Z%I'C8
M:M^R;\'[]/%6D>$-2BU'PKI.MQ3^.3#>:5X<U"TM[[0],,4=AI5U$DME;0,.
M>1E_X-E_CW-HND>&Y?\`@K=X]?P_X?O==U'0M%/[&7P1&F:/?^)SI;>([S3K
M-?&HAM+G76T/1FU::%5>_.E:>;@N;2$K_6T``,`8&2?Q8EB?Q))I:WI<?<<T
M(QC1XQXHI1A*,X1I9]FE.,)PH1PL)14<4E&4,+&.&C)).-!*BFJ?NF%7@C@N
MO*4ZW"/#-64XRC*53(LKG*49UWBIQDY85N498EO$23NG6;JM.;<C^5?X3?\`
M!NO^U%\#_B+X4^+'PS_X*[^+M!\=^";ZXU+PWJ]Q^PY\`M8AL;R[TR_T>>63
M3-4\7W.GW8?3]2O81'=02HC2B55$L:,O[H_L@?`K]L#X+MX_/[57[=-Y^V>G
MB$>&1X&2Z_9I^$7[/7_"NO[*_MO_`(2(HWPLNKD^+/\`A*?M^C;O[<V?V)_8
M*_V?N_M.\Q]KT5XV;9YG6?5Z>*SS-\SSC$T:*P]+$9ICL3CZU*A&<ZBHTZN*
MJU9PI*I4J5%3C)1YZDY6YI2;];*\FR?)*,\-DV59=E.'JU77J4,LP6&P-&I6
M<(4W6J4\+2I0G5=.G3@ZDHN;A3A%NT8I%%%%>6>D%%%%`!1110`4444`%%%%
M`!1110!\J_%C]LKX(?!KQAJO@_QAJ?B>63PAI'ASQ%\5/$GAOP5XF\4>"O@K
MX<\8W=Y8^%->^,'BS1+"ZTCP'IFMS:=?7:2:C-+/I/AZTN/&/B*WT7P7$_B(
M30?MA?!B;XK6GPGDNO%]G>:GX^U;X1Z+XYU#P%XLL?A1KOQ?T'3-3UG6?A7H
M_P`2KG3(_#%]XUL+#1=9C-HEVNEWNMZ/J_A+3-8OO&&EZAX?MOBK]K7X%_&3
MP]-^UMIW@30K/QA\*O\`@H19^"OAG\4?%MC9_$/Q-X__`&<I=6^#5S^SWXN\
M>:3\+?`?A#Q3JWQ0\)7G@;1O"C:/9>']5\)WG@[Q_J-YKWBWSO`%UKOB7PSZ
M-:_"_P#:E\5_M6^$/$?Q7^$WPWU?]GOX,>,+J#X!6FB_M!:E+)X:L[7PEJ'A
M2Q^/7Q&\":E\%H;_`,??&J;3=4UW0_#OA4^.['P)\--%\0WNIZ9/XJ\=2CQ?
M9`'V'XM_:)^%?@/QQK_@7QIKTOA:Z\,?"RV^,.N>(M=TZ[TWP1I_@Z[\77/@
MFV,OC&Y1-$;7I]?MC;0>&HKA]:N(Y[.6VM)C>VR2>/6_[=GP=UWX(_!3X\?#
M_0OBU\4/"_[0>I76G_"SP_X#^%_B"_\`B#K8T[2_%6M:M?:AX(U@Z#J_ANRT
M?3/!VLSZJ?$8TNZL9EM-/GM%U.\ALJ^E?B$WB73O"VM:WX#\$^'_`!UXZLK.
MR;0?#>O^(X_!>GZQ/::I:7<=A=^,/^$;\5RZ+!;D3:A;W"Z!J2K>V\(2"&24
M74'Y*?L__LA?M!^%?V/_`-G_`.!_QQ_9L_9=^+&O_L\^+O$<J>#?%/QG\7:[
MX(\=Z)XLT_Q[Y_B.PU@_!^/2=.U/2;CQL-'O/!/Q`^&_CCP[X@TR.\U:TU/P
M_KMCHLK`'[!>#?$G_"8>%/#WBDZ%XD\+GQ!H]CJ__".^,-*.A>*=$^W0)/\`
MV9X@T8W%T=+U>SW^3?6)N9S;3J\1D8KFNEKY^_9;^%7BKX)_`CP#\,O&FOVO
MB'Q!X9MM=6>;3;[7M4T;0M/U?Q5KVOZ#X&\.ZIXHED\0ZIX7^'&@:MI?P^\+
MZGK26FI:AX>\,:9>7>G:7+,=-M/H&@`KPWXR_M!>!?@E-X2TGQ!:>+_$_C'Q
M]<:U#X)^'GPX\(:UX]\?>)[?PQ96VI>*]6TWPWH4$MQ'H/A73[VQGU_7M1FL
M-(L;G5-#T<7<VO\`B+P_I.I^Y5\1_M.>!_BWX:^)/P\_:R^"?@[2/BWXP^#'
MPE^.WPZUCX)ZOXGU3P==_$#PC\4K[X5^-9)?`_B2UT/Q9IUAX_T;Q3\%O#EK
MIFG:MX:DLO$>CZ]K.GC6-*U&VTM;P`L>(/V_OV;]#\.:#XUM=<\9>*O`NI?#
MBP^,7B+QOX+^&7C[Q/X8^&7PIU'4M>T6'QW\5]0T_0#)X`TJUUCPIXMT[6=.
MUNVC\3^'G\'^,[WQ!H&EZ5X.\3W^E?1OC/XI^%?`VI?"W2]8;5KBX^,'C^+X
M<>#9=$T:_P!<LW\03>!O&WQ#CGUF\TZ.:WT/0F\.>`=?<:_J+Q:6=0.F:8)S
M=ZM9))^0Q_9^_:TO_@7\*O@9X4\#>"/B;^S=XLT7QO\`%/X^6>L?$KXA_LR?
M$7XM?$'XV_&7QU\7O'?P5U;PE\0O@;XJ\:?#K]G>VN/&-[INK:5.^B_%/Q]H
M5Q;>!=?@\">&+?Q-8>,OVP2TCDMK(SV%HL]FJ3V]O^[FCLKK[)+;%;69H%\O
MRXKB>T2>*&$_9I9$$:Q2-"0#PWX(?M0_!3]HR\^+-O\`![QA%XRM/@OX[M?A
MSXTURST_4+?PX_B.\\$^%OB#"_AC7KRW@TWQAX?D\->,-$N8/%GAN?4?#-[-
M)=0:=JM[]BN)%D_9[_:8^$_[3^A^._$GPAUC4=<T3X>_%+Q=\(M<U#4-"U/0
MX;GQ1X.AT>[O[O1!JD,$FM>&=3TW7]'U?PWXFLT;2O$6C:C9ZKI4UQ87$,\G
MYZ>#OV8OVMO'NM?M^>'?B+H'@#]GCP?^V3XJ\">,-"\<_"WXLP_%[Q3X*T_P
M/\$/@)\"M6^'FI^#/$/P>\!:+?:;\1-`^%?B=-5UC3]<MY-&\->*1I6F1P:Y
M'%K5E]!?L#?LN?&C]F.3]JQ/B_\`$OPS\18?C+^U#XJ^,'@$^&?"^G>%8=&\
M(ZMX%^'WA:VBU/3--L[2TTW5+J3PB+=O#]C)?Z3H6G:3I@T[4;AM0O(;4`_0
M>BBB@#Y_\>?M-_"#X8^*?''@_P`>>(9_#>L^`_@\OQUOX]0TN]%OK?P\CU[4
M/"VIWO@^YBCE3Q9K.A^);;2="UKPQHPN/$.GZIXS\`6DFG,_CCPW_:'RQXP_
MX*@_!+X>ZW\;-$\<?#+]I;PN_P"SWX&TGXC?%/4-4^"6JC2M`\)>*KSQ+IG@
M'48;VVUFY_M63XB:OX/\2:/X-LM-BN+S4=0TFYCO(=-BV3-ZS^U-^S-=?'?X
MG?L6^.]/L_#+K^SQ^TI+\3O&LVMWFHV.H:E\-I?@[\4-&D\,:2EA9W,6NB7X
MQR_!#QW-X:UN6TT"74/ASHOBF25M>\(^'XV^6/VO?V'_`(U?&I?^"B=]X#O/
MA\U[^T_^S-^R3\+?A9:>)?$6L:.B^,_@'X^^/?B_Q2GC.]L_"VM'0="U:U^)
M'AFST75M.M_$=U+<1ZL][I%K'96QOP#[X^#W[1O@;XQZQXE\(V&E^.O`OQ%\
M&Z9X?U[Q3\,_BGX,U;P'XYTKPYXKN-9M/#/BB+2]366QUWPMKE]X=\0:99>)
M/#.JZWHRZUH6M:%=WMKK6EWMA#YQX^_;M_9P^%W@!?B-X]\6:MX9T:Z^-7B/
MX!:1I>H>$_$/_"6^(/B!X4^,H^!6N#0/"4%E-KFJ>%+#QT\#7?CB&T7PE8^&
M;NS\6:CJ]EH=W;7<N5\'/A'\7=<_:*\4_M1?&[P_X+^'>MS?!S0_@?X%^&G@
M/QYJWQ'AL=`B\>:S\1?%WBOQCXNO_!7@"PO=9UO7+G0-+\.Z#I'AZ>W\,Z/H
M>I7USXCU:^\73Z;H'%_\%'?@S\<_CE^S_+\'_P!GOX?_``U\0ZSXJ\:?#_Q'
MKFM^/?B1=?#2Q\,VOP\^-/PR^,5P+1-*^&_CZ[U^Y\92^";_`$FY55TE+#4)
M['5+V34D,B0`'NGC#]I_P[X6^,MM\$M.^&_QJ\>>(X[7P/>>)-?^'_PXN_$?
M@?P/;_$#5=9TS0)/&'BI]2T^TTO;#H.I:SJJ6T&H/I.AQPZC>K&MY:13?3-?
ME7\<_P!EGXP?'?7V\6M\&/V??`WQ(\>>%_A&!\=E^)_CW5?BW^S+XI\`^(;[
M6-1O?AX+3P-!I7C;4],M[ZX7PEXD\*:I\%9_$?VVY\+_`!+L]4\*VD+WWZIJ
M"!R<G+'/L6)`_`$#\.,#B@!:\N\??&#P3\,O$GPL\->,KV[TF?XP^-9OAUX,
MU22PG?0)?&I\-:WXITKP[J^M+_H6AW_B6P\.ZO9^%_[3>"#7]?@M_#EA-)KF
MIZ58WWJ-?(/[>_P`\3?M0_L?_'WX%^!KG1M.^('CWP#?V7PZUS7=6U;P_8^&
M?B+IMU9:YX%\6)XAT"UO=>\.W_A?Q/IFF:[I>OZ);2:QHVHV-M?Z=MN848`'
MG^K_`/!17X/V/C_X3_#_`$;P!\?/&EQ\==2\2:?\(/%'@SX37^M>"?B!%X-N
M]1C\6ZOH'B635[&"30-!TK3+CQ3-K=U!:Z?J?A.6R\0:!-J]C?V;3=+\`_V^
M/@=^T-=^`8/"UC\3_"]E\7X_$MQ\%=?^)'PT\0^"_#/QCMO"5IJ&IZXWP\\1
M7BW6DZK?P:%I.J^)K7P_J-UI'B;5/"VDZUXDTO1+W1M"UN\T^7XE?LUZUK7[
M1_[#7Q'\!VWA#P]\-/V7W^.-GKGAU))]+NK70O'?P7A^&O@K2_!FCV&E3:;)
M:Z1=6]O#=6D][I$&GZ/#&;(73HMK7R!^R1^QY^TYX6^'/[#WP6^.F@_"/P;X
M*_8A\2WGCD>*/`'Q/\4>/O$GQ@\8:1X&^*7P[\$6UEH]U\.?A_8^`O"<5A\6
M-;\3>*6U35_%.K7]_H^C^&;+3ET^^U778P#]&_$W[2?PD\$ZW\6]&\:>(+GP
MG%\%/"/PX\:>.-=U_1M4L?#B:5\5=0\8:3X+L_#VL&VDA\6^(M5U?P5JFCQ^
M%O#::EXA?6+[P]I%MIUSJ?B+2+2ZY>Y_;`^!]I^R?IO[:,^O:PGP-UKX2Z-\
M9]$U,^%]</BK6/"7B30+;Q#X<LM-\"BT/B>Z\7:[:WME9:9X.2P&OW&L746D
MFTCO/,2/U3XIMXQTSP7X@U3X9>`O#7Q`\>M#ID&E>'?$OBY?A]IVJ>5?+%YM
M[XRC\)^-)].;1;2\OM4T_P#XI_4#+=Q"TA-DUXUY%^/_`(9_8$_:S\7_`+`_
M[/'[.WBSQ[X+^!WQ._9A_9Z\4_`_1=*\)ZAIOQK^%_Q5\0W7[/\`9_!_P[\3
M]7U;Q+X#\#>(/`^H:4M_XTTO0;?3](UFX\/Z1XNUC59AJVK_`-D'2`#]G_`7
MC;0/B3X'\'?$/PK<2WGACQWX5\.^,_#MW/;R6D]UH7BG1K+7M'N)K6;][;2S
MZ=J%M+);R_O(79HG^9376U\^_LG_``P\9_!/]F3X`?"#XB>(M.\6^.?AA\'?
MAUX"\4^(='LX[#2=3UGPEX3TK0KN33+:*"U4:=;M8BSL9VM;::]M;:*^N;:V
MN;F:"/Z"H`****`"BBB@`HHHH`****`"BBB@`HHHH`,`]1TY'L?6BBB@`HHH
MH`****`"CKUHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHH)Q^8'YG%`!17\JNK_\`!PE\8=-U
M;5M.C_9M^&<J:;JVJZ:DK?$/Q>K2IIVI75BDK*/#A"M*MN)&4$A68J"0`3]:
M?L'?\%AOB1^UW^TOX1^!7B+X)^!_!>D^(]`\;:S/XAT3QCXBU?4;63PKH$NL
M6\$5AJ&C6=K+'>2QB"9WN%:*,EXU=@%K]=S/P,\2,HRK'9SCLFPU++\NP5?,
M,75CF^4U94\+AJ,J]:HJ5/&3JU'&G&34(0E.322BVTC\IRWQI\/<VS/!91@<
MVQ-7'YAC*&`PM*64YI3C/%8FM"A2A*K4PD:<%*K-1<YRC".\I):G[[4445^1
M'ZL%%>7>._C!X*^'/C'X->!O$UU?P:_\=_'>M_#GX?0VFG3WEM>>)_#_`,,/
M'OQ>U&#4KJ(B+2K1/!GPV\47,5Y<YBFOH+33D_?WL1&7X5^/WPJ\76^N7%GX
MLTW2QH'Q&\8_"NZA\27=EX<N;KQCX'\9R>`-9L=+M]5N[>34X)O%B+H^DW-H
MLBZK=SVT%HKSW$4+`'LM%?-MA^UG\#9OBQX?^!>L>,;;PE\7?&>K?%?3O`?@
M#Q4L>EZ_XZLO@Q?^']/\<>(/"T$=Q=PWNAV\_B?23I4US/9:AKD1U&73--G7
M1M8^P>NP_$GX>W'A^Z\66_CGP?/X6L=5.AWOB2#Q/H<V@6>L+J46COI=UK,5
M^^FV^HQZK/#ILEC-=)=IJ$L=DT(NI$B8`[6BOEO3_P!L7X&ZA^SK=_M2+KVM
M0_"6UU?7?#T=^_A;7;GQ#J/B'1/BKJ/P4A\/Z-X3TRTU#7M8USQ#\3-/7PKX
M4TO3;2YN_$.H:CI*V,96_C*T='_;6^`<VJ_#WPIXU\1:M\'OB%\4?B9J7P>\
M%?#7XR>&]6^'GC?7/B+I?@>3XD3:#IVG:M"^GZI;7'@Q$U33/$FCZMJ7A35K
MVYL_#.G:[<^+KJ#0'`/K*BO`?B5^U1^SG\'_``AK?CSXD?&?X>>%_"/AKQQX
M2^&OB'6[GQ/I=Y;:%X\\<^)-,\)>%_"NL1Z7<7USI>LZCKNL6-O):7T%N^FV
M;76LZM]@T33=2U&S]9L_&?A'4-8O_#UAXG\/7NO:5I=EK>IZ)::WIEQJ^G:-
MJ2L^G:M?:9#=O?6>F:@B.]CJ%S;Q6=XBEK:>5030!TM%8'AGQ5X9\9Z3#KWA
M'Q#H7BG0[B6X@M]8\.:QINNZ5/-:3/;W44.HZ3=7EE+);7$;P7$:3L\,R/%*
MJ.I4;]`!117QY^U/^TQKG[/MSX)@T?PKI/B1?%4'B"6X;4]3O=/-F=&ETB.,
M0BTM;@2B<:DYD,FPH8D"[MS8`/L.BOR*'_!2+QL2!_PJ_P`*\D?\S+K/_P`K
M*_3+X3^-+KXB_#;P5XYO;&WTR[\5>'=.UJXT^UFEN;>SEO8O,>"&>9(Y9HXS
MPKR1HS#DJ.E`'H=%%(S!1D],JOXLP4?J10`M%?#'P6_X*!?!CXWZ]X,TO0_#
M?Q?\+Z+\4/%GC_P+\)/'OCOX;W_A[P#\4_%_PSD\;MXK\/>$/$D&H:K&NJP:
M?\-_'.M:79>);;PY/K^C^&-6O-$6_-JT)^JG^*?PSC\+1^.)/B%X'3P9+?#2
MX_%K^+O#J^&)-2-\VF"P3Q"VI#1WO3J2-IXM%O3<&^5K01?:`8@`=[17C_A/
MX_\`P:\<_%CXF_`SPE\0_#FN_%OX-6/A'4_B=X#L;MGU[P?8>.]/FU3PI<ZG
M;O&D;1ZK80-<9LY;DV(FLX]2%G-?V,=P[XG?'WX,_!OPI\2_&WQ,^)7@_P`(
M^'/@[X/N/'OQ,O-3URP^T^#?"<%I/>)K&M:3;SS:Q;0ZA';O%HL1L#<Z[>M#
MI^C0WU]<06\@!Z]17EGPV^+_`(2^)?PZ\#?$NQ>Y\.:-\0?#G_"5>'[#Q;-H
MVE:T^B_9'U%KJ>UL]8U2S`BTM4U.X^RZC>)9V,L<UW)`1*D73ZIX\\$Z'9-J
M6M>+_"^D:>EUI-B]]J?B'1]/LTO=>6%]#M&NKR]AMUNM86X@;2K<R";41+&;
M))PZD@'645X=\4/VBOA1\(M1\":/XO\`$D2ZO\1/BOX*^#/A_2=(6/6-33QO
MX^FCAT"VU;3[.=KO2-.+7%DU_J=["D%A%J.FRS@)?VIE;H_[1GPG\0_&N7X`
MZ#XCCUKXA6_PYU7XGW5OI*1ZEHUGX=T/QU!\.=7M;S7+*>>RM?$.G>*KB.QO
M?#TY34K1`\MS%%L9``>YT444`%%%%`!1110`4444`%%%%`!2'I^*_P`Q2T4`
M?YH/BAT_X2?Q1\R_\C1XF_B'_0P:E[U^H'_!%)E/_!0SX7`,I/\`P@_Q?X!!
M/_(D7/;-?UN3?L1?L<W$TUQ/^RQ^SU-/<32W$\TOP?\``;R33SR----([:&6
M>265WDD=B6=W9F)8DUU?@;]EW]FWX8^)+3QC\.?@)\'?`GBRPM[VULO$OA#X
M<>$_#NNVEMJ4!M=0M[;5=*TNUO8(;VV)M[N..94N(28I0R'%?UYQ-])'(\]X
M7SSA^CPWFU"KFN2X_*Z>(JXK!RITJF+P=3#0JSC!\SA"4^:2C[SBK+4_E/AO
MZ/6=9'Q+DN>U>(<KKT<KSC`YG4H4\-BXU*L,)C*6)E2A*2Y5.:IN,7+1-J^E
MSW>BBBOY#/ZL/D?]J7X->/\`XA:[^S7\4?A9!X4U?QW^S1\<-1^+.F^$/&_B
M+5O"'AWQOI7B7X'_`!A^!GB30)/%>B^%_&=YX<U:UT?XMS>)-"U"3PSK&GW&
MI:!%HVHP6=KJKZOIOYS_`!-_X)D?%KXFVOQIU;64^"TWB;XJ?L;_`/!0GX>:
M+9:IJVN^(-)\`_M(?M>_'&P^+?P]U?0]4U+X?V]V?"_PXM+"RTR[^(<&CZ;X
MN36+*76-"\)6D&H+8V/[H44`?@5X@_X);_'?5?$WB?Q9!XG^&5EXG\:Z_P#\
M%*_"W_";:=K.LVWC3X:^#OV]M`^$=EX?^+OA#4I?!$\VH_$?X7ZK\,]3EO\`
MP6E_X:@U6T\::E<Z3\0;*[MI;?4>O^'?_!.CXQ^#%^'_`(UU+P_\,O%^M_#[
MXQ>"/&EW\#?''Q9M_$/PC\=^'_!OP(^)/P0T6^;4/#7[*7PW\-^#O%'@:7Q]
M9>+/`MPOP<\3ZI?6OA/3-+\5^*#JH\.:GX+_`'&HH`_,KX)_L9>.OA?_`,$[
M[?\`9(\0Z#^S_P#$+Q-#=?$K^U/!WC#2/$6K?`;Q1X<\;?'_`,9_$]_!5S;Q
MZ;!XCT&PN?!GB2/P]I&OV^B:O<^`O$D6G^(K;P_XJAT"/2M4\"L?V`_CY9>(
MOA'\2K2R^',Z?`_]IZ'XN?"']G[XD?&GXG_'GP]\*O"'B']F+XH?`'QW_P`(
MQ\;_`(G^!+WQS+/=^-_'WAGXUZ;\*8-&TGP'IMY\-X-!\->)/"^J^*KG7]%_
M;*B@#^<*_P#^"3/[2WB:SO[OQ3??`V[N8?@M\#?#-YX$F\4W$WPT\>_%?]G+
M]L'X/_M(:#K=IX9\.?L^^!/"GPD\"?$#PQX-^('@"UT72?!?C75/AIIWC5K>
M>Y\;VUUJRS>Y:%_P33^+EYXU^.>K>/[SP]XLT/XHVW[87B"VMM8^,>LV&F:S
M=_M=:'XCT^\^$_B_2/AU\!O`OQ&3P?X)TOQ%9_#M/%8^/'B6*'P]X`\#>,?`
MG@#PMKUMIN@^#OW+HH`^%OV(/@/\8/@7I/Q2L_B<?A]8:9XN\7>'];\(>'?"
M?_")Z_XETJWTGP7H_A/5KKQU\2_!GP2_9XTWX@WVI-H6EIH%UJOPT?Q1HF@:
M?;:?KGC3Q)YEG8^'ONFBB@`K\I?^"E)`U'X09('^A^.>O_7QX6K]6JY'Q/X`
M\#>-FLG\8^#_``SXI?3EN%T]O$&B:=J[62W1B:Y6U-_;SF`7!@@,PB*B0PQE
M\E%P`?S*J1D<CJ.X]:_HB_9B(/[/OP@(.1_P@>@\C_KVK>_X4/\`!+_HD?PW
M_P#"+\/?_*^O2-*TG3-"TZRT?1=/LM)TK3K>.TT_3=.MH;.QLK6$;8K>UM;=
M(X8((UX2*)%11PH%`&A374L`!C[Z-SZ*ZL?QP#CW]*=10!_/OIO_``2#^)^F
M_`/PI\/['XFKIGQ`U;X??MP?#?Q]J5U\5_B]XT\$^`;G]I3Q%X[\7>`OBK\!
M_"/B^34_"GP]\<:/#J,/PD\>1>"_!O@@ZM\)?B_\8--M[_4I[;2[/6O0F_X)
MT?%O_A7\-U/X;\'ZEX_C^-MS\1;3P]J?Q\TNYTWPIITWP+/P-EU#PM?K^Q;;
M?`N\OM7\-S77AWQ%X0\7?LIZ[I.K^$ETW5G\20^.]-M[H?N-10!^9G['W[(7
MQ1_9U^.7CKXC>,K;X,^(S\8/V</V7/!GCSQE\/=,'@*\T;XH_L[>"K_X?ZKH
MGAWX?6G@^'2Y/AMXNTS4-/UC1[^T\2Z"?#\WAV+1$\`VFG2:5_9?R3\;?^"7
M7QC^*O@OX\?#ZW3X%VDWB/PU_P`%&I?"WQ@O[_69_B/\;M9_;5\-_$*R^''@
M?XZ6D?PY2+P_X.^#&M>,O"]Y>:WIWB3X@SZE<?!7X1ZIX8\,:`VEMIVB_O31
M0!\+_M._LEW_`,8_@I\*/AGX#G\'^#;[X?>*_!FG722Z>]EH1^#OB70M1^#O
M[0_@[18M'L!)87GB7X#^.OB'8^#HH+:ST^#QK%X3O;Y["VLGN[7X_MO^">WQ
MJ\.^'OAI>ZA8?`#X_P"M>"M1_:8\':G\,/BS=:_HWPNU?X<^/O#?@#X+?LZ^
M,);X>`_B#<7'Q&^$G[/OP:\%>#/%EG<^%?)\0CXD?&>+1/$EB=2MFUK]J**`
M/P?\._\`!*OXO^&])@TQ_B1X5\0>)K+]JK]B7XDI\8;_`%'6+3XD7_PJ_9J_
M8Z^#/P"\5WOGR^'=5.F^.[GXE^!_%GC_`,'>'#J6HZ%)]MTC5-;\11ZW/J`C
M]P_8N_8:^)_P#^.7P]^)'BKPO\!_!F@_#K]AWPO^R+=1?"75-:OM6^(OBCP5
M\1]'\5#XN:]!??#[P7;Z8OC*QMM0U*Y\/W-YXFUGP[K=]?07GBKQ2-0;4H/U
MPHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
J****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/_9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>biib-2015630_amortchart.jpg
<TEXT>
begin 644 biib-2015630_amortchart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`#P`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^3?VU_VF)?V2?@)?_&6
M#1/"&N31?$GX%_#>*/X@^/F^%_@/1Y/C9\;/`'P<3Q;XU\>KX;\6OX:\*>##
MXY'BK7[Y/#VHN=,TBY@58#,+F'ZRKP;]HWX#:/\`M&>`=#\`:YKE_H%AHOQB
M^`'Q?^U:?8Z=J,E]>_`/XW^`?C9IF@75KJB2VC:5XEU'P%:Z!K$NQKFWTO4;
MNXLL7D<!`!X9X+_;K^%,&C>%(_BY\0?@Y'XF\5-HNH1ZI^SQXL\??M"?!?1/
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MIM^^^&'[)?@_X?\`[,WBW]E[5/$.O^+?!WCFX_:)_P"$DUF>.PT/7)]/_:/^
M)'Q/^(7BJQLCID3VEB=(;XHZKHNB7:123+;:?8WMTLMVT^X`^</@W_P5(^$'
MQ-\=3^&?$_A7QC\*M`U'X<?L:>./"?B+Q=X;\;-/+JG[9=UX\T7P3X7^(=C;
M>"ETSX3&/QAX3T;P7X<\0^,]>L]$\>^(?%^CVV@SQQSV,FH?7_PH_:@^"7QM
MU[4/#GPW\77.MZE::9=Z_ITE[X3\9^&M*\8^%K#65\.7_C+X;Z]XI\/:+HGQ
M.\%6.OO#H]WXO^'^H>(_#EO>WNE"34E@UO1+C4?B/0?^"7.C6O@/X@>#/%/Q
MP\6^*;CQ_P"'_P!A3PG?:T/!GA'03;>'?V"OBS<_$?X=VPTK3I)+&>\\9Z2=
M/\(>.KQ6M8GAM)];\/V6CW=[]BMO6_V0/^">_P`*OV.?$6J:O\/O^$::RM_"
M+_#KP6FG_"#X3^#_`!9I7@)]:L-;72O&GQ,\,>&K7QY\3M6@?1M!TQ=:U_5[
M&&^T_1+"^U[1]9\5B?Q/*`>"_'__`(*'_'K]GCQA^V):^*?V??@UK'@']D7X
M#>"OVB]6U_2/V@_&\'B?Q?X#^*GB?XU^%O`&G0>'-1_9Y@T70O$EK<_!;4K_
M`,=)/XLU#2-$L=<LCH&I^)Y[.ZB/UXO[=W[,'_"1:=X/G\?:O8^,=4\=>*OA
MO:^#M4^&_P`3](\71^+O!?A;P9X]\0V&I^&M4\'6FLZ)8V?PY^(/A'XFKK^L
MV5AX>G^&>K?\+`AU5O"EAJFJ67#?M"?L&>%OV@KK]K.ZU;XA^*/#;_M8?LZ?
M!K]G?75TG2M#NQX.TCX.>+_C/XOT[Q-H)U"-C?ZOK5Q\9=1L]0M-4+Z?;6^A
MZ=)9JLUS>%L+Q)_P3F^'7C']I/QI^T+XF\:^*=4A\>^)/B/K?B+X>&RTJUT&
MZT[XF_LF_"7]DO7O#Z:S:^7K\%FGA7X4V_B6WO(9X[X:WK^HVWF"QM;+:`>L
MZ=^W3^S/JGAB]\667C?7'T^+_A7\FB6$WPQ^*EGXG\?V7Q8O]3TSX7:Q\*/!
MM[X*M_%GQ9\/_$:^T36HO!/B'X<Z-XET3Q%'HVK7=C?O9:;>W,/KUC\=?AAJ
MGPJN?C3INO7M_P##^R@U>2\OK3PMXPN?$%I>:!K=WX:UWP_=>!(-`D\>V_C#
M1?$UA?>&=6\$R^&%\7:?XEL[KP_=:+%JT$MHOYJZ1_P1L^`.E_#(_#YV\$75
MQX<USX5ZQ\/-;7]G;X%:;#;GX.67BS2?"Y^+FA:5X6M+3X[7GB'0_&WB#1_'
MLWC&[L--U-;F/7?!^B^`O%J3>(;GZYN/V,?"@_9$U/\`9+T#Q9J7@#1-5LKY
MKCQ1\+_"G@7X:>7J^J>.?^%B:RD'@?P5H.B^"D\'^(];>YT+Q=X,;3GA\8>!
M-3UOPWXGU?5;W7=6U^\`()_^"A'[*UH+"UN_&WBV#Q'J.M>/O#47@$_!OXSS
M?$^V\2_#'P7X3^)/C?P[J7PPMO`$_CW2];T3X=^./"_CS^SK[P_!/J/@[58?
M$>E"]TJ.>YBX3XF?\%(_@?X:U#X2Z5\,+F3XRW/Q0^.G[,?P<;6/#EEXPM?`
M.A0?M-2^&=6\-:L?B?%X,U3X>W_BFS^'?BS0_B7;?#9_$>G^*-4\)ZKI&H2K
MIEKJ^GW,_GGP?_X)8_#WX1?%RV^,.D>/KJVU>7Q?\4?'>L>%?"'PT^''PU^'
MTOB/XL?LY?"3]G7Q`/#_`(1\$Z;I^G^&=)MM*^$6D^++2TMS?ZC>^)-6U>XU
M[6=8EG^V/D?#3_@E)X:^%G@_X-?#+PW\>?B(OPQ^%/Q%_98^-VH>$I_#'@9I
M?&_QK_9B\+_"WP5;^+=3U\6!U72/#_Q$T+X2^&M2\4^"])=;6P\8/>Z]H.K6
MFG3R>')`#V?X_P#[<%U\&_CQI?P*TSP5\/;G6;[X=^%OB)IEQ\6OCKH/P(G^
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M_@FYX7M-<U_Q#I?Q@^(6FZDG[1>K_M5?#26.WTJY_P"%<?&F[\#_``Q^%VE^
M(S+=O+=>-K?3?A;X#\4?#F]L/%-Q*GB3PM\9?BFFNRW.KZGH6K:$`>P_'[]K
M=?@/^T1^RA\%]2\!/K7A/]I*^^(VCZ]\2T\1_P!GI\+-7\/7OPU\,_#I+WPS
M_8=\_B33OB7\1OB?X:^'BW\>LZ-_PCFNZWX>D>#5H=6=+/R'X9_\%*?ASXP^
M(G[2GA'Q9X3UOPEH7P<^-W@[X,?"?5O#EKXK^*_BS]HFZ\4_##4OB&^L^"/A
MK\/O!>K>*5^S#PG\09;73=*B\3"X\$>$+CXA7]]I.CW,MO9>X?M,_LC>&_VF
M6DEUOQIXK\&7D/P,^,WP>T'5_"*:;#KOA+6OBAXO^!_Q`\,?%CPQJ=_!<MIO
MC_X0^.?@-X-\6^`YW@N-.&N1+<ZK;74=K#"_@5E_P36\/^$?&MU\3/AA\8O&
M/@GQ_H_BGX/>*/AMJUQX8\(^*=-\&'X7?LS7W[*NJ:)J.B:K!#'XNT;Q[\.M
M5U#4M<6[O=)U+3O%\>EZSI&I0PV,]E?@'M>F_P#!0#]DS6M5TG2-"^*;:_<:
MQ;?!6\M[S0_`_P`1=6T&TM?VB[J]TOX'RZYXFL?"4WA[PT?B=XDL+GP5X3A\
M1ZEI5Q?^/E3P,\,/BJ1=*KX_^%'_``66^"'Q&U;0=0\0_#OXH_"CX8:G\%/C
MQ\8]8\9^/O!/CV+7O"6G?`7]H73/@5XJN_$?@G1/`VIWFF_#^SM[^3QMXE^*
M5YJ-MX5\"V5E?:'XHEL]5TO6O[-]#\-?\$M?ASX.\.>//#'A[XH^/8['QSJO
M[$&N75YJ6G>&+[5(]<_8P^/<W[1$>MW4\%CI]E?ZC\8_'E_K%QXZ$>GZ?I^C
MQ:M<)X1T_3((+.U@Y?3_`/@D[X2T_2_CMX8C^-GC8^$OBQ^S1^US^RWX4TD>
M%O"BWWPW\!?M=_$N_P#BWXIOTUD%I?&>N^#O&&N:\GA6YUJSL8;C0+RRTW7H
MM2OK&75[\`^Z_`W[4OP4^)7Q#UWX9>"/$FM>(/$'AW5_&'AS4-5M/`/Q"3X?
MS>*/A[J*Z3X]\*:1\5+GPK!\--=\5>#-2<6'B7PYHWBR]U?2[R*^MI;0S:5J
MR6#-3_:J^!FD?$N]^$U[XNO5\7Z9K"^&-2DM_!WCB]\):?XUF\&#XB6?P[O?
MB'9^&Y_`%M\2]0\#%/%6G?#J7Q*OC.^T2YL+NWT5_P"U-,2\\0\`_L+Z=X'_
M`&C;'X_Q?%'6Y)=)3Q$T>A^'O`WP_P#A]JOC,>)O"_\`PBSZ#\:?&G@72=$U
M'XU>#?"=M]GU/X?:1XXTNY\0^'->T?PYJ^H^,?$=UH<#S<Y<_P#!-KX0#]I7
MQ?\`M&:9_P`(W::KX[\93_%'Q!!J7PB^%GB7QI!\3)?AY8?#?^U/#/Q?\0:!
M??$'PGX5?3=(TCQ#+X5T.]MKR+Q=:7-[I/BC1]"U?5O#EX`>C>'?^"A?[)7B
MSPA)XW\._$V^U/1)O#/P=\8^'88_AU\3X-?\?^&OV@-2GT/X-:O\+?"MUX-@
M\2_%*U^(7B&SU'PWX?;X?Z5XC,GB'2]4TB[%I=:==+'YI\*?^"F?P*\;V7CN
M[\:_VM\/6\(?&?X]_#B*%/#7Q&\6O:>!/@7\0_\`A7&I?&3XFC2OA_#+\$O!
M5[X@+:?JM_\`%"+P_HWAG5;35M.O->N4T+7+O3>)T_\`X):^$M%L_@3<:)\9
M/&]AXM_9P_9D_99^`'PK\4OX=\)WCZ;KO[*.OZYK/A#XF:KH]Q"=/U6Z\6V'
MB77_``GXW\(;K31KGPSK5_%H5_H>LIINM:=PTW_!''X0W_BW6O'GB'QM!XZ\
M9>.O%WQ)UWXD^(/B;\$O@E\2IM:TKXF_$G5OBMJ6G>$M,\:>%=8T#X?:OX?\
M4>)O%UAX;\0:5I&HP_\`"*>(6T3Q)H'B2ZT7P_K&F@'U-KG[>7PO'[1'P+_9
M[\"6FI>.=4^+'QL^+'P2\1>+(M)\9:%X0\'^(?A!\$_BQ\5O%\/A_P`7:EX-
M_P"$%^)VL^'M=^&<?P]\8^'?"7BZ2]\&ZYK<ZZS*FHZ!J>C+K?';]MCX>_LX
M_&;2OA_\5K?_`(1SX?/^S7\6OVBO$WQ3,VJZHOAJR^&/Q:^`7PHA\/'P=H>@
M:IJVK'7[[XZ6E^-4LKGS-,_L3[,VEW<>HO>:?R'A?]@S3_"?Q<^%7CC3?C!X
MR_X5U\#_`(\?&[]H3X7?!QO#O@V/1-#\8_M%>$OC9HGQ1T[4?%<&G1>*M<\/
M'Q!\=O&OBGP78W4\-QX6:]DT&XN]>TF+2!HC_CI^P/X8_:5\4?&#Q!\8_B+X
MFU>V\>?`[Q?^S[\/]*\.Z'X:\-)\*?`OCSQ5\/?B#XGO[:_^S:I>>-O%=QX]
M^%/P_P!<L=0\3E=%L++P\NC+X=GBU36KS4`#N/%O[?'[+'@GQ9XB\":W\0]6
MF\9^%_%OQ#\#:MX5\._#7XH^,?$'_"4?"CX>?##XL_$/3=,TCPCX-UR_US_A
M%?AQ\8O`'B_4KO1K>^L1I&JWTD%S+-X?U^'3>J\-?MC?LZ>,?&.@>"?"WQ$C
MU^^\43>';'0O$.D^&O&%Y\.=0U[Q?X`L?BKX4\(1?%6+P^?AJOCGQ)\-M3T[
MQQHO@>7Q4GBN_P##6HZ;J<6D>7J5@MS\S^"_^";FD>'?B]<_&_Q!\:_&WB[Q
MUK?B?]H3QIXKFN/#7A+1=+UCQ%^T3\!?V=/@3XC:RT[2H5&BZ1X<TS]G70];
M\,Z9!-=RI<Z[?V6K:AJ:V=O?3<?^SC_P23^"O[-WC3X8>+?#FJ:-XEG^'VE?
M#*\O=4\5_!GX0:O\1->^(/PU^#/A+X*V_BBQ^*NH>'+_`,8^"]!U[2O!FD>+
MM3\&^%KBT:P\:MJ$_A[Q-I'AG4]0\,W0![S^UM^U_P")?V7KS2[YOAIX.\4^
M%;R+P['IEKJGQN\.^#OBU\6_$NM^(CH=W\-/V;?A&WAOQ#JOQ:^)ND6MUHNJ
MGP]K&L>`K#7)]?T30M!U>\O+K4;S1LO3?VX9KSXB:7#=_#6ST_X#>)/VGO%W
M['?AKXL/X^@F\4W?QO\`!,WBCP[J<FH_#2/PP+73_AWJGQ-\%^*/A3H>OQ^/
M+WQ7+XKL--U&^\#V?A36X]:T_L/VE?V2]9_:/M_%/A'5?CCXQ\.?"+XE>$X_
M!'Q'^&UOX1^'WB`-H;0WUIJE_P###QAKVAS>)/A7XN\06%\MGJGB>PE\03Z=
M+I>C:]X,L_"7BRP_X2"?,T_]B/P_9?%.Q\42?$/Q1>_";1?CIXA_:B\/_`VX
MTGPU_P`(_I7Q_P#%4.N/K/BD^+EL?^$LO?"O_"2>*/$OQ+T_P3<3E++XH:U-
MXA?7KK1++2?"VG@'TG\5O%GQ`\+>&K*X^%_PV/Q0\8:UK^BZ#INCWGBFQ\$^
M&=&MM2ED?4O%GC7Q1<V.MZAI7A7P]IMM<W5\/#GA;Q;XGU*]?3='T7P[>7.H
MF>S^(_#7[=_C_P"(EYHGPX^&?P$T3Q!\>V\1_M.Z3XJ\(ZU\9;7P]\,;+1_V
M3?'7@SX;_$/Q%X0^*<'@'6M5\8V7B;QQ\1O!/A#P,DWPY\/F'Q#<>,-.\=R>
M$;OX>Z_:R^S_`!+^`OQ^^)G[-6@_!_\`X:F\0>`OBE*-!B^('QK\'?#_`,+V
M^L^+=*M;BZG\2^';'1K"[\.6_@VV\56DMMH5]XA\%:AX=\4Z7I<-W<>%M5\/
M:S>Q:I8>=Z+^Q-XM\.>&?A+)X3^.%A\-?BE\&?#WQ`^&W@WQM\*/@7\.O"/A
M*T^#/Q(O/!NIZY\.#\)=8N_%WAI5T[7/`'A+Q5X<\2)J0O\`3O%&B07>H6FL
M:-J?B70->`*/A#_@H5HGQ%^*7[%W@WP/\(O&-UX`_;&^'_B[QUHGQ9\0ZQX>
MT32?#-UX<^%,7Q1B\%V?AZSN-;UCQ=XDM(/MFA^-KRV.C^&/"&KVL5A;:[XE
MU*YEL;"_\!/VT]2^,WQV\5_"^^M_@+X:T;2_$?QE\/>&]+L_C'XTUGXS:[)\
M(OB#K?@.\FG\$7_P8\/_``_%X5T"X\0^*M`\,_%GQ7KW@33-1TA-<L"UQ-+!
MQFL_\$]_%>F>/_V3==^#_P"T(WPT^'W[&OABY\)_";X>7_P<\+>.Y[O3M>\`
M6_PW\93^,/&FI>)M&U;6M1\0Z##+>)>VNGZ8]CK]W<ZG,-3C<68^A],_9J\4
MS_%GP?X^\??'?QO\1?"OPK\:>,_B%\)?`>K>&/`6C-X8\5^./"WC7P/=W/B'
MQ?X=T/3];\:6'A?P=\1/&/AGP5875OI#6NGZM'?>,+OQOXBTW3M<MP#KO%/[
M4GP7\%?$O2?A/XJ\0:_H?BG7/$>B>#-+U"_^'OQ%A\!77C?Q-I]IJGAGP.OQ
M2;PI_P`*U7QGXDL[ZV_L/PPWBL:MJ-Y<V>E0VW]K:AI]A=>2>&O^"C7[('C#
MPK!XQ\-?%*^U;2-3\-?"[Q?X3@@^&WQ4CUWXC>'?C1K#^&_AEJ/PI\,W'@J+
MQ!\55\4^)H;OPU##\/=-\1SZ;K]C>Z9K<>FS6LS+Y?\`%;_@FKX+^+?Q]C^.
M?B/XC:U<7MA\>/@;^T/X=MM5\#?#_P`3>*_!_BKX(ZE\/;BQ\!^#/BCK^E7G
MC7PC\$_$5MX`%[JOPR\-7&DV\7B[Q;XT\4+K%S'XAOM$EXC1O^"4OA/PU8_L
MS7'A[XV>.K#QE^R9^S=\'O@1\)/%LWAKPC?R6NM?!CQ+#K6B?$77-%N(O[.U
M2;Q'HTVO^"?%GA*-K32KKPSXFU)M&U#0]>M='UK3@#Z1^"?[7>H_'CX+?&OX
ML>`OA!XB\0:I\,/C5^T'\&?"GP^TS6;33_$7Q$U+X)_$35_AWIMVTWCBP\&6
M_@>[\5W^FK=:KI?BB*)O!*&^@U&XU&73F6?RZZ_;K\<Z/XP\2?`S7/@GX<;]
MH^T^+WPB^#WA3P]X:^+LNN?!G7];^,/PP\=_&FRN-5^*U]\-]!\3>&KGP'\+
M_A;X_P#%OQ`\*S?"N_\`%4&F6O@J]\-:=KMA\2/#=VGJOP\_9/\`%'PB^!'Q
MK^%OPT^/GB_0?B'\8/B/\;?BW#\;]0\&^!==\2>"_'WQR\77OC77=:T;P?=Z
M?#X(U"/P]K.IWQ\,:9JVF3:=;6RV$&HVVHI9N+KRKP%^P/XE\*_#/3?!FJ?'
M5+OQ?X%^+6C_`!V^%'Q1\-?"71/#OBS1?BY#H?BCPSXS\;_$V37/%_CF;XV:
MU\5?#?B_7_#OQ%U/Q=J5EK6IZ+K.IQ:5J^C:@-$U+0@"CK__``45NM%\-_"*
M_A^`GB/5?$'BO]K_`,-?L=_&6WL/&WA\^"_@9XXU3XXZ!\$-2U"Y\8W5C::G
MX^%YJ'B;0_%_P_T+0O!FGZQXH\%ZE#K/BF/X??9=1M[7UGXZ_MEV/PA^/7[.
M?P+T3P-+XZO?C)\6_#?PT\>^(H?$46BV/PB@\<?#[XM^-?`M_<6K:1J3>+/$
M/BB7X1>(8X?"=M<Z1)I?AJVNO%FKZG:0S^&M.\2^,?$S_@G?XP\4_#[X>^`_
M`O[2>H>")?#W[06C_M8?$+Q7K'P=\$^./$/Q2_:#T/XO:3\:].\4ZAYFL>&=
M*\,>&8O%&DVFB+X.T#3MD/@BRTKP[::U;2Z=_:=UTGQ'_P""9OP7^*/Q$^$/
MQC\0>(_B3I7Q4\!_'?P)^T/X^UWPA\3?BWX9\+_%GX@^"OA/JWPI^UZA\-[3
MXFR>"/!B:EIMUHTKW?A+2K?5[?2O#MKX1DU&^\-ZIKUIJ0!^CRG<JMC&Y0<=
M<9&<4M(HVJ%'88Y_SQ[`<`<```"EH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HK\?O\`@H%\5?B7X,_;Q_X(Z_#O
MPAX_\7^%O`WQE_:1_:&\-?%;PKX>\0:CH^B_$+0?#G[+7C7Q9H.D>+;/3YX!
MK.G:1XDL+/6["TNF:"#4K>*Z"&6-&7]84\.:840E;[)53_R&-:[@'OJ)/YDG
MWH`Z"BL'_A&]+]+[_P`'&M?_`"QH_P"$;TOTOO\`P<:U_P#+&@#>HK!_X1O2
M_2^_\'&M?_+&C_A&]+]+[_P<:U_\L:`-ZBL'_A&]+]+[_P`'&M?_`"QH_P"$
M;TOTOO\`P<:U_P#+&@#>HK!_X1O2_2^_\'&M?_+&C_A&]+]+[_P<:U_\L:`-
MZBL'_A&]+]+[_P`'&M?_`"QH_P"$;TOTOO\`P<:U_P#+&@#>HK!_X1O2_2^_
M\'&M?_+&C_A&]+]+[_P<:U_\L:`-ZBL'_A&]+]+[_P`'&M?_`"QH_P"$;TOT
MOO\`P<:U_P#+&@#>HK!_X1O2_2^_\'&M?_+&C_A&]+]+[_P<:U_\L:`-ZBL'
M_A&]+]+[_P`'&M?_`"QH_P"$;TOTOO\`P<:U_P#+&@#>HK!_X1O2_2^_\'&M
M?_+&C_A&]+]+[_P<:U_\L:`-ZBL'_A&]+]+[_P`'&M?_`"QH_P"$;TOTOO\`
MP<:U_P#+&@#>HK!_X1O2_2^_\'&M?_+&C_A&]+]+[_P<:U_\L:`-ZBL'_A&]
M+]+[_P`'&M?_`"QH_P"$;TOTOO\`P<:U_P#+&@#>HK!_X1O2_2^_\'&M?_+&
MK]CIMKI_FFV$X\W9O\Z\O;O[F[;M^V7-QY?WCGR]F[C=NPN`"_1110`4444`
M%%%%`!1110`4444`?B!_P4G_`.4DG_!"G_LZW]J#_P!8Y^(-?MY'_JX_]Q?_
M`$$5^'O_``4NGAM?^"CW_!"R>=_+BC_:M_:?W.5=L;OV._B`BC;&KL=S,JC"
MD`G)(4$C]HX_$VB>6G^F@_(O(M[W!X'/-J#^8!]J`.BHK`_X2?1?^?T?^`]Y
M_P#(U'_"3Z+_`,_H_P#`>\_^1J`-^BL#_A)]%_Y_1_X#WG_R-1_PD^B_\_H_
M\![S_P"1J`-^BL#_`(2?1?\`G]'_`(#WG_R-1_PD^B_\_H_\![S_`.1J`-^B
ML#_A)]%_Y_1_X#WG_P`C4?\`"3Z+_P`_H_\``>\_^1J`-^BL#_A)]%_Y_1_X
M#WG_`,C4?\)/HO\`S^C_`,![S_Y&H`WZ*P/^$GT7_G]'_@/>?_(U'_"3Z+_S
M^C_P'O/_`)&H`WZ*P/\`A)]%_P"?T?\`@/>?_(U'_"3Z+_S^C_P'O/\`Y&H`
MWZ*P/^$GT7_G]'_@/>?_`"-1_P`)/HO_`#^C_P`![S_Y&H`WZ*P/^$GT7_G]
M'_@/>?\`R-1_PD^B_P#/Z/\`P'O/_D:@#?HK`_X2?1?^?T?^`]Y_\C4?\)/H
MO_/Z/_`>\_\`D:@#?HKC-<\8Z98Z+J][:WT:W-GI>H75N9+6\=!-;6<TT1=/
MLXW*)(U++D;E!&>:_C1B_P""X7_!0.41+'XF^%4LLHB6.*#X06TTTLLH4)%!
M!#KDDTTTLC".&"%))99&6*)'=E4_HW`7A?Q'XC1S6>0U<KI1R>6"CB_[1Q-?
M#MO'+%.C['V.$Q/.DL)5]IS.'+>%N9-N/Y_QQXD\/^'\\LAGE/,JCS98QX7^
MS\/1KV6">$5;VOM<5AW%OZY2Y.7GO:?-RI)O^V&BOXX;C_@K/_P56M?&E[\.
M)O#>D?\`"PM.MQ=W_@:#]G+5+WQ;:69MK>\%[-H%C?76IBQ^RW=M-]N6W:S"
MSQ*9Q(P2L71O^"Q7_!3;Q$VO+X>M/"_B!_"MM/>>*$T/]GO4M8D\,VEL\\=S
M<^(H].O;E]"@MY+2[CGDU9;-87M+M)"K6MP(_NE]&_CF4/:+-.$73]G2K<ZS
MC%.'LJ[2H55)9;RNG6=U1FGRU6O<;Z?%/Z0?!2ER2RWBI3]I5I<CRG#J?M:"
M3KTN5Y@I>THJ[JPMS4UK-1OI_9Q17\7\G_!9;_@I7%X9MO&TO_"&1>"[W4'T
MFR\8R?`2[C\)7FJQ^9YFF6GB9]1&AW.H(89E:RAOWN0\,R>5OAE5,RR_X+8?
M\%$M2CU.73M8^&VH1:+IKZSK,MA\%X[V/1]'BNK:RDU?5I+;694TS2DO;VSL
MWU&^:WLEN[NUM3/]HN(8WU7T:>/Y1E)8_A5QA-TIR6:8QJ%12C!TY-97[LU*
M2BX.TN:RM=Z9OZ1/`B<$\'Q*G."JP3RS"IRIRCS*I%/,4Y0<;R4EHXJZ=KV_
MM3HK^4[]AK_@K9^V)\<OVLO@G\)OB=XC^'%QX#\;>)-6TWQ)#I'PVM])U-[2
MT\'>)M8MUL]1@U:[FM)/[1TRR+2);2EHA)$559&=?ZH-/U2RU(2&SG$QA$?F
M$1S1A3(&*_ZZ*+.=K?=SC'..,_F''7`6=^'N9X3*<]J8"IBL9@(9C2>7UZV(
MI*A/$8C#)3E6P^&E&I[3#5+Q4)+EY7S7;2_1^"N.<FX]R[%9IDD,;3PV$QTL
MOJK'T:5"JZ\,/A\3)PC2KXB+I^SQ--*3E%\W,G%63>C1117Q)]D%%%%`!111
M0`4444`%%>3WOQY^!^F^)&\&ZC\8_A58>+TN_L#>%;WXB>#[7Q&M[YBP_9&T
M2?68]26Z,KK$+9K99S(0@C+$"O6*`/Q`_P""DY(_X*2?\$*<''_&5O[4`_`_
ML<_$$$?B.#[5^W<8S&A)))1226;).!R>:_$3_@I/_P`I)/\`@A3_`-G6_M0?
M^L<_$&OV\C_U<?\`N+_Z"*`'8'O^9_QHP/?\S_C2T4`)@>_YG_&C`]_S/^-+
M10`F![_F?\:,#W_,_P"-+10`F![_`)G_`!HP/?\`,_XTM%`"8'O^9_QHP/?\
MS_C2T4`)@>_YG_&C`]_S/^-+10`F![_F?\:,#W_,_P"-+10`F![_`)G_`!HP
M/?\`,_XTM%`"8'O^9_QHP/?\S_C2T4`)@>_YG_&C`]_S/^-+10!S_BOCPQXC
M()!&@ZP<ACVTVZ([^M?YR?P2\23>#OBCX`\56WB#PMX6N=!U4:A;:_XWM/$-
MWX0TZX&CZA;PMXD'A)6\4V6DW;SKI]QKGAW;K?AAKR/Q/ILL%UHT<\7^C9XL
M_P"17\1_]@'6?_3;=5_FB1<1Q$<'RHO_`$!:_L+Z+%"&*P/B#AJE_9XF&18>
MI90D^2M1SVG.T:D9TY/ED])PG![3A*+<7_)?TF:\\-C^`L33_B8:6>UZ=W)+
MGHU<@J0UA*$XKFBKN$X36\91E:2_9?X^V?@OXB?&7Q5HEA^U3;>#?!\'@_29
M_C-X)L_V@M+U=M5;0?$<>K_#_P"&GP(^(/Q$N/#-E)>:[)=WOC?Q1IFJ>*M3
M\%?"S5YK?Q7JVJ>+M>OK#PG;KX9^//@7QKK2:OXVUCX5^`_%<7[87B[XH?&;
M4++]H3Q/X5N/#OPTUSP+\.O#_A'XA_!OQG\.==M&^-'Q+\!:'X=\4:+9ZAYG
MC/4W\8:A=W;^!+U/B/XCOK+\:A\H`7"@#`"@*`.3@`8`&23P.I)[TH)&<$C/
M7!//U_,_G7]"4^`*"P=#!U,SQ%2.%PWU?#UZ=)8;$P=2C"ABYU*U"K">)5>%
M.CR?6G7KT_J.7*>(KK#UEBOP:7'-=XNMBX9=AX/$XGZQB*,ZCQ&'FJ5:5;"Q
MA1KTIPP[HSG5<_JJH4*CQF8.&'H/$TGAOTB\4_$+P%/X*\:^)M-^)F@WWPV\
M0?L1^!OV?/"'PAN_$2KXYL/BYX=U/PA;6TNJ_#&(E-#AT+Q7H'B/XXW7Q"2!
M=`NG\12P:9J]UXAUN^TI.8^!MIXB\->!OVM_A)<_&#X(:?X6\2_##QIX-TVS
M'QF^&.CZ'\0?BC'XI^$U]X?O=+UC5;_1M7\5>&+?P[I7B"3PWKMX_P#PA>GW
MJZX=/%KK=[>27'P)DXQDX],\>O\`.C)]3^=>K'A6G3PE7!TL6I0GBL)BHRQ.
M%I5W"I@)X.6#J6C*BI8B"PC5;%2O7KRJ<[G#V=)0\R7$U2IBJ>+J87EG##8G
M#..'Q56BIT\;3Q4,73O.%9QH5'B;TL-&U"C&GR*$E4J.7Z$_\$M(V@_X*(_L
MS0,\3M!X^\40-);SQW%O(T/P[\>1.]O<P.\-Q;R%2T-Q"[PSQ,DT3O&ZL?[S
M$^ZO4Y49R2>WN37\%O\`P2K_`.4A'[+W_8[>(/\`U6WCFO[TD^XO^ZO\A7\>
M_2E5N-LA3UMPIAU?:_\`PK9OTUM][/ZR^C/_`,D=GEM%_K1B;*][?\).3VUT
MO;O8=1117\S']'!1110`4444`%13PQW$$T$T:S1312121.,I)'(C(\;#^ZZL
M5;V)J6D;H><<'G.,<=<]L>O:@#\>?B5\0OVEK'XM:Q\&/AW\!-*T?X0^!_B]
MX5M;KPQ;_LTZUJ_@7XG?#;QMK?[/_A#PUX?B\=7"KX$E@UBP\6_M*_%'Q_XT
M\):?(/@U9_"3P;H'C^VM!J=R?&WZ\:7IMAH^FV.DZ596VG:9IMI;V&G:?90I
M;V=E8VD2P6EK:V\86."W@@CCBA@152*-5C1550!^#7C_`$KPG8?MU?$'7O$?
MPJ_9M^+&GR_M"_"6T?XW_%3X7_M+>-=8^"OB34M'^%FF:%\,V^-MG\+_`!!\
M%_`.O6UW<>']5\`^$+/Q-H_ASPSXF\4Z3;^+-8T_Q+XMB:Y_?,<CMU/3ZGKT
MY]1V.:`/P\_X*6F9?^"C_P#P0K-O'%+,/VK?VGMD<TSP1-_QAW\0`VZ5(+ET
MPNXC$+[F`4[02R_M1'/XA\M/^)7HWW%_YCM]Z#_J7*_%S_@I/_RDD_X(4_\`
M9UO[4'_K'/Q!K]O(_P#5Q_[B_P#H(H`R?/\`$/\`T"]&_P#![??_`#.4>?XA
M_P"@7HW_`(/;[_YG*V:*`,;S_$/_`$"]&_\`![??_,Y1Y_B'_H%Z-_X/;[_Y
MG*V:*`,;S_$/_0+T;_P>WW_S.4>?XA_Z!>C?^#V^_P#F<K9HH`QO/\0_]`O1
MO_![??\`S.4>?XA_Z!>C?^#V^_\`F<K9HH`QO/\`$/\`T"]&_P#![??_`#.4
M>?XA_P"@7HW_`(/;[_YG*V:*`,;S_$/_`$"]&_\`![??_,Y1Y_B'_H%Z-_X/
M;[_YG*V:*`,;S_$/_0+T;_P>WW_S.4&?Q`.3IFC`>IUZ]_\`F<K9KXM_X*(_
M$KQS\'OV+?V@_B7\-/$5UX3\=>$/!,>I^&_$5E;Z?=W6E7Y\0:':&YAM]5L]
M0TZ5S;74\6V[LKB/;*QV;@K#T,HRVMG.:Y9E&'G2IXC-<PP66T*E9S5&G6QV
M)I86E.LZ<*DU2C.K&51PA.:@FXPD[)\&:YC1RC*\RS7$0J5*&68#%YA6IT5!
MUJE+!X>IB*D*2G.G!U)0IN,%.<(N37-**NU];_:M>_Z!VB?^#^]_^9VC[5KW
M_0.T3_P?WO\`\SM?Q&_#+_@H'_P5-^,WC*Q\!?#'X[?$+Q=XHU'S9(=.T[PM
M\+TBM;2!D6?4=5U"Y\$0Z?H^EP/+!#-J6IW-K9I<7%K:^<;BZ@BD:?\`@H!_
MP5=2'XB7$_Q;^,EI#\(X;2?XI/?_``X\!Z>OP]6_U6RT2QB\6F^\`6XT>[OM
M6U&RLK*PG/V^]><7%I;364<UU'^_R^C1Q3"M+#5.*>"H8B$</.=">8YG"M"&
M+K+#X:<J4LH4XQQ&(?L*$G&U6M^ZIN52T7^%0^D7PS4I0Q$.&>,9T*DZU.%>
M&7Y=*C.>&HQQ&)C&HLU<)2P]!NO6BFW2HKVE11A[Q_;I]JU[_H':)_X/[W_Y
MG:/M6O?]`[1/_!_>_P#S.U_$_P#\-T?\%:O^$*L_B,WQ=^*,?@?4+6SU"S\1
M3>%OA%!;SZ1J&L)X?L?$`L)_"T>M1>%KK7)8M)A\77&EP^%GOI$A_MD%@3'X
MX_;O_P""KGPWT;2_$7C7XY^,]%T'6M8O/#^E:O##\`_$%A>ZYIUA;ZI?Z3'/
MX4TG7ECOK/3;NTO;F"<0F&WN[21R/M=L)8C]&SB6=6-"'%W`LZTZU7#1HQS7
M'RJRQ%",95\/&G'*G.5>A%\U:DHNI2BTYQ2LW<OI#\.PIRK3X5XUA1A1I8B=
M6668&-*&'KM1HUY5'FBA&C6DI1HU6U3J25H2DU8_MD^U:]_T#M$_\'][_P#,
M[2BYU\]--T4_37KT_P`O#M?Q,7?[>'_!66Q\`0?%2\^+WQ6MOAY<VECJ,7BN
M7P=\*Q8_V3JFJ2Z)I6O36:^$&UFT\-:KK4,NCZ5XHO-+M_#FIZJO]GV&JW-V
M\<3_`*E?\$6?VR?VF_VE?C-\:/#7QT^+NN?$70_#7PP\/ZYH>G:KI'A+3HM.
MU:[\8/IUS>Q2>'O#NC7,DDMD!;M'<S30A1N2)9#OKQN(_`7B/AOA[-^)*^?\
M+9A@\DM'&TLLQN/Q&(C6>(P^&EATIY;2HQKTIXF$JM*K6IRA&]U?E4O7X>\<
M>'^(L_RGAZCD?$N!QF<MO"5<QP>!P^'=+ZO6Q$:[<<QJU9T*D:%2-.K2I5(S
ME:SY5*2_?_Q7/X@_X1CQ%NTS1P/[!UG)&N7I(']FW70'PZH/TR/K7^:Y'_JH
MO^N47_HM:_TN_%G_`"*_B/\`[`.L_P#IMNJ_S1(_]5%_URB_]%K7ZK]$_P#A
M<=?]?.'/_2<[/R_Z47\?@G_KWQ'_`.E9"/HHHK^P#^40HHHH`^__`/@ED9E_
MX*!_LP&WCBEF'C77_+CFF>WB8_\`"N/'`(>9(+ET`7<05@DRP"D`$LO]Y=B^
MH.K?;K6SML+'Y7V2_GO=^0=_F>=IUAY>W"[=OF[LMG9M&[^#G_@E7_RD(_9>
M_P"QV\0?^JV\<U_>DGW%_P!U?Y"OX1^E-_R6^1?]DKA__5OFY_;/T9O^2.SO
M_LI\3_ZJ<G'4445_,I_1X4444`%%%%`!6;K-Y-I^D:I?6\<$L]GIU]=01W3W
M<=M)-;6LT\:7$EC9:C>I`[QJLSVEA>W2QEFM[.ZF"02:59NLP7-UI&J6UGY1
MN[C3KZ"U\Z\OM/A^T2VLT<'FWVF,NI64?FLGF7=@RWMLF9[1A<1QF@#^?6]^
M*WA#XG?M&Z!J%CHFD/X+^(?Q0^$'BSQK\/K?XM_M]^%/ASXT^)FEOX&MU\:^
M(?A)=?L"Q>$-2UG0/$&A:;)IMI>?%7P5X!\?-X4\+^(OBGI-K>7.N&V_H;7I
MQV)'Y$\G(')ZD^O<]3^`EKINL>&OVD],\"^%XOB/XQM/`'Q'^&'AKQMJ/AGX
M^_\`!;/XR:!X8\73:7X&\2>)_#_B+Q-HB>+_`-GM[C27U];ZXT/QQXH;0;+P
MW>Z1_P`+/@TB"\UFSM_W[']3Z^I]?_U>G&*`/Q!_X*3_`/*23_@A3_V=;^U!
M_P"L<_$&OV[C(\N/D?<7N/[HK\/_`/@I=%Y__!1__@A9%YL\&_\`:L_:?'FV
MTGE3+C]COX@-\DFUL!L;7&/F0LO&[(_:--")1#_;&O<JIYU,D\@=3]G&3ZG`
MS0!T&1ZC\Q1D>H_,5@_V$?\`H,:[_P"#(_\`QBC^PC_T&-=_\&1_^,4`;V1Z
MC\Q1D>H_,5@_V$?^@QKO_@R/_P`8H_L(_P#08UW_`,&1_P#C%`&]D>H_,49'
MJ/S%8/\`81_Z#&N_^#(__&*/["/_`$&-=_\`!D?_`(Q0!O9'J/S%&1ZC\Q6#
M_81_Z#&N_P#@R/\`\8H_L(_]!C7?_!D?_C%`&]D>H_,49'J/S%8/]A'_`*#&
MN_\`@R/_`,8H_L(_]!C7?_!D?_C%`&]D>H_,49'J/S%8/]A'_H,:[_X,C_\`
M&*/["/\`T&-=_P#!D?\`XQ0!O9'J/S%?GI_P5;(_X=Y_M3<C_DG4??\`ZFCP
MY7W;_81_Z#&N_P#@R/\`\8K\_/\`@JEI)MO^"?/[4<W]IZO/L^'<9\JXO_-@
M?_BI_#PQ)'Y*[QSG&X8_&OJN!?\`DM^#?^RJX>_]6^#/F.-O^2-XM_[)K/?_
M`%5XH_D3_8=^('ACP!\;[.Y\9>.?#'@KPWK7]D6&JIX^\$3^,OA[XDMM.\2:
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MU'[>WPSM_".@6JQZ];7]BOR_X[O?A]XNUOX-?#CPWXWT/PI\-_`WPD\,Z7=>
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M-Q]I*I.?]7GBPC_A%_$?(_Y`.L]Q_P!`VZK_`#18_P#51?\`7*+_`-%K7^D]
MXIT0KX9\1-_;&NG&A:P<?VD><:=<G_GA^7O@]J_S88_]5%_URB_]%K7Y1]$_
M^#QU_P!?.'/_`$G.S]-^E%_'X)_Z]\1_^E9$/HHHK^P#^40HHHH`_03_`()5
M_P#*0C]E[_L=O$'_`*K;QS7]Z2$%%P0?E7I]*_@G_P""6<7G_P#!0+]F*'S9
MH/,\:>(!YMO)Y4R8^''CALQR;6VYQM;Y3E"R\9R/[R=/L39*Y-Y?W?FB,_Z=
M=?:3'M!_U9\N/;NW?/UW$*>,5_"/TIO^2WR+_LE</_ZM\W/[9^C-_P`D=GG_
M`&4^(_\`53DYHT445_,I_1X4444`%%%%`!2'H<=<''^3Q^=+378*K,6"A59B
MS$!5`!)8DD``=220,=2!S0!^3VO_``,^/\'[5GC;QNO@#XJ>*O`WB;XN>"?$
M^C>)_"_[>WC3X&^$M&\*Z9H?@S2+NSU3]G'X>Z)I/A3QBNDW.BZK?ZE-XON]
M>\2?$:UNO[$\2:L-'M-&T^Q_6(?U/?/<_P"<=NG:OR8UZ_\`CEK'[4OBF?Q#
M<?MOZAX"@^*?@F/X87WP+\=_L9>&OV=S\/!I7A)[FS\6>'/$WQ-_X71KT=MX
MG_X2>?QYJUSI+:_KFF7C6/A'2;>WLM-TN']9Q^/4]<>I].WIWQC/-`'X@_\`
M!2?_`)22?\$*?^SK?VH/_6.?B#7[>1_ZN/\`W%_]!%?A]_P4MGAMO^"C_P#P
M0KFN)HH(4_:M_:>WRS2)%$F[]COX@*NZ1RJ+N9E49(RQ`')`K]J(_$?A[RT_
MXGNC?<7_`)BECZ#_`*;T`;E%8W_"1^'O^@[HW_@TL?\`X_1_PD?A[_H.Z-_X
M-+'_`./T`;-%8W_"1^'O^@[HW_@TL?\`X_1_PD?A[_H.Z-_X-+'_`./T`;-%
M8W_"1^'O^@[HW_@TL?\`X_1_PD?A[_H.Z-_X-+'_`./T`;.<?_J)_E29'O\`
MD?\`"OY\/^#@'Q.T7P&^`K>'?$DUO.WQKU%9WT#7;BTG:`?#GQ.=L[Z5>0RO
M")-C;96,8DV,`'"FOYX_A5\'/BC\4OA_XW^)(^,>D^`O#GA-;BSTNZ^(7Q-\
M4^'[7Q;XEL=3\"66H>'[/5//N=)\/K9P_$3PR[Z[XIO=*T>34]7TK28YBMUJ
M.I:+^^<%>"%'BSA'!<68KB^CDE#&XRM@8X6>2U,=)5J>,E@Z<8U:>9X>5256
M4>=J.'2I0YY3E[.G.HOPWC'QEK<+<58SA?#<)U<YK8/"4<9+$T\WA@DZ-3"4
M\74<J4\NKQIJE&?(FZ[]K/DC!>TG"G+_`$*\CW_(_P"%&1[_`)'_``K_`#K-
M?^'?QE\-?"?P-\8-6\9WR:%\0O%TOA#P]X?LOB3K&J>,H[D^&;+Q9INIZYHF
MG:M<Q^'K'7]*OHI-!LM6O;;Q!?1A;Z31K;3+K3[V\[36?@!\?-!\<_#OX?:C
MX_LQK?Q`^'&I_%2XOK/XM:UJWACP!X/\.7_C>R\9WGCSQ/HU[J.E6<W@5/A]
MXDN/%<7AZ;Q)':36T6C:=-JFO2C3:^ME]&O`1BI2\2L`HMXZ*?\`8+=WEJE+
M'M6SW6.$4)^VDO=BXV;YI)/Y6/TB,?)\J\.\=S*."DT\[LTLQE3C@;WR71XI
MU(JC%^]*]TK)L_T'\CW_`"/^%&1[_D?\*_SD/&VC>-_"/BO1?"FG?%A_',OB
M*ST&ZT?4O"_C;QW8Q"?Q#>/IMIHOB+1O&B>%/$_@CQ+:WZ>5JF@^,-$T:\L;
M6>QU9C+HVHV6H3=O\8/A/\4O@W;:G<ZI\6H_%)\.?$;5_A%XSM_"_BSXJ03^
M$?B3H>FSZKJ'ANZ/B_1O"L7B"V2TL[\P^)?",FN^'Y9;)D>]ACOM'FU/5?1D
MP[J8.E_Q$&BJF/A*>%A+AC$1G.,'3C)SC+.5*@U*I"GRXA4I.K*-%)U7R+/_
M`(F.Q')BZG^H=5PP,H0Q,X\1T91A*HI.*@XY3)5TX0G4O0]K%4HNLVJ2YW_H
M<YS_`/J(_G7YZ?\`!5O_`)1Y_M3?]DZB_P#4I\.5\/\`_!`OQ.)?V6_BPWB'
MQ))<78^/^K+"^OZ[-=W2V_\`PKGX>%5BDU6\FG6#S/-*I&PB\PRL%WER?LW_
M`(*J:UHUU_P3X_:D@M=6TRYGD^'<02&WO[6:5S_PE'ASA(XY6=C[`$U^08;A
MR7"7B[DW#<L6L?+*>-.'L,\8J#PRKO\`M++ZO.J#K5W3_B<O+[:IM?FULOU?
M$\0+BKPJS;B!81X%9IPAGF)6$=;ZPZ"_L_&PY?;*E1]I\%^;V4-[6TN_X1W^
M^W^\W\S3:<_WV_WF_F:;7^G$=EZ+\C_.`****8!7]`__``;S_P#)P7[0G_9&
MO"W_`*GCU_/Q7[^_\&^-]96/Q_\`V@I+Z\M;.-_@WX65)+JXBMT9AX[<E5:9
MT5F`()`)(!!K\M\:_P#DUO&'_8#A/_5KEY^F>#G_`"<WA'_L.Q/_`*K,<?U=
M^+/^17\1_P#8!UG_`--MU7^:)'_JHO\`KE%_Z+6O]*/Q7XB\/MX8\1!=<T<D
MZ#K(`&IV1)/]FW7``GR:_P`UR/\`U47_`%RB_P#1:U^(_1/_`(7'7_7SAS_T
MG.S]B^E%_'X)_P"O?$?_`*5D(^BBBO[`/Y1"BBB@#]!/^"5?_*0C]E[_`+';
MQ!_ZK;QS7]Z2?<7_`'5_D*_@H_X)93PVW_!0/]F">XFBMX8_&NOF2::1(HD!
M^''CA07D<JB@LRJ"Q&6(`Y(%?WEV.HZ??JWV&_L[WREC\W[)=07/E[P=GF>2
M[[-VUMN[&[:V,X./X1^E-_R6^1?]DKA__5OFY_;/T9O^2.SO_LI\3_ZJ<G+U
M%%%?S*?T>%%%%`!1110`54O[.+4+*\L)UC>"]M;BTF2:""ZB:*YA>"19+:ZC
MFMKB-DD97@N(98)5)CFCDC9D:W10!^:.F?L#^&/#'B/2;GPI^S]_P3KTZ30[
M[3]4T/XD1_L;^'M+\?:%J6F7,%WINK6FCZ#JUAI'_"1:;<V\5W::UIGB7P_!
M%J,4-]::-8I$EF/T?TJVN[+3-/M-0U!]6OK:SMH+S5);:ULI-1NHH42XOGM+
M)([2U:ZF#SFWMHT@A+^7$NQ15^B@#\0/^"D__*23_@A3_P!G6_M0?^L<_$&N
M-_X*=_\`!47X^_L6?'[PM\*OA=X2^$VN^']9^$V@>.;J\\<Z-XKU#5TU;4_$
MWB[19[>"?0_%V@VBV"6N@6<D4<EG)<+/)<,UP\;QQQ=E_P`%)_\`E))_P0I_
M[.M_:@_]8Y^(-?E1_P`%^?\`D\OX?_\`9N?@[_U/?B77[)X$Y#D_$G'U#+,]
MR_#YG@)95F-:6%Q*E*DZM*-+V<[1E%\T')N.O75,_(O&W/,WX>X'K9CDF/KY
M;CHYEE]*.)P[BJBIU:DXU(7E&2Y9JU].B-O2_P#@O;^VQKFHV>CZ+\)O@%K&
MK:A(\.GZ5I?@WXEZAJ5]-%!-=216=C:_$66YNI([:WGN9(X(W=+>":9@(XG9
M:UO_`,%^/VSKNTN=0M/A=^S[=Z?9I!+>ZA:>#OB9=6%C%=-LM9+Z]@^(DEK9
M1W3@I;/=30K<."D)=P17Q?\`\$W_`!#>Z%\=[BWT^?PY%<Z_H<6E-'=?$N#X
M2^/9+6WN+C69I/ACXOU"UET6;5(9=-ME\5^%]4NK0:_X7GEN+9+W^Q+B*+ZZ
M^%WQ`^'>F^*=(U'6_B]K'B?X0_"OXM_&G7_BMXKTKXC?!W2/"OQY\,_$+P-X
M;O\`7_\`A>G@2UU;0?$'C36[$G4OAAX+U;X>^`/'?ACXS-81S^$8_`L]Q?ZR
M_P#3^=<&^'>4YEF&`I^&V38N."P.%QE.<:]>%7$NO2QDE0A2C3JJ-;$8G#T,
MOPE)S5:M7Q$J]*G6H8;&O!_S;D_%O'V:9?@,;4\1,XPLL9C<1A*D)4*$Z>'5
M"K@HRK3JRG2;I8?#5J^/Q=6,'2HT:"H59TJ^*P:Q6R__``7T_;2CM(=0D^%?
MP`CT^YN);2VU%_!GQ-33KF[MP6N+2VU!OB&+.XN[=06N+6&=[B``F6-`#A(O
M^"^W[:$\%W=0?"S]G^>TL%A?4+N#P;\3)K33TN)/)MGU"ZB^(;V]@ES,##;/
M=R0K<3`Q0EY`5'R?K%O\7O#O[+NIP>,O$MIX_C^+7PQ^$W@OPG\/=)^(/PWE
M^&7P`^'V@>*/"VJ>%_%&N:#9^+A;VGQOU1],M=+6R\+^'!J?A;3O%?C?Q;\5
M_%$^OZ]=Z);]7\"-0/@;1O@?X>O/&_A#PYX$^$'Q;_:*M/VVO"O_``L;PD-)
M\4:#J`T_3;*?5-'L_$#V_P`:_#GBGX=6.H?#GX=R>%(/&>GQ>+(+A='-A<:M
M;:K=[5>"_#.G@\3B:?`G#F*G0S#%X.G##8RO4IUZ>#RZ>,J5%)4E6A.MC(+)
M<-&5#EQ./Q."GAYU*.,PWM,:7%_B-/&8;#5.-^(L-"M@,+BZD\3A*-.I1J8O
M,*>#C3<?:NC.-+!SEG&(E&OS8?`X?&PKPIU<)B'3]_7_`(.`/VQ2P!^&_P"S
MF,L`?^*8^(F>3@_\U(ZU_3M^Q]\8/$OQ_P#V8O@A\9_&-CHNF^*/B3\/M$\5
MZY8>'(+VUT.UU'4DE:>'2[?4;[4KV&S4H/*2ZO[J8`G?,_;_`#N+<86`;70!
M8@$E;?*@"KA)7RV^5!A9'W-O<,V3G-?WX?\`!,S_`),%_9/_`.R,>%/_`$7<
M5^9_2'X%X1X5X8R3&</9#@<JQ6(SQ8:O6PL9QG4H?4,74]E)RJ33C[2$)Z=8
MJSL?H_@%QIQ5Q-Q'G&%S_/,=FF'H9)+$4:.*E"4*==8[!4O:14:<'S>SJ3CK
MTD]#\V/^#AK_`)(#^S__`-EPU'_U6OBFOP8_9/\`VH?!?[/?AGXF67B#PSX[
M\1:EXFTVU$/AO3/&%E_PJWXEQV_BOP+J:>#?BIX#\1:!KVC1Z6NE:#XDTZZ\
M7:-`VO7WA;Q-X@\*)#9ZA<Z!XBTC]Y_^#AK_`)(#^S__`-EPU'_U6OBFOY-Z
M_2?`W*<%G?A!E67YA"=7"U,RS&K.G"M5HN;P^;5*T(RE2E&3@YP5XMZ:3@X5
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M:^WO^"K?_*//]J;_`+)U%_ZE/AROB'_@WR_Y-3^+G_9PNL?^JV^'-?;W_!5O
M_E'G^U-_V3J+_P!2GPY7\'<5_P#*0S_[+_A[_P!3<K/[=X8_Y,+_`-V/GG_J
M'F!_!H_WV_WF_F:;3G^^W^\W\S3:_P!$([+T7Y'\"A1113`*_H'_`.#>?_DX
M+]H3_LC7A;_U/'K^?BOZ!_\`@WG_`.3@OVA/^R->%O\`U/'K\M\:_P#DUO&'
M_8#A/_5KEY^F>#G_`"<WA'_L.Q/_`*K,<?U8^+/^17\1_P#8!UG_`--MU7^:
M)'_JHO\`KE%_Z+6O]+OQ9_R*_B/_`+`.L_\`IMNJ_P`T2/\`U47_`%RB_P#1
M:U^(_1/_`(7'7_7SAS_TG.S]B^E%_'X)_P"O?$?_`*5D(^BBBO[`/Y1"BBB@
M#]!/^"5?_*0C]E[_`+';Q!_ZK;QS7]Z2?<7_`'5_D*_@M_X)5_\`*0C]E[_L
M=O$'_JMO'-?WI)]Q?]U?Y"OX1^E-_P`EOD7_`&2N'_\`5OFY_;/T9O\`DCL[
M_P"RGQ/_`*J<G'4445_,I_1X4444`%%%%`!1110`4444`?AW_P`%+GEC_P""
MC_\`P0L>"#[3*O[5G[3^R'S4@WY_8[^(`/[V0%%VJ2^",OMV+AF!K\H_^"]L
MUU-^V-X!:[L_L4@_9V\(*L7VJ&[W(/'OQ*P_F0*J#))7:1N^7?G:Z@?K#_P4
MG_Y22?\`!"G_`+.M_:@_]8Y^(-?E1_P7Y_Y/+^'_`/V;GX._]3WXEU^]_1N_
MY.9A_P#L39K_`.DT#\-^D-_R;G$?]C;*_P#T[,_#X%E.59E(Y!5BK`^H92"/
MP/0D=Z841F5V1"Z9\MRBEXP>"$8C<@(X(4@$<'.*=17^AO6_7OU/X)_1W^>G
M^2(1;6P?S!;6PDY/F"WA$F3G<?,";\MD[CGYLG.<G+_+CS&?+CS%_JCY:?NL
M@*?*^7]UE0%^3;\HV].*?11=]_+Y=@LELK=?GW')]]?]Y?YBO[U/^":M[JT7
M[!G[*:0:-Y\2_!KPJ$F_M.SB\Q1'/A_*>,O'NZ[6)(SMZJ:_@K3[Z_[R_P`Q
M7]]O_!,S_DP7]D__`+(QX4_]%W%?S!]*?_DD.'O^RC7_`*K,<?TG]&7_`)*O
M/O\`LGI_^K++S\Q_^#@RYOY_@'\`A>:;]B5?C=J!1_MUO=;V_P"%;^*1LV0H
MK)\N6W,2!MQ_&N/Y2*_K(_X.&O\`D@/[/_\`V7#4?_5:^*:_DWKZ_P"CM_R:
MW*/^P[.?_5C7_P"&/E/'[_DY>;?]@>4_^JW#!1117[@?BX4444`?UN_\$`+G
M4(/V5OBTMIIGVU#^T'K!:7[?;6VU_P#A7'PY!3RYD9SM4*V\':V_`&4;/VQ_
MP52O=5E_X)]?M1I<:/\`9H6^'<8>?^TK2;RQ_P`)/X>.?)C0._('"D8[]17Q
MS_P;Y?\`)J?Q<_[.%UC_`-5M\.:^WO\`@JW_`,H\_P!J;_LG47_J4^'*_P`[
MN*_^4AG_`-E_P]_ZFY6?WUPQ_P`F%_[L?/?QP>8_E?\`#2RLE_!H_P!]O]YO
MYFFTY_OM_O-_,TVO]$([+T7Y'\"A1113`*_?O_@WTFNX/C]^T$UI9_;7/P<\
M+AD^U0VNQ1XZ<AM\RLK9/\(&>,=Q7X"5_0/_`,&\_P#R<%^T)_V1KPM_ZGCU
M^6^-G_)K.,?^P'"?^K7+S],\'/\`DYO"/_8=B?\`U68X_J3\4ZAK1\,^(@V@
MX!T+6`3_`&O8C@Z=<_\`3/\`_5UZ"O\`-BC_`-5%_P!<HO\`T6M?Z7?BS_D5
M_$?_`&`=9_\`3;=5_FB1_P"JB_ZY1?\`HM:_$?HG_P`+CK_KYPY_Z3G9^Q?2
MB_C\$_\`7OB/_P!*R(?1117]@'\HA1110!]_?\$LWEC_`."@7[,3P0_:)E\:
M>("D/FI!YA_X5QXX!'FR`HFU27^8'=MVCEA7]Y&G7%].K_;+#[#L$?E_Z9!=
M^;D-NY@50FS"C+9W[LKC!K^#W_@E7_RD(_9>_P"QV\0?^JV\<U_>DGW%_P!U
M?Y"OX1^E-_R6^1?]DKA__5OFY_;/T9O^2.SS_LI\1_ZJ<G'4445_,I_1X444
M4`%%%%`!1110`4444`?B!_P4H('_``4C_P""%))`'_#5O[4')X'_`"9S\0:_
M*?\`X+\LI_;+^'^&!_XQS\'=Q_T/OQ+K^AW]N'_@GG\-?VZKOX':[XN^+_[1
MWP,\<?LZ^,/%/CCX5_$G]F7XDZ7\,/'^@:YXS\)2^!_$#)K^I>$?%NVWO?#5
MS>:8RVEM9S_9[Z]A:X>"ZEA;\X?B7_P;F?`+XSZ[:>)_B[^W[_P5?^)7B.PT
MJ'0K'7/&7[6GA;6=3M-%M[N]OX-*M[F?X,;X[&&^U&_NX[=?D6XO+B7&Z5C7
MZ/X5\:X+@#BREQ#C\'BL?AZ>!QF$>'P;HQKN6)C!1FG7J4Z?+%P][WKV>B;/
MSWQ-X.Q?'7"]7(<%B\-@J\\;A,4J^+55T5'#SE*46J,*D^:5UR^[;>[1_)]D
M>H_,49'J/S%?T^_\0M_[%_\`T=U_P4R_\2=\'_\`SF*0_P#!KA^Q>`3_`,-=
M?\%,N`3_`,G.^#^PSW^"Y_D:_IO_`(FJX7_Z)CB'_P`&99Y?]1GK_6_\X_\`
M$L?$O_129#_X+S'_`.9?7^EK_,'D>H_,49'J/S%?OK\"_P#@W'_92^)?B[]I
MS0=>_:U_X*,QV?P;_:&N_A5X6;2OVE/"MO<2^'(/@M\$_B$DNN/+\(KE;O6#
MK?Q%UR,W4*641TR/3+<VGFV\ES<_1'_$+?\`L7_]'=?\%,O_`!)WP?\`_.8H
M_P")JN%_^B8XA_\`!F6>7_47Z_UN?\2Q\2_]%)D/_@O,?_F7U_I:_P`PB$;U
MY'WE[CU%?WV?\$S'3_A@;]D_YE_Y(QX4_B'_`#SN/>OR/'_!K?\`L7@@C]KO
M_@ID"#D'_AIWP?P1_P!T8KZ3\*?\$.=$\">&]%\'>"O^"IG_``63\*^$_#>G
MP:3X?\.:'^V;X<L='T73+5=EMI^G6<?P7\NVM+=/DAA3Y47@<5^1^,'C+D_B
M1DF695EV49GEU7`YHL?4JXZ6$E3G36$Q&'Y(+#UZLN?FK*7O)148O5NU_P!5
M\)O"/-O#W.<QS/,,URW'TL;ECP,*>"ABHU(5'BL-B/:3=>C3CR<M"4;1;E>2
MTLFSS7_@X993\`?V?\,I_P"+X:CW'_1-O%/O7\G&1ZC\Q7]<WQ._X-__`(8?
M&K2]-T3XP?\`!2+_`(*[_$S1M'U$ZOI.E^,_VP/#.M66FZJUI<6#:C9P3_!?
M;#>&QN[JT,R_-]GN)H_NR-GQ;_B%O_8O_P"CNO\`@IE_XD[X/_\`G,5[?AAX
M\Y%P)PA@>&\=D>;XW$87$8ZM/$8.>"5"4<5BIUXJ*KXBG4O&,^65X6YD[-JU
M_&\2?!#.N-N*\9Q!@LYRK!X?%4,%2C0Q4,8ZT987"TL/-R=&A.G:3IN4;2;L
MU>ST/Y@LCU'YBC(]1^8K^GW_`(A;_P!B_P#Z.Z_X*9?^).^#_P#YS%?..F?\
M&YG[*EY^UKXS^!<O[6O_``48'A#P]^SK\-?BO931_M)^%1XA;Q)XO^*/Q;\%
MZG%=7I^$;6\FC)I?@;1WL;5;"*6&^?4)GO)A.D5O^@_\35<+_P#1,<0]/^7F
M6>5_^8M[:_UO\'_Q+'Q+_P!%)D/_`(+S'_YE]?Z6OX(9'J/S%&1ZC\Q7]/O_
M`!"W_L7_`/1W7_!3+_Q)WP?_`/.8H_XA;_V+_P#H[K_@IE_XD[X/_P#G,4?\
M35<+_P#1,<0_^#,L\O\`J,]?ZW/^)8^)?^BDR'_P7F/_`,R^O]+7W'_@WS91
M^RG\7,LH_P",A=8[C_HFWPY]Z^WO^"K;*?\`@GI^U-AE_P"2=1=Q_P!#3X<]
MZ^'_`(9_\$!OAO\`!?1+WPU\(O\`@I/_`,%>_AKX>U'59=<O]$\&_MA>&M&T
MV\UF>TL[";5;BU@^#!22^EL=.L+22<_.UO96T9XB7'0>,?\`@AEX>^(?AC6/
M!7CS_@J-_P`%C_&'A#Q#:_8=>\,^(/VS/#FH:+K%EYL<_P!EU"RE^"_EW,'G
M0Q2^6_REXT)SBOYASGC3!YGXF_Z]4\'BJ6!_UDRS._J51T7B_8X&O@ZTZ-XU
M'1]K-8:2@_:<B<H\TDKM?TCE'!^+R[PY_P!2JF+PU3&_ZOYAD_URG&K]5]MC
M*&)I0K<LH*M[*#KQ<UR<]HRY4]+_`,>KD;VY'WF[CU--R/4?F*_I^/\`P:W_
M`+%Y))_:[_X*9$DY)_X:=\'\D_\`=&*3_B%O_8O_`.CNO^"F7_B3O@__`.<Q
M7]/+Z5/"Z27^K'$.R_Y>99Y?]1?K_6_\W_\`$L?$O_11Y%_X+S'_`.9?7^EK
M_,%D>H_,49'J/S%?O_\`%_\`X-P/V3_`7Q)_99\(:/\`M;?\%''TWXU?&WQ/
M\.?%;:C^TIX4GO8=#T;]G#X\_%NUDT&6/X0P)9ZH?$OPS\/Q3W$\5]&^BR:M
M:K;)-<Q7EI[]_P`0M_[%_P#T=U_P4R_\2=\'_P#SF*/^)JN%_P#HF.(?_!F6
M>7_47Z]_\U_Q+'Q+_P!%)D/_`(+S'_YE]?Z6O\P61ZC\Q7]`_P#P;SLH_:"_
M:$RP'_%FO"W<?]#X]>[?\0M_[%__`$=U_P`%,O\`Q)WP?_\`.8KTWX8_\&['
MP-^"FI:IK'P?_P""@W_!63X9:MK=C!IFL:CX,_:V\+:+>:IIUM<-=V]C>S0?
M!?=/;073O<11-\J2LSCDG/R''WTAN'^+N#\\X;PF09UA<3FN'HT:6(Q,\`Z%
M*5+&87$N514L34J-.-"45RQD^9KHKOZS@;P$SWA3BS)>(<5GF48K#Y7B*M:K
MA\/#&JM5C4PF(PZ5-U:$*::E64GS22Y4UO:_[V^+'3_A%_$?S+_R`=9_B'_0
M-NO>O\T6,CRHN1_JHNX_YYK7]F,G_!&&YFCDAE_X*T?\%II(I4>.2-OVV-`*
MO&ZE71@/@N"5925/(X)KY._XA;OV+N!_PUU_P4R````'[3O@\``#`'_)&.PK
MX#P9\5\J\,X<0QS+*\QS%YS/*Y47@)86*HK`+'JHJOUFM2NZGUR')R<WP3YK
M>ZG]SXN^%V9^(U3()Y?F6`R]91'-(U5C8XF3J_7WESA[/ZO2JVY%@I\_/R_'
M&U[,_F"R/4?F*,CU'YBOZ??^(6_]B_\`Z.Z_X*9?^).^#_\`YS%?-_[7G_!N
M9^RI\!OV:OC'\7O!W[6O_!1B?Q/X!\&7GB#18O$7[2?A6]T1[VWN[*!%U*TM
M_A'833VQ2X?=&E[;DD*?,!`K]N_XFJX7_P"B8XAZ?\O,L\K_`/,6_/\`K?\`
M&O\`B6/B7_HI,A_\%YC_`/,OK_2U_!+(]1^8HR/4?F*_I[7_`(-<?V+W!)_:
MZ_X*9??D7C]IWP?C"NRCK\&,]!WY]23S3O\`B%O_`&+_`/H[K_@IE_XD[X/_
M`/G,4?\`$U7"_P#T3'$/_@S+/+_J+]?ZW/\`B6/B7_HI,A_\%YC_`/,OK_2U
M_(;_`()6,O\`P\(_9>^8?\CMX@[C_HFWCFO[THR"BX(/RKT(/;VK^<WP9_P;
M2_LO_#GQ/I'C7P!^W#_P5,\&^,-`GFN=#\3>'?VJO">G:UI%Q<V=SIUQ-87L
M7P8\RWDGL+V\LI63E[:ZGB/RR,#^L'[(/[&,_P"R0WCYIOVM_P!M7]J/_A/!
MX:55_:^^-NG_`!A7P5_PC9UPEO`(L?!7A#^P#X@_ML#Q,93?_P!IC1]#V"U^
MPMY_\[>,'B'E_B1G^79QEV`QN74L%D]++9T<=+#RJSJPQN-Q3J0>'JU8*FXX
MJ,$I24N:$M+6;_??"?@''^'N1YAE688[!X^KC,WJYC"K@HUXTX4ZF"P.%5.2
MKTZ<N=3PDY:)QY9QUNF?:M%%%?DQ^IA1110`4444`%%%%`!1110`4444`%%?
M$WQ@_;<\)_";Q3\3]+C^&OQ*\>^$/V??#OA_Q7^TE\1O!MOX6D\/_!?0?$VC
MW7B>UGO]+USQ+H_BCQOJ&@^";9?B-XVT;P!HNOZEX7^']YINLM#J&JZMI7A^
M\U=0_;`TW0OBIX2\#>)O@_\`%KPQX&^('Q7N/@5X$^,FMZ?X8M/"?BOXI1:!
MXF\1VMGIOA?_`(25_B4G@?7;;PAX@TSPQ\3+GP?%X3\0:OIQGL[@>%=1T/Q5
MJ@!]8:=H>BZ//J]SI.D:7I=SK^J-K>NW&G:?:64^M:RUAI^E-JVK2VT,4FI:
MFVF:3I>G-?WK3W9L--L+,S?9K.VBBU*\"\8_'NS\#?$#7?!^L_#WXEW6A:%\
M*M-^)3>/?#GA6]\6:'JNH:MXYF\#6/PWT'1/#*:KXRUGQ_<72VFJPZ78^'Y;
M-]+U"UF>^C87'D?+%Q_P4>\(WW[,?P!_:5\+_"[Q+)I_[0>JZU9:%X0^(/C_
M`.$'PDO?!EEX<T[QMJ6O7_Q`\9>-?&EO\/-&?31X+FT]K#3O$VKW%UJFJ65O
M8M<V\5]>6X!^DE%<=\/?$][XT\#>$/%VH:-'X>O/$_AS1]?GT6'Q!H7BN'36
MU:QAOEM(/$WABZOO#NOP1QS(8=7T.\NM*U")DN;&XFMY(Y&[&@`HHKYW^-/[
M0"_"WQ+X#^'7A?X=>,?B]\6/B78^,-=\*>`/!MUX5T:1?"/P[_X1M?'/C/Q%
MXH\<:]X;\+^'O#VA7GC+P=H$,EUJ,VI:OXH\7^'=)TW3I8)M4U+2`#Z(K*30
MM$CUJ?Q)'H^EIXBNM+M=$NM>33[-=:N=%L;R]U"QTB?55A%_-IEG?ZEJ-[:Z
M?)<-:6]W?WMS#"DUU.\GPAX@_P""@WA6P^%J_''PU\$/CKXO^$'ASX8ZW\6_
MC#XVMM"\(^'(/@YX:\(:MXWT#XA:!KVF^+O&.B7WC'XF?#+5OAQXW3XA?#KX
M:CQ;K7AVT\.M,9;N[\1^![#Q7]9^-OB6WA/4?A#9:?X.\5>,+;XK_$.'P,^J
M^&[>R>Q\"V$_P]\>>/E\<>,CJ-W93VOA0?\`"$P^&6EL(;S4QXB\5>';<V`M
MIKRXM0#U&BOD[X#_`+8/PY^/=U^T,=(T3QMX#T;]G+QYIO@KQ3KOQ6T$_#^'
M5[+5/A)X&^,UKXYT[2-?GMO$6A^#)O"/CS3;F"\\;Z5X7U:2"TN]5DT>WT:;
M3[Z\N_LK?M5>%OVKM"^*GB#PIX0\:>#K3X7?&KQC\&KJU\=6FFZ=JFO2>&-'
M\*>(],\9:?IMAJ-_=:;X>\7^&O&>@Z]H=AX@32_$]I97BP>(-$TC44FL8@#Z
MDHHHH`**^4/BY^UWX!^"/Q`UCX>^/]"\6V.J2?":3XH?#:XL;*QOX?C-?Z?X
MNL/`VO?"[X<0I>QW5_\`%+1_$WBOX7V*^&=2BT]-8B^*GA:]T6]O;.P\5R^'
M_DOXG?\`!3CQ+\'==_:4TOQ]^R%\4K&Q_9?^&7@3XJ^.M8TSXI?`G6(=2\.?
M%K7/B#X8^%,'A^QM_&L=_)J?BOQ!\-?$5E?6^J1:;%X8M7T[4M6G-I=EH@#]
M4;[1='U.[T>_U+2M-U"^\/:A-JV@7E]8VMW=:'JMQI6I:%/J6CW%Q%)-IFH3
M:)K&K:/+>V3P7,FEZIJ.GO*UG?74,NE7S)\'?VD#\0_'7B3X0^/?AIXL^"WQ
MC\+^#_#WQ"NO`_BK5O!OB>SUWP)XEUC6_#MEXK\'^,/`>OZ_X?UZQT[Q'X?U
M'P]XETZ=])\1>&M5_LU]3T6/2/$7AG5M8\L^+W[>7A'X(?"J;XH>//A%\:[5
M3\<?$?P7L/"^G>$[;4=4N+;0?V@=/^`$'Q4U+6H=17P?X7^&6N:CK6@^,]"U
M/Q-XATO6]9\+:YIEIHNA:IXJN5T"@#[NHKXE^(W[8O\`PAG[26@_LZ:-\-XO
M$5_J(^'R:EXHU7XR?!GX>)#=^/M1UN)-.\+^"O''BO3/'GQ"U'0=$T637]4M
M?"&A7S317EIINFF\U,74%O\`;0_S_3\Z`"BBO#?C-\>/#7P+OOA=+XXTS5K;
MP=\2/B'IWPQO?B#"U@/"WP]\2>)M/OSX$N/'L]S=07.D^'_&_BNTL/AUI.N0
M0W-I:>.?$_A+3-5^Q6>MC4+8`]RK*UO0M$\3:3?:#XCT?2M?T/5(&M=2T;6]
M/L]5TK4+5F5FMK[3K^&XL[N!F16:&XADC)525RH(_.?5O^"@_B(_$K]G7P1X
M._9:^)OB[P]^U/+XNN/@[X\?Q[\(_"FGZQX<\$Z9>>*-7\5ZKX:\3>*+/Q;H
MVCZEX"@L_''A>*?2Y-3UG1]9TJUFL=-U66XLK;;_`&<O^"A&C_';3_@=XCU_
MX(_$WX0^!_VGKG5[/]G[QSXIUCX<>)=`\:ZII7AWQ'XQM_#.OQ^!_%NMZS\/
M_%?B'PCX0\6>(?#>F>)M*CT[4H?#&LZ1)K=IXE&E:+JH!^B6`.@QU/XDY)_$
M\GWHKYY\4_M"6?@SQ%\7='UOX:?%:?3/A9X2^%?B.PU[PSX0N?&*?$[5?BIJ
MGC71;#P5\.-#\,OJ/B'5O$_A_5/"=A;>)5U+3M*T72HO%^@:G>:Q;:-%K6I:
M7Y3)^W1\.4_8A\%_MO+X3\:R^&_B-\$_#_QC\"?"F%?#DOQ3\3W'BGP')X_T
M3X=:9:IKK>%IO&<NE07G]HSKXC;PMHMII>M>(M4U^W\+:-J.LVX!]N45Y_\`
M"?XB:5\7?A=\./BKH=I>V&B_$OP%X.^(&D6.I&W.H6>F>-/#>F>);"TOS9S7
M%I]MMK35(8+O[-/-;_:(Y/)EDCVNWH%`!1110`4444`%%%%`!1110`4444`%
M%%%`'Y9_M5_LJ?%S4+S]H"7X-W<.O?#/]MB'PCX&_:M\$6OA_P`/7GQ3T?PU
M'\-;OX+^*O'GP0UWQ7X\\#^"9-=\0_#.R\'>"]=T+QXUY;^&;'2;KXC>$1K_
M`(@L7^'WB;M-!_9L_:5_X:ML?C)X]\9?`'QM\+O!.LZII/P0\%_\(;\4]&UG
MX'_#.\T&7PY)'X2L%\?W_@35OC%K^E-)IWBOXOZ_HUWJ;>'-0U'P5X,T[P;X
M3U#7-,\0?HQ10!QOC^+Q[+X.UR/X8W/A*S\>-:Q#PY<^.K/7=0\)17JW=NTC
M:U9>&M1TG6Y[4V8NE1-/U"VE^T-`SNT"RQO^:W[.W[&'[2_P2_9O^#7P;U/Q
M_P#LM>,?$O[/WB?6-2\!ZMKOP%\7:_X:UC2/$=KXLBU*:[M=>^(L_BGP)XUT
M^X\9:DNF>*/!'B`07>@B_P##6L:3=6>NSW.G_JW10!X;^S?\%8?V>_@YX4^%
M$.N0^(VT"Y\5ZI>:K9:!9^$M'?5?&OC7Q)X\UFS\,>$M/NK^R\(^#=*U;Q/>
MZ3X*\(V^H:C%X7\)6.C:"-2U`Z>;V?W*BB@`KXZ_:7^#GQ7U/Q3X2_:-_9SU
M'P9'\?\`X1?#?XN^`O#GA+XCZ3=WO@/XF^$/BA-X"\2:OX(UO5](UG0-;\(:
MG_PF?PH\!:QX>\76E]=6-@;76-'UK2+C3M??4]&^Q:*`/QHD_8I_:<U/X=_!
M+P#X9\9?"]O@CX<L=3^*'Q$^!_[0W@#Q);>(/B/^TCX[^+'BGXS>./&'Q<F^
M!OQ:U#P7K?@*W\;>)+G6_#?P,TO4]7\"V>M3O=^,-;^(MKI/ARTTG]CXEN!;
M1B4P_:A"OF&-9!;FX\L>8RJ[F7RC*690[M)LQN8OEJL44`?E%X/_`&'_`(^^
M*M=_;(T_]H7XI?#5OAU^V-XJ\%>/?%,7[/NE?$KX=_$7POK_`,/OAQ\#_A7H
MN@:9XH\8>*O&FA:IX-U_PW\&5F\9Z=JGAF5M>C\4ZSX8O8;OPY-/#/[U^Q9^
MQ[K'[)5Q^TA+J_QM^('QF'QV^/VN_&:RN/'US876H>&K;5O"OA/P[_9UQ<V&
MEZ7%J>O7<GAUY]<UJ&VLK&_MHM#M;32-.?3+J?4ON.B@`HHHH`^8_P!H+]G>
M+XX>._V3/&;ZIHVFM^S/^T>?CP\&I^'DUNZ\00'X$_&WX0KH&DWC7-N?#U\N
MI?%;2O$PU@I>QJOA@68LQ=7-I?V'S+^TY^P+XD^/"_MR3Z)\3="\,WO[6?P`
M_9F^#_AU=6\):GK%GX'UC]GKQI\9_&+:]K:V/B'2Y_$6E^*)/BE8V`TO39-$
MO=*CT6[F_M&\?4+=+/\`3:B@#X^^#/P!^(VG?&7Q)^T=\>O&'@7Q1\5-5^&>
MB_![PSHWPO\`">O^%/`O@?P'IWBS5O'&N""7Q9XI\5^)_$WB;QMXHOM,O==U
M6^NM)TK3]+\+>&=&T30+>>WUS6O$'-_M]_L]?&K]J+X+1_!OX2>,OA9X'LM:
M\5^!?$OB_6?B5X6\:^+)=GPU^)G@'XI>&[/P_8^$/%GA1(CJ.K^"GTK6IM3N
M+@Q:=J"SZ:L5S;ND_P!RT4`?G/\`%O\`9'^,7QTL=6T?QQXS_9]TG3_BOX0^
M'OAWXR:WX>^`EU<_$S1;CP#K$VO"7X0_$G5?&BZC;0W%[<SW/@:Z^(.E^)=4
M^$'B.6Z\7^&+C5KNX@TFP_1=1M&,YY8_]],6/X`G`]NN:6B@`KYA_;1_9X/[
M67[*?Q\_9N76M+\-R?&CX8^)O`%OX@UK03XGTS0[O7+416FL7>@B[L'U-=-N
M4BO([>.^LYO.BCD@N8)HTD7Z>HH`^6OBA^SK<^/_`-HC]D_XW6/B6PT33?V;
M+_XTW=UX6.BRW$WB>'XJ?"\?#RRM]/U&"_M;;0UT"0+J,OG6&H)>VZBR@2S8
M"<?)/[+G[!/Q@^%_A/\`92^&7QH^+'PQ\8_#']C#5KOQ-\+-'^'?PW\4>&_$
M/CCQG#X/\<^!/"OBGXCZ]XM\=>*+6QM?"6@_$7Q9?Q>&/"&CV<6L>*[K1=8N
M=<L],\/?V!JWZMT4`>>_%&T^)%WX&UJT^$EUX&LO'<R646C3_$>P\2:IX.2%
MKZW75%U:P\):MH>O3^9I)O8[+[#J=MLOFMI+@R6R2Q/^6/AO_@F-\0M?_8W^
M#7[-OQ8_:`U+P_XT_9S^!GBC]G_X5^//V>&U_P`"^%]8\+Z]\'_#7PK/B7XD
M^!/'UQ\0QJ_BF>WT?5$N9M!U;19-.\.^)?$?AWP_J6G6OB'63=?LA10!X;^S
M/\'[S]G_`/9]^#/P2U#QCK'Q`O?A5\-O!W@.Y\9:[Y0U+Q!-X8T*RTE[^2.&
M&%;>U9K4Q:99LLDUCI<5E97%U>W%O+>W'N5%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
=110`4444`%%%%`!1110`4444`%%%%`!1110!_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>biib-2015630_avxchart.jpg
<TEXT>
begin 644 biib-2015630_avxchart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`$V`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^2OVW/VF9_V1_@!J7QG
MM=%\'ZY<0?$?X&?#F%/B'X\?X8^`M'?XU_&SP#\'1XL\:>.X_#GBR3PYX6\&
M_P#"<_\`"4Z[>IH-\S:=I%Q;C[/YWVJ'ZUKPK]H?X$Z)^T3X#T3P%X@UB_T3
M3]%^+_P%^+JW6G6ME>37>H_`;XU^`_C5I.BW$%^KVYTWQ!JG@.TT359`IN(-
M-O[J:T_TJ.&@#P'P1^W=\+H-%\)1_%WQ[\(#XE\6/I>HQZY^SGXE^(/[07P0
MT+PCXO\`'NH?#3X>>*/&/QKTSX7^'O"_@33/&'CC2-9\(V.I^-QX?T&7Q+HN
MMZ=8:S?PZ)K%W8=WJ'[:7P;E^`/QS_:+\%GQG\0/`OP%\/\`Q0U7Q+_PCW@#
MQQ#>:YJ_PB/BNR\:^$_""ZIX=M!XFUW1/$7@W6O"^MKHBZA:>'=:M9K?7+BR
M^S77D\C\;/V'/#'QC\?^+/$X\?>)O!WA+XP>$/A;\/\`]H/X=:)HWA6[TCXL
M^#/@SXO\1^,?`VDQZUJ>F3>(/`L\C>,/$_A/Q5J'AJ[:37?!FKM8V,.@^(]/
MTKQ79=[\,_V3_!?@']FKQ9^S#J&MZ[XH\%^-Y_VA1XCU2<6>CZW<6'[1GQ%^
M)GQ`\6V5H^GQO;61TR7XGZOI&CW*1O(EK965U.CW)F#`'S3\'O\`@J-\)/B3
MX[/AKQ-X4\8_#+P[JWPS_8K\=^%/$WB/POX^N'&J_MH_\)[IW@SPM\2K2V\"
M1Z;\(3;>+_"6C>!]!\0^.-;T[1/'/B7Q;I=IHMQ$DMC)J'U[\)OVH_@E\;]?
MU#PW\./%=YK&HVNE7?B+2Y-0\)^,O#.E>-/"EAK:^&[_`,9_#;7/%'A_1M&^
M)G@JQ\026^D7?B[P'?>(/#\%W?Z07U`6NN:'<ZE\8Z#_`,$O_#=IX#\=>"_$
M_P`8_%GBB?QUX;_86\'7^MMX4\,Z+)'X=_8(^*4_Q"^&D+Z;832V<^H>+M.%
MCX8\=7L;6=O.+>YUG0=/T:6\33K3U7]D7_@GU\)_V//$>JZS\/(O"RVL7A*3
MX=^$%TOX._"'P7XKT[P+)KUIX@73?&_Q*\)^$[#Q]\4=8MYM-T;2H]<\2:U;
M17FEZ)IMYKFD:SXN%[XLO0#YZ^/_`/P4/_:!_9X\9_MC6GBCX`?!?6/A]^R+
M\`_!?[1NI:_I/Q]\<V_BCQAX'^*GB?XS^%_A]I47AZ_^`46BZ#XCM;CX,ZI?
M>.?-\4ZEI6CVFKV8T&]\136UPM?7Z?MW_LS'Q%I_@Z?QIXAL/&>I^/?%_P`-
M;?P9J_PP^*>B>+H/%?@7PSX/\>>)+?5/#6M>#-/UC1-*LOAOX]\*?%!?$FL6
M=CX:N/AEJC>/X-7?PKIVJZG8\C^T!^PAX/\`V@+K]JVZUKQSXET%OVK?V>/@
M]^SQXC32]/TBX7PMHGP?\7?&3Q=IGB#1#>J3=ZKJ]S\8]4M+^VU'=900:/I[
MVP$DUUG#\1_\$[?AIXO_`&C_`!E^T)XE\5^)=5/COQ)\1=<\1>`FMM/M="N[
M'XF?LI_"?]D[7]"75;5HM;AM/^$0^%5IKT%U#-'>KK.N:A")$M+>T(`/2]._
M;M_9HU3PS?\`BJS\9>(VL8#X"?0]-G^%OQ5LO%7Q!LOBM?:KIOPNUGX3>#+W
MP7;^+/BSX>^(U[H6MQ>"_$7P[T?Q'HNO1:+J][:WWV#3;VZA]ATSX[?#+6?A
M//\`&O2];U*_^']K;ZQ+=W=GX3\87?B.UO?#VMWGAC7_``]<>`K;0)?'L7C'
M0_$^G:AX8U;P4WAG_A++#Q+8W>@W&C)JD$EJOYO:-_P1R_9^TGX8-\.VB\!7
MDWAW7/A'J_P[UD_LW?L]Z=!9+\$;3Q;IG@Y/BKH&C^"+"P^.MQK.C>-_$&D^
M.YO'%Q!9:LDUOK?A+2O`?BZ&3Q)<?6L_[&?A$?LBZC^R7H/BG4?`>A:I8WIN
M/%'PS\)_#_X;[-6U/QQ_PL+5U@\!^"O#6B?#^/PCX@UIKC0_%/@DZ&VG^+O`
M^HZSX:\47^KW&N:OK=Z`4;O_`(*%?LN6`LK2[\5^-8O$]]KOQ"\+K\/4^#'Q
MEN?BA:>)OA9X+\*_$CQUX>U+X9V?@.X\<:=K.B_#SQMX8\=K8W6AQR:IX0U6
M'Q#I!OM-2>>+A_B;_P`%(O@GX:U#X3:5\,)9_C#<?$[X[?LO?!Q]9T'3?&ME
MX!T2W_:>?P_K'AS5Q\3X_!6I_#V_\4:?\.O%&@?$B'X<2>(]/\3ZEX8UW0KV
M>/2[76+.Y?A?@_\`\$M/AI\(?BM;?%W1_&EQ;ZU)XM^)OCK5O#7A+X<_#OX;
M^`9/$?Q5_9T^$_[.OB$:!X/\$Z7IFE^&M'MM$^$ND>(["Q@%_J%QKFIZG+KN
MM:U/*U_+D?#?_@E1X2^%WA3X._#?PU\;OB`GPO\`A3\1OV7/C;=>#)?#G@DC
MQA\:OV8_"7PS\"V7C+4M?&G?VWIFC^/]`^%?AJ^\5>#]/N6LK/Q6ESKFA:C8
MZ?<7/AZX`/7/VA?VW[SX+?'72/@AI_A#X:R:IJ'PY\-?$32KKXO?'71O@3-\
M69_$?B[Q+X2D^&?[/,WBCPGJGA+XD_%7PTWAZWU3Q1X;\0>,?`=KI4/C#X>P
M27YM?%-SK.@=UX?_`&V_A!/XR\?>!?%/B70]-\1>&OC-XT^#WAO2O#MMX_\`
M$-_XDU[P9:_!LWWAQX[WP!H%NWQ&^U?&GPO<GP9X5NO%]K<^&Y+GQ-HWB'5]
M/T#QO_PB47[3_P"R/J?[2NF>,/!U[\:_%_ACX6_%/P"?AI\4_AC<>$O`'Q`\
M,:MH$D6NVEUK_@F/QWH>J/\`#SX@7VF^(+G3;OQ':+KNCRQ:?H6I#PHGB#2(
M-9?RB?\`X)N>#QK^N>)-+^*OC[2-3C_:)UC]JCX<301V%X?AW\:KWPE\*OAU
MI?B97U&:[F\90Z3\,_AUXA^'<]AXIEN$\0>%_B_\4$UZ2\U75-&U31`#USX_
M?M;-\"/VB?V3_@Q?^`_[9\)?M(7WQ'T?Q%\2!XB?3S\+M5\/7WPT\+_#I;GP
MTNA7_P#PD>G?$?XC_%#PS\/WOAK>B'P[K&LZ#,8-7BU22.S\<^&7_!2OP#XO
M^(7[3'A3Q;X,U[POH'P<^.7@WX+_``CU7PI8^,?BUXP_:(E\5_"S4?B.VN>#
M_AGX"\#:CXH@-JGA/XAW%MIVE)XHCN/`G@^;XA7VIZ7I5U-:V/OG[2O[)/A?
M]I<S/X@\6^*/"=VGP/\`C)\'M%U;PI]@@UOPKJ?Q1\6?!3QYX?\`BAX:U*\A
MN#IWCOX4^-_@5X-\6>!;AH)["/6[=+G4K>YCMHH9/`;3_@FSX9\)^,9?B3\+
MOBWXP\!_$'1/%'P@\4?#G7&\.>$?%%AX.?X6_LTW_P"RO?Z->Z'K=H;?Q1HW
MCKX<:MJ-YKJW%UI.IV/BD:=K&CZG;K936UZ`>R:7_P`%`?V4-<UO1=#T'XEW
M>O3:Y%\%)X-4T3P#\2=5\-:;!^T9<:EIWP0D\2>*;'PA/H'A/_A9?B+2;[P7
MX8B\3ZAI%Q=^/HE\"2Q0>*Y%TD?('PJ_X+*_!3XB7_AC5]>^'7Q0^&7PPUKX
M(?';XS:YXO\`&/@7XD2>(O!>G_`?]I+3?V??%%QXI\#:+\/;^_TOP%:0WS^.
MO$GQ0N[V#PGX'TZVNM&\2W%KJ>G:R=-]-\-_\$NOA?X/\-^-O"WA[XA>-X;#
MQIJ'[$6L7EU?V?AZ]U(:Y^Q=\<Y?V@K+7+J:&TL+.\U+XM^/KW6+WQTL&GZ;
MIFF#6+J/PGIFE6D-E96W,Z?_`,$H_`]AI7QP\,+\7?&;^$OBI^S;^UM^R[X8
MTH^'O#BWOP\^'W[77Q/U+XO^+KB/5][OXLUKPGXRU[78_"MUJMG8QR>'I]/T
MS7(]2O\`3Y]9U$`^X?`W[47P:^)'Q%U_X8>"]<\0:WK_`(;U;Q=X>O\`5X?A
M]\0X?A]<>)?A_?0:9XZ\+Z/\4KKPM!\-]<\3>$-0N(['7]`TGQ3=ZI97<5_;
MK;32Z3K"Z?!J?[5OP-TCXG7OPCOO%>I)XNTS5T\,:C<0>"_'%WX-L?&\_@W_
M`(6'9_#B[^(MIX<F\`6_Q,U#P,T7BK3OAY+XE7QA?:/=:?<6^CO)J>F0WGC'
M@/\`89TKP3^T78_']/B9K,UWI1\1RQZ3H7@3X<^`M:\8)XF\(V_@[_A&_C'X
M[\#:#H>N?&CP-X-LK:UU+X<:#X[M;[6O#&NZ;HNK:CXM\27>C64@Y^X_X)P_
M!T?M*>+OVB]-@\+6FJ^./&=S\4]=M]0^#OPD\2^,[?XG7'PVLOA<^L^&_C+X
MA\+W_P`3?"GAN;1M+TO7I_"NAZQ;3P>+;)[[1?$>B:%JFM>&]1`.W\.?\%$?
MV2_%O@RX\=^'OB+K&I:(WAGX/^,?#ENGPR^*D'B+XB>&_C]>3:3\&]6^%'A.
MX\%Q>)OBO:^/]>M+_P`.:*WPZTGQ*5\0:9JNDWPL[C3KKR_./A;_`,%-/@?X
MPL?'MWXYCUGX>OX.^-?Q^^&PMX_#/Q%\5S:;X#^!'Q%'PUU+XR?%.+3?`-O<
M_!#P;?:^9+'4KWXG6^@:1X>U.RUG3I]<O/\`A'O$%SI?*6?_``2Y\$Z/IWP2
MD\/_`!9\9Z7XO_9V_9H_9<^`/PG\7-H/AB_FT/6?V4?$FL>(/!7Q*U#1KN)M
M,UB^\2VGB'7_``KXS\*SK#I%WX9US4H]&O=%UL:9KFF</-_P1V^#=]XKU;QU
MKWBRT\;^,_&OBWXE:_\`$;Q+\3?@C\"_B?>:WIWQ.^)FH?%K5+/PEI_COP9K
MWA_X<ZUHGBS7O%%IH'B+0=&NHCX7\13Z-XAT'Q!>:/X:UK1@#Z=UW]O#X:K^
MT3\"_P!GOP-I^J^-=2^*WQP^+GP.\2>+/[&\::!X1\(>(O@Y\$OBI\5?%\/A
M[Q9J?@T>"/B9K.@>(/AL/AWXM\/^%?%CW7A'7-2OUU>9-1\.ZAH[:GQW_;8^
M'_[./QGTKP!\5;7_`(1_X>M^S5\6_P!HGQ-\3UDU?57\.6GPQ^+?P"^%$'AX
M>#M"\/ZIJNK#7[[XZ6M^=4L[H2Z9_8@MFTN[BU"6]T[E/"O[!>C^$OB]\+_'
MFF_%CQB?A_\`!3XZ_&_]H+X6_!]]"\(1Z%X<\:?M%^$?C#H'Q2LKKQ-:Z;;^
M)M9\/2ZW\:O&/BCPAI]W-'-X8GU"YT>XN]=TP:0-"E^.'[!7A?\`:1\4?&+Q
M!\8_B)XHUNV^('P.\6_L^>`M)T'1O#7AR/X3^`_'/B?P)X_\2WNGWRVFIWGC
M#Q9<^/\`X9>!-?L]3\3$Z-96?ARUT;_A'+B*]UB\U$`[#Q?^WW^RWX)\5^(_
M`FL^.]=NO&GA;Q;\1/`VJ^%/#7PQ^*/C+Q`WB?X3_#KX8?%KXAZ=I>D^$O!V
MM7VN+X6^'/QB\`^+-0O-'@OK%M+U._-M<SW&@:]!IW5^&_VR/V=?%_C3P_X'
M\,>/SKM[XHE\-V.@^)=-\+^,;GX;:CX@\8^`;#XJ>$_!T7Q53P__`,*W7QWX
MC^&VJ:9XXT;P1+XHC\4W_AO4M-OXM*/]HV$=S\X>"_\`@F]X?\/?%FX^-GB+
MXP>,_&'C[6_%'[0?C7Q7>77A_P`,:/INM>)?VBO@7^SW\#?%,MIINEQB/1=*
MT+2?V>]"U7PWI=O+<O#-K-]9:G?:B+6&^GY+]G;_`(),?`_]G+QM\,O%OAF\
MT+7G^'NG?#34)]0\4?!?X-:Q\0]:^(?PV^"WA+X'VWBNR^+NI>%-0^('@_1-
M>T+P=I/BC5O!OAC5+1+/QD+NX\/^(=&\-:CJGA>_`/;OVN/VP/$G[+E]HU\_
MP\\"^(_"NHIX?M])LM;^-VA>#/BY\8/%>M>(&T>[^&/[-?PF/AGQ%J7Q6^)F
MC6$^DZPV@ZQK'@:QUJ;7M$T31=4GEFU;4]#R],_;@NKSXDZ;#=_#?3M-^`7B
M+]I[Q?\`L<>&_BM+X]67Q?>?'+P3+XHT#4I=1^&L7A8V&G?#S4_B7X*\3_"G
M1-;A\?WWBN;Q59Z9J5_X+L?#.L?VGIO;_M(?LGZO^T7!XK\)ZI\</&WAOX1_
M$SPE;>!_B7\,K7PSX"U^VN]"C^VQZC=_#OQ/X@T*ZU_X8^)_$=E>)I^N>(=/
MDUU[==-TC6?"ECX5\5V"^(I,NQ_8F\/V?Q5LO%<GQ$\67GPIT?XZ>(?VH="^
M!EQIOAL^&M+^/_BJUUM-9\6CQ4E@/%UUX:_X2#Q+XC^(^G^")[P6EE\3-;N_
M$,FKW>D6FC^&-,`/HWXL^+?B#X4\,6=S\+OAN/B=XQUGQ!HF@:;I%]XHLO!?
MA?1H-4GD.H>+/&OB>:PUW4]+\*^'K"">ZOAX:\*^+?$VHWLFG:3I'A^XEOY+
MNQ^(_#/[=GQ#^(UUX>^''PQ^!/A[Q#\>Y_$/[3^F>*/"^L_&./0/A;;:+^R7
MX]\'?#/XA^)?!GQ/A^'VL:YXPT[Q1X\^(?@[PCX&-U\-O#@@UZ3Q?8>-Y/#%
MWX#U>UO/:?B3\!/CW\3/V:O#_P`'W_:F\3>`_B>Y\/I\0/C7X.\!^$[?7/&&
MDV=W<W/B;PU:Z18/X=M/!]IXNLI+?0=1\0>"+OPWXJTO2X[N?PMJWA[6;R/5
M++SO1OV)/%GA_P`+?"8>&?CG!\.OB=\&M!^(GPX\%^./A1\$?AOX)\+V'P7^
M)ESX1O=:^&B_"B[D\2^%UBT;5?`GA'Q/X4\0I?"]TKQ9X>LM1U"SUK2+_P`2
M^'O$`!0\(_\`!0?2OB)\4_V*?!_@CX1^+;KX>?MD?#SQCX[T;XL^(-;\.Z/I
M?AJ]\-?"JV^*$7@JR\/:?<Z[K'BOQ':0->Z)XTO4_L+POX6U2UCL].USQ3J,
MMW8:7;^`G[:6N?&3X]^*_A?J5K\!O#/AW3O$?QJ\.^%;&T^+'CS5OC%XAF^#
M_P`0-7\"7C2>$]1^#/A_X:RZDJ:%=^(_%_AKPI\7/%GB+P!I.I:$=<TXB]FG
MM^7UK_@GWXHT[Q_^RAKWPC_:"G^&O@']C;PQ/X3^$'P\O/A)X9\;M)INO^`K
M7X;>.)?%OB[4/$FCZGKU_P")?#=O)<17D>GZ?)IGB"[NM7E&JI(MBOT'I?[-
M7B*7XM^$_B%X[^.7CGXA>&?A=XS\<?$#X2>`]8T#P1I:>$_$_C[PWXP\&7TV
MN>+=#T2RU_QMIWA;P=X]\6>%_`MAJ2Z?)I^F:J+OQ9>^-O$&G:5K=B`=;XI_
M:B^#G@GXE:3\*O%.L>)-$\1ZWXET#P3INKW_`,._B)!\/;CQSXLTZ'5O"O@9
M?BDWA8?#D^,O$ME/%_8OAM?$[:G?7L]II*0KK%_86%SX]X;_`."CW[(?B_PE
M'XT\-_$G6-5T?4?#'PO\8^$K>'X7_%=/$'Q*\/?&?57\/_#6_P#A)X7F\$Q^
M(OBP/$OB2*Y\-K#\/-,\23Z5KEG>V&MQZ:UI-(OF_P`5?^":W@7XM?'^/X[>
M)/'^L75[8_'3X'?M">'K/4_`_P`/O$7BCPCXO^"-[X'?3O!O@_XI:YHUUX]\
M+?!O7[7P0+S4OAEH&H:=8P>*O%7C/Q)#J<T/B/4-#EXW2_\`@E3X)\.:9^S?
M+X9^+_C72O&G[*?[.GP>^!?P?\92>'O"VHS:9J_P6\56WB+0/B'J^B7<9TO5
M[G7M-;7?!WBKPN_V?3+SPSXGU9M)O]%U^#1]<TP`^B/@G^UWJ?QV^"OQO^+'
M@;X0>(==U;X6_&O]H?X->%?A[IVL0:9XB^(.H_!#XBZQ\.].NIY/'6F^#H_`
MU[XJOM+6[U;2O$MNLO@I&O;>^EU.?3VCG\LNOVZ_'VC>+?$WP-UWX*^%I?VD
M+'XQ_"/X,>%-#\+_`!<N]:^"GB#7_C#\+?''QKLKG4_BIJ7PU\/^+?#EQX#^
M%OPS\<>+O'OAB3X4:EXEBTV#P9=^'[/5[+X@Z/<V7K7@#]D_Q)\)?@-\:OA5
M\,?CSXP\-_$'XP?$+XW?%>+XXW?A#P)KOB?P9\0OCGXMO_&FO^(M&\(7VF1^
M!+\Z#K>J7TWAO2]5TB;2;>(64%_97\=HRW/E7@3]@?Q%X5^&MCX,U/X[27?B
MOP1\6M#^.WPF^)?AOX5>'_#7BCP]\6K31?$OA[QAXV^(TFI^)O&,_P`;-;^*
MVA^+?$.A_$O5O&FI0:[K>DZ[JT>GZSH^H'1M3T,`SM?_`."B5_H?ACX/Z@GP
M(UK5O$/BO]L+PW^QO\:(=-\<:(W@OX'>.]1^.&A?!'5-0G\67.FVFL>.EU"^
M\2:)XO\`AYHNC^#-.U'Q)X/U"/4O%K?#V6UN[5?4_CQ^V?:?"'X__LX?`C0/
M`X\=7/QB^+?AKX9_$7Q(GB1=%LOA##X[^'GQ<\;>`;I[4:-JO_"6>)O%$WPA
MU\)X2CN]$?2O"T4_BS5-4MDN?#.F^)/(OB5_P3Q\6^*?A]\/?`?@G]I/6?!3
M^&_V@-,_:P\>>*=5^$W@KQGXA^*'[1&B?%O3?C1I/C'5@=4\,:1X>\.VWBG3
M;?2CX*T'3$M%\(6FE>'[35+0Z=]ONNF^(?\`P32^"OQ.^(GPF^,?B#Q#\2M-
M^*G@7X]_#[]H_P`<^(/"7Q.^+/ACP[\5?B7X!^%>I?"R'4]3^'>G_$G_`(0C
MPD=1TR?1WDN/"ND6VHP:3H%MX2>]O/#FIZ[::D`?HRIW*K8QN4''7&1G%+2`
M8`&<^I/<]SZ<GL.!VXI:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`**_'_P#;^^*WQ-\#_M]?\$:_`W@SX@>,?"O@
MWXL_M+_M$Z!\4/"WA[Q%JND>'_B'H6@?LI>._$>AZ-XTTFQNH++Q+I6D>(;:
MUUW3M/U>&[M+/6+6UU."%+VV@GC_`%^C)*(3R2BDGU)`H`=1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44C,JJS,P55!9F8@*J@9
M+,3@```DDG`')KC?^%C?#[_H>O!W_A4:'_\`)]`'9T5QG_"QOA]_T//@[_PJ
M-#_^3Z/^%C?#[_H>?!W_`(5&A_\`R?0!V=%<9_PL;X??]#SX._\`"HT/_P"3
MZ/\`A8WP^_Z'GP=_X5&A_P#R?0!V=%<O8^-_!FIW<%AIOBWPQJ%]<L4MK.RU
M_2;NZN'5'D9(;>WO))I6$:/(5C1B$1F(VJ2.HH`****`"BBB@`HHHH`****`
M"BBB@#\//^"EB/)_P4A_X(4K'*T+?\-7_M.'S%5'8*O['OC]G4+(K)F1`T>X
MJ2F[>HW**_:"/2]9\M/^*BF^XO\`S"],]!_TQK\8_P#@I/\`\I)/^"%/_9UO
M[4'_`*QS\0:_;R/_`%<?^XO_`*"*`,+^R]9_Z&.;_P`%>F?_`!FC^R]9_P"A
MCF_\%>F?_&:Z"B@#G_[+UG_H8YO_``5Z9_\`&:/[+UG_`*&.;_P5Z9_\9KH*
M*`.?_LO6?^ACF_\`!7IG_P`9H_LO6?\`H8YO_!7IG_QFN@HH`Y_^R]9_Z&.;
M_P`%>F?_`!FC^R]9_P"ACF_\%>F?_&:Z"B@#G_[+UG_H8YO_``5Z9_\`&:/[
M+UG_`*&.;_P5Z9_\9KH**`.?_LO6?^ACF_\`!7IG_P`9H_LO6?\`H8YO_!7I
MG_QFN@HH`Y_^R]9_Z&.;_P`%>F?_`!FC^R]9_P"ACF_\%>F?_&:Z"B@#G_[+
MUG_H8YO_``5Z9_\`&:/[+UG_`*&.;_P5Z9_\9KH**`.?_LO6?^ACF_\`!7IG
M_P`9H_LO6?\`H8YO_!7IG_QFN@HH`Y_^R]9_Z&.;_P`%>F?_`!FC^R]9_P"A
MCF_\%>F?_&:Z"B@#C]5TS5QIFHEO$,S#[!?97^S--&<VDPZB'/\`CT[U_,@D
M$&Q?W$'W5_Y8Q>@_V*_J.U?_`)!>I?\`7A>_^DLU?R[)]Q?]U?Y"@!GD0?\`
M/"#_`+\Q?_$4>1!_SP@_[\Q?_$5+10!%Y$'_`#P@_P"_,7_Q%'D0?\\(/^_,
M7_Q%2T4`?07[)]LK?M$_"M;?R[68Z[?[+B.W@=XB/#>NEBJNA0EEW)R#@,2.
M0*_H%T^UO+8/]KU)]0WB/R]]K:VWE;=V['V9$W[\KG?G;M^7&37X!_LD_P#)
MQOPI_P"P[J/_`*C.O5_08O0?0?RH`6BBB@`HHHH`****`"BBB@`HHHH`_$#_
M`(*3_P#*23_@A3_V=;^U!_ZQS\0:_;R/_5Q_[B_^@BOP_P#^"EBRM_P4A_X(
M4B&18G_X:O\`VG"':/S5VK^Q[X_:12F^/(DC#1Y#@INWKDJ`?V@CL?$'EI_Q
M/H?N+_S!H/0?]/M`'1T5S_V'Q!_T'H?_``30?_)M'V'Q!_T'H?\`P30?_)M`
M'045S_V'Q!_T'H?_``30?_)M'V'Q!_T'H?\`P30?_)M`'045S_V'Q!_T'H?_
M``30?_)M'V'Q!_T'H?\`P30?_)M`'045S_V'Q!_T'H?_``30?_)M'V'Q!_T'
MH?\`P30?_)M`'045S_V'Q!_T'H?_``30?_)M'V'Q!_T'H?\`P30?_)M`'045
MS_V'Q!_T'H?_``30?_)M'V'Q!_T'H?\`P30?_)M`'05Q_C_QQHGPV\':]XX\
M1_;?[$\.60O]1_LZU-[>^09X;?\`T>U$D1F?S)T^7S%^7<V>,'0^P^(/^@]#
M_P"":#_Y-KYX_:PM=8C_`&=OBN]UJ\5S`/#2;X5TR*W9Q_:VF<"5+J0H>V=C
M#GIG%`'"G_@H'\`@2,>.^/\`J47_`/EA1_P\$^`7IX[_`/"1?_Y85^)+=3]3
M_.DH`_;?_AX)\`O3QW_X2+__`"PH_P"'@GP"]/'?_A(O_P#+"OQ(HH`_;?\`
MX>"?`+T\=_\`A(O_`/+"O7O@]^TO\-OCAK&L:)X)'B+[;H>FV^JWW]M:*VEP
M_9;F[-G'Y,K74_FR^<#NC"KA/FW'I7\]5?H5_P`$[8KR;X@_$9;*\2SD'@K2
M2TCVJW6X?\)`<`(TL(4C!YW'.[ID"@#]?=7_`.07J7_7A>_^DLU?R[)]Q?\`
M=!_`#D_A7]->JV6OC3-1+:["P^P7V1_8\(S_`*)-CD7IQS@]/KQ7\X'@&-)?
M%WAM)-%@\1I]O5CH-Q=:;9QZN4M;ATLDFUG_`(E#74CJKV%KJ:R6.HZA':Z;
M=0SQ7C0R`')NZ1C,CI&,XS(RH,XSC+D<XYQUQVHWQX5O,3#D!#O7#D]`ASAR
M>P7)/:OOWQ_::EHOCGQAJMEH/B/Q'K6K>$]':#3/!_ACP9X:^(NC06/B>PAG
ME\2Z8-.\31W=MK$<0M=-\2:3X7N=1ETM8[+4K33-/BM[^6IX=\*:;87MS8Z7
M<ZSXCUK6/BUJ6A>.M;A\)^!O$AT#1;SPQX;U'21\28-2M;G2;+PMI$^J^)X?
M%-MH$F@V6JZMH6L31Z_I\NBZ=9``^#\C.,C.,XR,XSC..N,\9QC/&<TQI8D(
M#RQH3T#R(A/;@,P)YXX[U]!ZKX?U6X^`]I=6W@9;2VT7XF,O_"3:3X;UC=X@
MT1O!=Z\_B>^UV[AGDNM$NKU;=;"2.>W\/Z?&L%O:PQW<MS+<=;\,M$\0V>C+
MX-NO#?Q#T*_N/B)J^B^*O$.B6GA);7PC'+H>@6IE\:6^OZ/J^HV5KX=C%[JT
M]I?S^%--N=.GU*>SUR:_@DCM@#G?V2?^3C?A3_V'=1_]1G7J_H,7H/H/Y5_/
MC^RK"Z_M&_#""UNHMT?B'5(H;R.(S02)%X>UY5N(HI&C9H;B--\0=E=4D0M\
MP(K]_M/@U"$/]NOTOMPC\K99):>7C=OSLGF\S?E<9V[=O&=W`!HT444`%%%%
M`!1110`445'*[QQ2/'$TSHCLD2LB-*RJ66-6D9(U9V`0,[JBE@695!(`)**^
M%O%O[0OQ"\(>-O#/A[Q%\0OV//"&N>+_`!M8?#KPQ\(/$_Q/\3IX[UWQQJ>B
MZ?XFTWP7%XJM[.*WM/%VH>'-4TO58-'B^&6K!X-:T.2SN-0M=8TJXO\`[:TN
MXO;O3=/NM1L?[+U"XLK6:^TT745\+"\EA1[FS%[`J0WBVTQ>%;J*.-+@()5C
MC#[%`/Q/_P""D_\`RDD_X(4_]G6_M0?^L<_$&OV\C_U<?^XO_H(K\0_^"D__
M`"DD_P""%/\`V=;^U!_ZQS\0:_;R/_5Q_P"XO_H(H`?1110`4444`%%%%`!1
M110`4444`%%%%`!7SA^UU_R;?\6?^Q:3_P!.VF5]'U\X?M=?\FW_`!9_[%I/
M_3MIE`'\_<<4L\R001R33S2".&&%'EFFD;.V.**,-)+(V#MCC5G;!PIQ4*LK
M!65@RL`RLI#*RD;@RD9#*5^8$$C;SG'-?1?[,=S/;?$ZV%K:VUS<7,$%LC1:
M[I.@^([2-M3M)KBZ\*S:U;7-I?7HB@^SZQI<)M]0NM!N;UK*YC,<Y/I7@^/P
M5I?B_P`9QI\2?"]_XB\2Z3\1+#7=2U'1+FU:TT`_"W4IUL;.;PGHFI>#9-5O
M?$<[R>+K_0=1\B];PPEIH$=]+K<\5R`?%60>A'4KU'WE`9E_WE4AF7J%(8@`
M@TO_`.KVSW&?4=QVR,]17U5%I_C*P^%3+XON9)/"WB7POX<T3P]INF:=!>^%
M?`7AZ'7-+N6^*^O6UF6EMO%$UO!=7&G:990/XOUIM9O[WQ,VFVTMKIMW'\1]
M.TGQ1X*^&&B>`=:T#6X=-\5_$[1O"^@Z<FJ:=J/_``C]K8>$M06\U.Z\1Z3H
M%L=3G-CJ.MZ[=7MQ"+W5M8EM]#^W6]JT5H`?+>Q]N_8^S^_L;9UQ][&WKQUZ
M\=:_13_@G!_R4;XC_P#8DZ3_`.I`U>#ZA/=ZO\*((K\:[H7AG2?A?H3Z/K-M
M\38-0\*^(O$VG7MN+?PRW@*WV6Z:EJ\UQ=S:A9O&?$6@ZG9/JNIS?V;$$;WC
M_@G!_P`E&^)'_8DZ3_ZD#4`?KCJ__(+U+_KPO?\`TEFK^74*K1A6565D"LK`
M,K*5P592"&4@D$$$$'!&*_J*U?\`Y!>I?]>%[_Z2S5_+LGW%_P!U?Y"@"W->
MWES>2:A<7=U-?S/YDU])<3->ROY20;Y+O?\`:';R(TA+-(2842(DQJ%%=69`
MZHS(LB&*149D62(L&,4BH0LD18!O*<-'N`;;D`TE%`%C[7=^5Y'VN\\G9Y?D
M_:[GR?+SGRO)\WRO*S_RSV>7_LU%YDN93YLN;A0MQF60_:%#;@EQEOWZAOF"
MS;U#?,!NYIE%`'T7^R3_`,G&_"G_`+#NH_\`J,Z]7]!B]!]!_*OY\_V2?^3C
M?A3_`-AW4?\`U&=>K^@Q>@^@_E0`M%%%`!1110`4444`%(P!!!S@@@XZXQVQ
MSGTI:1NAP`3@\'H>.AZ\'Z4`?AEXS^#NM^//VOOC*W@OX?\`Q(U_P,OQI^'%
MAXXG\2?%OX-?#G3/#VL76O\`[,7Q?^*>I^`_"^I>%-5^*GBGPK\1$^"7P5L;
MO6/$6NVU_'9^"/$V@_!^#0K#5K/Q#%^YH&!^)/YDG]<YQVZ5^%?Q?^"E[J?[
M:'B'Q_-^SHFO?%P_M`?!*X^&26W[%/P;\7_!/QO\&[2/X<GQ7\5?BI^U;JWP
M6UCQQX8^)_@N!/B'?:;=W'QO\$^)O!^K^#O!.E>"_AIXWL+N*?QE^ZB]/S]L
M\GDC`P3U/`Y)H`_#W_@I8LC?\%(?^"%(BD$3_P##5_[3AWE!(-J_L>^/VD4H
M67_61AH]P8%-V]<LH!_:&.QU[RX_^)\GW%_YA%M_='_3U7XQ?\%)_P#E))_P
M0I_[.M_:@_\`6.?B#7[>1_ZN/_<7_P!!%`&']AU[_H/)_P""BV_^2J/L.O?]
M!Y/_``46W_R56_10!@?8=>_Z#R?^"BV_^2J/L.O?]!Y/_!1;?_)5;]%`&!]A
MU[_H/)_X*+;_`.2J/L.O?]!Y/_!1;?\`R56_10!@?8=>_P"@\G_@HMO_`)*H
M^PZ]_P!!Y/\`P46W_P`E5OT4`8'V'7O^@\G_`(*+;_Y*H^PZ]_T'D_\`!1;?
M_)5;]%`&!]AU[_H/)_X*+;_Y*H^PZ]_T'D_\%%M_\E5OT4`8'V'7O^@\G_@H
MMO\`Y*KYX_:PM-6C_9U^*[W.KI<PCPTF^$:;!`7']K:9P)4G=E/49VGKZXKZ
MFKY9_;7U[1?#'[+/QGU[Q#J=IHVBZ9X42XU#4[YVCM+.`ZUI,7FSR*CLJ>9(
MB9",=S#CO6E*E5Q%6E0H4JE>O6J0I4:-&$JM6M5J24*=*E3@I3J5*DY*$(0B
MY3DU&*;:1G5JTJ%*I6KU*=&C1ISJUJU6<:=*E2IQ<ZE2I4FXPITX03E.<VHQ
MBG*3239^"`=XY!)&[QR1OO22-F1T<$X='0JZ.,G#*0P[$5'M7`7:NT8`7`V@
M+C:`,8&W`VX'RX&,8%>+M^T=\!]S?\78\&]3_P`O]QZ_]>=)_P`-'?`?_HK'
M@W_P/N?_`)#KZ#_4WC#_`*)/B?\`\,&;?_,GG^?9GA?ZW<)_]%1PY_X?,K_^
M:CV?RH@V\11!\D[Q&@?)ZG<%W9.3DYR<G/6G%5.=RJVX`-N53N`.0&R#D*>0
M#D`\C!KQ;_AH[X#_`/16/!O_`('W/_R'1_PT=\!_^BL>#?\`P/N?_D.C_4WC
M#_HD^)__``P9M_\`,GG^?9A_K=PG_P!%1PY_X?,K_P#FH]HV(',@1!(1@R;%
M\PCC@OC<1@`8)Z`#I7Z&_P#!.R*[F^(/Q&6SNULY!X*TDM(ULEUN'_"0'`"/
M)&HQ@\Y/7IP*_(K_`(:.^`__`$5CP;_X'W/_`,AU^H?_``2R^*7PY\>_%#XI
M6'@OQGH7B:]L/`.BW=[:Z3<2SRVMK+XE>".>99((@L;S`QJ022P/`'-<^*X8
MXFP.'JXO&\.9_@\+1BI5L3B\FS+#8>C%RC!2JUZV&A2IQ<Y1BG.44Y24=W8W
MPW$G#F-KT\+@^(,CQ>)K-QHX;"YME^(Q%62BY.-*C1Q$ZE1J,92:A%M1BY/1
M-G[&:W;ZS;Z-JT\VO)Y4.EZC+)C2+?(2.RG=B-MR22`"0`"21CO7\?"?MC_L
M_;$_XJ[5.44_\B?XFZ%01_S#_2O[&O%G_(K^(_\`L`ZS_P"FVZK_`#1(_P#5
M1?\`7*+_`-%K7['X'^%O#OB1#B66?8K-\.\GGE,<+_9>)PF'4UCEF+K>W^M8
M#&N;7U2E[/D=/E3J<RFW%Q_(_&?Q-S_P]J\.PR3#93B%FT,VEB?[3P^*KN+P
M+RQ4?8_5L;@^52^N5?:<ZJ<UH<O)9\W[1_\`#8_[/W_0W:I_X1_B;_Y7T?\`
M#8_[/W_0W:I_X1_B;_Y7U^+]%?O7_$KWA[_T,^+O_#CE/_SB_J[\K?B'_$RG
M'O\`T+N%?_#?FG_SZ_J[\K?M!_PV/^S]_P!#=JG_`(1_B;_Y7T?\-C_L_?\`
M0W:I_P"$?XF_^5]?B_11_P`2O>'O_0SXN_\`#CE/_P`XOZN_*Q_Q,IQ[_P!"
M[A7_`,-^:?\`SZ_J[\K?TC_L2?M-?![QU^U5\%_"7A7Q5?S>(=;\2:G;:9%/
MX5UVWB>:'PCXDO95>:\M(+:,?9;6<[I947(`!+E%/]0&GP7\*O\`;;];[<(_
M*Q9Q6GEX#;\^7+)OWY7KMV[>,[CC^#S_`()5_P#*0C]E[_L=O$'_`*K;QS7]
MZ2?<7_=7^0K^:/&G@#)?#OB/+,HR.OF6(PV,R2EF-6>9U\-7KJO/'X_#.,)8
M;"8.$:7L\+3:BZ<I<[F^=Q<8Q_HKP>X[SCC_`"#,<TSJAEU#$83.:N7THY;1
MQ%"BZ%/`Y?B5*<<1BL7-U74Q51.49QCRJ"4$TW)U%%%?CI^MA1110`4444`%
M8WB.W^U^']<M3:I>BYT?5+<V<EI::A'=B:PN(OLTEC?W5C97B7&_R7M+N]M+
M6Y5S!<75O#(\R;-5KVTM;^TNK*^MK:]LKRVGM;NSO(([FTNK6XB>&XMKJWE5
MXI[>>%WBGAD1XY8G>-U96((!_.9X'^!'Q/U+XQ_#;Q?XS_9,T\ZQ9^-/AA+?
M^+]9_8"_8/T76M+T_P`+WGAK3-(O3XJT7_@H9XI\3^'T\+^'M'TVUT?6-`\.
M^)-6\.Z9I5A-X?T36IK"QTZZ_H[']3V`ZD^F?SZGJ<'BOY_]=^#W@3Q1^VQX
MSU&Q^!WB>^M?AG\=/A/X5\/:]\!_V!_V-/$'PS\-Z?X1\(?"F[TK2O&OQE^,
M/PVU#XT+XI\(PR6Z^)_$_P`.]=M-#\$>$E\*Z1\.9[#Q!X6U%;3^@`?U/7`[
MGT]>W<CD\YH`_$'_`(*3_P#*23_@A3_V=;^U!_ZQS\0:_;R/_5Q_[B_^@BOP
M_P#^"EHE;_@I!_P0J$$B12?\-7_M.D/)$9D`'['GC\N#&)82=Z!D!$BE"P?#
M;=I_:*.U\1>6G_$YT_[B_P#,#?T'_4:H`Z&BLWR=5^R&,W]K]M.<70TYA$#O
MR,VO]H'($?RD?:02WSY'W*9+!K!'[K4K2,^=NRVEM)^X\M!Y6/[2C_>>8)'$
MW3:X0PG9O<`U:*R)K?6FDG,&IV<4;,IMT?2GF:%01N61QJD7GEER`P2':2"5
M.-I9%;:ZLBF;5K&2(9WHFC/$S?*0N)/[7EVX;:3^[;(!7C.Y0#:HK%DMM=/E
M^5JUBF(D63=HSR;YAG?(O_$VC\M&&W$1\PH0?WK;@%C^R^(O^@SI_P#X(W_^
M75`&]17Y\?MW^+/B#X(\"^!KSP]XUU;0;F]\9W-I<W'AB;4/#ES<6X\/:A.D
M%U/9ZK*UQ;K+$)5@8!?."2$YC4'\PO\`A>GQL_Z*]\2O_"TU_P#^3J`/Z1**
M_F[_`.%Z?&S_`**]\2O_``M-?_\`DZC_`(7I\;/^BO?$K_PM-?\`_DZ@#^D2
MBOYN_P#A>GQL_P"BO?$K_P`+37__`).H_P"%Z?&S_HKWQ*_\+37_`/Y.H`_I
M$K\]/^"K?'_!/3]J;'_1.HO_`%*?#E:O["WBCQ_XU^&7BG4?$'C34]=N[;QY
M=6,-UXFDO_$5[#;)X>T&X%O!=WFJQ/%:B6XDD6V52BS/+*#F5P.5_P""J,&L
MQ_\`!/G]J5KO4K.Y@_X5U%NBBTI[9S_Q57AL_+-_:EP%)`*\Q,.<XR!7U7`O
M_);\'?\`95</?^K?!GS'&W_)&\6_]DUGO_JLQ1_"4Y.]N3]YNY]33<GU/YFE
M?[[?[S?S--K_`%=25EIT7Z?Y+[C_`"_N^[^_^NR^X7)]3^9HR?4_F:2BG9=E
M_7_#+[A7?=_U_P`,ON%R?4_F:_H'_P"#><D_M!?M"9)/_%FO"W?_`*GQZ_GW
MK]_?^#?*.\D^/O[0BV5S#;2_\*:\+9DGM6NUQ_PGI/$:W5I@X#`DR,/F!`!7
MG\M\:]/"WC#3_F!PG_JUR_\`KY'Z9X.?\G-X1U_YCL3_`.JS'?Y6/ZN_%G_(
MK^(_^P#K/_IMNJ_S1(_]5%_URB_]%K7^D_XIMO$`\,^(R^KZ>Z_V!K65&B2*
M<G2[L`AAK)P58AAP02,'@FO\V"/_`%47_7*/_P!`6OQ'Z)_\+CK_`*^<.?\`
MI.=_U\_4_8OI1?Q^"O\`KWQ%^>1#Z***_L`_E$****`/T$_X)5_\I"/V7O\`
ML=O$'_JMO'-?WI)]Q?\`=7^0K^"G_@EB)6_X*"_LOB"1(Y?^$WU[:\D1F08^
M'/C<MNC66%F#(&7B5"I8,"=NUO[Q]/BU&)6^WWMO=[EC\KR+%K+R\!M^[-[>
M>9NRN/\`5[-I^]N^7^$?I3?\EOD7_9*X?_U;YN?VS]&;_DCL[_[*?$_^JG)S
M1HHHK^93^CPHHHH`****`"D.,'/3!SSCCOSV^M+52_FFMK&\N+>**>>&UN9H
M89YI;>&:6*"22.*6>"UO9H(Y'54DFBL[J6)&9X[:=U6%P#\Q/'&C?L/ZU^U'
MK6J7/PZ_:%\<_&S3OB-X%L?&'C+X6^#OVT?%WPTT#XAZ=8^%;SPYIGC#Q5\-
M6N?@?I=SX;T:]\+WOB73-3G&E^&]'NXCXQMK."6]B/ZBCV]3Z^ISU]^G;'3C
M%?AW9:5\6]<^+=Q\>=0N?!G@#PMXE^(?A#Q5\0E\`_\`!7;XA0?"RQ_L$^'M
M'U6ZC^%I_98\.>$;UO[%T6"'7/#-UJ/AM_&$L`TSQ%J=G).+JR_;?3-1LM8T
MVPU;3;A;O3M4L[?4+"Z0.$N;*]B2YM;B,2(D@CF@DCD0,BG8PXH`_$[_`(*3
M_P#*23_@A3_V=;^U!_ZQS\0:_;N,XCCZ_<7L3V'H*_$3_@I/_P`I)/\`@A3_
M`-G6_M0?^L<_$&NB_P""@NH:A:_&?PY'::AJ%I&?AKHKF.TO[RUC+G7_`!."
MYCMYXD+D*H+E2Q"J"<*``#]G,CW_`"/^%&1[_D?\*_E[_MG6L9_MG6\9"Y_M
MC5,%BI;:#]KP6V@MMSNV@MC:"0Q=<U=\[-=U=]IVMLUO4GVM_=;;>'!]C@T`
M?U#Y'O\`D?\`"C(]_P`C_A7\O!UW5E7>VNZNJ=G;7-2"')P,.;P*<D$#!YP:
M4ZWK"@LVMZRJ@9+-K6IJH'J2;P`#W)H`_J&R/?\`(_X4M?R\1Z[JSX:/7=7=
M=P&Y-;U)QGCC*WA&>1QG/(]:_H._9?EEG_9]^$<T\LL\LG@G26DEGEDFED8K
M)EI)96>21CW9V8GUH`^7O^"D'_)._AW_`-CY<_\`J,:M7YL>"_A;)XK\(^*?
M&-[XETSPUI/A]7M[>YU*PUN]L[G4XKGP_'+!JM]I.G7L'AZQ,'B"U,%_?%I+
MFX\QH;1].L-6OK+])_\`@I!_R3OX=_\`8^7/_J,:M7YV_"?XLV7PQM?$$B>'
M;F_UN^M(TTZ^M?$6J:78WI35]!U!='\7Z1"9;+6O#RKI5SNB@CM+ZZMM1U30
MKJ:33M7DN+``YT?#VUF\/:GJ]CXRT34]2\/:#H?BCQ-H5C8ZI*-(T37-2TO2
MU,&O^7_8VK:UI-UK.FQZSHEL\+V\TT]I:7M_=V%[##LP?">UU4>&&\.^,8]2
M7Q(/$VH9U+PGK.AR:;X6\(6LL^N>+)K9+S6+N^TQ+FWNM*TZTLH&U'5]6M+B
MRTZ"9HR]5-8\<^%+GP/!X0T#PSK_`(;D*6-[K$UOXATBXT[Q/XEMF+MK/B&'
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MI*:UX@UTR7%M8^&=&DCU$WFOR1+-'<_9%M+:-/LAF=I5`/U*_P""<W_)(_&/
M_92+W_U%_#-1?\%6_P#E'G^U-_V3J+_U*?#E2_\`!.;_`))'XQ_[*1>_^HOX
M9J+_`(*M_P#*//\`:F_[)U%_ZE/AROJN!?\`DM^#?^RJX>_]6^#/F.-O^2-X
MM_[)K/?_`%68H_@T?[[?[S?S--IS_?;_`'F_F:;7^KL=EZ+\C_+X****8!7]
M`_\`P;S_`/)P7[0G_9&O"W_J>/7\_%?T#_\`!O/_`,G!?M"?]D:\+?\`J>/7
MY;XU_P#)K>,/^P'"?^K7+S],\'/^3F\(_P#8=B?_`%68X_JQ\6?\BOXC_P"P
M#K/_`*;;JO\`-$C_`-5%_P!<HO\`T6M?Z7?BS_D5_$?_`&`=9_\`3;=5_FB1
M_P"JB_ZY1?\`HM:_$?HG_P`+CK_KYPY_Z3G9^Q?2B_C\$_\`7OB/_P!*R$?1
M117]@'\HA1110!^@G_!*O_E(1^R]_P!CMX@_]5MXYK^])/N+_NK_`"%?P6_\
M$J_^4A'[+W_8[>(/_5;>.:_O23[B_P"ZO\A7\(_2F_Y+?(O^R5P__JWS<_MG
MZ,W_`"1V=_\`93XG_P!5.3CJ***_F4_H\****`"BBB@`HHHH`\^NOA-\+K[Q
M3%XXO?AQX"O/&<+I)#XMN_!WANY\3Q21E2CQ^()M,?6$="B%76]#J54A@5&/
M00,<?Y_S[T44`?AY_P`%+1,W_!2#_@A6()(XI?\`AJ[]I[:\L331@#]CSX@%
MP8TF@9BR!E4B5=C$.0X4HVE_P4"2\3XS^'!?3VUS+_PK;12'M;66SC"?V_XF
M`4QRWE\Q;<&)<3*"&`"#:6:C_P`%)_\`E))_P0I_[.M_:@_]8Y^(->%_\%9_
MVF?`WP<_:/\`"'A?Q+I'BF_O[SX-^'-;CFT2TTR>T6UN?%?C6R2-WO=5L91.
M)+"9G41%`C1D2%BRKZ^29!G/$F.CEF19?B,SQ\J52M'"X91=5TJ23JU+3E!<
ML$TY:WUT3/)SG/<HX>P3S'.\?0R[`QJ4Z+Q.(<E356JVJ<+QC)WFTTM.A[+H
MFEW&I?LY1);Z-IEBEIJ5KJ*+>Z1X5\1:!XYU.&.X>"RBU2SFM/%_A_Q]K=Q-
M;^'8M+\Z_P!2:>!=(@ATW0]3:6#G?B/8^.-+LO#FD^+?`?\`PEGCY?%>LZM%
MIL7@6ZM_#>AV3Z#.ME\*]/G\/6&ECQ6ME=0_\)#J.AZ5=W^DZ$FEPZ1#?WYN
M/$./R!'[?'PK$/V8:!\1A;_:1>^0+'0A#]L6`VJW?E#Q&$^U+;,ULMQM\Y;=
MC"'$9*D_X;Y^%OR_\2+XD_(<QG[+HN8S@KF,_P#"2_(=I*Y7'RDKT.*^S_X@
M]XG?]$9G/_@NA_\`+_ZL_*_R/_$6?#C_`**_*?\`P.M_\I/VD\7Z%XIT?QK\
M=;SPGX9O+/Q_=77@B\\$6UMX6MOM4_AJ<6L7C>]\&:/=Z8]E<)#J1T&PU5M(
MLI18:3=:C;D0637^WBFT>/2_CK=:WX=\-7>H>&D\3:WH^GQ>%Y-#M[.3QI%X
M`>^US0_"=UJSG0I+[1]?U"ZN]&L%2YC>*"SM]*M;Z5K&SF_(YOV]OA4Y5G\/
M_$9V3/ELUEH;-'NR&\MCXD)3<"0VTC<"P.03F/\`X;Q^$FT+_P`(S\0-HQA?
M[-\/[1C&,+_PD6T8P,8`Q@8Z#!_Q![Q._P"B,SG_`,%T/_E_]6?E<_XBSX<?
M]%?E/_@=;_Y2?IU\7;.\CO\`PIJ>J3>)K?6-9\-FXU#PWXRNK"\\2>&!9ZQJ
M%A8P7EQ8Z3H+&SUJUB&MZ7%J.C:?JL-O<R"YAEMWLKJ?]J?V88=:;]G[X2-;
M:AID,!\$Z3Y<<VD75Q*JXEP'F36[978#`++!&"1D*,X'\CX_;R^$S/D^&_B$
MS.X9F;3M!+.QP"SL?$19F(`!9B6(`R>!7]9?[$GBW3O'G[)OP"\8Z1!>6VF^
M(OAKH&J64&H1PQ7L4%RDQ1+F.WFN(4F7:=RQSRH.SFO!S_@7B[A;#4<9Q#D&
M/RG#8BO]6H5L5&G&%2O[.57V47"I-\WLX3EJDK1>NU_<R+C7A7B;$5L)D.>8
M+-,3AZ/UBM1PTIN=.@IPINI+GA!<OM*D(Z-N\EH?`/\`P62^->I_`OX0?!_6
M[[1;'Q>FN?%2]T=+6UFG\.-:-'X(U[4!<M/*^OBX4BV:'R!#`<RB3SB(S&_\
M]7_#P0_]$H'_`(69_P#F:K]J?^#AK_D@/[/_`/V7#4?_`%6OBFOY-Z_J;P9\
M)N`.+.`LMSK/\A6/S*OBLRI5<3_:><8;GAA\;5I4E[+!YAAZ$>6G",+QI)NU
MY.4FV_YG\7O%+CGA?CC,,GR/._J674,-EU2EA_[-RC$\LZ^"H5JLO;8O`5Z[
MYZDI.TJK4;VBDDDOT?\`^'@A_P"B4#_PLS_\S5'_``\$/_1*!_X69_\`F:K\
MX**_5/\`B`7A/_T2JZ?\SKB+R_ZF_D_O9^8_\1S\4?\`HIET_P"9-P_Y?]2K
MR_JR/T?_`.'@A_Z)0/\`PLS_`/,U1_P\$/\`T2@?^%F?_F:K\X**/^(!>$__
M`$2JZ?\`,ZXB\O\`J;^3^]A_Q'/Q1_Z*9=/^9-P_Y?\`4J\OZLC^U'_@CO\`
M&+5/CC^S]\1?$MEI-AX1CTOXR:EH;6%T]QXB>X>+P1X+OS=K=Q2Z"L*NNH+"
M+8VTI4P&7[0PE$<?M/\`P53AUE/^"?'[4K7=_IL\`^'46Z.WTFYMI3_Q5/AO
M[LTFLW:KQD<P/R0<<8/QI_P;Y?\`)J?Q<_[.%UC_`-5M\.:^WO\`@JW_`,H\
M_P!J;_LG47_J4^'*_CW,<FR[A_QRP>391A_JF6Y?QSP[0PF']K7K^RI?7\MG
MR^UQ-6M7G[\Y2O4JSEK:]DDOZRR_-\PSWP7Q>;YKB/K688[@S/*V*Q'LJ%'V
MM1X''1YO98>G2H0]V*5J=.$5:]KZG\*WA;PCXJ\>>)-.\)>"?#FM>+?%&M7+
MV^D^'_#VG7.JZOJ$R(\TBVUE:1R2LL4,;RSS,%@@C4R32QI\U6M(^'WC_7['
MQ!J>A>`O'.M:=X261O%E_I'@[Q+J5GX6\F.6:9?$MQ9:7/%X?E@AM[B:XAU=
MK.:WAM[B6=(XX)F3Z\_X)]>+[7PG\?[6._\`$W@'0-/\1VVF:+J-AX_U[Q=X
M+MO$MC!XGTK77T[P]\0/"<UL/"?B+3[K2+/6(8/$LZ^%?%FG6NH>'=5@O9I[
M&TE^P?`OQ;^`>F:EX:@@^*VA_$7P[H/QI\:_$C6/B9\5_CIXC\*?$;X*ZGK?
MPZ\%>%)/%OP]TN;0-(N?VNK<RZ"EUH=WXX\+:V_BJ3P=HNA7O@KPK%XGUJ_U
M;^Y\ZXJS3*\QQF!PV2UL;2PV"P>*HUZ<*S5256.+E4IRJ35+#QE4EAX8>A%U
MHN<_:+"2S#'I94OXIR7AC+<SR[!XS$9Q2P=3$8W$X:K1J2I)TX4GA(PJ1A%U
M:\HTXXB=>M-4I*$%!XJ.`P-\T?X^OX&\;Q^$D\?R>"_%\?@.6Z^PQ>.'\+Z\
MG@V6\\]K7[+'XJ;3QH$DYND>U$2:@6-TCVH!N%:()XE\#>-_!B:3)XQ\%^,/
M"$>O69U'0I/%?A;7_#::UIX\HF]TA];TZP74[51-"7GLC/'&)X2[*)HM_P"F
M\_Q'^$5S\#UT*+X@>!M*N])_98^'7PF\)_&S_A9.OR?%F;7=*\8>&/%%S\+]
M?_93TZUN],T;P_X<U1M3TZX^(FF:*_B>'P]X1L/&5GXZ\0ZSKO\`9=QY=\6+
MK2?%WP>\&_"R\^*OPB?XAWOQ[\6>/M4\1P_M!:Q\3O#'Q&AO?AE>V^L_&?XA
M>,O%D>IR_"#5];U+1K'1/#W@:"XTV3Q3J'B:>37/!^E:EH>G7ITPG%6/K8F$
M,1E=3#4'F6*PU24X5%*&!I8:.(IXW>34:;?)B*,J<<=0G)?7\!EM.,JR6*X8
MP-+#RGA\SAB*W]G87$TX0G2<98RKB70G@]5%-S7[S#U8U)8.O%/ZCC<QJ2C2
M?P-;:#KM[I&K>(++1-8O-`T"?2[77==M-+O[G1=$NM<EG@T2VUG5H+>33]*N
M=9FM;J+28+^YMY=3DM;E+%)V@E"?O3_P;XI>/\?OV@Q97%M;R_\`"F_"V7NK
M26\0C_A/&P!'%>V+`XW9)D8'(X&T[O@[3/B1\`3^Q[\5_A9X>^('C/P]J<W@
M7X)ZR_@S7?A]HME<>.OC7%\3K3Q#XW\0P:Q;_$N>77;*SL;73/"6F.?#]I/X
M!^'&APZI_9^J:KK6OVMW]]?\&\__`"<%^T)_V1KPM_ZGCU\=XJYE6S+PN\1%
M6P=?!+!5<-@\/&O1Q%&>(PRQ&18F&)_?TJ2E[2IB:L&J/M*</9<CJ2ES'UOA
MAE]'+_$KP_='&4<8\9#$8NNZ-6A5A0Q#P^=8>>&_<U:K7LZ="E.]7V=2;J.2
MIQCRH_J9\50:^/#'B/=JFD,O]@ZUD+H=XI_Y!EUC#'Q`P&#@_=.0,<9R/\X[
MX;Z3X1U[QIX1T;Q]XE/@WP7J.HP6_B;Q2'B@&AZ7]CGE:\>[N++4[738I+B*
MWLI]9O-,U*RT*"ZDUR^TZ_L].GLYO](GQ9_R*_B/_L`ZS_Z;;JO\V+PGXH\0
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MMH'B#7K?4-::U\"6LDQ\TUGX%_!?X5_&7X^?#WQOX1\1^//`?P9\/0_$N]\>
MZ9\6Y/#NN6WA'Q3X4\$:A\/O`MO8^'?#.J^$_$/C/6?&?C_P[X,'B.&ZMM&O
M6?5O$4&GKI.FI;2>(>,OVL_BMX\\9:EXN\3Z=\+M:L[_`$I-%A^'VN?"3X?^
M(/A?H]@NHV&MR/HO@C5]"N=-T[5;K7].AUS4/$$++KVJW;/9ZMJ5_HBQ:3'Y
MCJ_Q@^(GB`?%,Z[XA?6+GXT:IX=UGXD7]_8Z?)J&OWWA76Y_$.A>7<Q6T(TB
MSLM4G#+INDQ6>F_8[73M-CM(K#3K*WA_H/+<BXM5&E3S/-8N,L!AL-7CALSS
M>->%;V^3TZF(I8KVRG[?#8+#YO5C.7-+%YACH+&5L5A*>'A@OPG,,[X6=6I4
MRW*Y1E''8BO1EB<NRJ="=)4,UG"C5POL7%4,1C,1E5*4(N*PN`P,W@Z.&Q=3
M$3QGNGA7X5?"GQM^SU\2?'.C:9KUKXP^&/@#3_$E[J__``MKPAKNO:UXRB\8
M>'=&\2Z8?@#I>B-XFT'X-:7HNOSS1?%G4-;CGTN^TNVNO$#%-;CT.S]%_9=_
M9>\"?&#X?Z5X@\26]U=:YXI^+NI_#VSMK[XK:/\`"F\B\+:7X2T_6+CQ!\&O
M#>K>$_$%U^T7\1;?6KN\TJ_^'&@7,-Q8WT7A;07L9;WQM;:GI?S+/^T#\2I_
M"-WX.-QX2@@U+P;8?#G5_%5E\/\`P;8_$C6_AYICV+67@76OB'::/%XGU+PP
ML6E:58W-I->"]U/2M,L-'U?4;_2K5+.M[2_VH_BOHVHC5;&+X:+=6'B[5_'O
M@Y;CX/\`PXO+/X6>+]=FT^[U36_A!I]UX?FLOAL]SJ&DZ7JZZ=X?@31+;7--
ML=>M-+@UJW2_KKQN5\55<'F-#"8VAAJV)S&IBL+4GF68U7A\.L+1IPP_M51A
M74*F-4L3*%&KAZ%*E%TX8>5*I/"RY,'F/#%+%X"OBL'7KT</E]/#8FE'+L!3
M6(Q#Q-2=3$.G[6=#GIX1QP\9UJ=>O5J-5)UXU(1Q,?>_^"6L5Q'_`,%"?V9(
M(F:"XB\=^(X<WUG(DL;P_#SQS'(EW8^?#+;W`"/'/:M.'M+C=$[R&%@_]XUC
M'J**WV^[L[G*Q^5]DL)K+9@'?YGFZC?^;NRNW;Y6S:V=^X;?X/\`_@EE--<_
M\%#_`-F2YN9I;BYN?'OB:YN;B>1I9[BYN?AWX\GN+B>5RSRSW$\DDT\KLSRR
MR/([,[$G^\U/N+_NK_(5_)/TI;_Z[9#??_53#7[7_M;-[]NODC^IOHSV_P!3
M\\MM_K1B;>G]DY/ZCJ***_F8_H\****`"BBB@`HHHH`****`/Q`_X*3_`/*2
M3_@A3_V=;^U!_P"L<_$&ORH_X+\_\GE_#_\`[-S\'?\`J>_$NOU3_P""EHF;
M_@I!_P`$*A!)'%+_`,-7?M.[7EB::,`?L>>/RX:-)H&8L@95(E78Q#D.%*-^
M4?\`P7O2\3]L?P`M[/;W,W_#.O@[:]K:R6<83_A._B2-IBEO+UB^\,Q<2J,,
M%$8*EF_>_HW?\G,P_P#V)LU_])H'X;](;_DW.(_[&V5_^G9GXC45[+!^SY\8
M[GX17'QU@\"ZI+\,+6_%I/XA62R,Z6?[V-_$@T3[2-:?P=%?Q/H\WBM+%M&C
MUC%F;C8LL\=6S^`_Q@U#3_A3JEAX`UR\L_CCJ6OZ5\)S;MISW'C6[\+SVL&O
MMIUD;];RSL---Y#<2ZOK4&EZ/+IZW.JV]_-I5E>WMO\`WZLVRM^TMF6`_=8B
MO@ZO^V8=*GB\-AZF+Q.&FW4M&OA\+1K8FO1E:I2P]*K6J1C3ISDOX7_LO,O<
M_P"$_'?O,/1Q=.V$KOGPN)KT\+A\3"U/WJ%?$UJ6'HU8WIU:]6G1A*52<8OR
M2BO6+CX&_%:#XA>$OA8O@^XOO''C[^Q9/`VF:+JWAW7]-\86?B&:Y@TC5O#7
MBK0M8U'PAK&A7,UCJ,<^O6>O2:/IK:7JPU6^L?[)U'[+S$7@+Q,_CB\^',]M
MINE^+M.U[6O#&HV6O^(_#7AW3M.USP]<WUEJ]E?^)==UC3O"]F+2[TV\M1=W
M&LQV-S<1I%9W-P]Q;";6&88"HG*GC<).*PRQC<,31DE@W*<5BFXS:^K.5.I%
M5_X7-":Y[QE;.>`QU-VG@\7!O$?5$IX>M%O%6A+ZM9P7^T<M2G+V/\2TX/EM
M*-^03[Z_[R_S%?WV_P#!,S_DP7]D_P#[(QX4_P#1=Q7\*/C_`.&/C+X7:AH%
MAXSLM)M)O$WA^T\6Z!+HOBSPCXQL-4\-WU_?Z;9ZM;ZIX,UWQ!I@MKN]TK4(
MK99;N.>=+5[F*)[5XIY/[FO^":D.M/\`L%?LHM:ZCIL$)^#/A79'/I%S<R*-
MMT5#3)K-LK$*54D0H"06``;:/YF^E#7H8G@OANOAJU+$4:G$=X5J%2%6E-++
ML?%N-2$I0DE*+B^5NTDT]4S^COHUT*V'XOX@HXBE5H5H</24Z5:G.E5AS9AE
MTES4YJ,HWBU)72NFFM'<_.S_`(.&O^2`_L__`/9<-1_]5KXIK^3?_/\`];W.
M`3CT!/8U_5U_P<'1ZE'\`O@#]NO+.Z!^-^I;!:Z?-9%3_P`*V\38+&74;X,`
M`X("H264[@$(?\:/V+_A1\.OB1\-/BKIFK?#?P_XN^)WB%3H/@:7XF0_$SP_
MX.UY'\8_!G1;'PY\.OB;X'6ZT?P1\2+?7?%5S;:Q>>(-)OY5B\3>!GN+RP\$
M-XW@O?<\$LYHY%X/93C\10KUZ<<US"C*&'5+G2KYO4I.HW5JTJ<:=*,G4J3G
M4C&$(RG4E"G&<X>+XR916SOQ8S7`4*U&A4EEN`K1G7=3D;H910J*FE2IU9RJ
M59*-.E",)2G.480C.<HPE^;F#UQP.I],]*7!R!@Y(R!@Y(]1ZBOTRT?]E'0O
M#?[,GB3Q)X\\!:CJGB#3]=_9J\?>-/B7X>U?2-8OO!7P\\?>.]7TWQGX!\%6
M.E:[=66IZ_HOP[MK7Q!XQF;3;^]E\<:YIOA'0DD_X16^%Z[XL?#/X?:;X1C\
M=_#OP)^S9K7BFS_:VE^`_P`-/!_@6_\`&?CKP9X]^'_C#PCKEUX4A^*-AK_B
M-;L?%#PUJUGX=EU!);W0?&FD3>)G7XA>&M.F'AZU?]6AQME=;$SP^&IU\1&.
M/K9<L33EAGA77IX;!8FG-UHXB3C1K+'4E"HX)PBI5JT:=!1J2_+Y<&YG1P\*
M^)J4*#G@:.8?5IK$+%*A4Q&*P\X^R=!)UJ/U2JYP4[3FXT:4JE?FIK\RR"#@
M@@^A!!H*L.H(^H(_G7O?[15SX0B^,?B/1/`GA'P;H>@_#NXM?`5[)X1T2_TK
MPWXR\1>"KJ72?%WC:ZTBXU;5O[.L?%GBF#54T[38-0B@A\*P:':%WU)KV[N.
MD^/MSX>L/!_P<T)?AC\+_!GQ`\1>$;7XP>,-5^'GAC4O"XM?#WQ$A:7X9^!I
M+2Z\1ZY#.+?PA:6_CO6+QTCNGU#QAI6F0O'::'(+WVJ.;.JLH:P=>+S:FZBA
M*5)5<)!8;ZSSXBFY\R@HNG2FX\TH5ZU&E**E41XU7*U2>:IXNC+^RYQIN<8U
M?9XJ;Q$</R4)\EG)OGJ04N55*5&M4A)QIN_])_\`P;Y?\FI_%S_LX76/_5;?
M#FOM[_@JW_RCS_:F_P"R=1?^I3X<KX2_X-_HM4D_96^+9L;VQMD_X:#U8,MU
MIT]ZY<?#?X=[F5XM3L0JL"@"F-BI1CO(<*GVS_P53AUE/^"?'[4K7>HZ=/!_
MPKJ+='!I-Q:RG_BJO#?W9GUBZ5>,CF!^N<<8/\#<5_\`*0S_`.R_X>_]3<K/
M[EX8_P"3"_\`=CYY_P"H>8?G^NMM3^$>0`LX(!!+`@@$$9.00>"#W!&*-S?W
MCR<GD\D]3]32O]]O]YOYFFU_H@MEZ(_@47)QC)QTQDXQUQ^=&2>I/?N>_7\^
M])13`*_H'_X-Y_\`DX+]H3_LC7A;_P!3QZ_GXK]_?^#?)+Q_C]^T&+*XMK:7
M_A3?A;+W-I)>(1_PGIP!'%>63`X#`DR,#N'RC;\WY;XU_P#)K>,/^P'"?^K7
M+S],\'/^3F\(_P#8=BO_`%68X_J[\6?\BOXC_P"P#K/_`*;;JO\`-$C_`-5%
M_P!<HO\`T6M?Z47BJW\0#PQXB+ZKI++_`&#K60-#NU)_XEEUC#?V^V,'!Z'.
M,<9S7^:['_JHO^N4?_H"U^(_1/\`X7'7_7SAS_TG.S]B^E%_'X*_Z]\1?GD0
M^BBBO[`/Y1"BBB@#]!/^"5?_`"D(_9>_[';Q!_ZK;QS7]Z2?<7_=7^0K^"G_
M`()8B9O^"@G[,`@DCBE/C;7]CRQ-/&N/AQXW+;HDFMV;*!E&)4VL0QW!2C?W
MDV$>HQJWV^[L[K*Q^5]EL)K+9@-O\SS=0OO-W97;M\K9M;._<-O\(_2F_P"2
MWR+_`+)7#_\`JWS<_MGZ,W_)'9W_`-E/B?\`U4Y.7Z***_F4_H\****`"BBB
M@`HHHH`****`/Q`_X*3_`/*23_@A3_V=;^U!_P"L<_$&ORI_X+\''[9GP^/(
MQ^SIX..1U_Y'WXE]/>OU6_X*3_\`*23_`((4_P#9UO[4'_K'/Q!K\J/^"_/_
M`">7\/\`_LW/P=_ZGOQ+K][^C=_R<S#_`/8FS7_TF@?AOTAO^3<XC_L;97_Z
M=F?)_ASXQ_L]O^R#!X!^*%W>_$KQ-I&MV5KX;\`MX(M?!_Q&\*7MMHFI+$_A
MOXX>'=547/PG@_M+68(V\8:'XIUBRMO$%]X*L?#5NR:=KUKVMQ^UW\`M<MOA
MW<R^&?B5X2O&\9_M1Z-XCLCK>B>+K'X7?#'XY_`GP=\$O#;^#-,TOP'X(M]7
ML/`^DZ/IMOX4\+:?JUEJ&E:'X.U.VU2XU?4O%VG7-G^7%%?VY/@C**M2O5K5
MLQG.MBLRQ4>7%NC2H?VK@YX/%T*.&P\*6$5*<)^VE.I0J8FMB(0J8K$5TIQG
M_&T.,\UI4Z%*E1R^%.CA<NPLN;">VJU_[+Q=/&86M6Q->I5Q3J0G3]E&%.O3
MP]&A.5/#4*#Y)1_0GPU^T%\#_AEHOPJ^&\>G>*?B7'X"\'CP?=_&7P9?O\,9
M;#3_`!K\<;[XK_$S1/"7AKQMX$\4:]<>%;[1SHGA&ZO;ZP\,>)-3TH>.M(TN
M#3].\83SS_/WQKU'X1?$3XO_`!!^(7A[Q1K6G^&/B!^T-XSOI_#.JZ-J=]XA
MTWX:^(_$0U^[^(HU^VTG1M*F;5)-7UE-*\"PZ4GBG04M+6+4I]1<I>W7SO17
MH8+AK!8#&5<?AL3F$<9B%BOK-:6)C46(GC,0L7B*DJ$Z4L+AYSQ*=91P-#"4
MH5)5'3IQ56JI\&+XAQF-PE/`XC#X"6$H/#+#4HX>5-X>&$H?5J%-5X55B<1&
M&'_<N6-KXJI."ASU)2I4G#U;XW>-K#XB?&'XA>+]$7R?"^H^*K^S\#V2V[V<
M.D_#KP_(OASX<:):V,B1OI]IH_@;2=`L(;!HXWM3#(LL:SM,3_<S_P`$S/\`
MDP7]D_\`[(QX4_\`1=Q7\"2??7_>7^8K^^W_`()F?\F"_LG_`/9&/"G_`*+N
M*_GKZ3V'IX3@;A;"44U1PN>4</24G>2IT<IQE.";LKM1BKNRN^A^]_1NQ%3%
M<9\2XJK9U<3DF(KU7%-)U*V:X&I-I-NR<I-I7=C\V/\`@X:_Y(#^S_\`]EPU
M'_U6OBFOY?\`P5\8/BG\.-#\9>&?`?Q`\7>$=`^(.E+HOC'2=`U[4M,L=<L%
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M^_N-8`;5+Z[L+*>_O+J2U@:/S"BOVZI@\)5JJM5PN'J5H^T<:M2A2G53K4H4
M*K5247)>UH4Z=&I9^_2IPIRO",8K\9ABL53INC3Q.(ITG[.]*%:I"F_959UZ
M5X1DHOV5>I4K4[KW*LYU(VG*3?16WB[Q59V7B[3;3Q%K%MI_Q`BM8/'-E#?3
M1VWB^&RUZ'Q39Q>(H@=NJ1VOB6W@U^!;C=Y>K11WH_?*&JIK>OZYXEO8=1\0
MZOJ.MW]OI>BZ'!>ZI=27=S#HWAS2K30]`TN.64EDL-%T:PLM*TRV!\NTL+2W
MMH@(XE%9%%7&A0A-U(4:4*CO>I&G!3=X4J;;FDI-NG0H4VV]84:47[M."42K
M5IP5.=6K*G&UH2J2E!6G5J*T6W%6G7K35EI.M5DM:DV_Z[_^#?+_`)-3^+G_
M`&<+K'_JMOAS7V]_P5;_`.4>?[4W_9.HO_4I\.5\0_\`!OE_R:G\7/\`LX76
M/_5;?#FOM[_@JW_RCS_:F_[)U%_ZE/ARO\\^*_\`E(9_]E_P]_ZFY6?WMPQ_
MR87_`+L?//\`U#S`_@T?[[?[S?S--IS_`'V_WF_F:;7^B$=EZ+\C^!0HHHI@
M%?T#_P#!O/\`\G!?M"?]D:\+?^IX]?S\5_0/_P`&\_\`R<%^T)_V1KPM_P"I
MX]?EOC7_`,FMXP_[`<)_ZM<O/TSP<_Y.;PC_`-AV)_\`59CC^K'Q9_R*_B/_
M`+`.L_\`IMNJ_P`T2/\`U47_`%RB_P#1:U_I=^+/^17\1_\`8!UG_P!-MU7^
M:)'_`*J+_KE%_P"BUK\1^B?_``N.O^OG#G_I.=G[%]*+^/P3_P!>^(__`$K(
M1]%%%?V`?RB%%%%`'Z"?\$J_^4A'[+W_`&.WB#_U6WCFO[TD^XO^ZO\`(5_!
M;_P2K_Y2$?LO?]CMX@_]5MXYK^])/N+_`+J_R%?PC]*;_DM\B_[)7#_^K?-S
M^V?HS?\`)'9W_P!E/B?_`%4Y..HHHK^93^CPHHHH`****`"BBB@`HHHH`_,_
M_@H+^P/\0OVQ?%G[*OQ/^#G[4.J?LI_&#]DKXD^.?B1\/O'VG_![P;\:H9[[
MQ[\.M0^&NKV5[X2\=:SI?A]T70M4OQ#/>0:HBR7+.MI'<PVUW!^7/[0G_!!;
M]LS]J?QKIWQ#^./_``6'\4^+/%VE>&K+PC8ZE9_L'_L[>&XH=`T_4-4U2TLV
ML=!\4V-G*\=]K.HRFZDA:X=9EB>0QPQ*O].U%>AEF;9KDN*6.R?,L?E6-C"=
M)8O+L77P6)5.I95*:KX:I3JJ$TDIPYN622YD['!F.599G&&>#S;+L#FF$<X5
M'A<PPE#&8=U*;;A-T,13J4W.#;<9.-XW=FC^1/\`XA@?C1_TE@\:?^(7?!'_
M`.;:D/\`P;!?&@`G_A[!XTX!/_)E_P`$>PS_`-#K7]=M!&00>AX-?2?\1'\0
M?^BYXO\`_$CS?_YL\OS[L^?_`.(?\!_]$5PG_P"(]E/_`,R>7Y]V?Q2?"'_@
MW?\`C?\`%#Q+\?O#\W_!4+Q;HR?!3XVW7PCMKJ']C[X+WK>([:W^%?PG^(ZZ
M]<12^++9=.G>;XE3Z0;&![F$1:/#=B82W<L$/M__`!#`_&C_`*2P>-/_`!"[
MX(__`#;5_6!X9\#>$_!U_P",M3\-:+:Z3?\`Q!\5R>./&-S;M<,^O>*I?#WA
MSPI)K-V)YYD2Z;P]X2\.Z65M5M[?R-*MV$`F:>67K*/^(C^(7_1<\7?^)'F_
M_P`V>7]78?\`$/\`@/\`Z(KA3_Q'LI_^9/Z^;/Y%!_P;!?&@$$?\%8/&F0<C
M_C"[X(]1_P!SK7Z#?"__`()F_P#!4GX-?#[PA\+/AU_P6XUS1/`_@31+3PYX
M7TF?_@G/^RKJTUAH]B&%K;2:EJ>M75_>O&'8&XNYY9I.KNQYK]Y:*\K-N*N)
M\^HT\-GG$6>9QAZ-7VU&AFF:X['T:5;DE3]K3IXJO5A"IR2E#GBE+EE)7M)W
M]/*^&>',DK5,1DN09+E->K3]C5K99E>"P-6I1YHS]E4J86A2G.GSPA-PDW'F
MC&5KI,_G-_:,_P""-G_!0?\`:Q\/>'?"OQX_X+/>(_%^A^%->E\2Z%:67_!/
MS]F;PR]IK,VF76CR73W/A_Q%83W*'3KVY@^SW#R0!I!*$\U$9?D7_B&!^-'_
M`$E@\:?^(7?!'_YMJ_KLHK;+>,^+\FPD,!E'%/$.5X&E*<J>#R_.<QP>%IRJ
M3=2I*%##XBG2C*I-N<VHIRDVW=MWRS#A'A3-L5/'9KPSD&98VI&$:F+Q^3Y?
MC,3.-.*A3C.OB,/4JRC"$8P@I2:C%*,4EH?R)_\`$,#\:/\`I+!XT_\`$+O@
MC_\`-M7A=A_P;Q_&^]_:2\4_`,_\%0?%L=KX<^"'@3XO)XH'['_P7:YN[GQE
M\0_B1X'DT!M+/BM;>&WT^#P%%J4=\MY)-<2ZG+;O#%':QM-_;!7(P^`_"-OX
MZU#XEPZ':Q^.=5\)Z/X&U#Q&'N?MMUX4T#6M=\1:1HLB&<V@M;'6O$NNZA$Z
M6RW!FU&823R1+%''W_\`$1_$+_HN>+O_`!(\W_\`FS^OFSA_XA_P'_T17"G_
M`(CV4_\`S(?R@_\`$,#\:/\`I+!XT_\`$+O@C_\`-M1_Q#`_&C_I+!XT_P#$
M+O@C_P#-M7]=E%'_`!$?Q!_Z+GB__P`2/-__`)L\OS[L/^(?\!_]$5PG_P"(
M]E/_`,R>7Y]V?SK_`+.W_!'G_@HA^REX2UCP-\"O^"T7B+PCX8U_Q'-XLU6P
MO/\`@GS^S)XEDN->N-,TW1Y;Q;SQ!XAO[J%&T_2-/A%M%*MNK0M*L8DEE9NZ
M^+7_``3"_P""H7QR^'/BSX3_`!-_X+:Z[K_@/QOIJZ1XET>W_P""=/[*^C37
M^GK=VM\(8]3TK6[74+0_:;.W<RVMQ')A"F[:S`_O=17S=7-LTKYE_;%?,<=6
MS;ZQ3QG]J5<77J9A];HRA*CB?KDZDL1[>E*G"5.M[3VD'"+C).*M]#2RO+:&
M7_V30R_!4<K]A4PO]FTL+0IX#ZM54HU</]4C!8?V%2,YQJ4O9\DU*2E%J3O_
M`"*'_@V"^-!))_X*P>-,DY/_`!A=\$>I_P"YUI/^(8'XT?\`26#QI_XA=\$?
M_FVK^NRBOI/^(C^(/_1<\7_^)'F__P`V>7Y]V?/_`/$/^`_^B*X3_P#$=RC_
M`.9/+^KL_BM^)O\`P;L?&_X?>.OV>/!L/_!43Q;JL?QR^+.O_#2ZU"7]CWX+
MVDGAJ#1?@9\8?C$FL6UO'XMFCU.6YN/A;!X?:SGEM8XX-:GU!9FFL8K:X]F_
MXA@?C1_TE@\:?^(7?!'_`.;:OZP]?\%>%_%&K^"=>U[1[;4M7^'7B.\\6^"K
MZ=KA9?#_`(BU#PCXG\"7FJV8AFBC>XG\)>,O$VB.MU'<0"UU>Y98EN5MYX>I
MH_XB/XA?]%SQ=_XD>;__`#8+_B'_``'_`-$5PI_XCV4^7_4)Y?GW=_Y$_P#B
M&!^-'_26#QI_XA=\$?\`YMJ^A_V<_P#@A9^VY^R=XB\1^*_@/_P6.\4>$-=\
M6:):>'=>N[W]@K]G+Q,EWI%CJ!U2UMDMO$'BB_MK9H[TF4SV\23.#Y;N8P%'
M],M%<F.XXXTS/"5L!F7%O$N88'$QC#$8/&YYF>*PM>,9PJ1C6H5L3.E4C&I"
M$TIQDE.*DM5<ZL%P9PAEN*HX[+^%N'<!C</)RP^+P>2Y;AL30E*+A*5&O1PT
M*M.3A*4&X33<92BW:33_`!.N_P!@_P#X*[7UK<V5U_P7*UB2VO+>>UN(Q_P3
M9_9(0O!<Q/#,@=-45U+1NRAE(9<Y!!`K\PQ_P;`?&=0%'_!6#QIA0%'_`!A?
M\$3P!@?\SMZ"OZ[:*X<HXEXBX?6(60Y[G&2K%ND\4LJS+&9>L2Z'M/8NNL+6
MI>U=+VM54^?FY%4FHVYY7[<UX>R#/70>=Y)E&</"JHL,\TR[!X]X=5O9NLJ+
MQ5&K[)5?8TO:<G+S^SAS7Y8V_D3_`.(8'XT?])8/&G_B%WP1_P#FVKPK]IC_
M`(-Y/CA^S]\!_BA\9K3_`(*@>+?%5S\//"USXC@\/7/['_P7TJWU:2WNK.W%
MI+J%OXKO9[5'6Y9S+%;2N"@`4@D'^V&N1\>^`_"/Q/\`!_B#P#X\T.U\2>$/
M%.GR:5K^AWKW,=IJ>GRR1RR6L[VD]M<K&TD,;$PSQ/E!AP,@^S_Q$?Q!_P"B
MYXO_`/$CS?\`^;/+\^[/(_XA_P`!_P#1%<)_^(]E/_S(?R@+_P`&P?QG;<1_
MP5?\:`!Y%&?V+_@B3A'902?^$T7)(7)^5>>PZ4O_`!#`_&C_`*2P>-/_`!"[
MX(__`#;5_76``,`8&2?Q8EB?Q))I:/\`B(_B#_T7/%__`(D>;_\`S9Y?GW8_
M^(?\!_\`1%<)_P#B.Y1_\R>7]79_*O\`";_@W7_:B^!_Q%\*?%CX9_\`!7?Q
M=H/COP3?7&I>&]7N/V'/@%K$-C>7>F7^CSRR:9JGB^YT^[#Z?J5["([J"5$:
M42JHEC1E_=']D#X%?M@?!=O'Y_:J_;IO/VST\0CPR/`R77[-/PB_9Z_X5U_9
M7]M_\)$4;X675R?%G_"4_;]&W?VYL_L3^P5_L_=_:=YC[7HKY_-L\SK/J]/%
M9YF^9YQB:-%8>EB,TQV)Q]:E0C.=14:=7%5:LX4E4J5*BIQDH\]2<K<TI-^Y
ME>39/DE&>&R;*LNRG#U:KKU*&68+#8&C4K.$*;K5*>%I4H3JNG3IP=247-PI
MPBW:,4BBBBO+/2"BBB@`HHHH`****`"BBB@`HHHH`^5?BQ^V5\$/@UXPU7P?
MXPU/Q/+)X0TCPYXB^*GB3PWX*\3>*/!7P5\.>,;N\L?"FO?&#Q9HEA=:1X#T
MS6YM.OKM)-1FEGTGP]:7'C'Q%;Z+X+B?Q$)H/VPO@Q-\5K3X3R77B^SO-3\?
M:M\(]%\<ZAX"\66/PHUWXOZ#IFIZSK/PKT?XE7.F1^&+[QK86&BZS&;1+M=+
MO=;T?5_"6F:Q?>,-+U#P_;?%7[6OP+^,GAZ;]K;3O`FA6?C#X5?\%"+/P5\,
M_BCXML;/XA^)O'_[.4NK?!JY_9[\7>/-)^%O@/PAXIU;XH>$KSP-HWA1M'LO
M#^J^$[SP=X_U&\U[Q;YW@"ZUWQ+X9]&M?A?^U+XK_:M\(>(_BO\`";X;ZO\`
ML]_!CQA=0?`*TT7]H+4I9/#5G:^$M0\*6/QZ^(W@34O@M#?^/OC5-INJ:[H?
MAWPJ?'=CX$^&FB^(;W4],G\5>.I1XOL@#[#\6_M$_"OP'XXU_P`"^-->E\+7
M7ACX66WQAUSQ%KNG7>F^"-/\'7?BZY\$VQE\8W*)HC:]/K]L;:#PU%</K5Q'
M/9RVUI,;VV23QZW_`&[/@[KOP1^"GQX^'^A?%KXH>%_V@]2NM/\`A9X?\!_"
M_P`07_Q!UL:=I?BK6M6OM0\$:P=!U?PW9:/IG@[69]5/B,:7=6,RVFGSVBZG
M>0V5?2OQ";Q+IWA;6M;\!^"?#_CKQU96=DV@^&]?\1Q^"]/UB>TU2TNX["[\
M8?\`"-^*Y=%@MR)M0M[A=`U)5O;>$)!#)*+J#\E/V?\`]D+]H/PK^Q_^S_\`
M`_XX_LV?LN_%C7_V>?%WB.5/!OBGXS^+M=\$>.]$\6:?X]\_Q'8:P?@_'I.G
M:GI-QXV&CWG@GX@?#?QQX=\0:9'>:M::GX?UVQT65@#]@O!OB3_A,/"GA[Q2
M="\2>%SX@T>QU?\`X1WQAI1T+Q3HGVZ!)_[,\0:,;BZ.EZO9[_)OK$W,YMIU
M>(R,5S72U\_?LM_"KQ5\$_@1X!^&7C37[7Q#X@\,VVNK/-IM]KVJ:-H6GZOX
MJU[7]!\#>'=4\42R>(=4\+_#C0-6TOX?>%]3UI+34M0\/>&-,O+O3M+EF.FV
MGT#0`5X;\9?V@O`OP2F\):3X@M/%_B?QCX^N-:A\$_#SX<>$-:\>^/O$]OX8
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M\5>-/AU^SO;7'C&]TW5M*G?1?BGX^T*XMO`NOP>!/#%OXFL/&7[8):1R6UD9
M["T6>S5)[>W_`'<T=E=?9);8K:S-`OE^7%<3VB3Q0PG[-+(@C6*1H2`>&_!#
M]J'X*?M&7GQ9M_@]XPB\96GP7\=VOPY\::Y9Z?J%OX<?Q'>>"?"WQ!A?PQKU
MY;P:;XP\/R>&O&&B7,'BSPW/J/AF]FDNH-.U6]^Q7$BR?L]_M,?"?]I_0_'?
MB3X0ZQJ.N:)\/?BEXN^$6N:AJ&A:GH<-SXH\'0Z/=W]WH@U2&"36O#.IZ;K^
MCZOX;\36:-I7B+1M1L]5TJ:XL+B&>3\]/!W[,7[6WCW6OV_/#OQ%T#P!^SQX
M/_;)\5>!/&&A>.?A;\68?B]XI\%:?X'^"'P$^!6K?#S4_!GB'X/>`M%OM-^(
MF@?"OQ.FJZQI^N6\FC>&O%(TK3(X-<CBUJR^@OV!OV7/C1^S')^U8GQ?^)?A
MGXBP_&7]J'Q5\8/`)\,^%].\*PZ-X1U;P+\/O"UM%J>F:;9VEIINJ74GA$6[
M>'[&2_TG0M.TG3!IVHW#:A>0VH!^@]%%%`'S_P"//VF_A!\,?%/CCP?X\\0S
M^&]9\!_!Y?CK?QZAI=Z+?6_AY'KVH>%M3O?!]S%'*GBS6=#\2VVDZ%K7AC1A
M<>(=/U3QGX`M)-.9_''AO^T/ECQA_P`%0?@E\/=;^-FB>./AE^TMX7?]GOP-
MI/Q&^*>H:I\$M5&E:!X2\57GB73/`.HPWMMK-S_:LGQ$U?P?XDT?P;9:;%<7
MFHZAI-S'>0Z;%LF;UG]J;]F:Z^._Q._8M\=Z?9^&77]GC]I27XG>-9M;O-1L
M=0U+X;2_!WXH:-)X8TE+"SN8M=$OQCE^"'CN;PUK<MIH$NH?#G1?%,DK:]X1
M\/QM\L?M>_L/_&KXU+_P43OO`=Y\/FO?VG_V9OV2?A;\++3Q+XBUC1T7QG\`
M_'WQ[\7^*4\9WMGX6UHZ#H6K6OQ(\,V>BZMIUOXCNI;B/5GO=(M8[*V-^`??
M'P>_:-\#?&/6/$OA&PTOQUX%^(O@W3/#^O>*?AG\4_!FK>`_'.E>'/%=QK-I
MX9\41:7J:RV.N^%M<OO#OB#3++Q)X9U76]&76M"UK0KN]M=:TN]L(?./'W[=
MO[.'PN\`+\1O'OBS5O#.C77QJ\1_`+2-+U#PGXA_X2WQ!\0/"GQE'P*UP:!X
M2@LIM<U3PI8>.G@:[\<0VB^$K'PS=V?BS4=7LM#N[:[ERO@Y\(_B[KG[17BG
M]J+XW>'_``7\.];F^#FA_`_P+\-/`?CS5OB/#8Z!%X\UGXB^+O%?C'Q=?^"O
M`%A>ZSK>N7.@:7X=T'2/#T]OX9T?0]2OKGQ'JU]XNGTW0.+_`."COP9^.?QR
M_9_E^#_[/?P_^&OB'6?%7C3X?^(]<UOQ[\2+KX:6/AFU^'GQI^&7QBN!:)I7
MPW\?7>OW/C*7P3?Z3<JJZ2EAJ$]CJE[)J2&1(`#W3QA^T_X=\+?&6V^"6G?#
M?XU>//$<=KX'O/$FO_#_`.'%WXC\#^![?X@:KK.F:!)XP\5/J6GVFE[8=!U+
M6=52V@U!])T..'4;U8UO+2*;Z9K\J_CG^RS\8/COK[>+6^#'[/O@;XD>//"_
MPC`^.R_$_P`>ZK\6_P!F7Q3X!\0WVL:C>_#P6G@:#2O&VIZ9;WUPOA+Q)X4U
M3X*S^(_MMSX7^)=GJGA6TA>^_5-00.3DY8Y]BQ('X`@?AQ@<4`+7EWC[XP>"
M?AEXD^%GAKQE>W>DS_&'QK-\.O!FJ26$[Z!+XU/AK6_%.E>'=7UI?]"T._\`
M$MAX=U>S\+_VF\$&OZ_!;^'+":37-3TJQOO4:^0?V]_@!XF_:A_8_P#C[\"_
M`USHVG?$#Q[X!O[+X=:YKNK:MX?L?#/Q%TVZLM<\"^+$\0Z!:WNO>';_`,+^
M)],TS7=+U_1+:36-&U&QMK_3MMS"C``\_P!7_P""BOP?L?'_`,)_A_HW@#X^
M>-+CXZZEXDT_X0>*/!GPFO\`6O!/Q`B\&W>HQ^+=7T#Q+)J]C!)H&@Z5IEQX
MIFUNZ@M=/U/PG+9>(-`FU>QO[-INE^`?[?'P._:&N_`,'A:Q^)_A>R^+\?B6
MX^"NO_$CX:>(?!?AGXQVWA*TU#4]<;X>>(KQ;K2=5OX-"TG5?$UKX?U&ZTCQ
M-JGA;2=:\2:7HE[HVA:W>:?+\2OV:]:UK]H_]AKXC^`[;PAX>^&G[+[_`!QL
M]<\.I)/I=U:Z%X[^"\/PU\%:7X,T>PTJ;39+72+JWMX;JTGO=(@T_1X8S9"Z
M=%M:^0/V2/V//VG/"WPY_8>^"WQTT'X1^#?!7[$/B6\\<CQ1X`^)_BCQ]XD^
M,'C#2/`WQ2^'?@BVLM'NOAS\/['P%X3BL/BQK?B;Q2VJ:OXIU:_O]'T?PS9:
M<NGWVJZ[&`?HWXF_:3^$G@G6_BWHWC3Q!<^$XO@IX1^''C3QQKNOZ-JECX<3
M2OBKJ'C#2?!=GX>U@VTD/BWQ%JNK^"M4T>/PMX;34O$+ZQ?>'M(MM.N=3\1:
M1:77+W/[8'P/M/V3]-_;1GU[6$^!NM?"71OC/HFIGPOKA\5:QX2\2:!;>(?#
MEEIO@46A\3W7B[7;6]LK+3/!R6`U^XUBZBTDVD=YYB1^J?%-O&.F>"_$&J?#
M+P%X:^('CUH=,@TKP[XE\7+\/M.U3RKY8O-O?&4?A/QI/IS:+:7E]JFG_P#%
M/Z@9;N(6D)LFO&O(OQ_\,_L"?M9^+_V!_P!GC]G;Q9X]\%_`[XG?LP_L]>*?
M@?HNE>$]0TWXU_"_XJ^(;K]G^S^#_AWXGZOJWB7P'X&\0>!]0TI;_P`::7H-
MOI^D:S<>'](\7:QJLPU;5_[(.D`'[/\`@+QMH'Q)\#^#OB'X5N);SPQX[\*^
M'?&?AV[GMY+2>ZT+Q3HUEKVCW$UK-^]MI9].U"VEDMY?WD+LT3_,IKK:^??V
M3_AAXS^"?[,GP`^$'Q$\1:=XM\<_##X._#KP%XI\0Z/9QV&DZGK/A+PGI6A7
M<FF6T4%JHTZW:Q%G8SM:VTU[:VT5]<VUM<W,T$?T%0`4444`%%%%`!1110`4
M444`%%%%`!1110`8!ZCIR/8^M%%%`!1110`4444`%'7K110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1103C\P/S.*`"BOY5=7_X.$OC#INK:MIT?[-OPSE33=6U734E;XA^+U:5
M-.U*ZL4E91X<(5I5MQ(R@D*S%02`"?K3]@[_`(+#?$C]KO\`:7\(_`KQ%\$_
M`_@O2?$>@>-M9G\0Z)XQ\1:OJ-K)X5T"76+>"*PU#1K.UECO)8Q!,[W"M%&2
M\:NP"U^NYGX&>)&495CLYQV38:EE^78*OF&+JQS?*:LJ>%PU&5>M45*GC)U:
MCC3C)J$(2G)I)1;:1^4Y;XT^'N;9G@LHP.;8FKC\PQE#`86E+*<TIQGBL36A
M0I0E5J82-."E5FHN<Y1A'>4DM3]]J***_(C]6"BO+O'?Q@\%?#GQC\&O`WB:
MZOX-?^._CO6_AS\/H;33I[RVO/$_A_X8>/?B]J,&I741$6E6B>#/AMXHN8KR
MYS%-?06FG)^_O8B,OPK\?OA5XNM]<N+/Q9INEC0/B-XQ^%=U#XDN[+PY<W7C
M'P/XSD\`:S8Z7;ZK=V\FIP3>+$71])N;19%U6[GMH+17GN(H6`/9:*^;;#]K
M/X&S?%CP_P#`O6/&-MX2^+OC/5OBOIW@/P!XJ6/2]?\`'5E\&+_P_I_CCQ!X
M6@CN+N&]T.WG\3Z2=*FN9[+4-<B.HRZ9ILZZ-K'V#UV'XD_#VX\/W7BRW\<^
M#Y_"UCJIT.]\20>)]#FT"SUA=2BT=]+NM9BOWTVWU&/59X=-DL9KI+M-0ECL
MFA%U(D3`':T5\MZ?^V+\#=0_9UN_VI%U[6H?A+:ZOKOAZ._?PMKMSXAU'Q#H
MGQ5U'X*0^']&\)Z9::AKVL:YXA^)FGKX5\*:7IMI<W?B'4-1TE;&,K?QE:.C
M_MK?`.;5?A[X4\:^(M6^#WQ"^*/Q,U+X/>"OAK\9/#>K?#SQOKGQ%TOP/)\2
M)M!T[3M6A?3]4MKCP8B:IIGB31]6U+PIJU[<V?AG3M=N?%UU!H#@'UE17@/Q
M*_:H_9S^#_A#6_'GQ(^,_P`//"_A'PUXX\)?#7Q#K=SXGTN\MM"\>>.?$FF>
M$O"_A76(]+N+ZYTO6=1UW6+&WDM+Z"W?3;-KK6=6^P:)INI:C9^LV?C/PCJ&
ML7_AZP\3^'KW7M*TNRUO4]$M-;TRXU?3M&U)6?3M6OM,ANWOK/3-01'>QU"Y
MMXK.\12UM/*H)H`Z6BL#PSXJ\,^,])AU[PCXAT+Q3H=Q+<06^L>'-8TW7=*G
MFM)GM[J*'4=)NKRREDMKB-X+B-)V>&9'BE5'4J-^@`HHKX\_:G_:8US]GVY\
M$P:/X5TGQ(OBJ#Q!+<-J>IWNGFS.C2Z1'&(1:6MP)1.-2<R&384,2!=VYL`'
MV'17Y%#_`(*1>-B0/^%7^%>2/^9EUG_Y65^F7PG\:77Q%^&W@KQS>V-OIEWX
MJ\.Z=K5QI]K-+<V]G+>Q>8\$,\R1RS1QGA7DC1F')4=*`/0Z**1F"C)Z95?Q
M9@H_4B@!:*^&/@M_P4"^#'QOU[P9I>A^&_B_X7T7XH>+/'_@7X2>/?'?PWO_
M``]X!^*?B_X9R>-V\5^'O"'B2#4-5C758-/^&_CG6M+LO$MMX<GU_1_#&K7F
MB+?FU:$_53_%/X9Q^%H_'$GQ"\#IX,EOAI<?BU_%WAU?#$FI&^;3!8)XA;4A
MH[WIU)&T\6BWIN#?*UH(OM`,0`.]HKQ_PG\?_@UXY^+'Q-^!GA+XA^'-=^+?
MP:L?".I_$[P'8W;/KW@^P\=Z?-JGA2YU.W>-(VCU6P@:XS9RW)L1-9QZD+.:
M_L8[AWQ.^/OP9^#?A3XE^-OB9\2O!_A'PY\'?!]QX]^)EYJ>N6'VGP;X3@M)
M[Q-8UK2;>>;6+:'4([=XM%B-@;G7;UH=/T:&^OKB"WD`/7J*\L^&WQ?\)?$O
MX=>!OB78O<^'-&^(/AS_`(2KP_8>+9M&TK6GT7[(^HM=3VMGK&J68$6EJFIW
M'V74;Q+.QECFNY(")4BZ?5/'G@G0[)M2UKQ?X7TC3TNM)L7OM3\0Z/I]FE[K
MRPOH=HUU>7L-NMUK"W$#:5;F03:B)8S9).'4D`ZRBO#OBA^T5\*/A%J/@31_
M%_B2)=7^(GQ7\%?!GP_I.D+'K&IIXW\?31PZ!;:MI]G.UWI&G%KBR:_U.]A2
M"PBU'399P$O[4RMT?]HSX3^(?C7+\`=!\1QZU\0K?X<ZK\3[JWTE(]2T:S\.
MZ'XZ@^'.KVMYKEE//96OB'3O%5Q'8WOAZ<IJ5H@>6YBBV,@`/<Z***`"BBB@
M`HHHH`****`"BBB@`I#T_%?YBEHH`_S0?%#I_P`)/XH^9?\`D:/$W\0_Z&#4
MO>OU`_X(I,I_X*&?"X!E)_X0?XO\`@G_`)$BY[9K^MR;]B+]CFXFFN)_V6/V
M>II[B:6XGFE^#_@-Y)IYY&FFFD=M#+/)+*[R2.Q+.[LS$L2:ZOP-^R[^S;\,
M?$EIXQ^'/P$^#O@3Q986][:V7B7PA\./"?AW7;2VU*`VNH6]MJNE:7:WL$-[
M;$V]W'',J7$),4H9#BOZ\XF^DCD>>\+YYP_1X;S:A5S7)<?E=/$5<5@Y4Z53
M%X.IAH59Q@^9PA*?-)1]YQ5EJ?RGPW]'K.LCXER7/:O$.5UZ.5YQ@<SJ4*>&
MQ<:E6&$QE+$RI0E)<JG-4W&+EHFU?2Y[O1117\AG]6'R/^U+\&O'_P`0M=_9
MK^*/PL@\*:OX[_9H^.&H_%G3?"'C?Q%JWA#P[XWTKQ+\#_C#\#/$F@2>*]%\
M+^,[SPYJUKH_Q;F\2:%J$GAG6-/N-2T"+1M1@L[757U?3?SG^)O_``3(^+7Q
M-M?C3JVLI\%IO$WQ4_8W_P""A/P\T6RU35M=\0:3X!_:0_:]^.-A\6_A[J^A
MZIJ7P_M[L^%_AQ:6%EIEW\0X-'TWQ<FL64NL:%X2M(-06QL?W0HH`_`KQ!_P
M2W^.^J^)O$_BR#Q/\,K+Q/XUU_\`X*5^%O\`A-M.UG6;;QI\-?!W[>V@?".R
M\/\`Q=\(:E+X(GFU'XC_``OU7X9ZG+?^"TO_``U!JMIXTU*YTGX@V5W;2V^H
M]?\`#O\`X)T?&/P8OP_\:ZEX?^&7B_6_A]\8O!'C2[^!OCCXLV_B'X1^._#_
M`(-^!'Q)^"&BWS:AX:_92^&_AOP=XH\#2^/K+Q9X%N%^#GB?5+ZU\)Z9I?BO
MQ0=5'AS4_!?[C44`?F5\$_V,O'7PO_X)WV_[)'B'0?V?_B%XFANOB5_:G@[Q
MAI'B+5O@-XH\.>-OC_XS^)[^"KFWCTV#Q'H-A<^#/$D?A[2-?M]$U>Y\!>)(
MM/\`$5MX?\50Z!'I6J>!6/[`?Q\LO$7PC^)5I9?#F=/@?^T]#\7/A#^S]\2/
MC3\3_CSX>^%7A#Q#^S%\4/@#X[_X1CXW_$_P)>^.99[OQOX^\,_&O3?A3!HV
MD^`]-O/AO!H/AKQ)X7U7Q5<Z_HO[944`?SA7_P#P29_:6\36=_=^*;[X&W=S
M#\%O@;X9O/`DWBFXF^&GCWXK_LY?M@_!_P#:0T'6[3PSX<_9]\">%/A)X$^(
M'ACP;\0/`%KHND^"_&NJ?#33O&K6\]SXWMKK5EF]RT+_`()I_%R\\:_'/5O'
M]YX>\6:'\4;;]L+Q!;6VL?&/6;#3-9N_VNM#\1Z?>?"?Q?I'PZ^`W@7XC)X/
M\$Z7XBL_AVGBL?'CQ+%#X>\`>!O&/@3P!X6UZVTW0?!W[ET4`?"W[$'P'^,'
MP+TGXI6?Q./P^L-,\7>+O#^M^$/#OA/_`(1/7_$NE6^D^"]'\)ZM=>.OB7X,
M^"7[/&F_$&^U)M"TM-`NM5^&C^*-$T#3[;3]<\:>)/,L['P]]TT44`%?E+_P
M4I(&H_"#)`_T/QSU_P"OCPM7ZM5R/B?P!X&\;-9/XQ\'^&?%+Z<MPNGMX@T3
M3M7:R6Z,37*VIO[><P"X,$!F$142&&,ODHN`#^952,CD=1W'K7]$7[,1!_9]
M^$!!R/\`A`]!Y'_7M6]_PH?X)?\`1(_AO_X1?A[_`.5]>D:5I.F:%IUEH^BZ
M?9:3I6G6\=II^FZ=;0V=C96L(VQ6]K:VZ1PP01KPD42*BCA0*`-"FNI8`#'W
MT;GT5U8_C@''OZ4ZB@#^??3?^"0?Q/TWX!^%/A_8_$U=,^(&K?#[]N#X;^/M
M2NOBO\7O&G@GP#<_M*>(O'?B[P%\5?@/X1\7R:GX4^'OCC1X=1A^$GCR+P7X
M-\$'5OA+\7_C!IMO?ZE/;:79ZUZ$W_!.CXM_\*_ANI_#?@_4O'\?QMN?B+:>
M'M3^/FEW.F^%-.F^!9^!LNH>%K]?V+;;X%WE]J_AN:Z\.^(O"'B[]E/7=)U?
MPDNFZL_B2'QWIMO=#]QJ*`/S,_8^_9"^*/[.OQR\=?$;QE;?!GQ&?C!^SA^R
MYX,\>>,OA[I@\!7FC?%']G;P5?\`P_U71/#OP^M/!\.ER?#;Q=IFH:?K&CW]
MIXET$^'YO#L6B)X!M-.DTK^R_DGXV_\`!+KXQ_%7P7\>/A];I\"[2;Q'X:_X
M*-2^%OC!?W^LS_$?XW:S^VKX;^(5E\./`_QTM(_ARD7A_P`'?!C6O&7A>\O-
M;T[Q)\09]2N/@K\(]4\,>&-`;2VT[1?WIHH`^%_VG?V2[_XQ_!3X4?#/P'/X
M/\&WWP^\5^#-.NDET][+0C\'?$NA:C\'?VA_!VBQ:/8"2PO/$OP'\=?$.Q\'
M106UGI\'C6+PG>WSV%M9/=VOQ_;?\$]OC5X=\/?#2]U"P^`'Q_UKP5J/[3'@
M[4_AA\6;K7]&^%VK_#GQ]X;\`?!;]G7QA+?#P'\0;BX^(WPD_9]^#7@KP9XL
ML[GPKY/B$?$CXSQ:)XDL3J5LVM?M110!^#_AW_@E7\7_``WI,&F/\2/"OB#Q
M-9?M5?L2_$E/C#?ZCK%I\2+_`.%7[-7['7P9^`7BN]\^7P[JITWQW<_$OP/X
ML\?^#O#AU+4="D^VZ1JFM^(H];GU`1^X?L7?L-?$_P"`?QR^'OQ(\5>%_@/X
M,T'X=?L.^%_V1;J+X2ZIK5]JWQ%\4>"OB/H_BH?%S7H+[X?>"[?3%\96-MJ&
MI7/A^YO/$VL^'=;OKZ"\\5>*1J#:E!^N%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
5%%`!1110`4444`%%%%`!1110!__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>biib-2015630_coschart.jpg
<TEXT>
begin 644 biib-2015630_coschart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`$V`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^2OVW/VF9_V1_@!J7QG
MM=%\'ZY<0?$?X&?#F%/B'X\?X8^`M'?XU_&SP#\'1XL\:>.X_#GBR3PYX6\&
M_P#"<_\`"4Z[>IH-\S:=I%Q;C[/YWVJ'ZUKPK]H?X$Z)^T3X#T3P%X@UB_T3
M3]%^+_P%^+JW6G6ME>37>H_`;XU^`_C5I.BW$%^KVYTWQ!JG@.TT359`IN(-
M-O[J:T_TJ.&@#P'P1^W=\+H-%\)1_%WQ[\(#XE\6/I>HQZY^SGXE^(/[07P0
MT+PCXO\`'NH?#3X>>*/&/QKTSX7^'O"_@33/&'CC2-9\(V.I^-QX?T&7Q+HN
MMZ=8:S?PZ)K%W8=WJ'[:7P;E^`/QS_:+\%GQG\0/`OP%\/\`Q0U7Q+_PCW@#
MQQ#>:YJ_PB/BNR\:^$_""ZIX=M!XFUW1/$7@W6O"^MKHBZA:>'=:M9K?7+BR
M^S77D\C\;/V'/#'QC\?^+/$X\?>)O!WA+XP>$/A;\/\`]H/X=:)HWA6[TCXL
M^#/@SXO\1^,?`VDQZUJ>F3>(/`L\C>,/$_A/Q5J'AJ[:37?!FKM8V,.@^(]/
MTKQ79=[\,_V3_!?@']FKQ9^S#J&MZ[XH\%^-Y_VA1XCU2<6>CZW<6'[1GQ%^
M)GQ`\6V5H^GQO;61TR7XGZOI&CW*1O(EK965U.CW)F#`'S3\'O\`@J-\)/B3
MX[/AKQ-X4\8_#+P[JWPS_8K\=^%/$WB/POX^N'&J_MH_\)[IW@SPM\2K2V\"
M1Z;\(3;>+_"6C>!]!\0^.-;T[1/'/B7Q;I=IHMQ$DMC)J'U[\)OVH_@E\;]?
MU#PW\./%=YK&HVNE7?B+2Y-0\)^,O#.E>-/"EAK:^&[_`,9_#;7/%'A_1M&^
M)G@JQ\026^D7?B[P'?>(/#\%W?Z07U`6NN:'<ZE\8Z#_`,$O_#=IX#\=>"_$
M_P`8_%GBB?QUX;_86\'7^MMX4\,Z+)'X=_8(^*4_Q"^&D+Z;832V<^H>+M.%
MCX8\=7L;6=O.+>YUG0=/T:6\33K3U7]D7_@GU\)_V//$>JZS\/(O"RVL7A*3
MX=^$%TOX._"'P7XKT[P+)KUIX@73?&_Q*\)^$[#Q]\4=8MYM-T;2H]<\2:U;
M17FEZ)IMYKFD:SXN%[XLO0#YZ^/_`/P4/_:!_9X\9_MC6GBCX`?!?6/A]^R+
M\`_!?[1NI:_I/Q]\<V_BCQAX'^*GB?XS^%_A]I47AZ_^`46BZ#XCM;CX,ZI?
M>.?-\4ZEI6CVFKV8T&]\136UPM?7Z?MW_LS'Q%I_@Z?QIXAL/&>I^/?%_P`-
M;?P9J_PP^*>B>+H/%?@7PSX/\>>)+?5/#6M>#-/UC1-*LOAOX]\*?%!?$FL6
M=CX:N/AEJC>/X-7?PKIVJZG8\C^T!^PAX/\`V@+K]JVZUKQSXET%OVK?V>/@
M]^SQXC32]/TBX7PMHGP?\7?&3Q=IGB#1#>J3=ZKJ]S\8]4M+^VU'=900:/I[
MVP$DUUG#\1_\$[?AIXO_`&C_`!E^T)XE\5^)=5/COQ)\1=<\1>`FMM/M="N[
M'XF?LI_"?]D[7]"75;5HM;AM/^$0^%5IKT%U#-'>KK.N:A")$M+>T(`/2]._
M;M_9HU3PS?\`BJS\9>(VL8#X"?0]-G^%OQ5LO%7Q!LOBM?:KIOPNUGX3>#+W
MP7;^+/BSX>^(U[H6MQ>"_$7P[T?Q'HNO1:+J][:WWV#3;VZA]ATSX[?#+6?A
M//\`&O2];U*_^']K;ZQ+=W=GX3\87?B.UO?#VMWGAC7_``]<>`K;0)?'L7C'
M0_$^G:AX8U;P4WAG_A++#Q+8W>@W&C)JD$EJOYO:-_P1R_9^TGX8-\.VB\!7
MDWAW7/A'J_P[UD_LW?L]Z=!9+\$;3Q;IG@Y/BKH&C^"+"P^.MQK.C>-_$&D^
M.YO'%Q!9:LDUOK?A+2O`?BZ&3Q)<?6L_[&?A$?LBZC^R7H/BG4?`>A:I8WIN
M/%'PS\)_#_X;[-6U/QQ_PL+5U@\!^"O#6B?#^/PCX@UIKC0_%/@DZ&VG^+O`
M^HZSX:\47^KW&N:OK=Z`4;O_`(*%?LN6`LK2[\5^-8O$]]KOQ"\+K\/4^#'Q
MEN?BA:>)OA9X+\*_$CQUX>U+X9V?@.X\<:=K.B_#SQMX8\=K8W6AQR:IX0U6
M'Q#I!OM-2>>+A_B;_P`%(O@GX:U#X3:5\,)9_C#<?$[X[?LO?!Q]9T'3?&ME
MX!T2W_:>?P_K'AS5Q\3X_!6I_#V_\4:?\.O%&@?$B'X<2>(]/\3ZEX8UW0KV
M>/2[76+.Y?A?@_\`\$M/AI\(?BM;?%W1_&EQ;ZU)XM^)OCK5O#7A+X<_#OX;
M^`9/$?Q5_9T^$_[.OB$:!X/\$Z7IFE^&M'MM$^$ND>(["Q@%_J%QKFIZG+KN
MM:U/*U_+D?#?_@E1X2^%WA3X._#?PU\;OB`GPO\`A3\1OV7/C;=>#)?#G@DC
MQA\:OV8_"7PS\"V7C+4M?&G?VWIFC^/]`^%?AJ^\5>#]/N6LK/Q6ESKFA:C8
MZ?<7/AZX`/7/VA?VW[SX+?'72/@AI_A#X:R:IJ'PY\-?$32KKXO?'71O@3-\
M69_$?B[Q+X2D^&?[/,WBCPGJGA+XD_%7PTWAZWU3Q1X;\0>,?`=KI4/C#X>P
M27YM?%-SK.@=UX?_`&V_A!/XR\?>!?%/B70]-\1>&OC-XT^#WAO2O#MMX_\`
M$-_XDU[P9:_!LWWAQX[WP!H%NWQ&^U?&GPO<GP9X5NO%]K<^&Y+GQ-HWB'5]
M/T#QO_PB47[3_P"R/J?[2NF>,/!U[\:_%_ACX6_%/P"?AI\4_AC<>$O`'Q`\
M,:MH$D6NVEUK_@F/QWH>J/\`#SX@7VF^(+G3;OQ':+KNCRQ:?H6I#PHGB#2(
M-9?RB?\`X)N>#QK^N>)-+^*OC[2-3C_:)UC]JCX<301V%X?AW\:KWPE\*OAU
MI?B97U&:[F\90Z3\,_AUXA^'<]AXIEN$\0>%_B_\4$UZ2\U75-&U31`#USX_
M?M;-\"/VB?V3_@Q?^`_[9\)?M(7WQ'T?Q%\2!XB?3S\+M5\/7WPT\+_#I;GP
MTNA7_P#PD>G?$?XC_%#PS\/WOAK>B'P[K&LZ#,8-7BU22.S\<^&7_!2OP#XO
M^(7[3'A3Q;X,U[POH'P<^.7@WX+_``CU7PI8^,?BUXP_:(E\5_"S4?B.VN>#
M_AGX"\#:CXH@-JGA/XAW%MIVE)XHCN/`G@^;XA7VIZ7I5U-:V/OG[2O[)/A?
M]I<S/X@\6^*/"=VGP/\`C)\'M%U;PI]@@UOPKJ?Q1\6?!3QYX?\`BAX:U*\A
MN#IWCOX4^-_@5X-\6>!;AH)["/6[=+G4K>YCMHH9/`;3_@FSX9\)^,9?B3\+
MOBWXP\!_$'1/%'P@\4?#G7&\.>$?%%AX.?X6_LTW_P"RO?Z->Z'K=H;?Q1HW
MCKX<:MJ-YKJW%UI.IV/BD:=K&CZG;K936UZ`>R:7_P`%`?V4-<UO1=#T'XEW
M>O3:Y%\%)X-4T3P#\2=5\-:;!^T9<:EIWP0D\2>*;'PA/H'A/_A9?B+2;[P7
MX8B\3ZAI%Q=^/HE\"2Q0>*Y%TD?('PJ_X+*_!3XB7_AC5]>^'7Q0^&7PPUKX
M(?';XS:YXO\`&/@7XD2>(O!>G_`?]I+3?V??%%QXI\#:+\/;^_TOP%:0WS^.
MO$GQ0N[V#PGX'TZVNM&\2W%KJ>G:R=-]-\-_\$NOA?X/\-^-O"WA[XA>-X;#
MQIJ'[$6L7EU?V?AZ]U(:Y^Q=\<Y?V@K+7+J:&TL+.\U+XM^/KW6+WQTL&GZ;
MIFF#6+J/PGIFE6D-E96W,Z?_`,$H_`]AI7QP\,+\7?&;^$OBI^S;^UM^R[X8
MTH^'O#BWOP\^'W[77Q/U+XO^+KB/5][OXLUKPGXRU[78_"MUJMG8QR>'I]/T
MS7(]2O\`3Y]9U$`^X?`W[47P:^)'Q%U_X8>"]<\0:WK_`(;U;Q=X>O\`5X?A
M]\0X?A]<>)?A_?0:9XZ\+Z/\4KKPM!\-]<\3>$-0N(['7]`TGQ3=ZI97<5_;
MK;32Z3K"Z?!J?[5OP-TCXG7OPCOO%>I)XNTS5T\,:C<0>"_'%WX-L?&\_@W_
M`(6'9_#B[^(MIX<F\`6_Q,U#P,T7BK3OAY+XE7QA?:/=:?<6^CO)J>F0WGC'
M@/\`89TKP3^T78_']/B9K,UWI1\1RQZ3H7@3X<^`M:\8)XF\(V_@[_A&_C'X
M[\#:#H>N?&CP-X-LK:UU+X<:#X[M;[6O#&NZ;HNK:CXM\27>C64@Y^X_X)P_
M!T?M*>+OVB]-@\+6FJ^./&=S\4]=M]0^#OPD\2^,[?XG7'PVLOA<^L^&_C+X
MA\+W_P`3?"GAN;1M+TO7I_"NAZQ;3P>+;)[[1?$>B:%JFM>&]1`.W\.?\%$?
MV2_%O@RX\=^'OB+K&I:(WAGX/^,?#ENGPR^*D'B+XB>&_C]>3:3\&]6^%'A.
MX\%Q>)OBO:^/]>M+_P`.:*WPZTGQ*5\0:9JNDWPL[C3KKR_./A;_`,%-/@?X
MPL?'MWXYCUGX>OX.^-?Q^^&PMX_#/Q%\5S:;X#^!'Q%'PUU+XR?%.+3?`-O<
M_!#P;?:^9+'4KWXG6^@:1X>U.RUG3I]<O/\`A'O$%SI?*6?_``2Y\$Z/IWP2
MD\/_`!9\9Z7XO_9V_9H_9<^`/PG\7-H/AB_FT/6?V4?$FL>(/!7Q*U#1KN)M
M,UB^\2VGB'7_``KXS\*SK#I%WX9US4H]&O=%UL:9KFF</-_P1V^#=]XKU;QU
MKWBRT\;^,_&OBWXE:_\`$;Q+\3?@C\"_B?>:WIWQ.^)FH?%K5+/PEI_COP9K
MWA_X<ZUHGBS7O%%IH'B+0=&NHCX7\13Z-XAT'Q!>:/X:UK1@#Z=UW]O#X:K^
MT3\"_P!GOP-I^J^-=2^*WQP^+GP.\2>+/[&\::!X1\(>(O@Y\$OBI\5?%\/A
M[Q9J?@T>"/B9K.@>(/AL/AWXM\/^%?%CW7A'7-2OUU>9-1\.ZAH[:GQW_;8^
M'_[./QGTKP!\5;7_`(1_X>M^S5\6_P!HGQ-\3UDU?57\.6GPQ^+?P"^%$'AX
M>#M"\/ZIJNK#7[[XZ6M^=4L[H2Z9_8@MFTN[BU"6]T[E/"O[!>C^$OB]\+_'
MFF_%CQB?A_\`!3XZ_&_]H+X6_!]]"\(1Z%X<\:?M%^$?C#H'Q2LKKQ-:Z;;^
M)M9\/2ZW\:O&/BCPAI]W-'-X8GU"YT>XN]=TP:0-"E^.'[!7A?\`:1\4?&+Q
M!\8_B)XHUNV^('P.\6_L^>`M)T'1O#7AR/X3^`_'/B?P)X_\2WNGWRVFIWGC
M#Q9<^/\`X9>!-?L]3\3$Z-96?ARUT;_A'+B*]UB\U$`[#Q?^WW^RWX)\5^(_
M`FL^.]=NO&GA;Q;\1/`VJ^%/#7PQ^*/C+Q`WB?X3_#KX8?%KXAZ=I>D^$O!V
MM7VN+X6^'/QB\`^+-0O-'@OK%M+U._-M<SW&@:]!IW5^&_VR/V=?%_C3P_X'
M\,>/SKM[XHE\-V.@^)=-\+^,;GX;:CX@\8^`;#XJ>$_!T7Q53P__`,*W7QWX
MC^&VJ:9XXT;P1+XHC\4W_AO4M-OXM*/]HV$=S\X>"_\`@F]X?\/?%FX^-GB+
MXP>,_&'C[6_%'[0?C7Q7>77A_P`,:/INM>)?VBO@7^SW\#?%,MIINEQB/1=*
MT+2?V>]"U7PWI=O+<O#-K-]9:G?:B+6&^GY+]G;_`(),?`_]G+QM\,O%OAF\
MT+7G^'NG?#34)]0\4?!?X-:Q\0]:^(?PV^"WA+X'VWBNR^+NI>%-0^('@_1-
M>T+P=I/BC5O!OAC5+1+/QD+NX\/^(=&\-:CJGA>_`/;OVN/VP/$G[+E]HU\_
MP\\"^(_"NHIX?M])LM;^-VA>#/BY\8/%>M>(&T>[^&/[-?PF/AGQ%J7Q6^)F
MC6$^DZPV@ZQK'@:QUJ;7M$T31=4GEFU;4]#R],_;@NKSXDZ;#=_#?3M-^`7B
M+]I[Q?\`L<>&_BM+X]67Q?>?'+P3+XHT#4I=1^&L7A8V&G?#S4_B7X*\3_"G
M1-;A\?WWBN;Q59Z9J5_X+L?#.L?VGIO;_M(?LGZO^T7!XK\)ZI\</&WAOX1_
M$SPE;>!_B7\,K7PSX"U^VN]"C^VQZC=_#OQ/X@T*ZU_X8^)_$=E>)I^N>(=/
MDUU[==-TC6?"ECX5\5V"^(I,NQ_8F\/V?Q5LO%<GQ$\67GPIT?XZ>(?VH="^
M!EQIOAL^&M+^/_BJUUM-9\6CQ4E@/%UUX:_X2#Q+XC^(^G^")[P6EE\3-;N_
M$,FKW>D6FC^&-,`/HWXL^+?B#X4\,6=S\+OAN/B=XQUGQ!HF@:;I%]XHLO!?
MA?1H-4GD.H>+/&OB>:PUW4]+\*^'K"">ZOAX:\*^+?$VHWLFG:3I'A^XEOY+
MNQ^(_#/[=GQ#^(UUX>^''PQ^!/A[Q#\>Y_$/[3^F>*/"^L_&./0/A;;:+^R7
MX]\'?#/XA^)?!GQ/A^'VL:YXPT[Q1X\^(?@[PCX&-U\-O#@@UZ3Q?8>-Y/#%
MWX#U>UO/:?B3\!/CW\3/V:O#_P`'W_:F\3>`_B>Y\/I\0/C7X.\!^$[?7/&&
MDV=W<W/B;PU:Z18/X=M/!]IXNLI+?0=1\0>"+OPWXJTO2X[N?PMJWA[6;R/5
M++SO1OV)/%GA_P`+?"8>&?CG!\.OB=\&M!^(GPX\%^./A1\$?AOX)\+V'P7^
M)ESX1O=:^&B_"B[D\2^%UBT;5?`GA'Q/X4\0I?"]TKQ9X>LM1U"SUK2+_P`2
M^'O$`!0\(_\`!0?2OB)\4_V*?!_@CX1^+;KX>?MD?#SQCX[T;XL^(-;\.Z/I
M?AJ]\-?"JV^*$7@JR\/:?<Z[K'BOQ':0->Z)XTO4_L+POX6U2UCL].USQ3J,
MMW8:7;^`G[:6N?&3X]^*_A?J5K\!O#/AW3O$?QJ\.^%;&T^+'CS5OC%XAF^#
M_P`0-7\"7C2>$]1^#/A_X:RZDJ:%=^(_%_AKPI\7/%GB+P!I.I:$=<TXB]FG
MM^7UK_@GWXHT[Q_^RAKWPC_:"G^&O@']C;PQ/X3^$'P\O/A)X9\;M)INO^`K
M7X;>.)?%OB[4/$FCZGKU_P")?#=O)<17D>GZ?)IGB"[NM7E&JI(MBOT'I?[-
M7B*7XM^$_B%X[^.7CGXA>&?A=XS\<?$#X2>`]8T#P1I:>$_$_C[PWXP\&7TV
MN>+=#T2RU_QMIWA;P=X]\6>%_`MAJ2Z?)I^F:J+OQ9>^-O$&G:5K=B`=;XI_
M:B^#G@GXE:3\*O%.L>)-$\1ZWXET#P3INKW_`,._B)!\/;CQSXLTZ'5O"O@9
M?BDWA8?#D^,O$ME/%_8OAM?$[:G?7L]II*0KK%_86%SX]X;_`."CW[(?B_PE
M'XT\-_$G6-5T?4?#'PO\8^$K>'X7_%=/$'Q*\/?&?57\/_#6_P#A)X7F\$Q^
M(OBP/$OB2*Y\-K#\/-,\23Z5KEG>V&MQZ:UI-(OF_P`5?^":W@7XM?'^/X[>
M)/'^L75[8_'3X'?M">'K/4_`_P`/O$7BCPCXO^"-[X'?3O!O@_XI:YHUUX]\
M+?!O7[7P0+S4OAEH&H:=8P>*O%7C/Q)#J<T/B/4-#EXW2_\`@E3X)\.:9^S?
M+X9^+_C72O&G[*?[.GP>^!?P?\92>'O"VHS:9J_P6\56WB+0/B'J^B7<9TO5
M[G7M-;7?!WBKPN_V?3+SPSXGU9M)O]%U^#1]<TP`^B/@G^UWJ?QV^"OQO^+'
M@;X0>(==U;X6_&O]H?X->%?A[IVL0:9XB^(.H_!#XBZQ\.].NIY/'6F^#H_`
MU[XJOM+6[U;2O$MNLO@I&O;>^EU.?3VCG\LNOVZ_'VC>+?$WP-UWX*^%I?VD
M+'XQ_"/X,>%-#\+_`!<N]:^"GB#7_C#\+?''QKLKG4_BIJ7PU\/^+?#EQX#^
M%OPS\<>+O'OAB3X4:EXEBTV#P9=^'[/5[+X@Z/<V7K7@#]D_Q)\)?@-\:OA5
M\,?CSXP\-_$'XP?$+XW?%>+XXW?A#P)KOB?P9\0OCGXMO_&FO^(M&\(7VF1^
M!+\Z#K>J7TWAO2]5TB;2;>(64%_97\=HRW/E7@3]@?Q%X5^&MCX,U/X[27?B
MOP1\6M#^.WPF^)?AOX5>'_#7BCP]\6K31?$OA[QAXV^(TFI^)O&,_P`;-;^*
MVA^+?$.A_$O5O&FI0:[K>DZ[JT>GZSH^H'1M3T,`SM?_`."B5_H?ACX/Z@GP
M(UK5O$/BO]L+PW^QO\:(=-\<:(W@OX'>.]1^.&A?!'5-0G\67.FVFL>.EU"^
M\2:)XO\`AYHNC^#-.U'Q)X/U"/4O%K?#V6UN[5?4_CQ^V?:?"'X__LX?`C0/
M`X\=7/QB^+?AKX9_$7Q(GB1=%LOA##X[^'GQ<\;>`;I[4:-JO_"6>)O%$WPA
MU\)X2CN]$?2O"T4_BS5-4MDN?#.F^)/(OB5_P3Q\6^*?A]\/?`?@G]I/6?!3
M^&_V@-,_:P\>>*=5^$W@KQGXA^*'[1&B?%O3?C1I/C'5@=4\,:1X>\.VWBG3
M;?2CX*T'3$M%\(6FE>'[35+0Z=]ONNF^(?\`P32^"OQ.^(GPF^,?B#Q#\2M-
M^*G@7X]_#[]H_P`<^(/"7Q.^+/ACP[\5?B7X!^%>I?"R'4]3^'>G_$G_`(0C
MPD=1TR?1WDN/"ND6VHP:3H%MX2>]O/#FIZ[::D`?HRIW*K8QN4''7&1G%+2`
M8`&<^I/<]SZ<GL.!VXI:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`**_'C_@H-\3?B/X1_;U_X(U^`?"?C[QEX7\$
M_%K]IG]H;0OBCX4\.^)M9T30/B)H?AW]E3QUXET+1?&NEZ9>6MIXFTG2/$5K
M:Z[I^FZQ%=V5KJ]K:ZC%`+NWAEC_`%FC\-:240F*Y)**2?[3U7DD#_I^H`Z&
MBL#_`(1G2/\`GC<_^#/5?_DZC_A&=(_YXW/_`(,]5_\`DZ@#?HK`_P"$9TC_
M`)XW/_@SU7_Y.H_X1G2/^>-S_P"#/5?_`).H`WZ*P/\`A&=(_P">-S_X,]5_
M^3J/^$9TC_GC<_\`@SU7_P"3J`-^BL#_`(1G2/\`GC<_^#/5?_DZC_A&=(_Y
MXW/_`(,]5_\`DZ@#?HK`_P"$9TC_`)XW/_@SU7_Y.H_X1G2/^>-S_P"#/5?_
M`).H`WZ*P/\`A&=(_P">-S_X,]5_^3J/^$9TC_GC<_\`@SU7_P"3J`-^BL#_
M`(1G2/\`GC<_^#/5?_DZO#_VDFN/!?P.^(_BCPO?:CHVOZ/H*W6F:I:ZC?M<
M6=P=1L(?-B%Q<SQ;O*ED3YXF&'/&:`/H^BOY^_"GQC_:=\<ZW!X>\*_$#QKJ
M^JW`>000W]O%%!`A57NKV[GACM;&T1WCB:YNI8XO-EAA4M++&C:MM\0_VO;R
M/4G@\1_$O.D75[8W]O/+:VE]'?Z9:+J&IV%KIMX+?4-4O=-L'COK^UT>UU":
MTLY8;J=$@FBD<`_>^BOP$_X6K^U9_8$/B?\`X3/Q\=#N;6"_M[Q;_3WFFTZZ
MO%T^UU2+2T9M9?2;F^=+.WU9=..FS7+I%%=,TD>Z/Q)\6?VJ/!ZVK^)_&WCS
M1TO)[JT@>XU#3YD^W6(B:^TV=[%KM++5K%9X&OM(OFMM4LUFC:XLXU8&@#]_
MZ*_`*3XK_M50^'T\52^-?'<>@26<>I)?OJ.FAFTN:Z%C#J_]G;_[771I;PBU
MBUAM/72WF*JMV0Z%OJ_]ASXC>/?B?XW\<Z7X_P#%^O\`B>PTSPIIM_86VH:A
M,L=K>3:T;:6>/[(;9][P#RCN=E"]%!))`/U.HK`_X1G2/^>-S_X,]5_^3J?%
MX?TN&6.:.*Y#Q.KH3?ZHZAE.1E)+QD<9ZJZLIZ%2*`-RBLV?2[&Y+M+'*3)$
MD+;;B]C'EQR^<H"Q3HJL).2ZA9&'R,[)E:@DT/393<,\=P3<NDDV+W4E!9&9
MUVA+I1$`S'*Q"-2/E92H``!LT5A_\(_I7E>3Y5SY?F^?C[?JF?,">7G?]L\S
M;MXV;_+S\VS=\U2/HNG22W,S1SF2[5UG(O-14,KNCMM1;H)$2T:X,*QE<$*0
MI8$`V**Y_P#X1K2/^>-U_P"#+5O_`).K0L=,L].\W[*DJ>=LW^9<W=QG9NVX
M^U3S;,;VSLV[N-V<#`!H4444`%%%%`!1110`4444`%%%%`'X@?\`!2?_`)22
M?\$*?^SK?VH/_6.?B#7[>1_ZN/\`W%_]!%?B'_P4G_Y22?\`!"G_`+.M_:@_
M]8Y^(-?MY'_JX_\`<7_T$4`/HHHH`****`"BBB@`HHHH`****`"BBB@`KYP_
M:Z_Y-O\`BS_V+2?^G;3*^CZ^</VNO^3;_BS_`-BTG_IVTR@#\8?@1XDTCPUX
M[M[G7==T_0],N_LD%T-<\/+XA\-ZC';:C;WXM=:5)%O='-O+;0W^DZ[I\<L]
MEJ5M''*8+>YDG7K=-U;X::9J=YXV\,^,[+3M:T>^N$^&WACQ7;>.VT?P;<2:
M-8V^H^,HUATGQ3<71NM86[N/!WA6?4T;3+:#2[GQCJ.HW&GPZ8_S0>I^I_G2
M4`?5=M\3O!NG>$[1+"_T2+4-&^'WA7P_X<O'\*:Q<?%RR\3:!K&D:Z+35_%<
MD,7AG4OAS;:Q:W\J:&+_`!=>'(M(T2&WMKR.=DQ_&WB?X>:SH+^#]#U/PUI`
M\3_$S4OB-K?B+2](\?3Z5ILD?AS5[&V%U:^(89M?6]US4-1=3H6CP7VF>'(4
M@6?6]7::6YM?FRB@#Z;O_'_@:Y^'MWI"SZ(TW_"JM&\':07\-ZROQ<@UZSN=
M.U"YTK6/&@MQX;NOAS'J2ZFL>F07DA?PXFCZ5:VD5[;RX][_`."<'_)1OB1_
MV).D]>O_`",#=:_.FOT6_P""<'_)1OB/_P!B3I/_`*D#4`?KEJK,NF:@RLRL
MMC>%64E64BVE((8$$$$`@@@@@$<U_-SHOC#XIZ]J-AH^E^.?'%QJ&H2>3:Q2
M>.=>M8BRPR3RR3W5SK$5M:VUO;PS7-U=7$B06UM#+/*X2,U_2+J__(+U+_KP
MO?\`TEFK^9#PUJ4&C:UI.JW#:S'%87"W)F\.ZE'H^O6\B0R""[TC4IH;B"UU
M"SN&BNK<W$+VT[0FTN3'!<22H`>XZOHWQ>T75]6TZ]^,D<6FZ-:6-Y>>*Y/B
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MD\-2ZE!!I6IFYM8X;RRM85`.-NH/C39Z'-K4WQ$UXS6GA^P\6ZCX;C^)/B"3
MQ;IGA34Y[:"Q\17^BB^"Q:=*U[83RQQ7L^HV=C?V6HWNGVUC<I<#-\&WGQD\
M=WFI66@>.O%Y;2=(U#6K^XU#QYXDL;.&UT^TN;S[.+AM0E\S4K];2>'2K"-&
MFOIXI0OEPV]S/#OGXNZ3!X'U;2;6VOY_$>N>`8_AO-)>>'_#,7]F>'1J5K-]
MG_X32UN#XC\1:;I6D6-MI/AG2M1TNQO+)3&^LZUK$&EZ;;AG@3XJ^$O`FH?V
M9'X3E\0>%;36?%FK6>K7UWJ6C^+=2?6O!VJ^%=*&N:?HVO)X?E&G0:E<6L$2
M2SC2[35-:O-/EDU.X20@'9_LJ^.?&FK?M`_"VSU'QEXNU+3[O6;X3V6H>)]=
MO;.XC/AK6Y42XM+K4)K>95=4D"2QNJR(C@;E4C]YAT'T%?SZ?LEE3^T?\*BD
M20)_;VI;((WEDC@3_A&M>V0I).SSR)"N(TDF9II%4/*S2,S'^@M>@^@_E0`M
M%%%`!1110`4444`%%%%`!1110!^'G_!2Q'?_`(*0_P#!"I8Y6A;_`(:O_:</
MF*J.P5?V/?'[.H$BNG[Q`T>XJ2F[<HW`5^T,>F:OY:?\5%/]Q?\`F&:9Z#_I
MA7XQ?\%)_P#E))_P0I_[.M_:@_\`6.?B#7[>1_ZN/_<7_P!!%`&'_9FK_P#0
MQ3_^"S3/_C%']F:O_P!#%/\`^"S3/_C%;]%`&!_9FK_]#%/_`."S3/\`XQ1_
M9FK_`/0Q3_\`@LTS_P",5OT4`8']F:O_`-#%/_X+-,_^,4?V9J__`$,4_P#X
M+-,_^,5OT4`8']F:O_T,4_\`X+-,_P#C%']F:O\`]#%/_P""S3/_`(Q6_10!
M@?V9J_\`T,4__@LTS_XQ1_9FK_\`0Q3_`/@LTS_XQ6_10!@?V9J__0Q3_P#@
MLTS_`.,4?V9J_P#T,4__`(+-,_\`C%;]%`&!_9FK_P#0Q3_^"S3/_C%?/'[6
M%CJ,/[.OQ7DGUJ:ZB7PTFZ!K&PA5Q_:VF<&2&%9`,9^ZP.><\8/U-7SA^UU_
MR;?\6?\`L6D_].VF4`?S[MU/U/\`.DI6ZGZG^=)0`4444`%?H5_P3L@N;CXA
M?$9+:]>Q<>"M))D2"WN"P_X2#@%+A'4`8;D`'+9SP!7YZU^BW_!.#_DHWQ'_
M`.Q)TG_U(&H`_535=-U8:9J)/B"=A]@OLC^S=,&<VDPZB#/O[].]?S)I]Q?]
MU?Y"OZB=7_Y!>I?]>%[_`.DLU?R[)]Q?]U?Y"@!U%%%`!1110!]#?LH)))^T
M1\+$BF:WD;7;_;,J1R,F/#>N$D)*K1MN4%?F4@!B0,@$?T`V%K>6P?[7J,E_
MO";-]K:VWE;=V['V:--^_(SOSMV_+C)S^`?[)/\`R<;\*?\`L.ZC_P"HSKU?
MT&+T'T'\J`%HHHH`****`"BBB@`HHJ.5WCBD>.)IG1'9(E9$:5E4LL:M(R1J
MSL`@9W5%+`LRJ"0`245\+>+?VA?B%X0\;>&?#WB+XA?L>>$-<\7^-K#X=>&/
MA!XG^)_B=/'>N^.-3T73_$VF^"XO%5O9Q6]IXNU#PYJFEZK!H\7PRU8/!K6A
MR6=QJ%KK&E7%_P#;6EW%[=Z;I]UJ-C_9>H7%E:S7VFBZBOA87DL*/<V8O8%2
M&\6VF+PK=11QI<!!*L<8?8H!^)__``4G_P"4DG_!"G_LZW]J#_UCGX@U^WD?
M^KC_`-Q?_017X?\`_!2QI5_X*0?\$*C#&LLG_#5_[3@"/)Y2[6_8]\?J[%]D
MA&R,L^`A+E=@P6##]H8[WQ!Y:?\`$CMON+_S&H_0?]0Z@#HJ*P/MOB#_`*`=
MM_X.H_\`Y74?;?$'_0#MO_!U'_\`*Z@#?HK`^V^(/^@';?\`@ZC_`/E=1]M\
M0?\`0#MO_!U'_P#*Z@#?HK`^V^(/^@';?^#J/_Y74?;?$'_0#MO_``=1_P#R
MNH`WZ*P/MOB#_H!VW_@ZC_\`E=1]M\0?]`.V_P#!U'_\KJ`-^BL#[;X@_P"@
M';?^#J/_`.5U'VWQ!_T`[;_P=1__`"NH`WZ*P/MOB#_H!VW_`(.H_P#Y74?;
M?$'_`$`[;_P=1_\`RNH`WZ^</VNO^3;_`(L_]BTG_IVTRO</MOB#_H!VW_@Z
MC_\`E=7SQ^UA<ZQ)^SK\5TNM*@MH#X:3?,NJ+<,@_M;3.5B6RBWGO@R*,`\Y
MP*`/P.;J?J?YTE*W4_4_SI*`"BBB@`K]%O\`@G!_R4;XC_\`8DZ3_P"I`U?G
M37Z%_P#!.R6\B^(/Q&:RM([N0^"M)#1R70M`J_\`"0'!#F"<,3D\%1PO7)%`
M'Z^:O_R"]2_Z\+W_`-)9J_EV3[B_[J_R%?TV:K>:^=,U$-HELH^P7N3_`&RC
M8_T2;'`TX9Y]_KQ7\R:?<7_=7^0H`=1110`4444`?1?[)/\`R<;\*?\`L.ZC
M_P"HSKU?T&+T'T'\J_GN_90:9/VB/A8T$2SS#7;_`&1/+Y*OGPWK@;,NR38%
M4LWW&R0%P,Y']`-A-J$P?[=8Q66T1^5Y=ZMYYF=V_.VVM_+VX7&=^[<>FWD`
MT:***`"BBB@`HHHH`*1@""#G!!!QUQCMCG/I2TC=#@`G!X/0\=#UX/TH`_#+
MQG\'=;\>?M??&5O!?P_^)&O^!E^-/PXL/'$_B3XM_!KX<Z9X>UBZU_\`9B^+
M_P`4]3\!^%]2\*:K\5/%/A7XB)\$O@K8W>L>(M=MK^.S\$>)M!^#\&A6&K6?
MB&+]S0,#\2?S)/ZYSCMTK\*_B_\`!2]U/]M#Q#X_F_9T37OBX?V@/@E<?#)+
M;]BGX-^+_@GXW^#=I'\.3XK^*OQ4_:MU;X+:QXX\,?$_P7`GQ#OM-N[CXW^"
M?$W@_5_!W@G2O!?PT\;V%W%/XR_=1>GY^V>3R1@8)ZG@<DT`?B#_`,%)_P#E
M))_P0I_[.M_:@_\`6.?B#7[>1_ZN/_<7_P!!%?B'_P`%)_\`E))_P0I_[.M_
M:@_]8Y^(-?MY'_JX_P#<7_T$4`/HHHH`****`"BBB@`HHHH`****`"BBB@`K
MYP_:Z_Y-O^+/_8M)_P"G;3*^CZ^</VNO^3;_`(L_]BTG_IVTR@#^?=NI^I_G
M24K=3]3_`#I*`"BBB@`K]%O^"<'_`"4;XC_]B3I/_J0-7YTU^BW_``3@_P"2
MC?$?_L2=)_\`4@:@#]<=7_Y!>I?]>%[_`.DLU?R[)]Q?]U?Y"OZB=7_Y!>I?
M]>%[_P"DLU?R[)]Q?]U?Y"@!U%%%`!1110!]%_LD_P#)QOPI_P"P[J/_`*C.
MO5_08O0?0?RK^?/]DG_DXWX4_P#8=U'_`-1G7J_H,7H/H/Y4`+1110`4444`
M%%%%`!6-XCM_M?A_7+4VJ7HN='U2W-G):6FH1W8FL+B+[-)8W]U8V5XEQO\`
M)>TN[VTM;E7,%Q=6\,CS)LU6O;2UO[2ZLKZVMKVRO+:>UN[.\@CN;2ZM;B)X
M;BVNK>57BGMYX7>*>&1'CEB=XW5E8@@'\YG@?X$?$_4OC'\-O%_C/]DS3SK%
MGXT^&$M_XOUG]@+]@_1=:TO3_"]YX:TS2+T^*M%_X*&>*?$_A]/"_A[1]-M=
M'UC0/#OB35O#NF:583>']$UJ:PL=.NOZ.Q_4]@.I/IG\^IZG!XK^?_7?@]X$
M\4?ML>,]1L?@=XGOK7X9_'3X3^%?#VO?`?\`8'_8T\0?#/PWI_A'PA\*;O2M
M*\:_&7XP_#;4/C0OBGPC#);KXG\3_#O7;30_!'A)?"ND?#F>P\0>%M16T_H`
M']3UP.Y]/7MW(Y/.:`/P]_X*6RI!_P`%(/\`@A7(XD*K^U=^T\"(H9IY,O\`
ML>?$!!B*!))6&YAN*H0BY=RJ*S#]IH]?L/+3]SK'W%_YEWQ!Z#_J&5^+O_!2
M?_E))_P0I_[.M_:@_P#6.?B#7T#^V1^T/\7_`(4?$_0_#G@'Q6FAZ-=>!=*U
M>>T;0]`U(R:C<:QKUI-<>?JFFWEPH>WLK:/REE$2^7N5`SN6`/TD_M^P_P">
M.L?^$[X@_P#E91_;]A_SQUC_`,)WQ!_\K*_$Y?VHOVPG\+R>-D\0ZHWA.*_&
MF2>(%\!>%VTM+O:6(>Z&@;%@5Q]G>\/^A1WA6Q>X6\=8#77]JS]KQKO0K!?$
M>K-?>)[.WU#PY9+\/_#37FO6%W/<V]K>Z3:KX>,]]:7,UI=)!<P(T,HMYI$<
MQ1M)0!^W/]OV'_/'6/\`PG?$'_RLH_M^P_YXZQ_X3OB#_P"5E?BZO[1O[:SZ
MQ+H"ZAKYUJ'3XM6ET[_A7_A031Z5.XB@U1Y3H8M!IT\Q$$%]]I-K/<_Z-#*]
MP#$,"+]K?]K*?6AX;A\5ZA-XA:^?3!H4?@+PR^L'48W:.2Q_LY?#QNQ=1NCB
M2$Q!HPCN^U%9@`?N#_;]A_SQUC_PG?$'_P`K*/[?L/\`GCK'_A.^(/\`Y65^
M(.M_M:?M9^&;]=,\1>++S1+]H(+M+34O!/A*VEEM+C=Y%W`3H9CN;6;8XBN;
M>26!VCD19"\;JOZ]_`3Q1KGC7X-_#CQ7XEO1J.O:]X6T[4M5OA;VUH+J]G5S
M+,+:SA@M80Y`_=P0QQK_``J*`/0_[?L/^>.LGZ>'/$)_EI=']OV/_/#6O_";
M\1?_`"KKX/\`^"A^KZOH_P`/_A_-I&K:KI$TWCFXBFETK4K[3)98AX:U5Q%+
M+8W%O)+&'57$<C,@=5?;N4$?F[X2TKXH^+]$UK7[3XBWNDV.DK)';'Q%\1]5
MT9M;U"&ZT.WN-,TR2[U5(%FMQXATII+J_EM-/%S?6&G_`&D75]'Y0!_0E_;]
MC_SPUK_PF_$7_P`JZ/[?L?\`GAK7_A-^(O\`Y5U_.[>6OQ;T_P`+^'/%M[XL
M\3V^F>*M9&B:-;MXYUI]6FGDL;;4+:[N=-BU.2:PT^_M[E&TZ:]:">^"/-!:
MM:>5<R[=SH/Q)BU[_A'+7XKOJ&H6Z>(;G5Y8?&_Q`LM.\/Z9X5BGEUW6M6U'
M6],TFW;2+'[+<PBZT@ZN]S<QBVM(9II[=9@#^@?^W['_`)X:U_X3?B+_`.5=
M']OV/_/#6O\`PF_$7_RKK^=+7Y_B9H&H:/8R>./$.JQ^)+"PU/PWJ>B>-O$=
MYI6O6&I7L^F6L]A<7%W8SHZZI:W6EWEKJ%I8W>GZA:W%M>P0&/<VEXML_B;X
M.BN9;WXC7^J#3?$-UX1UQ-`\?>*;^30/%-E;RW5QH>J"Y;3U-RD-O=%;G37U
M'3I'M+B-+TLL?F@']#?]OV'_`#QUD?7PYXA'\]+KY!_;W^)ND>`OV/\`X\^,
M;K3-=U*V\/\`@R.^GL8=+U'3IKE#K^B6WEQ7FIV$-E"VZX5BT\BJ%5OJ,#_@
MGOJVJZO\*/%UQJ^JZGJUQ'\1+R&.?5=1O=2GCA'AKPY((8YKZ>XE2(.[N(E<
M1AW=PNYF)R_^"K?_`"CS_:F_[)U%_P"I3X<KWN%<!ALTXGX<RS&0=3!YCGV3
MX#%TXSG3E/#8S,,/AZ\(U*<HS@Y4JDXJ<)1G%OFC)-)GA\3X[$99PWQ!F6#F
MJ>+R_),UQN%J2A&I&&(PN!KUZ$Y4YJ4)J-6$9.$XN,DN62:;1_+T_P"W]X)4
MN3\.?&`"DEB=8\/```XR22`![G`I#^W[X*!`/PX\8@DD`'6/#P)(&2`,Y)`Y
M(Z@<FO*O^">&B:/K'[0EJ^L_#S4O',.GVFFRVNJ:?X(TKXG1?#N[NO$^E6S>
M+]6^'FJZIIRZ]I%W8_;?"MQK%K#JT_@NXUZT\0#2YF6.2+Z"^%/PDGT3X[7/
MPO\`'?P@^'5SX)\9^.]3TRSU'P7^S=JGB3P-\0-8U'X?Z#>/\,=?\=>*=5UW
MQA^R-X:\#2ZWH^M^)_[)TG_A*_A5X@UGQ-<:M!J&F>$]-?3O[(S3PH\(<KQV
M9X"?#>.J5<MRRCFC_P",BS;FQ-*2J3KTZ-.GB:LO:TJ=.,HTYM5)<[K8B&$R
M^#S"7\CY9XH>*V9X++<=3XAP<*68YC4RU7R#*G'#U8NE&C4K5)X:E'V56<YJ
M52"<(\JHX>>+Q\U@(\E_PW]X)SC_`(5SXQSC./[8\/9QG&<9Z9XSTSQUH_X;
M^\$G./ASXQ^4[3_Q./#W##JIYX(]#S5GPO\`"+2/$VCZ!\.(/AMX%N/A=??L
MD?"#XD>&_BQJ>AZ?X=77/VC/$WBSP1I%_#J_Q^BT\ZE%;^*_B9K/BOX(ZUX4
M_MN\TO0_"UB+_3?#-MJN@)J;4OVO/AMX7U[PD-;^#O@?6;V:S_:3\;_#W3=`
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MD>E?.\8^%_AMA>`>+\_R+),=@<QR*5*EA:M?-LUQ$7SXO+XQQ"HXFLJ-:G6P
M^)DX3A'$X65^:CB:W*VO?X1\2?$/$\=<)9%G6=8/&Y?G:J5<52H97E="24,)
MC92H.KAZ/MJ-2CB,,N>$Y8?$QLX5\/1NHR_JFU;7;%M,U$"'5\FPO>OA[7U'
M_'K-U+:8`/J2*_F/3[J_[H_D*_J`\1SFV\/ZY<JH=K?1]4G522`QBL+B0*2.
M0"5P2.0#D5_!T/\`@H%XM2`2R?#?PA&B0B61W\0:ZD<:+'O=W=H0J(B@L[,0
MJJ"20`37\[<'>'7%G'JS"7#.`I8Y97+"QQGM,=@<&Z;QOMWA^58S$4'4YEAJ
MU_9\W+RI2MSQO^_<6^('"W`\L!'B/'5<$\R6*EA/9X+&XOVBP;PZQ',\)0K*
MGR?6J-O:<O/S/EORRY?U'HK\Q;G]O3QU9WLVFW?PJ\.VNHV\GDW&G7&J^)8-
M0@F\A+KR9[&6U2ZAE^RR1W7E20J_V9TN-ODNKFLO_!0'Q<ZLR?#;PE(B1">1
MX]>UZ1(X"=HN)'2%ECMRV%$[E8BQ"[\D`_:+Z/7BI))K(L(TU&2:SS)&FI6:
M:_X4-4[NSZVTW/CWX]^&2;3SK%)IM-/)<YNG'XD_]AWCK=;KK:^GZAT5^7O_
M``W_`.+^1_PK7PGD;<C^WM?XW`E=W[GY2P!*@X+`$J"`2)XOV]?',R-)#\*O
M#TT:$AY8-3\3SQ(0`2'EAM'C0@$$AV!`()&""1_1Z\5$KO(L(E=*[SS)-W;_
M`*C_`#?W>8+Q[\,GHL[Q3?99+G+[?]0/K^'?3]P?V3YD@_:)^%DSB5D37-0+
M"&":YE.?#6NJ-D%O'+-(<D9$<;$+EB`JDC^@2RU"WO@_D)>)Y03=]KT[4+#.
M_=CR_MUK;>;C:=WE;]GR[]NY<_R`_P#!/']LKQ-\1OVTOV?_``3>^!/#FEVO
MB'Q7K5I/J%GJ^L7%U:K!X%\6WX>&"YB6%W,EFL;+(0`KL1\RBO["U.54^J@_
MI7Y]Q=P5Q%P-C\/EG$F#IX+&8K!PQ]&G3Q>$QBEAIUJ^'4W4PE:M3B_:X>K'
MDE)3M%2Y>646_O.%.,<@XUP.(S'A[%U,9A,-BY8*M4J87%81QQ,*-#$2@J>*
MHT9R2I8BE+GC%P?,TGS1DDM%%%?*'U`4444`%%%%`!2'&#GI@YYQQWY[?6EJ
MI?S36UC>7%O%%//#:W,T,,\TMO#-+%!))'%+/!:WLT$<CJJ2316=U+$C,\=M
M.ZK"X!^8GCC1OV']:_:CUK5+GX=?M"^.?C9IWQ&\"V/C#QE\+?!W[:/B[X::
M!\0].L?"MYX<TSQAXJ^&K7/P/TNY\-Z->^%[WQ+IFISC2_#>CW<1\8VUG!+>
MQ']11[>I]?4YZ^_3MCIQBOP[LM*^+>N?%NX^/.H7/@SP!X6\2_$/PAXJ^(2^
M`?\`@KM\0H/A98_V"?#VCZK=1_"T_LL>'/"-ZW]BZ+!#KGAFZU'PV_C"6`:9
MXBU.SDG%U9?MOIFHV6L:;8:MIMPMWIVJ6=OJ%A=('"7-E>Q)<VMQ&)$201S0
M21R(&13L8<4`?B=_P4G_`.4DG_!"G_LZW]J#_P!8Y^(-:_\`P4,_Y+7X:_[)
MGHG_`*D'B>L?_@I00/\`@I'_`,$*22`/^&KOVGQDG'+?L=?$``<]R2`!W)`'
M)K6_X*%.DGQI\-LCJX_X5GH@RC!AG^W_`!.<9!(S@@_0@]Z`/,K'Q/X0N/@.
M^DZWXFTV;7+)TTSP]9Z;;^(M#\7:=?IIU[+I^D:W'#)-X9\3^!X+NZN);[5=
M038=+F6W6W'B*RL[9LSQG>V6OW'PRO;_`.+OAB\UC2_"6H^'?$FN0:MXHUJZ
M76;KQ-XYUN,:C)9Z58:H_AO4M-U?3M%U35-/>5M.MK^6W739K.UDB'SC_GW_
M`#I<GU/YT`?8!\;?#T:"GAV.7X87E\/!FA^'+KP=JS>,_P#A0ZVMAXV\0>*'
M;3M3BLG\8R>)[>2[L-2DDEU./1S?:GKJ66H7OEP:2OE7BJ3PQKOQ(UWQ+H_C
M^QTK2=8\3:G:65Q>P>(Q=6]J/#=JZSWL>DZ7IUY;>!-3OGN/!UC>0+_;=OHD
M:W&J:"L0F:7Q3)SG)SZ]Z2@#UOXIZSH&IIX!L-#E\/A_#GA.XT?4M-\&-K$O
M@C2)G\2:OJEK;^'+GQ!$NL74MY;Z@=0\0RW%Q?68UFXDCTVZ-NC00?N!^RU_
MR;S\(?\`L2-(_P#09*_GE'+#/J*_H5_9<G@3]GKX0AYHD/\`PA&D\-(BG@2@
M\$@]01]01U%`'S/_`,%(/^2=_#O_`+'RY_\`48U:OS^^$'Q1\-^`=$\66&NV
M?B34QJ]M&9/#L-SI5]X-\7(FK>'IUTG7]%UK3KZ#2YA9:?J=I-XBLEN+N32-
M0N+:WAM=6M-(NQ]_?\%'98I/AW\._+DC?_BO+G[CJW3PQJN?ND]-RY],CU%?
MD)0!ZW'XC\#0?#NP\-Q7/C`:[9>-AX^*1:-HMMI#7[:'INBOH<&K'Q+=ZG!:
MP)8M-9Z[+H]S=@^2)=)<QL3W+_&G3([JWSK/Q,\117GB77=>U/5?&)\*:[JF
MEZ;KOAO4_#]YX4T[2K^74-#US1=6.H0W'B^VO?[!T_7X=+TZ+3M+T&\B34(?
MFNB@#VOQ5\0_"GB?5?#5Q?:-J5YHW@#0?#NA^&]#-CH6AZ?XCM[7Q9<>(/$M
MIXAL]&E,/AK1]1L]2U*QT>R\//JES8JED+^\O99;^\>[\4OBU;>/]`M-*GOO
M%7B._M_%-WK^GZKXLL/#.F2^%M'N].-E+X0T9/#4DHU.PFE33IY[W43;"#^Q
M;&/3]/M_M%XU>#T4`?LE_P`$YO\`DD?C'_LI%[_ZB_AFHO\`@JW_`,H\_P!J
M;_LG47_J4^'*7_@G3+%'\(_&`DEC0_\`"R+TX=U4X/A?PU@_,1UP<>N#Z&H?
M^"K,T,G_``3T_:G6.:)S_P`*ZB.$D1C@^*O#8!P"3U('U('4BOJN!?\`DM^#
M?^RJX>_]6^#/F.-O^2-XM_[)K/?_`%68H_A2T#Q'K_A#Q!IOBCPKK6J>'/$F
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MZ\3-&\Y1F4ZMSXX\<7EWI-_>>-_&MY?Z!;2V6@7]YXO\2W=_H-E/`UK/9:%>
MW.J2W6C6<]J[VL]KI<MI;S6SO;RQO"Q0\O10Z%!N[HTF[U'=TXO6JN6J]5O4
MCI-[S5U*Z;&JU9;5:BLH+2<DK4G>FK)[4WK!?9>JLS9/B3Q(V@1>%#XC\1'P
MI!="]@\*'7]8/A:"]#M(+R#PT;TZ'#=B1FD%U%IZ3B5WE$@D=F/[W?\`!O/_
M`,G!?M"?]D:\+?\`J>/7\_%?T"_\&]+HG[0/[0C.ZHH^#7A8DLP4`?\`">L,
MDD@=2!]2!U(K\P\:80AX6\9<D(PY\'A9RY8J/-.6:Y?S3E9*\I6UD]7U9^D^
M#TYS\3>$.>4I<N,Q$(\S;Y81RS'*,(WVC%;16BZ(_JS\6?\`(K^(_P#L`ZS_
M`.FVZK_.7^!FHMH_Q7^'6K1V?@_49=,UN"^M]/\`'WB"P\)^$KZZM],O7M+3
M5?%.K66HZ1X;GGNO)70=>UFQNM%TCQ/_`&)?ZQ"VF6]UC_1B\5W%NWACQ&%G
MA)_L#6C@2H3@:9=$G`;H`"3Z`$GBO\TE`##&"`RM#&K*P#*RM&H964@AE8$@
M@@@@D$$&OPSZ+%".*P/B%AI6Y<1#(J$F^:RC6HY[3=^2=.=K2?P5*<OY9Q=I
M+]F^DS6>&Q_`6(BFY8>>>UXI<MW*E5R"HE[\*D-7%?'3G'^:$E>+_=3XY>$_
MC%XJ_:+\72?##XU:QX3N'\`Z+-\8M=:\^&/B'X_?"#PIHOB*&Y\.>#O"/B[X
M<W^C^(OB%K?Q/NS+K?AWPN]UH_B(:;I]M9?$K4?#'PTM=)NY[GPI\8Z;JWBC
MQ+?7WA+Q5\/_`/A+_P!K+Q=XP\>>'O!'Q"^&/P^MO@IX=MO!OA7PWI]S^V!H
MU_K.E:?\8?ACXFC$OQ'U+PAX2'A/PU$9_BII6C>*Y]8\66_A^R_"&X2.\=I+
MR-+R1F+M)>(MW*SE50LTEP)9&8HB*69B2J(I.U%`B-M:D1*;6V*P?Z@&WA(@
MYW?N04Q%\P#?N]OS#/7FOWQ>'G-E]'`U<SPJ5'`TL%3J4,F6%GRPIPC*5>>'
MS*E/%<LZ6'>']K-5*-/!86E4JXA5LWEFWX?_`*^\N/JXVGEN);K8VKC*E.OF
M[Q,%*=2<HQH0KY?4AAKPJXA5U2C[*K4QF)J4Z5#V651RO]"O$WA7XDZS^PII
M%I_PA>B0>'/!?[0<GB_1-0\*:+X9T!-=^',WPBU;3=2^+&J`:A_PD^N6WB#Q
M$UC:MJ^MB6YL8(])T*PTS2K*R6T')_!KQ+\5OV=M/_:,O)/'?B;P5K_P?T:Q
MT32/`6B?$)SH%Q\8/B;K]E\/K?Q-/I?AGQ!=>&/%TO@/PFGB7Q+%=6YUK3/[
M:T[PK/=S36MDD3?$/V6U,GG&UM?.W^9YWV>'SO,_YZ>;L\S?_M[MWO4BQ1($
M"11H(@5B"1HHB5AAEB"J!&K``$)M!`P0:^ECPZY83&8#$U\%7P6-S">.JT5E
MCAS1JXO"XC$4)NICL13G]9HT\9A\365*$ZDL;]8@J,J,H5_GI9^HXG"8W#T,
M72Q>#P$,%2K2S%3494L+B*%"O!4\%1J0^K59X2OAZ+JSA"&#5"<JL:JG1_0?
M_@E6`/\`@H1^RZ!G`\;>(`"S,['_`(MMXYY9V)9V/5G8EG;+,2Q)/]Z2?<7_
M`'5_D*_@L_X)6$#_`(*$?LO$D`?\)OKXY..3\-_'``^I)``[D@#FO[SX98I%
M'ER1R85<['5\9'&=I.,X.,]<&OXW^E-_R6^1?]DKA_\`U;YN?UM]&;_DCL[_
M`.RGQ/\`ZJ<G)J***_F4_H\****`"BBB@`HHHH`\^NOA-\+K[Q3%XXO?AQX"
MO/&<+I)#XMN_!WANY\3Q21E2CQ^()M,?6$="B%76]#J54A@5&/00,<?Y_P`^
M]%%`'X>?\%+(HI_^"D/_``0JCFCCEC/[5W[3Q,<B+(A*?L>?$!T)5PRDJZJR
MDC*LH888`C3_`."@=I:V7QG\.16=M;VL3?#717,=M#%`A<Z]XF4N4B1%+%54
M%B,D*!G``%#_`(*3_P#*23_@A3_V=;^U!_ZQS\0:\Y_X*D_';X6?#+]H+PIH
M'C;Q,='U:Y^$?A_58;4:1K6H;["?Q1XQM8I_.T[3[J!=T]G<)Y;2"4>7N9`K
M*3Z&6Y3FF=8I8+)\MQ^:XV4)U(X3+L)B,;B73IV=2HJ&&IU:KA!-.<U'EBFG
M)HX,QS3+<HPSQF;9A@<LPBG"F\5F&+H8/#JI4=H0=;$U*=)3FT^6+ES2:M%-
MGS917S9_PUW^SY_T/;_^$SXJ_P#E+1_PUW^SY_T/;_\`A,^*O_E+7T/_`!#O
MC_\`Z(?B[_Q',X\O^H/S1X'^O_`O_19\*?\`B0Y1_P#-G]6?E?Z3HKYL_P"&
MN_V?/^A[?_PF?%7_`,I:/^&N_P!GS_H>W_\`"9\5?_*6C_B'?'__`$0_%W_B
M.9QY?]0?F@_U_P"!?^BSX4_\2'*/_FS^K/RO]*+U'U'\Z_H(_9@T?2;G]GWX
M1S7&F:=/,_@G26>6:QM99'8B4EGDDA9V)))))))YZU_+(O[7?[/FY?\`BNWZ
MC_F6?%7K_P!@6OZDOV-O$>C>+OV7/@9XF\/7?V_1-;^'>AZAIEX8+BV^TVDZ
M2F*7[/=Q0W,6X`_)-%'(/XE%>7FO"_$N14:>(SOA[.\GP]:I[&E7S3*L=@*-
M6LX.HJ5.IBJ%*$ZG)&4^2+<N6,G:T7;T\LXEX=SNK4H9-GV39M7I4_;5:.6Y
MI@<=5ITN:,'5J4\+7JSA34YPASR2CS2C&]Y*_P`X?\%%M.T^R^'OP]:SL;.T
M9_'=RK-;6L%NS*?#.J':QAC0E<JIP21D`GD#'Y'5^OW_``4@_P"2=_#O_L?+
MG_U&-6K\@:\(]NZ[_P!?TU]X4444"NNZ_K_AU]X4444!==U_7_#K[S]A?^">
M&FZ=>_"7Q?)>6%E=2+\1KQ%>YM;>=U0>&?#;!`TT;L%#,S!0<`DD#).:W_!5
M32-*M?\`@GQ^U+-;:;I]O,OPZBVRP65K#(O_`!5/AL_*\<2..0#P>H!Z@5K?
M\$YO^21^,?\`LI%[_P"HOX9J+_@JW_RCS_:F_P"R=1?^I3X<KZK@7_DM^#?^
MRJX>_P#5O@SYGC;_`)(WBRW_`$36>_\`JKQ1_!H_WV_WF_F:;3G^^W^\W\S3
M:_U=CLO1?D?Y?!1113`*_?\`_P"#?"TM;SX__M!QW=M;W48^#7A8A+B&*=`?
M^$]8Y"RHZYRJGIU4'J!C\`*_H'_X-Y_^3@OVA/\`LC7A;_U/'K\M\:_^36\8
M?]@.$_\`5KEY^F>#G_)S>$?^P[%?^JS'']3GBK0M$3PQXC9=(TM6&@ZU@KIU
MF",Z9=`X(@!Z$CW'!XK_`#68_P#51?\`7*/_`-`6O]+OQ9_R*_B/_L`ZS_Z;
M;JO\T2/_`%47_7*+_P!%K7XC]$_^%QU_U\X<_P#2<[/V+Z47\?@K_KWQ%^>1
M#Z***_L`_E$****`/T`_X)8113_\%!?V7XIHXY8V\;:_NCE19$;;\./&[KN1
MPRG#*K#(X90PP0"/[RK+3[&Q4_8K.TM/-6/S/LUM!;^9L!V[_)C3?MW-MW9V
M[CC&3G^#G_@E7_RD(_9>_P"QV\0?^JV\<U_>DGW%_P!U?Y"OX1^E-_R6^1?]
MDKA__5OFY_;/T9O^2.SO_LI\3_ZJ<G'4445_,I_1X4444`%%%%`!1110`444
M4`?B!_P4G_Y22?\`!"G_`+.M_:@_]8Y^(-?E1_P7XP?VS/A_Z?\`#.G@[IS_
M`,S[\2_Z5^J?_!2R/S?^"D/_``0I3?)'_P`97_M.-NB<QO\`N_V/?'\FW<O(
M5]NQP,;D9ER-V:_*+_@O;:_8_P!L;P!$+BZN,_L[>#G\R[G:XE!_X3OXD+M$
MC!2%&S<%Q]YF;JV!^]_1N_Y.9A_^Q-FO_I-`_#?I#?\`)N<1_P!C?*^G_3V?
M7H?(.D_!#X0Z_P#L97OQ%\+:1?\`C#XKZ-JO]I^.=5TWXCV.D>*OAU!9:+JF
MJZS#>?![7O#]A_PF/PNTGP[%I7B&[UGP5K^M>))X=2?Q?/J>B:-HNIZ%#S'B
MW]G7POXS\9_LQ^#_`-GNV\:RVWQE^$%WXSUC6/'4<>IZS`/#GQ*^+/AOQA\0
M=5T#PK'?6^@Z'I?A+X?'Q-)X0T";6I[*WMUTB#5=>UZ]^UWOD5O^TM\:+7X1
MCX(1>,IO^%?K=PLMG)IVE3:N-`AMYHCX#/B*6R;6W^'D\\[WUUX.DO7TJXF9
M[*2,Z)-<:3-2\;_M`_$SX@Z5X9T?79_!NG6O@RV^P>$[CP1\-?A_\.=7\/:4
M=1UK5WT/2M>\">'/#VM6OA^;5_$6MZM<:&M]_9ESJFHSWT]L\_ELG]JT,JXI
MI8FO46845">:YMB:$JV88W&*E@\9@94<&JN%J86E1K?5<8Z5>E@*-3!X6A1I
M2A&I6KU)8A_QY6S/AFKA\/"6`K.<,KRO#UXTL#@\(ZF+PF-A5Q;I8J&(JUJ7
MUG!JK1J8ZK#%XFO6J1G*E1HTHT#ZO\4_`7X=>&OC]\)/`FE_!CQ6O@7XM?!/
MX;>/$N/C-X@^)W@[5?!]O!HGB#Q'\6O'NJMX=;P]<W%UH_ACPY>>(M<\$*SV
M'A6[>/PW;&&>2WNIO`/@WX.^%GQI_::LO#T&A:_X3^"VLZUXR\1#2)/%,IO_
M``;\.-#T'7-;TN_\<^/-1M;^ZT#POI8L=)F^)7CJ6QOI_#&@W&NZCIEO?7MC
MIT$_G4_QN^*MWJ6G:Q>>,]3O]2TGX57WP3TV[U%;749;3X9ZGX>U+PIJ/AZ(
MWT%P!-?:!J^HV%UKQ!\0SBY^TRZJ]W%#/'3\(?%OQ_X"M-,L_"&M6FBQ:5K>
MO:[!+%X<\+WEY=S^*/#<'A#Q'I&N7VIZ+?77B3P?KGANW73-3\">(9=3\&72
M37=T^A?;[RYNI=Z.3Y]1P&)I/,75Q]7)EEU#$SS/,W"CC&L9&68>SJ1K4U74
M?[-4:L*4:WM*>+K.;E5<*V%;-LDJX[#5(Y>J6!I9O]?K8>.6Y;[2KA$\%*.`
M]I3E1FZ/,LQ<Z<ZCHN%3"THP4:<94O5/VEOA=X:^&^I?"V^\*6GAR'3?B!\/
M3XJN;GX>_$;4/B[\*+K5;7Q;K^@747P\^)&L6EGK.N1Z?::=IUOXRTG5HI+K
MPIXODO\`1X[F>U\A8O[4O^"9A`_8&_9/R0/^+,>%._\`TSN*_A1\=_$[QG\3
M+O09O%NH:?+;>&-+?0O#&B:#X=\-^#_"_AK2+C4;C5KRRT#PMX1TG1-`TM-1
MU:[NM5U6XM]/%[JVI3R7NI75W.(W3^YC_@FMI`N?V"_V4)?[1U:#/P8\+?N[
M;4)(8AN^UOP@1@,;]BX/"*B_PY/\_P#TD*&-POA_PM0S"M'$8NGQ'552M&K6
MKJ4)8/,IT$ZV)2KU9PH.E3G.HN:4XR=Y+WG^[_1ZKX/$\=<35\!1=#"U.'H.
MG2E3HT7&2Q>5QK-4:%Z-.,Z\:DX1I^[&,DK1?NKXK_X+N?$[QO\`#'X(?`[4
MO`VN'0[W4_C'?Z?>SK8Z;?\`GV:?#[Q)=K"8]2M+R-,7$,4F^-$D^7:6V,5/
M\\?PZ\>_MR_%O1/&/B+X:Q>*_&>C>`M/74?$U[H7@OPS=K:H]Q8P"QL8ET3S
M];UM8M0AU&30=&COM8CT>.YU5[,6<'F/^Z'_``<&6'V+X`_`'_3+^ZW?'#4Q
M_IMV]SC=\-O$A^7<J@%?+^4]@\G7?Q^*_P"Q_P#%+X+>%?AI\5/"OQM\8::?
M"UQ`VKR_#[4O`FO3>*[M+OQG\&Y=0U7X&_$_P7KNC^(=!^(>IZ9X0=+GP]JU
M[I7AZTU?POX&\<W<FKZ)H'BBSA?A5P_D-7PERO.*G!O#^?9M+-L30J5<;PWA
M\ZQU7#/.'1FHQC05>O4IT/=H*MBL/AZ7NRJ5HTX>SFO$_/<[I^*>8Y33XMSW
M(\KCEF&K4Z>#XBKY-@J5=9/3KP<I2K?5Z,*F(M.O*EA:]>IJH4I3ESP\KG^.
MW[7=KX-T'XAW.I^([?P/XJ\1:AX2\+^*9O!7AR/2/$GB72K2VO=2T;0)FT,2
MZQ=V-O>6QN&TZ&XMDN)EL!<-J"R6B>D:EJW_``4(TC5_#N@ZEX?\;6VL>*[_
M`%C2=$L%\*>`[N235O#NF#6_$>D:K+8V]U:^%=7\-:*?[:\2Z5XON-`U'P[H
MZR:IK=M86$,]Q%R.I:]X,UW]EWP;X/\`$7[0VC7OB;PS\9X/B#9>%#%\4]=\
M9>%OAD/AGX>\#Z;X,\-S7W@C2O!*>+?#%W:ZC>VOAZP\7:)X/DFB:ZL_$UO)
M?M(OHT.N_`/5OA_X4^"6J_M#>!_`VCR?$SQ-XH\2?$KX1?"[XQ^'?^$K^'=Y
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M`CX;7QMJWB#PG)XO\+Z?XV\,P>(/!OAK2[K6?".KW6H6>E>(;6SN=$2[33-2
MN-+OUL9;J"VDNHK<W,436DUO/-C?&K5/"?BSQ#:'PY\1?AOHOA#X3?#WP)X/
M^#/A;PLGQ1\0HOARR\:7QDT"X\5^(_AYX3O;SQQI5UK_`(@^*WCOQ+J^A:/X
M>U>;4;W3?!=M'+'I/AFVW/VG=<\->+O#?P+U2R^.GA7XN^,O!OPN/@/Q_-9?
M\+4N?$>I^*;KXJ?%OQ]>^)GU?X@>`_#<6LZ5)IWC#1;>?4+C5?[8?5)9K==*
M:TM6NQZ6&X2X/G+)85O#OA2#QLJU/,+<&T(/"SC@UB</-OZC5P^&A*3HT:_M
M,5BJ-/$5)X6CBL1*A5K'G8CBGBN$<YE1X^XHFL%&C4P%^+J\_K,7BXX:M&RQ
MU.O7DHJK5H<F&P]6>'I0Q5;#8>-:G2/Z:/\`@A?\2/&?Q,_9G^*6L^.-:.MZ
ME8_';5=,M;EK+3K#RK%/A]X!ND@\K3;2SA?%Q=7$GF/&TAW[2Y555?J;_@JV
M0?\`@GG^U-@@_P#%NHN__4T^'*^$/^"`&G?;?V5OBV_VW4;7;^T'JR[;.\>V
M0[?AO\/#N955LLV_#'N$0<;>?MG_`(*H:2+7_@GS^U+-_:.K7&/AS$/+NK^2
M>(_\57X:;)C**"?EVG)^ZS#OD?QSGV"P>6^/E'`Y=A,-@<%AN/.':>'PF#H4
ML-AJ%/Z]ECY*-"C"%*G&[<N6$(IR;>[;/ZVR/&8O,/`ZKC,?BL1C<7B."<\J
M5\5BZU7$XBM/ZEF"YJM>M*=6I)I17-.3:5E>R/X2W^^W^\W\S3:<_P!]O]YO
MYFFU_HU'9>B_(_S\"BBBF`5_0/\`\&\__)P7[0G_`&1KPM_ZGCU_/Q7[^?\`
M!OG:?;/C[^T)%]HNK;_BS7A;]Y:3M;R?\C]N^^H)_@V]#\KN/XLC\M\:_P#D
MUO&'_8#A/_5KEY^F>#?_`"<WA+_L.Q7_`*K,<?U=^+"/^$7\1\C_`)`.L]Q_
MT#;JO\T6/_51?]<HO_1:U_I/>*=#V>&?$;?VMKC8T#6AM?4Y&7G2[L9(\L<C
M.1Z$`\XQ7^;#'_JHO^N47_HM:_$?HG_PN.O^OG#G_I.>?E^I^Q?2B_C\$_\`
M7OB/_P!*R$?1117]@'\HA1110!^@G_!*O_E(1^R]_P!CMX@_]5MXYK^])""B
MX(/RKT^E?P4?\$L8O._X*"_LOQ^9+'N\;Z]\\+F.0;?ASXW?"N`2-VW:V.J,
MRY`;-?WCZ=8?84?_`$R_N_-6/_C^NVN=FP-_J]RKLW;OGQG=M7/W:_A'Z4W_
M`"6^1?\`9*X?_P!6^;G]L_1F_P"2.SO_`+*?$_\`JIR<TJ***_F4_H\****`
M"BBB@`HHHH`****`/Q`_X*3_`/*23_@A3_V=;^U!_P"L<_$&ORH_X+\_\GE_
M#_\`[-S\'?\`J>_$NOU7_P""D_\`RDD_X(4_]G6_M0?^L<_$&ORH_P""_/\`
MR>7\/_\`LW/P=_ZGOQ+K][^C=_R<S#_]B;-?_2:!^&_2&_Y-SB/^QME?_IV9
M^'M%%%?Z&G\$A1110`Y/OK_O+_,5_?;_`,$S/^3!?V3_`/LC'A3_`-%W%?P)
M)]]?]Y?YBO[[?^"9G_)@O[)__9&/"G_HNXK^8/I3_P#)'\/?]E&O_5;CC^D_
MHR_\E7GW_9/3_P#5EEY^;'_!PU_R0']G_P#[+AJ/_JM?%-?R;U_61_P<-?\`
M)`?V?_\`LN&H_P#JM?%-?R;U]?\`1W_Y-;D__8=G'_JQKGRGC]_R<O-O^P/*
M?_5;A@HHHK]P/Q<****`/Z[_`/@WR_Y-3^+G_9PNL?\`JMOAS7V]_P`%6_\`
ME'G^U-_V3J+_`-2GPY7Q#_P;Y?\`)J?Q<_[.%UC_`-5M\.:^WO\`@JW_`,H\
M_P!J;_LG47_J4^'*_P`[N*_^4AG_`-E_P]_ZFY6?WUPQ_P`F%_[L?//_`%#S
M`_@T?[[?[S?S--IS_?;_`'F_F:;7^B$=EZ+\C^!0HHHI@%?T#_\`!O/_`,G!
M?M"?]D:\+?\`J>/7\_%?T#_\&\__`"<%^T)_V1KPM_ZGCU^6^-?_`":WC#_L
M!PG_`*M<O/TSP<_Y.;PC_P!AV)_]5F./ZL?%G_(K^(_^P#K/_IMNJ_S1(_\`
M51?]<HO_`$6M?Z7?BS_D5_$?_8!UG_TVW5?YHD?^JB_ZY1?^BUK\1^B?_"XZ
M_P"OG#G_`*3G9^Q?2B_C\$_]>^(__2LA'T445_8!_*(4444`?H)_P2K_`.4A
M'[+W_8[>(/\`U6WCFO[TD^XO^ZO\A7\%O_!*O_E(1^R]_P!CMX@_]5MXYK^]
M)/N+_NK_`"%?PC]*;_DM\B_[)7#_`/JWS<_MGZ,W_)'9W_V4^)_]5.3CJ***
M_F4_H\****`"BBB@`HHHH`****`/S/\`^"@O[`_Q"_;%\6?LJ_$_X.?M0ZI^
MRG\8/V2OB3XY^)'P^\?:?\'O!OQJAGOO'OPZU#X:ZO97OA+QUK.E^'W1="U2
M_$,]Y!JB+)<LZVD=S#;7<'Y<_M"?\$%OVS/VI_&NG?$/XX_\%A_%/BSQ=I7A
MJR\(V.I6?[!_[.WAN*'0-/U#5-4M+-K'0?%-C9RO'?:SJ,INI(6N'698GD,<
M,2K_`$[45Z&69MFN2XI8[)\RQ^58V,)TEB\NQ=?!8E4ZEE4IJOAJE.JH322G
M#FY9)+F3L<&8Y5EF<89X/-LNP.:81SA4>%S#"4,9AW4IMN$W0Q%.I3<X-MQD
MXWC=V:/Y$_\`B&!^-'_26#QI_P"(7?!'_P";:D/_``;!?&@`G_A[!XTX!/\`
MR9?\$>PS_P!#K7]=M!&00>AX-?2?\1'\0?\`HN>+_P#Q(\W_`/FSR_/NSY__
M`(A_P'_T17"?_B/93_\`,GE^?=G\4GPA_P"#=_XW_%#Q+\?O#\W_``5"\6Z,
MGP4^-MU\([:ZA_8^^"]ZWB.VM_A7\)_B.NO7$4OBRV73IWF^)4^D&Q@>YA$6
MCPW8F$MW+!#[?_Q#`_&C_I+!XT_\0N^"/_S;5_6!X9\#>$_!U_XRU/PUHMKI
M-_\`$'Q7)XX\8W-NUPSZ]XJE\/>'/"DFLW8GGF1+IO#WA+P[I96U6WM_(TJW
M80"9IY9>LH_XB/XA?]%SQ=_XD>;_`/S9Y?U=A_Q#_@/_`*(KA3_Q'LI_^9/Z
M^;/Y%!_P;!?&@$$?\%8/&F0<C_C"[X(]1_W.M?H-\+_^"9O_``5)^#7P^\(?
M"SX=?\%N-<T3P/X$T2T\.>%])G_X)S_LJZM-8:/8AA:VTFI:GK5U?WKQAV!N
M+N>6:3J[L>:_>6BO*S;BKB?/J-/#9YQ%GF<8>C5]M1H9IFN.Q]&E6Y)4_:TZ
M>*KU80J<DI0YXI2Y925[2=_3ROAGAS)*U3$9+D&2Y37JT_8U:V697@L#5J4>
M:,_95*F%H4ISI\\(3<)-QYHQE:Z3/YS?VC/^"-G_``4'_:Q\/>'?"OQX_P""
MSWB/Q?H?A37I?$NA6EE_P3\_9F\,O::S-IEUH\ET]SX?\16$]RATZ]N8/L]P
M\D`:02A/-1&7Y%_XA@?C1_TE@\:?^(7?!'_YMJ_KLHK;+>,^+\FPD,!E'%/$
M.5X&E*<J>#R_.<QP>%IRJ3=2I*%##XBG2C*I-N<VHIRDVW=MWRS#A'A3-L5/
M'9KPSD&98VI&$:F+Q^3Y?C,3.-.*A3C.OB,/4JRC"$8P@I2:C%*,4EH?R)_\
M0P/QH_Z2P>-/_$+O@C_\VU>%V'_!O'\;[W]I+Q3\`S_P5!\6QVOASX(>!/B\
MGB@?L?\`P7:YN[GQE\0_B1X'DT!M+/BM;>&WT^#P%%J4=\MY)-<2ZG+;O#%'
M:QM-_;!7(P^`_"-OXZU#XEPZ':Q^.=5\)Z/X&U#Q&'N?MMUX4T#6M=\1:1HL
MB&<V@M;'6O$NNZA$Z6RW!FU&823R1+%''W_\1'\0O^BYXN_\2/-__FS^OFSA
M_P"(?\!_]$5PI_XCV4__`#(?R@_\0P/QH_Z2P>-/_$+O@C_\VU'_`!#`_&C_
M`*2P>-/_`!"[X(__`#;5_7911_Q$?Q!_Z+GB_P#\2/-__FSR_/NP_P"(?\!_
M]$5PG_XCV4__`#)Y?GW9_.O^SM_P1Y_X*(?LI>$M8\#?`K_@M%XB\(^&-?\`
M$<WBS5;"\_X)\_LR>)9+C7KC3--T>6\6\\0>(;^ZA1M/TC3X1;12K;JT+2K&
M))96;NOBU_P3"_X*A?'+X<^+/A/\3?\`@MKKNO\`@/QOIJZ1XET>W_X)T_LK
MZ--?Z>MW:WPACU/2M;M=0M#]IL[=S+:W$<F$*;MK,#^]U%?-U<VS2OF7]L5\
MQQU;-OK%/&?VI5Q=>IF'UNC*$J.)^N3J2Q'MZ4J<)4ZWM/:0<(N,DXJWT-+*
M\MH9?_9-#+\%1ROV%3"_V;2PM"G@/JU52C5P_P!4C!8?V%2,YQJ4O9\DU*2E
M%J3O_(H?^#8+XT$DG_@K!XTR3D_\87?!'J?^YUI/^(8'XT?])8/&G_B%WP1_
M^;:OZ[**^D_XB/X@_P#1<\7_`/B1YO\`_-GE^?=GS_\`Q#_@/_HBN$__`!'<
MH_\`F3R_J[/XK?B;_P`&['QO^'WCK]GCP;#_`,%1/%NJQ_'+XLZ_\-+K4)?V
M/?@O:2>&H-%^!GQA^,2:Q;6\?BV:/4Y;FX^%L'A]K.>6UCC@UJ?4%F::QBMK
MCV;_`(A@?C1_TE@\:?\`B%WP1_\`FVK^L/7_``5X7\4:OX)U[7M'MM2U?X=>
M([SQ;X*OIVN%E\/^(M0\(^)_`EYJMF(9HHWN)_"7C+Q-HCK=1W$`M=7N66);
ME;>>'J:/^(C^(7_1<\7?^)'F_P#\V"_XA_P'_P!$5PI_XCV4^7_4)Y?GW=_Y
M$_\`B&!^-'_26#QI_P"(7?!'_P";:OH?]G/_`((6?MN?LG>(O$?BOX#_`/!8
M[Q1X0UWQ9HEIX=UZ[O?V"OV<O$R7>D6.H'5+6V2V\0>*+^VMFCO293/;Q),X
M/ENYC`4?TRT5R8[CCC3,\)6P&9<6\2YA@<3&,,1@\;GF9XK"UXQG"I&-:A6Q
M,Z52,:D(32G&24XJ2U5SJP7!G"&6XJCCLOX6X=P&-P\G+#XO!Y+EN&Q-"4HN
M$I4:]'#0JTY.$I0;A--QE*+=I-/\3KO]@_\`X*[7UK<V5U_P7*UB2VO+>>UN
M(Q_P39_9(0O!<Q/#,@=-45U+1NRAE(9<Y!!`K\PQ_P`&P'QG4!1_P5@\:84!
M1_QA?\$3P!@?\SMZ"OZ[:*X<HXEXBX?6(60Y[G&2K%ND\4LJS+&9>L2Z'M/8
MNNL+6I>U=+VM54^?FY%4FHVYY7[<UX>R#/70>=Y)E&</"JHL,\TR[!X]X=5O
M9NLJ+Q5&K[)5?8TO:<G+S^SAS7Y8V_D3_P"(8'XT?])8/&G_`(A=\$?_`)MJ
M\*_:8_X-Y/CA^S]\!_BA\9K3_@J!XM\57/P\\+7/B.#P]<_L?_!?2K?5I+>Z
ML[<6DNH6_BN]GM4=;EG,L5M*X*`!2"0?[8:Y'Q[X#\(_$_P?X@\`^/-#M?$G
MA#Q3I\FE:_H=Z]S'::GI\LD<LEK.]I/;7*QM)#&Q,,\3Y08<#(/L_P#$1_$'
M_HN>+_\`Q(\W_P#FSR_/NSR/^(?\!_\`1%<)_P#B/93_`/,A_*`O_!L'\9VW
M$?\`!5_QH`'D49_8O^").$=E!)_X31<DA<GY5Y[#I2_\0P/QH_Z2P>-/_$+O
M@C_\VU?UU@`#`&!DG\6)8G\22:6C_B(_B#_T7/%__B1YO_\`-GE^?=C_`.(?
M\!_]$5PG_P"([E'_`,R>7]79_*O\)O\`@W7_`&HO@?\`$7PI\6/AG_P5W\7:
M#X[\$WUQJ7AO5[C]ASX!:Q#8WEWIE_H\\LFF:IXON=/NP^GZE>PB.Z@E1&E$
MJJ)8T9?W1_9`^!7[8'P7;Q^?VJOVZ;S]L]/$(\,CP,EU^S3\(OV>O^%=?V5_
M;?\`PD11OA9=7)\6?\)3]OT;=_;FS^Q/[!7^S]W]IWF/M>BOG\VSS.L^KT\5
MGF;YGG&)HT5AZ6(S3'8G'UJ5",YU%1IU<55JSA252I4J*G&2CSU)RMS2DW[F
M5Y-D^249X;)LJR[*</5JNO4H99@L-@:-2LX0INM4IX6E2A.JZ=.G!U)1<W"G
M"+=HQ2****\L](****`"BBB@`HHHH`****`"BBB@#Y5^+'[97P0^#7C#5?!_
MC#4_$\LGA#2/#GB+XJ>)/#?@KQ-XH\%?!7PYXQN[RQ\*:]\8/%FB6%UI'@/3
M-;FTZ^NTDU&:6?2?#UI<>,?$5OHO@N)_$0F@_;"^#$WQ6M/A/)=>+[.\U/Q]
MJWPCT7QSJ'@+Q98_"C7?B_H.F:GK.L_"O1_B5<Z9'X8OO&MA8:+K,9M$NUTN
M]UO1]7\):9K%]XPTO4/#]M\5?M:_`OXR>'IOVMM.\":%9^,/A5_P4(L_!7PS
M^*/BVQL_B'XF\?\`[.4NK?!JY_9[\7>/-)^%O@/PAXIU;XH>$KSP-HWA1M'L
MO#^J^$[SP=X_U&\U[Q;YW@"ZUWQ+X9]&M?A?^U+XK_:M\(>(_BO\)OAOJ_[/
M?P8\874'P"M-%_:"U*63PU9VOA+4/"EC\>OB-X$U+X+0W_C[XU3:;JFNZ'X=
M\*GQW8^!/AIHOB&]U/3)_%7CJ4>+[(`^P_%O[1/PK\!^.-?\"^-->E\+77AC
MX66WQAUSQ%KNG7>F^"-/\'7?BZY\$VQE\8W*)HC:]/K]L;:#PU%</K5Q'/9R
MVUI,;VV23QZW_;L^#NN_!'X*?'CX?Z%\6OBAX7_:#U*ZT_X6>'_`?PO\07_Q
M!UL:=I?BK6M6OM0\$:P=!U?PW9:/IG@[69]5/B,:7=6,RVFGSVBZG>0V5?2O
MQ";Q+IWA;6M;\!^"?#_CKQU96=DV@^&]?\1Q^"]/UB>TU2TNX["[\8?\(WXK
MET6"W(FU"WN%T#4E6]MX0D$,DHNH/R4_9_\`V0OV@_"O['_[/_P/^./[-G[+
MOQ8U_P#9Y\7>(Y4\&^*?C/XNUWP1X[T3Q9I_CWS_`!'8:P?@_'I.G:GI-QXV
M&CWG@GX@?#?QQX=\0:9'>:M::GX?UVQT65@#]@O!OB3_`(3#PIX>\4G0O$GA
M<^(-'L=7_P"$=\8:4="\4Z)]N@2?^S/$&C&XNCI>KV>_R;ZQ-S.;:=7B,C%<
MUTM?/W[+?PJ\5?!/X$>`?AEXTU^U\0^(/#-MKJSS:;?:]JFC:%I^K^*M>U_0
M?`WAW5/%$LGB'5/"_P`.-`U;2_A]X7U/6DM-2U#P]X8TR\N].TN68Z;:?0-`
M!7AOQE_:"\"_!*;PEI/B"T\7^)_&/CZXUJ'P3\//AQX0UKQ[X^\3V_ABRMM2
M\5ZMIOAO0H);B/0?"NGWMC/K^O:C-8:18W.J:'HXNYM?\1>'])U/W*OB/]IS
MP/\`%OPU\2?AY^UE\$_!VD?%OQA\&/A+\=OAUK'P3U?Q/JG@Z[^('A'XI7WP
MK\:R2^!_$EKH?BS3K#Q_HWBGX+>'+73-.U;PU)9>(]'U[6=/&L:5J-MI:W@!
M8\0?M_?LWZ'X<T'QK:ZYXR\5>!=2^'%A\8O$7C?P7\,O'WB?PQ\,OA3J.I:]
MHL/COXKZAI^@&3P!I5KK'A3Q;IVLZ=K=M'XG\//X/\9WOB#0-+TKP=XGO]*^
MC?&?Q3\*^!M2^%NEZPVK7%Q\8/'\7PX\&RZ)HU_KEF_B";P-XV^(<<^LWFG1
MS6^AZ$WASP#K[C7]1>+2SJ!TS3!.;O5K))/R&/[/W[6E_P#`OX5?`SPIX&\$
M?$W]F[Q9HOC?XI_'RSUCXE?$/]F3XB_%KX@_&WXR^.OB]X[^"NK>$OB%\#?%
M7C3X=?L[VUQXQO=-U;2IWT7XI^/M"N+;P+K\'@3PQ;^)K#QE^V"6D<EM9&>P
MM%GLU2>WM_W<T=E=?9);8K:S-`OE^7%<3VB3Q0PG[-+(@C6*1H2`>&_!#]J'
MX*?M&7GQ9M_@]XPB\96GP7\=VOPY\::Y9Z?J%OX<?Q'>>"?"WQ!A?PQKUY;P
M:;XP\/R>&O&&B7,'BSPW/J/AF]FDNH-.U6]^Q7$BR?L]_M,?"?\`:?T/QWXD
M^$.L:CKFB?#WXI>+OA%KFH:AH6IZ'#<^*/!T.CW=_=Z(-4A@DUKPSJ>FZ_H^
MK^&_$UFC:5XBT;4;/5=*FN+"XAGD_/3P=^S%^UMX]UK]OSP[\1=`\`?L\>#_
M`-LGQ5X$\8:%XY^%OQ9A^+WBGP5I_@?X(?`3X%:M\/-3\&>(?@]X"T6^TWXB
M:!\*_$Z:KK&GZY;R:-X:\4C2M,C@UR.+6K+Z"_8&_9<^-'[,<G[5B?%_XE^&
M?B+#\9?VH?%7Q@\`GPSX7T[PK#HWA'5O`OP^\+6T6IZ9IMG:6FFZI=2>$1;M
MX?L9+_2="T[2=,&G:C<-J%Y#:@'Z#T444`?/_CS]IOX0?#'Q3XX\'^//$,_A
MO6?`?P>7XZW\>H:7>BWUOX>1Z]J'A;4[WP?<Q1RIXLUG0_$MMI.A:UX8T87'
MB'3]4\9^`+233F?QQX;_`+0^6/&'_!4'X)?#W6_C9HGCCX9?M+>%W_9[\#:3
M\1OBGJ&J?!+51I6@>$O%5YXETSP#J,-[;:S<_P!JR?$35_!_B31_!MEIL5Q>
M:CJ&DW,=Y#IL6R9O6?VIOV9KKX[_`!._8M\=Z?9^&77]GC]I27XG>-9M;O-1
ML=0U+X;2_!WXH:-)X8TE+"SN8M=$OQCE^"'CN;PUK<MIH$NH?#G1?%,DK:]X
M1\/QM\L?M>_L/_&KXU+_`,%$[[P'>?#YKW]I_P#9F_9)^%OPLM/$OB+6-'1?
M&?P#\??'OQ?XI3QG>V?A;6CH.A:M:_$CPS9Z+JVG6_B.ZEN(]6>]TBUCLK8W
MX!]\?![]HWP-\8]8\2^$;#2_'7@7XB^#=,\/Z]XI^&?Q3\&:MX#\<Z5X<\5W
M&LVGAGQ1%I>IK+8Z[X6UR^\.^(-,LO$GAG5=;T9=:T+6M"N[VUUK2[VPA\X\
M??MV_LX?"[P`OQ&\>^+-6\,Z-=?&KQ'\`M(TO4/"?B'_`(2WQ!\0/"GQE'P*
MUP:!X2@LIM<U3PI8>.G@:[\<0VB^$K'PS=V?BS4=7LM#N[:[ERO@Y\(_B[KG
M[17BG]J+XW>'_!?P[UN;X.:'\#_`OPT\!^/-6^(\-CH$7CS6?B+XN\5^,?%U
M_P""O`%A>ZSK>N7.@:7X=T'2/#T]OX9T?0]2OKGQ'JU]XNGTW0.+_P""COP9
M^.?QR_9_E^#_`.SW\/\`X:^(=9\5>-/A_P"(]<UOQ[\2+KX:6/AFU^'GQI^&
M7QBN!:)I7PW\?7>OW/C*7P3?Z3<JJZ2EAJ$]CJE[)J2&1(`#W3QA^T_X=\+?
M&6V^"6G?#?XU>//$<=KX'O/$FO\`P_\`AQ=^(_`_@>W^(&JZSIF@2>,/%3ZE
MI]II>V'0=2UG54MH-0?2=#CAU&]6-;RTBF^F:_*OXY_LL_&#X[Z^WBUO@Q^S
M[X&^)'CSPO\`",#X[+\3_'NJ_%O]F7Q3X!\0WVL:C>_#P6G@:#2O&VIZ9;WU
MPOA+Q)X4U3X*S^(_MMSX7^)=GJGA6TA>^_5-00.3DY8Y]BQ('X`@?AQ@<4`+
M7EWC[XP>"?AEXD^%GAKQE>W>DS_&'QK-\.O!FJ26$[Z!+XU/AK6_%.E>'=7U
MI?\`0M#O_$MAX=U>S\+_`-IO!!K^OP6_ARPFDUS4]*L;[U&OD']O?X`>)OVH
M?V/_`(^_`OP-<Z-IWQ`\>^`;^R^'6N:[JVK>'['PS\1=-NK+7/`OBQ/$.@6M
M[KWAV_\`"_B?3-,UW2]?T2VDUC1M1L;:_P!.VW,*,`#S_5_^"BOP?L?'_P`)
M_A_HW@#X^>-+CXZZEXDT_P"$'BCP9\)K_6O!/Q`B\&W>HQ^+=7T#Q+)J]C!)
MH&@Z5IEQXIFUNZ@M=/U/PG+9>(-`FU>QO[-INE^`?[?'P._:&N_`,'A:Q^)_
MA>R^+\?B6X^"NO\`Q(^&GB'P7X9^,=MX2M-0U/7&^'GB*\6ZTG5;^#0M)U7Q
M-:^']1NM(\3:IX6TG6O$FEZ)>Z-H6MWFGR_$K]FO6M:_:/\`V&OB/X#MO"'A
M[X:?LOO\<;/7/#J23Z7=6NA>._@O#\-?!6E^#-'L-*FTV2UTBZM[>&ZM)[W2
M(-/T>&,V0NG1;6OD#]DC]CS]ISPM\.?V'O@M\=-!^$?@WP5^Q#XEO/'(\4>`
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MEY?:II__`!3^H&6[B%I";)KQKR+\?_#/[`G[6?B_]@?]GC]G;Q9X]\%_`[XG
M?LP_L]>*?@?HNE>$]0TWXU_"_P"*OB&Z_9_L_@_X=^)^KZMXE\!^!O$'@?4-
M*6_\::7H-OI^D:S<>'](\7:QJLPU;5_[(.D`'[/^`O&V@?$GP/X.^(?A6XEO
M/#'COPKX=\9^';N>WDM)[K0O%.C66O:/<36LW[VVEGT[4+:62WE_>0NS1/\`
M,IKK:^??V3_AAXS^"?[,GP`^$'Q$\1:=XM\<_##X._#KP%XI\0Z/9QV&DZGK
M/A+PGI6A7<FF6T4%JHTZW:Q%G8SM:VTU[:VT5]<VUM<W,T$?T%0`4444`%%%
M%`!1110`4444`%%%%`!1110`8!ZCIR/8^M%%%`!1110`4444`%'7K110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%?FS_P`%+OVY?%7["OPU^'7CKPIX`\/?$&[\
M;?$&?P9=:?XBUW5-!M["UB\*ZUXA%];SZ587\L\YFTN.V,,L<<8BF>0/O15/
MKY#D69<2YO@LCRBC'$9EF%25+"T9UJ.'C4G"G.K).M7G3HPM"G-WG.*;5KW:
M/*SS.LNX=RK&9UFM:5#+\!3C5Q5:%&K7E"$ZM.C%JC0A4JSO4J05H0DTG>UD
MV?I-17\HO_$0_P#&3_HVGX8_^'$\7_\`S.5^_'["'[2^N?M=?LS^"/CMXB\*
MZ3X,U;Q5J?C2PN/#VB:G>ZQIUFOA?QAK7AJ"2&_U"UL[N9KN#2TNIEDMT$4L
MSQ1EXT5V^OXM\*>-N",LI9OQ'EM#!X&MC*6`IU:699?BY/%5J->O3A[+"XFM
M42=/#5FYN"@G%)R3G%/Y/A;Q0X-XRS&IE7#^8U\7C:6#J8Z=*IE^/PL5AJ57
M#T)S]IBL-2IMJKBJ45!2<WS.2BTI-?85%%(S!59CT4%C]`,G]*_.3]!%HKXA
M\+_M^_`WQ-\4M<^&367Q'\.6^D?&CQM^SQ:_$OQ5X&N]'^$NO_&CX>:+JOB'
MQ3X!TGQS]NN;>'4[32=!UR>QO?$%CH.BZW<:3=Z9HNJ7^JFWLKCZO@^('@:Y
MO]'TJV\8^%;C4_$%QK-KH6G0^(M&EO\`6KGPZVW7[?2;*.^:ZU*?0V!&L0V4
M4\NED$7ZVY!%`'7T5X/>?M*_!JQ^,.E?`Z;QII+>.]5\&^./&WDQ7EC+H^EV
M'P^\;_"SX>Z_I.NZTMY]BT7Q2?%/QE\!:=IGAC4##J^IOJS?9K=I(/*?TNX\
M?>![22SBNO&'A:WEU#Q-+X+L(YO$.CQR7WC"`R+-X5LXWO5>[\2Q-%*LF@6Z
MR:NC1N&L@48``ZVBO'_A%\?O@U\>D\>2?!_XB>'/B`GPP^(?B?X4>/3X?O#<
MGPQ\0?!MX;#Q'X:U%7CB876GW0:-;F%9=/O@CRZ=>7D,;R+[!0`445\>?M3_
M`+3&N?L^W/@F#1_"ND^)%\50>();AM3U.]T\V9T:72(XQ"+2UN!*)QJ3F0R;
M"AB0+NW-@`^PZ*_(H?\`!2+QL2!_PJ_PKR1_S,NL_P#RLK],OA/XTNOB+\-O
M!7CF]L;?3+OQ5X=T[6KC3[6:6YM[.6]B\QX(9YDCEFCC/"O)&C,.2HZ4`>AT
M44C,%&3TRJ_BS!1^I%`"T5\,?!;_`(*!?!CXW:]X,TK0_#GQ?\+Z+\4/%GC_
M`,"_"3Q[X[^&]_X>\`?%/Q?\-)/&Y\5^'O"'B6#4-5C758=/^&_CG6=*LO$M
MMX<G\0:1X9U:\T-;\VS0GZ[T?Q[X(\0V\=WH/B_POK5K*-;:*YTGQ#H^IV\H
M\-W$%IXA,<]C>W$4@T*[NK:UUDH[#2KBX@@O_L\LT2.`=917@7Q8_:<^"OP;
M^'GQ8^)7BOQOI%YH?P4\"W'Q&^(FF^%;VP\5>*M#\)P6']I1:C)X6TB]GU@C
M4+,K-I2R6\(U-60V;RAE)T/AG^TC\"OC'JOQ'T3X9?%+PAXPUCX1^.?%/PV^
M(^FZ7JL7V[PIXT\%1Z9)XJT;4;6Y^SS'^Q!K&G)?:C;)/I*3W#6RW[W%O<Q0
M@'MM%0VUS;WEO!=VD\-S:W,,5Q;W%O+'/!/!/&LL,T,T3/%+%+$Z212QNR2(
MRNC,K`F:@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"OY\_P#@
MX9('[/?P$R0/^+YWG4X_YIKXM]:_H,KSGXD?"#X5?&'3=/T?XK_#?P-\2M)T
MF_;5=+TWQUX6T7Q58:=J;6LUBVH65IK5G>06MZUG<3VIN8428V\TL)?RY&4_
M7\!<24.$.+LDXCQ.&JXRAE6(J5ZF&H2A"K54\-7H*,)5/<34JJD^;HGUL?*<
M;\/5^*N%<XX?PV(I86MF="E1IXBO&<Z5)T\50KN4XT_?:<:3BE'JUTN?YM>]
M/[R_]]#_`!K^X+_@BL0?^">/P>(((_X2+XN<@@_\U6\7>E?67_##O[&G_1J?
M[.__`(9WP%_\HZ]X\#>`/`_PR\-V7@[X=>#_``SX$\)Z;)>3:?X:\(Z)IWAW
M0;*74;N:_OY;32M*M[6RMY+V^N)[RZ>*%6GN9I9Y2TDC,?U[Q:\;,J\1N&<+
MD6"R3,,NK8?.<+F;KXJOAJM*5.A@\=AI4E&D^=3E+%QE%OW5&$D]6C\H\+/!
MO,_#_B/$YWC<YP&84J^48G+50PM#$4ZD9U\7E^)51RJKE<(K!SBTM;SBULSK
MJ;(I9'48RR,HSTR00,]>*=17\Y']!'XY67_!,B^N/`G[;-WXFU<:W\6?C;\7
M_P!L_P"*'P$BN_BU\5[OX2?#O5/V@/`GBGP#\/\`Q7<?#:2>/P)X;^(&DZ'X
MJUFP\0>)]%\$ZUK&EQ:YKEUI&K:C>WKS-QK?\$S/B7IKZ)X9T(?"*WTG6O"7
M[#5G+\5XM0O].^*?[-/B#]E'7],\0>/%^`EA_P`*ZU:VUZ/XK:E:ZKKFFZ]?
M^*O`-WI/C3QCXQ\1^+M,\6VE^NE7?[?T4`?SU7O_``2J^.][8?#:SM--_9P\
M+W_P+_9WLOA1I'B7PYJ_B>VUO]H3Q]\/_P!LC]CC]J[PG\0/BI<)\-+:7P:W
MQ,F_9K\2Z?X\E23XG:UX5\7^/=5\36=[XQ@NI(6].\,_\$\?C]HOC?QMX]\4
M>&?V9_BM_P`+0\>_M6ZM<?#_`.(^O>,M4\%?"*W_`&BOCAX-^,.E?$+PD]O\
M.H]5\5^,]%TWP^/!/C/3;.7X:ZAXG;PEX"UKP_XY\*107ME8_N/10!\1_L=?
MLY>)OV;M?_:ITK4='\"+X5^+?[3OQ-_:&\&^*O"MY-#KVMP_&359/$6L>'O&
MWAE_"^E0:)J7@34$.D:9J=GXF\60>)]-O%U(CP[/'/I3?;E%%`!7Y2_\%*2!
MJ/P@R0/]#\<]?^OCPM7ZM5R/B?P!X&\;-9/XQ\'^&?%+Z<MPNGMX@T33M7:R
M6Z,37*VIO[><P"X,$!F$142&&,ODHN`#^952,CD=1W'K7]$7[,1!_9]^$!!R
M/^$#T'D?]>U;W_"A_@E_T2/X;_\`A%^'O_E?7I&E:3IFA:=9:/HNGV6DZ5IU
MO'::?ING6T-G8V5K"-L5O:VMND<,$$:\)%$BHHX4"@#0IKJ6``Q]]&Y]%=6/
MXX!Q[^E.HH`_`WPC_P`$D_B9X9^"_@OP;9_$BVL?'^H_#K]O#X9>/-3U'XG_
M`!@\?>"/AO??M1WGQ+USX<_&CX!>"?%FH/X6\!_$/P<^O6?P\\6V_@GPW\.V
MU?X9_$_XKZ;:ZW-=6VDKJFCXN_8V^*NF^--(UNQ\&_#[X/>,OCE\3/A3\-U^
M%7[.VC^,O%/PH\!?`32_A1XE^$O[5/B[5/B+!\/OAQH?@[Q9X_\`A=XATR[\
M+3ZYX>TB`Z_\$/@!X=L+KQ1KUA=VEC^\-%`'\YOQQ_X)5?M6_%6#XD0:+XE^
M"?A*;7_AS^WC\+K-=`\2:CX1\"^*_#G[3/AF[A^$*O\`#'P?\$M#MO`<?@#6
M+#PA_P`)F^L^+?B_XE\0:OI=YXO'BC4M06%+SU?QO^Q/\0?`?Q$^('AWP?HV
MA0:C^TC^V]XX^)^@?$7P5H?BJ^OQ\!?VD_AQI/@;]K[P=\43IOA'3?#'PUO_
M``=X1T%/%7PS\5ZMX^UB+X@_$.U\$6^GZ7I^MVE[ITW[MT4`5+"QM--L;/3M
M/M8+&PL+6"SLK*UACM[:SL[6)(+6TMX(E6*&"V@CC@ABC54CCC5%`4`5;HHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
L*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>biib-2015630_elochart.jpg
<TEXT>
begin 644 biib-2015630_elochart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`$V`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^2OVW/VF9_V1_@!J7QG
MM=%\'ZY<0?$?X&?#F%/B'X\?X8^`M'?XU_&SP#\'1XL\:>.X_#GBR3PYX6\&
M_P#"<_\`"4Z[>IH-\S:=I%Q;C[/YWVJ'ZUKPK]H?X$Z)^T3X#T3P%X@UB_T3
M3]%^+_P%^+JW6G6ME>37>H_`;XU^`_C5I.BW$%^KVYTWQ!JG@.TT359`IN(-
M-O[J:T_TJ.&@#P'P1^W=\+H-%\)1_%WQ[\(#XE\6/I>HQZY^SGXE^(/[07P0
MT+PCXO\`'NH?#3X>>*/&/QKTSX7^'O"_@33/&'CC2-9\(V.I^-QX?T&7Q+HN
MMZ=8:S?PZ)K%W8=WJ'[:7P;E^`/QS_:+\%GQG\0/`OP%\/\`Q0U7Q+_PCW@#
MQQ#>:YJ_PB/BNR\:^$_""ZIX=M!XFUW1/$7@W6O"^MKHBZA:>'=:M9K?7+BR
M^S77D\C\;/V'/#'QC\?^+/$X\?>)O!WA+XP>$/A;\/\`]H/X=:)HWA6[TCXL
M^#/@SXO\1^,?`VDQZUJ>F3>(/`L\C>,/$_A/Q5J'AJ[:37?!FKM8V,.@^(]/
MTKQ79=[\,_V3_!?@']FKQ9^S#J&MZ[XH\%^-Y_VA1XCU2<6>CZW<6'[1GQ%^
M)GQ`\6V5H^GQO;61TR7XGZOI&CW*1O(EK965U.CW)F#`'S3\'O\`@J-\)/B3
MX[/AKQ-X4\8_#+P[JWPS_8K\=^%/$WB/POX^N'&J_MH_\)[IW@SPM\2K2V\"
M1Z;\(3;>+_"6C>!]!\0^.-;T[1/'/B7Q;I=IHMQ$DMC)J'U[\)OVH_@E\;]?
MU#PW\./%=YK&HVNE7?B+2Y-0\)^,O#.E>-/"EAK:^&[_`,9_#;7/%'A_1M&^
M)G@JQ\026^D7?B[P'?>(/#\%W?Z07U`6NN:'<ZE\8Z#_`,$O_#=IX#\=>"_$
M_P`8_%GBB?QUX;_86\'7^MMX4\,Z+)'X=_8(^*4_Q"^&D+Z;832V<^H>+M.%
MCX8\=7L;6=O.+>YUG0=/T:6\33K3U7]D7_@GU\)_V//$>JZS\/(O"RVL7A*3
MX=^$%TOX._"'P7XKT[P+)KUIX@73?&_Q*\)^$[#Q]\4=8MYM-T;2H]<\2:U;
M17FEZ)IMYKFD:SXN%[XLO0#YZ^/_`/P4/_:!_9X\9_MC6GBCX`?!?6/A]^R+
M\`_!?[1NI:_I/Q]\<V_BCQAX'^*GB?XS^%_A]I47AZ_^`46BZ#XCM;CX,ZI?
M>.?-\4ZEI6CVFKV8T&]\136UPM?7Z?MW_LS'Q%I_@Z?QIXAL/&>I^/?%_P`-
M;?P9J_PP^*>B>+H/%?@7PSX/\>>)+?5/#6M>#-/UC1-*LOAOX]\*?%!?$FL6
M=CX:N/AEJC>/X-7?PKIVJZG8\C^T!^PAX/\`V@+K]JVZUKQSXET%OVK?V>/@
M]^SQXC32]/TBX7PMHGP?\7?&3Q=IGB#1#>J3=ZKJ]S\8]4M+^VU'=900:/I[
MVP$DUUG#\1_\$[?AIXO_`&C_`!E^T)XE\5^)=5/COQ)\1=<\1>`FMM/M="N[
M'XF?LI_"?]D[7]"75;5HM;AM/^$0^%5IKT%U#-'>KK.N:A")$M+>T(`/2]._
M;M_9HU3PS?\`BJS\9>(VL8#X"?0]-G^%OQ5LO%7Q!LOBM?:KIOPNUGX3>#+W
MP7;^+/BSX>^(U[H6MQ>"_$7P[T?Q'HNO1:+J][:WWV#3;VZA]ATSX[?#+6?A
M//\`&O2];U*_^']K;ZQ+=W=GX3\87?B.UO?#VMWGAC7_``]<>`K;0)?'L7C'
M0_$^G:AX8U;P4WAG_A++#Q+8W>@W&C)JD$EJOYO:-_P1R_9^TGX8-\.VB\!7
MDWAW7/A'J_P[UD_LW?L]Z=!9+\$;3Q;IG@Y/BKH&C^"+"P^.MQK.C>-_$&D^
M.YO'%Q!9:LDUOK?A+2O`?BZ&3Q)<?6L_[&?A$?LBZC^R7H/BG4?`>A:I8WIN
M/%'PS\)_#_X;[-6U/QQ_PL+5U@\!^"O#6B?#^/PCX@UIKC0_%/@DZ&VG^+O`
M^HZSX:\47^KW&N:OK=Z`4;O_`(*%?LN6`LK2[\5^-8O$]]KOQ"\+K\/4^#'Q
MEN?BA:>)OA9X+\*_$CQUX>U+X9V?@.X\<:=K.B_#SQMX8\=K8W6AQR:IX0U6
M'Q#I!OM-2>>+A_B;_P`%(O@GX:U#X3:5\,)9_C#<?$[X[?LO?!Q]9T'3?&ME
MX!T2W_:>?P_K'AS5Q\3X_!6I_#V_\4:?\.O%&@?$B'X<2>(]/\3ZEX8UW0KV
M>/2[76+.Y?A?@_\`\$M/AI\(?BM;?%W1_&EQ;ZU)XM^)OCK5O#7A+X<_#OX;
M^`9/$?Q5_9T^$_[.OB$:!X/\$Z7IFE^&M'MM$^$ND>(["Q@%_J%QKFIZG+KN
MM:U/*U_+D?#?_@E1X2^%WA3X._#?PU\;OB`GPO\`A3\1OV7/C;=>#)?#G@DC
MQA\:OV8_"7PS\"V7C+4M?&G?VWIFC^/]`^%?AJ^\5>#]/N6LK/Q6ESKFA:C8
MZ?<7/AZX`/7/VA?VW[SX+?'72/@AI_A#X:R:IJ'PY\-?$32KKXO?'71O@3-\
M69_$?B[Q+X2D^&?[/,WBCPGJGA+XD_%7PTWAZWU3Q1X;\0>,?`=KI4/C#X>P
M27YM?%-SK.@=UX?_`&V_A!/XR\?>!?%/B70]-\1>&OC-XT^#WAO2O#MMX_\`
M$-_XDU[P9:_!LWWAQX[WP!H%NWQ&^U?&GPO<GP9X5NO%]K<^&Y+GQ-HWB'5]
M/T#QO_PB47[3_P"R/J?[2NF>,/!U[\:_%_ACX6_%/P"?AI\4_AC<>$O`'Q`\
M,:MH$D6NVEUK_@F/QWH>J/\`#SX@7VF^(+G3;OQ':+KNCRQ:?H6I#PHGB#2(
M-9?RB?\`X)N>#QK^N>)-+^*OC[2-3C_:)UC]JCX<301V%X?AW\:KWPE\*OAU
MI?B97U&:[F\90Z3\,_AUXA^'<]AXIEN$\0>%_B_\4$UZ2\U75-&U31`#USX_
M?M;-\"/VB?V3_@Q?^`_[9\)?M(7WQ'T?Q%\2!XB?3S\+M5\/7WPT\+_#I;GP
MTNA7_P#PD>G?$?XC_%#PS\/WOAK>B'P[K&LZ#,8-7BU22.S\<^&7_!2OP#XO
M^(7[3'A3Q;X,U[POH'P<^.7@WX+_``CU7PI8^,?BUXP_:(E\5_"S4?B.VN>#
M_AGX"\#:CXH@-JGA/XAW%MIVE)XHCN/`G@^;XA7VIZ7I5U-:V/OG[2O[)/A?
M]I<S/X@\6^*/"=VGP/\`C)\'M%U;PI]@@UOPKJ?Q1\6?!3QYX?\`BAX:U*\A
MN#IWCOX4^-_@5X-\6>!;AH)["/6[=+G4K>YCMHH9/`;3_@FSX9\)^,9?B3\+
MOBWXP\!_$'1/%'P@\4?#G7&\.>$?%%AX.?X6_LTW_P"RO?Z->Z'K=H;?Q1HW
MCKX<:MJ-YKJW%UI.IV/BD:=K&CZG;K936UZ`>R:7_P`%`?V4-<UO1=#T'XEW
M>O3:Y%\%)X-4T3P#\2=5\-:;!^T9<:EIWP0D\2>*;'PA/H'A/_A9?B+2;[P7
MX8B\3ZAI%Q=^/HE\"2Q0>*Y%TD?('PJ_X+*_!3XB7_AC5]>^'7Q0^&7PPUKX
M(?';XS:YXO\`&/@7XD2>(O!>G_`?]I+3?V??%%QXI\#:+\/;^_TOP%:0WS^.
MO$GQ0N[V#PGX'TZVNM&\2W%KJ>G:R=-]-\-_\$NOA?X/\-^-O"WA[XA>-X;#
MQIJ'[$6L7EU?V?AZ]U(:Y^Q=\<Y?V@K+7+J:&TL+.\U+XM^/KW6+WQTL&GZ;
MIFF#6+J/PGIFE6D-E96W,Z?_`,$H_`]AI7QP\,+\7?&;^$OBI^S;^UM^R[X8
MTH^'O#BWOP\^'W[77Q/U+XO^+KB/5][OXLUKPGXRU[78_"MUJMG8QR>'I]/T
MS7(]2O\`3Y]9U$`^X?`W[47P:^)'Q%U_X8>"]<\0:WK_`(;U;Q=X>O\`5X?A
M]\0X?A]<>)?A_?0:9XZ\+Z/\4KKPM!\-]<\3>$-0N(['7]`TGQ3=ZI97<5_;
MK;32Z3K"Z?!J?[5OP-TCXG7OPCOO%>I)XNTS5T\,:C<0>"_'%WX-L?&\_@W_
M`(6'9_#B[^(MIX<F\`6_Q,U#P,T7BK3OAY+XE7QA?:/=:?<6^CO)J>F0WGC'
M@/\`89TKP3^T78_']/B9K,UWI1\1RQZ3H7@3X<^`M:\8)XF\(V_@[_A&_C'X
M[\#:#H>N?&CP-X-LK:UU+X<:#X[M;[6O#&NZ;HNK:CXM\27>C64@Y^X_X)P_
M!T?M*>+OVB]-@\+6FJ^./&=S\4]=M]0^#OPD\2^,[?XG7'PVLOA<^L^&_C+X
MA\+W_P`3?"GAN;1M+TO7I_"NAZQ;3P>+;)[[1?$>B:%JFM>&]1`.W\.?\%$?
MV2_%O@RX\=^'OB+K&I:(WAGX/^,?#ENGPR^*D'B+XB>&_C]>3:3\&]6^%'A.
MX\%Q>)OBO:^/]>M+_P`.:*WPZTGQ*5\0:9JNDWPL[C3KKR_./A;_`,%-/@?X
MPL?'MWXYCUGX>OX.^-?Q^^&PMX_#/Q%\5S:;X#^!'Q%'PUU+XR?%.+3?`-O<
M_!#P;?:^9+'4KWXG6^@:1X>U.RUG3I]<O/\`A'O$%SI?*6?_``2Y\$Z/IWP2
MD\/_`!9\9Z7XO_9V_9H_9<^`/PG\7-H/AB_FT/6?V4?$FL>(/!7Q*U#1KN)M
M,UB^\2VGB'7_``KXS\*SK#I%WX9US4H]&O=%UL:9KFF</-_P1V^#=]XKU;QU
MKWBRT\;^,_&OBWXE:_\`$;Q+\3?@C\"_B?>:WIWQ.^)FH?%K5+/PEI_COP9K
MWA_X<ZUHGBS7O%%IH'B+0=&NHCX7\13Z-XAT'Q!>:/X:UK1@#Z=UW]O#X:K^
MT3\"_P!GOP-I^J^-=2^*WQP^+GP.\2>+/[&\::!X1\(>(O@Y\$OBI\5?%\/A
M[Q9J?@T>"/B9K.@>(/AL/AWXM\/^%?%CW7A'7-2OUU>9-1\.ZAH[:GQW_;8^
M'_[./QGTKP!\5;7_`(1_X>M^S5\6_P!HGQ-\3UDU?57\.6GPQ^+?P"^%$'AX
M>#M"\/ZIJNK#7[[XZ6M^=4L[H2Z9_8@MFTN[BU"6]T[E/"O[!>C^$OB]\+_'
MFF_%CQB?A_\`!3XZ_&_]H+X6_!]]"\(1Z%X<\:?M%^$?C#H'Q2LKKQ-:Z;;^
M)M9\/2ZW\:O&/BCPAI]W-'-X8GU"YT>XN]=TP:0-"E^.'[!7A?\`:1\4?&+Q
M!\8_B)XHUNV^('P.\6_L^>`M)T'1O#7AR/X3^`_'/B?P)X_\2WNGWRVFIWGC
M#Q9<^/\`X9>!-?L]3\3$Z-96?ARUT;_A'+B*]UB\U$`[#Q?^WW^RWX)\5^(_
M`FL^.]=NO&GA;Q;\1/`VJ^%/#7PQ^*/C+Q`WB?X3_#KX8?%KXAZ=I>D^$O!V
MM7VN+X6^'/QB\`^+-0O-'@OK%M+U._-M<SW&@:]!IW5^&_VR/V=?%_C3P_X'
M\,>/SKM[XHE\-V.@^)=-\+^,;GX;:CX@\8^`;#XJ>$_!T7Q53P__`,*W7QWX
MC^&VJ:9XXT;P1+XHC\4W_AO4M-OXM*/]HV$=S\X>"_\`@F]X?\/?%FX^-GB+
MXP>,_&'C[6_%'[0?C7Q7>77A_P`,:/INM>)?VBO@7^SW\#?%,MIINEQB/1=*
MT+2?V>]"U7PWI=O+<O#-K-]9:G?:B+6&^GY+]G;_`(),?`_]G+QM\,O%OAF\
MT+7G^'NG?#34)]0\4?!?X-:Q\0]:^(?PV^"WA+X'VWBNR^+NI>%-0^('@_1-
M>T+P=I/BC5O!OAC5+1+/QD+NX\/^(=&\-:CJGA>_`/;OVN/VP/$G[+E]HU\_
MP\\"^(_"NHIX?M])LM;^-VA>#/BY\8/%>M>(&T>[^&/[-?PF/AGQ%J7Q6^)F
MC6$^DZPV@ZQK'@:QUJ;7M$T31=4GEFU;4]#R],_;@NKSXDZ;#=_#?3M-^`7B
M+]I[Q?\`L<>&_BM+X]67Q?>?'+P3+XHT#4I=1^&L7A8V&G?#S4_B7X*\3_"G
M1-;A\?WWBN;Q59Z9J5_X+L?#.L?VGIO;_M(?LGZO^T7!XK\)ZI\</&WAOX1_
M$SPE;>!_B7\,K7PSX"U^VN]"C^VQZC=_#OQ/X@T*ZU_X8^)_$=E>)I^N>(=/
MDUU[==-TC6?"ECX5\5V"^(I,NQ_8F\/V?Q5LO%<GQ$\67GPIT?XZ>(?VH="^
M!EQIOAL^&M+^/_BJUUM-9\6CQ4E@/%UUX:_X2#Q+XC^(^G^")[P6EE\3-;N_
M$,FKW>D6FC^&-,`/HWXL^+?B#X4\,6=S\+OAN/B=XQUGQ!HF@:;I%]XHLO!?
MA?1H-4GD.H>+/&OB>:PUW4]+\*^'K"">ZOAX:\*^+?$VHWLFG:3I'A^XEOY+
MNQ^(_#/[=GQ#^(UUX>^''PQ^!/A[Q#\>Y_$/[3^F>*/"^L_&./0/A;;:+^R7
MX]\'?#/XA^)?!GQ/A^'VL:YXPT[Q1X\^(?@[PCX&-U\-O#@@UZ3Q?8>-Y/#%
MWX#U>UO/:?B3\!/CW\3/V:O#_P`'W_:F\3>`_B>Y\/I\0/C7X.\!^$[?7/&&
MDV=W<W/B;PU:Z18/X=M/!]IXNLI+?0=1\0>"+OPWXJTO2X[N?PMJWA[6;R/5
M++SO1OV)/%GA_P`+?"8>&?CG!\.OB=\&M!^(GPX\%^./A1\$?AOX)\+V'P7^
M)ESX1O=:^&B_"B[D\2^%UBT;5?`GA'Q/X4\0I?"]TKQ9X>LM1U"SUK2+_P`2
M^'O$`!0\(_\`!0?2OB)\4_V*?!_@CX1^+;KX>?MD?#SQCX[T;XL^(-;\.Z/I
M?AJ]\-?"JV^*$7@JR\/:?<Z[K'BOQ':0->Z)XTO4_L+POX6U2UCL].USQ3J,
MMW8:7;^`G[:6N?&3X]^*_A?J5K\!O#/AW3O$?QJ\.^%;&T^+'CS5OC%XAF^#
M_P`0-7\"7C2>$]1^#/A_X:RZDJ:%=^(_%_AKPI\7/%GB+P!I.I:$=<TXB]FG
MM^7UK_@GWXHT[Q_^RAKWPC_:"G^&O@']C;PQ/X3^$'P\O/A)X9\;M)INO^`K
M7X;>.)?%OB[4/$FCZGKU_P")?#=O)<17D>GZ?)IGB"[NM7E&JI(MBOT'I?[-
M7B*7XM^$_B%X[^.7CGXA>&?A=XS\<?$#X2>`]8T#P1I:>$_$_C[PWXP\&7TV
MN>+=#T2RU_QMIWA;P=X]\6>%_`MAJ2Z?)I^F:J+OQ9>^-O$&G:5K=B`=;XI_
M:B^#G@GXE:3\*O%.L>)-$\1ZWXET#P3INKW_`,._B)!\/;CQSXLTZ'5O"O@9
M?BDWA8?#D^,O$ME/%_8OAM?$[:G?7L]II*0KK%_86%SX]X;_`."CW[(?B_PE
M'XT\-_$G6-5T?4?#'PO\8^$K>'X7_%=/$'Q*\/?&?57\/_#6_P#A)X7F\$Q^
M(OBP/$OB2*Y\-K#\/-,\23Z5KEG>V&MQZ:UI-(OF_P`5?^":W@7XM?'^/X[>
M)/'^L75[8_'3X'?M">'K/4_`_P`/O$7BCPCXO^"-[X'?3O!O@_XI:YHUUX]\
M+?!O7[7P0+S4OAEH&H:=8P>*O%7C/Q)#J<T/B/4-#EXW2_\`@E3X)\.:9^S?
M+X9^+_C72O&G[*?[.GP>^!?P?\92>'O"VHS:9J_P6\56WB+0/B'J^B7<9TO5
M[G7M-;7?!WBKPN_V?3+SPSXGU9M)O]%U^#1]<TP`^B/@G^UWJ?QV^"OQO^+'
M@;X0>(==U;X6_&O]H?X->%?A[IVL0:9XB^(.H_!#XBZQ\.].NIY/'6F^#H_`
MU[XJOM+6[U;2O$MNLO@I&O;>^EU.?3VCG\LNOVZ_'VC>+?$WP-UWX*^%I?VD
M+'XQ_"/X,>%-#\+_`!<N]:^"GB#7_C#\+?''QKLKG4_BIJ7PU\/^+?#EQX#^
M%OPS\<>+O'OAB3X4:EXEBTV#P9=^'[/5[+X@Z/<V7K7@#]D_Q)\)?@-\:OA5
M\,?CSXP\-_$'XP?$+XW?%>+XXW?A#P)KOB?P9\0OCGXMO_&FO^(M&\(7VF1^
M!+\Z#K>J7TWAO2]5TB;2;>(64%_97\=HRW/E7@3]@?Q%X5^&MCX,U/X[27?B
MOP1\6M#^.WPF^)?AOX5>'_#7BCP]\6K31?$OA[QAXV^(TFI^)O&,_P`;-;^*
MVA^+?$.A_$O5O&FI0:[K>DZ[JT>GZSH^H'1M3T,`SM?_`."B5_H?ACX/Z@GP
M(UK5O$/BO]L+PW^QO\:(=-\<:(W@OX'>.]1^.&A?!'5-0G\67.FVFL>.EU"^
M\2:)XO\`AYHNC^#-.U'Q)X/U"/4O%K?#V6UN[5?4_CQ^V?:?"'X__LX?`C0/
M`X\=7/QB^+?AKX9_$7Q(GB1=%LOA##X[^'GQ<\;>`;I[4:-JO_"6>)O%$WPA
MU\)X2CN]$?2O"T4_BS5-4MDN?#.F^)/(OB5_P3Q\6^*?A]\/?`?@G]I/6?!3
M^&_V@-,_:P\>>*=5^$W@KQGXA^*'[1&B?%O3?C1I/C'5@=4\,:1X>\.VWBG3
M;?2CX*T'3$M%\(6FE>'[35+0Z=]ONNF^(?\`P32^"OQ.^(GPF^,?B#Q#\2M-
M^*G@7X]_#[]H_P`<^(/"7Q.^+/ACP[\5?B7X!^%>I?"R'4]3^'>G_$G_`(0C
MPD=1TR?1WDN/"ND6VHP:3H%MX2>]O/#FIZ[::D`?HRIW*K8QN4''7&1G%+2`
M8`&<^I/<]SZ<GL.!VXI:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`**_'C_@H-\3?B/X1_;U_X(U^`?"?C[QEX7\$
M_%K]IG]H;0OBCX4\.^)M9T30/B)H?AW]E3QUXET+1?&NEZ9>6MIXFTG2/$5K
M:Z[I^FZQ%=V5KJ]K:ZC%`+NWAEC_`%FC\-:240F*Y)**2?[3U7DD#_I^H`Z&
MBL#_`(1G2/\`GC<_^#/5?_DZC_A&=(_YXW/_`(,]5_\`DZ@#?HK`_P"$9TC_
M`)XW/_@SU7_Y.H_X1G2/^>-S_P"#/5?_`).H`WZ*P/\`A&=(_P">-S_X,]5_
M^3J/^$9TC_GC<_\`@SU7_P"3J`-^BL#_`(1G2/\`GC<_^#/5?_DZC_A&=(_Y
MXW/_`(,]5_\`DZ@#?HK`_P"$9TC_`)XW/_@SU7_Y.H_X1G2/^>-S_P"#/5?_
M`).H`WZ*P/\`A&=(_P">-S_X,]5_^3J/^$9TC_GC<_\`@SU7_P"3J`-^BL#_
M`(1G2/\`GC<_^#/5?_DZC_A&=(_YXW/_`(,]5_\`DZ@#?HK`_P"$9TC_`)XW
M/_@SU7_Y.H_X1G2/^>-S_P"#/5?_`).H`WZ*P/\`A&=(_P">-S_X,]5_^3J/
M^$9TC_GC<_\`@SU7_P"3J`-^BL#_`(1G2/\`GC<_^#/5?_DZC_A&=(_YXW/_
M`(,]5_\`DZ@#?HK`_P"$9TC_`)XW/_@SU7_Y.H_X1G2/^>-S_P"#/5?_`).H
M`WZ*P/\`A&=(_P">-S_X,]5_^3J/^$9TC_GC<_\`@SU7_P"3J`-^BL#_`(1G
M2/\`GC<_^#/5?_DZC_A&=(_YXW/_`(,]5_\`DZ@#?HK`_P"$9TC_`)XW/_@S
MU7_Y.J_8Z99Z=YOV5)4\[9O\RYN[C.S=MQ]JGFV8WMG9MW<;LX&`#0HHHH`*
M***`"BBB@`HHHH`****`/Q`_X*3_`/*23_@A3_V=;^U!_P"L<_$&OV\C_P!7
M'_N+_P"@BOQ#_P""D_\`RDD_X(4_]G6_M0?^L<_$&OV\C_U<?^XO_H(H`?11
M10`4444`%%%%`!1110`4444`%%%%`!113))(XD:25TCC099W9411G&69B%`R
M>I(H`?15'^T]._Y_K/\`\"[?_P".U+'>6DPD,5S;R")=\ACFBD$:'/S.4=@B
M_*QW-@85CG"G`!9HJL;RU$*W)N8!;L<+.9HA"QW%<++O\LG<"N`Q.X%>H(!%
M>6L^_P`FY@E\M0TGES12;%.<,^QVV*=IY;`X;T.`"S15'^T]./2^L_\`P+MO
M_CM30W=K<,RP7$$S*`S"*:*4J"<`D1NQ`)X!(`S0!8HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@#\//^"EB.__``4A_P""%2QRM"W_``U?
M^TX?,54=@J_L>^/V=0)%=/WB!H]Q4E-VY1N`K]H8],U?RT_XJ*?[B_\`,,TS
MT'_3"OQB_P""D_\`RDD_X(4_]G6_M0?^L<_$&OV\C_U<?^XO_H(H`P_[,U?_
M`*&*?_P6:9_\8H_LS5_^ABG_`/!9IG_QBM^B@#`_LS5_^ABG_P#!9IG_`,8H
M_LS5_P#H8I__``6:9_\`&*WZ*`,#^S-7_P"ABG_\%FF?_&*/[,U?_H8I_P#P
M6:9_\8K?HH`P/[,U?_H8I_\`P6:9_P#&*/[,U?\`Z&*?_P`%FF?_`!BM^B@#
M`_LS5_\`H8I__!9IG_QBC^S-7_Z&*?\`\%FF?_&*WZ*`,#^S-7_Z&*?_`,%F
MF?\`QBC^S-7_`.ABG_\`!9IG_P`8K?HH`P/[,U?_`*&*?_P6:9_\8KXI_P""
MC'B3Q-\-_P!B7]HGQMI>J6^HZCX>\"QWME::GI=HVGRS'Q'H,!%TEI]DN)(O
M*FD^6*YA;?L;>0I1OO6OST_X*M_\H\_VIO\`LG47_J4^'*^BX/PN'QW%O"V"
MQE&&(PF,XCR3"XJA45Z=?#XC,\+2K4:BTO"K3G*$UUC)KJ?/\68G$8+A;B7&
M82K.ABL)D.<8G#5Z;M4HUZ&7XBK1JP?2=.I&,XOI))G\@3_MU?&4,P&E?#W&
MX_\`,OZKZG_J8J_07]BK]MSQ%J7A_P"*$/Q(\:?!SP3X;TW2YM<U22T\4>+_
M`(8_$KPQ:1Z[\.-*F\=>'G*>)/#GQ"TJTTR^U?R?",>FZGXEC\2:+9Z)!9V6
MF>/9M0/X6/\`?;_>;^9IOI['(]B`0"/0X9AD<X8CH3G_`$/S+P6\.L?@JF%P
M_#.59;5JNE_M>%PB5>$(SA*I&$G-.$IPBXJ<91<9--\\.>G/^!LM\8?$#!8N
MGB<1Q)F>84Z:G?"XG%2=&<I0E&$IQ4;24)-2<)1DI132Y)N%6'[6^(?VN/B[
MX0^!6N>)W\>_`[XG>(_'?@S1M&TSP_I/CGP/96?PN^%>F^(;&\TB#Q%\/3\1
MCXNU_P",FLV^G:9,O@GPUX=^Q?#"UOM9O]>U_P`1^*KFZL-)[KX,?MCWFC:#
MX8\'>*?$G[/ECXE\#?M):Q/\;?$MG\8[SPAHMM\'9O#7A&+1_B3\&M:\/Z^L
M7Q4U[PZT/C;3[&WT@^+Y;?57TRPM_`>HVWBN[U.V_!?:N<X&1T.!G\Z=DCH2
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M3L2..)Q(V\R,HV'^8NOZ!_\`@WG_`.3@OVA/^R->%O\`U/'KYKQ7\-.`\E\.
MN)\SROA;*<%F&"P>%GAL;0PZAB*4Y9C@J,IPG%I*4J<YQE9)-3DK*Y]'X7^(
MO&^<^('#66YGQ+FF,P&,QF(AB<'6Q#G0JPC@,95C"<6FW&-2$)*[;3BG?0_J
MR_LS5_\`H8I__!9IG_QBC^S-7_Z&*?\`\%FF?_&*WZ*_@(_N@P/[,U?_`*&*
M?_P6:9_\8H_LS5_^ABG_`/!9IG_QBM^B@#`_LS5_^ABG_P#!9IG_`,8H_LS5
M_P#H8I__``6:9_\`&*WZ*`,#^S-7_P"ABG_\%FF?_&*OV-K>6WF_:]1DO]^S
M9OM;6V\K;NW8^S1IOWY&=^=NWY<9.="B@`HHHH`****`"BBB@`HHJ.5WCBD>
M.)IG1'9(E9$:5E4LL:M(R1JSL`@9W5%+`LRJ"0`245\+>+?VA?B%X0\;>&?#
MWB+XA?L>>$-<\7^-K#X=>&/A!XG^)_B=/'>N^.-3T73_`!-IO@N+Q5;V<5O:
M>+M0\.:II>JP:/%\,M6#P:UH<EG<:A:ZQI5Q?_;6EW%[=Z;I]UJ-C_9>H7%E
M:S7VFBZBOA87DL*/<V8O8%2&\6VF+PK=11QI<!!*L<8?8H!^)_\`P4G_`.4D
MG_!"G_LZW]J#_P!8Y^(-?MY'_JX_]Q?_`$$5^'__``4L:5?^"D'_``0J,,:R
MR?\`#5_[3@"/)Y2[6_8]\?J[%]DA&R,L^`A+E=@P6##]H8[WQ!Y:?\2.V^XO
M_,:C]!_U#J`.BHK`^V^(/^@';?\`@ZC_`/E=1]M\0?\`0#MO_!U'_P#*Z@#?
MHK`^V^(/^@';?^#J/_Y74?;?$'_0#MO_``=1_P#RNH`WZ*P/MOB#_H!VW_@Z
MC_\`E=1]M\0?]`.V_P#!U'_\KJ`-^BL#[;X@_P"@';?^#J/_`.5U'VWQ!_T`
M[;_P=1__`"NH`WZ*P/MOB#_H!VW_`(.H_P#Y74?;?$'_`$`[;_P=1_\`RNH`
MWZ*P/MOB#_H!VW_@ZC_^5U'VWQ!_T`[;_P`'4?\`\KJ`-^OST_X*M_\`*//]
MJ;_LG47_`*E/ARONS[;X@_Z`=M_X.H__`)75^?O_``51N=7D_P""?/[4JW>E
MP6L/_"N8MTJ:FMRP_P"*K\-`@1+919(4LW,BC"XSDBOJN!?^2WX-_P"RJX>_
M]6^#/F.-O^2-XM_[)K/?_59BC^$I_OM_O-_,TVG/]]O]YOYFFU_J['9>B_(_
MR^"BBBF`5_0/_P`&\_\`R<%^T)_V1KPM_P"IX]?S\5^_O_!OE)=Q?'W]H1K.
MVCNI?^%->%OW<ES]E'_(_8XD,$XSM+MRH'R8SEA7Y;XU_P#)K>,/^P'"?CFN
M7_UY;O0_3/!S_DYO"/\`V'8K_P!5F./ZVZ*P/MOB#_H!VW_@ZC_^5U'VWQ!_
MT`[;_P`'4?\`\KJ_S)/]'#?HK`^V^(/^@';?^#J/_P"5U'VWQ!_T`[;_`,'4
M?_RNH`WZ*P/MOB#_`*`=M_X.H_\`Y74?;?$'_0#MO_!U'_\`*Z@#?HK`^V^(
M/^@';?\`@ZC_`/E=5^QFU";S?MUC%9;=GE>7>K>>9G=OSMMK?R]F%QG=NW'I
MMY`-"BBB@`HHHH`****`"D8`@@YP00<=<8[8YSZ4M(W0X`)P>#T/'0]>#]*`
M/PR\9_!W6_'G[7WQE;P7\/\`XD:_X&7XT_#BP\<3^)/BW\&OASIGA[6+K7_V
M8OB_\4]3\!^%]2\*:K\5/%/A7XB)\$O@K8W>L>(M=MK^.S\$>)M!^#\&A6&K
M6?B&+]S0,#\2?S)/ZYSCMTK\*_B_\%+W4_VT/$/C^;]G1->^+A_:`^"5Q\,D
MMOV*?@WXO^"?C?X-VD?PY/BOXJ_%3]JW5O@MK'CCPQ\3_!<"?$.^TV[N/C?X
M)\3>#]7\'>"=*\%_#3QO87<4_C+]U%Z?G[9Y/)&!@GJ>!R30!^(/_!2?_E))
M_P`$*?\`LZW]J#_UCGX@U^WD?^KC_P!Q?_017XA_\%)_^4DG_!"G_LZW]J#_
M`-8Y^(-?MY'_`*N/_<7_`-!%`#Z***`"BBB@`HHHH`****`"BBB@`HHHH`*_
M/3_@JW_RCS_:F_[)U%_ZE/AROT+K\]/^"K?_`"CS_:F_[)U%_P"I3X<KZK@7
M_DM^#?\`LJN'O_5O@SYCC;_DC>+?^R:SW_U68H_@T?[[?[S?S--IS_?;_>;^
M9IM?ZNQV7HOR/\O@HHHI@%?T#_\`!O/_`,G!?M"?]D:\+?\`J>/7\_%?T#_\
M&\__`"<%^T)_V1KPM_ZGCU^6^-?_`":WC#_L!PG_`*M<O/TSP<_Y.;PC_P!A
MV)_]5F./ZT:***_S)/\`1P****`"BBB@`HHHH`****`"BBB@`HHHH`*QO$=O
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M\3WUK\,_CI\)_"OA[7O@/^P/^QIX@^&?AO3_``CX0^%-WI6E>-?C+\8?AMJ'
MQH7Q3X1ADMU\3^)_AWKMIH?@CPDOA72/AS/8>(/"VHK:?T`#^IZX'<^GKV[D
M<GG-`'X>_P#!2V5(/^"D'_!"N1Q(57]J[]IX$10S3R9?]CSX@(,10))*PW,-
MQ5"$7+N5168?L'J?Q0\`^'IH;+7_`!/IVA7LEM'<QV>M&?2;N2W<M&EPEMJ,
M-M.\#R1R(DRQF)GCD17+(X'Y`?\`!2?_`)22?\$*?^SK?VH/_6.?B#7Y[_\`
M!<;XS_$_X>_M:^!=#\&>+;O0=*N/@#X3U*:S@L=&N4DOIO&_Q#MY;@R:AIMW
M,&:&U@C*K*(@(P50,69OL.!N"\RX]SZ'#^58G`X3%U,+B,6JV8SQ%/#*GAE!
MSBY8;#8JKSR4UR)47%N_-*.Y\GQIQAEW`^23SW-,/C<3A88G#X9TL!"A4Q'/
MB).,)*.(Q&&I\B:?,_:\RNK1D?TZ_P#"[?A+_P!%!\+DG@`:I;DDG@``-DDG
M@`=3712^/O!\'E>=KUG$)A.R-+YL:*+6.YFN_/=XU2U-G!97=S>"Z:$VEK;7
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MH7A/PMX;L;:.71?!_@7PUJFO:QI<.HWNK>*=>\1ZOJ=W>:<4OHX\;5:F`I?7
M<HA4QJE*:J4.(Z=/`J%"G7<<=B)9`L+3G>K3P\52K5U.NZD:<IPP^)J475^D
M'P=2IXVK]3S:=/!N"BZ=;()U,;SUYT5+!X=9Z\1.-J52O)U:5'DH>RE-1GB,
M/3K?VP?\+M^$O_10?"__`(-+?_XJNNL?%NA:G:6^H:9/>:C87<2SVE]I^CZS
M>V5U"^=DUM=VNGRV]Q$V#MEAD=&P=K'%?YY*?M1?'S>N?B1J1&Y<C^R/#'/(
M_P"H'7]Q/_!.O7]7\4?L/_LP^(=?O9-2UG5_A%X8O=2OI8X(9+JZECG\R9HK
M6*"W1G(&5AAC0=E%?,>(/@[Q%X<99@LTSG,,DQE#'8Y8"E#+*^/JU8U7AZN(
MYJBQ67X."IJ-&<;QG*7,XVBU>2^DX#\6L@\0<QQF6Y3@,XPE?!8)XZI/,J.!
MI4I4E7HT'"F\+C\7-U.>O%VE",>52]ZZ2?UO_;]A_P`\=8_\)WQ!_P#*RC^W
M[#_GCK'_`(3OB#_Y65M45^2'ZF8O]OV'_/'6/_"=\0?_`"LH_M^P_P">.L?^
M$[X@_P#E96U10!B_V_8?\\=8_P#"=\0?_*RC^W[#_GCK'_A.^(/_`)65M44`
M8O\`;]A_SQUC_P`)WQ!_\K*_/O\`X*IZO:77_!/C]J6&*/4E=OAU%@W&C:Q:
M1#_BJ?#8^:>ZL884Y(Y>1>,GH"1^CU?GI_P5;_Y1Y_M3?]DZB_\`4I\.5]5P
M+_R6_!O_`&57#W_JWP9\QQM_R1O%O_9-9[_ZK,4?P:/]]O\`>;^9IM+(0&<D
M@`%B22``,G))/``[DG%)@\\'CK[?7TK_`%=6R]$?Y?!12X.,X./7''YTA!'4
M$?6F`5^_W_!OC=Q6?Q^_:#DF6Y93\&_"P`M;*\OG!_X3QAS%907$BCYA@L@!
MYP?E;'X!8.,X./7''I_.OZ!O^#>?_DX+]H3_`+(UX6_]3QZ_+?&O_DUO&'_8
M#A/_`%:Y>?IG@Y_R<WA'_L.Q/_JLQUC^K?\`M^P_YXZQ_P"$[X@_^5E']OV'
M_/'6/_"=\0?_`"LK:HK_`#)/]'#%_M^P_P">.L?^$[X@_P#E91_;]A_SQUC_
M`,)WQ!_\K*VJ*`,7^W[#_GCK'_A.^(/_`)64?V_8?\\=8_\`"=\0?_*RMJB@
M#%_M^P_YXZQ_X3OB#_Y65=L]0M[[S/(2\3RMN[[7IVH6&=^['E_;K6V\W&T[
MO*W[/EW[=RYNT4`%%%%`!1110`4444`%(<8.>F#GG''?GM]:6JE_--;6-Y<6
M\44\\-K<S0PSS2V\,TL4$DD<4L\%K>S01R.JI)-%9W4L2,SQVT[JL+@'YB>.
M-&_8?UK]J/6M4N?AU^T+XY^-FG?$;P+8^,/&7PM\'?MH^+OAIH'Q#TZQ\*WG
MAS3/&'BKX:M<_`_2[GPWHU[X7O?$NF:G.-+\-Z/=Q'QC;6<$M[$?U%'MZGU]
M3GK[].V.G&*_#NRTKXMZY\6[CX\ZA<^#/`'A;Q+\0_"'BKXA+X!_X*[?$*#X
M66/]@GP]H^JW4?PM/[+'ASPC>M_8NBP0ZYX9NM1\-OXPE@&F>(M3LY)Q=67[
M;Z9J-EK&FV&K:;<+=Z=JEG;ZA872!PES97L27-K<1B1$D$<T$D<B!D4[&'%`
M'XG?\%)_^4DG_!"G_LZW]J#_`-8Y^(-?E1_P7Y_Y/+^'_P#V;GX._P#4]^)=
M?JM_P4H('_!2/_@A220!_P`-7?M/C)..6_8Z^(``Y[DD`#N2`.37Y3_\%]W1
M_P!LKX?E'5Q_PSGX.&58,,_\)Y\2CC()'0@_0@]Z_>_HW?\`)S,/_P!B;-?_
M`$F@?AOTAO\`DW.(_P"QME?_`*=F?A_1117^AI_!(4444`.3[Z_[R_S%?WV_
M\$S/^3!?V3_^R,>%/_1=Q7\"2??7_>7^8K^^C_@F=/"G[`W[)X>:)#_PICPJ
M<-(BG`2Y4G!(/#`@^X(Z@U_,'TI_^20X>_[*-?\`JMQQ_2?T9?\`DJ\^_P"R
M>G_ZLLO/NZBH/M5M_P`_$'_?Z/\`^*H^U6W_`#\0?]_H_P#XJOX6/[5)Z*@^
MU6W_`#\0?]_H_P#XJC[5;?\`/Q!_W^C_`/BJ`)Z*@^U6W_/Q!_W^C_\`BJ/M
M5M_S\0?]_H__`(J@">OST_X*M_\`*//]J;_LG47_`*E/AROT$^U6W_/Q!_W^
MC_\`BJ_/;_@JS-#)_P`$]/VIUCFB<_\`"NHCA)$8X/BKPV`<`D]2!]2!U(KZ
MK@7_`)+?@W_LJN'O_5O@SYCC;_DC>+?^R:SW_P!5F*/Y'O\`@G[X>\+:_P#'
MVV/BWP#>^-=/TZVTN2TU+_A`9_BCX;\":C?^)]+LD\2>,_`]KK.D37^AZA8G
M4/#%KKCIK5GX4UO6=-U:ZT#4V-M]GZ6\^&WA;P[9?MO>!];^#?@<>._!OPHT
M3Q[X;\7>$W\?7?A[P;#J?CO]GH:/H?PX\'^+4.M^"+Z^T3QUK=YXKM?&<VI^
M._#PU)OA\;;PY;Z#JBZI\,>$_&'BOP!XFTSQAX(\1:SX3\4Z'<R7&DZ_H%_/
MINJ6$KH\4AAN;=E8QS1.T<]O*)+:X0[)X9%``Z#PU\8?B[X+LKK3?!_Q7^)W
MA33[^_N=5O[+PW\0O&&AVNH:I>"(7FJ:A!IFM6L=_J=[Y$!O=1NUFO;MH8GN
M9Y7C1A_I9C\@S2OF^*S/#9ART*^'R6%/!2Q.,P\8ULLS&&-J2E4HRFO95:4)
MT70]G/#UOK524Z$)4ZTLP_SJP&>9;0RG"Y=B,!>O1K9O*IC(X?!UY2HYC@'A
M*<8PK1@_:TJLHUE6YXUZ7U:G&%:<:E*.!^M/#^C^'5^#-I<?$SX)>"?"6A^*
MO#WP\\/?`>UTKPG?7/QY^)WQ%C^(?A>W\8?&`^)Y##XAN/AAJ>BQ>,M#U"U\
M0^3X!UG5=4\->!_A=I>H:IHVI>(-/A_:7\'6'BO2+WQC\-O"^K:+H^B?'OQK
M\*X/`5Y^R[X1^!OC![W^Q=9\86:Z#;>`O[1U_P`9Z/X4\-Z'+I7BG1O%:_\`
M"3>"+]=,U355(\2RM:?*>H?&/XOZOX=E\'ZM\5_B;JGA*?3K;1YO"VI>/_%M
M_P"')M'L_+^QZ3+H5WK$VE2:79^3$+33GM&L[411B"",(N*=Y\4OBAJ.JZ'K
MNH_$SXBZAKGA>SN-/\,ZU?\`COQ9>ZQX<L+NUDL;NR\/ZI=:Q-?Z+:W=E-+9
M7D&F7%K'=V<CVMRLL#&.E0R#-*6-CCEBL/"I#%X[$1H>TK8G#>SKT</2I4X_
M6J-3$4JE54$\97A7]K/$5,3B4YTZU/!4+K9[EM7!RP7U:O*$\+@J$JWLZ.&Q
M#J4*U:K5J2>%K0H5(4G6:PE"=#V<</2P^&DHU*4\97^P?"/A+1==_9V^+FE>
M)/A=X5\/>,O!?P`TKXE^#[67X.^(O#_B:_TQ/%/@W4F^/L_[2%_J-_;>(/\`
MA(_#.NW^FZ9\)?(L_"/B6VO;'3?#*Z?K&EQ177Z&?\&]`Q^T'^T*.F/@WX7&
M,YQCQZ_?O]:_"!_'/C>7PG;>`I/&GB^3P)9SI=6?@B3Q3K\G@VTN8YGN8I[7
MPJ^HMH%O+%<R27,3PZ>ABN9)+B/9.[2']W/^#>ET3]H']H1G=44?!KPL268*
M`/\`A/6&220.I`^I`ZD5\1XJY?B<!X8>(4J^(]M'&_5L52IIS<:$'C\II2C!
MS=XQJ3I2KRA/VM6-2K4Y\7B;J4?L_##'X?'>)7`,:&'=%X-U\+5FU!2KR6"S
M.JIS4-&Z<:JH*<?94Y4Z=/DPV'LXO^M.BH/M5M_S\0?]_H__`(JC[5;?\_$'
M_?Z/_P"*K_.$_P!!B>BH/M5M_P`_$'_?Z/\`^*H^U6W_`#\0?]_H_P#XJ@">
MBH/M5M_S\0?]_H__`(JC[5;?\_$'_?Z/_P"*H`GHJ#[5;?\`/Q!_W^C_`/BJ
M>DL4F?+DCDQC.QU?&<XSM)QG!QGK@T`24444`%%%%`!1110`4444`>?77PF^
M%U]XIB\<7OPX\!7GC.%TDA\6W?@[PW<^)XI(RI1X_$$VF/K".A1"KK>AU*J0
MP*C'H(&./\_Y]Z**`/P\_P""ED44_P#P4A_X(51S1QRQG]J[]IXF.1%D0E/V
M//B`Z$JX925=5921E64,,,`1^4G_``7PM+6S_;'\`16EM;VL9_9U\'.8[>&*
M!"__``G?Q)4L4B5%+%452Q&<*HS@`#]7_P#@I/\`\I)/^"%/_9UO[4'_`*QS
M\0:_*C_@OS_R>7\/_P#LW/P=_P"I[\2Z_>_HW?\`)S,/_P!B;-?_`$F@?AOT
MAO\`DW.(_P"QME;_`/*LU^K/P]HKZ!_9R_9^U?\`:&\9WWANT\2:7X-T/0-,
MAUCQ5XJU/3->UY='L+V[.EZ8;;0/#.FZIJ^IS7VL26]I+)Y5GI>F6K37VJ:G
M:!;.WOIO!'P.\*^+Y?&=E+\>O`6G7O@?1O%WBG5-0TKPE\0?&7@>Y\&^$]-M
MKY?%UCX_T72K?3/[*\1W5[I^AZ!9WFGVVNS>(M5TG0KG2H=4OTM$_O>OGF68
M:OB\-5KU'7P-/#U<73H8/&XIT(8OF^KN?U7#UES5%%OD3<X1E2G4C"->BZG\
M.T<FS'$4<+B*=&FJ.-J8BEA:E;%X/#*O/"\GMU!8G$46XP<U%3:4)SC5A3E*
M5&LJ?SQ17OTGP$ED^'WB'QCI'Q-^'OB+Q'X)\`>&/BEX[^'&B'Q'=:SX4\$^
M*]7\.Z%;7,GBX:/_`,(!K?B/0]2\7>%X/&'A#1M?GU;PY)K'V1I-0U/2M;T[
M3L;PI\$?$7BSX3_$_P",$&O>#]-T'X8V&FW]SH%_KL$GC7Q-%>^,_"'@F]GT
M'PQ8_:;^VTC0M3\;Z$^I>(?$"Z3H]R]S_9FASZOJ45]#87'.,ME3E5^M1C".
M-P^77J4ZU)RQF+E0CAJ5.-2G"558CZS0G1K4HSH5:-15X594$ZBAY3F*G&G]
M6E*4L'7S!*$Z511PF%C6EB*LY4ZDHTW0^KUH5:524:U.M!T)TU6:IOQQ/OK_
M`+R_S%?WN?\`!-+1])N?V"?V4);C3-/GE;X,>%2TDUE:RR,66Z8DO)$S$EF9
MCD\LQ)Y))_@C3[Z_[R_S%?WV_P#!,S_DP7]D_P#[(QX4_P#1=Q7\Y_2G_P"2
M/X>_[*-?^JS'']!?1E_Y*O/O^R>G_P"K++S[2_L#0_\`H#:5_P""VR_^,4?V
M!H?_`$!M*_\`!;9?_&*UZ*_A8_M4R/[`T/\`Z`VE?^"VR_\`C%']@:'_`-`;
M2O\`P6V7_P`8K7HH`R/[`T/_`*`VE?\`@MLO_C%']@:'_P!`;2O_``6V7_QB
MM>B@#(_L#0_^@-I7_@MLO_C%?GU_P54TC2K7_@GQ^U+-;:;I]O,OPZBVRP65
MK#(O_%4^&S\KQQ(XY`/!Z@'J!7Z.5^>G_!5O_E'G^U-_V3J+_P!2GPY7U7`O
M_);\&_\`95</?^K?!GS'&W_)&\6_]DUGO_JLQ1_!H_WV_P!YOYFFTY_OM_O-
M_,TVO]78[+T7Y'^7P4444P"OW_\`^#?"TM;SX_\`[0<=W;6]U&/@UX6(2XAB
MG0'_`(3UCD+*CKG*J>G50>H&/P`K^@?_`(-Y_P#DX+]H3_LC7A;_`-3QZ_+?
M&O\`Y-;QA_V`X3_U:Y>?IG@Y_P`G-X1_[#L5_P"JS'']77]@:'_T!M*_\%ME
M_P#&*/[`T/\`Z`VE?^"VR_\`C%:]%?YDG^CAD?V!H?\`T!M*_P#!;9?_`!BC
M^P-#_P"@-I7_`(+;+_XQ6O10!D?V!H?_`$!M*_\`!;9?_&*/[`T/_H#:5_X+
M;+_XQ6O10!D?V!H?_0&TK_P6V7_QBK=KI]C8[_L5G:6GF[?,^S6T%OYFS=LW
M^3&F_;N;;NSMW'&,G-RB@`HHHH`****`"BBB@`HHHH`****`/Q`_X*3_`/*2
M3_@A3_V=;^U!_P"L<_$&ORH_X+\_\GE_#_\`[-S\'?\`J>_$NOU3_P""ED?F
M_P#!2'_@A2F^2/\`XRO_`&G&W1.8W_=_L>^/Y-NY>0K[=C@8W(S+D;LU^4/_
M``7MM?L?[8W@"+[1=7.?V=O!S^9=SM<2C_BNOB0NT.P4A/DW!<8W,S?Q8'[W
M]&[_`).9A_\`L39K_P"DT#\-^D-_R;G$?]C?*^G_`$]GUZ'YM_LJ?&CPQ\!_
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M^J?$J\MO%7P_O+7XM^+M%U"*[N-2\7ZJWA!/%<?A71XIM4/PY\`Z7>6?AKPI
MJLUKXBU>T\3>(Q=:Q)#X!^*'P&\'^'_CQX;N?!/QLFT_XR:6/!VG_P!F^-_A
MNUSX6\"Z/\3O"'Q)\)I>7FI^!F;Q!XPMY/!]IHOB'4A;:;H5]#>7=]I6D:9,
M(H5^7**S_P!7\O\`8U*/-C.2KC(9A4?U_%NI4Q=.OA\33K5*KK.I4E2JX3#^
MR]I*2ITZ4*$4L/%4C3^W<=[:G7Y<)STL'+`4DL%A53IX6I1KX>K2ITE25.FJ
MM+$XCVCA&+G5JSKS<J[]H/&/,^7(7S/E#8+!=WRABH"E@N-Q4!2V2`!@5_?7
M_P`$S"!^P-^R?D@?\68\*=_^F=Q7\":??7_>7^8K^];_`()K:0+G]@O]E"7^
MT=6@S\&/"W[NVU"2&(;OM;\($8#&_8N#PBHO\.3_`#W]*?3@_AY?]5&E_P"8
MS''[U]&;_DJ\^_[)Z?\`ZLLOZ?U8^_\`(]1^8HR/4?F*P/[`_P"HOKW_`(-9
M?_C5']@?]1?7O_!K+_\`&J_A<_M4W\CU'YBC(]1^8K`_L#_J+Z]_X-9?_C5'
M]@?]1?7O_!K+_P#&J`-_(]1^8HR/4?F*P/[`_P"HOKW_`(-9?_C5']@?]1?7
MO_!K+_\`&J`-_(]1^8K\]/\`@JV0?^">?[4V"#_Q;J+O_P!33X<K[L_L#_J+
MZ]_X-9?_`(U7Y^_\%4-)%K_P3Y_:EF_M'5KC'PYB'EW5_)/$?^*K\--DQE%!
M/R[3D_=9AWR/JN!?^2WX-_[*KA[_`-6^#/F.-O\`DC>+?^R:SW_U5XH_A+?[
M[?[S?S--IS_?;_>;^9IM?ZNQV7HOR/\`+X****8!7]`__!O/_P`G!?M"?]D:
M\+?^IX]?S\5^_G_!OG:?;/C[^T)%]HNK;_BS7A;]Y:3M;R?\C]N^^H)_@V]#
M\KN/XLC\M\:_^36\8?\`8#A/_5KEY^F>#?\`R<WA+_L.Q7_JLQQ_6WD>H_,4
M9'J/S%8']@?]1?7O_!K+_P#&J/[`_P"HOKW_`(-9?_C5?YDG^CAOY'J/S%&1
MZC\Q6!_8'_47U[_P:R__`!JC^P/^HOKW_@UE_P#C5`&_D>H_,49'J/S%8']@
M?]1?7O\`P:R__&J/[`_ZB^O?^#67_P"-4`;^1ZC\Q2Y!Z$&N?_L#_J+Z]_X-
M9?\`XU6A8V'V'S?],O[OS=G_`!_7;7.S9N_U>Y5V;MWSXSNVKG[M`&A1110`
M4444`%%%%`!1110`4444`?B!_P`%)_\`E))_P0I_[.M_:@_]8Y^(-?E1_P`%
M^?\`D\OX?_\`9N?@[_U/?B77ZK_\%)_^4DG_``0I_P"SK?VH/_6.?B#7Y4?\
M%^?^3R_A_P#]FY^#O_4]^)=?O?T;O^3F8?\`[$V:_P#I-`_#?I#?\FYQ'_8V
MRO\`].S/P]HHHK_0T_@D****`')]]?\`>7^8K^^W_@F9_P`F"_LG_P#9&/"G
M_HNXK^!)/OK_`+R_S%?WV_\`!,S_`),%_9/_`.R,>%/_`$7<5_,'TI_^2/X>
M_P"RC7_JMQQ_2?T9?^2KS[_LGI_^K++S[IHHHK^%C^U0HHHH`****`"OST_X
M*M_\H\_VIO\`LG47_J4^'*_0NOST_P""K?\`RCS_`&IO^R=1?^I3X<KZK@7_
M`)+?@W_LJN'O_5O@SYCC;_DC>+?^R:SW_P!5F*/X-'^^W^\W\S3:<_WV_P!Y
MOYFFU_J['9>B_(_R^"BBBF`5_0/_`,&\_P#R<%^T)_V1KPM_ZGCU_/Q7]`__
M``;S_P#)P7[0G_9&O"W_`*GCU^6^-?\`R:WC#_L!PG_JUR\_3/!S_DYO"/\`
MV'8G_P!5F./ZT:***_S)/]'`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`/S/_X*"_L#_$+]L7Q9^RK\3_@Y^U#JG[*?Q@_9*^)/CGXD?#[Q]I_P
M>\&_&J&>^\>_#K4/AKJ]E>^$O'6LZ7X?=%T+5+\0SWD&J(LERSK:1W,-M=P?
MES^T)_P06_;,_:G\:Z=\0_CC_P`%A_%/BSQ=I7AJR\(V.I6?[!_[.WAN*'0-
M/U#5-4M+-K'0?%-C9RO'?:SJ,INI(6N'698GD,<,2K_3M17H99FV:Y+BECLG
MS+'Y5C8PG26+R[%U\%B53J652FJ^&J4ZJA-)*<.;EDDN9.QP9CE669QAG@\V
MR[`YIA'.%1X7,,)0QF'=2FVX3=#$4ZE-S@VW&3C>-W9H_D3_`.(8'XT?])8/
M&G_B%WP1_P#FVI#_`,&P7QH`)_X>P>-.`3_R9?\`!'L,_P#0ZU_7;01D$'H>
M#7TG_$1_$'_HN>+_`/Q(\W_^;/+\^[/G_P#B'_`?_1%<)_\`B/93_P#,GE^?
M=G\4GPA_X-W_`(W_`!0\2_'[P_-_P5"\6Z,GP4^-MU\([:ZA_8^^"]ZWB.VM
M_A7\)_B.NO7$4OBRV73IWF^)4^D&Q@>YA$6CPW8F$MW+!#[?_P`0P/QH_P"D
ML'C3_P`0N^"/_P`VU?U@>&?`WA/P=?\`C+4_#6BVNDW_`,0?%<GCCQC<V[7#
M/KWBJ7P]X<\*2:S=B>>9$NF\/>$O#NEE;5;>W\C2K=A`)FGEEZRC_B(_B%_T
M7/%W_B1YO_\`-GE_5V'_`!#_`(#_`.B*X4_\1[*?_F3^OFS^10?\&P7QH!!'
M_!6#QID'(_XPN^"/4?\`<ZU^@WPO_P""9O\`P5)^#7P^\(?"SX=?\%N-<T3P
M/X$T2T\.>%])G_X)S_LJZM-8:/8AA:VTFI:GK5U?WKQAV!N+N>6:3J[L>:_>
M6BO*S;BKB?/J-/#9YQ%GF<8>C5]M1H9IFN.Q]&E6Y)4_:TZ>*KU80J<DI0YX
MI2Y925[2=_3ROAGAS)*U3$9+D&2Y37JT_8U:V697@L#5J4>:,_95*F%H4ISI
M\\(3<)-QYHQE:Z3/Q6_X8:_X*^_])S=7_P#%:W[(W_RSH_X8:_X*^_\`2<W5
M_P#Q6M^R-_\`+.OVIHKP#W#\5O\`AAK_`(*^_P#2<W5__%:W[(W_`,LZ\-L/
MV??^"P=[^TAXH^`1_P""UNHQVWASX(^!?B^OBD?\$Y_V2VN+NX\9_$+XC^!W
MT!M*,P@A@TZ'P#'J:7ZWTDUQ+JDEN\$26L;S?T-UR,/@/PC;^.M0^)<.AVL?
MCG5?">C^!M0\1A[G[;=>%-`UK7?$6D:+(AG-H+6QUKQ+KNH1.ELMP9M1F$D\
MD2Q1Q@'Y"?\`##7_``5]_P"DYNK_`/BM;]D;_P"6='_##7_!7W_I.;J__BM;
M]D;_`.6=?M310!^*W_##7_!7W_I.;J__`(K6_9&_^6=>=?%K_@F%_P`%0OCE
M\.?%GPG^)O\`P6UUW7_`?C?35TCQ+H]O_P`$Z?V5]&FO]/6[M;X0QZGI6MVN
MH6A^TV=NYEM;B.3"%-VUF!_>ZBML/B*^$KT,5A:U7#XG#5J>(P^(H5)4JU"O
M1G&I1K4:L'&=.K2J1C.G4A)2A.*E%II,RKT*.*HUL-B:-+$8?$4JE"O0KTX5
M:->C5@X5:56E-2A4I5(2E"I3G%QG%N,DTVC^10_\&P7QH))/_!6#QIDG)_XP
MN^"/4_\`<ZTG_$,#\:/^DL'C3_Q"[X(__-M7]=E%?7?\1'\0?^BYXO\`_$CS
M?_YL\OS[L^6_XA_P'_T17"?_`(CN4?\`S)Y?U=G\5OQ-_P"#=CXW_#[QU^SQ
MX-A_X*B>+=5C^.7Q9U_X:76H2_L>_!>TD\-0:+\#/C#\8DUBVMX_%LT>IRW-
MQ\+8/#[6<\MK''!K4^H+,TUC%;7'LW_$,#\:/^DL'C3_`,0N^"/_`,VU?UAZ
M_P""O"_BC5_!.O:]H]MJ6K_#KQ'>>+?!5].UPLOA_P`1:AX1\3^!+S5;,0S1
M1O<3^$O&7B;1'6ZCN(!:ZO<LL2W*V\\/4T?\1'\0O^BYXN_\2/-__FP7_$/^
M`_\`HBN%/_$>RGR_ZA/+\^[O_(G_`,0P/QH_Z2P>-/\`Q"[X(_\`S;5]#_LY
M_P#!"S]MS]D[Q%XC\5_`?_@L=XH\(:[XLT2T\.Z]=WO[!7[.7B9+O2+'4#JE
MK;);>(/%%_;6S1WI,IGMXDF<'RW<Q@*/Z9:*Y,=QQQIF>$K8#,N+>)<PP.)C
M&&(P>-SS,\5A:\8SA4C&M0K8F=*I&-2$)I3C)*<5):JYU8+@SA#+<51QV7\+
M<.X#&X>3EA\7@\ERW#8FA*47"4J->CAH5:<G"4H-PFFXRE%NTFG^*W_##7_!
M7W_I.;J__BM;]D;_`.6='_##7_!7W_I.;J__`(K6_9&_^6=?M317RQ]*?BM_
MPPU_P5]_Z3FZO_XK6_9&_P#EG7AG[2W[/W_!83]GWX$?$_XSVW_!:S4/%=Q\
M._"USXCA\.W/_!.?]DO28-7>WNK.W^QRZC!/?36J.MTS^;':RL"@`4@D'^AR
MN1\>^`_"/Q/\'^(/`/CS0[7Q)X0\4Z?)I6OZ'>O<QVFIZ?+)'+):SO:3VURL
M;20QL3#/$^4&'`R"`?D&O[#?_!7ULD?\%S=7P'=1_P`:U_V1CPCLH)/]HKDD
M+D_*.O04O_##7_!7W_I.;J__`(K6_9&_^6=?M0``,`8&2?Q8EB?Q))I:`/Q6
M_P"&&O\`@K[_`-)S=7_\5K?LC?\`RSK[2_9`^!?[8/P8?Q^?VJ_VZ;S]L]?$
M0\,CP,EU^S3\(?V>O^%=G2O[<_X2(HWPLN;@^+/^$I^WZ-N&M[!HG]@K_9V[
M^T[S'VO10`4444`%%%%`!1110`4444`%%%%`!1110!\J_%C]LKX(?!KQAJO@
M_P`8:GXGED\(:1X<\1?%3Q)X;\%>)O%'@KX*^'/&-W>6/A37OC!XLT2PNM(\
M!Z9K<VG7UVDFHS2SZ3X>M+CQCXBM]%\%Q/XB$T'[87P8F^*UI\)Y+KQ?9WFI
M^/M6^$>B^.=0\!>++'X4:[\7]!TS4]9UGX5Z/\2KG3(_#%]XUL+#1=9C-HEV
MNEWNMZ/J_A+3-8OO&&EZAX?MOBK]K7X%_&3P]-^UMIW@30K/QA\*O^"A%GX*
M^&?Q1\6V-G\0_$WC_P#9REU;X-7/[/?B[QYI/PM\!^$/%.K?%#PE>>!M&\*-
MH]EX?U7PG>>#O'^HWFO>+?.\`76N^)?#/HUK\+_VI?%?[5OA#Q'\5_A-\-]7
M_9[^#'C"Z@^`5IHO[06I2R>&K.U\):AX4L?CU\1O`FI?!:&_\??&J;3=4UW0
M_#OA4^.['P)\--%\0WNIZ9/XJ\=2CQ?9`'V'XM_:)^%?@/QQK_@7QIKTOA:Z
M\,?"RV^,.N>(M=TZ[TWP1I_@Z[\77/@FV,OC&Y1-$;7I]?MC;0>&HKA]:N(Y
M[.6VM)C>VR2>/6_[=GP=UWX(_!3X\?#_`$+XM?%#PO\`M!ZE=:?\+/#_`(#^
M%_B"_P#B#K8T[2_%6M:M?:AX(U@Z#J_ANRT?3/!VLSZJ?$8TNZL9EM-/GM%U
M.\ALJ^E?B$WB73O"VM:WX#\$^'_'7CJRL[)M!\-Z_P"(X_!>GZQ/::I:7<=A
M=^,/^$;\5RZ+!;D3:A;W"Z!J2K>V\(2"&2474'Y*?L__`+(7[0?A7]C_`/9_
M^!_QQ_9L_9=^+&O_`+//B[Q'*G@WQ3\9_%VN^"/'>B>+-/\`'OG^([#6#\'X
M])T[4])N/&PT>\\$_$#X;^./#OB#3([S5K34_#^NV.BRL`?L%X-\2?\`"8>%
M/#WBDZ%XD\+GQ!H]CJ__``COC#2CH7BG1/MT"3_V9X@T8W%T=+U>SW^3?6)N
M9S;3J\1D8KFNEKY^_9;^%7BKX)_`CP#\,O&FOVOB'Q!X9MM=6>;3;[7M4T;0
MM/U?Q5KVOZ#X&\.ZIXHED\0ZIX7^'&@:MI?P^\+ZGK26FI:AX>\,:9>7>G:7
M+,=-M/H&@`KPWXR_M!>!?@E-X2TGQ!:>+_$_C'Q]<:U#X)^'GPX\(:UX]\?>
M)[?PQ96VI>*]6TWPWH4$MQ'H/A73[VQGU_7M1FL-(L;G5-#T<7<VO^(O#^DZ
MG[E7Q'^TYX'^+?AKXD_#S]K+X)^#M(^+?C#X,?"7X[?#K6/@GJ_B?5/!UW\0
M/"/Q2OOA7XUDE\#^)+70_%FG6'C_`$;Q3\%O#EKIFG:MX:DLO$>CZ]K.GC6-
M*U&VTM;P`L>(/V_OV;]#\.:#XUM=<\9>*O`NI?#BP^,7B+QOX+^&7C[Q/X8^
M&7PIU'4M>T6'QW\5]0T_0#)X`TJUUCPIXMT[6=.UNVC\3^'G\'^,[WQ!H&EZ
M5X.\3W^E?1OC/XI^%?`VI?"W2]8;5KBX^,'C^+X<>#9=$T:_URS?Q!-X&\;?
M$..?6;S3HYK?0]";PYX!U]QK^HO%I9U`Z9I@G-WJUDDGY#']G[]K2_\`@7\*
MO@9X4\#>"/B;^S=XLT7QO\4_CY9ZQ\2OB'^S)\1?BU\0?C;\9?'7Q>\=_!75
MO"7Q"^!OBKQI\.OV=[:X\8WNFZMI4[Z+\4_'VA7%MX%U^#P)X8M_$UAXR_;!
M+2.2VLC/86BSV:I/;V_[N:.RNOLDML5M9F@7R_+BN)[1)XH83]FED01K%(T)
M`/#?@A^U#\%/VC+SXLV_P>\81>,K3X+^.[7X<^--<L]/U"W\./XCO/!/A;X@
MPOX8UZ\MX--\8>'Y/#7C#1+F#Q9X;GU'PS>S274&G:K>_8KB19/V>_VF/A/^
MT_H?COQ)\(=8U'7-$^'OQ2\7?"+7-0U#0M3T.&Y\4>#H='N[^[T0:I#!)K7A
MG4]-U_1]7\-^)K-&TKQ%HVHV>JZ5-<6%Q#/)^>G@[]F+]K;Q[K7[?GAWXBZ!
MX`_9X\'_`+9/BKP)XPT+QS\+?BS#\7O%/@K3_`_P0^`GP*U;X>:GX,\0_![P
M%HM]IOQ$T#X5^)TU76-/URWDT;PUXI&E:9'!KD<6M67T%^P-^RY\:/V8Y/VK
M$^+_`,2_#/Q%A^,O[4/BKXP>`3X9\+Z=X5AT;PCJW@7X?>%K:+4],TVSM+33
M=4NI/"(MV\/V,E_I.A:=I.F#3M1N&U"\AM0#]!Z***`/G_QY^TW\(/ACXI\<
M>#_'GB&?PWK/@/X/+\=;^/4-+O1;ZW\/(]>U#PMJ=[X/N8HY4\6:SH?B6VTG
M0M:\,:,+CQ#I^J>,_`%I)IS/XX\-_P!H?+'C#_@J#\$OA[K?QLT3QQ\,OVEO
M"[_L]^!M)^(WQ3U#5/@EJHTK0/"7BJ\\2Z9X!U&&]MM9N?[5D^(FK^#_`!)H
M_@VRTV*XO-1U#2;F.\ATV+9,WK/[4W[,UU\=_B=^Q;X[T^S\,NO[/'[2DOQ.
M\:S:W>:C8ZAJ7PVE^#OQ0T:3PQI*6%G<Q:Z)?C'+\$/'<WAK6Y;30)=0^'.B
M^*9)6U[PCX?C;Y8_:]_8?^-7QJ7_`(*)WW@.\^'S7O[3_P"S-^R3\+?A9:>)
M?$6L:.B^,_@'X^^/?B_Q2GC.]L_"VM'0="U:U^)'AFST75M.M_$=U+<1ZL][
MI%K'96QOP#[X^#W[1O@;XQZQXE\(V&E^.O`OQ%\&Z9X?U[Q3\,_BGX,U;P'X
MYTKPYXKN-9M/#/BB+2]366QUWPMKE]X=\0:99>)/#.JZWHRZUH6M:%=WMKK6
MEWMA#YQX^_;M_9P^%W@!?B-X]\6:MX9T:Z^-7B/X!:1I>H>$_$/_``EOB#X@
M>%/C*/@5K@T#PE!93:YJGA2P\=/`UWXXAM%\)6/AF[L_%FHZO9:'=VUW+E?!
MSX1_%W7/VBO%/[47QN\/^"_AWK<WP<T/X'^!?AIX#\>:M\1X;'0(O'FL_$7Q
M=XK\8^+K_P`%>`+"]UG6]<N=`TOP[H.D>'I[?PSH^AZE?7/B/5K[Q=/IN@<7
M_P`%'?@S\<_CE^S_`"_!_P#9[^'_`,-?$.L^*O&GP_\`$>N:WX]^)%U\-+'P
MS:_#SXT_#+XQ7`M$TKX;^/KO7[GQE+X)O])N55=)2PU">QU2]DU)#(D`![IX
MP_:?\.^%OC+;?!+3OAO\:O'GB..U\#WGB37_`(?_``XN_$?@?P/;_$#5=9TS
M0)/&'BI]2T^TTO;#H.I:SJJ6T&H/I.AQPZC>K&MY:13?3-?E7\<_V6?C!\=]
M?;Q:WP8_9]\#?$CQYX7^$8'QV7XG^/=5^+?[,OBGP#XAOM8U&]^'@M/`T&E>
M-M3TRWOKA?"7B3PIJGP5G\1_;;GPO\2[/5/"MI"]]^J:@@<G)RQS[%B0/P!`
M_#C`XH`6O+O'WQ@\$_#+Q)\+/#7C*]N])G^,/C6;X=>#-4DL)WT"7QJ?#6M^
M*=*\.ZOK2_Z%H=_XEL/#NKV?A?\`M-X(-?U^"W\.6$TFN:GI5C?>HU\@_M[_
M```\3?M0_L?_`!]^!?@:YT;3OB!X]\`W]E\.M<UW5M6\/V/AGXBZ;=66N>!?
M%B>(=`M;W7O#M_X7\3Z9IFNZ7K^B6TFL:-J-C;7^G;;F%&`!Y_J__!17X/V/
MC_X3_#_1O`'Q\\:7'QUU+Q)I_P`(/%'@SX37^M>"?B!%X-N]1C\6ZOH'B635
M[&"30-!TK3+CQ3-K=U!:Z?J?A.6R\0:!-J]C?V;3=+\`_P!OCX'?M#7?@&#P
MM8_$_P`+V7Q?C\2W'P5U_P")'PT\0^"_#/QCMO"5IJ&IZXWP\\17BW6DZK?P
M:%I.J^)K7P_J-UI'B;5/"VDZUXDTO1+W1M"UN\T^7XE?LUZUK7[1_P"PU\1_
M`=MX0\/?#3]E]_CC9ZYX=22?2[JUT+QW\%X?AKX*TOP9H]AI4VFR6ND75O;P
MW5I/>Z1!I^CPQFR%TZ+:U\@?LD?L>?M.>%OAS^P]\%OCIH/PC\&^"OV(?$MY
MXY'BCP!\3_%'C[Q)\8/&&D>!OBE\._!%M9:/=?#GX?V/@+PG%8?%C6_$WBEM
M4U?Q3JU_?Z/H_AFRTY=/OM5UV,`_1OQ-^TG\)/!.M_%O1O&GB"Y\)Q?!3PC\
M./&GCC7=?T;5+'PXFE?%74/&&D^"[/P]K!MI(?%OB+5=7\%:IH\?A;PVFI>(
M7UB^\/:1;:=<ZGXBTBTNN7N?VP/@?:?LGZ;^VC/KVL)\#=:^$NC?&?1-3/A?
M7#XJUCPEXDT"V\0^'++3?`HM#XGNO%VNVM[966F>#DL!K]QK%U%I)M([SS$C
M]4^*;>,=,\%^(-4^&7@+PU\0/'K0Z9!I7AWQ+XN7X?:=JGE7RQ>;>^,H_"?C
M2?3FT6TO+[5-/_XI_4#+=Q"TA-DUXUY%^/\`X9_8$_:S\7_L#_L\?L[>+/'O
M@OX'?$[]F']GKQ3\#]%TKPGJ&F_&OX7_`!5\0W7[/]G\'_#OQ/U?5O$O@/P-
MX@\#ZAI2W_C32]!M]/TC6;CP_I'B[6-5F&K:O_9!T@`_9_P%XVT#XD^!_!WQ
M#\*W$MYX8\=^%?#OC/P[=SV\EI/=:%XIT:RU[1[B:UF_>VTL^G:A;2R6\O[R
M%V:)_F4UUM?/O[)_PP\9_!/]F3X`?"#XB>(M.\6^.?AA\'?AUX"\4^(='LX[
M#2=3UGPEX3TK0KN33+:*"U4:=;M8BSL9VM;::]M;:*^N;:VN;F:"/Z"H`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`,`]1TY'L?6BBB@`HHHH`****`"CKUHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHH)Q^8'YG%`!17\JNK_P#!PE\8=-U;5M.C_9M^&<J:
M;JVJZ:DK?$/Q>K2IIVI75BDK*/#A"M*MN)&4$A68J"0`3]:?L'?\%AOB1^UW
M^TOX1^!7B+X)^!_!>D^(]`\;:S/XAT3QCXBU?4;63PKH$NL6\$5AJ&C6=K+'
M>2QB"9WN%:*,EXU=@%K]=S/P,\2,HRK'9SCLFPU++\NP5?,,75CF^4U94\+A
MJ,J]:HJ5/&3JU'&G&34(0E.322BVTC\IRWQI\/<VS/!91@<VQ-7'YAC*&`PM
M*64YI3C/%8FM"A2A*K4PD:<%*K-1<YRC".\I):G[[4445^1'ZL%%>7>._C!X
M*^'/C'X->!O$UU?P:_\`'?QWK?PY^'T-IIT]Y;7GB?P_\,/'OQ>U&#4KJ(B+
M2K1/!GPV\47,5Y<YBFOH+33D_?WL1&7X5^/WPJ\76^N7%GXLTW2QH'Q&\8_"
MNZA\27=EX<N;KQCX'\9R>`-9L=+M]5N[>34X)O%B+H^DW-HLBZK=SVT%HKSW
M$4+`'LM%?-MA^UG\#9OBQX?^!>L>,;;PE\7?&>K?%?3O`?@#Q4L>EZ_XZLO@
MQ?\`A_3_`!QX@\+01W%W#>Z';S^)]).E37,]EJ&N1'49=,TV==&UC[!Z[#\2
M?A[<>'[KQ9;^.?!\_A:QU4Z'>^)(/$^AS:!9ZPNI1:.^EW6LQ7[Z;;ZC'JL\
M.FR6,UTEVFH2QV30BZD2)@#M:*^6]/\`VQ?@;J'[.MW^U(NO:U#\);75]=\/
M1W[^%M=N?$.H^(=$^*NH_!2'P_HWA/3+34->UC7/$/Q,T]?"OA32]-M+F[\0
MZAJ.DK8QE;^,K1T?]M;X!S:K\/?"GC7Q%JWP>^(7Q1^)FI?![P5\-?C)X;U;
MX>>-]<^(NE^!Y/B1-H.G:=JT+Z?JEM<>#$35-,\2:/JVI>%-6O;FS\,Z=KMS
MXNNH-`<`^LJ*\!^)7[5'[.?P?\(:WX\^)'QG^'GA?PCX:\<>$OAKXAUNY\3Z
M7>6VA>//'/B33/"7A?PKK$>EW%]<Z7K.HZ[K%C;R6E]!;OIMFUUK.K?8-$TW
M4M1L_6;/QGX1U#6+_P`/6'B?P]>Z]I6EV6MZGHEIK>F7&KZ=HVI*SZ=JU]ID
M-V]]9Z9J"([V.H7-O%9WB*6MIY5!-`'2T5@>&?%7AGQGI,.O>$?$.A>*=#N)
M;B"WUCPYK&FZ[I4\UI,]O=10ZCI-U>64LEM<1O!<1I.SPS(\4JHZE1OT`%%%
M?'G[4_[3&N?L^W/@F#1_"ND^)%\50>();AM3U.]T\V9T:72(XQ"+2UN!*)QJ
M3F0R;"AB0+NW-@`^PZ*_(H?\%(O&Q('_``J_PKR1_P`S+K/_`,K*_3+X3^-+
MKXB_#;P5XYO;&WTR[\5>'=.UJXT^UFEN;>SEO8O,>"&>9(Y9HXSPKR1HS#DJ
M.E`'H=%%(S!1D],JOXLP4?J10`M%?#'P6_X*!?!CXWZ]X,TO0_#?Q?\`"^B_
M%#Q9X_\``OPD\>^._AO?^'O`/Q3\7_#.3QNWBOP]X0\20:AJL:ZK!I_PW\<Z
MUI=EXEMO#D^OZ/X8U:\T1;\VK0GZJ?XI_#./PM'XXD^(7@=/!DM\-+C\6OXN
M\.KX8DU(WS:8+!/$+:D-'>].I(VGBT6]-P;Y6M!%]H!B`!WM%>/^$_C_`/!K
MQS\6/B;\#/"7Q#\.:[\6_@U8^$=3^)W@.QNV?7O!]AX[T^;5/"ESJ=N\:1M'
MJMA`UQFSEN38B:SCU(6<U_8QW#OB=\??@S\&_"GQ+\;?$SXE>#_"/ASX.^#[
MCQ[\3+S4]<L/M/@WPG!:3WB:QK6DV\\VL6T.H1V[Q:+$;`W.NWK0Z?HT-]?7
M$%O(`>O45Y9\-OB_X2^)?PZ\#?$NQ>Y\.:-\0?#G_"5>'[#Q;-HVE:T^B_9'
MU%KJ>UL]8U2S`BTM4U.X^RZC>)9V,L<UW)`1*D73ZIX\\$Z'9-J6M>+_``OI
M&GI=:38O?:GXAT?3[-+W7EA?0[1KJ\O8;=;K6%N(&TJW,@FU$2QFR2<.I(!U
ME%>'?%#]HKX4?"+4?`FC^+_$D2ZO\1/BOX*^#/A_2=(6/6-33QOX^FCAT"VU
M;3[.=KO2-.+7%DU_J=["D%A%J.FRS@)?VIE;H_[1GPG\0_&N7X`Z#XCCUKXA
M6_PYU7XGW5OI*1ZEHUGX=T/QU!\.=7M;S7+*>>RM?$.G>*KB.QO?#TY34K1`
M\MS%%L9``>YT444`%%%%`!1110`4444`%%%%`!2'I^*_S%+10!_F@^*'3_A)
M_%'S+_R-'B;^(?\`0P:E[U^H'_!%)E/_``4,^%P#*3_P@_Q?X!!/_(D7/;-?
MUN3?L1?L<W$TUQ/^RQ^SU-/<32W$\TOP?\!O)-//(TTTTCMH99Y)97>21V)9
MW=F8EB375^!OV7?V;?ACXDM/&/PY^`GP=\">++"WO;6R\2^$/AQX3\.Z[:6V
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M@MC8_NA10!^!7B#_`();_'?5?$WB?Q9!XG^&5EXG\:Z__P`%*_"W_";:=K.L
MVWC3X:^#OV]M`^$=EX?^+OA#4I?!$\VH_$?X7ZK\,]3EO_!:7_AJ#5;3QIJ5
MSI/Q!LKNVEM]1Z_X=_\`!.CXQ^#%^'_C74O#_P`,O%^M_#[XQ>"/&EW\#?''
MQ9M_$/PC\=^'_!OP(^)/P0T6^;4/#7[*7PW\-^#O%'@:7Q]9>+/`MPOP<\3Z
MI?6OA/3-+\5^*#JH\.:GX+_<:B@#\RO@G^QEXZ^%_P#P3OM_V2/$.@_L_P#Q
M"\30W7Q*_M3P=XPTCQ%JWP&\4>'/&WQ_\9_$]_!5S;QZ;!XCT&PN?!GB2/P]
MI&OV^B:O<^`O$D6G^(K;P_XJAT"/2M4\"L?V`_CY9>(OA'\2K2R^',Z?`_\`
M:>A^+GPA_9^^)'QI^)_QY\/?"KPAXA_9B^*'P!\=_P#",?&_XG^!+WQS+/=^
M-_'WAGXUZ;\*8-&TGP'IMY\-X-!\->)/"^J^*KG7]%_;*B@#^<*__P""3/[2
MWB:SO[OQ3??`V[N8?@M\#?#-YX$F\4W$WPT\>_%?]G+]L'X/_M(:#K=IX9\.
M?L^^!/"GPD\"?$#PQX-^('@"UT72?!?C75/AIIWC5K>>Y\;VUUJRS>Y:%_P3
M3^+EYXU^.>K>/[SP]XLT/XHVW[87B"VMM8^,>LV&F:S=_M=:'XCT^\^$_B_2
M/AU\!O`OQ&3P?X)TOQ%9_#M/%8^/'B6*'P]X`\#>,?`G@#PMKUMIN@^#OW+H
MH`^%OV(/@/\`&#X%Z3\4K/XG'X?6&F>+O%WA_6_"'AWPG_PB>O\`B72K?2?!
M>C^$]6NO'7Q+\&?!+]GC3?B#?:DVA:6F@76J_#1_%&B:!I]MI^N>-/$GF6=C
MX>^Z:**`"ORE_P""E)`U'X09('^A^.>O_7QX6K]6JY'Q/X`\#>-FLG\8^#_#
M/BE].6X73V\0:)IVKM9+=&)KE;4W]O.8!<&"`S"(J)##&7R47`!_,JI&1R.H
M[CUK^B+]F(@_L^_"`@Y'_"!Z#R/^O:M[_A0_P2_Z)'\-_P#PB_#W_P`KZ](T
MK2=,T+3K+1]%T^RTG2M.MX[33]-TZVAL[&RM81MBM[6UMTCA@@C7A(HD5%'"
M@4`:%-=2P`&/OHW/HKJQ_'`./?TIU%`'\^^F_P#!(/XGZ;\`_"GP_L?B:NF?
M$#5OA]^W!\-_'VI77Q7^+WC3P3X!N?VE/$7COQ=X"^*OP'\(^+Y-3\*?#WQQ
MH\.HP_"3QY%X+\&^"#JWPE^+_P`8--M[_4I[;2[/6O0F_P""='Q;_P"%?PW4
M_AOP?J7C^/XVW/Q%M/#VI_'S2[G3?"FG3?`L_`V74/"U^O[%MM\"[R^U?PW-
M=>'?$7A#Q=^RGKNDZOX273=6?Q)#X[TVWNA^XU%`'YF?L??LA?%']G7XY>.O
MB-XRMO@SXC/Q@_9P_9<\&>//&7P]TP>`KS1OBC^SMX*O_A_JNB>'?A]:>#X=
M+D^&WB[3-0T_6-'O[3Q+H)\/S>'8M$3P#::=)I7]E_)/QM_X)=?&/XJ^"_CQ
M\/K=/@7:3>(_#7_!1J7PM\8+^_UF?XC_`!NUG]M7PW\0K+X<>!_CI:1_#E(O
M#_@[X,:UXR\+WEYK>G>)/B#/J5Q\%?A'JGACPQH#:6VG:+^]-%`'PO\`M._L
MEW_QC^"GPH^&?@.?P?X-OOA]XK\&:==)+I[V6A'X.^)="U'X._M#^#M%BT>P
M$EA>>)?@/XZ^(=CX.B@MK/3X/&L7A.]OGL+:R>[M?C^V_P"">WQJ\.^'OAI>
MZA8?`#X_ZUX*U']ICP=J?PP^+-UK^C?"[5_ASX^\-^`/@M^SKXPEOAX#^(-Q
M<?$;X2?L^_!KP5X,\66=SX5\GQ"/B1\9XM$\26)U*V;6OVHHH`_!_P`._P#!
M*OXO^&])@TQ_B1X5\0>)K+]JK]B7XDI\8;_4=8M/B1?_``J_9J_8Z^#/P"\5
MWOGR^'=5.F^.[GXE^!_%GC_P=X<.I:CH4GVW2-4UOQ%'K<^H"/W#]B[]AKXG
M_`/XY?#WXD>*O"_P'\&:#\.OV'?"_P"R+=1?"75-:OM6^(OBCP5\1]'\5#XN
M:]!??#[P7;Z8OC*QMM0U*Y\/W-YXFUGP[K=]?07GBKQ2-0;4H/UPHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
D@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>biib-2015630_gainlosschart.jpg
<TEXT>
begin 644 biib-2015630_gainlosschart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`#P`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^3?VU_VF)?V2?@)?_&6
M#1/"&N31?$GX%_#>*/X@^/F^%_@/1Y/C9\;/`'P<3Q;XU\>KX;\6OX:\*>##
MXY'BK7[Y/#VHN=,TBY@58#,+F'ZRKP;]HWX#:/\`M&>`=#\`:YKE_H%AHOQB
M^`'Q?^U:?8Z=J,E]>_`/XW^`?C9IF@75KJB2VC:5XEU'P%:Z!K$NQKFWTO4;
MNXLL7D<!`!X9X+_;K^%,&C>%(_BY\0?@Y'XF\5-HNH1ZI^SQXL\??M"?!?1/
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MIM^^^&'[)?@_X?\`[,WBW]E[5/$.O^+?!WCFX_:)_P"$DUF>.PT/7)]/_:/^
M)'Q/^(7BJQLCID3VEB=(;XHZKHNB7:123+;:?8WMTLMVT^X`^</@W_P5(^$'
MQ-\=3^&?$_A7QC\*M`U'X<?L:>./"?B+Q=X;\;-/+JG[9=UX\T7P3X7^(=C;
M>"ETSX3&/QAX3T;P7X<\0^,]>L]$\>^(?%^CVV@SQQSV,FH?7_PH_:@^"7QM
MU[4/#GPW\77.MZE::9=Z_ITE[X3\9^&M*\8^%K#65\.7_C+X;Z]XI\/:+HGQ
M.\%6.OO#H]WXO^'^H>(_#EO>WNE"34E@UO1+C4?B/0?^"7.C6O@/X@>#/%/Q
MP\6^*;CQ_P"'_P!A3PG?:T/!GA'03;>'?V"OBS<_$?X=VPTK3I)+&>\\9Z2=
M/\(>.KQ6M8GAM)];\/V6CW=[]BMO6_V0/^">_P`*OV.?$6J:O\/O^$::RM_"
M+_#KP6FG_"#X3^#_`!9I7@)]:L-;72O&GQ,\,>&K7QY\3M6@?1M!TQ=:U_5[
M&&^T_1+"^U[1]9\5B?Q/*`>"_'__`(*'_'K]GCQA^V):^*?V??@UK'@']D7X
M#>"OVB]6U_2/V@_&\'B?Q?X#^*GB?XU^%O`&G0>'-1_9Y@T70O$EK<_!;4K_
M`,=)/XLU#2-$L=<LCH&I^)Y[.ZB/UXO[=W[,'_"1:=X/G\?:O8^,=4\=>*OA
MO:^#M4^&_P`3](\71^+O!?A;P9X]\0V&I^&M4\'6FLZ)8V?PY^(/A'XFKK^L
MV5AX>G^&>K?\+`AU5O"EAJFJ67#?M"?L&>%OV@KK]K.ZU;XA^*/#;_M8?LZ?
M!K]G?75TG2M#NQX.TCX.>+_C/XOT[Q-H)U"-C?ZOK5Q\9=1L]0M-4+Z?;6^A
MZ=)9JLUS>%L+Q)_P3F^'7C']I/QI^T+XF\:^*=4A\>^)/B/K?B+X>&RTJUT&
MZT[XF_LF_"7]DO7O#Z:S:^7K\%FGA7X4V_B6WO(9X[X:WK^HVWF"QM;+:`>L
MZ=^W3^S/JGAB]\667C?7'T^+_A7\FB6$WPQ^*EGXG\?V7Q8O]3TSX7:Q\*/!
MM[X*M_%GQ9\/_$:^T36HO!/B'X<Z-XET3Q%'HVK7=C?O9:;>W,/KUC\=?AAJ
MGPJN?C3INO7M_P##^R@U>2\OK3PMXPN?$%I>:!K=WX:UWP_=>!(-`D\>V_C#
M1?$UA?>&=6\$R^&%\7:?XEL[KP_=:+%JT$MHOYJZ1_P1L^`.E_#(_#YV\$75
MQX<USX5ZQ\/-;7]G;X%:;#;GX.67BS2?"Y^+FA:5X6M+3X[7GB'0_&WB#1_'
MLWC&[L--U-;F/7?!^B^`O%J3>(;GZYN/V,?"@_9$U/\`9+T#Q9J7@#1-5LKY
MKCQ1\+_"G@7X:>7J^J>.?^%B:RD'@?P5H.B^"D\'^(];>YT+Q=X,;3GA\8>!
M-3UOPWXGU?5;W7=6U^\`()_^"A'[*UH+"UN_&WBV#Q'J.M>/O#47@$_!OXSS
M?$^V\2_#'P7X3^)/C?P[J7PPMO`$_CW2];T3X=^./"_CS^SK[P_!/J/@[58?
M$>E"]TJ.>YBX3XF?\%(_@?X:U#X2Z5\,+F3XRW/Q0^.G[,?P<;6/#EEXPM?`
M.A0?M-2^&=6\-:L?B?%X,U3X>W_BFS^'?BS0_B7;?#9_$>G^*-4\)ZKI&H2K
MIEKJ^GW,_GGP?_X)8_#WX1?%RV^,.D>/KJVU>7Q?\4?'>L>%?"'PT^''PU^'
MTOB/XL?LY?"3]G7Q`/#_`(1\$Z;I^G^&=)MM*^$6D^++2TMS?ZC>^)-6U>XU
M[6=8EG^V/D?#3_@E)X:^%G@_X-?#+PW\>?B(OPQ^%/Q%_98^-VH>$I_#'@9I
M?&_QK_9B\+_"WP5;^+=3U\6!U72/#_Q$T+X2^&M2\4^"])=;6P\8/>Z]H.K6
MFG3R>')`#V?X_P#[<%U\&_CQI?P*TSP5\/;G6;[X=^%OB)IEQ\6OCKH/P(G^
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M_@FYX7M-<U_Q#I?Q@^(6FZDG[1>K_M5?#26.WTJY_P"%<?&F[\#_``Q^%VE^
M(S+=O+=>-K?3?A;X#\4?#F]L/%-Q*GB3PM\9?BFFNRW.KZGH6K:$`>P_'[]K
M=?@/^T1^RA\%]2\!/K7A/]I*^^(VCZ]\2T\1_P!GI\+-7\/7OPU\,_#I+WPS
M_8=\_B33OB7\1OB?X:^'BW\>LZ-_PCFNZWX>D>#5H=6=+/R'X9_\%*?ASXP^
M(G[2GA'Q9X3UOPEH7P<^-W@[X,?"?5O#EKXK^*_BS]HFZ\4_##4OB&^L^"/A
MK\/O!>K>*5^S#PG\09;73=*B\3"X\$>$+CXA7]]I.CW,MO9>X?M,_LC>&_VF
M6DEUOQIXK\&7D/P,^,WP>T'5_"*:;#KOA+6OBAXO^!_Q`\,?%CPQJ=_!<MIO
MC_X0^.?@-X-\6^`YW@N-.&N1+<ZK;74=K#"_@5E_P36\/^$?&MU\3/AA\8O&
M/@GQ_H_BGX/>*/AMJUQX8\(^*=-\&'X7?LS7W[*NJ:)J.B:K!#'XNT;Q[\.M
M5U#4M<6[O=)U+3O%\>EZSI&I0PV,]E?@'M>F_P#!0#]DS6M5TG2-"^*;:_<:
MQ;?!6\M[S0_`_P`1=6T&TM?VB[J]TOX'RZYXFL?"4WA[PT?B=XDL+GP5X3A\
M1ZEI5Q?^/E3P,\,/BJ1=*KX_^%'_``66^"'Q&U;0=0\0_#OXH_"CX8:G\%/C
MQ\8]8\9^/O!/CV+7O"6G?`7]H73/@5XJN_$?@G1/`VIWFF_#^SM[^3QMXE^*
M5YJ-MX5\"V5E?:'XHEL]5TO6O[-]#\-?\$M?ASX.\.>//#'A[XH^/8['QSJO
M[$&N75YJ6G>&+[5(]<_8P^/<W[1$>MW4\%CI]E?ZC\8_'E_K%QXZ$>GZ?I^C
MQ:M<)X1T_3((+.U@Y?3_`/@D[X2T_2_CMX8C^-GC8^$OBQ^S1^US^RWX4TD>
M%O"BWWPW\!?M=_$N_P#BWXIOTUD%I?&>N^#O&&N:\GA6YUJSL8;C0+RRTW7H
MM2OK&75[\`^Z_`W[4OP4^)7Q#UWX9>"/$FM>(/$'AW5_&'AS4-5M/`/Q"3X?
MS>*/A[J*Z3X]\*:1\5+GPK!\--=\5>#-2<6'B7PYHWBR]U?2[R*^MI;0S:5J
MR6#-3_:J^!FD?$N]^$U[XNO5\7Z9K"^&-2DM_!WCB]\):?XUF\&#XB6?P[O?
MB'9^&Y_`%M\2]0\#%/%6G?#J7Q*OC.^T2YL+NWT5_P"U-,2\\0\`_L+Z=X'_
M`&C;'X_Q?%'6Y)=)3Q$T>A^'O`WP_P#A]JOC,>)O"_\`PBSZ#\:?&G@72=$U
M'XU>#?"=M]GU/X?:1XXTNY\0^'->T?PYJ^H^,?$=UH<#S<Y<_P#!-KX0#]I7
MQ?\`M&:9_P`(W::KX[\93_%'Q!!J7PB^%GB7QI!\3)?AY8?#?^U/#/Q?\0:!
M??$'PGX5?3=(TCQ#+X5T.]MKR+Q=:7-[I/BC1]"U?5O#EX`>C>'?^"A?[)7B
MSPA)XW\._$V^U/1)O#/P=\8^'88_AU\3X-?\?^&OV@-2GT/X-:O\+?"MUX-@
M\2_%*U^(7B&SU'PWX?;X?Z5XC,GB'2]4TB[%I=:==+'YI\*?^"F?P*\;V7CN
M[\:_VM\/6\(?&?X]_#B*%/#7Q&\6O:>!/@7\0_\`A7&I?&3XFC2OA_#+\$O!
M5[X@+:?JM_\`%"+P_HWAG5;35M.O->N4T+7+O3>)T_\`X):^$M%L_@3<:)\9
M/&]AXM_9P_9D_99^`'PK\4OX=\)WCZ;KO[*.OZYK/A#XF:KH]Q"=/U6Z\6V'
MB77_``GXW\(;K31KGPSK5_%H5_H>LIINM:=PTW_!''X0W_BW6O'GB'QM!XZ\
M9>.O%WQ)UWXD^(/B;\$O@E\2IM:TKXF_$G5OBMJ6G>$M,\:>%=8T#X?:OX?\
M4>)O%UAX;\0:5I&HP_\`"*>(6T3Q)H'B2ZT7P_K&F@'U-KG[>7PO'[1'P+_9
M[\"6FI>.=4^+'QL^+'P2\1>+(M)\9:%X0\'^(?A!\$_BQ\5O%\/A_P`7:EX-
M_P"$%^)VL^'M=^&<?P]\8^'?"7BZ2]\&ZYK<ZZS*FHZ!J>C+K?';]MCX>_LX
M_&;2OA_\5K?_`(1SX?/^S7\6OVBO$WQ3,VJZHOAJR^&/Q:^`7PHA\/'P=H>@
M:IJVK'7[[XZ6E^-4LKGS-,_L3[,VEW<>HO>:?R'A?]@S3_"?Q<^%7CC3?C!X
MR_X5U\#_`(\?&[]H3X7?!QO#O@V/1-#\8_M%>$OC9HGQ1T[4?%<&G1>*M<\/
M'Q!\=O&OBGP78W4\-QX6:]DT&XN]>TF+2!HC_CI^P/X8_:5\4?&#Q!\8_B+X
MFU>V\>?`[Q?^S[\/]*\.Z'X:\-)\*?`OCSQ5\/?B#XGO[:_^S:I>>-O%=QX]
M^%/P_P!<L=0\3E=%L++P\NC+X=GBU36KS4`#N/%O[?'[+'@GQ9XB\":W\0]6
MF\9^%_%OQ#\#:MX5\._#7XH^,?$'_"4?"CX>?##XL_$/3=,TCPCX-UR_US_A
M%?AQ\8O`'B_4KO1K>^L1I&JWTD%S+-X?U^'3>J\-?MC?LZ>,?&.@>"?"WQ$C
MU^^\43>';'0O$.D^&O&%Y\.=0U[Q?X`L?BKX4\(1?%6+P^?AJOCGQ)\-M3T[
MQQHO@>7Q4GBN_P##6HZ;J<6D>7J5@MS\S^"_^";FD>'?B]<_&_Q!\:_&WB[Q
MUK?B?]H3QIXKFN/#7A+1=+UCQ%^T3\!?V=/@3XC:RT[2H5&BZ1X<TS]G70];
M\,Z9!-=RI<Z[?V6K:AJ:V=O?3<?^SC_P23^"O[-WC3X8>+?#FJ:-XEG^'VE?
M#*\O=4\5_!GX0:O\1->^(/PU^#/A+X*V_BBQ^*NH>'+_`,8^"]!U[2O!FD>+
MM3\&^%KBT:P\:MJ$_A[Q-I'AG4]0\,W0![S^UM^U_P")?V7KS2[YOAIX.\4^
M%;R+P['IEKJGQN\.^#OBU\6_$NM^(CH=W\-/V;?A&WAOQ#JOQ:^)ND6MUHNJ
MGP]K&L>`K#7)]?T30M!U>\O+K4;S1LO3?VX9KSXB:7#=_#6ST_X#>)/VGO%W
M['?AKXL/X^@F\4W?QO\`!,WBCP[J<FH_#2/PP+73_AWJGQ-\%^*/A3H>OQ^/
M+WQ7+XKL--U&^\#V?A36X]:T_L/VE?V2]9_:/M_%/A'5?CCXQ\.?"+XE>$X_
M!'Q'^&UOX1^'WB`-H;0WUIJE_P###QAKVAS>)/A7XN\06%\MGJGB>PE\03Z=
M+I>C:]X,L_"7BRP_X2"?,T_]B/P_9?%.Q\42?$/Q1>_";1?CIXA_:B\/_`VX
MTGPU_P`(_I7Q_P#%4.N/K/BD^+EL?^$LO?"O_"2>*/$OQ+T_P3<3E++XH:U-
MXA?7KK1++2?"VG@'TG\5O%GQ`\+>&K*X^%_PV/Q0\8:UK^BZ#INCWGBFQ\$^
M&=&MM2ED?4O%GC7Q1<V.MZAI7A7P]IMM<W5\/#GA;Q;XGU*]?3='T7P[>7.H
MF>S^(_#7[=_C_P"(EYHGPX^&?P$T3Q!\>V\1_M.Z3XJ\(ZU\9;7P]\,;+1_V
M3?'7@SX;_$/Q%X0^*<'@'6M5\8V7B;QQ\1O!/A#P,DWPY\/F'Q#<>,-.\=R>
M$;OX>Z_:R^S_`!+^`OQ^^)G[-6@_!_\`X:F\0>`OBE*-!B^('QK\'?#_`,+V
M^L^+=*M;BZG\2^';'1K"[\.6_@VV\56DMMH5]XA\%:AX=\4Z7I<-W<>%M5\/
M:S>Q:I8>=Z+^Q-XM\.>&?A+)X3^.%A\-?BE\&?#WQ`^&W@WQM\*/@7\.O"/A
M*T^#/Q(O/!NIZY\.#\)=8N_%WAI5T[7/`'A+Q5X<\2)J0O\`3O%&B07>H6FL
M:-J?B70->`*/A#_@H5HGQ%^*7[%W@WP/\(O&-UX`_;&^'_B[QUHGQ9\0ZQX>
MT32?#-UX<^%,7Q1B\%V?AZSN-;UCQ=XDM(/MFA^-KRV.C^&/"&KVL5A;:[XE
MU*YEL;"_\!/VT]2^,WQV\5_"^^M_@+X:T;2_$?QE\/>&]+L_C'XTUGXS:[)\
M(OB#K?@.\FG\$7_P8\/_``_%X5T"X\0^*M`\,_%GQ7KW@33-1TA-<L"UQ-+!
MQFL_\$]_%>F>/_V3==^#_P"T(WPT^'W[&OABY\)_";X>7_P<\+>.Y[O3M>\`
M6_PW\93^,/&FI>)M&U;6M1\0Z##+>)>VNGZ8]CK]W<ZG,-3C<68^A],_9J\4
MS_%GP?X^\??'?QO\1?"OPK\:>,_B%\)?`>K>&/`6C-X8\5^./"WC7P/=W/B'
MQ?X=T/3];\:6'A?P=\1/&/AGP5875OI#6NGZM'?>,+OQOXBTW3M<MP#KO%/[
M4GP7\%?$O2?A/XJ\0:_H?BG7/$>B>#-+U"_^'OQ%A\!77C?Q-I]IJGAGP.OQ
M2;PI_P`*U7QGXDL[ZV_L/PPWBL:MJ-Y<V>E0VW]K:AI]A=>2>&O^"C7[('C#
MPK!XQ\-?%*^U;2-3\-?"[Q?X3@@^&WQ4CUWXC>'?C1K#^&_AEJ/PI\,W'@J+
MQ!\55\4^)H;OPU##\/=-\1SZ;K]C>Z9K<>FS6LS+Y?\`%;_@FKX+^+?Q]C^.
M?B/XC:U<7MA\>/@;^T/X=MM5\#?#_P`3>*_!_BKX(ZE\/;BQ\!^#/BCK^E7G
MC7PC\$_$5MX`%[JOPR\-7&DV\7B[Q;XT\4+K%S'XAOM$EXC1O^"4OA/PU8_L
MS7'A[XV>.K#QE^R9^S=\'O@1\)/%LWAKPC?R6NM?!CQ+#K6B?$77-%N(O[.U
M2;Q'HTVO^"?%GA*-K32KKPSXFU)M&U#0]>M='UK3@#Z1^"?[7>H_'CX+?&OX
ML>`OA!XB\0:I\,/C5^T'\&?"GP^TS6;33_$7Q$U+X)_$35_AWIMVTWCBP\&6
M_@>[\5W^FK=:KI?BB*)O!*&^@U&XU&73F6?RZZ_;K\<Z/XP\2?`S7/@GX<;]
MH^T^+WPB^#WA3P]X:^+LNN?!G7];^,/PP\=_&FRN-5^*U]\-]!\3>&KGP'\+
M_A;X_P#%OQ`\*S?"N_\`%4&F6O@J]\-:=KMA\2/#=VGJOP\_9/\`%'PB^!'Q
MK^%OPT^/GB_0?B'\8/B/\;?BW#\;]0\&^!==\2>"_'WQR\77OC77=:T;P?=Z
M?#X(U"/P]K.IWQ\,:9JVF3:=;6RV$&HVVHI9N+KRKP%^P/XE\*_#/3?!FJ?'
M5+OQ?X%^+6C_`!V^%'Q1\-?"71/#OBS1?BY#H?BCPSXS\;_$V37/%_CF;XV:
MU\5?#?B_7_#OQ%U/Q=J5EK6IZ+K.IQ:5J^C:@-$U+0@"CK__``45NM%\-_"*
M_A^`GB/5?$'BO]K_`,-?L=_&6WL/&WA\^"_@9XXU3XXZ!\$-2U"Y\8W5C::G
MX^%YJ'B;0_%_P_T+0O!FGZQXH\%ZE#K/BF/X??9=1M[7UGXZ_MEV/PA^/7[.
M?P+T3P-+XZO?C)\6_#?PT\>^(H?$46BV/PB@\<?#[XM^-?`M_<6K:1J3>+/$
M/BB7X1>(8X?"=M<Z1)I?AJVNO%FKZG:0S^&M.\2^,?$S_@G?XP\4_#[X>^`_
M`O[2>H>")?#W[06C_M8?$+Q7K'P=\$^./$/Q2_:#T/XO:3\:].\4ZAYFL>&=
M*\,>&8O%&DVFB+X.T#3MD/@BRTKP[::U;2Z=_:=UTGQ'_P""9OP7^*/Q$^$/
MQC\0>(_B3I7Q4\!_'?P)^T/X^UWPA\3?BWX9\+_%GX@^"OA/JWPI^UZA\-[3
MXFR>"/!B:EIMUHTKW?A+2K?5[?2O#MKX1DU&^\-ZIKUIJ0!^CRG<JMC&Y0<=
M<9&<4M(HVJ%'88Y_SQ[`<`<```"EH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HK\?O\`@H%\5?B7X,_;Q_X(Z_#O
MPAX_\7^%O`WQE_:1_:&\-?%;PKX>\0:CH^B_$+0?#G[+7C7Q9H.D>+;/3YX!
MK.G:1XDL+/6["TNF:"#4K>*Z"&6-&7]84\.:840E;[)53_R&-:[@'OJ)/YDG
MWH`Z"BL'_A&]+]+[_P`'&M?_`"QH_P"$;TOTOO\`P<:U_P#+&@#>HK!_X1O2
M_2^_\'&M?_+&C_A&]+]+[_P<:U_\L:`-ZBL'_A&]+]+[_P`'&M?_`"QH_P"$
M;TOTOO\`P<:U_P#+&@#>HK!_X1O2_2^_\'&M?_+&C_A&]+]+[_P<:U_\L:`-
MZBL'_A&]+]+[_P`'&M?_`"QH_P"$;TOTOO\`P<:U_P#+&@#>HK!_X1O2_2^_
M\'&M?_+&C_A&]+]+[_P<:U_\L:`-ZBL'_A&]+]+[_P`'&M?_`"QH_P"$;TOT
MOO\`P<:U_P#+&@#>HK!_X1O2_2^_\'&M?_+&C_A&]+]+[_P<:U_\L:`-ZBL'
M_A&]+]+[_P`'&M?_`"QH_P"$;TOTOO\`P<:U_P#+&@#>HK!_X1O2_2^_\'&M
M?_+&C_A&]+]+[_P<:U_\L:`-ZBL'_A&]+]+[_P`'&M?_`"QH_P"$;TOTOO\`
MP<:U_P#+&@#>HK!_X1O2_2^_\'&M?_+&C_A&]+]+[_P<:U_\L:`-ZBL'_A&]
M+]+[_P`'&M?_`"QH_P"$;TOTOO\`P<:U_P#+&@#>HK!_X1O2_2^_\'&M?_+&
MK]CIMKI_FFV$X\W9O\Z\O;O[F[;M^V7-QY?WCGR]F[C=NPN`"_1110`4444`
M%%%%`!1110`4444`?B!_P4G_`.4DG_!"G_LZW]J#_P!8Y^(-?MY'_JX_]Q?_
M`$$5^(?_``4G_P"4DG_!"G_LZW]J#_UCGX@U^WD?^KC_`-Q?_010`^BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBOF?]L;XZ:Q^S1^S-\7_CIH&@Z9XGUCX;
M^&$UZPT'6;V\T_3-3F;5]+TW[/>7NGQ37EO$([]Y=]O$[[XU7&UF([,OP&)S
M3'X'+,%!5,9F.,PV`PE.4XTXU,3BZT,/0A*I-QA!2JU(1<YR48I\TFDFSDQ^
M.PV68'&YCC)NGA,!A,1C<54C"524,/A:,Z]::IP4IS<:<)-0A%RDU:*;:1],
M45_)TW_!PW\<PS`?LX_"7`)`SXX\;9P#W_XE5*O_``<,_'9Q*R_LW_"=E@@>
MYG9?&WCAE@MDE@@>YG9=)(AMTGN;:![B4I"L]S;0LXEN(4?]D_XEV\4[7_L7
M`VT_YGF3]>7_`*C//YV/R3_B/OAE_P!#C&?^&;-OG_S!]-?N^[^L2BOY-_\`
MB(?^.&XI_P`,Z?"+>"04_P"$\\:;P0,D%/[+W`@<D8R!UI'_`.#B#XWQX\S]
MG;X01[L[?,\>>,X]V"`=N_3!NP64'&<%E!QN&6OHZ^*C_P"9+@NG_,[RCK;_
M`*C/-_<+_B/WAC_T.<7V_P"1-FV^FG^Z?UIWT_K)HK^3G_B(<^.G_1N/PE_\
M+CQM_P#*JOTJ_P""9G_!3GXA?MT_$KXE^!_&7PM\%^`K3P-X%T?Q99WWACQ#
MX@UFYO[G4O$;Z+):7,.L65M##!%"!.DL+O*TIV,H09KQ\_\`!/Q"X9R?'9[F
M^586AEN74X5<55IYMEN(G"%2M1H1:HT<5.K.]6M"+4(-I7;5DVO6R+QCX"XC
MS;!9)E6:8FOF.85)TL+2GE>8T(3G"C4KR3JUL-"E!*G2J.\Y13:26K2/V<HH
MHK\F/U$****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BO)[WX\_`_3?$C>
M#=1^,?PJL/%Z7?V!O"M[\1/!]KXC6]\Q8?LC:)/K,>I+=&5UB%LULLYD(01E
MB!7K%`'X=?\`!2Y9G_X*/?\`!"Q;>5()C^U;^T_LE>'[0JX_8[^(!;,7FP[]
MR@K_`*U=I(<;MNT_M*EIXAV)C6K'&U?^8&1V'8:P0/H.!7XP?\%)_P#E))_P
M0I_[.M_:@_\`6.?B#7[>1_ZN/_<7_P!!%`&)]D\0_P#0:L?_``1M_P#+BC[)
MXA_Z#5C_`."-O_EQ6]10!@_9/$/_`$&K'_P1M_\`+BC[)XA_Z#5C_P""-O\`
MY<5O44`8/V3Q#_T&K'_P1M_\N*/LGB'_`*#5C_X(V_\`EQ6]10!@_9/$/_0:
ML?\`P1M_\N*/LGB'_H-6/_@C;_Y<5O9Q_P#J)_E29'O^1_PH"Z[_`-?TU]YA
M?9/$/_0:L?\`P1M_\N*/LGB'_H-6/_@C;_Y<5NY'O^1_PHR/?\C_`(4"NNZ_
MK_AU]YA?9/$/_0:L?_!&W_RXH^R>(?\`H-6/_@C;_P"7%;N1[_D?\*,CW_(_
MX4!==U_7_#K[S"^R>(?^@U8_^"-O_EQ7Y^?\%4K?64_X)\_M1M=:I:7$`^'<
M1DACTG[.[K_PE'AWA9SJ4_EGISY3^N,@5^D.<_\`ZB/YU^>G_!5O_E'G^U-_
MV3J+_P!2GPY7U7`O_);\&_\`95</?^K?!GS/&W_)&\6=?^,:SW_U5XH_@T?[
M[?[S?S-?JY_P3NBNM0^'_P`=-!MAH_A>TU;3777_`(J6]Q\'O$-UX3T:76_A
M7ISVWQ;^&7Q4BMVU[X+V-O<ZIXF.HV.NZ3H<_P!F^(6E:G;ZMXF7P9%9_E&_
MWV_WF_F:='-+$MPD4LD2W=L]E=K'(\:W5E)/;W,EG<JC`7%G)<V=G<O:S!X'
MN;.TN&C,UK`\?^H/$.3//LJGET:]/#.I5PM55JN'>+IQEA\12KIRPSK4*=9I
MT[PA7=2ASJ+JT:L%*G+_`#8R#-UDF9T\P=&IB%"CB:3I4L1]5J26(H5*+4<2
MJ-:I134VI3HJ%;D<E2JTIM37Z9>+8M7U[]FN;2+\?$;P;\,_!7[.OAJX\,^/
M]+^,WA[5?@/\4_'?A;Q-;6NG^#=-^&%CI,$BZU\0KVZOM0&F76LM\3O!NNZ8
MNI>,M#M/#^G7,<7HO[+/@RY\%>"](\%?V9XV\-?%"V_:@\1>#/VEKGPWJ?PC
MMW^%WPX7P;X.7P9XJ^,-I\0='\6Z+XL^"VA1ZA\1M5UGP9YNE>!O$NJ6VN0>
M*?$\.MVW@^S/Y`^5%O\`-\J+S223*(T$A+*%8F0+O)*@*23DJ`I.`!33!`0J
MM!`RH-J!H8V"+D-A`5(0%E5B%P"RJW501XN(X.G7R_$Y=',:-*AB<=6Q\X?4
M*]6E.M4I1I1^L0K9G.6(2DZF*G#VE*A/&T\%6I8?#TL-6P^,]BAQ9"CCL-CY
M9?5J5\-@J.!C/Z]1I5(T:=7VLOJ\Z66PCAW*,88:$U3J5X8.>,HU:U>IB:.(
MP>A?PV]MJ&H6UI>6^HVEMJ%_;6FHV<,EM9ZC:6]Y/#:ZC9VTH$MM:7]O''>6
MEM*/,M[>>*&3YXS7[X_\&^<=[+\?OV@A8W4-I(/@YX7+O-9_;%9?^$[?"A/M
M5KL(.<MO;.?NY49_`.OZ!_\`@WG_`.3@OVA/^R->%O\`U/'KP_&I6\*^+TVW
M;`8--NR;MFN7ZM)*.N[2272UM#V_!UI^)W"3244\?BFHJ[27]FX[1.3;LO-M
M]V?U9_9/$/\`T&K'_P`$;?\`RXH^R>(?^@U8_P#@C;_Y<5O45_F4?Z-F#]D\
M0_\`0:L?_!&W_P`N*/LGB'_H-6/_`((V_P#EQ6]10!@_9/$/_0:L?_!&W_RX
MH^R>(?\`H-6/_@C;_P"7%;U%`&#]D\0_]!JQ_P#!&W_RXJ_8PZC%YOV^]@O-
MVSRO)L39>7C=OW9O+OS-V5Q_J]NT_>W<7Z*`"BBB@`HHHH`****`"HIX8[B"
M:":-9HIHI(I(G&4DCD1D>-A_==6*M[$U+2-T/..#SG&..N>V/7M0!^//Q*^(
M7[2UC\6M8^#'P[^`FE:/\(?`_P`7O"MK=>&+?]FG6M7\"_$[X;>-M;_9_P#"
M'AKP_%XZN%7P)+!K%AXM_:5^*/C_`,:>$M/D'P:L_A)X-T#Q_;6@U.Y/C;]>
M-+TVPT?3;'2=*LK;3M,TVTM[#3M/LH4M[.RL;2)8+2UM;>,+'!;P01QQ0P(J
MI%&JQHJJH`_!KQ_I7A.P_;J^(.O>(_A5^S;\6-/E_:%^$MH_QO\`BI\+_P!I
M;QKK'P5\2:EH_P`+-,T+X9M\;;/X7^(/@OX!UZVN[CP_JO@'PA9^)M'\.>&?
M$WBG2;?Q9K&G^)?%L37/[YCD=NIZ?4]>G/J.QS0!^(/_``4G_P"4DG_!"G_L
MZW]J#_UCGX@U^WD?^KC_`-Q?_017X??\%+GEC_X*/_\`!"QX(/M,J_M6?M/[
M(?-2#?G]COX@`_O9`47:I+X(R^W8N&8&OVB34-;"(/[!_A7_`)B]B>P[B/!^
MHX/44`=%17/_`-HZW_T`?_*M9?\`QNC^T=;_`.@#_P"5:R_^-T`=!17/_P!H
MZW_T`?\`RK67_P`;H_M'6_\`H`_^5:R_^-T`=!17/_VCK?\`T`?_`"K67_QN
MC^T=;_Z`/_E6LO\`XW0!^#O_``<%ZIJFE_`7X!RZ7JFJ:7++\;=1CEETO4[_
M`$R66,?#?Q0XCEEL+FVDDC#JKB-V9`ZJX4,H(_E*'B[Q>2`/%_B_).!_Q5OB
M3J?^XK7]2W_!P9<W\_P#^`0O--^Q*OQNU`H_VZWNM[?\*W\4C9LA163Y<MN8
MD#;C^-<?RD5_HG]'BC1GX791*5*G*7U[.%>4(MZ9E7ZM/JC^`_'RK5AXE9JH
MU)Q7U/*=(RDE_P`B[#/9/OY'U5?_``>^*&D_`C3OCIK'QDTK1H-;N;:YT'X?
MZM\3?%&G>-]?\*7=E>W5MXET2.YG30]3NYVTZ_N(O!]IJ\GB=]`LKSQ!]C6.
MVEL!SGQ`^'/QA^&GP\^%7Q%\4>-]3AL_BV?$QT?PY;>./%TOBGPZGARR\(:Q
M"?&-A+/!:Z//XC\.^.O#'B?0;"*^O;XZ#JMG=ZK;Z9+=06[^V>"_VLO!'@S]
MEVY^#/\`P@?B/QCX@N_$$4\OA#XB^)(/&GP*BF2PM)G^(>E>&M2TI/$GAO7)
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MMT_P?J=AXMO-$BTF:5X/`#XN\7@D'Q?XOR.#_P`5;XD_^6M?2]Q^T9X7G\'7
M>H?\(EXF7XT:I^S/I/[*NIZQ_:^B'X:?\(5IMEI7AB;QQ9:5]C_X2L>-K_X=
M:)I_@Q]%N+D^&[6]^U>+X[V6ZEAT2#Y()R23W)/YU[V34\=4CB_[4PE*G*.(
MM1_=8>*MR0=2%'V4I^TPD*EUAJU;DQ-6%_;4XN,93\/-JF"A+"_V9BJM2,J%
MZW[RN_>4FJ<JJJQA[/%5(+FQ-"ESX>E*RI5&I2C#^OO_`((`:EJ6J?LL?%J?
M5-3U/5)H_P!H+5XHYM4U&^U.>.(?#CX=N(HYK^XN94B#N[B)'6,.[N%#.Q/V
MC_P5;_Y1Y_M3?]DZB_\`4I\.5\'_`/!`"YU"#]E;XM+::9]M0_M!ZP6E^WVU
MMM?_`(5Q\.04\N9&<[5"MO!VMOP!E&S]L?\`!5*]U67_`()]?M1I<:/]FA;X
M=QAY_P"TK2;RQ_PD_AXY\F-`[\@<*1COU%?P;Q3&,?I"\L4HQCQ_PZDDK)+Z
M[E>RV^X_M[AEREX#7;;;X'SUMMMMVP>8WNW>^S_76Y_"8_WV_P!YOYFFTY_O
MM_O-_,TVO]$8[+T7Y'\"!1113`*_H'_X-Y_^3@OVA/\`LC7A;_U/'K^?BOW[
M_P"#?2:[@^/W[036EG]M<_!SPN&3[5#:[%'CIR&WS*RMD_P@9XQW%?EOC9IX
M6<8_]@.$_P#5KEY^F>#G_)S>$?\`L.Q/_JLQQ_6[17%ZYK?B&PT75[ZWT-5G
ML]+U"Z@9]5L719K:SFFB+H4`=1(B[ER,C()`K^-!/^"XG_!0!D1CXI^$V61&
M/_%I;'JR@G_F/G')]:_@_@'POXC\1HYI+(*N5TEE$L%'%?VCB:^'<GCOK+H^
MQ]CA,3SI+"5?:<SARWA;F3;C_;G''B3P]X?RRR&>T\RJ/-HXR6%^H8>C726!
M>%5;VOML3A^6_P!<I<G+SIVGS.-E?^V.BOXP/"7_``64_P""E/CWQ%IGA'P3
M-X!\6^*-:F>#2?#WAWX)QZOK&H2Q1/<2K:V-GK<DSK#!')--*0L4,:%Y9$&,
MV-+_`."Q/_!3C7-/\0:MHEEX9UC2O":N_BO4]+_9XU74+#PLL:222_\`"37=
MI=S0>'FACAFDN$UF2RDMXX9I)TC2&5D^\G]&SCRG*4*F9<)TYPC2E.,\VQ<9
M0C7G*G1E)2RQ.*K5(5*=)M)5*D)0C>2DE\/#Z0_`]2,9T\!Q1.,I5(QE#*\-
M*,I480J5HQ:S!J4J5.<:E5)MTX2A*?+&29_9O17\7OAG_@LQ_P`%*?&NJ+H?
M@QO!7C#6WMI[Q=&\)_`:Y\2ZLUG;;/M-V--T34K^]^R6_FQ">Y\CR(FEB621
M6EC#8L__``6]_P""@UM/-;7/B/X66US;336US;7/P?MK>YMKFWD:&XM[FWFU
MR.:WN+>9'AG@FCCF@F1XI421&4:+Z,_B#*<J2QW"SJ0C"<Z:S3&.<83;4)2C
M_9?,HR<9J+:2DXRL])6E_2*X#4(U7@^)53G*48U'EN$4)2BHN<8R>8\KE!2B
MY).\4XN27,?VN45_*=^PS_P5H_;.^/'[67P3^$7C_6OAQJG@[QSXDU;3-=L-
M'^'MCH&IW-K9^#O$^M0K9ZQ_:]U]AD2]TNUE:3R)#)"DD``,VY?ZH-/N;ZX$
MAO;#[#M$?E_Z9!=^;N#%^8%4)L(`^;.[=E<8-?E_'7`6=^'N9X7*<]J8"IBL
M9@(9C2>7UZU>DL//$8C#)3G6P^&DJGM,-4O%0DE%Q?-=M+](X*XYR;CW+L5F
MF24\=3PV$QTLOJK'T*="JZ\,/A\3)PC2KXB+I^SQ--*3G&3DI+E25WHT445\
M2?9!1110`4444`%9NLWDVGZ1JE];QP2SV>G7UU!'=/=QVTDUM:S3QI<26-EJ
M-ZD#O&JS/:6%[=+&6:WL[J8)!)I5FZS!<W6D:I;6?E&[N-.OH+7SKR^T^'[1
M+:S1P>;?:8RZE91^:R>9=V#+>VR9GM&%Q'&:`/Y];WXK>$/B=^T;H&H6.B:0
M_@OXA_%#X0>+/&OP^M_BW^WWX4^'/C3XF:6_@:W7QKXA^$EU^P+%X0U+6=`\
M0:%ILFFVEY\5?!7@'Q\WA3POXB^*>DVMY<ZX;;^AM>G'8D?D3R<@<GJ3Z]SU
M/X"6NFZQX:_:3TSP+X7B^(_C&T\`?$?X8>&O&VH^&?C[_P`%L_C)H'ACQ=-I
M?@;Q)XG\/^(O$VB)XO\`V>WN-)?7UOKC0_''BAM!LO#=[I'_``L^#2(+S6;.
MW_?L?U/KZGU__5Z<8H`_$'_@I/\`\I)/^"%/_9UO[4'_`*QS\0:_;R/_`%<?
M^XO_`*"*_$/_`(*3_P#*23_@A3_V=;^U!_ZQS\0:_;R/_5Q_[B_^@B@!]%%%
M`!1110`4444`?SW_`/!PU_R0']G_`/[+AJ/_`*K7Q37\F]?UD?\`!PU_R0']
MG_\`[+AJ/_JM?%-?R;U_HQ]'?_DUN3_]AV<?^K&N?Y_^/W_)R\V_[`\I_P#5
M;A@HHHK]P/Q<****`/Z[_P#@WR_Y-3^+G_9PNL?^JV^'-?;W_!5O_E'G^U-_
MV3J+_P!2GPY7Q#_P;Y?\FI_%S_LX76/_`%6WPYK[>_X*M_\`*//]J;_LG47_
M`*E/ARO\[N*_^4AG_P!E_P`/?^IN5G]]<,?\F%_[L?//_4/,#^#1_OM_O-_,
MTVG/]]O]YOYFFU_HA'9>B_(_@4****8!7]`__!O/_P`G!?M"?]D:\+?^IX]?
MS\5_0/\`\&\__)P7[0G_`&1KPM_ZGCU^6^-?_)K>,/\`L!PG_JUR\_3/!S_D
MYO"/_8=B?_59CC^K'Q9_R*_B/_L`ZS_Z;;JO\T2/_51?]<HO_1:U_I=^+/\`
MD5_$?_8!UG_TVW5?YHD?^JB_ZY1?^BUK\1^B?_"XZ_Z^<.?^DYV?L7THOX_!
M/_7OB/\`]*R$^[O^">WBZ#PM\=XK:[\2^`-"L?%%AI>B:AI_C[Q%XI\"Q^)+
M.U\06.O&Q\,_$/PS+;Q>%/$.G7>DV6J_9?$UPOACQ9I,&I:)?V]_=KIUG)[O
M\+?'/@+PW\=?^$[A_:*TCQQ\*-'\;ZYJD7B#XD?'?QAI7Q"^%&J:U\/]&T/Q
M;\4]"\$:IH^CZ9^U%>:F[OH7A2>^\)ZO+\1K#P+HEKXX\.>&AK\JG\G2`000
M"",$$`@CT(.01[$4NYN?F/))/)Y)ZD^Y[^M?TAFG"&'S/'YGCIXW$4?[5RVE
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M"E&.%C0G1C5>$]O*56G4_?RKK`X2-2=:G.HH83#4Z4Z=.FX3\BOF4:F64,MI
M4*E&%.O&O4D\3*M"M*FL3[%*E4I_N(T'C,7*G"A4A3<\5B*E2%2I44X?H)_P
M2K_Y2$?LO?\`8[>(/_5;>.:_O23[B_[J_P`A7\%O_!*O_E(1^R]_V.WB#_U6
MWCFO[TD^XO\`NK_(5_%'TIO^2WR+_LE</_ZM\W/[$^C-_P`D=G?_`&4^)_\`
M53DXZBBBOYE/Z/"BBB@`HHHH`*0]#CK@X_R>/SI::[!59BP4*K,68@*H`)+$
MD@`#J22!CJ0.:`/R>U_X&?'^#]JSQMXW7P!\5/%7@;Q-\7/!/B?1O$_A?]O;
MQI\#?"6C>%=,T/P9I%W9ZI^SC\/=$TGPIXQ72;G1=5O]2F\7W>O>)/B-:W7]
MB>)-6&CVFC:?8_K$/ZGOGN?\X[=.U?DQKU_\<M8_:E\4S^(;C]M_4/`4'Q3\
M$Q_#"^^!?CO]C+PU^SN?AX-*\)/<V?BSPYXF^)O_``NC7H[;Q/\`\)//X\U:
MYTEM?US3+QK'PCI-O;V6FZ7#^LX_'J>N/4^G;T[XQGF@#\._^"ET\-K_`,%'
MO^"%D\[^7%'^U;^T_N<J[8W?L=_$!%&V-78[F95&%(!.20H)'[1Q^)M$\M/]
M-!^1>1;WN#P.>;4'\P#[5^,7_!2<D?\`!23_`((4X./^,K?VH!^!_8Y^(((_
M$<'VK]NXQF-"222BDDLV2<#D\T`8G_"3Z+_S^C_P'O/_`)&H_P"$GT7_`)_1
M_P"`]Y_\C5O8'O\`F?\`&C`]_P`S_C0!@_\`"3Z+_P`_H_\``>\_^1J/^$GT
M7_G]'_@/>?\`R-6]@>_YG_&C`]_S/^-`&#_PD^B_\_H_\![S_P"1J/\`A)]%
M_P"?T?\`@/>?_(U;V![_`)G_`!HP/?\`,_XT`?SO_P#!P9JUAJ/P$^`26=P)
MGC^-VHNZB*="%_X5OXH7.988U/)48!)^8<<''\I%?UD?\'#/_)`?V?QDX_X7
MAJ/!)(X^&WBKU/N?S-?R;U_HQ]';_DUN4?\`8=G/_JQKV_`_S_\`'[_DY>;?
M]@>4_P#JMPP4445^X'XN%%%%`'];O_!`#5]/T_\`96^+45W<"*1_V@M7D5#%
M<.2A^''PZ4-F*&1>65Q@L&&TD@`J3]L?\%4M>TJ[_P""?7[4=O;W0>:7X=QJ
MB>3=*6/_``D_AT_>>!4'3^)A7QS_`,&^?/[*7Q<&3C_AH76.,D#GX;?#C/`/
M?`_(5]O?\%6^/^">?[4V"?\`DG47<X_Y&CPZ.F<=S^=?YW<5_P#*0S_[+_A[
M_P!3<K/[ZX8_Y,+K_P!$/GO_`*AYC;]/^#N_X-'^^W^\W\S3:<_WV_WF_F:;
M7^B$=EZ+\C^!0HHHI@%?OW_P;Z7]II_Q^_:!ENYA"C_!SPNBDI*^6'CMR1B&
M.0CMR0!SUZX_`2OZ!_\`@WG_`.3@OVA.2/\`BS7A;H2/^9\D';V)%?EOC9_R
M:SC&W_0#A/\`U:Y?_7Z,_3/!S_DYO"/_`&'8G_U68X_J4\5>)=%;PSXB47HR
M="U@#-O>=]-NO^G;MUK_`#88_P#51?\`7*+_`-%K7^EWXKX\,>(R"01H.L'(
M8]M-NB._K7^:)'_JHO\`KE%_Z+6OQ'Z)_P#"XZ_Z^<.?^DYV?L7THOX_!/\`
MU[XC_P#2LB_KH/HHHK^P#^40HHHH`^_O^"6=Q#:_\%`OV8KB=_+AB\:Z^SN5
M=MH/PX\<*/EC5W.691\JG&<G`!(_O)T[5+'45?['.)O)6,28CFCV[P=O^NBB
MSG:?NYQCG'&?X//^"5?_`"D(_9>_[';Q"...OPV\<@_I7]Z2?=7J<J,Y)/;W
M)K^$?I3?\EOD7_9*X?\`]6^;G]L_1F_Y([//^RGQ'_JIR?\`K;_@NHHHK^93
M^CPHHHH`****`"JE_9Q:A97EA.L;P7MK<6DR30074317,+P2+);74<UM<1LD
MC*\%Q#+!*I,<T<D;,C6Z*`/S1TS]@?PQX8\1Z3<^%/V?O^"=>G2:'?:?JFA_
M$B/]C?P]I?C[0M2TRY@N]-U:TT?0=6L-(_X2+3;FWBN[36M,\2^'X(M1BAOK
M31K%(DLQ^C^E6UW9:9I]IJ&H/JU];6=M!>:I+;6ME)J-U%"B7%\]I9)':6K7
M4P><V]M&D$)?RXEV**OT4`?B!_P4G_Y22?\`!"G_`+.M_:@_]8Y^(-:G_!0[
M_@J[XF_8=^-?AOX1Z-\%-"^(UKK?PRT3QZ^N:GX]U/PQ<6\VJ>(/%&AMIJZ?
M9^%=;BEBA3P]'<+=&[1W:Z>(P*L2O)E_\%)_^4DG_!"GK_R=;^U!T!/_`#9S
M\0?3]:_*C_@OR"/VR_A_D$?\8Y^#^H(/'C[XF`\$#H01]01U%?K_`((<-9)Q
M7QW0RCB#`1S'+I99F&(EAIU\5ATZU&-)TI^TP=?#UDX.3:2J*+O[R9^3^,_$
M6<\+\%5LUR''2R_'PS'`48XB-'#5VJ56I)5(>SQ=&O2:DDM73YE;W6CWK_B(
MF\>?]&K>$?\`P\&N_P#SO:/^(B;QY_T:MX1_\/!KO_SO:_G#HK^SO^($^%'_
M`$2-'_P[9_Y?]37R_JRM_(7_`!&SQ0_Z*JMT_P"97D?2W_4L_NK\3^CS_B(F
M\>?]&K>$?_#P:[_\[VC_`(B)O'G_`$:MX1_\/!KO_P`[VOYPZ*/^($^%'_1(
MT?\`P[9_Y?\`4U\OZLK'_$;/%#_HJJW3_F5Y'TM_U+/[J_$_H]7_`(.)?'A8
M#_AE;PB,D#/_``N#7N,G'_1/:_H>_9:^,]W^T1^SS\(/C??^'[;PK>?$[P/I
M'BZX\.VFI3:Q;:/+J:R,UC!JD]EITU]'#Y>%N)+&U9\\Q+BO\Z9/OK_O+_,5
M_?;_`,$S./V!OV3\@_\`)&/"G8_\\YSUQZ$'\17X+](#PYX+X-X;R;'<-9)3
MRO%XK.UA*]:.-S+$NIA_J&*J^SY,;C<33C>I2A+FA",_=LI*+:?[CX$^('%_
M%W$.;X+B+.:F987#9++%4*,L'EV&5.NL;@J*J<V#P>'J2?LZDX\LYRA[S?+=
M)KG_`/@H=^PD?V\?`'P_\#CXGGX7_P#"#>.+GQE_:8\'KXP_M/[1X:U7P]_9
MWV1O$7AW[)L_M+[7]J^T7&[R?(\@>9YJ_DS_`,0Z;?\`1W+_`/ACX_\`YY]?
MTW9'O^1_PHR/?\C_`(5^)<.^+/'_``IE=')<@S[ZAEN'G6J4L-_9F3XGEG7J
MRK57[;%Y?7KRYJDI2M*JU&]HI))+]DX@\+>!>*,SJYQGN1_7LQKPHTZN(_M+
M-L-SPH4X4:2]EA,?0H1Y:<(QO&FG*UY-R=S^9'_B'3;_`*.Y?_PQ\?\`\\^C
M_B'3;_H[E_\`PQ\?_P`\^OZ;LCW_`"/^%&1[_D?\*]O_`(CYXL?]%5_YA.'O
M+_J4^7]65O$_X@9X6_\`1,/_`,/.?_\`ST_J[\K?S(_\0Z;?]'<O_P"&/C_^
M>?1_Q#IM_P!'<O\`^&/C_P#GGU_3=D>_Y'_"C(]_R/\`A1_Q'SQ8_P"BJ_\`
M,)P]Y?\`4I\OZLK'_$#/"W_HF'_X><__`/GI_5WY6^"O^">_[$A_84^%/B[X
M9'XDGXG?\)3\0[SQY_;1\)KX0-C]K\->'/#W]E_V>NO^(1<>7_PC_P!K^V?:
MX2WVOR/LX\GS9/</VK_@/_PTY^SQ\5/@./%!\%_\++\.+H'_``E`T<:^=&VZ
MKINI?:O['.HZ2+_/]G^3Y!U&T_UN_P`WY-C?0N1[_D?\*,CW_(_X5^=XOB7.
M\=Q#_K5BL;[7/OK^'S3Z]]7PL/\`;L).E4P]?ZM3H1P?[N=&D_9_5_8RY;3I
MR3DG]_A>',FP60?ZL8;!^SR/ZC7RWZE]8Q4_]BQ,*E.M1^LSK2Q?OPJU%[3V
M_M8\UX3BTFOYDC_P;J,23_PUR_))_P"2'Q]SG_HI])_Q#IM_T=R__ACX_P#Y
MY]?TW9'O^1_PHR/?\C_A7Z)_Q'SQ8_Z*K_S"</>7_4I\OZLK?`?\0,\+?^B8
M?_AYS_\`^>G]7?E;^9'_`(ATV_Z.Y?\`\,?'_P#//H_XATV_Z.Y?_P`,?'_\
M\^OZ;LCW_(_X49'O^1_PH_XCYXL?]%5_YA.'O+_J4^7]65C_`(@9X6_]$P__
M``\Y_P#_`#T_J[\K?S(_\0Z;?]'<O_X8^/\`^>?7Z"_\$\O^"79_8.^(/Q#\
M='XV-\4/^$[\&:5X1_LP_#Y?!_\`9?\`9FO-K?V_[6OB[Q%]L\_=]F^S?9K;
MR\"7SG_U=?K3D>_Y'_"C(]_R/^%>7G7C%XC<0Y5C,ESCB'ZWEF/IPI8O#?V5
MDE#VL*=6E7C'VV&RVC7IVJT:<KTZL&^7E;<6T>GDWA)X?</YG@\YRC(7A,RP
M%257"XC^U,YK^RG.E.C*7LL3F%:A.].I.-JE.:7,VDI*+5#5K'^U-+U+3?-\
MG^T+"\L?.V>9Y7VNVEM_,\O<F_R_,W[-Z[MNW<N<C^9]?^#=%E55_P"&N7.U
M57/_``H^/G:H7./^%GG&<9QDX]37]-^1[_D?\*,CW_(_X5XG"?B!Q;P/''QX
M7S;^S(YD\-+&KZCEV,]L\'[?ZN[X_"8IT_9K$UM*3@I\]Y\SC!Q]GBG@/A7C
M26!EQ+E?]HRRY8E8-_7<PPGL5BWAWB%;`XO#*I[3ZK0_B\_+R>YR\TK_`,R/
M_$.FW_1W+_\`ACX__GGT?\0Z;?\`1W+_`/ACX_\`YY]?TW9'O^1_PHR/?\C_
M`(5]?_Q'SQ8_Z*K_`,PG#WE_U*?+^K*WR?\`Q`SPM_Z)A_\`AYS_`/\`GI_5
MWY6_F1_XATV_Z.Y?_P`,?'_\\^C_`(ATV_Z.Y?\`\,?'_P#//K^F[(]_R/\`
MA1D>_P"1_P`*/^(^>+'_`$57_F$X>\O^I3Y?U96/^(&>%O\`T3#_`/#SG_\`
M\]/ZN_*WX*?LJ?\`!$<_LS_M"_"[X[G]I)O&?_"M];U#6/\`A&#\)TT`:Q]N
M\-:YX>^S_P!L#Q]JQL?*_MG[7YHTZZW_`&?R-B^;YL?[U@8`'H`/R&*,CW_(
M_P"%+G/K^((_G7PG%/&/$?&N-P^8\2YC_:6,PN$C@:%;ZI@L)R86%:M7C2]G
M@<-AJ4K5:]6?/.$JGO\`+S<L8QC]OPQPCP]P=@Z^7\.8#^S\)B<5+&UJ7UK&
M8OGQ,Z-&A*ISXW$8FI&]+#TH\D9Q@N7F45*4FRBBBOF3Z0****`"BBB@`HHH
MH`****`/PZ_X*76\%U_P4>_X(607,230R?M6_M/;XI!N1MO['?Q`=<COM=58
M>X%?E)_P7NL;.P_;&\`0V-M#:1-^SMX/D:.!-B%V\>?$I2Y'=MJJN?11Z9K]
M8?\`@I/_`,I)/^"%/_9UO[4'_K'/Q!K\HO\`@O[<VT/[9GP_6:YMH6/[.7@Y
M@LUQ#$Y7_A/OB6-P61U8J3D`@8)!`/!Q^^?1M3?B9ATDV_[&S71*_P!F@?AO
MTAG;PYQ%W;_A6RO_`-.S/R'^%WPF^(WQI\6VO@?X7^$M4\8>);JWN;S[#IR1
MI#9V-HFZ?4-5U&Z>'3M(T]7,5JEYJ5S;6\U_<V=A"[WEW;PR2:;\'/BQJ^NQ
M>%[#X<>,I?$TOB;5O!O_``CTVAW-AK4'BKP_HZ^(?$.AWNGZB+2XT^Z\.:$Z
M:SXCGOTMM/T#2Y(K[6+VRMIH9)/??V&OB=X&\!?%V5O&GQ'\#>#O#FO6%I9:
ME:?$3PF_C'X=>)X],DOM5MK'Q+?:1?1^(/!.HZ3?QVFK>%?%6C6T[&^6_P!"
MN[C34UBWN7[SQ9J/P"^(&H_"B+P?\9[KX(?`2/6/C_X,\5^*-=F\5>(?$=E%
MX@7PCXBOM#ET:&YU_P`7W]A\3?#36_AKP/9^.[F^M;3POX=M='^(.JW<OAK5
MHI_[<Q^>9MA,\Q>7K`3^H0P-*OAL='*LSQ<(UG@\QQ-6%26'<7C:TJF$HTL/
ME^74:M6HI3OBXXJ<,)'^-<%DV5XK)\+CGC8?7IXVI1Q&"EF>6X6<J/US+L/3
ME3C64UA*,:6+JU<1C\PJT:=-J#6%EAHSQ4OC'Q9\._'?@7Q+!X.\7>$];T/Q
M1>0:1=Z?HL]JMY=:O9Z^$.@WV@R:5+J%EXBL-<,B)HU_H%UJ=EJDI,%C//.K
MQ+U/BKX!_&GP/>:?I_BWX9^*=#O-6M?%%WIL-S;V5T+Q?!%@^J^,[.*?3+Z_
MMEUOPEIT;7OB3PS+-%XFT6W`?4-'M]Z!O5OB9XC\%>*_'?A1/"WQR^$OPZ\'
M_![P9\.O"'P5/AO6/BMXC;P[H-G\1;N:4W7B]?AUX9\0W7Q!\.ZCXE\2?&GQ
MQX@A\.Z-I5WYMSI7P\MX[^#0_#4/M>D>)OA/X2^(_P"SQ\/_`(3?%_X=>,/A
M#\.OC+KGQJ\>^+8[_P`3VWC/QAK-KX:MI?B5\3_'.F>*?"'A;0O"7AVY^'WA
M>Y\(>#_`>A:OXFU**"^N'\4:QX@\3>(9KBVFOGN;TL/@ZBP$E6E@L=BL=2J9
M5F=.G2>&P4\52OBW.6%PLY3>&I3PD*F9SJ5JU?#T,2X8*MC).CDN55:^+IO'
M)T8XS!8;!5:>9Y;.K5^L8RGAJML(H+$XF"@L35ABIT\MA"C2H5ZV'C+&4L+'
M\XXR"R$$$$J000002"""."".01P1R*_O7_X)J:!HMW^P7^RG<7.F6<T\OP:\
M*O)+)"K.[,EP2S$]2222?4FOX'HK[3B8O*NK*",[#%;M>6H:WB.#%;M^]P&A
M0K$PSP4(SWK^_?\`X)E,C_L"?LG.CI(C?!?PH5>-U=&!CN""KH2K`]BI(K\2
M^E0G_J?P\VFO^,C35U;?+,=ZK;S:['[+]&5I\5Y]9I_\8[-Z/_J99?Z/\$?9
MO_",>'O^@/8?^`Z?X4?\(QX>_P"@/8?^`Z?X5NT5_"Q_:QA?\(QX>_Z`]A_X
M#I_A1_PC'A[_`*`]A_X#I_A6[10!A?\`",>'O^@/8?\`@.G^%'_",>'O^@/8
M?^`Z?X5NT4`87_",>'O^@/8?^`Z?X4?\(QX>_P"@/8?^`Z?X5NT4`87_``C'
MA[_H#V'_`(#I_A1_PC'A[_H#V'_@.G^%;M%`&%_PC'A[_H#V'_@.G^%'_",>
M'O\`H#V'_@.G^%;M%`&%_P`(QX>_Z`]A_P"`Z?X4?\(QX>_Z`]A_X#I_A6[1
M0!A?\(QX>_Z`]A_X#I_A1_PC'A[_`*`]A_X#I_A6[10!A?\`",>'O^@/8?\`
M@.G^%'_",>'O^@/8?^`Z?X5NT4`87_",>'O^@/8?^`Z?X4?\(QX>_P"@/8?^
M`Z?X5NT4`87_``C'A[_H#V'_`(#I_A5ZRTO3M-\PV%G;VGG;/-\B,1^9LW;-
MV.NW<V,],FK]%`!1110`4444`%%%%`!1110`4444`?B!_P`%)_\`E))_P0I_
M[.M_:@_]8Y^(-?L3KOPY^'_BVYM]2\4^!_!_B748K.*SBO\`7_#&AZS>QVD;
M22QVL=UJ=A=3I;I+--(D"R")9)9'5`TCD^*?&_\`9*^&GQZ^+_[,'QO\7ZCX
MOT[QQ^R1X[\;?$/X5'P]JNG6FBSZ]X_^'NJ_#/7H_%NEW^C:F=;TX>&]8O&L
M+>UNM*GM=2\JZ-U-$KVTGT$-*U,``>([[``'_(/T4=/8:<!^0`K2E5JT9JI1
MJ5*4TFE.G.4)6>ZYHM.SZJ]GU,ZE*E6CR5J<*L+I\E2$9QNMGRR35UZ''?\`
M"D?@U_T2;X9_^$#X2_\`E/1_PI'X-`Y'PF^&8.,9_P"$!\)9P"2!G^Q\X!).
M.F23WKLO[*U3_H8[[_P`T7_Y7TC:7J@4G_A([X8!.?[/T4XX]#I_/TKI_M+,
M/^@[&?\`A36\O[_DCG_L_`?]`6$_\)Z7_P`AY?GW9Q__``I+X-_]$G^&?_A!
M>$OK_P!`?\:0_!'X--P?A-\,R,@X/@'PD>000>='Z@@$>A`/45XK^SUXT\?^
M/O&O[6>C^)?&]UJ-C\+OVFKWX=>#8(]%\+VIT?PG%\!_@%XUCTF22STB&6\>
M/Q#XW\1WXN]0:XOW345@>X-K;6<,/TY_96J?]#'??^`&B_\`ROH_M',/^@[&
M?^%-;R_O^7]78?V?@/\`H"PG_A/2_P#D/+\^[.-_X4E\&AT^$WPS_P#"!\)?
M_*>O0=+TK3-$T^TTG1M/L=)TO3X$MK'3=,L[:PL+.WCR(X+2SM(H;:VA3)V1
M011QKD[5%4/[*U3_`*&.^_\``#1?_E?1_96J?]#'??\`@!HO_P`KZQJXK%5X
MJ-?$5ZT8OF4:M6I42E:UTIR:3M=7WU?=FM+"X:@W*CAZ-&37*Y4J4(-K1V;C
M%-JZ3L^NNYO45@_V5JG_`$,=]_X`:+_\KZ/[*U3_`*&.^_\``#1?_E?6!N;U
M%8/]E:I_T,=]_P"`&B__`"OKY=TGQQ\0+K]L[QU\()O&]T_@71/V8?A5\1M/
MT7^Q/"XF@\6^)OB]\:/"^KZL;Y=)&INEWHGA'0M/6TEN7T^+["]S!;1WD]S+
M*`?8%%8/]E:I_P!#'??^`&B__*^C^RM4_P"ACOO_```T7_Y7T`;U%8/]E:I_
MT,=]_P"`&B__`"OH_LK5/^ACOO\`P`T7_P"5]`&]16#_`&5JG_0QWW_@!HO_
M`,KZ/[*U3_H8[[_P`T7_`.5]`&]17RA\;?%OCSP=\4_V0?#.@^-[NPTCXK?'
MWQ9X'\:VC:+X8N&UKPYI?[+?[17Q*LM.CFNM)EN+)H?%W@'PQJIN=->VO'CT
MZ2TDF:PN+RWG^D?[*U3_`*&.^_\``#1?_E?0!O45@_V5JG_0QWW_`(`:+_\`
M*^C^RM4_Z&.^_P#`#1?_`)7T`;U%8/\`96J?]#'??^`&B_\`ROH_LK5/^ACO
MO_`#1?\`Y7T`;U%8/]E:I_T,=]_X`:+_`/*^OEO]M?QO\0?@Y^RK\<OB;X#\
M<76A^,/!O@2^UGP_J\NB>%K^/3]1AO=/BCN7L]4TBYT^X"QS2)Y5W;S0GS"Q
M0NB$`'V%16`NF:H^YO\`A(KX`R2X'V#1L*!(X"@G3R2%`"@DEB!EB232_P!E
M:I_T,=]_X`:+_P#*^@#>HK!_LK5/^ACOO_`#1?\`Y7U?L;2ZMO-^TZE/J&_9
ML\ZWLH/*V[MVW[';V^[?D9\S?C:-NW+9`+]%%%`!1110`4444`%%%%`!1110
M`4444`%%?$WQ@_;<\)_";Q3\3]+C^&OQ*\>^$/V??#OA_P`5_M)?$;P;;^%I
M/#_P7T'Q-H]UXGM9[_2]<\2Z/XH\;ZAH/@FV7XC>-M&\`:+K^I>%_A_>:;K+
M0ZAJNK:5X?O-74/VP--T+XJ>$O`WB;X/_%KPQX&^('Q7N/@5X$^,FMZ?X8M/
M"?BOXI1:!XF\1VMGIOA?_A)7^)2>!]=MO"'B#3/#'Q,N?!\7A/Q!J^G&>SN!
MX5U'0_%6J`'UAIVAZ+H\^KW.DZ1I>EW.OZHVMZ[<:=I]I93ZUK+6&GZ4VK:M
M+;0Q2:EJ;:9I.EZ<U_>M/=FPTVPLS-]FL[:*+4KP+QC\>[/P-\0-=\'ZS\/?
MB7=:%H7PJTWXE-X]\.>%;WQ9H>JZAJWCF;P-8_#?0=$\,IJOC+6?']Q=+::K
M#I=CX?ELWTO4+69[Z-A<>1\L7'_!1[PC??LQ_`']I7PO\+O$LFG_`+0>JZU9
M:%X0^(/C_P"$'PDO?!EEX<T[QMJ6O7_Q`\9>-?&EO\/-&?31X+FT]K#3O$VK
MW%UJFJ65O8M<V\5]>6X!^DE%<=\/?$][XT\#>$/%VH:-'X>O/$_AS1]?GT6'
MQ!H7BN'36U:QAOEM(/$WABZOO#NOP1QS(8=7T.\NM*U")DN;&XFMY(Y&[&@`
MHHKYW^-/[0"_"WQ+X#^'7A?X=>,?B]\6/B78^,-=\*>`/!MUX5T:1?"/P[_X
M1M?'/C/Q%XH\<:]X;\+^'O#VA7GC+P=H$,EUJ,VI:OXH\7^'=)TW3I8)M4U+
M2`#Z(K*30M$CUJ?Q)'H^EIXBNM+M=$NM>33[-=:N=%L;R]U"QTB?55A%_-IE
MG?ZEJ-[:Z?)<-:6]W?WMS#"DUU.\GPAX@_X*#>%;#X6K\<?#7P0^.OB_X0>'
M/ACK?Q;^,/C:VT+PCX<@^#GAKPAJWC?0/B%H&O:;XN\8Z)?>,?B9\,M6^''C
M=/B%\.OAJ/%NM>';3PZTQEN[OQ'X'L/%?UGXV^);>$]1^$-EI_@[Q5XPMOBO
M\0X?`SZKX;M[)['P+83_``]\>>/E\<>,CJ-W93VOA0?\(3#X9:6PAO-3'B+Q
M5X=MS8"VFO+BU`/4:*^3O@/^V#\.?CW=?M#'2-$\;>`]&_9R\>:;X*\4Z[\5
MM!/P_AU>RU3X2>!OC-:^.=.TC7Y[;Q%H?@R;PCX\TVY@O/&^E>%]6D@M+O59
M-'M]&FT^^O+O[*W[57A;]J[0OBIX@\*>$/&G@ZT^%WQJ\8_!JZM?'5IING:I
MKTGAC1_"GB/3/&6GZ;8:C?W6F^'O%_AKQGH.O:'8>($TOQ/:65XL'B#1-(U%
M)K&(`^I****`"BOE#XN?M=^`?@C\0-8^'OC_`$+Q;8ZI)\)I/BA\-KBQLK&_
MA^,U_I_BZP\#:]\+OAQ"E['=7_Q2T?Q-XK^%]BOAG4HM/36(OBIX6O=%O;VS
ML/%<OA_Y+^)W_!3CQ+\'==_:4TOQ]^R%\4K&Q_9?^&7@3XJ^.M8TSXI?`G6(
M=2\.?%K7/B#X8^%,'A^QM_&L=_)J?BOQ!\-?$5E?6^J1:;%X8M7T[4M6G-I=
MEH@#]4;[1='U.[T>_P!2TK3=0OO#VH3:MH%Y?6-K=W6AZK<:5J6A3ZEH]Q<1
M23:9J$VB:QJVCRWMD\%S)I>J:CI[RM9WUU#+I5\R?!W]I`_$/QUXD^$/CWX:
M>+/@M\8_"_@_P]\0KKP/XJU;P;XGL]=\">)=8UOP[9>*_!_C#P'K^O\`A_7K
M'3O$?A_4?#WB73IWTGQ%X:U7^S7U/18](\1>&=6UCRSXO?MY>$?@A\*IOBAX
M\^$7QKM5/QQ\1_!>P\+Z=X3MM1U2XMM!_:!T_P"`$'Q4U+6H=17P?X7^&6N:
MCK6@^,]"U/Q-XATO6]9\+:YIEIHNA:IXJN5T"@#[NHKXE^(W[8O_``AG[26@
M_LZ:-\-XO$5_J(^'R:EXHU7XR?!GX>)#=^/M1UN)-.\+^"O''BO3/'GQ"U'0
M=$T637]4M?"&A7S317EIINFF\U,74%O]M#_/]/SH`***\-^,WQX\-?`N^^%T
MOCC3-6MO!WQ(^(>G?#&]^(,+6`\+?#WQ)XFT^_/@2X\>SW-U!<Z3X?\`&_BN
MTL/AUI.N00W-I:>.?$_A+3-5^Q6>MC4+8`]RK*UO0M$\3:3?:#XCT?2M?T/5
M(&M=2T;6]/L]5TK4+5F5FMK[3K^&XL[N!F16:&XADC)525RH(_.?5O\`@H/X
MB/Q*_9U\$>#OV6OB;XN\/?M3R^+KCX.^/'\>_"/PII^L>'/!.F7GBC5_%>J^
M&O$WBBS\6Z-H^I>`H+/QQX7BGTN34]9T?6=*M9K'3=5EN+*VV_V<O^"A&C_'
M;3_@=XCU_P""/Q-^$/@?]IZYU>S_`&?O'/BG6/AQXET#QKJFE>'?$?C&W\,Z
M_'X'\6ZWK/P_\5^(?"/A#Q9XA\-Z9XFTJ/3M2A\,:SI$FMVGB4:5HNJ@'Z)8
M`Z#'4_B3DG\3R?>BOGGQ3^T)9^#/$7Q=T?6_AI\5I],^%GA+X5^([#7O#/A"
MY\8I\3M5^*FJ>-=%L/!7PXT/PR^H^(=6\3^']4\)V%MXE74M.TK1=*B\7Z!J
M=YK%MHT6M:EI?E,G[='PY3]B'P7^V\OA/QK+X;^(WP3\/_&/P)\*85\.2_%/
MQ/<>*?`<GC_1/AUIEJFNMX6F\9RZ5!>?VC.OB-O"VBVFEZUXBU37[?PMHVHZ
MS;@'VY17G_PG^(FE?%WX7?#CXJZ':7MAHOQ+\!>#OB!I%CJ1MSJ%GIGC3PWI
MGB6PM+\V<UQ:?;;:TU2&"[^S3S6_VB.3R99(]KMZ!0`4444`%%%%`!1110`4
M444`%%%%`!1110!^6?[5?[*GQ<U"\_:`E^#=W#KWPS_;8A\(^!OVK?!%KX?\
M/7GQ3T?PU'\-;OX+^*O'GP0UWQ7X\\#^"9-=\0_#.R\'>"]=T+QXUY;^&;'2
M;KXC>$1K_B"Q?X?>)NTT']FS]I7_`(:ML?C)X]\9?`'QM\+O!.LZII/P0\%_
M\(;\4]&UGX'_``SO-!E\.21^$K!?']_X$U;XQ:_I32:=XK^+^OZ-=ZFWAS4-
M1\%>#-.\&^$]0US3/$'Z,44`<;X_B\>R^#M<C^&-SX2L_'C6L0\.7/CJSUW4
M/"45ZMW;M(VM67AK4=)UN>U-F+I433]0MI?M#0,[M`LL;_FM^SM^QA^TO\$O
MV;_@U\&]3\?_`++7C'Q+^S]XGUC4O`>K:[\!?%VO^&M8TCQ':^+(M2FN[77O
MB+/XI\">-=/N/&6I+IGBCP1X@$%WH(O_``UK&DW5GKL]SI_ZMT4`>&_LW_!6
M']GOX.>%/A1#KD/B-M`N?%>J7FJV6@6?A+1WU7QKXU\2>/-9L_#'A+3[J_LO
M"/@W2M6\3WND^"O"-OJ&HQ>%_"5CHV@C4M0.GF]G]RHHH`*^.OVE_@Y\5]3\
M4^$OVC?V<]1\&1_'_P"$7PW^+O@+PYX2^(^DW=[X#^)OA#XH3>`O$FK^"-;U
M?2-9T#6_"&I_\)G\*/`6L>'O%UI?75C8&UUC1]:TBXT[7WU/1OL6B@#\:)/V
M*?VG-3^'?P2\`^&?&7PO;X(^'+'4_BA\1/@?^T-X`\26WB#XC_M(^._BQXI^
M,WCCQA\7)O@;\6M0\%ZWX"M_&WB2YUOPW\#-+U/5_`MGK4[W?C#6_B+:Z3X<
MM-)_8^);@6T8E,/VH0KYAC606YN/+'F,JNYE\HREF4.[2;,;F+Y:K%%`'Y1>
M#_V'_C[XJUW]LC3_`-H7XI?#5OAU^V-XJ\%>/?%,7[/NE?$KX=_$7POK_P`/
MOAQ\#_A7HN@:9XH\8>*O&FA:IX-U_P`-_!E9O&>G:IX9E;7H_%.L^&+V&[\.
M33PS^]?L6?L>ZQ^R5<?M(2ZO\;?B!\9A\=OC]KOQFLKCQ]<V%UJ'AJVU;PKX
M3\._V=<7-AI>EQ:GKUW)X=>?7-:AMK*QO[:+0[6TTC3GTRZGU+[CHH`****`
M/F/]H+]G>+XX>._V3/&;ZIHVFM^S/^T>?CP\&I^'DUNZ\00'X$_&WX0KH&DW
MC7-N?#U\NI?%;2O$PU@I>QJOA@68LQ=7-I?V'S+^TY^P+XD^/"_MR3Z)\3="
M\,WO[6?P`_9F^#_AU=6\):GK%GX'UC]GKQI\9_&+:]K:V/B'2Y_$6E^*)/BE
M8V`TO39-$O=*CT6[F_M&\?4+=+/]-J*`/C[X,_`'XC:=\9?$G[1WQZ\8>!?%
M'Q4U7X9Z+\'O#.C?"_PGK_A3P+X'\!Z=XLU;QQK@@E\6>*?%?B?Q-XF\;>*+
M[3+W7=5OKK2=*T_2_"WAG1M$T"WGM]<UKQ!S?[??[/7QJ_:B^"T?P;^$GC+X
M6>![+6O%?@7Q+XOUGXE>%O&OBR79\-?B9X!^*7ANS\/V/A#Q9X42(ZCJ_@I]
M*UJ;4[BX,6G:@L^FK%<V[I/]RT4`?G/\6_V1_C%\=+'5M'\<>,_V?=)T_P"*
M_A#X>^'?C)K?A[X"75S\3-%N/`.L3:\)?A#\2=5\:+J-M#<7MS/<^!KKX@Z7
MXEU3X0>(Y;KQ?X8N-6N[B#2;#]%U&T8SGEC_`-],6/X`G`]NN:6B@`KYA_;1
M_9X/[67[*?Q\_9N76M+\-R?&CX8^)O`%OX@UK03XGTS0[O7+416FL7>@B[L'
MU-=-N4BO([>.^LYO.BCD@N8)HTD7Z>HH`^6OBA^SK<^/_P!HC]D_XW6/B6PT
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M]C?X-?LV_%C]H#4O#_C3]G/X&>*/V?\`X5^//V>&U_P+X7UCPOKWP?\`#7PK
M/B7XD^!/'UQ\0QJ_BF>WT?5$N9M!U;19-.\.^)?$?AWP_J6G6OB'63=?LA10
M!X;^S/\`!^\_9_\`V??@S\$M0\8ZQ\0+WX5?#;P=X#N?&6N^4-2\03>&-"LM
M)>_DCAAA6WM6:U,6F6;+)-8Z7%965Q=7MQ;RWMQ[E110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
B1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`?_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>biib-2015630_highlightschart.jpg
<TEXT>
begin 644 biib-2015630_highlightschart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`&J`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"D8[1G&?F4?]],%
MS^&<^]+2,-PQ[J?^^6#?KC%`'Y+_`+.'_!3C3?C!8>-O'7CR?]F_P3X"\)^.
M/B+\.W\"^`?COXJ^,W[4MGXK\-_M":_^SW\/])\0?L_^&?@Y9:M::G\4?$?A
M]IM"T71M8UW63>ZUHNCZ99:V9+N^MOL3P-^V9^SW\2?&OA3X<^"O%NMZWX[\
M7:'XA\1V?A-/AW\1K+7-$TCP?XV\1?#;QG<>.+#4O"EG-\/)?!?Q"\+ZIX)\
M76?CE?#]WX=\4MI6AZG#!J&OZ%!J/E.E_L"^#=!_9U\)_`S0_'/B+3=<^'/Q
MOUW]H?X<_%*/1_#T^O\`AOXF7_QU\>_'72;J\T*ZMYM!\0Z%I^I?$+7_``?J
M&C:BB-JWA.^OO(O]&U^Y@UJQT/@#^PQX7^!/QFU#XZ0?$#Q/XP\<^)_`'CGP
MQXZN=9TKP]IMMXJ\6?$KXWZI\<_%_CHVNAVMG;Z/+)K>HP^&=$\.V$)T[2/"
MNCZ3;RW.I:M'?:M?@'C?Q!_X*D^!?!?QA\=_"&V^$_Q+NKWX7_MA?L\?LF>,
MO$.M>&/&6AZ1?7O[0'PQ;XD:=XL^'*6W@O5[OXBW6BK)8Z-#X,T*-]:\2?VC
MIOB#2)6\.ZSH-_JGT3IG[?'[+6K0>$;JQ^(6HSVGBRQL]0GO5^'OQ+6P\`6U
M_P"/M?\`A3:M\9;Z3P?':?!!Y?BAX4\5?#P0_%R7P9.GB_PMXFT::*.;P]K+
M6/G7CC_@G[X;\8_M!:E\<(_B7XFTFQU[]H']GW]I[7O`ZZ'H=]:W/Q<_9\^'
MK?"71+S3_$4CV^I:=X:\2_#JVT/2]?\`#\MIJ#PZSHL>O:1J=@=0U+3KCQ;3
M_P#@D!\"M.\<OX[?4=$\1:MXA\9^+O$_CVZ^('P4^#/Q+U35;+6OVD?C!^TE
MX>TWP3K'C_PMXBNOAA?^'M9^,_B7P/?:[X=CNW\2>#K72+J?3=,\::7IOBRR
M`/H[]M3]I'XW?LWVOP=U/X5_"KX5?$S3/BE\9_A=\![D^/\`XM>+_AK?:#XS
M^,OCG2?`W@S58(?#GP@^)EOJOAG3[S4)[[Q1+)=:;JMK;V\46E:?J<L[F'SC
MX;?\%-/@]?+\9=.^.2I\&]>^#'Q/_:3^'>L7$-IX_P#&'@?78_V6_!D?Q"^(
M^I:)X_3X>Z+X=F\0)X$M/$GCNS^&RW4WCR7P5X<U'Q!#H]Q;VUX+3ZO_`&@/
M@%HWQ_TGX8Z5K.O:GH$?PQ^/?P7^/5A+I=M9W+ZGK/P8\<V'CG2]"O%O`5AT
MS6;RP2RU"Y@_TR"VD>2V/G`&OC/XF_\`!+?X??$WP9X[\&W_`,3_`!GIEKXZ
M^.W[8GQVN[RSTC0)KBQUC]L/]FSXR?LV>)M#MHYQY4FF>$-"^,FJ>)-`N)O]
M+O=7T?3[74\V,]T"`?3.C?MN?LY:_P"(_#GA?2_&&O37_B>X\(VEI>S?#7XG
M6?AW2;OXC:Q<:)\+[/QAXJO/!\'AKP+>_%B]@BD^%=GXRU70[KXB:?JOAS5?
M"L.I:9XK\+W6L=9\)OVI?@E\;]9U'0OAKXLN]:O[31I_$^ER7_A3QEX8TOQK
MX1MM6_L"X\;?#76_%/A_1M(^)G@:#7##I4WC+P%>^(?#D=U>Z4S:C]FUO1+C
M4?E[4O\`@F9\%K_X^Z9\=WC\,WVK7$GP:U+QG%XJ^#OPC\>^)-:\0?`CP[HW
MA?P/J?A+XA^-/"^M>+/AC;W^C>'/#UGXLT_PI,7NWT+3M5\)W_@GQ'+JVN:I
MTW[('_!/3X3?L<:Q?WWP\3PN;.S\$1?##P<^F_!WX0^"_%]CX!@U:TUB&Q\=
M_$KPCX3T[QS\4]?B?3=&TUM?\1:O907^GZ)IU]K.B:IXM-_XJO@#S4_\%*/L
M_@C]OK6;WX-W$7C?]C[QUXK\)?#7P/!XU6X'[15A'J6K^`_AMK>FZRWAB&3P
M6?&7QF\*>-OAOK]BND^+5\$Q^&V\237NLVUZEA#Z_P#"7_@H+\!?B'X<^"\V
MMZW<>%?&?Q9^'WP;\57NA6F@^-_$W@[P7XP^-7PLTCXL>#_A9KOQ7L?"%OX#
ML?'VO>'-4CN?"/A76]4T/Q5XOM+G0KC3/#RW'BGPY8ZER6M_\$Y/A]K?C6R\
M<S?$'QM::E:^(OVL]?N;"RMM`CT?73^U+?:MK,=EXDLY;*:36(O@YXBUW5_$
MWPOE>X@FTS7]3O\`4K@M-=.1S?@O_@F9X4\%:=X-\%V?Q@\=7WPHT6Z_9N\9
M^+OAS>Z!X,^S>.?C!^RQ\)OAI\(OAC\0+GQ'%IB^(-!T^;2?@Y\+?$/BGP7I
M=S)8:OXG\"Z//9:MI&C:EXLT7Q(`7/&G_!5O]EO0_A_X.^(?@EOBA\6=,\;>
M+OV5=(T+3O`WP>^*LNLZKX(_:X^(&F?#[X:_%O0--U'P5:WGBOX=/JMW?6+Z
MWX7@U:*]\7::GPXLG/CG6-$T:^T/A/\`\%.OV>_&'A#Q;X@^)NIW'P<U7P?X
M@_:AM+W3-=T7QWJ.BZIX;_9D_:+\2?`#Q#J?A;QC_P`(/IV@>,_%=Q<6G@S7
M=;^&OA";7?&GA6Y\?:-H-QINH2I]NGX@_P#!+'P9:^$/A1X?T;XO^-M,UKX)
M_LR?L@_L_?#_`,3-H'AB_DM-:_8L^-WA3X_?"?XE:MI%RHL=6N[_`,<^#='@
M\7>$R]KH^I^'WO["QO=-NYX-1M-V'_@FCX9B\.?#C1_^%N^*5U/X?/\`MSW0
MUE_!'PXUJTUV^_;M^(.I_$3XAKJWA#QIHGB[P;?:-H.H:OJ&BZ;X>UC1-;TS
M6/#MW<6.LH]T\=]"`?;'A?X\?#7Q1\.O$_Q4_M/6?"7@SP/'XDF\;WGQ.\'>
M,OA1J/@V#PAIHUCQ+=>*=`^)&@^%]=T6QTG2"-6EU.\TY=,N-*9-2L;R[L9$
MG;QB3]O?]F2#2=%U*\\7>+=.OO$GCK1/AMX?\':I\(?C!I7Q*UOQAXK\!^,O
MB;X+TW2_A?J7@6T^(-Y!XY\$_#_Q?K'@G5H/#;Z1XIDT.^TG2;ZXUJWFTZ+#
M^'O["_@3PY^SG\=_V;/&GB+4_&'@3]HF'QW8>-=!T32=*^'G@CPAH'Q!\!Z7
M\/=;\)?!?X?:)_:.@_"OPF=-TR3Q&NAZ9+J5M+X\UWQ/XJG+RZW+91>:?#/_
M`()I?#KX=:E\*=?L]>\/:?KWPO\`V@/"_P`=A/\`#GX&?!?X,Z9XLN?!7P3^
M,OP1\/Z'XFTKX:>&=%.I7$NE_&KQ'XHUOQ%?7]]<3^)49/#VE^%?#][-H<8!
M9^-__!3SX#?#SX4#XB?"^34OC9JESI?P1\066A:#X?\`B%IFBZ?HGQR^-?A_
MX+^%1X]\;Q^`M7T'X7^)+W6+_P`22:/X*^(!T#Q5K.I^#M8T(:597*//%[2W
M[=W[,$=AXTU6;XA7EOI?@NTU#4#JEQX$^(L.F>.+#3?'FD_"RXO/@[?OX2%M
M\;[=OB7X@\.>`+9_A%)XT^W^+_$_A;0].%W<^*/#W]I_(6F?\$DO"/A_X?\`
MB'X7>&OCIX_T7P1\0]3\&>(?BQI4?A;P3>S>//$_PP^/NL?'7X=:P-0O;2:]
M\."Q;5;;P#XJL-)F-OXK\)>&_#LL+>'=<CUW4M?UO!W_``2.^!_@32?$VC^$
M=5TSPE]GN/#]_P#"+Q/X0^#/P2\._$;X=:OX,^,GA7X\>"-9\2_$B#P7<>+O
MC!>^$_'O@?PG:VL'C;4(M*U_PGI":=XTTWQ-XEGD\8J`?7O[,/[4&E?M-7O[
M1BZ+X6U7PUIOP'_:"NO@7;S:[;Z_I&N>)'L_@W\&?BK=:WK'A+Q5X;\+^(O`
M^HVUY\6)_#%SX7U>QGO('\.?VHUV4U:.SM/&O"7_``4C^!#>&?C'KWQ:U#_A
M5EU\&+[]L7Q!XCTQ;3Q5XT)^"W['W[2GBK]F[Q1\5_M>A>$UBSK.O>'K/4AX
M*LDU#Q)8G5&M+&+6[2Q;5I_7/@K^S7KWP5\.?M#MIGQ;U?Q%\2_VB/B=J7QF
MU_X@:[X1\.K:Z!\0]0^$7PP^%$4VC>#=,ELM+E\,:9:?"S0]0T_P_?:A)=>5
M+/IU_KM_,'U>?Y'^(/\`P2<\"^._A[J/@L?&?XA:)K'CSX6_M2?"KXU^,K+0
M?!$NI_%#1_VM_B]=_M!?$^]73&TJ'2?!=[!\8KNXU?P]_P`([#LL?"5]J/A&
MZ-Y/)IWB32@#ZC;]OK]E&'Q#XN\.7WQ272)O`FL?&3PWXIUS7/"'CO1/!>F>
M)_V?M/O=:^+_`(4_X3S4_#-MX,O/%7@KPYIM_P"*[_PU8:Y=:W>>$K.Z\3:5
M8W^C6\UVGM?PG^-_P\^--CKUUX'OM=2]\*ZI;:/XH\->,O!GC+X;>-O#5[?Z
M59:]I0U_P-\0M!\,>+M(M]:T+4++6=#O;[1H;+6--G%QI]Q.(KE8/@[XC_\`
M!*?X-_%KPOK'@?QYXR\8:KX1\1_M%_M8?M"Z_I4-GH-M)>ZC^U?\,_B=\-]?
M\-0W,UK>PPZ?X,7XE2^(_#=Y<6-^U_JF@:=:>(+#4-)NM1LKCZ?_`&6_V5/"
MG[,GASQEIFB#P6^K^/==M=;\2:A\/O@W\+O@7I$\FF:+;Z!I:P^&_A7H.D0S
M7<=E!)>WFK:UJ6M:C)JNH:@=+ET70AIGA[3`#Y<US_@I/+\/=>^+^@?$_P"&
M/@N#5OAC\*-9^)%WX5^%GQZ\*_%7QOX-\2#Q]X`^''P]^"WQZTVR\.Z%X=^$
M/Q3^,.O?$G0)?AU;6WBGQKX<U2UTCQ[(^M&R\'?VKK?UO\#/CKXE\?\`C;XM
M?!_XG>"]`\!?&+X-#P!JWB;1O!WC6]^(?@S5?!GQ4T?6-2\"^+/#?BC5O!_P
M_P!<EM[S4?"GC?PMJFG:WX.T:[L=>\'ZE):'4M%O=*U*Y\"UK_@GSIWQ(N];
ME^.WQO\`B)\653X0>./@KX'U230O`/@CQ=X=T'QWK7P^\37OC+Q)XG\)>'K7
M_A8/Q.T+Q)\*_`FN^%O$&LZ3I_AC2=8T3^V9O`]_K5W<:D?2?`G[,WQ#\">*
MKCXC#X[:QXH^*7C[XB?#_5/C=XWU?P-X*T^+QM\)/AEX/\8^'O"GP@T'POIU
MA+IG@S1[?5O$TOBNYUW2KI_$D_B?5_%%]%J=KHVIVOAO3@"G^T]^U%\2?V=+
M/Q?X]7X&V_B7X*?##2?`^K>.?&6H?$FQ\-^+_$\WC3Q/_P`(VWACX'^`8/#'
MB)/'WB_06N-):;1O%_B7X9Q^*=<\0:#X.\$7FO:U>7<NF\K8?MQ7-U\1;%+O
MX;6%A\`M=_:9\:?L>^&_BJWCQ;CQC??'+P(?%6B:HU]\,H?"K65C\/\`5?B7
MX(\4?";0-9M_'U_XMN?%]GI=]?>";'PWK2ZGIU[X\_LF?%_XP?''PA\6-*_:
M3BT#PK\/K3P_=^`O@_XI^"/A'XC>"/"'C_3+V]GU3XN:6U[XG\.7=[\2[_3[
MF'0M!\0>(X]=7X=Z7#>R?#^U\/ZOK_B'5-4NI^Q#I$'Q+3Q+;_$WQ4/ACIGQ
ML\5?M/\`ACX+7.B^&KOPYH7[1'B^PUZ/4_&I\2-:1^*M2\+P>)_%'B'XFZ?X
M!N;R*SM_B5K-WK<FM7&AVVC^%]*`/,=._P""@WB#5O@9^U?\5[KX)6_PUU_]
MG']HW0?V>[#P?\8/B7IOAZVU*7Q;I'[/>K>'?&7Q&\1>$]`\:6OP[M$M_C]I
MUWX@\.Z+;_$'5=$M="FLQ/?:_=RZ38?3'[.OQ_D^+/PAUSXE^,+[X66UQX8U
MOQ7IOB>V^$_BSQUXWTKPRGABTM]2N-.\1P^.?AC\+?'F@>,+?2KB+4M5\):O
MX#L]0M+.\TJZLFU*UU2SGE\"^#/[%GQL^%T_[1EY?_M?Z_JFH_M$?$&#XSZG
MJ_AKX+?#SPAJ?A7XO6NA?";PDFMZ.-1U+QMI&I>#[_P?\(-!\.ZUX%US1[M-
M1M]6\07</B"POKG3[C3?;?"G[+O]F?#WX_\`ASQ1\5O'VM_$+]II=;F^)WQ=
M\,-I7PY\5Z5J.I?"_1OA#HU_\+[7PW:RV7@"X\$^#_#NBGPE>>;K^M6VO6C>
M(-7UK6;^<M&`<Y-_P4"_9>LC':ZKXN\9:%K]QXR\#>`['P3XB^#7QE\/?$74
MO$?Q1T'QWXE^&-MIOPZUGP%9>-KZT^(NE_#+QTO@O4[;09-/U[5?#>I>'[6X
M_MZ!]-'D'Q[_`."HOP!^%OP1\0_%GX=/JWQCU32?!'A'QY!X6TKPS\1]$L-/
MTKQE\5C\(-'LOB3XO_X5]J^E_!S7K[QAI?C/1=.\-_$F'P_XAO\`7_`OBG08
M]+2\TF^:VX3X;_\`!)GX;?#_`.)_@_XNP^//)\6>'/&7[._C+5++P3\)OA?\
M+O"GB2__`&;M,_::T3PG-?>'O!.F6*'5?$6F?M+ZXWC'Q%?WFL:WJE_X:T>6
MUNK'3)$T;3\VZ_X)'^#X_`7Q0^&GA[XZ?$+PYX1^.S:E-\:K.U\,^"+ZY\:W
M=G^T+\2OV@O`5Y9W^HV,UWX7F\+WWQ.U3P'K`TR6:+Q=X+T?01)'H7B&VO=;
MOP#[P^._Q4^+7P\@M9OAE\*/"WC6PLO#'C;QIXT\8?$?XKVOPB^'OA'1/!,.
MGW!TJZ\0Q>$?'NKS^*?$\5W?76C"3PS:>$-(TCP_X@U?Q9XMT<V^D:;KGR"?
M^"EEGJ_A34?B]X3^$TTOP/\`AE\+?V;OBK^T)X@\8^-H?"OQ$^&ND?M)^%]$
M\?Z=I6B>`+/PSXBTKQ1K/PJ^'/B30?'?Q4M];\;^"8HM(U.+3_`\WB[7(+FP
MC]W_`&N?V7/B#^TP/`6D:)\=!\/OA[X:NM:U/QM\*M8^%'ACXG>`/C#JEQ)I
MLOA7_A9&FZQKGA[4-9\.^"KBUO\`4K'P,VIMX*\2ZS>V=_XXT+Q)%H.CV=MR
M7C?]A.'XB:KK-UXG^+OB1=$^,/AOX2:+^U=X1T+PKX8TKP_^T#??"!84TK5E
M^TC5-7^&)\7:;!;^#OB!8>%M5OH==^']AI?A_3)M`U:R/BBX`/0OAC^U/J/C
M_P#:A_:'_9VUKX3^(/AYIWP,^''PH^(NE^._%FNZ,'^(FD?$?QU\>/`ESJ^F
M^%]--Y+X<\):=J'P-U&\T'6_$&L0:MXITO55U>3PUH.DQ:9>ZUS_`.RW^V3#
M^TW\6?VD?`FE^`9O#?A+X-7'P<U+X>^-[K7FO;KXM>`OC%X(U/Q9H'CIO#$F
MB:=+X,T_4'T6^G\-Z?<ZGK-[K?A*]\/^)[T:)<:L^AV7%/\`L/>,_$?[1/QO
M^+_Q,^/2^.OAU^T)\);3]G_XE?!6/X4Z9X2LM2^"?A^]^-6H^$/"5C\0O#OC
M:'Q?I>L:=<?'/Q7#KOBVR$6H>(;*WTZ"*VT.XCDO&[G]F[]A+X5_LO?&CXZ_
M&/X>>(OB;>W/QPT'X0^&KWPSXT^)_P`2_'^C^&=*^$'AJ^\-Z-!I<WC[QKXJ
MN[Z2XM[Q1;W6I&6\\/Z?;CP_H-S9Z%-/8.`?;=%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'COQH^)_B#
MX7Z!I>H>%_A?XI^*>LZSK(TB#2]!U;PCX7TC1(5TZ^U*?7O&/C'QQKFA>'_#
M6@)]A32K><RZEJNHZ]JFCZ5INCW7VJXN;+RJT_;%^'MY^RSH_P"U7%X9\?KX
M:\0V^A66A>`Y-%TT?$/6/&WBGQ]9_"GPM\/M-LTUF3PQ?:YXE^)6HZ;X5T'7
M+7Q1-X&U5-1L?$]GXJE\(746NMV7[1GPK\:_%OPC:>&?"^J?"FYT>:ZN(_&O
MPZ^.?PEL_B_\*?B7H$]NK6VC^)=!_MGP[J]E<:)K=OIOB+2+^PU2XLVNK%[/
M5M%U&.>UNM+^7HOV*OB/%\"_!_[,(^*VA/\`#WP;H=KX\\.^-I?`<USXC\(_
MM">!_P!I'PQ^T!\$Y/!GA_4/&^H:3IGP#^$\^B'P7X?^$5U+<ZI9_#S1_"'A
M*P^(UJNF7-Y(`=C_`,-RPN(/`D'P3\?S_M)2?%>\^#TO[/B^(OAVFL6^OZ=\
M*K3XX7GBB3Q_+XF3P$?AP?A9J&G>(++Q8NHFZO-6U&S\%#08O%XO=)LN<U/_
M`(*/>`'\-V_BWP5\*?BUXZT;PU\)M3^./QTBT^P\+:-K7P%^'F@>,_'GPZ\2
MQ^+M(U[Q+9/XF\=:!XU^%'Q:TF[\#>`+GQ'?7<'PK\:WFE7U](?"5EXLRU_8
MB^),?C9?VDXOB=\-U_:W;XOWGQ/G\42?"W77^#\WAZ]^!6G_`+/;?"K_`(0Q
M?B(GCA?#\/A+2=.\51>)?^%@G7V^(<$NH2V[>$K@^#X^,;_@FWXF\+^$O%'A
M;X9?&_2]&F^.OP4\4_`[]J/Q!XF^%MGK%_XYLO''Q.^-7Q>\3?$?X;V>D>*=
M!LO`?CA?%O[1WQMMM#TWQ(?'_A2QTGQ1X;2_L=5F\$A?$H!^J.F:G8:SIUAJ
M^E7=OJ&F:I9VNHZ=?6DJ3VM[87T$=U9WEM-&2DMO=6TL4\$BDK)%(CC@U=)Q
MSS^`)_0`FL/PQX;T?P=X<T#PGX>LTT_0?#&BZ5X>T2PC9VCLM(T33[;2],LT
M9RSLMK8VEO`K.Q9A&&8Y)K*\=>`O#7Q'T)O#GBNWU*YTIKRTOS'I7B+Q+X7N
MOM-DSO;L-4\*:QH>JB-6=C);B^%M<#"W$,JJH`!V((/3/XJP_F!2U^%7V+4/
MAC_P7*^"?P+\&>,?B7IOP<\6_P#!,_X]?$CQ+\,[SXK?$WQ!X*UGQ_X=_:,^
M&/A[0?&=YX?\2>+M8T]_$NCZ%JNI:1IVLK$M_::??75K!.D,SH?VV_X1G2?^
M>=W_`.#75_\`Y/H`WZ*P/^$9TG_GG=_^#75__D^C_A&=)_YYW?\`X-=7_P#D
M^@#?HK`_X1G2?^>=W_X-=7_^3Z/^$9TG_GG=_P#@UU?_`.3Z`-^BL#_A&=)_
MYYW?_@UU?_Y/H_X1G2?^>=W_`.#75_\`Y/H`WZ*P/^$9TG_GG=_^#75__D^C
M_A&=)_YYW?\`X-=7_P#D^@#?HK`_X1G2?^>=W_X-=7_^3Z/^$9TG_GG=_P#@
MUU?_`.3Z`-^BL#_A&=)_YYW?_@UU?_Y/H_X1G2?^>=W_`.#75_\`Y/H`WZ*P
M/^$9TG_GG=_^#75__D^C_A&=)_YYW?\`X-=7_P#D^@#?HK`_X1G2?^>=W_X-
M=7_^3Z/^$9TG_GG=_P#@UU?_`.3Z`-^BL#_A&=)_YYW?_@UU?_Y/H_X1G2?^
M>=W_`.#75_\`Y/H`WZ*P/^$9TG_GG=_^#75__D^C_A&=)_YYW?\`X-=7_P#D
M^@#?HK`_X1G2?^>=W_X-=7_^3ZOV.F6FG>;]E69?.V;_`#;N\N<[-VW;]JN)
M]GWVSLV[N-V<+@`T****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#\
M._'_`/RL0?LX?]HF_P!I+_UJ3X0U^XE?AWX__P"5B#]G#_M$W^TE_P"M2?"&
MOW$H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBOFCXK?M@_LZ?!7Q
M+'X.^(OQ+TW1O$YBMI[G1;/3=<\07VF6]VHDMIM8B\/:9J?]D+<0LL\$>H-;
MSS6[+<1PO`RR-V8++\?F5?ZMEV"Q>/Q')*I[#!X>KB:W)&W-/V=&$Y\D;KFE
M:RNKO5'+B\=@LOH_6,?B\-@J'-&'ML77I8>ESRORP]I6G"'-*SM&]W9V6A]+
MT5SWA/Q;X:\=>'-(\7>#M<TWQ)X9UZT2^TC6](NH[S3[^U=F3S()XB5)21)(
M9HG"36\\<MO<1Q3Q21KT-<LX3I3G3J0E3J4Y2A4ISBX3A.#<9PG&24HRC).,
MHR2<6FFDT=$)PJ0A4ISC4IU(QG3J0DIPG":4HSA*+<91E%IQDFTTTTVF%%%%
M24%%%%`!1110`4444`%%%%`!1110`4444`>+?&/XC>/O`T7A73?AI\(-<^+?
MBOQ;J]YI\-O%KVG>"_!GABPTW2Y]4O-<\=>.=3L=730K*Y:*WT30;+3-`\0Z
MUKOB+4K*T@TRWTJ#6M;T?PVX_;6\-7W[&D?[7WA?P?>S:=>Z39-8^#/&WB?P
M[X#%IXFNOB'!\++G1_$OCN637_"6BZ#I/C)[E-1\=V,NO>&IO#UE)XHT6;6-
M*N;%[GK/VMO@C\9?CYX,\/\`@7X6_&_0O@WH$VOR7/Q4M-5^'7B?QC<_$_P3
M_9ES;_\`"NHO$?@OXN_"#Q?X`T35=3FM[KQ7J_A+Q!;^)M=T.UE\+6&K^'[/
M5-3O+C%;X(?'*;P-X:^%UO\`$;X.>$/"GA_X/VWA:&V^'_[.^CZ?X+T[Q[X9
M\<>%-3\!7/AGX:>-?'?CO3]'^&6B^!/#UYX-U7X>R:O<7TT>I0:QX3\<>#]7
MTS2[C30#SO1/VXM5U_P?\.(_#O@3X8_$3XQ?&'XH>-_AU\.?`GP>_:-\,_$;
MP'=6GPZ\*S>,_&GBSQ5\88_`^A6?A>Q\-Z+:FWU;1(O!6N>(X=<UGPGIEOIU
MU%KTU]I/-W?_``4CT+4O#,_BSP!\%_'GC'3OA[\'M7^.O[1NFSZYX2\.>(O@
MGX+\,^/OB/\`##Q5X>&FW=[?V?Q`^)VB^,O@Q\9K8>$?#^K6&BZEIGPP\07F
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MW$+8!:.120"2!HD@#)S^`+'\E!/Z5D^']!TCPMH6C>&O#]A!I6A>'M*T[0]%
MTRVW_9]/TG2+*#3M-L8/,9Y/)L[&V@MHM[L_EQ+N8MDG#\=_#WP;\3=!;PSX
MZT&S\1Z$UY::@VG7SW20&\L':2TGW6EQ;3;X'=F0>;MRQW*U`'XV^/B#_P`'
M$'[.!Y_Y1-_M)]58'_DZ3X0]B`>WIZ>HK]Q,CW_(_P"%?SZW'PC^''PY_P"#
M@S]GO1?!7A/3?#^EWW_!*/\`:2N[NSLVO'CGN1^T]\)[83N;JZN9#((+B6($
M2#"MQC:FW][/^$6T#_H&0?\`?4O_`,<H`WLCW_(_X49'O^1_PK!_X1;0/^@9
M!_WU+_\`'*/^$6T#_H&0?]]2_P#QR@#>R/?\C_A1D>_Y'_"L'_A%M`_Z!D'_
M`'U+_P#'*_.K_@I3\3/$/P5^"V@I\.&D\-ZUX]\8+X7O/%&G2SPZMH^CV^B:
MGK5ZFC72DOI^HZFUC!8C4H98[JSLVO?LA6XE2>#U<DRC$9]FV!RC"2IPKX^N
MJ,*E9M4J:Y93J5)N*E)QITX3FXQBY2Y>6*<FD>9G.:4,DRS&YKB8U)T,%1=6
M<*23J5&Y1A"G!2<8ISJ3C&\FHQOS2:29^F>X'^]^*L/YBC(]_P`C_A7\G'[/
M7[2GQE\#_%OP3>1>+/&'CK3]7\2:)H&L^"?$GBS6-8TOQ/I^MZG;:6^GJNNW
M]]:Z;J>^\672=9C6*73KY8I99'LS<PR?T6QW7QDU0NFG?`'P)H*[F$<_C+XR
M3),$4R;?-L?!W@7Q6@E8(H=8]3:.-I$VRRJ)"GU/%GA_F'"N*P]&ICLOQ=#%
M495:.(EBL-E\[TY*%6$L/C,3"I)TW*#YJ,JT7&<;N,[P7S?#''&!XEPU>K3P
M6/PU;#58TJM".&Q&-C:I'FI36(PM"5.*G::M65*2E"6CARSE]-9'O^1_PHR/
M?\C_`(5\RVW@OX_W\A^U7_P$\*Q,02+/PC\0_',\8!&0DM_XT\"VTA(5B6>R
M4$2[`BM`)IIT^"WQ)OF_XGGQSO[2-OOQ^!OAC\//#(`.Q6$-QX@LO'5]%\GF
M%7:ZDD21HY%8>6R2_)O+Z,=*F;99"2WA?,*S^4\-E]>C)^E6WG;4^F6.K2LX
M97F$XO[3^HTK>L,1CJ-5+UIW\KZ'TGD>_P"1_P`*-P]QCN58#CW(`_6OF[_A
MF;0+Q]WB'XG?'7Q*G4PW'Q7UWPS;$G=G-K\/H_!L`4[Y/W801JK^4J"**!(M
M./\`9=^!6]7O_`D7B-ESC_A,_$'BWQSUWY)'C#7]<4L2Y8L5+%UC?.^*-D/8
M97'2IF.*G*V^&RV-2G?MS8G'8.I\_8]_*[=;,I6=/`8:,>JQ.82IU$M/LX?!
M8N#ZZ>UZ;H](UKXF?#GPTQ7Q'X]\%^'R!DC6_%>@:40,1MDB^U&!L8EB.<=)
M$/1USY[+^TY\#!,(+#X@Z=XCF)`$7@O3O$'CJ5BQ`"I'X-T?76=V9D144%FD
MDBC4%Y8PW1:1\"/@EH$@FT/X0_#/1IP5;[1I?@;PU87`922C"XM=-CF#(6)0
M^9E23M(S7>1^'-%AC$4%BL$(``A@FN(8@`H4`113(@`4!<!<;0!C``HY\HAI
M]7S+$K^?ZWA<%\_9_4L?;KI[5^H<N:SU]ME]#^[]5Q.+LNWM/K>"OZ^S7IIK
MXY-^T#IDS!=`^&'QV\2AQF)[/X0>*M`@F4ERK1WGCR'P?9['4(Z2/.D;+,F&
MW+,L2R_$_P"+=]@Z!^SEXQCC<D)-XR\=_#'PTG#$;I8-%\1^--0B4A&QFR9B
MS180Q.\T7KS>%]`8Y;386)R26:9B2>223(223R2>IH_X1;0/^@9!_P!]2_\`
MQRG];P$+*GE-&HNKQF+QE:7R>$JY?&__`'#MY=E]5QT_XF9U8/\`ZA,+A*4?
MNQ5+'2UU^WVUW/(9M4_::U(*UIX-^"OA.-F4,=4\>^-_&=U&H:/<YL]+\`^$
M[:3A9"L2ZFOF"2,-)$8W$G\OW[3G@GXC>`_CE\2=/^*=M<1^*-5\8>(/$+ZO
M)%=Q:9XGM=:U2YO;/7?#]U>?\?NDW5M+%#:*DLL]@EN-+O!%=V<L2_UO_P#"
M+:!_T#(/^^I?_CE4;[P%X*U3[/\`VIX6T/5?LCF6S_M33K;4OL<I(9I;3[<D
M_P!ED9E5FD@\MV*J225!'V/!G'W^J6,Q5>.28.OA\705&I2P]6KAJ\90GSTY
M1Q6(^O5)0O=3I334FXS4HRA:7RG%G!'^M&%P]&6<8NC7PU=U:=6O2I8BC)3@
MH5(RPU#ZE34VDG"K&SBN:/*U-M?G_P#\$L_!/CSP=^SQJ=SXRLM2TC3?%GCK
M4O$W@S2-5MY[6[CT"YTC1K.;5UM+A$GM+/7]4M+S4+..5(VNH?\`B:+'Y=^D
MLOZ69'O^1_PK"/A?0223IL))ZDO,2>,#),N>``!Z``#@4G_"+:!_T#(/^^I?
M_CE?(Y[FU3/<XS#-ZM&GAYX_$2KNA2;<*2:48P4FHN<E&*YZCC%U)\U1QBY6
M7U&2Y73R7*L!E5.M4KPP.'A05:K93J-7<I<J;4(N3?)33:IPY8*4N6[WLCW_
M`"/^%&1[_D?\*P?^$6T#_H&0?]]2_P#QRC_A%M`_Z!D'_?4O_P`<KR3U#>R/
M?\C_`(4N<^OX@C^=8'_"+:!_T#(/^^I?_CE7['2]/TWS?L-K';>=L\W87._9
MNV9W,WW=[8QCJ:`-"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`_
M#OQ__P`K$'[.'_:)O]I+_P!:D^$-?N)7X=^/_P#E8@_9P_[1-_M)?^M2?"&O
MW$H`****`"O+/C)\&O`7QX\"ZC\//B-I4FJ:!?S6][$]K<R6.IZ3JMD7-AK.
MC:A"#+8:G9&658I@LD4L$UQ:7<-Q9W-Q;R>IT5MA\17PE>CBL+6J8?$X>I"M
M0KT9RIU:56G)2A4ISBU*,HR2::::9C7P]#%4:N&Q-*G7P]>G*E6HU81J4JM.
M:<90G"2<91DFTTTT?GW\$_\`@F]\!?@KX[TSXAVM[XS\:Z_X?N5OO#4?C'4=
M)FTO0]2CW"#5X=/T;1M)CO=4L]VZPN-0>YAL9PMY:VT=Y'#<1?H)117;FN=9
MKGF(CBLVQV(Q]>%-4H5*\^;V=*+;4*<4HPIQYFY-0C'FG*4Y7DVWR99E&6Y-
M0EALKP5#!4)U'5G"C&W/4:47.I*3E.<N6,8ISDVHQ459)(****\P]$****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBHIP[0RK')Y
M+F.0)+L63RW*,%D\MOE?8Q#[&X;&T\$T`/WIG&Y<YQC<,Y].O7VIU?C'\4/V
M@O"GA#XNMX+M=5_:E\6^(M!^+B^!?B'\1++X_P`7A&Q\):*FL?LZ^$KSQSH?
MP7TY9_!'B:TB^)?[3?PZ\':)X-U#X9Z3+XFL-%^(6NZ5/J=AH>BVWC#]CM+M
M[JSTVPM+W4)M5O+6SM[:[U2X@M;:XU*Y@B2*:_GM[&"VL8)KN1&N)8K*VMK2
M.21EMK>"`1Q(`>5?%KQM\4/"[^$=(^$_PGM_B9XB\5:O?V=U>^(_&\?PY^'O
M@O2M,TBZU2?6?&?BRV\,>/?$4']I7,=GH'AS2_#'@'Q1J&IZWJ$;7ZZ-H=EJ
M>LVG@FG?MN>%]6_8[\+?M::?X%\22+XW;PCX:\)?#6;5/#\&KZ]\3O'WQ1T[
MX(^#/!^G>*3=OX:N]#\2?$_5M-LM(\?6DEQHFH>#[VV\;V5I<:?/%9/U7[7/
M[/\`\3_VC/!_ASP-X%^.0^#_`(877Y[SXH:%+\/%\<Z;\8O![Z7<VJ_#/Q1/
M:>.?A]XDT;P3J6HS0WOBVT\+>)=*O_&&EVK>$-8OCX4U7Q!I6L<?XF_97^(?
MQ#^'/AKX0>._B_I-KX(\/?#C0+*T/PM^%'A7X;C0OC3\-?BKX'^(_P`$/BIX
M%T*ZOO&MEX4L?A4/`NF6%A\/YKW6O"6L_NOM]NMI']A4`Y(?MP>*Y/%</P'A
M^$'AC_AK!OC+?_"6Z^%\WQ@DC^&5K8:=\&K#X^2_%#_A;$7PSN/%$OP]N?A[
MJNEV-GM^#2^+W\?WP\+W/ABUTJUN_%47&2?\%)3KGA36?%GPY^!^J>*8?A)\
M%-<^.G[3FBZS\0O#_AG7OA)H'A3XD?%+X4^*?!?A6WM='\2Z=\3?B;IOB[X#
M_'`6FD3ZGX#\(ZGI7P_%VGC:VO/$^@Z?+WO_``PYJRZDOQ=B^,]U'^U9_P`+
M=N/B_+\:Q\./#I\-2W-U\)+3X$S?#MOA1_;(B'PN'PRT_3K>'1SX[;Q;'XOL
MH?&3>-Y+N2YL)^4N_P#@FWH>F^%KKPG\/_C3XZ\&VGQ%^$.N_`[]HW59_#_A
M#Q%K_P`:_!GB[X@?$CXH^+/$*W=S9:?IWP_^)NJ>,_C1\9KJU\6:#I&H:%I6
MF?$W7K"V\$R7.D^#M2\-`'Z.:#KND^)]$TCQ'H%_!JFAZ_I>GZUHVI6Q9K;4
M-*U:SAU#3;Z`NJ,8;RRN8+F(LJL8Y5W*#D#5)`&3G\`6/Y*"?TK,T31=+\.:
M/I7A_0[*#3=%T/3;#1](TZV4K;6&F:9:0V.GV5NI)*P6EG;PV\*DDB.-023D
MG!\=_#WP9\3-";PSX[\/:?XFT)KRTU!M,U)9FMC>6#M):7!$$T#^9`[LR'?C
M+'(-`'XV>/B#_P`'$'[.!Y_Y1-_M)]58'_DZ3X0]B`>WIZ>HK]Q,CW_(_P"%
M?S[7/PC^&_PY_P"#@S]GO1?!/A#1_#FEWW_!*/\`:2N[RRTZ*98;BZ'[3WPG
MMA/+YTTSM*(+B6(,7R%;`(VIM_>O_A%O#_\`T"K;\I/_`(N@#>R/?\C_`(49
M'O\`D?\`"L'_`(1;P_\`]`JV_*3_`.+H_P"$6\/_`/0*MORD_P#BZ`-[(]_R
M/^%&1[_D?\*P?^$6\/\`_0*MORD_^+H_X1;P_P#]`JV_*3_XN@#>R/?\C_A1
MD>_Y'_"L'_A%O#__`$"K;\I/_BZ/^$6\/_\`0*MORD_^+H`WLCW_`"/^%&1[
M_D?\*P?^$6\/_P#0*MORD_\`BZ/^$6\/_P#0*MORD_\`BZ`-[(]_R/\`A1D>
M_P"1_P`*P?\`A%O#_P#T"K;\I/\`XNC_`(1;P_\`]`JV_*3_`.+H`WLCW_(_
MX49'O^1_PK!_X1;P_P#]`JV_*3_XNC_A%O#_`/T"K;\I/_BZ`-[(]_R/^%&1
M[_D?\*P?^$6\/_\`0*MORD_^+H_X1;P__P!`JV_*3_XN@#>R/?\`(_X49'O^
M1_PK!_X1;P__`-`JV_*3_P"+H_X1;P__`-`JV_*3_P"+H`WLCW_(_P"%&1[_
M`)'_``K!_P"$6\/_`/0*MORD_P#BZ/\`A%O#_P#T"K;\I/\`XN@#>R/?\C_A
M1D>_Y'_"L'_A%O#_`/T"K;\I/_BZ/^$6\/\`_0*MORD_^+H`WLCW_(_X4N<^
MOX@C^=8'_"+>'_\`H%6WY2?_`!=7['2M/TWS?L-K%;>=L\WR]WS[-VS.YC]W
M>V,>IH`T****`"BBB@`HHHH`*0YP<=<''UI:J7]VMC8WEZ\-W<):6MS=-!86
MTUY>S+;PO,T5G:6ZO/=74H0I;VT*-+/,R11JSNH(!^*WC2*67]NGQU;^+]!_
M:*T?Q'KWQ<^#FJ^$&^$/[./[&=]X"^(7@'X;:9X1D\'^)/&/C#XD^!?%_P"T
M=XM3X=>*]2\:)X@\=6>MZ5IO@.QNR?AA'X=O=)FU1OVS'3\_0<9]NWI[5^#G
MQ$\%1>)_VH-5N+/X=?$5-%^)WQY^`'QFU+XIZU_P3\^/'B#X[>`]5\.V'PEO
M-,\(>!_VB[>6W\$>%O!=G;>'(-$U'7=;M+>X^#VDZU\2?"=YH6ON;B\L?WC'
M3OU/7ZGI[>GMB@!:***`"BBB@`HHHH`_#OQ__P`K$'[.'_:)O]I+_P!:D^$-
M?N)7X=^/_P#E8@_9P_[1-_M)?^M2?"&OW$H`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`K%\1H9/#^
MN(MLUXSZ/JBBT2SEU![DM87"BW2PAOM,FO6G)\I;2+4;"6Y+B".]M&D%Q'M4
MC?=;C/!XY&>.F1DC/L":`/YM?"_P)7X=?'#X8Z/J?P4\%VUW8>,OA3JT6LZ;
M^Q'\9?#5O$FH7OA?6DN-.U[Q-_P5;UYM)N-!FNWTO4-6NO`?C"PT#Q!I&IQ/
MH'BV'2WL=2_I*']3_,^Y_P`]ATK\*/$_AWP5;?MR?%'4_$/AWX*Z/KNK_M!?
M#/4-+N?'/_!-C]H_]J+QYX@2V\)?"[3K+Q!HO[6UG<^'_`/PZ$UW8-I7A_2;
M*TUSPU\$KG1UUZ[U6\@OKJPLOW7']3VQW/\`DGN>>]`'R3^W'^TOXB_9%_9E
M^+'Q_P##'PCUGXS:C\,_!'C#QK/X6L/$.D>$-(M=)\&^%=9\6ZOK7BSQ7JWV
MJ31M`M;#1)K7.A:#XJ\2:CJ][I>EZ5X=N?M=Q>Z?UW[3?QKU'X$?`'QI\7M(
MTKP[JNK:!9^&DTRQ\7:]?^&O"J:CXK\5>'/"=E=^)==TK1_$.J:=H&E7/B./
M4M7N-+T35M2-A93Q6%A<W<L,9P/VR?V<=:_:R^`GCO\`9_LOBQKGPC\-_%/P
MYXE\"_$/5_#?A/PGXJUK6O`7B_PWJWAS7]`T[_A+H+JQT.\N(M22[M==M;>>
M\LY[2-$B>*605#%\$_CI>:'H_AW7?VJ/'2QV/P[U30+_`,2^$O`_PM\)>(;_
M`.(2_$30?%GA+XAPVS>$=?TNQ/AKPMHUQX!O_"+B^\'>,="UO4Y?$&A2:DT-
M["`?.WA;]M[XA>*=$^&7@OP[H'P1\9?M#_%KXN?$GX<Z1X6TOQK\6?!W@3P)
MIOPL^'EK\3/%FI?%*3XA?![1?BUX9\2V7A[4?#BVO@Y?A@]WJ;^/O`^LVU]'
MX3U&[\06_,/_`,%)/$GB?PKXE\5?#+X(Z;K?_"C/@CXB^.?[4F@>)?BC9Z+J
MO@.R\&_$WXT?"/Q3\./AS<:1X7U^P\>^.;;Q9^SG\;KC2=0\1-X`\*:EI?A3
MPY]IU#3)O&XD\->UO^P\'F7X@K\</B!'^TBGQ0/Q8C^/2>'?AY]KAUF3X3P_
M`^X\*0_#=O#3>`A\.[CX:00Z5-X=DL9=8DURWL_&,OBF3Q+86=]#S6I?\$XO
M`<?AF'PGX*^+'Q9\"Z;XH^%.L_!+XZW>GW?A/6=:^//P^\3^-/'OQ&\4R^+=
M2U[PS>)X9\=:WXV^+'Q:U=O''@&S\.7>F0_%/QG9Z5IUH5\)W/A0`^_?#7B+
M1_%WA[0O%7AZ]CU+0?$NCZ7K^B:C"'$-_I&M6%OJ>F7L0D5'$=W8W5O<('56
M"R`,`0:V\X__`%$_RJAI6EZ?H>F:?HVDV<&GZ7I-C::;IMA:QK#:V6GV%O':
M65G;1*`L=O:VL,5O!&.$BC1><9K"\9^`O!'Q&T4^'/B!X0\->-_#[7=K?MHG
MBO1--\0:2;ZR9GL[PZ?JMM=6IN;5W=K><Q>9"S,8V4DT`?C/X^_Y6(/V</\`
MM$W^TE_ZU)\(:_<2OY_=0^%/PP^'_P#P<'_L]:/X%^'?@?P;I-[_`,$H_P!I
M&\O=-\+^%=#T&QO+M?VG_A+;K=W=KI=C:PW-TEO-);K<3(\RP.85<180?O/_
M`,(UX=_Z`6D?^"ZT_P#C5`&W16)_PC7AW_H!:1_X+K3_`.-4?\(UX=_Z`6D?
M^"ZT_P#C5`&W7/>(?%OA7PC!;W7BOQ+H'AFUNYS;6MQK^L:?H\%S<K&TS6]O
M+J%Q;QS3+"CRF*-F<1HSE=JDB;_A&O#O_0"TC_P76G_QJOSN_P""BVE:98>`
M/AVUCIUC:,_CF\5VMK2"%G4^&=28JQCC4E=R*<$XRH-`'W''\9?A#-)'#%\4
M_AU++-)'#%%'XU\-O)++*ZQQ11HNI%GDDD94C106=V55!8@5Z37\O>@C&O:#
ML@BF?^W=$V0N$C29_P"U;/9"\AC<1I,^V-Y"CB-6+E'V[3_04FI>+D<_:_V>
M8I@'D$K:5XK^']V6?<V)(%U.;0S);LPSOF:VN`K*3:[MT:@'O5%>%GQ%/`K&
M]_9X\:1M&3YILH?A9J<03((>$V_CI9[GY2"T<5L90P9%1RN3`?&^A1$K=?!#
MXCVKXW*H^'NFZ@'3GYA+H^J:E"I!!'E2RQS=&$91E8@'O=%>%KX^^'*$?;/`
M?C?3U9<QM=_!/Q]MD;C,:_9?"ET=Z@Y(954@':QQBH6^*/P1B_X^HQIXW;'?
M5?AUXNTJ.&3D>5<2ZCX5MHK>;<I013.DAD'EJI?"D`]ZHKPJ+XI?L^28W^*/
MA]:L6"LFHFQTR6/)`#31:C;VLD$9#!A),L<90B0.4.ZM:+QS\!K@,8/&/PGF
M"$!O+\1>$6VD@D!O]-XR`<>N#Z4`>OT5P-M=_#&]<QV=UX'NW5/,9+:ZT"=U
MC)`#E8I7(3+`;B-N2!G)%;T6@^%IT22'2-#FCD4/&\5E8R+(I&0R,D;*ZD<A
ME)!'(.*`.@HK#/AOP[_T`M)Z@?\`(-M>YQ_SQK\S]=_;R\+:+KFMZ*?@+87)
MT;6=6T@W(\3Z;"+@Z7J-SIYN!$?"<AB$YM_-$1DD,>_87?;N(!^IE%?+?[.7
MQ9\-?M`^'/$'B!/AQI?A0:#KZ:&;22XL=:-T7TNSU+[2)DTC31"`+L0^28I"
M3&9/,^;8OT3_`,(UX=_Z`6D?^"ZT_P#C5`&W16)_PC7AW_H!:1_X+K3_`.-4
M?\(UX=_Z`6D?^"ZT_P#C5`&W16)_PC7AW_H!:1_X+K3_`.-5=L],T[3O,^P6
M%G9>=M\W[+;0V_F;-VS?Y2+OV;VV[L[=S8QDT`7J***`"BBB@`HHHH`*1C@$
M^@)[#H,]3Q^?%+56^MFO;*[LTN[JQ>ZM;BV6]L7BCO;1IX7A6ZM))H;B%+JW
M+B:W>6":-9D1GBD0%&`/S-\2_MR:^G[3GBOX(Z5X[_8:\!V'@CXG>"?AU?\`
MA;XT_M3+X;_:"\5+XDTCPAKDFM>%?A3H/A[4[2!M>3Q1/HOP]T/5-=DU/Q'J
MVDLVI#1FOETZS_3L?AU/3V)'Y^OH<U\!:C\'O`?_``M?X=W][^W#\7K7Q'XM
MU*QNO`_PSF^)G[/RV?Q(G^%EAH]KXOM=%T2\^$DOC#Q4LQT*;4?B/_PCFLM>
M6-YJ>KS)<>'8&LX-/^_A]<]3^?/Y>GM0`4444`%%%%`!1110!^'?C_\`Y6(/
MV</^T3?[27_K4GPAK]Q*_#OQ_P#\K$'[.'_:)O\`:2_]:D^$-?N)0`4444`%
M>:_$OX1?#_XOZ=INE?$#0VURPTB_?4]/A74M4TTP7LEK+9-,9-+O+*63-M/+
M'Y<KO&-VX*'`8>E44`?+-K^Q=^SC9W5K>6_@&6.XL[FWO+>3_A*?%K^7<6D\
M=Q`^Q]<9&V31(^UU9&QM92I(/U-_G\Z**`$P/0?E1@>@_(4M%``1GU_,C^5)
M@>_YG_&EI-PSC(R.V<G\NM`",BNK(RAD8%65@&5E(P0P;(8$'!!!!'!&*R;G
MP]H5ZRM>:+I-VRJ45KG3;&=E1B2R*9;=R%)))48!))(I-;\1:!X:L)=4\1:W
MI.@:;",S:AK>HV>D640`))DN]1GMK=``"26D&`">QKYWU;]M+]ES2[P:;:_&
M?PAXOU8DJ=&^&<FI?%G6U<''EOH_PPT[Q?J,<I(.V.2V1VP2`0"1WX/*\SS"
M_P!0R['8WE^+ZIA,1B>7K[WL:<[::ZVTU.'%9GEN!Y5C<PP6#YOA^M8JAA^;
M9>[[6<+ZOI?\&>RS?"SX97(5;GX=>!+A4)9%G\(>'I55B,%E#Z<0I(X)&"1Q
M6-/\#?@[/O)^&7@>%G?>9+3PWIMC*K%BQ,<UE!;RQ`DD,(G164E&!0E3Y(/V
MI-1UJ9X/A]^S5^TYXWRI-M?7OPYTSX3:1+D'RW>\^.7BGX:7J0-][S(])G<+
MR(6)56C'CC]L?Q-$XT+X#_"#X=(6^2[^)WQOU7Q'JL2'(S)X9^&7PZU/3))%
MX+1)X_2,XVK/SN'=_J[F,+?699?@;6YX8[-LLPF)IIVUE@JV+CCKKK&.&E/1
MI1;./^W\OE_N\<=C$[\D\%E>98JA-JVD,71PL\'U^*6(C#O)*S/5/^%#?"N-
M@UKX8?3B'1T&D:_XHT98I%*D30)I6MV:6\X*JWVB!8YMZARY<;J_G,^+WB7P
ME\.OB7XT\)^,O$FB^#M<L?$.KW(T'Q;K5OH^N1Z5J.IWMUHE]/::W<PZE+;:
MIIKP7MCJ$ZR#4[>5;Q)[CS&E;]X/^%;?M:^)##+XF_:6\&>!XB1YVG?!WX$Z
M9'=0J,96+Q%\7O%_Q,BG<]?//A.U4$DK`.`/RH_X**?\$H?&GQZ\8?`SQOX+
M^(WQ&^)?B_6/'&B_#'XP>*?B%>>%+F^\/?"K4I;K48_&.DV'A+PGX+T/3[3P
M1<?VXDFFVFG2SW\WB33L;Q9.Q^BX4X;X3S'.:&!XDXQPN78&O1Q/^UY=A\=5
M>&Q%&E*O!8F>89?A,+[&I&E4HQE0K593KU**A>+E)?/<3\0\4Y?E%;&\/\)8
MG'XRA6PZ^JX_$8*FL10K5(T9O#PP..Q6)]K3E5A5DJU&E&-"G6<K221]Z_\`
M!-N*6?X0^)O$$$<DV@^*/%L6K^&M:C1WTGQ#I(T'3K$ZIH>H!3:ZKIWVVTNK
M07MC+/;&XMIX1*7B<#]%:Y;P/X,\/?#KP;X4\`^$M/CTKPMX+\.Z+X5\.Z;'
MRECHN@:=;Z7IEMNP"[16=K$LDC#=+)OE<EW8GJ:^%Q"H*O66%=5X95:BP[KJ
M"K.ASR]DZRA[BJNGRNHH>YSWY=+'VV'==T*+Q*IK$NE3>(5'F=%5^2/M52<_
M?]FJG-[/G][EMS:W"BBBLC4****`"BBB@`HHHH`****`"L?Q!IR:QH.M:3+<
M:O9Q:II.I:=)=Z!?W.DZ[:QWME/;/<:+JME+!>:9JT*RF33=0M)X;FRO5@N8
M)8Y8D8;%%`'\[7A']CW]G[PB/"_AWQ+^UEX_'C3PCJW[-_A+0O#L<7QW\,?%
MG0OA+^S1XFNO'&C>'?#G@"3Q)JWB]/B+\1O']R-2\9^)="TI?#$,6I:E+X/\
M-0W1M;Z;^A?2[U=2TW3]12VO;-+^RM;Q;34K26PU"V6Y@29;>^L9_P!_97D(
M<1W-I/B>VF5X9@LB,!<V#.?F&,<!W`X_V0VW'MC'M3NG2@#Y!_;M_:,\<_LH
M?LM?&+X^?#_X5+\6M<^%_@'QGXZGT2_\4Z=X/\,Z5H_@OPIK/BO5==\5ZU/]
MKUHZ5#:Z,VGVFF>$=!\0^(M7UW4=)T];/2M'FU;Q1H7<_M'_`!PN/@5\&;SX
MC:?X?M?%/B;4?$?PM^'O@CPQ>ZQ_PC^FZW\1?C5\1_!_PF^'^G:OK@LM4ET?
M07\8^.-'EU_5+;3=4O;#0X-1NK'3=1O8[>SGS/VM_P!F\?M9_`_QM\`]1^*W
MQ`^%'@_XF>'_`!%X+^(5_P##?3OAS>Z_XE\#>+/#VJ>'/$'A<7?Q'\#^.['1
M8;VUU/[2FKZ)I]CKUI=VEN;74HX&N()^4\1_LKZY\0O"EG\/OBK\>OBE\0/"
M,7P^FT"_N)+?X=>#/$=]\1M+^*/A?XF_#?XS6MU\/_`'AG3M!\?_``EO?"6D
M6?@J31K&W\-3"%+[Q+X7US48Y+RY`/`O^&TOC!+X_B_95M_"/PE/[62_&.^^
M&]W?2^(_%X^#$?@K3_@-I?[0W_"U4M5TW_A/`U]X<UK2_`T?P^:Y:\L_&SW]
M])XONO"MC;WVI<0O_!1OXC^,O"OC#Q1\,_A'X)DG_9U^!?B;XY?M1>&_%?Q!
MU!+JPG\$?%;X[?!WQ/\`"OX4:QHGA^6UU77G\1?LR_&K4]%\;>,-/TC0;JPT
MOP/97_A^P?QGJFI^"_IK_AB#PT+>/Q&GQ=^+<?QVC^*]S\9F_:.4_#-OB7+X
MRO/AE!\%[BTET"3X;O\`"1O!;?"JUM/!J>!O^%;CP]"EI;>*8K=/'49\4MSN
MJ_\`!.KX0S>&M/\`"7A?QQ\7_`FCZC\+=5^"OQ;_`.$;\5Z1<:C\?/AIX@\6
M^*O'WB71_BCJWB7PSK]_'KOB#QI\0/B5K][XZ^'\W@;QG:S_`!-\>6VD:UIM
MIK%G#I0!]P>%/$VD>-/#'AWQ?X?N?MFA>*="TCQ'HMWL:,W6D:[IUMJNF7)C
M<!HS/8WEO,8VY0OM))&:U;R^LM/A^T7]W:V5OO5#/=W$-M"'?(1/-G>--S$$
M*N[<QZ`TEA8V6EV5IIVG6MO8V%A;6]E965I#';6EG9VD*6]K:VUO"J106]M;
MQQP00QJJ111HB`*H%8?BWP5X.\?:2=`\<>%/#7C+0VN;>];1O%>@Z3XCTHWE
MFS/:71T[6;.]LC<VSNS6\Y@\V!F9HG0DD@'XK>--1T^^_P"#AS]G&>ROK.[A
M_P"'3?[2?[VUNH+B/C]J7X2`_O(9'3@Q29^;CRW_`+C8_<K[1;_\]X?^_J?_
M`!5?@5JWPS^'/@?_`(.$?V>=*\%^`?!7A'3+W_@E'^TC=WFG^&/"F@>'[&[N
ME_:?^$ENMS<V>D:?9VT]PMO(\"S2Q-((6:,-L9@?WC_X1[0?^@+I/_@ML?\`
MY'H`TOM%O_SWA_[^I_\`%4?:+?\`Y[P_]_4_^*K-_P"$>T'_`*`ND_\`@ML?
M_D>C_A'M!_Z`ND_^"VQ_^1Z`-+[1;_\`/>'_`+^I_P#%5\:_MW_M"_%']F#]
MGOQ#\<?A1X"\,?$Z7P+J.EWOC;P]KVM:GI!L_`UY,VG:IXDTZ?1[>]N)YM`U
M"ZTN[U&UDM3$-#;4[XS1M8[9?KC_`(1[0?\`H"Z3_P""VQ_^1ZQ/$WP\\%>+
M_#FO^%/$/AG1M1T#Q/HNJ^'M<TZ33[5([_1]:L;C3=3LI'BBCD5;FRNIX2R.
MC+OW*P(!'I9-BL%@LVR[%YE@:>9Y?A\;AZN.R^I.K3CC,'&K%XG#^THU*56G
M*I1YXTZD*D90J.,[NUGYV;X;&8S*\PPN7XV>6X^OA*]/!8^G&G.6$Q<J<OJ^
M(]G5IU:=2-.KR2G3G3DIP4HVUNOYX?V<_P#@MI\??VA/C9\/?A#IW[/_`,(?
M#\7BS7$C\0>)]2^(OBB#3?"/@_3(WU3Q?XJOY;W2K.T\C0M`M+ZZAAGNH%O+
M_P"Q6`E1KM6'[8ZY^VE^RMH-U_9S_'7X>Z]K&\QGP_X$UH?$GQ(),D>5_P`(
MY\.X?%.MF48^9!8;A@D@`$C\Y?\`@GA_P2>\&?L[:U\===^.O@OP5\3[^^^(
M=]X7^#K^,]`\/>,+?3_A+X=G:ZT'Q9'9ZI!J=II?BKQ?+?1IK)$$=]9PZ!;P
M+*D5W*K_`+*Z+X,\(^&[467A[PMX<T&S"A1::-H6E:7;!1P%$%C:01!0#@`)
M@"OTSQ+QGAC+/UA^#LGQ,<JP6%HTY5<MS"6&HX_$UZ<,15Q'UG,:>=57&@JD
M,&J,<-04:M"O-SFJD''\X\.L)XDQR+V_%N;X>69XS$5:BI9C@(XBM@</1D\/
M2P_U;+YY13YJSISQ3K2Q-=RIUJ,.2#IM2^=/^&JCK,AC^'O[//[37Q`C=6:V
MU`?"Y/A?HTXP=D@U/XZ:_P#"W$#$`^=%:SG:?EC=@5JJOQ'_`&N?$J2IX?\`
M@#\*OA^C']U>_%CX]'4M1B4YPTGAKX5^`?%EA-(HY:%/',*%AL6XP?-7ZB;P
M]H+,6;1=)9CR6;3+$L3ZDFW)/YT?\(]H/_0%TG_P6V/_`,CU^>+,\MI:8?A_
M`S22Y:N88O,\7B%)=9/#8O+\'4_PRP*B^L;:'W_]FYC5UQ&>XV-_BI8'"Y=A
MJ#6FD?K&$Q^,AL]5C7+725]3Y=?P+^UOXF6%O$?[2'PQ^'T7_+6Q^$/P2BOM
M10,<D#Q-\6O'?C:QF=!A4E7P/:`Y+-;C@"3_`(9;L=8F:?X@_M#_`+2_Q"$J
MD7-E/\8I_AII$V\$21G2?@5I7PJMC`V2#!(\J[?D+,N0?I[_`(1[0?\`H"Z3
M_P""VQ_^1Z/^$>T'_H"Z3_X+;'_Y'I_ZQ9G#_=G@L"U=1J9=E>6X#$03MI'&
M87"TL8[6T<L1*7>3>HO[`RZ7^\+&8U/E<H8_,LQQV'FX]983%8JKA->JC04=
M;)):'SKH?['7[*.A77V]/@G\.-=U4,'&M^.-*C^(WB#S`21*?$'Q!G\3ZR9<
MG<93?>8S`,S$@8^B=*TW0-"LH=-T6STG1]/MU"P6.E6]GIMG"HZ+%:V2001J
M.P2,"E_X1_0?^@-I/_@ML?\`Y'IO]@^'SG&CZ0V.NW3;%B/P6W)KAQF9YEF#
M3Q^88W&N/PO%XJOB7'2VCK5)VT70[<+EV78%-8+`X/!J6ZPN&H8=2VW5*$+]
M-7<T_/MLY\Z#([^9'G\]V:7[1;_\]X?^_J?_`!5<?KUQ\/O"UC)JGB:7PAX=
MTV$%I=0UYM"T6RB55=V:2ZU,VL"!4C=R6D`"HS$X5B/FGQ!^V;^P]X<N38W'
MQS^"6LZH&93HG@K6-%^(OB`.IP8O[`^'UOXHU@S9#!819&5BK!4)5L8T<)B\
M3_N^&Q&(MH_8T:E6UN_)&5K>?Z%XC'8+"6>*Q>%PR>WM\12HWOV]I.)]C?:+
M?_GO#_W]3_XJOC_]J+]O7]ES]CG4_AEHWQ\^)>G>$M4^*WB&'1/#=C%!+JMS
M8Z<9C;7_`(W\2P6/F2^'?A_HEXUO9ZSXNU!%T^RNKJ*)?/,5X;7RKXF_MAVD
MG@/Q1>?LR?LM?'/X]_$<:#?R>`M)O?V?/B%\*OA_K/B(Q%=-BUOX@_%CPMX#
MTFRT1)62ZO;BQEN;B[M8VM=.(N[B*2+_`#Z?VCOBI\9_C+\:_B#X^_:!OM8N
M?BW?^(+[3/%]CK6ER^'Y_"][H5Q-IJ^";/PO+'%_PB6D^$1$^D:=X82&/^RX
MHG-R;J_N;R_N_O>#.!)\08FO+,ZL\%@\+#WZ$)TX9C5J5(M4G&C44YT*$7>4
MJU:E:I*/L:492]K.C^:\?>(]/AC"8:&4489ACL9.]+$SA4J972I4I1=6^(I.
M%/$XB<6HPH4*W-2C+V]:4(^QAB/]2*SU33=0M+6_L-0L;RQOK:WO+.\M;NWN
M;6[M+N%+BUNK:XADDAN+:YMY8Y[>>%WAGADCEB=XW5C9^T6__/>'_OZG_P`5
M7\KW_!NG\8?VHO'GAOQI\)?&'@>+QM^RK\.;&2V\&?%3Q.(H;[X?^,6N(+K_
M`(5'X4NKNRN)/&F@W%G?7.MSZ1%-$OPS;R(&OQ8>(=)T&U_J/_X1[0?^@+I/
M_@ML?_D>OE.(<EJ</YMBLKJUZ.)>'E%QK491:E3J14Z?M()RE0K<K7M:,WS0
MEK%SIRA4G]IPOG]+B;),'G%+#8C"+$QDIT,1"47"K3;A5]E4<8QQ&'YT_8XB
MFN6I'24:=6-2E#2^T6__`#WA_P"_J?\`Q5'VBW_Y[P_]_4_^*K-_X1[0?^@+
MI/\`X+;'_P"1Z/\`A'M!_P"@+I/_`(+;'_Y'KQ3Z`TOM%O\`\]X?^_J?_%4]
M)(Y,^7(CXQG8RMC.<9VDXS@XSUP:RO\`A'M!_P"@+I/_`(+;'_Y'JY::=86'
MF?8K*TL_-V^9]EMH+?S-F[9O\F--^W<VW=G;N;&,G(!<HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`/P[\?_`/*Q!^SA_P!HF_VDO_6I/A#7[B5^
M'?C_`/Y6(/V</^T3?[27_K4GPAK]Q*`"BBB@`KYS_:G_`&I_@[^QW\'O$7QJ
M^-?B-=#\,:(JVFFZ;:K%=>)/&/B2ZBE?2/!W@[2'EADUGQ+K,D+K:VJO%:V=
MK%=:OJ]UI^C:??W]O]&5_,Q_P7[_`."??Q[^/&F:!^U%\)_$WB_XCZ)\(O"E
MWIOBKX!@F]C\-:$LLU]K/Q*^%VCV%O')J6L7$`B3X@Z1-'?^(=1T;2M.O=`N
MI;?2)_#\WN\-9?E^:9U@L%FF-6!P=:HHU*MK.I+[&'C4:<*,L1*U.-:I[E-N
M[4I<L9?-\6YIFF3Y!F&89/@'F..P]+FIT=XTHMVJ8F=)-5*\,/"]65"E^\J*
M-DX1YIQ]"_X)P_\`!=OPO^U3\8_$/P5_:#\-^&?@OXD\:^+;Q_V?]2T_4KB;
MPWK.F7DH32/A=XLUC4I1&GQ+C1`VDZ]"FF^'_'5U/-I&FZ;HVL6^EV.O?T,7
MNI:?IMK+>ZC>6NGV<"EYKN^GBLK:%%&6:6XNGBAC4#J7<`<YQ@X_S!_V1OV3
MOC-^V=\9O#WP;^"&C#4-<O\`R-7USQ1=FXB\)_#[PK!=0K=>.?%NK6BNUCI&
MGRF/^S8;5FU?7]8^R:/X>BGU*8/;_P"@/\&_^";G[,OP[\#^#M$^)'@K2?VD
M_B!H.A:?8^)?B[\?]/7XG>,/&NNP('O_`!!?)XUN/$5EIOVFY+BQTZR1ET[3
MUM[)[J^F2XO+K[7Q!X<X:R3'X=X+%U,)4Q%)2JY3AZ*Q<J*@E&.(52KB:3H4
MZ]FN2I*I.513J4TZ?-&G^?\`AAQ7Q;Q#EV)CC\%2QU/#5I*EG>*KO!1KN;YI
M87V=#!UEB*N'O?GHPI4XTG"G5<:BC*K[#XK_`&T_V2?!,LEKXC_:1^"MGJ43
MF-M$M?B/X7UGQ"T@&?*B\.Z#J.J:[-*?E"Q0Z<\CNZ(BL[HIXYOVY_A/JL"R
M_#KP/^T;\7&=BL3?#S]FGXU7&E3`!&$D7BSQ9X/\(>"WA=75HYAXC\J1&1T=
MDDC+_3?A'X<?#[X?VOV'P)X&\'^"K(*$%GX2\,:'X:M0BYVH(-$L+&(*NXX4
M+@9..ISV.Q<8(W#T8EA_X\37Y[[3*X[83&U6MI5,;1IPE_BHT\&YI>4<3?\`
MO'ZA[+.)I<V,P%%-:QI8"O5J0>GPUJF/C3DUKK+"I7M[I\9S?M#_`+1>N")O
M`G[#_P`4XHIL!+_XO_%7X%?#&Q!+.H::S\-^-?BQXI@B'R,WF>&OM`3S2MNS
MI$EPKWG_``4`\0SHUOH?[(OPHLY<9^W^(OC+\==2MP1@^9;6'A_X"Z;)(I`;
M8FI-$V2GFG:6?[,``X``'H!BEH^O4H_PLMP%.6RG)8NN[:;PQ.+K4)/3K1MY
M(/[.KS_C9MF-6+:;IQ>"P\=+7M/"X.CB(IVZ5[KN]6_C)/@9^U9KEPTGC#]M
M?5M%MI0?-L?@K\`/A/X(10R8:."_^*/_``O;5(PK<)*+A9MI?D,4:)8OV)_!
M^I&7_A87QL_:O^*"S_Z^W\2?M)_$GPGI<^75SYOA[X.:C\+O#I0NK'R1I0@4
M/M2-4C@6'[,HH_M3&K6E4IX=Z>]A,-A<'-VVO4PM&C-_.7EL-9/@'_%IUL5'
M7W,;C,9CJ:O:]J>,KUZ:VV4;+ITM\F^'OV$_V//#<XO+;]G'X3:QJ:NLBZYX
MT\)V/Q$\1"12"DA\1?$`>)];+H0I5C?DJ54@C:N/I70?#'ASPM81Z5X9T'1O
M#NF1!5BT[0=+L-%L8E10BB.TTRWM;=`JJJJ%C`50%&%&*W:*YZV+Q>)M]8Q.
M(KVV]M6J5;6VMSRE8Z</@<%A/]UP>%PW3]Q0I4?O]G"-_F-**1@J&'^U\WM_
M%GM_,^M?CC^W[_P1E^`G[<OQ0\$?%]M=U'X0^.[;6](M?BYK?@_2[*>X^+'@
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M(I1C&*2BDDDD@HHHJ"PHHHH`****`"BBB@`HHHH`****`"BBB@`KY\_:G^*O
MB?X*?`CQY\2/!NFZ-JGB?0H?#]KHL'B*R\3:GH%O?>)/%WA[PHFJZUIG@RVN
M_%FJ:3H::[)K>H:9X<MY-:U"UT^6ST[9<SQR)]!UQ?Q"\&MX_P#!^L^$X_%?
MC+P//JBV3VOBWX?ZVOA[Q=H-]INI6>K6.H:/J4MGJ5DS1WEC`M[IFKZ7JWA_
M7=.>\T/Q%H^K:'J.H:=<@'YVZ!^V5\5M>@^'/PD\.W?P@\6_M(_$_P",?Q%^
M'X74_`?QX^#'@[X7>'?AI\+M,^+6NWWQ$^&WQ0@C^,(\57/AO7/")\/Z&G]@
MZ=XCL/'_`(>\5Z?JZ>';*XFU/SZ/_@I5\0/%/@WXG_$+P+\+/`@T;]DSX.7?
MQ:_:Z\/:]XZUB77;'4/#7Q"^.G@'XA?#GX0ZII_A^VT?4]2\)VO[./Q.\9Z9
MXM\7V]GI?BRTN?`?AG^Q/#M]XBU[6_"'U=)^Q%X9D`\3_P#"W?B^GQR7XGQ?
M%R/]H=)?AH/B+#XJC^%Z_!AK&#PX?AJ?@]'X-F^&`_X16?P5_P`*R;0IY%B\
M5SQ2^.;>W\3Q<S??\$Y_@R^@6_A+0?&'Q=\)>%-<^&]E\)/C3H.B>+],GC_:
M+\!6_B_QEX^OM,^+VJ:]X:UG7GU7Q%XL^)'Q,O\`Q/XK^'^J>`O$^MV/Q&\8
M:#<ZHNBWFF6>D`'WGI]_::I866IV$Z7-CJ%K;WUG<QA@EQ:7<*7%M.@=4<+-
M!+'(%=58!@&&0:HZ_P")/#WA6P.J^)M=T;P]I@GAMCJ.NZI8:/8BXN"5@@-Y
MJ5Q:VPFF92L47F^9(00BL0:UXXTB18XT6.-%"HB`*B(HPJ(H`"HB@*B@!54!
M0``!61K_`(;\/>*K`Z5XFT/1_$.F&>&Y.G:YI=AJ]B;BW):"<V>HV]U;&:%F
M9HI?*\R,DE&4DY`/PQ\1^,O"/B?_`(.%OV=K_P`.>*/#NOV4'_!)_P#:2AGN
M]$US2M6MH)O^&H?A)*(IKC3[NXACD,4<D@1Y`WEHSXVJQ'[L?VMIG_00L?\`
MP,MO_CM?A/XC\'>$O#/_``<+?LZV/ASPOX=T"RG_`."3_P"TE-/::+H>EZ5;
M3S?\-0_"2(2S6^GVEO#)((Y9(P[QEO+=TSM=@W[L?V3IG_0/L?\`P#MO_C5`
M!_:VF?\`00L?_`RV_P#CM']K:9_T$+'_`,#+;_X[1_9.F?\`0/L?_`.V_P#C
M5']DZ9_T#['_`,`[;_XU0`?VMIG_`$$+'_P,MO\`X[2'5=+(P=0L<?\`7Y;?
M4$$39!!Y!'(/(YI?[)TS_H'V/_@';?\`QJC^R=,_Z!]C_P"`=M_\:H`\4^$'
MP(_9Z^`5W\0[[X->`/`7PZN_BMXRN_'WQ!G\,6]CI\GB;Q3>QB.6_O6$[^5;
MQ9GELM(LOLNBZ=<WVIW>GZ=:W.J:C+<^U_VMIG_00L?_``,MO_CM']DZ9_T#
M['_P#MO_`(U1_9.F?]`^Q_\``.V_^-5I5K5:]256O5J5JLN52J59RJ5)*,5"
M*E.;E)\L(QC&[=HQ459)(RH4*&&I1HX:C2P]&#DXTJ-.%*G%SDYS<8048IRG
M*4Y-*\I2E)W;;#^UM,_Z"%C_`.!EM_\`':/[6TS_`*"%C_X&6W_QVC^R=,_Z
M!]C_`.`=M_\`&J/[)TS_`*!]C_X!VW_QJLS4/[6TS_H(6/\`X&6W_P`=H_M;
M3/\`H(6/_@9;?_':/[)TS_H'V/\`X!VW_P`:H_LG3/\`H'V/_@';?_&J`#^U
MM,_Z"%C_`.!EM_\`':/[6TS_`*"%C_X&6W_QVC^R=,_Z!]C_`.`=M_\`&J/[
M)TS_`*!]C_X!VW_QJ@`_M;3/^@A8_P#@9;?_`!VC^UM,_P"@A8_^!EM_\=H_
MLG3/^@?8_P#@';?_`!JC^R=,_P"@?8_^`=M_\:H`/[6TS_H(6/\`X&6W_P`=
MH_M;3/\`H(6/_@9;?_':/[)TS_H'V/\`X!VW_P`:H_LG3/\`H'V/_@';?_&J
M`#^UM,_Z"%C_`.!EM_\`':/[6TS_`*"%C_X&6W_QVC^R=,_Z!]C_`.`=M_\`
M&J/[)TS_`*!]C_X!VW_QJ@`_M;3/^@A8_P#@9;?_`!VC^UM,_P"@A8_^!EM_
M\=H_LG3/^@?8_P#@';?_`!JC^R=,_P"@?8_^`=M_\:H`/[6TS_H(6/\`X&6W
M_P`=JQ!=VMUN^S7$$^S&_P`F:*7;NSMW>6[;<[3C.,X.,X-5_P"R=,_Z!]C_
M`.`=M_\`&JL06EK:[OLUO!!OQO\`)ABBW;<[=WEHN[&XXSG&3C&30!8HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`/P[\?\`_*Q!^SA_VB;_`&DO
M_6I/A#7[B5^'?C__`)6(/V</^T3?[27_`*U)\(:_<2@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"OST_:5_:G^+/P\\<?&;P]\)/#WPZU+3OV7_V9-(_:H^+L
M7CW_`(2DZEXZT#Q%KGQ1M=`^&?P_O=!O-.L?!^O7F@?`[XDZM=^/->L_'&F:
M?JDO@[0F\%3VVK:OKFB_H77RS\</V1OAM\>/$%SXA\2:U\0O#5SXB\`S?"/X
MEVG@+Q<_AFP^+GP?GU>ZUV3X8?$&,Z?J%S<>'%U'5-?^R:GX7NO"OC73-/\`
M%/B_1-+\666B>+/$.G:@`?0?A#Q3I7CCPIX:\9:$\\FB>+/#^B^)M'DN86MK
MA]+U_3+75].>XMV+-!.UE>P--"Q)BD+1DDKFH_%OC;P=X!T@Z_XY\5^&O!NA
MK=6]DVL^*]>TGPYI0O+QF2TM#J.LWEC9"YNF1EMX#/YL[*PB1RI`Z"UM;:QM
MK>SLK>"TM+2&*VM;6VBC@MK:V@C6*"WMX(E2*&"")$BABC58XXT5$4*H`9>6
M-GJ$/V>_M+:]@WJ_D7=O#<P[TSL?RITD3<I)*MMW+V(H`_F'_:T_;X_9!_9N
M_P""X?[.7QZ^+7QS\*Z9\(H_^":/QX^'$_C?PA:^(/BQI=IXW\1_M(?#O6M$
M\.WT/PCT;QUJ%A>:CI?AW6;V"2\LH+4163"2X226WCF^V?\`B(?_`."/7_1W
M\7_AA?VH/_G)5^S5EI>FZ:)%T^PLK`2D&065K;V@D*C"F06\<8<@<`MD@<#%
M7L#W_,_XT`?BO_Q$/_\`!'K_`*._B_\`#"_M0?\`SDJ/^(A__@CU_P!'?Q?^
M&%_:@_\`G)5^U&![_F?\:,#W_,_XT`?BO_Q$/_\`!'K_`*._B_\`#"_M0?\`
MSDJ/^(A__@CS_P!'?Q?^&%_:@_\`G)5^U&![_F?\:9(FZ-U&<LC`?,>I4@=_
M6@#\5T_X.(_^".LF_P`O]L2UE\N1X9?*^!7[3LGE31X\R"79\%&\J>+<OFPR
M;98]R[T7<,O_`.(A_P#X(]?]'?Q?^&%_:@_^<E7Z"_LQ_"_QA\,YOVA7\765
MO9+\0?VGOBU\3?#!M]1M;_[7X1\6)X871+V<6DLGV*XG.F7?F:?<[+JVV+YT
M:^8N?J/`]_S/^-`'XK_\1#__``1Z_P"COXO_``PO[4'_`,Y*C_B(?_X(]?\`
M1W\7_AA?VH/_`)R5?M1@>_YG_&C`]_S/^-`'XK_\1#__``1Z_P"COXO_``PO
M[4'_`,Y*C_B(?_X(]?\`1W\7_AA?VH/_`)R5?M1@>_YG_&C`]_S/^-`'XK_\
M1#__``1Z_P"COXO_``PO[4'_`,Y*C_B(?_X(]?\`1W\7_AA?VH/_`)R5?M1@
M>_YG_&C`]_S/^-`'XK_\1#__``1Z_P"COXO_``PO[4'_`,Y*C_B(?_X(]?\`
M1W\7_AA?VH/_`)R5?M1@>_YG_&C`]_S/^-`'XK_\1#__``1Z_P"COXO_``PO
M[4'_`,Y*F/\`\'$?_!'6/9YG[8EK%YDBPQ>;\"OVG8O-F<,8X(O,^"B^;/($
M<QP1[I9`CE$8(V/VKP/?\S_C7R[^TQ\+_&'Q*OOV<9_"5E;WL?PZ_:=^&?Q-
M\5&XU"UL39^$?#6C^-K/5KV`7<L9OKB&?6]/6.PMA)=3B5VBC81.5`/SY_XB
M'_\`@CS_`-'?Q?\`AA?VH/\`YR5'_$0__P`$>O\`H[^+_P`,+^U!_P#.2K]I
MHTVHBG.510?F)Y``/.>?K3L#W_,_XT`?BO\`\1#_`/P1Z_Z._B_\,+^U!_\`
M.2H_XB'_`/@CU_T=_%_X87]J#_YR5?M1@>_YG_&C`]_S/^-`'XK_`/$0_P#\
M$>O^COXO_#"_M0?_`#DJ^TOV0/\`@HG^QU^WH_C^/]E#XPI\5G^%P\,GQT%\
M`_%'P1_88\8_VY_PCA)^)'@CP<-2_M'_`(1S6<?V.=0^R?8S]N^R_:+7S_M;
M`]_S/^-+C'K^))_G0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`'3K2;EQNR,>N1CGISTYKQC]H+[<GPJ\1W4'QE@^`&E:<^EZKX
MN^*S6/A^ZO?#7@?2]4M+[Q>FC7WBPS^&?#FLZSH4%WHFG^*]8TCQ##X:EU$Z
MM::!J6IVUA&GY?\`@3QS^TQXX\9?`SX%>+/BO\9_AM\+?C7\0OVJ?%OPL^*F
MN:#X/\&_M,^)O@U\&O"?PD?X1^#O&D'B;P9]F\-^(_&?B/QE\3_B5I\.J?#K
M3_B1JOP<^&OA*P^(NGZ;K]Y\0X+T`_:C(XYZ\#W."<#\`3]`:3(!`)&3G`SR
M<=<#OC(SZ9K\5_AG^TG^TW\0-=_X))^.=>^(]AIG@?\`:`\;?&#X=?%/P9H7
M@71;&3XO:CX)_9N_:M\5:5\4=2\3&_U>/3?!WBJ]^$_P^^(O@;PEX(L/#=M9
MR:YJ5SK6O>(]&?0]'T?#F_;_`+OQI_P5$_9\^#OA_P"*]_X:^&6M7W[7OP8O
M/@Y<^%[W3KCQMXQ^$GA_X=7=C\1O$]WK'AE-4M))?&J^-]`^&=IIFKVV@WO@
MG1IO&E[-J@\>:)!HH!^XM%`((!'0C(^AHH`****`"BBB@`HHH.<'!P<<'&<'
MUQQGZ9H`3(SC(SC.,\X]<=<4`@D@$$CJ`>1]?2OS4^*6K?&S3_VI_`>@?"[X
MZ^,?'/C36?BSX)U;QM\&=+\)>&+?X%?!W]DP6"0>-KOXJZ@=&U/7[#XB>*I-
M-U>]^%'B*?QWI?C+QG\0K_3+#PSX*_X5%X/^(KVG@O[-?QT_:,\77?[(?B@_
M%F^\5>)_VY?@9^T'X^\7^"O&/ASPQKGPZ_9T\?\`@"V\':SX9?PYX9\)3^#O
M%\'A#X::SXCE^"/Q`\-7OCR^OO%&OW/AW4=4U[0_%RZIJ.K`'[2%E`W%E"YQ
MDD`9SC&2<9SQ]:4$$`@@@]"#D'Z$5^)WPL\6_M4?'']A_P"`\5K\7O%7B7XO
M:]^U_P#M)_#SQMXWL/'_`,._V?O%OC;P1\)?CI^UEX1T:SMM;B\">*;/1+.S
MMOA[X"EU[1OAQ\./%?BT>#]#U0:;I%Y;P:MJD?Z*?L>^-V\<_`GP_+=S>-Y]
M>\&^)?B1\*O&,OQ"\6:9X^\3MXX^$OQ&\4_#OQD;CQYHND:!I/C/3SXB\.WY
MT/Q'::'HDE_HGV#^T]"T+68M2T:Q`/IZBBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`/,/B]\%OA/\??!=Q\.OC1\/?"
MGQ.\#76JZ%KMQX5\9Z1;:WHDFM>%]6MM>\-ZL;&Z5HAJ.@ZW966L:/>KMN-.
MU2SM;^TDBNK>&5/.K3]CO]EVS^&\_P`(%^!/PTN?AE<^+9/'DO@K4O#-GJ^@
M_P#"9RV<>G3>*([75A>M;ZY-IR-ITVHV\D5S-I\]Y82N]I?7L-Q]*44`?+'Q
M&_8A_9(^+?B'PQXK^)'[/7PK\7^(O!&D:1H'@O5=7\*V4ESX0T;0;:]LM'T[
MPN(/(A\/VVG6&I:AIMJFD16?EZ7>W6F`_8)Y+=O>=4\`^"M;\6>%/'>L>%M"
MU3QGX%MO$MGX-\47^G6UUKOA>T\96VFV7BNUT+4ID>ZTRW\0VFCZ5;ZQ#:R1
MQW\.GV:7"NL$87KJ*`"BBB@`HHHH`****`"@@$$'D$8(]0:**`/F%OV+OV56
M^+%Y\=%^`WPWA^+VI>,M.^(FI_$*VT".U\3:IXZTFQT_2]-\6ZI?VTL)U+Q!
M8Z7I.EZ9:ZG?1W%U#ING6-@KBTM884Z5OV7OV=C<_$^^C^"OPUM;_P"-%CJ&
MF?%34;#PCI&G:EX\L-6N7OM6M?$>HZ?;6M[?0ZMJ4LVJZHIG3^TM7FFU>^^T
M:G+)=M[S10!\F>%_V$?V.?!7@SQ%\._"O[-GP?T/P-XKUK3?$NO>%+'P7I::
M'?>)-(EU:XTWQ&+"2.2&S\06=UKVM7L6N:>+351?:OJ=ZUXUU?74LOTCX2\(
M^%?`7AS2/!_@GPYH?A'PIX?LTT_0_#?AK2;'0]"T>QC9W2TTW2M,@MK&RMU>
M21_*MX(U,DDDC!I)'=NBHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBDW#UX]>WY]/;KUXH`6BBB@`HHIOF)NV[TW9QMW#=D]!C.<T`.HHH)`QD@
M9.!GN?0>IX-`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`#78(K.0Q"J6(52S$*"2%502Q..``
M23@#)(KY1/[8'@)20?AW^T9D$CC]G#XOD'!(R"/#!!!QD$=1@C@U]84F![_F
M?\:[<'5P%+VGUW!U\7S<GLO8XV.$]G;FY^:^$Q/M.:\;?!R<K^+F]WCQ5+&U
M/9_4\70PMN;VGML)+%<]^7DY>7%8;V?+:5[\_-S+X>7WOACXE_MO>&O#'P]\
M;>(O#_PZ^-YUW1/"^LZCH_\`PE/P)^*7AWPVNJ6]E*=/?7M<U+P];:?I>D1W
MAADU"\O+FV@CM4D5KB(LKC^?A_VM?VFY?%9\8M\<_B.FNMJ']H8B\0WJ:"EQ
MG_4)X05_^$7&EJ"85T<Z2UD;;]RT;.3*?ZWM6TG3==TK4M$UBS@U+2-8T^\T
MK5-.NT\ZTO\`3M0MI+2^LKJ%CMEM[JVFE@FC;AXY&7OFORZD_P""27P#?Q8=
M63QA\28O"AO/M/\`PA2:AHI@6U^]_9*>)&TH^(%T_=^Y64SMJJ6F(AJ?GC[7
M7ZOP#Q7P+DM'-(9KE%2C5Q'LW3JXBG3SIXBC&$E/"1;PM#ZO>3YG"4/8U^;]
M]5C[*FC\SXVX9XSS>MEL\LS2G5IT.>-2G0J5,H5"K*<)0Q4DL36]NU%6YXS]
MK14?W-*3J39[+\*?VX/#_BKX:^!?$?B?X>?&MO$6L^&-*O=<D\(_`OXH>)/"
M\VK-`(M1GT#7-*\/7.FZCI-Q>133V4UE=74"0R+;BYF>%W/H!_;!\!`$_P#"
MN_VC>`3Q^S?\8">.>!_PC')]!U)X%?3>AZ'I'AK1M)\.Z#86^E:)H6FV6CZ1
MIEFIBM-/TS3;:.SL;*VC!.R"VMH8X8U))"H"S,Q+'5P/?\S_`(U^=XG'<.U<
M1B*E'(\;2HU*U6=*DLXA%4Z<ZDI0IJ/]FSLH1:BESSM:W-+=_=X?!Y]3P]"G
M6SC!U:L*-*%6H\IG)U*D81C.;?\`:,+N<DY-\D+WORQV4<,JW$,<RB1%FB21
M5DC>&5%D0.!)'(%>.10P#HZAD8%6`8$5^(7[5OQ/\6?LZ?MM>+?B%J'QA_:+
MUWX2?#W]AOXQ_MAZK\"=`\?65EX*U[QU\*/BK\*O`VB>'EMI/#%[=:/X&U/0
MO$>J1^)+)[NYTRU>\NO%%W!+)IP4_N%7#ZM\,_AWKWB2;QAKG@?PGK'BJY\$
MZU\-;CQ#JF@:9J&KW'P]\2:A8ZMXA\$7%]=VTTUQX3US4],T^^U;P_,SZ7J-
MU96TMW;3-$A'S_I_7Y'NK;75]7M<_%7XE?\`!07]JGX??M?^`OA!XRM/@!X(
M\"_"?PA^T)XY_::U&SU_QMK7@?Q)X7\+?LZZ'\=O`M_H7CV_^'_]O>![GPE:
M?V[:^,;9]`UFZDT\:5XO.F7^FZ_I?A6RM:?_`,%"_C1\1/VB?@!\"-7\,:E\
M)O$VC?M9?`&S^(C66A^+_#6D_$?X,_M`?LL?MV^-O#OAR3PU\5/#6C>.M.71
MO'7[.L%U>ZG=Z;H4^MMI6CWL&GZ"S:MH$7ZEQ_L@?LKP^$=%\`P_L[?!>+P5
MX=\5R^.=$\+)\-_"BZ'IGB^XTP:'=>(K73AI?V=-5O-`5?#E[=LKO>^&D3PW
M=^?H2)IZW/"/[*'[,W@&[T&_\$_`/X1>%;_POJFB:WX>O]!\`>&],OM'UCPU
MI_CS2/#NJV%Y:Z?'<P:CH6E?%'XC:7H]Z)3<Z;IOC?Q/I]G)#::S>0R`'QU^
MUK^W]XV_9Q^*WQ!\!^'OA#:>/])^'/P8_9H^)5_>PZGXIF\1:QXB_:E_:%^(
MO[,W@+PMI/AGPIX4\4ZI<V6E>-_#>A>)_$^KV=CJ&H0>%%UNPT70=;\1WFAV
MHRM`_P""@GQ(2QTRU\9_!2?PWX@\5?\`"UOAO\-T\0Z=\0/ATGQ)^/W@[7?A
M9:_#KPSI?A;XC^&]$\<^&/#GQ6\._%&76[*'Q9HUCXJT&7X9_$J);/7='L-!
MU[6OT3\2?![X4>,;_P`5ZIXM^&W@;Q/J/COP/IGPS\:7GB#PMHNLS^+/AYHN
MI^(-9TGP1XB;4;.Y&L^%=-U;Q7XEU*QT*_$^G6M]KVKW4,"3W]P[X>B_L\?`
MGPYX>\$>%-"^#WPVTKPW\-?&4?Q&\`Z)9>#-!@T[PA\08K/5[!?'7A^V2Q":
M;XR-IK^N02>*(-NN31ZQJ0FOY/MMP9`#\F]1_P""MGQ`@^%GQS^-6F_LU^(K
MGP#X&^'OQD\=^`KS7=%^*?@BQOS\%_C%X=^$O]A>*?&?BWP!I7@C4]3^)@UB
M]\3:"/A=J_C.+P)_9DGAOQJUS=S0:M+Z7KG_``4?^(W@?XM^.O@QXX^%7@1/
M$/POU;]J/3/&7B+P[XT\2W/A1U^#G[)_P1_:W^'DVF7&M>&-'NX'\3>$?C3%
MX8\60ZA&!I>J^$-6UG1);W3;Z*WL?OZ\_93_`&9]0O\`XCZI??`+X/W>H_%^
MUN;'XHWMQ\//"TMSX_L[[4[/6]1M?%DS:9OUJWU36M.L-:U:*\,B:MK%E::K
MJ:W>H6T-RFOXI_9R^`?CBZUJ]\9?!GX8^*;OQ'XTTGXC:_<^(/!/A[5Y]9\>
MZ#X,LOAUH_C#4Y+^PG:]\1Z=X`TVQ\$VVK3E[Q/"=K#X>,C:4GV4@'YH?`W_
M`(*A?$'XR^+?!MM:?LX^)4\'ZA#\*_"_B_5]-T7XFOI^C^./B+^RYX$_:2O_
M`!%#\3-7\"Z9\%M.^'?ABX^('A_P)+9:_P".K?QUJ=I<77Q"M=,31;*'2-2^
MI_V-/VK_`!I\?[KQ3X9^+/@[PS\+/B5H_@[X>_$9?AK;O\3+7Q9H_AOX@'Q#
M92P7Z>/OA[X3\-^.M"\.>(O#=]X9TWXP_!SQ5X^^&7Q!O;>_NM*F\/16MG!J
MWO\`IG[,W[/&B^+O#_C[2/@?\*=-\;>%/#&F^"_#7BJR\!>&8-?T+PKHV@MX
M5T?0M+U1--%U9Z=I7A=YO#.FPPR*UAX=N+G0K5XM)N;BSEU?A7\`O@C\#EUM
M/@Y\)?AU\+D\1RVDFNKX"\':#X575!IYN3IMO=C1K&T\RQTO[;>_V5IPVZ?I
M?VV\_LZUM1=7`D`/7****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBDR/?\C_`(4`+1110`444WS$W;=Z;LXV
M[ANR>@QG.:`'444$@8R0,G`SW/H/4\&@`HHHH`****`"BB@$'H0>2./4=1]1
MWH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`1FVJS$$A06(4$L<#.`!R2>P')/`KY]/[1WA<$C_A`_C><$C(^"OQ"
M(.#C(/\`8W(]".".17T'28'O^9_QH`^+?C3^T+IUY\)OB);:#X;^-/A_69O"
M.LQZ;K=S\,/'WAJWTJ\>V*07TVOS:;:PZ/';NP=M0EN;=+8#>94XS^0'_"W_
M`(L[O^2H_$;&[I_PF_B?IGT_M3]*_H;^)'@M/B'X"\7>!I-1?24\5Z!J.A/J
M26PO7L5U"!H3=+:23VZ7#0YW"%IH@^-I=0<U^?'_``[6T[.?^%PZCUS_`,B1
M9>N?^ACH`]4_9[_:#M+#X,^`;7Q-H7QG\4:Y%I$XU'7[/X;^/?%UMJ<QU742
ML\/B.#3[R'5E6+RX3<174ZJT30%PT+(OLQ_:/\+@$_\`"!_'#CT^"GQ"S_Z9
MJ[WX2?#R/X5?#KPK\/HM6DUR/PQ82V*ZK+:+I\EZ)+Z[O?-:SCN+I("#=&/:
ML\N0@;=EL#T;`]_S/^-`#(W$T22*)$$L:N%=&CD4.H8!T8!D=0<,K`,K`J0"
M"*_#[]J[XE^*/V=/VV_%WQ%O_BY^T9KWPH^'G[#/QD_;#U3X%:#\2#8>!]>\
M>?"CXJ_"KP/HFA&Q?0;U]&\"ZAH/B+5(O$MBTMUH]H;N\\4WEG//IP!_<6N)
MU7X;?#[7/$DOC#6O!'A/5_%4_@O6?AQ/XAU/P_I=_K$_P_\`$>H6.J^(/!,]
M_=VLUQ-X4UO4M-T^_P!6T"5WTO4;NRM9[NUF>&,J`?B?\2?^"@G[5?P]_:^\
M"?"/QDG[/_@OP#\)?"'[0GCK]IK4K'5O&^M>!?$_ACPO^SEH7QY\"WFB^/+W
MP/-XB\"7?A"S.N6_B^V70-?NY=,;2/&?]D:CIWB'2_"-A<L/^"@_QL^(G[1?
MP`^`^M>&=2^$_B71?VL_V?[?XA/8:+XJ\+Z7\2/@S^T%^RM^W=XV\/>&Y_"_
MQ+T>S\;Z<NB^.OV=H+N\U"_L]"N=<;3-%OH]'\.N-4T%/U1B_9%_9:@\):+X
M"@_9W^"L/@KPYXJD\<Z%X5B^&GA%-`TKQA-IPT:X\266EKI(M8=9NM#`T"\O
MA&9KSP\%T"[:;1E6P%SPC^RK^S3X!N=!O?!/P#^#_A.]\+ZGHNM>';SP_P##
MSPOI-YHNK^&]/\=:5X>U33;JRTV&XM=1T/2_B=\1-,TB]CD%SIVG>-_%-C:2
M0VNMW\4P!XUXT_:>\>V?[1?B/X1^"O!_@23PC\(/#_[/_B3XO^(/B#XSU7P?
MX@UFS_:-\:^-?!GA:R^$MFGA^^T'6=3T`^!=2NGAU[5K3_A.?%5_I?PS\-+I
M_B">358_DG2_^"DGQNUKPGX*US1_@1X+UW4OC]\$O`W[1?P1TCPKXX\0^)-6
M\)_"_P`4?%CX>?#GQ!:_%KPZ/#>E:SKWQ#\(^'OB7HOCK3O`'PL&H^)/B-J^
M@_$#X8>#],;6O"$'B/Q!^IOB;X,?"/QIXU\(_$?Q=\,O`?B;Q_X!)/@GQIKW
MA/0]5\4>%#]H-VO]@:Y>V4VHZ7Y5X3>VXM+B,6M\?MMMY-V3-7%K^RE^S(FE
M>/M"3]GWX,+HWQ3U"UU;XCZ6OPS\'+8>-]4L-5N->T_4?$UJNCB+5KW3O$%Y
M>^(=.N;I7ET_Q!>WNNV36^KWEU>R@'P'\!/VPOV@OC9^VS\)_`L>J_"BW^!6
MJ?LE_'#Q=\2_"VAZ-\1(/%&F?'7X/_M(Z-\&-9MHI_B3X'^'OCKPKJ&CKJ.E
MQ:W\/?&?A?2K[PX=5URTOQK]Q9^&O%&H]+\9/^"B.M?"W]HK1_AWI_@K1/&G
MPNO/V@O`W[+&L^+?#<'CZZN?"GQ:^(G@.W\7:1'XF\5:AX<T7X=6]_H^HZCH
M^FZY\/?#&I^,M;M]"U>S\17OB;1=7,O@N/[RT?\`9X^!'AZ3X:2Z!\'OAMH<
MWP:?Q#)\*)M'\&:!ID_P\;Q=#-#XL/A":QL8)=#'BD3R2^)%L7B77KHK>ZL+
MN\2.X2OJ_P"S9^S[X@\>7?Q1USX)?"K5_B/?7GAW4KSQUJ7@+PQ>>+;K4O"+
MV[^&-3N-?GTU]3EU/0!9V4>DZD]R;^R@L;&VAN!;6=K#"`?E3\._^"I/QC\<
M6O[/OA>Z^#'PVT3XF?M=?!?]D7XU_!)G\>>*[SP#X0T']I;2?B%>:O8?%[5Q
MX4AU*+5/"1^&>HR^&K7PO$T'CK6/%/AWP5]NT"[M[CQ-J/H'PJ_;6^(WPY_8
M2_:(_:8^*6FWGQ;\:?#W]KS]K'X8:)X6\+:A=:W9S)IW[<7C'X`_"_PGHVKZ
M1X8;6;WP7X3CO?#FG/JUMX2O_$4/A+2+BY;2-3UF+[/<_H7>_LN_LX:EX?@\
M*:A\"?A+>>&K;X;>$?@[;:#<>`/#,VE6OPJ\`:M#KW@7X=VMC)IS6]MX-\&:
M[;V^M>%?#\"1Z?X>U>WM]2TF&TO8(ITZ_2?@[\)M!\#:Q\,=%^&?@'2OAOXA
M_P"$C&O>`+#PAH%MX+UE?%]Q=7?BJ/5/"\6GKH=_%XCN;Z\GUR&ZL98M4ENK
MA[U)FFD+`'YNP_\`!0OXFZ/I?PV7QM\'[/PWJ/CO]H*^_9CCO_$UE\1?ANA\
M5:QI?P\\1>`_B_+X&^('AO3?'WACX,26OB?7?!7C:?Q98V>O:'\2?^$`TS29
MM8\.?$'2]?3R3Q/_`,%:/'?@+P<OQ,\0?`K1?$?A'QCXN_:S^%?PST'P%XF\
M6:]X_A^)?[+_`.TW=_L])-\1M$M/!VJ+HG@?QH\VG:O?ZEH$>M:[X+OX[71F
MT?Q+>^+=)MM(_531?V9OV>?#GAAO!6A?!+X6:3X1?0_$?AN7PU8>!?#EOHD^
MA>,+_1-5\6Z5<:;'IXM;BS\4:EX;\/7_`(ACGCD;6;O0M&N-1>XFTNQ>#S_X
M0_L1?LT_!K1/&>D:#\+_``IXCO/B->_%^7Q_XI\<>%_"7B+Q;XVT7XV_%GQE
M\9/&O@WQ7K+>'[1M?\%OXJ\;ZE:6/A[5(+JV;0M/T*QU9M6N-+BOF`/B$_\`
M!0S]H2_UKX>?#72/@-X<TGXC>,)_VJ+0ZM\4!\4_A7X:U&S_`&<OAK\'?B?8
M>*]+\$^)_"*?%/1M&\9VOQ1F\&RZ7XHT>VU71_$&AW>N6%QK_AEK";6':/\`
M\%1?$%['X!^*WB+X167@?]G7QU\*?@[\0]#UN_O/'GBWQ1XJN/C#^SWI_P`<
M;'PQH7B3P)X%UWX6>$OB3I^N:OI7PK\.?"/XR:]\-O$GQ.U74=,\5>%-<@TW
M7_"FC>(OTA\+_LV?L^^"8?#-OX0^"GPL\-1>#+?QE;>%1HG@7PYIK>'X?B):
MZ;9>/ETJ2TT^*2T;QK::-I-MXJD1_.U^#3+"+5)+I+2`1YVC?LJ_LT>'O$O@
MWQEH/P!^#NC>+/A[X?\`#OA7P-XCTOX<>$['6?"7ASP?HMOX;\(Z-X?U&WTJ
M.YTNQ\*^';:+0?#45K(C:!HH.E:0]G8.]NP!^<O@3_@HW^T)X_\`A;+XMTO]
MF#4[76_$,?[/WB/PO=:AH/Q;TG2-+\&?'1?%UWK9L_"'BCP7X7^)?QV\2?!_
M2?"L6KZE9?!#1-0M_B?INMF^\$+9)X8\30VGZ3?LX?&"/X[?!SPE\2F/AQ-1
MU1_$.B^([+PM<^,)]*T?Q=X,\4:UX+\7:`UO\0?!7PZ\=:1JFA>(]`U+2M<\
M/>+_``5X>\1^&]9M;_0=5LFNM.>ZN<2V_9!_96LO"OBCP-9_LY_!&S\'>--6
MT_7O%7AFT^&'@VVT37=;T>:YN-%U;4=.@T>.WFU#0KB\N[C0+L(DV@SW-Q-H
MSV,D\K/[/X.\&>$?A[X:TCP9X#\,>'_!GA'0+9K/1/#/A;1[#0=!TFU>:6Y>
M#3M)TNWM;&TCDN9Y[F400(9KF>:XE+S2R2,`=+1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`444F1[_D?\*`%HHHH`***3()(!!(Z
MC/(SR,^F10`M%%%`!1110`44@(89!!'J"".#@\CT/'UI:`"BBB@`HHHH`**0
MD#&2!DX&3C)]!ZGVI:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@!DCB-'<AF"*SE44N[!5+$(B@EF.,*H&6.`.2*^#&_P""@WP_
M5F7_`(4'^VP=K,N5_8[^.3*=I(RI'AC!4XRI'##!'!!K[VI,#W_,_P"->IEN
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M"(7#>)H-(:Y\+1:B9R1X=NYK`H5$93]>\//$_AS@N.>T_P#5>=:ECLOG5PE+
M&XVAFD/[8PL6L#&U7*Z+PV'KJK4ABZL'4<HPH7I3=.+7Y1Q]X;<0<8RR2I_K
M-"C5P./A2Q53!X.OEDWE.)E!XU_N\RK+$UZ+HTYX6E-02E.M:K'GES?,?PP_
M;,^''PQ^'?@KX>V_P@_;W\51^#O#6D>'F\3^*?V3_P!H37/$?B2XTVSBM[SQ
M!KFJZOH=]J%[JFM7BSZG>2W-S(RS731)MBCC1>[/_!0CX?@$_P#"@OVVN`3Q
M^QS\<R>!G@#PQDGT`Y)X'-?>V![_`)G_`!HP/?\`,_XU^<ULWX:Q%:KB*_#N
M8U*U>K.M6J/B**=2K4GSU)M+)%%.4W*3225WHK73_0:.5<18>C2H4>(,OA1H
MTX4J4%P_)J%.G&,(03EG+=HQBDKMNV[>MXK:=;FW@N%CFB6>&*98[B)X)XUE
MC60)-#(!)#*@;;)$X#QN&1@&4BOQIUK]KCX^>$_VW_C7\"O")T/QL/'_`.TC
M\`_@9\+=+^(.L:CI7@WX50ZW_P`$]_C/^TSXE\1K%X<TJXUO5K?5/$WPF1=1
MT@7,,UXVK2_9=1TS8MQ;_LY7F\GP<^$\OC(?$23X:>!)/'H\2:=XQ'C-_"FB
MMXI'BS1_`VN?#'2O$HUTV9U(:[IOPY\2^(?`ECJOVC[;:^$=<U;P]#,FEZA=
M6TGRCM=V5E?17O9=KZ7];'TZO97=W;5VM=][:V]+GY>_`O\`X*<>+OCGX57X
MN:7\+_!7ASX7^`?!OP\O/C!H&L^.]5_X6OJWC'QS\.-=\?WVG_`S1G\/6FD^
M/-/T>718_#GA"SU-]-USXK:Q-X@LM,C\*7W@^2T\08\7_!27XW6NK?!7P;K'
MPF^$[^+?VBS^R=XH^'FI>&?'GB[7_!?AKP)^UUI_QNB\,V7C34YO#&E75WXL
M\$:U\(DNIKC0UBTCXC>&[_5[S0;3PS<Z#.'_`$VT+]FO]GOPQKG@GQ-X<^!_
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MMX@^$?AG7-9T'QG_`,(1XE&F^/-%\/\`B.WL+;4(_"7C&TLO$&D:@+G1M5&I
M65LFJ:G]92?LT?L\3:/'X?E^!OPDET*+PSXW\&1Z-+\//"DNEIX1^)?BW2_'
MWQ#\,)I\NEO:+H/CCQQHFC^,/%>E"+[%KWB?2M.U[48I]4L;:ZCZK1OA#\*_
M#OPZN/A%H/PX\#Z-\++S1]:\/WGPZTSPMHMCX*O-$\217D/B+2[SPU;646D7
M=EK\>H:@-<AN+64:N;Z]?43<R74[R`'XL_L_?MZ_'_PK\-5\`>)?#7ASXB^+
M_`</[#WPTOOB1XP\<^,;B3QI\<?V\O#OPS\4>']=\3WYT*_F\,?#;P'J7Q"U
MF36G@M9;N^BC\*>!O!>D:''/'=V6Y\0_^"K/Q;^'UK\7[6?X+_#[6->_9G^$
MG[1_Q8^,9M?&OBBS\/>*[']E/XV>"?AYX^TSX3:K-X>N)WNO&?A+QM:ZGX=F
M\2V;VG@[X@:3XA\">)KG6+71Y/$-S^N3?`#X&OHOC+PV_P`'OAD_A_XBZ7X:
MT/Q]H;^!_#DFD^--'\&Z%9>&/".E^*=.?3FM-=L/"_AW3=.T3P]:ZE%<1:-I
M=A966G+;PVL"QY(_9B_9S&A/X7'P)^$/_".2?#O7_A')H7_"N_"@TB7X7>*]
M8C\0^*/AY+IZZ6MK+X,\1Z_%'KFO>'9(FTS6-87^T]1M[F^+3D`^>_"G[87B
M'2O!?[=>K?%GP+IJ^)_V&O$'B8>)M-^&.IZIKMCX\\*V_P"SEX$_:=\,OX<7
MQ#INEZG;>*9_"'CZU\(:KI4]M<V+^)]'GU+3+QM-U.#3]/\`F>^_X*&_'/1?
MB!\*?@=K/PZ^![_%'XT>+_@!9>%?$_A_XB>+]:^%.B>&/VE?@K^U=\2?",6M
MZG-X;TO6-1\8^$=>_9>U/3+G2]-%M:_$7PMXGT#Q-H/_``B,]_/IND_K1I?@
MKP?H>J^,=<T;PMX?TK6?B%JECK?CO5=/T>PM-0\9:QIOAK1_!NG:IXHNX8$G
MUW4+'PGX?T+PS:7>I/<30:#H^F:3&ZV-C;PQ_,7BS]@C]E'Q5I7PY\.)\&?`
M7A7P?\-_C&?CE;^!O!G@OP7X?\%^+_&O_"K_`(B?"-5\>^&X?#DNG>)-'B\)
M_$O6A;V31VEQ:7VF^'GL[ZWL=*&GS@'PC\,/^"JGQ)^*GCOPQX5T#]FSQ'=0
M^'-9^%/@SXR3Z!HWQ&\5:)<>)_B1\7_&?PAU?7?AI\2+;PGIOP^M/AUX//@N
M?QSI/B'XDZAH5]\3-*OYO"_AZPTC7]*6ZU>MXE_X*=?&2S^''B/Q_H'PQ^&F
MJ7^BW?[8_B"P^'NCWGQ2\8>.M3^&?[%GQN\<_!3QEXPU>'0_#5EX4\#Z#XVU
M_P`+6L>G>*O%'B^VM_"LUW;1Q>&?'MWJ-[IOA?\`5%_V;OV?)-;^'?B1_@A\
M)GU_X1Z3I>@_"W63\//"?]I_#O1-#D,VAZ1X+O!I(F\-:;HDY:XT:QTAK6UT
MBY>2YTV*TN)))7JZQ^S#^SCX@LO#FFZ[\!_@_K.G^#]<\:^)?"MEJGPX\(ZA
M:^'=?^)&MZAXF^(.KZ-!=Z3-'I]_XX\1ZKJ'B#Q=<6RQMXBURZEU?5A=ZAMN
M%`/QG\!_\%!OCOXT^)>N^*O&,T%Y\%_$'[<'[)'@WX&^$_A^=1\->-M`^%_Q
MG_X)X:=^UEJN@^.I(++58?B:TA\0647_``CJ-:RZQXYNM1AL]:TSPYH_AO1E
M]:A_X*;_`!G@M?@;:7_P?^%UQK_[3=A^QQX_^%:Z'X_\6:GH'ACX;_M>^/=6
M^'^FZ;\2M8E\*V<T7C;P3<PZ3KUO=:!8R:'\0K&/QGI^D66A3^$!?ZS^H%M^
MS+^SM9^)=`\96GP-^$UKXK\+6?@K3_#?B*V\`>&8-8T*S^&VGWVD_#V#2K^+
M34N+)?`VDZIJ>E>$6A=9/#NF:A>Z=I+VEE=30.S0?V8/V</"PF7PU\!O@]H"
MW'CC0/B9,-%^''A'2Q)\0O"MY>:CX8\;,+'28!_PD_AW4-1U"^T+61B\T>\O
M[ZYTZ2VFO;IY0#\UK+_@I;\5EMM'USQ-\+?AWX1\"^`O$7Q+\$?'WXE76N?$
M[Q3X'TGQC\(?VH?B+^S;XXCM[CP!X"\6>)_@[X,;3_AU<_%3PM\2OC7X3M_`
M&NP:K-\/[KQ'H][X1\6^,--_9T'(_$CCV)'?Z?\`USUKP/4_V5/V9M:U;1]>
MUC]G[X,:IK7A_P`1>(_%VB:MJ'PT\'7FHZ7XG\7^+-0\>^*=>L[RYT>6XAU3
MQ%XYU74?&FLW8D,FH^+KR?Q+<[]:D-]7OO\`G\^M`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`445Q3_$CP!'X_B^%+^,_#*?$N
M?PK+XYA\!-K6GKXNE\&PZFFBR^*8_#YG_M-]!CU:1-.?5%MC:+=MY)EW`@5&
M$YWY(2GRQ<Y<L7+EA'XI.R=HKK)Z+JR)U(4^7GG&'/.-./-)1YIS=HPC=J\I
M/115V^B.UHHHJ2PHHI-R\_,/E^]R/EXSSZ<<\]N:`%HHI"0,9(&3@9.,GT'J
M?:@!:***`"BBB@`HHHH`**3(SC(SG&,C.<9QCUQS].>E+0`444F1@G(P,Y.1
M@8ZY/;'?/2@!:*.O2B@`HH)`!).`.23T`]330Z,,JZD9`R&!&3T'!ZGL.]`#
MJ***`"BBDR,D9&1C(SR,],CMGM0`M%%%`!1110`4444`%%%%`!1110`4444`
M,D<1QO(5=@B,Y6-2[L%4L51%!9G(&%4#+,0HY(K\Y6_X*5^`59E/[,7_``4!
M.UF7*_L/?'AE.UBN58>'2&4XRK#AE((X(K]':3`]_P`S_C79A:N#I<_UO"5,
M5S<O)[/%?5N2W-S7_<5N?FO&WP\O*]^;3BQE''5?9_4L;2P?+S^T]I@_K7M+
M\O);_:*')R6E?XN;F^SRZ_B?^UM_P6/T'X$_`CQE\0/"'[,7[5Z>,818Z%X0
MN/C7^S9\5/A!\+;/Q-K\S66DWOC+QMXITO3[*#2[28-<+H=A<+K?B:ZC@T+2
MGM);V34;'^)JZ_:S_:*O/VC#^UG/\6/%'_#0O_"4+XMC^),<\<>HV^H1H;6+
M2[?3MITJ'P=#I1/AV/P,+4^&/^$89_#\FGR6,DH?_3H\>>`O!OQ0\&^)?A[\
M0O#>D>,/!/C'1[W0/$_AC7[./4='UK2-0B:&[L;^SG!26*1#N5E*303+'<6T
ML-S#%,G\N=U_P;1Z?)^TX-6M?C99V_[(C^(1K4G@\QZX_P`<(-#*-=OX`MO$
MC6S>'7L_M@72(/'<]R?$4.@.;F32KCQ)"-3F_5>!.)>$,JPV:4\=@_J&(JTY
M.5;$2EF'UW"<D8RP,&L/!0<I)R=!P5/$<R=2I)TX1C^+^)'"?'.<XK)ZN78_
M^TL-0K04*&&4<L_L_&\]X9C44L3/VG+%I+$1J.KAN1JG37M9RG]]_L=?\%D]
M)^._P%\*>.?'/[,_[5%SXXBEOO#?C*^^!G[-WQ3^+WPLU'Q+H)A@U+4/"7B[
MPKIFHVD5I>F6*YN?#6HW+ZUX5O)9]%OY;V.VM=4O_J`_\%+?``!/_#,/_!0,
MX!.!^P[\>23@9P!_PCO)]`.2>!7W7\._AUX'^$W@?PO\-OAMX8T?P7X$\%Z/
M::!X7\+:!:+8Z3HVDV*;(+6TMT))))>:YN9WEN[Z[EN+V]GN+RXGGD[/`]_S
M/^-?GN+QV0U<5B*F'R3$4</.M4G1I?VFU[.E*=X0L\)4:M&RY?:3Y=N>5FY?
MJ&!R[B2C@\+2Q>?X;$8FGAZ,,16_LA/VE:,(JI.\<;24N:2;YO9T^:[ER0YG
M%0VMPMW;6]TL<\*W$$,ZQ7,+V]Q&LT:RB.>"4"2&9`X66&0!XI`T;@,I%?A!
M^U+^TG^T!\#/$O\`P4?\8#XIZ[#\)'U31/@C\+9IDT]8OV<?CG'^R?\``;XC
M_#/5-$U-;2-K'PG\>/%'Q(\4^$]6EUU]6AT?XM:=\.+?3A:6_P`0=02#]YJ\
M\\1_"3X6>,-%\<^&_%GPW\"^)_#WQ.OK'4_B/H?B#PIH>L:1X]U'3-,T#1=.
MO_&.FZA8W%GXDO+#2/"OAG3+*ZU>&[GM;#P]HEK`\<.EV2P^`?2K;75]7M<_
M%GXR?\%+OVD=8^$'[9'B#X.?"#4?`<W@#X3_`+>%[\'?B+XP^'WC9]/\*>,/
MV.KCQKH"Z_XIN_%5CI'@;QW)X^U+P1XDO/#OA/P8-:G\!ZM:>&],^(%IXDTS
M5]7DTO[4^*WQM^(G@7X<?L`7_C2ZBU+QS\9OVB?V?/AUX^OOA]KFK>#?#5SJ
M'CCX>^.]=UNZ2PN(-6O=9\*RWNBQNWA34KBVCO6>VFEOX#8Q12?7EA\!?@AI
M?C'Q?\0]-^$'PQL/'GQ`L+S2_'7C*T\!^%K?Q1XQTW48X(=1L/$VNQZ4NI:W
M9ZE#:VD6I6VHW-Q#J4=I:)?I<K:VXBGTGX'_``;T+POX"\$Z/\+/A]IO@_X6
M:W8>)?AIX7LO".AV^@?#_P`0:4=4_LO6_!FE1V0LO#.J:8-;UA-/OM'AL[BR
MCU._BM9(H[J56`/QV^&O_!5SXP>,?#?[.\>L_![X<:3XR_;%^#/P#^)GP--I
MXM\6WGA3P5>_%OXJZ!\)-9MOC%?2Z/'>'3M(N_$>E>)?#C>%V@N/$6J:A8_#
M&>XL-4OK+QI=>X>*_P#@H#\6O"FH^*%N/AY\(M6TSX`^'O@/K?[0,GACXB>(
M_$5UXS?XY_'+Q[\#[.R_9V>W\,VMIK6H>&KKX?:IJ5YI/BU_MNH>/KEO@ANT
MO7]'U/QD/ON;]F7]G2XT#3_"L_P(^#\WAG2?A\GPGTOP_+\./",FC:9\,(M8
MTGQ##\/=/TU]):TLO!<.OZ#HFMP>&[:*/28-7T?2M3AM8[[3[2>&R?V<OV?S
MJ/P[U?\`X4C\)?[4^$5I;6'PLU#_`(5UX1^V_#BQL[I+VSL_`]R-($WA>UL[
MV..]M(-&>SBM;Z-+ZW6*\43@`_(R[_X*G?'F/P+XJ\>67P:^$<^G:-^S5^V3
M^U)IUM=^._&5E/-X/_8%^/Y^#WQF\*:@\7AO4(H?$'Q,TO5?#NN?"_5[5Y=,
M\-7JZU:^,K#5;=-/,_TE^SO^W_XY^/?Q[D\'6?P+\6Z)\(M9\?\`QR^&V@^+
M]4\+^,]%NM#O_@9=ZSIL_BGQ)XIU^PL/`&O67CW5O#6N:=IG@WP/=:GXI\'*
M_AW4=>GU:RUC5I/#'W(O[.WP#32)=`3X*_"I=#G\%_$;X<3:.O@'PN-,E^'_
M`,8-;M_$GQ7\$26(TP6S^$_B5XAM+77/'GA]HSI7BS5K>#4-<M;VZB25='1?
M@=\&/#?C_4_BKX?^$_PXT3XFZUIT.D:O\0M)\$^&]/\`&NIZ7;VEEI\5A?\`
MB>UTV+6KJU6PTS2[$Q37K+)9Z7IEI+YEOIUE';@'Y_?'_P#;_P#%_P`)?V@-
M*^'GASP=X>\8_#P?M"_L_?LK^+?$>E:=XYO+KP3\5/VD?^$,M/"4_BOQ/?6W
MAGP-977AR\^(_@C6-4^'/AB?QUKNK^#=9M=6O?%?@75K^TT5/S6^&G_!2/\`
MX*`>#OA!\%?CO\7=:^#'Q'\-VW_!-3]MG]K;XI>#]+\&:IX1U3QOXW^`?QI^
M%7A'PK:Z?K5I,MMX;U&VT?QM;Z4UK9VD&@2VU[X@N]6TBYU2'P]J&G_T.ZS^
MSY\"?$7CS_A:.O\`P:^%NM?$GS?#$_\`PGVJ^`O"]_XR\_P5JNGZ[X/N/^$E
MN=+DUC[3X6UG2=*U3P[=?;/M&C7VFV,^GRP-:6_E\MK7[(O[+'B/3[C2-?\`
MV<_@CK6E77BCQCXUN-,U3X7^#;[3YO%OQ$TV'2/'_B&2SN-'>W.K>.--MX;+
MQA=^6)/$T$4:ZT;XQHP`/R8\3?M1?M4W/[>/@KX$>%]9\->'_%Q^.VM^!?%7
MA[6_'/BC4_@QKDFJ_P#!.>_^.GAVQM=)_L*'Q-:Z5X0\016]_<Z;HESI]YXT
M\1VU_P"+9YO#EMG2+;N?!/\`P5:\9>.-'L-63X2^&?#9UOQ[_P`$V/`>D6VI
M>)=8U"*[N_VV?C3XF^#/CO4M'U$6.D)XIT#P1J/A'6M?^'NMZ?9:<GCCPW';
M:IJ5EHQFGMK/]4?%G[.GP!\>3^);OQM\%/A3XNN_&5Q:W?BVZ\2>`/"VMW/B
M6[L="L?"]E=:[<:CI=S-J=S9^&],T[0+6YNWEGM]&L;33(9$L[>.%;%_^S]\
M"M5UKPCXDU+X-?"V_P#$'@#1_#GA[P-K=WX`\*S:KX.T'P?KFG^)O"6B^%K]
MM*^TZ!I7A?Q%I6G:YX<T[2I+6ST/5;*WOM+AM+B,.0#\,?A__P`%/?VH_`_[
M&FC?%+XFV7PQ^-7QH\+_``__`&L_V@/BAX>\%>$_'FE:O'\'/@)\:?B#X%TR
M.6PTFSLO!/@*QO;?P5K>B0_$/Q1XF>:.YT>SAM?AEXUO;?Q7KEIE7W[?_P"T
M?HW[//[5'C>+6=-UWPMXN_:"_P""B?P<^#_BM/$5XOQF^$FJ>#/V??B_^T+\
M%]6A\/V^A77AD^#_``'H/P]?1-2TNZU!]7T2VNM*\<OJM_I$-YHS_MUJ?[(W
M[+.M:E>ZQK'[.7P.U75-2\0>*?%5_J&I?"OP1?7=YXE\<V4&G^-==N)[G1)7
MEU7Q=:6UM'XFO7)FUU[>&XU-KJZB2==#_AEW]FS^T+_51\`?@S_:>J>%?$/@
M;4]0_P"%9^#3>:AX,\6VUQ9>*?"M[=?V-Y]SX?\`$=G=W5GKNE2R-::M9W$M
MI?Q3VSM$0#\]?V7_`-OSXJ?$_P"*'@?X8WGP@\8ZQX)M?$FD?`SQ/\2;WPGX
MSL[U_'>A?`#0_B=XA^*6H^,+^PL?AE<^&M;\27,_AG3_``-I.H77CRYTV]T_
MXD(SZ-<7WA[2I/CS^V)^T3\!?VN?VFM*NQ\._%'P$^'W[*_['?BSX:>!+NTU
M+PUKL?Q@_:4_:7^)O[/UOXC\9?$-(=3&F^!-.U?1++4_B'>0Z1K$'AOP1HFE
MZAH&CQZW)XFN=4_2+2O@%\#M"\=VGQ1T3X/?##2/B3I^A67ABQ\?:;X$\,67
MC&S\.Z;I$7A_3]$M?$EMID>KP:99:#!!H=K:17:10:-!#I,873HH[9;WB_X+
M?"#X@:]!XI\<_"_X?^,/$EMX3\2^`HM=\3^#]`UW51X&\90FW\6^#'OM3L+F
MXF\*>)8"8]=\.SO+H^J*3]LLY2S$@'PMXU_::^*FI_L@?\%%-1U%=!\%_&O]
MDGPI^T!X*;QO\-K_`%34_!NH^+_#7[-&C_&OPAXX\&/XAL3J&G76E6?C[P[9
MZ_X9U.;6YO#7C30=:TIM6UBSCM;J;\[OA9^T5\>_A%J/P:\/?%'7/V@--7XO
MVG_!.G5O#W@/XM_''P[\2?%'B?4_BK^U?\+/A1\6_BUH?Q(\%1Z[/X<\"6EK
M\2/"OAOQ+\$_%=S#;^/?[<M[CPW#X9L]+\67-[^_^A?!WX3>&/AY>_"3PY\-
M/`6A?"W4=,US1M1^'6D>$M!T[P3J&D^)H[J'Q)IU]X8M+&'1[VT\0QWU\NN0
MW5I*NKB\NO[0^TFXE+^=^!?V0/V5?AEISZ3\//V<O@CX+TV37/!/B5[+PU\,
M?!^D0/K_`,--:B\2?#G6&%GI$3&_\`^(8(M<\%W&[=X7U=1J6B?8;PM,0#\T
M;K_@J7\3M/\`A[X/^(E[\*/AT=(^/WPGTKXS?!B/3?&'C#5]1^&/@^\_:'^#
M/P&U9/V@]%TWPM<ZW>ZYX>L/C=H7CJ70/A=87>OZUKWA+X@?"71]'N-1\/P>
M-[_)7_@I?^TEX;B\-Z'KO[.^K^+O&R_#;Q/^T%XJLO#?P[^*5CI6N?"^^^/?
MQ)^%7PM\/^"+BYL))/`LWC#P3\.+CXGVWC_X[2>&+*RTSQ'X.TOQ1X4T"Y\0
M7]WX8_0;XP_L'_LY_%KPIXK\-P>!?#WPUN_''CCPS\1_&/B+X<^"_AU87OC?
MQ9X1UJ]\1Z-/\2M"\1>#/$O@GXKZ-_PD&H7>N7_A?XF>%_%6@7NN3#Q$;&'Q
M+;6>M6TWPS_84_9P^'_@WPIX1UGX=^$?BF_@OQAXG\>^&=<^)/@+X;:C<>%_
M%/C#4+'5==NO`WA[P_X+\.>!_AMI<]_I>F7</ASX>>%O#.A17VGV^KRV-SKQ
MN-7N`#YR^%'[?/Q$\:_M`^%OAWXC^&_@O3?AWX^_:R_;%_9#\*:OH_B77;GQ
MG!XN_9;TCQ_XWL_&FM:?>:8-"7P[XM\)_#CQ%I%WH]I>#5-)\1+INI07MYI>
MH7&F:7Y;XN_:\^//@7]NWXN_`_PE)HWC*T^(?QN_91^!_P`-='\?:IJ-CX-^
M%TOCG]C']J_X^^*O%T,'A^S;6-3&H:Y\#M)34]$6Y@?5$NFBM=3T>79?0?JU
MI_P;^$FE:GI>M:9\,?`.GZQHGCCQC\3-'U2R\(Z%:ZAI7Q%^(=AK&E^//'>G
M7D-BEQ9^+_&FF^(=>L/%7B.WDCU;7[/6M5MM3NKF&_NDD=<?!WX3WGC!/B%=
M?#/P%<^/(]>T3Q2GC.?PEH<OBE/$OAKPGXF\!^'O$"Z\]DVIC6M"\$>-/%_A
M#2-3%R+S3O#/BCQ!H=I-%INL7]O.`?FU^R[_`,%$/B'^U'J'A;5M!\`?"KP/
MX/T%?@[X;^,%EXZ^).J:+XIOO'?Q;U'Q?H<G_"FIKK0+?2/$GAOP]J_A)[7P
M['KT-MKGQ0U.;7O#.E1>%]<\(2#Q!^L%A?V6J65KJ.G7=K?V-[#'<6MY8W,-
MY:7,$@W)-;75N\D%Q"XY26)V1QRK$5Y%H_[-_P"S[X>USP;XGT'X'_"71O$?
MP[L]3T[P%KVE?#OPG8:QX+L-:U+6-9U:S\+:G;:3'>Z%;:CJWB+Q#J=W#IL]
MNDNH:_KEV0)]7U%[GO?`O@/P1\+_``?X<^'OPW\(>&?`/@/P?I%IH'A/P7X-
MT/3?#7A7PSH>GQ^58Z/H&@:/;6>EZ1I=G%^[M;"PM8+6W3Y(HE7B@#K****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#__
!V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>biib-2015630_investeechart.jpg
<TEXT>
begin 644 biib-2015630_investeechart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`#P`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^3?VU_VF)?V2?@)?_&6
M#1/"&N31?$GX%_#>*/X@^/F^%_@/1Y/C9\;/`'P<3Q;XU\>KX;\6OX:\*>##
MXY'BK7[Y/#VHN=,TBY@58#,+F'ZRKP;]HWX#:/\`M&>`=#\`:YKE_H%AHOQB
M^`'Q?^U:?8Z=J,E]>_`/XW^`?C9IF@75KJB2VC:5XEU'P%:Z!K$NQKFWTO4;
MNXLL7D<!`!X9X+_;K^%,&C>%(_BY\0?@Y'XF\5-HNH1ZI^SQXL\??M"?!?1/
M"OC'QU>_#3P!XF\7_&G3/A;X9\+^!=+\7>/=*UCP;INH^.$\.:)=>)M'UC2]
M.U?4#HNM3Z=VNI_MI_!EO@'\;OVB?!#>-/B1X&^!.A?$K4_$X\*_#_QLE]K&
ML?"F3Q1I_C3PGX3&L>'].A\2Z]X?\0>$-:\-^($T9[^T\-:O:SP:_<:?]FN?
M*XGXU?L*^%OB[X[\8>(K;Q]XD\#^#OC)X.^&7P]_:%^'.@:%X4NM(^*O@SX0
M>+O%'B[P9I=IK&HZ=)K/@&ZO/^$V\6>%/&6I>'9)IO$'@[5UM+&+0/$>G:?X
MIM^^^&'[)?@_X?\`[,WBW]E[5/$.O^+?!WCFX_:)_P"$DUF>.PT/7)]/_:/^
M)'Q/^(7BJQLCID3VEB=(;XHZKHNB7:123+;:?8WMTLMVT^X`^</@W_P5(^$'
MQ-\=3^&?$_A7QC\*M`U'X<?L:>./"?B+Q=X;\;-/+JG[9=UX\T7P3X7^(=C;
M>"ETSX3&/QAX3T;P7X<\0^,]>L]$\>^(?%^CVV@SQQSV,FH?7_PH_:@^"7QM
MU[4/#GPW\77.MZE::9=Z_ITE[X3\9^&M*\8^%K#65\.7_C+X;Z]XI\/:+HGQ
M.\%6.OO#H]WXO^'^H>(_#EO>WNE"34E@UO1+C4?B/0?^"7.C6O@/X@>#/%/Q
MP\6^*;CQ_P"'_P!A3PG?:T/!GA'03;>'?V"OBS<_$?X=VPTK3I)+&>\\9Z2=
M/\(>.KQ6M8GAM)];\/V6CW=[]BMO6_V0/^">_P`*OV.?$6J:O\/O^$::RM_"
M+_#KP6FG_"#X3^#_`!9I7@)]:L-;72O&GQ,\,>&K7QY\3M6@?1M!TQ=:U_5[
M&&^T_1+"^U[1]9\5B?Q/*`>"_'__`(*'_'K]GCQA^V):^*?V??@UK'@']D7X
M#>"OVB]6U_2/V@_&\'B?Q?X#^*GB?XU^%O`&G0>'-1_9Y@T70O$EK<_!;4K_
M`,=)/XLU#2-$L=<LCH&I^)Y[.ZB/UXO[=W[,'_"1:=X/G\?:O8^,=4\=>*OA
MO:^#M4^&_P`3](\71^+O!?A;P9X]\0V&I^&M4\'6FLZ)8V?PY^(/A'XFKK^L
MV5AX>G^&>K?\+`AU5O"EAJFJ67#?M"?L&>%OV@KK]K.ZU;XA^*/#;_M8?LZ?
M!K]G?75TG2M#NQX.TCX.>+_C/XOT[Q-H)U"-C?ZOK5Q\9=1L]0M-4+Z?;6^A
MZ=)9JLUS>%L+Q)_P3F^'7C']I/QI^T+XF\:^*=4A\>^)/B/K?B+X>&RTJUT&
MZT[XF_LF_"7]DO7O#Z:S:^7K\%FGA7X4V_B6WO(9X[X:WK^HVWF"QM;+:`>L
MZ=^W3^S/JGAB]\667C?7'T^+_A7\FB6$WPQ^*EGXG\?V7Q8O]3TSX7:Q\*/!
MM[X*M_%GQ9\/_$:^T36HO!/B'X<Z-XET3Q%'HVK7=C?O9:;>W,/KUC\=?AAJ
MGPJN?C3INO7M_P##^R@U>2\OK3PMXPN?$%I>:!K=WX:UWP_=>!(-`D\>V_C#
M1?$UA?>&=6\$R^&%\7:?XEL[KP_=:+%JT$MHOYJZ1_P1L^`.E_#(_#YV\$75
MQX<USX5ZQ\/-;7]G;X%:;#;GX.67BS2?"Y^+FA:5X6M+3X[7GB'0_&WB#1_'
MLWC&[L--U-;F/7?!^B^`O%J3>(;GZYN/V,?"@_9$U/\`9+T#Q9J7@#1-5LKY
MKCQ1\+_"G@7X:>7J^J>.?^%B:RD'@?P5H.B^"D\'^(];>YT+Q=X,;3GA\8>!
M-3UOPWXGU?5;W7=6U^\`()_^"A'[*UH+"UN_&WBV#Q'J.M>/O#47@$_!OXSS
M?$^V\2_#'P7X3^)/C?P[J7PPMO`$_CW2];T3X=^./"_CS^SK[P_!/J/@[58?
M$>E"]TJ.>YBX3XF?\%(_@?X:U#X2Z5\,+F3XRW/Q0^.G[,?P<;6/#EEXPM?`
M.A0?M-2^&=6\-:L?B?%X,U3X>W_BFS^'?BS0_B7;?#9_$>G^*-4\)ZKI&H2K
MIEKJ^GW,_GGP?_X)8_#WX1?%RV^,.D>/KJVU>7Q?\4?'>L>%?"'PT^''PU^'
MTOB/XL?LY?"3]G7Q`/#_`(1\$Z;I^G^&=)MM*^$6D^++2TMS?ZC>^)-6U>XU
M[6=8EG^V/D?#3_@E)X:^%G@_X-?#+PW\>?B(OPQ^%/Q%_98^-VH>$I_#'@9I
M?&_QK_9B\+_"WP5;^+=3U\6!U72/#_Q$T+X2^&M2\4^"])=;6P\8/>Z]H.K6
MFG3R>')`#V?X_P#[<%U\&_CQI?P*TSP5\/;G6;[X=^%OB)IEQ\6OCKH/P(G^
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M_@FYX7M-<U_Q#I?Q@^(6FZDG[1>K_M5?#26.WTJY_P"%<?&F[\#_``Q^%VE^
M(S+=O+=>-K?3?A;X#\4?#F]L/%-Q*GB3PM\9?BFFNRW.KZGH6K:$`>P_'[]K
M=?@/^T1^RA\%]2\!/K7A/]I*^^(VCZ]\2T\1_P!GI\+-7\/7OPU\,_#I+WPS
M_8=\_B33OB7\1OB?X:^'BW\>LZ-_PCFNZWX>D>#5H=6=+/R'X9_\%*?ASXP^
M(G[2GA'Q9X3UOPEH7P<^-W@[X,?"?5O#EKXK^*_BS]HFZ\4_##4OB&^L^"/A
MK\/O!>K>*5^S#PG\09;73=*B\3"X\$>$+CXA7]]I.CW,MO9>X?M,_LC>&_VF
M6DEUOQIXK\&7D/P,^,WP>T'5_"*:;#KOA+6OBAXO^!_Q`\,?%CPQJ=_!<MIO
MC_X0^.?@-X-\6^`YW@N-.&N1+<ZK;74=K#"_@5E_P36\/^$?&MU\3/AA\8O&
M/@GQ_H_BGX/>*/AMJUQX8\(^*=-\&'X7?LS7W[*NJ:)J.B:K!#'XNT;Q[\.M
M5U#4M<6[O=)U+3O%\>EZSI&I0PV,]E?@'M>F_P#!0#]DS6M5TG2-"^*;:_<:
MQ;?!6\M[S0_`_P`1=6T&TM?VB[J]TOX'RZYXFL?"4WA[PT?B=XDL+GP5X3A\
M1ZEI5Q?^/E3P,\,/BJ1=*KX_^%'_``66^"'Q&U;0=0\0_#OXH_"CX8:G\%/C
MQ\8]8\9^/O!/CV+7O"6G?`7]H73/@5XJN_$?@G1/`VIWFF_#^SM[^3QMXE^*
M5YJ-MX5\"V5E?:'XHEL]5TO6O[-]#\-?\$M?ASX.\.>//#'A[XH^/8['QSJO
M[$&N75YJ6G>&+[5(]<_8P^/<W[1$>MW4\%CI]E?ZC\8_'E_K%QXZ$>GZ?I^C
MQ:M<)X1T_3((+.U@Y?3_`/@D[X2T_2_CMX8C^-GC8^$OBQ^S1^US^RWX4TD>
M%O"BWWPW\!?M=_$N_P#BWXIOTUD%I?&>N^#O&&N:\GA6YUJSL8;C0+RRTW7H
MM2OK&75[\`^Z_`W[4OP4^)7Q#UWX9>"/$FM>(/$'AW5_&'AS4-5M/`/Q"3X?
MS>*/A[J*Z3X]\*:1\5+GPK!\--=\5>#-2<6'B7PYHWBR]U?2[R*^MI;0S:5J
MR6#-3_:J^!FD?$N]^$U[XNO5\7Z9K"^&-2DM_!WCB]\):?XUF\&#XB6?P[O?
MB'9^&Y_`%M\2]0\#%/%6G?#J7Q*OC.^T2YL+NWT5_P"U-,2\\0\`_L+Z=X'_
M`&C;'X_Q?%'6Y)=)3Q$T>A^'O`WP_P#A]JOC,>)O"_\`PBSZ#\:?&G@72=$U
M'XU>#?"=M]GU/X?:1XXTNY\0^'->T?PYJ^H^,?$=UH<#S<Y<_P#!-KX0#]I7
MQ?\`M&:9_P`(W::KX[\93_%'Q!!J7PB^%GB7QI!\3)?AY8?#?^U/#/Q?\0:!
M??$'PGX5?3=(TCQ#+X5T.]MKR+Q=:7-[I/BC1]"U?5O#EX`>C>'?^"A?[)7B
MSPA)XW\._$V^U/1)O#/P=\8^'88_AU\3X-?\?^&OV@-2GT/X-:O\+?"MUX-@
M\2_%*U^(7B&SU'PWX?;X?Z5XC,GB'2]4TB[%I=:==+'YI\*?^"F?P*\;V7CN
M[\:_VM\/6\(?&?X]_#B*%/#7Q&\6O:>!/@7\0_\`A7&I?&3XFC2OA_#+\$O!
M5[X@+:?JM_\`%"+P_HWAG5;35M.O->N4T+7+O3>)T_\`X):^$M%L_@3<:)\9
M/&]AXM_9P_9D_99^`'PK\4OX=\)WCZ;KO[*.OZYK/A#XF:KH]Q"=/U6Z\6V'
MB77_``GXW\(;K31KGPSK5_%H5_H>LIINM:=PTW_!''X0W_BW6O'GB'QM!XZ\
M9>.O%WQ)UWXD^(/B;\$O@E\2IM:TKXF_$G5OBMJ6G>$M,\:>%=8T#X?:OX?\
M4>)O%UAX;\0:5I&HP_\`"*>(6T3Q)H'B2ZT7P_K&F@'U-KG[>7PO'[1'P+_9
M[\"6FI>.=4^+'QL^+'P2\1>+(M)\9:%X0\'^(?A!\$_BQ\5O%\/A_P`7:EX-
M_P"$%^)VL^'M=^&<?P]\8^'?"7BZ2]\&ZYK<ZZS*FHZ!J>C+K?';]MCX>_LX
M_&;2OA_\5K?_`(1SX?/^S7\6OVBO$WQ3,VJZHOAJR^&/Q:^`7PHA\/'P=H>@
M:IJVK'7[[XZ6E^-4LKGS-,_L3[,VEW<>HO>:?R'A?]@S3_"?Q<^%7CC3?C!X
MR_X5U\#_`(\?&[]H3X7?!QO#O@V/1-#\8_M%>$OC9HGQ1T[4?%<&G1>*M<\/
M'Q!\=O&OBGP78W4\-QX6:]DT&XN]>TF+2!HC_CI^P/X8_:5\4?&#Q!\8_B+X
MFU>V\>?`[Q?^S[\/]*\.Z'X:\-)\*?`OCSQ5\/?B#XGO[:_^S:I>>-O%=QX]
M^%/P_P!<L=0\3E=%L++P\NC+X=GBU36KS4`#N/%O[?'[+'@GQ9XB\":W\0]6
MF\9^%_%OQ#\#:MX5\._#7XH^,?$'_"4?"CX>?##XL_$/3=,TCPCX-UR_US_A
M%?AQ\8O`'B_4KO1K>^L1I&JWTD%S+-X?U^'3>J\-?MC?LZ>,?&.@>"?"WQ$C
MU^^\43>';'0O$.D^&O&%Y\.=0U[Q?X`L?BKX4\(1?%6+P^?AJOCGQ)\-M3T[
MQQHO@>7Q4GBN_P##6HZ;J<6D>7J5@MS\S^"_^";FD>'?B]<_&_Q!\:_&WB[Q
MUK?B?]H3QIXKFN/#7A+1=+UCQ%^T3\!?V=/@3XC:RT[2H5&BZ1X<TS]G70];
M\,Z9!-=RI<Z[?V6K:AJ:V=O?3<?^SC_P23^"O[-WC3X8>+?#FJ:-XEG^'VE?
M#*\O=4\5_!GX0:O\1->^(/PU^#/A+X*V_BBQ^*NH>'+_`,8^"]!U[2O!FD>+
MM3\&^%KBT:P\:MJ$_A[Q-I'AG4]0\,W0![S^UM^U_P")?V7KS2[YOAIX.\4^
M%;R+P['IEKJGQN\.^#OBU\6_$NM^(CH=W\-/V;?A&WAOQ#JOQ:^)ND6MUHNJ
MGP]K&L>`K#7)]?T30M!U>\O+K4;S1LO3?VX9KSXB:7#=_#6ST_X#>)/VGO%W
M['?AKXL/X^@F\4W?QO\`!,WBCP[J<FH_#2/PP+73_AWJGQ-\%^*/A3H>OQ^/
M+WQ7+XKL--U&^\#V?A36X]:T_L/VE?V2]9_:/M_%/A'5?CCXQ\.?"+XE>$X_
M!'Q'^&UOX1^'WB`-H;0WUIJE_P###QAKVAS>)/A7XN\06%\MGJGB>PE\03Z=
M+I>C:]X,L_"7BRP_X2"?,T_]B/P_9?%.Q\42?$/Q1>_";1?CIXA_:B\/_`VX
MTGPU_P`(_I7Q_P#%4.N/K/BD^+EL?^$LO?"O_"2>*/$OQ+T_P3<3E++XH:U-
MXA?7KK1++2?"VG@'TG\5O%GQ`\+>&K*X^%_PV/Q0\8:UK^BZ#INCWGBFQ\$^
M&=&MM2ED?4O%GC7Q1<V.MZAI7A7P]IMM<W5\/#GA;Q;XGU*]?3='T7P[>7.H
MF>S^(_#7[=_C_P"(EYHGPX^&?P$T3Q!\>V\1_M.Z3XJ\(ZU\9;7P]\,;+1_V
M3?'7@SX;_$/Q%X0^*<'@'6M5\8V7B;QQ\1O!/A#P,DWPY\/F'Q#<>,-.\=R>
M$;OX>Z_:R^S_`!+^`OQ^^)G[-6@_!_\`X:F\0>`OBE*-!B^('QK\'?#_`,+V
M^L^+=*M;BZG\2^';'1K"[\.6_@VV\56DMMH5]XA\%:AX=\4Z7I<-W<>%M5\/
M:S>Q:I8>=Z+^Q-XM\.>&?A+)X3^.%A\-?BE\&?#WQ`^&W@WQM\*/@7\.O"/A
M*T^#/Q(O/!NIZY\.#\)=8N_%WAI5T[7/`'A+Q5X<\2)J0O\`3O%&B07>H6FL
M:-J?B70->`*/A#_@H5HGQ%^*7[%W@WP/\(O&-UX`_;&^'_B[QUHGQ9\0ZQX>
MT32?#-UX<^%,7Q1B\%V?AZSN-;UCQ=XDM(/MFA^-KRV.C^&/"&KVL5A;:[XE
MU*YEL;"_\!/VT]2^,WQV\5_"^^M_@+X:T;2_$?QE\/>&]+L_C'XTUGXS:[)\
M(OB#K?@.\FG\$7_P8\/_``_%X5T"X\0^*M`\,_%GQ7KW@33-1TA-<L"UQ-+!
MQFL_\$]_%>F>/_V3==^#_P"T(WPT^'W[&OABY\)_";X>7_P<\+>.Y[O3M>\`
M6_PW\93^,/&FI>)M&U;6M1\0Z##+>)>VNGZ8]CK]W<ZG,-3C<68^A],_9J\4
MS_%GP?X^\??'?QO\1?"OPK\:>,_B%\)?`>K>&/`6C-X8\5^./"WC7P/=W/B'
MQ?X=T/3];\:6'A?P=\1/&/AGP5875OI#6NGZM'?>,+OQOXBTW3M<MP#KO%/[
M4GP7\%?$O2?A/XJ\0:_H?BG7/$>B>#-+U"_^'OQ%A\!77C?Q-I]IJGAGP.OQ
M2;PI_P`*U7QGXDL[ZV_L/PPWBL:MJ-Y<V>E0VW]K:AI]A=>2>&O^"C7[('C#
MPK!XQ\-?%*^U;2-3\-?"[Q?X3@@^&WQ4CUWXC>'?C1K#^&_AEJ/PI\,W'@J+
MQ!\55\4^)H;OPU##\/=-\1SZ;K]C>Z9K<>FS6LS+Y?\`%;_@FKX+^+?Q]C^.
M?B/XC:U<7MA\>/@;^T/X=MM5\#?#_P`3>*_!_BKX(ZE\/;BQ\!^#/BCK^E7G
MC7PC\$_$5MX`%[JOPR\-7&DV\7B[Q;XT\4+K%S'XAOM$EXC1O^"4OA/PU8_L
MS7'A[XV>.K#QE^R9^S=\'O@1\)/%LWAKPC?R6NM?!CQ+#K6B?$77-%N(O[.U
M2;Q'HTVO^"?%GA*-K32KKPSXFU)M&U#0]>M='UK3@#Z1^"?[7>H_'CX+?&OX
ML>`OA!XB\0:I\,/C5^T'\&?"GP^TS6;33_$7Q$U+X)_$35_AWIMVTWCBP\&6
M_@>[\5W^FK=:KI?BB*)O!*&^@U&XU&73F6?RZZ_;K\<Z/XP\2?`S7/@GX<;]
MH^T^+WPB^#WA3P]X:^+LNN?!G7];^,/PP\=_&FRN-5^*U]\-]!\3>&KGP'\+
M_A;X_P#%OQ`\*S?"N_\`%4&F6O@J]\-:=KMA\2/#=VGJOP\_9/\`%'PB^!'Q
MK^%OPT^/GB_0?B'\8/B/\;?BW#\;]0\&^!==\2>"_'WQR\77OC77=:T;P?=Z
M?#X(U"/P]K.IWQ\,:9JVF3:=;6RV$&HVVHI9N+KRKP%^P/XE\*_#/3?!FJ?'
M5+OQ?X%^+6C_`!V^%'Q1\-?"71/#OBS1?BY#H?BCPSXS\;_$V37/%_CF;XV:
MU\5?#?B_7_#OQ%U/Q=J5EK6IZ+K.IQ:5J^C:@-$U+0@"CK__``45NM%\-_"*
M_A^`GB/5?$'BO]K_`,-?L=_&6WL/&WA\^"_@9XXU3XXZ!\$-2U"Y\8W5C::G
MX^%YJ'B;0_%_P_T+0O!FGZQXH\%ZE#K/BF/X??9=1M[7UGXZ_MEV/PA^/7[.
M?P+T3P-+XZO?C)\6_#?PT\>^(H?$46BV/PB@\<?#[XM^-?`M_<6K:1J3>+/$
M/BB7X1>(8X?"=M<Z1)I?AJVNO%FKZG:0S^&M.\2^,?$S_@G?XP\4_#[X>^`_
M`O[2>H>")?#W[06C_M8?$+Q7K'P=\$^./$/Q2_:#T/XO:3\:].\4ZAYFL>&=
M*\,>&8O%&DVFB+X.T#3MD/@BRTKP[::U;2Z=_:=UTGQ'_P""9OP7^*/Q$^$/
MQC\0>(_B3I7Q4\!_'?P)^T/X^UWPA\3?BWX9\+_%GX@^"OA/JWPI^UZA\-[3
MXFR>"/!B:EIMUHTKW?A+2K?5[?2O#MKX1DU&^\-ZIKUIJ0!^CRG<JMC&Y0<=
M<9&<4M(HVJ%'88Y_SQ[`<`<```"EH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HK\?O\`@H%\5?B7X,_;Q_X(Z_#O
MPAX_\7^%O`WQE_:1_:&\-?%;PKX>\0:CH^B_$+0?#G[+7C7Q9H.D>+;/3YX!
MK.G:1XDL+/6["TNF:"#4K>*Z"&6-&7]84\.:840E;[)53_R&-:[@'OJ)/YDG
MWH`Z"BL'_A&]+]+[_P`'&M?_`"QH_P"$;TOTOO\`P<:U_P#+&@#>HK!_X1O2
M_2^_\'&M?_+&C_A&]+]+[_P<:U_\L:`-ZBL'_A&]+]+[_P`'&M?_`"QH_P"$
M;TOTOO\`P<:U_P#+&@#>HK!_X1O2_2^_\'&M?_+&C_A&]+]+[_P<:U_\L:`-
MZBL'_A&]+]+[_P`'&M?_`"QH_P"$;TOTOO\`P<:U_P#+&@#>HK!_X1O2_2^_
M\'&M?_+&C_A&]+]+[_P<:U_\L:`-ZBL'_A&]+]+[_P`'&M?_`"QH_P"$;TOT
MOO\`P<:U_P#+&@#>HK!_X1O2_2^_\'&M?_+&C_A&]+]+[_P<:U_\L:`-ZBL'
M_A&]+]+[_P`'&M?_`"QH_P"$;TOTOO\`P<:U_P#+&@#>HK!_X1O2_2^_\'&M
M?_+&C_A&]+]+[_P<:U_\L:`-ZBL`^'-*4%F^VJJ@EF.LZR``!DDDZC@`#DD\
M`5RW]J_#C_H:]'_\+@__`"^JX4JE2_LZ<YVM?EBY6OM>R=K_`*/LR)U*=.W/
M.$.:]N:2C>S2=KM7M=7]3TBBO-_[5^''_0UZ/_X7!_\`E]1_:OPX_P"AKT?_
M`,+@_P#R^K3ZMB/^?%;_`,%S_P`O/\^S(^L8?_G]2_\`!D?+S\T>D45YO_:O
MPX_Z&O1__"X/_P`OJ/[5^''_`$->C_\`A<'_`.7U'U;$?\^*W_@N?^7G^?9A
M]8P__/ZE_P"#(^7GYH](HK@+.Y\!ZA<Q6=CXBT^\NYV*P6UKXQGN;B9E1I"L
M4$&MR2R,$1W(1&(568@*I(["QTVUT_S#;"?]]LW^=>7MW]S=MV_;+FX\O[QS
MY>S=QNW87&<Z<Z;2G"4&U=*47%M=[-+3IZZ%PG"HFX3C-)V;BU))V3M=7ULT
M_F7Z***@L****`"BBB@`HHHH`****`/Q`_X*3_\`*23_`((4_P#9UO[4'_K'
M/Q!K]O(_]7'_`+B_^@BOQ#_X*3_\I)/^"%/_`&=;^U!_ZQS\0:_;R/\`U<?^
MXO\`Z"*`'T444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`<_XL_Y%?Q'_P!@'6?_`$VW5?YGT=O;>5%_HUO_`*J/_EA%_<7_`&*_TP?%
MG_(K^(_^P#K/_IMNJ_S1(_\`51?]<HO_`$6M?V3]$]M4>.K-_P`3AS\(YW;[
MC^1?I1?Q^"?^O?$7_I60GT-^S-^SG<?M&_$"?PC!K-EX4T;1M-MM;\4:^OAK
M5O%FI:?I-YK%AX?M9-(\+>';&[U+5YVU?5+%+VXE:PT;1-.-SJFM:K90QVZ7
M79>#?V0O^$TE\$:9IOQ:^&EQXA^,?C3QSX"^`-AI&@>,];TGXOZ[X`M-'?5I
MX_$']A:8?`&EZCJ^NZ?X5T:7Q;HYU-?$9O8?$&E:!H^GSZVW'?LQ_&'PQ\#O
MBQH/C[Q3X1UKQ-9:5<03V][X2\8ZOX'\;^&+F!I&;4O"^KZ?(^FW;W\$DFE:
MSHGB.PO-+U'39_-@ETW4K*UNS]#>%OV__$OAOQ-XB\?6_A3Q#9>+KOQO-\0/
M#VE:+\3IX?AU#XD7P-X=\%:;JGC/P[JW@[5/$/B'786\-6?B7QEXF\(^*_AY
MJ?QDUR>\B^)T>IZ3*MDG]"YW5XUCF68QR6E.I@E@,-/`RG/**-%8WDQ4)4D\
M2L1B:G/B'A:N)JU8TH1PM!X/#T:-7$QS:C^"Y/3X/EE^`>;U8T\8\=B(XR,(
M9I6J_4U/!RA5:P\L/AZ?+0AB:6&I4Y592Q%:&+Q%:K3PSRNM\S_`SX`WGQME
M\<"SDUS3HO`NB^']5OK7PM\+=>^*?B6^G\1^)[;PQ9:?:>%O#%[IUW$MK<2W
M-YJFIW-ZEE86MC*&\V66%3Y)XH\/6GAWQ+K_`(?1+N==#UB_TGS=:\+W?A'6
M'?3[A[:7^U/"NK//JGAS4$ECDCN]%U&:6]T^9'@N',BL!ZCX:\;_``MTW3M0
MT+7O`/Q#U+2/%/@?P]HOC>Z\/_&6X\,:YJGC31?$5_K=]XFTZ,>#]4\*/X7U
MZ"73K.7P)XM\,^*_[$U'3QXE\/\`B*QU218UP/C!\2;WXO\`Q)\5?$;4-+M]
M%F\1W&EK#I-O?7NK#3]-T#P_I'A;1;:ZUG4O^)EKVIIHNA:>=8\0:B%O]>U=
MK[5[N.&6]:&+W\+4S>6;XOV\*\<JE1;PT:D<OA"A5IPP,(J$J%:MC<0\34>.
MJN5=T(8:-&G!4ZCK0G3\/$PRF.587V$J+S.-6V(E3ECYRK4IRQ<G*<:]&CA,
M.L-3C@:<84/;3Q$ZE2;J4_8RA4^MO^"54$"_\%"OV766"%6'C;Q`0RPQJP/_
M``K;QR,A@H(XR.#T)%?WKI]Q?]U?Y"OX+?\`@E7_`,I"/V7O^QV\0?\`JMO'
M-?WI)]Q?]U?Y"OXL^E-_R6^0_P#9*X?_`-6^;G]@_1F_Y([._P#LI\1_ZJ<G
M'4445_,I_1X4444`%%%%`!1110`45Y/>_'GX'Z;XD;P;J/QC^%5AXO2[^P-X
M5O?B)X/M?$:WOF+#]D;1)]9CU);HRNL0MFMEG,A"",L0*]8H`_#K_@I<LS_\
M%'O^"%BV\J03']JW]I_9*\/VA5Q^QW\0"V8O-AW[E!7_`%J[20XW;=I_:5+3
MQ#L3&M6.-J_\P,CL.PU@@?0<"OQ@_P""D_\`RDD_X(4_]G6_M0?^L<_$&OV\
MC_U<?^XO_H(H`Q/LGB'_`*#5C_X(V_\`EQ1]D\0_]!JQ_P#!&W_RXK>HH`P?
MLGB'_H-6/_@C;_Y<4?9/$/\`T&K'_P`$;?\`RXK>HH`P?LGB'_H-6/\`X(V_
M^7%'V3Q#_P!!JQ_\$;?_`"XK>HH`P?LGB'_H-6/_`((V_P#EQ1]D\0_]!JQ_
M\$;?_+BMZB@#!^R>(?\`H-6/_@C;_P"7%'V3Q#_T&K'_`,$;?_+BMZB@#!^R
M>(?^@U8_^"-O_EQ1]D\0_P#0:L?_``1M_P#+BMZB@#!^R>(?^@U8_P#@C;_Y
M<4?9/$/_`$&K'_P1M_\`+BMZB@#!^R>(?^@U8_\`@C;_`.7%'V3Q#_T&K'_P
M1M_\N*WJ*`,'[)XA_P"@U8_^"-O_`)<4?9/$/_0:L?\`P1M_\N*WJ*`,'[)X
MA_Z#5C_X(V_^7%'V3Q#_`-!JQ_\`!&W_`,N*WJ*`.#\56OB`>&/$6[6;(C^P
M=8R!HAR1_9MST)U<@?E[=Z_S8(_]5%_URB_]%K7^EWXL_P"17\1_]@'6?_3;
M=5_FB1_ZJ+_KE%_Z+6O[(^B?_"XZ_P"OG#G_`*3G9_(OTHOX_!/_`%[XC_\`
M2LB'T445_8!_*(4444`??_\`P2R69_\`@H'^S"MO*D$Q\:^(/+EDA^T(A_X5
MQXX)W0^;#O!4%1^]3:2&R=NT_P!Y&GQ:C$KF_O8+P,L?E>38?8O+P&W[A]LN
MQ)NRN`/+";3][=Q_!Y_P2K_Y2$?LO?\`8[>(/_5;>.:_O23[B_[J_P`A7\(_
M2F_Y+?(O^R5P_P#ZM\W/[9^C-_R1V=_]E/B/_53DXZBBBOYE/Z/"BBB@`HHH
MH`*BGACN()H)HUFBFBDBDB<922.1&1XV']UU8JWL34M(W0\XX/.<8XZY[8]>
MU`'X\_$KXA?M+6/Q:UCX,?#OX":5H_PA\#_%[PK:W7ABW_9IUK5_`OQ.^&WC
M;6_V?_"'AKP_%XZN%7P)+!K%AXM_:5^*/C_QIX2T^0?!JS^$G@W0/']M:#4[
MD^-OUXTO3;#1]-L=)TJRMM.TS3;2WL-.T^RA2WL[*QM(E@M+6UMXPL<%O!!'
M'%#`BJD4:K&BJJ@#\&O'^E>$[#]NKX@Z]XC^%7[-OQ8T^7]H7X2VC_&_XJ?"
M_P#:6\:ZQ\%?$FI:/\+-,T+X9M\;;/X7^(/@OX!UZVN[CP_JO@'PA9^)M'\.
M>&?$WBG2;?Q9K&G^)?%L37/[YCD=NIZ?4]>G/J.QS0!^(/\`P4G_`.4DG_!"
MG_LZW]J#_P!8Y^(-?MY'_JX_]Q?_`$$5^'W_``4N>6/_`(*/_P#!"QX(/M,J
M_M6?M/[(?-2#?G]COX@`_O9`47:I+X(R^W8N&8&OVB34-;"(/[!_A7_F+V)[
M#N(\'ZC@]10!T5%<_P#VCK?_`$`?_*M9?_&Z/[1UO_H`_P#E6LO_`(W0!T%%
M<_\`VCK?_0!_\JUE_P#&Z/[1UO\`Z`/_`)5K+_XW0!T%%<__`&CK?_0!_P#*
MM9?_`!NC^T=;_P"@#_Y5K+_XW0!T%%<__:.M_P#0!_\`*M9?_&Z/[1UO_H`_
M^5:R_P#C=`'045S_`/:.M_\`0!_\JUE_\;H_M'6_^@#_`.5:R_\`C=`'045S
M_P#:.M_]`'_RK67_`,;H_M'6_P#H`_\`E6LO_C=`'045S_\`:.M_]`'_`,JU
ME_\`&Z/[0UO_`*`/_E6LO_C=`'045@?;]<_Z`!_\&UE_\;H^WZY_T`#_`.#:
MR_\`C=`&_16!]OUS_H`'_P`&UE_\;H^WZY_T`#_X-K+_`.-T`;]%8'V_7/\`
MH`'_`,&UE_\`&Z/[0UP==`(_[BUE_P#&Z`$\6?\`(K^(_P#L`ZS_`.FVZK_-
M$C_U47_7*+_T6M?Z3OBG4-:/AGQ$&T'`.A:P"?[7L1P=.N?^F?\`^KKT%?YL
M4?\`JHO^N47_`*+6O[(^B?\`PN.O^OG#G_I.=G\B_2B_C\$_]>^(_P#TK(A]
M%%%?V`?RB%%%%`'Z"?\`!*O_`)2$?LO?]CMX@_\`5;>.:_O23[B_[J_R%?P3
M_P#!+-Y8_P#@H%^S$\$/VB9?&GB`I#YJ0>8?^%<>.`1YL@*)M4E_F!W;=HY8
M5_>1IUQ?3J_VRP^P[!'Y?^F07?FY#;N8%4)LPHRV=^[*XP:_A'Z4W_);Y%_V
M2N'_`/5OFY_;/T9O^2.SS_LI\1_ZJ<G-*BBBOYE/Z/"BBB@`HHHH`*S=9O)M
M/TC5+ZWC@EGL].OKJ".Z>[CMI)K:UFGC2XDL;+4;U('>-5F>TL+VZ6,LUO9W
M4P2"32K-UF"YNM(U2VL_*-W<:=?06OG7E]I\/VB6UFC@\V^TQEU*RC\UD\R[
ML&6]MDS/:,+B.,T`?SZWOQ6\(?$[]HW0-0L=$TA_!?Q#^*'P@\6>-?A];_%O
M]OOPI\.?&GQ,TM_`UNOC7Q#\)+K]@6+PAJ6LZ!X@T+39--M+SXJ^"O`/CYO"
MGA?Q%\4])M;RYUPVW]#:]..Q(_(GDY`Y/4GU[GJ?P$M=-UCPU^TGIG@7PO%\
M1_&-IX`^(_PP\->-M1\,_'W_`(+9_&30/#'BZ;2_`WB3Q/X?\1>)M$3Q?^SV
M]QI+Z^M]<:'XX\4-H-EX;O=(_P"%GP:1!>:S9V_[]C^I]?4^O_ZO3C%`'X@_
M\%)_^4DG_!"G_LZW]J#_`-8Y^(-?MY'_`*N/_<7_`-!%?B'_`,%)_P#E))_P
M0I_[.M_:@_\`6.?B#6)_P4M_X*H?&;]B7X\>%_A/\/?AS\,/%VBZU\*M!\=7
M&I>,Y?%J:K#J.J>)/%FB2V<(T+5K&S-C';^'[:6(R0M<>=-<;Y#'Y:K]+PIP
MGG7&F;QR3(:-&OF$\/7Q,:=?$4L+3=+#J+JOVM9Q@FE)6BW>6R/G>*.*<GX/
MRJ6<YY5JT<#&O1P\IT:%7$S52O)QIKV=*,IV;3O*UEU/W:HK^1C_`(B$OVH3
MT^"'P"_\"/B/_P#-%4TO_!P5^U1`MH\_P*^!$*7]FNHV#S/\2HDOM.>YNK)-
M0LF?Q`JW=@][8WMFE[;F6V:[LKRU64SVL\<?Z?\`\2Y^*"LGEF6*[LO^%G`:
MNU[?Q.R;]$^S/S9?2`\-G_S,<QT2;_X2,=HFXJ[_`'6BO*WKIU/ZX:*_D9/_
M``<(_M0C&[X'_`-<J&&Z?XD+E6&Y7&[Q",HRD,K#Y64AE)!!H/\`P<(_M0C;
MGX'_``#7?&DT>Z?XD+YD$A(CGBSXA'F02%6$<R;HG*L$<E3@_P")<_%'_H69
M9KM_PM8#K_W$\_S[,/\`B8'PU_Z&.8]/^91CM/A_Z=>?X']<U%?R,K_P<(_M
M0%@#\$/@%@D#_CX^(_<X_P"ABK^EK]D?XQZ]^T'^S5\%OC7XHTK2-$\0?$OP
M#HOBS5])T`WK:-I]]J2RM-;::VI3W-\;2,H!%]JGEFP3N<\5\AQEX6<8<!X'
M"YCQ'A,)A\+C,4L%0EA\?AL7*5=T:E?EE"C.4HQ]G2F^9JR:2>K1]7PCXF\)
M\;XW$Y?D&*Q5?$X3"O&5HU\#B,+&-!5:5%M3K0C&4O:5H+E5W:[V3/HRBBBO
MSH_0`HHHH`****`"OA7_`(*8^+?%7@3]A3]I+Q=X(\2Z]X/\5:'X#CO-%\2^
M&-5O=#U[2+L^)-`@-UIFJZ=-;WME<&"::'SK>:.3RY9$W;78'[JK\]/^"K?_
M`"CS_:F_[)U%_P"I3X<KZ?@BG"KQGPC2JPA4I5.)\@IU*=2*G"I">:X2,X3A
M).,H2BW&49)J2;333/FN,ZDZ7"'%52E.=.I3X<SN=.I3DX3A..6XF49PG%J4
M91DDXRBTTTFFFC^,UOVT_P!L,,V/VJ_VB_O'_FLGCWU/_4;KW'X2_$?_`(**
M_&O1_%>N>!?VFOC?)IWA2TE9Y?$/[2.L>%&\1:U%<:!"?"7A$>(_&&F#7_%!
M@\2Z3>R6-LRVMK!>Z?!?7UKJ&MZ!9ZI^>K_?;_>;^9K[P_9!^._PC^%/A3XJ
M^'_BY=^*]8\.^(](>XOOA7<^"?!7Q!^'/Q1MUU_X=R3>'X[?Q'/INJ^`?'E_
MHNA^(M'/C&TU!]*DT*^LM3D^R^(O`_AVVUC_`$JXBR?!X+*IXC)N&LDQ6.C6
MPD8TIY)0Q7-2J8BE"NXT*$*=2<O9.7*^>%.,FIUJE&BJE:G_`)V</YKB\9F=
M.AF_$6<X?!RHXF4JL<ZKX;EJPH3G1YJU>I4IPC[2,'+W)U)).-&G5K2A1J5=
M;^/7[<'AOPEI/BW6_P!M/Q[8'7/#NC^+-*\&3?M4>(?^%F7F@:_<20:5?IX!
M76VUA!=)#-?F"5DN(=+AEU":-(4YO_"[XT?MT_%ZY33_``G^VEXXL=9GN[ZU
MM/#_`(S_`&KM?\&Z_?)IFDR:YJ.HVFG:OK:A]%L=*M[V\O-9FGM]/M8=.U*2
MYFABLII!DZC^T+X2O/@[KG@^]\;_`!'\4Z?J'P9M?AAX2^`_B3P-X17P7\-?
M$^GZW87>@>/M-^)EC?PWFN)X#TVRF'A+5)/#%M\2]:>]7P]XRUF7P]'>S7_C
MVA>,/A[\/=*_:/TGPCK/B;Q!?>-O"NC?#?X6>*M2\+1>&KR?P;K7C31M4^*%
M]KVE1Z[K'_"):CKW@_0T\+PV-MJ6M_:].UG6=/DO8X+R;?Q4LKIU<'C(2X9R
M>AF"QT:.#J?V!"IAO85,1@\/[6M&MA,(W'"/%>VQ'LZLZ>(H4,35P&+Q,*=6
M='NJYC.EB\)./$>;5L`\$ZV+A_;TZ>)]M"AB:ZITI4L5BHJ6*^JJCA_:4H5<
M/7KX>ECL+AYU*4*VP/VU/VPB`5_:M_:)93RKI\9O'K(ZG[KHW]MC<CC#(V!N
M0AL8-?N1_P`$*?CW\<?BW\<OCII/Q4^,?Q1^)6EZ3\)O#6HZ5IOCSQUXD\5V
M.FZA/XUDM9[ZPM=:U"\@M+N:UQ;2W$")*\`$3,4XK^9\DDDGJ3D_4U_0/_P;
MS_\`)P7[0G_9&O"W_J>/7SOC)D>2X7PRXMKX;*,LP]>G@<(Z=:A@,+2JP;S/
M`1;A4IT8SBW%N+<6FTVMF[^_X19QF^(\2.%*&(S7,J]&IC<2JE&OCL55I32R
MW&-*=.I5E"23C%I23LTGNC^K'Q9_R*_B/_L`ZS_Z;;JO\T2/_51?]<HO_1:U
M_I=^+/\`D5_$?_8!UG_TVW5?YHD?^JB_ZY1?^BUK\E^B?_"XZ_Z^<.?^DYV?
MJ/THOX_!/_7OB/\`]*R$?1117]@'\HA1110!^@G_``2K_P"4A'[+W_8[>(/_
M`%6WCFO[TD^XO^ZO\A7\%O\`P2K_`.4A'[+W_8[>(/\`U6WCFO[TD^XO^ZO\
MA7\(_2F_Y+?(O^R5P_\`ZM\W/[9^C-_R1V=_]E/B?_53DXZBBBOYE/Z/"BBB
M@`HHHH`*0]#CK@X_R>/SI::[!59BP4*K,68@*H`)+$D@`#J22!CJ0.:`/R>U
M_P"!GQ_@_:L\;>-U\`?%3Q5X&\3?%SP3XGT;Q/X7_;V\:?`WPEHWA73-#\&:
M1=V>J?LX_#W1-)\*>,5TFYT75;_4IO%]WKWB3XC6MU_8GB35AH]IHVGV/ZQ#
M^I[Y[G_..W3M7Y,:]?\`QRUC]J7Q3/XAN/VW]0\!0?%/P3'\,+[X%^._V,O#
M7[.Y^'@TKPD]S9^+/#GB;XF_\+HUZ.V\3_\`"3S^/-6N=);7]<TR\:Q\(Z3;
MV]EINEP_K./QZGKCU/IV].^,9YH`_#O_`(*73PVO_!1[_@A9/._EQ1_M6_M/
M[G*NV-W['?Q`11MC5V.YF51A2`3DD*"1^4?_``7MOK6__;&\`S6DPFC7]G;P
MA&S!)H\.OCSXE,1B:.)C\K*V0I&&`SN#`?K%_P`%)R1_P4D_X(4X./\`C*W]
MJ`?@?V.?B""/Q'!]J_*C_@OR2?VR_A_DD_\`&.?@_J23SX^^)A/))ZDD_4D]
M37[W]&[_`).9A_\`L39K_P"DT#\-^D-_R;G$?]C;*_\`T[,_$.W57N+=7:V1
M&N+=7>]$C62(TT8=[U8@TS62*2UZL*M,UJ)A$K2%5/[8?M*-\,_%NE_LV>(_
MCM\1O#_@SPOI^G7FMVGP=M=<\,?%_P`"^)[.*_\`C#?Z4/AAXS^$7AN[^)/A
M/X)ZGKFF>%/!&MVNJZ$-&B\%ZWH,?AZ&^\>>$/$,UO\`B33F=W"!W=Q%&(8@
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M^$D6O7?@/3O#>LQ7WAKPGXKU#0EOO`W@C2;;2=<O+K\K_+BRI\J+*.TB$1H"
MDCY#R*=N5D<,P=P0SAF#$Y.4CAAA#"&&&$.V]Q%%'$'<]6<1JNYCW9LGWKCH
M<)JC+A^^/YJ?#\(T:#C@X4L15H4Z>&5.BJM.O&AA8^UH3C7^K82FL3@:D,#5
M7[J6(J]5;BB56.>VP7+//9RJUN;&3JT*5:I4KNI5=.I1=;$R]G5BZ/UC%3>'
MQD)XRF_WD:%*9/OK_O+_`#%?WJ_\$U-?TFU_8+_93MYKL)+%\&O"J2)Y%TQ5
MECN,C<ENR'!R,JS`X.#C!/\`!4GWU_WE_F*_OM_X)F<_L#?LGY)_Y(QX4[G_
M`)YSCIGT`'X"OQ#Z4_\`R2'#W_91J_\`X;,=^I^T?1E_Y*O/O^R>G_ZLLO/L
MK_A)]%_Y_1_X#WG_`,C4?\)/HO\`S^C_`,![S_Y&K>P/?\S_`(T8'O\`F?\`
M&OX6/[5,'_A)]%_Y_1_X#WG_`,C4?\)/HO\`S^C_`,![S_Y&K>P/?\S_`(T8
M'O\`F?\`&@#!_P"$GT7_`)_1_P"`]Y_\C4?\)/HO_/Z/_`>\_P#D:M[`]_S/
M^-&![_F?\:`,'_A)]%_Y_1_X#WG_`,C5^??_``52U[2KO_@GU^U';V]T'FE^
M'<:HGDW2EC_PD_AT_>>!4'3^)A7Z18'O^9_QK\]?^"K?'_!//]J;!/\`R3J+
MN<?\C1X='3..Y_.OJN!?^2WX-_[*KA[_`-6^#/F.-O\`DC>+;_\`1-9[_P"J
MO%6_$_@T?[[?[S?S--IS_?;_`'F_F:;7^KL=EZ+\C_+X****8!7[]_\`!OI?
MVFG_`!^_:!ENYA"C_!SPNBDI*^6'CMR1B&.0CMR0!SUZX_`2OZ!_^#>?_DX+
M]H3DC_BS7A;H2/\`F?)!V]B17Y;XV?\`)K.,;?\`0#A/_5KE_P#7Z,_3/!S_
M`).;PC_V'8G_`-5F./ZE/%7B716\,^(E%Z,G0M8`S;WG?3;K_IV[=:_S88_]
M5%_URB_]%K7^EWXKX\,>(R"01H.L'(8]M-NB._K7^:)'_JHO^N47_HM:_$?H
MG_PN.O\`KYPY_P"DYV?L7THOX_!/_7OB/_TK(OZZ#Z***_L`_E$****`/O[_
M`()9W$-K_P`%`OV8KB=_+AB\:Z^SN5=MH/PX\<*/EC5W.691\JG&<G`!(_O)
MT[5+'45?['.)O)6,28CFCV[P=O\`KHHLYVG[N<8YQQG^#S_@E7_RD(_9>_['
M;Q"...OPV\<@_I7]Z2?=7J<J,Y)/;W)K^$?I3?\`);Y%_P!DKA__`%;YN?VS
M]&;_`)([//\`LI\1_P"JG)_ZV_X+J***_F4_H\****`"BBB@`JI?V<6H65Y8
M3K&\%[:W%I,DT$%U$T5S"\$BR6UU'-;7$;)(RO!<0RP2J3'-')&S(UNB@#\T
M=,_8'\,>&/$>DW/A3]G[_@G7ITFAWVGZIH?Q(C_8W\/:7X^T+4M,N8+O3=6M
M-'T'5K#2/^$BTVYMXKNTUK3/$OA^"+48H;ZTT:Q2)+,?H_I5M=V6F:?::AJ#
MZM?6UG;07FJ2VUK92:C=10HEQ?/:621VEJUU,'G-O;1I!"7\N)=BBK]%`'X@
M?\%)_P#E))_P0I_[.M_:@_\`6.?B#7Y4?\%^?^3R_A__`-FY^#O_`%/?B77Z
MK_\`!2?_`)22?\$*>O\`R=;^U!T!/_-G/Q!]/UK\J/\`@OR"/VR_A_D$?\8Y
M^#^H(/'C[XF`\$#H01]01U%?O?T;O^3F8?\`[$V:_P#I-`_#?I#?\FYQ'_8V
MRO\`].S/P]HHHK_0T_@D****`')]]?\`>7^8K^^W_@F9_P`F"_LG_P#9&/"G
M_HNXK^!)/OK_`+R_S%?WV_\`!,SC]@;]D_(/_)&/"G8_\\YSUQZ$'\17\P?2
MG_Y)#A[_`+*-?^JW''])_1E_Y*O/O^R>G_ZLLO/NFBDR/?\`(_X49'O^1_PK
M^%C^U1:*3(]_R/\`A1D>_P"1_P`*`%HI,CW_`"/^%&1[_D?\*`%K\]/^"K?_
M`"CS_:F_[)U%_P"I3X<K]"LCW_(_X5^>O_!5OG_@GG^U-@'_`))U%V./^1H\
M.GKC'8_E7U7`O_);\&_]E5P]_P"K?!GS'&W_`"1O%O\`V36>_P#JLQ1_!H_W
MV_WF_F:;3G^^W^\W\S3:_P!78[+T7Y'^7P4444P"OZ!_^#>?_DX+]H3_`+(U
MX6_]3QZ_GXK^@?\`X-Y_^3@OVA."?^+->%N@)_YGR0]O8$U^6^-?_)K>,/\`
ML!PG_JUR\_3/!S_DYO"/_8=B?_59CC^K'Q9_R*_B/_L`ZS_Z;;JO\T2/_51?
M]<HO_1:U_I=>*SGPOXCP"?\`B0ZS_"W_`$#;KVK_`#18_P#51?\`7*+_`-%K
M7XC]$_\`A<=?]?.'/_2<[/V+Z47\?@G_`*]\1_\`I61#Z***_L`_E$****`/
MT$_X)5_\I"/V7O\`L=O$'_JMO'-?WI)]Q?\`=7^0K^"W_@E7_P`I"/V7O^QV
M\0GCGI\-O')/Z5_>DGW5ZC"C.01V]P*_A'Z4W_);Y%_V2N'_`/5OFY_;/T9O
M^2.SO_LI\1_ZJ<G'4445_,I_1X4444`%%%%`!1110`4444`?AU_P4NMX+K_@
MH]_P0L@N8DFAD_:M_:>WQ2#<C;?V._B`ZY'?:ZJP]P*_*3_@O=8V=A^V-X`A
ML;:&TB;]G;P?(T<";$+MX\^)2ER.[;55<^BCTS7ZP_\`!2?_`)22?\$*?^SK
M?VH/_6.?B#7Y4?\`!?G_`)/+^'__`&;GX._]3WXEU^]_1N_Y.9A_^Q-FO_I-
M`_#?I#?\FYQ'_8VRO_T[,_#VBBBO]#3^"0HHHH`<GWU_WE_F*_O6_P"":F@:
M+=_L%_LIW%SIEG-/+\&O"KR2R0JSNS)<$LQ/4DDDGU)K^"E/OK_O+_,5_?;_
M`,$S/^3!?V3_`/LC'A3_`-%W%?S!]*?_`))#A[_LHU_ZK,<?TG]&7_DJ\^_[
M)Z?_`*LLO/D#_@LG^T%\5_V4_A#\'_%'P&\0:?X&USQ3\5+WPWKM\?"WA?Q%
M]NT:'P1K^L1V?V?Q-I.K6UOMU"SMKCS[6*&X/E"(RF)Y$;^>K_A[-^WO_P!%
MKT[_`,-1\)/_`)BZ_:W_`(.&O^2`_L__`/9<-1_]5KXIK^3@'!!SC!!SC..>
MN.^/2NOP(X-X2SCPXRO'YMPOP]F>-J8S-8U,7F&39;C<34C3Q]:-.,Z^)PU6
MK*,()0@I3:C!*,4DDCD\;N+>*<I\0LSP65\29]EN#IX3*Y4\)@,WS#!X:$JF
M`P]2I*-##XBG2C*<Y.4VHIRDVY-ML_6%/^"@W_!4J3X9R_&6/Q5KC_"J'6_^
M$=F\?)\#/AHWAJ'5!'O99=1'@0Q)8)+C3Y-:8C1H]8*Z(]^NKD61YK7_`/@I
MQ_P4B\*1>'9_%'Q'N_#L7B[PY9^+_"KZY\%?AAI?_"1>%-1N[ZQT[Q+HZ7G@
M>&2^T/4+S3-1@L=2B0VMXUG.]M)+$JR-GZ7\2?A-J'[$:^&/&/Q+T"\\<:-)
M;^&OA]I?AVP\>>#/BEX=UVUT.2XT#PMXY@LYKOX=_$3X+:9?WVJ3ZOXJUR-X
MIO#DME8V^GKX_P!(L=//GO[0+:-\5C^SG/K7[37P?\5^)]&^%ESX$^)GC#4O
M&7CWQ+<Z?XM_X63\:OB&=8UFY_X0`ZKJ6@3Z/K_AO1;;5=+M[P6NM:KI^BQZ
M;:Z;93W5E];@N'>$:F,J4<9X;\*T<-3SC-,$ZT>#:"D\'A,&\3A<31C++9O$
M0J3C["KB'&A"I6G&CA</5YHU9?*8O/N*H8.G6PGB'Q16Q$\IRS&*C+BVM)+&
M8O%PP^)P]9K,(>Q=.$O;4Z$95Y0HPG5Q%>G:5)>Y3_\`!0S_`(*DVO@.W^*5
MSXG\0P?#>Z,'V;QS+\"OADOAJ:.YU"72+6Z74#X'VKIUWJT$^DV>KR(FD7NJ
MPRZ9:7TVH(UL//?^'LW[>_\`T6O3O_#4?"3_`.8NI-/^-WPIM_@EXJ\3^(;O
MP/J_Q:\6?L9:;^RM9:3H?B#XC/XGC%CJ'A_2/#<7B'X;ZIX/LO`OAA_!7AWP
MY9ZUKGC[2_B%XDT#Q7J.G:5)X0\(:1XKU[Q!J=A^<+'))]23^9KV,DX+X0Q[
MS!8_PYX4P7U3&RP]"4N%\II0KTXPIR<J7M,/4EB*<)MP6,2P\<1K_LF%J1J4
M8^5G/&'%>!^H/`^(/%&,6)P<:]>,>)<TJSH5'-Q2J\E>G&A4J1BIRPC=>5#_
M`*"L3"<*LO[3/^".WQV^)W[5'[/WQ%\;_';6]/\`''B?0?C)J7A32M3'ACPU
MX=^RZ#;^"?!6KQ6/V3PUI>DV4VS4-6U"X^T3P27)^T&)IC%'$B>U?\%4]"T:
MS_X)\_M1W%KIEG!/'\.XFCFCA59$/_"4>'>588Q_];TSGXW_`.#?+_DU/XN?
M]G"ZQ_ZK;X<U]O?\%6_^4>?[4W_9.HO_`%*?#E?QGGV"P>6^/E'`Y?A,-@<%
MAN/.':>'PF#H4L-AJ%/Z]ECY*-"C"%*E'F;ERPA%7;=KMG]=Y)C,9F'@=5QF
M/Q6)QN,Q'!.>3KXK%UZF(Q->;P6/3G6KUI3JU)627-.4G9)7LD?P:/\`?;_>
M;^9IM.?[[?[S?S--K_1J.R]%^1_GX%%%%,`K]_/^#?.PLM0^/W[0,5]:PW4:
M?!SPNZ).@=58^.W!8`]"0!S["OP#K^@?_@WG_P"3@OVA/^R->%O_`%/'K\M\
M:_\`DUG&'_8#A/\`U:Y>?IG@Y_R<WA'_`+#L3_ZK,<?U*^*O#7A]?#'B(C1[
M`$:#K!!$"@C_`(EMUZ8K_-@C_P!5%_URB_\`1:U_I=^+/^17\1_]@'6?_3;=
M5_FB1_ZJ+_KE%_Z+6OQ'Z)_\+CK_`*^<.?\`I.=G[%]*+^/P3_U[XC_]*R(?
M1117]@'\HA1110!]_?\`!+.W@NO^"@?[,-O<Q)/!)XUU\212+N1P/AQXX8!E
M/!PRJPSW`-?WDZ?I>G:<K&PLK>T\Y8_-\B,)OV`[-V.NW<VW.2,GUK^#S_@E
M7_RD(_9>_P"QV\0?^JV\<U_>DGW%_P!U?Y"OX1^E-_R6^1?]DKA__5OFY_;/
MT9O^2.SO_LI\3_ZJ<G'4445_,I_1X4444`%%%%`!1110`4444`?B!_P4H('_
M``4C_P""%))`'_#5O[4')X'_`"9S\0:_*?\`X+\LI_;+^'^&!_XQS\'=Q_T/
MOQ+K^AW]N'_@GG\-?VZKOX':[XN^+_[1WP,\<?LZ^,/%/CCX5_$G]F7XDZ7\
M,/'^@:YXS\)2^!_$#)K^I>$?%NVWO?#5S>:8RVEM9S_9[Z]A:X>"ZEA;\X?B
M7_P;F?`+XSZ[:>)_B[^W[_P5?^)7B.PTJ'0K'7/&7[6GA;6=3M-%M[N]OX-*
MM[F?X,;X[&&^U&_NX[=?D6XO+B7&Z5C7Z/X5\:X+@#BREQ#C\'BL?AZ>!QF$
M>'P;HQKN6)C!1FG7J4Z?+%P][WKV>B;/SWQ-X.Q?'7"]7(<%B\-@J\\;A,4J
M^+55T5'#SE*46J,*D^:5UR^[;>[1_)]D>H_,49'J/S%?T^_\0M_[%_\`T=U_
MP4R_\2=\'_\`SF*0_P#!KA^Q>`3_`,-=?\%,N`3_`,G.^#^PSW^"Y_D:_IO_
M`(FJX7_Z)CB'_P`&99Y?]1GK_6_\X_\`$L?$O_129#_X+S'_`.9?7^EK_,'D
M>H_,49'J/S%?OK\"_P#@W'_92^)?B[]IS0=>_:U_X*,QV?P;_:&N_A5X6;2O
MVE/"MO<2^'(/@M\$_B$DNN/+\(KE;O6#K?Q%UR,W4*641TR/3+<VGFV\ES<_
M1'_$+?\`L7_]'=?\%,O_`!)WP?\`_.8H_P")JN%_^B8XA_\`!F6>7_47Z_UN
M?\2Q\2_]%)D/_@O,?_F7U_I:_P`PB$;UY'WE[CU%?WV?\$S'3_A@;]D_YE_Y
M(QX4_B'_`#SN/>OR/'_!K?\`L7@@C]KO_@ID"#D'_AIWP?P1_P!T8KZ3\*?\
M$.=$\">&]%\'>"O^"IG_``63\*^$_#>GP:3X?\.:'^V;X<L='T73+5=EMI^G
M6<?P7\NVM+=/DAA3Y47@<5^1^,'C+D_B1DF695EV49GEU7`YHL?4JXZ6$E3G
M36$Q&'Y(+#UZLN?FK*7O)148O5NU_P!5\)O"/-O#W.<QS/,,URW'TL;ECP,*
M>"ABHU(5'BL-B/:3=>C3CR<M"4;1;E>2TLFSS7_@X993\`?V?\,I_P"+X:CW
M'_1-O%/O7\G&1ZC\Q7]<WQ._X-__`(8?&K2]-T3XP?\`!2+_`(*[_$S1M'U$
MZOI.E^,_VP/#.M66FZJUI<6#:C9P3_!?;#>&QN[JT,R_-]GN)H_NR-GQ;_B%
MO_8O_P"CNO\`@IE_XD[X/_\`G,5[?AAX\Y%P)PA@>&\=D>;XW$87$8ZM/$8.
M>"5"4<5BIUXJ*KXBG4O&,^65X6YD[-JU_&\2?!#.N-N*\9Q!@LYRK!X?%4,%
M2C0Q4,8ZT987"TL/-R=&A.G:3IN4;2;LU>ST/Y@LKG.1G&,Y&<9SC/IGGZTI
MD)ZN3]6_^O7]/G_$+?\`L7_]'=?\%,O_`!)WP?\`_.8KYQTS_@W,_94O/VM?
M&?P+E_:U_P""C`\(>'OV=?AK\5[*:/\`:3\*CQ"WB3Q?\4?BWX+U.*ZO3\(V
MMY-&32_`VCO8VJV$4L-\^H3/>3"=(K?]!_XFIX6W_P!6.(;Z?\O,L\K_`/,6
M_/[EVU^$_P")9.)?^BDR+I_R[S'I;_J%\M/EVU_!#<,8W#'IGC\J,CU'YBOZ
M??\`B%O_`&+_`/H[K_@IE_XD[X/_`/G,4?\`$+?^Q?\`]'=?\%,O_$G?!_\`
M\YBC_B:KA?\`Z)CB'_P9EGE_U&>O];K_`(ECXE_Z*3(?_!>8_P#S+Z_TM?<?
M^#?-E'[*?Q<RRC_C(76.X_Z)M\.?>OM[_@JVRG_@GI^U-AE_Y)U%W'_0T^'/
M>OA_X9_\$!OAO\%]$O?#7PB_X*3_`/!7OX:^'M1U677+_1/!O[87AK1M-O-9
MGM+.PFU6XM8/@P4DOI;'3K"TDG/SM;V5M&>(EQT'C'_@AEX>^(?AC6/!7CS_
M`(*C?\%C_&'A#Q#:_8=>\,^(/VS/#FH:+K%EYL<_V74+*7X+^7<P>=#%+Y;_
M`"EXT)SBOYASGC3!YGXF_P"O5/!XJE@?]9,LSOZE4=%XOV.!KX.M.C>-1T?:
MS6&DH/VG(G*/-)*[7](Y1P?B\N\.?]2JF+PU3&_ZOYAD_P!<IQJ_5?;8RAB:
M4*W+*"K>R@Z\7-<G/:,N5/2_\>KD;VY'WF[CU--R/4?F*_I^/_!K?^Q>22?V
MN_\`@ID23DG_`(:=\'\D_P#=&*3_`(A;_P!B_P#Z.Z_X*9?^).^#_P#YS%?T
M\OI4\+I)?ZL<0[+_`)>99Y?]1?K_`%O_`#?_`,2Q\2_]%'D7_@O,?_F7U_I:
M_P`P61ZC\Q1D>H_,5^__`,7_`/@W`_9/\!?$G]EGPAH_[6W_``4<?3?C5\;?
M$_PY\5MJ/[2GA2>]AT/1OV</CS\6[63098_A#`EGJA\2_#/P_%/<3Q7T;Z+)
MJUJMLDUS%>6GOW_$+?\`L7_]'=?\%,O_`!)WP?\`_.8H_P")JN%_^B8XA_\`
M!F6>7_47Z]_\U_Q+'Q+_`-%)D/\`X+S'_P"9?7^EK_,%D>H_,5_0/_P;SLH_
M:"_:$RP'_%FO"W<?]#X]>[?\0M_[%_\`T=U_P4R_\2=\'_\`SF*]-^&/_!NQ
M\#?@IJ6J:Q\'_P#@H-_P5D^&6K:W8P:9K&H^#/VMO"VBWFJ:=;7#7=O8WLT'
MP7W3VT%T[W$43?*DK,XY)S\AQ]](;A_B[@_/.&\)D&=87$YKAZ-&EB,3/`.A
M2E2QF%Q+E45+$U*C3C0E%<L9/F:Z*[^LX&\!,]X4XLR7B'%9YE&*P^5XBK6J
MX?#PQJK58U,)B,.E3=6A"FFI5E)\TDN5-;VO^]OBQT_X1?Q'\R_\@'6?XA_T
M#;KWK_-%C(\J+D?ZJ+N/^>:U_9C)_P`$8;F:.2&7_@K1_P`%II(I4>.2-OVV
M-`*O&ZE71@/@N"5925/(X)KY._XA;OV+N!_PUU_P4R````'[3O@\``#`'_)&
M.PKX#P9\5\J\,X<0QS+*\QS%YS/*Y47@)86*HK`+'JHJOUFM2NZGUR')R<WP
M3YK>ZG]SXN^%V9^(U3()Y?F6`R]91'-(U5C8XF3J_7WESA[/ZO2JVY%@I\_/
MR_'&U[,_F"R/4?F*,CU'YBOZ??\`B%O_`&+_`/H[K_@IE_XD[X/_`/G,5\W_
M`+7G_!N9^RI\!OV:OC'\7O!W[6O_``48G\3^`?!EYX@T6+Q%^TGX5O=$>]M[
MNR@1=2M+?X1V$T]L4N'W1I>VY)"GS`0*_;O^)JN%_P#HF.(>G_+S+/*__,6_
M/^M_QK_B6/B7_HI,A_\`!>8__,OK_2U_!+(]1^8HR/4?F*_I[7_@UQ_8O<$G
M]KK_`(*9??D7C]IWP?C"NRCK\&,]!WY]23S3O^(6_P#8O_Z.Z_X*9?\`B3O@
M_P#^<Q1_Q-5PO_T3'$/_`(,RSR_ZB_7^MS_B6/B7_HI,A_\`!>8__,OK_2U_
M(;_@E8R_\/"/V7OF'_([>(.X_P"B;>.:_O2C(*+@@_*O0@]O:OYS?!G_``;2
M_LO_``Y\3Z1XU\`?MP_\%3/!OC#0)YKG0_$WAW]JKPGIVM:1<7-G<Z=<36%[
M%\&/,MY)["]O+*5DY>VNIXC\LC`_K!^R#^QC/^R0WCYIOVM_VU?VH_\`A/!X
M:55_:^^-NG_&%?!7_"-G7"6\`BQ\%>$/[`/B#^VP/$QE-_\`VF-'T/8+7["W
MG_SMXP>(>7^)&?Y=G&78#&Y=2P63TLMG1QTL/*K.K#&XW%.I!X>K5@J;CBHP
M2E)2YH2TM9O]]\)^`<?X>Y'F&59ACL'CZN,S>KF,*N"C7C3A3J8+`X54Y*O3
MIRYU/"3EHG'EG'6Z9]JT445^3'ZF%%%%`!1110`4444`%%%%`!1110`45\3?
M&#]MSPG\)O%/Q/TN/X:_$KQ[X0_9]\.^'_%?[27Q&\&V_A:3P_\`!?0?$VCW
M7B>UGO\`2]<\2Z/XH\;ZAH/@FV7XC>-M&\`:+K^I>%_A_>:;K+0ZAJNK:5X?
MO-74/VP--T+XJ>$O`WB;X/\`Q:\,>!OB!\5[CX%>!/C)K>G^&+3PGXK^*46@
M>)O$=K9Z;X7_`.$E?XE)X'UVV\(>(-,\,?$RY\'Q>$_$&KZ<9[.X'A74=#\5
M:H`?6&G:'HNCSZO<Z3I&EZ7<Z_JC:WKMQIVGVEE/K6LM8:?I3:MJTMM#%)J6
MIMIFDZ7IS7]ZT]V;#3;"S,WV:SMHHM2O`O&/Q[L_`WQ`UWP?K/P]^)=UH6A?
M"K3?B4WCWPYX5O?%FAZKJ&K>.9O`UC\-]!T3PRFJ^,M9\?W%TMIJL.EV/A^6
MS?2]0M9GOHV%QY'RQ<?\%'O"-]^S'\`?VE?"_P`+O$LFG_M!ZKK5EH7A#X@^
M/_A!\)+WP99>'-.\;:EKU_\`$#QEXU\:6_P\T9]-'@N;3VL-.\3:O<76J:I9
M6]BUS;Q7UY;@'Z245QWP]\3WOC3P-X0\7:AHT?AZ\\3^'-'U^?18?$&A>*X=
M-;5K&&^6T@\3>&+J^\.Z_!'',AAU?0[RZTK4(F2YL;B:WDCD;L:`"BBOG?XT
M_M`+\+?$O@/X=>%_AUXQ^+WQ8^)=CXPUWPIX`\&W7A71I%\(_#O_`(1M?'/C
M/Q%XH\<:]X;\+^'O#VA7GC+P=H$,EUJ,VI:OXH\7^'=)TW3I8)M4U+2`#Z(K
M*30M$CUJ?Q)'H^EIXBNM+M=$NM>33[-=:N=%L;R]U"QTB?55A%_-IEG?ZEJ-
M[:Z?)<-:6]W?WMS#"DUU.\GPAX@_X*#>%;#X6K\<?#7P0^.OB_X0>'/ACK?Q
M;^,/C:VT+PCX<@^#GAKPAJWC?0/B%H&O:;XN\8Z)?>,?B9\,M6^''C=/B%\.
MOAJ/%NM>';3PZTQEN[OQ'X'L/%?UGXV^);>$]1^$-EI_@[Q5XPMOBO\`$.'P
M,^J^&[>R>Q\"V$_P]\>>/E\<>,CJ-W93VOA0?\(3#X9:6PAO-3'B+Q5X=MS8
M"VFO+BU`/4:*^3O@/^V#\.?CW=?M#'2-$\;>`]&_9R\>:;X*\4Z[\5M!/P_A
MU>RU3X2>!OC-:^.=.TC7Y[;Q%H?@R;PCX\TVY@O/&^E>%]6D@M+O59-'M]&F
MT^^O+O[*W[57A;]J[0OBIX@\*>$/&G@ZT^%WQJ\8_!JZM?'5IING:IKTGAC1
M_"GB/3/&6GZ;8:C?W6F^'O%_AKQGH.O:'8>($TOQ/:65XL'B#1-(U%)K&(`^
MI****`"BOE#XN?M=^`?@C\0-8^'OC_0O%MCJDGPFD^*'PVN+&RL;^'XS7^G^
M+K#P-KWPN^'$*7L=U?\`Q2T?Q-XK^%]BOAG4HM/36(OBIX6O=%O;VSL/%<OA
M_P"2_B=_P4X\2_!W7?VE-+\??LA?%*QL?V7_`(9>!/BKXZUC3/BE\"=8AU+P
MY\6M<^(/ACX4P>'[&W\:QW\FI^*_$'PU\165];ZI%IL7ABU?3M2U:<VEV6B`
M/U1OM%T?4[O1[_4M*TW4+[P]J$VK:!>7UC:W=UH>JW&E:EH4^I:/<7$4DVF:
MA-HFL:MH\M[9/!<R:7JFHZ>\K6=]=0RZ5?,GP=_:0/Q#\=>)/A#X]^&GBSX+
M?&/POX/\/?$*Z\#^*M6\&^)[/7?`GB76-;\.V7BOP?XP\!Z_K_A_7K'3O$?A
M_4?#WB73IWTGQ%X:U7^S7U/18](\1>&=6UCRSXO?MY>$?@A\*IOBAX\^$7QK
MM5/QQ\1_!>P\+Z=X3MM1U2XMM!_:!T_X`0?%34M:AU%?!_A?X9:YJ.M:#XST
M+4_$WB'2];UGPMKFF6FBZ%JGBJY70*`/NZBOB7XC?MB_\(9^TEH/[.FC?#>+
MQ%?ZB/A\FI>*-5^,GP9^'B0W?C[4=;B33O"_@KQQXKTSQY\0M1T'1-%DU_5+
M7PAH5\TT5Y::;IIO-3%U!;_;0_S_`$_.@`HHKPWXS?'CPU\"[[X72^.-,U:V
M\'?$CXAZ=\,;WX@PM8#PM\/?$GB;3[\^!+CQ[/<W4%SI/A_QOXKM+#X=:3KD
M$-S:6GCGQ/X2TS5?L5GK8U"V`/<JRM;T+1/$VDWV@^(]'TK7]#U2!K74M&UO
M3[/5=*U"U9E9K:^TZ_AN+.[@9D5FAN(9(R54E<J"/SGU;_@H/XB/Q*_9U\$>
M#OV6OB;XN\/?M3R^+KCX.^/'\>_"/PII^L>'/!.F7GBC5_%>J^&O$WBBS\6Z
M-H^I>`H+/QQX7BGTN34]9T?6=*M9K'3=5EN+*VV_V<O^"A&C_';3_@=XCU_X
M(_$WX0^!_P!IZYU>S_9^\<^*=8^''B70/&NJ:5X=\1^,;?PSK\?@?Q;K>L_#
M_P`5^(?"/A#Q9XA\-Z9XFTJ/3M2A\,:SI$FMVGB4:5HNJ@'Z)8`Z#'4_B3DG
M\3R?>BOGGQ3^T)9^#/$7Q=T?6_AI\5I],^%GA+X5^([#7O#/A"Y\8I\3M5^*
MFJ>-=%L/!7PXT/PR^H^(=6\3^']4\)V%MXE74M.TK1=*B\7Z!J=YK%MHT6M:
MEI?E,G[='PY3]B'P7^V\OA/QK+X;^(WP3\/_`!C\"?"F%?#DOQ3\3W'BGP')
MX_T3X=:9:IKK>%IO&<NE07G]HSKXC;PMHMII>M>(M4U^W\+:-J.LVX!]N45Y
M_P#"?XB:5\7?A=\./BKH=I>V&B_$OP%X.^(&D6.I&W.H6>F>-/#>F>);"TOS
M9S7%I]MMK35(8+O[-/-;_:(Y/)EDCVNWH%`!1110`4444`%%%%`!1110`444
M4`%%%%`'Y9_M5_LJ?%S4+S]H"7X-W<.O?#/]MB'PCX&_:M\$6OA_P]>?%/1_
M#4?PUN_@OXJ\>?!#7?%?CSP/X)DUWQ#\,[+P=X+UW0O'C7EOX9L=)NOB-X1&
MO^(+%_A]XF[30?V;/VE?^&K;'XR>/?&7P!\;?"[P3K.J:3\$/!?_``AOQ3T;
M6?@?\,[S09?#DD?A*P7Q_?\`@35OC%K^E-)IWBOXOZ_HUWJ;>'-0U'P5X,T[
MP;X3U#7-,\0?HQ10!QOC^+Q[+X.UR/X8W/A*S\>-:Q#PY<^.K/7=0\)17JW=
MNTC:U9>&M1TG6Y[4V8NE1-/U"VE^T-`SNT"RQO\`FM^SM^QA^TO\$OV;_@U\
M&]3\?_LM>,?$O[/WB?6-2\!ZMKOP%\7:_P"&M8TCQ':^+(M2FN[77OB+/XI\
M">-=/N/&6I+IGBCP1X@$%WH(O_#6L:3=6>NSW.G_`*MT4`>&_LW_``5A_9[^
M#GA3X40ZY#XC;0+GQ7JEYJMEH%GX2T=]5\:^-?$GCS6;/PQX2T^ZO[+PCX-T
MK5O$][I/@KPC;ZAJ,7A?PE8Z-H(U+4#IYO9_<J**`"OCK]I?X.?%?4_%/A+]
MHW]G/4?!D?Q_^$7PW^+O@+PYX2^(^DW=[X#^)OA#XH3>`O$FK^"-;U?2-9T#
M6_"&I_\`"9_"CP%K'A[Q=:7UU8V!M=8T?6M(N-.U]]3T;[%HH`_&B3]BG]IS
M4_AW\$O`/AGQE\+V^"/ARQU/XH?$3X'_`+0W@#Q);>(/B/\`M(^._BQXI^,W
MCCQA\7)O@;\6M0\%ZWX"M_&WB2YUOPW\#-+U/5_`MGK4[W?C#6_B+:Z3X<M-
M)_8^);@6T8E,/VH0KYAC606YN/+'F,JNYE\HREF4.[2;,;F+Y:K%%`'Y1>#_
M`-A_X^^*M=_;(T_]H7XI?#5OAU^V-XJ\%>/?%,7[/NE?$KX=_$7POK_P^^''
MP/\`A7HN@:9XH\8>*O&FA:IX-U_PW\&5F\9Z=JGAF5M>C\4ZSX8O8;OPY-/#
M/[U^Q9^Q[K'[)5Q^TA+J_P`;?B!\9A\=OC]KOQFLKCQ]<V%UJ'AJVU;PKX3\
M._V=<7-AI>EQ:GKUW)X=>?7-:AMK*QO[:+0[6TTC3GTRZGU+[CHH`****`/F
M/]H+]G>+XX>._P!DSQF^J:-IK?LS_M'GX\/!J?AY-;NO$$!^!/QM^$*Z!I-X
MUS;GP]?+J7Q6TKQ,-8*7L:KX8%F+,75S:7]A\R_M.?L"^)/CPO[<D^B?$W0O
M#-[^UG\`/V9O@_X=75O"6IZQ9^!]8_9Z\:?&?QBVO:VMCXATN?Q%I?BB3XI6
M-@-+TV31+W2H]%NYO[1O'U"W2S_3:B@#X^^#/P!^(VG?&7Q)^T=\>O&'@7Q1
M\5-5^&>B_![PSHWPO\)Z_P"%/`O@?P'IWBS5O'&N""7Q9XI\5^)_$WB;QMXH
MOM,O==U6^NM)TK3]+\+>&=&T30+>>WUS6O$'-_M]_L]?&K]J+X+1_!OX2>,O
MA9X'LM:\5^!?$OB_6?B5X6\:^+)=GPU^)G@'XI>&[/P_8^$/%GA1(CJ.K^"G
MTK6IM3N+@Q:=J"SZ:L5S;ND_W+10!^<_Q;_9'^,7QTL=6T?QQXS_`&?=)T_X
MK^$/A[X=^,FM^'O@)=7/Q,T6X\`ZQ-KPE^$/Q)U7QHNHVT-Q>W,]SX&NOB#I
M?B75/A!XCENO%_ABXU:[N(-)L/T74;1C.>6/_?3%C^`)P/;KFEHH`*^8?VT?
MV>#^UE^RG\?/V;EUK2_#<GQH^&/B;P!;^(-:T$^)],T.[URU$5IK%WH(N[!]
M373;E(KR.WCOK.;SHHY(+F":-)%^GJ*`/EKXH?LZW/C_`/:(_9/^-UCXEL-$
MTW]FR_\`C3=W7A8Z++<3>)X?BI\+Q\/+*WT_48+^UMM#70)`NHR^=8:@E[;J
M+*!+-@)Q\D_LN?L$_&#X7^$_V4OAE\:/BQ\,?&/PQ_8PU:[\3?"S1_AW\-_%
M'AOQ#XX\9P^#_'/@3PKXI^(^O>+?'7BBUL;7PEH/Q%\67\7ACPAH]G%K'BNZ
MT76+G7+/3/#W]@:M^K=%`'GOQ1M/B1=^!M:M/A)=>!K+QW,EE%HT_P`1[#Q)
MJG@Y(6OK==475K#PEJVAZ]/YFDF]CLOL.IVVR^:VDN#);)+$_P"6/AO_`()C
M?$+7_P!C?X-?LV_%C]H#4O#_`(T_9S^!GBC]G_X5^//V>&U_P+X7UCPOKWP?
M\-?"L^)?B3X$\?7'Q#&K^*9[?1]42YFT'5M%DT[P[XE\1^'?#^I:=:^(=9-U
M^R%%`'AO[,_P?O/V?_V??@S\$M0\8ZQ\0+WX5?#;P=X#N?&6N^4-2\03>&-"
MLM)>_DCAAA6WM6:U,6F6;+)-8Z7%965Q=7MQ;RWMQ[E110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
D`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`?__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>biib-2015630_oiechart.jpg
<TEXT>
begin 644 biib-2015630_oiechart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`#P`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^3?VU_VF)?V2?@)?_&6
M#1/"&N31?$GX%_#>*/X@^/F^%_@/1Y/C9\;/`'P<3Q;XU\>KX;\6OX:\*>##
MXY'BK7[Y/#VHN=,TBY@58#,+F'ZRKP;]HWX#:/\`M&>`=#\`:YKE_H%AHOQB
M^`'Q?^U:?8Z=J,E]>_`/XW^`?C9IF@75KJB2VC:5XEU'P%:Z!K$NQKFWTO4;
MNXLL7D<!`!X9X+_;K^%,&C>%(_BY\0?@Y'XF\5-HNH1ZI^SQXL\??M"?!?1/
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MIM^^^&'[)?@_X?\`[,WBW]E[5/$.O^+?!WCFX_:)_P"$DUF>.PT/7)]/_:/^
M)'Q/^(7BJQLCID3VEB=(;XHZKHNB7:123+;:?8WMTLMVT^X`^</@W_P5(^$'
MQ-\=3^&?$_A7QC\*M`U'X<?L:>./"?B+Q=X;\;-/+JG[9=UX\T7P3X7^(=C;
M>"ETSX3&/QAX3T;P7X<\0^,]>L]$\>^(?%^CVV@SQQSV,FH?7_PH_:@^"7QM
MU[4/#GPW\77.MZE::9=Z_ITE[X3\9^&M*\8^%K#65\.7_C+X;Z]XI\/:+HGQ
M.\%6.OO#H]WXO^'^H>(_#EO>WNE"34E@UO1+C4?B/0?^"7.C6O@/X@>#/%/Q
MP\6^*;CQ_P"'_P!A3PG?:T/!GA'03;>'?V"OBS<_$?X=VPTK3I)+&>\\9Z2=
M/\(>.KQ6M8GAM)];\/V6CW=[]BMO6_V0/^">_P`*OV.?$6J:O\/O^$::RM_"
M+_#KP6FG_"#X3^#_`!9I7@)]:L-;72O&GQ,\,>&K7QY\3M6@?1M!TQ=:U_5[
M&&^T_1+"^U[1]9\5B?Q/*`>"_'__`(*'_'K]GCQA^V):^*?V??@UK'@']D7X
M#>"OVB]6U_2/V@_&\'B?Q?X#^*GB?XU^%O`&G0>'-1_9Y@T70O$EK<_!;4K_
M`,=)/XLU#2-$L=<LCH&I^)Y[.ZB/UXO[=W[,'_"1:=X/G\?:O8^,=4\=>*OA
MO:^#M4^&_P`3](\71^+O!?A;P9X]\0V&I^&M4\'6FLZ)8V?PY^(/A'XFKK^L
MV5AX>G^&>K?\+`AU5O"EAJFJ67#?M"?L&>%OV@KK]K.ZU;XA^*/#;_M8?LZ?
M!K]G?75TG2M#NQX.TCX.>+_C/XOT[Q-H)U"-C?ZOK5Q\9=1L]0M-4+Z?;6^A
MZ=)9JLUS>%L+Q)_P3F^'7C']I/QI^T+XF\:^*=4A\>^)/B/K?B+X>&RTJUT&
MZT[XF_LF_"7]DO7O#Z:S:^7K\%FGA7X4V_B6WO(9X[X:WK^HVWF"QM;+:`>L
MZ=^W3^S/JGAB]\667C?7'T^+_A7\FB6$WPQ^*EGXG\?V7Q8O]3TSX7:Q\*/!
MM[X*M_%GQ9\/_$:^T36HO!/B'X<Z-XET3Q%'HVK7=C?O9:;>W,/KUC\=?AAJ
MGPJN?C3INO7M_P##^R@U>2\OK3PMXPN?$%I>:!K=WX:UWP_=>!(-`D\>V_C#
M1?$UA?>&=6\$R^&%\7:?XEL[KP_=:+%JT$MHOYJZ1_P1L^`.E_#(_#YV\$75
MQX<USX5ZQ\/-;7]G;X%:;#;GX.67BS2?"Y^+FA:5X6M+3X[7GB'0_&WB#1_'
MLWC&[L--U-;F/7?!^B^`O%J3>(;GZYN/V,?"@_9$U/\`9+T#Q9J7@#1-5LKY
MKCQ1\+_"G@7X:>7J^J>.?^%B:RD'@?P5H.B^"D\'^(];>YT+Q=X,;3GA\8>!
M-3UOPWXGU?5;W7=6U^\`()_^"A'[*UH+"UN_&WBV#Q'J.M>/O#47@$_!OXSS
M?$^V\2_#'P7X3^)/C?P[J7PPMO`$_CW2];T3X=^./"_CS^SK[P_!/J/@[58?
M$>E"]TJ.>YBX3XF?\%(_@?X:U#X2Z5\,+F3XRW/Q0^.G[,?P<;6/#EEXPM?`
M.A0?M-2^&=6\-:L?B?%X,U3X>W_BFS^'?BS0_B7;?#9_$>G^*-4\)ZKI&H2K
MIEKJ^GW,_GGP?_X)8_#WX1?%RV^,.D>/KJVU>7Q?\4?'>L>%?"'PT^''PU^'
MTOB/XL?LY?"3]G7Q`/#_`(1\$Z;I^G^&=)MM*^$6D^++2TMS?ZC>^)-6U>XU
M[6=8EG^V/D?#3_@E)X:^%G@_X-?#+PW\>?B(OPQ^%/Q%_98^-VH>$I_#'@9I
M?&_QK_9B\+_"WP5;^+=3U\6!U72/#_Q$T+X2^&M2\4^"])=;6P\8/>Z]H.K6
MFG3R>')`#V?X_P#[<%U\&_CQI?P*TSP5\/;G6;[X=^%OB)IEQ\6OCKH/P(G^
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M_@FYX7M-<U_Q#I?Q@^(6FZDG[1>K_M5?#26.WTJY_P"%<?&F[\#_``Q^%VE^
M(S+=O+=>-K?3?A;X#\4?#F]L/%-Q*GB3PM\9?BFFNRW.KZGH6K:$`>P_'[]K
M=?@/^T1^RA\%]2\!/K7A/]I*^^(VCZ]\2T\1_P!GI\+-7\/7OPU\,_#I+WPS
M_8=\_B33OB7\1OB?X:^'BW\>LZ-_PCFNZWX>D>#5H=6=+/R'X9_\%*?ASXP^
M(G[2GA'Q9X3UOPEH7P<^-W@[X,?"?5O#EKXK^*_BS]HFZ\4_##4OB&^L^"/A
MK\/O!>K>*5^S#PG\09;73=*B\3"X\$>$+CXA7]]I.CW,MO9>X?M,_LC>&_VF
M6DEUOQIXK\&7D/P,^,WP>T'5_"*:;#KOA+6OBAXO^!_Q`\,?%CPQJ=_!<MIO
MC_X0^.?@-X-\6^`YW@N-.&N1+<ZK;74=K#"_@5E_P36\/^$?&MU\3/AA\8O&
M/@GQ_H_BGX/>*/AMJUQX8\(^*=-\&'X7?LS7W[*NJ:)J.B:K!#'XNT;Q[\.M
M5U#4M<6[O=)U+3O%\>EZSI&I0PV,]E?@'M>F_P#!0#]DS6M5TG2-"^*;:_<:
MQ;?!6\M[S0_`_P`1=6T&TM?VB[J]TOX'RZYXFL?"4WA[PT?B=XDL+GP5X3A\
M1ZEI5Q?^/E3P,\,/BJ1=*KX_^%'_``66^"'Q&U;0=0\0_#OXH_"CX8:G\%/C
MQ\8]8\9^/O!/CV+7O"6G?`7]H73/@5XJN_$?@G1/`VIWFF_#^SM[^3QMXE^*
M5YJ-MX5\"V5E?:'XHEL]5TO6O[-]#\-?\$M?ASX.\.>//#'A[XH^/8['QSJO
M[$&N75YJ6G>&+[5(]<_8P^/<W[1$>MW4\%CI]E?ZC\8_'E_K%QXZ$>GZ?I^C
MQ:M<)X1T_3((+.U@Y?3_`/@D[X2T_2_CMX8C^-GC8^$OBQ^S1^US^RWX4TD>
M%O"BWWPW\!?M=_$N_P#BWXIOTUD%I?&>N^#O&&N:\GA6YUJSL8;C0+RRTW7H
MM2OK&75[\`^Z_`W[4OP4^)7Q#UWX9>"/$FM>(/$'AW5_&'AS4-5M/`/Q"3X?
MS>*/A[J*Z3X]\*:1\5+GPK!\--=\5>#-2<6'B7PYHWBR]U?2[R*^MI;0S:5J
MR6#-3_:J^!FD?$N]^$U[XNO5\7Z9K"^&-2DM_!WCB]\):?XUF\&#XB6?P[O?
MB'9^&Y_`%M\2]0\#%/%6G?#J7Q*OC.^T2YL+NWT5_P"U-,2\\0\`_L+Z=X'_
M`&C;'X_Q?%'6Y)=)3Q$T>A^'O`WP_P#A]JOC,>)O"_\`PBSZ#\:?&G@72=$U
M'XU>#?"=M]GU/X?:1XXTNY\0^'->T?PYJ^H^,?$=UH<#S<Y<_P#!-KX0#]I7
MQ?\`M&:9_P`(W::KX[\93_%'Q!!J7PB^%GB7QI!\3)?AY8?#?^U/#/Q?\0:!
M??$'PGX5?3=(TCQ#+X5T.]MKR+Q=:7-[I/BC1]"U?5O#EX`>C>'?^"A?[)7B
MSPA)XW\._$V^U/1)O#/P=\8^'88_AU\3X-?\?^&OV@-2GT/X-:O\+?"MUX-@
M\2_%*U^(7B&SU'PWX?;X?Z5XC,GB'2]4TB[%I=:==+'YI\*?^"F?P*\;V7CN
M[\:_VM\/6\(?&?X]_#B*%/#7Q&\6O:>!/@7\0_\`A7&I?&3XFC2OA_#+\$O!
M5[X@+:?JM_\`%"+P_HWAG5;35M.O->N4T+7+O3>)T_\`X):^$M%L_@3<:)\9
M/&]AXM_9P_9D_99^`'PK\4OX=\)WCZ;KO[*.OZYK/A#XF:KH]Q"=/U6Z\6V'
MB77_``GXW\(;K31KGPSK5_%H5_H>LIINM:=PTW_!''X0W_BW6O'GB'QM!XZ\
M9>.O%WQ)UWXD^(/B;\$O@E\2IM:TKXF_$G5OBMJ6G>$M,\:>%=8T#X?:OX?\
M4>)O%UAX;\0:5I&HP_\`"*>(6T3Q)H'B2ZT7P_K&F@'U-KG[>7PO'[1'P+_9
M[\"6FI>.=4^+'QL^+'P2\1>+(M)\9:%X0\'^(?A!\$_BQ\5O%\/A_P`7:EX-
M_P"$%^)VL^'M=^&<?P]\8^'?"7BZ2]\&ZYK<ZZS*FHZ!J>C+K?';]MCX>_LX
M_&;2OA_\5K?_`(1SX?/^S7\6OVBO$WQ3,VJZHOAJR^&/Q:^`7PHA\/'P=H>@
M:IJVK'7[[XZ6E^-4LKGS-,_L3[,VEW<>HO>:?R'A?]@S3_"?Q<^%7CC3?C!X
MR_X5U\#_`(\?&[]H3X7?!QO#O@V/1-#\8_M%>$OC9HGQ1T[4?%<&G1>*M<\/
M'Q!\=O&OBGP78W4\-QX6:]DT&XN]>TF+2!HC_CI^P/X8_:5\4?&#Q!\8_B+X
MFU>V\>?`[Q?^S[\/]*\.Z'X:\-)\*?`OCSQ5\/?B#XGO[:_^S:I>>-O%=QX]
M^%/P_P!<L=0\3E=%L++P\NC+X=GBU36KS4`#N/%O[?'[+'@GQ9XB\":W\0]6
MF\9^%_%OQ#\#:MX5\._#7XH^,?$'_"4?"CX>?##XL_$/3=,TCPCX-UR_US_A
M%?AQ\8O`'B_4KO1K>^L1I&JWTD%S+-X?U^'3>J\-?MC?LZ>,?&.@>"?"WQ$C
MU^^\43>';'0O$.D^&O&%Y\.=0U[Q?X`L?BKX4\(1?%6+P^?AJOCGQ)\-M3T[
MQQHO@>7Q4GBN_P##6HZ;J<6D>7J5@MS\S^"_^";FD>'?B]<_&_Q!\:_&WB[Q
MUK?B?]H3QIXKFN/#7A+1=+UCQ%^T3\!?V=/@3XC:RT[2H5&BZ1X<TS]G70];
M\,Z9!-=RI<Z[?V6K:AJ:V=O?3<?^SC_P23^"O[-WC3X8>+?#FJ:-XEG^'VE?
M#*\O=4\5_!GX0:O\1->^(/PU^#/A+X*V_BBQ^*NH>'+_`,8^"]!U[2O!FD>+
MM3\&^%KBT:P\:MJ$_A[Q-I'AG4]0\,W0![S^UM^U_P")?V7KS2[YOAIX.\4^
M%;R+P['IEKJGQN\.^#OBU\6_$NM^(CH=W\-/V;?A&WAOQ#JOQ:^)ND6MUHNJ
MGP]K&L>`K#7)]?T30M!U>\O+K4;S1LO3?VX9KSXB:7#=_#6ST_X#>)/VGO%W
M['?AKXL/X^@F\4W?QO\`!,WBCP[J<FH_#2/PP+73_AWJGQ-\%^*/A3H>OQ^/
M+WQ7+XKL--U&^\#V?A36X]:T_L/VE?V2]9_:/M_%/A'5?CCXQ\.?"+XE>$X_
M!'Q'^&UOX1^'WB`-H;0WUIJE_P###QAKVAS>)/A7XN\06%\MGJGB>PE\03Z=
M+I>C:]X,L_"7BRP_X2"?,T_]B/P_9?%.Q\42?$/Q1>_";1?CIXA_:B\/_`VX
MTGPU_P`(_I7Q_P#%4.N/K/BD^+EL?^$LO?"O_"2>*/$OQ+T_P3<3E++XH:U-
MXA?7KK1++2?"VG@'TG\5O%GQ`\+>&K*X^%_PV/Q0\8:UK^BZ#INCWGBFQ\$^
M&=&MM2ED?4O%GC7Q1<V.MZAI7A7P]IMM<W5\/#GA;Q;XGU*]?3='T7P[>7.H
MF>S^(_#7[=_C_P"(EYHGPX^&?P$T3Q!\>V\1_M.Z3XJ\(ZU\9;7P]\,;+1_V
M3?'7@SX;_$/Q%X0^*<'@'6M5\8V7B;QQ\1O!/A#P,DWPY\/F'Q#<>,-.\=R>
M$;OX>Z_:R^S_`!+^`OQ^^)G[-6@_!_\`X:F\0>`OBE*-!B^('QK\'?#_`,+V
M^L^+=*M;BZG\2^';'1K"[\.6_@VV\56DMMH5]XA\%:AX=\4Z7I<-W<>%M5\/
M:S>Q:I8>=Z+^Q-XM\.>&?A+)X3^.%A\-?BE\&?#WQ`^&W@WQM\*/@7\.O"/A
M*T^#/Q(O/!NIZY\.#\)=8N_%WAI5T[7/`'A+Q5X<\2)J0O\`3O%&B07>H6FL
M:-J?B70->`*/A#_@H5HGQ%^*7[%W@WP/\(O&-UX`_;&^'_B[QUHGQ9\0ZQX>
MT32?#-UX<^%,7Q1B\%V?AZSN-;UCQ=XDM(/MFA^-KRV.C^&/"&KVL5A;:[XE
MU*YEL;"_\!/VT]2^,WQV\5_"^^M_@+X:T;2_$?QE\/>&]+L_C'XTUGXS:[)\
M(OB#K?@.\FG\$7_P8\/_``_%X5T"X\0^*M`\,_%GQ7KW@33-1TA-<L"UQ-+!
MQFL_\$]_%>F>/_V3==^#_P"T(WPT^'W[&OABY\)_";X>7_P<\+>.Y[O3M>\`
M6_PW\93^,/&FI>)M&U;6M1\0Z##+>)>VNGZ8]CK]W<ZG,-3C<68^A],_9J\4
MS_%GP?X^\??'?QO\1?"OPK\:>,_B%\)?`>K>&/`6C-X8\5^./"WC7P/=W/B'
MQ?X=T/3];\:6'A?P=\1/&/AGP5875OI#6NGZM'?>,+OQOXBTW3M<MP#KO%/[
M4GP7\%?$O2?A/XJ\0:_H?BG7/$>B>#-+U"_^'OQ%A\!77C?Q-I]IJGAGP.OQ
M2;PI_P`*U7QGXDL[ZV_L/PPWBL:MJ-Y<V>E0VW]K:AI]A=>2>&O^"C7[('C#
MPK!XQ\-?%*^U;2-3\-?"[Q?X3@@^&WQ4CUWXC>'?C1K#^&_AEJ/PI\,W'@J+
MQ!\55\4^)H;OPU##\/=-\1SZ;K]C>Z9K<>FS6LS+Y?\`%;_@FKX+^+?Q]C^.
M?B/XC:U<7MA\>/@;^T/X=MM5\#?#_P`3>*_!_BKX(ZE\/;BQ\!^#/BCK^E7G
MC7PC\$_$5MX`%[JOPR\-7&DV\7B[Q;XT\4+K%S'XAOM$EXC1O^"4OA/PU8_L
MS7'A[XV>.K#QE^R9^S=\'O@1\)/%LWAKPC?R6NM?!CQ+#K6B?$77-%N(O[.U
M2;Q'HTVO^"?%GA*-K32KKPSXFU)M&U#0]>M='UK3@#Z1^"?[7>H_'CX+?&OX
ML>`OA!XB\0:I\,/C5^T'\&?"GP^TS6;33_$7Q$U+X)_$35_AWIMVTWCBP\&6
M_@>[\5W^FK=:KI?BB*)O!*&^@U&XU&73F6?RZZ_;K\<Z/XP\2?`S7/@GX<;]
MH^T^+WPB^#WA3P]X:^+LNN?!G7];^,/PP\=_&FRN-5^*U]\-]!\3>&KGP'\+
M_A;X_P#%OQ`\*S?"N_\`%4&F6O@J]\-:=KMA\2/#=VGJOP\_9/\`%'PB^!'Q
MK^%OPT^/GB_0?B'\8/B/\;?BW#\;]0\&^!==\2>"_'WQR\77OC77=:T;P?=Z
M?#X(U"/P]K.IWQ\,:9JVF3:=;6RV$&HVVHI9N+KRKP%^P/XE\*_#/3?!FJ?'
M5+OQ?X%^+6C_`!V^%'Q1\-?"71/#OBS1?BY#H?BCPSXS\;_$V37/%_CF;XV:
MU\5?#?B_7_#OQ%U/Q=J5EK6IZ+K.IQ:5J^C:@-$U+0@"CK__``45NM%\-_"*
M_A^`GB/5?$'BO]K_`,-?L=_&6WL/&WA\^"_@9XXU3XXZ!\$-2U"Y\8W5C::G
MX^%YJ'B;0_%_P_T+0O!FGZQXH\%ZE#K/BF/X??9=1M[7UGXZ_MEV/PA^/7[.
M?P+T3P-+XZO?C)\6_#?PT\>^(H?$46BV/PB@\<?#[XM^-?`M_<6K:1J3>+/$
M/BB7X1>(8X?"=M<Z1)I?AJVNO%FKZG:0S^&M.\2^,?$S_@G?XP\4_#[X>^`_
M`O[2>H>")?#W[06C_M8?$+Q7K'P=\$^./$/Q2_:#T/XO:3\:].\4ZAYFL>&=
M*\,>&8O%&DVFB+X.T#3MD/@BRTKP[::U;2Z=_:=UTGQ'_P""9OP7^*/Q$^$/
MQC\0>(_B3I7Q4\!_'?P)^T/X^UWPA\3?BWX9\+_%GX@^"OA/JWPI^UZA\-[3
MXFR>"/!B:EIMUHTKW?A+2K?5[?2O#MKX1DU&^\-ZIKUIJ0!^CRG<JMC&Y0<=
M<9&<4M(HVJ%'88Y_SQ[`<`<```"EH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`R/7KT]Z*_(3]OOXO_$_X?\`[>O_
M``1T\">#/B#XJ\)^"?C%^TC^T/X:^*OA?1-:N=-T'X@Z!X>_9:\:^*M"TCQ=
M81,L&M:?I/B2PM-9T^UNPT5OJ4$5W&OGQQLOZY)=6Q1";F`DJN3YT9R<#)SN
MY^M`%FBH/M5M_P`_$'_?Z/\`^*H^U6W_`#\0?]_H_P#XJ@">BH/M5M_S\0?]
M_H__`(JC[5;?\_$'_?Z/_P"*H`GHJ#[5;?\`/Q!_W^C_`/BJ/M5M_P`_$'_?
MZ/\`^*H`GHJ-)HI"1'+'(0,D(ZL0.F2%)(&>]24KKNOO`****+KNOO0KKNOZ
M_P"'7WA1111==U]Z"Z[K^O\`AU]X45&\T,9`DECC)&0'=5)'3(#$'&01GVIG
MVJV_Y^(/^_T?_P`53&3T5!]JMO\`GX@_[_1__%4?:K;_`)^(/^_T?_Q5`$]%
M0?:K;_GX@_[_`$?_`,51]JMO^?B#_O\`1_\`Q5`$]%0?:K;_`)^(/^_T?_Q5
M'VJV_P"?B#_O]'_\50!/14'VJV_Y^(/^_P!'_P#%4?:K;_GX@_[_`$?_`,50
M!/14'VJV_P"?B#_O]'_\51]JMO\`GX@_[_1__%4`3T5!]JMO^?B#_O\`1_\`
MQ5'VJV_Y^(/^_P!'_P#%4`3T5!]JMO\`GX@_[_1__%4])8I,^7)')C&=CJ^,
MYQG:3C.#C/7!H`DHHHH`****`"BBB@`HHHH`****`/P\_P""EL,-Q_P4?_X(
M5PSQ1S1/^U;^T^'BFC26-L?L=_$!ANCD5D;#`,,J<,`PP0"/VICT#0S&A_L;
M2N44\:;8@=!V%O@?0<5^+7_!2?\`Y21_\$*?^SK?VH/_`%CGX@U^W4;*(X\L
MH^1>I'H/>@#-_L#0_P#H#:5_X+;+_P",4?V!H?\`T!M*_P#!;9?_`!BM7>G]
MY?\`OH?XT;T_O+_WT/\`&G9]G_7_``Z^\5UW7]?\.OO,K^P-#_Z`VE?^"VR_
M^,4?V!H?_0&TK_P6V7_QBM7>G]Y?^^A_C1O3^\O_`'T/\:+/L_Z_X=?>%UW7
M]?\`#K[S*_L#0_\`H#:5_P""VR_^,4?V!H?_`$!M*_\`!;9?_&*U=Z?WE_[Z
M'^-+N7^\/S%(9^!/_!>GQ)XB^'?P,^!>H?#_`,0:YX%O]0^,U_8W]]X,U?4/
M"MY?62?#SQ-=+9WMUH%QI]Q=VBW,45PMM<220B>**8()(T9?Y>/^%^_'?_HM
MOQ@_\.?XY_\`E]7]-W_!PSS\`OV?P.3_`,+PU'IS_P`TV\4^E?R<@$$<$<CJ
M"1U].]?Z%_1]R[+L1X8Y15Q&!P5>L\;FZ=2MAJ%2HU',:RBG*<)2:5DE=Z;(
M_@KQXS#'X?Q(S6E0QN+H4U@\J:IT<36I03>78=MJ,)QC=MMMVU;/?1\2OVIC
MX0;X@#XB?M`GP*OB`>%&\9#QM\2#X87Q*UD=070VUL:O]@74C9@S"W,XYQ!N
M^TD0G.NOC!^TG8Z5I.O7OQ3^/%EH6ORZG!H.MW?COXCVNCZY-HD\-MK4.BZI
M/JT=AJTNCW-Q!;:M'I]Q<OIMS/#!>B":1$;[J\-^-_AUK/["=IX8^)7QDM?#
MUAI=U8^$=,M/A%XO\6VGQ'O5AT\ZS_PK'QY\#O$,1\%>,LM?ZSJ,GC;3[WPI
MX9N$LO#7C2_\0:MXGL+G2KOB/CYXI^#_`,:OA3\!_!WPR^*MGI;^'OBU\=M-
M\(>"?B-I&F?#/P[\+OA6_A'X3CPO9>(==E\=^+X]'BG3P?<?8-?GLII?BAX^
MUCQ=JUT-$OUV:E]GA<RPM3'_`%7$<*8:CAX9WF>`KXU955GAJ.!P.7U<50Q+
MJQP,J?/B*U*-.7M9484H1J.HH2E157X_$Y=B:>!^LX?BC$UJ\\FRW'4<$\TI
MQQ-7&8S'4,-7PZI/&JIR8>E4E./LXUYU9N"@Y155T_ER3XE_M40^%[?QQ-X_
M_:+A\$W=\VEVOC.7Q5\5(O"-SJ:R21-IUOXGDOUT*>^$T4L/V2*_>?SXI8-G
MG12(O-_\+]^._P#T6WXP?^'/\<__`"^K[CLOBW\.6_9]\4^)/%.MZ,_B3Q)^
MQ)HO[-6A^`]%^,5MK.F/XFT77-`M_!]X_P`!?^$9L?$W@GQAX?&A?\)WXV\0
MZYJUS\/[+68M0\2>"-6UOQ-XV2RTS\Q&!+,0#@DD<'IFO;R2E@\R>8+%\.8#
M!/!XV6&IR^J86=.LH0I2ER34'SNE-NE.:45*4?X=*?/2AXV<U,7EWU!X7B#'
M8Q8S!QQ,U];Q,9T92G*,>>+FN158I580;DXQ?\2K!PJ3_L#_`."$6OZ]\0OV
M8OBIJOC[7-9\<ZI9_'G5M.M-3\9:I?>*=1M=/3X>_#ZY2PMK[7I]0NH+)+FX
MN+A+2*5+=9[B>98Q)-*S?MY_8&A_]`;2O_!;9?\`QBOPM_X-\^/V4_BX#P?^
M&A=8Z\?\TV^'/K7[T;E_O#\Q7^=_C!2I4?$OB^E1ITZ5*&:)0ITH1A3A'ZKA
MW:,(I1BM;V22UN?WUX3U:E;PZX4J5JDZM2>6ISJ5)RG.3]O6UE.3<I/S;9D_
MV!H?_0&TK_P6V7_QBC^P-#_Z`VE?^"VR_P#C%:N]/[R_]]#_`!HWI_>7_OH?
MXU^;V?9_U_PZ^\_0[KNOZ_X=?>97]@:'_P!`;2O_``6V7_QBC^P-#_Z`VE?^
M"VR_^,5J[T_O+_WT/\:-Z?WE_P"^A_C19]G_`%_PZ^\+KNOZ_P"'7WF5_8&A
M_P#0&TK_`,%ME_\`&*/[`T/_`*`VE?\`@MLO_C%:N]/[R_\`?0_QHW*>C*?Q
M'^-*S[?U_37WCNN_]?TT97]@:'_T!M*_\%ME_P#&*/[`T/\`Z`VE?^"VR_\`
MC%:V1ZC\Q32Z@'#)G!QE@!G'&3V&>M`&7_8&A9Q_8^E9ZX_LZRSCU_U%']@:
M'_T!M*_\%ME_\8K\5_B?^VI\</@=^W5\0;#XN>,KOPO^S_HGP=\2:_\`#SP-
MI_PLTKQ?\,?BAJ&C77C>3P]IUK\;O#GB*X\5_#SXW>*+SP;XAT--%\?Z+IOA
M>ZU7PUJ'@'PWX5U_5K[0O%VH=)\4_P!J3]I7P_I7[1OC#2_'6DZ*/V'?V4?@
MG^T%XM\)GX?Z!J&E?M&^*O''ASX@_$3QYH%WJE\@UOPKX.;P]\/)?`?PXF\#
MSZ-KFF^-=0U36_$NI>+[31HO#%P6?;^OZ:`_83^P-#_Z`VE?^"VR_P#C%']@
M:'_T!M*_\%ME_P#&*^3?VT/$/CCPO\&)?'7@#XM?$?X7>)M-U#0]!\,:!X#\
M.?"#5M2^)7Q!^)GB#P_\/?A;X"U5OB_\.?B-9:+::KX^\3:#IUWJFBV5I=:=
M!?:A?W<MY:Z>+8=#X`\6?$3P7\5/AS\#/B1XWB^)>KZS^S7_`,)??^-V\.Z/
MX6O-:\>_"CQ/X-\&_$WQ+/I/AZRM-$TRP\=7'Q.\)ZQI>@6B0V^@RZ3J=OIZ
M26MTR6H!](_V!H?_`$!M*_\`!;9?_&*MVNGV-CYGV*RM+3S=OF?9;:"W\S9G
M9O\`)C3?MW-MW9VY.,9.;6]/[R_]]#_&G9!Z$&@`HHHH`****`"BBB@`HHHH
M`**\GO?CS\#]-\2-X-U'XQ_"JP\7I=_8&\*WOQ$\'VOB-;WS%A^R-HD^LQZD
MMT976(6S6RSF0A!&6(%>L4`?AK_P4VLDU#_@HQ_P0PLY)[ZV2?\`:K_:>5I]
M.O;G3KU`O['GC]_W-Y:217$.XJ$D\N13)$TD3'8[`_&W_!8']K']IO\`9E_:
M:\'>`?@A\=_B/X&\):G\%/#7BJ^TB'5-.UI9]>O_`!?XYTRZU`W?B32=8OT>
M6QTC3H&ACNDM1]F$B0)))*S_`&I_P4G_`.4DG_!"G_LZW]J#_P!8Y^(-?E1_
MP7Y_Y/+^'_\`V;GX._\`4]^)=?MWT?LMR[-O$2AA,UR_`YGA'E.9U'A<PPF'
MQN&=2$:/)-T,33JTG.%WRRY>:-W9J[/QGQWS',,KX!KXO+,?C<NQ4<TRV"Q.
M`Q5?!XA0G5FIP5;#U*=10DM)1YN62W3/BK_AYU^W]_T=5\3?^_?@_P#^92C_
M`(>=?M_?]'5?$W_OWX/_`/F4KX2HK^\/]1.!_P#HC.$__$<R?_YC\OS[L_B3
M_7;C/_HK^*/_`!(,V\O^HOR1]V_\/.OV_O\`HZKXF_\`?OP?_P#,I1_P\Z_;
M^_Z.J^)O_?OP?_\`,I7PE11_J)P/_P!$9PG_`.(YD_\`\Q^7Y]V'^NW&?_17
M\4?^)!FWE_U%^2/N]?\`@IS^W\64']JKXFX+`?ZOP?Z_]BI7]?W["MQXB^+O
M[(/[//Q,^(?CGQ]XB\;^-?AAX>U_Q/KDOB[5["35-7O4F-S>-9:3-I^FVS2L
MH)BLK.W@4`!(EP<_P*)]]?\`>7^8K^^W_@F9_P`F"_LG_P#9&/"G_HNXK^<?
MI*\.</9-PKD5?)\AR7*:]7/U2JULLRO`X"K4I?V=C)>RJ5,+0I3G3YHQER2D
MX\T8RMS)-?T']';B#/LWXFSNAFV>9QFE&GD,JM.CF.9XW'4J=58_`052%/%5
MZL(5.24H<\4I<LI1O9M/T/XW_L9_`#]I'1-%\.?'+PSX@^(^A^'=8?7]$T[6
M_B%X^MX-.UB2PN=+>_A.D>(].E:9K"\NK;;+))$$F<B,.=P^:_\`ASE_P3I_
MZ-ZC_P##E_%S_P";FOTZHK^4LNXPXLR?"PP.4\3\099@J<ISIX/+\YS'!X6$
MJDW.I*%##XBG2C*I-N<VH)RDVY7;=_Z>S#A+A;-L5/&YIPUD.98RI&$9XO'Y
M1E^+Q,XTXJ%.,Z^(P]2K*,(1C""E)J,4HJRT/S%_X<Y?\$Z<Y_X9ZCSC;G_A
M9?Q;SMSNVY_X3G.W=\VW.-W.,\TO_#G+_@G3_P!&]Q\=/^+F?%SC_P`OFOTY
MHKN_XB'Q]_T6_%W_`(D><?\`S9Y?GW9Q?Z@\"_\`1&<*]/\`FG\IZ6M_S">2
M/S&_X<Y_\$ZL8_X9[3'I_P`+,^+F/R_X3FD_X<Y?\$Z?^C>H_P#PY?Q<_P#F
MYK].J*/^(A\??]%OQ=_XD><?_-GE^?=A_J!P+_T1G"O_`(C^4]+?]0GE_5V?
M,/P3_8]^!'[.7AO4_"'P0\/^(_AUX9UC7)O$NIZ/HOQ!\>7%K>:[/86&ES:E
M(VK>(M1G6>33]+T^U98Y4B\NTB(C#[F;QC_@H1J7BGX*_L9_'_XI?#3Q[X_\
M,^._!G@N/5?#6O0^+=5U"33+\Z_HMF;A;+6)=1TRY)M[N>/9>65Q%B0GR]X5
ME_06OST_X*M_\H\_VIO^R=1?^I3X<J>%Z];.N.^&:N<5JN;5<PXHR&&/J9E.
M6.GC85<SPE*K'%SQ3JRQ,:E+]W4C6<U.G[DDXZ#XDH4<GX)XBI912IY72P'#
M>=2P-/+H1P4,'*GE^*J4Y86.&5-8>5.I^\A*BH.$_?BU+4_DA;_@IS^W\&8#
M]JKXFX#$?ZOP?Z_]BI3?^'G7[?W_`$=5\3?^_?@__P"92OA1_OM_O-_,TVO]
M+EP)P/9?\89PGLO^:<R?R_Z@_P"M>[/\ZO\`7;C/_HK^*/\`Q(,V\O\`J+\D
M?=O_``\Z_;^_Z.J^)O\`W[\'_P#S*4?\/.OV_O\`HZKXF_\`?OP?_P#,I7PE
M13_U$X'_`.B,X3_\1S)__F/R_/NP_P!=N,_^BOXH_P#$@S;R_P"HOR1]V_\`
M#SK]O[_HZKXF_P#?OP?_`/,I7[&?\$9OVG/VC/VH_C'\9?"_QU^.'Q%\>:'X
M7^&7A_7]"L;C5K/1%L-6O/%SZ;<W:S>&=-T6YG,MF%A,5S/-`JC<D2R'?7\P
MU?T#_P#!O/\`\G!?M"?]D:\+?^IX]?FOC!PAPGE_AKQ7C,!POP[@<90P6%E0
MQ>#R3+,+B:,I9G@8.5*O0PL*M.3A*47*$XMQE*+=I-/]$\)N*^*,?XB\+8/'
M<2\08W"5L9B(UL+B\YS+$X:M%9=C)*-6A6Q,Z52*E",DIQDE*,9)729_4;??
M#R":RO(K+Q-XYMKR6UN([2Y;QOXF=;>Y>%U@G9#J#!Q%*4D*E2&"X((.#^-0
M_8=_X*Y8`/\`P4XLB0J@G_A`YAE@!N./[)X!.2!VZ5^[-%?P?D'%&/X<6*6"
MP>18M8QT74_MGA_)L\=/V'M5'ZL\VP6+>&4E6E[54/9JLXTW5YO90Y?[<SWA
MK`\0O"O&8O.\+]4594UE&>YODJJ>W=%S^L+*\9A5B7'V,?9.NJCH\U3V?+[2
MHI?S*W__``1<_;4U3XMZO\=-1_;.^']W\4]?\-ZCX6UGQ1)\/-77[=I^LV^H
M6.L:@^B111^&X/%6JZ5JNI:+?^-;;1X?%MSH]]=6,FLLEQ.TFQXD_P""0'[?
M?C2_\(:OXR_;R\-^*-8\$Z'X9\-:3J.H^$?%,']H:!X,U:W\0>$]&\7Z;IL]
MEHWQ!T?PWXCMHO$^A:/\0-/\4Z5H_B9[O7=,LK34-1U"6Z_I2HKWO^(DYSS*
M?]C<#\R4E_R0?"/+[[@Y-P_L?D;O!<LI1<H+F4'%3J*?A_\`$/,H<>5YOQG:
M\'_R6_%7,G!2C&T_[6YXJTI<R4E&;Y'-2=.#7\Y(_P""4G_!14KJZR_\%!=+
MO$USXOZ3\?-2CU+P_P",-6BD^+NA2Z!/HOC*TBU2YO(M)ETNX\+:!<V.@:.F
MG^$K>[TY;N/P^+JZOIKKN#_P3O\`^"J;>+X_'4O_``4JT^7Q/;^&9/"%CJ3^
M!KTR6.@7>JPZWJ=E;H;`P#^U=2LM*GOIO($\JZ/IL)E,4&T_O]13?B7G<G!O
M)^"/<ES1Y>`^$8J_*X>\HY.E.-I2M":E!2Y9J//"$DEX=9-%22S?C/WX\LK\
M<<5R=N:$_=<LV;@^:"]Z#C+EO!R<)3C+\?O@;^Q__P`%(/"7Q8\$^(_C7^WZ
M_P`3?A;I6I7<_C'P'I?AR]\/W_B33Y-'U.VM;.VUFVL;6>P>#5Y]-U%I8[B)
MGBLI+<MB8@_K'HGA^WT+[1Y&H:]?_:1#O_MO7=4UKRO)\S!MO[2N;C[/O\P^
M=Y(3S=L>\'RUQO45\QGV?XOB'%4<7C,-E.%J4<.L-&&3Y-EF2X>4(U*E7GJ8
M;*\+A*%6LY59)UZE.55TU3IN;A3@H_2Y)D>%R##5<+A,3FN*IUJ[Q$IYMF^9
M9Q7C.5*E2<*>(S/$XJM2HJ-*,E1A.-)3E.:CSSG*11117AGLA1110`4444`%
M13PQW$$T$T:S1312121.,I)'(C(\;#^ZZL5;V)J6D;H><<'G.,<=<]L>O:@#
M\>?B5\0OVEK'XM:Q\&/AW\!-*T?X0^!_B]X5M;KPQ;_LTZUJ_@7XG?#;QMK?
M[/\`X0\->'XO'5PJ^!)8-8L/%O[2OQ1\?^-/"6GR#X-6?PD\&Z!X_MK0:G<G
MQM^O&EZ;8:/IMCI.E65MIVF:;:6]AIVGV4*6]G96-I$L%I:VMO&%C@MX((XX
MH8$54BC58T554`?@UX_TKPG8?MU?$'7O$?PJ_9M^+&GR_M"_"6T?XW_%3X7_
M`+2WC76/@KXDU+1_A9IFA?#-OC;9_"_Q!\%_`.O6UW<>']5\`^$+/Q-H_ASP
MSXF\4Z3;^+-8T_Q+XMB:Y_?,<CMU/3ZGKTY]1V.:`/P[_P""ERS/_P`%'O\`
M@A8MO*D$Q_:M_:?V2O#]H5<?L=_$`MF+S8=^Y05_UJ[20XW;=I_*7_@O='=Q
M_MC^`%O;J*ZE/[.WA`B6*S^Q*L9\>_$K"F(7-UN(.YB_F#A@@3"!F_6#_@I/
M_P`I)/\`@A3_`-G6_M0?^L<_$&ORH_X+\_\`)Y?P_P#^S<_!W_J>_$NOWOZ-
MW_)S,/\`]B;-?_2:!^&_2%_Y-UB/^QME?_IV?I^9\=>$OV6_`OCO]E?2?B)X
M)E\:>-_BIJWCCP]X>U;4?"6M^"=2\,_#+5=?NI]%3PE\2_AY+=VWCK1O#5A-
M/H>JZK\2;9KIHYM=TR[LM-D\)?;IH_-](^#?P?UK1_VL;JR\8>-IM?\`@IX=
M\5ZY\.M`32+%+#4](\'?$OX>_#^Z\5>-_$LH$4H\0MXLOY]#\'>&M,CN[![=
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M5K"X_P!KA:BC+'/`XVE3Q6&5"O>3IXFI2JUYXF=1RDJ-2,:B@J=#N[G]G[X?
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ML3X4L=/MXXYO#.EWL>OZ?X/U2-=>\*V^CZ\9-3DO$9=Q;/`8RAA\?3I8RKB*
ME;#XB>(J5(*7L)TH2?)"C4P^&EBJM'&QP=*=2GAU@Y49K&X?$5,'.</C^%H8
M_!UZ^!JU,)3H4Z=>A"A3ISY?;TZLXISG6I5\1'#4JN#EBZL*<Z[QBKP>#KX>
MGBZ?(>./`EMX7\/?##Q)97$\L/C71?%-MJUO/+'-_9WC;X=>-]4\%>,+:RE2
M&!I-%O3!H>O:+Y\9N[>VUF6PN9;A[(7$O]Q/_!-2WUI_V"_V4VMM5M((3\&O
M"ICBDT@SNBF.XPK3#4X?,(Z%O*3.-VT;B!_#)XI\:+XA\/?#'PI9V$FG:1\.
M/"^HZ/`)[H7=QJGB#Q/XHU/Q;XO\03.L<8A34=0OK'3]/LR99;32=#T];FYN
M+N2YD/\`=E_P3,_Y,%_9/_[(QX4_]%W%?AOTF8XE<$</+%MNLN*\6XM\M_JS
MH9J\$I<KDN98-T%-.4I*:DI2E*[?[3]')X=\99Z\*DJ7^JV&4K<UOK"K90L8
MX\RB^5XQ5W"T8Q<6N6*C9+[+^R>(?^@U8_\`@C;_`.7%'V3Q#_T&K'_P1M_\
MN*WJ*_B(_LLP?LGB'_H-6/\`X(V_^7%'V3Q#_P!!JQ_\$;?_`"XK>HH`P?LG
MB'_H-6/_`((V_P#EQ1]D\0_]!JQ_\$;?_+BMZB@#!^R>(?\`H-6/_@C;_P"7
M%?GY_P`%4K?64_X)\_M1M=:I:7$`^'<1DACTG[.[K_PE'AWA9SJ4_EGISY3^
MN,@5^D-?GI_P5;_Y1Y_M3?\`9.HO_4I\.5]5P+_R6_!O_95</?\`JWP9\QQM
M_P`D;Q;_`-DUGO\`ZJ\4?P:/]]O]YOYFFTY_OM_O-_,TVO\`5V.R]%^1_E\%
M%%%,`K]_/^#?..]E^/W[00L;J&TD'P<\+EWFL_MBLO\`PG;X4)]JM=A!SEM[
M9S]W*C/X!U_0/_P;S_\`)P7[0G_9&O"W_J>/7Y;XV:^%G&/_`&`X3_U:Y>?I
MG@Y_R<WA'_L.Q/\`ZK,<?U9_9/$/_0:L?_!&W_RXH^R>(?\`H-6/_@C;_P"7
M%;U%?YDG^CA@_9/$/_0:L?\`P1M_\N*/LGB'_H-6/_@C;_Y<5O44`8/V3Q#_
M`-!JQ_\`!&W_`,N*/LGB'_H-6/\`X(V_^7%;U%`&#]D\0_\`0:L?_!&W_P`N
M*OV,.HQ>;]OO8+S=L\KR;$V7EXW;]V;R[\S=E<?ZO;M/WMW%^B@`HHHH`***
M*`"BBB@`K-UF\FT_2-4OK>."6>STZ^NH([I[N.VDFMK6:>-+B2QLM1O4@=XU
M69[2PO;I8RS6]G=3!()-*LW68+FZTC5+:S\HW=QIU]!:^=>7VGP_:);6:.#S
M;[3&74K*/S63S+NP9;VV3,]HPN(XS0!_/K>_%;PA\3OVC=`U"QT32'\%_$/X
MH?"#Q9XU^'UO\6_V^_"GPY\:?$S2W\#6Z^-?$/PDNOV!8O"&I:SH'B#0M-DT
MVTO/BKX*\`^/F\*>%_$7Q3TFUO+G7#;?T-KTX[$C\B>3D#D]2?7N>I_`2UTW
M6/#7[2>F>!?"\7Q'\8VG@#XC_##PUXVU'PS\??\`@MG\9-`\,>+IM+\#>)/$
M_A_Q%XFT1/%_[/;W&DOKZWUQH?CCQ0V@V7AN]TC_`(6?!I$%YK-G;_OV/ZGU
M]3Z__J].,4`?AW_P4N:9/^"CW_!"QK>))YA^U;^T_LB>;[.K9_8[^(`;,OE3
M;-JDM_JFW$!!MW;A^4/_``7QN9O^&Q_`!U".UL9O^&=O"`6%=0CN@T8\>_$K
M;(9&M[0@EMR[?+(^7>'P^U?UD_X*3_\`*23_`((4_P#9UO[4'_K'/Q!K]HKW
MPWX?UAX;G5=#T?4KA+>.!)]0TNPO9EA4LZQ++=6\TBQJ\DC+&&"!G=@H+,3^
M@>&G&\/#[BBEQ%4RV6:QIX+%X3ZI#%K!-O%*"53V[PV+24.2[C[%\U[*43X3
MQ%X,GQYPW4R"&8QRN53&83%?6I85XQ)8:<I.'L5B<+=SYOB]K[MOA>Q_F??:
M;;_GYM_^_P#%_P#%T?:;;_GYM_\`O_%_\77^EI_P@W@S_H4_#/\`X3^C_P#R
M%1_P@W@S_H4_#/\`X3^C_P#R%7]%_P#$V&&_Z(:M_P")'#R_ZD?K_6_\_P#_
M`!*]B/\`HM:/3_FGY^5_^9UZ_=]_^:7]IMO^?FW_`._\7_Q='VFV_P"?FW_[
M_P`7_P`77^EI_P`(-X,_Z%/PS_X3^C__`"%1_P`(-X,_Z%/PS_X3^C__`"%1
M_P`388;_`*(:M_XD</+_`*D?K_6Y_P`2O8C_`*+6CT_YI^?E?_F=>OW??_FF
MI<6V]?\`2;?[R_\`+>+U'^W7][?_``33NM8'[!7[*7V33+*YM_\`A3/A7RIV
MUCRC*GEW&U_+73)PFX<D"60#.W<2I)^U_P#A!O!G_0I^&?\`PG]'_P#D*NBM
M;2VL;>&TL[>"TM;>-8H+:VABMX(8U^['%#"B11HO\*(BJ.P%?EGBOXT4O$O)
M\MRJGP[4R9X#,EF#KRS6./55+"U\/['V:R[!\FM?GY_:2MR<O(^927Z9X7^#
M]7PZS;'YG4S^GFRQN7/`*A'+)8%TF\3AL1[7VCS#%J:7L'#DY(OWE+GTL\G[
M7XA_Z`MC_P"#QO\`Y3T?:_$/_0%L?_!XW_RGK>HK\'/V\P?M?B'_`*`MC_X/
M&_\`E/1]K\0_]`6Q_P#!XW_RGK>HH`P?M?B'_H"V/_@\;_Y3T?:_$/\`T!;'
M_P`'C?\`RGK>HH`P?M?B'_H"V/\`X/&_^4]?GY_P52N-9?\`X)\_M1K=:7:6
M\!^'<0DFCU;[0Z+_`,)1X=Y6`Z;!YAZ<>:GIG)%?I#7YZ?\`!5O_`)1Y_M3?
M]DZB_P#4I\.5]5P+_P`EOP;_`-E5P]_ZM\&?,<;?\D;Q;_V36>_^JO%'\&C_
M`'V_WF_F:;7M'P.^!_B?X]^-QX0\.ZKX:\-VMLMG=>(/%OC'4CIGAOPU8:GK
M%CX>TRXOGABN=0OKK5-?U33='TK2]+L[N^OKV[7:D=O!<W$4^G?L_P#CC4=2
MM=/_`+7^'5I;7GB'Q5H</B:?XA:#/X'EL?`O@VP\>^-/&=IXRTUK_1M2\#>'
M?#6K:-/<:UIDMY?:AJ6L:?X?T?1=0\0-<Z7;?ZESS?+*->MA*N-P]/$86A"O
MB*,II3I4ITZE12DNZI4IUIQ5YTZ*C5J1C3J4Y2_S.IY5F-:A0Q5+!UYX?$U9
M4*%6,&X5*L)TZ;C%]G4JPI0FTH3JN5*$I5*=2,?$**^F(?V7/%\ERTTOC;X9
M1>$+CP%H?Q(T#XB6VI^-==\(^+?#?B'QU<_#6PC\.VOAGP!K7CB37H/&^G:S
MH&L>']5\%Z3J.B76B:I)J4<%K%;W%SYEX1^%NM>/?B%/\//!^L^%=8FM8O$V
MHW7B^75+W1/`UEX7\&:+J'B/Q7XUU'6-?TG2]4TSPMH6@Z5J.IWUQ?Z#;ZMY
M=M]D@T>;4I[:RF*><9;5AB:L,7!TL'2G5Q=5QJ1HX:-.'M*L:]64%3IUJ,-:
MU"4E7HV:J4XM-)U,IS&E/#TYX6:J8NI&GA:2E3E5Q$IRY*<J-*,W4J4JLK*E
M7C%T:MU[.I)-7\TK]_/^#?.2]B^/W[01L;6&[D/P<\+ATFO/L:JO_"=OA@_V
M6ZWDG.5V+C'WLL,?C?XK^`OC+PM93:S'J7A+Q5X;D^'5M\6-!\3^$-9O-2T;
MQ;\/V\9_\*^UK7O#W]I:/HVJ&;P;XQ#Z)XXT+7-+T37_``U/%/<76FR64+7)
M_9O_`(-Y^/V@OVA`>O\`PIKPM_ZGCU^;^,6+PV-\*>,JF%K0K0C@\+3FX/6G
M46:9<YTJD7:4*M-ODJTY*,Z=12IS4:D)1C^A^$N$Q.#\4.$*>)HSHSEC,14@
MII6G3EEN/Y:D))N,Z<TN:G4@Y0J0<9PE*$HR?]6?VOQ#_P!`6Q_\'C?_`"GH
M^U^(?^@+8_\`@\;_`.4];U%?YI'^BA@_:_$/_0%L?_!XW_RGH^U^(?\`H"V/
M_@\;_P"4];U%`&#]K\0_]`6Q_P#!XW_RGH^U^(?^@+8_^#QO_E/6]10!@_:_
M$/\`T!;'_P`'C?\`RGJ_8S:C+YOV^R@L]NSRO)OC>^9G=OW9L[3R]N%Q_K-V
MX_=V\WZ*`"BBB@`HHHH`****`"D/0XZX./\`)X_.EIKL%5F+!0JLQ9B`J@`D
ML22``.I)(&.I`YH`_)[7_@9\?X/VK/&WC=?`'Q4\5>!O$WQ<\$^)]&\3^%_V
M]O&GP-\):-X5TS0_!FD7=GJG[./P]T32?"GC%=)N=%U6_P!2F\7W>O>)/B-:
MW7]B>)-6&CVFC:?8_K$/ZGOGN?\`..W3M7Y,:]?_`!RUC]J7Q3/XAN/VW]0\
M!0?%/P3'\,+[X%^._P!C+PU^SN?AX-*\)/<V?BSPYXF^)O\`PNC7H[;Q/_PD
M\_CS5KG26U_7-,O&L?".DV]O9:;I</ZSC\>IZX]3Z=O3OC&>:`/P\_X*73"W
M_P""CW_!"R9HYI`G[5O[3Y*6\,EQ,<_L=_$!?DAB5I'QG<VU3M0,QX4U^TJ:
M_;A$']GZ]PJCG0M4!X`ZC[-P?4=J_%__`(*3_P#*2/\`X(4_]G6_M0?^L<_$
M&OV[C`\N/@?<7L/[HH`QO[?M_P#H'Z[_`."+5/\`Y&H_M^W_`.@?KO\`X(M4
M_P#D:MS`]!^0HP/0?D*`,/\`M^W_`.@?KO\`X(M4_P#D:C^W[?\`Z!^N_P#@
MBU3_`.1JW,#T'Y"C`]!^0H`P_P"W[?\`Z!^N_P#@BU3_`.1J/[?M_P#H'Z[_
M`."+5/\`Y&K<P/0?D*,#T'Y"@##_`+?M_P#H'Z[_`."+5/\`Y&H_M^W_`.@?
MKO\`X(M4_P#D:MS`]!^0HP/0?D*`,/\`M^W_`.@?KO\`X(M4_P#D:C^W[?\`
MZ!^N_P#@BU3_`.1JW,#T'Y"C`]!^0H`P_P"W[?\`Z!^N_P#@BU3_`.1J/[?M
M_P#H'Z[_`."+5/\`Y&K<P/0?D*,#T'Y"@##_`+?M_P#H'Z[_`."+5/\`Y&K\
M_/\`@JEK$-U_P3Y_:CA6SU>)G^'<2B2XTB_MX%_XJCPZ<R3S0)'&..K,!C/I
M@_H_@>@_(5^>G_!5L#_AWG^U-P/^2=1]O^IH\.5]5P+_`,EOP;_V57#W_JWP
M9\QQM_R1O%O_`&36>_\`JLQ1_&Q^R%\8_"WP,^->B^.?%NI_$K0=-@:&V?Q#
M\,=7LX-3TRV^W176HVNO^%=3M9]*^('A76;6!;+4O#5W/8S6UY'INN6,\UQI
MK6=QZ!XQ^+/[.WQ;U?X9>(?'OA7Q-X.^'OA+QW\34\4_"[X8?\(G9>--8TSQ
M/HG@CQ!HGBNP80^&?!6DS^,O&>@>(F^)=SX4M=(M_#6HZCL\$Z39VUUHDEK\
M./\`?;_>;^9IM?Z>XCAO`8G,Y9S[3%T,PGA(X15\/B)4W3I*AB\/S4E9JG55
M/&U73J*_L*J56@J4ZN*>(_S;PW$&.PV6PRGV>$KX"&)>*="OAX5%4JNO@\0E
M5>CG2=3!4E4@[>VIR=*LZD*>&5#[=U3]H?PG=^+/%+Z1\2?VA_`'A+7OAMX6
M^'OAMO@_H7@SX9#X<>'?!_BBXU[2?AYH_@>U^).L_P!N^`T6:34UU>7XHZ#X
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MR+@\,P"G#<\5^`5?T#_\&\X!_:"_:$R,_P#%FO"W_J>/7YWXL91A,I\*>-*6
M$4HQJ8/"2]YIV<LWP56J[145>MBJV(Q4W:WM<1.,%&E&G3A]]X6YIBLT\4>#
MJN*<93AC,3&\4]5'*L72IIW<G:EAJ.'PT%=_NZ$)2<JDJDY_U:?V_;_]`_7?
M_!%JG_R-1_;]O_T#]=_\$6J?_(U;F!Z#\A1@>@_(5_FZ?Z%F'_;]O_T#]=_\
M$6J?_(U']OV__0/UW_P1:I_\C5N8'H/R%&!Z#\A0!A_V_;_]`_7?_!%JG_R-
M1_;]O_T#]=_\$6J?_(U;F!Z#\A1@>@_(4`8?]OV__0/UW_P1:I_\C5>LM0CO
MO,\NWOX/*V9^VV%U9;M^['E_:8H_,QM._9NV97=C<,WL#T'Y"EP!T`%`!111
M0`4444`%%%%`!52_LXM0LKRPG6-X+VUN+29)H(+J)HKF%X)%DMKJ.:VN(V21
ME>"XAE@E4F.:.2-F1K=%`'YHZ9^P/X8\,>(])N?"G[/W_!.O3I-#OM/U30_B
M1'^QOX>TOQ]H6I:9<P7>FZM::/H.K6&D?\)%IMS;Q7=IK6F>)?#\$6HQ0WUI
MHUBD268_1_2K:[LM,T^TU#4'U:^MK.V@O-4EMK6RDU&ZBA1+B^>TLDCM+5KJ
M8/.;>VC2"$OY<2[%%7Z*`/P\_P""ELT-O_P4?_X(5S3RQPQ)^U;^T^7EFD2*
M-<_L=_$!1NDD947+$*,L,L0HR2`?VICU_0Q&@_MG2N$4<:E8D=!W%Q@_4<5^
M+/\`P4I57_X*1?\`!"I6564_M6_M095@&!Q^QU\02,@@@X."/0@$<U^VT=M;
M>6G^CP?<7_EC&.P[!<4`4O[?T/\`Z#.E?^#*R_\`C]']OZ'_`-!G2O\`P967
M_P`?K0^RVW_/O!_WYC_^)H^RVW_/O!_WYC_^)H`S_P"W]#_Z#.E?^#*R_P#C
M]']OZ'_T&=*_\&5E_P#'ZT/LMM_S[P?]^8__`(FC[+;?\^\'_?F/_P")H`S_
M`.W]#_Z#.E?^#*R_^/T?V_H?_09TK_P967_Q^M#[+;?\^\'_`'YC_P#B:/LM
MM_S[P?\`?F/_`.)H`S_[?T/_`*#.E?\`@RLO_C]']OZ'_P!!G2O_``967_Q^
MM#[+;?\`/O!_WYC_`/B:/LMM_P`^\'_?F/\`^)H`S_[?T/\`Z#.E?^#*R_\`
MC]']OZ'_`-!G2O\`P967_P`?K0^RVW_/O!_WYC_^)H^RVW_/O!_WYC_^)H`S
M_P"W]#_Z#.E?^#*R_P#C]']OZ'_T&=*_\&5E_P#'ZT/LMM_S[P?]^8__`(FC
M[+;?\^\'_?F/_P")H`S_`.W]#_Z#.E?^#*R_^/U^?7_!536-)NO^"?'[4D-M
MJ>G3S/\`#N()%#?6DLKG_A*/#IPD<<S.QXZ*I_45^BOV6V_Y]X/^_,?_`,37
MY[?\%68($_X)Z?M3,D,*L/AU$0RQ(&!_X2CP[T8+D=>Q]#V%?5<"_P#);\&_
M]E5P]_ZM\&?,<;?\D;Q;_P!DUGO_`*K,4?P<O]]O]YOYFFTY_OM_O-_,TVO]
M78[+T7Y'^7P4444P"OW^_P"#?"\M++X__M!27EU;6B-\&_"ZJ]S<0VZ,P\=N
M2JM,Z*S`8R`2>1QR*_`&OZ!?^#>J..3]H']H,2(D@'P:\+$!T5P#_P`)XXR`
MP.#]/;T%?EOC9?\`XA9QC;?ZCA-_^QKEY^F>#G_)S>$?^P[$_P#JLQQ_5Y_;
M^A_]!G2O_!E9?_'Z/[?T/_H,Z5_X,K+_`./UH?9;;_GW@_[\Q_\`Q-'V6V_Y
M]X/^_,?_`,37^9)_HX9_]OZ'_P!!G2O_``967_Q^C^W]#_Z#.E?^#*R_^/UH
M?9;;_GW@_P"_,?\`\31]EMO^?>#_`+\Q_P#Q-`&?_;^A_P#09TK_`,&5E_\`
M'Z/[?T/_`*#.E?\`@RLO_C]:'V6V_P"?>#_OS'_\31]EMO\`GW@_[\Q__$T`
M9_\`;^A_]!G2O_!E9?\`Q^K=KJ%C?>9]BO;2[\K;YGV6Y@N/+WYV;_)D?9NV
MMMW8W8.,X.)?LMM_S[P?]^8__B:>D44>?+CCCSC.Q%3.,XSM`SC)QGIDT`24
M444`%%%%`!1110`4444`%%%%`'X@?\%)_P#E))_P0I_[.M_:@_\`6.?B#7[>
M1\1H#UV+_(5^'O\`P4O@CN?^"CW_``0L@E#&-_VK?VGMP266%OE_8[^(#C$D
M$D4JX90?E=<CY6RI*G]I(_#>E^6GRWP^1>!K&M8'`XYU$G\R3[T`=#16#_PC
M>E^E]_X.-:_^6-'_``C>E^E]_P"#C6O_`)8T`;U%8/\`PC>E^E]_X.-:_P#E
MC1_PC>E^E]_X.-:_^6-`&]16#_PC>E^E]_X.-:_^6-'_``C>E^E]_P"#C6O_
M`)8T`;U%8/\`PC>E^E]_X.-:_P#EC1_PC>E^E]_X.-:_^6-`&]16#_PC>E^E
M]_X.-:_^6-'_``C>E^E]_P"#C6O_`)8T`;U%8/\`PC>E^E]_X.-:_P#EC1_P
MC>E^E]_X.-:_^6-`&]7YZ?\`!5L'_AWG^U/Q_P`TZB_]2CP[_@?R-?=O_"-Z
M7Z7W_@XUK_Y8U\W?M??LX7/[1G[-GQ<^"7AG7;;PQKOQ$\,IH>FZ_KLWB#5]
M)TR==7TS43<7NFV^I":ZB,=@\8CC(;S'1L[58'Z'A'&8;+^*^&,PQE54,'@>
M(<EQF+KR4I1HX;#9EAJU>K*,(RG)4Z4)S:A&4FE:,6[)^#Q5A,1C^&.(\#@Z
M3KXO&Y%F^%PM&+A&5;$8C+\12H4HRJ2A"+J59Q@I3E&"<KRDDFS_`#V'^^W^
M\W\S3:_H3;_@WD^.99B/VCOA+@DG_D1_&W<Y_P"@K2?\0\?QS_Z..^$O_A#>
M-O\`Y:U_HDO&WPKLE_KC@ME_S`YQY?\`4M\_ZNK_`,!?\0:\3?\`HD\9_P"%
MN4__`#P\U]Y_/;17]"7_`!#Q_'/_`*..^$O_`(0WC;_Y:T?\0\?QS_Z..^$O
M_A#>-O\`Y:T_^(W>%?\`T6."_P#"'./+_J6^?]75S_B#7B;_`-$GC/\`PMRG
M_P">'FOO/Y[:_H'_`.#>?_DX+]H3_LC7A;_U/'JW_P`0\?QS_P"CCOA+_P"$
M-XV_^6M?H]_P39_X);^._P!B7XC?$GQIXZ^*/A#Q]8^-O`^D>%;&P\)Z1XJ\
M.7=A=Z=XB;69+RZN;S5&2XMY82L"0(`Z2KO/R$@_GWBKXK^'N?>'W$V49/Q-
MA<=F6.PF&IX7"T\)F=.=:<,PP5:48SKX*E23C2A.?OU(IJ+2=VK_`'GACX7\
M>Y'QYPWFV:\.8G!Y=@L77J8K$SQ673C1A/`8NE&4H4<;4JR3J5:<;0A)^\G:
MUVOVHHK!_P"$;TOTOO\`P<:U_P#+&C_A&]+]+[_P<:U_\L:_@P_M\WJ*P?\`
MA&]+]+[_`,'&M?\`RQH_X1O2_2^_\'&M?_+&@#>HK!_X1O2_2^_\'&M?_+&C
M_A&]+]+[_P`'&M?_`"QH`WJ*P?\`A&]+]+[_`,'&M?\`RQJ_8Z;:Z?YIMA./
M-V;_`#KR]N_N;MNW[9<W'E_>.?+V;N-V["X`+]%%%`!1110`4444`%%%%`!1
M110!^('_``4G_P"4DG_!"G_LZW]J#_UCGX@U^WD?^KC_`-Q?_017S#\;_P!D
MKX:?'KXO_LP?&_Q?J/B_3O''[)'COQM\0_A4?#VJZ=::+/KWC_X>ZK\,]>C\
M6Z7?Z-J9UO3AX;UB\:PM[6ZTJ>UU+RKHW4T2O;2?00TK4P`!XCOL``?\@_11
MT]AIP'Y`"@#?HK!_LK5/^ACOO_`#1?\`Y7TC:7J@4G_A([X8!.?[/T4XX]#I
M_/TH`WZ*^1?V>O&GC_Q]XU_:ST?Q+XWNM1L?A=^TU>_#KP;!'HOA>U.C^$XO
M@/\``+QK'I,DEGI$,MX\?B'QOXCOQ=Z@UQ?NFHK`]P;6VLX8?IS^RM4_Z&.^
M_P#`#1?_`)7T`;U%8/\`96J?]#'??^`&B_\`ROH_LK5/^ACOO_`#1?\`Y7T`
M;U%8/]E:I_T,=]_X`:+_`/*^C^RM4_Z&.^_\`-%_^5]`&]16#_96J?\`0QWW
M_@!HO_ROKY=TGQQ\0+K]L[QU\()O&]T_@71/V8?A5\1M/T7^Q/"XF@\6^)OB
M]\:/"^KZL;Y=)&INEWHGA'0M/6TEN7T^+["]S!;1WD]S+*`?8%%8/]E:I_T,
M=]_X`:+_`/*^C^RM4_Z&.^_\`-%_^5]`&]16#_96J?\`0QWW_@!HO_ROH_LK
M5/\`H8[[_P``-%_^5]`&]16#_96J?]#'??\`@!HO_P`KZ/[*U3_H8[[_`,`-
M%_\`E?0!O45\H?&WQ;X\\'?%/]D'PSH/C>[L-(^*WQ]\6>!_&MHVB^&+AM:\
M.:7^RW^T5\2K+3HYKK29;BR:'Q=X!\,:J;G37MKQX].DM))FL+B\MY_I'^RM
M4_Z&.^_\`-%_^5]`&]16#_96J?\`0QWW_@!HO_ROH_LK5/\`H8[[_P``-%_^
M5]`&]16#_96J?]#'??\`@!HO_P`KZ/[*U3_H8[[_`,`-%_\`E?0!O45@_P!E
M:I_T,=]_X`:+_P#*^OEO]M?QO\0?@Y^RK\<OB;X#\<76A^,/!O@2^UGP_J\N
MB>%K^/3]1AO=/BCN7L]4TBYT^X"QS2)Y5W;S0GS"Q0NB$`'V%16`NF:H^YO^
M$BO@#)+@?8-&PH$C@*"=/)(4`*"26(&6))-+_96J?]#'??\`@!HO_P`KZ`-Z
MBL'^RM4_Z&.^_P#`#1?_`)7U?L;2ZMO-^TZE/J&_9L\ZWLH/*V[MVW[';V^[
M?D9\S?C:-NW+9`+]%%%`!1110`4444`%%%%`!1110`4444`%%?$WQ@_;<\)_
M";Q3\3]+C^&OQ*\>^$/V??#OA_Q7^TE\1O!MOX6D\/\`P7T'Q-H]UXGM9[_2
M]<\2Z/XH\;ZAH/@FV7XC>-M&\`:+K^I>%_A_>:;K+0ZAJNK:5X?O-74/VP--
MT+XJ>$O`WB;X/_%KPQX&^('Q7N/@5X$^,FMZ?X8M/"?BOXI1:!XF\1VMGIOA
M?_A)7^)2>!]=MO"'B#3/#'Q,N?!\7A/Q!J^G&>SN!X5U'0_%6J`'UAIVAZ+H
M\^KW.DZ1I>EW.OZHVMZ[<:=I]I93ZUK+6&GZ4VK:M+;0Q2:EJ;:9I.EZ<U_>
MM/=FPTVPLS-]FL[:*+4KP+QC\>[/P-\0-=\'ZS\/?B7=:%H7PJTWXE-X]\.>
M%;WQ9H>JZAJWCF;P-8_#?0=$\,IJOC+6?']Q=+::K#I=CX?ELWTO4+69[Z-A
M<>1\L7'_``4>\(WW[,?P!_:5\+_"[Q+)I_[0>JZU9:%X0^(/C_X0?"2]\&67
MAS3O&VI:]?\`Q`\9>-?&EO\`#S1GTT>"YM/:PT[Q-J]Q=:IJEE;V+7-O%?7E
MN`?I)17'?#WQ/>^-/`WA#Q=J&C1^'KSQ/X<T?7Y]%A\0:%XKATUM6L8;Y;2#
MQ-X8NK[P[K\$<<R&'5]#O+K2M0B9+FQN)K>2.1NQH`***^=_C3^T`OPM\2^`
M_AUX7^'7C'XO?%CXEV/C#7?"G@#P;=>%=&D7PC\._P#A&U\<^,_$7BCQQKWA
MOPOX>\/:%>>,O!V@0R76HS:EJ_BCQ?X=TG3=.E@FU34M(`/HBLI-"T2/6I_$
MD>CZ6GB*ZTNUT2ZUY-/LUUJYT6QO+W4+'2)]56$7\VF6=_J6HWMKI\EPUI;W
M=_>W,,*374[R?"'B#_@H-X5L/A:OQQ\-?!#XZ^+_`(0>'/ACK?Q;^,/C:VT+
MPCX<@^#GAKPAJWC?0/B%H&O:;XN\8Z)?>,?B9\,M6^''C=/B%\.OAJ/%NM>'
M;3PZTQEN[OQ'X'L/%?UGXV^);>$]1^$-EI_@[Q5XPMOBO\0X?`SZKX;M[)['
MP+83_#WQYX^7QQXR.HW=E/:^%!_PA,/AEI;"&\U,>(O%7AVW-@+::\N+4`]1
MHKY.^`_[8/PY^/=U^T,=(T3QMX#T;]G+QYIO@KQ3KOQ6T$_#^'5[+5/A)X&^
M,UKXYT[2-?GMO$6A^#)O"/CS3;F"\\;Z5X7U:2"TN]5DT>WT:;3[Z\N_LK?M
M5>%OVKM"^*GB#PIX0\:>#K3X7?&KQC\&KJU\=6FFZ=JFO2>&-'\*>(],\9:?
MIMAJ-_=:;X>\7^&O&>@Z]H=AX@32_$]I97BP>(-$TC44FL8@#ZDHHHH`**^4
M/BY^UWX!^"/Q`UCX>^/]"\6V.J2?":3XH?#:XL;*QOX?C-?Z?XNL/`VO?"[X
M<0I>QW5_\4M'\3>*_A?8KX9U*+3TUB+XJ>%KW1;V]L[#Q7+X?^2_B=_P4X\2
M_!W7?VE-+\??LA?%*QL?V7_AEX$^*OCK6-,^*7P)UB'4O#GQ:USX@^&/A3!X
M?L;?QK'?R:GXK\0?#7Q%97UOJD6FQ>&+5].U+5IS:79:(`_5&^T71]3N]'O]
M2TK3=0OO#VH3:MH%Y?6-K=W6AZK<:5J6A3ZEH]Q<123:9J$VB:QJVCRWMD\%
MS)I>J:CI[RM9WUU#+I5\R?!W]I`_$/QUXD^$/CWX:>+/@M\8_"_@_P`/?$*Z
M\#^*M6\&^)[/7?`GB76-;\.V7BOP?XP\!Z_K_A_7K'3O$?A_4?#WB73IWTGQ
M%X:U7^S7U/18](\1>&=6UCRSXO?MY>$?@A\*IOBAX\^$7QKM5/QQ\1_!>P\+
MZ=X3MM1U2XMM!_:!T_X`0?%34M:AU%?!_A?X9:YJ.M:#XST+4_$WB'2];UGP
MMKFF6FBZ%JGBJY70*`/NZBOB7XC?MB_\(9^TEH/[.FC?#>+Q%?ZB/A\FI>*-
M5^,GP9^'B0W?C[4=;B33O"_@KQQXKTSQY\0M1T'1-%DU_5+7PAH5\TT5Y::;
MIIO-3%U!;_;0_P`_T_.@`HHKPWXS?'CPU\"[[X72^.-,U:V\'?$CXAZ=\,;W
MX@PM8#PM\/?$GB;3[\^!+CQ[/<W4%SI/A_QOXKM+#X=:3KD$-S:6GCGQ/X2T
MS5?L5GK8U"V`/<JRM;T+1/$VDWV@^(]'TK7]#U2!K74M&UO3[/5=*U"U9E9K
M:^TZ_AN+.[@9D5FAN(9(R54E<J"/SGU;_@H/XB/Q*_9U\$>#OV6OB;XN\/?M
M3R^+KCX.^/'\>_"/PII^L>'/!.F7GBC5_%>J^&O$WBBS\6Z-H^I>`H+/QQX7
MBGTN34]9T?6=*M9K'3=5EN+*VV_V<O\`@H1H_P`=M/\`@=XCU_X(_$WX0^!_
MVGKG5[/]G[QSXIUCX<>)=`\:ZII7AWQ'XQM_#.OQ^!_%NMZS\/\`Q7XA\(^$
M/%GB'PWIGB;2H].U*'PQK.D2:W:>)1I6BZJ`?HE@#H,=3^).2?Q/)]Z*^>?%
M/[0EGX,\1?%W1];^&GQ6GTSX6>$OA7XCL->\,^$+GQBGQ.U7XJ:IXUT6P\%?
M#C0_#+ZCXAU;Q/X?U3PG86WB5=2T[2M%TJ+Q?H&IWFL6VC1:UJ6E^4R?MT?#
ME/V(?!?[;R^$_&LOAOXC?!/P_P#&/P)\*85\.2_%/Q/<>*?`<GC_`$3X=:9:
MIKK>%IO&<NE07G]HSKXC;PMHMII>M>(M4U^W\+:-J.LVX!]N45Y_\)_B)I7Q
M=^%WPX^*NAVE[8:+\2_`7@[X@:18ZD;<ZA9Z9XT\-Z9XEL+2_-G-<6GVVVM-
M4A@N_LT\UO\`:(Y/)EDCVNWH%`!1110`4444`%%%%`!1110`4444`%%%%`'Y
M9_M5_LJ?%S4+S]H"7X-W<.O?#/\`;8A\(^!OVK?!%KX?\/7GQ3T?PU'\-;OX
M+^*O'GP0UWQ7X\\#^"9-=\0_#.R\'>"]=T+QXUY;^&;'2;KXC>$1K_B"Q?X?
M>)NTT']FS]I7_AJVQ^,GCWQE\`?&WPN\$ZSJFD_!#P7_`,(;\4]&UGX'_#.\
MT&7PY)'X2L%\?W_@35OC%K^E-)IWBOXOZ_HUWJ;>'-0U'P5X,T[P;X3U#7-,
M\0?HQ10!QOC^+Q[+X.UR/X8W/A*S\>-:Q#PY<^.K/7=0\)17JW=NTC:U9>&M
M1TG6Y[4V8NE1-/U"VE^T-`SNT"RQO^:W[.W[&'[2_P`$OV;_`(-?!O4_'_[+
M7C'Q+^S]XGUC4O`>K:[\!?%VO^&M8TCQ':^+(M2FN[77OB+/XI\">-=/N/&6
MI+IGBCP1X@$%WH(O_#6L:3=6>NSW.G_JW10!X;^S?\%8?V>_@YX4^%$.N0^(
MVT"Y\5ZI>:K9:!9^$M'?5?&OC7Q)X\UFS\,>$M/NK^R\(^#=*U;Q/>Z3X*\(
MV^H:C%X7\)6.C:"-2U`Z>;V?W*BB@`KXZ_:7^#GQ7U/Q3X2_:-_9SU'P9'\?
M_A%\-_B[X"\.>$OB/I-W>^`_B;X0^*$W@+Q)J_@C6]7TC6=`UOPAJ?\`PF?P
MH\!:QX>\76E]=6-@;76-'UK2+C3M??4]&^Q:*`/QHD_8I_:<U/X=_!+P#X9\
M9?"]O@CX<L=3^*'Q$^!_[0W@#Q);>(/B/^TCX[^+'BGXS>./&'Q<F^!OQ:U#
MP7K?@*W\;>)+G6_#?P,TO4]7\"V>M3O=^,-;^(MKI/ARTTG]CXEN!;1B4P_:
MA"OF&-9!;FX\L>8RJ[F7RC*690[M)LQN8OEJL44`?E%X/_8?^/OBK7?VR-/_
M`&A?BE\-6^'7[8WBKP5X]\4Q?L^Z5\2OAW\1?"^O_#[X<?`_X5Z+H&F>*/&'
MBKQIH6J>#=?\-_!E9O&>G:IX9E;7H_%.L^&+V&[\.33PS^]?L6?L>ZQ^R5<?
MM(2ZO\;?B!\9A\=OC]KOQFLKCQ]<V%UJ'AJVU;PKX3\._P!G7%S8:7I<6IZ]
M=R>'7GUS6H;:RL;^VBT.UM-(TY],NI]2^XZ*`"BBB@#YC_:"_9WB^.'CO]DS
MQF^J:-IK?LS_`+1Y^/#P:GX>36[KQ!`?@3\;?A"N@:3>-<VY\/7RZE\5M*\3
M#6"E[&J^&!9BS%U<VE_8?,O[3G[`OB3X\+^W)/HGQ-T+PS>_M9_`#]F;X/\`
MAU=6\):GK%GX'UC]GKQI\9_&+:]K:V/B'2Y_$6E^*)/BE8V`TO39-$O=*CT6
M[F_M&\?4+=+/]-J*`/C[X,_`'XC:=\9?$G[1WQZ\8>!?%'Q4U7X9Z+\'O#.C
M?"_PGK_A3P+X'\!Z=XLU;QQK@@E\6>*?%?B?Q-XF\;>*+[3+W7=5OKK2=*T_
M2_"WAG1M$T"WGM]<UKQ!S?[??[/7QJ_:B^"T?P;^$GC+X6>![+6O%?@7Q+XO
MUGXE>%O&OBR79\-?B9X!^*7ANS\/V/A#Q9X42(ZCJ_@I]*UJ;4[BX,6G:@L^
MFK%<V[I/]RT4`?G/\6_V1_C%\=+'5M'\<>,_V?=)T_XK^$/A[X=^,FM^'O@)
M=7/Q,T6X\`ZQ-KPE^$/Q)U7QHNHVT-Q>W,]SX&NOB#I?B75/A!XCENO%_ABX
MU:[N(-)L/T74;1C.>6/_`'TQ8_@"<#VZYI:*`"OF']M']G@_M9?LI_'S]FY=
M:TOPW)\:/ACXF\`6_B#6M!/B?3-#N]<M1%::Q=Z"+NP?4UTVY2*\CMX[ZSF\
MZ*.2"Y@FC21?IZB@#Y:^*'[.MSX__:(_9/\`C=8^);#1--_9LO\`XTW=UX6.
MBRW$WB>'XJ?"\?#RRM]/U&"_M;;0UT"0+J,OG6&H)>VZBR@2S8"<?)/[+G[!
M/Q@^%_A/]E+X9?&CXL?#'QC\,?V,-6N_$WPLT?X=_#?Q1X;\0^./&</@_P`<
M^!/"OBGXCZ]XM\=>*+6QM?"6@_$7Q9?Q>&/"&CV<6L>*[K1=8N=<L],\/?V!
MJWZMT4`>>_%&T^)%WX&UJT^$EUX&LO'<R646C3_$>P\2:IX.2%KZW75%U:P\
M):MH>O3^9I)O8[+[#J=MLOFMI+@R6R2Q/^6/AO\`X)C?$+7_`-C?X-?LV_%C
M]H#4O#_C3]G/X&>*/V?_`(5^//V>&U_P+X7UCPOKWP?\-?"L^)?B3X$\?7'Q
M#&K^*9[?1]42YFT'5M%DT[P[XE\1^'?#^I:=:^(=9-U^R%%`'AO[,_P?O/V?
M_P!GWX,_!+4/&.L?$"]^%7PV\'>`[GQEKOE#4O$$WAC0K+27OY(X885M[5FM
M3%IEFRR36.EQ65E<75[<6\M[<>Y444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
80`4444`%%%%`!1110`4444`%%%%`'__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>biib-2015630_otherrevchart.jpg
<TEXT>
begin 644 biib-2015630_otherrevchart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`&"`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^2OVV_VF9_V1_@!J7QG
MMM$\'ZY<0?$?X&?#F&/XA>/'^&/@+1Y/C7\:_`/P=7Q9XT\=Q^'/%C^'/"W@
MT^.?^$IUV]30+]FTW2+B`"W\[[5#]:UX3^T1\"=%_:)\!Z)X!U_6+_1-/T7X
MO_`3XO+<Z?:65[+=ZA\!OC7X#^-6DZ+<07ZM;G3?$&J>`[/1-5E"FX@TV_NI
M[3_2HX:`/`O!'[=WPM@T7PE'\7?'OP?_`.$E\6/I>HQZW^SGXF^(/[0?P1T+
MPCXO\>ZA\-/AYXH\8_&O3/A=X<\+^!-,\8>.-(UGPC8ZEXW7P]H,OB71=:T[
M3]9U"+1=8N[#O-0_;2^#<OP!^.?[17@L^,_B!X%^`OA_XH:KXE/A[P!XXBO-
M<U?X1'Q79>-?"?A!-3\.V@\3:[HGB'P=K7AC6UT1=0M/#NM6TUOKMQ8_9KKR
M>/\`C9^PYX8^,7C_`,6^)U\?>)/!WA'XP>$/A;\/_P!H3X=:+HOA:\TCXL>#
M/@SXO\2>,/`VDPZUJ6FRZ_X$GE;QAXG\)^*M0\-W3R:[X,U=K*Q@T#Q'I^E^
M*[+OOAG^R?X+\`_LU>+/V8=0UO7?%'@OQO/^T*/$>J3BST?6[BP_:,^(OQ,^
M('BRRM'T^-[:R.F2?$_5M(T>Y2-Y$MK*RNIT>Y,P8`^:O@]_P5&^$GQ*\=GP
MSXF\*^,?AEX>U;X9_L6>._"?B;Q)X7\?7#C5/VT?^$]T[P7X6^)5G;^!(M.^
M$!MO%_A+1O`^@^(?'.MZ=HGCGQ+XNTJST6XB6:P?4?KSX3?M1?!/XW:_J'AO
MX<>*[S6-1M-*N_$.F2:AX3\9>&=*\:>%+#6E\-ZAXS^&VN>*/#^C:-\3/!5C
MK\EOI%WXN\!WWB#P]!>7VDE]0%MKFB7.H_&.@_\`!+[PY:>`_'7@OQ/\8_%7
MBB?QUX:_85\'7^MGPGX:T62/P[^P1\4I_B%\-(7TVQN)K.?4/%VG"Q\,>.KR
M)K.WG%O<ZSH.GZ-+>)IUGZK^R)_P3Z^$_P"QYXCU36?AY%X66UA\(R?#KP>N
ME_!WX1^"_%FG>!)->M?$"Z;XX^)?A3PK8^/?BCK-O-INC:7'KGB/6K2*]TO1
M--O-=T?6?%PO?%EX`?/7Q_\`^"A_[0'[/'C/]L:T\4?L_P#P8UCX??LB_`3P
M7^T;J?B#2OC_`..+?Q1XP\#?%3Q/\9_"_P`/M+B\.W_P`BT70?$=M<?!G5+[
MQR)?%6I:5HUGJ]F-!OO$DUM<+7U^G[=_[,Q\1:=X.F\:>(+#QGJ?CWQ?\-;?
MP9J_PO\`BGHGBZ#Q7X%\->#_`!WXDM]4\-:SX,T_6=%TNR^&_CWPI\4%\2:Q
M9V/AJX^&6J-\0(-7?PIIVJZK9<C^T!^PAX/_`&@+K]JZZUKQSXET!OVK?V=_
M@]^SQXC72]/TBY7PKHGP?\7?&3Q=IGB#1/MBDWFJZO<_&/5+2_MM1S900:/I
M[VV))[FL/Q'_`,$[?AKXO_:0\9?M">)?%GB75#X[\2?$77/$7@-K;3[70KNQ
M^)G[*7PG_9.U_0EU6U:+6H+0>$?A5::]!=0S1WJZSKE_")$M+>T(`/3-._;M
M_9HU3PS?^*[/QGXB:Q@/@%]$TV?X7?%6R\5?$&R^*U_JFF?"[6?A-X,O/!=O
MXL^+7A[XC7NAZW%X*\1?#K1O$FB^((M&U:]M+[[!IM[=0^P:;\=OAEK'PGG^
M->EZWJ-_\/[6WU>6[N[3PGXPNO$5I>>'M;O/#&O^'KGP';:!+X]B\8Z)XGT^
M_P##&K>"F\,_\)98>);&[T&YT:/58)+5?S=T;_@CE^S_`*3\,&^'CQ^`;R?P
M[KGPBU?X=:T?V;?V?=.M[-?@A:>+=,\&Q_%?P_I'@NPL?CM<:SHWC?7])\>2
M^-KFVL=66:WUSPEI/@+Q?%+XDN/K6?\`8R\)+^R+J7[)>@^*M1\!Z'J=C>FX
M\4?#+PGX`^&^S5M3\<?\+#UA8?`?@OPWHO@%/"/B#6FN-#\5>"CHK6/B[P-J
M.L^&O%&H:O<ZYJ^N7H!3O/\`@H3^RY8?8K2\\6>-8?$U]KGQ"\+K\/5^#'QF
MN/BA:^)OA9X+\*_$CQUX?U+X9VG@*X\<Z=K.B?#SQKX9\=K87>A1RZIX/U6'
MQ#I'V[38YYXN'^)O_!2'X*>&=0^$VE?#&6?XPW/Q/^.W[+_P<?6-!TWQI9>`
M=$M_VGG\/ZQX;U<?$^/P5J?P]O\`Q18?#OQ1H'Q(A^&\GB.P\4:EX7US0KZ:
M/2[36+*ZDX/X/_\`!+3X:?"'XK6WQ=T?QI/;:U)XN^)OCO5O#/A+X<?#SX;^
M`)/$GQ6_9S^$_P"SKXA'A_P=X)TW3=,\,Z/;:+\)=(\26%E`-0U"XUO4]3EU
MW6M:GF>_ER/AO_P2H\)_"[PI\'?AMX:^-_C]/A?\*OB-^RW\;KKP;-X;\%,?
M&'QJ_9B\)?#+P+9>,=1\0"P_MO3-&^(&@?"KPU?>*?!^GW+V=EXL6YUO0M2L
MM-N+CPY<`'KO[0O[<%W\%OCMI'P/T_PA\-I-5O\`X<^&OB+I=S\7?CKHOP*G
M^+$WB/Q?XE\)2?#/]GF3Q3X4U/PG\2OBKX:;P[;ZIXH\-^(/&7@*UTF'QA\/
M8)-0-KXIN-8T'N_#_P"VU\()_&7CWP+XI\2Z'IOB/PU\9O&?P>\-Z5X=M_'W
MB&_\2:]X,MO@V;_PZ\=[X`T"W/Q&%U\:O"UP?!?A6Z\86USX<EN/$VC>(=7T
M_0?&W_")0?M0?LCZI^TKIGC#P;>_&OQ9X9^%GQ3\`_\`"M?BE\,;KPAX`^(/
MAG5-!>+7;6Z\0>!T\=:+J;_#SX@7NG>(+G3;KQ';)K^CR1Z=H6I+X3CU_2(=
M8D\IG_X)N>$!K^N>)-+^*WC[2-3C_:)UC]JGX<30QV%X?AW\:KWPC\*OASI?
MB8/J,]U-XS@TGX9?#KQ%\.Y[#Q3+<)X@\,?%_P")ZZ])>:MJ>BZKH@!ZY\??
MVMC\"/VB?V3_`(,:AX#.L^$_VD+[XCZ/XA^)`\1-I_\`PJ[5?#U[\-?"_P`.
MEN?#8T*^_P"$BT[XC_$?XG^&?A^U\-;T1O#NL:SH,I@U>+5)([/QSX9?\%*_
M`'C#XA?M,>%/%O@S7O"_A_X-_'+P;\%_A'JOA6R\8?%GQA^T1-XK^%FH_$=]
M<\'_``S\!>!M1\40-:KX3^(<]MIFE1^*$N/`O@^;XA7VI:7I5U-:V/O?[2W[
M)/A?]I<S2:_XN\4>$KQ/@?\`&3X/:)J_A06$&M^%=4^*/BSX*>/?#_Q1\-ZC
M>0W!T[QU\*/&_P`"?!GBOP-.T$]@FM6ZW&HV]Q';1P2>`VG_``39\->$_&4O
MQ*^%_P`6_%_@/X@Z)XH^$'BCX<ZVWAOPEXHT_P`'/\+?V:;_`/97O]&OM#UN
MV\CQ1HWCKX<ZMJ%YKJW%UI.J6'BE=.UC2-4MULYK:^`/9M,_X*`_LH:YK6B:
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M'I].TS7(]2U#3Y]:U(`^X_`_[47P:^)'Q%U_X8>#-=U_6_$'AS5?%WA^_P!7
M@^'WQ#A^'UQXE\`7T&F^.O"^C_%*Z\+0?#;7/$WA#4+B.Q\0:!I'BJ\U6QNX
MK^W%K++I.L+I]?4_VK?@;I'Q.O?A'?>*]13Q=INKQ^&-1G@\%^.+SP=8>-Y_
M!O\`PL.S^'-Y\1;3PY/X`M_B9J'@8Q^*M.^'<OB1?&%]HUUI]Q;:/(^IZ9%>
M>+^`_P!AG2_!/[1=C\?X_B9K$MSI1\1S)I&A>!/AUX"UOQBOB;PC;^#O^$<^
M,GCOP-H>AZU\:/`_@VRMK74?AQH7CNRO=<\,:YINBZMJ/B_Q+=Z-9R#G[C_@
MG!\'1^TKXM_:+TZ#PK:ZKXW\:7/Q4URWU#X._";Q+XTMOB?<?#:Q^%SZSX:^
M,GB'PS?_`!+\*>&IM&TK2]>F\*Z'JUM/!XNLGOM%\2:)H.J:UX:U$`[GP[_P
M40_9+\6>#+CQWX=^(VKZEHC>&?@_XQ\.6Z?#/XJ0>(?B)X;^/UY-I7P<U;X4
M>$[GP7%XF^*]KX_UZUO_``YHC?#K2?$O_%0Z9JFD7WV.YTZ[$?F_PM_X*:?`
M[QA8^/+SQS'K/P]?P?\`&KX_?#86\7AGXB>*Y=-\!_`CXBCX;:E\9/BG%IO@
M&WN/@AX,O=?+V.IWWQ.M]`TCP[JEEK.FW&N7?_"/Z_<Z9R=G_P`$N/!6CZ?\
M$9?#_P`6?&6E^+_V=?V:/V6_@%\)_%S:!X9OY=$UK]E'Q)K'B#P5\2M0T:[C
M;3-8O?$UIXAU_P`*^,_"LXATB[\-:YJ4>BWVBZVNF:YIG#3_`/!';X.7WBK5
MO'6O>+;+QOXS\;>+?B5KWQ'\2_$SX(?`WXG7FM:;\3OB9?\`Q;U2R\(Z?XZ\
M'Z[X?^'.M:+XMUWQ1::#XAT/1KR(^%O$4^C>(=!\0WFC^&]:T<`^G]=_;P^&
MB_M$_`O]GKP-8:IXUU/XK?'#XN?`_P`2>+/['\9Z!X1\(>(O@Y\$OBI\5O%\
M/A[Q9J?@T>"/B9K.@>(/AL/AWXN\/^%?%CW7A#7-3OEUB9-1\/:AHS:GQW_;
M8^'W[./QFTOP!\5;7_A'_AZW[-7Q;_:)\3?%!9=7U5_#EI\,?BW\`OA1!X>'
M@[0O#^J:KJPU^^^.EK?G4[.Z\W3?[$%LVEW<6H27NG<IX5_8+TCPE\7OA?X[
MTWXL>,3\/_@G\=OCA^T%\+?A`^@^$(]#\.^,_P!HOPC\8M!^*5C=^)[73K?Q
M+K/AZ37/C7XQ\4>$-/NI8Y_#,^H7.CW-WKVF#2/["D^./[!/A?\`:2\4?&+Q
M#\8_B)XGUJV\?_`WQ;^SWX!TG0-%\-^'(_A/X#\=>*/`?C_Q-?6%\+74[OQC
MXLN/'_PQ\":]9:GXE/\`8UE9>'+;13X<N(KW5[W40#LO%_[??[+?@GQ7XC\"
M:SX\URZ\:>%O%OQ%\#:KX5\-?#+XH^,?$#>)_A-\.OAA\6OB'IVEZ3X3\':U
M?:XOA;X<_&'P#XMU"\T:"^L3I>J7[6]S-/X?UZ#3NK\.?MC_`+.OB_QIH'@;
MPQ\0/[=O?%$OANQT'Q)IGA?QC=?#;4=?\8^`;#XJ>$_!T/Q63P]_PK9?'?B/
MX;:IIGCC1O`\OBF/Q5?^&M2TW48=*(U&PCN?F[P7_P`$WM`\/?%FX^-GB+XP
M>,O&'C[6_%'[0?C7Q9=W/A[PQHVF:SXE_:*^!7[/?P-\42V>F:6NS1=*T+2?
MV>]"U7PWI<$MV\4VLWUEJ=_J(M8;Z?DOV=O^"3'P/_9R\;?#+Q;X9O-!U]_A
M[I_PTU&?4/$_P7^#FL?$/6OB)\-O@KX3^!]OXKLOB[J7A;4/'_@_0]>T/P=I
M/BC5?!OAG4K5;+QD+N?P]XBT;PSJ6J>%[X`]O_:X_;`\2?LN7VC7LGP\\#>)
M/"NHIX?M])L]:^-VA>#/BW\8/%6M>(&T>[^&/[-?PE/AGQ%J7Q7^)FC6$^DZ
MPV@:QK'@6QUJ77M%T71=5N)9M5U+0\O3/VX+J]^).FP7?PWT[3O@'XA_:>\7
M_L<^&_BO+X]67Q=>?'+P3+XHT#4I=1^&D?A4V&G_``\U+XE^"_$_PIT37(?'
M]]XKF\566FZEJ'@JQ\,ZP-4T[MOVD/V3M8_:+A\5^$]4^.'C3PY\(_B9X2MO
M`_Q*^&=MX7\!:_;W.A1_;8]1O/ASXH\0:'=:_P###Q1XCLKR/3]<\0V#Z^UL
M-,T?6?"=CX5\5V`\129=A^Q-H%G\5K/Q7)\1/%5Y\)]'^.GB']J+0?@9<:7X
M</AS2_V@/%=KK:ZUXM'BM;$>+;OPS_PD/B;Q'\1].\$372VME\3-;NO$,FL7
MFCVFD>%],`/H[XL^+?B!X4\,65S\+OAO_P`+.\8ZSX@T30--TB^\467@OPQH
M]OJDTAU#Q9XU\3S6&NZEI?A7P]803W5\/#?A7Q;XFU&\DT[2=(\/W,M_)=V/
MQ'X9_;M^(?Q&NO#_`,./AC\"/#WB'X]S>(OVG]+\4>%M9^,D6@?"VVT7]DOQ
MYX.^&?Q#\2^#/B?#\/M9UOQAIWB?QY\0_!WA#P-]I^&WASR=?E\76'C>3PO=
M>`]8M;OVCXD_`7X^?$S]FGP_\'S^U-XE\!_%%SX?3X@?&OPAX"\*0ZWXOTFS
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M7<^`G[:6M_&3X]^*_A?J5I\!O#/A[3O$?QI\.^%K&T^+?CO5OC'XAE^$'Q!U
MCP)=M+X0U#X,>'_AO)J(CT&[\1^+_#7A7XN^+/$7@#2M2T+^W=.(O99[?E=:
M_P""??BG3O'_`.R?KWPC_:"E^&W@']C7PQ/X3^$/P\O?A%X:\</+INO^`K7X
M;>.)O%WB^_\`$VBZEKM_XF\-V\EQ#>1:=I\FE^(+NZU>4:K'(+!?H32_V:O$
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MW5[8_'3X&_M">';/4_`_P_\`$7BGPAXO^"-[X&?3_!G@_P"*>N:1=>//"WP:
M\06O@C[9J7PST"^TZRM_%?BKQIXDAU2>'Q'J&A2\;I?_``2I\%>'--_9OF\,
M_%_QII7C3]E/]G3X._`OX/\`C&7P[X7U&73=8^"WBJV\0Z!\0]8T2Z7^S-7N
M->TQM=\&^*O"S&VTV\\->)]5;2-0T37[?1]<TP`^B/@I^UWJ7QU^"OQO^+/@
M7X0>(==U7X6_&K]H;X->%?A[IVL6^F^(OB#J7P0^(NL?#O3KJ:3QSIW@Z/P-
M>>*K[2UN]6TKQ+;I)X)1KVWOYM2GT]DG\LNOVZ_'NC>+?$_P-UWX*^%Y?VD+
M'XQ_"/X,>%-"\,?%R[UKX*>(=?\`C#\+?''QKL;G4_BKJ7PU\/\`BSPY/X$^
M%WPS\<^+?'OAF3X3ZCXFATVW\&W?AZRUBR^(.C7-GZUX`_9/\2_"7X#?&KX5
M_#'X\^+_``U\0OC!\0OC=\5XOCC>>#_`NO>)O!GQ"^.7BV_\::]XBT;P?>Z;
M'X%OSH.MZI?3>&]+U729M)MXA90:A9ZA':.MSY5X$_8'\1^%OAK8^#=3^.S7
MGBSP/\6M#^.WPF^)GAOX4Z#X:\4>'_BW::)XE\.^,/&WQ'DU3Q3XRG^-FM_%
M?0O%OB'0_B5JWC/4[?7=:TG7=6BT[6='U#^Q=3T,`S]?_P""B5_H?ACX/Z@G
MP(UO5O$/BO\`;"\-_L<?&>'3?&^B-X+^!OCO4?CAH7P1U2_N/%MSIUIJ_CI;
M^_\`$FB^+_A[HNC>#-.U'Q+X0U"/4O%K?#V6UO+6/U/X[_MGV?PA^/\`^SC\
M"-!\#_\`"=77QB^+?AKX9_$3Q(GB1=%LOA##X[^'GQ<\;>`;J2U&C:H?%GB;
MQ1-\(M>6/PE'=Z(^E>%HI_%FJ:I;I<^&M,\2>0?$K_@GCXN\4_#[X>^`_!/[
M2FK^"Y/#?[0&F?M8>//%.J_"3P7XS\0?%#]HC1/BYIOQHTGQCJH&K^%M(\.^
M'+7Q3IMOI1\%:#IBV@\'V>E:!:ZK:-IW]H773_$3_@FE\%OB=\1/A+\8O$'B
M+XE:;\5/`OQ[^'O[1_CK7_"7Q/\`BUX8\-_%7XE^`?A5J7PLAU/4OAS8?$H^
M"/")U#3)]'=[GPKI%MJ,&DZ!;>$I+V]\.:IKMIJ0!^C*G<JMC&Y0<=<9&<4M
M(!@`9SZD]SW/IR>PX';BEH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HK\@/V_?BO\3?`W[?/_!&SP-X,\?\`C#PK
MX,^+?[2W[1&@?%'PMX?\0ZII.@?$/0O#_P"RGX[\2:'HWC/2K&YAL_$FEZ3X
MAMK77=.L-6BNK6TUBUM=2AB2\MX)H_U]C)*(3R2BDGU)`H`=1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110!^'G_!2V1HO^"D'_``0J=899V'[5W[3H
M$4/E"1M_['GC]"09I(8P$#%W+2+\BMM#-A3^TD>L7?EI_P`4[KGW%[Z+Z#_J
M,U^+_P#P4G_Y22?\$*?^SK?VH/\`UCGX@U^WD?\`JX_]Q?\`T$4`8W]L7?\`
MT+NN?GHO_P`N:/[8N_\`H7=<_/1?_ES6Y10!A_VQ=_\`0NZY^>B__+FC^V+O
M_H7=<_/1?_ES6Y10!A_VQ=_]"[KGYZ+_`/+FC^V+O_H7=<_/1?\`Y<UN44`8
M?]L7?_0NZY^>B_\`RYH_MB[_`.A=US\]%_\`ES6Y10!A_P!L7?\`T+NN?GHO
M_P`N:/[8N_\`H7=<_/1?_ES6Y10!A_VQ=_\`0NZY^>B__+FC^V+O_H7=<_/1
M?_ES6Y10!A_VQ=_]"[KGYZ+_`/+FC^V+O_H7=<_/1?\`Y<UN44`8?]L7?_0N
MZY^>B_\`RYH_MB[_`.A=US\]%_\`ES6Y10!A_P!L7?\`T+NN?GHO_P`N:/[8
MN_\`H7=<_/1?_ES6Y10!A_VQ=_\`0NZY^>B__+FC^V+O_H7=<_/1?_ES6Y10
M!S5YKU[;6EU<+X<UDM!;7$ZB1M&"%H8))0&*ZP6PQ0*=H+<\`G%?E`/^"D'Q
M'(!_X5SX(Y`/_(5\0]Q]*_7/5_\`D%ZE_P!>%[_Z2S5_+LGW%_W5_D*`/T7_
M`.'C_P`1_P#HG/@C_P`&OB#_``H_X>/_`!'_`.B<^"/_``:^(/\`"OSJHH`_
M17_AX_\`$?\`Z)SX(_\`!KX@_P`*/^'C_P`1_P#HG/@C_P`&OB#_``K\ZJ*`
M/UA^#?[<_CKXE?$[P?X&U#P#X8M++Q'J-S9W%SI6I:I+J,*0Z5J%^K6L>H2P
M63.9+-%?[1,B")I"I,@13^E%C>378?S=.OM/V!"/MALOWN_=GR_L=[=_<VC?
MYGE_>7;N^;;^`/[)/_)QOPI_[#NH_P#J,Z]7]!B]!]!_*@!:***`"BBB@`HH
MHH`****`"BBB@#\0/^"D_P#RDD_X(4_]G6_M0?\`K'/Q!K]O(_\`5Q_[B_\`
MH(K\0_\`@I/_`,I)/^"%/_9UO[4'_K'/Q!K]O(_]7'_N+_Z"*`'T444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`9VK_`/(+U+_KPO?_
M`$EFK^79/N+_`+J_R%?U$ZO_`,@O4O\`KPO?_26:OY=D^XO^ZO\`(4`.HHHH
M`****`/HO]DG_DXWX4_]AW4?_49UZOZ#%Z#Z#^5?SY_LD_\`)QOPI_[#NH_^
MHSKU?T&+T'T'\J`%HHHH`****`"BBB@`HHHH`****`/P\_X*6F5?^"D'_!"H
MP1QRR_\`#5W[3H5)96A0@_L>>/PY,BQ3L-J%G4")M[*$RH;>O[2QW/B'RT_X
ME&E?<7_F.W/H/^H#7XO?\%)_^4DG_!"G_LZW]J#_`-8Y^(-?MY'_`*N/_<7_
M`-!%`&/]I\0_]`C2O_![<_\`RAH^T^(?^@1I7_@]N?\`Y0UMT4`8GVGQ#_T"
M-*_\'MS_`/*&C[3XA_Z!&E?^#VY_^4-;=%`&)]I\0_\`0(TK_P`'MS_\H:/M
M/B'_`*!&E?\`@]N?_E#6W10!B?:?$/\`T"-*_P#![<__`"AH^T^(?^@1I7_@
M]N?_`)0UMT4`8GVGQ#_T"-*_\'MS_P#*&C[3XA_Z!&E?^#VY_P#E#6W10!B?
M:?$/_0(TK_P>W/\`\H:/M/B'_H$:5_X/;G_Y0UMT4`8GVGQ#_P!`C2O_``>W
M/_RAH^T^(?\`H$:5_P"#VY_^4-;=%`&)]I\0_P#0(TK_`,'MS_\`*&C[3XA_
MZ!&E?^#VY_\`E#6W10!B?:?$/_0(TK_P>W/_`,H:/M/B'_H$:5_X/;G_`.4-
M;=%`&)]I\0_]`C2O_![<_P#RAH^T^(?^@1I7_@]N?_E#6W10!RFK7/B`Z9J.
M[2=*4?8+W)&N7+'BTF(P/["&23QU`YY(%?S()]U?]T?R%?U$ZO\`\@O4O^O"
M]_\`26:OY=D^XO\`NK_(4`.HK<3PSXBET6+Q''H6KR:!/JBZ)#K*:==/ILNK
MLB.FGQWBQ&%[EQ(B(JL5>=OLJ,;H&$:.H>`?'6DR6$.J>#/%>GS:K>G3M+AN
M_#VK0RZEJ(02FPL(FM!)>7HB(E-I;K)<"(B0Q[/FH`Y*BM34=#UO1]1_L?5]
M'U72M6S;K_9>I:?=V.H9N]OV7%G=0Q7#"ZWI]F98RMQN7R6?-:&N>#?%WAF&
M"Y\1^%O$.@6]U/):VUQK.CW^FPW%U%&)I;:&6[@BCEN(H2)9(48R)$RR,H0@
MD`]B_90:9?VB?A8;>..68:[?[(YIF@B8GPWK@.^9(;AD`4LP*PR$D!<#.X?T
M!V,NHR!_M]G:6N`GE?9K^6]\S.[?O\RPLO+VX7;CS-^XYV;1N_`']DG_`).-
M^%/_`&'=1_\`49UZOZ#%Z#Z#^5`"T444`%%%%`!1110`4444`%%-WINV[EW?
MW=PW?EG-.H`_$#_@I/\`\I)/^"%/_9UO[4'_`*QS\0:_;R/_`%<?^XO_`*"*
M_$/_`(*3_P#*23_@A3_V=;^U!_ZQS\0:_;R/_5Q_[B_^@B@!]%%%`!1110`4
M444`%%%%`!1110`4444`%%%>,_M"^,M>^'WP8^('C+PO<P6FOZ!HBWNF7%S:
M0WT$5P=0LK?=):3YAG7RYI!L?Y<D-U44`>S45^$I_;G_`&C@3_Q4_A[J?^9-
MT;_"D_X;H_:._P"AG\/?^$;HW^%`'[MT5^$G_#='[1W_`$,_A[_PC=&_PH_X
M;H_:._Z&?P]_X1NC?X4`?NW17X2?\-T?M'?]#/X>_P#"-T;_``K['_8R_:'^
M*?QD\9>,]'\?:OIFHV&C>&-/U.PCL="L-)DCN[C5S:2O)+:`/*A@`41O\H;Y
MAS0!^@>K_P#(+U+_`*\+W_TEFK^7>/[J=OE7GTX%?U$:O_R"]2_Z\+W_`-)9
MJ_EV3[B_[J_R%`'U8WB/P]=?L\'3-6\6Z>-2LHSI6AV/AW5O$VF:_<75MI]C
M<V?A3Q9X3N(Y_#^L:.DKW<MSX@MI-.LWBM]-U>.>\\0+-92>=W.HV8UCP-X:
M\/>,=.T+2]`\'6\TFN2:EJFGZ7>^,/%.B_VMXSMM3U?1U:^TUM5GNX_`-SJF
M!#I>GZ7;V]Q-;V4<TR>,]\]\8SWQG./IGG'KS10![?\`%.?1=:M?"\FD:QX3
MM7\%^`M-TF^\,Z/XEOM?TZSGF\6ZT\&E>#]=U&&>_P#%-T+74D\0^(4N-3O;
M?0C=W%GIVI7%I:QV-KQ_CG4;#R/"/AK1+Z"]T;P]X5T>XN);24R6]WXO\265
MOK?C"^F;CS+VWOY[?PV2X+6UGX=M+-"(XB&X')]3SU]Z2@#Z+_9)_P"3C?A3
M_P!AW4?_`%&=>K^@Q>@^@_E7\^?[)/\`R<;\*?\`L.ZC_P"HSKU?T&+T'T'\
MJ`%HHHH`****`"BBB@`J.82&&412+%(8W$<KQ^:L;[3L=H]\?F*C88IO3>`5
MWKG<)*0]#WX/J?Y9/Y#-`'Y%_$;X\^"/!WQ2M?#,_P`2_P!L/Q)XHT_XH7/P
M]\9^/?#'BGX9Z#\/_`EMI5W\!]#\0>-I/AWJIL/#7B/P9X<\>?M(_"3P#>:;
MIOP[\4^+I]2U/Q-<V=AKNE>$M8UR3]9M+@O+73=/MM0OCJE_;6=M;WNI&UAL
M3J%W!"D5Q>FSMRUO:-=3*\[6]N?(A+F.$"-5`_$KQKX9BU?]N7XF:OXBT3QE
MX#U&[^,GP+AL+CP'_P`$W?B;\5?#OQ9\-?#N+X?^)?`_B?QK^TM=?#W6-#FU
M+PQXW%_#>^)=,U+2?"7PO?0/"NIS7%YJOA&V\20_N&.GXGMCN?\`.>_7O0!^
M'O\`P4M$Q_X*0?\`!"H0/%'+_P`-7?M.[7FB::,`?L>>/R^8TF@9B8]RH1*H
M5RK$,JE&_:6.'Q'Y:?\`$RT3[B_\P2_]!_U,%?B]_P`%)_\`E))_P0I_[.M_
M:@_]8Y^(-?MY'_JX_P#<7_T$4`8_D^(_^@EHG_@DO_\`YH*/)\1_]!+1/_!)
M?_\`S05MT4`8GD^(_P#H):)_X)+_`/\`F@H\GQ'_`-!+1/\`P27_`/\`-!6W
M10!B>3XC_P"@EHG_`()+_P#^:"CR?$?_`$$M$_\`!)?_`/S05MT4`8GD^(_^
M@EHG_@DO_P#YH*/)\1_]!+1/_!)?_P#S05MT4`8GD^(_^@EHG_@DO_\`YH*/
M)\1_]!+1/_!)?_\`S05MT4`8GD^(_P#H):)_X)+_`/\`F@H\GQ'_`-!+1/\`
MP27_`/\`-!6W10!B>3XC_P"@EHG_`()+_P#^:"OG?]K*+6U_9U^*YN[[2Y8!
MX;3S([?2KNWF8?VMIG"32ZS<HA]V@D';'<?4=?.'[77_`";?\6?^Q:3_`-.V
MF4`?S[MU/U/\Z2E;J?J?YTE`!1110`5^AG_!.M+Y_B%\1183VEO(/!6DEVN[
M2:\1E_X2`X"I#>V+(PY)8R.#P-HY-?GG7Z+?\$X/^2C?$?\`[$G2?_4@:@#]
M5]5A\1?V9J.[4M%*_8+W(71;X$_Z)-C!.OD#G'.#QVK^9!/NK_NC^0K^HG5_
M^07J7_7A>_\`I+-7\NR?<7_=7^0H`=1110`4444`?0W[*`F;]HCX6"WDBBF.
MN:AY<DT+SQ*?^$;US)>&.:W=P5W`!9X\,0Q)`*G^@.Q34D#_`-H7-C<9">5]
MCL9[/9C=O\SS]0OO,W?)MV^5MPV=^X;?P!_9)_Y.-^%/_8=U'_U&=>K^@Q>@
M^@_E0`M%%%`!1110`4444`%5;ZZBL;.[O9_/\BTMKBZF^RVMU?7/E6\3S2?9
M[.RAN;R[GV(WE6UK;SW-Q)MA@AEE=(VM5C>(EW:!K:_O.=(U,?N;35+^;FQN
M!^ZL=#FM]9O).?DM=)GAU.Y?$.GRQWDD+J`?A/\`$G0M#\1?M=WFJ6'AQ;O6
MO'7QU^`'Q*\._M+Z]^S!^VG+^T'\&/#&GZ;\,+R7X*>`=?L/V8=1^&-IX#\0
MV.DW^CZI?ZA\:O`/@WP?8_$OQ]9?%OX>>(]=TGQ2VN?O@O`_/\.3P.!P.@..
M1@U_.KX'^".M^#/B]\.-.U"]\3W4^F>,_AIJ4LVB_L<_\%L9_#[1:C>^'-?A
M0^.?$'[5GBOX6:2\5K?Q0:[>>-H-9\->#]4CU.P^(FE2+HGB+2$_HJ']3ZCN
M?7_]1ZCC%`'X@_\`!2?_`)22?\$*?^SK?VH/_6.?B#7[>1_ZN/\`W%_]!%?B
M'_P4G_Y22?\`!"G_`+.M_:@_]8Y^(-?MY'_JX_\`<7_T$4`/HHHH`****`"B
MBB@`HHHH`****`"BBB@`KYP_:Z_Y-O\`BS_V+2?^G;3*^CZ^</VNO^3;_BS_
M`-BTG_IVTR@#^?=NI^I_G24K=3]3_.DH`****`"OT6_X)P?\E&^(_P#V).D_
M^I`U?G37Z+?\$X/^2C?$?_L2=)_]2!J`/UQU?_D%ZE_UX7O_`*2S5_+LGW%_
MW5_D*_J'UIUCTC5'=E1$TZ^=W8A555M)BS,QP%50"220``2:_DT3XO?"?8O_
M`!<[X?\`W5_YF_0/0?\`3_79A<OQ^.Y_J6!QF,]ER^U^J86OB/9\_-R>T]C3
MGR<_++EYK<W+*U^5VY,3C\#@N18S&X3".IS>S^M8FCA_:<G+S\GMIPY^7FCS
M<M^7F5[71Z-17G?_``M[X3_]%.^'_P#X5^@?_)]'_"WOA/\`]%.^'_\`X5^@
M?_)]=?\`8&??]"3./_#9C?\`Y1Y_GV9R_P!NY)_T.<I_\..#_P#EWG^?9GHE
M%>=_\+>^$_\`T4[X?_\`A7Z!_P#)]'_"WOA/_P!%.^'_`/X5^@?_`"?1_8&?
M?]"3./\`PV8W_P"4>?Y]F']NY)_T.<I_\..#_P#EWG^?9GV?^R3_`,G&_"G_
M`+#NH_\`J,Z]7]!B]!]!_*OYOOV-OB5\.=:_:<^$&EZ/X^\&:KJ=YX@U..TT
M[3?$VCWM]=2)X5\0S,EO:V]Y)/,ZQ122LL:,1'&[D!58C^D%>@^@_E7#BL'C
M,%.-+&X3$X.I*"J1IXJA5P\Y0;<5.,*T(2<'*,H\R37-&2O=-+MPV,PF,A*I
M@\5AL73C+DE/#5Z5>$9\L9<DI4I3BIJ,HR<6U)*2;5FA:***YCH"BBB@`HHH
MH`*1ONM]#T.#T]>WU[4M(3@$^@)_*@#^>?QS+\(Y/^"@GQ+3QS!^Q._C*+]H
MKX4)X<E_:+TGXF?$K]H(Q#PQ\+5TAOAAXET!K;P;X%T2/4XY8OAKX$Q>KX3\
M5Q:KXB\1W1N?%4UC9?T,#IVZMT^I_7U]\U^=&M?MH>)G_:*\6_!O0&_9%\.:
M9X&^)/A#X>ZO9?&3]K[_`(0+XXZ[_P`)#H_A/79=>\)_!7P_\*?&T$]EJD'B
M:73?A]I^N>-](U/QIJVCW275OX<MKB&0?HP.?3J>AST./S]1V/%`'X>?\%+$
M>3_@I!_P0J5)6@8_M7_M.'S$6-V"K^Q[X_9E`E21/WBAHR2A*ABRX8`C]HH]
M+U7RT_XJ*\^XO_,/T?T'_3C7XP_\%)_^4DG_``0I_P"SK?VH/_6.?B#7[>1_
MZN/_`'%_]!%`&)_9>J_]#%>?^"_1_P#Y!H_LO5?^ABO/_!?H_P#\@UO44`8/
M]EZK_P!#%>?^"_1__D&C^R]5_P"ABO/_``7Z/_\`(-;U%`&#_9>J_P#0Q7G_
M`(+]'_\`D&C^R]5_Z&*\_P#!?H__`,@UO44`8/\`9>J_]#%>?^"_1_\`Y!H_
MLO5?^ABO/_!?H_\`\@UO44`8/]EZK_T,5Y_X+]'_`/D&C^R]5_Z&*\_\%^C_
M`/R#6]10!@_V7JO_`$,5Y_X+]'_^0:/[+U7_`*&*\_\`!?H__P`@UO44`8/]
MEZK_`-#%>?\`@OT?_P"0:^>/VL;"_A_9U^*\D^M75U&OAI-T#V>FQ(__`!-]
M,X9X+2.4#&1\CJ<D'/&#]2U\X?M=?\FW_%G_`+%I/_3MIE`'\^[=3]3_`#I.
MO3GZ<^^/KC!QZ$'H:4JS-M0$N[;$`(!9V.U54D$!F8@*2"H)!((R*^M_BGX7
MTO2?#_@#7O!?@+PS%#9WEOX<FTSQ%X?\1V'B>/5M9UOQS8:7H'C30->N[K1O
M$US--I4P;7;&]DO[34],:X:VLM`U31+6``^2,'T/Y4E?3=Y#X./B/XD:?;:'
M\-K36_`^CZ'X=T6ZU_1;W3/A[JNN:7KSV'CW7]6M=-:73[;5;^Y:73_!UOJ4
MD5E+IUL(+?[3XC>T,O->,_#.C^%?C9J^@^'/![>,=-AO+6VT7PFJ:XUE)XAU
M?PKINHKHKQ?+K-[9>'M=U-VFT.[NK;4IM/L8]/UF[M`;R:@#PFOT+_X)V6]Q
M<?$'XC);WLMBX\%:23)%#;3%A_PD'"LEU#,F!@X*A3ELDG`%?'GQ-B\/V^JZ
M-:Z1!X=M]:M?#MG!XZB\'R&7PE'XQ6^U%KJ#0F2ZO;,_9-*;2;36FTFYET)_
M$$.IG1G:T&]_L[_@G!_R4;XC_P#8DZ3_`.I`U`'ZC>*=,U-?#/B,MX@O'7^P
M-:&W[#I"Y)TN[`.5L<\$AL=\8/!K_->C1?*B^5?]5'_"/[B^U?Z7OBS_`)%?
MQ'_V`=9_]-MU7^:)'_JHO^N47_HM:_LCZ)_\'CK_`*^<.?A'.[?F?R+]*+^/
MP5_U[XB_/(A=B?W5_P"^1_A1L3^ZO_?(_P`*=17]@679?U_PR^X_E$;L3^ZO
M_?(_PHV)_=7_`+Y'^%.HHLNR_K_AE]P'W]_P2PB+_P#!07]E]8Y#`Y\;Z]B6
M-(F=0/ASXW9MHE22/+*&3+(V`Y8#<`1_>3I]K=VRM]IU&:_WK'L\VWLX/*VA
MMVW[)!#NWY&=^[;M&W&6S_!Y_P`$J_\`E(1^R]_V.WB#_P!5MXYK^])/N+_N
MK_(5_"/TIO\`DM\A_P"R5PZ_\R^;G]L_1F_Y([._^RGQ/_JIR<=1117\RG]'
MA1110`4444`%5+^.XEL;R*UFEM[F2UN8[>XA^S>=!.\$BPS1?;+>ZM#)%(4>
M/[5;7%OO5?/@FBWQM;HH`_&Z#X/^-K7XCZ/XA\7^//VQ/&GCS3?$^AZW>Z3J
MO[&?["FJ0>*)M&U#3IA;WGQG\.?L\6/A>QM]2ALX[4Z[:_%'PUK6G69%U8WN
MAWUK;O:?L'I=Q=W>FV%W?V#Z5?75G;7%YIDEQ;WDFG74T*23V,EW:,]I<R6D
MK-;O<6KR6\S1F2"22)E=KFQ,[MJ[NN=HSGUSC-.H`_$#_@I/_P`I)/\`@A3_
M`-G6_M0?^L<_$&OV\C_U<?\`N+_Z"*_$/_@I/_RDD_X(4_\`9UO[4'_K'/Q!
MKZE_:P_:D^)OP5^(NC>%/!D7A632[WP9IFNS-K>C7FHW?VZZU36K*0)/;ZQ8
M(L'D6%N4C,+,',C&1@X50#]&J*_$?_AX'\>O^?;X>_\`A+ZG_P#-+1_P\#^/
M7_/M\/?_``E]3_\`FEH`_;BBOQ'_`.'@?QZ_Y]OA[_X2^I__`#2T?\/`_CU_
MS[?#W_PE]3_^:6@#]N**_$@?\%`OCT2!]F^'O)'_`#+&I_\`S2U^LGP2\9:M
M\0/A-X`\::^+)-9\2^&K#5M173X'M;(75RKF06UO+/<R0PY4;$>>5AW<T`>1
M?M:?';Q;\!_"GA77/".F^']2N]<\32Z-=Q^(;?4+BWCM8]'OM0$ENNGZCITB
MSF:VC4M))(GE%P(PQ#CX0_X>*_&G_H5OAI_X+/$W_P`U%?0O_!1\@_#OX=X(
M/_%>7/\`ZC&K5^1NGZ=?ZO?6NF:797.HZC?3+;V5C9QF:YNIV#,L4,8QEMJL
MS,Q6..-7EE=(D=U`/NW_`(>*_&G_`*%;X:?^"SQ-_P#-11_P\5^-/_0K?#3_
M`,%GB;_YJ*^4[WX.?$C3M=U'P[>>&9;>_P!+M[:\N[F?4='L]$%G?7;V%A=1
M>(M0U"ST*>+4-0BFT^Q5-0\^ZO[>ZM(8&GM;A(N<_P"$&\8^1XKN7\-:Q#;^
M!2%\837%F]M'X=E-_#IBVNI/<&-8[UKZXB@2QB,MXZL;A(&M$DN$`/L__AXK
M\:?^A6^&G_@L\3?_`#44?\/%?C3_`-"M\-/_``6>)O\`YJ*^)]!\+:WXE_M%
MM)ALFBTF&UN-2NM2UK0]!LK2.]NOL5GYM]KVI:99F2ZNLPP0).\\K!BD95&8
M8UY:S6-W<V5QY/GVD\MO-]GN;:]@\V%S&_DWEE-<6=U%N4[+BUGFMY5P\4KH
M0Q`/WL_90^-OBKXZ^!=>\3^+=/T'3K_2_%MQH-O#X?@O[>U>TAT;2-1669-0
MO]1E-P9M0F1F29(S$L8$08,[ZO[77_)M_P`6?^Q:3_T[:97A'_!.<@?"/QCD
M@?\`%R+W_P!1?PU7NW[71!_9O^+."#_Q32]_^HMIE`'\_#=6[@D@@\@@Y!!'
M<$<$'K72ZCXS\6ZO%X>AU/Q)K=]'X3BCA\-"ZU.[F.BK#=O?0O8-)*S0SPW+
MAH;K)N8HHK6UCF6UL[2&'FFZGZG^=)0!O:3XJ\3Z#J5UK.A^(]<T?5[W[1]M
MU/3-5O;&^O/M<_VJY^UW-O-')<^?=?Z5*)VD#7(6YQYZ)(MG3?&_C/1Y8IM)
M\6^)--FAO]4U6&6RUK4()8]4URS33];U)9$N`_V_6-/CCL=4NRQGU"T18+MY
M8QMKF**`-G6_$6O^);F&\\0ZSJ6MW=O;K:07.IW4EW-#:H[R+;1/*24@6221
MUC7"AG8@<U]^_P#!.#_DHWQ'_P"Q)TG_`-2!J_.FOT6_X)P?\E%^(_\`V).D
M_P#J0-0!^L7BS_D5_$?_`&`=9_\`3;=5_FB1_P"JB_ZY1?\`HM:_TNO%A'_"
M+^(^1_R`=9[C_H&W5?YHL?\`JHO^N47_`*+6O[(^B?\`PN.O^OG#G_I.=G\B
M_2B_C\$_]>^(_P#TK(1]%%%?V`?RB%%%%`'Z"?\`!*O_`)2$?LO?]CMX@_\`
M5;>.:_O23[B_[J_R%?P6_P#!*O\`Y2$?LO?]CMX@_P#5;>.:_O20@HN"#\J]
M/I7\(_2F_P"2WR+_`+)7#_\`JWS<_MGZ,W_)'9W_`-E/B?\`U4Y..HHHK^93
M^CPHHHH`****`"BBB@`HHHH`_#S_`(*6Q+-_P4@_X(51LTB`_M7_`+3K$Q2R
M0O\`)^QYX_<`21,CJK%=KA6&]"R'Y6(K1_X*`VB6?QF\.1)+=3`_#;17+W=W
M<7DH)U[Q*N!+<22.$^4$(&"ABS``L:I?\%)_^4DG_!"G_LZW]J#_`-8Y^(-:
M_P#P4-_Y+5X;_P"R9Z)_ZD'BB@#X/HHHH`****`%7J/J/YU_0)^S%H\%S^S]
M\(YFO-6B9_!.E$I;ZOJ%O$"1*?DABN%CC`S@*BJH4``=S_/VO4?4?SK^AK]E
MK_DWGX0_]B1I'_H,E`'RE_P44TZ*R^'OP]:.XU"<MX[NE(O-0N[Q0#X9U,_*
MMS-(J,"G#*`V&<9(8BORU\(:G#HWB/2]3GU.[T>*U>ZW:G9:19>();3[1I]Y
M9YFT+4)(K/6M/G^T?9=7TJ9Q]OTF>^MX@\\D4;_HI_P5G^*W@GX3_"OX5:IX
MWU&[TZRU7XEW>FV4EGI5_JSR7B>#M;O&C>*PCEDB06\$C>:X"%@$SN8`_A)_
MPV3^S_\`]#1K?_A&^(O_`)$KZ?+.">,,ZPE/,,HX7S_,\#5E.%/&8#*,?B\-
M4E3FZ=2,*]"A4IR<)IPFE)N,DXM)Z'S69<9<)9-BYX#-N)<BRW&TXPG4PF.S
M7!87$PC5BITY3HUZ\*D8SA)3@W&THNZNFK_JIXUU/X'>*O'>MZG<^(+2WTJT
MB%[>Z3I^D>+]+\&?$CQ+_:=\VF.T>E0^(;K0=(TC1IDA\0ZA9:?97?B"[N+J
M#PY9Z&US>ZL>6T_Q5IVLM\8)?%WQ0T=+GQUIFK:=I\46A>._[%?5]0\2>"M8
M?7[/3+/P[<1:5IDFE^'&T>WCEA36HX;&PM+BW-JJ3M^:G_#97P`_Z&C6_P#P
MC?$?_P`B4?\`#9/[/_\`T-&M_P#A&^(O_D2O0_XAIXA_]$/Q9_XC^:^7_4+Y
M_P!75^#_`(B-P!_T6G"W_A]RS_YI_JS\K_H%X/U;3O#D&MV&G?$/1](G\0:/
MX:O'U'5/AS=>)]+M-2T_4;^XN]&>._T[5;NVU#3$ECGMM7L=!OM-UF*ZN-.:
MXTPCSVXKQQJ&@:KXO\1:EX6L1IOAZ\U)YM*LQ9QZ<D<'DPI--%IL,L\.EPWM
MXEU?P:5#-+%I<%U'I\;E+9<?&7_#9/[/_P#T-&M_^$;XB_\`D2C_`(;)_9__
M`.AHUO\`\(WQ%_\`(E'_`!#3Q#_Z(?BS_P`1_-?+_J%\_P"KJY_Q$;@#_HM.
M%O\`P^Y9_P#-/]6?E?\`HD_X)Y:;%>_";Q?(]SJ,!7XBWB!;/4;RS0@>&?#C
M9:.WFC1G)?!<J7*JJYPH%>Y_M8Z1!:_LZ_%>9;O5I63PTA"7.K:A<0D_VMIG
MWX9;AHW'&,.K#!/&<$?+O_!*'XH>#?BK\#/'NN>"=0N]1TVP^+.H:5=37FEW
MNE2)?1^#O"%X\2P7\<4LB""[MW$RJ8RSL@.Y&`^M_P!KK_DV_P"+/_8M)_Z=
MM,KY/'8#&Y9BZ^`S'"8G`8[#3]GB,'C*-3#XFA/E4N2M1JQA4IRY91ERSBG9
MIVLT?58+'8/,L+0QV7XK#XW!8F'M,/BL+6IXC#UH7<>>E6I2G3J1NFN:$FKI
MJ^A_/NW4_4_SI*5NI^I_G25R'4%%%%`!7Z%_\$Z[..]^(7Q&CDFNX0O@K22&
ML[NXLY,GQ`>LEM)&SC`P%<LHRQ`!.1^>E?HM_P`$X/\`DHWQ'_[$G2?_`%(&
MH`_4?Q3H5NGAGQ$WV[6VQH&M##ZWJ;+SI=V,E3<X)&<C/`8`X/2O\U^/_51?
M]<H__0%K_2[\6?\`(K^(_P#L`ZS_`.FVZK_-$B&8X@.IBB`_[X6O[(^B?_!X
MZ_Z^<.?^DYW_`)G\B_2A_C\$K_IWQ%_Z5D0^BOH6?]F[Q=9?!G2?C3JGBKX;
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M(:_\.M`L_%?_``EGPX\>^&)O&.L_#K4->^&OBFY\2:=H'Q!T'38=8U+PCK+7
M^B:!/]K;29CJ>D:UI,&K>%/$-C;WL^A>(+\6<X7ICF>`E/"TUB::GC'4CAX2
MYHRE.DY1J4Y1DDZ56,X5*;I55"I[6G4I<OM*<XKG>6XZ,<1-X:IR850E7DN6
M48QJJ$J<XN+:JTY0J4ZBJ4N>G[*I3J\WLZD)2^FO^"6,2S?\%!?V7XV:15;Q
MOKQ)BEDAD^7X<^-WP)8F210Q4*VU@60LI.&(/]X^GZ?'8JWEW%_/YJQY^VWU
MU>[=@./+^TRR>7G<=^S&_"[L[1C^#S_@E7_RD(_9>_[';Q!_ZK;QS7]Z2?<7
M_=7^0K^(/I3?\EOD7_9*X?\`]6^;G]E_1F_Y([._^RGQ/_JIR<=1117\RG]'
MA1110`4444`%%%%`!1110!^('_!2?_E))_P0I_[.M_:@_P#6.?B#6O\`\%#?
M^2U>&_\`LF>B?^I!XHK(_P""D_\`RDD_X(4_]G6_M0?^L<_$&M?_`(*&?\EJ
M\-_]DST3_P!2#Q/0!\>>#/!'B+Q]K"Z)X;M()[D1&>YN+V^M-,TVP@R4CFO]
M1OI8;:V6XGV6MJA9IKFZD2*"*3$K1RZ?\/O&6IW_`(FTNUT*X%_X-TG4];\3
MV]Q<65M_9&GZ1`]S>O-/+<K;3S^3'))9VMG/<SZDD<DFG)=11NZ]K\#/%NB^
M#_&2WVO:[=:#I]S;B">9O#VF>*=!O$B\^;[)XCT:_*SM;B7R+C3-1TMQ?6&H
MQ!"OV:]GEA[/0OBQ\+=)N];TZR\!ZSHOAF\L?B`\`TOQ#_9[:E?>)/`5[X3T
MJ"^T,Z/KHTNUM/ME_;:+;0Z]?67A.#7;^<)J;QR&<`\6'@77'\.7GBN&Z\,W
M.DZ=::=>ZBEIXM\.W.K6$6K7<=CI\=YH<.HMJL%W<7<@B6R>U^UKY<[M"([:
MX>-=%\`>+/$.DRZUI&F1W-BDNI06ZR:EI=I?ZO<:-8)JFL6_A_2KR]@U+Q#<
M:1ITD=[J<&C6M[+:021^8AED6(SW.MZ2?`OAOPM9RW-M//XLUSQ#XND:V=T"
MB+3-&\*"-PT8U)=(T=O$%TL"^4([S5;I1LDN=Z^F^%_&_@;09/`=U/K&KW$W
MP<\4^--5\.PP>&YHD^(6G:QJ$.L:$TCOJ+#PE=MJ=OY.MPZI]N2/0[A$M9[N
M^M6MI`#YY4@[2""#M((.00<$$$<$$<@C@CFOZ&_V6O\`DWGX0_\`8D:1_P"@
MR5_/(@(V@[<_+G:,+GC.P'D+G.T'HN!7]#7[+1Q^SS\(>O\`R)&D=B?X9/04
M`?C;_P`'#7_)`?V?_P#LN&H_^JU\4U_)O7]9'_!PR<_`']G_`*_\EPU'L1_S
M37Q3ZU_)O7^C'T=_^36Y/_V'9Q_ZL:Y_G_X_?\G+S;_L#RG_`-5N&"BBBOW`
M_%PHHHH`_KO_`.#?+_DU/XN?]G"ZQ_ZK;X<U^K7[77_)M_Q9_P"Q:3_T[:97
MY2_\&^9Q^RG\7.O_`"<+K'8G_FFWPY]*_2?]OOQMI_PZ_8]^//C75+*^U"P\
M/>#8[ZYLM/,"7MQ&=>T:WV6[7;Q6P??.K9ED5=JMSG%?YF^+.$Q.8>+7%&`P
M=*5?%XW/J&$PM"+BI5L3B:6$HT*47.48*52K.,$Y2C%-IRDE=G^C/A=B\/@/
M"WAO'8NK&AA,'DE7%8FM)2<:.'P\\15K59*$93<:=.$IM1C*32=DW9'X5-U/
MU/\`.DKX4;]OGX=!F'_""^.^&(_X^/#/K_V$J;_PWS\.O^A$\=_^!'AG_P"6
M58_\06\4O^B-S'_P?EOE_P!1OFC;_B,'AI_T5N`_\$9C_P#,7FOO/NVBOA+_
M`(;Y^'7_`$(GCO\`\"/#/_RRH_X;Y^'7_0B>._\`P(\,_P#RRH_X@MXI?]$;
MF/\`X/RWR_ZC?-"_XC!X:?\`179?_P"",P_^8O-?>?=M?HM_P3@_Y*-\1_\`
ML2=)_P#4@:OY_/\`AOGX=?\`0B>._P#P(\,__+*OUZ_X(]?M(^%_C7\7?C!H
MN@^'?$6C7&B_#;0-4N)M9DTJ2&:&X\6/9K%`-.NKB3S5<;V,BJFS@,6R!YV;
M>%GB!D678K-LVX8QV"R[!0C4Q6*J5L#*%&$ZE.E&4HTL74J-.I5IQ]V$G>2T
MM=KT,K\3.!,ZS#"Y5E7$F#QN88V<J>%PM.CC8SK3C3G5E&+JX6%--4X3F^:<
M5:.]VD_WK\6?\BOXC_[`.L_^FVZK_-$BXCA_ZY1>W\"]^U?Z77BPC_A%_$?7
M_D`ZSV/_`$#;KVK_`#18_P#51?\`7*+_`-%K7]$_1/\`X7'7_7SAS_TG.S^?
M_I1?Q^"?^O?$?_I60GW9:_M-_#ZT_8ZOO@)-H?C_`,2^*+N_O(=,\/\`C75O
M#OB?X:^!]4N='TE1\4_AYJ-_H#>,?!M_#JEGJ-W8^`-`U/3[*#7]<URZU+5M
M6\*7O]B2\IX;_:,\+^&/C)\-/'NF^'O$UEX?^%_P2\+_``N\#S:>^@'QA\._
M&6F^");6]^+WA"RU1[WPIJ7B72_BEK?B[XA:+IOB!H['5)-9W:I+INJQP7%E
M\@T5_3T.%LGIPQ\%2K2AF57,:V+C/$591J5,SA2I8J?*Y<O/*E25)3:<W2J5
MH5)5(U9I_P`XSXFS6I/`S=2BIY=2R^CA90H4XRA3RV=2KA8<RC?EC5J.JX)J
M"J0I3A&$J4&OK_XY?&CX8?';6O#.K>,]0^,VN>(/"G@3P=X(O/B9J>B?#&V\
M9?$[['X]OKW7M7\<>'M-U1?#^F/X1^&.I?\`"(_#:#3-4U:^UO4]&TR;Q]JJ
MV-Q/):\_\??B1\)?%.A>$/!?P0/Q"\-_#;P9JFL76A_#_P`7^%O">F+%=ZQ8
MV5MJOC[Q3XQT+QWXHU3X@_%#Q*-,TZQUC5M0T?P_H6C:%966@>#M*T+0[*/2
MI_F"BM<+P_@L'++_`&%3$PHY9*O/"87GI/"4YXBFJ=24,/['V='EC[58=4%2
M6#I8C$87!^PP=:>'>.)SW&8M8[V]/#2JYC&C#%8I0J+%58T*BJ04\1[5U*O,
MXTG7]NZKQ=6A0Q.*=;%THUS]!/\`@E7_`,I"/V7O^QV\0?\`JMO'-?WI)]Q?
M]U?Y"OX+?^"5?_*0C]E[_L=O$'_JMO'-?WI(<HO7[J]01V]Z_B[Z4W_);Y%_
MV2N'_P#5OFY_7_T9O^2.SO\`[*?$_P#JIR<=1117\RG]'A1110`4444`%%%%
M`!1110!^'G_!2V&*?_@I!_P0JBGC26,_M7?M.L8Y%#H3'^QYX_D0E6!!VNJL
M,@\J#6C_`,%`;&SL/C-X<ALK:"UB;X;:+(T<$:QH7.O>)4+E5`!8JB@D\D*,
MU2_X*3_\I)/^"%/_`&=;^U!_ZQS\0:U_^"AO_):O#?\`V3/1/_4@\44`?!]%
M%%`!1110`J]1]1_.OZ!/V8M!T6[_`&?OA'/<Z78SS/X)TIGEDMHVD=F\YBSN
M5RS$L268D]LX``_G[7J/J/YU_0U^RU_R;S\(?^Q(TC_T&2@#\7?^#@[2].T_
MX!?`$V-C;6A;XWZF&,$*1E@WPV\2E@Q4`D$Q1G!.,J"!FOY>/A[X$UWXF^-/
M#_@/PT;)=;\27-W;V4NHO>)8VZ:?I>H:WJ%U<C3;'5-4GCL]*TN^NQ9Z1I>J
M:QJ#PI8:1IFHZG=6EG/_`%+?\'#7_)`?V?\`_LN&H_\`JM?%-?RO>"]=TWPS
MXHT?7M8T*X\2:=IMQ--<:19>)]9\%:G*7M+FWM[S1O%_A\/JWAK7M(NYK?6M
M!UJUM[Y+'6-.LI;S3=4L!=:?<_Z(>`+KKPCP#PJOB57SYX=*-.=Z_P!=Q+I>
MY5JT*4_WG+[M2O0A+:=:E%NI'^!O'3V+\5,:L398?V61_6&Y3@O8?4<)[6\Z
M5*O4C^[YO>IT*TX[QHU9)0E]$:_^RKJ-G^T0?@'X6^)O@3Q?%%=N=;^(,">(
M=)T7P#HME>QV6NZI\3=!U+28/$/A*[T%YK62;18[75+C6AJ_ANW\-W.JWOB/
M3K8OT?\`9'\5:EJ]UX<O_'?@KP]XGU7XO_$GX%_"W0-7M?%+W'Q;^(GPKO8=
M-\36.CWVG:/>Z;X0TF?5[_1/#FAZWXSN;"SU/Q5KUCH>+>.WU/4['VKXN?M_
M7/C'XJ7GB7PW\-?#.M^"YK[PA'J$_P`9+"/QS\4/&.C>"_B//\3-$MM=\7Z=
M/X;_`+.AT36;I;3PMH21ZQI>B6NB^&I;Z;79](LQ;<HW[9'AO4_'%M\0_$/P
MASK_`(`^/OQ._:!^"6G^$_$MIX:\+Z#X@^).KZ1XDF\._$72[K0]=O?$^BZ;
MXO\`#/AWQQ-?>&=4\,ZIK'B!?$=A.UGHNOPII'V-+$\?RPN%E4P2I5'EL/;)
M5,JK8J6.AAJDJ<ZG.L-AH3Q6/GAZ6+H4Z4*-#+X5YT*E'&U(1P_R-7#<"PQ.
M)4,9[6"S&7L;T\SI898*>(I1G"#A+$8F4,+@HXBIA:TZDJM?'SHPK4ZN$IR=
M?Y9^$?PMU[XP>/\`1/`6C75AH,FH3>;KGB/Q&+NWT#P3H-M<V]MJ_B;Q2]G!
M<WMOINCRW5M:RVUI;W&I:AJUWIV@Z7;7.KZG8VTW->-O"U[X%\:>,O`^I3P7
M.I>"O%WBCP=J-S:K*EK<ZAX4U[4/#][<6R3A9TMKBZTZ6:W695F6%T$H#AA7
MM7P[^/\`;_"J\B;PMX#\/>(=-\2?\*MUCXJVOQ/L;/Q=?>)?&'P^\73^-+^^
M\'ZEI`\+3>$/#6K:X;'5M-\-7W_"0I8ZYI6EZIJUUK;Z5IB6OF?Q<\>1?%+X
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MH\_VIO\`LG47_J4^'*_@GBO_`)2&?_9?\._^IN5G]P\,?\F%_P"['SS\<'F%
M_ONS^#1_OM_O-_,TVED(4R,<84N>2%'&3RS$*@]78A5&68A037W%\6OV/O#O
MP<O_`(5Z7XT^..E^';OQAX=UW7_&$^O_``V\?:?I^FV>@7?C5)-5^%]Y)81:
M?\6=+UC_`(16RT/PM;V>IZ%J?B'7?$GAC68$M?!/B>RUO3O[^QN;X#+JN"PV
M+JU8U\='$O"TJ.%Q>*J55@J'UC$M1PM"M**ITK-<R3J3E"G34ZDHQ?\`"V"R
MK'9A2Q5?"TZ<J.">&6)JU<3A<-3I/&5EA\.G/$UJ,6ZE1N_*VH0A.I4<*<)2
M7PY17VSX=_8\7Q9?0W_ACQWXD\6>$-5^!NF?'KPK8>#O@_K7B7XX^*_#6H?$
M:^^%MUI&C?`ZR\5I<WNI>'_$6EW^KZ[J^F^--3\.)X'2S\6:=J&H6U^MM;?/
M_B_X/^(_#_QHU;X':!+%XX\66OC*T\$:.NC0263ZSKFH"R%KIT]A=S32:'JU
MC<WO]E^*=,OKJ8>%-9TW7;'4;V2+1[F\..$X@R?&UZ^'P^,3K86A4Q.)A5HX
MC#?5Z-%TXUI5I8FC2A2E1E5A&M3G*-2E)R52$7":CKB<BS;"4*&(KX.2HXFM
M3H8>=.MA\1[>K54Y4HT8X>M5G4C6C3FZ52$94ZJ2=.<E.#EY-7[^_P#!OE8V
M=_\`'W]H2&]MH+J(?!KPL1'/&LB@_P#">EL@,#@DHN2,$[0.E?C3\=_A):?!
MCQEHOA?3O&^E_$33M<^''P\^(>G^*]$TRZTO1[ZV\=Z%_:WV?3(KVZN[B^TZ
MQN([BVT_6W-JNOV"VVL1:?I\5XEK'^T'_!O/_P`G!?M"?]D:\+?^IX]?GOC!
MB\/C_"/BG&86;J8?$Y;@:U&<J=2E*4)YIE\HN5*M"G5IRLU>%2$)P=XRC&2:
M7WWA-AJ^"\5>&,)B8*GB,/F6,I581J4ZJC..6XY24:M&=2E4CVG3G.$E9QE*
M+3/ZEO%/AO0(_#/B-DT?3E8:!K0!%K%D!M+NU.,KP<$C/4=000#7^:_'_JHO
M^N4?_H"U_I=^+/\`D5_$?_8!UG_TVW5?YHD?^JB_ZY1?^BUK\:^B?_"XZ_Z^
M<.?^DYW_`)L_6OI1?Q^"O^O?$7YY$/HHHK^P#^40HHHH`_0#_@EC#%<?\%!?
MV7XIXTFB;QMKVZ.15=&V?#GQNZ[E8%6`=58`@C*@]J_O'T_2].TU6^P65M:>
M<L?F_9XEC\SRPVS=M`SMWMC/3<?6OX//^"5?_*0C]E[_`+';Q!_ZK;QS7]Z2
M?<7_`'5_D*_A'Z4W_);Y%_V2N'_]6^;G]L_1F_Y([._^RGQ/_JIR<=1117\R
MG]'A1110`4444`%%%%`!1110!^('_!2?_E))_P`$*?\`LZW]J#_UCGX@UXK_
M`,%8/VE/A[\'_P!HSPCX8\5VGBB?4;OX.>'=:B?1=)M;ZU%G<^*O&EG&KS3Z
MG9NLXEL9BT8B91&8V#DLP7:_X+,?&3X>?LW_`+7O_!&K]H/XQZOJ/A;X/_"K
M]I_]HC4OB#XSLO"GC#QA!X9L=>_97\8>&-(N;W2?`^@>)-?F2^UW5;#3X5LM
M)N9/,G,KHMM!<SP_@;_P6!_X*5_L8?M-?M->#O'WP.^*GB/QYX1TSX*>&O"E
M]K%G\#?V@],BM]?L/%WCG4[O3FM]>^%6E7C20V.KZ=.98[=[=EN559FD25$_
M1?"[).%.(.*Z>7<99A2RS)98'&5IXJMF>&RF"Q-*,'0@\9BOW2<VY6IOWJEK
M1V/S_P`2\YXHR+ABIC^$,!5S+.(XW"4H8:EEV)S2;P]2<E7G]5PO[UJ$4FY_
M##[6Y]._\-T_!?\`Z!WQ`_\`"<L/_E[0_P"W5\%HU#R:?X^CC,?G"23P]IT<
M9AWR1><'?7E0P^;#-%YP8Q^;#-'NWQ2*OX(VW[3OP4EN;:(Z_P")%$MS;QL;
M[X3?&BSL0LD\:,;Z[_X5_%]DL0K'[;=^;&;6U\Z<21F/>O\`2MX[U?PG#XI_
M98\8^*_#L_A2/2_A_P#$^]\%?`%_@QX#\4_$OQ1;:9X:^.NIQ0?L<>+O`GA7
M^ROC#+X7@30]9^&&C>*?"\OA*[UL_"WQAIMSXU\5Z_K]A?\`[OG?`/@)E3PK
MPV>4<TA7AC75EAN.\J<Z-7#X65;"4/94,-BYMX^O'ZO&M55'#8?656K*;I4:
MOXEDW&_CEF:Q'UG):V62HSP:IK$\$YI&-:E6Q-.EBZWM*^)PL+8*C+ZQ*C3=
M;$5U>-.DH*I5I^*)^W;\$Y5#Q67CR:,Y`DAT#3)8R0<$!X]?920>"`>#P>:$
M_;N^"4A=8[3QU*T9VR+%H6ER-$W(VR*GB!C&V01M<*<AAC@X^0/VIO%_PV?X
MD?"KQ+XHA^-D?@S0_@U\&/&W[1-]\1/@MXPT3X[_``V\$^)_C?J/PWNO$G[2
MVC>!O`\%CX4\3>()-1L;;P!)_9-IXHU#X:WWPZU[6=+1[V/5+KT'_@H3\1O!
M'@SP-K&K>*5^)_@3PWX7_:E\5?#?X1:+XR^!D%OI/CSX>'P=J&L:;XN_9KOO
MAO\`#*T\22?`30-`LO!]O<H^J_$7P%K%[XK\%^);/X@2^.+_`,1Z8\TN!/`.
MI4RJ$LZITHXZ%66,J3XYRU0RYPK1P].#_P!C4J\JU:6CJQP:AA_]JE^ZC/EJ
MIQKXYPIYG..3U*LL%*E'!TX<%YDYY@I4EB*DE;&.-%4J*U]F\4YUW]6C:K*"
ME]!K^W3\%RRC^SOB!RP'_(N:?Z_]AZOZO_V*/%FE^.OV4/@)XOT5+R/2O$/P
MWT'5+!-0A2WO5MKE)3&+F".:X2*4`'<BS2`<88U_FEK^U%\%`RDZ]XNP&!/_
M`!9[XT]`?^R>5_7]^PK_`,%U?^"6GPA_9`_9X^&?Q%_:6U7PWXX\%?##P]H'
MBC09_P!GC]J2\FTG6+))UNK*2ZTSX)WMA.\)909+6ZGA;.4D8<U\/XN\&>%_
M#>2Y;BN!L_PV;9C7S18?%T:'$67YS*G@_JN(J.K*AA&YTH^WA2C[67NIR4-Y
M(^T\*>+?$KB'.,QPW&V1XG*\!1RUU\+6K\/X_*(U,8L3AJ:I*OBUR59.C.M/
MV4?>?*Y[19Z3_P`'#7_)`?V?_P#LN&H_^JU\4U_)O7[/?\%F?^"O?_!/;]J3
MX/\`P=\,_`?XYZY\0-<\,?%:]\1:[867P#_:2TJ2PT:7P/K^DQWSR>(/@_I,
M$J-J-[;6WEP2RSAI0YB\I7=?YX?^&H?@K_T'O%W_`(9[XT__`#O*_=?`?B[A
M3*?#?*L%FO$_#V68VGC,UE4PF89UEN"Q4(U,?6G3E/#XG$TZL8S@U*#E!*46
MI1;3N?BGC?PKQ1FOB%F>,ROAO/\`,L'4PF5QAB\!D^8XS#3E3R_#PG&%?#X:
MI2E*$XRA-1FW&2<9)-6/H"BOG_\`X:A^"O\`T'O%W_AGOC3_`/.\J(?M4?`X
MSM:CQ)XH-RL*7#6P^$GQD-REO)))#'</;CX?^>MO)-%+#'<-&(9)HI8DD:2*
M15_8_P#B('`?_1;<(_\`B29-_P#-I^2?ZA\<?]$9Q7_XCN;_`/S&?0M%?/\`
M_P`-0_!7_H/>+O\`PSWQI_\`G>4?\-0_!7_H/>+O_#/?&G_YWE'_`!$#@/\`
MZ+;A'_Q),F_^;0_U#XX_Z(SBO_Q'<W_^8S^V_P#X-\O^34_BY_V<+K'_`*K;
MX<U]O?\`!5O_`)1Y_M3?]DZB_P#4I\.5_/=_P1P_X+#_`/!.W]E[]GSXC>"_
MCK\=]<\`^)]<^,VI>*=*TJ]^`/[2NJ27>@W'@?P5I,6H+/H'P=U:UC1]0TG4
M+812SQW`:W9VB$;Q._U3_P`%"/\`@N7_`,$O/C7^QG\?_A;\,?VDM6\4^//&
M?@J/2O#7A^W_`&>?VHK&;5+\>(-$O#;QW>J_!2PT^%A;6MQ+ON;N&/$97?N*
M@_P=Q-F>6U_';^UJ&88&ME?^O&18K^TJ6+P]3+_JM+%Y;*KB?KD*CPWL*483
ME4K>T]G",).4DHNW]N<.Y;F-'P4_LNME^-HYG_J=G&%_LZKA*]/'_6:N%QT*
M6'^ISIK$>WJ2G"-.E[/VDY2BHQ;DK_S.EBLNX!24D#@.H=&*ON"R1M\LD;$8
MDC;Y9$+(W#&OO34OVS?!.L>%OA'\/M8_9P\-ZK\+O`-V/$OB7X72_$?QY%X0
MUWQAIVH_$^\\/1>$H]3NO$LG@;P!:2?$FYO]?\)V5O<WGC!=/TKP;KNMR^"?
M#FBV+?D2W[47P4+,1KWB[!8D?\6>^-/0G_LGE)_PU#\%?^@]XN_\,]\:?_G>
M5_;F8\3>&>;K"O'\9<+U'A)5*F']EQA@\(Z=6K1G0=5/!YK0?MJ<)R>'KW]M
MA:C5;#5*55*9_&N7<->(^5?6/J/"'$U/ZU"G3K^UX2QF*52G3K0KJDUB\LKQ
M]E4G3BJ]&WLL333HXB%6DW`_4B]_:NL]0U_XBW]YX*\<3Z5\5=-\%6WBV:'X
MX7_A[XA6%S\/KW4IO"UEX&^(/@SX=^&;3P9\/K/3;ZWT23X4V?@FZ\()9Z-H
M$^FIIEQH>E_9N:\3?M2:]JWQ-UGXU^'?"&@^%/BKKNK:_%J'B*XN%\?:1<^`
M]:^&VB?#,>#[_P`+>/=(UK3-7UV;2M.U;4?$_P`3M2DG\6^,-4\3ZQ/?QV+2
M"1_S7D_:H^!T3P1R^)/%$4ES(T-M'+\)/C)%)<S+%)<-#;))\/U>XF6WAFN&
MBA$DBP0S3L@AAE=)?^&H?@K_`-![Q=_X9[XT_P#SO*YJ6=>$]&;G#BCA%\V%
ME@IPJ<6X*M0J8.=##8:>&JX:KFL\/5HSP^#PE*=.I2E&<,-0C)-4H<O34R;Q
M2JQ4)\-<6>YB8XR$X<*XRE6IXN%;$8B&)IXBCEE/$4JT*^+Q5:%2G5C*%3$U
MY1:=6=_NGXV?&W6OCAJ/@34=:\.>$/#<G@3X7^"?AE:0>$/#/AOPU:ZA;>#M
M,73QJMS;>'-"T*WB6]*A]/T,13Z=X6M,Z5H3Q6#-&?V>_P"#>?\`Y."_:$_[
M(UX6_P#4\>OY>/\`AJ'X*_\`0>\7?^&>^-/_`,[ROV+_`.",_P#P5`_8A_9;
M^,?QE\4?'CXN>(?A_H7BCX8^']!T&_O?@7^T/JB:AJ]EXN;4KJS2'0/A/JUQ
M$T5DPG,D\,4+`[$D9P5'QGBGQ/P-/PNXFR;(^)>&*]1X'#4\%EV7YYEF)KSM
MFF"JSAA\/1Q=2M4:2J5)*$9-14YO12:^P\,N&N-8>)?#F;YUPYQ+0IQQU>IC
M,PQ^2YEAJ%-/+<71A.OB*V%IT:46W3IQ<I1CS.$%JTG_`'6^+/\`D5_$?_8!
MUG_TVW5?YHD?^JB_ZY1?^BUK^QOQ#_P<)_\`!(>^T'6[.U_:NU&6YN](U.VM
MXA^SA^U@IDGGL;B*&,,_P*5`7D=5!9@HSDD#-?PRI^U!\%A'&#KOBX$1QJ1_
MPI[XT<$(H(_Y)YV(-?D_T9.(<@R*EQFL[SS)\G>)J9`\,LUS/!9>\0J,<X]J
MZ"Q=>BZJI>TI^T=/FY/:0YK<\;_IWTCL@SW.ZW"#R;)<VS=8:GGRQ#RS+<9C
MUAW6>2^R59X6C55)U?95?9^TY>?V=3EOR2M]!45\_P#_``U#\%?^@]XN_P##
M/?&G_P"=Y4,_[5/P.M89+BZ\2^)[6WA7?-<7/PE^,=M;PID+OFN)_A_'#"FY
ME7?+(B;F49R0#_5/_$0.`_\`HMN$?_$DR;_YM/YF_P!0^./^B-XK_P#$=S?_
M`.8SZ&HKY_\`^&H?@J"0==\7@@D$'X/?&D$$<$$'X>9!!X(/(-'_``U#\%?^
M@]XN_P##/?&G_P"=Y1_Q$#@/_HMN$?\`Q),F_P#FT/\`4/CC_HC.*_\`Q'<W
M_P#F,_83_@E7_P`I"/V7O^QV\0?^JV\<U_>DGW%_W5_D*_S;_P#@GY^WC^RW
M\%_VRO@)\4/B9X]\4>%O`G@[Q5K&H>)/$%Q\%/CQ>P:99W7@CQ7I$$\EKI?P
MROK^82:AJ5E;A;:TF<-.'95B21T_NZ_8_P#^"B/['W[>1\>Q_LJ?%FX^)[_"
MY?#!\<B?X;?%KX??V)_PF`UO_A'=I^*'@/P4-6_M#_A'-9S_`&(=2^Q?8Q_:
M'V3[39_:/XM^DGG.3YWQADN)R;-<MS?#TN&J%"IB,KQV%S"C3K+-,UJ.C4JX
M2K6A"JH5(3=.4E-0G"7+RRBW_7_T>,GS;)N%,XP^<97F.4XBKQ%B*U.AF6!Q
M.!K5*+RS*J:K0I8JE2G.DYTZD%4C%P<X3BG>,DOMBBBBOYW/WX****`"BBB@
M`HHHH`****`$(SZ\>A(_/!&?QHP/?\S_`(TM%`"8'O\`F?\`&HC;PA6"PQ+N
M&,!%`.&9UR``#MD9G7/W78L,,2:E)`(!(!/0$C)QUP.^/:C(SC(SC.,\X]<=
M<4`?-/[/_P`,_%7@#QE^U5K/B6SM;6P^*G[2=[\2?!TEM?6UV][X6G^!WP*\
M#I>7<=LS2:?='Q#X%\16S65V$N1!;0717[/=P%OI18XUY5%7@+\HV_*"2%XQ
MA022!T!+'&2279&<9&<9QGG'3..N,]Z0N@&XLH7IDL`,^F2<4`+@>_YG_&C`
M]_S/^-`((!!!!Y!!R"/4$=:6@!,#W_,_XT8'O^9_QI:0D*,D@#U)`'YF@`P/
M?\S_`(U\Q:5\,/%MI^V-XW^,4UI;+X&UO]FKX7_#73[\:A;M>2>*_"_Q9^,7
MBS5[1],#_;(K:'1O&&A317[H+:XEGFMHG,MM,!].D@8!(!/`!(&3Z#UI20,9
M(&3@9[GT'J>#0`F![_F?\:,#W_,_XTN0<@$9'4>G?GTXYI`0<X(.#@X.<$=0
M?0CTH`,#W_,_XT8'O^9_QI:*`$P/?\S_`(T8'O\`F?\`&C(Y&1D<D9Z`]"?3
M.#^5-\V/D>8F1G(WKQCKGGMWH`^=_C1\.?$_C/XG_LD^*-!M;>XTCX2_'?Q5
MX[\:337T%K+8^'=5_9C_`&@_AE9W-I;SNLNI3OXM^('AFT:SM`\\=K=7%^R"
MVL[AT^BL#W_,_P"-`(894@CU!!'YBC(P3D8!P3D8!!P03ZYX^M`!@>_YG_&C
M`]_S/^-(712%9U#'&`6`)R<#`)R<G@>].H`3`]_S/^-&![_F?\:6C(R!D9/0
M=SCKCZ4`)@>_YG_&OF']L[X8>+?C-^R[\:_A?X#L[:_\7^-?!%[HF@6=[J%O
MIEK<:A->6$T<<VH7CI:VJ%+>0F69E0$`$_,`?IPR1@X+H#Z%E!].A.>O%*&5
ML[65L=<$''UP>*`&HN`0<Y+R-]X]&D9AT/H1QVZ4_`]_S/\`C2Y&2,C(QD=Q
MGID>^#CZ4F1C=D;<9SD8QZYZ8]Z`#`]_S/\`C2XQZ_B2?YT=>E%`!1110`44
M44`%%%%`!1110`4444`%%%%`'XW?M-?&KXT0:S_P4*\?>'_C-XA^%$G["'PU
M\">+O@[\.M)M?!I\)?%35=5^#<_Q>?6/BAI_B'3;_6_&6A?%7Q?]L_9_\/:5
M8ZQX5BTBY\):]>^$9E\>S)K%EZM-K?QP?]K'X=:)X!^,_CWQ]KU]XZNO%7[1
M'PQN_#GA2V^`GP"_9MU7P)XAN_#7@7Q!<Z?I-UJVG_'B?Q3+X*G\&74/CFZ\
M>>.[B;Q7XMUKPKI/P8M;?3M(^J?CE^RK\)?CWKG@#QIXHT>#2/B5\+O$^@^*
M/`?Q0T3P_P"![_QMH$V@W5]=1:.MSXW\(^,=%U7PW=/J>H32:%KFB:E9:;J\
MUKXN\.KHGC;1M"\2:95TG]C#]E/0/BC=?&O0_@!\+='^+%_XTU;XC7_C[2O"
MEAI_B6_\>Z]$]OK7C*_U"T6%KWQ-JUNPM]2UNZ274+V".&*YGDC@A6,`W_&?
M@/XR7OCS7?&'@;XP0^'-+U#X6:9X&T3P5XA\*1^*O!V@>-V\<RZMJ/Q2ETNR
MU#PWK.L:T/"EV?#UGI$OBBQT9I+.QN+VWDA^UK/^5_P9\8?M3_M(?L(?L$WN
MG_%OQ/K7Q4^(>N^.;KXH>*H?C!X0_9[\9_$&R\(Z3\7[#3[J\\1Z3\./&%U'
MI4.NZ?X9U3Q/HWPL^%6L7\:6MA,VCZ?X6M]4FA_9[QYX!\&?$_PAK?@'X@>&
M]*\6^#?$EHECKOAS6[87>E:I:1W,%W';WEL642QI=6MO.HW`K+#&P(*BO`O#
MO[#/['GA+P!>_"OPU^S1\%M%^&]]XBL_%\W@:Q^'^@1>%X_%.GV-QIEEXALM
M&-HUGINL6^G7=[8QZAIL=G=?8[_4+9I&AO[Q)P#=_9(^(EE\4?V>?AMXKLCX
MP9XK#6O".K/X]\2Z5XS\5OXF^'/BK7_ASXMDU7QEHB0Z1XQ\SQ3X4UA['Q=I
MUM96GB?36LM<AT_3UOOL5O\`1]9&@:!H7A71-)\->&-&TKP[X=T'3[32-#T'
M0M.L](T;1M*L(4MK'3-*TO3H+:QT_3[*WCCM[2SM+>&WMX42**-$4`:]`!7P
MK^T5KWCGQ9^TI^SM^S;I'Q+\7?!OP3\2?AM^T'\3?$?C'P#/X:TWQOXI\1_"
M+4O@KHWA7X:>']?\1:;KXT:"XLOBCXE^(NO)I>A2:OK%CX!M;`:C;>'%\46>
MH_=5>-_'?X`_"C]I/X=ZS\,/C!X0TKQ;X8U:VO4@^VVEI)JOA[4KO3;W2H_$
MGA35)[>>Y\.^)]/M-0NTT[7-.,5W;I//;N9K*ZN[6X`/R2F^,W[0_P`2_P!F
MKX<^/_#?[0_CV]_:4\3:#\2_AS^S9\*OA-X0^'D.E?&SXG?"[XV_$SX<:3^T
MM\8;:XT+Q%ITGP`\<>#]%^&_C#X@3K<>!?AEX!\+ZWXCO/#FIW?CCQK\,M-T
M+]@?&GA/QOXEU'X1W^A^/;WP;!X+^(,7BSQ_I>CVEK-9_$CPROP_\=^&YO`=
M^VH6UY<V.BR>+?$?AGQDEQ:26VIBY\'V%JUWY-Q=P3^&:U^P9^ROXW3PG?\`
MQ8^#OP_^,'C7PC\._#GPLMOB1XX\!>`[/QEJ'@?PI=7M_H7AVZ/@/PQX)\-:
M?H&F:CJ5_J.G>%_#?AO0O"FDWMW/-H^A:>7P/KV.V@AMTM8HD2WBA6WCA48C
M2%(Q$D:KV18P$`_NC%`'Y(?#C]I_XL_!&V_X*>>)_P!H3QO>_&N3]F[XY_#'
M2?!.E>%/`\_AG1M.@^(W[+/[-OC32/A_X4\/Z#:^+?$6D^#D^(_Q.NA?^)?%
M&I>,];T?3+_5_%_B?7'TNQDM]/V_^"5?[2'B3]H'0?VOK+Q?\9;CXUZW\*_V
MR/B-X/L?$+^'Y_#>G:5X2U+P7\./%&B^'?#.FSZ)HTMOX-T;7-6\8:;X0MM0
M.HZ_!X?L[`^(M2O=1E-W<?8GPE_8X_9:^`_B[6?'WP;^`OPQ^&GC7Q'8W.F^
M(/%/@WPM8Z)KNNV=V=-\^+6-1M`MQJ9=-'TF`2WKS3QVNF6%I%*EK:00I[7X
M7\">#/!,WBBX\(>%M`\,S^-O%6H>.?&$VAZ7::9+XG\9:M9Z;IVI^*-=>UBC
M;4]>U"PT;2;.\U2[,MW<6VFV4,DK1VT2J`=71110!^;'[87CW]H3X5_&CX):
M-\+O%BGPM^V-?/\`LGZ?;ZG'IDZ?`CXPV7ASX@?&'2?V@?#MK=I'+K<4GP>\
M'?%_2/$/A2[N+RSU/QYX5^![VVG6ND77CN[G_.G]KG7?CK\%O$?_``4VU'P-
M^U=^TQ##\!?V6OV4_B%\*M+U7Q_HVJZ9X7\6_M(?$+]H'P=X\U:*SN/"+?;9
M-.TCX>^''\&V^HS7MGX7U"WN+VSMI9+IPO\`0MX@\%^$?%E_X1U3Q-X:T/7]
M1\`^)CXS\$7VL:9::A=^$_%I\/>(/"1\2>'I[F*232-;/ACQ7XF\/G4[)HKL
MZ/K^KZ=YOV;4+F.3B_&OP$^"GQ'M/B18^/?A3\/_`!A9_&'PEX>\!_%2W\1^
M%=(U:/XA^#/"5QX@NO"_A?QB+RUD_P"$@T+P[=>*O$MSHFFZB9[;3+C7M6GL
MTBDOKAG`/ECX)Z[X_P#AS^USX_\`V9)?B1X\^,GPXT[]GKP-\9(-;^)=_HGB
M+QM\+_%NM_$SQMX%3POJGBO2=%T+4=7\/_$G0O#\OBGPK9>*;74=9TF^\%^,
MY+'7[S0=3T_2M#\B_;MU/]IW]GK]E#7O&W@G]HB\M]7TK]I+PSXDU?Q!=>#-
M%U/Q?>?#KXN?ME?#_2_"GP>\/ZE<K'H'AOPQX3^'/CNY^'^K:S/X7U[Q;JV@
M:39+HVM:#K-Q=>(A^A?PH^!WP?\`@7H]_H/P>^&G@KX;:5JU\NJ:Q:^#O#VG
M:&=9U-+=+./4=:N+.%+O6+^&SBALH+S4[B[N(+*&"SADCM88XEP?C?\`LS_`
M#]I33M#T?X^_"#P!\7])\-W=S?:'I?Q!\.6/B73M-O;M[&2:ZMK'4$EMEG,V
MEZ;<)*\3O#<V%G<PF.XMH9$`/@3]JKQ7\6/`7QS\=_&[4?%WQ#F_9Y^`VB?`
M35/$_A+X9_M&>$_`-U8VVH^*_$,GC!]0^#P\#>)=5^(>NZJE]X=N;C0_&GC/
MX76WBSPA:0Z-\.M3UKQ#)=Z?<_K8I!&1G[S#GU5BI_#(./:O`;?]E7]FVVU#
MX>ZNGP,^%<FK_"C2='T+X<:O<^"-!O=5\&Z1X=NY;_P[I^A:E>V5Q>V=MX>U
M">XU'0(_/?\`L34KBXU'239WT\UP_O\`0`5\,_\`!0#XI_$#]G/X'77[5G@?
M4-1U'2_V9KRY^*7Q4^%4$NFV]I\9O@[!I-]HOQ`\'PWNI&&/2/&&B:;JD/Q`
M^'6JB]L;1O&7A'3M`UVX7PYXBU=H_N:N7\;>"?!_Q(\)>(?`?C_PQH7C3P5X
MMTF\T'Q/X4\3Z7::UX?\0:+J$1AOM*UC2;^*:SU#3[N(F.YM+F*2&9#M="*`
M/R#^)/@SX_Z'^U1_P3Q\%>./VH?C?8:K\=+_`./%Y\>O#/PW\:67A_X;:AK?
MPY^&UY\7-%\/^#])E\-3:AI'A/0O$5^/",;I>P:KXG\%Z+IR>(9I]1NKZXD\
M_P#V+/B]\<[+X6?\$U/B_P"(_CQ\3?C!XD_;4\5^(O#?Q@^&WQ!U/PGK.F?V
M9=_"SXS_`!*N/B+\-K:V\/Z+KG@BW^%FK_#KPSI^HV6EWVH>%+SPKXJO-+U?
M27\0W7A?7++]N-7\">"]?\3>$/&FM^%?#^K>+?`$NNS^"/$NHZ59W>N>$IO$
M^E?V%XCE\.ZG/$]WI$FN:-_Q*]5:REA-]8?Z+<&2'Y*\D^$/[)7[,GP"UB]\
M0_!7X#?"CX7ZY?VE_I\^K^"?!&A:#J2Z9JE_'JNIZ3:WME:)<:?I&HZI!;ZE
M?Z3I\EIIU[?VUM>7-K+<6\$D8`SQCX$^-1U;XR>(_!7QI'A^+QKX*^&>A>`M
M'\0^#K'Q=H?PEU7PK?\`C:7XA^,M!T5+O09-<\2>-M#\0Z+!8VWB+5]0\/:5
MKOA'0M0OM%U721JNA:Q^2'BW]N_Q[X2_X)/_`+)GBSQ'\4_$OA_X]_M(?L1K
M\0=7^/K>%9M6O_#6K>&?V>['QMXR\<PG2?"%]X,M_B9XF\5ZMX?T7P-I.IZ5
MINB#5O$.J>+X-'O=!\":IHLO[?\`Q(^&?@'XP>#M6^'WQ.\):)XX\%:Z;(ZQ
MX9\16:W^D:B=-O[;5+'[7:.567[+J%G;7<()PL\$;\[<'AOAI^S-^S]\&_AQ
MK7P@^%?P=^'O@#X5^(DU*+6_AWX5\,Z?I'@S4K?6-$M_#>IV=SX<MHUTMK&]
MT"UM]'GL%MELVTZ%+00"$;:`.;_8R^)\_P`:OV2?V:?BS>:[)XFU'XA?`KX4
M^*M9\036\UK+J^OZMX'T.?Q'?RV\]K8R1RSZ^=3>0?9+>-GW/!&(&B)^EZR/
M#_A_0_">@Z+X7\,Z1IV@>'/#>D:;H.@:'I%I#8:5HVB:-90:;I.E:;8VR1V]
MGI^G:?;6]E96L")#;6L$4,2K&BJ->@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
MPM<\4>&O#$=O+XC\0:'H$5W(\-K)K>KZ=I,=S+&GF21V[ZA<VRS21QD.Z1%V
M1#N8!>:YS_A;'PO_`.BC>`__``L?#?\`\M*_`7_@XIAAF^&7[,`F@AF"_$WQ
MZ5$T,<H4GP1;`E?,5MI(X)&,C@U_*RME99'^@V74?\NEMZ_]<J_I?PY^C_A>
M.^$LNXFJ\45\MGCJF.IO!PRBGBXT_JF-KX1-5Y9EAW+VBH\[3I1Y7-QO+E3?
M\Z^('CIBN">*L?PY2X;H9C#!PP4XXN>:U,+*I];P6&Q;3HQR_$*/(Z[IIJK+
MF4>;1NR_TT-+U72]<L+?5-&U&PU;3;L.UKJ&F7EMJ%C<K%*\,A@N[26:WF$<
MT<D3F.5@DB/&V'5E&A7YI_\`!'U$C_X)Q_LU)&B1HND^/]J1HL:+GXL^/2=J
M(%5<DDG`&22>I-?I97X#Q%E4<BX@SS)(UWB8Y/G&997'$RIJE+$1R_&UL(JT
MJ2G45-U524W352:@Y<JG*UW^Y\/YI+.\AR7.945AY9ME.6YG+#QJ.K&A+'X*
MABW151PINHJ3K."FX0<U'FY(WY44T.A8J'4L,Y4,"PQUR,YX[TZOYM_`O[3W
M[0?AWXO:WXXU;7?VIKO31^WU_P`%`/"NH:QXF\0_##Q;^S7XR_9X_93\6_'_
M`%K6/@C\+?AEI.O7WQ-TSXU1_#7X=0VGPPBN_#'@8:UKW@7Q1KM]XUU7PYIF
MH:3XI\8]<_I(H)`!).`.23T`]37Y!^'_`/@I)XW\,W?A:_\`CG\//AWX>\#:
MW\+O@?\`M`:]XV^'OC?Q!XJT;P5\)_VD='^+&D_##2=:O-8\,Z#;7/C:/XN?
M#[PSX">]M6B\/>,+'XA66O:';:-+X?U#2KOP?]H+_@IO\:/#7A/QCX<C\$Z/
MX=N?&7@C]J'X1^'/B'X`/CN_@^%?[2OP5_9"^-/QVUBQN_&OB[PKHO@KQ1K7
M@_Q7\(?%/@37?"O@ZR\16WA7Q1HQEO?'&N3:?KF@Z<`?OIUZ45^$'[.W[>_[
M0OA35?C=XJ_:3U7P)XD_9[^'OQ._9H^'EMXGTZQOM'\9^!-*^+'[`OPA^-MA
MK?B"[%M%H_B9O&GQI\;:#X1FDNI8;FU\5?$22WTZXBT#3=(TQ/VR\`ZGXFUO
MP-X.UGQIHD'AKQAJWA?0-3\4^'+:>2ZM]`\0W^E6EWK.AP74P66ZCTC4)KC3
MA=21Q/<?9C,8HM^Q0#K:***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`_);_@J]^PS\7_`-M_P=\&
MM`^$>L^`='O?A_XP\3Z_K;^/-8UO2+>>RUGPY#I%JFFOHOASQ%)/<)<QEYTN
M(K6-82&261\QU^*(_P""`_[:`(/_``F_[._!'_,Y^.__`)V=?V+T5^M<*^-7
M&_!V287A_)JV60R_!RQ$Z,<3EZKUKXK$5,55YJKJQYOWM6?+[JM%J.MKGY9Q
M/X.\&\6YSB<^S>GF4L?BXX>%5X?'.A2MAL/2PU+EI^REROV5&',^9WE=Z7L?
M(/[!?P&\9?LQ_LF?"'X&?$"]\/:CXO\``=CXHMM9O?"MY?:AH$\FL^./$WB2
MU.GWFI:;I%[,JV&L6L<YGTZV*72SQH)(T263Z^HHK\TS7,L3G&9YCF^-<'C,
MTQV+S'%.G#V=-XG&XBIB:[IP3:A!U:LN2%WRQLKNUS]%RS+L-E&6Y?E6#4UA
M,LP.$R_"JI/GJ+#X+#T\-052=ESS5*E!2E9<TKNRN%>:Q?!OX3P6EC80?#;P
M/!9Z9\2M5^,FG6L'AC1XH+'XL:[K>L^)-:^)-I&EHJV_CC5]>\1:]K&J>)X@
MNKZAJ.M:M=7=U+)J-V9?2J*X#N/E+7/V,?@)=>%4\!>#_`GA3X5>`M6^)'@_
MXC_$;P?\,_`OP]\.:-\6+CP+K$'B;P]X=\<HWA.\N)-`M_%&G:)K,HT&;1-8
M:/2%T2WU:UT'4M7T^^Z_5?V5/V9]<\2>)?&&L_`#X.:KXK\8W%]=^*_$>H?#
M?PC=:UXCN]5\,:YX*U6[UG4I=):[U"ZU;PAXEU_PSJMS<2O-JFA:QJ&EW[W-
MG<O$??J*`/E;XA?L;_`OQ_>Z1>?\(;X>\)-'<_#*S\9?\(EX.\"V-U\2_`?P
M>UG3_$_P[^%?C/5;_P`+ZEJK^`/#GBG0O#6LV6G:'>:-J<$6@6N@VNKVOAZ]
MU73+WZH`P,#W/U).2>.Y))/O2T4`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`9VHZQI.D+$^J
MZGI^F).S)"^H7MK9+*Z+O9(FN98A(RI\S*A8JOS$`<UE?\)IX/\`^AJ\-_\`
M@]TK_P"2Z_/3_@I0B/X5^%6]$?'BGQ#C>BN!G08LX#`X_"OR46"#(_<0=1_R
MQB]?]R@#^I.SO;/4+:.\L+JVO;28,8;JTGBN;>4([1L8YX'DB<*ZLC%'.&5E
M.&!`LU\O_L8JJ_LT?#!55546GB+"JH51_P`5AXAZ*H`'X#K7U!0`4FY=VW<-
MV,[<C=CUQUQ[T,<`G...O''J3GC`ZGZ5^17@OXN^+OL'CO\`:E^(G[1OC/P[
MJO@O]J+]J?X3S_LT6=EX1USPGXB\%?`W6_B[I/A'X'^&O!,/V'66^,?C+X??
M#K2?CCI/CR+Q'<>*[^ZUED:SN_AE>6GARU`/UVHK\63_`,%)/CK9:O\`!CP/
MJ'PE^$5]XU_:&G_9-\2?#[4?#7C_`,7ZMX$\.^!?VNM'^/#^';3QEJ\WABRO
M+CQ5X$U3X,27\MQH<0TOXD>&;[4;O0-/\,7>D3`48_\`@JIX]\,^"=4^*_C?
MX0^#-8\"S:/^W[9>'-*\!>,=?N/&=KXQ_8*^)?C+P1KMQXWAU#P_?:3X=\"_
M$&R\-QW<VNPRWEW\-KJ;3_[9MO$D'B*&+1`#]M**_'?Q)_P4-^,?P_\`C#IO
M[/7COP1\$[#QWI_COQ9H_COXDVWC3QM#\&-!\$:'^R[=_M5#Q,FH7?AY_$D.
ML:/X6T#Q'X;\3>';BTNC:Q77@GQY%>V^C^*)]`TCYP^(O_!2_P#:P\42Z+\.
M_A;X7\`_#OXB:G\1O^"=OQ"T;Q?XK\&_$/\`X0KQ9^SS^US^UC'^SUJN@V6A
M^-+/1/&\L@U"*P4_$6Y\/^"+K6/"6MZO=Z%X/\$^+-+TR=@#^A>BOS%_9D_;
MR\>_M`_&FX\*3?`KQ?X:^%VNZ[\?_#GA3Q?J/A+QUH4FC7?[/OQ#U#X<75[X
MG\0^*])TGP5XF'Q%U'1->O=.T3X<WNLZI\.Y+/3M&\6R:K+JD^IZ5SOQ(_X*
M%^+OAO\`&OXTZ!JO@WX;I\'?@'^T]\%?V</'>N7_`(TURP\?-'\>/@+\*OBU
MH7Q'M-(AT/4='M?#/@+4?B%<?\)S!>-)//X"T7Q+XNTJ6WN?!]QI?B,`_5RB
MOPKT_P#X*K_%U_%6E?#2Z^"WAM_'7CW5OV.=3^'&J7Z_$3P+X(U3P'^V#\1_
MB3\*M(UAU\9Z3#X]OK/P1X@\"6FMQ>([GP;X7D\=>'M3O(H/`_A+5M-C@O9_
MA)^VM^VC)\3_`!C\(?%EK\$/'/B[Q_\`\%%OVC/V5/A'J$]GXK\&^&OAUX)^
M$G[*6K?M`Z=?^(8M*BU#6/%<#7GAW[%!$7AUJ^CUJ\-SXA$,.G36(!^YM%?B
M5\!/^"L'C;]H7Q5\*CX/_9R\51>#->/[-6@?$.X31O'>K1Z3XF_:#T71-3UG
M6]#^(\'ARQ^&6G^"?A0^OZ>TH\87]AXI^)EE#KH\-:7H>L:3IND^(_O;]AC]
MH+QQ^U1^S?X`_:!\:>%O#'@J/XH:;'XA\,>&?#FJZIK<FG^'T+:49-;U'4K>
MTC;4]0UC3=5U""TL('M]/T>ZTRSN+R^U&*]N&`/K^BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/D#]KKX!>,OCSHO@
MG3O!^H>'K"?PYK6JZC?-X@N]0M8Y(+W3$LXEMC8:;J3/(LJDR+(D2A,%78_+
M7PX/^"=WQL!!_P"$C^&W!'_,7\1?_,O7[144`>-_L_?#W6OA7\(/!O@'Q#<:
M;=ZSX?@U6*]N-(FN)].D:^U[5=4B-M+=VMG<.JV]]$K^9;1$2K(J[E"NWLE%
M%`!7F$7P4^#\/Q,G^-$/PM^'L7Q=N;+^SKCXG1^#O#Z>/I['[!'I7V:7Q:FG
MC79(SI44.EDM?&1M+AATUG-A#';KZ?10!X;X<_9C_9R\'I:Q^$_@/\'_``Q'
M8^.-/^)EDGA_X<>$-'6S^(>D6>IZ?I/C:U73](MQ;^*-*T_6M7L-,UJ$)?Z=
M8ZIJ%I8S6]O>3QOQWP3_`&-?V>?@+I_BJW\%_#KPY>:SXXU3XMWOC'QGXD\/
M>%]5\;>*=,^-'Q7\9?&+Q?X1\0>(XM!L;O6/!J>*?&^J6NE>'=06XM(="L]&
MT[4#J<FFQW;_`%'10!XIX5_9M_9[\#6OAJR\&?`_X2^%+3P;J7B76/"=MX=^
M'OA31X/#>K>,M!/A7Q9J>B1V&E0+IM_XE\,8\.:Y=VPCGU30531KQYM-CCMD
MYZR_8_\`V4M-\-Z_X.T[]FWX%V'A3Q5H+^%_$GARR^%7@BUT77?#;:X/$RZ#
MJNG0:)':WVD0>(ECURSL)XWMK'58;>_L8[:YMK>2+Z,HH`\H\*_`CX*^!O&F
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M#X6Z/!X?^&VM6'PW\(6NJ>`M#M;S4-0M-(\(7\.D)<^'M.LK[5]8O+"TTN6V
MBL+K6-6GLE@EU._:X].\&^"O!_P[\,:-X*\`^%_#_@OP?X=LUT[0/"WA72+#
M0?#^BV"223+9:5I&F06UA86JRS2R+;VL$<0>61@NYV)Z:B@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
JHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>biib-2015630_plegchart.jpg
<TEXT>
begin 644 biib-2015630_plegchart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`$V`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^2OVW/VF9_V1_@!J7QG
MM=%\'ZY<0?$?X&?#F%/B'X\?X8^`M'?XU_&SP#\'1XL\:>.X_#GBR3PYX6\&
M_P#"<_\`"4Z[>IH-\S:=I%Q;C[/YWVJ'ZUKPK]H?X$Z)^T3X#T3P%X@UB_T3
M3]%^+_P%^+JW6G6ME>37>H_`;XU^`_C5I.BW$%^KVYTWQ!JG@.TT359`IN(-
M-O[J:T_TJ.&@#P'P1^W=\+H-%\)1_%WQ[\(#XE\6/I>HQZY^SGXE^(/[07P0
MT+PCXO\`'NH?#3X>>*/&/QKTSX7^'O"_@33/&'CC2-9\(V.I^-QX?T&7Q+HN
MMZ=8:S?PZ)K%W8=WJ'[:7P;E^`/QS_:+\%GQG\0/`OP%\/\`Q0U7Q+_PCW@#
MQQ#>:YJ_PB/BNR\:^$_""ZIX=M!XFUW1/$7@W6O"^MKHBZA:>'=:M9K?7+BR
M^S77D\C\;/V'/#'QC\?^+/$X\?>)O!WA+XP>$/A;\/\`]H/X=:)HWA6[TCXL
M^#/@SXO\1^,?`VDQZUJ>F3>(/`L\C>,/$_A/Q5J'AJ[:37?!FKM8V,.@^(]/
MTKQ79=[\,_V3_!?@']FKQ9^S#J&MZ[XH\%^-Y_VA1XCU2<6>CZW<6'[1GQ%^
M)GQ`\6V5H^GQO;61TR7XGZOI&CW*1O(EK965U.CW)F#`'S3\'O\`@J-\)/B3
MX[/AKQ-X4\8_#+P[JWPS_8K\=^%/$WB/POX^N'&J_MH_\)[IW@SPM\2K2V\"
M1Z;\(3;>+_"6C>!]!\0^.-;T[1/'/B7Q;I=IHMQ$DMC)J'U[\)OVH_@E\;]?
MU#PW\./%=YK&HVNE7?B+2Y-0\)^,O#.E>-/"EAK:^&[_`,9_#;7/%'A_1M&^
M)G@JQ\026^D7?B[P'?>(/#\%W?Z07U`6NN:'<ZE\8Z#_`,$O_#=IX#\=>"_$
M_P`8_%GBB?QUX;_86\'7^MMX4\,Z+)'X=_8(^*4_Q"^&D+Z;832V<^H>+M.%
MCX8\=7L;6=O.+>YUG0=/T:6\33K3U7]D7_@GU\)_V//$>JZS\/(O"RVL7A*3
MX=^$%TOX._"'P7XKT[P+)KUIX@73?&_Q*\)^$[#Q]\4=8MYM-T;2H]<\2:U;
M17FEZ)IMYKFD:SXN%[XLO0#YZ^/_`/P4/_:!_9X\9_MC6GBCX`?!?6/A]^R+
M\`_!?[1NI:_I/Q]\<V_BCQAX'^*GB?XS^%_A]I47AZ_^`46BZ#XCM;CX,ZI?
M>.?-\4ZEI6CVFKV8T&]\136UPM?7Z?MW_LS'Q%I_@Z?QIXAL/&>I^/?%_P`-
M;?P9J_PP^*>B>+H/%?@7PSX/\>>)+?5/#6M>#-/UC1-*LOAOX]\*?%!?$FL6
M=CX:N/AEJC>/X-7?PKIVJZG8\C^T!^PAX/\`V@+K]JVZUKQSXET%OVK?V>/@
M]^SQXC32]/TBX7PMHGP?\7?&3Q=IGB#1#>J3=ZKJ]S\8]4M+^VU'=900:/I[
MVP$DUUG#\1_\$[?AIXO_`&C_`!E^T)XE\5^)=5/COQ)\1=<\1>`FMM/M="N[
M'XF?LI_"?]D[7]"75;5HM;AM/^$0^%5IKT%U#-'>KK.N:A")$M+>T(`/2]._
M;M_9HU3PS?\`BJS\9>(VL8#X"?0]-G^%OQ5LO%7Q!LOBM?:KIOPNUGX3>#+W
MP7;^+/BSX>^(U[H6MQ>"_$7P[T?Q'HNO1:+J][:WWV#3;VZA]ATSX[?#+6?A
M//\`&O2];U*_^']K;ZQ+=W=GX3\87?B.UO?#VMWGAC7_``]<>`K;0)?'L7C'
M0_$^G:AX8U;P4WAG_A++#Q+8W>@W&C)JD$EJOYO:-_P1R_9^TGX8-\.VB\!7
MDWAW7/A'J_P[UD_LW?L]Z=!9+\$;3Q;IG@Y/BKH&C^"+"P^.MQK.C>-_$&D^
M.YO'%Q!9:LDUOK?A+2O`?BZ&3Q)<?6L_[&?A$?LBZC^R7H/BG4?`>A:I8WIN
M/%'PS\)_#_X;[-6U/QQ_PL+5U@\!^"O#6B?#^/PCX@UIKC0_%/@DZ&VG^+O`
M^HZSX:\47^KW&N:OK=Z`4;O_`(*%?LN6`LK2[\5^-8O$]]KOQ"\+K\/4^#'Q
MEN?BA:>)OA9X+\*_$CQUX>U+X9V?@.X\<:=K.B_#SQMX8\=K8W6AQR:IX0U6
M'Q#I!OM-2>>+A_B;_P`%(O@GX:U#X3:5\,)9_C#<?$[X[?LO?!Q]9T'3?&ME
MX!T2W_:>?P_K'AS5Q\3X_!6I_#V_\4:?\.O%&@?$B'X<2>(]/\3ZEX8UW0KV
M>/2[76+.Y?A?@_\`\$M/AI\(?BM;?%W1_&EQ;ZU)XM^)OCK5O#7A+X<_#OX;
M^`9/$?Q5_9T^$_[.OB$:!X/\$Z7IFE^&M'MM$^$ND>(["Q@%_J%QKFIZG+KN
MM:U/*U_+D?#?_@E1X2^%WA3X._#?PU\;OB`GPO\`A3\1OV7/C;=>#)?#G@DC
MQA\:OV8_"7PS\"V7C+4M?&G?VWIFC^/]`^%?AJ^\5>#]/N6LK/Q6ESKFA:C8
MZ?<7/AZX`/7/VA?VW[SX+?'72/@AI_A#X:R:IJ'PY\-?$32KKXO?'71O@3-\
M69_$?B[Q+X2D^&?[/,WBCPGJGA+XD_%7PTWAZWU3Q1X;\0>,?`=KI4/C#X>P
M27YM?%-SK.@=UX?_`&V_A!/XR\?>!?%/B70]-\1>&OC-XT^#WAO2O#MMX_\`
M$-_XDU[P9:_!LWWAQX[WP!H%NWQ&^U?&GPO<GP9X5NO%]K<^&Y+GQ-HWB'5]
M/T#QO_PB47[3_P"R/J?[2NF>,/!U[\:_%_ACX6_%/P"?AI\4_AC<>$O`'Q`\
M,:MH$D6NVEUK_@F/QWH>J/\`#SX@7VF^(+G3;OQ':+KNCRQ:?H6I#PHGB#2(
M-9?RB?\`X)N>#QK^N>)-+^*OC[2-3C_:)UC]JCX<301V%X?AW\:KWPE\*OAU
MI?B97U&:[F\90Z3\,_AUXA^'<]AXIEN$\0>%_B_\4$UZ2\U75-&U31`#USX_
M?M;-\"/VB?V3_@Q?^`_[9\)?M(7WQ'T?Q%\2!XB?3S\+M5\/7WPT\+_#I;GP
MTNA7_P#PD>G?$?XC_%#PS\/WOAK>B'P[K&LZ#,8-7BU22.S\<^&7_!2OP#XO
M^(7[3'A3Q;X,U[POH'P<^.7@WX+_``CU7PI8^,?BUXP_:(E\5_"S4?B.VN>#
M_AGX"\#:CXH@-JGA/XAW%MIVE)XHCN/`G@^;XA7VIZ7I5U-:V/OG[2O[)/A?
M]I<S/X@\6^*/"=VGP/\`C)\'M%U;PI]@@UOPKJ?Q1\6?!3QYX?\`BAX:U*\A
MN#IWCOX4^-_@5X-\6>!;AH)["/6[=+G4K>YCMHH9/`;3_@FSX9\)^,9?B3\+
MOBWXP\!_$'1/%'P@\4?#G7&\.>$?%%AX.?X6_LTW_P"RO?Z->Z'K=H;?Q1HW
MCKX<:MJ-YKJW%UI.IV/BD:=K&CZG;K936UZ`>R:7_P`%`?V4-<UO1=#T'XEW
M>O3:Y%\%)X-4T3P#\2=5\-:;!^T9<:EIWP0D\2>*;'PA/H'A/_A9?B+2;[P7
MX8B\3ZAI%Q=^/HE\"2Q0>*Y%TD?('PJ_X+*_!3XB7_AC5]>^'7Q0^&7PPUKX
M(?';XS:YXO\`&/@7XD2>(O!>G_`?]I+3?V??%%QXI\#:+\/;^_TOP%:0WS^.
MO$GQ0N[V#PGX'TZVNM&\2W%KJ>G:R=-]-\-_\$NOA?X/\-^-O"WA[XA>-X;#
MQIJ'[$6L7EU?V?AZ]U(:Y^Q=\<Y?V@K+7+J:&TL+.\U+XM^/KW6+WQTL&GZ;
MIFF#6+J/PGIFE6D-E96W,Z?_`,$H_`]AI7QP\,+\7?&;^$OBI^S;^UM^R[X8
MTH^'O#BWOP\^'W[77Q/U+XO^+KB/5][OXLUKPGXRU[78_"MUJMG8QR>'I]/T
MS7(]2O\`3Y]9U$`^X?`W[47P:^)'Q%U_X8>"]<\0:WK_`(;U;Q=X>O\`5X?A
M]\0X?A]<>)?A_?0:9XZ\+Z/\4KKPM!\-]<\3>$-0N(['7]`TGQ3=ZI97<5_;
MK;32Z3K"Z?!J?[5OP-TCXG7OPCOO%>I)XNTS5T\,:C<0>"_'%WX-L?&\_@W_
M`(6'9_#B[^(MIX<F\`6_Q,U#P,T7BK3OAY+XE7QA?:/=:?<6^CO)J>F0WGC'
M@/\`89TKP3^T78_']/B9K,UWI1\1RQZ3H7@3X<^`M:\8)XF\(V_@[_A&_C'X
M[\#:#H>N?&CP-X-LK:UU+X<:#X[M;[6O#&NZ;HNK:CXM\27>C64@Y^X_X)P_
M!T?M*>+OVB]-@\+6FJ^./&=S\4]=M]0^#OPD\2^,[?XG7'PVLOA<^L^&_C+X
MA\+W_P`3?"GAN;1M+TO7I_"NAZQ;3P>+;)[[1?$>B:%JFM>&]1`.W\.?\%$?
MV2_%O@RX\=^'OB+K&I:(WAGX/^,?#ENGPR^*D'B+XB>&_C]>3:3\&]6^%'A.
MX\%Q>)OBO:^/]>M+_P`.:*WPZTGQ*5\0:9JNDWPL[C3KKR_./A;_`,%-/@?X
MPL?'MWXYCUGX>OX.^-?Q^^&PMX_#/Q%\5S:;X#^!'Q%'PUU+XR?%.+3?`-O<
M_!#P;?:^9+'4KWXG6^@:1X>U.RUG3I]<O/\`A'O$%SI?*6?_``2Y\$Z/IWP2
MD\/_`!9\9Z7XO_9V_9H_9<^`/PG\7-H/AB_FT/6?V4?$FL>(/!7Q*U#1KN)M
M,UB^\2VGB'7_``KXS\*SK#I%WX9US4H]&O=%UL:9KFF</-_P1V^#=]XKU;QU
MKWBRT\;^,_&OBWXE:_\`$;Q+\3?@C\"_B?>:WIWQ.^)FH?%K5+/PEI_COP9K
MWA_X<ZUHGBS7O%%IH'B+0=&NHCX7\13Z-XAT'Q!>:/X:UK1@#Z=UW]O#X:K^
MT3\"_P!GOP-I^J^-=2^*WQP^+GP.\2>+/[&\::!X1\(>(O@Y\$OBI\5?%\/A
M[Q9J?@T>"/B9K.@>(/AL/AWXM\/^%?%CW7A'7-2OUU>9-1\.ZAH[:GQW_;8^
M'_[./QGTKP!\5;7_`(1_X>M^S5\6_P!HGQ-\3UDU?57\.6GPQ^+?P"^%$'AX
M>#M"\/ZIJNK#7[[XZ6M^=4L[H2Z9_8@MFTN[BU"6]T[E/"O[!>C^$OB]\+_'
MFF_%CQB?A_\`!3XZ_&_]H+X6_!]]"\(1Z%X<\:?M%^$?C#H'Q2LKKQ-:Z;;^
M)M9\/2ZW\:O&/BCPAI]W-'-X8GU"YT>XN]=TP:0-"E^.'[!7A?\`:1\4?&+Q
M!\8_B)XHUNV^('P.\6_L^>`M)T'1O#7AR/X3^`_'/B?P)X_\2WNGWRVFIWGC
M#Q9<^/\`X9>!-?L]3\3$Z-96?ARUT;_A'+B*]UB\U$`[#Q?^WW^RWX)\5^(_
M`FL^.]=NO&GA;Q;\1/`VJ^%/#7PQ^*/C+Q`WB?X3_#KX8?%KXAZ=I>D^$O!V
MM7VN+X6^'/QB\`^+-0O-'@OK%M+U._-M<SW&@:]!IW5^&_VR/V=?%_C3P_X'
M\,>/SKM[XHE\-V.@^)=-\+^,;GX;:CX@\8^`;#XJ>$_!T7Q53P__`,*W7QWX
MC^&VJ:9XXT;P1+XHC\4W_AO4M-OXM*/]HV$=S\X>"_\`@F]X?\/?%FX^-GB+
MXP>,_&'C[6_%'[0?C7Q7>77A_P`,:/INM>)?VBO@7^SW\#?%,MIINEQB/1=*
MT+2?V>]"U7PWI=O+<O#-K-]9:G?:B+6&^GY+]G;_`(),?`_]G+QM\,O%OAF\
MT+7G^'NG?#34)]0\4?!?X-:Q\0]:^(?PV^"WA+X'VWBNR^+NI>%-0^('@_1-
M>T+P=I/BC5O!OAC5+1+/QD+NX\/^(=&\-:CJGA>_`/;OVN/VP/$G[+E]HU\_
MP\\"^(_"NHIX?M])LM;^-VA>#/BY\8/%>M>(&T>[^&/[-?PF/AGQ%J7Q6^)F
MC6$^DZPV@ZQK'@:QUJ;7M$T31=4GEFU;4]#R],_;@NKSXDZ;#=_#?3M-^`7B
M+]I[Q?\`L<>&_BM+X]67Q?>?'+P3+XHT#4I=1^&L7A8V&G?#S4_B7X*\3_"G
M1-;A\?WWBN;Q59Z9J5_X+L?#.L?VGIO;_M(?LGZO^T7!XK\)ZI\</&WAOX1_
M$SPE;>!_B7\,K7PSX"U^VN]"C^VQZC=_#OQ/X@T*ZU_X8^)_$=E>)I^N>(=/
MDUU[==-TC6?"ECX5\5V"^(I,NQ_8F\/V?Q5LO%<GQ$\67GPIT?XZ>(?VH="^
M!EQIOAL^&M+^/_BJUUM-9\6CQ4E@/%UUX:_X2#Q+XC^(^G^")[P6EE\3-;N_
M$,FKW>D6FC^&-,`/HWXL^+?B#X4\,6=S\+OAN/B=XQUGQ!HF@:;I%]XHLO!?
MA?1H-4GD.H>+/&OB>:PUW4]+\*^'K"">ZOAX:\*^+?$VHWLFG:3I'A^XEOY+
MNQ^(_#/[=GQ#^(UUX>^''PQ^!/A[Q#\>Y_$/[3^F>*/"^L_&./0/A;;:+^R7
MX]\'?#/XA^)?!GQ/A^'VL:YXPT[Q1X\^(?@[PCX&-U\-O#@@UZ3Q?8>-Y/#%
MWX#U>UO/:?B3\!/CW\3/V:O#_P`'W_:F\3>`_B>Y\/I\0/C7X.\!^$[?7/&&
MDV=W<W/B;PU:Z18/X=M/!]IXNLI+?0=1\0>"+OPWXJTO2X[N?PMJWA[6;R/5
M++SO1OV)/%GA_P`+?"8>&?CG!\.OB=\&M!^(GPX\%^./A1\$?AOX)\+V'P7^
M)ESX1O=:^&B_"B[D\2^%UBT;5?`GA'Q/X4\0I?"]TKQ9X>LM1U"SUK2+_P`2
M^'O$`!0\(_\`!0?2OB)\4_V*?!_@CX1^+;KX>?MD?#SQCX[T;XL^(-;\.Z/I
M?AJ]\-?"JV^*$7@JR\/:?<Z[K'BOQ':0->Z)XTO4_L+POX6U2UCL].USQ3J,
MMW8:7;^`G[:6N?&3X]^*_A?J5K\!O#/AW3O$?QJ\.^%;&T^+'CS5OC%XAF^#
M_P`0-7\"7C2>$]1^#/A_X:RZDJ:%=^(_%_AKPI\7/%GB+P!I.I:$=<TXB]FG
MM^7UK_@GWXHT[Q_^RAKWPC_:"G^&O@']C;PQ/X3^$'P\O/A)X9\;M)INO^`K
M7X;>.)?%OB[4/$FCZGKU_P")?#=O)<17D>GZ?)IGB"[NM7E&JI(MBOT'I?[-
M7B*7XM^$_B%X[^.7CGXA>&?A=XS\<?$#X2>`]8T#P1I:>$_$_C[PWXP\&7TV
MN>+=#T2RU_QMIWA;P=X]\6>%_`MAJ2Z?)I^F:J+OQ9>^-O$&G:5K=B`=;XI_
M:B^#G@GXE:3\*O%.L>)-$\1ZWXET#P3INKW_`,._B)!\/;CQSXLTZ'5O"O@9
M?BDWA8?#D^,O$ME/%_8OAM?$[:G?7L]II*0KK%_86%SX]X;_`."CW[(?B_PE
M'XT\-_$G6-5T?4?#'PO\8^$K>'X7_%=/$'Q*\/?&?57\/_#6_P#A)X7F\$Q^
M(OBP/$OB2*Y\-K#\/-,\23Z5KEG>V&MQZ:UI-(OF_P`5?^":W@7XM?'^/X[>
M)/'^L75[8_'3X'?M">'K/4_`_P`/O$7BCPCXO^"-[X'?3O!O@_XI:YHUUX]\
M+?!O7[7P0+S4OAEH&H:=8P>*O%7C/Q)#J<T/B/4-#EXW2_\`@E3X)\.:9^S?
M+X9^+_C72O&G[*?[.GP>^!?P?\92>'O"VHS:9J_P6\56WB+0/B'J^B7<9TO5
M[G7M-;7?!WBKPN_V?3+SPSXGU9M)O]%U^#1]<TP`^B/@G^UWJ?QV^"OQO^+'
M@;X0>(==U;X6_&O]H?X->%?A[IVL0:9XB^(.H_!#XBZQ\.].NIY/'6F^#H_`
MU[XJOM+6[U;2O$MNLO@I&O;>^EU.?3VCG\LNOVZ_'VC>+?$WP-UWX*^%I?VD
M+'XQ_"/X,>%-#\+_`!<N]:^"GB#7_C#\+?''QKLKG4_BIJ7PU\/^+?#EQX#^
M%OPS\<>+O'OAB3X4:EXEBTV#P9=^'[/5[+X@Z/<V7K7@#]D_Q)\)?@-\:OA5
M\,?CSXP\-_$'XP?$+XW?%>+XXW?A#P)KOB?P9\0OCGXMO_&FO^(M&\(7VF1^
M!+\Z#K>J7TWAO2]5TB;2;>(64%_97\=HRW/E7@3]@?Q%X5^&MCX,U/X[27?B
MOP1\6M#^.WPF^)?AOX5>'_#7BCP]\6K31?$OA[QAXV^(TFI^)O&,_P`;-;^*
MVA^+?$.A_$O5O&FI0:[K>DZ[JT>GZSH^H'1M3T,`SM?_`."B5_H?ACX/Z@GP
M(UK5O$/BO]L+PW^QO\:(=-\<:(W@OX'>.]1^.&A?!'5-0G\67.FVFL>.EU"^
M\2:)XO\`AYHNC^#-.U'Q)X/U"/4O%K?#V6UN[5?4_CQ^V?:?"'X__LX?`C0/
M`X\=7/QB^+?AKX9_$7Q(GB1=%LOA##X[^'GQ<\;>`;I[4:-JO_"6>)O%$WPA
MU\)X2CN]$?2O"T4_BS5-4MDN?#.F^)/(OB5_P3Q\6^*?A]\/?`?@G]I/6?!3
M^&_V@-,_:P\>>*=5^$W@KQGXA^*'[1&B?%O3?C1I/C'5@=4\,:1X>\.VWBG3
M;?2CX*T'3$M%\(6FE>'[35+0Z=]ONNF^(?\`P32^"OQ.^(GPF^,?B#Q#\2M-
M^*G@7X]_#[]H_P`<^(/"7Q.^+/ACP[\5?B7X!^%>I?"R'4]3^'>G_$G_`(0C
MPD=1TR?1WDN/"ND6VHP:3H%MX2>]O/#FIZ[::D`?HRIW*K8QN4''7&1G%+2`
M8`&<^I/<]SZ<GL.!VXI:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`**_'C_@H-\3?B/X1_;U_X(U^`?"?C[QEX7\$
M_%K]IG]H;0OBCX4\.^)M9T30/B)H?AW]E3QUXET+1?&NEZ9>6MIXFTG2/$5K
M:Z[I^FZQ%=V5KJ]K:ZC%`+NWAEC_`%FC\-:240F*Y)**2?[3U7DD#_I^H`Z&
MBL#_`(1G2/\`GC<_^#/5?_DZC_A&=(_YXW/_`(,]5_\`DZ@#?HK`_P"$9TC_
M`)XW/_@SU7_Y.H_X1G2/^>-S_P"#/5?_`).H`WZ*P/\`A&=(_P">-S_X,]5_
M^3J/^$9TC_GC<_\`@SU7_P"3J`-^BL#_`(1G2/\`GC<_^#/5?_DZC_A&=(_Y
MXW/_`(,]5_\`DZ@#?HK`_P"$9TC_`)XW/_@SU7_Y.H_X1G2/^>-S_P"#/5?_
M`).H`WZ*P/\`A&=(_P">-S_X,]5_^3J/^$9TC_GC<_\`@SU7_P"3J`-^BL#_
M`(1G2/\`GC<_^#/5?_DZC_A&=(_YXW/_`(,]5_\`DZ@#?HK#C\.Z5%(DJ17`
M>-@RDZCJ;@$>JO>LC?1E(]J9_P`(SI`_Y8W/_@SU7_Y.H`WZ*P/^$9TC_GC<
M_P#@SU7_`.3J/^$9TC_GC<_^#/5?_DZ@#?HK`_X1G2/^>-S_`.#/5?\`Y.H_
MX1G2/^>-S_X,]5_^3J`-^BL#_A&=(_YXW/\`X,]5_P#DZC_A&=(_YXW/_@SU
M7_Y.H`WZ*P/^$9TC_GC<_P#@SU7_`.3J/^$9TC_GC<_^#/5?_DZ@#?HK`_X1
MG2/^>-S_`.#/5?\`Y.H_X1G2/^>-S_X,]5_^3J`-^BL#_A&=(_YXW/\`X,]5
M_P#DZK]CIEGIWF_94E3SMF_S+F[N,[-VW'VJ>;9C>V=FW=QNS@8`-"BBB@`H
MHHH`****`"BBB@`HHHH`_$#_`(*3_P#*23_@A3_V=;^U!_ZQS\0:_;R/_5Q_
M[B_^@BOQ#_X*3_\`*23_`((4_P#9UO[4'_K'/Q!K]O(_]7'_`+B_^@B@!]%%
M%`!1110`4444`%%%%`!1110`4444`%5+_4+'2[2>_P!3O;33[&V3S+F]OKF&
MTM+>,LJ;Y[FX>.&)-S*NZ1U7<RKG)`-NOF_]KM5;]F[XM*RJRGPTF58!E/\`
MQ-M,Z@@@_B*`/7/^%C_#W_H>O!O_`(5&A?\`R?1_PLCX>_\`0]^#?_"HT+_Y
M/K^9=H(,G]Q!U/\`RQB]?]RD\B#_`)X0?]^8O_B*`/Z:?^%D?#W_`*'OP;_X
M5&A?_)]'_"R/A[_T/?@W_P`*C0O_`)/K^9;R(/\`GA!_WYB_^(H\B#_GA!_W
MYB_^(H`_II_X61\/?^A[\&_^%1H7_P`GUK:3XJ\,Z_+-!H7B+0M9GMXUFGAT
MG6-.U&6&)W\M)98[.YG>.-GRBNZJK.-H);BOY@/(@_YX0?\`?F+_`.(K]&/^
M";L<:?$;XD%(XT)\$Z1DI&B$_P#%0-P2H!(]J`/V%HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@#\//^"EB._\`P4A_X(5+'*T+?\-7_M.'
MS%5'8*O['OC]G4"173]X@:/<5)3=N4;@*_:&/3-7\M/^*BG^XO\`S#-,]!_T
MPK\8O^"D_P#RDD_X(4_]G6_M0?\`K'/Q!K]O(_\`5Q_[B_\`H(H`P_[,U?\`
MZ&*?_P`%FF?_`!BC^S-7_P"ABG_\%FF?_&*WZ*`,#^S-7_Z&*?\`\%FF?_&*
M/[,U?_H8I_\`P6:9_P#&*WZ*`,#^S-7_`.ABG_\`!9IG_P`8H_LS5_\`H8I_
M_!9IG_QBM^B@#`_LS5_^ABG_`/!9IG_QBC^S-7_Z&*?_`,%FF?\`QBM^B@#`
M_LS5_P#H8I__``6:9_\`&*/[,U?_`*&*?_P6:9_\8K?HH`P/[,U?_H8I_P#P
M6:9_\8H_LS5_^ABG_P#!9IG_`,8K?HH`P/[,U?\`Z&*?_P`%FF?_`!BOGC]K
M"QU&']G7XKR3ZU-=1+X:3=`UC80JX_M;3.#)#"L@&,_=8'/.>,'ZFKYP_:Z_
MY-O^+/\`V+2?^G;3*`/Y]VZGZG^=)2MU/!/)P`,DG/0`<DGH`.2>!R:]&\7?
M"[Q'X,M-"GU&XT*^N];;[,^BZ+K5CJNNZ3JIU+5=+31]3TJVE:[^V27>D7=J
M);..ZLEU**?1Y+E=2MVAD`/.**]0U#X2>*-(UN^T75[SPUIBZ3X;T7Q5K6MW
M>M$^'M'TSQ`T-OID-YJ-I9W4LVJ3ZC.FD)IFF6>HW,VJ)/!:BXAMY[F/A=4T
M6]TO6;K07:SU&_M[Q+&-M#OK?6[+49IC%]D.DWVGO-!J45]Y\'V-K<EY7E2%
MHX[D20(`9-?H5_P3L@N;CXA?$9+:]>Q<>"M))D2"WN"P_P"$@X!2X1U`&&Y`
M!RV<\`5\0>,_!FM>`]9CT'7SIYU"32-(UG&F7R:C;);:S:_:H(6NHT2)KNVV
MR6U]'"98H+N&6*.>=4$C?=?_``3@_P"2C?$?_L2=)_\`4@:@#]8_[,U?_H8I
M_P#P6:9_\8H_LS5_^ABG_P#!9IG_`,8K?HH`P/[,U?\`Z&*?_P`%FF?_`!BC
M^S-7_P"ABG_\%FF?_&*WZ*`,#^S-7_Z&*?\`\%FF?_&*/[,U?_H8I_\`P6:9
M_P#&*WZ*`,#^S-7_`.ABG_\`!9IG_P`8J_8VMY;>;]KU&2_W[-F^UM;;RMN[
M=C[-&F_?D9WYV[?EQDYT**`"BBB@`HHHH`****`"BBHY7>.*1XXFF=$=DB5D
M1I652RQJTC)&K.P"!G=44L"S*H)`!)17PMXM_:%^(7A#QMX9\/>(OB%^QYX0
MUSQ?XVL/AUX8^$'B?XG^)T\=Z[XXU/1=/\3:;X+B\56]G%;VGB[4/#FJ:7JL
M&CQ?#+5@\&M:')9W&H6NL:5<7_VUI=Q>W>FZ?=:C8_V7J%Q96LU]IHNHKX6%
MY+"CW-F+V!4AO%MIB\*W44<:7`02K'&'V*`?B?\`\%)_^4DG_!"G_LZW]J#_
M`-8Y^(-?MY'_`*N/_<7_`-!%?A__`,%+&E7_`(*0?\$*C#&LLG_#5_[3@"/)
MY2[6_8]\?J[%]DA&R,L^`A+E=@P6##]H8[WQ!Y:?\2.V^XO_`#&H_0?]0Z@#
MHJ*P/MOB#_H!VW_@ZC_^5U'VWQ!_T`[;_P`'4?\`\KJ`-^BL#[;X@_Z`=M_X
M.H__`)74?;?$'_0#MO\`P=1__*Z@#?HK`^V^(/\`H!VW_@ZC_P#E=1]M\0?]
M`.V_\'4?_P`KJ`-^BL#[;X@_Z`=M_P"#J/\`^5U'VWQ!_P!`.V_\'4?_`,KJ
M`-^BL#[;X@_Z`=M_X.H__E=1]M\0?]`.V_\`!U'_`/*Z@#?HK`^V^(/^@';?
M^#J/_P"5U'VWQ!_T`[;_`,'4?_RNH`WZ^</VNO\`DV_XL_\`8M)_Z=M,KW#[
M;X@_Z`=M_P"#J/\`^5U?/'[6%SK$G[.OQ72ZTJ"V@/AI-\RZHMPR#^UM,Y6)
M;*+>>^#(HP#SG`H`_`\XW'<H9=WS*20'7/*%ADJ&&5+`$@$D`D8KZFU_X[^&
M_P"S_`$VDZ!J7BSQ!X7M9VMM3^(=Q;SZKX5#S>+;=-+T[Q/X?CTOQ!KUQ#!K
M6D7UAJ^H7<=MIL_A_1+VUTV+7/[3F3Y8;J?J?YTE`'TPOQOT+R[K3-+TO7/`
M=GJ7PT^'7@^;Q!X3N9-6\2:+K?@"X>XM;W2E\1ZZ#)IKP7.H:.+B'6-(UZ6S
MNTOKBZDNHI89^2U#XE^'T\?W/Q+T7P_-+K4NKWK0Z-K:6]MI<=I_PC-AH]IX
ML-_X:O--O(?'MWK"ZIXCO?L5M!H^GZM<V^H:?+<7,9*>*44`>B?$;QAHWC&[
M\+3Z+X=3P]%H7@7PKX5NHA?:G?\`VBZT&P%HYBDU+4=1E-E;<PV$[O'>W<!,
MVJ"2ZPX^TO\`@G!_R4;XC_\`8DZ3_P"I`U?G37Z%_P#!.R6\B^(/Q&:RM([N
M0^"M)#1R70M`J_\`"0'!#F"<,3D\%1PO7)%`'[&T5@?;?$'_`$`[;_P=1_\`
MRNH^V^(/^@';?^#J/_Y74`;]%8'VWQ!_T`[;_P`'4?\`\KJ/MOB#_H!VW_@Z
MC_\`E=0!OT5@?;?$'_0#MO\`P=1__*ZC[;X@_P"@';?^#J/_`.5U`&_16!]M
M\0?]`.V_\'4?_P`KJOV,VH3>;]NL8K+;L\KR[U;SS,[M^=MM;^7LPN,[MVX]
M-O(!H4444`%%%%`!1110`4C`$$'.""#CKC';'.?2EI&Z'`!.#P>AXZ'KP?I0
M!^&7C/X.ZWX\_:^^,K>"_A_\2-?\#+\:?AQ8>.)_$GQ;^#7PYTSP]K%UK_[,
M7Q?^*>I^`_"^I>%-5^*GBGPK\1$^"7P5L;O6/$6NVU_'9^"/$V@_!^#0K#5K
M/Q#%^YH&!^)/YDG]<YQVZ5^%?Q?^"E[J?[:'B'Q_-^SHFO?%P_M`?!*X^&26
MW[%/P;\7_!/QO\&[2/X<GQ7\5?BI^U;JWP6UCQQX8^)_@N!/B'?:;=W'QO\`
M!/B;P?J_@[P3I7@OX:>-["[BG\9?NHO3\_;/)Y(P,$]3P.2:`/Q!_P""D_\`
MRDD_X(4_]G6_M0?^L<_$&OV\C_U<?^XO_H(K\0_^"D__`"DD_P""%/\`V=;^
MU!_ZQS\0:_;R/_5Q_P"XO_H(H`?1110`4444`%%%%`!1110`4444`%%%%`!7
MS-^V/?66F_LS?%^^U&\M-/LK?PPCW%Y?W4%E:6Z?VQI:[Y[JZDB@A3<RKNED
M5=S*N<D`_3-?GG_P5<`/_!/+]J<,`P/PZBR&`8'_`(JGPYU!!!'L1BO7X?RR
M.=9]DF3SK2P\,VS?+<LG7C!5)4(X_&4<+*M&FY14Y4U5<U!RBI.*BY).Z\K/
M<QED^29QFT*4:\\KRO,,PA0E-TXUI8+"5<3&E*:C)PC4=-0<E&3BFVDVK'XB
MM\0?`(9@?'7@K.3_`,S;X=]?^PE2?\+!\`?]#WX*_P#"M\.__+*OY['AAWM^
MYA^\W_+*/U/^S3?)A_YXP_\`?J/_`.)K^OE]%+*6D_\`7+,-4G_R)\/Y?]3#
MU^_R/Y1_XF?S/_HD<#_X=J_E_P!0/K_6W]"O_"P?`'_0]^"O_"M\._\`RRH_
MX6#X`_Z'OP5_X5OAW_Y95_/5Y,/_`#QA_P"_4?\`\31Y,/\`SQA_[]1__$T?
M\2I93_T668?^&;#^7_4P\G]_D'_$S^9_]$C@?_#M7\O^H'U_K;^A7_A8/@#_
M`*'OP5_X5OAW_P"65?I5_P`$R_$WAO7/B5\3(=$\1:!K,T'@71Y9H=(UK3-3
MEAB?Q$Z+++%8W5P\4;."BR.JH7^4$MQ7\8'DP_\`/&'_`+]1_P#Q-?T$_P#!
MO*B)^T%^T)L1$S\&O"N=B*N?^*\?@[0./:ODN.OH[9=PAPEG7$E'BC&XZKE6
M'HUH86KE="A"LZN+PV&<958XVI*"2KRFFH2NTHV2=U]3P3X_8_BSBK)N':O#
M>$P5/-*]6C/%4\RK5IT53PE?$*4:4L'3C-MT>2SG&RDY:V2/ZTZ***_E<_IH
M****`"BBB@`HHHH`****`"BBB@`HHHH`*QO$=O\`:_#^N6IM4O1<Z/JEN;.2
MTM-0CNQ-87$7V:2QO[JQLKQ+C?Y+VEW>VEK<JY@N+JWAD>9-FJU[:6M_:75E
M?6UM>V5Y;3VMW9WD$=S:75K<1/#<6UU;RJ\4]O/"[Q3PR(\<L3O&ZLK$$`_G
M,\#_``(^)^I?&/X;>+_&?[)FGG6+/QI\,);_`,7ZS^P%^P?HNM:7I_A>\\-:
M9I%Z?%6B_P#!0SQ3XG\/IX7\/:/IMKH^L:!X=\2:MX=TS2K";P_HFM36%CIU
MU_1V/ZGL!U)],_GU/4X/%?S_`.N_![P)XH_;8\9ZC8_`[Q/?6OPS^.GPG\*^
M'M>^`_[`_P"QIX@^&?AO3_"/A#X4W>E:5XU^,OQA^&VH?&A?%/A&&2W7Q/XG
M^'>NVFA^"/"2^%=(^',]AX@\+:BMI_0`/ZGK@=SZ>O;N1R><T`?A[_P4ME2#
M_@I!_P`$*Y'$A5?VKOVG@1%#-/)E_P!CSX@(,10))*PW,-Q5"$7+N5168?KI
MKOQD^&'A&Z@TSQ5XRTGPWJ,UG%>16&O&YTF\EM)'DACNH[:_MX)GMWE@FC29
M4,;/%(BL61@/R/\`^"D__*23_@A3_P!G6_M0?^L<_$&M;_@H:`?C5X;R`?\`
MBV>B=1_U,'BB@#]/_P#AHWX%_P#14_!__@TC_P#B:/\`AHWX%_\`14_!_P#X
M-(__`(FOYT,+Z#\<"EVC^[TZ\?\`UJ`/Z+O^&C?@7_T5/P?_`.#2/_XFC_AH
MWX%_]%3\'_\`@TC_`/B:_G0VCT'Y"C:/0?D*`/Z+_P#AHWX%_P#14O!__@TC
M_P#B:]!TOQGX=UO3[/5M&N[O5M*U"!+FPU+3='UF]L+VVDSY=Q:7=MI\D%Q"
M^#LEBD=&P<,:_F04#(X'4=AZU_0W^RU_R;S\(?\`L2-(_P#09*`/8_[?L/\`
MGCK'_A.^(/\`Y64?V_8?\\=8_P#"=\0?_*RMJB@#%_M^P_YXZQ_X3OB#_P"5
ME']OV'_/'6/_``G?$'_RLK:HH`Q?[?L/^>.L?^$[X@_^5E']OV'_`#QUC_PG
M?$'_`,K*VJ*`,7^W[#_GCK'_`(3OB#_Y65^??_!5/5[2Z_X)\?M2PQ1ZDKM\
M.HL&XT;6+2(?\53X;'S3W5C#"G)'+R+QD]`2/T>K\]/^"K?_`"CS_:F_[)U%
M_P"I3X<KZK@7_DM^#?\`LJN'O_5O@SYCC;_DC>+?^R:SW_U68H_@T?[[?[S?
MS--IS_?;_>;^9IM?ZNQV7HOR/\O@HHHI@%?O]_P;XW<5G\?OV@Y)EN64_!OP
ML`+6RO+YP?\`A/&',5E!<2*/F&"R`'G!^5L?@#7]`_\`P;S_`/)P7[0G_9&O
M"W_J>/7Y;XU_\FMXP_[`<)_ZM<O/TSP<_P"3F\(_]AV*_P#59CC^K?\`M^P_
MYXZQ_P"$[X@_^5E']OV'_/'6/_"=\0?_`"LK:HK_`#)/]'#%_M^P_P">.L?^
M$[X@_P#E91_;]A_SQUC_`,)WQ!_\K*VJ*`,7^W[#_GCK'_A.^(/_`)64?V_8
M?\\=8_\`"=\0?_*RMJB@#%_M^P_YXZQ_X3OB#_Y65=L]0M[[S/(2\3RMN[[7
MIVH6&=^['E_;K6V\W&T[O*W[/EW[=RYNT4`%%%%`!1110`4444`%(<8.>F#G
MG''?GM]:6JE_--;6-Y<6\44\\-K<S0PSS2V\,TL4$DD<4L\%K>S01R.JI)-%
M9W4L2,SQVT[JL+@'YB>.-&_8?UK]J/6M4N?AU^T+XY^-FG?$;P+8^,/&7PM\
M'?MH^+OAIH'Q#TZQ\*WGAS3/&'BKX:M<_`_2[GPWHU[X7O?$NF:G.-+\-Z/=
MQ'QC;6<$M[$?U%'MZGU]3GK[].V.G&*_#NRTKXMZY\6[CX\ZA<^#/`'A;Q+\
M0_"'BKXA+X!_X*[?$*#X66/]@GP]H^JW4?PM/[+'ASPC>M_8NBP0ZYX9NM1\
M-OXPE@&F>(M3LY)Q=67[;Z9J-EK&FV&K:;<+=Z=JEG;ZA872!PES97L27-K<
M1B1$D$<T$D<B!D4[&'%`'XG?\%)_^4DG_!"G_LZW]J#_`-8Y^(-:_P#P4-_Y
M+5X;_P"R9Z)_ZD'BBL?_`(*4$#_@I'_P0I)(`_X:N_:?&2<<M^QU\0`!SW)(
M`'<D`<FM/_@H9/`?C5X;(GA/_%L]$_Y:Q_\`0?\`$Y_O>A!HLWLK@W;<\-_9
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M=1N#F>^EQ)=22N`P=GV?W,GFCW7]?\/^?9GLP^%\.G_!'Q-JKZ)I>K>);>S^
M'7BJ?Q1;ZSHEV^D6^OZI?PW/A?2H+;5WF4VFC1VMYXA$EE]KO-:OETC3TD&A
MRK-PGA.Q\-77P_\`BRE]X<,GBK0/#VE:Q::]?WTZMI*OX^\':%]BTW1EB@CM
M;J>VU/4X]5O]0DO+B1'M[.SM]/2.[>[\LM-4GL(;BWL=1:S@NYM.N;N&UNE@
MBN;C2+EKS2I[A(G599M,NW>ZL)7!>TN'>:!HY&+'K+/XH^/].&H"P^('B:S&
MK7UYJFJ_9_$=Y&=3U+4)UN;^_P!0*W.;V[O+E%N+F>Y,DDTZK,[&10P+/L_N
M8<T>Z_K_`(?\^S..7J/J/YU_0U^RU_R;S\(?^Q(TC_T&2OYXA/$6R9X22V23
M-'DDG))^;J3R?>OZ&/V7+B!?V>?A!NGA&?`^D$9EC&1B49'S<C((R.X(Z@T6
M:W37R&FGLSZ"HJ#[5;?\_$'_`'^C_P#BJ/M5M_S\0?\`?Z/_`.*I#)Z*@^U6
MW_/Q!_W^C_\`BJ/M5M_S\0?]_H__`(J@">BH/M5M_P`_$'_?Z/\`^*H^U6W_
M`#\0?]_H_P#XJ@">OST_X*M_\H\_VIO^R=1?^I3X<K]!/M5M_P`_$'_?Z/\`
M^*K\]O\`@JS-#)_P3T_:G6.:)S_PKJ(X21&.#XJ\-@'`)/4@?4@=2*^JX%_Y
M+?@W_LJN'O\`U;X,^8XV_P"2-XM_[)K/?_59BC^#E_OM_O-_,TVG/]]O]YOY
MFFU_J['9>B_(_P`O@HHHI@%?T#_\&\__`"<%^T)_V1KPM_ZGCU_/Q7]`O_!O
M2Z)^T#^T(SNJ*/@UX6)+,%`'_">L,DD@=2!]2!U(K\M\:_\`DUO&'_8#A/\`
MU:Y>?IG@Y_R<WA'_`+#L3_ZK,<?UIT5!]JMO^?B#_O\`1_\`Q5'VJV_Y^(/^
M_P!'_P#%5_F2?Z.$]%0?:K;_`)^(/^_T?_Q5'VJV_P"?B#_O]'_\50!/14'V
MJV_Y^(/^_P!'_P#%4?:K;_GX@_[_`$?_`,50!/14'VJV_P"?B#_O]'_\53TE
MBDSY<D<F,9V.KXSG&=I.,X.,]<&@"2BBB@`HHHH`****`"BBB@#SZZ^$WPNO
MO%,7CB]^''@*\\9PNDD/BV[\'>&[GQ/%)&5*/'X@FTQ]81T*(5=;T.I52&!4
M8]!`QQ_G_/O110!^'G_!2R**?_@I#_P0JCFCCEC/[5W[3Q,<B+(A*?L>?$!T
M)5PRDJZJRDC*LH888`C\IO\`@O?;P6/[8W@"&RACLXC^SKX/=HK1%MHV<^._
MB2F]HX0B%]JJN[;NVJJYPH`_5W_@I/\`\I)/^"%/_9UO[4'_`*QS\0:_*C_@
MOS_R>7\/_P#LW/P=_P"I[\2Z_>_HW?\`)S,/_P!B;-?_`$BB?AWTA6UX=8AI
MV?\`:V6?^G9K]6?B!YDO_/67_O[)_P#%4>9+_P`]9?\`O[)_\53**_T+Y(_R
MK[O3_)'\%<\OYG]_I_DA_F2_\]9?^_LG_P`51YDO_/67_O[)_P#%4RBCDC_*
MON]/\D'/+^9_?Z?Y(E267>O[V7[R_P#+63U'^U7][/\`P33TC2KK]@K]E&:Y
MTVPN)G^#/A4O+/9VTTKDK<L2\DL3NQ9F9B68DL2QY))_@C3[Z_[R_P`Q7]]O
M_!,S_DP7]D__`+(QX4_]%W%?S#]*:,5PAP\TDO\`C(X_AEF.1_27T9FWQ7GU
MVW_QCTM_+,<O1]I?V!H?_0&TK_P6V7_QBC^P-#_Z`VE?^"VR_P#C%:]%?PN?
MVH9']@:'_P!`;2O_``6V7_QBC^P-#_Z`VE?^"VR_^,5KT4`9']@:'_T!M*_\
M%ME_\8H_L#0_^@-I7_@MLO\`XQ6O10!D?V!H?_0&TK_P6V7_`,8K\^O^"JFD
M:5:_\$^/VI9K;3=/MYE^'46V6"RM89%_XJGPV?E>.)''(!X/4`]0*_1ROST_
MX*M_\H\_VIO^R=1?^I3X<KZK@7_DM^#?^RJX>_\`5O@SYCC;_DC>+?\`LFL]
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MV-2DHK$X=2IU*TIPG0I<]2@L14_V2OV/B']C?1O"-UXMU+Q)IWQ]BMO!_P`)
MOAU\2M6^#6@^'O`GBKX]6TOQ+^(.L^!M'C.H>')]5^'VH>$K*PTFU\8:EXJT
M>ROI;*W\3>&/"NJ:5I6KWUQJ-KP-Q^R9/I/[6'B/]FW6?$.N3VWAO2O$'BQ=
M0T+PU;7?CWQ/X<TGX2M\9=*\.>&_!;ZI)92_%+Q'H$EGX;M/#!U>[LK7Q;)=
MQ)<ZE:621W?)0?M.ZK!?>&4B^%WPR@\'^"?`>I_#OP5X"L+GXI:-8^$]$USQ
M;=^-_$%UHOC70_B9IGQ1@U7Q+XAU#43XDD?QO)I6L:'?W/AJ71XM',<$?.ZC
M\?\`7-=\<P_$GQ-X'^&_B7QH?'>H>--0UC4=&U^S34M/N/#&E^$]$^'Z6.A>
M*-(MM`\%>!M.TFUN?A__`,(K_8?BSPIJL=OJ%KXIFDT_3DMO/PF&XSC];6(Q
MEXU<LQ]+#2C2P5\-CJD,(LJJPISQ-6_U7V&/J8NG6Q&(O5S'#866-S.E@GCE
MZ&)Q/",EA'A\(XNEF>!JXB,JF+MB,%3GB7F=*52.'I6^LJM@:>%G1H4/W>7X
MC$QP>75<7]2=KX]?!6+X3VOPA\3:7'XULO"_QJ^'-Q\0?#NA_$K2-/T3X@^&
MO[*\7Z[X*UK1/$UEI8BL+A3J.AIK'A_6;>QT@ZSX<UC3;J?1M-N%E27]?/\`
M@WPM+6\^/_[0<=W;6]U&/@UX6(2XABG0'_A/6.0LJ.N<JIZ=5!Z@8_%/XL?%
MWQ)\7M6T*_URTT[2--\*>'T\+^%?#ND7'B"^L-%TE]5U/Q!J,DNK>+-<\3>*
M_$6NZ_XBUK5M?\2>)O$_B'5]<UO5;YY+F[2UM[&SM/VT_P"#>?\`Y."_:$_[
M(UX6_P#4\>OE_%6&/I^#O%,<SG&IC/J5*4W'E]VE+/<+/"4JCBW&5:AA)4*-
M>I&4XU*].I4C.:DI/Z7PPG@9^+?#$LMA*GA'C9J"?,N:I'),3#%5(1E:4*-;
M%*O5H4Y1@Z=&I3IN$'%P7]77]@:'_P!`;2O_``6V7_QBC^P-#_Z`VE?^"VR_
M^,5KT5_FV?Z&&1_8&A_]`;2O_!;9?_&*/[`T/_H#:5_X+;+_`.,5KT4`9']@
M:'_T!M*_\%ME_P#&*/[`T/\`Z`VE?^"VR_\`C%:]%`&1_8&A_P#0&TK_`,%M
ME_\`&*MVNGV-CO\`L5G:6GF[?,^S6T%OYFS=LW^3&F_;N;;NSMW'&,G-RB@`
MHHHH`****`"BBB@`HHHH`****`/Q`_X*3_\`*23_`((4_P#9UO[4'_K'/Q!K
M\J/^"_/_`">7\/\`_LW/P=_ZGOQ+K]4_^"ED?F_\%(?^"%*;Y(_^,K_VG&W1
M.8W_`'?['OC^3;N7D*^W8X&-R,RY&[-?E#_P7MM?L?[8W@"+[1=7.?V=O!S^
M9=SM<2C_`(KKXD+M#L%(3Y-P7&-S,W\6!^]_1N_Y.9A_^Q-FO_I-`_#?I#?\
MFYQ'_8WROI_T]GUZ'XL:3I&JZ]J=EHNA:9J&M:QJ,KPZ?I.DV=QJ.IW\L4$U
MW+%96%I'+=74D5K;W%S(D,3LEO!-,P$<;LL^F^'O$.M6,VJ:+X=\1:UIEN'-
MSJ>C>']:U?3;81Q?:)?M.HZ;8W5E;>5`?/E\^>,Q0?OI-D7SU]V_\$WO$=UH
M'QXG@L[SPS;S:_H<>E20WWQ,/PA\<7%I;SW6LSM\,_&MS:RZ*=5MY=.M3XH\
M+ZU<V\'B+PQ-//;PW\FAR0Q>UV&L^%M>?4?"-Q\1M&\;_!Q?BC\6M3^)?[0,
M?[3]Q\-/B!H>F>-O"7@6:_\`$^H?"_P;J?@SPS\2M;L=2T272/#OB+3?!_Q+
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M]<?"7X9Z=\5O`/B+XOZ#X&^)GB7X>_M6>"OBS/<>&M4\5Z'_`,([HOPG\::!
MX(\&^!OB'X5U"\\(^)='U;Q4TGCO6AHFH3W?Q"UG3?`7A?PR;Z+3H9=6N?%E
M6GEN-QCRNM5Q.&K.%/!8;ZUBJOLX8:EB<1]:CA\%5K8:M@N>6%Q<8T*V'IXY
M4<-+$QE7_=1#A>E/,,'A/[2I4L/B:2G/&8CZMAJ?//$5,/0^K2Q&,IT<12QG
M+'$X5NO2KU,$ZV(CAY1H?O/S,3[Z_P"\O\Q7]]G_``3,('[`W[)^2!_Q9CPI
MW_Z9W%?P**JK(%1_,17VI)M9/,16PDFQ_GC\Q0'\M_G0-L?Y@:_O5_X)K:0+
MG]@O]E"7^T=6@S\&/"W[NVU"2&(;OM;\($8#&_8N#PBHO\.3^)?2G?\`QA_#
MNF_$:^7_``F8[O9_@F?LGT9O^2KS[_LGI]?^IEE_W^O^9]_Y'J/S%&1ZC\Q6
M!_8'_47U[_P:R_\`QJC^P/\`J+Z]_P"#67_XU7\+G]JF_D>H_,49'J/S%8']
M@?\`47U[_P`&LO\`\:H_L#_J+Z]_X-9?_C5`&_D>H_,49'J/S%8']@?]1?7O
M_!K+_P#&J/[`_P"HOKW_`(-9?_C5`&_D>H_,5^>G_!5L@_\`!//]J;!!_P"+
M=1=_^II\.5]V?V!_U%]>_P#!K+_\:K\_?^"J&DBU_P""?/[4LW]HZM<8^',0
M\NZOY)XC_P`57X:;)C**"?EVG)^ZS#OD?5<"_P#);\&_]E5P]_ZM\&?,<;?\
MD;Q;_P!DUGO_`*J\4?PEO]]O]YOYFFTY_OM_O-_,TVO]78[+T7Y'^7P4444P
M"OZ!_P#@WG_Y."_:$_[(UX6_]3QZ_GXK]_/^#?.T^V?'W]H2+[1=6W_%FO"W
M[RTG:WD_Y'[=]]03_!MZ'Y7<?Q9'Y;XU_P#)K>,/^P'"?^K7+S],\&_^3F\)
M?]AV*_\`59CC^MO(]1^8HR/4?F*P/[`_ZB^O?^#67_XU1_8'_47U[_P:R_\`
MQJO\R3_1PW\CU'YBC(]1^8K`_L#_`*B^O?\`@UE_^-4?V!_U%]>_\&LO_P`:
MH`W\CU'YBC(]1^8K`_L#_J+Z]_X-9?\`XU1_8'_47U[_`,&LO_QJ@#?R/4?F
M*7(/0@US_P#8'_47U[_P:R__`!JM"QL/L/F_Z9?W?F[/^/Z[:YV;-W^KW*NS
M=N^?&=VU<_=H`T****`"BBB@`HHHH`****`"BBB@#\0/^"D__*23_@A3_P!G
M6_M0?^L<_$&ORH_X+\_\GE_#_P#[-S\'?^I[\2Z_5?\`X*3_`/*23_@A3_V=
M;^U!_P"L<_$&ORH_X+\_\GE_#_\`[-S\'?\`J>_$NOWOZ-W_`"<S#_\`8FS7
M_P!)H'X;](;_`)-SB/\`L;97_P"G9GX?`D<@D'U5BI_-2"/P(IA569'959X\
M^6S*"R9&#L8@E,C@[2,C@Y%.HK_0T_@D;L3<S;$W,H1FVKN9`<A&;&2@/(4G
M:#R!FC:H`4*H5=NU=HVKMQMVKC"[<#;@#;@8Q@4ZB@!R??7_`'E_F*_OM_X)
MF?\`)@O[)_\`V1CPI_Z+N*_@23[Z_P"\O\Q7]]O_``3,_P"3!?V3_P#LC'A3
M_P!%W%?S!]*?_DC^'O\`LHU_ZK<<?TG]&7_DJ\^_[)Z?_JRR\^Z:***_A8_M
M4****`"BBB@`K\]/^"K?_*//]J;_`+)U%_ZE/AROT+K\]/\`@JW_`,H\_P!J
M;_LG47_J4^'*^JX%_P"2WX-_[*KA[_U;X,^8XV_Y(WBW_LFL]_\`59BC^#1_
MOM_O-_,TVG/]]O\`>;^9IM?ZNQV7HOR/\O@HHHI@%?T#_P#!O/\`\G!?M"?]
MD:\+?^IX]?S\5_0/_P`&\_\`R<%^T)_V1KPM_P"IX]?EOC7_`,FMXP_[`<)_
MZM<O/TSP<_Y.;PC_`-AV)_\`59CC^M&BBBO\R3_1P****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@#\S_^"@O[`_Q"_;%\6?LJ_$_X.?M0ZI^RG\8/
MV2OB3XY^)'P^\?:?\'O!OQJAGOO'OPZU#X:ZO97OA+QUK.E^'W1="U2_$,]Y
M!JB+)<LZVD=S#;7<'Y<_M"?\$%OVS/VI_&NG?$/XX_\`!8?Q3XL\7:5X:LO"
M-CJ5G^P?^SMX;BAT#3]0U35+2S:QT'Q38V<KQWVLZC*;J2%KAUF6)Y#'#$J_
MT[45Z&69MFN2XI8[)\RQ^58V,)TEB\NQ=?!8E4ZEE4IJOAJE.JH322G#FY9)
M+F3L<&8Y5EF<89X/-LNP.:81SA4>%S#"4,9AW4IMN$W0Q%.I3<X-MQDXWC=V
M:/Y$_P#B&!^-'_26#QI_XA=\$?\`YMJ0_P#!L%\:`"?^'L'C3@$_\F7_``1[
M#/\`T.M?UVT$9!!Z'@U])_Q$?Q!_Z+GB_P#\2/-__FSR_/NSY_\`XA_P'_T1
M7"?_`(CV4_\`S)Y?GW9_%)\(?^#=_P"-_P`4/$OQ^\/S?\%0O%NC)\%/C;=?
M".VNH?V/O@O>MXCMK?X5_"?XCKKUQ%+XLMETZ=YOB5/I!L8'N81%H\-V)A+=
MRP0^W_\`$,#\:/\`I+!XT_\`$+O@C_\`-M7]8'AGP-X3\'7_`(RU/PUHMKI-
M_P#$'Q7)XX\8W-NUPSZ]XJE\/>'/"DFLW8GGF1+IO#WA+P[I96U6WM_(TJW8
M0"9IY9>LH_XB/XA?]%SQ=_XD>;__`#9Y?U=A_P`0_P"`_P#HBN%/_$>RG_YD
M_KYL_D4'_!L%\:`01_P5@\:9!R/^,+O@CU'_`'.M?H-\+_\`@F;_`,%2?@U\
M/O"'PL^'7_!;C7-$\#^!-$M/#GA?29_^"<_[*NK36&CV(86MM)J6IZU=7]Z\
M8=@;B[GEFDZN['FOWEHKRLVXJXGSZC3PV><19YG&'HU?;4:&:9KCL?1I5N25
M/VM.GBJ]6$*G)*4.>*4N64E>TG?T\KX9X<R2M4Q&2Y!DN4UZM/V-6MEF5X+`
MU:E'FC/V52IA:%*<Z?/"$W"3<>:,96NDS\5O^&&O^"OO_2<W5_\`Q6M^R-_\
MLZ/^&&O^"OO_`$G-U?\`\5K?LC?_`"SK]J:*\`]P_%;_`(8:_P""OO\`TG-U
M?_Q6M^R-_P#+.O#;#]GW_@L'>_M(>*/@$?\`@M;J,=MX<^"/@7XOKXI'_!.?
M]DMKB[N/&?Q"^(_@=]`;2C,((8-.A\`QZFE^M])-<2ZI);O!$EK&\W]#=<C#
MX#\(V_CK4/B7#H=K'XYU7PGH_@;4/$8>Y^VW7A30-:UWQ%I&BR(9S:"UL=:\
M2Z[J$3I;+<&;49A)/)$L4<8!^0G_``PU_P`%??\`I.;J_P#XK6_9&_\`EG1_
MPPU_P5]_Z3FZO_XK6_9&_P#EG7[4T4`?BM_PPU_P5]_Z3FZO_P"*UOV1O_EG
M7G7Q:_X)A?\`!4+XY?#GQ9\)_B;_`,%M==U_P'XWTU=(\2Z/;_\`!.G]E?1I
MK_3UN[6^$,>IZ5K=KJ%H?M-G;N9;6XCDPA3=M9@?WNHK;#XBOA*]#%86M5P^
M)PU:GB,/B*%25*M0KT9QJ4:U&K!QG3JTJD8SIU(24H3BI1::3,J]"CBJ-;#8
MFC2Q&'Q%*I0KT*].%6C7HU8.%6E5I34H5*52$I0J4YQ<9Q;C)--H_D4/_!L%
M\:"23_P5@\:9)R?^,+O@CU/_`'.M)_Q#`_&C_I+!XT_\0N^"/_S;5_7917UW
M_$1_$'_HN>+_`/Q(\W_^;/+\^[/EO^(?\!_]$5PG_P"([E'_`,R>7]79_%;\
M3?\`@W8^-_P^\=?L\>#8?^"HGBW58_CE\6=?^&EUJ$O['OP7M)/#4&B_`SXP
M_&)-8MK>/Q;-'J<MS<?"V#P^UG/+:QQP:U/J"S--8Q6UQ[-_Q#`_&C_I+!XT
M_P#$+O@C_P#-M7]8>O\`@KPOXHU?P3KVO:/;:EJ_PZ\1WGBWP5?3M<++X?\`
M$6H>$?$_@2\U6S$,T4;W$_A+QEXFT1UNH[B`6NKW++$MRMO/#U-'_$1_$+_H
MN>+O_$CS?_YL%_Q#_@/_`*(KA3_Q'LI\O^H3R_/N[_R)_P#$,#\:/^DL'C3_
M`,0N^"/_`,VU?0_[.?\`P0L_;<_9.\1>(_%?P'_X+'>*/"&N^+-$M/#NO7=[
M^P5^SEXF2[TBQU`ZI:VR6WB#Q1?VULT=Z3*9[>))G!\MW,8"C^F6BN3'<<<:
M9GA*V`S+BWB7,,#B8QAB,'C<\S/%86O&,X5(QK4*V)G2J1C4A":4XR2G%26J
MN=6"X,X0RW%4<=E_"W#N`QN'DY8?%X/)<MPV)H2E%PE*C7HX:%6G)PE*#<)I
MN,I1;M)I_BM_PPU_P5]_Z3FZO_XK6_9&_P#EG1_PPU_P5]_Z3FZO_P"*UOV1
MO_EG7[4T5\L?2GXK?\,-?\%??^DYNK_^*UOV1O\`Y9UX9^TM^S]_P6$_9]^!
M'Q/^,]M_P6LU#Q7<?#OPM<^(X?#MS_P3G_9+TF#5WM[JSM_L<NHP3WTUJCK=
M,_FQVLK`H`%()!_H<KD?'O@/PC\3_!_B#P#X\T.U\2>$/%.GR:5K^AWKW,=I
MJ>GRR1RR6L[VD]M<K&TD,;$PSQ/E!AP,@@'Y!K^PW_P5];)'_!<W5\!W4?\`
M&M?]D8\([*"3_:*Y)"Y/RCKT%+_PPU_P5]_Z3FZO_P"*UOV1O_EG7[4``#`&
M!DG\6)8G\22:6@#\5O\`AAK_`(*^_P#2<W5__%:W[(W_`,LZ^TOV0/@7^V#\
M&'\?G]JO]NF\_;/7Q$/#(\#)=?LT_"']GK_A79TK^W/^$B*-\++FX/BS_A*?
MM^C;AK>P:)_8*_V=N_M.\Q]KT4`%%%%`!1110`4444`%%%%`!1110`4444`?
M*OQ8_;*^"'P:\8:KX/\`&&I^)Y9/"&D>'/$7Q4\2>&_!7B;Q1X*^"OASQC=W
MECX4U[XP>+-$L+K2/`>F:W-IU]=I)J,TL^D^'K2X\8^(K?1?!<3^(A-!^V%\
M&)OBM:?">2Z\7V=YJ?C[5OA'HOCG4/`7BRQ^%&N_%_0=,U/6=9^%>C_$JYTR
M/PQ?>-;"PT768S:)=KI=[K>CZOX2TS6+[QAI>H>'[;XJ_:U^!?QD\/3?M;:=
MX$T*S\8?"K_@H19^"OAG\4?%MC9_$/Q-X_\`V<I=6^#5S^SWXN\>:3\+?`?A
M#Q3JWQ0\)7G@;1O"C:/9>']5\)WG@[Q_J-YKWBWSO`%UKOB7PSZ-:_"_]J7Q
M7^U;X0\1_%?X3?#?5_V>_@QXPNH/@%::+^T%J4LGAJSM?"6H>%+'X]?$;P)J
M7P6AO_'WQJFTW5-=T/P[X5/CNQ\"?#31?$-[J>F3^*O'4H\7V0!]A^+?VB?A
M7X#\<:_X%\::]+X6NO#'PLMOC#KGB+7=.N]-\$:?X.N_%USX)MC+XQN431&U
MZ?7[8VT'AJ*X?6KB.>SEMK28WMLDGCUO^W9\'==^"/P4^/'P_P!"^+7Q0\+_
M`+0>I76G_"SP_P"`_A?X@O\`X@ZV-.TOQ5K6K7VH>"-8.@ZOX;LM'TSP=K,^
MJGQ&-+NK&9;33Y[1=3O(;*OI7XA-XET[PMK6M^`_!/A_QUXZLK.R;0?#>O\`
MB./P7I^L3VFJ6EW'87?C#_A&_%<NBP6Y$VH6]PN@:DJWMO"$@ADE%U!^2G[/
M_P"R%^T'X5_8_P#V?_@?\<?V;/V7?BQK_P"SSXN\1RIX-\4_&?Q=KO@CQWHG
MBS3_`![Y_B.PU@_!^/2=.U/2;CQL-'O/!/Q`^&_CCP[X@TR.\U:TU/P_KMCH
MLK`'[!>#?$G_``F'A3P]XI.A>)/"Y\0:/8ZO_P`([XPTHZ%XIT3[=`D_]F>(
M-&-Q='2]7L]_DWUB;F<VTZO$9&*YKI:^?OV6_A5XJ^"?P(\`_#+QIK]KXA\0
M>&;;75GFTV^U[5-&T+3]7\5:]K^@^!O#NJ>*)9/$.J>%_AQH&K:7\/O"^IZT
MEIJ6H>'O#&F7EWIVERS'3;3Z!H`*\-^,O[07@7X)3>$M)\06GB_Q/XQ\?7&M
M0^"?AY\./"&M>/?'WB>W\,65MJ7BO5M-\-Z%!+<1Z#X5T^]L9]?U[49K#2+&
MYU30]'%W-K_B+P_I.I^Y5\1_M.>!_BWX:^)/P\_:R^"?@[2/BWXP^#'PE^.W
MPZUCX)ZOXGU3P==_$#PC\4K[X5^-9)?`_B2UT/Q9IUAX_P!&\4_!;PY:Z9IV
MK>&I++Q'H^O:SIXUC2M1MM+6\`+'B#]O[]F_0_#F@^-;77/&7BKP+J7PXL/C
M%XB\;^"_AEX^\3^&/AE\*=1U+7M%A\=_%?4-/T`R>`-*M=8\*>+=.UG3M;MH
M_$_AY_!_C.]\0:!I>E>#O$]_I7T;XS^*?A7P-J7PMTO6&U:XN/C!X_B^''@V
M71-&O]<LW\03>!O&WQ#CGUF\TZ.:WT/0F\.>`=?<:_J+Q:6=0.F:8)S=ZM9)
M)^0Q_9^_:TO_`(%_"KX&>%/`W@CXF_LW>+-%\;_%/X^6>L?$KXA_LR?$7XM?
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MB_:V\>ZU^WYX=^(N@>`/V>/!_P"V3XJ\">,-"\<_"WXLP_%[Q3X*T_P/\$/@
M)\"M6^'FI^#/$/P>\!:+?:;\1-`^%?B=-5UC3]<MY-&\->*1I6F1P:Y'%K5E
M]!?L#?LN?&C]F.3]JQ/B_P#$OPS\18?C+^U#XJ^,'@$^&?"^G>%8=&\(ZMX%
M^'WA:VBU/3--L[2TTW5+J3PB+=O#]C)?Z3H6G:3I@T[4;AM0O(;4`_0>BBB@
M#Y_\>?M-_"#X8^*?''@_QYXAG\-ZSX#^#R_'6_CU#2[T6^M_#R/7M0\+:G>^
M#[F*.5/%FLZ'XEMM)T+6O#&C"X\0Z?JGC/P!:2:<S^./#?\`:'RQXP_X*@_!
M+X>ZW\;-$\<?#+]I;PN_[/?@;2?B-\4]0U3X):J-*T#PEXJO/$NF>`=1AO;;
M6;G^U9/B)J_@_P`2:/X-LM-BN+S4=0TFYCO(=-BV3-ZS^U-^S-=?'?XG?L6^
M.]/L_#+K^SQ^TI+\3O&LVMWFHV.H:E\-I?@[\4-&D\,:2EA9W,6NB7XQR_!#
MQW-X:UN6TT"74/ASHOBF25M>\(^'XV^6/VO?V'_C5\:E_P""B=]X#O/A\U[^
MT_\`LS?LD_"WX66GB7Q%K&CHOC/X!^/OCWXO\4IXSO;/PMK1T'0M6M?B1X9L
M]%U;3K?Q'=2W$>K/>Z1:QV5L;\`^^/@]^T;X&^,>L>)?"-AI?CKP+\1?!NF>
M']>\4_#/XI^#-6\!^.=*\.>*[C6;3PSXHBTO4UEL==\+:Y?>'?$&F67B3PSJ
MNMZ,NM:%K6A7=[:ZUI=[80^<>/OV[?V</A=X`7XC>/?%FK>&=&NOC5XC^`6D
M:7J'A/Q#_P`);X@^('A3XRCX%:X-`\)064VN:IX4L/'3P-=^.(;1?"5CX9N[
M/Q9J.KV6AW=M=RY7P<^$?Q=US]HKQ3^U%\;O#_@OX=ZW-\'-#^!_@7X:>`_'
MFK?$>&QT"+QYK/Q%\7>*_&/BZ_\`!7@"PO=9UO7+G0-+\.Z#I'AZ>W\,Z/H>
MI7USXCU:^\73Z;H'%_\`!1WX,_'/XY?L_P`OP?\`V>_A_P##7Q#K/BKQI\/_
M`!'KFM^/?B1=?#2Q\,VOP\^-/PR^,5P+1-*^&_CZ[U^Y\92^";_2;E5724L-
M0GL=4O9-20R)``>Z>,/VG_#OA;XRVWP2T[X;_&KQYXCCM?`]YXDU_P"'_P`.
M+OQ'X'\#V_Q`U76=,T"3QAXJ?4M/M-+VPZ#J6LZJEM!J#Z3H<<.HWJQK>6D4
MWTS7Y5_'/]EGXP?'?7V\6M\&/V??`WQ(\>>%_A&!\=E^)_CW5?BW^S+XI\`^
M(;[6-1O?AX+3P-!I7C;4],M[ZX7PEXD\*:I\%9_$?VVY\+_$NSU3PK:0O??J
MFH(')R<L<^Q8D#\`0/PXP.*`%KR[Q]\8/!/PR\2?"SPUXRO;O29_C#XUF^'7
M@S5)+"=]`E\:GPUK?BG2O#NKZTO^A:'?^);#P[J]GX7_`+3>"#7]?@M_#EA-
M)KFIZ58WWJ-?(/[>_P``/$W[4/['_P`??@7X&N=&T[X@>/?`-_9?#K7-=U;5
MO#]CX9^(NFW5EKG@7Q8GB'0+6]U[P[?^%_$^F:9KNEZ_HEM)K&C:C8VU_IVV
MYA1@`>?ZO_P45^#]CX_^$_P_T;P!\?/&EQ\==2\2:?\`"#Q1X,^$U_K7@GX@
M1>#;O48_%NKZ!XEDU>Q@DT#0=*TRX\4S:W=06NGZGX3ELO$&@3:O8W]FTW2_
M`/\`;X^!W[0UWX!@\+6/Q/\`"]E\7X_$MQ\%=?\`B1\-/$/@OPS\8[;PE::A
MJ>N-\//$5XMUI.JW\&A:3JOB:U\/ZC=:1XFU3PMI.M>)-+T2]T;0M;O-/E^)
M7[->M:U^T?\`L-?$?P';>$/#WPT_9??XXV>N>'4DGTNZM="\=_!>'X:^"M+\
M&:/8:5-ILEKI%U;V\-U:3WND0:?H\,9LA=.BVM?('[)'['G[3GA;X<_L/?!;
MXZ:#\(_!O@K]B'Q+>>.1XH\`?$_Q1X^\2?&#QAI'@;XI?#OP1;66CW7PY^']
MCX"\)Q6'Q8UOQ-XI;5-7\4ZM?W^CZ/X9LM.73[[5==C`/T;\3?M)_"3P3K?Q
M;T;QIX@N?"<7P4\(_#CQIXXUW7]&U2Q\.)I7Q5U#QAI/@NS\/:P;:2'Q;XBU
M75_!6J:/'X6\-IJ7B%]8OO#VD6VG7.I^(M(M+KE[G]L#X'VG[)^F_MHSZ]K"
M?`W6OA+HWQGT34SX7UP^*M8\)>)-`MO$/ARRTWP*+0^)[KQ=KMK>V5EIG@Y+
M`:_<:Q=1:2;2.\\Q(_5/BFWC'3/!?B#5/AEX"\-?$#QZT.F0:5X=\2^+E^'V
MG:IY5\L7FWOC*/PGXTGTYM%M+R^U33_^*?U`RW<0M(39->->1?C_`.&?V!/V
ML_%_[`_[/'[.WBSQ[X+^!WQ._9A_9Z\4_`_1=*\)ZAIOQK^%_P`5?$-U^S_9
M_!_P[\3]7U;Q+X#\#>(/`^H:4M_XTTO0;?3](UFX\/Z1XNUC59AJVK_V0=(`
M/V?\!>-M`^)/@?P=\0_"MQ+>>&/'?A7P[XS\.W<]O):3W6A>*=&LM>T>XFM9
MOWMM+/IVH6TLEO+^\A=FB?YE-=;7S[^R?\,/&?P3_9D^`'P@^(GB+3O%OCGX
M8?!WX=>`O%/B'1[..PTG4]9\)>$]*T*[DTRVB@M5&G6[6(L[&=K6VFO;6VBO
MKFVMKFYF@C^@J`"BBB@`HHHH`****`"BBB@`HHHH`****`#`/4=.1['UHHHH
M`****`"BBB@`HZ]:**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`***"<?F!^9Q0`45_*KJ_\`P<)?
M&'3=6U;3H_V;?AG*FFZMJNFI*WQ#\7JTJ:=J5U8I*RCPX0K2K;B1E!(5F*@D
M`$_6G[!W_!8;XD?M=_M+^$?@5XB^"?@?P7I/B/0/&VLS^(=$\8^(M7U&UD\*
MZ!+K%O!%8:AHUG:RQWDL8@F=[A6BC)>-78!:_7<S\#/$C*,JQV<X[)L-2R_+
ML%7S#%U8YOE-65/"X:C*O6J*E3QDZM1QIQDU"$)3DTDHMM(_*<M\:?#W-LSP
M648'-L35Q^88RA@,+2EE.:4XSQ6)K0H4H2JU,)&G!2JS47.<HPCO*26I^^U%
M%%?D1^K!17EWCOXP>"OASXQ^#7@;Q-=7\&O_`!W\=ZW\.?A]#::=/>6UYXG\
M/_##Q[\7M1@U*ZB(BTJT3P9\-O%%S%>7.8IKZ"TTY/W][$1E^%?C]\*O%UOK
MEQ9^+--TL:!\1O&/PKNH?$EW9>'+FZ\8^!_&<G@#6;'2[?5;NWDU.";Q8BZ/
MI-S:+(NJW<]M!:*\]Q%"P![+17S;8?M9_`V;XL>'_@7K'C&V\)?%WQGJWQ7T
M[P'X`\5+'I>O^.K+X,7_`(?T_P`<>(/"T$=Q=PWNAV\_B?23I4US/9:AKD1U
M&73--G71M8^P>NP_$GX>W'A^Z\66_CGP?/X6L=5.AWOB2#Q/H<V@6>L+J46C
MOI=UK,5^^FV^HQZK/#ILEC-=)=IJ$L=DT(NI$B8`[6BOEO3_`-L7X&ZA^SK=
M_M2+KVM0_"6UU?7?#T=^_A;7;GQ#J/B'1/BKJ/P4A\/Z-X3TRTU#7M8USQ#\
M3-/7PKX4TO3;2YN_$.H:CI*V,96_C*T='_;6^`<VJ_#WPIXU\1:M\'OB%\4?
MB9J7P>\%?#7XR>&]6^'GC?7/B+I?@>3XD3:#IVG:M"^GZI;7'@Q$U33/$FCZ
MMJ7A35KVYL_#.G:[<^+KJ#0'`/K*BO`?B5^U1^SG\'_"&M^//B1\9_AYX7\(
M^&O''A+X:^(=;N?$^EWEMH7CSQSXDTSPEX7\*ZQ'I=Q?7.EZSJ.NZQ8V\EI?
M06[Z;9M=:SJWV#1--U+4;/UFS\9^$=0UB_\`#UAXG\/7NO:5I=EK>IZ)::WI
MEQJ^G:-J2L^G:M?:9#=O?6>F:@B.]CJ%S;Q6=XBEK:>5030!TM%8'AGQ5X9\
M9Z3#KWA'Q#H7BG0[B6X@M]8\.:QINNZ5/-:3/;W44.HZ3=7EE+);7$;P7$:3
ML\,R/%*J.I4;]`!117QY^U/^TQKG[/MSX)@T?PKI/B1?%4'B"6X;4]3O=/-F
M=&ETB.,0BTM;@2B<:DYD,FPH8D"[MS8`/L.BOR*'_!2+QL2!_P`*O\*\D?\`
M,RZS_P#*ROTR^$_C2Z^(OPV\%>.;VQM],N_%7AW3M:N-/M9I;FWLY;V+S'@A
MGF2.6:.,\*\D:,PY*CI0!Z'112,P49/3*K^+,%'ZD4`+17PQ\%O^"@7P8^-^
MO>#-+T/PW\7_``OHOQ0\6>/_``+\)/'OCOX;W_A[P#\4_%_PSD\;MXK\/>$/
M$D&H:K&NJP:?\-_'.M:79>);;PY/K^C^&-6O-$6_-JT)^JG^*?PSC\+1^.)/
MB%X'3P9+?#2X_%K^+O#J^&)-2-\VF"P3Q"VI#1WO3J2-IXM%O3<&^5K01?:`
M8@`=[17C_A/X_P#P:\<_%CXF_`SPE\0_#FN_%OX-6/A'4_B=X#L;MGU[P?8>
M.]/FU3PI<ZG;O&D;1ZK80-<9LY;DV(FLX]2%G-?V,=P[XG?'WX,_!OPI\2_&
MWQ,^)7@_PCX<^#O@^X\>_$R\U/7+#[3X-\)P6D]XFL:UI-O/-K%M#J$=N\6B
MQ&P-SKMZT.GZ-#?7UQ!;R`'KU%>6?#;XO^$OB7\.O`WQ+L7N?#FC?$'PY_PE
M7A^P\6S:-I6M/HOV1]1:ZGM;/6-4LP(M+5-3N/LNHWB6=C+'-=R0$2I%T^J>
M//!.AV3:EK7B_P`+Z1IZ76DV+WVI^(='T^S2]UY87T.T:ZO+V&W6ZUA;B!M*
MMS()M1$L9LDG#J2`=917AWQ0_:*^%'PBU'P)H_B_Q)$NK_$3XK^"O@SX?TG2
M%CUC4T\;^/IHX=`MM6T^SG:[TC3BUQ9-?ZG>PI!81:CILLX"7]J96Z/^T9\)
M_$/QKE^`.@^(X]:^(5O\.=5^)]U;Z2D>I:-9^'=#\=0?#G5[6\URRGGLK7Q#
MIWBJXCL;WP].4U*T0/+<Q1;&0`'N=%%%`!1110`4444`%%%%`!1110`4AZ?B
MO\Q2T4`?YH/BAT_X2?Q1\R_\C1XF_B'_`$,&I>]?J!_P1293_P`%#/A<`RD_
M\(/\7^`03_R)%SVS7];DW[$7['-Q--<3_LL?L]33W$TMQ/-+\'_`;R33SR--
M--([:&6>265WDD=B6=W9F)8DUU?@;]EW]FWX8^)+3QC\.?@)\'?`GBRPM[VU
MLO$OA#X<>$_#NNVEMJ4!M=0M[;5=*TNUO8(;VV)M[N..94N(28I0R'%?UYQ-
M])'(\]X7SSA^CPWFU"KFN2X_*Z>(JXK!RITJF+P=3#0JSC!\SA"4^:2C[SBK
M+4_E/AOZ/6=9'Q+DN>U>(<KKT<KSC`YG4H4\-BXU*L,)C*6)E2A*2Y5.:IN,
M7+1-J^ESW>BBBOY#/ZL/D?\`:E^#7C_XA:[^S7\4?A9!X4U?QW^S1\<-1^+.
MF^$/&_B+5O"'AWQOI7B7X'_&'X&>)-`D\5Z+X7\9WGAS5K71_BW-XDT+4)/#
M.L:?<:EH$6C:C!9VNJOJ^F_G/\3?^"9'Q:^)MK\:=6UE/@M-XF^*G[&__!0G
MX>:+9:IJVN^(-)\`_M(?M>_'&P^+?P]U?0]4U+X?V]V?"_PXM+"RTR[^(<&C
MZ;XN36+*76-"\)6D&H+8V/[H44`?@5X@_P""6_QWU7Q-XG\60>)_AE9>)_&N
MO_\`!2OPM_PFVG:SK-MXT^&O@[]O;0/A'9>'_B[X0U*7P1/-J/Q'^%^J_#/4
MY;_P6E_X:@U6T\::E<Z3\0;*[MI;?4>O^'?_``3H^,?@Q?A_XUU+P_\`#+Q?
MK?P^^,7@CQI=_`WQQ\6;?Q#\(_'?A_P;\"/B3\$-%OFU#PU^RE\-_#?@[Q1X
M&E\?67BSP+<+\'/$^J7UKX3TS2_%?B@ZJ/#FI^"_W&HH`_,KX)_L9>.OA?\`
M\$[[?]DCQ#H/[/\`\0O$T-U\2O[4\'>,-(\1:M\!O%'ASQM\?_&?Q/?P5<V\
M>FP>(]!L+GP9XDC\/:1K]OHFKW/@+Q)%I_B*V\/^*H=`CTK5/`K']@/X^67B
M+X1_$JTLOAS.GP/_`&GH?BY\(?V?OB1\:?B?\>?#WPJ\(>(?V8OBA\`?'?\`
MPC'QO^)_@2]\<RSW?C?Q]X9^->F_"F#1M)\!Z;>?#>#0?#7B3POJOBJYU_1?
MVRHH`_G"O_\`@DS^TMXFL[^[\4WWP-N[F'X+?`WPS>>!)O%-Q-\-/'OQ7_9R
M_;!^#_[2&@ZW:>&?#G[/O@3PI\)/`GQ`\,>#?B!X`M=%TGP7XUU3X::=XU:W
MGN?&]M=:LLWN6A?\$T_BY>>-?CGJWC^\\/>+-#^*-M^V%X@MK;6/C'K-AIFL
MW?[76A^(]/O/A/XOTCX=?`;P+\1D\'^"=+\16?P[3Q6/CQXEBA\/>`/`WC'P
M)X`\+:];:;H/@[]RZ*`/A;]B#X#_`!@^!>D_%*S^)Q^'UAIGB[Q=X?UOPAX=
M\)_\(GK_`(ETJWTGP7H_A/5KKQU\2_!GP2_9XTWX@WVI-H6EIH%UJOPT?Q1H
MF@:?;:?KGC3Q)YEG8^'ONFBB@`K\I?\`@I20-1^$&2!_H?CGK_U\>%J_5JN1
M\3^`/`WC9K)_&/@_PSXI?3EN%T]O$&B:=J[62W1B:Y6U-_;SF`7!@@,PB*B0
MPQE\E%P`?S*J1D<CJ.X]:_HB_9B(/[/OP@(.1_P@>@\C_KVK>_X4/\$O^B1_
M#?\`\(OP]_\`*^O2-*TG3-"TZRT?1=/LM)TK3K>.TT_3=.MH;.QLK6$;8K>U
MM;=(X8((UX2*)%11PH%`&A374L`!C[Z-SZ*ZL?QP#CW]*=10!_/OIO\`P2#^
M)^F_`/PI\/['XFKIGQ`U;X??MP?#?Q]J5U\5_B]XT\$^`;G]I3Q%X[\7>`OB
MK\!_"/B^34_"GP]\<:/#J,/PD\>1>"_!O@@ZM\)?B_\`&#3;>_U*>VTNSUKT
M)O\`@G1\6_\`A7\-U/X;\'ZEX_C^-MS\1;3P]J?Q\TNYTWPIITWP+/P-EU#P
MM?K^Q;;?`N\OM7\-S77AWQ%X0\7?LIZ[I.K^$ETW5G\20^.]-M[H?N-10!^9
MG['W[(7Q1_9U^.7CKXC>,K;X,^(S\8/V</V7/!GCSQE\/=,'@*\T;XH_L[>"
MK_X?ZKHGAWX?6G@^'2Y/AMXNTS4-/UC1[^T\2Z"?#\WAV+1$\`VFG2:5_9?R
M3\;?^"77QC^*O@OX\?#ZW3X%VDWB/PU_P4:E\+?&"_O]9G^(_P`;M9_;5\-_
M$*R^''@?XZ6D?PY2+P_X.^#&M>,O"]Y>:WIWB3X@SZE<?!7X1ZIX8\,:`VEM
MIVB_O310!\+_`+3O[)=_\8_@I\*/AGX#G\'^#;[X?>*_!FG722Z>]EH1^#OB
M70M1^#O[0_@[18M'L!)87GB7X#^.OB'8^#HH+:ST^#QK%X3O;Y["VLGN[7X_
MMO\`@GM\:O#OA[X:7NH6'P`^/^M>"M1_:8\':G\,/BS=:_HWPNU?X<^/O#?@
M#X+?LZ^,);X>`_B#<7'Q&^$G[/OP:\%>#/%EG<^%?)\0CXD?&>+1/$EB=2MF
MUK]J**`/P?\`#O\`P2K^+_AO28-,?XD>%?$'B:R_:J_8E^)*?&&_U'6+3XD7
M_P`*OV:OV.O@S\`O%=[Y\OAW53IOCNY^)?@?Q9X_\'>'#J6HZ%)]MTC5-;\1
M1ZW/J`C]P_8N_8:^)_P#^.7P]^)'BKPO\!_!F@_#K]AWPO\`LBW47PEU36K[
M5OB+XH\%?$?1_%0^+FO07WP^\%V^F+XRL;;4-2N?#]S>>)M9\.ZW?7T%YXJ\
M4C4&U*#]<**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
$@#__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>biib-2015630_rdchart.jpg
<TEXT>
begin 644 biib-2015630_rdchart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`)H`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^3?VU_VF)?V2?@)?_&6
M#1/"&N31?$GX%_#>*/X@^/F^%_@/1Y/C9\;/`'P<3Q;XU\>KX;\6OX:\*>##
MXY'BK7[Y/#VHN=,TBY@58#,+F'ZRKP;]HWX#:/\`M&>`=#\`:YKE_H%AHOQB
M^`'Q?^U:?8Z=J,E]>_`/XW^`?C9IF@75KJB2VC:5XEU'P%:Z!K$NQKFWTO4;
MNXLL7D<!`!X9X+_;K^%,&C>%(_BY\0?@Y'XF\5-HNH1ZI^SQXL\??M"?!?1/
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MIM^^^&'[)?@_X?\`[,WBW]E[5/$.O^+?!WCFX_:)_P"$DUF>.PT/7)]/_:/^
M)'Q/^(7BJQLCID3VEB=(;XHZKHNB7:123+;:?8WMTLMVT^X`^</@W_P5(^$'
MQ-\=3^&?$_A7QC\*M`U'X<?L:>./"?B+Q=X;\;-/+JG[9=UX\T7P3X7^(=C;
M>"ETSX3&/QAX3T;P7X<\0^,]>L]$\>^(?%^CVV@SQQSV,FH?7_PH_:@^"7QM
MU[4/#GPW\77.MZE::9=Z_ITE[X3\9^&M*\8^%K#65\.7_C+X;Z]XI\/:+HGQ
M.\%6.OO#H]WXO^'^H>(_#EO>WNE"34E@UO1+C4?B/0?^"7.C6O@/X@>#/%/Q
MP\6^*;CQ_P"'_P!A3PG?:T/!GA'03;>'?V"OBS<_$?X=VPTK3I)+&>\\9Z2=
M/\(>.KQ6M8GAM)];\/V6CW=[]BMO6_V0/^">_P`*OV.?$6J:O\/O^$::RM_"
M+_#KP6FG_"#X3^#_`!9I7@)]:L-;72O&GQ,\,>&K7QY\3M6@?1M!TQ=:U_5[
M&&^T_1+"^U[1]9\5B?Q/*`>"_'__`(*'_'K]GCQA^V):^*?V??@UK'@']D7X
M#>"OVB]6U_2/V@_&\'B?Q?X#^*GB?XU^%O`&G0>'-1_9Y@T70O$EK<_!;4K_
M`,=)/XLU#2-$L=<LCH&I^)Y[.ZB/UXO[=W[,'_"1:=X/G\?:O8^,=4\=>*OA
MO:^#M4^&_P`3](\71^+O!?A;P9X]\0V&I^&M4\'6FLZ)8V?PY^(/A'XFKK^L
MV5AX>G^&>K?\+`AU5O"EAJFJ67#?M"?L&>%OV@KK]K.ZU;XA^*/#;_M8?LZ?
M!K]G?75TG2M#NQX.TCX.>+_C/XOT[Q-H)U"-C?ZOK5Q\9=1L]0M-4+Z?;6^A
MZ=)9JLUS>%L+Q)_P3F^'7C']I/QI^T+XF\:^*=4A\>^)/B/K?B+X>&RTJUT&
MZT[XF_LF_"7]DO7O#Z:S:^7K\%FGA7X4V_B6WO(9X[X:WK^HVWF"QM;+:`>L
MZ=^W3^S/JGAB]\667C?7'T^+_A7\FB6$WPQ^*EGXG\?V7Q8O]3TSX7:Q\*/!
MM[X*M_%GQ9\/_$:^T36HO!/B'X<Z-XET3Q%'HVK7=C?O9:;>W,/KUC\=?AAJ
MGPJN?C3INO7M_P##^R@U>2\OK3PMXPN?$%I>:!K=WX:UWP_=>!(-`D\>V_C#
M1?$UA?>&=6\$R^&%\7:?XEL[KP_=:+%JT$MHOYJZ1_P1L^`.E_#(_#YV\$75
MQX<USX5ZQ\/-;7]G;X%:;#;GX.67BS2?"Y^+FA:5X6M+3X[7GB'0_&WB#1_'
MLWC&[L--U-;F/7?!^B^`O%J3>(;GZYN/V,?"@_9$U/\`9+T#Q9J7@#1-5LKY
MKCQ1\+_"G@7X:>7J^J>.?^%B:RD'@?P5H.B^"D\'^(];>YT+Q=X,;3GA\8>!
M-3UOPWXGU?5;W7=6U^\`()_^"A'[*UH+"UN_&WBV#Q'J.M>/O#47@$_!OXSS
M?$^V\2_#'P7X3^)/C?P[J7PPMO`$_CW2];T3X=^./"_CS^SK[P_!/J/@[58?
M$>E"]TJ.>YBX3XF?\%(_@?X:U#X2Z5\,+F3XRW/Q0^.G[,?P<;6/#EEXPM?`
M.A0?M-2^&=6\-:L?B?%X,U3X>W_BFS^'?BS0_B7;?#9_$>G^*-4\)ZKI&H2K
MIEKJ^GW,_GGP?_X)8_#WX1?%RV^,.D>/KJVU>7Q?\4?'>L>%?"'PT^''PU^'
MTOB/XL?LY?"3]G7Q`/#_`(1\$Z;I^G^&=)MM*^$6D^++2TMS?ZC>^)-6U>XU
M[6=8EG^V/D?#3_@E)X:^%G@_X-?#+PW\>?B(OPQ^%/Q%_98^-VH>$I_#'@9I
M?&_QK_9B\+_"WP5;^+=3U\6!U72/#_Q$T+X2^&M2\4^"])=;6P\8/>Z]H.K6
MFG3R>')`#V?X_P#[<%U\&_CQI?P*TSP5\/;G6;[X=^%OB)IEQ\6OCKH/P(G^
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M_@FYX7M-<U_Q#I?Q@^(6FZDG[1>K_M5?#26.WTJY_P"%<?&F[\#_``Q^%VE^
M(S+=O+=>-K?3?A;X#\4?#F]L/%-Q*GB3PM\9?BFFNRW.KZGH6K:$`>P_'[]K
M=?@/^T1^RA\%]2\!/K7A/]I*^^(VCZ]\2T\1_P!GI\+-7\/7OPU\,_#I+WPS
M_8=\_B33OB7\1OB?X:^'BW\>LZ-_PCFNZWX>D>#5H=6=+/R'X9_\%*?ASXP^
M(G[2GA'Q9X3UOPEH7P<^-W@[X,?"?5O#EKXK^*_BS]HFZ\4_##4OB&^L^"/A
MK\/O!>K>*5^S#PG\09;73=*B\3"X\$>$+CXA7]]I.CW,MO9>X?M,_LC>&_VF
M6DEUOQIXK\&7D/P,^,WP>T'5_"*:;#KOA+6OBAXO^!_Q`\,?%CPQJ=_!<MIO
MC_X0^.?@-X-\6^`YW@N-.&N1+<ZK;74=K#"_@5E_P36\/^$?&MU\3/AA\8O&
M/@GQ_H_BGX/>*/AMJUQX8\(^*=-\&'X7?LS7W[*NJ:)J.B:K!#'XNT;Q[\.M
M5U#4M<6[O=)U+3O%\>EZSI&I0PV,]E?@'M>F_P#!0#]DS6M5TG2-"^*;:_<:
MQ;?!6\M[S0_`_P`1=6T&TM?VB[J]TOX'RZYXFL?"4WA[PT?B=XDL+GP5X3A\
M1ZEI5Q?^/E3P,\,/BJ1=*KX_^%'_``66^"'Q&U;0=0\0_#OXH_"CX8:G\%/C
MQ\8]8\9^/O!/CV+7O"6G?`7]H73/@5XJN_$?@G1/`VIWFF_#^SM[^3QMXE^*
M5YJ-MX5\"V5E?:'XHEL]5TO6O[-]#\-?\$M?ASX.\.>//#'A[XH^/8['QSJO
M[$&N75YJ6G>&+[5(]<_8P^/<W[1$>MW4\%CI]E?ZC\8_'E_K%QXZ$>GZ?I^C
MQ:M<)X1T_3((+.U@Y?3_`/@D[X2T_2_CMX8C^-GC8^$OBQ^S1^US^RWX4TD>
M%O"BWWPW\!?M=_$N_P#BWXIOTUD%I?&>N^#O&&N:\GA6YUJSL8;C0+RRTW7H
MM2OK&75[\`^Z_`W[4OP4^)7Q#UWX9>"/$FM>(/$'AW5_&'AS4-5M/`/Q"3X?
MS>*/A[J*Z3X]\*:1\5+GPK!\--=\5>#-2<6'B7PYHWBR]U?2[R*^MI;0S:5J
MR6#-3_:J^!FD?$N]^$U[XNO5\7Z9K"^&-2DM_!WCB]\):?XUF\&#XB6?P[O?
MB'9^&Y_`%M\2]0\#%/%6G?#J7Q*OC.^T2YL+NWT5_P"U-,2\\0\`_L+Z=X'_
M`&C;'X_Q?%'6Y)=)3Q$T>A^'O`WP_P#A]JOC,>)O"_\`PBSZ#\:?&G@72=$U
M'XU>#?"=M]GU/X?:1XXTNY\0^'->T?PYJ^H^,?$=UH<#S<Y<_P#!-KX0#]I7
MQ?\`M&:9_P`(W::KX[\93_%'Q!!J7PB^%GB7QI!\3)?AY8?#?^U/#/Q?\0:!
M??$'PGX5?3=(TCQ#+X5T.]MKR+Q=:7-[I/BC1]"U?5O#EX`>C>'?^"A?[)7B
MSPA)XW\._$V^U/1)O#/P=\8^'88_AU\3X-?\?^&OV@-2GT/X-:O\+?"MUX-@
M\2_%*U^(7B&SU'PWX?;X?Z5XC,GB'2]4TB[%I=:==+'YI\*?^"F?P*\;V7CN
M[\:_VM\/6\(?&?X]_#B*%/#7Q&\6O:>!/@7\0_\`A7&I?&3XFC2OA_#+\$O!
M5[X@+:?JM_\`%"+P_HWAG5;35M.O->N4T+7+O3>)T_\`X):^$M%L_@3<:)\9
M/&]AXM_9P_9D_99^`'PK\4OX=\)WCZ;KO[*.OZYK/A#XF:KH]Q"=/U6Z\6V'
MB77_``GXW\(;K31KGPSK5_%H5_H>LIINM:=PTW_!''X0W_BW6O'GB'QM!XZ\
M9>.O%WQ)UWXD^(/B;\$O@E\2IM:TKXF_$G5OBMJ6G>$M,\:>%=8T#X?:OX?\
M4>)O%UAX;\0:5I&HP_\`"*>(6T3Q)H'B2ZT7P_K&F@'U-KG[>7PO'[1'P+_9
M[\"6FI>.=4^+'QL^+'P2\1>+(M)\9:%X0\'^(?A!\$_BQ\5O%\/A_P`7:EX-
M_P"$%^)VL^'M=^&<?P]\8^'?"7BZ2]\&ZYK<ZZS*FHZ!J>C+K?';]MCX>_LX
M_&;2OA_\5K?_`(1SX?/^S7\6OVBO$WQ3,VJZHOAJR^&/Q:^`7PHA\/'P=H>@
M:IJVK'7[[XZ6E^-4LKGS-,_L3[,VEW<>HO>:?R'A?]@S3_"?Q<^%7CC3?C!X
MR_X5U\#_`(\?&[]H3X7?!QO#O@V/1-#\8_M%>$OC9HGQ1T[4?%<&G1>*M<\/
M'Q!\=O&OBGP78W4\-QX6:]DT&XN]>TF+2!HC_CI^P/X8_:5\4?&#Q!\8_B+X
MFU>V\>?`[Q?^S[\/]*\.Z'X:\-)\*?`OCSQ5\/?B#XGO[:_^S:I>>-O%=QX]
M^%/P_P!<L=0\3E=%L++P\NC+X=GBU36KS4`#N/%O[?'[+'@GQ9XB\":W\0]6
MF\9^%_%OQ#\#:MX5\._#7XH^,?$'_"4?"CX>?##XL_$/3=,TCPCX-UR_US_A
M%?AQ\8O`'B_4KO1K>^L1I&JWTD%S+-X?U^'3>J\-?MC?LZ>,?&.@>"?"WQ$C
MU^^\43>';'0O$.D^&O&%Y\.=0U[Q?X`L?BKX4\(1?%6+P^?AJOCGQ)\-M3T[
MQQHO@>7Q4GBN_P##6HZ;J<6D>7J5@MS\S^"_^";FD>'?B]<_&_Q!\:_&WB[Q
MUK?B?]H3QIXKFN/#7A+1=+UCQ%^T3\!?V=/@3XC:RT[2H5&BZ1X<TS]G70];
M\,Z9!-=RI<Z[?V6K:AJ:V=O?3<?^SC_P23^"O[-WC3X8>+?#FJ:-XEG^'VE?
M#*\O=4\5_!GX0:O\1->^(/PU^#/A+X*V_BBQ^*NH>'+_`,8^"]!U[2O!FD>+
MM3\&^%KBT:P\:MJ$_A[Q-I'AG4]0\,W0![S^UM^U_P")?V7KS2[YOAIX.\4^
M%;R+P['IEKJGQN\.^#OBU\6_$NM^(CH=W\-/V;?A&WAOQ#JOQ:^)ND6MUHNJ
MGP]K&L>`K#7)]?T30M!U>\O+K4;S1LO3?VX9KSXB:7#=_#6ST_X#>)/VGO%W
M['?AKXL/X^@F\4W?QO\`!,WBCP[J<FH_#2/PP+73_AWJGQ-\%^*/A3H>OQ^/
M+WQ7+XKL--U&^\#V?A36X]:T_L/VE?V2]9_:/M_%/A'5?CCXQ\.?"+XE>$X_
M!'Q'^&UOX1^'WB`-H;0WUIJE_P###QAKVAS>)/A7XN\06%\MGJGB>PE\03Z=
M+I>C:]X,L_"7BRP_X2"?,T_]B/P_9?%.Q\42?$/Q1>_";1?CIXA_:B\/_`VX
MTGPU_P`(_I7Q_P#%4.N/K/BD^+EL?^$LO?"O_"2>*/$OQ+T_P3<3E++XH:U-
MXA?7KK1++2?"VG@'TG\5O%GQ`\+>&K*X^%_PV/Q0\8:UK^BZ#INCWGBFQ\$^
M&=&MM2ED?4O%GC7Q1<V.MZAI7A7P]IMM<W5\/#GA;Q;XGU*]?3='T7P[>7.H
MF>S^(_#7[=_C_P"(EYHGPX^&?P$T3Q!\>V\1_M.Z3XJ\(ZU\9;7P]\,;+1_V
M3?'7@SX;_$/Q%X0^*<'@'6M5\8V7B;QQ\1O!/A#P,DWPY\/F'Q#<>,-.\=R>
M$;OX>Z_:R^S_`!+^`OQ^^)G[-6@_!_\`X:F\0>`OBE*-!B^('QK\'?#_`,+V
M^L^+=*M;BZG\2^';'1K"[\.6_@VV\56DMMH5]XA\%:AX=\4Z7I<-W<>%M5\/
M:S>Q:I8>=Z+^Q-XM\.>&?A+)X3^.%A\-?BE\&?#WQ`^&W@WQM\*/@7\.O"/A
M*T^#/Q(O/!NIZY\.#\)=8N_%WAI5T[7/`'A+Q5X<\2)J0O\`3O%&B07>H6FL
M:-J?B70->`*/A#_@H5HGQ%^*7[%W@WP/\(O&-UX`_;&^'_B[QUHGQ9\0ZQX>
MT32?#-UX<^%,7Q1B\%V?AZSN-;UCQ=XDM(/MFA^-KRV.C^&/"&KVL5A;:[XE
MU*YEL;"_\!/VT]2^,WQV\5_"^^M_@+X:T;2_$?QE\/>&]+L_C'XTUGXS:[)\
M(OB#K?@.\FG\$7_P8\/_``_%X5T"X\0^*M`\,_%GQ7KW@33-1TA-<L"UQ-+!
MQFL_\$]_%>F>/_V3==^#_P"T(WPT^'W[&OABY\)_";X>7_P<\+>.Y[O3M>\`
M6_PW\93^,/&FI>)M&U;6M1\0Z##+>)>VNGZ8]CK]W<ZG,-3C<68^A],_9J\4
MS_%GP?X^\??'?QO\1?"OPK\:>,_B%\)?`>K>&/`6C-X8\5^./"WC7P/=W/B'
MQ?X=T/3];\:6'A?P=\1/&/AGP5875OI#6NGZM'?>,+OQOXBTW3M<MP#KO%/[
M4GP7\%?$O2?A/XJ\0:_H?BG7/$>B>#-+U"_^'OQ%A\!77C?Q-I]IJGAGP.OQ
M2;PI_P`*U7QGXDL[ZV_L/PPWBL:MJ-Y<V>E0VW]K:AI]A=>2>&O^"C7[('C#
MPK!XQ\-?%*^U;2-3\-?"[Q?X3@@^&WQ4CUWXC>'?C1K#^&_AEJ/PI\,W'@J+
MQ!\55\4^)H;OPU##\/=-\1SZ;K]C>Z9K<>FS6LS+Y?\`%;_@FKX+^+?Q]C^.
M?B/XC:U<7MA\>/@;^T/X=MM5\#?#_P`3>*_!_BKX(ZE\/;BQ\!^#/BCK^E7G
MC7PC\$_$5MX`%[JOPR\-7&DV\7B[Q;XT\4+K%S'XAOM$EXC1O^"4OA/PU8_L
MS7'A[XV>.K#QE^R9^S=\'O@1\)/%LWAKPC?R6NM?!CQ+#K6B?$77-%N(O[.U
M2;Q'HTVO^"?%GA*-K32KKPSXFU)M&U#0]>M='UK3@#Z1^"?[7>H_'CX+?&OX
ML>`OA!XB\0:I\,/C5^T'\&?"GP^TS6;33_$7Q$U+X)_$35_AWIMVTWCBP\&6
M_@>[\5W^FK=:KI?BB*)O!*&^@U&XU&73F6?RZZ_;K\<Z/XP\2?`S7/@GX<;]
MH^T^+WPB^#WA3P]X:^+LNN?!G7];^,/PP\=_&FRN-5^*U]\-]!\3>&KGP'\+
M_A;X_P#%OQ`\*S?"N_\`%4&F6O@J]\-:=KMA\2/#=VGJOP\_9/\`%'PB^!'Q
MK^%OPT^/GB_0?B'\8/B/\;?BW#\;]0\&^!==\2>"_'WQR\77OC77=:T;P?=Z
M?#X(U"/P]K.IWQ\,:9JVF3:=;6RV$&HVVHI9N+KRKP%^P/XE\*_#/3?!FJ?'
M5+OQ?X%^+6C_`!V^%'Q1\-?"71/#OBS1?BY#H?BCPSXS\;_$V37/%_CF;XV:
MU\5?#?B_7_#OQ%U/Q=J5EK6IZ+K.IQ:5J^C:@-$U+0@"CK__``45NM%\-_"*
M_A^`GB/5?$'BO]K_`,-?L=_&6WL/&WA\^"_@9XXU3XXZ!\$-2U"Y\8W5C::G
MX^%YJ'B;0_%_P_T+0O!FGZQXH\%ZE#K/BF/X??9=1M[7UGXZ_MEV/PA^/7[.
M?P+T3P-+XZO?C)\6_#?PT\>^(H?$46BV/PB@\<?#[XM^-?`M_<6K:1J3>+/$
M/BB7X1>(8X?"=M<Z1)I?AJVNO%FKZG:0S^&M.\2^,?$S_@G?XP\4_#[X>^`_
M`O[2>H>")?#W[06C_M8?$+Q7K'P=\$^./$/Q2_:#T/XO:3\:].\4ZAYFL>&=
M*\,>&8O%&DVFB+X.T#3MD/@BRTKP[::U;2Z=_:=UTGQ'_P""9OP7^*/Q$^$/
MQC\0>(_B3I7Q4\!_'?P)^T/X^UWPA\3?BWX9\+_%GX@^"OA/JWPI^UZA\-[3
MXFR>"/!B:EIMUHTKW?A+2K?5[?2O#MKX1DU&^\-ZIKUIJ0!^CRG<JMC&Y0<=
M<9&<4M(HVJ%'88Y_SQ[`<`<```"EH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HK\?O\`@H%\5?B7X,_;Q_X(Z_#O
MPAX_\7^%O`WQE_:1_:&\-?%;PKX>\0:CH^B_$+0?#G[+7C7Q9H.D>+;/3YX!
MK.G:1XDL+/6["TNF:"#4K>*Z"&6-&7]84\.:840E;[)53_R&-:[@'OJ)/YDG
MWH`Z"BL'_A&]+]+[_P`'&M?_`"QH_P"$;TOTOO\`P<:U_P#+&@#>HK!_X1O2
M_2^_\'&M?_+&C_A&]+]+[_P<:U_\L:`-ZBL'_A&]+]+[_P`'&M?_`"QH_P"$
M;TOTOO\`P<:U_P#+&@#>HK!_X1O2_2^_\'&M?_+&C_A&]+]+[_P<:U_\L:`-
MZBL'_A&]+]+[_P`'&M?_`"QH_P"$;TOTOO\`P<:U_P#+&@#>HK!_X1O2_2^_
M\'&M?_+&C_A&]+]+[_P<:U_\L:`-ZBL'_A&]+]+[_P`'&M?_`"QH_P"$;TOT
MOO\`P<:U_P#+&@#>HK\VO^"F/Q6^,G[.7[+OB[XE_`/2+L^(-)@U:77/&Q\+
M^)OBTWPWT:S\+Z]J=GXF/PQT[Q/HU[XH@O?$MEH7AB[NA<WMEX4MM<D\4ZKH
MFLZ;IES:CXJ^,O\`P42^(OP]\)^._B+I'B;X17V@?"G]FS1/CGX4T33O`GQD
MUN/]M77-#U?XH0_'+P+\']5O/&MEXB^$FM_":P^']AX>\4>%M7T?Q?XY^%GC
MSQ!+>?%W3X?!.B0CQ$`?OU17Y4:'\:?C;I/[2M[I7Q4N?&?A'X*:_P#&'Q9\
M*/A=I%W\`/[%\&>*]7'AJ\NOAKI3?M`7WQ7N_'7V[QQ)9/KUAXKD^%-E\.+W
M6IT^&5KXD.NBW@OO7/V+_BE\4?C5>?M9Z/\`&[2/`NA>)?@;^U1JGP>T#1OA
MCKOC?4=%TWP@?@/\`OBQIFGZIXD\0WMCJ'C/Q)IFI?%;6--UGQ;#X=\(Z9J\
MEG$=*\+Z7I\%OYP!]]T5^8WQ"^,?QK^&7[6?P<^&.NZAX1O/AQ\8/B;>^%(=
M'G^&/QC\):!X>\#W/@CQ_K/AK4[7]J;7O%+?#WQ?\>]2\5>#]/M1\"-+T.&Z
MU;PSKDIT6T2XT&;Q9JOZ-#PYI9`.+WD`\:SK)'(SP?[1Y'H>_6@#?KS#XS^+
M/&7@7X6^-_%OP_\`!ES\0?&&@Z#=:AH7A*S^T27&JW<;Q(WEVEBDFIZI]@MI
M+C57T71HY-<UV.P?1M#C?6+^Q4]C_P`(WI?I??\`@XUK_P"6-<QXR^%?@[Q[
MX9U;PCXEMM:N-%UF&&&[73O%WC#0-3A>UO+;4;*]TO7M`U[3=<T35-/U"RM+
M_3=6T?4++4M/OK:"ZM+F*:)6H`_%OX#_`/!2CXP?$/X,_L_77BOXJ?LR>'/$
M/Q-^)/Q(\'_$']H/7O`7Q(T#X;_">;P?X.E\5>#/A_\`$CX/^*O&7@#6O!/Q
M9^+-R9[?P'!KGQ,L/"FO^%O#FKZUHUUJ7BS4M#\'W?M&B?M;?M.?';X`?LP_
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M-\\_B/6;ZZURYU'6M?U6]O[O4=;U&XN`#Y#\`_MX>)?'_P"T1!X;BU?P#X7^
M$4_[3WQ?_97T_3?$GPP^,"ZEKOC'X/P>,O#FJ)9_M!6%S<?"/2?BAXA^('@;
M7;GPI\%-9\+V\6K_``Y@@OC\28/B#J6G^"9?7?VROCE^T'\!/#_B#XE^!1\%
M3X+\,:)X9B\&>`/%FG^-O$OQ2_::^,'B/6-4L=/^`_P[;PUKF@6?P^\0>)(H
M=$T;P-K[Z'\5KG6_%.OSWNM>%?#GA#P=JVH:UV2?L+_`=/BC'\31;>.3%!\2
M+_XUV?PU/Q$\5_\`"HK'XXZG9W5AJ'QCM/A\+X:;%X\NHKZ_OWNC.VAIXIO[
MWQW#H,7CN[G\2R>:^(/^"<_@O7O$_P`+/&I_:-_;%LO%_P`(/AC:_"WPEXE;
MX^WGB'5UL/M%[/K_`(OO;KQMX8\5LWQ,\;PW<&E>.?B'IZZ;XF\3^']*TGP[
M?WAT.S_L^4`_0V-F=%9T,;,`6C)!*$]4)4E6*_=+*2K$$H2I!+ZY]/#.EHJK
MG4'VJ%W/K.LL[8`&YS_:`!9L98@`$DG`S6C8Z;:Z?YIMA./-V;_.O+V[^YNV
M[?MES<>7]XY\O9NXW;L+@`OT444`%%%%`!1110`4444`%%%%`'X@?\%)_P#E
M))_P0I_[.M_:@_\`6.?B#7[>1_ZN/_<7_P!!%?B'_P`%)_\`E))_P0I_[.M_
M:@_]8Y^(-?MY'_JX_P#<7_T$4`/HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHKY]_:JU+4=(_9\^*.I:3J%]I>HVGAU9;74--O+BPOK63^U-.3S+:\M)(;B"
M38S)OBE1MK,N<$@@%3]I_P#9>^&'[6GPQU/X7?$YO%NFV%Y#J"Z9XI\`>*M9
M\$>.?#%SJ>EW>C7]WX?\1Z+/#-";W2KZ[T_4=.U&'4M#U6SF:WU72KV-(1%R
M&L_L._L[ZWIWAKPY/H'C&R\">'["+3=1^&.E?%+XGZ=\,O']M#XMU?Q_YGQ4
M\"P^*SH/Q,U'4O'&OZWXI\5ZSXQMM5UGX@:EJ^I1_$/4/%FFWD]@_P"+Y^*/
MQ/+8'Q)^(`RV!GQQXG4#)QDLVK!54=V8A5&2Q`!(\,^%_P"VQ=_%W6/'&E>%
M/B1\:H(?`]S;^;XA\1W7Q$\.>$O$VC7'ACPIXL3Q5X1\2ZG=0Z3JGAX:3XRT
M2Z,US<6&HR:;<V_B.WTZ;PM?Z?K5R`?T9R_LD?!VX^(G_"R;F+Q[>:G!XIU7
MX@Z/X:U#XH?$34OAWX9^)>M:?K&EZC\2?"_PYU'Q#=>#M`\:26>O:LUMJ>G:
M3%;:7J>H7OB#2;"P\17MWJTWE/@3_@GS\*/A[#\7XM"^*7[53R?'36-.\3_$
M>_O/VG_B\VL:KXQTS_A7EI#XRT[7++7;#6/#OB6;P[\+?!O@R^U#0;[3TO\`
MP787?AF[MY=-U?58[O\`GSO/^"B_A73O@]XJ^.FH_&KXO6'P_P#"7BWQQX)N
MGN;GXA?\)-K/B#X?74L.O0>%_"4&HSZUKEH]G#)KVGZ@D%M:2>&$D\1ZD^E:
M5#<7$/NGCG]HGQ9\.?#=YXJ\4_%+XEV^F6EYH^E0P:=XF\9ZSK&K:YXCUFQ\
M.^&_#N@:-IVI37^M>(/$6OZGIVC:+I5G&TUY?WD2EH;=9[F$`_>H?LA?!5OB
M18?$J]LO&VKW6C^/+[XK:!X*USXF?$/6_A5X=^*NI2ZQ/>?$?0?A=JOB*[\%
MZ5XJ:X\0:S?VD]KI2Z;I6MZC=>)-'TO3_$DAU<?3XP``!@```8(``X`'':OY
M:O`O[2GB_P"(-KKDFC_$/XNZ9J?A37YO"OB[PQXJU[Q;X?\`%7A/Q'#IFEZV
MNE:[I$FMW443WFAZWHVNZ5?Z=?:GHVLZ+JMCJ6DZG>6\S-'^FW_!/GQAXN\1
M^/\`X@VWB+Q5XFU^WMO!VESV]OKGB#5]8@MYGUUHWF@AU&\N8X96C_=M)&JN
MR?(6*\4`?JCJCO'IM_)&S(Z65VZ.A*LK+;2LK*P((96`(((((!'(K^;'6OVC
M_BCX9T6^\0>(?C;\0])T72K9+G4=1N?&GBEX;6%Y8;>,^3:75S>7,T]S/!:6
MEE96UU?W][<6UC86MU>W-O;R_P!)FK_\@O4O^O"]_P#26:OY3?&>A2^)O".M
M^'XM,\*ZT^K6$=FVC^.(M6E\(ZK$;JUEN-/U\Z"RZY:V-W;130IJ>CK-J>C7
MC6FLV5K>W&GQV=P`<_'_`,%---B^"]W\>M;_`&@_C#X2\"Z?+=6E_:>+;CXD
M:)XUAU.U,\ATBU\$7`;7M:U&>Q@DU>!/#]OJMFNC)<ZE=WMK;Z9K#:=Z#\3O
MVU_B7\)F5_$GBS]J;5].$%G-<Z]X$T7XA>-_#]A+J.KQZ%8Z;?ZKH^IF.#6+
MS5)[2UMM)BBN+VX:_P!/%O%*][!&_P"6>E_LY?M/6?[#WQ%^`\NCZ+K_`(J^
M)7A;7?!WA+P5XI^,37&G_`S3=9M]236[P?$/7O#&L:GXCL/%FLRKK,O@W0H5
MLO#EO>21V.K7+:EJ]C:_=FL^'_&_C_7/@AKGB30-*\)Z;X3\7>*O'WCKPDOB
MJU\62P>(]+\,:UHWPJAL=9L-)TO3_$-OI>OZY/XONYEM+!-+U33-"ECAN;JQ
M$R`'L,W[:OQ,M?B/I7POO?%?[4^GZWKNJZYI&BZ]?Z+\0;?P!JMQX;TBXUS6
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M%M7N)M9B\*://>W4G@NW;Q,O@WPWX5SHNEWM_<J`?N=^S'\5OBKK7[0'PWT+
MQ!\1_'6L:9=:[J5KJ.E:IXKUO4-/NQ!H&MOY5S:7-[+;W")<01RH)$91)&D@
M&Y5(_<D=!]!7\^?[))E/[1WPJ:>X%W.VO:BT]V+9+(74Y\,ZZ9KH6<<DT=F+
MF7?.+..::.U$GV=)I4C$C?T&+T'T'\J`%HHHH`****`"BBB@`HHHH`****`/
MQ`_X*3@G_@I)_P`$*<#/_&5O[4!_`?L<_$$D_@.3[5^W<9Q&@(((1005;(.!
MP>*_#[_@I=!#=?\`!1[_`((603IYD4G[5O[3^Y"SKG;^QW\0'4[HV1AM9588
M8`D8(*D@_M''X9T3RT_T(#Y%X%Q>X'`XYNB?S)/O0!T.1[_D?\*,CW_(_P"%
M8/\`PC&B_P#/D/\`P(O/_DFC_A&-%_Y\A_X$7G_R30!O9'O^1_PHR/?\C_A6
M#_PC&B_\^0_\"+S_`.2:/^$8T7_GR'_@1>?_`"30!O9'O^1_PHR/?\C_`(5@
M_P#",:+_`,^0_P#`B\_^2:/^$8T7_GR'_@1>?_)-`&]D>_Y'_"C(]_R/^%8/
M_",:+_SY#_P(O/\`Y)H_X1C1?^?(?^!%Y_\`)-`&]D>_Y'_"C(]_R/\`A6#_
M`,(QHO\`SY#_`,"+S_Y)H_X1C1?^?(?^!%Y_\DT`;V1[_D?\*,CW_(_X5@_\
M(QHO_/D/_`B\_P#DFC_A&-%_Y\A_X$7G_P`DT`;V1[_D?\*\#_:AT?4_$'P"
M^)VC:-9RW^IW_A]8;.SB,:23RC4]/D**\SQ1*=B.V7D484\YP*]>_P"$8T7_
M`)\A_P"!%Y_\DUQ?Q$T#2K7P9K]Q!:!)HK(-&_G73;6^T0+G:\[H>&/#*P]J
M`/P1/P.^+(8D>"]31@<K(MSI!,;`Y60`ZDH8HV'"EE#%0I902P_-CP-_P3._
M:OCU[]H:RU5[3X.>`OB=KUH1X<^#DEKXA\(^.T30/@K]I\27/PT^(>J:CX8^
M'5A=R^"?'OA#6O"VC&XU;7M#^(/B32-1URY\+Z3X/FN/U[_X*$?&/XU?`C]F
MOQE\1?@=HWG:]HUOJ4^O^,D\"WOQ0?X9Z%;:)J=Y9>+#\.=.U/2;KQ-;ZAXG
M@T+PC=WDDU[IWA2#Q"?$>J:)J]K:"*'P;X\?M]7OA'X>_"J]^%?Q!_9Z\4^,
M+OQG^SM??&7Q+#=:C8^!],^''Q8_:>\+_`"?1O"G@WQUXAT3Q]X?^('BL7WC
M;5!I'C!KO4_@W8?#7QM=^-+;4+JWT/\`M$`^!/$'_!/7]MVU_9F_:E^"^G6/
MAGXG>+/VBOB;^T!K>GZ_XGUCPU\*M)\(>&/B[??;[37+RV\&^#M>&JZY>7*1
M3Z]X/L[*PT;1F/V3P]K;Z?$('^E_&_[-'[5'Q5\'ZYX9\7?`SP/I$-SH'A3Q
M)H4=G\8_$,VJZ3\6/#/Q!DU^S-CXN\/^$_#]_P"'K;P]I6B^&/$_@SXB:/IU
MUJ]AXYN+G3=7\&W_`(<TJ637_HCQK^V1X_\``%AXJ^/FJVWAK6?V?]$_:G^,
M_P"R_%\,-'\':L/B<+3X3V_Q-T#3_BI!X_&NW=OJ.I^*/B3\+-5M[OP5_P`(
M1'X>TWX;>(-)UK3]=NO$.EWTNJ^N_`?XR?%W5?B%\/\`X>?&"^\#>)+_`.,G
M[*^E_M2^%K_X?^#=7\)V?@.6+Q)X$T#QG\*]1.H>)?%'_"6Z3I2?%+P7>>#/
M'=X^@>(=;.G>+8M<T%%.DM:@'P_\!/V,?C?\-9?BKXI\4>%]0O/&7QC\=Z7X
MS\11KXO'C-K"'PWX$\,_#WP[9WWBW5H?#DGB779-)\.'4=>U?3_"OA301>:A
M'HWA[P]8Z)HEB]Q^NO[`OP]\:>#O'GCZ]\3^'[O2+6\\(:7:VLT\MG*LT\>N
M-*\:BUN;AP5C^<EU5<="3Q7@]QK7QO'[5^@_#_2/C#X:UGX=P^$]<^+?Q&\!
M7'P/\/V-_P"$/AYJ-]J/@GX8^&K#XHVOCB?6]0\6>,O'UCKE_;ZC>>&8HD\'
M_#OQE-<62W5_HNW]'/@OIUGJ&L:Q'>0B98M+MW0;Y8\.;TJ3F&2,G(/1B0/2
M@#Z;U;G2]1`!)-A>`?*>]K*!V]:_EV3[B_[J_P`A7]->J^&M%73-0;[$"18W
MA&;B\[6TI_Y^?:OYE$^XO^ZO\A0`ZBBB@`HHHH`^B_V2?^3C?A3_`-AW43QS
MT\,Z\3^E?T&+T'7H.H(_G7\]O[*-O#=?M#_"VWN$\R&76]061"SKN`\-:XP^
M:-D<895/RL,XP<@D'^@*PTNQTX2?8X!#YPC\S$DTF[8&V_ZZ63&-Q^[C.><\
M8`-&BBB@`HHHH`****`"BBB@`HHHH`_$#_@I/_RDD_X(4_\`9UO[4'_K'/Q!
MK]O(_P#5Q_[B_P#H(K\0_P#@I/\`\I)/^"%/_9UO[4'_`*QS\0:_;R/_`%<?
M^XO_`*"*`'T444`%%%%`!1110`4444`%%%%`!1110`5PGQ,_Y$7Q)_UX#_TJ
MMJ[NN$^)G_(B^)/^O`?^E5M0!^6_[1/[._PZ_:;^'.J_#3XC#Q)96%[%?KI?
MB;P5XFUCP?XT\*WFI64NEW^H>'-?T:ZMY(9;_2I[G2M2T_4H=3T+5=/N7@U/
M2;MHK22VY'QC^Q5^REX\\%:3\/\`Q-\!OAMJ'AS1-<\*^(=-EN/"^D7_`(I3
M4O"'Q%L?BMISWWCW6K/5O'.M1:KXZL6UCQFFN>(=2D\=KJOB*S\72ZO;^(]9
M6\^HFZGZG^=)0!X0G[-7P=3XAS_$K_A'=2DU2?Q1K'CX^%)_%'B&?X40?$?Q
M#X3E\!Z_\3+3X22W[^`;7XA:UX)N+KPOJ7B6+15DN-,OM2G%K'K.J:EJUWS6
MB?LB_!OPSX>\0>'/#K?%#18-=\*^$?A]9:S8?&?XFQ^+_`OPS\!^)H?%OA'X
M6_"SQB_B*7Q%\-OAMHVLPLR^$_#%]:VVHZ=/-HVLW&IZ4EE:67TY10!R&G^!
M?#6E^/?&WQ,LK&2+QA\0M(\#Z#XHU`WES):W.D?#G_A+3X1L;#3'<V6DPZ<_
MCCQ++.MA'"+^;4%FNQ));0LOU#\"_P#D.:Y_V";;_P!+Z\-KW+X%_P#(<US_
M`+!-M_Z7T`?1NK_\@O4O^O"]_P#26:OY=D^XO^ZO\A7]1.K_`/(+U+_KPO?_
M`$EFK^79/N+_`+J_R%`#J***`"BBB@#Z+_9)_P"3C?A3_P!AW4?_`%&=>K^@
MQ>@^@_E7\^?[)/\`R<;\*?\`L.ZC_P"HSKU?T&+T'T'\J`%HHHH`****`"BB
MB@`HHHH`****`/Q`_P""D_\`RDD_X(4]?^3K?VH.@)_YLY^(/I^M?MW&<1H"
M""$4$%6R#@<'BOP^_P""EUO!=?\`!1[_`((607,230R?M6_M/;XI!N1MO['?
MQ`=<COM=58>X%?M+'X8\/>6G_$GL!\B\?9U]!Z\T`;^1[_D?\*,CW_(_X5A_
M\(QX>_Z`]A_X#I_A1_PC'A[_`*`]A_X#I_A0!N9'O^1_PHR/?\C_`(5A_P#"
M,>'O^@/8?^`Z?X4?\(QX>_Z`]A_X#I_A0!N9'O\`D?\`"C(]_P`C_A6'_P`(
MQX>_Z`]A_P"`Z?X4?\(QX>_Z`]A_X#I_A0!N9'O^1_PHR/?\C_A6'_PC'A[_
M`*`]A_X#I_A1_P`(QX>_Z`]A_P"`Z?X4`;F1[_D?\*,CW_(_X5A_\(QX>_Z`
M]A_X#I_A1_PC'A[_`*`]A_X#I_A0!N9'O^1_PHR/?\C_`(5A_P#",>'O^@/8
M?^`Z?X4?\(QX>_Z`]A_X#I_A0!N9'O\`D?\`"N%^)ASX%\2<'_CP'8_\_5O[
M>U;W_",>'O\`H#V'_@.G^%<5\1-`T6T\%^(+BVTRSAGBL@T4L<*K)&WVFW7*
ML.0<$C/IQTS0!\A-U/U/\Z2E;J?J?YTE`!1110`5[E\"_P#D.:YU_P"03;=`
M3_R_>U>&U[-\%]/L=1UG6([ZT@NTCTNW>-9T#JCF]*EE!X!*G!/IQTH`^F-7
M.=+U'`)_T"]_A;_GUE]J_EW3[B_[J_R%?TZW?A?PZ;6Y#:-I[`P3`@VZ$$&-
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M(-??UEI>G:;YGV"SM[3SMGF^1&(_,\O=LW8Z[=S8],F@"_1110`4444`%%%%
M`!1110`4444`?B!_P4G_`.4DG_!"G_LZW]J#_P!8Y^(-?MY'_JX_]Q?_`$$5
M^(?_``4G_P"4DG_!"G_LZW]J#_UCGX@U^WD?^KC_`-Q?_010`^BBB@`HHHH`
M****`"BBB@`HHHH`****`"N$^)G_`"(OB3_KP'_I5;5W=<)\3/\`D1?$G_7@
M/_2JVH`^*VZGZG^=)2MU/U/\Z2@`HHHH`*]R^!?_`"'-<_[!-M_Z7UX;7N7P
M+_Y#FN?]@FV_]+Z`/I>Z_P"/:X_ZX3?^BVK\NOB;X6N?&_P^\5>$;71_`_B&
M;Q#I2:<=`^)<&N3>`M;@>^LI[O2O%+>&&'B2QT^^M()X(=:T%+G6/#FI/8>(
MM.L-2NM)BTZ[_46Z_P"/:X_ZX3?^BVK\]5Z#Z#^5`'Y*_LN?LX_M8?"K]F'3
M_A=\1-$T_P`;^&=<UB-KW]GZ?]JCXJ>#O&OPL\.6$UUJ'D>`?VGO#VG1ZQ&/
M%'CB)/%^M>""\.B>'M"OS9^%/%AU/4/$?A^Z^A?AE^SC\3?"O@?]B;X>^,-8
M\(:YH'[/FN^-O&?Q!@T=Y+>SGUG0_#GC*Q_9R\/:'')H>D2>+[7X8ZAXVAEU
M?QCK&FZ!JWBCQ1X"T/XE:II"^(=8N8[7[FHH`^%5\$?'^/\`;LA^,EO\'/!=
MO\&8OV?]6_9^?Q+#\;_#\7B>634_CA8?%R7XEM\.H?`BW#07%M8_V5>^&Y/$
M;^(KC49%O)M2EMT+'BOB5\"/VC?B+9_&'6(/"GPK\/>)/VP_V3_!W[/'QHT2
M\^+&NZWH_P"S]XF\.Q_&/P[/XQ\$ZQ;_``_LW^,_AH^!_C=XB"Z-::9\-M<N
M_&WAS0;B2>+0==UB\T3]'Z*`.I^$&FVVB^)?`NBV<ES-9Z+:V.B6<U[+YU[-
M9Z-X?;2[2:]FR?.O9K:TBDO)LGSKII9,_-7W/7Q/\-?^1[\-_P#7Y/\`^F^\
MK[8H`****`"BBB@`HHHH`****`"BBB@#\0/^"D__`"DD_P""%/\`V=;^U!_Z
MQS\0:_;R/_5Q_P"XO_H(K\/O^"EL$-S_`,%'_P#@A7#<0Q3PO^U;^T]OBFC2
M6)]O['?Q`9=T;AD;:RJPR#A@".0#7[41^'/#WEI_Q(M&^XO_`#"['T'_`$PH
M`W**QO\`A'/#W_0"T;_P5V/_`,8H_P"$<\/?]`+1O_!78_\`QB@#9HK&_P"$
M<\/?]`+1O_!78_\`QBC_`(1SP]_T`M&_\%=C_P#&*`-FBL;_`(1SP]_T`M&_
M\%=C_P#&*/\`A'/#W_0"T;_P5V/_`,8H`V:*QO\`A'/#W_0"T;_P5V/_`,8H
M_P"$<\/?]`+1O_!78_\`QB@#9HK&_P"$<\/?]`+1O_!78_\`QBC_`(1SP]_T
M`M&_\%=C_P#&*`-FBL;_`(1SP]_T`M&_\%=C_P#&*/\`A'/#W_0"T;_P5V/_
M`,8H`V:X3XF?\B+XD_Z\!_Z56U=%_P`(YX>_Z`6C?^"NQ_\`C%<3\1=$T6U\
M%>()[;2-+MYX[$-'-!86D4L;?:;<;DDCB5T."1E2#@D=":`/C]NI^I_G24K=
M3]3_`#I*`"BBB@`KW+X%_P#(<US_`+!-M_Z7UX;7M'P5L;&_UG68[ZSM;U(]
M+MW1+NWAN$1S>[2R+,CA6*_*6`!(XSB@#ZANO^/:X_ZX3?\`HMJ_/5>@^@_E
M7WE<^'?#XM[@C0M'!$,I!&F60((1B""(,@@]#7P:O0?0?RH`6BBB@`HHHH`[
MCX:_\CWX;_Z_)_\`TWWE?;%?$7P\@@NO&OAZWN88KB"6[F$D,\:2Q2`6-VP#
MQR*R.`P#`,I`(!Z@5]HVFG:?I_F?8+"RLO-V^;]DM8+;S-F[9YGDQIOV[FV[
ML[=S8QDT`7****`"BBB@`HHHH`****`"BBB@#\0/^"D__*23_@A3_P!G6_M0
M?^L<_$&OV\C_`-7'_N+_`.@BOQ#_`."D_P#RDD_X(4_]G6_M0?\`K'/Q!K]O
M(_\`5Q_[B_\`H(H`?1110`4444`%%%%`!1110`4444`%%%%`!7"?$S_D1?$G
M_7@/_2JVKNZX3XF?\B+XD_Z\!_Z56U`'Q6W4_4_SI*5NI^I_G24`%%%%`!7N
M7P+_`.0YKG_8)MO_`$OKPVO<O@7_`,AS7/\`L$VW_I?0!]+W7_'M<?\`7";_
M`-%M7YZKT'T'\J_0JZ_X]KC_`*X3?^BVK\]5Z#Z#^5`"T444`%%%%`'<?#7_
M`)'OPW_U^3_^F^\K[8KXG^&O_(]^&_\`K\G_`/3?>5]L4`%%%%`!1110`444
M4`%%%1S2K!%),XD*1(\CB**6>0JBEF\N&%))I7P#MCB1Y)&PD:,Y"D`DHKYV
ME^-WCDRF]LOV9_C??^%E2:3^W1-\)M.U2:&.1E2[M_`FL_$_3O&OD/'B<65[
MI%AXA*!D703<F.WD][TR_BU73K'4X(;VWAU"TM[R*#4K"\TK4(8[F%)DBOM,
MU&&VO]/NXU<)<V5[;P75M,KPSQ)(C*`#\2_^"E4D<7_!2'_@A7)+(D4:_M6_
MM/EGD=8T7/['7Q!`R[D*,DA0"<EB%&20#^U\>JZ8(T']H6/"*.+VU(Z#N)L'
MZCBOQ0_X*51QR_\`!2'_`((5QRQI+&W[5O[3X9)$61&Q^QU\02,HX*G!`8$C
M(8!A@@$?M?'I6F&-#_9]CRBGBRM0.@["'`^@XH`?_:VF?]!"Q_\``RV_^.T?
MVMIG_00L?_`RV_\`CM']DZ9_T#['_P``[;_XU1_9.F?]`^Q_\`[;_P"-4`']
MK:9_T$+'_P`#+;_X[1_:VF?]!"Q_\#+;_P".T?V3IG_0/L?_``#MO_C5']DZ
M9_T#['_P#MO_`(U0`?VMIG_00L?_``,MO_CM']K:9_T$+'_P,MO_`([1_9.F
M?]`^Q_\``.V_^-4?V3IG_0/L?_`.V_\`C5`!_:VF?]!"Q_\``RV_^.T?VMIG
M_00L?_`RV_\`CM']DZ9_T#['_P``[;_XU1_9.F?]`^Q_\`[;_P"-4`']K:9_
MT$+'_P`#+;_X[1_:VF?]!"Q_\#+;_P".T?V3IG_0/L?_``#MO_C5']DZ9_T#
M['_P#MO_`(U0`?VMIG_00L?_``,MO_CM']K:9_T$+'_P,MO_`([1_9.F?]`^
MQ_\``.V_^-4?V3IG_0/L?_`.V_\`C5`!_:VF?]!"Q_\``RV_^.UQ'Q'U&PF\
M$^(8HKVTDD>Q`2..ZMW=C]IMSA460LQP"<*">*[?^R=,_P"@?8_^`=M_\:KB
M/B/IUA#X)\0RQ65I'(EB"DD=K;HZG[3;C*NL893@D94@\T`?&[=3]3_.DI6Z
MGZG^=)0`4444`%>V?!*YM[;6M::XGA@5M*MU5IIHX0S"]+%5,C(&(`R0"3CM
M7B=>V?!*VM[G6M:6X@AG5=*MV59H8Y@K&]*EE$BN%)!P2`#CO0!]'7.JZ8;>
M<#4+')AE`_TRUZE&`_Y:^IKX$7H/H/Y5]]W.E:8+><C3['(AE(_T.UZA&(_Y
M9>HKX$7H/H/Y4`+1110`4444`=K\.9(X?&_AV661(HTNYR\DKK&BC[!=C+.Y
M55R2`,D9)`')`K[3@N[6ZW_9KB"?9C?Y,T4VS=G;N\MVV[L'&[&<'&<&OBSX
M<QQS>-_#L4L:2QO=SAXY461&'V"[.&1PRM@@$9!P0".0#7VG!:6MKO\`LUO!
M!OQO\F&*'?MSMW>6B[MN3C=G&3C&30!8HHHH`****`"BBB@`I&^Z>=O!^;TX
MZ\\<=>:6D;@$\G@\#KT[9[^E`'X%?%_PIJGCS]L7QAI\/CKQUXX@\$_M&?#G
M6_!NM^!/@Y^UI\2--^#_`(]U^^_9AU/QA:>)?%W@WX=:U\"/!'B;X7_"3X::
MAX*\%V5AXG&E#0_VCOB#K?Q@/A3SO$T/C7]]5&`!Z9XZ`<G@<#@=!QR`#7X)
M_$_QQ8^&?VR_B%KFF_$C7?":V7[2_P`$/`VO?L]6G[8_Q3\(_&/XM:UXPL_A
M5IMG\2?AI^SII<9\`WW@#^SO$-D]YH(TC5C\2_"W@KQMK&O>.?"TFFR:=HW[
MV*<@'Z^_<]#_`'?[OMB@#\0?^"D__*23_@A3_P!G6_M0?^L<_$&OV\C_`-7'
M_N+_`.@BOQ#_`."D_P#RDD_X(4_]G6_M0?\`K'/Q!K]O(R!$A/01J3]`HH`?
M17PUIO[<.@Z[^V#J7[)WASX4?$7Q''X?T'4;GQ7\6M'D\*W/ACPIXHTVY\.K
M/H&N^$VU^+XA6>B+;>*-'5O';>&SX=?5+^TM+0WFEM=:]9\UJ/\`P4<^$EEX
MT_:+\'VG@OXD:[_PH(_LYZ5I6L:'9>&+C3_C=XT_:9^+OCWX`>`_!OPE^W>)
M=.:ZNX/C;\/]7^&>J^(?%S^%O"$6OQWMW;:[/X?T?4]9A`/T*HK\_;7]OC2]
M0U:X^%VF?!'XG:C^TUI?Q$U7X;^(/V=;?6OA:/$F@7>@_"[P9\:-4\7:AX\F
M\=1_#,>`9?AY\0_`UYHWB%?$HN=3\2>+M$\&S:1IVO)K<&B_0GASX\6WQ.^`
M&D?';X)^#]:^)*^)O#EIKGAGP)/J.@^!O$UW?/J*Z5K'A?6;KQ7?6^A>&O$G
MA?48-7TOQ%8ZGJ!CL=8T/4=,CGN)UA:4`]^HKYS_`&9OCKKO[0/@OQ'XNUOX
M5ZY\*SH7Q`\5^`K.SU;Q;X(\;6?B9O!EQ!H^O>(?#OB#P%JVKZ1=Z)9^+8O$
M/@YVGEMKMM=\*:VT,$VE_P!GZA??1E`!1110`4444`%%%%`!7"?$S_D1?$G_
M`%X#_P!*K:N[KA/B9_R(OB3_`*\!_P"E5M0!\5MU/U/\Z2E;J?J?YTE`!111
M0`5[E\"_^0YKG_8)MO\`TOKPVO<O@7_R'-<_[!-M_P"E]`'TO=?\>UQ_UPF_
M]%M7YZKT'T'\J_0JZ_X]KC_KA-_Z+:OSU7H/H/Y4`+1110`4444`=Q\-?^1[
M\-_]?D__`*;[ROMBOB?X:_\`(]^&_P#K\G_]-]Y7VQ0`4444`%%%%`!1110`
M5B^))&B\/ZY(MTUDT>CZHZWBWATYK5DL+AA<K?BQU,V30$"878TZ_-L4\_[%
M=^7]GDVJJ7]H+ZQO+(SW=L+NTN;4W%A<O9WL`N(9(3-9W<9$EM=1!_,M[A"'
M@F5)5.Y!0!_.5X1_:.U#QU\>?AEJTO[1W@>.]N_%7PV\-Q:)X>_;XU?7VNK*
M.[\,Z)?:;8:-JG_!+W0M5U=O%\EC_:&O^'(_B'X3T[Q3K>IWT9U?PW;W\=SI
MW]'XZ=<\GW[GCH.G3VZ9/6OP8\:^-WT3]LZ;X<WO[2.D?#5O!7Q)^#GA33_`
M'Q@_X*+?&+1?B#\2]+DT#P%-8^)M(^"?A+PW>^#7L_'+W%QI>G^%_$>O76I^
M.=>M=7UCQ0VD1>*ETZS_`'G'3KGD]\]SQ^'3';IVH`_#W_@I;-#;_P#!1_\`
MX(5S3RQPQ)^U;^T^7EFD2*-<_L=_$!1NDD947+$*,L,L0HR2`?VI37]#\M!_
M;.E`[%&1J5B<':.1^_(/MU!^E?BS_P`%*55_^"D7_!"I6564_M6_M095@&!Q
M^QU\02,@@@X."/0@$<U]/_M8_M,_$;X+?$71O"O@RQ\'OI=[X,TW79FUKP_/
MJ%T+ZZU76K*4)-;ZK81I!Y-A;[(C"S*_F-YA#A5`/+OB?^PGX@^*G[=&A?M,
MZM\=?!7A[P7X>\&7.FZ1KO@+P[8>!_VFM+NWU>&9/A_!\5]`U>WTJ^^&=UIT
MNHVU_J&K^';_`,5R:/,OA;]Y*+?Q;98?AO\`X)F>'O!6O?'>?2_VC]:^)'@C
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M0ZQJ_A;Q;XD^%^N>#?%OPF^&_P`([SX?ZB-?^+.I_&/6[O3;3X3^!_'(^)/B
M;XH:SXM\0>-+/7K;48;+PCKVGZ!X9^G_`()?!;Q;\`_AS8_!GP3\8/AU+\/]
M#^#NJ:=HVN:AX3>+XBW'[1OBWQ=XV\8>._BSK%[:>-1X2_X077=:\4V^MZ=\
M-]-\,6NHZ)JZ:HO_``F>H:9=65E8_!B?\%#OB[)JD^AQS?"*36[6S@U*ZT2/
M15DUJUTZZ?RK74;K1T\5MJ=MIUS)^[MM0GM([.XD(CAG=R%,=[_P43^+&FWN
MF:9J5U\'M.U+6Y9(-$TW4=)BT_4=:GA&9H-&T^\\6P7NKSQ`CS8=-@NI(]R[
MU7(R`?K'\!O!GAKX(?!/X2_!ZU\2Z)J<7PQ^''@KP(^K0W%G9C6;GPMX=T[1
MK[7);=[R>1+G7+ZTN=8NS-<7%P]U?327%Q/.\DS^L_V_H?\`T&=*_P#!E9?_
M`!^OQ8'[>_QS)'_$N^'&"1_S*-]_\T5?K)\$O$]]\0/A-X!\::_:Z8NL^)?#
M=AJNI+I]E]ELA=7(<R"VMY9;F2&+Y1M1YY6'.7-`'H?]OZ'_`-!G2O\`P967
M_P`?H_X2#0_^@SI7_@RLO_C]:'V6V_Y]X/\`OS'_`/$U^2__``4%_:;^/'[.
MGQB_9P'AO6M"^%?[/FN^)[\_$3XHZK\%M0^-?AB^FTCX3?M!^-O$_ACXIQ^%
M/%>E>-OA3X$\-:;X!\$>,V\>:%H%W;1Z=+XP\6>(_%7A[PG\+?$'A[QL`?JQ
M_;^A_P#09TK_`,&5E_\`'Z/[?T/_`*#.E?\`@RLO_C]?CYXA_P""D?A:]_;Q
M^$'PI\+_`!A^`>F_L]-IO[6/A+XCF_\`$'@R]\5ZYX_^!/A;P1K^H>*(=5'B
M07G@_P`'^"=<G\7^!(].N-%_M'QGKGAOQ[K(:/PYX<\/WNKTO@%^V=XC_:Q^
M,/[8'@GPW^T3\)/ASX%TCX#?LQ_'KX$:CX,L?A9X[\=?#'P+XO\`%OQ_T[Q_
MJ?Q%M]4UCQ!H^MZ[J_AGX8>!/%/B;0M3T>U3X0V?Q#TGPW>>=KZ#4;X`_9#^
MW]#_`.@SI7_@RLO_`(_1_;^A_P#09TK_`,&5E_\`'Z^5?V.;_P"+7BK]G;0/
M'OQ+\:Q^/O$'Q)&J?$'X>ZEXC\`^%O`FJ:5\-/%,,6H?"G2?&FB>!2NCCQ%+
MX7.E>(O%IL8K:33=5\07_AJ+[2-"AU"\\3_9H^,GQTO/VI?B5^S_`/&/7=)\
M26FB?"^+QS9:GK_P5O\`X#:IJWB_2O'I\(>,I?@9I%WK7B5?BI^S_I=OJ&@2
M2>,=0U2Z\2>#]7U[P?8:SKWBJ/QW9OH(!^BW]OZ'_P!!G2O_``967_Q^O#?V
ME/B]X(^%OP-^(_Q`\1ZBUUHGA;05U'4;?06L=4UB6`ZE86P6PT\WUM]JF\RX
MC_=^?'A-S;L@`_07V6V_Y]X/^_,?_P`37PM_P4O@@3]A7]I%DAA5AX"C(98D
M#`_\))H/1@N1U['T/4"NK`T88C&X/#U+^SKXK#T9\KM+DJU80ERNSL^63L[.
MSZ'%F6(J83+L?BJ7+[7#8/$UZ?,KQ]I2HSG#F5U>/-%75U=75UN?F.W_``5%
M_9F#,/L?Q6X8C_D2+#U_[&>F_P##T7]F;_GR^*W_`(1%C_\`-/7Y/_L:>'/A
MYXD^,EK!\2/#L>OZ1`NF)IC:WH/BG7_A_INN:CX@T^RBD^(=MX1DBU&VTK4=
M*.K:=X>NKUWT)?%<NEKK%K>0F*)=N\^'GPZ\/V'[6?AOQ)\.K+2?B#X'^&&B
M?$;PA>6'Q'U3Q)X-\'Z#K/C#X(1:%-X-74K33?$&O_\`"4Z%\0-1U`:UX^FE
MOM(T#4=*T%M$A\11:QJA_1Y\+9#"O+#NGF#E&.'DY1KTN5JO5A2O'F4925-S
MBZCBGRJ25N9PC4_(J7&O$]7"PQ:K95&$Y8F/++#5W*+P]"5>TN1RC%U8TZD:
M2<DI.+;:C&K*G^HW_#T7]F;&?L7Q7QZ_\(/8X_/_`(2>D_X>B_LS?\^7Q6_\
M(>Q_^:>OS:A^$/@O7-.D^%NA^!]#;Q!_PR-X$^/N@_%1]5U2QU_6?B/XJN/"
M=ZNDZGJFH:\G@VU^'6KZGXKF^$UEI\FD6HT;7=*@UQ]:?5H]4CEH?M+_``$T
MWX5_"3X0ZAHG@:[L;NR\<_%OP!XO^(DUP\TOQ*O]`MOA[>Z-XD2R75KZ#3O#
M]YJ.H>-[;P):V-E:3-X0TRPOM>9]6O)&J8<,\.RJT:'^W1J5ZCA!2Q%)7BJ+
MK*H]&TI\O)&%O:\[7-345*2TJ<8<60H5\1S99.GAZ<9U'#"UY6G*O##RI+WM
M94Y3YY33]CR1;C5<G&+_`$U_X>B_LS8S]B^*^/7_`(0>QQ^?_"3U]O?L-?MD
M_!O]H#QOXXT#P0_BG3[WP_X3TW6;Z3Q?H]CX?M)+2ZULV,:6DXUJ^^T7(G&7
MAV1[8RK[R6"U_-M#8?#B;X%^(==\1?#7PWX%@_X0S1](^$?C"Z\0:Y/\5_BI
M\:[/Q!H@\7ZG86DNK1Z1J_PHL]&D\4+X@2#PA8Z#X-,/A?1--\2:KXWEOA=_
MHS_P0L2.3XY?'0.B2*/A/X;*B1%?&?&KC.&!`..I'?Z"N7-.&LIPN59AC,/'
M&1K82T8>UK4YP<N>C&3_`':DI)*HXM<RE&HG&6L&GVY)QAGF,SK*L#BJF`J8
M?')SG[##U:=6,/9UI13]K)2@VZ:G%\C4Z4HSB[33/Z7KG7]#-O.!K&E$F&4`
M?VE9<DHP`_U_<\5\%KT'T'\J_0.YMK86UP?L\'^HE_Y8Q_\`/-O]FOS\7H/H
M/Y5^='ZR+1110`4444`=G\.YH;?QMX>GN)HH(8KN=I)II$BB0?8+L`O)(RHH
M+$*"S#+$`<D"OM&UU"QOO,^Q7MI=^5M\S[+<P7'E[\[-_DR/LW;6V[L;L'&<
M''QE\-U5_'/AQ7564WDX*L`RG_0+SJ""#Z].O-?:J111Y\N../.,[$5,XSC.
MT#.,G&>F30!)1110`4444`%%%%`!2$9!!Z$$=CU]CD?F"*6JU[<"TM+JZ,-Q
M<"WMYYS!:0O<W4PAB>4Q6UO&1)//($V0PH0\LK)&IW,*`/SXU[PGX'^&/[0.
MORZ=^WO+\$-4^*OQ%\-?$/6_V=H_^&/M*MO&/B'4;'PUX4(%OXV^%>H?&+49
M_'UAX7TO1+K4;3Q4^LWACCB\.WUC=06[)^B`^N>3Z>O3CTZ>O'/-?A)H&H^+
M[O\`::\2>//"7PS^(VA^%OB]\9O!/C;5=-^*?_!*7XC^)/%FAWR:=X-\(:I/
M/\?=3^.VCR:';R:=X9L9[7Q!=^"Y-*\!0PI<:?H<MAIS6<_[M#I^)[8[G_)]
M>N!TH`_$'_@I/_RDD_X(4_\`9UO[4'_K'/Q!K[A_:+\`>"O%/C72M0\1>&=*
MUF^B\+:?:1W5]%,\R6T>H:K*D"M'/$/+62:5P"I.Z1N<$`?#W_!2?_E))_P0
MI_[.M_:@_P#6.?B#7Z(?&S_D:=._[%ZR_P#2S4:`/PH_X*J?`+X>:C^R_J6I
MZ7\-_%,M[X9U/^U;74/`OPNLOC+X>TJXOY-,T`-\3/AC=WSZ[K/AV]M=4O(M
M`\1>#[237O!_BV'3GDU'0]+UV]O9/$O'?@/X3>)-(\%_`WQ]^Q]=_`#XE>-_
M#?PNO_C=\5/!W[//QY\9:'\*?!_@CXBWNJ>`?AW^SEJ?A'PM\3(/"'Q8U_1-
M)M=9O-''B_2_"?[+X\;ZK_PF7B'Q[\1-'T_2+S]X^A!!(*G*D$@@X(R",$'!
M(R#T)'0FG+)(B[4DD1<8VI(Z+CTVJP&/;%`'XRZ+\`;/3/B5X2T:_P#@5J\/
MQ?\`!?[>G[0WQ[^*_P`5K+X5>(G\->)?V4-?A^-FL:/8Z/\`$RWB;1_&-CXS
M^'WB/X._!OPA\*-)U_5?%VG^+O`T=G<>$-*M/!5OJ]>.?M*?!B_^(/CKQ_\`
M%'X;_!3QEI]M\0_A'^S-9?"_X3:[^S+XW\5:U^TIIFEW3?$C5=%E^*=_IJ:Q
M_P`$\?'?AR[\6Z_\-O&DFKR:)KNBW&GVWQ-\5V9N=.TB:T_?OMCL"6`[!B,%
M@.@8@`$]2``3@"@Y.[))WXWY)._!R-_]_!Y&[.#R.:`/.Y_@]\*Y+J>0>!/#
MK"2YFD#+;W&UM\SME0MT$V'.5V@+MQM&,"OT3^%6F:?HWPZ\'Z7I5I#8:=8Z
M%9V]G9VX98+:!`^V*)69V"+DX!8D>M?&*]1]1_.OMSX>?\B5X9_[!%K_`">@
M#LR<>OX`G^5?*/QX_8J_9T_:2\;_``Y^('Q;\"GQ!X@^'&IO>6PM]8UK2-*\
M9:2?"_CSPK#X,^)NCZ5>VNG?$/P+:VWQ'\4W]KX5\3V]]IL=_J%[`R/H>M^*
M-%U_R/\`X*(:MJVD_#_X?RZ3JNJ:5++XYN(I9=+U*^TV66,>&M5<1RR6-Q;O
M)&'4.(Y&9`X#[=R@C\=_%/Q<UGP7H&H^)_$7COQK:Z/I8LA=26VO>*=1O)9]
M2U.QT72["PTZSOY+O4-3U;6-3T[2=+L+9#->ZC?6MLA3S2Z`']">L_LN?L]Z
M_P#%#P-\9]4^$O@N;XE_#F'QO!X2\4PZ':6-W8I\1M/TW2_&#WMM8PVUAKEQ
MJUAI-E;"ZUVUU&YL$6<Z;+:->7AGRS^R'^S:NN?&'Q):?"3PMI&M_'KX4Z5\
M$_BIJ'A^TF\-S>)OAIHP\>+8^'4_L&33DT1L?$OQ?]LU?0%TO6]2^W:>=1U&
MZ/A[P\=+_F<\"?M=>)?B-\/?!OCKPOX6_:DU#4/&SS1:;\/X-&\0+XPMOLVF
MIJ]Q?7EYJ7BK2?`XT%K":W.G^(8?&#Z9K>I3CP]H[WOB&VU#2[+%?]NWPG+H
M,'B[2/&?QB\1^"[;P%X5^)_C'QAH:^))M#^&7@3QK/JUOX>U[XB)?^(M.UG2
M3,=`U^]U32=$TCQ)K7A_0]#U3Q%K6GV>A007]T`?U:>(/@?\-?%`^'D.LZ-J
M4^F_"^UUW3_"WAZV\4>+=-\)SZ7XC\`ZK\,M5T?Q?X2TS6K/PU\0M$D\':S?
M6-IHOCS2_$>EZ9J#6OB'3+2S\0Z?8:I;<O\`"?\`9?\`@S\%]?E\5>"-!\02
M>)!X4M?`.F:YXT^(/Q&^)FJ>&?`%E>V^I6_@+P9>_$?Q5XJG\&>"QJ%G87T_
MAKPP^EZ7?76F:/-J,%X^C:2;+^=/QY\=]?\``4F@V$^N?%'Q1XD\5WVJ6'A?
MPCX-UV_U/Q#KCZ#IDFM>(;Z`ZKXIT'0;#1/#^E(EYK&O:UKVEZ3:M>:58QW5
MQJ>LZ58WG2^'OB=XK\2:%I'B"T\2_$K3;;6=/MM1AT[Q+?>,O#/B+3UN8P[6
M.N^'=8N[;5=$U>S??;:AIE_!'<6ES%)&=Z!)9`#^HO.?_P!1'\Z^%/\`@IC_
M`,F*?M)?]B%'_P"I)H%4_P#@GMJNJ:M\*/%T^K:IJ>JSQ_$2\ACGU34;W4IX
MX1X:\..(4FOIYY$B#N[B)6$8=W<+N9B;G_!3'_DQ3]I+_L0H_P#U)-`KORK_
M`)&F6_\`8?@__4BF>7GG_(FS;_L6X[_U&JG\</@'XC>.?A5XKLO&GP[\4:OX
M2\2Z:\@M]2TB[EMVEAD(\VSO[<-]EU33IF6.2;3M1AN;*66&"9X#+!"\?2>'
M?CW\:_"4&MV_ASXI^--+C\2WMUJ7B1DU..]N?$6H7TMG/?7FO7VK6VH7^L37
MEQI]A<W/]H75Q'+<V5K=-']H@CE7R9_OM_O-_,TVOWMT*-36I1I3<HP4G.G"
M3:@^:*;DG=1DVXI_"VVK-L_F&&)Q%*,8T\16IQBYRC&G5J049348S:49))SC
M&*FU\2BD[I';7/Q*^(=YX._X5Y=^-_$]SX#%TU[_`,(=-J]R_AW[0^H3:L2=
M-+>2;<:M<W.K1Z><Z9#JMQ-JD-G'J$CW)J:#X[\9^%CX=/AKQ1K.@?\`"(7W
MB74_"O\`9-W]B_X1W4?&6GVND^+;[2!$@%G=>)=+L;+3]:FC^:_M;2VBFR(4
M(Y2BJ]E2LX^RI\LG*4H\D;2E.+C.35K-RBW&3>LHMIW39/MJUXR]K5YH1A"$
MO:2O&%.2G",7>\8PG&,X15E&45))-)GJ6J?&[XO:YX5M/`VL_$7Q-JO@_3_#
MVF>$K#P[J%Q976GV'A?151-(\.V+2V+7EGHVF+&HL;"VNXH+<[V10TLQD_77
M_@A3S\<OCH?^J3>&O_4V>OPXK]Q_^"%/_)<OCI_V2;PU_P"IL]>#Q+3IT\@S
M-4Z<*:E3IRDH1C%.3KTKR:BE=OJWJ?3\(5:M7BC)W5J5*KC5G&+J3E-QBL-6
MM%.3=HKHEHNB/Z<KK_CVN/\`KA-_Z+:OSU7H/H/Y5^@][(D5G=R2NL<<=M</
M)([!41$B=G=V8@*JJ"S,2``"20!7Y*+^T7^S\54CXX_"7!4$'_A8/A?D$`@C
M_B9=".17XK3HUJM_94:M7EMS>SISGRWVYN6+M>SM>U[/LS^AZN)P]#E5>O1H
M\]^7VM2%/FLTGR\[5[.4;VVNK[GLM%>-_P##17[/W_1<?A+_`.'`\+__`"RH
M_P"&BOV?O^BX_"7_`,.!X7_^65:_4\9_T"8K_P`)ZW_R'G^?9F/]HX#_`*#<
M)_X44?+^_P":/9**\;_X:*_9^_Z+C\)?_#@>%_\`Y94?\-%?L_?]%Q^$O_AP
M/"__`,LJ/J>,_P"@3%?^$];_`.0\_P`^S#^T<!_T&X3_`,**/E_?\T?3GPU_
MY'OPW_U^3_\`IOO*^V*_-CX-?&[X,^)OBAX.T'PY\6?AQK^N:EJ-U#IVCZ-X
MS\/ZEJ=_-'I6H7$D5G8VE_+<W,B6\,T[I%&[+#%)(1M1B/TGZ]*QJ4JM)J-6
MG4I2:NHU(2@VGI=*23:NFK[736Z9O2KT:\7.A5IUHI\KE2G&I%2LI<K<6TG:
M2=M[-=PHHHJ#4****`"BBB@`J.:&*XBD@GBCFAF1XI89462*6.12DD<D;@H\
M;H2KHP*LI*L""14E%`'SK)^R[\,#*8K>^^*>G>'V25&\#Z1\;_C%I'@+RY9&
MD-M%X1T[QQ;:39Z:"0G]B6$5IH1A!MSIGV=Y(G]]TW3=/T;3['2=)LK;3M+T
MRTM[#3]/LH4M[2RLK2%+>UM;:")5CA@@AC2**)%5$1550`*NT4`?AW_P4MGA
MMO\`@H__`,$*YKB:*"%/VK?VGM\LTB11)N_8[^("KND<JB[F95&2,L0!R0*_
M0SXQ7MG?>)=/FLKNVO(ET&SC:6UGBN(UD6[U!BA>)W4.`RDJ3N`8$C!%?GQ_
MP4G_`.4DG_!"G_LZW]J#_P!8Y^(-?HA\;./%.GYX_P"*>LO_`$LU&@#QZBOG
M.3]JOX,Q_'^+]FO^V/$,OQ'DT:[U%[RW\%>++GP!:ZS97UC:7/@2_P#B);Z3
M+X3L/'D-OJ5GJ<^AWFHPV]I;W$&FWNIVWB:ZM-`N*6A_MB?LX^)O!'Q9^)/A
MSXDVNO>!?@M\0;/X5^-?$VBZ'XBU;3[SQ_JFG^!K_0_#?@%-/TJYO?B?=>)I
M?B3X*T?PC<^`;37[#Q=X@UVVTGPS=ZJZM-0!],T5\S)^UM\'YH4MK.#XI:EX
MT'BWQ!X&O?@[I7P:^(NJ?'/1?$_A/PWH7C/Q/9>(/A-9:)-XFT:ST3P?XI\*
M^*9]?NT'AO4=%\5>%Y?#^L:U>>(M'L;SU32/B[\+]<^%VE_&S3_'OA@_"36?
M#%GXSL/B'?:BND^&#X8OP@M]6NKS58[*;3U\^06$]A?VUMJUMJZOH4^GIK:-
MIX`/1EZCZC^=?9'@+7-$M_!WAV"XUC2X)HM*MDDAFU"TBEC<!LH\;S*Z,.ZL
M`1W%?G?\'OBSX%^.WPR\$_&'X9:I>:U\/_B%I#Z]X3U;4-%U;P[>W^EQZKJ.
MC-<7.A:]:6&M:5+]OTF^B-GJEE:7T:QJT]M"S[!^DGP\_P"1*\,_]@BU_D]`
M'R'^VWX1O?BEX+\%Z9X1U3P_=7>F>+9]2NUGU>)%2U?0M1LU93;1W;%C--&,
M,J+@GYLX4_EKXS_9'^*?B;POK6@6DGPMEEU:UCM&MO&UO<>+O!]_:M=VTE_I
M?B;PY'#I\^J:+JUA'<Z9>I:7D%[:1W8U&Q,MY9P6\W[B_'?_`)`>A?\`88D_
M](+BOF.@#^?#X'_\$QOVH/AY^SYH/PM\8+^S]X^TK4)=,N/%7P.\9^._BC+\
M.O#=OINE:+;6^G^"?B%I=CK_`(EM3<^)-*O_`!MXETQ/#X\(:AJ.OSV'A6Q\
M(I8376MR>*O^"37QS\2?#K3_`(97GB_X8:G!XD^"VE_!+XJ>.I/&_P`4_#NK
M:WX9TW5?$3V-I=^`-%AN?!GQ3TSP7X5\2W?A;X3Q_$"^T;6O"TUO'JOBS6?&
M^GWEWX>7^@NB@#\3_B3_`,$]OCG\0O%'@CQMJ^B_LZ^([CX4>(_BMH/A/X<>
M+/%7CJ\^'?CGX-_$#1_".G:1;?$:1_!VL2V_Q"T#4O!VCZW)':^&?$_A"1K.
M2UMA%>7EMJ^D^Q?!K]B;XM?"WX5>`OAWJGBGPYXLU#P?X?BT>YUZ;6=21+LK
M>7MW#:6$>HP7^I1:)H5M=P^'/#<.IZAJ&J0^&]'TB'4KZZODN)G_`%.HH`[#
M]BKPM<_"_P"'/B71?%NJ>'[6_OO&]UJMND&K0NC6<F@Z%9JQ-PEJ^[SK28$!
M&7`!WDDJ.1_X*?\`B_PKIW[!/[3-]>>(=(BM;7X?QR3RI>PW!C0^)O#R!O)M
M6FG?YG48CB<\YQC)'U'\#/\`D6=5_P"P[+_Z;]/KXV_X+(_\HR?VP?\`LE\7
M_J7>&*]7(Z:JYWD]*3:C5S7+Z<FK72GBZ,6U=-72>ETU?HSQ>)*CH\/9[6BD
MY4LGS.I%.]G*&"K22=FG9M*]FG;9K<_BH?XR_##>W_%86'WF_P"775?4_P#4
M/IO_``N7X8?]#A8?^`NJ_P#ROKSS]A;X3?!SXT?'_1_!/QGUB.+2KQ;8^&_!
M]SXVL?AK;?$CQ#/KNFV5SX6D\?:EINJ6N@RV/ANXUOQ3:V")8:AXIN-#70--
MUG3)YV>;HQ^SM\*+'0?VR;37K?XW^&?B?\$/A[8>/?`'@#Q;%X(%MX?T"X\?
M_`WP]'JGQ`\;>%;F_P!$^(MWXATOXJWTG@\?#W3M'\*:CX?L=,^(,FMSP^(-
M*\/6W]-5,!E='$RPDJF/]K"&$D[*BXN.+KQP].4;TU*5.G.4?;5N548.7LU4
M=9.E'^0:..S>O@Z>-ITLN=&I+&07-.M&498'#?6JL)_O.2-2I2C/V%'G=>:7
MM'2A0M5?0?\`"Y?AA_T.%A_X"ZK_`/*^C_A<OPP_Z'"P_P#`75?_`)7UE_\`
M"B?@[KGPE\(WG@:[^'_B;QW%\)OAY\4/BSJ%M^T;K$GCCP#H][XFTJR^+&N7
M'P@3X>Q^!HM+^'&G:I!'K^@3_$V3QOX?T;[5XZU+PY_8]E(Z<K^U'\(/AKX/
ML;OQ3\$++P3J_P`-M#^*_B;X8ZGXX\$_M!Z[\;&75$MM2U?P7I7B>RUOX>^`
MK+1+WQ'X4T;4O$FD>(?!USXN\%>)9-/U[3-)\0O-H;QR*G@<LJ5H4%+,8RG4
MJTN:I]4C"+I\EG/5SBJW,E07)[2H[WIQ7*W57&9K1H5,1*.63A3I4*W+3^N3
MJ35;FYHTTDH3EAU"4L3)5/94E**564KJ/??\+E^&'_0X6'_@+JO_`,KZ_=[_
M`(()?$CP)KOQW^/,.E>)],N9+?X0^&9IED::S"1MXY>-6WWT-LC9<@;49G&0
M2H4YK^;77/A9\*8?V1/#GQC\,ZSXYUCXG?\`"^[#X9>.EU:QT[1?!&CV.K?"
M/7_']MH/A33HI=0UG7;S2KG2;,ZMXWU2\TJUU.6^ETK1O#5M9:=_:^I?MO\`
M\&R?/[2?[2^?^B%^#O\`U8\U>'Q=E6#7"V=XBC4Q?-AHPI.-90@G..+PT)/E
M]E&7*U/F@]+IIVM8^CX%S3'/C/AS#5Z6$Y,5*593H2G-J%3!8B<5S>UE!3C*
M+4X^]RN\7JG;^P[Q+XB\/MX=UX+KFCDG1=5``U.R))_L^YX`$^37^??&B%(Q
MM49CCYVCCY%YZ5_H4>)O^1<U[_L"ZM_Z;[FO\]E/N1_]<X_?^!>QXK\V\/\`
M;->U\']Z^L_TC]4\4OCR6W;,?_=#_@'VII/[*NC^(/V>_!?Q)\/:OXMU[QOX
MW\;^'/"]G)HGA_2-:^&.@ZIXJOM.T'3_``3XYUC3=<N/$?@76K+5KY#J'BGQ
M%H=KI+:A-:Z%9:9=V=]IOB*[Z'6/V0O#>E^-O#7A7[9\4$LY?%WQ3\&Z]J^K
MV?PJTC3M9OOAIX`UGQD)?#>M1^*=2TWX?ZQXAO-'-K;^`?C#;Z9XGTWPY?Z?
MXKN9YHO[1T[3_(/#W[4'C7PC\+E^'OA+0/!?A?7/MD:3_%#0="73O'-YX>@L
M-#M8-(O)8)QHUSJPE\.Z0MSXRFTJ3Q'?:386NE7=S)-'+JD\&N?M(ZOKLLRS
M_#'X/P:3KOCO6OB;\0?#:^&-:OM`^)GCS7]"UCP[J'B#Q-:ZMXGO[K29+?3_
M`!#X@N?#UEX(O?"UKX5UO6K[7M"6UU(6<EI]:Z6;\]1>U7LW/$^S?[MM0E%*
ME>W+90=_9J[E.5^=44U*'P_M<C5.C^YDZD:6#]K_`!%&52$KUTKJ>M1:57I&
M$;.BZ[4J=3!\7?!ZXM?B1X!\">%])UBPB^);^$+3P=J/B;Q/X$\8:;KTWB[Q
M*WA2UUG2/%WPT$OA35?#D.LEM.NGL99]1TZ_T[5K+4$CNX4MTU/BA\)?`_A_
MPMK'C#X<^)/%'B#2/!WQ>U;X*>+1XPT;0](NKCQ!:Z1JFLZ%XN\-Q:)>7:IX
M5\46WASQ-''H^KL^O:#/IEH+V]U%-4#6>%K7QIU'5$TJ'3_!O@OPQ#X/TS0]
M-^%X\/1^)HKGX5SZ/XYF^(E]K_A74=2\2:E?:EXG\5>);FZF\3ZWXRF\2R7=
MO,D.G6^E?9+)K=GQ'^-6M_$;3'T9_#'@SP9I>H>-=7^)GB:R\$Z?JUA;^+/B
M-KMC_9NH^+M735M;UL6KI927L&D>']#_`+*\,:"-6UE]*TB!]2E*=,(XWGH<
MWNQAS*I9Q:E&\7>:<JDW)PM"*C-\E53;E.ER2?%.67*&)Y;RG)1E2]V:E&5N
M7EIR4:4%&-5.;E.DG4P\H)0I5E.$?>?^";DMO:_MR_LY3W$D%O#'XOUPR33/
M'%'&&\`>,%!:1RJH"S!02PR6"]3@_P!JUCJ.GWZM]AO[.]\I8_-^R74%SY>\
M'9YGDN^S=M;;NQNVMC.#C^*__@FM_P`GT_LW_P#8X:[_`.J_\95_:XGW%_W5
M_D*_..//^1IA?^P&'_I^N?KGAC_R)<=_V-*G_J)A!U%%%?#GZ0%%%%`!1110
M`4444`%%%%`'X@?\%)_^4DG_``0I_P"SK?VH/_6.?B#7Z'_&WGQ1IXXY\.V7
M7D?\?FH]?;UK\\/^"D__`"DD_P""%/\`V=;^U!_ZQS\0:_1#XV?\C3IW_8O6
M7_I9J-`'XQ^(OV9?C[)_P4"TWX]>!H/!7P]^'+^#PWCSQKX0\<>,+*Y^+^A1
M>,]&NM3^#WQ/^"VIV=_X,UKQQXMT#2['29_BM;WMIH^DZ-HFA^-H(U\=Z);>
M%[O+\,_L_P#[07BK3?VT]%^)?P'\">%[#X]?&KP3^T+\*9=#_:DMVU#PAXO^
M&/P__9L\(>!=(@\0^"OA*-3\">+O#7B/X'W/C[P9X^TK1/$?A;0[R#PSH.M>
M%-5TB?7+4_J?10!^4]A\#/VS_AG;?%GQ1\,M/TG5?B+^U/\`%K0/$OQB\4:Q
M^T'X;?XG_"CX=?#3X1^$OAAX.3X?>+M;^#]C\*_$'QF\9G1=0O+_`,0Z3\-_
M#GPQ^#5@-%3P?X%\=:OH.F:A+]A_#G3OB)\)_`O@[P/X(_9O\#Z9X(^&WPG\
M!MX+\`_\+[T_4-2C^(&A^,Y8;_X<7OB36?`%WI%QI>D^%[/3O'R?&C4;K4-1
M\6>-]1U+3KSPU9:K"WBB\^E:*`/C;]@?X<?&'X+_`+,?PV^#/QJ\&>&O"GBG
MX8:?J.@17WA3XEV/Q+TCQ7;:KXM\5>+I-9AN[7PSX8N=#-J_B&'3'T[4K:ZN
MKJ:":^2X2!DC/[3?#S_D2O#/_8(M?Y/7Q&O4?4?SK[<^'G_(E>&?^P1:_P`G
MH`\^^.__`"`]"_[#$G_I!<5\QU].?'?_`)`>A?\`88D_](+BOF/G#'!(5=SD
M`D(I94#,1PJEV5-S8&]E7.Y@"`%%'].#[$]!03C!/`8!E)X#*QPK+GJ">`1D
M$Y`.10`44$$$@@@J2&!&"I'4$'D$=P<$4>GNH8>ZGHP]5.#AAP<'!X-`'U+\
M#/\`D6=5_P"P[+_Z;]/KXV_X+(_\HR?VP?\`LE\7_J7>&*^R?@9_R+.J_P#8
M=E_]-^GU\;?\%D?^49/[8/\`V2^+_P!2[PQ7L</?\C_(_P#L<99_ZFT#P>*O
M^28XB_[$>;?^H%<_@"^!/Q^^('[.?CV/QSX!?0;N9GM8=;\->+O#VD>*O"/B
MFQT_4(]5L+'7M$UFSNXW&G:K;V^J:7J6G2:?K6E7\`FT[4[83727'9Z'^U[\
M6M)?XC76I:7\(?'.J_%K3(/#_P`0M<^(WP;\%>+M8\0^$[*;P=<Z5X($TEM8
M66C>!=!G^'_@U_#7A#P_I^E:+X<B\/:=9:/;VFG0BSKY@D_UDG^^W_H1IE?U
M[/`X.K.56IA:$ZM2%*-2I*G%SG&E)3IISMS-0FHRCK\4*;WIPY?X:I9ECZ%*
MG1I8S$4Z-*=6=.E&K-4X2K0]G5<87Y4ZD'*$K+X9U%_R]J<WT)%^U!\7;3PJ
MGA72[[P?H;+X<T?P5+XRT#X;^!M&^)MYX$\/:U8>(-!\!ZA\1K+1$\3W_A#2
MM3TG1S#I=S=27%YIVC:3H>LZAJN@V$&F"[K/[57Q3UZ]T:YO].^$L>GZ1XKU
M[Q]=>%=,^"?PRTGP/XL\?^)?#FH>%=5\>>/O!FG^'X-`\:^*SHNJ7\.E7^LV
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M(%)(!*:9=N`2.0#MP2.1G-?YBR_M/:TD"R2>%=!CC2!9)))-5U*..-$B#O)(
M[J%CC106=W8*B@LS``FO].3QI_R*/BC_`+%W7?\`TTWE?Y<O[.^JMH7QG^&&
MM1V/@;5)M)\00:A;Z9\2O$NG^#/!6HW=MI.H-9V.L^,-7LM1T;PI/<79@7P[
MXDURQNM"T/Q;_P`(_J>MQ'2;:\(_./"C#8>MAN(ZM>@J\J"R^=.#J2IW?L\P
MDX\RE&,>9PBN:>D=W97/U3QJQ.)HXOA.C0Q#PT<3/-*=6:IQJV3J95!3Y'&4
MI<BG)\L+.6JWM;T6]_:-\5:;>W&FZCX'T[3]1M)H[>[T^^N=:M+^TN)HXIH;
M>ZLKB".ZM[B:&X@FB@FB266&>"6-&CFB9ZP_::UX]/"6BGAFP-2U0G:F-[8$
M9.U`REV^ZFY=Q&Y<_M5XB/B^S_X*A_!3Q%H>MZ=X_P!5DFT.Q^+MK\2[?X*>
M-?'G[-G@&/7;:T:[U+XI:--9Z(P^(&E7%U/HOB3Q!!)\5/"'@_4M6T.)/#FA
MZOX<O)OST_9<^%_QYTSX4?MJ?"F?X2V.GR:Y^SMXKT&\N;O2_`L/CW6/B0OB
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M^#/C/X#;5K;P[^S;XX^(6@ZGX3^(^C^//$/QX'QAO&U[P['/J'@N/2+_`$+P
M-H\5O\+_``0OAW7]5T.WG7QA\1/%EYHVF^,1=6>U^PKX>^'/P<\?^)_!_C[X
MH>`?A]\?=6/[0?PR^(.@^,=*\2Z]:^$/ACI7[/?Q!F.E>$?'7@S0/&'PVU'5
M_B%XRN;'4/%.IVOBV&ZA\)>!M.\%^%CJVM^.=0L9MYSRR&&Q^(655I3P=:I3
MI8=K&1JXBE2PV&Q,L0X^S<Z-'EQ"4I\DXP3I*4E5KPI+GI4,TJ8O*\.\YH1I
MX_#T:M;$IX"5'"UZV+Q6%CA%-5E3KXARP]XP]I2E-^V<8.CAZE9];_P2?^/.
MK^*_^"B7[*_A^X\.:39P:GXX\0P274%]J$LT(3X9^.[D-''*@B<EK<(0YQM8
MD<@5_?LGW%_W5_D*_P`Y#_@CG#';?\%,/V0K:&\AU"&V\=^(;>&_MXKN""_A
MM_A1\088KZ""_@M;^"&]C1;J&"^M;:^ABF2*\MK>Z2:"/_1O3[B_[J_R%?CW
MBOAJ&%SW`4\/3]G"64TYM7F[R>,QBNU-MIVBE;2UMKG[IX*8O$8OAW-)XFI[
M6<<[K03M#2*P&7.R<$HM7E)WUO>][#J***_+C]E"BBB@`HHHH`****`"BBB@
M#\.O^"EUQ!:_\%'O^"%D]S*D,,?[5O[3V^60[47=^QW\0$7)[;G95'N17Z&?
M&"^L[_Q)I\UC=0W<2Z#9QM)`X=!(MWJ#%"1T8*RMCT8?2OSY_P""D_\`RDD_
MX(4]?^3K?VH.A(_YLY^(/I^M?5W[5G[0GP2^%?Q"T?P[\2/BAX4\&Z[=>#=-
MU>WTO7KN]BO)M,N-5UNVAOD6"RND-O+<V=W$K&0,9()<H!@MI2HUJ\_9T*56
MM.S?)1ISJSLMWRPC*5E?5VLNIE6KT,-#VF(KT</3NE[2O5IT87;LESU)1C=O
M97N^@M%?,G_#9_[*7_1??AU_X,-3_P#E31_PV?\`LI?]%]^'7_@PU/\`^5-=
M/]FYE_T+L?\`^$>)_P#E1Q_VOE/_`$-<L_\`"_"?_+O-?>?3=%?,G_#9_P"R
ME_T7WX=?^##4_P#Y4T?\-G_LI?\`1??AU_X,-3_^5-']FYE_T+L?_P"$>)_^
M5!_:^4_]#7+/_"_"?_+O-?>?3B]1]1_.OL3P'X@T2V\'^';>XU2RBGATJV26
M)YE5XW`;*NIY!&>17Y0+^V?^REN7_B_OPZZC_F(:GZ_]@FOU:^"WB?P_XT^%
M7@/Q5X5UBSU_PYKWAO3]1T;6=.DDDL=2L)U?R;JU>1(I&AD"_*7B0\<J,5E6
MPF+P\5+$87$T(R?+&5:A5I1E*U^52J0BF[)NR=[)NUD;T,=@L5)PPN,PF)G&
M/-*.'Q-&O*,;I<THTIR:C=I<S25VE?5'%?&K5],U'1M%CL;ZVNY(]6=W2"0.
MR(;*X4,P'1=Q`R>YQ7\Z?_!2_P"+.I_"OXX_LT>))_B[XJL/"?A/6I?$^K_"
M#X5_&`?"+XR+):_"O]IJ]N_'O@O0==T2]\#?'^7Q';Z5I7A+2?AUX@O+QE\5
M^&M-^'FGZ!<ZI\;;.\MOZ/?CMQH>A]>=8?N3TL+GU/N:^0M;\)>%O$FH^$]7
M\0^'-$US5?`6O3>*O!&I:MIEI?WWA#Q-<:+JGAR?Q!X:NKF*271M8FT#6M6T
M>74+%H;A]/U"Y@+X*-'SG4?G-J/QAG\`_MR_M#V_B3]H+Q%XC\*6/[`%U\7=
M)^&&DMX5U6Y^&>NZ%\</B':2:1\.O@AHUP-5\5_%72_"6@Q/J&G>(X=6^(/C
M;5(K?0M472]`2QT:P^!M/^-/QV\*>![3X=ZM\3[^Q^*'Q2^"?[-VKZ#XH\'?
MM9ZU\;_!'Q3\7^(?CYX)TCQ?XT^.OQ:NM=D'_!/R\^*GA.2X\`:X?AU<:IX7
MT33/'OBB\^%7B7QSXJ^&?A;P[<_OG!\)OA1:^*AX[M?A5\+K;QT-3EUL>.;;
MX;>!K?QLNMSAQ-K2^,8?#\?B8:S,)'$VKC51J4H=Q)=,';.S8^"/!&EVNOV.
ME^"?!6EV/BR6:?Q98Z9X.\,Z=8^*Y[A&CN)O%5E9:5!:^)IKB-WCGEUZ'4))
MHW=)6=7<,`?#O[(OQGTI?!OQB\+_`!%\<Z9X/USPE\>/BEX$\,>'[CXU_P#"
M]M'T72?"WPB\'?%";0?@K\:_%<]]XK_:%L_"_@:]OOB?XJ2]T&7Q)\,]=U#Q
M=\/-=\'V&B>!+9;OG/V8/$]S:?M2>+/`VC_$W6/'OPW\0_LTZ/\`$CP==V_[
M2&H_M5:7X^GLOBK#H;_'+QYX@U2*P'P!^(OC3P]X@T2PTWX2>%M,3P#XWTE?
M$FO:+=QW?PVDTNU_0G3_``=X/TB'PW;Z3X0\(Z3;^#);N?P;;Z3X5\/:7;^#
MI]0M9[&_G\(0:?IMM#X5GO[&ZNK*_G\/IILM]975U:7;S6]S/')/HGA?POX9
M.IGPSX8\,>&3K5^^JZT?#7AS0_#O]LZK(&#ZIK!T73[`ZMJ;AW#:CJ/VJ]8/
M(#.?,?<`?5_P8UC2].\.ZE#?7]M:ROK4LB1S2JCM&;&Q4.`>JEE9<^JD5\9?
M\%B-=T:\_P""9_[7UO:ZG9SSR?#")8XHYE9W/_"7>&#A5'7_`.OZ9(^W_@9S
MX9U3DX&NS8&2!SI^GY.`<9.!D^P]*^-O^"R/'_!,G]L'!/\`R2^+N<?\C=X8
M'3..A/YU['#W_(_R/_L<99_ZFT#P>*?^29XB_P"Q'FW_`*@8@_SEI/\`62?[
M[?\`H1IE/D_UDG^^W_H1IE?V/'9>B_(_@T****8!7]*?_!L]J%CI_P"T?^TK
M)?74%HC_``,\'JCSN$5F'Q'F)52>IY'YC/'-?S65_2]_P;)9_P"&DOVE^2/^
M+%^#NA(Z_$><'ICJ"1]#7R/'G_)(9Y_V#T/_`%-PI]UX:?\`)=</?]A5?_U"
MQ1_8!XR\2^'V\)>)P-8L"3X=UW`\]23_`,2F\X&,_7\/7`K_`"GHP##&"`0T
M**RD`JRM$%96!R&5E)5E((8$@@@D5_J^^,QCPCXHP6'_`!3NN]&;_H$WA]?4
M`_6O\H*/_51?]<HO_1:U\!X-?P^(?\>5_P#I.8'Z7X]_Q.%O\&=?^E96/N0M
MZ[27R)?2,_F-)?(M[(TFQ8_,:2Z$SM)Y:)'YC,7\M$CSL15%8V5BP4-86#*J
M[45K&T940DL416A(1"Q+%5`4L2V-Q)-FBOVV[6B=EV/YZ:3;;5V]V]6_7N)M
M7Y?D3*`A#L7,89=K",X_=AE`5@FT%0%(*C%-$<001"*)8E`"Q"*,1*%(90L0
M41J$8!D"J`K`,N"`0^B@#]*O^"/=Q#;?\%+?V2+BYE2&&/Q]XD,DLC;44-\+
M/B"H+,>F695&>Y`[U_HRZ?JFG:BK"PO;>[\E8_-\B0/LW@[-V.F[:VW."<'T
MK_.?_P"".G_*3+]D7_L?_$HXXZ_"KXA@_I7^C>GW5ZG*C.23V]R:_G?Q?_Y'
M^7?]B>E_ZFXT_J/P+_Y)O-?^Q[6_]5V6CJ***_)S]M"BBB@`HHHH`****`"B
MBB@#\0/^"D__`"DD_P""%/\`V=;^U!_ZQS\0:^"_^"W3,/VK_`V"1_Q87PIT
M)'_,Z_$+T^@K[T_X*3_\I)/^"%/_`&=;^U!_ZQS\0:_._P#X+F>)?#FC_M;^
M!+75M>T?3+E_@!X3G2WU#4;2TF:%O&_Q$195CGE1VC9T=5<`J61P#E37UW!$
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M[N'M'"A&[K2<G/$0LJ2P1\&;:[\">)?%.A?$_P`)^(_$7@?P'X9^)7C?P5I%
MAK\D>@^%O$^M>'O#\4-KXZ:$^%=>\5:%J?BOP];^)_#%G]FDT^>]N['3]2UC
M4]%U:RMYOA/\$5^+-L+;3OB+HFC^*[Q_$HTOPS<^&_&.JVMK;^&-"GUV;5/'
M_C/2]/;PM\,=!UJ*TO;+P_K6OW5[;7-U97<^J)HVF0K?R96K_M*_L]R_"31?
MA=X8T[5?",,2^&]2\:SZ?\7/`\UA\3?%^CSHUUXB\9D^`8?$=Q8VEM-J=MX$
M\'V>OVWA?P%+=QZG:Z=JFL_;]3O]+X:?M:?!+X4ZQ<:]X3T>ZM;RQUSQ/=Z/
MI?\`POQAX1\7>&M6>]7PYX0^.?A<^'Y-/^)6F>%K*]FTZ[.D+X.M/%]C+<VV
ML:9:R3O>%RI9HZ%;DP^*]M[2;H7I89-14(<BJ?8Y)U+N-N:I&#C&4^9.<9A4
MR7ZSA_:8K!^P5*FL3RU,9:4W4;G*E9>T=2%+E4G)PI2J*4H4G&T)>#PS&00R
M*T@618I%#95@LBJX#+GY6`8!ER<-D9.*_MS_`.">1)_8E_9D).3_`,*C\+\G
M_KE/7\,47CGP0#&O_"8>&/E*+_R&M.4<8'`%QA1QP!PHXSQ7]RO_``3GN[6_
M_8<_9>O+&Y@O+2X^$'A:6WNK:5)[>>)HI]LD4L;,DB-@[75BI[&OEN/Z<X9;
M@G*G.">-2O*$HI_[/5:5VDF[=.B/MO"ZI3GFV8*%2$VLN;:C*,FE]9PRO9-M
M*Y[!\=_^0'H7_88D_P#2"XKYCKZ=^.P)T/0L`G_B<2=`3_RXW'I7S)L?^ZW_
M`'R?\*_*+KO_`%_37WG[>-HIVQ_[K?\`?)_PHV/_`'6_[Y/^%*Z[K^O^'7WB
MNNZ_K_AU]XVBG;'_`+K?]\G_``HV/_=;_OD_X477=?U_PZ^\+KNOZ_X=?>?4
M?P,_Y%G5?^P[+_Z;]/KX]_X+$VUS>?\`!-#]KVVL[:XN[F;X8Q)#;6D$UU<3
M-_PEOA@[8K>W22:5L`G;&C'`)(P"1]A_`T$>&=4!!!_MV7J,?\P_3_6O+/V]
MB5_9"^.Q4E2/!JX*DJ1_Q/=&Z$$$?@:]OAN//Q%D$;V4LZRJ-][<V.H*_P")
MXO$T5/AO/XWLI9)FJNM=\#7U\S_,^D\)^*_,D_XI;Q/]]O\`F7-;_O'_`*<*
M9_PB?BO_`*%;Q/\`^$YK?_R!7]"$EQ.&<^?/P6/,\@'!/5BV%'JQX49)X%?9
M&O\`[+`T7Q)\+_":>-O%&HZWXWT?Q-J>I06/@35C#>0^&K'QOJLVI?#?5;K5
M+;0/&&E7=OX4M+.RCO-8T?4;A-<TCQ*L2Z#JJ)IW]F8SZCESHQQ>+E3=:&)J
M4[8>K4O3P=!XC$SDZ2FH1I4ES.4^5.Z4;O0_BS"<.XG'*H\+>JJ4\-3G[U&F
MU/%UHX?#PBJE6#G*K5?*E!2LDY2LDV_Y)_\`A$_%?_0K>)__``G-;_\`D"C_
M`(1/Q7_T*WB?_P`)S6__`)`K^JW1OV>[[6_%/B30+67XJ*?#W@+3?'5KX=@\
M#Z-KWQ*\:V>HZ_;Z%(_@'PUX<\?ZEX?\1Z/I1N5U#5]<L_%DZ6-G:W\9L9+F
MW=(_,=7\"V?A_P"*NJ?#K6O&<MMI^CZY<Z/?>([/1=4U:\66"S6Y_L^'PMIU
MY/=R^*#?NGAB;0EU/[+9>*A/976LII]K-J0FC4R[$3J4Z.-=6I2PWUN<*>'K
M3DJ'+3ESQ4(R]JVJM/EA2YYS<N6$92C.,:J\-XNC"G4K)TX5:_U:$YRH0BZW
M-.+C)RK+V:3IU.:=3DIP24IRC%QE+^:#_A$_%?\`T*WB?_PG-;_^0*_I1_X-
MG]&UC3/VD/VE)-2T?5M-CD^!O@](Y-1TO4+".1Q\1IF9(WO+:%)'5?F9$9F"
M_,0!S6E\6?AY/\,M5\.6/]JZ_+_PDGA+3_%JZ1XIT.?PCXU\-Q:AJ&JZ?%I/
MB[PR=4U=-+U"=-+_`+8TQX=1N(=3\/ZEI6IHMO\`:6@3]'?^"04DC_%SXO;Y
M)'`^&^@$!W=P#_PECC(#$@''&:^7X[HT*O`V=XO#UW5I2PM"4'[.4.9?VAAH
M/2=I*S36L=;75TTSZO@'*ZF!XZR*%6356EBZJG!J$K.6!Q#2YH3E&]FGHW;9
MV:9^[?C,$^$?$X`))\.ZZ``,DG^R;S@`<DGL!UK_`"DH])U7RHO^)5JG^JB_
MYAE__P`\U_Z=J_U?-?\`^0'K'_8*U'_TBGK^*!6D(0>9)RB#_6/_`'1_M5\#
MX(X58BEQ(W-PY*F4[1YKWCF-_M1MHC]`\<<-]8J\,KGY.2&<?9O?FEE?FK62
M/YY?[)U7_H%:I_X++_\`^1J/[)U7_H%:I_X++_\`^1J_J=U#X'Q:-\%?#OQ;
MUKQJ]A-XFU*U&DZ(OAGQ'>:;?:1<PJS6MEXMMX/[#E\:6WE7UU<>'KJXLM/B
MCLY-'GUFW\0(UH;-E\#=,\27'P]M/!WCK5[^X\>0>+]?,/B'P-=Z%<Z+X`\#
MVE_/K7CJ2QT?Q7XMO-5L+JYTC6]+\/Z/9PQ:OX@U'1[J+3XS%+:33_LGM\LY
M9U'C:BITZV*P\ZKP.*]DJN"ISK8J/M>3V;5.G2K24U)TZGLY1IRG.,HK\5_U
M8Q_-"%H\\Z6&KQI^UPOM'2QE2E2P\O9O$\Z=2I5A'D<>>'/"52,(R3?\K/\`
M9.J_]`K5/_!9?_\`R-1_9.J_]`K5/_!9?_\`R-7]+OQ,\#_\*\UNRTDZIKEQ
M]LT*RUR6V\2^$-?\!>(]'%Y)=1_8-;\.ZS+>K'-Y=J+ZUOM'U?6](O\`3[JW
MDAODO$O;"TW/B'\)-3^''A/P!K^K:Y#<:OXQF\56>L^%X;:[AO/!.J>&4\+W
MC:+K%])</!=ZQ+I?B[2;G4K.U@A_L&]-QHUX\U_:W0@WC#!S^IVQCOF#FL'%
MX>K&5;V5*5>I)0E:5.$:4)R<ZJA"[I0YN>K3C/"608J/UKF>F!5-XMKV4HTO
M:U:=&"YHU7&<Y5:BBH4W.=E.?+R4JLH?EC_P1YT[48/^"E_[(TDVGZA#&OC[
MQ(6DFL+R*-!_PJOXA#+R20*B#)`!9@"2`.2!7^C&GW%_W5_D*_E&_8,9S^UW
M\#07<C_A)]6X+L0?^*,\4=020:_JZ7H/H/Y5_._C1AUA^(LLBI\_-DE*5^7E
ML_K^/C:UY=NY_1O@I0^K\.YG'FYN;.ZTKVM9_4,N5MWV%HHHK\>/V4****`"
MBBB@`HHHH`****`/PZ_X*7SQVW_!1[_@A9/*6$:?M6_M/;BD4LS?-^QW\0$&
M(X(Y96RS`?*C8'S-A06'X4?\''UY;WW[<?PVFMS(R+^S!X'C)EMKJU;<OQ&^
M*I.([R"WE*D,"&5"AR5W;E=5_=W_`(*3_P#*23_@A3_V=;^U!_ZQS\0:_"W_
M`(.2B3^W/\-<DG_C%WP-UY_YJ1\5S_,D_4U^C>%O_)5TO^P'&?E3/RKQE_Y(
MFO\`]C'+_P#TY,_GPHK[4_80^$/P9^-/QM@\(?&75(S9OIC3^$_!$_CO3?A;
M!\1]>9YEO]$;XA:OIFJ66BSZ#H27GBJTTH+IMYXFETUK.WUBSM[*^M[[ZI^'
M/[!/PYUS1+F#Q-X9^)OA_P`3ZI\3OC)X5_X1CXC?%CP%\/\`XN^%O!/P^\!:
M%XJ\*ZW\(/A?I'A;7M._;(\6:OJ%_J]EKEM\,=7M/#]Y)8Z#INAP:4?%":]I
MO]!XS.\%@:]7#U_:QG2ITJC?+349PJ1JR;I\]2#FJ<:4N>:CR.;C0IRJ8ENB
MOYAP/#V89CAZ.)PWL94ZU2M2BG*HY1G1E1ARU%3I5(QE4E7C[.#E[14U+$58
M4L*E7?Y!45^F/C']D#X?:%^RVWQ1L+/6)/&6C_LY?"GXT>(;B7XJZ)<?$32O
M&OC[Q1H6D:SX8\7?LK+X4B\7^`_@GINE:M/?^'_CGJ?B-[#5-/E\%>)Y+R[L
M_'ECX>L^!_9?_90TSXH>!_'OC_XB:/\`$273-3^&/[0]Q\"K+P9I^H1_\)+X
M_P#@E\)O$7Q%UOQ5KFI1Z%K%O+X"\+ZII?A_P(VC6S6NI>./''BW^PM*OK=?
M"7B$BEG.">'KXKFFJ>'KRPTDU!U)U(PC5?LX1G)M*E)U6I<LX4HSG4A!0E:)
M9!F,<7AL'R4W5Q6&ABH-2G[.%*<W27M9RII1;K)4(N//3J5ITZ=*=252*?PA
M%_K8O^NB?^A"O]'?_@E)KFGVO_!.7]C>"5KOS(_@3X.5A'IFJS("([H';+#8
MR1.,Y`:.1E.,@X()_P`XF($31!@582(&5@596#`,K*P!5E8%64@%2""`0:_T
MC?\`@DX3_P`.W_V-.?\`F@_@W_T5=?X#\J_.O%__`)$>6_\`8T7_`*BX@_5O
M`O\`Y*#-_P#L3R_]3<&?*_\`P6@^)_BSPE\'O@Y=_#_QEXN\'W]W\5[ZUO[K
MP]?>(/#-Q>62^!?$$ZVMQ<PK8&Y@6Y2&<6YDD42HDH3='N7\#?AW\4_VDOB3
MXW\-^!-(^/?Q/L=2\37TUE:W=[X[\:7,,+6^G7VIR[+'3;VXU/5+V6WL)H-+
MT72X)M4US5I;'1M-C>^O[<5^Q_\`P<1_$/\`X5W\`/V?-0.D_P!KC4/CCJ5C
MY/VW[%Y.WX:>*;GS=_V:YW_ZHILVK]\MNXP?Y1?#G[6EAH>M6.J:E\)](\7:
M?;&Y6\\-ZYXFU:RTW5(+JSN+-HI-0T.UL-8TNZM_M`O=+U;3+J.\TG5K6QU&
M%+@VIMIO$X-R/$8WANCB*.!HUI3GC53JSCA92YH5IQ6E:I!OEDK)3<8NUN91
MU/:X_P`_H9?Q;B,-6S"O0IPA@)5:,)XR$.2="C*?O8>G4Y>:+3<H1G-;J+DK
M'[5^+T^*GA?XQ>+/A?'^V#\>M9_L!+5=/TO0/"?QI\1?%G5=4N;^2TE\/?\`
M"L;?4-)47NE6,1\3:GJ]OXEDT2;PY=:=)H\NH:O<W&DV570=!_:<U;X@_&+P
M1>?M3^-;/3_A"WCW2W\86?C?QMJVB^-/&'@SP=XG\<VW@_PS;QZO:77]IZIX
M=\(:]J.KR7;A?!EOIUP-;BFNGL;6^^$_BU_P5+\.?%;Q[=Z[K/[/NN-X<TNQ
MFTOP!?Z=\=_%?ACXO^%[.Y\0ZMXDU!I_B7::'KT=]:ZK<ZU=Z:WAPZ"^D>']
M'M-*M_"4VBSP:A/J4-C_`,%=_B%;^/=9\87?P;^&NHZ1J=W\3]1LO"5YH_A?
M45T74_B?\/Y/A]JNH6WBS6O!>K>*-0NWT^#1;OQ!/J5Y/+XS;2[BQUIH[#6;
MZ%?6CPSGSHIK*L.JKPWO*L\ITQ"]FXNFZ4=937/&I&K&-.G-R<9SC&+EXDN*
M^'%7?-G.*=%8Q<OU?^V[O"MS4E5]M-6A3?)*G.A*=:K",>:%.4I*'UM\$O$G
M[1?QDA\;7=K^T!\>(X_`^@:'K]UX?\$S^/?BC\1O$$&OZ[;^'X1X4\`:+XDT
M>^U>QT6ZN8+KQ7JYU"&UT"QN=/>:.>74;=%X'X@_%O\`:&^'_CKQ=X&G_:&^
M).N3^$M?O]!FU?2?B%XK_L^_EL)`DDL"2ZF9K>2-B;:^L9V:?3-2@O=,G>2:
MSDD;Y!\$_P#!0S0_!FAZUX8L_@?K6GZ/XKT_P)<>*M3\%?&_6O`'CFZ\8^"9
M?$,LNM>'_&&D^"KU_#7@_P`1/KXEO_AA#I5]H.GWVC:#JNF:C%?:5:NGG7Q4
M_;@O?BO\1O&/Q'U/X;Z;HE]XPU<ZM<:5I.OSR65FRV=I81H+FZTLW>H7DT%C
M%<ZMJ]Z3>ZWK$^H:Q>A;J_F4=M+AK,GBJCJ93AXX5Q_=I_V:VI)4$M85'4=Y
M>W<N9\J2CO>R\ZKQ7EBP5!4LZQ4L:IKVTE+-4G!RK/:I!4DHQ6&2Y+R;Y^:R
MC>7]C'_!&KXF>)_%?[//Q'O_`!_XN\5^+]5M_C/J=I:7_B"[\0>);NWT]?`W
M@B9+.&\F2_,-LMS-<SK;"50LLTLIC!E#/]A?MW:YI]U^R1\<X(FN_,D\'*J"
M33-4@0G^W-'/S2SV,4*#C&9)%&2.:_.+_@WI\?\`_"P_V4/B]JHTO^R19_M#
MZQIWD?;#>^9L^&OPXN?.\S[/;;<_:`FS8WW-V[G`^^_^"H6LZEX?_8'_`&FM
M9TBY-IJ-A\/XY[2X$<4WE2_\)-X?CW>5.DD3_)(ZX=&'S'C/-?F-'!3CXE97
M@(TX4*DN*<DP\8/E4*<ZN-P48W]GS)1O--N/-I>R;T/VW#X^G4\,<7F$JE2O
M37"^;UY5'S.K4C3PF,D[>U<9.34;+G<>B;2/Y@2Q60L-N5DW#<JNN5?<-R,"
MKKD#<C`JZY5@5)!^F==_:.M]7\+^#?!4'PL\'V/A'1&>^\2^%H]3\6C0]<U8
MS^/UAD\-QKKS7/@"PM+7X@:K<VT6@2?:AJZ6:7D^H>'-&T?08/R>^&6N?M)_
M&?QE8^`_ABFI>+O%.I>=+#IVGZ-H:16UI"R+/J.JZA<V<.GZ/I<#RP0S:EJ=
MS:V:7%Q:VWFFXN8(I&MJ_P"U$D/Q$N)]!\:6D/PCAM)_BD]_X(MM/'P]6_U6
MRT2PB\7&^TNW&CW=]JVHV5E96$Y^WWCSBXM+:>RCFNH_[AQG!<,57IT,;C\H
M>)PCHUX8>698BA5I/&S>#PU:5&$:<KUJTG1P=6<>98KE6&E'$6:_C_"<:.A1
MG7PF`S?ZOB_:T)5XY=AZU*LL)"&+Q-&-6<ZD6J-%>VQ5.$DGAT_K$70DT?J7
M%\>8H=`?P%%X!L+3X9IHNF:-9>%])\8^*-'\0V?]F>)]>\8G4/\`A8=D%UJZ
MEU7Q!XDU.ZUC2YM,7P[<QQ:0MKHUC=Z+8WZX_B/XOZ?XO\7W?C7Q/\-O#.L:
MMJ>JW,FK1W&M^+%M;WPX/!^D>$-&T.-X]2%]::UH"Z2OB&U^(!N[GQ1J?B2Y
MEO\`6_M\(-K)^;-U<?M56/P_A^*EYH?B6V^'<]G9:E'XKE\/^'A8#2-3U271
M-,UZ:T$3:S:>&=3UJ&71],\4WFEV_AO4M53^S['5KBZ9(GY[Q;XT_:&\!'PX
MOC:+7_"4GB_PMIOC?PQ#XA\+Z;I5SK?A#6+K4+/2?$=E:76GQW7]E:G<:5J"
M6%Q/#`;I+5KB&-K:2":7+#\!8>5:;PN.RJ6(J5,7AJCH9QC95IXCEH2Q].?L
MY.<L6HTZ%3&2?^U<U.C6KRYX4YPTK\=U8T81Q."S:%"G3PN(IJOE."C2AA^:
MI'!5(^T2BL+S5*]/"J/^S6G5I45R3G!_I#\0/B"_CB/PCIUOHL.@:#X&\/W/
MAOP[I[:QJOB74Q97VN:EXCOY]7\2ZV5U'5KF;5=5NC:Q""QT[2;$0:?I>GVT
M*2M/^D7_``2-OK>P^+/Q;DN3*%?X<Z"B^3:W=TV1XK=CE+2"X=1C@,ZJI/`;
M@X_F[F\;?M"VW@BQ^)5S'KUM\/\`5/$]UX+TOQE<^&-,M_#NI^*['3#K-]H&
MFZA-IZ)J&H66F*UW>K9K/!:*##<SQ77[BOVW_P""!OQ"\7^,?CQ\>[/Q'J_]
MH6]G\(?#-S;1_8[&U\N:3QP\+ONM+:!WW1_+M=F4=0,\U\CXE\*5\N\..**U
M+$8">'P="FJL:&)K8BHJ[S;">WC.=2DY2K^WJRG6=:I[1S<I5&YMI_5^'?%6
M'S'Q`X:H5,/CZ>(Q=>3I2KX>A0INE'+,0Z,H1IU.6-'V-.,:/LJ?LU3C%4TH
M6M_33KWB/2VT36!NO03I>H@9TC60.;*<<DZ=@?C7\72\*G?Y$X/3[HK^V+7S
MC0]9YQ_Q*M2_](IZ_B;5TVI^\C^XG_+1/[@_VJ_&?`B_LN)_^OF3_P#I.9?\
M`_7O&G^+PY_U[S;_`-*RT^C--^/$.B?!/6_A5HG@NRTS5/$YN=/\1:_#K>N2
MZ)JNDW.F:39R:O/X-N+Z71QX\:;1[0+KRH+"S*/KFFZ=9^(;B2Y7'TSXXZMH
MWQ#\-^.]+T2VMH/#_P`.]*^%Q\.)JE_!;WGA*'P`_@#7[6'6+)+74M(N]?MK
MS5];CU#3U^U:-KFH_:[9KLV^;CPS>G_/2/\`[^)_\51O3_GI'_W\3_XJOV^.
M3Y?'ZS_LSE]<>)>)YZM>HZOUN%*G73<ZLG&,J=*G"$8.*HP3C15-3ES?CSS3
M'2^K_P"T<OU7ZO\`5U"G0@J;PLISH-*%.*E*,ZDISE/F=:4E*LZC46O;M;^+
M>FWT/A*WTCP8VEI\,=#T?2?A9-J7BB?Q1=>';FT\>7GC[6-5\2C4]#ATSQN=
M8O\`4+JQM=#N=*T?P]X?L_)-EI]RWVI;N+Q_\;?$/Q'\&^'/"FO:+X3@N=#\
M5^-O%UWX@T;POX=T/4=:U'QK)HT]V;A='TBQ-LRW&ES7.IS17,C>([N[M[K5
MD>;2+!U\6WI_STC_`._B?_%4;T_YZ1_]_$_^*JH95@(3H5(X:,JN&K5*]"K4
MG5K5:56M"I"K.-2K4G/][[:K.I%R<9UZL\3*+Q$Y57$LQQDX5J;Q#5/$4J=&
MM3IQITJ=2G2E3E2C*G2A"%Z?LJ4*<E'FA1A3H1DJ$8TU];_L)SQVO[6WP1GF
M+B./Q-JK,8XIIWY\&^)U&V*".69R6(&$C8@98X4$C^K.PU*UU`2"V,Y\D)O\
MZSO;3[X;;M^V6UOYGW3GR]VWC=MRN?Y4?V"V4_M>?`T!T)_X2?5N`ZDG_BC/
M%&>`2>G7VK^KT=!]!7\W^./_`"4F5?\`8BI?^K#,#]_\'+?V!F7_`&.:O_J!
ME_\`P/ZW6BBBOQ8_70HHHH`****`"BBB@`HHHH`_$#_@I/\`\I)/^"%/_9UO
M[4'_`*QS\0:_"S_@Y)_Y/G^&O_9KO@;_`-6/\5Z_=/\`X*3_`/*23_@A3_V=
M;^U!_P"L<_$&O@?_`(+>?LW>!_B]^U?X&\2^)-4\3V5]:?`3PIHL<6C7FFV]
MJUK;>-?B#>1R.EWI5[*9S+?2JS"54**@$8(+']+\)Z4ZW%U*$+<WU#&RU=E9
M*FV?EOC!3E5X,K0A;F>8X!J[LK*I*^OS/YAO@)^T'\0OV=/&+^+_``$WAV^^
MV6\=GKWA?QEX:T7Q=X/\36EL+J33HM:T/6[*\B,VD7MW)J.DZEISV&JV%R9X
M8;X6&H:G9WG=6?[:?[0T%]I^NZGXH\,^*_%_A^]UC4O`_CWQK\-?A_XH\=_"
MZ^UW:VHR_";Q)J'A\S?#FV6=%O-%T?P];PZ%X1OTCO\`P;I?AZ\19Q]I>%?^
M"=?@WQSK=IX:\'#XJ>)M?OA.UKI.BS:3?WLJ6T+SW$OE0^'2(H(8D+2SS-'`
MA,<9D$LL2/<T_P#X)M:#JMAK6JZ9I'QMU#3?#;W$7B&_M-,6:UT*6TB,]Y#K
M$J^$<:=<64`,]];70CN;"`&:]BMXAOK^D:^4X*5:I/$T<N=>4*,:LJSP[J^S
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M#NY<BYJE5U(^[=SJ-W;D_P`A8V9YT=V9W:96=W8N[NS[F=W8EG=V)9W8EG8E
MF)8DG_2-_P""3G_*-_\`8T_[(/X-_P#1=U7\94?[#7PF\R/&O^/OOK@_VGH9
M'WAC_F7^:_MU_P"">'A33O`W[$G[,GA'29KRXTWP_P#"/PQIEE-?R0RWLL%O
M'<!'N9((;>%Y3N.YHX(D/9!7YAXR8>I0R+*W-)*6:J*LT]?JF(?RLD?K/@AA
MZM'/\V=1+WLHDM'?7Z[A'^C/QI_X.</^3;?V:_\`LX#5?_55>+Z_D+^$/PWO
M/B]\3/!WPTT_6+#0+WQCJLNEVVJZC;S7T-M)!I>HZMY5MIEM-;76M:QJ*::^
ME>'/#]I=6EUXC\2W^CZ!;7=I/J<=S%_7G_P<XLH_9M_9KW,JY_:`U7&Y@N?^
M+5>+^!DC)]J_CF\(^(M/\,>(=/UK4?"WA#QWIUJ+V'4/"'C>WO;WPOK]EJ.F
MWNEW5CJ::1J>D:S:L(;U[K3M6T75=.UG0]7MM/UK2KR&^T^`GO\`#?VG^I6&
M5*7+5=3,E2ERQERU/K-90ERS<82M-Q?+.2B]I-)MGSGBPZ2X_P`4ZT5*BJ>5
M.M%RG!2I+"8;VD>>G&52'-"ZYH1E.-[QC)I)_HOXF_X)YP6/QF^-?@OPQXL^
M+7B7P/\`!:W\'+K]O9?`75H?C@/$OQ"UW5M&\(^"HOA]XD\2>$/"%^]YIWA[
MQ!XWNOB+#X\M?A]!X.TX1B\'BRZ@\/-Y)X!_8TE\9_$3XY^$K_XB2>&/#'P@
MC^+&D:)XKU[X>^)?#VM?$3XB?#CX:^-OBK:_#VU^'?BN?0O$WA36I?!_@+7M
M8\>?VX9'^'%E#9F\AUB;7O#::OWOQA_X*&WOQEU/XB>%?%?PFT;5?V>?'>B:
M1H#_``>O/B/XXL?$%M'X<^(VL_%7P_KES\6;>^U3Q'<ZSIOBWQ+XF@ATAM/E
M\"V?A?6IM"T3PMH]Q;VFL0XNF?\`!2?X^67Q,UWX@WEK\-M7TO59/BM/IO@'
M4O`7@;5M"\*W/Q4^%I^$UW+H'B/Q1X8\3^/@-*\.6'A7[0NI^)K]O&:^$M/T
MSQE+J>E7^IVLWM4EQ.\/-2=)5WA%&E[:I@TXUH4<-:4I4J%6,\36KK$*I"5.
MGA,/3E#EKXN;4J?SU:7!WUJFX*J\.L9>JJ-+&M2H3Q&)4HJ-;$4I4\+1PSPL
MJ=2-2IC,35A4Y\-@X>Y4\(_97^`VG?M)_%+0OASJ/Q.\,?"Z/7(BMC?ZU9:C
MKVMZ]JUQIFI7VE^'?!WAC2UB?6]3N9M/=]5O=2U30M!\-:(MSK>J:FSI8Z7J
M7S?;RB>WMK@#:+BVM[@+G.T3PI+MS@9V[]N<#.,X&<#ZJ^"7[0O@7X+_`!5\
M`_%VV^!^E:_XB\`:+HC6EDOQ7\6>&]'UKQ_:VOB&Q\2_$'5[.RT74UMT\5V6
MO)$/`6@+HWA/PM)IEN^@;(;B>U'SGXAO?#5YJ]W/X3T&3PGX=(MH])\.W?BB
MX\7W.EVUO9V]N89O$M_I^CW>K/+-%+<FXGTVT:,3BV6,QP)(_NT98IXS$.I"
MK'"NAAO8*;PCC&NI5_K"C[*K.N^>$\,TZJY$XR4.1W]I\Y7C@HX'"^QJT9XV
M.)QBQ/LUC>>>'E3PCPDI.M1AADJ<XXN+C1E[1^T@Y\ZM[/\`M0_X-G?^3./C
M9_V<UK?_`*JOX75^EO\`P5;_`.4>?[4W_9.HO_4I\.5^:/\`P;.D']C?XV$%
M6'_#36M\J0P_Y)7\+N,@D9]J_2[_`(*M_P#*//\`:F_[)U%_ZE/AROP/_F\N
M5?\`9:\._P#JPRX_J/+O^3+XO_LC,\_]0<<?Q^?L._$#PQX`^-]G<^,O'/AC
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MU*7-+](--^/'PJT[X4^)M=U/5?`&L?&CQ;^RIH7[+%K>Z-8_%RS\46%II6M^
M%]&T'4O$VBZQI!^&&CZ3X"\(^$M+U2;QYX5UO7-7\>3Z7X<M].\`>%M=N/%.
MH/Y[\>+CP1\3C^SY)?\`[3OP\\3:[X?^%4O@3XE^+KZ'XU>(=0@\6KX^^-'Q
M(G\1ZC/JWPTLM8\1:5JD7B;P[H(U6UENM53Q!JZ+<:7%HNGWNIV_Q!2Y)ZDG
M\:G#\)X3"8F.*PV.S"E6AB<1B(2<L'5]BJV">!IX:@JV"J1H8/"TFY8?#4U&
MG&?(IJI1ITZ4+K\48K%8=X;$X+`5:,L/A\/4BEBZ3J^QQD<;4Q%9T<93=;%X
MJK%1Q.(FW4G!RE!TZTZE67V'>>(-`US]CZQ\%:]\>/"&I>-M'^*>@?$'PY\/
M=4NOB??ZOX>\":/\)M?\*)X"TJ>3P#+X/TO6;?Q+K3S1:'I_B"+PY*;F]U5]
M<,\TKR?J'_P;S_\`)P7[0G_9&O"W_J>/7\_&3C&3CT[5_0/_`,&\_P#R<%^T
M)_V1KPM_ZGCU\/XMY?#+_"SCM4ZM2I'%0HXQQJ1H0C2G6S3+5.G25"C1_=WB
MFO:>TJ-N3E4DV?:^%6/GC_$W@ASI4Z;PM2IA%*$J\Y584LLQ_+4JNO6JOVEG
M9^S]G345%1IQ2L?U8^+/^17\1_\`8!UG_P!-MU7^;Q\-_!&N_$WQIX2^'WAR
MXM8=<\7:A#I&F2ZE-?+8Q7!LI[QY;A-.M=0U*XV6UI.T-AI6GZAJ^J7(@TO2
M-/OM4O;.TF_TA_%G_(K^(_\`L`ZS_P"FVZK_`#8O"6KZ=H.N:+K&K^'+3Q=I
ME@XEO?#=[J^M^'X=5ADLI;?RH]?\.7-IKNA7]L\R7^DZUI<QNM)U:TL;\6U]
M%;RV%U^-?19]M]1\0OJ_^\<F1?5_<IU+5_8Y[[)JG5JT*<VI\ON5*]"$_AG6
MI1;G']:^DRZ2Q_`7UC_=^?/?;KGG33H^UX?]K>=*E6J0]SF]^G1K5(_%"E4D
ME"7V'+^QI)J'[2D'[/7A?XY_#JZ\^72K:?Q5XJA\4>"]3T75=8%M!IWA35?A
MWK.FVWBR^\:ZI>W=J^CZ#X9AUJUN="O(?$6IZOHNG6.MOIGB_P`%OA7X0^+$
ME_9:U\6;CX=ZCI>D^)/%.IM>?#;Q%XM\/:-X)\*:%_;FL^+=>\2Z1XDTV/2K
M.V"MIR6":9?7]UJD^E6%BEY?:U8V9^I_%O[</@OQ7^TC\,OC=JOPQ\=:QHWP
M1N(+WX=:?>?$W3&\<ZU>-JD6LW4/Q&\:ZUX+\1-J/ANPN#<:=X5\,^'[/2XO
M#=@]S-;ZC/+J]_`GR+9?$;POX7\,_&KPCX(\+>(+/3?BOHOP^\,Z=J?B?Q-I
M>L>(?#7AWPGXPTOQMXCTR_NM&\,>']/UM/&&KZ%H<<IM+#1%L;+2[>&=-2<R
M.W]%Y=+BZO@E2QT,7@\74RW)(QQ"60U)4,;/'8FAF]>H_95*5:I3P57"9A4H
M+!4:-J,\#A9/$1J5L1_/^/CPI1QGM,%+"XK"T\PSF4Z$GG=.-?!PP>%KY50I
M?O*=6C3GC*6*P$*[Q=6M>M#&8J*H.%'#]'#\"K34?A]XH\6>'OBWX1\1^*_`
MOPRT3XP>-_A[IFF>)BWA[P1KFO\`ASPZ;<>/FC?PAJ7COP_>^+_#7_"5>![=
MH9=)FU"ZTBRUG6/$&C:GI4-SX5_LZZA\2]"\)ZK=_$+P]X(O_B?\1=4^$OP>
MT77=,\1ZG)\0?B!HVFZ%>ZAI]UJFBQ2V'@?P^FH^*_"/A6'Q5KHN[6;Q3XDM
M+,V$6F6&L:Q87->^,_PPF^!MC\(O!?PZ\?\`@6\FM-$U'QSK%C\0_"NH:9\5
M/'FD3&:#Q+X_AF^&T'BR_P##FBM/>?\`"#?#K3O%FG>%_!\\RZN(=7\2/=Z[
M<[_@S]I'P+X)F\.06GPAU?5=%^$/QEUWXV?L]Z?JWQ+$EUX.UW7+3PL9?#?Q
M,U&W\%Q'XE^%H_$/@;PAXM*Z/;^`M8EU/2K[3/MZ:/KEW%;;U9\4O!XOV%#%
M_6)8_%/#>UCD7UFE@J6#C'#0C:LL&XXG,W"I&-;VU>EE/UE5<9_:*PYC2I\,
MK%X1UJ^%="."PL<2J<LZ>'J8RIBN;$3DW2>,YL/EJE"4J/L:%3-5AG2PKP#K
MGIO_``2RBNK;_@H?^S+:W<=Q;W5KX]\3VMW:W!99K:ZMOAYX\M[JUG3<P6:V
MN(I()D!8++&ZACMS7]YB?<7_`'5_D*_@U_X);W=UJ'_!13]FG4+Z=KJ^U#XA
M>*]0OKIU57N;Z_\`A_X^O+VY=4`1&N+J>:=D0!%:0J@"@`?WE)]Q?]U?Y"OY
M%^E)?_77(.914O\`53#<RC?EYO[6S>_+>SM>]KI.VY_5?T:+?ZGYYR\W+_K/
MB;<UN:W]DY/:]KJ_>SMVT'4445_,Q_1P4444`%%%%`!1110`4444`?AW_P`%
M+9D@_P""C_\`P0KE<2LB?M6_M/9$,$US*=W['?Q`4;8;>.69^2"=D;;5RS85
M6(^<O^"M?B;0(?VD/""7FKV.F2GX-^'&6#69UT6Z=#XK\:`2I:ZM]BN7A9@R
MK.D30LZ2(KEXY%7Z2_X*3_\`*23_`((4_P#9UO[4'_K'/Q!K\I_^"_2JW[9?
MP_W*I_XQS\'=5!_YGWXE\<CI[5^T^`>71S3Q!H82=65%2RG,I\\8*;O"-*RY
M7**UOJ[Z=C\>\<<QGE?`M;%PI1K..9Y=#DE)P5IU):W2;NFEI;74Z;]DKXH>
M!O#_`,1Y[?5/B3\+-&TW7+"WLKW3_&WB&\TO2M?AL9KC5(K>U\6^&]1BG\+:
MMIMW;VVH6LNI"32-8M_MFG7"27J:;#+Z/X)^*_P0T+XF3>,K;X]>"-=\$Z=K
M7B:;3;SQ[\3O%H^)GP_?5/"R:7JGB[X?:/?`Z7\3M8\0RS&UT6Z\2:#=WFJ6
MVB:(GCC2M%G>:Z3^<[RX^1Y<9!Z@HI!YSR",'D`\]P#2[5Y^5>>3P.2>I/'.
M:_L?&>%.#QF)QN)GG..I?7L)3P=:E2H4(P]G%3A.=]9NI*G)04W*_*I4:SKX
M2?U6/\EX3Q2QF$P^#PZR?!5/J6*GBZ56I7KRGSN5.I"#6D%3C4ASN"BESN-6
ME['$Q^L/^BW7?C!\"=1^%FIZ-;_$3X3+>GX$_#?X9^&O&K^/+B/XO:S?Z%JG
MA2[N/`/C?X?B&3PGH'@;1YX=0LKCQ/I\4>JP>'O"?A_4;?Q;XHOM3OK"XE^"
M_P`9?@OX'/@.X\;_`!*^%&J0?`3QU\5;O2W\/_%FYLW\3Z7XCMXGO#:^##X9
M:/XE6GB^\@.G>%M4T[7O#:II5Q]C^(=I%X>L;2&X_G-V)C&U<#H-HQ^6*-B<
MC:N#R1M')]3QS6,O"/`3PM;!RSG,'2KUJM:3Y(*I"5;!_4*GLIJ:=-2PLZ\/
M9P4<.I59<E"-&]%ZQ\5\?#$T<5')\`JE"E3I13G-TY1I8J.-I^T@X-5''$PI
M252;EB)1IQ<Z\JMJJ_46'Q5X5!A_XJ7PV@'ECRUU_26$8&W]VI%V-RIC8IP,
M@`X&<5_6I^Q%X@TQ_P!DSX`/`U]>0M\,_#YCN;#2=6U"SF79-B2WO+*QN+6X
MB;^&6":2-ARK$5_GSI'&'0[$^\O\*^H]J_OP_P""98`_8%_9/`&`/@QX4``Z
M`>7<<5^-_2.X=IY1POD>(CBIUW5SY4G&5-023R_&3;NIR;=XV]-3]=^C]Q#4
MSCB3.:$\-"@J61RJJ4*CFW;'X*'+9QBDO?;OY6M8^6_^"O<UAJ_PF^$D36,\
M_D_$^]E"ZEH5[#&I/@O74W1'5+".,O\`,`1$3)M)R-H:OPT\#^&O`^I>*]$L
MO&R6>B>%)KBX.MZK%IMI;_8K6'3[RXBDGO8]$U=]+LI;Z&TM=1UE=)U0Z'IU
MQ=:S_9UZ+`VTGZJ_\'!FI:EIGP$^`4NFZC?Z=))\;=1CDDL+RYLY)(Q\./%#
MB.1[:6)G0.H<(Q*A@&QD`U_++X;^*'Q)\'ZYIOB;POX\\6:)K^D3/<:;JEIK
M5W+-:RRV\UI,#;WSW=A>6]S:7-Q:7EAJ%G>:=?V=Q<65_:7-I/-`_M>"W"F)
MS?PUP6)H8RGAYUJV<TZ5XRC*%18RO"$E64:OLVI6DI^PK*#M+V57EY)>/XP<
M48;*?$/&8;$8.=>%&EE%2I*+A)2IO"8:I.'LI.ESW@VG#V])3UC[6G?F7[W_
M`!(^"GPU\+_%Z_\`"V@?`76?%$WBDP0?#7PAH7C?1=0\%ZVUCK&HV/B_6K/Q
MMH6E-XAL[#0+:SMK.XT76XX)/"NL-K>J^,=2AT*QT^TN^.L?`?P+TSQ/\:K8
M>!M-^('PX^&4FOZIIWCE?$.JZ1JVLV=UJ%GX8\">'-,30;6V\/:A/K'BV^BA
M'B-M/$5[H%EK&OQ68ACL[4?F1JW[>'[3.M>(O'7B&_\`&6A70^(6F6>@ZWX>
MU#P#X+UCPI9>&[+4KG6D\,^&]!U?1;VV\.Z%>:S>7&KZY9:8T+>*-1:*Y\3S
M:PUI9BW\2N_C=\4+NP\;:2OBF?3=(^(6K^&M<\4:3H=I9:%I<U]X0GU.Y\/)
MI-CI<%M#X<T^PN-8U"9M*T`:=IMY),C7MM<&WM_*^UP/AMQ*Z$*6/S7#4Y1P
M^"HRGALRS>K*I+VN#^N5G*I[.=+$4<+#$T\.Z4YPQ.)E*OBI2A6I4L!\;C?$
M7AQ5IU,#E6(G%XC&5HQQ&7Y53C"/L\3]4I*,/:0JT*N(EAYUU4IPEA\.E1PJ
M4J-6KCOU:\!>#/`$7@7XD_$GQAX1M_%EGX&O/`>@V7A>RNX_#$-_JOC:\\0M
M<:CJ>LZ?IMYJ-M9Z3I/A74DL[2V2-KC6M3TQKV5[*UGM+S,^+OPTT'X>_$KQ
M=X.TNSM[[2M'U"T;2;F^TG3!J!TG6=&TOQ%I<&I^391PG5++3]8MK#4VABBA
MDO[6XEBAACD6&/\`-W0/VF_C;X9O+6ZTKQA`(K?P1H/P\N-(U'PQX4UKPWK7
MA?POJ/\`;'A^/Q/X9UC1;[0O%&N:9JXCU2#Q;KUA?^*WOX()KC69UC\MO.M?
M^)/Q#\4ZYK'B;Q%XY\6ZQK_B#4[[6=:U:^U_4GO-2U34KA[J]O;ADN(X_-GG
MD=RD,<4$2E8;>*&"..)/8P_`&<K,*]>OF6$CA)TVJ=&$\36M)PP$::]C.G2I
M4O8SH8ZHZM.3G7^NQA436&I6\NOQYD[P%"A0RW$/%0G%U*LX8:E>*GC)5'[6
M$ZM6K[6-;!P5.HE"C]2E*F^;$5.;^S'_`()&W%CI/P&^(,`LKB#S/B]J$VW3
M="OI8CGP9X/3<[:7I\D(D^3!#D2A0I(V%"?5/^"JFK6MS_P3X_:DACBU-7?X
M=Q`&XT76;6('_A*/#GWY[JPA@C'N\BCWKY`_X(`:CJ.I?LK_`!:FU+4+[49D
M_:"U>))K^[N+R5(A\./ATXC22YDE=8PS,P16"AF9L98D_:7_``5;_P"4>?[4
MW_9.HO\`U*?#E?QWG&$E@/'C#8.4U4E0X[X=@YQBXJ3^O98[J+;:6MK79_6.
M58N..\$L1BXP=.-?@K/9J#:;C?!9A9-I).WHC^#1_OM_O-_,TVG/]]O]YOYF
MFU_H]'9>B_(_SW"BBBF`5^_O_!OC>16?Q_\`V@I)DNG5O@WX64"UL;V^<$>.
MW/S1V-O<2(O/#.JJ3D`D@BOP"K^@?_@WG_Y."_:$_P"R->%O_4\>ORWQK_Y-
M;QA_V`X3_P!6N7GZ9X.?\G-X1_[#L3_ZK,<?U,^*]<LCX8\1`0:QDZ#K(Y\.
M^(%'_(-NNI;3`!]20*_S7(_]5%_URB_]%K7^EWXL_P"17\1_]@'6?_3;=5_F
MB1_ZJ+_KE%_Z+6OQ'Z)_\+CK_KYPY_Z3G9^Q?2B_C\$_]>^(_P#TK(1]%%%?
MV`?RB%%%%`'W_P#\$LIDM_\`@H'^S!,XE9$\:Z^6$,$US*<_#CQPHV06\<LT
MAR02(XV(7+$!58C^\NQOX+U6\E+Q/+6/=]KT[4+#.X''E_;K6V\W&T[O*W[,
MKOV[ES_!S_P2K_Y2$?LO?]CMX@_]5MXYK^])/N+_`+J_R%?PC]*;_DM\B_[)
M7#_^K?-S^V?HS?\`)'9W_P!E/B?_`%4Y..HHHK^93^CPHHHH`****`"BBB@`
MHHHH`_$#_@I/_P`I)/\`@A3_`-G6_M0?^L<_$&ORH_X+\_\`)Y?P_P#^S<_!
MW_J>_$NOU7_X*3_\I)/^"%/_`&=;^U!_ZQS\0:_*C_@OS_R>7\/_`/LW/P=_
MZGOQ+K][^C=_R<S#_P#8FS7_`-)H'X;](;_DW.(_[&V5_P#IV9^7G[.G[/\`
MK'[0OC*^\.6?B32?!VAZ!IL&K^*O%>KV&NZU%HUA?7G]E:6;?0O#6G:GK&J3
M7VL26]I(R0VNG:;:M/?ZGJ5HJ6D%]UWA+]DWQ!XO'A&QTWXH_"B?Q+\5-?\`
M'?AOX&:#I6H>*/$-K\:[_P"'45O_`&Y=>$_%&E^&6T+0M)U34KA?#OA&]\:2
M:'-KWB.*ZTNZLM$2UFO%QOV5?C/X6^!'Q7TSQYXITCQQ=VUI%+%:ZY\-O'%]
MX)\:>&Y'M+Z&:73]D-WH7B73=76YBL=8\/\`B2S:U`AL=8TZ\L]0TI8K_P"@
M/"O[?-YX8\0Z]X[L?"'B;1O%8\<>*/B!X*\.:'XK\'2_#;1_$7B/P;H?A4:I
MJD6K_#>?QUI>K2W^AP^+?B+>_##Q/X$L/C5KTTL?C#2-+T]Y89_[3SJOQI#,
MLQADV&57!1P.%G@9U99=1HO&.EC(RH\U58C$5%4Q;PD\55G&C&&#I3PU&E@Z
MM>&</^/\GH\'RR[`3S?$.EC)8[$T\;"G''UJJPBJX*4:W+3=##TW3POUJ&&I
M0=:4\55AB:M3%TZ,\I/`-:_9D\2:'\,8/B+=>+?#LMV_PJ\(_&NX\(Q:+XV1
MK?X=^-]9T[0]"N(OB!/X=C^&NI^,!=ZK9MJGP^TWQ)/XATW;J5@QN-=T/6=(
MLLSX7_L_7?Q5M/#]KH_Q*^'>E^._'-WXNL/AW\,M2G\0WGB?Q7=^"]-GU/48
M]2U#1-&U+P[\/AK*VE]9>#G\<ZCI:^*+NQNIHOL&CK%K$OLNL?M@:;K?PGUG
MX97GACQ^=%\0?#;P+\-7^&:^.M!_X9^\$S>$;[PS=7WQ7^&?P^;P@=6\/?%W
M6Y-$UO68]<N]9N/L/BWQWXQUC5-4\3:=J":(O)>#?C%\!O`?A3Q[I7A'P+\:
M?"_C'QGJ/C+28_B/I_C#X::QXKTGX4:VUU9:5\.M)O-6\(6\7AJYU+0)H],^
M*/C+PS96?B+QM!+?Z+I%YX7\)W=YH5^X8GB[ZABXU\+6IX^>8S6"J48Y96HT
M\).A2]FL5%R@XX>CBIU%5C2IXG%UJ%&5&EBU.O3Q]"9X;A7Z]A'0Q-&I@(8"
M'UVG5EF-*M4Q<:\^=X:7+)/$5L-&'LI59X?!TJ]6%2KA'&C4P-;Y$@D698)H
MR3',L4J$C!*2JKH2#T)5AD'H>*_OP_X)F?\`)@O[)_\`V1CPI_Z+N*_@1C&#
M&,*,;!A!M08P,(O\*#&%7LN!VK^^[_@F9_R8+^R?_P!D8\*?^B[BOQGZ4_\`
MR2'#W_91K_U6XX_7_HR_\E7GW_9/3_\`5EEY^;'_``<-?\D!_9__`.RX:C_Z
MK7Q37\K/A/PIK_CGQ'I?A/PO91ZAKNLR74=C;3WUAI=HJ6&GWFKZC>ZAJNJW
M-GI>DZ5I6D:=J&K:OJNI7=M8:9I=A>7]W/'!;R,/ZIO^#AK_`)(#^S__`-EP
MU'_U6OBFOY</AKXGL_!GCOPWXJOKWQKID&AWL]XNJ_#G5].T/QSI%TVG7MM8
MZOX9U#6+:ZTAM1TN^N+>];3-6B33->LX+O0-0N["TU.:^M_J/`&5>'A'@)X6
M,9XF-;/I8>$TY0E7CC,2Z,9QC*$I0E445*,9PDXMI3BVI+YOQTC1GXJ8Z&)E
M*&'E2R..(E"2C.-"6!PBK2A*4*D8S5-R<92A.*DDW"233]L\3?LB_$GPGXI\
M:Z#K'BGX/6?ASP'#HD^M_%2\^*/A^W^%R_\`"3:SJ/A[PYIZ^(+;^T=1MO$6
ML:UHVN6</A>_T6VUZSMM#U;7-6L]/\.6C:PV9I/[*'Q=U3Q1J7@.X_X0#P[\
M0K7QMK7PXT7X>>*?B/X7T?QMXZ\<Z!IMKJ]_X>\`:(MS>'Q%)-IVH:7-HFKS
M7.E>&_$TNK:99^&];U:]NUMT^LOBQ^UC\"/'/Q2^)C6MCJJ>!/&^D:5!XJ\4
M7_P'^%_BVU^+_BGPYXWU/Q%X4\8^+/A+/XE\"6NC^(/`?A;6;OP?X%\;6GBK
M_A)]3`OE^)VG>)O#NKR:5;<_HW[8'PWN?C_XZ_:-UH?$[PYK7C'QI>W/BWX<
M:7X3^%WC+0OBC\+;+P]I_A7POX$N/&6I3>&M;^$WB"[\.VE]HWC;Q;X2L=31
M_P"V9-7\&PZ+<:;9Z6_UE#...9X*52IEE*&(_LKVU.,\#BE+^T%0R]X6A5A"
M7-_MN(EFKK\D%]6H4LOI8VEDU6OBJV%^4K93P7'%QIT\RJRH?VG[&HXXW"M+
M`NMC5BJU.I*"B_J6'66JASSMB:U3'U,'4S>G0P]/$_$7P]^&6I_$6T\3ZG:^
M)/`_A+1O"%KH%QK>N>/]>OM`TN.3Q1JDVD:%I]HVG:'K]_>ZG?7EM=$6D6G@
M06UK<7-Q-%'$<\-J=E'IVI7^GQ:GI&M16-Y<6D>L:!=RW^AZHD$C1KJ&CWT]
MK8S7FF784365S+9VLD\#I(]O"6V#Z2^%7Q+\'?#BU\3:7X7^,'[0GPF/CGP;
MX#?6_$GPU\/^%);O2/%N@:WJ^IZUX1CL9?&&@^(=:\(:?#>6+>#?&FG^-?">
MMS7\5[#XP\)ZCH]ZT-OYA\;/'>D?$_XM_$'XA:!H#>&='\7>(YM7L-&E&G+>
M0HUI9VD^H:HNC6UGHR:YX@O+6Y\2^((]'M;?28]>UG4H],B6R6`M]AA,7F%7
M-L91JX><<N5)5,+6E"I2<'&E@5[*K&KAX>TJUZ]3'RA*AB:L:5'"Q5>E2E7H
M3K?*8K#9?2RK"5:5>$LP=5PQ-)3IU5-2J8Q^TI2I8B?LZ5&A3P*E&OAZ4JE;
M%2=&I5C2K1H_U/?\&^7_`":G\7/^SA=8_P#5;?#FOM[_`(*M_P#*//\`:F_[
M)U%_ZE/AROB'_@WR_P"34_BY_P!G"ZQ_ZK;X<U]O?\%6_P#E'G^U-_V3J+_U
M*?#E?P3Q7_RD,_\`LO\`A[_U-RL_N'AC_DPO_=CYY_ZAY@?P:/\`?;_>;^9I
MM.?[[?[S?S--K_1".R]%^1_`H4444P"OZ!_^#>?_`)."_:$_[(UX6_\`4\>O
MY^*_H'_X-Y_^3@OVA/\`LC7A;_U/'K\M\:_^36\8?]@.$_\`5KEY^F>#G_)S
M>$?^P[$_^JS'']6/BS_D5_$?_8!UG_TVW5?YHD?^JB_ZY1?^BUK_`$N_%G_(
MK^(_^P#K/_IMNJ_S1(_]5%_URB_]%K7XC]$_^%QU_P!?.'/_`$G.S]B^E%_'
MX)_Z]\1_^E9"/HHHK^P#^40HHHH`_03_`()5_P#*0C]E[_L=O$'_`*K;QS7]
MZ2?<7_=7^0K^"W_@E7_RD(_9>_[';Q!_ZK;QS7]Z2?<7_=7^0K^$?I3?\EOD
M7_9*X?\`]6^;G]L_1F_Y([._^RGQ/_JIR<=1117\RG]'A1110`4444`%%%%`
M!1110!^(G_!5[P;^T'9?M'?\$O?VEO@E^S/\5/VH=%_99^/WQO\`&WQ-\$?!
MZ_\`A]9>,[?0_'7[/?B/X:Z#=V*_$7Q?X.T:=&\0:_#)<`ZE\EI9709HYI+4
M2_BI_P`%*]/_`."@O[:_QW\,?%;P'_P26_;7\*Z1H?PKT/P'=:?XOUS]FH:E
M/J6E^)O%VM27ENNB?&C4[5;%[7Q!:01^9=?:#<07+-$D;19_MD95;AE5AZ,`
M?Y@TWR8O^>4?_?"_X5]+PGQ9G/!>;PSS(:U&AF$*%?#1J5\/2Q-/V6(4557L
MJT90;:BK2:;B]5J?.\4<+91QAE4LFSRE5K8&=>CB90HUZF'FZN'DY4W[6DXS
MY4V[QO9Z7O8_SDO^&,/^"G?_`$B\_:M_\'OP"_\`GL4?\,8?\%._^D7G[5O_
M`(/?@%_\]BO]&WR8O^>4?_?"_P"%(T,1!'E1\@C[B]Q]*_4/^)C/%'_H9Y;_
M`.&;`>7_`$Z\OQ];_FO_`!+]X:_]"[,>G_,WQWE_T]\G][/\VKPY^S+_`,%$
M_%M_XQTSP[_P33_:FU2_\`>*6\%>,+:'6?@7&^A^*%\.>'/%O]D71N/BC"DD
MY\.>+?#NK++:M<6KVVJ0!)VF2>*+J?\`AC#_`(*=_P#2+S]JW_P>_`+_`.>Q
M7]_?P>^#DWPO\3?M`Z_<ZS9ZS'\:OC?<_%NSM8=,>Q?P[:7'PI^$WPX&A7,L
MMU=+J4Z7'PVN=6_M"&.RB,.KPV?V026<ES<^Y>3%_P`\H_\`OA?\*/\`B8SQ
M1_Z&>6_^&;`>7_3KR_K6[_XE^\-?^A=F/_AWQWE_T]\G][/\Y-?V,/\`@IV&
M!/\`P2\_:MP"#_R'?@%V.?\`HK%?TH?LF?MN?MC?L^_LV_!?X*^(O^"-7_!0
MC6-<^&G@'1/">JZIHNL?LG2:3?WNFQR+/<Z>U_\`M`V%Z;61W+1?:;2"8+\K
MQY7<W]#GDQ?\\H_^^%_PH\F+_GE'_P!\+_A7Q_&7BGQAQY@<+EW$6+PF(PN#
MQ:QM".'P&&PDE75&I0YI3HPC*4?9U9KE;:NTWK%,^KX1\,N$^",;B<PX?PN*
MH8G%X5X.M*OCL1BHRH.K1K-*%:<HQE[2C!\R5[75[-W_`)-O^"GGQ?\`VZ/V
MY/AG\-/!/@'_`()!?MW>%-0\$_$.Y\87UYXPUK]EV.RNK&?PGK6@?9;0:'\=
M-7G:[^TZE!-^^2&%8(I?WC2,B#\6_P#AC#_@IW_TB\_:M_\`![\`O_GL5_HV
M^3%_SRC_`.^%_P`*/)B_YY1_]\+_`(5W\+>,G'/!V3T,BR/&X*CEV&J5ZM*G
M6R["8FHIXFM*O5;JU82G).<I63=HJT5HK/BXE\(^"N+<WK9WG6#QE;'XBG0I
MU9T<PQ6'IN&'I4Z-)*E2G&":ITTFTKRW9_G)?\,8?\%._P#I%Y^U;_X/?@%_
M\]BN4A_9G_X*)7'C?4?AQ#_P35_:ED\;:3X4T;QOJ/A\:S\"Q=VOA7Q!K.O>
M']&UB24_%$6?V?4-7\,:]901)<M=;]-GDDMT@,4LG^DQY,7_`#RC_P"^%_PK
MP?3_`(+S67[2WBKX]MK5G)8^(_@=X"^$4?A@:7(MU:7?@WXA_$OQO-KKZJ;M
MH)H-0@\>P:='IZV$<MO+I<MR]Y,ETD$'T/\`Q,9XH_\`0SRW_P`,V`\O^G7E
M_6M_!_XE^\-?^A=F/3_F;X[R_P"GO6WXL_@*_P"&,/\`@IW_`-(O/VK?_![\
M`O\`Y[%'_#&'_!3O_I%Y^U;_`.#WX!?_`#V*_P!&WR8O^>4?_?"_X4>3%_SR
MC_[X7_"C_B8WQ0_Z&>6_^&;`>7_3KR_'UNO^)?O#7_H79CT_YF^.\O\`I[Y/
M[V?RF_\`!,OXX?MQ_L0?!CQK\-O'G_!'_P#;R\5:MXG^*&H>.;:_\(:U^RU)
MIT&G7?A3PIH$5G.-;^.VD72WJ7.@W<TACBEMV@GM]L@D65:^@OVR_P!L[]LO
M]I/]F+XQ?`WPQ_P1M_X*"Z)K_P`1_"RZ%I>K:]J_[*":/8W*ZOI>H^=?MIO[
M0&H7P@\NP=#]FM)I"[*NU5)D3^C#R8O^>4?_`'PO^%'DQ?\`/*/_`+X7_"OR
MW&\59SC^*/\`7#$UJ4L\_M/"YO[>.'IPH_7<'4HU:$_J\5[+DC.A3<J=N623
M35FS]+P?#&48'AK_`%3P]*K')O[.Q.5>QE7J3K?4\53JTZT?K$FZO.XUJBC4
MYN:+::?NH_SDV_8P_P""G9)/_#KS]JWDD_\`(=^`7<_]E8I/^&,/^"G?_2+S
M]JW_`,'OP"_^>Q7^C;Y,7_/*/_OA?\*/)B_YY1_]\+_A7ZE_Q,9XH?\`0SRW
M_P`,V`\O^G7E_6M_S3_B7[PU_P"A=F/3_F;X[R_Z>^3^]G^;9KO[,'_!1?PS
MJO@S1-<_X)H_M3Z?JGQ"\27?A'P=:2ZQ\"W?7?$=CX1\4^/+K2K5X/BC+#%<
M0^$?!7BG7"UW);0M::-=JDK7'DP2]-_PQA_P4[_Z1>?M6_\`@]^`7_SV*_T!
M/B?\(Y?B#X\_9V\8V^KVFEP_`[XM>(/B5>Z?+IKW<GB2WUKX$_&/X/)I%M<1
MW5NFF36]W\4;;7VO9X;Z.2WT:?3EMDFOHKRU]I\F+_GE'_WPO^%'_$QGBC_T
M,\M_\,V`\O\`IUY?UK<_XE^\-?\`H79CT_YF^.\O^GOD_O9_G)?\,8?\%._^
MD7G[5O\`X/?@%_\`/8K],O\`@F'>_M__`+#?Q,^)WC?Q]_P22_;<\66/CCP)
MHWA33[7P?K?[,[W=I=Z;XC?69KB]77/C9I,(MI(66.(P3RR^:&#Q!&#K_9WY
M,7_/*/\`[X7_``H\F+_GE'_WPO\`A7C<0>-_B!Q/DV/R'-L?@:N79E2A2Q5.
MEEF#H5)0IUJ5>*A5ITXS@U5HP;<7=JZZN_KY#X,\"\-YO@<\RO!8VEF&75)U
M<-4J9EBZU.,YT9T).5*I4E":=.I-6DFDY76J3/Q:UC_@IC^U?J6DZGIR?\$6
MO^"C:M?Z??62LVK_`+(:*K75K+`&9A^T5*5`,@)81R%1R$?&T_R:I^Q=_P`%
M.U1%/_!+S]JW*HJ_\AWX!?PJ%_Z*P/3TK_1O\F+_`)Y1_P#?"_X4>3%_SRC_
M`.^%_P`*^?X*\2.*>`(YC'AO$X7#K-9826,^L8+#XMS>"^L*AR.O"7LU%8JM
MS*-N>\>:_*CWN,/#WAGCJ67RXAPV(Q#RM8I83ZOBZ^%Y5C'AG7Y_8RC[3F^J
M44N:_+9VW9_G)?\`#&'_``4[_P"D7G[5O_@]^`7_`,]BN3\=?LT?\%$?AKX1
M\0>//''_``35_:E\/>$O"VG2ZMK^MW>L?`R:VTW3X61);J:.R^*-U=.B-(FX
M06\KX);9M5B/])GR8O\`GE'_`-\+_A7@_P"T[\%YOV@?@)\4O@U8:U9^%[SX
MA^%;KPY;^(+K2Y-6M]*DN+FTG%W+IL%WI\UXB"V*F&.]MV8N#Y@`(/W/_$QG
MBC_T,\M_\,V`\O\`IUY?CZW^+_XE^\-?^A=F/_AWQWE_T]\G][/X"O\`AC#_
M`(*=\_\`&KS]JW@D?\AWX!=C@X_XNQR..".".02"#1_PQA_P4[_Z1>?M6_\`
M@]^`7_SV*_T:T@B4$>7&<L[?<7^-V;'3MNQ^%.\F+_GE'_WPO^%'_$QOBA_T
M,\M_\,V`\O\`IUY?CZW/^)?O#7_H79C_`.'?'>7_`$]\G][/X+/V-O@]_P`%
M'/V;_P!ISX0?'#Q3_P`$I_VQ=<T#X=Z_JFKZEI/A_7?V=#K%[%?>$_$6@0QV
M(U+XPV5BTD=UK%O/*MQ=VZM;Q3*D@E,8/]@_[(W[4/Q8_:.?QY'\3OV)_P!I
M']D%?!\?AEM%E_:`N_@[=1^/VUQM=74(_"@^%7Q)\?R(_A@:19/K1UV/24==
M?TK^S&OF6_6S^S/)B_YY1_\`?"_X4Y41,[55<]=J@9^N`*_..,N-^(./,PPV
M:<15Z&(Q>$P4,!1GA\+1PD5AH5Z^(C&4*,8QE+VN(JOG:<FFHMM11^@<(\&9
M%P1@,1EN04*U#"XK&2QU:-?$UL5-XB="AAY24ZTI2C%T\-27(FHW3E:[;;J*
M**^1/JPHHHH`****`"BBB@`HHHH`****`$+`'!S^"L0/J0"!^)&!R>.:-PSC
MG/KM;'_?6-OMUZ\=>*_!?]LDZ>?B5^W#%\2[CQ)%^T7<?#KP#;_\$N8=/G\7
M0^)[CQE%\(KC4="3]GR/0"MM<_$M/VF[+Q->?&&/1A-J<?PPT_PO<_%=$^$%
MM!(NSIOC3]G#QU^WGX&\'?"[XJ>&_"_Q[^&?QW\0ZW^TI\3O$7Q5O8/'?Q+\
M42>!/$^AW7['7PG\&>(]1_MSQS\-='OM6T:_URWM]'M_A/\`"^Q\#:3IOA/_
M`(2'XP7FM:UX+`/W/)`Z\8&<GI^?3]:,C`///L<_B,9'X@5\L?&KX9_"+0]1
M\;_M$>/?B?XC^#\Y^$&E_"7Q/\2;+Q]!X)TWPW\/X/B`/%K7%OJFH6]SIWAO
M5]2UG59=&E\56ZV^M6VGZBL&CZEI6I1V&IVGX>_LXZK\!/C5_P`$V?V%-`\;
M?&WX/0>'_A3XX\;V'CUOC?X#\4?M!>!=$\377A_XT:?X-TOXHVVI>)M+TCP[
MXNATSQ!8ZUX.U?XW>(18:Q*VVQ76/%VH^'_M`!_3517S#^QIK^I>)/V:?A7J
M.I>`?#WPU$&DZOHFC>%_"'A/6_`7A%O"7AGQ3K_AKP3XG\)>!O$I;Q#X*\*>
M/O!VDZ%X^\->$-<FN=7\,Z)XGL=%U&\O;JREO)_IZ@`I"0.N?P!8_D`3^/K@
M=2*6OS._;:G^'-M\<?V=[G]J2ZTNR_8VM?A]^T'<^,[GQE<ZG:?"2+X_17/P
M>_X4Y)\6;E&C\.0Z='\/#\>9/`S>,I4\.#QLMN]KGQQ'X'(`/TOW#CJ<^BL>
M^.<`XP>N<8YSC!IW^?\`/I^-?S$_$/QI\((_@I\+/@S\:_B+?^"?VO?&?PL\
M<67P/\??M&?%/Q;\.6_9!_9W/QZ^+5K\`_VE+V\\8:MHVL:;^T/'\*U\#BST
M.U%[\;OBGXJ\!Z#X9^(<_A;P7H?C3Q-IO]$'C#X7>$_B-<_!_P`0^)+[5;ZY
M^#?CV#XK^#[^QU0V$%YXF7X>>.OAVE[K<=BD5MJVFS>'?B+X@O&TYT6P.J?V
M=?I$!80QT`>J@@]/Y'GOQZCGJ,CWI0<^O4CD$=/KV]#T/:OP!_9=^/VD^'?%
M7_!5'PU^RK\2;G]K?XQR_&CX:>,?@[H&H?%KPWX\\:^/+&]_93_97\'>,_B7
MI]SXO\5^#_"NL>"OA_\`$'5/$EWKOAOPKJ_A#PA!=>%=3^&OA>W\.ZHUEI\7
MOO\`P2)N?$<&E_MR^'->^'GQM\#)H_[=OQ4U&SN?CC?>&-3\3Z_=>)OA_P#"
M;5/$5U/J'AGQSXVLKK5Y_$JZKXC\0MI-Q!X.AO?%<%IX/N+FTMK_`$_1`#]@
M:***`$R.?;V/^2?8<]..11N'/7C_`&6_3CG\,U^7'[;O@+Q3:_'C]F74O`'B
MOQ!X7TW]KCQK)^Q5^T9::.-;<:E\((/AU\8/VA=&\8:+=Z=>1P>#OB)X9?X:
M^._A+X>\:>1']D\,_M!>*+B::?Q!X;\!'3_R]_;L_9Q^#?@C6O\`@KSXH\(_
M!CPGX6NO#W[&?[$NN^'==\-^#I-,ETC4?B%\3_VJ+#XS:IX?OM+M4>TU#Q;X
M8TO1[+XBW6BNE]J^AZ?I<7B-IK2"SH`_J)!!SC/!QR"/RR!D>XR*"0/7KCH<
M]<=,9Q[XQCGIS7Y7?LAO\-Y/VJ?BH/V/I=";]CJ+X&^`H_$B_#HW;?`M?VBQ
MXW\2FQ'PH,6?!P\3)\*!"/C&O@(_V:&/PM'B`?V^&KPC_@JKX7^#G[.W['L^
MEQ_&3Q/\.K_7?VG-`^,GA[P=/\3K[0A\1?&'Q"_;.^&7Q:^*-U>V-B;;Q#XL
M\-_#ZV\4>)]<L_"4.H'PAX?\/3?:_$NAZQ9Z-ID^E@'[D9YQS^1Q^>,4M?A+
M^T[K?PAU7X_S_M(>#-6_9W^/?Q&G\'?L[Z[^SQ\*_&OP&\6_$OQI\5;;2O%7
MBN>SLOV=/C!!KL'A[3H]3U/6VUB#Q7\-M"\2Q?#SQ=9IXB^+TD?A"UMK=OW8
M4DC)&#N8?4!B`?\`@0`;\:`'49_7C_/I_CQU-%?GE_P4T?Q-X$_9B\5_M/?#
M-Y(?C1^R%;ZG^T!\+8C;:MJ&D^*+[P]HU]I'B_X9>,-%T.2+4]>\$_%'P'K/
MB'PAK=A:.;[2[^[T/QEH@3Q)X3T2>(`_0S(]^_\`"W;\/R]>U(&!..<GIE6`
M^F2`,]\=<<XQ7X??&']CCX.Z!^V?_P`$PM+\2?#_`$;XJZ]<:I^T])\4_B=X
MQ\+0ZSX@^)'B?0_@Y>^.]/\`%WQ`OVBNK.6[/Q)U/5?%OAG3KV3^R?"NK7D5
MEX1M[""PLX8OE_\`X)L3?#&7X?\`_!-4?LYS:8W[2K:QXEG_`&VQX-;Q&VH/
M\*6^&GQ:'CU_VGA:9TK_`(2Q_BR?@R/`;?$''Q`/C01?\(H3X;'CH4`?TQ9'
M/MCL>_3'J?8<_G1GC/.,9Z'/KTQG/MC/;&:^0/CE\./@GX(TWXY_&SXB_%?Q
M#\%+#XG^$OA!X*^)OQ`MOB8_P\LM.\/?#3Q#XK/A;2]'\32@2^"+KQ5=?$C6
M_"NMZYX=NM,\37]GJEE%H6KZ1KEIIFIVWXP>&_B_XS^(O_!%C]F7P'\(/"'Q
M"^//@Q?V&;KP7^U1K_P;\8^";GQMX!U[P1^S#HKK\(?&*>,?B=X$\<:1K?BS
MQ'XAL+GX@7FCR:[XQT_P9X5\4>&)--3Q#X[T/4H`#^E^BOE']A/6-9U_]B_]
ME/5O$.@^)O#.MW/[/'P;74]&\8KIR>);>\M?A[X>LIKC54TO5M<M$FU-K?\`
MM6)3J4UXMK?0+J<-CJ8O-/M?JZ@`HHHH`****`"BBB@`HHHH`****`"BBB@#
M@OB)\,?`OQ6T6U\/^/O#UKXATS3]9TSQ%IJ33W]E=:5KND2.]AJ^DZGI5YI^
MJ:7J$44UU9276GWMM+=:7?:CI-VT^EZE?V=SW@4#IGKG[Q_EG@>W0=`,4M%`
M!3=H_P!K_OIL_GG./;IT]!3J*``#`P.WXG\2>2?4GD]Z***`"L?Q#X?T/Q9H
M6M>&/$NE6&N^'?$6DZCH6O:)JEM'>:9K&C:O9S:?JFEZC9S*T-W87]E<36MW
M;3*T4T,KHZD&MBB@#G/"7A/0_`_AO1?"7ANUGLM!\/:?!I>E6D^I:IJLT%G;
M`B))M1UF^U'5+Z7DE[K4+Z[NYF)::>1N:Z.BB@!,#GJ<^I)'Y$D4``=/\_X#
MV'%+10`4444`'^?\^OXTA&<]>>.I'Y8/'U'-+10`@`&<9Y.>23^62<#V&!01
MGU_`D?R(I:*`$*@G)SV_B8#CU`.#[Y'(X.12T44`%!&>/Y$C]1S110`8_3W/
MZ^OXT@4`YYX]68_H21GWZXXZ4M%`!28'U^I)/YGFEHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`**^7OCS^VC^S#^S%KF@>&_CO\7-#^'.M^*-)N]<T&PU;
M3?$E[+J6E6-ZFG7=Y$^B:)JD$<<-ZZ0,L\L4I9@R1LGS5X0?^"MG_!.L`D_M
M0>#<`%C_`,2'Q]P%!)/_`"*'8`FOHL'P?Q;F.&HXW+^%^(L=@\1%RH8O!Y)F
M>*PU>,9RIRE1KT,+.E5BJD90;A.24XRBW=-'S^+XLX5P&)JX/'<2Y!@L70DH
MUL+B\XR[#8BC*48SC&K1K8B%2FW"<9I3BFXR4EH[GZ,45SWA+Q7X?\=^%?#7
MC;PEJ<.M>%O&&@Z1XG\-ZQ;QSQ6^JZ#KVGV^J:1J,$5U#;W,<5[875O<QI<0
M0SHD@66*.0,@Z&O`J4YTJDZ56$Z=6G.5.I3J1<*E.<&XSA.$DI1G&2<91DDX
MM--)H]Z$X580J4YQJ4ZD8SIU(24X3A-*4)PE%N,HRBU*,HMJ2::;3"BBDR,9
MY].AS^(QD?B/?I4%"T449Z^WL?\`)_"@`HHHH`**,_IQT(_GU^HXHH`***,_
MIQT(_GU^HXH`**/\^O\`*B@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@#^37_`(.&68?'K]G?!(_XM!XPZ$C_`)GF
MT]*_GPD=_*E^9O\`52_Q'_GFWO7]PW[?_P#P2_T7]O'QU\/O&VJ?&76_AG)X
M"\):OX4BT[2O!>E>)X]3CU;6XM9:]EN=0UO2WM9(&B%NL$<4J2*QD,BL`M?`
MK?\`!NGX1967_AK#QA\RLO\`R27PUQN4KG_D;ATSGK7]Q^&'C-X=<-\`\-Y'
MG&>3PN9Y?A,12Q>'64YQB%2G4S#%UXKVV&R^M0J<U*K";=.I-)OE;YDTOXN\
M2?"+C_B'CCB'.<IR6&)R['XG#U,+7>:930=2%/`8.A-NEB,=2K0M5I3C:=.+
M?+S).+3/V[_8VY_9%_9<)Z_\,\_!G_U7?AVOI*O.OA!\/H?A+\)_AE\++?59
MM<@^&WP_\'^`X=:N+2.PGU>+PCX?T_08]3FL899X;.6_6P%U):Q3S1V[RF))
M9%0.?1:_BW.,12Q>;9IBJ$N>AB<QQN(HSY91YZ5;$U:E.7+-1G'FA)/EE%25
M[22::/[!RFA5PN599A:\>2MALOP5"M!2C)1JT<-3IU(\T6XRY9Q:YHMQ=KIM
M68UP2K`'!VG!X.#C@@'C(/(S7\?]Y9_%32/^"=W@K]DU[?XGP>%?`'A7]C3]
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MYS_&_<YX&[`Z\8Q@<#@"EQ]>?<_X\?A0!_-#XB_:!_:K^)'@OX&>//$_[2E[
MX3^$_P`.?VWOV8+GX@?&+X3ZSX$UR!/`WB[P1\2;?XEZ!\9M7T;X(>$?AEI/
MPZ\-^,D^'EI9Z'/9ZGJ_A:\\<OHGQFN[C6/#WAS53U?PQ_;J_;I\3_#/Q%XE
M\;W?@WPC?WMI\%G^-PL;31O&_BC]B>[\<_'7PEX/^+$USX#TSX7:##HNE?"3
MX::SXSN=0T'XY>)OB'XNTC5_!]G\3]6_M_X7Q^([6/\`HRV@#&6Z@\LQ/'N3
MG'J,X/?-&T<_>Y_VVX^GS<=>V...E`'X1?`SXL_$7X5_L3_\%A_CUX2\:ZAX
MT\6_#SXN_MG_`!=^$7Q&\2>%_LNG^*SX)_9:^%_BCP#XKLO#,UI:Z#J7AN_U
M+1K>YCD\.:=9^#O%2B\UC0+"VTS6(H$?X+_:N_:>^('QR^#GPJ\"_&P>+OA-
M\5/CEX/\+ZO\=[#X*>'+&]\/W.J_L<_M,_'/XJ_!71M/O=$C\/1W_P`+_&GP
MD^$@LO%&NZ7J&J>%X_BQ/X!\>R^*_%FBA7_;'QWX&\)?$WP/XR^&OCW0=/\`
M%7@7XA>%/$7@?QIX8U>-[C2O$?A/Q9I%YH/B/0=3A62-YM/UC1[^\T^]B66-
MI+:XE170D,.AL;*UTZSM-/LHA;V=C;P6EI;HSE(+:VA2""%-[,VR**-$4%CP
MH));)(!_/7%^W)^U[<:!X;U"'QJDVH>,-'TVY_:\LS\$K2V'_!,S4KC]H[X7
M_#_6K,K<:5N\9-HWPW\6?%"62W^)Y\7RJ/A6/V@)R_P@DU+P]>>$^%/VK/C]
M\`-&_;S\3>#OB'K'B7P[XHM/^"JWC[X-^/=8^%K:FWQ*_:<^'/PN_8GUG]E7
M_A%M)30Y;'4CXB\(W_Q9US0_"/ABPLO`_P`4[+1?$7BW1]'_`+(TADT_^I+:
M.?O<_P"TW'?CGY>O\....G%&T=,MQ_M-_/.3^/3M0!^`GQN^.?[3'Q;^!G[>
MOA#0/COXZ\`_'O3O@C^V#I/P\_9X^&/P5-YX_P##_A_P#\-YK_X&_%OP?\4M
M-T.YU72M?^-T2:/K6E^)+J[O-%UMOB6/!'P?L/"OQ*^'LWB"#NO@]^U[\2(_
MVB_@]X#;]H23X^?#7QAJOPU\#^%+'P!X2\`ZOXJUGPYJ?P&T_4=>^(_Q<\-'
MP+X"\8BVM?BG;:]JFN?M`?!'Q1XG^!7AK1?[,^''B/X:Z)XTTGQCJ^G?N%M&
M2>><_P`38Y]!G`/'4`'.3U)RFT9!RV1_M-C@8Y&<'WR#D\GGF@!5.5!Y&0#@
MC!&1GD=CZCM2T44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`45X9\5OVE?@=\#]4TG1?BI\0=+\':IKNGW&J:3:7]GK5S
M)>V%I=+9W%S&VEZ7?Q(D5RZPLLLD<A9LJA7YJ\K/_!0+]CP`D_''PY@`DG^R
MO%O``R3_`,B[V`KU\/P_GV,HT\3A,DS?%8>JFZ5?#Y;C:]&JE)P;IU:5&4)I
M23BW&32DFGJFCRJ^>Y)A:L\/BLYRK#5Z32J4:^8X2C5IMI22G3J5HS@W&49)
M2BKJ2:T:/L>BLCP_KVD>*M!T7Q/X?O8]2T+Q%I.G:YHNHPI+'%?Z5JMI#?:?
M>1)/'#.D=S:3Q3(LT44JJX$D:,"HUZ\J<90E*$XRA.$G&<)IQE&46U*,HM)Q
ME%IIII----7/3C*,XQG"49PG%2A.+4HRC)7C*,DVI1DFFFFTT[IV"BB@'//\
MP1^AYJ2@HHHH`****`"BD!!S@@X)!P<X(Z@^X[BEH`***0D`9)``ZDG`'XF@
M!:***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`/P!_X*_DCXK?!_!(_XMUXCZ$C_`)FNUK\AF=]K_,WW'_B/]P^]
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M\%-.N];\*)X0A\6^,_AI\0+V^\=ZEX?^'VG>$9]=\7V.KZ/_`$74W:,8RWK]
MYL_GG/X9Q7(=1_*=IW[8?[>,/B3_`(:"U/Q-XQ'C_6?V0OBU\/?`WP,O-!AL
M_@_XT^)'P+_;U^)GP8\?_$[2M#O_`(=>'_$&L^.?!G[.>@V/[3WB6STG1?#F
MI:WH-HTEKX2M/APR>#]._:?]D[XS_&WXB?LY_&'QGXL\3>!O$^L>%O$'CJQ^
M$OC[2KH?%JQ\1:'I7@'0=;T[4O%\WP<^'/PS\-?$&]TCQU?^(=&N(/@CX96U
MUWP]I6F:-93GQ^FNV\/Z%;1[]"/O-W_'KZ'J.Q%*``,<_B23S[DD_KQVH`_F
M0UO]I?\`:*^(WAWX&7WB']J/X@:7I/P@_:]_9&\4?'GXT?"G2?A/+\$E^'_Q
M+\-?&30/%_A[4?B!H_P^\/[/"FB>.O"WA\^(OA)\7?A?X3\??":R\<^!?^%I
M:IXPNO$'A_5M`6Z_X*9_M1::VJZG#XQBE^'_`,0?A!HGQ%M=<U_PCX'D^)GP
M3\26_P"U-^S3\,/&?PJ?P%IG@3PUX%^'/QJB^$/QN\8:MI7P=^,WQ4^-=]X-
M\=>$M)OOB5XQT[PKI_B"'5OZ;0@'=NW5W)X]RQ//?^]WS7FWQ2^$'PZ^-'AN
MU\*_$GPW#XCTK3=?T7Q7HL@U#6-&UOPUXL\.77VS0/%GA+Q1X>U+2/$_A'Q7
MHMP9'TKQ+X9UC2M;T\37"6U]'%<3I*`?S]']M7]L[0M/\`:?X/\`B-X)\76?
MB'P[\6?B#X:^(WC7QU\.WM_BE\3KK]H'Q?I'P]_9[\:67A;X8_$*PL/%/@CX
M'6OPHO?BA\#_`-GRTT#Q[;>)OB)J=_\`#[Q-K&B>&9_M?Z0?MS_M&>,/@U\4
MOV/?!%O\8;#X"_#_`.-WB;X[Z#\4OB//X6\->*+CPK8>!?@'XD^(_AS4M.NO
M%VC:SX?T22U\4:':VTVJ:[I-YHUY:W<FEW-H;_4-+>#[J^&7PG\!_!_P_<>&
MO`&BRZ1I]_K.H>(]8NK[6O$'B;Q#XC\1:KY"ZCXB\6>+?%>K:[XK\6^(;R&T
ML[6XUSQ+K>JZI)96-C8FZ%G96L$-OQ%\,O`7BWQ?\/O'WB/POI6K^,OA5?>(
M]3^'GB*[BD;4_"-_XN\-W?A#Q+=:-,DJ"WEUGPU?7>C7K.DHDLIY(U",0X`/
MP7\"?MK_`+<WB?0O$OB?XE:P?A-H?AW4_P!@_P`(?$K4(/@WIT$7P3\/_M%?
M![P9XW^,WQJU2Q\4:7J^H1KX:UZ*"QT71/$+7V@?!N7XHZQJ?Q:@\4:1\/DT
MW2^9\0?MR?M->)/%_P`.OA;J/QST7P+H6J:J'T+XDR:7X!^$FG?%WX4Z5^V+
MXJ\"3_%7XL>+?%]I]N^&F@_$O]F3P1=:M\+KOX$Z+:ZAKOCZXOO%UQ!X=\`^
M+OAW:C^DC:,8Y[?Q-GCT.<C/?!YYSG)KYU^(O[)WP#^*OBW4?&_C;P(=1\0:
M_H>B>&/&4FG>*O''AC2OB1X8\-S:S/H'ACXL>&_"GB?0_#/Q:\-:,WB+7X],
M\/\`Q+T?Q7I%E;ZWJUK!9I:ZA=P2@'XN>._VU_VOM/\`A?/KUC\2=;TGXC>)
M/$7[?]_\/='U7X:_#_P+X"O[']E3]ISQ[\&OA=\-+;Q#J_PN^*_BCX@?%+QW
MX7T72=?N?A9X0\(6?BCXA:7%?:]X5\=?#[3-#NKSQ3WWPW_:^_;#^,/B#X;:
MK_PF,GP\T+XN_MA^"OV9[CPQ8_"/0-0?X?>!_B?_`,$N/`7[9T_CK1]7\1:3
M=WMQXL\!_&2;7/!&@:AXI_MGP2^BZS?:'XM\/^(_$5AI5Q8?O=M&`/FXSC#L
M.ISV;D>@/`'`P.*7'U]>I],>OZ=,\]>:`/Y[/@%^WY^TMXU\0?LF>)?BAXWL
MH;7XJ>%?V<=+UCX*_#KX;Z+;^/M:\0>.M9U3P+\1?'?B'X>>/M#TGQEXA\$2
MZ\++QE=>./@'\4[S1_V?_"5AXD7XG?#7Q"/#]S<WW]"8S@9ZXY.,9/KC)X/4
M<GZTFT9S\W;^-L<9ZC=@]><CGOG`IU`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%?(G[1O[>7[)'[)/B#PWX6_:)^-7A
M[X7Z_P"+M&O?$'AS3=9TOQ5?S:IH^G7Z:7>WT#^'_#^L01QV]_(ELZ7$L,Q=
M@R1M&"X^=#_P6E_X)@J"Q_:X\#`*"Q/_``CGQ*X"@DG_`)$?L`37J4,DSK%4
MH5\-E&:8BA43=.M0P&+K4JB3<6X5*=*4))23BW&32::W3/'Q/$7#^#K5,-B\
M\R?"XBDTJM#$YG@J%:FW&,DJE*K7C.#<91DE**;C*+6C3/U&HKF?!7C+PS\1
M/!_A3Q_X+U:#7O"'C?PWHGB[PKKEM'<PV^L>'/$>FVVKZ)JEO%>06UW%#J&F
MW=M=11W5O!<(DJK-#%(&0=-7FRC*$I0G&4)QDXRC).,HRB[2C*+LU)----)I
MJSU/6C*,XQG"49PG%2A.+4HRC))QE&2;4HR3333::::=@HHI`0?7\01_,"I*
M%HH_SZ_RHH`****`"BDR,XR,XSC/..F<=<9[TM`!1110`44`@\@@CGD<]#@_
MD>#[T4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`?QA_\'-K,O[1G[,6UB/\`BR'CKH2/^:BV'I7\S<LDGE2_._\`
MJI?XF_YYM[U_H+_\%)_^"1N@?\%%OB'\-/'^K_'7Q!\)Y?ASX*UOP;#I>C^`
M]&\6PZM'K7B"#7FU":ZU/Q!H\EI);O`+9;>**9)%8RM(K#8?S<;_`(-?/!3(
MZ_\`#97C8;T9,CX+>%,C<I7(_P"*W[9S7]!<(<=\+Y5P[E6`QV8SHXK"TJD:
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MG'FBW%VE%JZ;3W3:$/3\5_F*_E+_`.">GQ9^''P/_82\->-_"NM_LNV/[1]U
M\(O@!X7U_7?@9X-MKC]I7P)H_C+XB^#_``O\1_%7[6FM_%'5M?L?#NEZ'K.K
M>'[KXF?$SQ%X9O\`PS\/-234/%VL>#/%<%CI/AJ\_JUI-HQCYO\`OIL]<]<Y
M_7IQTKE.P_F0OOVL_P!L7XY?#?X]?![QCXH_LK0_"G[-/_!4RZUOQ/X6\'66
MNZC\8+#X%^&_V5I_@MJ.D>.(OAO\--.@C\8^'OVE/%UE<^*/`/P\\(P^,[#P
MS8ZOX#TG2;II=?C_`$7_`&'?BS\:?$.O^$/@/K\NHP>'_A'\#/A9\4M1UW5?
M"(M9_$OPV^,OPF\"VWP,\-/K%Q&J7&L^'_'/A_\`:(T/Q3>6;?\`"1/#\)/"
MMYXB"-XRD^U?JQM&,?-C!'WFSS[YSGT.<CL17"^$OAIX*\#ZUXY\1^&]':SU
M[XD>(8_$_C/6+O4]9UG4=9U6WT^WTJR4W>N:CJ4NGZ1IEA;+;Z/X=TEK#P[H
MXGOI-+TJTFU'4)+H`_$']I']H7]J'5_B'^UE\!?"_P`8?$5YX@\7>"_VFO!?
MP8\(?L_^"?#;^-/AF_AW]G/Q/XY^'>N^,=!\:>$M`^-'@?7M2\3>%[G0M,^/
M>A:[\6?@EX]\1>,/!/A7P)IW@?Q1KFE:MI'D7AS]OGXZ>%M%_9SM?AW\7]:^
M+NG^#H_V#?!'Q(LOB'H_@72-2^*WA[XT>-?AIX$^.7Q%T"S\/?"O7_'/Q%B^
M$J>-==T3QA\1+/Q?\"?!_P`,OB%X$U[PUXYL/''B#PWXFBUS^E3:,YRV?]YL
M<C'W<X_3@\CGFJUY866HVEUI^H6L%]87UM-9WMC>1K=6=Y:7,307-K=VTXD@
MN;:XA=X;B"9'BGB=XY5=&8$`_F)\,?M^_M@^(=#U+XAZ=\5/#OB236+_`.$_
M@SQE9SZY\)_AYI/P,TG7/B%\3;SXN_&'P'X5N/"OC4V_P433;#X`?#;P7\8_
MVD=$\1Z[X#\0?$._F\=>%X;6XU-;?]$_BK^U1^T-\//^"4GQ)_:CN-5\&Q?&
MWP9X%\6>(=`\1Z)I<OC3PSK.EZ'\49O#_@_Q+<:4_A;P?:^);WQ-X"CTS4]>
MC\*>'-,\-:SKFH7]U\.=WAV[\.7;?=?PD_9:^!WP-U*WU7X:>#KK1+K3/"R^
M!?#::AXQ\>^++'P-X$6;1YQX"^&VE^,O%/B'2_AEX$:3P[X=,G@OX?V?AKPQ
M)_PCV@K)I;)HVF):^D?$OX9>`OC%X%\1_#/XG>%M*\:^`_%M@NF>)/"^NQ27
M.E:S8+=6UZMK>Q)+%))$+JTMIP%E4^9"ASQ@@'XT:%^U9^U9XB_:8\,_"'X>
M_$=OBC\(KOXD?M'GPS\4+7X;>#M,U#XP:'\(O@5^SW\5(OA[8:]'X?M_!6CO
MH'Q?\7^._@I?>/=.T:*.YT:?4O#TT-S\2_`6I^+;;P[4_P#@H9^TKH/PZ\.^
M(I_BPOB#3?%WAG]F#6/C3XBTSX.^$O#WC#]FSXN_$/QQX@MOC/\`LU?#C1?%
MMEIG@W4O'/A[PCH^J:CI^@?&V77?$GPUTWP5K6H^/M=US4?'W@'3Z_I!"@>O
M?JS-U]<DY'H.@[8KRWXJ_!7X;_&G3-"TSXB:#<:J?"NOCQ5X1UK2?$7BCP=X
MO\&>)O[&UGPW)XA\%>.?!.M^'/&?@[6[CPYXC\0>';K5/#.O:7>W>@:[K&BW
M4TVF:G>VLX!^&_P]_:[_`&H]+\"_$K4_%OQP?Q3IOPI_9W_9%\4ZGXH^&_A?
MX<_$G3=6^,'[4G[0?[27PU^(WB#Q-\2=2TZ+P9X2\$?!_3O!/A/5?'Z:597O
M@_X`7&G^)KV\TKQ=\/?!=IX0\6\!:?MY_MS:MI'Q0\.6_B_3;"\^$'P[_P""
MBGC/0_B%HW@#0_B+!\6X?V:?A/\`L,_&[X%:DVO2?"WX8^%=>T?Q@_Q_^(W@
M35=5\"?#CP=8>-O#FG-<>#$@\0:9;^,X_P"B+X>?#?P7\*O"MIX,\!Z)'H/A
M^TO-7U/[,M[J>I7E[K'B'5[[Q!XAUW6-9UF]U+7->\0>(==U/4=9U_7];U+4
M=9UK5;ZZO]3OKJZGDE;N`H`QSW'+,3SCN23VX/4<XZF@#^>K6_VTOVMK74?%
MWAK6_C!X1\#:+I^M_LS_`!%N?&OB/PGX4^&FIP^&/VAOV;?B!\0=4^#G@7Q[
MXV^'GCGX(:$_@7XF>$]+N-%U/XW:?8:UXN\(7FJ_#H?$*+XC-H6M7_[7_LZ?
M$2^^+7P&^#WQ,U33_%6EZGXY^&_@[Q/J5EXW\%_\*Z\5Q:AJ^A65U>MKO@4:
MOX@C\)W\]T\US)H4.O:W;:>DT<%KJ^I6PAO9O9BH/KVZ,PZ9'8CUY]>">0*4
M#`QZ<<DD_B3R?J>:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`**^<?C7^UQ^SI^SKK&B:!\:?BCHW@+6/$>F7.LZ+8ZG8
M>(+N2_TRSNUL+F[B?1]'U*%(X;MT@99I(I"S`JA7YJ\7/_!3_P#8-`)/[1OA
M/`!)_P")+XWZ`9)_Y%;T%=E/+LPK0C5HX'&5:<TW"I3PM><))/E;C.,'&233
M3LWKIN>=6S?*L/5E1KYGE]"M!I3I5L9AZ=2#:C)*4)U(RBVI1:NE=-/8^]J*
MPO"_B70_&GAKP]XP\,:C%J_AOQ5HFE>(_#^JP)/'!J>BZW8P:EI=_#'<Q07$
M<5Y97,%Q&D\,,RK(%EBC<,HW:Y&G%N,DU)-IIIIIIV::>J:>C3U3/0C*,HQE
M&2E&24HRBTXRBU=2BU=-----.S6J"BBD#`G'/3/*L/;J0!GVZ]^E(8M%%%`!
M1103C_ZP)_E0`4444`%%'^?\_P">.]'^?7^5`!11_G_/^>>U%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'\QG_!
M=<D?&OX$8)'_`!:OQ7T)'_,YVM?AD[-Y<GS-_JY.Y_N-[U_8M^W!_P`$YM(_
M;3\9^!O&&H_%G6/AY)X)\+ZIX:BL--\):9XBCU%-3UB+5VO);B^U?37MGA:+
MR%A2.5'5O,+A@!7Q(W_!!?PNRLO_``TWXJ&Y67/_``K#P]QN!&?^1H'3.>O/
M2OU+(N)<FP64X+"XG%.%>C3G&I#ZOB)\K=:<E[T*4HOW9*7NR?;<_%.)>#^(
M,QSS,,9A,#&KAJ]2E*E4>*PE/F4:%&FWR5*\9QM*,E[T5LVM+-_L+^R?_P`F
MN?LX?]D)^$O_`*@>@U]`5P7PK\#1?##X8_#OX;0:E+K,/P_\#^%/!46KSVT=
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M]$^)>@?L\VG@F\^+5_\`%'Q%X\,-O;:=J?QNT;X207#:A\!KJ2W^*>GQ>(+S
M]]]@QC+=S]]\\^^[/T'0=L4;0/7_`+Z;'(QTSC/?/7//7F@#^;;P1^W7^V9X
MK^('@_X6Z+\1M,UGPS\1_B/^Q3;Z3\8],\->!OB1>Z1X<_:$7]K/P_\`&3PH
MUUX6^$/P[^&&G^(?AQ??!_X?:I9Z,D/Q(E^'GB#4FTWQUX_\;V&KKX?M]7XT
M?'7XX_&3]F#QM;>*OBUJ5G\8S\>_V6O^$U_9[M/@M?17/[,^M^'?^"GOP`\'
M^%;.[\;^&[?0Y]5M=3\"P3ZMK>A>.]3U23XOZ9%>_$CX?WGACX4IJ6E/_1J%
M`Z9_%F/3ZD_CZ]Z3:!GKS_M-ZYX&<#Z#'''3B@#\I/"W[47QG\+_`+,7[=GB
M'QU?>+?&GB_]E;XY?&3X3>#?'/AOX3Z-?>-O%WAC1-#^'?B7PMXSU#P#IS^%
M?!&IW?AM/B1<6.N:SID.C>$6T'PA<>*]5T]!:ZW8R_(OP<_:]_;,^*WQY\(?
ML\M\4;33/"NN?M`^-O!5M\=?"/A?P)\5)?%/PMOOV))OCWX5UWP]XU_X4O\`
M##X4ZU?:!\5=+U#0(?$^B_#0>%+NR:\\&7;^*M;TH^)9OZ%L#!'//N<_@<Y'
MX8H"@>OKRS'^9/Y=*`/YA5_:R_:#_:B^&_[,7B+XM^,[SX<>--?_`&D_^"1O
MC#1/V<?#'PLNK./X@?#/Q-\3?V5_B)\3/V@W\426EUXRTKP]%\3-;^(W@K4]
M/CUZW\$^`]'^'TO@?QOI6J>(_$T6JR_2_P#P5\^+'Q83X?\`[7WP<M_B!JWP
MM\*3?L*Z_P"(/@UX=\/_``\;Q3KO[4'Q/\52_%?1/B7X*TKQ+%87>NZ->_"+
MPSX:^'6I0:3X!O-!\4Z>WQ-_X3_7]0U#PEH/]GP_O'M&<_-QC^)L<>HS@^^1
MSWS05!ZY_!F'\B*`/YUO$O[6'QU^%'A+7/$.D>-_#?PV\*Z=^TE_P4YN+_P=
MX2^&GA73/B=\3]2^&G[9GC+1OAVG@C2?B)X4?X=_%_4=:\&VFI'Q!\)_#7Q!
M^%7Q^^,7B[Q#HOC+P5XON=*EU;RO;=7_`&QOVA4\-?M`^+-/\?7>G_%;PWXA
M^)>EZA^S!J7[.^JZU?\`[./P9T3]H;P5\._"G[0NJZMHMM!X@UW4K#]G76KW
M]HJ_\)>*=6US2OB[<WMQH7PRL-&T_P"'OBJ"\_;PJ#UW=^C,.O7H1^'IVQ2;
M1SUY!'WFP,\<#.%/H1@CG'4T`?B)H/[6?[3%IK3Z7HGC^7XP_"SXF_%?QQ^R
MI^S=\=U^%6CV,7CCXD:QX5^#'Q%\!_&+5E\,^']/\-7GA'P5#J_[4WP\UWQ/
MI6DZ?\,_%FH?`'PS=V=A:ZAXBU%]7^;[+]OO]O>;X3?%[QM?OX'\.>.]+TSP
M)-K?P\N;#2_'/B;X"_$3Q)^U[\&_A1;?#S4/A]X:^&WAO5=`T?\`X5CXS\?P
M^*++XL_$'Q-XWUS5/#6E^//AUJ-IX/O=3NM&_I,"@8Z\'/+$G\R<D>QXZ<<"
MDVCGEN>OS-ZYXYX_#'''3B@#X"^$_P`1_CRG[47B[]FCQEXGOO%%A\+-/@^,
M.H_$34_`NAZ,_CGX/_$SPS9>%/A/X>FN_#NF:9X8M?$MM\8O#WQX;6#H5E8:
MC%X=^%GA5]0@6W\7227GW_7"^&/AMX,\'>(_'/B[0-':V\2_$?5=/UCQCK-U
MJ>L:O?ZK<:1IRZ7I%I%+K.HZA_9.B:3:&X_LKPWHBZ;X=TVZU'6-0LM+@U#6
MM7NKWNJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HKG-:\7>'/#LT%OK6J0V$US$\T"2QW#F2*-Q&[@PPR`!7(7#$$D\`CFL7_
M`(6AX"'_`#,EI_WXO?\`Y%H`[VBH+6Y@O;:WO+6036UW!%<V\JA@LL$\:RQ2
M*&"L`\;*P#*"`>0#Q4]`!1130P)QS^*L`>O0D8/0G@G(Y''-`#J*,Y]?R(_G
M10`4444`%%%%`!11_GU_E10`444?Y]?Y4`%%%`.>?Y@C]#S0`4449[>GL?Y]
M#^'3O0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M?,7QU_Y#6@_]@J]_]+HZ\+;H?H?Y5]C>./AQ#XUO;&\EU>;3C8VLUL(XK2.X
M$HFG6;>6>:,J5*[<`$$'.1TKB3\!+0@C_A)[OD8_Y!EO_P#)5`'L/A/_`)%;
MPW_V`=(_]-]O7050TJQ&EZ7IVF+*9ET^QM+$3,H1I1:P1P"1D!8(7$>XJ&(4
MG`)`S5^@""Z\_P"SS?9?*^T^4_V?S_,\CS]I\GS_`"OWGD>;L\[9\WE;]O.*
M_F,_LSQGK?P.^&.G?L[ZI\7-!_;TN_V9OVJ8_P!OS6/"4?BAOBM9?$0_LV_$
M22[B^(*^(;:\TG_A/+O]L)/AU9_LWM=VDVH0>`9]>N?@6]K\.HKN\@_IZIH4
M`YY_%F('7H"<#J1P!@<#CB@#^6O]E#XT_';P9K_CCXQ^!_C)XH^+&FZA\5O^
M".?PA\8P>)_"FD^(8_BLGQK\#_"OX'_%^\UOQ"FE:?+X6\0?#R^\6ZG/->>#
MK7PX=%\<>#;Z3XIC7Q=Z];6_J?@[]O']OC6?A#XO\7:S>>`-"\>SW_[+UAXN
M\&C3M/\`'7B+]GKXD?%O]LSX*?!SQC\,;OP%X=^&OA6?P]HNB?#;QY\0+35=
M#^+?CWQ1\38=6\'V'C/1M=_X175+O4=*_I"``XY[=68]/<DGZ^O?-)M`SRW/
M^TQ[YXR>/PQQQTXH`_.K]ISXD?M"?#OXG?L2?"#X9>+=3U-OBCK/QDT3XG^(
MY?!OA"^\1>+T^$_[/_B+XF:&+>YGT)?!7@?6O&_C'PK::-=:@FBP:#:6OB'4
M8-,TB.YATEK+\]_A7^VI^V[XU^!GQ`\9^*_'OPA\`:_:^&_V?->\:W6N7EMJ
M5]\"?'?C7XFV^G_%OX1S_P#"-?L_ZEX9^"LMGX0.K^&_"UW^TC;?%+5?A/XR
MTBT\2_&6]U#P)KJZMI_]#^,_YX_$=#^--VCD9;G'\;YX.>#NR/?&,C@\<4`?
MSJ7/[?7[8^LZU\,M.\#SV%AH)\+,O@OQ;\8(/A]X&LOVH?BII_[1'Q(^'?B;
MPSI7_"%>`?BE:_$_P+HG@3PO\/K[0_$/[.$GP_U[QK:_$6/XMV6F:5X1C7PC
MI'*_M`?\%(OVM_`.M_''6_A9>W.M:):^`/\`@H'%I'A#QCX,\.S^+O@Q\1/V
M9?!OC[QI\(&\1?#;PI\-CK7A33_'<OP_DLM%@^)7QE\=:Q\9?!NLV?CGPKX-
M\!I=P6=A_2KM''WN/]MO7//S<_CGCCIQ1M`S][G/\38Y]!G`]L8QVQ@4`?@]
M^TS\7?C3;^'OVW?@S\0_C]K%IKOA+X-_&7PI\./A/!\#K-=7_:!^&>L_L7^(
MOB3J/QTTWQAX0TF+4_!8TCXKZOXI^&V@^(-'U0>"_"$'PDL?!/C33?$GQ-^(
M6G>(9?IG_@G[\2/C*NM^,_@G\3/$E]XZ\/?#G]D_]A?XO^#]=NO`MGX7U>QU
M'XU^#_B_HWC3X>VS:9%%'K^E>&KKX,:+JNBOK4NJ>.;*X\7:AIOB;7=70:-<
M)^I)4$Y.?^^F`[]@<9YZXSG!Z@87'\L<\_Y]_7O0!_,L?^"C'[9-W?11>"_$
ML>L>'_B?X1^"7C#0];\3?#_PWK?BSX,^)]>_;P_8\^`WCGX5^.?AWX+\`^&M
M'^&_BI/A%^T1XMU'Q1\(_&7Q3^,GQ&\`:MX9CO\`4_'NBKI]W)?7?C_^U/\`
MM+^)?AS^VI\`O'_Q1U?PEH7PV^&W[?7PP\`?$JU^$>CS>+?VI/B3X5\)^'C\
M/_AA)9Z'H$&EZ+XETSP5\0Q?0V'PJT_POXK^)\ZP>(/"5[H]KX%\;Z=>?TM!
M0.[?BS'ISW)]/QZ'@F@J#_>_!F'IZ$<<=.@YQU.0#\KO&7Q>^(_PT^&/_!/_
M`,/0>,YO@S\+_'OA/0+#XO\`QQO/#.F^,+OPMJ?A[X):'K/P]^'MPGBC3=8T
M/P_/\6/%7V[2YO%>NZ7<SS3>'3X)T"73O&OCKPYJ5I^8/_!/?]I+]L?0_#7[
M)'P.GDTSP9X>M_"O[/7A_2=!^(%]9Z-XL^*OA#XA:AJ-Q\<?B?;^#O$7PP\:
M_%;5O$/P^OM1\4:3X;TK1O&/AGPQ\-O$'P[MK7XVPWF@^(Y=3A_J0*@\'/'H
MQ!_,$']>N#U`I-HR#SQ_M-C\1G!^ISV]!@`_GV\=_MO_`+9L/A_X;)'-IO@S
M1O#?C#5/V:?VEOBAJT?@;X8Z7H'[0GP7\(^*]5\<^(/#_BSXG?#SQ[X!T#P=
M\8M?O/`\/@F_U?PKK'AF^M--UOP?X6U"R\7>)-#U*TXWPI\>_P!H/PO\9OC/
MX\\6:];_``JE^*]C_P`$N]'_`&A/C)HOA+7_`!-X$^`N@>+/V=_CYXB\;^//
M!6C?$'0+?2=*TK6/B3I/@3X;#6_'GA$Z=X"'Q)M/$/CSP^3H/E+_`$=E0?7J
M3PS`\^X(('MTSSC(I=H/'/;^)ATZ<@Y^OKWS0!_.(_\`P4`_:R?Q'XC\-R?$
M>QL_&7A;X(_"/XA_`'P(?@;#:7_[9VN:_P#ME?M;_!?PA]HT_4=-FUKP+9?M
M(?!+X1?"[QS%H7AZ\T'5O!<_B2[^(VCW6G^`=&U[2)MOQ)^V%^VW%X%\1>*M
M*^)1M+O4_@9_P5R^*NC6@^"'AC4U\.ZY_P`$[OVHE\!?!'1+`G2XI-7L/C1X
M"UZVT_XA6^JQW6I>(;/0+'5_A1=^#]1OM4UF;][+3X=>";#X@Z]\5;/PYIUO
M\0_%'@[PE\/_`!!XMC24:QJ_@WP)K7C+Q%X0\.WT_G&.;3?#^M?$'QIJ.G1&
M(/%<^)-49I'6<(G:8^O?N>_7O^7IVQ0!_.E>_M_?MP:C<?M&>)ELO!/@:]\'
M_"G]J;Q?H7P@O+G2O$?B3P?X0^'?[.OBOX@_`GXHZ'X%L/A=<^/-7OO'/C+2
M_!&JW/B/QU\19/A1XG\.>,]0\(^&O#]IXYT*VTR_YKXK?'G]K#4/BE\#=#\=
M_M$>/_!/PZ^&GQH_X)[?'7XH_%#PKX#\'>`M!T[P1^U%\(?VJM.\<^`?'\DO
MA?5M"F^$OA+XD?"_P+8Z.?$K7>H:;J/Q1MK7QUK.M:EI7@K7-*_I2VC.?FY&
M/O-CICIG`/'4#.<GJ31@'U[?Q,.G3H?S]>^:`/S;_:%^/'Q)\'_M0>$/AK+\
M4V^!OP_?X=?#KQ3\/;K_`(4S>?%9OVC_`(J^)?BWK?A/QW\'@MO:W&L6P\`^
M"]+\%ZI)I7@:]\/^,ROQ4'CV]UF7P=\/M=L)_BO6?VSOVO)I/'*>'_'WAG1O
M'LFE?M5Q_%/X<>+_`(2ZAJ/AC]BA?A;\8=%\)_`_Q%KNO^"O"6M^,=8M?B5X
M&GF/]N>+=.\>:!XMN==M?CIX2T"S^#G@+Q?H%[^_!`)!YX]"1Z'D`@'IWSW'
M0FDV#G[W/'WFX_W>?E^JX([4`?S=1_M)?M`>+OC'^RW\2H?VC?B5H/@_PFG[
M=/PEN-:\0^#/`/BGX`_&3XMP?#KX'^.O@'8WNL?`;PT^E?M":;KD_B+Q)X=\
M.Z]\*=%^'?BSQ#KWP^\=_#WP'X0\,_$/3_%?_"2_HM_P3I_:(^(7QHLOB=X<
M^(WCVY^*NM^"+;X:ZK-\0=#TGP!?_"^[OO&>CZ_'K?AOP1\0_AYH7@.'5K[1
M-8\+W5_K7PW\=?##P?\`%3X4Z3KOA6R\;W?B:7Q%8:E!^E^T>K=2?O,>OU/(
M]CP.PI0H7IG\69NG^\3^/KWH`6BBB@`HHHH`****`"BBB@`HHHH`****`"BO
M*?B#\</A7\*[_3M,\?\`C&P\-7^K6DU_I]M=VVJ3O<VEO.MM-.AL+"[152=E
MC(D9&)((4KS7GY_;#_9L`)/Q5T4`#)/]G^(N`/\`N"T`?2U%9NCZOIVOZ1I>
MNZ/=)?:3K6GV6JZ9>QK(D=WI^H6\=W9W,:S)'*J3V\T<JK+''(`P#HK`J-*@
M`HHI,C&>?3H<_B,9'XCWZ4`+129^OY$=\=2,=ORYZ$4M`!1110`4444`%%%'
M^?3^=`!112`YSUXXY!'Y9'/U&10`M%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`?D#_`,%("1\0?AM@D?\`%&:UW_ZC
MT-?G(Y.QN3]UNY]#7]"?QE_9F^'7QSU?1=:\:3^)H;S0M-N=+LAH6KPZ;`;:
M[NTO)3/'+I]X991,@".&0*F5VDG->.'_`()[?`<@@WOQ"P00?^*IM.AX_P"@
M%0!]-_!3_DCGPH_[)OX(_P#4:TVO3JQ/#.@6/A3PYH'A?3&N&TWPYHVF:%I[
M7<HGNFLM)LH+"U:YF5(EEG,$"&:41QB23<P10=HVZ`&N"58`X.TX/!P<<$`\
M9!Y&:_D`NK;XJ:'_`,$[_!/[*3VWQ2C\*_#OPM^QG^V_X<\46]MXUDDOO!OQ
ME^+7P.U+PG\(+KQ8LCZC>ZMX-_::U+X_:YK/A:]NI;_1?AO\./A_'J5M'H6O
M6R/_`&`TF![]NY[?CU]3U(X.10!_*JWQX_:'^'7QG^)GQ(^'/AV#3-773/CG
M\-]9U6+2K'P/X,^'_P`-9O\`@MS^UQX#\1_%FYAU[PYXC\#6/B+3OA[I6BZA
MJ_C_`,2>&=?TF*_\32?%KQMI6L>%;75HI_J+QQ^VO^U3X-^'_P`'/'_B?XJ>
M#;/23X8^+^OR>&_ACHGAGQO\3/CL/!GQ>N-(\"2>"YO''PO\`_"SX\ZMKGPX
MTXZ5K'PD_9_\3?!GQ_XO\;ZA9^-_A5JVK?#W7]#L[3^@@J#Z_P#?3#OGC!X_
M#MQTXI"@..6XR.'<=3GG##/U/('`XH`_G-^&OQW^/?PI\;?&KX9_$;]J3X@^
M#O#NK?M_?M/V_P`1/BY\2_"O@3Q/KO[._P`+;GPGJ?C;]F70=%TC5_!+>'O#
M'@KX]R6UPOA#Q'XLTC6_"1MO!EU\/_`,.B>+/%UE)::7@O\`;@_;PU*VOOB%
MXMM6TW4O!GQ)_P""9?@>^^`$7PDLM"M_%ES^V%X=^'&@?%2SU77M<M+GQEX3
METW6O&J>-O#%K%JD%W\,=9FG\+_$:\U_2=/N[#3OZ("H/K^#,.V,#!&![#`S
MSC/-+@>_;J2>GU/Y^O?.30!^1O\`P35_:7_:@^/M_KLOQTN?!=Q%_P`*M\">
M*?%OAS2M6TR\\4?"'XS:]J>HQ^*_A5>:+X9^&'A"W\%:-H5M'/8#P+\3O%7C
M+XS>&]2\/37GB#6-4T?7K.[@^%_V@?\`@I#^USX&U7XX:U\*M2NM5T>+X<?\
M%`H='\+^,/`WAV?QA\$_B1^S5X(\?>,_A!<^(?A;X:^&[:WX3L?&\_@&2VT2
MP^*'QF\=:S\9/!VKV?C3PUX.\!)=Q6=A_2T%`SC//JS-Z^I..O;^@I-HR3EN
M<_Q-CGT&<#KQC&.W04`?A[K/[5/[1OA/]ISQW^SM\0?C/)X&^$G@7XMV<4_[
M3MU\'/#-UJ6H77B[]G;X:?%'X=_`5M%AT2\\&65GXH\9>(?B3#H_BM=,N?%>
MM:3X%TSX5V.NM\1M8MO%6IQ_`OXJ?&;X&?\`!*/_`()D>-M(N]0T#^S8?V%]
M`_:+UCQ7X=N-1O/#/P9\0ZEX?\-?&35/%5MXDAN]8\,1Z7:7\0UWQ!?8U/P;
M";C4]2O;6&PO[Z']QRH/K^#,.V.Q''MT)YZ\T8!&.?S.?SSG]>1P>*`/YEA_
MP4:_:RO&\;6=W\5+?PSXQTCX&_M&_%WX(>`KSX$6-QJWQ[^)_@'_`(*%?M3?
M`_X%_`V?3+G08=<L['XK_"WP#\+O!WV+15T'Q_J\ER?'^A:SI\MCXJFO(O@C
MXY_:P^&7[0/Q7A\!>*O%WQ*\6?&K]J/_`(*9:KXL;Q=\.?`C>,/'&F?L6Q^`
M7_9V^$&C^-[?P7I46@>&?$0U[4?`&FWEXFHZ;IGAW5M7D^'UIHNJR1:Q9?T:
M1_#+P'%\2KOXPQ^&-,3XFWW@?3OAK=^-%28:Y<>!-)\0:IXJTWPO+<^=L?2;
M/Q#K6JZK!`8MR75]<-YA1]@[K`]^_<D<]>,X^@[=L4`?SU:#^V9^UCXFU_X$
M>$?!'QJ_X3GPW\7?B/\`L@>&_B'\6H?@/H.D7'PK\=_&;P9^TI?_`!W^`NG:
M!=:'#I=AJ/PXC^'?P[\4:9;^-+76?''PHU+4X-`^+.J>+T\3:;I4G0?L4?&C
M]H/XD?MO>%O$OQP^,_CVRT'Q7^S3\9/A;X/^'.H:!X>\(_#3XL?$O]FG]MG]
MH_X0>(O%FBZ"?#D3V_Q*OOA9X"\%?%KQC;>&-5LV%GXGWV$+?#>ST71M*_?0
M*!T+>O+,>G'<G\1T/4\TN!G//&>Y[\\C.#[9Z=!@4`?B'/\`M;_M5W7[6GQA
M^'GBG7_"'P?^'?A+Q_\`%SPL-(U/4/#6J>)O#GP`\*?!+5?%7AC]I/PY\/X_
MA+XA\<^(]<O/%5OIWB:U\1^(/'T?P1U/1Y+_`.$S>&?^%E6=O_:'F&N?MX_M
M$0ZM^SSX1^-7Q<M?V2/$'C^']KW3_CW]H^#^B>()?@]XH^#/P]^`?BCX/66A
M_P#"2Z9XCL+S3O'_`(=\90_$]IM3_M@ZD?BI-\++*YL?%VBZ!%HG]!6T9SS_
M`-]-C_OG./?IUYZ\UP^M?#/P'XB\=>"/B;K?AC3-1\>_#?3O&.D^!O%-Q'*=
M7\,:;\0(=#M_&=EI4Z3(L$'B*'PUH*:DC1R>;_9=HR&-D+,`?AA\&/VW/V]_
M'7Q:\/:-\6/"OA#X.ZU-IWA(:]\%-5OM(L=>F\$ZC^RMHOQ+\3_%/P]X!N/A
MKXB^)MQK%K\6=1UNQT[6M4^)>F?";PW9>&KWX0>,=+/Q*MKC5KOEM!_;3_;0
M3X:_"UO%OQA\)Z%J?Q6_8L_8(_:N\6?$+Q?\-M(^'6E?#S6?C7JWCK0?C1\-
MO"OB<_#WQWX#\`W&HC0/#6H>&/%7QY\)>*?#/@K7)];TWQ5?Z;8>+O"2>%OZ
M,-HSGG_OIL=,=,X[]<=>>O-*5!X^;MT9AT.1R"#]?7H<B@#^>CP[^WC^V+XN
M^(OPAT;0DL-&\,WVA_!ZW\*W7Q7M_!'PUNOVEM>U;XY^/OAU\9;[3?#^@>!O
MBM?^.-$T?PQX4T2X\"ZW^S_XG\(:*MMXDT/XX^)E/PH\9:/H>A_6O[)'[3GQ
M<\9_M1>/?A'\3/B$OQ*^TVWQNUBRM/AWX+T*V^'_`,-++P#\6=*T/PCHOC*U
MU#PYX(^.'P1\87_@W7[/3$\)?&2P^(^G?%;7=&\6>,_AI\1K3PMH]IINL_K#
MM''WN/\`;;GG//S<_CGCCIQ2A0#GGOU9B.3GH20/;`X'`P*`%HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
$H`__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>biib-2015630_reserveschart.jpg
<TEXT>
begin 644 biib-2015630_reserveschart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`&I`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^3?VV/VF)?V2?@'?_&6
M#1?"&MS1?$GX%_#>)/B%X];X8>`M&D^-GQM\`?!M?%OC7QXGAOQ:_AOPIX,/
MCG_A*]?OD\/Z@[:9H]S;JL#3"YA^LJ\'_:+^`^C?M%^`=#\`:[K>H:#8:)\8
MO@#\7Q=:=9:=J$E[??`/XW^`?C9I>@W5KJD4UHVE>)-2\!6N@:Q)Y9N;?2]1
MNY[(K>1P,`#PGP7^W9\*;?1O"J?%SX@_!U/$OBEM%U!-6_9W\5>/_P!H/X+:
M%X5\9>.K[X:>`/$WB_XTZ7\+O#?A?P+I?BWQYI.L>#M.U'QPOAW1+GQ+H^L:
M;I^K7XT36KC3NVU/]M/X-/\``/XW_M$^"#XU^)'@;X$Z%\2M2\3+X6^'_C:.
M^UG6?A1+XIT_QIX3\)#6?#^G0^)=>\/^(/"&L^&_$"Z*]_9^&]7M9X->N;#[
M-=>3Q?QJ_86\*_%[QWXO\1P>/O$W@CP?\8_!_P`,_A]^T)\.M`T3PG<Z/\5O
M!OPA\6^)_%O@S2[;6-2TR76O`5S=GQMXL\*>,=2\-S/-XA\&ZN+.RCT'Q%IV
MG>*+7OOAA^R7X.\`?LS^+?V7]3\0Z_XL\'>.;C]HC_A)-8G2PT37)]/_`&C_
M`(D?$[XA>*["R.EPFSL#I#_%'5=%T2ZCA>9;73[&\NEENVGW@'S=\&_^"I'P
MB^)GCJX\->*?"GC+X4Z!J'PX_8S\;^%/$7B[PWXV>>35/VR[KQYHG@KPQ\1+
M*U\%C3/A,8_&/A/1O!?ASQ#XRUZST7Q[XA\7Z1;Z%/%%/8R7_P!?_"?]J'X)
M?&[7M0\.?#?Q==:UJ-IIEWX@TV2^\)>,_#.E>,O"VGZRGAR_\9?#;7O%/A[1
MM$^)W@JQ\020Z/=^+_`&H>(O#L%Y>Z5YFHK;:YH=QJ7Q+H/_``2YT.U\!_$#
MP9XH^-_B_P`4W'C_`$#]A7PG?:U_PAO@_0FMO#O[!?Q9N?B/\.K4:5II>PGO
M/&6E'3_"'CJ\!MHI8+2?6M`LM'O+W[';>N?L@_\`!/?X4_L<^(M4U?X>_P#"
M--90>$G^'?@R/3_A!\)/!_BO2O`;ZS8:TNE>,_B7X6\+67C[XGZM;OH^A:8F
MM>(]:M8K[3]$L+W7=(UGQ6+CQ1.`>`_M`?\`!0[X^?L\>,/VQ+;Q1^S_`/!C
M6?`/[(OP&\%?M%ZKKVD?M`^.;?Q1XO\``GQ4\4?&SPMX`TV'P[J'[/<.B:%X
MCM+CX+:C?^.EF\6:CI&BV.NV1\/ZEXGGL[J,_7J_MW_LP_\`"1:?X.G\>:Q8
M^,M3\=>*_AO;>#M4^&WQ/TCQ;%XN\%^%O!?C[Q!8ZGX;U3P=9ZQHEC9_#?XA
M>$?B<FOZS9V'AV?X9ZJ?'T6JGPMI^J:G9<1^T)^P9X4_:"NOVL[K5OB%XI\-
MM^UA^SK\&_V=]>72=,T*Z'@_2/@YXO\`C-XOTWQ-H)U"%S?:QK5S\9-1L]0M
M-5\S3[>WT/3I+)%FN+PMA>)/^"<_PY\8?M)^-/VA?$WC3Q3JL?CWQ)\1]:\1
M_#QK/2K70+O3OB;^R=\)?V3->\/IK%JL>OP6:>%?A5;^)+>[AN8[Y=<U_4;?
MS!8VMB$`/5M._;J_9GU3PS>>*[+QMKKV$?\`PK^30M/G^&/Q3L_%'Q`L?BQ?
MZIIGPMUCX4>#;WP7;^*_BQX?^(U[HFMQ>"O$/P[T;Q'HGB"+1M6O+.^-CIMY
M=0^OV'QV^&&J?"JY^-.FZ]?7_P`/[*'5WO+VS\*^,+KQ#:7N@:W=^&==\/W7
M@.W\/R^/K?QCHOB:POO#.K>"9/#"^+M/\26=UH%UHL6K026B_FOI'_!&W]G_
M`$OX9'X?.?!5W/X=USX5ZQ\/-:7]G;X#:;#;'X.67BS2?"S?%K0M*\(V=E\=
M[WQ!H?C;Q!H_CV?QM<VNGZJES'KGA'1_`?BU)O$5S]<W'[&/A+_AD74OV2]!
M\5ZGX!T/5+*]:X\3_##PKX#^&GEZOJ?CG_A8FL);^!_!/A_1?`\?@_Q'KC7.
MA^+?!9TI[;QAX$U/6_#7BC5=6N]=U?7KP`JS_P#!0K]E:U^P6MUXU\70^)-1
MUKQ]X:B\`#X-_&:X^)]MXE^&'@KPE\2?&_AW4OAE:>`;CQWI>M:+\._''A?Q
M[_9]]H$$VH^#M5A\1:7]MTR.>XBX3XF?\%)/@AX;O_A)I7PON)?C)<?%#XZ_
MLQ_!M]9\.V'C&U\`:%#^TU+X9U;PWJI^)\7@S5/A]?>*K/X=>+=#^)EM\-Y/
M$6G^)M3\)ZKI%_,NEV^L:?//P'P?_P""6/P[^$/Q;MOC#H_CZ\M]8E\7?%#Q
MWK'A;PE\-OAM\-OA]-XC^*_[.?PD_9U\0#0?"'@G2M-T_P`-:1;:3\(M(\5V
MEG;_`&W4+SQ)JNKW&O:SK,L_VQ\?X:?\$I/#'PL\'_!GX9^&_CQ\1E^&/PH^
M(O[+/QNO_",_AKP*S^-_C7^S%X7^%O@JV\7:IKPTW^UM)T'XAZ%\)?#6H^*O
M!>D2)9V/C!KW7]"U2ST^XE\.R@'LO[0'[;]W\&OCQI7P,TWP7\.[C5[[X=^%
M_B'I=U\7/CKH?P(E^*\OB?Q7XK\)O\-?V=I/%7A35/"GQ.^*OAJ3PS;ZKXK\
M-^(/&7P^L='MO%_P^AEU0P>*I]5T+N?#?[;7P>O/&'Q`\#>*?$^A:1XD\+_&
M/QC\(/#ND:!;^/O$=_XCU[P;9_!][_PY*MS\/]"LQ\2%O/C-X5E?P/X5O?&4
M,_AVY?Q-I'B'5M.T3QJ?"5;]J+]D34_VE]*\7^#+_P"-GBSPW\+/BEX&/PX^
M*7PQO?!GP[^(7AG4=`>#6[.?Q!X!'CG0M1G^''Q#NM/\07=E<^*+;_A(=*<:
M=H&H1^%8=:TD:G<^4)_P3<\*VFN:_P"(M+^+WQ#T[4D_:*U;]JGX:21PZ3<_
M\*W^-5WX(^&/POTOQ(LEV9KGQI!IGPN\!>)_AQ>6'BFXG3Q'X5^,GQ4CUV6Z
MU;5=$U70@#U_X_?M;CX#_M$_LG_!C4?`3:UX3_:1OOB-H^O_`!+3Q&=/7X6:
MOX>O?AKX8^'*WGAG^P[Y_$FF_$KXC_$_PU\.Q?QZSHQ\.:[K?AV5X-6AU5UL
M_(/AG_P4J^'7C#XB_M*>$?%GA+7/"FA_!WXW>#O@S\)=5\-6OBOXK^+?VBKG
MQ3\+]2^(CZUX)^&OP_\`!>J^*$%LOA/X@S6NG:7'XE6X\#^$)_B#?W^DZ3<R
M6UG[E^TS^R-X:_:9:237?&GBOP;=Q?`WXS?!W0M7\(+ID.N^$]8^*'B[X(>/
M_#/Q7\,:G?V]RVF^/_A#XY^`W@WQ;X"N&AGTY-<A6ZU2VNDM8(6\#LO^":_A
MWPEXUNOB9\,?C#XS\$>/M'\4?!_Q/\-M7F\->$/%&G>##\+OV9[[]E74M%U#
M1=6M8XO%NC>//AUJM_J.N)>7FF:CI_B^/2]:TC4H(K":RO@#VG3?^"@7[)FM
MZKI6D:#\4I-?GUBV^"EY;WNA^!?B-JN@V=K^T9=7NE?`Z77?$UEX2F\/>&C\
M3O$UA<^"?"D'B34M)N;[Q\J>!9(8/%,@TL?'_P`)_P#@LM\$OB+JV@ZCXB^'
M/Q2^$_PPU+X)_'CXQZSXS\?>"?'J:]X2T[X"?M"Z9\"O%5YXC\$Z'X'U.ZTW
MX?V=O?R^-O$WQ1O-1M?"W@:SLK[0O$TEKJNEZU_9OHOAO_@EM\./!_AOQYX7
M\/?$_P`?16/CG5/V(==NKO4;#PO?:I'KO[&'Q[F_:(BUNZGAT_3[._U+XQ^/
M+_6+CQYY>GZ?I^DQ:M<)X1T_2X(+.U@YC3_^"3OA#3]+^.WAF/XU>.#X1^+'
M[-'[7'[+?A72!X8\)+>_#?P%^UW\2[_XM^*KZ+6=K3>,==\'^,-;UY/"MUKE
MI:0S:!>6>FZ]%J=[8RZO?@'W3X%_:F^"GQ+^(>O?#+P/XCUOQ!K_`(<UCQAX
M;U#5K3P!\0X_A]-XI^'FHKI/CWPGI/Q4N?"L/PTUSQ5X,U)Q8^(_#FD>++S5
M]-NXKZV>T>;2M62PCU/]JSX&:1\2[[X37OBZ^'B[3-87POJ4MOX-\;WOA'3_
M`!M-X+'Q%L_AU>_$.T\.3^`+;XEZAX&:/Q5IWPZE\2KXRO=%N=/NK?1G.J:7
M'>^)>`OV%],\$?M&V/Q_C^*.NRS:2GB)H=#T'P1\/?`&J^,/^$F\+_\`"*R:
M#\9_&O@71=#U7XU>"_"=J+?4_A]HWCK3[S7O#>NZ/X<U>_\`%_B*[T.W>3G+
MG_@FW\'A^TKXO_:,TP>'+/5O'?C*X^*/B"#4?A%\*?$OC.#XES?#W3_AN=4\
M,_&#Q#X<O_B)X3\+2:9I&D^(9O"FA:C:W,7B^TN+_2?$NCZ'JVK^';T`]#\.
M_P#!0S]DKQ9X/D\;^'?B9J&IZ+/X9^#OC'PY!'\.?BA!X@^('AK]H'49]$^#
M6K_"WPK=>#8/$OQ2M?B%XAL]1\-Z"_@#2_$6_P`0:5JFE7GV2XT^Z\OS7X4_
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M>ZOH'BGQ-XML?#?B'1M(O8QX4\1/HGB/0O$=UHOA_5],`/J+7/V\OAA_PT1\
M"_V>_`EGJ7CG4OBQ\;/BQ\$O$7BV/2/&>@^#_"'B+X/_``3^+'Q5\7P^'O%^
MI>#?^$%^)VL^'M>^&4?P\\8^'O"?BY[SP=KFM7"ZO,NH^']3T8:WQW_;9^'O
M[./QFTOX?_%:V_X1WX?-^S5\6_VBO$WQ2\[5M4_X1JS^&/Q;^`7PHA\/?\(=
MH>@:IJVK?V_??'2TO_[4LKH2:9_8?V9M+O(M1DO=.Y'PO^P9IOA3XN_"OQSI
MOQ?\9CX=_!#X[_&W]H/X7?!QO#W@R/0M"\9?M$^$OC9HGQ1T_4/%5OID7BO7
M/#S>(/CMXU\5>#+"[N8I_"KWTFA37>NZ3'I"Z))\=/V"/"_[2OBCXP>(/C'\
M1?$^L6WCWX'>+OV??`&E>'M$\,>&D^%'@7QWXI^'WQ`\3WUG?BTU2\\:^*KG
MQ[\*OA_KMCJ/B@G1K"S\.IHR^'9H=4UJ[U$`[;Q;^WS^RSX*\6>(O`FM_$'6
M)O&GA;Q;\0_`VK>%?#GPT^*/C'Q`?%'PH^'?PO\`BS\0]-TS2/"/@W6[_7!X
M5^''QB\`^+]2O-&M[ZP_LG5+YX+J:;P_KT.G=5X:_;'_`&<_&/C'P_X*\*_$
M2/Q!>^*)O#MAH7B+2O#7C"\^'&H:_P"+_A_8_%7PIX0B^*L7A\_#9?'/B3X;
M:GIOCC1?`\OBF/Q5?>&]1TW48M)*:EIZ7/S3X+_X)N:+X=^+US\;]?\`C5XX
M\7>.];\3_M">-/%<USX<\):-I>L^(_VB?@-^SK\"O$CV>G:3;HNBZ3X=TO\`
M9VT+6O#.F6\UU(EUKFH6>K7^II:6UY+R'[./_!)3X)_LW>-/ACXM\-ZII'B2
M?X?Z3\,KN]U3Q9\&?@YK'Q$U[X@_#3X,^$O@K;^*++XK7_A>^\:^#-!U[2?!
MFD>+=3\&>%;NS%CXU;4+GP]XDT?PUJFH^&+L`]V_:V_:_P#$W[+UYI=\?AKX
M,\4^%KV/PY%IEGJOQO\`#W@WXM_%SQ-KGB(Z'=_#3]FWX1MX:\0ZI\6/B9I%
MK=:)JO\`8&L:SX#T_7)]?T30=#U>ZN[G4K[1LS3?VX9[SXB:9%=_#6RT_P"`
MWB3]I_Q=^QUX:^*[^/H9O%5W\;O!,WBCP[J<VH_#2/PP+33_`(=ZG\3O!?BC
MX4Z'KL7CR]\62^*;'3-3OO!%GX4UR/6=.[']I3]DO6/VC[?Q5X1U;XX^,_#?
MPC^)?A-/`_Q)^&MMX3^'OB!)=">&^M-4OOAGXNU_0;CQ+\*_%GB&POELM5\3
MZ=/KUQI\NF:-KO@VT\)>++#_`(2&;,T_]B/P[9?%.R\4R?$/Q5>_"C1?CGXA
M_:A\/_`RXTOPU_PCFE?M`>*H=<;6?%?_``EBV'_"77GA<^(_%'B7XEZ?X)N;
MHPV7Q0UJ;Q&VMW.CV6D^%]/`/I'XK^+/B!X6\-65Q\+OAM_PL_QAK6OZ+H.G
M:1>^*;'P5X9T:VU*61]2\6^-/$]S8ZWJ.E^%O#VG6US=7J^&_"WBWQ/J5])I
MNCZ+X=N[C46N++XC\-?MW_$#XB7FA_#CX9?`70O$/QZ;Q%^T[I7BKPIK7QFM
MO#_POL]'_9-\=^"_AO\`$+Q%X/\`BE!X`UK5O&-EXG\<?$;P7X0\#I-\.?#[
M6_B&?QCI_CM_"=W\/M=M9_:/B9\!/CY\3?V:M"^#S?M3>(_`GQ0E&@Q?$#XV
M>#?`'A6VUKQ=I5I<74_B7PY9:-87'AZV\'6GBNTEMM"O]?\`!5[X=\4Z9I4-
MW/X6U7P]K%]'JEAYYHO[$WBSP[X9^$K^%/CC:?#;XH_!GP_X_P#AOX,\;_"?
MX&_#;PAX4L_@S\2+SP;J6N_#8_";59?%OA=8].UOP!X2\4^&_$4=^NH:;XGT
M.WN[ZUU?1]1\2:!KP!G^$/\`@H5HWQ&^*7[%O@[P/\(O&-S\/_VQOA_XN\=:
M+\6?$6L^'M$TGPU=>'/A1%\48O!=EX=LKG6]9\7>([2'[9H7C:]MSHWA?PAJ
M]K%86FN>)M1N9K+3[WP$_;3U3XR_'?Q7\+[^W^`OAK1=+\1_&;P[X:TRT^+_
M`(WU?XRZ]+\(OB#K?@2[EF\&:A\&?#_P]:\*:!<>(?%7A_PQ\6?%>O>!--U#
M25URP)GFE@X_6O\`@GOXITSQ_P#LG:[\(/VA)?AG\/\`]C;PQ<^$_A+\.[WX
M/>$_'4EUIVO>`+?X;^,I_%_C/4_$6DZQK>H^(M`AEO%O;:RTR2QU^[N=4F&I
MHXLQ]#Z9^S7XGG^+'A#Q]X]^._CKXB^%OA9XS\9?$+X2^`]8\.>`M(_X1?Q7
MXW\+>-/`]W<Z_P"+_#NA:=KOC2P\+^#OB'XP\,>"=/O(M*-GINK1WOBZ[\;^
M(M-TW7+8`ZSQ5^U+\%O!/Q,TCX3^*]?\0:%XHUWQ'HG@O2M1U#X>?$6#P#=^
M./$VGV>J>&?`Z?%%O"G_``K8>,O$=G?6O]A^&CXJ_M34;VYL])A@_MB_L+"Z
M\D\-?\%&_P!D#QAX4@\8^&OBAJ&K:3JGAGX7^,/"-O!\-?BI'KWQ(\._&C6'
M\.?#+4/A1X9N/!4/B#XJ+XI\30W?AJ*'X?:=XBFTS7K&^T[6X],>UF=?,?BM
M_P`$U/!'Q;^/J?'/Q'\1=;N+ZQ^._P`#?VAO#UMJ?@?X?>)?%7A#Q7\$=1^'
ML]AX$\&_%'7]'O?''A+X)^(K;X?I>ZI\,?#5YI-I%XN\6>-?%":O<)XCO]$E
MXG1O^"4OA#PW8_LSW'A_XU>/+#QC^R;^S=\'O@/\(_%TWASP??RVFL_!CQ)!
MK6B?$76]&N;<Z;JESXBT:77O!/BSPFAM-)N_"_B;4SH]]HFO6VCZUIP!]'_!
M+]KO4OCQ\%OC9\6/`7P@\0^(-5^&'QJ_:#^#/A/X?:;K-KIOB'XB:E\$_B+J
M_P`.]-NY)O'.G^#(/`UWXKO]-6[U;2_%$,;^"4-]!J%QJ4NG,MQY;=?MU^.]
M&\8>)/@7KGP2\-O^T?:?%_X1_![PIH'AKXNS:W\&=?UOXP?"_P`=_&FSN-5^
M*E_\.-!\3^&KOP#\+_A=X^\6_$#PI-\++_Q5#IEMX(O?#>GZW8?$GP[=1>K_
M``]_9/\`$WPC^!/QJ^%GPU^/GC+0/B#\8/B/\;?BU%\;[_P?X#UWQ-X,\??'
M+Q=>^-=>UO1?"-WID7@>_C\/ZSJ=\?#&FZMI4^FVML+"WU"VU&.R87/E7@+]
M@;Q'X5^&6F^"]4^.OVOQ=X%^+.D?';X4?%#PU\)]`\.>+-#^+<.A^*/#7C/Q
MM\29-:\5>-YOC7K7Q5\.^+]?\._$;4_&.HVVMZMHVM:K'IFL:/J/]BZGH0!0
MU_\`X**WFB^&_A'?1?`3Q%JOB#Q5^V!X:_8[^,L%AXW\/GP7\#?'.J?''0/@
MAJ6H3^,+JQM-5\?"]O\`Q-H?C#X?Z%H?@O3M7\3^#-1BUCQ4GP^-IJ%M;^L_
M'7]LNR^$7QZ_9S^!>A^!I/'=Y\9/BWX;^&?C_P`10^(X]%L?A%!XX^'OQ;\;
M>!KZ>U.D:FWBSQ%XGE^$7B!8O"=M<Z/)I7ABWNO%FKZI:0W'AK3_`!)XS\3/
M^"=_B[Q5\/OA[X#\#?M)ZIX(D\/?M`Z1^U?\0?%>K?!_P-XW\1?%+]H/0_B]
MI/QKT[Q7J1EU3PWI7AGPU%XITFTT4>#O#^G+%#X(L]+\.6>L6KZ>-2N>C^(_
M_!,SX*_%'XB_"+XQ^(/$/Q'TOXJ>!/CKX%_:&\>Z]X0^)?Q9\,^&?BS\0O!?
MPGU7X4B\U/X<67Q+?P1X.34M-NM&F>[\):3:ZM;Z7X=L_"4FHWOAK4M=L]2`
M/T>4[E5L8W*#CKC(SBEI%4*H4=`/\_3Z#@=``.*6@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`#(]>O3WHK\A/V^OB
MY\4/`7[>_P#P1Q\">"_B!XM\*^"_C#^TC^T1X;^*GA70M;O--T'XA:#X>_99
M\;>*M"TCQ?IUNZV^N:=I'B*PM-:T^TO5DAM=2@BO(U$\4;K^O$;`HA+`DHI)
MR.20*`'T4F1ZC\Q1D>H_,4`+129'J/S%&1ZC\Q0`M%)D>H_,49'J/S%`"T4F
M1ZC\Q1D>H_,4`+129'J/S%&1ZC\Q0`M%)D>H_,49'J/S%`"T4F1ZC\Q1D>H_
M,4`+129'O^`)_D*,CW_(_P"%`"T4F1[_`)'_``HR/?\`(_X4`+129'O^1_PH
MR/?\C_A0`M%)D>H'UX/Y&C(]1^8H`6BDR/4?F*,CU'YB@!:*3(]1^8HR/4?F
M*`%HI,CU'YBC(]1^8H`6BBB@`HHHH`****`"BBHIIDMX99Y-WEPQO*^R.25]
MD:EVVQ0I)+(VU3M2-'D<X5%9B`0"6BOGF;X\:Z#->V?[._[0&H>&(IG0>)XO
M#W@*Q:2W294-[#X$UKXD:5\5Y;<QEIEA_P"$!759$4K%I;RE8F]YTW4+?5M/
MLM3M!=+:ZA:V]Y;K?6%]I=XL-S$LT:W>FZG;6>I:?<A'`GLK^TMKRVE#0W,$
M4R/&H!^)'_!2Z+S_`/@H]_P0LB\V>'?^U9^T^/-MY##,N/V._B`WR2`$J&QM
M<8^9"R\9S7[1)H.40_VOK_*J>=6D)Y`ZGRAD^IP/I7XQ?\%)_P#E))_P0I_[
M.M_:@_\`6.?B#7[>1_ZN/_<7_P!!%`&%_8'_`%%]>_\`!K+_`/&J/[`_ZB^O
M?^#67_XU7044`<__`&!_U%]>_P#!K+_\:H_L#_J+Z]_X-9?_`(U7044`<_\`
MV!_U%]>_\&LO_P`:H_L#_J+Z]_X-9?\`XU7044`<_P#V!_U%]>_\&LO_`,:H
M_L#_`*B^O?\`@UE_^-5T%%`'/_V!_P!1?7O_``:R_P#QJC^P/^HOKW_@UE_^
M-5T%%`'/_P!@?]1?7O\`P:R__&J/[`_ZB^O?^#67_P"-5T%%`'/_`-@?]1?7
MO_!K+_\`&J0Z!P?^)OKW0_\`,5E_^-5T-(W0_0_RH`_F-_;E^%WQ:U7]JOXN
MW_AS]M']L+X<:+<:CX:-CX*\`_%_5-#\(:$D?@CPS%-%HNE0,D5G%=W$<VHW
M*(H#WUY=3'+2%CX+X*_9=_:6\>SZA#H?_!0;]N"*+3+.XN;R^UG]HRYT/3HY
M8]/U+4K;3Q>ZE>V\+ZCJ,&DWYL[=6(6.UNKV\DM=.M+J[A^[/VQ/^3DOBA_U
M_P"@?^HAX>KEO@GXX\/^#-0\0GQ%JNLZ;9ZIH>JVK6]MH6A^*_#VL;O#WB"S
M@TW7/#>MF%)[M[S4;?\`L?4(KI((_,O]+U58M,U2YN[?VZ7$><T:5.C2QD8T
MZ5.%*G%X/`2Y84XJ$(\T\+*<K1BES2E*3U<FVVW\[6X4R#$5JN(K8&<ZM>K4
MK59?7LQ@I5*L^><N6&+C"/-.[Y81C%7M&*5DOC>?]E[]J2T\-ZQXMO/V[OV^
M++0-#UN#PY?7UW\>M1@W:S/=WEB]I8PFZ,FII9WEC<6NH7M@)["RN%2&6Z\V
M14J#7/V:/VG/#6B>&_$&N_MY_M[Z9IWBU=1DT+[5\>=42]NX-,73I)[F73A<
M&]L;::'5K"XL)+Z&`ZA:SK=VB26K1S2?:/\`PD'PXN?"OQ-TVWU#5O"__"9Z
M]H>J^&_"T'AJZUS3O"ND^&=>\3:K8Z`VMMKML)X[JWUFVACFM[)(;*9;AITN
M<+))4O\`4_`&H^!O`WARX\8>(3?Z'XG\0ZQK4R^")YLV7BX^#;:[6QN+GQ,J
MWEYH%GX?O)(DN?LT&KL+.S@EL$=I8M/]9\\_Z#8?^$.7?_,GE^?=F?\`J=PY
M_P!"^>EO^9CFG2W_`%&^2/D6Q_9;_:=U'P__`,)):_M_?MR-9R6&LZO96,O[
M1=S!K^JZ-X<E,/B'6M'\/RW:ZGJ>DZ+*LRZA>VT+*@L]0>!+B/3;][;BE^#W
MQT#*?^'@_P"WD?F'_-==9P>?:7H:_0/1OB'X4TVS\+:M(^MOXE\`>"_&_@71
M-+32[;^Q_$5OX@E\7IH.NZAJ9U02Z-_9]MXTU%]=T<:=J$FH3:?8QV-XJ7=V
M]MX+&H01H"2$"(">I"@*"?<@<^]'^L^>?]!L/_"'+O\`YD\OS[L7^IW#G_0O
MJ?\`APS3R_ZC?)'[M?L7>$]8T[]EKX*6/B#XD_$KX@ZS:^#8HM0\9^.?%-SK
M7BWQ#.-2U%CJ&NZK,CRWU\R,L+3R,6\F&%,X2OI_^P/^HOKW_@UE_P#C5>*_
MLE_\FY?"3_L58O\`TOOZ^BJ\.K4G6J5*U1\U2K.=2I+EC'FG.3E)\L%&,;R;
M?+&,8K9)*R/HZ-*G0I4J%).-*C3A2IQ<I2<:=.*A!.4W*<FHI+FE*4GO)MML
MY_\`L#_J+Z]_X-9?_C5']@?]1?7O_!K+_P#&JZ"BH-#G_P"P/^HOKW_@UE_^
M-4?V!_U%]>_\&LO_`,:KH**`.?\`[`_ZB^O?^#67_P"-4?V!_P!1?7O_``:R
M_P#QJN@HH`J65I]CA,7VB[NLNS^9>3FXE&[`V"0JI"#&57&`2?6K=%%`!111
M0`4444`%(>AYQP>?3WYXXZTM(>AR,C!XZYXZ8[YZ4`?@?\:O"FB>)OVSO%FB
M>)OVA_",.H^%_C%\./BC\._[1L/CE=7_`,/-=\0_$?\`8T\%^*R?$$'AJ[^"
MVA^-OA[X<TOPO\)_AUH&@>(%/]F?M8^)M:^+EMX9MM?U(?$']\%Z#G/4\]LG
M..0#QTY`/'/-?S$_M'^+O#/AG]L[X@ZQX]T6V\&ZIH7Q/TOPE#I]W\2_B8GP
M+>?QM\3OV8_$^C?M$?'SX37_`(,T+2]#^%5[I'AOX=>*/$,_@O\`:#\/Z)\1
M/&O[,?BB?Q5;KX:U'X@CP?\`T'?LY_$W4_C/\"/A)\5]9T>#0=4^(7@'PUXM
MO=.LVE?3DFUO38;PW6D27$L]S)HNIK(NJZ(]S-+<OH]]8M<223&1V`/RI_X*
M3_\`*23_`((4_P#9UO[4'_K'/Q!K]O(_]7'_`+B_^@BOP^_X*7"<_P#!1_\`
MX(6"V>&.<_M6_M/^6]Q')-$/^,._B!NWQQ2P.V4W!<2KARI;<H*G]I(X?$GE
MI_IVB?<7II>HXZ#UUK/Y\T`=!16%Y/B3_G^T3_P5ZC_\NJ/)\2?\_P!HG_@K
MU'_Y=4`;M%87D^)/^?[1/_!7J/\`\NJ/)\2?\_VB?^"O4?\`Y=4`;M%87D^)
M/^?[1/\`P5ZC_P#+JCR?$G_/]HG_`(*]1_\`EU0!NT5A>3XD_P"?[1/_``5Z
MC_\`+JCR?$G_`#_:)_X*]1_^75`&[16%Y/B3_G^T3_P5ZC_\NJ/)\2?\_P!H
MG_@KU'_Y=4`;M%87D^)/^?[1/_!7J/\`\NJ/)\2?\_VB?^"O4?\`Y=4`;M(W
M0_0_RK#\GQ)_S_:)_P""O4?_`)=4AA\28/\`IVB=#_S"]1_IK5`'X.?MB?\`
M)R7Q0_Z_]`_]1#P]7S17TC^UV+A?VC/B:+MX)+@7V@^8]M%)#"Q_X1+0-I2.
M6:XD7Y=H8-,^7#$$*0H^;J`"BBB@`I5ZCZC^=)2KU'U'\Z`/Z#?V2_\`DW+X
M2?\`8JQ?^E]_7T57R_\`LIQ:XW[/'PH-K=Z3';GPO%Y23Z??33*OVZ^XDDCU
M2"-VSGE(4'^STKZ#\GQ)_P`_VB?^"O4?_EU0!NT5A>3XD_Y_M$_\%>H__+JC
MR?$G_/\`:)_X*]1_^75`&[16%Y/B3_G^T3_P5ZC_`/+JCR?$G_/]HG_@KU'_
M`.75`&[16%Y/B3_G^T3_`,%>H_\`RZH\GQ)_S_:)_P""O4?_`)=4`;M%5;-;
MU8B+^6UFGWL0]I!-;Q>7QM4QSW-TY<'=N;S0I!`"+@DVJ`"BBB@`HHHH`*1C
MA2<XX."><''!QW^G>EI&^Z>_!]?Z<_ESZ4`?SG?'?7+?Q/\`M-:M\5=-_:4T
M+XE>'K;]H[P=\)8O"NC?MJ^-M#^'W@&!O'/[-1T;3/%7[,?@SQ_HFC_$+S--
MO?C%\*O$G@C2?"GCC5?&_B?QOX(U[5K.[T;6M=U'P!_1="B1QI'&JI'&H1$1
M0B(B?*J*JX5510%"J`B@`(`H`K\,K/X0Z=X"_;)\=7VC?!WXX_"^QA^/?AC6
M_!FK_LZ_L'_LQW?PB\1:7KNA>"QK7B;Q;\9_&'PD\:_%H:[J>MGQ#9_$CQCX
M=\5>"['2]&%M%X3@LKO3+W5[G]T!_C_/V[>GM0!^(/\`P4G_`.4DG_!"G_LZ
MW]J#_P!8Y^(-?MY'_JX_]Q?_`$$5^(?_``4G_P"4DG_!"G_LZW]J#_UCGX@U
M^WD?^KC_`-Q?_010`^BBB@`HHHH`****`"BBB@`HHHH`****`"D;H?H?Y4M(
MW0_0_P`J`/Y__P!L3_DY+XH?]?\`H'_J(>'J^:*^E_VQ/^3DOBA_U_Z!_P"H
MAX>KYHH`****`"E7J/J/YTE*O4?4?SH`_H-_9+_Y-R^$G_8JQ?\`I??U]%5\
MZ_LE_P#)N7PD_P"Q5B_]+[^OHJ@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MI&QM.3@8.2."!CKGVZTM(>A^AZ]/QX/\C]*`/P"^,/PDOM4_;+\>?':P\?>&
MK3X2>'OC)\.OA-\4?BU<>!_'D_Q=\!^-?$'Q(_9%^(/AGX?^'=;LI)/"NN>`
M/`^M_"?1/!VG^+3/HFB_#&?]H+QNFN^&_&$ND^*;O4_W\7[H_P#U8.>0!V`/
M`'8"OPR\?+X7L?\`@H)XH77=._90\9ZHGQ%^$_C6TD\9_%+]HWP?XC\-F+4/
MA5\/-&N/%7@GP1\$]1_9F^('Q5\(>)?''P^'PWOO'NOWWQ,\+MXQ^'%IJOBC
M2=+E\'ZE8?N<O0>G;KT[=><XZ^]`'X>?\%+I6A_X*/\`_!"R18)KEE_:M_:?
MQ#;B(S/G]COX@+\GG2PQ?*#N;=*N$5B-S84_M)'J]WY:?\4]K?W%ZKI`/0=1
M_;/%?C!_P4G_`.4DG_!"G_LZW]J#_P!8Y^(-?MY'_JX_]Q?_`$$4`8O]L7?_
M`$+VM_\`?.D?_+FC^V+O_H7M;_[YTC_Y<UNT4`87]L7?_0O:W_WSI'_RYH_M
MB[_Z%[6_^^=(_P#ES6[10!A?VQ=_]"]K?_?.D?\`RYH_MB[_`.A>UO\`[YTC
M_P"7-;M%`&%_;%W_`-"]K?\`WSI'_P`N:/[8N_\`H7M;_P"^=(_^7-;M%`&%
M_;%W_P!"]K?_`'SI'_RYH_MB[_Z%[6_^^=(_^7-;M%`&%_;%W_T+VM_]\Z1_
M\N:/[8N_^A>UO_OG2/\`Y<UNT4`87]L7?_0O:W_WSI'_`,N:0ZQ=X/\`Q3VM
M]#_#I'_RYK>I&Z'Z'^5`'\_/[7DK3_M&?$V5[>>U9[[028+D1":,CPEX?&'$
M$T\7S8W+LF?Y64G#94?-U?2_[8G_`"<E\4/^O_0/_40\/5\T4`%%%%`!2KU'
MU'\Z2E7J/J/YT`?OO^RGJ5S!^SQ\*(DT75KE$\+Q*L\"Z;Y,H^W7IW1F;5()
M=O./GAC;C[M?-G_!3C]J;]I?]E_X`>'/B#^S%\)K3Q_\0-2^*OAWPGJ6C>+/
M#5]XGTVW\*:EX=\7:CJ.HQ6'A;QCH>HQ7L&HZ/H\$-U+=R6<<5S/'+;O+-`\
M?U3^R7_R;E\)/^Q5B_\`2^_KQ;_@HB`?@AH&1G_BY>@?^F+Q175@L13PN*H8
MBKAJ.,IT:BG/"XA2="NE?]W54)1GROKRR3TW./,,+4QN"Q.%HXO$8"K7ING#
M&85P6(P\FU:I1=2,X*:M9<T9+5Z'\[__``^<_P""Q'_1H_PP_P##0?$W_P">
MW5R3_@L7_P`%F(IK.WE_8X^'L=QJ-M:WNGV[?!7XJ?:+^SO@S65U8P#XL&:[
MM[P*QM9;=)$N`K>47P:]]TIDBU72Y6:PB6+4].E,NIP27.F1B*]@D,FI6T,4
MTUQIR!=U_;Q0RRSV8GACBD=U1ON7Q^VM^*-5\"KH7Q(T;PUXDU+PE=C4[>?Q
M]H?B;1=!\)ZKH]M/K'B7PAXED%IK^G2:O.D?A_2=`@U%==UZW57TK^S;5=9G
M/U7^M>6?]$;PYT^QC?+_`*BNNOWGQ7^I>;_]%]Q7T_Y>9?Y?]07D_P"FS\FD
M_P""Q_\`P65DN);2+]CGX>2W<`F,]I%\%/BK)=P"V&;@SVJ?%9IX1;CFX,L:
M"`<S;!58?\%G/^"Q!QC]D?X8'.,8^$'Q,.[<0%VX^+?.XD!<9W$@#)(K].-6
MUS6=27Q5I/A?5SX6\=VLWP?M=.US6_&OAK3/$WBCP3X-TSQ%I]UKFM^*['7Y
M-(DU1O$,^A^)/$.B1ZW=W":/9:=!-_;*Z$\TO`WGGGXS7?C'X<CPU_9&M^._
M$UWX6G:[\*QI96&G:S:1ZKK<.F:]=P1^'2/MDVI>%[K4+>TN/)E%WH$;S6+-
M;'^M>6?]$9PY_P"`8WR_ZBO7[_(?^I>;Z?\`&?<5^?[S+_+_`*@O)_TW?X'?
M_@LS_P`%BXW>.3]D3X9QR1LR21R?!WXGQR1NA*NDD;_%I71T8%71U5T8%6`8
M$#]+O^"7G_!0']N_]J;XQ_$+P9^U'\`_#7P^\&^'?AB/%'A[5/"7@7Q+X7OK
M[Q.?%FC:0=/N;SQ5\0==LKBT_LF]O;G[-;VT%UYT*3>>8HWB?Q7XQV,MK\3_
M`!Y<R-9S6VL>,/%>MZ9=6.IZ9J]M>Z5J?B75I["]CNM+O;^$+=0D3)'/+'=!
M&5YH4WJ6^O/^"<@`^+'CG``_XMV.W_4T:17)CN(L!B\)6PU+A?(\%4JP48XK
M#1Q:KT6I1?/2<\1*"D^5KWHR5I-6V.W+N%<SP.-P^+K<8\19A2H3<IX+%SP;
MPV(3@X\E54\+3FXIOF7+.+O&.N]_V'L[F2ZB,DEG=63!V3R;L6XE(`!$@^RW
M-U'L;.%S+ORIW(O&;5%%?+'V84444`%%%%`!2-C:<C(P<CU&.1S@<^YI:1C@
M$GG`Z?Y_4G@=3Q0!_-[^T5K/PBT']MWQC\0_&'Q#^%W@OP!X&^-7@#X=^.?V
M<O%W[8/PY\#^.OBGJWQ(\2_LR^-==^,>@_"WQ#X)D;0/"/\`PD?PW^%_BOQ#
MX/?XL>&[;XF:3\&_$VKZU)X:CU3Q+HGB3^B[0M:T;Q)HND^(?#NJZ9KN@:[I
MMEK.B:WHVH6FJZ1K.DZG;QWNGZKI>J:?-<6.HZ=J-I-%=V5]9SS6UW;31SP2
M/&ZL?S+TW]L+X6?%?Q1XRT;P]^Q#^TCXH\>:5\9H?A`;KQK^R=XK\*^'-<\O
M5?"NFZUX[U/XJ^,?!4?A#0/!^BZ/K5]KUQ<>)M8MK^[TWPU<VME:37NI:';W
MGZ@65I:Z?:6MA8VMO8V5E!%:6=G:0Q6UK:VMNBPV]O;6\"1PV\$,*)'%!$B1
MQ1JL:*JJ``#\2?\`@I/_`,I)/^"%/_9UO[4'_K'/Q!K]O(_]7'_N+_Z"*_#[
M_@I=/!;?\%'_`/@A9/<S1P0I^U;^T]OEF=8XTW?L=_$!%W.Y"KN9E49(RQ`'
M)%?M-'XE\.^6G_$]TC[B_P#,1M/0?]-:`-ZBL<>(M!*/(-:TLQQE`[B_MBB&
M0L(PS"7:I<HX4$C=M;'0T]]<T:*-99-5T^.)\;)9+N!(WW#<NQV<(VY067:3
ME02,CF@#5HK'_P"$BT'<$_MG2][;=J?;K;>=V"H">9N)8$%0!\P(QG(IH\1^
M'RVT:WI18G:%&H6I8L3@*%$N22>``,D\8S0!M45DRZ]HD!"SZMIT#,-RK->0
M1%E!P2HD=20#P2,@'BHO^$E\._\`0=TC_P`&-I_\=H`VZ*Q/^$E\._\`0=TC
M_P`&-I_\=H_X27P[_P!!W2/_``8VG_QV@#;HK$_X27P[_P!!W2/_``8VG_QV
MC_A)?#O_`$'=(_\`!C:?_':`-NBL3_A)?#O_`$'=(_\`!C:?_':/^$E\._\`
M0=TC_P`&-I_\=H`VZ1NA^A_E6+_PDOAW_H.Z1_X,;3_X[2'Q+X=P?^)[I'0_
M\Q&T_P#CM`'X-?MB?\G)?%#_`*_]`_\`40\/5\T?_6_7I^?;UKZ1_:\N;>Z_
M:-^)MQ;317$$E_H)CF@=9HG"^$M`5BCH65\,K*<$_,".HKUK1?`L'B+X:_"^
M"+P?X:TNWMO%'AVZU.Q\::-%IEKXFCO9_AO!?7/A_P"*&BW=S-?-XQ^U7<EQ
MHM_;W-_<V%QK.C:=81WW@^V#`'PGD$$@@@9R000,<G)'`QW].^*7C&<C&,YR
M,8]<],>^<5]A^+]'CE;PKXH\)>&KC6P=;^)-M<'Q%\&]%\,>*=)T73H-"EBN
M-/\`AC9"PTGQ;8>#=/U$WVCZS=O?3)K5S>Z=JNF646EHL?2Z#X+\)R?%GP'K
M-U;^#)9]7M/A+;6/A#Q3;:#X,U/7KSQ%=RV7BGQGXC^&]V8]/L-3^PVEQ#IG
MA#2DOK?5-5U/0]?C6>$S^>`?"_\`3D_0=3^%*O53U!(((Y!&>H(X(]Q7O7PQ
M\&VQ\;:^^NZ?]KMM-\-_$S4?!YM-)B\5Z1XD\4>$HHF6R\/VI==&\9WNC6UU
M/J$&CQW,UE)J%I8IJ<;V@EMIN;^+VFK8>(]"NA%%;'7_``5X9U][.3PU8^$-
M:M'O$O+8KXJ\.Z5*^D6/B.Y%DM_<W&E6^G6.K:?=Z9JZ:78RWLT;`'[;_LE_
M\FY?"3_L58O_`$OOZ\6_X*(_\D0T#_LI>@?^F+Q17JG[*6NZ):_L\?"BWN=7
MTVWGB\+QK+#/>V\4L;?;[XX>-Y%93@]"`:\:_P""@NKZ3?\`P5T&&QU.PO)E
M^)&@R-%;7<$\@C&A^)U+E(G9@@9E!8C`+*.]`'XUTC`.,.`X]'`<?DP(X[>G
M04M%`#0B`;0B!<YVA%"Y'0[0,9'4'&0>>M*55L[E5LD$[E#9(Z$Y!SCMG.,G
M&,TM%`"!5485549SA5"C)[X4`9]^M?H3_P`$Y?\`DK'CG_LG8_\`4HTBOSWK
M[^_X)X7]E8?%3QO+?7=M9QO\/0B274T<",X\3:2VQ6D95+;03M!S@$]`30!^
MS5%5K2]L[^(SV5U;W<(=HS+;31S1B1<%D+QLR[E#`E<Y`(SU%6:`"BBB@`HH
MHH`*0]#VX/.<?KSCZX.*6D;[IXW<'CUXZ?CTH`_GH_:$\-32?MD?$>P\)7?[
M)&I?&27XO?!KXF>$_BO\3_B?^T5H/QP^&GA_2-<^"GA*'X.>'O'7A3]GSQ9\
M/?`?A_Q!XH\3^#?#-Y\.=)\;W%D-'^-BWOCOPIK$OCM;[4_W\\,2>(I?#>@2
M^+[31;#Q7)HVF2>);'PWJ-_J_AZSU][.%M7M-"U75=+T34]2T>WOS<0Z;?ZC
MHVDWUW9I#/=Z;93O);1_@Y\9],^"LW[97BS5]:U7Q9I_C_3?V@?AAX%TS]CJ
M+XIZ?87G[0'ASXC:]^SOXU\:_'KPU\/+CX::IXNDT%?%7PK^&GB_6K/P5XZM
M/ACXATCX$^+S\4];\*7VM>--.B_?U<;1CW/U).2?^!'G\:`/Q"_X*3_\I)/^
M"%/_`&=;^U!_ZQS\0:_;R/\`U:?[B_R%?B'_`,%)_P#E))_P0I_[.M_:@_\`
M6.?B#7VK^T_^WKX$_92\8>&_!'BKX-?M&?$>]\1^%$\5V^K_``<^'FC>+]`L
M;7^U;W1_[.U2_P!2\8^')K76/.L9+K[&EI/%]AFMY_M.^0Q)MA\/6Q554:$5
M.HTVHN=.FK15W[U24(JR[ROV.?%8JA@Z3KXB;A2BXQ<HTZE5IR=H^Y2A.;N^
MJC9;MI'W517Y`_\`#Y7X._\`1J_[='_AD/"O_P`]*C_A\K\'?^C5_P!NC_PR
M'A7_`.>E7?\`V)F7_/BG_P"%>#\O^HCS1YO^L.4?]!-3_P`(\=_\S'Z_45^0
M/_#Y7X._]&K_`+='_AD/"O\`\]*C_A\K\'?^C5_VZ/\`PR'A7_YZ5']B9E_S
MXI_^%>#\O^HCS0?ZPY3_`-!-3_PCQW_S,?K]17Y`_P##Y7X._P#1J_[='_AD
M/"O_`,]*OO/]F+]I3PW^U-\/M1^(OA?P%\5?AUIVF^*]3\(R:%\7_"UAX1\4
M3W>EZ?I&HRZG:Z9IVO>(8)=%N(]8A@M+UKZ.2:ZM;Z)K:-8%>7'$9;C,+2=:
MO2A&FI1CS1KX>H[RV7+3JSEKWY;+JT=&%S?`8RJJ.'K3G4<92Y98?$TERQW?
M-5HPAI?;FN^B9]%T445P'I!1110`4444`%(>A^AI:1NA^A_E0!_/_P#MB?\`
M)R7Q0_Z_]`_]1#P]7SI)J%]+I]KI4MY<R:797=W?V>G/,[65K>WZ6T5[=V]L
M28H;F[CM+9+B9%#RB"/<<ABWT7^V)_R<E\4/^O\`T#_U$/#U?-%`&A+JVK3W
M5O?3ZMJT]]:*BVE]/JFH37UHL>?+6TO9;E[JU6/<WEK!-&$W-M`W-F![V]>Z
M-^][>27[3+<-?27=R]\UPI4K<->O*UTUPI52LYF,RE5*N"JXK44`65O;U?LV
MR]O4^Q327-ELN[E/L=S*Z22W-GME'V2YEDCCDEN+;RII9(XY)'9XT9637$]U
M<27-U//=7,\AEGN;J>6YN9Y6QNEGN)WDFFD;`W22R.Y``+8`J&E7J/J/YT`?
MT&_LE_\`)N7PD_[%6/\`]+[ZO%O^"B/_`"1#0/\`LI>@?^F+Q17M/[)?_)N7
MPD_[%6+_`-+[^O%O^"B/_)$-`_[*7H'_`*8O%%`'XM4444`%%%%`!7Z$?\$Y
M?^2L>.?^R=C_`-2?2*_/>OT(_P""<O\`R5CQS_V3L?\`J4:10!^R%%%%`!11
M10`4444`%(>AZ=#U.!^)[#WI:.O6@#\:/BC\14E_:\U7PQJG[2GB/1O!OAOQ
MOX7UF^^">GZ9\:-,^$_B&X3Q9\%/`.I?\)5^T3HT%SKFA>*-"\6?&3X83^(/
M@MX$GM?V?X1XF\.K\:-)U"3Q#XFUC1OV67H,>_KUSSG/(.>H['CM7P)\9?V1
M?V7+#XL0_M5?$&#XFP7MAJFA+K?@_P`,>)_BGK7PU\4>*=;\9?"R32/$/B+X
M,>"H=;M=8U.X\8_#3X/:MKM[::/!HVH7'P_\-Z[X[MKZRT:^OZ^];6XANK:"
MZMVWV]S#%<0OM=-\4R++&^V14D&]&#8=5<$X8!LB@#\1_P#@I/\`\I)/^"%/
M_9UO[4'_`*QS\0:ZS_@HP!_PM;P'D#_DFT?4?]3+J]<=_P`%+H4N/^"C_P#P
M0LAD,@1_VK?VGMQAFFMY/E_8[^(##;-;R13)RHSLD7<,JV59E/3?\%#+*"Q^
M*7@:.`W!5_AS&Y^TWEY>ON_X235EPLE[/<2(N`/D5PF<MMW$D@'P&0`"<*,`
MG+#Y1@9RQ'0#J3V&:^SM"^$?@KQKX9^%VFZ+H=O:7%[XHT>P\:ZU=:CK>A^/
M-'AU2X\"V&IOJ&C:S:G1-8TB_P!5US^S=`OM):.+1H=<\-ZG;+>I>:W&_P`9
MUV5W\0_'%]X>T7PK=>*=<FT'P]>&_P!'T]M1N@EE=(;0VDB2K*)W&EM9PMHL
M<DC)HK&9M,6V,K8`LNW]?TD=9\2=%\/#0O#7B?PMIWA:UTG4-9\6>&[F[\+7
M/C!;?^U=".D78TJ]TWQF9[QK[3-/U:V8>)=/NOL'B2*Y62XTK2+^SD@GKZX=
M$@^&>@W=QX/\+:?X@\5:K=_V-J>E0:[;ZA;>&O"<J:;JFIWQN_$%_975YXD\
M022Z=$JV$$-M;:+JEQ$B27ML+?G=0^(OCO5KL7VI>+-9O;L:5K.B+-//$=NE
M>(HWBU^S2%(4MT&MI(_]K7"PB]OW/FW-S),J2+S5WJFHW]MI=G>WMQ<VFB6<
MNGZ1;S.&BTZQGOKK4YK6U4`>7#+J-]>7KJ2Q:XN97S\P`!679?U_PR^XS\#T
M'Y"OVH_X)WC'P.UW`P/^%E^(/_3'X6K\6*_9;_@GWI5I>_!/7)9VO0X^)&OQ
MC[-JFIV4>T:)X889BL[R"(MECERA=AA68JJ@`[+M_7])'Z!45B?\(_IW]_5?
M_!_KW_RRJ6'1+&"021OJ18!EQ+K6LSIA@5.8YK^2,G!^4E"5.&4A@"`#6HK(
M70[%91,'U(N)/-`;6]9:/?NWX,+7YA*;O^61C,6WY-FSY:D&D68B,(:_V$3C
M)U;56E`N=OF8F:],RD;!Y)60&WRWV<Q;WW`&G169-I%G.H61K\`2/(#'JVJP
M-NDQN!:&]C8IP-D1)CC_`.6:+DTQ-%L41HU?4=KK*IW:SK#OB7R]^V1[]I$8
M>4GELK*T67\HIYLN\`UJ0]#]#6+_`,(_IW]_5?\`P?Z]_P#+*D/A_3L'Y]5Z
M'_F/Z]_\LJ`/P:_;$_Y.2^*'_7_H'_J(>'J^:*^D?VO(([;]HWXFP1&4QQWV
M@A3-//<R\^$M`8[Y[F2:>0Y)P9)&VC"KA54#YNH`****`"E7J/J/YTE*O4?4
M?SH`_H-_9+_Y-R^$G_8JQ_\`I??5XM_P41_Y(AH'_92]`_\`3%XHKU3]E+1K
M&Y_9X^%$\K:@))/"T;,(=8UBVCS]NOA\D%O?Q01CC[L<:+G/%>-?\%!=*M++
MX*Z#+`UZ7/Q(T&,_:=4U.]CVG0_$S'$5Y>3Q!LJ,.$#J,JK!68$`_(GP[X7\
M1^+M0;2O"^AZIK^HI:75])9Z59S7D\=I9027%S<2+"C".-(XV"%RIGG:*UMQ
M+=3P0R6[;P/XRO-)N==M?"NO3:-9-?K=ZFNFSI9VK:62NII/)*(S')I[!DO8
MROF6LBF.95D!0>K_`+/^O:;I&L^(+/5]<\,Z;IVJZ/?&XT[Q4/$%A9:HUAX;
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MVU+Q$LUU</P?Q0UWPE\0](\!?V9XKDBU/3M`^(LFIV_B2QL]"L]*MO\`A)-8
MU?1/#-E%HMWKJ6E[<6`LM'\(:9#OT[^SAIHOM1L;@W"1@'C=[X4\4:=H]CXB
MU#P[KECH.IF(:=K5WI=Y;Z7>F='EM_LU[+"L$@N8XI9+1MX6[BBEDM3-'&[+
M]T_\$Y?^2L>.?^R=C_U)](KQCQ)XZ\)77@CQYJ$]UH=[XP^(_A/X9^'YK;1M
M>US4!!>^$[OP]<S7\WAC4=`TVW\&KI.G^'VL98I=8UY;S5+TQ^%#::%/>NWK
MG_!/"R@OOBIXVCG-P%3X>AU^S7EY9/N_X2;25^:2RGMY'7!/R.S)G#;<@$`'
M[-T55M+.&RB,,!N"A=GS<W=W>R;F`!Q->3SS!>!B,.$4Y*J"3FU0`4444`%%
M%%`!2'.#C@X.">0#VR*6D;&UL]-ISQGC'IW^G>@#\(OCQ\7?BC8_MA:M\--1
M_:J\&^!;S0?CA\,=<^&7@NU_:0\,^&I]9MOB)KW[-^FZ=X7\5_"/1'MO$=QH
M'@?X9>%_CM-K?P\^(D^HQ?%SQM\=?!WB7P;9,NG:1JW@#]W%Z#\1ZG@D`$Y.
M2!P3DY()K\5O$/C+XD_#K]I+XT>-_A[X_P#C'X3_`&;K;]J7X8^#_C@=#TC]
MDY-$M_C)X[TWX.^%'M=%\#^)/A5J'QI\4^%M>B\3?#G1?&OBV?XE:/XT:34K
MO5?AIX1UZPTRSO\`7/VJ!R/S_#D\?ATSWQGF@#\0?^"D_P#RDD_X(4_]G6_M
M0?\`K'/Q!KK/^"B__)5O`?\`V3:/_P!275ZY/_@I/_RDD_X(4_\`9UO[4'_K
M'/Q!KK/^"B__`"5;P'_V3:/_`-275Z`/SZHK8M/#VO7VD:GK]EHVJ7>AZ++:
M0ZOJ]M87,VG:;+?&1;1+V[CC:&!IC$_WVQ$NQYS$DL+251I>IG3DU<:=?_V3
M)J!TF/5/L=R=.DU58%NFTR.]$7V:345M72X-BDK70@=)3%L96(!1HKHY?!_B
MZ'5K?0)O"OB6'7KN`7-IHDN@ZM'J]U;$2-]IM]->T6\FMPL4I>=(3#&(I?,=
M#%(%QKVQOM,O+G3]2LKS3M0LYFM[NPO[6>SO;6=<;H+FTN8XKB"9=RDQRQJ^
M&4XPP)`*M?M/_P`$\/\`DA^N_P#92_$'_IC\+U^-^L>']>\/306^OZ'K.A3W
M5N+NU@UG2[_2IKFU9B@N;>._M[=YH-ZE#)&K*L@,;E7&VOV0_P"">'_)#]=_
M[*7X@_\`3'X7H`^C?V@_BIJ?P1^#/Q!^*NC>!-6^)NI^"=";6;/P)H>KZ/H.
MK>)IEO+.U_LZQU?7Y(M'L)BET\_GW\B0!(&0G>Z5^09_X+)_%P$C_AW-\9S@
MD9_X7=\#!G!Z_P#(3[U^JO[6W_)N/Q:_[%9__3A85_/DP&3P.I[#UKOPF,PV
M'A*-;*L%CY2GS*IBJN90G"-HKV<5@\?A*;C>+=Y0E.\FN?E2BO,QN!Q>*J0G
MA\YS'+8QARRI8.CE-2G4ES.7M)/'Y9C:JG9J-H5(T^6*]SF<I2^M_P#A\G\7
M/^D<OQG[?\UN^!G<X`_Y"?4D@`=R0!R:7_A\E\7?^D<OQH_\/=\#.W7_`)B?
M:N7_`&<])TW4=1\5-?>%CK$RZ)J%M8ZW<^#Y?'>BZ)+<>%O%\DMEJWAZTNX-
M1C_MTP6PL]4L+6^NV?3+C0;)+:^UR"ZC]*3X<Z#INCOX2U'1?#$'BNXT+XQZ
MQ)I^D^%YO$?AK7_[&O?$J:%?P_&*[6XOO``\,1Z+>1V.B"6Z#IHVFQ^)+VQU
M#Q/<)%U_VI@?^B=RCI_S$9[Y?]3GR?WLXO['S+_HJL\_\)>&_P#YP>7Y]V<[
M_P`/D_B[_P!(Y?C1_P"'N^!G_P`LZ3_A\G\7/^D<OQG_`/#W?`S_`.6=<C\*
MO#FD6?A/Q%XDUK1[NYU^W\6?#O1;;3Y_AS%X]U"U\-^*]/U;4DU6V\'ZQ<:=
M9_9?$%U:6-BVMSL93I__`!+O#KIJ.N07<?C_`(ZT;_A'O&WC#02-*!T7Q1KV
MED:(;EM&7[%J=S`(]*-[-<WJZ?$$$=I'>7-Q=PPHL%S/-/')(Q_:F!_Z)W*.
MG_,1GOE_U.?)_>P_L?,O^BJSO_PEX;\O^I!Y?U=GW]^S?_P4V^(_QX^-7@;X
M3:Y^Q/\`$_X5Z7XON=8M[OQ]K_Q5^$_B'2/#RZ7X<UC78I;S1_#E_-K5ZM]/
MI<6EQ+8QLT5Q?17$V+>*8C]<"<J3ZKG]*_`']C@`?M)_#'`'_'YXA[?]2?XA
MK]_?X/\`@/\`2O/Q=>CB*D9T<%AL#%0472PT\7.$I)MNI)XS%8NHIM-1:C4C
M"T4U!2<I2]3!8:OA:4J>(S#%YE.51S5;&4\#3J0BXQBJ48X#!X*BX)Q<TYTI
M5'*<KU'%1C'\`/VQ/^3DOBA_U_Z!_P"HAX>KYHKZ7_;$_P"3DOBA_P!?^@?^
MHAX>KYHKE.P****`"E7J/J/YTE*O4?4?SH`_H-_9+_Y-R^$G_8JQ?^E]_7BW
M_!1'_DB&@?\`92]`_P#3%XHKVG]DO_DW+X2?]BK%_P"E]_7BW_!1'_DB&@?]
ME+T#_P!,7BB@#\6O\_U_0\CT/(YHR>F>/2BB@`R>F>/2BBB@`K]"/^"<O_)6
M/'/_`&3L?^I1I%?GO7Z$?\$Y?^2L>.?^R=C_`-2C2*`/V0HHHH`****`"BBB
M@`K*UV6X@T36)[29[:ZATO49;:XC2PD>"XCLYWAF1-5NK'3':*55D5-1O;2Q
M9E"WEU;VQEF35JAJMFVHZ9J-@DYM6O;&\M%N1;6EX;=KFVE@686E_#<65T8C
M()!;WEO/:SE?*N(987=&`/YZ;7Q8OQ+_`&H_AM\6M1\,:0?&8\5?"S38?%>O
M_#O_`((_^*/&UJ^D)X=T"\NX_'VA?MS^(OB?!)>2Q:I=Z=/X3\/^(?%_A.RU
MF[T3P%8W[QVMA?\`]$@Z?3([=`<#I_GUP>*_!"Z^%6L:5^U3%X>\!^#98?#/
MPT^)7PK\.ZSJFL_#C_@FM\)K75=0LM(\#ZOK7B7P;X>\1_`^\^-FL^&M5>\G
MOX_$OA_5_#5_?^)3XCTGX;+866B:'J+?O>/ZGT]3Z?\`Z_7)H`_#O_@I>DS_
M`/!1[_@A8MO,+>8_M6?M/[)FA6X"$?L=_$`G,3/&&W*"F=X*;MXR5`/3_P#!
M0N*\B^*7@9;V\2]D/PZ1DD2T2S"Q_P#"2:J`AC2:<,=P+;MPQG:`<9KGO^"D
M_P#RDD_X(4_]G6_M0?\`K'/Q!KK/^"B__)5O`?\`V3:/_P!275Z`/)_AMXB\
M/K\&O%.C>(_&-AH]I9>>MJFB:KXBT7QUI=SK!\52+9)I,*2Z#XYTK7;UK&*2
M%H[<KINH:IIFNZKI]IIFEN-O0OB+\*--T7P0MMKFOP:+X+^+_P`/]7T[PKJ?
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M'?":_NYA:"1M8>XBNI_@4?&'2F8`:)JS,2``+BR+$DX"@"0DEB0H`ZD@=Z]8
MADDEABEEB>WDEBCD>"1E=X6=`QBD9,HSQ$E'*DKN!P2*]7.>&<]X?CAY9SEU
M3`+%.HL.JM;#3E5=%0=7EA1KU9V@JE/FDXJ*<XJ]VD>9E/$62YZZ\<IQT,:\
M,J;K^SI8B"I*KS>SYI5J-.-Y\D^6*;D^23M:+9[?\4K[1;C0O"]K#JNAWGB&
M#7?&MWJ-EX0\5^(?%OAE=(U*;1Y=+URXN]>O;\6WB_7[R'4IM<%E-#+?V5MI
ME[K6GZ=JC&`_I3_P3\M]4E^"FN-9:E%9Q#XD:^&B?3X[HEQHGA@E_-:YA(!4
MJNS80-I(8EB!^->2>IS7[3_\$\/^2'Z[_P!E+\0?^F/PO7A'M'IW[5EKK$?[
M/'Q7>YU>&X@7PPYDA72XX&D7[?8_*)EO)#&<X^8(WTK\"VZGZG^=?T&?M:_\
MFX_%K_L5G_\`3C85^#7A'PIJ7C37[;0=,ELK:299;J[O]1G-OI^F:9:M']NU
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M_;:UJEO?'38(8K>#3C>07<=R=/@MX(+>"Q,IM88(888H4CBC5<?_`#]?4GU)
M[FN\U3X?WNG>'K[Q%;>(/">O6VC7>@V'B*T\/ZQ-J-WX?N_$UM=7.BQ7LIL+
M?2[X7/V*[MIY=!U+5X;&]@>UNWC(WU:T_P"&.MZCH&FZZFI:#;2Z[I?BC6_#
MVA7=W?KK6NZ1X--XOB*^M#!I=QH]HMDVG:@L5OJVL:==7ALY#;PE9;0W(!Z;
M^R"D\G[1GPU2VG6VG:[\0B.=H%N50_\`"(^("<PM)$K[E!7F1=A;>-Q4*?WE
M^Q:_M_Y#L'W?^@+#Z>GV_'X=*_"']C@@_M)?#`CD&[\0$'U!\'^(2#SSR#WY
M]:_?S^#_`(#_`$H`_GZ_:[2>/]HSXF)<SK<SK?:"))U@6W5S_P`(EX?(Q"LD
MJIM4A>';=MWG!8J/FZOI?]L3_DY+XH?]?^@?^HAX>KYHH`**Y'Q=XHE\*VMI
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M1?IUKQO_`(*"6^J0_!706O=3BO(C\2-!"Q)IT=J0_P#8?B<A_-6ZF8@*&7R]
M@#;@Q8%`#[Y^R7_R;E\)/^Q5B_\`2^_KQ;_@HC_R1#0/^REZ!_Z8O%%`'XM4
M444`%%%%`!7WY_P3RBO)OBIXV6RO$LI!\/@7D>T2[#I_PDNE#8$>:'8=Q!WA
MB>,;>]?`=?H1_P`$Y?\`DK'CG_LG8_\`4HTB@#]A;**[BA*7MTEY-O8B5+9;
M4",@;4\I99@2I!R^\%L_=&.;=%%`!1110`4444`%(1D$>H(_S@@_J/K2U6O;
MJ"QL[J]N9/*MK2VGNKB7;(_EPV\3S2R;(DDE;9&C-MC1Y&QA$9B%(!^<6M_L
M,:Q=_M'>+/C?:?\`#(>O67B[XF>$OB'<3?%S]C[5_BW\:M#/AS2?"NC/IOA3
MXXZM\?M-;PV+:W\,177@Z/3/`\.A^!M5N'U#3M`NG>[BNOTF''IU/08ZG/Y^
MI[GFOYRIOB)\!_'W[9.J>/DTK]DKXU0>//C7\-M8^'WC?XMS_M:GXU>";.WM
M?!?A^V\/>%;"7]G'4OA[H-IH>M:1-K7@C0;/Q-H?A^UU?4+N_P!?U=;S5=5U
M>/\`HT'3MU;I]3^OK[]*`/Q!_P""D_\`RDD_X(4_]G6_M0?^L<_$&NL_X*+_
M`/)5O`?_`&3:/_U)=7KC?^"ETDL7_!1[_@A8\,!N9%_:L_:?VPK+%"7S^QW\
M0`<23%8UVJ2^&(+;=B_,RUT__!0N>YN/BEX&:ZL7L'7X=(BQ/<VUT70>)-5(
M</;.Z`9)7!()(R!@B@#\_;N[M-/L[S4+^ZM;#3].M+G4-0O[ZX@L[#3["SA>
MXO+^_O;F2*ULK&SMXY+B[O+J6*VM8(WFGECB1G&-K&N^%+5=,TS7O$'AS3_^
M$M=M,T*SU;7M'TV;Q+/=0*WV'0(+^\@EUR[E@GB>.WTE+R=DG@=(R)H2_P`U
M?MS:)HWB?]EGXS>&=3\(^+/'6I>(OAS\0]%\%^%?"/A/QOXUNM6^(.H_#SQ;
M9^"HM1\/>"+'46NM/37;BVE@F\4VDGA&QUI-(O\`4C%?6NESP_.'QH\+:Y\0
MO!^LZOX%\(^-M=U?XP_LCV_P"L]&\:?L\^/+S4_"WBOPT?%%OI-WX-U?7U\/
MQ?"/Q'+XH\2C5_$^I?$_2=$\&WFE^%_"/Q'T#Q/JNH>%$T"]J$Y4YQG"4H3A
M*,X3BW&491:<91DK-2BTFFFFFKHF48SC*$XQG"47&49)2C*,E:491=TXM-II
MIIIV>A]:Z/X/;3?$6N2ZI?VNDZ3X+BEUF\UO4Q:IIEO9V\;WEM?ZA-?RVUE;
MV,%E%+?ZC=7=Q!;6<5M)+/-$B,P]C_M*^CO(-/7Q-X0NM0N=-DUFVL+I?LFH
M76CQ%5EU>&TMM:FN)M+C9X_-U.&T:PC:3YYU7:I^/?VL8M.\8_LH?';X:^(_
M!7Q0^(/C'1/AMK?PYT^'3/AA\2=<M/B1\8+SX$WUQX<\0^'[7PQIE['XY\(7
M'B35XV?Q'K%I-X'T7QU"+'6&M_$&A6SV^7XX\(W'CSPWX-\=?#_PO\1[W7;O
MP3H]WXJT'Q%X8\2^!5ELOA?X'U?X:7F@7.G^)]#T/QQ::QXOTWQ_XE\,0>%+
M":PL?%?AQ-?\76L,VK:?X?U.[^OXBXUS3B3%X?$XZE@Y1P^"PV%C2J8/"U[U
M*=&"Q=>-:I0=>E];Q2JU_9TZD8THRITUS.GSR^5R#@_+>'\-7P^#JXR+KXO$
M8F56GB\31]R=27U6C*E"M["I]5PRIT/:5*<I5)1J5&HJI[./W'#?:]+%#<0V
M&A:C;7$44\%QIVN3)#<6\Z++#/;O/ILD,L,T,B2PRI</'+&1(CLDB$_KA^PM
M\0O%_AKX/:U#'\%?B!XITP_$#7)I-6\'ZO\`#C4(XKE]%\.A[,Z;KGC7PUK$
MCPI"LCS06,L#K/`D3/.TD,7X_?#_`%77M;\':'J?B;18O#^LW,5^EQID%A<Z
M3`MG9:SJ6G:)J,&B7LDM]X>@U[P_9Z5XAA\,W\LM_P"&8]670+V1[K396/[B
M?\$_;R^@^">MI;:3)?1GXD:^QF6\LH`KG1/#`,?EW$J2$J`&W@;3OP#E6KY_
MZ]AF_?RC+I7WDJF:4Y>J4,S5&+]*-O(]SZEB%\.:XZ*2LHNGELX^5W++W5?G
M^]NUUOJ:'[2_QMT_5_@)\4-)U#X=_&;PO=7?APP)-X@^%OB7^RH9&U"S(-YK
M^A1:[H-G%@1GS[G4HH,S)&)#,DT47X[_``[^)7A'PEXRT77]5U35[."PNXY#
M<Z)J5WX9US3F,\)-[:S7EF(;Q(X5G@O='N@MKJ]E/=V3SP2-'-'^[/[5=]J4
MG[/'Q7CET.6UB?PPX><W^GR",?;['YC'#*TC],80$U^!SEW)0EGRVT)R^XD[
M0H7G).=H`!))P`<XINME4G>67XV#?2AF=*%->:C7RS$U'Z.MY7Z@J.9QLHX[
M!R2ZULNJRF]MY4<QP\%UVI]=CZ(G^-/PAUGQGK_CJWM-5MO%8FL[?PGX@TZ#
MP-JYMGLY;N67QUJNA/?^'M-N/']Y+-"-,F>WNM*T*.QL]1EM-7\2(^K1^(V?
M[5MW\.=.U#1I-,UK6?&&@V/Q`T+PO>:M8>%)]';3_'3:B+35I?$,BS>.M-LE
MM-8N]6UGP?IU_J&FZWXF9[N/7]-T^[U2PN?FH_'7X&ZM8?%W4M/UO3?%MI\#
M;O1]-^(\OAKPU>>*7T_5]>L+?4=)T;0FTS3KH>,M6O%GM[%;3PI+JVS6G&AR
M2+JD-Q:PT[K2[;XA:=9ZMX8\$^.O!EW!KO\`PCU_HWQ`^'OB'X::Y*DOV<KJ
MB^'O$]I8WTNFVLMP(UU6.$6DY2\@C=GLI0OU_!$N#9YS#"\04*D\%C(\L)XU
MPC1P>(I*52G.KC*&(H3]C7BIX>I3^J-2J5*-3GI>RYCY3C!<60RF>)R2M3AC
M,+)2G#"<SJXJA4<:=2%/"5J->'M:4G"O"?UI.,*=:FHU/:I'V%X>^,?A'Q'\
M//\`A&KBT\<VWA"Y\1^&+NQT?7]2\*W*^`K/19IG\3OX$U4-#/KFHZU#>7>D
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ME98K>`37,KI!"[C]M$^,OB_4H6_X1[]GGXRW[!6*S:X/AQX*M&79E"X\2_$&
MVU2/<7B9E_LEI8XVES$;BWFMA^//[(<LZ?M&?#62*!KR5;OQ#L@\Z*%I,^$/
M$`($L[+$NU26PS#=MV+\S"OWC&I:L%X\.3#Y>VIZ6.WJ)\?CTKA6)RZFOW>6
M2J/_`*C<=5KK_P`LJ66M_@=OU?,)_P`7,8T_^P/!4Z3_`/+NICU^'R/Y%_V^
M?VP?%W@S]KKXR>'M<\,Z5X?U#3M2\+"X\-MITGBC4=,%SX#\*7D4=[XFT[QA
MI&@W]Q/!<)=LNF61ALEG73Y)KFYM)KB;XKU7_@H9=:1%9BZ\+:%!)J>IV.BZ
M9/JVIIHR7^KZ@Y6QTJRMUO+]KS4KXI*MO8P3R7#B)Y4C:,2>5L_\%99)9?\`
M@H7^TE)/;FUE;6_`Q>!I8IS&1\*?`8`,L+-&VX`/A6.W=M;YE85^.7QJL[FY
MN_AI=:9X%\4^*M2T#XF^!?$]UJ7ASP_!J[Z1X8T'6I;S7X1=SW]FUM=W"BVG
MCT^V!GU-8D4R%(EC']VY/X7>'\^!N',^J\(9=C<=B\@X?QV(ISGF"C4K8W!X
M*MB7".&G4KU9?O*DH0JRFYNRK56G*;_B3-O$KCN'&G$&24N*\?A,%A<\SW!4
M9PC@92ITL'C,71PZE+$0A0I1_=TXSG2C'D3;I4M(P/TMUO\`;X\3Z_J9\(W=
MMX!CFF6"YO/#<-XTFN2V4:I>.UO&UQ'<0W0MD^VP$1-*L&+MX6T]C*=[XE?M
M56OP>DT_7?#VI>&+:R;1K+4=2\0^))EBTW3+?Q%<6EMHUF7:>"".\OVN(894
ME82B:[M;6)1)*P;\LKSPEKU[X@T_3]+7Q%IVB3?%SPY\7KR]U'3-)@@L;F%;
M74->A3Q#_;=_>W<>H"*3P[%X5D\.6NM:4;Z^AEUD>%-.L4GY?XWZ-\3?B+\.
M-3_X17PC9B*]\,&.W\'>++N]TKQI9^)#XIMHI;Y++28-:\/W4D?A^R4Z4MSK
MMO\`9++4]7O"6O)[2*W]NGD&38#)\ZH8+@7#T</A'F'L<FPV7UEEV<VITZ<Z
MF*HTY5JF-C3IQHKVJC1JYC[:GAWAJ"P]9TO(EG^;XW-,FJXSC6O5KXM9>ZV;
MXC'4?KV3_O95(PPU6<:-+!NK.57]VY5:67*E4KK$UG7HJK^N^G_\%`?'L$MS
M;7^C>"M0FL+FUL]0BBFNK2>WNIYO(CMYE5IC%<W4["WACQE;A7MPIFCD1.WM
MOV^]<98TN/`.G1RY!::WU*6X1B7^ZL,_V;:NPCY_-+;EX7#9'Y+ZSH.OV.L3
M:WX<T:V>[MFO96@-S+=:;+K&MCQ'XGO)-&AN4M9FT%/%^J)!/?7XBOK7_A)M
M=URWAA_X1VPMHO7H]V8]P"ME-RJQ95;C<JN0I=0<A7*H6`#%$)*C7+_"WP]S
M:MCZ68<`97@:N#KJ%.KAJ&-PF&Q4'*K#VE!QJX?VD8RIRIS3HQA-PCBH-PQ,
M*-#'&>)G'F5TL!4P''.8XVGBZ/-4IXBO@L7B<+-1HR=.NI4L0X2E&HJL6JTI
M0YY8::Y\/*K7_NO_`&&/B-\>O&7[)?P,\:Z%X$^%6M>'M?\`!5OJ&FP7_P`0
M/%7@_P`0_9)=0U&W$5]8IX!\9:/;W44T3RRM;ZU<021'9$J2`%N8_;G\7_%;
M4/A%H]IXN^#\'AVSC^(&B3Q:IHWQ)\/^)K:2YCTCQ'%]C^RSZ5X<U%6G1WGM
MIC:F$PPL+MK2=XX6[?\`X)<W^I0_\$_OV68X-$EN8E^&5L$G74-/B$@_MO6L
M,(I95D3KT8>W4&O%?^"QWQI\3?!_]EWPEXGT_P`):?>SW?QN\):(T6M:F3:+
M'=^%/'=TSHND7`NS.&L4"%OW`5I!)\[1D?Q)CLH68<>YIPID>0Y75KU.)<TR
MC*Z%7$9AAH\N'Q^)HT*<JJS3#T86ITDG.?*FUJ^A_9."S7ZAP/EG$^=9WF5*
MA#AW+,US*M3H8'$2YJ^!PU:O4C3>75ZT[U*C:A!MZZ(_,X:Q=+_KO#NOIU!,
M$6FW@!'O;ZFS%<<[M@!(VC+<5#/K=G)%-!/;>(K(31O$93HFK12Q>:A420RV
MT$Q25=VZ(AMRNH)`XS^9L_\`P4`^($$$TR_#?P?<M#%)*+:TO/$,EU<&-&<0
M6L<NH0127$Q410))/#&TK(LDT2%I%\?TG_@JSX\U'PO::U=?";X>Z'JVI^/O
M'/@'3](U'Q9XBDM8;CP-K'BBRU+4]2U6PBN9)+>WTKPK>ZI=6NBZ?J=S-=2V
MND:4+V2ZAO#];C/!CC3+*L5F'#V"P<XX>IC8RPO$6&A!4J&(PF'D_:XB>8TE
M4>(QF'IT:$INO7E4_=4ZJA4</EL)XO\`!^8TY?4<_P`9BH2KT\'*&)R'$SFZ
ME>AB<0DZ5"&7U'35#"8FI6KJ/L*,*;]K.FYTU/\`0"^\0>*;&\N+-O$.MR&"
M9XE?[5>1-,@;]U*L,RQS+YZ%'5'16RX4"OI/PO8ZA8:)91:K=W5[J4J?:;R6
M[G>>2.:XP_V57=F(CMDVPA1@&19'QES7X_77[?7B'6O#$OQ3O/A5X7UG7-%T
M6YU?3M"\&>)-1U_2_$G]@S:G))!'J4QM+FYE=+-&TV(VME>V<[2Z7KEA%?:=
M-9MGZ?\`\%5/'FI:?-J.G?#+X7^);*"<*VN>#?%WBK7O#-T[:2VM)HEIJD]I
MIUS_`,);+:O:0Q:;<6,=CY^H64EQ?6@F>UM_JN/^$^(\URKAO!83(<IRNKB\
M#3S?'N%;+:56M.5)QH0HU:%.C.>'5/VV)K?NZ<82J8:->G0JP4'\UP-Q7P]E
MN9\0XO$YWFF94L)C:F58-3HYC4IT81JP=:56G7G5C#$.;HX>E:<W)4L1*E4K
M4IN:_;&OT(_X)R_\E8\<_P#9.Q_ZE&D5_,SIG_!0OQYJ=K]LB^'O@58)9[@6
MV-3\1O(]JDF+6>XC%UFUGN[8Q7QLG)FMK>ZMDF/G%U7]DO\`@C'^T_XO^,G[
M0'Q4T#4?!6@646E?!M=8CET34KY;AY/^$Y\/V7ER_P!L7+0&';.6_=8F\Q5'
MW":_.LW\%^/LCR+%<29AEV#AE&#PT,76Q%/-,!6FJ%2=.G"<:%.NZT^:56%H
MJ',D[N*UM]]E7C!P-G.=X;A[`YABYYKB\1/"T:%3+,?2BZ].$YSA*M4H1I02
MC3G[TIJ-XVOJC^F2BJEE/<7$)DNK-K&0.RB%YX+@E`%*R;[=WC`8DC:3N&W)
M&"*MU^4GZ>%%%%`!1110`5'+$LT4D3F15E1XV,4LL$H5U*L8YH'CFB<`G;+%
M(DD;8>-U<!A)10!\[R_`GQ/NDL;+]H_X^Z?X7D>0_P#"-)JOPXU&XB@DF5_L
M4'CW7/AGJGQ/2W$0,"W$OC2XUE$9GCUA)MDJ^]Z;80:5I]EIEL]Y);Z?:6]G
M!)J%_?:K?216T20QO>:GJ=Q=ZCJ%TZH&N+V_NKF\NI2\]S/+,[NUVB@#\0/^
M"D__`"DD_P""%/\`V=;^U!_ZQS\0:\!_X+'_`+3T'P0^/GPK\.2^"KCQ*VK?
M!F/6Q>0Z_#I2P#_A-O$5A]F,$FE7YD.;3S?-$J#$@3R\KN/OW_!2?_E))_P0
MI_[.M_:@_P#6.?B#7YF_\'!G_)TOP1_[-ZC_`/5C^+:_5_!;AG).+N/,%DO$
M&#>/RVM@<RK5,.L3BL*Y5,/A95*,O;8.OAZZY)I2M&JHRVDI+0_+_&#B/..%
M.",9G&18M8+,:.-RVC3KO#X;$\M/$8J%*K'V6+HXBB^:#:NZ;E'>+3U/C_\`
MX>"V@Z?">]';_D<[;IZ?\B[0?^"@EF3D_">])QC)\96I.!@@<^'.@(!_`>E>
M3_#G]F+PQXQ_9;^)'QZO_$_CBZUKPK=^5::3X!\%6?CC1?!RZ=<Z]!-#\5;6
MP\00>+]%@\4I8:9=V'B2UT`>&_"6A:G8^(-1OM=CFUG3_#_G7CKX)^$_"W@/
MX`>+=&^+&C>(6^,&I_$#1?%&K3Z+K>D>!?`&J>"-5\"65U%#JTNGS^)O$NG:
M1;>-2WB?6[7PQ%"^H:3?VWA73M;LH[74-3_J^EX1>"-?%U<#3X=Q,L11S'$9
M5-+,.+73^O87+YYG7I>VCF#I+EPE*M*+E./M904:7M/:475_EZIXK>,E+"TL
M;4S_``T:%;+Z&9PD\!PLIO!8G'4LNHU?9/`JJU+%5:49*,)>SC/FJ\GLJRA]
M._\`#P6T'3X3WH[?\CG;=/3_`)%VE/\`P4%M#U^%%\?KXSMO_F=]A7D6O?LT
M>!_#WCGQA`_Q'\2>(/A3\/\`]F[X:?M$:WXMT?PC8:3XO\2V?Q-T[P';>'?#
M/A7PQK^J+8:3/K/B_P"(.CZ?9W_BB^9M&\.P7NK:S93ZG"ND2>5^./A+X8\&
M?%3P;X5O?'\EC\,_'WASX;_$/1/B1JOAFYGU/2_AK\2M$MM?L]5UWP=H-WJ$
MTOB?0(CJ>B:GH.CZC/:7VO:4S6.HPZ3>Q7EO6%\'_!/&.*P_#F*J.6#^NQ7]
MH<71DZ?L</B72Y)8]5%C%A\5AZWU%P^N<E:#5!M326(\6/&/"*3KY_AH<F+^
MIR?U'A1QC4=:MAU4<XX)P^J.OAL11^N\WU13I-2K)<KE]8?\/!;/_HD][_X6
M5M_\SE?TL_\`!'SXP1_&S]E_Q5XLB\/R>&UL_C5XMT(V$NIQZJTAL_"_@:[-
MU]HCLK%4$GV\1B$PL5,18R,'`7^/CXL?##P=X5\#_";XF>`]<\:77ACXL_\`
M"P8],T'XE:'X?T+QK9Q?#W7-*T.7Q/`OA;5=6T/6?!'BFYU26U\/ZQ:/`T.N
M^'/%V@2'4CHHU2Y_J9_X(`_\F6^./^SC/'G_`*A?PUK\S\8/#3P\X=\/ZG$/
M"V2U<#CHYSA\O]O5S#.JTZ?L\5BL'CL//#9ACJ])2AB<-4I.?LGK3<J4W!J<
MOT3PG\1N/L_X[I9!Q+G%/&8.645\>Z%/`Y/2A/VF'P>+P5>.(P&"HU'&>'Q,
M*JBJJTJ*-6"G%Q7Z>?M:`G]G+XM!06)\+/@*"Q/_`!,;#H`"3^`K^??RI@^?
M*G7#@[A#+E?F^\,*#E?O#!!R."#7[+?\%2+R[L/^"?\`^U'>6%W=6-W!\-97
M@N[*YGL[J!_[>T-=\%S;213POAB-\<BM@D9P2#_"8_CCQL&<GQIXO`!8DGQ5
MKX``))))U+``'))X`ZU^8>&7@MB_$K)\=F^'S_#Y3#!9G/+70K9?4QDJDH87
M"8EUE4AB\.HIK%*'(X-W@WS/FLOTKQ&\8<)X>9O@\IQ&18C-)XS+X9A&M1Q]
M/"QA&>)Q&&]DX3PM=R:>'<^;F2:DH\MU=_I/H/PN^-&I^,?VK'\2_`?POI?@
MWXWV_P`)9O"VGW/QOLX;&(?"7P%HWA(^']7/PVT&U\3^%_\`A)K[39-4T#7?
M#0N8_#+BT_MBTG7[7`_J_P`-_`_Q2^'\OB.7PYX`\/>$?#WCSQ]X=?3OA_'\
M0;GQ!IOP1\.VG@34-/\`$OQ`L)7T==-\6ZWXD\=6FAZOJ/PO\*W/A_1IK>6?
M5X_$\.MW.O?:/@\?`/\`:QE\)?#SQA8IXOU6W^)_B/2_"WACP_I7Q)2^\:IJ
MOB27PY#X-&N>#HO$_P#;N@VGC9O%6C-X:N]3M((GAO+2XU@Z/;ZIHTFI\'XJ
M\)?'+PE=^%[6;Q7?^*%\::QJ'AOPMJ'PV^+EM\3-&UOQ3I%_I>F:MX3L]7\$
M^)M8L?\`A*-+O=<T.*]T.66.\$6M:5>VZW&GZA;7<GVM#Z-4,3-4Z'B/D5:H
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M^'FB6,%NG@M_(_,OQ9X0_:`\%_%FX^!NL:AXRN?BE!XAT'PK'X6\.^.[WQ0^
MH>(/$]KI-YH&FZ/J>AZY>:3J\FJ0:YI9M9["]FM&:Z`-P$CE=*WQ$\/_`!J^
M%[Z*?%/BS4Y]/\1QZRV@^(?"7Q6A\=>%=6G\-ZH=$\3:;9>)_"/B35M&EUCP
MSJ^S3_$&DFZ2^TV:XLII(6L=1TZ\N]J?T8JE9X2-+Q!R:I+'T88C!1AEDI/%
MX>=+V\*V&2S5NO2G14ZL)TE*,J4)5(MPC*2RJ?20ITHXJ57@/-Z<<#6>'QLI
MYBHK"5XU(T9T<2Y96E1J0K25*4*O+*-64*;2G.*?]-O['44J_M)?#$M%*H%Y
MXAR6C=0/^*/\0]25`'XFOWY_@_X#_2OX9_\`@DSXK\5:C_P4)_9RL]0\4>);
M^SGU;QV)K2^\0:Q>6DP3X4^.Y$$UM<WLL$H61$D421L%=%=<,JD?W,?P?\!_
MI7X[XF>'F(\-L[P62XC-*6;3QF54<T6(HX6>$C3C5Q>,PGL73G7Q#E*,L'*?
M.II-32Y5RMO]:\.>/J'B'DV+SBAEM7*X87,ZN6NA5Q4,7*<J6$P6*=55(4:"
MBFL8H*'(VG3<N:TDE_"'_P`%;?\`E(E^TMW_`.)YX%XSC_FE'@+OV^M9.I?L
M[?`J#]F;X5_%^TO?B-XBM[GQ39+\8/B9\/M9\!>,++P1IMQ#\*4\6^&O$?PE
MO;C1?%/@^[\(ZEXMUSPUX6UZ[OKVQU?Q5#H]QXJN8?#OCKPD-,UO^"MP!_X*
M(_M+`@$'6_`P(/((/PG\!`@CN".".XKP6T_:]^,%KX%\(>`&7P%J.C^%-7M+
MZZN-9^'7A#5-0\=Z+I+^`9M`\#_$NXETJ*7QOX(T>Z^&OA"XET+6)95\2C0]
M"M/%\^NV7AO0+>Q_O/(,)G6)X'\-)9/7C2CA\AX<JYA">*GAHU<)_8&'A**4
M,/6]K54I?N(UG+"PK.G4Q&%Q$8QGA_X?SS%91AN-/$2.:T9577SOB"E@9QPT
M<0Z6*6?5IQD^>O25.FXQ?MI4E'$RHJI"AB</*3A7];@_9[^#VK>'/#/Q.DT;
MXG^`-`7X3?'?XT>(/A!KWC/0M=\>^)?AU\+YO!FD_#;QAX=\6#P1H;>&]`^+
MWBCQE-H4E[K'@S48K6P\%>*/%G@LZWHMSI@BZS0?V4?A9JOAW0_B)HOAOXJ_
M$;1O'^G?!7Q%I7PG\,>/O".A^.OA9X%^(=U\0]`\?_$/QCXEU/PC>6_B?PMX
M&\;?#C4/#OA[6O\`A&O#?AZ:WU73-2^(6IZ%YT$=W\QZ_P#M0_$GQ!\0I/BE
M/I/PST[QMJ,/B>R\5ZII/@"T2W^(>C>,M(&@>(_#7Q&TS5M1UJP\6>%[[1-V
MEPZ!/!:6.EV3)%HZ:>;/36L*MO\`M+?$2+Q#+XCNM'^%&M7$-IX)LO#6E>(_
MA#X'U[PW\/K7X;07%MX#M_AQH>HZ=+;^$+3PQ'=W+6^G6LESI6L74SZCXKT_
MQ%J>+P=D\HXNG02IYA&C4<+^SJ9AC:D(4Y8^=>67.I!0Q-1TZ4J<*><?6Z6.
MJT:/L*M&G"I4B^2&;<*0KR=3`.M3YN55*>`PE.4JBP-*A',.2;EAZ7M*L:DZ
MF4?5:F"I5:KK4ZLYTX27I?A3]EJRN/VF/CM\%M>U\ZOX9_9XM/C?K_B;6=/U
M?1/!L_BW0?@[J7]D6JVOB#Q$E]H'@V+Q)?7VASZUXAU.'5+/PIH;ZYJ-O9ZO
M=V-C9W?DGQ[^'FC_``Y\:Z)9^&],U/3?#/BGP)X/\<Z!)=^-?#?Q)T;5+37X
M;R"\U/P5\0?#%AH]IXN\%R:OI>I6>DW^JZ!X<\56%W9:IH'BC0[+5M(FDN:.
MC?'?XB:'J]IX@M9_#=YK_P!I^)DWB77-;\(Z%KFJ_$JT^,#1GX@Z)\6+S4;:
M:3XB^'M959UMM'U\20:*;Z_GT9[&\G2Z@YGQ_P#$?Q/\3=:TO5_$SZ1`NA^'
M]'\(>&M#\-Z)I_AGPMX4\)Z$UT^E>&_#/A_3(TM-*TJUN+_4;^1=UQ>7^J:E
MJ6K:G>WVHW]S=2>Y@L)Q##-,/7QN+P];!0RVGA:\85*\74Q=.4E5Q,</!0PO
M-BI1IXB,Y0=2A3G/"Q?+#FJ^-B\5D,\MK4,'A*]+&3S*6)HSG"C-4\+44'3P
MTL1)SQ/+AH2J4'%24*]2$,3-<TG"E_<U_P`$K_\`E'Q^RM_V3"V_]/FMU\;_
M`/!P!_R9AX$_[.-\"_\`J$_$NOLC_@E?_P`H^/V5O^R86W_I\UNOC?\`X.`/
M^3,/`G_9QO@7_P!0GXEU_!W#7_*0-+_LX6;?^K+'']N\2?\`)B*G_9!91_ZK
ML"?R*>%_A]X_^)M_=^%?AGX=\1^)?%<FC:UJ=M:^%_#EQXIU'3[/2--N=1O]
M:DTB&*2*XM=*MK>2ZDBNS'!=R+#IR&6[O+6VG\'\(_`3Q'I?AW5[HZ[XF\16
M_@?Q_=?$"/Q4/`.E6$7PZ\8_$#5O%J7::W)96\VG);>*[OQ/KVB:?HFOO87+
M0QR66E3C4+3[7;?J=^P)XVTOPOXS\?:/K?C#X=^']'\3^#]9:_T7Q_XC\=_#
MR77CH'P]^*4^GWWA3XH^!Q(WA?6?#]]JJK=:3KEKJ-KK>F:U-K.@Z7J7C'PA
MX>MJZ:^UVP\4?!S]L7P%X:_:'\*:M\/_`!EXY\+:_P#!+3_BY\5O"OA?X@>+
MKS1_C#=^)?&'CKQ?I&IIIFN77BS5="AM;JS\1>+;>+6/$&FI9V^E6VFO>7&B
MQ?VMG.-57/J^%Q>5SJ4,%_8-'#XV6+S7"TEALXS/#4LPK16&E'"U<3@94Z>.
MP]XTYX?^SIX^CC_;8*='!_QUE&"=/)*.)PF9QIXC&?VW5KX..$RO$U77RG+J
M]3`492Q*EB:6&QJJU,%7M*I"O_:,,#5P7L<9"KB_S`O/V=_&47@&#Q!J.D_$
MR/X4>+[GQ+#?^))_"$]GX7\:>.?%'BN/Q+-KUKXT70H]-75+?6-,U2QLO#&C
MW#>'-3M9-1TG4-*U1K*>-K_B+X)>,_A_KVLK\2](\;^'?%?C.P\-3ZG:>+/!
MDO@"XU7PGH=]JS:9:6OA^73=,$FG:A_:&J:3JNMA;R]O;7SM'6YLK>RM]/L_
MVIL?C]^SA8^,/#?Q6U'5/".F^`--LOV+IO"7AGPAXT\?:G\73JOPGU/X;V_C
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M_P#LW]?_`%9/A:OEKXY_$_X.^(_@S\4;31?$_@&]U?5/AM^S?X'\#?$'1O'.
MMZG\9_C1:?"NZ\'VDGA;XO?`ZYL4\(_![3_#FD:6^HW.N>';'PW?1ZGX!\+Z
M0NM^/X_%>N:C??4O_!O?_P`G2?&O_LW]?_5D^%J^;X[Q,\1X-<;4WED\IIX3
M#QH4,+*-2*]G4Q&58V<HNK4J5&HXC%UZ$W4]E652C..)PF!Q*K8'#?0<$X:&
M'\7.#9K,HYI4Q6)=:MB8RIR?/2P^98.$9>RA""<L/A*->*@JE+V=:#P^)QN'
M=+&XC^NJBBBO\[C^_`HHHH`****`"BBB@`HHHH`_"+_@KGJ7BGX:_M4_\$DO
MVD(/@]\>_BO\,_V?OVD?CWXB^*TO[/\`\%?'WQT\3^%=)\8?LS>+O`WAJ^O?
M"/PZTG6-<%GJ?B?5[/3UNC;+#$HN9B[&W\I_Q+_X*V_M+ZS^UY\<OAGX[^#7
M[&__``4BU7P_X8^$8\'ZK/J__!/?]I[0)XM97QCK^M>5%:ZGX&AFGB-CJ-NY
MGC4Q!R8]Q<,%_N0(SUS^!(_D12;1ZM_WV_\`\57U7!O%^:<#9[1X@R>G@ZN.
MH4,3AX0Q]*K6P[ABJ3I5'*G1KX>;DHMN#55)2U<9+0^9XNX4RSC3):V0YM4Q
M=/!5J^&KSE@JM*E7Y\+556FE.M1Q$%%R2YDZ;;6S6Y_G>?"O]HW]ISX0_#?Q
M5X+\*_\`!.W]LN/Q5K4<5GH7Q7?_`()\?M*0^.?#6F7$'C>RUFSN7L_#-MI'
MC"1K#Q]X@M?"UYXMTS59O"2:C?10C4K(:19:+C:W\7/BEK?PY^'/PSD_X)6_
MMH6>A_#+5]<UC0KJU_9,_;M;4[M_%VI>%]1\;6FIRW)FMY+;Q0/">G69>VM[
M>Y\/6\MW)X>FLKEXY8_]%S:/5O\`OM__`(JC:/5O^^W_`/BJ_27X_P#%WUJI
MC8Y3PU3Q57%K&U*]&CGM"I/$QPT\)&<G1S^"<8X>MB:<*+7L8_6\7.--5,7B
M9UOSO_B!7"GU6G@Y9IQ%/"TL+]3A1JULEK0CAWB*6*E!*MD=1J4L10H5)54_
M;2^K82,JCAA,-&G_`)VM_P#M;_%SQ1XQU.QT;_@FY^U=!>Z3\'_"/P+^*7P]
MT_\`9+_;4UY->^$UEX>T*S^'6A^+["^N+KQ%X1U73E\$:+XI\*>,]$NM"\07
MFNZ"NL?:;^V2[M9</5?C!\<O$OBR'Q7XQ_X)C_M>>+1IVH_#*'P_X<U']A/]
ML2R\->&_A[\*]!NO#FB?!_3+'28;.XG\`ZQIS:6WBB;5;O4/%NK7FC1W:>)+
M:36/$`U/^]KX=?!SQ'X/_:"_:*^+>I:MI-UX?^,&G_!2T\/:;9SZDVKZ;)\-
M?"WB70];;6DGMHK)4O[S6;:?3/L-U=LT,4S78MY1&C_1FT>K?]]O_P#%44?'
M_B_#I*CE7#=-QH+#QG&EGWM8TN:E*T:SX@=:,FJ%&FZBFJCH4:.&<WAZ-.E%
MU?`OA6NVZV:<0U$ZWUAP=3(_9.KRSCS.BLB5)Q3JUJBIN#IJO6JXE0^L5*E6
M7^<)\;OB9\>OC=XFB\7ZA_P3P_;U\*:X8?L=[-H_['7[8FN6,^F6L5O;:!H6
ME:/XJT;4](\'^&O"EE#)I_AOPUX.LM%T/3;"<VT5B$AA*_MW_P`$G?\`@H'X
M>_9(_9M\3?#3XP_LA_\`!2[2_%.J?&'Q5XRMK;2O^"<_[56NVK:+JOAOP9IE
MG,U[IG@*>!)GNM%OE>W=A+&J([#;*A/]8&T>K?\`?;__`!5&T>K?]]O_`/%5
MX7%/C#Q/Q;PW3X5S#!Y+ALJI5L-7I+!4,P6(IO"N;HTXUL9F>-?LH\[BH.+Y
M(*%.FX0@HGL\,^$W#?"W$,^)L#B\XQ.:5*.(HU)8RM@'0J+$JFJM25'!Y=@U
M[63IJ;FI+GG*4ZBG.4I/^<;]NO\`X*D?#GX]?LC_`!V^$'P__9*_X*;WOC/Q
MYX)ET3P]:WW_``3;_:QTRSGU`ZKIEXD=Q?WO@"&UM(S':29FF<*N/XFVHW\J
MTFD?'=O,Q^Q)_P`%"_F#@;OV$OVC67+`@;U_X0P;EY^9<C<,KD9R/].+:/5O
M^^W_`/BJ-H]6_P"^W_\`BJG@3Q?XI\/,MQ659%A\GK8;&8Z68599CA<57JJO
M.AA\.U"5#'86,:?L\-3:BX2ES.3<FFHJ^-O"CAGCW,<-F>=5\VI8C"8*.`IK
M+\5AJ%)T85ZV(3G&M@\3)U'.O-.49QCRJ*Y;IN7\.6B?M$:%IOPH_9Y7QS^Q
M!_P5&^+7C'X=>-[?4]+@N/\`@GI\;?"?Q6^#$?AR3X7217\/Q<\*:#X<U'X@
M>%)K?PS<Z/X1\,W$NG:IXAT#3=.L/%&O^"[_`,%Z#>ZKYC\7OVO=>T.U\`:O
MXO\`V)_VZOB5X_M;/XN^![7XB:)_P3]^./[&_AW3-9^/^I>&](\*6O@;PIX=
M\#^*M!N?C']OF\9:/:>-5\,66OZB_CG0])L&\0ZSX/\`#FMVW][>T>K?]]O_
M`/%5\^_M%_"/Q!\8/#OPZT;P[JFEZ7/X/_:`_9_^+.I2:Q-J"07>@?";XK^&
M?'NOZ;9_8;>[=M6U+2]#GM-(2=(K)]0DMQ>W5K;[YTVI>,O%-*NJ[P>25;5L
M96]E+#8^E32QRQ<:]"C+#9G0K87#SCC:ZK4<'5P\,;+DJYBL95IQJ+*KX1\-
M5*#H1Q><TKTL'2]K'$8"I4;P3PLJ-:K'$9=7HXG$1>#H^QK8REB)X.//3R]X
M2E4E3?\`$[XG^-E]%^U5HW[3W@G]A'_@IS9V?@OQA\"I++X<W_["?[16IW7B
M_P`-:#\+['P;\0=9MO%<_A#3+;PAJWAZ'1['1/"FA2:-K5MK]T8_%4^M:&GG
MZ.GA'Q2U3QK8?"SX;?!/X:_LA_\`!2KQMH_@SQO\3OB/J?C;Q#_P3L_:*\&3
M76H?$'3O`?AK2/#>F^'AI/B.>&/0_#/P]TZ\\1:E/J(@U+Q/J]Y#I5NVEZ7;
M7U__`*+2IA5!+$@`$[WY(')Y;/-+M'JW_?;_`/Q5>EA/'OC;!5,OJ4J&2366
MX;!X3#PK83&U4Z.7X/%8/!QK5)9E[>H\/#'YC4BW63E5QM1U?:4Z&#IX;S\5
MX'\&XNGCZ=2MG,/[1Q.*Q6(G2Q6"IM5L=B\+C,8Z5..7>QIJO/`8"G)*D^2G
M@X>SY*E;&5,3_GS?\$_/B?X^_9[_`&O_`(-?&+XE?L8_\%&M/\$^"[[Q;<ZW
M=Z;^P#^TOK%[$NJ_#_Q9H%@(=.LO!;75P)-4U6QBE,*NT$,DEP4=8F4_U)_\
M/I/@1MQ_PRI_P5!Z8_Y1F_M=>G_9//Z_C7[#;1ZM_P!]O_\`%4;1ZM_WV_\`
M\57Q''7'F=>(6:X;.,]I8"EBL)E]++:4<NH5J%%X>EB,5BHRG"OB<5-U74Q=
M5.2J*/(H)04E*4OL>">!\GX"RS$93DM7'5<-BL?4S"I+'UJ->LJ]7#87#249
M4</AH*G[/"4FHN#DIN;<VFDO\^/_`(*`?$[Q_P#M!?M?_&?XQ?#;]C#_`(*-
M:AX)\;:CX4N]#N]2_8"_:6TB]F32_`'A/0+[SM.O/!2W5N(]4TJ]BB\Y5::&
M..X"(LH4?'/]D?'?_HR3_@H9_P"(*?M&_P#S&5_IQ;1ZM_WV_P#\51M'JW_?
M;_\`Q5?HV4_2+X\R;*LLR?"83AR6%RK+\%EN&E7P&.G6EA\#AJ6%HRK3AFE.
M$JLJ=&+J2C3A&4VW&$4^4_/\T^C_`,$9OF>8YMBL5Q#'$YGC\9F.(C1QV"C2
MC7QN(GB:T:49Y9.4:2J5)JG&4YRC!I2E)IM_YCO]D?'<=?V)?^"AG_B"G[1O
M_P`QE9&C7/Q9\1P7ESX?_9`_;UUVWT[5]8\/ZA<:-^Q-^T#JD%CKWA[4;C2-
M>T2\ELO"4\=KJ^AZK:W6F:QIL[)>:9J-M<65[##<PR1K_I\,F58`L"00#O?@
MD<'AL\5\_P#[.GPCU_X/>&OB'HOB+5-+U2X\7?'_`/:#^+&G2:/-J#P6N@?%
MOXN>*OB#H&FW?VZWM'75M-TK7[>TU=($ELDU&.Y%E=75MLG?T/\`B9WQ#_Z`
MN%__``W9CY?]3?R_'UOP?\2W\`_]!G$O3_F/P'E_U*O)_>S_`#GO[(^._P#T
M9)_P4,_\04_:-_\`F,I5TGX[AE)_8D_X*&8!!/\`Q@I^T;V/_8F5_IP[1ZM_
MWV__`,51M'JW_?;_`/Q5'_$SOB'_`-`7"_\`X;LQ\O\`J;^7X^MVOHW\`K_F
M,XEZ?\S#`=+?]2KR?WG\Y'["_P#P5)^'/P'_`&2?@3\(?'_[)?\`P4WL_&?@
M/P/;Z'XBM;+_`()M?M8ZE9P:BFI:E=21V]_9>`)K:[C5+J/;-"Y1A_=;<B_.
MG_!63_@H%X?_`&M_V;O"_P`-?@[^R'_P4NU3Q3I7QB\+^,KJVU;_`()S?M4Z
M%:KHFE>&?&FF7DRWNI^`H('F2ZUNP5+="TLBO(Z@+$Y']86T>K?]]O\`_%4;
M1ZM_WV__`,57XY@>+<SP'%T>-*-/!RS:.<8C.U2J4JLL%];Q->K7J0=%5XUO
M8*=::C#ZQSJ*BG4DTV_UK&\*Y;CN%7P?7GBUE3RG#Y,ZE.K3CC/JN&HTJ%.2
MJRHRI>V<*,'*?L'!RNU32:2_S'#H_P`=B,']B3_@H61D'!_83_:-(RI#*<'P
M7U5@&4]0P!&"`:=_97QY'`_8F_X*&@>G_#"O[1W_`,QE?Z<.T>K?]]O_`/%4
M;1ZM_P!]O_\`%5^Q_P#$SOB'_P!`7"_3_F79ATM_U-_+^M;_`)*OHW\`K_F,
MXEZ?\S#`=.7_`*E7E^)_F"WM[\6-/U?1O#NH?LA?MZ6.O>(8]4E\/Z%>_L4?
MM`6VKZY%HD%O<ZS)HVES^$DO-3CTBWN[6?5'LH)ET^"YMY;HQ1S1LVR=*^/)
MY/[$W_!0TG&,G]A7]H[IZ?\`(F=/:O\`16^(?P=\1>+OVA?V=_BYIVJZ3:^'
M_A!I7QML/$&FWDVHKK&I2?$OPYX3T?1'T9(+:6R:/3[K0;N?4_MMU:,L4T#6
MBW$AE5/HO:/5O^^W_P#BJ/\`B9WQ#_Z`N%__``W9AY?]3?R_'UN?\2W\`_\`
M09Q+T_YF&`Z6_P"I5Y/[S_,>_LGX\8Q_PQ+_`,%#<>G_``PI^T=C\O\`A#*_
M5?\`X)(?M-:Q^R%\<OB7X[^,W[&__!2+2M`\3?"=?".E3:1_P3W_`&G]?GEU
M@>,M$UHQ2VVF>!9IH(A96$[B>11$7`CW!RJM_<5M'JW_`'V__P`51M'JW_?;
M_P#Q5>'Q+X^\;<4Y%F7#V983A^G@<TH1P^)GA,#C:6(C"-6E63I5*F95H1ES
M4HJ\Z4URMJU]3V>'O`O@[AG.LNS[+\5GT\;EE9U\/'%8S!U*$INE.BU5A3RZ
ME.4>6<G:-2#O;WK)I_//[,G[2?A7]J?X=77Q*\(>`_CC\.]*M/$^I^%7T']H
M#X)_$/X">.)+S2K+2KZ;4;?P3\3-&T/Q#<^'[F/5X(=/U^&S?3+^[MM2M+:=
M[C3;R.+Z(I`,<<_B2?U))I:_$#]F"BBB@`HHHH`****`"BBB@`HHHH`0D#J0
M.">2!P.I^@[GM1N7U';N/XNGY]O7M7YB?M&^)K;7OVL+GX6_&#XW^-O@!\#_
M``_^R1J_Q;\'>(O!WQ8U'X(MXB^)$/Q"UW0OB-XHU#Q=IU]I3^(!\!/!6F_#
M_P`06?A'5[S4_!1/Q,NM9\9^$/$EM!I+:9\FZ1\5_B;\5?"?[,,B?M!_$2P_
M;S^(/P^_8Z^(OC/X>VWQ"T_P3\'_`-F[P'?0^"M<^+/B7XU_"73[CPYX6U5_
MC?IX\=V^@^!_'^B^*/B=XB\2^(-)\-?"^T\#^%/`6M^./"8!^]U&1_\`JY]N
MWO7BGQ(^'>O^(/%7@OXA:/\`%CQ/X`'PZ\/?%*"3P_;7+S>`?$M[XT\-V.F:
M/KOQ`\.RZKI>G>(XOAU=:8=>T*WU&XBBBNKK42M[IXN9;D?CU\(OB!XU^(W[
M,7[3W@K6/VL;?Q1XF\/?\%+O&_P[C^(?Q+_:-O/@]?ZI\.=+^.'@W[/X%M/B
M5\'8-/UCX<Z5XELDU'P[X0\*?#ZS\+6^H6EY'\.]`U#3&UE;]@#]\**^+_V'
M/&</B+X8>,?":6N^Z^#_`,6O&7PLU/Q)8_&;XD?'[POXVU72K+P[XGO_`!+X
M.^*'Q;U?7?'NL:.DOBX>&]4T/7-8U-_`?C/P[XK\`VVH7]IX:AO;C[0H`*.G
M6BOD?]O#XA?$?X5?LC?'7Q_\*)[G3_&OAOP3+=V7B"RLK?4KWP;I$^K:58>+
MOB!8Z?>6FH65[>_#OP9>>(?'5I:WVGZA8SW'AV)+VQO+4S6TH!];[E]1V'4=
M3C`_'(QZY&.M+D'H<]1^(."/P/!]Z_$K5_'_`,/_`(=?$CXW_#[4?VPOB9HO
M[(/AGX5?LS_$_P`4_$9OC_K'Q$\9V'Q2\7_$#XJ:-+\%/!OQ<O;[Q7\48=3_
M`&B?"WAOP#K2^`OA[XD;Q];N]M%\*;/PPWQ4M7G^S?V0]$^*/B?]G;QMIWCS
MQOXSLHO&GC7XO_\`"J5UWQO:>-?C+\(?A)XEO;JW^''A?Q[\0]+UK7)=:^)W
MA33[F37)I[WQ)X@UWPHFHZ)X/UCQ5XGU?PK=>)=3`/NC_/\`G\Q17X^_%/7/
M&_P*_;/_`."9_P`-=4_:O\6:SX/O]'^+'PS\6>!?$GBOP]HL7CN?P1^RSXBO
M[3XB_%F>>\N/%7Q"\9^(_&&BZ;KVG7NN:G'HFB:BUY-8:-?:WJ,FN5Y]X7_:
MK^(/C+_@JA\#O#&OG]I?X?>#O&OPI_;>\&:'\%/$WP=^.O@SX=7-C\(?&O[,
MMEX+^+/B&YUOP/IO@3Q5X@\47.H_$/7K#Q]8:SJ7A_X?^!/%?PX\$7.HZ1XG
M\9WT7B4`_<.BC_/I_.B@`HR/_P!7/\JYSQ?X>A\6^%/$WA:YU37]$MO$F@:S
MH-QK/A36K[PWXHTF#6-.N=.FU/PYXATR2'4M"UZPCN6N]&UG3YHKW2]2AM;Z
MVD2:!"/P)\8^+/C;\6?^">?_``40^+/Q4^,GQ"TCXD?L:?"?]JWX$^`/%'P<
M^+?Q#^$G]K?%;]C;P?\`$6UU']I[7V^''B#P=Y?B_P"*OBN#1_$&H_#S67UW
MP=X-LO#5CI5O'J,>I:L\P!_0QD#DG`]3P/3J:6OY\=1B\&>#/C#^V#HOB_\`
M:K^/?PHT+X"?L*?LD_$SX1ZUJO[7'QFOYO!/C7XB77[8>O>-O',OAGQS\2->
MT?XM:KK.L^#_``9`^C?$?P_\0=/U&RT+1_!MAI(T<QZ0_P"L?@?0/BA\;O@Q
M^R7XY^(_B+QA\'?B9H]G\'_C)\6?!GA&YOO#]KK/BV;X87L7C;X1^+K`7<4M
MSX-3Q5XLN)[_`$*^-U&NH^%]'$\$DUDLL8!]5_TZT9S_`/J(_G7X;>'_`(G>
M/V^*/_!7KX;:M^UW%KFJ>'?@Q\'=9^&WB/Q7\3=`^''@WX-ZOXQ^$?Q<?6KK
MPB_A&+41\(?#/A^ZT_0;K7?%T-GXE\2:5?Z;)XW\0:MJ]_#&EO\`7W[$?B&+
M3?%WQP^#+2Z=KU]X&M_ACX\F\:>&/VG_`(W_`+47A.]L/BC#XYM='\)/XD^.
MNO>(O$?A#QMX7LO`/]I^(O"^EWXT75?#OBOP3XZAL],F\4R:99@'Z%T444`%
M)GZ_D?\`#G\*_+3]I'6_B]X0_;'^"_P?\(?$SQ#IOP[_`&YM/U7P]XDC?Q/J
M<&N?!C5/V9M%/Q)\9:_\'%9ISIL_Q[^%L\_PP\40:9<:*O@KQ#I.A?%70?/\
M07'B"/4OSO\`C5I]_P"`_&?_``4(@TOXZ_M(Z!H_@']M?_@EE\'/#HO/VP/V
MC!IW@;X8?M&>.?V-KWXU>']&N-;^+4T/A>/QJGCKQ?!/X@AFM-?T/2/$6I:9
MX:UG1-)F%JH!_2V"#T.<<'V/7!]#@C@TO]>E?GQ^REXC>W_:&_:D^$/@3XF^
M*?BS\!OAOX?^`&J^%M<\5>/M8^+-]X"^+'C.S^)9^*/P>M?BAXCU#7_$WB2S
MTCPAX:^#OQ'?1O$_BKQ'KGA.Z^*-Q!]NMM$UO0]'TOYY_;"M/B#^S)\./V,]
M,MOVP/B1;6VB?MJ_LO>'/%K>)/%VB:=XN^,?AWXI?M;^#;#Q%IGQ!\8Z[>WG
MBK6/`6A>"?%.K>%9?"&B76E6.HZ<NE_\)'J-[HFE'0)@#]C:*_"W]L3]KOQY
MI/[8_P"R!X6TVX_:-^'OPTT7]LSX4_#15\(_";XW'P!^T58?$'X`_&7Q1XJU
M:^\<^&O!-]X!^(_P\T*Z?P1H_A/PCI_B:[N?^$GT#XD_$'7-%DTCP/X>UG3O
MW/C.40G).T9)[D#!.>^3WY!Z@D'-`#Z***`"BBB@`HHHH`****`"BBB@`HHH
MH`\F^,WP1^&OQ]\&2^!OB=X;M-?TE-2TGQ!HMV52WUSPIXM\.ZA;:SX8\9>$
M-;6-[[PWXL\,ZU966K:)KFF2175I>6L8?SK9Y[:;`OOV8?V?-<UG3/%?B[X,
M_"[QWXYTR'P\H^(GCOX>>"?%WQ"OKSPOI]CINC:OJ?C36O#]UX@OM:L[?3;/
MR=4EO?M4+P1&W:!8XD3WBB@"CJ6F:=K.G7^CZO866J:3JME=Z;J>F:C:6]]I
M^HZ??P26M]8W]E=1S6MY9WEM-+;W5K<Q2P7$$LD,T;QNRGR'PQ^S5^SOX)LO
M$>G>#?@/\&?">G^+]+31/%ECX9^%?@+0+/Q-HT;O*FD^(;72?#UG!K>F))(\
MB:?JD=W:*[LZPAF)/ME%`&/H'A[0?"FC:=X=\,:+I/AW0-(MDL]*T30M-LM'
MT?3+.//EVNGZ9IT%M8V-M&22EO:V\,*DL50$DG8HHH`*1E#`JP!#`@@\Y!!!
M'X@D4M%`'S%X=_8Z_9T\-6?C[P_;?"_PKJ?@'XA^,[?XBZI\*_$>A:)XD^%.
MC>.\7SZMXL\(_#W6M+O/#7A;6_$M]J%SJOB.\TFRA;4]6=K\K!,\QE]I\!?#
M?X>_"S01X6^&7@3P;\._#0O+G41X>\"^%M"\(:&-0O!$MW??V1X=T_3=.^V7
M2P0+<77V;SYQ#$)9'$:;>THH`\;\8?L[?`'X@^)XO&WCSX(?"#QKXQACT^*'
MQ7XM^&7@?Q+XEBBTE_,TN./7M;T&^U:./3I/GL$2\"V;_-;")N:]0GT/1KK5
M]-\07.DZ9<:[H]EJNFZ3K,^GVDVK:9I^N2Z;-K5CI^I20M>V-GJ\VC:1+J=K
M:SQ0:A)I>G27D<SV-J8=2B@`HHHH`.O6N8/@KP<=&\1>'3X4\-'0/%\NO3^*
M]$.@Z2=(\33^*1*OB6;Q!IAL_L.MR^(1/.-<DU."Z?5Q-*-1:Y$C[NGHH`\N
MUKX(_!KQ)XRT/XB>(?A-\,]=\?\`ABWT^T\.>.-9\`^$=4\7Z!:Z5//<Z9;:
M)XFO]'N-<TF#3KBYN9["'3[^WCLYKB>6V6*261F]1P.G^>N<_7/.?7FBB@#Q
MCPS^SC^S[X+\3W'C7P?\#/@[X5\8W:ZJMSXK\-_"_P`"Z#XEN%UT2#6EGU[2
M=`L]6F75Q-*-466\<:B)9!>"8.V>^\'^!O!GP]T<>'O`?A+PSX+T$7=S?C1?
M"7A_2/#6D"]O6#WEX-,T2RL+$75VZJ]S<"#SKAP&E=R`1U-%`!1110!D7N@:
M%J.J:/K>H:-I-]K/AYK]]!U:\TVRNM3T1]5M/L&IMI%_/!)=Z8VHV/\`H=^U
MC-`;RU_T:Y,L/R5S7B/X6_#/QAIOBK1O%GP\\#>)](\=3:5<>-=+\0^$?#NM
MZ=XON-"CL8=%G\46.J:;=VOB&;2(=+TV+2Y=8BO7T^/3[%+-H5M+<1]Y10!S
M'@[P3X.^'F@67A3P%X4\->"O"^FB4:=X<\(Z#I/AK0;`32--,++1M$L[#3;0
M2RNTLOV>UC\R1B[[F.:Y'XB_`OX*?%ZXTN[^*WPA^%_Q,N]$@N[71KGX@_#[
MPAXUN-)MK]XI+VWTR;Q/HVJRV$%Y)!#)=16C0QW#PQ/,KM&A7U6B@#FE\&>$
M$L/"^E)X6\.+I?@B;3KCP9IRZ%I2V'A*XT?3+C1=)G\,V8M!;:!-IFCW=UI6
MG2Z1%9O9:;<W%A:M%:32POTO3I110`4444`%%%%`!1110`4444`%%%%`!117
M'>/OB%X%^%GA74_'/Q(\7>'?`O@W1C9+JWBCQ5JUGHFA::=1OK;3+`7NIW\L
M-K;&\U&\M;*V\V1?.NKB&%,O(H.E*E5KU:="A3J5JU:I"E1HTH2J5:M6I)0I
MTZ=."<YU)R:C"$4Y2DTHIMI&=6K2H4JE:M4IT:-&$ZM6K5G&G2I4X1<IU*E2
M;480A%.4YR:C&*;;239V-%?(/_#P#]B#_H[+]GW_`,.IX1_^6=>R_"KX\?!?
MXY6VM7GP<^*?@+XGVOARYL[/7KCP+XHTGQ+#H]UJ$,MS8V^I2:7<W"VDUW;P
M336\<Q5I8HI'0%5)KTL5D.>8&A/$XW)LVP>&I\JGB,5EV,P]"#G*,(*=6K1A
M3CSSE&,;R7-*48J[:3\_#9YDN-K1P^#S?*\7B)\SA0PV/PM>M/EBYRY:5*K*
M<N6"<I6B[13;LD[>LT445Y)Z@44A8#KD<9S@X`]SC`_$TO\`G_/K^%`!1110
M`444@((R""/4'(]/YT`+1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%?EY_P65X_X)U?'O'_`#W^%O\`
MZMSP17ZAU\G_`+;W[..I_M9_LT?$/X"Z/XJL/!6H>-I/"3P>)-3TBZUVRT\>
M&_&6@^*91-I=G?Z9<W)NXM'>SC,=[#Y,DZ3OYB1M$_T_!./PF5\9<)YGCZRP
M^!R_B3),;C,0X5*BH87"YEAJ^(K.%*%2K-4Z4)S<:<)SDE:$92:3^;XQP.*S
M/A+BC+L#1>(QN/X?SC!82A&4(.MB<5E^(HT*2G5E"G!U*LXP4JDX0C>\Y1BF
MU_GL9/J?S-?U)?\`!NN2?!'[5623_P`5U\+^O_8I^(J\>_XAW/B5_P!'1^!?
M_#4>)?\`YN:_6C_@FC_P3^\1_L%Z!\7='\0_$S1/B1)\2_$'A/6K6?1?"VH^
M&$TF/PWH^I:7);W$>H:WK37CW;WZS1R1-;K"L;(RR%@R_P!;>,GBIX?\3>'F
M=9-D7$5#,,SQ53*GA\+#`YK0E56'S;+\36:J8K`4*,>3#TJE1\]2+:CRQO)J
M+_E;PC\,>.N'./<FS?.N'ZV!RW"T\S5?%3QN5UHTW7RO%T*2=/#8ZM6ESU:M
M."Y*<K.2<K13:_3ZBBBOXB/[-/PM_:0\1?!=?VW/VT'^.W[0?BKX0M\,?V%O
MV6O%GP7N-#_:%\;_``UUGPAXI\3>*/VWHO%/B[X<?#O0O&VEZ-XW\8WUSX3\
M"0RV5SX'\:R>([S1/#?AF^TC5[.ZCT6]\5\+?MU_M8>"O"?CNY\53?!;P!\1
M=,^,&G:?\:+'QAJ6GZOXXA\7:#_P3R_82^,7B/2O"7PQ^+O[1WP.\"ZA!9_$
M3XI>-=*^(_ACX<?$'P;KGAG1[;PT?!/PL\1^)=8\;^-8/Z#]2\!>"-9\1:7X
MNU;P?X6U/Q5HB1QZ-XEU#P[HU]X@TE(I)98DTS6KJQFU33UBEGFDC6SNX`DD
MLCJ`TCEK6I>#_">LP7-MJWAGP_JEO>:M:Z]=V^HZ)I=]!=:W90VMO9:Q<0W5
MI+'/JMI!96<-KJ,JO>V\5K;Q0SI'!$J`'XXZ9_P4A^)&O^'_`(Y?%?PWJ?PF
MUBW^'GA?XI7_`,-_V4KSPCXX\/\`[07Q5T;P)^S!8?'OP?\`%/33>^(I_$VC
M:-\3+[4+.[L?#&M_"^SMM(^'>MZ+9OXHN?BI"?#6MVO!W_!0/XF6?QO^%7P^
M\2?$S]G/XI_!C5OC5X$\*>/OVH/AOI4WA;X4QZ-\4OV4/VH_B]I7P^M=4U'X
MI>--!T+QYX8^)WP?^&$-OJ\_B;4X]?\``OQA\$>'+[P_IWC75K35-6_94:-I
M(U9]>&F:>-<DT^/29-8%E;#57TN*XDNXM-?4A$+U["*[FENH[)IS;1W,CSI$
MLK,YI0^%/#%MI9T.W\.Z%!HQOAJ9TF'1]-BTPZBNIIK0O_[/CM5L_MHU>--4
M%WY'V@:BB7WF_:D68`'X$?!G_@II^T]\0?AUX7^)WB)_@SI>D:1X`_X)#>(_
M'6@V?@/Q)'JNO:M_P49\?VOPF^((TO4;WXC6\/@RR^'>I:WI_C+P=::AIGB.
MYU2XTV[\):_)!:3MJR^;?"C]O?\`:G^$?[.'@G5/B=^T/\'OB)K?AO7_`-M/
M6_C/XA\5>&?!=U\<M`E^"7Q]UGPWH7@J]^!VK?M#_!_4=7\)Z9X-M]7O];?X
M;:UXU^-FCR:C\+O"6@_";5[*]AUOQ!_2"OA;PTL4L*^']#6&<:2LT2Z1IHCE
M70+G[9H8EC%J$D&CW8%SI0<,-.N`)[(02_/52X\#^#;N9[BZ\)^&KF>3Q!!X
ML>:?0-(FE?Q3;6EO86WB1Y9;)Y&U^"QM+6SAUEF.I16EM;VT=TL,,:*`;&D:
MI::WI6FZQ8/+)8ZK86>I6;SV=YI\[VE_;17=LTUCJ$%M?V<K031F6UO;:WN[
M>0M#<P0SI)$FC110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%8GB+Q)H'A+2+K7_`!/K&FZ!HEB8!>:K
MJUW#8V%L;FXBM;<3W4[)%'YUS-%!'N8;Y9$1<LP%`&W17C'_``T5\"/^BO\`
MPZ_\*S2/_DFNW\(_$'P/X^BOIO!7BSP]XJBTR6"'49-`U6TU1+*:YC>6WBNF
MM9)!"\T<;R1*^"Z(S*"`30!V%%%%`!12$@=3_P#6'/)]!P>3@<4M`!102!C)
M`R<#/<^@]3P:*`"B@D`9)``ZD\`?C10`449Q_+H3_+^?2B@`HI"<>OX`GISV
M!_\`K]!S2T`%%&0,`D9/0>O?CUXYHH`***,C(&1DYP.YQUP/;(S]:`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`KY3_`&V?^3:O
MB%_UT\*?^ICH-?5E>1?';X9W7Q@^%WB3X>V>KV^A7.NMI#1ZI=6<NH06W]F:
MWIVJL'M(;BTDE\Y+)H5VSIL:0.=RJ5(!_.)7ZP_\$U_^0#\6_P#L/^%/_31J
M5<9_P[:\3?\`16-!_P#"/U/_`.:&OL']E[]G;4?V?-.\8V.H^*;'Q.WBC4=(
MOHI++2+G25LUTRRNK5HY%N+^_,YF-P'5D:,(%*E6)!`!]4T444`?D%^TGXN\
M#2?M._'70OVGOCMX[^`_P^\"_LS_``L\;?LT77@CXL>+?ASJ5YXLU'6OC7:?
M&#XB^!?#OAN[M+;XR?%[PAJVF?"OP_I7@#5-%^)D=E9ZCX7TF'X?W=O\4]2L
M?$OAGQR_X*5_'?X6Z-\?/$NAZE\'-3U?X:7W[9W@>S^`6N>&M3B^,7@+2/V9
MOV:?C!\9_`W[3/Q1O+?QU8N_P_\`B+KWPZ\(3:MH$7P]\+:#;>#OC;\.+/0/
M%A\4VTD'BC]W=0T31]6FTZXU32].U&?1[Y-3TF:^L;6\ETS48XI(4O\`3I+F
M&5[&^2&:6);RT:&Y6.1XQ*$=@8+CPWX?N[K4;VZT32+F\U?2O[#U6[N-,L9K
MG4M%S<'^R-0GEMWEO=+!NKDC3KIYK(&>8B`>:^X`_G_^(_[8W[5MW^TM\!_A
M5K/QN^'OPS\/>"_VK/V5]3^*GBOPM\/QH_A7Q1\)OVIOV5_VHO'>E_"_QL/&
M'Q(OH=.TS0OB!\(X/#&A^*GU73+CQ9KWC'X?7*Z+#XD\+QZ1XQY37O\`@J[^
MT;I7[+GP]^,RZG\(KCXI>+?V?_C)^T[%\-(/AW8Z'X<O?"?PD\07'@_3?"<?
MC[XD?M#^`TU^_P!?U/0-8U#Q-H'PO\/>._B=:2:UI]OHWAG2M,L-(U#QO_1/
M>>%O#6HPW]O?^']#O8-4CTV+4H;O2-.N8M0BT:43Z1'?1SVTB7<>ES`2Z<EP
MLBV,H\RT$+_-37\*>&)(]+AD\.Z%)%H<MS/HT3Z/IKQZ3->0W%O=S:9&UJ4T
M^6ZM[NY@N9+-87GAN)XIF>.616`/Y_\`X_?MX?M%_%;]E+]L_P`7_"?XR_#'
MX&?$70/@K^T;J/PV^"VA^#]3\4_M.^!+#X2_#JP\=Z#\6(M5_P"$Q?2[N'X@
MZ!>QZ_IFI7O@70]`T#P=XY^'FO\`A;5?$GBO3;G2/%7J?B;_`(*._$SX??$=
M_AYJ'CKX/>.K#3_VM?V<OACIGBGP_P"%;N\U7XC_`+.?CC]B"/XV_$3XR>%?
M"OA'QIXCN]2M;[XRZ'XU\/>%=<\+KKF@@Z+=?#C2T\1>,+5)Y_VVMM`T.RNY
M+^ST?2[6^ETZSTB6\MM.LX+J72M/\XV&FR7$,"32:?9&XG-I8N[6ML9I3!#'
MO;-"R\%^$--%@-.\+>';`:7:6EAIGV+0]*M/[.L;"YDO;*RL/L]I']BM+2\E
MEN[6VM?*AM[J62X@2.:1W(!_-D__``40^-7QS\??!'X>:KXDTJWT:^^/O_!-
M3XS^'O'7PXO?#'@N7Q'X0^-G[0WB?P#XR^%_B/0_AK\>/C?9P^'9;;1]$N1X
M4\8^+8/&0M;[4-+\<Z%=PW&D7%?;O_!1K_@H3\0_V3=?\36_PSN?!NL7?PB^
M"7AWXZ>-O`7B[0_#.E2^*_#VM>(_'FDI::5XT\7?&WP%K>K^?IW@'7RVE?!K
MX7_%;Q/X4U&UL=2\9"PLO$/A;0?$'ZY6O@[PG9+"EGX8\/6J6]XVH0);:'I4
M"PW[:BVKM>Q+#:((KMM4=M2:Y0+.;]FO3)]I)E-O4O#N@ZQ<6MWJVBZ1J=U8
MVVI6=E<:CIEC?3VEKK-L+/5[:UFNK>:6WM]4M%6UU&"%TBOK=1!=)-$`E`'\
MMO[;W[<GQPO[?P9X^D^(?@K2+G2]9_X*+>&]>_9?T.Z\>^$O%?@+0_AAX>\8
M?"KPIIWQTU/P/\7-+\0:YJ&O:-91?$.QU&&T^'5YH7B36]"U?X8:K>:1ID>N
MW_V+XJ_X*5_'W2/%&J^!](N?V=['QUHGB?\`X*QZ=JFC_$:XU'PGH/A72OV3
M/B/IFD_LLZM\3]9A\4RW?@#P]XT^'^MZ3XK\5Z_K-O86OC+2+ZU\4Z#)X6\+
M27>K6'Z\?%_]G7X0?';13X<^)OA*+7=!NO$GA[Q1KVE6>I:MX=MO&-WX6CE3
M1=+\=MX;OM)N?&WA6`O"UWX.\37&I>&-66SLK;5M*O;*W6V/JP\/:$NH7&JC
M1M*&J7;B2ZU+^SK/[?<N+,:<KW%Z8#=3,NG@6*F25BMD!:#%L!$`#^?_`,0_
MMJ?'[Q?XF_9-U;2?VB=#\%:-X*_;&^*/PE^/WVGX5>`M*\#^--/N_P!A;XA_
M'7X6>$/%/C'PA^T5\7?A-J\VHZU:VVE:9??#7XK:GIT_C/6/"4>JZ1H7CCP;
M<>$/$$^C?\%+_P!J2S^'?@CXE>(O^%(ZE87_`.R[_P`$M?VP/$>@Z;X&\2Z7
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M"'A+5OCM\,?"'A+X'?$S]N#X&^,X-7\)7'@/X1_'?QMX&_9T_9?_`&@?@W;^
M-;V7Q?XPUSP-K;V7QJU#PU:6/A1O&&O36O@CQ;XS\/>&=4FUB;0-"_H(/A7P
MRSZM(WA_1&?7[JRO=<=M)TXOK-YIOD?V?=ZLQMBVI75C]EMOL=S?&>:U\B'[
M/)'Y2;77/ACPY>'==Z#HMRPURT\3!KC2M/F8>([".WBL=?!DMF(UJRBM+6.T
MU;/]HVR6\"07,:PQA0#\_?\`@G]^U9XU_:&C^(OACXF^*?`WB7Q]X&T;X8^+
M-2_X5MX>\)MX*L-+^)EEXJ$$.@?$?X:?'G]H#X=>/M(;7/!WB!/#T@\0>#/B
M+I_AJWTF_P#'WP\TD:]H&LZY^C]9.CZ#H?AZ"YMM!T?2M%MKR^NM4N[?2=.L
M]-@N=2OG$EYJ%Q#8P01SWUVX#W5W*KW%PP#32N0"-:@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHKA/B7\3_AW\&_!FK_$3XK>-O#/
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M62C%RDXTZ=24Y<L4Y.R=HIMZ'M=%%%<1Z`44A8`X.>>^UB/Q8#:/Q(I<C&<\
M=<]L>M`!11UZ44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%?D7_`,%T_P#E&!^T=_U\?"'_
M`-75\/Z_72OC7]O[]EK5/VS_`-E+XF_LY:-XRT_P!J/C^3P9);^*]4T.Z\1V
M.F#PKXZ\.>+Y1-H]GJ>CW-W]MAT)[&/R]0M_(DN4N'\U(FB?UL@Q-#!Y[DV+
MQ-14L/A<UR_$5ZKC*2IT:.+I5*LW&$93DH0C*34(RD[6C%NR/$XEPF(Q_#N?
M8+"4W6Q6+R?,L-AJ2E"#JUZ^#K4J5-3J2A3BYSE&*E.<8*]Y22NS_,L9WR?F
M;J?XCZ_6OZ_/^#7\D_#_`/;%R2?^+A?"'J<_\R9XGKQ<_P#!L'\2B2?^&P/`
M?)S_`,D4\3__`#RZ_9W_`()2_P#!-7Q'_P`$Y/#GQJT+Q#\6M#^*S_%?Q)X-
MUVUN=$\&ZEX0318_"NAZKI$MM<1:CXB\0M?/>/J2SQRQ26JP+$T;I*SAU_:.
M..,>&\VX8Q^7Y?FD,3BZTL$Z=%8?&4W-4L;AJM2TZV'ITURTX2E[TE>UE=M)
M_@'AUP)Q9DO%V69CFF45,+@J$,:JM>6+P%50=7`8BE3]RABZM1\U2I"'NP=N
M9-VC=K];****_`3^FC^<G]OZ_P#B9_PU7^VWXD\-Z'X@UO1O@O\`L,_LD^);
M#XAV/[4'QH^$T_[*5WX^^(7[9>C>*OVA?#/PC^&UA?Z5\5/^$)T?P[I_Q0\>
M6-W>^'=:U7PW\(K?P_IUQJ]Q>6EI;W_%O[=/[97C;3/VIOA7X.NO#?A[Q%X0
M\#_MG>`_"'B"UD^#$WQ>T34?V=O`_CE?AU\<]!\"Z#\?]9^*GBS6?C9J?A;2
M/%MAX=OOV>_`/@G0/#?Q4^'WB+PAXJ\1:9I=G<?$'^AB72M,FDOIIM.L99=3
MLHM.U*62SMI)+_3X/M8ALKUWB9KNSA%_?"*UN#+!&+RZV1K]IG\RO::!H=A?
M2ZG8Z/I=GJ,]C9Z9-?VFGV=M>S:=IWF?V?82W<,,=Q)8V/FR?8[1Y6MK3>WV
M>*/<<@'X"?#+_@HW\;]#T;X:>"=;^(OPJ^).J^()O^"/VA^"O&LVBP#6OB]H
MW[6'QO/PE_:I\4Z?;:%XVU&QUF^\$QVMWHRZKHK3:;X&\9Z?>3>*4OIKN/1D
MH^&_^"C'[8GB?X0^`?B3;ZW\`=-O_&'[!7[:7[:MSITWPR\4:EIUD_[)/Q#^
M#/A+0/`UO+'\4]-N+FU^(%IXN\0W7C+Q!)+;?\(V]_:6OARPNY-+AOKW]_K7
MPAX5L4LH[+PUH%I'IK73Z>EMHNF6Z6+WVKP:_>M9K#:(MJUYKMK;:S=&W$9N
M-6MX-2F+WL4<ZSIX:\/10QV\>A:,D$6G7VCQ0II6GI%'I6IR13:CID<:VP1-
M/OY8(9+VR51:W<D43W$,KQHR@'Y+?`?]OCXA?$;]J'PKX$\9>(/A;I_@;XL:
MO<Z+\-_`G@'3O#WQ!\2Z8C_`^/XRZ5:_$CQ'H_QI3XH_#;QY96UCXGC\5KXW
M_9NT_P"#ESIUMX5L_"/Q0N-7\4>'9_%'["5BVOASP_9:D=9L]$TBUU=M,@T5
MM4M],L8-2.CVKB6VTHWT5NEV=-MY`'@L#-]DA<!HH4(!K:H`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHJM>7EII]K<7U_=6]E96D,EQ=7=W/%;6UM!$I>6:XN)WCAAAC0%I)972
M-%!9F`!--)MI)-MM))*[;>B22U;;V0FTDVVDDKMO1)+=M]$BS17#_P#"S/AU
M_P!#[X+_`/"K\/\`_P`L:Z32-;T;7[5KW0]6TS6;-)GMWNM*O[34;9+B-4:2
M!I[*:>%9D62-GB+AU5T+*`RYUGAZ]./-4HU:<;I<TZ<XQN]E=I*[_K8SA7HU
M'RTZU.<K7Y8SC)V5KNR;>ES4HHHK$U"BD+`'!STSG:V`/=L;1T[D4M`!1110
M`449&2,C(ZCN,],_6B@`HH!R,\\^H(/Y'!'XBB@`HHHH`****`"BC/;U]C_/
MH/QZ]J*`"B@$'H0<'!QV/I]:*`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`/E[5?CW\3M/U34K"U_9-^..KVUCJ-]96VK6&K_``<2QU2W
MM+J:W@U*R2]^)EK>+9W\4:7=JMW;6]TL$T8N((9@\2<_K'QP^(6OZ5J>A:U^
MQ?\`'34]'UFPO-*U73KS5?@A-:7^G:A;R6E[97,+_%,K+;W5M-+!-&PP\;LI
MZU]@8'H/R%&!Z#\A7MT\TP%/D:R#+^>'*U4^N9U&?-&S4[QS.*C*ZYO=22=K
M)6/&GEN.GS)YWCN2=TZ;PV4RARRLG!J67-RC:Z:DVVKW;N[?QT?$CX(>+/!/
MQ;N?A8OP[\0Z+KFL:U:P>!?"'B.TT.X\47VD^)=1FMO!EK<RZ'>ZGH]Y?W4?
ME:==3Z;J5Q;?;K:[,DL+QS+%_0#^S[X@\;_`'X1^#?A;H'['7QT=/#NF*=7U
M*#4O@?`==\2W[&]\1ZY*!\38)"=2U::YEMUF4R6]@MG9[MEL@'UCXK^!'@#Q
ME\7/AO\`&G6=/,OC+X7Z=XCT[0)E6$VT\>OQ1QQ2ZA')$[SS:"[ZE<Z$R/']
MBNM7OYQND>,I[+M4=%'Y"OO>+/$J/$N6Y/@<1E=#$*A16(S&G7Q&84Z;S.$J
MV'C*B\-C*,JE)8:U:,JTJDHSQ4Z=[TG.?Q7#/A]+A[,,UQE',:M!UJOL,!.C
M1P-2HLODJ->2JK$82K&%1U[TI*E&G&4<-":2C548?*!_:'^*H!/_``QY\?#@
M$X_MGX)9.!T'_%T^IZ#]:^G-#O[K5=%TC5+W2;[0+S4=,L+Z[T+5'LY-2T:Y
MN[6*XGTK4)-.N;W3WO=/ED:TNGL;R[LVGBD-M<SPE)6T\#T'Y"EK\VQF*PN(
MC!8?+,+@)1DW*>'K8^JZB:249+&8O$Q23NTX*,M;-M'Z!A,+B</*;KYCB<:I
M12C&O2P5-4VMY1>%PN'DV]FIN4>J2;9^#?[1WP[^.OQQ_P""AO[27@+X/OKF
MG^)/#/[)'[%]]\/_`(OR?M(?$3X;:-^S%XJ\:?$_]L6'5_B-I7P;\+F^T/XO
M:GKUGX0TB;5O#FM:?:Z5XNC\&:/X+\5:C%X;U:ZNK#RR'_@JU^U7<_"CXO?%
M&7P#\*_#&HZ)X:L?$FF^`O&&K?#>?6_A5XDD_:N^#WP-T_X;^,?"_P`/_P!H
M+QW\6=3:\\)>/?$@\;Z]\0_AU\$]3\+_`!&\*R6>@>']3T_68=%T#^BY+*SC
MN[B_CM;9+VZ@MK:YNT@B6ZN+>S>Y>T@GN%0330VKWEVUO%([1P-<W#1*C3RE
M\UO#?A]WU61]#TAY-<FL[C6I'TRP9]7N-.6%-/GU1FMRVHSV*6]NEG->F>2U
M6&)8&C$:`<!W'XJ>*/\`@H!^T)\/?"?[3/B2ZUWX)^//B1\!W^/?@O3OV7;?
MP3KGAGXNZDOP4N-.T[2/VA]>F7XE7T.E_#;Q?8:C;_&+5]&U&R\/^'[;X/\`
MB'PE9^'/B)<>*K;4=0UU/A[^V[^U1\2O&/P!^$NF:[\'=`O?C#\=?CE\*(_B
M=<Z1\-?B7>/X<\`?LH1?'C2]=D\'_`O]I/XF?#O2/%NE>-S/X<N=!7XMZC%J
MO@>XTGQ!?V6A:S/+ITO[<IIFG1ZA/JT=A9IJEU:V]C<ZDEK`M_<65I+/-:V<
M]ZL8N9K6VFNKF6WMI)6A@DN)WB1&E<M3L/#?A_2X-,MM-T/1]/MM%:Z?1[>Q
MTNPM(=*:^$PO6TV*WMXX[!KL7$_VIK183<>=-YQ?S7W`'XO?\$U?VI_C;^TM
M^T)\0O'GQ0^+&FQ>#/BY^Q5^PG^T#\,OV>8]'T[3M,\':A\5?!?C2Y^*&N?#
MG5;KQ%>>(_$GAC2/&.CW>D^(=3FT^Z,MSJGAS3]8O["_\/VZ:M\X?M8_\%`O
MVG=2_9Y_:D;P'\2_`?PZ\9S_``5_X*%:@_A/P;X4>?XW?L=/^R5K.N:-X+\3
M^/M8N/B-(CW7QAT?2[32(M;O_#7@^?PWXP^)'@#Q5\,1XGT30[IM=_HQMO#F
M@6=QIUW::)I%M=:1IT^D:5<V^F6,$^FZ5=/;2W.F:?-%;I)9:?<265I)/96K
M0VLLEK;O)$S01%%E\/:#,^L2RZ+I,LGB&"WMM>DDTVQDDUJVM()+:UM]6=X&
M;4X+:WEE@MX;XW$<,,CQ1*D;LI`/S0_:O^,GBO\`81_9T_9L\-^'_&O@_1(M
M5\>>'_@]XO\`BAXH\-7WBJ;2[&S^%'Q(\9'7?"O@'QA\7/#T>OZSXC\7^"]%
MT>YTOQ-\93)H'AC7-?UVUO/$=[H=M:/\D^!OV[_VN;#PM\0D\=^(_A!%+\+;
MG]@#X=^-_'=WI>A^-?#O@?Q3^V'X"^#GB+XI_&+QGXW\!^+O"?P]U[X5_!C5
M?%7BQ/"\GA2'1?#OB>'5-`N-?\8Z5X7T"^U_6/V%^-7[.?PX^.T_@S5/%W_"
M6:1XI^'5_K6I>`_&O@3QIXD\"^+?"USXDTI="\1+I^J^'K^U2XM-<T5?[-U&
MPU6UU&RDB6*XB@AOK6UNX>I^&?P:^&OPA\!6'PT\`^%;#1_!UA8W.GG39C/J
M\VI0WUQ>WFHRZ]J>L2WVI^(+O4[S4]1N]2N]:N[Z>]N+^[>9V6=TH`_$[Q/_
M`,%+?CMX7M+/6]9\;_`6'X>>`=9^-MCKOQ!\->&]`\1>(_CQX>^$GQ*M_#%A
M\2OAO\'?$W[1/PX\0:[\-M6\,_V]X>UF?X`^(/CA\0G^-7A6_L?"O@+4?"NJ
M>%=.\2?4_P"SY^VMXZ\;_M:>)O@G\0_%OPSU&PU[6/V@+7X?>'/A=H.C>+K7
M3=+^#WC.VL-!;Q)XXT+XQ:S\0O`WBM?!%U&OQ0\-_'']G_X9:4_Q.-YX=^&/
MBS4]/TJQB\6?I[-X9\.W$6B03Z%HTT/AN:UN/#T,NEV$D6A3V4!MK.?1HWMV
M32IK2V)M[:73UMI((/W43)'\M6(-$T>VU/4-:MM*TZWU?5HK2#5-5@L;6'4M
M2AL8VBLHK^_BA2[O8[.-V2U2YFE2W5BL(0$B@#\3/B5_P4/^-7A/XO?M!>%=
M$\2_!741\)/VJO%O[/NE?!L^&[Z7XJ7_`,/%_8O\$?M&Q?'"XU(^/[3_`(E?
MPV\4ZYJ4OB=5\)-X:U3P%I.NV%SK6E>*GT>6UYV3_@H9^TGI7@3X>^,/$'B7
MX%Z5XHUC]E/]ES]J30?AE?\`@76;35?VG_$7[2&O:_I^M?L^_`2>7XHQZI%J
M_P`,;/2?#WA^+Q/;Z1XQUW5_'7Q1\#:MXD\)>&_",<>D^)/V6\&_!3X8>`?$
M'Q.\4^%O"=C8:_\`&+QK??$'XB:G<2W>JW&O^*=3\&>`_A_J-VIU:XO5TJPO
MO"GPR\$:;=Z%HRV&AW$FA0ZC-ISZG<WMW<]\="T4OI,ATG3#)H`8:&YL+0OH
MP:T:P8:2WDYTW=8LUDWV(P;K0FV.8?DH`_F3^/7[>?[2J^*_AE\=/#7CKP+%
MXZ\(_!C_`(*1^,+W]F+1]+\0B;X/7WP@\7_!'PII/A;]H+1+'XC7">.?$GA;
MP;8>,/$>IW^MZ-X/>Q\0Q>*-9\!PR>#(Y1']7W?_``4@^)/B/XL?&CPAHWQ8
M_9R^%WPJ\%?%[]H"S\`?'WQ]X>U/Q)\.O%F@?!;X'_L8>/\`PU\(XK[2/B'X
M?@UWQ?X_UK]H'XF^*KCQ/X6O-0U:Z^'GPWO;#P#X/UW6+34]<TS]O!H.B+>W
M.HKI&EKJ%Y+YUY?#3[,7EU-]ABTSSKFZ$'VB>7^S8(=/\R61V-C%':$FWC2-
M8$\+^&X[:TLDT#14L["\T[4+*T32=/6VM+_1X;:WTF]M;=;80V]WI=O96<&G
M74*)/8PVMO%:R11PQ*H!^;W_``3Z^(?Q@\4^-_V_/#OQA^-@^)&M>`?VOO&F
MD>!?!>I^'],\.ZY\+_AA?^"/!7B+P3:Q:5!K-SK4G@?7;;5Y9?!USJ^G:7]O
M32M8U*"XN;G5+^WTOX#\$?\`!3_]L35_#W[-?B'5/#OP;O9?C!^R_P#LT?M-
M0V[3_#'X;>%O'>I_';5M9\.Z[\&_"VN_%O\`:4\%^+'N/`5EX5@U+4/%/PW\
M!_%_Q"?&_P`4?!^E:AX$TOPU:^'[7X@?T51:3I<&HWNKPZ=81:KJ-M9V=_J<
M=G;1ZA>VFGM<O86MY>I$+JZMK)[V\:T@GEDBMFNKDP)&9Y2]7_A'-``T4#1-
M(`\.'/A\#3+$#0R;5[(MHX%OC2F-G(]J6T_[,3;.UOGR24H`_%;XM?\`!0W]
MH;P#H/CCP]H_A;PIK7CGX*?&G2OV>?CIKR:'HNDZ5X+U/XK?%R_;X-_$^2V\
M??%/X?>!=%T_5/V:](\/>.VTOQ?\3="\,2>./CI\,+34O%%KI&GWVG:SYIXM
M_P""DO[5FE>"O&GBNU7X'Z2WPC_8'_:;_;,URW?2]'^(<?Q"F_9J^/GB#P)H
M6@V^M_#'XV^(_`WA:P^*G@31$;Q=-X9\<?$.'X<>+YKNW\/ZKXIM+)D/[^SZ
M1I5S#JEO<Z;87%OK<;PZQ!/96TL.JPR6BZ?)%J44D3)?Q/8HEF\=XLR-:(ML
M5,"K&*Q\.:`T/V9M$T@VXT<^'A`=,L#"-!*JIT41&W*?V2555.F;?L.U57[/
MA0``?@5\5/\`@J=^T)\.=5\8Z-I'A?X<^-/''@KXF_\`!2:SNOA3:Z/>P>+I
MOAW^SK\.YOB!^S3?ZM#%XP6ZT)/%F@WNC^+M?UVYCMH_'G@V'4-3\'VNFQ'[
M9:]</V_/VGKOX9:?J,>O_L^:/_Q?.;P(_P`0-2\8?LS7OB?Q-X4'P9B^(K6?
MA+P3I?[9-Q^S]-XUT?QE<V5OK.@ZQ^U'HWB"^^"UZOBO0O#LWBNSO53]S4T/
M1H[YM3CTK38]1<PLU^EA:+>L;:UGL;<F[6$7)-O9W-Q:0$RYAM9YK>/;#*Z-
M0?P?X4DT,>&7\->'W\."3SAH#:+IC:()?MIU+S?[(-J=.\W^T2;_`,P6V_[8
M3=;O/)D(!P?[/_Q1L?C;\#OA%\7M.NGO;/XE_#?P9XVBO&\*Z[X'%T?$>@6&
MIS7$7A#Q-=ZCK_ARWFN+B62VT?5M2U2\L;9HH9-5U0*NHW7K]``'3C_/^?PX
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
'"BBB@#__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>biib-2015630_sgachart.jpg
<TEXT>
begin 644 biib-2015630_sgachart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`#P`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^3?VU_VF)?V2?@)?_&6
M#1/"&N31?$GX%_#>*/X@^/F^%_@/1Y/C9\;/`'P<3Q;XU\>KX;\6OX:\*>##
MXY'BK7[Y/#VHN=,TBY@58#,+F'ZRKP;]HWX#:/\`M&>`=#\`:YKE_H%AHOQB
M^`'Q?^U:?8Z=J,E]>_`/XW^`?C9IF@75KJB2VC:5XEU'P%:Z!K$NQKFWTO4;
MNXLL7D<!`!X9X+_;K^%,&C>%(_BY\0?@Y'XF\5-HNH1ZI^SQXL\??M"?!?1/
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MIM^^^&'[)?@_X?\`[,WBW]E[5/$.O^+?!WCFX_:)_P"$DUF>.PT/7)]/_:/^
M)'Q/^(7BJQLCID3VEB=(;XHZKHNB7:123+;:?8WMTLMVT^X`^</@W_P5(^$'
MQ-\=3^&?$_A7QC\*M`U'X<?L:>./"?B+Q=X;\;-/+JG[9=UX\T7P3X7^(=C;
M>"ETSX3&/QAX3T;P7X<\0^,]>L]$\>^(?%^CVV@SQQSV,FH?7_PH_:@^"7QM
MU[4/#GPW\77.MZE::9=Z_ITE[X3\9^&M*\8^%K#65\.7_C+X;Z]XI\/:+HGQ
M.\%6.OO#H]WXO^'^H>(_#EO>WNE"34E@UO1+C4?B/0?^"7.C6O@/X@>#/%/Q
MP\6^*;CQ_P"'_P!A3PG?:T/!GA'03;>'?V"OBS<_$?X=VPTK3I)+&>\\9Z2=
M/\(>.KQ6M8GAM)];\/V6CW=[]BMO6_V0/^">_P`*OV.?$6J:O\/O^$::RM_"
M+_#KP6FG_"#X3^#_`!9I7@)]:L-;72O&GQ,\,>&K7QY\3M6@?1M!TQ=:U_5[
M&&^T_1+"^U[1]9\5B?Q/*`>"_'__`(*'_'K]GCQA^V):^*?V??@UK'@']D7X
M#>"OVB]6U_2/V@_&\'B?Q?X#^*GB?XU^%O`&G0>'-1_9Y@T70O$EK<_!;4K_
M`,=)/XLU#2-$L=<LCH&I^)Y[.ZB/UXO[=W[,'_"1:=X/G\?:O8^,=4\=>*OA
MO:^#M4^&_P`3](\71^+O!?A;P9X]\0V&I^&M4\'6FLZ)8V?PY^(/A'XFKK^L
MV5AX>G^&>K?\+`AU5O"EAJFJ67#?M"?L&>%OV@KK]K.ZU;XA^*/#;_M8?LZ?
M!K]G?75TG2M#NQX.TCX.>+_C/XOT[Q-H)U"-C?ZOK5Q\9=1L]0M-4+Z?;6^A
MZ=)9JLUS>%L+Q)_P3F^'7C']I/QI^T+XF\:^*=4A\>^)/B/K?B+X>&RTJUT&
MZT[XF_LF_"7]DO7O#Z:S:^7K\%FGA7X4V_B6WO(9X[X:WK^HVWF"QM;+:`>L
MZ=^W3^S/JGAB]\667C?7'T^+_A7\FB6$WPQ^*EGXG\?V7Q8O]3TSX7:Q\*/!
MM[X*M_%GQ9\/_$:^T36HO!/B'X<Z-XET3Q%'HVK7=C?O9:;>W,/KUC\=?AAJ
MGPJN?C3INO7M_P##^R@U>2\OK3PMXPN?$%I>:!K=WX:UWP_=>!(-`D\>V_C#
M1?$UA?>&=6\$R^&%\7:?XEL[KP_=:+%JT$MHOYJZ1_P1L^`.E_#(_#YV\$75
MQX<USX5ZQ\/-;7]G;X%:;#;GX.67BS2?"Y^+FA:5X6M+3X[7GB'0_&WB#1_'
MLWC&[L--U-;F/7?!^B^`O%J3>(;GZYN/V,?"@_9$U/\`9+T#Q9J7@#1-5LKY
MKCQ1\+_"G@7X:>7J^J>.?^%B:RD'@?P5H.B^"D\'^(];>YT+Q=X,;3GA\8>!
M-3UOPWXGU?5;W7=6U^\`()_^"A'[*UH+"UN_&WBV#Q'J.M>/O#47@$_!OXSS
M?$^V\2_#'P7X3^)/C?P[J7PPMO`$_CW2];T3X=^./"_CS^SK[P_!/J/@[58?
M$>E"]TJ.>YBX3XF?\%(_@?X:U#X2Z5\,+F3XRW/Q0^.G[,?P<;6/#EEXPM?`
M.A0?M-2^&=6\-:L?B?%X,U3X>W_BFS^'?BS0_B7;?#9_$>G^*-4\)ZKI&H2K
MIEKJ^GW,_GGP?_X)8_#WX1?%RV^,.D>/KJVU>7Q?\4?'>L>%?"'PT^''PU^'
MTOB/XL?LY?"3]G7Q`/#_`(1\$Z;I^G^&=)MM*^$6D^++2TMS?ZC>^)-6U>XU
M[6=8EG^V/D?#3_@E)X:^%G@_X-?#+PW\>?B(OPQ^%/Q%_98^-VH>$I_#'@9I
M?&_QK_9B\+_"WP5;^+=3U\6!U72/#_Q$T+X2^&M2\4^"])=;6P\8/>Z]H.K6
MFG3R>')`#V?X_P#[<%U\&_CQI?P*TSP5\/;G6;[X=^%OB)IEQ\6OCKH/P(G^
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M_@FYX7M-<U_Q#I?Q@^(6FZDG[1>K_M5?#26.WTJY_P"%<?&F[\#_``Q^%VE^
M(S+=O+=>-K?3?A;X#\4?#F]L/%-Q*GB3PM\9?BFFNRW.KZGH6K:$`>P_'[]K
M=?@/^T1^RA\%]2\!/K7A/]I*^^(VCZ]\2T\1_P!GI\+-7\/7OPU\,_#I+WPS
M_8=\_B33OB7\1OB?X:^'BW\>LZ-_PCFNZWX>D>#5H=6=+/R'X9_\%*?ASXP^
M(G[2GA'Q9X3UOPEH7P<^-W@[X,?"?5O#EKXK^*_BS]HFZ\4_##4OB&^L^"/A
MK\/O!>K>*5^S#PG\09;73=*B\3"X\$>$+CXA7]]I.CW,MO9>X?M,_LC>&_VF
M6DEUOQIXK\&7D/P,^,WP>T'5_"*:;#KOA+6OBAXO^!_Q`\,?%CPQJ=_!<MIO
MC_X0^.?@-X-\6^`YW@N-.&N1+<ZK;74=K#"_@5E_P36\/^$?&MU\3/AA\8O&
M/@GQ_H_BGX/>*/AMJUQX8\(^*=-\&'X7?LS7W[*NJ:)J.B:K!#'XNT;Q[\.M
M5U#4M<6[O=)U+3O%\>EZSI&I0PV,]E?@'M>F_P#!0#]DS6M5TG2-"^*;:_<:
MQ;?!6\M[S0_`_P`1=6T&TM?VB[J]TOX'RZYXFL?"4WA[PT?B=XDL+GP5X3A\
M1ZEI5Q?^/E3P,\,/BJ1=*KX_^%'_``66^"'Q&U;0=0\0_#OXH_"CX8:G\%/C
MQ\8]8\9^/O!/CV+7O"6G?`7]H73/@5XJN_$?@G1/`VIWFF_#^SM[^3QMXE^*
M5YJ-MX5\"V5E?:'XHEL]5TO6O[-]#\-?\$M?ASX.\.>//#'A[XH^/8['QSJO
M[$&N75YJ6G>&+[5(]<_8P^/<W[1$>MW4\%CI]E?ZC\8_'E_K%QXZ$>GZ?I^C
MQ:M<)X1T_3((+.U@Y?3_`/@D[X2T_2_CMX8C^-GC8^$OBQ^S1^US^RWX4TD>
M%O"BWWPW\!?M=_$N_P#BWXIOTUD%I?&>N^#O&&N:\GA6YUJSL8;C0+RRTW7H
MM2OK&75[\`^Z_`W[4OP4^)7Q#UWX9>"/$FM>(/$'AW5_&'AS4-5M/`/Q"3X?
MS>*/A[J*Z3X]\*:1\5+GPK!\--=\5>#-2<6'B7PYHWBR]U?2[R*^MI;0S:5J
MR6#-3_:J^!FD?$N]^$U[XNO5\7Z9K"^&-2DM_!WCB]\):?XUF\&#XB6?P[O?
MB'9^&Y_`%M\2]0\#%/%6G?#J7Q*OC.^T2YL+NWT5_P"U-,2\\0\`_L+Z=X'_
M`&C;'X_Q?%'6Y)=)3Q$T>A^'O`WP_P#A]JOC,>)O"_\`PBSZ#\:?&G@72=$U
M'XU>#?"=M]GU/X?:1XXTNY\0^'->T?PYJ^H^,?$=UH<#S<Y<_P#!-KX0#]I7
MQ?\`M&:9_P`(W::KX[\93_%'Q!!J7PB^%GB7QI!\3)?AY8?#?^U/#/Q?\0:!
M??$'PGX5?3=(TCQ#+X5T.]MKR+Q=:7-[I/BC1]"U?5O#EX`>C>'?^"A?[)7B
MSPA)XW\._$V^U/1)O#/P=\8^'88_AU\3X-?\?^&OV@-2GT/X-:O\+?"MUX-@
M\2_%*U^(7B&SU'PWX?;X?Z5XC,GB'2]4TB[%I=:==+'YI\*?^"F?P*\;V7CN
M[\:_VM\/6\(?&?X]_#B*%/#7Q&\6O:>!/@7\0_\`A7&I?&3XFC2OA_#+\$O!
M5[X@+:?JM_\`%"+P_HWAG5;35M.O->N4T+7+O3>)T_\`X):^$M%L_@3<:)\9
M/&]AXM_9P_9D_99^`'PK\4OX=\)WCZ;KO[*.OZYK/A#XF:KH]Q"=/U6Z\6V'
MB77_``GXW\(;K31KGPSK5_%H5_H>LIINM:=PTW_!''X0W_BW6O'GB'QM!XZ\
M9>.O%WQ)UWXD^(/B;\$O@E\2IM:TKXF_$G5OBMJ6G>$M,\:>%=8T#X?:OX?\
M4>)O%UAX;\0:5I&HP_\`"*>(6T3Q)H'B2ZT7P_K&F@'U-KG[>7PO'[1'P+_9
M[\"6FI>.=4^+'QL^+'P2\1>+(M)\9:%X0\'^(?A!\$_BQ\5O%\/A_P`7:EX-
M_P"$%^)VL^'M=^&<?P]\8^'?"7BZ2]\&ZYK<ZZS*FHZ!J>C+K?';]MCX>_LX
M_&;2OA_\5K?_`(1SX?/^S7\6OVBO$WQ3,VJZHOAJR^&/Q:^`7PHA\/'P=H>@
M:IJVK'7[[XZ6E^-4LKGS-,_L3[,VEW<>HO>:?R'A?]@S3_"?Q<^%7CC3?C!X
MR_X5U\#_`(\?&[]H3X7?!QO#O@V/1-#\8_M%>$OC9HGQ1T[4?%<&G1>*M<\/
M'Q!\=O&OBGP78W4\-QX6:]DT&XN]>TF+2!HC_CI^P/X8_:5\4?&#Q!\8_B+X
MFU>V\>?`[Q?^S[\/]*\.Z'X:\-)\*?`OCSQ5\/?B#XGO[:_^S:I>>-O%=QX]
M^%/P_P!<L=0\3E=%L++P\NC+X=GBU36KS4`#N/%O[?'[+'@GQ9XB\":W\0]6
MF\9^%_%OQ#\#:MX5\._#7XH^,?$'_"4?"CX>?##XL_$/3=,TCPCX-UR_US_A
M%?AQ\8O`'B_4KO1K>^L1I&JWTD%S+-X?U^'3>J\-?MC?LZ>,?&.@>"?"WQ$C
MU^^\43>';'0O$.D^&O&%Y\.=0U[Q?X`L?BKX4\(1?%6+P^?AJOCGQ)\-M3T[
MQQHO@>7Q4GBN_P##6HZ;J<6D>7J5@MS\S^"_^";FD>'?B]<_&_Q!\:_&WB[Q
MUK?B?]H3QIXKFN/#7A+1=+UCQ%^T3\!?V=/@3XC:RT[2H5&BZ1X<TS]G70];
M\,Z9!-=RI<Z[?V6K:AJ:V=O?3<?^SC_P23^"O[-WC3X8>+?#FJ:-XEG^'VE?
M#*\O=4\5_!GX0:O\1->^(/PU^#/A+X*V_BBQ^*NH>'+_`,8^"]!U[2O!FD>+
MM3\&^%KBT:P\:MJ$_A[Q-I'AG4]0\,W0![S^UM^U_P")?V7KS2[YOAIX.\4^
M%;R+P['IEKJGQN\.^#OBU\6_$NM^(CH=W\-/V;?A&WAOQ#JOQ:^)ND6MUHNJ
MGP]K&L>`K#7)]?T30M!U>\O+K4;S1LO3?VX9KSXB:7#=_#6ST_X#>)/VGO%W
M['?AKXL/X^@F\4W?QO\`!,WBCP[J<FH_#2/PP+73_AWJGQ-\%^*/A3H>OQ^/
M+WQ7+XKL--U&^\#V?A36X]:T_L/VE?V2]9_:/M_%/A'5?CCXQ\.?"+XE>$X_
M!'Q'^&UOX1^'WB`-H;0WUIJE_P###QAKVAS>)/A7XN\06%\MGJGB>PE\03Z=
M+I>C:]X,L_"7BRP_X2"?,T_]B/P_9?%.Q\42?$/Q1>_";1?CIXA_:B\/_`VX
MTGPU_P`(_I7Q_P#%4.N/K/BD^+EL?^$LO?"O_"2>*/$OQ+T_P3<3E++XH:U-
MXA?7KK1++2?"VG@'TG\5O%GQ`\+>&K*X^%_PV/Q0\8:UK^BZ#INCWGBFQ\$^
M&=&MM2ED?4O%GC7Q1<V.MZAI7A7P]IMM<W5\/#GA;Q;XGU*]?3='T7P[>7.H
MF>S^(_#7[=_C_P"(EYHGPX^&?P$T3Q!\>V\1_M.Z3XJ\(ZU\9;7P]\,;+1_V
M3?'7@SX;_$/Q%X0^*<'@'6M5\8V7B;QQ\1O!/A#P,DWPY\/F'Q#<>,-.\=R>
M$;OX>Z_:R^S_`!+^`OQ^^)G[-6@_!_\`X:F\0>`OBE*-!B^('QK\'?#_`,+V
M^L^+=*M;BZG\2^';'1K"[\.6_@VV\56DMMH5]XA\%:AX=\4Z7I<-W<>%M5\/
M:S>Q:I8>=Z+^Q-XM\.>&?A+)X3^.%A\-?BE\&?#WQ`^&W@WQM\*/@7\.O"/A
M*T^#/Q(O/!NIZY\.#\)=8N_%WAI5T[7/`'A+Q5X<\2)J0O\`3O%&B07>H6FL
M:-J?B70->`*/A#_@H5HGQ%^*7[%W@WP/\(O&-UX`_;&^'_B[QUHGQ9\0ZQX>
MT32?#-UX<^%,7Q1B\%V?AZSN-;UCQ=XDM(/MFA^-KRV.C^&/"&KVL5A;:[XE
MU*YEL;"_\!/VT]2^,WQV\5_"^^M_@+X:T;2_$?QE\/>&]+L_C'XTUGXS:[)\
M(OB#K?@.\FG\$7_P8\/_``_%X5T"X\0^*M`\,_%GQ7KW@33-1TA-<L"UQ-+!
MQFL_\$]_%>F>/_V3==^#_P"T(WPT^'W[&OABY\)_";X>7_P<\+>.Y[O3M>\`
M6_PW\93^,/&FI>)M&U;6M1\0Z##+>)>VNGZ8]CK]W<ZG,-3C<68^A],_9J\4
MS_%GP?X^\??'?QO\1?"OPK\:>,_B%\)?`>K>&/`6C-X8\5^./"WC7P/=W/B'
MQ?X=T/3];\:6'A?P=\1/&/AGP5875OI#6NGZM'?>,+OQOXBTW3M<MP#KO%/[
M4GP7\%?$O2?A/XJ\0:_H?BG7/$>B>#-+U"_^'OQ%A\!77C?Q-I]IJGAGP.OQ
M2;PI_P`*U7QGXDL[ZV_L/PPWBL:MJ-Y<V>E0VW]K:AI]A=>2>&O^"C7[('C#
MPK!XQ\-?%*^U;2-3\-?"[Q?X3@@^&WQ4CUWXC>'?C1K#^&_AEJ/PI\,W'@J+
MQ!\55\4^)H;OPU##\/=-\1SZ;K]C>Z9K<>FS6LS+Y?\`%;_@FKX+^+?Q]C^.
M?B/XC:U<7MA\>/@;^T/X=MM5\#?#_P`3>*_!_BKX(ZE\/;BQ\!^#/BCK^E7G
MC7PC\$_$5MX`%[JOPR\-7&DV\7B[Q;XT\4+K%S'XAOM$EXC1O^"4OA/PU8_L
MS7'A[XV>.K#QE^R9^S=\'O@1\)/%LWAKPC?R6NM?!CQ+#K6B?$77-%N(O[.U
M2;Q'HTVO^"?%GA*-K32KKPSXFU)M&U#0]>M='UK3@#Z1^"?[7>H_'CX+?&OX
ML>`OA!XB\0:I\,/C5^T'\&?"GP^TS6;33_$7Q$U+X)_$35_AWIMVTWCBP\&6
M_@>[\5W^FK=:KI?BB*)O!*&^@U&XU&73F6?RZZ_;K\<Z/XP\2?`S7/@GX<;]
MH^T^+WPB^#WA3P]X:^+LNN?!G7];^,/PP\=_&FRN-5^*U]\-]!\3>&KGP'\+
M_A;X_P#%OQ`\*S?"N_\`%4&F6O@J]\-:=KMA\2/#=VGJOP\_9/\`%'PB^!'Q
MK^%OPT^/GB_0?B'\8/B/\;?BW#\;]0\&^!==\2>"_'WQR\77OC77=:T;P?=Z
M?#X(U"/P]K.IWQ\,:9JVF3:=;6RV$&HVVHI9N+KRKP%^P/XE\*_#/3?!FJ?'
M5+OQ?X%^+6C_`!V^%'Q1\-?"71/#OBS1?BY#H?BCPSXS\;_$V37/%_CF;XV:
MU\5?#?B_7_#OQ%U/Q=J5EK6IZ+K.IQ:5J^C:@-$U+0@"CK__``45NM%\-_"*
M_A^`GB/5?$'BO]K_`,-?L=_&6WL/&WA\^"_@9XXU3XXZ!\$-2U"Y\8W5C::G
MX^%YJ'B;0_%_P_T+0O!FGZQXH\%ZE#K/BF/X??9=1M[7UGXZ_MEV/PA^/7[.
M?P+T3P-+XZO?C)\6_#?PT\>^(H?$46BV/PB@\<?#[XM^-?`M_<6K:1J3>+/$
M/BB7X1>(8X?"=M<Z1)I?AJVNO%FKZG:0S^&M.\2^,?$S_@G?XP\4_#[X>^`_
M`O[2>H>")?#W[06C_M8?$+Q7K'P=\$^./$/Q2_:#T/XO:3\:].\4ZAYFL>&=
M*\,>&8O%&DVFB+X.T#3MD/@BRTKP[::U;2Z=_:=UTGQ'_P""9OP7^*/Q$^$/
MQC\0>(_B3I7Q4\!_'?P)^T/X^UWPA\3?BWX9\+_%GX@^"OA/JWPI^UZA\-[3
MXFR>"/!B:EIMUHTKW?A+2K?5[?2O#MKX1DU&^\-ZIKUIJ0!^CRG<JMC&Y0<=
M<9&<4M(HVJ%'88Y_SQ[`<`<```"EH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`R/7KT]Z*_(;]OGXO?%#P#^WM_P1
MS\!>"O'_`(L\+>"OC'^TC^T/X:^*GA;0M9NM/T+XA:!X>_99\:^*]"TCQ;I\
M#"'6M/TCQ'86FM:?:W8>*VU*"*[11-'&Z_KO&240GDE%)/J2!0`ZBBB@`HHH
MH`****`"BBB@`HHHH`****`"BBN>\6>+O"O@/P[JOB[QMXDT+PAX5T*V%YK7
MB3Q-JUCH>A:3:&6.`7.I:MJ4]M8V-N9IH8?.N9XX_,EC3=N=0;ITYU:D*5*$
MZE6I.-.G3IQ<ZE2<VHPA"$4Y2G*348QBFY-I)-LF<X4H3J5)QITZ<93J5)R4
M(0A!.4YSE)J,8QBG*4I-**3;:2.AHKYC_P"&U?V/AU_:G_9W_P##R_#[_P"7
M]'_#:O['O_1T_P"SO_X>7X??_+^O5_U>S_\`Z$><?^&S&_\`R@\O^W\B_P"A
MUE/_`(<L'_\`+O-?>?3E%?,?_#:O['O_`$=/^SO_`.'E^'W_`,OZ/^&U?V/?
M^CI_V=__``\OP^_^7]'^KV?_`/0CSC_PV8W_`.4"_M_(O^AWE'_ARP?_`,N\
MU]Y].45\Q_\`#:O['O\`T=/^SO\`^'E^'W_R_KT'X=_'SX'?%S4-1TCX5_&'
MX8?$C5=(LHM2U73?`GCOPSXLOM-T^>X-K!?7]KH>I7L]I:370-O%<3HD4DX,
M2N7&VLJ^2YSAJ4Z^)RG,\/0II.I6KX#%4J5--J*<ZE2E&$$Y-13DTFVENT:T
M<YRC$U84,/FN6UZU1M4Z-''86K5J-)R:A3A5E.344Y-13=DWL>MT5E:[>S:=
MHFKZA;A#<6.EZA>0"12T?G6MG-/%O4,I9-\:[E#*2N0&!.1_'FO_``7$_P""
M@G_".0^+F\*?!H>%Y=9_X1I?$G_"I?%HT%_$BZ?'JLF@+JW_``GQL3K"Z?(M
MZ=.$YN1;,)-F,U];P/X:\1>(,<QED,\MBLKJ8*EB/[0QCPKE/'K%.A&BE1J^
MT;6$K.2]UJT;)W=OE>,_$3A_@267PSR.82>90QE3#O`X6.)488%X55Y5FZU+
MV:7URCRO5/WKM65_[(:*_C0F_P""['[>%M'9S7&B_`ZWAU"T6_T^:X^%WBF"
M+4+!YI[=+ZPEF\?I'?6+W%M<VZ7EHTUJ\]M<0+*98)D2U)_P7)_;_BT:+Q'+
MX5^#L7AR>]ETR#Q%+\(/&D?AZ?4H$:6?38->?QRND3:C!&CR3V$5Z]Y#&CO)
M"J(Q'W__`!+;XBKEO/AY<\N2-\UFN:?6*_V362M+1:^Z^SM\,OI#^'[O:.?/
MECSR_P"$R'NQ]WWG_M6D?>6KLM5WT_LEHK^.:^_X+<?\%$-,GTBVU/P+\+=,
MNO$,<,WA^UU+X(^/]/NO$$-R\45M-H%M>^,X)]<BN)9H8K>32H[Q)Y9H8XF=
MY8U:EK'_``7+_;\\/7]SI7B'PQ\&O#^JV00WNEZ_\(_&.AZI9"2,31F\TW5O
M'5G?6HDA99HS<6\8DA994+1D,9A]&_Q$FXJ%3AV3DG**CFTY.48R4925L)K&
M,GRR:T4E9M-HJ7TA>`8*3G3S^*A*,).65Q2C*4>:,9-XI6E*-Y).S<5?:[7]
MDU%?S%_L9_\`!5[]M7XS?M7_``%^#'Q=\)_#SPYX.^*>KZG'=21_"KQCX1UK
M4M#M_!_B37+74?#>H:]XIGM[BUDOM+L@=1MK'4+.2!WB5PTR2+_3FIRJD]2`
M3^(K\SXUX&SK@/,,)EN>2P,\1C<#',*$L!B7BJ+P\L1B,+[U1TZ5IJMA:J<4
MFDDG>[LOT7@[C3)^.,!BLQR:.-A0P>-E@*T<=AUAJJKQP^&Q3Y8*I4O!TL52
M:DVFVVK65VM%%%?''UP4444`%%%%`!1110`4444`?AW_`,%+GEC_`."C_P#P
M0L>"#[3*O[5G[3^R'S4@WY_8[^(`/[V0%%VJ2^",OMV+AF!K]HDU#6PB#^P?
MX5_YB]B>P[B/!^HX/45^,7_!2?\`Y22?\$*?^SK?VH/_`%CGX@U^WD?^KC_W
M%_\`010!A?VCK?\`T`?_`"K67_QNC^T=;_Z`/_E6LO\`XW7044`<_P#VCK?_
M`$`?_*M9?_&Z/[1UO_H`_P#E6LO_`(W7044`<_\`VCK?_0!_\JUE_P#&Z/[1
MUO\`Z`/_`)5K+_XW7044`<__`&CK?_0!_P#*M9?_`!NC^T=;_P"@#_Y5K+_X
MW7044`<__:.M_P#0!_\`*M9?_&Z/[1UO_H`_^5:R_P#C==!10!S_`/:.M_\`
M0!_\JUE_\;H_M'6_^@#_`.5:R_\`C==!10!S_P#:.M_]`'_RK67_`,;K\^_^
M"JE[JDG_``3X_:E6YT=;>`_#J,R3-J=I*L:CQ/X>;<T21&1ER!N*ABHR=K'`
M/Z25^>W_``599D_X)[?M2.I`9/AY`ZDJC@,GBKPVRDI(KQN`0,I(CQN,K(CH
M64_5<"_\EMP=_P!E5P]UM_S-\)UZ>I\QQM_R1O%O_9,Y[_ZJ\5KKIIO^I_(O
M\?\`]D;P;\%K/X./<?%*^L5\?:;JMYX@\<>,?ASJ]M\(KFRTO5/&@N?&'PV\
M;^#KGQA'XJT9M,\.Z4-*\'M;1^-==C\1^&/$$,&GV7B"]TSPOX!\9O@ZOPU^
M/GC7X'^&]3E\72>'O'>G^!_#^LZAIEMH%UX@N-9315T>XO--CNM2@T:2\N=;
MMH9K=;V]2R&=T\Y1F;U3Q[^U:GCSP+X*^%][\&?A[HGP]T2=-7\<>#_!VH>+
M_"&D^//%%CJOQ3U#1M2T]M/UV\D^'&CZ4WQ8\1WJ^'O!,6GV]WJ]W<K<W#^&
MX=`\.Z#RGQ.^._AWXJ>/?B)\4]0^%>E>$?'?C'3+:\TJ_P##'C'QMJ-KX?\`
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M^LR3_P!FW/$G[5%]XGN-0?4/@]\)3IWC+Q_>_%/XPZ`\'C*[T7XO>/;_`,.:
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MQ>-+Z_N['P=?:!J&O0Z?X;\827UKJ^LG3M)NKN3]_/\`@CQ\&Y/@3^T_\3]*
ML(O%<USXS_97^'GCZZ\(?$+1-)\$_$CP`-7^*/B33+;P_P"-]*TW4]<T0WU]
M;:'%XFT6\TG42FH>&=<TBXO+#2]0>>S7^>FR^)?A#3M5348/@?X`U&!_$7BC
M4]1L/%>O_$+Q:=6\.>*/#5GH4GA"\U._\26NHP-H>IQZGXS\.^/-.ELO'VG^
M*M7DN)]:O=/T^PL%_?S_`((;?%6Y^)'QY^(VBV_AC1?!?@_X7?LXZ)X0\"^%
M=%U#Q!KBZ5I>K?&/7/&6M3:AXC\5ZEJOB#7+_5?$>O:C?O)=7-OI^G0/#IVC
M:7IUG"RS?$^,<,\?ASG;JSQ'U:ED>$HYJZU/*Z5/$XF..PD?K,(86OB*U'$5
M<3&C4EAJ,IX14)IT\70GAZN&S#[+PCEDJ\0<E5*GAUB*N=8JKEBHSS*I/#X>
M6"Q$OJTYXFCAZ56A2PSJTX8BJH8J5:#53"UH5Z>)P/\`1]XHU#6CX:\0YT(`
M?V'J^2=6L<#_`(EUSR1Y?(]?SZ"OXO\`3O%^DZS_`,$]].\/ZY\5/#&@2Z.]
MEX:\(:'X,^)<[P>-_$%AIF@:WI/PG^+OP'\5:>UI#JMWJE[?WWB;Q_X?N-`\
M.Q6^C:9\2+_7=;34-3MKO^UWQ9_R*_B/_L`ZS_Z;;JO\T2/_`%40[&&($>HV
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M=4UVY^`7VY]5N=1\"^.])\;_`!SU?Q7/H,6C>)O#6JSVG_"0ZA=^*;C1I?RK
MA9K:02VS-;2A9$66V8V\H2:-XI4$D)1PDL4DD4JAMLD4DD3AHY'5F@`<@`$`
M+D#!V@Y"YZ[0>0.@/(%?U5/A+VN#PN!GC:-*A@YU9X?ZGE].BJ'UC&SQE7ZO
M1KUL70HU*3CA:>!JJG)X2G3KQY*JQ/[K^8X<4^RQ>(QL,'5J5L7&E'$?6\?4
MK.LZ&#IX2E[>M0HX6O6IU4\34QM)U(_6JE3#RYZ3P[=7]T=0^,OPWD\>Z#X^
MU'Q)X5\!^)3\;?C_`/$33/`D_P"TUH_QHT_XPKXT^#'B3PSINH6'Q376KNT_
M9(TSQC>ZG)X/T22*ZTNS\/ZKXAT_Q/H;6E]X$T633_B/]I"PT7Q3K'P?U3PE
MXT\%>#Y/AM\*?`NF>,/#FO?&[2OC-J'PKUG4/C)XEM--\GXFPSZ[KOQLEW:O
M;?$[Q!I&@V/B#5?A5X1OAH%UI9TS1X;=O@H`#(``#$EL`#<6&&+8ZDC@DY)'
M4T@`&```%&%```4=<*`/E'TQ6&5\$4<JQ6&Q6'S"LY8:@L.J=2%:O3]@JF-?
ML4L5B\0ZD53S#%>RK8MXO&4*LHTZ&*IY6ZV55NC,N,ZV:8;$8;$8&ER8BL\1
M*<)TJ,_;^SP<56;PV%PZA)SP.'52CA8X7!UJ2E.MA:F9*CF=']_?V0_%=Q<_
MM`_L8>&_$?B_2?$?Q-L_VK?B7XRU"VM/C_IG[1%U\2;;Q%^SUXKTS6_B];>*
M+>XO/^%1^'KS6M,M;/3OAN[6J>*)]9?7)-.MKGPLGE_UE:=<7TZO]LL/L.P1
M^7_ID%WYN0V[F!5";,*,MG?NRN,&OX/?^"58`_X*$?LOX`&?&_B%C@`98_#;
MQSECCJQ[D\GN:_O23[B_[J_R%?QM]([+(91Q7D6$A44T^''B'RPE"G">)SW.
MJTX4HU*M>K&FI3?+&IB*W)?DI.G0C2H4OZW^CYF4\UX8SO$SIN#CQ`\.N:<:
ME24,/DF2TH2JRA3HTI5'&*4I4J%%3LIU8U*\JM:HZBBBOYY/WP****`"BBB@
M`HHHH`**\GO?CS\#]-\2-X-U'XQ_"JP\7I=_8&\*WOQ$\'VOB-;WS%A^R-HD
M^LQZDMT976(6S6RSF0A!&6(%>L4`?B!_P4G_`.4DG_!"G_LZW]J#_P!8Y^(-
M?MY'_JX_]Q?_`$$5^'W_``4M,R_\%'_^"%9MXXI9A^U;^T]LCFF>")O^,._B
M`&W2I!<NF%W$8A?<P"G:"67]J(Y_$/EI_P`2O1ON+_S';[T'_4N4`;E%8WG^
M(?\`H%Z-_P"#V^_^9RCS_$/_`$"]&_\`![??_,Y0!LT5C>?XA_Z!>C?^#V^_
M^9RCS_$/_0+T;_P>WW_S.4`;-%8WG^(?^@7HW_@]OO\`YG*//\0_]`O1O_![
M??\`S.4`;-%8WG^(?^@7HW_@]OO_`)G*//\`$/\`T"]&_P#![??_`#.4`;-%
M8WG^(?\`H%Z-_P"#V^_^9RCS_$/_`$"]&_\`![??_,Y0!LT5C>?XA_Z!>C?^
M#V^_^9RCS_$/_0+T;_P>WW_S.4`;-?GI_P`%6_\`E'G^U-_V3J+_`-2GPY7W
MEY_B'_H%Z-_X/;[_`.9ROSZ_X*J2ZRW_``3X_:D%U8:9#`?AW%ODM]6NKF51
M_P`)1X<Y2&31;5'/L9XQ[U]5P+_R6_!O_95</?\`JWP9\QQM_P`D;Q;_`-DU
MGO\`ZK,4?PCO]]O]YOYFFTY_OM_O-_,TVO\`5V.R]%^1_E\%%%%,`K^@?_@W
MG_Y."_:$_P"R->%O_4\>OY^*_?W_`(-\7O4^/_[01L;>UN)#\&_"V];J\ELT
M5?\`A.WP5DAL;YF8G(*F-`!@[CG`_+?&O_DUO&'_`&`X3_U:Y>?IG@Y_R<WA
M'_L.Q/\`ZK,<?U=^+/\`D5_$?_8!UG_TVW5?YHD?^JB_ZY1?^BUK_2C\5S^(
M/^$8\1;M,T<#^P=9R1KEZ2!_9MUT!\.J#],CZU_FN1_ZJ+_KE%_Z+6OQ'Z)_
M\+CK_KYPY_Z3G9^Q?2B_C\$_]>^(_P#TK(1]%%%?V`?RB%%%%`'Z"?\`!*O_
M`)2$?LO?]CMX@_\`5;>.:_O23[B_[J_R%?P4?\$LC,O_``4#_9@-O'%+,/&N
MO^7'-,]O$Q_X5QXX!#S)!<N@"[B"L$F6`4@`EE_O+L7U!U;[=:V=MA8_*^R7
M\][OR#O\SSM.L/+VX7;M\W=EL[-HW?PC]*;_`)+?(O\`LE</_P"K?-S^V?HS
M?\D=G?\`V4^)_P#53DY>HHHK^93^CPHHHH`****`"HIX8[B":":-9HIHI(I(
MG&4DCD1D>-A_==6*M[$U+2-T/..#SG&..N>V/7M0!^//Q*^(7[2UC\6M8^#'
MP[^`FE:/\(?`_P`7O"MK=>&+?]FG6M7\"_$[X;>-M;_9_P#"'AKP_%XZN%7P
M)+!K%AXM_:5^*/C_`,:>$M/D'P:L_A)X-T#Q_;6@U.Y/C;]>-+TVPT?3;'2=
M*LK;3M,TVTM[#3M/LH4M[.RL;2)8+2UM;>,+'!;P01QQ0P(JI%&JQHJJH`_!
MKQ_I7A.P_;J^(.O>(_A5^S;\6-/E_:%^$MH_QO\`BI\+_P!I;QKK'P5\2:EH
M_P`+-,T+X9M\;;/X7^(/@OX!UZVN[CP_JO@'PA9^)M'\.>&?$WBG2;?Q9K&G
M^)?%L37/[YCD=NIZ?4]>G/J.QS0!^(/_``4G_P"4DG_!"G_LZW]J#_UCGX@U
M^WD?^KC_`-Q?_017XA_\%)_^4DG_``0I_P"SK?VH/_6.?B#7[>1_ZN/_`'%_
M]!%`#Z***`"BBB@`HHHH`****`"BBB@`HHHH`*_/3_@JW_RCS_:F_P"R=1?^
MI3X<K]"Z_/3_`(*M_P#*//\`:F_[)U%_ZE/AROJN!?\`DM^#?^RJX>_]6^#/
MF.-O^2-XM_[)K/?_`%68H_@T?[[?[S?S--IS_?;_`'F_F:;7^KL=EZ+\C_+X
M****8!7]`_\`P;S_`/)P7[0G_9&O"W_J>/7\_%?T#_\`!O/_`,G!?M"?]D:\
M+?\`J>/7Y;XU_P#)K>,/^P'"?^K7+S],\'/^3F\(_P#8=B?_`%68X_JQ\6?\
MBOXC_P"P#K/_`*;;JO\`-$C_`-5%_P!<HO\`T6M?Z7?BS_D5_$?_`&`=9_\`
M3;=5_FB1_P"JB_ZY1?\`HM:_$?HG_P`+CK_KYPY_Z3G9^Q?2B_C\$_\`7OB/
M_P!*R$?1117]@'\HA1110!^@G_!*O_E(1^R]_P!CMX@_]5MXYK^])/N+_NK_
M`"%?P6_\$J_^4A'[+W_8[>(/_5;>.:_O23[B_P"ZO\A7\(_2F_Y+?(O^R5P_
M_JWS<_MGZ,W_`"1V=_\`93XG_P!5.3CJ***_F4_H\****`"BBB@`K-UF\FT_
M2-4OK>."6>STZ^NH([I[N.VDFMK6:>-+B2QLM1O4@=XU69[2PO;I8RS6]G=3
M!()-*LW68+FZTC5+:S\HW=QIU]!:^=>7VGP_:);6:.#S;[3&74K*/S63S+NP
M9;VV3,]HPN(XS0!_/K>_%;PA\3OVC=`U"QT32'\%_$/XH?"#Q9XU^'UO\6_V
M^_"GPY\:?$S2W\#6Z^-?$/PDNOV!8O"&I:SH'B#0M-DTVTO/BKX*\`^/F\*>
M%_$7Q3TFUO+G7#;?T-KTX[$C\B>3D#D]2?7N>I_`2UTW6/#7[2>F>!?"\7Q'
M\8VG@#XC_##PUXVU'PS\??\`@MG\9-`\,>+IM+\#>)/$_A_Q%XFT1/%_[/;W
M&DOKZWUQH?CCQ0V@V7AN]TC_`(6?!I$%YK-G;_OV/ZGU]3Z__J].,4`?AY_P
M4N\__AX__P`$+/LOD>?_`,-6?M/^7]I\SR?^3._B!NW^5^\SLW;,<;]N[Y-U
M?M$G_"3;$Q_86-JXQ_:F.@Z9YQZ9Y]>:_&+_`(*3_P#*23_@A3_V=;^U!_ZQ
MS\0:_;M&`CCSG[B]%8]AW`(H`P_^*F_Z@?\`Y4Z/^*F_Z@?_`)4ZWMP]&_[X
M?_XFC</1O^^'_P#B:=GV?]?\.OO%==U_7_#K[S!_XJ;_`*@?_E3H_P"*F_Z@
M?_E3K>W#T;_OA_\`XFC</1O^^'_^)HL^S_K_`(=?>%UW7]?\.OO,'_BIO^H'
M_P"5.C_BIO\`J!_^5.M[</1O^^'_`/B:<#GG^8(_0\TAGA'Q8^.G@/X$Z5I6
MM_&3XF?"[X9:1KFI/HVCZEXV\02>'K/4]5CLY]0?3[*>_EBCN+M+&VN+MH(R
M7$$,DI&U2:\+_P"'A_['_P#T=E^S-_X<S3O_`)+K\VO^#ADD?`']G_!Q_P`7
MPU'_`-5MXIK\#OV;?V9/"?QH^%OQA\>:UXC\>SZOX$TZ<V'A?X5>%M'\>>)?
M#B6VI>!,>-_%O@N7Q)I/B[Q#X3U"R\2Z[;6=GX.TVY>"+PIXKU6^UBUU#2]$
M\/Z__2/`G@YPKQ%P+@>,,]S[.,N>*Q];`RHX*AAZU*,UF/U&A9/#U:OOOE<F
MV[RERP4IRIPE_/7&WBWQ/D'&N,X3R3),HS!8;!4<9"KC:]>C5G%X"&.KJ4EB
M*5+W(N:C9*T5S3:C&=2/]BW_``\/_8__`.CLOV9O_#F:=_\`)='_``\/_8__
M`.CLOV9O_#F:=_\`)=?QH>,?V>-$\,_"30?'.F6OCGQ-JTWPT^%7Q.\6WNC_
M`!`^"=_HWAG1/B"FBRZA>W?PZL)[KXMZ;X=TV[U>+PK8^*]9M8-)7Q1-8MJ_
MV?3KJ))^O\+_`+,GPY^)5_\`"32_`^H?&/1=6\?>$OB?\8==T/Q/'\/?%&N:
M?\#?AII6K20^)-`M?#UMX7M)_%WQ"\1:!K>B>!]$UN]M=(&G6,?BO7M4T_1+
MVWD'V$O`#@"&'EBY\5<0?585<52JUXTLLJ0HSP6$>.K*M&E1G5I-X6$ZD(3I
MQJ2]V'(IU*,:GR</'7CJI7CA8\,9"\3.EA*M.A*IF-.=:.,Q4,'2]C*I5A3J
MKZS4A3G.$W37-*49RA3J2I_V`?\`#P_]C_\`Z.R_9F_\.9IW_P`ET?\`#P_]
MC_\`Z.R_9F_\.9IW_P`EU_$S\4_@A-X6^)?P]\`>$+7QE'/\3M'\!W?ANT^(
M)\&O(-5\=:]/X9L8=-\<?#K6_$/P_P#'GA-M5BB^S>.O"MU!9$OJ.D:AI%AK
M6@:A!+W'[2?[-FF?`S2XKG39OB=>SZ9\2O$WPNUO5?%>B^!4\*:QJWAK3([R
M;5-%NO!GBO7-;\!W]]/'=W%C\,/BIIFF>.IO"LNF>+4G>)M6TO3.B'T=^`:E
M;+*$>+L]=;-H5*N"IJE@&ZE.CR^TE=89QMS7C%Q<HSM*I3<Z5.=2///Q]XYI
MTLQK2X4R54LKJ4J6,FZF.2ISJVY(V>(4N9Q]Z46HRAS1A-1JSA3?]U/PI^-?
M@KXYZ'?^)O@]\1OAE\2_#^EZM)H6HZSX*UZ7Q!IUEK,5G::A+IES=6$DL4-[
M'8W]E=M;NPD$%U!*1MD4GY,_X*I?V[_P[Z_:C^U_V1]G_P"%=Q^9]G_M#S]O
M_"3^'O\`5^;^ZSG'W_P[U\<_\&^9)_93^+F3G_C(76/_`%6WPYK[>_X*M_\`
M*//]J;_LG47_`*E/AROPW_5[#\)^,N5<.X6O6Q6'RGC;A[#4L1B%!5JL?[1R
MZIS5%3C&"E>HU[L4K):7/VG^WZ_%'A'F6?XJA1P^(S/@[/,15H4'-T:<GE^.
MA:FZCE.UHI^\V[G\&C_?;_>;^9IM.?[[?[S?S--K_3".R]%^1_G.%%%%,`K]
M^_\`@WT^W_\`"_OV@O[/^Q^;_P`*<\+[_MOVG9M_X3I\;/LWS;L_WOEZ>]?@
M)7]`_P#P;S_\G!?M"?\`9&O"W_J>/7Y;XU_\FLXQ_P"P'"?^K7`'Z9X.?\G-
MX1_[#L3_`.JS'']2?BG_`(23_A&?$6[^P]O]A:QG_D)]/[.N<]/U]L]\5_FQ
M1_ZJ+_KE%_Z+6O\`2[\6?\BOXC_[`.L_^FVZK_-$C_U47_7*+_T6M?B/T3_X
M/'7_`%\X<_\`2<[/V+Z47\?@G_KWQ'_Z5D0^BBBO[`/Y1"BBB@#[^_X)9^?_
M`,/`OV8OLOD_:/\`A-/$'E?:/,\G=_PKCQQG?Y/[S[N[;M_CVY^7-?WD:=_:
M>U_[1^P8Q'Y/V+[5C&&W^9]JY_N[-O.,[N<5_![_`,$J_P#E(1^R]_V.WB#_
M`-5MXYK^])/N+_NK_(5_"/TIO^2WR+_LE</_`.K?-S^V?HS?\D=GG_93XC_U
M4Y..HHHK^93^CPHHHH`****`"D/0XZX./\GC\Z6FNP568L%"JS%F("J`"2Q)
M(``ZDD@8ZD#F@#\GM?\`@9\?X/VK/&WC=?`'Q4\5>!O$WQ<\$^)]&\3^%_V]
MO&GP-\):-X5TS0_!FD7=GJG[./P]T32?"GC%=)N=%U6_U*;Q?=Z]XD^(UK=?
MV)XDU8:/::-I]C^L0_J>^>Y_SCMT[5^3&O7_`,<M8_:E\4S^(;C]M_4/`4'Q
M3\$Q_#"^^!?CO]C+PU^SN?AX-*\)/<V?BSPYXF^)O_"Z->CMO$__``D\_CS5
MKG26U_7-,O&L?".DV]O9:;I</ZSC\>IZX]3Z=O3OC&>:`/Q!_P""D_\`RDD_
MX(4_]G6_M0?^L<_$&OSN_P""YGQ@^+O@']KGP)HO@/XK?$WP1H]Q\`/"6HSZ
M1X-^('B[PMI<^H3>./B);RWTVG:#K.GV<M[+!;6T$EV\#7$D-O!$\C1PQJOZ
M%_\`!2X3G_@H]_P0L%LT*3G]JW]I_P`MKA))(1_QAW\0-V](I(9&^3<%VR+A
M]I;*@J?RE_X+W+>K^V/X`^WR6DLW_#.WA`AK*&X@B$?_``GOQ*V@K<W%T^_.
M[Y@X784&S<&9OW;Z.N'H8GQ)P]+$4:5>F\GS23IUJ<*L.91HV?).,HW71VNN
MA^)^/]>OAO#VO5P]:K0J+-<L2J4JDZ<[.K--<T&G9K=7U[,^+?M?[:R_!?\`
MX7E-^T?\1[3PW)<6TUIX;O?VFO$UG\0-0\,75O?20^-M.\'W7C:+4[[P]+<:
M=>06\-NDFOWEG:W?B"RT>X\.6EQJD=W3K+]O74])^$&LV_QP^+D-G\;HO'-]
MX-&H_M'>,M,FT_0/ASH6G>*_%?BWQRM_XJ@A\#^%+/P=JEKXSM=9UN=$O_"1
M&NVT#VMQIXOKOA/]I7X.Z-^R6?A%XN\-^+?BKK]MK\+Z1\,/B):^&M4^'OAW
M4?[+NI'\=^"OB#8P6'Q#\#Z`+^>Z>7P#H%Q;:I-J^M:U82:Y<>$-6O738O?V
MT_!6O?\`"L-5F^'^K?#_`,6:-\9/CGXW\>:SX9U&;XCZ2_@OXP?#_P`$^`+W
MPEH_@CXFZL?"_B3PSJVA^'&\+^(/`&LQZ+H^C^`M&TK0/!NL:7=ZG<7^F_U_
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MZ%T3]J+X,CXQ?LSZ]J;^+/#_`,-/V6-#O;?PY8^#?A%X9TR?QOK/B;Q1XK\4
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M_P"U+_@G/KNN>)OV'/V7]?\`$FM:OXBU[5OA#X8O=5US7M3OM9UG5+R6.?S;
MO4=5U*>ZO[ZZEP#)<7=Q-,Y`W.<"OXE/VBOC1X=^*,/P=\(^"M*73?!?P7\"
MZOX1T:9/".D>`(=5U#Q5XUU?QQXAO--\$:+KOBJ#PQH-M>:E:Z7HMAJ'BOQ3
MXBO5L;W7_$FNW>K:U-#:?V?_`/!-2/76_8+_`&4S:W.D)`?@UX5\M9[*^DF"
M>7<;1(\>I11LV.I2-`6R0`,`?A/TB<-R<!<,XFOEF$R_&U>)*\)K#X:GAYRP
MT<-F:P<ZL8PC.G4KX2&'KUZ$E'V->I.DZ<'#EC^W>`.(Y^..(Z%#,<5C\'3X
M=I2A*OB:E>$<1+$94\7"E*4I0G3H8J>(H4*T>95:,(5%4FI\\OSO_P"#AK_D
M@/[/_P#V7#4?_5:^*:_G,^!?[3GB7X!Z7XB@\,^"OAUK/B&]2VO/!OC;Q#X;
M%QXL^'WB.V\5^!?%D.L:9JME<V,FO:?:ZGX`T/4].\+^)QJFAZ;XDM+37K2"
M-/[9TK7OZ(_^#@U-57X!_`+^T)].E0_&[4=@L[:[@</_`,*W\4<N;B\N59=N
M[(55.=AW<,#_`"CU^@>`N`P>9^$N4X3'X>&)P\LQS2<J4W)1<J6:59QNX2C)
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M+RUNYY3)_P`*X^'62K07ML@3;M`4H6W;R7(*A?MG_@JE'KB_\$^?VHS=W.DR
M6X^'<7F);V5]%.5_X2CP[_JWEU&>-3TY>)N<<8S7\!<5_P#*0S_[+_A[_P!3
M<K/[HX8_Y,*O^R'SS_U#S`_A*?[[?[S?S--IS_?;_>;^9IM?Z(1V7HOR/X%"
MBBBF`5_0/_P;S_\`)P7[0G_9&O"W_J>/7\_%?OY_P;YK?M\?OV@AI\MG%+_P
MISPOO-Y!<3H4_P"$[?`1;>YMF#`Y)+.P/R_+US^6^-G_`":SC'K_`+#A-O\`
ML:Y>?IG@Y_R<WA'_`+#L3_ZK,<?U>>+/^17\1_\`8!UG_P!-MU7^:)'_`*J+
M_KE%_P"BUK_2?\51>)/^$8\1;KO0R/[!UC(_L_402/[-N<X/]JG'Y=,]\5_F
MP1_ZJ+_KE%_Z+6OQ'Z)_\+CK_KYPY_Z3G9^Q?2B_C\$_]>^(_P#TK(A]%%%?
MV`?RB%%%%`'Z"?\`!*O_`)2$?LO?]CMX@_\`5;>.:_O23[B_[J_R%?P4?\$L
MA.?^"@?[,(M6A2<^-?$'EM<)))"I_P"%<>.,ETBDAD;Y=P4+*F&VDDJ"I_O(
MT]-317_M&:PF!6/R?L5O<P;<!M_F?:;NZ+@_+LV[",-NW9&/X1^E-_R6^1?]
MDKA__5OFY_;/T9O^2.SO_LI\1_ZJ<G-&BBBOYE/Z/"BBB@`HHHH`*J7]G%J%
ME>6$ZQO!>VMQ:3)-!!=1-%<PO!(LEM=1S6UQ&R2,KP7$,L$JDQS1R1LR-;HH
M`_-'3/V!_#'ACQ'I-SX4_9^_X)UZ=)H=]I^J:'\2(_V-_#VE^/M"U+3+F"[T
MW5K31]!U:PTC_A(M-N;>*[M-:TSQ+X?@BU&*&^M-&L4B2S'Z/Z5;7=EIFGVF
MH:@^K7UM9VT%YJDMM:V4FHW44*)<7SVEDD=I:M=3!YS;VT:00E_+B78HJ_10
M!^('_!2?_E))_P`$*?\`LZW]J#_UCGX@U^5'_!?G_D\OX?\`_9N?@[_U/?B7
M7ZK_`/!2?_E))_P0I_[.M_:@_P#6.?B#7Y4?\%^?^3R_A_\`]FY^#O\`U/?B
M77[W]&[_`).9A_\`L39K_P"DT#\-^D-_R;G$?]C;*_\`T[,_#VBBBO\`0T_@
MD****`')]]?]Y?YBO[[?^"9G_)@O[)__`&1CPI_Z+N*_@23[Z_[R_P`Q7]]O
M_!,S_DP7]D__`+(QX4_]%W%?S!]*?_DC^'O^RC7_`*K<<?TG]&7_`)*O/O\`
MLGI_^K++S\V/^#AK_D@/[/\`_P!EPU'_`-5KXIK^3>OZR/\`@X:_Y(#^S_\`
M]EPU'_U6OBFOY-Z^O^CO_P`FMR?_`+#LX_\`5C7/E/'[_DY>;?\`8'E/_JMP
MP4445^X'XN%%%%`']=__``;Y?\FI_%S_`+.%UC_U6WPYK[>_X*M_\H\_VIO^
MR=1?^I3X<KXA_P"#?+_DU/XN?]G"ZQ_ZK;X<U]O?\%6_^4>?[4W_`&3J+_U*
M?#E?YW<5_P#*0S_[+_A[_P!3<K/[ZX8_Y,+_`-V/GG_J'F!_!H_WV_WF_F:;
M3G^^W^\W\S3:_P!$([+T7Y'\"A1113`*_H'_`.#>?_DX+]H3_LC7A;_U/'K^
M?BOZ!_\`@WG_`.3@OVA/^R->%O\`U/'K\M\:_P#DUO&'_8#A/_5KEY^F>#G_
M`"<WA'_L.Q/_`*K,<?U8^+/^17\1_P#8!UG_`--MU7^:)'_JHO\`KE%_Z+6O
M]+OQ9_R*_B/_`+`.L_\`IMNJ_P`T2/\`U47_`%RB_P#1:U^(_1/_`(7'7_7S
MAS_TG.S]B^E%_'X)_P"O?$?_`*5D(^BBBO[`/Y1"BBB@#]!/^"5?_*0C]E[_
M`+';Q!_ZK;QS7]Z2?<7_`'5_D*_@M_X)5_\`*0C]E[_L=O$'_JMO'-?WI)]Q
M?]U?Y"OX1^E-_P`EOD7_`&2N'_\`5OFY_;/T9O\`DCL[_P"RGQ/_`*J<G'44
M45_,I_1X4444`%%%%`!1110`4444`?AU_P`%+EF?_@H]_P`$+%MY4@F/[5O[
M3^R5X?M"KC]COX@%LQ>;#OW*"O\`K5VDAQNV[3^4G_!>Z.[C_;&\`+>W45W+
M_P`,[>$"LD5F+)0A\>_$K:AB%S=9(.YM_F#A@FW"!F_6'_@I/_RDD_X(4_\`
M9UO[4'_K'/Q!K\J/^"_/_)Y?P_\`^S<_!W_J>_$NOWOZ-W_)S,/_`-B;-?\`
MTF@?AOTAO^3<XC_L;97_`.G9GX>T445_H:?P2%%%%`#D^^O^\O\`,5_>M_P3
M4M]:?]@O]E-K;5;2"$_!KPJ8XI-(,[HICN,*TPU.'S".A;RDSC=M&X@?P4I]
M]?\`>7^8K^^W_@F9_P`F"_LG_P#9&/"G_HNXK^8/I3_\DAP]Y<1K_P!5F.1_
M2?T9?^2KS[_LGI_^K++S\R/^#@V'4H_@'\`C?7]O=J?C=J(1(=.^QE6_X5OX
MH.YG^VW1<!<C;M7)8'=A`&_E'K^LC_@X:_Y(#^S_`/\`9<-1_P#5:^*:_DWK
MZ_Z.W_)K<H_[#LY_',:[/E/'[_DY>;?]@>4_^JW#!1117[@?BX4444`?UO?\
M&_\`#J<G[*WQ:-CJ%O:1C]H+5P\<VF_;"S_\*X^'1+B47]J5!4JNSRS@J3O.
M\A?MG_@JE;ZRG_!/G]J-KK5+2X@'P[B,D,>D_9W=?^$H\.\+.=2G\L].?*?U
MQD"OC?\`X-\O^34_BY_V<+K'_JMOAS7V]_P5;_Y1Y_M3?]DZB_\`4I\.5_G=
MQ7_RD,_^R_X>_P#4W*S^^^&'_P`:%7EP-GB^_!YA_F?P:/\`?;_>;^9IM.?[
M[?[S?S--K_1".R]%^1_`@4444P"OW\_X-\X[V7X_?M!"QNH;20?!SPN7>:S^
MV*R_\)V^%"?:K780<Y;>V<_=RHS^`=?T#_\`!O/_`,G!?M"?]D:\+?\`J>/7
MY;XV:^%G&/\`V`X3_P!6N7GZ9X.?\G-X1_[#L3_ZK,<?U*^*K7Q`/#'B+=K-
MD1_8.L9`T0Y(_LVYZ$ZN0/R]N]?YL$?^JB_ZY1?^BUK_`$N_%G_(K^(_^P#K
M/_IMNJ_S1(_]5%_URB_]%K7XC]$_^%QU_P!?.'/_`$G.S]B^E%_'X)_Z]\1_
M^E9$/HHHK^P#^40HHHH`^_\`_@EDLS_\%`_V85MY4@F/C7Q!Y<LD/VA$/_"N
M/'!.Z'S8=X*@J/WJ;20V3MVG^\C3XM1B5S?WL%X&6/RO)L/L7EX#;]P^V78D
MW97`'EA-I^]NX_@\_P""5?\`RD(_9>_[';Q!_P"JV\<U_>DGW%_W5_D*_A'Z
M4W_);Y%_V2N'_P#5OFY_;/T9O^2.SO\`[*?$?^JG)QU%%%?S*?T>%%%%`!11
M10`4444`%%%%`'X@?\%*"!_P4C_X(4DD`?\`#5O[4')X'_)G/Q!K\I_^"_+*
M?VR_A_A@?^,<_!W<?]#[\2Z_H=_;A_X)Y_#7]NJ[^!VN^+OB_P#M'?`SQQ^S
MKXP\4^./A7\2?V9?B3I?PP\?Z!KGC/PE+X'\0,FOZEX1\6[;>]\-7-YIC+:6
MUG/]GOKV%KAX+J6%OSA^)?\`P;F?`+XSZ[:>)_B[^W[_`,%7_B5XCL-*AT*Q
MUSQE^UIX6UG4[31;>[O;^#2K>YG^#&^.QAOM1O[N.W7Y%N+RXEQNE8U^C^%?
M&N"X`XLI<0X_!XK'X>G@<9A'A\&Z,:[EB8P49IUZE.GRQ</>]Z]GHFS\]\3>
M#L7QUPO5R'!8O#8*O/&X3%*OBU5=%1P\Y2E%JC"I/FE=<ONVWNT?R?9'J/S%
M&1ZC\Q7]/O\`Q"W_`+%__1W7_!3+_P`2=\'_`/SF*0_\&N'[%X!/_#77_!3+
M@$_\G.^#^PSW^"Y_D:_IO_B:KA?_`*)CB'_P9EGE_P!1GK_6_P#./_$L?$O_
M`$4F0_\`@O,?_F7U_I:_S!Y'J/S%&1ZC\Q7[Z_`O_@W'_92^)?B[]IS0=>_:
MU_X*,QV?P;_:&N_A5X6;2OVE/"MO<2^'(/@M\$_B$DNN/+\(KE;O6#K?Q%UR
M,W4*641TR/3+<VGFV\ES<_1'_$+?^Q?_`-'=?\%,O_$G?!__`,YBC_B:KA?_
M`*)CB'_P9EGE_P!1?K_6Y_Q+'Q+_`-%)D/\`X+S'_P"9?7^EK_,(A&]>1]Y>
MX]17]]G_``3,=/\`A@;]D_YE_P"2,>%/XA_SSN/>OR/'_!K?^Q>""/VN_P#@
MID"#D'_AIWP?P1_W1BOI/PI_P0YT3P)X;T7P=X*_X*F?\%D_"OA/PWI\&D^'
M_#FA_MF^'+'1]%TRU79;:?IUG'\%_+MK2W3Y(84^5%X'%?D?C!XRY/XD9)EF
M59=E&9Y=5P.:+'U*N.EA)4YTUA,1A^2"P]>K+GYJRE[R45&+U;M?]5\)O"/-
MO#W.<QS/,,URW'TL;ECP,*>"ABHU(5'BL-B/:3=>C3CR<M"4;1;E>2TLFSS7
M_@X993\`?V?\,I_XOAJ/<?\`1-O%/O7\G&1ZC\Q7]<WQ._X-_P#X8?&K2]-T
M3XP?\%(O^"N_Q,T;1]1.KZ3I?C/]L#PSK5EINJM:7%@VHV<$_P`%]L-X;&[N
MK0S+\WV>XFC^[(V?%O\`B%O_`&+_`/H[K_@IE_XD[X/_`/G,5[?AAX\Y%P)P
MA@>&\=D>;XW$87$8ZM/$8.>"5"4<5BIUXJ*KXBG4O&,^65X6YD[-JU_&\2?!
M#.N-N*\9Q!@LYRK!X?%4,%2C0Q4,8ZT987"TL/-R=&A.G:3IN4;2;LU>ST/Y
M@LCU'YBC(]1^8K^GW_B%O_8O_P"CNO\`@IE_XD[X/_\`G,5\XZ9_P;F?LJ7G
M[6OC/X%R_M:_\%&!X0\/?LZ_#7XKV4T?[2?A4>(6\2>+_BC\6_!>IQ75Z?A&
MUO)HR:7X&T=[&U6PBEAOGU"9[R83I%;_`*#_`,35<+_]$QQ#T_Y>99Y7_P"8
MM[:_UO\`!_\`$L?$O_129#_X+S'_`.9?7^EK^"&1ZC\Q1D>H_,5_3[_Q"W_L
M7_\`1W7_``4R_P#$G?!__P`YBC_B%O\`V+_^CNO^"F7_`(D[X/\`_G,4?\35
M<+_]$QQ#_P"#,L\O^HSU_K<_XECXE_Z*3(?_``7F/_S+Z_TM?<?^#?-E'[*?
MQ<RRC_C(76.X_P"B;?#GWK[>_P""K;*?^">G[4V&7_DG47<?]#3X<]Z^'_AG
M_P`$!OAO\%]$O?#7PB_X*3_\%>_AKX>U'59=<O\`1/!O[87AK1M-O-9GM+.P
MFU6XM8/@P4DOI;'3K"TDG/SM;V5M&>(EQT'C'_@AEX>^(?AC6/!7CS_@J-_P
M6/\`&'A#Q#:_8=>\,^(/VS/#FH:+K%EYL<_V74+*7X+^7<P>=#%+Y;_*7C0G
M.*_F'.>-,'F?B;_KU3P>*I8'_63+,[^I5'1>+]C@:^#K3HWC4='VLUAI*#]I
MR)RCS22NU_2.4<'XO+O#G_4JIB\-4QO^K^89/]<IQJ_5?;8RAB:4*W+*"K>R
M@Z\7-<G/:,N5/2_\>KD;VY'WF[CU--R/4?F*_I^/_!K?^Q>22?VN_P#@ID23
MDG_AIWP?R3_W1BD_XA;_`-B__H[K_@IE_P").^#_`/YS%?T\OI4\+I)?ZL<0
M[+_EYEGE_P!1?K_6_P#-_P#Q+'Q+_P!%'D7_`(+S'_YE]?Z6O\P61ZC\Q1D>
MH_,5^_\`\7_^#<#]D_P%\2?V6?"&C_M;?\%''TWXU?&WQ/\`#GQ6VH_M*>%)
M[V'0]&_9P^//Q;M9-!EC^$,"6>J'Q+\,_#\4]Q/%?1OHLFK6JVR37,5Y:>_?
M\0M_[%__`$=U_P`%,O\`Q)WP?_\`.8H_XFJX7_Z)CB'_`,&99Y?]1?KW_P`U
M_P`2Q\2_]%)D/_@O,?\`YE]?Z6O\P61ZC\Q7]`__``;SLH_:"_:$RP'_`!9K
MPMW'_0^/7NW_`!"W_L7_`/1W7_!3+_Q)WP?_`/.8KTWX8_\`!NQ\#?@IJ6J:
MQ\'_`/@H-_P5D^&6K:W8P:9K&H^#/VMO"VBWFJ:=;7#7=O8WLT'P7W3VT%T[
MW$43?*DK,XY)S\AQ]](;A_B[@_/.&\)D&=87$YKAZ-&EB,3/`.A2E2QF%Q+E
M45+$U*C3C0E%<L9/F:Z*[^LX&\!,]X4XLR7B'%9YE&*P^5XBK6JX?#PQJK58
MU,)B,.E3=6A"FFI5E)\TDN5-;VO^]OBQT_X1?Q'\R_\`(!UG^(?]`VZ]Z_S1
M8R/*BY'^JB[C_GFM?V8R?\$8;F:.2&7_`(*T?\%II(I4>.2-OVV-`*O&ZE71
M@/@N"5925/(X)KY._P"(6[]B[@?\-=?\%,@```!^T[X/```P!_R1CL*^`\&?
M%?*O#.'$,<RRO,<Q><SRN5%X"6%BJ*P"QZJ*K]9K4KNI]<AR<G-\$^:WNI_<
M^+OA=F?B-4R">7YE@,O641S2-58V.)DZOU]Y<X>S^KTJMN18*?/S\OQQM>S/
MY@LCU'YBC(]1^8K^GW_B%O\`V+_^CNO^"F7_`(D[X/\`_G,5\W_M>?\`!N9^
MRI\!OV:OC'\7O!W[6O\`P48G\3^`?!EYX@T6+Q%^TGX5O=$>]M[NR@1=2M+?
MX1V$T]L4N'W1I>VY)"GS`0*_;O\`B:KA?_HF.(>G_+S+/*__`#%OS_K?\:_X
MECXE_P"BDR'_`,%YC_\`,OK_`$M?P2R/4?F*,CU'YBOZ>U_X-<?V+W!)_:Z_
MX*9??D7C]IWP?C"NRCK\&,]!WY]23S3O^(6_]B__`*.Z_P""F7_B3O@__P"<
MQ1_Q-5PO_P!$QQ#_`.#,L\O^HOU_K<_XECXE_P"BDR'_`,%YC_\`,OK_`$M?
MR&_X)6,O_#PC]E[YA_R.WB#N/^B;>.:_O2C(*+@@_*O0@]O:OYS?!G_!M+^R
M_P##GQ/I'C7P!^W#_P`%3/!OC#0)YKG0_$WAW]JKPGIVM:1<7-G<Z=<36%[%
M\&/,MY)["]O+*5DY>VNIXC\LC`_K!^R#^QC/^R0WCYIOVM_VU?VH_P#A/!X:
M55_:^^-NG_&%?!7_``C9UPEO`(L?!7A#^P#X@_ML#Q,93?\`]IC1]#V"U^PM
MY_\`.WC!XAY?XD9_EV<9=@,;EU+!9/2RV=''2P\JLZL,;C<4ZD'AZM6"IN.*
MC!*4E+FA+2UF_P!]\)^`<?X>Y'F&59ACL'CZN,S>KF,*N"C7C3A3J8+`X54Y
M*O3IRYU/"3EHG'EG'6Z9]JT445^3'ZF%%%%`!1110`4444`%%%%`!1110`45
M\3?&#]MSPG\)O%/Q/TN/X:_$KQ[X0_9]\.^'_%?[27Q&\&V_A:3P_P#!?0?$
MVCW7B>UGO]+USQ+H_BCQOJ&@^";9?B-XVT;P!HNOZEX7^']YINLM#J&JZMI7
MA^\U=0_;`TW0OBIX2\#>)O@_\6O#'@;X@?%>X^!7@3XR:WI_ABT\)^*_BE%H
M'B;Q':V>F^%_^$E?XE)X'UVV\(>(-,\,?$RY\'Q>$_$&KZ<9[.X'A74=#\5:
MH`?6&G:'HNCSZO<Z3I&EZ7<Z_JC:WKMQIVGVEE/K6LM8:?I3:MJTMM#%)J6I
MMIFDZ7IS7]ZT]V;#3;"S,WV:SMHHM2O`O&/Q[L_`WQ`UWP?K/P]^)=UH6A?"
MK3?B4WCWPYX5O?%FAZKJ&K>.9O`UC\-]!T3PRFJ^,M9\?W%TMIJL.EV/A^6S
M?2]0M9GOHV%QY'RQ<?\`!1[PC??LQ_`']I7PO\+O$LFG_M!ZKK5EH7A#X@^/
M_A!\)+WP99>'-.\;:EKU_P#$#QEXU\:6_P`/-&?31X+FT]K#3O$VKW%UJFJ6
M5O8M<V\5]>6X!^DE%<=\/?$][XT\#>$/%VH:-'X>O/$_AS1]?GT6'Q!H7BN'
M36U:QAOEM(/$WABZOO#NOP1QS(8=7T.\NM*U")DN;&XFMY(Y&[&@`HHKYW^-
M/[0"_"WQ+X#^'7A?X=>,?B]\6/B78^,-=\*>`/!MUX5T:1?"/P[_`.$;7QSX
MS\1>*/'&O>&_"_A[P]H5YXR\':!#)=:C-J6K^*/%_AW2=-TZ6";5-2T@`^B*
MRDT+1(]:G\21Z/I:>(KK2[71+K7DT^S76KG1;&\O=0L=(GU581?S:99W^I:C
M>VNGR7#6EO=W][<PPI-=3O)\(>(/^"@WA6P^%J_''PU\$/CKXO\`A!X<^&.M
M_%OXP^-K;0O"/AR#X.>&O"&K>-]`^(6@:]IOB[QCHE]XQ^)GPRU;X<>-T^(7
MPZ^&H\6ZUX=M/#K3&6[N_$?@>P\5_6?C;XEMX3U'X0V6G^#O%7C"V^*_Q#A\
M#/JOANWLGL?`MA/\/?'GCY?''C(ZC=V4]KX4'_"$P^&6EL(;S4QXB\5>';<V
M`MIKRXM0#U&BOD[X#_M@_#GX]W7[0QTC1/&W@/1OV<O'FF^"O%.N_%;03\/X
M=7LM4^$G@;XS6OCG3M(U^>V\1:'X,F\(^/--N8+SQOI7A?5I(+2[U631[?1I
MM/OKR[^RM^U5X6_:NT+XJ>(/"GA#QIX.M/A=\:O&/P:NK7QU::;IVJ:])X8T
M?PIXCTSQEI^FV&HW]UIOA[Q?X:\9Z#KVAV'B!-+\3VEE>+!X@T32-12:QB`/
MJ2BBB@`HKY0^+G[7?@'X(_$#6/A[X_T+Q;8ZI)\)I/BA\-KBQLK&_A^,U_I_
MBZP\#:]\+OAQ"E['=7_Q2T?Q-XK^%]BOAG4HM/36(OBIX6O=%O;VSL/%<OA_
MY+^)W_!3CQ+\'==_:4TOQ]^R%\4K&Q_9?^&7@3XJ^.M8TSXI?`G6(=2\.?%K
M7/B#X8^%,'A^QM_&L=_)J?BOQ!\-?$5E?6^J1:;%X8M7T[4M6G-I=EH@#]4;
M[1='U.[T>_U+2M-U"^\/:A-JV@7E]8VMW=:'JMQI6I:%/J6CW%Q%)-IFH3:)
MK&K:/+>V3P7,FEZIJ.GO*UG?74,NE7S)\'?VD#\0_'7B3X0^/?AIXL^"WQC\
M+^#_``]\0KKP/XJU;P;XGL]=\">)=8UOP[9>*_!_C#P'K^O^']>L=.\1^']1
M\/>)=.G?2?$7AK5?[-?4]%CTCQ%X9U;6/+/B]^WEX1^"'PJF^*'CSX1?&NU4
M_''Q'\%[#POIWA.VU'5+BVT']H'3_@!!\5-2UJ'45\'^%_AEKFHZUH/C/0M3
M\3>(=+UO6?"VN:9::+H6J>*KE=`H`^[J*^)?B-^V+_PAG[26@_LZ:-\-XO$5
M_J(^'R:EXHU7XR?!GX>)#=^/M1UN)-.\+^"O''BO3/'GQ"U'0=$T637]4M?"
M&A7S317EIINFF\U,74%O]M#_`#_3\Z`"BBO#?C-\>/#7P+OOA=+XXTS5K;P=
M\2/B'IWPQO?B#"U@/"WP]\2>)M/OSX$N/'L]S=07.D^'_&_BNTL/AUI.N00W
M-I:>.?$_A+3-5^Q6>MC4+8`]RK*UO0M$\3:3?:#XCT?2M?T/5(&M=2T;6]/L
M]5TK4+5F5FMK[3K^&XL[N!F16:&XADC)525RH(_.?5O^"@_B(_$K]G7P1X._
M9:^)OB[P]^U/+XNN/@[X\?Q[\(_"FGZQX<\$Z9>>*-7\5ZKX:\3>*+/Q;HVC
MZEX"@L_''A>*?2Y-3UG1]9TJUFL=-U66XLK;;_9R_P""A&C_`!VT_P"!WB/7
M_@C\3?A#X'_:>N=7L_V?O'/BG6/AQXET#QKJFE>'?$?C&W\,Z_'X'\6ZWK/P
M_P#%?B'PCX0\6>(?#>F>)M*CT[4H?#&LZ1)K=IXE&E:+JH!^B6`.@QU/XDY)
M_$\GWHKYY\4_M"6?@SQ%\7='UOX:?%:?3/A9X2^%?B.PU[PSX0N?&*?$[5?B
MIJGC71;#P5\.-#\,OJ/B'5O$_A_5/"=A;>)5U+3M*T72HO%^@:G>:Q;:-%K6
MI:7Y3)^W1\.4_8A\%_MO+X3\:R^&_B-\$_#_`,8_`GPIA7PY+\4_$]QXI\!R
M>/\`1/AUIEJFNMX6F\9RZ5!>?VC.OB-O"VBVFEZUXBU37[?PMHVHZS;@'VY1
M7G_PG^(FE?%WX7?#CXJZ':7MAHOQ+\!>#OB!I%CJ1MSJ%GIGC3PWIGB6PM+\
MV<UQ:?;;:TU2&"[^S3S6_P!HCD\F62/:[>@4`%%%%`!1110`4444`%%%%`!1
M110`4444`?EG^U7^RI\7-0O/V@)?@W=PZ]\,_P!MB'PCX&_:M\$6OA_P]>?%
M/1_#4?PUN_@OXJ\>?!#7?%?CSP/X)DUWQ#\,[+P=X+UW0O'C7EOX9L=)NOB-
MX1&O^(+%_A]XF[30?V;/VE?^&K;'XR>/?&7P!\;?"[P3K.J:3\$/!?\`PAOQ
M3T;6?@?\,[S09?#DD?A*P7Q_?^!-6^,6OZ4TFG>*_B_K^C7>IMX<U#4?!7@S
M3O!OA/4-<TSQ!^C%%`'&^/XO'LO@[7(_AC<^$K/QXUK$/#ESXZL]=U#PE%>K
M=V[2-K5EX:U'2=;GM39BZ5$T_4+:7[0T#.[0++&_YK?L[?L8?M+_``2_9O\`
M@U\&]3\?_LM>,?$O[/WB?6-2\!ZMKOP%\7:_X:UC2/$=KXLBU*:[M=>^(L_B
MGP)XUT^X\9:DNF>*/!'B`07>@B_\-:QI-U9Z[/<Z?^K=%`'AO[-_P5A_9[^#
MGA3X40ZY#XC;0+GQ7JEYJMEH%GX2T=]5\:^-?$GCS6;/PQX2T^ZO[+PCX-TK
M5O$][I/@KPC;ZAJ,7A?PE8Z-H(U+4#IYO9_<J**`"OCK]I?X.?%?4_%/A+]H
MW]G/4?!D?Q_^$7PW^+O@+PYX2^(^DW=[X#^)OA#XH3>`O$FK^"-;U?2-9T#6
M_"&I_P#"9_"CP%K'A[Q=:7UU8V!M=8T?6M(N-.U]]3T;[%HH`_&B3]BG]IS4
M_AW\$O`/AGQE\+V^"/ARQU/XH?$3X'_M#>`/$EMX@^(_[2/COXL>*?C-XX\8
M?%R;X&_%K4/!>M^`K?QMXDN=;\-_`S2]3U?P+9ZU.]WXPUOXBVND^'+32?V/
MB6X%M&)3#]J$*^88UD%N;CRQYC*KN9?*,I9E#NTFS&YB^6JQ10!^47@_]A_X
M^^*M=_;(T_\`:%^*7PU;X=?MC>*O!7CWQ3%^S[I7Q*^'?Q%\+Z_\/OAQ\#_A
M7HN@:9XH\8>*O&FA:IX-U_PW\&5F\9Z=JGAF5M>C\4ZSX8O8;OPY-/#/[U^Q
M9^Q[K'[)5Q^TA+J_QM^('QF'QV^/VN_&:RN/'US876H>&K;5O"OA/P[_`&=<
M7-AI>EQ:GKUW)X=>?7-:AMK*QO[:+0[6TTC3GTRZGU+[CHH`****`/F/]H+]
MG>+XX>._V3/&;ZIHVFM^S/\`M'GX\/!J?AY-;NO$$!^!/QM^$*Z!I-XUS;GP
M]?+J7Q6TKQ,-8*7L:KX8%F+,75S:7]A\R_M.?L"^)/CPO[<D^B?$W0O#-[^U
MG\`/V9O@_P"'5U;PEJ>L6?@?6/V>O&GQG\8MKVMK8^(=+G\1:7XHD^*5C8#2
M]-DT2]TJ/1;N;^T;Q]0MTL_TVHH`^/O@S\`?B-IWQE\2?M'?'KQAX%\4?%35
M?AGHOP>\,Z-\+_">O^%/`O@?P'IWBS5O'&N""7Q9XI\5^)_$WB;QMXHOM,O=
M=U6^NM)TK3]+\+>&=&T30+>>WUS6O$'-_M]_L]?&K]J+X+1_!OX2>,OA9X'L
MM:\5^!?$OB_6?B5X6\:^+)=GPU^)G@'XI>&[/P_8^$/%GA1(CJ.K^"GTK6IM
M3N+@Q:=J"SZ:L5S;ND_W+10!^<_Q;_9'^,7QTL=6T?QQXS_9]TG3_BOX0^'O
MAWXR:WX>^`EU<_$S1;CP#K$VO"7X0_$G5?&BZC;0W%[<SW/@:Z^(.E^)=4^$
M'B.6Z\7^&+C5KNX@TFP_1=1M&,YY8_\`?3%C^`)P/;KFEHH`*^8?VT?V>#^U
ME^RG\?/V;EUK2_#<GQH^&/B;P!;^(-:T$^)],T.[URU$5IK%WH(N[!]373;E
M(KR.WCOK.;SHHY(+F":-)%^GJ*`/EKXH?LZW/C_]HC]D_P"-UCXEL-$TW]FR
M_P#C3=W7A8Z++<3>)X?BI\+Q\/+*WT_48+^UMM#70)`NHR^=8:@E[;J+*!+-
M@)Q\D_LN?L$_&#X7^$_V4OAE\:/BQ\,?&/PQ_8PU:[\3?"S1_AW\-_%'AOQ#
MXX\9P^#_`!SX$\*^*?B/KWBWQUXHM;&U\):#\1?%E_%X8\(:/9Q:QXKNM%UB
MYURSTSP]_8&K?JW10!Y[\4;3XD7?@;6K3X277@:R\=S)91:-/\1[#Q)JG@Y(
M6OK==475K#PEJVAZ]/YFDF]CLOL.IVVR^:VDN#);)+$_Y8^&_P#@F-\0M?\`
MV-_@U^S;\6/V@-2\/^-/V<_@9XH_9_\`A7X\_9X;7_`OA?6/"^O?!_PU\*SX
ME^)/@3Q]<?$,:OXIGM]'U1+F;0=6T633O#OB7Q'X=\/ZEIUKXAUDW7[(44`>
M&_LS_!^\_9__`&??@S\$M0\8ZQ\0+WX5?#;P=X#N?&6N^4-2\03>&-"LM)>_
MDCAAA6WM6:U,6F6;+)-8Z7%965Q=7MQ;RWMQ[E110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
@0`4444`%%%%`!1110`4444`%%%%`!1110`4444`?_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>biib-2015630_taxchart.jpg
<TEXT>
begin 644 biib-2015630_taxchart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`%2`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^2OVV_VF9_V1_@!J7QG
MMM$\'ZY<0?$?X&?#F&/XA^/7^&/@+1W^-?QL\`_!U?%GC3QW'X<\6/X<\+>#
M3XY_X2G7;U-`OV;3M(N+<?9_.^U0_6M>$_M$?`G1/VB?`>B>`?$&L7^B:?HO
MQ?\`@)\75N=/M+*]EN]0^`WQK\!_&K2=%N(+]6MSIOB#5/`=GHFJR!3<0:;?
MW4UI_I4<)`!X%X'_`&[OA=!HOA*/XN^/?@__`,)+XL?2]1CUO]G/Q-\0?V@O
M@AH7A'Q?X]U#X:?#SQ1XQ^->F_"_P[X7\"Z9XP\<:/K/A&RU/QNOA[09?$NB
MZUIUAK.H1:)K%W8=WJ'[:7P;E^`/QS_:+\%'QG\0/`OP%\/_`!0U7Q+_`,(]
MX`\<0WFN:O\`"(^*[+QKX3\(+J?AVT'B;7=$\0^#M:\,:VNBKJ%IX=UJUFM]
M=N+'[-=>3R/QL_8<\,?&+Q]XL\3KX^\2^#O"/Q@\(?"WX?\`[0?PZT71?"MW
MI'Q9\&?!GQAXC\8^!M)BUK4M-EU_P)/*WC#Q/X3\5:AX;NFDUWP9J[65C#H'
MB/3]*\567>_#/]D_P7X!_9J\6?LPZAK>N^*/!?C>?]H4>(]4G%GH^MW%A^T9
M\1?B9\0/%EE:/I\;VUD=,D^)^K:1H]RD;R);65E=3H]R9@P!\U?![_@J-\)/
MB5X[;PUXF\*>,?AEX>U;X9_L5^._"GB;Q'X7\?7#C5?VTO\`A/=.\%^%OB59
MVW@2/3?A"UMXO\):-X'T'Q#XXUO3M#\<^)?%NE6>BW$22V,FH_7GPF_:C^"?
MQNU_4/#?PX\67FL:E::5=^(M,DU#PGXR\,Z5XT\*:?K2^&]0\9_#;7/%'A_1
MM&^)G@JQ\026^D7?B[P'?>(/#T%Y?:27U`6VN:)<ZC\8Z!_P2^\-VG@/QUX+
M\3_&/Q7XHG\=>&_V%O!U_K9\*>&M%DC\._L$?%*?XA?#2%]-L9YK.?4/%VG"
MQ\,>.KV-K.WG%O<ZSH.GZ-+>)IUIZM^R+_P3Z^$_['GB/5-9^'D7A9;6'PE)
M\._""Z7\'?A%X+\5Z=X$DUZT\0+IOC?XE^$_"ECX^^*.L6\VFZ/I<>N>)-:M
M8KW2]$TV\UW1]9\7"]\67H!\\_'_`/X*'_M`?L\>,_VQK3Q1^S_\%]8^'W[(
MOP#\%_M&ZGK^D_'[QQ;^*/&'@;XJ>)_C/X7^'VE1>'K_`.`,6BZ#XCMKCX,Z
MI?>.?-\4ZGI6CV>KV8T&]\1S6UPM?7Z?MW_LS'Q%I_@Z;QIX@L/&>I^/?%_P
MUM_!FK?##XIZ)XN@\5^!O#/@_P`=^)+?5/#6L^#-/UG1-*LOAOX]\*?%!?$F
ML6=CX:N/AEJC?$"#5W\*Z=JNJ6/(_M`?L(>#_P!H"Z_:NNM:\<^)=!;]JW]G
MCX/?L\>(TTO3](N5\+:)\'_%WQD\7:9X@T0WBDWFJZO<_&/5+2_MM1W64$&C
MZ>]MB2>YK#\1_P#!.WX:>+_VC_&/[0GB7Q7XEU0^._$GQ%USQ%X#:VT^UT*[
ML?B9^RE\)_V3M?T)=5M6BUN"T'A'X56FO074,T=ZFLZWJ$(D2TM[0J`>F:=^
MW;^S1JGAF_\`%5GXR\1-8P'P$^B:;/\`"WXJV7BKX@V7Q6O]5TSX7:S\)O!E
M[X+M_%GQ:\/?$:]T+6X_!7B+X=:-XDT77X=%U>]M+[[!IM[=0^P:;\=OAEK'
MPGG^->EZWJ-_\/[6WU>6ZN[/PGXPNO$=K>>'M;O/#&O^'KCP';:!+X]B\8Z)
MXGT^_P##&K>"F\,_\)98>);*[T&YT:/58)+5?S>T?_@CE^S_`*5\,&^';1^`
MKR;P[KGPCU?X=:R?V;OV?-.M[)?@C:^+=,\&Q_%;P_H_@JPL?CM<:UHWC?Q!
MI/CR;QO<V]CJZS6^N>$M)\!^+H9?$EQ]:S_L9^$5_9%U+]DO0?%.H^`]#U2Q
MO3<>*/AGX3^'_P`-PFK:GXX_X6'JZP^`_!?AK1?`">$?$&M-<:'XJ\%'1&L/
M%_@;4=9\->*+_5[G7-7UR]`*5Y_P4)_9<T\65I>>+/&L/B:^USXA>%U^'J_!
MCXRW'Q0M?$WPK\%^%?B1XZ\/:E\,[3P'<>.-.UG1?AYXU\,^.UL;O0HY=4\'
MZK#XATDWNFQSSQ<-\3?^"D/P4\-:A\)M*^&$D_QAN/B=\=OV7O@Y)K&@Z;XT
MLO`.B6_[3S^']8\.:N/B?'X*U/X?7_BC3_AWXHT#XD0_#>3Q'I_BC4O#&NZ%
M>SQZ7:ZQ9W3\+\'_`/@EI\-/A#\5K;XNZ-XSGMM:D\6_$WQWJWAGPE\.?AY\
M-_`$GB3XJ_LZ?"?]G7Q"/#_@_P`$Z9INF>&='MM%^$ND>)+&Q@%_J%QKFIZG
M+KNM:U/*U_+D?#?_`()4>$OA=X4^#OPW\-?&[X@)\+_A5\1OV6_C==>#)?#G
M@EO^$P^-7[,?A+X9^!;+QCJ7B`:?_;>F:/\`$#P_\*_#5]XI\'Z?<M96?BQ;
MG7-"U*RTZXN?#MP`>N?M"_MP7?P6^.VD?`_3_"'PUDU34/ASX:^(NEW7Q>^.
MNB_`J;XL3>(_%WB7PE)\,_V>9?%'A/5/"?Q)^*OAIO#UOJGBCPWX@\8^`[72
MH?&'P]MY+\VOBFYUG0>Z\/\`[;7P@G\9>/O`OBGQ+H>F^(O#7QF\9_![PWI7
MAVW\?>(;_P`2Z_X,M?@V;[PX\=[\/]`MS\1OM7QI\+7!\%^%;KQ?;7/AN6X\
M3:-XAU?3]`\;_P#")0_M0?LCZI^TKIGC#P;>_&OQ=X8^%OQ3\`_\*T^*7PRN
M?"/@#X@^&=5T%XM=M+KQ!X(C\=Z)J<GP\^(%[IOB"YTV[\1VJZ]H\L>G:%J2
M^$X_$&D0ZS)Y3<?\$W/"`U_7/$FE_%;Q]I&J1_M$ZQ^U3\.)H8["\/P[^-5[
MX2^%7PZTOQ,'U&:[F\9P:3\,_AUXA^'<]AXIEN$\0>&/B_\`$]=>DO=6U/1=
M4T0`]<^/O[6Q^!'[1/[)_P`&-0\!G6?"?[2%]\1]'\0_$@>(FT__`(5=JOAZ
M]^&OA?X=+<^&AH5]_P`)'IWQ'^(_Q/\`#/P_:^&MZ(WAW6-9T&4P:O%JDD=G
MXY\,O^"E?@'Q?\0OVF/"GBWP9KWA?0/@W\<O!OP7^$>J^%++QA\6?&'[1$WB
MOX6:E\1VUSP?\,_`7@?4?%$#6J>$_B'/;:;I2>*$N/`O@^;XA7VI:7I5U-:V
M/O?[2O[)/A?]I<S2:_XN\4>$[M/@?\9/@]HFK>%/L$&M^%=3^*/BWX*>/?#_
M`,4/#>I7D-P=.\=?"GQO\"O!GBOP-<-!/8)K5NMQJ5O<QVT4#^!6G_!-GPUX
M3\92_$KX7_%OQAX#^(.B>*?A!XI^'.MMX;\(^*+#P<_PM_9IO_V5[_1;[1-;
MM?(\4:-XZ^'.K:C>:ZL]UI.J6'BD:=K&CZG;K936UZ`>R:9_P4!_91US6]%T
M+0?B7=:]-KL7P4G@U31/`/Q)U;PUIT/[1EQJ6F_!"3Q)XIL/"$^@>$S\2_$6
MDWW@SPQ%XGU#2)[OQ]$/`DL4'BN1=)KY`^%/_!93X*?$2_\`#&KZ]\._B?\`
M#+X8:U\$/CM\9M<\7^,?`WQ(D\1>"[#X#_M):;^S[XHN/%/@;1?A[?W^E^`K
M2&^?QUXE^*-W>P>$_`^G6UUHWB:XM=3T[63IOIOAO_@EU\+_``?X;\;>%O#W
MQ"\;PV'C34/V(M8O+J_LO#U[J0US]B[XYR_M!6>N74T-I86=YJ7Q<\>WNL7O
MCE8-/TW3-+&L74?A/3-+M(+*QMN9L/\`@E%X'L-*^.'AA?B]XS?PE\5/V;?V
MMOV7?#&E'P[X<6]^'GP^_:Z^)^I?%_Q=<)J_F._BW6O"?C+7M=C\*W6JV=C'
M)X>GT[3-<CU*_P!/GUG4@#[A\#_M1?!KXD?$77_AAX+UWQ!K?B#PYJWB[P]?
MZO#\/OB'#\/KCQ+\/[Z#3?'7A?1_BE=>%H/AOKGB;PAJ%Q'9:_H&D^*;S5+*
M[BO[<6TLNDZPFGP:G^U;\#=(^)U]\([[Q7J2^+M,U=/#&HW$'@OQQ=^#;#QO
M/X-'Q#L_AS>?$6T\.3>`+?XF:AX':+Q5IWP[E\2KXPOM'NM/N+?1W?4],BO/
M%_`?[#.E>"?VB['X_P`?Q,UB6ZTH^(YDTG0O`GPY\!:WXQ7Q-X1M_!W_``CG
MQD\=^!M"T/7/C1X&\&V5M:ZC\.-"\=VE]K?AC7--T75M1\7>);O1K*0<_<?\
M$X/@Z/VE/%W[1>G0>%;75?''C2Y^*FNV^H?!WX2^)?&EO\3KCX;67PN?6?#7
MQE\0^&;_`.)GA3PU-HVEZ7KT_A30]6MIH/%UD]]HOB/1="U36O#>H@'<>'?^
M"B/[)?BWP9<>._#WQ%UC4M$;PS\'_&/AVW3X9?%2'Q#\1/#?Q^O)M)^#FK?"
MCPG<^"XO$WQ7M?'^O6E_X<T5_AUI7B7'B'3-4TF^%I<:==>7YQ\+?^"FGP.\
M86/CR\\<QZS\/7\'?&OX_?#86\7AGXB^*Y=-\!_`GXBCX;:E\9/BG%IO@&WN
M/@AX,O=?+V.IWOQ.@T#2/#VIV6LZ=/KEY_PC^OW.E\G9_P#!+CP5H^G?!&7P
M_P#%GQGI7B_]G;]FC]EOX`_"?Q<V@>&+^71-:_91\2:SX@\%?$K4-&NXVTS6
M+WQ-:>(=?\*^,_"LXATB[\-:YJ4>C7NBZV-,US3.'F_X([?!R^\5ZMXZU[Q;
M9^-_&GC7Q;\2M>^(_B7XF_!#X&?$Z[UO3OB=\3+_`.+>J6?A'3O'?@W7?#_P
MYUK1/%NN^*+30/$.A:-=Q'POXBGT;Q!H/B"\T?PUK.C`'T]KO[>'PT7]HGX%
M_L]>!M/U7QKJ7Q6^.'Q<^!WB3Q9_8WC30/"/A#Q%\'/@C\5/BMXOA\/>+-3\
M&CP1\3-9T#Q!\-A\.O%WA_PKXM>[\(:[J=^NKS)J/AW4-&;4^._[;'P__9Q^
M,VE>`/BK:_\`"/\`P];]FKXM_M%>)OB@LNKZJ_ART^&/Q;^`7PH@\/#P;H7A
M_5-5U8:_??'2UOSJEG="73?[$%L=+NXM0DO=.Y3PM^P7H_A+XO?"_P`>:;\6
M/&)^'_P3^.OQO_:"^%OP@DT+PA'H?ASQG^T7X2^,6@_%*QNO$UKIUOXFUGP]
M)K?QK\8^*/"&GW<T<WAB?4+K1[B[U[3!I`T*3XX?L%>%_P!I'Q1\8O$/QC^(
MGBC6[?Q_\#O%O[/G@'2=!T;PUX<C^$_@/QUXG\!^/_$M[I]\MIJ=YXQ\67'C
M_P"&/@37[/4_$S'1K*S\.6VB_P#".7$5[K%YJ0!V/B_]OO\`9;\$>*_$?@36
M?'>NW7C3PMXM^(O@;5?"GAKX9?%#QCX@;Q/\)OAU\,/BU\0].TO2?"?@[6K[
M7!X6^'/QB\`^+=0O-&@OK%M+U._-M<SS^']>@T[K/#?[9'[.OB_QIX?\#^&/
MB`==O?%$GANQT'Q)IOA?QC<_#;4=?\8^`;#XJ>$_!T7Q63P__P`*W7QWXC^&
MVJ:9XXT;P/+XIC\57_AO4M-U"+22-1L([GYN\%_\$WM`\/?%FX^-GB+XP>,_
M&'C[6_%'[0?C7Q9=W7A_PQH^FZSXE_:*^!?[/?P-\4RV>F:6@CT72="TC]GO
M0M5\-Z7!+=/#-K-]9:G?ZB+6&^GY+]G;_@DQ\#_V<O&WPS\6^&;S0M>?X>Z?
M\-=0GU#Q1\%_@WK/Q#UKXA_#;X*^$O@?;^*[+XNZEX5U#X@>#]$U[0_!VD^*
M-5\&^&=3M$LO&0NY_#WB+1O#.HZGX7O@#V_]KC]L#Q)^RY?:->R?#SP+XC\*
MZC'H%OI-EK?QNT+P9\6_C!XKUGQ`VCW?PQ_9K^$W_",^(M2^*_Q,T:PGTG6&
MT#6-8\#6.M3:]HFBZ+JMQ+-JVI:'EZ9^W!=7OQ)TV&[^&^G:;\`O$/[3WB_]
MCCPW\5IO'JR^+KSXY>"9?%&@:E+J/PUB\+&PT_X=ZG\2_!?B?X4Z)K<7C^^\
M5S>*K/3=2O\`P78^&=8_M33NW_:0_9/UC]HN'Q7X3U3XX>-?#?PC^)GA*V\#
M_$OX9VOACP%K]O=:%']MCU*\^'7BCQ!H=UK_`,,/%'B.RO(]/UOQ!8/KS6PT
MS1]9\)V/A7Q78#Q%+E6/[$V@6?Q5LO%<GQ$\5WGPHT?XZ>(?VH="^!EQIGAP
M^&]+^/\`XJM-;36?%H\5K8#Q;=>&O^$@\3>(_B/I_@B:[%K9?$S6[KQ#)J]W
MH]II'AC3`#Z.^+/BWX@^%/#-E<_"[X;CXG>,=9\0:)H&FZ1?>*++P7X8T>WU
M2>0ZAXL\:^)YK#7=3TOPKX>L()[J^'AKPKXM\3:C>R:=I.D>'[B6_DN['XC\
M-?MV_$/XC77A[X<?#'X$>'O$/QZG\0_M/Z9XH\+ZS\8XM`^%MMHO[)?CWP=\
M,_B'XE\&?$^'X?ZQK?C#3O$_CSXA^#O"'@8W7PV\."'7Y?%]AXWD\+W7@/5[
M6[]I^)/P%^/?Q,_9J\/_``?;]J;Q-X#^*#GP^GQ`^-?@_P`!^$[?7/%^DV=W
M<7/B;PW:Z182>';7P?:^+K*2#0-1\0>"+SPWXKTO2X[NX\*ZMX>UF\CU2R\[
MT7]B7Q9X?\+?"8>&/CG;_#KXG_!K0?B)\.?!?C?X4?!#X<>"O"UA\%_B9<^$
M;W6OAHOPHNYO$OAA8M&U7P)X1\3^%/$*7_VW2_%GAZRU'4++6M(O_$GA[Q``
M4/"/_!0?2?B)\4_V*O!_@CX1^+;KX>?MD?#SQCX[T;XL^(-<\.Z/I7AJ]\-?
M"JV^*$7@JR\/:?<:YK'BSQ':0/>Z)XTO8_["\+^%M4M8[+3]<\4ZE+>:?I=S
MX"?MI:W\9/CWXK^%^HVOP&\,^'=.\1_&GP[X6L;3XL^/-6^,7B&7X0?$#6/`
MEVTOA+4?@SX?^&TFI!-"N_$?C#PUX5^+GBSQ%X`TG4M"_MW3B+V6>WY76O\`
M@GUXIT[Q_P#LGZ]\(_V@YOAKX!_8V\,3^$_A!\/+SX1^&?'#2:;K_@*U^&WC
MB;Q=XNU#Q+HVIZ]?^)O#=O)<17D6G:?)I>OW=UJ\HU5)%L5^A-+_`&:O$<OQ
M<\)_$+QW\<_'/Q"\,_"[QGXX^('PC\!:QX?\#Z6GA/Q/X^\->,/!E[+KGB[0
MM%LM?\;:=X5\'>/?%GA?P+8:BNGR:?IFJB[\6WOC?Q!IVE:W9`'6^*?VHO@Y
MX*^)>E?"GQ3K/B31/$>M^)-`\%:;J]_\._B)!\/;CQSXLTZ'5O"O@9?BD_A8
M?#@^,O$ME/#_`&)X;7Q0VIWU[/::0D"ZQ?V%A=>/>&_^"CW[(?B_PDGC3PW\
M2=8U71]1\,?"_P`8^$K>#X8?%=/$'Q*\/?&;57\/_#6^^$GA>;P3'XB^+'_"
M2^)(KGPVL'P[TSQ)/I6N6=[8:W'IK6DTB^;_`!4_X)K>!?BU\?T^.OB3Q_J]
MU>V/QU^!O[0GAZSU/P/\/O$7BGPAXO\`@C>^!WT_P9X/^*>N:/=>//"WP:U^
MU\$"\U+X9Z!?Z=8V_BOQ5XS\20ZI/!XCU#0I>-TO_@E3X)\.Z;^S?+X9^+_C
M72O&G[*?[.GP=^!?P?\`&,OA[POJ,NFZQ\%O%5MXAT#XAZOHEVATS5[C7M-;
M7?!WBKPNYM]-O/#/B?56TC4-$U^WT?7-,`/HCX*?M=ZG\=?@K\;_`(L^!OA!
MXAUW5OA;\:OVA_@UX5^'NG:Q!IGB+X@ZE\#_`(BZQ\.].NII/'.F^#8_`U[X
MJOM+6[U;2?$MNLG@I&O;>^FU.?3VCG\LNOVZ_'NC>+?$WP,USX+>%I?VD;+X
MQ_"/X+^%-"\,?%R[UKX*>(-?^,/PM\<?&NQN=3^*FI?#7P_XM\.S^!/A;\,_
M''B[Q[X8D^%&I>)HM-@\&W?AZRU>R^(.CW-EZWX`_9/\2?"3X#?&KX5_#'X\
M^,/#?Q"^,'Q"^-WQ7B^.-YX/\":]XG\&?$+XY^+;_P`::]XBT;PA?:9'X$OS
MH.N:I?3>&]+U72)M(MXA907]EJ$5HZW/E7@3]@CQ'X6^&MCX-U/X[/>>*_!'
MQ:T/X[?";XE^&_A3H'AKQ1X>^+5IHOB7P]XP\;?$:35/$_C&?XV:Y\5]#\6^
M(=#^)>K>--3@UW6])UW5H]/UG1]0.C:IH8!FZ_\`\%$K_0_#'P?U!/@1K6K^
M(?%?[87AO]C?XSPZ;XXT1O!?P-\=ZC\<-#^".IZA<>++K3;36/'2ZA?>)-$\
M7_#W1=&\&:=J/B7P?J,>I>+6^'LMM=VJ>I_'?]L^S^$/Q_\`V<?@1H'@?_A.
MKKXQ?%OPU\,_B+XD3Q(NBV7PAA\=_#SXN>-O`-T]J-&U4^+/$WBB;X0Z\(_"
M45WHCZ5X6BG\6:KJMM'<^&=-\2>1?$K_`()X^+O%/P^^'O@/P3^TIK'@J3PW
M^T#IO[6'CSQ3JOPE\%>,_$'Q0_:(T7XN:;\:-)\8ZJ/[5\+Z1X>\.6OBG3;?
M2CX*T'3$M!X/M-*\/VFJ6C:=]ONNF^(?_!-'X+?$WXB?";XQ^(/$/Q*TWXJ>
M!?CW\/?VCO'7B#PE\3_BUX8\.?%7XE^`?A5J7PLAU/4OAUI_Q)/@CPB=1TRX
MT=Y+CPII%MJ,&DZ!;>$GO;WPYJFNVFI`'Z,J=RJV,;E!QUQD9Q2T@&`!G/J3
MW/<^G)[#@=N*6@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHI#G!P,G!P.F3V&:`%HK\H_BK\<_VVA\?]5\'>`?`GB'2O!7P^^-
M'@D2"+X(>(-;\-_%#X;^-]9_9^\&^&O#L'Q9OC<>'FAN=.\2_M+_`!4^(OC'
MP9!;W/P73X9?#_PUXX%C!JSI\0/U;&<<^_XC/!/N1@D<8]!0`M%?CQ_P4&^)
MWQ'\(_MZ_P#!&SP!X3\?>,O"_@GXM_M,_M#:%\4?"GAWQ-K.B:!\1-#\._LJ
M>.O$NA:+XUTO3+RUM/$NDZ3XBM;77=/TW5X[NRM=7M;748X!=V\,L?ZS1^&M
M)*(3%<DE%)/]IZKR2!_T_4`=#16!_P`(SI'_`#QN?_!GJO\`\G4?\(SI'_/&
MY_\`!GJO_P`G4`;]%8'_``C.D?\`/&Y_\&>J_P#R=1_PC.D?\\;G_P`&>J__
M`"=0!OT5@?\`",Z1_P`\;G_P9ZK_`/)U'_",Z1_SQN?_``9ZK_\`)U`&_16!
M_P`(SI'_`#QN?_!GJO\`\G4?\(SI'_/&Y_\`!GJO_P`G4`;]%8'_``C.D?\`
M/&Y_\&>J_P#R=1_PC.D?\\;G_P`&>J__`"=0!OT5@?\`",Z1_P`\;G_P9ZK_
M`/)U'_",Z1_SQN?_``9ZK_\`)U`&_16!_P`(SI'_`#QN?_!GJO\`\G4?\(SI
M'_/&Y_\`!GJO_P`G4`;]%>;:AJGPTTF\GT[5/%.@:=?VQ1;BRO\`QFEG=P-)
M&DJ+-;7.MQ3Q%XI$D421J6C='7*LI-+_`(27X2?]#MX5_P#"]M?_`)?UT+"8
MJ24HX:O*,DG%JE4:::3334;--2336C3,'BL-%N+Q%%23<6G5@FFFDTUS:--V
M:>SWV9ZM17E/_"2_"3_H=O"O_A>VO_R_H_X27X2?]#MX5_\`"]M?_E_3^IXO
M_H%Q'_@FIY?W?-"^MX7_`*":'_@V'E_>\T>K45Y3_P`)+\)/^AV\*_\`A>VO
M_P`OZ/\`A)?A)_T.WA7_`,+VU_\`E_1]3Q?_`$"XC_P34\O[OF@^MX7_`*":
M'_@V'E_>\T>K45RMAI/AK5+.WU#39UU"QNHQ+;7MCKE_=VEQ$25$D%S;ZE+!
M,A96`>.1ER",Y!JW_P`(SI'_`#QN?_!GJO\`\G5SM--IIIIM--6::T::>J:>
MC3V-TU)*46G&2333NFFKII]4UJF;]%8'_",Z1_SQN?\`P9ZK_P#)U'_",Z1_
MSQN?_!GJO_R=2&;]%8'_``C.D?\`/&Y_\&>J_P#R=1_PC.D?\\;G_P`&>J__
M`"=0!OT5@?\`",Z1_P`\;G_P9ZK_`/)U'_",Z1_SQN?_``9ZK_\`)U`&_152
MRLK>PA,%LKK&7:0B2:>=MS`!CYES+-)CY1A=^T=@,G-N@`HHHH`****`"D/0
M\XX//I[\\<=:6D/0\;N#QZ\=.>.>E`'\V?QFUJ[F_;G^)7CS1?&3"RTWQ1I'
MA'5M0O?"_P`9=#^.H\2^'/C_`/L?:IH7P!^"ZZGX&M_@%\4=7BU3P!:VO@_2
MM,^-7A.VT;P/^U-K7CKX@>&]5TS3_&3>(_Z%/AG\0_#'Q9^'_@_XE>#+N6]\
M+>-_#^F^)-$GN(&M+L6.J6ZW"6][:.3)9W]D[265_9R'S+2]M[BW?+1$G^=O
M]K/1AXA_;5U^'6O"W@+X<^&/$7QN\"^%?#CQO^TK)\:_&?Q2T_7?V7;"Z\7_
M``0_X1/]I;X<_!GP]\8->\%^-O#GQ5T35=(^$_B75M7\*_L]W&K^/XO&6G_#
M[Q!'X7_HH^''@'PQ\*_`7@[X;>"[*33O"G@7PWI'A7P_:3W5Q?W4>E:)90V%
MH]]J-V\M[JFH7$</VG4=5OIIK[4[^:YU"]FENKF61@#\=?\`@I/_`,I)/^"%
M/_9UO[4'_K'/Q!K]O(_]7'_N+_Z"*_$/_@I/_P`I)/\`@A3_`-G6_M0?^L<_
M$&OV\C_U<?\`N+_Z"*`'T444`%%%%`!1110`4444`%%%%`!1110`4C=#]#_*
MEI&Z'Z'^5`'\'G_!7"WMI/\`@HG^TL\EM;2.=<\"Y=[:&1SCX3^`@,L8V=B!
MP,DG``'85YK/^Q8UI\/O@+XHO?'_`(8T_P`6?'KQEX8\/>'?!EWX'\7BUGTC
MQH?ANVC:GX8\9#04\+>,]9T2S^(<.J>,=`T[4[:&S@TS5M*T35]7\0>&O$VG
M6'J'_!6[G_@HC^TL,D9USP,,@X(S\)_`7(/8CJ#SSV-<-I/[8>F^&_@%X<^#
M7A[X3P6KQ>+;/7O&L5Q\1?B`?`FM1Z/JOPJUZVUKPIX6M-:MM0\!>/\`Q'JG
MPV<ZUXL\/ZY;W7A0:_XIOOA^VD7/C75;?2?].,AGG\>!?#7^PU5E?(>'(YA&
MG]026$?#]!*=2>/EI3I57"HZ.&I^WQ,HPHQQ&$C*54_S?SN.1/C7Q#_MKV4;
M9YQ`\"ZGUYMXI9]6;A3A@HZU*E)3I^UQ%3V&'C*=9X?%2C&F>5?$C]G_`,(_
M"KQ=X>T#QKKWQ+\-:/K=CX@NVUWQ3^S!KGAG4';2+M+"P7PYX6U#QZ]QXLMM
M3O/,M[VYM=8TZY\.S"VM[_3KBYO(X$[/0/V.(_%G[1R?`'P]X^T)K/2Y/!NG
M^//B+KO@2[T73OA_XE\8WVCZ!;>#-7\-VNLZW=:EXMM?&WB+1?`":3I.NS+?
M^+9M5LX;F*S\.:U?6V,G[07A#1]4^#MIX5^%6HP?#_X6?&VY^/6I>%_&?Q)N
M?'6O>-?%^HW7A)M2TV[\52>$=`M-&\.OIO@S2K!+>V\,WFHZI=S7VO\`BC4=
M=U*:W2S@^"_[5?CGX/>,K;Q&-"\%>-M)N/C;X7^.GB?1O%WA+PYK&K:WXN\+
MZQ?:I:7.G>+]4TK4=7\.7\::OK::;J5BDXT;4=8O=;L[(ZC*[O[53_71Y?5G
MAZM19A#+L33I0QCR:G"OC:F-G'#XKDPM#$TZ&)P^!IN<:$\15R^I5Q6%5>[P
M^+C/R*;X06/HQQ%*#P$\PPU2K/"?VM4G1PE/!4Y8C#.6)KX>=;"XC&U.25>&
M'I9A3IX;%.BHJOA7#P+P[X`U3Q;XRT_P'X<T>RU/Q%JNMW&A6%OY-I;6[3VL
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M"5JJG_!/?]E5$141?A?:A4151%']N:WPJJ`JCV``K]`Z_/[_`()7_P#*/C]E
M;_LF%M_Z?-;K]`:_R\XY_P"2UXO_`.RGS[_U:8H_THX,_P"2/X3_`.R:R+_U
M5X4****^6/I0HHHH`****`"BBB@`HHHH`****`"D;H?89Z9Z<XQWST(R,CN.
MM+2'H<`$X.`>A]C['O0!_/\`Z+\,/B\/VDOBO\.#\8?CC\6_A;I/[5?AKQ'X
MT\/_`!F_:Z^#'P@>\GU0_"WXB6^EZ%\+?#7[-FO_`!#\0?#+1I(=*'A:UL?B
MC\,1\1;C1M>\/#1+#P_>ZCJ_BC^@`<#\3WSW//X]2.W3M7X)?&+PI\2)?^"A
M>H-%^RCX2\4WFN:_X(U7P3XPN?V0OAKXH\"W,7A_XF_LQW.G^/\`Q1^U#<?#
MG4_$N@>.F^&,O[3[ZK:>(_'OA_5O"MW\-_`__"O?"6MZE_9-WXU_>U>GY^V>
M3R1@8)ZG@<DT`?A[_P`%+8VE_P""D'_!"I$FD@8_M7?M.D2PB(R+M_8\\?L0
M!-'-&0X!1]T;'8S;2K;6'[2QZ3=^6G_%1:W]Q?X=$]!_U!:_%[_@I/\`\I)/
M^"%/_9UO[4'_`*QS\0:_;R/_`%<?^XO_`*"*`,?^R;O_`*&+6_\`OC0__E+1
M_9-W_P!#%K?_`'QH?_REK;HH`Q/[)N_^ABUO_OC0_P#Y2T?V3=_]#%K?_?&A
M_P#REK;HH`Q/[)N_^ABUO_OC0_\`Y2T?V3=_]#%K?_?&A_\`REK;HH`Q/[)N
M_P#H8M;_`.^-#_\`E+1_9-W_`-#%K?\`WQH?_P`I:VZ*`,3^R;O_`*&+6_\`
MOC0__E+1_9-W_P!#%K?_`'QH?_REK;HH`Q/[)N_^ABUO_OC0_P#Y2T?V3=_]
M#%K?_?&A_P#REK;HH`Q/[)N_^ABUO_OC0_\`Y2TC:3=X/_%1:WT/\&A^G_8%
MK<I&Z'Z'^5`'\'O_``5GC>+_`(*&_M)QO/+<LNN>!\S3"$2ON^%7@1AN%O#!
M"-H8(NR)/D5=VYMS-^=5?HU_P5M_Y2)?M+?]ASP+_P"JH\!5^<M?ZM\`?\D)
MP5_V27#G_JGP1_F!QS_R6W&'_94\0?\`JVQ84445]:?+!3D^^O\`O+_,4VG)
M]]?]Y?YB@<=UZK\S^\'_`()<:?<S_P#!/W]E>2/6=4M%/PPML0VRZ48E_P")
M[KAX-QIEQ*<9VC=*QVJ,DG)/WU_9-W_T,6M_]\:'_P#*6OAG_@E?_P`H^/V5
MO^R86W_I\UNONK6O$&A>'+5+[Q!K.DZ'923I:QW>L:E9:7:O<R)))';I<7\]
MO"T[I%*Z1*YD9(W95*HQ'^47&T)3XWXMA",ISEQ1GRC&*<I2;S7%:)*[;\D?
MZ@<'2C#@WA64Y1A&/#.1.4I-1BE_9>%U;;22\VR/^R;O_H8M;_[XT/\`^4M'
M]DW?_0Q:W_WQH?\`\I:YO_A:WPP_Z*+X$_\`"Q\-_P#RSH_X6M\,/^BB^!/_
M``L?#?\`\LZ^>^HXW_H$Q/\`X(J^7]WS1[WUS"?]!6'_`/!U/R_O>:.D_LF[
M_P"ABUO_`+XT/_Y2T?V3=_\`0Q:W_P!\:'_\I:YO_A:WPP_Z*+X$_P#"Q\-_
M_+.C_A:WPP_Z*+X$_P#"Q\-__+.CZCC?^@3$_P#@BKY?W?-!]<PG_05A_P#P
M=3\O[WFCI/[)N_\`H8M;_P"^-#_^4M']DW?_`$,6M_\`?&A__*6N;_X6M\,/
M^BB^!/\`PL?#?_RSK9T3QIX0\2W$UIX=\4^'->NK>#[3/;:-KNE:K<0V_F+%
MY\L-A>7$L</FNL?FNBQ[V5-VY@#,\)BJ<7.>&KPA%7E*=*I&*6FK;BDMUN^I
M4,5AIR4(8BA.4OAC&K!REI>R2E=NVMDOR9NVEO);1&.6\N;YM[-YUV+42@$#
M"#[);6L6Q<$KF(OECN=A@"S117.;A1110`4444`%(WW6Z]#TR#T[$9(/I@9I
M:0]#SC@\^GOSQQUH`_$KQSHFJ7_[4'Q6^'FM)\2?#O@GQ=^U/\%/BU?>(;']
MAG]I[XM>+M6U[P7I?PFE\(W/PU_:X\%V$?PA\!^#K6[\*-X7UN3Q=X9U;5/A
M!H5WXZLM,\577A[Q/8ZEX2_;4=/7KZCG//7MZ>V,$BOYX_C3-XTA_P""BOB#
M4],\>31^`)_&GP]\`>,OV@H[?X__`-B_!/Q%J/Q0_9%^(?@GX%ZQ?:1\*]8^
M`\6I1Q>!/$GA'1()?B=X8T.2?]IZ>/XLV<>M3S:-\0?Z'%Z#\?PYZ=!]WIT!
MXY`-`'X@_P#!2?\`Y22?\$*?^SK?VH/_`%CGX@U^WD?^KC_W%_\`017X?_\`
M!2U9F_X*0?\`!"H021Q2_P##5W[3I5Y8FF0`?L>>/RX,:RPL=Z!D!$B[&8/A
MMNUOVDCM?$/EI_Q.-+^XO_,"N/0?]1R@#?HK#^R^(O\`H,:7_P""*X_^7M'V
M7Q%_T&-+_P#!%<?_`"]H`W**P_LOB+_H,:7_`."*X_\`E[1]E\1?]!C2_P#P
M17'_`,O:`-RBL/[+XB_Z#&E_^"*X_P#E[1]E\1?]!C2__!%<?_+V@#<HK#^R
M^(O^@QI?_@BN/_E[1]E\1?\`08TO_P`$5Q_\O:`-RBL/[+XB_P"@QI?_`((K
MC_Y>T?9?$7_08TO_`,$5Q_\`+V@#<HK#^R^(O^@QI?\`X(KC_P"7M'V7Q%_T
M&-+_`/!%<?\`R]H`W*1NA^A_E6)]E\1?]!C2_P#P17'_`,O:1K7Q%@_\3C2^
MA_Y@5QZ?]AV@#^%[_@K;_P`I$OVEO^PYX%_]51X"K\Y:_17_`(*SK,O_``4-
M_:36XDBEF&N>!]\D,+01MGX5>!"FV)YKADVH50YF?<RE_EW;5_.JO]6^`/\`
MDA."O^R2X<_]4^"/\P..?^2VXP_[*GB#_P!6V+"BBBOK3Y8*<GWU_P!Y?YBF
MTY/OK_O+_,4#CNO5?F?WJ_\`!*__`)1\?LK?]DPMO_3YK=?&G_!P)%%+^Q=X
M$66**9?^&CO`I"RQI*H/_"$_$L9"R*R@@$X.,C)P:^M_^"7$&LO_`,$_OV5V
MM-2L+>'_`(5A;;8YM)FN9!_Q/==(W3+JMLK$*57B%02I;`S@?'7_``7UAU6/
M]C3P*U]?V5U%_P`-%>!PL=OILMG()#X*^))5S*^I7BE54."GE`L6!WKMPW^<
M_#/_`"D#2Z?\;"S?_P!66.[=_P#AS_0#B3_DQ%3_`+(+*/\`U78$_F1_9G_9
MDB_:&UCQE%/KMKX/\.>`_#-YX@\0ZO8^!==\>ZQ%OT'Q9JFDM!X7\*Z==ZA_
M8PNO"MQ%K^O7;VMCIL=QI^EVC7OB3Q!X?TN\I^!OV9IO&_A7XV>-+;Q3X,B\
M-?"3PSXYUK0=9L](U'4;#XOZG\/[6PUGQ!I/@/[39Z/J%O8V/A;4;#Q)J>O:
MYI]LFBQ:UX8T>_TL:WXAMK.WL_LT?&_P]\"/&]WXMUSP-J'BJ=]%\066CZUX
M8\=>)?AUXY\*ZAJ?A#Q7X;CDT'Q+X?NEC72]5D\10?\`"06E]875U:MIFD>(
MO#EW8:_H-I'?^FC]NKXDWU]\1[GQ%X$^#FLV7COP1\;/"&G:7_PK'P<B^$'^
M..KC7O$EU::Q?:+J6NZ_IXU=I;W4=,UV_FN/$TZV<NL:KYFGVAB_N3,I\9+-
M<PCE<(SRYTLKGA*F(K8"A"DX3JRS"EAH>RQ6(Q-7$.-.G6JXZ6#IT*%2:PM*
M5:%/$5?XMR^'"#RO`2S*4H9@JN9QQ<,/2QU:=13C2C@*F)FZV&P^'HT%*I.E
M3P4,74K5H1>*J*E.I0I\'X2_9`\6^,_AEX2\=:1<^'!XD\?_`!7^&?PU\&_#
MBZTSR-8U'2OBK+XYT_PI\1=3UIR-.T+PMJ.M?#SQ3::?#<VMQ>ZCI&DWWBF)
MH=&6P;4^.^.GP)TGX+)X:G77[KQ##XAM_$-PL6O_``;\<?"C4C9>'KFWMT\3
M:'8>-[$Q>*O`?B99WG\*>)]+OX[ZY%G=VWB#PYX;NQ:PW?NGAG]O7XL>&]-5
MT\+?"B[\8V'Q)^`7Q#T+QI%\,_!>B:CI_P#PS[IFO:-X7T6[30]"L;J^\_2-
M4L-#MM:@U+3M3T#0+/5M*TL[/$VH31>?^.OCYX*\9^'])\#I\+/$5GX$TGQ#
M\8OB-'IVL?&77?%?B@_%;XL^']*T:'7HO%VH>%;1H/!?@^Y\/Z'J,7@;^QY+
MOQE+;WTOB[Q;>:EJ":E93A*O&T<VYL?1A/*UB*LU2P%?+9*5">`<U2J5<53P
MN+DJ&-]E0P<J4*-7$5'B:V.G1PJH0=8JEP=+*^7`UIPS*6'HP=7'4<?%QKPQ
MT8.K3IX6>)PL77P?M:^,C4E6IT(+#T<#&MB95Y)?&W[)W_"(^%_B1?6OC'P]
MXB\=?!+PQ\*_&7QH\!6?@G6-/MO!OAWXOGPY%X<NM&\=7;2Z+XQN-)O?&'A;
M3_$MM#IVA1)+J\EWX7N_%6FZ3J=Y#^H__!O7;V\/[4WQL:*WMX6/[/RJ6B@B
MB8C_`(63X6.TM&BDC/."<9`.,BOS1\3_`+6OB#6O@?<?!C3--\5V-MKOA?P!
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M$MO:O9QA"!M7RGNKQBP.XE_-`;(`1<9-JO\`.,_T'"BBB@`HHHH`*0XP<\#!
MS]*6D;[IXR<$@<]1R.G/7N.1VYH`_,+XQ?LZ_LT>/=8^*?Q+US]JCXX^#-#D
M^+_A6U^(?AWX<?M#WWA?X>:%\9-$O?`'A?P[I-_X.T73;NPM/%*Z]??#P76D
M7T-U+J6OW?AN^UFWN[I-.D@_2'POH:^&/#7A_P`-KJVN:\-`T73-%&N>)M2D
MUGQ'K']EV<-E_:FOZO+'%+JFM7_D?:M3U&2*-[V]EGN'16D*C^>/QC\'_AW^
MSM^U/\1?B+\.?V7$T;7_``O^TY\/_%'A#PK\,O\`@EOXU^*W@#Q)X4\2VWP_
MO?B3\5)_VD_#?P$\5^-?#_Q'L%N/'.IZ;/\`"/QSX?\`"W@SQ%HF@:9#\/O&
M=_J>N:CKG]$'AW7+7Q-H&B>([&VUBSLM?TG3M9L[3Q#H.M>%M>M;74[2*]M[
M?6_#7B.PTOQ!X>U:&&9(]1T37--T_5]*NUFL=1LK6[@EA0`_%G_@I/\`\I)/
M^"%/_9UO[4'_`*QS\0:_;R/_`%<?^XO_`*"*_$/_`(*3_P#*23_@A3_V=;^U
M!_ZQS\0:_;R/_5Q_[B_^@B@!]%%%`!1110`4444`%%%%`!1110`4444`%(W0
M_0_RI:1NA^A_E0!_"%_P5M_Y2)?M+?\`8<\"_P#JJ/`5?G+7Z-?\%;?^4B7[
M2W_8<\"_^JH\!5^<M?ZM\`?\D)P5_P!DEPY_ZI\$?Y@<<_\`);<8?]E3Q!_Z
MML6%%%%?6GRP4Y/OK_O+_,4VG)]]?]Y?YB@<=UZK\S^]7_@E?_RCX_96_P"R
M86W_`*?-;KXW_P"#@#_DS#P)_P!G&^!?_4)^)=?9'_!*_P#Y1\?LK?\`9,+;
M_P!/FMU\;_\`!P!_R9AX$_[.-\"_^H3\2Z_SGX:_Y2!I?]G"S;_U98X_T`XD
M_P"3$5/^R"RC_P!5V!/X\****_T8/\_@HHHH`*_>[_@WN_Y.D^-?_9OZ_P#J
MR?"U?@C7[W?\&]W_`"=)\:_^S?U_]63X6K\P\:/^37<9_P#8LI?^I^#/TCP@
M_P"3E\(?]C*I_P"H.+/ZZJ***_S&/](`HHHH`****`"D;[IYV\'GTXZ_AUI:
M0]#]#VS^@Z_3O0!^"7Q>\$?$.X_;=\;?%;2/B9X9M_A7I_Q0^%_PC\<?&6;7
M?C!!XL^%'B76_B9^R5\1_"/PJLO">F_#G5OAEKGAOP\?AWX@\#W'B>T\?^&O
M!V@ZE^U!J$'Q:L[C4['Q18>*/WM7@=N_3H.3P.G"].@Z=*_'CXK?#G7=;_:Z
MFNM+^"FO?\('/\5_AYXO\<_$F;Q?\;X/AW>^(_#9\#Q:%KFJ_L7^&_B5IVA?
M'+Q)IM]I'A_1[7]IZ]\/6OP\\#ZC9>'-9\0^&_&5U\*7NK+]AUX'Y_S_`%^O
M?KWH`_#W_@I:9E_X*0?\$*C!''++_P`-7?M.[4EE:&,@_L>>/PY:1(9V4JA9
ME`B;>P"$H&+K^@/QP_;>_9[_`&:/$.B^#_CI\3O`GPX\2Z]H"^)=(TG6M2\6
M7%S?:%]ON=*_M*)M(\"ZG`L/]H65U:[9)DF\R%SY?EE7;X"_X*3_`/*23_@A
M3_V=;^U!_P"L<_$&OS._X."V8?M2?!(!B!_PSU&<`D#/_"Q_%O/%?H_A3P;E
MW'?&.$X=S3$XW"X/$8/'XB=;`3H0Q*GA</*K3498BAB:7+*2M-.DVULXO4_/
M?$_B['\$<)8K/\MP^$Q.*H8O`8>-+'0K3P[ABL1&C-RC0KX>IS*,FXM54D]T
MUH?N+_P]K_8/_P"CD/A9_P"!7Q"_^=I1_P`/:_V#_P#HY#X6?^!7Q"_^=I7\
MG'PC_9W^'OQ"_9>^*OQ0M[CQ[XT^)_A*1)I/#OPXU;P1=W_PWM+-_%,MG=^*
M?AMK&H6?C+Q;X:\2Z?I%KKFN^)M`9(_#GAM;R?0+;5-7\.>)K.6]X*_9[^!?
MQ1TOPM?^'/&'Q)^'WAV_^.OPH^"UM\3_`(F7'A&+PW\6'\96VHR?$#5/`OA@
M:?H<W@_5OAR]E87<NG:KXL\8Z%:Z9XI\,VWC+Q!H&M7T$-U_0-7P%\,J,\?"
MIGG&J668WZCC:D7E<XT:SIT*D)<D,GE7G"K]8BJ,8495JU.%;&4Z,LOI3QB_
M":7CAXC5H8&<,FX/;S+!K&X.#_M*#K4O:5:<USSS6-&$J?L)NM*=6-&E4G2P
ME2K''U:>$?\`5S_P]K_8/_Z.0^%G_@5\0O\`YVE'_#VO]@__`*.0^%G_`(%?
M$+_YVE?RE?$']GCX:_#?PMX&^)WC?P/^T;X$L?&&M?%#X?Z=\`?$FH>&IOBQ
MK/Q&\#WO@0^&U/BN#P+9CPSX5\7:#XWN+^4W/PRUG79=>\*7&B>#H]=TWQ3H
MFN6?E_B[X+>"?"_[4_ACX*W'B;5M+\&ZIXH^$VF>+KCQ1K/AK3O$OPV?QQI_
MAG4O'/@?Q=XDB2/P?;^+/AA=ZQJOA37M=-K9Z-!J^D27&IZ9ILMOJ.EVNN$\
M`/#7&QE.CGG&3A'#9CB?:>VR2I3E'*<3#"YA3I3HY75A7GAZU2G!U*+J86JY
MJ-#$591J*&>*\=/$/!RC"MDW"2G+$9?A^3V.<0J1>:8>6*P%2K3JYC2G1AB*
M-.I/V=:-/$TE!NOAZ,94I3_L%_X>U_L'_P#1R'PL_P#`KXA?_.TKZM^!_P"T
M5\/?VD?"-YX\^!_B;PE\1/"%AKU[X7O-<T;5]?M[6#7].M-/O[W3'35O!^FW
M)GM[35=/G=E@:$I=1A)68.J?P5_'3X<:%X,M_"/B#P3I$$7@SQ%/XGT>+Q'I
M/QO\._'+1M0\3^&+C3&UGP^VM>'O`7P^'AW7?#UAJ^DW&HZ1>Z9?PZI9ZOIV
MN:%JM]I$RS-_4;_P0"9F_8M\;[B3C]HSQX!DDX'_``A?PUXYKXKQ,\&N%.$.
M!_\`6K),RS[$XAYCAL$L/F6)RFO1@JE:O0KJI_9V#BO;4JE&47&.*E[.:E"K
M%5(RA'[#PZ\7>)^*N,UPQG.79)AZ"R_$8QU\OP^:4:LG3I8>K0E#Z_BI-T:D
M*ZE>6&C[2+C.E-TY1E+]JOM/B+_H$Z1_X/KO_P"9^C[3XB_Z!.D?^#Z[_P#F
M?KR#]J#XZ6G[-'P#^)_QVOO#=YXOM/AIX;?Q%/X;L-2MM(O-71;^QL?LMOJ5
MY;W5M:.3>B7S9K>5,1E=F6!'X9-_P<4>"P6'_#*GC;Y2<G_A:GA4#"YR3_Q3
M'``&22<`=37X]PQX<<:<98.OF'#623S/!X;$O!UZT<;EN&5/$QI4JSI.&,QF
M'J2M2KTI\T82@^;E4G).*_6>)/$+@_A'&4<!Q%G,<NQ>(P\<71HRP68XESP\
MJM2C&ISX/"8BG&]2E4CRRFI^XWRV<6_Z+/M/B+_H$Z1_X/KO_P"9^C[3XB_Z
M!.D?^#Z[_P#F?K^=+_B(I\%\?\8J>-OFQM_XNIX5^;<,KM/_``C'.X<KC.1R
M,BC_`(B*?!>0/^&5/&V3G`_X6IX5R<#)P/\`A%^<#D^@ZU]+_P`0)\5O^B3J
M_P#AVR'_`.>G]6?E?YW_`(C;X8?]%13_`/#5GG6W_4L\_P`/2_\`1;]I\1?]
M`G2/_!]=_P#S/T?:?$7_`$"=(_\`!]=__,_7\Z7_`!$4^"\D?\,J>-LC&1_P
MM3PKD9Y&1_PC'&1R,]::?^#BSP0&VG]E;QH&/13\5?"@8YZ<?\(QGFC_`(@3
MXK?]$E5_\.N1>7_4T\_ZNKG_`!&WPO\`^BIIZ_\`4KSSR_ZEG]6]+_T7_:?$
M7_0)TC_P?7?_`,S](USXBP?^)3I'0_\`,>N_3_L7Z_%K]E#_`(+4^%_VI?V@
M?AU\!;#]GOQ5X,N_B#=Z[:P^)M0^('A_6;/2SH?A77?%#/-IEGH-G<W0N8]$
M>S18KF(QR7"3,62-D;]P"<J3ZKG]*^&XGX2XAX-QU'+>),NEEF-Q&$ACJ-"6
M(PF)<\+4JUJ$*O/@\1B*23JX>M#DE-37)S./+*,I?:<-\59!Q=@JV8<.YA',
M<'0Q4\'5K1P^*PRAB84:%>=+DQE##U)<M+$49\\8.#YTE)M22_@]_P""L[3M
M_P`%#?VDS<QQ13'7/`^^.&9[B)<?"KP(%VS/!;.^Y`K-F!-K%D&X*';\ZJ_1
MK_@K;_RD2_:6_P"PYX%_]51X"K\Y:_TXX`_Y(3@K_LDN'/\`U3X(_P`X>.?^
M2VXP_P"RIX@_]6V+"BBBOK3Y8*<GWU_WE_F*;3D^^O\`O+_,4#CNO5?F?W@_
M\$N)M93_`()^_LL+:Z=IT\(^&%MLDGU:XMI2/[=UP#="FCW2J2H!($SX)(R<
M9/QU_P`%]9=5D_8T\"B^L;"VA_X:*\#D26NISWDAD'@KXD[5,4NE62A""Q+B
M8E2H`C8,2OVS_P`$K_\`E'Q^RM_V3"V_]/FMU\;_`/!P!_R9AX$_[.-\"_\`
MJ$_$NO\`.?AK_E(&E_V<+-O_`%98X_T`XD_Y,14_[(+*/_5=@3^/"BBBO]&#
M_/X****`"OWD_P"#?E[U/VH?C4;&WMKF7_A0*ADNKN2S0)_PLCPMR)(K*]8M
MG^$Q*,<[\\5^#=?O=_P;W?\`)TGQK_[-_7_U9/A:OS#QH_Y-=QG_`-BRE_ZG
MX,_2/"#_`).7PA_V,JG_`*@XL_KAM'O'B+7UO;VTV]@([:[DO(R@`VMYTEI9
M,&)W`IY)"X!#MG`LT45_F,?Z0!1110`4444`%!&01R,C&1U'T]Z*0G`)P3@$
MX'4X[#W-`'Y'?$O_`()]?%/Q=^V7<_'/1OB!\-['X=>*+O1M4\4:YJ'ACQ)-
M^T%HHT/XC?LV_$C3?"?ACQ-:7G_"-W_A_0]3_9R72_`-]J1TL_#[2OBKX^`\
M.^*KIS<:M^N(&!^?ZG./H.@]J_';]HC]KOQCXH^+OB/]G>U^%_AW6/#'@#X[
M?"[2?B1HU_K/Q,TOQ_K7@OQ#XR_9MTCX5OX6O?!6I^$K3P]XN^)/CCXD_$3Q
MOX(^VZYXE\-ZU\-/V</'%MXDT=HM<U^?P1^PEM"EO;PP1F0QP11PHTLTUQ*R
M1((T:2XN))KB=V507FGEEFE8EY9'D9F(!^(W_!2?_E))_P`$*?\`LZW]J#_U
MCGX@U^9O_!P9_P`G2_!'_LWJ/_U8_BVOTN_X*6R-'_P4@_X(5ND,EPP_:N_:
M>`BA,0D;=^QY\0%)!GEABP@)=MTBG8K;`S[4;\R/^#@*XEN?VH?@F\ME=6+#
M]GQ%$5VUFTC#_A8_BT[P;*[O(@N>,-(KY_@Q@U^Z_1R_Y.AEO_8LSC_U"F?B
M?T@O^3:9C_V,LG_]3J9^57@/]I_XF?#CX:Z]\-/#,?A*&WU0Q)HWC&Z\'^'K
MGX@^";.=O%7]N6/A+Q=)IS:M91ZY%XR\011W-U<75]X8.K:S/X2N=&GUF^=G
M>//VE_%'Q"/@R35/AU\#=)N?A[!X7T_P7+X=^&\]I8>'=`\)SI<6/A/3O">K
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MK'6-,\87MKITM]%#%9K`_E%%52R/*:,JDJ6!HP=:G"E623Y:T(5I8A1K0;<*
MMZ\ZM:4JD92G4K5YS<I5JKDJF<YI6C3C4QM::HU)5:+;7-1G*E"@W2ER\U)*
MA2I4HQIN,84Z-&$%&-&DH>G>/OBQK_Q`TWP_X?GT3P-X-\)^%[S7=4T3P;\-
M_"D'A#PQ;:YXG_LU?$7B&XLA>:G?:CKFK6^C:-827NH:G<QV.DZ3INCZ-;:9
MI=JMHW]8G_!`'_DRWQQ_V<9X\_\`4+^&M?QVU_8%_P`$"[VXMOV,?&Z1:3J%
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M?_@GY^U-')HNIVB'X9RYGN)-(:),^(=!&6%KJMS,<9R=D+'`/&<`_P`)EAJ.
MH:/JEAK&DWMWIFK:1J-KJFE:G87$EI?Z;J5A<)=65_8W4+)-;7=K<1I-!-$R
MNCJ.2"0?F/HV86>/\.N*\%2J^PJ8K/L?AX5K3_=2K9+E4%.U.=.;Y7*]HS5[
M6=U>+^D^D/BH8+Q`X8QE2E[:GALDP>(G27)^\C2S?,)N'[R%2*YE&VL':]TT
M[-?KMXG^&?B'PG^T+\1+J3X2_`R#X3Q>,/!WQ"^+?Q1N_@)K.I6&E_#36KO6
MMOP?M_A!XJL_$%YX4^,WQ,@LM1U*Z\&?#BUTOQ;XFU2ZT/QCH^J^$/AK,=7M
ML'PS\*_AKKWPD\*Z=\.O"=GI8^,WPW_:S\;:CJ7C?X*Z7\0?#?P^UOP'XH^)
M"^'/"7Q/^.^HZ[I'BGX/:I\,O`GASP5'X6G\'W$5O9>+M:M_%?Q)@\3Z+XOM
M],K\T['XH_$_2KS5]0TGXE_$71KWQ!K%WXAUVZT3QUXKT2;6=>U!R]]K>J-I
M&KV(O]6NV.)]0N1)=/&$A$H@CCC3`'BGQ,-/UG21XH\2#2?$=X-0\1Z2/$6M
M+I7B+4!)YPU#Q#I@OQ8Z[?B;]]]MU>WO+KS@)?-\P!J_9EPAFOL:%.6<TZ57
M#K+XJO1HRE'%+!Y?B,(JV,PU>=2%6O2Q>(I8V@X3I4::P.$P^&H8*I[7%S_(
M7Q7E?M:TUE%2K2KO'2=&K7BIX;ZWC\)BG3PF)I0A.G1JX;#U<'74X5*U26-Q
M6(Q%;%P=/"P_4O\`:9^$GA.;X7_$'2?A[X#-OXJ^'/CG]GGP/'X+L/@)_P`(
M8GA'6_$VDW/AK7])^$'QIL-!@\4?M9'XA^-8PTG_``DL&FZO-I<L'CCPOIOB
M*P6+4X_-/A]X/@\2_`_PC\/;?PIXY\#:_JGPR_:"\3:_\1-9_9Z^%&L?#*>Y
M\#Z]X]UN[D\4?%_Q'H]_\2M`2#2=`MOAT^H:'K'AJZ^'7B=--MCHVK3:H&/P
M._C/QC+!H%I)XR\7RVGA.>&[\*6DGBOQ#+:>%;NV9&MKOPO:OJ;0>'+JV:.-
MK:YT2.PGMS&A@DCV+BNOB;Q,FE:EH*^)?$BZ#K-__:FLZ"OB'65T+6-4\Q9?
M[3U?11?#2]5U+S424ZAJ%I<WAE2.0S[XT9>O#\*YA1RVC@)YK3Q$Z&84\?0Q
M5;"QJRA.&7_45*=*;]C7<:W_``I?O8RJ5L1*4<77Q.*G6S*OS8CB7`5LQJXZ
M&63H0K9?/`U</1Q,J49PGCEC6H58KVM%2H_\)_[J:A1P\8O"4</AH4<NH_H%
M_P`$B7\S_@H?^S5)M9/,U3QT^QQATW_"3QXVQQV=<[7'9@1VK^[G^#_@/]*_
MA#_X))R/%_P4._9PD2"6Y==7\>8AA:!97W?"GQXIVFYFMX1M!+MOF3*J0NY]
MJM_=%_:M[L_Y%S6ON_\`/;0/3_L.U_(_TI?^2[R3_LDL)_ZN,[/ZI^C1_P`D
M3G'_`&5.,_\`53DG3<_A=_X*V_\`*1+]I;_L.>!?_54>`J_.6OT5_P""L\CR
M_P#!0W]I.22"6V=M<\#Y@G,#2ICX5>`U&XV\UQ"=P`==DSX5E#;7W(OYU5_8
MG`'_`"0G!7_9)<.?^J?!'\E\<_\`);<8?]E3Q!_ZML6%%%%?6GRP4Y/OK_O+
M_,4VG)]]?]Y?YB@<=UZK\S^]7_@E?_RCX_96_P"R86W_`*?-;KXW_P"#@#_D
MS#P)_P!G&^!?_4)^)=?6O_!+C4+J#_@G[^RQ''HNIW:#X86V)[>31UB?_B>Z
MX,J+G5K:89`!&^%3@C(!R!\=?\%];VXN?V-/`J2Z3J%BH_:*\#L)KN32VC+#
MP5\20(P++4KR;>P8E28A'A&W.IVAO\Y^&O\`E(&E_P!G"S;_`-66./\`0#B3
M_DQ%3_L@LH_]5V!/Y`****_T8/\`/X**7!]#^1I,$=1BBZ[_`-?TT`5^]W_!
MO=_R=)\:_P#LW]?_`%9/A:OP1K]Y/^#?FXEM_P!J'XU/%975\Q^`**8K5K-9
M%'_"R/"QWDWMW9QE<\861GS_``XYK\P\:/\`DUW&?_8LI?\`J?@S](\(/^3E
M\(?]C*I_Z@XL_KTHJM:SRW$1DEL[FQ8.R^3=M:-*0`")`;*ZO(=C9(`,H?*G
M<BC!-FO\QC_2`****`"BBB@`I#G!QUP<?7\>*6LW6;\:7I.IZD8XYAI^G7U\
M8IKRUT^*7[):S7/ERW]])%9V4;^5M>[NY8[:V4F>XD2&-V`!^)?C_P`<0:=^
MWKXD\#^.DO?'&N:G\9_A:WP^NE_X*+?&OX16'@C1]8\.>!?[$\#ZA^S_`/#[
M3='^"MGK<UU;:OXG\-^`/&FNW/CSXY6&NR_VG9:G8ZMIT5S^XH_J>^>Y_P`X
M[=.U?SHZQ^T%\)/B+\?T\->%_BUX5N/A)\:/C=\$?B1XU^%GA#]N#_@G3JGA
M7QE\3XIOA+=?:[%KK6M2^/\`':0>*O"'AVW\0^!_`VN&X\>ZUX5(\$7.E:7X
MIN].UO\`HN7I^)[@Y.3D\<<GG';I@8Q0!^(/_!2?_E))_P`$*?\`LZW]J#_U
MCGX@U^9O_!P9_P`G2_!'_LWJ/_U8_BVOTR_X*3_\I)/^"%/_`&=;^U!_ZQS\
M0:_,W_@X,_Y.E^"/_9O4?_JQ_%M?NOT<O^3H9;_V+,X_]0IGXG](+_DVF8_]
MC+)__4ZF?@Q7>_#OX9^,?BIK-WH'@G3[;4M4L=-DU>YAN]3LM*C2PBN;:T>5
M;B_DBBD<3W<"^2K&0ARX!56(X*OMS]@S_DK/B?\`[)[?_P#J0>'Z_N/Q`S_&
M\+<&\0<09=##5,=E6!>)PT,73J5<-*HJM*%JU.E5H5)0Y9MM0K4W>SYK'\7\
M"9'@^)>+LAR+,)XB&"S/'+#8B>%G3IXB--TJD[TIU:5>G&5X+6=*:M=<O5<)
M_P`,;_M`?]"KHW_A8^'?_DNOG;Q#H.I^%]=UCPWK4,=MJ^@ZE=Z3J=O%/%=1
M0WUE*8;F*.Y@9H9T20%1+$S1OC*DBOZ**_%+XR^(O`EE\6_B7%/\,EUC48O&
MWB-+O4-3\?\`B>"WN[S[?(LUPNEZ-;:6EK;N<O#:)>R/`Q^>[N$`6OQ/P=\9
M.+>/,VS?`YODV"Q5+`Y;3Q=*.04*6$Q$:DL52H.6(GG6?PHSH\DFE&BW5]HU
M)KD3M^Q>+7A)PKP1E658S*<WQF'JXW,)X6K+/:]3%T94XX:=51H1R?(IUH5>
M:*;E62I."DD^=H^;,$]`37]B?_!`$$?L6^-\@C/[1GCO&>,_\47\->E?R:_\
M)YH$)_T+X1?#6'#`JVH+XWUY]J#]WO\`[2\9>2[AOGE<VX6Y/RRP^7F,_P!5
M?_!$/PWI?Q'_`&2?%VMZC_:7AE;7X\^--,&A_#GQ!XG^'_AR86_A+P#<+J%S
MI/AS7+9;C5I'O&2?4))_,F@@L[=U,-I"@[OI$XO&XCPXK1K95B,%1_MG*FZF
M)Q&!G-24JUHJG@\3BXMMWNW522LU=W1Q^`.%P5'Q"HRIYG0QE;^Q\S2IX;#X
MV%-QMA[R=3&8;"25K*R]DV[VTW?V_P#\%5&`_P"">W[5))V@?#.7);Y0/^*@
MT$<DX`_.OX-HK2[NW86EG>7GWF_T.TN;OY0VTM_HT4ORAB%+?=#$*2&(%?W(
M?\%(_ASX7\!_L.?M(^,?#":Y9^*-!^'4MUH^MWOBWQ9KM[I]S_;NBHUQ;_\`
M"0:WJL"S.)',CF`[W82,"Z(R_P`5%W\6?BE=,RS?$?QN4#@B.#Q-JME&"F0N
MV.PN;6-<`DX5%#,2[!G):O"^C)/-(\'9W'`X7+ZM)\35W.KBL?B,/5C/^R\I
MO&.'I9;B83@H\K]H\53DVY1]DE%3E[7TCH99+B[)I8W$XZG47#M)1I8;`X>O
M3E#^TLQ:D\15S'#3A/FNG!8:<>6TO:7?*LRT^'?Q"U`?Z#X"\;W66V`P^$O$
M++OVA\>8=.6,'80WS.HVD'."*_<&T^#?PF^R6GF?"_P#YIM+4R[_``CH9?S?
ML\?F>9NLB?,W[M^>=^<\YK\(+WQ7K.HB<ZAXJUB_$2O'<&_\2ZE>+"KL6:.X
M%SJ$JQ*TF2T<H56?)*ELU^KME^W1\$&M;:.-?&TY@MK:"5K?P_8W""2*".-@
M7CU]NK*2-V"RX;'-=7CYD7B-G$.%7P]ALQQKP\LZ^N0X:AF%/ZO[591[#Z[5
MAB?WRJNG5^KIT:7(X5[<ZG[O-X&YWX?Y3/B99]B<!A/;QR;ZI/B*I@*BKNF\
MS]O]3I2PW[ITW4I^W:K5>93HWY>2\N#_`&P_@[:+H'@1_A?\,+9;L:[K8UIO
M!'A2%+G[(VE6ILAJ/]D6BRFV^T+/]G\X&-9M^TASS^?UU\.?B'8AVO/`'CBV
M$;^4[3>$/$:JLA)`0O\`V:4+$@@88@X^4D<U],?M3?M$?#_XR:-X1L/!DVO0
M7'AG6=8O=7;6+.WTJ.*"_P!.M;2!0\&J7A\SS87+QSK"%4!E9B2*^2[7Q)X@
MM&S8^)-?M6$2+FR\0:O;MY)^XN;>^0B%M@V*/W9V#:/E&/O/"++>-LLX#RC"
MYSRX;,*5;-'6P>>87'O,X1J9IBJE)XC%SQ\G.-2A.%2C_LL5&A.E%<]N>7Q'
MBKF'!N9<<9KBLGOB,!4I9:J.*R7%8%9=.5/+,)3JJCAHX&/*X5HSA6_VE\U:
M%67NM\J_1G_@DQI&KZ?_`,%$?V<6U#2-7T]8=9\=I,U_I6HV*PN_PH\=JB2O
M=VT*Q.[.JJLA5F9E502P!_NE5T>,,C!U*\,GS*>.S+D'\#UK^&'_`()7^(/$
M'B_]O+]GOPGXLU_7?%'A;5-1\;6^I^&O$FM:IKN@:C!:_#'QI?6L-]H^JW=W
MI]W%;7MG:7<"3VT@BN;:":/;)$C#^T27X#?!Z4,R?#SPU9LS"4/I=DVD/%(`
M"6MWTN6S:V+8^?[.8@X+!]P=L_S3])IXU\;Y-]>AA855PIA%#ZK5JU82A_:V
M<^]+VM&E*$W/F]Q<Z22?M'=I?T5]')8-<&YM]2GB9TWQ/C'+ZU3I4YQG_962
MWBO95:L914>5\[Y&Y.2Y(I*_\3G_``5NDC'_``43_:64R1AO[<\"_*9$#`_\
M*G\!<%=VX$CD#&2""."*_.@?,,K\PZ9'(SZ<5^H7_!3SQAK?@+]NS]H#P=X9
M&B0>&]$U;P?;:=IFJ>$_"?B(16]Y\-?!NH7$,U_XAT34]6O(GN[ZZF5;S4)S
M%Y@CA,<,<42?`_\`PM+69-IO/"_PMU`KE2;OX6^#49XV))B9].T[3V"<L%:,
MQSJ&.V8$*5_K?@3$9Y#@C@U1RO+:E%<*\/*G*&<XCVTZ:RG"*$ITJF2TZ=*I
M*/*Y4XXBK&$I-*M4C'GE_*_&N'R:?&7%O-F684ZKXGSYU(SRFA[&%1YMB>>,
M*M/.*E2I",G+EJ2P].4XQYG2IM\J]`^!_P"SEKOQQTWQ%J6D^)]%\/1^'=1L
M-.FAU6PU*\DNI+^SFO$EA:Q(6-(TA*.L@+,S`J<`U[9/^P-XR@AGG;XC^$66
M""><JNB^(,L(8GE*@EL`L$*@G@$@GC->T_L.Z\?$/AGXB2)X;\+:$;3Q'H,3
M)X3T)]'ANQ+HUTZR7T0N[Q9YH=C);R#RF2*21&\S(*_;5\DBV5ZQ@=@ME>L5
M>*4HP6UF8J^T*VQP-K[65MI;#*<,/YD\1_&SQ%X=X[SW(LNS'#8#`X'$X&E0
MP53+LIQDZ,:^78#$3B\55PDZE7GJ5ZE12E-N*J*&B@HK^C_#WP<\/^(.",DS
MK,,!B,?C<;A\94K8R&89IA(5I4<PQ="#CAJ6*A3I\E.C"DU&"4I1<]7*[_G&
M`)`.#R,]#0'177<RKAESN8+CD=<D8_&O1Q\294&;;X?_``ALV(`#Q_#NQNV5
M,@^6%U6^U&)A@*#(\37!"Y\[+.7EC^+'BF)T^Q:=X!TT+M6(Z=\,/A_`]N.`
M?L\LWAVYG0L"P9GED8AF`(!`']BO%YY+^'D^#CKMBLWE2?3=X;+,:MWNF]+O
MHE+^2EALFBUSYKBY.Z_W;*H55NO^@C,L&WZ66ME>W,X_W%?\$KV!_P""?'[*
MI!W`_#"V(*_,"/[<UOD$9!_`U\<_\%_@7_8Q\"*@9G_X:+\#N$569RJ^"OB2
M&8*H+;5+*"V,`L`2"1GZ*_X)P_#'P/\`$#]AO]FSQ7XOT*+6-<USX<6]UJ=P
MUYJ5C9S.=9UF,Q0:/I=[8Z+866Q`!IVGZ=:Z>"TK"V#33%_E7_@M]X7T#X3?
MLD^#?$?PSTR#P+X@O/CYX+TBXUOPN9-(U672KGPA\0[FXTUK^V=;D6%Q<VEI
M<7%HLBP336MM)*C/!$5_SZX<EB?^(\TI1I8=XO\`U^S5^QEB*BPWM?[1QO-#
MZRL*ZKIIW2J_4U.22;HQ;Y5_=_$4</\`\00G&=6NL+_J-E2]M&A3>(]E_9^"
MY9_5GB5351JSE2^M.,6W%5II*3_DHM_#GB.[)6T\.>(KM@@D*VN@:S<,(S@"
M0B&Q<A"64!\;267!Y&?7/A#\+O%>I?$SX=Q:_P##OQ1<^&KOQ9H@UD:MX1UU
M-&FT=KD->G4);K3XK46!@#&=II%BV9RPS7G5S\0_B#>+LNO'OCBX7?YI67Q?
MXC=?,^;Y]IU/:&^9N0``"0,"MKX;^/WT'XB^"?%GB7Q#KEWH>B^*]'UG6[@Z
MKJ.KN]CI]VDMVYAEOG6]D14&(I')9E"DJ0"/[PSV'$]?(\YAAUE]+$3RG,84
M(858[%XF=>6"JQI0P\X/!2C7E4:5&48N2J<MHR=K?Q%DL^&Z.=91/$/'U*$,
MTR^=>>)>"PN'C1CC*$JL\1&7UR+H1IJ3K1<DG3YKR2LG^S7_``H+X(_]$F\`
M_P#A.VE?FE^V7X0\*^"OB9H&E^$/#NC^&M.N/!%C?3V.BV4=C;37LFMZY`]U
M)%'PT[0P0Q-(>3'%&O117VFO[;/P&8`KJ/BY@P#*5\(7;!E(R&4B[(((.002
M".0<5\#?M2_%CP9\7?'FB>)?!=Y>7&DV?A2ST.:;4K$Z9*=2BU?5[MX8HI9I
M?-7RKR':Z/EI"\87<AS_`"]X)9'XGX'CS"XCBC!\94<H679C"I/.GFSP*KSI
M0]@I?7).A[1RYE3O[SE?E/Z4\9,X\-\;P1B*'#.+X1K9J\PRZ=.&3_V5]>="
M-3]]*/U2*K>R47%5>5\NW-H?-U?O=_P;W?\`)TGQK_[-_7_U9/A:OP0!!S@@
MX)!P0<$8)!]"`0<'G!!Z$5^]_P#P;W?\G2?&O_LW]?\`U9/A:OZ!\:/^37<9
M?]BRE_ZGX,_"?"#_`).7PA_V,JG_`*@XL_KJHHHK_,8_T@"BBB@`HHHH`*S-
M:6]?1]533ED;4'TV_6Q6*XMK25KQK286JQW5[9ZC:6SF<QA+BZL+VWA8B6>T
MN8D>"33I#G!P`3@X!Y!..A&1D?B/K0!_/A=?%#XE_#+]I?PA\'_$_P"TWXOO
MM8TSQM\(-/\`$7A?Q!^TO^QG)K\=YXJB\'ZO?^'/$?@OP;_P3EAUBVGEDUJX
ML+31XO'7@_Q!XGT-M-U[2M1\*0>(]*OK+^@\'(_$C\B1Z#_/4GK7Y.7W@WX[
MZ#^U5\2]4L-#_;@T7P%XK^-?@OQ%IK?L^V/["WAW]G;6-"7PSX`TC6==\?6O
MQ1\3:M\?=7U.^O=)U2'XH^(-)@TC4]:T*RLD\$Z':ZA8Q27/ZR#\>IZX]?;M
MZ=\=><T`?AY_P4ME2#_@I!_P0JD?>5'[5_[3JXCBEF<F3]CSQ_&N(X4DD;YF
M&=J$*,LQ5`S#\QO^#@"]@OOVH/@E-;B?8/V?$0^?:W=HV?\`A8_B[[L=W!!(
MR_[2H5R",Y!K]/?^"D__`"DD_P""%/\`V=;^U!_ZQS\0:_,W_@X,_P"3I?@C
M_P!F]1_^K'\6U^Z_1S_Y.AEO_8LSC_U"F?B?T@O^3:9C_P!C+)__`%.IGXL>
M`/A[>>/IO$$@\3>"_!>@^$M%CU_Q/XL\>ZW<Z-H.D6%SJEEHFGQ)%I6E:_XC
MUS5M5U?4+6QTW1?#?A[6=2F)N+R>"VTVRO+V#Z7^&?P3^-_P]^)MYX5\+_$W
MX,^`_B/KNL>'OASX,T[6O'6DW]Q\6K[QQH7A[QUX/A^'D4'AWQ'#<^'_`!=H
MVL^%+_0_&7B:'PCX;GN]<T[19]8MM575;#3O#_@=JOP.T'Q7>ZW\=/#WC#Q9
MI&F:---X2\.^&].T75-#U'Q>]Q%':-\0]/U/Q5X,U#5?!-G:&>ZOO#GA_P`1
M:1>^)[I+?2-2U.ST*74%NOH_P#^T[X(\&_%_7?C+>^,?VA]5\8:EXLMM5\0Z
MII>A?![1]/\`C#X"33M'C;X3^+?!MYJ&JZ-\+]"M7L-0\+65]X(OO%NG1>`-
M0M--L/"NBWNAV,<W]M\2_P!IXU9KEM/+Z698"IELDL'C\KAB<!B\5*>%EAJ#
ME5CBJ6)I<ZKK,/;8=J,:V!AAJ--4<PS"A_&W#O\`9N$EE>85,?5R_&PS&+^M
M8',IX?'87#0C7CB:T8TY8:IAZO)*@\![*O=NEC9XBK4E6R_+Z^+X`^,7[4'C
M^?QBX^*OACP9H/PZT4:]X^\7>.M.T'2_#GA2QE\06/A.P@O6T;PAXBUO4M7U
MCQ1J5EH6C:-X?T36-1U"]DEDC@6PM+R\@PO%W[*/Q\U/Q!K&JZZ_A'6O%7B+
M6X=8@ATKQ#!=/XR\/Z_J_@.P'Q5\.7ECI4/AJ?X<S7/Q/\%:@^KS:CI=[#HF
MJW6M?V!'INBZQ+9<]\+OBI\-/`.LZS<I#XZTS0_B+X"\2>'_`(B^%8?!OPJ^
M(W@>VU2Y^('_``DGA30K#P)\1)UL?'?P_P##^A:9H#6<OB'6O"7CC1O&MHFM
MZ1JSZ=8FQU?VV]_;@BU3XE>-/&6J:1XUU#POXD3X:>`]-\"7NKZ++H-A\*?!
M7@G3O`NOZOJGA^R33?!^I_%+Q5H_ASP]8O!:Z#I_@O3M$NO$^@6VVPN=):R\
M2EDN*R',\76X1X2X?RFA/"VJ3P638++L3B8TZV`A3PDZF&IT%4]I7>98FI)X
MFI16#PN$Y*='$585\5[-7.,-GF6X6CQ5Q3GV:5H8E.G3QN;XW'X?#RJ4<9*I
MBH4\14KNG[.@LOP\%]7IU7B\5BO:5*M"G.CAOS\NX8K:[N[:"]L]2AMKJYMX
M=2TZ2673M1BMYY(8M0TZ::&WFFT^^1%N[":6WMY9K2:&62"%W,:_U\?\$#=6
ML[#]C'QM%<?:M[?M$^.I!Y&GZC=IM;P9\-U&9;2TGC#90Y0N'`P64`J3_)W\
M3_$7AWQ;X\\1>(O"FB_V!H.IS::UEIQL-*TAY)K/0M)TW5M8FT702=!T.X\3
MZW9:GXHNM"T)GT;1+C6I=*TR22SM(9&_K6_X(`_\F6^./^SC/'G_`*A?PUKX
M_P"D5.=7PK56I3E1J5,UR2I4I5'%SI3FJLITYN"47.$FX2<4HN2;BK6/JO`"
M$*?B:J=.<:M.&5YQ"G5@FH5(1G0C"I!2O)1G%*45)\W*TGK<^K/^"I6M6-W_
M`,$_/VIX81>;V^&<F/-TO5;>,9\1:`@+2W%E%$@W,!EG`YR<#)'\(P4O.J+$
MT[/.B+;J)6:X9Y55;=5@*SLUP2(0L#+.QDVP,LI1A_>?_P`%4_\`E'O^U1_V
M3.7_`-2#0J_@M?[[=B&)!'!!!R"".00>01T->-]%G_DBL^_[*C$6_P##3E'F
MOP:_4]CZ3'_)8Y)_V3='_P!6>9>7^9^G7Q['[0'PT^'OAN'XB^"KOPK\:KWX
MM>$O$7PX_P"$6^$UEX/\%_LQ>'KCPQKVAZ;\'M(\<0>&HM&U#7_'TNM:'=ZC
M\.;?6_%UIX'T_P`'6^I>(-:N?B)J^N6]AX/^U%-XR\>?&7QKX1WZ]XXT#]F+
MP[<>"/%'BJSTZQEU<^'O`.OV>A_%#XH>([K3;.S9QK7Q%UK4GLKB1)4TG3+S
MPGX>L(TMK*(/\A275U*BQRW5W+&A!2*6[N98D*Y*E(I)6C1E))5E4%23@C)S
M#N;+'<V6SN.YLMDY.XYR^3R=Q.3R<D`U^XY9PU]0GAL1*I@)XO#PQB52AEJP
MU&$L94PE_JU%8JK/"T\/AZ&(P]"E&O/GEC*^*Q=3%XNMBJ^*_&,QXB>.A7P\
M:>-AA:TL(W3K9D\16G'"4\2DL35>%IPQ52O7K4*]:I.C!1CA*&%PM/"X2EAJ
M.&_93Q[<:CX7UKXK3:O\/K?4?#"?''PA\//V!QX.T7P/H&KW/@CXB>$?B#X5
M75_@?K\V@76F^(]+T/P=?_"_QU-KGB*/7]#TSXG_`&&^UC4-,\6:IJ\Z?,O[
M8/@CPN^A:-\3/A]?^&+/P%>>,-<LK30O#NBI!I6J^*_&7B'XA77C37="\6PM
M;V_BB+2=;^&\VB/H-MHFCVG@SP-/\+[^SB_XK&^@B^!`2-FTLOEJRQ[6*^4K
MN972+!'E*\K-*ZQ[5>5FD8%V+$YP%R=JEF5<G:K.$#LJ_=5G$<8<J`7$408D
M1H%Y<MX0GEN+P6,IYFG5POLX584\&X4,10CA*6%G!4:F+K0H5JTZ=3&5,3"]
M66-Q^9UI.2Q:A2ZLQXKAF&$QF$J9=^[Q/M*E*<\6IUZ%>>)GB(3=:&%HSKTJ
M4)PPE/#U+4HX/!9;1BHO"N57]&O^"2D\=O\`\%#?V;YI/,*+K'CL$10S7$A+
M_"GQVBA88$DE?+,,[$;:,LV%!(_N>_X233-G_,0^[_T!=;]/^P;7\,W_``2-
M_P"4B7[-O_87\>_^JF\>U_=O_!_P'^E?R']*7_DN\D_[)+"?^KC.S^K/HT?\
MD3F__94XS_U4Y(?P??\`!6:9+C_@H;^TG-&)`CZYX(`$L,UO)E/A7X$C8-#.
MD<J89&`WHNX89<JRD_-_P-^$/@3XLZMX7\*:W\4=1\,>.?B)\0]*^&G@/PGX
M<^'UWXZNUU/5X;(6OB[QS*/$/AS^PO`O]I:C;Z:9O#L7BSQ.T=CXCUF30K?2
MM`+ZE]*_\%;?^4B7[2W_`&'/`O\`ZJCP%7SI\'?CMX;^$_A#Q?X>?X2Q:_XE
M\9O/IVI?$S2/B9XD\`^.K+P/>6"66J?#W0M0TS0M=C\/:#XA8W+^*M2T!=+\
M1^);*X7P]J>JOX;CGTJ]_JWAS^TGX:<'K*5B'CY<)\,QHO#2RZ$X.648).K/
M^U+X:5*E_$J4DG5JJ/LJ<J;FZM/^8.(/[/\`^(B\6/-'AU@H\4<1RK+$QS"4
M)J.;8MJE#^S;8F-6K_#IU+JE2<O:U%-05*>_X1^#OBS2?@C\8?BN/BE?>#)_
M!0T_4?#7@_PU?ZDZ_$W1[#XK^'O@WXI\9IJVFZQI<&G>%-%\3^*+72?"^N2Z
M?J;^,=2T_P`1V.G16=KH-_=TWX%10?%'5[[0?''QP^.O@Q['3]=\3:MK?AVT
MA\6>%O#OP^\+:'+K/BOQ5XGNM;^*/A/4X?[.BA:TM=(TO3-2EUJ^O-)TJRG.
MIZK;VHH:=^UI\5+#X;^.OA;(/"FI>&?%GPQ\/?"'0Y-3\"_#RYUGP/X(\+^+
MM,\4Z+I>F:\/!2:WKBV$6G2:79OKNHS26-Q?W'BFPDM/$\5K?Q<!#\4[#2(/
MC-IW@_P'I7A+1?B_X4\.>#!ID7B'Q!KTO@O0M&\6>#O&6JVVD:OK;SZIK`\5
M:KX-M4U7^V)LV]G>SVMJS06]O$.R64YMBH9PLPP>!6-Q>8QEEN886EE>(^J9
M>Z65X=>T6,P,*E6M0YL;BW"M3Q7MZF&Q-&-?#T9Y?1J<BS3*\++*7@<7COJF
M%R^4<QP.)JYE1^M8]5<RQ#]D\'C)4Z5&ORX/"J=&>%]A"OAZTJ%>M#'UJ?K6
ML_LMIIGPSL?BI:^,[V_\-_\`"*PZ]J17PO`]Q>:CK_@S0O%'@W1?!T6F^(=3
MG\0+<:OKESX'\:ZC>V^C1^"]>\$_$2^EBO\`2?#$SGY(CY9#D$$J05.5()!!
M4]U(Y![C!KZ:^#O[3NO_``6L-)TKPUX2T6;3K6XU'6M>4:SKFC:AXM\72>*?
M"GB30?$&LZOH[0WJ6?ARS\%:/X/3PM`3H^L>$-6\=:;J#I<^.=5O8/FEI&FN
M'F<1J\]Q).ZPQK#"KS2M*ZPPI\D,*LY$,*?)#&%B3Y4%>WD\<ZIU<?2S:2KT
MH5D\!BE]6INM0<ZJ<:F'H)NE4ARPDIN;A4HU:,53IUZ>(B>-FDLGG3R^IE<7
M1JSI6Q^&?UB<:-=1HM.G7KM>TIRYI1Y5#FA6IUY.I4HSH2/[O/\`@ESK5C9_
M\$_OV5X9A>[Q\+[8_N]+U6X0XU[75)66WLIHF&Y2,JYSC(X()^._^"^FK6=_
M^QIX%AM_M6\?M%>!Y#Y^G:C:)M7P5\2`<2W=I!&6RXP@<N1DJI"L5^VO^"5_
M_*/C]E;_`+)A;?\`I\UNOC?_`(.`/^3,/`G_`&<;X%_]0GXEU_`G#/\`RD#2
MO_T<+-_+_F98ZW?Y]_(_N?B3_DQ%3_L@LH_]5V!/Y,OA-:>(+[XF^`[/PG\/
MK3XK^)[CQ/ID7A_X;:AH]YXAL/&FLF1CIVAW^A6-Q:3ZQ92W0CN;O3GN8;&Z
MM[62/5G.CF_1OU,T[PKI\&JZI9_$OPG?>)?VE_A3^SW\2/$R>)/A_P#`CPM;
M-X]\9W7Q4^'MF_A3X5>%=1\%:!\.?B_XS^`GPPU#QDR_$JU\':]X>TNXUR_O
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M\--8\>_#:X\9?`+_`(3OPWHOPHT+PQ<V'BSXH?#VR\0Z3\,/B#X`\/7UGX!L
M_C$+VUNM5\:?#[3=0\/:;X\U+1O$4=GI'A^/5[S1]-^C;RU\'>$[7X+6GQ.T
M+3/&_P`7_&R_%^?XC^-A\#-!^"45K\`_AMXA\.^)3K?C+X;>-_!/AS4M*\"7
M6BQ?$KPWJGC6;P9X9\<7FD^'(/#G@N3Q!9:5I-_J/XR/<W,D<\4EU=2175P+
MRZBDN;B2*ZO`92+VZC>1DN;T&:8K>7"R72F:8K*#-+OEN-0U&\N)[R\U'4;V
M\NHA!=WEYJ%[=WEW`JHBV]W=W$\MQ=6ZI%$BP7$LL*I%&@0)&@7S<5P?B,8L
MMC7S9J.7X"E@I*AA%06(>'P6)P]*I+DK\U"F\5BEC*V&PTZ5#$K!8'#XN-=8
M;#U:'H8;BRAA'F$J.5)RQV.JXR+K8IUO8>WQF%KU8+GH<M>:PV%>$HXC$0JU
ML,\7C*^%EAWB*]*O],?M4_#&/X=^*O#%SIDVF)X2U[PZFF>"M)L]'OM'O=,\
M.^"K/0]/M)]3N+Z-6\87/B"#6;;7KSXBVK26'B[Q)>^*4LO*MM&BB7]0/^#?
MJ]@L?VH/C7-/YY3_`(4"B_N+6ZNV!/Q)\+?>CM()Y%7D#>R!<D#=DXK\(99Y
MY_*\^XN+C[/!':V_VB>:?[/:PES#:6_G._D6D!DD,%K#LMX3(_E1IO;/[T_\
M&]W_`"=)\:_^S?U_]63X6KYSQ6PM?!>#_%6%Q&)^N5J&4TX3Q+I*BZR6987D
ME*"E+WU2Y(3J.<I59QE5FW*;/H/##$T,7XK\,XG#X;ZI1KYK.<<,JKJJE)Y?
MB5-1FXQ]QU%.<(*,8TX2C2@E"$3^M^SO8+Z(S6_G;`[1GS[:ZM'W*%)_=7<,
M$I7###A"C<A6)!`MT45_FH?Z)A1110`4444`%(20"1U`)'7K^`)_($^@-+5/
M4+--0L+VPDVF.]M+FT</YVW9<P20-N^S3VMQMVR'=Y%S;S8SY4\,FV10#\O_
M`!-\:OCU=?M1^+?!M]\2/B7\,_!'AKXI>!O#/A/PGX4_X)U_M'?&#PAX[\&7
M^D^#]1O=7U7]IBT\(R_#[3+S6M;U3Q'H6O:OI=U:>&/AK8V5G/J-Y?26.I:S
M<_J8/ZGMCO\`YY[]:_*+0_V)]'\&>)M`ET#]E3PM<:UX<U#3-8T7QTO[9W[0
MMMX2AU/1+VWOM,U&]\(ZNFN:ZI2ZMHKN;PY+8>)=.EV_V=<ZW?V\LMVWZGZ8
MNHKIU@NL264VK"SMAJ<NFPW%MITFH>2GVQ["WNI[JY@LVN/,-M%<7-Q/'"46
M6:1PS$`_$[_@I/\`\I)/^"%/_9UO[4'_`*QS\0:_,W_@X,_Y.E^"/_9O4?\`
MZL?Q;7W#_P`%F?C-\.?V;OVOO^"-/[07QFUN^\)?!_X6?M0?M$ZEX_\`&=MX
M7\6^++;PU8Z[^ROXP\,Z3<WNE^"]"\1:]*E[KFJV&GQ+9Z7<OYDYE=%MH+F:
M'\*/^"R/_!3K]B/]I[X^_"OQE\"OC!K'C_PWX>^#*>%]8U.Q^"WQ^TV.RUX>
M-_$>K'3WAUSX6:9<R.-/OK2Y\V&&2#;,$\WS%9!^T>`69Y;E/B/E^-S7,,#E
MF#AEV;0GB\PQ>'P6&C.I@YQIPE7Q-2E2C*<O=A%S3E+2*;T/R#QSRW,<U\/<
M?@\KP&-S+&3S#*IPPN7X6OC,3*%/&0E4E&AAJ=2JXPBG*<E&T5JVD?!U%?/7
M_#4_P/\`^AE\2_\`AI_C'_\`.^H_X:G^!_\`T,OB7_PT_P`8_P#YWU?WG_K]
MP)_T6O"7_B1Y/_\`-A_$'^HG''_1&\5_^(]F_P#\Q^:^\^A:*^=E_:N^!+R2
MPIXKU]YH!$9X4^%OQ?>:`3JSP&XA7P"98!.BL\!F1!.BL\6]%8B3_AJ?X'_]
M#+XE_P##3_&/_P"=]1_K]P)_T6O"7_B1Y/\`_-@?ZB<<?]$;Q7_XCV;_`/S&
M?0M?V)?\$`?^3+?''_9QGCS_`-0OX:U_#1_PU/\``_\`Z&7Q+_X:?XQ__.^K
M^EK_`((\_P#!93_@G!^S+^R]XJ\`?'']H34/`7B_4?C7XM\5V>BWOP+_`&CM
M2FFT#4O"_@?3[+41<:'\(=3LUCGO-)U"!8GN%N%:V9I(41HV?\0^D%Q7POF_
MAY6P>4\29!FF+><9746%R[.,NQN)=.G*MSU%0PV)JU7"%USSY>6-U=JZ/V3P
M)X7XFRGCZCC,UX=SW+,(LIS*F\5F&49A@\.JD_J_)!U\3AZ=)3G9\L>;FE9V
M3L?O_P#\%4_^4>_[5'_9,Y?_`%(-"K^"U_OM_O-_,U_31_P4#_X+G_\`!+7X
MS_L:_M`_"_X:?M-W7BCQWXS\"R:1X9\/V_P%_:8LI]4U%M9TBY%M'<ZG\&;*
MQA8P6T\F^YNH8\1D%\D`_P`B3?M4?`\LQ'B7Q*06)!_X5/\`&3D9]_A]FO$^
MC9Q-PYDO".=8?.>(,DRG$5>)*]:G0S/-L!@*U2C++,KIJM"EBL12J3I.=.I!
M5(Q<'.$XWYHM+VOI#<-\19SQ7D^(RC(<ZS7#T^'Z5&I7RW*\=CJ-.LLQQ\W2
MG5PM"K"-10J0DZ<I*2C.$K6DF_H.BOGK_AJ?X'_]#+XE_P##3_&/_P"=]4<O
M[5OP*@"--XJ\00K)+%!&TWPL^+\*R3SN(H((VE\`H)+B>5EC@@0M-/(PCA1W
M(4_T5_K_`,"?]%KPE_XDF3__`#:?@/\`J)QO_P!$;Q5_XCV;_P#S'YK[SZ)H
MKYZ_X:H^!_\`T,OB7_PT_P`8_P#YWU'_``U/\#_^AE\2_P#AI_C'_P#.^H_U
M^X$_Z+7A+_Q(\G_^;`_U$XX_Z(WBO_Q'LW_^8_-?>?M)_P`$C?\`E(E^S;_V
M%_'O_JIO'M?W;_P?\!_I7^<!_P`$X_V_OV3_`((?MI?`_P"*?Q3^(^N^$O`7
MA/4O%\_B'Q#=?!WXYWL&FQ:G\._%^B6+R6NE_#.^OY1/JFI6-HHM[64J\ZO(
M$B5Y%_K8_P"(AW_@CYMQ_P`-=29VX_Y-\_:GZX_[(?7\5?22SC*,ZXTR?$Y-
MFF79MAJ?"^%H5,1EF.PV/H4Z\<VSBI*C.KA:M6G"K&G4IS=.4E-0J0DURRBW
M_8?T>LHS7)N$,UPV;Y9F&58BIQ)BZ].AF6"Q.!K3HRRO)X1K0I8JE2G*E*=.
MI"-2,7!RISBFW&27\]7_``5M_P"4B7[2W_8<\"_^JH\!5^<M>I_\%&/V_/V4
M/C=^VE\<OBE\+?B/KWBWP%XMU7PG<^'O$-K\'?CE90:E#IOP\\(Z)>O':ZI\
M-+*_B$&IZ9>VK"XM82S0,Z!HF1V^)_\`AJ?X'_\`0R^)?_#3_&/_`.=]7]6\
M$<;\%X7@OA##8GB_A?#XG#\+Y!0Q&'K\0932KT*]+*<)3JT:U*IBXU*56E4C
M*%2G.,9PG&4914DTOYAXRX+XQQ/%_%>)PW"?$V(P^(XDSRO0KT,AS2K1KT:N
M:8JI2K4:M/"RA5I582C.G4A*4)PE&46TTW]"T5\]?\-4?`__`*&7Q+_X:?XQ
M_P#SOJCB_:M^!4X=H?%7B"98Y98)&A^%GQ?F6.>!VBG@D:+P`X2>"56BG@<K
M-!*K1S(CJ5'U'^OW`G_1:\)?^)'D_P#\V'S7^HG''_1&\5_^(]F__P`Q^:^\
M^B:<GWU_WE_F*^>/^&I_@?\`]#+XE_\`#3_&/_YWU.7]JCX'AE)\2^)0`P)/
M_"I_C(<#/)Q_PKZC_7[@3_HM>$O_`!(\G_\`FP:X$XWNO^,-XJW7_-/9OW7_
M`%!^:^\_T6O^"5__`"CX_96_[)A;?^GS6Z^-_P#@X`_Y,P\"?]G&^!?_`%"?
MB77RY_P3_P#^"Z'_``2U^#/[&W[/OPP^)?[3=WX7\=>#/`4&C^)O#]S\!?VF
M+R?2M235M5N&M9;G3/@S>V,S"&XADWVUU-&0X`<D$#YF_P""P_\`P64_X)P?
MM-_LP>$O`'P-_:$U#Q[XOTWXU^%/%=[HUE\"_P!H[398-`TWPKXYT^\U!KC7
M/A#IEHR0WFKZ?`8DN&N&:Y5DB9%D9/X'X>S++J/CE3S6MC\%2RQ<=YGBGF57
M%4*>`6%J9AC)T\2\9.HL.L/.$HRA6=3V<HRC)2::;_N+B#+LPK>"\\KI8#&U
M<S_U)RO"_P!G4\+7J8[ZU3P&"A4PRPD*;Q#Q$)QE"='V?M(RC*+BFFE^%E%?
M/7_#4_P/_P"AE\2_^&G^,?\`\[ZC_AJ?X'_]#+XE_P##3_&/_P"=]7]\?Z_<
M"?\`1:\)?^)'D_\`\V'\.?ZB<<?]$;Q7_P"(]F__`,Q^:^\^A:*^=6_:N^!*
M2Q0/XKU])IQ*8(7^%GQ?2:<0*KSF"%O`(EG$".CSF%'$".CS%%=29?\`AJ?X
M'_\`0R^)?_#3_&/_`.=]1_K]P)_T6O"7_B1Y/_\`-@?ZB<;_`/1&\5?^(]F_
ME_U!^:^]=SZ%K][O^#>[_DZ3XU_]F_K_`.K)\+5_,9_PU/\``_\`Z&7Q+_X:
M?XQ__.^K]>_^"-7_``4\_8A_9@^/OQ3\9?';XPZQ\/\`PWX@^#J^&-'U.^^"
MWQ^U*.]UT>.-`U8V"0Z%\+-4N8W_`+/L[FY\V6!(-L3)YOF%4;\Y\7.,N$,Q
M\-^+<%E_%7#>.QF(RZG##X3!Y[E>)Q->:QV$DX4:%'%3JU9J,92Y80E+EBW:
MR;/T#PLX0XLP'B%PMC,?POQ%@L'A\PG.OBL7DF98;#48/!XF*G6KUL-"E3BY
M2C%2G.*YI15[M7_OBHKYJ_95_:__`&=_VV?AG<_&+]F3X@GXE_#FS\5ZUX(N
M/$3>$?'?@HQ^)_#UOIEUJ^F?V/\`$/PQX2UY_LD&L:<_VV/2WTZX^T;+6[G>
M&X6+Z5K_`#J/[^"BBB@`HHHH`****`"BBB@!",^O'H2/SP1G\:,#W_,_XTM%
M`"8'O^9_QHP/?\S_`(T$@=2!SCDXY/0<]Z,C(&1D]!GDXZX'M0!\M?"WX6^,
M/"_[3/[4/Q+UBRMX?"7Q/TWX`VWA"]BU&UN+B]E\`^#?%>C^)1<V,4ANK`6M
M]JME'`UVB"\21I;?>D;D?4N![_F?\:,C(&1DYP,\G'7`[X[T%E`)+``<$D@`
M'T)Z#\:`#`]_S/\`C1@>_P"9_P`:`RL,J0P]001^8XI:`$P/?\S_`(T8'O\`
MF?\`&EHH`3`]_P`S_C7S-^U)\,_%GQ0\+_"S3/"%G;WMYX6_:7_9I^)6L)<Z
MA;6"P>%/AK\9?"?C+Q7>127<B)<7%GH6E7MQ;V$1:YOYHTM;:-YI$4_3(92"
M0P(&<D$8&.N3T&._I1D8SD8QG.>,=<YZ8QWH`:B[40'.0J@_,>H`![T[`]_S
M/^-&1QR/FZ<CGC/'KQSQVYHR,@9&2"0,\D#J0.N!D9^M`!@>_P"9_P`:,#W_
M`#/^-+10`F![_F?\:,#W_,_XTI(`))P!R2>@'J::S*OWF5?]X@?S(H`1UW(X
M&<E6`^8]2"!WKYI_9<^&?BSX7^%?B?I7C"SM[*\\3_M+?M,_$K2([;4+:_6;
MPI\2_C7XP\:>$KR22TD=+>XO-`U>QN;BPE*W5A-(]K=(D\<BCZ6$D9(`="3T
M`923SCCGGD$<=^*<2!C)`R<#)QD^@]3[4`&![_F?\:,#W_,_XT9'/(X&3R.!
MSR?0<'D^AI%96SM96QUVD''UP30`N![_`)G_`!HP/?\`,_XTM%`"8'O^9_QH
MP/?\S_C1D<\CCKSTXSSZ<<\]N:;YL?/[Q..3\Z\#ID\\<\4`?+OQ/^%WB_Q/
M^TY^S!\3-(LK>;PE\,=&_:`L_%U[+J-K!<V4_C_PIX+TKPTMM82R"ZOUNKW1
M;^.=K5'%DL:27!1)4)^I,#W_`#/^-`((!!!!Z$'(/T(HR,`Y&"<`Y&"2<``^
MN>/K0`8'O^9_QHP/?\S_`(T$@8R0,G`R>IP3@>IP"<>@-+0`8Q_^LG^=%%%`
M!1110`4444`%%%%`!1110`4444`?G3\</$WQ#^(7[5E[\`;+XW>*_P!G7P'X
M'_96D_:`M/&/@A/!-IK'BSQGJ/Q+UWP1=WVMZCXZT3Q+97?@7X):7X=T;7O$
M_AF#3+#1]=O/B;H0\8ZI/I-O8Z=-\Q:+\8_VF/BOX!_9%^)WA7XO>+HOVE_C
MS\/_`-EOXC:-^S3X3\'>%K;X-^"?A]K4?@S4/VA_B)\?Q<6/B?Q!;_#[Q+H\
M_CBX\*>);[QAX1U>PU(>"/AW\(]/UKX@0^(+_P`1?IA^T9^S%\(OVH_!:^#O
MBIX9T_4I-/GCO_"GBI=&\,ZCXI\#:S%?Z9J2:MX7NO%&@^(]*B-Q=:-IT>NZ
M%K&CZQX3\8Z3!)X<\:>'O$/AR[O-*GY36?V(/V5_%7CB+XJ>-?@C\._&?Q;D
MB\#'6?BIK?A+0K;QQXFO_AO86NG^#=7\0:AX?L-#L;N^T"&T4Z-%!IMIINB"
M:XMM$T_3;&4V@`/2?B#X/^)FL>,O`OBWP1\27\+:3X/T/XG1:YX'O-)BU/PO
MX]UKQ+X>T^Q\"7OB=8!::Z++P/K5E<:N+30]:T6YU%=0NK9[O(@>'\LOAKX]
M_:F^)?[,W[1WA2^^-&K>*?BYX>_X*0>._@1I?C?2M>\!_`/6;CX<^&_C5X0M
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M3Q3X6?PYXV\/'2)-5\#^#]>T5OM?AK7O#]CJVC71E^P*Y#P)X`\$?##PQIW@
MKX=>$O#O@CPEI'V@Z;X<\*Z/8:%HUF]Y<RWM]-#8:=!;P?:;^^GN+Z_NW1[J
M_OKBXO+R:>ZGEE?KZ`"OE#]N/XO>-?@/^RC\;/BM\.TM4\8>$O"(GT?5M0L;
M?4],\)MJFM:1H%]X]U?3KR>ULK_1_AYIFKWWCO5[.]N8;*YTWPY=0WD@M7FS
M]7U2U+3K#6-/OM)U6RM-2TS4[.YT_4=.O[:&\L;^QO8)+:\LKRTN4EM[JTNK
M>62"YMKB*2"X@DDAFC>-V4@'Y/ZMX@^(WP]^*7QZ^`&M?M;?$/1_A'X)^"WP
M&^/GB?X]^.X?AGJ_Q%^'<'BOXE?%[P=XY^'%EXKM?"OA_1-'F^+NE^`M"UOP
M-J%[X(U_5_!KMXTT_P`!:=<C6O`UMX-^F/V6$^/GB[]GOQ=#\2O$/C?1M4\0
M>)_BK:?`[Q3\1/#VGZ!\;M,^#M]<W5C\(/$?Q9\.1:+I&GZ?\18;1WUP:9J7
MAS2?$=OX>_X1:T^(VB6?Q"3Q?9K!HO\`P3S_`&4]+\._$/P#J/PK\)>*_A-X
M^^)V@_&&W^$'BCP=X%O/`7@7XA^'U+V'B#P1%8>%-,\2V<MI>K;7_A^VU[Q)
MXBM?`36%AIOPWB\':#9V^D1_27PJ^#OPP^!_A8^"?A)X(T#P!X4;5-0UMM!\
M-V?V'3FU;56B?4M0,.^0FZO6@B:XD+$R-&I/-`'Y_>-_$?[2?PH_:T_X)N?"
MW6/CH_BCP#X[T?XN?#SXCZ%#X+TC3]7^*7B[X<?LOZMXLN?B-X\\5SR74KW=
MWXST6/5]"\->#=(\%:-ICW>JSZY)XGDN=)MO#?A?@K]OR?XG?\%1/A%\+-(^
M+&I:/\+_`!=\._VR_`.F?`ZX\(ZYHTVK>+?@;XN^`-KH'Q0\6SZ]X2M=5M?$
M'B>]O_C%%X*TZUUBW\/VGPRT?0M=U"*;7?'$$%E^DOQ+_8S_`&5_C'\0=+^*
M_P`4O@+\,_'OQ)T1=.31?&_B?PU:ZIXET8:4KI8_V3JLQ^TZ:T4,DEN[V30/
M<6LCVMRTULS1'W"]\#^#]2\7>'?'VH>&M%OO&WA'1_%/A_POXJN]/M[C7_#V
MA^-[CPY=^,-'T;4Y4:ZT[3?$UUX0\+7&N65K)';ZE-X=T62Z21M-M3&`=5UH
MHHH`YSQAHEWXE\)^)_#MCXBUKPA>Z]X?UG1;3Q7X;>RB\1>&+G5--N;&#Q%H
M,FHV6I:>FM:)+.FJ:6U]I]]9?;K6`7=G=6YE@D_";QU\8/VHOBU^PC^W;\;O
M$'Q@\:_!SXD?L4_"K]H7X7Z)>?!?6M"T33O'7[1?[('A+Q]/\1_CC?17WAS6
M6E\`_$SQEIWAQO"?PVU.*W;0/#ND:I;ZPLUYK226G[]D`@@C((((/0@\$'ZU
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M@F\*VT!U`>;=+-M>-/V0/V7/B-X]T[XH>/?@!\)?&/C_`$K1/#WANS\5>)/!
M&AZQJRZ!X1O-2U'PIHUQ+?6LT5]IGAC4-8U2_P##UE?PW5OHU[J%W=Z=';SS
MR2'Z.P,8QQU_$'.?<YYR>IY-`'X\Z3\4?VG6^(/_``5C^'NN_&:PU?7_`(9?
M"#X,:_\``J:QT[PA\+?"?PIU[XG_``@^*-];V'A[5O%NHWUI;2Q:WHN@ZA<^
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M1ACM5OK]=.MX'OKJ*S@M["WFNWF>UT^VM;"U,-E;06\8!Z71110!^8_[1'Q`
M^/?@3]K+X8_`[P;XXOU\%?MLZ=)H_AO7;AM$.H_LX^(?V?['_A-_C3K'A>&?
M1Y)=7M?C'\&)5T;PA:7T6M+X*^,&D)XHO%E\-Z[>V%E^?7Q7U?X[^!_&?[=V
MD:'^UI^TXMC\-OVOO^";WP!\`P7OC[0-0/A+P%^UIX[_`&3)OBT=*EG\$F27
MQ";7XG>,-'\*:_J(O[SPUI.I+;6""2W@E7^A'6/`?@OQ#XF\(>,]=\*Z!J_B
MWP!)KTW@CQ)J.E6=WK?A*7Q1I/\`87B.3P]J4T3W6DOKFBDZ5JK6<D1OK#_1
M;@O#\M>?^-_V;O@'\2=(^).@^/?@]\.O%VD?&'5/!^N?%*PU[PII6H0>/]:^
M'T>@P^!=8\5B:W+:SJO@Z/PMX;7PSJ-VSWFA_P!@Z0VG36[:?;&,`\$_9O\`
M$GCGP]^T/^TK^S;J_P`2_$?QB\$_"+PC^SYXW\*^-O&[^'[_`,>>&-:^+=O\
M4(?%'PC\6>(M`LM$C\23Z'IWP[\*_$;1+W6-$3Q3::'\4[:TUC5-3TT>&YU\
M*_:7O/VH_P!GOX:?L@P6?[1MWK3M^VC^S%\._BUKUWX'T&?QI\6O#'QH_:G\
M.^%IO"E[KTJQZ'X3\):9X$\4SZ%J<6@>$5\5Z[-INAM;>+?#]G;ZS;>)/T6^
M%_PA^%_P4\,GP=\)/`/A+X<^&)-0N-7N-%\'Z'8:%8WFL7<-M;WFLZBEC#$^
MIZQ=V]E96]UJVHR76HW$%G:037+Q6L"1\%\;OV4?V;_VDKCP]=_'GX+?#SXM
M7'A/S6\,R>.O#UKKYT*66]M-1^TZ4MWE+.\AU"PLK^UO856[L[RU@NK2>">-
M7`!^7W[7O[?MWX/_`&U?V7/@[X;^*FK?#7POX;_;`^%?P:^*/AE_"6JK/\99
M_BG\%/BSXEU*RN-2U#PM>P/\./!=Y_PJZ#2M4\*ZG!<>(OB-K&MV]Y?6FD?#
MF^AUC]PD)*KG[V`&_P!X<-[=0>G'IQ7`7'PH^&UYIOP[TB]\#^&;[3?A+JNA
MZ[\,K.^TFVO8/`>M>&O#VI>$]`U?PJMTLIT75-)\-:SJVA6-_9&.Z@TO4[^S
M67RKN=7]!``&`,`<`#H!Z4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!7.ZYXO\*>&9+>+Q'XE\/Z#)
M=I+):QZUK6F:4]RD+(DSVZ:A=VS3)$TD:R-$'6-I$#D%E!Z*OY5_^#BB"";X
MC?LLF:""8KX(^+84S0Q2E0?$?@'(4R(Q`/<#&:^X\.>$*?'7%V6\,5<?/+88
M^GCYO&4\-'%RI/!X#$XU)4)5\.IJH\/[-OVL>52YDI-<K^+\0.+*G!/"N8<1
MT\##,9X&I@8+"3Q#PL:BQ>/PN";=:-'$.'(L0ZB7LI<SCRWC?F7]-/\`PM;X
M8?\`11?`G_A8^&__`)9UVME?66I6EMJ&G7=M?V-Y!'<VE[97$-U:75O,H>*>
MWN8'DAGAE0AHY8G>-U(9&((-?YE*V5ED?Z#9=1_RZ6WK_P!<J_T'O^"?2JO[
M#O[):HJHJ_L^_"Q55%5%51X2TT!550%51V```["OO_%GP:P_AGE659E1X@K9
MQ+,<PG@G2J9;#`JDH8:=?VBG''8MS;<.7DY8I*5^;2Q\+X6^+M?Q%S/,\OK9
M%2RE9?@(8Q5:>8RQKJN6(IT'3<)8+"\B7.Y\RE+^7EZGV%113)"0H(.#OC'X
M-(BD?B"17X0?MPX$$9!!'J#D>G\Z6OYUO@I_P5`^._A3X1^(=1\6>&-`^*EI
M\&_AYJ_Q[^*GCCQ;XJO]$\6ZQX#\3?\`!0G]K?\`9NM_!_A33-#\-W.D-KGA
M'P7\'M$U'0;_`%9[;3KN/3CH>J!9-037=-^R$_X*!?%"Y\$VWQ(L_AC\,#X:
M^+_Q-L/A1^SWH^I?$O7]+\;:9KNI?M0Z5^RY9:Y\=_#Q\&WLWA[PW%K>KV_B
MGQ-=>#_[5E\&ZL^G_";4?MWB;7M'\12@'ZPT5^&WQ"_X*L_%7X>VWQ?L[CX*
M>`M8\0_LT?"+]I/XL_&;[)XZ\36?ASQ+8?LH_&+P!X%\?Z9\)M6F\+7%Q=7G
MC+P?X_L]5\-/XEL8K/PEX^TKQ!X$\3WFI6NC/XBNN@\>?\%.?C!X*^*WCO\`
M9R7X"6GB/XT?#WQU\1(=5U#P'IOQG^)G@._\`^$O@Y^SQ\;/#JP6O@/X;:OX
MSTOQGXEL?VDO"/@?59]4TU/!O@^^T'7O'%[J6HZ1=:1X9F`/VIHK\S/VQ/VC
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M44OP/TGQA\(;?PMJ?Q>^.WB3]F^*]\4V7C;P!]G\6Z=?^`-3\,_%"7P/XXTO
M3OB#X;^%'BWPOXBUWPDJ>,M(TGQ!I/Q[O/A1\+DFUC3_`(L:%XL@`/U@HK\.
M/$W_``5J\=>!/!@^)WB#X%:)XC\'^,?%W[6GPK^&>@^`/%'BOQ!X^B^)/[+_
M`.TQ>?L^QS_$/1K/P;J::/X%\:M+I^K7VJ^'X]9USP;?)9Z0VC>)+SQ=I-KI
M'<_\/#/V@[_6OAY\-=(^`WAS2?B/XQN?VI[/^U?B@/BI\*?#6I6G[.GPT^#W
MQ1T_Q7I?@KQ3X/C^*>C:+XSMOBA-X-FTOQ1HUMJND>(-#N]<L+C7_#+6$VK@
M'['45^.W@[_@J)KGB";P1\2O$GPFM/`_[/\`\0OAIX#\<>"]1O+GQYXG\8>-
MKKQU^RSIW[2-KX?\,>*/!_@?6/@[IGQ(AUB[O_A/I7P0^)OBSX<?$+Q5<:9#
MX^T"XN=/\2>%/"^M_0G[#G[8/Q`_:DM]6N/''P:U[X<6ES\._A?\6/"FM3^&
M_B+X?T.\T7XI0:]<)X*$OQ.\*>#-4\4:]X,BT>SEO_'?A'2[KX>^+;;6H9]`
MGL;C3;^PH`_06BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`*_$[_`(*O_P#!.WXY_MO>+?@KKGPBUSX:Z19_#SPYXZTG7$\>
M:[K^CW$]UXEU;PQ?6#::FC>%O$*3PQPZ-=+=-<26KQR/`(TF5W:/]L:*^BX5
MXHS3@[/,)Q#DTJ$<QP4<3"@\315>BHXO#5<)6YJ3E%2;HUIJ+O[LK2UL>!Q/
MPUEG%V38G(LWC7E@,7/#3K1P]5T*K>%Q-'%TE&HHRLO:T(<RL[QNNI_'*/\`
M@@3^VF"#_P`)G^SQP1_S.OCG_P"=I7]3_P"RS\,?$'P6_9O^!OPD\5W&E7?B
M;X;_``M\%>"]>N=#N+F[T>?5O#VAVFFWTNF75Y9Z?=7%B]Q`[6TUQ8VDTD15
MI+>)B4'O=%?3<;>*G%?'^"P6`X@J8">'P&*EBZ"PF#6&FJTJ,J+<Y*I-RCR2
ME[NFKO>ZU^<X-\,N%^!<7B\;D-/'0KXW#1PM=XK%O$1=*-2%5*,7"/++G@FW
M=Z75NH4$`]0#R#SSR#D'Z@@$>A&:**_-S]"/!T_9<_9NCT?Q%X?C^`_PB30_
M%_AC_A"_%.CK\/O#"Z;XB\(GQKXK^)!\,ZU9#3OL^I:"?B!XZ\9^-?[*NXY;
M/_A*?%7B'7?*.HZO?7$T\_[,W[.US/\`$JYN?@9\)+B?XR*Z?%B6;X>>%)7^
M(ZR7IU.4>-2^E-_PD8FU1FU:;^U/M!FU=FU>4OJ;&[/N-%`'A'_#+O[-_P#8
M$GA;_A1'PB_X1N7X<^)/A#+H/_"O?"XTF;X6^,M9B\1>+OA[/8+I@MI_!_BG
MQ!#'KOB/0)8WT_7-97^U-3ANK]FN&F\:?LR_L[_$=]<?Q_\``[X4>-'\3^+-
M+\=^(G\4>`?#.NOKGC+1?"6E^`=+\4:L^I:;<O?ZY9^!-%TKP5'J5R9+AO"5
MA:^&Y7DT:(65>XT4`<)XV^%_PY^)'@F\^&WC[P-X3\8^`+^WTZUN_!OB/0-,
MU;PU+#HUS:WNC*-'N[:2QB;1KVPL;[2)8(8I=*O;&SN]/DMKBU@EC\VTW]DS
M]F#1M<D\3:1^SY\&=+\0RZ]<^*)-;T_X;^$K/56\07MUIM_>ZN;ZWTJ.X%]?
M:CI&FZE?3!Q]LU.SAU*Y66_#7#?0E%`'`S_"OX:7?A'Q-X`O/`/@Z]\"^,[[
MQ5J7BWP;>^'-)O/"_B6^\<ZS?^(?&=UKF@75I-I6J3>*M>U34M:\0/>6LQU;
M5M0O=1O?.O+F:9^.TO\`9I_9[T3PY#X0TCX*?"W3O"UOI%UH,/A^S\#>'(-(
MCTB_\26'C'4;`6":>+<P:EXMTK2_$^I%D:74/$&G6&LWLL^I65K<P^WT4`?)
M_P`)/V)/V:_@YH_C?3-#^&/A7Q)?_$K4/C#<?$+Q5XX\,>$_$7BWQMH_QQ^+
M7C/XS>-_!OBK66\/VC:_X+D\5^.-3M;+P]JD%U;-H6GZ%8:NVK7&EQ7S>B>%
M_P!FS]GWP3#X9M_"'P4^%GAJ+P9!XQM_"HT/P+X<TQO#\7Q$M=-L?'PTJ2TT
M^*2T;QK9Z/I-KXJE1_.U^WTVPAU22Z2T@5/;**`/`_#G[*_[-7A#Q5X7\<>%
M?@'\'O#GC'P5X>T+PIX1\3Z)\.?">F:YX:\.^%_#EMX.\,Z1HFIV>E176FV?
MAWPC9VWA30UMI4ETGPS"F@6$MOI`^QGJOAE\#_@W\%DU^+X1?"OX>_#&/Q3?
M1:EXC3P%X/T#PFNMWMN;DVLVIKH=A9"\^Q_;;P6,4VZ"P6[NELHH%N)A)ZE1
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%8G
MB/78/#6AZEKMS8ZOJ4&EVS74MCH&E7FN:Q<JK*IBT_2=/CEO;ZX)<%8+>-Y"
MH9@,*:`-N@G'K^1/\J^>_P#AHSP[_P!$\^.G_AE_'G_RKKX9_;B^+4?C#PW\
M/H=#TCXG>$WLO$>L37$_B;PEXK\"0WJ/HR1K!:7.HPV*:C-$S>;+;1/*\$9$
MSHBE6(!^M.1[_D?\*6OY>I=>U\Q2@:_KH)BD`)US5@!E&&2?MF`!W)X`Y/%?
MNKX"_:"T.P\#>#+*X\"?&V\N+3PGX;MI[NU^$7CF_MKJ6'1;&.2YM[^/3GCO
M8)W4RPWD;O'<QNL\<CI(KL`?6%%>(:'\=M#U[6=,T6#P-\8;";5+R&RBO=9^
M$_C+2-)M7F)`FU'5+W3H[2PM$Q^]NKF1(8\C<PR*]LD)"@C()>(>^&D0$?B"
M0:``2(20'0D9)`8$@#J2`>,=_2G!E;[K*>`>"#P>AX['L>]?RU^`_CE^V=H'
M_!+?X\?MI6'B_P".EO\`&2W^"OC/4O!WQ%^,_P`8O#?Q"^#?B&YU;XWZUX:U
M+Q1X!^#WAG49;WP3XE\)^#M.LG\$2^+-"M]+L+FYAM[[1M41=327TKX0_ML?
MM8_![XG_`!I^&OC>'4OC?XSN?VD?BE^S_P#"R/1M/^.OQ-\)>!?AK^R=\%/@
M[XVUNYUOP[X7TGQ1X[\1>/?B-K7QDT>&Y\<7I_M.]EG\4^)O%FI7^A>#/#7A
M24`_I+HR,D9&1C([C/3(]\''TK\L_!W[:OQR^,\_BZ?P%\.?A?\`"_3O#6G^
M#O`5_H/QD\>:C!\3['XU?$W]EGP]^TAX?;2?#6BZ4NA^,/"_A=_&GAOPG/H>
MBZLWB'X@+IOCWQ+X9U+2[#PA#IOB#Y5_9+_X*"_&Y/!/PM^(?[24GAW71J'[
M)O\`P2]^*_[0?CS3==O/#O@?PIX?_;"M/VGM,/Q*T?P)-IT.D^%M8T?QIX8^
M&*?%B]M;\>'-0T75]3O=*T[P[IW@G2[74`#]]J*_(7X,_P#!1CXP?%#XU:1X
M#U#]FOQ3H?A:+XF^%?@_XQO8?#7Q!EF\/:]XV^$WAWXTV/C"?QWJ&AV'PMMM
M!\-^'_'7@CPYK/@VYUV3QUK=[=:YXKT"%=*TZPT'5)OV@/VOOCO\#_VUOB?X
M9NO$/PMC_9U\(?L/^!?BMH7A;Q/HWB^#Q!J?QP\=?M$:G\&/#EJ/$7@KPUXS
M\3WQUW5;C0?#VF^%M`\,Z[=ZO>WVC:7I>EVVLZQ+K5N`?KI17XM>&O\`@I_\
M0GO;KPCXQ^%.@>'?%^@?M3P?L?\`BFYUV7Q-X/MM*\<>-_AC\'/C#\,_BKK'
MAB_/B'5O"GPF@\-_$NX\*?$1=5UV]UG0O&^H_#"&SO#8_$!H]$^O_P!IW]J_
M7_@3\7OA%\/-/T;P)'X:\8_!?]IWX]?$#Q[\0/$FM^']%\!^!/V7;CX)7WBJ
M67^P]%UVZF;5]%^*=Y']K-A.F@RZ>NL36FK06<NAZJ`?<U%?SW^//^"D7[6W
MB/Q+X,^%G@3PQX*^%_Q!M/VBO^">EQXEUSQ9X'\>0>'/&'[/?[9?Q$^+?@*3
M1=)\->-X=.\;:5J.G:W\*+JTG\9ZEI_A/4-<T36([K2?#/@?7;.:T;[4_8__
M`&]?''[3_P`118W7P,\8>$/AAXOTCXNZUX%\5:KX2\=:#/HD7PC^(]I\/XM,
M\7:UXMT?1O"?BS6/'EO/<^(H8?AA=:O;_#Z[TZ?PEXJDO[JZL-=G`/T\HK\J
M/BI_P4"\>^`_&WQ,N]-^&GA2^^$WPZ^/.M?LK2C4/$'B*#XL:C\6;7]G4_'N
MP\:P^%X-%&@I\+U:YT[0[ZV&KMXA/@T:S\5X-0BTS2XO#&H>D?L9?MC>.OVA
M?$,GA7XD^`_"?@[6=;_9;_93_:X\)GP;XBUOQ!:0>`_VG[?XB:?;^#_$DFMZ
M1I3#Q;X.\1_"[7/M.IZ1YVBZSI.M:6(;>PO--O'OP#]#Z*_!BQ_X*X_%6W^!
MG@;XVZM\%OAKJ5G\8?@C:?&'X:Z!X<^(OB![W2[CPY^U;\!OV7O&_A3X@W=[
MX=>STR75[[X\:1XE\&ZQIDTXL;CPWXH\,:YI>I76F1ZC>^W?#3_@HS\4]?\`
MBGXI\+^)_P!G;QQJO@SP5\0OC9\&/$6M_#+X;_%OQ!J#>-_@#INN'Q-XM\,W
M5_H$?AGQMX=\;>*?#.M>&_!?P[\):EJ_Q+M--G\-^,M6%SI>JZ[8^%`#]>:*
M_$C1/VW_`-J6R^+_`.U=X3U2/X=:S;S?M2_#;X2_LK_#F_\`AW\4X?BAI/A;
M6_V,?A?^TSXJL-:\#^&=+_M?Q7KVBZ;XN2_\51>*?$G@"P\'ZM>^*S?^,H-)
MTKP?X,O_`%']E#_@I-JO[3?C+]G7PXWP\T;P-9_M!?![4_C%I]SJNO7<UQHD
M?@'6/B%\//B1\-W"PI:W_C^[\?\`@^'Q-\,[436B>+OA!HWQ:\42V=MJ/PGU
M2TU4`_6;(R1D9&,CN,],CWP<?2BOR*^-G[:WQ#^%7[9?B+X&>"?"MGXGU/QG
MXG_8=^%NAR>-/'&LV_@GP]=_M`>&?VY/$-]XIL_#>E:+)<:=<Z++\`-+.NI:
M:A<S^-;*YL[`2>'[C1K2_FM?LY_\%"/BC^T9X@L[+1/AO\*?".E?#74/`'A3
MX_3>,OB1KVC3:EXO\=?M`_&3]G4K\#KN[\+0Z=K6E:=XC^"NM:SH$/BLVVK^
M/M8UJS^%FDPZ3XKTVYU:\`/UKHK\2Y/^"I?Q,L?"/PJ\<WOP@\`7>D?M)^'/
MA/\`$/X)Z5H_CGQ%=:UX3\(>/_VOOV=?V6M0T#XX--X;AMM`\86UO^T9X:\6
M65QH"7&FQ>)_#OCGX;W&FWEQX:MO$NO\IXG_`."N?Q+^%6CZKK?Q(^`_AK78
MM'\0?MC?!8:;\-/%/BS5=5UGXZ_LA^,--\.W>J65K>^%KB>R^$OQ#M-6CO!(
M]MJGC/P+_9MY-/:^+K:YC2T`/W?HKY2_9-^.?C[XW>%_'4GQ'^'6K^`O$?@#
MQ[+X,-W?>%?&7@?3O&MA+X6\,^*K3Q/HO@WXCVFG_$#PS;1'Q'-X>N]-\467
MG7%]HDNMZ1>W^@:QIDP^K:`"BBB@`HHHH`****`"BBB@`HHHH`****`"OE']
MJG]GS7OC_HW@_3-"\0Z1X?D\-ZSJ.IW$NK6=]>)<Q7NFBR2*%;)T9)$D'F,T
MF5*<*-W-?5U%`'X_/_P3=^(3I(@^)7@P%XW0'^Q=>X+*5!/[[H">:_5_PCHT
MWASPIX9\/W$\=S/H7A_1='FN(5=(9YM+TRUL99HDDRZ1RO`TB*Y+JK`,<@UT
M5%`!00#U`/(///(.0?J"`1Z$9HHH`^5/#W[#'[&OA(^*_P#A&?V7/@/H47CG
M0]:\,^,;32OA?X2LK#Q-X=\1ZU:>(]?T/6].ATQ;#4=)UCQ!866MZEI]Q;/:
MWFJVT-_-&]R@DKT#Q1^S;^SWXVTG7=`\8?!#X3^*-$\3^.9?B=XCTGQ!\/O"
MNKZ?KOQ&N-,L]$N?'>JVM_I=Q#?>+KG1+"ST6Z\0W"OJMUH\":5<74NG[K9O
M:Z*`/+8/@=\&;7QSH7Q-M?A1\.+;XB^%_#T'A+PWXYM_!/AN#Q9H'A>UM)]/
MM?#^C:_%IJ:GIFCVFGW=YI]II]E<PVUII][>V%M'#9WEU!-R6D_LI?LR:#X=
M\>^$=%_9]^#.E>%/BGI*:!\2/#5A\-?"%MH'CO08M2\0ZQ#H7BS1HM)73M=T
M2#5?%WBG4;;2-0MI].MKWQ'KEQ;VT4NJ7C3>_P!%`'EUQ\$/@W=_$RT^,]U\
M*OAW<_%VPL$TRQ^)T_@SP[-X]L]/CM)["*TMO%DFG-KD,4-A=WFGP[+X/!I]
MY>6$+QV=W<02P?$/X$?!7XMW^FZK\4?A-\.?B)J6CZ+XB\.:9?>-?!GA[Q-=
M6/A[Q=:I9^*=!MY]8T^[D31/$-O%!'K.DECI^HFVM9;FW>:UMY(O6**`/"=)
M_9>_9PT'2]=T31/@1\(M(TCQ/X<N?"/B/3--^'GA6RL=>\,7EAX?TN\T+6;6
MVTN.'4]-N]/\*>&+*[MKQ9DNK?P[H<=QY@TJQ\CT?6_A_P"!O$NMZ7XE\1>#
MO#&O>(=#\/>+/"6CZYK.A:;JFJZ9X7\>'0CXV\.V-_?6T]Q;:'XO/A?PV?$V
MEQR+9:X=!TC^TH+G^SK7RNOHH`^=++]D+]E;3?"FO^!=._9R^".G^#?%.D:3
MH'B3PO8_"_P;::%KNBZ!X@O/%>@:7JNFV^CQVU]9:!XGU"\\0Z#!/&ZZ)K5Q
M)J6E?9+O;*O<^$?@?\&O`/C'Q1\0_!'PJ^'?A'Q[XV5U\8>-/#?@WP]HOBKQ
M.LMQ#=SC7M>T[3[?4]4%S>6UO>7?VNYE^V7L$-[=^?=QI,OJ5%`'D>L?`'X&
M^(/'%_\`$S7?@_\`#+6?B)JOAZ\\):EXYU3P+X9OO%U_X8U#2;K0;[0+SQ%<
MZ9)JUSI-WH5]>Z)<6<MT\4NCWEUI3@Z=<36S]!X9^%OPV\%W]OJOA#P%X/\`
M"VIVG@CP?\,[;4?#_AS2=(O;?X=?#Z?6+GP+X$ANK&UAFC\(>#Y_$.O2^&O#
MJ.-*T236M5?3K6W:_N3)WE%`'Q[\%/V#/V6/@5\*K#X1>&?A%X*\0:##HWAG
M0]=UKQMX0\&Z[XM\=6O@SQ;/XY\)3^/M<A\-Z:?%5]X:\63C7M#N=0M2=,U2
MWM-0M$BO;=+BO<;/X(?!O3_B5J7QEL?A5\.[/XM:Q9G3]5^)EKX,\.P>.]1L
MC:0:>]O>^*XM.76[E)=/M;/3YC+>L\^GV5E8S/)9V5K!#ZC10!X3XU_9>_9O
M^)'B>\\:?$#X#_"'QKXMU&+P]#J'B7Q3\._"FNZY?1^$II9_"XN]3U+2KB[N
M6\/O<7*:/)-*\FGV]U=6=LZ6=S/;R;>@?`/X(^%8M+A\,_"/X<>'H=$\36OC
M318M$\&>'M*CTCQ;96.LZ79^(]+2QT^!=/UBVTSQ%X@T^"_M!#/%8Z[K-I&Z
MV^J7T4_K=%`'F>J?!?X0ZYXOA^(.L_##P#JOCJWU+P?K$'C'4?"6AWGB>'5O
MA[:>,;#P)J46N7%E)J27W@VQ^(?CRT\,72W`GT.V\9^*(-->WCUW4EN.?M/V
M:_V>K#7/"7B:Q^!WPEL_$7@+4/$>K>"==MOAYX4AU?PEJGB_Q+K'C/Q3J/AW
M48]*6[T>^\0^+_$.O>*=7NK&6&:]\1:UJVMRN=2U&\N9O;**`/$++]FC]G?3
MKCQ5=:?\#/A'8W/CGQ1X;\;>,Y[/X=>$K6;Q5XP\'>+K7X@>$_$_B"2WTF-]
M6USPWX\L[;QMHFI7K37.F>+X_P#A)K22+6WDOGO3_L]_`BZD>:Y^#7PNN9)-
M8^)7B"5[GP'X8N?-USXRVEU8?%O5I5N-,D2;4/B=8WMY9>/[J57E\76MU<V^
MO-?0SR(WL-%`'!?#CX6?#3X/>&T\'?"GP!X.^&_A1+RYU%?#O@?PWI'A?1CJ
M-XL2W>H/I^C6EG;2WUTEO`EQ>2QO<S)!!')*R0Q*G>T44`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
=%%`!1110`4444`%%%%`!1110`4444`%%%%`'_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>biib-2015630_tecchart.jpg
<TEXT>
begin 644 biib-2015630_tecchart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`$V`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`IKML1FQG:
MK-CIG:"<9YQG'I3J:R[E92<!E*Y],@C-`'Y2?#K_`(*567BKXQ?M'^'/&E_^
MR_\`#7X8_LR_%;XQ?#WQS;:M^T3K.L?M*S>'_A1!H-I'\0K']G_2_A0TDFC>
M)_$GBGP_IFF:?;^+KR]FAU73DTIM9US5-,T.[^J?"_[;W[.GC#QEX3^&^B>*
M?$[_`!)\8ZCXNTJP^'.H?"WXI:-X^T>]\!7GP]MO&:>-/!^L>#['7_`5OX;M
M?BM\/->U/4?&5CHFF)X3\7:'XMAO9O#E_;:E)Q+_`+!GP]NOA1^T;\*;[Q9X
MJ:U_:%^/GC/]HJ;Q-86^@V?B+P%X_P#$/C7P5\1?#EUX8:YT[4M+OH_`_C7X
M?>%=<TJ+Q%IVIV6K/ID=EK]A?Z>TELT?PB_8>TOX<_M%']JKQ'\3O$GQ`^,^
MO^$_BSX=^(>LWOA_PWX<T;Q;<?$Q?V:M+TZZLM"T*)8?#6G>`?"7[,/@OPSX
M:TF"YU2XOH]6\0:QXCUK5M6N8)H@#S7]H+_@IIX'^!/QC^)7P5G^%GQ)UC7?
MA5J'[#3>)_%=WX9\5Z5\.[CP]^VA^T1)\![>^T#Q=9^%-;L=9UOP*D%UXBM/
M#MJ7G^(6I66J^#?"]Q_;/AGQ9)HGN$W[?'[,$/A[2?$C>-O$4EIJ#?$MM5TR
MV^%GQ8N_%/@.Q^#/B&U\*?%O6_BOX.M?!,OBKX2>'?AKX@O[#3/&GB+XCZ1X
M9T70YK^QDN+YK:ZAG;C_`([_`+".A_&KXUK\8(_B7XC\'QZY-^R;<?$/PE8Z
M#H.L6'BVZ_8N_:(U+]HSX*W5AJVI&/5/"TR>(_$WB_P_XN2R-_:^(-`U;3FA
MMM+U31([V^\)\;?\$B_@KXT\7^)?'6I:UIFL>)O&/Q$_:`\3ZW=_$#X,_!_X
MNV%MX1_:'\9>'/'?B7PMX<T/XG^&O$^A^']<\+:_X<\[P9XZBT^ZNX[;6];L
M/%.@^*[!]+M=*`/I7]MO]I#XK?LU_"/0/C!\)OAU\,?BQHEQX\^%7@;Q!9>-
M/BGXE^'DT,GQL^+7PV^#G@75_#-[X9^%_P`3+37+&V\0?$6WUGQ&+UM':+P_
MIS2:*^K7MXEO%QGP_P#V_/"K?&CXI?L^?'+1]/\`AK\2/AG\3/A+\'X]1\+2
M>/\`Q]\.O%7CWXG_`+.O@7X[6^E6OCIOAMX>T;PM<7U]XIUGP5X!TGQG<:+X
M@^(=[X<231M*CU?6+;P_#]$?'[]GCPW\>?@W;_!>]U6]\)Z!9^-/@9XPL[O0
M;+3GGM6^!7QA^'7Q?T'28+.>*.PBL-3OOASIVA7OE11FTTR]N9+%(YX;<+X7
MXY_8(\&^./'7Q*\=7?COQ18WGQ*_:R_9L_:QO[&VT_1Y+73?$?[-OP]^&GP^
MT+PK:/,IEET/Q'9?#2PU#5[R?.I6MUJ5Y'8L(8K?`!T7A?\`X*%?LH^,[/P7
MJOAOQ_KNIZ!X]T3P3XIT/Q1'\+OBK#X3M?!WQ+OXM'^''CCQ1XHG\%QZ#X)\
M#?$'7WN?#W@GQCXOU#1/#GBG7-(\0V&BZE>'PYKLNG^K>`/VH/@M\3?'.I_#
MSP=XGU"_\06#^-$L+B]\(>,]#\+^,/\`A6WB2W\'?$9_ASXUUWP_IO@_XE1>
M`/%=W:^'O&<W@36_$$7AW5KF&VU%XO,5Z^'-"_X))_`WP[<_L^WD5_H?B"_^
M#7P)_9E^`6O:OX_^"GP7^)FN^,?#'[*$$R?#37-`U;Q_X2\23?"GQ/??;=2L
M/%]_X22XL=7T>ZMTL=/TCQ'H^C^*K/UW]FG_`()W_!O]F#XIZ]\0?`=IX52V
MEC^(D'A*TA^$'PHTCQKHEG\5/&2^.?%5EXD^,^F>&$^*7C^"RU0/IGAA-=\0
MVK6_AZ1+;Q9_PFVL66F:_8`'8?$G]KB[\-^(I/`G@+P'9^-O'?B3X^Z+^S3\
M+]-U7QA%X3T+Q+\1X_A'J?QR^(NJ^(M:30_$&H>'_`OPT^'.CZO?:MJFD>'_
M`!3KNK:YHM_X=TK0#<SV5U+RFE_M;?&7Q9H'BJT\&_`3P;_PL'X0>._BKX!_
M:!/CCXZ6W@_X/_#76/A?X?\``OC2R&G_`!)A^'FO>)O$4/Q3\"?$?PKXV\!7
M=_\`#'PS8Z/X9/B&Z^(]UX1U/0;;1M>VO$/[(<^NZOX]O=+\4O\`#_6;/]HJ
MR_:D^!OQ$\.6MAJNM^"OB5K?PI'PO\>:=XE\,:Q8_P!D>*/#'B&PN?&%CK>F
M2W=M/K?ACXA7UAI^I>'?$7A_2/$<'S:G[!'QQ^(7PI\/>'O'?QML_`OBG7OB
ME\0_BO\`M/\`AP^#_"WQN^&?[4WQ%UVW\+:!X9U_QIHFJV/PUN-,^&7A?P_X
M/TB+P9\#84G\,V^AV/A?0_BI/\4;OPP^JZJ`?:?P#_:@T?X[0?#N^M_">N^#
M[3XL?L[?#/\`:-\#VOB/9'K,OAKQTJQ:WH&LV4,1M[+7O!5]J'AF/47L[R_T
MW4;7Q1IEYIUT\:S*.<\7_M\_LO?#YO'#>/?'&O\`@BS\`^%_&/C;5=5\7?"_
MXJ>&M&UKPC\._$>B^$_'WB/P+J^L^#+*P^(FC>#-=\1Z%;>(K_P1/KMO96>J
MV>LK)-HDO]I#L?!/P@\86?Q@TCXF>/\`Q)I/BC4O"/P&T/X1:1KVG:-;>'KS
MQ%K&L>*+?Q;\3O$UYH%D]W8^&]-U:\\*_#^WT;0+#4K^"T^P:NTEP8I+$5^>
MGB__`((Q_"WQO/XDN=>^+OC&[UK6/"7[0'@*W\;2>`_AP?B7JOAC]H+7?"OB
M?7I?B?\`$Q-%B\8?%[Q-X;U7PG8VGAC7_%NJK#::"L.G3:1)J,4VM78!]KZW
M^WG^SKI-GJD<>O\`B^Z\7:7X@\>^%;KX='X2_&"+XB:9K?PX\)>'?''BBX\2
M^!$\`S^,?"G@_3?"OC3P'XCN?B#KV@V7@I=`\>>"]5AUN>#Q1HHO?/->_;P&
MC?L/?LX?MB2_#O3["+]H7PA^S?XCGT_Q'XXDT3X7_!Q/VA/#WA_7/^$C^+OQ
M;A\)ZM)X:^%_@237$T_7/'R^";B*>\ET9;C3='M=6FO]+3Q-_P`$_P#2[SX]
M_%?]I#P3\8?&GP^^)GQ?U_5$\2ZCIGAWP?KUI%\-?%?P9^`?P@\9?#RRLO$5
MA?01G4'_`&=O`GCS0/%;(=4\.>*UU"&:SU[PW=W6B7'L/A_]F6^\!?LR_`O]
MG7X7_&+QW\/[C]GOP)\*O`W@WQ]I=GX=U*^US3?A5X*M/`MC8^/O"^M6%[X<
M\5>'O$VBVQ'B;0'6P=KM[?5-"U?0]:TS2M5M`#S+1?VZ_"]G:_"W4OB2?AMX
M;T?QY\/_`(_?$2Z\0?#_`.)6H?&WPMJ/@_X'>/?A#X)N_B-\./%OP\\"7GA[
MQ+\+I8_BUI6N>+=<\:WOPW\6>!+!5FO?!>J:9IGC#6/"WT1XK^/O@[1?@IX@
M^-WA\W'BSP[I]KJ:^&X;**XL3XSUF+Q'+X,\/Z?H5Q?6T:SV'B[Q:;'3?#GB
M&.*;1M7T[4[#Q%I=S?Z'>6=[<_%VC?\`!,/P)IVK1^)9OB;XG;Q#K]C^TY:?
M$^?2_"'@KPOH?C+_`(:WU?\`9Q/Q=30O"^BZ9;:-\/[2]\(_LZ:5X/T]=#BO
M=3W^,?%?CC6M8UGX@7C^))_?K_\`9432OV2Y_P!F7PIXEFU&T\'V=O'\'+WQ
M9`D\?A:R\`>.;/QY\#/!^KS0">?5M`^&O_".^#?!%MJ\\;Z_J7A;PY9WVK37
M_B)KS4+P`XV']L;Q9J?Q8\6?LRZ5\+-)3]IKPYXTU18O!>K^,]4M?!UQ\!&\
M)2^*?"7[3-WXIL/!6IZM:_#;Q+JTEE\)I+>U\,ZAJ&G?&F+7?!4<E_9Z'<:Y
M+\V>%O\`@H)^U3XBT#P#)-^SE^S_`&7BKXJ?MQ?%G]A_P9I\?[1WQ(N?#]KX
MG^`L/[3I^)OCOQ/K#_LUVVI6>@WL_P"S9>IX%TK2="U74-4B\5VTGB&;PZ^E
M317?Z!Z7\`M-B_:7U#]J6YU?48/%>N?L_P#A;X%7OA!4L;C0['3O#_Q%\4_$
ML:K!JBPPZA<ZB^I^++O29%9([)[*RM[F.)+B611\W^)/V`Y?^$0\`Z3\-_C3
MK?@7QC\,_P!MSXY?MO>%/%^H^!O#WC2U3Q?\>=2_:&N?$O@S4_#-YJ.C6E]X
M;TW3_P!HOQ1IVE7D>IV>KJVD:/?7$CS&ZCE`/2OA=^UK<^,?%\'PZ\:_#S_A
M!O'6B?&KQO\`L[_$73+'Q=8^*]%\._%'0_A1I'Q[\"S>'];.E^'[[Q'X%^*'
MP9U)O%WA[7M3\/\`A76]-OS:^&-;\,6FKF]6TY*U_;MT;3OVE/VK_@1XZ\#3
M>%]!_9T^&GAOXE^%OB#:^(/[9_X6K9Q>"/"7C#XIZ!;>'#HVG'P]XA^'K?$S
MX56-E81:QX@?Q;%X]L+J`:5+:R6<VQX-_9'F\'^*?AQJU[XMN_B#J=M\<_'/
M[3WQD^(WC*"P@\5>/?C!J'PBO/@GX*MM(T/0;'3_``]X7\*>%_`VM1:-HNEZ
M6J+H>@?#WPMI=Q)K^K:QX@U^YK>/_P!A#P!\1?BJOQ8U7QGXNT_54_:/^'?[
M0TNGZ3%H]M9:DG@7X0>#OA-??"W6Y+BSNI]7^&WC8?#[P7XM\5:7+Y4][K_A
M;0A',+33T1P#SG]G3_@IO\)_B?\`!'X,?$7XSZ7-\#?B#\3-#DUCQC\.[*+Q
MG\4/#_P;C;XQ^,/@;IM]\2_BCH'@/3O#'@CPIK?Q!\&:OX>T;QGX_B\&:%J.
MIV&M16\[6?A[6;^SN?&;_@JA^R_\*/A%\9/BII5S\0/B1)\'_!'QC\9R^%/"
MOPQ^(UMJ/C3_`(4#\1?^%3?&+1/!6M:UX2L_#>O:G\,/'LEMI7Q'33=2O1X$
MTV[MO$WB1++P[+_:*\;H7_!+'P?X<\&GX>:;\:OB''X&\:>"(/A?\>]!D\/^
M")6^,OPYTGXZ_%_X\>'M`FU2;29=5\$7]KJWQR^(W@G6-=\.W,]YK?@37Y;2
M*WTCQ18:'XHTC1\6?\$L?A7XW^'VD_#;Q)\0_',OAVR\)?\`!0[P??/IUGH-
MAJ-[8?\`!0_XC7_Q(\;W5O.UM=0V%_\`#K5;Y;;P41:W=I>P6T)\16EZC3P2
M@'H'@3_@HM\'?$'QB^+7PC\<VVM_"RX\"_%GP+\+O".N^+_#7C[3-,\37?CK
M]E_X:?M+Z='XWOM5\$:5H7P:\73:9XU\0^'=,\`>/M<LO$>KW/@F^FM(1J-\
MNB6OTM\$/VB_A=^T-I%UKOPPO?%E]I$&G>&]<M-0\3_#;XC_``]M=?\`#7C.
MSNM1\(>+?"<WQ`\*>&8_%OA+Q/I]G<7FC>(_#;:II5S"FU[F&8B$_*8_X)\V
MNK7FK>)O&OQG\4:]X\\3_M8_`']KSQ/XHTSPAX7\.P7WQ$^`OP<^'?P<TW3]
M,\/;M7T_2M%U^Q^'.F^(;R*1]3:QU:\N8;=;G3$CMCZ)^RG^QGI?[+VN>.->
ML?'MWK[^,]#\(^&G\.>'_`?@/X1?#Z*+P=>>([R+QM>_#;X8:7HW@F[^+OBY
MO$LMM\0_B+IVBZ`/$VG:-X;TZW\.Z+8Z-#"X!8O/^"A'[)>FZ!XH\6:G\4)]
M,\*>%8=-OW\4:EX%^(MAX>\4Z%J?Q(\.?"&+Q7\-]9NO"<5A\4O!MI\2/%OA
MKPIJGB[X=S^)O#^E7NNZ-=7U_%I>K:7?WG.?$+_@HM^SQX/^'GC+Q=HVI^*O
M$_BGPIX;^.FLW'PU7X9_%O3O&FD7GP`\.:?KOCN+XD>'A\/K[Q)\)?#FER^(
M_!%E?>-_'F@Z1X9@C\>>$-0M;V_M=?TQKGYU\._\$=O@5X2\`^*OAMX6UG3?
M"_AR_M_AWH/A+4_"_P`%_@MX;\?Z/X/^'OQV^''QYL]"\9_$O1?"5CXY^*5Y
M<ZU\,/#?A9M9\2ZU:+)X;L[>_P!:TOQ!XVM_^$MF]$\5_P#!-'PYJ_Q!^/GQ
M+\+?&?QWX&\4_M)7_P`7](^)MYI?A[P9JRW?PL^-'PZ^#W@?Q'X`TF/7M.OE
MTN]T/4O@WI/BSPCXTB$FHZ;?^)?%6FZGI>MZ=<Z4NE`'J_PH_P""@'P"^(/A
M?P9JGB'Q"W@/6==^'>A>,/%!U;1O&#_#;P=XEN/@K8?'KQ=\-Y_C5=^%M,^&
MFI>-_`GPXGU#Q7X@\-P:[#XCL_#.BZKK=]HEBFFZI;6&G\!_VT?!W[0WQZ^)
MOPA\"^&O$MOX>^'WP,^`OQHM?&7BSP[XX\`ZQK\/QQ\7_'7PY8Z8OP_^(/@S
MPIX@L-*L],^#MEXCT?Q1ON['Q/9^+%BM;>T.C2RWGRWX,_X(Y_LV^%KK7=/N
MX-#U[P?XJ\$^)/#GB6UO/A%\(U^).H:QXX^"'_"B/&^JV?QSN/"VH?%+0=%U
MKP]/J?B:R\-:)K5E-H7B[5[Y+#Q$W@@Q>"(_K/X!?LJZI\'_`(I^-_C)XO\`
MC+XL^,'CSQQ\(/@_\$[[4/$/AKP=X7M+7PA\#_$OQ9U_P;<6VG^$;"QMSKE_
M_P`+;UMO%5](#;ZIJD0U#3;+0]/EMM!TX`^PJ***`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"OQ=_X*0?'?XE?#[XS>"=4_9V\10^)_B=\!?V1?^"B/QF\1
M?##2=7F\06UKK_A_X!^"]2^"MY\4?AYHFLVMY=Z3J_C2XMK7PG;ZW#:2ZM>7
MMS%X>N!/--*/VBJC%IFG07MYJ,%C9P:AJ"6T=_?0VT$5Y>I9H\=HEW=1QK/<
MK:I(Z6RSR2"W5W6$(&8$`_%<_MV_&KXN_M1I\#/@=\0OA##\//''[3VL_!SP
M)\6K+PB/B5IT7@G3_P#@FKX*_:M'B319--\::1H/C:]7XNZGK>B"_@U6'1?[
M"2XT9Q-J6C2RR^5?LT?\%1?VDOV@/B)^S]'?^`/`/@[1/B1IG[+?VKP?J&O_
M``MT!_''A[XU?"?PUXX^)/Q7\&?\)5\<;7XV7=AX6\1ZKX@TKX>:!X,^#'CS
MPYJ4'P\\8Z'XQ\:1:ZUY?>"_WVM=#T:Q^S?8M)TVT%F0UH+:PLX!:L+7["#;
M>5"GD'[&3:@Q;,6Q-N,0_)1#H6BV\]E=0:3IL-SIMG+I^G7$-A:136%A.T33
M65E+'"LEI9S-!"TUK;M'!*T4321L44@`_)W_`(*CZWX3M/!VLK8_%G0_!_QE
M\/?"3Q;XG\%:!XU_:3^)_P"SMI>DZ<T&M`?%+X1P>"+&+2/BO\>_#'B72-(T
M[PGX3US55M[**]M-/U.]\+:7XR>ZU_YXG^*7B#5OB7KWBZ]\=_$G2/VN(_VM
M?V,/"_P`^#_BWQEXF\*^)?$'[)WQ!\(_LSWWQ&3Q%\#=/>#PC<Z/K'@[Q+^T
MOXQ^-&NV_A'5+'P;\4?!6MP?\)3I-Q\*O#-MH7[WWNE:9J3V<FHZ?97SZ==Q
MW]@UY:V]TUC?1!EBO;-IXY#:W<2NZQW5N8YT#,%D`)%.?3K![Z'4WLK5]2M[
M>:TM[]K>%KV"UN9(9;BVANRAN(K>XEMX))X(Y%AFDAB>5':-"H!\J?M"?%S]
MG34/V7_&?Q1\>?M$6?P__9]LY[5/%OQA^'_Q'B\/QRV?AWXAVOAO6O!.E^.?
M#3W6L6^H^+_%.E77PDU'3O!5S;>/[S5-6U#PIX/O=+\9W%A<VOY,>!O%OA/7
M-5^%=I\3?B]_PA?["?Q&^-W[1VMVWAAOVJ-0U.+X*:GX:^#GP7MO@/\``_XQ
M_'#P=\0=1/A*]\5WVG_M"?M$:=\+IOBS+HW@7Q+JW@WP3IU_J5YX3T;3K3]]
M[;P5X2M/#X\*0^'-&_X1L2W$YT2?3K2[TQY[K49]7NIY;.[BG@FGN-4N;C4)
MYIDDEEO9Y;IV,[ERFG>!_!FD:7<Z)I?A/PUINC7MS'>7FDV&@:19:9=7<1MS
M%<W.GVME#9W%Q&;6V,<TT+RQFW@*.IAB*@'\_E_^T#K?AG2O^"._CGX_?M7:
MKX#\3ZY\;X-.\5?#?QQ\4O#'@"V\:?!R^^!/[:`\&?&WXPZ)J:^&?%_B?4/&
MFC^'?@]<7MQXYED\%Z-XV8W=AH-IXYU&2_7VWP_>>'O`_P"W2GC6W\7_``E^
M,OQ%\?\`[5?B[X=S?#W1/'/QKN_C[\-/!NO_``XNEMO&=_X/U'QO;^`;#P1\
M/=!T:&'5=''P;'@^X\':O;_$+P[\7+S7=3LM+UC]E-<\">"O$UTM[XC\(^&-
M>O%M%L%N]:\/:-JUR+%9FN%LQ<:C97,PM1<.TXMQ)Y(F9I0GF,6.W'I.EPW[
M:I%I]E'J3VD5@^H):VZ7SV$$C2PV+7:QBX:SAE=I8K1I#;QR,TB1*Y)H`^(O
M%7A/4/VA/C)^T7\*O$WB/QQX)T+PKX'_`&9T\+7?@[Q5J7AS4H[>_P#&?B?X
MH>(=?LI-)U&UNH7\3:WX&TKP+J\\WE"YT+PSJ&DP;K2_U>.\^1=)^,WAS1O^
M"JOQ_P#AP?VL/^$HO_$?[%&GRZ#\/-2^)/AN^L/`'Q,T_P".'Q:MQX.\!_"S
MPD87A\9>'?"EG8WNMPQ^']=^*WB&TMX;G7[[5+:UT/3M._8)?"'AU/%\WCR/
M3DB\57/ANW\(W>JQ37$;WOA^RU6YUK3]/O8$F6TO$TS4[_4[G3);B"2XTXZM
MJZ6<L,6J7Z7%=/`7@B/63XBC\'^%H]?-]+J9UM/#NBIJ_P#:4\303:A_:BV(
MO_MTL+-%)=_:/M$D3-&\A0D$`_!#X":QHGPL^$?Q]\._#7QK\+_B9K6F_L16
M/[0EU\<O@'\3OC#XK3PI\3_A(IU#POX(^)FJ_%+X@>.-/N_$GCKQ+'=>+]&U
M'[-\*]8\4Z7I'CO0_&7PMLK2QMKNX^Y/V\OVL?B%\"K#X4:!X`UG0_!WQ`^(
M/@WXG^.K72O&&A>!VTS5;CX<:7X,G7PFGC7XD?%CX9^%;/49M;\86.G7/@_P
MU8>._B;XMTY[N\\)Z3H-AX?USQ%#^@OB'X>>"_%.@ZIX8UOP[IMWH&N:G9:O
MK>EI`+2TUF_L-6T_6DEU:.R-M_:275_I=D=4AO3-%J]K&]AJB7=C//;2=-=Z
M;I]^;4WUC:7AL;R/4++[5;0W'V2_A$@AO;7SD?[/=PB60174.R>(22!)%#L"
M`?SY>#O^"HG[3GBGP[IOQSM_!W@C4_!=Q\7/V,OAE9?`+1O#6J?\)UXGO?VN
MOV#?@;^T8=(T[X@7OB*)=+\0^&/BO\3CX=\-0S>%-0&KZ/--I.M0'4#I^H6'
MKW[#OQY^(/QM_;7?7?$_QR\%_%S3/$7_``3D^!?Q`U+3_A59ZEX?^'W@GX@>
M,/CY\5+[Q)X/N?#<OCCQK81>+_"5E-IGA>\N=0ET[QS#HUEIEKXPLDNY+:6?
M]J(]$T>)52/2].C1+BSND5+"T14N=/@AM;&X4)"`L]G;V\$%I,`);:&&**!X
MXXHU5]GI&E:?)++8Z;86<LTEQ+-):V=M;R2RW=RUY=R2/#$C2275V[W5P[EG
MGN6:>4O,Q<@'X%^*?B;IFN_%[XO7?["/[1.H_$;XR_#3X=?MH7OCS5?$/Q^T
MSQY>_M!_'FR^'GC4?#C]GKX;?`T:_?:3JD7P&^)8TK5=2\7^#OACX>\+?#2V
M\$6GPCT'4/%^K>)OBY:^'M+P3X\^'=AI_P`8M'^$G[5OBGP]^S=J?[$WPK\:
M_$[XUWGQ[?6]7\(_M*>(/%7B:V72X/B!\5KOQ/!\.OBU\9_!$&I6GQ*T/2KK
MP[XS\.7UAX2\2Z/HW@[QIJ^F>(+S]Q;'P!X&TS6/^$AT[P=X5L->S<,-:LO#
MFBVFK@W221W)&IVUC%?`W$<LL<Y^T9F21UD+*[`W;WPEX7U+3[S2=0\.:%?:
M7J-^VJ7^G7FCZ;=V%[J33K=-J-Y9W%K+;75^URB7#7D\4ERTZ),TID56`!_.
M5\4?VIO&OBK_`((P_`*W^&^I?&#XD6?B7_@F_?:U\>/C[\"M6U#QYK_@KQQ\
M/OV1O#NJOX"\7_$#PMXBG\6^`/B!XL^(&O:;KWC3Q??WJZYH/@WPIXXM[J^T
MWQ3XDT34[;]0=/\`B9XE\3_LW?L&WO\`Q5VA0?&CQ3^S=I7CVZ\11S>'O%ME
MI+_#[4O']S9:_%>7*W]I/XQ\5^"="\):M:I/-=ZC9>*Y[7+QZA(U?>^F>%O#
M6BZ?<Z5H_A_0]+TR]ENI[S3]-TC3K"QNI[Z-8;V:YL[2VAMIY;N)5BNI)8G>
MXC54F+H`!6\3>#?#?B_1[?0?$&F17FF6>J^'=<L8(Y)[)]/U?PEK>G>(O#>I
M6%Q8RVUQ97FCZSI.GW]C-:RQ-%+;(HS$TD;@'X[?\%/(](_9J_9$DO(/VI_&
MWPQU"]_:?\+?%#3=+U/XL:7X5U?XA77Q/_;8^%_C;Q5X2_M[6;N/QK=_#?X;
M>&O&OB'3HO`OA#7-)\-Q^"!8Z1XMM+OP?IZZ++YS_P`%&OVH?&;_`!`_9VOO
M!>A_M`7GP5\&?M8?L":YX,^(/P.T._\`$'PX_:!U+XG?M"^$+/Q?;-X^\$^)
M7L/$W@W0OA[=77@;1?`-[BQ\=^/_`!Q?76H6%W9^$?#-S=_NMKOA/POXH%F/
M$GAW0M?_`+/:=['^V]'TW5_L374:Q7+6G]HVMS]F:XB58IS!Y9EC54D+*`!:
MM]!T2TT^QTFUTC2[;2],%F-.TZWTZRAL+`:?(LMB+*SB@6VM!9R*KVHMXHOL
M[@-#Y;`$`'@'[.FNZM?:E^T1X7O;^YU/1OAY^T7XO\->$;Z\NH[V9]"UWP9\
M._B=?:='=+)+,;/PSXO^(?BGPI86MTPETVQT2VTJ-$M+&V4?2M<UX5\(>'?!
M6GW>E^&M-CTVTO\`7?$/B:_"R33SWVO^*];OO$/B#5;VZN9)KFZO-2U?4;NY
MEEFE?8KQVT(BM;>W@BZ6@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#Y>^-?[6WPS^`WQ
MI_94^!'C+3/&5[XR_;`^(/CGX;_"^\\/:7I-[X?TK7?A]\-=;^*>MW7C6]O]
M>TN^TK2I_#VA75GIL^C:9XANY]9GM;>XL;6R:?4+?Z@!#`,.A`(^A&:_#W_@
MI9((O^"D/_!"IRLC@?M7_M.*5BC:5_G_`&/?'Z;MB`L53=O<@':BLV,"OVBC
MU^/RT_XE6O?<7_F$77H/]F@#H:*P?[?C_P"@5KW_`(*+O_XFC^WX_P#H%:]_
MX*+O_P")H`WJ*P?[?C_Z!6O?^"B[_P#B:/[?C_Z!6O?^"B[_`/B:`-ZBL'^W
MX_\`H%:]_P""B[_^)H_M^/\`Z!6O?^"B[_\`B:`-ZBL'^WX_^@5KW_@HN_\`
MXFC^WX_^@5KW_@HN_P#XF@#>HK!_M^/_`*!6O?\`@HN__B:/[?C_`.@5KW_@
MHN__`(F@#>HK!_M^/_H%:]_X*+O_`.)H_M^/_H%:]_X*+O\`^)H`WJXSXA^.
MM&^&?@SQ!XZ\01:A/HWANR%_J$6E6\5UJ#P&X@ML6MO/<6D4LGF7"':]Q$-@
M8[L@`ZO]OQ_]`K7O_!1=_P#Q-?/'[6.KQW7[.OQ7A%AJT!?PV@$ESIMQ!"O_
M`!-M,'SRNNQ!SG+$#`/.<`@'FQ_X*'?`L9SH_P`2@!U/_".:1@<XR?\`BI>E
M(?\`@H?\"@0#H_Q)!8X4'PYHX)(Z@`^)N2/05^;?[-5I!=?$B%IO#=UKS6\-
MJ\-W9:/I?B2X\-R2:K9H^M'PWJD\2:I;26_G:3=75K'<7>A)J*:I%&NW>/2?
M!_A*\L/'MSX:UKPIH%WX;UCQ!>6QO?#GPMM;[PSK=_<>'+":;PSXKU?4;O5-
M9^#^B^'3?6E[J\&F6XU#PKJ5SK=P@NH-*M9K4`^V_P#AX?\``K.W^R/B3NQG
M;_PCFCYP>AQ_PDV<>_2@?\%#_@4<XTCXDG!(./#FCG!'4''B;@CN#R*^`/!V
MD1R>!-7M/&7@XM8:5X1\/^(-/M[?P-I>FZ1K&D1^*?#LUWXGT[XNPW%WJNH>
M.O$NEW.IZ-I>@RW-GI&IS7@TUY+":QCLDL?%GPBMSX9!M]*BN_%T_P`6-<TK
MP=I>@_#'4?`>ICP):>';_4[_`$&70Y=%TG4=<;PK<6^E_:;Y+35[;2I9[NVA
M\3:N)[HVX!][_P##P_X%9V_V1\2=V,[?^$<T?.#T./\`A)LX]^E>R_!C]IWX
M>?'76=:T/P;8^*[2\T+3+?5KQ_$&E6-A;O;7-V;*-;>2UU;4&DF$PRR/'&HC
M^8.Q^6OR'TC2;FZ^%/C"VUSPQ%I[:=\.K'Q%X:FD\`:98:!<6YUG1+F#QI#\
M58);[5M4\9ZQ:7=YI]KX:EEM])U1IY-*86DUA'IZ^Z_\$[;Q;+XA_$:1K>[N
M`?!>E*$L[:6ZD&/$)'S)&"0/FX)P#M;N,4`?L;16#_;\?_0*U[_P47?_`,31
M_;\?_0*U[_P47?\`\30!O45@_P!OQ_\`0*U[_P`%%W_\31_;\?\`T"M>_P#!
M1=__`!-`&]16#_;\?_0*U[_P47?_`,31_;\?_0*U[_P47?\`\30!O45@_P!O
MQ_\`0*U[_P`%%W_\35^RU!;[S-MK?VWE[,_;;.6UW[]W^K\T#?MV_/M^[E<_
M>%`%^BBB@`HHHH`****`"BBB@`HHHH`_$#_@I/\`\I)/^"%/_9UO[4'_`*QS
M\0:_;N,#RX^!]Q>P_NBOQ$_X*3_\I)/^"%/_`&=;^U!_ZQS\0:_;R/\`U<?^
MXO\`Z"*`'8'H/R%&!Z#\A2T4`)@>@_(48'H/R%+10`F!Z#\A1@>@_(4M%`"8
M'H/R%&!Z#\A2T4`)@>@_(48'H/R%+10`F!Z#\A1@>@_(4M%`"8'H/R%?.'[7
M0`_9O^+.`!_Q32]O^HMIE?2%?"O_``4Q\4ZYX)_84_:2\4^&KQ+#7-%\!QW>
MG7CVMM>I!.?$F@0EVM;R.:VF'E2R+LEC=<MG&0"._*LNKYQFF6Y1A94H8G-,
M?@\NP\Z\I0HQKX[$4\-1E6E"%2<:4:E6+J2A3J24$W&$FE%\.:9A0RG+,PS7
M$QJSP^6X'%X^O"C&,JTJ.#H5,15C2C.=.$JDH4Y*$9U(1<FE*<5>2_%VQO[[
M2K^VU/3+RYT_4;&;S[.^LIGMKNUF`9/-MYXBLD4FQV3<A!*LRG()!9!>7EK!
M<VUK>WMM;7B".]MK:\N;>WO8U!"I>P0RQQ7B#)PMTDJC)XY.?Q/?]K_]H/<V
M/&MEC<?^93\+^I_ZA5-_X;`_:$_Z'6R_\)/PO_\`*JOZ`7T7O$%_\S3A'7_J
M89OY?]2+S_/LS\)_XF4X$_Z%G%/_`(0Y3Y?]3OS?W?=^V1O+QK-=.:\O&TY)
M3.FG-=W+:>LY)+3K8&4V:SL68M,L`E8LVYSN;,CZGJ<D\%S)J6I27-K"+:UN
M9-1O9+FUM@C1K;6MP\[36ULL;O&MO!)'"J.Z!`KL#^)/_#8'[0G_`$.ME_X2
M?A?_`.55'_#8'[0G_0ZV7_A)^%__`)54_P#B5[Q!_P"AIPC_`.'#-_\`YP^?
MY]F+_B93@3_H6<5=/^8'*?+_`*G?F_N9^V1O;TVB:>;V\.GQRF>/3S=W)T^.
M<YS/'8&4V<<Y+,3,D*RDDDN23G]#?^"<'_)1?B/_`-B3I/\`ZD#5_*!_PV!^
MT)_T.ME_X2?A?_Y55^Y'_!"CXW_$SXI_'+XZ:7XYU^#5[+2_A-X:U"QAAT71
M],,-W-XUDMI93+IMG;2RAH,)Y<C,@.650W->#Q/]'_C3A/(<RXBS+,.&ZN!R
MNE3K8BG@\;F53%2C5Q%'#15&%?*,/2E)3KP;4ZU-**DTW)*+]SAKQUX0XISS
M+N'\OP'$-+&YG5G1P]3%X3+J>&C.G0J8B7MIT<UKU8Q<*4TG"C-\]DTDVU_3
MQ@>@_(48'H/R%+17X:?M(F!Z#\A1@>@_(4M%`"8'H/R%&!Z#\A2T4`)@>@_(
M4N`.@`HHH`****`"BBB@`HHHH`****`"BF[TSMW+NZ8W#.?3&<TZ@#\//^"E
MIF'_``4@_P""%1@2*27_`(:N_:=PDTC11E?^&//'XDS(D4S*1'N*8C8,X56V
MJ2P_:2.;Q)Y:?\2_0_N+_P`Q>_\`0?\`4#K\7_\`@I/_`,I)/^"%/_9UO[4'
M_K'/Q!K]O(_]7'_N+_Z"*`,;SO$O_0/T/_P<7_\`\HZ/.\2_]`_0_P#P<7__
M`,HZW**`,/SO$O\`T#]#_P#!Q?\`_P`HZ/.\2_\`0/T/_P`'%_\`_*.MRB@#
M#\[Q+_T#]#_\'%__`/*.CSO$O_0/T/\`\'%__P#*.MRB@##\[Q+_`-`_0_\`
MP<7_`/\`*.CSO$O_`$#]#_\`!Q?_`/RCK<HH`P_.\2_]`_0__!Q?_P#RCH\[
MQ+_T#]#_`/!Q?_\`RCK<HH`P_.\2_P#0/T/_`,'%_P#_`"CH\[Q+_P!`_0__
M``<7_P#\HZW**`,/SO$O_0/T/_P<7_\`\HZ_/S_@JE)K;?\`!/G]J47EGI<4
M!^'46Y[;4KN>4?\`%5>&\[8I=*MT;Y=W!E3G'.,U^C]?GI_P5;_Y1Y_M3?\`
M9.HO_4I\.5]5P+_R6_!O_95</?\`JWP9\QQM_P`D;Q;_`-DUGO\`ZK,4?P:/
M]]O]YOYFFTY_OM_O-_,TVO\`5V.R]%^1_E\%%%%,`K]_?^#?)KU?C]^T&;&&
MUGE_X4WX6RMW<RVL8'_">G!#PVEXS$C=QL7!"\D$X_`*OZ!_^#>?_DX+]H3_
M`+(UX6_]3QZ_+?&O_DUO&'_8#A/_`%:Y>?IG@Y_R<WA'_L.Q7_JLQQ_5KYWB
M7_H'Z'_X.+__`.4=-^T>)/\`H'Z+_P"#74O_`)15>U8D:7J)!((L+P@@D$$6
MLN"".01V(Y%?S.Z1?>,=;O['2=+UGQ#=ZC?N(;6W_P"$CU"W$CK$\TC27-UJ
M,-K;00P12W%S=74T-M:VT,UQ/+'#$[C_`#)/]'#^E3[1XD_Z!^B_^#74O_E%
M1]H\2?\`0/T7_P`&NI?_`"BK^?M_AC\7W\:1^!M,UF?7M2FMEOHM3T;QV]YX
M=%BS)";J[UA=5\G30MXZ:<MKJ"6VH7-]);06-G=&\LS/RGAO1O'OBBR_M"R\
M5?V=:3:FNAZ;-XD\?R>'$UO7VLQ?C0M$?4]2BCO]32T>&:=6>WL[7[78QW=[
M!-?VD<P!_1?]H\2?]`_1?_!KJ7_RBH^T>)/^@?HO_@UU+_Y15_.5?:3\2-+\
M):7XVU&_\0V7A_6]5?1]*GN/$FHI=WUPEC)J'VF+3OMYNTTR6""=+;4IHXK:
M]GMYX[)KA899$N>&?#GQ'\662W^DZ_=I'=:I+H6CV^I^-KG2[[Q-KT%BFI3Z
M%X8M+J_636-6ALI;:62W0PQ>;>V%DMPU_?VEK,`?T4B?Q(>/[/T7\=5U$?J=
M"Q6A9/J;^9_:-O8P8V>5]BO+B[W9W;_,\^QLMF/DV;?,W9;.W:-WX)_LH:WK
M=S^T1\+(+K6=:N()-<U`2V]UJVISPN!X:UU@LUO/=/&VU@#LEC.UU!(#*,?O
MRO0?0?RH`6BBB@`HHHH`****`"HIA(891%(L4ACD$<K1^:L;E&".T>^/S%1L
M,4WIO`*[USD2TAZ'OP?4_P`LG\AF@#\BOB/\>?`_@WXIVOAF;XD?MA^)/%&G
M_%&Y^'WC3Q]X9\7?#;0/`'@2UTJ\^`VA>(/&[_#K5'L/#'B/P=X<\>_M)?"3
MP#=Z9IOPY\3^+;C4=1\3W=G8:[I/A+5M:E_6?2H+RUTS3[;4;\ZIJ%M9VUO?
M:F;6&Q.H7<$*17%ZUG;$VUJUU,CSM;V^((6<QPA8U51^)7C7PU'J_P"W+\2]
M7\1Z)XW\!ZE=_&3X%0Z?<^`/^";WQ"^*?AOXL^&?AW%X`\2^!_$_C?\`:4O/
MASK6E3ZEX7\;_;X;WQ/IFJ:1X3^%QT/PMJ)GNM4\)6_B6']PQT_$]L=S_G/?
MKWH`_$'_`(*3_P#*23_@A3_V=;^U!_ZQS\0:_;R/_5Q_[B_^@BOP_P#^"EJ/
M)_P4@_X(5(DTENQ_:N_:=(EB6)I%"_L>>/V8`3Q318=08V+1L0K$H5<*R_M+
M'I>H>6G_`!4FK_<7_EVT#T'_`%!*`-ZBLPV-V;98/[9U`3+(7-X(=)^T,AZ0
MLATPVFQ>H9;99?60\Y=+974AMRFKWT`A1%E$<.EL+ME(+23^=ITI1I`"K"U-
MN@#'8B,%(`-&BJ0M;@7AN3J5X8#G_B7F+3_LHS'LXD%D+[AOWHS>'Y^#F/Y*
MIC3+_<&/B+5B-P8I]FT':1NSLS_8V_:1\N0V_'(?=\U`&S165<6%Y-,\D6N:
MC:1MC;;P0:.\4>``0K76EW$YW$%COF?DG;A<*(?[+U#_`*&35_\`P&\/_P#R
MDH`VZ*Q/[+U#_H9-7_\``;P__P#*2C^R]0_Z&35__`;P_P#_`"DH`VZ*Q/[+
MU#_H9-7_`/`;P_\`_*2C^R]0_P"ADU?_`,!O#_\`\I*`-NBL3^R]0_Z&35__
M``&\/_\`RDH_LO4/^ADU?_P&\/\`_P`I*`-NOST_X*M_\H\_VIO^R=1?^I3X
M<K[P_LO4/^ADU?\`\!O#_P#\I*_/O_@JG87D/_!/C]J6276]1O$'PZBS!/!I
M"1/_`,55X;/S-:Z7;S=`1\DJ]2<Y`Q]5P+_R6_!O_95</?\`JWP9\QQM_P`D
M;Q;_`-DUGO\`ZK,4?PD/]]O]YOYFFTY_OM_O-_,TVO\`5V.R]%^1_E\%%%%,
M`K^@?_@WG_Y."_:$_P"R->%O_4\>OY^*_?W_`(-\K>:X^/W[0:0WMS8L/@WX
M6)EMDLY';_BO3P1>VMW'@`$?+&I^8Y)PN/RWQK_Y-;QA_P!@.$_]6N7GZ9X.
M?\G-X1_[#L5_ZK,<?UD:VZ1:/JDDC*B1Z;?N[L<*J):3,S,>RJ`23V`S7\GG
MA?\`:*^!^C:YI&JS_%[PS:Q6%PMS]K\.>,M%L=>M'6"58+S2;F^$UDMY:S/'
M<)#>)]EO$CDL;B2&&Y>>/^IWQ5IE^OACQ$6\1:LX_L'6OE-OH(!SIET!DKHH
M/!YX(Z8/&:_S78_]5%_URC_]`6OX\\&O"C*_$V'$,\QS7,,M>33RN-%8&&&F
MJRQZQ[J.K]8I5+>S^IP4.3EOSRYKZ-?UEXN^*.9>'-3(89?EF`S#^UXYG*J\
M;/$1=+Z@\N4/9^PJ4[J:QL^?FOK"/+:\C^I[6?VROV1]0^-/AGQY_P`+<\,6
M]EX5O[+5M3US3K+PQ;ZGX^O;:>&2SCO-$T_7-'L=.?1;(-8VVN7TE]J>H.&^
MUPI#!8R5S_@?]LK]FSP?H^C^&'^-NA3Z-X6\9ZGXF$EE:>#W/Q%T#7=+T*'6
M?`_B6QUK7;O^PM/N+S0Q"9UN-<L;O3[Z:XNM/^VV&FJ/YA**_;O^)5>&?^BG
MS[_P3EWE_P!0_K_3T_&_^)G.(_\`HF\CZ?\`+[,/*_\`R_\`7\#^D6?]I#]E
MN7X87/AM/C?X<@\03^,U\;Q:>D>F2:/:%/#5QX?@\,1:S)XL-R]M:+,AM]7?
M2@@MH5B.G*[%AO>&_P!J_P#98T0^&+:X^+^F7EG\,/B+JOCGP=/#>^&K:Z\7
M6E^OAV\71_$,)\0-'X6NUUCPMI\K:C9R^(85TN[O[9;=KJ&T>7^9RBC_`(E5
MX9_Z*C/O_!.7>7_4/Z_T]#_B9SB/_HF\C_\`!N8>7_41Z_AJ?U&_L=_&?X7^
M+?VJOA/8Z/\`$3P5J^N:WXKUR:WTS2==LKFYNKNX\-^)M0N(K.UCD:1PBBXD
M6-<E((B3PA-?TE+T'T'\J_@H_P""6,;R?\%!/V8$2:2W9O&VOXFB$+2)CX<>
M-V.T3Q31'<`4.^)L*Q*X<*R_WDV%K<6RMY^I7FH;UCV?:HM/C\G:&SY?V&RL
M\[\C=YOF8V+LVY;=_.WB_P"'F`\-^(,NR?+\PQF8TL;D]+,YUL;"A"I"I4QN
M-PKI06'A3BZ:CA8S3E'FYIRUM9+]\\)^/L=XA9'F&:X_`83+ZN#S:IET*6#E
M6E3G3IX+`XKVDG7G.2FYXN4;)J/+"+M=LOT445^3GZD%%%%`!1110`55O;J*
MQL[N]G$Y@L[:XNIA:VMU?7/E6\3S2?9[*RAN;R[GV(WDVMI;SW-Q)MAMX99G
M2-K58WB(;M`UL?O3G2-3&(;/5-0F.;&X&(K#1)K?6+V3GY+32KB#4KE\06$T
M5W)#(H!^%/Q)\.Z+XB_:YO=4L/##W>L>//CK\`?B9H'[2^O?LJ?MK3_M!?!G
MPWINF_#"[D^"O@#Q18?LQ:A\,;+P'K]EH]]H^IZCJ/QI\!>#O!=A\2OB!I_Q
M:^'GB37-*\5-K?[W+P/S_#D\#@<#H#CD8-?SI^"/@=J_@OXO_#C3]0E\1W5Q
MI?C/X9ZG+/HG[%7_``6?D\/M%J%[X;\0P(?'6O\`[7/BOX7Z.\%K?PP:Y?>,
M[76_#?@[5HM3LOB#I,PT/Q#I*_T6#^I]1W/K_P#J/4<8H`_$'_@I/_RDD_X(
M4_\`9UO[4'_K'/Q!K]'_`(Q?M7_#KX'>)=/\(^+-)\7WVI7V@VFO13:#IVEW
M=FMG=7=]8QQR2WNLZ?*+@2Z=.SHL#((VC(D+,RK^<'_!2?\`Y22?\$*?^SK?
MVH/_`%CGX@UK_P#!0SGXU^&^O_),]$[<_P#(P>)^E`'UA_P\4^"?_0N?$K_P
M2:!_\U%'_#Q3X)_]"[\2O_!)H'_S45^=5GX'\&:C\$)]?TC2_P"UO&-A<?;M
M?N_^$CFTOQ#H,-OI]W?7TUOX5U'3(+'Q'X0M-)6TU%_[$U"ZU*:&>;6IKZQ3
M3Y[)9;3X<>!?$'B[X4Z?H0U:Q\.>(_AMXC\:ZVVNZS:6^JZJ?"%_\09+QIKZ
M".73/#QUFS\(VT+I80WEOH5M--+$VJ7ENUS=@'Z(?\/%/@G_`-"[\2O_``2:
M!_\`-11_P\4^"?\`T+OQ*_\`!)H'_P`U%?G-<>&/##:CX:E\/_#^R\9S>-]`
M6?PM8>'/''BK_A![JYTG7-2L/&&JW=]K%MHGC?0DT2VMK2TNK;6KU-'TR4WO
MB6[U&32'L[!/+_$*>%=$^(.MVWAB"+QGX4L-=O;?0K6]O[[9KFGEFM[13J.D
M2Z1J%U$;ES'8ZC:/8MJB06UT8XX[J2$@'ZTC_@HI\$R0/^$=^)7/_4$T#_YJ
M*^R?`/C32_B+X-\.>.-$@OK;2?$^E6VKV$&I10P7\5M=!C&EW%;W%U!',`IW
MK%<3(#TD:OYW/BA9Z#I/BV;0-#T:TT:7PY;6^B^(UL-1UG4;&\\66I=O$,EB
M^N7^I7D%CI]]*VA6R?:F%T-*DU%EC:]\F+]U/V6CC]GGX0]?^1(TCL3_``R>
M@H`]^HI,CW_(_P"%&1[_`)'_``H`6BDR/?\`(_X49'O^1_PH`6BDR/?\C_A1
MD>_Y'_"@!:_/3_@JW_RCS_:F_P"R=1?^I3X<K]"LCW_(_P"%?GI_P5;.?^">
M?[4W7_DG474$?\S3X<]17U7`O_);\&_]E5P]_P"K?!GS'&W_`"1O%O\`V36>
M_P#JLQ1_!J_WV_WF_F:;3G^^W^\W\S3:_P!78[+T7Y'^7P4444P"OZ!_^#>?
M_DX+]H3_`+(UX6_]3QZ_GXK^@?\`X-Y_^3@OVA/^R->%O_4\>ORWQK_Y-;QA
M_P!@.$_]6N7GZ9X.?\G-X1_[#L3_`.JS'']6/BS_`)%?Q'_V`=9_]-MU7^:)
M'_JHO^N47_HM:_TNO%A'_"+^(^O_`"`=9['_`*!MU[5_FBQ_ZJ+_`*Y1?^BU
MK\1^B?\`PN.O^OG#G_I.=G[%]*+^/P3_`->^(_\`TK(1]%%%?V`?RB%%%%`'
MZ"?\$J_^4A'[+W_8[>(/_5;>.:_O23[B_P"ZO\A7\%O_``2K_P"4A'[+W_8[
M>(/_`%6WCFO[TD.47K]U>H([>]?PC]*;_DM\B_[)7#_^K?-S^V?HS?\`)'9W
M_P!E/B?_`%4Y..HHHK^93^CPHHHH`****`"D;[K?0]#@]/7M]>U+2$X!/H">
MW;ZX'YD"@#^>GQS)\(W_`."@?Q,7QQ:?L3OXSC_:*^%*^'9_VB?"?Q/^*?[0
M+Q#PO\+4TA_AEXPT-K3P;X"T:/4XY8?AMX%07\?@WQ3#JGB/Q#=FY\4S:?8_
MT+#IVZGI]3^OKZG-?G'KG[:?B1OVC?%OP9T&Z_8^\,Z;X'^)/@_X>ZMIWQF_
M:]_X03XZ:^?$.C^$]<EU[PG\%O#_`,+O&=O+::K#XFETSX>Z;K?C72M3\9ZK
MH]RMW!X=M[F(Q_HZ.?3J>AST./S]1V/%`'X>?\%+(8Y_^"D'_!"J.5=R']J_
M]IQ\99?FB_8]\?RH<J5;AT4XS@XPP*D@_)O_``5^_:7F^`O[3'@WP;I7@6PU
MZWOO@IX9\0M>77B'4+"2.6Z\6^.-/-NL*V5\&1$TQ)!)YP),C*8QMW-];?\`
M!2?_`)22?\$*?^SK?VH/_6.?B#7Y4?\`!?G_`)/+^'__`&;GX._]3WXEU^O>
M"'#61\6<=4,HXAP$<QRZ669AB)8:6(Q>&3K4(TG2G[7!U\-7]QR;45547?WH
MR1^4>,W$>=<+<%5LUR'&RR_,(9C@*,<1&AA<0U2JU)*I#V>+H8BC:225_9\R
MM[K1X-'_`,%3_BE%X/'@-/!=G_PC"W,<RZ>WBV]=Q;1J^-'^UOH37)\/F=C=
MOH32'3I+GYG@:%G@:S>?\%6?BI>R:#._@+PW:7/A>:.;P]=Z1=:-H5WHYCFO
MK@065UHO@FPG2P>?4]0EN-+>233;J2]NFNK2;SG!_*VBO[-_X@1X3_\`1(TO
M_#OQ!Y?]3;R_,_D+_B-OBA_T557I_P`RK(>EO^I7_=7XGZMQ?\%9/B[#_:"I
MX&\.&VU32+30+O3I;C0YM'_L.QO9]2M]'M=%E\#OI.GZ8=2N9]1N;/3[.U@O
M[^3[7J"7<Z12)RT__!3'QO<&$M\-/#D0M_$G_"6VZ6>JVNGQ0:_Y-G;B\@BL
M/"EM'%`L6GVFS2T5=(CDC:>.P6>:XEE_,VBG_P`0(\)]/^,1I:?]3CB#I;_J
M;>2'_P`1M\45_P`U55_\-61>7_4K\E^)^C5Y_P`%$/$>J:C>:E?_``QTFYOM
M3O[K4+ZY?Q;?J]Q>W]U)=WEPZQZ&B*\]S-+*PC14#.0B*H"C^N_]AC4M/^)?
M[(7[/'CN^T:+3KKQ1\+_``]J\UA#J%]<Q6CW8N':!+@O;&94.<.8(B<GY0,`
M?Y_"??7_`'E_F*_OM_X)F?\`)@O[)_\`V1CPI_Z+N*_!?'_PXX+X,X;R;'\-
M9)#+,7BL[6$KUHX[-,4ZF'^H8JK[/DQV-Q-.-ZE*G)RA",_=MS<K:?[AX$^(
M'&'%W$.;X+B+.9YEA<-DTL50I2P66X;V==8W!4544\%@\-4E^[J3CRSG*'O7
MY>9)KV?XR?$GX8?`S2-'UOQKINNRV>MZJ^CV0T*WNM2G%W'8W&H,9XY-5M!'
M#Y%M(!('<F3:FW#;A\]_\-P_LUD$_P!C?$/`&2?^$?EP!N5<D_\`"1\#<Z+D
MX&]T3.YU!Q/^"D]U:VOPZ^'+75U;6JOX]N51KJY@ME=AX7U8[5:>2-6;`)VJ
M2<`G&!FOCC]G:33M5\%?$&QAE\.627L/DZAXPND\`^*M'L;.36?!,*V'CW1-
M;O(-5TOPM9!KK58]7L[^RLY+:XU^ZBAO]>T+24B_E&-*K)<T:<Y1>B:C)IN]
MK)I:ZZ>I_3\JM*+Y95(1DE=ISBFE:^J;NM-?34^X?^&XOV:<X_L?XA9QG']@
M/NQG&=O_``DF<9XSC&<C.12']N/]FA02VD_$!0OWBVA,JJ>.')\2`*>1PQ!Y
M''(S^=>J:7J5W\!?#6I1^"X;*PTKXB7+_P!N:7HU^B:[H-QX+TDCQ)JGB&<2
M37]AK&J2>38Z@MS!H]OO@LM(@M90R2>AZA::OIOB;X/>(KOX>7V@/-\)_$>G
M1Z)X:TK3_"LEMXD:_P#B?:Z5INCMXM26UNO%5GIHL=1MK743K7BO51;KJ$-E
MK&H/%%-/)-NRA)O56Y7>ZW6W3J5SPM?GC:R=^96L]G>^SZ/J?:"_MR?LT.,I
MI/Q`=>FY-"9USZ;E\2$9'<9XIW_#<7[-7(_L?XA$@X(&@.2#UPV/$G!P0<'!
MP0<8(K\SOB?IMY<ZO:ZV\NMWEU'X4\/ZSXNT3Q)J6CWOB#P&-0\1W?AK2-'\
M1W6E6NB&"+6[A;"?0_MFCZ5K/E:]96EW:"[:":?2^-UE?V6E?"S7=5\)VW@>
MUN/A];6%W;0Z+/X:T:QU6/QGX[%MI+OJ6V1]671[>SFD_M.\NM<OX`-1O9KA
MI6F->RJW2]G.[V7)*[T3TT[23]&GLT+VE.S?M(66[YHV6K6KO;=->J:W3/VK
M^#OQ!^&GQP\/ZCXE\&:=K46G:7K,NA7*ZY!=:=<F]BL;+4&,4,>J78>#R+^`
M"0R*3()$V#:"WRQ_P51T/2['_@GQ^U-<6UL8Y5^',6&$]PQP/%7AIP,37#1_
M>1>7VKQ\S!=QK6_X)P7-M=?"'QD]K<VURB_$J]5GMKB"Y16_X1;PR=K/!)(J
MM@@[20V"#C!!+O\`@JT0/^">O[4I9$D4?#R$M'(&,<BCQ5X<)CD"LCF.0`I(
MJ21N49@LB,0P^GX'BX\;\'*2:DN*N'KJ2LT_[7P;5T[?C8^:XTDI<&<62C)-
M/AG/;2B[IIY7BEH]O+\&?QS_`!7_`&1O$WPMO_A[X>O?B+\+]1\<>,[74Y?$
M/@RZ\17/@V]\`3Z3J_C;3]3U'6-7\=:;X<T+5/`NEP>!]6_M/Q]H^H7&D1:M
M`^G6,&I6>H>%]6\2^(_%WX9:K\'OBGXX^$^L:MHFNZOX%\1-X<O-<T*6[3P]
MJDXM;&[BU'3)]6MM/O4TNXAOX)(I]1M+*58<S7$%N-R)]3_&7]J3X9_%SX5?
M"?X,WO@7XFV/@OPFOVW7WO\`XBZ?X^\3^#)[34OB@]GX2^"FN^.O#TT^E^$K
MVT\:Z'_;<WB^[UF\N](\)>#_``NEJ+CPA'XFUSS;XU?$_P"#'Q@^*?Q2^+</
MAKXE:+J'BVRMO$6E^%O$/B+PW?Z?+X\BU_P3IITVXU'POH&G7G_"%3^`].\3
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MPQX%^'6A_$KQ7X@3P'\8?^$JT/3?$/BJ'P9IN@ZG\%I?`\7Q7LO$S:Q<VE[<
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M-7&C6^MQ7%O!^Z__``1!^$#>!OCW\3+]]?T7QUX'^)W[-GACQM\/O&F@6_B'
M2-/\1:+:_%[6O"FLPSZ/XAL='\0:'K?AWQ5X:U70];TC4;8^1<6L5S97E_IU
M];74OXWZG^TEX4O_`(\?\-`6'@WQ[X2\77WCS6-8UL>#_'WA;2WN_"-_\/=-
M\'*R33_#JYTN_P#B3XAUU?$'C+XH:KK?AV]^'OQ&F\1ZEH%[X&T_3]0U*XN/
MW._X(V?':?XW?M(_$*VM[#5--\+?"S]F+PQX'\)V^NS^&Y=<N(+[XO:YXLUS
M5-1M_!?AWPEX+T5+[6=;E@TGPOX/\-Z5X<\,Z%I^EZ991W=RM]J-[\1XOUN)
MJGAYG2Q6%C2P4^'LL>;*I/"?NLPCCJ?UI4HT?:U*E1XQ9?["I#$1PT<++%7H
M5:KIU:'V/A/1X<I\?Y-]6Q,JN,CG^8?V4X0Q:]K@)8.?U9U95O9PIP6$ECG6
MA/#RQ,L5##6KTZ2J4ZW]!WBGPUHT?AGQ&RV>&&@:T`?M-X>&TN[4\&Y(Y!(Z
M?3!YK_-BC_U47_7*+_T6M?Z7?BS_`)%?Q'_V`=9_]-MU7^:)'_JHO^N47_HM
M:_//HG_PN.O^OG#G_I.=_P";/N_I1?Q^"?\`KWQ'^>0CZ***_L`_E$****`/
MO_\`X)8PQW'_``4%_9?BE7<C>-]>)7<RY*?#GQO(O*,K##(IX/;!R,@_WCZ=
MI=CIJ/\`8X?)\Y8_,_>SR;O+#;?]=++C&]ON[<YYS@8_@]_X)5_\I"/V7O\`
ML=O$'_JMO'-?WI)]Q?\`=7^0K^$?I3?\EOD7_9*X?_U;YN?VS]&;_DCL[_[*
M?$_^JG)QU%%%?S*?T>%%%%`!1110`54OX[B6RO(K2:6WNI+6YCM[B#[-YT$[
MPR+#-%]LMKRT\V*4H\?VJTN;?>J^?;SQ;XGMT4`?CO;_``F\>6?Q$T?7?%GC
MW]M'QGXXTWQ+HFMWFDZI^R)^P1JEGXHETC4-.G^SWOQD\.?LZZ;X:L;74X;.
M.U?6[7XF>&-=L++_`$FQN]"U"UMFM/UZTNXO+O3;"ZU"P;2KZYL[:XO-,>YM
M[U].NIH4DGL7N[4FUNGM)6:![BV9[>9HS)#))&RNUS8F=VU=W7.T9SZYQFG4
M`?AY_P`%+9HK?_@I!_P0JEGD2*,?M7_M.J7D8*@:3]CWQ_&@+'`&Z1U4$D#)
M&37Y1?\`!>Z^L[_]L;P!-97$5S$O[.O@Y#)"X=0__"=_$E]I(Z-L=&([!A7Z
MP_\`!2?_`)22?\$*?^SK?VH/_6.?B#7Y4?\`!?G_`)/+^'__`&;GX._]3WXE
MU^]_1N_Y.9A_^Q-FO_I-`_#?I#?\FYQ'_8VRO[O:S_6WXGX>T4>W?T[_`)=:
M4JPZJ1GID$9K_0T_@D2BEP<XP<^F#G\NM)0`Y/OK_O+_`#%?WK_\$U=>T:S_
M`&"OV4(;K4K2"5?@QX6W1R3*'7:+N-@R]5(=&4@X.1TQ@G^"A00Z@@@[EX/!
MZBO[[/\`@F8,_L#?LG]?^2,>%.Y'_+.X]#7\P?2G_P"2/X>M_P!%&ON_LS';
M?T_U/Z3^C+_R5>??]D]/_P!667GYD_\`!P=J>F:E\`?@`+.[M;S;\<-3++&R
M2E0OPU\2AB5.2`/-0;B`#NP">0/Y3K>YN+2*_@M9Y;:#5;-=.U2"WD:&'4M/
M2^L]42PU"*(K'>V2:EIVGZBMI=++;K?V%E>",7-K;RQ_U@_\'#(Q\`?V?^O_
M`"7#4>Y/_--?%/K7\F]?7?1W2?A9DZDDU]?S=V:NKQS*M*+L[ZQDE)/I)*2L
M[6^4\?6UXF9LT[/ZEE2NM':668=-7WLTVFMFFT]&3_:;GRQ#]IN?)"A!#]IG
M\D1@AA&(?,\H1JP!5`FQ2,JH(%)-<7%P`MQ<7$ZK(LJB>XGG"RK]R51-(X69
M.-DJ@2)CY6%0T5^X<JO>ROO\W;7\%]Q^,7?=[);]%LO1=`)RTCG.^5M\KY.^
M9]P??,V=TSAP'#REV#@.#O`8337%Q<+LN+BXN$W;]EQ/-<)OQC?LFDD7>!P'
MQN"Y4'!(J&BBRNG;5;/MMM]R^X7=='NN^M]>^NOJ?UN_\&_NJZ5IO[*OQ;CO
M+RULV;]H/5G"2,D197^&_P`/%5PH`R"8G&['5,$]*^V_^"J.NZ/??\$^?VI8
M+34K2XF;X=1;8HY5+MGQ7X:0;5X+'<RC`R><]`2/C;_@WS&?V4_BYU_Y.%UC
MN1_S3;X<^E?;O_!5L8_X)Y_M3=?^2=1=23_S-/ASU-?YW\5W_P")AG_V7_#O
MW?7<K/[ZX8LO`5:?\T/GG_J'F!_!J_WV_P!YOYFFTY_OM_O-_,TVO]$([+T7
MY'\"A1113`*_?W_@WROK.P^/W[0DU[<PVT7_``IKPM\\SA%)_P"$^*X!/4Y=
M1@9/.>F37X!5_0/_`,&\_P#R<%^T)_V1KPM_ZGCU^6^-?_)K>,/^P'"?^K;+
M[_A?T>NNS_3/!S_DYO"/_8=BO_59CC^I;Q1XET"3PUXB1=7L23H.M?\`+9>`
M-,NV8\XSA03CJ<8&3@5_"`O[-'@*3]CG2OCQI.K^/?$OBR37M/MO$6M>%8/"
M7B/X=?#]KFVLX+KP;\2M#TS7)?B#X).CRSK<7GCS4M&>"ZU>[TS3M.T"]\/:
MKINLR?WM>*QCPQXC(SQH.L]R?^8;==B<5_GK:;^U#X[TWX+Q_!RS\/\`P\M[
M*X4:9JOC2W\&Z59>.]=\!S:+I6C7?P]UC7M/BLY[O2M2L=(L=,U?Q"IB\8:I
MX;@A\+W.N'3X4E/\Z?1LH9S6H<3O)ZT:3HYSPE6Q\95(TU6R^$,_6(I7<)-\
MUXM)-KF2YJ55.]/]^^D/6RBC7X<6;4I555RGBJE@7&G*;I8Z4L@]A5TJ02Y;
M.]UK%M*K2>E3-^/?PN\$?#*7X1S>`/&&N^.=!^(OP=T?XAS>(M<T!/#!N]5N
M/'/Q#\&ZDVB>'C+<:EI?AN1_!,=WHEMK]U/XB>TNA<:PMA=SMI.G^FWO[.7A
M`>&=2\-:7J?CR^^..A?LW>$?VG;V"*WT*[^'^L:'XHM?"_B2;X9:!I5I8'Q@
MWB[3/`GC30=9LO$<FJW>G^(?$\.J^$X/#>GQG3=6GXG7?VB;#Q;??#!O$WP-
M^#)T7X5Z2WAO0]&T'3/'5O'>^$8G\9ZG8>$-7/B3XB>*+:\T.V\5>-=0\2/.
M;1==-Y#:QQZM]FMX[5LNQ_:8^*&E^$-,\.:7+X<TGQ'I?@SPQ\.(OBYI&C7.
MF_&&3X=^#==L/$OACP4WC2VU988-*T?6-)T=K74[+1;7Q;)I6C:/X<N_$MSH
M&FP:</ZK]CQ/4PV!I0G4AB,/7G4KUL57PD7B(U,=.6'>(>$ISIU(8?`TG#%X
M>C1HQJU,71>'E!X>4J?\Q>UX;AB<;4G"G.A7H0A1HX:ABY1H.&"I1KJ@L74A
M4A4K8VISX7$5:U:5*&%K?6(R5>,:GOH_9.^'>DW_`,!=&UWQOJ5YK?BS4OVC
M_#GQDBM_%7@3PEX;T+QU\"_!GA_Q6W@CP7XV\26=WH5FUKJOB.T\!>)_%7B8
MZGI4GBG3M;ET2S&G6]B;[YJ^,?P[L/!'B;PU!HVFW.D>$?%OAS2]>\.:_=_$
M?PE\6]#\0:?-JNH:+JGB'1/&_P`/?#'AW2;_`$C3M5T^]TK4-)305\0Z)J>D
MZC8ZC;R73VL!Z_4/VN/CCXBT3P3X:\=^)H/BEX?\#Z_XX\0P:'\5+2?Q]I/B
M2Y^(&F6&CZU;>+K+7+^6+5;>QTZSGA\,7EC_`&1KOA6XU75=3T36K359[>^M
M..\4?&K4_%MI'I>H^`_A;;:%I7A_1/"_@S0-+\+ZI::=\.]&TOQG=>.]63P7
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MIIVI*WV"\@N_)6/S?)</L\P-LW8Z;MC8]=IK^*?_`()^_&N;XI_MV_L4:'=?
M#3X7>#8OA[K&K>$O"]_X&L/'-GJ5GX1LO!7Q<URV\,3R>)OB!XLL[O3$UKQ5
MK.J&XEL1K+7$T,3:J;.!;4_VSH,(O7[J]23V]Z_C#Z1\<=#BCAV&8NK+%1X8
MM.=>6'E6G3>?YY*A*J\(HX?VCH.DIJE"$(S4E&"C9']>_1[E@I\-Y_/`*E'#
M2XC;C"C'$0I0J+(LBC7C36*<L1R>W51P=6<YRBXN4W)L=1117\\'[\%%%%`!
M1110`4444`%%%%`'X@?\%)_^4DG_``0I_P"SK?VH/_6.?B#7Y4_\%^/^3S/A
M_P!3_P`8Z>#N!U/_`!7OQ+Z>_I7ZI?\`!2UWC_X*0?\`!"ITADN&'[5W[3H$
M431+(P;]CSQ^K$&>6&+"*3(P:1254A`SE5;\H_\`@O?/+<?MC^`'FL[BQ<?L
MZ^#E\FY>T>0C_A._B2=X-E=7<6S)*`-(KY4DH%*LW[W]&[_DYF'_`.Q-FO\`
MZ30/PWZ0W_)N<1_V-LK_`/3LSYOT;X3?#[7/V'KSQ#X8^&7AN]^*/A\?\+`\
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M7Z=K$]OX@TGP[8>'5\(V.AZ?J(W2VVEVGA9%\.V]I'B*/1A]@`\@LI_M>AP]
MFU.>85*V/>(53'YMCL%3EF69T9)8S"+#87"U<30<9X7!PE.I55+"495<%.EA
MZM&OB*G.U_'5;/LKG#`4Z."6']G@<JP6-J1R[+:L9/"8KZQB<53PU;FCB<7.
M,(4W5Q-:-+%PJUZ=6A0IN,7]I^,O#7P9\'>!OB5\3;3X;?![Q9\5_A)X#^"F
MA_%+X7Z%J?B/Q'\"/"7Q,^(_Q'^(=AXBU*VM-"\<S7%YJ7ASP1X;\">#/$^F
MZ+XVU#P1X:^*WC74_P"Q;BYO]/M;>#'TG]GCX<7'[='B+X-7$;6GPWT`>-/&
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M3E/,L-BL+0QGQ454RNG5ITW#&RH8/U[]HCPYX6M8/@SX_P#`NF>`+3P?\4_A
M[J>M:9JOPZT3QUX+T;Q%J7A7QUK_`(1U^_NOAQ\0-:\3:IX'U"QN[*WTDQ:-
MXFUWPOXGM;.W\2Z=<6.I7FMZ38_VL?\`!,S_`),%_9/_`.R,>%/_`$7<5_!_
MXR\?>./B1KB>(_B!XN\0^-->6TM-,CU7Q'J4^I75OIMDTAL]-L_-(AL-.M6F
MG>"PL8;:SBEGN)U@$]Q/))_=9_P34O[R']@K]E&.+0]2NT7X,^%0)X)]'2-\
M+=`%5N=5MY@&`##?$APP!`8$#\(^DGAL1@^`>%\-BJSKUZ?$E7FJ.I.L^2>#
MS*I1IRK3IT75E1HRIT958X?"TZLJ;G2PF$I2AAJ7[?\`1YQ-#%\<\28C#450
MHU.'8<M-4X45SPQ>5PJU(T85*JI1K5H5*T:3KXFI3C44*N*Q56,L15_.S_@X
M:_Y(#^S_`/\`9<-1_P#5:^*:_E%M-+U/4+?5KNPTZ^O;30-.35]=NK.TGN;?
M1=)DO[/2DU35YX4>/3=.?4]0L-.2]O&AMFOKVUM1(9IXT;^JS_@X.N[BY^`7
MP!$^F7EAM^-^I$&ZETZ0.1\-O$P"K]AOKP@MN8C<%4"-LL"4#?E%^P+XIM;+
MX1?&_P`-ZM\1]"^%_AN2'^VO$/CGP]\4=&\%?$?P19WGBWX,:#<>(_$_@#QA
MI%_X8^,'P\ATI-0?1M$MHM3U9[Y?&WP]B@T[4/B?H\T_T7@SF]7(_!K*<?1P
MJQDHYQC*#I2JRHI0Q&=2H3GS1I5IN45/W*<*4ZE6;C"C"K5E3HU/`\7LII9U
MXN9I@:V*>$C+*\'656-*-5\^'R6C5A#EE5HQ49./OSG4A3IP4JE6=*E&=6G^
M7<GASQ'#I2Z]-X;\1PZ"ZHZ:_-X>UJ+0'263R8G37)+!=)9)9OW,3K>E99OW
M49:3Y::/#_B%KC3;1?#WB%KO68!=:+9KH&L->:U:D;A=:+:"Q-QK%J5!87.F
M17<!4;A(5YK](WO/"WC'X9^$K3X@>)_"'PY\`>'_`(8_`+0_`OQ+T?\`:"\2
M_$2QU7QEX3\1^!?#T^D^*/V6V\216,6EZ=X;'BGQ5X_\)7/PVT74?!^I^'9=
M0?XA>)8-7M!JWT9\1OBEHVI>(+;Q/8?V;I7B_7OC'\<=0\-^"?'W[9^A^)[/
MX@:3X]^!?C/PG9^./AC\2?"NNZG_`,,S^&!>WL.F>'OAZ]_I&D^)-9\2^&-%
MTGXAZ<_@RUO-*_2ZW&N,I35*&32JS<LQC-_7<+"E3J83#4:^'IJHJDXU75G4
MG3Q;@U4RITI5,VH8##-8A?G-#@["U8.K+-U3I\N73@E@\3.=2&*Q-2A7J.'L
MX2HJ$81J8533AF?M%3RNMCL0GAW^)&IZ5JNB7+6>MZ5JNB7JQ).UEK>F7^C7
MJP2AFBG:SU2VM+E8)55FBG:(12A6,;L%8B.[T_4;`6C:AIVHZ>M_:I?V#:AI
M][8+J%A(<1W]@UY!`M]8R'B.]M#-:R'A)F)%?6WQO\'QZSXL\/>)-*\0>&-$
M\3:+X!\`ZU\9M*USXWCXJZ'\,O%VJ_$?4?"6D:7H'BCQ3XD\=>)O&>G6>BOX
M3\:>+_!6A:K\2[SX<6VJ:]!?RW6E6%W:V/IO[3/B+5]0_9[\*:'\0O%[:Q\3
M;?X\ZYXGNVU3X\>%OVAKGXB:?K?@!M.UKXE^`[_PQ.(_@Y\,DU;3=/M+7P#+
M9QV?BJ^U[3-2L)8V\&36-M[-/B*52>2PIX>E4_M&M/#XJ*Q--8C"3C252-6G
MAZ?M_KE!J5.HZN%JU:<<+B,-CG/^SZOUN/C3R!4X9O.I7JTUE]&G7PTOJTW0
MQ4)U?9NG4KU/8?5*\6JD/8XFE2J/$X?$8)0^O4OJLOWA_P"#?+_DU/XN?]G"
MZQ_ZK;X<U]O?\%6_^4>?[4W_`&3J+_U*?#E?"7_!O]>7-O\`LK?%M8-*OK\'
M]H/5F,EK+IL:*3\-_AV"C"]U"T?<H56)5&0B1<,2'"_;/_!5._O)O^"?'[4L
M<NB:C9H?AU%F>>?2'B3_`(JKPV/F6UU2XFZ$GY(FZ$8R1G^%^*_^4AG_`-E_
MP]_ZFY6?VMPQ_P`F%_[L?//PP>8?UY]-T?PD/]]O]YOYFFTY_OM_O-_,TVO]
M$([+T7Y'\"A1113`*_H'_P"#>?\`Y."_:$_[(UX6_P#4\>OY^*_?W_@WRN)K
M?X_?M!O#97-\Q^#?A8&*V>SC=?\`BO3R3>W5I'@@D_+(Q^4Y`RN?RWQK_P"3
M6\8?]@.$_P#5KEY^F>#G_)S>$?\`L.Q7_JLQQ_5WXL_Y%?Q'_P!@'6?_`$VW
M5?YHD?\`JHO^N47_`*+6O]*+Q5J=^WACQ$&\.ZL@_L'6OF-QH)`QIET1D+K1
M/)XX!ZY/&:_S78_]5%_URC_]`6OQ'Z)_\+CK_KYPY_Z3G9^Q?2B_C\%?]>^(
MOSR(?1117]@'\HA1110!^@G_``2K_P"4A'[+W_8[>(/_`%6WCFO[TD^XO^ZO
M\A7\%/\`P2QD>/\`X*"?LP.D,EPR^-M?Q#$85D?/PX\;J=IGEAB&T$N=\JY5
M2%RY56_O)L+JXN5;S]-O-/V+'L^U2Z?)YVX-GR_L-[>8V8&[S?+SO79NPVW^
M$?I3?\EOD7_9*X?_`-6^;G]L_1F_Y([._P#LI\3_`.JG)R_1117\RG]'A111
M0`4444`%%%%`!1110!^('_!2?_E))_P0I_[.M_:@_P#6.?B#7Y4?\%^?^3R_
MA_\`]FY^#O\`U/?B77ZK_P#!2?\`Y22?\$*?^SK?VH/_`%CGX@U^5'_!?G_D
M\OX?_P#9N?@[_P!3WXEU^]_1N_Y.9A_^Q-FO_I-`_#?I#?\`)N<1_P!C;*__
M`$[,_#VBBBO]#3^"0HHHH`<GWU_WE_F*_OM_X)F?\F"_LG_]D8\*?^B[BOX$
MD^^O^\O\Q7]]O_!,S_DP7]D__LC'A3_T7<5_,'TI_P#DC^'O^RC7_JMQQ_2?
MT9?^2KS[_LGI_P#JRR\_-C_@X:_Y(#^S_P#]EPU'_P!5KXIK^3@,1P"1GK@D
M`\@\@$`\JIP<C(!ZJ"/ZQ_\`@X:_Y(#^S_\`]EPU'_U6OBFOY-Z^O^CO_P`F
MMR?_`+#LX_\`5C6/E/'[_DY>;?\`8'E/_JMPPT*H<R!5$C*%:0*H=E7[JLX&
MYE7C"DD#`P.*18XU#A8XU$A)D"QH!(6&&,@``<L,ABV202#G-/HK]P/Q<:$1
M0@5$41C$8"J!&,$8C`&$&"1\N."1T)H5$3=L1$WL7?8JKO<]6;:!N8]V.2>Y
MIU%`']=__!OE_P`FI_%S_LX76/\`U6WPYK[>_P""K?\`RCS_`&IO^R=1?^I3
MX<KXA_X-\O\`DU/XN?\`9PNL?^JV^'-?;W_!5O\`Y1Y_M3?]DZB_]2GPY7^=
MW%?_`"D,_P#LO^'O_4W*S^^N&/\`DPO_`'8^>?\`J'F!_!H_WV_WF_F:;3G^
M^W^\W\S3:_T0CLO1?D?P*%%%%,`K^@?_`(-Y_P#DX+]H3_LC7A;_`-3QZ_GX
MK^@?_@WG_P"3@OVA/^R->%O_`%/'K\M\:_\`DUO&'_8#A/\`U:Y>?IG@Y_R<
MWA'_`+#L3_ZK,<?U8^+/^17\1_\`8!UG_P!-MU7^:)'_`*J+_KE%_P"BUK_2
M[\6?\BOXC_[`.L_^FVZK_-$C_P!5%_URB_\`1:U^(_1/_A<=?]?.'/\`TG.S
M]B^E%_'X)_Z]\1_^E9"/HHHK^P#^40HHHH`_03_@E7_RD(_9>_[';Q!_ZK;Q
MS7]Z2?<7_=7^0K^"W_@E7_RD(_9>_P"QV\0?^JV\<U_>DGW%_P!U?Y"OX1^E
M-_R6^1?]DKA__5OFY_;/T9O^2.SO_LI\3_ZJ<G'4445_,I_1X4444`%%%%`!
M1110`4444`?F?_P4%_8'^(7[8OBS]E7XG_!S]J'5/V4_C!^R5\2?'/Q(^'WC
M[3_@]X-^-4,]]X]^'6H?#75[*]\)>.M9TOP^Z+H6J7XAGO(-419+EG6TCN8;
M:[@_+G]H3_@@M^V9^U/XUT[XA_''_@L/XI\6>+M*\-67A&QU*S_8/_9V\-Q0
MZ!I^H:IJEI9M8Z#XIL;.5X[[6=1E-U)"UPZS+$\ACAB5?Z=J*]#+,VS7)<4L
M=D^98_*L;&$Z2Q>78NO@L2J=2RJ4U7PU2G54)I)3AS<LDES)V.#,<JRS.,,\
M'FV78'-,(YPJ/"YAA*&,P[J4VW";H8BG4IN<&VXR<;QN[-'\B?\`Q#`_&C_I
M+!XT_P#$+O@C_P#-M2'_`(-@OC0`3_P]@\:<`G_DR_X(]AG_`*'6OZ[:",@@
M]#P:^D_XB/X@_P#1<\7_`/B1YO\`_-GE^?=GS_\`Q#_@/_HBN$__`!'LI_\`
MF3R_/NS^*3X0_P#!N_\`&_XH>)?C]X?F_P""H7BW1D^"GQMNOA';74/['WP7
MO6\1VUO\*_A/\1UUZXBE\66RZ=.\WQ*GT@V,#W,(BT>&[$PENY8(?;_^(8'X
MT?\`26#QI_XA=\$?_FVK^L#PSX&\)^#K_P`9:GX:T6UTF_\`B#XKD\<>,;FW
M:X9]>\52^'O#GA236;L3SS(ETWA[PEX=TLK:K;V_D:5;L(!,T\LO64?\1'\0
MO^BYXN_\2/-__FSR_J[#_B'_``'_`-$5PI_XCV4__,G]?-G\B@_X-@OC0""/
M^"L'C3(.1_QA=\$>H_[G6OT&^%__``3-_P""I/P:^'WA#X6?#K_@MQKFB>!_
M`FB6GASPOI,__!.?]E75IK#1[$,+6VDU+4]:NK^]>,.P-Q=SRS2=7=CS7[RT
M5Y6;<5<3Y]1IX;/.(L\SC#T:OMJ-#-,UQV/HTJW)*G[6G3Q5>K"%3DE*'/%*
M7+*2O:3OZ>5\,\.9)6J8C)<@R7*:]6G[&K6RS*\%@:M2CS1G[*I4PM"E.=/G
MA";A)N/-&,K729_.;^T9_P`$;/\`@H/^UCX>\.^%?CQ_P6>\1^+]#\*:]+XE
MT*TLO^"?G[,WAE[369M,NM'DNGN?#_B*PGN4.G7MS!]GN'D@#2"4)YJ(R_(O
M_$,#\:/^DL'C3_Q"[X(__-M7]=E%;9;QGQ?DV$A@,HXIXARO`TI3E3P>7YSF
M.#PM.52;J5)0H8?$4Z495)MSFU%.4FV[MN^68<(\*9MBIX[->&<@S+&U(PC4
MQ>/R?+\9B9QIQ4*<9U\1AZE6480C&$%*348I1BDM#^1/_B&!^-'_`$E@\:?^
M(7?!'_YMJ\+L/^#>/XWWO[27BGX!G_@J#XMCM?#GP0\"?%Y/%`_8_P#@NUS=
MW/C+XA_$CP/)H#:6?%:V\-OI\'@*+4H[Y;R2:XEU.6W>&*.UC:;^V"N1A\!^
M$;?QUJ'Q+AT.UC\<ZKX3T?P-J'B,/<_;;KPIH&M:[XBTC19$,YM!:V.M>)==
MU")TMEN#-J,PDGDB6*./O_XB/XA?]%SQ=_XD>;__`#9_7S9P_P#$/^`_^B*X
M4_\`$>RG_P"9#^4'_B&!^-'_`$E@\:?^(7?!'_YMJ/\`B&!^-'_26#QI_P"(
M7?!'_P";:OZ[**/^(C^(/_1<\7_^)'F__P`V>7Y]V'_$/^`_^B*X3_\`$>RG
M_P"9/+\^[/YU_P!G;_@CS_P40_92\):QX&^!7_!:+Q%X1\,:_P"(YO%FJV%Y
M_P`$^?V9/$LEQKUQIFFZ/+>+>>(/$-_=0HVGZ1I\(MHI5MU:%I5C$DLK-W7Q
M:_X)A?\`!4+XY?#GQ9\)_B;_`,%M==U_P'XWTU=(\2Z/;_\`!.G]E?1IK_3U
MN[6^$,>IZ5K=KJ%H?M-G;N9;6XCDPA3=M9@?WNHKYNKFV:5\R_MBOF..K9M]
M8IXS^U*N+KU,P^MT90E1Q/UR=26(]O2E3A*G6]I[2#A%QDG%6^AI97EM#+_[
M)H9?@J.5^PJ87^S:6%H4\!]6JJ4:N'^J1@L/["I&<XU*7L^2:E)2BU)W_D4/
M_!L%\:"23_P5@\:9)R?^,+O@CU/_`'.M)_Q#`_&C_I+!XT_\0N^"/_S;5_79
M17TG_$1_$'_HN>+_`/Q(\W_^;/+\^[/G_P#B'_`?_1%<)_\`B.Y1_P#,GE_5
MV?Q6_$W_`(-V/C?\/O'7[/'@V'_@J)XMU6/XY?%G7_AI=:A+^Q[\%[23PU!H
MOP,^,/QB36+:WC\6S1ZG+<W'PM@\/M9SRVL<<&M3Z@LS36,5M<>S?\0P/QH_
MZ2P>-/\`Q"[X(_\`S;5_6'K_`(*\+^*-7\$Z]KVCVVI:O\.O$=YXM\%7T[7"
MR^'_`!%J'A'Q/X$O-5LQ#-%&]Q/X2\9>)M$=;J.X@%KJ]RRQ+<K;SP]31_Q$
M?Q"_Z+GB[_Q(\W_^;!?\0_X#_P"B*X4_\1[*?+_J$\OS[N_\B?\`Q#`_&C_I
M+!XT_P#$+O@C_P#-M7T/^SG_`,$+/VW/V3O$7B/Q7\!_^"QWBCPAKOBS1+3P
M[KUW>_L%?LY>)DN](L=0.J6MLEMX@\47]M;-'>DRF>WB29P?+=S&`H_IEHKD
MQW''&F9X2M@,RXMXES#`XF,88C!XW/,SQ6%KQC.%2,:U"MB9TJD8U(0FE.,D
MIQ4EJKG5@N#.$,MQ5''9?PMP[@,;AY.6'Q>#R7+<-B:$I1<)2HUZ.&A5IR<)
M2@W":;C*46[2:?XG7?[!_P#P5VOK6YLKK_@N5K$EM>6\]K<1C_@FS^R0A>"Y
MB>&9`Z:HKJ6C=E#*0RYR""!7YAC_`(-@/C.H"C_@K!XTPH"C_C"_X(G@#`_Y
MG;T%?UVT5PY1Q+Q%P^L0LASW.,E6+=)XI95F6,R]8ET/:>Q==86M2]JZ7M:J
MI\_-R*I-1MSROVYKP]D&>N@\[R3*,X>%5189YIEV#Q[PZK>S=947BJ-7V2J^
MQI>TY.7G]G#FORQM_(G_`,0P/QH_Z2P>-/\`Q"[X(_\`S;5X5^TQ_P`&\GQP
M_9^^`_Q0^,UI_P`%0/%OBJY^'GA:Y\1P>'KG]C_X+Z5;ZM);W5G;BTEU"W\5
MWL]JCK<LYEBMI7!0`*02#_;#7(^/?`?A'XG^#_$'@'QYH=KXD\(>*=/DTK7]
M#O7N8[34]/EDCEDM9WM)[:Y6-I(8V)AGB?*##@9!]G_B(_B#_P!%SQ?_`.)'
MF_\`\V>7Y]V>1_Q#_@/_`*(KA/\`\1[*?_F0_E`7_@V#^,[;B/\`@J_XT`#R
M*,_L7_!$G".R@D_\)HN20N3\J\]ATI?^(8'XT?\`26#QI_XA=\$?_FVK^NL`
M`8`P,D_BQ+$_B232T?\`$1_$'_HN>+__`!(\W_\`FSR_/NQ_\0_X#_Z(KA/_
M`,1W*/\`YD\OZNS^5?X3?\&Z_P"U%\#_`(B^%/BQ\,_^"N_B[0?'?@F^N-2\
M-ZO<?L.?`+6(;&\N],O]'GEDTS5/%]SI]V'T_4KV$1W4$J(THE51+&C+^Z/[
M('P*_;`^"[>/S^U5^W3>?MGIXA'AD>!DNOV:?A%^SU_PKK^RO[;_`.$B*-\+
M+JY/BS_A*?M^C;O[<V?V)_8*_P!G[O[3O,?:]%?/YMGF=9]7IXK/,WS/.,31
MHK#TL1FF.Q./K4J$9SJ*C3JXJK5G"DJE2I45.,E'GJ3E;FE)OW,KR;)\DHSP
MV395EV4X>K5=>I0RS!8;`T:E9PA3=:I3PM*E"=5TZ=.#J2BYN%.$6[1BD444
M5Y9Z04444`%%%%`!1110`4444`%%%%`'RK\6/VRO@A\&O&&J^#_&&I^)Y9/"
M&D>'/$7Q4\2>&_!7B;Q1X*^"OASQC=WECX4U[XP>+-$L+K2/`>F:W-IU]=I)
MJ,TL^D^'K2X\8^(K?1?!<3^(A-!^V%\&)OBM:?">2Z\7V=YJ?C[5OA'HOCG4
M/`7BRQ^%&N_%_0=,U/6=9^%>C_$JYTR/PQ?>-;"PT768S:)=KI=[K>CZOX2T
MS6+[QAI>H>'[;XJ_:U^!?QD\/3?M;:=X$T*S\8?"K_@H19^"OAG\4?%MC9_$
M/Q-X_P#V<I=6^#5S^SWXN\>:3\+?`?A#Q3JWQ0\)7G@;1O"C:/9>']5\)WG@
M[Q_J-YKWBWSO`%UKOB7PSZ-:_"_]J7Q7^U;X0\1_%?X3?#?5_P!GOX,>,+J#
MX!6FB_M!:E+)X:L[7PEJ'A2Q^/7Q&\":E\%H;_Q]\:IM-U37=#\.^%3X[L?`
MGPTT7Q#>ZGID_BKQU*/%]D`?8?BW]HGX5^`_'&O^!?&FO2^%KKPQ\++;XPZY
MXBUW3KO3?!&G^#KOQ=<^";8R^,;E$T1M>GU^V-M!X:BN'UJXCGLY;:TF-[;)
M)X];_MV?!W7?@C\%/CQ\/]"^+7Q0\+_M!ZE=:?\`"SP_X#^%_B"_^(.MC3M+
M\5:UJU]J'@C6#H.K^&[+1],\':S/JI\1C2[JQF6TT^>T74[R&RKZ5^(3>)=.
M\+:UK?@/P3X?\=>.K*SLFT'PWK_B./P7I^L3VFJ6EW'87?C#_A&_%<NBP6Y$
MVH6]PN@:DJWMO"$@ADE%U!^2G[/_`.R%^T'X5_8__9_^!_QQ_9L_9=^+&O\`
M[//B[Q'*G@WQ3\9_%VN^"/'>B>+-/\>^?XCL-8/P?CTG3M3TFX\;#1[SP3\0
M/AOXX\.^(-,CO-6M-3\/Z[8Z+*P!^P7@WQ)_PF'A3P]XI.A>)/"Y\0:/8ZO_
M`,([XPTHZ%XIT3[=`D_]F>(-&-Q='2]7L]_DWUB;F<VTZO$9&*YKI:^?OV6_
MA5XJ^"?P(\`_#+QIK]KXA\0>&;;75GFTV^U[5-&T+3]7\5:]K^@^!O#NJ>*)
M9/$.J>%_AQH&K:7\/O"^IZTEIJ6H>'O#&F7EWIVERS'3;3Z!H`*\-^,O[07@
M7X)3>$M)\06GB_Q/XQ\?7&M0^"?AY\./"&M>/?'WB>W\,65MJ7BO5M-\-Z%!
M+<1Z#X5T^]L9]?U[49K#2+&YU30]'%W-K_B+P_I.I^Y5\1_M.>!_BWX:^)/P
M\_:R^"?@[2/BWXP^#'PE^.WPZUCX)ZOXGU3P==_$#PC\4K[X5^-9)?`_B2UT
M/Q9IUAX_T;Q3\%O#EKIFG:MX:DLO$>CZ]K.GC6-*U&VTM;P`L>(/V_OV;]#\
M.:#XUM=<\9>*O`NI?#BP^,7B+QOX+^&7C[Q/X8^&7PIU'4M>T6'QW\5]0T_0
M#)X`TJUUCPIXMT[6=.UNVC\3^'G\'^,[WQ!H&EZ5X.\3W^E?1OC/XI^%?`VI
M?"W2]8;5KBX^,'C^+X<>#9=$T:_URS?Q!-X&\;?$..?6;S3HYK?0]";PYX!U
M]QK^HO%I9U`Z9I@G-WJUDDGY#']G[]K2_P#@7\*O@9X4\#>"/B;^S=XLT7QO
M\4_CY9ZQ\2OB'^S)\1?BU\0?C;\9?'7Q>\=_!75O"7Q"^!OBKQI\.OV=[:X\
M8WNFZMI4[Z+\4_'VA7%MX%U^#P)X8M_$UAXR_;!+2.2VLC/86BSV:I/;V_[N
M:.RNOLDML5M9F@7R_+BN)[1)XH83]FED01K%(T)`/#?@A^U#\%/VC+SXLV_P
M>\81>,K3X+^.[7X<^--<L]/U"W\./XCO/!/A;X@POX8UZ\MX--\8>'Y/#7C#
M1+F#Q9X;GU'PS>S274&G:K>_8KB19/V>_P!ICX3_`+3^A^._$GPAUC4=<T3X
M>_%+Q=\(M<U#4-"U/0X;GQ1X.AT>[O[O1!JD,$FM>&=3TW7]'U?PWXFLT;2O
M$6C:C9ZKI4UQ87$,\GYZ>#OV8OVMO'NM?M^>'?B+H'@#]GCP?^V3XJ\">,-"
M\<_"WXLP_%[Q3X*T_P`#_!#X"?`K5OAYJ?@SQ#\'O`6BWVF_$30/A7XG35=8
MT_7+>31O#7BD:5ID<&N1Q:U9?07[`W[+GQH_9CD_:L3XO_$OPS\18?C+^U#X
MJ^,'@$^&?"^G>%8=&\(ZMX%^'WA:VBU/3--L[2TTW5+J3PB+=O#]C)?Z3H6G
M:3I@T[4;AM0O(;4`_0>BBB@#Y_\`'G[3?P@^&/BGQQX/\>>(9_#>L^`_@\OQ
MUOX]0TN]%OK?P\CU[4/"VIWO@^YBCE3Q9K.A^);;2="UKPQHPN/$.GZIXS\`
M6DFG,_CCPW_:'RQXP_X*@_!+X>ZW\;-$\<?#+]I;PN_[/?@;2?B-\4]0U3X)
M:J-*T#PEXJO/$NF>`=1AO;;6;G^U9/B)J_@_Q)H_@VRTV*XO-1U#2;F.\ATV
M+9,WK/[4W[,UU\=_B=^Q;X[T^S\,NO[/'[2DOQ.\:S:W>:C8ZAJ7PVE^#OQ0
MT:3PQI*6%G<Q:Z)?C'+\$/'<WAK6Y;30)=0^'.B^*9)6U[PCX?C;Y8_:]_8?
M^-7QJ7_@HG?>`[SX?->_M/\`[,W[)/PM^%EIXE\1:QHZ+XS^`?C[X]^+_%*>
M,[VS\+:T=!T+5K7XD>&;/1=6TZW\1W4MQ'JSWND6L=E;&_`/OCX/?M&^!OC'
MK'B7PC8:7XZ\"_$7P;IGA_7O%/PS^*?@S5O`?CG2O#GBNXUFT\,^*(M+U-9;
M'7?"VN7WAWQ!IEEXD\,ZKK>C+K6A:UH5W>VNM:7>V$/G'C[]NW]G#X7>`%^(
MWCWQ9JWAG1KKXU>(_@%I&EZAX3\0_P#"6^(/B!X4^,H^!6N#0/"4%E-KFJ>%
M+#QT\#7?CB&T7PE8^&;NS\6:CJ]EH=W;7<N5\'/A'\7=<_:*\4_M1?&[P_X+
M^'>MS?!S0_@?X%^&G@/QYJWQ'AL=`B\>:S\1?%WBOQCXNO\`P5X`L+W6=;UR
MYT#2_#N@Z1X>GM_#.CZ'J5]<^(]6OO%T^FZ!Q?\`P4=^#/QS^.7[/\OP?_9[
M^'_PU\0ZSXJ\:?#_`,1ZYK?CWXD77PTL?#-K\//C3\,OC%<"T32OAOX^N]?N
M?&4O@F_TFY55TE+#4)['5+V34D,B0`'NGC#]I_P[X6^,MM\$M.^&_P`:O'GB
M..U\#WGB37_A_P##B[\1^!_`]O\`$#5=9TS0)/&'BI]2T^TTO;#H.I:SJJ6T
M&H/I.AQPZC>K&MY:13?3-?E7\<_V6?C!\=]?;Q:WP8_9]\#?$CQYX7^$8'QV
M7XG^/=5^+?[,OBGP#XAOM8U&]^'@M/`T&E>-M3TRWOKA?"7B3PIJGP5G\1_;
M;GPO\2[/5/"MI"]]^J:@@<G)RQS[%B0/P!`_#C`XH`6O+O'WQ@\$_#+Q)\+/
M#7C*]N])G^,/C6;X=>#-4DL)WT"7QJ?#6M^*=*\.ZOK2_P"A:'?^);#P[J]G
MX7_M-X(-?U^"W\.6$TFN:GI5C?>HU\@_M[_`#Q-^U#^Q_P#'WX%^!KG1M.^(
M'CWP#?V7PZUS7=6U;P_8^&?B+IMU9:YX%\6)XAT"UO=>\.W_`(7\3Z9IFNZ7
MK^B6TFL:-J-C;7^G;;F%&`!Y_J__``45^#]CX_\`A/\`#_1O`'Q\\:7'QUU+
MQ)I_P@\4>#/A-?ZUX)^($7@V[U&/Q;J^@>)9-7L8)-`T'2M,N/%,VMW4%KI^
MI^$Y;+Q!H$VKV-_9M-TOP#_;X^!W[0UWX!@\+6/Q/\+V7Q?C\2W'P5U_XD?#
M3Q#X+\,_&.V\)6FH:GKC?#SQ%>+=:3JM_!H6DZKXFM?#^HW6D>)M4\+:3K7B
M32]$O=&T+6[S3Y?B5^S7K6M?M'_L-?$?P';>$/#WPT_9??XXV>N>'4DGTNZM
M="\=_!>'X:^"M+\&:/8:5-ILEKI%U;V\-U:3WND0:?H\,9LA=.BVM?('[)'[
M'G[3GA;X<_L/?!;XZ:#\(_!O@K]B'Q+>>.1XH\`?$_Q1X^\2?&#QAI'@;XI?
M#OP1;66CW7PY^']CX"\)Q6'Q8UOQ-XI;5-7\4ZM?W^CZ/X9LM.73[[5==C`/
MT;\3?M)_"3P3K?Q;T;QIX@N?"<7P4\(_#CQIXXUW7]&U2Q\.)I7Q5U#QAI/@
MNS\/:P;:2'Q;XBU75_!6J:/'X6\-IJ7B%]8OO#VD6VG7.I^(M(M+KE[G]L#X
M'VG[)^F_MHSZ]K"?`W6OA+HWQGT34SX7UP^*M8\)>)-`MO$/ARRTWP*+0^)[
MKQ=KMK>V5EIG@Y+`:_<:Q=1:2;2.\\Q(_5/BFWC'3/!?B#5/AEX"\-?$#QZT
M.F0:5X=\2^+E^'VG:IY5\L7FWOC*/PGXTGTYM%M+R^U33_\`BG]0,MW$+2$V
M37C7D7X_^&?V!/VL_%_[`_[/'[.WBSQ[X+^!WQ._9A_9Z\4_`_1=*\)ZAIOQ
MK^%_Q5\0W7[/]G\'_#OQ/U?5O$O@/P-X@\#ZAI2W_C32]!M]/TC6;CP_I'B[
M6-5F&K:O_9!T@`_9_P`!>-M`^)/@?P=\0_"MQ+>>&/'?A7P[XS\.W<]O):3W
M6A>*=&LM>T>XFM9OWMM+/IVH6TLEO+^\A=FB?YE-=;7S[^R?\,/&?P3_`&9/
M@!\(/B)XBT[Q;XY^&'P=^'7@+Q3XAT>SCL-)U/6?"7A/2M"NY-,MHH+51IUN
MUB+.QG:UMIKVUMHKZYMK:YN9H(_H*@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`P#U'3D>Q]:***`"BBB@`HHHH`*.O6BB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB@G'Y@?F
M<4`%%?RJZO\`\'"7QATW5M6TZ/\`9M^&<J:;JVJZ:DK?$/Q>K2IIVI75BDK*
M/#A"M*MN)&4$A68J"0`3]:?L'?\`!8;XD?M=_M+^$?@5XB^"?@?P7I/B/0/&
MVLS^(=$\8^(M7U&UD\*Z!+K%O!%8:AHUG:RQWDL8@F=[A6BC)>-78!:_7<S\
M#/$C*,JQV<X[)L-2R_+L%7S#%U8YOE-65/"X:C*O6J*E3QDZM1QIQDU"$)3D
MTDHMM(_*<M\:?#W-LSP648'-L35Q^88RA@,+2EE.:4XSQ6)K0H4H2JU,)&G!
M2JS47.<HPCO*26I^^U%%%?D1^K!17EWCOXP>"OASXQ^#7@;Q-=7\&O\`QW\=
MZW\.?A]#::=/>6UYXG\/_##Q[\7M1@U*ZB(BTJT3P9\-O%%S%>7.8IKZ"TTY
M/W][$1E^%?C]\*O%UOKEQ9^+--TL:!\1O&/PKNH?$EW9>'+FZ\8^!_&<G@#6
M;'2[?5;NWDU.";Q8BZ/I-S:+(NJW<]M!:*\]Q%"P![+17S;8?M9_`V;XL>'_
M`(%ZQXQMO"7Q=\9ZM\5].\!^`/%2QZ7K_CJR^#%_X?T_QQX@\+01W%W#>Z';
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MUSI>LZCKNL6-O):7T%N^FV;76LZM]@T33=2U&S]9L_&?A'4-8O\`P]8>)_#U
M[KVE:79:WJ>B6FMZ9<:OIVC:DK/IVK7VF0W;WUGIFH(CO8ZA<V\5G>(I:VGE
M4$T`=+16!X9\5>&?&>DPZ]X1\0Z%XIT.XEN(+?6/#FL:;KNE3S6DSV]U%#J.
MDW5Y92R6UQ&\%Q&D[/#,CQ2JCJ5&_0`445\>?M3_`+3&N?L^W/@F#1_"ND^)
M%\50>();AM3U.]T\V9T:72(XQ"+2UN!*)QJ3F0R;"AB0+NW-@`^PZ*_(H?\`
M!2+QL2!_PJ_PKR1_S,NL_P#RLK],OA/XTNOB+\-O!7CF]L;?3+OQ5X=T[6KC
M3[6:6YM[.6]B\QX(9YDCEFCC/"O)&C,.2HZ4`>AT44C,%&3TRJ_BS!1^I%`"
MT5\,?!;_`(*!?!CXWZ]X,TO0_#?Q?\+Z+\4/%GC_`,"_"3Q[X[^&]_X>\`_%
M/Q?\,Y/&[>*_#WA#Q)!J&JQKJL&G_#?QSK6EV7B6V\.3Z_H_AC5KS1%OS:M"
M?JI_BG\,X_"T?CB3XA>!T\&2WPTN/Q:_B[PZOAB34C?-I@L$\0MJ0T=[TZDC
M:>+1;TW!OE:T$7V@&(`'>T5X_P"$_C_\&O'/Q8^)OP,\)?$/PYKOQ;^#5CX1
MU/XG>`[&[9]>\'V'CO3YM4\*7.IV[QI&T>JV$#7&;.6Y-B)K./4A9S7]C'<.
M^)WQ]^#/P;\*?$OQM\3/B5X/\(^'/@[X/N/'OQ,O-3URP^T^#?"<%I/>)K&M
M:3;SS:Q;0ZA';O%HL1L#<Z[>M#I^C0WU]<06\@!Z]17EGPV^+_A+XE_#KP-\
M2[%[GPYHWQ!\.?\`"5>'[#Q;-HVE:T^B_9'U%KJ>UL]8U2S`BTM4U.X^RZC>
M)9V,L<UW)`1*D73ZIX\\$Z'9-J6M>+_"^D:>EUI-B]]J?B'1]/LTO=>6%]#M
M&NKR]AMUNM86X@;2K<R";41+&;))PZD@'645X=\4/VBOA1\(M1\":/XO\21+
MJ_Q$^*_@KX,^'])TA8]8U-/&_CZ:.'0+;5M/LYVN](TXM<637^IWL*06$6HZ
M;+.`E_:F5NC_`+1GPG\0_&N7X`Z#XCCUKXA6_P`.=5^)]U;Z2D>I:-9^'=#\
M=0?#G5[6\URRGGLK7Q#IWBJXCL;WP].4U*T0/+<Q1;&0`'N=%%%`!1110`44
M44`%%%%`!1110`4AZ?BO\Q2T4`?YH/BAT_X2?Q1\R_\`(T>)OXA_T,&I>]?J
M!_P1293_`,%#/A<`RD_\(/\`%_@$$_\`(D7/;-?UN3?L1?L<W$TUQ/\`LL?L
M]33W$TMQ/-+\'_`;R33SR----([:&6>265WDD=B6=W9F)8DUU?@;]EW]FWX8
M^)+3QC\.?@)\'?`GBRPM[VULO$OA#X<>$_#NNVEMJ4!M=0M[;5=*TNUO8(;V
MV)M[N..94N(28I0R'%?UYQ-])'(\]X7SSA^CPWFU"KFN2X_*Z>(JXK!RITJF
M+P=3#0JSC!\SA"4^:2C[SBK+4_E/AOZ/6=9'Q+DN>U>(<KKT<KSC`YG4H4\-
MBXU*L,)C*6)E2A*2Y5.:IN,7+1-J^ESW>BBBOY#/ZL/D?]J7X->/_B%KO[-?
MQ1^%D'A35_'?[-'QPU'XLZ;X0\;^(M6\(>'?&^E>)?@?\8?@9XDT"3Q7HOA?
MQG>>'-6M='^+<WB30M0D\,ZQI]QJ6@1:-J,%G:ZJ^KZ;^<_Q-_X)D?%KXFVO
MQIU;64^"TWB;XJ?L;_\`!0GX>:+9:IJVN^(-)\`_M(?M>_'&P^+?P]U?0]4U
M+X?V]V?"_P`.+2PLM,N_B'!H^F^+DUBREUC0O"5I!J"V-C^Z%%`'X%>(/^"6
M_P`=]5\3>)_%D'B?X967B?QKK_\`P4K\+?\`";:=K.LVWC3X:^#OV]M`^$=E
MX?\`B[X0U*7P1/-J/Q'^%^J_#/4Y;_P6E_X:@U6T\::E<Z3\0;*[MI;?4>O^
M'?\`P3H^,?@Q?A_XUU+P_P##+Q?K?P^^,7@CQI=_`WQQ\6;?Q#\(_'?A_P`&
M_`CXD_!#1;YM0\-?LI?#?PWX.\4>!I?'UEXL\"W"_!SQ/JE]:^$],TOQ7XH.
MJCPYJ?@O]QJ*`/S*^"?[&7CKX7_\$[[?]DCQ#H/[/_Q"\30W7Q*_M3P=XPTC
MQ%JWP&\4>'/&WQ_\9_$]_!5S;QZ;!XCT&PN?!GB2/P]I&OV^B:O<^`O$D6G^
M(K;P_P"*H=`CTK5/`K']@/X^67B+X1_$JTLOAS.GP/\`VGH?BY\(?V?OB1\:
M?B?\>?#WPJ\(>(?V8OBA\`?'?_",?&_XG^!+WQS+/=^-_'WAGXUZ;\*8-&TG
MP'IMY\-X-!\->)/"^J^*KG7]%_;*B@#^<*__`."3/[2WB:SO[OQ3??`V[N8?
M@M\#?#-YX$F\4W$WPT\>_%?]G+]L'X/_`+2&@ZW:>&?#G[/O@3PI\)/`GQ`\
M,>#?B!X`M=%TGP7XUU3X::=XU:WGN?&]M=:LLWN6A?\`!-/XN7GC7XYZMX_O
M/#WBS0_BC;?MA>(+:VUCXQZS8:9K-W^UUH?B/3[SX3^+](^'7P&\"_$9/!_@
MG2_$5G\.T\5CX\>)8H?#W@#P-XQ\">`/"VO6VFZ#X._<NB@#X6_8@^`_Q@^!
M>D_%*S^)Q^'UAIGB[Q=X?UOPAX=\)_\`")Z_XETJWTGP7H_A/5KKQU\2_!GP
M2_9XTWX@WVI-H6EIH%UJOPT?Q1HF@:?;:?KGC3Q)YEG8^'ONFBB@`K\I?^"E
M)`U'X09('^A^.>O_`%\>%J_5JN1\3^`/`WC9K)_&/@_PSXI?3EN%T]O$&B:=
MJ[62W1B:Y6U-_;SF`7!@@,PB*B0PQE\E%P`?S*J1D<CJ.X]:_HB_9B(/[/OP
M@(.1_P`('H/(_P"O:M[_`(4/\$O^B1_#?_PB_#W_`,KZ](TK2=,T+3K+1]%T
M^RTG2M.MX[33]-TZVAL[&RM81MBM[6UMTCA@@C7A(HD5%'"@4`:%-=2P`&/O
MHW/HKJQ_'`./?TIU%`'\^^F_\$@_B?IOP#\*?#^Q^)JZ9\0-6^'W[<'PW\?:
ME=?%?XO>-/!/@&Y_:4\1>._%W@+XJ_`?PCXODU/PI\/?'&CPZC#\)/'D7@OP
M;X(.K?"7XO\`Q@TVWO\`4I[;2[/6O0F_X)T?%O\`X5_#=3^&_!^I>/X_C;<_
M$6T\/:G\?-+N=-\*:=-\"S\#9=0\+7Z_L6VWP+O+[5_#<UUX=\1>$/%W[*>N
MZ3J_A)=-U9_$D/CO3;>Z'[C44`?F9^Q]^R%\4?V=?CEXZ^(WC*V^#/B,_&#]
MG#]ESP9X\\9?#W3!X"O-&^*/[.W@J_\`A_JNB>'?A]:>#X=+D^&WB[3-0T_6
M-'O[3Q+H)\/S>'8M$3P#::=)I7]E_)/QM_X)=?&/XJ^"_CQ\/K=/@7:3>(_#
M7_!1J7PM\8+^_P!9G^(_QNUG]M7PW\0K+X<>!_CI:1_#E(O#_@[X,:UXR\+W
MEYK>G>)/B#/J5Q\%?A'JGACPQH#:6VG:+^]-%`'PO^T[^R7?_&/X*?"CX9^`
MY_!_@V^^'WBOP9IUTDNGO9:$?@[XET+4?@[^T/X.T6+1[`26%YXE^`_CKXAV
M/@Z*"VL]/@\:Q>$[V^>PMK)[NU^/[;_@GM\:O#OA[X:7NH6'P`^/^M>"M1_:
M8\':G\,/BS=:_HWPNU?X<^/O#?@#X+?LZ^,);X>`_B#<7'Q&^$G[/OP:\%>#
M/%EG<^%?)\0CXD?&>+1/$EB=2MFUK]J**`/P?\._\$J_B_X;TF#3'^)'A7Q!
MXFLOVJOV)?B2GQAO]1UBT^)%_P#"K]FK]CKX,_`+Q7>^?+X=U4Z;X[N?B7X'
M\6>/_!WAPZEJ.A2?;=(U36_$4>MSZ@(_</V+OV&OB?\``/XY?#WXD>*O"_P'
M\&:#\.OV'?"_[(MU%\)=4UJ^U;XB^*/!7Q'T?Q4/BYKT%]\/O!=OIB^,K&VU
M#4KGP_<WGB;6?#NMWU]!>>*O%(U!M2@_7"B@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
6BBB@`HHHH`****`"BBB@`HHHH`__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>biib-2015630_tyschart.jpg
<TEXT>
begin 644 biib-2015630_tyschart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`$V`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^2OVW/VF9_V1_@!J7QG
MM=%\'ZY<0?$?X&?#F%/B'X\?X8^`M'?XU_&SP#\'1XL\:>.X_#GBR3PYX6\&
M_P#"<_\`"4Z[>IH-\S:=I%Q;C[/YWVJ'ZUKPK]H?X$Z)^T3X#T3P%X@UB_T3
M3]%^+_P%^+JW6G6ME>37>H_`;XU^`_C5I.BW$%^KVYTWQ!JG@.TT359`IN(-
M-O[J:T_TJ.&@#P'P1^W=\+H-%\)1_%WQ[\(#XE\6/I>HQZY^SGXE^(/[07P0
MT+PCXO\`'NH?#3X>>*/&/QKTSX7^'O"_@33/&'CC2-9\(V.I^-QX?T&7Q+HN
MMZ=8:S?PZ)K%W8=WJ'[:7P;E^`/QS_:+\%GQG\0/`OP%\/\`Q0U7Q+_PCW@#
MQQ#>:YJ_PB/BNR\:^$_""ZIX=M!XFUW1/$7@W6O"^MKHBZA:>'=:M9K?7+BR
M^S77D\C\;/V'/#'QC\?^+/$X\?>)O!WA+XP>$/A;\/\`]H/X=:)HWA6[TCXL
M^#/@SXO\1^,?`VDQZUJ>F3>(/`L\C>,/$_A/Q5J'AJ[:37?!FKM8V,.@^(]/
MTKQ79=[\,_V3_!?@']FKQ9^S#J&MZ[XH\%^-Y_VA1XCU2<6>CZW<6'[1GQ%^
M)GQ`\6V5H^GQO;61TR7XGZOI&CW*1O(EK965U.CW)F#`'S3\'O\`@J-\)/B3
MX[/AKQ-X4\8_#+P[JWPS_8K\=^%/$WB/POX^N'&J_MH_\)[IW@SPM\2K2V\"
M1Z;\(3;>+_"6C>!]!\0^.-;T[1/'/B7Q;I=IHMQ$DMC)J'U[\)OVH_@E\;]?
MU#PW\./%=YK&HVNE7?B+2Y-0\)^,O#.E>-/"EAK:^&[_`,9_#;7/%'A_1M&^
M)G@JQ\026^D7?B[P'?>(/#\%W?Z07U`6NN:'<ZE\8Z#_`,$O_#=IX#\=>"_$
M_P`8_%GBB?QUX;_86\'7^MMX4\,Z+)'X=_8(^*4_Q"^&D+Z;832V<^H>+M.%
MCX8\=7L;6=O.+>YUG0=/T:6\33K3U7]D7_@GU\)_V//$>JZS\/(O"RVL7A*3
MX=^$%TOX._"'P7XKT[P+)KUIX@73?&_Q*\)^$[#Q]\4=8MYM-T;2H]<\2:U;
M17FEZ)IMYKFD:SXN%[XLO0#YZ^/_`/P4/_:!_9X\9_MC6GBCX`?!?6/A]^R+
M\`_!?[1NI:_I/Q]\<V_BCQAX'^*GB?XS^%_A]I47AZ_^`46BZ#XCM;CX,ZI?
M>.?-\4ZEI6CVFKV8T&]\136UPM?7Z?MW_LS'Q%I_@Z?QIXAL/&>I^/?%_P`-
M;?P9J_PP^*>B>+H/%?@7PSX/\>>)+?5/#6M>#-/UC1-*LOAOX]\*?%!?$FL6
M=CX:N/AEJC>/X-7?PKIVJZG8\C^T!^PAX/\`V@+K]JVZUKQSXET%OVK?V>/@
M]^SQXC32]/TBX7PMHGP?\7?&3Q=IGB#1#>J3=ZKJ]S\8]4M+^VU'=900:/I[
MVP$DUUG#\1_\$[?AIXO_`&C_`!E^T)XE\5^)=5/COQ)\1=<\1>`FMM/M="N[
M'XF?LI_"?]D[7]"75;5HM;AM/^$0^%5IKT%U#-'>KK.N:A")$M+>T(`/2]._
M;M_9HU3PS?\`BJS\9>(VL8#X"?0]-G^%OQ5LO%7Q!LOBM?:KIOPNUGX3>#+W
MP7;^+/BSX>^(U[H6MQ>"_$7P[T?Q'HNO1:+J][:WWV#3;VZA]ATSX[?#+6?A
M//\`&O2];U*_^']K;ZQ+=W=GX3\87?B.UO?#VMWGAC7_``]<>`K;0)?'L7C'
M0_$^G:AX8U;P4WAG_A++#Q+8W>@W&C)JD$EJOYO:-_P1R_9^TGX8-\.VB\!7
MDWAW7/A'J_P[UD_LW?L]Z=!9+\$;3Q;IG@Y/BKH&C^"+"P^.MQK.C>-_$&D^
M.YO'%Q!9:LDUOK?A+2O`?BZ&3Q)<?6L_[&?A$?LBZC^R7H/BG4?`>A:I8WIN
M/%'PS\)_#_X;[-6U/QQ_PL+5U@\!^"O#6B?#^/PCX@UIKC0_%/@DZ&VG^+O`
M^HZSX:\47^KW&N:OK=Z`4;O_`(*%?LN6`LK2[\5^-8O$]]KOQ"\+K\/4^#'Q
MEN?BA:>)OA9X+\*_$CQUX>U+X9V?@.X\<:=K.B_#SQMX8\=K8W6AQR:IX0U6
M'Q#I!OM-2>>+A_B;_P`%(O@GX:U#X3:5\,)9_C#<?$[X[?LO?!Q]9T'3?&ME
MX!T2W_:>?P_K'AS5Q\3X_!6I_#V_\4:?\.O%&@?$B'X<2>(]/\3ZEX8UW0KV
M>/2[76+.Y?A?@_\`\$M/AI\(?BM;?%W1_&EQ;ZU)XM^)OCK5O#7A+X<_#OX;
M^`9/$?Q5_9T^$_[.OB$:!X/\$Z7IFE^&M'MM$^$ND>(["Q@%_J%QKFIZG+KN
MM:U/*U_+D?#?_@E1X2^%WA3X._#?PU\;OB`GPO\`A3\1OV7/C;=>#)?#G@DC
MQA\:OV8_"7PS\"V7C+4M?&G?VWIFC^/]`^%?AJ^\5>#]/N6LK/Q6ESKFA:C8
MZ?<7/AZX`/7/VA?VW[SX+?'72/@AI_A#X:R:IJ'PY\-?$32KKXO?'71O@3-\
M69_$?B[Q+X2D^&?[/,WBCPGJGA+XD_%7PTWAZWU3Q1X;\0>,?`=KI4/C#X>P
M27YM?%-SK.@=UX?_`&V_A!/XR\?>!?%/B70]-\1>&OC-XT^#WAO2O#MMX_\`
M$-_XDU[P9:_!LWWAQX[WP!H%NWQ&^U?&GPO<GP9X5NO%]K<^&Y+GQ-HWB'5]
M/T#QO_PB47[3_P"R/J?[2NF>,/!U[\:_%_ACX6_%/P"?AI\4_AC<>$O`'Q`\
M,:MH$D6NVEUK_@F/QWH>J/\`#SX@7VF^(+G3;OQ':+KNCRQ:?H6I#PHGB#2(
M-9?RB?\`X)N>#QK^N>)-+^*OC[2-3C_:)UC]JCX<301V%X?AW\:KWPE\*OAU
MI?B97U&:[F\90Z3\,_AUXA^'<]AXIEN$\0>%_B_\4$UZ2\U75-&U31`#USX_
M?M;-\"/VB?V3_@Q?^`_[9\)?M(7WQ'T?Q%\2!XB?3S\+M5\/7WPT\+_#I;GP
MTNA7_P#PD>G?$?XC_%#PS\/WOAK>B'P[K&LZ#,8-7BU22.S\<^&7_!2OP#XO
M^(7[3'A3Q;X,U[POH'P<^.7@WX+_``CU7PI8^,?BUXP_:(E\5_"S4?B.VN>#
M_AGX"\#:CXH@-JGA/XAW%MIVE)XHCN/`G@^;XA7VIZ7I5U-:V/OG[2O[)/A?
M]I<S/X@\6^*/"=VGP/\`C)\'M%U;PI]@@UOPKJ?Q1\6?!3QYX?\`BAX:U*\A
MN#IWCOX4^-_@5X-\6>!;AH)["/6[=+G4K>YCMHH9/`;3_@FSX9\)^,9?B3\+
MOBWXP\!_$'1/%'P@\4?#G7&\.>$?%%AX.?X6_LTW_P"RO?Z->Z'K=H;?Q1HW
MCKX<:MJ-YKJW%UI.IV/BD:=K&CZG;K936UZ`>R:7_P`%`?V4-<UO1=#T'XEW
M>O3:Y%\%)X-4T3P#\2=5\-:;!^T9<:EIWP0D\2>*;'PA/H'A/_A9?B+2;[P7
MX8B\3ZAI%Q=^/HE\"2Q0>*Y%TD?('PJ_X+*_!3XB7_AC5]>^'7Q0^&7PPUKX
M(?';XS:YXO\`&/@7XD2>(O!>G_`?]I+3?V??%%QXI\#:+\/;^_TOP%:0WS^.
MO$GQ0N[V#PGX'TZVNM&\2W%KJ>G:R=-]-\-_\$NOA?X/\-^-O"WA[XA>-X;#
MQIJ'[$6L7EU?V?AZ]U(:Y^Q=\<Y?V@K+7+J:&TL+.\U+XM^/KW6+WQTL&GZ;
MIFF#6+J/PGIFE6D-E96W,Z?_`,$H_`]AI7QP\,+\7?&;^$OBI^S;^UM^R[X8
MTH^'O#BWOP\^'W[77Q/U+XO^+KB/5][OXLUKPGXRU[78_"MUJMG8QR>'I]/T
MS7(]2O\`3Y]9U$`^X?`W[47P:^)'Q%U_X8>"]<\0:WK_`(;U;Q=X>O\`5X?A
M]\0X?A]<>)?A_?0:9XZ\+Z/\4KKPM!\-]<\3>$-0N(['7]`TGQ3=ZI97<5_;
MK;32Z3K"Z?!J?[5OP-TCXG7OPCOO%>I)XNTS5T\,:C<0>"_'%WX-L?&\_@W_
M`(6'9_#B[^(MIX<F\`6_Q,U#P,T7BK3OAY+XE7QA?:/=:?<6^CO)J>F0WGC'
M@/\`89TKP3^T78_']/B9K,UWI1\1RQZ3H7@3X<^`M:\8)XF\(V_@[_A&_C'X
M[\#:#H>N?&CP-X-LK:UU+X<:#X[M;[6O#&NZ;HNK:CXM\27>C64@Y^X_X)P_
M!T?M*>+OVB]-@\+6FJ^./&=S\4]=M]0^#OPD\2^,[?XG7'PVLOA<^L^&_C+X
MA\+W_P`3?"GAN;1M+TO7I_"NAZQ;3P>+;)[[1?$>B:%JFM>&]1`.W\.?\%$?
MV2_%O@RX\=^'OB+K&I:(WAGX/^,?#ENGPR^*D'B+XB>&_C]>3:3\&]6^%'A.
MX\%Q>)OBO:^/]>M+_P`.:*WPZTGQ*5\0:9JNDWPL[C3KKR_./A;_`,%-/@?X
MPL?'MWXYCUGX>OX.^-?Q^^&PMX_#/Q%\5S:;X#^!'Q%'PUU+XR?%.+3?`-O<
M_!#P;?:^9+'4KWXG6^@:1X>U.RUG3I]<O/\`A'O$%SI?*6?_``2Y\$Z/IWP2
MD\/_`!9\9Z7XO_9V_9H_9<^`/PG\7-H/AB_FT/6?V4?$FL>(/!7Q*U#1KN)M
M,UB^\2VGB'7_``KXS\*SK#I%WX9US4H]&O=%UL:9KFF</-_P1V^#=]XKU;QU
MKWBRT\;^,_&OBWXE:_\`$;Q+\3?@C\"_B?>:WIWQ.^)FH?%K5+/PEI_COP9K
MWA_X<ZUHGBS7O%%IH'B+0=&NHCX7\13Z-XAT'Q!>:/X:UK1@#Z=UW]O#X:K^
MT3\"_P!GOP-I^J^-=2^*WQP^+GP.\2>+/[&\::!X1\(>(O@Y\$OBI\5?%\/A
M[Q9J?@T>"/B9K.@>(/AL/AWXM\/^%?%CW7A'7-2OUU>9-1\.ZAH[:GQW_;8^
M'_[./QGTKP!\5;7_`(1_X>M^S5\6_P!HGQ-\3UDU?57\.6GPQ^+?P"^%$'AX
M>#M"\/ZIJNK#7[[XZ6M^=4L[H2Z9_8@MFTN[BU"6]T[E/"O[!>C^$OB]\+_'
MFF_%CQB?A_\`!3XZ_&_]H+X6_!]]"\(1Z%X<\:?M%^$?C#H'Q2LKKQ-:Z;;^
M)M9\/2ZW\:O&/BCPAI]W-'-X8GU"YT>XN]=TP:0-"E^.'[!7A?\`:1\4?&+Q
M!\8_B)XHUNV^('P.\6_L^>`M)T'1O#7AR/X3^`_'/B?P)X_\2WNGWRVFIWGC
M#Q9<^/\`X9>!-?L]3\3$Z-96?ARUT;_A'+B*]UB\U$`[#Q?^WW^RWX)\5^(_
M`FL^.]=NO&GA;Q;\1/`VJ^%/#7PQ^*/C+Q`WB?X3_#KX8?%KXAZ=I>D^$O!V
MM7VN+X6^'/QB\`^+-0O-'@OK%M+U._-M<SW&@:]!IW5^&_VR/V=?%_C3P_X'
M\,>/SKM[XHE\-V.@^)=-\+^,;GX;:CX@\8^`;#XJ>$_!T7Q53P__`,*W7QWX
MC^&VJ:9XXT;P1+XHC\4W_AO4M-OXM*/]HV$=S\X>"_\`@F]X?\/?%FX^-GB+
MXP>,_&'C[6_%'[0?C7Q7>77A_P`,:/INM>)?VBO@7^SW\#?%,MIINEQB/1=*
MT+2?V>]"U7PWI=O+<O#-K-]9:G?:B+6&^GY+]G;_`(),?`_]G+QM\,O%OAF\
MT+7G^'NG?#34)]0\4?!?X-:Q\0]:^(?PV^"WA+X'VWBNR^+NI>%-0^('@_1-
M>T+P=I/BC5O!OAC5+1+/QD+NX\/^(=&\-:CJGA>_`/;OVN/VP/$G[+E]HU\_
MP\\"^(_"NHIX?M])LM;^-VA>#/BY\8/%>M>(&T>[^&/[-?PF/AGQ%J7Q6^)F
MC6$^DZPV@ZQK'@:QUJ;7M$T31=4GEFU;4]#R],_;@NKSXDZ;#=_#?3M-^`7B
M+]I[Q?\`L<>&_BM+X]67Q?>?'+P3+XHT#4I=1^&L7A8V&G?#S4_B7X*\3_"G
M1-;A\?WWBN;Q59Z9J5_X+L?#.L?VGIO;_M(?LGZO^T7!XK\)ZI\</&WAOX1_
M$SPE;>!_B7\,K7PSX"U^VN]"C^VQZC=_#OQ/X@T*ZU_X8^)_$=E>)I^N>(=/
MDUU[==-TC6?"ECX5\5V"^(I,NQ_8F\/V?Q5LO%<GQ$\67GPIT?XZ>(?VH="^
M!EQIOAL^&M+^/_BJUUM-9\6CQ4E@/%UUX:_X2#Q+XC^(^G^")[P6EE\3-;N_
M$,FKW>D6FC^&-,`/HWXL^+?B#X4\,6=S\+OAN/B=XQUGQ!HF@:;I%]XHLO!?
MA?1H-4GD.H>+/&OB>:PUW4]+\*^'K"">ZOAX:\*^+?$VHWLFG:3I'A^XEOY+
MNQ^(_#/[=GQ#^(UUX>^''PQ^!/A[Q#\>Y_$/[3^F>*/"^L_&./0/A;;:+^R7
MX]\'?#/XA^)?!GQ/A^'VL:YXPT[Q1X\^(?@[PCX&-U\-O#@@UZ3Q?8>-Y/#%
MWX#U>UO/:?B3\!/CW\3/V:O#_P`'W_:F\3>`_B>Y\/I\0/C7X.\!^$[?7/&&
MDV=W<W/B;PU:Z18/X=M/!]IXNLI+?0=1\0>"+OPWXJTO2X[N?PMJWA[6;R/5
M++SO1OV)/%GA_P`+?"8>&?CG!\.OB=\&M!^(GPX\%^./A1\$?AOX)\+V'P7^
M)ESX1O=:^&B_"B[D\2^%UBT;5?`GA'Q/X4\0I?"]TKQ9X>LM1U"SUK2+_P`2
M^'O$`!0\(_\`!0?2OB)\4_V*?!_@CX1^+;KX>?MD?#SQCX[T;XL^(-;\.Z/I
M?AJ]\-?"JV^*$7@JR\/:?<Z[K'BOQ':0->Z)XTO4_L+POX6U2UCL].USQ3J,
MMW8:7;^`G[:6N?&3X]^*_A?J5K\!O#/AW3O$?QJ\.^%;&T^+'CS5OC%XAF^#
M_P`0-7\"7C2>$]1^#/A_X:RZDJ:%=^(_%_AKPI\7/%GB+P!I.I:$=<TXB]FG
MM^7UK_@GWXHT[Q_^RAKWPC_:"G^&O@']C;PQ/X3^$'P\O/A)X9\;M)INO^`K
M7X;>.)?%OB[4/$FCZGKU_P")?#=O)<17D>GZ?)IGB"[NM7E&JI(MBOT'I?[-
M7B*7XM^$_B%X[^.7CGXA>&?A=XS\<?$#X2>`]8T#P1I:>$_$_C[PWXP\&7TV
MN>+=#T2RU_QMIWA;P=X]\6>%_`MAJ2Z?)I^F:J+OQ9>^-O$&G:5K=B`=;XI_
M:B^#G@GXE:3\*O%.L>)-$\1ZWXET#P3INKW_`,._B)!\/;CQSXLTZ'5O"O@9
M?BDWA8?#D^,O$ME/%_8OAM?$[:G?7L]II*0KK%_86%SX]X;_`."CW[(?B_PE
M'XT\-_$G6-5T?4?#'PO\8^$K>'X7_%=/$'Q*\/?&?57\/_#6_P#A)X7F\$Q^
M(OBP/$OB2*Y\-K#\/-,\23Z5KEG>V&MQZ:UI-(OF_P`5?^":W@7XM?'^/X[>
M)/'^L75[8_'3X'?M">'K/4_`_P`/O$7BCPCXO^"-[X'?3O!O@_XI:YHUUX]\
M+?!O7[7P0+S4OAEH&H:=8P>*O%7C/Q)#J<T/B/4-#EXW2_\`@E3X)\.:9^S?
M+X9^+_C72O&G[*?[.GP>^!?P?\92>'O"VHS:9J_P6\56WB+0/B'J^B7<9TO5
M[G7M-;7?!WBKPN_V?3+SPSXGU9M)O]%U^#1]<TP`^B/@G^UWJ?QV^"OQO^+'
M@;X0>(==U;X6_&O]H?X->%?A[IVL0:9XB^(.H_!#XBZQ\.].NIY/'6F^#H_`
MU[XJOM+6[U;2O$MNLO@I&O;>^EU.?3VCG\LNOVZ_'VC>+?$WP-UWX*^%I?VD
M+'XQ_"/X,>%-#\+_`!<N]:^"GB#7_C#\+?''QKLKG4_BIJ7PU\/^+?#EQX#^
M%OPS\<>+O'OAB3X4:EXEBTV#P9=^'[/5[+X@Z/<V7K7@#]D_Q)\)?@-\:OA5
M\,?CSXP\-_$'XP?$+XW?%>+XXW?A#P)KOB?P9\0OCGXMO_&FO^(M&\(7VF1^
M!+\Z#K>J7TWAO2]5TB;2;>(64%_97\=HRW/E7@3]@?Q%X5^&MCX,U/X[27?B
MOP1\6M#^.WPF^)?AOX5>'_#7BCP]\6K31?$OA[QAXV^(TFI^)O&,_P`;-;^*
MVA^+?$.A_$O5O&FI0:[K>DZ[JT>GZSH^H'1M3T,`SM?_`."B5_H?ACX/Z@GP
M(UK5O$/BO]L+PW^QO\:(=-\<:(W@OX'>.]1^.&A?!'5-0G\67.FVFL>.EU"^
M\2:)XO\`AYHNC^#-.U'Q)X/U"/4O%K?#V6UN[5?4_CQ^V?:?"'X__LX?`C0/
M`X\=7/QB^+?AKX9_$7Q(GB1=%LOA##X[^'GQ<\;>`;I[4:-JO_"6>)O%$WPA
MU\)X2CN]$?2O"T4_BS5-4MDN?#.F^)/(OB5_P3Q\6^*?A]\/?`?@G]I/6?!3
M^&_V@-,_:P\>>*=5^$W@KQGXA^*'[1&B?%O3?C1I/C'5@=4\,:1X>\.VWBG3
M;?2CX*T'3$M%\(6FE>'[35+0Z=]ONNF^(?\`P32^"OQ.^(GPF^,?B#Q#\2M-
M^*G@7X]_#[]H_P`<^(/"7Q.^+/ACP[\5?B7X!^%>I?"R'4]3^'>G_$G_`(0C
MPD=1TR?1WDN/"ND6VHP:3H%MX2>]O/#FIZ[::D`?HRIW*K8QN4''7&1G%+2`
M8`&<^I/<]SZ<GL.!VXI:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`**_'_P#;^^*WQ-\#_M]?\$:_`W@SX@>,?"O@
MWXL_M+_M$Z!\4/"WA[Q%JND>'_B'H6@?LI>._$>AZ-XTTFQNH++Q+I6D>(;:
MUUW3M/U>&[M+/6+6UU."%+VV@GC_`%^C)*(3R2BDGU)`H`=1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`45#<SI:V\US(&,<$,LSA
M`"Q2*-I&"@D`L54A02`3@$CK7PN/^"AWP*(!&D?$GD`_\BWI/?\`[F2@#[NH
MKX2_X>&_`O\`Z!'Q)_\`";TG_P":2C_AX;\"_P#H$?$G_P`)O2?_`)I*`/NV
MBOA+_AX;\"_^@1\2?_";TG_YI*/^'AOP+_Z!'Q)_\)O2?_FDH`^[:*^1/A]^
MVK\(_B5XST#P+X?TWQU#K/B.ZFL["75-#TVUT])8+&[U!S=7$.NW4L2&"SE"
MLEO*3*8UV@,67Z['(!]:`"BBB@`HHHH`****`"BBB@`HHHH`_$#_`(*3_P#*
M23_@A3_V=;^U!_ZQS\0:_;R/_5Q_[B_^@BOP_P#^"EL,-Q_P4@_X(513Q1S1
M-^U=^TZS1RHKHQC_`&//'\B$JP*G:ZJXR#AE![5^TD?AGP]Y:?\`$DTO[B_\
MN5OZ#_IG0!OT5A_\(SX=_P"@)I?_`(!6_P#\;H_X1GP[_P!`32__``"M_P#X
MW0!N45A_\(SX=_Z`FE_^`5O_`/&Z/^$9\._]`32__`*W_P#C=`&Y16'_`,(S
MX=_Z`FE_^`5O_P#&Z/\`A&?#O_0$TO\`\`K?_P"-T`;E%8?_``C/AW_H":7_
M`.`5O_\`&Z/^$9\._P#0$TO_`,`K?_XW0!N45A_\(SX=_P"@)I?_`(!6_P#\
M;H_X1GP[_P!`32__``"M_P#XW0!N45A_\(SX=_Z`FE_^`5O_`/&Z/^$9\._]
M`32__`*W_P#C=`&Y7!?%#Q]8_"[P#XF\?ZE87NJ6/AC3QJ%S8:<ULE[=1FYM
M[;R[=KN2&V5]UPK9ED1=JMSNP#T/_",^'?\`H":7_P"`5O\`_&Z^=_VL=#T:
MS_9U^*]Q:Z5I]O/'X;0I-%:0)(A_M;3#E'5`RGCJI!QD9P30!X,?^"D/P^!(
M_P"%<>.^/^GOPQ_\M*/^'D/P^_Z)QX[_`/`OPQ_\M*_(5NI^I_G24`?KW_P\
MA^'W_1./'?\`X%^&/_EI1_P\A^'W_1./'?\`X%^&/_EI7Y"44`?KW_P\A^'W
M_1./'?\`X%^&/_EI7O'P$_:H\,_'W7M?T'0_"WB+0)]`TBUU>>?6IM(EAN(K
MJ]-BL,(TZ\N9!*CC>QD54V=&+<5^!E?H7_P3KL++4/B%\18KZTM[R-?!6DLJ
M7,,<RJQ\0'+*)%8*QV@%A@D#&<<4`?KYJ_\`R"]2_P"O"]_])9J_EV3[B_[J
M_P`A7]-VK>&_#ZZ9J)71=+!%A>X(LK?(S:3`X_=\'!Z]1U'-?S(I]U?]T?R%
M`#J***`"BBB@#Z+_`&2?^3C?A3_V'=1_]1G7J_H,7H/H/Y5_/=^RA!#<_M$_
M"R"XBCGADUV_#PS(LD3A?#>N.`\;@JP#*K`,",@'M7]`=CIFG:<'^P6-K9^<
M$\W[-!'#YGE[MF_RU7=MWMMSG&XXZT`7Z***`"BBB@`HHHH`****`"BBB@#\
M0/\`@I/_`,I)/^"%/_9UO[4'_K'/Q!K]O(_]7'_N+_Z"*_$#_@I7)'#_`,%(
M?^"%4DLB1H/VKOVG@7D=40%_V._B`B@LQ"@L[*JC.68A1DD`_M5'KFC>6G_$
MVTS[B_\`,0L_0?\`3>@#8HK*_MW1?^@MIG_@PL__`(_1_;NB_P#06TS_`,&%
MG_\`'Z`-6BLK^W=%_P"@MIG_`(,+/_X_1_;NB_\`06TS_P`&%G_\?H`U:*RO
M[=T7_H+:9_X,+/\`^/T?V[HO_06TS_P86?\`\?H`U:*RO[=T7_H+:9_X,+/_
M`./T?V[HO_06TS_P86?_`,?H`U:*RO[=T7_H+:9_X,+/_P"/T?V[HO\`T%M,
M_P#!A9__`!^@#5HK*_MW1?\`H+:9_P"#"S_^/T?V[HO_`$%M,_\`!A9__'Z`
M-6OG#]KK_DV_XL_]BTG_`*=M,KWK^W=%_P"@MIG_`(,+/_X_7SK^UIJVF7/[
M.GQ7AM]1L)Y7\-($BAO+:61S_:VF<*D<K.Q]@#0!^`[=3]3_`#I*<02Q`!)+
M8``)))/0`9)/L`2>U1ET4J&=%+_<!=07[_("<MP0?ESU'J*`'44W<F[9O3?C
M=LW+OV_WMF=V/?&*7(R0""1C(!!(SR-PSD9'(R!D<B@!:_1;_@G!_P`E&^(_
M_8DZ3_ZD#5^<^Y=VS>N_&[9N7>%_O%,[@OOC'OS7Z(?\$Z+NUL_B'\1I+NYM
M[9&\%:2%>XFB@5C_`,)`<@-*R*2,C@'/(]:`/UYU?_D%ZE_UX7O_`*2S5_+L
MGW%_W5_D*_IUU;6]&;3-1`U732387N`+^S)/^BS=`)B:_F*3[J_[J_R%`#J*
M`01D'(/0CH>W\Z/Z\#W/I0`44?\`Z_PZ9_/BC^O`]SZ4`?1?[)/_`"<;\*?^
MP[J/_J,Z]7]!B]!]!_*OY[_V3I8H/VBOA7+-)'#$FNZ@7DE=8XU!\-:ZH+.Y
M"KEB%&2,D@#DBOZ!;2^LKT-]CN[6Z\L)YGV:XAGV;\[=_E.^W=M;;NQG!QG!
MP`7****`"BBB@`HHHH`***CE=XXI'CB:9T1V2)61&E95++&K2,D:L[`(&=U1
M2P+,J@D`$E%?"WBW]H7XA>$/&WAGP]XB^(7['GA#7/%_C:P^'7ACX0>)_B?X
MG3QWKOCC4]%T_P`3:;X+B\56]G%;VGB[4/#FJ:7JL&CQ?#+5@\&M:')9W&H6
MNL:5<7_VUI=Q>W>FZ?=:C8_V7J%Q96LU]IHNHKX6%Y+"CW-F+V!4AO%MIB\*
MW44<:7`02K'&'V*`?B=_P4H`;_@I'_P0I#`$?\-7?M/'!`(RO['?Q`93SW5@
M&!Z@@$<BOVSCL;+RX_\`0[7[B_\`+O%_='^Q7XF_\%)_^4DG_!"G_LZW]J#_
M`-8Y^(-?MY'_`*N/_<7_`-!%`$'V&R_Y\[7_`,!XO_B*/L-E_P`^=K_X#Q?_
M`!%6J*`*OV&R_P"?.U_\!XO_`(BC[#9?\^=K_P"`\7_Q%6J*`*OV&R_Y\[7_
M`,!XO_B*/L-E_P`^=K_X#Q?_`!%6J*`*OV&R_P"?.U_\!XO_`(BC[#9?\^=K
M_P"`\7_Q%6J*`*OV&R_Y\[7_`,!XO_B*/L-E_P`^=K_X#Q?_`!%6J*`*OV&R
M_P"?.U_\!XO_`(BC[#9?\^=K_P"`\7_Q%6J*`*OV&R_Y\[7_`,!XO_B*^<_V
MM[6UB_9Q^++QVT$;CPTF&2&-&'_$VTP\,J@]0#UZ@&OI:OG#]KK_`)-O^+/_
M`&+2?^G;3*`/Q_\`V9(R_P`3;=DT*?69T@M_(N=/AT#4-9T`MJ=IYNLZ9H?B
M!9(=84P++IFIC3XQJNEZ?J$FHVL]JL<TI].\%^']7T[QSJ.CW^EV&K^#]1U^
M^@O]3\*_#[P<?"-[J=QX;L7OM'^*K-<:E??#SPYX>^V03:K8:+-%%HVJ+XEO
M?#\MR]K#=P?&%O<W%E=0WEG<36EW:S">UNK:5X+FVF7<%FMYXF66&50S!9(V
M5P&8!L$Y@0F-'BC+1Q2(L<D4;&.*2-#E(Y(T*I)&A^XCJR)DE0":`/M"7PWI
MMQ\*TT1W;3$L?A1X;OI_$5QX;T@_!B35KW6]-N[KQ19^/K?3G\6WOQ%BL-0^
MR7=@)9;6YU>TUG182UI;0V1Y'XE^%;'4O!'PRT[P!_PC/B&.U\5_$WP]H5OX
M3G75O$OB/3=,L?".HMK&IB#3;6XU#47>+6-<UF.262/0(=5L]+LM]G`I3Y>W
MOY8BWOY0D,PBWMY0F(P9A%GRQ,1P90HD()!8@D4HDD&W$D@V%BN)'7:6&&*[
M6&TL.&*X+#`8D`"@#Z;TFPU:7X/^+8/$&C36EA;?#VQUKPI>2^%?#$'@&6,:
MSHUW;:Y9>.;#[1KU]\4M6BGOM.BTZ6Z`NI9;W2=6AMDLTLH/=?\`@G)%%+\1
M?B.LL<<JCP5I/RNBNO\`R,!Z!@1V'Y#TK\[M[^6(M[^4)#*(M[>4LK##2K%G
MRUE8$AI542,"0S$'%?HI_P`$X/\`DHWQ'_[$G2?_`%(&H`_6C5K*S&EZB1:6
MP/V"]Y$$0/-K,#_!Z5_-5X#M;>]\6>';:\T"[\4VDEYFY\.V$<<][J\45I<S
M-:6MI)=62:A,/+%PFE&\M6U?R/[*2>.2]5A_2]J__(+U+_KPO?\`TEFK^79/
MNIR0=JD$$JP(P0RLI#*RD!E92&1@&4A@"`#[@\=^`-*3XI1>)+^#X>QV,=EI
M]]HGA?4(++X:77B[5O[7M-$MT\3>&/$>J6NGRZ?I4GVC4M0NM!D^Q>)M*T^R
MT:%+F]N;^XCN:-X(\+_\+!U7PRVA^%4L)/C]XST/Q>+WPA<>)[/4?`,MQ:3:
M7H?@WQ+HFG:CHG@^[\+Z5)JU[KUO_:_A34/#\LEAJM[?-9:1-I\'Q-J>KZKK
M6HSZOJ^I7NIZK<O%)<:E>W,MQ>S/!''%`SW$C&3,$<4:18(\L(NS!R2Z/6]:
MBCU**+6M9BBUDL=9BBU;48HM8+L[N=6CCN535"[R2.YOUN"[2.S9+N6`/I#6
M?#FB1:!KNEV?A_39/!&G?`_1/''A[QXNAQ)JFH^-KJ^TE$N)/%PMTN;^76M;
MO-6\'3^&7NFL[>WLD%OIEM>:?)<UA_#/2KK3K:>?Q;\/],@\$:'KU]#X_P!7
M\1^$KK4O$NO$V$0M?ASX8AO;3^T],\3(JRW-N/#O]F7>ES7X\0>*-2M=.T^R
MBF\%.I:DU@FE-J.HMI4=RUY'I37]V=+CO'!5[R/33,;&.[920UTD"SL"09#D
MYV(/&?C*U\\VOC'Q;;&ZN)[NY-OXHUZ`W-W<[/M-W<&'4$,]U<^7']HN9=\\
M_EQ^;(_EIM`/9?V3%5_VC/A4KH"IU[4,QN1)C'AK72%=BH#LA`#.57<P+;5S
M@?T$0P00C]S#%%N"[O*C2/=C.-VT#.,G&>F3CK7\_'[)1)_:.^%1)))U[422
M3DDGPSKQ))/))/))Y)Y-?T&+T'T'\J`%HHHH`****`"BBB@`I&`((.<$$''7
M&.V.<^E+2-T.`"<'@]#QT/7@_2@#\,O&?P=UOQY^U]\96\%_#_XD:_X&7XT_
M#BP\<3^)/BW\&OASIGA[6+K7_P!F+XO_`!3U/P'X7U+PIJOQ4\4^%?B(GP2^
M"MC=ZQXBUVVOX[/P1XFT'X/P:%8:M9^(8OW-`P/Q)_,D_KG..W2OPK^+_P`%
M+W4_VT/$/C^;]G1->^+A_:`^"5Q\,DMOV*?@WXO^"?C?X-VD?PY/BOXJ_%3]
MJW5O@MK'CCPQ\3_!<"?$.^TV[N/C?X)\3>#]7\'>"=*\%_#3QO87<4_C+]U%
MZ?G[9Y/)&!@GJ>!R30!^'O\`P4LECA_X*0_\$*9)6")_PU?^TXFYLX#2_L>^
M/XD!P#C<[JN3P,Y8@9(_:&/Q/H?EQ_\`$PB^XO\`RSN/[H_Z85^,7_!2?_E)
M)_P0I_[.M_:@_P#6.?B#7[=Q@>7'U^XO<_W1[T`8G_"3Z'_T$(O^_=Q_\8H_
MX2?0_P#H(1?]^[C_`.,5O8'O^9_QHP/?\S_C0!@_\)/H?_00B_[]W'_QBC_A
M)]#_`.@A%_W[N/\`XQ6]@>_YG_&C`]_S/^-`&#_PD^A_]!"+_OW<?_&*/^$G
MT/\`Z"$7_?NX_P#C%;V![_F?\:,#W_,_XT`8/_"3Z'_T$(O^_=Q_\8JU;ZWI
M=TL[P7:2+;1&><JDP\N)<[G(:)20,<[0Q]JU,`=21_P(_P"-)E?7_P`>_P#K
MT`9)U[20K-]MCPMO%=,=DW$$S(L4G$1.'9U``^8$\J!DB676=-A^R>9=(OVY
M4>URDQ\Y9"JH5Q&<;BRC#[2,C(`K1ROK_P"/'_&EROJ./]K^?//XT`9%SK^D
MVD\EO<7D<4T1`=&2<E20&'*PLIR""""1@T2Z_I,(#27L:@RS0@E)S^\@V>:G
MRQ'E/,3/;G@G!QK97U_\>/\`C1E?7_QX_P"-`&%_PD^A_P#00B_[]W'_`,8K
MYX_:PUW2KS]G7XKV]M>1RS/X:0(BI,"Q_M;3!@;XE'?U_3-?4N`>A)_X$?\`
M&OG']KE2?V</BR%#,3X:0`#<Q/\`Q-M,Z`9)_`4`?S[MU/U/\Z2I&CER?W4O
M4_\`+*3U_P!VD\N7_GE+_P!^I/\`XFE==U]Z'9]G_7_#K[QE%/\`+E_YY2_]
M^I/_`(FCRY?^>4O_`'ZD_P#B:+KNOO06?9_U_P`.OO&5^A?_``3LO[33_B#\
M1I;N98$;P5I*JS!R"1X@.1A%<_Q#MW^M?GOY<O\`SRE_[]2?_$U^BO\`P3A1
MU^(OQ'W(Z@^"=)Y963/_`!4#="0/THNNZ^\5GV_K^FOO/U2U7Q+HC:9J*K?Q
M$FPOL#9<=K28]X!Z?_KK^9-/N+_NK_(5_41JX']EZEU_X\+WN?\`GUF]Z_EW
M3[B_[J_R%,!U%%%`!1110!]#?LH3Q6W[1'PLGG<1Q1Z[?[W()"[O#>N(N0H)
MY9E'3OZ5_0%8:I8ZD'^Q7"3^2(_,VK(NWS`VW/F1IUV-C&>ASCC/X!?LD_\`
M)QOPI_[#NH_^HSKU?T&*,`=>@ZDGM[T`+1110`4444`%%%%`!6-XCM_M?A_7
M+4VJ7HN='U2W-G):6FH1W8FL+B+[-)8W]U8V5XEQO\E[2[O;2UN5<P7%U;PR
M/,FS5:]M+6_M+JROK:VO;*\MI[6[L[R".YM+JUN(GAN+:ZMY5>*>WGA=XIX9
M$>.6)WC=65B"`?SF>!_@1\3]2^,?PV\7^,_V3-/.L6?C3X82W_B_6?V`OV#]
M%UK2]/\`"]YX:TS2+T^*M%_X*&>*?$_A]/"_A[1]-M='UC0/#OB35O#NF:58
M3>']$UJ:PL=.NOZ.Q_4]@.I/IG\^IZG!XK^?_7?@]X$\4?ML>,]1L?@=XGOK
M7X9_'3X3^%?#VO?`?]@?]C3Q!\,_#>G^$?"'PIN]*TKQK\9?C#\-M0^-"^*?
M",,ENOB?Q/\`#O7;30_!'A)?"ND?#F>P\0>%M16T_H`']3UP.Y]/7MW(Y/.:
M`/Q!_P""D_\`RDD_X(4_]G6_M0?^L<_$&OV\C_U<?^XO_H(K\/\`_@I;*L/_
M``4@_P""%4C+(RC]J[]IT$11232?/^QYX_0$1Q*\C!2P9RJG8@9SA5)'W)\>
M/VR8?@CXNTSPDGP[OO$@O?#5CKQOKK6IO#<D1NKW4;+[*+&[T"]DD6/^SQ)]
MJ64([2M$$!B9F`/M^BORT_X>5I_T1N7_`,+J/_YE:/\`AY6G_1&Y?_"ZC_\`
MF5H`_4NBORT_X>5I_P!$;E_\+J/_`.96C_AY6G_1&Y?_``NH_P#YE:`/U+HK
M\M1_P4K0D#_A3<O)Q_R/4?\`\RM?>OPU^*-O\0O`/A+QNV@ZOI;>*-%M=8.F
MP66I:O'8FY,@^S+J4.FV\-X$V9$\<,:.K`A1R*`/F;]O/QWXT\!>!O`U_P""
MO%6N>%;V^\9SV5[=:'?/8SW5HOA[4[A;:=T#%X1/%',$/'F(K=17Y>?\-&?'
MO_HL/Q!_\*"?_P"(K]!_^"BFHQ7WP]^'JQV^H0E?'=TQ^V:=>V2D#PSJ8^5[
MJ")'8E^%5BV%<X`4FOR1H`]G_P"&C/CW_P!%A^(/_A03_P#Q%'_#1GQ[_P"B
MP_$'_P`*"?\`^(KQBB@#V?\`X:,^/?\`T6'X@_\`A03_`/Q%'_#1GQ[_`.BP
M_$'_`,*"?_XBO&**`/V[_82\;^,?'?PQ\4ZIXT\3:UXIU&U\>W=A;7NN7KWU
MS!9)X>\/W*VL4C@%(%GN)Y@@&!)+(V?FKE?^"JTTUO\`\$]_VI)H)98)H_AW
M$R2P2R0RH?\`A*/#HRDL3)(AP2,HRG!(SS6?_P`$\M3ALOA-XOCDM]1F+?$6
M\<&STV^O4`/AGPXN&DMH)45P4R49@X5E;;M8&JW_``51U>"[_P""?/[4L*6N
MJQ,WPZBP]UI.HVL/_(U>&UPTT]LD2]<_,P&T,<\5]3P,E+C;@^,DFI<4\/II
MZIIYMA$TUU36C/F>-6UP;Q8TVFN&L\::T::RS%.Z:VMO?H?PMOK.L[V_XG&L
M?>;_`)BVI>I_Z>J;_;.L_P#08UC_`,&VI?\`R56>_P!]O]YOYFFU_JPL-A[+
M]Q1V7_+N'EY?UKW9_F']8K_\_JG_`('+_/R_J[-+^V=9_P"@QK'_`(-M2_\`
MDJC^V=9_Z#&L?^#;4O\`Y*K-HI_5L/\`\^*/_@N'^7E^?=B^L5_^?U7_`,#E
M_GY?GW9I?VSK/_08UC_P;:E_\E5_0!_P;WW]_=_'_P#:"2[OKZ[1/@YX6=$N
M[VZNE1CX[<%D6XFD5&(X+*`2."<<5_/;7[^_\&^5W'9_'W]H262*ZE!^#7A8
M!;2TN;R0G_A/2/\`5VT<K@?-G+``A6()VFOR[QIH4(>%W%\HTJ49+`X2TE"*
M:_X5<O6C2O?_`(/=GZ7X.UJTO$SA*,JM22>.Q-TYR::_LS';J^NW7U/ZRM7_
M`.07J7_7A>_^DLU?R[H#L7@_=7L?05_3!XF\00#PWX@:.TUR)UT+6720Z)JT
M>QTTRZ=2K_9!M;*C8<CY\<CJ/\Z:/XS?%XQQG_A:7Q!YCC/_`"-VM_W%_P"G
MSGZ]^M?Q+X9>%&8^)L,YG@,VP66?V-++XU5BZ%>M[;^T%C'!TW1:4?9K!SYE
M+5\\>79H_LCQ&\4<O\.9Y1#'97C<R_M>./E3>$K4*2H_4'@E-5/;?%[18V/)
MR[<DK[H_?O!]#^1HP?0_D:_`?_A<OQ?_`.BI?$'_`,*W6_\`Y,H_X7+\7_\`
MHJ7Q!_\`"MUO_P"3*_4_^)5.(O\`HJLF_P#"+&^7][U_K?\`,_\`B9W(/^B8
MSC_PKP7EY>OX>9^_&#Z'\C1@^A_(U^`__"Y?B_\`]%2^(/\`X5NM_P#R91_P
MN7XO_P#14OB#_P"%;K?_`,F4?\2J<1?]%5DW_A%C?+^]Z_UN?\3.Y!_T3&<?
M^%>"\O+U_#S/Z@_V20?^&C?A3P?^0[J/8_\`0LZ]7]!:]!]!_*OX8?\`@F+\
M5?B3JW[>O[-.G:YX_P#'&LZ3=^,]<BO=,O-?UK4[6[B'P]\:.B3V+3SK<(DR
M13;3$^PQ"7`\O</[C]/U"*_5O+@OX?*6/=]ML+NRW;PV/+^U0Q>;C:=^S=LR
MN[&X9_&/$CP\QOAOG&"R?'9CA<RJXW+*>9QK82E5HPITZF*Q6%5*4:S<G-2P
MLYW7N\LXK=,_7O#WC[!^(>58S-<%E^*RZG@\QGETJ6*J4JLYU*>%PF*=2,J/
MNJ#CBXQ2?O7A)O1HT****_/#[X****`"BBB@`I#C!STP<\XX[\]OK2U4OYIK
M:QO+BWBBGGAM;F:&&>:6WAFEB@DDCBEG@M;V:".1U5))HK.ZEB1F>.VG=5A<
M`_,3QQHW[#^M?M1ZUJES\.OVA?'/QLT[XC>!;'QAXR^%O@[]M'Q=\--`^(>G
M6/A6\\.:9XP\5?#5KGX'Z7<^&]&O?"][XETS4YQI?AO1[N(^,;:S@EO8C^HH
M]O4^OJ<]??IVQTXQ7X=V6E?%O7/BW<?'G4+GP9X`\+>)?B'X0\5?$)?`/_!7
M;XA0?"RQ_L$^'M'U6ZC^%I_98\.>$;UO[%T6"'7/#-UJ/AM_&$L`TSQ%J=G)
M.+JR_;?3-1LM8TVPU;3;A;O3M4L[?4+"Z0.$N;*]B2YM;B,2(D@CF@DCD0,B
MG8PXH`_$[_@I/_RDD_X(4_\`9UO[4'_K'/Q!K7_X*&?\EJ\-_P#9,]$_]2#Q
M/61_P4G_`.4DG_!"G_LZW]J#_P!8Y^(-;'_!0S_DM?AKO_Q;/1./7_BH/$]`
M'P=[=\9QWQG&<=<9XSTSQ1@^G7I7U?9>$M.U#]GF:\L_"6GV6J6*_P#"1ZIJ
M?B'P[JT%_JMI;6-[-<>(O!_CNQOKG2G,MJUOI]EX>UJSL=--S;WVB"TU'7)K
M2:3/_LKP7<^+/@O<GP-:Z+HVO?#;7KQ]&73?$/B2RD\1V>M?$K3_``]J?BU;
M2"77O$EO;W.D:-?^+&MK4376E6=TT.FQ:5"+!`#Y@P>F.?2BOL=/AYX9GU'X
M;>)[M/A]?ZM)X9L=2U[PI8W&F>#?#7C'7;SQ_J/A[P[J%EHGB&;PV)_#G]@V
MLVK>)'TC3[&U\1MI%I;Z5I_E>(?M<W#:/\/=,G_:"\0>&M7TVVC\-V/BSXFK
MIMG!"^HZ%J%WX=T[Q'XA\.^%(SH,KI>O<+::5;W/AO2[M-7DMV.C>79W,^(@
M#YR`((R,<CK]:_H9_9:`/[//PAR`?^*(TCJ/]F2OP_\`BEIUI$G@3Q!86NFV
MMGXJ\+W%]$+3P<O@#4;F33/$.IZ1<7FL^$[74M4T>QFEDMQ#IVHZ%-%IVLZ;
M!%<2VZZG!?R2?N#^RU_R;S\(?^Q(TC_T&2@#YB_X*/@#X=_#O``_XKRY_P#4
M8U:OS&\)_#/6_%^AZWX@M=2\-Z18:0DB6[>(M<L]&.M:A!<Z'!<:;ILEVZ0)
M+;KXATII;N_EM+`7%]86`N?M-ZGE?IS_`,%(/^2=_#O_`+'RY_\`48U:OS^^
M$'Q2\-^`-#\6V&N6?B34_P"U[6,MX=ANM*O?!OBU4U7P].ND^(-%UG3;^#2Y
MOL>GZG:3>(K)+B[DTC4+FUMX;75K72+H`'#'X9>(&TB34[:^\.7][:Z9H>MZ
MEX9L=:6X\3:3HWB6\T[3]&U'4;,VT>G(D]WK&CQW=K:ZM=ZCI"ZM82:O96*R
MRF&_J?PEUS2KV2RN/$'@=OL&NZGX8\1WH\1O;Z=X2\0:-IMWJVIZ9X@O-0TV
MQ436]C87S1/HJ:U'?W-I)8Z>UU>2VD-SN1>,/AMHWA?3]'\/Z?XE>2YN?#^J
M>/-+U72=)2U\>SZ9JUMJMQX6N?$EGXEEU+0O`D#1R+IVFZ?HLM]?7D=MJWB&
MYU"]CMDT[IO%OQC\.^,X-,L_$MW\0_$1LO$^H>(M*UV\MO!>DZWX$@N-,:UL
M-%\-6^FF>P\06%KJ,.D7]Y#K<NE17,&B6EKIRZ7)<7,U`'BGB#PAJ7A^^T2T
M>ZTK5K?Q+IFFZSX=U;1+R2\TK6=,U6]N=-M+JUEN+6RO(B-1LKRQN;>]L;2Z
MM[FUF1X"GER23>+O![^#[LV-SX@\/ZO>QWE_97-KHH\1%[633KA[2>5YM:\.
MZ):W5J;N*:VBNM,GOH9)89/F6/8[]AXW\=>'O%^J:?K%T_BZ_P!8\/>'_#NF
M6FO7L?A_3]3\7:EI?B"6\N;_`,2QZ<UQ9Z'%8^'9TT7P\VCIJUVLNF:=<:NU
MR'N`CO'_`,1;'Q/H3Z/;ZIX\\2SWGC"X\7R:O\0[W3;R_P!$6?3;FP?0-$;3
MKF\5K>]>Y2[UN^7^R;._GTS2FM?#]@T,KD`_3#_@G.`?A'XQR`?^+D7O_J+^
M&JA_X*M@#_@GG^U-@`?\6ZB[?]33X<J;_@G-_P`DC\8_]E(O?_47\,U%_P`%
M6_\`E'G^U-_V3J+_`-2GPY7U7`O_`"6_!O\`V57#W_JWP9\QQM_R1O%O_9-9
M[_ZK,4?P:/\`?;_>;^9IM.?[[?[S?S--K_5V.R]%^1_E\%%%%,`K^@?_`(-Y
M_P#DX+]H3_LC7A;_`-3QZ_GXK^@?_@WG_P"3@OVA/^R->%O_`%/'K\M\:_\`
MDUO&'_8#A/\`U:Y>?IG@Y_R<WA'_`+#L3_ZK,<?U8>+`/^$7\1\#_D`ZSV'_
M`$#;JO\`-%C_`-5%_P!<HO\`T6M?Z7?BS_D5_$?_`&`=9_\`3;=5_FB1_P"J
MB_ZY1?\`HM:_$?HG_P`+CK_KYPY_Z3G9^Q?2B_C\$_\`7OB/_P!*R$?1117]
M@'\HA1110!^@G_!*O_E(1^R]_P!CMX@_]5MXYK^])``BX`'RKT^E?P6_\$J_
M^4A'[+W_`&.WB#_U6WCFO[TD^XO^ZO\`(5_"/TIO^2WR+_LE</\`^K?-S^V?
MHS?\D=G?_93XG_U4Y..HHHK^93^CPHHHH`****`"BBB@#SZZ^$WPNOO%,7CB
M]^''@*\\9PNDD/BV[\'>&[GQ/%)&5*/'X@FTQ]81T*(5=;T.I52&!48]!`QQ
M_G_/O110!^'?_!2UWC_X*0?\$*GCA>=A^U?^TX/*1HT<JW['OC]78&9XX_W:
M%I""ZE@I5<L5!T?^"@,\]Q\9?#CW%E+8N/AMHJB&::VF9E_M[Q*PD#VLTT84
MEF4`L'^4DJ`5)I_\%)_^4DG_``0I_P"SK?VH/_6.?B#7PU_P6P_:(^)OPG_:
ML\#^&_!M[H=OI=U\!_"NL3)J6@6NJ3F^N/&GQ`M)&2XFE1UB,-E`!%@JK!V!
MRYKZO@W@[-N.L[AD.2SP5/'5,-7Q498^M5H8?V6&4743J4</B9J;4ER+V=F[
MWE$^8XNXMRK@K)YYYG$,9/!PQ%##..!HTJU?VF(DXP:A5KX>'(FGS/VEUI:+
MZ=$FOZY'H_\`PC\>L:DFA#5(]:&D)>W"Z<NKQ1&"/45M5<1+=)&?ED"C$H6X
MQ]H591J7OCKQQJ7V7^T?&GB_4/L-W%?V/VWQ/KMT;*_@W^1?69GOW-K>0B20
M175N8YXQ)($D'F/N_$?_`(;6^//_`$%/"?\`X1VG_P#Q^C_AM;X\_P#04\)_
M^$=I_P#\?K]<_P")9/$?_H(X7Z?\S3'>7_4H\W]S/RG_`(F/\/O^@;B7_P`-
MN!_^>OG^?9G[.7^J:IJFH/JVJ:GJ.I:K))%-)J>HW]W?:B\MOL%O*U_=S37;
M20".,0.9BT(C01%`B@2MK6LNJJVL:JRKJTVOH#J5\0FO7`03ZXF9_DUF811B
M;5EQJ$HCCWW+;$Q^+W_#:WQY_P"@IX3_`/".T_\`^/T?\-K?'G_H*>$__".T
M_P#^/T?\2R>(_P#T$<+]/^9ICO+_`*E'F_N8?\3'^'W_`$#<2_\`AMP/_P`]
M?/\`/LS]G]2U;5=;O7U'6=3U+6-0E$:2W^K7]WJ5]*D0V1))=WTUQ<.D2?)$
MC2%8U^5`H)%?OE^S'J&H0_L__"..'0[NZC7P3I(6=+S2XDD`$P#*D]['*`0`
M1O1&&<$9%?PX+^VM\>=R_P#$T\)_>'_,G:?Z_P#7Q7]KO_!/CQ1J_C7]BG]F
MCQ7KTEO+K.O?";PUJ6HR6EJEE;/=3QS^:T-K&62",E1B-6*KVKXCCGPCXJ\/
M<NPF9Y_5RB>&QN,6!HK+L9B<1559T*N(O.-;`X6,8*%*:<E.3YN5<MFVOL^"
MO%7AGCW'XK+LCI9M3Q&#PCQM5YAA,/AZ;HJM1H6A*CC<3*4^>M#W7"*Y>9N2
M:2?C?_!1.\N[GX>_#T7.EW%@!XZNB'FN;&=7(\,ZF`JBTN9V!(9B2RJH"?>)
M8"OR2K]*?^"NWQC\(_!OX3_";5_%\6MRVFL?$Z\TJT&AZ?#J$XNH_!FNWQ,T
M<UY9".$PV\@$@=SYA12@#%A^!W_#<_P3_P"?+X@?^$S8_P#R^KY_)_#_`(US
M_`T\SR7AG-\SP%:52%+%X3"SJT)SI3=.I&,UHW"HG"7:2:/=S;CO@[(L;4RW
M..(\JR['4HTYU,+B\5"E6A"K"-2G*4).Z4X24HOJM3[(HKXW_P"&Y_@G_P`^
M7Q`_\)FQ_P#E]1_PW/\`!/\`Y\OB!_X3-C_\OJ]3_B$OB5_T17$'_A#/_/S7
MWGF_\13\.O\`HL<A_P#"ZE_G_5GY7^R**^-_^&Y_@G_SY?$#_P`)FQ_^7U'_
M``W/\$_^?+X@?^$S8_\`R^H_XA+XE?\`1%<0?^$,_P#/S7WA_P`13\.O^BQR
M'_PNI?Y_U9^5_P"DC_@GG>7EM\)O%ZVVE7%^I^(MXQDAN;"!58^&?#@,96ZN
M87+`*K952A#X#;E856_X*HW]_/\`\$^?VI8Y]%NK.,_#F+,\EWIDR+_Q5?AH
M'<EO>22X"EFRJ-]W;C+`CB_^"27Q;\*_&+X#_$#Q!X1BUF&PTWXNZCHUPNMV
M$.GW)O(_!G@Z]8Q0PWEZKP>3>P@2&129!(NP!0S>E?\`!5O_`)1Y_M3?]DZB
M_P#4I\.5Q<+9;C\H\1.%LMS/"UL#C\)Q=P[3Q.$Q$.2M0J?VK@I\E2#UC)QE
M%V[-'9Q-F.!S7@#B7,<MQ5'&X'%\+9[4PV*H352C6I_V;BX\].<=)+F35UI=
M,_@\MK.[U"^M]/T^UN;^_OKD6MC8V5O-=WM[<R;F2VL[2W22XNKAU1V2"".2
M5U1BJ$*<1VUM<WL)N+*VNKVW"AC<65K<7EN$*[PQGMHI8E4IEPQ<`H-X.WFO
MOO\`X)O:M>Z5^TCIZZ=:Z1=WNK6=CI28\?:#\.?B!9VS^)-*O[V^^%NL^)=/
MOM)U37$AT\6GBGPNLEAJVN^![W6H])NT>VN17T5H5V+^[UGP+:^-M:\4_#&^
M^,GC;4_C!^T'X%_:8\)?!BY\$:3XS^&WPMCU[Q%X]^&OPZN=-\%^,=6\%2Z-
MJNE1Z_;1>*?AQ\7=5TGQ9IG@JSAU;Q"UX_\`HUFG%U7+<UQ>6_V=2K4\)@L'
MC?;O,*-&I.GB/K"J?N:M.-*+C*C"C0HRQ,<7C:M1QP6&Q'LZSH_Y]Y7PK3S'
M*\)F']H5*4\5C,5@_8+`5JL(3H?5G"]6E.522E"M4JUZT,-+"X.E",L97P_M
M*/MOQU"LRLRAF50I9E5F50[;4+L`50.P*H6(#L"JY((I.P/9L[3S@[69&P>C
M;75D;!(5U9#AE8#]+O"LWPDM?V-OC-\//`WQ9\%ZC?77AG]GCQKXH\/ZGX-^
M(NB^*?&?QA?XPVLLOAU3?>%[?3IO#WA[0/LGP\\(6FD>(;G3[*6]\6^-?$U_
MHUGXE-YI^'^U+\-_C/\`$$_LM7>H^!=&TOQ#<?`2S\"ZEI&BR_#?P5X8\->*
MO#_Q"^.WBJ+P';Z=8:]8^'O"YT;X?6VFWNGV-U-")M.;3Q+J&HZWJ2&^Z*'%
ME*>/GA<3AEEU&.:8W+XULQK5,!7E0PF487-88Z.%QF%P[="JJ]2G4M6:PT(X
M>I5ESXF5##XUN%JL,%'$X;$/,*LLMP>.='+Z,,=2C6Q6:XC+)8)XG"8FNE6I
MNC"I#]U?$3=>G3BH8>-:O^=P5B&8*Q5-I<A6(0.2J%V`(0.P*H7*[V!5<D$#
M]^_^#?*>>W^/O[0CV]E+?/\`\*:\+?NH9;:$_P#(_$<O=30(!M9F&&8_)C`W
M`U\2:#>_"&W_`&)?C=X'\&?%_P`'R75WX-_9_P#'_B_2;_PE\1-*\7^)?B]+
M\4X[R^T>*>_\(QZ9=Z)X2\/&W\`^#$TC5[[3+:>;Q7XZ\3S:39^*3-8_<W_!
MO/\`\G!?M"?]D:\+?^IX]?">*N:RS3PO\18RP>)P:R^KA<#36)HXBC4Q%)8C
M(<9#%>SQ&'H.G&K];E&--.LU3A"I.<*E1TJ7VWA?ED<M\2_#^4<7A\8\?"OC
MIO#5</6IX>JZ&=86>%]IA\17525+ZJI3J-4DZDYTX0G"FJM3^I7Q3J>IMX9\
M1!O#UZB_V!K66^WZ.V"-+NR,A;_."0`2,XSG!`K_`#8(_P#51?\`7*/_`-`6
MO]+OQ9_R*_B/_L`ZS_Z;;JO\W;X<>!M9^)GC3PE\/_#TME!K?B[4(-(TV;43
M>FRBN&LY[MY)XM,L]1U2[*6]I.T&G:3I^H:QJMT(-+TBPO=3O;2UE_)?HJU:
M>'PG']>M-4Z-#_5^M5J2^&G2I4L]G4G*WV8P3E)ZV4=.M_U'Z3E*I7QG`M"C
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M5.<_W<)2J>X?$E%>\Z9\`?$-[\!?&7QZO-<T?2M*\,ZMX7L]'\*S0W=WKOC/
M1->\7R^`M2\9:/=VY&G6?A;0O%R#0(M0NS)_PDNIVVMV^BJT?AW5+A+?P;^!
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ME8&7_@H3^R^K`!E\<>(D=0R.%=/AQXZ5U#QL\;A6!`>-WC<#<CLA5C_>BGW%
M_P!U?Y"OXF^E-KQOD+O=/A7#V[?\C?-]3^QOHS?\D=G?_93XG_U4Y..HHHK^
M93^CPHHHH`****`"BBB@`HHHH`_$#_@I/_RDD_X(4_\`9UO[4'_K'/Q!K\J/
M^"_/_)Y?P_\`^S<_!W_J>_$NOU3_`."EIF'_``4@_P""%1@2*27_`(:N_:=V
MI-*T,9!_8\\?A\R)#.RD1[F0")@SA5)56+K^4?\`P7N:\?\`;'\`?;8+:";_
M`(9V\'!4M;J6[C*?\)W\2?F,DUI9,&+EAL$3`*%;S"6*K^]_1N_Y.9A_^Q-F
MO_I-`_#?I#?\FYQ'_8VRO_T[,_$:BOI9/V8?$_\`PI70/C%=^-OAOI$_B[6=
M)M/"/P\UWQ&VB>+/$^B:U_:$&GZUI%_JEG:^$IKZXO=+OY4\+2>((]:3P]8:
MAXBNEM8[*2P>^W[)_B[4KO0X?`OC_P"%?Q*L+_X@:W\,/$7B'PIKGB*U\-^`
MO%WAGPCJOC_Q#)XHU7Q/X6T%;GP=IO@?P_XE\51^/O"\/B#PSJ>D^&]7;3[B
M:X&FV^I?WH^(<E3JWQ]*,:%;%4*U24:L:-&K@XJ6(56O*FJ-.,/AA4G-4ZU2
M,J=&=2I"45_$*R#.'[-1P-64JU+#5Z5.,J4JM6GBY<M!TZ*FZLY2=G.G&#J4
MH2C4JQA3G&3^6J*^GXOV8;V:3Q3J,?Q9^&DG@;P5X*\->./%'CB+3?BM+-H5
MIXN\5S^"]`T/6/ADOPY_X6]I/B2^UN`S+9ZGX)L].7P[<Z7XG_M9M+UG2C><
M;8_`CQ5/\<;SX"W^J:#I?B;3=6\0:9J>MXUW6/#UI!X;\+ZEXQO]5BAT;1KK
MQ-?VTGA_39+JUTZU\/GQ`]W/!I-QH]KJHN+."Z>>Y546)<<5_NF&JXO$J5'$
M0E1HT:5"O7YX3I1FJM"EB<-4KX?E^L48XC#NK2A[>CSYSR7,Z;PZGA7_`+7B
M*6%P[C6P]2-6M6J5:-!0E3JRBZ5>K0Q%.AB+_5ZTL/B%2JS]A5Y/%$^^O^\O
M\Q7]]O\`P3,_Y,%_9/\`^R,>%/\`T7<5_"=\0_!"?#[Q,/#?]OC7[B*QL+V\
MD?P;\0O`=UI\]\'FCT^]\._$WPQX2\3P7"VHM[M;EM(&GW,%W"UG=3E)O+_N
M=_X)J2ZVO[!7[*(M;'2I81\&?"NQ[C5;NWE8;;K:6BCT:Y1"5VD@3/ABP!(`
M8_SC]*"M3Q'!7#5>DY.E6X@A4IN=.I2DX2RS&N+=.K"%2%UK:<(NS6FJ/Z$^
MC71J8?C#B*C5454I9!4A-0J4ZL5)9EEZ:52E.=.=GHW"<HWTN?G9_P`'#7_)
M`?V?_P#LN&H_^JU\4U_)O7]77_!P<^I/\`O@#]OM;&W`^-^I;#:7UQ>%C_PK
M;Q-M#";3K$*"#(2P9R"J`*=S%/YH/AU\!OC%\7-$\8^(OAK\._$_C/1O`=@F
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MZ/\`#CQ1J%I\76\4CX9W%O:6_E>,XO!!4>,+W2FENHO)TGPTC&?6-<U3^SM%
ML[.*YOWU`V%I=7,/[5_:>6\DJG]HX#V<:U;#RJ?7,/R1KX>A4Q6(H2G[3E5:
MAAJ57$5Z3:J4:%*K6J1C3ISDOQS^SLQYXT_J&-]I*E1KQA]5K\\J&(KPPU"L
MH^SYG1KXFK2P]&JER5:]2G2A*52<8ORFBNP\9?#_`,:_#WQ"OA7QIX9U/P_X
MAEL]*U&TTVY6WO&U/3==B6;0]4T2]TFXU'3-?TK6HF#:1JFA7VI:?J1W1V=S
M--')&F_\0_@M\6/A-%ID_P`2?`6O>#H-8N]1TVPGU0:?-"VL:/':S:QX?O)=
M*O\`48](\3Z/#?64VL>%=:;3O$NE17=O)J&DVR2*U5''X&4L+&.-P<I8Z,IX
M*,<30<L9"$%4G/")3;Q,(4Y1J2E14XQ@U-M1:9#P6-BL3*6#Q48X*488R4L/
M64<).<G"$,4W"V'E.:<(QK<CE-.*3DFC^J#_`(-\O^34_BY_V<+K'_JMOAS7
MV]_P5;_Y1Y_M3?\`9.HO_4I\.5\)?\&_TFJ)^RM\6Q86FGW"?\-!ZL6:[U"X
MM'#_`/"M_AWN4)#IEZ&4`1E6,BDDN"@"JS?;/_!5.76F_P""?'[4HN['2X8#
M\.HMTEMJEW<RK_Q57AO[L,NCVJ-QG@S)S@9P21_GSQ7_`,I#/_LO^'O_`%-R
ML_O'AC_DPO\`W8^>?A@\P_KSZ;H_A+$DD4PEBDDBECDWQRQ.\4L;J25>.6-E
MDC=?X71E=>Q%5FA@9HF:"%F@P(&:&-FA```$+,I,6`!CRRN,#'05,_WV_P!Y
MOYFFU_HA'9/K9*_E;;\7][/X%Z6Z7O\`/3_)?<-9$8@LJL5W;2RABH<;7`)!
M(#K\K@<,N5;(XJ!;*R0$)96:!E",$M;=-R!@X5ML8RH<!PIR`RAL9`(LT4[O
MN*R[+[N^_P!XA5258JI9<E6(!92PPQ5B,KN'#8(W#@Y%?T$?\&\__)P7[0G_
M`&1KPM_ZGCU_/Q7[^_\`!ODUZGQ^_:#-C!:SR_\`"F_"V5N[J6TC`_X3TX(D
MAL[UF.-V08U`(7YCDX_+?&O_`)-;QA_V`X3_`-6N7GZ;X-_\G-X2_P"P[$_^
MJS'']7?BS_D5_$?_`&`=9_\`3;=5_FQ>$]7T[0=;T;5]6\-V/B_3+%A)>^&M
M1U36M"MM6@DLIK<PKKOARZL]=T.]MWF2^TK6M*G^UZ3JUI8Z@L%[';R6-S_I
M">*IO$/_``C'B+?IVC!?[!UK)76KYF_Y!EUC`.@*#SC/(XR>O%?YKL?^JB_Z
MY1_^@+7X=]%.G&KAN/:<^;DJ2X>A+DG.E/EE3SQ/DJ4Y0J4Y6;Y:E.<9P=I0
ME&237[)])Z<J>*X'J1Y>:FN()QYX0J1YHSR&4>:G4C.G4C=>]"I"5.:O&<91
M;3_0KXO_`+?7B+QQXVDU#PMX%\-2>!Q9>&](FT[XQ:;IOQA\;>(]'\.^+K#Q
M[8V&N>+O$%JDUAI^C^)[02^%M"T6--%T-+6RU!H+W45S!=L?V_;F'QQK'CIO
MAQJOAJXF^-GQ`^-5CX>^$OQ(D^%7A3QE=>.]1@OG\'?'[1-+\':M!\8/#NG6
M]LVDW%P[>';O6='USQAIUW;PCQ+/=6_YUT5_2\>!^%HX:EA5E4%2I49T$UB,
M5"K4A5A"G5=:M3KPJUJE2%.$)5*LY3Y8J$91A&,5_.\N,^)98BKBGF<W5JU8
M5FG0PLJ4)TYRJ4E1HSH2I484YSE*-.E&,.:4I2C*4I-_6=S^USXJU?X6_$CX
M8^(?A[\)+V+QQX/^&'@31]>TCX<^&?#VH>#_``S\,?$]SX@TK3K0V5E))?&U
MANIK?PW=F>SNO#FK2W/B7S=3U6\NVFL>!?CI\$?A]I/Q`M/#'P>^)WASQ!XT
MU?7+'3O'NA?&;PU-XY\)_"O5].33W^&V@ZUXA^#^K1:3=:K'+J,/C7Q_H%EH
MOBOQ5H]XOAJVG\/Z"=4L=8^1**[GPSDWLJ]"&%G0H8G$QQ6(H87%XS"T*]>%
M+!T(RK4</B*5*I%4L#AHJG*#I)PE+V?-5K.IQ+B+-_:T*]3%1Q%;#8=X7#UL
M5A<)BJU"A*IBJSC2K8BA4JTY.IC,1+VD9JI[\(\_+1HQI_H+_P`$K`@_X*$_
MLO"-=D8\;^(1&G'R1CX;^.1&GRJB_(@53M1%R/E15PH_O13[B_[J_P`A7\%/
M_!+$S+_P4$_9@,"122CQMK^Q)I6AC;_BW'C<-NE2&X9<)N9<1/E@JG:&+K_>
M38/J3JW]H6UC;X6/ROL=]/>;\AM_F>?I]CY>WY-NWS=V6SLVC=_%_P!*;_DM
M\B_[)7#_`/JWS?J?U]]&;_DCL[_[*?$_^JG)R_1117\RG]'A1110`4444`%%
M%%`!1110!^('_!2?_E))_P`$*?\`LZW]J#_UCGX@U^5'_!?G_D\OX?\`&?\`
MC'/P=QZ_\5[\2^*_5?\`X*3_`/*23_@A3_V=;^U!_P"L<_$&ORH_X+\_\GE_
M#_\`[-S\'?\`J>_$NOWOZ-W_`"<S#_\`8FS7_P!)H'X;](;_`)-SB/\`L;97
M_P"G9GQ/X0_:D^'_`(>_95U?X`ZEX2^(FK7/B;619Z]I%]XUT[Q'\-+.PO\`
M2FM-5^*'@GPUXH\/W]WX.^)EG+B^T#0M'UBP\,0^-`GBZ^NYM&GU3PC>[-K^
MUK\-OAYXX^&&N?!'PK\4?#7P_P#ARWCS2;?X5ZW=?#_3[7^P_BAX"U3P!XZ\
M9CQOHPUS6_$?QSU;3[^UNX/'OBS2;G1])?1M%T?0?#VC>%],M]!'Y^45_<L^
M#\CJ3QDJE'$5(8^MCZ^,H5,7B*E#$5<RPRP6*J2IU*DHQJRPO-AZ6(I\F(H4
M:M:E1K0IUJL)_P`71XLSJ$,+&%:A">!HX&A@ZU/"8>%>A2R[$_7,+3C4A33E
M2CB5&O4H5.>A6K4Z56K2G4I4Y1_1C3OVWM,T;3M'\/:%??M%^';_`,.>"=,\
M':3^TCIGCWP;>?M6W.G0>.?%/CO5_#.J^)=7TRYT)/AYJ=YXBTZPM?#>FZU%
MJFFQ>$M%ENM>UK2[J^\,IXSK/QZ^'^K_`!PU?XZ6?A/XG^"/$'B'XB>*M9O[
M7X;?$'0/!5WI/@_Q%X!3PQ_:?AOQ#HWA:UN;'XLWWBBZUWQIXNOETRT\`>(F
MUB]T*W\/Z1:7UU<Q_)M%7A^$LCPM3$U:&&J4ZN,H8G#8J<<37C*O2QC@\5&;
M51-1JSIPG&$7&GAYJ;PL*'MJ_M8Q'%.<XJGAJ5?$4ZE/"5L/B,-"6'H.-&KA
M%)8:4$Z;]ZE&4XRG+FG7BXK$RK>RH^S]Q^,GQ2TGXAP?#'0/#\'C6;0_A9X/
MU'PCIOB/XF:]8^(_B'XF76?%^L^,KF?7K[3(QIVGZ1HUUK4FC^$/#5E<ZG#H
M.D13%M4NKC49T@_M^_X)F?\`)@O[)_\`V1CPI_Z+N*_@23[Z_P"\O\Q7]]O_
M``3,_P"3!?V3_P#LC'A3_P!%W%?SY])O"4,#P1PYAL/%QI0XEJ5/>E*<I5*^
M"S'$5ZDI2;?-5K5:E1I6C%R<81C!1BOWGZ.&*K8WC+B#$5Y*56?#D8-QC&$5
M"AC,KH481C%)*-.C2ITXMWDU%.<I3<I/\V/^#AK_`)(#^S__`-EPU'_U6OBF
MOQ%_9!^*7P5\*_#+XK>%/C?XNTZ3PK<VSZK-\.M2\!:W<^*;]+SQG\')M0U/
MX'?$[P=KVB^(-`^(>J:7X0DBNO#^K7^D^'+75_#'@;QS>RZOHGA_Q190_MU_
MP<-?\D!_9_\`^RX:C_ZK7Q37\F]?1>".44<[\(,HP5>OB<+'^U<PQ$:^#=&&
M)I5,-FU2K"5"K5HUG0J-QY56I*%:"DW3J19X'C-FM;)O%?-<;1H8?$R_LS`4
M)4,6JL\-4AB,HH4I*M2I5:/MH)2YG1JRE1J62J0DMON2?6/@[X)^$FHG1/C!
MHWQ1\:?%?PY\/](^.:ZA<?$[2/B);_"_0/$WA76T_9[^%]QK/PVG\+0ZA86_
MA?PY!XJ^*7B'Q,;!AX7L-`^''A[2_#=BTWB3VZ]_:F^`_B73/AM%8-XA\+-=
M^*/VG_"_C+PA\3(9=?\`A]X6^"'Q:^%WPT^'^B>`%?X2>&=$\6:1X;?2O!>E
M>&/!FN>")M6\1>`DT'5/%'BK0?%;ZE%8WWY6T5^L5N#<OQ+53$XS,JV(C6QU
M:.)=>A3J16.R_P#LV5-4J.&IX6-.AAHT8X9+#\U)X;#IRE",X3_+:7%V/PZ<
M,/A,NHT)4<%1EAU0K5*<OJ6.CF,:CG6Q%3$NI6Q+K/$-U^6HL37:C&I*,X_;
M?QC^)OPXU?6?@Q<?"SQ1X5\)1?LJ?##X>:)X.;3?#GQ`UFP\=^+[;XV:_P#$
M74X?"$OB[3[76-3LO`'_``E7]I3:W\3(O!J>//[#UI-)TC0UU;1M'CV_VCOB
MY\&M2^$^M_#SX80^"+_6?B+^T?>_M!>+-6\!V'Q:@TBSE7P?XB\/#[5)\8H+
M/7-+UGQ1J7BZ_P!0;P-H":UH/@?3-)CL[KQQXPO]2@GL/@FBNFCPM@J4\NG]
M;S&HLMKU<13A4Q%.V)JUJL<5*6.G"A"KBG''^US"GSU%[/$XBM&-L-*.'CSU
M>)L95ACX?5<OI_VA1I4)SIX>HGAJ5*D\-&."C.O.EA4\"J6`GR4_?PU"BY7Q
M,98B?]=__!OE_P`FI_%S_LX76/\`U6WPYK[>_P""K?\`RCS_`&IO^R=1?^I3
MX<KXA_X-\O\`DU/XN?\`9PNL?^JV^'-?;W_!5O\`Y1Y_M3?]DZB_]2GPY7\)
M\5_\I#/_`++_`(>_]3<K/[8X8_Y,+_W8^>?^H>8'\&C_`'V_WF_F:;3G^^W^
M\W\S3:_T0CLO1?D?P*%%%%,`K^@?_@WG_P"3@OVA/^R->%O_`%/'K^?BOZ!_
M^#>?_DX+]H3_`+(UX6_]3QZ_+?&O_DUO&'_8#A/_`%:Y>?IG@Y_R<WA'_L.Q
M/_JLQQ_5CXL_Y%?Q'_V`=9_]-MU7^:)'_JHO^N47_HM:_P!+OQ9_R*_B/_L`
MZS_Z;;JO\T2/_51?]<HO_1:U^(_1/_A<=?\`7SAS_P!)SL_8OI1?Q^"?^O?$
M?_I60CZ***_L`_E$****`/T$_P""5?\`RD(_9>_[';Q!_P"JV\<U_>DGW%_W
M5_D*_@M_X)5_\I"/V7O^QV\0?^JV\<U_>DGW%_W5_D*_A'Z4W_);Y%_V2N'_
M`/5OFY_;/T9O^2.SO_LI\3_ZJ<G'4445_,I_1X4444`%%%%`!1110`4444`?
MF?\`\%!?V!_B%^V+XL_95^)_P<_:AU3]E/XP?LE?$GQS\2/A]X^T_P"#W@WX
MU0SWWCWX=:A\-=7LKWPEXZUG2_#[HNA:I?B&>\@U1%DN6=;2.YAMKN#\N?VA
M/^""W[9G[4_C73OB'\<?^"P_BGQ9XNTKPU9>$;'4K/\`8/\`V=O#<4.@:?J&
MJ:I:6;6.@^*;&SE>.^UG493=20M<.LRQ/(8X8E7^G:BO0RS-LUR7%+'9/F6/
MRK&QA.DL7EV+KX+$JG4LJE-5\-4IU5":24X<W+))<R=C@S'*LLSC#/!YMEV!
MS3".<*CPN882AC,.ZE-MPFZ&(IU*;G!MN,G&\;NS1_(G_P`0P/QH_P"DL'C3
M_P`0N^"/_P`VU(?^#8+XT`$_\/8/&G`)_P"3+_@CV&?^AUK^NV@C((/0\&OI
M/^(C^(/_`$7/%_\`XD>;_P#S9Y?GW9\__P`0_P"`_P#HBN$__$>RG_YD\OS[
ML_BD^$/_``;O_&_XH>)?C]X?F_X*A>+=&3X*?&VZ^$=M=0_L??!>];Q';6_P
MK^$_Q'77KB*7Q9;+IT[S?$J?2#8P/<PB+1X;L3"6[E@A]O\`^(8'XT?])8/&
MG_B%WP1_^;:OZP/#/@;PGX.O_&6I^&M%M=)O_B#XKD\<>,;FW:X9]>\52^'O
M#GA236;L3SS(ETWA[PEX=TLK:K;V_D:5;L(!,T\LO64?\1'\0O\`HN>+O_$C
MS?\`^;/+^KL/^(?\!_\`1%<*?^(]E/\`\R?U\V?R*#_@V"^-`((_X*P>-,@Y
M'_&%WP1ZC_N=:_0;X7_\$S?^"I/P:^'WA#X6?#K_`(+<:YHG@?P)HEIX<\+Z
M3/\`\$Y_V5=6FL-'L0PM;:34M3UJZO[UXP[`W%W/+-)U=V/-?O+17E9MQ5Q/
MGU&GAL\XBSS.,/1J^VHT,TS7'8^C2K<DJ?M:=/%5ZL(5.24H<\4I<LI*]I._
MIY7PSPYDE:IB,ER#)<IKU:?L:M;+,KP6!JU*/-&?LJE3"T*4YT^>$)N$FX\T
M8RM=)G\YO[1G_!&S_@H/^UCX>\.^%?CQ_P`%GO$?B_0_"FO2^)="M++_`()^
M?LS>&7M-9FTRZT>2Z>Y\/^(K">Y0Z=>W,'V>X>2`-()0GFHC+\B_\0P/QH_Z
M2P>-/_$+O@C_`/-M7]=E%;9;QGQ?DV$A@,HXIXARO`TI3E3P>7YSF.#PM.52
M;J5)0H8?$4Z495)MSFU%.4FV[MN^68<(\*9MBIX[->&<@S+&U(PC4Q>/R?+\
M9B9QIQ4*<9U\1AZE6480C&$%*348I1BDM#^1/_B&!^-'_26#QI_XA=\$?_FV
MKPNP_P"#>/XWWO[27BGX!G_@J#XMCM?#GP0\"?%Y/%`_8_\`@NUS=W/C+XA_
M$CP/)H#:6?%:V\-OI\'@*+4H[Y;R2:XEU.6W>&*.UC:;^V"N1A\!^$;?QUJ'
MQ+AT.UC\<ZKX3T?P-J'B,/<_;;KPIH&M:[XBTC19$,YM!:V.M>)==U")TMEN
M#-J,PDGDB6*./O\`^(C^(7_1<\7?^)'F_P#\V?U\V</_`!#_`(#_`.B*X4_\
M1[*?_F0_E!_XA@?C1_TE@\:?^(7?!'_YMJ/^(8'XT?\`26#QI_XA=\$?_FVK
M^NRBC_B(_B#_`-%SQ?\`^)'F_P#\V>7Y]V'_`!#_`(#_`.B*X3_\1[*?_F3R
M_/NS^=?]G;_@CS_P40_92\):QX&^!7_!:+Q%X1\,:_XCF\6:K87G_!/G]F3Q
M+)<:]<:9INCRWBWGB#Q#?W4*-I^D:?"+:*5;=6A:58Q)+*S=U\6O^"87_!4+
MXY?#GQ9\)_B;_P`%M==U_P`!^-]-72/$NCV__!.G]E?1IK_3UN[6^$,>IZ5K
M=KJ%H?M-G;N9;6XCDPA3=M9@?WNHKYNKFV:5\R_MBOF..K9M]8IXS^U*N+KU
M,P^MT90E1Q/UR=26(]O2E3A*G6]I[2#A%QDG%6^AI97EM#+_`.R:&7X*CE?L
M*F%_LVEA:%/`?5JJE&KA_JD8+#^PJ1G.-2E[/DFI24HM2=_Y%#_P;!?&@DD_
M\%8/&F2<G_C"[X(]3_W.M)_Q#`_&C_I+!XT_\0N^"/\`\VU?UV45])_Q$?Q!
M_P"BYXO_`/$CS?\`^;/+\^[/G_\`B'_`?_1%<)_^([E'_P`R>7]79_%;\3?^
M#=CXW_#[QU^SQX-A_P""HGBW58_CE\6=?^&EUJ$O['OP7M)/#4&B_`SXP_&)
M-8MK>/Q;-'J<MS<?"V#P^UG/+:QQP:U/J"S--8Q6UQ[-_P`0P/QH_P"DL'C3
M_P`0N^"/_P`VU?UAZ_X*\+^*-7\$Z]KVCVVI:O\`#KQ'>>+?!5].UPLOA_Q%
MJ'A'Q/X$O-5LQ#-%&]Q/X2\9>)M$=;J.X@%KJ]RRQ+<K;SP]31_Q$?Q"_P"B
MYXN_\2/-_P#YL%_Q#_@/_HBN%/\`Q'LI\O\`J$\OS[N_\B?_`!#`_&C_`*2P
M>-/_`!"[X(__`#;5]#_LY_\`!"S]MS]D[Q%XC\5_`?\`X+'>*/"&N^+-$M/#
MNO7=[^P5^SEXF2[TBQU`ZI:VR6WB#Q1?VULT=Z3*9[>))G!\MW,8"C^F6BN3
M'<<<:9GA*V`S+BWB7,,#B8QAB,'C<\S/%86O&,X5(QK4*V)G2J1C4A":4XR2
MG%26JN=6"X,X0RW%4<=E_"W#N`QN'DY8?%X/)<MPV)H2E%PE*C7HX:%6G)PE
M*#<)IN,I1;M)I_B==_L'_P#!7:^M;FRNO^"Y6L26UY;SVMQ&/^";/[)"%X+F
M)X9D#IJBNI:-V4,I#+G(((%?F&/^#8#XSJ`H_P""L'C3"@*/^,+_`((G@#`_
MYG;T%?UVT5PY1Q+Q%P^L0LASW.,E6+=)XI95F6,R]8ET/:>Q==86M2]JZ7M:
MJI\_-R*I-1MSROVYKP]D&>N@\[R3*,X>%5189YIEV#Q[PZK>S=947BJ-7V2J
M^QI>TY.7G]G#FORQM_(G_P`0P/QH_P"DL'C3_P`0N^"/_P`VU>%?M,?\&\GQ
MP_9^^`_Q0^,UI_P5`\6^*KGX>>%KGQ'!X>N?V/\`X+Z5;ZM);W5G;BTEU"W\
M5WL]JCK<LYEBMI7!0`*02#_;#7(^/?`?A'XG^#_$'@'QYH=KXD\(>*=/DTK7
M]#O7N8[34]/EDCEDM9WM)[:Y6-I(8V)AGB?*##@9!]G_`(B/X@_]%SQ?_P")
M'F__`,V>7Y]V>1_Q#_@/_HBN$_\`Q'LI_P#F0_E`7_@V#^,[;B/^"K_C0`/(
MHS^Q?\$2<([*"3_PFBY)"Y/RKSV'2E_XA@?C1_TE@\:?^(7?!'_YMJ_KK``&
M`,#)/XL2Q/XDDTM'_$1_$'_HN>+_`/Q(\W_^;/+\^['_`,0_X#_Z(KA/_P`1
MW*/_`)D\OZNS^5?X3?\`!NO^U%\#_B+X4^+'PS_X*[^+M!\=^";ZXU+PWJ]Q
M^PY\`M8AL;R[TR_T>>633-4\7W.GW8?3]2O81'=02HC2B55$L:,O[H_L@?`K
M]L#X+MX_/[57[=-Y^V>GB$>&1X&2Z_9I^$7[/7_"NO[*_MO_`(2(HWPLNKD^
M+/\`A*?M^C;O[<V?V)_8*_V?N_M.\Q]KT5\_FV>9UGU>GBL\S?,\XQ-&BL/2
MQ&:8[$X^M2H1G.HJ-.KBJM6<*2J5*E14XR4>>I.5N:4F_<RO)LGR2C/#9-E6
M793AZM5UZE#+,%AL#1J5G"%-UJE/"TJ4)U73ITX.I*+FX4X1;M&*11117EGI
M!1110`4444`%%%%`!1110`4444`?*OQ8_;*^"'P:\8:KX/\`&&I^)Y9/"&D>
M'/$7Q4\2>&_!7B;Q1X*^"OASQC=WECX4U[XP>+-$L+K2/`>F:W-IU]=I)J,T
ML^D^'K2X\8^(K?1?!<3^(A-!^V%\&)OBM:?">2Z\7V=YJ?C[5OA'HOCG4/`7
MBRQ^%&N_%_0=,U/6=9^%>C_$JYTR/PQ?>-;"PT768S:)=KI=[K>CZOX2TS6+
M[QAI>H>'[;XJ_:U^!?QD\/3?M;:=X$T*S\8?"K_@H19^"OAG\4?%MC9_$/Q-
MX_\`V<I=6^#5S^SWXN\>:3\+?`?A#Q3JWQ0\)7G@;1O"C:/9>']5\)WG@[Q_
MJ-YKWBWSO`%UKOB7PSZ-:_"_]J7Q7^U;X0\1_%?X3?#?5_V>_@QXPNH/@%::
M+^T%J4LGAJSM?"6H>%+'X]?$;P)J7P6AO_'WQJFTW5-=T/P[X5/CNQ\"?#31
M?$-[J>F3^*O'4H\7V0!]A^+?VB?A7X#\<:_X%\::]+X6NO#'PLMOC#KGB+7=
M.N]-\$:?X.N_%USX)MC+XQN431&UZ?7[8VT'AJ*X?6KB.>SEMK28WMLDGCUO
M^W9\'==^"/P4^/'P_P!"^+7Q0\+_`+0>I76G_"SP_P"`_A?X@O\`X@ZV-.TO
MQ5K6K7VH>"-8.@ZOX;LM'TSP=K,^JGQ&-+NK&9;33Y[1=3O(;*OI7XA-XET[
MPMK6M^`_!/A_QUXZLK.R;0?#>O\`B./P7I^L3VFJ6EW'87?C#_A&_%<NBP6Y
M$VH6]PN@:DJWMO"$@ADE%U!^2G[/_P"R%^T'X5_8_P#V?_@?\<?V;/V7?BQK
M_P"SSXN\1RIX-\4_&?Q=KO@CQWHGBS3_`![Y_B.PU@_!^/2=.U/2;CQL-'O/
M!/Q`^&_CCP[X@TR.\U:TU/P_KMCHLK`'[!>#?$G_``F'A3P]XI.A>)/"Y\0:
M/8ZO_P`([XPTHZ%XIT3[=`D_]F>(-&-Q='2]7L]_DWUB;F<VTZO$9&*YKI:^
M?OV6_A5XJ^"?P(\`_#+QIK]KXA\0>&;;75GFTV^U[5-&T+3]7\5:]K^@^!O#
MNJ>*)9/$.J>%_AQH&K:7\/O"^IZTEIJ6H>'O#&F7EWIVERS'3;3Z!H`*\-^,
MO[07@7X)3>$M)\06GB_Q/XQ\?7&M0^"?AY\./"&M>/?'WB>W\,65MJ7BO5M-
M\-Z%!+<1Z#X5T^]L9]?U[49K#2+&YU30]'%W-K_B+P_I.I^Y5\1_M.>!_BWX
M:^)/P\_:R^"?@[2/BWXP^#'PE^.WPZUCX)ZOXGU3P==_$#PC\4K[X5^-9)?`
M_B2UT/Q9IUAX_P!&\4_!;PY:Z9IVK>&I++Q'H^O:SIXUC2M1MM+6\`+'B#]O
M[]F_0_#F@^-;77/&7BKP+J7PXL/C%XB\;^"_AEX^\3^&/AE\*=1U+7M%A\=_
M%?4-/T`R>`-*M=8\*>+=.UG3M;MH_$_AY_!_C.]\0:!I>E>#O$]_I7T;XS^*
M?A7P-J7PMTO6&U:XN/C!X_B^''@V71-&O]<LW\03>!O&WQ#CGUF\TZ.:WT/0
MF\.>`=?<:_J+Q:6=0.F:8)S=ZM9))^0Q_9^_:TO_`(%_"KX&>%/`W@CXF_LW
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M1M*\1:-J-GJNE37%A<0SR?GIX._9B_:V\>ZU^WYX=^(N@>`/V>/!_P"V3XJ\
M">,-"\<_"WXLP_%[Q3X*T_P/\$/@)\"M6^'FI^#/$/P>\!:+?:;\1-`^%?B=
M-5UC3]<MY-&\->*1I6F1P:Y'%K5E]!?L#?LN?&C]F.3]JQ/B_P#$OPS\18?C
M+^U#XJ^,'@$^&?"^G>%8=&\(ZMX%^'WA:VBU/3--L[2TTW5+J3PB+=O#]C)?
MZ3H6G:3I@T[4;AM0O(;4`_0>BBB@#Y_\>?M-_"#X8^*?''@_QYXAG\-ZSX#^
M#R_'6_CU#2[T6^M_#R/7M0\+:G>^#[F*.5/%FLZ'XEMM)T+6O#&C"X\0Z?JG
MC/P!:2:<S^./#?\`:'RQXP_X*@_!+X>ZW\;-$\<?#+]I;PN_[/?@;2?B-\4]
M0U3X):J-*T#PEXJO/$NF>`=1AO;;6;G^U9/B)J_@_P`2:/X-LM-BN+S4=0TF
MYCO(=-BV3-ZS^U-^S-=?'?XG?L6^.]/L_#+K^SQ^TI+\3O&LVMWFHV.H:E\-
MI?@[\4-&D\,:2EA9W,6NB7XQR_!#QW-X:UN6TT"74/ASHOBF25M>\(^'XV^6
M/VO?V'_C5\:E_P""B=]X#O/A\U[^T_\`LS?LD_"WX66GB7Q%K&CHOC/X!^/O
MCWXO\4IXSO;/PMK1T'0M6M?B1X9L]%U;3K?Q'=2W$>K/>Z1:QV5L;\`^^/@]
M^T;X&^,>L>)?"-AI?CKP+\1?!NF>']>\4_#/XI^#-6\!^.=*\.>*[C6;3PSX
MHBTO4UEL==\+:Y?>'?$&F67B3PSJNMZ,NM:%K6A7=[:ZUI=[80^<>/OV[?V<
M/A=X`7XC>/?%FK>&=&NOC5XC^`6D:7J'A/Q#_P`);X@^('A3XRCX%:X-`\)0
M64VN:IX4L/'3P-=^.(;1?"5CX9N[/Q9J.KV6AW=M=RY7P<^$?Q=US]HKQ3^U
M%\;O#_@OX=ZW-\'-#^!_@7X:>`_'FK?$>&QT"+QYK/Q%\7>*_&/BZ_\`!7@"
MPO=9UO7+G0-+\.Z#I'AZ>W\,Z/H>I7USXCU:^\73Z;H'%_\`!1WX,_'/XY?L
M_P`OP?\`V>_A_P##7Q#K/BKQI\/_`!'KFM^/?B1=?#2Q\,VOP\^-/PR^,5P+
M1-*^&_CZ[U^Y\92^";_2;E5724L-0GL=4O9-20R)``>Z>,/VG_#OA;XRVWP2
MT[X;_&KQYXCCM?`]YXDU_P"'_P`.+OQ'X'\#V_Q`U76=,T"3QAXJ?4M/M-+V
MPZ#J6LZJEM!J#Z3H<<.HWJQK>6D4WTS7Y5_'/]EGXP?'?7V\6M\&/V??`WQ(
M\>>%_A&!\=E^)_CW5?BW^S+XI\`^(;[6-1O?AX+3P-!I7C;4],M[ZX7PEXD\
M*:I\%9_$?VVY\+_$NSU3PK:0O??JFH(')R<L<^Q8D#\`0/PXP.*`%KR[Q]\8
M/!/PR\2?"SPUXRO;O29_C#XUF^'7@S5)+"=]`E\:GPUK?BG2O#NKZTO^A:'?
M^);#P[J]GX7_`+3>"#7]?@M_#EA-)KFIZ58WWJ-?(/[>_P``/$W[4/['_P`?
M?@7X&N=&T[X@>/?`-_9?#K7-=U;5O#]CX9^(NFW5EKG@7Q8GB'0+6]U[P[?^
M%_$^F:9KNEZ_HEM)K&C:C8VU_IVVYA1@`>?ZO_P45^#]CX_^$_P_T;P!\?/&
MEQ\==2\2:?\`"#Q1X,^$U_K7@GX@1>#;O48_%NKZ!XEDU>Q@DT#0=*TRX\4S
M:W=06NGZGX3ELO$&@3:O8W]FTW2_`/\`;X^!W[0UWX!@\+6/Q/\`"]E\7X_$
MMQ\%=?\`B1\-/$/@OPS\8[;PE::AJ>N-\//$5XMUI.JW\&A:3JOB:U\/ZC=:
M1XFU3PMI.M>)-+T2]T;0M;O-/E^)7[->M:U^T?\`L-?$?P';>$/#WPT_9??X
MXV>N>'4DGTNZM="\=_!>'X:^"M+\&:/8:5-ILEKI%U;V\-U:3WND0:?H\,9L
MA=.BVM?('[)'['G[3GA;X<_L/?!;XZ:#\(_!O@K]B'Q+>>.1XH\`?$_Q1X^\
M2?&#QAI'@;XI?#OP1;66CW7PY^']CX"\)Q6'Q8UOQ-XI;5-7\4ZM?W^CZ/X9
MLM.73[[5==C`/T;\3?M)_"3P3K?Q;T;QIX@N?"<7P4\(_#CQIXXUW7]&U2Q\
M.)I7Q5U#QAI/@NS\/:P;:2'Q;XBU75_!6J:/'X6\-IJ7B%]8OO#VD6VG7.I^
M(M(M+KE[G]L#X'VG[)^F_MHSZ]K"?`W6OA+HWQGT34SX7UP^*M8\)>)-`MO$
M/ARRTWP*+0^)[KQ=KMK>V5EIG@Y+`:_<:Q=1:2;2.\\Q(_5/BFWC'3/!?B#5
M/AEX"\-?$#QZT.F0:5X=\2^+E^'VG:IY5\L7FWOC*/PGXTGTYM%M+R^U33_^
M*?U`RW<0M(39->->1?C_`.&?V!/VL_%_[`_[/'[.WBSQ[X+^!WQ._9A_9Z\4
M_`_1=*\)ZAIOQK^%_P`5?$-U^S_9_!_P[\3]7U;Q+X#\#>(/`^H:4M_XTTO0
M;?3](UFX\/Z1XNUC59AJVK_V0=(`/V?\!>-M`^)/@?P=\0_"MQ+>>&/'?A7P
M[XS\.W<]O):3W6A>*=&LM>T>XFM9OWMM+/IVH6TLEO+^\A=FB?YE-=;7S[^R
M?\,/&?P3_9D^`'P@^(GB+3O%OCGX8?!WX=>`O%/B'1[..PTG4]9\)>$]*T*[
MDTRVB@M5&G6[6(L[&=K6VFO;6VBOKFVMKFYF@C^@J`"BBB@`HHHH`****`"B
MBB@`HHHH`****`#`/4=.1['UHHHH`****`"BBB@`HZ]:**`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`***"<?F!^9Q0`45_*KJ_\`P<)?&'3=6U;3H_V;?AG*FFZMJNFI*WQ#\7JT
MJ:=J5U8I*RCPX0K2K;B1E!(5F*@D`$_6G[!W_!8;XD?M=_M+^$?@5XB^"?@?
MP7I/B/0/&VLS^(=$\8^(M7U&UD\*Z!+K%O!%8:AHUG:RQWDL8@F=[A6BC)>-
M78!:_7<S\#/$C*,JQV<X[)L-2R_+L%7S#%U8YOE-65/"X:C*O6J*E3QDZM1Q
MIQDU"$)3DTDHMM(_*<M\:?#W-LSP648'-L35Q^88RA@,+2EE.:4XSQ6)K0H4
MH2JU,)&G!2JS47.<HPCO*26I^^U%%%?D1^K!17EWCOXP>"OASXQ^#7@;Q-=7
M\&O_`!W\=ZW\.?A]#::=/>6UYXG\/_##Q[\7M1@U*ZB(BTJT3P9\-O%%S%>7
M.8IKZ"TTY/W][$1E^%?C]\*O%UOKEQ9^+--TL:!\1O&/PKNH?$EW9>'+FZ\8
M^!_&<G@#6;'2[?5;NWDU.";Q8BZ/I-S:+(NJW<]M!:*\]Q%"P![+17S;8?M9
M_`V;XL>'_@7K'C&V\)?%WQGJWQ7T[P'X`\5+'I>O^.K+X,7_`(?T_P`<>(/"
MT$=Q=PWNAV\_B?23I4US/9:AKD1U&73--G71M8^P>NP_$GX>W'A^Z\66_CGP
M?/X6L=5.AWOB2#Q/H<V@6>L+J46COI=UK,5^^FV^HQZK/#ILEC-=)=IJ$L=D
MT(NI$B8`[6BOEO3_`-L7X&ZA^SK=_M2+KVM0_"6UU?7?#T=^_A;7;GQ#J/B'
M1/BKJ/P4A\/Z-X3TRTU#7M8USQ#\3-/7PKX4TO3;2YN_$.H:CI*V,96_C*T=
M'_;6^`<VJ_#WPIXU\1:M\'OB%\4?B9J7P>\%?#7XR>&]6^'GC?7/B+I?@>3X
MD3:#IVG:M"^GZI;7'@Q$U33/$FCZMJ7A35KVYL_#.G:[<^+KJ#0'`/K*BO`?
MB5^U1^SG\'_"&M^//B1\9_AYX7\(^&O''A+X:^(=;N?$^EWEMH7CSQSXDTSP
MEX7\*ZQ'I=Q?7.EZSJ.NZQ8V\EI?06[Z;9M=:SJWV#1--U+4;/UFS\9^$=0U
MB_\`#UAXG\/7NO:5I=EK>IZ)::WIEQJ^G:-J2L^G:M?:9#=O?6>F:@B.]CJ%
MS;Q6=XBEK:>5030!TM%8'AGQ5X9\9Z3#KWA'Q#H7BG0[B6X@M]8\.:QINNZ5
M/-:3/;W44.HZ3=7EE+);7$;P7$:3L\,R/%*J.I4;]`!117QY^U/^TQKG[/MS
MX)@T?PKI/B1?%4'B"6X;4]3O=/-F=&ETB.,0BTM;@2B<:DYD,FPH8D"[MS8`
M/L.BOR*'_!2+QL2!_P`*O\*\D?\`,RZS_P#*ROTR^$_C2Z^(OPV\%>.;VQM]
M,N_%7AW3M:N-/M9I;FWLY;V+S'@AGF2.6:.,\*\D:,PY*CI0!Z'112,P49/3
M*K^+,%'ZD4`+17PQ\%O^"@7P8^-^O>#-+T/PW\7_``OHOQ0\6>/_``+\)/'O
MCOX;W_A[P#\4_%_PSD\;MXK\/>$/$D&H:K&NJP:?\-_'.M:79>);;PY/K^C^
M&-6O-$6_-JT)^JG^*?PSC\+1^.)/B%X'3P9+?#2X_%K^+O#J^&)-2-\VF"P3
MQ"VI#1WO3J2-IXM%O3<&^5K01?:`8@`=[17C_A/X_P#P:\<_%CXF_`SPE\0_
M#FN_%OX-6/A'4_B=X#L;MGU[P?8>.]/FU3PI<ZG;O&D;1ZK80-<9LY;DV(FL
MX]2%G-?V,=P[XG?'WX,_!OPI\2_&WQ,^)7@_PCX<^#O@^X\>_$R\U/7+#[3X
M-\)P6D]XFL:UI-O/-K%M#J$=N\6BQ&P-SKMZT.GZ-#?7UQ!;R`'KU%>6?#;X
MO^$OB7\.O`WQ+L7N?#FC?$'PY_PE7A^P\6S:-I6M/HOV1]1:ZGM;/6-4LP(M
M+5-3N/LNHWB6=C+'-=R0$2I%T^J>//!.AV3:EK7B_P`+Z1IZ76DV+WVI^(='
MT^S2]UY87T.T:ZO+V&W6ZUA;B!M*MS()M1$L9LDG#J2`=917AWQ0_:*^%'PB
MU'P)H_B_Q)$NK_$3XK^"O@SX?TG2%CUC4T\;^/IHX=`MM6T^SG:[TC3BUQ9-
M?ZG>PI!81:CILLX"7]J96Z/^T9\)_$/QKE^`.@^(X]:^(5O\.=5^)]U;Z2D>
MI:-9^'=#\=0?#G5[6\URRGGLK7Q#IWBJXCL;WP].4U*T0/+<Q1;&0`'N=%%%
M`!1110`4444`%%%%`!1110`4AZ?BO\Q2T4`?YH/BAT_X2?Q1\R_\C1XF_B'_
M`$,&I>]?J!_P1293_P`%#/A<`RD_\(/\7^`03_R)%SVS7];DW[$7['-Q--<3
M_LL?L]33W$TMQ/-+\'_`;R33SR----([:&6>265WDD=B6=W9F)8DUU?@;]EW
M]FWX8^)+3QC\.?@)\'?`GBRPM[VULO$OA#X<>$_#NNVEMJ4!M=0M[;5=*TNU
MO8(;VV)M[N..94N(28I0R'%?UYQ-])'(\]X7SSA^CPWFU"KFN2X_*Z>(JXK!
MRITJF+P=3#0JSC!\SA"4^:2C[SBK+4_E/AOZ/6=9'Q+DN>U>(<KKT<KSC`YG
M4H4\-BXU*L,)C*6)E2A*2Y5.:IN,7+1-J^ESW>BBBOY#/ZL/D?\`:E^#7C_X
MA:[^S7\4?A9!X4U?QW^S1\<-1^+.F^$/&_B+5O"'AWQOI7B7X'_&'X&>)-`D
M\5Z+X7\9WGAS5K71_BW-XDT+4)/#.L:?<:EH$6C:C!9VNJOJ^F_G/\3?^"9'
MQ:^)MK\:=6UE/@M-XF^*G[&__!0GX>:+9:IJVN^(-)\`_M(?M>_'&P^+?P]U
M?0]4U+X?V]V?"_PXM+"RTR[^(<&CZ;XN36+*76-"\)6D&H+8V/[H44`?@5X@
M_P""6_QWU7Q-XG\60>)_AE9>)_&NO_\`!2OPM_PFVG:SK-MXT^&O@[]O;0/A
M'9>'_B[X0U*7P1/-J/Q'^%^J_#/4Y;_P6E_X:@U6T\::E<Z3\0;*[MI;?4>O
M^'?_``3H^,?@Q?A_XUU+P_\`#+Q?K?P^^,7@CQI=_`WQQ\6;?Q#\(_'?A_P;
M\"/B3\$-%OFU#PU^RE\-_#?@[Q1X&E\?67BSP+<+\'/$^J7UKX3TS2_%?B@Z
MJ/#FI^"_W&HH`_,KX)_L9>.OA?\`\$[[?]DCQ#H/[/\`\0O$T-U\2O[4\'>,
M-(\1:M\!O%'ASQM\?_&?Q/?P5<V\>FP>(]!L+GP9XDC\/:1K]OHFKW/@+Q)%
MI_B*V\/^*H=`CTK5/`K']@/X^67B+X1_$JTLOAS.GP/_`&GH?BY\(?V?OB1\
M:?B?\>?#WPJ\(>(?V8OBA\`?'?\`PC'QO^)_@2]\<RSW?C?Q]X9^->F_"F#1
MM)\!Z;>?#>#0?#7B3POJOBJYU_1?VRHH`_G"O_\`@DS^TMXFL[^[\4WWP-N[
MF'X+?`WPS>>!)O%-Q-\-/'OQ7_9R_;!^#_[2&@ZW:>&?#G[/O@3PI\)/`GQ`
M\,>#?B!X`M=%TGP7XUU3X::=XU:WGN?&]M=:LLWN6A?\$T_BY>>-?CGJWC^\
M\/>+-#^*-M^V%X@MK;6/C'K-AIFLW?[76A^(]/O/A/XOTCX=?`;P+\1D\'^"
M=+\16?P[3Q6/CQXEBA\/>`/`WC'P)X`\+:];:;H/@[]RZ*`/A;]B#X#_`!@^
M!>D_%*S^)Q^'UAIGB[Q=X?UOPAX=\)_\(GK_`(ETJWTGP7H_A/5KKQU\2_!G
MP2_9XTWX@WVI-H6EIH%UJOPT?Q1HF@:?;:?KGC3Q)YEG8^'ONFBB@`K\I?\`
M@I20-1^$&2!_H?CGK_U\>%J_5JN1\3^`/`WC9K)_&/@_PSXI?3EN%T]O$&B:
M=J[62W1B:Y6U-_;SF`7!@@,PB*B0PQE\E%P`?S*J1D<CJ.X]:_HB_9B(/[/O
MP@(.1_P@>@\C_KVK>_X4/\$O^B1_#?\`\(OP]_\`*^O2-*TG3-"TZRT?1=/L
MM)TK3K>.TT_3=.MH;.QLK6$;8K>UM;=(X8((UX2*)%11PH%`&A374L`!C[Z-
MSZ*ZL?QP#CW]*=10!_/OIO\`P2#^)^F_`/PI\/['XFKIGQ`U;X??MP?#?Q]J
M5U\5_B]XT\$^`;G]I3Q%X[\7>`OBK\!_"/B^34_"GP]\<:/#J,/PD\>1>"_!
MO@@ZM\)?B_\`&#3;>_U*>VTNSUKT)O\`@G1\6_\`A7\-U/X;\'ZEX_C^-MS\
M1;3P]J?Q\TNYTWPIITWP+/P-EU#PM?K^Q;;?`N\OM7\-S77AWQ%X0\7?LIZ[
MI.K^$ETW5G\20^.]-M[H?N-10!^9G['W[(7Q1_9U^.7CKXC>,K;X,^(S\8/V
M</V7/!GCSQE\/=,'@*\T;XH_L[>"K_X?ZKHGAWX?6G@^'2Y/AMXNTS4-/UC1
M[^T\2Z"?#\WAV+1$\`VFG2:5_9?R3\;?^"77QC^*O@OX\?#ZW3X%VDWB/PU_
MP4:E\+?&"_O]9G^(_P`;M9_;5\-_$*R^''@?XZ6D?PY2+P_X.^#&M>,O"]Y>
M:WIWB3X@SZE<?!7X1ZIX8\,:`VEMIVB_O310!\+_`+3O[)=_\8_@I\*/AGX#
MG\'^#;[X?>*_!FG722Z>]EH1^#OB70M1^#O[0_@[18M'L!)87GB7X#^.OB'8
M^#HH+:ST^#QK%X3O;Y["VLGN[7X_MO\`@GM\:O#OA[X:7NH6'P`^/^M>"M1_
M:8\':G\,/BS=:_HWPNU?X<^/O#?@#X+?LZ^,);X>`_B#<7'Q&^$G[/OP:\%>
M#/%EG<^%?)\0CXD?&>+1/$EB=2MFUK]J**`/P?\`#O\`P2K^+_AO28-,?XD>
M%?$'B:R_:J_8E^)*?&&_U'6+3XD7_P`*OV:OV.O@S\`O%=[Y\OAW53IOCNY^
M)?@?Q9X_\'>'#J6HZ%)]MTC5-;\11ZW/J`C]P_8N_8:^)_P#^.7P]^)'BKPO
M\!_!F@_#K]AWPO\`LBW47PEU36K[5OB+XH\%?$?1_%0^+FO07WP^\%V^F+XR
ML;;4-2N?#]S>>)M9\.ZW?7T%YXJ\4C4&U*#]<**`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
9HH`****`"BBB@`HHHH`****`"BBB@#__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>biib-2015630_ujbchart.jpg
<TEXT>
begin 644 biib-2015630_ujbchart.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`(%`3T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^3?VV/VF)?V2?@'?_&6
M#1/"&N31?$GX%_#>)/B#X];X8>`M&D^-GQL\`?!Q?%OC7QXGASQ:_AOPIX,/
MCG_A*M?OD\/Z@[:9I%S;JL!F%S#]95X/^T9\!]'_`&B_`.A^`-=UO4-`L-$^
M,7P`^+XNM.LM.U"2]OO@'\;_``!\;-+T"ZM=4CEM&TKQ+J7@*UT#6)=AN;?2
M]1N[BRVWD4#``\)\%_MV?"FWT;PHGQ;^(/P=3Q+XJ;1=035OV=_%7C_]H/X+
M:'X5\9>.K[X:>`/$WB_XTZ7\+O#?A?P+I?B[QYI.L>#M.U'QPOAS1+GQ-H^L
M:9I^K7XT76I].[;4_P!M/X,O\`_C?^T3X(/C7XD>!O@3H7Q*U+Q,OA;X?^-H
M[[6-9^%$OBG3_&GA+PD-8\/Z=#XEU[P_XA\(:SX;\0+HKW]GX;U>UG@U^YL/
MLUUY/%_&K]A;PM\7O'?C#Q';^/O$W@CPA\8_!_PR^'W[0GPZT#1/"=UH_P`5
MO!OP@\6^*/%W@S2[;6-2TV76O`5S=_\`";>+/"GC'4O#<TDWB'P;JZV=E'H/
MB+3M.\46W??##]DOP=X`_9G\6_LOZGXAU_Q9X.\<W'[1'_"2:Q.EAHFN3Z?^
MT?\`$CXG?$+Q7861TN$V=@=(?XHZKHNB74<+S+:Z?8WETLMVT^\`^;O@W_P5
M(^$7Q-\=3^&O%'A3QE\*M`U#X<?L9^-_"GB+Q=X;\;-/)JG[9=UX\T3P3X7^
M(EC:^"QIGPF,?C'PGHO@OPYXA\9Z[9Z+X]\0^+](M]"FBBFL9-0^O_A/^U#\
M$OC;KNH>'/AOXNNM:U&TTR[\0:;)?>$_&?AK2O&7A;3]93PY?^,OAMKWBGP]
MHNB?$[P58Z_)!H]WXO\``&H>(O#L%[>Z5YFHBWUS1+C4OB70?^"7.B6O@/X@
M>#/%'QO\7^*;CQ_X?_85\)WVM?\`"&^#]":V\._L%_%FY^(_PZMAI6FE[">\
M\9Z4=/\`"'CJ\4VL4L%I/K6@66C7=[]CMO6_V0?^">_PJ_8Y\1:IJ_P]_P"$
M::S@\)/\._!B6'P@^$O@_P`5Z5X#?6;#6UTKQG\2_"WA>R\>_$[5K=]&T+3$
MUKQ%K-I#?:?HMA?:[I&L^*Q<>)Y@#P+]H#_@H=\?/V=_&'[8EKXH_9_^#&L^
M`?V1O@-X*_:,U77](_:"\<P>*/%W@/XJ>)_C9X6\`:;#X=U#]GN#1="\26MQ
M\%M1O_'23>+-0TC1;'7+(Z!J7B>>SNHS]>K^W?\`LPCQ%I_@Z?Q[K%CXRU/Q
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M`#U;3_VZ_P!F?5/#%YXKLO&VNOI\8^'\NAZ?/\,?BI9>*/B!9?%F_P!3TSX6
MZQ\*/!M[X+M_%GQ9T#XC7NB:U%X*\0_#K1O$FB>((]&U>\L[\V.FWMU#Z_8?
M';X8:K\*KGXTZ9KU]?\`P_LH=7>\O;/PKXPNO$-I>Z!K=WX9UWP_=>`[?P_+
MX^M_&&B^)K"^\,ZMX)E\,+XNT_Q)9W6@76BQ:K!):+^:^D?\$;?V?]+^&1^'
MSGP3=S^'=<^%>L?#S6E_9V^`VFPVQ^#EEXLTGPLWQ:T+2O"-G9_'>]\0:'XV
M\0:/X^G\:75II^JI<QZYX0T?P'XM2;Q%<_7%Q^QCX3_X9$U+]DO0?%>I>`=#
MU2RO6N/%'PP\*>`_AIY>KZIXY_X6)K*0>!O!7A_1?`\?@_Q%K;W.A^+?!;:6
M]OXP\"ZGK?AKQ1JNK7FNZOKMX`5I_P#@H5^RM:_8+6Z\:^+H?$>HZUX_\-1>
M`1\&OC//\3[;Q+\,/!?A+XD^-_#NI?#&U\`S^/-+UK1?AWXX\+^/1I]]H$$V
MH^#M5A\1Z7]LTQ)[B+A?B9_P4D^"'AN_^$NE_"^XE^,EQ\4/CK^S'\&WUGP[
M8^,+7P!H</[3<OAG5O#6JGXGQ>#-4^'U]XILOAUXMT+XF6_PVD\1:?XGU3PG
MJND7\RZ7;:QI]Q-Y]\'_`/@EC\._A#\6[;XPZ/X^O+;6)?%WQ1\=ZQX6\)?#
M7X;?#;X?3>(_BQ^SG\)/V=?$`T'PAX(TK3=/\-:3;:3\(](\66EG;_;M0O/$
MFK:O<:]K.L2S_;'R/AI_P2D\,?"SP?\`!GX9^&_CQ\1E^&/PH^(O[+/QNU#P
MC/X:\#,_C?XU?LQ>%OA;X*MO%VJ:\-..K:3H'Q#T+X2^&M1\5>"](D2SL?&#
M7NOZ%JEII]Q+X>E`/9?V@/VX+OX-?'?2O@7IO@OX>7&L7WP[\+_$/2[GXM_'
M70O@1-\5Y/$WBSQ7X3?X:_L[2>*_"FJ>%/B=\5?#4GAJWU7Q7X;\0>,OA]8Z
M-;>+_A]#+JI@\53ZKH7=>&OVVO@]>>,/B!X&\4^)]"TCQ)X7^,?C+X0^'=)T
M"#Q]XCO_`!'KW@VS^#[W_AR5;GX?Z%:#XD+>?&;PK(_@?PK>^,H)_#UT_B;2
M/$6K:=HOC4^$JO[47[(FI_M+Z5XP\&7_`,;/%GAOX6?%/P,?AQ\4OAC>^#/A
MW\0O#.H:`\&MV<_B#P"/'.A:A/\`#GXAW>G^(+JQNO%%N?$.E.-.T#4(_"L.
MM:2-4N?*$_X)M^%K37-?\1:7\7_B'IVII^T5J_[57PTEC@TFY_X5O\:;OP/\
M,?A=I7B0279FN?&L&F?"[P%XG^'-Y8>*;B9/$?A;XR?%2/79+G5M5T35="`/
M7_C]^UN/@/\`M$_LG_!C4?`3:UX3_:1OOB-H^O\`Q+3Q&=/7X6:OX>O?AKX8
M^'*WGAG^P[Y_$FF_$KXC_$_PU\.Q?QZSHQ\.:[K?AV5X-6AU5UL_(?AG_P`%
M*OAUXP^(O[2GA'Q9X2UOPGH7P=^-O@[X,_"75?#=IXK^*_B[]HFY\4_"[4OB
M(^M>"?AK\/\`P7JOBE/LR^$_B#-:Z=I<?B47'@?PA/\`$&_O])TBYEMK+W']
MIG]D;PU^TRTDFN>-/%?@V[A^!OQF^#VA:OX073(-=\)ZQ\4/%WP0\?\`AGXK
M^&-3O[>Y;3?'_P`(?'/P&\&^+?`-PT,^G)KD*W6J6UTEK!"W@=E_P37\.^$O
M&MU\3/AC\8?&?@CQ_H_BCX/^)_AMJ\WAKPAXHTWP8?A=^S/??LJZEHFH:+JU
MK''XMT;QY\.M5O\`4=<2\O-+U+3_`!?'I>M:1J4$5A-97X![3IO_``4!_9,U
MO5=*TC0?BD^OSZQ;?!6\M[W0_`WQ&U;0;.U_:+NKW2O@?+KGB>Q\)3>'O#1^
M)WB6PN?!/A2#Q)J6DW-]X^5/`KPP>*I!I0^/_A/_`,%EO@C\1M5T'4O$7PY^
M*7PH^&&I_!/X\?&36?&?C[P3X]CU[PEIOP$_:%TSX%>*;SQ'X)T3P/J=WIOP
M_L[>_E\;>)?BC>:C;>%O`UE97VA>)Y+75=+UK^S?1?#?_!+;X<>#_#?CSPOX
M=^)_CZ*Q\<ZK^Q#KMU=ZCI_A>_U2/7?V,/CW-^T1%K=U/#I^GV=_J7QC\>7^
ML7'CSR]/T_3])BU:X7PCI^EP06=K!R^G_P#!)WPAI^E_'7PQ'\:O'!\(_%C]
MFC]KC]EOPKI(\,>$EO?AOX"_:[^)=_\`%KQ5?1ZR%,OC'7?!_C#6]>3PK=:W
M:6D,^@WEGINO1:E>V$NKWX!]U>!?VIO@I\2_B'KWPR\#^(];\0>(/#FK^,/#
M>H:M:>`/B$GP^F\4_#S45TGQ[X3TGXJ7/A:'X::YXJ\&:DXL/$GAW2/%E[J^
MFWD5[;26C3:5JR6$>I_M6?`S2?B7??":]\77P\7Z9K"^%]2DM_!OCB]\(Z?X
MVF\%CXBV?P[O?B'9^')_`%M\2]0\#%/%6G?#J7Q*OC*^T6YT^ZM]&<ZIID=Y
MXEX"_87TSP/^T;8_'^+XH:Y)-I,?B)HM#T#P1\/?`&J^,1XF\+CPK)H/QG\:
M^!=&T/5/C5X,\)VPM]3^'VC>.=.N]>\-Z[H_AS5]0\7^(KO0[>27G+G_`()M
M_!X?M*^,/VC-,'ARSU;QWXRG^*/B"#4?A%\*O$OC.#XES?#VP^&_]J>&OB_X
MA\.W_P`1/"?A9],TC2?$,OA30M0M;J+Q?:7-]I/B;1]#U?5_#MZ`>A^'?^"A
MG[)7BWPA)XX\._$R_P!3T2;PS\'?&/AR&/X<_%"#Q!\0/#7[0&HSZ)\&M7^%
MOA6[\&P>)?BC:_$+Q#9ZCX;T!O`&E^(M_B'2]4TF\^R7.GW7E^:_"G_@II\"
M_&UEX]N_&W]K_#QO!_QG^/GPYBA3PS\1_%KV?@+X%_$+_A7&H_&7XFKI7P^A
ME^"7@N]\0;M/U2_^)\/A_1O#6JVFK:?=Z[=)H6NWFF\98?\`!+7PAHUG\";C
M1/C'XYL/%G[.'[,O[+?P`^%?BE_#WA*\DTS7/V4M?US6?!_Q,U32+BV;3]5O
M/%EAXEU_PGXW\(DVNBW7AC6M0BT.]T/65T[6M.X:;_@CE\'[[Q;K/CSQ!XUB
M\=>,O'/B[XDZ]\2/$/Q,^"GP0^)<^M:5\3?B1JWQ6U+3O">F^-O".M:!\/=7
M\/\`BGQ-XML?#7B'1](OHQX4\1/HGB/0O$=UHOA[6-,`/J37/V\OAA_PT1\"
M_P!GOP)9ZEXYU/XL?&SXL?!+Q%XMCTCQGH7@_P`(>(?A!\$_BQ\5O%\/A[Q?
MJ7@W_A!?B=K/A[7?AE'\/?&/A[PGXN>\\':YK5PNL2KJ/A_4]&75^._[;/P]
M_9Q^,VE?#_XK6W_"._#YOV:_BU^T5XF^*7FZMJ@\-67PQ^+?P"^%$/AX^#M#
MT#5-6U;^W[[XZ6FH?VI97/F:9_89MFTN[BU%[S3N1\+_`+!FF^$_BY\*_'.F
M_%_QG_PKOX(?'?XV_M!_"[X.-X>\&1Z'H7C']HGPE\;-$^*.GZCXJ@TR+Q7K
MGAYO$'QV\:^*O!EC=W,4_A9[Z30I[O7=)CTA=$D^.?[`_A?]I7Q1\8/$'QC^
M(OB?6+;QY\#O%W[/O@#2O#VA^&/#2?"GP+X\\4_#WX@>)[ZTOQ::I>>-?%5Q
MX]^%7@#7;'4?%!.C6%GX>31E\.S0ZIK5WJ(!VWBW]OG]ECP3XL\0^`];^(.K
MS>-/"_BWXA^!M5\*^'?AI\4?&/B`^*/A1\._AA\6?B'INF:1X1\&ZW?ZX/"O
MPX^,7@'Q?J5YHUO?6']D:I?2074TV@:]#IW5>&OVQ_V<_&7C'0/!7A7XB1^(
M+WQ1-X=L-"\1:5X:\87GPYU#7O%_P_L/BKX4\(1?%2+P^?ALOCGQ)\-M3T[Q
MQHW@>7Q2GBJ^\-:CINI1:3LU*P2Y^:?!?_!-S1O#OQ>N?C?K_P`:O&_B[QWK
M?B?]H/QIXKGN?#GA+1M+UCQ'^T3\!OV=?@5XD>ST[2H%&BZ1X=TS]G;0M:\,
MZ9;S74B76N:A9ZM?ZFEI;7LO(?LX_P#!)/X)_LW>-/AAXM\-ZII'B2?X?:3\
M,[N]U3Q9\&?@[K'Q$U[X@_#7X,^$O@K;^*+'XK7_`(8OO&G@O0=>TGP9I'B[
M4_!GA6ZLQ8^-3J%SX>\2:/X:U/4/#%T`>[?M;?M?^)OV7;S2[X_#7P9XI\+7
ML?AR+3+/5?C=X>\&_%OXN>)M;\1'0[OX:?LV_"-O#?B'5/BQ\3-(M;K1-5.@
M:QK/@.PUR?7]$T+0M7N[NYU&]T;,TW]N&>\^(NEQ7?PULM/^`WB3]I_Q=^QU
MX:^+#^/89O%5W\;O!,WBCP[J<NH_#6/PP+33_AWJGQ.\%>*/A3H>NQ^/+WQ7
M+XJL=-U._P#!-GX4UR/6=/[']I3]DO6/VC[?Q3X1U7XX^,_#?PC^)7A-/`_Q
M)^&MMX3^'NOI+H30WUIJE]\,_%VOZ#<>)?A7XL\0Z??+9:KXGTZ;7KC3Y=,T
M;7O!MIX2\6:?_P`)!-F:?^Q'X>LOBG9>*9/B'XJO?A/HOQS\0_M0^'_@9<:5
MX:_X1W2OV@/%4.N-K/BO_A+5L/\`A+;SPO\`\))XH\2_$O3_``3<W)ALOBAK
M4WB)M;N=&LM)\+Z>`?2/Q7\6?$#PKX:LKCX7_#8_$_QAK6OZ+H.G:1>^*;'P
M3X9T:VU*:1]2\6^-/$]S8ZWJ.E^%O#VG6US=7J^&_"WBWQ/J5])INCZ+X=O+
MG46N+/XC\,_MW^/_`(B7FA_#CX9_`70_$'QZ;Q%^T[I7BKPGK7QFMO#_`,,+
M/1_V3?'?@SX;_$+Q%X/^*4'@#6]6\8V7B;QQ\1O!?A#P.D_PY\/-;^(9_&.G
M>.W\)W?P^UVUG]H^)?P$^/GQ,_9JT'X/']J;Q%X#^*$HT&+X@?&SP=X`\+6V
MM>+M*M;BZG\2^';+1K"X\.VW@ZU\56LMMH=_X@\%7OASQ3IFEPW<_A;5?#VL
M7T>J6'GFB_L3>+/#OACX2OX4^.-G\-?BC\&?#WC_`.&_@SQO\*/@;\-_"'A2
MS^#/Q(O/!FI:[\-S\)M6G\6^&%CT[6_`'A+Q3X;\11Z@NH:;XGT.WN[ZUUC1
MM2\2Z!KX!0\(?\%"M&^(WQ2_8M\'>!_A%XQN?A_^V-\/_%WCK1?BSXAUGP]H
MFD^&;OPY\*8OBC%X+L_#ME<:WK/B[Q':0?;-"\;7MN=&\+^$-7M8K&TUSQ-J
M-S-8Z?>^`G[:>J?&;X[^*_A=?V_P%\-:+I?B+XS>'O#6F6GQ@\;:Q\9==D^$
M7Q!UOP'>2S>"[_X,^'_A\;PKH%QXA\5:!X8^+/BO7O`FF:CI*:W8$SS30\=K
M/_!/?Q5IGC_]D[7?A!^T)+\,_A_^QMX8N?"?PE^'=[\'O"GCJ6ZT[7O`%O\`
M#?QE/XP\9ZGXBTG6-;U'Q%H$,MXM[;6.F26.O7=QJDPU-'^R5]#Z9^S5XHG^
M+'A#Q]X]^._CGXB^%OA9XS\9_$+X2^`]8\-^`M'_`.$7\5^./"WC3P1=W.O^
M+_#NA:=KGC33_"W@[XA^,?#'@G3[R'2FL].U:.]\77?C?Q%INFZY;`'6^*OV
MI?@MX)^)>D?"?Q7K_B#0_%&N^(]$\&:5J%_\//B+#X"N_&_B;3[/4_#'@=?B
MBWA3_A6R^,O$EI?6PT/PTWBK^U=1O;BSTF&W_M?4-/L+KR/PU_P4:_9`\8>%
M8/&/AKXHZAJVDZIX9^%WC#PE;P?#;XIQZ]\1_#OQHUAO#?PRU#X4>&;CP5#X
M@^*B^*?$\-UX9BA^'VG>(IM,UZQOM.UN/3)+69U\P^*W_!-3P3\6_CXGQS\1
M?$76[B^L?CQ\#OVA_#UMJG@?X?>)?%?A#Q7\$=1^'L]AX$\&_%'7]'O/''A'
MX)^(K;X?I>ZI\,?#=WI5K%XN\6>-/%":O<)XBU#1)N)T;_@E+X0\-V/[,UQX
M?^-7CRP\8_LF_LW_``>^!'PC\73>&_"%_)::S\&/$D.M:)\1=;T:Y@.FZI<>
M(M&FU_P3XL\)H;32;OPQXFU,Z/?:'KUKH^M:<`?2'P2_:[U+X\?!;XV?%CP%
M\(/$.OZK\,?C5^T'\&?"?P^TS6;73O$/Q$U+X)_$75_AWIMY)-XYT_P9!X&N
M_%=_IJW>K:7XHAB?P2AOH-0N-1ETYEG\MNOVZ_'>C^,/$GP+USX)^&V_:/M/
MB_\`"/X/>%-`\-?%V;6_@SK^M_&#X7^._C39W&J_%6_^'&@^)_#5WX"^%_PN
M\?>+?B!X4G^%E_XJATRV\$WOAO3];L/B3X=NHO5_AY^R?XF^$?P)^-7PM^&O
MQ[\8Z!\0?C!\1_C;\6HOC??^#_`FN^)?!?C_`..7BV]\:Z]K>B^$;O38O`]_
M'X>UK4[X^&-,U?2I]-M;86%OJ%MJ*63"Z\J\!?L#>(_"OPSTWP7JGQU%WXN\
M"_%G1_CM\*/BAX:^$^@^'/%FA_%N'0_%'AKQEXV^)4NM>*_&\WQKUKXJ^'/%
M^O\`AWXC:GXQU&UUO5=&UG58],UC1]0_L74]"`*&O_\`!16[T7PW\([^'X">
M(=5\0>*OVP/#7['?QE@L/&_A\^"_@;XXU3XXZ#\$-1U"?QA=6-IJOC[[;?\`
MB;0_&'P_T+0_!>G:MXG\&:C%K'BI?A\;34+:V]9^.O[9=E\(?CU^SG\"]#\#
M2>.[WXR?%OPW\-/'WB*'Q%'HMC\(K?QQ\/?BYXU\#7T]JVD:FWBSQ%XGE^$/
MB%8O"=M<Z/)I7AFWNO%FKZI:0W'AK3_$GC/Q,_X)W^+O%7P^^'W@/P-^TGJ?
M@>7P]^T#H_[5_P`0?%>K?!_P-XW\1?%+]H/0_B]I/QKT_P`5:EYNJ>&]*\,^
M&HO%.DVFB+X.\/Z<L</@BRTOPY::Q;/IPU*YZ/XC_P#!,WX*_%'XB?"+XQ^(
M/$/Q'TOXJ>!/CKX%_:&\?:[X0^)?Q9\,^&?BS\0O!?PGU7X4_;-2^'%E\2W\
M$>#DU+3;G1IGNO"6DVVK6^E^'+/PE)J-[X;U/7;/4@#]'E.Y5;&-R@XZXR,X
MI:15"J%'0#_/T^@X'0`#BEH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HK\??^"@?Q3^)?@W]O'_@CI\//"/C_P`8
M>%_`_P`9/VDOVAO#?Q5\*>'O$.I:-H?Q#T'P[^RUXU\5Z#I'B^RT^XMTUS3M
M(\26%IK>GV=XSV]OJ=O%=K&9HT9?UA3PWI11"4O<E5/_`"%]:[@'OJ)/YDGW
MH`Z&BL#_`(1K2O[E[_X-]9_^6-'_``C6E?W+W_P;ZS_\L:`-^BL#_A&M*_N7
MO_@WUG_Y8T?\(UI7]R]_\&^L_P#RQH`WZ*P/^$:TK^Y>_P#@WUG_`.6-'_"-
M:5_<O?\`P;ZS_P#+&@#?HK`_X1K2O[E[_P"#?6?_`)8T?\(UI7]R]_\`!OK/
M_P`L:`-^BL#_`(1K2O[E[_X-]9_^6-'_``C6E?W+W_P;ZS_\L:`-^BL#_A&M
M*_N7O_@WUG_Y8T?\(UI7]R]_\&^L_P#RQH`WZ*P/^$:TK^Y>_P#@WUG_`.6-
M'_"-:5_<O?\`P;ZS_P#+&@#?HK#C\/:9%(DJ+>;T8,N[5=6=<CU22_9&'LRL
MOJ#2+X;TM0P"7F&7:<ZKJ[8&0>"U^2IX'S*0W49P2"`;M%87_".:7MV;+S;N
MW?\`(5U?=G&/O_;]V,?P[MN><9`-#>'-+;:"EY\JA1C5=77@$D9*WX+'G[S;
MF/<X```-VBL+_A'-+V[-EYC<&_Y"NKYR%*_>^W[L8/W=VTG#$%@"&_\`"-:5
M_<O?_!OK/_RQH`WZ*P/^$:TK^Y>_^#?6?_EC1_PC6E?W+W_P;ZS_`/+&@#?H
MK`_X1K2O[E[_`.#?6?\`Y8T?\(UI7]R]_P#!OK/_`,L:`-^BL#_A&M*_N7O_
M`(-]9_\`EC1_PC6E?W+W_P`&^L__`"QH`WZ*P/\`A&M*_N7O_@WUG_Y8U?L=
M,M-.\W[*)AYNS?YUW>77W-VW;]KN)]GWCGR]N[C=G`P`:%%%%`!1110`4444
M`%%%%`!1110!^('_``4G_P"4DG_!"G_LZW]J#_UCGX@U^WD?^KC_`-Q?_017
MXA_\%)_^4DG_``0I_P"SK?VH/_6.?B#7[>1_ZN/_`'%_]!%`#Z***`"BBB@`
MHHHH`****`"BBB@`HHHH`*HZEJ>FZ-8W.IZQJ%CI6FV<?FW>H:E=V]C8VL6Y
M4\RYN[J2*W@CWNJ;Y9$7<RKG)`-ZOF_]KL`_LW_%H$!@?#29#`$'_B;:9U!!
M!H`]/_X6S\+/^BE>`/\`PL_#?_RSH_X6U\+/^BE>`/\`PL_#?_RSK^:9HHLG
M]U$>3QY4?/L/EZGH/UKU[Q'\&;SPO<^&[#5O%7@"SO\`68KMM7M+S5VLY?"<
MMC=:[;77]K)/IXGOK.)O#][;+?Z%!J45QK030[..YN;C3IM1`/W[_P"%M?"S
M_HI7@#_PL_#?_P`LZ/\`A;7PL_Z*5X`_\+/PW_\`+.OP#M_@S?W,J20Z[H-S
MHUUX7T[Q9I>N:;HOBW5QJNG:GXBN/"L%O;^']-\,S^*;?4(]9LKZ*YM[S1H8
MHK6SDOTN);1X97X&U\.VUYXA;04UC0+:!;J[@;Q!JXN]%T>*"RBFFN+RX2_T
M]-6MP$MY8XM/?3#JUQ=^580V#WDT<)`/Z.O^%M?"S_HI7@#_`,+/PW_\LZV]
M#\:>#_$\\]MX;\5^&O$%S:Q+/<V^B:[I6K3V\#OY:33Q:?=W$D43R#RUDD54
M9_D#%N*_FT\5>#Y/"KZ)(U]H^LZ;XDT2+Q#H6K:5'>1V]_ICW^H:5(\EEJVG
MZ;JNGW-OJ.EWUK+;7UC"S")+BV>XM9XIF^[?^";RHOQ&^(^U$7/@G2,[452?
M^*@;J5`H`_82BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/
MQ`_X*3_\I)/^"%/_`&=;^U!_ZQS\0:_;R/\`U<?^XO\`Z"*_$/\`X*3_`/*2
M3_@A3_V=;^U!_P"L<_$&OV\C_P!7'_N+_P"@B@!]%%%`!1110`4444`%%%%`
M!1110`4444`%?+G[:FMZ/X;_`&6_C-K>OZG9:-H^G>%4GO\`4]1F%O96</\`
M;.E1B6XF8$1Q^9(B;B/O.H[U]1U^>G_!5OC_`()Z?M38_P"B=1?^I3X<KV.'
M<MIYSQ!D63UJE2C1S7.,LRVK5I<OM:5/'8VAA9U*?.I0]I"-5RAS1E'F2YDU
M='D<09C4RC(LZS:C3IU:V693F.84J57F]E4J8/"5L1"G4Y'&?).5-1GRR4N5
MNS3LS\%C\?\`X'A_F^*_@)@&^96U^#:PS\R-M`;:PRK;2&P3@@X(^D?%'[<7
M[+WB'P[X(\-W'C>SO;'04$\]UJ7Q*L+WQ'X4GM[GQ6;&P\$>(KK1C?75C;G6
M='OIAXADN+6^M_#FA:-):VT]G=ZS<_S&N3O;D_>;N?4TW)]3^9K^RU]%;A9I
M/_6;B'6WV,L\O^H/U_#S/Y&_XF<XF_Z)S(?_``/,?_FOU_IZ?TN:Q^VO^SSK
MLRV]_P#&+4XXO^$0M/"U[XPL/B-HEIX[\0FR\0W.NVLGB>.&WBT;6-,T^"XB
MT71=/FO6N])M+"RNSJ=](C6:\YKO[6?[,7B7Q;<^+M7\>Z8MW?ZM(UU%I_C_
M`$B&Y@TNR\.:9I/A_5X-4DTLW%_XXM]7T]_$&OWNH0KHVNW,IC^S6<DTUTO\
MXV3ZG\S1D^I_,T?\2K<+?]%-Q#_X!EGE_P!0?K^'F+_B9SB;_HG,@_\``\Q_
M^:_7^GI_11\2/VM_@3XWNO#TL?Q7\.W<^@Z`NAW7B/Q3XITJ]\5^)BFHWM];
M7.MSZ=#'9K'I-K=Q:+HUNDE[/;Z59PI<W]RY58?O?_@EO\2OA]XW^)_Q1LO!
M_C/PYXFO++P#HUW>6VBZC'>S6UK)XD:&.XF1`-D3S?NE8GE\K7\<&3ZG\S7]
M`_\`P;SDG]H+]H3))_XLUX6[_P#4^/7Q_'WT>>'N$>#\\XDPF?9UBL3E6'H5
MJ6'Q,,`J%657&87#-5'2PT*G*HUYR7+.+YE'6UT_K.!O'O/N*^+<DX>Q629/
MA</FF(JT:M?#RQSKTHT\)B,0G357$SIMN5%1?-%KE;:5[6_K0HHHK^3#^I0H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/P[_P""ES3)_P`%'O\`
M@A8UO$D\P_:L_:?V123&W1S_`,,=_$`'=,(IRFU<L,1-N("?+NW+^TD=UXAV
M)C1M/QL7'_$]<]AW&B`'Z@#-?C!_P4G_`.4DG_!"G_LZW]J#_P!8Y^(-?MY'
M_JX_]Q?_`$$4`8GVKQ%_T!M/_P#!X_\`\I:/M7B+_H#:?_X/'_\`E+6]10!@
M_:O$7_0&T_\`\'C_`/REH^U>(O\`H#:?_P"#Q_\`Y2UO44`8/VKQ%_T!M/\`
M_!X__P`I:/M7B+_H#:?_`.#Q_P#Y2UO44`8/VKQ%_P!`;3__``>/_P#*6C[5
MXB_Z`VG_`/@\?_Y2UO44`8/VKQ%_T!M/_P#!X_\`\I:/M7B+_H#:?_X/'_\`
ME+6]10!@_:O$7_0&T_\`\'C_`/REH^U>(O\`H#:?_P"#Q_\`Y2UO44`8/VKQ
M%_T!M/\`_!X__P`I:_/S_@JE<:T__!/G]J-;K2[."`_#N/S)8M7:X=!_PE'A
MWE8#I=N)#G''G)]>17Z0U^>G_!5O_E'G^U-_V3J+_P!2GPY7U7`O_);\&_\`
M95</?^K?!GS'&W_)&\6_]DUGO_JKQ1_!H_WV_P!YOYFFTY_OM_O-_,TVO]78
M[+T7Y'^7P4444P"OW\_X-\Y+V/X_?M!&QM(+N0_!SPN'2>\-DJK_`,)VY#*X
MM+O>2<@J47`'#$MQ^`=?T#_\&\__`"<%^T)_V1KPM_ZGCU^6^-?_`":SC#_L
M!PG_`*M<O/TSP<_Y.;PC_P!AV)_]5F./ZK;G4?$%K;SW+Z+8,EO#+,RKKK;B
ML4;2,%W:,!N(4@9(&>I`R1^?H_X*2>""`1\,O&?(!_Y"GASO_P!O-?HKJ_\`
MR"]2_P"O"]_])9J_EV3[J=OE7^0K_,D_T</UU_X>1^"/^B9>,_\`P:^'/_DF
MC_AY'X(_Z)EXS_\`!KX<_P#DFO@"?X5Z/'\&;/XB6M[XDU;5[G4(8IFT32;'
M6/#6F27"1Q#PUK;66I2:WHFKQ7#;?[5U'3XK2XU&:TTJULIK:\M-5FNGX,Z/
M"G@Z.[\3W0N[BW^*5U\15LK;3[V+PVWPLT32/$.N:1X?*W"#5M7MK754T.]>
M\EBL8?$L5Q$C'3[5I9P#[R_X>1^"/^B9>,__``:^'/\`Y)H_X>1^"/\`HF7C
M/_P:^'/_`))K\Q?%OA?3M)B\(:QHEY?2^'_&VBS:MIW]N+:IJFDSZ?KM_P"&
M]:T[59-+1K.Y6PU'3WG@U&QMXUO-.N;>3[%#=)+;U8^(/A'1O"4GA`Z%K\_B
M2R\2^#++Q*VIRZ8^DP274VN>(=%N4TZRG9KU=+#Z&);&74EAU"XAF\ZZM;-W
M%I"`?K3\-_VZ/#?Q-\<>'?`>C_#WQ+8:GXENY[.SN]3U;1%L()(+"\U!FN6M
M&NK@(8K*1%\JWE;S&0%0I9E^W[&749?,^WV5O:8V>5Y%^U[YF=V_?FRLQ'MP
MN,&3?N/W=OS?@#^R3_R<;\*?^P[J/_J,Z]7]!B]!]!_*@!:***`"BBB@`HHH
MH`****`"BBB@#\0/^"D__*23_@A3_P!G6_M0?^L<_$&OV\C_`-7'_N+_`.@B
MOQ#_`."D_P#RDD_X(4_]G6_M0?\`K'/Q!K]O(_\`5Q_[B_\`H(H`?1110`44
M44`%%%%`!1110`4444`%%%%`!7YZ?\%6_P#E'G^U-_V3J+_U*?#E?H77YZ?\
M%6_^4>?[4W_9.HO_`%*?#E?5<"_\EOP;_P!E5P]_ZM\&?,<;?\D;Q;_V36>_
M^JS%'\&C_?;_`'F_F:;3G^^W^\W\S3:_U=CLO1?D?Y?!1113`*_H'_X-Y_\`
MDX+]H3_LC7A;_P!3QZ_GXK^@?_@WG_Y."_:$_P"R->%O_4\>ORWQK_Y-;QA_
MV`X3_P!6N7GZ9X.?\G-X1_[#L3_ZK,<?U>ZY*D.C:M-*P2*+3-0ED<@D*D=G
M.SL0`20J@G`!/'`)K^/9/VJ_V?-B'_A9FE<HI'_$K\2="H(X.B^G8_C7]?OB
MS_D5_$?_`&`=9_\`3;=5_FBQD^5%R?\`51=S_P`\UK^1/!/PKR'Q*I\1RSK'
M9O@WD\\ICAO[+K8*DJBQZS!UO;_6\#C')Q^IT_9^S=-+FGS*=XN/]5>,?B=G
MGAW4X>AD^"RK%K-XYK+$/,Z6,JNF\`\M5+V/U7&X11YUC*OM.=5+\L.7EM+F
M_H9TO_@H=\(-"\()X8T/Q]X-T745G"MXRTKPUXBL?$\FE+:V%NEA)<0:0MHU
M[NTRR$GB`VIUF:SM8+.6X9XS=/-_P\@\!RVWAZTU'XRZ1K4'A[4?$^H>7K6B
M>([V/6X_%^GQ:1K>F>((QH\*W^FSZ6+RQCBB^RW"1ZI?RFY:Y-M/;?SQY/J?
MS-&3ZG\S7[K_`,2L\#?]#SBWI_S%Y-Y7_P"9'Z_?]WXG_P`3,<;?]";A7_PE
MS?R_ZG/K_6_[Z:O^W'^S_K,,5G<^)_`D.G:=I&EZ'X;TZVT;QZL/A73;#6Y]
M>O5T:>83WDMYXCO;N_7Q#J6L7&J7MY%?3&WDLYH[66WD\6_MQ_L\>+-/\/:>
M=?\``^@CPQI<.AZ7=:-:?$N6Y718+W5=1CTZ==:EU:VG7[?K-Y<M=F!;XGRH
M?M`MX_+/X#Y/J?S-&3ZG\S1_Q*SP-_T/.+>G_,7DWE?_`)D?K]_W'_$S'&W_
M`$)N%?\`PDS?_P"?/K_2U_IB_8E_:'^"_B_]JGX,>&O#?CS3]5US5O$>J6^G
M:?#I^NQ2W4T7A'Q)=2(DEUI4%NA6WMYI299HU(C(!+%5/].B_=7Z#^5?P6_\
M$K"?^'A'[+W)_P"1V\0=_P#JFWCFO[T4^XO^ZO\`(5_-OC-X?91X<\0Y;E&3
MXO,L9A\9DM+,JM3,ZF%JUHUYX['864*<L)A,'!4N3"PDE*G*?/*;<W%QC'^A
MO"'CS-O$#(<QS7-\+EV$KX/.*N74X9;3Q-*C*C3P6`Q*G..*Q6+FZCGBJD6X
MSC'DC!*-U*4G4445^0GZP%%%%`!1110`4444`%%%%`'X@?\`!2?_`)22?\$*
M?^SK?VH/_6.?B#7[>1_ZN/\`W%_]!%?B#_P4I94_X*1?\$*F=E11^U;^U`2S
ML%4?\8=?$$<LQ`&3P.>20!R17[:QWEGY:?Z7;?<7_EO$>P[A\4`7**K?;;/_
M`)^[;_O_`!?_`!='VVS_`.?NV_[_`,7_`,70!9HJM]ML_P#G[MO^_P#%_P#%
MT?;;/_G[MO\`O_%_\70!9HJM]ML_^?NV_P"_\7_Q='VVS_Y^[;_O_%_\70!9
MHJM]ML_^?NV_[_Q?_%T?;;/_`)^[;_O_`!?_`!=`%FBJWVVS_P"?NV_[_P`7
M_P`71]ML_P#G[MO^_P#%_P#%T`6:*K?;;/\`Y^[;_O\`Q?\`Q='VVS_Y^[;_
M`+_Q?_%T`6:_/3_@JW_RCS_:F_[)U%_ZE/AROT"^VV?_`#]VW_?^+_XNOSW_
M`."K%S;2?\$]?VI5CN('8_#J(!4FC9B?^$H\.GA0Q)Z=@?U%?5<"_P#);\&_
M]E5P]_ZM\&?,<;?\D;Q;_P!DUGO_`*K,4?P=/]]O]YOYFFTY_OM_O-_,TVO]
M78[+T7Y'^7P4444P"OZ!_P#@WG_Y."_:$_[(UX6_]3QZ_GXK^@3_`(-ZY8HO
MV@?V@VEDCB!^#?A8`R.J`D>/')`+$9..P]O45^6^-?\`R:WC#_L!PG_JUR\_
M3/!S_DYO"/\`V'8G_P!5F./ZM/%G_(K^(_\`L`ZS_P"FVZK_`#1(_P#51?\`
M7*+_`-%K7^EGXKO+0^%_$8%W;?\`(!UC_EXB'73;KU>O\TR/_51?]<HO_1:U
M^(_1/_A<=?\`7SAS_P!)SL_8OI1?Q^"?^O?$?_I61#Z***_L`_E$****`/T$
M_P""5?\`RD(_9>_[';Q!_P"JV\<U_>DGW%_W5_D*_@K_`."5K*G_``4'_9?9
MV5%'C;Q`2SL%4?\`%MO'(Y9B`,G`'/)(`Y(K^]"":&50(IHI2JKN\J1)-N1Q
MG8QQG!QGKCBOX1^E-_R6^1?]DKA__5OFY_;/T9O^2.SO_LI\3_ZJ<G)J***_
MF4_H\****`"BBB@`HHHH`****`/P\_X*60Q3_P#!2#_@A7%/%'-$_P"U;^T^
M'CFC26-L?L=?$!AN2160X8!ERIVL`PPP!'[5QZ%HA1"=(TO)12?^)=9#J!V$
M&!^%?BQ_P4G_`.4DG_!"G_LZW]J#_P!8Y^(-?MY'_JX_]Q?_`$$4`9G]@Z)_
MT"-+_P#!=9?_`!BC^P=$_P"@1I?_`(+K+_XQ6M10!D_V#HG_`$"-+_\`!=9?
M_&*/[!T3_H$:7_X+K+_XQ6M10!D_V#HG_0(TO_P767_QBC^P=$_Z!&E_^"ZR
M_P#C%:U%`&3_`&#HG_0(TO\`\%UE_P#&*/[!T3_H$:7_`."ZR_\`C%:U%`&3
M_8.B?]`C2_\`P767_P`8H_L'1/\`H$:7_P""ZR_^,5K44`9/]@Z)_P!`C2__
M``767_QBC^P=$_Z!&E_^"ZR_^,5K44`9/]@Z)_T"-+_\%UE_\8K\^O\`@JII
M.EVW_!/?]J2:WTW3X)4^'<126&RM8I$/_"4>'1E9(X5=3@GE6%?HW7YZ?\%6
M_P#E'G^U-_V3J+_U*?#E?5<"_P#);\&_]E5P]_ZM\&?,<;?\D;Q;_P!DUGO_
M`*K,4?P:/]]O]YOYFFTY_OM_O-_,TVO]78[+T7Y'^7P4444P"OW_`/\`@WPM
M+6\^/_[04=W;6]TB_!OPNRI<P13JK'QVZEE69'521P2`#P.>!7X`5_0/_P`&
M\_\`R<%^T)_V1KPM_P"IX]?EOC7_`,FMXP_[`<)_ZM<O/TSP<_Y.;PC_`-AV
M)_\`59CC^ISQ5H>BKX8\1,ND:6"-!U@@_P!G67!&FW7_`$P_STZ5_FLQ_P"J
MB_ZY1?\`HM:_TN_%G_(K^(_^P#K/_IMNJ_S1(_\`51?]<HO_`$6M?B/T3_X7
M'7_7SAS_`-)SL_8OI1?Q^"?^O?$?_I61#Z***_L`_E$****`/T`_X)80Q3_\
M%!/V8(9XHYHI/&OB`/%-&DL;@?#?QPP#1R*R-A@&&Y3A@&'(!K^\NSL+*R4F
MSL[6U\U4,GV:V@M]^T';O\F--VW<VW=G;DXQDU_!Q_P2K_Y2$?LO?]CMX@_]
M5MXYK^])/N+_`+J_R%?PC]*;_DM\B_[)7#_^K?-S^V?HS?\`)'9W_P!E/B/_
M`%4Y..HHHK^93^CPHHHH`****`"BBB@`HHHH`_$#_@I/_P`I)/\`@A3_`-G6
M_M0?^L<_$&OV\C_U<?\`N+_Z"*_$/_@I/_RDD_X(4_\`9UO[4'_K'/Q!K]O(
M_P#5Q_[B_P#H(H`?1110`4444`%%%%`!1110`4444`%%%%`!7YZ?\%6_^4>?
M[4W_`&3J+_U*?#E?H77YZ?\`!5O_`)1Y_M3?]DZB_P#4I\.5]5P+_P`EOP;_
M`-E5P]_ZM\&?,<;?\D;Q;_V36>_^JS%'\&C_`'V_WF_F:;3G^^W^\W\S3:_U
M=CLO1?D?Y?!1113`*_H'_P"#>?\`Y."_:$_[(UX6_P#4\>OY^*_H'_X-Y_\`
MDX+]H3_LC7A;_P!3QZ_+?&O_`)-;QA_V`X3_`-6N7GZ9X.?\G-X1_P"P[$_^
MJS'']6/BS_D5_$?_`&`=9_\`3;=5_FB1_P"JB_ZY1?\`HM:_TN_%G_(K^(_^
MP#K/_IMNJ_S1(_\`51?]<HO_`$6M?B/T3_X7'7_7SAS_`-)SL_8OI1?Q^"?^
MO?$?_I60CZ***_L`_E$****`/T$_X)5_\I"/V7O^QV\0?^JV\<U_>DGW%_W5
M_D*_@M_X)5_\I"/V7O\`L=O$'_JMO'-?WI)]Q?\`=7^0K^$?I3?\EOD7_9*X
M?_U;YN?VS]&;_DCL[_[*?$_^JG)QU%%%?S*?T>%%%%`!1110`4R22.)'EE=(
MXXU9Y))&5$1$!9G=V(555069F("@$D@`FGTR1%D1XW5'5T9&1U#(RLI5E=2"
M&5@2&4@@@D$$&@#YXN?VKO@/:W<L#>-Y9M.@N6M9_%MEX1\=ZC\/+>5)!%+]
MH^)NG>%KKX=P1PR-MFGE\4);Q89I9D56*_0%C?66J65IJ6FWEKJ&GW]M!>6-
M]8W$-W9WEI<Q+-;W5K=6[R07-O/"Z2PSPR/%+&ZR1NR,"?Q9^.?QO_:2T+]J
M8_#%/C'X9^&FG^'_`(P^`=;^&OA&X^*?[+_A'2?B3X+\<^(_V>?"'A[PK>>%
MO$?B(?&/7?"7AOP;:_M1^)?B9I=[HOA_Q1JOCWQ/\+;+X0W?BJVT[1+#3/VJ
MMX8K>"*""*.&&%%BBAAC2***-!M2-(XU6.-44!0B*JKC"@`4`?B-_P`%)_\`
ME))_P0I_[.M_:@_]8Y^(-?MY'_JX_P#<7_T$5^'W_!2Y9V_X*/\`_!"Q;>6.
M&8_M6_M/[))H6N(U_P",._B`6W0K-;L^5W*,3)M8A_FV[6_::.V\0^6G_$WT
MK[B_\P*Y'8=O[>H`WJ*Q/LWB'_H+Z5_X(KG_`.7U'V;Q#_T%]*_\$5S_`/+Z
M@#;HK$^S>(?^@OI7_@BN?_E]1]F\0_\`07TK_P`$5S_\OJ`-NBL3[-XA_P"@
MOI7_`((KG_Y?4?9O$/\`T%]*_P#!%<__`"^H`VZ*Q/LWB'_H+Z5_X(KG_P"7
MU'V;Q#_T%]*_\$5S_P#+Z@#;HK$^S>(?^@OI7_@BN?\`Y?4?9O$/_07TK_P1
M7/\`\OJ`-NBL3[-XA_Z"^E?^"*Y_^7U'V;Q#_P!!?2O_``17/_R^H`VZ_/3_
M`(*M_P#*//\`:F_[)U%_ZE/AROO#[-XA_P"@OI7_`((KG_Y?5^??_!5.#64_
MX)\?M2-=:EI\\`^'<7F10Z1/;RN/^$H\.\).^KW*QGW,$@]NE?5<"_\`);\&
M_P#95</?^K?!GS'&W_)&\6_]DUGO_JLQ1_"0_P!]O]YOYFFTY_OM_O-_,TVO
M]78[+T7Y'^7P4444P"OZ!_\`@WG_`.3@OVA/^R->%O\`U/'K^?BOW]_X-\DO
M9/C_`/M!"QN;:UD'P;\+[WN;.2]5E_X3M\*L<=Y9%&!SEC(XP1A01D_EOC7_
M`,FMXP_[`<)_ZM<O/TSP<_Y.;PC_`-AV)_\`59CC^KOQ9_R*_B/_`+`.L_\`
MIMNJ_P`T2/\`U47_`%RB_P#1:U_I0^*K?Q`/#'B,MJVE$?V#K&0-"N<D?V;<
M]SKIQ]<'T(P37^:]'_JHO^N47_HM:_$?HG_PN.O^OG#G_I.=G[%]*+^/P3_U
M[XC_`/2LA'T445_8!_*(4444`?H)_P`$J_\`E(1^R]_V.WB#_P!5MXYK^])/
MN+_NK_(5_!1_P2R69O\`@H'^S"MO+'#.?&NO^7+-"UQ&A_X5QXX)+PI-;LX*
M@J`)HR"0V2!M/]Y5A'J,:M]OO+2[RL?E?9;"6QV8!W[_`#-0OA)NRNW;Y6S!
MSOW#;_"/TIO^2WR+_LE</_ZM\W/[9^C-_P`D=G?_`&4^)_\`53DY?HHHK^93
M^CPHHHH`****`"D;&ULG`VG)]!CDTM9VKS7=OI6ISV'_`!^PZ?>RV?\`H$NJ
M_P"E1VLKV_\`Q+(+S3IM1_?*G^@Q:A8RWG_'M'>6KRB>,`_$GQ'J'BGP%^U=
M\9_'/A`Z>?@3=?M._##2?BY\2-5_9.^%/C'2/!7Q2U[1_A!X0G\._P#"Q]<_
M:E\-?&O54N(]3\%:-J/CWP_\%->\)_#;5]0M(=-L;S2?#WB5]'_<93D9]SVQ
MCD\'W'0^I&:_!6:P\9?$C]ISP3\6=7^`7BZSOKSQI\*M0UR?Q/\`\$[OV@-,
ML+[Q%X8B\/:,GCWQ3<V?[?\`:_"=O$V@2V4E[X'^(_B[X,^,?$7PKT:Q\-0Q
MW/B27P;:WE[^]0Z?3(_`'CN>W?OUXZ4`?B#_`,%)_P#E))_P0I_[.M_:@_\`
M6.?B#7[>1_ZN/_<7_P!!%?B'_P`%)_\`E))_P0I_[.M_:@_]8Y^(-?MY'_JX
M_P#<7_T$4`/HHHH`****`"BBB@`HHHH`****`"BBB@`K\]/^"K?_`"CS_:F_
M[)U%_P"I3X<K]"Z_/3_@JW_RCS_:F_[)U%_ZE/AROJN!?^2WX-_[*KA[_P!6
M^#/F.-O^2-XM_P"R:SW_`-5F*/X-'^^W^\W\S3:<_P!]O]YOYFFU_J['9>B_
M(_R^"BBBF`5_0/\`\&\__)P7[0G_`&1KPM_ZGCU_/Q7]`_\`P;S_`/)P7[0G
M_9&O"W_J>/7Y;XU_\FMXP_[`<)_ZM<O/TSP<_P"3F\(_]AV)_P#59CC^K'Q9
M_P`BOXC_`.P#K/\`Z;;JO\T2/_51?]<HO_1:U_I=^+/^17\1_P#8!UG_`--M
MU7^:)'_JHO\`KE%_Z+6OQ'Z)_P#"XZ_Z^<.?^DYV?L7THOX_!/\`U[XC_P#2
MLA'T445_8!_*(4444`?H)_P2K_Y2$?LO?]CMX@_]5MXYK^])/N+_`+J_R%?P
M6_\`!*O_`)2$?LO?]CMX@_\`5;>.:_O23[B_[J_R%?PC]*;_`)+?(O\`LE</
M_P"K?-S^V?HS?\D=G?\`V4^)_P#53DXZBBBOYE/Z/"BBB@`HHHH`*SM8LFU'
M2M3T]#9J]]I][9JVH6":K8!KJUE@4WNF236Z:A:`R`W-B]Q`MY`)+9IHEE+K
MHTAY!'J#0!^`&F?LWZ?IO[2Z:9\(OV//@5K_`(1^$GQ3^&GAGQ1\0_!?_!-+
M]E'POI?A_P`7Z3HGP_\`%/B_4?#OQ!\??MB_#SXEPKI4VMKX@M?%O@WX0^*+
M?PI-=+I7A-_'FJ^%I3>_O^/ZGL!U)],_GU/4X/%?E!XO_8>\<ZU^U=XE^.-Q
M\-OV3_B/I.O?$_P+XTTWQE\7&^,^O_&GP;HWA;3O"^GC1/"5Y9.W@O1+'0)]
M#O=9\$Z!8VUKHNF:UJ5_?ZDUY=ZMJ=T_ZO@8_,G\R3_^OWH`_$'_`(*3_P#*
M23_@A3_V=;^U!_ZQS\0:_7'Q9\9/A;\/]0MM%\:^//#/AC5KC3X-1AT_6=3A
ML[J6QFEFMXKM(I/F:!Y[:XB5^A>&1?X37Y'?\%)_^4DG_!"G_LZW]J#_`-8Y
M^(->)_\`!6']I;X?_![]HSPCX8\4V?BFXU&[^#GAS6HGT33+*\M!:7/BKQI9
MHKRW&JV+B<2V,Q:,1,HC,;"0DE5];)<BSCB/'1RW(\NQ.:8^5.I6CA<)#VE9
MTJ5G4FHW7NP4ES.^ESR\XSO*>'\&\PSK'X;+<$JE.B\3BI^SI*K5;5.#E9^]
M-II>A^W5O^TK\!;N>*UM?BQX)NKJ=BD%M;ZS#/<3NJ/(R0P1*\LKB-'D*QJS
M!$=R-JL1"O[3W[/CJ&3XP>`G4J'#)K]JZF,E0)-RY&PET`?.W+J,Y89_G)_8
MR_;*^&OBKXJ2Z+X<MM;BUJ_TV.&VM=4USPO\/_%-U!')<WUV_@75=<UIM*U.
M^M4LHSXBT%KJUOKO0;AKVS6YM]-U$0>A:3^T=X=\2Z!^T_I?@A-3^(OAN/3M
M)?3_`!GI-M\)M,N_B5XOMO'7PPN=5T+0]3_X3'24\27GA2TN]:FN#H45IX-O
MUTKQ/XIT2ZU6WN;.ZE]W$>'G&V$K5</BN&LSPU:C'#RJPKTHT?9QQ=14L-*<
MJDXPBJ]1RA2;E:;IUK75"LZ?B4./N#<51IXC#<19=B*-:5>-*="K*K[26%I^
MUQ$81A"4Y.C3<95$H^ZJE%/6M24_WV'[3?[/Y!8?%WP*54@,PURW*H6)"AV`
M*H6*L%#$%BK!<D'`/VF_V?V61U^+G@9DA"M,Z:W`R0JYVHTSJ"L2NPVH9"H=
MOE4D\5_._8?MA_LS7W[/7Q#TKPG\1;JXNM-7X+ZAJWAJ_P#!7B#0O%6N_$3Q
M)XIU:RGL+6;65M-&U"STJ18/#%G>V.L3:!X=TVTN/$WB'4-/M-?:YK=^"'[3
M_AO1KZ?3-?O-7TOP=H/B7XB^&O&]VOQ!^$=OX.^&.MZ397V@^(=8^,WAF+Q?
M)J/C[PM=)%:W?A*/PY?Z]IWBJRMVM_!E]?:A<-IK%3P[XYI>U]OPMG.'=&HZ
M52.)P=3#3514:>(Y5"NJ<YN5*M1E!PC)5'6I1IN4ZM.,B''_``75]G['B;**
M_M::JP>'Q<,1%TW5G0YI3H>TA!1J4JL9\\H\BI59SY84YRC_`$!?\-._L_?]
M%?\``?\`X/K:O8-"U[1_$^CZ=X@\/ZE9ZQHNK6L=[IFIV$RW%G?6DN3%<6TR
M_+)$X!VN.#@U_%=#^W9\&\0J-,^(9^6)07T'30QPJKEPWB`,&/5@RA@<A@&R
M!_6)^Q/XMTSQW^RA\!/&&C)>1Z7XB^&^@ZI8QZA#'!>I;7"3&-;F&*:XCCF`
M4[D2>51V<US9]P1Q;POAZ.+X@R#,LHPU>LL/1K8VA[*G4KNG.JJ47=WG[.$Y
MV[1?8Z<DXRX6XDQ%7"Y#GN7YKB*%'ZQ6HX.M[2=.ASPI^UDK*T.>I"-^\DCZ
MCHHHKY4^F"BBB@`HHHH`*_/3_@JW_P`H\_VIO^R=1?\`J4^'*_0NOST_X*M_
M\H\_VIO^R=1?^I3X<KZK@7_DM^#?^RJX>_\`5O@SYCC;_DC>+?\`LFL]_P#5
M9BC^#1_OM_O-_,TVO5?A#\&_'?QS\:V_@?P!8Z?/J4P2XOM3UW6=,\.>&]`L
M9[VWTV#4-?U_6+BVL=.MKG4[VRTNRC#3WVHZG>VMCIUE=W$A1>ET;]F3XU:U
M=ZSI\?A;2]*U+1_$L_@E--\2^.?`7AJ\\2^-[;P_%XKG\&>`!K'B6UMOB'XF
M3PS<V.NC3_!EUK4<VFZIHDT%U(^NZ+%J'^IE7-\JPU6KA\3F6!H5\/1I5J]&
MMBZ%*I1HUFXTZM2%2I%PIR<7:<DHK1MI2C?_`#-HY5F>)I4J^'R['5Z->K4H
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M>25_0/\`\&\__)P7[0G_`&1KPM_ZGCU^+-W\!OB;8^"8O'MWI6APZ3-X+LOB
M4FBMXS\'GQ\OPTU'48M*T_XCS?#E=:/C6#P+>WMQ;BW\12:,MJ]I<V^JE%T>
M>/4&_:;_`(-Y^/V@OVA`>O\`PIKPM_ZGCU^:^,>+PN+\+.-'A<30Q*HX7#4:
MKH58553K0S7+W*E-PE)1J133<)6DKJZU/T3PCPN)POB=P<L3AZV'=7%8BK35
M:E.DZE*668[EJ04XQYH2L[25T[/70_JQ\6?\BOXC_P"P#K/_`*;;JO\`-$C_
M`-5%_P!<HO\`T6M?Z7?BS_D5_$?_`&`=9_\`3;=5_FB1_P"JB_ZY1?\`HM:_
M&?HG_P`+CK_KYPY_Z3G9^M_2B_C\$_\`7OB/_P!*R$?1117]@'\HA1110!^@
MG_!*O_E(1^R]_P!CMX@_]5MXYK^])/N+_NK_`"%?P6_\$J_^4A'[+W_8[>(/
M_5;>.:_O23[B_P"ZO\A7\(_2F_Y+?(O^R5P__JWS<_MGZ,W_`"1V=_\`93XG
M_P!5.3CJ***_F4_H\****`"BBB@`JO=W-O96MQ=W=Q#:6MK!-<W-U<RQP6]M
M;P1M+-<3S2D1Q0PQ(\LLLA"1QHSN0JDU8J*:(30RPEY8Q+&\9DAD:*9`Z%"\
M4B_-'(H.Y'4AD<!E((%`'X$W?QE^"WCC]KK5O$#?%[]FOXXZ9XJ^,WP^N?A-
MXEM/^"O^K^`M9\.>'?L7@K2;/P;X>_9>^'MO:^!=832_%-EJ^KZ3X8N+W6=1
M^).J:]=6GB6]>7409?WZ7!&1C&3T.1U/.??T[=.U?,\GP:^+J:FL-C^T9KUO
MX9\Z.3-U\+?A7J/CZWC1T816OC6?1(]%=HU0QQ7VJ_#_`%;4SD3W5Y=W8:X;
MZ*TJP_LO3-/TTWE_J)L+.VLS?ZI<_;-2O3;0I";J_NMD7VB\N"AEN9A'&))G
M=Q&@(4`'XD_\%+YXK;_@H]_P0LGF8K''^U;^T]N8))(1N_8[^("*`D*22'+,
M!\J$#.6(4%A^4?\`P7MOK:__`&QO`,UK(TD:_L[>$(RS0W$!WKX\^)+8V7,,
M+D;65@P4KAL9W!E7]8O^"D__`"DD_P""%/\`V=;^U!^O['/Q!S7Y4_\`!?HD
M_ME_#\DDG_AG/P?R3GKX^^)9/YDD_4U^]_1N_P"3F8?_`+$V:_\`I-`_#?I#
M?\FYQ'_8VRO_`-.S/P^1WC97C=XW0Y1XW:-T."N4="KH=I*Y5@=I*YP2#6DM
M;29MTUI:RL%5`TMM!(P1?NH&>-B$7^%<[5[`5/17^ANSNM':U^MNU^Q_!+U5
MGJM[/:_<:40XRBG:&"DJI*AAM8`D<!U^5P.&7Y6!'%,,$!,3&"`M"`(6,,9:
M$#H(3MS$!V$94#L*EHH`<GWU_P!Y?YBO[U/^":NOZ7:?L%_LI033R++'\&O"
MR.JV6H2`,L=P"-\=H\;8.1E78'&02,$_P5I]]?\`>7^8K^^[_@F82?V!?V3\
MDG_BS'A3_P!%W`_D`/H!7\P?2G_Y)#A[_LHU?_PV8[]3^D_HR_\`)5Y]_P!D
M]/\`]667GO'Q3_:#^'?P@TK2]8\63:V]IJ^I-I=H-)T*^O9OM*6D]ZQE29;-
M4B\FW<!P[DN579@EAXB/^"@/P"8A5_X3MF8A55?!\[NS,0JJB+>EG=F(544%
MF8A5!8@'Y[_X*U?%GP5\)?A5\*=4\;WVH65EJWQ+N],LGT_2KO5G>[C\':Y>
M,DD-H"T2"WAE82O\N["#YFK\5OAM^VY\!-/\<^&[R/QL-!E@O+CRM7\8^%_%
MFG>%[*2;3;ZW5]:U;2()=3T2TF\XVR^(+%!/X?NI[?6Q-;K8-<1?Q]EO!/&&
M<X&.9Y3POGV9Y?-U5#&8#*L=B\--T9.%6,*U"A.$Y4YQE&<8R;C*+35U8_K#
M,>,N$\HQLLNS7B3(\MQ\%2<\)CLTP6%Q$%6C&=*4Z5>M"<8U(3C.+DDG%\R=
MK,_I"O/VY?@YI^KR^'[[2?B;::]!.;:719_`.H)JJ7`B,YA_L_[2;MI/(!G"
MI$V8`TPS&K,)]-_;:^$^LVSWNC^'/BWJ]E'(T+WND_#/7-3LTF14=XGNK%KB
MW654DC=HVD#JCHY4*ZD_EAJ?[5_P1TO]JBUTS2OCEX>@.D13V7Q)N?$'COPQ
M/X;\(:;/?:]]D\->'OB-XJN=$_M&WU-&M-4\0>'?"MWK=UHS:DFF:EJ%W87,
MMM;_`!SX<_:]^"7PZT7XH7E[\0Y+;Q7X5TWPMX5T/3]$NX]:$^I^/IIK37/$
M/A>;PSJVI:1XC_X1OPO8:C9ZCJVBW=]!X>O=>L9+J>&]CMQ'I1X#XVQ#BJ/"
M?$564J6'K1C#)\?*4J.*E"&&JJ"H.3IUY5:?LIVY9JI3<6U.-\ZW&_!U!2=;
MBC(*<8U*U&4IYM@5%5<,I2Q%-R=>RJ45"I[2%^:+IU$U>$DOZ!M._;N^"FL7
M(L]'T[XEZO>&.286FE>`=2U*[,,0!EF%M8W%Q/Y4093)+Y?EQ[EWLNY<TF_X
M*`_`)6*L?'2LI*LK>$)U964E65E-\"K*P*LK`,K`JP!!%?AQ\+/VH_@3_9WB
M+P=-\3M!TIO''@[X=^/;'4;#XA:#\/M8L+>WUS4C;^';KQ!XC,?A^QU?3!.^
MI^._`.I:E8>*M`MK31->L+#6;JR73'\Q^-/[=/[,WB'XL?$#6O#GB76;K1;_
M`,1W#65]8>#_`!!+8ZF;:WM;*\UBRGN+:UN+FSUG4;6\U:UO+FVMKF^@O4O;
MBW@FN)(DVI>'?'M><Z5'@WB>I4IJ,IPCDF8N4(S=H2DEA[I2:ERMZ2Y9I7<)
M6RJ<?\#T80J5>+^&Z<*CE&$I9UEZ4I1Y>>*?UBS<%*+FEK%2BW92C?\`J)^%
MWQ]^'WQ=T.^\0>%)M:6QT_59-'N%U;0[ZRN/M<=G9WI,<<27:O"8;V(!S(K;
MPZE``K-\C?\`!5+7M,O/^"?/[4=O!/*TLGP[B5%:SOXP3_PE'AT\O+:1QJ..
MK.HY%<S_`,$GOBGX.^+'P+\>ZYX*O;^]TW3_`(M:CI-U)?Z7=Z3*MZG@WP?>
M.B078#R1^1=V[><OR%BR?>0UWW_!5LG_`(=Y_M3\_P#-.HO_`%*/#O\`B?S-
M7PG@,=E?B%PKE^983$X#'87BWAZGB<'BZ-3#XFA4_M7!2Y*U&K&-2G+EE&7+
M**=FGLR.*,?@LSX"XFQ^7XK#X[!8GA?/:F'Q6%JPKX>M#^S,7%3I5:<I0G'F
M35XR:NFC^.O]B_XJ>$OA'\;=,\1>-?&NO^!=!NC865_JECX0\/>/_"=Y:VVL
MVFJW&E_$3P?KR_:-0\/R-8V]]I6K>'7_`.$@\,^)K#2]3M;>ZMVNC!](^'OV
ML/V<H+7PIX?M/";>`?A?\//B?XX\5:E\+O\`A2?@WQS9?'7X=?$'PI\/X_%7
MP]C?5]:U*S^"*Z]XY\':[J4>DZ?JFH:+X3T#Q9H*Z/XDU#5/AMHEI=?EN_WV
M_P!X_P`S3:_TIS'A#*\VQM7,,34Q<:];#T*#C1G0A2@Z-+%4%75.>'J*KB'A
ML97H4ZV(]M+!QG*KE[PF)E*N_P#.[+N*\SRO!4<!AJ>$E1HXBK74JT*\JLU5
MJ86NZ#J0Q%-TL/\`6,'0K5*6']C'%RA&EC_K>&C&@OMCX??$WX*^#OA)X^\$
MIXP\000_%;P+IWA_4O#H^#&DP^./`?Q`N/%'A/5[GQ<OQV\/ZYI?B+QE\*O!
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MAJES>'3Y_P!GCPI\*?"WPWF^&%HWC_PM\1=&U+0O$&H>*-3_`&GO[>&N>(_A
M0_C"#Q+XFM?A@]J?#T^DZMHW@J+P%H*:#!XA'W3_`,&^NH6MA\?_`-H*6Z=H
MT?X.>&%3;#<3DD>.W8@BWBF8<$<L`"3UZX_`.OZ!_P#@WG)'[07[0F#_`,T:
M\+?^IXX_D2/QK\X\5<EPF3>%7'<,'*JUC*>&QE7VLJ;?MIYCEE.4KTZ5+VE2
M:IQE5Q.(]OC<14;J8O$XBI[Q^@^&&<8O-_$_@>>+5)/!U:^$I>RC4BO8PR_,
M:D8VJ5*BIPC*I)4\/0]CA,/"U/#8:C"\7_4GXJ\2Z._AGQ$HN)<G0M8`S8:F
M!SIMUW^Q?Y^O%?YL4?\`JHO^N47_`*+6O]+OQ62/"_B/!Q_Q(=9_]-MU7^;#
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MSR[%K$.=6"H>QFZS=&4H5'&DDYR@IPG!5$G"4HN,9-V1XA17L][\`?B5I_@'
M_A8EU9:`NF1^$M'^(5[X;C\5Z)+\1-)^&_B'75\,Z%\1]8\`I<'7M.\#:OKD
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M*"1_>3I^IV>HJXM)'D\E8Q)NM[J#&\-MQ]I@AW9V-]S=MXW8R,_P>_\`!*S(
M_P""A/[+XZ$>-O$(./\`LFWCD&O[T5Y5<_W1_*OX@^E-_P`EOD7_`&2N'_\`
M5OFY_9GT9O\`DCL\_P"RGQ'_`*J<G_K;_@NHHHK^93^CPHHHH`****`"BBB@
M`HHHH`_$#_@I/_RDD_X(4_\`9UO[4'_K'/Q!K\J/^"_/_)Y?P_\`^S<_!W_J
M>_$NOU7_`."D_P#RDD_X(4_]G6_M0?\`K'/Q!K\J/^"_/_)Y?P__`.S<_!W_
M`*GOQ+K][^C=_P`G,P__`&)LU_\`2:!^&_2&_P"3<XC_`+&V5_\`IV9^'M%%
M%?Z&G\$A1110`Y/OK_O+_,5_?;_P3,_Y,%_9/_[(QX4_]%W%?P))]]?]Y?YB
MO[[?^"9G_)@O[)__`&1CPI_Z+N*_F#Z4_P#R1_#W_91K_P!5N./Z3^C+_P`E
M7GW_`&3T_P#U99>?FQ_P<-?\D!_9_P#^RX:C_P"JU\4U_)N"0<@X(Y!'4'UK
M^LC_`(.&O^2`_L__`/9<-1_]5KXIK^3>OK_H[_\`)K<G_P"P[./_`%8USY3Q
M^_Y.7FW_`&!Y3_ZK<,)@8`P,*,*,#"CT4=`/88%``'0`?08I:*_<#\7#V[<<
M?0Y'Y'D>]%%%`']=_P#P;Y?\FI_%S_LX76/_`%6WPYK[>_X*M_\`*//]J;_L
MG47_`*E/AROB'_@WR_Y-3^+G_9PNL?\`JMOAS7V]_P`%6_\`E'G^U-_V3J+_
M`-2GPY7^=W%?_*0S_P"R_P"'O_4W*S^^N&/^3"_]V/GG_J'F!_!H_P!]O]YO
MYFFTY_OM_O-_,TVO]$([+T7Y'\"A1113`*_H'_X-Y_\`DX+]H3_LC7A;_P!3
MQZ_GXK^@?_@WG_Y."_:$_P"R->%O_4\>ORWQK_Y-;QA_V`X3_P!6N7GZ9X.?
M\G-X1_[#L3_ZK,<?U8^+/^17\1_]@'6?_3;=5_F\_#7Q':>$/&GA/Q1?7_C+
M2;?0KV+4#JWP\O\`2M-\;Z3,EC<16FJ>&+G78+C1'U/3KN:"\&G:Q&FEZU:P
MW.AW]U8VNI2WUM_I#>+/^17\1_\`8!UG_P!-MU7^:)'_`*J+_KE%_P"BUK\,
M^BK1AB,)Q_0J*].M_8%*HE;6%2EGD)K5-:Q;6S/V;Z3E6=#&<"UJ;M4H_P!O
MU8/M.G4R"<7I;:274_47XO?M6?"CQ'\4?'.J_"_X@_%/X0WGBGPCI>A^(_CU
M\-/A?X&T;6?B9J6E^(]-U_2#XG^'FE:WX<U73%\,:3`?#VC^-O#GB_1/&.KW
M]N\/BVTU3PLMC'%<TG]M[X7W&K*+[3?%_@WPEX>^.VO?%2[\-Z/\-?ACXN;]
MH#P/XM\%?#CP[X\^&_Q(AU2^T[P_X$N/B+XA^',_BKQ/)H5AK_@XOX^UA6TJ
MZU'PAX;N+S\L:*_I"/`60K#T<-*.(J+#X=8>G4J/"RJI.C2PU2I*7U5*I*>&
MI1P]&%6-3#Y=1M#*:.7\L7'^?9<<9Y*O6KJ6'@Z]=UZM."Q,:3:JU,13IQC]
M:;IPCB*DJ]6=*4*^/JWEFE;'\TD_MW7_`-H3X9:IH7BSQAI^G>+--^*/C/\`
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M/;K\._'@@GDMC),;=YH@DKVYFF\AG,/G3;/-?^\Q/N+_`+J_R%?P6_\`!*O_
M`)2$?LO?]CMX@_\`5;>.:_O23[B_[J_R%?QE]*56XVR%7;MPIAU=VN[9MF^K
MLDK^B2\C^N_HSZ\'9YHE_P`9/B=%>R_X2<G[MO[VQU%%%?S,?T>%%%%`!111
M0`4444`%%%%`'X@?\%)_^4DG_!"G_LZW]J#_`-8Y^(-?E1_P7Y_Y/+^'_P#V
M;GX._P#4]^)=?JO_`,%)_P#E))_P0I_[.M_:@_\`6.?B#7Y4?\%^?^3R_A__
M`-FY^#O_`%/?B77[W]&[_DYF'_[$V:_^DT#\-^D-_P`FYQ'_`&-LK_\`3LS\
M/:***_T-/X)"BBB@!R??7_>7^8K^^W_@F9_R8+^R?_V1CPI_Z+N*_@23[Z_[
MR_S%?WV_\$S/^3!?V3_^R,>%/_1=Q7\P?2G_`.2/X>_[*-?^JW''])_1E_Y*
MO/O^R>G_`.K++S\V/^#AK_D@/[/_`/V7#4?_`%6OBFOY-Z_K(_X.&O\`D@/[
M/_\`V7#4?_5:^*:_DWKZ_P"CO_R:W)_^P[./_5C7/E/'[_DY>;?]@>4_^JW#
M!1117[@?BX4444`?UW_\&^7_`":G\7/^SA=8_P#5;?#FOM[_`(*M_P#*//\`
M:F_[)U%_ZE/AROB'_@WR_P"34_BY_P!G"ZQ_ZK;X<U]O?\%6_P#E'G^U-_V3
MJ+_U*?#E?YW<5_\`*0S_`.R_X>_]3<K/[ZX8_P"3"_\`=CYY_P"H>8'\&C_?
M;_>;^9IM.?[[?[S?S--K_1".R]%^1_`H4444P"OZ!_\`@WG_`.3@OVA/^R->
M%O\`U/'K^?BOZ!_^#>?_`)."_:$_[(UX6_\`4\>ORWQK_P"36\8?]@.$_P#5
MKEY^F>#G_)S>$?\`L.Q/_JLQQ_5CXL_Y%?Q'_P!@'6?_`$VW5?YHD?\`JHO^
MN47_`*+6O]+OQ9_R*_B/_L`ZS_Z;;JO\T2/_`%47_7*+_P!%K7XC]$_^%QU_
MU\X<_P#2<[/V+Z47\?@G_KWQ'_Z5D(^BBBO[`/Y1"BBB@#]!/^"5?_*0C]E[
M_L=O$'_JMO'-?WI)]Q?]U?Y"OX+?^"5?_*0C]E[_`+';Q!_ZK;QS7]Z2?<7_
M`'5_D*_A'Z4W_);Y%_V2N'_]6^;G]L_1F_Y([._^RGQ/_JIR<=1117\RG]'A
M1110`4444`%%%%`!1110!^'?_!2Z-IO^"C__``0LC2>:V9OVK?VGL30>5YJ8
M_8[^(#';Y\4\7S`%&W1-\C-MVMAA^4G_``7OMY+;]L?P!')>7=\Q_9V\(,)K
MS[+YJ@^//B4/+'V2UM(]@P6&8R^YF)?;M5?U@_X*3_\`*23_`((4_P#9UO[4
M'_K'/Q!K\J/^"_/_`">7\/\`_LW/P=_ZGOQ+K][^C=_R<S#_`/8FS7_TF@?A
MOTAO^3<XC_L;97_Z=F?A[11WQD9QNQD9VY"[L==NXA=V,;B!G/%+@\\'@X/'
M0@9(/O@@XZXK_0T_@D2BCMGM@'/;!(`.?0D@`]R11@YQ@Y]._P"5`#D^^O\`
MO+_,5_>O_P`$U--N9_V"_P!E*1-;U>V5O@UX5(@@_LHPQ@I<85//TN:7:.@W
MRNV`,L2"3_!0GWD]V4CW!(P1[5_?;_P3,_Y,%_9/_P"R,>%/_1=Q7\P?2G_Y
M)#A[_LHU_P"JS''])_1E_P"2KS[_`+)Z?_JRR\_,G_@X.LIK7X!_`$RZGJ%^
M&^-VHJ$O/L&Q#_PK?Q0=Z?9+"T?=@;<,[KAF.W)4K_*-7]9'_!PU_P`D!_9_
M_P"RX:C_`.JU\4U_)O7U_P!';_DUN4?]AV<?^K&NSY3Q^_Y.7FW_`&!Y3_ZK
M<,%%%%?N!^+A1110!_6__P`&_P!8S77[*WQ:>+5=1L`O[0>KJ8[/^S_+<CX<
M?#H[V^UZ?=R;R#M.V14(5,(&#%OMG_@JGIMQ!_P3Y_:DEDUK5KI5^'<1,%Q_
M98AD'_"4>'1A_L^EP38R004F0^_-?&W_``;Y?\FI_%S_`+.%UC_U6WPYK[>_
MX*M_\H\_VIO^R=1?^I3X<K_.[BO_`)2&?_9?\/?^IN5G]]<,?\F%_P"['SS\
M<'F']>739'\&C_?;_>;^9IM.?[[?[S?S--K_`$0CLO1?D?P*%%%%,`K]_/\`
M@WRMI+KX_P#[0217UY8,OP;\+DR6?V7>X/CMQM;[7:W:;1C(VHK<D%B,8_`.
MOZ!_^#>?_DX+]H3_`+(UX6_]3QZ_+?&O_DUG&'_8#A/_`%:Y>?IG@Y_R<WA'
M_L.Q/_JLQQ_4OXJTF[7PQXB)\0ZVV-!UC@C1L'_B6W7!QHP/Y$'.#GBO\UZ/
M_51?]<HO_1:U_I=^+/\`D5_$?_8!UG_TVW5?YHD?^JB_ZY1?^BUK\1^B?_"X
MZ_Z^<.?^DYV?L7THOX_!/_7OB/\`]*R(?1117]@'\HA1110!]_\`_!+*-IO^
M"@?[,,:3S6S/XUU\">#RO.CQ\./'!RGGQ3Q<@%6WQ.-K-@!L,/[R;"SFM5;S
M=2O]0\Q8]OVW[#F+:#GRS9V5F3OW#?YGF?=79L^;=_!W_P`$J_\`E(1^R]_V
M.WB#_P!5MXYK^])/N+_NK_(5_"/TIO\`DM\B_P"R5P__`*M\W/[9^C-_R1V=
M_P#93XG_`-5.3CJ***_F4_H\****`"BBB@`HHHH`****`/Q`_P""D_\`RDD_
MX(4_]G6_M0?^L<_$&ORI_P""_'_)YGP_XS_QCIX.XZ9_XKWXE\9[5^JW_!2?
M_E))_P`$*?\`LZW]J#_UCGX@U^5'_!?G_D\OX?\`_9N?@[_U/?B77[W]&[_D
MYF'_`.Q-FO\`Z30/PWZ0O_)NL1_V-LK_`/3LSQGPK\);7Q?^P:C^&_A!X=T_
MQ/87-EXUU/5OB#\.M4CG^(K6]GJB?\)7\+OCWX>\1I#IVLZ[#=:5X,T;P#XM
M30M'_M.TUCP%;V-YXKU32=3JEJG@Z^U_P-X!\1>'_P!F?PKXS^,VE_M$:[\-
MI?A.?V>=2^#=MX:U75_A/XAO-!^&-IX6MKR[?]H?PI\._$VB7OC;7?&'C765
MN/#S^&],T[XC23^%/'.H7U?F?_PE7B8>%)/`G_"0:S_PA4VOKXJE\)'4;H^'
M)/$J6$FEIKKZ09#9-J:Z?+):_:3%N*.7(,P64:Y^)OQ+.H:/JQ^)'Q$.J^';
M&YTOP]JK>//%S:GH&F7D`M;S3="U%M9-[HVGWEJ!:WECID]K:W=JJVUS%+`J
MQC^SWPIFBJXN:S2C45;-<QS&A"I3Q<53IXW#QH_4ZM6GBHXET)M?O'AZ^'Q$
M$DOK-;#_`.R'\A+B?+)4\)3EEE6FZ.6Y=@*\Z<\+)U)X.O[5XNG2J8:6'5>"
MO[-5Z.(H3;DWAZ->V*/NC78M(TKQCIEQIWP]\#W^I^%?AIX3\-?M%_&7P#^S
M!:_&+P!X;^)&J^,_%M_8ZO\`#;X,^;X8^'^O2ZIX>M=!^%?B/XAZ9X?M_"/B
M;7]!UW4O`PMI=3@UOQ#P_P`1?A=KWA;]LWQYH/PU_9UM/'.F#XH>)/#GPV^%
MMMH?B/Q+X#;Q!JG@RV\2>']'GMGMK""[O/!=AK^F^//$GPT\1W-I8^$Q:3>&
M?'<4/A?2-1GF^5I?BM\5)M<M_$\WQ1^)DOB:TTZ71[7Q))\0O&3^(;72)YOM
M$^DVVNMK9U:#2IKC_2)=,BO$L9+@"=[=I@'K+TKQUXYT&2*70O&_C31)8-2U
M/6H9=&\6^(])EAUG6K$:9K6L12Z?J=M)'J^LZ:JZ=K&J(RW^JZ>!8ZA<7-H!
M#79AN'LQPSJ3CC,//VF58K`RP]26*]C.MB98>I&K.=">&K1I86=&K2PU"A*E
M2PV#Q+P^7PP$X8JOF7)B,^R_$1I0EA:\.3,\+CE7IK#>VA2PZJPE2C"O#$4I
MU<1"K"IB*]95:F)Q>'5?'3QM.>&HY?[A^TXOABU\4>`M)TS3O"4?CC1/A[8:
M9\9?$7PZ\,P^$?AMXN^):>(_$-S/?>"=*T_3](\/W]KH'A>Y\-^$/$'B_P`)
M:1I?A'QIXIT/6-<\/6MQI\D6L:M_:M_P3,_Y,%_9/_[(QX4_]%W%?P:>(O&'
MB[QG?6NH^,O%GBGQAJ%I;K96M_XL\2:WXFOK6R$S3BSMKS7;_4+FWLQ/)),+
M6&5+<3222B,2.[-_>7_P3,_Y,%_9/_[(QX4_]%W%?@?TD\)4P/`'"N%JS]I4
MI<0/GDI.<>:>`S"HXT[PIJG1@Y\E"C"G"GAZ,84*453IP1^Y_1WQ5/&<<\38
MFE#V=.KD#<(N*C)1ACLLIIU/?J.=:2CS5ZTIRJ8BLYUZDG4J29^;'_!PU_R0
M']G_`/[+AJ/_`*K7Q37\F^0,9(&3@9.,G!;`]3M!;`YP">@)']9'_!PU_P`D
M!_9__P"RX:C_`.JU\4U^.7[#_P`+/#'Q'^%OQ7T>7X5>'O$GCWQ8[^&O"GBK
MXH^"/'6N_#+6Q)XP^">G67@G3?'_`("U>'5/A'XJTG5=?NM2UGQ"-$FE_LOQ
M+H/B:^\0Z1X.\%>*;/4/I?!7.J&0>#N49CB:52M2CFV/H2C2<%**KYM4IRJ/
MG:O&E%RJ3LG:,7*;IT8U:U+YWQBR>MGGBUFN`H5:=*H\LP-92JJ;C+V&44*B
MIKDB[2JR4:<+VO*2C!5*LJ=*I^8N#C.#CUP<?G1M;CY3STX//T]:_0+0/!VA
MZ[\+])T#Q;\$/AUX/U7XAI\(/`O[-&DVMQ)H_P`:/B;\1)_B+X5T+QW\4?$?
MQ(O;J.2W^#?BS3%\9:-<>(O%-G;^!H]=USPM8_"6TO8/!VLZXGTEXQ^'O[/(
MU;4?'7@[P=X=\3^!_`OQ>^.?@F^M/!G[+FO6>K_#2TT_X%^.];\">#/%/PY\
M2:A$O[2-KX:\1:++XGU+XLZE=:9%HB>#)M3\9QZ=I'B^**P_4\3QMAL-5E2G
MEV-G*,\;#GH^SQ%!RPE"A4A#ZSAG7H1G7KUIY?%2G&,\QPF-P&%GB\7AU1J_
MF.&X.Q&)IQJQQ^#A&4,%-PK<^'KJ.*K5*<Y+#XF-&M*%"A3ACYN--SAE^*P>
M.Q,,+A*_MH?C601P00?0C%)@X!P<'H>QQUQ]*^G_`(U?#>^O_%7PSUKPK'I*
MZ%\7?`GA3Q3X?$_PU\-_`JU\)V&M>.=?^'%I)\2M"\-W5_X)\)VESXET6YNK
M;Q^-7.@^)_#%WI>N07*E7LH?9_VK/@EX8^&WP'^"&I^$/#'@^*WTCXF?&[X<
M:W\3=&\5>"-=\0_%W^PM,^$]_I7C+6%\-^+=>G.F7FN:EXXE\):-!;H?!/@N
M?PWIWB1;+6-5234_37$V`]ODF%;7UC.J^)PU."G&"P]7"8;$UJT:JQ*P]9R]
MKAGAH4HT?;2JR<O9JG"<EYKX=QOL,YQ*3]AD]'#5YR<'-UZ>+Q.&HT94W0=>
MDH.EB5B9U76=*%./*ZCG.$9?O3_P;Y?\FI_%S_LX76/_`%6WPYK[>_X*M_\`
M*//]J;_LG47_`*E/AROB'_@WR_Y-3^+G_9PNL?\`JMOAS7V]_P`%6_\`E'G^
MU-_V3J+_`-2GPY7\(\5_\I#/_LO^'O\`U-RL_MOAC_DPO_=CYY_ZAY@?P:/]
M]O\`>;^9IM.?[[?[S?S--K_1".R]%^1_`H4444P"OZ!_^#>?_DX+]H3_`+(U
MX6_]3QZ_GXK^@?\`X-Y_^3@OVA/^R->%O_4\>ORWQK_Y-;QA_P!@.$_]6N7G
MZ9X.?\G-X1_[#L3_`.JS'']6/BS_`)%?Q'_V`=9_]-MU7^:)'_JHO^N47_HM
M:_TN_%G_`"*_B/\`[`.L_P#IMNJ_S1(_]5%_URB_]%K7XC]$_P#A<=?]?.'/
M_2<[/V+Z47\?@G_KWQ'_`.E9"/HHHK^P#^40HHHH`_03_@E7_P`I"/V7O^QV
M\0?^JV\<U_>DGW%_W5_D*_@M_P""5?\`RD(_9>_[';Q!_P"JV\<U_>DGW%_W
M5_D*_A'Z4W_);Y%_V2N'_P#5OFY_;/T9O^2.SO\`[*?$_P#JIR<=1117\RG]
M'A1110`4444`%%%%`!1110!^('_!2?\`Y22?\$*?^SK?VH/_`%CGX@U^5'_!
M?G_D\OX?_P#9N?@[_P!3WXEU^J/_``4NE,'_``4>_P""%DJPS7!3]JS]I\B&
MW1'F?/['?Q`7Y5>2)2%SN<F0;45F`8@*?RD_X+W7+77[8W@&1K2\LR/V=O""
M>5>Q112D+X]^)1WA8I[A2ASMR7!WJZ[<*&;][^C=_P`G,P__`&)LU_\`2:!^
M&_2&_P"3<XC_`+&V5_\`IV9^(]%%%?Z&G\$A1110`Y/OK_O+_,5_?;_P3,_Y
M,%_9/_[(QX4_]%W%?P))]]?]Y?YBO[U?^":NJRV_[!?[*<2Z1K%P$^#7A51-
M!;VK0R8CN/FC:2^C=E/4$QJ=N#@$X'\P?2G_`.20X>_[*-?^JS''])_1E_Y*
MO/O^R>G_`.K++S\\/^#AK_D@/[/_`/V7#4?_`%6OBFOY9?#GC_QQX0TGQ=H7
MA7Q=XD\.:+X]T9/#WC32M%UF_P!-L/$^BQWUIJ*:=K-M:3Q17<`NK&W)9E$S
M6IN=.>5M-O\`4+.Z_J*_X.#+^2\^`?P"5].U&R"_&[46#WL,$4;_`/%M_%*[
M4:*ZN"6YR`5485^<J,_RCU]7]'NE2K^%644ZU*G6I_VAFL^2K"-2'/2S2K4I
MRY9IKFIU(1J0E:\)QC.+4DFOE_'JK5H^)N;3HU*E*?U'+(<].<H2Y*F54*=2
M/-%I\M2G*4)QO:4)2C).+:?IFJ_&KXQZ[X:/@O7/BS\2]9\'G3=,T?\`X175
MO'7B?4?#O]D:*MLFBZ2-&O-3FT\:9HZ6=FFDV`MQ:::EK;)90P)!$J5]1^+_
M`,6]8O\`PWJNK?%7XF:IJO@UVE\(:GJ/C_Q=>ZCX5F9$C>?PY?7.L2W6BW$L
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M9.=24G*,JKK23<FVU*LW5DGHZK=1WFVS^N__`(-\O^34_BY_V<+K'_JMOAS7
MV]_P5;_Y1Y_M3?\`9.HO_4I\.5\'_P#!O_J$EI^RM\6D33=2O0W[06L.9+."
M"2)3_P`*X^'2[&>6[@8.,;BH0@*R'<2Q"_;/_!5+5);C_@GS^U'$VD:O;*_P
M\B4SW%O:K!'_`,51X=.9'COI74<?PQL>O'%?YY\5_P#*0S_[+_A[_P!3<K/[
MVX83_P"("K_LAL\?R6#S#_)G\);_`'V_WF_F:;3G^^W^\W\S3:_T0CLO1?D?
MP*%%%%,`K^@?_@WG_P"3@OVA/^R->%O_`%/'K^?BOW[_`.#?.Z:T^/W[04B6
M=Y>EO@YX74QV444KICQVYW.)9[=0IZ`AF/!XX&?RWQL=O"SC%_\`4#A/_5KE
MY^F>#G_)S>$?^P[$_P#JLQQ_5[XL_P"17\1_]@'6?_3;=5_FB1_ZJ+_KE%_Z
M+6O])[Q3K4S>&?$2G0M=4'0M8&?LMF0,Z;<^FH_EZG`[YK_-AC_U47_7*+_T
M6M?B/T3_`.%QU_U\X<_])SL_8OI1?Q^"?.GQ'_Z5D0^BBBO[`/Y1"BBB@#]!
M/^"5?_*0C]E[_L=O$'_JMO'-?WI)]Q?]U?Y"OX*/^"64I@_X*!_LPRK#-<%/
M&OB`B&W57F?_`(MOXX&$5WB0XSN;=(N$5B,D`'^\C3[U[Q7#V%_8^6L>/MT4
M,7F;@V?+$-S<9*;?G#;<;EQNR<?PC]*;_DM\B_[)7#_^K?-S^V?HS?\`)'9W
M_P!E/B/_`%4Y.:-%%%?S*?T>%%%%`!1110`4444`%%%%`'X@?\%)_P#E))_P
M0I_[.M_:@_\`6.?B#7Y4?\%^?^3R_A__`-FY^#O_`%/?B77ZK_\`!2?_`)22
M?\$*?^SK?VH/_6.?B#7Y4?\`!?G_`)/+^'__`&;GX._]3WXEU^]_1N_Y.9A_
M^Q-FO_I-`_#?I#?\FYQ'_8VRO_T[,_#VBBBO]#3^"0HHHH`<GWU_WE_F*_OM
M_P""9G_)@O[)_P#V1CPI_P"B[BOX$D^^O^\O\Q7]]O\`P3,_Y,%_9/\`^R,>
M%/\`T7<5_,'TI_\`DC^'O^RC7_JMQQ_2?T9?^2KS[_LGI_\`JRR\_-C_`(.&
MO^2`_L__`/9<-1_]5KXIK^3>OZR/^#AK_D@/[/\`_P!EPU'_`-5KXIK^3>OK
M_H[_`/)K<G_[#LX_]6-<^4\?O^3EYM_V!Y3_`.JW#!1117[@?BX4444`?UW_
M`/!OE_R:G\7/^SA=8_\`5;?#FOM[_@JW_P`H\_VIO^R=1?\`J4^'*^(?^#?+
M_DU/XN?]G"ZQ_P"JV^'-?;W_``5;_P"4>?[4W_9.HO\`U*?#E?YW<5_\I#/_
M`++_`(>_]3<K/[ZX8_Y,+_W8^>?^H>8'\&C_`'V_WF_F:;3G^^W^\W\S3:_T
M0CLO1?D?P*%%%%,`K^@?_@WG_P"3@OVA/^R->%O_`%/'K^?BOZ!_^#>?_DX+
M]H3_`+(UX6_]3QZ_+?&O_DUO&'_8#A/_`%:Y>?IG@Y_R<WA'_L.Q/_JLQQ_5
MCXL_Y%?Q'_V`=9_]-MU7^:)'_JHO^N47_HM:_P!+OQ9_R*_B/_L`ZS_Z;;JO
M\T2/_51?]<HO_1:U^(_1/_A<=?\`7SAS_P!)SL_8OI1?Q^"?^O?$?_I60CZ*
M**_L`_E$****`/T$_P""5?\`RD(_9>_[';Q!_P"JV\<U_>DGW%_W5_D*_@M_
MX)5_\I"/V7O^QV\0?^JV\<U_>DGW%_W5_D*_A'Z4W_);Y%_V2N'_`/5OFY_;
M/T9O^2.SO_LI\3_ZJ<G'4445_,I_1X4444`%%%%`!1110`4444`?B!_P4G_Y
M22?\$*?^SK?VH/\`UCGX@U^5'_!?G_D\OX?_`/9N?@[_`-3WXEU^J_\`P4G_
M`.4DG_!"G_LZW]J#_P!8Y^(-?E1_P7Y_Y/+^'_\`V;GX._\`4]^)=?O?T;O^
M3F8?_L39K_Z30/PWZ0W_`";G$?\`8VRO_P!.S/P]HHHK_0T_@D****`')]]?
M]Y?YBO[[?^"9G_)@O[)__9&/"G_HNXK^!)/OK_O+_,5_?;_P3,_Y,%_9/_[(
MQX4_]%W%?S!]*?\`Y(_A[_LHU_ZK<<?TG]&7_DJ\^_[)Z?\`ZLLO/S8_X.&O
M^2`_L_\`_9<-1_\`5:^*:_DWK^LC_@X:_P"2`_L__P#9<-1_]5KXIK^3>OK_
M`*.__)K<G_[#LX_]6-<^4\?O^3EYM_V!Y3_ZK<,%%%%?N!^+A1110!_7?_P;
MY?\`)J?Q<_[.%UC_`-5M\.:^WO\`@JW_`,H\_P!J;_LG47_J4^'*^(?^#?+_
M`)-3^+G_`&<+K'_JMOAS7V]_P5;_`.4>?[4W_9.HO_4I\.5_G=Q7_P`I#/\`
M[+_A[_U-RL_OKAC_`),+_P!V/GG_`*AY@?P:/]]O]YOYFFTY_OM_O-_,TVO]
M$([+T7Y'\"A1113`*_H'_P"#>?\`Y."_:$_[(UX6_P#4\>OY^*_H'_X-Y_\`
MDX+]H3_LC7A;_P!3QZ_+?&O_`)-;QA_V`X3_`-6N7GZ9X.?\G-X1_P"P[$_^
MJS'']6/BS_D5_$?_`&`=9_\`3;=5_FB1_P"JB_ZY1?\`HM:_TN_%G_(K^(_^
MP#K/_IMNJ_S1(_\`51?]<HO_`$6M?B/T3_X7'7_7SAS_`-)SL_8OI1?Q^"?^
MO?$?_I60CZ***_L`_E$****`/T$_X)5_\I"/V7O^QV\0?^JV\<U_>DGW%_W5
M_D*_@M_X)5_\I"/V7O\`L=O$'_JMO'-?WI)]Q?\`=7^0K^$?I3?\EOD7_9*X
M?_U;YN?VS]&;_DCL[_[*?$_^JG)QU%%%?S*?T>%%%%`!1110`4444`%%%%`'
MX;_\%,[VST[_`(*-?\$+[W4+NTL+.W_:J_:@DN+N^NK>SM84/['?C]`TMS=2
M101AG9(TWR*7D=(DW2.BM^37_!>WQ!H&H_MB>`+G3]>T*^@'[.WA"-I;36])
MN8UD3Q[\2MT;O!>2*C@,K;&(?8R/MV.C-_4W^TE^Q[^RY^V%H'A[PM^U#\!/
MA9\>-`\):O<:]X8TSXG^$-,\56_A_6+NS^P7FH:/]OB:73[F[L@MK=O;2QBY
MACB2=9!#%L^._P#AQW_P2*/_`#CM_9/_`/#2:&/Y5]YX<<;R\/N):?$4<L6;
M.G@\7A/J;QCP*E]:4%[3VZPN+:Y.2_)['WK_`!1MK\/X@\&1X\X=J9!+,7E:
MGB\+BOK2PGUVWU:4I<GL/K.$OSMKWO;+EM\,KZ?PX?VEIO\`T$],_P#!E8?_
M`"31_:6F_P#03TS_`,&5A_\`)-?W'_\`#CO_`()%?]([?V3_`/PTNB4C?\$.
M_P#@D6`<?\$[?V3R<'`_X5+HG7''0Y_*OZ$_XFPK?]$)3_\`$EE_\X?ZN_*W
MX-_Q*[3_`.BVG_XCB_\`G[_5WY6_AQ_M/3/^@GIG'7_B9V'_`,DT?VEIO_03
MTS_P96'_`,DU_7S^S_\`\$2_^"9]]XS_`&K(O'7_``3J_9V31]._:3NK#X8?
M\)#\';:&Q/P\3X%?`>ZC;PB^H*L5SX9D\;7?C=Q/IK2Z=_PD/_"0P1.ES!=P
MQ?2W_#CO_@D5_P!([?V3_P#PTNB4?\385O\`HA*?_B2R_P#G#_5WY6/^)7:?
M_1;3_P#$<7_S]_J[\K?PY)J6F[U_XF>F?>7_`)B=AZC_`*>:_O2_X)J^-O!M
ME^P9^RI;7?BSPQ;W$/P:\*)+!+XBT5)8G\J<E)(VOPR,`1E6`93E6`8$#SK_
M`(<=_P#!(K_I';^R?_X:71*7_AQW_P`$BO\`I';^R=_X:30Z_,?%+QIJ>)>4
M9?E4N'(Y,L!F*S#VZS9Y@ZML-7P_LO9O+<%R7]MS\_M)_#R\FMU^D>&G@_#P
MZS7'YG'B"6;O&Y>\![!Y6L`J5\3A\1[7VBS'&<[_`'')R<D/CYN;W>5_$O\`
MP<%^*_"^J?`3X!IIWB7P[?/%\;M0DDCM->TBXD1&^&_BE0[1Q7KNJ;L*7*[0
MQ4$@NH/\I/\`:6F_]!/3/_!E8?\`R37]R!_X(=_\$BC_`,X[?V3O_#2:&/Y4
MG_#CO_@D5_TCM_9/_P##2Z)7K^'GC]4X"X7P?#4>%89JL)7QE;ZX\Z>"=3ZW
MB9XCE^KK*<7R^SY^3F]O+FMS6C>R\KC[P,AQSQ+B^(I<3RRQXJCA*/U-9,L8
MH?5<-2P_-[?^U<+S>T]GS6]C'EYN6\FN9_PX?VEIO_03TS_P96'_`,DT?VGI
MG_03TS_P9V'_`,D^QK^X_P#X<=_\$BO^D=O[)_\`X:71*^8M*_X(F?\`!-)O
MVQ_'.E77_!.K]G?_`(5)%^S3\++_`$5YO@[;CP6/B)/\6/C+:^)AI]TRC2'\
M3MX7M_"#ZO;QROJ,6DKH<DL<5G-;F7[?_B;"M_T0E/\`\267_P`X?ZN_*WQG
M_$KM/_HMI_\`B.+_`.?O]7?E;^0W^TM-_P"@GIG_`(,K#_Y)H_M+3?\`H)Z9
M_P"#*P_^2:_N/_X<=_\`!(K_`*1V_LG_`/AI=$H_X<=_\$BO^D=O[)__`(:7
M1*/^)L*W_1"4_P#Q)9?_`#A_J[\K'_$KM/\`Z+:?_B.+_P"?O]7?E;Y,_P""
M`/BWPKI?[*WQ9BU'Q-X<LI9/V@M8D2*ZU_1X)6C'PX^'*^8(I;Y9/++`JK[=
MC,KJK$QN%^U_^"J/C7P=??\`!/O]J*UL_%GABYN9OAY&D4$/B'19)9&'B?P\
MQ6.-;XNYVJQPH).,`$D`\Y_PX[_X)%#_`)QV_LG?^&DT,_SH_P"''?\`P2*_
MZ1V_LG?^&DT.OYYS7C669^(/^OG]FJA+^W\OSS^R_K?M%?`5L+66&^N_5H:5
M?JW+[;ZI[G/?V4^6TOWO+.#8Y;P'_J1_:+K+^P\=DW]I_553=L;1Q%'ZS]3^
ML37[OV_-['ZU[_);VL.:\?X<7U+3=[?\3/3/O-_S$K#U/_3S3?[2TW_H)Z9_
MX,K#_P"2:_N/_P"''?\`P2*_Z1V_LG_^&ET2C_AQW_P2*_Z1V_LG_P#AI=$K
M^A5]+"JO^:$IZ?\`52R\O^I#_5WY6_!?^)7:?_1;2_\`$<7_`,_?ZOZ6_AP_
MM/3/^@GIG/3_`(F=A_\`)-']I:;_`-!/3/\`P96'_P`DU_8+\:/^")7_``3)
MM/B=^R3:^#_^"=7[.3>&]3^//BFU^*;Z)\'K672U\#P_LP?M#WVF#QA)9J]I
M:^'F^)-KX!:UGU0Q6C>*X_#-M#+]NN+6"X^BO^''?_!(K_I';^R?_P"&ET2G
M_P`385O^B$I_^)++_P"</]7?E9?\2NT_^BVG_P"(XO\`Y^_U=^5OX</[2TW_
M`*">F?\`@RL/_DFOWZ_X-]?$GAW2_C]^T#-J/B#0;&*3X.^%HXWN];TJW61Q
MXZD<HAFO$#,%!)"Y(!&?O+G]E?\`AQW_`,$BO^D=O[)__AI=$H_X<=_\$BA_
MSCM_9/\`_#2:&?YU\MQI](NKQAPOG'#3X1AEZS:A2H/&K/7BG0]EBL/B>;ZO
M_8^&]KS.AR<OMZ=N=RN^51?TW!WT?X<)<393Q&N*Y8]Y57JUE@WDBPJK^TPU
M?#<KK_VMB/9V]LYW5&=W'ELD[K]"?%/CWP/)X:\0HOC+PF6?0]750?$NAJ"S
M:=<J!EM0"CDC))`'4D`$U_FR1ZEIOE1?\3+3/]5'_P`Q*P_N+_T\U_<G_P`.
M//\`@D7_`-([?V3O_#2:%2?\.._^"17_`$CM_9/_`/#2Z)7Q7A3XM3\,(9Y"
M.0QSK^VI9=)N69O+OJW]GK&JR2R_'>V]M]<U=Z7)[/[?/>/V'B?X5P\29Y+.
M6>/)_P"QXYC%)9:LP^L?7W@6W?Z_@O9>R^I)?\O.?VCUAR>]_#A_:6F_]!/3
M/_!E8?\`R30=3TP<G4],`]3J=A_\DU_<?_PX[_X)%?\`2.W]D_\`\-+HE?,/
M[9__``1+_P"":>E?LN?&W4/A!_P3J_9X?XEVO@>^E\&CP3\';:Z\5_VU]KLE
M@.A6^CK)J,U^L33/$EI')*55_E9`ZG]>_P")L*W_`$0E/_Q)9?\`SA_J[\K?
ME/\`Q*[3_P"BVG_XCB_^?O\`5WY6_D._M+3?^@GIG_@RL/\`Y)H_M+3?^@GI
MG_@RL/\`Y)K^XU/^"'?_``2+(.?^"=G[)X.YQS\)=%Z!V"GDD\J`1VP?E`&!
M3O\`AQW_`,$BO^D=O[)__AI=$H_XFPK?]$)3_P#$EE_\X?ZN_*Q_Q*[3_P"B
MVG_XCB_^?O\`5WY6_EN_X)9ZWHMI_P`%`OV8[FZUG1K:WA\:>('FGN-7TR&&
M-?\`A6_C@9>66[1%RQ"J"P+NRHH+LJG^\[1_$&A:XLHT76=)U<VJQ?:?[+U.
MQU'R/-#^5YWV*XG\H2>7)Y9DVA]C[-VUL?F%_P`.._\`@D5_TCM_9/\`_#2Z
M'7U1^S-^PS^R!^QI)XSF_98_9R^$GP$E^(::!'XXD^%_A#3_``L_BF/PJVLO
MX<36VLAF^716\0ZVVG+*<6S:K?&,`W#Y_"O%'Q%EXEYW@,YEE"R9X+*J>6?5
MUCWF'M?9XO&8KV_M7@\%R7^M>S]G[.5O9\W.^;EC^U^&GA_'PZR?&Y3'-GF_
MUS,ZF9?6'@5@/9NIA,'A?8^R6+QG/;ZHJGM/:1NZCCR+EN_JZBBBOS0_1@HH
MHH`****`"BBB@`HHHH`****`"BOS2^.?[8_Q:\&Z[^UAKOPR\&?#W5_AE^PG
MX2T+Q;\<K7QEJ7B2T\;_`!&FN/AA;?'7Q?X8^%]UHS?V#X2O/"?P?U+0]7TC
M6_%MAXFL/&OC/6O^$0FL?!VFZ5=>+9^LU[]I+X[>$OC?\$]"UWP=\*K[X:_M
M"_%KQ'\.?AWX,\->(/$6I?'"W^'_`(?\#>(?%\O[1.M2SBV\)GP5:MH6G+XN
M\&PZ):S^!M*\;^#SJ'Q`U+QMJEIX"O@#]`:*\!\9^+?CYH'CWQ`?"WPO\/>.
M/AE9_">PU+PZMOXJL_#GC;6OC+=^-Y]+F\-7MWKMXGA[2/!%CX-DL?$%]KAL
MKS5HIH]1@TZRUB\6QT:[^"/"O[<7[07Q+_8^_9$^-WAKP?X*\-_$;]H+7O%=
MEXW@T;X4?'/]HCPKX1M?"6A?%/4)K+PMX,^&>H^%?'VMW6MZEX'TRQTO6_$>
MK>&](M;2?4KS4K:&\ET_2E`/UUHKR7X%?$.T^*WPD\"^/;3Q7X;\;-KVB(VH
M^)/"7ASQ+X-T&^U[3KJZT?Q)!:>#O&=_J?C#P?/I?B#3M3TC4O"7BR^G\3>&
M=5T^^T/7RFJV%W%'ZU0`445\D_'/XR?$W2OB]\)OV=_@C8^`5^)'Q+\$?%CX
MKZAXJ^)T?B/4/"'A'X=_!_5/AGX9U=E\.^%+[1-:\3>)?$GB_P"+W@S1])L8
M_$>AV&DZ1%XE\1W]U?3Z7IGA_6P#ZVHK\EO%7[<_[0`_9OD_:A\-_#3X.Z#X
M0^'OASQ9:>/_``9XN\;^*-7\7?%7X^?#SXP^//@AXN_9S^!MSX?TO35LM:UC
MQU\/GT3X5>-O$VA>(I_B5KWCKP=H%I\/-+E@UN^A_1CQKJ_Q3AU'X1'X?>&?
M#]_H^L_$2*T^,+>)[Z>TU+PI\,F^'WCS4I=6\,Q:?=?9]1\61?$2Q^'WA]K*
MX:[TXZ/K.O7BAY+.WN8@#U&BOS\^"?[9/BCQ#<_MMWO[07@'0O@OI'[*'Q/\
M,>%XM*TOQ++X]\12^$_$G[.WP@^-=BWB6ZTBV&CZG\0]0O?B6^B6WA/P`-=T
MY]1?2?#&@ZUXMU1_[4U#JOV)OVC?B;^T3I/[0DGQ7\#^&OA]XC^#_P"T[\1?
M@S8>'O#>HZCJS6_A?0?#/P^\8>&AXFU&^DDM;KQO9Z;X\CTCQB^@A/#7]O:9
M>#0/.TT07=P`?;-%%%`!17PI^T?^U/\`$#]G_P"*OA;P"WP[L/%>F_'OPNW@
MW]F;4K&36H7US]JC3KW4[VY^$/Q&NXH;O3_#_AWQ#\.Y6^*VA^+;9;==+\&?
M"#XZR:PDU_I7A.VU;XH_:!_;<_;9^`FO?MOI<O\`LK>*]#_91^!7P+^+^A6]
MO\.?C)HNJ^*[O]HOQ?\`&/P7X6T;6;Z7XRZK9Z?:^![OX6P:MKUWI^G3S>+K
M369;#38?"<]FMY,`?N%17QI\'_CC\4X?CSXE_9D^/%I\/=2\>6GPHT;XV>#/
MB!\*+'Q1H/A+Q9X/N/%][X`\5Z)JO@OQAK7BK6?"/B;P=XGAT6:.9?&7B32?
M%6A^*[*ZLFTJ^T/5[%O)_P!J']J7]IO]FG]G[4OBGJ7P5^'^NZ_;?M!_\(=<
M7'_":W.G^#_#OP3\2_M0^'/A-\,O%.HV<<NH>+/$'Q&\8?#+Q?H'B`>'-%@L
M?#6F>*QJZZ_KOA_2K.QTW50#](Z*_.#XX?M4_$[X;_M%WOA&;6_`WPX^!?@[
M3_@S>^+O&GC']GK]H'XDQ7B_$/Q%XGL=;O+[XM^!/$_AKX4?"70[6'2-+\/Z
M=K'C.V\10Z1KM[=Z]XLBL/"]M&\GZ/`@C(.>2/Q!((^H((/N#0`M%%?*7[6G
M[0NI?LM>#O#/QLUO2]+N_@/X4\66T7[27B&2+5KCQ#\,_A7K%A>:5%\6=%L=
M,>8ZQHW@/QG<^&;WXC:8=.N[VV^'%YXF\5:46O/"O]FZJ`?5M%?E!XK_`&DO
MVV[/XZ?L:>`;?1OV??A[H/[65Q\5+Z^\(^//`?Q2\0_$GX5:1\-_"-[\3;?1
M-=U70_BMX;\-:MXQU3P=)H^A:];0:)9:9X2\9?VN;>?Q3I=I;Q3Y7[+/[</[
M0/CWP)^QM\7_`(W^'_@PWPZ_;9\0W/@SPK9_"^R\?:'XJ^$OC#4_!7Q#^('@
MG3O$Z^+-?\6Z9\0]"UK2_A?XD\/:SXBT4>![W0O$=[X<N8O#6J:%>ZO>:(`?
MKI17SMXK\8_M"Z!K_P`7I]`^%7A/QQX2TGPE\*YO@M;P>-8?".L>*O&VNZIX
MTLOBE;^/M8UK[=IWACP=X)L+?P'KEOJFD:'J^OWFF7GB>+2]"\2ZU;:5H\WR
M)#^WGXTO/^"<_P`%/VHK#P;X-O/VA?CS^RW9?&3P9\,UO]?7X?VOB\?!.X^+
M7BJ_UK456;Q39_"CP%9VES=Z[J[I%K-]%)H/A6PEC\8^+_#]K.`?J)17D?P`
M^(FH?%[X%_!GXK:OI]II.J_$SX4?#CX@:EI=@;@V.FZAXT\&:)XFO;"S-W)+
M=&TL[K5);:V-Q+).8(HS+(\A9SZY0`4444`%%%%`!1110`4444`%%%%`!111
M0!\"_M-?L7-\6-3\2>*/AWXKU'PQ/\4I/!?A_P#:-^&%[K^HZ/\`"S]I/X:^
M&+75=%'A7Q]/H>B:KXO\,:DFB:M%IU[XB^']]H-_XZ\(Z+:_"WQ^^K^#+NW;
M0^L\&_L:6G@G]H/QI^T7I_[0OQ_U3Q)X^UL7FO>%/$C_``-U_P`*0>$+3S6T
M/X1^'-3O_@=)\3/"'PC\.SS/J.E>"_"OQ$T>&77)+CQ%K-YJ_B&^O]5N_LZB
M@#E?&OAS4O%GA;6/#ND^-?%7P\U+4[>."U\:>"H_"DOBG09([F"<WFCQ>-_"
MWC/PH]S(D+VLBZSX7U>U^SW$^RV2X\B>'XU^#W[!>E?`SX->"_@IX`_:;_:I
MLM#^&^MWFJ^`?$,WB[X61>(_#>GZK#K"ZSX5N[/2_@WIO@CQWX9U2\UR^U8V
M?Q.\&^-K_1]9%GJGAO4]$N]-L'M_O2B@#SGX3?"WPK\&/`.A_#KP8NJG1=%?
M6+V2^U[6+[Q!X@US7O$VO:IXL\6^*/$6N:E))>:OXC\6>+==USQ/X@U&4H+O
M6-7O9HH+:!HK:+T:BB@`KYI_:*_9ZN/C+9Z3XG\#?$7Q9\%OCIX"T'QYI7PI
M^,/@UM*N[_PR/'NDZ?:Z[HGB'PSXCTK7O"_C3P-KNI^'O"&K:_X9UK1Y9&U'
MPGH&M:#J.A^(='T[58/I:B@#\TM)_P""=6ES'X&>)(_C3\9?@[XB^"G@&;P[
MX7\$?"SQ#\,_B'\,/#/C+7M7\0:WXY^*NC#]HOX%?$GQ)JWQ?\;77B34;;Q)
M\7=9>W\::A8W&H0V;Z-_;_B;^V_TGCB9($A:>65TB6,W,@A$\C+&$,[B.&.`
M2N<R,$@2+>2%B6/"":B@#X'\&?\`!/CX=:-XA^/&J?$WXI?%G]I+PW^TIK7A
MOQ5\8/AE\?=+^`?B+X;^*/&'@KPY\-O"/@KQ9_87@[X&>!+_`$_5_"7A[X3>
M";+1(+'6(=$CO=+'B&[TB\\3M'K4/IO[+_[%W[/O['9^,"_`3P7:^#+?XV_$
MZ]^*OC&RM(=.@LH-:NM%TC0K;1="@T_3M/&G^%-'M=)>?1-&F:]?3[S5];F6
M\D6_\N+ZKHH`****`/(OB=\%?"/Q9\1_!#Q1XGN==@U'X`_%MOC1X(31M0AL
M;2Z\6M\+OB;\(S;^(X9;*[;4]#_X1?XK^)I_L$$MA-_;$&D7OVWR;.:SN_#O
MC5^PO\'OCK'^TR/%FL?$+2Y_VJ_A1\'?@_\`$.\\,^(-*L+C1O#OP-\0_$;Q
M/X&U/P4NH^'=7M=)\0IJ_P`3M?FU>[U6VU[3]2BM=(@.E0QVMR+W[.HH`^=_
MA#^SCH/PK\7^,/B5JWCOXC_&'XK>-M%\-^%-9^)OQ8U'PK=^(X?!7A&XU?4/
M#W@O0=(\!>#OA_X$\+^'++6O$7B#7KNW\/>$-.OM>UK59-1\1ZAJ\UEI`TW!
M_:S_`&5M(_:[^'EM\+O%/Q:^+_PR\(?VWH&OZU9_"2Z^&MA=>*+_`,)>+?"_
MCKPG_;5_X_\`AE\1+JWA\.^*_".DZO91^'GT(WK&[LM;?5=-N/L<?U-10!\@
M>,?V/M(^(EK%I'C[XY_M$>+O"NK>'_#'AWXG>"]2\;^&++PA\9+3PO>2W23>
M-="T'P)I%OX:?Q%'*-/\<V/P:?X5:+X[TF--+\6:5JMD9(Y/KX`*,#U)_%B6
M)_$DG\>*6B@`KQ[]H'X(^#_VDO@I\4/@+X_N=?L_!7Q;\%:[X#\3W7A;48=)
M\16^B^(+1K.^ET;4[FRU*"QU!(F)MKF:PNXXG^9K>0?+7L-%`'BOCCX#>"OB
M!\7?@;\:M<N?$$7B_P#9^O/B/?>!H-.U&WMM#N9OBCX,_P"$%\2#Q%826%Q/
MJ4<.C?O-*6WO=/-G?_Z1*UU'^XKYX_9^_P""?OPV_9^B^#VF6GQ2^.7Q0\*?
ML\6VN1_`?P1\4O$W@J[\)_"R]U_2-6\-76NZ/I_@/X>>`+KQ-XEL_"7B+Q/X
M2T3Q'\1;_P`::QH&@>)_$=KH]U9W&M7]W+]XT4`<3\0_".J>.?".J^%]&^('
MC/X7:AJ8M%A\;?#Z+P7+XLTA+>\@N9TTQ/B#X.\?>$R-0MXI=-O#J7A74G2R
MN[AK!K*_%M?6_P`,Z+_P2X_9A;]F_P`'?LP_%.SUW]HCP5\,?AYJWPG^$7BG
MXXZ3\+=?^)/PC^'>K>#_``[X+E\,>`O%GA3X9^"ULX8+#PKH>I+JFL:9K>O7
MVN:=8:AK6JZJNF:5;V/Z.44`>6?!#X->!/V>?A%\.?@A\,=+.C^`?A;X/T/P
M5X6L'^SFX32M"L8K**YOI+6VL[>XU/4)(Y=1U:[BM+9+W5+N\N_(B,Y1?4Z*
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBO@'X[?\%-_V//V;OB;KGP@^+?Q"US0/'?AVST2^U72[+X=^
M/-?MX+;Q#I<&L:4Z:KH>@WVFSF>PN(972&Y=X&8Q3!)591ZF4Y)G&?XF>"R/
M*LPS?%PHRQ$\+EN$KXVO##PG3ISKRI8>%2<:4*E6E"51Q48RJ0BVG)7\S-<Y
MRC(\-'&9SF>`RK"SK1P\,3F.+H8.A.O.,YPHQJXB=.$JLH4ZDXP4G)QA-I-1
M=OOZBORML/\`@L__`,$^]3O[#3+/XL>)I+S4[^QTRSC;X2_%"-9+S4;R"QM(
MVDD\+K'&LEQ<1(TDC+'&&+R,J*Q'ZI`@]/4C\0<']16V<<-\0<//#QS[),UR
M9XM57A5FF`Q.!>(5'V?MG16)I4W45+VU+VG)?D]I#FMS*^.4<19#GZKO(\YR
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M9>^,WP!UN[N_C1:_M`W_`(G\+ZS\&/CE\5K+QAX8\.^&](^$&C:[I?[15M=^
M(O`VHRZWK?@RT\#:WXC\)>([C2/?X?\`@IU\&)-'\,ZA/\.OC9IVI?$S0_@]
MXK^!?AO5?#W@?3-6^.G@SXY>+%\&>`O&7@N[N?B*/#?A71)M8GTR7Q%!\8-?
M^&NN^$-/\1>%9O$6CV-WXFT:PNNCT_\`X)]_!/5/&FB^/?'OCWXQ?&CXG^"O
M&7PQ\1VWC7XE?$>SUKQ!9P?"O_A.M7\%^![W3/#_`(>\-^'(/!WVOXI>*=;U
MK1!X<M;[Q7/J.F7&OZGJ5II&B0V?A?QI_P""5_@_6OAKHWA#X0^)=9D/AR]^
M'_AZR\._%OQUXSU[2X_@/\,!XEU3P3^SMX+\86$>IZY\,/`^@^.-5\+^,WU?
M_A'/B%KOB*/P!X;\*^*SK6F6&@7GA@`T]`_X+"_LO75O\,E\5O>^$-7^(FA^
M&O&%_I%YXO\`A<;[X?>$/'_Q8\:_";X?7GB33=9\<>&O$GC+7=6UGP-K5QXD
MT#X&^'/B\G@ZTL+S5;K5M3\*3>'/%/B;T&7]O9/BC;>)OA[\`O`WB'1/C7XJ
MTO\`:Z\,?LZZK\;M#TJR^$?Q%^,_[(7Q`UCX4?$GPG>3>%O'TGBR/2-'\::=
M%?KJ=Y:^&M*\2^%#?W7A[Q%)J6DZI96>G\)_V$K+0[;P5XI^)GQ%\87_`,4M
M&LM+\/>*]4^'7B2[\%:#XT^'G@?QWXI\8?!7X7^,18:9INI^*M'^#5AXGO/"
M&C^*;=/!WB;QCH+7^G>,/MN@ZE)X>A]+\"?L;_`7P3XP^&OB?PR_B&3Q#\"_
M&W[4GC'PY%-XQEOTT[Q)^V5XSO\`XI?%^/7[!8U^T0WNL>(9;WPGI]TMLOAO
M2)[2WT\36HAD8`D\,_MF_#SQ9^TGXM_9BT;PQXVF\8>!M;;PWXEUZZ/@/2M*
MLM63P!IOQ%%W%X/U7Q[:?&2]\%WFC:O8Z?I?Q3L/A?=_"W4_%#7'A:S\8RZO
M9SQB/7_VTOASH7[3EI^RJGA7Q[JGCZ2T\'7NH:I;Q^!M)T2PM?'4>J3Z+?Z7
MH_BOQWX<^(OQ!T2QBT:]_P"$O\2_"KP)X\\.^!)O+M?%^IZ3<0ZG'IFAXE_9
M-^%/B'XV>#OC3XP\3?$77-6\(^/S\1/A_P""?$GQ'U+4O`/A?XHMX*UKP<WB
M7P=H6J";5M%GD\):GX@63P7HGB"V^'TEW?:KXE?P2VNS7.K&U\4OV1?AG\8?
MB#X=\=>.-?\`B;J>G^'_`!1\.O':_#=OB'K$GPOO/''PE\0Z;XJ^'/BU/"EZ
MM[)X<U;P_P"(=%T74[H>!=5\):=XNFTNTC\<V'BB#SX9P#XI_9J_X*L:%\0/
MV>/A=X^^,WPT\7>$_BIXL_9C^%O[1MYI6F6O@3PCX`\:^&O&WBC1?A[XF\2?
M#SQ!\0?BW::?X8\'^"_'>O:38:Q<_&/Q'X%NX]$UK0M>TI]?T_5+>4]CI/\`
MP5[_`&4=8\.-XLM$\=S>&]*^&7QL^+?CCQ'9VO@;6/#7P]\&_L\?$4?"WXL7
M>O\`B30O'NJ:%KT^C^+[O0;+P]#\/-0\:KX]@\3Z'?>"Y-:M'U*73.PD_P""
M77[,2Z%\$='TZ3XG:+>?LY_"?P3\(O@YXETOXAWL/B/P=I?P\\=^'_B'X0\2
MQ7=QI]U8:KXRTGQ%X;M<:MKFF:E87EA<ZA8WVCW*7"/!T/A__@FI^ROHE]X_
MN[WPYXL\61?%+P5\=?`OC_3_`!GX[\0>(K7Q-H_[1WQ!\.?%#XKW=[-<S1ZG
M%K>M>-O#-CK&G:U9:A;7OAQY;B'0GL(OLBV8!Z)^SM^VK\$_VD_#/Q)\2>#]
M7ATE/A'?6]M\0['4?%7PS\60^&K2^\-1^+M.U6X\7?"+Q[\3/AU?6-QH/VNX
MNETKQE?7VBWFEZMI>NV>G7]BT,GQA\=O^"I6H:9\+/#6H?`3X$?$O5/BA\5]
M8_96E^$&G?$;2_ASING>)?A'^U5\:_#7P7\*_';2]%G^-OA0:SHVG:]XET33
MY/AOXD\8_#;Q[8Z]XS^'O_"=V7@;P?KNK>*]"_1OX5_`WPW\+_#/B#PT_B3Q
MU\1X_%=U)+X@U/XI^*'\8W^I6K:7#HL6D"V-GIN@6&D1Z3"MM-8:7H=BFJS3
MWVK:Z^K:WJ>HZG=_.F@_\$Y?V=M!LM!L/-^)>M1>#-<_9^NO`$GB7XD:WKUU
M\/O!W[,7Q:T+XU_!SX5>$KJ_1YK#X;Z!X[\.:-=ZII5VVH:[XMT[3=*TGQ3X
MEU>TT305TL`]!^-G[5^C_`+Q!\//A]KGP\^*7Q3^(WCSX6?%GXJ:?H'PG\.^
M%9KBY\._`=_AA!\3KIHO%7C_`$'3+"]MF^*>@WFA:&OB#4;G6REUHFD76IZV
MVF6VJ?.FK_\`!6G]F#3M&U3Q-9V_C+4?"<7Q%\$_"7PMXROKSX7>!/!WQ`^(
MGQ"^!_@_]I/PSX>\+^*/BE\3?`FBV43?`OQC:_$76=>\8WGA;P]H%EIU[X>U
M'4T\:WFA>&-7]A_:3_8XB_:-^./P2^)VH?$OQGX$T#X7?"']I/X7ZOI_PZUW
M6?!_C+Q!'\?M7^`=S-)9^,=*NO+TO2;+2/A#K>D:K83:7=:A=3>)=-UKP_JG
MA[7/#5GJ0='_`,$_?V=]+\-ZYX=\):;XG\!O>_&#P[\<_"6M^#_$KZ9K?PN\
M?^%/@/X)_9HT>Y^&TEU9:AIVB:%%\$_`VG^!;SPOJ>EZ]H.J:7JOB'^U;&\E
MU>1X0#PKXI_\%2/AW9?#W]G/QO\`L[>'+#]H74_CC\=O@K\*M<^'VA?$?X8Z
M'X^^''AWXJ^--2\#W/BC7M"U7QK;Q/):>(](OO#GA^[M]0G\%^(]:C6ZL_%L
MGAF6WUVX[&__`."H/[/^C?$OQS\)M:T;QMI_C3P/X5^)/CRXT2'4/A-KVN:C
MX)^#?B70-#^*?B)O"/A3XI>(/&OA#_A#](UY?''_``CWQ(\.>"_%OB7P?I6M
MW'A/0=9UW3GT!_<?&7[*WP7^*7PLT;X0WFJ^*)9OAGXK\">)="\?:7XZN+_X
MO^#_`(E_#K5['QOX1\67'CC5?[<U*?Q1I^I3QZJ;'Q/::EH]WIVJ2V%QH#Z!
M>16->1Z!_P`$S/V;/#UWX.>UN/BG=:%\/+;XHZ%X"\'ZE\3=9OO"/A7P)\:]
M9T#7OBO\.-/TF2!6N_"'CO4/#MK'K\>LW>J^(;K2KS5/#Z>(8]`OI-,4`]B\
M<_M@?"_P!^S4G[5FK:=XRU#X67EQX+?0FT'1K+5/$7B?0OB/\2/#WPY\`>*M
M`T=-6C6\T7QC)XL\.>+=$CEN[;5Y?"6KV=S<Z7::RTFBQ>/2?\%)/@YI_C@_
M#7Q+X$^+W@[QYHK_`!GN/B5X<\1Z-X(0_!_PY\`]#^!WC7XC>-?B'KND>/\`
M5_"T?A"U^&G[0GPW^)>AZMX4UWQ3-XC\-W]YI.E6,_CBU_X1-YOVA/V//`GC
M[]C_`,4_L@>!O'UO\-O"]QXL\)ZOH]QK.KW.HQ^`?#W@_P"-GA#X^WW@KPXN
MGZOH&K^&_#WA[PWHLWAWP#8V&IVH^''A:3PY_9C+HGA_3X*['PK^PG^S_I?B
MVW^(^HQ>*_B+XOU3PU\=_#WB[Q)X_P#&%QXNE^)VD_M'Z?\`!G1?'K>.XI+>
MWTW7XT\$_`7X5^!?"5O:6NG:5X8\$^'QHNEV/E7]W<3`'R9\>_\`@I_XET;P
MK\/-$^"7P`^)-K\8/BQ\1_V5O#GAO2/BSH_PZMX])^%7[57BOQ#H'@GXUIX9
MM?CGX9C\1V=ZW@KQ9X<@\!:CX[\$>,/"_C1-)B^)&G>%=%O;.ZU/B_A=_P`%
M>/[0UCQ#)XZ^$GC'Q!\)_!G[+-]^T3KOQH\%>&-%T&[OKVV_:7^+7[/Y\,VW
MP<N_BKXT\0Z+I<.H_#J.VD\5ZCXIN=&LYHM;\9>,+KP/X`MO[7M?LG1/^"=7
M[/VEGPE<7E]\5/%.K>`_&WP&\6>$=?\`%_Q.U[Q+KNAZ1^S+K'B+7O@G\.+?
M4;]6DF^'O@W5?%WB2^ETJ]6YUKQ/>:O/?^+_`!%KVH16EW;T/"G_``3=_9^\
M`P^%T^'^N_&?P%=>&O`/C+X8S:QX*^+_`(G\,^(/$7A'Q7\3?%_QEL-.\0Z]
MI!MM6EG\$?%#QSXE\6^"K[2;O1KRPEU*[T'6)->\*7NHZ!>@'TS\!_C;HOQ]
M^'EK\1=`T#6_#NFW>HZIIL-IK.J^`?$:73Z3(D4NH:-XH^%WC7X@_#_Q1HET
MSYLM8\,>,-6LY'CN;*Z:RU.ROK&U^2!_P4)\+Z+\6_'OP;NO!OQ'^)WCR+]H
MKXK_``0^'WA;X;^!/#.AW4U]\(OV:O@]^T1XDTS4]>\;?%^U\/ZKYGASXC7%
MUIOC>_N/`&EWM]L\'/X9L]0TVRUWQ=[!\,OV2?`WP-U6U\5>%?B'\2[`R^-O
M'OQ8^+-YK/C.+[+\9/&GBSX=^&_AQ_PD7Q.LK'3]#\+7$'A?PIX/\/RZ+:Z/
MH6@:9I^J:+;:])!)JESK%]J2:7^Q#\#-,^-`^/MG;^+#X];XO_$WXXB:3Q9>
M3:*WC?XN?`SP#^SWXME&D&'[.='E^'?PX\-1:9I0D\C3M:2^UJ*1Y[Z2-0#Y
MS\9?\%.?!OB/]GCXR_&O]F[P!\0OB3HG@+]G[Q;\3=)^*5]X0M7^#NA?$&/]
MEV7]I_P1X!^(\,'C'3/B'IK3^#]1\'GQ?JECX;3PIX=UCQ5H_@C4_&NE^,+_
M`.Q6?4V'_!3/X(Z%X-LO$'Q/MO%'AA]'^*EY\$/B%K]OHEFWA'P_XX\,_L.'
M]O+QIXG@/]OWFMO\.K#X46FHZ9IUTME>>)[OQE%!H*:!-;2IK#W?#W_!+_\`
M9K\)?#:X^#WAF_\`C#H7PNU/X/)\(/$7@72_BUXDLO#GBM(O@6/V;8?B'XHT
M^W$<6M_$M/@Y#I_A>;7[K_B4ZC>:'X=\6:MX<U#QAX=T77;'HM5_X)O_`+,N
MN^(H-:UW1O%^M:2NLP>)]0\!ZGXUU6Z^'NO>+9/V9];_`&/]>\5:]X4*+::G
MKGBW]GK6A\/_`!+/),EO=P:;8ZW8VNF^(9=7U350#P"X_P""C'C:3]HBT^&6
MM?"WQ-\&_".KM^P%;>'=-^)GP_TW6OB7J6K?M>?$K]K'PMJ5IJJ>#_C3-X4T
M'0GT#X%>%)=+UQ+W5_$'P^\0W/BK3O%W@7Q%<R6>GZ1VOA3_`(*N?`;Q=X.\
M&>++3X>_'#3)_BK\._V?_BA\%_#&N^&O!.F:_P#%OPE^TCXWL?AOX!O_``_+
M)\0W\/\`A9++QOJ-GHOBFY^*.N>`;#2(;W2]<M[O4=%UG2;R\](TK_@G3\"K
M+Q1HGC?6?$'QE\;>,=!U_P#9WUVR\2^.OBMKWBC5F7]ECQ+\5_$_P5T>YN+Z
M$+/HWAJ\^,WCB#4+<QK=^*8KV"\\3W^JZXMWK%[\_?&__@E'\/\`7/A7\'?!
M/P5UB_T.7X*_"/X3_L]6.A^._%/B6YTGQY\!_A#KX\9>'/`FM>*=$M;K6O#7
MB-_'6E^$/$]_\18/#OBR?4;/PS<>%M0\*W-CXBN-0TT`^_/V9/CQIO[3'P8\
M+_&C1]`O/"^E>+;_`,8V]AH6IZE8ZKJ^G0^%/''B3P7);ZW=:2LFB+K:77AR
MY&KVN@:EXA\/V=^)[;0O%?BO28[/Q#J/OE>`_LR?#7X@?"/X/>'/`7Q(\;6W
MCG7=#N=;2PN[*S2"Q\.^%+C5[N?P?X#L+TZ?I%WKUAX#\./IWA:R\1ZGI.F:
MIK=MIL5[>Z?:2OY*^_4`%%%%`!1110`4444`%%%%`!7\//\`P6E_Y2)?&+_L
M5?@__P"JYT>O[AJ_(;]K#_@CU\&_VM?CEXI^.WB[XK_%?PMK_BK3O"^FW>B^
M%XO!#Z+:Q>%=!M=`M)+8ZUX:U'43)<V]HD]SYUW(@G9O)6./"#]E\#N,LAX'
MXOQN;\0XBMAL#7R#%Y?3J4<-6Q4WB:V897B(1=.C&4U%TL+6;FURIQ2;O)'Y
M#XT\(9WQIPK@\JR"A2Q&,HY[A,=4A6Q%+#16'I8+,:$Y*I6E&+DJF)I)03NT
MV]HL_C'\$?\`([>"?^QU\'?^I/I-?Z5Z]#_O/_Z&U?@7I'_!OS^SUH^KZ3J\
M/QT^.<TVD:MI6KPQ2P?#412S:5J-MJ,44IC\'+)Y4LEJL<NQE<1LQ1E?##]]
M0,?F3^9)_K7T/CYXA\,<?5N%Y\-XK$8E973SB.,]O@\1A.1XQY6Z"C[>$/:<
MWU6MS<M^7E7-;F1X/@;P#Q)P-2XECQ#AJ&&>93RF6$5'%T,5SK"QS!5^;V$Y
M\G*\12MS6<KNR]UV6OD+_@H#X&\=?$K]AK]K[P'\+[GQK;?$GQ3^S9\:=)\`
M)\.;T:=XVU'QG/\`#W7V\,Z%X=O?L]Q);W_B+6([/0`UJ(+YH=3FCT^]TZ_>
MVO[;Z]K!\4^*?#7@?PWKWC+QEK^C^%?"?A;1]1\0>)?$OB'4K31]"T#0M(M)
M;_5=8UC5;^6"RT[3-.LH)KN]O;N:*WMK>*266144FOYY/WP_FK^$NL_M.?#/
MQ)\9OC3^SWJ_QR\=#Q/^UQ^PK\/+'PW\1/AW=VVD_'/PSXE_8N_9\^%?C[Q?
M\3]5\0?"WP_XW1O"WC+2&T?4?&^COX%T7P#K7A"^E\0PM;OXAMY_T1_X)H?$
MS]K;XBP>++G]HW6KK4HH?`7PON]:TO7O#WQ#T_Q#X5^.%^?$#?%3P_#=^*/V
M8/V;_#>A:3:(FCVTOPL\/W'Q9F^'UY8Q3R?$&^T[Q-8R7GKO@W_@I+^S5XJ\
M7?&K0KKQ3%X<\._"/Q'\+/"]EXQU66[D@^(&M_$WX7O\6%T[PQX5M=/D\;07
MWA/PO!=ZCXIL-5T&WNM,T:SNO$U[%:>'8GU`?2ES^TG\`['2-9\0WGQ=\`V?
MA_P_XEM_"6MZ]=^([&#1-,UZ[^'-C\7K:TN]7FD73HH+CX7:E8_$&'4?M)TJ
M3P?=1>($OCIQ,X`/Q-\9?&/_`(*&:=X1\">*CXU^(^E>'O&OQG_;V\.^*M;U
M+P=K?AZZ\"/\&?VGO%/P]_9`\(:/I7P^_8^_:3\67/AWXB_#8:MXSOM4USP"
MMI\6KGPIX/T/3_B!X=T[6]-T'QUOZ3XQ_;9U/]H/6/!M_J/CGX<VOQ*^-J:5
M\3_'/PE^"6D>&(IK31?^"0?P3^(R:QHOB3QI\+M:O&L+3]IRRUC0?#NN_$&+
MQ'J^GW<,GP@GN$;1[7PWH_Z7:K^W5\$H?&7P"\.>']5B\2:#\<?%?Q@\*7'C
M5=1M_#>D?#*]^#GP:UOXW>(9?B%8^+$T76]#BN?"NCPW%O%>V=D\.G:OI/B.
M<?\`".W<%_)T-I^W1^R/?>&[?Q99?'GP%=Z)>>)KKP;8R6VH7TU]?^*K?P1J
M7Q'A\/Z?H<=@VN7VJ:M\/M(U#QKX<L[33)G\4^%[=M=\,C5["2*XD`/PR\2^
M-?VQ/BCXG_8'UGXT:C\?(?#+>#OV%OVU/BIXP\-_`R+^U?V>OB7\3_V7O^"@
MGP[_`&C='\(Z5IWPRO[CPWX>\.2Q_"^/4O"WBS3?'GC#X7:EXG36YU+:[&B^
MF^(_VC/^"@_A[PGXQ9M1^.VH/XK^'7PKM_V;=:_X41*/$_C&P\*?\%&OBQX7
M\8?$;QUHNG_"^VL?`WCSQ=^Q!J'P1\6^/]"\6Z=X2@31[Z[\1^%?!^@>(8?$
M6DZ/^QC?MM?LE"^T#3Q^T%\,))O%&G^#=3T"6'Q1;SV.JZ;\1?#FJ>*OA[>V
MFJ0B32WA\>:-H^J2^"Y6O4/BJ\LI=(T+[?K033FNP?MD?LNW-G\/K^V^-W@&
M>T^)RWC>#YH-7>1;R/3O$\_@C4I=6V6Y?PM#IOCNVN?`NHS^,%T&&P\<V]SX
M.NY(?$T,VEH`?E#X^^*'[9VD_"_2_B3J7QI^-.A7NL?M%_MU^&9?`UG\)M1\
M/W3>$?A)^TK\3_`/[,FE^%O'OAS]EC]H:V\,SZKX'TC0]:TW3/B;\--0T+]H
MF'4M*NK+X@^&=%\/1Z3XPZ/P?\?/V]?%?[3PL_$&G>+?AIX*O[_PA?>'OAGX
MQ\)>+3K5S\"=7_9M\+^*_$6M>(-&\&?LR^*?AMH_Q7T[XPZGXBTO5_%UY^U=
MHVB^#_&WA:+X6CX?7VF:CI[^,OT#^)/_``4%_9'^&.C_`!:U+6_C!X?U?4?@
MKX>^+7B#QMX2\*/<Z[XQCG^"%O<77Q*\*Z3I$$42ZIXV\.0VYGO?"<%X-5MM
M.DCUZ[@MO#*3ZU!Z;H?[47P3UGX#>#/VDI_%J>'/A5X]T'POKOAO5?%.GZGH
M>J7O_"8BVB\.Z)%X;N+0Z[>>*-4OKF'2=-\.Z;IM_J^JZFR6NC6VH":WDF`/
MQ1T;XY?\%#]&^%_@3QS?>,_CEX@\20_L??\`!*W]IKQ!X9U7X,>'8;?5OC7\
M=OB]J?PL_:M^#VJ6FG_"F#6K+PCI7P[T>V\4^(/`=H8?B!\,M=U:[\;W?B+3
MK233["WR6_:(_P""G!^&'QQUW4M7\1:#\4M)L/"L6M^#O#WPW\=>.=3^&OQ(
MU/\`:X^"WA&QTSP/I.M_LG?#GX?VG@VP^">L_$>VU+2[+XL?M#R^//#5AHGQ
M5L?$^GZ='K7B?7/W:T3]I#X%>([G0;+0OBCX2U6]\3Z;X.U3P]9V6J-->:U8
M^.M=\1^&?#4VFVJQ_:+M[KQ!X0\4:1?PQ1M=:%?^']7M_$<6DO83A.`\/?MQ
M?LC^+/#_`(@\4^&_C]\.-:T/PWX<\&>+=1O].UUYQ+X=^(EY#I7@75-$MUMQ
M>>([;Q;K\T/A;05\,6VKS:EXP8>#X(6\4`Z0`#\H;*V_:-D_X*"?!35OBC\0
MOVF;KX/_``&_:F_:?_9]\,^*Y=%>R\.^/=%^(_[/O[)OQ)^$2_%*+P;\,;#0
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M?2)W6,@'YM?L3_#[XN_!C_@EO\3+_P`+>+?BEX=^/WBOQ-^U3X_A^('Q'^$%
MS\4_BE:>,]0^-?Q$TG0/&&N_#?PYX+T'QG\2[Z[T31]'\41VU]H/BSQ-JL6J
M-/I%EX@T5-`\*#YSU_\`:5_;NG\/>$M-\':A\6](^&VG^)_BY8:E\<_$\'BW
MQ'_PEWC:'PC\#-8^#'A;P%XB\)_\$[-<^(WB_P"'<&L>)OB[;:U%XY_9>^']
MWXM^(7@FY^%]M\6M5L;/2K/Q5^S&I_MI_LN:+X,TKQUJWQF\)Z=X?UK7M6\,
MV`O3K$&NMKF@:9!KWB"QN?"4NE#QAI[^'?#MW9>*-?GU'0;2VT+PKJ&F^*-5
MGL]`U&QU*X^D]*U/2M=TO3=;T34K'6-&U>PL]4TG5]+O8=0T[5-,U"WBO+#4
M-/U"TEFMKVPOK2:&ZM+JWFEM[JWEBFA=XI%8@'\KGQY\(_M&GXM?'#XB7/PS
M\2:K\1'\7?M4>,I]2T+X.^)-<\':EXWO_P#@WW_9P\*1W>B>&O%GA?6K/6/#
M>L?&#2M7\"Z)H/B33]5@UCQ!877P[U2RU+7;35-$'T[?_M`_MF?"OP[K/Q.U
M#QKXT\->$?!O[3>C?!6/PMXL^$'ARP^$/@[X":C_`,$O_`?QBU3XF:]9VW@[
MPOKAT/P+^TK'?21^([?QOX9\+Z;>6^L_"B:ZM?M=Q:6W]"VT>X^A('3'`!X&
M.@'`/(YYK)U_P_H/BO0]9\,>*-%TKQ)X;\1:7?Z)X@\/:_I]IK&AZ[HNJVDM
MAJFCZSI.HPW.GZII6I6,\UI?Z=?6\]G>6TTL-S#)'(ZD`_)3_@FW\4_C/XJ\
M.?'CQ+\:/&OQ-\:_$C_A$OA+XLL/A'\0[+7=)^,_A33SX!UVUU>>U\$^(/AO
M\!_`&G>&/B-\5=$\>3_#:X\/^"XIKN.SGT7QKXZN8]&T3PQX#^)/!W[3G_!0
M_P`0^*?#6B:=??'+3_!?Q+U/]BO6;WQ)K_PROO$/CCX9>(/&7[97PJ^%/[2'
MP_UVYUO]EWX.>"=#UC1/@YXWUN]\<^&M$\->,?!7PXN?#DOB?2/%?]GV6MR7
MW]`?PK^!'P>^"-OK%O\`"GX=^%_`P\03PSZW/H6G+#?:I]D>[DL+:^U&=[C4
M+C3]+?4-0.D:9)='3=(%_>C3+2T6[N!)ZSM'^UUS]YO7/KT]NF..G%`'\PO[
M2?C_`/;%^(_[/'[</P/^)VN?M'MX?TCX&_M^_!7]GC_A#_@5!XI\0?M4^,O#
MWC'X[>!?#FA_%ZXTCX/WUI$4^#"?"P^#+[P\OPVT?XD6/B/QA\1;76M8UCPS
M++H7]+/A%&B\+>'(WC>)X]!T5&BD5T>-DTNT5HW254D1T(*LLB*ZL"'56!`Z
M':/?\&8>OH>@R<#H.P%+0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`5X9^TK\#-&_:4^!WQ&^">NZUJ7ANS\>:$MA!XATF&WNKW0M8T[
M4M/\0>'=973[MELM7@TOQ#H^E7U]H=^RZ=KMA!=:-?D6=],P]SHH`_&KQY_P
M2M\4_$KXS^*?VD?&7QS\+:G\9/%/B?P[KCVVG?#OXK^"_A?I>FVWP?T#X0>)
M-#MM$^'7[2O@WXE74E]9^#_"OB71]:NOBP]S9WL/B#0-6M-7\/ZY9P:#V_Q!
M_P""5G@7Q]X=U;X>GX@7'A;X4:O^RUX,^!K_``]\*^$QI.GZ?\4OAMX<M_`'
M@#X[:5<P^*`]G/H/PL2?X93^`0K6FH>$VM+-O$]L]A%,WZO44`?CAJ__``24
MT;QGX>T_0O&'Q-TK2TU35/VCKCXD3_#WPEX]AO?%VF_'W]DC7/V346T\0_%_
MXT_&CQC;Z_X/T#6O^$@L==\1^)?$UM<1V5EX2L]$TC0K.W95^(?[#W[3]U^T
M)^SG^T'IGQ4^'WC/XOZ)\:M&U/XA^/?^%7-X2^&7@WX6_"_]C_\`;&^%'P_4
M?""7XMWOB7Q5K'BOXD?M&ZB?%]_H/Q&L-8T^#Q/IZ>'K?2/"_@N:/4?V.HH`
M_'[P5_P2BM_`]I?V.G_&^ZO8M2\=?\$]_'][->^`XTGN=:_8G_:'\1?M'>*<
MQ6_BP6EM:?%[QAXKUBWT73[2-++X5V9T]+&/Q2NGQB3F-1_X(]>'[_Q]\0/'
M%W\3=&\0I\7_`!U\7=6^)F@^,?"'Q)O]&O/`GQ"_:6^-O[1>@>%O#NB>$/CW
MX!\+MJGAV3XX^)O!>NWGQ'\._$KPGXJ2TT7Q3'X*T.\M-4TC7_VHHH`_)WQ+
M_P`$N[#Q?9:IHNM?&*_BT+Q!^U7^VM^T;KT&C^#XK#4KG2_VQ?V=OCE^S_=>
M"K*]F\0W=K;ZIX!LOC1)XALO%]W87T>MR^'HM+D\/Z9#J!N;/TSXG?L+ZQ\8
M?V7/@'\$?'GQ+T:[^(/[.OBKP+XR\(>.]#\,^//"G@_7];^&_AOQ/\/M!_X2
M7PCX9^+^D?$"VL]6^'WB>^M=:3PW\8M'OK/Q@T/B?1K^"QLH/#LGZ+44`?FU
MX'_X)^MX#\3?L]^--"^(^D:+K_[.-]XQNO"%AX<\#ZU:>%-4B^.OCKQ%XJ_:
MBAU^R\3?$;QGXKUB3XJV&IZ!#X8U77_&NN^(/`OBWPHGCK5-9\;:AXI\4V%_
M\1_!W_@DA\2O&?[+_P"RAX<_:0^)6EZ!\6?V;/@+\&/`GPS\*^&?#^L6.A>`
MO$/A#Q)X.\=>--/^)OB3X;_%_0=2^+2:EJ7@_1_">FZQX!\1?"HZ'I>FMXIT
M>XF\6:C+J$/]`-%`'Y!7W_!*RWN_!_Q)\-6/Q4T/PU/\2_V'?VLOV1M2D\/?
M#WQ))ING>)/VK?B1/\1_$'Q7MQXN^*_C#Q;JK:3?S>3J6A>(_&FL:]XSO%?7
M=;\;1:C<2J(OB7_P2NU+XJR_$WP_K/Q[;P?\,_B3IOCIM?\`"?PN\%^+?!<W
MCCQ)XM,6IZ1K7Q9TJ/XR7WPF\5W?A+QAI?A_Q?-XI\&_"CX:_%'Q]?:9]G\:
M_$.Z.L>,KWQ=^P5%`'Y+K_P33U6S\&6EKH_C?X3:9\16^)^M_$?5?&*_#GX]
M2W(N]7^'_A+X;0W7ACQ\O[6T/[2'A7Q5IOAWPK!:R>(+#X^/I>NZ++%X/U?P
ML^@:-X;.B_I5\*?!VL_#SX8_#SP%XB\<^(OB=K_@OP1X5\*ZU\1_%R6$?BKQ
MYJOA_0['2M0\8>(TTN&WTY-<\27=I+J^J+901VPO;N81*5^=N^HH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBORB_:C_`&IO
MC3\,OC3XE\&^#O$6EZ?X?TW3O#5Q:6MUX:TC49HY=2T2UO;MFN[N)IY!)<2N
MZJQ(C4A$PH%`'ZNT5^%VE?MN_M&76JZ5:S^+=$:"ZU73+6=1X-T!2T%SJ%M!
M,H8094M%(ZAARI.X<@5^Z`_J?T)H`6BBO"_VGOCEIO[,O[.GQS_:'UCP_J7B
MS2O@A\)_'OQ5U#PQH]W8V&J^(+/P+X;U#Q%/HVG7VJ,FFV5[J4=@;2WNK]EL
M[>659;@^4C4`>Z45^?\`X0_;U\-:;XG\:>`_VC?"5I\!?&7@_P`&?#[X@*MG
MX_T/XP>%/$&@?$_Q7XO\$^$-*T+Q!X%TR#5;GQYJ7B+P/KMO:^!'\*)K.M6<
M?]H^%&\16VG>(CH7TEHO[2/P+\16=UJ&A_%'PCJ=E90_#"XN+FSU+S8DM_C/
MK#^'OA=.K"("6'QMK\-UH>B20^8DNL6&IZ9.;>^TO48+4`]NHKY=@_;4_97N
M/#UUXLC^./@)?#=KXI\)^#1K,VI7%M87VN>/[J]L/A^NCSW-G"-=TOQ_?Z;J
M%CX$\1:(-0\.>,[VQO+3PSJ^JW%M-&E>7]M[]DZ'P]J?BJ;X\?#Z'0-%^&DO
MQ@UK49=5GCCT;X=6OCO4OAAJ'B75XGLQ<Z9!I/Q&T?5_`VLV-]!;ZOHOBO2M
M2T+5M.LM1L;J"(`^JJ*\?\,?'[X-^,_B%XC^%?A;XB>&]<\>^%'U6'6O#]A=
MR2S0W7AZ[M=.\46-G>M`FE:QJ'A#4[ZQTOQEIVBW^HWW@_5+VSTWQ/;:3?74
M%O)FZI^TM\!M%^*0^"VJ?%3P=9_%#[.TQ\&RZGG54NE\.7/C)=$E*1/91>*)
M_!EE>>,K7PC)>+XJO/"%K/XIM-&GT&)]04`]RHKPOX.?M,_`3]H+[<?@Q\5O
M!WQ&&G:!X1\67'_",ZG]LW^%?'EC/?\`@[Q1:"2*`ZCX<\1Q6>H6^EZ[IPN]
M*N-2TK6-(^UKJ^D:G8VG+Z5^V;^RWK<?CJ?2_CC\/[RW^'-L]]XHNH]7<6<>
MGQ^(E\'-J.B7DELEKXNT_P#X3-XO!:W_`(.F\06;^,I[?PFD[>(;F#39`#Z<
MHKXDO/V^?@%%X[^&OANR\3Z==^#O'7PQ_:0^)FO?$R\U2W\.^'?AA;?LT:M\
M#M*\8:!\1=)\2PZ5XE\-:]=GXY:#=PV.KZ9IUUI]M8,VH6J_VSHAN^WU?]M7
M]EO0/"6A>-M;^-'A#2M"\1:CXATO3_M[ZM;:U%=>#X;.Y\9G5O"TFEKXJ\/6
MG@JRU+2M0\::CXAT32M.\(Z9K&BZGXCN],T_6-,N;L`^I**\/^*?QV\'?"R+
MX3:CJ^L>%QX>^*?C6]\+6.O:AXNTO1[1;#3_`(0_$WXQWFL^'UEANSXSGA\+
M?#+5M4_L/19$O)/#T>J^)H9Y+#0KJ&XF^$O[1GP0^.UMK-W\(?B9X4^(,&@6
M'AG5]4;PU?M>M#H?C/2I=:\(>(88VAAEOO#?BG3K:^F\.>(M/2ZT36Y-+U>T
MTV_N;W2-3MK0`]JHK\L/"W_!7W]D?Q==_#O4[76_$'ASX<>.X?VO([CXC>/]
M$U+P3IWAG5/V/?B;\,?AIXTM=1T+5K#^WKW3_$LGQ(3QAH>N:9;3V&B>#?#^
ML7_CC_A&=0LM4TS2/N;2OVBO@AKGQ''PET;XF>%-5\?-:074>A:=J!O1-+<^
M'[;Q?!I5OJ]O%)H%SXBE\&WMGXS3PO;ZM+XD/@V[MO%O]DCP[/%J;@'M-%?/
MOB[]JK]GCP'XH\6^"_%WQ;\':%XK\":/INO>,-`O;^;^U/#VEZ[%9/X<N-3M
M8+69X&\53ZC8Z9X2M?FO/%>N7<'A_P`.6^J:ZXTZL36?VS?V7_#VD^#-;UOX
MT^"M+T[Q[#K-WX?EO+R\AF73_#.MVWAGQ5JOB"R-C]N\&Z-X1\3WEIX9\8:S
MXSM?#VE>$_$EU;Z#XBO-,U>:.S8`^G:*^8OV=OVN?@_^U#K/QVT+X67'BB6_
M_9W^,.O?!#XA+XD\*:QX:A/C'P[;6=Q>S^'Y]3@CBUK0Y7NI+:UOH'2Y:6SF
MDN;&UM+G2KG4?"OCK_P4^_90^#GPK\<_$C2/B%I'Q4O/!_BOX?\`@*'PIX`N
M;O5M0U;Q9\5O'*_#7P!*E]9:5J-O'X&U7QFM_I=Y\1["#6?"EM)H6OZ?IMUK
M7B:QM_#E\`?HE17AOB']HCX4?#W1=-U#XL^.O!_PTOI_`FE^/]4LO$7B".WL
M],T.^U[POX/N+Y=7O+33H+S3;3QIXR\-^%_MWV>T>34M=T6.:RM'U2VA.-XP
M_:W_`&;/`&K:+H?C/XS^`_#FJ:_XAUSPQIUKJNL"V)U7PUXI@\#:^;Z8PM;Z
M1IFD>-KJU\'7^O:S-I_A^W\5W5OX<?5?[9GCLF`/HNBOA;Q7_P`%"/V>_#OQ
M>\`?"RR\6:+KUGXCUC]H'0_B#X_M?$&F:=X,^"FH?LX>$?%'BKXAVWQ(U35_
MLEOI]QI)\&^(],UBWAN3-X:ETYM0U]+/3+FSN+GK_P!GO]L?X:_M+?%'XZ_#
MOX:PWNHZ?\#[3X/W-YXR>18=+\2-\7O"FM^++"ULM&O+>Q\1Z+=Z)9:.BZA;
M>(-.L9[J/4M/OK&*2QN(YI`#ZZHHHH`****`"BBB@`HHHH`****`"BBB@`K\
M'_VX(Y&_:1\9E8I&']D>#.5C=@?^*9LNA"D'WYZU^\%1M#"Y+/%&S'JS1JQ.
M.!DD$\#B@#^830HIAKNA$PS8_MW1/^64G_05L_\`9K^GX=/Q;^9J+[/;CI!#
M_P!^D_\`B:FH`*^?/VLO@2/VG_V8_P!H']G-O$B^#E^.GP=^(GPF?Q4^CCQ"
MGAU/'WAC4?#;ZR^A'4-)76$T]=0-R^F-J=@M\J&W:\MQ(9%^@Z*`/R1^)_\`
MP2=^&6M^(-9U+X-W_@KX*^&)_'OPH^-^@_#'PQ\/=6\-?#_3_CO\.?AM\5_@
M?K_C34+;X.?$+X->)GT;XB?!KXF6'A[4]!\,^)_"MSH7B_P!X<\=6FJ:DVJ^
M+/#^N]QI?_!-7PEI\OPFL(O'*Z+X-\,?#/XC>`/B]X*\'>%;[0=,^+M_XGUG
MQ_XK\!^*K'4-7\:^+->\%:E\*O&_QD^,?C'09]0U?QWK>L:]XWCU36O$-QJF
MDMJ&H?IM10!^.'PW_P""35CX"\/_``_T4?$[PX]W\-_BC^Q[XLTOQ#IO@/X@
M3:YK_@;]D+Q_?>.]`\'^);KQ_P#';XCI;WWBB[O2"W@F+P=X!\':DU[J_AKX
M>(^IW%M'F_$'_@DCJ7B[3OC'::'^T,GARX^.<7[3>@>.+R]^%C>(I(/!/QV_
M:\\4?MA>$])\,QR?$+3+?1]:\!>+?%>L>#M=UN]M]:MO&WA>_DN['2/!NNVE
MA>Q?M#10!^;/[/W_``3L\,_`;X[:K\5[3Q%HGB/1H/%7QY\:>";'4]#^(EYX
M[\.:W^T-X\U_QWXSBN?$_B+XS>)OA_%86-QXGUS1;&7P-\(/`6M:YHDVEKXO
MU76M4TV]U/7=/7_V$;_6?BKXB\0P_%:WLOA/XF_:9T+]L+4/`3^![BZ\;1_'
M#PS\+]#^'6DV]I\3CXVAMX?AB]]X5\->,;[PL?`S>)9+ZPO_``K;^-+?P3J[
MZ-9_HG10!^>W[+7[";_LU^*/@EXA7XGGQ=#\'OV!?@1^Q"--'A'^PHM??X*:
MW<ZN/B6)%\1:HFE-XA2X^RCPHL%Y_9&TRKX@OMQC'CD?_!-_XI:=%XZL/"/[
M4<GPP\.:_:7,.F>"?A-X$\=>`/`&OW%Y\8/A_P#%2^N_B5X&TKX\R>&M.N-:
MTOPCXF^&OB>Z_9FL?V:-2\2>&/BG\0=6O=0CURZ\-_\`"-_K910!^%TO_!%+
MPYJDGCS^V?C-!:Z?X[U?XX^+I="\)?#_`%WP_HV@>,OBU;?L#:CH\ND-<?%;
M5O$\WA3PEXS_`&%M)UG4=#U#Q9/KOB_1_B'JNCS>+M#U+1[?Q!>>T7?_``3/
MU9/`FFZ1X;^(?PN\*?$!_&GCKQIK?C[2_AG\;4UNTU;QYX.^&G@*?6_!'Q!M
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M2T#P=_P4>\&>`;'_`(5Y>+XJTZQ_X**_%3P=\9_$UWXK\22^/;FQ\07WPR\9
M:%K6GZ%+HWA_PLGB3POJFEVNK16FL:3>:MK&'^S-_P`$J/#W[.GQ(^'WC$>/
M=$\=:5X&U70?'<4>O>%OB-_PE`^*%E\$=.^#NM:_H$UQ\<=0^%_AW1=1-MJ6
MOZ8J_"'4/'NB:?K=WX'3Q]=^'$#2_KK10!^8WQQ_X)MZ)\;O&G[2/C;5OB/<
M6%Y\;?$7['7C3PSIT>B:_;6/@[Q1^Q]J6NZQX=3Q%>>%?'W@[Q+XP\,^+K_6
MY!JFF:'XC\`ZYH<(EN_#OB:RUX6.L67!>(?^"8FN3>`/"WASX??%KP7\*O&]
MCI_QB@UGXI^"OAO\4-+^(&AZW\8=<L=:U'Q?\,/'ME^TC9_$S3M8TQ]*TB6_
MT#XM^._C'\/_`(@:[HFA>)O'/A#4+W3/LES^NU%`'R9\!OV:-1^"7B3]I/S/
M'D?C#P'\?_BC??&*WTJ^\/W>D>-?#/C#Q=X1\.>%/B)::AXNT_Q(VCZ]H6L/
MX1TO6_#4>E>#_"6H^&KK4M9L9[O6;5-)DL?CJ+_@EWKEYX4^%_A3Q)^T#%J<
M'[/_`(/_`&8OA'\#+_2OA:/#]YH_P>_9S_:@^`'[1YT[XAE/'VI1^-_B+XPM
M_P!G+X>_#]_&6CIX*\.^'(;75?%6E^!7O]?U/3*_7BB@#Y"_:A_9`\)_M2:O
M\)+KQ;X@O=,T/P!J_CB+QAX:ATRUU*P^*'@'QMX/N;.?X?ZT]U/'_9FGZ;\4
M-"^$?Q>M-2MXKNX.O?"C2-.$$<&IW%Y:_+6H?\$S_$DW@#_A!+3]HR\NW^*'
M[*6D?LG_`+5WBWQ/\,[+7?%'QET!?%7Q)\<^,_B;X(GMO&.B:?\`"GXG^/?$
M_P`;/C-=:Q>W^G_$+P[;'QKI-]!H,FH^"=,EU']8J*`/Q_\`'/\`P2<TCQ]X
M3TCP7JOQFOK'1K'XF?\`!1#XA74VE^"8EU2=?VZO%?CKQ;I6GV]S>^)[F`W?
MP@U'Q9I8EOM7M]6M/B3#H$MKK.F:19:S=6T/U_\`L^_LU^-/A9\9?VAOCM\1
M?B;X>\?^-OVB;3X+1:[8>$?AW=_#OPMX9D^#OA3Q'X2M8]#L-3\=>/\`6;JV
MUNUUN+4;DZQK][>6E^EW##=-ILFGV6F_8-%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
:%%%`!1110`4444`%%%%`!1110`4444`?_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>biogenlogostandard.jpg
<TEXT>
begin 644 biogenlogostandard.jpg
M_]C_X``02D9)1@`!`@$`E@"6``#_[0`L4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``E@````$``0"6`````0`!_^%2)&AT='`Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"\`/#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#96AI
M2'IR95-Z3E1C>FMC.60B/SX*/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN
M<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0($-O<F4@-2XS+6,P,3$@-C8N
M,30U-C8Q+"`R,#$R+S`R+S`V+3$T.C4V.C(W("`@("`@("`B/@H@("`\<F1F
M.E)$1B!X;6QN<SIR9&8](FAT='`Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M
M<F1F+7-Y;G1A>"UN<R,B/@H@("`@("`\<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TB(@H@("`@("`@("`@("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G
M+V1C+V5L96UE;G1S+S$N,2\B/@H@("`@("`@("`\9&,Z9F]R;6%T/FEM86=E
M+VIP96<\+V1C.F9O<FUA=#X*("`@("`@("`@/&1C.G1I=&QE/@H@("`@("`@
M("`@("`\<F1F.D%L=#X*("`@("`@("`@("`@("`@/')D9CIL:2!X;6PZ;&%N
M9STB>"UD969A=6QT(CY":6]G96Y?3&]G;U\Q,C`S,30\+W)D9CIL:3X*("`@
M("`@("`@("`@/"]R9&8Z06QT/@H@("`@("`@("`\+V1C.G1I=&QE/@H@("`@
M("`\+W)D9CI$97-C<FEP=&EO;CX*("`@("`@/')D9CI$97-C<FEP=&EO;B!R
M9&8Z86)O=70](B(*("`@("`@("`@("`@>&UL;G,Z>&UP/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C`O(@H@("`@("`@("`@("!X;6QN<SIX;7!'26UG
M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O9R]I;6<O(CX*("`@("`@
M("`@/'AM<#I-971A9&%T841A=&4^,C`Q-"TQ,BTP-50Q,#HT.3HR,"TP-3HP
M,#PO>&UP.DUE=&%D871A1&%T93X*("`@("`@("`@/'AM<#I-;V1I9GE$871E
M/C(P,30M,3(M,#54,34Z-#DZ,C=:/"]X;7`Z36]D:69Y1&%T93X*("`@("`@
M("`@/'AM<#I#<F5A=&5$871E/C(P,30M,3(M,#54,3`Z-#DZ,C`M,#4Z,#`\
M+WAM<#I#<F5A=&5$871E/@H@("`@("`@("`\>&UP.D-R96%T;W)4;V]L/D%D
M;V)E($EL;'5S=')A=&]R($-3-B`H36%C:6YT;W-H*3PO>&UP.D-R96%T;W)4
M;V]L/@H@("`@("`@("`\>&UP.E1H=6UB;F%I;',^"B`@("`@("`@("`@(#QR
M9&8Z06QT/@H@("`@("`@("`@("`@("`\<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*("`@("`@("`@("`@("`@("`@/'AM<$=);6<Z=VED=&@^
M,C4V/"]X;7!'26UG.G=I9'1H/@H@("`@("`@("`@("`@("`@("`\>&UP1TEM
M9SIH96EG:'0^.#@\+WAM<$=);6<Z:&5I9VAT/@H@("`@("`@("`@("`@("`@
M("`\>&UP1TEM9SIF;W)M870^2E!%1SPO>&UP1TEM9SIF;W)M870^"B`@("`@
M("`@("`@("`@("`@(#QX;7!'26UG.FEM86=E/B\Y:B\T04%14VM:2E)G04)!
M9T5"3$%%<T%!1"\W44%S54=H=F1'.7IA1SEW241-=4U!0311:VQ.02LP04%!
M04%!0D%"3$%!04%!14$F(WA!.T%117-!04%!05%!0B\K24U716Q$43$Y455K
M.4=357A&04%%0D%!04U317AP8FTX0T5!04%B5S4P8VQ*2%%I0EE75F]G0C@T
M04%G04HF(WA!.T%!64%-44%!65=.>F-%,512;%%!04%!05-55D1)2$Y34C!)
M04%!04%!04%!04%!04%!04%!4&)704%%04%!04$P>3%)54-!9T%!04$F(WA!
M.T%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!
M04%!04%!04%!04%!04%!4EDS0GED04%!059!04%!07HF(WA!.UI'5GI9=T%!
M05E104%!0G-D,U)W9$%!04%F04%!04%566UT=V1!04%!9U%!04%!56-L:%I7
M9T%!06AG04%!055:,6A:5V=!04%I=T$F(WA!.T%!0559;&A:5V=!04%K04%!
M04%56D<Q=5I!04%!;%%!04%"=UI',6M:04%!07-104%!0TED;E9L6D%!04$P
M=T%!04-'9&UL;&1W04$F(WA!.T$Y44%!04%K8DA6=&%104%!+V=!04%!56)7
M5FAC=T%!0D%W04%!06MD1U9J84%!04)$04%!04%-8VQ24U%W04%"1'=!04%G
M35HQ4E,F(WA!.U%W04%"1'=!04%G35EL4E-1=T%!0D1W04%!9TUD1U8T9$%!
M04%!0D1B,T(U8VUL;F%(46=+1TUP241%-4]49V=31U8S8D=6,&1#,5$F(WA!
M.UE73G)96$IK245.=F)80FAB;FM!04=2;&,R34%!04%!04%!045N3E-2,$EG
M4U561$YJ135.:EET36DT>$%!04%!04%!04%!04%!05,F(WA!.V,Q2DA1:4)*
M4E5-,DU4:S).:3!Y3&I%04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!
M04%!04%!04%!04%!04%!04%!04%!04$F(WA!.T%!04%!04%!04%!04%&:%I7
M:4%!04%!04%!1'I544%"04%!04%28DU71FQA24%!04%!04%!04%!04%!04%!
M04%!04)95U9O9T%!04$F(WA!.T%!04%B-DE!041J,4%!041K1FA:5VE!04%!
M04%!04)I;5%!070T54%!0FIA5T9L84E!04%!04%!04-39T%!05!H04%!=',Y
M:UI83FHF(WA!.T%!04%!04%!04):2E)536=A2%(P8T1O=DPS9#-D>35P6E=-
M=5DR9T%!04%!04%!04%!04%!0EI*4E5-9V%(4C!C1&]V3#-D,V1Y-7`F(WA!
M.UI73759,F=!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!
M04%!04%!04%!04%!04%!04%!04%!04%!6D=6>EEW04$F(WA!.T%!04%!04%U
M4U561$E$67A/5%DR3%1)=4U30D5:5UIH9%=X,$E&2DA1:4)J8C)X=F1826=C
M,T)H63)59TQ30GI5:V1#04%!04%!04$F(WA!.T%!04%!04%U4U561$E$67A/
M5%DR3%1)=4U30D5:5UIH9%=X,$E&2DA1:4)J8C)X=F1826=C,T)H63)59TQ3
M0GI5:V1#04%!04%!04$F(WA!.T%!04%!04%!04%!04%!04%!04%!04=2;&,R
M34%!04%!04%!04Q&2FQ:;59Y6E<U:EI30E=A5U8S85<U;DE%3G9B;5)P9$=L
M=F)I0G`F(WA!.V)I0DI254TR351K,DYI,'E,:D5!04%!04%!04%!04%!04-X
M4UI76FQC;59U63)59U9M;&QD,FQU6GE"1&(R-6MA6%)P8C(T9V%7-&<F(WA!
M.U-55D1.:D4U3FI9=$UI-'A!04%!04%!04%!04%!04%!04%!04%!04%!04%!
M04%!04%!0C)A5U8S04%!04%!051P4#1!1D8X=4%"1%`F(WA!.T9!040W8W=!
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M.TUP<WDQ1$U.33!9>F9Z3S1-+T4P2WI2;$Y*-#`R1%543E4P,6AZ6$-.9C`R
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M4$%%.4HF(WA!.U0U3E`S5D%N54A&474Q14=55D)2;3%(;55J1E-F1DQ(57A.
M5%@Q3W%5+UI546Q34%9.=%9+1E8Q5F-*5T0Q6F-6<6Q7.3%D158U2E@F(WA!
M.S1&9W972#%9>3%K85=7;%IU1F](5VQ:87!L<C%7,%9B;%9V;%A$5F-H;'I7
M6%-D9&5&,TI8:'!E8D8V.5AW.6995BMZ64%69U8R0W$F(WA!.UE0>&A4,D=I
M6696:5-72V-9=D)J43)/6%DK=&M11U-56D]L;%!75U-:961M4%=A4UIU:&Y0
M5V546BML;U`R:5=A3WAP43)M86%F1G$F(WA!.U-'<69A=F1R5#)U;F$O.7-6
M,GEV8E%H=%E',C5B:$IU83(W16)X-79E1R]28T-T=VAN1&=C5'!X;%A(=V-K
M='EP;DU"8S$Q>G5(454F(WA!.V1(0C!Z2%5O9%E6,31862MD<'0R*TAD5V0W
M3C1%6&AU94UX-4MN;4IE960V4FYQ;&5W4C=9,W9#9D-&.&=8>FAF548Y;U@T
M0F9M2BLF(WA!.W=N.&IF-%(O-5E"2&=+:4)#;T9R9V,R0TU)2U-G=E-$5C1/
M-FA",D5G251J:%5E1G$T64]H;DM',31C-V@U*TE"26AP:4TV2DTT;5HF(WA!
M.VEF-DM:27)+:7I#3&QO=CAJ1T]->6\P>&I::4XO-#5M:G,V4$YO*V5K06%1
M8G!$5VM4*U)Q2DE2:VYQ4S0U3DYK-V%524I32VQ04U8F(WA!.U@U6$IL:E-7
M;C5C2VPS5U@T2FA-;4QI6DI*;5%M9GEA84IR5FTP2V)R-7=C;DEM8SDU,6MN
M9$ME44HV=6YX,F9I-2\V;T=M9S)+1D@F(WA!.V]B86E*<4M7;W=A:F1Q4&UP
M1F%K>#95-'!A;6U'<6%,<'8R;F)Q9F=Q1DMO>$MK,W%A;7%(2W%0<7=+<F1A
M=G!R1GES,$LQ17)B:74F(WA!.TQA-FAR>&%V:3=!07-(5W<V<D9G<V1A>5,W
M3$-S>FEZ<G)1;'1*>3%%-U=+=&=',F5B8G=T,FDS-$QH6G5.1S53<FY#=6IU
M-G1B<W4F(WA!.W4V93A)8GEB=E)7.6HW-$MV;U,K+S<Y-G8O6$%C341S=U=F
M0C0X2F9W='9$5TU057A&2$5Z<U9,>&-J1U)S8D1X,$A(=CAG.7E,>DHF(WA!
M.T]S;35Y:FI+=#AS,GDW8DU.8WDQ>E183G1C-#)Z<F)03C@K-#!$;E%U=$4X
M,&(W4U`Y3$(P,%14>'122C%-=E94=%A2,6Q85S).9&,F(WA!.S$K1%E:3FIO
M,E=Z6CAD<#(R=G9B9TYW1C-)<F1%3C)7,VAZ96]T.'`S-B]G3G5#.3155&AZ
M3TI4-'1V:EDK4'(U2%!K+T]7135G,VTF(WA!.VQU8V8U-FYO375I.#958G`P
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M.W`W9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;RM#:S535FQP95EM6G%B;DHR96XU
M2VIP2U=M<#9I<'%Q=7-R839V;U)!04E#05%)1$)1544F(WA!.T)1645#04U$
M8E%%04%H141"0T53355%1E523FA)9UIX9UI%>6]B2'=&34A2-%-.0T962FEC
M=D5Z2D121&=H85-5>5=I63=,0T(S4%,F(WA!.TYE2D5G>&15:W=G2D-H9UI*
M:EI&1VED:V1&53,X<4]Z=WEG<#`K4'IH2E-K=$U453504FQD65=6<&)81C%E
M6#%2;%IM9&]A5W!R8D<F(WA!.S%U8C)2,61N9#1E6'`W9D@Q*V8S3T5H66%(
M:4EM2VDT>4YJ;RM$;$I75VPU:5IM<'5C;EHV9FMQ3VMP86%N<4MM<7$V>71R
M<2MV+V$F(WA!.T%!=T1!44%#15%-4D%$.$$Y43,Y+V)71G$Y>F-T>&I4=S-*
M2C9!1'54:V]236I167EK26EY.#`Q+W=!-#8W8S-+>3(X<E=C151";V\F(WA!
M.UEZ,4E0-UHO82M85$YL:3`X04XY,UA:33AI9'1M3BM99E!V;4<O;6%/-'57
M9V=04S-G2FI3;G91.&TK:S5D2%,T=TMQ,G%E;VY,<7@F(WA!.VAY1UES1TQC
M=#9N<CE/8W!R.4=C138O:%!*67ET3TY%.#)E63E+;%9R3SEK15DV=U-%=D52
M-&-'<5!U>D=H;6Q(:U<R1U-1-48W0C4F(WA!.U`X-U<R=E)E:DUG='12459E
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M=DQ&<71X64Q+-2MW>%$F(WA!.V=$=T%0-FIN2#ET=T5-*S,X478Y2#9(33`T
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M,4(W:D]D,4=!-'`X2F5G=UIX;&IX0C1F*V)/=F$U82\F(WA!.VU"<7-&<G%.
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M=VUE=VTF(WA!.T=Y1F@K-EEB14U84%$Y46-Y.%=U9TDK<S`T;6)3>31V5'E5
M9$TO2W%/;VLQ4S0R-BMH0C$K;'E0,41-3%`R=T]50CA3,EDY168T:7HF(WA!
M.T=X,#=4=$UT>&(R34-14D1Q1D<U23=S5'5X*V5A4$YN;FM.>4YU9$-!:4M#
M;&5145A(.31T5TA2:#%(,#5I5$%,26AD<%=H=%!/04,F(WA!.V9253%D<61"
M-&902C9F5$=C=DI&57I&5E9&0W%+2V]O04]W1V(P0VA3=FUJ.#1V+T%#62MR
M+SA!4G8X03E1<U=D5#)D+V-2*U`S;#4F(WA!.W)T1"LK;#A0=40Q+SAL=B]!
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M.V=B:DMT3G`X.&]!=VQ59F57,U5A:D)'6D5O,TPS0FUF:V95=$(Q3'DU0F0V
M1F%'>#`Q,FM%5G-Y2D=62W51>#1O>G)U,B]834Q646XF(WA!.T=:17IC;DXP
M,#139T1!545X,6I7.4LP87AE*S%/-5,Q=%4R3'5E<#=+<6EP62MW1F-R>#1P
M5$Y21FQS>5I)=T9Y3D(U,V4O.#5!95<F(WA!.UEP:6QP65A6>D=#4C9P-%)G
M*S9G;&I4-3!Z67@W2FU2=5%(6%,W5F=$<T-56&]V-39E56(K9%E,>$HY3EIJ
M4EI:9TAI<5115EI#4U`F(WA!.W!7;G9K379:95-)<U9*;FHW5'AY3DA:-DI&
M3$9,1VMS5')*1DE!>4]P1$MY;F-%16)%2$YC4E1S06)5-S(Y=$Q',&QU-WE:
M24QA1F4F(WA!.U5S,&@T<6](:51H:D5Y3D1M:55H15=E5'IJ5E!Z.#AQ,C!R
M4C).<F,S+T@O04AA07-56BM833@O=E5:<V]D;%I$>DE$<G`Y<5EX>4(F(WA!
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M.V)Z9C4W.'8K5EE%9E5P5V$T;$)-1G!#03!R9V)6;U-!1CDR3UEU;C!S.'`Y
M4$IY8RMP:&E(<5E:8F8X04]16&PQ-6Q7-#`R-FAI2F\F(WA!.UI&36)K9357
M<35M>3=*;E=X1&AJ=%=&-V=V4CE',7)3.6$P*U!53DUU1G5B5U0W36DQ1D-/
M<7-P;U9).$1M='E9<%%.4T9&,D]02D<F(WA!.UEU2G-),TLR8G-68U%#2T56
M0C9J16A51F-A5VML5$<S02M",T=9=5139SAT:S)G6#!3.$HR94]N>F(K;5EX
M,%4K.$QA*T1Y*V])864F(WA!.U1L+VMR="M*>6-.0U`T:71P=$9&2$5G4TY1
M<41O0FUD1TEI2T-&,E-6.'HO04IX9BM42#%F+V\S+W=#;U=,3V\W3R]U22](
M-WDX,3(F(WA!.V@O9E,K2#-":V9K1#@S=$4X="M73&938G%Y=5IP;UAK6G!)
M=E0T;FTU654U340S>D8Q9EHX<W51>4)$:S986'AX=T530WE#6"]N250F(WA!
M.WDK23)-5VU88GE!9D-R;4Y62CDR1$Y4-W-X>#)24'%1,VYT5TAC6&PR=6%R
M-6HX*RM:1W59<E(U-VQW23=E,&=5=4EO;$HT<EAW<7@F(WA!.TQ-9G=Z831S
M8TY00W(R9%IL;E!03S8S93<O;&HU26)Y<&]*:'53<F%L94U*<GAL,T-K0VEX
M9SEW;2LO:51M9S%U<#A79&HV4GED-V\F(WA!.SE.-%5+4$UV1G9Z:2]W1$IJ
M-G8O04Y'+R]53$9M.#=/+W5)+T@W>398=$0K*VPX4'5$,3,X;5I%:B],<7IK
M9&=Q23EW>DUE9T%L66LF(WA!.VY.3C)K3'I(-$\S-U!0-VMF1C1R-2\X04]L
M-35P,3)7-5IY3E!H67!95R]13$=$<WA(.'HY5RLW;TTS;6LP=WA1<G(Q9$QQ
M=%%C<W(F(WA!.S9D1V$K5"]Y3"]33VMW-FAR9#5*871C;TI)<E-&5C5Q:F)Q
M6%IU5S5'+T=M,EE/;S=5-%IC34)D3V)P*WI/2TYY3E=K4#5J9FQ:8V4F(WA!
M.U9)63<K,75$96%822]P<S=+1FMI8VEQ:#9B14Y4-U@P6FMA4%A$2V%)<512
M<3E%8U%S1S1P-2M2+VYE-6<Q16578C)5=F%825IT4#4F(WA!.T=V<'EQ0WI)
M2R]S=4MM;FHX.&\W5#!W369%2$UC,B]S,U5K2&=023AL,S4O-B]D='%L;&]5
M8FQB4T]%6%5Y1%E023=-<3AV2&EQ8F8F(WA!.U!",E1I2$-:.653.7%:5'A#
M2%1M;&XU469L-7!V;5=3-C%(5F<P;&A:<W-59'-R1F95:TDU2&UY,&)I;W`P
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M=D]F;5@V<3`W8W!/5GAF,VML6%E*56-M3F9T37AA9SDF(WA!.S@S=6]Z>'=W
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M4U9(0E!S.'$Y9D4Q>E@U9%9$5%)%26EY-T1(<'`V9VUC:E%3;CAX9GDF(WA!
M.W9U+TM+43-K5GHY9#`R9"]4.55R=V5/4VA)5F=#=TE)0F]C=#!E=4=B87%K
M,6%V4DA&=F1H3F9Y1S%Q93(X,%1A5UA0,6$O9UIV5#<F(WA!.V5R1#A3="]W
M2$E:5C)R:D)X.%A51G,W37E%5#1E:&4O6GIZ=C-9<3=&6%EQ-T9867$W1EA9
M<2M:+W=!-'8O2FHV=CA!.4<O+T%&0W@F(WA!.UHQ2%HS.7A(-"]E6&UU,%`W
M-EAW*S1*,35(+THR,CAY*UA)3EAF5DAT;6UA4E1#<TEC1#`S2R]A3'(Q<&Q'
M<3=23TM::E9T*VTW4$<F(WA!.U-!;&1*-B\O041J=F$X5'<Q>'<S66TS0D@O
M2G=::B]Y=V8U=C)T+SAK:BMD.6IZ>GI:-5$X=V539%9H17-X55-697DQ0S-:
M:T1C858F(WA!.V]24FQ:86EO>EIA9E51>G@K.$]U>C9E94=8,T8V>BM4,S5I
M6&9M0TMB4CE79C%.4W1%.5='-#9'5T5%2V58*U5P23,W9RMX>E5D;S8F(WA!
M.TU9+U9(-E,W8G,O5FY*-EIF54AM6#5X9BM42#%F+V\S+W=#;U=,3G`R9"]C
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M9'5M64](<VU1;&-Y2SAN3GDY<5)-86E$9FTX,#AK*U0F(WA!.TY4.#`V=DAA
M,C!B3%IO=TXW9#`K0TM/=2LO5&M2.6QF-%9Z6C9N57AX4G,X*VIR9$YP-5I:
M54]85FYN+T%$:T9.-F,K:&%F1T]&=D0F(WA!.T9+-F]/;3521BLT2FUV-TI&
M:5(V=60R<60T:#4O=T-69D]M="M6-4QI6%-J17-L,$975G!%1#=)4U%"6'`Q
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M04-I9TQ(-E=*3V-P<4IC5U-2.'DY4G`T.$]/23AM3"\F(WA!.T%*-"\X;TA,
M+W=!>$U0-GIM5C):+V9F075.,FPO9&9&-5HK4S,O:W=B2"]J2%`X03AM5WIB
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M6FIN5S5Z,5!Y+UDS:E)90C`K,6QU;C)M;C)T;VM';G<F(WA!.WA15VDO=T(S
M2$%Q<D=01V=88DU/8VE48W5B;'AI04M(2C5(+T%--41A835J,&95,5@Y,G!L
M='!7.$-W5C1X+W=R-75/>4HO5D@T=7`F(WA!.S=7:#E-:W8O04]C9F159V<Q
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M.R]W0UEA3"]I07IK8W8Q2#-V5C0O<$AU65HK95`O2T)Y+W=$351$*W,U;3EM
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M4V9S670U82]-9GIB-61T5&%A9&1J-G`F(WA!.U5L8F5:0DEI:S=K<%AD82M!
M3DUY.#)J>#5$8VAU-'5(5C5-66](6D-A>C5G.#!E8G13:"MU>7DS.3$Y:3)T
M;VLR5W954GAO2V(P,S(F(WA!.W%C;FIW-#A-9'1G>'E:6C5:8C=L-U@K52]W
M0U<P;FQU,V)63E559G!I-E1I26A1*VA'9'ET4C%D=C)Q9DQ.2'(Y8C1P-%DO
M4U!T9'HF(WA!.V]D2#19-'!F569S65`K971X-6)N.'=21WEL6CE::5%286EQ
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M4$4O9CA!5T\K8G)&;&@F(WA!.VUJ='5/-3`R5$901$QF63DW230O>GDX.7)B
M0T5Y5WIU0E0V=S!)-3$X9&E%<B]S8WAJ,EAH=3DS24AA5U=U:D@Y4#!V>E8U
M,S$Q,FHF(WA!.T5L.694<T1C,V-M,&-9-F-N641I:6=D05!K0FU24$IJ=U$W
M9S!1:&MZ5#=Y*VMF2B]L97HX<S9$8C968DAM639V8U15;UI*5RLR-4@F(WA!
M.S1$=T9--7)56GIL;5I&-E!4-%)J9TEH.'1A,2]X,F(O05`U:4IF.$%I6GIQ
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M<U9D:7)S5F1I<G-69&ER<U9F+SEK/3PO>&UP1TEM9SII;6%G93X*("`@("`@
M("`@("`@("`@/"]R9&8Z;&D^"B`@("`@("`@("`@(#PO<F1F.D%L=#X*("`@
M("`@("`@/"]X;7`Z5&AU;6)N86EL<SX*("`@("`@/"]R9&8Z1&5S8W)I<'1I
M;VX^"B`@("`@(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B`@("`@
M("`@("`@('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C`O;6TO(@H@("`@("`@("`@("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87`O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*("`@("`@("`@
M("`@>&UL;G,Z<W1%=G0](FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S
M5'EP92]297-O=7)C945V96YT(R(^"B`@("`@("`@(#QX;7!-33I);G-T86YC
M94E$/GAM<"YI:60Z,#@X,#$Q-S0P-S(P-C@Q,3@R,D$Y0S4U,#$P0S$P,D8\
M+WAM<$U-.DEN<W1A;F-E240^"B`@("`@("`@(#QX;7!-33I$;V-U;65N=$E$
M/GAM<"YD:60Z,#@X,#$Q-S0P-S(P-C@Q,3@R,D$Y0S4U,#$P0S$P,D8\+WAM
M<$U-.D1O8W5M96YT240^"B`@("`@("`@(#QX;7!-33I/<FEG:6YA;$1O8W5M
M96YT240^=75I9#HU1#(P.#DR-#DS0D9$0C$Q.3$T03@U.3!$,S$U,#A#.#PO
M>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/@H@("`@("`@("`\>&UP34TZ4F5N
M9&ET:6]N0VQA<W,^<')O;V8Z<&1F/"]X;7!-33I296YD:71I;VY#;&%S<SX*
M("`@("`@("`@/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*("`@("`@("`@("`@/'-T4F5F.FEN<W1A;F-E240^=75I9#HV
M839F9#DR9"UD-#DQ+34V-#<M8C5B8BUB8S!E9CDX-&0S9C`\+W-T4F5F.FEN
M<W1A;F-E240^"B`@("`@("`@("`@(#QS=%)E9CID;V-U;65N=$E$/GAM<"YD
M:60Z,#,X,#$Q-S0P-S(P-C@Q,3@P.#-%144Q040S0T1$034\+W-T4F5F.F1O
M8W5M96YT240^"B`@("`@("`@("`@(#QS=%)E9CIO<FEG:6YA;$1O8W5M96YT
M240^=75I9#HU1#(P.#DR-#DS0D9$0C$Q.3$T03@U.3!$,S$U,#A#.#PO<W12
M968Z;W)I9VEN86Q$;V-U;65N=$E$/@H@("`@("`@("`@("`\<W12968Z<F5N
M9&ET:6]N0VQA<W,^<')O;V8Z<&1F/"]S=%)E9CIR96YD:71I;VY#;&%S<SX*
M("`@("`@("`@/"]X;7!-33I$97)I=F5D1G)O;3X*("`@("`@("`@/'AM<$U-
M.DAI<W1O<GD^"B`@("`@("`@("`@(#QR9&8Z4V5Q/@H@("`@("`@("`@("`@
M("`\<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*("`@("`@("`@
M("`@("`@("`@/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@
M("`@("`@("`@("`@("`@("`\<W1%=G0Z:6YS=&%N8V5)1#YX;7`N:6ED.D9%
M-T8Q,3<T,#<R,#8X,3$X,C)!1C$S0D4T0T(X.38U/"]S=$5V=#II;G-T86YC
M94E$/@H@("`@("`@("`@("`@("`@("`\<W1%=G0Z=VAE;CXR,#$T+3$R+3`R
M5#$T.C,P.C$Q+3`U.C`P/"]S=$5V=#IW:&5N/@H@("`@("`@("`@("`@("`@
M("`\<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B!#4S8@
M*$UA8VEN=&]S:"D\+W-T179T.G-O9G1W87)E06=E;G0^"B`@("`@("`@("`@
M("`@("`@(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B`@("`@
M("`@("`@("`@(#PO<F1F.FQI/@H@("`@("`@("`@("`@("`\<F1F.FQI(')D
M9CIP87)S951Y<&4](E)E<V]U<F-E(CX*("`@("`@("`@("`@("`@("`@/'-T
M179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@("`@("`@("`@("`@
M("`@("`\<W1%=G0Z:6YS=&%N8V5)1#YX;7`N:6ED.C`X.#`Q,3<T,#<R,#8X
M,3$X,C)!.4,U-3`Q,$,Q,#)&/"]S=$5V=#II;G-T86YC94E$/@H@("`@("`@
M("`@("`@("`@("`\<W1%=G0Z=VAE;CXR,#$T+3$R+3`U5#$P.C0Y.C(P+3`U
M.C`P/"]S=$5V=#IW:&5N/@H@("`@("`@("`@("`@("`@("`\<W1%=G0Z<V]F
M='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B!#4S8@*$UA8VEN=&]S:"D\
M+W-T179T.G-O9G1W87)E06=E;G0^"B`@("`@("`@("`@("`@("`@(#QS=$5V
M=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B`@("`@("`@("`@("`@(#PO
M<F1F.FQI/@H@("`@("`@("`@("`\+W)D9CI397$^"B`@("`@("`@(#PO>&UP
M34TZ2&ES=&]R>3X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@("`@(#QR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B`@("`@("`@("`@('AM;&YS
M.FEL;'5S=')A=&]R/2)H='1P.B\O;G,N861O8F4N8V]M+VEL;'5S=')A=&]R
M+S$N,"\B/@H@("`@("`@("`\:6QL=7-T<F%T;W(Z4W1A<G1U<%!R;V9I;&4^
M4')I;G0\+VEL;'5S=')A=&]R.E-T87)T=7!0<F]F:6QE/@H@("`@("`\+W)D
M9CI$97-C<FEP=&EO;CX*("`@("`@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*("`@("`@("`@("`@>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N
M8V]M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D9CI0<F]D=6-E<CY!9&]B92!0
M1$8@;&EB<F%R>2`Q,"XP,3PO<&1F.E!R;V1U8V5R/@H@("`@("`\+W)D9CI$
M97-C<FEP=&EO;CX*("`@/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H\/WAP86-K970@96YD/2)W(C\^_^(,6$E#0U]0
M4D]&24Q%``$!```,2$QI;F\"$```;6YT<E)'0B!865H@!\X``@`)``8`,0``
M86-S<$U31E0`````245#('-21T(``````````````````/;6``$`````TRU(
M4"`@````````````````````````````````````````````````````````
M```````18W!R=````5`````S9&5S8P```80```!L=W1P=````?`````48FMP
M=````@0````4<EA96@```A@````49UA96@```BP````48EA96@```D`````4
M9&UN9````E0```!P9&UD9````L0```"(=G5E9````TP```"&=FEE=P```]0`
M```D;'5M:0```_@````4;65A<P``!`P````D=&5C:```!#`````,<E120P``
M!#P```@,9U120P``!#P```@,8E120P``!#P```@,=&5X=`````!#;W!Y<FEG
M:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD``&1E<V,`````
M````$G-21T(@245#-C$Y-C8M,BXQ```````````````2<U)'0B!)14,V,3DV
M-BTR+C$`````````````````````````````````````````````````````
M`````````````%A96B````````#S40`!`````1;,6%E:(```````````````
M``````!865H@````````;Z(``#CU```#D%A96B````````!BF0``MX4``!C:
M6%E:(````````"2@```/A```ML]D97-C`````````!9)14,@:'1T<#HO+W=W
M=RYI96,N8V@``````````````!9)14,@:'1T<#HO+W=W=RYI96,N8V@`````
M````````````````````````````````````````````````````````9&5S
M8P`````````N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A
M8V4@+2!S4D="```````````````N245#(#8Q.38V+3(N,2!$969A=6QT(%)'
M0B!C;VQO=7(@<W!A8V4@+2!S4D="`````````````````````````````&1E
M<V,`````````+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V
M,3DV-BTR+C$``````````````"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I
M;VX@:6X@245#-C$Y-C8M,BXQ``````````````````````````````````!V
M:65W```````3I/X`%%\N`!#/%``#[<P`!!,+``-<G@````%865H@``````!,
M"58`4````%<?YVUE87,``````````0````````````````````````*/````
M`G-I9R``````0U)4(&-U<G8````````$``````4`"@`/`!0`&0`>`",`*``M
M`#(`-P`[`$``10!*`$\`5`!9`%X`8P!H`&T`<@!W`'P`@0"&`(L`D`"5`)H`
MGP"D`*D`K@"R`+<`O`#!`,8`RP#0`-4`VP#@`.4`ZP#P`/8`^P$!`0<!#0$3
M`1D!'P$E`2L!,@$X`3X!10%,`5(!60%@`6<!;@%U`7P!@P&+`9(!F@&A`:D!
ML0&Y`<$!R0'1`=D!X0'I`?(!^@(#`@P"%`(=`B8"+P(X`D$"2P)4`ET"9P)Q
M`GH"A`*.`I@"H@*L`K8"P0++`M4"X`+K`O4#``,+`Q8#(0,M`S@#0P-/`UH#
M9@-R`WX#B@.6`Z(#K@.Z`\<#TP/@`^P#^00&!!,$(`0M!#L$2`15!&,$<01^
M!(P$F@2H!+8$Q`33!.$$\`3^!0T%'`4K!3H%2058!6<%=P6&!98%I@6U!<4%
MU07E!?8&!@86!B<&-P9(!ED&:@9[!HP&G0:O!L`&T0;C!O4'!P<9!RL'/0=/
M!V$'=`>&!YD'K`>_!]('Y0?X"`L('P@R"$8(6@AN"(((E@BJ"+X(T@CG"/L)
M$`DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5`IJ"H$*F`JN"L4*W`KS
M"PL+(@LY"U$+:0N`"Y@+L`O("^$+^0P2#"H,0PQ<#'4,C@RG#,`,V0SS#0T-
M)@U`#5H-=`V.#:D-PPW>#?@.$PXN#DD.9`Y_#IL.M@[2#NX/"0\E#T$/7@]Z
M#Y8/LP_/#^P0"1`F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2
M)A)%$F02A!*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P
M%1(5-!56%7@5FQ6]%>`6`Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8
M&QA`&&48BABO&-48^AD@&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC
M&XH;LAO:'`(<*AQ2''L<HQS,'/4='AU''7`=F1W#'>P>%AY`'FH>E!Z^'ND?
M$Q\^'VD?E!^_'^H@%2!!(&P@F"#$(/`A'"%((74AH2'.(?LB)R)5(H(BKR+=
M(PHC."-F(Y0CPB/P)!\D321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W)N@G
M&"=))WHGJR?<*`TH/RAQ**(HU"D&*3@I:RF=*=`J`BHU*F@JFRK/*P(K-BMI
M*YTKT2P%+#DL;BRB+-<M#"U!+78MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'+_XP
M-3!L,*0PVS$2,4HQ@C&Z,?(R*C)C,ILRU#,-,T8S?S.X,_$T*S1E-)XTV#43
M-4TUAS7"-?TV-S9R-JXVZ3<D-V`WG#?7.!0X4#B,.,@Y!3E".7\YO#GY.C8Z
M=#JR.N\[+3MK.ZH[Z#PG/&4\I#SC/2(]83VA/>`^(#Y@/J`^X#\A/V$_HC_B
M0"-`9$"F0.=!*4%J0:Q![D(P0G)"M4+W0SI#?4/`1`-$1T2*1,Y%$D5519I%
MWD8B1F=&JT;P1S5'>T?`2`5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB
M3"I,<DRZ30)-2DV33=Q.)4YN3K=/`$])3Y-/W5`G4'%0NU$&45!1FU'F4C%2
M?%+'4Q-37U.J4_940E2/5-M5*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RUD:
M66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8`5@
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MB,Z),XF9B?Z*9(K*BS"+EHO\C&.,RHTQC9B-_XYFCLZ/-H^>D`:0;I#6D3^1
MJ)(1DGJ2XY--D[:4()2*E/257Y7)EC26GY<*EW67X)A,F+B9))F0F?R::)K5
MFT*;KYP<G(F<]YUDG=*>0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%:D
MQZ4XI:FF&J:+IOVG;J?@J%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZA
MKQ:OB[``L'6PZK%@L=:R2[+"LSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-&Y
M2KG"NCNZM;LNNZ>\(;R;O16]C[X*OH2^_[]ZO_7`<,#LP6?!X\)?PMO#6,/4
MQ%'$SL5+Q<C&1L;#QT''O\@]R+S).LFYRCC*M\LVR[;,-<RUS37-M<XVSK;/
M-\^XT#G0NM$\T;[2/]+!TT33QM1)U,O53M71UE76V-=<U^#89-CHV6S9\=IV
MVOO;@-P%W(K=$-V6WAS>HM\IWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@WF
MEN<?YZGH,NB\Z4;IT.I;ZN7K<.O[[(;M$>V<[BCNM.]`[\SP6/#E\7+Q__*,
M\QGSI_0T],+U4/7>]FWV^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_
M;?___^X`#D%D;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!
M`0$!`0$"`0$"`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@!(@-H`P$1``(1`0,1`?_$`/T``0`"
M`P$``P$!```````````)"@8'"`4#!`L"`0$!``$%`0$!``````````````<$
M!08("0,!`A````8!`P("`P@(#0T+"@<```$"`P0%!A$'""$2$PDQ02)1,A1V
MMU@Y"O!A<2,5UI<8@:'A0C,DE-46EC@9&I'14F)#TS34M1=WAWC!\6-SDR65
M-E8W5[&"PE-D-;;G:*B2HL0FQTB($0`!`P,!!`4&!0T,"`8"`@,!``(#$00%
M!B$Q$@=!46$3"'&!(G.S-Y$R0A15H5)B<I+2(Y.4%187&+'1@J*R,U/3=(2T
M=?#!0V.C)#0VX52DY"5E-2;$1<*#9/_:``P#`0`"$0,1`#\`O\`B`B`B`B_A
MQQMEM;KJT---(4XZZXI*&VVT)-2UK6HR2A"$D9F9GH1#Z`7$-:*N*^$@"IV`
M*.3D%YB^WFVIS\=VMB1MSLN92\PJU;DJ;P6JEI[D)-VRC*^$9(;2R)1MP5(8
M<3T*6E6I%*NF.5>4RW#=9EQL[$T/#3\,X=C3LCKUOJ1]80HUU%S)QN,XK;$@
M75X-G%7\$T_;#:_R-H#]>"MO\0>5%3R4PM\[%N#3[EXN3+.88]$\1J(^T^:D
MP\CH6I#\F0NFGFDT+0IQ;L20DVW#-*F7';%KG1DVD\@.Z+I,3-4Q/.TBF]CZ
M`#C&\&@#F[1M#@V\Z-U9#J>Q/>\+,I%LD8-QKN>RI)X3N(J2UVP["TGKU2DH
M2I:U)0A"34M:C)*4I26JE*4>A)2DBU,S]`P<`DT&]9D2`*G<N$=Z?,6XX;0.
M3*J%D#^YN515+971X`4>S@QI*>Y/AV.4//,X^PEMU)H=3'>ER6E%HIG7H)'T
M_P`K-5YT-FDB%G9.V\<U6DC[&,`O/6.(-:?KE@&<YDZ:PQ="R0W5V/DQ4<`?
MLGU#!VT+B/K5%]NIYL._N4_"XVUU%B6UL)2'"A2GHK>:Y&VLRT0IRPO8[..F
MKI[)'5=J5*]HU$0R75_(K*MTE<.TA?N=K"-O''QLC$,O"#6(!_%P/?\`(D<\
ML#@`\!I+FQK=<WLO<W'#;0Q6UH=E?YQX[:N`:?)P?"H]LVY8\G,[>D(RW?'<
MZ2AQ;J9-7$RFTQ^I-9FI+B'*&@>JJA)IU-)%X!=I&9%H1F0YK9C/ZN%W+8Y>
MZO([N*1S)(BYT?`]I+7-=&WA`+2"""-AJ%Y3Z@S-Z.*6ZF<P]`<6M/F;0?46
MA;&UM+=\Y5M93[24?=K)L9DB:^?>M3B]7I+CKA]SBS4?7JHS/TF,:DEDE=Q2
MN<YW622?JJV/>^0\4A+G=IK^ZOH#\+\K9&.;R;NX<ZA_$]TMQ<9=;7WH70YK
MDE29*,S,S,H-DPE1*U/N(R,E$9D>NHN-OF,M9GBM+JXB(^MD>W]PA5D.1R%N
M:V\\S#]B]P_<*ZTV\\S3E_@"HS;VX<3/JV-V:56X=#7WB7B0>IE)NX":?+'O
M$+HHSL==/09'U&58_F3JVP(!N!/&/DRM#J^5PX7_`,=7ZTUIJ"TH#,)6#HD:
M'?"X4?\`QE)+LUYQ^W=ZY%J][]O[?`I3BFV5Y3B#SF5XV2E:>)+GTSK<3(ZJ
M*@M?8C%;.GH7NGI(V'YOX^<B+-6[X'?7Q^FSRENQ[1Y.,K,L=S#M)2(\G$Z)
MWUS/2;Y2-C@/)Q%2S[>;G[>[LX^SE.VV8T&9T+QI0<^BL&9A1GC3W_!+",DR
MEUDY*>JF)+;3R/UR2$JX_)X_*VXNL;-'-`>EIK3L(WM/80#V+/;2]M+^(3V<
MC)(CTM-?,>D'L-"L[%<JI`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`
M1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`
M1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`
M1`1`1`1`1`1`1`1`1`1`1`1`1`1`18/N'N/A^UN,S<LS6W9JJJ(1I;(_OLVQ
MEFDS9KJN$@_&G3Y!E[*$%HDM5K-*$J4FXXO%7V9NVV6/87S.\P:.ESCN`'7Y
MA4D!4&2R=EB;5UY?/#(6_"3T!HWDGJ\YH`2H..2?+?<#>]R9052Y6&[;][C;
M>.0I"D3[U@CT0_E4YA1?#/$+VBAMZ1&]2(R>6@G3V)TGHC%Z>#;F8"XRU/CD
M>BP]48.[[8^D?L0>%0-J?6.1SI=;PU@QGU@.UXZY"-_VH]$?9$<2X1G0="5[
M/Z0D>.18#(R@7L[6[GY9LCN%0[B8=)\&TI)/[8AN+6F%=53RDILJ2R0C0W8%
MBP7:K]<VLDN(T<0A1>&9P]EJ'%R8N_%89!L/2QP^*]O46G;V[0=A(7OB<K=X
M+(QY*R-)6':.AS3\9KNL$?!L(V@+W.3/.7>W?R=94ES;KPS`5NJ*-M_B\E^+
M5R(GM$U_"&R(F;'*75MF1K*0:8?BI[VXS1EH5#I3E_IW2[&SP1_.,F!MFD`+
M@?L&[6QCJX?2IL+W*NU+K?/:C>Z&9_<X\[H8R0TC[-V]_;7T:[0T+BH[)O[7
MZ)C/.\"PK@*_I-BV?N?U0XPG`:KZ-DPW8I)U@B.6VGM))%[<E"="2T?7VW6T
M^\_7*+V"U]@BT_\`$SR*;J^RDU]I*'_]JMHZW$3!MNX6#XS0-]Q$T>B`.*6,
M<&US8VF]XJ_,)%M,?P1.P]1ZO(?J>18J.::RA`1`1`1?,TWW'J/R3\"_0%5M
M+;/<C<+:;(HV5[;Y?>8;?QS1^WJ6:Y'*2TA9+^"640^^#;0%K+VXTIIYAST*
M09"HL,MD<1<"[QLTD-P.EII4=1&YP['`@](5RL;N[L91/9R.CE'2#2O81N([
M"".Q3Y<4/-`Q_/%U>#<@F:[#,K?-F'!W`A%\$PR[?/[VW^'X[JU'BDYY7;W/
MDI=<M:E*/X(@DH.=M)<V;2_<S'ZD#8+LT`F&R)Q^S'^S)Z]K*UKP#8I4P>LH
M[KAMLH!'.=@>-C#]L/DGM^+]JI=D+0ZA#K2T.-N(2MMQ"B6A:%D2D+0M)FE2
M%)/4C+H9"9P014;05G>_:-R_L?40$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$6LMV=UL9V?Q&7E61N*=,C.-3T\=:$S[
MVT6A2F($,EZD@M$FMYTR-++1&HR,]$JN^$PMWG;YME:BG2YQ^*QO2X_N`=)V
M=HM68R]KA;,W=T:]#6C>]W0!_K/0-O8H.-X-SLQWJRA_),JDK3&:4ZU14##K
MJJG'H#BD_M6`RO1*GW4MI.1(-).R%I(U:)2A"-B,%B+'3]F+2R'IFA>\CTGG
MK)ZAMX6[FC=M))@7-96^SEV;F[)X1\1@)X6#J`Z^L[R>R@&D9E7H1^S[OJ&1
M1S*POBV+!;.#V]Q:>[ZA<89*JBD8M=V<;3NZ>[]GI%UA>K=*U:?S*H<EQ%R(
MJ3.9$)2VTI+53[1=7&.G4U:=4?VW3UF+BQQX=BH7`5VK0IV^AZ=WV?HAWO6O
MG=K^T6_7WWZ?4.]7WNUZ#-OZ/:_3'[$J_!C7W'7&Y1'(;U\0M#D%[XM3,DD^
M1EU(EJ,B5K^O,CU/NT3S@\4/)INF,D>8.FHN'3M[+2YC8/1M[AY^.`/BPSG^
M"R:K:@21L&1XR[,K.XE/X5HV=H_?"^N-/U=D!%\B$&H_M#\DKZ`O5CLZ^H>3
MG+W8U9!%C:Z=/ZHI7O59&Q93#B>CH*21ZK8XU*5PNYPY#LR[6[=[F2K#(MJ'
M5LQ*Z6XIV9<;?]RD-I>KM2<D3\9:1^RP"U4PDN^*1&2F7I0T#S0N-.2,Q6:<
M^;!$@-.]\'15N\NC'2S>-[-M6NSC`9Z:QI:W1+[/<.DL\G6WLZ.CJ-@>JM:R
M]K(%U2SXEK4VL2//K;*!(;E0IT*4VEZ-*BR65+:>8>:62DJ29D9&-JK>X@NX
M&75J]LEO(T.:YI!:YI%001L((4D,>V1H>P@L(J"-Q"]`>R_2`B`B`B`B`B`B
M`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B
M`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B
M`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`BQO+\LH\&QNWRO(
MYB85/31%RI3O13KAD9(8BQ6S4GQYDQ]:6F6R,C6XM*?6*NQLKC(W;+*T;Q3R
M.H!^Z3U`#:3T`*EO;RWL+5]Y=.X8&"I_U`=9)V`=)4)&ZVX^1;TYC)R>[-;$
M%KQ(F.T:7#7$I*GQ34U';T)*7IC_`$7)?T)3SOJ2A*$(V#PN*M<!8"SMZ&0[
M7OZ7NZ^P#<T=`ZR23!&8RESG+TW4^Q@V,9T,;U=I/RCTGL``P,Z71/O?5Z-/
MU!<OG&U6[N=FY8Y9U7:E7LZ>GU?[XJX9ZE4TD2UA<P>WNT+[.HO%O+7>K9,Q
M:FN(^G?T%[@<K5,U:TLVM#5^B+M"5;)0N4-SJE='8IM(Z#37V:U=^A>Q'G=5
MK;Z=$ID)(UI^V2B]!$/Q<@QD/'Q3^ZOU`>,<)^,%K1%M_;?I_9H*7O54&/8O
M38MNI>W^F/1LJ_!C610;;M6A6I*T,M4F:B)1?KDJ-*DJ[5%T/0R/04>7Q>-U
M!BKC"9>)L^,NHG1R,=N<UPH>T$;VN'I-<`YI!`*_#>*-XD9L<#598VZV\A+C
M9D:5EW$1+):D=3+L7H23):3+UD6OI+H9&.07-3EWD.66L)]-W9,EG_.6TI%.
M^MW$\#N@<;2"R0#8)&NI5O"3E%O.VXB$@W](ZBOE2DU&(X)50!5>DPSKIT'D
MYR]F-JO?BQCZ=!3/<JMC%D\.+KIT%)(]5L<:R^##]'04,CU<(HUFE?"][T%#
M)(KE%$I2."O)V3MO:0]I\ZL3/;Z\F&WC]C,</PL,O)SRE]ANJ,TQ\=N9;I^.
M1_>XTE?CZH0J0HYBY3<R3@KQFF\U)_\`"3/I&]QV02./7T1/<?2Z&./'L!>5
MF.#OW6Y%K,?P!W?8G]XGX#MZU-\-N%F*`B`B`B`B`B`B`B`B`B`B`B`B`B`B
M`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B
M`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B
M`B`B`B`B`B`B`B`B`B`B`B`B`B`B`BB?Y;[O.9[FG^;VBEJ5BN%S'&K)3#AF
MQ<92V1LRW5D1%XC-%W+C-EZ/&-Y1:D:#*:=$8,8VP_.ERW_G;AOHUWMCWCSO
MV./9PC9M4/ZRS1R%]^;;<_\`*0.]*FYTFX^9FUH[>(]2T#3TO<E/L^HO4?09
M-/<;5C<,-0LG<HM&]?#]7N"C%S4[U5&#8L%NZOL2OV?N"XV\U2%03Q46E,@A
M]OB%I[OV?H#(;:2M"K+<,6D[QG0U_HC(;=RLL[5J>U01&KI[O^Z+U"2K3*%J
MG+:1C(*B?52-$E):5X+NFJH\E'MQI"?61M/$1G_9)U+T&8KG1MFB,9Z1\!ZU
M2M>8I`\="X+F2)57/EULU)LRX,EV+);,_>NLK-"B(_0I)F6J5%T,NI=#&-.<
MZ-Y8_8X&A5\`:]H>WXI%5]J-:ZZ>T/VV1?DL63PK/T>U]KT_U14,D7BYBV'0
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MUYI*-(5Z5$32U&:W%#<KDGKTZGPIP>1?7-6#`*G?)!\5C^US-C'G[1Q)+BLN
ML93)$&/^.WZHZ%V:)O5<@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(M(\AMS"VIVLR#(HSR6KV8A%#C"3+52KVU2XVP^A)D:5'61
M4/2S(^BBCFGTF1'D.E\1^>LS%:O%;9OIR?:-WC^$:-_A*Q:DROYHQ,ERTTN'
M>@S[=VX_P15WF4,^-0UO+)QTU...+-;CBU&M:UK,U*6M2M5*4I1F9F9ZF)ZO
M)`T4&P=2@ZV87&IWKH7':7O2C1/I(O5]SH,7NKBA606\-5F4JA[&3,T>KW/M
M>G[@H&7-7;U6OMZ-6G<GKR;)?L]=#]S]$7ZSEJK/<QTJN=<F8T-ST>L93:.W
M+';EN]:#R!'5?Z/^^,FM3L"L-P%I^W26J_L]P7V`JSS=:U[.Z&?V>L7.-6]^
MY<8\A<=.MGP<OB(T8L5(K;7M+HF<RT:H4A6GKDQ&E-F?0B-E/K4+)FH#&YMT
MW<[8?+T'SC9YE=L7+QM-N[>-H\G3]7]U:`B6>IE[7K]W[/6+,V17-S%E]?8Z
MZ>UZ14L>O![%G5;.U[?:]P5L;U2O:N@L3GE:PB[S-4F-VMO&9FI2R,OO3RC/
M]<XE)D9F9F:DF8YG>*;EN-(:Q&JL7&6X',%SW4'HQW8VS-[!+LF;4[7.E#0&
ML`&18J?OXN[<?PC/JCH/^I;%B1==.@U3>]7^-A66P8GHZ>YZA12/5?%&LQ@0
MO>]/60H9)%<8HUG%=!][T]S[/M"WRR*YPQ+/:V![WV?<]706Z6176&);$J*M
M;RVVT([EJ/0B,ONF?Z!$6HMLCRX\(WJ[P0UV+JO9G*']K\OQ_(H9N+9ARB;M
MV4F>L^LF$3%FQV%[!J.,9J:UU)+J$*ZFG49CH;44VD=1VN:AJ8HWTE:/EQ/]
M&1M-U>':VNYP:=M%>H&B.E%-=&D,2X[$N,ZA^-*9:D1WFSU0\P^A+C3J#]:'
M&U$9?:,=$X9HKB)L\+@Z%[0YI&XM(J".P@U5>OF'HB`B`B`B`B`B`B`B`B`B
M`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B
M`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B
M`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`BBHYXYNNUS_`!+;V,\9P\8J%7ED
MVA>J%6]^[X<=I]LCT\6#504+09]23,5[HF?EOCQ#C)\H\?A)G\#?M6;Z>5Q(
M/VH41<P;_OLC#C6GT(F<;OMG[J^1H!'VRYXQ&,2C:U+^Q^Z,HOGTJL8LV[EU
M;AM<ETFB-/I[?5[HPN_EX:K*K..M%L2_J$Q8G5)%JWKKI[I=/5Z.HM5M/QO\
MZN$\(:Q<P9BTE/BZ%Z-?L_2&86!)HL9O`!6BY=RK3[Y[O7_=&96/0L7NMY7/
M>0'U7^B,HMEC]STK3=N?58OL'0K--U+7D[TG]GK%TC5O?N6M<[QIK+\6N\?<
M)).3H:_@;B^A,6#&DB`\:M#-*6Y;2.[3J:-2]!C[=VXNK9\!WD;.P]'U5]MY
MC;SME&X';Y.GZBC!CRGF'UL/I6T^PXMEYIPC2XTZTLT.-K2?5*T+(R,C]!B/
MFN(/"[8X%9DYH(J-Q6:ULW7MZ^YZ_P#<%7&]4[VK8E7+,^WK[@KHW*C>U;AP
MNY_!MI%?6HB8<,H\K70B*.ZI)*69^&XHO"425^R7<?;IJ6IC!.;&@X.9.@K[
M3+@WY^YG>VSC\BYB!=$:FO"'&L3R!7NY'@;2OMI<?-+ILOR*T/D._P"#?YEU
MK!BD9)41:D>AD?J,CZZ_<T'&"Z9-;3/M[AKF3QN+7-<*.:YIHYI!V@@BA!V@
M[%(D3`0'#<LR@P^I=/TA;))%<HH]JS>O@^]]GW/L^T+?+(KG#$L[K8'O?9]S
MU"W2R*ZPQ+8]-4.R%)2VC7JGN6?1""/UJ/0R+T'T])Z="%ND?Q;MRNT$))H%
MMNHK&H22[/;<46BG#+0S(C]Z1:GVEK_5T'X8T5JKQ%&&#M6:PV_1^J*^)JJF
MA2M<;<H5D>V%7$?<-<W&'GL>>-6G<<6,EM^K,B_]6W72&V2/UFR8WDY-YPYC
M1,,$IK<V3C;G[5M'1^81N:P?:%5+=RWZ)57Z0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$4`V]62*RS?C="X4X;K99A9U$9PSZ+A8X
MXG'H*D>XVJ'5H-)>G0^O4;+Z?M!9:<LX*4/S=KCY7^F?JN*UWSMU\\U!=SDU
M'?N:/(ST!]1H64X@9$;6OH]GT_<]8H[^NU>]GT+J[#93;)-J,R+0D^LNGH&%
M7["ZH65V;P%FF3W"7XQD:O0C0NNOH+3U&*"S@+755;<S!S5RMF4I*C=Z_P!D
M,SL&$46*WCZU7+V4OD9N?H_9Z]!F%FTT"QBZ=OHN?,A<U-S]$91:C8%C]P5I
MVW5J:OT1?8-BL\Q6OYI]3^Z?_D%TC5`\KQ%>DQ4#<O!1F[Y4Q8YNMD+;2?#C
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M3@EYJ?\`P_T_T*NC&-:*-W+)HC?H^S[.@JHPO=H64PFNI=!<(FKV:%V[Q(ME
M1[O**%2]&["IBVC:%="\:KE?!E^'J>G>MJTU,BZF2-?UHV/Y`9$Q96^Q+CZ,
MUNV4#MB?PFG:1+MZP.Q>[=R[J&TB_2`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B
M`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B
M`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B
M`B`B`B`B`B`B`B`B`B`B`BK0P+1=I:SK1W4G+&PEV#A*-)J[YDER0ON-*4),
M^YSKH1%]H;;2P"&%L(W-:&_`*+5QDIEF=*=[G$_":K?.+2B1X?7W/T!C5XRM
M5?;5]*+H*BN":;1[6G0O7]A#&+F"I*R"":@7H6U]WM*]OU>[]KUCR@MJ.7I+
M<5"T/E-D2R<]KW?7]G49)9Q4HK%=2UJN=,EE]QN=?=^X,JM&;ECERY:'OG]3
M<Z^Z,EMF[`K%.5J2U<U-77W1>X0K3*5@LQ6IGU%Q8J%Y7DGZ3^Z/<;EY%<(\
MKXJ$9?B<TD:.2,?D15+]GVD1+)UUM'0N_P!A4Y1]>GM=/6,.U*W_`)J)W26$
M?`?_`!638)WX"1O0'U^$?^"T55$?LZ^X7^X+-$KG)O6SJC7V?T/ZHN,2HWT6
MT*C7V?L]0N$2HI=VQ=4["O/.93^!6DFZNYAJ;880A2G'I<362TE&FNG;&)XS
MUZ:$-6/&5IB++\I/TB`:+G#WL4O$=_<SN%M(P'H#I)('N]6*K(-'3.&8^:`$
M]\P@#[)OI#Z@<I"J+;N89(=LW$0T=#\%OM>D&7M:D9D9M-'T+UKZ'Z"'(N?(
MPC8RKSV;!\)_U`@]:F^VQ,N^8AHZMY6T:ZGKZM';$82E>FBGE^V\OHDCU<5U
M)*C01]I:)U]!"T2W,LVQQHWJ&[H^'=7;T[E>X;>*$>@-O7TKVFDZ_HF/)H50
M%[49'H^S[7]053`OV`LDAM^C]`5T87LT++(37O?]\7&)J]VA=,\<WU1-SJ1L
MCT3.B7$19]"(TE52IB2,S].KL1.GKUT$O\G)S;ZZM6#8V6.9A_%/?^ZP>>B]
MP-BD=&YJ^("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"*KSC\G0T=?<&X5TQ:I6[J+>%!8=I(]KW/7^J,=N8JJ^6\E%MFONNU!>WZO=
M%DEMZFJNT<U!M7]3[W5"O;]W3KT"*WVI)/L6J;^U[B7[1GZ?6+U;0T5IN):K
M1N03N[OZ^G7U^Z,BM8U9+AZTQ=2=>_K[HO\`;M5FG=5:PLW=35U]T7B%JM<I
M6'25:F?V>@5[1L5&[>O/'HOPN"N3EBS8Y]5UC)DM5)0LHE&1=42K"2]+\%7W
M(?@K+_C!AFH9!)>MC'R&;?*37]RBRC#,++5SS\IVSR#9^[5:BJHYEV]/<^SJ
M+9&U5[RME5+)EV]/<%?$%1R%;-J6O>_H"XQA44A72>QTM5=N9@L@B,S7D=9!
M/MTUTM'TUJE>T1EVDF69GZ]/1U$:\],=#DN2VJK><!S&X&]E`/UT$#YV'RA\
M;2.H@*Y::F=!J.R>W>;F-OF>X-/U'*7L<#%M`GI'U?5]]A'H'JP+]!>]%;]'
MV?9T%9&%Z-63PV_0*^)J]VA9?!:]'3](7*)J]VA=`[&M=NY6*'IZ)4O_`"9.
M$G<KF_\`[QCS_O'^R>O:GHJ2,;KK\("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("*K_`)#"7C><9?C[B?"<HLKR&F6WVDWX:ZRWEPE(
M\-))2CM-C30B(B]&@W`M9!=XZ"Z&T20L=]TT'_6M5+F,VM]-;G88YGM^Y<1_
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MYZ'EF1EVD4AAM):GH:U$7KT$.>)#4-MIGD9J2]N33YQC9+1@V5<^]I:@`'?3
MO2YU-H8USNA7O2%JZ]U/9QM%>"42'L$?IU^%M!VD*5D<(%LVO[06I_<'Z"^K
MU8Z/1]GI_K$*A@7["R*(WZ!6QM7LT+*X37H_WQ<(FKV:%F,!GWO07.%JJ&A=
M&;"P?'W&H5FG5$1JTDK+0^G;53&FSU(^G:\\D^O0_0)8Y2VW?:XLW4JV-LKS
MYHG@'[HA>I^(I!1N,O)`1<S<N^3%'Q$V+R7?3(\9MLOJ<:L<;KGZ*DF0X-C)
M7DE]`H6'&I,XE1D)C/3R<61]32DR+J,PT)H^YUWJ2'3=I,R">9DC@]X):.[8
MYYJ&[=H%`L3UMJRWT3IV74-U"^>&)S&EC"`X\;PP;3LV5JH>?Z0[LU\W;<[^
M-.*_WH3U^RKJ#Z5L_P`7(H._:<P7T7=_C(T_I#NS7S=MSOXTXK_>@_95U!]*
MV?XN1/VG,%]%W?XR-/Z0[LU\W;<[^-.*_P!Z#]E74'TK9_BY$_:<P7T7=_C(
MT_I#NS7S=MSOXTXK_>@_95U!]*V?XN1/VG,%]%W?XR-/Z0[LU\W;<[^-.*_W
MH/V5=0?2MG^+D3]IS!?1=W^,C3^D.[-?-VW._C3BO]Z#]E74'TK9_BY$_:<P
M7T7=_C(T_I#NS7S=MSOXTXK_`'H/V5=0?2MG^+D3]IS!?1=W^,C3^D.[-?-V
MW._C3BO]Z#]E74'TK9_BY$_:<P7T7=_C(UE%;]82XRNG%_"^RV^T$EDCX<=:
MSM_:G'4:?;**4K,Z;X825="-?@=Q=="]`HYO"SK!O%W&0QKNKB,[:^6D3Z>:
MJK(O$SI,T[^PR+>OA$+J>2LK:^>BW3B/GI\$,D6TBYLMV-OTN>'WN9=MTY-0
MQWF9*\4L#N,V</PB+578E>I'[.IZD,>OO#;S+M`3;LL;JG]%/2OD[YL._MIV
MJ_67B'Y=71`G?>VU?Z2"M/Q+I=W95=P;5<Y^(&]C\2%MKR'VPO;:>YX4''IN
M0LXOE,US4B[(F*Y:BBR.2>IE[R*KTB.,WRWUYIUKI,OBKR*!HVO##)&/+)%Q
MQCSN4@X;F'HC/N;'BLI:23..QA>(Y#Y(Y.!Y\S5U<,)69("("("("+1')K?:
MIXR[%[A;Z7M#8Y/4[>UU=8S**IDQH=C8HL;ZJH4-QI,PCC-*;>M4N&:^AI09
M>DR&2Z/TU/K#4EKINVE9#/=/<T/<"6MX6.?M`V[FTV=:QW5NHH=)Z=N=0W$;
MIH;9K7%C2`YW$]K-A.S>ZOF4*_\`2'=FOF[;G?QIQ7^]#87]E74'TK9_BY%`
MG[3F"^B[O\9&G](=V:^;MN=_&G%?[T'[*NH/I6S_`!<B?M.8+Z+N_P`9&G](
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M("("("("("("("("("("*NER_P`<5A7)?<V(39MQ;NVC9;#<[>U,A.40(MO-
M=06O7LMY,ELS]:FS,;3Z&N_SAI*S?6KXV&(]G=DM'\4-/G6M>L[4V.J+IGR9
M'B0=O&`X_P`8N'F6FJZR[2+VO5[HOTL-58XY-BRAJVT26JNGW11F!539E\$F
MWU2?M>KW1^F0;5^73+#K*SU[O:]WUBX0P]:HY):A:ZM9VO=U]WUBZ0QJW2O6
MO+&3J:NONBZ1,5OD<L,ENZF8N$;51/*UUE^94N(0E3+1_5Y:5?`Z]DTJFSG"
M_6LMF9=K9&9=SBM$)]9ZF1'\N+J&UCXY3M.X=)_TZU]AMY+A_"P;.D]`7#N9
MY)<YW<'9VI^&PSWMUU:VM2HM='49'X;>I)\5]WM(W73(E.&1="224IQ&[GEO
M)>\D^+T#H`_TWE9);0QVL?`S?TGI/^G0%X\2LT,O9]SU?H#R;&O1SUET"NT,
MO9_2%2R-4[WK.:V#[WV/<%;&RBIGN6P*R'[WI[GI_KBMC8J1[E)MQRVN=P^D
M<R>ZC*8OK^.A$>,\WV/UM.:DO-MN$KVVY$]:4N.)/0TI2@C(E$HAR3\97/.U
MU[J"/E[I>9LNE<1,732L-67-Z`YAX#N=%;-<^-CAL?(^5PXF"-YG7E[IE^+M
M79:];PWUPVC6G>R/8=O4YYH2.@!H-#4+I@:0J2%]EE.NGVQZ-"_07M1D>C[/
MLZ"J8%Z`+)H;?HZ?^05T35[-"RV"U[WH+C$U>[0LSKV?>]/<%TA:JAH77'&V
MI-R_NK92#-%?4HB)/U)?L9*%H/IZ5>#!<+[AG]H3[R/QYES5UD2*LAM@P=CI
M7`CS\,;AY_(OW)L;3M78PV:7B@(HHO.L^CUW6^,^UGRB8\)N\//O3LO4W/L'
MJ&N?GNRO/76_MF*D$.BZY_("("("("("("("("("("+OWBKYE?*KB?95D;%<
M]L,VVZB.--S=J=PIL_(L1<KR4?BQJ!<F0JTPR025J6VY6/,->-VJ?9D((VU1
MAK7E#HK6\+WWMLVVRSALN8`V.7BZ"^@X91T$2!QIL:YIVB2='<UM8Z,E8VSN
M77&+;OMYB7Q\/4RIXHCT@QD"NUS7#8;?G";GMLQS>PQZUP24YCN?X_$C.YWM
M;=R&59%C:WC2S^$8+J$M-9%B[\H^QFPCH21&I*'VX[RB:&A_,3EEJ#ESD!!D
MFB7%RN(AN6`]W)3;PN&WNY`-I8X]9:7-%5NYH#F/@>8%@9L<>ZR4309K=Y'&
MRNSB!V<<9.P/`Z@X-<:+N$1RI!0$0$4=_FP?1Z\EOBQB_P`HF'"5>2/O3P_K
MI/82J,.<WNRRWJH_;Q*AJ.F"YT("("*^5Y3_`-'KQI^+&4?*)F(YG\[O>GF/
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M]5A5A+0A+CCCB6VT$I2W%J)"$)3U4I2E&1)21>L_0*]C0!4[E1O=7<M`9CND
MS%)Z'CB$S9?5*K!U)G!8/T:L(]E4M:3]!]&RZ'JLN@\)[T1C@AVNZ^@?O_N+
MUBM>,\4NQO5T_P#@N9[-NPMYCL^SDO39CQZN/R%&M9EJ9DA/ZUMM&OLH21)2
M70B(660/E>7R$EQ5UCX6-X6"C>Q?5;J.I>S^EH/R(U],B]:-5:&7L_I?U?TA
MZMC7F7K)H59II[/VO0*AL:\7/6<4U-(ER(T2)&>E2Y3S,:+%C-+?D29#[B6F
M6&&6DJ<>>>=624H21J4HR(BU'N3'#&Z:9S60L:7.<2```*DDG8`!M).P#:O'
MTI'B-@)>XT`&TDG<`.DE2M;0<$<ZQ;'*[='<>E:*6V93H>"F9O6M-&0@G8]O
MD<0D*:\=.G?\#2M3D8NTWTDOO;:Y^>)KQ(Y27$3Z0Y425M'M='>7["0_@.QS
M+,BGH$<39+C>0?P&RDRF72/+B>`,S.?9^$!XF0':6]3I1U](9T?+VU:-[#EZ
MI47^D6ID0^A?5Z#">I?U![,"_07OQ6_0*R,+U`640FO0*^)J]FA9A`:][T%R
MB:JAH6;5[/O>@NL+54-"[_V(H#J,*1/=1VR+Z6[.ZEHHH;'[4B)/^U4;:W$^
MZEPAMWRAPYQNE1>R"DUY*9.W@;Z#!YZ.<.QR_,AJZG4MU"5%YH"**+SK/H]=
MUOC/M9\HF/";O#S[T[+U-S[!ZAKGY[LKSUUO[9BI!#HNN?R`B`B`B`B`B`B`
MB`B`B`B`BVALUO+N/L#N/C6ZVU.2S,5S3%9A2J^PBGWL26%^Q-J;:$O6-:TE
MK&-3,J*\E33[2C2HO096;4&G\3JC$S83-PMGQ\[:.:=X/0YIWM>T[6N&T':%
M=\%G<IIO*19G#2NAOX75:X;B.EKAN<QPV.:=A"OG\)>7>%<T-BZ'=C&&VJB_
M945#N+AAR$ORL-S6$PRNQKN_7Q)5-/;=3+K91D1R(3R.]+;Z7F6^9W,30F1Y
M?:DEPEX3):GTX):4$L))X7=CVT+9&_)>#0EI:X]&=`:VL->:>CS-H`RY'H3Q
M5J8I0!Q-[6GXS'=+2*T<'-'78P19L@(H[_-@^CUY+?%C%_E$PX2KR1]Z>']=
M)["51ASF]V66]5'[>)4-1TP7.A`1`17RO*?^CUXT_%C*/E$S$<S^=WO3S'KH
M_81+HOR9]V6)]5)[>52("*E)Z`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`
MB`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`B`
MB`B`B`B`B`B`B`B`B`B`B`B`B`B`BYYY4[4KWEV+SK#H;'CWZ*\K_%2)*ENG
MDF/J_",",P23Z.6R&G()F9'VHE*/34B&4:,S0P.H[:_D-+;BX)/5O]%Q/VM0
M_P`K5CFK<0<W@+BR8*W'#QQ_;L](`?;;6^1RK!,S5MJ-"^Y"TF:5)41I4E23
MT4E23T-)I/74O48W`=&"*C<M5@\C8=Z^^FQ/3WWH+[/NCR,07IWB^%VQZ'[7
MV>D?IL2_)D7@RY^B5&:B)):F9F>A$7K,SZ:=!4LC7B^1:UOLQB0R6B,E4Y\B
M/0FS)+"5%_9OGKK_`.82OND*MK"T;0J4O!.Q:*R.RN;U2BFR%%'UU3#8U:BI
MZZEW-D9FZI/J-9J,NNF@\I`YVP[EZ,+6[1O6"/5/]K^D*<Q+V$B^D=1_:_U!
M^.Z7[,E%_:*C^U'T1+X9.E>FQ4]2]GW/4/V(E^"]=,;$<6MUM^K1$;",><12
MLR$,VF86Z7H&+5/5/B$]8FTLYLMM"B/X-%0_)T/7L).JBP377,S1_+JS,^H;
MD?/2VL=M'1]Q)OIPQU'"TD$=Y(61UV<5=BOV!TQF=2S=WCHCW`-'2NV1MZZN
MIM/V+:N[**>CCEPSVOX\QXUNAE.8[B^"12LTMXK9*@..-&V^QB]:I3S5'&6E
M:DFX2G);B5&2W>PR0GGWS1YZ:JYC.?8`FQTQ79:QN/I@&H-Q)L,IK0\-&QM(
M!#.(<1V%TMH3$Z::+BG?Y2FV5P^+U]VW;P#MVN/2:;%UBZ[Z>OZGZH@M[UG*
MYMW'V9A7*W[C%4,5]JM2W9-;[+,">M7M*4P?1$*4M7I]#2S/KVGJHX_S^E(;
MPF[QW#'<G:6[FN[1]:?J'LWJAGLP_P!.+8[JZ#^\N495?-K)CT*QBOPY<=9H
M>CR&U-NH47NI41:I474C+4E%U(S(1I+!-;RF&=I9*#M!&W_3ZBMA:6GA<*%?
M<CH]'V?='HP+]A9'$;]`K8VKU:LKA->]Z"XQ-7NT+,H#7O1<X6JH:%M+"\=D
MY)>5=)$+1VPDMLJ<[343#):KD25EZ31'82I9EZR2,KTYAI\[E[?$VW\[/(&U
MW\+=[G'L:T%Q\B]QZ(JI,(4./7PXD"(V346%&8B1FB]#;$=I++2"]'O6T$0W
MIM+6&RM8[.V'#;Q1M8T=36@-`\P"IR:FIWK[0J$0$447G6?1Z[K?&?:SY1,>
M$W>'GWIV7J;GV#U#7/SW97GKK?VS%2"'1=<_D!$!%/+Q/\DC\Z#CUMIOQ^<U
M_`?_`#B5EI9?P5_S,?PE_`_X-R*XH/!_#G^=C'_PAXWX)\7N^!L=OB=NA]O<
M>L^M_$5^ANJKS3/YG^<_-'M;WGSON^/BC8^O!\V?PTXJ?'.ZO31;&:,Y`?I=
MIFTU'^=OF_SICG=W\U[SAX7N93C^<,XJ\-?BC?3HJNB/Z.9_]8W_`-O?_P`\
M!BO[6'_T'_KO_9K)_P!EW_[S_P!%_P"[3^CF?_6-_P#;W_\`/`/VL/\`Z#_U
MW_LT_9=_^\_]%_[M/Z.9_P#6-_\`;W_\\`_:P_\`H/\`UW_LT_9=_P#O/_1?
M^[7QN_5S72:<-CF&VX\3:S9;=X_J9:6Z23-M#CR-ZWUM-J7H1J)"S274DGZ!
M];XL!4<6`(;7;2]K]3YH*_"/*OA\+IH>'.`NIL_Y.GU?G1_<*YJW9\@KE5AT
M&39[8YQMCN^U&2M2:1N988'E<PR2:D%"AY"S(Q8]>TR/QKEDR4:="41F:<OP
M?B=T5?RB',VUY8./RZ-FB'E+")/@B/3NZ<4S/AOUC8QF;$7%I?-'R*NAD/D#
MP8_AE'GZ(;MS]IMS-E<MFX)NQ@V3;?9=7D3C]'E%5)JY;D93CC;-A!4^@F+.
MJE*95X$N,MV,^DNYMQ1=1/N&SF'U#8MR6#N8;JQ=N?&X.%>EIIM:X5VM<`X=
M("@O+X7+8"]=CLU;RVUZW>R1I::=!%=CFFFQS26GH)6O!=5;$!$!%*GY07*N
M7QNY9XSCMO8.L[:;[/UNV6915OFB##N[&;X>`94XVI:&"?I<BEE%<>69)9KK
M*6KJ?:0A7GOHIFKM#S7<#`<OC0ZXB--I8T?AX^NCXQQ`#?)'&.M3%R1UB_2N
MM(K6=Q&)R);!**[`]Q_`R=56O/"2=S'O*O#CG(N@B`BCO\V#Z/7DM\6,7^43
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MMO.ZN1LZ1OV[2VGX-_G:.$G>7-<3O6LO,+!'"9UT\+:6-U61G4'5_"-\SCQ`
M#<US1T+G';?9[=O=R2F+MQ@.2Y47B&TY/@P5,TD9TM/8G9!.5$HH"NOH?D-Z
MC*\MG<)@V<>5N8H=GQ2:O/D8*O=YFE8UC,+F<P[AQEO+**[P*-'E>:-'G(4C
M6V'E8Y?:QRG[O9]`Q7Q&#-G'\08+(+1MQ:%$@K*WF_`ZJ*N.[H:FX[<U#B>A
M.H/J459CG+8PN[K!VSIJ':^4\#?X+15QKUN+"/K2I*Q7*>\F;WF9N&PU'Q(Q
MQN\[C1HIU`.KUA1#[MX)F&U^?Y3MQG+"XU[BMH]72VDD:8DIDB2]`M(/1/C5
M]K`=;DQUF6JF74F>AZD4X87(V&9QD.5QY#K:9@<.L'<6GJ<UU6N'6"H>R]A>
MXG(RXV^%+B%]#U'J<.L.%'`]16I9%>AS4TD7W!<G,!5`'D+P)%3Z?8_2'BZ)
M>H>O(=J.OO/TAY&)?L/7U#J.OO/_`,H_/=+Z9%MG:SCSNGO)8%7[>89:WK:'
MT,3+8F2A8_6*41+,[*\F*8K(BDM:K)LW/&6DM$(4>A'B&K-<:1T/;?.M37T-
ML2VK8R>*9XW?@XFUD=MV$AO"/E$#:KWAL%F<_+W6*@?+0T+MS&_;/-&CKI6I
MZ`5+EL9Y96#8BJ%?[T6S>>W;/8\6)U!R8.&Q'B(C)$Z6M,>XR+PG")1:E"85
MU2XRZGTZ:<P/%/FLHV3':$@./LCL^<2\+[EPZV,]**&NT;Y7;G-<QRFO3O*>
MQM"VYS\@N;@?[-M1$/*=CG_Q!T$."DMKJVIH*R%34=;`IJ>MCHB5U75Q(\"N
M@Q6BT;CPX<5MJ/'907H2A)$0U,O\A>9&ZDOLA+)/>RN+GR2.+WO<=Y<YQ+B>
MTDE2W!!#;0M@MV-C@8*-:T!K0.H`;`.P+^77?3U_4_5%L>]>R\QUWT]?L_KB
MD>]?5YKKOV>Y^J*5[_@181E&+T64L>%;1$K=;291YK6C4V-J>OWI\DF9I,RZ
MH42D'ZR%ER-A9Y%G!<M!<-SAL</(?]1V=B\Y(8Y11XV]?2N>[K;&XIG%NUY_
MA>"7<I*F4]DQM!$I6CL74^\R(M-6S5W'ZB]`PB[P%S:DN@_"0_QAYNFG9OZE
M;WVDC-K?2;]7X%CT9A;:C0M"D+0?:I"TFE25%T-*DGH9&*)C"TT<*."\VA99
M!:]`N$35[M"S2O9]Z+I"Q5+`NZ]@,%54UCF76+/9,MV/!J6UIT4S5&I*URM#
MZI78.(+MZ:^$@C(S)P;3\G=).Q]B[4MZVEU<MX80=[8J@E_ED(%/L`"#1Z/=
M\D+HX3<O-`1`111>=9]'KNM\9]K/E$QX3=X>?>G9>IN?8/4-<_/=E>>NM_;,
M5((=%US^0$0$5\KRG_H]>-/Q8RCY1,Q',_G=[T\QZZ/V$2Z+\F?=EB?52>WE
M4B`BI2>@(@(@(@(N>>2G%S9CEAM[-VYWDQ2+=U[B77*._C(8BY9AUHLD]ESB
M=\IAZ34SD*0GQ$D2X\ILC:D-.M*4@\JTCK/4&B,JW+8"=T<H^.PU,4K?K)65
M`<.K<YI])I:X`K&-5Z0P.L\8[%YV$21GXCQ021.^NC?0EIZ][7#8X$5"H=\L
MN,^:\1]],QV2S993Y%`\Q.Q[(V8JX<'+\1M$J?H,G@,+=D$RW.CI4V^R3KOP
M6:R_'-:E-*,^EVA]88_76F[?46.'"R4$/C)JZ*5NQ\;C05H=K30<3"U]`'!<
MZ=9Z3O\`16H9\!D/2=$06/`H)8W;62`;:5&PBIX7!S:DM*YO&6K%D!%\T>1(
MAR&)<1]Z+*BO-2(TF.ZMB1'D,+2ZR^P\TI+C+S+B24E23)25$1D>H_+V-D:6
M/`<QPH0=H(.\$=(*_37.8X/82'@U!&P@C<0>@A?HR\:=SE[T<>MDMUWW&W)V
MX&UV$93;^$220U>VN/0)%_%(D$E!'#NE/M&22(B-!Z=!R?U?AQI[561PC01'
M:WLT;>UC7N##YV<)\ZZB:4RQSVF<?F7$&2YLXI'=CW,!>/,^H\RW>,<60+'<
MLQ#$\]QZSQ'.L7QW-,4NFFF+G&,LI*W(\>MF6)+,QEFSI;B-,K9[3,N.VZE+
MK2R2XVE1>TDC*KL;^^QETR^QLTMO?1DEDD3W1O:2""6O:0YI()!H1L)"I;VQ
MLLE:OLLC#%/92"CHY&->QP!!`<QP+30@':-X!6AOS*.&GS2.,GY!=J_Q4&3?
MK$Y@?3N8_+;G^L6.?H#H7Z%Q/Y';_P!6GYE'#3YI'&3\@NU?XJ!^L3F!].YC
M\MN?ZQ/T!T+]"XG\CM_ZM/S*.&GS2.,GY!=J_P`5`_6)S`^G<Q^6W/\`6)^@
M.A?H7$_D=O\`U:WSB>(8G@6/5F(X+B^.X7BE*TZQ38QB=)6XYCU2R_)>F/,U
ME+3QH=;`:>ER''5)::02G'%*/VE&9XS?7]]D[I]]DII;B^D(+Y)7ND>X@``N
M>XESB``!4G8`%D=E8V6-M666.AB@LHQ1L<;&L8T$DD-8T!HJ23L&\DK(A2*J
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$7,V^/,
MGB_QP:D?YY-Z\'Q"SCM$\>+_`(3.\S5UM7O%L83CK5ME;S2U="<*'X1'Z5$7
M49AIS0&LM6N'Z/XZYGA)IWG#P0CRS2<,0/9Q5[%B>H-=:1TL#^?;^W@E`KW?
M%QR^:)G%(1V\-.U1C0?/1V7SK??:C9W:?:[,;BAW!W.P[`+;<C-K"NQ&'41<
MIR.OH/PW48U$3?V%I%:.>3FLV15N-H29J;/3M$Q2>&W4.-TU?9_-WMO'<VMG
M+.VWA:Z4N,<;G\#I#P-:3PT]!L@)W'I421^(;`Y'45E@\-9SOMKF[BA=/*YL
M8:)'M9QMC'&7#;7TG1D=(Z%.D-;5L.@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(L3RS`\(SQFMC9OB.-Y?&I[!-
MM5QLEI:^[C0;)#+L=$V-'L8\AEN0EE]1$HDZEKKZ2(RK;+)9#&N>_'SRP/D;
MPN,;W,);4&A+2#2H5'>8^QR#6MOH8IFL=Q-#VAP#J4J`X$5H5DL6+%@QV8<*
M,Q#B1FTLQXL5EN/'8:06B&F6&DH::;070DI(B(4CWOD<7R$N>34DFI)[255,
M8R-H8P!K`-@`H!Y`OG'Y7Z4<'F#</"W^P].X.!5Z#W>P>O<)B*PVDG<YQEDW
M)+^-.&G12KF"M:WZQ9ZDIQ3D=1:/(<9E;EAKO]&;_P#->2<?S'<.VD[H9#L$
MGVIV"0=``</BD.C3F)HS](;+\XX]O_S$#=@'^U8-I9]L-I9VU;\H$5J7V'XK
M[T:2R['DQW7&)$=]M;+[#[*S;=9>:<)+C3K3B32I*B(TF6A]1MHUS7M#V$%A
M%01M!!W$'J6L;FN8XL>"'`T(.P@CH*_N)!E64IB#!B2)\V4XEF-$B,.R94AU
M9Z(:8890MYUQ1^A*2,S'XGFAMXG3W+VQP,%7.<0UK0-Y)-``.LK['')*\1Q-
M+I'&@`!))Z@!M*ZSVUX)[\[CG'E2\9;P&D>-)JM,X6Y52?"T-2S8QY#4C(%N
M=A%V>+'8:6:B^^$6II@_5WB&Y9:6#H8KLY+(-_V=F!**]%9JM@`KOX9'.'UA
M-`<_PO+75>7(D?#\UMC\J:K33LCH9*]56@'KWTD8VH\NS9;!#BV><*F;H7S)
MDX;=NC\&8JTZ6AD;..Q'W7)A)U,E%-E2F5EH?A),:IZU\3^N-0A]KIYL>(QS
MME8SWEP1TUG<`&]8,4<;VGY94O8+E1@,:1-DBZ]NA]=Z,0/9&"2?X;G`_6A=
MRP*^KHZ^-54M;7T]7!:2Q"K:N''KZ^&P@M$,1(<1MF/':070DH21$-:[_(7F
M0N7WE_++/=R&KGR.<][B=Y<YQ+G'M)4FPP0VT38+=C(X6B@:T!K0.P"@`\B_
MAUWT]1;'O7LO,==]/7]3]44KWKZO,==]/7[/ZXI'O7U>:Z[]GN?JBE>_X$7F
MNN^GJ*1[U]7F.N^GK]GNF*5[U]7T%*-1_:%,35?5YLNKKI_69#COJT,B<6V7
MBI(R(C[74Z.IZ$7H,O07N#QD@AE_G&M=Y0OPZ-C_`(P!*\S^"]2G3PD/LZ'K
MJAXU:^GI]^)TM.OW>@I_F%L!1H(\A/\`KJOQW+.BJW/M-M0SE5DF7,9>+'ZU
MY*IC[BEI.>\G1:*UA2";0?<1D;RD]4-GZ24I)B3>76@AJ:^%S=L(PL#P7N-1
MWCMXB:10;=A>1M:T[P7`K\OX6#9\9=V-MH:0AII"&VVT);;;;22$-H01)0A"
M$D24H2DM"(NA$-N&,9&P1Q@-8T```4``V``#<!T!>"_L?I$!$!%%%YUGT>NZ
MWQGVL^43'A-WAY]Z=EZFY]@]0US\]V5YZZW]LQ4@AT77/Y`1`17RO*?^CUXT
M_%C*/E$S$<S^=WO3S'KH_81+HOR9]V6)]5)[>52("*E)Z`B`B`B`B`BK1_6'
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M,XW`R:FP[#\?99D7>2Y#/8K*:J8D2X\%AV=/DK0Q';>F2FVDFHRU6M)>DQ6X
M[&W^7O8\;BX9+B_E)#(V-+GN(!)`:-IH`3Y`J/(9&QQ5F_(9*6."QB`+Y'D-
M:T$@`DG8*D@>4KF?^<%X/_.LV+_*)CW^.#,/U6\QOH3)?B'_`+RQ/]9G+[Z9
MQWXYG[Z?S@O!_P"=9L7^43'O\<#]5O,;Z$R7XA_[R?K,Y??3.._',_?3^<%X
M/_.LV+_*)CW^.!^JWF-]"9+\0_\`>3]9G+[Z9QWXYG[ZZ8PC.<.W*Q6GSC;_
M`":FS'#\@9>D4F2X]/8LZ:U8CRY$%]V#/C+6Q(;9F17&E&DST6A1>DAA^1QM
M_B+V3&Y2&2WOXB`^-[2U[20"`6G:*@@^0K+,?D;'*V;,AC98Y[&4$LD80YK@
M"02"-AH01Y0LJ%$JQ`1`1`1`18#N)NKMGM%1+R;=/<##=NZ!!.Z6V9Y)4XY"
M?6R@EKCQ';67%*;+,E))++/>ZM2DI2DU*(CN>*PF8SMS\SPMK<7=UL]&*-TA
M%>DAH-!VF@&\E6W*9C$X2W^=YBY@M;;ZZ5[6`TZ`7$5/8*D]`49^Y7G:\#-O
MI#T2HS'.-U94=9MOM[:X+.>CI<3W:I9L\WE8/3S4="T<CR'6C[BT4?728,1X
M=N9F4:'SV]M9,.[YQ,T'SMA$SQY'-![%$^5Y_<N<8XL@GN+QXW]Q"2/,Z4Q-
M/E:XCM7)UW]8=V:8\7^#G';<VUT\+P/PWE.*X_XFO;X_B_`&LE\'P]3[-/$[
M]"U[=>F;V_A5U`ZGSO*V;-]>".1_DI7NZ]NZG:L,N/$Y@FU^:XN[?U<<D;/+
M6@DI]6O8O*K/K$>VKKJRN.,V<P&2)/AN5FX-!;.J4:M%DMF5CU*A!)1U(R6K
M4^FA>D>\WA4R[6_\OF+9SOLH'M'PA[_W%XQ>)[%$_A\3<-;]C,QWU"QO[JZ.
MV_\`/AX1Y9)8B97%W?VM4M1)D6.581$NZ9C51_?$NX!?9?=O-)1H:O\`F]*]
M=2))D6IXEE/#1S%L6%]DZPO0-S8YBQY\T[(F`_PZ=JRG&^(O0%ZX,O!?69Z7
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M,-[+24,.K1H:D)<<))GH2E::G>&^$]Q:"_/`/IM`LJBO30_.Q4=M!Y`K2[Q1
M-#CPX,EM=E;RAIVCYJ:>2I\J]2I^L68\\K_GWB;<UR?&;3K4[S0;I7P<S+Q7
M>V9ME0EXR"U[6]>U7K6D>,_A1NF_]-G(WFGRK0LV]&ZX?L[?J%>T/B@MG?\`
M4861HK\FZ#MG3O@9M[/JA;QQ'ZP-Q4M5M,9AM;OEB3KJNTY4&KPK**J.6L@S
M7)?;S&HM>WPT-Z>%"=4:W#(R)*.]6-WWA<UM""ZPO<;.T=!=+&X[MP[IS>O>
M\;!UF@R&R\2VCIB&WUGD(">D-BD:-^\]ZUW5N8=I[*GJ_&O.$\O;(Z6;<+WW
M3CSE=#5-F4V2X+N#7W26T]I>#"C,8Q,CW4Q2E:$S`>E.GH9]NA:C";OD-S3M
M+AMN,9WH>Z@?'-`YGE),@+!VO#0LRM>>'+.ZMW3G(]T6MJ6OAF:_R`",AY[&
M%Q7!N^WU@K;"B.95<=]G\CSZ<@U,LY;N--:PS&DK))FF9"QZK.XR.YB&>B?#
MD.T[NNI]"(NZ2]->%O,W/#/JJ_BM8]YB@!ED\A>[AC8>UHE'^J.M1>);$6_%
M#IBQEN9-PDG/=1^4,;Q/<.QQB/\`KA9W[\T[FSR"5*B7V[]E@.,RB4A6';1%
M(V^I?"<-?BQI-A6S'LNMXCJ%]JF9]G+:-*2]G74SV%TSR6Y=Z6I);6#+J\'^
MUNJ3OKT$-<!$TCK9&T]J@74?.#7^IJLN;Y]M:'_96U864Z02TF1P/4^1P[%'
MJZZZ^ZX^^XX\\\XMUYYU:G'777%&MQQQQ9FM;BUF9F9F9F9ZF)3:T-`:T`-`
MH`.A1D27$N<27$[2O5QR]GXOD-#DU6LF[/';FKO:YQ6II1/J)S%A#69%H9DF
M1'28\+NVBO;66SFVPRQN8[[5P+3]0KVM;B2SN8[N'9+%(U[?*TAP^J%^E/CE
M[`RG'J')JM9N5F14M7>USBM"4N!;P6+"&L].FJH\A)CD5=VTME=RV<VR:*1S
M'?;-):?JA=6+6YCO+6.[AVPRQM>WR.`</J%>T*=>Z`B`B_E:T-(6XXM+;;:5
M+<<6HD(0A!&I:UK49)2E*2U,SZ$0^@$F@VDKX2`*G8`N&=XO,JX1;'/RJ_-.
M0&&S[V&XXP]CN"*G;BW+,QH]'(,UG"8EY%IY:#]\F<]%[3+0S(^@DC`<HN8N
MHVMEQ^+N&VSA4234@80>D&8L+Q]H'*/<YS6Y?Z><8[_)P.N&FA9#6=P/41$'
MAI^W+5P+F'U@7BI4//1\.VPWNS%;1]J)DNLP[%ZN3]\;+NCNR,LM+4F_!-:O
MOL)I7<DD]NBC4F3K#PNZVG:'W]YCK<'H#I9'#RTB:W?3<\]?10QO?>)71T#B
MVQM,A.1TEL4;3Y*R.=NKO:/]8U%*^L38&B0ZF'Q>RZ1%)1DP]*W.IHDAQ'31
M3L9K#YK;*M?43KA?;%]9X4\F6@R9F`/Z0+=Y'F)E%?@"LC_$_C@XB/$3EG03
M<-!^`1&GPE9UCOUA7CQ*?0C*]C-YJ1@_!);U#+PG)G$&I#GCGX,^]Q0E):<)
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MQW+_`%OE[*/)8O%7UQ82@EDC(GN8X`D$AP%#0@CRA8GD-=Z,Q5X_'Y+)V4%]
M$0'QOE:US20"`0345!!\A6*_S@O!_P"=9L7^43'O\<%;^JWF-]"9+\0_]Y4?
MZS.7WTSCOQS/WT_G!>#_`,ZS8O\`*)CW^.!^JWF-]"9+\0_]Y/UF<OOIG'?C
MF?OK?^V6[6V6\^.+R_:?.\7W$Q=JRE4[E_B-O$NZI%K":C/RZ]4R$XZR4N.S
M,:4M&O<E+B3/TD,7S&#S&G[L6&<MIK2]+`_@E:6.X22`ZAVT)!H>PK)<3FL3
MGK4WV%N8;JS#RWCC<'MX@`2VHV5`(J.T+88M2N:`BCIY`^:KPHX[3)U'D.Z:
M,\R^N<=9EX;M+"3G-M'D,'V2(<VWC2H>&5=A&=]AR-,M8\A"]2-!=JM)7TOR
M4YAZKC;<VED;:P>*B6Y/<M(.XAI!E<T[PYL;FD=.T*+]2\XM`Z7D=;W5X+B^
M;L,5L.^<"-X+@1$UPW%KI&N!Z-A4>.0_6']H(TE:<4XY;DW4,G=&W\AR_&,9
MDJ9\-)^(N)6Q,M:0[XIF783RB[2(^[4^TI5M?"KGGLK>Y:TCDIN9%)(*^5QB
M-.VGF48W7B=PC'TL\7=2,KO?+'&:>1HD^"OG7J8Q]88V&F/1TYCL'NW0,K+]
MLNXW<8?EBV%>)H7A-64[#?A"/"]HS-39]W0DGZ1X7GA7U-&TFPR=C*[H$C98
MJ^4M;+3;Y5[6GB;TX]P%]C;V)O26.BDIY`XQ5^IY%(+L;YIO"#?N5"J,;WFK
M,0RB<I#;&*[HQ)&`63C[A:LQ8UI=$G$[.8\O5"&8=E(=4LM"3JI/=%VI.2_,
M;3#'3W>/?/9MWR6Y$[:=)+6?A6@;R71M%.G?22]/<X.7^I'M@M;]D%V[='<`
MPNKT`.=^#<3N`:]QKT;E(4E25))23)25$2DJ29&E23+4C(RZ&1D(K((-#O4F
M@UVC<O\`01`1`1`1`1`1`1`1`1`1`1<&[R^7_L-NCG\_=6?CEE^';0B?R/'J
MFW>I:#)+`G%.R+R3'K6X]DW>32,BD*8E,(DF7B*2;ZEN.9'=\SN9&$TT,5I6
M>`.BKPNDB$DS64V,B+R8Z-^2U\;]_"T@`-6$Y#EYI?+91V5O8G]Z_:]K7EC'
MNZ7.#:.XCTEKA7>1Q$D^AA6U&W.V;*XF#X/CN**T-J0]6U4>/9/]AFDT3K):
M%6<Q2#+3[\ZLR&KFI=9ZOU5.7:GR%W=O:X^A*]W`P[CPQ;(V'K#6-64XS!8?
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MM:C-2E&9F9F8VQQV.LL391X_'QMBM(FT:T?5).\DG:2=I-2354I))J=Z]`5R
M^("("("**+SK/H]=UOC/M9\HF/";O#S[T[+U-S[!ZAKGY[LKSUUO[9BI!#HN
MN?R`B`BOE>4_]'KQI^+&4?*)F(YG\[O>GF/71^PB71?DS[LL3ZJ3V\JD0$5*
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M_G=[T\QZZ/V$2Z+\F?=EB?52>WE4B`BI2>@(@(O%R+(\?Q"AM\IRJ[JL;QN@
MKY5K>7UY/C5=145D)I3TN?8V$QQF+#B1VDFI;CBDI21=3%1:6EU?W,=E91OF
MNY7!K&,:7.<X[`UK14DD[@`O"ZNK:RMWWEY(R*UC:7/>\AK6M&TESC0`#I)5
M:'FWY[$Y4JVV[X70V8\1DWX,W?3*:=,B3*62DEX^W>'W#!QXT=)),DSKJ.ZM
MTEJ),%KM0^K;[EUX:XPQF5YA.)>:$6<;J`=D\K#4G[")P`H*R&I:-4-?^(B0
MO?C-!M`8*@W<C:D]L,3A0#[.5I)KLC%`XUUMP]S=Q=VLDEYAN?G&5;@91-,_
MA%[E][8W]B;?<:D1F9%E(D*BPF->UIAKL9901)0E*2(BVMQ6'Q.#M&V&&MH+
M6S;N9$QK&^4AH%2>EQJ2=I)*U?R>6RF:NG7V7N)KF\=O?(]SW>0%Q-`.@"@`
MV``+!A<E;T!$!$!%ZM)>7>,VT"_QNXM<?O:J2B95W5)82ZJVK9;>OARH%C`>
MCS(<EO7V5MK2HO48\;FVM[R!UK=QLEMGBCF/:'-<.IS7`@CL(7M;W%Q:3-N;
M5[XKAAJU['%KFGK#@00>T%3E<,_/"WEVHEU&%<G6YN]>W!.-1#S1'@HW:QJ,
MMQM)RG9[CD>#GD2*WWJ4U/\`"L7%*U^'&24M'K?S`\.6G\W')D='%N.RU">Z
MV_-I#U!NTPD[-K*QC^CVERV$T)X@L[AGLL-6AU_BM@[W9\YC'63L$P&W8^CS
M_2;**U=M#O)MEOU@=-N9M'F%1F^%WK9G#MZEY2O`DMH;7)J[2$\AJ?374'Q4
MID0Y33,EA1D2T)U(:49W`9C3.3DP^=MY+;(1':UPWCH<TBK7L=3T7M):[H)6
MXV$SN)U'CH\MA)V7%A(-CFG<>EK@:%KA\IK@'#I"V:+.KL@(@(@(OC==:8:<
M??<;999;6Z\\ZM+;333:36XXXXLR0AM"",S,S(B(M3'UK2XAK02XF@`Z5\)#
M07.(#0-I5<GGAYXM?A]A=;5\-T5.2WD%UZON=\K:,Q:8O72V3\-]K;NBD(<A
MY2ZR[JDK2<2JTU-GX,:8TXB06V7+3PXRW\4>:U^7PVS@',LVDMD<#N,[QMCJ
M/]FS\)M])\;@6K5SF+X@XK&63#Z%#);AI+77;@'1M(WB!AV24/\`M'^AL]%C
MVD.5:C='>+=3>W)I&8[M[@99N'DDA3I_A3*KJ;:N16WEDM42L8D.JB5%<@TD
M3<6*VS':2DDH0E)$1;=X7`873MF+#!6L%I:"GHQL#:TZ7$;7.ZW.)<=Y)6J6
M8SF8U!=F^S5S-=71KZ4CBZE>AH.QK>IK0&CH"UL+NK4@(@(@(@(@(@(@(@(@
M(OT"O+KSLMQ^#G&#)C?*2ZUM)C>*2I!+4XIZ?M\T[@-@X\M6JE25SL9<-TS_
M`+IW#EWS6QGYIYCYFSI1IOI)`.IL])VT[*2"G91=*N5^1_.O+[$7=:D63(R>
MLP_@37MK&:]J[0$?+/$!%&MSH\SK8WA7#D8U(66Y6]LF$3]7M;CU@PTNI*0P
M3T*QSZZ2B4UB=:^A:%MLFV]8R6UI6U'-E1O(EWEMR=U)S"D%XT?,].AU'7+V
MGTJ&A;"S897#:":AC2"'.XO1,4\P^;>GM!,-HX_.\^6U;;L</1J*ATSMHC:=
MA`H7N!!#>'TA4RY1>8IRJY9S+"-N)N)/H\%EJ=0QM9@CLO%\!8AK7WHBV-9%
ME+FY6IHRU2]<2)[J#,R0:$GVEO#HSE1HK0\;7XJT;)DFTK<S`23$];7$4C\D
M36`]-3M6F.K^:&L=:/<S)W3H\<[=;PUCA`ZG-!K)Y97/(Z*#8N&Q(ZCU`1`1
M`1`1=%\>^67(/BWD+.0;*;F9#B2/A:)5IC/PI5CA61:&TEUK(<0GF_169OL-
M>%XZF4RV4&9LO-+T46*:IT/I;6=J;745G%.>&C9*<,T?462MH]M#MI7A)^,U
MPV+*-,ZTU-I"Z%S@+N6$<571UXHG_;Q&K'5&RM.(#XK@=JM=\`?-]VQY5RZC
M:[=J'5;1[[2R:BUD9,MU.`[BS>SJWB-A8NN2:2\?<2?93SGG7'=4IC292S4V
MWI)S0Y$9C1+),S@W/OM--J7&GX:`?[UK11[!TRL``V\;&"A.Y7+;G=B-8O9B
M,TUEEJ)VQHK^!G/^[<[:QYZ(GDD[.![S4"900`IT0$0$0$5#7S8/I"N2WQGQ
MCY.\.'3#DC[K,/ZF3V\JYS\Y?>;EO71^QB4=XE51B@(KE_D+?R'[;_3KGO\`
M\.X*-`/$S[QF?Y;#_+F6]?AR]W[_`/,9OY$*EUW'W&PC:/!LFW)W'R.NQ+",
M/K';?(<@M'%-Q($-M:&D))#:7'Y4R9*>;8C1F4.2)4EUMEI"W5H2<%8G$Y'.
MY*'$8F)\^1N'AK&-WN._R```N<XD-:T%SB`"5->4RF/PF/FRN5E;#CX&<3WN
MW`;O*220&M`+G.(:T$D!4V_,`\VS=KE58W.WVU,V\VHX^ZNPOP)#DI@9CN%&
M]IM<S.[6O>4XQ5RT&?;2Q7O@9(5^V52EI0IO?SE?R-P>BHH\IFVQWVJ=AXR*
MQ0'JA:X;7#^E<..OQ`P5!T8YE<Z<UK&63&89TEEIK=P`TEF'7,YIV-/]$T\-
M/CEYH1#^)X4(("("("*2;A7YH/(CAY85="Q;R-S=F&7$,S]J<ML9#T2MA&M)
MN.8+=N)DS<.FM%W&AIHG:UQ2E&[%6LTN(B/F%R:TIKV)]TZ,6>H"*MN8F@%Q
M_P!\S8)1UDTD&RCP-AE707-W4^AY&6S7F[P(-#;R.)#1_N7[3$>H"K#MJPG:
M+E7&#E)M%RXVPKMTMH;W\(5SJD0<@H)Z41<FPS("8;>E8[DU8EQPX<]@G-6W
M$*<C2FC)UAQQI1*/0'66B\[H7,OPN>BX)1M8]NV.5E:!\;NEIZ0:.:?1<`11
M;TZ1U?A-:XAN8PDG%$=CV'9)$^E2R1O01T$5:X>DTD&JZ*&*+*$!$!$!$!$!
M$!$!$!$!$!%B60XE"NB5(:[8ECITD)3][?,BZ)DH+WW0M"67M%]LB(AB&HM(
M66;!N(J0Y&GQP-CNH/'3U<0](=H`"_37$>1:/NJJRI7C9GQUM:F9-O$1JCO$
M7K9>(NU73J9=%%ZR(0CF,1DL--W-_&6@G8[>QW:UVX^381T@+V!!W+%W7?3U
M%@>]?I>8Z[Z>OZGZHI7O7U>8Z[Z>OV?UQ2/>OJ\UUW[/<_5%*]_P(O-==]/4
M4CWKZO,==]/7[/=,4KWKZOH*4:C^T*8FJ^K^!^5\7R,LO2'6V([3C[[RTMM,
MLMJ===<4>B4-MH)2UK4?H(B,S'I%%+/(V&%KGRN-`UH)))W``;23U!%T+@NQ
M\N8IFSS'OA0_9<;I6U]LV26A*+X:\@_VFT?K0DS>/J1FV9=9LTARCN;ES;_5
M%8K;>(`?PCO6$?$'6T>GO!+"-OB^4;F[UU'$B18$9F'"CLQ(D9LFF(T=M+3+
M3:?0EMM!$E)?[HV$MK:WLX&6MHQL=M&*-:T`-`Z@!L"IR:[3O7V![H@(@(@(
M@(HHO.L^CUW6^,^UGRB8\)N\//O3LO4W/L'J&N?GNRO/76_MF*D$.BZY_("(
M"*^5Y3_T>O&GXL91\HF8CF?SN]Z>8]='[")=%^3/NRQ/JI/;RJ1`14I/0$0$
M0$0$0$5*OSJ>4E5R!Y3MX+B%DU:8+Q^K+'!8LV,Z;T*QSN?/;D[AV$)PE>&I
MB-+KX56:DEVN.5:G$J4A:#+H7X>M&3Z7T6<E?L+,EE'MF(.PMA:VD#3VD.?)
MV"0`@$%:%<^]7PZEU@,=8O#\=C&.A!&T.F<:S$=@+6Q]IC)!((4/(GI0<@(M
MG;+[5Y'OANSMWM%B3*G<@W$RZDQ6`LFS=1#*TFM,2[64E)D:8%/!-V7(7J1(
M896HS(B,6?4.:M-.8.[SM\:6MI`^1W;PBH:/LGFC6CI<0%=L#A[K4&:M<)9"
MMS=3LC'9Q&A<>QHJYQZ`"5^C5B&+4V#8EB^$XY&^!X]AV.TF+443V/VK38_6
MQJFKC?>T-M_>(41"?92DNG0B+H.3M_>W&2OILC=GBNKB5\CSUO>XN<?.25U&
ML;.#'V4-A:CAMH(F1L'4UC0UH\P`61"D54H[_-@^CUY+?%C%_E$PX2KR1]Z>
M']=)["51ASF]V66]5'[>)4-1TP7.A`1`17RO*?\`H]>-/Q8RCY1,Q',_G=[T
M\QZZ/V$2Z+\F?=EB?52>WE4B`BI2>@(L?RO*L;P;&;[,LPNZ[&\5Q>IG7N0W
MUM);AUM145D=R5.GS9+ADAIB/';4HS])Z:$1F9$*JRLKO)7D6/L(WS7LSPQC
M&BKG.<:!H'22537EY:XZTDOKZ1L5G"PO>]QHUK6BI)/4`J37F2^9;FW,[+Y>
M&87+M\1XY8W8+1CF)D^[#F9W)AR$K8S+/&&5DB3)<<92[`KU][%8C0R[I!N.
MJZ(\H^4..Y?6#<AD&QSZLF;^$EH"(01MBA)W#;1[Q0R'J91HT$YJ\U[_`%W?
M.L+!SX-+1.]".I!F(.R68#>=E6,-1&.MU7**H34H=0$0$0$0$0$0$0$7:7"3
MF_NKPEW/CYAA<EZ\PFX>C1MQMLYLUYFAS*G0LB4X@NUYNIRBN;-2J^R0VIQA
M>J'$NQW'F'(^YB<N<)S$PQL,@!'D8P3!<``OB?\`4XHW?+C)HX;06O#7#/-`
M<P,SH#+B^L"9,>\@3P$D,E;]7AD;\B0"H.PAS2YIO0\?]_-M>3.U6,;P[4W1
M7&*9-'49LO$TS<4%O&[46N-9'`;>?.LOJ>0KL?:-2D*2:76EN,.-.KYMZHTQ
ME]'YN;`YN/N[V$[Q4M>T_%DC=0<3'C:#OWM<`X.`Z&::U)BM68:'.8:3CLY1
MN.QS'#XT;Q4\+VG81NW%I+2"=SC'U?D!$!%5P\Y[S(+F=D&0<.=CL@=KJ&H2
M]4[]995/K:FWMPO0I.UU;,:[51J2I:]F\4VLUS9*U0%^&S'E(E;F^'WE+;QV
ML6OM1Q!]U)1UE$X5#&=%RX'>]Q_F:BC&@2BKG,+-0N>_-.>2YET-IZ4MMF5;
M>2-.U[NFW:>AC?\`:T-7./=FC6O#ZV@VX6JR`B`BVOM-L5O+OM=+Q[9S;'-=
MR+5CPSFM8GC]A:QJMMWN\)^ZL6&3K:2*X:#)+LMYEHU=.[4R(63.:ET_IJW^
M=9^\M[2`[C*]K2[L8TGB>>QH)[%><+IW.ZBN/FV#M+BZF&\1L<X-[7.`X6#M
M<0%(=CGDG>8%>P$3INV^(XHMQ*%HK\CW+PXY_8LU]IK;Q^ROV&5$A)*-"W$K
M22R(R)1*2F*KOQ$<KK:4QQW<\X'RH[>7A_CM83Y0*;.JA,G6O(+F5<1]Y):P
M0D_)?/%7^(YX'D)KMZZT\G,O)C\P/$8:Y\?:2GS*.RTEV06&[@87/F,D:EH-
M"*RTN::TG.I-*3-,9E]6BR,M=%]OOC_$#RNOY.Z??26[R:#O8)6@_P`)K'M`
M^V(W>2OA?\B.9=BSO&V3)V@5/=31.(_@N<UQ_@@[_+2.+.]N\^VOR&5B6Y.%
M95@.40B2N5C^8T%ICEPTVLS)M\Z^WBQ)*H[Q),VW"2;;B>J3,NHEK&Y7&9FU
M;?8BX@NK-VY\3VR-/9Q-)%1TC>.E1;D<7DL1=&RRMO-;7;=[)6.8X=O"X`T/
M0=QZ%AHKU0H"("*9#@?Y4V*<XMKGMQJ3E-78A9T5L_1YQM^WM6[D618I9D^X
M[5IDR'MP\>9D5.0TR"DPYZ&C:6LG6.TW8[Z40%S+YV7O+C,C$W&%?/#*P/AG
M^<B..1M*.H!`\AS'^B]A-0.%U>%[29SY=<G+/F#B#E+?,-@EC>62P_-^-\;J
M^C4F9@+7M])KP*$U;2K7`264/U>+9B.7_P"Y^1&Y]N>CG6AQ?%,<+4U)\(]+
M!>4]$)(R47ZXS(R-.FAQ#<^*K4#_`/H\59Q_;R22>7XO=_Z=:E>V\,>!;_U>
M4NW_`&D<;/)\;O/].I3-<7>-^'<3=FL=V.P'(,RR/$L8FWTZJF9U/I;&\8/(
M[F9?V,0I%#08W7E"3:V#[C22C=Z?%/N6KTC7_6>K;_7&H)=1Y2*WBOIFL#A"
MU[6'NV!C31[Y'5X6@$\5-FP!3MI#2MCHS!1:>QLL\ME"YY:9BUSQQN+W"K&,
M%.)Q(]&NW:2NA!BJR90O^:CYGD+B;32=E=G)<*TY%9-4(>EV1_!IU?M#1VC'
M=%N[2*OQ6I69645PGJJO>0;;32D39*5,G'9E[!\E>3DFN+@:AS[7,TI#)0-V
MAUT]IVL:=A$33LD>#4FL;"'<3HX'YP\VX]&0'`X)S7ZHE94NV%MLQPV/<-M9
M7#;&P[`*2/'#PM?38NKNXR2WL\@R&UL;V]NI\JTN+FWFR+&TM;*<\N1,GV,^
M6X]*F3)3[BEN..*4M:C,S,S,;^6]O;VD#+6U8R*VC:&L8T!K6M`H&M:*``#8
M`!0+1:XN)[J=]S=/=)<2.+G.<2YSG$U)<34DD[23M*\P>R\D!%_:$+=6AMM"
MG''%)0VVA)K6M:S)*4(2DC4I2E'H1%U,P)`%3L`7T`DT&TE9BYMON(U7)MW<
M"S1NI6XII%HYBUXBN4ZGO[FTS502C*<3X:M2)6I=I^X8MXR^*=+W#;JW,]*\
M/>,XJ>3BJJXXK*"+OS;3B"OQN[?P_#2BPL7!4"`B`B^1IUUAUM]AQQEYEQ#K
M+S2U-NM.MJ);;C;B#):'$+(C(R,C(RU(?'-#@6N`+2*$'I7T$M(<TD.!V%6Y
MO*'\SB=OU%A<9]_KLI.\-%5*5MWG%@\DI.Y]#51S7*IKUYU9'*SZCA->*3Y:
MKM83;CKO[98==DZ+\]N3L>F7NUAIB.F!D?\`AX6C9;O<=CV`;H7G9P[HWD-'
MH.:&;K<D^;4FHV-TGJ22N<C9^`E<=MPQHVM>>F9@VUWR,!)]-KB^?`:QK8]`
M1`14-?-@^D*Y+?&?&/D[PX=,.2/NLP_J9/;RKG/SE]YN6]='[&)1WB55&*`B
MN7^0M_(?MO\`3KGO_P`.X*-`/$S[QF?Y;#_+F6]?AR]W[_\`,9OY$*AI\WCS
M`YO)S=.;LOMI?+/8':NYD0T/ULEPH6Y><0#.)9Y7+4TX<>PH:62EV+2Z=[:V
MO$F$H_A+:6I_Y$\KH]'85NH<Q%_^SWL8-'#;;PNVMC%=K7O%'2[B#2.GH$N@
MKG9S+DU;F'8'$R?_`*W9R$5:=D\HV.D/0YC35L6\$5?\H`0S#8!02@(@(@(@
M(@(NU>!7,+*N&&_N.[B5LB9*P2Y?B8]NQBC*S./DF%29)%)?;CFE2#O<<4X<
MZN<+M63[9LFHF7WDKCSF;H*RY@Z8EQ4P:W)Q@OMI#OCF`V"OUDGQ)!NH>*G$
MUI&>\N=<7F@]2192(N=CI"&7$8W/B)VFGU[/CL.^HX:\+G`W[L?OZ;*J&DRC
M';&/;X_DE16W]%;0U&N)9TUQ"9L:RQBK,DFN/-A2$.(,R(S2HAS$NK6XLKJ2
MRNV&.ZAD<Q[3O:]A+7-/:"""ND5M<P7EM'>6K@^VE8U['#<YK@'-<.P@@A>N
M/!>Z`B`B`B`B`B`B`B`B`B`B^"3&CS&5QY3#4EAPM%M/-I<;5]U*R,M2]1^D
MAX7%M;W<)M[IC)(';VN`(/F*;EJ^[VKKIG>]3RW*UX]3*.\2I,,SUUT2HU%(
M9(]?3JX1>HA&V9Y8X^ZK+B976\I^0ZKX_,?C-^%PZ@O02'I6I+C;[+JTU&=6
MY.:+71ZL5\-)6GI[6$$4PONFT7]:,,IH35./))MC-$/E1'O*_P`$>G\+`O4/
M:5KJ8B1%<4U)9>CNI]+3[:VG$_=0XE*B/]`81<QSV[S%<,?'(.AP+3\!H5^_
M(O'==]/46][U]7F.N^GK]GNF*5[U]7T%*-1_:%,35?5DM5A6679I*LQ^TD(4
M9$3ZHJX\7KZ-9<GP8J?T5ET%_P`=I34F6(%A97#VGY7`6L^[?PL_C+\%[1O*
MVYCVP%O)4V]DEG'K&/94J'7Z39JB_7-K?428<=9>I2?'+[0DO"\F,G.1+G;A
MEO%LJR/TY.T%QHQI[1W@[%YNF'R5T%C."XQB2"_`]:VB2:32Y8R/VS8.D9:*
M(Y+A=S2%%Z4-DA!_V.HFG`:0P&FF?_%P-%Q2AE=Z4AZ_3.X'I:WA;V+Q<YSM
MZRX9,OR@(@(@(@(@(@(HHO.L^CUW6^,^UGRB8\)N\//O3LO4W/L'J&N?GNRO
M/76_MF*D$.BZY_("("*^5Y3_`-'KQI^+&4?*)F(YG\[O>GF/71^PB71?DS[L
ML3ZJ3V\JD0$5*3T!$!$!%AV<;AX#ME12,HW'S;$\"QN+TD7V8Y#4XU4-*TU)
MM5A<2X<7Q5?K4$KN4?0B,Q7XW%9/,7(LL3;SW5V[<R)CI'?<L!-.U4.0R>-Q
M-N;S*7$-M:C>^5[8V_=.('F5<KS#/.OQ^QQR_P!FN&]C/FR;J++ILHWS=A2Z
MEBO@/D4>;"VTA6#4>S=L931N,JN)#+"8R3-<)+BU-2V=LN5?AXNH;N+4&OV-
M:R,A\=G4.+G#:#<%I+0T&A[II=Q'9(0`YCM7.9W/RVEM9,%H5[G/D!;)=T+0
MT'81`'4<7':.]<!P[XP20]M8Q2C49J49J4HS4I2C,S49GJ9F9]3,S&XF[8-R
MU*W[3O7^`B`BM1^1UP/GX;6*YC[I4SD.^RBHE5&R%-8L&W+K,5M&U1[O<)QA
MYLGHTC*8AJA5BM4&JK7(=T6U,946EGB.YEQ9";]`<+('6T,@=>/:=CI&[605
M&PB,^G)O_"!C=CHW!;A^'SEU)81?ISF(RVYF86VC7#:V-VQ\U#M!D'HQ[OP9
M<=H>TJQN-35M&@(H[_-@^CUY+?%C%_E$PX2KR1]Z>']=)["51ASF]V66]5'[
M>)4-1TP7.A`1`17RO*?^CUXT_%C*/E$S$<S^=WO3S'KH_81+HOR9]V6)]5)[
M>52("*E)Z`BJ?^=]SPD9UF,CA[MC=*3A&!V+$G>:P@/*2C*,]@N)?A86XZWH
M3]/@[A)=EM&I2';@R2M"7("%*W=\.?+1F-L!KW,1_P#R-RPBT:X?S<)V&7L?
M-N:=XBV@D2D+33Q`<Q79&^.A\1)_\?;.!NG-/\Y,-HB[6Q;W#<9=A%8PJ\HV
MH6LB`B`BD>X=>5YR7YBQ(N6X]5P-N]IGWW6D[GYVF7$K+8HSJF9:<.I8S2[C
M+%,/MK:-YI+5<3S:VERT.H4@HFU]SETAH&1UC=/==YP`'YO#0N;7:.]>3P15
M%#0DR4(<&$$%2EH;E%JS7+&WMJQMKA22/G$U0UU-A[I@]*2AJ*BC*@@O!!"F
M\P'ZO=QUJX44]R]ZMX<SMFO#7)<Q%G#\!I)*T]AK;_!MG29[:-L+,E%[-@E>
MAEHHC+KKGD_%-JN:1WYGQUA;P'=WIEF>/X37PMK_``*=BV`QOAFTO#&/SM?W
MT\XW]V(H6'^"YDSJ?PZ]JRS)_J_W$2SBK_@SN)OSBUB378PZ]D.$W]9XFJC\
M:57R<#ASGU^T1:-S64Z%Z-=3%%9^*'7<+_\`G+3&315VTCF8[R!PF('G856W
M?AKT3*S_`)2ZR4,M-E7Q/;Y2TP@GS."B<Y7>21R0V$I['--J[6'R&PBL:>E6
M,?&:672;D54-DE..2G<&5+N$W<5EK0C.LFRY2C)2CBH;(U";]$^(K26IKAF/
MS3'8K(O(#3(\/@<3T":C.`G_`'C&MW#C)V*&=9<@-4Z<@??X=[<GCV`EPC86
M3M`Z>YJ[C`_W;W.Z>`!0NJ2:3-*B-*DF:5)41D:3(]#(R/J1D8V#W[1N4#;M
MAWK_``$0$4J7E3\ZY_$+?")C.7VCQ;$;LV5?29[$>>UAXI<O*3"H]Q8K:U$B
M.=0XXEFS-)D;U8I:C2XY'CI*%>=G+6+7>G'7E@P?I+8L<^$@;9&#:^`]?%OC
MKNDH-@>XJ8>3G,231.H&VE\\_H[>O:R8$[(W'8R<=7#NDZXZG:6M5X9"T.H0
MXVM+C;B4K;<0HEH6A9$I"T+29I4E23U(RZ&0YRD$&AV$+H(""*C:"OZ'Q?5R
MGS>Y`EQ@XL[Q;S1U-%>XWC"J_#FW22M+N;9/+C8SB2U,*;>*4Q"O+9F4^WVZ
M*C,.:FE)&HLVY<Z7_3+6EAI]U?FTTW%+3^AC!DEV[*$L:6@_7$;]RPWF!J7]
M$='WV=;3YQ%#2+ULA$<>S;4![@XCZT'=O7Y[MC83[>PG6UK-E6-G9S)-A8V$
MY]R5-GSYKZY,R;,DO*6](E2I#JEN.+,U+6HS,S,QU,BBB@B;!"UK(6-#6M`H
M&M`H``-@`&P`;@N9TLLD\KIIG%TSW%SG$U))-223M))VD]*^F/VOP@(I,?+/
M\ORWYP[H3GLBDS\>V/VZ=KIFXN0PB2W8W,J6X;M=@F-/.$I#5S<QV'')$KM6
MBOB(-Q1&ZY';=B#F_P`T8.7&&:VT#9=1W8<((S\5@'QII!]8PD!K=A>XT'HA
MY;+'*?EI/S!R[G71=%I^U+3.\?&<3\6&,_7.`)+MH8T5.TM#KM.V&U.W&RV&
MU6WNU.&4.!X;3-DF!0X]!1#BDZ;;;3LV8[[<JSM9:64G(F2G'I4A9=SKBU=1
MSMS.;RVH<@_*YNXEN<A(?2>\U/8!T-:*^BUH#6C8T`+?O$8;%X&P9C,-!';6
M,8V,8*#RGI<XT])SB7..TDE;`%K5S0$7.G)CBOLQRTV\F[=[Q8K%N(JFI"\>
MR2*VQ&RW"[5YM*476)WBF79%;,0MM!N-F2XLM"";D-.M&:#RO1^M=0:'RK<K
M@)W1OJ..,U,4K1\B5E0'#?0['-)JQS3M6+ZLT?@=:8QV+SD(D90\#Q021./R
MHWT):=U1M:X;'`C8J(W+?C!G'$'?+*ME<Y6F>]4^!:XQDL>,N)`S+#;1;_X"
MR>!'6Z^<=,LH[C,AGQ'?@LZ.^QWK-HUGTKT+K+&Z\TW!J'&^BU]6R1DU=%*V
MG'&XT%:5!::#B8YKJ"M%SLUKI'(:(U#-@<CZ3F4='(!02Q.KP2`;:5H0X5/"
M]KFU-*KFD9>L40$4AOEB<JY_%/E=@M[-LE1=M]Q)\';?=*(ZZ2(!8YD4]B-`
MR203G<VT[A=XXQ8FZE)O?!&I+"#(I"]8KYQZ)BUMHBYMHV5R]HTW%L:>EWD8
M)=&.L2LK'3=Q%CC\4*3>4FL9-&ZRM[F1],5=.$%P.C@>0`\^J?1]=_"'-'QB
MKYHYG+HR@(N-.>'+B@X8\><GW7G-Q+++9CB<5VRQJ4MPF\ASNUC2G*UN2EG[
M[^"*:+%>L)QDIONC15-)6EUUK7/^6FA;KF#JJ'"1%S+%H[RXD'R(6D<5*_*>
M2&,W^DX.(+6E8+S%UK;:$TS-F9`U]ZX]W!&?ES.!X:T^2T`O?N]%I`(<0J#&
M;9IE.XV7Y)GF;74W(\NR^YL,@R*\L7/%F6=M9R%RIDEU1$E""4ZX9(0@DMMH
M(D(2E*2(NG6.Q]EB;"'&8Z-L5C!&UD;&[`UK10`?ZR=I.TU*YO9"_O,I>RY'
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M7@<\B,?:Q-I&P=C6A;<X'2&F-,Q-BP5C;V_"*<36`R'[:5U9'>5SBM^#&%DB
MYDWWX:\9.2E;.@[P;.89DMA-:<0C+8]4Q29W`<<[3*179K2I@Y)'4AU"%FV<
ME4=XT$3K;B-4GF.FM?ZQTC,V3`W]Q#$T_P`T7%\+NQT+ZQGI%>'B%?1(.U8E
MJ+0NDM51.CSEC!+(X?S@:&3#M;*VCQT&G%0T]($;%5/\Q+RD\[XC1;#=?:JP
MM]SM@4R-;*9+C,+S3;-$AU#41O,6Z]MB+<4;SKA(1<18\=I#ADW(88,VEO[K
M\J>>6-UT]N$S;8[/5%/1`)[JXH*GNN*I:\#:8G.<2-K'.](-TYYG\ELCHICL
MSAG/N]-5](D#O8*F@[WAH',.X2M:T`['-;L+H<!/J@Q`1>]BV49#A&2T.8XE
M;S:#*,7MZ^^Q^[K738GU5Q52FIM?/BND1DEZ-)92HM2-)Z:&1D9D*:]LK7(V
MDMA?1MELYHW,>QPJUS7"CFGL(-%46=Y<X^[COK)[H[N%[7L>TT+7--6D=H(5
M_'@7ROJ>8_&[#MV62B1,NCDK$MSJ2(>C5+N%1Q89W28[)FI3%;=,2V+.$@U+
M4W$FMMJ6I:%F.8?,S1$^@=6W&#=Q.L3^%MWG>^!Y/!4]+F$&-YV5<PD``A=)
M.7.LH=<Z5@S3>%MZ/P<[!N;,P#CH.AK@1(T;:->`22"NRQ'ZSI`14-?-@^D*
MY+?&?&/D[PX=,.2/NLP_J9/;RKG/SE]YN6]='[&)1WB55&*`BG$V@Y<O<:?*
M`R+$,2MCKMU-^=^-SL$QAV*Z3=A2XFWBN`*W"RF.9:.,N1:B:U6L.MJ0\Q,M
M6GVSU9/37+/:%;J_GQ%?WS./"XS&6\T@(]%\O>3]Q&>NK@9"#4%L;FGXRV"P
M>M7:4Y(2V5D_AS&1R,\,=/C-C[N'OI!Y&D,!%"'2-</BJ#L;&K7U=`\?N+6_
M?*/)5XOL=MO>YM*BJ:*WM6$,UV+X\V[U0]D.56KL*@I^]LE*;:>D)?D$@R9;
M<47:,7U1K33&C+/Y[J.[BMV.KPM-72/IT,C:"]W:0WA;7TB!M62Z:T?J35]W
M\ST]:R7#Q\9PHV-E>E\CB&-[`34_)!.Q3%X+]7LWXMJUN5N'OIM?A5@ZT3A5
M6.4V2YTJ.I78:6)DV46&1DOH(U$OP?A#9*3HE:R/N*`\EXI],P3%F*QM[<1`
M_&D?'#7M`'>FG57A/6!N4Y8[PS:CFB#\GD;.WE(^*QLDU.PD]T*]=*CJ)WK!
M=Y/(0Y1X)33+S:[-MO=Z4P6E.KQV(J=@V834I0:U%5P;]4K&I2DDD_8<MV'%
M'H2$K4>A7+`>)O1F2N&VV9M[K'EQIWAI-$/MBRD@\HB(ZR%;L[X<-7XZ!UQB
M+BVOPT5X!6*4_:A]8SY#(#U`J$_+<1RG`LENL-S;'KC%,KQR>]67N.Y!7R:J
MXJ9[&GB19T"8VU(CND2B47<DB4E1*+5)D9[$6-]99.SCR&.ECGL96AS)&.#F
M.:>EKA4']_8H#O;*\QMW)8W\4D-[$XM>Q[2US2.@@T(_T*QT52I4!$!%=;\D
MC?*5NWPJJ,2N9JI=_L;EEQMHI3ZR5*=Q8V(>38<^HD^RF'"K;Q=5'+0E>'5Z
M&1Z=RN>7B*TXS!\PY+ZW;PVN2@9<;-PDJ8Y1Y2Y@D=VR>8;[\@-0OS6@F64[
MN*YQ\SH-N_NZ"2(^0->8QV1^<R_B!U-Z`B`B`B`B`B`B`B`B`B`B`B`B`B^%
MZ.Q)1X<AAE]']@\VAU'_`.%:5$/*6&&=O!.QKV=3@"/@*+PG\.Q.3KXV,T*S
M5IJO\$P4N'IZ/OB6$N?IBS2Z6TU/7O<?9$GI[F.OPAM?JK]<3NLKZR,#PI"N
MXL5H%'UZ.5<-U/7^T=:6DS_0'BW1VE&'B&.LB>V%A'P$$)QNZRO9ATE-7F1U
M]160321$DX<"+&-)%VZ$7@M(T(NTOZA"Z6N)Q5E0V5M;PD?61L9_)`Z@OA).
M\KTQ<%\0$0$0$0$0$0$0$0$0$447G6?1Z[K?&?:SY1,>$W>'GWIV7J;GV#U#
M7/SW97GKK?VS%2"'1=<_D!$!%MO'M_M]\1IH..8IO7NWC&/5;;C5;18]N/F-
M+35S3KSLEUN#5UMS&A1&W)#RW%$VA)&M:E'U,S%CNM,::OKAUW>XZQFNGFKG
MO@B>]U!05<YA)V`#:=PHKU;:DU%90-M;._O8;9@]%C)Y6M;4UV-:X`;23L&\
MKV?SH>3'SB=]/RMY_P#C`*?]#=(?16-_)8/O%[_I=JSZ4R/Y3-]^GYT/)CYQ
M.^GY6\__`!@#]#=(?16-_)8/O$_2[5GTID?RF;[]/SH>3'SB=]/RMY_^,`?H
M;I#Z*QOY+!]XGZ7:L^E,C^4S??K_`!7*#DLI)I5R'WS4E1&E25;M9\:5),M#
M(R/(-#(R#]#=(#:,5C:_V:'[Q/TNU6=AR>1_*9OOUJ:]R/(<HG'9Y-?7.162
MFT-'87MI.MYQM-I)+;9R[!^0^;;:2(DEW:$7H%\MK2ULH^YLXHXH:UX6-#17
MR-`"LMQ=75Y)WUW))++3XSW%Q^%Q)7BBH7@@(O8Q_'<@RRZK<;Q6CN,FR*YE
M(A5%!C]9-N;JUFNZ^'$K:NN8DSITIS0^UMIM2STZ$/"ZNK6QMWW=[)'#:1MJ
MY[W!C&@=+G.(`':2`O>VM;F]N&6EG')+=2&C6,:7/<>IK6@DGL`JK(WEW^2G
M=(N,>WHYE5,6%`KGV+?&MA'UQY\FSD-'XL&9NB['<>@QZYI9(>*D;6ZY(/1N
M>;:">ANZD<U?$-;FWET]H![G2O!;)>BK0T'81;UH2[>.^(`;OBJ>&0;4<L>0
MDXGBSVNF!L;2'1V9H2X]!N*5`;N/=`DG=)0<3#9X:::8:;88;;999;0TRRTA
M+;333:20VVVV@B0AM""(B(B(B(M"&G+G%Q+G$EQ-23TK;8`-`:T`-`V!?(/B
M^H"*._S8/H]>2WQ8Q?Y1,.$J\D?>GA_72>PE48<YO=EEO51^WB5#4=,%SH0$
M0$5\KRG_`*/7C3\6,H^43,1S/YW>]/,>NC]A$NB_)GW98GU4GMY5(@(J4GKD
M/G9R5C<3N+NZ&\+;K)91!J#Q[;N*\VR^F;N'DW=5XL:XKY&S,B5$MU5E+95I
MXD*$\1==!G?+72#];ZSLL"0?F3I..<BHI!'Z4FT;07`=VT]#WM6$\Q-5LT9I
M"\S@(^=M9P0@T-9I/1CV'80TGC<.EC'+\_"TM+&[L[&ZN)TJSMK>=+M+2RFO
M+DS;"QGR')<V=+D.FIQ^5+DNJ<<6HS4I:C,^ICJ-##%;0LMX&M9!&T-:T"@:
MUHH`!T``4`ZES3FFEN)G3SN+YGN+G.)J7.)J23TDDU)ZU]`>B\T!%+?Y2W`:
M+S`W;L,UW)KGG]AMI)%?)RB*:G8[>=99*/X52X&W(0;:SK?@S*I=NIE?BM1?
M!9^]JF-NH@SGCS.?H/!LQV(>!J:^#A&=A[F(;'S4^NJ>&($4+N)VWNRTS5R7
MY;LUOFG7^583IRR(,@VCOI#M9#7ZV@XI*&H;PMV=X"+K]=75]17P:FI@PZNJ
MJX<6NK*RNBL0J^NKX3"(T*#!A1D-1HD.)&:2VTTVE*&T))*2(B(ASQEEEGE=
M/.YSYWN+G.<27.<34N<3M))VDG:3M*WXBBB@B;#"UK(6-#6M:`&M:!0``;``
M-@`V`+[@\UZ("("*KCYVGE\4>)1G^8VS6/QZFKGV[$3??&ZEGP(,>VO9K<6I
MW,A0T$4>(5Q<240K=+1))R;)CR20:WI;HW-\.W-*YOGC0.H)2^9L9-G(XU<6
ML%76Y.\\#07Q5W,:YE:-C:M0N?W+.WLF'7."B#(7/`NV-%`'/-&S@;AQ.(;)
M3>YS7TJ7E5LQMPM5D!$!%=S\F[E+(Y%<3*K%\EG_``S<+8.5"VSR!QYXG9UG
MBS,!+VW>0R2,UN_MFB8<K%..*4Y(E5#[RCU6.=?/[1;=*:X?>V;>'%9-IN&4
M%`V0NI.P=&QY$@`V-;*UHW+?[D7K!VJ-%LL[MW%D\:1`^IVNC`K`\^5@,9)V
MN=&YQWJ6<0<IH4"WU@C+Y55Q<VHPZ,^XRC+M[(<^P2V2B*77XMAV4.?!'E$?
M9X/X3N(KW:9:FMA)D9=ID>S/A<L&3ZSOK]X!,&.+6]CI)8]H[>%CAY">M:Y>
M):]?#I"RL6$@3Y`%W:(XI-A[.)S3Y0.I5#AO8M)D!$!%?$\J39ZLV=X*;%QH
MD9MNUW%QQO=[(YI,FR]9V&XI(O:IY\E)2I9P,2=K82%>A;<5*BU(]3YH\[<]
M-G^962>\DP6DWS6,5J&M@]!P'VTHD>>HN(71;DW@XL'R[QS&`":ZB^<O-*%S
MI_3:3Y(RQHZPT%2+"*%*"`B`B`BKG_6&=KJV7MAL%O4U$:;N*#/+C:Z=.03*
M7IE;EV/6&654249_?WVJV5A,Q;&GL-'+>UZN%KMAX5\U,S,Y33SG$P2VS;D-
MVT#HGMB<1T`N$S`[I/"WJ6KOB;Q$3\1C<^&@3QW+K<G94MD8Z1H/2>$Q.(Z!
MQ.ZU55&ZJT[0$0$7Z+_%?.)6Y?&7CWN!82#DVF9;*[8Y%</*6IQ:KNTPRFE7
M25NK:9-UQNU<>2I?:DE&1F1:&0Y0:UQS,/K#*XN(<,-OD;B-@^P;*\,V;:>C
M3978NH>CL@_+:3QF3E-9I["![C]FZ)I?U5]*NU;[&,K(U2>\YWE,_O\`<K[;
M;VDGF]MWQY.QV\I66G35&G9M\(8/<F]4CJE,DKR$W4D9&:%,5#;B=#<5KT/\
M/NBVZ8T0S*W#:97*\,[R=XAH?F[/)P$R]=92#N"T&Y[ZP=J363\9;NKB\9Q0
MM'09:COW^7C`CZJ1@C>5$,)V4)("*6KRA.%%;RPW_DY3N#4MVFS6R3=5DF6U
MLI*50LLRBP>E'AF&RFG"-,JJE/UDB;8M]JVW(D/X,X1%*2H0=SWYAS:(TN++
M%O+-09$NCB<-\4;0.]E!Z'`.:R,["'/XQ\0J:.26@8M9ZE-YDV!^"Q_"^1IW
M22.)[J(CI:2USWC:"UO"?CA7;&FFF&FV&&VV666T-,LM(2VTTTVDD-MMMH(D
M(;0@B(B(B(B+0ASL<XN)<XDN)J2>E;^@!H#6@!H&P+Y!\7U`1`1>?;5-7?55
MG1W=="MZ6YKYE3;U-E%9FUUI5V,9R'/KK"%)0Y'EPIL1Y;3K3B5(<;4:5$9&
M9#U@GFMIF7-L]T=Q&X.:YI(<US35KFD;000""-H.T+RFAAN87V]PUKX)&EKF
MN`+7-<*%K@=A!!((.PC8J)WF><,RX:\D++'\:CRO\TNXD5_-]K)+YK=*OK)$
MM;5WACLI9&;\K#;17@H-2ENJKGH;KJC<=4.E')SF!^G^DF75X6_GRT<(;D#9
MQ.`JR6G0)6[3N`D$C6BC0N=_-O0GZ"ZI?;6@/YEN@9;<GH:31\5>DQ.V#>2P
ML)-25',)847("*;'R-N2\G:7E&_LM=6)M8/R"JETK,=]WMBP=Q\:CS+;$+!!
MK[DMN6T'X?5&A!)5)D3(O<HR920UX\1^D&9S1@U#;LKD<6_C)&\P2$-E;V\)
MX)*GXK6/I\8J??#WJQ^%U><#.ZF/R;.$`[A/&"Z)W\(<<=!\9SF5^*%<I&@*
MWI0$5#7S8/I"N2WQGQCY.\.'3#DC[K,/ZF3V\JYS\Y?>;EO71^QB4=XE51B@
M(O0DVME+@UU9)FR'JZH*659!6XHXL(Y[_P`)FN,,%HVAZ6\23<7IWK)"$F9I
M0@D^3((8Y'S,:!+)3B/2>$4%3U`;AN%3UE>CII7QMB>XF)E>$=`J:F@ZR=YW
MF@Z@I#?+AX`9/SCW1D,V#]AC.RF!O0)>YF9Q4-E,?.4I;L'"L65(2MEW)KUE
MAPU/&AUFMBI-]Y*EJCL2(KYL\T+/EQA@Z(-FU%<APMXCN%-AEDIM$;"1LJ#(
M[T6D`/<R3N5O+6[YA9<ME+HL!;$&>4;S7=%'79WCP#MH1&WTG`DM:Z[OM/M'
MMML;@E'MIM-A]/@^$X\P3-;24S!MMFX:4%(L+"6\MZ?<7$]2"7*FRW7I<IW5
M;KBUF9CG3G,[E]29*3,9R>2YR,IJY[S\#6@4:UC=S6-`:T;&@!=`,-A,5I['
M1XG"P1V^/B%&L:/A<XFI<X[W/<2YQVN)*V,+2KH@(HE_-;X"8]RNV:N]Q<+H
M([/(7:ZCF76*VE?%)-GGF/5+#\ZSVXM393W6;DU@G':<W"4Y&LB2VA;3,F3W
M3CR2YGW6B=01XG(2DZ5O9`R1KCZ,+W$!L[:_%H:"6FQT=207,92%^<G+:VUE
M@I,I81@:FLXRZ-S1Z4S&@ET#J?&J*F*NUKZ`$->^M(T=%%H"@(@(K&?U=_-W
M8>YG)#;=3ZC8R'!<+S=F,IS5"'<.R"RH9+[+1Z]BG49TTEQ2=.XD()6O:G34
M_P`5>.;)A\1EP/2BN982>R5C7@'R=R:>4TWE;1>&+(.9ELKBB?1EMXI0.V)[
MF$CR]\*^05W!6IQI4MQ$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!%%%YUGT>NZWQGVL^43'A-WAY]Z=EZFY]@]0US\]V5YZZW]L
MQ4@AT77/Y`1`1`1`1`1`1`1`1`19)B5Q2T-_7VF0XE69Q3QG>Z;C-O99!40K
M)KUM+L<8M::XBJ]Q3;Y:>LC%)?6]Q<VKH;6=]M<$;)&M8XM/VLC7L/G"JK*>
MWMKELUU`RX@!VQN<]H</MHW-</,58GX0>:_P0V7;C8[/XB1>-DN6TS73=PMN
M$,[G*FL&IKO=RB]NHT#=,ZMKM-1,$]>N)46I$9K49:I<QN2/,O4)-W%G79=C
M27"">MO0[=D;&%UMQ'KI"/@6S_+_`)R\NL"!:R808I[@&F:"D]1UR/>!<</9
M68_"K'>T.^&T6_F*MYKLWN'B^XF-+<)AZPQNR:EN5TI2?$*!=5R_"M*&R\/1
M9QIK+$@D&2C1H9&>IF=TYG=,7IQV?M9K2\I4-D:1Q#ZYCMK7MZ.)A<VNRJVE
MPFH,)J2S%_@KJ&ZM*T+F.KPGJ<WXS'?8N`=3;1;4%E5X0$0$4=_FP?1Z\EOB
MQB_RB8<)5Y(^]/#^ND]A*HPYS>[++>JC]O$J&HZ8+G0@(@(KY7E/_1Z\:?BQ
ME'RB9B.9_.[WIYCUT?L(ET7Y,^[+$^JD]O*I$!%2D]5:_K">]SDW+MC>.M=,
M_:=#266[V516UI<:=M+Z5.Q/#D2"29^!,JJZHMU]AZ*-FR0HR[5),]S_``L:
M<$=CDM5RM_"2R-M8STAK`)9:=8<YT0KUQD;P5J#XF=0&2]Q^EXG?@XXW7,@Z
M"YY,<5>HM:V0TZG@]2K<C;9:KH"("+]`WR_>.T;C!Q+VBVQ<A%#RAS'H^8;A
MJ4WV27\_S!EFYR)F4KM0;QT;C[=6RLTI4<6`UJ1&1CEUS1U6_66N+_,!W%9B
M4Q0=0@B)9&1U<=#(1]<]RZ5\M=,,TCHNRQ!;PWAB$LW69I0'/!Z^"HC!^M8U
M=FB/UG:`B`B`BPC<K;[&MV-O<VVRS*&4_%L^Q>[Q*^C=K9N*K;VO?KY#L93K
M;J6)L9+_`(K#O::F7D)6G122,7'$92\P>5M\QCW<-[:S,E8?LF.#@#3>#2CA
MT@D'85;\KC+3,XRXQ-\WBL[F%\;Q]B]I::=1%:@]!`/0OSF=T]O;O:7<O<#:
M[)$]M_MWF>2X5;J)M33;T_&KB942)+"%*69Q9:XGBM*)2DJ;6E1&9&1GUAPN
M5M\YA[7,VG_2W=O'*WIH)&AP![16AZB"N768QEQA<M<XBZ_ZFUGDB=T5,;BT
MD=AI4=A6!"YJW("*:#R+][']N.92=MI4HVZ#?;"[S%W8ZWC:BIRG$XDG-<9L
M'"]XY)1#JK*`RD]-5V1D7M&1'K[XDM.MRV@/SNP5NL9<,D!I4]W*1#(WR5=&
M\]D:GCP\Y]V*UU^:GG_ELC`^.E=G>1@RQN\M&O8.UZN=#GXM[E`1]80QF3.X
MT[,Y8RAYQC'=[$T\OPR[FV49-A&3R&I$@B0I2&R?QQ+9+-24$MTDGJI:1L]X
M6KQD>K\A8N(#I<=Q#M[N:,$#S25IOH*]!6MWB8M'R:4L+UM2V+(<)[.\BD-3
MYV4KUFG2%4<&\ZTJ0$0$7Z#GE_9/6Y=PAXI6M4ZV[%B;#[;8PZMMU+R2LL)Q
MF!AERT:TD1$XS;T#Z%I]*%)-)ZF6HY;<T+.:QYC9N"<$/=D[B0;*>C-(Z5A\
M[7@@](VKI?RUNXKWE_AIH2"QN.@CZ_2BC$3O@<P@]6Y=?#`UFZ`B`B`B@`^L
M*97#A\;]D,&6ILI^1;W*RN,@R/Q50\,P/*:B<I!]Y$3:'L\CDKV3ZJ3U+T'M
M!X6+&235N1R0KW46.[H^66:-P^I"[ZJUL\35ZQFEL?CS3O)<AW@\D4,C3]69
MJJ2#>5:6("("+]$7AGC#^&\1N,>,2VW&9U1L)M/'LF7%&I3-JO!Z1^U:(U-M
M*)MJQ>=2DC22B21$?4ARIY@7C<AKK,7D9!BDR=R6GK;WSPT]/R0*KIWH2T=8
M:*Q-H\$2,QMN'#J=W3"X?=$K(N3>[[&P7'S>/>1TF5O;>[?Y'D%4Q(T-B;D+
M$!UC&:UW4TEX=GD+\6.?_&^OT"DT?@7:GU388!M>&ZNHV.(WAA=61P^U8'.\
MRJM6YMNF],WV==3BM;9[V@[B\"D;3]L\M'G7YT<^?,M)TVSL9+TVPL9<F?.F
M2%F[(ES);RY$J2^XK53CS[[BEJ4?4U&9CJ]%%'#&V&(!L3&AK0-P`%`!V`;%
MR]DDDFD=-*2Z5SB23O))J2>TE?4'[7X0$5XOR;MF(>TG!7;:U7#3'R+>"9=[
MK9$^:$>*^W=S55>)I2]VDZJ*G"J:O=2A1FE#S[II]\9GSCY_:@DSO,F\@#JV
ME@UEM&.K@'%+LW5[Y[Q7I`;7<N@O(O`LPO+RTF+:75\Y]P\]?&>&/;OIW36&
MG02:;U*>(64PH"("("("*$OSXMHX>;<.:[<U$1M5ULKN+CMJFQ\%+C[&,9R^
MWA%U7$Z>BF(]A?V-,\LRU)2X;9&7H,MB/#1G9,=KY^'+C\WR-I(WAKL,D([Y
MCJ=):QLH'8XJ`?$7A(\AH9N6#1\XL+ICN*FT1S'NGM[`Y[HB>UH5-D;^K1=`
M199@>97>W.<8=N#C4E4/(L&RG'\OH92%*0J/<8W:Q+BM>):?:3X<R&@^@HLG
MC[?+8VXQ=X.*TN87Q/'6R1I8X?`2JS'7]QB\A!D[0\-U;S,E8>IS'!S3\("_
M2"P+,:G<3!L+W`H5^)1YSB>.YC2N=R5^)4Y-3P[JN7WI(DK[H<U!ZET,<E<G
M83XK)7&+N=ES;3R1/^VC<6.^J"NIN-OH<GCX,E;;;>XA9*W[61H>WZA"RP4*
MK50U\V#Z0KDM\9\8^3O#ATPY(^ZS#^ID]O*N<_.7WFY;UT?L8E'>)548H"+[
M<"!,M)T*LKHSTVPL9<:!!AQT&[(ES);R(\6,PVG53CS[[B4)274U&1#\2RQP
MQNFE(;$QI<XG<`!4D]@&U?N..2:1L,0+I7.``&\DF@`[25^A)PIXU47$WC=M
MQL[5Q8S=U6U$>ZW`LF#0M5]N-=Q8TG+K9Q])J\=E,])1(AFI1MP(L=K4R;(Q
MRSYAZON=<:MN\_,XFW?(60-/R(&$B)M.@\/I.ZWN<>E=,M`Z4M]&:5M<'"`)
MV,#IG#Y<[P#(ZO2*^BWJ8UHZ%U6,)68H"("("+\]3G1MC!V<Y@\BMNZJ*U!I
M:/=/)9=!`8)*6:_'<CE%E&/5[*4:)2U!I;IAI)>HD#J?RVS,N?T'B<K.XNN)
M+*,/<=[I(QW;W'[9["?.N9?,/$1X+7&4Q<(#;>.\D+`-S6//>,:/(UP'F7*`
MS98:@(IMO(-FR(G-K)6&%DEJSV`SJ%,(T)4;D=O,-N;)*$FHC-LREU[2M2T/
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M/'0YA!Z*T)"O6`U%FM,9!N4P5Q);WC>EIV.'UKVFK7M/2UP(Z:5HKEOEO^9G
MA?-FA7A>4Q(>$<@\7ITV&1XLPLTT.7UT=PHTK*L$<D/O2U165K:5-KWC.1!4
M\GM7(9U>+0'FUR?R'+NY_.%DYUSI::3ACD/QXG':(YJ`"IV\#QZ+Z&H:[T5O
M7RLYLV&O[;YA>-;;ZFACXGQCXDK1L,D-230;.-AVLKL+F^DI41"JF%`11W^;
M!]'KR6^+&+_*)APE7DC[T\/ZZ3V$JC#G-[LLMZJ/V\2H:CI@N="`B`BOE>4_
M]'KQI^+&4?*)F(YG\[O>GF/71^PB71?DS[LL3ZJ3V\JD0$5*3U0[\V+/W]P^
M?O(6<J0X]"QC(:?`*QA1&2(3&#XS38]81V25JHFW;^',D'U,C<?49:$9$72[
MDABVXKEABHP`))HGSN/69I'O:3Y&%C?(`N=/.;).R?,G)R$DQPRMA:.H11M8
MX#^&''RDJ.D2NHO0$74/"?;5G=[EQQTV\F1CFU=_NWAJ[Z(39N')QJFMF+_)
MV="2LDDYC]7)(U&1I07M*(R(QAO,3+NP6A<ME8SPS16,O`>J1[2R,_=N;Y=R
MR[0.*;F]:XO&/'%#+>Q<8ZXVN#Y!]PUWDWK]#D<K%TX0$0$0$0$0$5(#SI=O
M&<#Y][DSXD=,6%N/C>";AQV6^SP_&FX]'QJXD))*E+)4[(,6ER'.[0S==49%
MVFD=&?#WE79/EA:1//%):330$]@>9&CS,D:T=@'35<_>?.,;CN9-W(P4CNHH
M9@.TL$;CYWQN)[2>A12";%#:`BWUQ8SQ[:_DML%N"T^<=&([P;>7,U9::.54
M7*JO\,Q7-33]YFU*GF5Z&D^QP]#(]#+&=:8QN9TAE,6X5,]A.P?;&-W`?*'4
M([0LCT?D78C5>-R8-!!?0N/VHD;Q#R%M0>PK]&`<H%U#7%7F&\?)/)OB%O'M
M?3P3GY@="C+<"CMEK*?S3"Y+614]9#U4EM,G(TP7:KN7[*43E'TT)12'RKU2
MS1VN[#,W#N&P[WNICT"*4&-[CV1U$FSI8%@7,W3+]6Z(OL1`WBON[[R$=)EB
M/&UH[7T,>WH>5^?ZM"VEK;<0IMQM2D.-K2:%H6@S2I"TJ(E)4E1:&1]2,=0@
M014;05S7((-#L(7\`OB`BLQ^1=SBH::#*X:;EW+%6]-NY^0[&V=C(0Q#FS+E
M:I>2;<I<<\-J//E69+LJQ!F:IDB5+9(_$^#MN:@>)+EQ<W$C>8&(C+VMC:R\
M:T5(#-D<_:T-I'(?DM:QV[C(VP\//,&V@C.A,M(&.=(7VCG&@)=M?!V$NK)&
M/E%SV[^$&SN-.5ML@(@(OC==:8:<??<;999;6Z\\ZM+;333:36XXXXLR0AM"
M",S,S(B(M3'UK2XAK02XF@`Z5\)#07.(#0-I5'[S=.8E-RPY+?`L"M&[?:39
MJME83A-G',SA9'<2I3<K-LOA*/7OA6MG%9AQ7$&;<F#6L/I(O%,AT9Y%:"N-
M$:0[S)L,><R#Q-,T[XV`4AB/:UI+W`[6OD<T_%7/SG9KB#6>J^[QK^/"V##%
M$X;GN)K+(.QS@&M(V.9&UP^,HJA-:AU`1=)\0M@K7DYR0VFV7K8LA^'EF5P3
MRJ1'[T_@K!ZE1VV9VRWTJ03!P\<A2#:,UH\20;;:3[UI(\1UWJ>#1VDK[4,S
M@)((#W8/RIG>C$VG360MKL-&U)V`K*M$:;FU;JJRP,0)CFF'>$?)B;Z4KJ]%
M&!U-HJZ@&TA?HA,,,QF68T9EJ/'CM-L,,,-H:989:03;3++39)0VTVA))2E)
M$22+0ARJ<YSW%[R2\FI)VDD[R3UKIVUK6-#&`!H%`!L``Z`H:O/9W"<P_@XY
MB\=Y27=U-U\%PZ2RVXE*UUE0BXW#D.N(-:5+BMS\*BH5H2M%NHU+0]2G_P`-
M>*%_S'%ZX>C96,TH/V3N"`#R\,SCY`5!7B(R9L>7QLVG;>7L,1'V+>*8GR5B
M:/*0J7XZ"+0]`1`16G-G_/7XR;6[2;7;8M[-;W/M[<[=83@B'H[6!_!WD8AC
M-9CZ76/$RUE?@N)K]4]R$GVF6I%Z!I=GO#7K#-9R]S!R&.!N[N::A[ZH[V1S
MZ'\$=OI;=I6X&#\1&D\/A;/$BPR!%K:Q0U'<T/=QM9L_"#9Z/4MB_P!(3XS_
M`/@KOI_R6`?CB+3^RSJ_Z1QO_'_JE=/VF=)_^0R/_!_K4_I"?&?_`,%=]/\`
MDL`_'$/V6=7_`$CC?^/_`%2?M,Z3_P#(9'_@_P!:G](3XS_^"N^G_)8!^.(?
MLLZO^D<;_P`?^J3]IG2?_D,C_P`'^M3^D)\9_P#P5WT_Y+`/QQ#]EG5_TCC?
M^/\`U2?M,Z3_`/(9'_@_UJ?TA/C/_P""N^G_`"6`?CB'[+.K_I'&_P#'_JD_
M:9TG_P"0R/\`P?ZU<P<S_.:X_P#)OC%NUL7C^U>[M%=Y_35<.JMKZ/A3E/"G
M5&34F1QW)Z864RY:65.4Y)[FVEK0I1*(C,AF7+[P_:HT=K&QU)=7MA+;6LCB
MYK#-Q$.C?&>&L8%?2Z2`=RQ'7?/;36K=)7NGK:SO8[BYC:&N>(N$%LC'BM)"
M:>CT`D;U6]&VJU90$0$5\KRHLZ>W`\O[CE:2WO%F4>,76"OIT7JPS@&79!A]
M0R9J,R5_S#3Q%EVF9=JB+H9&DN9_.W&MQ?-#+0L%(Y)F3#M,\3)7'[M[AYO.
MNC')K(NR?+7%S/-9(X70GL$,CXFC[AK?]-BD0$5*3E0U\V#Z0KDM\9\8^3O#
MATPY(^ZS#^ID]O*N<_.7WFY;UT?L8E'>)548H"+OGROMLXVZ_/+CCC<]A$BM
MJ<T>S^>AY/?'-&VE':Y]#;DM]BTN,R[3'8[!H41H6;I)5[)F91CSES#\)RSR
MUW$2)GVX@;3?_P`P]L)IVALCG5WBE1M4C\HL2S,\QL7:R`&)EP9C7=^`8Z85
M["Y@%-QKMV*_".9"Z/H"("("("*BSYQ:$-^8[R,2VA*$FK:59I0DDD:W=B]L
MG'%F22(C4XXLU*/TFHS,^ICI+R#)/*7$D[3_`,S_`(RX7/+GD`.:64I__P`W
M^$@498F!1,@(IB/(Q==;YYTB&W'$(?VNW':?2A:DI>:*%7ODVZE)D3C9/,H6
M1'J7<@C])$($\2+0>6<A(!(O8".S:X;/,2/.IQ\/1(YC1@$T-G/7MV-/[H!5
MU(<]5OJ@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(HHO.L^CUW6^,^UGRB8\)N\//O3LO4W/L'J&N?GNRO/76_MF*D$.BZY_("("
M*]9Y56*XO/\`+]XVS)V-T,V6_C63J>E2Z>ODR'E)W"R]"3=?>CK=<,D)(BU,
M^A$0YL\Z[V]BYHY>.*:5K!-'0![@!^`BW`%=#N3EG9R\M<4^2*-SS%)4EK23
M^&EZ2%(/_`G#/^R.,?\`0%5_B@BS\XY#^GF^[=^^I-_-]A_00_<-_>3^!.&?
M]D<8_P"@*K_%`_..0_IYONW?OI^;[#^@A^X;^\G\"<,_[(XQ_P!`57^*!^<<
MA_3S?=N_?3\WV']!#]PW]Y/X$X9_V1QC_H"J_P`4#\XY#^GF^[=^^GYOL/Z"
M'[AO[RQ/+-C=E,\A'6YQM!M?F->I)H.%E&`XK?1>T^[H3%I52FTZ&HS+0B,C
M/45UCJ346,D[['7][;R]<<TC#\+7!45YI[`9&/NLA8V<\75)#&\?`YI44?*3
MR/N,>[M7/N-C4/<?MPR0MZ&FI7.NMM[:21$91[G$Y\IZ33-ND@FT/5,B*W'[
MU.*BR3(D'-NC/$;K'!3-@U(1E,5N/%1EPT=;)6@!]-Y$K7%U*![-ZAO5_A^T
MEFX73Z>!QF3WCAJZ!QZG1DDMZ@8W-#=Y8_<JGN__`!]W5XR;F7.T^\.-/8WE
M=03<EI25_"J>^IY2G"K\AQNU0E,>XH[`FE$V\C12'$+9=2V^TZTC=W2^J<)K
M'#QYS`S":RDV'H<QP^,R1N]KVU%0=X(<TEI:3IGJ73.9TEEI,-G(C%>,VCI:
M]IW/8[<YCN@C<06D!P(&EAD*L*`BS?;?<7,]H\\Q3<S;V]EXWFF%7,2^QZZA
M*+Q8D^&O4DNM+)3,N%+94MF3'=2MF3'<6TXE3:U).W9?$X_.XR?#Y6-LV/N(
MRQ[#N+3]4$&A:X4+7`.!!`*N&*RE_A,C#EL9(Z*_MY`]CAT$?4((J'--0YI+
M2""0K_O#+E!C/+_CWA&]./HC0+&TCJILYQR.Z;O\$\_IVF&\EH-5K<>^")>>
M;E05.&3KU;*CNK)*G#27+_F!HV\T'JFYT]=$NB8>.&0BG>P/KW;^JM`6O`V"
M1KVBH%5TFT)JZTUOIFWSUL`V5XX96#_9S-IWC.NE2',KM+'-<:5HNIAA:S!1
MW^;!]'KR6^+&+_*)APE7DC[T\/ZZ3V$JC#G-[LLMZJ/V\2H:CI@N="`B`BOE
M>4_]'KQI^+&4?*)F(YG\[O>GF/71^PB71?DS[LL3ZJ3V\JD0$5*3U^<QR@O#
MR?DMR'R0W#=/(=\]VKPW5-)84X=MGV03S<-E)$EDU_"->TNB?0.L.C;;YGI#
M%6E*=UC;9G7\6!C=_3N7+K5UQ\[U7D[JM>]R-R_J^-,\[NC>M&#)%CR`BE2\
MEV@1=>89L]+=8<?1C5'NA?F1):6RTO\`S;912,/R4NMK,VVI%T@VS3VK2_X:
MB/H9'"OB#NC;\J[^,$`S26[.FI_YB-Y`\H8:]'#4*8>0UL+CF;8O()$4=P_L
M_F)&`GR%XIVT5X@<Y%T%0$0$0$0$0$52#ZPG2$QR5V3R/PDDJUV-32&^3JS6
MX5!GV73B:4P:C;;2R>2F9+(B4LW#(S,DEIO-X6+CBTAD;2OQ,EQTI]?#$VM>
MWN]W13M6E?B9M^'5>/NJ?'Q_!7[2:0TIV=YYZ]B@$&SZUM0$7]H6MI:'&UJ;
M<;4E;;B%&A:%H,E)6A23)25)46I&74C`@$4.T%?02#4;"%^EYC5HN[QR@NG#
M8-RWI*JT<.+K\%-<^`Q+4<;N<=5X'<[[&JU'VZ=3](Y!7D(MKN6W%:1R.;MW
M^BXC;NV[-NQ=7;28W%K%.:5?&UVS=M`.S?LV[%[8IU4*ICYQ_EN6^W>7Y#RQ
MV2QZ58;:YA/E76[N-4\1Z4[M]EDUQZ7:9FU'CH6MK"<ED*4]+69>'6V"UZJ3
M'D,H9WAY!<VX,M8Q:'U%*UF7MVAEK(X@">(4#8B3OFC&QHWR,`V%S7%VF'//
ME7/B[V76>`B+L5.XNN8V@GN9#4NEH-T4AVN.YCR?DN:&U\QM(M:$!%\C3KK#
MK;[#CC+S+B'67FEJ;=:=;42VW&W$&2T.(61&1D9&1EJ0^.:'`M<`6D4(/2OH
M):0YI(<#L*FTXO>>5R0V6J*_$=XJ&OY$8O6LL1(-M>W4C&MRHD5E)-(;E9FU
M77<?)":;]HW+&"_/>47WR7UU+7;67APTEJ&=]_@)7XJ]>27-8P26Y)V[(BYA
MCKU1O#!T1J?M(^(356!@;99R-N4LV``.>XQS@#KE#7A_E>PO/2]2<4?U@_BI
M(@H<R7:#D'4V1Z>)$HZG;C(8*?9(U=EA/W%QB0YHO4BUBIU+KT]!0]<^%K6S
M9*6E_BWP];W3L/W+8)!_&4M6_B8T<Z.MW8Y-DO4QL#Q]T9XS_%7B9C]86X[P
MH3CFW^Q>]&36)-)-F+F,K!\&A+>^_=S;D^ER#<1]IHNUO191EF?<KV2[2[ZB
MP\+&JY)`,IDL?#%7:8A-,:;/DO9`"=^SB'1MV[*>^\36F(XR<;CK^66FP2F*
M(5V]+'S&F[;PGIV;-L.O,'S;>37+.HL<$0[5;/[3V1.L6.$8&_.78Y)!6M"T
M0\SS&:M-G=1T=II7'B-5D"0@]'XSAD1E/F@N1FC]#SLR1#[_`#C-K9I@.&,]
M<40]%AZG.,CVGXKPH-UQSJU9K.!V.!98X9^QT4)/$\=4LI])PZVM$;'#XS"H
MM!,ZB!`1?/%BR9TF/"A1WYDR8^S%B1(K+DB3*DR'$M,1X[#25NOOONK)*$)(
MU*49$1&9C\O>R-ADD(;&T$DDT``VDDG8`!O*_3&/D>(XP72.(``%22=@``WD
M]`5SSRA_+WF<4=NYV[>Z]247?K=2JBLO54DB.3MO@BUL6$7$W4FDC9R.YEMM
M2K@C,_!6S'C$25,/*=Y]\]N:<>M\JW!81_%IFR>2'#=<3;6F4=<;!5L76"]^
MT.:&[W\D^6;]&XMV:S+*:CO&`%IWP0['"/L>XT=+U$-9L+7%TRX@!3JJX'UB
M:^5'P/B[C!/I2FWR[<Z^.,9.][JL<IL/KTOI41^"28Y92:3)1=QFZ7;T)0VT
M\*=L'Y/,WE-L<%NRO5WCY74Z]O=_4V]"U9\3]R6X[$6E=CY[A].O@;$VO5L[
MSZOE560;HK3]`1`1`1`1`1`1`1`1`1`1`1`17-_(<N56G!N5!-YETL<WLW`I
MDH:,S7'2_4X?D/@R"-2NUY2KXW"+1/WMQ/3UGS]\2]OW/,ALE".]QT#_`"T=
M*RH[/0IY05O;X=)^^Y>NCJ#W60F;Y*MB?0]OIU\A"FC&OBGE4-?-@^D*Y+?&
M?&/D[PX=,.2/NLP_J9/;RKG/SE]YN6]='[&)1WB55&*`BFF\AJD*UYQSYYL*
M>_@SLAG]V3B5)244W[O"\<\=9*,C6E19`;6B=3[G"/T$8U[\3%QW'+AL5:=]
MD8&>6C)9*?Q*^93SX<[?ON8+I*5[K'S/\E7Q,K_'IYU<T'/Y;VH"("("("*B
MYYQWTC_(S_5%\A&V`Z2<@O=+B?[U_C+A<\N>?O3RG]V_PENHR!,*B9`13">1
MI_+UQ_\`T8[D?Y.AB!?$A[LI?[9!_**G#P]^\>+^R3_R0KJPYZ+?9`1`1`1`
M1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`111>=9]'KNM\9]
MK/E$QX3=X>?>G9>IN?8/4-<_/=E>>NM_;,5((=%US^0$0$5\KRG_`*/7C3\6
M,H^43,1S/YW>]/,>NC]A$NB_)GW98GU4GMY5(@(J4GH"("("("("*.+S.^&=
M-R]XXY)'K*AE[>+;2MM<QVGMF62.SD64&)\*M<(\5)$X]7YM"B?!4M*432)Y
M17S_`&'K+/)SF!<:$U;"Z:0C`WCVQ7+2?1#2:-FIT.A)XJ[RSC;\I1;S;T)!
MK;2TK8F`YRT8Z6W<!Z1<!5T7:V4#AIN#^!WR51"'2Q<ZT!$!%8`\@7D!*Q/?
M7<#CQ:3-,?W:Q9[+<;C.+(_"SS`VS?DM0T*6CM_#&&29KLDTDM2OP6P6A))1
MEJ_XG]+LOM-6NJH6_P#-6,XBD/7#-L!/VLH8&[OYQW8MD_#;J5]EJ*YTQ,[_
M`):]A,C!U30[33[:(O+O5M5MH:-+=-1W^;!]'KR6^+&+_*)APE7DC[T\/ZZ3
MV$JC#G-[LLMZJ/V\2H:CI@N="`B`BOE>4_\`1Z\:?BQE'RB9B.9_.[WIYCUT
M?L(ET7Y,^[+$^JD]O*I$!%2D]?F[;XM.L;U;OL/MN,O,[H[@-/,NH4VZTZWE
MELAQMQM9$M#B%D9&1D1D9:&.MFFW!VG;!S2"TV4!!'3^":N6&H06Y^^:X$.%
MY-4?_P"QRU<+RK0@(I@/(W=:;Y[XTAQQM"W]M=R6F$K6E*GG2J8[YMM)49&X
MX3+*UF1:GVH,_01B!_$>UQY93$`D"\MR>P<1&WSD#RE3?X>R!S'B!(J;2>G;
MZ(/[@)5UH<\EON@(@(@(@(@(JH?UAU2?\\_'=.I=Q;89.HTZEW$E65H))F7I
M(E&D]/=T,;M^%4']'\J>CYY'[-::^)P__/8L=/S23VBKPC:I:QH"("+])C:2
M#(J]J=LJR622E5VWN%P9)(42T%(B8W6QWB0LNBTDXV>A^LAR.SDC9LW>3,^(
M^ZE(\AD<0NJ>%C=#AK2)_P`=MM$#Y0QH*V$+6KFO+NWZ:-36LC(WJN/C[5=-
M7>/7;D1JF:J4QW/PBNU<GFF$BN*)W^,;QDUX>O=TU'M;MN'W#&V@>;HO'`&5
M+^*OH\/#MXJTI3;7<O&X=`R![KHL%L&GC+Z!O#3TN*NSAI6M=E-ZHO>977<#
MXN\4N3PMO;B44F?,7G5+15D=W92#8N*<<=>VRR"18M6GP<Y9F2X4:&_2(0HC
M@24,I3'+I'RAEYEOP#6<PHHVT:.Y>]Q^=EO5<,#2VM-SW/$Q/\ZPN)<N>?-:
M+ETS.%^@I'N!<>^8QH^:AW7`\NXJ5WM:TQ`?S;PT!JC:$N**T!$!$!$!$!$!
M%N79+CYO1R-RUC"=E=N\CS^^<<83**GAZ55*S)<-MJ=DE_+5&HL;K361E\)G
M2([.I:$K70A8-1:IT]I.Q.1U#=Q6ML`:<1])Y'1&P5?([[%C7'L5]P&F<]JF
M]&/P%K+<W)(KPCT6`]+WFC&-^R>X#M5M?R\/**P/BI(J-VMXY-1N;OW';;E5
M/@,KD8/MG*4E*O$Q=F<PR_=9-'5J16\AIHV/1%9941O.:-\U>>N3ULR3!X`2
M6>F":.J:37`_WA:2&1G^B:37Y;G#T1NERQY)X[1SF9K.EEWJ0"K:"L4!_P!V
M"`72#^D(%/D-;\8S/#7U3N@(JR7UC/\`_IS_`/Z$_P#X/&X?A/\`_P"__N/_
M`/,6IGBB_P#Z/^^__P`15DAN$M3$!$!%VU5^7!SENZRNN:KC1N3.J[>!$LZV
M:Q!KS9F0)\=N5#E,FJQ29M2([J5IU(CT,1W-S:Y;V\S[>?,6C9HW%K@2ZH<T
MT(/H]!%%G\/*SF%<0MGAQ-TZ%[0YI`;0@BH(]+I!JOO_`,V9SU^:]N=^X:[]
M\AY?K@Y9?3-G\+OO5Z?JGYC_`$1=_`W[Y/YLSGK\U[<[]PUW[Y!^N#EE],V?
MPN^]3]4_,?Z(N_@;]\G\V9SU^:]N=^X:[]\@_7!RR^F;/X7?>I^J?F/]$7?P
M-^^3^;,YZ_->W._<-=^^0?K@Y9?3-G\+OO4_5/S'^B+OX&_?)_-F<]?FO;G?
MN&N_?(/UP<LOIFS^%WWJ?JGYC_1%W\#?OD_FS.>OS7MSOW#7?OD'ZX.67TS9
M_"[[U/U3\Q_HB[^!OWR?S9G/7YKVYW[AKOWR#]<'++Z9L_A=]ZGZI^8_T1=_
M`W[Y/YLSGK\U[<[]PUW[Y!^N#EE],V?PN^]3]4_,?Z(N_@;]\G\V9SU^:]N=
M^X:[]\@_7!RR^F;/X7?>I^J?F/\`1%W\#?OE9[\ES8?=SCWQ8S?#]YL'N-O\
MHN=^<JRN!1WJ&&Y[E!+P';&DBV"FV'GT(:D6-!*0G56I^'KZQIQX@]38+5.M
M+:_T_<QW5E'C(XW/97AXQ-</+=H&T->T^=;;\AM.9K3.C[BQSUN^VO),C)(&
M/I7@,-NP.V$[W,</,I=A!2FQ4-?-@^D*Y+?&?&/D[PX=,.2/NLP_J9/;RKG/
MSE]YN6]='[&)1WB55&*`BG2^K[_RR]S/]F3,_E4V8&MOBC]W]G_G$7^&NUL-
MX:?^^KO_`"F7_$6JN$#0Q;P("("("("*BYYQWTC_`",_U1?(1M@.DG(+W2XG
M^]?XRX7/+GG[T\I_=O\`"6ZC($PJ)D!%,)Y&G\O7'_\`1CN1_DZ&(%\2'NRE
M_MD'\HJ</#W[QXO[)/\`R0KJPYZ+?9`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1
M`1`1`1`1`1`1`1`1`1`1`1`111>=9]'KNM\9]K/E$QX3=X>?>G9>IN?8/4-<
M_/=E>>NM_;,5((=%US^0$0$5\KRG_H]>-/Q8RCY1,Q',_G=[T\QZZ/V$2Z+\
MF?=EB?52>WE4B`BI2>@(@(@(@(@(@(OSKN7>&P]O>57(_":R.W$J<9WQW1J:
M6,T9*1'HX^:7)4K)=I$23;JC9(T_K3(R]0ZM:$R$F5T5B<C,2Z>;&V[GGK>8
MF<9^ZJN8&MK&/&:QRN/A`$,.0N&M'4P2NX!]S1<[#*UC"`B[/\NO,9F#<Y^*
M]U!6\V]-WGPW#EJ8T[SA[B6"=O[!"M7&OO+L#)G4N=3^]FKHKWIQ]S7L(\ER
MWS5O)0M;CY9=O7`WOV]>WBC%.WJWK/.5]\_'<P\/<1U#G7\46SJG=W+O-20U
M[.M?H%CEVNE2CO\`-@^CUY+?%C%_E$PX2KR1]Z>']=)["51ASF]V66]5'[>)
M4-1TP7.A`1`17RO*?^CUXT_%C*/E$S$<S^=WO3S'KH_81+HOR9]V6)]5)[>5
M2("*E)Z_/*YP8PYAW,?E%CZT*;;B[\[I2H:5^(:RK+?,;:XJ36IQ*%+4JKGL
MF:M-%&>I&9&1GU2Y<W@O]`X:Z!J78RV!^V;$UCOXS2N9',&T-CKG+VQ%`,C<
M$?:NE<YO\4A<M#,UB"`BDT\GK)6L:\P[8-4DVDQ;Q6X6-/+<+VTNW&V.8M5I
M,&;S*$NO7"([9Z]^J%J)*34:=(?Y]6;KSE5DPRO''W$@\C;B(NKL.P-XCT;0
M-M*J6.1]VVTYG8TOIP2=]&?*Z"4-IM&]W"/(3LK17IAS:70Y`1`1`1`1`14^
M?K`60L67+[;J@CJ:7_!O8'&_AAI)9.M6%QG6X4U49TS/L-*:U$5U.A:_?CU,
M^FF^?A>M'0Z$N[IU1WV4DIU%K(8!7[KB'F6D'B4NFRZWM;9M/P6-97[9TTQI
M]SPGSJ"L;)+7A`1>M0TTS(KRFQ^O3WS[VVKJ:"CM6OOF6<QF%&3V-I6XKN>?
M26B2-1^HC,>%U<1VEM)=2_S43'//D:"3]0+VMH'W5Q';1?SDCVM'E<0!]4K]
M+J%#C5T*)7PV_!AP(L>'$9[W'/"C16D,,-^(ZI;J^QI!%JI1J/34S,QR$DD?
M+(Z60UD<XDGK)-3NV;UU=CC9%&V*,48T``=0`H-Z\'-LUQ3;C$<CSS.;VOQC
M#\2J)M[D=_:.FS!JZJO94_*DO&E*W7#)"=$-MI6ZZX:4-I4M24G58['7V6OH
ML9C8G37\\@9&QHJ7.<:`#_630`;20`2J;(7]GBK*7(Y&1L-C`PO>]VP-:T5)
M/^H"I)V`$FBI.^8=YGVY_,O(;/#,4E6N`<=:VP4FBP>-(7#M,U;B/$N)D6Y+
MT20XW92WGFTOQZQ*E5]?HWH3\ALY2^A_*ODWAN7]JS(7K676JWM].8BK8JC:
MRW!'H@#8Z2G&_;\5AX!H+S.YN9?7=R^PLR^VTNQWH1`T=+0['SD'TB3M$?Q&
M;/C.'&8KQ-*A]2!<!/+ZW)YU9Q9PJ>>6$[6X<Y#//MR9L!4]J"]-);D/',;K
M3?B)O<HGL-*<\/Q6V(<<O%D+2:X[4B+N9_-+$<ML:R2=OSC-7`/<6X=PD@;Y
M)'4/!&TFE:%SW>BT&CG-DKEORTRO,/(/C@=\WP\!'?3D5H3N8QM1QR.`K2H#
M1Z3CM:'6`LP\@+B7;T\*-A^X.]6&WD.(U&<MI5SB^3P+1Y#1)<GVE/*QBN<^
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MZO8OJ5GD2<ZIZG2E-[.TA-FT2%6>X4EU+Y.&LEJ:_`V-VZB)CM+O[R09]Q=O
M=UT_<WB5Y;1`<!OY*U^+`!3[N1N_HI7MHOQ%X=N8<E>,6,=/KICM^Y8[=VT[
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M,Q`^4R^5SEX[(9BXFNKUV]\KW/=UT!<30#H:*`;@`%-V,Q6,PUHVQQ-O#;6;
M=S(V-8WRT:!4GI)J3TDK-Q;E<$!$!%7-^L14#DC;+C1E!-D;5/G>?4"WO@_<
MIMS),?H;%MLI7]Q)U.*K,V_[KV$?]S&V'A4N@S,9BSKMDMH'TK_1O>W=TT[P
M;>BO:M7?$];%V)Q-W38RXF96GU[&.W]'\WNZ:=BJKC=5:=H"("+]'[C_`&#-
MOL-LE:QDNHCV>T>V]@PA]*$O(9FX;326DO);6XA+J4.$2B2I1$?H,_2.2^J(
MG0:FR,#Z%[+ZX::;JB5X-.Q=2]-2MGTYCYF5X7V4#A7?0Q-.U;<%B5[0$0$0
M$0$0$0$0$0$0$0$5#7S8/I"N2WQGQCY.\.'3#DC[K,/ZF3V\JYS\Y?>;EO71
M^QB4=XE51B@(ITOJ^_\`++W,_P!F3,_E4V8&MOBC]W]G_G$7^&NUL-X:?^^K
MO_*9?\1:JX0-#%O`@(@(@(@(J+GG'?2/\C/]47R$;8#I)R"]TN)_O7^,N%SR
MYY^]/*?W;_"6ZC($PJ)D!%,)Y&G\O7'_`/1CN1_DZ&(%\2'NRE_MD'\HJ</#
MW[QXO[)/_)"NK#GHM]D!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!
M$!$!$!$!$!$!%%%YUGT>NZWQGVL^43'A-WAY]Z=EZFY]@]0US\]V5YZZW]LQ
M4@AT77/Y`1`17RO*?^CUXT_%C*/E$S$<S^=WO3S'KH_81+HOR9]V6)]5)[>5
M2("*E)Z`B`B`B`B`B_Q2DI2:E&24I(U*4HR)*4D6IF9GT(B(`"30;T)IM.Y?
MG*<F,\B;I<B]^=R:Z2<NKSO>+<K+*=\UFLETU]F-Q94Z6U&I?WEJLD-(;+4R
M)"2(CT(=8]'XR3"Z3QF(E'#-;6%O$X?9LB8U_GX@2>U<N=69%F8U1D<K$>*&
MYOIY&G[%\KG-\W"13L6D1D2Q]`1=!\28,FSY5\9:V&I*)=AR#V8@Q5K6IM"9
M,O<?&V&%+<22E(2EUPC,R(S(NHQ;7,C(=%9B:3^;9B[LGR""0GZBR71<;YM8
MXF*/X[LG:@>4SL`7Z*XY1KJ"H[_-@^CUY+?%C%_E$PX2KR1]Z>']=)["51AS
MF]V66]5'[>)4-1TP7.A`1`17RO*?^CUXT_%C*/E$S$<S^=WO3S'KH_81+HOR
M9]V6)]5)[>52("*E)ZI.^=WM>[M_SORO)$,>%6[O8/@VX4$VT:1R?C5:L!MV
MR66J?A3EIA+DEU)GW%\)2HR(EI,^A_ATS+<IRT@M":S6%S-`>NA=W[?-PS!H
MZ/1(Z"M!?$!B'8WF+-=`4BO;>&8=50WN7>?BB+C]M7I"B'$[*$T!%NGCAN<K
M9??_`&6W8-QQN/M[N?A.5V1-D9JD4M1D$"5>0C(B4HT6%.A]A7;[7:X>FAZ&
M,>U;A_TATOD,'0%]U9S1M['N8X,/\%]"/(K]I;+'`ZEL,S6C;:[BD=VM:\%X
M\[:@^5?HUQY$>9'8EQ'V9464RU(C28[J'X\B.^A+K+[#S2E-O,O-J)25),TJ
M29&1Z#DZ]CHW%CP6O::$'801O!'00NHS7->T/806$5!&T$'<0>D%?,/ROT@(
M@(@(@(J&_FM[H-;J\]N0%I#?\:KQ/(H&V=<DE^(EA6W5+7XK>-H470T.9576
M#NA="-S3KZ3Z7\DL,["<LL7#(*33Q.N'=O?O=(S_`(;F#S+G1SDR[<SS'R4T
M9K##*(&]G<-;&_\`XC7GSJ.T2LHP0$7:/EV;:N[L<WN-&(H85(CL[IT&86;1
M)[D.4VW2W=P+AE\]4]C$FNQEQI1ZD>B_9]K01]S6R[<'RZS%\31QLGQ-/V<_
MX!I':'2`^;;L6><L,4[-<P,39`5:+QDKOM8/PS@>PMC(\_6OT"1R[72I5G_K
M`/)NTKVML^)^-6;D6%>5J-UMT&(YF7X2@M6TFKV]I)+J#T^#LVE+8V$B,O4S
M=:@O:%VH-6W_`(7M'0RNO-;WC`Z2-_S:W)^2>$.G>!UEKV,:X=!D;TFFJ'B4
MU;-$+31EH\B.1GSBX`^4.(MA8>P.:]Y:>D1NZ!6L*-QEJ0@(KUOE#8%0X)P!
MV-72M0_A>;1LFSW)9\3L-=I?7V46S!.S7$)1XDRKI*Z%6GKJI"(*4&9]NHYL
M<]LG<Y/FADA<%W=V[HX8VGY+&1M-!V.>Y\G:7D]*Z'\DL;;8[EMCS`&\=P))
MGD?*>^1PV]K6-8SR,`Z%):(A4KH"("("("("("("("("*';SS-O7LTX)VV0Q
MV/&<VKW.P'.WC0E:GD0IKUGMY)-'9[1M(5G:''"/V"2WWG[PC*>_#?E6X_F5
M':O-!>V<\(ZJ@-G'G_`D#IVTZ5!WB%QCK_EV^Y:*FSNX9CUT)="?;`GR5Z%2
MN'0I:%("("*_OY:F=Q]Q."'%^\CNMN%5[5TF"/$@T:MR-LUR=NWFG$H(NUQ*
ML7UZEW&1D9ZZZGS!YNXU^*YEYFV>"..]?,/)<4G'M%TEY4Y%N3Y=8BX:0>"S
M9"?+!6`^S7<8CA2"@(@(@(@(@(@(@(@(@(@(J&OFP?2%<EOC/C'R=X<.F')'
MW68?U,GMY5SGYR^\W+>NC]C$H[Q*JC%`13I?5]_Y9>YG^S)F?RJ;,#6WQ1^[
M^S_SB+_#7:V&\-/_`'U=_P"4R_XBU5P@:&+>!`1`1`1`147/..^D?Y&?ZHOD
M(VP'23D%[I<3_>O\9<+GESS]Z>4_NW^$MU&0)A43("*83R-/Y>N/_P"C'<C_
M`"=#$"^)#W92_P!L@_E%3AX>_>/%_9)_Y(5U8<]%OL@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(HHO.L^CUW6^,^UGRB8\)N\//
MO3LO4W/L'J&N?GNRO/76_MF*D$.BZY_("("*^5Y3_P!'KQI^+&4?*)F(YG\[
MO>GF/71^PB71?DS[LL3ZJ3V\JD0$5*3T!$!$!$!$!%$)YN?.K'N,VQ>0;3XC
M?M*WZWBQ^7045=6R4G985AMPEZNR'.[/PE>-5J=KRD0ZA7<V\Y8.>.SW(B/]
ML[\B^6UUK#4D6<OHC^C-A*'O<X>C-*VCF0MKL=1W"^7>`P<+J&1M82YU\Q+;
M2>GI<-92#]([Z(L8UI]**)U6OF=TM]&K8]Q+SQ-J&.5*`=#EH,@(@(I!?*PP
M!_<;GSQPJFVC7'Q_,I&?SGO#-QJ*QMY1VN91W7M-/#)ZSIH["%'Z'GD"+N=.
M4;B>6.6F)]*6W$`'69WMB-/(U[B>P%27R>QKLIS(Q4('HQ3F8GJ$+'2BOE<T
M`=I"OJCF6NC:CO\`-@^CUY+?%C%_E$PX2KR1]Z>']=)["51ASF]V66]5'[>)
M4-1TP7.A`1`17RO*?^CUXT_%C*/E$S$<S^=WO3S'KH_81+HOR9]V6)]5)[>5
M2("*E)Z@&\_G8)W,]A=N]_J:"I^RV:REW'\I>9;ZMX/N(N#!:G3%I0HUM5>9
M5U<PR1F1(.T</U]=GO##J=N/U-=Z7N'4AR$(?&#_`$T'$2!VNB=(X]?=A:V^
M)+3;K_3EKJ2!M9;"8LD(_HIZ`$_:RM8!U=X54>&\ZTK0$0$5X_RB.4L#D=Q'
MQ"AL[1N3N3L?$K]LLVA.O=T]ZLJHRF,$R1:%J4^[&N\8BMLK?6>KMA!E_P!B
M.<7/;1<ND]=3W,+",1DG.N(33T0YQK-'U`LD)(`W,>Q=!N2>L(]4Z*@MY7@Y
M7'M$$HKM+6BD,G71\8`).]['J4L0NI@0$0$0$7.7+3D'C_%SCUN;O5?R(J7<
M4QV66,5TE:25D&;62#K\/H&6C6AU_P#"-[(9)_PR4IF(EYXR[&EF66:'TM=:
MSU39Z>M0:3RCO'#Y$+?2E>3N'"P&E=[N%N\A8OK34UMI#3-WG[DBL,1[MI^7
M*[T8F`;SQ/(K3<WB=N!7YXES<6>0W%K?W4UZQN;RRG7%M82#)4B?9V<IV;/F
MOJ224F]*E/K6HR(B[E&.JEO!#:P,M;=H9;QL#6M&YK6@!H'8``%S&GGFNIWW
M-PXOGD>7.<=Y<XU)/:225YH]5Y("*Q7]7VV%>NMR=WN1]M`4=3@^/Q]L<0E/
M(5X#^596Y&N<FD0EI+M.908W71F724>A-71:$9GJG5'Q1ZF;;XBPTE`[\/<R
MFXE`WB..K(P>Q\CG$=L/P[0>&G3CKC*WVJ9F_@;>(6\9.XR24=(1VL8UH/9+
M\%J\:4+<94</.>M9UCYBF]\.6HU1Z&KVGJJLC-XR1!>VCPB\<2DG7%H21V5S
M(/1LD(U/4R[S4I71[P^P1Q<J<=)'\:5]RYV[>+J9G\EC=]3YJ`<^.>\TDO-#
M(,?\6-ENUN_<;:)_\ISMU!YZE1:"9U$"`BLK>2_YCF#8-B\+B%OED$3%(D>Y
MLYVS.;WDQB%CB$Y!-7966WMW825M,4\AZ]E2)E9(>43$AR6[%4MMQ,5#^HGB
M"Y39+)7KM=Z;B=.\QM%W"P$R>@.%L[&C:\!@:V1HVM#0\`@O+=K.0_-+'XZS
M;HG4,K86"1QM97D!GIGB="]QV-)>7.C<=CBXL)!#`ZT&E25))23)25$2DJ29
M&E23+4C(RZ&1D--2"#0[UMT#7:-R_P!!$!$!$!$!$!$!$!$!%IWD+M-`WWV,
MW9V=L5MLL[CX#DV*L2W"(TUUG9U<AJFMB(T.%XE1;^!*3JE1=S1=#]`O^E<Y
M+IK4ECGXJEUI=1R$?7-:X%[?X3:M/E5CU-A8]1:>O<'+0-NK:2,'ZUSFD-=_
M!=1P\B_.9N:>SQZXM:"ZA/5US1V4ZGMJ^01)D0+.LE.PI\)]*34DGHLIA:%$
M1F7<DQUAMYX;J!EU;N#[>1@<UPW.:X`M(["""N74\$UK.^VN&ED\;RUS3O#F
MFA![000O-'JO)`16G?(#Y,UECA.XG%3(;)AB_P`<N)6YNW;$EU+;UICETW#A
M9A3P$J<23JL?N8K,[PTI-U2;-Y?5#2NS2[Q/Z/FBR-IK6U83:RQBWG(&QLC*
MF)SNKC82RNX&-HWN%=P?#9JR&6PNM'73P+F)YG@!.US'T$K1]HX!]-Y$CCN:
M:6/1J6MI4!$!$!$!%Q'YA7*.NXE<6]P]QT6+,3.+:O?PG:N(H^Z1.W"R.'+8
MJ)+#)*1XC.-QFW[:1JI!''@J22N]:$JD7E7HR77.L[7$EA=CHW":Y/0((R"X
M$]<AI$W?Z3P=P)&`<S=7Q:+TA=90/#<@]IBMQTF9X(:0.I@K([=L81O(5*W#
MN=',K`B:;QCD]OA$C,:>!7S]Q<EOZE@DI>1VLT^03[2K:29/J,R2R1*425'J
M:$F70J_Y;:`R=3>8;'.>=[FP1L<=V]S&M<=W7UCI*T)L>8>NL=06F7R#6#<T
MSR/:-^YKRYO3U=1Z`NJ\.\Z7S!<56R5ANMCV<Q6#;[8>8[;X,M"D(6E:FWIN
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M".X=&TO97BX7$`N;Q4'%PFHK05I6@7M"G7NJ&OFP?2%<EOC/C'R=X<.F')'W
M68?U,GMY5SGYR^\W+>NC]C$H[Q*JC%`13I?5]_Y9>YG^S)F?RJ;,#6WQ1^[^
MS_SB+_#7:V&\-/\`WU=_Y3+_`(BU5P@:&+>!`1`1`1`147/..^D?Y&?ZHOD(
MVP'23D%[I<3_`'K_`!EPN>7//WIY3^[?X2W49`F%1,@(IA/(T_EZX_\`Z,=R
M/\G0Q`OB0]V4O]L@_E%3AX>_>/%_9)_Y(5U8<]%OL@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(HHO.L^CUW6^,^UGRB8\)N\//O
M3LO4W/L'J&N?GNRO/76_MF*D$.BZY_("("*XIY<//#B!M1PGV%V]W%W^P+$<
MTQJ@R"+?8Y;2YS=C5R)6<918QVI*&H+K:5.PIC3A:*/V5D-".;7+37F;YB9/
M*XG%W4^/FE862-`X7`0QM)&T;B"/,MX^5G,71&&T#C<9E,E;07\4;P]CB>)I
M,LCA78=X(/G7;O\`.9\"OG0[8_NZQ_>T1U^I_F;]#7GW+?OE('ZV.7'TO:?"
M[[U/YS/@5\Z';']W6/[VA^I_F;]#7GW+?OD_6QRX^E[3X7?>I_.9\"OG0[8_
MNZQ_>T/U/\S?H:\^Y;]\GZV.7'TO:?"[[U/YS/@5\Z';']W6/[VA^I_F;]#7
MGW+?OD_6QRX^E[3X7?>K#LK\VCR^<1C+>E\BJ*X=2E)M0L4QC.\IDR%K2ZI#
M2'*7%Y<)E1DR>IO/-(09I)2B-2=:^RY'<TKYX;'B98V])DDAC`^[D!._H!)Z
M!L*H;SG1RSLF\3\I&]W5''-(3]Q&0-W20!T[PHM>3/U@&O<K+''.*&V=FW:2
M6'8S6Y>Z[,%ANK<6EQI4RBP*IG6:+%]LE$Y&>L9S;2'$D3T)U&J#FC1_A>E$
MS+O6]XPP@U-O;$GB['S.#>$=#@QA)'Q9&G:H@U9XE(C"^UT;:/$Q%._N`!P]
MK(6EW$>EI>\"OQHR-BK=[@;A9ONMF5_N#N-D]OF6:91-587V1WDI4NQL))MH
M9;[UGHAF/%C-(988:2AF.PVAII"&T)26VV+Q6.PF/BQ6)ACM\?"WA9&P4:T;
M_.2222:EQ)))))6J^3R>0S-])D\I,^>_F=Q/>\U<X[O,`*``4#0`````L-%>
MJ%`1`168OJ^O':0J?N_RCO(3C<5J(WL]@#SS:R1*>D/5V2Y]8LI<2E!E#1%J
M(C+[?>2C>EM:I-"B5J!XI-5M$=AHRV<"\N^=3@=``='"T^6LKB#3<P[:A;8>
M&C3#N\OM7W#2&!OS:$GI)+9)G#R4C:".MXV4*L\#3E;;*._S8/H]>2WQ8Q?Y
M1,.$J\D?>GA_72>PE48<YO=EEO51^WB5#4=,%SH0$0$5\KRG_H]>-/Q8RCY1
M,Q',_G=[T\QZZ/V$2Z+\F?=EB?52>WE4B`BI2>M>;M;8XKO1MEG>T^;Q#F8K
MN%B]OBMTTWVE(:BVT1R,4Z"XM*RCV5:\I$B*Z1:LR&D++JDA=<'F+W3V8MLY
MCG<-[:S-D9U$M-:'K:X5:X=+21TJV9K$V>>Q-SAL@WBL[F%T;^NCA2HZG-/I
M-/0X`]"_/"WVV;R[CYN_N#LSG494?)=OLDGT,M[P'([%K#:43]/D%>V]JX=3
MDE,_'GQ%*ZJC2$&?4QU4TUG[#5.!M=08TUL[J%KP*U+2=CV.I\J-X<QWV32N
M8VHL%>Z9SES@<B*7=M*6$TH'#>U[:_)>TA[?L7!:E%\5E0$76O"_EWG_``PW
MKI]U<-)RUJ'FRI<_PEV6J)79OB$A]MV95/N^%(1#LHKK:9$"83:U192",TK:
M4ZTY@_,'0F+Y@Z>DPF0HR<'C@F`JZ&4"@<!45:?BO;4!S3O#@UPS30>MLEH/
M/LS-AZ<!'#-%6C98R:EI.VCAO8ZAX7#I!<#>AXV\HMF.5^WL+<79K+8E[7N-
MLMWE#(6S%RS#K1Q!J<I,MH?&<E5-@TI"B0H^^-*0GQ8[KS*DN*YN:NT9J#1&
M5=B=00.BE!/`\5,4K?KXGTHYIZ1L<T^B]K7`@=#-*ZOP.L\8W*8*9LD1`XV&
M@DB=]9(RM6N'1O:X;6ES:%="#%5DR`BPC<7<G`MH\.N=P-S,MH\(PS'XYR;;
M(<@G-08$5!^RTRA2S\25-E.:-L1F4N2)#JDMM(6M1).XXG$9/.W\>+P\$ESD
M)31K&"KCV]@&]SC1K1M)`%5;\IE<;A+&3)9::.WL(A5SWF@'9VD[@T5<X[`"
M=BI7^9]YBUGS8SZ'BV$%8TG'[;RQE.8=53"5%GYG>FEZ$_N!D,+1*HSKT):F
M:R&YW+@Q''%*[7I+Z$]"N3?*B'EWC'7N1X)-4W;!WKAM;$S81`P](!VR.&Q[
M@*5:QI.A?-SFA-K[)-L\?Q1Z:M7'NFG897[09GCHJ-D;3M8TFM'/<!%8)J4.
MH"+V<<QV\R[(*/%,9K)=UD>2V]=0T-/`;\:;:W-O,9@5M=$:U+Q),R9(0V@M
M2U4HA3W=W;6-K)>WCVQVD,;GO>[8&L:"YSB>H`$E>]K:W%[<QV=HQTEU*]K&
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MJ2VU-&T_,[R`1N--@FAV4)Z.*,MX0=IX'TW;(!1L\M;4!$!%U!M7S5Y9;)UT
M:FVPY!;H8O0P?#^`XVC)YMMC$$FW&W23"QJ]5:4,-*U-$2R;CI)Q/LJU29D>
M&YKEYH?44IN,SB[.:Z=OD[L-D/1MD9PO/95QH=HVK+L/KW6>`B$&(R=Y#;-W
M,[PNC'DC?Q,';1NW<=BWA_.P>85\Y;)_XL;=_B<,<_4CRL^AX?QD_P#6K(/U
MR\S?I:;\7#_5)_.P>85\Y;)_XL;=_B<'ZD>5GT/#^,G_`*U/UR\S?I:;\7#_
M`%2?SL'F%?.6R?\`BQMW^)P?J1Y6?0\/XR?^M3]<O,WZ6F_%P_U2?SL'F%?.
M6R?^+&W?XG!^I'E9]#P_C)_ZU/UR\S?I:;\7#_5)_.P>85\Y;)_XL;=_B<'Z
MD>5GT/#^,G_K4_7+S-^EIOQ</]4LSQKSD_,.QU;!/[X0\FB,:Z0<EVUVQEH<
M[G_'7X]A7XC67;O=J:.LKV4'HGMT3I;[SD#RJNP>'&NAD/3'<7`Z*;&NE<P=
M?Q=^_I5?:<].9UJ1Q9!LK!T200'IKM<V-KS]UNW="[EV?^L);J54B)#WTV.P
MO,:TW&V95WMM:VV%7<>.:T^+-53W[V755O+0WW:,H?K&UJT]M!$>L;Y[PLX6
M9CI--Y*XMYJ5#+AK9F$]7$P1.:.TB0CJ*D+!^)G,0N;'J+'V\\5:%\#G1/`Z
M^%YD:X]@,8/6%.WQ8\P;B]R^81$VJSQ$/-DQER9NV&:,LXWN!#::(E/NQZEV
M3)A9#$CH4E3LBIDSV&26DG5H4?:-:M:<K=9:#<7YNV+L=6@N(B9("3N!<`"P
MGH;*UCC0T!&U;$Z/YEZ1UNW@PUR&W]*FWE`CF'71M2'@=+HW/`J*D'8NUQ'B
MSY`14P?.SXJN['\GWMX<>@*;V_Y%?A#+?$:;TCU>Y<)<=.?UCBDDKM7=/RV+
MI"W%$IYZPDI07;'5IT$\.VM6ZCT:,#=.KE,3PQ;=[K<U[AW\`!T1`W!C"=KE
MHAS^T<[3^KCG+9M,9E.*39N;.*=\W^&2)03O+W@;&J&,;`J"$!%L3:;=7.MD
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MI97A?\ESI#!%:DU`1`1:PW@WFVQV#P.YW+W<S"HPK#J-E3DJSM7R2Y*D&A2H
M]7406R7.N;J<I!ICPXK;LA]?1"#ZB\X'3^8U/DX\1@K>2XOY#L:T;ATN<=S&
M#Y3G$-`WE6C.9W$Z;QTF6S4[+>QC&USCO/0UHWN<?DM:"XG<%1U\PWG?EG.7
M=QK(51)F,[4X2F?4[681)?2Y(@U\Q]M5CDV0>`MR*YEF3?!6%22:4IF*PRS&
M;4YX2GWNCG*OEI8\M\$;4.;-F[CA=<S`;'.`]&-E=O=1U/#7:XESR!Q!K>?7
M,[F+>\PLV+DM=%AK>K;>(G:&D^E(^FSO)*#BIL:`UH)H7.C^$H*-4!%*MY/_
M`!7E\CN6N,9+;UJI.VNQ#];N;F,EZ.;M?,O*^8;FW^+NJ4E<=;]QDD0I;C#J
M5(?KZV6@_26L*<^-:LTGH::T@?3+Y,.MX@#1P8X?AY.NC8SP@C:U\C"IBY(:
M/?JG6D-W.RN*QQ;/*2/1+VG\#'U5<\<1!V%D;PKP@YRKH(@(J&OFP?2%<EOC
M/C'R=X<.F')'W68?U,GMY5SGYR^\W+>NC]C$H[Q*JC%`13I?5]_Y9>YG^S)F
M?RJ;,#6WQ1^[^S_SB+_#7:V&\-/_`'U=_P"4R_XBU5P@:&+>!`1`1`1`147/
M..^D?Y&?ZHOD(VP'23D%[I<3_>O\9<+GESS]Z>4_NW^$MU&0)A43("*83R-/
MY>N/_P"C'<C_`"=#$"^)#W92_P!L@_E%3AX>_>/%_9)_Y(5U8<]%OL@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(HHO.L^CUW6^,
M^UGRB8\)N\//O3LO4W/L'J&N?GNRO/76_MF*D$.BZY_("("("("("("("("(
M"("("("+>/'+C[N'R@W@Q#9G;.N.9D.4S23)L'FW3J<8H8QI<N\JOY#25?!*
M6DAF;CBO?O.&AAHEONM-KQS5FJ<5HW`SZ@S#^&UA;L:*<4CS\2-@Z7O.P=`%
M7.HUKB,@TMIK)ZNSD&!Q+>*YF=M<:\,;!\>1YZ&L&T])-&BKG`']`K8/9/"^
M.FS^!;+[?Q?@V,8%1,5,9Y;;3<NVG+6Y,NL@L_!2EM=MD-S)?FRE)(DF^^K0
MB3H1<N]3ZBR&J\]=:ARCJWEU*7$;:-&YC&U^2Q@:QO8`NE>G,!8:7P=M@<:*
M6EM&&@]+CO<]U/E/<2]W:2MOBPJ]J._S8/H]>2WQ8Q?Y1,.$J\D?>GA_72>P
ME48<YO=EEO51^WB5#4=,%SH0$0$5\KRG_H]>-/Q8RCY1,Q',_G=[T\QZZ/V$
M2Z+\F?=EB?52>WE4B`BI2>@(H$?.TX)2=X\`9Y2;8TYR]Q]IZ-R)N'45[&LS
M+ML8;CTQ5PTTRTI4NZP%;STA6IDIVI6^1J4<:.TK9OP[<RF8#*'1F9DX<3?2
M5@<X[(K@T'"23L9-0-ZA*&[!QN<M<.?W+M^=QHU?B&<64LHZ3-:-LD`J>+9O
M=#4GMC+MIX&A5$QO4M*$!$!%L#;/=;<K9G*HF;[49UE&WN60VUL,WN*7$RGG
M+BNJ;6_`EKB.MHGULE32?&C/I<CO$1$M"BZ"UYC"8C4%D['9NVANK%QJ62-#
MA7H<*_%<.APHX=!"N6)S.6P5X,AAKB:VO6B@?&XM-.D&F]IZ6FH/2%*C@?GJ
M<Z\/@-PKV7M)N>XVV;96.>;?O1)ZBT225.'MUD&`1''$$GWQM&:M3-6I]1"V
M3\-G+6_D,ELV^LP3\6&<$?\`'9.?J^13%CO$/S$L8Q'<.LKL@?&FA(/_``'P
MCZGE7KY3Y\_.'((3D6IK=C<&?6TIM-EBV`WTN:TM6NC[;>;9OF%<;J->A*CJ
M1TZI,4]EX9N7%K('SOR5RVOQ9)F`'L_`PQ.I_"KVKVO/$;S!N8RR%F/MW4^-
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MQT>6_P#)QN&T`BAN".BH/##7HXI*;8W*RV-0EM<@(N>.4_&W!.6.R68;*Y^V
M;5?D,=$JCO6&&7K+$<KKB6[0934^*7276R5FEQ!*1\)B.O1U*)MY8RK1>KLE
MH?45OJ'%FLL1H]A)#98G;'QNIT.&X[>%P:\"K0L8UAI7':ST_/@,D*12BK'@
M`NCD;\21M>EIWC9Q-+FDT<50EY(\<-T.*^Z^1;1;K4RZ^\I'S776T9N2O'\M
MHWC[J[)L7L9#$<K*FL63(R424N,.DMAY#;[3C:>FNDM6X;6N$BSN$DX[:0>D
MTTXXGCXT<C03PO:?,X4<TEI!/./56ELOH[,RX3,Q\-Q&?1<*\$C#\62-Q`XF
MN'G!JUP#@0-##)ECB`B`B`B`B`B`B`B`B`B]&HM[;'[2OO*&TL:2ZJ)D>QJK
MBHFR:VTK+"(ZE^).K["&ZS+A3(KR"6VZVM*T*(C(R,AY3P074+[:Y8R2WD:6
MN:X!S7-.PAS34$$;""*%>L$\UM,VXMGNCN&.#FN:2US7#:"UPH00=H(-0K9W
ME4>:](WVF4_'#DC:Q6]W383$VZW$>)F%&W,:A1=3Q[(R(VX\;/TLL*<8?02&
M;=)&@THF)3\,T>YU\D6::CDU;I%CC@JUG@%2;>I^/'TF"IHYIJ8M]3&3W>Y_
M)SG*[44C-+:J>!FZ4@G-`)Z#XC^@34%0102[J!X''/V-8%LDN5^9?%C$.8>P
M>6[-92IJ!/FI1=X-DRFC>=P_/*IB25!?MH3[;L4OA+L6:TG13]?*?;2:5*2M
M.:\O]:7^@M3P:@LJNB;Z$T=:"6%Q'&SR[`YAZ'M:34`@X?KO1]CKC3<V"O*-
MD=Z<4F\Q3-!X'^3:6O'2QS@*$@B@ENUM3G>QVX^7[4;F44C',WPBW>I[RKD%
MW))U"4/19T&01$U/J+:"\U*A2F]6941YMULS0M)GT[P>;QNH\3!F\/*)L=<Q
MA['#JW$$?)<T@M>T[6N!:=H*YNYK#9'3^5GPV6C,60MWEKVGX00>EK@0YKAL
M<TAPV%:Z%U5K0$7MXYDN18=>U648E?7&,9+1S&K&ER#'[*93W53/8/5F;6VE
M>]'FPI31G[+C:TJ+W13W=I:7]L^SOHHYK.1I:]CVA['-.\.:X$$'J(7O:W=U
M8W#+RRD?#=QN#F/8XM<TC<6N:00>T%3%['^>ES`VRA0Z7<2'@^^E1%3X?P_+
M*Y_'<U-E':3+7\)L6<A5TGL01DIV95RY+AZ&MTSU,X#U'X;=!YB1UQB77.-G
M=\F)PDAKTGNY*N'D;(UHZ&J<]/\`B'UOB8VP91MOD8&],C2R6G0.\CHT^5T;
MG'I*["8^L8O)993)X>M.R$M-D^ZQO\N.RX\2")UQEAS9:2MAI:]32A3CAI(]
M#4K34\"=X3VEQ+,\0RNP&RJ:=%3\[%3VT'D"S=OBB<&@/P8+J;:7E!7L'S4T
M\E3Y2M.[F?6#]_+^))B;5;)[:[;JD-NM)L\FN+W<BU@DLW/#?@&TS@]/\+92
M:=#DPI+)J29FT9&1)O\`A_"UIBUD$F;R-Y=@$>C&UENT]CJF9U#]B]I[58\M
MXF-27+"S#X^TM2?E2.?.X=HV1-J/LFN'8H;-]N2V^O)C)&\JWQW+R//[.*<C
M\%QK.0U%H:%N4I"I#&.XS6,P<>H&7S;1XB8D5GQ>Q)K[C(C$_::TAIK1]H;+
M3EG%:PFG$6@E[Z;C)(XE[R-M.)QI4THH+U%JO46K+OYYJ"[EN917A#C1C*[P
MR-H#&`]/"T5IMJM&#)%CR`BS';[`,QW4S;&-N=OJ"?E&:9E<0Z''*&M0E4JP
ML9KA(;1WN*;CQ8K*.YU^0\MN/&80MUU:&T+45!E,I887'39;*2MAQ]O&7R/=
MN:T?5).YK0"YSB&M!)`5=C,;?9C(0XO&1NFOYWAC&-WN<?J`#>7$@-`+G$`$
MJ^OP,X>8SPKV"H=L:]R%;9K9N%DNZ.71633_``DS2:PTB2W$==;;DGCV/QT)
M@UK:TM_>&C>6VE]]\U<R^9FO;SF%J>7,RAS,>P=W;Q$_S<0)I4#9QO/IR$5]
M(\():UM.C?+G0]IH+3<>(B+7W[SWEQ(!\>4C;0G;P,'H,!IL'$0'.=7M(1ZL
M]0$5#7S8/I"N2WQGQCY.\.'3#DC[K,/ZF3V\JYS\Y?>;EO71^QB4=XE51B@(
MITOJ^_\`++W,_P!F3,_E4V8&MOBC]W]G_G$7^&NUL-X:?^^KO_*9?\1:JX0-
M#%O`@(@(@(@(J+GG'?2/\C/]47R$;8#I)R"]TN)_O7^,N%SRYY^]/*?W;_"6
MZC($PJ)D!%,)Y&G\O7'_`/1CN1_DZ&(%\2'NRE_MD'\HJ</#W[QXO[)/_)"N
MK#GHM]D!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!
M%%%YUGT>NZWQGVL^43'A-WAY]Z=EZFY]@]0US\]V5YZZW]LQ4@AT77/Y`1`1
M`1`1`1`1`1`1`1`1`1;RX_<<-Y.4&?0=N=E\,L<LO9"F5V4MM)QL?QBM<6I+
MEWE5\\15]%4LDA1][JO$?6GPF$.O*0TK'-4:MP&C<8[+:AN&06PKPC>^1WUD
M;!Z3W'J&P#TG%K02,ATUI;.ZNR3<7@8'37)IQ'<R-OU\CSZ+&CK.TG8T%Q`-
MVG@%P"VXX.;<?@^O^!Y3N]E,.*O<K<I<7L?L7T=KY8UC1/I*3589522^]->R
M[,=24B07?X;;'.WF?S/RW,?+=[+Q08&!Q^;V]=C1N[R2FQTKAO.Y@]!FRI=O
MWRVY;8OE]B^ZBX9LW,T=_/3:X[^[CKM;$T[AO<?2=MH&]_B+U)2`BCO\V#Z/
M7DM\6,7^43#A*O)'WIX?UTGL)5&'.;W99;U4?MXE0U'3!<Z$!$!%?*\I_P"C
MUXT_%C*/E$S$<S^=WO3S'KH_81+HOR9]V6)]5)[>52("*E)Z`B_Q24J2:5$2
MDJ(TJ2HB-*DF6AD9'T,C(`2#4;T(KL.Y5+?-5\J"ZVNN,GY(\:<:59;23UO7
MFX&VU#%=>L-L9BS2NSO\=K62==F8!)=-4A]EDM:3N69(*`DCB[Q\E.=UOF8(
M=(ZOFX,XVC(+AY`;<#Y+)'&@$X%&M)_GMFWO3Z>E_.+DU/B)YM5:4BX\*ZKY
MH&`ET!^4]C1OA/QB!_-;=G=CT*_`VB6M*`B`B`B`B`B`B_U*349)21J4HR2E
M*2,S49GH1$1=3,S#=M.Y-^P;U8N\L7R?;K+;+'^0/+;%GJ?"8;C-O@NR^015
MQ[C,9+2FWH-]N%4R$I>JL2:67>S4R$HDV:DDJ2VB%HW-U0YQ\^;>QAETOH:8
M29%P+9KMAJV('860.&QTIW&5M6Q[F$R;8]H>4G)"XO98M2ZUA,>/:0Z&U>*.
ME.\/F:=K8^J-U'2;W@1[)+4[333#3;##;;+++:&F66D);:::;22&VVVT$2$-
MH01$1$1$1%H0TJ<XN)<XDN)J2>E;B`!H#6@!H&P+Y!\7U`1<@<P.;FQ_"W!B
MRG=.[.7D=LS)3A&V]&XQ(S/-)K!&2O@,);B45M'%<,BEV<HVXD8C)!&Y(6RP
M[GF@^76H^862^986/AM(R.^N'U$40/6?E//R8VU<[?L:'.;A&M]?Z?T%C_GF
M8DXKIX/=0,H992.H?)8/E2.HUN[:XM::;/.+S"-WN<^0U3V<5&+8E@N)3K"7
M@F$4-9"F2J`K%"&)3MCFTV"C);N?.C,,IDDE<2N=6PAQ$)I22,;^\N.5F"Y;
MVKVXZ2>?)3M:)IGN(#^':`V$'NV-!)X=CI`"09'`K1;F#S,S?,.Z8[(,AAQT
M#G&&)C02SBV'BE(XWD@#BVM82`1&"N"A)BCE`1`1`1`1`1`1`1`1`1`1??J[
M2RI+.NNJ:?,JKBHG1+2JM*Z2]#L*VRKY#<N#/@S(ZVWXLR'*:2XTXA25H6DE
M),C(C'G-##<POM[AK7P2-+7-<`6N:X4+7`["""00=A&Q>D,TMO,VX@<YD['!
MS7-)#FN::@@C:""*@C:"K]/EW<J/SON+6#;H6CL4\[K%2<&W/CQ$M---9WC3
M40I\Y$9D_#B-9'53(=JADB)+*)Q-ET1J?,7FMHK]`]:7.&A!_-CZ36Y-3^!D
M)H*G>8W!T9/265Z5TAY8:Q_3?1]OEYB/SBRL5P!3^>C`J:#=QM+9`.CCIT+N
M(1PI!48WF/>7#AG-_#&;RC>KL-W[PVNE-87FCL5*8610DI=D-81F[L=I<Q_'
MWYBS5%E))Q^J?<6XVAQMQ]AZ8N4O-K(<N<@;:Y#[C3%P\=[%7;&=@,T()H'@
M?&;L$@`!((:YL2\TN5MAS`L!<6Y;!J.!I[J6FQXVGNI:"I83\5VTQDD@$%S7
M4I]V]H=R=BL]O=LMV<1ML*S7'7_!L::V9)*EM+-7P:QKI;*G85M3V#:?$C3(
MKCL:2V9+;6I/4=#<'GL1J7&1YC!SLN,=**M>T]/2UP.UKV[G,<`YIV$!:$9K
M"973N2DQ.:@?;W\1HYKA\#FG<YKM[7-):X;02M;"[*U("("("("("("+8.UN
MU.XF]>;TFW&U>(W&;9ID+_@5E%2QO'?4E)EX\R6\M3<2MK(2#[Y$N0XU&CMD
M:W%I21F+7FLWBM/8Z3+9J>.WQ\0JY[S0=@`WN<=S6M!<X[`"5<\/ALIG\A'B
M\/!)<7\IHUC!4]I)W-:-[G.(:T;20%<_\M?RS,2X4X^>=9C(A9CR'RJE1`R'
M(8Y*<HL(JY2F9,S$<+)UMMUU#C[393K)Q*7IIM)2VAEGN0OGUS=YP7W,.Z_-
MM@'6^E8).)C#\>9PJ!+-38-A/!&-C*U)<ZA&]_*KE-9:!MOSC?%L^IYHZ/>/
MB1--"8XJ[]H''(=KJ;`UNPRM"$U,B`B`BH:^;!](5R6^,^,?)WAPZ8<D?=9A
M_4R>WE7.?G+[S<MZZ/V,2CO$JJ,4!%.E]7W_`)9>YG^S)F?RJ;,#6WQ1^[^S
M_P`XB_PUVMAO#3_WU=_Y3+_B+57"!H8MX$!$!$!$!%1<\X[Z1_D9_JB^0C;`
M=).07NEQ/]Z_QEPN>7//WIY3^[?X2W49`F%1,@(IA/(T_EZX_P#Z,=R/\G0Q
M`OB0]V4O]L@_E%3AX>_>/%_9)_Y(5U8<]%OLN1^6O)S*>,&,P,RJ./VXF]>+
MQZ+.,FSNZP:?2086W%!A%?5VLFTR15PZA:HMA72Y;K9LDHTHKWNXNJ=<ZT-H
MZRUE>.Q\^4M,=>F6&.%DS7DSOF<YH;'P#>UP:#6FU[>U85K35MYI&T;?0XRZ
MO[,1RR3/B+`(&1-:XN?Q=#FEQ%.ACNQ<.2_.`9J=AFN1U_Q*WBH]KK>ZH:/#
MLAG7^*'!S.9=2<CB/)I7VE+49U3^,OI=)Q"349^SZ!(\?(=T^ICI*USEA)F8
MXWOE8&2UB#!&1Q@_7"04H?*H]?SO;#IP:IN<+?1XA\C&1/+XZ2EQ>#P$?6F,
MUJ/(L_WS\VO979783CKOJ6'9-F<;D933[R@Q*ELZB/;8[%H(]>SE;=W-?-V$
M;V.Y'9-U;A(Z.R4N&@]$*%KTWR-U#J'4^6TU\XAMWXF1K'RO:XMD+RXQ\`&V
MDD;3(*[FTKO"N>H>=.`P.F\7J+N)9VY2,O9&QS0Y@8`).,G95CW",TWNK3<I
M7!"2F1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`11A><)B65
MYQP.W.QS"\9R'+\AEY'MH[$HL7I;+(+F2U$SZADRG(]74QI<UYN-';4XX:4&
M2$)-1Z$1F)DY"WUECN9=G=Y":*"U;#<`OD>UC!6%X%7.(`J=@V[3L41\\+*\
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MZ(ZL^B\C^33?>)^:]R8^;MOI^23/_P`7P_3+2'TKC?RJ#[]/T1U9]%Y'\FF^
M\7R-<6>3K[K;#''+?AYYYQ#3++6T.X+CKKKBB0VVVVC'C6MQ:S(B(B,S,]"'
MQVM-'-!<[+8P-`J2;J#9_'7T:/U:XAK<7D2XG8/FTWWBSNFX%\V+Z3\%@\3^
M0;#O<TCNN=ILUQR-J\HTH/X9D-/5Q.TC3[2N_M0751D1D+9<<S.7=LSCDSF*
M(^PN8I#L[&.<?J;>A7*#ESKZY?P1X;)@_96TK!M[7M:/J[.E=1[=>2_S]SYY
M@[#;"@VUKW^PTVNXN=8U"902^W4WZG&)>5Y0QX:5:J)<`CZ&1$9EH,,RWB#Y
M88QI[J\EO)1\F"&0GS.D$<9\SUEV+Y#\R<D1WMI%:1'Y4\S!\+8S)(/.Q2H;
M`?5]L$HY5?=\DMW[+.ELFT_)P3;2"[BV/.O-J0I<2PS&U5)R*UK7T]R5%%A4
M\DNAI=28A;5'BCR=RQUOI&P9;`U`FN")'TZVQ-I&UP^R?*WK:5,.FO#3CK=[
M;C55\^X(VF&`=VRO4Z5U7N:?L6Q.ZG!3Q[1;)[3;"8A#P/9W`<<V^Q6&2#*M
MQ^"3+DU]"/#^'7-D\I^VO[5Q!:+ESGY$IS]>X8UGSNHLYJ:_=D\_=375Z[Y3
MS6@ZF-%&L;U-8&M'0%L9A,!A=.63<=@[:*VLV_)8*5/6YQJY[NMSRYQZ2MHB
MS*[H"("+@GS/\<R'+N!W(C',4H;G)\AM,<QMJMHL>JYUU<V+K6?8G)=;@U=:
MQ)FRW&X[*W%$VA1DA"E'T(S$F\F[NUL>9F*N[V6.&U9-(7/>X,8VL,H%7.(`
MVD#:=YHHXYN6MU>\N<I:V<<DUR^*/A8QI<YU)HSL:T$G8"=@W!4C_P`U[DQ\
MW;?3\DF?_B^.BGZ9:0^E<;^50??K0']$=6?1>1_)IOO$_->Y,?-VWT_))G_X
MOA^F6D/I7&_E4'WZ?HCJSZ+R/Y--]XGYKW)CYNV^GY),_P#Q?#],M(?2N-_*
MH/OT_1'5GT7D?R:;[Q7</+`QS(<1X'<=\<RNAN<8R&KQS)&K*BR&KG4MS7.N
MY]EDEIN=5V3$:;$<<CO(<23B$F:%I470R,<Z^<EW:WW,S*W=E+'-:OFC+7L<
M'L=2&(&CFD@[01L.\46_W*.UNK+ESB[6\CDAN612<3'M+7-K-(=K7`$;"#M&
MXKO81DI'0$0$0$4)O-+R5-DN0,VWW`V/GP]B-TK%V186,"+7KE;7998O:K<>
ML<>B*1(Q&=*>(C<EU1''U-;CD%YY:G!L1R]\0VHM+1QXO4;79/"L`:UQ=2XB
M:.AKSLE:!N;)Z6X"1K110%KWD)@-2R/R>GW-QV8<27-#:V\CCTN8-L9)WNCV
M;R8W.-56WW]\N3F-QQDS%YYLODUMC<4UJ3G6W\5[/,,=C(Z?#)%IC[4J30,K
M5J246L>O?,R_8]#(SVWTQS9T#JUC1C,A"R[=_L9R(90>H->0'GMC<\=JU6U)
MRNUSI9[CD;"9]J/]M"#-$1UES`2P=D@8>Q</B1E'Z`B`B^U"A3;*7'@5T25/
MG2W4L184*.[*ER7EGHAF/'80X\\ZL_0E)&9C\221PL,LKFMC:*DD@`#K).P+
M]QQR2O$<32Z1QH``22>H`;2I(>//E,<U>04F!*3MA-VEPZ4XTJ1F>\+<K"F6
MXCFCA2*_%I<9>;W)2(^JX[C%<<-T^WND-I42Q$FJN>/+S2S',-XV^OVC9%:T
MF->IT@/<LH=C@9.(;:-)%%*>F.2^O=2O:\6CK*Q)VRW-8A3K;&1WKJCXI#.$
M[*N`-59/X7>45QVXHR*K-\E1_GLWEKU,RXV:996LQ\=Q>>WJHGL(PPWIT&NE
M,+[5-SYKLZ>VXCQ&'(Q*-L:C<PN>NJ];L?CK/_X[3[J@Q1.)DD;U32T!<#TL
M8&,(-'!]*K:K07)/3&C7,R%W_P#(9UM")9&@,C=UQ15(:1T/>7O!%6EFY2P"
M$5,R`B`BT=R2WYQ#C+LCN%O=FZC72X-1N3F:UIU#4O(+R4ZW7X[C5>I9*2F;
M?W<IB*A9D:&O$-Q>C:%&61Z1TS?ZPU%:Z=QW_47,E"ZE0Q@]*21W8Q@<XC>:
M4&TA8]JK4=CI+3]SJ#(?S%O'4-W%[SZ+(V]KWD-!Z*U.P%?G_<@M^]QN3&[&
M5;P[HW+MMDV3S%+;CI6[^"\>IF5N%4XQC\1Q:RKZ*EC+\-AI/51]SKAK><<<
M7U"TMIC$Z/P<&!PL899PMW[.)[S\:1Y^4]YVD^1HHT`#FQJ;4F4U9F9LYF)"
M^[F=N^2QH^+&P?)8T;`/*35Q).EQD"L*D3\M'A'(YL[^-XY>KFP-H]OHD/*]
MUK:$:VI,BM=EJ9IL-KI39I.);YE+CNMI=U2J/"CRGT=SC*&UQ3S?YBLY=Z8-
MW;<+L[=.,5LT[0'4J^5PZ6Q`@D?*>YC30.)$G\J-`.U_J06MQQ-PELT27#AO
M+:T;$T]#I2"*]#&O<*EH!ME;@^5SP*W(@QH=QQNP>B7"AQX4.?@)V^W4]I$5
MA$9AZ2[A5E1M6\I+2"[G)R)2G5>TYW*ZC1_%\YN9N(D,EOE[F0.<26S\,[34
MU(`F:\M%>AA;3<*!;G9/E#RXRL89/BK>,M:`##Q0$4%`3W3F<1[7AU=YJ5P]
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M*.[4RB2C4>G0NIBKM/%<[O`+["#NB=\=UM`^U=!1Q_A-5+=>%]O=DV69/>@;
MGVVPG[9L]6_<N47O)[RFN7_&&JL,MM,3K=T-OJQMZ38YKM3*G9$Q306D$\J9
MD&.S*ZKRJIB,,]RI$HH3T"-V*-<@D]JE3+HWGAH/64[+&&=]GE'D!L-R!&7D
M[*,D#G1N)/Q6\8>ZHHRM0(CU=R8UOI&%U[-"R[QC`2Z6W)>&C?5["ULC0!\9
MW"6-IM=NK&>)?43H"("*R-]7AW+FQ\SY%;.OR5.5UMC&)[EU<-:O8A3<?M9&
M+7TF.@C+VK-C)JY+QF2ND1O3MZ]VI/BJP\;L?B<^T4E9-+;N/6'M$C`?M3')
M3[8[^C:CPQY:1M_E,&XUB?#'.T=18XQO(^V$C*_:CSVE!I@MOD!%S/R;XB;#
M<NL/_@AO5AD>Z5$;>+'LLK5-U>;XA(?[5+E8SD;;+LB&3CC:5.QG4OP9)H3X
M[#I)(AF&CM=ZFT+?_/\`3UP8PXCCB=Z4,H'1)'4`]CA1[:GA<%B>K=$Z<UM8
M_,<_`).$'@D;Z,L9/3&^A([6FK'4'$TJL;R<\B?D9ME*L+SC];5N_6%I-;\>
MF6]!Q/<RN8[NXV)-39RVL=R`HS2B(GH4Y$F2I*C3";U2D]Q-'>)32>88VVU3
M&_&9#<7T=+;N/6'-!D94]#V%K>F0[2M2]6^'?5&)>ZXTT]F1L-X;41SM'46N
M(8^@Z6/#G=$8V!0TY]M?N3M5<+Q_<W`,SV^O&U+2=5FF,W.,SU>&9$I;4:XA
MPW'FM#(R6@E(4DR,C,C(Q/\`C,SB,W`+K#W5O=6Q^5%(R1OG+":'L.U05DL1
ME<//\VRUM/;7`^3+&Z,_`X"OE"P47)6Y`1`19_M_M3N?NQ:E1[7[=9QN)<&I
M*3K<)Q6[RB6WW%KW/LTT&8N.TE)&I2W.U"4D:C,B(S%LRF;PV$A^<YF[MK2#
MZZ:1D8\Q>17R#:KEC<-E\S-\WQ%K<74_UL4;Y#YPT&GE.Q3)\9/(FY&[ERZ^
M\Y!6]9L-A:_"D2*9M^OR[<RQCJ,G$L1JJJEO8YC_`,)9(R4[.G+E15J+O@N&
M2D%`&L?$II/#L?;:6C?D\AN#Z.BMVGK+G`2/H>AC`UPW2#85.FDO#MJC+/;<
M:F>S'6&\MJV2=PZ@UI+&5'2]Y<T[XSM"LU<8>'FP7$+$E8KLKA;%0_.:CIR3
M,K9:+;.LP?C)(D2,DR1QEEY]I+G<XW#CHC5T9QQ9L1VN]6NGNLM>ZGUW??/=
M0W!D:TGNXF^C#$#T1QU(!Z"YQ=(X`<3W4"VSTCH?3>B;+YG@(`QS@..5WI32
MD=+WT!/6&M#6-)/"T5*Z>&'++4!$!$!%20\S_8'??+N>/(C(\4V4W;R?'K3(
M\;=K;W'MN,QNJ:Q::P'$XSKD&TK::3"EMMR&5MJ-M:B):%)/J1D.BG)O4^FK
M'EIBK2]R-C#=,AD#F/GB8]M9I2*M<\$;"#M&XU6@/-S3>HKWF+E+JSL+V:V?
M*SA>R"5S7?@8QL<UI!V@C8=X7!'YKW)CYNV^GY),_P#Q?$F_IEI#Z5QOY5!]
M^HX_1'5GT7D?R:;[Q/S7N3'S=M]/R29_^+X?IEI#Z5QOY5!]^GZ(ZL^B\C^3
M3?>*:?R*-FMW]N^7&XMUN!M5N3@U-*XY9=5QK;,<&R?&:R19O[F;0RV:YB?=
M5<**]/>BPGG4LI6;BFV5J(M$*,M>_$IG\#E="VEOB[VTN;AN6B<6Q31R.#1;
MW0+BUCB0T$@5I2I`Z0IZ\.^"S>,UK=7&2L[JW@.+D:'2Q21M+C/;$-!>T`D@
M$TWT!/0K7XTB6Y:`B`B`B`BI9^;3L-OEFGF";_Y+AVS&Z^68Y9?YJOP=D&-;
M=9?>TD_X'LGMO`E_`K6KIY4"5\%GQ76'/#<5V/-J0K123(NA/([4VF\?RMQ=
MG?Y"Q@NV?.>)DD\3'MK=W#A5KGAPJT@BHV@@[BM"^=&G-0W_`#+R5W8V%Y-:
MO^;\+XX)7L-+6`&CFM(-""#0[""-X4<OYKW)CYNV^GY),_\`Q?$L?IEI#Z5Q
MOY5!]^HN_1'5GT7D?R:;[Q/S7N3'S=M]/R29_P#B^'Z9:0^E<;^50??I^B.K
M/HO(_DTWWBE@\E_9#>C`^;U%D&<;0[H890M[<[@Q7+O*\`RO':AN5)KXB8T9
M=E;U,.&E^0I)DA!K[EF70C$(>(/4>GLGRZDM<;?V=Q<F[@/!'/'(Z@<:GA:X
MF@Z338IFY#Z?SV.Y@1W.0LKN"V%K,..2&1C:D"@XG-`J>@5VJX,-#5N^N<N8
M=79WG$?E+2TM=/N+FXXY;WU=34U<2186=I9V&V>3Q(%=70(C;TJ;/FRGD-,L
MM(4XXXHDI(S,B&6:"FAMM=86XN'MCMX\M9N<YQ#6M:VXC+G.<:`-`!))-`-I
M6+:XAEN-%9BWMVN?._%W;6M:"YSG.@D`:T"I))-`!M)V!0YQ=J,]F^6%Y>."
M6.V^82;RDY3[/SLRP^7B%VY<4^.M;J;C/6TW)*%VO.=6T[-;-0N0[):0RAEU
M*EF25$9SX_-XR/G)JK)17=N+:3"W0BE$K.%\AMH`T1O#J.>7`AH:2200-H4&
MLPV2DY1Z8QTMK.;B/,6QEB,3^)K!<3EQ>SAJUH:027`"A%=A7`>8<#=[,3VR
M\P&EL\0S_*\>X^(Q':7BY1M8[?W#UUCVX7*'#]QKC),'AQ8#\FX=A8A`-=FZ
MQXZ6CM'TJ4KP5*;D^PYF:=OLQI>XAGM8+K*][<Y%YD8P,?!CI8&1S$N`:#*Z
MD8-*]VT@#B%8WON7.?LL3J6":"YFM<9W=MCV!CW%S)K^*=SX@`2XB(5D(K3O
M'`GT32XJ-"%O&@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(M,9_Q
MQX^[K.OR=S-C]I,^F2#-3MAEVW>)9!9^(:%M^.W9V=3)L&9"6W%$3B'$N)(S
MT,AD&+U;JG"-#,/DKZUC&YL4\K&^3A:X-(["**PY+2VF<RXORV/LKF0_*D@C
M>[R\3FEP/:#5<YV_E@\!;OO^&<8=NV?$E*EJ_!!7V/Z.K\75"/P#=5OA12\4
M]&$Z,IT3H@NU.F60<Y.9UO\`S>9NS1M/2X'[/X;';=F_?V[2L7GY1\M[C^<Q
M%J*FOH\;-O\``>W9MW;NS8%Z%+Y:?`VA5'5!XN;5OG&;-MO\-5$K)$J29ZZR
M$Y%.M$RG/[9TEJ+W1Y7'-[F9<U[S-7HJ?D.$?P<`;3S47K!RIY<VU.[Q%F:#
MY32_X>,NKYZKI[!MG]I=KVE,;:;7;=;=LJ(TJ9P;"<:Q)I1&DD&2FZ"LKT&1
MH21>CT%H,.R6>SF9=Q9>]N[MW7--)*?X[G++<=@\+B!PXFSM;5O5#%''_(:U
M;%%I5T0$0$0$0$5=+ZPSNC/J-LN/FST*2XW$S?+\OSJ^::<-'B-8#64]12QY
M22T-V-)EYS(=2D]4^+$)1EJE)C:_PKX:*?,97/2`&2V@BA83USN>YY'40(6C
MR.ITE:O>)O+R08G&8.,T9<3RS/IU0M:U@/83*X^5O8%52&ZRTZ0$5JOZN_;8
M\YM=R1HF&XZ,KAY]A-M:NDX7PM_'K+'K2'0-K9-LC^#Q+*ILS2HE*]I]1&2>
MAJTI\5<%T,SB+EQ/S%UK,UHZ`]LC2_;UEKH_@&_HW%\,4UJ<1E;=H'SQMS$Y
MQZ2QS'!GF#FR?"=W38O&J"VA0$0$0$0$0$0$0$5)KSG^,V(\>>6*+C;ZKAT.
M&[T8FSN&UC]=&3#K*'*BM;&FRV#516DDQ'KITJ$S9);0:4,NSW&FT-M(;2.B
M'A]UA?:JT08,H]TN0Q\Y@+W&KGQ\+7Q%Q.TN`)CJ=I#`22XDK03GQI.RTQK/
MO\8QL=C?PB;@:*-9)Q.;(&C<&D@/H-@+R```%$4)U4*("*=KZOK$D+Y@;I3D
MM&<2-QLRF(\]JGM;D3=S]HWHK1I,^\S>;@/&1D1D78>NFI:ZU^*1[!H.RC)]
M,Y>,@=@M[H'X.(?"MB?#0QQUO>2`>@,5(">TW%L1\-#\"N`#0Y;NH"("("+R
M+S'Z')ZYZHR6DJ,AJ9!I4_5WE;#MJYY2-30;T*>S(C.&@SZ:I/0>]M=7-G*)
M[222*<;G,<6N'D+2"O"XMK:[B,%W&R6$[VO:'-/E!!"Y9R7@#PERUYR3<\6=
MCRD/.^.^_3[?T&-//O&MUQ;S[N-Q*E;SKRWE*<4HS-P]#5KH6F:6?-#F)8M#
M+?-9'@`H`Z=\@`V;!WA=0"FRF[H6'W?+70%ZXOGP^/XB:DMA9&2>L]V&UK7;
MU]*UZUY67E_,SUV2.,F#G(6MU9MNV&7/P"-XE$LD53^2.5;:")7LI2R24'H:
M2+0A=7<Z.:#HNY.8N>#9N;$';/LA'Q>7;MZ5;6\G^6K9>]&)M^(];I"W;]B7
M\/U-G0ME8OP+X68<M#M%Q:V,0^T9J9E6NW&-9'-96:U+[V)N10+66RX1J,B4
ME9&2?9(^WH+1><S.85^"VYS62X3O#9Y(P?*(W-!\X[=ZNMIRYT%8FMOA\=Q#
M<701O(\A>'$?#V+J.HIJ>@@,U=%55M)61B[8]=408M;`83H1:,PX;3,=HM"+
MWJ2&&3W$]U*9KE[Y)CO<XESCY2225E\,$%M&(;=C(X1N:T!H'D`H%Z0\5ZH"
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("*KQ]8JKI:,AXHVQM
M'\`D4N\%<V^1D9?"X<[;F2\TLBZH/P9S9IUT[_:TU[5:;E^%&6,VF;@K^%$E
MJZG81.`?A!\FSK6HGB@B>+K#34_!F.Y;7M!@)'P$>7S*M8-NEJH@(NV^`?,>
M^X4;_5&YD>++NL'NHBL4W1Q6(;)R;S#9LJ/)=?JTR7&HR,AH)L9J9!4I;1.+
M:5'6XAF0Z8COF?H&UYB:7DP[W-CR4;N\MY#6C)0"`'4J>!X)8_8:`AP!<UJS
M_EMKFYT#J1F6:'28^1O=W$8I5\1(-6UV<;"`YFT5(+20UQ5[?:7=W;G?3`<?
MW.VIRNJS+"LFB(E5MQ5/DX2'.U/PFML8RNV5575:ZHVI<*2AJ3%>2;;J$J(R
M'-3.8++:;RDN&S<#[?(PNHYKA\#FG<YCAM:]I+7#:"0NB6%S>+U#C8LOAIF3
MV$K:M<T_"UPWM<T['-<`YIV$`K9`M*NJ`B`B`B`B`B`BI5^=MR`QS>KF"K%\
M/L6K6@V/P^)MO-L(KQ/P)>:_A:UO<P.$ZA9H4FJ?L8]6_P"R1_"ZYTB-2>PQ
MT+\.VE[O3V@OGM^PLNLE<&<-(HX0\+615^V#72#[%[=QJM">?VI;7/ZX^:6+
MP^VQ\`@)!J#+Q.?+3[4N;&?LF.WBBAY$]*#T!%:7^KT[.S*[#M^]^+*(XW&R
MBYQO;/%9"R4WXL?%V)>09:ZTD_V>,_,OJQI+A>R3L1U.IF2B+3#Q3Y^.6_QF
MF87`OACDN)!VR$,B'80&2&G4X'J6W_AEP3XK'):CE:0V:1D$9[(P7R'M!+XQ
M7K:1UJR&-25M.@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(H</.]X_V.\/#YW.\=@.3LCV#R9G<)YIAKQ93N#2X3]+
MG*6BZ&AFMC2(MM(7KHF-5N'H9Z"??#IJB+`:]&-NG!MIDX3`"=@$P(?#YW$.
MB:/KI`H,\0&FI<YH<Y&U:776-E$Q`WF(@LE\S06R./UL95+0="%H8@(@(NF^
M,G,#?[B+E;N4;)YO*HVK!3/\(L2LF_POA&6,L'][:R'&I#B8DA]I'<AJ8R;%
MA'0M9,OMDM6N'ZPT'IC75D++45LV1S*]W*WT9HB?K)!M`Z2T\3'$#B::!9;I
M+7&I-$WAN\!<&-KJ<<;O2BD`^OC.PGH#A1[03PN%2K%&P_U@79_((<.LY$;5
M95MY>DVTU)R7;Y3.:8?)?U^_3':F?)JLHH8QD?LL-%<++3JX8U2U+X7<]:R.
MFTK>P7=M4D1SUBE`Z`'-#HWGM/=#L6S^G/$K@[EC8M3V<UK<4VR0TEB)Z3PD
MMD8.P=Z>U278)YF7`W<1EEZCY/;95?C:EX6=V4O;-YI:4$I:'D;B0<8[.W73
MNU-"C]ZI0B#)<G^9F*<6W.&O'TZ86BX'F[@R?O\`6%*^.YL<N<FT.M\O:,K_
M`$SC`?/WXC_>ZETC3[\[&Y"EE=!O/M/>(DOHBQUT^XN(6:9$IPVR;C,JA7#Y
M.OK-U.B$ZJ/N+0NI#$9],ZDM21=8^^C(%3Q02MH.LU8*#9O650:CT]=`&VO[
M*0$T'#/$ZIZA1QV]BS'^&V&?]KL8_P"GZK_&Q0?F[(?T$WW#OWE7?G"P_IX?
MNV_OK!KWD+L%B[3S^3;X[/XZS'.0E]Z]W+PNH:85$2I<HGG+"ZCH;.,A!FYW
M&781&9Z:"Y6VE=3WI#;/&W\KC2@9;RNK7=3A8=_1UJW7&IM-V8+KO(6,316I
M?/$VE-]>)XW=/4N2MSO->X$[6QY1SM_L=S.QCZDS4;8P[7<&1/<(^K<6UQZ'
M*Q=OH1F2W[!EH_4K4R(\YPW)'F;FG-[O%RV\1WNN"V`-\K7D2>9K">Q87E^<
MO+C$-/>9**>4;FVX=,3Y',!C\Y>!VJ#OF/YZFX6Z=+<;?\7\9M]G<9M&WX4[
M<B^FQ7-T9M<\3C2VZ*)4O2JC!'GV5Z*D,R[":@]%,/QUI[CV.T#X;,5A;B/*
M:RFCO[QA!%NP'YN'#;Z9<`Z8`_)+6,.YS7#8M?=<^(?)YB!^-TC$^QM'@@SO
M(^<%IV>@&DMA)'R@Y[Q\ES3M4`*UK=6MQQ:G''%*6XXM1K6M:S-2EK4HS4I2
ME'J9GU,QM```*#8`M;"234[25_`+XMJ[);,Y]R#W3PW9_;*H5<YCFULW65S)
M]Z(<%A*%R;.[MI#;;IPJ2BK679<Q_M5X4=E:B)1Z).RZBU!C-+86XSV8D[NP
MMF<3CTD[FL:-E7O<0UHZ7$;MZO&G\#DM39B#!XEG>7UP_A:.@#>Y[CT,8T%S
MCT-!W[E^@QQQV*Q+C1LCMULAA1*71X#C[5:JP=1X<F\NI3SUGDF1S4=[A-3,
MBR";)FN-I/PVE/\`AMD3:4I+EMJW4M]J_4=WJ/(_]3=2EW"-S&`!L<8[(V!K
M`=YI4[22NE^EM.V6E-/VNG[#_I[:(-J=[W$ESWGM>\N>1N%:#8`MVC'5?T!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!%]2?`A6L&;5V<2//KK*))@6$&8RW(B384QE<>5$E1W4J:?CR6'%(6A1&E25
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MM+`\1+;]WDENZ2:^@HX9K+Q)4EQMLE&E"34XM"%6'4>IL'I+%OS&?N&6]DP;
MR?2>[H9&WXSWGH:T$[R:`$B]Z?TYF=4Y)F)P<#Y[QYZ!Z+1TO>[XK&#I<X@=
M&TD`W5_+N\NK`^#>%2IK\J+F6]^9UT)K/L\)@TQ(,=M+4E6&X6V^VB1"Q:)8
M)\1QY:42K1Y"'GTH2W'CQ^>?-;FOD^9&1;&UKK?3EN\F&&NUQW=[+389"W8`
M*MC!+6U)>Y^^_+#E?CN7M@9'$3Z@G:.^FIL`W]U%7:(P=I)HZ0@.<``UK9(Q
M$BE1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1
M`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1
M`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1
M`1`1`1`1`1`1>?;5-5?5=C27E97W-+;PI5;;5%M#C6-7:5TUE<:;7V,"8V]$
MFPI<=Q3;K3J%-N(4:5$9&9#U@GFMIF7-L]T=Q&X.:YI+7-<#4.:X4((.T$&H
M.T+RFAAN876]PQLD#VEKFN`<US2*%K@:@@C8010C>H$>6'D.[3[CS9^7\8<K
M:V6R*6IV1(P'(6K"\VQF27.Y?_-,ME4G)L+0Z^LU+2A-I$0DB0Q%826@V;T1
MXE\YB8VV&L8#D+1M`)F%K+@#[(&D<M!NKW;CO<]Q6N.L_#IA<I(Z]TE,+"Z=
MM,+ZO@)^Q(K)%MWT[QHW-8T*!+>SRT.;.P[TYS+-B,MR"A@FXL\NVWC'N)CC
MD-LE&JQ>>Q8K"SI87L'J=E%@K3T[DEW)UV:T[S?Y=ZF:T6.3@BN7?[*X/<25
M^M`DX6O/JW/'4=A6N.?Y4:^TXYQO<=-+;-_VD`[]E/KB8ZN:/6-8>L;EPM(C
MR(C[L64P]&DL.*:?CR&ELOLNH/M6VZTXE+C;B#+0R,B,C$DL>V1H>P@L(J"-
MH(["H\<US'%CP0\':#L(\H7PC]+\H"("("("("+H?9_B7R7W\?BM[0[(;BYM
M%EFDFKV!CDR'B:#49$GX7F5LFOQ2`2]>AOS6R,B,RZ$>F*Y[7&D-,-<<]D;2
MW>W>QT@,OFB;Q2N\S"LGP>B]5ZD<!A,?=7#'?+#"(_/*[AC'G<%-=QF\@/.K
MF579#RKW#KL-I?O4E_;O;*4S>Y;)29-J5`N,PF0UXS0NH7W)<^`LW"5H]X\@
MS[DZ\:P\3^-MV/M=$VC[BXV@3W`+(A]DV('O']G&8J'>T[C/FD_#9D9WLNM8
MW38+?83!`0^0]CI2.[9V\`EKT.&\6.-A^.6RO&;#&\#V1P"DP6A-33]BN`VY
M)NL@G-(4A-GDV0SW)5WD-BE#BDH=EONFRV?AM]C9)06INIM6:AUAD#D]174E
MS=;F\6QC`?DQL;1C&]8:!4[34U*VDTYI;`Z3L!CM/VT=O;;W4VN>?KI'FKWN
MZBXF@V"@H%NT8ZK^@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(HT>=_P#@3OT;?^"L?RX?^*1^P?\`
MZ?\`\T2_RT_G!_W=\8__`(C_`%__`.7G44<Q?YL_]J[A_P#EO)T?ZO,JE')O
M_"+7^15_<OY,G^#_`/O*'_[J_P#2_P#9O$&\FCOBL_[AZ?\`\AO^*?C?ZOLJ
M+2W5OQG_`/X#^X;OC#XO^GQ:KBH2$L"0$0$6Q-KO^M\#_N\_N?\`WH_]4/\`
M#(G^'_\`I?\``^(+5F?^@=_U?]W_`)W<?B_Z;Z*YXC_KF_\`2_WC^:WC?_IN
MJK,?`S_"<?\`H9_\*K_^I'_?S^QI_9O_`&K_`-1_PWBC3_F9\27W@;G?SW_1
M>;LZ^SA6V/+GX\?_`&)O;_-?]9Y^WJ[:JQ<Q^PL_L7[$W^P?L/O"_8?^"_L?
MM#5%WQCOW]._S]JVA;\4;MW1N\R^4?E?4!$!$!$!$!$!$!$!$!$!$!$!$!$!
C$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!%__]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978503435968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation between the U.S. federal statutory tax rate and effective tax rate</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">A reconciliation between the U.S.&#160;federal statutory tax rate and our effective tax rate is summarized as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Statutory rate</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State taxes</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Taxes on foreign earnings</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(11.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(8.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(9.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(8.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Credits and net operating loss utilization</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Purchased intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Manufacturing deduction</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other permanent items</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Effective tax rate</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">23.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">27.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">24.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">26.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426085216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details Textual) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2015</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Feb. 12, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementsChangesInValuationTechniques', window );">Changes in valuation techniques</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 302.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 302.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 274.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember', window );">6.875% Senior Notes due 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated rate on debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember', window );">Convergence Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration</a></td>
<td class="nump">$ 274.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately', window );">Potential future milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">In-process research and development and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 424.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential future milestone payments commitment to third party approximately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51824106&amp;loc=d3e2420-110228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionContingentConsiderationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph b<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4845-128472<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.22(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value.  For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (bbb)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementsChangesInValuationTechniques">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the changes in valuation technique(s) and related inputs used to measure fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (bbb)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementsChangesInValuationTechniques</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978494683952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory Inventory (Details Textual) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_InventoryVariousProgramsGross', window );">Inventory, Various Programs, Gross</a></td>
<td class="nump">$ 35.8<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_InventoryVariousProgramsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross inventory of various programs which have been capitalized in advance of regulatory approval.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_InventoryVariousProgramsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>37
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0````(`&:#^$;G]9[`0P(``"DO```3````6T-O;G1E;G1?5'EP97-=
M+GAM;,W:W6[3,!0'\%>I<HL:U]\#K;MAW,(D>`&3N$W4)+9LK^O>'CO=$%0%
M;;!*_YNFZ;'/.<E)?E>]_O;H;5P<QF&*ZZI+R7\@)#:='4VLG;=3CFQ<&$W*
MIV%+O&EV9FL)6ZT4:=R4[)26J>2H;JZ_[&T(?6L7'X^!DGM=&>^'OC&I=Q/9
M3^U)UJ7;;/K&MJZY'_.6.N72]EV.5XL[$])G,^84Y#"0.7#\I'6)D[<I&'VP
MIHV=M6D<ZI@>!QO/U3]&GBO?VHVY']*K"C_=NSK885X3N]X_E?ITR%EB_FU=
MY6A\4873C7_KK!_+T/RT_6U'.?_':SFYB?MQN`WFH3\IL+_8F,JQ'DT_G1O5
M@PN[[\[MWO(QL>6J6MLN?<@+0^K//"5Y\5V.1I)3_U?MYR>E<<&^J&!9>,&7
MHC/!ME]3R/,]_V[\NN!R?92YSM__-/0Y&,E\N"`2K^J#@?3!0?H0('U(D#X4
M2!\:I(\KD#[>@_1!5RB-H(A*44BE**92%%0IBJH4A56*XBI%@96BR,I09&4H
MLC(461F*K`Q%5H8B*T.1E:'(RE!D92BR<A19.8JL'$56CB(K1Y&5H\C*463E
M*+)R%%DYBJP"15:!(JM`D56@R"I09!4HL@H4606*K`)%5H$BJT215:+(*E%D
ME2BR2A19)8JL$D56B2*K1)%5HLBJ4&15*+(J%%D5BJP*15:%(JM"D56AR*I0
M9%4HLFH4636*K!I%5HTBJT:15:/(JE%DU2BR:A19-8JL5S]E)?,_Y&]^`%!+
M`P04````"`!F@_A&2'4%[L4````K`@``"P```%]R96QS+RYR96QSK9++;L)`
M#$5_)9I]<4HE%A%AQ88=0OR`.^,\E,QXY#$B_?N.V(#"0ZW$TJ][CZZ\#JFL
M#C2B]AQ2U\=43'X,J<K]VG2JL0)(MB./:<&10IXV+!XUE])"1#M@2[`LRQ7(
MK8[9K.?:Q<[51G;NTQ1'E):T-M,(9Y;AFWE89.D\^(GT%V-NFM[2ENW)4]`'
M_K,-`\]YEE<>QW8OG*\M"_V/Z'D4X$G1H>)%]2-F`Q+M*;V"^GH`A3&^.R6:
ME((C-Z."N[_8_`)02P,$%`````@`9H/X1L`AU&6!`@``[2\``!H```!X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<\7:RV[;,!"%X5<Q]`"1.$,.%2/.*IML
MF[Z`8-,7Q)8$D46;MX_J1>%>=-"%@;.Q80D8_JO/`L6G/C?K+^G<E=/0Y^-I
MS*L?EW.?U_/U374L95S7==X>TZ7+#\.8^OGN?I@N79E_3H=Z[+;OW2'5TC16
M3[=SJN>G/V>O7G>;:GK=N6KUM9L.J6RJ[\/TGH\IE5Q?O]S#O,!\^V-,_[/\
ML-^?MNEEV'Z[I+[\HZ+^M4!5+P?)<I!0@G0Y2"E!?CG(4X+"<E"@!-ERD%&"
MXG)0I`2URT$M)>AQ.>B1$N0:(&/#24)8<[1V@&O'\=H!L!U';`?(=ARS'4#;
M<=1V@&W'<=L!N!U';@?H=AR['<#;<?06H+=P]!:@MY">M='#-D=O`7H+1V\!
M>@M';P%Z"T=O`7H+1V\!>@M';P%Z"T=O`7H+1V\%>BM';P5Z*T=O!7HK::\$
M;99P]%:@MW+T5J"W<O16H+=R]%:@MW+T5J"W<O16H+=R]/9`;\_1VP.]/4=O
M#_3V'+T]T-N3]KK19C=';P_T]AR]/=#;<_3V0&_/T=L#O3U';P_T]AR]`]`[
M</0.0._`T3L`O0-'[P#T#AR]`]`[D-Y5HI>5'+T#T#MP]`Y`[\#1.P"]`T?O
M`/0.'+T-Z&T<O0WH;1R]#>AM'+T-Z&T<O0WH;1R]#>AMI+,FZ+`)1V\#>AM'
M;P-Z&T=O`WH;1^\(](X<O2/0.W+TCD#OR-$[`KTC1^\(](X<O2/0.W+TCD#O
M2#HKB`X+<O2.0._(T3L"O2-'[Q;HW7+T;F_TSL=N2KNW,IWZ0[YWS6_#8=$-
MWKE\G-/]4ZY38<.-UF5>*=77S[O_FUVG_@RI_SK9__P)4$L#!!0````(`&:#
M^$9,^,*AP@,``*(2```0````9&]C4')O<',O87!P+GAM;+U837/3,!#]*YJ<
MX%`<0OI!)W@F)`4Z0X<.">6LVIM$@RP%238)OYZ5G:1.NU9K'^BELKQO)>W;
M]ZQVI&S_\M;H-1@GP+)-)I6]Q,D/O95SZ\LHLLD*,F[?8(C"MPMM,N[PT2PC
MO5B(!*8ZR3-0+AKT^V<1;!RH%-*3]2%I+Q[Y5<;KM10)=T*K^$8D1EN]<.QJ
MDX`<18\#2@1FGD&2&^&V<;^*J4^5,;.$2YC@6O&"2PM5U,-D&3/1V9JK;50]
M?17JE_VQGNLI=U!'';^HLJ^X@107/<I^F"QCOFSQG-)C)RNNEI#68Y^^W-?B
M#HSU)WT[>-/'GT,)]O-5;N"I4,M;+HR-1X6[+"!QVNQH*EQ7EE*=>-+MW1SW
M9WOLGEOPPP^]@AO!E>LQ*_[BXZ!7+5O-EF.YML[$/[7Y95<`SHZBPV0YK,?6
MQV(87_3+"!P=1T:'D\6[LAV=V\_,A9-@ORUNN7'_J13EF?:%N.CW:J??IV!<
MI>Q*.6Q'=JVJI9"\>DD.HXE&72@+*<.1U5*DV&8IFSG\A;DZ8-YUP`S;8#YR
MR54"K`/FK,/>SDG,+,\R;K9,+]A,+)5`"K%IV#A)=(Z5)S'CY'<NK/!<6%9_
M(*._@P53H/LA@6PJ;)G8EMR.I=0DYEH5R+\VVX:W#M4N[B6PL;6P2_99Z_2/
MD)*$?,)>9W=<YL!N@-O<^*9P](8_"84U%EQBT^%SWAPY!2,*[,D"G@V]PBHY
M^CA8ZSS+9<G5-[<"P[RE&E@AEYB:3L>-0@E;A@;(2LNDV?5O3KSH4G;+M\W;
MNU:)SH#-^0;H@/W&:GWU4*>9:V31NG)1)A26'PW)DX;\@6E89Z*EY/?:5%7U
MO%8K?P?IQ4]BOF+W+4/6D&5BMPV?$`_AL':`>V_8Q"R_M_`[]Q9T592XHYGV
M0AK0XFL4$GLUQTJUE]/@?5A.55ZPKSOHBO:I!F'M%WJYP,);HY46QE22"\<$
MM?>.MMFGV@NO48GPXY$(GR/B08WAR*`LA_WVG3I\V[93I^!X>\R0_KR&,?3G
M-:B(X6D'#,U[347^S$(VLK>/>XI@<]JH@](;-JDZ@#FEN6^4:[6_]IC300<,
MS7T80W/?8"5!?L*8!IL+84YI=P]C+CI@Z#Z@,8?95GZZ*T+03X/%?12$_;YQ
M.9<=W/>,9CR,H=5..7;P%+1E=X<PVE7#&%I98<S\!=^39\R+"`VS&/P&G=-:
M#V-HYH/7R7.:^>!U\ISV^8?KY#.U:KY8EK5K?QEED_;7T8LCHW_RM_ZCO^RC
MX_](Q?\`4$L#!!0````(`&:#^$9T!,>_/P$``&D#```1````9&]C4')O<',O
M8V]R92YX;6S-DTU/PS`,AO\*ZKU+V\$F15T/@#@Q"8DA$+>0>%M8\Z'$4]=_
M3Y9U+0,NO7&K:[^/7\=)R2WEQL&3,Q8<2O!7!U5K3[E=)%M$2PGQ?`N*^4FH
MT"&Y-DXQ#*';$,OXCFV`%%DV(PJ0"8:,'(&I[8E)50I.N0.&QG5XP7N\W;LZ
MP@0G4(,"C9[DDYPDU8O>:=/HD@SZJ@R.:^9Q:81<2Q"W[5#V.Q4Z(SCE3W(0
M??OX]T\/,4.2KO+@95_5-,VDF<:Z,'!.WI:/S_%L4JD],LTAJ+RDV%I8).?.
MK].[^]5#4A59?I-F\[2X7N4S6LQI-G\_3G;A;S"LNB'^K>.SP;A=E%C#R-U&
MC8C+C9\1),!S)RU*HT?A(N:;.,+\_N,3.(X'=<)XV7;0-L8)7\7[-43'EQ-6
MMC&N/:5^1!>OJOH"4$L#!!0````(`&:#^$:97)PC$`8``)PG```3````>&PO
M=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$
M[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4
M\GA@V2_;UKNW+][@5S(D$4$P&:>O\,`*I4Q>M5II`,,X?<D3$L/<@HL(2W@4
MR]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A`T%116F]?(+3E'S/X%<M4C66C
M`1-702:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6
M:\?1TDB`@LE]E`6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+
MTHMP'`3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG`J-6T_3
M:W?=TXZ)QJW0>`V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@
M`%AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9`%#@`W
MQ-%,4'RO0;:*X,*2TER0UL\IM5`:")K(@?5'@B'%W*_]]9>[R:0S>IU].LYK
ME']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+`GQ^R-;88<G;CL3<CH<9T)\S_;V
MD:4E,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?
MR"VZY!$XM4D-,A,_")V&F&I0'`*D"3&6H8;XM,:L$>`3?;>^",C?C8CWJV^:
M/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#Q
MK9P\'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G--`\)0O)/I*D8]ILR.G=";-
MZ#,:P4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB
M&38:<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.
MBY`1OQZ&.$J:[:)Q6`3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR
M-`>CFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[`?_1VC?"J_B"
MP#E_+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,I
MV#F?P.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO`JQ`GH9%LE"<M4TV4W
MBA*>0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F
M.$KTL<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1
MN0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/
MPT.'>7M?F&>5QE`T%&ULK"0L1K=@N-?Q+!3@9&`MH`>#KU$"\E)58#%;Q@,K
MD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;
M\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\
MX^;'<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;Z
MEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10
M[I*0!A,!S93)1/`"@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L`P%
M(1=RX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^
M)F!+PWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#
M7N83+$.D?L%]BHJ`$:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1
M/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO
M0=5`Y3_;U`UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%```
M``@`9H/X1@`ST=:K`@``?Q````T```!X;"]S='EL97,N>&ULS9C=:MLP%,=?
M1:ACM#!J)VV3=G4,HQ`8;&607NRNR+&<"/3AR7*6]')O4]A3[4FF#R=*S)PT
M65J<&\E'1[_SU[$DCA,5:D'Q:(JQ`G-&>3&`4Z7RCT%0C*>8H>)<Y)CKD4Q(
MAI1^E).@R"5&:6$F,1ITP[`7,$0XC"->LB%3!1B+DJL![(0K&W"`.Y'B`7P\
M??^C%.KV'7#MR8>3D_#Q[+9N/[4#9Q`XQN=4(WM7,'@Y]#QLYNJQ&KJW)WHK
MNP[O[PO?3J_CK_?#;V'7P#<-8`_Z]\1^N$/1GU^_&S7YL09X9S_X%G0-W-T)
M?MZB^GF[ZHL=\-%0-L+]6`/\TL"#Z@C&42:X/XE=Z`QQ5#R!&:+:WV9P+*B0
M0.FCKE6XG"*&G<<=HB21Q!@SQ`A=.+--D+T=*C]&N)`VMHM0CW,>^DARD@Q@
M6/U>'B[Q=-N8Y1%*-Y>G#7&4(Z6PY$/]`*K^PR+7B^."8R?2^NWPGDBTZ'2O
MUB;81L=-A$RQ]%<<7)KBB.),Z0F23*:F52(WTH52@NE.2M!$<$0-<CFCZFCL
M&%,Z,G?Q]VR#/<^`\S'O.(3`J%AV=2*JKM\&-JG!.LVQU[']@[A@GJT"Z-DH
MS^GB$R43SK`3ZTQ#43WMPG<:\'&$EE0P%9(\:7^S$<;:@"4$,RP5&:];?DJ4
M/^"YJG9P,,^:%!ZZY-?4=/RL>35Z"[YU>@X.;DWW)4NP'-JK<7])%_W=K\R>
M3EB3^;:[Y@`)1TB.J9Q:*ZW77FFOLZ>.(NVZO=)N6BNMW]X3JJO:UDKKME?:
M17NE7?ZGM*"JW=8*Q(WR<&4%24FH(GRI`9F"_M[HIAN5FR\--3.=^ZK0CBJ4
M4+P91<-2G*&2JF]D)I0='$#?_V+D=WHKKX<58@!]_RM.2<GLIV3@_W*(_P)0
M2P,$%`````@`9H/X1LD$[6"?!0``VA@```\```!X;"]W;W)K8F]O:RYX;6R5
MF%USVC@4AO^*QE>[%[N`/TFF="9MTFYFVFTG9+K7PA9!4]FBDIR/_OJ5##2O
MRT&37($-?BS)CUX?Z8T]?]#F^TKK[^RQ59T]-XMDX]SV?#*Q]4:TW/ZMMZ+S
MOZVU:;GSA^9NHM=K68M+7?>MZ-PDG4[+B1&*.ZD[NY%;F^QI]B4TNS6"-W8C
MA&O5#M9RV25OW]CSM53BFS#6@QG?;O_EK5@DCRIABEMWU4@GFD62^T/]($8G
M3+]]UTL5#HIID4P"[-#5KX;5NA$[V.U&VO_V/R2L$6O>*W?K&WNX[R*9I7F:
MECM&^-LW*1XL`L,)QFLG[\4M7RV2:<)X[_0'J9PPE]R)CT;W6]G=>5;"UM)8
MMPS='?[9RDZV\F=HMS^R&_WPCS;RI^X<5\O::*6&J\(/PT7^#O;7&=]&)^O1
M'QU?W80GL4C*J0?>2RM74DGWM$B&[TJ$GDQ^Z\HP_,_?6#<,SN$1,]XU[*IS
MGL*NN]W#\T,3VN#_?-T,-S;GTG\QU\UL-U0(>J^[1G16-,Q_LUK)QH]*PY;.
M?_@;`"@%4/I:4`:@#$#9:T$Y@'(`Y2\&O>.*=[5@`"H`5+P65`*H!%#YVJY5
M`*H`5!V#EGW;<O/$])HMY5TG_:SG7H:+NM:]EP%`<P#-CT$7]8_>NS?D`\,#
M0)P!XNP8<2.L,/?",F\?NY1V:((=Q+Q02J.*4W1Q>HRZ[NZ]T]H\X44C@0F#
MK_U\[.["]&$7UHK]K3]JW3Q(I9"$!L\(A3]P:=@WKGK!/@MN>Q-F@,.AF*&[
M,T+>#[+S3DBN_&RTSO1'`'1V1DA[*8R\YR&P3A%0UAEAZY5_B&XT@FCEC-#2
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M%<+^B:].-#DC$S06AOC.R]#DC##Y1!H>FH4H-#FC@I5*1;)_H]J`$)F.1Q*%
M=F>$W;N<)"]%GS/"YVA@9E@09.AS1OA\')ADB]#EC"H(AN1\-TI.$H0F9X3)
M&*$D`/W-"'^C69I/L7Q#F7-"YNA<SV>(0IES0N;(7+\4CB,*9<X)F:.H'`O=
M'&W."9OCJ%&I.ZIU"9NC"907B$*[<\+N.`KMSM'NG+`;PBP,LU0CEW*T.B>L
M?K[\&,1NL;3(T>N<]#H2C#DF=(Z&YV1"1U`%&EZ@X05A^,F,W74246AX\9JX
M#J@B110:7KR\#MZCT/`"#2^H>CB*0L,+-+P@##_Q$B&\*D;K.<+P.&JT,D3#
M"\+P**K`>J1`VPO"]CAJCBBTO2!LCZ/0]@)M+PC;:=2OL[CX1=M+PO93+^_]
MN",*;2\)VP\O;^+IEZAW2>C]V[4^2!Y=S]6(@5Z79')'*H`2O2[1ZY+P.H["
MY"[1ZY):^A'%!#5"HVT*JL@FJPF*A$Z7+ZY+#B./K_`2G2Y/+@Y/H3#@2G2Z
M))R.HVYQ'P:=KLB"&^LE8H@J5+DB5XP$@9*R0K$K0NQHZ55A;E?H=T7X'4>A
MWQ7Z71%^1U?$%?I=H=\5N1$761%76)E4J'A%*/Z\(J:?VF@#CA#[]-IX>(J(
M0K$K0NSH,IN]1Q2*75%BQQ;:<RQ-YBCV?+K?>1Y^'C:;&[&6G6C"5KP=;E-S
M58?]>?\Q[,6D>1'V8\+Q9]WX>X>-]82M>Z7>^W-?ND^:A__MR8<=^;?_`U!+
M`P04````"`!F@_A&_\;VP4("``".!P``&````'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;'V5RXZ;,!2&7P7Q``.V@5Q$D))45;NH-)I%NW:($]#8F-I.F+Y]
M;4,8@LUL\(7_/Y^OQWG'Q;NL"%'!!Z.-W(654NTVBF19$8;E"V])H_]<N&!8
MZ::X1K(5!)^MB=$(QG$6,5PW89';OE=1Y/RF:-V05Q'(&V-8_#L0RKM=",)'
MQUM]K93IB(H\&GWGFI%&UKP)!+GLPCW8'@$R$JOX79-.3NJ!&?R)\W?3^'G>
MA;$9`Z&D5"8$UL6='`FE)I(F_QV"?C*-<5I_1/]NIZN'?\*2'#G]4Y]5I4<;
MA\&97/"-JC?>_2##'%(3L.14VF]0WJ3B[&$)`X8_^K)N;-GU?Q(TV/P&.!C@
M:(#)EP8T&-!H`-80]2.S\_J&%2YRP;M`])O18K/G8(OTRI6FTRR4GI/4_XRB
MR.]%G$=W$V90'*8*:!5@5$0Z]@B`/L`!.G;X##BZ"N0'(.\,T,2.K#WQVQ.O
M/9G8$VM/9PO@*C(_(/4"4L>^F@%Z16,5J56L5VF<I'Y*YJ5D#F4]H[B*C1^P
M\@)6CAW,3XI'LG!4UE[$VO7/SLK!(UDX+!LO8N/ZDQG"(UG8"9,??%<J=B-D
M\TL5.WL.XT7.PM4%+F=^M)XT6:]9+U"\]W</H$O9S"FN!L8+%/\E!LB-`&9Y
M8M`\K1E*0;:!<+YPT23],2*N]EF00<EOC>KSW-@[/CU[:-/GI[S(6WPEO["X
MUHT,3ESI)&S3Z(5S1?2(XA=]<RO].(X-2B[*5%>Z+OKGHF\HWCY>O_$)+OX#
M4$L#!!0````(`&:#^$;P'"[16@4``&L9```8````>&PO=V]R:W-H965T<R]S
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M8+L"-]6AN?R?;%Z;MBK?0Z:3,O_1?^Z/E\]S_TM0US`Y`*\!>`NXU2,'Z&N`
M_@@P/PTPUP#S?VNPUP!+:ICUVB\]E^5MOIC7U7E2]\-]RKM9!?<VC<VFN]D-
M1>JU)OW6$8OYVP)Q/GOKRKDBRR&"/:(_(QE'X$;,4OVW1J#4B"7R&CY7L!((
M0]KPRT+6/RWD4S.UV%=Z$*_[>"O'&S'>#.)-'^](7_?(\8+X'H$8K"/<2N"4
M=1B)Y(QS1GL50B!=PSGM8U36R_JLJ,]R?9[HLX-Z;%^/]A84D2=@2F,DO9!Q
MS+D`"$2<@"D%862*.E&;X]I('RX=J\9:/G*<<A`<G<R<`N4M[8"U@%F(;F16
M>E&9Y\HB4>99-6@C.$-7J<`9!&/IK.2<!>.<LD0>YXRU@$K+^H*H+[!5JY4<
M'\7XR/I'DPFVC%QW<*F=I'L$+$((9(UD'+-I"[!T5@N8!]`H:^NRI;3]*ZZ.
M[?^*#T-4GL[_E<09CYXE"\[%-*J>],-:XKR#L3T)1A(<<(6:*@1!(81HJ4+.
M6>\<S9B9P(&RB):N7Q$,8;C3?=8HYL]'0*[14(W(>S/914,E<@S`!9JH,HD+
M/DT+JI!SF';?,))X0<Z\H+E`2P5J5M,71`54(,>,@DCE<<HZHZDX3FG$D=T%
M9%,`W!5HZ@K`\,[6-EA#DXL$&IUF*-UC!!!]M(Y.F[4$AI@,1!Q1*5L#X-Y`
M4V\`/$_3'51`=%2*BOME06L!\2F_CFB2+0%P3Z"I)P`A0Z/6BF;RE0"F7O9H
MJ3;.H;8J>IH>I)I3BE5^)'F"[`Z`VP--[0'P//VEV\8BU2CD\Y0GJ4*A-+3!
M4W,@<=Z,+3[9&T!@ZHRBZH(PA.F/;G4K`8PQ+5.V=7(.-5HV)]92S<Y&K<>&
M4#8PP!V,H0X&)&^2VL1V3X%SP5++G0F<]48'>B03.&-<U",.%F47@]S%4&^Z
M1,&=A$#U"11$ZA<R@4K>BTY0@8IVL$-\5B:[%^3NA6:A)7(3$=$$NG6L!,ZC
M!NKW,H$#;TR,D0H40%3)^HXL0I3="W+W8JA[06XCOJ"AGG@E8,$Q[R(59@+0
M,[%4F(YCXR<;%^3&Q5#C@D,7X:_CEWPS31$"Y]/A2C%YG$OC%P-0;R:!$-/Z
M&SE#H.Q@<.A@^A.6&?&O*+L#Y.[`4'>`PXP=^D1T%ZE]%2G%9CBG_!V=<VN!
MLG=J;&>2/0)RCV"H1T`G*=-4F431_3D3J*2,/0CC5%(VDE50-@;H^:B/^">4
MDR\*R9>-NI0K+=*<NA(YYYBYD,L#>H);R^5Y'%,H9UX4,B\;?2&CZI1-Z.E:
MY)+?80K%\ASSAW)YPP-`KW`V>))<%O7+Y1E^,]E4K\>V'_C;W=M[@D?LGD23
M^TNX7X%P/X/[=?\6X*/XQ?R4OQ1_YO7+_MA,GJJVK<K+$^SGJFJ+U'QUEQ;G
MKLBWMR^'XKGM+GVZKOMW`?V7MCJ]O]JXO5]9_`=02P,$%`````@`9H/X1B2\
M7CY$`P``E@P``!@```!X;"]W;W)K<VAE971S+W-H965T,RYX;6R-ETUSFS`0
MAO\*XWN*/I'(.)X)MCOMH3.='MHSL66;*2`7<-S^^TI`"%FMTUX,R,]^O"LA
M+<NK;7ZV)V.ZZ'=5UNW#XM1UY_LX;G<G4^7M!WLVM?OG8)LJ[]QC<XS;<V/R
M?6]4E3$C)(FKO*@7JV4_]K59+>VE*XO:?&VB]E)5>?,G,Z6]/BSHXF7@6W$\
M=7X@7BWCR6Y?5*9N"UM'C3D\+![I_99RC_3$]\)<V]E]Y)-_LO:G?_B\?U@0
MGX,IS:[S+G)W>39K4Y;>DXO\:W3Z&M,;SN]?O'_LY;KTG_+6K&WYH]AW)Y<M
M641[<\@O9??-7C^948/T#G>V;/O?:'=I.UN]F"RB*O\]7(NZOUZ'?S09S7`#
M-AJPR6"*@QOPT8"_&HAW#<1H(/XW@AP-)(@0#]K[RFWR+E\M&WN-FF&ZS[E?
M5?1>NKG9^4$_%:YJK?O/$ZOE\TJ29?SL_8Q(-D=8CS#^%MF$")V(V,6?DF!8
M$AD+([P-L$8(`7+XIY/MNT[>I,G16O&9/1]J=4.F0.W%S%[T]D*"6@](W2.J
M1U*FF$I`.4),42$)P#8A1I5(-56@,`A'4R$2AJN3J#H95N>&?8+:)T%U)%AF
M63++4_;(':-@':P1*-$)*/0FI"C1`-HBKB05!%>E4%4J5`42SE08)4VH3(&N
M$*-$)>!EW2#.=$I!(;>(KT3>6LP:%:9#87`QZR`*T[,@@ZP0NJ,*J@HA00DH
MT#:$$I'@DE)44AI*`F]4EH8Q..%`^#JD[C01X*W;(!17FFH@"\&<]O3&9/E3
M$=OF2:@-Y).-S-N$B-"`6V.<X`SLMAL4HY+#S0?A*$EN3!R]<8K14)Z&\F@0
M1Z>)TO`]0SA%"=7PO$$XMW`UTP0*1$":2LGT#8WH(?E(6:@QA1H9LD.R!!X?
M"*83!D\/S)F0'.XEF#.>WM*&GZR4!]K@SI:-S/R4TJF0L!=9(YRB6E.XIR"<
MFS^NX'NZQ4!&>,K@&HUG35=EFF/?[K;1SE[J;C@3I]&II7YDOFD#XQF]7U-D
M?.-;\+[)>W6_6I[SH_F2-\>B;J,GV[E6L6_V#M9VQN5//KB3^>0^$J:'TAPZ
M?ZO<?3.TS<-#9\\O7P'3I\CJ+U!+`P04````"`!F@_A&7B3VN!@"```W!@``
M&````'AL+W=O<FMS:&5E=',O<VAE970T+GAM;(U5VW*;,!#]%88/B$`@I_5@
M9H+M3/K0F4P>VF<9"\-$0E223?KWU05C+&C:%TM:G;-[=A>MLYZ+=UD3HH(/
M1ENY"6NENC4`LJP)P_*!=Z35-Q47#"M]%"<@.T'PT9(8!3"*5H#AI@WSS-I>
M19[QLZ)-2UY%(,^,8?&[()3WFS`.KX:WYE0K8P!Y!D;>L6&DE0UO`T&J3?@4
MK_?(("S@1T-Z.=D'1ON!\W=S^';<A)&10"@IE?&`]7(A6T*I<:0#_QI\WD(:
MXG1_]?YLL]7J#UB2+:<_FZ.JM=@H#(ZDPF>JWGC_0H84K,*24VE_@_(L%6=7
M2A@P_.'6IK5K[VZ^1`-MF0`'`AP)8YQE0C(0DALA_920#H3T?R.@@8"\",#E
M;BNWPPKGF>!](%RW.VP^JGB-=&]*8S2MT%63^LX@\NR2K^(,7(R?`5),(=!"
M8'(/V<TA-R=`QQ]%P"41!9Q'N`^P74"DGH9_.ME_ZN1.9K)8JV3"3RP?_27-
M=)&?3OBIJ[4GL7"0UD(>72%3Y-5BCDDC^-6KQART@EYC]W-,$L5H.2.TF!&:
M9^1]&@6:JT5>Z[9S#%Q%7D(+?OS^SB%^,F#R+!@1)SN09%#R<ZM<3T?K./.>
MH'E6GKV(U]MXP;[3,]*-M)O[/.OPB7S'XM2T,CAPI1^S?8X5YXIHX=&#5E[K
M*3X>**F4V3[JO7"#S1T4[ZYC>OROR/\`4$L#!!0````(`&:#^$9N^B*KL@0`
M`"46```8````>&PO=V]R:W-H965T<R]S:&5E=#4N>&ULC9C;;B)'$(9?!7&_
M2U=5'RV,E"&*DHM(J[U(KL=F;-`"0V;&R^;MTP.80%6U$\DR<_BK^^_#?%W=
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MKOYQ_MWL3[_'\YOP'J8'X"4`KP%@/PR@2P"Q@-G9V:E=/]=#O9AW[7'2G0?C
M4(]C#@^4>^YY?#AV5&Y3G]^-BL7\^\+;^>S[6,Y%4MU*\"3!>\52*KR[2F:Y
M_JL)5$W@33R=X[T>3VH\W<3;<WQ@C3A+]B=).$D`(YH065,TG;$)K>['JGZL
M],/JJ>Q-/>Y<CXG>)<?\2)VWQGJCVW&J'2?M)&;'23N4#2$P.XH.<^?8PG![
MU8\7?H)A?KRHAY`"L*FYE#*,1*7>":J;(-VP5E=!5).'*A"?.XK,6(.HNXFJ
MFRC=L*^MBJ*:X(PA-J1+*;,V6%]PDU0W2;HAYB:):IR'F"*?R%)G?4!_4]Z=
MGY&]&J[,?W]:%\W=K``#(7F.+2D$&XQWA3Z"`D)!]I)@*,BJ(@7/)_Y2$P;O
M?"SUDTY40.G)<4\HAP23#8E_])K08'0F%#SIE`:)Z>"Y)U+&SEFRPI,4YGXR
M:%/!DTYJD*@.?.D`R>#@P$7^^2NZ_"6$5&`CZ+`&26N^2%6@8-@'EX"3:ZDI
M+8%WKM1/.K+AEMGG)3J42M`Q"Y*SD5,?)$$)O<@V%!50(6$`';,@.1LY]4$A
MJ`N!KYU+10<^&A<+CG34@F1MY.0'"=&<Q`0C>DC189X=!4>HLQ8E:R.G/RH(
MC3EC2KR3=&$B*B16J+,6)6LC9RU*A*)S+A+O)DV(D/(*4/!4R%XE:_GJ5Z%$
MJ`L>3>"6%%U.4ST4'.FD14G:R$F+"D`I6D/<D=2YO$26NDC'+$K,1HY9E/A,
MD+,LCC1%YW/^DTJ.=,RBQ"P'>H6W\#QO!BQ$#SP'6BI"<@8=%!").F11)L:Q
M5((.60P"TZF0#*,.1I1@Y/E`A5$TEZ<Q'TKN?>@X1(G#Q'&($G-Y-\*=?"RZ
MWUWJ("0)PL1!2))O-D\`:_E<T820/)2^*-)!2!*$B8.0)-\^Y40X3TSN21&Z
M9&-AO2"=@R0YR+>S%4F^`1BB0#PY5Y0I;^Y2Z9NBPM&`1"'?!U0D$?<)/<#M
M0G`Q]3^4]ZYT'I+D81(G%LH1`;J0__BBH2E--"D/=<&5SD223$R<B2032BM.
M"121,U0RH\.0)`QY4E&1W/^?NBAQVTM-:2+8O#\ON-(!2S*+!</36`H"?H7T
M7%/JZ?GLYD#O4+\VO]?=ZV;?3Y[:86AWI].]E[8=FERJ^9R[?]W4J^O-MGD9
MQLN0K[OS*>;Y9F@/[X>RUY/AQ3]02P,$%`````@`9H/X1F38B%NU`0``1`0`
M`!@```!X;"]W;W)K<VAE971S+W-H965T-BYX;6R%5-MNG#`0_17+'[`VETV4
M%8O44$7M0Z4H#^VS%X;%BB_$]B[IW]<V+"44-2_8,S[GS!E?*`9M7FT'X-"[
M%,H><>=<?R#$UAU(9G>Z!^576FTD<SXT9V)[`ZR))"E(2ND=D8PK7!8Q]VS*
M0E^<X`J>#;(7*9GY_0A"#T><X%OBA9\[%Q*D+,C,:[@$9;E6R$![Q%^20Y4'
M1`3\Y##8Q1P%[R>M7T/PO3EB&BR`@-H%!>:'*U0@1!#RA=\FS;\E`W$YOZD_
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M]W,SWO(Q<+J_O=GYQU'^`5!+`P04````"`!F@_A&2Q"RG6H$```O%```&```
M`'AL+W=O<FMS:&5E=',O<VAE970W+GAM;(V836_C-A"&_XKA^ZXY0XH?@6,@
M=E&TAP*+/;1GQ:9C8R7+E91X^^]+28[CS`R!S2&6Y9<S+S_T#,7EI6E_=(<8
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MDQO@M0'>&MSRR`WTM8'^:#`.W6)R-O;KM[(O5\NVN<S::3+.Y3#G\*#3R&V'
MF\-`I3YUZ;=!L5J^K4`5R\7;$.BJ6=]K<-+<%(L4_98"I11K9,WQ<X*-H#!R
M!BUV0M^UU]=.6#F`$0.8NP!F#&`T&81)<AHE;LKAC`DAD+X(.E3HK9+]%**?
M0NB0DP-8,8!E'0+E28_LG=-B&O6`!9*.;[A,%P4HE.TXT8X3[)"!6SN6)VCK
M'''#55[[(C/97C3CN1E0Q(QG:;X$90UU(\C`V"*W^(+H)S`_2*<J\#R%IQ.Z
M$536(&C9S$`W"0B*KSW(/.^080H((XP4*L#=:A\4'6))!]X'F_,D0N@)D'ER
M0"TA3^4!@Z&6!)U#ZT/&D0PMT,(H4>I<19][;T-`BAU)J!6&G">9@\!!"&"H
M)\-2)1PH8#/'=1H@NQQE$D(A.&(%JA!6OM6.39R@<X4RF6(#,EM!@"M8:HEC
M$YQ76+!1$H0J%`BYF9,)"TYX;#,E`V0N@@1&2B+@R`LNU0/6+:X##:[`(N-)
M9B-P.`+0R@$"^%"9-+&6NA*4:5J<S1$;94BBXK:0UI"KZ'.RX%V@W!:$F=T"
MRL!%`;A(Z88"2!&=]<R.1%SP^J[>?#8E$Q<Y<0%I%4".4BQ4^J.>,KJ,(YFX
MR(G+*BU*P%5LS6UDG3.9Y8TR;U'@+=V`K9%S-"W:PH*F?).4%LV]\+,KF;DH
M;#]S&W*4&8D"(Y%B&SGZOJ3]2J`[4$FGM0TJ-]@R(E'8A2+E-O(-IC8.*=XD
M6=)E@(LR<%$`+LVT1@Y2&U+?J2$N\SJ8W`,BTQ9_82N*'*&07H,*ZD>0H5*9
MXJ]ES&H)L]20YO1T#MD#*\A2D7#&9Q:1EE&K)=32@J0Y01-#M*'OO8(.K;8Y
MK&D9M%H`K:;%2`M[UD0&!G]1%VQND#+OX\+65M-ZI#E!TPHQ`2G5!*%-&RF;
M>0/5,FJU@%I-RY&6WMY]6B9LF+C06PV!`F!Q=PY3Q_9E/)_J9MOF]=1/9QVW
MN[<SL"<<SG'(_34\;*:3K(\PJ^6Y?(E_E>W+\=3-GIN^;^KQG&??-'U,-M77
M1/)#+'>W+U7<]\.E2]?M=)XU?>F;\_OQW.V,</4_4$L#!!0````(`&:#^$:R
M1A";HP$``+$#```8````>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL;5-=;Z0@
M%/TKA!]0''7:9N*8=-IL=A\V:?JP^\SH54F!:P'']M\7T+&F]06XEW/./9>/
M8D3S:CL`1]Z5U/9(.^?Z`V.VZD!Q>X,]:+_3H%'<^="TS/8&>!U)2K(T26Z9
MXD+3LHBY9U,6.#@I-#P;8@>EN/DX@<3Q2'?TFG@1;>="@I4%6WBU4*"M0$T,
M-$?ZL#N<\H"(@'\"1KM:D^#]C/@:@C_UD2;!`DBH7%#@?KK`(T@9A'SAMUGS
MJV0@KM=7]5^Q6^_^S"T\HOPO:M=YLPDE-31\D.X%Q]\PM[`/@A5*&T=2#=:A
MNE(H4?Q]FH6.\SCMY-E,VR:D,R%="/=)-#X5BC:?N.-E87`D9CK:GH<;W!U2
M?Q!52(:^O47K]P*B+"[E+LL*=@E",^:TQJ039D$PK[Z42+=*G-(?]'2;GFTZ
MS%;T;':8;PODFP+Y2B"?!?;?6MS"W'XKPE9GJL"T\>E84N&@W71X2W9YG0]I
MO),O>%GTO(6_W+1"6W)&YV\VWDV#Z,!;26[VE'3^_RR!A,:%Y9U?F^E)38'#
M_OI!EE]:?@)02P,$%`````@`9H/X1I`SU9:D`0``L0,``!@```!X;"]W;W)K
M<VAE971S+W-H965T.2YX;6QM4\MNI#`0_!7+'Q`S0!X[8I`RB:+DL%*4P^[9
M`PU8L=W$-D/V[]<V#$$)%]O=KJJN]J,8T;S;#L"13R6U/=#.N7[/F*TZ4-Q>
M80_:[S1H%'<^-"VSO0%>1Y*2+$V2&Z:XT+0L8N[5E`4.3@H-KX;802EN_AU!
MXGB@.WI)O(FV<R'!RH(MO%HHT%:@)@::`[W?[8]Y0$3`'P&C7:U)\'Y"?`_!
M2WV@2;``$BH7%+B?SO``4@8A7_ACUOPJ&8CK]47]*7;KW9^XA0>4?T7M.F\V
MH:2&A@_2O>'X#',+UT&P0FGC2*K!.E07"B6*?TZST'$>IYTLFVG;A'0FI`OA
M+HG&IT+1YB-WO"P,CL1,1]OS<(.[?>H/H@K)T+>W:/U>0)3%N=QEMP4[!Z$9
M<UQCT@FS()A77TJD6R6.Z0]ZNDW/-AUF*WHV.[S;%L@W!?*50#X+_/K6X@8F
M3[X58:LS56#:^'0LJ7#0;CJ\);N\SOLTWLD7O"QZWL)O;EJA+3FA\S<;[Z9!
M=."M)%?7E'3^_RR!A,:%Y:U?F^E)38'#_O)!EE]:_@=02P,$%`````@`9H/X
M1EU-VW>C`0``L0,``!D```!X;"]W;W)K<VAE971S+W-H965T,3`N>&UL=5-=
M;Z0@%/TKA!]0U'%VFXECTFFSV7W8I.E#^\SH54F!:P'']M\7T+&FZ[X`]W+.
MN>?R48QH7FT'X,B[DMH>:>=<?V#,5ATH;F^P!^UW&C2*.Q^:EMG>`*\C24F6
M)<D/IKC0M"QB[M&4!0Y."@V/AMA!*6X^3B!Q/-*47A-/HNU<2+"R8`NO%@JT
M%:B)@>9([]+#*0^("'@6,-K5F@3O9\37$/RICS0)%D!"Y8("]],%[D'*(.0+
MO\V:7R4#<;V^JO^*W7KW9V[A'N6+J%WGS2:4U-#P0;HG''_#W,(^"%8H;1Q)
M-5B'ZDJA1/'W:18ZSN.TL[^=:=N$;"9D"^$VB<:G0M'F`W>\+`R.Q$Q'V_-P
M@^DA\P=1A63HVUNT?B\@RN)2IGE:L$L0FC&G-2:;,`N">?6E1+95XI3]0\^V
MZ;M-A[L5?3<[_(]`OBF0KP3R66#WK<4M3/ZM"%N=J0+3QJ=C286#=M/A+=GE
M==YE\4Z^X&71\Q;^<M,*;<D9G;_9>#<-H@-O);G94]+Y_[,$$AH7EC_]VDQ/
M:@H<]M</LOS2\A-02P,$%`````@`9H/X1MJ#(*^B`0``KP,``!D```!X;"]W
M;W)K<VAE971S+W-H965T,3$N>&UL;5/;;J,P$/T5BP^HP2%M%1&DIM5J]V&E
MJ@^[SPX,8-7VL+8)W;^O;0A!+2^V9WS.F3.^%".:=]L!./*AI+;'I'.N/U!J
MJPX4MW?8@_8[#1K%G0]-2VUO@->1I"1E:7I/%1<Z*8N8>S5E@8.30L.K(790
MBIO_)Y`X'I,LN2;>1-NYD*!E01=>+11H*U`3`\TQ><H.ISP@(N"/@-&NUB1X
M/R.^A^!7?4S28`$D5"XH<#]=X!FD#$*^\+]9\U8R$-?KJ_J/V*UW?^86GE'^
M%;7KO-DT(34T?)#N#<>?,+>P#X(52AM'4@W6H;I2$J+XQS0+'>=QVMFQF;9-
M8#.!+83'-!J?"D6;+]SQLC`X$C,=;<_##68'Y@^B"LG0M[=H_5Y`E,6E?,@*
M>@DZ,^2TAK`(N2&H%U\JL*T*)_:-SK;INTV#NQ5]-U7/]]L"^:9`OA+(MSO\
M#LGR^R\UZ.I$%9@V/AQ+*ARTFXYNR2YO\RE>(;W!RZ+G+?SFIA7:DC,Z?Z_Q
M9AI$!]Y*>K=/2.=_SQ)(:%Q8/OBUF1[4%#CLK]]C^:/E)U!+`P04````"`!F
M@_A&,L5&@J(!``"Q`P``&0```'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6QU
M4]MNW"`0_17$!P0OZVW2E==2-E75/E2*\M`^L_;81@'&!;Q._[Z`O8Z5NB_`
M#.><.<.E&-&^N@[`DS>MC#O1SOO^R)BK.M#"W6$/)NPT:+7P(;0M<[T%42>2
M5HQGV2>FA32T+%+NV98%#EY)`\^6N$%K8?^<0>%XHCMZ2[S(MO,QP<J"+;Q:
M:C!.HB$6FA-]W!W/>40DP$\)HUNM2?1^07R-P??Z1+-H`114/BJ(,%WA"92*
M0J'P[UGSO60DKM<W]:^IV^#^(AP\H?HE:]\%LQDE-31B4/X%QV\PMW"(@A4J
MET92#<ZCOE$HT>)MFJ5)\SCM'/8S;9O`9P)?"`]9,CX52C:_""_*PN)(['2T
MO8@WN#OR<!!53,:^@T47]B*B+*[E+K\OV#4*S9CS&L,GS()@07TIP;=*G/D_
M=+Y-WV\ZW*_H^]GAP[9`OBF0KP3R_[2XA?G\H0A;G:D&VZ:GXTB%@_'3X2W9
MY74^\G0G[_"RZ$4+/X1MI7'D@C[<;+J;!M%#L)+='2CIPO]9`@6-C\O[L+;3
MDYH"C_WM@RR_M/P+4$L#!!0````(`&:#^$;XF\10H`$``+$#```9````>&PO
M=V]R:W-H965T<R]S:&5E=#$S+GAM;'53VV[<(!#]%<0'!"_K;:N5UU(V5=0^
M5(KRT#ZS]MA&`<8!O$[_OH"]CI4Z+\`,YYPYPZ48T;ZX#L"3-ZV,.]'.^_[(
MF*LZT,+=80\F[#1HM?`AM"USO051)Y)6C&?9%Z:%-+0L4N[)E@4.7DD#3Y:X
M06MA_YY!X7BB.WI+/,NV\S'!RH(MO%IJ,$ZB(1::$[W?'<]Y1"3`;PFC6ZU)
M]'Y!?(G!S_I$LV@!%%0^*H@P7>$!E(I"H?#KK/E>,A+7ZYOZ8^HVN+\(!P^H
M_LC:=\%L1DD-C1B4?\;Q!\PM'*)@A<JED52#\ZAO%$JT>)MF:=(\3CO[?*9M
M$_A,X`OA6Y:,3X62S>_"B[*P.!(['6TOX@WNCCP<1!63L>]@T86]B"B+:[D[
M9`6[1J$9<UYC^(19$"RH+R7X5HDS_X_.M^G[38?[%7T_._RD?KXID*\$\D]:
MW,)\=,E69ZK!MNGI.%+A8/QT>$MV>9WW/-W).[PL>M'"+V%;:1RYH`\WF^ZF
M0?00K&1W!TJZ\'^60$'CX_)K6-OI24V!Q_[V099?6OX#4$L#!!0````(`&:#
M^$980='PH0$``+$#```9````>&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;'53
MVVZ<,!#]%<L?$`,+:;5BD;*IJN0A4I2']MD+`UBQ/=0V2_KWM0U+4$M?;,_X
MG#-G?"DG-.^V!W#D0TEM3[1W;C@R9NL>%+=W.(#V.RT:Q9T/3<?L8(`WD:0D
MRY+DGBDN-*W*F'LU58FCDT+#JR%V5(J;WV>0.)UH2F^)-]'U+B185;*5UP@%
MV@K4Q$![H@_I\9P'1`3\$##9S9H$[Q?$]Q`\-R>:!`L@H79!@?OI"H\@91#R
MA7\MFI\E`W&[OJE_C]UZ]Q=NX1'E3]&XWIM-*&F@Y:-T;S@]P=)"$01KE#:.
MI!ZM0W6C4*+XQSP+'>=IWBG2A;9/R!9"MA*^)M'X7"C:_,8=KTJ#$S'ST0X\
MW&!ZS/Q!U"$9^O86K=\+B*J\5FEQ*-DU""V8\Q:3S9@5P;SZ6B+;*W'._J%G
M^_3#KL/#AGY8'.;[`OFN0+X1R/_3XAZF^*L(VYRI`M/%IV-)C:-V\^&MV?5U
M/F3Q3C[A53GP#EZXZ82VY(+.WVR\FQ;1@;>2W!64]/[_K(&$UH7E%[\V\Y.:
M`X?#[8.LO[3Z`U!+`P04````"`!F@_A&:J\B>J(!``"Q`P``&0```'AL+W=O
M<FMS:&5E=',O<VAE970Q-2YX;6QU4]MNW"`0_17$!P0O>\EJY;64356U#Y6B
M/+3/K#VV48!Q`:_3OR]@KV.E[@LPPSEGSG#)![1OK@7PY%TKX\ZT];X[,>;*
M%K1P#]B!"3LU6BU\"&W#7&=!5(FD%>-9=F!:2$.+/.5>;)%C[Y4T\&*)Z[46
M]L\%%`YGNJ'WQ*ML6A\3K,C9S*ND!N,D&F*A/M.GS>FRBX@$^"EA<(LUB=ZO
MB&\Q^%Z=:18M@(+21P41IAL\@U)1*!3^/6E^E(S$Y?JN_C5U&]Q?A8-G5+]D
MY=M@-J.D@EKTRK_B\`VF%O91L$3ETDC*WGG4=PHE6KR/LS1I'L:=PW&BK1/X
M1.`SX9@EXV.A9/.+\*+(+0[$CD?;B7B#FQ,/!U'&9.P[6'1A+R**_%9L]H><
MW:+0A+DL,7S$S`@6U.<2?*W$A?]#Y^OT[:K#[8*^G1P^K@OL5@5V"X'=?UI<
MPQP_%6&+,]5@F_1T'"FQ-WX\O#D[O\XGGN[D`U[DG6C@A["--(Y<T8>;37=3
M(WH(5K*'/25M^#]SH*#V<?D8UG9\4F/@L;M_D/F7%G\!4$L#!!0````(`&:#
M^$;@Y8'EH@$``+$#```9````>&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;'53
MVV[<(!#]%<0'!"][:;KR6LHFJMJ'2E$>VF?6'MLHP#B`U^G?%[#7L5+W!9CA
MG#-GN.0#VE?7`GCRKI5Q)]IZWQT9<V4+6K@[[,"$G1JM%CZ$MF&NLR"J1-**
M\2P[,"VDH46><L^VR+'W2AIXML3U6@O[YPP*AQ/=T%OB13:MCPE6Y&SF55*#
M<1(-L5"?Z,/F>-Y%1`+\DC"XQ9I$[Q?$UQC\J$XTBQ9`0>FC@@C3%1Y!J2@4
M"K]-FA\E(W&YOJE_2]T&]Q?AX!'5;UGY-IC-**F@%KWR+SA\AZF%?10L4;DT
MDK)W'O6-0HD6[^,L39J':>=^HJT3^$3@,^$^2\;'0LGFD_"BR"T.Q(Y'VXEX
M@YLC#P=1QF3L.UAT82\BBOQ:;/9?<W:-0A/FO,3P$3,C6%"?2_"U$F?^#YVO
MT[>K#K<+^G:L?LC6!7:K`KN%P.X_+:Y@#I^;9(LSU6";]'0<*;$W?CR\.3N_
MS@>>[N0#7N2=:."GL(TTCES0AYM-=U,C>@A6LKL])6WX/W.@H/9Q^26L[?BD
MQL!C=_L@\R\M_@)02P,$%`````@`9H/X1F\G8S2A`0``L0,``!D```!X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL;5/;CML@$/T5Q`<L#G&V5>18VFQ5M0^5
M5OO0/A-[;*,%Q@4<;_^^@!VOE?4+,,,Y9\YP*4:T;ZX#\.1=*^-.M/.^/S+F
MJ@ZT<`_8@PD[#5HM?`AMRUQO0=2)I!7C6?;(M)"&ED7*O=BRP,$K:>#%$C=H
M+>R_,R@<3W1';XE7V78^)EA9L(572PW&233$0G.B3[OC.8^(!/@M872K-8G>
M+XAO,?A9GV@6+8""RD<%$:8K/(-242@4_CMK?I2,Q/7ZIOX]=1O<7X2#9U1_
M9.V[8#:CI(9&#,J_XO@#YA8.4;!"Y=)(JL%YU#<*)5J\3[,T:1ZGG:_93-LF
M\)G`[PAL*I1L?A->E(7%D=CI:'L1;W!WY.$@JIB,?0>++NQ%1%E<R]TC+]@U
M"LV8\QK#)\R"8$%]*<&W2ISY)SK?IN\W'>Y7]/WL<+\MD&\*Y"N!?!;([UK<
MPASNBK#5F6JP;7HZCE0X&#\=WI)=7N<33W?R`2^+7K3P2]A6&D<NZ,/-IKMI
M$#T$*]G#@9(N_)\E4-#XN/P2UG9Z4E/@L;]]D.67EO\!4$L#!!0````(`&:#
M^$8CSTA6H0$``+$#```9````>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;'53
MVV[C(!#]%<0'%(>D:14YEIJN5MN'2E4?=I^)/;91@?$"CKM_OX`=UVK=%V"&
M<\Z<X9(/:-]<"^#)NU;&'6GK?7=@S)4M:.%NL`,3=FJT6O@0VH:YSH*H$DDK
MQK-LS[20AA9YRKW8(L?>*VG@Q1+7:RWLOQ,H'(YT0Z^)5]FT/B98D;.95TD-
MQDDTQ$)]I`^;PVD7$0GP6\+@%FL2O9\1WV+P5!UI%BV`@M)'!1&F"SR"4E$H
M%/X[:7Z4C,3E^JK^,W4;W)^%@T=4?V3EVV`VHZ2"6O3*O^+P"Z86;J-@B<JE
MD92]\ZBO%$JT>!]G:=(\C#O;;**M$_A$X#/A/A'86"C9_"&\*'*+`['CT78B
MWN#FP,-!E#$9^PX67=B+B"*_%)O]/F>7*#1A3DL,'S$S@@7UN01?*W'B7^A\
MG;Y==;A=T+>3P[MU@=VJP&XAL/NFQ37,_:<B;'&F&FR3GHXC)?;&CX<W9^?7
M^<#3G7S`B[P3#3P+VTCCR!E]N-ET-S6BAV`EN[FEI`W_9PX4U#XN[\+:CD]J
M##QVUP\R_]+B/U!+`P04````"`!F@_A&3)V&"*,!``"Q`P``&0```'AL+W=O
M<FMS:&5E=',O<VAE970Q.2YX;6QU4]MNW"`0_17$!P0OZV3;E==2-E75/E2*
M\M`^L_;81@'&!;Q._[Z`O8Z5NB_`#.><.<.E&-&^N@[`DS>MC#O1SOO^R)BK
M.M#"W6$/)NPT:+7P(;0M<[T%42>25HQGV0/30AI:%BGW;,L"!Z^D@6=+W*"U
ML'_.H'`\T1V])5YDV_F88&7!%EXM-1@GT1`+S8D^[H[G/"(2X*>$T:W6)'J_
M(+[&X'M]HEFT``HJ'Q5$F*[P!$I%H5#X]ZSY7C(2U^N;^M?4;7!_$0Z>4/V2
MM>^"V8R2&AHQ*/^"XS>86[B/@A4JET92#<ZCOE$HT>)MFJ5)\SCM'/*9MDW@
M,X$OA$]9,CX52C:_""_*PN)(['2TO8@WN#OR<!!53,:^@T47]B*B+*[E[N%S
MP:Y1:,:<UQ@^818$"^I+";Y5XLS_H?-M^G[3X7Y%WT_5#]FV0+XID*\$\O^T
MN($Y?&R2K<Y4@VW3TW&DPL'XZ?"6[/(Z'WFZDW=X6?2BA1_"MM(X<D$?;C;=
M38/H(5C)[NXIZ<+_60(%C8_+0UC;Z4E-@<?^]D&67UK^!5!+`P04````"`!F
M@_A&C::,VZ$!``"Q`P``&0```'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6QU
M4]MNW"`0_17$!P0O=IIJY;64356U#Y6B/+3/K#VV48!Q`:_3OR]@KV.E[@LP
MPSEGSG`I)[2OK@?PY$TKXTZT]WXX,N;J'K1P=SB`"3LM6BU\"&W'W&!!-(FD
M%>-9]HEI(0VMRI1[ME6)HU?2P+,E;M1:V#]G4#B=Z('>$B^RZWU,L*ID*Z^1
M&HR3:(B%]D0?#\=S$1$)\%/"Y#9K$KU?$%]C\+TYT2Q:``6UCPHB3%=X`J6B
M4"C\>]%\+QF)V_5-_6OJ-KB_"`=/J'[)QO?!;$9)`ZT8E7_!Z1LL+=Q'P1J5
M2R.I1^=1WRB4:/$VS]*D>9IW\GRA[1/X0N`KX7.6C,^%DLTOPHNJM#@1.Q_M
M(.(-'HX\'$0=D['O8-&%O8BHRFMU>.`ENT:A!7/>8OB,61$LJ*\E^%Z),_^'
MSO?I^:[#?$//%X?YOD"Q*U!L!(K_M+B'*3X489LSU6"[]'0<J7$T?CZ\-;N^
MSD>>[N0=7I6#Z."'L)TTCES0AYM-=],B>@A6LKM[2OKP?]9`0>OC\B&L[?RD
MYL#C</L@ZR^M_@)02P,$%`````@`9H/X1O=9`SJ?`0``L0,``!D```!X;"]W
M;W)K<VAE971S+W-H965T,C$N>&UL=5/;;N,@$/T5Q`<4AR3-*G(L-5U5NP\K
M57W8?2;VV$8%Q@4<=_]^`3NNU7I?@!G..7.&2SZ@?74M@"?O6AEWHJWWW9$Q
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MH]"$.2\Q?,3,"!;4YQ)\K<29?Z'S=?IVU>%V0=].#N_7!7:K`KN%P.X_+:YA
M#I^*L,69:K!->CJ.E-@;/Q[>G)U?YP-/=_(!+_).-/!+V$8:1R[HP\VFNZD1
M/00KV=V>DC;\GSE04/NX/(2U'9_4&'CL;A]D_J7%/U!+`P04````"`!F@_A&
MHL)NH*,!``"Q`P``&0```'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6QU4UUO
MVR`4_2N('U`<DJQ9Y%AJ6DW;PZ2J#]LSL:]M5."Z@./NWP^PXUJ=]P+<RSGG
MGLM'/J!]=2V`)^]:&7>BK??=D3%7MJ"%N\,.3-BIT6KA0V@;YCH+HDHDK1C/
MLB],"VEHD:?<LRUR[+V2!IXM<;W6POXY@\+A1#?TEGB13>MC@A4YFWF5U&"<
M1$,LU"?ZL#F>=Q&1`+\D#&ZQ)M'[!?$U!C^J$\VB!5!0^J@@PG2%1U`J"H7"
M;Y/F1\E(7*YOZM]2M\']13AX1/5;5KX-9C-**JA%K_P+#M]A:F$?!4M4+HVD
M[)U'?:-0HL7[.$N3YF'<V6\GVCJ!3P0^$PY9,CX62C:?A!=%;G$@=CS:3L0;
MW!QY.(@R)F/?P:(+>Q%1Y-=B<W_(V34*39CS$L-'S(Q@07TNP==*G/D_=+Y.
MWZXZW"[HV\GAUW6!W:K`;B&P^T^+*YA#]JD(6YRI!MNDI^-(B;WQX^'-V?EU
M/O!T)Q_P(N]$`S^%;:1QY((^W&RZFQK10["2W>TI:</_F0,%M8_+^["VXY,:
M`X_=[8/,O[3X"U!+`P04````"`!F@_A&@:JCR)\!``"Q`P``&0```'AL+W=O
M<FMS:&5E=',O<VAE970R,RYX;6QU4]MNG#`0_16+#XC!N[EHQ2)E$U7M0Z4H
M#^VS%P:P8GN(;9;T[^L+2U!*7VS/^)PS9WPI)S1OM@=PY$-);8]9[]QPH-36
M/2AN;W``[7=:-(H['YJ.VL$`;R))2<KR_(XJ+G16E3'W8JH21R>%AA=#[*@4
M-W].('$Z9D5V3;R*KG<A0:N2+KQ&*-!6H"8&VF/V6!Q.^X"(@%\")KM:D^#]
MC/@6@A_-,<N#!9!0NZ#`_72!)Y`R"/G"[[/F9\E`7*^OZM]BM][]F5MX0OE;
M-*[W9O.,--#R4;I7G+[#W,)M$*Q1VCB2>K0.U962$<4_TBQTG*>T\Y#/M&T"
MFPGL"X&F0M'F,W>\*@U.Q*2C'7BXP>+`_$'4(1GZ]A:MWPN(JKQ4Q4-1TDL0
MFC&G-88ES(*@7GTIP;9*G-@_=+9-WVTZW*WHNU3]_FY;8+\IL%\)[/_3XA;F
MJTNZ.E,%IHM/QY(:1^W2X2W9Y74^LG@GG_"J''@'/[GIA+;DC,[?;+R;%M&!
MMY+?W&:D]_]G"22T+BSO_=JD)Y4"A\/U@RR_M/H+4$L#!!0````(`&:#^$;Q
M1/F0H@$``+$#```9````>&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;'53VX[;
M(!#]%<0'+`YQTE7D6-IL5;4/E5;[T#X3>VRC!<8%'&__OH`=K]6Z+\`,YYPY
MPZ48T;ZY#L"3=ZV,.]/.^_[$F*LZT,(]8`\F[#1HM?`AM"USO051)Y)6C&?9
MD6DA#2V+E'NQ98&#5]+`BR5NT%K8WQ=0.)[ICMX3K[+M?$RPLF`+KY8:C)-H
MB(7F3)]VITL>$0GP0\+H5FL2O5\1WV+PK3[3+%H`!96/"B),-W@&I:)0*/QK
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MOW^0Y9>6?P!02P,$%`````@`9H/X1@$B_*>D`0``L0,``!D```!X;"]W;W)K
M<VAE971S+W-H965T,C4N>&UL;5/;;N,@$/T5Q`<4AR1M-G(L-5U5NP\K57W8
M?2;VV$8%Q@4<=_]^`3NNU?4+,,,Y9\YPR0>T;ZX%\.1#*^-.M/6^.S+FRA:T
M<'?8@0D[-5HM?`AMPUQG052)I!7C67;/M)"&%GG*O=@BQ]XK:>#%$M=K+>S?
M,R@<3G1#;XE7V;0^)EB1LYE720W&233$0GVBCYOC>1<1"?!;PN`6:Q*]7Q#?
M8O"S.M$L6@`%I8\*(DQ7>`*EHE`H_#YI?I:,Q.7ZIOZ<N@WN+\+!$ZH_LO)M
M,)M14D$M>N5?<?@!4PO[*%BB<FDD9>\\ZAN%$BT^QEF:-`_CSIY/M'4"GPA\
M)ARR9'PLE&Q^%UX4N<6!V/%H.Q%O<'/DX2#*F(Q]!XLN[$5$D5^+S>$^9]<H
M-&'.2PP?,3."!?6Y!%\K<>;_T?DZ?;OJ<+N@;R>'#^L"NU6!W4)@-PD<OK2X
MAOGVI0A;G*D&VZ2GXTB)O?'CX<W9^74^IDMDG_`B[T0#OX1MI''D@C[<;+J;
M&M%#L)+=[2EIP_^9`P6UC\N'L+;CDQH#C]WM@\R_M/@'4$L#!!0````(`&:#
M^$9[5DJVHP$``+$#```9````>&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;'53
MVV[<(!#]%<0'!"_>I.W*:RF;*FH?*D5Y:)]9>VRC`.,`7J=_7\!>QTK<%V"&
M<\Z<X5*,:%]<!^#)FU;&'6GG?7]@S%4=:.%NL`<3=AJT6O@0VI:YWH*H$TDK
MQK/LCFDA#2V+E'NR98&#5]+`DR5NT%K8OR=0.![ICEX3S[+M?$RPLF`+KY8:
MC)-HB(7F2.]WA],^(A+@MX31K=8D>C\COL3@9WVD6;0`"BH?%428+O``2D6A
M4/AUUGPO&8GK]57],74;W)^%@P=4?V3MNV`VHZ2&1@S*/^/X`^86;J-@A<JE
MD52#\ZBO%$JT>)MF:=(\3COYW4S;)O"9P!?"URP9GPHEF]^%%V5A<21V.MI>
MQ!O<'7@XB"HF8]_!H@M[$5$6EW+W+2O8)0K-F-,:PR?,@F!!?2G!MTJ<^"<Z
MWZ;GFP[S%3V?'?ZG_GY38+\2V,\"_$.+6YC\0Q&V.E,-MDU/QY$*!^.GPUNR
MR^N\Y^E.WN%ET8L6?@G;2N/(&7VXV70W#:*'8"6[N:6D"_]G"10T/BZ_A+6=
MGM04>.RO'V3YI>4_4$L#!!0````(`&:#^$:4:$+R]P$``!,&```9````>&PO
M=V]R:W-H965T<R]S:&5E=#(W+GAM;'55S8Z;,!!^%8L'6(.!D$0$:;-5U1XJ
MK?;0GAV8!+0VIK83MF]?&PB+R.PEML??SPPPD[Q7^MW4`)9\2-&:0U!;V^TI
M-64-DILGU4'K;LY*2V[=45^HZ33P:B!)05D8;JCD31L4^1![U46NKE8T+;QJ
M8JY2<OWO"$+UAR`*[H&WYE);'Z!%3F=>U4AH3:-:HN%\")ZC_3$*/61`_&Z@
M-XL]\<F?E'KWAY_5(0A]#B"@M%Z"N^4&+R"$5W+.?R?13T]/7.[OZM^'<EWZ
M)V[@18D_365KEVT8D`K._"KLF^I_P%1#Z@5+)<SP2\JKL4K>*0&1_&-<FW98
M^_%F&TXTG,`F`EL1Z&@TI/F-6U[D6O5$C\^VX_X51GOF'D3I@[YNEZ)Q=QY1
MY+<BVB4YO7FA"7-<8MB(F1'4J<\6#+,XL@<ZP^DQFF&\H,>C>YS@`@DJD"P$
MDJG$=%4BAMG@)BEJDB("V<H$PVQQDPUJLD$$=BN31XSK0-PD0TTR1"!:F6"8
M+U[J%C79/E82L97)(X:%,6ZR0TUVB,#ZV\8P*6[BNQOKH!"1V*Q;"`-E*Q^Z
M:%H)^C+,)D-*=6WMV)US=)Y_SVQH^D]XD7?\`K^XOC2M(2=EW>@8FO^LE`67
M2_CDOL/:3>CY(.!L_39S>SW.K/%@57<?P?/_0/$?4$L#!!0````(`&:#^$9`
MW9>"L`$``!8$```9````>&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;&U4VVZC
M,!#]%8L/J,%)NMF((#5=5=V'E:H^=)\=&,"JS5#;A.[?US:$HJQ?L&=\SIDS
MOI"/J-]-"V#)IY*=.2:MM?V!4E.VH+BYPQXZMU*C5MRZ4#?4]!IX%4A*4I:F
M]U1QT25%'G(ONLAQL%)T\**)&93B^M\))([')$NNB5?1M-8G:)'3A5<)!9T1
MV!$-]3%YR`ZGG4<$P)N`T:SFQ'L_([[[X'=U3%)O`224UBMP-US@$:3T0J[P
MQZSY7=(3U_.K^E/HUKD_<P./*/^*RK;.;)J0"FH^2/N*XS/,+02')4H3OJ0<
MC$5UI21$\<]I%%T8QVEEG\ZT.('-!'9#H%.A8/,7M[S(-8Y$3UO;<W^"V8&Y
MC2A]TO?M+!JWYA%%?BE8NL_IQ0O-F-,:PP(F6Q#4J2\E6*S$B?U'9W'Z)NIP
MLZ)OINJ;?5Q@&Q78K@2V<XL_;UJ,8+(T7F07+;*+"&0W16*8VZV@JX-3H)MP
M/PTI<>CL=$)+=GD"#RP<_#>\R'O>P!^N&]$9<D;KKD^X`#6B!6<EO7->6O=(
MET!";?WTAYOKZ=Y.@<7^^@J77T'Q!5!+`P04````"`!F@_A&;2`6+Z\!```6
M!```&0```'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6QU5,MNXR`4_17D#R@V
M<=(J<BPUK48SBY&J+F;6Q+ZV47EX`,>=OR_@1ZV4;@)<SNL:2#$J_68Z`(O>
M!9?FE'36]D>,3=6!H.9.]2#=3J.TH-8M=8M-KX'6@20X)FEZP((RF91%J+WH
MLE"#Y4S"BT9F$(+J_V?@:CPE6;(47EG;65_`98%77LT$2,.41!J:4_*8'<][
MCPB`/PQ&LYDCG_VBU)M?_*I/2>HC`(?*>@7JABL\`>=>R!G_FS4_+3UQ.U_4
M?X1N7?H+-?"D^%]6V\Z%31-40T,';E_5^!/F%D+"2G$3?E$U&*O$0DF0H._3
MR&08QVGGL-#B!#(3R$IX2$/PR2C$?*:6EH56(]+3I^VI/\'L2-R'J'S1]^TB
M&K?G$65Q+4FV*_#5"\V8\Q9#`B9;$=BIKQ8D9G$F7^@D3M]%$^XV]-WDGG\C
MD$<%\HU`/K>8W[08P^SC)ONHR3XB<+@QB6'N;TSPYN`$Z#;<3X,J-4@[G=!:
M79_`(PD'_PDOBYZV\)OJEDF#+LJZZQ,N0*.4!1<EO7-9.O=(UP6'QOKIO9OK
MZ=Y."ZOZY16N?P7E!U!+`P04````"`!F@_A&"W2D(:4!``"Q`P``&0```'AL
M+W=O<FMS:&5E=',O<VAE970S,"YX;6QM4UUOI"`4_2O$'U"4<;K=B6/2Z:;I
M/FS2]*'[S.A528%K`<?NOR^@8TW7%^!>SCGW7#Z*$<V;[0`<^5!2VV/2.=<?
M*+55!XK;&^Q!^YT&C>+.AZ:EMC?`ZTA2DK(TO:6*"YV41<P]F[+`P4FAX=D0
M.RC%S;\32!R/299<$R^B[5Q(T+*@"Z\6"K05J(F!YIC<9X=3'A`1\"I@M*LU
M"=[/B&\A^%T?DS18``F5"PK<3Q=X`"F#D"_\/FM^E0S$]?JJ_AB[]>[/W,(#
MRK^B=ITWFR:DAH8/TKW@^`1S"_L@6*&T<2358!VJ*R4ABG],L]!Q'J>='9MI
MVP0V$]A"N$NC\:E0M/F+.UX6!D=BIJ/M>;C![,#\050A&?KV%JW?"XBRN)0L
MNROH)0C-F-,:PR(F6Q#4JR\EV%:)$_N/SK;INTV'NQ5]-U7/]]L"^:9`OA+(
MYQ9_?FMQ`\/2;T7HZDP5F#8^'4LJ'+2;#F_)+J_S/EXB_8*71<];^,--*[0E
M9W3^9N/=-(@.O)7T9I^0SO^?)9#0N+#\X==F>E)3X+"_?I#EEY:?4$L#!!0`
M```(`&:#^$;G6F_2O0$``'L$```9````>&PO=V]R:W-H965T<R]S:&5E=#,Q
M+GAM;&U4W6ZD(!1^%>(#%&4<VTP<DTXW3?=BDZ87N]>,'I64'Q=P[+[]`CJ.
MF7(C</A^SL$#Y:3TI^D!+/H27)ICTEL['#`V=0^"F@<U@'0[K=*"6K?4'3:#
M!MH$DN"8I&F!!64RJ<H0>]=5J4;+F81WC<PH!-7_3L#5=$RRY!KX8%UO?0!7
M)5YY#1,@#5,2:6B/R7-V.!4>$0"_&4QF,T<^][-2GW[QLSDFJ4\!.-36*U`W
M7.`%./="SOCOHGFS],3M_*K^&JIUV9^I@1?%_[#&]B[9-$$-M'3D]D--;["4
ML/>"M>(F?%$]&JO$E9(@0;_FD<DP3O-.D2VT.($L!+(2GM*0^&P4TOQ!+:U*
MK2:DYZ,=J/^#V8&X@ZA]T-?M4C1NSR.J\E(1DI7XXH46S&F+(0%S0V"GOEJ0
MF,6)?*.3.'T7S7"WH>]F]_PI+I!'!?*-0+Z42.Y*C&%V<9-]U&0?$<CO3&*8
M?=RDB)H4$8'BSB2&>;PSP9ON$*"[<`D,JM4H[=P&:W2]9\\D=-<-7I4#[>`7
MU1V3!IV5=3T:NJQ5RH)+)7UP!??N)5@7'%KKIX]NKN?+,2^L&JY7?7UOJO]0
M2P,$%`````@`9H/X1B.J^\+``0``>P0``!D```!X;"]W;W)K<VAE971S+W-H
M965T,S(N>&UL=53=;J0@%'X5X@,4Q7':G3@FG6Z:W8M-FE[L7C-Z5%)^+.#8
M??L%=*R9I3<"A^_G'#Q03DJ_F1[`H@_!I3DFO;7#`6-3]R"HN5,#2+?3*BVH
M=4O=83-HH$T@"8Y)FNZQH$PF51EB+[HJU6@YD_"BD1F%H/KO";B:CDF67`.O
MK.NM#^"JQ"NO80*D84HB#>TQ><P.I[U'!,!O!I/9S)'/_:S4FU_\;(Y)ZE,`
M#K7U"M0-%W@"SKV0,WY?-#\M/7$[OZH_AVI=]F=JX$GQ/ZRQO4LV35`#+1VY
M?573#UA**+Q@K;@)7U2/QBIQI21(T(]Y9#*,T[Q3W"^T.($L!+(2'M*0^&P4
MTOQ.+:U*K2:DYZ,=J/^#V8&X@ZA]T-?M4C1NSR.J\E(1\E#BBQ=:,*<MA@1,
MMB*P4U\M2,SB1/ZCDS@]CV:8;^CY[%Y\X;^+"NPV`KNEQ&\W)48P>1HW*:(F
M140@NS&)8;XXBGW49!\1R&],8IC=C0G>=(<`W85+8%"M1FGG-EBCZSU[)*&[
M/N%5.=`.?E'=,6G065G7HZ'+6J4LN%32.U=P[UZ"=<&AM7YZ[^9ZOASSPJKA
M>M77]Z;Z!U!+`P04````"`!F@_A&RBG'H,L!``#@!```&0```'AL+W=O<FMS
M:&5E=',O<VAE970S,RYX;6QU5-MNG#`0_16+#XA9`TNZ8I&RJ:KVH5*4A_;9
M"\-%\87:9DG_OK9A"2+N"_:,SV7&V"XFJ=YT!V#0.V="GZ/.F.&$L:XZX%0_
MR`&$76FDXM384+58#PIH[4F<81+'1\QI+Z*R\+D7519R-*P7\**0'CFGZN\%
MF)S.T2&Z)U[[MC,N@<L"K[RZYR!T+P52T)RCI\/IDCN$!_SJ8=*;.7*U7Z5\
M<\&/^AS%K@1@4!FG0.UP@V=@S`E9XS^+YH>E(V[G=_5OOEM;_95J>);L=U^;
MSA8;1ZB&AH[,O,KI.RPM9$ZPDDS[+ZI&;22_4R+$Z?L\]L*/T[SR&"^T,($L
M!+(CX-G(E_F5&EH62DY(S5L[4/<'#R=B-Z)R2=>W+5';-8<HBUM)DJS`-R>T
M8"Y;#/&8PXK`5GVU("&+"_E$)V%Z$JPPV="3V3U+PP)I4"#="*1+B\==BR%,
M'C;)@B990.!Q9Q+"?`F;'(,FQ\\":;PS"6'^\[ORH$D>$"`[DQ`FV9G@S1'D
MH%I_TS2JY"C,?-;6['J9GX@_PA_PLAAH"S^I:GNAT54:>Q'\46ZD-&!+B1_L
MKG;VN5D#!HUQT]S.U7P#Y\#(X?Z>K(]:^0]02P,$%`````@`9H/X1AKM8DN\
M`0``>P0``!D```!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL;53=;J0@%'X5
MX@,4AU&G.W%,.MTT[<4F32^ZUXP>E13$`H[=MR^@8XW+C<#A^SD'#^2C5!^Z
M!3#H2_!.GZ+6F/Z(L2Y;$%3?R1XZNU-+):BQ2]5@W2N@E2<)CDD<9UA0UD5%
M[F.OJLCE8#CKX%4A/0A!U;\S<#F>HEUT"[RQIC4N@(L<+[R*">@TDQU24)^B
MA]WQG#F$![PS&/5JCESN%RD_W.*E.D6Q2P$XE,8I4#M<X1$X=T+6^'/6_+%T
MQ/7\IO[DJ[797ZB&1\G_LLJT-MDX0A74=.#F38[/,)>0.L%2<NV_J!RTD>)&
MB9"@7]/(.C^.T\Y]/-/"!#(3R(:`)R.?YF]J:)$K.2(U'6U/W1_<'8D]B-(%
M7=TV16WW'*+(KP5)DAQ?G=",.:\QQ&-V"P);]<6"A"S.Y#\Z"=/WP0SW*_I^
M<D\/88$D*)"L!)*YQ'138@B3A4W2H$D:$#AL3$*8^[!)%C3)`@*_-B8!3!IO
M3/"J.P2HQE\"C4HY=&9J@R6ZW+,'XKOK!U[D/6W@#U4-ZS2Z2&-[U'=9+:4!
MFTI\9PMN[4NP+#C4QDT/=JZFRS$MC.QO5WUY;XIO4$L#!!0````(`&:#^$9T
M<#`NI`$``+$#```9````>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;&U3VV[<
M(!#]%<0'!"][:;7R6LJFBM*'2E$>VF?6'MLHP+B`U^G?%[#7:R5^`68XY\P9
M+OF`]MVU`)Y\:&7<B;;>=T?&7-F"%NX!.S!AIT:KA0^A;9CK+(@JD;1B/,L.
M3`MI:)&GW*LM<NR]D@9>+7&]UL+^.X/"X40W])9XDTWK8X(5.9MYE=1@G$1#
M+-0G^K@YGG<1D0"_)0QNL2;1^P7Q/08_JQ/-H@504/JH(,)TA2=0*@J%PG\G
MS7O)2%RN;^K/J=O@_B(</*'Z(RO?!K,9)174HE?^#8<7F%K81\$2E4LC*7OG
M4=\HE&CQ,<[2I'D8=PZ'B;9.X!.!SX3O63(^%DHV?P@OBMSB0.QXM)V(-[@Y
M\G`094S&OH-%%_8BHLBO!=]O<G:-0A/FO,3PA+DC6%"?2_"U$F?^A<[7Z=M5
MA]L%?3M6/V3K`KM5@=U"8#>UR#^UN(;9?BK"%F>JP3;IZ3A28F_\>'AS=GZ=
MCSS=R1U>Y)UHX)>PC32.7-"'FTUW4R-Z"%:RASTE;?@_<Z"@]G'Y+:SM^*3&
MP&-W^R#S+RW^`U!+`P04````"`!F@_A&Z,-DG:X!```6!```&0```'AL+W=O
M<FMS:&5E=',O<VAE970S-BYX;6QM5,UNXR`0?A7D!R@.B=,J<BPUK5:[AY6J
M'MHSL<<V*GA<P''W[1>PXUHIEP##]S<&DH^H/TP+8,F7DITY)JVU_8%24[:@
MN+G#'CJW4Z-6W+JE;JCI-?`JD)2D+$WW5''1)44>:B^ZR'&P4G3PHHD9E.+Z
MWPDDCL=DDUP+KZ)IK2_0(J<+KQ(*.B.P(QKJ8_*X.9PRCPB`-P&C6<V)SWY&
M_/"+/]4Q27T$D%!:K\#=<($GD-(+.>//6?/;TA/7\ZOZK]"M2W_F!IY0OHO*
MMBYLFI`*:CY(^XKC;YA;"`E+E";\DG(P%M65DA#%OZ91=&$<IYV'=*;%"6PF
ML!L"G8Q"S&=N>9%K'(F>/FW/_0EN#LQ]B-(7?=\NHG%['E'DEX)ENYQ>O-",
M.:TQ+&`V"X(Z]<6"Q2Q.[`>=Q>G;:,+MBKZ=W/?;N,`N*K!;">SF%K.;%F.8
M?=PDBYID$8'[&Y,8YN'&A*X.3H%NPOTTI,2AL],)+=7E"3RR</#?\"+O>0-_
MN6Y$9\@9K;L^X0+4B!9<E/3.96G=(UT6$FKKI_=NKJ=[.RTL]M=7N/P5%/\!
M4$L#!!0````(`&:#^$811(Q,I0$``+$#```9````>&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;&U3VV[<(!#]%<0'!"][:U=>2]E45?M0*<I#^\S:8QL%&!?P
M.OW[`O8Z5N(78(9SSISAD@]H7UT+X,F;5L:=:>M]=V+,E2UHX1ZP`Q-V:K1:
M^!#:AKG.@J@222O&L^S`M)"&%GG*/=LBQ]XK:>#9$M=K+>R_"R@<SG1#[XD7
MV;0^)EB1LYE720W&233$0GVFCYO391<1"?!;PN`6:Q*]7Q%?8_"S.M,L6@`%
MI8\*(DPW>`*EHE`H_'?2?"\9B<OU7?U[ZC:XOPH'3ZC^R,JWP6Q&206UZ)5_
MP>$'3"WLHV")RJ61E+WSJ.\42K1X&V=ITCR,.]OC1%LG\(G`9\*7+!D?"R6;
MWX0716YQ('8\VD[$&]R<>#B(,B9CW\&B"WL14>2W@N^_YNP6A2;,98GA";.9
M$2RHSR7X6HD+_T3GZ_3MJL/M@KX=JQ^.ZP*[58'=0F`WUC]D'UI<PWQLDBW.
M5(-MTM-QI,3>^/'PYNS\.A]YNI-W>)%WHH%?PC;2.')%'VXVW4V-Z"%8R1[V
ME+3A_\R!@MK'Y3&L[?BDQL!C=_\@\R\M_@-02P,$%`````@`9H/X1I-05;"[
M`0``>P0``!D```!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL;53=;JP@$'X5
MX@,4E]UUFXUKTNU)TW-QDJ87[36KHY+RXP%<V[<OH&N-Y49@^'YF<"`?E/XP
M+8!%GX)+<TI::[LCQJ9L05!SISJ0;J=66E#KEKK!IM-`JT`2'),TS;"@3"9%
M'F(ONLA5;SF3\**1Z86@^NL,7`VG9)/<`J^L::T/X"+',Z]B`J1A2B(-]2EY
MV!S/F4<$P!N#P2SFR.=^4>K#+_Y6IR3U*0"'TGH%ZH8K/`+G7L@9_Y\T?RP]
M<3F_J3^%:EWV%VK@4?%W5MG6)9LFJ(*:]MR^JN$9IA+V7K!4W(0O*GMCE;A1
M$B3HYS@R&<9AW+E/)UJ<0"8"61'P:!32_$,M+7*M!J3'H^VH_X.;(W$'4?J@
MK]NE:-R>1Q3YM2`9R?'5"TV8\Q)#`F8S([!3GRU(S.),?M%)G+Z-9KA=T+>C
M^R&-"^RB`KN%P&XJ<;LJ,8;9Q4WV49-]1&"_,HEALKA)%C7)(@*'E4D,<[\R
MP8ON$*";<`D,*E4O[=@&<W2^9P\D=-</O,@[VL`_JALF#;HHZWHT=%FME`67
M2GKG"F[=2S`O.-363P]NKL?+,2ZLZFY7?7YOBF]02P,$%`````@`9H/X1G&A
MN=RB`0``L0,``!D```!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL;5-=;]L@
M%/TKB!]0')(V6^18:EI-V\.DJ@_;,[&O;53@NH#C[M\/L.-:J5^`>SGGW"_(
M![1OK@7PY$,KXXZT];X[,.;*%K1P=]B!"3<U6BU\,&W#7&=!5(FD%>-9]L"T
MD(86>?*]V"+'WBMIX,42UVLM[+\3*!R.=$.OCE?9M#XZ6)&SF5=)#<9)-,1"
M?:2/F\-I%Q$)\$?"X!9G$G,_([Y%XU=UI%E,`124/BJ(L%W@"92*0B'P^Z3Y
M&3(2E^>K^H]4;<C^+!P\H?HK*]^&9#-**JA%K_PK#C]A*N$^"I:H7%I)V3N/
M^DJA1(N/<9<F[<-X\RV;:.L$/A'X#8&-@5*:S\*+(K<X$#NVMA-Q@IL##XTH
MHS/6'5)TX2XBBOQ2\(?O.;M$H0ES6F)XPFQF!`OJ<PB^%N+$O]#Y.GV[FN%V
M0=^.T??;=8'=JL!N(;`;X^^SFQ+7,+=%LD5/-=@F/1U'2NR-'YLW>^?7^<C3
M3#[A1=Z)!GX+VTCCR!E]F&R:38WH(:22W=U3TH;_,QL*:A^/^W"VXY,:#8_=
M]8/,O[3X#U!+`P04````"`!F@_A&]9S'#<$!``!X!```&0```'AL+W=O<FMS
M:&5E=',O<VAE970T,"YX;6QM5-UNK"`0?A7B`Q07=[5GXYITVS3MQ4F:7O1<
MLSK^I"`6<.UY^P*ZUB@W`L/W,X,#Z2#DIZH!-/KFK%6GH-:Z.V*L\AHX57>B
M@];LE$)RJLU25EAU$FCA2)QA$H8QYK1I@RQUL3>9I:+7K&GA32+5<T[E_S,P
M,9R"77`+O#=5K6T`9RF>>47#H56-:)&$\A0\[([GV"(<X*.!02WFR.9^$>+3
M+EZ+4Q#:%(!!KJT"-<,5'H$Q*V2,OR;-7TM+7,YOZL^N6I/]A2IX%.Q?4^C:
M)!L&J("2]DR_B^$%IA(.5C`73+DORGNE!;]1`L3I]S@VK1N'<><^G&A^`ID(
M9$7`HY%+\XEJFJ52#$B.1]M1^P=W1V(.(K=!6[=)49D]B\C2:T82DN*K%9HP
MYR6&.,QN1F"C/EL0G\69;.C$3X^\&48+>C2Z)[%?8.\5V"\$]DX@^K.J<`LA
M2>3W.'@]#AN!^VCEL8609._WB+T>\=8C67EL(20YK#SPHC4XR,K=`(5RT;=Z
M[($Y.E^R!^):ZQ>>I1VMX"^55=,J=!':-*AKL5((#2:5\,[46YMG8%XP*+6=
M)F8NQYLQ+K3H;O=\?FRR'U!+`P04````"`!F@_A&RN_S<@8"```'!@``&0``
M`'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q]5-N.FS`0_17$!P0P"9"((&U2
M5>U#I=4^M,\.F02T-J:V$[9_7U\(R]+ION#;N<P,]I2#D*^J`=#!&V>=VH>-
MUOTNBE3=`*=J)7KHS,E%2$ZU6<IKI'H)].Q(G$4DCK.(T[8+J]+M/<NJ%#?-
MV@Z>9:!NG%/YYP!,#/LP"1\;+^VUT78CJLIHXIU;#IUJ11=(N.S#IV1WW%J$
M`_QL85"S>6!C/PGQ:A??S_LPMB$`@UI;!6J&.QR!,2MDC'^/FN^6ECB?/]2_
MNFQ-]">JX"C8K_:L&Q-L'`9GN-`;TR]B^`9C"ALK6`NFW#>H;TH+_J"$`:=O
M?FP[-P[^I(A'&DX@(X%,!%)\2DA'0OI.\)GZR%Q>7ZBF52G%$$C_+WIJ?WFR
M2TWE:KMI"V5R4N;,(JKR7I$\*Z.[%1HQASF&.$PR(2*C/ED0S.)`_J&3//]H
M<<0P!6Z2HGFD,X'4QYBN<8$U*K">":S'"+:+0B"8(L9--JC)!A%(%B8>TSG,
MYK-J9ZA%AE@07"!'!7)$(%W$B&'^4^T"-2D0@<W"!,-DN,D6-=DB`HN+=]C.
MJIWX!Y"0?+TBBPN*X9(B6RVSCF8/CX.\NH:D@EK<.NU?V+0[];PGXA[N.[PJ
M>WJ%'U1>VTX%)Z'-\W</^"*$!A-.O#*WI#%=>5HPN&@[S<U<^D;E%UKTC[8[
M]?[J+U!+`P04````"`!F@_A&!Y`<&T@"``"<!P``&0```'AL+W=O<FMS:&5E
M=',O<VAE970T,BYX;6R-55N/HR`4_BO&'U#O6AMK,O:2W8=-)O.P^TPMK69`
M7*#C[+]?4&J5,IV^"!R_RSD'`EE'Z#NK(.36)T8-6]L5Y^W*<5A900S8@K2P
M$7].A&+`Q9*>'=92"(X]"2/'=]W8P:!N[#SK8Z\TS\B%H[J!K]1B%XP!_5=`
M1+JU[=G7P%M]KK@,.'GFC+QCC6'#:M)8%)[6]HNWVJ<2T0-^U[!CD[DE<S\0
M\BX7/X]KVY4I0`1++A6`&#[@!B(DA83Q7Z5YLY3$Z?RJON^K%=D?`(,;@O[4
M1UZ)9%W;.L(3N"#^1KH?4)402<&2(-9_K?+".,%7BFUA\#F,==./W?`G=A7-
M3/`5P1\)HX^9$"A"\"PA5(3P1@@?$B)%B)YUB!4AUAR<H5E]J[>`@SRCI+/H
M<#Q:($^AMXK%9I8R*/=.M)F)?Q*19Q^YOUQFSH<44IABBO$5)IUC-@9,,(?L
M[B'>B'!$DF.FOBG3PK]W2%TM"P-FCM@:$*&6Y[<B^X<BLU("8].#"3]0I7S1
MB]`H$$X$0B6@);D9,$V/27I,$&O-N(=H#=U-$9XZ'TFXB+2&/!*:E1,9RXD,
MY01F@=@H$#_?T,0HD!@RT,Y%D1AZX;J++WR61I_E]QM7+*<^OJ'G,Y_4Z),:
M?+1-*]+[>D+A$VL^SN0JP9">^UN?626Y-'SH]A@='Y877UY%6GSCK;:>(;X3
M#]'P;MSD\ZP%9_@+T'/=,.M`N+@`^ROL1`B'(GMW(0Y-)9[*<8'@B<MI(N9T
M>#V&!2?M]2T<'^3\/U!+`P04````"`!F@_A&XU>@*B4"````!P``&0```'AL
M+W=O<FMS:&5E=',O<VAE970T,RYX;6R-54F/FS`4_BN(>\<+9HL(4B=1U1XJ
MC>;0GIW$"6@,IK8S3/]];4,H`TX[%[Q]RWNV>2YZ(5]4Q9@.WAK>JFU8:=UM
M`%#'BC54/8B.M6;E+&1#M1G*"U"=9/3D2`T'&,($-+1NP[)P<T^R+,15\[IE
M3S)0UZ:A\O<CXZ+?ABB\33S7ETK;"5`68.*=ZH:UJA9M(-EY&WY&FSUR$(?X
M4;->S?J!#?X@Q(L=?#MM0VAC8)P=M96@IGEE.\:Y53+.OT;1OYZ6.._?U+^X
M=$WX!ZK83O"?]4E7)EH8!B=VIE>NGT7_E8TYQ%;P*+ARW^!X55HT-TH8-/1M
M:.O6M?VPDI"1YB?@D8`G`OHW(1H)T4<)9"20!0$,J;B-V%--RT**/I##Z774
M7A*T(6:KCW;2[JS9!&76+*(L7DN<)P5XM4(CYG&.P0/F/6+G0>3I>\Q^C4GB
M"0),D%.DV!LIGO&CT0/Y!2*O0#03($X@768Z0%H'20</%).(H$4N:QQ*$XA)
M[H^'>.,AJWAP'OD%8J]`_/$=2;P"B2>";'&TR2I5@DD"H=\G]?JD'I]\X9/.
M?.+Q=.ZY9%Z7[+_GN\M6)@AGT3V;W&N3KVSF`H-/OO+YE)'\GH\M3+Y?$WJ<
MT/+/@VLK!.\ZW2D"R'-`\=()K6]"ZKD)8%9Z.GIAWZF\U*T*#D*;*N;JT%D(
MS8PF?#!7N#+/T33@[*QM-S5].13H8:!%=WMOID>O_`-02P,$%`````@`9H/X
M1L%G^5<1`P``#`T``!D```!X;"]W;W)K<VAE971S+W-H965T-#0N>&ULC5?+
MDJ(P%/T5B@^0)+PMI*JU'S.+J>KJQ<R:UJA4`W%(;'O^?A*(".'2LI$DG/N^
MYQJ2"ZL_^)%287V51<57]E&(T])Q^/9(RXPOV(E6\LV>U64FY+8^./Q4TVS7
M")6%0Q`*G#++*SM-FK/7.DW8611Y15]KBY_+,JO_K6G!+BL;V]>#M_QP%.K`
M21.GD]OE):UXSBJKION5_8"7+\15D`;Q.Z<7WEM;ROEWQC[4YN=N92/E`RWH
M5B@5F7Q\T@TM"J5)6OZKE=YL*L'^^JK]N0E7NO^><;IAQ9]\)X[26V1;.[K/
MSH5X8Y<?5,?@*X5;5O#FU]J>N6#E5<2VRNRK?>95\[RT;X)(B\$"1`N03J"S
M`PNX6L"=*^!I`>\FX'TKX&L!?ZZ%0`L$<RV$6B`T!)PVNTUM'C.1I4G-+E;=
M-M0I4WV+EZ&L_E8=JF++NG#Y3B'2Y#-U$4F<3Z5(8]9]#&DP)(J'F`V`<8>0
MIS$$=PA'.MEY2B!/UV1L(4:&%P!FB'@$$)[AYUTES_>5O$#>AG"X+E@8MZ?`
MU0HF\N6!"KR>`D\K,`+9M)BJP81M]0,C86.(D?2G/@*W/41";^$;2?M.T2`<
M'PS'!\)Q804!J""8G]`05!`"'AAE7X=`+A!:3-B)0#O1R(Z+#"Z]1*-D>OY$
M.F/02'R_.];QO<(.[*B)#PT8!(3CF=,#]4SY9B,.S4S,,0R8\4TS^+M^'YH!
MA]`#)H"9P)R7$&B"_!AF/W:!^D1&$VB0+E`[93SB+:9"@N<$'@\*%T43*F!N
M8G\^MS#,3AS,Z'H-&K3)5-MCF,1XS&*@@!`HGK`#DQ@#+,;(C"<:Q8.]*7K!
M/,80D4>-$H_LR*DT\><+TY@`-,93_]\P10F>WR4$IA\!F#7*J@;UH_7P1%8)
M3#\RAW[$'4T30LRL.KV+6$GK0W/)YM:6G2O19J$[[2[R#T1=Y(SS#5X^8N#\
M"2^?VVOZ37V:G+(#_975A[SBUCL3\OK87`#WC`DJ?4<+R=BC_#3I-@7="[4,
MY;IN+^OM1K#3]=NC^P!*_P-02P,$%`````@`9H/X1FKN=`=&`P``T`X``!D`
M``!X;"]W;W)K<VAE971S+W-H965T-#4N>&ULE9=-CYLP$(;_"N(>P&,^5P1I
MLU75'BJM>FC/;.(D:`&G0#;;?U\;V"R!UU)Z"=C,S#LV\^!,>I'-:WL4HK/>
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M79ZEC;Q8S;"WIUR_0O9`:B.V>E*O6Z78JF?:(DO?,LXH==]TH-%F,[6AWH9=
M+5P5_2I!2&)#"W?..`[`88Y\$H"/`7P<P(<!_$D`?PP0S!8YV-3#1@P[X<?<
MB;%.`'4"H!/.=(*ISKB;7DQ.A(5"*!0"H6@F%"Z%5A0Y`=:)H$X$=.*93@1T
M0I],.Q=#H1@()3.A&`AQ+S`))5`H60J1-Q-*ED)!XCF&DM/0([`\H&3@AAG8
M9/<7/H/L/3*ZH_1'HYL%^Y$3&I0PI(S?4?RCT8T2>8E#!BF,,T,\S\N?^4LI
M\SO$/#,$]+S^V93H8"A+%AB*DF&>&0)Z7O\,$>USQ_`M91AI!IA>$,``U$'@
M)`8ES#0#4)/I36-:67(_`80Y),#A@H#1Z&:]/(X<TSF'>25V!P*CT8U4'/BF
MRB3,-2&NYP@0X'K%$M,'DS#8A,">0T``[)4^/PTE0YAL0F3/.2!`]HK4%AJ.
M4,)P$X![`0*!XUHORU08&&\">),!6\+84O0?)&`>"1VR"Q+`*>LGQO5B;`F<
MLDL0P#'+C$H<T\T1W7,..*![%1N5,-P<P3W'@`.X5YX)`H[9YHCM.00<L1V9
MT.:&/]8`[04"_`;MX9]QP!;?*W?2<52B.?2-56MMY;GNAM;B.GMMWA[[%L?]
M-,_24WX0/_+F4-2M]2([U??TG<M>RDZH;#Q'`7E4[>5U4(I]IV\C==\,#=<P
MZ.3IHW^\-K'9/U!+`P04````"`!F@_A&IW;U*.X!``#7!0``&0```'AL+W=O
M<FMS:&5E=',O<VAE970T-BYX;6R-5,V.FS`8?!7$`V"P@4!$D+I457NHM-I#
M>W;`!+0VIK83MF]?&Q/*4F^5"_Z;&6:^3W8Q<?$J.T*4]\;H($]^I]1X!$#6
M'6%8!GPD@SYIN6!8Z:6X`#D*@IN9Q"B`89@"AOO!+XMY[UF4!;\JV@_D67CR
MRA@6OY\(Y=/)C_S[QDM_Z939`&4!5E[3,S+(G@^>(.W)_Q0=J]P@9L"/GDQR
M,_>,]S/GKV;QK3GYH;%`**F54<!ZN)&*4&J$](]_+9I_?VF(V_E=_<N<5KL_
M8TDJ3G_VC>JTV=#W&M+B*U4O?/I*E@B)$:PYE?/7JZ]2<7:G^![#;W;LAWF<
M[$D6+C0W`2X$N!*B^+\$M!#0C@"LLSG79ZQP60@^><+V8L2FY=$1Z<K59M,4
M2F>2^LP@RN)6(A@7X&:$%LS3%@-G#'R/J/Y%I,D*`=K`Z@(Z7<`-'RTN/A!`
M3@&T$8@7@707PV(&&]5F3?(PV*6M'+`X0T'FMA,[[<0..P>W0.(42!XO2.H4
M2!\H2+I-:ML6Q2C(=P5QP6`<I&X[!Z>=@\/.!Q7-G`+9XP7)G0+Y`P7)':V/
MTR#9%<0!0TD>P)T=L+F#([Z0[UA<^D%Z9Z[T=9XO9,NY(EHR#'3#._W*K@M*
M6F6F!ST7]N&Q"\7'^S.ZON7E'U!+`P04````"`!F@_A&;U&7W^L!``!B!0``
M&0```'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q]E-^2FR`8Q5_%\0$6!=$T
M8YQILM-I+SJSLQ?M-5&,SH*X0.+V[0MHK*ND-^'?.8??AX%\$/)--93JX(.S
M3AW"1NM^#X`J&\J)>A(][<Q*+20GV@SE!:A>4E(Y$V<`1E$*.&F[L,C=W(LL
M<G'5K.WHBPS4E7,B_QPI$\,AC,/[Q&M[:;2=`$4.9E_5<MJI5G2!I/4A_!KO
M3ZE5.,&OE@YJT0\L^UF(-SOX41W"R")01DMM$XAI;O1$&;-!9N/W*?/?EM:X
M[-_3O[EJ#?V9*'H2['=;Z<;`1F%0T9I<F7X5PW<ZE8!M8"F8<K]!>55:\+LE
M##CY&-NV<^TPKB1WF]\`)P.<#7'R7P.:#&AE`".9J^N9:%+D4@R!'+]%3^PG
MC_?(G%QI)^U!F9J46;.*(K\5"'[)P<T&39KC4@.=!GY6G+:*%,\28`!F"NBE
M@`L_&BE0Y`]`W@"T"$BF@'A5QJCIG"9SFCA#YN^\JL4C@SL4/<!)O#B)!V=U
M9L=DL0]V&ARGV0;')XOQ(QSLQ<$>'+3"P9M]X@SO-C@>69K`1SBI%R?UX"0K
MG'3S%78ISM!NA>.114D$X0H'+*Y#3R[T)Y&7ME/!66ASL]S=J(70U$1&3Z;$
MQCQX\X#16MMN9OIR?`/&@1;]_46;G]7B+U!+`P04````"`!F@_A&+]SL89X!
M``"R`P``&0```'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q]4]MNXR`4_!7$
M!P3;)-Y5Y%C:I*K:ATI5']IG8A_'*%Q<(''V[Q>PX[K9[+Z8`\P,,P=3]-H<
M;0O@T$4*93>X=:Y;$V*K%B2S"]V!\CN--I(Y/S4'8CL#K(XD*4B6)#F1C"M<
M%G'MU92%/CG!%;P:9$]2,O-["T+W&YSBZ\(;/[0N+)"R(!.OYA*4Y5HA`\T&
M_TK7.QH0$?#.H;>S&@7O>ZV/8?)<;W`2+("`R@4%YH<S[$"((.0/_APUOXX,
MQ'E]57^,:;W[/;.PT^*#UZ[U9A.,:FC82;@WW3_!&&$5!"LM;/RBZF2=EE<*
M1I)=AI&K./;#3IZ-M/N$;"1D$R%=_I=`1P*](9#!6<SUP!PK"Z-[9(:[Z%BX
M\G1-?>>JL!@:Y3-9OQ<097$N*5T5Y!R$1LQVCLDB)ON.V/V-R+]$B#<PN<CN
MNLAF?!KYZ?(?`O2N`)T)+,<8^4V,`:.&J&/6U>+G390[J'Q!;[R067L[=H`7
M9@Y<6;37SM]4['6CM0,OF"Q6&+7^`4T3`8T+Y0]?F^&?&B9.=]<7,CW3\@]0
M2P,$%`````@`9H/X1D:WBGCK!0``T"(``!D```!X;"]W;W)K<VAE971S+W-H
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MQ6`:AZM\5[9_)ZOWLLJS#Y/I)$M^GSZW^_;S>/H/46>&#61G(,\&YW&P@>H,
MU*>!_M)`=P9Z[`BF,S!C1Z#.@,8:V,[`.@:ST^RV:_.85,EB7N3'27':4(>D
MV;?BUM:KOVHN-HM=KTM9_Z]!+.:_%DK9^>Q7XZC#+"\QLL5(U8<\<H@X(V8U
M@3,+B5@L)1^A/\`#0&B'PZ"3IV$GSP`2.?,1<PP9'*V"<ZXN[-5I#"FQ`PT=
MZ`L'NENTT%FT$V;?8FR+L41"!8$S:R-Q,<#)P(H+7(^X@<0-(!XYQ,W%0*;%
MW"A%9!CSL<`8`84-R<>=('=BW*UQJ!,;2,M(VT@XS$?B8H`+9&@"BWE;R-NR
MW::T)_`0.@CYHCE9LPP9T:@N=@[J(61;2`@*)3FSPYV)T$:!DX5/W)NL5S34
M.+0(AA:!T)Q%6$:,CKL1OT+T2#1%$6EP`&A(5X0#,"V&9\4PKD_)4Q8$H*1<
M2H(-I80$E`9Q?4JP1MP+"2BY&[$#70Y5)TS(*0WB^I2PD`L%*+FBT('Z0PGB
ME`9Q?4JX-`A0&S2YE#0?R@:`TB"N3PF+O@"JKUF/P45:D@(+-XCK4\):+KB8
M*^U64,'E5Y@H`IR&@7U26*B%!:0BCPLLU2)D8N]M+0261`$TT03NU'#),UKQ
MYF(D+A[&]9M(K*,2Z"AK+R37QQL=J8AQ'PN,(3`4ULL>2ZX$DFO<8B2YE.I(
M<^Z7,.N#Q<`;^15'8EV60)<-:]\E(U1K@'<D++<2R*U1'A=8'J4>GR`2RYD$
M<F;8O0@">6X2)-8H"33*D,<%5A3)>S]_M%A1).C^>+0(Y&E2)98=B60GQ"X4
M3G\5C(]6X1Q4*`==\5.@G0D"P]5/\2R$P'B$QSY[G(D*9"+3/\4[GQNI(RDX
M_;'(&")51-X*J#PWQBC!70E4O$\R0DE.7['91[@8^*,@]':G"@N+`GV7\11O
MA85%F2OV+]8,A33#S58$(E^T6%@4:%7(<^*CL+"H*UH5A35#(<U@T2*01YLT
M%A8-^@KR'=A@8=%B?+0:9[=&==9-#LTST00:G/KP>NS@^I1POFJ0K^0IR-IS
ME'5%0=8X;S2JM:YH:W[?H&1$EL_,2&`,@6&@O7.(4U:#;&2BK?D=QDU]T\-O
MM<<"8P@,`N]YGL9"H($0\$UI^3U;)(A+=@]H_<`8>@P#__[%&J1!WT*>`R2-
M-4A'X_>OP?)B@+PP&4,@WZFSP1ID0'-#GH;28`TR\HIHL6885.-9M$A8/*)M
ML+`84)#)TU`:SVGU%079X.PVJ-9ZV@*#4\R`%+.NO!F>$-;4></.S'F&(5P,
M_"FA_:?].+\,R"]^WL_/>QEK?M;+"'_EI<\5)[(!?8+UM#2$$YFNN`$AG*.$
M<M2S7PCG*($^@>T7XGT":;Y=B+<)`!8/>NOSQL)`(.?99B'>K#/.@Y"X!W'W
M4Y\K%A?BXB(C3^-#6%SH"G$ASQ,I+BYU%>S'^DS$8M52^Y]]81$B)$(^ME@,
MZ(J&GW".$NKEW6Z#(A:P#(W@!WPC@"=2LXN'Z5E:O+4O2I235?Z^KTZAG*^>
M7\:XE\W#>.?Z4MP^"'#]4=P^G5ZU^'2_F!^2M_2OI'C;[LO)2UY5>=8^Q'_-
M\RJM^0??ZAVT29/U^<<N?:V:K[;^7IQ>N#C]J/+#Q_LCYY=8%O\#4$L#!!0`
M```(`&:#^$;5RVA$BP(``-L(```9````>&PO=V]R:W-H965T<R]S:&5E=#4P
M+GAM;(U6VW*C(!A^%<<'J'+RD#'.Y-"=W8N=Z?1B]YH8DCA528$TW;=?4&,,
MDC:YB(C?B1\$LS,7;_+`F/(^ZZJ1<_^@U'$6!+(XL)K*)WYDC7ZRXZ*F2M^*
M?2"/@M%M2ZJK`(9A%-2T;/P\:_M>1)[QDZK*AKT(3Y[JFHI_2U;Q\]P'_J7C
MM=P?E.D(\BP8>-NR9HTL>>,)MIO["S![!LA`6L2?DIWEJ.V9\!O.W\S-K^W<
M#TT&5K%"&0FJ+Q]LQ:K**&GG]U[TZFF(X_9%_4<[7!U_0R5;\>ION54'G3;T
MO2W;T5.E7OGY)^O'0(Q@P2O9_GO%22I>7RB^5]//[EHV[?7</8F2GN8FP)X`
M!\+@XR:@GH"N!/PE`?<$_*@#Z0G$<@BZL;>56U-%\TSPLR>ZZ3Y2LZK`C.BY
M*4RGF0I=-:F?&42>?>0H1EGP881ZS'*,@2T&6I#U%`(&1*`##"F@*\423AUN
M#58.!+8R?"OR_*7(34SD+!8:\5%?K#L"V"F`1P*X%R!6M3M,TV+B+F0*20BL
M@CA@44*@!5M/823&*+$K,X5A'*6(N`='G(,CCL%%5APR\B$=)@WUS^T3.7VB
MR2Q`&+D%8J=`[`@:6T'C25`01R'$J=LH<1HE$R.86#[)Q`>#>^5(G2:I8S26
MRS*=+A9`,,+V:DDG:6S<32"S!;OVE-`1Z4[AP)UM"3S^J@'GGK(`\/N7;=V#
M;A9D@NY-`'!O"P`]L/)[T'@.4.A8^L%HYZZ9V+=GIO0*?FI45XJA=SB7%]#L
M_%;_$LQ6P-&_-N=X>U)<Y?/L2/?L-Q7[LI'>ABM]WK0GQHYSQ73\\$F_N0?]
MI3'<5&RG3#/6;=&=O=V-XL?+I\3P/9/_!U!+`P04````"`!F@_A&6^/]N=8%
M``!9)P``&0```'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6R56MN2HD@0_17#
M#U#J7DRH$=OM3.\^;,3$/.P^TRW=&J/B`MW._OV"TJY5=0J2%Z\GDT,6>3@D
M+,Y%^;/:YGD]^778'ZOE=%O7IR_S>?6RS0]9-2M.^;'YY[4H#UG=?"W?YM6I
MS+/-)>BPG_,DT?-#MCM.5XO+;]_+U:)XK_>[8_Z]G%3OAT-6_ON0[XOS<LJF
MGS_\V+UMZ_:'^6HQO\5M=H?\6.V*XZ3,7Y?3W]B7)RM:R`7QURX_5W>?)RWY
MYZ+XV7[Y8[.<)BV'?)^_U&V*K'G[R!_S_;[-U&SYGR[I_]ML`^\_?V;_=MG=
MAOYS5N6/Q?[OW:;>-FR3Z623OV;O^_I'<?X][_9!M0E?BGUU>9V\O%=U<?@,
MF4X.V:_K^^YX>3]?_[%)%X8#>!?`;P%,]@:(+D!0`V07(*D!J@M0U`#=!6AJ
M@.D"C!<POU;WLC;KK,Y6B[(X3\KK`77*VN.6?3'-ZK^T/[:+W:Q+U?S7(E:+
MCY6PR6+^T2;J,`_W&'[!<!?Q&"*$92YF'6*T<B%?P8:D"_F&MN2Q>4(8<</,
MFWK<BL)A4?A=`M$ED#B!@`G$70+9)?!V]N&*.5XKWY6>63OS]G@-<)PQ-F.8
MD(2$)""D<0(%$RAZ231,H`$#XY5$W^VJNF!2XY?C'L.NJVN8GD76UT`N!G"Q
M'A<3;D?//-`:@E),Q4(J%E!)/2HVW`I+DIEW0*T!S/"9P6Q2R"8-V:2^&J3A
M9F0R\Y9R#5`B6IKV9(&T*0GI2'^=.I#+1[`DZ",$Y*D445(1P61A)Z217F18
M7A@G+'H'<NF:H,X(IF:1SF18K1B0JY3[?`2H<ZIFVC\5`+V2F@6M@_)QIORC
M^BO*QTTZ8_Z)`>*4CWN".)M$CP*LIPP(:GAH2K`V7-QI55<*@.,\3@DK-%-@
M%2.RR+!&,TU7>8:EE2%M]4]]#.@F8ZGU%VOM`%6G?#JV4UAA&9#8-+936!99
M2J\+QUK&@98%=>%`HIAII-X_8A#0RO2NR5Q.6,HX`Y51D101IS3"*G&L/IQB
MEK@(#@3NGYG6'$A*>U3%O!]N;0Y:.XUX)8Y;D8]P2QRW(J?X)1X:IJ`F?1"7
M"&YH3C%+G.26,"JB<AQW,Z<8)FZ'Z]('<8E@3>`4K\3382)]$/=2`RN+H+@D
M`00C7"",BBR0P*(B1O@C@45%4/R1X(.E[86X1"*7<11C)$)I"HCT05PB6),$
MQ6X(.4RD#^(2P<HFD,F(7&((K&QBA,D06),$Q62(T#L$Y>B#N$2P&@GD+2(G
M88%U1(SP%A(K@*1X"YD,EJ,7XA+!O2^1H8C(A\2]+T<8"HF[5E(,A1SNVEZ(
M2R0R=`F[5B:Q%+C?Y`@G(7&_28J3D)31BQPW>Y&X>27%4,CAYNV%N$1P\TJ*
ME9#$X0O"Q:<O$FN!I'@*21O`(%A\`J.PLBB*MU!P`I,(?S2P5J&^\%1$2J2P
MQ*@1]D)AB5$4>Z%HXQ<$BXY?%-8K17$9:EBO>B$N$:Q7BN(R%!I6@,*@V4>T
M,)&9<V@V9!);:RQ^:H394%BO%,5L*.I$0XV9:"@L7"H4+IGP2`JL-&J$Z]!8
M&S3%=6CJ1`,!>R8:&JN##@V(3"+%U5@=]`@#HG%#:XH!T92)A@,:GFAHW-<:
M^9#8+N%6U&/N_T1N`)'N``U/-'HA+A'<T)IB0/2P`>F%N$1P'VN*`='#LXQ>
MB$L$JX&F^`X]/,OHA;CWY;"F&(K?,,-7,KT0EP@6$C/"9A@L)(9B,\SP%*,7
MXA+!<F0H_L+0;N^L$<Z];>-2PHID*$[#``L!*2%'TD,)*YQ!9B.6`BN<&6$V
M3.3.-,5LF&%MZH6X1+`V&>0Q(E-P@U7%C/`8%NN!I7@,.ZP'O1"7"-8#BXQ%
MY,K%8CVP(XR%Q9UL*<;"WG>HP>7H@UR)S.\>(#IE;_F?6?FV.U:3YZ*NB\.R
M?9KHM2CJO$G77`Q/)]L\V]R^[//7NOW8]E1Y??+K^J4N3LON0;;;TW2K_P!0
M2P,$%`````@`9H/X1I'.O<,S`@``AP<``!D```!X;"]W;W)K<VAE971S+W-H
M965T-3(N>&ULC57;CILP%/P5Q`=@;&Y)1)"Z5*OVH=)J']IGAS@!K<&L[83M
MW]<&0EDX6>4%WV;&<WSP<=H)^:9*QK3S4?-&[=U2ZW:'D"I*5E/EB98U9N4D
M9$VU&<HS4JUD]-B3:HZ([\>HIE7C9FD_]R*S5%PTKQKV(AUUJ6LJ_SXQ+KJ]
MB]W;Q&MU+K6=0%F*)MZQJEFC*M$XDIWV[C>\RS&QD![QNV*=FO4=:_X@Q)L=
M_#SN7=]Z8)P5VDI0TUQ9SCBW2F;G]U'T_YZ6.._?U)_[<(W]`U4L%_Q/==2E
M<>N[SI&=Z(7K5]']8&,,D14L!%?]URDN2HOZ1G&=FGX,;=7T;3>LQ/Y(@PED
M))")@,,O"<%("!8$-#CKX_I.-<U2*3I'#LEHJ<TYW@7FY`H[:0_*Q*3,FD5D
MZ34+_4V*KE9HQ#S-,:3'D,^(?(V(HPF"C(')!0%=D!D_&%UL88$`%`AF`N$@
M@/U%&`.F&4(=8HV2K1<M8H%@F\@CL)T0M!,"=O#"3CC?9SRT`*_L0+`PN6<G
M`NU$@)T[`C$H$#^>GP042``'P>)`DEFD48]9IC!/UH>!B1?#3C:@D\T#?\IF
MO<W6"Q=>`!#&7@)[V8)>MH"7$!:PM0BZOO[CF<%W*@!^(#<CZ/-O2-9_*X@+
MPGLIPG`YP.2!)(V@Q7WV/;RT!.(";UF@T*QDMO3,?E%YKAKE'(0VU;>OGR<A
M-#.:OF=N5&E>Q6G`V4G;;F+Z<G@GAH$6[>W9F][>[!]02P,$%`````@`9H/X
M1O,Q*CF6`@``4@D``!D```!X;"]W;W)K<VAE971S+W-H965T-3,N>&ULC59=
M<Z,@%/TKCN^M@*(Q8YQI/G9V'W:FTX?M,TU(XE0E"Z3I_OL%--8`3?(2`<\Y
M]YX+YE*<&'\7>TIE\-G4K9B%>RD/TR@2ZSUMB'AD!]JJ-UO&&R+5E.\B<>"4
M;`RIJ2,$0!HUI&K#LC!KS[PLV%'654N?>2".34/XOSFMV6D6PO"\\%+M]E(O
M1&41#;Q-U=!65*P-.-W.PB<X74&@(0;QIZ(G,1H'.ODWQM[UY-=F%@*=`ZWI
M6FH)HAX?=$'K6BNIR'][T:^8FC@>G]5_&+LJ_3<BZ(+5K]5&[E6V(`PV=$N.
MM7QAIY^T]X"UX)K5POP&ZZ.0K#E3PJ`AG]VS:LWSU+U)84_S$U!/0`-AB.,G
MQ#TA_B(D5PE)3TCNC8![`K8B1)UW4[DED:0L.#L%O-ON`]&G"DZQVINU7M1;
MH:HFU#N-*(N/,H&XB#ZT4(^9CS'(8%!\"5FZ$#@@(I7`D`7R93%';H3+``L/
M(K%RN"FRNBIRD6;L+58\XL=]L5*_0.(52$8"22^06=7N,*W!9`83IP``JQXN
MRD(L703*$FP+K:X)73C"7D?8XVAB.<*C$-A@'A`"T'+DHA(`<\N4"\)I8AW&
ME0N*53R_J]3K*O6XLE*9ITX4>X]N(I8W$2L7\8#'I^'"3.8UDSEFXLDWIW;B
M%9C<?^QSKT#NEA-91N>YN_TIG#CGWH6A#$,;MO3`('8/OP<V`?EWY=4=Q_<7
M"CSVH/T?"ISO+,EQZOCSX%"6NP;OU%O=UNLL1J.&T5"^,ZU:!&MV;&6WZ\/J
M<!UX0KKA6.MS.%U`S_I27Q],@_J2+XL#V='?A.^J5@1O3*HV9QK5EC%)5?K@
M47W+>W7!&28UW4H]S-28=RV_FTAV.-]@AFM4^1]02P,$%`````@`9H/X1AKO
M?>36`@``0`L``!D```!X;"]W;W)K<VAE971S+W-H965T-30N>&ULE5;1<J(P
M%/T5A@\0$B"@@\Q4:^L^[$RG#[O/J49E"L0EL7;_?A-`"LG5NB\"X9Q[3G*O
MEYN>>?TN#HQ)Y[,L*C%W#U(>9YXG-@=64C'A1U:I-SM>EU2JQWKOB6/-Z+8A
ME86'?9]X)<TK-TN;M9<Z2_E)%GG%7FI'G,J2UG\7K.#GN8O<R\)KOC](O>!E
MJ=?SMGG)*I'SRJG9;NX^H-D:$0UI$+]R=A:#>T>;?^/\73_\V,Y=7WM@!=M(
M'8*JRP=;LJ+0D93RGR[HEZ8F#N\OT9^:[2K[;U2P)2]^YUMY4&Y]U]FR'3T5
M\I6?UZS;0Z0#;G@AFE]G<Q*2EQ>*ZY3TL[WF57,]MV\(Z6@P`7<$W!-Z'9@0
M=(3@7D+8$<(O0GB3$'6$Z%X%TA'(O0IQ1XCO)20=(3$(7IN.)IF/5-(LK?G9
MJ=L*/%)=Z&B6J'+9Z$5='2J10KW3B"S]R$*,4^]#!^HPBR$&-QB<3,>8)8`)
MQI"5#4$]PE,F>Z<8<KK`ML+4-UP`F#'B$4"$AL]O@SQ]'^09<AN/,6L;0R+X
M1`(P=\&`'[2Y0P0.$((!PD&`L$N^F;464S68N,'XL$0$2D2`A'G@T4`BNB5!
M0`EB2013(V-+,I!`;9T'/IX8L-5]L#6QSD1]"V#+,6@YMBQCRW)LB03$*&8;
M8OPA5K&](1R'D\@HZ%N!1MM)P.TD=I)1"`>8@@&F]U>R_A)!?<P'"BTRFQ0$
M(F:;N@T:F[G25!&0W^!*"+#;/2#\'T<"MP<4?%]EBPYTHT+&4G`C078G"7RC
MDSPCNY6$T94Z0W`W078["7QB;@D"Q5=TX):"[)Z"IXFY'Z!;J.8V,;/D#;[%
M):OWS6`FG`T_5;+-;;_:#W\/6'_+C?4EFCTB8'V%9D_M:/<5/DN/=,]^TGJ?
M5\)YXU)-$,T,L.-<,F7?GZAC.JAQMG\HV$[JVUC=U^V`USY(?KS,J_W0G/T#
M4$L#!!0````(`&:#^$8V51$/300``+D8```9````>&PO=V]R:W-H965T<R]S
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M3_KKFL/`Y?O/V;^.M]O;?\U:N:N+?_)#=^K=!JYSD,?LO>B^UY<_Y'P/X3#A
MOB[:\5]G_]YV=?DYQ'7*[.?TFE?CZV7Z)8SF87@`S0/H.H")FP/X/(`K`_S)
MV7A?7[(NVVZ:^N(TTV:<LV'/V1/O5VX_?#DL5']/;?_;H-AN/K:"XHW_,4PT
M:UZ6&AHUM%;L=$447B5^;^#J@J`+6HSGLXL$3\#A!'PQ@9@G2)7;F#35=*O3
MO7*6))Y0;@;HB#'F,6Q(0$-"-\0#Q9!87FA:-N8IB[\#HF`A6ED)H9406&&*
ME5"_RF_,2Q0O2$6+]5N9B:"9")A1TO02Z9<9-RI4[`!=OU'D&9(30T,Q,,3Q
M!`F<(+'/;@HG2"VRFX(EB4-/D>V@+##MT,`WA(3`(KNS2,DE4[FP5(63R.#%
M@"=F$=Y9M,XE,(-E9#"$2<7((L"SZ.YV85W@109+F'T,P(^;MAS3B@G[$#-,
M&08PH\68`8(D1)YVG@!=E))Q83!K&(*-%F1`D4`[$[#*%!U,&H90HV4YAB36
M%@C+#(<NP^1BB4V6$^V_<$)<M9.@_>*+P*_]8!`R0$)NJB,PNRBP#S)AY!!`
MCA9D`BR)6:`=44A'46I:&#*41P@Z:I`)P$2'X$IUD\B$:4.(-FJ*B5L1^:YL
M;0BSBU"II::80!D%]TMHRT.Q:8$P"`G56P9P$08710^D&,.&`&ST%`.*I$FJ
MU7U(%\;F%&/<$,*-EF)`DD`[.+'*4+81I@TAVFA!!A45"C*6&0YACMG%4=VE
M!IGK%56_8VH'HXO"Q)!BCBG(4>%E:#LXIA9_I*LSM'56?1V@2*"=F/=4:SL8
M-=RFJ^,Z0@+5RRW)V@AF#+?IZ7AXW\@MR=H()A6WZ>?XG>)I]O)(B<4Q]3@J
ML4R1PY3B#_1S').%VW1T'""#`'N1CJ6)\6D$9HNPZ>D$[.G4?;JG6MO!=!$V
M;9W`_9I:>QID)D.85<*FK1.@PAJV3,4OTMW:,LP^@0HMPXDK#`^A'FCK!":-
ML&GK!&K7M"1CE>F.,&^$34LG`$F8=F9CE2DVF#?"IJ43\5T."]3.F3.,R25L
MVCFQJIRFIYNA_M`1JM2M\A</F<_9F_PK:][RJG5>ZZZKR_&)\[&N.]G/V%?:
MKG.2V>'ZH9#';G@;]^^;Z<GZ]*&KSY]_*+C^M6+[/U!+`P04````"`!F@_A&
MD++TZD$"``#Z!P``&0```'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6R55=N.
MFS`4_!7$!V`;S"4K@M1-5;4/E5;[T#X[B1/0&DQM)VS_OK8AE`53T1=\FS/,
M&3C'><?%FRPI5=Y[S1JY]TNEVB<`Y*FD-9$!;VFC3RY<U$3II;@"V0I*SC:H
M9B"$,`$UJ1J_R.W>BRAR?E.L:NB+\.2MKHGX_4P9[_8^\A\;K]6U5&8#%#D8
MX\Y531M9\<83]++W/Z&G`XH-Q")^5+23D[EGQ!\Y?S.+;^>]#XT&RNA)&0JB
MASL]4,8,DW[SKX'T[SM-X'3^8/]BT]7RCT32`V<_J[,JM5KH>V=Z(3>F7GGW
ME0XY6(4GSJ1]>J>;5+Q^A/A>3=[[L6KLV/4G&1S"W`'A$!".`0C_,R`:`J)9
M`.B5V;P^$T6*7/#.$_W':(GYYN@ITLZ=S*8Q2N<D]9E!%/F]P!CFX&Z(!LSS
M%!-:3/@1<5@BDGB$`"U@5!$Z5823^&A0@=P$D9,@FA!@2Q!EZ2R-'M-83&HQ
MNQ3/$IEB4.]'BI(@<FO!3BUXH07CT$T0.PGB[6XD3H)D@QO)---P``79S`\'
M*L;!2C:I4TSJL&/%S\Q)D&VW8^<DV&VP8S=)-+88E,4S,Y:8"*[\YJ9UN*H-
M.LS`*Q0K!8NVVX'<U8;"#88,H`^?/L4P6)2^`Q>%:.T?0>[Z1<L"QGC-6W?9
M(?P?QK@+#\5;C(D7?03!N2GQLH]$<;";J0&3+MV2*_U.Q+5JI'?D2C=\V[(O
MG"NJ*6&@*4M]$8\+1B_*3%,]%_W5U"\4;Q\W[7C=%W\`4$L#!!0````(`&:#
M^$88`8*<0`(``*T'```9````>&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;(V5
MVXZ;,!"&7P7Q`("-.44$J4E5M1>55GO17CO$"6@!4]L)V[>O#82R9E+U)C[]
M__@;FXSS@8LW63&FG/>VZ>3>K93J=[XORXJU5'J\9YU>N7#14J6'XNK+7C!Z
M'DUMX^,@B/V6UIU;Y./<BRAR?E--W;$7X<A;VU+Q^\`:/NQ=Y#XF7NMKI<R$
M7^3^XCO7+>MDS3M'L,O>_81V1Q08R:CX4;-!KOJ.@3]Q_F8&W\Y[-S`,K&&E
M,B&H;N[LR)K&1-([_YJ#_MW3&-?]1_0O8[H:_T0E._+F9WU6E:8-7.?,+O36
MJ%<^?&5S#I$)6/)&CK].>9.*MP^+Z[3T?6KK;FR':25^V&`#G@UX,2#R3T,X
M&T++X$]D8UZ?J:)%+OC@B.DR>FKN'.U"?7*EF30'I7.2>LTHBOQ>$!+G_MT$
MFC6'M0:/&OQ1<=PJXFB1^!I@H<`@!5[YPYDB@0.$8(!P%8#,`5(KC4G33:E.
MN:(@C3TKW2.@BTG@/4F(@#P$X,DL'K+>!S_G`72&)X5Y(I`GVO)$@<43`3Q9
M1#QB\4"ZD(3>DPN+0:`8`$(64/P$*+*`(%U((@_#0`D(E`!`UF=^2("-2+(Y
M($B&8R^#<5(0)P5P0@LG_3\<2*9QGGP_&8B3`3C6/H=LNT^(TG3#`^@P0LA#
M,)"IPE#A"@"DR*Y<P?:_/#+9GQ`DU%!X<TK^JK#V],J^4W&M.^F<N-(U>JRR
M%\X5TT%UR7"=2K^=RZ!A%V6ZB>Z+Z369!HKWC\=Q>:&+/U!+`P04````"`!F
M@_A&>CXJP$$"```>!P``&0```'AL+W=O<FMS:&5E=',O<VAE970U."YX;6R-
ME5V3FR`4AO^*XWT713&;C'%F\]%I+SJSLQ?=:V)(=!;$`EFW_[Z`QABAV]Y$
M.#[O.><%`WG'Q9NL"%'!!Z.-7(>54NT*`%E6A&'YP%O2Z#<G+AA6>BK.0+:"
MX*,5,0I@%&6`X;H)B]S&GD61\XNB=4.>12`OC&'Q>T,H[]9A'%X#+_6Y4B8`
MBAR,NF/-2"-KW@2"G-;A4[S:9X:PP,^:='(R#DSO!\[?S.3[<1U&I@5"2:E,
M!JP?[V1+*#6)=.%?0\Y;22.<CJ_9OUJWNOL#EF3+Z6M]5)5N-@J#(SGA"U4O
MO/M&!@O()"PYE?8W*"]2<7:5A`'#'_VS;NRSZ]^@Y2#S"^`@@*-@K.,7)(,@
MN0G23P7I($C_MP(:!&A6`?3>[<KML,)%+G@7B'ZW6VP^JGB%]-Z4)FBV0J^:
MU.\,4>3O18JR'+R;1`.SF3+0,C"Y1W8N$H\$T`V,74!?%QOH5K@OL/40Z:R'
M?R;9?YKDKLW$NUC)1)_T+M%?$J3>!.DD03JL]F*VVCW36&9AF2R*EU$T6Q`7
M0YJ;8SL76RX0BF=%]RX6)_$"0>1WA[SND,?=X\P=FA1"EDD<:RX#'5\N@^;,
MWF72"7-G*/,:RCR&EC-#F;-R7YQ.MA[(W2H/].AX\D#0,04F_WY&Q-F>NS(H
M^:51_9<[1L>C_0F:TV,6W\2K;>R)[_15T)_<M_1%WN(S^8'%N6YD<.!*GUGV
MU#EQKHCN/7K0&U+IRVJ<4')29KC08]&?W_U$\?9Z&XU78O$'4$L#!!0````(
M`&:#^$8^F,@&X`$``#L%```9````>&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM
M;'U4VV[C(!#]%>0/*+ZG&SF6FE2KW8>5JCYTGXD]OJA@O(#C[M\7L..X#NJ+
M@>&<,V?&0#9R\2X;`(4^&.WDP6N4ZO<8RZ(!1N0#[Z'3.Q47C"B]%#66O0!2
M6A*C./3]%#/2=EZ>V=B+R#,^*-IV\"*0'!@CXO\1*!\/7N!=`Z]MW2@3P'F&
M%U[9,NADRSLDH#IX3\'^E!J$!;RU,,K5'!GO9\[?S>)W>?!\8P$H%,HH$#U<
MX`24&B&=^-^L>4MIB.OY5?VGK5:[/Q,))T[_MJ5JM%G?0R549*#JE8^_8"XA
M,8(%I])^43%(Q=F5XB%&/J:Q[>PX3CN[8*:Y">%,"!="\/@M(9H)T8U@6X<G
M9[:N9Z)(G@D^(C']BYZ87Q[L(]VYP@1-HW1-4N\91)Y=\CCU,WPQ0C/FN,:$
M%A-\19SN$7%ZPV#M8+$1NFP<PSN!<)/B'I$F[@R1L]!HQ8^F(I+8+1`[!>*5
M0#S7N#%Y=&$B=Y+$F21Q",2;)"Y,LNF6"Y.ZC:1.(ZE#8+<QXL(\;HRX,#\V
M1O#JL#(0M;W$$A5\Z-1T*I?H\DX\A?:PW^!YUI,:_A!1MYU$9Z[TE;&'ON)<
M@;;B/^BF-/HE6Q84*F6F.ST7T^6>%HKWUZ=J>2_S3U!+`P04````"`!F@_A&
M#XHST:@!``#T`P``&0```'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q]4\MN
MVS`0_!6"'V#JY3@U9`&U@R`]%`AR:,^TM+*(\*&0M)7\??B05<55>Q&YRYGA
M[*Y8#DJ_F@[`HG?!I=GASMI^2XBI.Q#4K%0/TIVT2@MJ7:A/Q/0::!-(@I,L
M2>Z(H$SBJ@RY9UV5ZFPYD_"LD3D+0?7''K@:=CC%U\0+.W76)TA5DHG7,`'2
M,"61AG:'OZ?;0^$1`?"+P6!F>^2]'Y5Z]<&/9H<3;P$XU-8K4+=<X`"<>R%W
M\=NH^>=*3YSOK^J/H5KG_D@-'!3_S1K;.;,)1@VT],SMBQJ>8"QA[05KQ4WX
MHOILK!)7"D:"OL>5R;`.\>0^&6G+A&PD9!,A+?Y+R$="?D,@T5FHZX%:6I5:
M#4C'6?34CSS=YJYSM4_Z1KF:C#OSB*J\5,4F*<G%"XV8_1R3!4SV%7'X&W&W
MGB#$&9A<9(LNLAF_&%VDRP+YHD`^$\BCQ6__$"@6!8H%!S=5[B-&QEZ-S5JO
M\IM>+*$VJ_L;,V0VH)Z>X"?5)R8-.BKK9AVFU2IEP2DFJS5&G7N"4\"AM7Z[
M<7L=_\H86-5?W]CTT*M/4$L#!!0````(`&:#^$;-`]D4RP0``)0:```9````
M>&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;)59R9*C.!#]%<+W`K2Q.%R.*"_$
MS&$B.OHP<Z9L>8EF\0`N]_S]L)4-TE,5]L$&_#*5^5`^*6%QRXM?Y4G*ROJ=
M)EGY.CM5U67N..7N)-.XM/.+S.I_#GF1QE5]6AR=\E+(>-\:I8E#7==STOB<
MS9:+]MJ/8KG(KU5RSN2/PBJO:1H7_ZUDDM]>9V3V>>'G^7BJF@O.<N'<[?;G
M5&;E.<^L0AY>9V]D'@G60%K$WV=Y*P?'5A/\>Y[_:D[^W+_.W"8&F<A=U;B(
MZY\/N99)TGBJ1_ZW=_H8LS$<'G]ZC]ITZ_#?XU*N\^2?\[XZU=&Z,VLO#_$U
MJ7[FMS]DGX-H'.[RI&R_K=VUK/+TTV1FI?'O[O><M;^W[I_`[<VP`>T-Z-W@
M/@XV8+T!>QCP+PUX;\"GCB!Z`S%U!*\W\!X&7DM^1U9+]2:NXN6BR&]6T<V/
M2]Q,0S+WZINY:RXV]ZZFN:S_:Q#+Q<>2^VSA?#2.>LQJB*$MABJ0C0XA8T2D
M([CWP#AUD/=(*8IT1?4HQD.L`8(K<7[K9/N]DTB'>`)GPB#G;&#/>LXY=L"A
M`SYPP'L'0LD483PED:\QHT`$#$0`![X2",($2B``XX4X$`\&XH%!0F4:=YBL
MF^K=7/>8K<S3S214!%`^M=UP^,'Q^S!^7X\_<)7(`&9`Y&B0``X2@$&4Q%;!
M,+&^DIFM3)QUH*=/;;76`(C9RDW90I`AJQ!F%8*L*';0K#%(`]WI!4D,,DI`
M%)J.DD&RHN-6$+5>)J&B$>I^HUQJ,T/<4%3?"`5QFU+':D:>D#."]8P`(=+9
MXWK&W->GW41<A'#,$[9I[F`%)$"Z`L-J0+!V$4\G,##(,,'R09!^^"J!OIYP
M2.U`Y6\2+$(P+[1-J6-%(DB2#-5/</F3<#I[%-<_=2>PUX-&^?JV6KR34!%"
M$5/E4JPX%"F.8<VAN/@I?8(Z7/R4?4]=U(.4=$VQ8HF@0")"U^`"ERH53Z2+
M2Y6"?4:H+J'4`P5D!^[PH^XZGK,9AXHE@0))"`W:1G%UTN`)PG!U4K`ZZX2%
M>O*N7EI34!%""=NP'#&L!PSH06BH3H:KDY'IU#%<G0PLS1IU/6A<6KZM-#6;
M;V'C@`QM"ZCUT,0LKF+&=5I,>P6&JYB!!3<4*BT"[`%<=0NP1K`7H;,'8'X]
MJ;XHZ.W(IMO%O1"#7C$L-@R)C6D.81%@_A-\8Q%@8(D.U<61H;9!Y7$]0OD]
M)RK7P!-3;]R6@;;AA1CG,]8FAK3)L/G@6"GX$YT#QTK!IW0.'.WV.=,+?2HP
M@D#B<]LPP3@6*8Y$RK"R<RPK_)G'(8;G(5/Z!X[V^U3K_Z?!(@03WF`Y&L>-
MM8SK6B9<@TAP+!(<-`]&]K!(<-0\:.R![3XE:CN_F0:+$(QQ4_/`L3)Q79F$
M:9/$L01PT#R8V!-8`@1J'E3V!-KP"UM]9C<-%D&89ZI<@75'Z+HC7(.`"ES\
M`O0/1O9P\0O4/VCL,5WMB6NKSZ"GP2(("[5VQ!D\04]E<6Q?=I36+K]F59?M
M_>K]A<H;;9[`*]=79+XFX/J&S+?=ZY*'^^7B$A_E7W%Q/&>E]9Y759ZV3^X/
M>5[).GK7KB7C)./]_221AZHY].OCHGMITIU4^>7S'=#]1=3R?U!+`P04````
M"`!F@_A&M2<@ZXD"```^"0``&0```'AL+W=O<FMS:&5E=',O<VAE970V,BYX
M;6R-5LN.FS`4_17$OL/[%1&D2:!J%Y5&LVC7#G$"&L#4=L+T[VL;0HCM2;()
MMCGGW'NN<:[3`>$/4D%(C<^VZ<C:K"CM5Y9%R@JV@+R@'G;LS0'A%E`VQ4>+
M]!B"O2"UC>7:=FBUH.[,+!5K;SA+T8DV=0??L$%.;0OPOPULT+`V'?.R\%X?
M*\H7K"RU9MZ^;F%':M09&![6YJNS*A*.$(#?-1S(8FSPW'<(??#)S_W:M'D*
ML($EY0J`/<YP"YN&"['`?R?-:TA.7(XOZM^%6Y;]#A"X1<V?>D\KEJQM&GMX
M`*>&OJ/A!YPL!%RP1`T1OT9Y(A2U%XIIM.!S?-:=>`[CF\B>:'J".Q'<F3#'
MT1.\B>!="?Y=@C\1_&<C!!,AD")8HW=1N1Q0D*48#08>=[L'_*-R5@';FY(O
M\JU@52/L'4=DZ3D+;"^USEQHPFR6&%=@7`F2JQ!G1E@L@3D+5Y?%QE4CW`;8
M:A"^E,-#D>*NR$V:GK98WH+O3<7Z0L#7"O@+`7\2"*1JCYA.8*(QR<BVI7*H
M(-^70;D*8GLK@0H5%"Z$;CP%6D^!QE,H>0H600*!^>;Z@2.94E%QZ$I2N4;*
MCYU8<J61\I)8;RO4V@HUMB+)5JA$D??I(2)_B"A4!-OJ+[8HTGJ)-%ZDBFTC
MM:Z)(W]2Q2/433*Q-IE8DTPB%396PKC*$5`Q<FF?4"GNJ=R82;1F$M6,(X78
M).I9=>5/7\5XB7*>GQ`J'@B-EJQ%=V@A/HJ^3(P2G3HZ_K/-JW/K?W5Y=Y'6
M-\YJZVC6<W95&#O[53Y+>W"$OP`^UATQ=HBRGB:ZT@$A"EGN]@L[M16[S,R3
M!AXH'T9LC,?^/DXHZB^WE?G*E/T'4$L#!!0````(`&:#^$:S"H(;&`(```D&
M```9````>&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;'54VXZ;,!#]%<0'!&-N
M2420-JRJ]J'2:A_:9X=,`EH;L[83MG]?VQ!"P<U#L,?G,N/+Y#T7'[(&4-X7
MHZT\^+52W3X(9%4#(W+#.VCURH4+1I2>BFL@.P'D;$F,!ABA-&"D:?TBM[$W
M4>3\IFC3PIOPY(TQ(OX<@?+^X(?^(_#>7&ME`D&1!Q/OW#!H9<-;3\#EX+^$
M^W)K$!;PJX%>SL:>R?W$^8>9_#@??&12``J5,@I$?^Y0`J5&2!M_CII/2T.<
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MUJKA&D_1J;N]8/-$%_&C[GI#DWK*%'E'KO"3B&O32N_$E6X`]@E?.%>@LT0;
M?4UJW9>G"86+,L-,C\70JH:)XMVC\4[=O_@+4$L#!!0````(`&:#^$;A_B_H
M+@0``.,5```9````>&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;)582W.C.!C\
M*Y3O'I#$T^6X*G[N'K9J:@Z[9V++CQI`7L#Q[+]?!-@!?4W"7,+#_;5:$MU2
M-+^K_&=QEK*T?J5)5KQ,SF5YG=EVL3_+-"Z^J:O,JE^.*D_CLGK,3W9QS65\
MJ(O2Q.:.X]MI?,DFBWG][GN^F*M;F5PR^3VWBEN:QOE_2YFH^\N$31XO?EQ.
MYU*_L!=S^UEWN*0R*RXJLW)Y?)F\LME.U)`:\?=%WHO.O:7%ORGU4S_\>7B9
M.%J#3.2^U!1Q=7F7*YDDFJEJ^=^6]*--7=B]?[!OZ^Y6\M_B0JY4\L_E4)XK
MM<[$.LAC?$O*'^K^AVS[X&G"O4J*^J^UOQ6E2A\E$RN-?S772U9?[\TOH=.6
MX0+>%O!GP;,=7"#:`O%1X'Y:X+8%[M@6O+;`&]N"WQ;X8PN"MB`P"NQF=.NY
M6<=EO)CGZF[ES0=UC?5WRV9!-?M[_5)/=C4O1?6;1BSF[PN/!7/[71.UF&47
MPVL,%WW(FD+8$V%7`IXJ.%*QY+2%?@,K@'`-#5^2;+XFV5*([_4A.PH1H<"]
M%7#,18=`M&,>8@(7$K@=`K<EB(Q):S!9C0EJS)0YS.%&;U8`Q_W`<8S!'4FW
M&4>W!3`O<L/0&&K$%G39>H/EP<'RZ&!QLW=>IQVOF5(A3-$;BIIR;TB,#\7X
M0`PSQ/BTF<`-B1H*$X-B`B@F`&(,RRP#*D8X;FA$Q`K`7&&2K1&*><(@VU`8
M<WP?]RR$/0M!SP8L&D&":+Q%]4J'@M498=(6U.TJ\<H*@%SBSS%,FS%,6P":
M$M0.H#Q_Z/-C`VL/&V'-%M1M**(=HR#F#JJ!:]`KXR.\V8*Z#7&JAH*F_O#@
MX$6"B:_=N6Y!O7XSJH>BIAX?U(/7'`86G<[JV:?`2<R\WW`5SD\&`I2ZBD:C
MSTF`K@!L&I#16X]CVXQCVP)8P(A3=XB-B\&5C^&`9RCA2?]HW/H^^(@`;'"]
M83B6&<IE8K$0#&35$A%$<7I',J0(YSR+QK@LHHI"$$(4QH9MS_&RP<&RT=ED
M]2EPK'(VWF8<9R$'64ALQD',\<`C/D,X%I$)78_DVXSDVR*<8#[Q&N8;GCB<
MUQSE->DB36*76@V@AM7@M.8HK4VG<9>T0Z1\!ND+P9G/T?;;-!BG.VLT+!0U
M/"QX^>!H_SVPL^0X4WGP&^[",<A!#%)W=>/M\1^77@&(O1`0N`O$*N+;0"!P
M%V@VBLAF:`=PFFUHWG!,<Q33I(<@ID5`5VJ$8VQ0DL!!+5!0FPX3=)=LJOD4
MTA>"XUZ@7;3I,,'H;*&Q03@T-G;G?"F5^:D^.RRLO;IE96.+Y]OG^>0KU^=3
MQOLEFZT8>+]FLTUS^OA!OYA?XY/\*\Y/EZRPWE19JK0^USHJ5<I*OO.MBHBS
MC`_/AT0>2WT;5/=Y<P;9/)3J^CA2?9[K+OX'4$L#!!0````(`&:#^$:]P#*'
M3@,``.\-```9````>&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;)6777.B,!2&
M_PKCO26?!!QDIJ([NQ<[T]F+W6NJ49D"<0%K]]]O`D@U.=;V1B$^Y^,]B2=)
M?%+U2[.7LO7>RJ)JYI-]VQYFOM^L][+,F@=UD)7^9:OJ,FOU:[WSFT,MLTUG
M5!8^02CPRRRO)DG<C3W52:R.;9%7\JGVFF-99O6_A2S4:3[!D_/`KWRW;\V`
MG\3^:+?)2UDUN:J\6F[GDT<\6^'0(!WQ.Y>GYN+9,\D_*_5B7GYLYA-D<I"%
M7+?&1::_7F4JB\)XTI'_#D[?8QK#R^>S]V^=7)W^<];(5!5_\DV[U]FBB;>1
MV^Q8M+_4Z;L<-'#C<*V*IOOTUL>F5>799.*5V5O_G5?=]ZG_)42#&6Q`!@,R
M&HQQ8`,Z&-!W`_:A`1L,V&<C\,&`6Q'\7GM7N6769DE<JY-7]]-]R,RJPC.N
MYV9M!LU4Z*HU^C=#)/%KPHF(_5?C:&`6EPSI&$*OD:6+X)'P=0)C%@3*8D'<
M"-<!4H!@5@YWG:P^='*5)@6+12_LZ5"L$';`0`?LP@'K'-#(*G:/5!TB.F2*
M41A:6.IB+`RP51'`%^&AX%99`$PP!.OBH"[NZK*C+/A%%-X7/R(<63FG`!:$
MG-C27(P+1D-[QEV,L2"B'!87@.("1QP)+&V!$V9*<!3RP`)3"$0\T)6P]`$@
MHT(OA-!2"(!41!'B`M8H0(W"T<CL^1-.H(@((FR%+B8PX\C"EBZ&!8M";/6>
M%<#A2,\A@=6%H+K04<=)!#N(0`?1Y__X9EN"^BRZ7^&!N5JM""-D51C`A`TM
M(8B%-K8"L"GEZ,:?']_80[!;7WK+!;@!/&+RA0K#S1G3^\UU8*S_GU-@E\+N
M/"PA9]2M,.2,W*PPO&]@8.-P&BQF0"1'FPM-:>!J^X2OU5U?U]+@K0.[>P>G
M-PX/&&[0./C"XH'['W8;(%!@MQE!JP>@N%M@@&)NA0$*WRPPW/RPV_V<_6M@
MKHX`##GYI!#'G36_A##!`7D`I^4Y`OV+TVPIZUUWCVB\M3I6;3_CX^AX5WDD
MYC1LC2_P+,7`^-+<;;K3\[O[)#YD._DSJW=YU7C/JM5G\.X4O56JE3I]]*"7
M[E[?OL:70FY;\RCT<]W?1_J75AW.UZOQCI?\!U!+`P04````"`!F@_A&_SC;
M/0$#``"=#```&0```'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6R55]MRFS`0
M_16&#RBL$#</9B8V[K0/G<GDH7TFMFPS`>2"'*=_7PDPP=*2."_!B'..=H\V
MRY)<>//2'AD3UEM5UNW2/@IQ6CA.NSVR*F^_\1.KY9,];ZI<R-OFX+2GAN6[
MCE25#G'=P*GRHK;3I%M[;-*$GT59U.RQL=IS5>7-OQ4K^65I@WU=>"H.1Z$6
MG#1Q1MZNJ%C=%KRV&K9?V@^PV$"D(!WB=\$N[>2WI8)_YOQ%W?S<+6U7Q<!*
MMA5*(I>75[9F9:F4Y,Y_!]'W/15Q^ONJ_KU+5X;_G+=LS<L_Q4X<9;2N;>W8
M/C^7XHE??K`A!U\);GG9=G^M[;D5O+I2;*O*W_IK47?72_\DO-)P`AD(9"3`
MQP1O('CO!/HA@0X$>N\._D#PM1V</O?.N2P7>9HT_&(U_7&?<E55L/#EV6S5
MHCH*Z5HKGRE$FKRFOD<2YU4)#9C5%$,Z#/%N(9D)@1'AR`#&*`@6Q8J8.]QN
ML$805(OA4Y'-AR(W87JH6=Z$[PUF>;@`107H1(`.`EH:JQY3=YBPP\0D)&&@
M&6+"0J"^J\$R$P8AC2,(-6L0',24!@1/ST?3\PU_:(SS`Y0?(/;XFCW!)%!_
M*$:?1+H]&"P(`M#L0=6`Z(6#JH5D)KD032Y$BB?`!2)4($+<T8YQ%1F!4M?5
MK#$QH8[)3$R@8S8F)IY@;A**T81B)*%(2RC&#B@$#;;&8"%U]>-&U8)0@VU0
MM<";Z17J181U5A=);Z9B8*8YP_TU`VAG?0!B1D%=O<$3(V$PRN8>4'8/:/,)
MZ#8MO!.#AZ0U\\H!O!<#_8*Y>+\#_QYS?;.:3'--D/&/FR$@SS37!/FSYN)M
M&)`^3&=>!(`W._A"MP.\W0'2[TQSS2:$5*X),DX@NP>T04">8:XSF;TJUARZ
MJ;>UMOQ<B]Z,<76<K!^(FMVT]14LUH"L9VH2[V:]=_DT.>4']BMO#D7=6L]<
MR(FQF_GVG`LF8W>_R<(XRF^%\:9D>Z%^RMG7:OKIN;\1_'3]&!B_2-+_4$L#
M!!0````(`&:#^$;=S+HB_P(``#H,```9````>&PO=V]R:W-H965T<R]S:&5E
M=#8W+GAM;)57RW*;,!3]%89]`4F(AP<S$S\Z[:(SF2R:M6++-A-`+I+C].\K
M`<987*>)%P;$N8]SKGQUG9U%\RH/G"OGO2IK.7</2AUGOB\W!UXQZ8DCK_6;
MG6@JIO1CL_?EL>%LVQI5I8^#(/(K5M1NGK5KCTV>B9,JBYH_-HX\515K_BYX
M*<YS%[F7A:=B?U!FP<\S?[#;%A6O92%JI^&[N?N`9FL4&4B+^%WPLQS=.R;Y
M%R%>S<//[=P-3`Z\Y!ME7#!]>>-+7I;&DX[\IW=ZC6D,Q_<7[]];NCK]%R;Y
M4I3/Q58==+:!ZVSYCIU*]23./WC/@1J'&U'*]MO9G*02U<7$=2KVWEV+NKV>
MNS=QVIO!!K@WP(/!$`<V(+T!N1J$'QJ$O4'XV0BT-Z!6!+_CWBJW8HKE62/.
M3M.5^\C,KD(SJFNS,8NF%%HUJ=\91)Z]Y30DF?]F'/68Q1B#6PRV(*LI!`T(
M7R<P9(&A+!9X&N$VP!)`A%8._W6R_M#)39H$%(N,[$DOUAT'(>@@'#D(>P?4
M4KO#U%U%NI*$B6<)O@10-/&0)0F`0B2UG:U!6.C%,#4*4J,`M<BB1L=QN@)\
MPYY=:AAE^5I!*&JCUC`*P\0BD%@$$(LM8M$T3!C9U5@"*$H]J_XK`(4(\:R0
M:PB&TY&W&VHQ2"T&J"46M1A0$&$OM;B!L&A"#H+I#6F7#80E7@*32T!RR80<
MN5/W%+1//_]C-T<1U%L#0-_4;J[!E"O&D[T#PL*)OA",QC9L#<+(J*BW].X<
M'6BJ,+GC`6S[#PA_06.X)2/R&8T)(%XT:3P03/_R[,X#P1+D);;&$"RXMX<1
M?&`@X,2@P1T7<&-&]`LBPRT003UP(O)-1T(7]28BCV%QATIMA0%7:>@%Z?AC
MRPW9!),SS!\-1A5O]NU(*IV-.-6JDV=8'<;>!VP&*VM]@69+!*ROS)C<#F)7
M]WEV9'O^BS7[HI;.BU!ZG&L'LIT0BNOL`T\7Z:`'^>&AY#ME;F-]WW2C;?>@
MQ/$RJ0]_%_)_4$L#!!0````(`&:#^$:>X'">.@,``!(.```9````>&PO=V]R
M:W-H965T<R]S:&5E=#8X+GAM;)57P7*;,!#]%89[`0EDP(.9B8T[[:$SF1[:
M,[%EFPD@%^0X_?M*"&.0EM3)(0;Q]JWV+7I(R94UK^V)4FZ]5V7=KNP3Y^>E
MZ[:[$ZWRUF%G6HLG!]94.1>WS=%MSPW-]UU05;K8\Q9NE1>UG2;=V'.3)NS"
MRZ*FSXW57JHJ;_ZN:<FN*QO9MX&?Q?'$Y8";)NX0MR\J6K<%JZV&'E;V$UIN
M<0?I$+\*>FU'UY:<_`MCK_+F^WYE>W(.M*0[+BER\?-&-[0L)9/(_*<GO>>4
M@>/K&_O7KEPQ_9>\I1M6_B[V_"1FZ]G6GA[R2\E_LNLWVM=`).&.E6WWW]I=
M6LZJ6XAM5?F[^BWJ[O>JGH1Q'P8'X#X`#P%#'CC`[P/\>T#P84#0!P2/9B!]
M`-$RN*KV3KDLYWF:-.QJ-:K=YUR^56A)1&]V<E"V0JC6BF<2D29O*2$H<=\D
M48]9CS&XPV!_"LE,R)W$%1,89H&A6:RQF6&:8`,@`FT._R79?D@RF:8/BN6/
MXOU>+`P3!"!!,"((%$%`-+45IE8=42T)(D<3?`.@2.1HG<L`%/)CG6P+P@(G
MA$LC8&D$*&VAE4;&>50#OF!';S6,TK@R"$5TU!9&S?1L`1:V``H+M<(69II@
MH7=C`Z`(<;3^9P`*^;ZCI=Q",!R/V":EA6!I(5#:C#812!`]OB!BD"`&9A!K
MXL9FI;&A+0`2RR&>_&E"`R'8:-H60OG.C+O);Q)DLAY0YAS%C$^CQZ5&H,D^
M(?R`V#UH4J^/G$B3&X*)MT];RAD$6YCO,@03;C;CS0@V9^2;Y1%_A@*V9Q1\
M0F38!A'D@X;(@"WYA@].4$2M</V;!V"PH2Z4C<RJ"[L@`FR0S%'`;H/"3Z@+
M^PV*'E$W`JS15#<RE#/$A8@")]#UA6">,_?JP4:(`"<D,V:.89?!WN/Z8MAE
M,'I`WQZDZ@W5ZZ3OUL:0?D>!]66?02AC#[.%4*'QG7-'&]Z*-L?NJ-%:.W:I
MN5)C&!V.,T]8;IBU\35:;A`PGHGCCSJLW.G3Y)P?Z8^\.19U:[TP+K;IW4;[
MP!BG8O*>(];>21S0AIN2'KB\#,5UHXXLZH:S\^T$-AP#TW]02P,$%`````@`
M9H/X1M?O^B9&`@``R`<``!D```!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL
ME57;CILP$/T5Q`<LV$!((H*4I*K:ATJK?6B?'7`"6AM3VPG;OZ]M"&'#1,J^
MX-N9,S,'CR?KA'Q7%:7:^^"L41N_TKI=!X$J*LJ)>A$M;<S)44A.M%G*4Z!:
M24GIC#@+<!@N`D[JQL\SM_<J\TR<-:L;^BH]=>:<R'\[RD2W\9%_W7BK3Y6V
M&T&>!:-=67/:J%HTGJ3'C;]%ZSV*+<0A?M>T4Y.Y9X,_"/%N%S_+C1_:&"BC
MA;84Q`P7NJ>,62;C^>]`>O-I#:?S*_MWEZX)_T`4W0OVIRYU9:(-?:^D1W)F
M^DUT/^B00V()"\&4^WK%66G!KR:^Q\E'/]:-&[O^),:#&6R`!P,\&HQ^8(-H
M,(AN!DZZH(_,Y?6-:))G4G2>[']&2^P_1^O(*%?832N4R4F9,XO(LTN>)(LL
MN%BB`;.;8K##H!$1&/;1!89<[/#,'']VL`<0,>PA`I.()O9QGT2,88(8)(@G
M!-&@0@H3)"!!`D00WLG88QJ'27H9TU48WL'V<QC&>`K[%,X"#&<Q#R>)8((4
M)$B?%V0)$BR?$&0Y%P0E<T$`V#)\*,@*#&<%"/+@BMFJAPHE?%X2]*#6T!.B
M#*!INDO@E@"PY+$H"*S,+<)`0`]J&\&EAZ(OR`(7'XJ?D26>Y1NEP&4!<+&[
M+G<A!9,'DE-Y<HU#>84X-[I_A,;=L3EMW1-^M[^S3<L]O#>:/&O)B?XB\E0W
MRCL(;9YO]P`?A=#4A!F^F"JO3%L=%XP>M9VF9B[[1M,OM&BO?7-LWOE_4$L#
M!!0````(`&:#^$9M9ADQVP$``*\$```9````>&PO=V]R:W-H965T<R]S:&5E
M=#<P+GAM;&U4R6[;,!#]%4$?$&JU$T,6$+LHVD.!((?V3$NC!>&BDI25_GVY
MR+)BT0>3'+YE..*PF+CXD!V`"CXI8?(8=DH-!X1DU0'%\HD/P/1.PP7%2B]%
MB^0@`->61`E*HFB'*.Y96!8V]B;*@H^*]`S>1"!'2K'X=P+"IV,8A[?`>]]V
MR@106:"%5_<4F.PY"P0TQ_`U/IQS@["`WSU,<C4/3.X7SC_,XF=]#".3`A"H
ME%'`>KC"&0@Q0MKX[ZQYMS3$]?RF_MV>5F=_P1+.G/SI:]7I9*,PJ*'!(U'O
M?/H!\Q%LAA4GTOX'U2@5IS=*&%#\Z<:>V7%R._MLIOD)R4Q(%L+BXR>D,R&]
M$ZP#<IG9<WW#"I>%X%,@W+<8L/GD\2'5E:M,T!1*GTGJ/8,HBVN9Y\\%NAJA
M&7-:8Q*+B1<$TNJ+1>*S."4;>O+5X.Q!9'Z'U'N(=,5/78+[R"^0>06RE4`V
M5^'EH0H.PRPFMYB=[@7]\QOE7J-\:[2+'HSRC='+\]K&U6R+BN-DFPU:700*
MHK4-(H.*CTRY8B_1I0=?$W.1'N(GW9NNE>XR93'@%GYAT?9,!A>N]#6U%ZWA
M7('.,GK2:7;Z]5@6!!IEIGL]%ZZAW$+QX?8\+&]4^1]02P,$%`````@`9H/X
M1DD&PJ_$`@``!0P``!D```!X;"]W;W)K<VAE971S+W-H965T-S$N>&ULC9;=
MDJ(P$(5?A>(!AA]!T$*J!-S:O=BJJ;G8O8X8E1H@3A+'V;??!!"A:1UO!.+7
M)WU"DW1T8?Q='"F5QE=5UF)E'J4\+2U+Y$=:$?'"3K16_^P9KXA4C_Q@B1.G
M9-<$5:7EVO;<JDA1FW'4C+WR.&)G618U?>6&.%<5X?\26K++RG3,Z\!;<3A*
M/6#%D=7'[8J*UJ)@M<'I?F6NG>7&<372$'\*>A&#>T,GOV7L73_\VJU,6^=`
M2YI++4'4Y9.FM"RUDIKYHQ.]S:D#A_=7]1^-797^E@B:LO)OL9-'E:UM&CNZ
M)^=2OK'+3]IY\+5@SDK1_!KY64A674-,HR)?[;6HF^NE_2>TNS`\P.T"W#Z@
MGP</F'4!LUN`]S#`ZP*\9V?PNP`?S&"UWIN5RX@D<<39Q>#MZSX1757.TE?O
M)M>#^E6H51/J/TW$T6?LSYW(^M1"'9,,&;=AW-D8R:;(3<12"?19N%@6B3N=
M83Q!BA`>R.%;D<U#D5&:,W2Q9H/X61L?V+B`APIX`P&O6VV09((Q8+G3)YCL
M"6;SF!D9\E%#/B(`WDN",3XP-&4\R&28SAP8>JPS,C1'#<V120)@"&-"8`AC
M%L`0P@S*J36$,7<^K0`U%"`"L.0P!I;<$TSV!+/!F#L?88@:"A$!4"K)E)F4
M4XKI@'+*,`94PP9C0MS0`C6T0`1`J20($X)223$&;.49QL!=\C$S,J3/8.Q0
ML1$)4`@)!@5@[T@Q:+(QH$JP[KY1&MNZ<U8Z$PDWA*ZFS'2W>P;*,"CTH*O'
MT-@5>O:N'1>1@!\4"LVA+0P*H"T,"J$M#%H`6]:@QZDH/S3=I3!R=JYE>S[W
MHWT'NVX:6#">.,O40<8SW?$V/=5-/HY.Y$!_$WXH:F%LF52=6=-;[1F35.5N
MOZ@SZ*AZ\OZAI'NI;P-US]LNM7V0['1MNOO./_X/4$L#!!0````(`&:#^$8`
M:6KWD0(``.L)```9````>&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;)56VY*B
M,!3\%8H/&`AW+*3*R^CNPU9-S</.<\2HU`!QDZBS?[\)040XCNP+)*&[3Y_D
MA"2Y4/;)#X0(XZLL*CXU#T(<)Y;%LP,I,7^A1U+)+SO*2BQDE^TM?F0$;VM2
M65B.;0=6B?/*3)-Z[(VE"3V)(J_(&S/XJ2PQ^SLG!;U,361>!][S_4&H`2M-
MK):WS4M2\9Q6!B.[J3E#DS7R%:1&_,[)A7?:AC*_H?13=7YNIZ:M/)""9$))
M8/DZDP4I"J4D(_]I1&\Q%;';OJJOZG2E_0WF9$&+CWPK#M*M;1I;LL.G0KS3
MRP_2Y%`[S&C!ZZ>1G;B@Y95B&B7^TN^\JM\7_26R&QI,<!J"TQ+:.##!;0CN
M6(+7$+P;P?N6X#<$?VR$H"$$8R.$#2'L$2P]N_7:++'`:<+HQ6"ZH(Y8U2V:
MA'+U,S6H%ENN"Y??%")-SJD?VXEU5D(-9M[%.#7&B>)[S`+`N/>0UR$$M0A+
MFFR=.I#3N3.@^S'JN1ABG'O$$D!X/9]/15;/1=9#B!L]2-<%%\;M"+A-N@XL
MX($"7D?`TP*1WYLO"!/T9@S"A+TI@S!1;](@3`PGY(,)^4.!N%=C:XVI=#GK
M>O:B%Q<.$X!A`B!,;W4702=,"%?1MY`[&R%H(P1L^+!`!`I$XPLH!@5BP$&O
M..;Q($ODVG`0=2)`/R`;"!,^D'CP#T/C4T7@SV6&G!')-B"=K?\D6WA7(Q>(
M$SV0@/<U\OXC6W@G(6@K#;+U1ZRMU3EG2L+V]1V"&QD]54*[:T?;>\K,4>=4
M;WR!)DL$C+^BR4K?0F[R:7+$>_(+LWU><6-#A3P=Z_-M1ZD@TKO](KT?Y,VK
M[11D)U0SE&VF[R*Z(^CQ>K5J[W?I/U!+`P04````"`!F@_A&:*G%MYP$``#K
M%P``&0```'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6R-6$USHS@0_2LNWS.@
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MJ,?,KC'482AQ,'.`D;>0)8>("R)H2%Z8$F(Z(SZ""1T6`'.+6`!$Y/#\TLGJ
M:R<IA\0*1RMA7N25?72V#]UHSYA#A]%]7D+EPI;#8"F'*7T]Y@WI")*.KDC+
MGK0GQPHZ4"!J9_+GZHJGZC"1D3SJ8;"4PRA6RA=V#%G'@+53_/.8C:-,&#'6
MPV`IAT6)3'RL-62M`6NGBN>:SXZ(..MAL)3#I/&S3B#K!+!6#NN$C2-B81CK
M8;`4P#1%/M8&LC:`=>RP-FR<F'A9#T*E'"4H-#[.K58C:0@9:TK<MA_R2I12
M,MH#<2G`J5![UZ/PB)H`\ZU=ZH)/4M).DW&Y#P2F&&BDC#SLH=`]"@)M-/&X
MP.HAD'PPR98@)VY&%@+(!^\`P)=F@K4"OI3PYA9KC(AX:,)5QAYT3>=.)3PV
M`-."!P=@@J^Z%<1%VAL@UD`!1%`(-T"N6R!U'"0DR\H2P!K:/#K@+?9N$`26
M2@&T4K@*+[B\W0DVW0L(`Z4)82![`/=)\K"H"JZJ,F3)XT)XEQ"/#\`(I`_`
M%"OB%8(U)>,+#ZNO2%AK(N/9X0DLA8)K(1E6`5S`VL)E,\1A;'8XA#3*_F>N
M;K].L%H25TOI=ESBZG8GPL3]F%K<X'2_OXN=,EHB;Z02[6R'5L#;G8Y\T6%%
M)<$2'POI<8%EC0A,D)OX'G3;UXBMC>5`7`IP#<A;]H3EE("<"G>O3%P"B7BE
M+0?B4H0+0V]#(BR7Q.62;>*(ZY9,#%MNRX&X%.`H,MXM,V$=)*2#[E:?N"@9
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M!!0````(`&:#^$;ZVNAY;P(``$<(```9````>&PO=V]R:W-H965T<R]S:&5E
M=#<T+GAM;(U6RW*;,!3]%88/"))`/#R8F1@[:1>=R631KF5;MID`HI)LTK^O
MA#`AH+1LC'0YY]R7N'+:,OXF+I1*Y[TJ:[%V+U(V*\\3APNMB'A@#:W5FQ/C
M%9%JR\^>:#@EQXY4E1X"(/0J4M1NEG:V%YZE["K+HJ8OW!'7JB+\SX:6K%V[
MT+T;7HOS16J#EZ7>P#L6%:U%P6J'T]/:?82K9P@TI$/\+&@K1FM'![]G[$UO
MOA_7+M`QT)(>I)8@ZG&C.2U+K:0\_^Y%/WQJXGA]5W_JTE7A[XF@.2M_%4=Y
M4=$"USG2$[F6\I6UWVB?`]:"!U:*[M<Y7(5DU9WB.A5Y-\^B[IZM>1.#GF8G
MH)Z`!@*"_R3X/<%?2@AZ0K"4@'L"7DH(>T*XE!#UA&A"\$QUN]YLB219REGK
M<'.@&J+/+5Q%JOL';=3-5GT1ZIU&9.DM"V&8>C<MU&,V8PSJ,,C_#-G.(7!`
M>"J`(0IDBV*#9G0?3ESD<TP(HTD8"W1V"W2>;)CX,^;9ADGL2?O6TOLC`=\(
M(&`7"*P"P4@@,'V9MLY`Z@X2&0A,8AQ.<+D%!W"($C0I\!P7^!&(XTEQ=G.<
M'R4)P)$]/VS-#\_R"]$7QRJT"H3+*QQ9!2)+!).2Y#:,;W<26YW$_VUC'L_*
MB7T,OD@EL7I)+&$&DR.=C-Q`4S`?/X1V-WK"VP8*L#C"D^^K!_6>#"K"$S_>
M:(95E)^[^TDX!W:MI>GG8!WNP$>D9^#$OH&K'%KL6[C:F9GY(9^E#3G3'X2?
MBUHX>R;5Y.UFYXDQ257LX$$=RXNZU8=-24]2+R.UYN:>,QO)FONU/?QWR/X"
M4$L#!!0````(`&:#^$:Z6)*V@`(``*H(```9````>&PO=V]R:W-H965T<R]S
M:&5E=#<U+GAM;(U678^C(!3]*\8?,`(J:&--IE_9?=AD,@^[S[2EK1F5+M#I
M[+]?0&NMTFE?%*[GG'ONA8#9F8L/>6!,>5]56<NI?U#J.`D"N3FPBLH7?F2U
M_K+CHJ)*3\4^D$?!Z-:2JC)``."@HD7MYYF-O8D\XR=5%C5[$YX\5145_V:L
MY.>I#_U+X+W8'Y0)!'D6=+QM4;%:%KSV!-M-_5<X64%@(!;QNV!GV1M[QOR:
M\P\S^;F=^L!X8"7;*"-!]>N3S5E9&B6=^6\K>LUIB/WQ17UER]7VUU2R.2__
M%%MUT&Z![VW9CIY*]<[//UA;0VP$-[R4]NEM3E+QZD+QO8I^->^BMN]S\R4!
M+<U-0"T!=80NCYL0MH3P2HB^)40M(7HV0]P2XF<SX):`!X2@:99M]8(JFF>"
MGSW1[(\C-=L03K!>S(T)FK73;9;ZFT'DV6>.$<Z"3R/48F9]#+(8%-Y"%F,(
M[!"!-M"Y0"X7,S3.<)M@[D!$`P\/19:/159C"([=E83.?H8]?MCVD[@%(J=`
MU!.(K$`X*&/60&H+(182I8"@9-`R!RPBB`R7;@Q+8X@(&?3.`2,8QG=JBYVU
MQ:/:\-#U+.[EB2TFB0$8>'X&M(I'CDG:`]WXQ4Z_V.$W=0L0IP!Y?C<D3H%D
M["`<-B,9-2,,=3?N5)HZ\Z2./'"0)QWEP>!N&G.<NXX;\'A[MYC^PMW6TVQO
M!PP"/-HJ#EA$DB%LZ8`A2$;5!;USM6)B;Z]`Z6WXJ5;-$G?1[II]1>9<'L1G
M<#*'CO@"3I;-)7J5S[,CW;-?5.R+6GIKKO1M8,_S'>>*:??@1>_U@_YQZ"8E
MVRDS)'HLFJNTF2A^O/P9=+\G^7]02P,$%`````@`9H/X1J,/X;[6`P``H1$`
M`!D```!X;"]W;W)K<VAE971S+W-H965T-S8N>&ULC9C;<J,X$(9?A>)^#`U(
M`I?CJL2.QSELU=1<[%X36[:IX>`%',^^_4H@.R"U=LE%#.+KO[OI1EVPN%;U
MK^;$>>O\+O*R>7!/;7N>>UZS._$B;6;5F9?BRJ&JB[05I_71:\XU3_>=49%[
M@>]3KTBSTETNNK4?]7)17=H\*_F/VFDN19'6_SSQO+H^N.#>%GYFQU,K%[SE
MPKO;[;."ETU6E4[-#P_N(\S?(9%(1_R9\6LS.'9D\!]5]4N>O.P?7%_&P'.^
M:Z5$*GX^^8KGN502GO]6HE\^I>'P^*:^Z=(5X7^D#5]5^5_9OCV):'W7V?-#
M>LG;G]5URU4.1`KNJKSI_CN[2]-6Q<W$=8KT=_^;E=WOM;\2^\H,-PB407`W
M".`_#4)E$$XUB)1!--6`*`,RU8`J`SK5@"D#-M4@5@;Q5(-$&213#63-^\KY
MDTWNQ8;))K=R@UYOKV^LKBW7:9LN%W5U=>K^63JG\I&%N;`2XG)5-KKHR49<
ME,AR\;FD8;#P/J628IZ&3-`Q09R,F17"A&-D8R(P)EY[0FX-<LT3D=_##]#P
MGP)#DX::WY7)A*`Q:T0'V)AYQGQ%6HX3?'W'=,B8V4Z(YV6"SJO)!"P>,V^8
M#ATS[QCS%<^H4B'>:.%`(50*,:X0X0K10"%2"GH;1JJ#),,ZYEL4QUJ?K1$*
M$KUO-@A%&.B50JB$V#(C>&;$R$Q_!E=DX(9T2)3X+-!JN4:PB`5,3\W$$@(!
MTSILBV",`K$4GN+)4;-LD:]E1PU'A!"J->':I"C$5'\$30I\1A)-;(M@!!)*
M\-P8GAM#<@-<(<85XNF/18(K)$@,^@Z>&$T:$%_\:4_Y$`.B=GI_9KDG<L*A
M(\5'(M(Z\`F%(HLCV^P"1(/HCL#(/2)&ZBL$H[%.;291+R-*W4<VT[=F1"NF
MNM8;II7,M`WM':.BQ%HX?)@^0H#<3ZK?3PQB^MW$H%B_F1.@ERG0^__$-$[>
M,I\@1#02/>30J!EA>LV^CRA5#3H++?%8IAT@XX[X>C$PR+(!@67X@#E]S+D*
MQ$C\FQA`6CQK,">&F*SF8X1@YGW<8EA"!M@X/\O\`7,`Z=/U&:BY25#?ZLDR
M#0`9!\1PQ0Q7C-A=6<8&Q(BK4'>%0;8]UC)=`!LOQN9ISA=@@=D="!:$9G>8
M6$C![`X,,[O#&[P*%;P^=F_XC;.K+F7;9W1?O7]%>`SDJY2VOH+Y,R#K&YAO
ML?57F+_UKV1?;I>+<WKD?Z3U,2L;YZ-JQ:M=]VIVJ*J6BZS$L'6=$T_W]Y.<
M'UIYR,1QW7]!Z$_:ZGS[('+_*K/\%U!+`P04````"`!F@_A&1V4<?:H!``#T
M`P``&0```'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6QM4]MNW"`0_17D#PA>
MUMY**Z^E;*JH?:@4Y:%]9NVQC<+%`;Q._[Y<;,=*>0%F..?,88!J5OK-#``6
M?0@NS24;K!W/&)MF`$'-@QI!NIU.:4&M"W6/S:B!MH$D."9Y?L*",IG55<B]
MZ+I2D^5,PHM&9A*"ZK]7X&J^9(=L3;RR?K`^@>L*;[R6"9"&*8DT=)?L\7"^
MEAX1`+\9S&:W1M[[3:DW'_QL+UGN+0"'QGH%ZJ8[/`'G7L@5?E\T/TMZXGZ]
MJC^'TSKW-VK@2?$_K+6#,YMGJ(6.3MR^JOD'+$<(#AO%31A1,QFKQ$K)D*`?
M<68RS'/<*59:FD`6`MD(L0Z.A8+-[]32NM)J1CJV=J3^!@]GXAK1^*0_M[-H
MW)Y'U-6]/I5EA>]>:,%<]Q@2,.2X0;"3WVJ05(TK^9]?I/G'I,?CCE]$C^20
M%BB2`L5.X+@<\I06*),"9<(!^=*E%.9KF_#N6@3H/KP^@QHU21O[OV6W!_Y(
MPK5^PNMJI#W\HKIGTJ";LNYQA.OME++@K.0/SLO@ON`6<.BL7WYS:QU?90RL
M&M<_MGWT^A]02P,$%`````@`9H/X1A/88D*G`@``W@H``!D```!X;"]W;W)K
M<VAE971S+W-H965T-S@N>&ULE5;;CILP$/T5Q`<LV-R2%4'*157[4&FU#^VS
M0YR`%C"UG63[][4-(20>MLG+8IN9<^:,.=E)SXQ_B()2Z7S652,6;B%E^^IY
M(B]H3<0+:VFCWNP9KXE46W[P1,LIV9FDNO*P[\=>3<K&S5)S]L:SE!UE53;T
MC3OB6->$_UW1BIT7+G(O!^_EH9#ZP,M2;\C;E35M1,D:A]/]PEVBUPT.=8B)
M^%72LQBM'5W\EK$/O?FQ6[B^KH%6-)<:@JC'B:YI56DDQ?RG![URZL3Q^H+^
MS<A5Y6^)H&M6_2YWLE#5^JZSHWMRK.0[.W^GO89(`^:L$N:ODQ^%9/4EQ75J
M\MD]R\8\S]V;F=^GP0FX3\!#PL`#)P1]0G!-B+],"/N$\)I@>NUU4DPC-D22
M+.7L[/#N]EJB/Q+T&JI6Y_I0=U8U0:AW.B)+3UD<):EWTD!]S&H<@TT,NHU8
MVQ%A?(WQ5`5#&1@J8X4M`'Q'84?$T>PV9@/%S.$R`K`;P0@@Z'2@&`8(08!P
M!!!V.N;AG9(NIC$Q21>#?9@D`DDBBR2.)P!B$"!^7&8"`B1`!7??Q":Q9*((
MYIB!'#.``\,`<Q!@_KA*_=,`F</__W6N^J";^XPFK@--F!`!6H-['C3BB3H]
MOC]%!-ILB3!`%$Y`P!9!3W@$P29!#[ADA4)+;C"I%O8)@HQBM36R>*+IML)^
M0C%`-/&Q(]A1*'FBK;!A$.082^[,DJMF@$F]L+/0'&":*!;#UL+^XWHQ[!K\
MB&NP[1HT*1?#KL&0:Y()"-@U^`G78-@UV'8-(-?^YQ+8<KW1=%!3?C!CEG!R
M=FQD-P8,I\,HM\1FNKB&9VE+#O0GX8>R$<Z6236CF"ECSYBDJAC_15FK4,/F
ML*GH7NIEHM:\&[^ZC63M99H<1MKL'U!+`P04````"`!F@_A&S1$N2Y<!``")
M`P``&0```'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6QM4]MNXR`0_17$!P2'
M7-I&CJ5-5]7NPTI5'W:?B3V.48%Q@<3=OU\NCM>J[`<S,YQSY@*4`]IWUP%X
M\JF5<4?:>=\?&'-U!UJX%?9@PDZ+5@L?7'MAKK<@FD32BO&BV#,MI*%5F6*O
MMBKQZI4T\&J)NVHM[-\3*!R.=$WO@3=YZ7P,L*ID$Z^1&HR3:(B%]DB_K0^G
M;40DP&\)@YO9)-9^1GR/SL_F2(M8`BBH?5008;G!,R@5A4+BCU'S?\I(G-MW
M]9?4;:C^+!P\H_HC&]^%8@M*&FC%5?DW''[`V,(N"M:H7/J3^NH\ZCN%$BT^
M\RI-6H>\\UB,M&4"'PE\(O!-*CPG2F5^%UY4I<6!V#S:7L037!]X&$0=@['O
M4*(+>Q%1E;=JOW\LV2T*C9C3',-'S-.$84%_2L(7D_"9P#8+/!3+`IM%@<U,
M8#,*K)<%MHL"VX4*^)<V,\;D4>PS:+<JGN;?EYQL-N9>7."7L!=I'#FC#R>6
M9MXB>@CRQ6I'21?>Q>0H:'TT'X)M\U7)CL?^?O&GUU?]`U!+`P04````"`!F
M@_A&"K<`9-8"``!(#```&0```'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6R5
M5]%RHR`4_17'#ZB`@MHQSFS3[;8/.]/IP^XS24CB5"6KI.G^_8*2K)%K:U\B
MX#GG<B\<)-E)-J_M7@CEO5=EW2[\O5*'VR!HUWM1\?9&'D2MWVQE4W&EN\TN
M:`^-X)N.5)4!08@%%2]J/\^ZL><FS^11E44MGANO/585;_[>B5*>%C[VSP,O
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M8J)KS!+"T&O,O8LAUXCO`&(4Z.%3D1^?BSQ"LV77F"<($U\P@:[JI;0$+"T9
M"(16(($%0E`@'`A$G4`XRO6^A]0=).X@48IBDHSJ"L"BF(P7^L&%I1230=9]
M@0%8S#"=*$X$YA8YN;$XA04H*$#G5Y>!`NS3ZBZ9DR@F$4((#A.#86(WT02-
MXL2#.+2?"IH,DX!A$B`,'NWHQ$F')M%4F!0,DP)AQE5+G3`A95-AS)<(.I:0
MNSHH'#L4.77#"$U7#D\<@1A(*IR0@*V.O^!U#)L=NVYG230^B2$0G8@#&P\#
MSDO8A`1L/?P%[V'8?-AU'Z-D?$H#_OM@=6'_8<B`$T<5AKV%DR_D"_L&N\8!
M]G/J[&=]2M.IA`EL'>):AR43LR6P(PB>GS"9^/B1&0E;T-6)E`()!X/;S('O
MQ$_>[(JZ]592Z8M1=[792JF$UD0W>G/N];7^TBG%5IEFK-M-?]'M.TH>SO?V
MRY^'_!]02P,$%`````@`9H/X1@:9,;Q4@0``E@8"`!0```!X;"]S:&%R9613
M=')I;F=S+GAM;.R]VW(CV9$M^'SF*\)DU`@T`UFX@ZS3W69(DIFB.F]*,JND
M'IN'(!`DHQ*(0",0R:*>]!'GI<WZ_,>\SY_H2\:7N^];7$"06=7=.F?,I"(2
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M^3GZY^2Q>MU9N=E@AJ_38D[7_3F)-UB%Z#S>UAYW=-0?'`W[+8]ZG2Z3371&
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MZ&N\+!-:NU42%^6&J0J#TI9L:5[X%W8G7>#`TP.;EWY>7>+J97@P'HD5QO";
M].Z^/C^EY-M-OHI(<L@3FTF`7E:H7I]XV$A:.N!-0NPZ,;=LXY_-/&7.M'QT
M-FF"LC"W]/%K4FR3A,?$%W1+R]#>8+4S_Z)QW],O,M'V7Z(.1CR,XNUVD]Z4
MVQA;OLVC+,=1VFYRIBG00T*'?UOL][S:<*_2G`@`_*4FF;R[:)^$R]2.U:NX
M2.<1'8.,9E.X"Y_SH/-T68(K?-LH/R:@MV1Q%'\EJB(9IFRQ+/C81"0#YN4R
M!L4W,(<]>#`Q=E)K[NDZ.K"[.?)NYFN';1VU7=^0@S$/;I)-JKW4YXR4L&7Z
M%WJ1.SJ:A5!40C2%0YK,RTVZ36F!XJ]QNN0%IA/$I]>G)?PYZ/1'XT,^2`>=
M4;<W.#WD:VDN]/]-DD0KD28)I$E$XB.Q>AC?!3G2)094K),YV-WR\;_+:)-!
M7X<==NEB-VR1_OS\09^U`F`7Z1W1!2M6\T=\\1!O%LP6L?9%?1E&XY%9AL&D
M]TLM0F<TT%''_X'O#WX&Z7)#0NDVI?>\6:9WC?S_S*P0%-QB*4(I7OQ4%MLF
M<2?B(F\E5.5LNQC66=-MS^`%C??_@@RU:?Q?AZ=T/L90^^^3;4H,;'\><PV9
M=7M+E(&]QIN4K<2P2>;Y7<:_/,49=CWF]EF/>?KX[;F@K^)EG,T3TK3)VBQ>
MQ)#/DSGIN_UF?=<87J)NU45'7(@".,<'Z!FD;6%[JQ>^BS=?$J$ZM\0UO6\^
MA[U=8+$2&NE&F7%MQJ6J4.4NQ;I%7R(5>MM@^:EH"5ZW117<>0W9`23`MX_=
M:+V,U:;&NK!NW#*EBE+;>-6;/%\\I,METPL))RKX6<)Y=LV_^3>ST<LTODF7
MO#WUW=9KUE#/137/\BT=E77\B,UJ.!_M/]K-;O]]4R9.X79OMWM;O!>HZ72[
M)OLVS^Z.B/NMR)BY338P-R#YS'`M!+.T=^UXKDQPQP6PFE-O$ZUM,F^XV'#^
M13)G]B^JWGV^)`NF^)TJ^W6R-"]5B&F^CHUE=-`[[O7Z3NULFAPX8^-]O7'[
MC;,%<2*B$WKW=9PNCE@-7:>T%@U[7:Z@GB:+1M$))EJW/[?$83W%N;;J&S;X
M'LW,XRU;<<V;XXG38#W_]M=_:UG1]RV2LWG\YC%JA.&9:]\N`.K2\R#ZKL6W
M&&CEK].,QDSA-LJ+]`D?8#ME[4E(+U,=(&]>+_.'E\D\OOV6;_=M<3A$H$TV
ML[^95?H*J$Z0Z+1*Q+8S9RM"I:)_S5\R_GE")$_++AHFO"2>'Z2V8=C&HYL8
MZX3#0BO6>-VYV1WG&VC@/_<D@<2)YLV4Y01/Q*-0%D[UI:E+[OWY^3ZLVXB>
M[2Z1HC+\F2_39/E[^[?>Y%]3V"`WCXW;^!1IB4ODB:TGK6&>)`N]A;UT/-=5
MO#7J*!']:A\EZF.YH14HGG''#.XU.>=\4Z!`L:N,M3QUPNU\WGJ7]M-PT!L]
M<$1$(@KH,+TN5_&:2'T5S=[(%&2B3VR:<7LT+?Y3&W8KW.^)#=.W9A,I$#2[
MMS8MBI+Y-9RQN%R,BY;#',6;#8AYU:127_P\ITUB)<58L4(]/&R^;G0M[B#N
MCB[:8>,*M/C'\.J).)CVM`0NK,&4_"Q'-4*DQ1[;_!ECM9H?75J2NS2#7L`[
M=,]>O#2O4>^.$1+PIUWW7I4K.E^/N.B*C+GTEL0LT;+R0CSZ(TFO)A6NX9(=
M$M9[3N$])W:#K%N>L_\,HU=ZZ*,/7Y/-US1Y,"I12IPHNEOF-Z0.W*0Y'\9X
MGI2L5#"UQAGLUSF3#^W>(BWF.0W"3G\-#/#G59R5M_2"Y89)B\,&RU2NQ#)O
M2#FDF>!`9$E)BE5^AV>0YE9N\W2U@@\(=R'PNI5?\;!\`T7M./I0;HB>B2;3
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M+'RURS_A,#$E@Q9+HU#R>X@N&C@:;JV"7#BMU-!7O%QZ_D%B)"S<1`KQRM+Y
M02P/6H_P6%*,B!(@;L'1<6#QYK&$K];^B]#].9%YX_-Q#ULAZ4H9%NM`>+/-
M@F4.4Y?/-N2T0-G0X-SR$;\GZZV(3ZS,YRRUZC>4[>.K8]JRV<?#8U*OP?H=
M4$!70&^E??C7,M[0A&C430*G`>CS-5T>(49.5)&72Q(]",[%$J7(LY_*;,Z#
M\63QLD^O/`BJMHGBF?"GA,%F649K'7VJ3>>?+;4](J@N;N=SVA`^:\8]%G7D
MC[WK4/A.`R^.0/*+I)AOTANWFG_[Z[]'XH8@Y2:P;YS1Y5DZ?_OK_S0S#Y_+
M[URN^59B$(6CG:Y=?;O2LE-XKZ,D:R7J&[4D&;@2T7>QH3T]BKRX$K&-UN5F
MG>,$/]"SB?^F?%[9U,%RZ/%IVBT2S24-G].]M$7!J8'D(,90(G"U233F2YJ)
MI3EY$?J9F#&?<A=#K40CF.OLCB)T>8<P![-VZ1+!S`4)'7Y'9;!.Z3</-H^Z
M+6G23"[T!1]9DH3"`(ORIJ`W`,\*S^2QM^L@\P]"X7MS&;*VEZP_M;`!L+-<
M]%)<$@@.3"I=I/2BB3DT>NF<E'8$L+_2;VPM&'<&K=Q6[(\'>BUB(0FO&BM%
M]%+@5:)\TC0VC\>@N?`EZO?37+!>&(9LP;P017_)NBSI@$2QO=^:M8>)G:_2
M.;W60\(6]V;AF]O/C&J8L]2RX$7@8M!'T"[2`M.@J@C.P8SODNH,\4I8Y4UQ
MGZ[=\FV,EXJ>7)0DW^QZ$%UOA9@U@E6=-9TU7'A,THL&,XJ6GE+=/X2DXKD*
M6BSH,ET142C[GON4AG'HI,)7F;)>3!O"I+I[2QE_D<FT'PVGW0C<P)[1;>XO
M).\5"7$($X@`LK7E0+%@CVD1:)^W=BY"&V8J]S%=>$.'*.KT#V52^0/]1(]8
MT+.(\OU59XD5*L7&8+$;Y&;>&<B(+MB'8>,;4B%OC$:2WW8C/=X,X5!/3X+Y
MJYDEIES7'YU?:,[B;$W<G;[DF=TDP>28B&(]4X_,S.CX!;8OD2CML[[E0_S(
M2RG"A3D,J#?Y6;4)ISEB=FPU8P@BP"`6X-F0K'6*=[G,RP([A+<NGD,,;4P"
M8UDKCE[53C.<&%AE239`$E+O*GY4_@K*+0N?>*$X;8A>*E\1,X=B#DI4;N<6
M)-_PDW"&,K8.?C2,'%$6N=?R]2*Y$TW0JJ#_!<R9S\*9+V@-5ZQZ7?.>)"*"
MG2[X/.'!!Q;^$>S0*OY"%&P>T(U^*A=W*D38_5@4Y4K<"$*WV*-8S'=A75"B
M$O93ELHT300K<+*)0[MK\6L!D$J>95P^3@6H8+2:'7BD?<%52OMT=)=CW6^@
M_S,#2N!<QG;SD;&KB`'L>XJ/C2@_7_`&)$(H-^S8"6ZC]2:5BLB*K5[,G80H
MM"4^9R(XZ4"Y\%NX<CA3-T0=R5?AEJ+S%GDF,<YMJ-4(&4*OYE_XG<0(C;_@
M);WYW^2E;,:<CCGKO>Q3]_:BOF0SHEFV0.2!V-5%2MNZ$05NRUS)O7I)]+71
M*W0G[,OEOJEW'%DW\"?K!O;58]\]K.P%*A?]M]"`KAKKZ@$U%@C4/S:F2[@7
MU3&:9F)6B(IJ:7!A8L-&^TD8D;<`V!`J`C&&+FFO)`'F$6D_'([RN>4=SGK&
MQJ81U:RRS1FB;'VD<Q)[*8GWM/@BEHK*<6QNWOS&AKTP?WU<J_`J,W;,LA9/
M/T!^\SDH$Z-S/)!P8/I*MLR`B3-M23'9&`\Q_!PXT<P3V0<B#@\V"QX26*.@
MPB3%)M(D-PQ\B><;8/96T"G<WMXE^1WQ+9HG9A,7HG"OXI^(\.7I+2]G6`M<
M\[QX6!3:OV$/KW':(WOBL8CX=)%*GFZ-!FVY%,V+#4ESIG2!'XC#W(MCRO`[
M^_J%BM,'4'^FOF<GTH2M%.L\$P7%A05D,?0)[)58)CPU=8?BMF3S%=R"41Q;
MB"K^VKRN'$=S1JP[PW))E61,B+&=\M_^^F]XO@:4,2E:+3HUAG2-0F18!.`-
M2VC[`@[8L)-T<P>Y1+1-.T*:QE%^>^NF>6_G3CN71Z*-8=4\YN5>CA8&HR08
M0SA&P\:R0@8KZ29),E^=8862K]\$^CW?X#@DB0=Z39KJAD66T@>99#_3[!F#
M?),\8H]4F+$/M.28L5`21]=YKC*L'#)=F6!/[N`G@JYXSR)!3?GX5KZC`Y6N
M$H."[MJILH`OV<K%%/P!A83H-"5.0EDA!D;A>8=9W\0##$T:ZE`KRS`H@#BP
MN0B)ZZEE_LT+^<@D(F=:XP&DSFSR!]:C,!B'"V!(&'-2+&(S-V_N()<EG07:
M+FS"MK8$[#8@R1D"6L0Q.:?3L?4T/#6&Q+]8!$?!4YL\D%,,MS&,ECQ3QUW>
MCFHVW&(?V\R99L>1`]M\M.&F"Q-NBG9"<7A]Q*"4U0$VP$:\8@^0L/#"LBSB
M&G]A4.'.!\)3<M#O#J:CXT&T(BHP85[ZLG\R.1ZY+_DPUC&/=7=4B(`\CMXG
M#X%W?T-F$G$15?]>LWA/)4R-OWC?A]`C&-R`-4+$2MPPH!_GI?(><X7DCGBS
M**)7.4!LG=>SJU>';!&+,T1_)T5[RS?<Y(O4L$M8'(M\O=6W9O@GO9%0K:#K
M8-V`"D@ISMA/P,,^0&O`X2V);A=\GA>Y<BK6M&1\#*@V%6#Y"00Y_#SR6H6=
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MS@EBP7)$0IHU-(U5,2]K5P>0`A53#6MG)(4;$',LV1CY`QF?,,B%$9S(W3PG
MCBG%)`IE7K37^8/S.K$BE.,M\1N?.SYQYIGN$)*V<)<"NU4]@S^J*B)2@Q9%
M+2TCR<2>8BZJ-&X=]-8WXKP<M#&65EEUXG/6?JI4JZL?*]TD6LX]3E*?UNW:
MDAK&O.*]QCOHV3F9]`Z_1Z!`(_U'V_SHG<`Q'N5>=5UTO8L,?\SNU*X]M_9L
MPP83%<;LF%83P)/U'D^FC3).\DTPFY693>@&Y`6R$[*Q?(W$)>Q'(F:!F7C6
MMG_DF<Z\,9B:E!EX`.FEZF_;8#'"Y[?/T_);?54-,A`!UE9#=1)0$X@:L0V[
MAD02,S(EEWH2QL:W(`L+(O*C"BZ@H1H'8C'1M.O)M4M2I#>E17EMC8]N7R>+
M[+,E?3Y-_H07I/9!Q(@\R5XN1YC@Y=TK;*E.\>.CWK`KCF1H<T?1Y6I=NIBB
M_:%S5=YLA?R'XZ,A3L`537"9WCZ:X_VQ$H\\3VZVT:6!M2#1L-@E!]3U2_=8
M*`PTK\('_<2^(LG76A0N:\YV$]5!$$:N6/-47_$"RCO/U+@VG*-$90=OD)F3
M?8Z-VAI;5GXWMD+3*^[/KB=/T4@JL3&14K(F_]'D,F9R46!Z011C`.A\P`1I
M=R2$0T+B"-[*J_QV^X`3[:AH..X=C4!%1C7Y7>$KCEB@UPD-_Q'&$$1Z=+;,
MRP5GAI1\R<QYKZ'^+=CF\M:*U!/XI.=\V]S>YCF]#?<$611FBDN2ZW2>916J
MWT;)TIH:'%?V!G-!ZY!O5<E%XM$6K^8,H.K#L#%/O4$]6MKR)OO,E,^'JC;6
MX/X[I6=5G)^D9G!X@"E^8.3Z.R\3V$C[`:CTW!,5>%D_N8*H\TRCI!=&F[H&
MXSC3U,HD`B9N!B-:GP-D/.-THPX&HT$N+,#LL)%)KO*O2:%N'"N/66F3@@50
MF55RL?O,Y3??I[0P)',?6;M/O8GC1=2C["ZG'=%\:-\)D27J!="K7"KJ&D1B
M?=]DO67?3#(7,3OKUB1=YHH?X>37%?Q:"W$5QLCXMCA.NQ$V7$U?0'G1M(+H
MMLP6A;ZL\R_+S1R!7='B=/'35UI/$Q?OFG&.;N+Y%R@>:0[X58:8P*/:#.P'
MQ@O+RJ@SLC(O41::9T4OY_R%[4NN+`?W2'2(CBM[WD)P3<O>>PH='_.WB%=%
MP\C+?3=AQ^HL_5<Q9K`U=M6K_:SC^:-Q!2[MH9>@<,@;VIP=#<O;LMT@NBSG
M5!RBUYND!OH)<26W.A]?`YRT\8<7ZH`[(=;^/VK)/0:&21+P!I%\OJ,=&[IK
MK."A9SFMY>:.8U8?`PQG@1C:Z^1F(\=ST%6.^B#F\C(QGM&*.`.?,;:B*_!A
MX,>W.Y_8\7X\[++T2S/\=%0PN*(=:"H8-@G0<GC61F1M\&B.F2PX=F6#K^MX
MBZ#&FKC&L3\S]K<N`3^S=^&D(LC_D6V?@9V:=T7G[/T/?;(C3WH#ZU^Y9R#4
M*L^XJ@6HQ-RGF`0NE$!SS&^/Z'_('4G(^BZVY<*$B;=D<B<K-KHQZ7AYE\8D
MH-Z\ER52X&.^6<._340-[/5QY-*LEJ2VNIGQC)S%K8Q6U6@PP^0KU^,0M:2Z
M2D+-RO.L)4B<<YY874>,_.A@T.L=]ZWWDI'4QGD/QRH=/0Z8KY<2UF\&_1NV
MAJ@G#5N%L`HH%,#>E/31;0[82+D6:V$5_YRN2K[M8#3N'??L7+HNG'HP#'X!
MSK0H<GAOE1<T(F?M8T'0;FD;D:FT4:H(>0<%7E_P*1\>YP`<6"J$EN,JMZ^I
M;`WZ9&PS-5@7BI4.F%G?0#X:&2.U2!AQZ%Y!RK"X#+WZX6%R32P9>TNC:"R%
M-K$*;9QT-*\OR6.4$./('Y.DJ'`"#1IE65)!>5;>S;O%@WYQ,,G9@MAON-/'
M=E=M/-B\NB<EE5>U$2"V#D0A5B&VS8GK+1V]\NZ>L2_LZJ)'K?(%B58V'1&.
MV*P9P5TX]ZB$;VA=;\Q\!16<A,@*0<>(GT<V^1[.:\_^H'/G$;WXTDJAB&7Z
M)5FF][GXVQ0>4'E+$W'3%_16Q*^(0[_(A-D[[:.6THPL$E'@\QOLLV)_Q-G'
MH:H:+DQW89<*4F$J'*TV"]0-68SP!3@R4;XDZA`)Z887AY()Z&4DAUSE(!+F
MU)IK)/0CB9@5-G<0C>C'273EL)QA$/D9U.5CSHR67(F6A=F%K0.)?ZVBQ#P3
MU"@X3>_T^RANSQ'3](Z`U]MW`5/G#"!&</\JJI2X_O3@"+Y!48ZDK=@8JZ&2
MVH84`IA*8`<LP!AN!;MFP#&FM%20=EU;<^L5-RY]GUUQ$.%6H]%?4[R60\^H
MYIPBL@(=HH&;<K2PZ*H>K9K,C<L)1KBVG,\-ID'#N)I.8$PARR&"\^Y0?&*2
M%8ZEU*<JSQ>U.<Z"[*YMU?!QO'$GH=X9I]'-(PG@22"9_<@EGW[!EQMI_(Z+
MBVFD<RPP>S/GRD%%C,.9D.YPZ,0!FN"@8/Z@64*[;@=(FG1917`:#5@6TS*A
M2',J.;^*3K!P8[<HC@Z+EQ!BD!$.69$8.ZE!3_?X9I4W7F9':Z0?%KRYC>7:
MP.4&X'*FZ%BE&$4TI=^L[Z\_.#D>1N>-!1*BSLGH^#0ZE)$DE-[ITY8?[F:O
M'SQR:C_'EQ\__9_Q:OW?SW$X[C;QRELRR4%PX!DKK1N%KTU_I*6(EX^%E7P2
MP;<W/&A)K6I"-QDDR_0O[**S_F#!9M!4^_W?1BIHG:J`^3EWQ`+)$ID)J,M+
M-JFBH57B:_8>XB+-@LULTTMYU^&!\#QP-[Y]1_8SD<<R->B906_0XY()\,6O
M5)><:Q5!5HI_Y@VC]SGHC\;>P=:3XC:P^FY[J-&"E8#D]L<U#@6G"SH!YLA#
MR;8BQ4I!TWK/!G-XR/TQ:B:0R07AN)8:GELIYV!/NB72@\&@5UN&^MHU[!:"
ML0^Y_S2;!><6>=0?!]Q3II.Y'=6]Q*]&2#5L:M^X?YK50``&-XD[#R_3`\O"
M`V8:_:_E@6Y;31*'6A16='AJDFZF[UEXR#=?:!WGR>^$NDD/U(1D-9=Y)P/N
MURB#8T$)TL;2:Z7%O9[O9DYGZ-9R($=^=0;JW`.T'YRM#3ROT(=]2?60XV>-
M6=TL!>#$%G'<`B5Y8!>_8%ZLMV[Y&*!U(W.S#6>TFEH5/=ZX`6W`[=C7A:V]
MXD9S>,/FZ9KP107O[%U1L1:;BHXR=A$[<&Z"<3SM&40SI\;4LJ`93&RO1KQ^
M6VZRZFU=%G.[G&W!TQ?!T^/6I^\UY6B6.6ED3`E)CE?J??*YHKNH/L+J@F@K
M154I<',X\]"6?G$3LSY:&D>BJUW50.H@-`ARDN,'T?!D2J86_?-4_IP,CT\B
M6S0*V-JB9O):I+=!(3)F<]`[/1Y$)^/1\2CJ8[1^MW<R.)X&T_2'(?%*:X-[
MBZA'-W7HKA/2/#HG=#/]&4S)RCN,/JIN_)V`?_>92J<_/F$EIH/W@7[3Z<F?
MR6C`S]AO4'^&G=&0U"A,B]YPB@]3F>VP-^8/E34/O>,'T7A,,Y`%QD*/^\?8
MA?$IWAQL9:OE@@W0]R;_FG1K;O%]\D`+@:7O15@SGJO\]Y,-O+?`B@^B_FC(
M;]%G]?/,AXK&[;5B1J,)[>1P#/JX#E_3K(!27FOI-R_,M^.PN\NO%3C&T[-E
M;N6WERU._&"9-:;=GP[I;0Y4N_Z1))JZBEES'_<G1"/C?I_>^S6J)M\G"\6H
M]:<@E_YD9!?#S>P@.IF,Z4;ZVQL1`<\:**EKHRQRCZ60@R$&=GC44(/#3?]R
M^?[5IS]?SWAK;M*\((MT&6^L=N[<XIPXE]C:7[Q.L#`77TTAE$URAP`JKZ?Z
M6X]UODV0U[8Y3VCQ]IJRSM%-<?&2&>ZHXS=SF3=M=?L".$7]UCU)=-<3&T9M
M+C58!3S[9:>Z'*!/-ROU?FWN]#0&%0YVG((FLFO;VO#$7%@=^VUZ*\BB`'T=
M5`E'Z/WI*SZ4VR/%2RR0E,#GN3\\&@R5,1,+8=9\0"SZ5+@]B[-1\,M)GYGV
M033I$^<Z%RT22J(+&O?';M!AMT=L?4C<OCLZ';`\&O=QXKT?AJ<39OR3W@D=
M\WWL=O1*N(5;"7DB9)(V%/F8C@=T\/_VU_^AGX;]$3T=_Y9/U\AJ@>9NLXE)
M'L2KI/`'GXQT#/X0_FOF.RW2S*VM1ASPM5GFX5%_:A=D<`J>UAF>]%@L#[JG
MQ.2P((,3EMY#=MKR#_3%T#*WJFY]$$V[$]H%WI=A=SB9\'BT9_2($:TH+ACT
M1"VA"_K3$]HQN:`WP%*_?D'9@+W+TXL@!F\Z'7C6FX#^25DZW<L=1EK$0;\_
M\1DR!AA,_*A;=0"URYS6$99OD/H@QR]Y?7]>[-B*5XE?<$2YM$33G`OQ&:O6
MYB^)@P&EC@_/6:OVN-R<1;EQD9#::TNHC4@TV3C[>4E,AG,C7(+/K1T8#B:3
M:6`\B?MW*?"GLW-Y1X+>]@!K!T,HB#9H6>7%OIN#<YK%.YLW\+ECCU%=.T;5
MR+W<XLOXUHVM:[XVS2Y$@&*_K%,FK<?W!!6^N9.B15)72FH;B?0[OSBK(03.
M-**FH>%!KS<T@",R=O/\2R4F(1B:)G69?4ECTH&&GG/&X[!!(XMSC\-VK%5_
MZ!GX7G!K6W-TI7>:O=?*M@UC,*DO0C3R;YMJ1S0^O_>WA-T5MT3YJ?%F;MO"
M$<?19T3P:M*`PZBL%UA7:<5I71;);;GD@_"","UVR7JG+8*DP4-B_;?6A=7@
M-I=8/EL&OD?-"]!J$,VZ=6^E!@N7U0XKR]TN2]BX"DOBR)=4#5@@@KUDC#'*
M](3@10^LWA#E&G0#&,\+0UN!_+STY.<G)S\_JOQ\CJRMGE^7E1SL'K;?LDX9
MA3$*%V0`!@=PO9Q''7Q[>"P_XDS9K27._#'9T``Y6W%`Z?`-^N4A*,,J>T09
MWW20!]T3,G=//:IP>N)KJ2M19<QU/9ASTOVK3+<4/Q;`A\-4=\%F:LA>#,`*
MBY?`$N='A3[3JBB0M$/'M!U3]069R>$^UH)5D.@J1'`'5YUFI"_'#L7!_#C7
MK%9-I>;\*,^GA)@6:N.U"KOZ/,R1,Z/@,P24%I[BK"V@B"*,LI5R`"Y"/D\W
MI(LCF`;WE+@JO<59!L4DGIQ=DK+]KROCK;>D]/&:1$UKPG1C9JQJ$5':9F'*
MDV%T"%\MY65?UAB6#;%0JS5H*1.#GFG0'?RX+B/<?1V&':&&AS<19$4/%'5.
MYUU4)NSK#HN&!^TS::&!>ITM>H[5A>"Y-*2"1R<:-1`HMS"$"E#"L7B7BNE5
M7?0*%8B7QR*DF*M9#%MN^T<M.>^`E;IW5^PB+Y<F4N/R%5V)1YN9S^553:7%
M^BMQ!4&#@F%^I.1E5KE;C?3*6@:;QY"M=FVP'H=[RFW$[*_C@DE.B80ITS\9
MDR$#4#79=0/Y.(T&)W#A(#F0/L).I8^GT6#:XX^#7C28P#TKEA4-TAV?PF5J
MO0=-\6ZMC\`A!?K)=JT(/-:VRI8+_HM'L?IN>SB6^]TI63D#Z(I"RK1>=MCA
M*0)N$K>&.?N$TW30[8^A!.+%_/-LQ]M72Q^KPNOE*QT,@UAE'7UE8%T+9+X3
M>19:8`ZWGGB:J5?-]]#$I$RQ@*W$@@PF7RO4,RK`KY*,0J/NIRW7NO!TA-U:
MW+'%`:@)8O;4>]VJEK4OFDB/2@,TS6*-ONGU&M2T_DDWJC97./.;*[Q0<=OO
MA9_"-?Y:6F6CIY?+77"@W_?U>1:EUC#QYF].1LW5V0+PVG&9GUG3[M!L`XYQ
M3$/*6K#Q;2*2P<)++21>\\;"1R[C5+RYR#ZQ.3`<%XY)7TVX&(1OU;&ZS:'Y
M1'$9"&@_E86C+-&!0-B60T]9R#H%D22:.F[L,2[LX89K]IZ&3%3X]Q_+''OV
M<<,87#A')/WFG58'ZD@4OG\8U(&6H_[!!?,O)<2O5P_"JS]G>=N5PT/5K+\7
M.*971YL8[^D4OL(#=AN&__*Z`G%ZI4LN_M[:'[6?2"CT3T_4D>E_?N-*-P57
M3WMP(<K5[O,[$MAWR#7P*N6QZ:%)0-X0`Q8TN,E]\J:N[16]&^"KP_]Q(?Y_
MGG#&$7;$-GA"G4N2U3PM^PEE3`SY<K#7X`^"JO"CWO&4+[<?C!0?=8=]"8%-
MV/E)_^X-.3:+J]YZO7V:YT12<LHQ(]DK[Q^M`%H'!BVBT>F8'F;>6OYEIC8>
MB/L\&%DNV2\>\'=`Z=/^Q'M'_U\OI?0>*6D]I5WWN9G23T:G2G/NTS.H'`=)
MCXG]]`25G_+_=U+Y=*`D:C_L1^-#,[+]8`AIT#W5R/&$_TO_'DXM2]F'QL=\
M0F23W.>]*'S0'^M197;`_[(3&_1X0O[`>@77QG*AT"P/Z\B(!+:6EB[.'L+)
M4UGW]N`'R2)=@?N(`9<%5=(:11?7&.<#8248)RZ94AHWR?8!;]B29<"RLWCA
MM"NX0EHL/;U1ZM5L\&M>%;6V#E[-O*;#V`8E%7\!JHFR<WPN54--=1AQ*5:<
MB-A(>JBI\\S>YH6F(%H-:RULS&_#L>M1\"7<2C%<46^[T?XM'KYOQ>5WC;*Z
M=Y'[(/$@K$S^'.48]7,*A="[#$Z_Q/6>&:`[=;%O7+7=-;6Z+U32I6R&1[>6
MNLUIKU3SE/5"W0QWDU]2TIR%H/+JKQ*8]\CHS,Q3_MG^2]!Z3QO[)%"J8>3W
MF'M+E+T_8'6ECQ`[Z3#3\6^CJR2#UTN&0&%,20W0TD?19`!DS'B*:.ADB(C!
M>#KTV/)DB-^)(4]/^>]D-&6TS?AD#-A,C:E@H;/6Z8:)89+'K>#7`!4+'NF[
MH@RFS%;4PS;7VH`&@8NBB>5A=DWKTL*X9&I=;VY=3779;')I.D*<EP9UC&S/
MDUNEQ+KM/>@RCN"&;N.4YE^4R7C2^BR0UA\\:?T"'U8E<\,4I7Q2,5!$OG&;
M-&2]@0%KM/V:A=X[$7;FRRN2?_I5>-[X:/+[NT^O[30KK8ZT&"6IUI,^FP"#
MZ9C1#Z*)T-\3:"DF:;B(."N'E1G.A&--R"D!'O%U!G1<#B-8;U#:`6`QR$>K
M$.'_G3'#)?T9:BLE-S=6^S$W18H&_V[B3&WE#RLH^6%O4"VN&&815&$2C?DF
MV'2!4.ZW]0G[%$S6D;KL'5I0U.[&3J%[Y.^%<$P74'?>8-L2()A#I?IF.Z3R
M5T[)[?X"2;EA*LV>V3IYN;T57U'^4S*W\/):AKA7_U78>6Q#,H/?1EZN3>CX
M=PD=Q`E=QS0IT\WR@!LX(*;EDF_=0@75"JNY>*Y:55.^H>D#\)^24_A?,GSN
MP`4O(V6IF2AI@$!KA<`#I=%M4Q(;O/^U6?BX&!]3BE.9U0)"6C-`8`UN$HTC
MA_3_[=DY?'IW9^@HY5K2Y-`_KY=%7IBZ!HV9N7^_N;.%`Z0IV(0F9:`FGN,\
MUA!]&PZSJR6HA2BT1K2?T6BQ+!)$Q.8BJ(Y4@A9TSG^A4UCSX3=54MS1M;PK
MII`IW4RL\<J9XSM"!8T%&SU_E3=*@QKHY<HPC55=`J9T<^#QVL<?[YE`;[C"
M_N>,%ES._QM4::]__58"+S.[^P)D_DK;B@D=$;D=(8UDEZ?09-D<1,.I)(?T
M!/,J.%KS]7NOW/?)`+J2),NP9G<R@'^QV;=HQI_VX:K&H#JR?.&/>WH"YR.4
M3+T$7_2>XXDT#T/DUVB5^.P_9:!/&>`IR*7!%Z=J].UP\-!*=/LG)V)KL@^Z
MTV?DM?EAO-/IV0TJIALW>Y_7VOC]IL^WH_^S2*7G>4([/:8"^7H2+/;D%%8Y
M+W:?`=83!L?O)I7!Y%0]MTH'P![T@G%ADI]&V+\.9G)(-GGOER<5B1`IJ>`5
MY8L]2&70[?=E;WM"*@.>I?R`Y*_GD0IG.['OP:XU#N43E07"PFM6(FWO*]VA
M70<UTVZCID5:Y:5J8;=VW#5`N*"UXCZ6RJ[\IS,K(4G@HL8@4@?Y((V1R80.
MM!GWW@(R:5/X=8^]6L2,>^E%2)D#R63)H]%SQ"LX'6&1AP.L^-4]D9187[48
M"RAN.+:\PT4H)7[#V5_-[KAYY3U\?X^QMXR_I\LR?8_7ZL()7GT7`]PHVM_#
MLX3#"(%I))/J[=)0P]&.H,CVG)V4_D:;K2V*AS$/$APOM.G'H[LR)I5CB^+C
M*W.*_4E*<6C3LR<PWNF@_98O&.`#-!C>#Q/,?W%/!,_7ZR>\OK,+\'V%@2)?
MN*H^-&*4&8EF6;$Q")O4"7\):LR:\7+>S&R][%\YK<J3/Q6!LL\UYR6;%[;-
M"FFDS($..%=W(EY<^VDRZJGSM4<''?>*3FQO-P[+6P3K)$VHWSV5!&#^.Z:_
MP]&0^##^PG7K1O%O&DUQB_QW`)Z+_QJ<6\/BM^@&1AGPA8#A^FROH7C>7>(V
MZT4[OS]5L]D5GI>I"9?A#KI1_U6E_[`!O2>Q6.^NT/DZN-@3,!RAXUSF_';G
M2]KZ_-)<0GD$-R@21(ZH,#MH^Y?SDGY\^FV()'M]ELSCB:C,IU-QE!*9]9$U
M_BE\AP/65PY8G\!_Q_S?D;M,7Y"%O"2C626\TU-54^7_%9>*1.,_O]+P<_R?
M+!3L*"Y:QA71:$737+P0)+PW;%UK]K*K-`;G!.W4P6CLI\_"<SJ:>BEG5<>I
M"SSY:>5!$=E0>;.PT&>K$BJAGGA-ZWJOA`SKN`7/\F^I]*N@KWU"CQP]YPHS
MJ$V^?!28=UA*MVT6;76&J[:N!V/885,W7\6O\OMD<<?%U%UWU+T2C%N&?*UA
MJS,3MGJM,137C^;(/M._\=QUM;M;YC>HN1-O2]>_TQ4"Z9J2?E;9<LTCT><V
MWFA370V=\8HRL;$&C"=PV\`%5)5-I7*S'<HB+&@@[_)"O;U:!J4H;WXR7<>\
MR,A3L;M+%$=>2-QY18M^IP#"P@&E'Z0P46TH$Y-RH!5T2$9=W;22W%2O8AK[
MQ1#9=J#12:W?&F54B@ISX019AF.[H3LF@`=+ML;^,@MXTT7IE7;IXSWZ)X'<
MXJ]:A=>U\4?I-!R&AHXZ33DV$1=;U.N>Z,[DJ,\1H2`B!,-2NN.V<UYS)X1#
MX;FK2"IH,]H0V)3UWF.7!%RJ75'3+$#:"G4R(T[NB>7A4(5=K#L;6VTHQSO-
M/IQ=VH05#_UZ>%R529Y<-:6)7`EVCQP87UJ=KJVNQ)5FO'9,DMR[%,M1<T5,
M23VS!C<)SCBO^2+L`,<-"+T53S-OS?D&WSO9K"#X:[FC?9SFD^5*U_:<[W.N
M)`]SPYV<$\W7R+E!`4_1.SR6:[07VGEOIB`M'6N,<I=1C.:FK'6,AH)/Z'?[
M7!_O+,[B18J*S\R<R*(E;6*,_/E7$"5<_135XFF2&Q;E`^@S0VC,?XA)HH!V
M'VD[.?[;ASH^0X%:(B`W9A\Z3=\YT/98.4X9Z0OPCE2EWD!M98_<&F-]>_([
MWI>X"+2+YQTG@PJ2@FTB?UV$5(_Y;70P&7II]*SX3`?^-R\V/'^T_2I1*CW@
MY6@,GFRW2^/JWW(^Y,_;"G,$:S)](Y_]_J;-L&G2S,$G5[9#0B],TJ8K.,==
M>2XN2XLU-MN=$V'2C3:F_]M?_RUH@YOOJHFK#"=H2!MY06,D/"OHC5N'DYZ$
M2NS;(K",O:A[<YI#V\;X\S0-F%2*-H?_GR;1_2J"BLCD,+%1I8J*Z+I71<D'
M,>;/+NG;8C9=A$A*%$%AU_)W'7$E'Z)5LT-,LIVD<H?VX8-MD7ZII'5AQ<I'
M.>>'+6,ZH0+87;*U(UPZ.>#&>&L*L#K;K>$KT_OP`,!W&.F=,9M1'QI%@W.V
M2A'2!@OR?]'5F0KVN,.NS1W+,]3+>!'W4NIEJ'./EG_4Z#F+3WD?84U/GZ`N
M*;\2.)4X?98([W,Z8[>J.]='Y2/M@=.L91?T!#/M2KQRD]R02(6!R/HX;$PE
MLLKO6:>1^KN[3<(3LAJ'WTHL*<)^&+49.W;(">VCZ<!O_0KY,YR,?133-W2#
MW7IRKC_T,`WR'"^//JR7&NC<BF]Z66O?KJ[EWN5E=M;!`;C'Z.5`&M56;H?'
M8L^*.)Z[.*#S^Y38NZ$NB\=U%\2AI9AIJUNO(U?A\"BA)/5[UZ(5=[+U1F[+
M9GLN<FPO>55Q;J_]7G_/@JFY0C3V(/B+Y>(DTG+U28G8DCL<7?'QMMS0=U<W
M')L&G\3WVK'+GYUPN;`M-AR#\/V^M0@N_XY9>\%"`)M/=,AF#"`*`"+L5>6M
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MAHLYX:+^I^KD>4@M-XLR)YT!AT=1D+,SXK@H(N^O`U>,[8Y9UW^#ABE^Z3UZ
M3I"/`C#/>5K(9)21F&LZIQR9]3YR9_>ERBOG+',*@4&:F;_\6M4$%W%/#!6(
MJ9_K_1F=.T]4EK-`\!F?P%M>SF==_4V/$D<(*C31+NUJ/?D?-:%]+!<O,O<L
M-VE`DC>/SJZM6APU<*;UYQ"E>"@*BR5BPY>Q1#MOW</O\CG3#H)79(J5S*H^
M$F/R-)A74C*(<^N+@(;]@OE[U_-7-"8@<()['/:U;&[G]%21BYWQ*9_?#T\Z
MHF],5SCC2C-=3H`1GDSHV*%Z4V<H-?"'*!,Q6]F"\17WV_-\X`SZG$I"FLU/
MFPJW`9$;&\$H-4\.""!0YX0+0_N3[HP$%_M$"2I!D4X&C'4T/0G@@>,"!O*Q
M)][*_SV);\@R9<*K,]0BVVCE(,2GB<(=+A[R392'A@D3!K*3\.GKBHL\^J5(
MKS/A6?=[6IV&:UD`*O\2LE-'-T?O_#GW=Y<]&UGQTYD:"%+_U)*:^3"8\'KN
MP67C;UR<>H,R?LLK$]!P'@>S#0T.^/U$Q[ZZ4)/VHP=EZ0Y*$XR/SQ@'R%L]
M[!;GW;?I&$/S[X&9J5?SS;N9<RR&3$/>Q_K,]@BF?C*1:PZ;=,8\!PX2F!#!
MSIGH2RB<366#8MI,"X[*`0ND*H=K'(A^*G79.S@,-;W@(MY`X>1&\*)7MU[Q
MT5RQR^-2&P[U'=.YFBA+-FT3_R)I=\\HYW@Y-QT1?A5TXOMRA0!2OOG>UYYW
MN6;@@YPR^G#:'RE(<<JU?A@N<(KOSA-4K,UDW!]-5JR!JV8ELUO/V%'KQW/4
M#H:@D,$07`&?^_KYP@4SL7(X:WYNU)4T_M:VMIQ`I4V`U:)RJ9.H`-3CG`SW
M_^MTE1Q]311J`75]+K%.L0\1"NYIOA(.4<\FZE0NZ>ME`[[LW,S4%1$-7US&
MFS)7A3YR)5^S9<]N+B$"=F"WTPN6"8L%U+'[/+%<C&L^VA[0K*^:@<7?X_GF
M,*IYE(Q^D\QCX,0$Q&\Z>7)8!F5SC^QV:!6?H`9Q#4UXY3D>3`)_#?CGT(&2
MK^'<$Y\T4`00.)WSIM%V',C&R_TO@V==:!7<)R13JRO%EG5N*"CQ[;'U%QWZ
M3VV%X5$_2E#F(RU7(G]@1%XE;/!W(^($B:V!NUBA&]!6`U@#;J`!*7&"A+83
M0(VORAN!OXQ0T&N,K*?^\!10'VXK<.;E)K>N(5P@A2G^T!FP%.J,S1]&,>^]
M_!:.PWX59A'&XSZ"'3!FB-*00?X#B0A8N:10BDY_(-VW^M+JHS,4[;##&43/
MG,R>'O$#K"N0!,-3J50S$J`X^,:WDF85OLE`&'4`M[L(M83^+TF8#<P4H2N\
MZ`F__&#"DF`_5CT$#0Y@*TZPFV.X=KA@GH$]:9%R#C;I+71Q'\Z:P50RLD80
M\96+X+C#-7U.#`&'O]@E9)#0"G\5*!_GZ>_H0!S(D3B00W&@Q^)`#\8;9%G!
M.%L8Q::)?ZI%]G1^H?H;[V14(+!T50N42"%!DJA[?V%#&\X':JP9W0`\\_O=
MFG8#K?6GI]U>CW9K,."_K<2B<KO?'_-U_9,>_ZV3RHD,.);?]Z'9J0PYZI_P
M7TM9HME\M-Y=4%;GXNKC1RC.8G"Y*!"/:"H42[.P1`H/^"R%UV*/!TB<!!]-
M\`'*P,K']^:8`GS:IB'T)J$]F%<>NDCF\N3^Z>F8!X0IJ!]M9(,#1,E"QO1\
M%S*-5?QSNBI7/@+&JI/.BUX+7=G:ZS>^0U[H9ZMOAV#/I#OHR6:YOD1/-V,*
M_/JGLG,FYL15Z8NBM(_#W-P"^,'42GR@/_`'TC'V09`TM(5C^7(=_USO#>I^
MV[?AFQOK):V;^*A;PH%4W9B2'L383S7]DCCA;Y\"XH!'Z^43W/A"L,W,!CU2
MX5BF?J1-X+A-%JSQ0"\KN0&?G;:!I3:\43M$^UO<`E=V#OR0(?R*OVW^PQX-
MS$=-C+ZI5PSQR=]ZIKLU*#J<:,A=2[DKJ.UA"DWG3+N+XK79NK;P0W@#M!ZG
MK&*G)_=7_T!Q^FA/8+TS`9X."0O/$"*K[^*LO`7V=B,`'A-[[T@7NX[TP=,"
M"OI'?"$T-^+%C/LG=5I<O<[4&NE5\HTQZ(;117TG09>TGJP3_)9I$W\F_&5X
M`E[:M"QJ[UD64E?JE%%#9)I=3:0%H(K7PF3;ML?/8&TOGW-UIHP#D:G&UL'3
M")'PB[6"E[N>8BAY*>`W#&L!E=TJ5**K21S/6)%9"+S\;)ZT17?/*&!Z/[IC
M7Y0W1;I(Z8R;;)&<SD`&]IW\'$L9Q)O'Z"M=D)<%GL]X/$%(2.([C7:;+L.=
MU=[':0,/^HG.0;%(M9R.&9@O8;.QZ`95'?W+\3"H][?)`YP!R;K6JT3894X+
MFT#-*FQG9P8'2O,YL\(/IC>W*9GJ`0^#&;/AQ(OA.I,(5D-=X^QSAQL3\^\B
MQRQ>=O$%:E?P4-[:>",534/U1L>"BH%]:UN`2=-?1L"@C(5D]!<%DYBEO/,8
MC6U9$LYTAQZCSM4_SZX/I;,7+0#=2L\XA:BYBSFOBTTFZ%JBV/Z<>%6>Z$!L
M+;I'*9<#YII]&B![D;*9+[^:_DHZFY@T7P@FS?3/Q*]MDB+,CP867#)W-N4#
MZ47P.[@ZYD^KT;,Y[KSHIKDZIK-,&$)9;KW\MC6I<;'F)L:D/F59(K4SR>1/
MN`$:D9/(5WU05[XSG7C]]S/Z';0P;0:/8;-@+Y@OY86B>8Z]3M*F.!E?G"ST
MC7JG8($'([]_B4_1!IZ@Y:J62]M_T3KCN&C6@AU>Q;K<2C4V(G*T2E%(4FZK
M4\5?$HM"]=<7*\F5EGF;]&S`^YT4MN2@]YY?T[N<]J$`0OJUGA/+<I@"/]IG
M/@>$(SD\6R_GP^N1:VJ9M7!12>^7EFC*GG%_6-QR,/*`@-46;TY*L.;A$GAB
MRPS"9T,NTW'=2M9>7.09&8:/F%+!*H'I4"A-BOE-;$>+IX1"M5ILF04^MI]R
M(@TB]R+-3&$V.XQ6$K>EKUGUULPAPTK::M0R-VGG]SYM<H=%*:T-$].#9S.U
M^$*B6BU=4#QXMLFXN)+RW%'G\M/5H0<5L9FV6!QOS+JD4JE=Y4[^0O#D5,G&
MNN+J)?(7D!@%P9%LMAXQ^,R-L]EYH\/=I4D^,DN`N$&)%Y>(@2J68.H>A6K>
MA!S#ZFPXL]26Z915^S#?YMKRK\\6`1'!3T0*86E&3ZCH\GZZ<H(P#D5A_5#T
MAWXUSS1S6JKFPM+2BY@BAC7%8>V=B-T"_N678C?>:([J:<'UH#([9OM`T@:(
MU0=H%RHFK"+R&)GBC32/W].4DLW_^_\L4.`N0\4,UC<"YB:9%J(AN[(XPLOT
M/;!9]J0$^&1F>Y:7<1L%B=]P*<;<=`,U^2Y215$J/JY*IAI;UL=5IP\,,.P$
MG@0Q;!.+[6+V/7D&J:P"94MOL];L0O@RW4,T09!/=.58&>*BS5VF*F!BX&&E
MS)!IQ;ZPI\&-6IU7*&='VHR5A'MB):/R%',G]B_YUQ*#B>2KFMTFRNRQ,%=^
MT,6NS[D28^WFS1V1B:D$Z08Q.2L?_1P+HN^&D7<%5)XU-S6[;+J:3=21]NGU
MHL4M*3W_(<5;#%C23`*8PR'C#T><\3!AK$C?76>\JYVQV*-3-5(%U]'IC]A:
M103=P"KRH&*)!*TY$WK(&`L.=#/FPN!D;.V%NR`.+W=J;3R]K\,16D"#'%A%
MKSNIN(YYFD,.Q$L\?<?B:UZ?=J9G@&%G,-9_JZ6O-*%N6=/SM"DIPA9-86TS
M-5::K0I3U4"X7WN0<36>^EEE+TY5,QD8%SZ'DRGO2,Y0==A6F+5>[IW5YPSX
MQB6J[U7F&V7*AU(1:C+FND`L_8^,#-DD-UR08S1"9&HX1O##>GC#/(AL8=0\
M=)1!*&-XBM2U3_ECO+0%BJ3#+UO%"3S>$R3`]#E=\-Q4BC`%&R8@\CXWH-&&
MB(RC&_>FMA-">P5P1@^<]"7\B$^(B,@P;Y&Q=(V,):^QSLYL)MV3YVW)?NLO
MU=T/(BGIOL_:<BP5ET]USD.N13H8H=F$?];:,K-.^V/![(V!+/BHTB=WG>'A
MH*!A'J.C:';Y>@:Q)J]=;DC!"3O,$O$;=SS.5QQ=?7H;=:3I(8T0N.KM!8?B
MMI4O,D_9Z#K+&HFH<Z]JN+GXO5%`WZ%Y!72(:,9U^J(._OZ%GJ"7HGW-,GK-
M/=AS:']XF4/14FS9+]LNE8NNK=+%D9=70=H4'!N)5(0G=KFZ*3>%MOTAP;M%
M#3TR,4AC@ARGW\I8JA#$TLT+,HK;5QB<`4DT`6QS6$IT,%[CL)]T;\+*A-]A
MNL\:Q2V7189.LEXGK.Z`:6_M&)4`^AQ;AN\_$=?MZJX62?)%:\*72S$%M?5Z
MTQNF"(LEL$CF"<)LL*'CK7D^]&]1T8[]N-&H*S.RL:)8%)92-`;G?Q2E:##2
M+&DL5I?M%^<^8BK(-S7JU/0@-ZXF;4NY[JW&BII>B6G*3Y\91G>Y>NH`,^,Z
M#+$Z%5@)]-[K(<@;/A@//>GAT9.MK%(Q98V[P.4AA!-QQ5O6*![N].`-9QB%
M)HA,QS,LG.7GZXAP4X`OT8[\CIM)I2N=%Z]R7C\-4I()ZKFRO,9E5`U(W;=2
MCZYV@(SB^H<X<V_)VYYY0;=EN5I#_8+)H-UE43_F\R<$'YPP%@>.]Y9.9X:W
MH=`7QZQF7[_"<"DW<?1&$";P*1/C9@TR)FZQW>8;5"75G\4IQ_ZN-9TAV!EA
M))1'K=P4S=F[!*>7";A]E:Q^-\EC/0O$Q>NL4L2T^+&-1S1V-JU'W;+<?.`X
M*&>MH%"AP9I-QUX.O.EH431+RT55[#8!BWZA1A_V%58PJ39/-^=1^F3?I-MI
MF-F\I$_1,/.)AB+Q8$_BGV<P+@D<`Y'YQ9KY[*@.CYG]0&:&MF)43?^"Z`"K
M^N(;=\98]QTC,+IV7/>A?<]WK9CH$?8"KQO[5_,LVTPJ,<^B&6OO"7&#JEC@
MB@:B%LVA.Z`V1$E?KW!BK\J;#_1G]@9G6+PD#Y5Z6+'4_.6&42P]0@)K'*SC
MOB4=)O;=)/0.WBVS-UW+'WU$G/2IJC138!<0O>U-OD@]&SYP]\^6?[DG'IQL
M_O;7?RO`*4#2P2MC.\HY`]D5C@>/V@++>/OH846A&\;KA)C*W'^JYV>&&0.5
MU>#!*R_1A>?>BZ&VO]-R:8JL:;U+AG;&J\=EGD*E)3:L,T`TGJZC<5?Q3=1Y
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MUKHXH6R)ZX!XH[HXT6J<Y9$<&2-F735:O)68=W$[N>>>H]<IG#:`D.5>ES"N
M^F4GZ16N]:K=<6C/Y#C+H3]&H')/K<-,0/0^NND^79L*1/R\'5J$.?5:D\A[
MI`;BEC'C^A`?>I`*MP(,E>B9JS(L_@.W]O1.&IG$A8!^Y2L2K:9%DRV@969B
M"L"&+V$4I$J%YGV*.MO=:]%GGEE7<&M#Y&&+"!,?K<RP;68\!"SDDZI[=>I5
M':CZ3#]PN7F!9-*Y%?`@HY&X8$JMHM<NM;$0.]79WD^^CR/Q0%-\<H&%!,U>
M[9C3@S:F5HFC)P$51THO8!PHC);P#-TT_UHK6_ZD"/L&;LA!5E].[\$;GMPO
MCV-XKH^GF,?^[5VKM<];9]+4]_6T&^UO1/V:=N29(\&OB1=1^.1SDQ?=%%W%
MJZ*DS7J5YLF:3L\?&-+P0R(UXF?6/"(MVO=9#9I,*X%#F/KR%=/*>]#;_"Z=
MP^P\CMYNB8PZWF]+_HUL`.MD%6M#-HH$:V7"7%E1*=VW4>2-M?<,L2L3,EW?
MLVN8+2'2;8^CVK.%^I!"0V\F@2)3S^@J+^E-_CDG&B'S%/C1:EPI:,EY:%Q>
M)^/?@@*^L`I977&UP?RGAJ..3I\SA=&X-@-%1*I)T:?)(.R_`0%XV*;/%L?>
MLH\NNDW'W`4TI/T[,P"I\^L.)AB<,1:YBE[ML09.;_($%=QIF4CH"%`Q;ON1
MHO)3DY3KMCTMK?4>Z;G.J+:3*7N>W%O8G5$+%\V4]MZ.L:<C'AJM4(RQ,*8R
MMH@_'W=E)Z&)+6T+HT6*@I5A"P[8:`$T2$(K[Y8M9.3&U_I.=?(4%2HOEPON
MZ?D0E86@=A2I&ZXT:9IS@`#NC'%+Q'OZ6W7A)C_#""RTGG):F"FE52T=-HN`
M??PFN?&C`=;*H+G?SM1KI;&*%]R*J'ZRF4]57S!P>S^HPB@^UB6$P6-P-%VV
MAP<Z69:%=Y">JW<]I:$T[HHJ6E./->`9R'/;FS8GGI'%2MJ)9^(<MII=7AV#
M>@75G8U3GE_J\Y79?79(<W]7?L@MK13CJ%!TO"82'FP-7.=]]M;3[:&>JE6R
MO9=2<%[I7.7+-N[C,AE=?*3)Q&K50)KV$1X!PP=2+BS(Z!_;ML![!,^7A2!2
MI]C>-P4<O,T)6F?KZ]'`G%EAMR=)@KH&+U,*@QIFS_`-A+&T6*>651>+B[9Y
M1H.`-'98W#6#O7KS::69]PO,=:_AGU.-/G@.QOY4RK]T@\`PMWU!`8/"H[U]
MM27A70WZ5LU[76<2@8M6D^RWY0JP^&2^(:6HB*`NT;\[U^]?'P:*DC;*F*.8
MPH(!(;1(:.ZPYHVV:S:/A:.#E/D!-)(_D!V@*VT<?$T#T:7"BH,&38.Q/`>C
M2=#HO%*\,(AV_5HFD"GU;S*6Q1R2L\Y=-DPI;N,W`[@?=1&0924APGAY7!<^
M!6+7DKO$1J?B@H.:H`?3BG_8^\WSVOG%PYLZ3(O;H#8IPUOJ&TX[M>8\X5H?
MZ*V8M*;=<S0F-8KN!]Q;.&03/1ZK`7)E,*E79/$OMW&6`.9L,<O.EJ.)-;)V
M6Z;=F1X",0J4U3AB%T5M&2PDUIT>*<E:"7#L/%LO\HI64`1<++E2+]TK:]G`
MHD28NOXMF?4G.6/;O%X#0QQ4&Z,-)]_.$O>WQ67VO@.SXEH)J^K6FGSW@#K=
MQZ;]-4WQMU+$GYY5^P5RS`+`YH]P'KBUH%F7V\C=C;:=6V16MP=PO8O_]M=_
MFX['T<>8,V:\'SYH[=X3)K*>Q66]FTF2=#,H2W\]-,@BR=V!K1"DBTFQR3D0
MM4`4&5/2?LT>ZH?H#^BRBDC1,M%JY[<X07)X2`]_%3_2%OT^B9?;^SF8P\?0
M!M>9\F6'4<>SX3==M>`3Z=U2(%&`#:97%]>SJXM/']ZKF>]N80C)GZYG/US.
M2(6]>'<.?I-G>5<?L]?PGRY>7;ZFVS_>TE'=Z)WS_,A>[EV#.]\3(R7+JZB]
M&KI7\T,;'V/F:71^7G7=Y/?Y<33MCD].NMCY3D`!-LU=83W8E5*D,)LAMWAC
M";4RO`7>^7Q%[-W4Z=E(:%4`85_3C5BY!L0N7VB$M0N!P&43<!=T!PU;.)H!
MMJS@;K];N(<6\8KLOR!+98FJ$"(@U'UMHHG'2AYHL>9Y`.N$:4!OI0U`<AHI
M@]VZ4:[G8&K.@<.[+5#3:R,R[Z=R<2=`*=AY)*UL96E#M#QR>-QL-6AFA_*=
M&!3(;^CJGLKC[")LD!YQ:PU^\!.8%XHD*G['4-AN0\#*+"Y.W'U<A%R,!<Y#
M'BWCAX)4>\W39+ER*^$+<X5-F2GTC?X]0'F$;SC3U,Z__?5_RG88RN\ZRL:#
MW&DR!O)2=TK[0"@]ZEL__42[;DV;Q-J766]9;*XEC+3Q/#ORV<RS-L&M>6T[
M*B_)Z"TE3\0'D`;B*-.]\5[45B>L*LK2^3J8E[)VPR8<_ZA0#W=@"M&$Z!2P
MMB$]ILQQ`3B*)B6A73<M#NF]SS7FSX$PJT<7:$#W-.+VV<#@_UW0O1WYW7US
MN`?@US<>!\-N.^A7B?@3R5CIS!>"?J_AH,I$FW\;_R7-H\[ETGZ+IM?>Y;D=
M1JJTI4NYY_`;4<,RQ>HRH%L[NP_7ZR7WB7C8I*3[L,Z:9_05,2?G%36PX`+,
MR-M-WEY;WB73@%=M=S6D;H'*Q3;E?-UGPI4Y*QJ[[%Z92[#`]=V*+F:6PD07
MP'MW0D&A#RD$5!:Z'07Z$M#M<?0&+K*,IVI43A.V6VKW63D^6Y,?;M)L[^R=
MP)Q[69\2!(2GAM50S=23\R?==DC9,/TLH-J*N46_:"!?^8&Q#XKR9ITG6>R%
M8IFS>0GWYA+'/.JSY&5:Y'-M/5?%DOJA]S!VJS&A1YNR3#HB:3`;F8\D8;LB
M)=90]9Z<FMZJ@G&E&_]8IM%UO*KHZES?:&+J&X&%$@--HRUZ#9A<3SGW3MNY
M43<#:E61T,=J0[>[CY>WQG3_G''$F[/DPC1D*><@V/*2U`MV&M.(S]'QW\5%
M09*O!+C90%;";'R7[!^F(D@HU^H`795K+:3BQ;41JDUS5U72W_#71!ND6XBF
M,9N+?B;42VI1Y'6D*IQ:$.%T+86^2?7EAN]&39W34YE%B$;:]9!25D%`CTA.
M7A+<8V$6(ESY>VZX`N>+6+T\$!GK'/>#5J:OXN<SXQXHH!RUB#-[#[\Z#986
MZO3!C1HN=_I=V`9.Q?CF:V)Z*&>/#@ZGJD'E'C80%Q(@8@2\`O+0'.(V_DJV
M-A:+C%?V@G$HZ;'Z'O!BI3PU8N6TI3>XA_DW?[-):(_YWR;=M\P,]AI,9!5K
M4SS:$%I/(&(`8.+\1,42.B0KW,7'MKRWV%N54T8ZJWIC3[K6GO<OGWUW%77"
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MEA/,W;A*\<4A'U2)"`T&/M"&\>XLY)8!Z-WOR\X'$#Y]4R2C&F3I!T$6U)NI
M34&JVQA[`5SDW57@,:5O+HX_'QL;N0`P=%&QD8>2O\=)ZEBB\,%>!K?)B:-G
MNA4*9A#4]I+9^+K=ZSR74D+GF_(N,!AAK;X^GQT>!PS"QR:N@%:J@&#">;&\
M$/>R!'U,K5#4?O#)AB;F_;3EVM\:#;4.#]8FME!9JZ6NM$<"%VEGM9%1`)6G
M&!*Q&!H+%1!T"(+=UC_0<%L0Z]@^)$B@E.14,;FZTDKOEA4[O=@G;1LL>G:[
M,Z:#N(H<:Z8"]O/%D&(\_,'(:[77O$S51-3V5V]TYXB283((#X:]VJ&SY8>"
MOG\.CU^=U<[E;SPN8Z91#C7F#[7(:#BEAF5C44_\_#$\Z^%D6Q:O>;)F"]);
MCV9(9=.=MN_9LM[B?4*'7S>%;@3,R5*<=23';+2Y=5<Q!6(=S`7=*,`NL<+%
M8P",BTV5^A*UTTMG5L*WBS(Q,&/[HPWM"AY&N1UXC]=0DXCJCEB,%-8J+"Y8
M*NC,$927LG^V&I4#UW"/!JAW7"AG;G0B*V1)2[BQ%?H8#=,H<TC@L(JT\0U%
ML_46$P.,BU>%R.7;A+@!4Q34>ZUC5]N?'36EA0],>J1K/IIZ,>;$:_LT?/10
M/;HG]XG_MBU;ZZ$:F,R.HZM\20I9N<FZT14]_"_)9HE3^3J>B^+VH5+BF-F*
M=I$+,"(^\H^'`!ZI>7!L]F3L!:/I1]J5UR1/YS9"(1AMHUMJ_17#MI/L:[K)
MC?<(A3@7J5=V7$#_%1"IF1PS<$S#@67LT[@@KJT1.2^+;<XYH4;R6X5,2ZT)
M:<;N>U'GL[RN[WF=UP*%3USHA7C1Q1S7O&V3QBV`49O):/JCLF*9SS7Q:>$$
M0TN%Y2M7O^GB*Q-=[9NG;]G1LN+Y@\VTC!42WY$Z>FV2/B1M>+,VL7OCVQIX
M-`@]ON1B5[6L6UL4)@GI4W$:;&EH'?@M9ZZ:%%D`1M(U#+#U/6WD$DDW&JA4
M",G>4^[,WER?'1IB]J?'#.(VGY>%44V"]*A;]M)NMG3T4W;I8"!.2MUZ6;8&
M*.2'06]R^&0<.J=@H*P%W/`;_NF(?OU"+_")II_E9+2F@&EU_O36U.1#`][D
MR`X2WKZMILW^Z>BM-U[*0>J4PU)Y$?.PICB[AX<)CK3IA..L9IDWGP`6K184
M9=Q<#9O#AF66<.C.^]T+._OG-7/811\^B95F2('XT64UZI3$E!*@>43?-(`F
MX15=6Q52E%VH-+?$LYSR8#0]J1H*1&(_J%U)%(L96?BE6;$8BHEW7>N[=&V]
MJMVP-5JB4JO2'W`+"A_&(ZJ6*[+D3'CV6.*>2CV-'YT0-!$JMXRJ*H+>>"A0
MB-MAHV`[-+FYKX$<A"`9'^4CA!:V?9T&DUA=@<Y?I^DB`9R5PY:?/6G@'=>N
M4$4+DLYL*<-$:DFXMAB)X%8\('B@(KIVY+*_FK<]F@X\_!0F9=!3[B@B6)\P
MML&P`Z$5/F*\"0S_KJ=7WQ/%&J_U@MZ+^:-)MO9P]IING96^F5.O2NCHW+Z[
M:=A]ZK]%#%BH*)_U#84#/[<E/*LSQN3\"1=:47S/&3<0Y4.^69(>MD@:2@VH
M!6D6NIE<CX4V[H6E.)H5D*)_S!PHP,)4.)*'L:7BY-*1IXV>QV(\.QRVU%?V
MGC3/CR3&D?@FCN_X$K,`RF_2;-GS*_#2,"6)GZ,!WVF/';@^EL,$!(VSSR(^
M8YD"+Y6YR,8($J-+<SP6O>CO2_BL^:6]?3+I]JWSF4MC+5]=,S:]5=*Z%06Z
M\LQB6R[D,-G]O7Q_?I3`B2IF1&FK9^!M?"81"@#E4NXL>%!;;FK&+1<]'@@\
ME17LJ+:T2054XB6^KDF!9U2)<9C,9C]$7[6O#.8D1PQ^`&@T2%9C;F@K.$@D
MU3T'1VZ3R*%-O2J-&,LKD>2GZH=@JNN*UVM_=;E:PIT=\PXNYD$>3/#'V3(/
M<<H<5./33FW_/=E`1U?S?+L]^I33T"0OD<&P00WFRQ73NO"BF80:^Z?3B4_[
M79,%!"DXM^#F7(HQ"/PVW32X#&QWLFNB6F9)'^/-%V<TV18U1G&%SFHUUQK.
MWB%3A?==I$6<&D0A_^.P:L&D517DUCP[S5JF![05G#!G\894RRSVMX2,#SCQ
MS%&V@W&`4TZBP5[&I/^7#'`\-C4B.7]'/'V`U1JD@6<V2R:`G2`,XXV0M<NH
M9#,'""F\\._@"8<.FW.1W]QG9D(`<=3O"7!X*75K3)AESBYGW<V;\C'2`NF!
M%6]GPWXF?B0?D9!'!>6VU1<7)D___\>!CL/5`YG?Q7WT8;-&JC6ISU_QV%4T
M>^5.@,4E[+JZ<Y7?$+&;5+Z%UDXSXBXNBG*U9_6CV=N/GSZ\O?R3RROI1I^`
M@R'"ORXW7Y+'`,H@&%JK;;Q+%PM:ZXM8^XVQ%ET67*BCGBQB-(O[9,G"%:T^
M\@>#"Q*G?6/"QH^^MFGR&F@)\+*<P<.5^L1JK;YI`GZ#Y)H?+B\O(W7:X-_T
MSO?)BJP@-%ZPQ\8GN8NW'\ZN9]<7?)=9*`';<SGSM`8M;RB7AGG^EP727W'9
M98[.77DI`5X+E8_T3`Y"/>/2COE4:\C[X2L2(Y*'ZO=J2G))E+ME?H,@9IJ'
M:>*1*6;/3@&)6!CMF`U)I0#^7*^3M2##1*ZL>#.RA,B>\[O0K"0NM[FI]@)@
M2$+[*[_B8<R1U6]&NDB&+-^EP:\O'.\U-45F/WQX?_&G;O3Q[<6;3Y?G?^ZZ
M(%+7@.J$G[R>O?OXYT^ST+]2S)>))(AUWET==MUAQ54>\;X2B6#(M?+K3`),
ML'5JIP@.F@S*E,A1).Q(4?HC*4J_2DQ+-@9@Y'/Z[QO25=?=)J],*Y?Y='G]
M^4^S]\W.$3@C?I\O[KZD&<FSY>-J?4\"H1O-22DFA5:_F3_"H;-,RB_)*HT]
M^]IW-F:FR:T/<]<*)GCVF]F__/F'F9>I&<01:S/;-8/:64(K:$%+>S78*Q=%
M/Z^6WQ=KHNE__`U?MOF:_.:?-%!IH`[0+1G[)J!JX[1GX@?YEAEWAY&$N6?7
M`8QM`P[-\=$2RQJQ50C!!JV8Y>P@\$3$@V15V.7@`5([]C9.-\'+F@R*QN=S
M#H26=S.E6!M"%%YX0@\8W/(.]$"_)^NM9YP%V*\.VVIO9C/C3O-9=%"I"KJ6
M2FBN;B)%RS++*_]H`+,WRK73EHX33Z^\\=8$FYCEDLSIIH3!9F*0?ZI-YY^#
MS@0:R:SGLG<J#/]0B_]YBVJ8M-C>IMF6KN;?_OKO+)Y8ZCS5!J"(@*EI%#3\
MSN7:``X+1SM=N_IVI66G\%Y'2=9*U$%2NIC]2GMZ>H/$N'*#PKS2"8=8-@-8
M&;7*$EJ/3]-N=;EQDI>1XD[-PL(W"A>EOWF,+,W)BS0GI%O^LG^FHJDV9M8N
M9<R/^.V^VOQWAXDU#S:/NBUITDPN0,MP$91'D__G@@SAF3R.ZM`4K\=$39X_
MLQBI)L:W<@EPN[RPY1<"411V:.,SI9<^M_R31HSK94Q?YY7S7+^?YH+EQ#!<
M)4O4_V7"[CK2T_N]GBV*82J2%3;K=+/PNT1KWXAJL^B6DH$V)O:<A&G:9(&'
M:<3+U`6IS!"OU%"I98,^'XJVX`"<70]%N+ADU>JLN0B*^$"]/D1ZB'7_@JY"
M6%!70%RXK2,\]J4N-.F#`>#W#%%Z8DO%R6DJ-B@CWDB'.1]HXRVDV.B2)0$)
M0>:OZN=0%6*.(<=;.Q>A#3,5P6`CP-3I'\JD&DK:F55G@>:GXGK@Z[#6!&;>
M&<B(8;PVOB&E],;H./DMM]OCK8%KUG?"VSX&X(-=?W1^H3E+.[^7VDU2+73(
M%\I-!JP0=%@H_'I\#_%CM0:(=&A296,>6#]A33ZO:(F7CZR&(,=[)4-1&K$]
MAQC:F`3GQ)C@,X"A9IKAQ,!)I9AH0+UA)[S23QADO6J#J'7XE=<6*S=MCLV"
MY)+HB3.4F0P(X?,,2N%[+=LODCLMUV"4VO]\`ZDJ)SX+HS9HVUK0^YIW+%G'
MFT"1?)YHX>-<:&DD]@3;YW5=/J.&!^`BT9"J[2@="]94&)N6)M9R=TP[7#^G
MZ]<'[6I4L>OJ`?AII%TM]R#P+Z<_2`*D10,UUQ[EM#2$,;(CZ9%P`P-#7*/2
M&TV<@?8E>0"7M\G!-JZIHX%WZ1AFRD6YVVB]21\CHF,K&W,G$0M52Z+%M@>>
MK2(4KER\L7W(%AI!L1T`DZX1$T8E$B(5?_U](N^DH6).<O/FSQX5#FP$M9F\
MO:@OV4PZV)D'2CNZ6Z3EFIREPB,+VRX25^A.V)?+?=.RWL7+J=6%LECF*JZ3
M(OVWT#Q+XS`6C)$?5F*[W99SX5)A8HYH]S9#?@`]6?T5:E%2<%L%SA"Z01MI
M5&LH233,(U*+UB2TECX;]=*DC`Q'(9T,^H`'Y9]S5VB2'<676E.^O/F-NUX4
M9?NX5JF&-">R(%G[A[];RX%J93D6#X@H@K22+7-F\0-SF_ML8?V,96$RVYR#
MSH,HB(L?[3[I1B]RRHD@;EOO$@3EUO>HNP[:-`WH?Y+.L,IMFK93N8J#LXEK
M;=C#:YPJ_$RJO.5DB1K-VQ4#3C9L@)KCI`O\@!"#(MF5U=G7+U3./C`H19LQ
M.EDG'`5EXD5S<7@I60Q]`CM`EN+O-X4!U>%0V-0:VOI%XKVNPDOT>%C/B660
M*N(DS]).F2,"],::PR#`;E=:W&I*ACN@?Z=$Z;E9^";1<MD+'#E-2SW*;V_=
M-._MW&GG\DC4-*R:Q[?<RR$9GT9),$;AU1,+-K:2KN7T'-8T^?I-H/A+\KEE
MCHP`X@R&3#+D-9XO>3W,KI-'CC*;:GJQ-M=42N*>'EHX0"()HHCRR@1[<@>7
ME"G0"MG/-IV+C!O@!CB"*]K$DE]0HY)XZ084$J+3Y*5_6OG%Q=P</HX543S`
MT*27,0/SRS`HX]O7"(")V,A"/C*)R)E61!GI.1N).&\,:HHM#&.&BB5MYN;-
M'>3BU;[;UI:`W0TD-,/F=.(#G2.PZZE^:B7E)G/4>U)0SLU52JO5VMO57>\9
M5:Z\DFY54?-1V[%VN8^!>%G!EMCG^JR+M?BQ0=P*.L!6H4.F#\-AP:@A@>:I
MVEZSEE^X(N3.!\+_<M#O#J:C:IFE?K=_,O%!5"_M]E==`53#";R(N2`@5TUH
MR]>L%3!]Y_P7J['C?@$+2!:=VL#.,^;%0JX46EU$KW(@K#NO9U>O#MG,%@>,
M@5Z;CEO:"\2<LGB1K[>Z)@Q9H?<5BG<=O!9<8/1SQLX''O8A+6PB>UN6EIX8
MU](9-"^UU.6U"CMUJ]YAA$?;C!K/YN->S=DR8V;/KHC/X65^9V/K:W[B2!1(
MK)Z9W^SJLR0XTJ]':!5K&B>S6#I35JM`U#,K5CO79/G,HTEO8@OW%"74AH3!
M@LNE;_+)@'KNM8P6*P*F:X2-$:YR9B,+>L[F\4BW:1[=E2D[M861@:3LCEM#
M);81+;'2M<*E>3H#[M.M[=U<,"">]5);/<W&S_&S5)A5G"3OG2VFJ^AMKQ>B
M)00S!Y%!A>\Q<#W<:T_6(@Z2O#GV-@GH[(6(>C(H8SDB(<T:FL:JF)>UJX/.
MR"KB&M;.2)FPC9U`A$W%!6$3)W(WSTDJM-BT,ZF@:UU9K$3EN0".Y-SQB;/)
M$?80DJ9QEW(=X,H9-`4*#,[#&&A&"GJE397&;5#`999:UPFR?@VMLMHE$/;6
M4Z4:8?U852MM[#Q)J'AR;4D-8TJ)0+R#GIV32>_P>P0G%&&#SC/OT.@-:M^U
MYP_I>A<9_IC=J3GLLB`;-IBH,&9GN)H/GI[@\>2M!4;#5/)FLS*SJ74L=]?Y
MY9NE,@$[IXA98":>D>X?>6V`XXHVVPX$79FJT-)2=;]ML!CA\]OG:?EM+>&G
MMAJJSX":$DUAM&N8FPSU?C=(\9:%!1'YD0P71%%MA>$)TZXGURXS@)ELNN'6
M./[V]<THLMV0OH$ZV0F;PMDB3[*7RQ$F>)N=/]Y)\>.CWK#K6@@<`?M3NCBF
M_:%S5=YLA?R'XZ,A3L`537"9WCZ:XUUMNGV>W&RCRP)%B^8HP&4+533+`?4G
MWVQYEGR/`&&]O,'85T+Y6I<T?I-XFZC.A3!:)GDSXH"V'>U=%1?K7W$8>S<G
M^QP;*;;0%O[=V!E-K[@_NYX\12.IQ.-\S-5_-+F,F5S(W$[9$CF*WMB\.PO=
M.1+"(2%Q!)_G57Z[?<")=E0T'/>.1J`BHYK\KO`51RS0:V0,?(0A!9$>G2WS
M<L$-U4N^9.9<X@YJZZV5-+4")*UD.(;>YN,GO22)PDS1@G-9^E6^C9*E-5,X
MENT-Y@+E(=^JDHO$P%V^KC6>J@_#QCSU!O4(;<N;[#-3/A^JVEAC_>^4GDUA
MCZ>H&1P>`(X?N-[]NR2&..!5,M)^`"H]]T0%7K;2B^5,0Z\71IOB%L5G\7+.
MYF+T/M&6\?H<%#J[8H1.!X/1(!=$$*0MT8"'C4QRE7]-"G4!67G,2AN-?T<J
MV5]L.J@@5M.-UO"_3VEA2.9R29C(KXF/%U%'M+L<S5%E%7P'1I:H!T&O6IM$
M>U-42UWFBY2/X[>1S`4G=BF(U6!EU_">`:@;-I-H:5=E2IG/8_8!<_>/0E_6
M^:;E9@[KKFAQD`%%FX`B'Q)L[YIQCF[B.?+66GI-R0OO:E(ERD+SK("AM;[&
M]B4W6.0R6]AB3>RU"P$]+7OO*71\S-]RAN_0[/7*;%O#+(,V"FH&6V/W^7W?
MO!Y72WOH)=(<\H8V5TA3+Z7F[0;193DW#R9ZO0G[4U4UP%K+0]8`)VW\X84Z
M8-7S,G.2``+0^T?GFAUP-?"H31>0SN2FDE#ULOO$I0#PE1PQ$,@;*-N()9LD
M;I-?OH\ZEYEQ2!6'Q,:*>Q\1'UK0!ZC#<MQWM5JVE0O@]!J3*8=]"6=$]X[H
MQTEUZA?V-#A2=BX@"8\BL4U[RTH<VX3"3%Y^)2:F:/!%PS)Y63\\4L$07V*H
MPF^37W$V2N.V=F+?YBQ[>U7=C\OLB&L4%5ZGW6JF)JWL@%96U;'4ZFMF8E/Z
MS>IM_<')\9#4=>W#C1(%3JWNG*#SQ:&,)$[2#O(1#Y^UI9],6`)L_]SHRH(H
MQ^H+'*:-Y&>D2#XJK)0U=1?M,?&.^BTT>--=_DU2I3&83>QFPPD:2@J\4T(H
M174_W.N<>0&.F0.7(MVYW-"1EA5[)49)5S>_[MG%&M+^'$3#DRF=K`/T&.(_
M)\/C$Y-&(^&L(K5M7M0C8(.KQO'/89)![_1X$)V,1\>CJ(_1^MW>R>!X&DS3
M'\:5VB^B'MW4H;M.:-,[)W0S_1F@V\^A+4GQG<3;]IE*IS\^8?KIX'U`6IV>
M_)F,!OR,_0;U9]@9#8F",2UZPRD^3&6VP]Z8/U36/!0J!]%X3#.0!<9"C_O'
MV(7Q*;UY#:.1;_TPFR]1]NHCU(3YV(9CQC>D['5KPFJOX270O!?=2F\H^>\G
M:PZW!`H/HOYHR(O49\9RY@=_3%4>V^C61=Q'(_1U&(Y!?I6ETP4VA-W4,S[C
M#)@VMF#G8-L)\?5-*SQOOO2%BQ4_6`4(K]&?#NGM#I2/_IAOOFA9.^;18U)I
MI_3?/JW#:U2]0L$>\23WIZ#._F1D%\?-["`ZF:#%$/WMC8Y[]=6Q+'WF0""6
MI;<MV655$CQY06-<+%Y!'3`=6&"II1O)L^40MK)2'UZ_8Z&;>I3-6EACN"E.
M47B;WHJ+*0C2S;QIL@WV]!4?RNV1&LX++?A.^S0\&@R5U1#5,K,Y(*9S*OR+
M&?0H^.6DSVSH()KTZ;"<BV2&;'76`UF?=M!AMT>,:DC\JSLZ'3"''?=!5-X/
MP],)L[))#PUM]U$"+C,N$Y9N$ZWI5$]*F8X'Q(O_]M?_H9^&_1$]'?^63]>`
M1B!B;;&JQ(+B55+X@T]&.@9_"/\U\S6@-'-KJSGSDBXGRSP\ZD_M@@Q.<6PZ
M0VYZ>1@-NJ=TCK`@:(,Y`F?O\3K1#_3%T)Z?JJ9S$$V[$]H%WI=A=SB9\'BT
M9_2($:TH+ACT1-#2!?TI.L_)!3TZT.,=VJE`(/W#('X4\\ZUV30DR\#FDY*!
M$F*7!"+17+I5!?39#ZPF:-XD3_(X/G\=UZ/3`?2Q*/V3,:T?['2BD(%\G$:#
M$S`RQ)OH(RB>/IZ2YM_CCR@H.X'J(GM$@W3'IZ=UCN_EU@$_C5?CLJMUK<_4
MQ&IB]55U7F$_7%=K]Z@0LK:(F(K5ZAKMH;SUN]-)CTCULJDVV?`4*:&BEN.`
M/:&8#+I]TFB&M7A]BTG:QO:]E6WI\.[#(9R=TZBL"`+E)D'XT`#T6G)`FY]E
M`SR2Y0IGCW4Y,3HLWFS2ZE24@7#>AY;E8A?&4TXOW6:-1.*@<2>N?RVY%'E4
MHOKQ7TRD5B%:@L%QPS7+J)`PA+;_6.8X:=QV@&EJ)MZN=PKDZXC?I7\89(\*
M.7RX@6*D+9W7I;MZ$%[].<O;KAP>JC;PO5CMB?4J@A&>3L&1#Y@YA_^2Z?&`
M',UPL;SO;9VJVD]$Z/W3$Q47_F>OS']P];0'1BU7N\_OB)G=(1G#0[NSVTM]
M;MX0`SX\N,E]\J:NI8V\&R`Q\7]<B/^?)^S@2[\Z_W:!7!7B8SPM^^GC$A@"
M(5\V$HUQ#$62!)B0TJA'(@J7VP^&PXVZP[[HMA,6,?3OWI!M.ESUUAV&[YOG
M1"=_RLJ?[)7WCU8_BTN(*$@?09$E\];R+S.U\4"4E&!DN60_K>OO@-*G_8GW
MCOZ_7DKIO<E0"<[_W$SI)Z-3I3GWZ1E4CH.DQ\1^>H+*3_G_.ZE\.E`2M1_V
MH_&A&=E^,(1$FI>:A!/^+_U[.+4L91\:'_,)D4URG_>B\$%_K$>5V0'_RTYL
MT.,)^0/S%3O$(C-[(WS"#L@2DW;!_T:EH_EVBVNNCN'#Q97TPX2*7\5>\M2&
M,S-/^6?[+Y('NXX?35[>:S@NZ7Q"T^GQ=HOQ0]H@^%L?E@\QO>GXM]%5DL%'
M(T,`]/Z.[12%)D63`6SB\12*_&0(K\*8+&FWCY,A?J<=G)[RW\EHRG;VF+3-
M0:-*9/=LO@<-_0+*8\4C;$#.3U)OI49?0S"&]MET];SF7-EWDB-KOKPBK5R_
M"O>8R8'WWGUR:],EO>TNS3)-<U=P,_%_LI!.6!R,V1"2`T5_3W"49@M36F`X
M,0*8O?I\7)T"[2E@G0%MU6$$%0.2!;:L+5]K3BW^WQFS+]"?H1:N=7-CV82Y
MJ1O4_W>-#!KA.FUZ<54:&-1NP%_WH!//4\Q$L-IGW'VT2N]<ON&4CL\9V12B
ML;Y!6D#]Z[>2K:">C62A3@]3%^Z(2/@(3M1=\L[XF`^BX51<HSVQC\7F-E^_
M]_#E)P/LN+B*>>M/!I"2S1+2C#_M0^'"H#JR?.&/>WH"$0HJU$OP1>\Y\M0\
M##:9(3M\]I\RT*<,\!1XDO'%J7*BZFYZ8]-*=/LG)\(`69/J]-E+8WX8[Q3=
MW0"B;Y3%/J^UD5[3YS/W_RQ2Z7GRO--C*I"O)\%B3TXA*GBQ^^R,F;`C;3>I
M#":GJG\H'<"[T`O&A9PXC;!_'<SDD`1%[Y<G%;%SE%3PBO+%'J1"QGQ?]K8G
MI#+@6<H/"'T\CU38&<\"T:XU'<I=.H[EC:KU,1Y)09B:;>U2^$U:5[6>TASJ
MMJ@ZH=Z]CSSU8JLA;.`Y,[*(/0.CMC'(O>=J^SSXQ4CV";#LB@N<6?<JZ4M`
MR"""QR=Z#`\_JCYEG(X.N/>F2)J1M.QBZT6(7(%VL^11J4I1#=,1=GLXP-9?
MW1-M'W$.5<UD`>D/QY:).8.?S:$=9.*G:;FM^-Z5%K5\X0DAV10YE\B`93A`
M>!K-:<?9:7CTS6/31'=&='Z)0(/'92ML<Y]KSDN./]OLM7PCY'W`\=B)*-#V
MTV344[VW1U2$>R7;S=YNZJ7>PK`2QWF_>RI!7OX[IK]#,M*F_)>T9F\4_R92
MK$?FOP-P%OS7^&MW[GL@`8W(\UF=\K:&!"WTGM##W+[US2GRX;V66S".W?2\
MV$5.-E5`\EQ4''*>I5\K:P<M_7+*>74E&MZ&2*#79WX_GH@B=CH5_9RVM8](
M_*?P'0Y8"AZPE,)_Q_S?D;M,7Y!%AX1#K&K7Z:D"(U*EN@&>*;^/ADU+DJ1W
M!@(P?[06E/,#:++7IE+K%%#09"$%9Q/BWUYZ9A-19*9UH[4!;W^-1^^"A;PW
M4Y"<W\B\^YE.8)?L0/8[[^=H*$9NO]N?<J`]SN(%.A,O4!>#.!3"@V/$QEZ!
M3AB:!4A@@1)>(.<!*&6(L_^'F"0;`&J/21:Q0=<'8YDA24NZ'>N8?5!+WRF\
M>ZP<!W'ZXNXA(NP-=HH4E_TD#A5#0DB+1M*Q!)4+7G4I]N,H2R7U,\K]/%,1
M^<;)/;,640OKN`AK7R$4S4K[=QU1T@_I['H)O\PK9A_.+H5@/]@R*)>:@7MA
M@;8?!;EWV#*FR:;@<7")&>$R2^ICO,T5D>OX5\-7)A7Q`(YQ"(;.F!54@T8+
MDX2=&BNXL@8N^K_HZDS%-]EA76W'\@SULB9^7/5A.BVK6I/0H^P7G)!=@S\'
MH&2TO;S<,M(7#_3/G%_J&-F(3Y[!E@@MZ<;(^;'K[RME#7K@[W7@2W]@@>S[
MLY,M"G/J(8YAO;DNF/X=LW9L%#RG)SHD,,JBR/N14F"+8#GP)4[R/F=JB.^\
M8&:P4%^VKG5=^MO6=G+*<!</@QZ:\;Q*)+J^99$`#WG!(HWK\,`+L=O;U"&P
ME`S%Q.VI5$-_W^IW^YS<C3Z$9OO,T:/.^[/+PU]2NZ7QVGS.`XD\"G**%0EV
M%#U9&)"'5%`:L,J=`:NP@.UT1JR[PAH)XP$VF:*.1@@PVA`A=UJCA9X3N*IA
M/9^;2D-:=\Y<TSEE[=G[R(G`VC7<(>$\\C$^)O.77ZOJ^Q;Q.507K'ZNYQ`X
M0)L0.)"1F^0>37A83Y?E?,O+^;RK6Q$EFG9010::8L3^B,%VOD#T>!"=9STJ
MH)*;1P<"K8J,FJ?4J@!H-^?L1NL9Y7CI%2SAG;=6#0#;2-J59_B<P:N32.G>
MDAGHQYQH+-F:'*]74K"0P[5%0%8^=GMO:+FZ1N$&$B?DL*]XM\[IJ;H1.^-3
M/E(?GEIA.ME:1-)H7Z:;$ASVDPF=!("<.D.!8P^!/#`%D38UC>U9FRL>V*F$
MCVPT:2H,`$S$,'E3P.?)`>&OZ)PPHM.?=&<D3NHGD%KBTIT,V-]GX/%0VC@F
M+A][HN#^[TE\0V;S$UZ=H:)CD54@Q*>AY`[C4;Z)\H#=GW!4B>1!7U=<1,0O
M17J="<^ZWU/`$\,C$+=Z"=FI;<2FN3_G_FYTX,A*A,[4>&[ZIY;4S(<!/`5-
M:DBP:A$C]O;EY"]@X?$WKGP]!XJ7T!;A=OJHV>,&@W`_P;>O[M.D[>@I7+I3
MV.3$EC)?.,"M%I^-Z/1MX'5H_CTP,V6QI@?4W<S1U"$3J/>Q/K,]G#R?C,^+
MS?C.F.?`1JLQ67?.1%]"78PJ>-3/:')!*J<W$-GL/G#ALJF@M3LX:36*OH@W
M&=<R\5*K6U07="B8"U@^799<W]J_F=.:7W*/%+\Q.=^_EKOX/1E07!OW>U]5
MKNK(VDF$FT+!/)VR.WC:'ZG7>,K`-/8RGN*[\P2EF#,9]\<$42J\P5=ZU%T2
M9:5I?X$,`E`UWK<(;/C!$.0Q&(+?X'-?/U\XSQI6CGL,>Q"(JVT^_V+;>C).
M8K5>YH\)2@_A)Y=?"+A:CT.O[O_7Z2HY@FG('EKHYG-QO.'6,D/R6$]A"3A!
M/1N/KUS2U\L&?-FYF:DK2Q2^N(PW97X-3>=*ON9RPQQV%")@WT8[O6"9L%@(
MN[C/M=Q)'OQ(4@4LAJ95+^>+I;A@@./34[E/PMHOX%,M]I[&,XH#/NU%?=&)
M^M2>1#L82`QKI#@T^0-S["IAT[EK>G)HQA/*LA=;+>8]X(05\-\3@$).$%CA
M`BA@?2-`.\=`#O2'IW"_#Y&Y>"8)[*S2M:ZAE,51A%5GP/R],S9_\.6SJ$#F
MPY%8OVIS-(+Z/N:PP9!#B`/QQ%B.KT[S3G\@^9M]2:WI#$6IZW#P^YF3R?;E
M:4/)N1N>"@1Q)&$Q.I0['*1/4B7)HAQ%'94N(_0]-P[+YINE-"+WNOREC\CS
M)R-U*'DRO^0!:>"8<%UBP4]X$P839O?[\>,ASL(`IN8$5,4MA!G"C1J02V3=
M><6"]1:ZN`_WRV`JH(91]+%V$;SCN*;/X6^P\8M=D@3@-'B@<`)QKO^.#N:!
M',T#.9P'>CP/Y(#N(']U!G)'6ZGNKPM$:E=^2SJ8*7DG-;)0?E\J@TME9K%K
M="UA#[X`\/-+3^'[W9IY`^7VIZ?=7H_V?C#@OZVDIZ*^WQ_S=?V3'O^M$][_
M5]RY[3:2&P'T5_HA`RB`QJN6?'T)X+$UN][XHMBSDPP&>9"LMJ<1W587>[SP
M4[XDKPOD*_(I^9*P>&MV5Q6;;,G(DV?4S6N315:QZO!897B@GH?,@".5Y7YZ
M#']Q"*X4?Y^&WSU(A(HA>92MGX$%LS9$]8=L+)<E6#PW,J`8)+:Z.F'FXE/-
MS\BH:,W(#8N0GQL5XSD^WT;QNK-UD(7TP"STCOXC=4:HC]['I2:""<27_-51
MCNRNK27=623_0/(%+`T!5KPSS2F`9DO]Q1XX@KZE8\Q4+[8Z*GWU#RR@ANQ"
MQ7%"Z2#A0+&'TXJKTL45!<VNI:*'6RK^6#NCZC]*VP20TE!&[N=B6Z4L=<5^
M=E^_I7XQN^9>TL=?L@O[H'=*)K^#/=(1_`'OH7?HF@"M;OMOTA):R%JHR('Q
M_A[BM#=\8G?KXD6%GPV'&3UYL+$O#]X.I<4K+=XS0KZEH!3:<--*E76JE2IV
M!:CJQC@T+Q&NE'8LG35ZTE(D-6II.3+6/GM-\V-)X;?@%E60TL2E-@@&SL+D
MIM\[KJQ@LIH]A_KBPWVK`VT=&"]/+EK=`_U_->")`PSND$UCBBS$A:44E1PQ
MC0VN!"VJ#\N`V(*>\E\[/)!>5=+^\;X@L(_D?1DNU,)N,DK+.33`WC34E5N2
MW@F$0-_:F^K5.11$PTO@(<`.TT,XR$R/8`!9'(]A`Q_"*$EE:),.'Y;F](/.
MD0V9\7`X0-4_3I4Z`_\ZP?XZOH-H_1GBOD)8EX/OD-Q$=L"D%-*=4AV#UX]T
M3_1D2$!74AC<\<D=JI^DBJQQ>-#!$21O=!FLDFTRAEY,[RO=8]7"?][,]NRI
MPB]WYTGK#W_4-QMA1SRA!YF#'?TJ0?,P$JJX..Y%2`7K4_TH1/K,N1(-90$Q
ML9T.DNC7UB2D[@A2F[U,7UKSFC"5'CC7/K"74L"5,7).H$MC4/R.4+>GFZFZ
M14*1$%!VU30]Y46.0X&^1V=U0F?%W1,0P7ZSH^5]HC^M?]RD)4\IY(29C?:2
M[K$:5<BT"<A!&`].#9*OEQ`&?P$;A+\35R&2\YIX[RE;/LH[E`:E.XQ1];V(
M.9K`5.:.Q7<M1"97.O?3M_EF)40-OAX!^L^PV?`<JR>Q%'*X%@G"$-OP[*=H
M;61F<E5NT$&?LN_@6A\\!@?66*HY)5-P05F#M[JY%X90=10B0Q,<2@C-(GR`
M6[Q]V7&($$-K(Y6>+B7J/.-8"+JSZ\^I$,#''121"N=X.+=;"U:1BKV\[$:L
M>7`?"Y^5OPK7<#/=8KB&BYT6"HHZ-@<J#4%\S5>K.G:?A6LK(+R%\K59E)]Q
M/&-\&E!?->#CH4K74_&8E2V"A-<L!T\5RAU5<E#@9@&6Q#3"$`\C233<;G01
M(I@;::XON1+_>EM07%)"`_F",7PE-AUNEQ^/QVJJ?CJ>!WG';0#8-8J&X1$1
M-"5Z7?5A!5Y'1%<[_#JZ#UD.7]$ZW,[HQ<9FT4X^ZXL9!]KTW5:!KK'$O.@>
M9XAC[>21*IZCSD6#_4Q'?3T=K>1411LTMRB'S:=C?ISK%+@ULF^(811P3`]C
M$ZY.@L(:9XA9P*$IT;E/<$H4FQ:<$GEBAJ;L(J.O'$QH^T;`"/&\7Z'-W37>
M[UT4XT!NKU#&(66+O8;6N%##B\L2\P?1Q):8.'*-POIDCUZ\N/*46H8V:DPN
M%&DQY!V^96*,!Y?$UY=Y^_3SS77_;^3>/(R9N$52OLE,WT;F37>$(3PVT*)P
M$DN@A"N;*:OY9I4];"9R3%+S1I9`3!:*>IE(["5Z\\O=Z8?;"[L=>8T!7C9<
MH6(T5YO8I]#[G+A8%<NS?)A"2<=__N62[SOJZ/[9QXOS_NVIZ.*/F^EP`5I0
M<OHCVJ%P9,18B\H5W+RF=0RT?78?(@7$-<PA(ZN&EA$9!@9`%PULEUH(EXV!
M=B$ZF[2N>$`-3G`-;@L&=R&])80C5DWDXL%"#4P^>%-`MX"RSF%,FF5'$DN:
M914.*:GF7P/B:VNZ5`H3)W[L[#;WF$^P\Y*#OM;.2VW^8>.XB8V^[AL4$?.)
MWZ;XH._\-D7OYF/[L9=;?^@=9-_T(^^FZ.@/O)MBFW_<NDU)A"%,7:IH`VF]
M^[H2NK%=05.2&9<(E3P&6F4\P$S(FAKP.7+`2$H]K^W-;OC^F#K\:KLGUV>E
M#8BOMRTD$6UG*$`B9_PE&\NC&WVO>_?3M9T8:Y!3L=;X*@A/;U!,;C2-U\KS
M0I*^9E+6T&.',%52(,@&:H#9F)\;DJ..\;X+F.](VR')?+5OJ;`^U.4EN!3>
M1=<@^\(3./@[K+YYH'UA+WMRCT?W;9&#KQX>,%_<P&MVYD%S\NQ%W&^&\*L2
M[9#1+@QIAS]*E6J'VLZ"[2*[&Z\%`=WM'H)=.02\,AE3AN#R0H!AO;5)+%YP
MXC(ZCTI6RXAKDZBZAEGY91!%FPOO`)S2W_H`7%W;T^*@Y/[VU@S&7OC&I)X*
MA\[U2@@X]NF$7$IJ*FXV`\B:V_7Z'=W0`NJ^RLF4;0J>\:Y\^\^_*`>L0+'4
M-GYOQ;$R[6R3[J78D:-+_7BJ(R8MCK(,(G1'DCHJ(^SCS(,#Y@']Z<(^:(QX
MA*@VL0&]3SSFPN*EPFM9^G4]S$6F'N/B5GLT%DE8?U1Z.7\6XT]>C2U#5#?Z
MDMHP?B#Z1NH357_^20S%799RS(P$V$O^`%M%&<%0XM_$EV*/,E5LC/+:S*>9
MN=-<I8);"IG:0'1RV0F=]]IW#Z7CJWI>@PA#D_11B(!'V.A::*3R2B+4UUK^
M&)J.NOI]XXAO-A/)*TV?>DUBZ^_L5,Y96B$!W?+,&UD75T$GG08;M&W77>@%
M@<5WI:\H3U1"?$%.7UMOS:WZVUN[MQFXM#M]?%\8`.)KPI89($R4EU+)">Q!
M1_$X(@NV&_I.^"(83:H]#W!_F<*\>BYW80@=6U?=!I;!]<_U)`ZPA5DJ;5ZP
M)V>$DY9$R<9_%0N:/5=0V/@<#)!V((&T=P9(&Y^1!==^R68-DCN`V\9M,1R_
M:*^P&,+?^R#$'X?0HP9:%#F/-QYN@<Q#@J]"S&/0@T@9J\'GD9WDM7A6OBAK
MX+1?MFU"@#U;3XM[K-]JZE=SXT`Q5J&;(*_H"I]IY(B,'-;DU<U:J$E2CP-9
M5V@UWK2Z&4[BPFDO.I?B;53A-^401D_$TS"DE]>DWY0V2*\B9&(9(<S!S`B+
M[W8`LPGAF1I'+:-R</L)<G,LU\5^3<>U7E(0R&H&SJNJ>8[X%B/V+V*JY0_R
M+$OZMGR$I1PVO(2-W,GY'-S%Q-\RU*[P<O>EI=%W_X\9$./^A3AO1=4-\BVP
M$KYIPM'DPK+>>C")U?UM:]!\-.Z\:A3FC)",Q<+EK&;^H5)PQ3S["A[)4TW4
MA"&&&NM%A^&-AA_:A8\8&C"[L,$K!E]&IY90$+3_J<6(T&=4OC=HD%BLM<U%
MV)RY0=I]FC`6QQ4S&!ZLG83R=WSUC4#NK$K,G6JFB((56RI]^%#'A/+M,;Q?
MM]FQH\+412"JQKGH#!-]1T*Q:G`[Z!BD2MM!,B)FNGE[2)K"&5'AP*Y7SHS7
M'*.X<AR]@R[-BZV:ZC!UKTS+5RLP#2ER4O]N,&"&KT8,&0F`Q9,+U:D^!9P.
M/@!QZ#K51YV]??P^"1=@,3S5%R65I_,.U1PH/=3/)WO']-L'Q,_A5!_<J".J
MI2?X1P_R!Q]"=7%Z,L0XW>OA'QE@$.J++MVA*=VA*=FA@S)B"/<$43\,&$('
M;CVJ!P$_1/RZ3WT"@!/A7\G)$.W_='._ME[_B"E2%%'XEMV_U#GOY?<*KP]&
MPY6U9EHO'9"XW^83=5>*R+FX.44(9P<RPYE88%]GXCTD\`(N=7F"4,K)BY`=
MR^+VF\5<><81\S3Y`IX!W4X'Q=\-EG.13B(P3/#L.%\-31@P`/FAUMHJ0=[U
MYF2/O`#=AR@.+Y(W%6U;&"RSQ3`?TW+.6.;[KF7^AC):->04,?;T*J:(75=8
MM`[*V`,KP@<<95X1O<$)CX56G]!>V&0)4U1L8YG#Q3YFMEX5WI:]0+`*WN(.
M3'S(K6J:2_>.]^OYC/$WLY_*?%+7^CICD]6RC[:;)X%O8Q%:M:O^]Y__#L5*
M<&2C$GJB_\MMTA*9$I<5.HPD]JV!/D8J;@`*%=(7HK]1?.EMED]'F^5*]<8D
MG^9KI?J,#>9$C,;Y9$-)U.X^<YINI:ESMO4*'4F;"`W)8*S/Q/(5N*2LY>$@
MD<@]515UA(AZ[2NOITY?],>ZS+$*E96.T:8FZP`C>CFS43YWPFG53;YYIJ]U
M!-5EG,$,R/7IQ`ATB))&^F1JDUL9H6N#%TNQ<9I.-S,D/@J@2V%X<-D_F(*C
M[A^ULE4JKM8C2HD?M76'L6))6?=PE#6:Z^7`>C$AT6'\-E"Y<BA`O&QQ-#5,
M0+S`Z!3BZWXB'MZ+*JP!#8'/`FSQ3UFQI"6WF;**KK[EBU42]M9[XT)]E8G%
M?UPZU*^@9TI2XW?XY0,C-13DZD3.]2XC-4JAF2&2Y<^W?P69\;M?LK!OE>K$
MON6JEWS'U%A@S5Z-LL_?6DB*];)1'O?WE;$JHYV+&;4&H_<#V+Z$+(&`.%1S
MH>%OQ,C_D(L=HAAP8CMV:@9F\O5*@GI(?I@]$93V5).-J)>N35N(*Z.OJ'&D
MO85'14D+/U/L,SVW7]K)KV"P7:LA*J:$^"\\4/_/9]+>H.)`YL^S;`E#U@'D
M58LY)M5@W$9M*MUI$P>V5LHR,?R']!I6[4RF'-"`U!E)1=S$M$B;F-.B*03$
MBZ8XWS];Y+'UHPD!^R>4DN;4!`DV5@0NEG-0;I092QJH:BI\0/;"I2CY4>-[
M.5N)=+LKM@T@U_T,O:G8%A2K09&RLL:ZL>[A_I!6-G404,45;R@ZW4;98^N!
M,CNQZHG>V<#D47>-EH7*<`$X+O?C8?D-S+>1:A)6E.11B3P!D.OC!/)'.<!S
M)H<^P/.'Q2""X:-?338+*1&?165?N/0W,S9K!1+F:LY^:!FTXGWJ&F_O/BZ#
M26QG/WU,6B(!7FC$'/@M6TY$47C\&G7!F*2<RGF'\B61V]UFM,I^W4#2_I-L
M'?XE?B?Y\V:REZ0'-))!/N1X#2KEH>=AAZ$[5NOM]Q?X\=.9V&`[:6#AQ1!4
MT\/.81B8>CDK0R@01:E_A9H.KU.J>C]?#?.`>G[*U&2>9(1O2-JA02YWS]D8
MG,!NE@MPT1>"]BD''ZN`\BZSX=@>'("+8UAW2L[<4[9\B4K[PVJU_M/_`%!+
M`0(4`Q0````(`&:#^$;G]9[`0P(``"DO```3``````````````"``0````!;
M0V]N=&5N=%]4>7!E<UTN>&UL4$L!`A0#%`````@`9H/X1DAU!>[%````*P(`
M``L``````````````(`!=`(``%]R96QS+RYR96QS4$L!`A0#%`````@`9H/X
M1L`AU&6!`@``[2\``!H``````````````(`!8@,``'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L!`A0#%`````@`9H/X1DSXPJ'"`P``HA(``!``````
M`````````(`!&P8``&1O8U!R;W!S+V%P<"YX;6Q02P$"%`,4````"`!F@_A&
M=`3'OS\!``!I`P``$0``````````````@`$+"@``9&]C4')O<',O8V]R92YX
M;6Q02P$"%`,4````"`!F@_A&F5R<(Q`&``"<)P``$P``````````````@`%Y
M"P``>&PO=&AE;64O=&AE;64Q+GAM;%!+`0(4`Q0````(`&:#^$8`,]'6JP(`
M`'\0```-``````````````"``;H1``!X;"]S='EL97,N>&UL4$L!`A0#%```
M``@`9H/X1LD$[6"?!0``VA@```\``````````````(`!D!0``'AL+W=O<FMB
M;V]K+GAM;%!+`0(4`Q0````(`&:#^$;_QO;!0@(``(X'```8````````````
M``"``5P:``!X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"%`,4````"`!F
M@_A&\!PNT5H%``!K&0``&```````````````@`'4'```>&PO=V]R:W-H965T
M<R]S:&5E=#(N>&UL4$L!`A0#%`````@`9H/X1B2\7CY$`P``E@P``!@`````
M`````````(`!9"(``'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+`0(4`Q0`
M```(`&:#^$9>)/:X&`(``#<&```8``````````````"``=XE``!X;"]W;W)K
M<VAE971S+W-H965T-"YX;6Q02P$"%`,4````"`!F@_A&;OHBJ[($```E%@``
M&```````````````@`$L*```>&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L!
M`A0#%`````@`9H/X1F38B%NU`0``1`0``!@``````````````(`!%"T``'AL
M+W=O<FMS:&5E=',O<VAE970V+GAM;%!+`0(4`Q0````(`&:#^$9+$+*=:@0`
M`"\4```8``````````````"``?\N``!X;"]W;W)K<VAE971S+W-H965T-RYX
M;6Q02P$"%`,4````"`!F@_A&LD80FZ,!``"Q`P``&```````````````@`&?
M,P``>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L!`A0#%`````@`9H/X1I`S
MU9:D`0``L0,``!@``````````````(`!>#4``'AL+W=O<FMS:&5E=',O<VAE
M970Y+GAM;%!+`0(4`Q0````(`&:#^$9=3=MWHP$``+$#```9````````````
M``"``5(W``!X;"]W;W)K<VAE971S+W-H965T,3`N>&UL4$L!`A0#%`````@`
M9H/X1MJ#(*^B`0``KP,``!D``````````````(`!+#D``'AL+W=O<FMS:&5E
M=',O<VAE970Q,2YX;6Q02P$"%`,4````"`!F@_A&,L5&@J(!``"Q`P``&0``
M````````````@`$%.P``>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+`0(4
M`Q0````(`&:#^$;XF\10H`$``+$#```9``````````````"``=X\``!X;"]W
M;W)K<VAE971S+W-H965T,3,N>&UL4$L!`A0#%`````@`9H/X1EA!T?"A`0``
ML0,``!D``````````````(`!M3X``'AL+W=O<FMS:&5E=',O<VAE970Q-"YX
M;6Q02P$"%`,4````"`!F@_A&:J\B>J(!``"Q`P``&0``````````````@`&-
M0```>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+`0(4`Q0````(`&:#^$;@
MY8'EH@$``+$#```9``````````````"``69"``!X;"]W;W)K<VAE971S+W-H
M965T,38N>&UL4$L!`A0#%`````@`9H/X1F\G8S2A`0``L0,``!D`````````
M`````(`!/T0``'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"%`,4````
M"`!F@_A&(\](5J$!``"Q`P``&0``````````````@`$71@``>&PO=V]R:W-H
M965T<R]S:&5E=#$X+GAM;%!+`0(4`Q0````(`&:#^$9,G88(HP$``+$#```9
M``````````````"``>]'``!X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L!
M`A0#%`````@`9H/X1HVFC-NA`0``L0,``!D``````````````(`!R4D``'AL
M+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"%`,4````"`!F@_A&]UD#.I\!
M``"Q`P``&0``````````````@`&A2P``>&PO=V]R:W-H965T<R]S:&5E=#(Q
M+GAM;%!+`0(4`Q0````(`&:#^$:BPFZ@HP$``+$#```9``````````````"`
M`7=-``!X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L!`A0#%`````@`9H/X
M1H&JH\B?`0``L0,``!D``````````````(`!44\``'AL+W=O<FMS:&5E=',O
M<VAE970R,RYX;6Q02P$"%`,4````"`!F@_A&\43YD*(!``"Q`P``&0``````
M````````@`$G40``>&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+`0(4`Q0`
M```(`&:#^$8!(ORGI`$``+$#```9``````````````"``0!3``!X;"]W;W)K
M<VAE971S+W-H965T,C4N>&UL4$L!`A0#%`````@`9H/X1GM62K:C`0``L0,`
M`!D``````````````(`!VU0``'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q0
M2P$"%`,4````"`!F@_A&E&A"\O<!```3!@``&0``````````````@`&U5@``
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+`0(4`Q0````(`&:#^$9`W9>"
ML`$``!8$```9``````````````"``>-8``!X;"]W;W)K<VAE971S+W-H965T
M,C@N>&UL4$L!`A0#%`````@`9H/X1FT@%B^O`0``%@0``!D`````````````
M`(`!REH``'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"%`,4````"`!F
M@_A&"W2D(:4!``"Q`P``&0``````````````@`&P7```>&PO=V]R:W-H965T
M<R]S:&5E=#,P+GAM;%!+`0(4`Q0````(`&:#^$;G6F_2O0$``'L$```9````
M``````````"``8Q>``!X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L!`A0#
M%`````@`9H/X1B.J^\+``0``>P0``!D``````````````(`!@&```'AL+W=O
M<FMS:&5E=',O<VAE970S,BYX;6Q02P$"%`,4````"`!F@_A&RBG'H,L!``#@
M!```&0``````````````@`%W8@``>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM
M;%!+`0(4`Q0````(`&:#^$8:[6)+O`$``'L$```9``````````````"``7ED
M``!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L!`A0#%`````@`9H/X1G1P
M,"ZD`0``L0,``!D``````````````(`!;&8``'AL+W=O<FMS:&5E=',O<VAE
M970S-2YX;6Q02P$"%`,4````"`!F@_A&Z,-DG:X!```6!```&0``````````
M````@`%':```>&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+`0(4`Q0````(
M`&:#^$811(Q,I0$``+$#```9``````````````"``2QJ``!X;"]W;W)K<VAE
M971S+W-H965T,S<N>&UL4$L!`A0#%`````@`9H/X1I-05;"[`0``>P0``!D`
M`````````````(`!"&P``'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"
M%`,4````"`!F@_A&<:&YW*(!``"Q`P``&0``````````````@`'Z;0``>&PO
M=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+`0(4`Q0````(`&:#^$;UG,<-P0$`
M`'@$```9``````````````"``=-O``!X;"]W;W)K<VAE971S+W-H965T-#`N
M>&UL4$L!`A0#%`````@`9H/X1LKO\W(&`@``!P8``!D``````````````(`!
MRW$``'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"%`,4````"`!F@_A&
M!Y`<&T@"``"<!P``&0``````````````@`$(=```>&PO=V]R:W-H965T<R]S
M:&5E=#0R+GAM;%!+`0(4`Q0````(`&:#^$;C5Z`J)0(````'```9````````
M``````"``8=V``!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L!`A0#%```
M``@`9H/X1L%G^5<1`P``#`T``!D``````````````(`!XW@``'AL+W=O<FMS
M:&5E=',O<VAE970T-"YX;6Q02P$"%`,4````"`!F@_A&:NYT!T8#``#0#@``
M&0``````````````@`$K?```>&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+
M`0(4`Q0````(`&:#^$:G=O4H[@$``-<%```9``````````````"``:A_``!X
M;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L!`A0#%`````@`9H/X1F]1E]_K
M`0``8@4``!D``````````````(`!S8$``'AL+W=O<FMS:&5E=',O<VAE970T
M-RYX;6Q02P$"%`,4````"`!F@_A&+]SL89X!``"R`P``&0``````````````
M@`'O@P``>&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+`0(4`Q0````(`&:#
M^$9&MXIXZP4``-`B```9``````````````"``<2%``!X;"]W;W)K<VAE971S
M+W-H965T-#DN>&UL4$L!`A0#%`````@`9H/X1M7+:$2+`@``VP@``!D`````
M`````````(`!YHL``'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"%`,4
M````"`!F@_A&6^/]N=8%``!9)P``&0``````````````@`&HC@``>&PO=V]R
M:W-H965T<R]S:&5E=#4Q+GAM;%!+`0(4`Q0````(`&:#^$:1SKW#,P(``(<'
M```9``````````````"``;64``!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL
M4$L!`A0#%`````@`9H/X1O,Q*CF6`@``4@D``!D``````````````(`!'Y<`
M`'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"%`,4````"`!F@_A&&N]]
MY-8"``!`"P``&0``````````````@`'LF0``>&PO=V]R:W-H965T<R]S:&5E
M=#4T+GAM;%!+`0(4`Q0````(`&:#^$8V51$/300``+D8```9````````````
M``"``?F<``!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L!`A0#%`````@`
M9H/X1I"R].I!`@``^@<``!D``````````````(`!?:$``'AL+W=O<FMS:&5E
M=',O<VAE970U-BYX;6Q02P$"%`,4````"`!F@_A&&`&"G$`"``"M!P``&0``
M````````````@`'UHP``>&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+`0(4
M`Q0````(`&:#^$9Z/BK`00(``!X'```9``````````````"``6RF``!X;"]W
M;W)K<VAE971S+W-H965T-3@N>&UL4$L!`A0#%`````@`9H/X1CZ8R`;@`0``
M.P4``!D``````````````(`!Y*@``'AL+W=O<FMS:&5E=',O<VAE970U.2YX
M;6Q02P$"%`,4````"`!F@_A&#XHST:@!``#T`P``&0``````````````@`'[
MJ@``>&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+`0(4`Q0````(`&:#^$;-
M`]D4RP0``)0:```9``````````````"``=JL``!X;"]W;W)K<VAE971S+W-H
M965T-C$N>&UL4$L!`A0#%`````@`9H/X1K4G(.N)`@``/@D``!D`````````
M`````(`!W+$``'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"%`,4````
M"`!F@_A&LPJ"&Q@"```)!@``&0``````````````@`&<M```>&PO=V]R:W-H
M965T<R]S:&5E=#8S+GAM;%!+`0(4`Q0````(`&:#^$;A_B_H+@0``.,5```9
M``````````````"``>NV``!X;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L!
M`A0#%`````@`9H/X1KW`,H=.`P``[PT``!D``````````````(`!4+L``'AL
M+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"%`,4````"`!F@_A&_SC;/0$#
M``"=#```&0``````````````@`'5O@``>&PO=V]R:W-H965T<R]S:&5E=#8V
M+GAM;%!+`0(4`Q0````(`&:#^$;=S+HB_P(``#H,```9``````````````"`
M`0W"``!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L!`A0#%`````@`9H/X
M1I[@<)XZ`P``$@X``!D``````````````(`!0\4``'AL+W=O<FMS:&5E=',O
M<VAE970V."YX;6Q02P$"%`,4````"`!F@_A&U^_Z)D8"``#(!P``&0``````
M````````@`&TR```>&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+`0(4`Q0`
M```(`&:#^$9M9ADQVP$``*\$```9``````````````"``3'+``!X;"]W;W)K
M<VAE971S+W-H965T-S`N>&UL4$L!`A0#%`````@`9H/X1DD&PJ_$`@``!0P`
M`!D``````````````(`!0\T``'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q0
M2P$"%`,4````"`!F@_A&`&EJ]Y$"``#K"0``&0``````````````@`$^T```
M>&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+`0(4`Q0````(`&:#^$9HJ<6W
MG`0``.L7```9``````````````"``0;3``!X;"]W;W)K<VAE971S+W-H965T
M-S,N>&UL4$L!`A0#%`````@`9H/X1OK:Z'EO`@``1P@``!D`````````````
M`(`!V=<``'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"%`,4````"`!F
M@_A&NEB2MH`"``"J"```&0``````````````@`%_V@``>&PO=V]R:W-H965T
M<R]S:&5E=#<U+GAM;%!+`0(4`Q0````(`&:#^$:C#^&^U@,``*$1```9````
M``````````"``3;=``!X;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L!`A0#
M%`````@`9H/X1D=E''VJ`0``]`,``!D``````````````(`!0^$``'AL+W=O
M<FMS:&5E=',O<VAE970W-RYX;6Q02P$"%`,4````"`!F@_A&$]AB0J<"``#>
M"@``&0``````````````@`$DXP``>&PO=V]R:W-H965T<R]S:&5E=#<X+GAM
M;%!+`0(4`Q0````(`&:#^$;-$2Y+EP$``(D#```9``````````````"``0+F
M``!X;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L!`A0#%`````@`9H/X1@JW
M`&36`@``2`P``!D``````````````(`!T.<``'AL+W=O<FMS:&5E=',O<VAE
M970X,"YX;6Q02P$"%`,4````"`!F@_A&!IDQO%2!``"6!@(`%```````````
M````@`'=Z@``>&PO<VAA<F5D4W1R:6YG<RYX;6Q02P4&`````%D`60!A&```
&8VP!````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978425227072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments (Details Textual) - shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_Employeestockpurchaseplanmaximumshares', window );">Employee stock purchase plan maximum shares</a></td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued under ESPP</a></td>
<td class="nump">98,000<span></span>
</td>
<td class="nump">112,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_Employeestockpurchaseplanmaximumshares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee stock purchase plan maximum shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_Employeestockpurchaseplanmaximumshares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978423502432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable Debt and Equity Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair Value</a></td>
<td class="nump">$ 3,188.4<span></span>
</td>
<td class="nump">$ 2,111.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">3,188.5<span></span>
</td>
<td class="nump">2,112.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_CorporateDebtSecuritiesCurrentMember', window );">Corporate debt securities Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable Debt and Equity Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair Value</a></td>
<td class="nump">375.9<span></span>
</td>
<td class="nump">370.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">375.9<span></span>
</td>
<td class="nump">370.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_CorporateDebtSecuritiesNonCurrentMember', window );">Corporate debt securities Non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable Debt and Equity Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair Value</a></td>
<td class="nump">822.2<span></span>
</td>
<td class="nump">692.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">823.0<span></span>
</td>
<td class="nump">693.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_GovernmentSecuritiesCurrentMember', window );">Government securities Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable Debt and Equity Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair Value</a></td>
<td class="nump">710.5<span></span>
</td>
<td class="nump">269.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">710.5<span></span>
</td>
<td class="nump">270.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_GovernmentSecuritiesNonCurrentMember', window );">Government securities Non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable Debt and Equity Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair Value</a></td>
<td class="nump">989.8<span></span>
</td>
<td class="nump">579.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">989.0<span></span>
</td>
<td class="nump">580.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember', window );">Mortgage and other asset backed securities Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable Debt and Equity Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair Value</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember', window );">Mortgage and other asset backed securities Non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable Debt and Equity Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair Value</a></td>
<td class="nump">289.8<span></span>
</td>
<td class="nump">198.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">289.9<span></span>
</td>
<td class="nump">198.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_EquitySecuritiesMember', window );">Marketable equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable Debt and Equity Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair Value</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="nump">$ 5.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51813488&amp;loc=d3e22054-111558<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -Subparagraph (aa)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27232-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49167202&amp;loc=d3e26610-111562<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of unrealized gain in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_CorporateDebtSecuritiesCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_CorporateDebtSecuritiesCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_CorporateDebtSecuritiesNonCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_CorporateDebtSecuritiesNonCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_GovernmentSecuritiesCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_GovernmentSecuritiesCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_GovernmentSecuritiesNonCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_GovernmentSecuritiesNonCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_MortgageAndOtherAssetBackedSecuritiesCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_MortgageAndOtherAssetBackedSecuritiesNonCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978496333200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingences (Details) - Fumapharm AG - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2006</div></th>
<th class="th"><div>Jun. 30, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash portion of consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=biib_FumapharmAgMember', window );">TECFIDERA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Maximum contingent consideration in the form of development and approval milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_CumulativeSalesLevelAxis=biib_FourbillionMember', window );">Four billion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash portion of consideration</a></td>
<td class="nump">$ 250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_CumulativeSalesLevel', window );">Cumulative sales level</a></td>
<td class="nump">4,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_CumulativeSalesLevelAxis=biib_FivebillionMember', window );">Five billion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash portion of consideration</a></td>
<td class="nump">300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_CumulativeSalesLevel', window );">Cumulative sales level</a></td>
<td class="nump">5,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_CumulativeSalesLevelAxis=biib_EachAdditionalOneBillionUpToTwentyBillionMember', window );">Each additional one billion up to twenty billion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_CumulativeSalesLevel', window );">Cumulative sales level</a></td>
<td class="nump">20,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_CumulativeSalesLevelAxis=biib_OneBillionMember', window );">One billion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_CumulativeSalesLevel', window );">Cumulative sales level</a></td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_CumulativeSalesLevelAxis=biib_ThreeBillionMember', window );">Three billion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_CumulativeSalesLevel', window );">Cumulative sales level</a></td>
<td class="nump">$ 3,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_CumulativeSalesLevel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative sales level</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_CumulativeSalesLevel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionContingentConsiderationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)(3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=biib_FumapharmAgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=biib_FumapharmAgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductOrServiceAxis=biib_TecfideraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductOrServiceAxis=biib_TecfideraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_CumulativeSalesLevelAxis=biib_FourbillionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_CumulativeSalesLevelAxis=biib_FourbillionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_CumulativeSalesLevelAxis=biib_FivebillionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_CumulativeSalesLevelAxis=biib_FivebillionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_CumulativeSalesLevelAxis=biib_EachAdditionalOneBillionUpToTwentyBillionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_CumulativeSalesLevelAxis=biib_EachAdditionalOneBillionUpToTwentyBillionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_CumulativeSalesLevelAxis=biib_OneBillionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_CumulativeSalesLevelAxis=biib_OneBillionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_CumulativeSalesLevelAxis=biib_ThreeBillionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_CumulativeSalesLevelAxis=biib_ThreeBillionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978493924176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Reserves for Discounts and Allowances (Details 1) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract', window );"><strong>Summary of total product revenue reserves included in consolidated balance sheets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Total reserves</a></td>
<td class="nump">$ 590.4<span></span>
</td>
<td class="nump">$ 483.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember', window );">Reduction of accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract', window );"><strong>Summary of total product revenue reserves included in consolidated balance sheets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Total reserves</a></td>
<td class="nump">143.9<span></span>
</td>
<td class="nump">124.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Component of accrued expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract', window );"><strong>Summary of total product revenue reserves included in consolidated balance sheets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Total reserves</a></td>
<td class="nump">$ 446.5<span></span>
</td>
<td class="nump">$ 359.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of product revenue reserves included in consolidated balance sheets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of allowances and reserves, the valuation and qualifying accounts that are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 09<br><br><br><br> -Article 12<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978494055584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesTextBlock', window );">Marketable debt and equity securities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following tables summarize our marketable debt and equity securities:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of June 30, 2015 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Available-for-sale:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">375.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">375.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">822.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">823.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">710.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">710.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">989.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">989.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">289.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">289.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total marketable debt securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,188.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,188.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities, non-current</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2014 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Available-for-sale:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">370.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">370.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">692.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">693.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">269.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">270.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">579.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">580.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">198.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">198.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total marketable debt securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,111.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,112.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities, non-current</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Summary of financial assets with maturities of less than 90 days included within cash and cash equivalents</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes our financial assets with maturities of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">less than 90&#160;days</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> from the date of purchase included within cash and cash equivalents on the accompanying condensed consolidated balance sheet:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Commercial paper</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">38.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">54.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Overnight reverse repurchase agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">185.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">305.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Money market funds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">740.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">321.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Short-term debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">10.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">974.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">716.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Summary of contractual maturities: available-for-sale securities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The estimated fair value and amortized cost of our marketable debt securities available-for-sale by contractual maturity are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due in one year or less</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,086.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,086.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">640.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">640.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due after one year through five years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,954.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,954.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,343.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,345.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due after five years</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">147.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">147.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">126.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">126.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,188.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,188.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,111.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,112.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock', window );">Proceeds from marketable debt securities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The proceeds from maturities and sales of marketable debt securities and resulting realized gains and losses are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Proceeds from maturities and sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">601.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">560.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">975.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,317.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Realized gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Realized losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 320<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62557-112803<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 7<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27337-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27198-111563<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 320<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62586-112803<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27290-111563<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized gains and losses on investments reported in the statement of income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedGainLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978504134288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies Commitments and Contingencies (Details 1)<br> SFr in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=country_CH', window );">Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">SFr 65.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6812-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978423288000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Consolidated Financial Statement Detail (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2015</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Expenses and Other</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Current portion of contingent consideration obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Revenue-related rebates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">590,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">590,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">483,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">393,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties and licensing fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">433,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">433,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">507,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total accrued expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,812,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,812,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,819,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNetAbstract', window );"><strong>Other Income (Expense), Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,300<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="nump">7,600<span></span>
</td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,800)<span></span>
</td>
<td class="num">(7,100)<span></span>
</td>
<td class="num">(12,500)<span></span>
</td>
<td class="num">(14,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Gain (loss) on sales of investments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">13,600<span></span>
</td>
<td class="num">(1,400)<span></span>
</td>
<td class="nump">16,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange gains (losses), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
<td class="num">(1,400)<span></span>
</td>
<td class="num">(14,500)<span></span>
</td>
<td class="num">(4,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,200)<span></span>
</td>
<td class="num">(2,600)<span></span>
</td>
<td class="num">(5,100)<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">274,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,889)<span></span>
</td>
<td class="nump">$ 4,861<span></span>
</td>
<td class="num">(25,875)<span></span>
</td>
<td class="num">$ (740)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Liabilities, Noncurrent</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_Employeerelatedliabilitiesnoncurrent', window );">Employee related liabilities noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">389,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">389,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">249,400<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">915,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">915,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember', window );">Convergence Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash portion of consideration</a></td>
<td class="nump">$ 200,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration</a></td>
<td class="nump">274,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">$ 474,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Component of accrued expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Expenses and Other</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Revenue-related rebates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 446,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 446,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 359,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_Employeerelatedliabilitiesnoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee related liabilities noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_Employeerelatedliabilitiesnoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Liabilities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 30<br><br><br><br> -Paragraph 7<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6578-128477<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 30<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6613-128477<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph b<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph b<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30700-110894<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30690-110894<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-04.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.7(b))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.7)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Liabilities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent portion (due beyond one year or one operating cycle) of other accrued expenses (expenses incurred at the end of the reporting period but not yet paid) not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.24)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.24)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (g)(4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 340<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5865-108316<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Assets<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 340<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5879-108316<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of allowances and reserves, the valuation and qualifying accounts that are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 09<br><br><br><br> -Article 12<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978499829728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract', window );"><strong>Summary of Contractual Maturities: Available-for-Sale Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less, estimated fair value</a></td>
<td class="nump">$ 1,086.6<span></span>
</td>
<td class="nump">$ 640.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in one year or less, amortized cost</a></td>
<td class="nump">1,086.6<span></span>
</td>
<td class="nump">640.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years, Estimated Fair Value</a></td>
<td class="nump">1,954.4<span></span>
</td>
<td class="nump">1,343.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years, Amortized Cost</a></td>
<td class="nump">1,954.5<span></span>
</td>
<td class="nump">1,345.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue', window );">Due after five years, estimated fair value</a></td>
<td class="nump">147.4<span></span>
</td>
<td class="nump">126.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost', window );">Due after five years, amortized cost</a></td>
<td class="nump">147.4<span></span>
</td>
<td class="nump">126.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Total available-for-sale securities, Fair Value</a></td>
<td class="nump">3,188.4<span></span>
</td>
<td class="nump">2,111.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total available-for-sale securities, Amortized Cost</a></td>
<td class="nump">$ 3,188.5<span></span>
</td>
<td class="nump">$ 2,112.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents debt securities, at cost, net of adjustments made for accretion, amortization, other-than-temporary impairments, and hedging, if any, which are expected to mature after five years from the balance sheet date and which are categorized neither as held-to-maturity nor trading securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the fair value of debt securities, which are expected to mature after five years from the balance sheet date and which are categorized neither as held-to-maturity nor trading securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the cost of debt securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (aa)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51813488&amp;loc=d3e22054-111558<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -Subparagraph (aa)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27232-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49167202&amp;loc=d3e26610-111562<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after adjustments of available-for-sale debt securities at cost, maturing in the second fiscal year through the fifth fiscal year following the latest fiscal year. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings less cumulative-effect adjustments, and fair value hedge accounting adjustments. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27198-111563<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of available-for-sale debt securities maturing in the second fiscal year through the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 320<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62586-112803<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (d)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27198-111563<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after adjustments of available-for-sale debt securities at cost, maturing in the next fiscal year following the latest fiscal year. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings less cumulative-effect adjustments, and fair value hedge accounting adjustments. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27198-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of available-for-sale debt securities maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27198-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 320<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62586-112803<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (d)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426302288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborative and Other Relationships Collaborative and Other Relationships - Equity Method Investments (Details)<br> $ in Thousands, &#8361; in Billions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 29, 2012 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>KRW (&#8361;)</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>KRW (&#8361;)</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>KRW (&#8361;)</div>
</th>
<th class="th">
<div>Feb. 29, 2012 </div>
<div>KRW (&#8361;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Recognized loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,881)<span></span>
</td>
<td class="num">$ (1,933)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,715)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,538)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">490,728<span></span>
</td>
<td class="nump">447,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">951,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">976,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSalesRevenueNet', window );">Revenue related to technical development and technology transfer services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,566<span></span>
</td>
<td class="nump">61,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=biib_SamsungBiosimilarAgreementMember', window );">Samsung Biosimilar Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement', window );">Contribution from Samsung to develop, manufacture and market biosimilar pharmaceuticals</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8361; 280.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_JointVentureOwnerShipPercentageByThirdParty', window );">Variable interest entity, qualitative or quantitative information, ownership percentage</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Contribution from Biogen to develop, manufacture and market biosimilar pharmaceuticals</a></td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8361; 7.5<span></span>
</td>
<td class="nump">$ 8,600<span></span>
</td>
<td class="nump">&#8361; 9.1<span></span>
</td>
<td class="nump">&#8361; 49.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of stake in entity minimum</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Additional contribution made to Samsung Bioepis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700<span></span>
</td>
<td class="nump">&#8361; 6.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_EquityMethodInvestmentOwnershipPercentageMaximum', window );">Percentage of stake in entity maximum</a></td>
<td class="nump">49.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Recognized loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,900)<span></span>
</td>
<td class="num">(1,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_AdditionalMilestonePayment', window );">Additional milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_EquityMethodInvestmentsExpectedProfitShare', window );">Expected profit share with Samsung Bioepis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSalesRevenueNet', window );">Revenue related to technical development and technology transfer services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,200<span></span>
</td>
<td class="nump">$ 12,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_AdditionalMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional milestone payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_AdditionalMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_EquityMethodInvestmentOwnershipPercentageMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity method investment ownership percentage maximum.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_EquityMethodInvestmentOwnershipPercentageMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_EquityMethodInvestmentsExpectedProfitShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Expected Profit Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_EquityMethodInvestmentsExpectedProfitShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments by third party in joint venture as per agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_InvestmentsByThirdPartyInJointVentureAsPerAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_JointVentureOwnerShipPercentageByThirdParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Joint venture owner ship percentage by third party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_JointVentureOwnerShipPercentageByThirdParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 323<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6382943&amp;loc=d3e33918-111571<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 323<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35755396&amp;loc=d3e33749-111570<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.12)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 323<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35755396&amp;loc=d3e33749-111570<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.12)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 11<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenues from the sale of other goods or rendering of other services, not elsewhere specified in the taxonomy; net of (reduced by) sales adjustments, returns, allowances, and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1(a),(d))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 730<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Research and Development<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=biib_SamsungBiosimilarAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=biib_SamsungBiosimilarAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426058960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Litigation (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2014</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=country_IT', window );">Italy</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_ReimbursementLimitStatedInResolution', window );">Reimbursement limit stated in the resolution</a></td>
<td class="text">24 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_ReimbursementLimitStatedInResolution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reimbursement limit stated in the resolution.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_ReimbursementLimitStatedInResolution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=country_IT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=country_IT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978503238672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Reconciliation between the U.S. federal statutory tax rate and effective tax rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory rate</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Taxes on foreign earnings</a></td>
<td class="num">(11.10%)<span></span>
</td>
<td class="num">(8.70%)<span></span>
</td>
<td class="num">(9.80%)<span></span>
</td>
<td class="num">(8.50%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Credits and net operating loss utilization</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization', window );">Purchased intangible assets</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction', window );">Manufacturing deduction</a></td>
<td class="num">(2.10%)<span></span>
</td>
<td class="num">(1.70%)<span></span>
</td>
<td class="num">(1.80%)<span></span>
</td>
<td class="num">(1.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Permanent items</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">23.90%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">24.70%<span></span>
</td>
<td class="nump">26.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation manufacturing deduction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_EffectiveIncomeTaxRateReconciliationManufacturingDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 13<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h)(2))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 6.I)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 13<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 13<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 6.I)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to depreciation and amortization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 6.I)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 13<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 6.I)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 13<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 6.I)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 13<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 6.I)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 13<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 13<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 6.I)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978503022736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Commitments and Contingencies</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Fumapharm AG</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In 2006, we acquired Fumapharm AG. As part of this acquisition we acquired FUMADERM and TECFIDERA (together, Fumapharm Products). We paid </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$220.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> upon the closing of the transaction and agreed to pay an additional </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$15.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> if a Fumapharm Product was approved for MS in the U.S.&#160;or E.U. In the second quarter of 2013, we paid this </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$15.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> contingent payment as TECFIDERA was approved in the U.S. for MS by the U.S. Food and Drug Administration (FDA). We are also required to make additional contingent payments to former shareholders of Fumapharm AG or holders of their rights based on the attainment of certain cumulative sales levels of Fumapharm Products and the level of total net sales of Fumapharm Products in the prior twelve month period, as defined in the acquisition agreement. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we paid a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$250.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> contingent payment as we reached the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$4.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> cumulative sales level related to the Fumapharm Products in the fourth quarter of 2014 and accrued </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$300.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> upon reaching </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$5.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in total cumulative sales of Fumapharm Products in the second quarter of 2015.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We will owe an additional </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$300.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> contingent payment for every additional </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in cumulative sales level of Fumapharm Products reached if the prior 12 months sales of the Fumapharm Products exceed </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$3.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, until such time as the cumulative sales level reaches </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$20.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, at which time no further contingent payments shall be due. These payments will be accounted for as an increase to goodwill as incurred, in accordance with the accounting standard applicable to business combinations when we acquired Fumapharm. Any portion of the payment which is tax deductible will be recorded as a reduction to goodwill. Payments are due within 60&#160;days following the end of the quarter in which the applicable cumulative sales level has been reached. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Solothurn, Switzerland Facility</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On June 30, 2015, we signed an agreement to purchase land in Solothurn, Switzerland for </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">65.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Swiss Francs. The contract also includes certain environmental remediation costs. Our obligation to purchase the land under the contract is subject to customary closing conditions as well as a condition that no material adverse changes in our business such as a decision to discontinue our aducanumab program have occurred during the period.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 460<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51674963&amp;loc=d3e12565-110249<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 440<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426381248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="nump">$ 292,501<span></span>
</td>
<td class="nump">$ 268,521<span></span>
</td>
<td class="nump">$ 574,382<span></span>
</td>
<td class="nump">$ 446,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Increase to goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">390,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Summary of roll forward of the changes in goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,760,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherChanges', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, end of period</a></td>
<td class="nump">$ 2,154,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,154,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductOrServiceAxis=biib_TecfideraMember', window );">TECFIDERA | Fumapharm AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Increase to goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillOtherChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other (increase) decrease of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (g)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillOtherChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -Subparagraph (a),(b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Income Tax Expense (or Benefit)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductOrServiceAxis=biib_TecfideraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductOrServiceAxis=biib_TecfideraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=biib_FumapharmAgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=biib_FumapharmAgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978425980192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions Acquisitions (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2015</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 274.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember', window );">Convergence Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash portion of consideration</a></td>
<td class="nump">$ 200.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration</a></td>
<td class="nump">274.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">$ 474.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 30<br><br><br><br> -Paragraph 7<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6578-128477<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 30<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6613-128477<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978499892336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Variable Interest Entities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_InvestmentInVariableInterestEntitiesTextualAbstract', window );"><strong>Investment in Variable Interest Entities (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">$ 490,728<span></span>
</td>
<td class="nump">$ 447,273<span></span>
</td>
<td class="nump">$ 951,277<span></span>
</td>
<td class="nump">$ 976,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities', window );">Investment in biotechnology companies that are determined to be unconsolidated variable interest entities</a></td>
<td class="nump">8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis=biib_NeurimmuneMember', window );">Neurimmune</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_InvestmentInVariableInterestEntitiesTextualAbstract', window );"><strong>Investment in Variable Interest Entities (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement', window );">Remaining potential development milestone payments and royalties on commercial sales under the terms of collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">335,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial', window );">Expected milestone payment for initiation of a late stage clinical trial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="nump">$ 10,600<span></span>
</td>
<td class="nump">$ 47,800<span></span>
</td>
<td class="nump">$ 21,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected milestone payment for initiation of a late stage clinical trial</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_Expectedmilestonepaymentforinitiationofalatestageclinicaltrial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in biotechnology companies that are determined to be unconsolidated variable interest entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_InvestmentInVariableInterestEntitiesTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in Variable Interest Entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_InvestmentInVariableInterestEntitiesTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected total payments including upfront and milestone payments as well as the greater of an annual maintenance fee or usage-based royalty payments under the terms of collaboration agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_RemainingPotentialDevelopmentMilestonePaymentsAndRoyaltiesOnCommercialSalesUnderTermsOfCollaborationAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 730<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Research and Development<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis=biib_NeurimmuneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis=biib_NeurimmuneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978504074272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Basic and diluted earnings per share</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Basic and diluted earnings per share are calculated as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income attributable to Biogen Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">927.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">714.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,749.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,194.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted average number of common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">236.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">236.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Effect of dilutive securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Stock options and employee stock purchase plan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Time-vested restricted stock units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market stock units</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Dilutive potential common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Shares used in calculating diluted earnings per share</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">237.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">237.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978497306656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details 1) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable, carrying value</a></td>
<td class="nump">$ 579.5<span></span>
</td>
<td class="nump">$ 585.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt instruments, fair value</a></td>
<td class="nump">631.5<span></span>
</td>
<td class="nump">647.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=biib_NotesPayableToFumedicaMember', window );">Notes Payable to Fumedica</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Notes payable, fair value</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable, carrying value</a></td>
<td class="nump">9.4<span></span>
</td>
<td class="nump">11.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember', window );">6.875% Senior Notes due 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Notes payable, fair value</a></td>
<td class="nump">621.5<span></span>
</td>
<td class="nump">634.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable, carrying value</a></td>
<td class="nump">$ 570.1<span></span>
</td>
<td class="nump">$ 573.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 10<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13433-108611<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13476-108611<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.16)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.16)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 13, 16<br><br><br><br> -Article 9<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19, 20, 22<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of notes payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19,20,22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=biib_NotesPayableToFumedicaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=biib_NotesPayableToFumedicaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=biib_SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978494086496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract', window );"><strong>Share-based Compensation Expense included in consolidated statements of income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Subtotal</a></td>
<td class="nump">$ 48.3<span></span>
</td>
<td class="nump">$ 58.1<span></span>
</td>
<td class="nump">$ 139.3<span></span>
</td>
<td class="nump">$ 134.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Capitalized share-based compensation costs</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="num">(5.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses', window );">Share-based compensation expense included in total costs and expenses</a></td>
<td class="nump">46.1<span></span>
</td>
<td class="nump">55.5<span></span>
</td>
<td class="nump">133.7<span></span>
</td>
<td class="nump">129.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax effect</a></td>
<td class="num">(12.9)<span></span>
</td>
<td class="num">(16.5)<span></span>
</td>
<td class="num">(39.6)<span></span>
</td>
<td class="num">(38.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract', window );"><strong>Share-based Compensation Expense included in consolidated statements of income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">22.1<span></span>
</td>
<td class="nump">24.5<span></span>
</td>
<td class="nump">57.5<span></span>
</td>
<td class="nump">53.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract', window );"><strong>Share-based Compensation Expense included in consolidated statements of income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">26.2<span></span>
</td>
<td class="nump">33.6<span></span>
</td>
<td class="nump">81.8<span></span>
</td>
<td class="nump">80.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ParentMember', window );">Total share-based compensation expense, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract', window );"><strong>Share-based Compensation Expense included in consolidated statements of income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 33.2<span></span>
</td>
<td class="nump">$ 39.0<span></span>
</td>
<td class="nump">$ 94.1<span></span>
</td>
<td class="nump">$ 90.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation expense included in costs and expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 14.F)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (h)(1)(i)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 14<br><br><br><br> -Section F<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense, net of income tax, recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the compensation cost capitalized during the period arising from equity-based compensation arrangements (for example, shares of stock, units, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (h)(1)(ii)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total recognized tax benefit related to compensation cost for equity-based payment arrangements recognized in income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (h)(1)(i)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978496309344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_DerivativeInstrumentsTextualAbstract', window );"><strong>Derivative Instruments (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLowerRemainingMaturityRange1', window );">Lower range of durations of foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 month<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeHigherRemainingMaturityRange1', window );">Higher range of durations of foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax', window );">Gain/Loss on fair value of foreign currency forward contracts</a></td>
<td class="nump">$ 63.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1', window );">Expected settlement time for contracts, in months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Net gains (losses) of other income (expense) related to foreign currency forward contracts</a></td>
<td class="nump">13.6<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 3.9<span></span>
</td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_DerivativeInstrumentsTextualAbstract', window );"><strong>Derivative Instruments (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Aggregate notional amount</a></td>
<td class="nump">1,517.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,517.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,302.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_DerivativeInstrumentsTextualAbstract', window );"><strong>Derivative Instruments (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Aggregate notional amount</a></td>
<td class="nump">472.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">472.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Other current assets | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueNetAbstract', window );"><strong>Summary of Derivatives designated as Hedging Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value, net</a></td>
<td class="nump">92.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Other current assets | Not designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueNetAbstract', window );"><strong>Summary of Derivatives designated as Hedging Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value, net</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Investments and other assets | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueNetAbstract', window );"><strong>Summary of Derivatives designated as Hedging Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Accrued expenses and other | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueNetAbstract', window );"><strong>Summary of Derivatives designated as Hedging Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value, net</a></td>
<td class="nump">9.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Accrued expenses and other | Not designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueNetAbstract', window );"><strong>Summary of Derivatives designated as Hedging Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value, net</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Other long-term liabilities | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueNetAbstract', window );"><strong>Summary of Derivatives designated as Hedging Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value, net</a></td>
<td class="nump">17.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember', window );">Revenue | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_DerivativeInstrumentsTextualAbstract', window );"><strong>Derivative Instruments (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Net gains (losses) in product revenue for the settlement of certain effective cash flow hedge instruments</a></td>
<td class="nump">40.4<span></span>
</td>
<td class="num">(5.2)<span></span>
</td>
<td class="nump">75.4<span></span>
</td>
<td class="num">(10.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other income (expense) | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_DerivativeInstrumentsTextualAbstract', window );"><strong>Derivative Instruments (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet', window );">Net gains (losses) in earnings of Foreign currency forward contracts due to hedge ineffectiveness</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="num">$ (1.0)<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="num">$ (1.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrencyAxis=currency_EUR', window );">Euro | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_DerivativeInstrumentsTextualAbstract', window );"><strong>Derivative Instruments (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Aggregate notional amount</a></td>
<td class="nump">1,437.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,437.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,174.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrencyAxis=currency_CAD', window );">Canadian Dollar | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_DerivativeInstrumentsTextualAbstract', window );"><strong>Derivative Instruments (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Aggregate notional amount</a></td>
<td class="nump">32.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrencyAxis=currency_GBP', window );">British Pound Sterling | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_DerivativeInstrumentsTextualAbstract', window );"><strong>Derivative Instruments (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Aggregate notional amount</a></td>
<td class="nump">21.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrencyAxis=currency_JPY', window );">Japanese Yen | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_DerivativeInstrumentsTextualAbstract', window );"><strong>Derivative Instruments (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Aggregate notional amount</a></td>
<td class="nump">15.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrencyAxis=currency_AUD', window );">Australian Dollar | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_DerivativeInstrumentsTextualAbstract', window );"><strong>Derivative Instruments (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Aggregate notional amount</a></td>
<td class="nump">$ 10.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_DerivativeInstrumentsTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_DerivativeInstrumentsTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 12<br><br><br><br> -Section 13<br><br><br><br> -Sentence Column B<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>invest_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetFairValueNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetFairValueNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4B<br><br><br><br> -Subparagraph (a),(c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624163-113959<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 7<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51825145&amp;loc=SL20226000-175313<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 860<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4D<br><br><br><br> -Subparagraph (c)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51814546&amp;loc=SL51823488-111719<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 860<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4D<br><br><br><br> -Subparagraph (c)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51814546&amp;loc=SL51823488-111719<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4B<br><br><br><br> -Subparagraph (a),(c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624163-113959<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 7<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51825145&amp;loc=SL20226000-175313<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeHigherRemainingMaturityRange1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>High end period remaining until maturity for the derivative contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeHigherRemainingMaturityRange1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4C<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624171-113959<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4D<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624177-113959<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4C<br><br><br><br> -Subparagraph (d)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624171-113959<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 25<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)(1),(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6886632&amp;loc=d3e76258-113986<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLowerRemainingMaturityRange1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Low end period remaining until maturity of derivative contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLowerRemainingMaturityRange1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4C<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624171-113959<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4A<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5618551-113959<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrencyAxis=currency_AUD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrencyAxis=currency_AUD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978497287744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Components of inventories</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 173,200<span></span>
</td>
<td class="nump">$ 128,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">516,700<span></span>
</td>
<td class="nump">511,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">175,800<span></span>
</td>
<td class="nump">164,200<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 865,738<span></span>
</td>
<td class="nump">$ 804,022<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.6(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 330<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 5.BB)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 5<br><br><br><br> -Section BB<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.6(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 330<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655945&amp;loc=d3e3927-108312<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 330<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 5.BB)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.6(a)(4))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 5<br><br><br><br> -Section BB<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.6(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 330<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 5.BB)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 5<br><br><br><br> -Section BB<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978503550144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions Acquisitions<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Acquisitions</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Acquisitions</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Convergence Pharmaceuticals</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On February 12, 2015, we completed our acquisition of all of the outstanding stock of Convergence Pharmaceuticals (Convergence), a clinical-stage biopharmaceutical company with a focus on developing product candidates for neuropathic pain. Convergence&#8217;s lead candidate is its Phase 2 clinical candidate (CNV1014802), which has demonstrated clinical activity in proof-of-concept studies for trigeminal neuralgia (TGN), a chronic orphan disease. Additionally, CNV1014802 has potential applicability in several other neuropathic pain states. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The purchase price consisted of a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$200.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> cash payment at closing, plus contingent consideration in the form of development and approval milestones up to a maximum of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$450.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, of which </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$350.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> is associated with the development and approval of CNV1014802 for the treatment of TGN. The acquisition was funded from our existing cash on hand and has been accounted for as the acquisition of a business. In addition to obtaining the rights to CNV1014802 and additional product candidates in preclinical development, we retained the services of key employees of Convergence.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In connection with our acquisition of Convergence, we recorded a liability of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$274.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> representing the fair value of the contingent consideration.&#160;This amount was estimated through a valuation model that incorporates industry-based probability adjusted assumptions relating to the achievement of these milestones and thus the likelihood of making the contingent payments. This fair value measurement is based upon significant inputs not observable in the market and therefore represents a Level 3 measurement. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The purchase price, as adjusted, consisted of the following:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash portion of consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">200.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">274.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase price</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">474.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Subsequent changes in the fair value of the contingent consideration obligation will be recognized as adjustments to contingent consideration and reflected within our condensed consolidated statements of income. For additional information related to the fair value of this obligation, please read Note 6,&#160;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Fair Value Measurements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;to these condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We adjusted our preliminary estimate of the fair value of the separately identifiable assets acquired and contingent consideration as of the date of acquisition to reflect revised estimates to our initial clinical development plans, resulting probabilities of success and the timing of certain milestone payments. The primary effects of these revised estimates resulted in an increase in the value of our estimated contingent consideration and goodwill by </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$36.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, as compared with March 31, 2015. Our revised purchase price allocation is reflected in the chart below. Our purchase price allocation is substantially complete.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the estimated fair values of the separately identifiable assets acquired and liabilities assumed as of February&#160;12, 2015, as adjusted:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In-process research and development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">424.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">128.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(84.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase price</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">474.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our estimate of the fair value of the IPR&amp;D programs acquired was determined through a probability adjusted cash flow analysis based on probability weighted net cash flows utilizing a discount rate of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">11%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. This valuation was primarily driven by the value associated with the lead candidate, CNV1014802, which is in development for the treatment of TGN and is expected to be completed no earlier than 2020, at a remaining cost of approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$145.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. The fair value associated with CNV1014802 for the treatment of TGN was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$200.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. We have recorded additional IPR&amp;D assets related to the use of CNV1014802 in two additional neuropathic pain indications, with a total estimated value of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$220.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. The remaining cost of development for these two indications is approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$415.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, with an expected completion date of no earlier than 2021. These fair value measurements were based on significant inputs not observable in the market and thus represent Level 3 fair value measurements.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have attributed the goodwill recognized to the Convergence workforce's expertise in chronic pain research and clinical development and to establishing a deferred tax liability for the acquired IPR&amp;D intangible assets which has no tax basis. The goodwill is not tax deductible.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Pro forma results of operations would not be materially different as a result of the acquisition of Convergence and therefore are not presented. Subsequent to the acquisition date, our results of operations include the results of operations of Convergence.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978627038128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract', window );"><strong>Reconciliation of equity attributable to non-controlling interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">NCI, beginning of period</a></td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="nump">$ 5,030<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income (loss) attributable to NCI, net of tax</a></td>
<td class="num">(2,451)<span></span>
</td>
<td class="nump">8,626<span></span>
</td>
<td class="num">(4,818)<span></span>
</td>
<td class="nump">8,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Fair value of net assets and liabilities acquired and assigned to NCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distribution to noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_Noncontrollinginterestincreasedecreaseother', window );">Translation adjustment and other</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">NCI, end of period</a></td>
<td class="nump">$ 421<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="nump">$ 421<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_Noncontrollinginterestincreasedecreaseother">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling interest, increase (decrease) other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_Noncontrollinginterestincreasedecreaseother</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of equity attributable to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_ReconciliationOfEquityAttributableToNonControllingInterestsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 27<br><br><br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 4J<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35736750&amp;loc=SL4591551-111686<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=SL4573702-111684<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase in noncontrolling interest balance because of a business combination that occurred during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1A<br><br><br><br> -Subparagraph (c)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=SL4573702-111684<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (e)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4845-128472<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>61
<FILENAME>0000875045-15-000024-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000875045-15-000024-xbrl.zip
M4$L#!!0````(`$"#^$9G1KUS>\H!``$,(P`1`!P`8FEI8BTR,#$U,#8S,"YX
M;6Q55`D``UB?LE58G[)5=7@+``$$)0X```0Y`0``[%U9<^)(MGZ>B;C_P>/G
M2QMM+([JFA`(JGW'+KL,U=WU5)%(:<@N(=$IR67FU]_4`@@0F%5D2J>CH[N*
M7)3GG.^LF4I]^/?;V+YZQ=0CKO/KM?1+]?H*.Z9K$6?XZ_777D7OM>_NKO_]
M\7_^^>%?E<J?K>?[*\,U@S%V_*LVQ<C'UM5/XH^N_K"P]^/JA;KCJS]<^H.\
MHDHE&36Y;9B-VL!J*I)45U4)51LOUD`;5&5EH"*IH0W^]^U6PDW5DC!"LJ6H
M:DT>J!;"U?H`US6DJ58CGNUM0&UR&_[WBBW<\6X'A`Q^O1[Y_N3VYN;GSY^_
M#(@[Q`ZQL/F+Z8YOY*JD56L*(RON;[J!X]/I?$@XU2\>ZSQT7V^2QG"04JE*
M%46:#PLH97S9-"YI#0>JRP,M3++'L(:,[OC-'&7W#ULB:I8'$.<5>W[VD+@M
M@QKBN:HLU9?X%HUTZ9!UKRHW28_9`)LX/[;T#IL'R,.S[@XBII>]IJ@I7)*T
MO"3'=9Q@G/T,RZ<W_G2";UBG"NN%*3'GX]X?M#R`XI>-E-1N6.NLHT?,;!)8
M0P8!GC^A&_JSEHP!@5<9(C29CWE!WB!:2-*0(6S60ET;>YECHI;L02$?L@=%
M+5F#?(J'&_G4O&'MLZYA@[4"\CD_X\:EKGYF5RWNZJ>[DFT`=3P?.>8<<F]K
M$/VI1+VE9K-Y$[7.NWI65D<VK73SY\-]SQSA,5IT)N]WKLQ7PVS4/SZ$#[OU
MHI9G_'(5/?QV%`$O-%>5F4WZA:WD.FD.!?'KM4?&$YO1=!/-$QL[TW5\_.9?
M$;;JKA&._2)_ZQO1HV9]F#4F_C3Z9?83LX#LQQ>"Z56T%+Q$Q@R;[;O_7'^L
MLG\:=:VJ:A]N5@?'3[E9>TSRE`E3+==:>C#C!/4-YA@^SF!5E683+-K2([!C
MI?K7*DIU\4!KWGOVV^*1LU\2#FW@V5W,LMX(4>P]!GXHJ="]<<O`&$Q^PHYZ
M1:K/9TU:CF%'!"'UB_Q%%`@Q#ZGN`R'U]!":\4P8M5/W5+MS\4P3"&?:GC@[
M@ZGJ)K:*6X8MFZ8T^2<Q37>1FJDBD*]6))G%2V<@7PCIJV>2OB*&])732S]6
M?:GMLJ2-L@S6Q$\L8AFC[TDZ\+T5>,3!GJ>;?P?$(SY+V/4WXGT/0\KO:\-,
M'/C$1+;W@,<#3/-DZMRZXF%8)HA_BW^TV,/?)C8QB1^OZ\HBK$]<?$@(O=U`
MZ/7'D-+;]RC]<)/YH&1E-^M+.\(`R@P&XF!@/LL3=:W`]!]I#]-78N+4%)]_
MEYAR-ZHRP"8%FSU6D<7;V1)6F`M(/0*IGW%`W0GR1\2<(.(0EM*9*'P*&+S3
M(_<]9HN,Y%2>`JZ6)U?+6W(6XT0"D/`,$GE/D,@5N<$M2"!@*U/`QAN49\6H
M!9:1'>YQ]$88^_=N'`!$2)QUT,UH`]5[QB8FKVA@8P%!N8'(ZX^S'INHS#,(
M.E?E;7=9/_HC3-O1OK=_3]"`V$R!L8C>[5V!;R4U-ZF?K^"XA]1!PX66]5[6
M'#2\`'9]<5Y@+M??D1W$/+!M]V?(&4]WK&?LL?@'>_WI!"_!(&GHNK2-O)%!
MO$@WQ$/!;F0O,+&-[GP#P4L?H#@"1+,TQZ?(]`-DZ]9?@>>';!'0CNR*H%GZ
MLI'HDL%G-<K8TP#UD(V9*_8#ZH3]%H.*BZ!9_W=(%SH>.=XS`3`N`XRB&!AP
M3OD[IYR3'(AU.8]U<RAK'8`'L`P7M0QY%#C!,HAC&3CT%!![7CPIR<-?;-V^
M[4\]-*`DV4!<V;+M$H?X^)Z\8NO.80L;DH&-=<_#OM>:/J"_F$+9B$T\G^W.
MN2<FDPVVGEA`+*2GV;ZAF\6N4VWB[L'M9#4;V%TH].Z#P=D8`[]BVYU@JX_-
MD>/:[G#Z3(8C?_<C"?KOCY\[?XJ'WKTP-!OT#KMR.*209K?0Z%V\EW:X$7T,
M?.&MZ/ZV;!/5.9:!>'E);Z6BN-5_=X,QFH1'B_3ASL:-J?D+DS=%XN%JNW=>
M8T8.IFN%F26L6A[JK<'8%2]R2U<GRI@]B!?#YU&7`"2(@`3>;,*.V5QA07&*
M]$P$2Y'&QYUCX9<#,'+GL!#-9(%A6/)#U!SI++J)^1;2+1Y2]F3$`BT[<:)0
MF(&84XR8DV?[T:?(PF-$?X2[`=%?/J.QB!LA!]N-K1P0'B/I:!0P(C9&!-UU
M$`DA0L>I>>`#XM1BQ:DYO;9RJD+(XD@/FV/Y4,<#>\0X&(N'I'P*)GLL:,[;
M!6B7F%NR4O^1<-YW;[ZLR,YY4QY`SH/-1F\E0/:E;'::N0!GB%P+$+D6&6A0
M9KE@F44$8)VLW@\>^>!]`7#)H@&Z%,G3Q0`-*=,%ZP*EL-4<U`5*;+57Z_\&
M'OAWCN?3Z"-R"\O<PPYQZ6?7QUZ/O#VYQ/$[H71Z3&I.ETGZ"5-FFGPCP/V?
M[/_3J!5C1SSTKK,@L;]'\D#HFO_J>81-.(FX\X2FX;UL?;?+6L/;J`L$@FT$
M%NHT`4CXDA*^I`Z#K1?'UN=R#A$1&KZ'CEO3*(A;CW&CGUO(_(&M'C8#FKJ@
M,6N6^1]_8W(,"XW3^S#X6YIRWN?.F02^%W60-T_Y@)$74!SRLTOQWT'XP=?L
M^5(]PSM$`TJ),Q0/N1N%DKHI=;-43A5-[R;4Q9*V2/4,2]H$BHSU;$%%477Y
M4"V40`M/BG\)\"\4_A7`_TGQKP#^2QC+@185,98#7>9*E]LNG;@4^3C,<\^I
MS1`3[J7-6^7"DSY#;'H9?2ZST@`R\K#T9488+V89D'Z._!RJQ%"?+0+^+QW3
M0X;.M?.`'+T8^KQGO0U4[]+%,4#Y`2C_VNO3B!E3W;$^N:^8.HMWBB#ZNYCJ
M;)4+3UX+HM!RZC-4EHNISU!9YDJ?<\LJP3\7,ZL$_\R5/N?FGZ%*5$S_#%4B
MKO0YIU-9$&US7'B"6+L8NKRW;P;5N[PC!:0G2)<`H8(CHZJ<Y]UA0(;8R-#.
MA@P9D"$Z,L[R-KH"IU\%1X9RMC@#;(;8R%#S^)H%5#QX.RT*M88\O^8"^W&\
MX1_VP2Z#?W@OICB;T(#T`Y`.YX@%V\X!E!^`<CA'S*?J"'.N`>(SL?49E._R
MR@=(/T<F#B?IX`1;$?`/)\RYU"->DGN(W(JASW#G,X_:+,B)5-!EKG09[@GD
M4YN%\<VPZ\N5/L/;7WSJLS!54LB=N=)GN/.+3WT6QC^#/G.ESW!["I_Z+(Q_
MAGB;*WV&M[-YU&9!:F&@RV7498BTBZC+$&?G^/W:Z$OR_>D$>X\O80+&8K;.
MWP%;Y@(AD=I$'[5]<*D_1$/,.CWZ(TPS`?79==J,7?.03R0EVI$;R?=M#V)'
M;NC)XYZ.7=$SZ[_:6&"$S`9DDUQ*%$0V9)$1EM%D[$)]>;&QH118$FSL0CU@
M8X4[Y3$=.S*@O`C9*1PK"5CVYT5Y<9/EDTL"DW=)%QH51HR*;WTC3PGNQ0%&
M)?4-9M23VSXD]N^<K?.V]`CL6(O^2SR;M5Q.DWI^Z)^&Q+QS7K'G1\63HJO0
M9IJ%UIW5FB_@@'\<Y%'[7U`7<F:IN)-U?D,D>:^3MJCB['TVI4!R?7`=/'U`
M]`?VNX%C%4RRV=0)+]NT#]\BVV<\":@Y0A[6AQ1C02WU-OENIE!X_[RCC$%_
M!93MCK:Y[8['F)H$V4^(/:=8HLTD3GC+O*-DP3(++.,=+3-HKW!V>4?)0BXD
MF%P/KG5`]9B#ZG$>OAIV*T7>K>0.(7`.AIMS,-QA`W:RA=C)Y@DW<,*RR-5Y
M.*5=U%/:W*$'SF!R<P8SC^I4"]G(,7%OA+%_[YK(9\Q;<BB1SJSM::<*'92\
MLE&O^(XMCP9AGV?B_5A^U\JEF`R=SILY0LX0M]F"*#)77]7^#5M#X@P-[+&^
MZPN9_8XMW4NZ+AXI'BXW,7[AU[(YOQ5]>SQ_F^!2[T-MD]RIEI(M^'3!Z5W)
M%ZK^M)M.)C8I<F>7TTKF.*VY>`JKA1F\+J$>9LA:>%^XO]XQ+I@Q'.X)&A`[
MZ]UF\(KGU<<M,BBA7O+D'_F)6?GPC^743_"7O.DE%W&K;IHTP!;XS0OHY2;>
M@UX6TE^*FD^63B_!7Y9*+T6-8Z'.4QX]O&2=!^+4DND=Q*5<Z!T7_@[T#O2N
M9'J7QWL*Y4JY1,HR\I!^'-,FM]^:R5^^=[X^EQ0?:7Y<?YPQY)8QI(QY;A[Q
M=C8"_^_I&R`PC4#&D#(B,(\*:#8"]:\&(#"-0,800&">7A@0"`B\K!>&.!#B
MP+R\<+GP!=+?Q0-^:CV5%!\;[`]C2!GMS^4\("`0$'C9/+2M0Q:PA$#&$$!@
MGEX8:G%0B[OL?@380+"!Y_P.`//"7_I&"D,G.TAPYYCN&/=\QK]PEJTOCKEL
M[:PUY&\XJ/,V8;+"XF&6H\W]+>Q??VEL&__/"_&E#STP1Z_N\Z&'E<#@)!]Z
MN+Q2])`MXOTTHF$_Q>820EP%B`/$SP-Q=4^(JX6$.(0V$-IPIA1[GG\4_*AO
M&4^W[K&K"-(5JEZ9I"7?P*&!0^/"H6E[?I3QC+GZ!94"$ID")S*\0%P%B`/$
MSY:6[/EIW2)"'$(;"&TX4XHXFY.X_4#W<KJCG&=S7`CRU3.0GV$2YRH4W]+=
M=L<3UV%_7?[,@6Z:P3BPPZ3W,_:_.A0CF_P76XOKDC\AXMR[GH`>?2L'EE[@
MWHL%)30L:JI,M#>N^A0YGAU;<>NO(&9I&="TA?`<"X?G.0JGI,K"AUB:F4IU
MJ3M>')MYI%\"IGPO4^;2V\@;=6WW9UBX$S&?.,CZ',:6W-"DG.U8VQ'V!?P6
M#W[KS#;G%`$..**\'1&7P<RQK@N,#4_&YAPNZ13&QL`OQ,%6"SOL#_Z3S32P
M7$9G!P:4T/@<%>D`IBZ-J1PRJV-C8<BL1,RL>(V9`5`B`8I+EW=4O`TNCR.7
M=Z[RSU$(@:S^@N7E<V5?&NQE%2!-Y_)PU+'0`GMST2IB46`$@<VE`YM"P@KR
M-6'S-1X@N/I.$`1>0@9>.=_&!3$4]S%4SK=C@=\JM-_*^:8KL"\BV9<\WE6&
M=$NX=(OWF`0\D*`>B-=X!O(@GO(@+N,4\$H<>:4SWIB9+ND]8]-&GL>X'K_9
M^!CXCR\IEL3?3V:LHW@4,CA\)S-\N7$)0X=.LO*N*SC)+!@?(Z$%RH\3T5;4
ME]'A<U<JS;CW$U0;5!M4^VC5YN6^TR)Y[6(E(Z57XTLG5MP=-,VXOQ54%E06
M5':CRE[\=MD">ED(H`NOQMP'T+QXXX+EQN"-"Z7&7'ECR'DW801TZH0Z54P_
M4["L#T+(B^L)A)"<9(<%VSF%$+)0:LQ;",G%CBA_WAATBN<0$OP,@%8LT/)B
M:?FKKP%H>08M%Q6F%=#JC!"+V$'XY8D>-@-*?(*]SIMI!Q:VPOPH9%[@Q\Q]
MZ2#JL.S(>\*T-T(4MZ;9$T28'A`R^/Z`Z`_L]WS7_/'5(;Z`8?89673],>31
M;3:/R@G.;WF"L\^D_3M+'+#US/Y+B<G^!%#=!M5=.%;"4$`%J\H=5"]N57E)
MKO(&9\3RQTDXW-,=JS.>V.X4X^CGIX":(^3A\$43`.TZ:/?C73G!#"$"UQ#F
M+$3@99<T[\0+@"LX<#E*RB!\$`3"W(8/O(`Y[_`!$C4Q$C4N0H2\P0F6MH"6
MEB,P0[S+-80YBW=YJ3#DO0D!5KB`5IB7C8F\P0SQK@#Q+B_@7(EW0T7]C)(#
M,05!4YHF7L3/2X2H;1'__$=,7UPZ1HZ)(_42'@+S7[,)*Z$5V`:#R`J$[V+T
ML._;V"H<'"*+\#Z!)83%N\ZA:`E?!C#XR]"X<!SO0@,L1AEA\:XC@7"RK`X#
MPDFP`A`W@(5X!QH%JKUFH(*?ZB@OMF)ECPHBAG+M]+PK?L@C`!802`(,(%J`
M5P_6#L*"N[AXH9J+(Z7;8`'N`F``N02('\I.Y88&E)UX""0YJD."K>#+5@B3
M8X"M*)?S6-FSB&^OFM^6>>_&UUXM)QLL#A?QXZ5;:$LE'"GB8,<"X'`Q.'#A
M+@Z``W.W&#'#JK,UX%=LNY/HVMVW">._@-<([H22'6@&\.P"GAZV;>(,/V$'
M4V0S=NK6F#B$!7`H?-TAX:B`$>I.,-J+^G(":M]8!0#%*:"XB'8TB'9XB'9X
MR84TL"_%L"^\%.(.L"\`*$X!Q86%.B`"@GR,@WQ,U&@'P'-I\/!B>0Z(C0`\
M'("'ES@(-AFXR+,N#8<0#=(7]='TYY+NH[>G:)8E^;-?OS%-DJO5IG@@6")I
M(?8UFG*4O521JOO(/NJO2!>6?;V`LJ^#['>2?:.`LF^44?99FT%S!_D)NT.*
M)B-BLGP_!(+I!HY/I]_O^B))?B,]UQ\3@F[O^B7;LKF+(S^0^?ED3APF639P
M/5B;M1PM0?6+"A+,18)J19)3IO<D$LPPO;\C2M#`QG>L&\6>WPF72;#7FK:7
M/W7X$K5,%V<#/^.`DO$X<`3,W@^A.CDTN$IVR<QX1@(/$!('0APD_5E;%P`A
M<2#$Z08&0$@<"/&PC1%&LTHZFF6BM`(;,T[]'3!Z'K`_<JT[YY5Q-:K:K_V*
M\?++$CTT]@)GV"*N1\;$1E0?4AP%E.+AZAANS&Y+?X<=N4722CZ1-`"H4`#B
M+O)>*Z``WHJ$M_,6;T+PR%^DG@'X*3Y^Y$I5KLC-DSN\E;P?`%0H`/%6)S!B
MD]7%`T!<"1`7&:T]$+=BY,Y55@#(%1=R/)0A,HJA`+GB0HZ7XJGR104K5P[(
M*7N>^5DIEYVL=J%"L;6H>,OAV$*2>\8WGP;CP(Y>`>LA&WOWX='Z!3*Z;D`'
MQ+89BV,BYZAK!1YQL.?I)F.H1^:GS.-AP1A-1HB.]:$X"(KO2=W`C@0::_S8
MBH4]8+N!G;/'KO*S7-GKO%P+B`7$7NJTWH[X>W1P"^`WQ\$J.P!]A^ZNRP<B
M:?'>%W6MP/0?:0_35V*F+ZW$Y@O#!$7B8.\<.-CCL5F\G%V/N<S,''?F3XX\
M%BM6:U_4=#VE>%:,2XN2CL"86/>*P%C_\R2=NT9@['>(P%+06>4'^,"SXJ\_
M8MDZQ&`IC[3&$$#@V0LG8`1+:`1%+IQTD#G2+2OB(+(7>=O72=_M_V3D3\&F
MIJX[WX];A41[3BY_]U<DV[^)`*\]7I%L_R:R!!,!]MP!60@Q&'CX[R#<B'EE
M_^E/)\N?VUII7[$U8??'%YU2Y`PCUJ7VL'YBBWBC1\H4P&D1]Y7X-!B+8W3F
MJ,AF4.HBORP.G<J^9#)XMBVVA<-YPK1>D6JGAZER?HCJG_IM`.3I`+G@9[[P
MJ\HG+K(Q^$D=XJ$<S&3T&`#AZ4"88FB^N04S@W-N[Y);I/N?ZD@QF$T!$9N7
MV5P'['[)</W$->Q5/[]Y/\P@GNF^8CJ=T#`R'WLK8`6H[[H9MH&3IX(Y*-EY
M8Y/=5>8>(PNTY4AM66<B*`J_BA(X)-82)UC#X!@C+Z#X8S(;^^-LGEE+:NIP
MHJQY$UHS)XYXEW0X9.KHB]];EAQW.&#FP`L_,!]]47QI>HN\,D5:$DDXYG,P
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MJ.*=23879:P)D)U:U3O`J#%V-=M*S5`:6IUA0>H8THR-BM'NK@&CV2@N&]-?
MAF`-79>VD3>*TJ_@77/4;73U:D/6N[*F&5*K5JWI,T`V6ZHLKW*RHA:?D=$#
MGK$?4"?LMQCT#B^5MF3(NM:6VYJBM]5VK=V<H;)I-/7J*B\;TEEX^8J8/QK8
M(1#";CUL!C2ZS,S``_\!^<G?]!<?T_!L1C1>'[O4)__%5MOU,IRG^D7=2';=
MT#5#:3840U=;[7:G(<NMF.R&T5+;S35EE&O+VGC\@L],/8/31NI;S&IWVTJK
M*AMUHU73I&:MD5#/?NVL"5U2ZRIGU'<1H:&*X#WEKM6[NE;7NEVM8[2:6DUI
MM&=RKVN2GB'WYO&4SQ=[1JJWR;O>J-8;W8ZLZZK:K&HUS6AW9O*NMHQUUW,2
M>6=2S5*>(4Y&3!]?'A#]@?UPZL6<ZZ91C0YUIPB25+W1:*C-KM:5)$6NR[*A
MMB3#4(PZ@Z\J7W]\DK2'^>IW>.C1:YP%4?,U:@VEVJJU]&ZGI:O-5D-IU[M)
MT,Q@UU;"-=8/7&/6:9],2'!TDBH-SD;:FVN&)ANU>I5I9:W6:=1434\\4)>I
MZ9I*RM7Y/PGSLL@[$Z].=DYR$S?TIESM-#19[ACL?RS6KK6T.3>D1F>5&]HE
MF7&J=Q<W,4-3Y09;CB'7JT:S60MMTHP9S9JB&ZO,4"_(C%.]2+>)%XK:J'=;
MS(PTVAV9&;E:1ZK%O&@V63:Q[K/_G[QKZVTC1]9_)<A[9DD6KX-%`%YGO9N)
M/=G,`O-TH+5:CG9EM2')L_&_/\66NM4R94F^R4X"##"Q+757%<FJ^NK&%Y3%
MTY6TWR6-*+CG1*`1#SHDF1`-N%8:X&.A-."^TICE>[G0H_USG&/#AWNWJV]F
M`WAOH$U=DA"DX$)Z(600-*R80FL716FF$02I3::>@.PC2>%XP!M24,:BIT"2
M`\FC-(&T6@2W4"%6+3C_4:3Z*!P.!+UIGHCSE$1"%;,L==A1IR+4Q8AA/YI@
M'XK+(QA`(4:FG/&)HX1%IPN2\Z6Z-_0911NNJS2K+W^?HG3F]60\'"RJX=_K
M\731ZO/],`QZW'EAM0B:,#`T)4D)UZW/!X$J5>P<#2![[.VGYW&TWP93?=HM
M\PDT#;CC&5%$:!%;VD6DL7!*@(&B_&&TQ]&H.L]&:GF9Y.?!UT_XZ4\5?O5\
M/!DW^_#7P?1ZE'7B#)<Q5'F-\;?;0%0>;M=GJ\^5]%1;38FC5"@TJA2!5>=>
M:-8_RVW^\!WY"0_]BJN'4_ILW/YQ-[>6TA2`:!45_H=:R[;[SQAF";N+6_U*
MN14[U];:%"(/3`22I"/@!5FE;XPS*LH[N&7T]7*[8VT%)PB<9!)<$Q.MT+X-
M[2DA'.+N8ZSMY=6DOJFJ6=:NU1"_A3BIP?!3?,I2P]XO<&6`(%!FF@/'1?0^
M:$[:-43L#%M0\H9K>`A%CZ5_9\@Q$&4,Y]%8[HWP4D'J]J"@A1/&&!>/IW^^
MJ,__>W4]._\RF%=7D\'T<O!U?'E]N4R=[^6`]!=`1**\]):#B]&92`Q1N!I6
M(#.XWWH,M-4*DFWC8#=-/1ZV9GE/_S>M9O,OXZNS:G:./S=!H^;[&]R\S`#=
MGNA./J9^`!*<$@ZRM5>@O%"H>KLS&>,VZT)^XL:THKNG*/8)<9ZOX3[';80^
MT6B\:*H_2C5S_#F)=\HO.<XU1\?($N.IX%:KE?P,=TSRK?(3.Z6W308]N:W^
M>-DFH:^62>A1C1H/CUVC!>O1(!_&>9;\^01_?SZ8+&;CP>0`)_K)+NRY$YQ(
MKI*QSA'K4;5R*N/*Z%EJHG.W%8[<C`\\3@!K0:;\Z6J"YF2('MY@>C%&MI'%
M:C$?7:/]J`;+K,B@-'5[H_J44&NX=,Z@RV*M4'H5U4<GSI.RTD"8S93RO6A;
ML_3+8#P]G6:X<#KZ-+[XLM@:L;_MD&SXT,[F`+[R5G`?T6FV6J:NI`!DX?_#
M1A*F).#>Q-T.P_2)`[":Q40-5YP*P80T*^=00R[F**I=E#!/1USIRFT0I[+Q
MCP:<!:6=C4KKL"(N,B:*Q.43DK5+9H0`!2!2.V!&.6J3:,V[BH$5"WH(62?3
M835JMNB'O$5/NBUJFRWZ^[P:74\^C$=;5/<M=;/G2>[FU\%_ZEFC>C;`>TY6
MUXC5YQDM#]!B(X(/.5)87_6U]GI;9SSA:)1`E98V<F"RS;-Y_-W;]VM*4""+
M<=:4EY=HOE!GK,[92C`',_^:Y/5Y-AA6EX/9?W.HH_DA&\!Y(2>MT!'TB@4K
MN=:6.MX&-[3GW+"^G!XCCZ5Q.9GF"K#Q<#R8W1RRL6^Y+E8"!$^2DL%Y%VCH
M0A7)4K4-*M*?.FVPC88^A;D@K9[=9'M87\_/5L74O\SJ0R(J&_ZU81Y0BBRD
M2"45F@CF:!!H'4(0MM`+$OH:=2<A#Z9WE_&R+OO2*<J0PPV)(3!MZ/5*HOW2
M911%Z`<2O'1W3G(!WZ(Z_S*M)_7%C:\OKP93]#@^?QDL[*P*%:[3Y7A:#3_7
MKMJ,S=SEK-QO@9)"7:`T-V!P)TFEN(:5"\R-<$5B3YG;_#X;(R\FKUT;!&T)
M`EUT?*-WS@8*MLUW66E5*"R*%B\J+U2*G[^,9\.SP6QQ<S)MXGG_PM^C%V7G
M"%`Z5[\H9SW^U4QW)=4D(EO-4.0N,0>)1&E%&Q7C-O2W:%-FS5#)W$JK/4`@
MWY,T-S2RD\Q'H:QUG!K*F4AMJ9$DZ/86$0_QA*+L?Z;!R?_<P,G]![[FN`&W
M*G*F3)2,"#2V(B:S4IH!E(I;<:]N@>\]A+"6W"J$\!FU0JIG]KQ)A*$#>%Z-
M_\S*X(#*'UQQZHQASCCE$>@D;]M8ND/76+]]?V9(6!&Y[WT]RM#]>21E@M)$
MM<BY4,FXM$3XMG(6\8[/E,&:LCWO6U/VL<YZ<S&K)PB"+\8K=3F>GB.$G%>X
MN,W_Z\67:DM^;0M4W$R*&X<&4A-`AP9TM+%-MVBFN"BJS]OC<P^:GHZ17=E]
ME3AWG`7-.:4J1.':,OK<1,%?$2-;(.A&9"6&$-%IL]82)Q'9:-Y6C[+@H%1L
M?:WV(MSL6A9'!`1JA*`>F/"$IK8`6@$JG<(1?3PWIW]6LVG&NC.$DK,Y?J6-
M!@]:O3B_6FJI>K2H%X/),B:SU]_L`_(0>=34)(,G1E%+%%JCU4F/P:$.VJ8Y
MURF?A]+X'%S>\A+[7#*GA.?>)$=EHBX1VCF)2FFRW3[@AYZ,RU5O3M:1\]/1
M@W2R\P9]?00$0H!"K<R4[XK<%+*6BY?>+.HWAKP9#F[F*]+WO;@@L2M"N+J:
MC*NAO1CD1M)]10&/*6?2B$.]0)BCE23&$9UXRY@*)):0E+,-C/=4A!]/%$=L
M)M+&2-S]EIF`QSD2IKOR$,ETD4[#53`_EFP?5=EDJ4Y">^ICRJ'J`"RTVE,+
M"D6'$5U%)WX\\3ZTODE0JT0R5FCE/8"@`KIN.-03\K:$7_/N[3J:[JTBHTDT
M(M.6D0B41"UE&UQ4/`5:EK&*IU.1'=G'$L/QU*/QD-"=4R07?R3C3%:3J^"1
M\&5TD0FN?ARY/DHU4DU0._)(0Y`JURD['KK472A+]SC`CR?9AVI%1K)CY*4%
M/.8^5VMYV?F"S!55G^IYM<%D,%VF5W"+A&I4H>(<Y@!J-9TWPN@ZO/+>F=1Y
M[L%6D-+)I?N"N^G^^;=Q-<NYM9MU$T'Q\9/IU?5B6:1/;S44]![YZW+T0I9!
MFC4=_^<WVY_7^V3VF=$BH`SV%10P+XE-B*5(;H^3#GW:#O9*>6?F]2%2?.5K
MP%YJ#510DE+!B4C1*\V<5:1-S1-)B]0\;'9O?H=+`2^U%#(Q/`V<(=K@#-T7
MSP2TQR%&\BT>A^<5&`K(4JX<08FAV@Y6>-KIC^A*7^_U[=W^>/-O695S"6AB
MG="Y0$.E:..ZR5+ZJ%_SWGWB-7@Q54X<HTZ%Q)R6W@6O>-L\Y)@1H>C@XYOU
MS-_A4KR<*H<L\"`):$-)B,&U_0$V!AF*VO)O8`V>5V`N$168TDX'';B7RG=A
MYP@N%<&+I]V[]0)I'0\FJ:G1O#TF:HX/NAPW*/ESO4YP(AB8U5^1F44UN2FR
MYN(WBCC[SVIV@8*JSG(+[N"PEMWB:^?5]2+7P>Z#.AYB5$0&9K@F*#4216A3
MNUK30@?S6^GQ)Q##MRK3`^:;^H__HNCG:,+V13JY042C+1,Q6`]2@UI%.HVU
MM)Q*!=_>,GPK(Y3O5,^1!Z(5HXSRJ'2"$$!QFV?W).UL,7U/&":^PR5ZX9&]
M=\;#0#`=6*Z[Y"Y2YPV)>76\2(3&+7I,?<.K<VQ!;\R),9$FL,Y3UM3B2D1-
M*&CJ+4%[;`M!%P,PGE;2L_JJGE=#5!R#-KKG;CX/OMKKQ9=Z.:\'K?OJV7EN
MTG(_SXMR*_H;/SU?K(4T^'K63//=K*P>?,VQN=S5MR]$@CY<8M$E18%&1I51
M72.O=;8<(@&WI/10QEZ!;/2^IGIAO"*)^-R^IR`JWXY@5%1J7G;,?$>R,?L2
M<BE(2$3D.4,B@D''ORVU:^#R,62S*KZH1[DKHIXVG9(%WR^ICS8\IR09T5H)
M9X1EFEEJI.+&`>+71'6ACV[+:QNS:UE\JL:7_[Z>S1NZ/HQ1,37WKPU/II^J
M>3VYWM7C?X\KZ$X^][-FN8R&>B-%]CB<M2E"F]JA5*JW[\\8;R>6'4)@GYW+
MP7B*R*I3POT^FMN:.*=6ZIO!).^9TZGO6F2:M,KOTV$U6]6]^'HR&?R[GBU3
M,UN+@E^H_3#J/!A:49VD0T7,9+"FG1)AJ2TJ"``V9R8?56#K=6K:0%VN7>OC
MT=P,.9WGAOC)]3`O<9[@F%^Z^L-A#8`;AT=312Q":!H\GB$*O0@<VO="/$)L
M.$T/)/-Y^-R5X`?PAJ6@'&5:&T17&6>MX!51L<B64F9>*:-[BD*IPYW.475P
MKVV>YY><:A<T0Y;"#9;TU?*Y:T&3TT;I(+UT+-(H;`JB=2&L*:<54@#UM(PN
M\/!6%^/S=07^63U;C.K)N-Z=Z6B:]K+-0SV0YW;FQS>U^^L)D[V:_?(U^R(Z
MFC$;P#-#.%?:J?SZMI+6A5@DY_AF]GH78P]EOQ\=?&[V)2`VMUY%"QJD0DDD
MV1426UN417,!]V<_J_'3T8=<5;S%,7J)6_EZQ0N>270?B;4B):9B\-$XQ5U.
M<`E/;!YX2OY8L=MC9,W=P3.:#F@QIPB$<@-&3B?XR$T>(;E*MPD?RPI)(,",
M7*_'0?.9[DOPKA9J9X$!<Y8GX2`Y1"?K1H?D2P<<::7--.YG(WA/*SJ"*(7H
MDH'BK'%W@C%MS[=A9<LI:D)!R3,3O$O"/$]&B,D'$I351@@;VY`SA%`V]DNI
M*;N_A&=5;N:NAKFW_4,]GV>7#/%.-;Y8#5<[OPF(U/YLID_./U8+5XWPSPB5
M[M=1BB;6>PG.2#QQVI@H33<2R`<HLA"*;9C<QQ#Z7.SN:@@UTB$J95$ZZ=`$
M$YU+T%;HA/!0N(P2GI;=837^V:(>'#;X=3*X.*"V'T!S';W0&I4CS4!1^-;]
M,U&C2APAH]5?_U(\O'OEJEPUC>>(W3*6C\N[!0]YNXI>HSVF,DJ>3*YE;D?&
M.O0^Y=OW[]Y1UEQ;N.M-'2FA/K^^[#ZQC#8D_-TAT[!#Y-J2Y))&W49-M@SM
MQ#7<P$F\??\;6Y)QYUONH"-3>B@5QKE(O-$HBAPD!S0.H:6"!'3'F_NVMM'1
MO:6@8DGAX:O"+.-4`>0=D7RD&O=R!PF,Y6\WKC>_\TT%'=E>'R("S<!Y3B5P
M8_-5-7G4].KU+N?=WU/R[K?-%^='=^];0F)?Y;+<21[+\/4?U8ZY"NN$OU`.
MH1`XP'W`).-<MKO12J?]YEUV=[[I-AU-\.2?.7C2N-;ST^M%OA]MB-!YZ\U!
MMS]T=_.IEYQH9HR7WA$AK4NL72B#IJ&/W=J)7PP$E8:Q309VD'B+FX3`?N:S
M'UCOFE71NYHG.*,1=JD@)4L.(67H]`NG*-,/@]E%]<:>GU>3?-M8-7S3O*-/
MW\9+;Q'T"3W2.8I_NL@MO0=0)(D,W@6PTE@&U%/MVL84KJQ'BMS)Z2_QXYN3
MC_ZG/A6;;VK(&#>>\,]KI?RQ7LZHMY<Y?+4;[;0J?1GN6OWP?_;W=13H;]7P
MHAG?-T<+,.A2L.V?V]]70SM???1D.L\W0%7[^T?0=7,^19\@FL3`0PN%$/*X
M+;#?M+5>>WA^+KEX>Q2Y4!:5"]0"=TS'Z`)CK$WZ*RW*5*94+RN7^/NG8\A%
MH8.?*VWPO-"`!DIJW6)'&HTHL".EBLN7E<PO[NPHDE&2@_1>*!\E\0@KVO$[
M*C'&BXIXZ,9&OI!<_G[VQS'DXBR3J#4HI=Z0I"*ELDUEA1QR*G:,/-I^>4[]
M$9.5X!'J6"5Q2R#X:>]4892:LB\/"(-7PO?'&CV8EO5]L21%&1%>X3E'ZX&6
M7<1V7B8N;BB@'4C!GI/-?ASM10UK8H)Y89GB*L\@2,+X=O8`B2R5]W:19UW^
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M02%?$$4?3/;LNEI7E1PLZ(T>'^:-X(P"T*`2S?.N6JW"'913@>GZM.VAXV&T
M[AQ(:JQ$<8DHC#!26LF9:&?2VFA*""X[@WA/6I<WCU7#4%W-D)9&H>&_)U6C
MV:9#VYNZG:OJJMGB)K>,M!GKJ[+&:6^J"/6']23W]:"'P]&ZT78\LS%;KO"F
M5,LM*_$DE!])'#M320YL$E9KL*#S+6MR;04D@Z(5DR+>8$<6QVD>&I9K1&;5
MEVHZ[^XCR9DK/+.GHZT)--BQ":),)*>`K',RV2A$]-VD,P!2>'SOF%)W,WT(
M?4_.6UG9N"SAR,^JITTE7-\SV%BC41[RZJHI_F.15V&^'B>RKS164HXF@U,5
MF):6"QW;&V7`>U?4-KVC1GXW@L/'M@G3?&W5VLD\G?UV/9B,1S?HFN7Y(6E2
M_R][:ONO'-=6`$&(P5UNFR-1M+=Z*F&T+J]O9_#][$-\[#H3O2[U:46\+_Y%
MP,3@T21)%R+ZY3IT0Z2]*N\>$]_//OP\PR,[67K_AQY<G8)+Z.,%EM!Y(B(Z
MTX[<A/]G[^IZ([MQ["]J0!1%BGK49S#`9!,@,PO,HS?M)-[IM`/'&R#_?BFW
M==T=5=M5Y7+5M6OR$'2<[D2B>,G#KT/GRXR8EA;M5<C+/>+"JJ1@._VF"*3L
MVD,9UY,Z^0FNO+.\JH_(?1;?'=68!V[6:AQODA?PK609&43?NS4FG7AW#_/>
MA.`.;\PE).^S!U4[P[X"D5^:/EMIT^QXWUKSAJ3Y#%M>BRJBAJ`"I4@FZQLO
M>^KZ7HS-RZW?@MSV,>5>@4&1Z!V:UE+1N+8MB7^`>?WU.UC95_OU=(3Z\X#0
MC*\)]%9H,@]2;LR4IBCY'04G4Z+GI'<[C2DO2)W`)5,&STFA.8QN`BD6XJP3
M"*O"0\\2W`N8<HV&;4VN;\A.H:,*,SZQRB5.20(/*T,4)X/EY*KDHB8\...:
M8O%(R["7I'DYY[N5V?(CP_+<(D<TAD+N"_JH`0^^F<919H,7PB/9E^,+[+$D
MK9!+Z%!2KA0XI1J0E@*#<1MR!0:,G7++)[W<::RY[V69R+X4K("&2LYC)R`%
MF4EUWEE/*].*-5GS2C$#@T0,E10N:<0[ECXSM#;E.'DA7W\3TGR&-2]!)+B^
MT\)&D$((,OQ@;LG,<Q5O1F[[&/.870@M]C97B"Y@S&.MB>3DY[K).T!_4&C^
M_OW5ISKL]Q=7?7+RXK>KV[^NH'T*@MM$G+T!5F\-V#FB_=(4'\T&4F/0CXCX
MRTML/LA^AWW,Q3BC*NFL==85T]"Z1DNY-98PC]I:`N=P]\-^^'#]8W^31V=6
MGR0A^/1^BR[^_?K'N83__<7-TYJ&+E>#,:I1TQ#)UT`P!N1J"3"Q=^"<N-GJ
M1J<2PN8EH_?_AZ<@%0<A&PT4W_ON52?\J&BILL!DLQZVJ[\.V?QP>;=AYQL%
M%C<7'WIM[?VO5Q_O!@9Z*\88DWZJK;*T[$%U1=AF]-*AV0@8Q<"\=ABG>/%D
M4NI@ZLNU:AT._'!Y>_OA\OWWES<_7=_\VCE7/HV8/%5'`.Z-U'U:!$R3*LDO
MT_H8_<REY-;S*<V"J+_^]N'ZS\O+NQ&;P:O2?]M3KHNB1V--+<RB)K7E-!!G
M55,Z=]A,GGY%0OCVXN;?E[=W(OBGGOI)D`,A9,G!29246C-Y$%/$YOW,8R!3
M!+:BN__CZM?+_^Z+!SLC_^W-55_<OK4D.$5HH#X$(:?0=[V$9<%OLWER*W8.
M1M<ABN6'.QJ#:A&H1O*E)>=<;=6,OJ*:RTRL=F);\*^7P!:]>'$WCFE=I.H<
M2!J>@4SQDQ($<UI;L*L0GH,M:J70.1T*,>G'XFVJHS.JM!HF4T$X-4:M6C:'
MP1;]JR%C8[8D-4*$SFTT7"K,O'MBIGC[9%(Z*+;`JA`"32H]>$(F"79,>H=D
MZY0,19JRH2L2Q+[8HE#.U#<O"E53`;EE,^:S*L#4Y#+GLE8DA!VQA1H,&RM5
MU`@UWTF@R)@!9G;3IV!QJ@FOZ/+/`A>]B%+0*;QJ5'(4<'%T&]@4<1YXE95^
M#/N""RY8LD:@Y%V+V5CR0<8XA>4RCU,L`ULG$`"]4.9"7[TV0>F4/M"*XNVR
M9"Z,ISES@2>$F'L(X3GHPDAJ%L@%%)6*0U=QK%7JO8'S\(`]H;'80S:'01<0
MH+16A3KC=TJIMN*'E"K/;%:6UZ-!!T4726&6X>Y2.2NT(&^<&<$*L)T_I37+
M85]P$4`:BE=4SI3)LG/R0+98PM>H9]<IA!W!!8;&O7O3*L3H5.K>/RA`(YIR
M>&$]YN+`V$+0Y60]FEZYZ$F\,MK2-6X/&PB(X801QV.BV!=;@`T-?0H:8VB(
M!7=\DDL?@6M3(01.:PM>)'&1!:E/IG(!Z8MT;;%Y<0PA3=%6<*?]'HZ9N&B^
MXXE@0:&F<UBYQ<$6@<AY3ER<,@C;0S:'@19DT?OD$B13J^=FS.#5"S[:.B<N
M3FQ&7BQQ84,JDC([FXBJQJV)1JSF:H-)7>Q<QUZ1(/;%%N@T:F>ND!6-@VJ$
MX\'JV?N7IJ*(K,>>/!];-+TD%D3#H?5J$.!"-E2BG8RIY35?_EG@P@DSQ(AD
MJ%;6N#7[A8&&!"=1\#RCM0Y1[`LN"A$%<-*J[^":DKJ2>P$D=24SN'!'R]QL
M[O[9AG4_AN+)BCXFJ=$W(=.2HP;*T[=->W[<FQMUGG^WQXC9BR)@;LU8GV(P
M.1;OQJR7VJTXS_2BVT]C7^1R3[#K-VMLKIF9*C5F0VR7CMF$;LHF.]DOB_92
M=WOLX3ITA5J<Z0RL-OO@['`XJJXT,YEA..3E/IO1_NZGOWV\O?CX\]7_?+C\
MM)]Q9]9Q/5D,#*YJ,!KZ8BJ@D>E#"7.>!H#%_J6/[-$3/??PC_%C2]5`HGKH
M`;8UQ9M,RSP%TSP6WP]^EZ\^RN&?8".OXF(ES!$5MUD?;-\Z\6F?+&0_)YI[
M%?^89W],\`BQ&"ZN,[ZGEKGYT8PA6?WOG"07_ZD`O=_A^X_^]NMO%U<W/;3(
MOW2*V.T.S9\+W(E(T(@!'#1;O'0&R_M#NS0W&']^V(TGF`_YET,]U<7IH4I(
MPI2BIY@Z,_I(B`![FEV`0V#U\E\*\BL"VW"6QYHTO8&*.8<L%MA8#ES*D(Y&
MHS-1G1XP@(?MSK(7[0UPL?I)L`([ZQF3)5S*<K[X#2M:O%5+L.%$&XE-'C_8
M8[+*I421OI:M02-03)(7%F.-VS>PPH+TOHQ=#O:<O?"O;K\Y(SNN^AG$@@)6
M?R%C]X5M#B:!\M2P\369K42R)]M:[EORJ=I8`A&RC::6@3*;<?/TN`T;NMU7
M+MR3[2%/3.JVLW-W!!=]CIQ&/R:CJ=,`X@ED^K("<-E&U["2M\&F(%+LJ/)9
M0W,,8X.;>ZT.+8D#;[D_F5%TJ;!G49_BL;HL'H9'3IV;9"H<\93F7+ED3V84
M,3N?0E#8VKB5"M74`2P4_Z2Y@13-W%B_<N&>S"CZJ)%CB:#"]:4A8QBK!!*T
MAI/'.8%,7UB[O'&1K$W.-,HUD!A<JGR^36EY!?5F2L5M)XD_+JX^=$[$OIWV
MXL-EWQ+WV7*X3Q%63RW\?ILN?K_:(CKYHM'%&Y_T`JP1JH(&Q61QB9<\S?N]
M+,`\DKGC"0]\O<<X]3@YPLK5`B6AE#N-\+A>]CPS4(/(5&X[Y/4>_N!N[Y1J
M8\7-P6#+.;*^$XUV9WV^>7.KOA-,:=*OGN4Y1][T[=UI]MW6VB^'.ON/T\6/
M_[Y\__`?_;H)>W7.O.=VR'+LC741,Q+&@<.KPJ?)Y9SAVYPN1E*$%:(BU\P:
MU&O$U.PHNQ?CYFY'"'.V^DS>Z&2H`C)63Z7OTDBD;X/>#R+!BG$F$GS%;_.R
M@C2I:-16;,;FV6O4"LM&DL;)S'F^%2I[OK[YK:\$_XN_?4/NPA4I(>2@J`NC
M/E/?";'LX[(PU9C.\G5.YC`Z.R<%3&QCLD7(+80;/A?CY[R]X;FC]6R>Z60^
M(]MH4P-6\1.HF:O9+*8NUYER]%6_S@M#)#+0K`W1>*G)00,[N!\+5YZ)\=>H
M\?_\X1\W=W?_,WY\_\WU'Y<W'Q_X8MZ$VU#G3E`LLP^MS^^$8)9L/QF:6#7.
M\G5.YC8:.J),56.***DDL&U,0?A:TF2/Q(6G\BEO]Y5.&&D4CQ5#SJFOA<]6
M1F]#7U0X;^!ZU:_SLJ*4OL+#6W6VS)3[+F5:EC1!R"M0^&\O_O?ZIF^+_OV[
MG[JGO5]T<?OG9UF\AU;MS3[YOH;_%'=+])2AKS8/'&JLE=)`]+EQF/>"^CDI
MO'Y9_-?UQ^W$@2Z3*D52(41B$OTU+,Q&SFZH^-NI`K,B<3Q\:[OJ13`)L5:?
M[U@UV9+S;61O<S538L-RF"JH*Q?$]DJ1K4=;`K4,K8\<JT3N9<$NTI0D);]J
M67Q[?7/[\\7/E_J;[E@"-^:!MI.,$Y/1E615.U*JU=G!0"O=Q,Z%]M<NEAUT
M)N:`()8PBJ06ZMC?+KGO[MZ0SSIR\6-;X8S?_]=_^>3J7>18K>/0._[1>EO:
M8DE+F!)Z<^_4X:__6-VM"EI.[&M#RHZDI<:#/3XH6MA4=SN")_Q*J?A,RU66
M%;LQML`Y6HTDG6K2J&'KEW;D=/LJW^9D820E2YV8A2F$SH/GG-Q_\,F$Q!-T
MLO>THF?X1B<+(DWMBW@9`_6Q'H)@QB+)I#`W'3F(?-&W>6%#Y,#D/LN&OJH0
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M'5"P28,M.42?ZF1[@QRCP+VW+`Y8L`*J*><F`5M&5POA@Y:8B#/_ZVL7R]8Z
MP\7ED*WMJQ:-3PXK#J*%E%1@DV16JS-[%JPJ=S1I@DD&+6`Q;9#!!O6^?OIH
MYKG6YU[_L_5MW]Q<__[[P^Z]OG$O7?YT?7.YU5;D+S5>47(!SI7!2`O%VK&%
M+ZFYG*XUD3D]][A'N/P)8$AN-7GC"T<K/H.(I+B4-QM-?O><);JU#7*IE(28
M.QMQ04<`?I"P)BCP#.O\VB6[/R[RS-6)`]/+<"$45/\W%-6XN%\<]A;%N;VG
M]$88JMK.BC;TY7>RT'M5*5/3R_:AV&L7ZR$[BUJ+#4"#F*#!38V^XF(*O(;#
M9ZFVAT5\%AV(-UBCJX@2^V:=H<<0<5[8=@YZO"=X=.@;A9:B:47#"*IF0<^E
M[P9\FD)][<)\K'?*&XV\(]M&5*J#Y#R/>#.ES!.W!KPZD'F:7)>7A"P4R:,Z
M:]/7ZBT@TQ)O&.@[<[%NCS1]3AH3H<(A<)(]\,+AA]SP*[L:ST&R^R--;IVO
M`)%R`\S1^1AH83PW9>J).1]M?1[<!%52XF!<`HV+,K0EX1TARKRHY6S$>D"X
M67PS[(QG4&-@$"P\[()'.^<%_R/?G?6XEKYMJCI;`^=L32]J+>8AE7FU^CGH
M\9YP4Z`J-#`0F^_#F\3BEJJ/CQO8,M9G:_^N_[1G2C.[6E+_6_$"9'.-#[,5
M;<-*`7L([_W%>8]P^Q/`30FE@`T!6TJL.#Z*6:9Y<DSS"L%S%^OV!;EB`G<:
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MK/X9`JO28AD,E2'F.,_!G(^Z/@MN0D(P&A"50DW]=>XK`I>./.]>I,;Q.L1Z
M0+B9]:-'2IF\JG"BQJ4MO6V0PN2__R/?G?785\0FI3DTP9A40AJ+/D,D3)-Y
M.$17R.KEO&\KIIAB"+,JJI<8.X?\V+ND&AQ6$1U]3J*_6_JRF&C95:-PASH)
MF2]I+#`@BV83,?Z3"PR^<K"#7>84\-"EC$#ZES6U6%:%&%1<B<5.\!"]V9Z*
MZQ5(:?N$C:%2/>=J;,P0!5U^2-N6N7.;P[SLZ%4(:G_L5E0XX'VS'0R+6A>A
M1406XUPQ\#O0-:Q=1%LK$E$ED4K50;$@/I$?[29LJYV*H"2O5$H'1%8!$JBO
M3U0,<@LH[);V>A_;K%EO5V!;ZUDL4AN6UI)JFX2B:C;6LZ4<\ASX[S(%OQ*Q
M[8E\^N!FJ`&PD30?I5NIA]7!9A+-#K.-+R"8Q[)FI/"W%VB\=>*-K1@-CY!#
M4IVZ@;;98_32ESG%."L$0HU_@]I7SBHND;SL;)696W*G<=97(*4=VD=L`^/0
M%F-L";FZ,/0I!!<GYR1V!Z;W-0GJ&2@'%!E'9MN077,A9C]X2C/G,'6*[30"
MNW81;:U(K5AL!J)>WB7K"N0Q3=_I;>:]9$'"ZU2D`Z*<SN?GNZ1,)\A68*A0
M9QFNWC!$=%*4LY*$$+3B8]2H%(SG4@G`C)I9:N!GBCC9@35X)6+;$^6D"KTE
MN"8GMI$-3D8&),12\QQH[#`OL(=@\CY;X&U&-2%L8XNUNV3F,046,=&\9)F=
M<;SM+?*F_>N[G_^Q9?$:X#5!\E5#8P4?Q7@_NK5CE9GO%HPP!7J1"W05^_;B
M=CSA3[>7-]]]O/S'+S?7__?S+^WJC\M_75[</"OE!HW0(3)8J-G6XI>$8B<S
MG\=ST-'V-FR/XQ]3,(^A=,7EXH4Y_S][3]K;1I+=7QE,@'R;3=U'@BQ0YT;`
MC.W83H+]%'#(EM08J:GP\-K_/J](54OL(IND2(J4QYC#UL'N=]0[ZQT8`GPX
M!1*['/*[Z&A9LZ\YV]UG.#=AVJD[^YV6@!D"8:!<A.@<D<ZT+;.+0&S-::&[
M:Z@]07\M@O2=$F595$%KCBTVW'I$V^XVIVBY)"*=DMW+PEZ#(/]3SV[K!AZ;
MGG6`(J&@VV.("GL7K*7&@Q+-E("?%98+M/[NJ?M=03XY!?K.`HB"X<(*%!7A
M5C#?CA`&X0CEDO)D-W;/R[\>"5ZH&R#2#%$*'BF%@!U3$7,7`PB(-T6"!@[`
M2_7E>G!/BGD?XWV0FG%O!++)8Q.!/%7=<UDN(#H:X_=%?7&[]_%9TT)GKHQ?
ML)C\YV>_N>>*(I7,H3%XX:<2E0^YH2&4/5>[^PHE<,?%ZN\]6)D@J0<UI6(,
ME',L.&KMFA+D@,K>DV+%^WD%@1671DLXEH\S!MLASTQA4OAVNU^\GQJK/EX1
MS;ECJ8.2@)+!03OTZ+%*&JDK=\Z\,E;ISKP[L&D'P;)>6=`@X(-3@AB)C.!V
MRP:3OMQI_3*TEM`=&:\^=E'CHM31,&RYYTQ+KG)$*S`KK\Y>J#".C]<6X1)<
M>(C6#4F[R&-0C*J\<`,D39:1^@7AU:L*,9@OP0(8<:NIX$SF;7J*!4**._/=
MG;B7X_5NW`Q?DHF0BAI#E047G2;^1&/;:7\&A*J0*2:16(2WN^#S!-41T.A+
M2,!Y\N!6$,LL@GA4(<,S&CKJ4-:88X2E%H>A8>?3NJFF4S>^_[UN!K-ZW+AQ
M,ZU'U63QQ>?)H)E>5_#!$5Y!9WG&<)L!RP\RP_^;U],Z??;YW4?SI9K<5,VP
M^G`[F-P/AM5\5@^!!MMRB![YJ!Q$&LHQ+!&F-M?`B$!IX8<PR;HNUSX8[D":
M6=T`'K.51Y@)/.-F.=/6W::_7C7@K<^;V?OK#1_YM1[\7M_5LV]XDTHZ,66]
MQI8QXH,%HB(K#`)7#[N@$`<_`I?KGD3W$N"5Z',$GGQ,?WM__7X^&X[OJ^GC
M&.F;VU(^Z;,<<"_=X_Q^\)`(;FXZ4Y$_3,:C^7#V?O*IFGRIA]739SY7P^L%
M?-MN^IA3AB%FP.3X$)$*)A=:<Q]#J<_X<5BSB4ROQ8&E@L3%D3Z.).S`(/?N
MOT&G,H7(M@*.(`SV7`3PN;FW$!.3O(N6:8*+W#=F/UAT'!:]J^:3\<,`HN/A
M`[CN=3."SZ>W;.W@<E9X"``-)AIA90,$%EFH8N2%4+$+E:I6,:Y37FMW$I]X
M.PH896N\15XCA0T+T3Y>HT@N0RD*1*'N+=\+D#\^\=@S7^;5B,>\TT[K8#A.
M_XHH",V+F`7X.&59)N\&A!="O+7;!4Y+/,-<&EDCK&4:@1@[%[-OB-)*ZY)X
M^D*)MU9LW]S6&,L(`M<E"N8YI=C$R%@^S-R1OHF5WR,?SK8?!KQY$H24(A@B
M),&+96]+N2#KZBZ^<SZ<;0&,!O\P@$P0"S92*'`Z<O^]3!-'R_Y[S+O9HTOF
MQXDWA2V61H,V04X2KFU@(:=_/=&FG,UZH<3CYW`K5*14,DO28`V'*0Y!MIJ8
M1%\.=Q1%R_Z%$&^M6_'F+"/#U#(969""!N4@9#0F;^S"HG3SOG,^G,\R$F4"
MQ.<T"L1"4%BY?*L)DE$.7/C.^7`VRXB](VE7$^)6.,0XCKKE0S!EJS`#4_J&
M]-.)#S'F01)%I",D@(WDQ.=Y`?"MLMOQ,HBW<XGI:C]>FL-%5!#>16*I<2$/
MB;*>E,U`1!S#"5A7NGE,C/MJ3(30AG'XAVJ<)I!9DF=L*.J4+GQWINGE8+S/
M_=T*FX7'B(D8(TU<QDZHMJ8L-;ZOOSL^%.F]+L1>C'=O)9E5&AB,/?`Z:.8%
MSEO*E$`J%@$S1<7JNI/B#1II?-.D:]RK$?QZ?5VGF\5%4\`ROSNI1J89Y2>G
MVL7I='Y?C7RUO$_[//CZ[(<;R'3:E/+FZ,Q9J0*A4DH4N'="VI"[8'24172F
MV`YIRY-1[&2LNFI&U74-F%:_UE_2E[-!<U.WG[T(3D45#`]:X6BPTTHBEH<Y
M"<Q0&<V07>Z`3T6Q/P&GCGF3!J*FL+3&HD`()HQ:U$Z-B7S34.P?S'V3=W#2
M8$^L(L:HJ`3Q0E$B&?8R$JI-N3B*D.^4V?E%%Z%?%\-0E%>!$2&9I031=KRC
MMJBH'Y6GU:XM;4Y&_W?517@@1%.;O`_!J?&..9\VJ2WI+B5E+ZQM.H0JIZ-X
MZ\A<CEN!!0[12@='/K#@`S@5/.]G-X$44<<O^)2ZJ$NA%5:XP?06/I7^2(VF
M7P9W*6%@9FXPF7P#7W]#,P/MJ9G4!G%,5>#148>L`U/]:'<-=Z&<3B$0X6*U
M9'(GJ(Z!!^LIFK0L(DX55P;1((GF1#Z[=+0%'DI0K.6Y\-C,#\,0*%Z)/$EK
M!XAR+&_^-"3*4@EC@IA>['4X`R)]5:P2>\]8#"%B[8$I.,E2MB8(E:511`'>
MZB2(M'DV7T^'=^.4:OM^K]^)2VME-`LI0HHD1FZR)'CARS:0K?1>0[T+I?G9
M+A2D="EA39W@7&GLT\BPIUM*7FB?M&:M8T3>.NW/=HG`N4GC(JEF:?^%80[G
MP4'2&T:*&^(+I/F)ZP],$(Y++6E0`E'X/\NM*X(C5C0M7\+A_%YN?$F`&)<+
M+X41$%)9ZF6^X8H>Q[X:G+=.\[,I8RLQ335.<(Z#0TY3:A_/N\6:LB)/J"7K
M>O1OG?9G4\;.X<@YN-Q,.Y^NUXW+NB9B*OKF:U\*S4]+("&BQ,PIQ3U&7A`?
M4,Q7WDS2(O5UXL/YH9K4X]%5,YP`+I6OEG_NU/7YW-G'8'HA<(Q4.A,H&%[+
M<DM\L&N&]Q%!NRF,?>`[(F)KVB/I2OE93+W[4=,898C>H9C781I)11F.0;3-
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M@U1LAU0P5UZW;[!_IX/\^(J((!=X<&`W%%:,$X8URHHH*E_*I>H6X9X?X_T4
M$03A`5&.7(HU0P@BAC;@!".T?K;%92&\IR(R,F&LC!-I8)K6FN>-L88;RXLN
M:CC5KZB(=L3Y!8I(*2N1=%AAIPE$6L*A+,XX:E2.,5$'*2*0NWH!^S1Y5+G`
M:5AW!U^T[M!3ALXCI:0,6!FB*&,0%+:S(30*70_UIZ_3^E^;^N[??YY-YM7/
M/_W+R^%8:,.G9`QE'AFNF;/"R@A!@&KWJQ-1M-MOAV/<?)J-AW]\&$S>3S[-
MTE*7!=W`O_QT.]B0@WK.SJMW<:4,@VJ1N@-`8:$H))B8/(6;6LPZ91CY)1#'
M_05XRI\Q=3MDAV/2L3.KF#@0P$@0,28:3)@WWHF<!?"N6VM_$DQ></W#N`)0
M"0;52>'$2D-BGLD,K&%K;DWTJC!UWKXG:'T7.G`.D"34&J,$E<9PS_.689XZ
MG`X%[6%2W5;-M/Y2050TOJ_>5;/WU\4"I@VCE5:"4?`8`"+#)>7&.),,;NX'
M9:8<D"XA:%.L"^LF<`X"NR_4A+A,\B",DE:";\<`@RQZ:9Y>.58.:\Z).CW<
M:R8CK83($?G40L$@2/8H8H-(KEY%CI256TH+J8JC<1*P^\BM%*-(2.G!$16!
M(Z)E&]D;3<LMAA*IY?:IH\)M9K-)_?M\ELH#/H_3[3_@,1G?W8%%N0*,)E5W
M+N4.$A"55,[S2*20C@1F@VI[\15U147)+TH0L2MFNT!\<NS[.$N1!)&VC*0M
M\]BZX'P._-/0RN*^XQ=%]<YB='[LMXBCIHGM$`\3G69R6\W#HSBF\=QE;Q,A
MX@VQ?ENZ3F$3G>,(I]&`'BWV&N04B"BGSS%.Z3F0AZ_NYB/XX(<TRG7<G$0+
ML"@0B+UBA"L(0:A&N8=$^FC%FDMIM5POM!,Y7H+"JY.G[ZS`X4CC":4EV#%-
MT]"27/FD"5FS=9D@JG=7DY=/GRV*)%(NF(Y2..:M,BCMH,UEB7Y=195FG.PL
M36^"/+U7'@Q,C,#2@KNNHA"!MAEUHYTMW6&)J&3R%>DSA2?];3P>33^-[T9[
M:P\5`%CO+45@1&60@%HK'BR6]5M$@_KHHK<"PM[@]4JO,I)!+.VLY(Q(HPS.
ML]&2_U;N!Y,84W(\\+8YQ8)Y0AQXQ#S-]A%8$-Q2#Y5+,8@2R\ST\<#KHY[C
MW&$EO*:*I]B8AKSZ1WK"RY6B/,5X>"_P4F8D?'V`L[WC=-R5*LBD8)0QP#1'
MP7@E59VGDF(ABY0I9E0(4IZ^YT#L#V$?!6.P+,")LB#606N()/+<5&G`K)1S
M;I56J@A[#H)PRQ'T'F)T'D5PVB@7O)<D]P<+H6@YGYYRQ5G7OAT*81\-"68X
M!L&QH!Q;Q8&0.023#/'2596:"]J-U'L@3%GK%^VT\4PR[=(X/V>Y,SX(UZ9S
MO2F5'\5TE7#/WKP[1+WEM#8:C2"ND0MW+DC1;A$T3KERN#?I5&GW07353&>3
M^:+BX87+`)0/G`NLF?&1&@=!A\U!AW5FS0X@V4U_;X#C9;#V[O#0H$QBB$R"
M:T,U8S*7!ZD0HRMAI;C;6KT_K-E$?QS,JF4&\4,U&<(/!C=;\O6KSWGJ=_A4
M-?5X\FX\JZ:?ZJ\?QG4S"_7-[>Q3]:5JTK*0QQ?X>?7Y'_#GM\5/JZHI,_JK
MB5-B4MVVCE@%1[%@@K.<Y[,QLN=^7S-?/"KE3(62?!.!^I#OH=GC%H1O?K$K
M<3J<U`_)$]JL9I[,AP`%PJA-VT.IC(IQF8<&8>&-_OFO=]5T^M/L=M#\I-$_
M_Q,6Z-]&@V_330AL@*0#^[)SU\%_]4(E+5:G/>OPZ)/[EMT+^J1W_JT:WTP&
M#[>IA67!]6&:DSOY]K]7GU>.ME@QFV#1I3"@\L%Q`]Q#R,T#D8:5TN_P7Q\A
MXBLN8W;&8BWN2Q<6O-=';6RKIKJN]P_-B''$HH"TH\)3;CRGN:07PGA=7"""
M,RXXZFK@7I@.@W^;>R6T2!LG+;,TI-$5C.4;WZ@%*V*#7\!_Z(0&+P'_8Q+]
M>?6B$1L0O'B1RB-`"08&9C8BDK.XVKG2XR+%^,[U8+P(TC[]+5,8XDT$#Y$Y
MZRPF)._=H4Z1XJI5D%)][PSH3I,+M@^FUYH&S-(,N+3GSRSV`3^FI00JB0MG
MF:\_S3O-!=@?^#[/PPM"@K#6F+0H`#FB17LE9>.:/4=4,40/@1YBXF&]:*.#
MO]]5B_"W&3VN/1JLMP';"A0)L:D@%?2$DP$L'(ZM4?-*%=G^M!4&=1VH[7`=
M`9$MJH4+T"&*6RFT$DI1<*%S:I^`\U566FK2S<J\`)%)_06^_:5J79VT#3-_
M<]&HV%_]9`=W@V98?;JMJMFOXV63^$KIP<+*N.>-CYT*YJ?7/9GEC_7TC]7*
MW/&DJF^:\'6X&"Z?+N8G0+3.H_ZC&MW4S0T8<OC=$I3\_6IDIH^_^LP3V-)+
MJC6XP=(!3SQEQ`CE\BA:`CYG4=TD=*F;MM/Z3\P<T!FCEC_;1D<Z&7U(TX$M
M@?!)2B?R:A.$%2Z8@;L5KQ?+BZ<:GK<I)BPDET(:+#5X=XY0Z[(2@\"P;#K&
MI:OQ*IQY[IB_)2DYA#<.W#]$'74N(.D"]KX=1H496=,]0[K5BC^8<S05AJ*,
MDI&(4701&2NES0-#@V.Q"(1D=_OJL7FQXWC@K?PPP^%D7CV??_`F^!&)C'#R
M.'B0%$>II,VC.I2+7A:%%;R[.7!7\AZ))WO)R`7QY!`%9A`/.#B$#=*1I09`
MFR-9[JDKLLIZ3_WU@T?[RXW&B$9OD=4:XO;4:..S'HM@^LM2A#?$DH5I>8IE
M+X$UAX@/E42H:$"WN>`BQRGCED.88'#IFZW)Y!_$K+03IYI\K.X7(\5N<NYU
ML3YGS9(T,#NKR5]N`X3Y`@X<XIH)";YF/FN<>L]__NL'S'];!V[OFX\#;9FJ
M#BD]!;ZP3?DV(CT$(5E;&218@E8=#=JG4S!-"T]_76QH'-X-IM/ZNJY&<3*^
M!PTSOY_?I</SWEU=-;/Q,@49KJ^K87K&8T%"=WC6LVO=4YSX)1!M=GRM)*9%
MA]L:%AR'R"-ZC833!LEH-<K#MJ(-IDS-\LW'^[C4/!_+_G[9++,&$0N!H47,
M>4V]4+)MW6`:E=6L93_1=\8S?O%B9AR708+%8-Y8E;K\5)[^%)ERA9@QM-E3
M_EY8=N%B1AD-B&.-5>H+UB!UN4/*Q"!8&6OV!#=G9%D>N]<L'W?55)T'+C/=
M\V8&=+V;CY;0M&]-<_P^5]/4T'6!%B[[FN.'Q33OY-8M:+:\&]PZF\/S2(7S
M6"FB,/(6TR?35U[DE(,.7Y7V%\;U,TKO05Q7R#C&6$26.QM9)![A;#V#$J7#
M4W3(_VFY?EXS>YBL6XA_HK`<F&^IU"+F1@@3"1?KBMM_,/T"#/6!3/>I5#$R
MB1425H7P=%.?YB\5E]S[&O#78/JOXW\<$OUCS1%&RGDKG,&:4D5<CJ>!/BK%
MTVO#Z;[W'@74(O170:>-)PPSH0GP2!EJ,JCPU1%`#8-)^HUI;E2V@VD]W*48
M^WG'.GA_Q$CLP5:0F/;&:9EG.SFB=:>=[JF1FO[E_\F[NNXV;QS]7_8^/23X
M!=[L.?S<Z=DFSC:9F>VEQE$:S3I6*MEM\^\7E,W7DBB]TFM;EJS>]#2.K!`/
M01``@0<,'E:_<2F/7.POVQ=KT`CGK,(0=)(Z*)<K(8S29IWTYV&QZH?EGN]G
M6VQ;HKV\6`03=>8J,4WJ:ASW=11UF7>S7C6[C*R5AUEL#[*XV'=()DCEE++.
MF3J@0>8<Q+;%FA_DDQ8;)U>W%",,U=J80N&B\)P):07/P=3V')060NC16KY]
MN?>+>?2"^_#U9*XP@W!:L(Q6B^J=&Q79^E/?BN:*`RVX7WN5MJ*PW!*<2CO+
MLPQUD+IF<IW);D5[#[C@'H3+<'+K&/K"QQF-]'175(2]=EL-&6EPCR';N.#%
MC7?QN3H$I?#YXGHS$=SPSB?PTBL2PDE2%N9980N_T^P8@FKJU]^`U6KEFA^R
MO&>4:T=EFR`C`BR"(.GHZ"8;5$=?ICVTX2E(COB<@G5->!]'?Y9?O2-VN:7=
MOOAV/SUKKU:FE5)F`M\IYDL)BZ=K/>IJAPR)N7)*'JKIP31"[;.VYQ3IE^TB
M,>ZXLH'4CBR3)''(`%0%E+A29;XDDK9'%:FU92M5E71R0F%3$PR-SREC'2%/
MCH^Q:;-(XN@B]>R202]\\2F1NZ"UCD%T'8C%8FP629H#B52BA^O+R=5=V:F[
MR>,RD.ZJ1$.W-]/9]Y4/[W/(5IM6/(A@I+'`D_26\3(`HK:2<<'L1FF%VB7L
MH%6_"`H].RX=8`*M`'5V4O/H.]\W>UCAO5G&8*>I.3$0VI.\1F&%W"-G/@/H
M0#<D`-9>-/"K99^O6!7Z#[^,!J/3A@&!$*U$7I_,7"DG"Z>I"O=IE)5/Q`G]
M8JFKF(RNAMZ]2J+B(0BR[LI[2\I0J5!0>+TR-K:B\(;]0#?`,!AV+?ME<.C1
MABR83Q1E!A:4B"IG*SM6%!G"I@M[@</`,W$"./3?\H*;#.5CQI*323=\\O<A
ME@>@Z'LS#ISSUXA#CSZ4#&$.A1XMQB1=%JYVUUN;\TIG^+(^6#PR#HN*LS*+
ML(R%NT^)+C>S[-,DU*,>D3SR8#380*&LR%PJ6Q-=T2:VV6B2JS$,E8%"'`6D
M'MT)='V0+^%4(3PI=(#<U=M5!:G8%I#$F8'4;V@*YU+4R"7CJ*U(.J1*3N(8
M#YL,30%IH)UY#2#U:!*0F\ZS\BXS+W@A-7`U0Q>96AD5L0S20!_E&"`M'G&&
M6I^4G1;:ZJB90HJI+7DN=0PA2KG)*!>J4OET.!;+/;#@/7K@@V&(R<EH8S3:
M1ZU=/2REX^05"]YO)7+I=D)GE0K@R%YXK.\_KA`X;HY9&=N9=#@-P7MV/)H0
M)#.(EG.?I,BY^J,8N'2;LRV,#73+GT_PQ6^Y3_^^O>^Y&WJTR:"A3(5^!R!%
M#5Z)W"4GLMV<,!NLX>NK/(R8/=MJ"Z^R`DGF2EB>M!0=X9")TF]Q#=A`U^`%
MQ.P_MA:S"2SQQ$PR"D)*W>5N-81MQ_;T=K/_D'K#L@8CLU!*@@H.1*T6(\_/
M;O&&7WPW%^4499+N]')TU7UN/\JQU>29#L#BXH73:>L\#]4;42%M]6L'NFS;
M5GM8L7O/+/E>#.G0)H=0R!YKXMN5F0WFU8K=?X8QT4V#V4;.0JEVQ:CN4Z44
M%!-FSW.&CR-VWYN`$UR@3TC_#9[,-+)N3!<9L6T^YD"7^]G$IA_>\Q`-/<W.
M"":8*YXE)S,=.0_UC=1S2)MBBS>/<#$>%OC<LO5Y3^B\SB[[[`NGL>986?.,
M2'F%EW5%MH%^XX%DVQ$XBQ`PD)):)R@8,-ZIKCNGC"X][7WK/WR9A"KIUTB.
M0_3D"9K<>8$AIDTVYSEE^_KM:OI]3!]>E-SO0TO61Q=E66FSL]Y(""XPGUR=
M=V-\T<RFU-"*]3;;G2MZZOK[2*1TYJ65WJ)6+$8DX^=JT$E1.#9S:X#+]6+)
MQZW_PWCV^Z2TD]X5/XT_%0Y@"DWNDA%75_=%H1>?'\HM[T8%+H@NP^C;Y&9T
M57YZ5V>Y%[/J*ONAEL%)LB%T!Z9%BC-UCX0B-N3XL#ZG\4""'`VL]9*4%2U1
M/#)0QA,((7A%%JD&JB*A:GF[UJNHSPJL#7RS*W.XO43IO/`YA!@=75&QXP!%
M%IOJ8SAWL/HTBR.ZI%%GX)"903#8#7N1RC3'4)WL,:3[YIZ3L-1Z+__-?<YE
ML(DB8ZQ=C*"U<PHD7965_1$C.-WR-NEU$JWG6?A+8=&G)T8SDE]+1W$X<#)`
MV5>B;L6`-]T[[>S`5X3%#@/#K9%)9NE9@B0X>ET'-F#2JB7VN!M`]7JQZ-.+
MK!./Y#XJ]-9;`.5,EX2*VL?6_WJ4`1F(Q6^WDYOO;\<W7\IDXTI1=O'']7@V
M_S+YMB_C\8?++^-/MU?CB\^;O[#]Z7C\;O1UO,2-//HZO[W^U4^F\\G7R=5H
MULTSW$5^["3SA2^NU#"7F8X0*H,NTL%CFU.UR]F0?2%X!N`*;O`__$,\#>BB
MTMIXIJ5&\@,4Z.CK_2^X=WHS=.HPV&V>!WDDG%8=<*/)H)-OE`U%N-Q'Y!VU
M/.'5E#EC<W`W"_SJ0,%EWS%EY!90EDG=HM1UU[C?JFS=LJ/]WS__\S_^TU:*
MAT/A<CQ[M!IF6P\*0B[TE11<@/$R=USUOHW6='/[GPDHR\IB`H49P<1LRUG*
M2*Y0K3]/PJR4U"^4I;*<'P*7H]O@%61TDLEYD$+)))SCA%+G(=&Y"NO(2'O6
MT*P.*E[PCQFFA2"_,)1R\9KP@<0:=@O94./OA<N?EZ7'=<5KVNQ9Y<GUZ/IR
M<OVK*PF]1=IH<"=0T+EXPAZX!V<UJE`=8I.3:-DA45BY)M-3UGM(R7?T"MD0
M0"BDR%GEDE@L84&7WX^Z2<QHJ^VA).](SGZ\_G9[,X^3^6)20U.V?2<6?R"6
MNYU/2D>TNR3%FD^Z5O"%GH<I:=BLS)0>OZ=5?1U=CF]ORBB(#2PNJVY8YMKH
M"(J9R',NPTLZZ^A%\IO=L.5.W1YYCB]W]RWO9]-2VW$QNX]?EK[BW3\X'1UD
MT$*UTBKL7<R2*1DT"F.%#O4-D"[=$#=7H2R_?`X&ZNUX-+^=+:S5/R<W7_Y^
M/?W7G%9?1KK=?<5J)I_^=#N;D>*5)MEY1YM7^_'O)L25;OS:DCA\S%9`="@E
M.1?DA,;`;!:U$$?$U`P5>B,97QUA]6*RG1"B.\;2`407=21G7C$T679#MP*3
M3>[JC8"UL6]_.41WC3$+'KWAP'G@+MAH4^JZ#5-NXR7"D__E`>U342/)#0H,
M6`B<822OJ#8&FI2P32F^45J*\T/T_>WL\LMH?6S=P2[I549#PA/0R)P3&5YF
MF??5?8F6+'([^$ZNI[@/A<;+0[[/DT"0`2`@*![)M$(TKILQSRD0;CS=LP:J
M+R\<`Y=20]"R%)`SGP#JC1X%8'/_G"]0.QX3G#!1!189V@`9C`G0Q4X94C-%
M2NCU>/#\\.I3+.=!,\4@):ZRC\:DFMU%G;UN!BB=B<GZ,+ZYN1KO7?6]QH&:
MHY`)"W^2RHX9:2N]#R3OFO>JPT&U),4QP>K3+S2"<YX2783<<2>-,EWS.@33
M3B0^\'$\!<AVF##TG&D;LBCSV(-SD?..5!\Y;X[DV8/5IU\R.5W>28$G$T5A
M6JJ3.ZQ!K1I[?QI@S<."QX9<X_(W=T^RX\LOUY/?;OML^$.>S&<)7J$*(<3D
M<\2.NTT%`7ZGG+T+6%W^A/`;_S3YO3CP-_1+I>UF,5_F[_/QY]NKGR:?MSYS
M/Q`I;OV2N?_^=O3OZ2P4$N$'%_S'ZY\FE^4A^M/[T<VXG8>U(,5;85A\._IS
M\O7V:_70'ZI.A()@O0Y*RN@I1G(//KE/R10V/O/+$EI[R/LZ`:)_8A-`7B>E
M%3=.19$R*V.ANF21T=P20.+UX7-Q>_-<&F2024,W5U32H+#@G4VUD9&"EP(0
M_$40VJ)"'%3$H.AJSREK[T$:Z-HN/!EA.F.O"Z'Z.W'\^_AJ^FW\:6$=IU?3
M7[__7.9M/UZ;O,%"@1:9)>_10I!"UDH4AHF'UZ=-SX#5%KW2*;G@371:.Y--
M\7\Z(LT@,"U&OAP&J_D2C_WV;OA=Y?0>58H47'&DR"I8](#5E1-:J^:=7W#3
MU(4,7^,A1'SVFVK[Q&K#0PKH`@10/'G!H*N-<$XU233!&#\SR+:9YI[$HP;R
M"+/64@9%+J%V'<^=LKP9I5*(H\X'LST-T/;D6C)6)$$Z)]&"RC9AI<`UTN@V
M;2ML4Y!S8O#]>/UI_/D1$/YX_7XV+2_H/X_GX]'LLA!LWL.Z1S%&S*7HS3H'
MD269(J=;KM*3):^:)XCSP^_C;/1I_'4T^[\Y`;?X0ZESV:6`W/-`T:MB*>2H
M0QDZ:3OJ5Z-Z,TK'QZVO'XM+9XIGR$@X+=%QU[5?1XVZ2?"+Q;5X<D=KN4+N
MX!=@X8@7$65V=("R8(8"D&K,M6OSBP+9N4$V^`+,W,0H&>F.#MKR)'6J%7*1
M/,<&,VG%>A/!*\;LJ1<@04$>`489F;12EU0M5HUS?D.+E[1P@C[7,GS'N0"#
M06DYMTQE8,[*0JM?>^6\%8V_?W[X/>X"]%KDH#$B8O82@Z`0N<9)Y-0>";>E
MW[EOBWE'>'W\8WSU^_@M@?=E<RWU]@8XP0+7/GC0DD)",E.UNM%S%D)NHT$8
M8MAW+_<)DM^-)?DTGEU\SI/YY>CJ%SH=P\0W)G*KP`!PIQ,#`;$&=E*S#?U_
MJ)XF_L8U/P&#\NN9/CMPU[/1*7E2;&&,U;(,`:F[SDW;T@6Z::E_W#*?*NGT
M=N`&"^$C(.,Z,_!")*=8=XU(WDY1!\.&)#NV+_.)DG[\,AL/W-2HA(+"`EGJ
M,KCC-G4#XR7##3P#R)\NZF*=3Y7UC^E`#]ZCYBI)%B`K!C$P"95<ES73-8JD
MZNGJ2ZO<5\[_FDWG.QJ@#NZQIX">9QV2(K`R"H3J?=*/8VA&=P@Z)>NT$[M$
M/"8>P]WQJ*4F)S(Y"E\C6)\?9G5'9$T!LI)"O`X\GNIJ9TQ`OK:@Z,X[8>D`
M046&"Q!-AP/!HEX8FA<-=@D%F94BT5,LQ>F@7.<Q)ZL:0RK`Z@&IRZ/C,?CH
MB"RM+EVDEEPD=&5$5'V.385`]/A'YUA1*FB(+C.5HM!:!*#_JR_Y3(H-CRD'
M/#K-B,D7OW,8\I@RN5!*JRQB:2BM4Z^$XVVH"832`#36!SF^*!;##TTDJV%=
M\!Z%Y!REUZE>P"!RVT\[Q!L[%A1//2\89#",YYS``[#D$F+ED@AHF](HS7!`
MO/545):M2&\U_L?O\]&_9I/[QK"UM^2#'S/CO`[1%9X>"X70!]/#F&78D!I#
MQ0=D%I\3Q<.[N=Q)[LL#CTI),'+SZXP`PYG9T-Y@N5XG@SI5+`:;'$8V5J%,
M"M`JMQ@&UU4%2=:V\$L[P.,_%A1/-3D4YV=A)6<1&#!R;)=8Z((WC3>GR.<]
M&U3VZ&%U_[AXE_YWUV7FG25'.((+FN)*;5!TXYZ#:'L]%)-/N=COIKG<<1M>
M?@_3NQG7BP]WE:.E!_9J6HI'=UQO]1?\]^Y__S89STHB_?M/!;[5^=JKG;:+
M#_!U"__PE4OUJWDV_NVVK'?S]RU7NG;ENKNNRQ23*PR*J&W&4/S+6D/AC11-
M]FH9[F$8GC3^<"S\I1;1&`/.YR1UF1W!N\Z=D$V3'3?0Q(%GM`WB6-L0$[DU
MQ5/,3I1!D\"K]4'0.C6YK!/'_[!@E3<K34&F8S+Q'+G(E:[-Q*ADD\TY,9U=
MN1!?L>F6UBB-P8$A9ST'*SVK]-)D2EBS#6>*_]%,=R!KD7T,0A<2[&#(4%3\
M;>"JN3HY:RM6SF@?CF:[,:FL8K!)6(<F:R$XU',0>4N&=.+X'Q8LBN83!^M=
M@*0LDLKZ+E8I;&S'4=J'?K*_E//M?5)22_`B>JZ"<=+6^BW`U>&^>VIN+Y"G
MOQ-'L^4<P0.R[(QA(*P1T-ERXYUNLH:J26N<Y7X<S::;E`*S3C@I-`5'W$A>
MDVY1!_$(FWXB.W%8V)1S%$[R:`KO;TZ&U+<^%D$.;8'&J:KQN;CH'I(68'@2
M4'+(FGN\#RO)4Y&AM\+O+'?B>'D6JRQ/GGF/#)D$5**;Q6.!MZ5+9L^8]95O
MR-$LO-0^Z1PU,B$-H$?R-.O10(N]W1\GO1.'A8T"?DA.2R^DPF@9BE1GO7$K
MVI+_P^OQQ]GH>DY?,)E>5^XS/_Y,G_DX^G,PRXRT@NZJ[)!N>9W0@<#N%<`&
MT:1#W_`=-UC?ZIY5JCZZ#N_*8P4/BF>(($)6O&,QS<(T3XAOY(Y->QFI=C"V
M4)SML?"RLE#>1I%1'%XI\MT&$I(W?$<D^6)2]>T5<Y)E%-8'NKH#.N=K5XA3
MVK%-&OA<8M6_O;A>^X8XGDU^']V-2IO?S&X7%N/=]":.Y_2I1:7__&_C3[^2
M^5CZP'"*)PJ"LC:FL$E[BH.BJ8</*4PU3?TBK)^]9Q;@Q<'I/<.6C!%DC#P&
MD<B9\+H[PYY<NPW]:6<$S@Y3H#EF$0'*D$I)V+!4B]3HCZ*M%^%BO1+IM:/3
M.QZ++`I$&;(3')$!69;*S6Q+0-N.MSD*.!]&A<M^Z\R$/0P(2"=L8:4B9X07
M1I18"Z`Q.2F;3N@^-6A6\Z15]VY/-M)&2-$;S1TM7V=5:_U5:)]@N7Z15>\:
M4(=`+G.6***79(V24-UT!`HTV^K[%UIS'](!I2W#K00YL;H,K`RI2SX;4,U!
M:+V[O5<]G7[Z8W)UM9NX9)E,&!Q`T`A,"Q[(2W.AEJD[)1@V'@TWFH%<Y1"O
M__*>RUEO0EDAB_9T#TNR%4J6B0#`H/KZKC2N;ACKJ:20_)'+N5O-_[-W9;UM
M'TG^N\R[@:ZJ/E\&Z',FP"3V)LXL]FG!2'1,1*(,2IJ)]M-O-:FF1#;YIRA2
MET=YB`U9$NOHKJ[[!]T:X"?>'HS\FA;B4^Q3G*_MX,!FN;HTY\XW!K3=41[B
M<4[M;'R:KFMTM4`+W/O@*F*;K(.I^UD@B0JEU;HT%/`YWF+!-Q&YB9Z#"7^8
MCLKU^>A;58[__<&]6Y_')U\FI^/9:&==B6\."E64PRQCCF(YOI]LA'X#K3A<
M0C^<?QO5;[PW\;KX4K4'_]C6Q;_"@KX_#TZ2KWL,%$$XR,E#>P><U\(,[?%X
M,$4;^?AX]74\NUU-N/?1Q%AT=-&77(+/SMI,+>4+D;_2=62NC[!OHF(CF0M-
M_#`]F8U'E^,T7ORY[>%Z:K.1M4?FMVC!!C@!NFHM(;CY7J32/W_=QN-AME8D
M<*?#^N*L=A8NF@[/:M/A-G_I&?MSE812P!MP+@;IO=2>VADNU.]4H2[3\$!>
M5^4S!_"NYWL!K#B]FDRO^>Y^_,:&HRK\-N!=`GV/+W^<3"]FDZL;_HCQC)]P
M/SU=_2T/PO%Z`"H(!0%0-%MP$Y)!`A!^V:41<A>:.$=JOHWLGDB>C[U7)=8A
MW`6OZ]8V5TRPF*/R/C>P%<-N73]F`5HY(GJ7ZPZ`$(IUORV*'(SQ;,>,-*YY
M&I']N]X=XO^$>9?K#IP0B-4?*2JP;^("(;!IO%LVE?O!,4(EW&NT`\<RC,Z:
MS'8QJN!#Q5_D$]>",5T13_M@S`W>WR?GY#4`[YD`ACU=CF!]H`K#YDK;YJ%R
M2-W[^J$;BWI.H0U="$O96^&UDRG*,M^`W"9NE27L@LL/3LU3FB_&R6M0/T<'
M*G"8XX/F")"R44$T0"RQP3I_<.NU@6<3VBX@*LS927(<KU6$;78-EZD.HXSL
MRQS26GA)3EZ#^H.H6]5]W74%(0IILFL1HBO!]6!3\L5N_X[G,%,&IMZ:E`JD
MG()=MO"3L:FK9GQ09EZ]>S%.7H7Z"Y;,MZ6.6LM2ISSSW?`CN+Z,J[K@ZI%"
M8U\B_SDZGTSG;L:G\71T5I$[Y][$K6-Q<C*[7@]!;U-ZV\LV?`@4("G*4==F
M:=4V31L,6G1O@.Q2;WN2MXVU^0J<6^S2O1T9&464BM@<\U\*YJ14@].*?$W[
MLJ6V"C?9LHZ40\B]6_P]/JE!_>3+Y&0N'H[I/WZYER!:Y%TNSK_-QE_Y]\YK
M.?635GI&'OM+UO)\OUSQ-]_=DOH#%]-ZYE8^[-[O_6E\U5+N]<3>U94^SO[K
M>G0V^7+#_F\<77XM9Q?_KI6FG4OO'(IH#2D(E%Q!1SXM$1"5A]Z#VOR"ONMJ
MDZY^G<[&K)7_&]^S)TU_NZ99HB>MG2ZQZ$S2"BIW6&LY]*Y-5[L[MF(&WR^I
M-,9<X6]T%CZS"6OIY@(".VJEU(XV/6!')?>[.4='OO/L)CG)KI)#&SP:2P7;
M.@D7Y09O8SU'_:ZK)[GS]?IPI(^HDB_!BBRQ%1A5T;I'3'[:.[\C9''DZJ94
ME`*L2&REP.NV[J:F,OI%'*C$$[[SZOMZ.XY\Y]D?4\(G$TE7`+QL"BT3;JC[
MY40?UE=BO.OJ2>Z\L^PM"\WO/'@`#1`:SIY-1H=.+T]JBG=$J2*4;*V0&CU%
M$<CX=N--UJB[LKLRDBP^-;DO7VP'YC*11`!%VDC6X7*=HG05(:CK11R(VXXN
MEK=^N8YL"'TV3B'5W)%!`\"O;<NT29\#]4FC=UT]AR$,)(VWN2AC)7F#L5##
MOW$J;%C,_3BUK'05_#!E\B^N%_,>X\D<;'/OV$=:LMX2NH"DD.]^3JE912#7
M'2BPUNG.#]I)UQ$8V6'>37%11<7.G(DF"%$RNF5?;.[=3[*NKW0>@8^:F;I7
ML_LTNGF47C10I&*2`Y#,FDU)+ST>=H)ZJPP`74'MH=0=CZL=2N)`6Q'(:%$6
M89P.%%M!6H8H^],F^'<^0$N'L-5&E28/Q)1?J7NI:)57%;')H?=@4FDCF0IU
M[NM>)-"YA_%SCZXC,+)#,3X$C(!!\+FKF(HH[NQ74*4O1H!FCH_.2;6[TZN+
MV6-T(8/R,:B<2A&>PX*@EWX,L0'H2M`&M=W%P#UZ#J%\A_`MTVJPV+IGU%J#
M(K:[;E0TKNMDMH#S38C'H7S^H-YV'51OY-OD:G36+?][2!</>;!4M`C!H_1&
ME=#&[#.JW"5CC1)R%QO;B#L:3SM4@XD?=9N-5E)$<-[Z%%J5)D7LWG6MR1R/
MI^J`C,[8=SF_F/["[O_XTE]=S2:_75]5\_;Y8OZU,)HW]-W4;_:S66VY?%CG
M@Y]>34XG9]=UXN.7.C$ZOZ'YSY.SZ]/QZ:(KY?P;?];<#?N21[,ITWOY:3Q;
M?.[-YE]P%X'\.)K],;[ZY>KBY(]?64H[-U\2)DTRH;79.Q$$AM)L4"HK]?#+
MN3#^\M<-8?Z!4OONE#`7_\=O\XXB/SW-Y]_.+F[&X_F7/UW/3KXRY9_.1M-=
MNUI%L2G+4&O[9&*RLDTR.J^MAPW*V>#COBMG53F?)^?C?]:J\NG/_/_9Y(3_
M]O#[8OC9@)+9E1+DHM/9MOO"-@K]!I5LB`;?@$K^YQ4;K<0^K`N"-$I70&GR
MV"9\2149-RAA0_KD70E/8K1\\(6\9*?<N(*2/418MM@(X<QW8[2>53D'&2V"
M0#HJ+2IZM_1:E`2M[L)>HMV@D@TU^]>N$O6Z/:VL`]810#!S.%073&Y>K9.K
M"VK?\+UX;B4<R6A%+15P'$C6R$01]1()R_F85[:5O2OG>8R63<DD;SF,S<9I
M9;3VV%1".M'W$9FHU^UID5$IA0Q$VF+T_)B;EB61=9#V70DO:+1L]-;[`B@2
MREB3H+'=D""]^WZ,UMOQM)P(IB:MO$L&**`C&]J.&0PEO$1D,@B(O!`<2VAP
MW\)2^B\#3VVUD*"\JG,.%4X.C);+[K,"_?H5Z&:D]Q7#*Y3AXR"J,Q21"NC,
MKDVQ.L32<%"-E$EWU1\MU\>L7UAT+X^.3M&Q935L4Z'6.I7WR_!)U#Q0GV/'
M[U"&CSM^JMY5RG7SEJ^(PS*G.[@_T9=4CW[\-H`E/NR^;H\50%)@YR=F,-)X
M871P;0<.8NKJCP:%Z<W10^@Z"BM#(,G61,^O$E!QI0C+ISRW:3A3R'3&@9UP
MZ-^K@UGY:7SU")VLU"&US1DQHXW%"Z^"6&;*`^70E8RD0*NZ5H3=5!V!C:%]
M0<@.MDJ&8YY$2?LL@VZE;;(J=DNS)3IIW'IGR/YLS"=\;KM@]MX9ID+2%?T6
MB_0>5"80T(B.3%UWB#9<AOL$[$W<X'*5DHPM(1A!D:PV`MN"?I-(;%A.U*_3
M.(2Z'2O`$JD\A__,)#!;"4#+MGJ.N+H9S@ZB_%#BAD171$:#GD#9#*'$%'SK
M,Z7(^NX7&?1)PR'J%K7RF[J2Y/+K^+2>S7I8/WZIC_3L7^LU_5UF.2AR3!_)
M@B*FNH+6B/9*8_(]F(N6?:BZDZ;#>1BRQ\G&G!TJZ56=[3?6MHZ0(%+N[S^8
M#2?BD3QLPX#=/L$CA'$I8\DF*2I%2K.<I%?\[G<=%(*M[GIO[]V'[T'5D`D%
M%W2T*94*?UJ\]M8N-\`IUW='6ZU,-Q:_BZJ?1__^<<1G>\*??\"1-6`R.2><
M,BXB`48H3=U:J*X[>L/FM-TD'<S!T($5CA)8FQ,;%#X$QCJ4K;(@A>I[RTP'
MG/E8#O[[8O;'TJ\_0`DV*I%(9CXGLNZ#"-"`*OCX1-$-HBGHMB`_@*;#>1A2
M@TH4<C3(<2\H$X@P+@=KV(9WIEI!!T;_&!X6W;J+'L!FZ_=V'Y)!:0*_@H;)
M=MZ)&-L:S,CVK1\*ZNOIFREY/+E#KZ)VJ9;0,!L;8Y+"X=+JL2GLU^2IWMLY
M*KF[/`P5$[_C69>L+5H$G>\Z=$%V_6$=).OQR1WT.3SH4.JLB+;S8+O(ULZF
M;$C=`VCZ<;:]R+W\CT*KDAQ3%"-\$<Z!Y]`U\.FX=88%'XTN&.^77PP)[C7)
M^,5@2HKUR$%&2!733K%1JWN);^>:58A#<+QO1[HOACF"MF;6A336\%N'T@(U
MZRLJ!.^KDNX3(Q.1"++N_C!6!2W)8QN@9Z=W`ZK]<U[F[P7]206K.?[5.6NP
M$A6[N"W5QY&:[#N1-T5C;T/&+P?<YR+%7+3&PE&$R#KD%K`54?I&_#<IW1<S
MF$XGJ#.E'`=G6\"7DJA!JT8:!&EZ?ND^.8!80;0F`ME,24>_3*[:X%SW,A]R
MF?\QFF[<Y'3']G)6\F_CB]]GHV]?Z\[D.;/S\;?9S?_&OP_$>QYEM):((S_!
M89.SH>)T..'91*TT])U\_<*L=%%()7"5XFV#3#O30$X:+#H(*"*G&$+$!MZK
M6-P]K(H2J&!U"&C;L-(@44-9().*]N!%(6%T!.EP"=@1**M^+Q98#8;V)<I/
M%ZT!7R_.3L>SR\78ZW[B4XXTQA(A2RRJ9$FF;?^.*>D^Y2<)M%);Y;>1I`/I
M'Y(T1^/1TCRD2$466S'@VG!T2+V!`6V4`P-'H7^!HK)OWE(%)Q7[33JRIUYB
MMBDWB6>^35W"H:*A"+V-X%L:]B9Q2*C6NJ0A")-B[8&+5JH6M7O!1'<D*E57
M?CZ2Q/^H&-@'8Z-C16-ASR-;;Z!!9&',.`3H.2RRUR3=%W/F5$D`E'41TDK@
M@-<O`<@P!>S>V`Z^]NW(^.60E8%#7PK%0.$'0@9;U!(BF)^P+F&-H-83UL\O
MY:<5B4#/IK*>.:=0>A6D:\M0$ZH-F)HHUJ/A)Q3)]Q(->R><!E!>.A\U)+#0
MQJY*">:%3.?W$@<'E16[K3%#"=D"D5V&)S5SWIG.'A?V[0CYQ6RG!1%2#N!5
M\88,.ZUE&0Z7T+>CL3U9KS`\OY2?.*7JR!DEV24OQK-G)"@OA\,HR[YVB+1>
M(]I+)',PG'AQN=;KO2@.T5U\?/W;Y9S7JUP+DY]OOJVN+%K[][4#5;_]XY=[
M3=%W_=W^;Y_C+D,7K=%(R>5BD1^4Q(&MD5XX'Y3AH+L/:?M#<L?F*O\7T]\_
MCV?G:?S;GF&+K$.5?!Y#(6V@]KFHUEK.7E0/K*PJ"MY:F'7OP_>@:BA2J8"Z
M2;`7S8\NN(IQ9]J%HBAE7PYEP:[UW0U0=7FYP.BH\%(W^?***;ABO7[B?Z@-
M;IL1PNY[(+NS+#]\WNYH1:NEBR:;J'6I[47+H3`G(MX/S?.O/V\\!@_A8(7G
M'T=_3LZOSW\>GX\F=7#AQ]%5G5"X^?AE*W#H)6POL]XUK4H-A</('-DE#Q1K
M7F0Y397(_.6OG\#^>$?YH^A8Y60-.*57%`UU<_%+J-EY(RE0>9U];GU[OBC3
M6Z5UR:]_^IZDR8&=Z\DP25I:8*,IK**43.NH+S'TUD&NQS@'T[:]$20B<7C@
M)4@M%)MQ6SM(;^=/P/>Q00=4>S!MVPV8QD1.":6C3MYD3[1,:CB7-C2I"#HJ
M;4-[]"OF+;(MT\C/8?8R>R]:7=&!Z`H]N.Y['4S;=A-;,AE=)04I\'N$/K4"
MB7-2]55[N;8:?R_2VL:<^>K$R>5BYJC.J7V^^.EB6NF>79R=S=&(%S_P]T6>
M;N^V'V<=>QA2FES0!PJH6]N5"QYZK$:WGL$^%N7/)XY!T/JL@\]:\1\6=#$*
MP](^2].#DS^/.'X:7]5-F9]F%_^:G(Y/P\VOEW4"HTRFH^D)_ZP_8</_N"UN
M$%-TTB%Y137P@2!;^9JMJNLWBK/;(.WJ`OB'DW<TKG:LKHK692N\DB89)VQ0
MTK?-CB&1[.RO,;A6"CDN3XN2U6&:JAO%ZD234]XFSVI+KMU4'8/INE39T$L@
M^1"N-I!W-*YV:$J5`I9?15<K_)C8.<H-<R3PN].%VQ]J+^+3LK5<3W:`LC#&
M6/T0;148E,5%JUHY)AO1`[BS6A]X!#>0=S2N=FV$PZB5=1Q1A%+QC22'\"V_
MYS/VC=+&LH]FCL35'>;/WL@V22C,**.7,DM53*QVX+9;-$39G3(.[-1:J6F%
M@/U)>TV+@@>*,JGF('PP&'/*:-D3:XM70:9>3&N/WR$R&CIW#I(58+6S%$)1
M47M[MVH]]ZCA`$Y*C<>D[4WH+V@/`))O*%_/PHY^T<OU*>R\=.[S!UJO2#Q:
M2CL@)Z(.Y&/=-J^B\J*J!UJQUY+O'F175WP?Z0*^/LB"[74[*B&C1@*=!(I,
M$EH3?M(Q=LV$4JS[GX=(:>@*4J!$0I+(09&,F99^HJT3<AM&HJ2ST)G^0VA[
M$QJL6YZE@8@5)1PA4M:QM>%P--N9*G:F'Z?!U444FV.)O=_)0+K@'&"(51KX
M#EK1H&SY8.8NN6DU#ES2AY#X!`P.'V/FJ\C$9]DJ9A7%,GL;@5V;CD%R]G4Q
MN,/09@_!::4=O^0YDE3@V_DK)H0>%0ZE@E?'X6`<1#&'($I0@ITW2JY61]HF
MC>SZ.$A:.*H.-WY+6W5<X_P&9\+6X[=;*,?]I[E]]C*BS"62+[4EQK:X"(/J
MD;[NL_<8`I^(Q:%<BY0F%BU4].0J2%Z,LK1&4&O[F?!N)<6K873'\)>"&#CH
M\PAL;-BT1KR;10DQO`E=[A@8@R!#G3O6RM@L,`)AJYH#)-]YGL=F\:*%CXN+
MO<\.A55D-&UD,"+6:60M@D[YEHV`($+W_DF[5MK;2LIA!+\FU^>E8&8\6_U4
M8DB`11>1.!IL'FBR072W"'K?^`F4,XBMR?<`M'0I>W3&%)!+E&N.6VWG,W^8
MK\]_>H+?3Q,'I*1BP"RT#Z9V\,74.B1=*-`CD%<TEB=6S@[/KDA23H;BD1TZ
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MYW3\<PW=G+F0#5U6F83)D`/44J@53C;.'T"3_SX>1Q^6EZOUIOM[/JQ^?[]>
MD2:NOGR]_K#\;7F926O?+S>?Z$_$F^7'?]&_?W2_72[GP&N!QX`\!TDA%\@R
MH0C]:"WXW,*NZ#9GO!_7DP!,@,*#U2$YPP0HA56[K(0DFX5V4MO#474<[8HE
M#Y@MW9=$OA\"AUZ[LK*VS8`/VY6.R-"QE"N%E!2GR-=D*X">-,-K5Z(M>"CM
M,8[X[%MPO?-$Q&'?#85`3B.B2EYSR8+7%?106F7;U#@?=LG-\')\OH^E`*4S
M(23E6$A8AA-DN/>*O&B];(7B165SM-O.,9,51&ZTX2:70@#T#>X:6D3/6[4_
M*;Z/I1/.>,X+&AR3V9F(3E1L;GH41M#6%&^`OG:2S4VAIJ!G?5]ONBSOA^67
M28SSAY2SAR^X!9$L&D=*;)/G@;,Z=Z,3!?8/0<5OOX+.]0'13Q+RB-YWC[VV
MO=H=I'&,28:2D_<(BCS(4$=KA14M?J$MFQ<?^_8C9.Q%YN2>5R-4DIA#!C+S
M*I=ND7L?DK4.EZ+'83`=?A`Z9R)O,L^0C"`])>]09I%XK'"0((-M9ZO+:(95
M1Z%SLNO-!6,\O;4^:FV]]J9OSP&4T$XDDBMG!R/@LW26<*G=;;KU!/@CPVER
M6:R'S&@?LU(RI;K$S;D46M^3Z>%+,$W.LRB?]$]=Y&6;;Z806DI,=-7J/HX$
MJNWO%M@,ZSR?\I(XWT?L*@;&3(CD[&L2J!,E67^7^@I6ME/MHO%%9REZ+OU3
MPD<*57C.2B/=/N^"]`9[4`DEVS4$Q@Z-ZS[T=RC.>R$=!,607C:5-*H,$+V^
M'_IP%-"TDPIZV+W4DK`SA9.`UR%&X;1GGKOD($H!/7I$#J+M6I!E[>*>%.ZB
MMX\2H#E:Y$[*@G%BR6FX!Q,ATFV+M`7F-BP<)7+^K'?1ST>@)]YRK5V*5J;,
M-*FH[E/+8VE_+8&B[WWH'$E;=27MWQ:KB\XW6F\^+"X>KE<Y_Y^;VSQ4ARCZ
M<?'[SKX%!JL$J;#7-H(KF!RYMB%KYT6;Z%1&C1S"`4A_.7E,%GDT>3'**R>1
MI"+18JZ=OKI@6S?R($,\\AB]'7G,.$MT-SUB5%:@LB0*;K$?DZ$GL&W/X"#>
MN#@FU8/),D-.KKCC(3D?[[M5R&UH&Q_+*-NIBF.?Y\(YK<!;)`\_THOA<ZF'
MUB7B`"--'GS$KNQ#ZA$9GARH8=8KS)&!<_0N0.Y;.*U/R)M@`1D<XL"/R/#,
MA8^H(&;`!.1H25<6;_5F64)JO)O26G_J_$Y.K(2@.N2BP%4TP8=@Z[(63]YH
MBU\WF`,\/K]^^7F]60X+7U<[F;A'T8XG!@%*?U:!A"97-E8T:"P>]TBI<,S?
MWH_:8W.]?X4OEGU(RW._O*3_N"Z+`A\\NW/EXN)D*Y6U#SRA)[L@ZCX4[@,V
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MP,PI9I)E@YY1-OA<UR]IX4>2CT.LE)]2I/O8$\<UA=HI<YF`!P_<JGY,UKFV
M['>&>CA\]A*R?`!5='\-W=7M!=P[+QEB(G95U.22)):]8^E^PZ#6;3&1W2ZM
MV8[WK6A^`0E,#D9EGKW*$9@-P=N<;:WK..1*M0WR2LKM0].3D,!,*D)Z\JBD
M%UA\?7*HF*[CB_1<F]0DV\ZL`KE]NNE41#!94\_9I&Q3XJY`-"2M1%WTFWQN
MAZK.C`4\10GL]0;0V1NEF-31,JL9N4-]Y45SWNXP.]0+<'2N)Q-2G'.GRE6W
M#AQ`8@JKUN-(0+9]^NT5>9ZYZ>3?YE)A8P:-)==!.13W2<<6Q$S([8L,K\OU
MU$E3?,T#*)MD`90#!*S]E%8%:`-&,5)$/C;3`US"SH\AVHL?<SGNU>QM\F,H
MR76>I#<%P$S)W+?4:NY5XXV?&2;TUA+9GY'7DM64ZKB8//D%DCRD($6T4;`Z
M4)"];2<;2QW#;N\=O#%AS;PNGK'(>`*&$(+.I5NC7PAK4KN\5B'#[5_5MR>K
M242%&$)@T@<9$O,6R=6LRPS1\M2\Q"7H@)%NA]<3UM[O3TD"\.BE(6=31*FR
MC14N*1@[4OH7R+=_D0_+Q]01:L?HI((+(+EW99"[+J<R00C9J#LPI5Z/C=?)
ML'G+F03-<G;EM%G0O"8I4,EVX^$N!9L3$M$14F;(I8PL6UE:0L!CK(B:F@N7
MFX"D:_)]HZ)[1A+,1R?19&[H.97<J`*+5:LJ.6"+@]B,T[T1,>V3V,HI<P5@
MN$H,<TH"8NV\MR9ABVNV6Z'D@-*9"UN@@!88#=R"C$:2+Q\JBI9`/0+0QH39
MWF4]+".372YTBX,"18&7E2Z""[8"1:'@L1G0.Q,@\149>1VC@=P)09YWTME8
MH\A@\!JE*O"AR6SO5)8Y(1D=WFH8KKT660DG8A1:=&G<NTQ.06<926.]6=$]
MPVI$6U`28\8<;6)9&99D1<_5HL4UA3>J8'L9#0;<Z)B-L>#)J4`C^LMG4RN;
M':LA.TOG??E!%[9TGWJ_OKK>+*]7MVMBQI^7O2.3K"1&)I&\=^-]*ONX;+^(
M*Z1V_%!OS_@S^'@U64UVZ)('4<#.R]ICY7FY035I[!BTF(=G2FP?_;PY8<TX
M,-J7F96H(2E.3ICT('S-C"",1/O<[%!C>HO2FAYP9%K3FRNR$9$\/DE>?77W
M$&5S#<E+8MN7HPXJK>=N<S56!8R1:V&C=E88T7>%R6!&!IX-6,21I/PVLW#/
MW>OJI2%MM:;`*VKPV4#L<9*)B;92:H`S.W(R.Q*[[^03D9B8TR'K@#+9H`3K
MJQU:M=Y0:6,<SI\^2<K>%$])&"+S@H$6&#C/3#B;^FW49'V;J)\NA\:1AV)+
MBLOOR+U\'EQ;Y%"FW2B2Z6;+++WS?0>!M>WV2B7X6.ETC)9]*9Z+PB@:S@P3
MB=C(Y(3EO`=O(?*;<)+4?B3SNC7!SP!9?-2L%BQYZT9PQE.T(:!S=22D!,:M
MP6WP,J8)>B[M4[V+:)Q@BJ1N<[*.8KMB#:O]B^U^F#M<II>A?0:&5"N=Z48*
M+C%S1\YA,=AWY3(+(S&[&4TQ'8WV*;ES)'N1+:>7C=.]S)XTO.)I<#$"^BM'
M(YT=:"_C%U=_+U@7-TLRF[M#B5I6!D/*)@+OG;0\25-!`Z*7+?0)&#5B#@=D
M[$WG?>SUZ>OR_.9B^>[S;?#UU^7UU_6#R+/]Z7+YM\4=J-HM,,CBV]7-Y1>_
M6E^MOJTN%AOW9;-<;A&122T%HW.,90T/Q61,U^=*8P$L&,%1&#O$@XADLE8J
M@^.>C``8J7V./F*NODRRL9W9DV#'9EP/1>@IG)T'F;S1@4-"X;P,P"MH@$'7
MSO'A^"C%\T4RAW\>A3>1PED=@,)?!!%Z!'M.3W1C$J4<*V8=BLY3.+J,@=Y]
M%T*9X?(B0L@5$AYR;G<X@AY]]P\BDLEK9X%Q0Y8U".4$HHW]CI!D8FPK1:QT
M8Q^/T%,X.U).LG>,BZ"U2*@\,5TA7<K.R_;:C=J]*9&\7_SH4(CR>O-^L_ZT
M7)YW2=SNSQUB;QG90%-0$&RR9/I4R"S5!H$HXT@NBNG!A.B.%!Z6NSFE-8I1
M2*,<4/`;8D99'4*7?&KWEP&#P9JO`W'W]^7WF\VGKXLK4M.P_O9M??GA>OWI
M?W>/@B"C-Z9LXF1T[0HD9NXC-]YB]B$JRYX\KR>H>C83<SLBDM.Q3%)R3"!$
MV254$R_!,-?BN/,RS7$`'CZNW2=Z#3;+IR=Y=SX1$5F,C$GI'?E,I=X)?5R:
MZ<T<V;JFU6![V0[T'8ZON>B5K@=2V&2]*<!#+-ZON`B@V^H89_0NB"/Q57<,
M+*_^LAEB;Q$O3/TJ'IJ$^O'N3U^MNL)$_]KGFV^+[U\7FV]N;NE[*LBK*2MD
MA@(RFR#6B0U'5INU4$RWEGE2`@-.GL5V6=:['<]A34_5IJS77KXOK"\^+6^N
MRY;OV4H?N,AS0O)/HF-E$V2(50L0L14!:S!"CR>"A][`+9NW%:G5;\O.I/XG
MF=2+!P=//__GZN*")#.`CSZ0OG"NHQ(IBZX'@K&L6;^.NRR6;,$E7E!?=A76
M^F9S7&$Q*<B'Y`)(OWSD-F#U>U5!X&TT2QY-6%W>O13`[WYSOKL7E32G^-DD
MYH%,&!EIZ'OT2"6:QW([)AJZ#LC0'(R&#<+$[+-6EAC37M19#2.M3>T"!FOT
M8!?7X1@;]^OG-]&]<&1@'JT*9(AEUY<I6W.Y-ZDN%S&2VT>+YO[C[__=]2C/
MJ_<3<O@IA/?H::"0,@&"#<F1"U+6^/00@D;'-G$^1'H_C.1NZW:;]?E-<>^7
MMX!ONQ>P2W.#,U`RC"RBP&!J6DU*BKR>>N<FN!DE[""\S$VX2*\B^4*>O/>H
M-,4@D5=?EZF\UYN]!S/TZ>_+S?6/4CZ]=I?GY72_?VNJ8-LL'$Q<BRAS(JMM
MA8LR]2M9RZA^<S@`!MG,,_<D=0=C:NZ4K)?H<M`L))LB65?=^VPQJ!9HML1?
MAV%JL_R\W-![WH5@[Q>;=YNNF>B\@X!^O]Q\(-=@?I7%+W_+#]F![)37Q%4P
M(OJD`]1M\?2_0Y3R^B5D8_^-?-$'+&U%VT'8&91>'[.3R/%))FNID%L@SE1E
MQ\D,PT5!QV.G^]QNA6ZK,E-6@Y.!J*=8J,?K<0*SGUHC-_+=N],V5=(66CO@
M/F)`<EN$I&"\HE5[)]I8;3?:OB]6YW>UJ-K0,?*$WM*(]R;TYI]7R_^[*<;R
M-_K'QQ_?'R^_&?Q^X&>7C[_[[#:;Q>67Y6/P=_>7CV$NK4SV)AB%A@-+CKP/
M*\O^D(R13L[XIBE!FB$0T!3;8_+YN/A]F&:8PSKV61IRCA1/WGB3DV/1>(T8
MDT<AVN8NJ8>UYH??O0-14P#&R1`%FON2E)=2<./)JZ<?F4R&PK?HT=RP83%E
M@JK[%.(O5U<W"PK(WWWNKNK5/R[/2TJQ@/87.WAYWOW8+ZZ6YZ7%B`ZAZ[#L
M>H;H8Q<WYZO++YW*OOO>03WL#DF0%$C,QDHE54S%1^V'/R#D-EY%NF4#1H_(
MSVM*;L[$*A<H,G*9%21F'F6H>>5N8+,IUF-)<IZ`Y![D3;O;G%>7],7/JR"@
M`>^*`X$"4#)C2N7C5HN\5ZQ%F.2,X9.RV(+"PW(WZTQ%S307F6PU/4MD2>IP
MBXZ)S&"+IV8'J-:'XJYD:4@7_KJX+BG3'V0:=DMB3S6?9)8+X#RJ5%:,6TQ.
MUZT?DASBIK@G59OFVX_4H[$[=:@^92"_RUI>BN-D?[SN!WT@CK1#(E"P\_2Q
MOCJ_,[U%P6;%LQ-!6A6Y*WL$*@HV,CX"BLI@.+!Q:NQ.3LR"X3X9"V3?<E;`
MN*K)%R8#;]@MD3@\_3P_@]W/J^N]5L2XD!@K&LIYY!XCE[I6'G34+5:4Y@5M
M8LC!W;?O0M2D6(6ET,5I\A0ECP5I356@6?"V)8H>>FY4HT:[4C734@*"XBB?
MC28_+#/N4+L^Z:[)1C>'S85IK_(>1$VF3S5+`92@>(0)J4NMI)\]I]A\I"@H
M"A+JEE2-1^)-K\1<.,<"!R3WSTN0/*<<6!_.@15C8RCD)IK&=#])S3/(GHKT
M8K0Y9FVX(K6+4/I,:J^3Q0!M3=^@5KI1P^W('N*IE?=@B_6D=^WF%(:OUN=[
M(SL33]HS5()1\"&ZX6-;IXZ=3DU,V^Q^/"3U+RZ6UQD*S>3!`F94Z"C6P5+#
MKS&1D*;M&/E3VH<?+X5N,R/R8(DZ%>E:^WXK`T5>(V"!0V?TCWL4SQA7-3J#
M8U9H3Q&,S4SWFYOHK0W8@M,U6!!_4+'O,_^:)&2RO11>203R6LB&U:RV9#HV
M'L+;E_+,#$%(FI4(U#CRX[PAW\WWVE?V&#3:I\5P(/A-"^:5S)W"6)KN4A`^
M2^N$C342CHF"IY]5#4_)W'D3D@60)&\D/UP7)(Z:C>`NME.[NBD1_W'/XAGV
M#LMV2,8Y>122V\PU5)04JZ082?3_*?2]K9W3F:(VE4/@UD6*TG15\:"":UR+
MEY'RU7*Q^?25PK]8>M_670!X5^Y*O]^EU6N'TB^774KHZBJLKQX'K/&$JGXH
MA!6>,^4H5D]<I`A9"RNU<:3=HNUGX*)]2O86RU'$V^DL_BI.9%S'1NYS$EEJ
M:T&`-IGW#?B6\R8)=K<Q_=0%/(=88@`LVC+@PB/R9).IT-W)^[::W#7UXUMA
MN]>K_UIL5B6O^PM];$-:DRZON[2N_Q$>O4&D=^4W/QZLH5_>;%;?OMU<+N=>
MP@P"=7(2F-`R.K+W=9>K!&A[A(&U0=9I"G)R#D?XD(-(G-X@WJVOK5O9#'<^
M-^^2U0JD?BMLOZ3^\$C2$TX*RRS=2*.#J4GX)(QH''8.P^;(DQ3D3)(_$Y\Q
MF4PA7R;[YI"+NMDEJ:S:B2'+2CW@C;#]DOIC7?",&^^==\8)YTS==NT05&@G
MA4=BC=,4Y"34CPV@F)$V9?/_[%WK<]M(CO]\5W7_`RMSLY>MLAWVF^WL;%7S
ME?55)IGS>&=G[LL5+=$V*Q3I):DDWK_^T)0H6:(L63;ULCL?'#U("HT&?D"C
MT0`,7Q?]F^S'A*[;6F))AK`X`/QA6\<?D!V&[=`//(_H9NF>CR;UN'1YGI8F
MMLJV=<?(*M)QCR`J,KBAG(N(])(UM\.$)PB#E6!`/=L+.:9A.,EN=!%MY?1(
M[!`Y=UIT-4W/'L+2NCZNDMP3*`22/3=`MO(F0X#):0?.D4V((/QY8ZC/+:^_
MQRUEB'PE6>@S3!VD=[91LYW,I&AY0IAB1!F>HW7TXX^G:!E*.(&#.(`$"L.P
M+MX4RB8$&8!D+&A;`3!AS[NY:U&TRNYY$L$RSO<<!V$O]!$-&V\Q4!2WCN%@
M()[39_%H!9+ZDL'"1U#J**XP^*_,;HZ%N@Z7[;Q21'7+E]44W3\$_R'/^^53
MRKH05U+IND2$B`4$V]1ICBN"0*&PM:6-;<:QG.77(D*>3.D$FN?#&)^'%2SS
M5\<Q9D('3WW(7(QA#V*>@@K`SS!0K@,+(,`K12;-T$+!VEUQYFO-;&:6)ISY
M$.?7171[H\_(UESIY<.L*N[^[^QB2>4L15SA,A8PW3;8DYXS*6XBB&H)'VOM
MUW<WJ&4J[#F,$,5M[A'B.VZ(G,DI'B+\!3W0A93VW&JL4TJ-DCR4ML<D@"K@
MENYL(G1%LTD9[R!H=S5`K=-6'4W3JK*C`6?,#XGO2<+!='JR*4KA(@E&LKTF
ME<Y\79].*34"]<`.?P"Z'@AP95SN,Q(@,@GC^<IGK51M:L\?"NENFI:FE(/3
M@+F+&`$!<GR'TZ#9'`_!YVH[8D3HO//-46H$ZH$"2"'Q?%<$X/D)(FU"F=V<
MU%4.;M>,$VQ]@8K3%,CZ$&=Q`;8XZZO^(,F2LBKJV@7KE+F<B0CHRNR^IUPI
MI(-@J83#)J(D=#VY!4>/^%Q[H,=1UM5@EH8W7*1\1W*AZQNY*+#Q)&D-V])I
MY<`BT!8\5YQKBZ-9U8:#$XHXE\1SA*]+7X:DR58/%3@B[6`?<N;.7&QW,,O/
M6+F$.!["CJ-<;;1]AS4K$EC*M:L5V@QC]ORI67AB:'U7,5!(ZIH6@8<EA=5E
MB">=RSG"+<%RB#-/^T)"GD3KJISK&G%@!<]T9X&0A"B<5#+SE-/B-/@J<R&^
M)]-Z;[O6O9M>,C[MH[Y%17^$T6<93-JP/@)4@_S%392-SVQ]@$=4Y5DVVK%>
MZ2KK-)_9+4T-W+_&597&^M3P55X,])FRT8FR-HS;]V-ZG+*0^T0QL+*NH,AN
M2K&`"58SB1!E_3B=5&T_@G7=\^50)N/GJ/@25_69O+\#[U9,@/3"D+L2(8HD
MPK"(#)MJ(=)UP8->,`%XWAB9"9B9@(MD$/^F-_[[Y_"W2'K5^'SW(Z8C4,)V
MA;1M?3P"VP''83")<<\V*V^F@\XU3333,9F.R8?K@9+$H:]+_0;<54PQ%Z"Z
M:96-=6[X@DE@KQJ3V`8-A!=(["-&"<(8B5#7S&X4`GMXH8%`S$Q&9P;"YXQR
M'BKDAK8,;/`<F^+P@L*:WEXT`4*:"=B0@="30,.`RL`G5')&&)W60D9T$381
M8?2A6P.A@XW$0;J&?QB"S^]1,;72U%LT"<X^J(26,5WQ(>[[PP*6=:-K1B,.
M!K=I?A?'HZ(^X[JV=4;_8Y9NLX6&7"P=P&SN45V3`%%!T*3U,Q(J6`C:<T[E
MTVC=S'C;R[^Y\:+0U\W4/.H(09ANK];4\I+2(V3!>.<J%G8VW&E-XE\*O8\T
M4,/J)B]TEKH:Z(TDM'I?WYGQA6SB2@`7%7);E^L&LSL>&B-!>V.Z*;O6&MQJ
MPAXQF/-X$"4Z->#34.MG4[5D^JB+W(VG=_57CW4F08F[..#<X;Z'E!LJ)7&3
M%N`[=*:5P41L6YN#G=#=9L5-GO;CHARI_YK9)=15`6*.K6P;NQB6VTT&I**Z
M<NB"$)TM1^<:Y\8U0\3:-"Y+'Y%N@,&Y=H@,&+R4[K0[0P!_V^DCF.FRI^)Y
M-$XJV/R2%S7^5F"-+X>53F2ZR'7[(QA#D=<AL":Q:<V#[@2%C.DR?]RETG6P
MZT]:+`2"+(C!@1$?;7TL&]=3"-\*+Y;-,6->J`L3\%"Z`A.B;.1."CJC=NNO
M>H[E(J#<-"]&X`L/+F+01C\>_;]^;Z+0]@,5A+!RP0+6+LQ%36R<Z-S1=I4#
M)A=BYR.(FQE17?T+O`;-@B<U[0L4%Q[C`0'OQD?4)VI2ZY]ZCM<NK,0=F\U.
MU`(:UJ=QJ3B%F.M,(%MG!`4ZY\9M:$3*\ULE"@#K!)?KT:A9.RSNZDD80_8Z
M=9IG3I8KSQ9!0`-""7CN^MSCI+*L+Q!:9%SFCWTMH>?I=*\Z',OT@=@`P_I/
MH("X"O%)S8O0)W(1W5V0_80BD4HXW$4!N."(8=V@0C9IE%(I3-LI6!PA,=</
MH4W#VB0N$UHO!#.`;/`*8>W@8.0A>Y)7@>"##DC4QQ)[^756NQ71]_'9W#4K
M$1+=(-DCBF%)!=)!XJ#IVDE"ZK4R4MN'N1X@8X943?QHX9.F^3>]^BI5IA?%
M<?$U+MTHU1^M5]>1N0Q[NG@1&%Y%N.X;V,2S.<%VR\A0A\QG"3^*JH[&,2UM
M/[KHUYLXKC[FH\WY^<UT[267YW$O3KYJQ%JQ0<ZQL"D+O"!4,K050A1/#CX&
M)&A-(<)T_KS/?G)BE*,P@NM[;4!7G4\,A.+,EI11!V$D`K<Q%PX7REM0T4;.
MP^].V+'\$9,CGDVOC:J`P0ZC='H^=F7)$]^GRN&4$<_!OL/#<%*A31+9WF@%
M:)@'^'UFS#3SI?XBS`L=C/:3LE:G5;QQ0@1ND*Z][>EF!#YS)ITBF(M;%H6V
MJL0>`FO&B3#5L,CT==.;5B4)8D_84G#E$@+ZA!WP=QO)<5G8QEJY,\%99NM\
MF-T`>[#H]&&9[P(NN,T)'=]3[>)RX*3/IQ)M<QP;-!F!`*\?YM+AX,Q+\%4]
MT;0-)KY#VB:#DOEBC?O)B:>9#(6(PX$/S%.4@R\DA)BT5G%PVPFBM-7;<B?L
MV+C)<(,@]+DCE:=TO3+'I[0Q&<)VVRMY<+)VJ?E;-1F>;8,8>*'R=>Q'J=!I
M\I:48XOV>5'&]D*%MF0R8"GIZ;/#KNTS;KM*L:")17*'T5:"'4//A]I_Q,GU
M317WU=>XB*[C40C63]*AWG:K5Z.?AU5915E]^&^B!&M7,I;*YCX3@02#XE'N
MV+[=M"]7`9_)2&U6RO,'I)](ZL:&NS2Z)<$!(@[82REUS7HN)RLM:7ONHFCY
MO*3OU7!7%#)&+@+_+_1=<!9@K<YP2)O9E0K-G..=9.;L^7"7S:[OA12Q0`"&
M:6D..0^:X;H*V8NVM.9=WXT-]_/50T]9.Q>;BA"Y(B#(DSB`%:+C2=3D'Q*?
M+-)93`2M=T=6C/1A*CL?X=(\6IM2!]P7[F*=8\FDY$W^!@Y(L"A^!R/DA.[/
M"%<D;7.]BZ5\%Y;QBNA&D6Y3L=I%OB,6IC`2)N;2YG8]PJ6G@QD7NG*ZPQ0#
M0Q)*G1/5[)SP$"\>(1<;E]+636Y4)KVUM=`A7&*&_(#YMCYF3)"8%-+FMEH$
M-IAPSA\UOL4T=CRZI7GX*F2<$-V_'%$ED8>:,N&.BV`V%X].8+D?HUMY3EPA
MC^O%HD3(=8(0U&_23--V%B7H@6R.JK/OQ^B6-[TF$F/A<J0P!33Q=16J<6Q`
M>L$#HT-S&=+KCTZOS4Y5%J5W95)^OAIE2,#_6=^[T2E"=6T*W;=N?'YIXJC7
MNYXP0C==VAY[.D`A[)#:#NB=&RK!'!DTNVA@#3E[\]<_I=7[?O+5*JN[-/[I
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MNT=B,7FEMS(U8=E/;Q!_8Q7`Z]&;R<7OJO[T9;'P$35I/[VA[,>9)]Q[]**G
M36]$3[WOR3<>RGT'0Z@9X$X'^)!FCF$&+&;=+7Z,!I=Y5>6#!CA&[T[1[7>K
MS-.D;_TPVH5^/X.+VHC<![W[[\=/N/]148.E_F3E,.XA\3QB32'0Z=9HZ<?5
M[[Z-4/TR3_NCY[\]RZS!J&]Z^>>E5F=VVB8#(V_VCNO+.:W;U,7%+GC=!(/+
M-?B\E+?;E]@<"+D"#^7T)NF#O["VGY5D-\"N:O%]T>#V_0^(V^^-'&Y4#N]M
MWSS6S]P+NN_M-1D-,AJT0TD<;V(9*312N$,IO,BK%0C^7)=YGUSBS05RQON_
M1SH`DU]9?MRK]Z,M@HXL':G=I9I?1KTOUP5XC7T=\<B+TQ_Z];]&#^J`3$L)
M]ICCXU%@)J+>Y>CI_]D5@Q]DUF,8O0%^UBJP`X92<<(WSM.]$<"EM@CNNRRL
M7AI'Q4]OLCR+W[R;,&$;$O>*3?KVL-#`W=IP=V"(1AQQ@C;.-X-:!K4,:AG4
MZLP/DP:T#&@9T#*@=4B@Y9`3QZ#61L)J("6SZHA>;%"M*<]P6^1?DU)O+UM%
MK-NP9M=6E5NE/@NB$Z5ZX^ON8`*>$B_&J^+%79J--<+"NU)?;,L3;-37.!W;
MV[(Q*CBK@@ZC)YUM&A@5-"IH5'!=%41FY6TTT&C@+C7PR';PB3!*:!:2SSQF
M,\WZFUE!WA9)7M3+QG7RL(R^/J"OMG%9C<$T!G-W"O@6?-;-QUW;TK2Y"/:.
M@O[K'&,Q:FS4N&,U=K:P\C1:;+38:/$FM1B+$V;4>(MJ;-:_#ZQ_QXU\RG>]
M(NXGE=E&W9(WSIP3VR"`,>3&D!^T'NMT)FGTV.BQT>.#UF/;:+'18J/%!Z[%
MG&(3Y#;KZL-95V]ZEWE%-8M7!Q"4G)#.\.&YS#7X8?R`[?@!!@;FPN^,=I@[
M9G#`X(#!@4/$`='A:L&@@$$!@P*'B`+$9@8']@H'GAE5>+%!A;E2@O\]S&*+
MV'49P>[2268$F(``]_.A;L+PG!*8>Y&SO4\%'U8Q^155A&"LP[V7)_/5'!XP
M+I3!18.+^X.+.K6DNUQO`XP&&`TP&F!\`<#(4(>'20TN&EPTN&AP\27@HNSR
ME/VK!\9[0<AW=1O2A=<O>/V7=]VTRIUVW76'99+%9?D9YNIK$G_[)4^3WMTZ
M/74#&=B,N;;K<C]$/D44-4V#F2ODCGKJWIOYG?38=9/\.LYTG]S(ND[SRRBU
M+I/\]B8J!E$O'M9J`<P=@`#?65=Y;UC&?2O/1AUW82Y@0$=6'^8PS6_KU\"=
MX97N?::_JMOQ]N,T&5VI6_@6T6TR[MJ;Q<,"].9:_\:1%0VK/!D,=$!7WW43
M#Z)J]*W^L5H7RQ/K\[#0*6-9+[D%P@91\26N@*+;D3#IC+)>.NS'EOKM\Z?@
M]R/KEX_!A_,S_X\CZR+PPC,_.%?P\H]?E7M^=E3_4*A^_N6/<U53-!BF57(+
M*EZ"SA2Y;CS\]N=?_WQDJ8^_G'_^>/9[?160!AQ*TB2RW/H1P<?/WH6Z".:_
M52?6/V`T:9EK$$@C0)2HBJUO275C?8@SW=>H=W-DG66]$Z#%^G8#%]T=Y]\R
M&-%@U")GW/?X/._!WP\`-K='FOWZLS'7=8Y=307,TB`N>@F(U+^B*H&KX.;S
MLXN__ZX^U93IFZHBCNI:+_I+0(3CO^7]ZR])]E^EE=X-;F]`NH^LWDV19\#W
MT2>]NTJ_CH=?X@$,2O]4KB=2ZUP_J>K*H_K#NM6VGHFK9-R(.<W+<CS7']3_
M_O$;L/X;".9-+6ZWNG`I#'0A9<LH.%D.7[,0M`(WI@!SEE6`2PF@CP*BJS+X
MK@4)A/9#GO>_)6FZ=A-OV\,\<"6A@1L(0>$-XB/`D4H%A+R.)MY3OEI1S=@C
MT/MZCJ->;P@*%VG]C08YF."1V!Y9"<!-4M2RT`.ANH['?;VGA8I`74#63&OO
M9:V]D6UWU\P;/[>9-WYRXV)Q(*V9#X7.I][G'`B=9OY>Y_B,?.ZL\_L^Y9YL
MH#OHAL)CAFN'P;6]"[I.R44'FNFXC9Z^L_'!^KMVQ_/-99$9.>U03E^`."X3
MP"=W1'Z2M=Y!A^]]LDN+)^+M66;!PU(=SNHN6W^?.;T[H0_**AGHN,]C0S5[
M0?7'Y"HVQJ%[XT!V8!M6\')?1=#+R\J(H!'!73HLTZC]0:&WNK?#8%3(J-`.
M1?%3;$#<2*#Q(XP(OF(1-'Z$42&C0MOR(\QQ\L7929^'U7&:P!3JM,9;`*.L
M6J<,W9YI];8SL.OG(7*,R=H%_/:,<WN'AYWSY\&=OC&@UMEI+33=8_W=Z)F*
M9QR9V`0_=W:>HM-JD7LO@>:0V6L'0X-W+_V(V%LJ3;\*4]/.0)^!OM<&?52:
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MM]^M?C[48MHT"7X*`_>_'?$^=4E<-0.F8_;X7/\1YZC#,O!/YOO>2+'9UC"(
M:Q#7(.[F=J&.".<=[D,]F_%K!2)>D.R;72P#VP<JN@:VM\UQ>H0E[:[@MG&4
M303BX(!U7R1OIXU&'\W:EPB,XY@!MD6'3:M60N&^R)U!/(-X!O%>(>+!FAT)
MI[OFS(_FZ*M8FIL$`@.4!BA?!%#2(QMWV#;'N(:CE\7T903#7WC]@M=_>7>9
M))>G9Y,\"56G203?>^E0R]V'/.]_2]+T0C_T`CC@IGGORU__X]__[2_UC>=Q
M+\]Z29K4+5<^7P7_'";5G:JJ(KD<UI1<Y)_@"AA"D:<@*M?P4W$1EU4Y^TA+
M7P)OSN.KG]Z$/K81^Q_\QX7_QDKZ\$'4JXYM1!D)/$%$P)&-?=OCOD\#3TGA
M*T[_G[UK[6T<1[:?=X']#T2`QDT#CD>2W[TS`S@/-[)WNF<VR>S%?&1D.M&T
M+'GT2#K[ZV^1LA,[L1/'IB1:/E^Z;4<OENJ<JB*+52<'/S][8_/2O_+&(F9?
MQ3V[",=\-0//G4Y/*XYNA2)\V[$^+&"S34!4&N$%1.C)IX9$9A'XN;H5;$2B
M#._I49@2,8NF;X%&*-0+8'SN#;`D9,'".Y!Y,=E+8(=?3\X_?GI5SUX3R1IB
M7#`6UC.QR>_S%PW":,S]!4G;\IC'"V<C<H7O3X_YZ<`Z4-\)NN[L^_L5X-X;
M)K?TD<8T90QB`Y]/8O%I]N&?SQG@Z:'F4Z^>6*2]-)-NC>PM]3`_'31;']XD
MJ$6JG)YH;WK>QB?NRGD[\Z`88*D#?%]>I0G[XI_Y)%V]]J>[5;3Q.(C.6_O4
M%KRYE_Y:SNG,KI!V,5\IJF_WF;6[#OUA=OU!&+&$+/O5;20$^T+'W,9LE5=X
M1K9SR/Z5!H(UK!JB8FU1,?1T73V]]+[GHZ4;$6\>KV.'B'GYJSH\#QA=S*>X
M+'[/U-GCP!I;@B#GG)?U`_ORP;28+;#\?<F0%URNG\NW5>,<9%F^0JY406W;
M?:&"8%(P*=083%J%@HME++I]/3FOL6MQXP6!G+,.1VQ"QX;#,J%M?LZE29G#
M2`S.R*"`LG[&Z!\RX,Q-[$#>QK:2JR)C96D9^@H]&:,QH***49'QQ@_.EW'.
M5ZN`YDO&Z!\8KV*,9XIBP?G*4U*6]GT#Y6L,JIZ5,64F$N8%;C@6[-`/X_CC
MBT10-:D6T&'AB"7\^R;3P"@V_:Q<AX.2\485VX`GLH<%0C7NO:N*F01.8-0V
M-FHZ*YG`J`&L,&H;&36T7T#LMYZN#+@7L3ONIT+&=C+$RTI>J_Z5OL>O/=]+
M/$'?YQM;TC'TE/0EBPUA.K>G_!R:,*,!$:S?_EF_'(`$O``OL$^P3\`;[).&
MG"EMJ055P0FBLQ6Z<NK%V4*<%P:(M6#+8,M@RPR!53;?WT/[2E2?-`U>,&<P
M9\`;S!G,66GF#!'=JD*<=$[LJ[JGC`__3.-D+.CJ<E&-+B*B7.QAD84B3`/V
M$GMIU1UM=G)3T<*.PHX:5A]NIY?HWI(=\`:\P2["+@*GU<-I%>`(NUCJ$F)E
MXTVU<T_(Z%)W(2STV"V]6`-Z[*[KV.@N4[.!S(W18+@]YI9[0!.UW.I!H(E:
MH]XKC@9-T3FPW;ZQG?$&&"ZDX6P)%Q*D"E*%"PD7$BZDX3UXM;72?>K.>^G>
MBF'JBU]'%T)N/W`3,;Q,Z)#?`R_Y3$JS41=>Q[&<P>"T9?=.VLV^9?6;61?>
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M(=S+N:W`%2R^Y9$PTY2:#-!EUM)N%6(MJP)5&,3BY6,RI#(0=2V=(*H*5F#6
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M9>E+@^R6E@:YZ7F%IT%6<X`;Y:Z5D,]B4FZ;^O8BL^7P/&!T,=\C6GM/Z>C'
M@360[Z8YWZT?R](IJQR:69KGR@.0+I=/NMRVBEY)?=Y$@T^%*\;7(F(-^U4M
M1L;=EN[MA9#AA*S[2V^#NRZ1;!*3J^L*[TZ%."6RA/FY9";MF<>6^&QQN:ES
M-ZCQ&HBYP6K-#1JC6*5N::\R9V4LY33K;6TL98K.8%FQA*3/<#PA8=(%,P<N
M2L60B>\3.1,9HX-#D:Y'L]FN:PNK4:L:WD=A2*T"(+/E_U:ON'+Q54':MJ:U
M6U7;>K6P[I>/6N5=7]!@&>]L"4&3PXLE0FWUC*@36!6ZA&-B(/\93',%$]N.
M\U<6274;]6YA$JL*,6V=GZ8YR4REKZ7QT0WGDT]]TD*YSL3]@1?0&1[WSP.U
MKT?^>NK%KA_&:?2N%+7.H-5Q.KW!F=UP6O3?H-,^RU+4CNU&[[11;(I:=S$C
MS=$,#N?)N+<Z7;O77K&P^JN<[F'SKX@]2IQ=)O2#ZNUY*A+N^:^JUL;)>78[
M_^2\)S^G<<VG?Y07_>21S^ZYKPJ'-#D<"W9XEDV3?:R1&B1:1%%:$<?':4"U
MK*ZF_&2"HAJF>!QF(!(D(!:<@&AO6XBQV:IF@E[E,Q`QP%T?X([4/S0N_GM\
MW([9$]/EE^Z\NHV$R*=X)_04>EK1$K-(TT>:?MEX05G:\N@:>?:YE*6%"E:&
M+-?/"2Q?<<&DNZO&8%)DJ[YCFGK6YFDZ-UTFHHW(4S`I8V9_$F*:]4;N4JO*
MHC*,:?'R,9B!]'+.CE-+YA;HRZT#9X`SX,[`G7FGS#H:MQ*:H$6@IFI1D\$,
M!'?F^?5:=1ON#"9SWC69,TTPW&3^\<V=BWNVA_BPI3'Q_2W9/:G:;K/X$CF^
M9P$<#H$FL%8!DQD*._JL8-7`!GB5MHM_WVRA[6BLIP%C"+3"&&YB#.UFO0-K
MJ,,:(I)<+L#/G(X_],,X_LC"@'F![),CMRG&:L\:C.GV-L#"FC<FB6$&MRC9
MV-"WS`*@`"C[;I`.;8U%B1#<`:RP:IM8M3:L&J*T]71E$$:";LC$=_>6!S>"
MW5#8%F=QFX@_(E339QDQ[0G+",M8\K2G/O^T:F`#O!`E%F4+FS"&,(8[BM8J
M@#*#(98`L028JP!59<[\0DBTJEDTJ]WBVF3`ZL+J%NLC[TNWFT-'>Q.Y-X56
M%;`"GJ;"<^]LL<8M5[#%L,4[!?8J8#I#<:-NP1;O0@1=\79UK_1^R$<_\^Y@
M9TQ[8Y.J6^39WFYG6VLO73^PZCUSI/XNQJZ0XL/WTN=[E4#-.ZJ(!7-NE:E5
M7:]9))6:HG/(G]\WMH,C"D=4OR/JM."(EJ_X<$1WFIIW5!'AB&J>;+7TI2.M
M+<V]H,R-IV)7=YPNS+&>DUJU^A6?I%$D>S;WXU@DL189E-:H.!N1.QT15R.2
ML]6RM7C,)I&8<$)*PK_3MT1.:-,3,SZ91.%W;\P3X3^P%P+0RM).UZJW9HW4
M<KT5X\$PY\&T.O5V06-1C:=SO8=L+?CDJ#2L&EO:%6BW7M&I<,7X6D1S`[/5
MP%YN/M%YVQJ+1#P1;N+=$:3J^\:K?=>-4C%DTP[PL7K/BIIVFUUGXQ+SX\I6
M!-TPB+TXZP\O.WIF3=_IB='V?=KVO=>K=ZV6U>XZ3IO&UVWI:P+?W;('?*=1
MS0;;Z"!N2-,UM+<MNV.C83WP%N?.5EC11Y]O6:PVZP2]\@#T=$1/Q\+T>1,-
MGOGF3+KDKV@QVD)NZ;;.)C@F(0D@#.0[(7<UH4'(7Y7G2AK+L[]=T[.ICZ_/
MA*#?$OHMY2.S9J]1P)YTY#CLC>76+A^#.4@OZ^PXN:CK.>V6/CJI"FO`4UJN
M+!?B3@2I.(J$SQ,Q9)&XIO_?XPFAU,PJL]YLPZS#K.<0D.]-F9A&JZ>OKD15
MD`)3MEQ9SL83/WP0@AYM+%>KLO!>+EA=BT",O#<R'6#5UK)JCMTLH,YV5;`*
MJP:K]M*J]1KZFG)6!2FP:BL"M/"!^XDW3;WP/9<LFTQA&PE$:3KLF=VV->ZC
M@#V#/=L[>V9W''TN8560`GNV*C]U)*)(S32JF4?8L.UM6+N(OK95`29,&$S8
M2Q/F:"SK4A6DP(2]LN4H%[N%2I:+*VB-AL8NLYL*MRIPAN$K#JE5`*2Z7LOJ
M:/0MWY!:59"&BI*O5I3D*S>5Y:-HJ..#.CYF4.JR^>=:UW;R*MC]'KD;H\7P
M@<Q-'D85'E3AR6\2AJBPEU?`MZ\E(5%2IY"2.K^$].17(AJS7SQ^[?F>7++7
M(HJ2*^OX<F")')C_-+!9\0>-M1_F,/1G&B?>Z&'E('>T'(1M62@`L0.%',P>
M(`I`H`#$3FZ81P&(78L$40"B8@4@2E/M4FI`A"CXL%,SQOM3\*%A.1K;)9N@
M1YBS-7?.%@4?UA#.CI++0>8P6/IZ15:%-9"\AEVR)>Z2=9I(R8:%1TKV=E9-
M6U..JB`%\7X)6=E[9KL:W9[&UN.P7;!=^V>[FCWLB,W!=E4\,3I<G7&AC8^1
M&5WV/#<RH]>3>,]N%=B5SWP=AA=C[AP[\J*1%YV;*-LMJ\@-(J9H';*B=S@K
M^K?(DPFS,AGFZH_+_O'%.:,[GM,I#^R(]<\'?2T2>4R.GM.SA61IJZ!DZ?-@
MF@B=1LDM^ROE$7GP<O2.9=LU=NR%-R(;O\?9Y<4O['`41F,1D3AF?QL*=^Z`
MCS5&UYK^$+`XO8Z]H<>CA]J3]8J$*[P[,61!2$BGNT?A6#W&[*RO:G6'(HLO
M8BC?AXA9G^[E/K!#^?]_Z5;30SD;"I\->#3F;LC"2+VBCW0Q3B+BOHCGWR0?
MR<&-O>'10%Q'--8'&J;58^*[*\20GH>S2'CCZS2*Q5@FX/C>V$N8B"74O/B6
MCIC0WU).?TI".EIJBV"G0D8]7I`M25T(HIY4?;RA%R*+DU\_J,>2FO28244W
M;M?9^<(O4N+W)`[/E\\2R':O0NX[O>%>$">/U^!#NID7)S(OZ$XNB-&[D[]?
MA&-1F^IJ+,0WJ<<THE2UCE42D3)>-D(O9FD@`GJUKI"L4F=7\O#I_>FO$Q%(
MW:V_[`&Z'1\8H/XJ.U/FKM4R`:L>NW=399B]RAH3HU'6)92P$M'?7@A"[SQ,
MKI=G8_KQEDFMK9&F)$FF(()-E#[+`3XGO_H3>J]N22&>1,.X'X=,2$4*5"G^
M54JF4#X'/+O!;D)Y9[K?/8^&==:/,Z&G?E*3=YY[-??RFFYX$]!(<F\6W"BJ
M\?$<-TW+BDG)9AT-B&#4*Z&SPV',KL6-%P127(LB5+B^%Y%\>>+."].8T#^<
M%BM3!/.KFX13?LD$2?H]"6.EX?+E^]E+HONIETH:SGU?/IJ$P__$Y!-P;SQ]
M+J4HX4MFI7%+$HT?NZHN50#2JZ<A9?KPDHR36XIF;V[9OWCP-$J%.5*UFYM(
MW)!XF)^.)V1<QDPVRGY0-Z$[G_U^D>L+:[0*:B,M"5C,OQU.`\\^W?.8_I"]
M,"G-_MU=Z/(DC3C[+`(1T:N1-M$/V67"$TX6DSSF*!`/LS]_5-+T9`?<"=F1
M,%!:,L-:JY9=]=E)S+TEE9$&6UF^C"/5D4\/69\2:#!<XC=D?<Q2(4\?>K&;
MQA+LI(>Q)[WX.3[)U$09':DG=?9_@MURJ98+W<_S?M>=@CA`TEJDG(]X>86)
MX;/*@[,N\7(C#MTF4/[6\NUN<P>0_(?RFD.552R#(\4RU]SG`7$^.3>R`?VC
M[$G(=+6<^F$7MA5P(&F#'F3J37K2PQEG;MH\G4GYS`&,A)9I\EN4IRQCC4TH
M:(JE"O,A^QH2.35KN5FHEW%,EK[ODA<8T`N\4*ZUB@QSU=JIU!9T:40.0.!Z
M)&ARF!,ES'BILN;K.^7=,IZ15HV9;1W][^OPF'W^\8<T/KKA?/*I_ZB*@YFH
MSI]4\I18T0_C-!)7A)5C/W2__?R/O__MQ\>S[[CGRS=+][\D;;P4;AHIG#\>
MKUB6OER(T4\'@U-)Y_]V_K@Z/6#>D'[@;G+4;G6;3L_J6V?'EC.P^OWC=O>T
M>7;2[W4:IV>GIP<_/X/VO+C>V"^Z;#9ENS"X***XFM\,S-3,2BS=BS&/Z$"E
MM/3QF\AVV@[%=:*H6?R5>HD,MF9O`CWDYWO(-]O=CL;F\79[R\W#S<+WUCJ[
ML@D8`\0`L?U[%[9_9SLU'_<42QO/2M\2OD<[90?<>SU=T[0'_@_WWU6N'@OJ
M`(UN'?P<A?':986,>.+?`XKG?3G;O%./_5DN%0'L`#O`7GVP_T)RUI=B"[0#
M[9O$(^.0)+1KT#D)XV1=Q<"6[+67(693U$>C,#J22R:O3XANBKYR"Y`91UO&
M"*NZ?`^-@\9!XZ!QT+C]T#CX?*NJ$T:3,)(9>&H1_&GE&QH)#C16<-`X:!PT
M;B<$9XRPH''[H'%;^GEV=1V]-(I$L/8<*2I-H]*TSEI>G9:^ON9&Z%&953!@
M-L%:8*W\9::SW(4)6@3.`F>!LZK-68=%D-9+_.4GR))T[SUI]R`^$!^(#R'F
M#KEKF"=;,4_V-0R.W'?/E:&(^PI4=AVT&$,05>AZ"2#X?!9#6PEX`!``!`#?
M'9+;!9A`A.1`,5"<JR?;0#NBHN++RH:7GR7@`U67#KFVQDPUPB!`XZ!QI@@.
M&@>-@\:9+SBL(6C+M474M2+JZM@6&IC#!F#B`UF0`"``N)<`1$H?U@^`XEU'
M,3S9`M</JAM;(C]-*RI[W5Z]"U3",,(PEA=?(FT;``0`$5\BO@2*@>(M/%GD
MIQ447U8VO/P21LD-OQ&J'2*=)B+&XU@D3&J$&")IK5"R,T98.VLEH''0.&B<
MR8(S1EC0N'W0."PL(&DM_QE-;'F'!<!<2&D`S*39=6PG?ST$$`%$`!%`!!`!
M1'.!")>TL+6!ZH:(>>>>O=&$=]\PZVC-3=M4N%5!-<QJ$685$,[-[`+``#``
M7'QN7*-T!"-W#BP`%BC9$]>7I+[OAGS;W+MN5>/KJS#A/AOSZ)M(^+6_34_F
M=VA@@S1P&*;R?C,5W`3&1JBM2:T7WA+R/O5FJ-G=KL8RU!N+MBH4"B\HKX2S
M0JEQ>C=YZDL_`+RIGS?S$'A9I&K7.^7+W!@-!MN";>&(PA%]8SK/SFM%;1.Y
M8CX/W`IN!;=6@UNS(%]?B:N]#_*Q1WG%'N6G"5+Q5^HE#W-3I#46;)2D9!"5
MSH542VYE\,O96:+-1>)ET7#;!`_7'!W&O`!\5_BN\%W?FDO55P%K[_U6T")H
M$;18!5K,8_L>Z!'T"'H$/5:`'ELFK,!7A1;G9CM_4)-[2X^?^SPW+GJ+XNA6
M*(ZS'>O#R@><.V>!#"Q2/B4<+R">R[[/7S0(HS'W%U38EL<\7CB;CG2%[T^/
M^>G`.E#?Z76XL^]+1'KEC47,OHI[=A&.^0N*O?>&R>VG7J_>M9KM;J?U8:8I
M]*)]/HG%I]F'?SY_N4_/-C]Y_*0@[:6)UVO,/ZMG^NF@:7]X4_<6$3`]<>/S
MG*)OB`%B@"8.\'TK0VON.S!I\:BKUX#+RZEO]QF=7X?^,+M^/V;AB)T*5XRO
M1<0:=HTYEMUDA^<!HYOX7AC$[\EE>!SPFT7YUGP;>C;.N&341%2&@`?<BUZ5
MGVD/_!_NIT*76X>033\B\JU6:80.?H["^/7=/J8]\>]!).@9_BN&._78G[D7
M:-M6!;`#[`"[N8_]"\E9WR9*H!W.[HMH8AS2\'<-%R=AO':J''(27TP,9U_E
M93YY"=W6G>K"'?=\.2MX-`JCHYC3G_.`5C&&TCCJ`35#?Z`_T!_HCYGR@?[`
MB7I_"Y(PFH013[8I?`/%`W&!N*`_T!\SY0/]@?Z4Y3A5MS+_^YNW:=<MTT6D
M+0-VQ_-8U?4:'4M?.;ZJ9*#".H$UP!JO"".'[4#@#G`'N&,/N.-08RN4E\"H
M@+9HJY@&J@'5[#75R."F#0<%4R<F-#7<FFU,056[YP!5L,7Y-1VJ#%(T>KK`
M"7!269P<VOJJQ2(D!+P`KV<.6T-?T[JJ&"*DWBU7EL\2L,%8!$B[VXT9J:K2
M,_0'^@/]@?Y`?\R1#^:.M:7=[5\8XK0U]LZN2A@"1@92D%X%O``OVZ44:>O:
M@/ECP`OP6G3<.E;=@B%"*(0T&HUR:G40#L'^P/ZLDT;3`$Z`$^#D[3!(VU9.
MA$&`%^"UZ+!U$0;I#H,J&P5]":/DAM\(QH,AH]-$Q'@<BX3)]DUBB-P:K&UC
M;=LT^4!_H#_0'^@/<FM,<J606X.=9I@B0PR/S!K@!7@!7H`7X,54O,`/0UQC
M2*),'HT5C<2<W>OJ2_]\2VI5026L%Y!6IG4#SH`SX*R`$JGK"@V)/H`GX`F'
MT]`PT.E6-0R\"A/NLS&/OHE$=@G>HN7=.Q2M08HV#%-Y/VWX-%"XVLHAKRV]
M7:Z7[-1LV\Z+VI;(K"K<!B\"U`1JRGGJH0-:`BV!ED!+)M'2H:-OR]7:`L-4
M#=@,;`8VRR7^<^I=.%K8!*=%G[X\36J)OU(O>9B;UJJQ8*/\!W`<.&ZK8OCZ
MBJ[L#;_!]0(M@9;R75/,:\4?M`1:`BV!EDS+1,+\%M@,;`8V*[2"$V*_;>:V
M?E!3.4N/7_+YQQ_2^.B&\\FG_AWW?'GJ((PNN2\N'R>!KFC@QW[H?OOY'W__
MVX^SXX]Y[,6_COJN&Z9!0DKV6^A[[D/V[^,I)--`"NY"C'XZ&)PZEMWZM_/'
MU>D!\X;T`W>3H^;QP!I8W6;GU#X]Z9^<##K=P6GS[*3?ZSJ]CMT^^/G9BY@7
MZI4W%C'[*N[913CFJ]EO[G121W%T*Q39VH[U80$T;4*(>M%>0&2:?&I(R!2A
M]><!2VX%"R=>X(4!"T>,AL-OA.SQ5E-_XB3I,:GG`STK2P.>#KU$R,Q/^:1Q
M]DEE)7+Y\\@+>.!ZW*<'I!_D96+F!:Z?#NE2OL_X\,\T3M3O-76J%\NW*.\<
MA-&83HRD!D3R-[IUE')?3@<*5\0QCQ[8*(P89R/N16P2B9BNPY/IDX=IM/S^
M_\_>M3ZW;2O[S_?.W/\!X]/,N#.R*DK6RSTY,XZ=9-(V34^<],[]")&0Q5.2
M4`#2COK7WP5(2=3+DF60@JCM3%M+(O%8[/[V@<5"O>,#/P@_)&/X+_?4F/3,
MA`>/,_+HQR/].>4I:!K&[(\#6.1[%C$!(Y^HW]E83=)/B?8UTI2X4QU)<OZU
M?E>?:Z[WU]=__%@G7^`Y/QJJF>EA9J3(VO`E^990`2.#Y@4;<Q$3>`A$(9RW
MY#0N_DWDB">!1P8,'J/Z;:#=?Y+(U:WJX:OI;U\+57)L95DCKF:0'YMJ[#J*
M@/KD\^9Q_:I)JYJ;`((0%JFW5\##)+_>`B.$`R;FPV@Y-0+RO;K3:K);<EYH
M\\6/?W7I@#D_P2+GF5YA*``OH4(EFDI7^(,YMT]/>S?76&6&AII^5,U<^3&H
M/'=Z%E)Q9\S)39Z[W\VX^V[&W872<$8`Y^>IA%2.*30\)&--X1JA<@Z\M1EB
MK:)3"G,*`BX``C:IA@$---;*$6,Q@>_H%,$55G$%7@!(`G#R@9%Q(L9<PK(_
MPB#`F(+OX"'!0TWWJ1):AW`U,DB@>0[O`JPMZ![/EV[`90*]`HQ^2WRAAC4A
MJ\B=S@B>2P+`3*5;0&]H!)<SR"MT;>*18&E]2.E_+Y8+0OAR),L`[U^2B.6`
MNZ&!>_5R;Y-=UC28*4:8<C*T!$SA@=6N&0W6-C6`]/H""DX7?;K,PP0X1ZLW
M^$);']$D*]HIDX$$-E+7X2Z:%_55.CYM!>]FU2X8PC=4CM2_;X&/'\!P!M:_
MCKSYKNH:0WH'J[C3:;QS;M^]?=?L-KK-ZX[3ZO92J[C;>G/9+-<J=GJ+5G#3
ML!6LV@/GBXNK?[2[/:??27]\3(<SX(&7=C=7-1\B&8MDO:[)K_#.,VPN&?Y.
MIWC#/YMRL]UM#>@:I;N>"+G]^KO=SI\\V_G)>;D'<884Y@]Y$/!'!01ZKA*$
M/`P!-?YF6O,L'\51"+V2OG"U-UEVD)B%2%5CB7W4YWRCJ4NUR'+JF5G#Z51<
M%@39,Z_/&F?ZLQQ3=_KY^;+^Z'OQZ*K?K_<:EYU>M_UJ&A0!Y@OH6+*KZ1\K
M2S\?6SY=9AXDZ:P]][=#QHT>T^NS2^?5UOC+8K`G>W'O]YIE=X@3Q`G:.,'G
MY<(5>'2XJ'2YGEG5U)LZQ2O:^%I[)<J@)E,[FIQ_B`AT$"@OY3D[2SM7WCW`
M2CQ-?5<YC^(0]']'?;&KEK=BP'_2(&&F-CAPNQ&%9@\>?"^XW-EEL&+$7R/!
M8`Q_,^^HAOV>^I&QV@`H["CL*.SV#OLWH+.Y2B`H[2CM^_@C(0<*'9OHW'"Y
M\_$B/,>UZW[M+*7G8LC%A:3P<R'21]V_[@5/(N\BBVA[^I^2Q,XZV+*&6-7%
M>^0XY#CD..0XY+C3X#BT^3;<NL;%F`L:OZ0>)7(D8B!BX%$0SAIB(<<AQR''
M(<=99N=5]QJJYU^O:WQS82.C6DR[>88M=0>F#^-N$]PC/82[AF:MKLE#N3;P
MT2$KGJ#:1-1"U"J>9@V#ER38P$6(68A9B%G5QJSS,D!K5?Z*(^2!>,]802<$
M/@0^!#YT,>TRUS!.=J#KVDUJ`]NNS5PCE;UFTV!IR:I+)=H2!O9+4`27HQCF
M[BY"`40!1`%\KDMNLNH[NN0HQ2C%![%D6_4&*M)R_,O*NI?OE<!'JNP8YMK:
M$VI$A8`<AQQG"^&0XY#CD./L)QSN(1C+M46O:X/7U74:]=6ZTNAUH0[`P`=F
M0:(`H@!67P`QI0_W#U"*CUV*T9(M<?^@NKXEYJ<9E<I^KU_OH52B8D3%>#C_
M$M.V40!1`-&_1/\2I1BE^`66+.:GE>1?5M:]_,A%?$_OTPMKT[M1J90L)HHC
MF(=):Z6"G37$.EHM@1R''(<<9S/AK"$6<MPI<!QN+&#26O$133SRCAH`8R$'
M$\"4FKVFTRR>#U$041!1$%$041!1$.T51#1)2]L;J*Z+6'3NV99+>$]-9IM&
M<]/V)6Y5I!K5:AEJ%46X,+6+`HP"C`)<?FY<Z^`2C+ESB`*(`@>VQ,TEJ9^Z
M(G]I[EVOJO[U%Q[3@(14_,5B.@A><B?S,SBP!1SH\43U-V7!?<38"K:UZ>J%
M;40^I;L9:DZO9[`,]=ZDK0J$HA545,)9J="8]:9>7;4#$#?-XV81!#\4J#KU
M[N%I;@T'(]HBVJ(ABH;HEG">4]2.VCYTQ7@>8BMB*V)K-;`U=?+-E;@Z>2<?
MSRAO.*,\#Y"R;XD?3W(ATAJ)]DI2L@A*<R[5FJXL7IRC!=I"*'XH&.[88.':
MP\,8%T#;%6U7M%VWQ5+-5<`Z>;L581%A$6&Q"K!8Q/$]A$>$1X1'A,<*P&/;
MAAWXJL!B+MKYDP[NK7T^]W=N7K"*[&+$-,8YS<:KC0/,O;,`!@U@/DT</P*<
M2S_G&XVX"&FPP,*.>F;6<!J.=%D09,^\/FN<Z<^P'.[T\QJ2?O%#)LGO[)%\
MYB%=@=A'WXM'5_U^O=>X[/2Z[5=33H&%#NA8LJOI'S\O+^Y\;/G@\9Q!.FL3
MKW>(/^LQO3Z[=%YMY;U%"<A>W/N]9MD=X@1Q@C9.\'D[0SN>.[!I\ZAG5H&K
MYO2GQQ3.!SSPTO:O)>%#<LM<%@Z8("VG1IH-YY*<?X@(=!+X/)+/R66837AK
M4;X=5\/,P1D7E!H3AR#P.^J+)^EGVX#_I$'"3)EUZ+*9EXABJU5:P8/O!9=/
MG_:Q;<1?(\%@#'\S[ZB&_9[ZD;%C52CL*.PH[/8.^S>@L[E#E"CM:.RN>!,A
MA^D?FUS<<+ESJASF)*X$AM./JIDK/X9NW8P7'J@?J*C@Q9"+"TGAYR)$JQQ%
M:1WT(#0C_R#_(/\@_]A)'^0?-**>?P4)%V,N:/R2PC?(>`A<"%S(/\@_=M('
M^0?YYU"&4W4K\S__\C;CO&4[B8QEP!YY'JMNK]5MF"O'5Y4,5-1.B!J(&D\0
MHX#C0(@=B!V('2>`'><&KT)9%8P*<(NQBFD(-0@U)PTURKGIH(&"H1,;+C5\
M,=K8(E6=?A.E"G5Q<9<.5492#%JZ*"<H)Y65DW/'7+58=`E1O%"\E@RVEKE+
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M("$5?[%8W1+\@BOOGL%H+6`TCR>J/V/R:2%QC95#WIEZQUPON5ES'*<H:%M#
MLZI@&UH1"$T(306''KH(2PA+"$L(2S;!TGG3W)&KG0F&H1I$,T0S1+-"_+]F
MO8>&%AZ",\)/'^=!+?8M\>-)+JQ5(]%>^0^(<8AQ+RJ&;Z[HRLG@&YI>"$L(
M2\7N*1:UXX^PA+"$L(2P9%LF$L:W$,T0S1#-2JW@A+[?2V);/^E0SKKG2QM8
MCFBP]NQBQ#2R.<W&JP4.U:>&-%G]"*`KOFJI+\K@L2\C1H8\`-B$L9`T^"63
M,*0"GI.$)X(,_8A&KD^#M"24)(]^/"(AC;/0&.%#LD(%DV,,F)0D'M&(]!MS
M(/;H9#79S&2W9"AX"/TRXM&8J5F.$^&.J&3$C]P@\9BG20&MNE2.=.DL_8<*
M'C[0`-81:!/I%JCK\A`D:J*H['*UR)*I9-5(IT]"^QX9T`#H#.0?,19?[<U7
MF[@F]\Z":FDLL9[ZG&\TXB*DP2*[JF=F#:=,X[(@R)YY?=8XTY\!0]SIYS6+
M\L4/@7M^9X_D,P_IBL)^]+UX!'_"G#+X`E@*Z%BRJ^D?/R]#T7Q0^<#V#,YZ
M:Q-T=PB-Z[&\/NNV7FT%RD54SEYT]GUO[Q>/Y;UR.GS>ED>!&>)%[8KTS"H(
MU9S^])B"P(`'7N9B?8@(-!;X`%W/<19V+J:TC>JJ(N&]X$GD*3S@XNH?GOZG
MB.5X>@E<@$LFBEV$;(K-=I>Z@PU+<CU3P>L,E%^2B)%6H[;Q@6;#,7Z=]0E[
M?<88O9+\O`\'WS*7A0,F2,MYDHMW3FW"#?`-I<MX&#*A3?TQ'3-Q2%38"/,6
M$W$1K`U'/+:IO2.-=*RA6:MG,*G'!C;"725[X[`89MV!.$>*+6D4]1*+'*$!
MM!NO?(*91VJT1##X4S+X_RSH1^\%8Z&*ZNWC#6P]CF[2K;7M'/H:)>_TVN:N
MIT`MCUK^]*KWM1H&1:@JDH*J;=,-+Q&;9'4;R!"0$K68`2W6O329<81:#+78
MZ6FQIL%DXJI("FJQ]<QR-^(BOHB9"%]0=\A8B;!3TW:.P1L%]Z9M540<E6%Y
M@EH%>4R596$YH5C*[S1+^17#38;RV:U0`C9M`F\C\@GM$O>[ET59(\\A;%50
M$LT1"_'/8I@K&=B.'+_28*'3J;=*HUA5@.G83_3DR'JP$SXN%4(?/7F@09*>
MV%$G>]RE?+]:=K!%/4E=5R3,@V]B)IB,:X3OMCE>(^'*5D-ZK3ST*#?&;P@=
MCP7_[H?JK,V0^B(=*_'@WYBK0S1^]CK1K\_/']7))VAYQ]$1*AC1QT>@%5B:
MO[-#//`(B]S)Q7U"@<8Q@Z]#Z.L>OEX8),P#V@6"0&/Y(0>38L]`.77G5:$=
MZ*D5VD.S\"D`6\>Z/'EV4(T6?S9-9=?/C0F59K\VG?ZX5FJ:<)V;F*,GMIIA
M;;+;&HB6'#,W]A]`GNJ&<3C#7:=3/.[.O976@&8_JD:O?&!.W]V0!'^GCUU.
M%,O>P`."NG$"O/QQ!G17Y/J!^H'2@1=#+B[N**C[N]TBX+O2JV.3V@*UH\'5
MRRL$Q?U48;/&;I?+>*K.-E]*0.@"X:0BW&"BCE_.R)SIDXE6$+,3L)["D/1\
MK,0CF44<R70Z+SR3>=FNYI'%RI_)Q`D>^P3W.E5KTT9U`0?<#.QV=8]T6]JN
M\["S<Z]XOK683=F7LFD%N/$I_ELXM5K<Z52L56!QK8(3.L+]=NJK[>HE63'J
M=\JO_%/YE:@AS&L(%)_==<8THG%4XG/#I;%B^"@X*#BH=U!\4'Q0[YC4.WB4
M8L,F7Z+J6!(>,3)A5!`NB"JT>4@\LB+)SJ9TS]/)YG1JC5ZGWBF<<E7)BGHQ
MZYRPG8"XA;B%N&4G;B$\F:>/Q2AD%G>.'%YT>YW+1MW8=B6B!J(&HL:)H(:Q
MFJE500V,_&R._-!AS,0\^!./P.B\'Y&A_Y!^@]6AC#@'_?9E?>?$#W0.,*BQ
MM_Y'(7Q2"(V9U"<OA"AK)UBDS:FU+EOU+EJ8*"LH*SO(2AM+&J(W]EQOK&#G
MR])3(P>S"R^[!ETSK&:(KEOQKAN*,(HP&K,5D-0J"&0J@LT.5B1%24-)*T72
MS%V+>"*2AK5_GZK]NZXLSEX5]9_!:U@9&"L#%TS45LWI]8IR#+`V,#KWY@A7
M*C1FO>ER80?5^*>"FT40_+"@:FX;?6^Z6\/%Z"&>&+!:#)$E@^*1VXRZO6;-
M<9RZ4QK-$)H0FA":$)IVA*9F4<&^"D/3L5\5<8@:VQ1X1EUR,*M_O5<Q;:RT
M?U25]LDCE:7>7M%5EX+$H]68\G$ME],N8QY+]R"L3JGB%R'\(;C+F"?)4/"0
M?)P#T:T"HBI?>#!>F/G\BAO-V0IH-<P^!<WZ?AJ9!#',#_ZBZ0TW]]2/TA\#
M+B63>,D!7G*PY;VC*76/$\0)%MDA7G)@Y24'!>?U'+`T*%?'L1GY,A*,D8_:
MW"2;'-"WH#N]V54'&,(S%L)#/MV53^_\[\5P*=Z#4)E[$`I.$-E]2_CPPK2X
MM;Y^O?#&FBK7A3XF;MW(G\:RZY`_$6819I&-$69?!+-XNGY]5/V/K1'U0R*`
M_4F.-J7J8B:N;KW3<`P>N;2>`S&7S=Y<MKTPSQ;&LKWH[-%BEFZOW6D83ZX]
M/,\@&%4,C*Q7?VB`66>`];OM$NJ)6L.!B'D5PSQ;&`L-L(++4#I=XP<V#\\U
M-I<+J6H4[?-"(JF5!IO%)+35)K,9PM;0K%%O%4ZUJ@`9VE7ET\=B!"K==+(9
M6C(PP0+=B!D'QPPK%!&:,X<Q9_!.&H0F>Z')8@1"<V;5G#&6D%D5S,!8SI98
M3GH4&*T?M'X.0+/S,LR?5>$\;KVWAH[/.<Z#)A2:4&A";2+&N<%\I:H!#T*-
M[5"#IM0IFU+F2@6B*87X9B.^6<Q*:$JM,:6,[:Y5#7B>!S45J6AJ;ZW!NUC0
MF-U#\Q^B!R;C$(9KN+!@V84$K[$6ZS'58JWI<KMRQH?^C`_)F(MXR`.?ZWJM
M+@_'PI?,4\L[?TJ26-WE!6Q7+'E^N&S76],R,D>^U#]<=NN]4N:R6,NU1A[A
MQ9$NO^E';I"HNDC08'XUU>2A?28(E9+!%_"[XA#J*@:@T42MM,L5J"A>@+]T
M+BYPCT<&-*"1RX@<,7BS3CYMYZQL&')A#-`E^Y:H:M"YVJ+`=2ZH:`H_#GP>
M,W<4`>3>3T@ZKNFAZJ5V'N"/!*;KTK$"8C($WT("&1A\I\I'P4<F`CVI!2IH
M"JT?Q8;>ZT\KU>SO?_Z4R(M[2L=7-U2.U+]OH8\'&JANKR-O7FYV7FCV"\#X
MFX"[?_WK?_[[O_XY>U\5`QUPH"ZL[;4`YKAG:O"WOG0#+F'2L_?4*BE=\)D-
M7Y^]NU5@^>_F_WVY/2.^!U]0-[[H7W<N^_UW;VX:MY?M1J?3[3?>WEZ^O;GN
M]_O-V^O.V;^6E$^>,[=4-%UG]CRMP'N+NJII6%<UY_JZW>TY_<X&[;Q`8LU=
MG[1D?&8!?`6</_+'9K3U,9DL-)0)B,L;G[.Q7XRQLLP`!<X>.'U6HF5A]JFE
MP7WH[,\,1*[O!=,R=MP6VH>(O&,#D5`Q4?9%$]0"([K,B%8',2>4_$=/?(J>
M=#IQ\NC'(Y)C@=\X0+LD-[Q.?HN].CG/_1;HWWZL$8!50#0?Q`5^H)'J"V"U
M1I98J0:F!/$8:"H^KA$`DF0(T*3[!]%+RTXK])4^3)T*,AY1$5*7)=IO`P">
M64XK@]`(*/Q!HM14H1JWV6O4VS#*$NR4.Y[`8OS*!0.:/O*(G)=84_^'9KM1
M;Y1BQ/Q(AEPHOBFTEU[[5;'+!4+PE[8JEMA><S=(8)Y%2US(R_YI\"OX#V6R
MJS(N!0O!7"W<-7**YES^&#&AC!VE'4!+R#B'M5^5!:VGNT%G:/4RHF!!19QP
MT`/WVGA28`^K_^!["M\G1&E&]7UFI*>JPM.^QVK_H`TF9,"(YP=:7KR$J?:&
M?@0."+RJ;?_4V8'./0Y=@]=!583/'P.WU4DUPQ2U3?3RR[UPI5$L1TX=6<&&
M`3BW,O50YPPT@U+%9T4O<Z?>.@7\;->[)<$G/*_@9.@+8-QO8*8"#ZM55-*C
M,4']RH9#6'GU=6[=,W]]$PSXWBH._*^Z>PK$1,45@*Q\/,.F1+@C*EF^?1DK
M;WJ-"H]'%&QCG@2@NM5%)B11<3$5W8#%@C86I7+,A"KKI^Z]2L;JN:(5?+]8
M<<QI`W6-#/L.\_/5K(=`&*!.1E3X2[D/64!)RR@/TJ"-)`.J0XL1K(Z.QB@=
M>N1D2>?/T@!I/OP54M!Y@PE9=5.T][7,7"H0]=UE4FNL1\UIF4*E`;"7-UDP
M'9.9/IY[;>,@D3G=74C$`C<8+(\Z'VR#0?&B2X70<OU`@X1-;_G+R<0Z4%5R
M4[2_WBW+^RE\??MUYQ3LD$Y)6R<E;`/UZIUR3*KUVT`@8FY`I?2'?GH)&]6[
M&3Q2\KBTR;>R+;2HR7?9#7HSU?#JG4"%^=).A@`(ZCF51;0:$@15I[:>$AA2
MZE;[^;VBG+;+;+^0Q2.N]RBSUZ:.Y*/RQUU^'P%MTCW/D=KER71T>FN=UBP<
MS+,TO`_?!GHJH)2WPQ70;6:M*F-2@'P(O=<4+7>AQZN#H.#$`LW9_%+3W.)D
MWDVZ-MGTH&%U<&:^/`S>B)A>KYA^WV%99`S_2Q=5-Z*ZKY/;1"A"J8$5RHJQ
MOE9(5S_VOQ<KO^E5F4!GKV@=<A!'/\_/P"$96T3+C%JTJ?3#9;U?%3PNR\5=
MAN,LNX**%&J*G:13G?52D>M#K%<6H!@+'S32!%`^6[YTGQC4A\^]+?D`^V\,
MV[(U>L/#4/GYX-H6M"]ZZ"MQ/T5DZC,1IZM!O553<2&94.@E,PIT9JC,&2*[
M;IVF+O^:S=?HB9<RQT@Q7$9]9<[`</R+.`F!'2/F"B[A(;5W"I_/O_S^[L>%
M75/!O<2-P2.+/&T2Z`##VT2`W:-D=L;>+DU#.,JNT1U`2_F&9@W4R"]T3*.U
M>P(PKU#.`D%K]@3&U"\\VZI3TL[/U'8;`:`/&)A]2D$+;VI<`X@`5JC\*T#&
M;)];+S+[/E:&VI[&FVH\A2-^+X!3U(=)9KHJ5LFV7F(PB$<^]*JN:+Y/X%<N
M)NFF`/CD]=6H$YA.(("^NN486H&IL#0+)A\0+7;ANF5MV6E[?3XK:`?,)^#[
M!0_`A495HL'"TJ4W7J^0<VKDKPI;G7P%#VM!?K6SH<,D0O%`$*B=+5HL;=L%
M[]"HF0_].'.RUJ%8U?5CFBIVQ\2#[YJ^++YL37CGA^"ZTHCQ)/7\TPT:=47Z
M=(MMK>,>2+Z<6`3TT5B74P64Z'S*%=F2&>URZE")&\VE!FGG_DEE62?3FT+1
MKSU"O[9@7ZA;;U;%&6IUZLZAO*$T,BA`=J,DM2=%EB*K%"?\"`(_E>:RW=UF
M=8X-P!+;[/"NSOZX-A:5HLA9@7XT5W!+@>"4WR6XI_X0U!8,P9VGBG,=^YVF
MXP._CP.=`Z"V:LGO'(SR)B!I4>NWT5O?)Y7=J'QDM%OP9[),#9U:,?-L9D=3
M<OY0H4,K?`]4V2`A<1H7OS[[E,CNISR63H>$H9_NW5Q'W@W7^R`,2,WD?@=$
MWEYW+WNW-^UVM]OLO6WT;KN][(#(=:??>-,[T0,B_\_>NS8I;B1MPY]W(_8_
M5/3MB:<=P6`DSKT>1]`GW[V/QYZ=:>\^?K\54M'(%A)62=V#?_V;626!:*`;
M:$D(D1OAG09TJ,K*O/)069ES*BN96J)S3OY-:0^&W$83KE+RV>#':@4"[SR`
M[$8GWHS\,W+0<DE/5Z638EK9(M*%ETFE2I;O^O7CX/KF\T?%+O<W5[=W\&G`
MSD/_02`@UU+/_:2#!_);E:560*#,-(M*Z6<1!D%4E!&@"+VX)%<*'B8!;Y06
M16</G3NE=Z=\5FCPR2@N^#0"GW9EV=6A6QU/0D4)MLG'+XDA]FO]2RK:"C_=
MU'^MLSO]HQ08/'R6.-E4S*MX2/%G56AG)8B+:9TS'2.0*<%:(F**>@E!A[/%
M5[>^;RNFNPZB!S:P)X[GJ..KR(SGM]<#+8@8T%*1C4#$0@W<.<&S'<\RD)?'
MI<+V:%&*./5@#,@I`A7(36,)@X&E?H+1.?--AGF2I$KO"S%I-=GD3<[&6M$$
M@Y%HY:G^PCK3XME;$F299]/.TS%TKB(F%.B[U]^VY`^$3\*%MZFP1.P+*!_/
M%F#=+:B>1L1YR"9SG^'0JJ*H/`J*,KTYRJ3`,.<P>X&GY#9`H0JG<6LL[/R9
M\IL6S+60%,3U*)=VTW&RFY%K!#XEH-6RCFQIB\.R@BCWR&.S4:RII7@@_R(=
M[:(8`-=1J:H53GA18ZVUC=I9;T4=6@G]-]Y&])^*W:\MD*G7@!U:=(`"P:Q`
M'Z%`=M\`>>O9/8%\9Y0RU`PST>IS2=F`DGC<)'\(+(AX-899P"Z3D35FH;-(
MF-BH1)!V>;M(RM4N9OIX8$CEI:C)>^"%H/(3P5HG!5P3G8!@1Z+.[M76S?S'
M>7*"3JV._5)TL;S%63=0O@_@2:EKN8KF1@%X26H7`6\,;)46/M]&3N5IRQ`T
M,`_4^7?7L7B<>S*,)`"O5-M&0\>+D[-58O7:B$R=#;R9*C(4;TXK&8AA8IY>
MC>G28-P"PZL<EV1NSW-VU`5Z(RN95IU]2BB"SB`>/HY#U9W&PI*U^4P"??`X
M8.(2",].AI/*%(\7!TFQF/8&YDRE%BD)SVO3I;QAQB]P5SB.`J_&O@#5_Q*!
MBV;;+;<<UPEGU8H\_N(Q=(]8XA4IQP7WG9`_TWF"Z0.KKJZ#Q390*O>3E9UV
M03O1."U`!;S5D@JL]$E(;H4Z0C.O+I9$1X3WZ`2^"IIP1/J)L!T=W[%\F90L
M>U:C("&KBI,@`1>IGO.W`9S(:/@[GDC&3+%(AOX$R^LDT4VT.AT-6\HGT]#(
M%]_K$\0>!I(`%7!#C-M@R\!KX>4`T?,Z;',L5.I,/<06EB/CT=J.U*@>B?A0
M?&1Q#X!QF.0'ZGQ`W]*H#.`U#UCHV,WN.U2[[#0]WZ2:!@)@7`+,W:ED1MP?
MW65;RKQI&(U&_^JFV>Q>=LS6;:/3B.N6#=KMR].L6S:P8NTADFW>)4HS36IV
M_I,OY<NU8#,#S$9!@'FOG/NYSE6J5$83$$:X+C;[%@+%4X3R8Y,H3:@XP?8<
MS]9\NW3.:CA;G)6[V)N$*9)9*D]N&Q9<JE_=>*:W\7/Z-1ZF,+C+7(K7S!^L
M260!(L77?#AKG*G/<LJMY//NP@,4?W`\/4@>A7[RA2ZDK+YY<NQP#%<#(>+V
M[BJ+8BK%1?+'"E,MQIUNJC4OL6PVEFHOS]?C];Y<:C`?SIK&NU>K-R^7CXYO
MW/N^PE]($Z0)T@0/,,'=6@(F+3$T,L;5Y8WI5Z:RI]C_--3_2M4UL)>M5N\E
MZ6PK!L[YG9<X&*\8,,O+-I]8\ZQT5'^9TBOF06&T_M4+DI:-/X(+);79*.2W
MN`^]*%+,!LD)=N5@?N&NV&%A7EP,:FA"C)LUX][Z`5SOL2OT@CUKAE\\8>3Q
M*G;I#]J9E+B7N-?#*IC`NU]"'D9JL^:3+\-`A$Z@0WZ7PA-XQ.Z3"T\F;B5N
M/2"WWF/:9GSB9V#_'FW3R8:XDK@R9Z[$#)%M:;R7=Y8-,>,E4\&YE?4J>S.Q
M2UWF2Z5\@I*:5\S86%RP#&U)CY7B9>U9F@<]#]C0-#.FS;:A:86X-K-NIZ]2
M^(1M!L)3PM/#XVG7J'=SIVEI&##SKJ>$A82%A(45P<+SIE'OD'%)QB4!*@$J
M`6H&@-KOUTT"5`)4`E0"5`+4#`"UW:^O'KXG0#T0H&:P*]4X;%)@CH>C7LO8
M9T,Q\@-UI"_N<V/ILX,[\/<BM?RU?=<L5=L.VZN'`HI&O9\[3%#@CLPB$L`-
M`MCIU`V20))`DL!#26"+!)`$D`3PD-LIW7JOG,YJB9TG"O"1&)=*C)O->I,4
M*46$WAP1&DRPDI1,!7RP1%7@3W:K])"+3+^2EG]J,M_(<-MN7])6!1)(*1>A
ME$F`EVUO[,YX<!$FVYQ@@&#@@#"@J=TS#3,[=47ZG`29!)D$F029!)D$>7?#
MO)5A4)P,\S(D<1F%8,`A0G8_BY"I4L18A%X5(#Y0?.[$4,*@O6M2XZ52XR<F
M@.>]`A(H20N3%),44PH8J5$2P&H*(*6`D1ZMHA@7&=3:_F!=23&@961X9K'0
MB!>=:7QM68`T!T".$E327&K\E@]W-X'E;#_"HOUO*0]+!\VS7`$ZB9YD"&97
M-FYOFI>&@\DQ*Z=%1VA+:%L%M.V8>6T:$]P2W!+<$MP2W*9#%F8WKY#%/E2G
MF`5A-F'V4;$N87;AF&TTNWD=>2+0)M`FT";0)M#.'+0;!H'VX3E_G]W![T+L
M)[WN^L+"-BD:PO3%^['N,6B8C7?_?*G'X?)K4T]90D8LQ*&>XG@`^OIS^C6>
M'TRXN\0I!EXS?[`B$+.$Z\;7?#AKG*G/P`Q6\GD-H>Z=B9#L9_'$/OL3OJ)O
M)CQX<#P]2!Z%?O*%YE[US9-CAV.X&@@1LRFLNLNG4EPD?_SS.=LMQIW>]UTD
M1336)AMLL76L!O/AK&F\>U4JEJ4]OG'O^PI_(4V0)D@3/,`$]SK$=8!FO'M;
M`H6UY3V_\Q@\S,5*W'N=Y:(6R#NTD0\$C.$O8;,?N>-)=OZ3+Z60WS+?8U^$
M%8&UY(`E,'CDCJN,B9$?L"\<S*Z,3&;RI8EQLV;<6S^`ZSUVI0Z.6C/\XHD'
M-KN"9P7<HL[SQ+T'YMY1!"Z=S;Z$/(Q4.N<G7X:!")U`3/"L\Z7PQ,@)V2>7
M[]2/@KB5N#5K;KV'9TA7M49A`_OW2(;(HL25Q)4'Y4H_Y.X>4<-]J^+N2\QC
M#=*N.W-P+2PQ&8J`-0UU[B"SLLSY'DLJ(6$SV^FI\GZ->EX[PX[(9>&80Z:/
MDKHE*"(HVHM2YV8SNT-')[7CFVUB#D$801A!V'X09O2SLZ<(P@C"",((PHJ%
M,*.1><+>X5F&/$+"(L*BH\,B/*=''F'^YA1UM=M,Q%]>JX?-AF+D!R+5]LY2
MFWF[[.!M79EL'[`L6PTQ;6;46UD)-AD2)V-(G)Z<=+([J$YR0G)263EI9!=W
M(SDA.:FLG)P;&1[(W,NE*KO!3T%HDJ^WA"RR,]A.6[PH*+&9B(.)'WFA3,4<
MA,U&@3]AW+*B2>3R4!RJE5<..;3EE/1.YJESKQ+M-)&`%"V)YS[[F-DU!WJ%
M:.0QDJ"=K*`=H'4UR1O)&\D;R1O)&\E;[O+6+*Z[557DC%JNE[_E>F7D\[Q=
M-RGB2G&6<JG'RHB7D6&8LRKZC02%!(4R4$A.2$XH`X4,MFK(5Q[QC*-J[1VG
MY1>V:5::HS7EB810MVVS861V+B2?/BEEX=J#GCS<FK25/9K8R.[\TNMM3<K"
M<^0KE/<8-:$=H5U^/ELW+[OP!6K206T"20))`LFC`4FC7V"O.T))0DE"24+)
MXT-)`DD"20+)ZK$>@62&IX@[V14^(Y3,Y!!RR?LAIY=,9<\^IVNZU7$33T87
M0>C[,?8T=`'586Q,-TR6T63"`[A.LA!^YF\\RWRQ-\E2%,*V2\YHMI$FJ<<L
MX7II>TCGT"#:Z+ZQ0;39VK-7K%G1KK:5;]M+$SSV"6X2Z?D3RM)3K;*-EXG2
MNU+Z3I^=P>Z?NMWG3[XNR;H#U1>3;)?[(-SA6@0F16@^KQAN@Y3AINOG7BT9
M;GJ!]K#!UQLFW2-.[3O<\MWZ@;*_[\>!$.PC7#.6;)-;<J/ZZ29I6N6*,67F
MB98N`$4<G@F'?W&^YL/?KR+36U7VD%M_/`0`LS:Z;WYP\3^V^E_ADG/X)8[G
M;[:[W!IN6'"S861>?.^$X]_4-WEWS,DR@9E8D)"4D)38.',D/29N?3O,4G?Z
M_?9N?N2.)W4%$B&_9;['I+`BD`M'2,8?N>.JO8L16-F2NUN[\T3Y+7L.)25@
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M9-4R:<N1^#[R`U@X+V[<:<WPBR<>(+MY8<"M4!ZO.!^"PI_%H_`BL0O5*$RV
M(4S6RK(5!<7)#JU-RZ-!3R=.ULXNR>VTXV0D7J3']M5CW3;I,=)CI,?>4EJ]
M09U53WK#Y^!"5S+Z4';CD>/:49TJ+C%GTJD3LC6RM34:]<P+!%5%V$B\R&<N
M3!?F[S-733Q)%Y9#6*L@DXD49I:I7#5A.PFWNSR[^D0K2D\BABLOK2@]B?B*
M@*RD1"2&(R"C/,OBW()[/^1NJN^C;M(D:\P3(?-'N(52'>D]N,2^K!9RZ69,
M%><R7`$J23?/=\VZV.8>1"\-"U.6T:FA:EDXCWK$'S3JW"BP0WQI>([0[M30
MKO0*F&S(DJ/ENESS5KUW>**7AH4)54\-5<O">61#'C9SH9E=%M_6U#R),N][
MYSU\%V)7M;77K_G[^^\B^?Z!\^G%4H=UG8/^LQ^*>YCVI>M;?_SPC[__[?O%
MQ9ZBI`JX?H*_K-G\0G6F'3Y\%J,/9[?7V`GRW^9O]]=GS+'A"VZ%[SO=F^9U
M>V!VVY>&V6Q<-WNW-]>MFZM!OS_H]9M79S\\(WZ:D/?.1$CVLWABG_T)WPR_
MJ=N![.)]'-(WS,:[)<;I`)>HQ74\0//PHFGN$?/?JTM;%""M;,SL5Y4`8I+"
MAY'C<<]RN`OO@B\F,"[)`C%RA14R'^Y;=T&-A6-?"HQ\XR5/8]]U9^_])P\>
M**.A=&R'!ZKWGF<O+K5`&#D,_!%^4_WX'.S)*&3(X)FZ5]\3Z"O!G@3C\`\V
MQ)X&SH0'L_A\`@PCF-49=LM>FL3J_3`6!E?A8\37J8_3#GWF"BGAL=QC*^R>
M);F-1N-=KB]06PY`'0%4\">.!0L"<P[@8V"K+8FD(1\6AOB6\3`,G&&DQ!7)
M`*:1J@8!JP:L.5\&"7^I]=S`*BD&@??'KQ!_1L`:\%"U6B+`1IO\03P?(2X&
M\D<@Q\YTL?"!0(Z`9\.;962-%RLYG*G[X:HI<"(`Q?-13WF`%];9'3X,Q@*`
M"GS"7>#6A/.`M!)0`+=J-"NXS@38.=0OM-+04E]EB32*;2OBAIG(>`K`#R+S
M=QZS!5`&)HSD`LE0K1I?EBU<-I`.M0JS6'IAI;"H""S%GY$3:$%*\85B/3Z=
MNG`]0V9P@$UPO>"[P.>PIB!PX7PL6DB3H8PY7`@Z=,S.C6_UH/PG^`E>8<.[
M`(+23,0!99@$LJH=."`5KNVCYI>$WQ8C/S?U$_TAK(1:8WPL'TH_&#)=,07N
MJB%G*D[#!<4KX+4"QQ\?B9)L%/B36OKI:D*6'[DV##?$+]7(AF)I<$HF>`QN
M@%KW8P$XB)1SP$[0&XC,`;:-9_G$9XJ4%CP9;L=FI2B,XJLC0UQ!,!I<#D:&
MIFX@7/T(D"?-[;XB*@^`5QZTF-;9?]4+X?;(CR2N$,Y:[L(,F]`:G\6L,;Y+
MXE3GPUP>&$QB%(41OB0MC!.8*SPK<A&J6"33L@C/@+ML\>PK3^#7$^3$6.TL
M".('ZDT("0@Q]8Q%N6C1A57SI\@B`HF<JR8!LN:LJ=1$<`6E>$"N!+R`F\?,
M`<'RK0BU#$BF[4@+O5VXL`9K_RA<?ZK^!KLK&@';1/B3XG,;4%Q?J<")3U'\
M45H\$8%R\!\0*&J,1Z'O3"81\`W>-183X!/U*[Y,V>JO,,HZRW6S,;IDM5[#
M^!Z5H-YY,@PB)8X#S_Y?83_`P`=SW+J&>0,6@8#L9-4:W=M>:W!UV6L/P*:]
MO!QT;K55V[V^[5P/"K5JC=ZR6)@9BX6Y"(RUNSVCW]$_KC3:7M"<I8B>#Q08
MG?RA8!$,;`YY_",^]`(4+'#>!BK<QO6_KI+Z7[=Q_:\K/Z[_Q=ZSF`TSIU.G
M+,;/=202F_3!]<$H9&#U10O5$:.22N&9^H%62O%O05SQ2UN,/(C-T[B@FK(U
ME/)4?@2^X=?ZE_HBFF:C5@J4N@?=Z4;JG?-G3@1'85=/7'>?1%Q<V%S@3/VN
MK"!_KFN=-37>Q%?]*T.=H4QBI@`.[YL`SCR@*@FU_1$_!E0_8.\6Y>*4WX2P
M!"]>?@]:$SY8"FA./SE@P_&$E@DI\>D6E]K>!NO!4S17F52:'L>NJ6]?)Q^2
M;33"1>2*Q7)5M_\"=;=@J6:CQE!]Y*OA4;OF^H9K,,@G0Q&D)F:HB:T>*,QT
M8F,.QD:46.IY+]UJIE"FDP$ISG?X/;#-O7"\JDB.B]F.?1G:12Q#+167<=.N
M;8QYVJT7`D,0Z!(K%8'^(I=CAAM:8([;#W&4!AW>`+'<G=42I0U8#C@>`R>\
M!,QY;\8B+Q!@6?P%#WM0A4_!Z$\<>2_6;ULH-*Z"&:BJM!Z&`423R%6#U*K=
M2D>HGP73SD$UBR".@\"<!K]<W>%3<-@JPB9AYC#%;^OL\_)H<;+Q<$=QT&$^
MP;3F5(&PY\.U_`=//0M>%6M/=./U>R5WE9DQ#7P[LL)D.',:#`5:>XKF-AH8
MB\?!VBU1'-3L@N;JAK3COCJ1Y[34]$LHEA2347G26>OZ0]N8:.!Y?FS0S"V]
M;0PJC`H]8:!:J)"*,HY\9"=-\)35-+<;8=%D-)GP0/$`1PYR@<GDQ=Y$W<+M
M6]JO;3RSL?!S^J&>'TRXN[Q6>,W\P3K\;`G7C:_Y<-8X4Y_EE%O)Y]T=UB?'
M#L<7_7Z]8;:;+<-H-CJ-EME_EVS(J3#15(J+Y(\5]ED,,7WL8;Y)UUM[I&.+
M@Q-J9!_..OUWKV[_+>]>QC<:^][7+/J%U9S@T1^(Z66+?8O'O>D<5O>U@W]+
MV_.K>^DY5V.P%"KG2\7UL9N?$VTRF.`6P!Y;\MNS:1Y$/B(VWBYX=L'.[SP&
MCW?1!=RK)MZKIUQ?68><3\%NG[1R>*%9SHY<OX*#N:.^+A,0PR,,HR*;+E@;
M+:%TP3=#_ENEH)BCN:50`B]S<!(+8Q@">X&+MZZUM9OR`'*72C/DY]W=1(%_
M2"0H15WP,AT8>,-Y@#(GMZZAF5%K-;L%5(ZEO/V34<29TZ?$*)0M[APYO,2`
M8G1;V358K@IND.FSGEVNN,=MAWM,IR3L8^]3]=MEE=XT,ZP$0?K\Y/7YZ56N
M;7>R*R)0%4$A!;:>5RZ!X(X<LRF")#Q4!'ABA/38V_68:=3[I,=(CY$>VQ>;
MFJWLSC%715!(CVW(YN4P'DQJFPF/M%<&@=5VAC4$2'N1]CHY[65T*(Q(VFL[
M7AE$,@S@G?D&$HM,GRF;2*Y3<8WL&L3O3=NJ2#:IP.($M0KRJ"6PGV&(Y!6B
M5470WJA"C<KJ4-UWX/4S)?DP7-Z%44M,_:.M?5KF9(2UN4YMHUMO')ZT58%2
MLEE*B(`E!KJ"H>W($2S&K&;#S,O-6D.SJD#35J5#"QM8^8N+W(^7CH7C*>T1
M=X+%6>.M3[SK$\<<BY%8;F3O<^P="[S@L7)ED&(EP'"6E`E=',?/N43&-YUF
MW4B.8^7ZIOSK3'S3-0N;"]6=.::Z,\^+:_Q7E;!5!81<=[DN$U:<%&'HH@0_
M"EU2P@.HRKO42[X+JPN8Z-H@WHQQ=1A6[@Y9FD#SZA0<'\FX_7LD0RQYIFM]
MJOH*2:%,59E343&NRQG7L5+E-57%R0B/A<6E9S5?]$RC^T]F!<)V0A8X\H^X
M%LDJ5J=K>F`!+EA-KHI],3YT7`14N$Y@Q51\P4Q7U116%,)P0CF_&^OM+FJ:
MRCH;D'P?EWRGF<5V;*PB$M=E6\,X21VUEU5\%8NKZ!(G6+E&EPZ9%T"1J=HY
M2")[7OE1/BLX-(X+'3J+0H<HGCL6N=Z_R$J*E@@[SFBVD7I'6G<%:YUG5FG%
MZ+^QU`K0_$@JF)C',M#*3[#PZCR5IVBY)[@)0I90J/"]S".M5G`;%[*['P="
ML(_:<K_Q,,20%-O8(SRT?EUH6;:O)"1"]B/&9+X[_TD5ZGNY=DW9AO]YWF@=
M.]0$_B2IL@@NT2_S@O*Z=="Q3$S_C(]-"GBK-Y[?S$M`?M*QOEW*#-%6S\OT
M(>PX1>Q8E$H%O,#I5`,I[A:U67?&"JH1EQ5__>1;*O!&*)T]2I>\6%[)X'N;
M>GA4T*Z<G%I)AMS(@EM7HR,6?!M]2&.3QCXJ'"2-31K[.#BUD@SY=HU]]#7R
M\]O#_JR32TB8B[%],CV:LGU=]'(Q7EE+\.9!ST.=66DUZIDY-.5G0#JL4C'(
M*PMCE;VL[]%"EMXM:&=707Q5I*K.9[0'6V($.SY/X)>U71&/EX;5Y['RVV7D
M&)3.,3`*:-I1&OXCOZ!BB%<6QB*_(%>_P,BNV@;Y!=N$Q4M^UOVE'8<C/Z$T
MX<&#X^E!\BCTDR\TOZIOYLVC>XUVH],SS0X0I=>F(TVE/;Y!$Z0C3<0RVT$(
M'6EZPY&F+\Y7.M!4ED4Y_D,)=*")W'XZT$3800>:Z$`3I4>?"$J7/#UZ^UC<
MX5'E.'.G,XMV5I?'3X^5-S(OG9,J:(.,#`$R!(X*),D0($.@ZCQ^>JS\=D.`
MCE_1\:MRF%2494E9EH40M-NFXU>49GFTD%<6QJ(TRWS3+!N49TGGKRH)8<?G
M"M#YJV/CL?(;9N09E,XS:))C0([!T2)>61B+'(.<SU]178:2G+_*H8M386C]
MTGB73EJ9STYG&9UI[BV\%KJY.>1KTO_6[WO<QEW.KI(N9[=QE[,K/^F;]YYI
M4_YZT?$K$RIUIB7I>_9?P;@K?:8VGW2^IVYT^'H+N!J+9,1==Z9ZM3)@(]U)
MD=E1H%L%UK"EX,0)L75@W&KN^5-53[I`Z!:+<+4%P,-A"D/N<L\23(Z%"-G4
MET[<?!`&/.:/0O6P$W$W6.RZ)K!9([9+Q,3VD3Y2(>&E0!,)HU4WY\/@A?:H
MXP\/@5#D!`+`I+@;]ZM<].?UHU"&W+-C0BS3>]$2$MOSKA`D4QW=ZIKU5E7:
MYS8[[;I)_7/+O$8EZ9^+^?(%]:<VFO5.902LWB]F*BEMHP$SA8DBP`:^\_,/
MV,)7M?P%Y:8AUE\;V:LQ3X0UI79R'7NHNI[A6DCG:[Y4BILB"W42L6I8M"RR
M-5QG7&4>:+:`Q62N.KF3OPA72476>X5,Y?GJ.;K_]31P0/YFX-3$BZGL=3:%
MY_AV7L9?>;V;+ZI[L>KQ75WO9>RH0A[:9XB;5Z>[,X-$,QD-?\?&S5JPE7_`
M@P"[7^NVR]I[6>FV7@-MP&Q?.1K^:"0!$Q9/!L2`+W3/>-?1[=3A'O4LY\5^
MSTN.S2FVT4YU&T?J34&688C*862[D"Y9[K2[DUYZT-%NI+X-QSYH^5<;=>_?
M=7L398^N@$T.+;;;;RQ'TVKN6=&B57BMCWU'FDWMC1*D0A_9^9/S.R^Q5UXY
MHDTG?=Y&Z<L8N;^H:-X>YWZ.Y5Q+R?+]MSFZ<HOZ^#]*'P^44DW*SJQWPS(Y
M%P`T+94@Y&(0K1KJZ@W_&UL>=]M:'K1/OLL^^?9(<5@D*!?AWBB^1A7E5SUO
M()<=OY<=Z%*+ZN$2(?7N4Q@[S8>DX$:A+S$ARYK)5^;4ES4TZYOU7NYDJTI"
M'NF##8#V4QSLFY%.V%NE6E80"9O%FV<ZB*KVU4@SD&8XA&8@Q9"38B"WM*3T
M.9POX/HX+Q%,TOMF!/P$_`>@F=$MH('2:2+_*4=X5U+&*;Y+\5V*[Y9->BF^
M2_'=,A"2C+ELRC35NV3+D3J@\.ZA-2J%=TDQE$DQ-$@Q5#V\&^=-FXT]TMRK
M'NHM-:VV]N8/X[27AU:4]4U9W\=&Z?)D?5<RN7L]T5?2N9-3\6SC87@*^%-*
M=VDCU^4W$H[),#BA4`Y%]BL5V2\[O8JL2%CF`(QZ7J=?SZP=$H563EO[EXP^
MA\"6.P_45ZBK5<RCZ83)A,F[$,.H]PF2R<.EE+;2:3CR;\F_)?^6_-M2TXML
MJ25;JDFV%.$TI92=<DI9V:E&B)UZ7H8]7"N(V-NU+$G^_OZ[2+Y_X'QZL7`(
M4UN?`\^.-T0'6*)7'?"\=J3E^C(*Q#U0Y-+UK3]^^,??__;]_$'SWW\97?D3
M%'.5+/!9U^J^\F4HOXQY("ZY%/8G/E-OFC]+E?"&#Y_%Z,/9[346+ONW^=O]
M]1ES;/B"6^'[MGESU>WUS<O6U;5YW>HU;EN-Z];-U:`_:-\VFN;9#\^6+KT,
MKY3-7+?R+Q=L[2TG%)D9L[VYR(1L=WM&O[,A64"1]/T0:<H2HK[(/EM/$$'A
M2.HDIVB09CUVH[5-)O3H3`_8,^2%@KPR-7DK/?E8U<95=(6]165C&<(_.DCM
MC^(2^513-X^:ND;GK45UVT77QMW[QF.Y[V@&2A,\Z`1I&_B-0?+N`7)!CR/S
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MVQ/'<V08J)SN?8*_9IGV,':(`1\LYM/)L`7-OK2MBJR3W9&=H%9!WM3SFLUZ
M)RL&(D$A02&-]K)&ZQD9MM,DC4:"6I2@5D$>M00VBI/`J@@:E2_8Y"=&P]`/
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M,DQJ"IVU*U993^Q.=8]@(?_*Q&@DK)#BJ`7$40TS\\/%%$BE0&HY%.GI!%*-
M3N8EFBB22O))NYK%:N-FG[8U21N?J+170:AC,>X5=QJS:M)*^YK%[VMZ(HR;
M-S(>AH$SC'1GQ-!GEX[_(#P&SGD]'XYN`D?;?H2O>PL0E"+`6J8*CZ\1^2TE
M(,M<,FT-49O-O-),=J%K5>*79!*5$/Y*C'(%X]J1PY<&K'Z]41C!")<(E\@L
M([.L<*+V6YG7;B"SC."O3/!78I0CLVQG:O4;&2:$G8I9EHK0?:>B2NNN+VQ@
M*:+!XHOW8]V>SS`;[Y985`4&GY-5?78\P++PHHD7%,%T]V/!1KX+.`IC8SHN
M)Z/)A`=PG=Q<%R")\W$I?<OA(?S^Y(1C)K@U9OZ(^5&P^>9IX#\$?"(O]B;F
M)M*D[ED"U$9"[YB^^#G]4,\/)MQ=7B.\9OY@31E+N&Y\S8>SQIGZ#()C)9_7
M+,J],P$Z_BR>V&=_PE?4U)-CAV/X$^84RRS(HLNG4EPD?ZPPRF)0Z9CT0H8[
M:[<MM@AKJ\%\.&NUW[T*#\M8%-]H['O?WC<>RWU',U":X$$GN-N&$]G>*^#7
M+?<N\>$:`]_Z`0M!V=^/`R'81[AFK.OZK#-R;CS<NOM7Y`G6;-3(1R0^+9Q/
MOSA?\^'2O2#V`!W&]W;*"ENJ\SN/P<-<,.GE+BE/\XF]M:][I@E\KRS'X>5E
M.<:Y?DG,AI%9HB[!=7:<6DF&W,B"+6+!\K%@SF"957%O0E)B8T+2G9&4CGVN
MCV]_Y,$?`I_F6W^PR'/"7<KI9"[4I=@F+E.^P@FE(U`!HEWT!>G3@NE38@3*
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M44?P\RJ:^TH5"Y(SDC/2AROZL)=7T7W2AR2GI`]?UX?=XCHU5T7.J,OCIBZ/
MT3#T0^Y26/3MBK'5RRZH0YJ/--_IA47;&=J6)"@D**>ND8QFGU0221JII#?L
MU#5;V84?JR(IM%6WZ7C9U`%G"KZT-[?&LGR94UHD!2J7M-^YF5?7]CUHNV#B
M78E;+CY?0^==&D.0@J5HYVZ8"E+<*4J*JR:L))YE%<^3T\7MXJ28=#$)>ZF$
MO0HRG4AQ819UU81U-_&D#<M-&Y:OM:MV/,N-L&L@/%=M;2J'FW'/3B[)K#_(
MUCWKJ>)VCD0^H9+<K2Q+<N]-UZI$,<D$*B'\E1CE"L:U(X<OO:'?SBM7;0W!
M")<(E\@L([.L<*(:S2R+^))=1OA7/OPK,<R17;9[5HO9)\/L+6DOWX4<9KCN
M^L(&EB(:K+YX/];-A0VS\6Z)1U4L4)'5\0"\X(H.?%&8EFP.>?PC/O1"Y<=8
M^IN5=L@_PDM"R7Z%<08L'>F[2D?Z/KGPVDQ(TWE&F::9/V74\^['@HU\%U0*
M#(4I7F(RFDQX`-=)YD<!$W]&3CAC#YHDH<]$7`=`UI@_&CF6"*2*:MI.(*S0
MAT^1HAO>;$5!(+RD*3)6"I`7>U-L$T%2]RQIE,8SJN+G]$,]+!#G+O,H7C-_
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M$"99LO.;+Y\^O7QFO?2IEG>>3L'!=(6:2HY4ZG\,%%`9E--I`/!GJZ2>2\=_
M$!Z[\ZRZNIYM09TZPV1._+/&GF!08S84%I\()D8C887.HV`^#L&=,:,6CR(0
M4Y=;SUYJ"TN_V>CWV^J!['S^Y[?)P\77J1/`G;Z>U@)=FPW]=#V>"?_J3*()
MXP\/@7C@H6!>-!EB=N@H#DWC7RI5U)],X&':)@K'/(1[9S"'>:,I.\XK#>-I
M,D>G/"VQ1)8KUJF9C?5F?I9OJ:].(A-1+XRQDTRT7*DDG:^Y/I\![V$.G5"Y
M<KF^:KVXY/K*FH87$$600`"`7%_67V]`9+I:,70\B4``#,AH#@Z()`O<PL(<
M'%$J](ND@&&LW]C-\AT+#HII$9,!JXV`,$X#!\1R!D9%3`2N-,`4GN?;]9>M
MGOCO[[^+Y/L'SJ<7UXZT7%]&@?AEE#X!\5FX0$W["@N)JE,2EPC3G_AL`@`D
M[P&,+EU`\Q_^\?>_?9\\ZX8''F"6_"0"=<O\*ABGA_CU68P^G-U>HTS\V_SM
M_OJ,.39\P:WP_>W@NGMY>6DT;J[Z_5YWT&I<=J];-U>#_N#6Z'=NSWYXAIAI
M(K^2D[_.('T9<'O+^&IFC*_FPI1J=WLPO4V&4TS0!4-,DT,KQVTP`3/!E?ID
MB1MAO$3$4T4VUA#`\#]P.JQ(<2+C,C[.0L=,DF,F1J.1W<$2XZTG2UKMH@]Z
M%'ZRA"9($RSC!(_D0$?I8H#SX7;I+-)Z$R3Q`._'@1#YG$8B/B4^K>B9N0.<
MHRG3F;KU2W5^YS%XF`M>IMREEO!\8DTZ9T?G[(X"KM_*J95DR(TLN/4Y.V+!
MRH#E]B=;#L^XA*3'R\:$I)35MUV`6G],9S6H-_P<343`0P"`7-CWL"9IZ>2>
M<#$CQB+^(?XA8"+&*AUCG2+_D+6U/AW@9Q%B3QU_(A@/P\`91GK?//33Z9)9
M22G5;J?:[842M6]VZ\W#$[8J^?JDA4N(?R6&N8*![<CQ2SVO:[2H=CL!4Q6`
MJ13JD`RSPP/;NK)/M6ZK7^\=GK2$@(2`9)J1:;;-`:2:T2?CC.J7Y+?3>2T\
M?^)XM-=9!HU`&I.V%(A_:*^3&*M\]"%@(GMK9_O]ORI=#\\S`PGX0[IH2E(F
M):Z=$H4RY!Y.;Q^>?+7%2V[5Y$K@*:V)]9C-=H:;<!3((?3?5M*J(%"Q"'6R
MZT%.DD*20CJI73=()Y&DD4XBG42Q[MR9Y4:5RT172Y6=PJII4E@1+(,C7JDJ
M12$E"BE12.G@]"'^(6`BQBHS8YTB_[S1WC(J:W#IDN;^%"O*2E7O4R35SG4Q
M\*0`.)NZW*.0PMM#"@T**!#L4T!A?\C*4(!(3DA.2!^1/B(Y(WU$^J@TX>WJ
MNEN9]J(DE;91I9FDTDBED4K;7Z5E5NF5Y(3DA/01Y;62G)$^>H,^RNPX;57D
MA%RL#;SRD0=_B#!WEZK(HNQED\F<HXC[DK8JHDTJL#@YK8(X9A[S>(5F)&<D
M9Z0/BPM!DCXD.25]N+,^S*F@;W7U(;F4&WCI.CF+,O5#X84.=Y<K`9!"+4*A
M9K8E00J5%"HIU-T5:F:G.$]%H9*<D3[,3Q]V2!^2G!Z=G%9!'&,![),^I*H'
M6;#2%UU/+I+"9G`GD,"*7![")'09!/@:*.[!9\FF(M!>9_["NT_K@9T:/V34
M6?J0Q8%RLHEW(?WV9#QBZ"`57:"45UZ88_'MYA536B>^)*4DI:2+21>3E).4
MDRY>HXMSBF>=JBY..=O?J6;-ZZXO;&`IH@%KB/=C563]PC`;[Y8X6FTB*[(Z
M'DAR>-'$+XI@P<$$\#R43'RUW,@&EWL4^!,6CL7"'_<]K$SH+7IAHS.>>.C*
M*6=#87'PX_$^)V!"E3.4[$G`3]P+G??SLH;J*\^'X0/W."/@8B]\I8%V_/?W
MWT7R_0/GTXN;."CP200JA'`/=+MT?>N/'_[Q][]]GUQURYW@/]R-Q+4C+=>7
M42#D_$I@<`_)_5F,/IS=7IL-H_UO\[?[ZS/FV/`%M\+WYM5-NW-Y>=7K]]N7
MK5:KW6\TKULW5X-^[[+3-QMG/SQ;X/1*X(%7R7X63^RS/^&;D7EK_N@MLX.9
M,3N8"_.BW>T9_8[^\4D/9^B[MGX=$I4IJK*/@B--)\"M+V<"["X#*6@YB$S<
M`_<K[)#`V*!?V11X!T8`_#_R@XD6"3[THY#Y4<"XE"+45:1<AP\=5Y7M!%G@
M(4/A",0#R%'@SMA$T\Q6UUH\"!S\.V0C).NC(BO^`O,%P0B5.#%7/`J7/3DP
M>D]]D;IX[(B`!]9XA@**O^'7>GBAL,:>\V<D4`P9")\+<[2Q<[TM0A%,8"68
MC*QQZG$O%QK==AE;+RQ2ZAE+"K[Q#/WP<_HE'E+=7>86O&;^8+5:S!*N&U_S
MX:QQICZ#&K.2S[L+ZI-CA^.+?K_>:[0;G9YI=F"^O?:[1)>"S+A\*L5%\L<*
M`R^&F`[]+O1K9ZUALD7T6`WMPUG+>/>JZEXV(N(;][[/+/J%-$&:8!DGN-N^
M3HX;A7EM_?2R5;#XN/5FQ4"B`OM7!#JIV:@Q-,?8^9W'X`4N5FC\=A\?]-5*
ML\6OQ,O4MT#UB>`0]+_W0^Y2'"3[.`CQX-8\^._(!W]R0>Y/@6.]DF-<MBG`
MW0,+W=RC&K4^.7Q<E#[_27E%QBZ*@4"+0"MK/ORRB&(M:/X+>.+!48G3+T.X
M]E%%2^>SN/.FT7&B@DFH0*A0%E0X)OGYU?,70'!,`S]>K&INC5641;H2K-<?
M\3$7#CBPCI5$$S`>3VVS"M`.I2%6==4J<1QQ''$<<1QQW&EP')6CV)"5<<7E
MF(D_(^>1NZ\FG>3LY)?B;.C;TX>_*0P&MSWFN#W)#I5RW>^VZHW<Z5:5=$S2
MGSD9'H1:A%H[T$PS8,\TS/Q%E["+L(NPB["++"Y"+4*MPW,;H1997,>!713[
M>K&[ASKD8HLA/%984:".&=$VYZ'U`BE4XCCBN+(0CCB..(XXKOR$>VLZ6Z^J
MIMZ5'TS]`$]_/[/T]F%):DFZ[)09-:/?R[!G6]4=,M(+&>@%$D**C)`@DB"6
M3A!)&Y(0DA"2-CPZ023G<8/S^"/*O8<UV<AQS%A5=AM9]E:LNH22JB152:J2
M!)$$L8J"2-J0A)"$D+3AT0DB.8Z;$LS\('S@#[K^M(\%K'19:X8L@67>R9O,
MLFU+OT$9[:0]27N2]B1!)$$\:4$D74@B2")(NO#(!)&.*KU^5`F+]80S\ATS
M%=9.O4="2MJ2M"4)(`D@">`)"B"9JR2()(@DB$<IB.0W;O`;K^&71ZZ:1&-S
MYH!;.Y5X)2'=E*O3:-3;))ZD)TE/DIXD021!/&%!)%U((D@B2+KPR`21?,8-
M/N,GEWLZ3U6RD1\P6XQ$$`@4O\E4>!+<2=_+16I?:79Y:E+=:M2[F8GSOK2M
MBKB3WBU"[Y($YZZ729!)D$F02163!),$DP23*CY>%[K5JJH+?>^'W,V'S9K`
M9K8?829PPF?[2&PI>+-,/51>(_()-5EIU9I&H]XZ/&FK@I-D\.QO\)0(&N.W
MX:VKRIYP,WO<S(/@54APWYOFI>%@0EM"6S)$R1!]U1!M-.N=PY.6H)&@D:"1
MH+$\T)A[./,4X?&MA>PJ&,[4'_$Q%TX(K[7T&WYR^-!QJ5=J.90/:6WB..*X
MDA"..(XXCCBN_(2C_.]\S@R_R('D!A<`A=7Q<LUNAFEW96`C"NZ54!,0:!%H
ME3PT5P9N(NPB["+LJC9VD<%%H$6@1:!U5*!%!A=5/\@L^G4%W\&(L=FSY7O2
ML46@"AXP?P@#47_F4T&/SFLMYW[UVWEE?IW@22TR53+87B$1/KQ>)D$F029!
M)D$F029!)D$FH_J(?6@J?[`'F]'1"CI:D3-1VV:SWCP\8:N"DF3HY)422\!(
MP%@I-Y#@D>"1X)'@\3CA,=/<&<)%PD7"1<+%"N!BCD''4P3&5-3QNY##U-==
M7]C`4D0#)A'OQT)!J&$VWFU\2>J>):QI`&\KRCL>P*C^G'ZHYP<3[BY)B('7
MS!^LR,$LX;KQ-1_.&F?J,ZRUE7Q>0Y9[9R(D^UD\L<_^A*\@^)-CA^.+?K_>
M:[0;G9YI=F!^O?:[A!N!F5P^E>(B^>.?SQEH,<1TH'C!A)VUFP=;Q)K5T#Z<
MM8QWK_+WLI3%-^Y]GUGT"VF"-,$R3G"W7:`M]\Z*-V(WJ[Q>MF9"+ZDJ\Z11
M?>B[MG[^0#)_Q*Z%)29#$;"F46-FPVBQ\SN/P4M<3+W\=@=#8OMS\<6OQLLK
M8('Z$\$AUB#3K3MRQ8@']^#!?T=^*.P%N3\%CB5>3KHNVQ3@[H&%)12.:M0?
M>?"'>*780]G&?/Z3>!0N,W91#`1:!%I9\^$7>+TS`A(!@8])?GX)@7F.:\1#
MN/9113Z.:=AWWC0Z3FPU"5L)6PE;=Q_WKYY/6%4L5C6WQBHJ]KMML=^!Z@6>
M2YW?8D"L=$J`E"3Q#_$/\0_Q3SGI0_R3G^%4X=(A7(Z9^#-R'KD+=O!!B^:6
MG5:995H=>;Z4>E[7Z&1WXJ@J>4ZDI@@U"#5>($8.QW$(.P@["#M.`#O(XB#4
M(-0@U""+HQRU8*H;%-$Y9>I@ABV&\%AA14%^C2-/,2!'>HOXA_B'^(?XI[3T
M(?[)SW8R>U6UG:[\8.H'/%PQG?;AO-=J9;[9>RN+EV+4&IUFO4$>"J%T7G5E
M*R,KY-&3O)"\D&XA62%9(=UR+-'BZGH\/Z+<>A/LOD7>SE84Z[7Z]1[)%^DC
MTD>DCTA>2%Y(LY"DD*209BF'O)"GLRDOQ@_"!_X@&/=LYF,1%L;QG#7#`K;"
M)O=GRX!<OT>)K*2D2$F1DB)Y(7DAS4*20I)"FJ4L\D+'`EX_%H`5$\(9.3S;
M$:Y3[Y.0D5(BI41R0G)"<D+&&\D+R0O)2QGDA9R=#3QS#;\\<FP'`H/SPH!;
M.Q6'.STAZYK9M=*MBG21-B)!(6U$\D+R0HJ%!(4$A10+N3GE<G,^N=S326R2
MC?R`V6(D@D"@^$RFPI/@`?E>'E*71ZND4DIE,\.H]FM$JXJXDGHC02N#^B-Y
M(WDC>2/%1H)&@D:*[0CE[8U^7ZM55;_OW@^YFP\W-8&;;#_"-,',1+&$%,RL
MROC6U#OF,N1FK=]JYF4OK*%950",#(820E/\4+SBL*KSZ'$K#TH>9;[JJ\0L
M#<\1VIT8VA&@5<P0:W:SJX9)AAA!$T$30=-1Q+DJ#$]OK=E3P3B7_HB/N7!"
M>*VEW_"3PX>.2]VLJ)M,H?0A_B'^(?XA_B'^*2%]*#TTGU-P^>9=EY!>U'HX
M];QVO945.:KBII&B(LP@S*`S+(0=A!V$'61O$&809A!FD+U11NR@H,C&%M]>
M""/&AG>6[TG'%H$Z)LO\(0Q$_9E+J:"3.?!@&NUZ.RMQ/)6C#J3J2=+*H/Y(
MWDC>2-Y(WDC>2-X.+F]D2=*A63HT6QX*4D+T3NAE-NC(+!D*=%*#@*E<P$0G
M-0B>")X(GDH*3QDF`A`L$2P1+!$LE3P856%@2D6COE/-1]==7]C`4D2#U1?O
MQT)AFV$VWBWQJ,I^4&1U/`"O\**)7Q02I((9"S;FCX(-A?#8RG2R?)GGY_IX
M-N$A_,A=YDRFW`DF0$G)_!'SHR"I6CX17$98L9Q[-K-X$#CX=\A&<#U[Y&XD
MF!T%L"XL'(M\J1&.`R'4.*3S-6?"P)=CR00PEYWOI/X5>6*A+IN-&C,;QBJ,
M9?G*.KOS&`H3IM+4<-V`HY_P_XZ:F:TQ]QZ$9'`;\J7.&0J%-?:</R/XW@_@
MIVD$/!V%C@LWV_A5"*^2(Q%($.?P"24ZQ=DQ\Z-<,%<\"E<2LQ\=LP-BI]<4
MX.TG7$IF`CO(,(@TZEDN`)XS4N@&G[@<JR[<<(_Z&1=BLFC0;8MAF&K/S9[@
M'EL`F$Y`:]G`'8$?/8SA7R>PV90'X8Q-`\="SH&A/CJ6D'5V"^S'X39I!<Y4
M9[AIZ(67.K;FWVG@6P)X#MX1"!?@&A[NJV?!-_#CHX.+-IR]^*H:W`LLCG?^
M[(>"&;7<EEE_Q,<L587X$DV`>C.<X!<P@X#.%H?W#2S+CU2V'_ODP\58-(+=
MXEK]1ZW5QX7\K:;\9<DE-:0-DAXS#GU%?2#KR/&X9Z%^E"%\H1G%\2PW0J(_
M.?!X3]V5Z]A`1%;][4P!`!AQPHS&^_\;\V2L&M`N\$;PFV;%%/_AG&UA.5)!
MK,\\G[D^@&^`C.8**U17.-ZCD&%"-?8(?\!B@FQ-D378*/)LF5`Q7!;2L2,"
M'ECCV7&Q[L_B:>F'P/?@;ZLH!@8B2G62&$QBJ9K,O,+,]7R,<:.3OS$.'I<?
M7/R/V>XVAWS-VJEOGO2(A[YK)P>N`;?O%K"?R?P[!_1%M-`DMOD,N4Y)T-R,
M5YHJI>AJ[`D>/V8<)%'IP84^-IF[*-Y34U=(Q?S*5N+8P<AUP>E]N:[/2U3;
M1)34/4MQG,8SRN+G]$,]!"=WF1GQFOF#M;:VA.O&UWPX:YRIS^"N6\GG-<MQ
M[TR`ABC/G_T)7XF./3EV.+[H]^L-L]UL&4:ST6FTS/Z[)&X`W.GRJ107R1__
M?!X#6`PQG0.RB"-TUB;\;)%&HH;VX:S5?O=JB&(Y'A+?:.Q[W]XW'LM]1S-0
MFN!!)[A;@M?!-@`V1R5[V2JLQ>/>E'79?6/6Y9!;?SR`7^;9[V/CP5;_RSL=
MTP+-)8)\R;NPAK@UW&#[#)1-@"XXV^AYT^[5P=FT`MSX$O]="W"'AN#1-0W%
M@UMO)>^%JGD0^XA0=_U"G-]Y#![FXD'*;_=A\==JG!V`ZF5E>@QF;>LNE6+`
M*O!&>B%[O4!"LS4/7L6A#!(<$AP2'-(V)#0D-*1M]A<<ZEZP?O\$=Q0EF_*9
MVB4(?78;380-I#@D(FT,4Y6F1=G>.W48F\HXL?6UF%X5F^.M(:C1R+#G5.D9
M\)")^IE&D2MF?1`6$A8>'@O[&1Y/*CW_T9FE:B%>B;$K6[2JPHDCPZQWLJ('
M@0:!!H'&*8"&4>\2:%"`:AM>Z=1[W?8[]D5XCA\P':ZR\5P$YL8OL$=G4O3V
MB1._M93=H9*J#N5<=$RCN(IW&XE;%;FG8$L&6STDPKN)<+O;J!LDPF3O'YVD
M5D$@M19MMK+SG$^E;BQ)&DG:[K6ZNDVJT$RM>3+BIO)7:"Z%O56F3<'7B/R6
M7<,RQ]K6^>[-W'SW70A;%90DYSVG+0`"1@+&@B,B?0)&<M0JC7\EAKF"@>W(
M\4N;<JUNW2R,8@1,!$P$3`1,V\3;>FT"II,K0ITBZV$+P<U+G&+I-V_3\295
MKE3(T)FHRH"1A!G%U4V9/\2JH>H.72VW%E>\Q&NL*`BP%JZ#Q][@`:KPW,@/
M@$!>_*,U8^*K+L7+`GB\7%>`-?>:F3IQ)M=7+&?E;"@`JXE:2U&UIHOU^4'@
M@W@K^DL@QZ(@K+U=\<WG5?VFP.(22"ZX'5?*-`LOE7GGX;B$[0F9;[5+JM:J
MJK5FC&*EK]YYY:NZJHA`\*=T0#EJZ?AE"`"L_LRXHF<I@%U5W43XU=4LXZK/
MDG'0_JZ+^/O$`QMQ=;F*[KP&J+6@F[5$-W]!M[@L:"PO,JZ1W4R70*?"GTGA
M3Z/1H%*?QU#PD29($\SSA53JLY2E/G-.WSE@@1_L6`)*_EYU!_GHJ\8=FYS<
M&]70(RGX24'"S(*$Q*?;\ND7YVL^7$K50"M3#;3(/)'#R\LVE9JI-#,513LP
M@.]2F9E8L#)@N7U=D\,S+B'I\;(Q(2F=@]\A#'X[CVG7V%`\.)Z'X7!_Q*9P
MBV\?4L++7R*J3$FW5*),/;W5,>J[E&O8CZBEX4#*:2MO3MM>F%<6QBI[,:*C
MQ2QMN73;F1=*.#S/$!A5#(Q*K_[(`"N=`68:[0Q//)6>`PGS*H9Y96$L,L!R
M-<!ZC7J?#+`=P(@J=VQ@I4&<5OYR?NR^U71.K()<LU-`MXVJB"39!]D)6A7D
M*46FGFF8F?$1R0O)RZDK)K/;*L"M)4DC22/-='J:B9RK#3QSI8X[XV'3U.D[
MTF=OUV?G9H;%%%ZCW8+?CKMJQQHZ[I+732J15.+R\UK913NJH@I)3DBI[5UM
M,</2]^2BD9R=G#YJ9F<45D5.R#7;P"N?^$R5+LE%<5%CI27%ED/HA-HKD0(L
M3%ZK():'$D22-Y(WTH^D'TE>JRNO51!+O:W0SC!_:TNB565W8;?]!#K0_/J!
M9N'9V1]E+K:'4&ERB\MTU";/!D-'F]>^[C!T/\N(^-Y4+PT/D[E4WL,ZU`&D
M$.H=<P<0L]O/J[U\A3N`$#"5$)C*KRO)WB-[C^P]@M6C@M42`R39>V3O4<>W
M[7LE%=8(:*":^:Q,(LM78`GV!8(V&S6VMGIJEJ]4O=!R?<.UL,1D*(+4Q`PU
ML7R;=-48GTX#_ZOJL.?.\IWC-\V&63>3(NY'OF#?F(U&O5'(9&HL$'(JK-!Y
MA#6JK3;02OIGA7[(W2V[:(D`F_"-7'BLL!F7<.UD"BB$S>CP<?"&@+D^`HH(
M)LQU^-!QG=#!'H*+%G7P`L`7*>SE%G=#[G+/$DR.A0CU#6K(@9AP1]5$C:^0
MRV/@BU'@(+AE!1'\(KY.\252K:H:67UU<8\+)^\\I)B'BPHKHPB$].36GY$C
M';U<(^P>!_H7EM(2-5@R():%BA=H-5^06>YX^XTZK5L8IT^!V87BX#5<CM]L
MXF]LX.E(=:WF=^QU.>3(G/`!4&Z84$S7/H;O/0'/X!)I'Z*QCU?]KM<D?SWV
M3:M='(+8CK3`N5RT4>6JZVGNDS3S;6Y:2]H!2L4:BUZQEB\5A*@&I'''39CU
MR`^2!K)3CH:M`V9I*&/66<A4C$HR1JU'![DH>3H;!?Y$_6+')$R++;X"11EP
M+L0FGQ9,"0UH&`K`MS_%-%\V!?23"M<C5['Z@CT=W0]11A;`HX8\?!6\VM&U
MI"VPR`%%D7%@1`"6V#I7)0_'G5G9Q`=PMP5<Y<*P;2&MP)DFF!+B3$.@M>2*
MT=>T9"V^(^M@0<#\.[(".:78I+K6=6<]N0:F:CD"H,;=I\_*(L7_KC.A0N>X
M-"YWI0__Y_J6XHZ<%8+9JG>*L8]C7:HMQFD46&.$@&G@6*H#-U_+``G:HF*U
M^%2QT%^QY>9ALVWN/3@8!>!2BE`WU.835#LI$FY\^K*^ELZ#YXP`.%4;;VSP
MC7W"E]M^JRG$<*YQ,I(+"T*924E[V)09D>H4&^/^'-AQ!'K%[=\CJ>``H1[Y
M!![J(@3S8+:XGLN$D.LT`<PTUB,K*D0FG:$/HB7N%0"J14+CW'79$&X5>L*@
M09S)%,BEAL`]+X*UFS%81`=]B\E$!`B/SE]<:P\^`@<A9@QXO5#C>+:P\2N`
M%T#G(L=@=)4YX7)W=S&*7-#!(T%Z[!!Z+/G[^^\B^?Z!\^D%9G_]!V7F&JQ'
MUT>ID?>`W9<@RW_\\(^__^W[E2M_6OB)'[6<V;]XGX45!0$PYB67COS56PCQ
M'4HV_.S#4,'Z0KK-7Z`,??CP68P^G-U>8Y#GW^9O]]=GS+'A"UCU]X->N]<S
MFIW^3>NVU;Z]Z1CMSG7KYFK0[UW=]&[-LQ^>J:8TV5_IH+PN4DG-N*D9]QZL
M1,VXJ95SF09*$Z1FW&_9EJ-FW'L<&SE\DV-JQEV*XTW$IZ_P*37C+A$PKU\J
M:L9-+61/!*ZIA2PUXSYR%J1FW(2D%6!C0E(ZNT[-N$M)\%P/+-%Y)'T>B9IQ
MTW&CPK1V]IA7%L:B7I#Y'C.B9MP$1J4'H]*K/S+`2F>`43-NPKQCQKRR,!89
M8+D:8-2,FYH29'28VZ9FW)E9#]2,F^P#ZJ=3LG8!)"\D+Z>NF*@9-TD::2;2
M3.1<%>I<43-N:L9='I9<0T=JQDTJD9IQD^E82CDY-:5&S;A)SD@?O4$?43-N
M<LVH&7?Y%%L.H1-J-DH*L#!YK8)8'DH02=Y(WD@_DGXD>:VNO%9!+/6V`C7C
M?AL!J1GW&PE(S;A+L1:Y'K6AYHS4G)',I:,SEXJ'U1(#9,&0F!^QJ#DC`1,!
M$]E[9.^1O5<R'B98/3%8+3%`DKU']EYYFG%OV=(HPT9%2YV0?O1]&_M=#3S[
M;MX0;:!:;2VZ*.W2X^C&O+TT;QJW`[/7[QO]@=EHW.@>1_W+;N^R4VB/(Z,W
M7>IA9&8L(.9"^[>[/:/?T3^NU,=<D)9IVJH.:`GM7^2GK:>*0'(<[1I7J)$)
M`0[8J7&YD:"LJ4:]NB%T-(E<U>`L;B87=Z%+M:RSQCQXB)M%ZSY^*IFKQG@@
MF(PF$QXX<=="W26+6E3ETJ+*?&N+*G/O=CS=(VDX="SCW/>^WI&,D];O-.='
M_$G]S/XJ63\SHEH%J%:Z@-5BN,:1)F"6I3O(0'7(35J/,6H64E(^K0`[OL2`
MU\(2DZ$(6--03)A3NY`<B7U$>FG]0NS;!.]X*7TXIK^1H3/!N,^VH9I2C/HG
M9[1+21=2#ELJ!^HDM34+7ODR)!8D%CRDP;*(VA\5>@]2.PPD0B1"!V3%GP6!
M.'$@V1'$@B?,@F1'D`B1"!5E1]`IW/792;]$X7O7@264PF93`*/="D653*H/
MDOUJ--^;3383/#ABRI4.#S.G3_E/093I)`\=U%%/;[>:]6;N1"T-!Q[R'$ZF
M._$$AGN"(>'=SGAW9)!VWNHW,VRI2"T%"/H(^@CZC@'Z6OWZUHE%5'>>?-3"
MZ5-B",H6=(X<6[+W#0DU"#4(-4X`-<Y;/:/>S9HB5?&RLO6K"&P(;$X:;#I&
M=F6FJF*A',-.<!&\<2T>A>M/A;TEKA0\O%!88P\<ZX?9\6J#PVQ'M]^;S<6:
MTKXT]70L)+C6K#4:[0(V2ZNBAVA3@(0P^\T]L];JFQD6XZ/M/9)DDN1#9!X9
M&?9X/7EE2I)VBDV2L[5(259(5BHK*V`X-ON=>B]K)JJ*?4@;$R1B;PW&-WKU
MS(IK5449'4,T_A!0<^>]GP:^):1D@9!`7&NL2D#;.FJ/-:#?S$H'IV9QLG?G
MV6+D>$XH6.2%C@MCG$Q$8#DP$#K*2CY],3Y]MVUFV'7WU'UZ"JN1"):B`3T)
M(@DB"2+I0HK9'86D54&@='S;:&6WTTN20I)264G)P>HC>2%YJ:R\D&8YTE!U
M$<QQ'W!;3'CPAUQ($_?*FD:.@_7X1!QQ#O2!(^;'2[CCU22G%@WHM"@80/$X
MDD`*C),@DB">M""2*J3H!44OWI1HEZ$$D:"0H%164"@L3O)"\D**A:+B;^>-
M@?5GY`3"5EG:CC=OJK$0+35V6<XP^5+\GMJ`[+5G]M[H4A<0BA(456W%['>R
MJR-X\H$""M61$.Y>;:79:V1WI(]JK9`<DQP?@OO,6M_H4+45"HY0<.0MU59,
MT(:9]=<@62%9J:RLG#<;C>P2;*MF'V9K$9*`G:"`@44'RHA*?SV;YQN#]4;1
MT=O"T.;>#[G+'"_DWH,S=`7C4HIC#H&7#H.(/F_Q*'6#X'CVS>E79OL1LFG2
M)'@?`I:_'7&9NB2^M@+4,3L^UU_K=(P,R\#O3??2<#%M:Q#B$N(2XN:W"U5K
M=CH9[D.]F?`[!2(JQ/NTBT6P?:2L2[!=-,5;-;/?RJ[@-AG*%($X.F`M"^<=
MM-'HUJ2M(C#&,0.ST<VP:=6K4%@6OB/$(\0CQ#M!Q`.?W>CVLFO.O#5%3\(U
MIP0"`DH"RDH`9:O6,#-LFT.FH?XS6/S)8?KKKB]L8"FB`7.(]V.A0-,P&^^6
M^%MEGRBR.AZ@8GC1Q"^*8,);/V#A6+"5:63YDG`<"*%.CTKG:ZYO8A/X<BR9
M`#+:^4[J7Y$G%AJGV:@QLV&L2G.6KZPQ/O%!]G5;'^:/&$^.YJ[D][`0\W[R
M)L(W?;/>8'"[NZ[/4*8KB^R3[UR,7K?>+V0R->Q\-156Z#P*=P;+*K%KTY3C
M2H9^WM,T.O5>5=;,[#3JQD'6#.Y&X)P&#D`H'HZ.EY#C!6P*S_%M66<$L$<%
ML&DQQ&63?#)?3%SR7%\/\UL]9)+M_'!.MK`"P:7`^>R@4)X`I8#;)SR`US,[
M`#;WV'#&^-(#!__YY>>;_Z=X\?ZW+X/+SW<@-W!E)"2SHP`L'C6&-;*B[AF#
M@20")KZBI,$P7&<D0@?68/X0&&3R8!B0[4@K@O'9;"C`K:RSP?832@TG5ZI7
M72;SY5G&7>G#ZEEN9,/R\YP52K-5[Q:C'!V0`"?`=I?,&O/@`7G<Y:'&'O`O
MD'O]*(#_PGG)%187,*FO4B$3O\/HY>]WQ%NTG6X?-XSUC_C0"P<,5L?2[[O6
MS4!AQO?"&GMPR\,LDREWDAFG'-@ESZM1D.>UF&$XGV$*7S4O2,4+P`0QK$X#
MWXZLL,:>X#5C!<F!L-"Q1X`#5/4\M%``^IZ<<*R@;2*`M0)DIDO'?Q!>C=UY
M5EV![=WUS17[!+PWX9:(5$Q!LBL_F/J!QD]XI-EH-.OL'A[DB9`-86+LD;N1
MXDZ8J]1@BE`,7U3-'E`$SA=OVHU6O5D(X%0>,U*-A3^G&PM?+QH+L_.[3Y\5
M$^%_UR\'TH\.4I;F!L`PQ?[*'L8"0'Q'H&QBT061A8%J1;.I!?,\C##F(7L2
MB1VE/X\YF&V>'\+=W!JG(0PQA(W`&'2&CNN$8!V&VN8$,)N;8])!=*FS7Z>^
MM]JNN(:O>P*!@.&$(I@`Z=4CA`1#4.G'2(I1Y"K;L`YHM@)[")BI%^%[KWSO
M$8'0LY25>BN&0<2#F8*06FI^`(I+1`2&>@CX1.H'<R\UBA1!\X:^;UIFJ]XI
M""7N%:I/_`@>JI9A"-2Q?X^DFC2XL_`?2`*0XBO8+1[:+;BX(Q<44Z16,'9[
M.1BF`;H;(7<P$@7FFQ4XTV1)E/8(88B26WK=IZ[R(H"I;/:S#\\T:[G1=0.&
M#!9LLWI$+E/5HAU,B:X0P@0:=_"7BLIK]G(\[J%8P!OABXDR^RJ.X$N5!N\6
ME0;99U5@4'W]:8L2?IDA=U%A^$TE%EFPF'AL^J_8B(F)^`SQ$#+G'KA^RBCP
M)^S&!11+&WE3UV+G^.VW=?TC&CUS.`0'_Y,(X`$^W`0>BS?3-\1??HMH>BTL
M,1F"D0EH2L9BGM'.6J]M%!2CKKRY>#/7Y+=1&(&B>AXZNEM$C`;:&*H6Z/R"
MH)&>,T;=/`SC23;DB#Z^CG&#A^GY$W@J*JAH,M?@*R&U.L-G3GP)8X2Y.2,P
M!V&\JZ$W'BQ'.Q8>;CIP&'N[\-B!YT7<Q;!['+3#.UP?TU"4!3(%W/+P>VMF
MN4(9=%,1@*$R09N->]R=24>A#HS'L9PIWQA<7!U'8A(E3\&_,2853;6F?AH+
M#QX0,'P*3`Y,'VT8J8BQY016-`$=#J8GF)%^Y-IIX@",\]$(K%=%Z5=')\`,
MA3?%E,G:'B@#1RKN"4"CP&-QA=FZ%598F]`_WHF!MP0V^Q/,^E#'.S`TJ3ER
ML70ZC(AZ%O^>1ZT5ER<QYY&&@YC&ZR+/:B\H<D,<#P;1ER+@^*P@<7?6B=>S
MW3Z]@Q2/6SX;<#KX::]YT3:#UARM];(>MTQBB_-(.G#[G/'QU<BJ`IZ'04KU
M?+`#4DR][(_IBQ1];JYN[ZYO/@_4GN:3`.\!E7VH8_J.5!13QHR/Q@Q:MV"&
MN.HK[L+\/;TE\/$+>AF3R-7^1"TF`=[]Z:>;'S_?7?]6TZ[HA,\4-<%5U#[:
MZI3J[%*A6315>.;(A+T2*M>>S2>FY=+BH>/SPEX"/'2^%+"F0[7*(]]U_2=Y
ML;>4IH02_2]G--LHAJG'+"6E-9ZI7_R<?H\'9.;N,A[@-?,'JRP:9L%2QM=\
M.&N<J<\25CWYO`8`[@&[)/M9/+'/_H2OI/H].78XAC]AFG%F$FAMET^EN$C^
M6`&EQ:#2)5[FV4JMM05[MB@2H\;RX:S7??=J'M1R1E9\H['O?7O?N--]N]7&
M69M/MIHQ5GSNZ.:\LUZV"JF7Q`>>M(P,?=>.DYOOO,3XEKMDX<XGUGRM/NDK
M5"_R^.S+2X`(*H)\%V'Y;.'Z)1G,G<EUZ7GH!S)T_S9=L-8MS*3&U&GU"$`Z
MLO-`3+BCS#3I?(WWI0^:K5Z*@K5E.L/\AB/*9>;!-30S>NT"*IA7,'&:L&T5
MVW8YSD3%R#=(9-,P22))(K.1R%T:Q)!$;I!($W1D=G4Z2")/6B)W8222R(T2
M:61X=IHD\J0ELD\2F8%$=ALDD221F4BDN4N3W>TELLB@\3%(;*>95_6Y'8A+
M$NV=1G.%?#@M[PJ?)2;MT1;Q++,&6A<AK[7[_3+4Z:P@5!YS]1&C4UB*)K!C
M<\C7I&BNW^S]T?=M/).0R;P[TP,57<%$+)T;I,X?JP2;:>`_.OJ`:P`_8;[1
M$P_L)),[E7N%>5L/,1W8D+N86+A_BM&F^5(^$>4343Y1-I)/^43'40[PC3WD
M]J92:2JS[:/,+K4&JL6G>N9G@9K&AN(09<C^.5:*ES4UZ&@K,:[UBKJ=1@$M
MTTO#@^4)'IU06\Z[Y/1)Z,^M^5QBPR<6^VWV&_5=@NRT6T/BN>9YO^"1I5SD
MD?9JEGL%Y=4<@W9J"O-?RB[,SUR4^9F07<Y^E&OSIC2V8YG\%VK/MN7V>,UH
MMZB/,>T)E;(B/6Z.I(_FS[<ZJ%SKT53!297VR+U>:Z-15`5Z"[X$#L3*`5,^
MTT7RK+$C'F&FY^*KY482:Q=@V8>\)]TKJ&8D"_E7-A2>&#GAMZJD@BYN,.6.
M^A.+-(B`R3$/Q-AW`<V5A74;3?@4ZXJRP8]8#B7U$XBO$Z3+6KU<K*_.E">V
MJ/^;;(2F6.QY/;JX^AR`&3Z0NW`SCE/7<4C?I\L\K"ZK3*I_OVUZ:PK:&;W"
M*]I=^9.)$^II(;VODNE:CBACB;LM%^]EMJ%:@H>J)5A<R;Q*%I%3I:O&/&>[
MP//SY4=N69$JWA,7!XK+G+N^E,O0G1AW+S-C\O?WWT7R_0/GTXLD#VC@V8LJ
M;;I(V[4C+7@1(/L]L.6EZUM__/"/O__M^^36.\_R)^*>?UUSH=(%\.&S&'TX
MN[W&U?ZW^=O]]1ES;/B"6^'[QDVKT;\>W#8&O>L;XZIS.S`OKULW5X-^U^S<
MW@S.?G@F/FEBOI+"LLZU>5GZGM72,S,6-G/A0+:[/:/?V9#&H&G*@*AK5$H6
MJ5EFJR!4H78M1P66:`4(53X/+6\T5E7EM=PK<9K->O]=SAB:=^\DLU7OYCN'
M0[:Y,KOUQM&O4"=O+MNOJ=6Q6XZJ9P;8PZZCW8JA")^$T%/_M?ZEOH"QD0#'
M+C:;H]`/9@N,27S7-?#C2":C"19I_@N+-E(AP*(3=PWSC9F[K?:^B;1FT2F_
M--#3&NB1'+`M5V9O&AS:;\S0R#D1HXBZBNN]N,3WN5?NR4?M.6S:9;I1'D6R
ME;[#.A"?$I]FPZ=?G*_Y<.F10&RAYU<R8.A2I<95HO9ME@E,!+W9<6HE&7(C
M"Q[TB`^QX$'`<OO4K<,S+B'I\;(Q(2EE>N\0VOTRC]-B(#8K@<[O3$;YDX6;
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MB$6AXSI_J0H"I%4ST*J-[&Q;TJJD54FK[J55,Y3"J@D;B1=YF*0+2RN>I`M)
M%V:M"_ND"\G#S(^`GZ+`&G,LU^S,J]@RKLK8DAK-H)-C`7N654DK(`U(&G!-
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MI)!!8T$WPV-/VY+W)$2>A+RD0DYVP2:[H)7A]BK9!6075`8R3@H9-!9T"O01
M3DKD]Q7R5(CANY`#^=9=7UCL(T4_F+IX/Q9J[0RS\6YI\0Q<JN<45I\=#X`A
MO&CB!460_-8/6#@6;&5:6;XD'`=B-<*1Y1O8!+X<2R:`?':^D_E7Y(D%HS8;
M-68VC-6RSEF^L@:R.IGR`*86^FJY))\(3.UV?*S#E.^$87JK.X'93@^G9`LK
M$%P*G(\?!4S,8V2.!]-?A,J8(YD="20%Z%(1,.X!O#I3^,G6_4G7M=2ID^#N
M_A+I?"6Q);'=16R?"^L3GTLK9T/AB9$3LD#(R%5ER4>!/U'/"<0$'A/A/S!$
M?P0R+-0_\,S(L\"$XO`&?.S4EP[619`U>+FT`F<(!!X*P(*:JGM^0%"(0<#H
MY`\""Q^I.>3QC_C0"R<$:++T-T]ZQ$/?M?4`!I8%SJ6F/`#(KPEAPQFNWYU>
MN_M7>SQO2YE.6=#ROT*Q!C*3C(;2L1T>.,`3()Q@$T=`$.'.F/@*;_"0FV;L
M$2[P(XF\@]3B43CVP5:$F^H,GC9RW&7%),(H\"12$;GYU_J7^@)M1@)L<NZR
MWZ/`D;:CJGK4YF_`:V&>P*E2,W#"I>G+\:U..&8C\03#M,0TE@`8@ALAO=5K
MIX$/T@$3L!W)71`$#@O,G@1^MB(I$S&!;W#F'FI0[T$HHOP.VA:E=/W0<8Z:
M/*I[@.*>&8@1/A+'BVC:9/"EFD@-G@L.3PV_`-/Y_?(S4V1+/5*N>V:C55]%
MR>-6W'<>^\@#:ZSTCUJ*0%@"[!P;`'($Q'!5.4TI%1#.\?&:>XX<HVRR0<R+
M,W;^Y?\.[K]5A!O!"L.M0+)^#9[XP`/%%4_`-&,0?\4A"@:1P_"!(<!VF(!M
M@J^`!")06LN;P14P$Z[9#WYY]-U'?`P*43P:/@(Y<!#F\:G<\]61PQBUYS_*
MU-K?PYMYI'I4Q)<A&^"%`,=J(D"6!@P0I/)AK+E*LVJHM*DK$-"'4<C&'$S#
MH1`><+W06A8FP-F$>QX,PH)!.S+$^2$-X")'44F]J*:_DPZL(@^6)@H_P4J.
MX3&S6$VIQWI+BZ)L+Q`TS:[/IA?Z(:[A!($VODO8\=0:?;1><U7+W[1Z]2:#
MV]UUM8.R-0`6Z*,81\@P10NT4`&$8GM'@M[&U7#@JQEH=(`51*5IA&CQA"OI
M.@(WQ,<\7*AXX(X_A)?8%FE60:9XY!C=0-:+`0T6'=@M3.`PM62/SH,/+"7=
M69UEC2B)UN\5IO4[W3Y&1E>UOG8-8LR>:W>%&I\2FF:KV8N&SVM='8M<GY*[
M/KA`V(%(N_$(]MS^/9)*XTBT,UXP[)73P-7MB<>`]T_!O/GJ3$"C`(+DBZ%F
MJ]XH!$-1+TW`$'11V[C:6XE]Q5#%.D`5Q^1CB2VV3#4\UE]G=R$J%O3$?(\/
MX6E`3*EJ<RM`!7Q\@MG$:Z">#^`9O>9AI<<47P;?8DQ9??N[#[`/RE@"4DAM
M6<P?@RIUA/4'`G##4$%(&:'U(5,6#T-`P1?!I!P/-.0D-B[1Z-EL@*?U#LS8
M&N,?4H2A*S1W*>6N%$#::@?#*WF?9L\[U%GX[L^@>#P@QA<1/#I@,)_???[R
MK788E$&C#=38"DX]<]5UB%W@YT94FA!J<*`JI[&]C5>[+GR(X`5HP`,%4\R0
MML%P1(Y:Z.75A4'.E,&"9O]#((1^B?*@`P`:T(PIV1+:=-*:]?EH9`2V#[*&
MMLES<I"+-+9_L4)_*)1=:2#GH)'P.S"RXC1-)XPV+AR1F#D^?UFX4WS9H2H8
MC(QFHR@T@LOG=2>U.8XLKYTRL%Z[J#H:/<6(RIA-X<.4S[3TX5U22Y)$$CXZ
MMG:ID<Y/X(P`P?PG=+-C+V+ND<^4VQAJ2_Y_8;XBT'K+;/7^:=?8M?``*_]0
M#OB2O0@+AA$H+'`"0P)_0"J;3YF'\7Q06.9();Y.A2=C9TA9DG/S$*X?@4Y.
M')U$;M0[E=PX'GRA!@F^1J2D5LF<,C-ANA:\+\#QA4_HG"2\A&]";RUV'L2"
MJ$;*VT'G+78W0IC-5,FDPKC42WS]5(6HSV`M$6Y@3R"/]CHX&SJX2J@ZN/V(
M'&S/T6CQU.?C6O;"6GH@@/WP],1OBC$]N1/74?P9X<-BO^C%3;SX[^^_B^3[
M!\ZG%SK\!+;J-?BRKH_!P'L`C4M@BC]^^,??__;]XD+`Z]`/9FLNU#[`U_"S
M&'TXN[U&2^??YF_WUV?,L>$+@-+W5^U6MW5[V1^TC/95I]$T^YW+Z];-U:`_
M:-_VC>;9#\_`+2U6]\X$IORS>&*??7`U-Z+8UMCXS&LP,X9"<^$UM+L]H]_9
M$!F<T_2XW0-TP%'U^I["(D!J)YF8$G093=#<^@O%%SD7,5U>[#WG+59_*4NB
M\8PN^#G]4`]M('>90?":^8/5'C=86:X;7_/AK'&F/DLP%)//N_/MDV.'XXM^
MO]YKM!N=GFEV8'Z]]KLDH0!8R.53*2Z2/U:":8LAIE/]YTD&O:7D@Y=W\I>>
MH$;VX:S;?/=J^L)R]D5\H['O?7O?>"SW%?/"W0Z!Y'C"**]C(KULL0P?MQZB
MST'5QU:@W*7XY'QBS;.W43W3'-%7EN/E);`$^ECY+L)R%N*&_32E8C;E"F'@
MA6&\9=,%:^,PE,[XL&<Z8V:,7DE^WH>#KX4E)N@]-XT7N7CK4@%45V:]W?J9
M/S$,)@0.=S,KTKE7@FX9#G^_/5_\FZQH^*K..](SS>MZ/76;V35/*P4?41&!
M\AXO*+!(0&$HGAGJ'#FX:#@Q>]3[BNR?+1/T_.`/C'RK`+K<Q0*:S\5\S>C/
MK7I0"21NC3IO&QTJ#$OJ/`?W^C5)JX)`Q2)DU#,+T%1%4DB%;3B1X^!NMK#9
M@^_;^6BP@]7'*X%`KG58VQFVLJ*J>*0!BY+4*@BD%L%.*\.8$=7%VTJ#5K8N
MWKTZ.N%LE8IR\$H6F_3!L99@R#6*_N;"-U6L*;*&XKU.NPSEADK#PV3PE#>"
M?S0%@HXO_K\U::L(BQH(&ZT":S"6ANL*,CN/LE92DDO<*"B7>)$:4ZVC>?J,
M4I(5K<]2Y7T&\9MFN]XKY@P+E]*W]`F-^?&>_^_NY\O/O]T/U#&,H>,G)QBF
M@?\0\,G\U/?B4+G%I^I,[5_QN7)]<`(9(A`/D<MU1CF>`GKD;IT5P"M)+E:*
M7PS%+WF7>3D(OW0*.L3^,KO$_+%@#WL?[G@9H-><@]E\O&7E'$Q\HO;*A7DX
M(T?8E[,K>%/`U8'"CSR,L%+$-<SO'B%_EW,RMRVS<=.XZAF=FUZO?=5M#[JF
M/B?3;5Y?=B\+/2=3FE(R>,($:PQ,%,N,N!/$1VG56;*)#_8'<H7ERS`Y78N'
MUH0^N6&+(8Q$6%%\@I0_<@`B^.7]R`_>2XZGU&9J;>(5Q*Q`M81T?.75XRM&
MHY'=@16C\\83*ZUV-0]T5/[$"DWPV">XUYFC,NU2YY#^G\&N5_=(]Z?+=5IH
M?BJ(3O_DLSG[5C:M`#>^Q']+9WKR.[M#)SE+?)+SA`ZXW22^VK9>4BE&?8M^
MY7_0KR0-D;V&(/'97F<D$8VC$I\K7X8D."0XI'=([Y#X'*/X5%_OT#F*315^
M=3,)3]>BPQ*6[FY'`C/'HU+D_I<IG?.$BB+4&KU.O9,[Y:J29/1FUCEA.X%P
MBW"+<*N<N$7PE#U]2HQ"V>+.D<.+>EZGU:"S\(0:A!J$&CNB1F9']*N"&A3Y
MV1SYX:,06\@EP9^D!<$(V\6HK@+[Q%VI--1SYZ#?;M6W3OP@YX""&GOK?Q+"
M%X4P,Y/ZY(609.T$*[09M6:KF5W%!)(5DI5*RTH[NVI-59$5\L9>\\9R=KY*
M>FKD8'9AJYNA:T95#<EUR]]U(Q$F$29CM@*26@6!U")H=NK]HD20)(TD[:0E
MK;`JW%61-"H!_&()X#5E<19%<_+AM;S+`I>8\$=;^;?,Z0]KB-JL&;U>7H[!
M+J2M"HJ2<Y]37A953*\T;AYM:>"-H)K=-CK53"</\<B`M<0063`H'KG-J)YG
MU@S#J!N%T8R@B:")H(F@:4MH,O,*]E48FK;JO/!Z4?!]:WTO%0W_23RH:T,1
MR(%GXP.`#85G.4+N4AV\:_3-P56[>W/=;'::G7Z_W35T=?#>S>"J;Q9:'=S`
M>&CJ(6;&$F`N?(]VMV?T._K'E?H?/SFA\\##=47K,^E]872FN5<Y7_A8S2&/
M?\2'7JB*]]:&F3.MD'JFT?UGM]UFGX`+83@9$V1=%?@EM=2>'JA9R"\>^\AG
M"ZUL]E1QS4:-73H^B!?[.&!WGE5GYR,_F(C`G24_W-G"2G[]EHT<%XN[@P!.
MIBYW8(`PCG`LV*_U+_7%XZ\=&0:.%;(K/PI"!L]4%\V_]D=*NOX%0BYFC+NN
M>``:P;-&`4H[X@@6FK_D,Q&P_Q7<#<<6%IC_-.;!A%LB4G`MXR&KR[YEYR"J
MT0C1)A!!+2YK#_=CY7LIX!T!OO?RYG[PY>;S+S^K[].WX*\W_^]^\)^[P;<U
M=O/QFGT1@>_YM?@U6SW^\\WEW2W<_FD$"Q#$=UK^^_GEJ6OPSI_]1P[*1ZY,
M[<H/INJE:U^3C#.IX8_D3YCZ9[_.NK5VKU=#3C]?R_G?)CTC+%C%B52K$TG5
M(L+!ZD0CG#D;BI"KQ7,FD\CS)[Z-S2-`6K#J31@(CM@,W/#H!-Q%4+8=_+46
M?V$[4G`I:LS"]A.!5'=%$S^0=89]"A9,)(7X0[():*Z0!S-F\PE_$+(6=_/`
ME[C8L&`:^",GE(H6@3\#M@"M4(_9!+M?3`/QZ/B1!/9=Y53^`/_`4R*9,*WD
M$QP%L&B-^4I"F-E-!`/'I*<'$N#R0'?-^#VR'Q1[AF,.S!^"30"JPO/#.?.J
M)Z^'&QRWN@\OF>KO'!S-(P"&78O76+]V3HQ`N(X8)4-&\<15`@WI!YZ8R?_#
M1@))A1T=-&7$UZGPI)@3&25PS"6NCXKZJ,X0^*SPR6<N?Y(1T%2__$G`ZV#M
M6>C/KP".QT*PV-$A/3.S\<^K]`/7SWB@;Z[/[S)>MDIV5SV;H'95.74+PEK%
MC@D"U!82C@1>H(INY@/0%W,JK!,*7BR/\6IO3^$YWZQC5E58.>$WS6RJ90<,
M"*S%]VG8W8D)%SRWPH[/)HL?$S&%:0MNC5,2NICY5E*W6<"`RI$G/!B?)50O
MCR'@CXVRK72,:H<C_@1^UXT^`+`B*UP`",S%E3!8>!6V$$*H6<`'B`0.CLD(
MQKX8'A"_#FL,<.@@Y,$XU(-4'QXIPI>[ZU30TKK#'[G'?E:D`9)\%+9CP>0D
M&Z`=_W+;W..WM.X2$0'8';,_(Y!]K;)!JQAS<TM3B7WY_-/":`J$)9Q'@3()
M-@`\(O`GZEFODI2=X[]_P0/C2Y$]77:K+`H?U>[@[A:,!24]F*Z@`.'^MR^#
MR\]W<1;]Q+'?WXIA$*&XFXU&'_2()82M1#00SF08@;&FA-!U)J#XP-\#*7+D
M&*Z8PF\1UT+"V:<`AW^-9LO$\;3!\%D`D$7JSW/]^^*;;]D#$!HA#FP^'"GB
MS+P./(RE4V>_++Y)6;'-6DQ64%PQG'C8V$JH/LV*>)_!M%1$&]@P&#1`84``
M0?>!,XSP>Z#$3_POQV?G=^[\6\$&D]3E_OPQH+=A3(ZK[_D6WP(^(M@X2/E9
M"KZ"R,4_YH"UCH3Q$)_3@\FQ'[DV3@0>"6#R!(XSX!M2U_?@JY0.5KSF!&#6
MK,A5IJ&5?+NXH:()QS)E):095'%L8K#&T.RM,JRV=Y+5!XT8.J!=P19"5*B#
M*:Y[6V!/@9IF,]T"+>;P.?7Y"`@Z22\>>!X.&GEK%U&)J=*!2HY20S*:]?@]
MJ/V>"[[JF`4FLA5)J5EFZL-?J)A2@TE<)^`ZQ[?URU9%-:E#\"]P4>;O/C7-
M\R,&M#VU,G$`J>*JYK]"6U,8]_-$[%H`*H>ZV]L(P!O=L(<Y73!U+0K'?M+=
M#?E:!>Y4$`1X$%U)K1_P`2`<$S]6.5,,XP%,Z5_4:^?Z"HQ#9:#*:#CUA<?!
M\TB&INRI^85\?LE"N:V.4O&\[5N1-EW5TY4T^FI\^C.8O&-GJGLB@F\9@HG&
MIMJ%GH'QY0EP%-&[!S\RT./!V5J^#X*D'Z=NQ1&DWJP!&?S@B6:@DY.A?T<.
MN^>3DPJ,_2L"E=K1#8]JRG`#L\UA(9`A\7UCVV(10!C.-!_Z`>B92(D.ADO&
MW!VAYE(1,<]!H?B"\JBE)N%3J;]Z0KT2@:?.76WZ)'$TMD7X[".7$IRH"%R,
M,/;TX\&N-HOE2Y:/.UN*!-3^?_:^M+=QY&KW<P+D/Q1\;^/M`6P/2>W.]`"R
M9<_M8'J9MB<O\I$F2Q;3%*EPL=OY]?=4%251MF1+,DF5J"=(TI+,]=0YSUGJ
M+)EKM$+NQ47O%5S0D]][X30`-%R0WBL2=')7E?-*+JGR(B44^?;#U,6;D#$<
MSSU,)O2>K\`JB;@<0#F-_#AT5ZF\59#G6(6E"*J.Y[YFS@>47J<BLO!)%4$6
M5T!X9<)I\R14ANJ"]X044NH?PNDKS>(=$N=4;&=LN^(Q9^=($M#%O%A\R,RX
M4%@*^9#)'`;%-3*/,+J?CG*U@\?I/6=>YI-S9#!6&K7AA)8P#!3&T_<T&-KW
M823]V#!-Z`+R/7+7G+X'62[<DX^6,QMIB6_E3D_>XEHX(N+$`PM_ES:.9%EY
M5R+A=-"HO!\M'-$[)4+1A4@2[V0T43S0)!3.N7"/?;)P#@Y3K\+HP8[<+,)[
M4-#ZF52K=.),M=_09$^(T?_YFKU?_&VZR2#"DDMBMC-_3F&CF!A&!C3WW3`:
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M+5;FBUQBF5+`Z`@1SB):'8!;*%A2NE[DWH7^O9+D248C?T:C;+-!D$H9+[XD
MU61.*G9'!A(9>"1\7N!XKG(B,T],S=-FMVDL8I%QSE8D*V;D^4H&IC*7,;ZR
M3LA8S-_%L0-E(M$UG)0@0UBIDTB$.:6)^D"689A94;['[]654S\3M5R\Y.E=
M^`\R?.56AO+HV(,,K2GG5/S(9=S>=N_%7C3CPR$7!G8@7W#V9J'H,A+81('\
M/N?+4OL\26:MW):%;)A//!+^:]\AAR26]Q0GDA\P";.O]-DA!$FCS=)C+AK]
M\XMNP[JZ[+>O#//*:AA=E1[3;UVUC<%!IL?DR:P1(%<"H,2,]X+9`N=9ED5I
M<+F`CE9U5NDL=FI:4Z__(?/!N'`8A>C;<UZ0F.+[4[^*\(P<6QE4IF<2XD9_
M>(%\['WNCR+K@PD?5*8;TG7((KCUPLG"*?)1!(HI-Y%L&X?L7^EQDOLN[)N[
M&9@[XDE<Z>`*.RG@PL*S)34F9#J?YI\LYR_'(FCHSL^6:0B)S$(A%+1FCY@[
MXOW%YW^:9-QV#>NG>8Q!6'ECDA<17!"[V-/S,EWPF"F><'A"_R5<<OA$+&7J
M>MD3)Y%'%J$G+'KQ\+9_Y]GL_<UOGQ6I1E%(%R0`)A(%TXP2,AA=!<%",QVS
M^9/))YK;5F('A1XG4W<B]$(4%/$*I>Z>4BN+S)P^-VX*RU'8"<^+8,@DC1RY
MN!.YVR1"0*09!;<3=Y>[>?1_R8\Z-:<CA<O=2'+L>$1K^:A\#)(/4HZT(,=L
MXJ<R!4:IW$01P.7*/7F:V)`)VLQ141M%Q#?T8&3@AV+K-9VHW<ZQ_<,;I_*T
M<JG8;!FG1B54/!8OHR2\W%=J5/9*`N#(70[)@DNF`3BQXBM76H#Z'%:F(5B9
M]"8/%ON3OWV>1E[GRD)XS\-4NNYRCT,HDYD1*KF3#AK)6V4!1A6C=52,5+F[
M6:[54R4T,TCE;J:=8:`TQV]%9%D%/,@>%H`4B]]SKR!O.8/-90I$0C6?07B.
M-,<J,TS<(\L=$X%,N1U$S_6=/S).RC-\Y.J'G,XIVK/=-902W0DY`NZHQ19L
MM,1<R!$@(YTCB@G$#MC<^RH=,*Q.\[15C71%G#@GYD$R9<&AF-1Z+R:USF/<
MR[$W%]"Y&0DI'0M!D'(TC:6XLPUN6UY38?98ANQ4'F9`])V$4<;&;DKVR..)
M2OY289TL*.#^.Y5*CZ`@'4]49"J_P:BD;B1<S*F49QN"<^!769RI$E'?^TX>
MZ2@,I2(=V]^G!,B];J:.Y*X$O6".-&.R9LAU&V>Y:^J!TXE(`2$V]X8DAW)7
M<D(VIW1_PULA>#+6E*DLE2"</12/.,$'GR\'/2W[7<@Q:^1O5IF%4U7,X[F%
M<RQ`=+K>QXOVCE+UOA\^T)N<;4V*W)N+VWC#QW5<X84@D?'$013?\_=1(99%
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M^-#GSG2[S%,Y42+[2;07<!?["<B=\UFMN8C'C[E,"\WO.7FB,GNL;C`M&LJ"
M[D_?T8MS[R)V;\6^/YUDBY89"6?MXQ<B%04MB_J:SYU1^=SB4?\I'_73/*3^
M/$VF2.982/M5.Q(K%F*>IS9?DJHVX:K,<)SNY`B>G(CV!"*')'J<Y]].X_S/
MA"?F$SM+,90)C=[0DT%TD4TM-DS$5E[$W:R:9)5\Q-/+N=G-\EN`23@5'B8Z
MDHA%FCY7/,V>]`)/YJ@LVV\E?K=%)4_$8Y'DJ/)]LETL3^VQQJGCR*3+(&OF
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M!'^->'..V^\Q.4L(N78L!C+^@E%\S`*^2<@`<KU*KLU3`V*]/V*-I$`D!>YE
MU!!)@4@*U-B-JE528&4]-'.)-:LSFCY^_29WTL3_!B)5Z"ZRQ[G,A0?9ID>-
M8U@HIE]:&R^;5(@=/V8'MO\8SPK3PV#A!+4A*N95\&1^4LQ2T5+SOYX:XN+%
MLJ\%B[(7>+8^15++--^5>OVL@'_>@D`05J53T269&WGW/)AV<E8KM*SGR&+K
MI7S[HFE?)3D4:B$A;%4#$KG))]I9_IBH1*$D%$F?\V9602B;9WJB-;%HH609
MEB%Z*,N9!^.L:8AHFBQSV$3WDQ^2V_RRT[/,9JNB_"R5]I83FZ>+LD:C%[G4
MY1)$%.=519!IZ]1Y8Y)YENXBFF194$_2=;-9<3G"94VT<]=YUEV+P--3R6FB
M2;GJ;99(FW2>GS7#M9)I;55'ZQLY_>6IJ"T1[E@-7,N1278MJE`FFV95,CEE
M@&".7!EFR=;JF;98`EZF)&C,5[11R=KJSQ36=GU4TGC>0F76/V7%#>N63CD;
MW9$D8AC2=%C@+&\W5T^0@4&^^>%#&'V7X]?^1^DD,?E.TGC:R4\BP4**RM($
M:+D.X7S(5&9.+(T^ST![9O`L0MBS[=U<]T+B,'$MXA<O2X^>O:BG6$7\F1`R
M=1)QA;JM]M<HE%WO["S76^:R9D-2!`"I=KE9<]YINUQAZWA#6@JY4C&;GCP?
M/;"J&]:3/D6B3[&X=B9JW#UEN3*863^F^=64P:3&P"Q[7#4PE&<3MY8=L4E[
MLN<M?+=KR+O0T_<S?^BK9F_$#5_%=,24'D1"R5?R`9U']?^;=/.]&O1:3>NR
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M15ET)):%39G^G]W]841>KT>\1P2,A^(5A`Z57=-G;2)%K>'L#54U4=;H3W)B
M5N@23ZL;<T5#,[:>/H,R&./L6<1DL<P`"&/^_,[9X#\U/:*56R0QOL=51HQ+
MSHT2^$4)G$JHH,KT96?4(8@0M56/9,@LH=VT^G)^0?&,JHWS=$J?J@?JJK/E
M,ZGQLW<15\\EJGD>F"A)D04G@H:C4+RE^)M$$8D?TWO.(26,O#O94ODIHDSG
MH*51I("!9\&,K&OAF!,954_@3&)G!6;SKLH9%JBQ(U->):AX5*BQ&B-44>D2
MD*@A+.1F3;Z("V)ZZ<U,<`2%KB7GBA7)D*#;-GXZ(_"8[MS0RYY\LI,T$K:O
M/'<V^FM^T%1W!7?9Q*VY8;*$74FF;-FS-N;$&T(!AE&D"JIR^E).S5(&5K3P
M-./ITR2YI\F6>_9`P]D#91/`I.-+T">>Q)T]W0*`2:G)74/*1@9M\E&59/AJ
MR.?"[8^?W'_U<\YTX;,FO,^HD8T2%+(A_2(Y9C2C83@=`935^4TGYBC""I&8
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MG]Q,V.2OO8$;<L7?4X-CU9NL\Z12VC.'0(93A-\%Z=1`.J?3!5^33;*+EK==
MF=G(EI"Y7/!-+MU'.=U:69+T;!=99XS+J4=U(T#]PO:=5.@5]IDT0U]$B+/[
M$.79]4C*M[@87>22V)L\)KK@3TL5V#B\SUH.Y*Q8Z;C1]>]"T9%@:N\]V<H?
M>;3,9*G*V9796.ZY":S"`+G#B;^R30B7I?%4[P92M8D7N)^]0"Q?()O?+5Q"
M8DG7D^#R-@&XE#,9LQ$[TY83$Y%DD,A([O^*@+&(O<NMOX6%F+8H$:-TA<GO
MV!-AD\K!&=/H_'Q?79TLQ_>,B3C'XD_W<COL)'P(1#`LN\Z)2+81YKI'MK0S
M"D(_O'O,X@9R*MW-TZ8E3YY+F:7+G\K+SR-83?)IDD;Z=,)'!F0S@V3IVN?<
M('ME[_Z;I4^9?Y5I8&\6OLMZSFP"-K,]8N[/($PL]N,3I%-1!^GN-HR<Y[.$
MO"N66S!=$#(_)!R/!/OE2?74;WK6E"IK!U6YW[2#+E#;>4X;;G%LNC^QL+DA
MK:3/89`%F'Z?MTNY$9NM&XTH[/2[@_->R^A<7#0-X_+BHM-0FQKG9J_;:^UF
M4Z/R<75J+F<HGH.@=:$!36:`8:+%KGK,=-_88Z;3J&>/F1V>AR8Z:**S$=4+
M+4?:O+M.;@G$5BV/REV$Q73XY4O2CZ?Y=\L2K&>&WJH#A"XO*KN^>I'0J]O1
M_G6+JIB?M^'@`2=S]I:L*M&0\04N;JZ[2EMI`YW0OOI1$;GFOILT6ZFN+Y7&
MA-6U]=2>E8$U#.O4*IUN=2GDT@_.M-/4A=-'8PPJ%G7V'%R.E,%@%%?G7Q?4
M0(>-Y<QRF4W+EGL3/(CG[=%O><"''CK0%3)+R\(L+6CX,GSQUR2M#@(UTVH=
M:#7X^YML5T%W%>"==GL5M(VJBT3J)WS07;O77<W>Z=HQ7.BNM5FB6U?EI?JC
MA:LS+@K#8S1+VW6<&\W2UJ-XSVP5YP"@61JLF!)C[.7`JBZ<M],(_=JDK2,L
MRNNU6\:I61T0ZL)U.V\.^7*R\KKYQ@M)RE\CD>:>/'[U[2#I!ZXHZI!=AS;O
MO-([-\S.Y?GYX*HUZ#0[5MNX-%22<N>\V^N='V;GE2F!C^4<6]7,B4^)+(L3
MYGWG$EG:*;N-JRFZ3CI.596G*UIPB3Y]HG&(**);^I>L+>4+-RR_=9]Y;'6:
MIU8EG=/DRY7].F:W?=JLZ'5FR5JEW4/D+,[-C6F5RIZOTC2-+?=BJC3K><RC
MR-LN#CO>M+AD7>A=P.MOG`#MO]S]S?:"W\,X_A+DZOHVKBLY[S6O+GJ-WD6[
M?=49--J-QF5;07:OW6NVNH<)V6HP>.AP[L:J#C[KE2$G'8MV';:O1B:K1HFR
M2$.6N^?:<,S[NZCF1&K9V!VMF_JC3ZO'57G:;$*SK"!3M2OQ]I4K:RS$P9:I
MF.TWUJDT6_4LXZA]G0I><-]?<._WFDM(^B]@$ZRS@V**O2B=N,I:Z=Z,(L[9
M)SIF%*\LDKB4G:VF%4$(<Q:_60L^?85/K[T?Y7`I2CQ1XKG><JP?J]V],*U3
M_XD"SCH7<.X3MZ[DS\+2>L"?@%G`+-@8,/LFF$6=U\J-T%<BZKM$`/VSK73*
M&$1"H,J#,<P*QM1KPX'(]],WWP_I?"46W.\M9LGKM=K%9^OMGF<`1C4#(^W5
M'PPP[0RP7J=505<#;3@0F%<SS-.%L6"`E4DI\[AA=@K$*5VX1I_:W,.)HGU;
M2"35TF#3F(2ZVF0Z0]@2FAFGC=*I5A<@@UU5/7TT1J#*32>=H24#D\(ZSP(S
M@!DP9V#.;&S.H#,FH$E?:-(8@6#./#=GT&<-L9S-8CFJ%!C6#ZR?'=#L?17F
MSW/AW&^]MX2.FY3SP(2""043:A4QWA>8KU0WX`'4Z`XU,*4.V93JPI2"*55K
M?-.8E6!*+3&E"MM=JQOP;`8U!31HW:!WWY.>?P[W[L7?X\V[LIYW&I;1:%^<
M&XV6T>HW&X->K],T>LV+;N/2ZEWNIL5?U2W]OJ21:*=*ZC2)1</5C)YL$GFB
M\Y[_R.C_8ZYJ$R=1Z*9.DK7YHQN)YBI_GEZ?S@%8U"Q>IJ*!HRQ?'-.*TC4B
MT8HUEGU=Q^I6;II=,Z0'>!B%=$%;-`OTXB3R;M,DC.)C-DEO:579*(PG7F+[
MJB)2C5ZX$_HDD)U;Z7^R7O*4782!*(55TX-E'T(GXJZ7,'J%[^S!2T;3OI0L
M">6=E[SZ,3V.YXQD_\'D<2+$G=X@#60+0^X>RS_XWMB3/6;I->A2@@X/GLO9
M/5&+)X_RUFE,LLZC.".$:(@8LS2F)9>WSHA)KVG'[('[OOB7+N1%@@H3.E&.
M^W,B$@@Z/7BDGX=#+CH8LSL>WD7V1"PR/8U-KRY:,X[M?X>D(N7=5[P<??Q/
MZM$+3.Q'U?:6B$(+^4S8B^2QAB%HU#.8:S\^#^86>:=3]K]$AC#PDJSSS]`+
M[,#Q;)\108>B72-QB%R0C#,>PD@0@,?QE&KS=8O%PMIT#&>./>T?+"1"!*5G
MC2PG(?U+[^>,[.!N)A:TBMD=Z+2AYW/Y:/3Y7K")$(;H7I3XRFQ%8L?(EC_/
M\(S1PS*"0)+"9!8(5X\SMA^S!II*@NS9(RLQ[%IFY^_B.52;ZT?Q<+3<IZP_
ME3TN9I;02\OGON7$W*)KI&C7*EA$\#>]3'1'?Z>'>""62GAP$@Z'\\<=S=Z!
M6"^DA4U(;@3U1B3`Q(0D-+F7)`*)JW!QC3AKX/R,,T?V/6=!F-`#\8#%I.R\
M(5TG2%YN'[LNPIK6KB#V8\#DVT:BION!P(L+CI*ORW\01WF<>-*E99S81.@H
M$`3*Q#.F(XCVXB6(+(^"TR2+A@+DG"05?)T)LAQ#(RFM+JLP+EO7!<ZZ(\2@
MHP4SB;[8G#URF\!BJ'XC/"/=)IY!`/+Q[%$)D^1;</4(^0LJ02`PX^)?U7P[
MXO<\2$4SV/OLLN)-0U=<6-Y@*EE3'J<?0M(S4_WPX!$@W@J<\MP,-,5%%"$?
M%QA=0>O)K1W3?6_#B.PJ<7@D+BJD*$X)S=7=%4[.GS'W#H+I?9)L8CK5<?PI
M*00\!V%PDG61ERB0Q%*LB9TCDBD2.:(AO1!]<$)QIH2">$&PI^K%D\P?$I=G
MW6UM.>>5UB.0/<Z5FLLN]%ZL*&F@GU0+]`RT,U9PQ5]$;XM`9KS+5XL3^F><
M74I=9-,NS*N-JZ<V6$8V1ZK=+VGR99AKPRZ;[U_0FT5\1`_JW?./\G$V;LEL
M]*[.+=.RSEM&L]NXN&RVK*NL)7/?.K\R*K77YFBRJB>S41&Z"(96C9&EC$@H
MG;5-E@;%3*8BGN-PI3IR[?(5PSGYE<HX9_N&RSD*_9MTE#=\7(?R"\[W0?5@
M[KRQ![/5W++?K%73SKBU;_V+%]SW%UPETK,KZ-&KJL8]1$'I32FM3#AV/;,R
M?P^5];<!U><OV4+_XN5DGCKLWYX9;ODY1]+"9@LF-E,+M$4(=[EALHL.T_O?
M'*\V;=(+*ZS6;A,0'+Z?#=;1CQ;]:&N0@Z!9/UK-&'(E"Z*SMX8L""0%DM:`
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M/CF[61&RM4VU=]T=7ZUIM7Z^8+EIK:_!FM9$!,.5P'#@*_`5@`P,IRNM`&3U
M,FGU2'P?AA$M7,!4=RWG4?SP8$?NK-?93J?`[!^%OV7]UQ`F>WN8K%G@Z"K$
MR7:N3?71H(<3)VL5E^1VV'$RB!?TV+9ZK-."'H,>@QY[@QXSC5,#BNR`-WQV
M+G2:T0?9C7N.:WM55:PQ9Z+J!+9&L;9&@>.'ZR9L$"_XS)7IPO)]YKJ))W2A
M'L):!YF<2B$&7Q^RVZW/KCYHA?0D,)R^M$)Z$O@*0*8I$<%P`#+D65;G%MR$
MB1S$NSBB,U931,4D5OM'?:1WYQ+[LEI8Z#O>F/Q@;IB*[LYOFB"#CG,%K@!:
MTLWR78MNMKD%T;5A8609'1JJZL)Y.VU(MS9IZXB*\GK&::<Z&-2%YX!VAX9V
MVBM@V)":H^6R7//F:7?W1->&A8&JAX:JNG`>;,C=9BXTBLOB6YN:!]'F?>N\
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MY37(M*`]C"=D$=_S%PW":&S["Y0TQ3&S"TO>90[W_>R8#T?&D?Q.DNE,OV^^
MP`^>FXS.>KW3KM$RVEW+:M/[=5OOIO!`HN_;DYB?33_\_:FXSQ]QZ:#N[M(-
MIC6V<>23?3CJ--Z]"D:+6)J=:&Y[WM8G[LMYU=QPJ^VY'<R[WEJ[53:2]?W'
M@-'%?+&%MU6AD^8CGC6;B[OHU2Y?DKY4)JL\N'^D`6<-XWCE`1@"7><AT)KQ
M\S8</.`.']^2[=0P7^3BDD9%$[FU@OKRS-8+V?<J89,P$KZ%6!-A\=-+B%^E
MY4H<:ZN_W=*SJ4R.78*'%BT@=(H-OR'TJW,<8UF&0*_(L(8.?(0`K;X!VC>7
M,>F%0<6BSIZ#B[R>U6X5!R=U00U82B]VMCR)N(RZLHC?TK]H=%F$6F^VH=:A
MUDMPR`^F4KG1ZA77/*<ND@)5MIQ9+L<3/WSDG!YM+':KE'LO-JRROE;0:@5H
M-<MLHN\EM!JTVANT6J]17#I?720%6FV%@Q8^VK[(8)&:S/<<D0P3W+$AAY=6
MA#XSV^9I#_H,^@SZ;%N(,CM6<29A720%^FPYLPSXD$>1C#3*R"-TV-MU6-M"
MH!$J#"KL#2K,,HJS`NLB*5!ARYE%EB:4HK>JS!C530Z7[:`U&L5-NMJ:N'41
M9RB^ZB2U#@(IK]<R.F65W-6WAOBMBK-;5\VI.JC9*XO*RF$TM'9`:P<]('59
M_/FX:UKH$`8;2!<;:`?`J@OGH;O#;H,P!(6]LAR^0^T25D"KAO7[*JQNQ_!:
M6X??PWCS'@W=_GF[?V5=#*YZ@\M>X[S5[O95CX9>WVB85[OIT9!CA(6>#=OT
M=M[*R,XW8V"JQ4&<CL=V1,?%LE>#,[*#._I,%[;G:S-K[)!;'3I$CH=\[],"
M_91O=<QN'^6AQ)'T=B^RXTLD?*EL<\^[0!#%[[Q`/:2=)N'T!V4HR%]4HPC3
M,(IK#6$9;^P-T:AIZX3:]X;`"^(%-7]!M"^I3?N2`^KJ\&<0<7J&_Y*)])OM
M!3%[+\Q5'O_$PH!=<R>-I"W,^O>VYTMC8AA&[-KV-\EN05P"C%LIXUZ%$1T?
M,-4LPWD4/SS8D<LNZ%H1^5<[[8<![@7W!L.47#J772=VDLK..E_#.(EXXD5\
M+#JYG*O"+O;5MW?;O07<>O#<>D/7B'U5=-AW_YW&B6!1<"6X<J=<*7;<MX@5
M5SW[39M8_#81UW.;](_#CYDME=1"F[=-VKE5VE=L7RFN:].QO=U[6T+0]T8%
M-=[/0:#&>\5+B+Q)U*:Z<I>:V0S`4^#I[O&T8Q8X_$Q[!MQE`A>P$%@(+-09
M"]\WS-,VC$L8EP!4`"H`M0!`[178)!&`"D`%H.X59P)0BP;45J^"?BH`U.IV
MI8RZ%M1^>2UCG]WR81AQ%CT9MXG>@06P<($]8PZ^^P3,(@C@YHW/V@563D,"
M(8&0P$U;-$$`(8`0P%UNIW2*:R9?K+.JL?.$`!_$6"LQ+K338=T5*2)"JR-"
M_3$M?!+G`C[<9<,H'&_6Z:$4F49[TR?AH^*V[=#<%$JY?*4,`5ZTO3NM4V/G
M(@S;'#``&-@A#"AJ=RW3*DY=09]#D"'($&0(,@09@KRY8=XL,"@.PUR')"ZS
M$@S81<CN,T^8(YLP)6Q"1X6[BL\=&$J8V+N&&M=*C1^8`+[O5I!`"2T,*884
M(P4,:A0"6$\!1`H8]&@=Q;C*H-;ZA76:8D#3K&Y.)VH:JPV''<YH[2>=-/^1
M!IPU#-E%LR3NQG!0#`?5%M6-`MO&83`H++K:3`S5GE>!MON'MFVKK$UCP"W@
M%G`+N`7<YD,65J>LD,4V5$?,`I@-S-XKU@5F5X[99J-35LD30!N@#=`&:`.T
M"P=MPP1H[Y[SM]D=_#D1\Z27'5]9V"9'0WI]?C)2,P9-RWCW]Y=F'"[>-G>5
M!604C3CD5;R`0%]]S]\F"*.Q[2]PBBF.F5U8$H@YW/>S8SX<&4?R.S&#,_V^
MA%`WWIC'[#-_8-_"L?U,WXSMZ,X+U$/::1).?U#<*W]Y\-QD1$<3(3(VI57W
M[4G,SZ8?_OZ4[>;/G=_WG2=%&$N3#=;8.I8/\^&H8;Y[52H6I3T[<>OS*K\A
M7A`OB!?<P0MN5<2U@V&\6UL"E8WE??\Q8'0Q7W3BWJJ6"R.0-Q@C'W%ZAO]R
ME_UF>T',WO\>QC&/?V)AP*ZYDY*UY)$ET+^W/5\:$\,P8M<VF5T%F<SPI<&X
M13/N51C1\0&[D(6CSJ/XX<&.7'9!UXIL!Y/GP;T[YMYA2BZ=RZX3.TEE.N?7
M,$XBGG@1'XM:YW,>\*&7L*^^O=$\"G`KN+5H;KVA:\2^'(W"^NZ_TS@1+`JN
M!%?NE"O#Q/:WB!INVQ5W6V+N:Y!V6<W!@#M\?,LCUC!EW4%A;9G++4O2D+"%
M[?34>;]&7J]5X$1D73AFE^FC4+>`(D#15I1Z;S6**SHZJ!W?8A-S`&&`,$#8
M=A!F]HJSIP!A@#!`&""L6@@SC<(3]G;/,O`(@47`HKW#(E&G!X^P?',*4^U6
M$_'+:_VPV2T?AA'/C;USY&;>)CMX:W<FVP8L=>LAILR,TV91@@U#XF`,B<.3
MDW9QA>J0$\A);>7$*"[N!CF!G-163MZ;!19D;N52Z6[P(P@-^7I+R*(X@^VP
MQ0M!B=5$[(_#-$CB7,R!NVP8A6-F.TXZ3GT[X;L:Y55"#JV>DMXN/'7N5:(=
M)A)`T4(\M]G'+&XXT"M$@\<(03M80=O!Z&K(&^0-\@9Y@[Q!WDJ7MT9UTZWJ
M(F<8N:[_R/7:R.?[UJF%B"OB+'JIQ]J(EUE@F+,N^@V"`D%!!@KD!'*"#!08
M;/60KS+B&7LUVCM+RZ]LTTR;TAI](B&8MFT99F%U(>7,2=&%:W=:>;@V:6M;
MFF@45[_T^E@377@.OH*^9=1`.Z!=>3Y;IRR[\`5JHE`;(`F0!$CN#4B:O0IG
MW0$E@9)`2:#D_J$D0!(@"9"L'^L!)`NL(FX7U_@,*%E($?+J><C+/O_R<QJ?
MW-GVY.S:&7$W]?F787]>FRN[BEWD,SX_RH1/,6;M1MSGAJAR[H?.]U__]M>_
M_/+\6N=I[`4\COO.?U(O]F3#L?/'W+?9!8C\@:#Q-S[\<'0UL`RS]8?UKYO!
M$?-<^L%VDA/3NNJ=]ZY,L]-O=]I6M]4?&(/FY46_UVFUK8YQ].N3-<O3_Y5A
MQLN6_-DPYSR_R=3?ITR1G]/<$&7=57#)B+-)&CDC.Z8/D9=M5]ER1A-WCP5A
M8R^6E=9#1@O*AJ%/^HM>Y.Q%_GJ)$KD7%[?QAH_K$'1!UV@[U[J$H=7--\ZL
M[G8P+Q?S<C$O5S/C&VD3RS72A1V/V"2,Y+!`4CI2`Q'WR(:CN_3\;FWG^UT4
MIH$K,#V,SOZ/*_^C,T6S![5:'=NY+=J%646/\M(3*_%.EM#,,HKLM*`#'R$A
M;`?(1K_1$XNJN&U!;?U4S]>$<Y]SK)=):*=98`TK)/1%":UOY:H<"?O$(]8[
MFKJ*5?<U=E6JQ?)J%N(;3)J]C<8NH7B3T+2DQF^;4%T;'JX(B]\>?ET_9+HB
MYGIA1]$C<?8_;3_E<3]P+^/$&XMP[I7M1>K7+\,!OTT^!G$2I7*.^V(T=XU@
M[-6YU36O+BZ:5Y<7`^NR<]$\'ZA@;/>BV3$ZE09CVT]BB0VKHMCKC0BG$E69
M'9!EEQ&>W4L:"\\W3"/F$J69-R?U,7N@RX^8'7'V.[_G_CSP8#'?LV\]G]:9
MTW'BB#@=C^V([NJ*J*X*W<;;!VYK%J7M]4X-J]5HFF;#:!M-JU=<S-9LOS%H
MVVS5,VB[P_/VYD'Q@ONWKZ!3!*.$?8/M$TQF+]%YXQ[!KB(:#FDN'I5+WD43
M?/DF3?]9%6'A3=@/.`^J,#:M`3>^Q'\#[O#Q+8]8P]RLDA6[M=BMW6BW5@NF
M%T[ONNZ2%@\L/73HA>+U`H1F;1Z<QI`@.!`<"`ZT#80&0@-ML[W@()]F19OI
M,.$QF]B/<I<@"=E5.N8ND6*7B*3_9J9.&_+8;Y=7-XT""T:U9\!=ME@J-(I<
M,^L#6`@LW#T6]@KL.J<]_Z';7+T03V/L*A:M]KS&0UE=%MK9`S0`&@"-34##
M+*YK15U``P&JY;S2/NUV6N_8-0^\,&(J7.6FG'VR(V<TQQZ52='=)D[\UH[_
MAU8FUK;,ZD8=UKZ,#,&6`K9Z(,*;B7"K4^'4^X,784@JQ@4_MVL:I94'(AP'
M28.DS:[7ZF`T-[H;%,5-LKM!.=Q4=CL#C4F[MQT+=(ZU+?/=&Z7Y[IL0MBXH
M">>]I"T``".`L>*(2`_`"$>MUOBG,<Q5#&Q[CE_*E&MV3JW**`9@`C`!F`!,
MZ\3;NBT`TVY;V!70@6YE;[MX1-<3_US^)_7N;7^KYG7=IM7J75Y:1L.PS&Z[
MU[^R+K))(@WCO%=M\[KY))&==*^;#@-AJE/;K-]<+)O7#;W`#AS/]ID=QSR)
MV8.7C!BM91K))G6BH<@S'BOR&7T>QRP9V0'K&7-]XMJ/<:FW9<,H',MI*2[Q
MK7C+64=9+W#\U.6N)`5=U1'=[E7_/_K`YVS)PD!>P7:<<$RP('L#$G/2(L?<
ME0VD1?!>R`6[M7VB,Y%_Q'F"]GYE#&'IOK&?7Z=1SV9IZ`:G27DV^A95FRFE
M?;7\^CWE5IE_LUYSJPY`#SIT?]"B*]TJ!EWH5O<"%Y?4Q>YP,MTOPO&81]+4
MG]@3_G(7&\QIVIO"8IT#-DMHUNB>;E)&L1W9ZA*U@4:NGCX:0U"QH+/GV**"
MP<WB8L%U`0T80,MYY0N]>2">ED6</L:<_IT%_>R[B',9I][&&\"HMR?-DKJM
M"KHEU45@H>6+D[0Z")2RDXT"1:@ND@+5MIQ9/A$E']G8CK[SA`T)*:'%"M!B
MG:918*8!M!BTV.%I,<N$@P8MMAZS7(_"*#E)>#16,Q5C[F19**5H,S1M**_!
M+7HV0!E6):AUD$>E+%NGO:HDL"Z"]E9=VJVK,D4A^=YM`J-><MYANM,LRQI!
MO23,$2WP3V.8JQC8]AR_5+#0;)\V*J-878"IX+*DUXN'5M4=A>,)#V([\<+@
M(HR3JS"Z'MD1/[=C[GZU'\7.<#\BMKA3F\1]GRXFC_XRG!_X]"KQ^>-7WPXV
M+E^Z:C6N&JUVLW,QZ!KG7:/3;IFJ?*E_==[N]W94OI3C(1W+F6*Q#B>WMJJ]
MF:\$XS_$9RXJG$+'D^4XLLJ)V\Y(I*:*.JB5)T^B\"ZRQS%J=LJHV3';;RS:
M:;;J6=-2^Z(=O."^O^!695?P-.:/V]$[\+G#(;MA)`MK;T81Y^P3'3.*5]:&
M7`:B5G=:"`6/&'Q:.9]>>S_*X5)4MJ*R=2\K`=>I;$5I*DI3=PS@F]25@@5K
M`Y;KSQ;=/>,"2?>7C8&DR'_<)(M?Y>_'B=@E2`-OHUJTPH5:BTUQG=(S#BC[
MHL#I73IP$5(K]$VM0.;$&L394VB1U^NB``28L7O,T$(1P9S9!<VL-NP98-,.
M*E=J4YEB-8J3H+H("J(8*[+TO#$_N>>Q2+.+Z)_(<\3'[:(:Z$VPJHV>B39Z
MT&G0:6_0:3TXIA"4$LN6#TPCM1NG'6@D"!HTTO:3K4X+RT:IBZ#`RUK1S5W,
M(HIYDOCD6TU(=$51D!@P!`^K*`\+O=^@SJ#.MH<HL\`6#A`4",JA*R2K@Y[:
M$#1HI#<U6(.#!0=K+5[Y"I^J>!568#-@:#!HL,/38'"I("=PJ8K31\WB#$(H
M)`C:X2DDTRBNZV%=!`4NU7)>N1Q/_/"1\RP7<#9[;^+;02G:#!,>GNQH8<`#
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ME]K0;Y65J[:$8,`EX!+,,IAEE1/5;!39Q!=V&?!//_S3&.9@EVV>U6+U8)B]
M)>WEY\2F-UQZ_)+/O_R<QB=WMCTYNW9&W$U]_F5XD0M>781Q<A5&,K9U+D);
M7^W',0^2?D1K>\?%Q[CO^Z$CC_XRG!_X]"KQ^>-7WPYNQ-/=$"G/Z:3OO_[M
MKW_YY?D3#(A0]W3F/?\8Q$F4RMO\9GO![V$<?PRN$SN1M_XRO/(".W`\V\^U
M]YI=G18T$*OVC0\_'%T-Q%3M/ZQ_W0R.F.?2#[:3G+0[G4OS8G!A&)?T]RO3
M&IQW!\W+BWZO,^A:#>/HUR=<D%]1,1DG9I_Y`_L6TIU7KFSN=)(&?C)2PY9-
MRWBW(+,R-OJ4S>1W+R!P3\X:XH`JI/!FQ-DPI'5]H&=CDJ-8G(['=D3'Q2RA
M/_/AD#L)"X?,G:U63)]C>G);#`BR8T;K>2<NX,U7D84!"]-(+(TK0IXB5AK(
M^+JMI@IE2QN+*WN!$X[YV8M2\!)Q<[3\=QHGWO!QG35:4$+&=$FR)1#?\_<)
M!-/YB\LHCIE=6!'/X;Z?'?/AR#B2WPEKG.GWS;GKP7.3$7VDU\Q@CN#+MR<Q
M/YM^>,9+\X?*1^[GL-=;NK>S1O!?/LR'(Z+YJXBZ"-_9B6;5YUG[\J"U?\'>
MOCSHWE!4[Q=<!2$+*%3YIO8K7MC+YJ!#BH%'.8#N%JN7Q>7DMP>E<VY#WU77
M)]-,*N.;4<0Y^T3'C&)V&8A-QG^D`6<-XW@+$W+YNF!9UEZ6SSQAPER-?WXO
M+%8>O[R[KMOC?^..;\>Q-_2(CX91.&;]+Q<?R1I+0O9EPB.R]<BH^RB-LWUY
M,?5G<=DSF0CO9'DCE]*,)=N5?0TCX:L@3ZF$/"5@QP%A1W@7R#H3B1?B=>J!
M%!\#OC56;)8TM3NAV#H$5AE__9Z%FH#2Q:-T0Z?4<>WA>W&[;3FWBI`C.%4_
M3JTE0ZYDP<):8H,%M6,[:.P#9$)H;&CL`^/46C+DVS7V5HZE3FJHO#WL;_R>
M!^G+80<(<V&V3Z&IJQD:R-WTG;;^U"FO]0UIJV70<V>E1D8%,WZT84"DL]8,
M\G1AK)VFLM89LM1N08'UZ%O5F^\UGV$/5F,$VS]/X$M"-,V22=G[K-8>/*8Q
MC^EOE\$QT,XQJ&(8M3;\![^@9HBG"V/!+RC5+S"+F]D(OV"=L/CJ>KC*H'7-
M$J5G.PY[7J$TMJ,[+U`/::=)./U!\:O\114Q]7JG7:-EM+N6U2:B=%LH:=*V
M?`,OB)(FL,QZ$(*2IC>4-%U[/U#0I,NB[']1`@J:X/:CH`G8@8(F%#0A/?I`
M4%KS].CU8W&[1Y7]S)TN+-I97QX_/%9>R;RHDZIH@PR&``R!O0))&`(P!.K.
MXX?'RF\W!%!^A?(K/4PJ9%DBR[(2@G9:*+]"FN7>0IXNC(4TRW+3+`WD6:+^
MJI80MG^N`.JO]HW']#?,X!EHYQDTX!C`,=A;Q-.%L>`8E%Q_A;X,FM1?E3#%
MJ3*T?NEY%RJMK"?5669[4OH(K[EN;MS:2]+_EN][O+RV[NIY<05-:]MD%MR*
MJX:Q)W;0KVPO^J?MIQM-@AM<-@:#]J71.+?Z/:M]U3UOM]4DN%ZG1V=@$MRJ
M27!#(C>[%_1F=N"R2<1C>D29RT!.WTO3WFYM7[``BT><JXEOXN`P3>*$KB1N
MF)\M1PZDG\I?DU$8\]=GS6T_.&Z-]=N/&LP2IL2UWEA1V6QL6935K+Q<;=LG
M+:9\3(/=_#U+H7K_,6!T,9^0YY4J`R2KO8W2YQER7POD9ENDKNU+:I9F*2OK
M9%\)\X=)^X?UI5*=5DZR3?*R-D,EHJE6@E"*0?3<DI9W^'^9Y?%Q7<L#H9Y-
M0CWK(\5ND4`OPKU1?,TZRJ^\7C^.26/E_(K]%=7=[>4Y:101SI'?1<3<*057
M"KW&A-1U,TKGZ.T2FO6LTV[I9*O+GA+TP0I`^]VS;SW?2QZA$[96J8X3I=QE
M669'+,.`H5`4T`S0#+O0#%`,)2D&N*6:TF=WOH`?BO?BT9CYF2KU=JM`M1!9
M`/\N:&9V*N@!?IC(?\@17@5T\TP$Q'<1WT5\5SOI17P7\5T="`ECKIA*X],.
M;#FH`X1W=ZU1$=Z%8M!),1A0#'4/[V9YTY:Q19I[W4.]6M-J;6]^-TZ[/K1"
MUC>ROO>-TOID?=<RN7LYT9^E<P^XP\>W/&(-4Z9TE]2M\)`#_DCI/F0C89\,
M@P,*Y2"R7ZO(ON[TJK*IALX!&'F]=N^TL([>"*T<MO;7C#Z[P):/`:FO1-J5
M\V@Z,!F8O`DQS-,>(!D>+E+:M--P\&_AW\*_A7^K-;U@2RW84@W84L!II)0=
M<DJ9[E0#8N>N5^`8HAHB]GI==S?NZKIIW]45/5TO[2@@?HN_\NAZ9$?\W(X]
MIQ^X`\]/$^[>B&??I'=KO]V]&K3[%V9GT+WJ7EUT+UL#U;NUW[JXO.A4VKM5
M-/C=2:M6246)I*ZB(^,9G=F$+.-84)J)_Y$`.*D_;9RJNKNB66HIS5+-]EN[
MI;:J;GJZ]8G[<M[>/"A><*<OB/V]-T8_.SM(\MN/E+XPDIW3;T81Y^P3'3.*
MV2KK[Y*TI#OKX;J_?B;X=&_Y]-K[40Z7(@E^UTGPZ,-=6A_N3;IM`ZZKX]1:
M,N1*%BPL2@86W!NP7'_(V.X9%TBZOVP,)$46VINRT#ZG8Q[9"0%`*>R+AF'`
MQ3(8"_P#_@$P@;&T8ZQ#Y!]86\O3`3[S1(Q,#<><V4D2>;>IVC=/0G;NA7<\
M8!\#Y[0H*5UT%1KD*KAA*F[W%E]!B^Y,.O7X>HW(!]0$K&=UBLO9W9ZP=<D=
M@Q;6$/\TAKF*@6W/\4M>KV,VBRNB?Y5B`"8`$PPS&&:5$]4\[C2+',`%TPP(
MJ!\":@QT,,TV+_\\-GLPSM!OH[R=S@$/PK$78*]3!XT`C8DM!?`/]CK!6/K1
M!\`$>VMC^_U_9;J>J&<F$MAWG`6I[)`>#NEAQ^,P4-7/,0O3)$[L0+S>-CQI
M50EV&^1%[BK68S5:!6["(9`#]%]7TNH@4)D(M8L;9P5)@:1`)[5.3>@D2!IT
M$G028MVE,\OE<,B=1+A:LNV4=\]9S)V4EL';K*LT0DH(*2&D!/[1CCX`)C`6
M@&G/8MWU[3]]G8BNJ.%$M%Q5G9/Y>.*'CYP,+_FG21HY(SOF;.+;6TUG14CA
MZ<!Y!!0`^P@H;`U9!0H0Y`1R`GT$?00Y@SZ"/M(FO%U?=TL,#3@1XUJYRR+Z
M)_(<\5&Y6FG@;31E#"IMI4JSH-*@TJ#2ME=IF(<$.8&+59@^0EXKY`SZZ`WZ
MJ+!RVKK("5RL%;SRR8Z^\Z1TEZK*INRZR63)4<1M25L7T88*K$Y.ZR".A<<\
M7J$9Y`QR!GU870@2^A!R"GVXL3XLJ:%O??4A7,H5O#28UJ),PH0'B6?[BYT`
MH%"K4*B%;4E`H4*A0J%NKE`+J^(\%(4*.8,^+$\?MJ$/(:=[)Z=U$,=,`'O0
MA^AZ4`0K7:M^<FG,749G$@F<U+<3>@G5!H%^)HH']#UF$QXIK[-\X=UF],!&
M@Q\*FBR]R^9`)=G$FY!^?3+N,71`15<HY;47YDQ\.V7%E):)+Z044@I=#%T,
M*8>40Q<OT<4EQ;,.51?GG.V?Y;#FI<<O^?S+SVE\<F?;D[-K9\3=U.=?AI>9
M^_F51])9/;=CS^D'[D"YIS?B^C=$C',_=+[_^K>__N67)=>0O?V\>_Y1#I*^
ML7]\LQ/^C3MAX'B^9XL6-(L7(NH'@L3?^/##T=7`,LS6']:_;@9'S'/I!]M)
M3LY[+:/;N[ALGYO=\T'7;':ZO4'S\J+?ZS0:`],Z^O7)DN7)+ZHQ8_:9/[!O
MX=A>#1NYTXFO^<E(=H@_,RWCW8(XRAUPR1->0#"4G#7$#U7(3Y]%"W1DMSQY
MX#Q@R8BS/T^O3^<H-N3$^[9/=[:3-`FC1Y;8/UA$2R';_X1IQ/ATI>9_\F(6
MI^.Q'=%]76;';!CZ!+BO]&1\B7`YV?EW&B?>\'$=^B_`H?&$W.)[_CY!&(UM
M?W&)Q#&S"ZLAY@[W_>R8#T?&D?Q.0N],OV_..0^>FXSH([UFAC6$([X]B?G9
M],/?GV+'_*&B98J$6'D9<*\179,/\^&HV7KW*K0M@FQVHFEM>V+5Y^%!]_-!
M-XL+P\I\!@XMO3=E'`)G'N7>NUNL'A27D]\>%.[?AKZKKG\51E(%WHPBSMDG
M.F84LU66U25I$9?](PTX:QC'\(;`IY7SZ;7WHQPNW1.(7>U0E;`4&NR&[[C)
M;\6\OQBW6RX)PLD#].XZ$%4,]&K/D"M9L+!](;#@WH!E45%3("G8&$BZ,9(B
M.6Q5A_9IG%8$8HL2Z/+2I=<GX:[VBANM4Z,R.LX9K3Q"5L&+2^@XA]%WT#.%
MZ9G"Z:.S=!8NCW43.PC:;@0-^A'Z$?IQ[\2VW&PIS417#^6I33)519H5?NIJ
M/U4F#&W4#P-*N()^%ZC?A=8\.*_2Q%@6R`F<PF*=F:YE6N63$_(&>8->.AR]
M!)=JQ;0PX4RQ,&##,.)TYUD7""BTMRNT]V:!DGC(8<Z?H`ZA#K?&N/?=XNJV
MZR9L$"]X=Q4IP]YI%[H0NG!OA+5N,CG5A85G[-9%V#83+WB4RPEX$7'72V)9
MZ1_PA(43'JE&@WX8QRQ-/-_[K^P@`*U:@%8MLF<VM"JT*K3J-EJU0"FLF[!!
MO.!A0A=J*Y[0A="%1>O"PKK6UTW8X&$60<"O:>2,;-7)/K&#.T]T6+/CF&\T
MAQMJ=`7\5[%G69>T`FA`:,`EZ3>%#>:%G$!.H(_*+Q6$G$'.:JR/"IM371<Y
M@6NUG%4^V4$ZM)TDC<2&G<O=U,%.74'120NYH(A.0A?N.#II8J<..W4ZB-=!
MZT(3N:#0A7LDK'63R<*EL&["AIVZ(@CX)2$A%?.DQW;`Z;)>PL?8HRND=4MQ
MD^$1$X7N.SC=5V#O(\@)Y`3ZJ/S,2\@9Y`SZZ'#T$9RJ%YRJPM"VRH$X.DMA
MR?TQMR5S78092J]<!JJ;.%8M@)`SR!GTX6OZL+`\,NA#R"GTX>;ZL#(!K(N<
MO=6)[-;5B[P<#KF3>/=RGD*Q<_\66*M!K.6&J2C1*T6'[NUHE24*UFH4N*WW
MYE4XB!$M*]N08Z;2SK3Y$F8]*&106-`IL.QI7?(>A,A#R#45<M@%J^R"9H';
MJ[`+8!?4!C(."AD4%K0K]!$.2N2W%?)<B.'GQ";R+3U^R>=??D[CDSO;GIQ=
M.R/NIC[_,IRYY1\#)QSS&_O'-W+-OW$G#!S/]V3?U!MQDQLBSKD?.M]__=M?
M__++D@N-)W[XR/DUC^X]AU^/[(B?BZ8Y%^%XPH-87JGOTQ7DIR]#<8^[@*CA
M?B7JA'1<G,2SN]!2!6(]OO'AAZ.K@668K3^L?]T,CICGT@^VDYQTV^=75PVK
M?]Z_&C2[5ZV+EM$<-"\O^KWNY7GC<G#TZY/US:_5C3?F,?O,']BW<&ROQJ7<
MZ;2R_&3$)6N:EO%N@3?;Q(B2?[R`8"XY:PC.K(*!;D:<#4.BZP,]"I/\P.)T
M/+8C.BYFL5B'DUO9O<C)K03C/\1GSKS`\5.7_OK@T3T#%J:1H+TK_BA.":0\
M$4\(V:9_QO1V,0N'XD1BF+,7N?8EZJU!\06T-9Y06'S/7S0(H['M+RR**8Z9
M75C1QN&^GQWSX<@XDM\)$YSI]\UYY<%SDQ%]I'?*H(A@QK<G,3^;?OC[4VB9
M/U0^2#B'I_8";FT09Y0/\^&HV7KW*O(M`G=VHKGM>5N?N"_G[<V#X@5W^H*;
M[0#`,'\&?IVC3:S($K;B7C8-'5(^/,J]=[=8U2XN)[\]*+UV&_JNNOY5&+&$
MU/W-*.*<?:)C1C$3-UVV8749"*7^CS3@K&$<PX$$GU;.I]?>CW*X="N(+6,Y
MRMJ&K6RIWG\,&%W,)X\@WJ2X>_9BC3<*0:$QV%>68_?RLACE6[XDPM4%7!</
MUV_EU%HRY$H6+"P1%BRX-V"Y?B!U]XP+)-U?-@:2HOYL@PCW-QZ3U^",Y(0W
ME]]S/YR(*#3;I6ROA.)]W8U:L@']?XLB\*MZJXZ[I\OR*JIHR:D-`Z*<0=]$
M!UWR&"I3(H5A69TA:YK\59C5K`W+`(MJAD7::S^87]J97ZU.@<BF/0,"\FH&
M>;HP%LRO,BG5*KXF;_<LHW/%;5W#9M?<IS/NCMD=#WAD^S)\9KMC+_#B)+)%
MSN\VP5]+ISV,#6+`.XOYM(N;SH<N%K`["A/4.LB;O%ZC<=HNBH$@*!`4:+27
M-5JWR&$JT&@0U*H$M0[RJ"30J$X"ZR)H;W03S?KZB>EM$B:V7XI$'IAJ;'8+
M[)@&U0?55Z8S5U2Z9X6QT6Z!^3.'$!N%B$&7;:O+S$8/R@R2MB?*3#>!RD2H
MP$9:=9$4[-<M9Y8+>^*1&R8:XJSNVN*()CF;)+XCRKGMR&A+@WV[YUR\*7'U
M8O0E=,9(:41*RP-5DN+"]@;7)5I=A!7BJ:MX'IPN;E4GQ=#%$':MA+T.,CV5
MXLHLZKH)ZV;BB;W.57N=:W=#I>O*75'I<<O4V>R0&+'E`O9)VQ440M<E8`9E
MB]#R\ZW05G&U;!`4",JA:R2ST2APY@E4$B3MX%22:?6@DPIVQ6KKB:EQ(W(6
M*)<C2!!'K2".:EIE#?-!(!6!U%V;K`<32#7;A;=H0B05\HE=S6JU<:.';4UH
MXP.5]CH(=2;&W>JJ,>LFK=C7K'Y?,^!)-KR1V4D2>;>IFHR8A.S<"^]XP,@Y
M/RV'HXL:J:M#@%6G#H]O'K)=/'SLRJQJ-,I*,]F$KG6)7\(DTA#^-$:YBG%M
MS^%+`5;OU*B,8,`EX!+,,IAEE1.UURR\=P/,,L"?3O"G,<K!+-N86CVCP(2P
M0S'+<A&ZGV54:>GQ2S[_\G,:G]S9]N3LVAEQ-_7YE^'E>.*'CYQ?\^C><[@,
M<IV+&-=%+L35]_W0D9^^#+]Q)[P+1`7]5WK#D(Z+D_B&R'5.QWS_]6]__<LO
MS^]R97O1/VT_Y?TXYDG<#]S?/?O6\[W$X_$G;L=IQ-TO`5T[C2)B8GH"+[X1
M[S:[,BU8(%;E&Q]^.+H:B+F3?UC_NAD<,<^E'VPG.>DW+R_,5L]J#SJ]?NNJ
M<=$RVP/ZK=_KMMM7E_VC7Y^L<G[%;KPQC]EG_L"^A6-[-;;F3B=FYR<C-8[0
MM(QW"R(I`Z%/V4A^]P+"[N2L(0ZH0LAN1B('B&@9LUM.VH--(AZ+V7Y>,`RC
ML0IBVK=AFK`PC9@METB68_CS16+)R$X8,0>+^%WJVY'_R,;9PLEC'9M63GQ.
MV)!6F]V+Y99_H?<E:4VXG%?NB]F"[,&CIP_D#[F#1QZ/Q!#"1Q8.Y=_$S^KQ
M$NZ,`N\_*3W(`V=IXJD>#DG(7)[P:$PKP>+4&>4N=_:B/*V[C,T7%BEWC055
M9DQ7/EMI\3U_DT!0W5_D%G',[,(J5NQPW\^.^7!D',GO!%G.]/OF3/S@N<GH
MK-<[[1HMH]VUK#:];[?U;HJ=A(F^/8GYV?3#,P:>/V)^;V".I>VEVT=K;"_(
M1_MPU#3?O0K3BSHA.W'K\ZRJ;X@7Q`OJ^(*;;?R5N`-=UM9@90.)^[%08/](
M22<UC&,F3!7V_F/`Z`8^*;-XDUR)V<MB(/3:]+_9L-4NO'SP8-$\^$<:)MR=
MD_MK1-[5RW7-NKT"G=UW7AUAI-M3?[*C[^2_[-4SO_]=>D4FDN@`6KODPVNZ
MO3<D$A&!9S3_0IYXM%?B].66CKV7D;'96WP,)NE^HH(%5``JZ((*^R0_?P;A
M'`CVZ<'W%ZL:5:49US'+6'T5ESF338J=:31!Q.-?CF9O"W)%5@-MCF[::0=M
MB%5?M0J.`\>!X\!QX+C#X#B4DZT<11&/&/]/ZMW;/IGMF[2\+-S)UR*54Z><
MX@-*&>XT"ZR,T(&/=ID2#/T)U`)JE4\SQ8!=R[3*%UU@%[`+V`7L@L4%U`)J
M[9[;@%JPN/8#NQ#[6A'[4CEZLLC%Y;=T65'W)<N,L,VY:[T`A0J.`\?I0CAP
M'#@.'*<_X=Z:SM:MJZEW$4:3,!+5WT\LO6U8$@.5G@Q4.C9[74SY@UZH4B]`
M"!$9@2!"$+431&A#""&$$-IP[P01SN,*Y_$W(??!6/0J@^-8K*KL&,9I`Q(*
M50E5"54)080@'K`@0AM"""&$T(9[)XAP'%<EF(51<F??J?[3H6A@I=I:,\$2
MW(4W6:CH6CT#&>W0GM">T)X01`CB00LB="%$$"((7;AG@HA2I==+E42SGN01
MOF.APMH^[4)(H2VA+2&`$$`(X`$*(,Q5""($$8*XEX((OW&%WSB@O]S;8GJ6
M'%P<V<Y&+5XAI*MR=0SCM`7QA)Z$GH2>A"!"$`]8$*$+(8(00>C"/1-$^(PK
M?,:OOAVH/-68#<.(N7S(HX@+\1M/>!"3.QD&I4CM*\,N#TVJF\9IIS!QWI:V
M=1%WZ-TJ]"XDN'2]#$&&($.0H8HAP9!@2#!4\?ZZT,UF75WHFS"Q_7+8K$%L
MYH:IR`2>\MDV$JL%;^HT0^4U(A_0D)7F<<,T3IN[)VU=<!(&S_8&CT;0F-U-
MG/I<V0,WB\?-,@A>AP3WK6FN#0<#;8&V,$1AB+YJB!J-T_;N20MH!#0"&@&-
M^D!CZ>',0X3'MS:RJV$X4WT5ESGS$KJMH^[PNV??>CYFI>JA?*"UP7'@.$T(
M!XX#QX'C]"<<\K_+J1E^D0/A!E<`A?7Q<JU.@6EW.K`1@GL::@*`%D!+\]"<
M#MP$[`)V`;OJC5TPN`!:`"V`UEZ!%@PN=#\H+/IU0;_1$XMASTX8Q)[+(]GP
M@(6W]"#R8SD=]%"OM9C[U6N5E?EU@)5:,%4*V%Z!".]>+T.0(<@09`@R!!F"
M#$&&4;W'/C3:'VS!9BBM0&E%R41M68W3QNX)6Q>4A*%35DHL@!'`6"LW$/`(
M>`0\`A[W$QX+S9T!+@(7@8O`Q1K@8HE!QT,$QES4\>?$IE=?=GQE#Y8C&C$)
M/QEQ":&F9;Q;>9/<.0M88Q!O2\I[`<&H^IZ_:!!&8]M?D!!3'#.[L"0'<[CO
M9\=\.#*.Y'=::V?Z?0E9;KPQC]EG_L"^A6/[&8(_>&XR.NOU3KM&RVAW+:M-
M[]=MO9MR(S&3;T]B?C;]\/>G##1_Q'R@>,Z$[:6;!VO$FN6C?3AJFN]>Y>]%
M*<M.W/H\J^H;X@7Q@CJ^X&:[0&ONG55OQ*Y6>=UBS83NM*O,@T+UV]!WU?7[
M,0N';,`=/K[E$6N8Q\PRS"9[_S%@=!-?I%[^M($AL7Y=?/6K\?(*.*3^>+2+
M-2ATZPZN&'AP"Q[\(PT3[L[)_37R'/YRTK5NKT!G]QW10F&OGOJ3'7WGKS1[
MT.V9W__.[[G/S$T4`T`+H%4T'U[3[;TAD8@(O$_R\R4AYMFO)[ZE8^]EY&.?
M'OMC,$GW$ULM8"NP%=BZ^7/_&83`JFJQJK$V5J'9[[K-?OMR%G@I?7ZK`3'M
ME`"4)/@'_`/^`?_H21_P3WF&4XU;A]CQB/'_I-Z][9,=O-.FN;K3JK!,JSW/
MEY+7ZYCMXBJ.ZI+G!#4%U`!JO$",$LIQ@!W`#F#'`6`'+`Z@!E`#J`&+0X]>
M,/4-BJB<,EF8X?);NBQWTJB\P9&'&)"#W@+_@'_`/^`?;>D#_BG/=K*Z=;6=
M+L)H$D9V\LQTVH;S7NN5^6;O31<OQ3PVVHU3`QX*4+JLOK*UD15X])`7R`MT
M"V0%L@+=LB_1XOIZ/+\)N0W&8OH6O)VU*-9M]DZ[D"_H(^@CZ"/("^0%F@62
M`DF!9M%#7N#IK,J+":/DSK[CS`Y<%HHF+,P6==9,-+#E+MR?-0-RO2X26:&D
MH*2@I"`OD!=H%D@*)`6:11=Y05G`ZV4!HF-"\@B'9SW"M4][$#(H)2@ER`GD
M!'("XPWR`GF!O.@@+W!V5O#,@/YR;XMQ(/1P01+9SD;-X0Y/R#I6<:-TZR)=
MT$80%&@CR`OD!8H%@@)!@6*!FZ.7F_/5MP.5Q!:S81@QEP]Y%'$A/N,)#V+R
M@,*@#*DK8U22EE+9*#"J_1K1ZB*N4&\0-!W4'^0-\@9Y@V*#H$'0H-CV4-[>
MZ/<UFW7U^V["Q/;+X:8&<9,;IB)-L#!1U)""A7497YMZ^]R&W#KN-1MEV0M+
M:%87`(/!H"$T91<51^Q6=>X];I5!R;W,5WV5F-KP'-#NP-`.@%8S0ZS1*:X;
M)@PQ0!.@"="T%W&N&L/36WOVU##.I;Z*RYQY"=W647?XW;-O/1_3K#!-IE+Z
M@'_`/^`?\`_X1T/Z(#VTG"JX<O.N-:071@_GKM<Z;19%CKJX:5!4P`Q@!FI8
M@!W`#F`'[`U@!C`#F`%[0T?L0%!DY8CO(*$G%@/OG#"(/9='LDR6A;?T(/)C
M*:V"#J;@P3);IZVBQ/%02AV@ZB%I.J@_R!OD#?(&>8.\0=YV+F^P)%$TBZ)9
M?2B(A.B-T,LR4#(+0P&5&@`FO8`)E1J`)\`3X$E3>"HP$0"P!%@"+`&6-`]&
MU1B8<M&HG^7PT:7'+_G\R\]I?')GVY.S:V?$W=3G7X97MA?]T_93WI<MK_N!
MFRL'_<3M.(VX^R7X)N::1L1?YW;LQ3?BKC=$HG,_=+[_^K>__N67YU?^+0S=
M!\_W9\?)@@GZ\HT//QQ=#2S#;/UA_>MF<,0\EWZPG>2D?779;S2:W<%E^]*X
MN.A?M%J=0?/RHM\[-R_[K8NC7Y^L4Y[F-]Z8Q^PS?V#?PK&]&AYSIQ._\I,1
MEVAL6L:[!:EJDPA)/O`"0MODK"%DJI*HVHBS8>@3TM.C,#5?=A*%]YY+[V<3
M%_N^:$W^8$<N"X<LH<.=D1W<T5_I1F$:L;N,]NS6]NW`X2_7];Y$D#6(N(#C
MQA.BB>_YBP9A-+;]!3J;XIC9A=7K.MSWLV,^'!E'\CN)JS/]OOGR/WAN,J*/
M]$X94A`"^/8DYF?3#W]_*O7SA\I'?6?(T5P:X5\C;BR?Y<-1M_/N54Q:!,#L
M1'/;\[8^<:/S-@N7E[@#4U9`O5NLY'>GM?D/2D9N0]]5UW__,6!T,5\D4/VT
M@:)<N[;Q-:K?VL[WNRA,`U>(2QB=_1]7_@=%D:_R=7$M);3I=+:-,CM7&NB8
MV;%05@/N\/$MCUC#/&9D`A3FEVY#ZI7<O:\4S][":G5LY[9HC^0U**AC5\,E
M!#6/.VWCU"J=K-KPH,8[Z_5-J?X8.!%Y7YPEX<R:W\8`>#7QI4@%KUO&RQ+I
M;?2,`GO]K2(>Q+/FXOF%G.ZH%'FLTB#?`WEMGIKE!`@W("VD60>GNS(7Y1]I
MP%G#D.Y)==%I^"]E^R^O-A2'@Z-V98[-_\_>M3XGCB3YS[<1]S]43%S$N2-H
MEO=C=F\CL(U[O=<SW>/VO.Y;(16@:9`8E60W]]=O9I;$PP8;VR40(K_,N`&5
MZI'YRV=E-AOE^N'W/3=4?#31G$<QERVQF6O_3OE1$,XOXC"$O]8#.CL$:BZ:
MC5:_WKELUVKGO:O+5KO?;II`3:]YWK^HGDZ@!MO"PJ'[$<D.+]U8(4,E=#R=
MRA"><5&TF)#.,S563R@6T^V6.Y5FI=6IU5JPOD[37F2F\\;(3+M>S,C,`9_C
MT!.'GHXI]+1R!`Z`IPJS/81U/6SSD?1(Q&Q3.!9FR[8?V#1G./G-'J$7DIY?
M0\%KL<$GJ'CGF"$[/#;KK3?R7DPET(`G)P>M7IL+EUN>?!1O<$$<F9>AVJ[O
M(8A:%"\!R^/][T^.,<@NZAPYN!@XJ77LN2R+@AJL_VPFEE^#\"NF2L_"P%$Z
MF])T)Q:G;59;Y3:+<Q;GULWKYSBM"`R5L%#5WFVHHG`*B[#-Q'+E^9X>*Y>2
M`P]27/74)%RUW2QWK$FX4\]%8@FX/TXM`D,:%FPU+/J,N'C=3A*T4U012L7K
MEAD;V=`59_IQIE\^$'3#CG=:38M&.^?YL<)S9.5D<D-Y1U]KYFAAT0!AI6'Q
M5MBS0)@7JCN:O.:G\Y6W)#G_&&#C&3GI34'F1/K3\%,<Z4CZ2+K+-KZ?`^U1
M@YH7YT!?M2]ZU7:_6^W66JUNI=&MMRY-#G2G?MGN7.TU!YJNVCVDAX,E1?O)
MUHL[+"V$.3_#((29^\*A`W3FBP(VBR[*(AK+2-RK4`G*3U(NZ.91@!=@X41'
MBH9PI([@BU`!/<18[T9SDO5S2=:56K/>J%;KE5:E4>OF)\FZU=UW#O+>L[J+
MN<!7)5GGR2V?0;ZC!3=?.]]NOL-EC::"7!A)GHWCB^\";#^`JT1X7R3"^WM1
M]-L!NZOHAV<:OCIP;(X.OCK`5P>.-&C2C\/@D$B0B\!XGF(=)W1CH-2HM_G.
M`$<<^,[`X6,&1PXO":!4VXURR]:6%`4W6/79TN5>^M+UI"]<=)AF4_WMQ'(J
MZS6+Y=U8GI^\/#_!2P,6K]T4A5%8@&VI<P@;[NFQF"%(PJ`JA`%&+,<LE,RK
M6FQ+RW*,Y=C)R;%Z@^^^L1S;C5;^)6$^2BLQ5SY++PN.59M=^%AZL?0Z.>E5
M;;$;D:77;K32BW44PCNS=23RY>UU$5?)JJ`YW]UF$9@AHQ:!'PT'=BVZ2/CJ
M]BXBM+CME\S5[>?OE&1#<%G?Z<[Q[A_MM>T\)R-LS'5J5MO[O)*8!UIDG26_
MR5"9(&".@6[/T';D")9@5KU2VV/?J*)`D]6;TF^Z]+SE(C4UN_PQ\(.9"N%Q
M?W3M.\%4];_-E*_5B^]-U_O5>O/\O'-YV>\TK_JU=K]]9>Y-GU>:U5KC-'I'
M7:SUC0IPBX5'^RK.E-G9=R7AJZC$K:2>O>5<K53LW6NNMMYXL;G1+&9SI<)W
MC^(%'OL"C^1J>NYT?[Z$OL,=:`%"6MR.0Z7$#_";L=YZT[`/4M)=-!)F&Y7I
M=.]T^L7[E@V5<ED%;K%XE/?*=ZF3P(4.N-#!@0'\)54*F`0+`Y9%JSC#2)I/
M,F8DY6S%%[BIKZD4IXX2W_0A.3H7,>H\Y4N<3CI$PV)8,0]4Q)D.^<UTX$2&
M'3;G2*'%J`5E:_858P9C!JLSK,Z\<,_:]FZ+Y8**&)J*!4TY1B!69QY5`+)7
M0JLHF,'.G&><.4F"X6O\CUP\85V6G]GL"OS<WBU)[;A1?,,^OB0`S@J!)68M
M`D\:+FS;DX)%8S9FKX-=[CXU65BM[:&24-'XDX5A/KBU"$R9L&'#7E'8HG';
MR_B++<G-&_A!PN_/)H'6[T3@"\^_`[-RBK?9Z,X:"].WRP";%8O82<QB\.3$
M8+7.1?F84=BZLV?=V4N<8...F96E&I>:Y7A?EK22]FU6WYRQ]$=*C,!LT\9N
M4_H=FVKV)".[/5DRLF0\L-O3GGY:-&9C]F(K<5^RT&(G'Q:&S*TL#%\E##D$
MR"'`3#>0JH)F9T)R`Y-UL=HIUZQ)U;?N;5&`@*5N/J3NR31!.:M9O/FUXZ85
MA5F9/?/*GB<GBRU>N6)9S++XJ)B]"#QMN+B>57\=EL5V+>A.44UHT\;LB=X/
MV=!GUOW+=B]EF*\SR;2Z19;-S;+8\,/%#RI9-8I\S:Z_"+$+1/BL>]G3O0X`
MS4=*B'O&W")#*XW7V">4YH7F.'_^U-".%5%61.TKHK4F*Z*')WQ61(\:FH^4
M$%D1M>QLK=A+1]IY-T\",E_MBGU[K^&7]`7>TEKX1CG!R(?%N-?85]8;>LKM
M::TBW7/^C+T0_N6['STY\"9>Y"D-W\53Y;ZXYW"O?][M5CJMBWJK`O]K]>H7
M3=-SN-<\K[0J>^TY7$5Z>T@F:TV(L77N/NAFK))6PC`U85KT+AH-:VHCIW3D
M366D7#&47BCNY"16U+$8O]1J)N'DU60..VV.C\:0=()")D<HI.^*R?(0\7L\
M1>QD#"-=J4$8RW"^%&G56DG@*9;P%]+](]8P@=<W.U[9:AS*&\YW.<(U<7=*
M_8\;;VQ_W&ES;UEN?)CKQH<9['KN]7_.8]Y6%/?]+`P<I;4(E58R=,8DL%QU
MIR;!#(L:'=($9>?6GGH('*V!M6%#&[7&'EH,Y(8"N;;`@:Y_",^/I#_REDK_
M:Z0Y7Z'D]B#,GG;9\T,0N/>@8C,_OIT?J[4.UV)DCGPC1UZJH0K1&Q;);PMO
MV)SYT\;=2)MY+GSA@GD\IW>B3XVOJQ9O:#!;9\[6U<+RM;FH,8M#9RRU$K/0
M<ZRU0N>4N(-[#3DE;D>W8MNF6_'5NYX;&MZ3&?7V3`TK:19;4CA^D9-81E[@
MPQ`_Q;";PSFP0,]QX.0B?>EI9Q+H.'Q1ND;KJG5YT:SW+FOUWE6ET[UH]&LF
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MY)S+";IC2LD5GTOEJ.E`A:)>I9L]UOMT<&R$,ZHSW=#&/I(R<T.`ARRA8C7+
MH6`B?7]8R'#W8K@[,D2K=]H6RQCG@8X8M1BU&+6*C5J-+H,6@Q:#%H/6,8%6
MIU[N,&IEXE8[H2SDBS@,%0PW"X,[3V-X681J0I671!0(+2>8_^0+)_G='`[@
M-?YBOH>PSKZU2M=B\[6BLR\K'19"-LR"ZRS8:3;L-?=F%F069!9\\2UXMKR9
M`YD##\F!I4JG9K&.;M&9D`W);==LEEE_:Q;D+/2"D,Q&KN-D@5\KK+*RP&2!
M><@"$MT]^%VY@@2S,;-QEFS<V8/ER5S,7,Q<G"47U]KE)K,QEW,ZO/W[6<[)
M^/VK$RK7BSB,NB=MO-GA@FXLR%F0'SD?8SH3UUME/F8^/FX^KC`7,Q<S%Q\Y
M%[<:-79RLUU]/'9UUE'F9ZI9G!Q`-.H6NY>\=7,9/U@/V(\>P##PP/W>;&35
M@YUQ@'&`<>!(<*!MT5I@%&`48!0X1A2H5YJ,`[G"`>ZIME,IP7_%OA+U"I41
MM)=.LM<>3#G>\4P+/F399NG(*D(TFQ9C+Z_>5[X\P"H4XR+C8GYP$5-+[.5Z
M,S`R,#(P,C`6`!B;58N721D7&1<9%QD7BX"+79NW[$\>&'?J.KRWB:ULVM,=
M>I%P#]*P]G:L1$3-X1?=:>4`(+LD/-^9Q*YR,>,IB$-L>@Q3TPJ#%CZYQV4$
M_Q@8[Z;08Z4B71(R5-R_]LG^M=5*Q5['VLX;&]:VZ\7L!LKM3G/2*(O;G>XW
M=OO,<3Q]!/OH6[:N`VT^DAY%RK:)W$4$;=L/;$;6V&#B/GROZ4OZ)`6OM9-[
M@HIW-@PX]KY9O;U1;NQ$@.QX&M(QK99!U764=T?6P0%1(O]=U/+D,N`V?C1Z
MM;&/J\NYH<!#^E!9\F>`>7DAK-<($VM@5F3,,BA5:UCL-IH7FLEQJ=_"*G`7
MP70&FPD#&@4NC)4KU+<9>B*UD+XK8"R537DC3KE>3VUIM"S6/WOMYA:%X5G[
MV!^G%H$A:;QZTV8CIV=VK2B<]E;1VBFJ;+U=B_ME0U:<0<$9%!EO*F=0L&*2
M([=()OB78YC;,[`=.7XM+@ED='=UPXX5!9AV2NW:]/??_QKK]R,I9]]_<<;*
MC2?JT_`7.8DE!H9ZOOM3#"L>SH&*>DF$Z-+3SB30<:AN84/.)X'S]1__^9?_
M^/O#<8+AE>=[D?KHW2GWVH^D/_)@8CVM5:2OX@@&Z$T#.+7_IW?UC=_B%B>_
M&!C3J7#;;]3P?[Z[NL38]4^UWV\OOQ.>"Q]()WH/EG?KJG)9[UQU*]5NOW?1
MO.A<-OH7O6ZW56E>U;_[QX-C7#V29W*2-E'!CKEJ*W1RD-RU<XG9:/$L\`4\
M8\)Z,+KTY62N/5V"3Y50.O*FE*DVI/,0<N5`Q#`(A73^C+V0$MW2`Q223E#`
MH.AK<O#Q*!`#926?;67SL(T5D!ZGN#TVSQ9`U7ACBENGS1E@G`'&&6"YR9C)
M60;8J_CHH'RR/TT5]U&<A6HJ0<_Q1T)[W\04?C=^$9_L+W4FQW927K-C\DR#
MFQ)@.LT]=.$IH,W$V/88VUZ2H[![-.K$XL+U:HTYDCG2#D>^I,`K<^06CJQU
M;-;&8XX\:8Y\"2$Q1V[ER*K%A$CFR)/FR)?D_S-';N/(=H4YDCG2"D?67M(4
ME/./7\NQK<RBYB>8?_QVCBYN&RA*C,R&TC@?DO,AL_:0EYK=[A[SBW)!BT>2
M>&0C86@]$PEVS!O"J?E1DKP$Q/L91)GC*?V2'*-.O7Y>[U<KM7J]WF_5&\WS
M_J7),3JO=B[;G?WG&*T,4K/,.;4EYS3;G6JWM24*_84*6<TQ%+VRT6*YTR+=
MZB=IZ=5EP*JM[%.IE@A2'\CD2QST>P^$H.=LV9GS6,-*M!:?`#7N/'5O90-:
MN4DM\X*1\C'_2XK1)!C(B1AXP6PLPZET5$PP"4PU!4";BV'@Q)B)%OC"];2#
MZ<JPH))PU9V:!#/Z&[@B'@*?Q?@5W5MTU<0SO\0\M5#.@(HH'\U7<0AG,L)W
ME(2,H\";3C'A`9\:JZF,S+?X,L)F71:?XA#;4OJ.-X.)`<U^59BS-@L#K'^A
MTV)NHO?+IQ_[OY7$YX_]#S?7E[^7Q&W_XNKZLG_3@S]__]([O[DNT8NN>C]\
M_OVF1S.:QI/(FP'D:\#0,-"P+6<_?'E7$KV/GV\^?;S^C7X%4X,=\B:>%.<T
M1/_CIXO;WFW_X;>]LO@55C/1@:"<,)`P,E+BWHO&XH/"RY[*&9?$M>^482[B
M?@P_FK\/[GU8T=3430&&Q.2^FP!P57P`X3,K"4H#5.FN3TTJ(-I;TZD*'0](
M*DGZ@X=OKF]__JWW(\T,'XI"):-I<LT4),3[?P;NZ*OG_[<6D_ET-@94*PEG
M'`8^[+OYQ)E'^+>*OZHI+&IQ%94*Y7GX(G,_58^Q)!Z<Q!`;BN(GDT#KY*P_
M]/[O]U]@Z^^!,,=$;C/XY1UF*VZ:V5,S*`MQ<B`DD11A7S[C)2:0IKCK=H%H
MW\!S;8@842,A54`..5)(`2:A%:O8$.X@<L2^C('83%'&3>49AYXO?21^F"!\
M0-UM%V@@)Q,A7<Q!I<]+]*BG2;`1'V`2*:;5QJ&!+;Q_#7Q;`HQR`/Q1-%(&
MK1A*#P%H>0KX/%:-W/A^?,;#/#-O*F;PW\"EOKJXLM"E:I*$!7(I9A-LPP:\
M@,N`EH`(^+V:1:9")>[,SS[MQ!=\$2#4S^4OY>7UC@^]WN=W98'U+CU_B"NC
M::Y6N:0DXC]C&<+,8/A0S4`30UBY@I\O1ZI6WO\$7!W$$Q<S@H$_Z6G8NS]B
MWQ0;HNDG13.?.0L$A$?'Z@>1TH\J</9\'W9?W&R?U_\N8`.[$POEX]./&,(F
MO::5K);3P))6&TM7V7RM.,MT^.SG__CHWADIODKTB6Y)-55=I9W0&RRIW3S=
MJ=4V7%VR--7'.$R3_Y&H,PK$Q2IU7RVH^\N"NC/=P\4&5/^6<DCAB(+@(9[1
M#E,#L07PEA:(]1B=#,PA!+Q7_E;1L%:Y5\!G,D7P1/T@0`+5#-14,8O#68!:
MRSU,`G1.CW24,)C2OJ=":!/"E<0@AN$#>!9@;4WVN(MK-GAY([F%,9B+Q\AM
M5@2_`TV4)'X`<D,:)2N%O$S/)AJ'RFC@VON6+168_-I]@#>F4:\`][:>=#9?
M:0I$(R&DE`PC`5&X8.T0H26:?7*^@(+IH:?'/(R!<DB\P0>D?8`)9C1O'0\T
MD!$JR^OJ1?GD5.,E-!^]2OQI>_'QC1I5J(83Y41;U4]4HP'*4@UUS;Q$"O)<
M#ZA2I:I9\E-'A9&$B=_!=W1WBBA,Z0@8-0)S#Z$1:!!45T4DCJ0*6BNYCP:@
ML@Y!E,/?983K]44\?A[F@L2-PZAO"+MT^VR"[I9H+/UL00'O;F4+<`F+*]B%
M8.HY<"#WB.VH_`,JD(@(IDJ<H9W\3L@H`KTG-A?68!O`.D=O9@BGAO"0'H-^
MID[]"H'`^Y-7`%@`:<"@=%HJQ-LO8&P]G"$>!M)'J,?>;'GPH4**,!J9CL%^
M7YPDR+#(R"N\/(BP]F#6(%?QAV5QC8.ECJ1$(B>4!UNKI9,X$I`4)MX4R#DQ
M>)Q5!K>.;X?VOX$9["K8F:FY=@*<00#_-&]1B3#?G,(\-:P`#8)0+=6+*%BE
M"R(].9NA-8FFW\2+C!@B/XR$,P6&BQ9S,4R:3F4LX8<#6)0XJ[XSDPKNX2MX
MA0OO`@A:)2(R6?6*%QG/]L[02TIORYF?U<R(P0!.PIBJ,*P<Z"`<I`ZD8%@2
MB5"D6!/^PI2V5<FVH-@$':VT.CHMR"'K=0:*/'Q(,P-+=G5RQ!,R`;<YJ5^`
M@^0?<!>:EP=DFZSR7LYI*XWU0G(9F5%]2]P)2T<?SBY4$S,$\--*%3<X7*`5
MX^S0Y"1$GO'\.(@UGA"N6K^$&+:A-8XEG#&^BPR9Q337)X8*AKDTO,:,4SE/
MM!)DQ%BO\B)Z3D*@EP<?^0H_GB(E)F)GN2%!2&]"2$"(*6>CJNR-=7]-E3>Z
M+)VI)(%MS5A2+;10K4;&!;?PU.;`ZY\CI?9Q_+6S;J=O++%R4!7Y9Z/8]9,"
M`79">`?3DF\)!I4QV)?^UY<ISB0C-4(:@.)4?EV63P`E[8_8'24*--(DH'$\
MG1E$)%&!L"B'PU3N&?<IM@":FJKK",@4YRZ)"8"R-R'95T(E#!"Y!`_<*3].
MM)^TQ*=Y%\$R#+5T&)!*3L)A1($>4Z^!HBO+L<OBDX\:0>"_'P7(<@-)=2%`
M<J@[*@"BC)1*%TD#+-9)_YJ"L`E<XCUE9!(,\O`QV.\Q2)`@I+@@SAT,"/2M
MD&@S1@/(L%3*/=PY%&,#``9UMZ@S$2JI`Q]%5RE5)5/7AT$@=&'3-[0F$Z:3
M7W&1*_,?!+$Y#`<D*WF6<=EJY2P>;UD/X,J4A:,7XJFZ'AQK:-P]$2D"RZ7'
M0%]A\HOD)!:+"U:#81G)M?R:X&DQ&7&S6[N!W$/,BGMZM8="HGVA'P?^"\1!
M=)*$GH66$PIEF`C-FF./8L0@]6:&3_".N0F[&"_D`CC<6"U=C6BN*QP4P<!8
MAJ!`E<0L!DW9$6"NS_!45K7*$<IFGV*HJ8561M\U6GNI*HMP`N:!!U:=I[^:
M`$YBOB%'!IN7GJH#I(?.9XF2'P-P.8!1KG%VH=E&X!6KU-2\!R6:0$%%I*B"
M)A&!/1HFD$/A>X1ATATIM&_B^.0"OE<8MD/H4!YR'DPRU`CYT@G!,$"E8[["
MD",5C$#/P$.6B"K&E3J5?P!:F;=O65PJ#T`SG=/FX:9X&7L?ZA7<HVY%N'*>
M;?B`L'P:^%Z4.A87,A$VE"*$*8(GE'$/\FQLLEY2Z;HX-YW82_>(M3X>V(R"
MB(G-8H28G@6^L4`3T\.P!9QB\@;*$I@HFAKF`2"9+/ORC8!!P((!FJ6/TW,R
MX+^L<Y18APN9G)@JQ$%R,>4T>E)M_PWG803`'"<'QPU2(.6]U/)-!5/LH^6"
M7@VJDP3D`8L)1Z@(`W,"28%)^3X8#I?3'2_6`*07"&-VX^ZMB,SE(F&#<!2%
M8^@M75N,Y8U.Y(%2_JK=>NS&TS4Z=F"UX9H_D):[U"I`I8)#@HT.2<U+V!-+
M5<'>NZ3GJ#E26J(``L$8F9XR,AZIV6F5U+<R;A$ZUS7*&F'V";HTQJ1&)7%E
M.32?`9YY4U+%$)!+BZF2/113'`FGL#J@800`,[74ZA:*'^)TZHKS`I?<(OB"
ME+-2&D^\LJE\N/<`$`>(4YZ;@";I/+21\S5"-]#Z?D"5P\#Z#H-[,OMQ4.0B
M<N.E,0,3<DKGN+(&)/H)<#80'1Y&]&@K*%('6B<F3BS54Y/VY`"O1RL.B<05
M:;*7]!ICKUB;Z!X%*D]::DJ*S2WJXALQE[I-$]7Y78F<J0EH[^(973I&3TY7
M^TQXC5;(YXE,$L?Z(/THC:Q8J8W+I<X62U7I4HFVC2O>4+83Z,@0DH'B>!HG
MIABJ:2`MC?NYM^4;).O9DR^\S]I)]%_54JW=*-?2"E_9>HQP<5DOI]IIE1M[
M6LZB#%>1@M#9G]*!TJ)**R&GR?SD4!PO(*SFYH>!#W\[6W*1CAK%K\@70\I1
M0/]'D+Y?3YE<73T!NZ=U;#)L4&%9)FRM[-F7"'A#AJZ&6<#_Q-E5[\OY.PJ`
MFA2+Y'L!"@T],`A<+[4V,"+C!K,H@0U\"5*C49,4N08Q^H-J1UG\[%-`FX:]
M1[<!:HTQ*$HN*9)ND"CXY!8SX^.`2<P)AC?E7O_=WI4U-VYKZ>>9JOD/K*Y,
M7;M*4DN6)=D]R:WRFG&FT]W3=B>91TB$)*2YZ'*QK?SZ.0L`DEILV19E66'=
MNDEDDE@.SOG."@"K1WA:L1VZ#:IA"U/075G?9"N2D2H<-"4CG+]I,YBI&9B$
ML6(M%BVI/:+#9VG.J`9W+PG[*_B/B%H<A$1>,-0^N?[F?`H;]+3>/*XY7]F*
M9S_S3'L=,4=2SJR?O'<33J#[;K.[;ZS;.,4`AG31LO:\?"Z.&]2F+RV$#DGH
M,#37DN&[?DB6M`O]1-.Z9KJ!,TH5U1.S+8\"8OG7!KN%W<?!Z5,VLVWOX(0%
MCDHX`SC$*8Q"K%=&9P%WO@PX@YA%`A2%G-DW84[4!2FQ]DIR*=2,K<T8V!V+
M\ZE<+GQ"AV>N9ZP?<'Y)/5JD3FZ17""`RSZ["QX,"WQ1`HV$(E7,9"UU`"*,
MM[>`=L;ARAK$,:84!_]%!"FF7UG='?'7-";:\"'`H^1Q"3Q%.2N9H*A(B+/$
M9X0BA!^FSPQ2PDB-0$2].43Y7<<CV.D"HN@@OW$(.91/AJR66%M];3/A64X;
M%L;R*L51"#668X0.\<R#Q`["`IV_N@(NM(`+;JS@((6NB7-Q1302''6;^Q^P
MICV-!F-PRV&R]5\%9DR3*7^KT^ZUW$M&=P4CG2#*#FQ?P*X@4X***758-N?X
MY_0EL)VI38T*H_'-:(H5.;3<=D!#.R`N$I54`P'0AR/)I:WR`$92DVN#9$-#
M&PV5)</309VD0(QB_\O':76AGJJN[05QFJ.&#E"@;*"(8FVQI2$P^,DD4IZ6
MZXY)TC%A423RQ;Q9';$./V#)N-.KE69TSUN(;"59,;T*0#.DY1>EZP@_U\JL
MFGEEGK6@1#B7)[ZK7#)EV&X)GF^O["`4,5?.J+]Y+.K4F^T:5]MAT*WN7/F3
M--NJ9!_L7:?]A(&IW:FW$9NN@=SZ?@CJX<O,-J=SV4^<*^B1\@5G8(G$#]D;
MNJ`,OE'F&PRRQ#;4B/HO'^^C=TV*E@JU,O'2>;5B*3\%"'4%FFLO0#?9VRP7
MK&T48C<S)MN/W0QF,C_\W(1V%TUQ=;.@^QC'*]XLD+]\H6+^ES!_AYA?'S<0
M`___#+8D+1@"^6?R[>HL!F!:U;$VYCH<)G>H.3*9:'>:]4.4"6/0_R/..X^X
MW)<2FO^"D7@TA)TS+TQ=!V]Q3>F5DZS"#UU`EP+^N94'HQ[K]@;TV<!^EBL,
M-%H:F3PV0P3$1ZQE*LS^U9&>C6_35KM<8]D^OJ)^G&5^WJ('(FR8S$3=9SM#
MF_RQ&<QOAEDRDU5&2M*N'0*;[:FD<PND4SO/C\HFV$67N'\6[R22SJ]2H!%%
M:VYLY`.4N?.<@85+=Q7<2KUS%V7M3&]0N#`>U0V"^IGP!A27=SZ!9J!S1G0_
M0'GGFO:F[V%CT`@F/,!C@@;W%RHP/[R5L<[G6BN6'#=H?P1NV5_2V'N43\<Y
M4;V1,U:PS&"I3LG#5[F!XT1T05/V.O"7SU3(Y_,"J1-I^BV<@-E<C]:N*;UR
M%8'+RP3@0E#V?@*:?Z!W"L?8HX\);I=K!P1>&*2"PGRP,M_L%($_H,D_$%21
MX@S3P(WU9+.2&?Z8MA#X0)P:/KH%>IHM*3733AW/V4%S785X/D*`)6E3'3>@
MBA:<,%-&5R?,C(O-TL6CPHN.;`'!<I)K`,5ON"X5P(=2\,5MU$O6/N<&$6A]
MQ$I9IVW6VC?+MF"4^:F8P)X-W^GZG*>`#:X?9]4]"V&\#:"(=!QUL->-6,]G
M`7F7+#<R71`Z7@@X'B'[S>[J+FZ"'.KQY/VF[N;]IH5PM(V>TX-:8\$Y3"L=
MEU0\82F!OXQ##TNN+ZA4%1=EP0UQ*QRR='9P>7C<.COH7AX?=MM')]W6Q04?
MLM1K=YMG)YL]9.EH.PY98J*^[=)(ODJ9*YEW-6D*P(7U@V5O2OZA5>MUCAO-
MS22X>8\[*X!=S`BC0E6Q73O>OH^[]P.,\>=V6\YNL]0G8.$A3%SN'V2-H&?G
M<EDW596QLV<4'VM<\@=-T2Z9:;KJ"BD.Z,Y&57[#5XUW15()+1;_P=CZ4WNF
MDC^)Y!B^0[M-5SC2L+B:3)_E,CLLP('ZDF'I+0HV]DKAU,08M;2[P/>AT1CA
MWZ%##\P!''WIA7=;M?MF(]EU=A:R(/P;WS!3<-"023GAC0$]"IWAMCR1)F/R
M:ZCD,L)":I]3<Y9QTDGIT/%#!]"POPDTM)N&<JR_1T;O[.)C<0528U\#C*$4
MB[4-<)BP`/AE2J<\;:[.5)ZBFVIY*O/2[N4@S5G"(E<4RC0?(A1@AM+LU*=4
MJVE)'[R6-<C2K<LZ'YR3H^(\EIBB?=H2?$\^$B!4J0O1:K0WH_XTC;(+_G@[
M#S+!I>Q'Y!,#K5K+:;7WX&.;Y+>>(NV9M$<5>I1UUVA?8#L3'(]S0UJJ1K"P
M\,UOG#U/S;;0<IFK.L#F925V=[(`,YGEX&X2(IJ-UD8A8LXB2JAR)DY*]W5^
M.#S85/5N!C4/*PC:R:V3L@4C<KJ,7(66E^-EPZE08#TH4':A[9UT<ABP2=-@
M0[+P^G+?;G<;QZ\@^`^)Y]_-Z?M4/+?(U$F\<=\/78!AB`6(A+5ZMRM,=*`P
M.V[B>*N>/+7WZ>QJ_\.S2;)LQKEO"G>$-&?(AK_SC?*YO46.PW=LPSRC@?0\
M_<Y/[YKOZ'<\$0/S^^DAZ#OE)N,/>("8N36"3KF9Q/*#^8^YY&PVJ/PM--EE
M$=V%-Q.M<)$-#>:G=X>=_WST'HKB;1CZP]9SOWOVAV_ENS<ST&J"KSK!MW=I
MW,S5,T?KU3^KG(BTPKUQO1?>&U?R]7"X*4=&Y5)QL:URJ0]RN*&S>G]E_P,[
M773YSP7Y)2:S_X1UV#+NQ3WS0S!D/HR5"];`D\VG!R].JOBT3#Z]5O?E<.FS
M@+>,Y7A#P+QXJ?:N`N.`QOO/$8+V-EWR.;\<NGMR$>;ZWC)A*EYUMWB]%H9_
M*RQ_,9:_E(U+H.7K,^12%IR//58L^.HL6"%IA:0[P,85DJ[!Y`5:;94]6UZD
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M_*XHM<KW6W:M2G9N(?AV]OC#N6MR^2S82&__QZO@1OJ*1/`-*]7Y<LBWM_8=
MK,U26TK"79'J2OM5VF\)F=8J2)6\5/)2Z:=*/U7R5NFG-=1,K:VT8%?DI/+.
MEIV0IV).Q.E3&2M?J])EE2ZK=-D6B!7'^X\;K74ST*Z$]:M`?N6:5>JL4F>[
M+V^[(%:5.ENK.JL\NF4'<>)5Q9Z^"\3],^7[M/B*+;SXHQ1]N,F#(K9-L!?H
MRV;C8&UZ\KFDK?1HI4>W['RX-YVB>XQVE;Q5\E;IQ4HO5G*Z>W*Z"^)8Z<57
M32'NK+])._=DX*[_(*PB9[6!L]PPQ?V"+Q'+[=\LOTV'-3RV`M5I#L:P6?<Q
M-<^@^=9P<&7V;.]Q#^6`ZK9PWJN>![$R:7<1%*F]=N-X<S"X+3Q7H=W?#>VV
M7@%7)N26HV5E0E:@6H%J94)6)F1E0FXN;OF>CMM:^/Z"__[Q?1K71T),/ESC
M-<7CT`-BQ1=TD>NG,)'G*AYX89Q&\@:F?^K!.__\CW__MQ_M5VD_EO]*99!<
MW,(_8ON6@U>^PH^O<OC3N\MSO!;C?P_^[^;\G:-<^(,8)/5>[^BT?7S>.CLY
M/;D\Z'9Z[?.+WN'1T>7Q::=YTNV]^^?,"N2I^<B5JHL6\.&[A8\FA3MT#];,
M^P>90=#I';6.N_QP[O*&C*`.4_1!%EAY=H@9LPQ<N$EY9OKEVD-/N4GY9#+Q
ME'2=GV4@0?Z=&SD8!]#2"(\3.`NC21A1'=1:Z-1]A$P;NVGY<^#\DGI3YX`N
M9>_0O>DB",":&^#A"0A5GNCKJ>M3%@8RB.&M420E58,EH>/*6^F%$V<$Q*OW
MZ<YU+`\3$R3>,(P</_42-0&X#"?C9"P\'\;GJEC"J[%SIY*QLRK]G;V3GV_.
M]AL.7A)='-Z=\CSH;9#&#FY`@N=Z7#3,<`CS@5:2(4!SB#^Q(9O$ZOU7K,<L
M4^Q_PE>*QS4\;-!+<>D<0/\Q$@6(C!H"%D&,8!!`%N6*1-),_ZC#T^\PD:\P
MC2",!V,5J]C9^^/CU^M]/HX"VI9UVTCQ<QQU$DF1F#'_4?^8:T\ET-87-<*G
M82RHV2^:&-F*""\.];#QBO@)4H?7`7`?5IO'#?0?H+$XM7.%;YSD+ERX2%3S
M%TB\9;N>>P[PZRILO^8(6$D)*R#P97-)MPINI:X:A,:1XDY_ZIRJ$%A%4V.>
MHXAC1)`.`;[3""E/-D/<V`Q(;4SZODV`3U'OP=!(](B#??$=A=!))\,(.YN(
MJ:$?<H?P03J)->:HL58SM'5PV&B:VQ5+[0H1!#D#2`"?C#/.%25/L=W<U`R7
M2D,-P6`BP%:,)$A:!--'J<@#E[R?2!0R,([B\I>]<]0XW`Q-<)Y)"#I9(P#*
MN:TL=H9R$[-M=QK=C<RVX?RNQ;LO'0!;,%KSV`<2@+*-2H)H@+">P3)1:BPU
MDN/+YKL%&,Y:!*]81LS##X#"@&R@;%@/B(2U#%BV2.`%BBB6GAS@RSL'N-`?
MZ]B"Y5!CQ02J5<(`E3Y&.)(#J6ZEQ6%<!>@9!!CUH$9E(.<(]-8(V@'VA='(
M^X&,-\"Y+8"N_D88]P8LF`R3TPG2IMRY'?8.&IW-@!#R`?(ZP.TT,\#`!@(7
MV<T9@:R9R+`B*1Z("(0N"J?"HP/'M'(>@P0XB&0>RN9(D77L*[>>2+!W)C+"
MZ_K`^"(&`4,[!;G#8\QB`7S5<*X"*[0S]H!EMTW0OW.\,?J+013&,1OK<U@&
M-J47@EB1@S!':R1KGM0Q`6-XMQJM=PS9%FB7NS#RW#OE(MCY/I!#P2#_8E>)
M[6G+\(OU3H-A<<P&?:9\XK&(BK[5((SU(7SP[1"70@P3C;3DM*!Z,7HFB?`G
M*!KA8#OB5B@/8TDU]@?R/0W".C3HAZ"3L*E8HKM!Q[J/P5K"SMQTP`L/$Q<3
M^,,MS%PSR+?&M9X"D88DFK#?C"0_!:L_T>="<H`.#5.09MV);AV^$CP$(I5Y
MB56*#QXN#1T>#U44(QO4QRFX,CSI.+,"XG2"ONCR\1!):_!>_T_`)R*&C!(!
M4[,N%SP&7Q8X'E4/-C339YRD+H.:7=^K3^=U&0"U\1-\;AQTG$W#R?1CT?W2
MYD:&248W"E)X7AKCCYPQD\*_YMQKH-\D4C(1(.*)<>]!VCT!/GGD$U0BUIV<
M_.;<PJ3#B,?&D!>K>XHOP*S9O`$B:U2.I#&G"_TAH$22P90U\U@$(_:SC5,%
MC5B=SAQL<6;7(.*&0@OPCB#;#LV=/'>E0`,?ET8[I`4^RV(@R!S@D2@=<T$`
MD9&O`F$8GWQ4#.8,Z#Z&.Z'(-.)R3B>U'/;?(DKJUX,P2>I?0V@:?,`@44D$
MXW"N?))DUG@G`UJFUG&OFY=LA@NTV<`_&B1\O">.79JW@#*1Z_PKA8Z@3V@"
M0UP;6M7M#71^-7[F#4`2:<\O(OKN7(H!'IXZ=;ZD\%#$<C<#G1CCM)%.NCJ9
M]`6P#D`9V'0($`0,9'-<J%BH&IAE@X:S1S_VD<LFFD3(96HV5#4TA(0!+J9U
MS?D$T#]VSD04PC1$7KR$XT;IR"H=VQCRNM89[&@,(Q&#L&"O<M>0ZBR-(NC0
MFW(\&N`==#?'!RB":Y$&I#]/;DK!L1HQ*P)J(HV(>K1\_P#]'F'DEM)S;I@W
M(AB:2HXYM>:/4UNK/3T%?B-J2;(UQN*6S3^5:(3LIZ!\QR(I$E)F=$PQ*$G$
M*BC3HG5C;!'2)XJ3`^A%*5:<MDQ@GIAOFS,K'5KI4,R>WDDP+L?.YV@")B6F
M,VZ1ZKYS<KJC:K-KU.8#4W?VKL,^:$AYC\XF)@'1$\R\.1''J5]T')']YKU3
MS,U]_/+U\\>K/Y`/+U)P',#Y^)K&L0)M>9-&WR6K1(-#('3?\1QXS;6_*M<%
MN;D`%<E>*0;8T[CLD-RFT@DF'&4\_K'TR.F5X.^$=PZE"P`N+AK?&N"IC5)P
ML$(`)>/![IJY\'L^G"O9<D-.1)[[,U1H2-@,]2S#231\@3K.;U=75_14_P;6
M&TL_G(Q!*PIK).11_.+CY[.;DYL+^LKP:\.YQ.1E2"XI>K4Z<]X/TX1-$9OE
MM..L@0N,&AO62K@.EL.`K-5*8]9YD&.C*XN(DV/O.I\I$?-5\@$P\5A-YJM$
MUIT'1!*!TB3[3*!"&H):#'"M,&N=:'6FH]$NT1`-/_BJU*$!]LU7U*YU[I<8
M`6DUZ__SL'0N**A:5AI5**#Z%LO/PXLX4<"0,EZA:JI]WKOLM"XOVY='I\U>
M]^CPN'-P?GAQ=G(,_VN?'FZT:LKJP]>P]RA!&UG-I#G4Q5"7NP*O1I*N(HE1
M_Y@(ES0+47/^3%VJYHAKYJZ2U-<%&V2F^P*`>S@D"W.,$(%V.^8.J0R`8]MT
M!THM?P%*36><:_`!<$6J8UN42HZE[BM"R8:F7%M\1Z8]D`'H3MIYX>4J#>=S
M0&':H#X*J2P&?+.8'6J\FP4Q&(ED)TD-V'ER'DTFX]#5Y3WDJ6#5T,QG0&_P
M\`",*3B*8X^4#`92UZ(XMP+,82SV(9R:HQSZC7WI*7FK/1\"V#@,.-C,U(Q3
MCXG(&I7CD&/)<]*%*-]QDKGQ$Y93X!:30/B0KJ3)K<4\R<``Q_R#Z1!7U56P
MK)$SC$)?Q[.SJ;.)SV_HE;"3"Z.<6_%4M"CB0`$B?@-R(FFN*"H2)Q?H2DP7
M5&:N@!Z'1P?ML\[12?NB?=[L7/0.SXY/&3V.CR^[S?._9<WEE:W^($/5T-LQ
M!'>(XL`N:[;/C#O5W59WZBP/HB63Y=54R><GZ@UMX^C$CGDAAUBWAE#*$$IJ
M0B%W:0^!PV<)J3%%H8F^#.1006/1=-V.P.;]]F[O&#<]+3%I/\D4)NVG@73`
M2OH<8$[J;3/150"N0;.W('H]6ZI;=#,64<+9R_ZZ#Q8!1K)BY2)C('OE/CGY
MN693Q2MY[P(8L1_:Y.)<4>N)]Q>0%KZ;S==QX#+7-4H,16=M>1Q,5B'1U7#J
M3,!7"BB[G"_=S?6.(]0R``U,0.BHNF?!9&HS8?SE<P.?V[B#8`I1=#E1=>%/
MO5"Y(%Z8U^81@/DEX#UHUQ=]9^_TZNJTV>[MUYY!%"WX"!9L+ZBXN.)4/'(N
M!]+O@^6`_@HQB;47)R'&:6\U6BB?$_#&^'"^4#ZCU=?9>9RG'7G#.:62;HH,
MD_G+\?EB_MP3`1N!:-M,X/^Y5=Q$T4J[W=E4-2>\'DE?J``99;XDK);9D^5.
MN;NQ^E7@-I@=:1OB`I?#VR9W@'4'\`+H'JYL%9J?VIJ=D-_S_/0[<PF54R&K
MS-7V4!E/6#>54^0+4-T.H\M4BP.'V(V09F)9CE[;&,J?:-_.NC%@"Z#(N5@[
MGQ,K).O#9<,QD]14F^CU*JH*ZH6@0OG]-(H-7`X]3@D0MS_<B:-C,$OLFYQ5
M`R.`R80^H/QE2OFY1?*C:)%K-L"9#287\'E"9[0GP1F,132B\I0@#-"'B8`.
MG$UE`ZI&]6%()'&/,5:)E(-9YRM$L&)I,":G\JVSV:760J5"ARY%QO2UNB\7
MI'SXXSC&\\.`#4KMZA>0OBS)V6YR<J3DF/^\Y%I8L+).]?3(TJ67S6](\2#C
ME%ULW#C:4-8&35!3;&PWN^2BV:C\:$-$5D]I5_9YP$>[LC!U+R(.@I6>`=O,
M=HH-\,5!J]%[%;[0)A#XZX#/5,_!"\B)&:X!`,]CQY)XM(-Q\67>16<4-7`0
M0K\P7C548%,F)G&4A4G8V^':BES()`3JF5TP('<)2I]8;MV$T4@$VO7+RFDP
MB:I07(/0](@U'6%^D!R23C!#3H:&H/"O-S79`!N_+RL$L[6QOF_!X#6B?:_-
MWH9YHGPVE6,SS"L/1/.,@>Z&Q/@Y^O&>6\<3@^^,&>$=%\"YP&,Z8Y3597%#
M.;D!?E2`+/I%+*X/<4\OV+QF#Y/.2^B1T#[C>'82)E"IBN%M4YK15V&NV)N@
M+#"A&2MY2X)7ZX>YC;MRY6\%>P5CM'SU:R)9N8FU:&+EIN'9RM9&6"&[9U*_
M,UR^C+NIB;+=D!^.-K9-JW1SJ]<X?@5KBP.XOKA7?NJCL<UI<-I(%J/9;7+D
MO$$7L.^AK$L,9HNOLM<?9Z'UJ/^C;=-RA=3$HR#/:M#HBP<(?`>*4F;Q?&U)
M01?#-%<+6,A09$7)6G<M?FJB;-8/>S3B]0)_##AC6@CKK6!;/LI\.8MS$LE;
M+(SPIH\9G[OF1%Q2G#FWZSVKP,L)\@(87T[8!<5YK>.-%^<]OW1@K6J@*M![
M1H'>RG4U5(V#IP=]&(9A`J:^Q*-_G'OZ4Q3B+,9),OGP_OW=W5WCOA]Y#?!0
MWQ\TF^WW^/@]OOA.OY],)_`^-$WAT'?4]ONYQN'//[['EM0'_"?\_']02P,$
M%`````@`0(/X1AV_'I>*)@``]JD!`!4`'`!B:6EB+3(P,34P-C,P7V-A;"YX
M;6Q55`D``UB?LE58G[)5=7@+``$$)0X```0Y`0``[%U9<QLYDG[?B/T/6L\S
M6KB/CNZ=</N8\(9[[/`Q,V\5.*W:IDA-%6G+\^LW0<FR+%&L8K$*I#W[8HLD
M,I'X,@%D)JY?_GQY/COY&)NV7LQ_?41^PH].XMPO0CW_\.NC]V_1X[=/7KQX
M].?__L__^.6_$/K';V]>GCQ=^-5YG"]/GC31+F,X^50OST[^'F+[QTEJ%N<G
M?U\T?]0?+4+75"=7?\WJ^1_.MO'DLJU_;OU9/+<O%]XNUS6?+9<7/Y^>?OKT
MZ:=+U\Q^6C0?3BG&[/2&ZL$2^1/Z4@SEKQ"AB)&?+MOPZ`3:-V][\+\N^?-E
M_N*;\I_8NC0QQIRN?[TIVM:;"@);<OJ/WU^^73<1U?-V:><^/@(,3DY^:1:S
M^":FD_S_^S<OOF'@ZL6'.*]#]#_YQ?EI+G+ZV`/:JUD&^M7R+#9/%N<733R+
M\[;^&%^`JL[CRT7;]BP&HN<6_'S6Q/3K(U?7#@`C`DN&,UQ_FJ:VY>>+^.NC
MMCZ_F`'.I\<`Q-.XM/6L,!YW*CU>6,A!<"%'#,P[ZV:QL+E\6^=(H/QS5;=U
M'G/;VW]W-VP[W:3"]>ZKO<A+B-JC__2C+R'LNWBY7-G9GB+?X3*IX'T[8Q_J
M401]LIC-K%LTX,Q\C(_G5[WZ39RMG9OVK+[H%+8_AT("=Y=X!I`N/_\>EV>+
M\&+^,;;+[!7V[:WE)!@)L//S^HH]B/)D,5^"APR><NS?WIX,)A6W[NXV/4BG
M%G'+3WT'V'&XC]30>8"I/>:JVL6L#GG>_\W.<E#P]BS&9?M^;E>AAF^[6[4S
MJ])->&T;0/8L+FO?/:?LRW>ZQKU=PK]K&WF5GMCV[/EL\6E//?5C6:A)]SW.
M$1O7@_GAF[F_H>Y54QD`QE;ME-I\&IOZXWJR?S%OE\TZQ]0Y6VTEFDZLGI-^
M']KIA.SG)O<@'4?$Z[0AS+G/8,I=?GXQ3XOF?.W-=<K8@W84(9_99@[>0/LZ
M-F_/H-MV"?90^4F$Z6ET'623B-;/U+93C2/8.B3H%.2;4B-6W%=%FPJ/+T;/
MR'X;S8A"];21#65'$>*YK9N_V=DJ_AYMNVIBK^EE*]%T8O4THSZTDPO9&8KU
M(IY<3+J/F+28F#V[[`XLIA.Y7X?N03J.B/4<PL;:SG;P'K?13"94W\[=33JU
MB-U=NP?MU$)V=^P>M%,+R?80DI42LN_8TYO#9`)WBS#(*G9@.UG3>@ZJG92C
M"'@5[K^SE]T2;2@ZM@@]!\Z'*282J&>_Z20<6[Q^IO0@P4CB+.W\0PU\'[=M
M7&?<_[)8A$_UK`=>G:13B]C;XOIR*"1PY\2]`XNI1>YKI3T9C"3N1QA1%TUG
M(N%>P7&K[VU_F\N/*\S=6GH/>_WHQQ6VKU5M+#Z:*-<+TB_F?[--G:L`,XX-
M?+W.8O98C-V)23FQ=[#+77F-THB7P/E#K\SR_9(C"]`3J@<)1A'G>I?9US6=
M&__Q9G'GJMHN,7=F5%;\GF`/Y5>V,;T+]AV)IZ^Y+$#]QOB![$9IRIO8Q@;&
MP.>+YFG=^L7J:L_)X]EL\2GO<>@4OC>#,N+V[%^[\BDJ?*=OO#.CLN(_L3/?
MF=T8QJU,0_IUVQW9C"+Z>E'R-]OF+1N?>R60'Z:82*">/;"3<%KQ.OM8-^6T
M`G9VH&[*:07L.:7WI9](V'Y=N8MN'.%6KHW_7`'W9SFF:^]^[A2R)WT18?OV
M\MW8C"3Z^;EM/K]*;^L/\SK5WLZ7C_UZ?*[G'UZ#D]5GD_%N7`H*WJ]4;_U,
M5N7103*NYH?5N1$4#Q[.ZNK0P$LH=%TTM_]`9R^OI(3Q.<Y#WD)Y;')NM+2C
M%Y=\+_)NFOO&E;;/4;T2-6XWI'6U4/%LX;\9,JXK6Y_23K9UZS/5JQ9]L/;B
M-`\EIW&V;+]\LQY<$";7Y[W_=/UU]=NJK>>QS8<]',3[69Z<`P#!F_6'=XV=
MMRDV30PWEC.S+LY^?00"54/85(IKFKC4R`;JD;%:(D.<1PK&OB",HU&E;\&8
MY?/OB^:+$B9#X\;O6JSU`][8=;MB^Y?FUM"T`8$NTHI@(XD(%!'-\LE[81%Q
MR2/OL*)1Z,@Y[FKU+>-[W/B310/X_OH(%/,IUA_.ENL_KSC8QM^SR6\/]%^7
M.&WS%)(YHGH9S[_0YPL*2JEX,3F2T-;);6?3_JV_U\NS]_.%RR'Z54[_8K5L
MWT2_F/MZ5J]Q@T^KIH'9&CS_NGU96P>_+#^_7C7^#&*!;38W5965Q#*:Q"*B
MDD:4B%/(:,D14\Y8ZX37>*"MTA_+5H](`[=L_)?3.[/4U%/70TY%\;DKHPR.
M\+]B>!%`%>`1VZ]+X5>C27@\#U\`!Y\8?EN=Q_#7N-QM>MNGIDI'36V2%(F`
M/=*6<P1F'E#@0BC'38Q*'F8&'+.E+\`&4CV'KOH2/+MP=VM"(;P[I*B8%5JE
MR`%\"CV?2H64H@:EJ!,V`3JB[_1&CFQ>+F>;B^]);R6\@+L[KS88]Y<BE2-8
M@YP<$<8UXE$*Q#11B!K.G6+<2V&_LUGV8):W!Z@ES&),J)[&*\_EG;V\]>-?
MP;L`EP(X%1I7N\2H'.;$8$,09N#">*8Y\A$SY"W3.@C"E!EHWNRK>:-_$_L^
M<LU];WWH:V.+^B)WJP6DL6<^)N2X,N#ATX2LL0DQF-NTD%2&P(;U$?YO-P4<
MF:*^MR[QU<$JYYG?U%@Q[0Q,W!BQ$!*B%N)=@95$04E'O=/>6#6L(XC_[P@'
MT]$A<Q(;5_9+I/.G7KC8]0JTLG6/>QO9N++O=+-8B:KOK<D6JG3+3],O$PZ^
MG*M06O'V(#@/;Y<+_\?98@9S2?OM=1@;9L<NTHI;1GC"`7F9+!(^481=),B&
MH+CB$)NF3G]OFE;?%_;%W,]68;V-H%G/J<ME4[O5,@]O[Q;90P*[`8V"*!^^
M'%;8@LTX%53&"@\H)12C9,AR0%`H8L$1(\*)0*5E[IC3=>.:R.)(,"[A[.[4
M$S<`&W!BW%B+B(X,2489TM(&)*5(6BGFL>3';#F'4&ZG?0U`M82MO&ZN<QQK
MB=<K=-O6[N^7KI@P#EO/D<8^(DL-04DQAWQ*!#.G2;3Q^[*6W51U=U%^%(A*
MJ#[[-HMY+[W?+5KYR+%EP-,XZ9!)GB&7'$0XR3F=?$C4#)Q<RF3D1U;Z"/B4
MT/CC$-:1EYV]MC6$%$_L1;VTVY9@'J"H#!'::T"'$&T0Y9(CXSE!0K`H+:4A
M2;]WROK[T?]X,!4Q@W[["O\:EZ_2.WNYS3QVXU2%()VB6")/3$(\!($8,PX1
M)HT7RJ>(!RXAE\GBCFTVD\-7PIS>Y$!X'L.7RQAOM>II3+6OMP4[W<05"4(*
M'S`*RB44(O0D'AS,HUQSC)4C*>ICSGB.;#23(%;"3MXUZZU?GWMY'/<+5]A1
MRPP-")QOX.\91MQBCYRWUFD9-)$#]]K),LND(QO"*!"54/SO]7S1K*.PSMS'
MW:*5BX(Z"O%7"%8@2B)&5.06*>)U3%9H,W#=[U".9O%8=`1,2UC)K7Q/O\1A
MQ:/"7%*/HD@211H,F'P22"7"&`W!>2R.V38FS7#M!U1AA3_IW)!SOS#,<E%@
MD!U86Y-'3(629C#?D:AX#"DD,M`O*)[@W$U##VMZ.#2%XH[UJ?O7]G,>[+J5
MOIF@HM1##T@&,<W7DR8T,3*#@N="PQ3JA*+?B>('*>Q^%#$.2D6<P'PM8&\#
MV%"Z4IS1F*1&$MN(DO46)<$X(B8Z25024@W,3A<?]<?0_C@0E5#].L3=:=!_
M@*+"06-L+$$F,0N^+HU(V@3P,0AXF.,AX<Y3`8?,/HUL`N/!5,(,GD:W[%;]
MK5)5I`8G$0B2/GO`-#@4J-+(*,MPU-X'-7"B+Y,U&EG=^T%3Q+-;S#^\B\UY
MEG2;3W>K6&4HP42KB#Q$)8@R0A'G,B&,,64J.,+)P(QR\6%]/V]N/U#*].#!
M^^H[=U0'9C!V"L-(!5.7]H8C8<%KX1;+I(D700[T[8H/[7N9P01`'6*.[V44
M#Q-5X*MXY5-`$.Q"VZCQB`GK$)4R2&4DX91\)T/_7N8P*D2E%I<[-O(]L,[\
M`%4E6."$B(0\R_-=S.U,E*$4".>.*BS)P'T&Q4>&\;,]XP)7)!G0=9SD^CQ!
M3,D3<%5!7$51C%ZC&"+X3#QBK(C+)]`/LQ'P2L`>68S;Y2IFHH4HC"(5(T-"
M8(:XAE$`:T]#2EB`8WC,R8LA:KF;L-@3D!+F>7.1]_;S[K>+5=`.9;B'EK#H
MP64S!,7D&#+&TI1(HORX#TCOH9?%J+`4F:!L>Y:'2O@OC[\?[6P]>"Z?V*;Y
M#(-GYY:H/O25#XR'Z!T2S,&<CR'8HSHOS5FCP'?G#J>!H6N9J&8\DY@*KR)S
MU4=;SW*"[?FB>0N"O\V7DO3,87725I12)ZSBR`@JD>)<HV"Y1,G[1)020?F!
M,T(9QV8\&YD"JY(+&V^BC_7Z*AL8]_HO;VPBJWB@/`J(]:V`[H"5LP@+K%$2
MB0C&;(2?CSGR&=$JQH5INT'<OU\R?U,]7<7GT,3W>7'^YBC._RSJ^?++&<(-
M>NY)64$0J)B#H0YSJY&RX$L)K"P*/'KO@Y"2'?61SOU5/1U2Q9(>?:.!^X4K
MB/Z5CCRAH(A'AG*+$M$"N2"LM53K@`=NII;?B?Y'!>>P'D&OC%<?<@"2PM06
M$PQH*2"I$X187"O$1-3":AC?[,#<5TG?<;](<1J<RARL65S$9OGY]<Q>/3,/
M3N]%3M!L#RBWD57*1Z*TY8AR`7A:I1&3-F\GIQ(;*Y40`Y>^2WJ*>UG$R/B4
M225\>R$72/KL\GH/8(];L/J05]IP2ZA.((,$ESC?\44BBP"I-RS@&(0?>(50
M26]Q+\N8"*<2%G(<=Z&5=!;WTO217V%VRXGIO_QUMWQEG-%1:H.B#`ZQ*!R*
MPC,$_A!/*;F\2^#XG<*]]#P6,)->KK+#)0VO;6[`65S6?LKK5C9*=/,T6?LJ
MY1S<\]GBTX&OC]B<$7P=FSI?=^+SZ8;X-%[]OW,B=C.;*B41'-$1*;`\)*P(
M*!K"P76DRF%J-2:=VPNF02/G-*`)X-]\!'6&WSZ_;_.E0J\NUC<QSS\\]LOZ
M8]?N^/Y,*D-D)-'!8$F2S4O2&-F\2(@=1&A!,J:Z;]8]Y&+%=&I?%,2TC/_Y
M+1H@>QY8;QIP?5BU:Z&K+Y/*)>NTPS`A"T[RP::<PW<""8UIBHE3:@<>V2%E
MSFE-I?%[#NN$D![&L.ZG:G<RJ?OD`'#0V(F\@1T<=L6E!(!)0)ABA@-C`>;^
MO9,@/Z0QC0)FH4Q)JI<O.UX-N2E4B:2-SDO)(4&H3W#`>7=[0![+_!(!MD0.
M](S+9$$*6<1>B)791GK11'_US`/\/8MK;<S#X_-\,/)?Z^^W;B7M)J^49LYP
M+Y"4W"+N?-YG31C2G@KM(>:'./&8\R*%;&4B+$M8T=>W(//M"1#W=-G-9H(J
M<&^,$P9Y#JWSW'K$L,GPA9`"-)S;@8=)R^15"EG*:.B5W*A^=97&.WOY[#*+
M''^+\YBV7DO105EIQYD*-"#I7$(D*8(L`]=,!F8]=4PJ/-#'+9.=*3:NC`UC
ML01>SC@!0E>27XO=E<3;1%-I:Y)+1B'F(>+D3.3F2;>^`X@P:4U(`Y?QU`_E
MP8Z)X&&BGR^['K?G:+;25<(8K@@3B'(C$#,D(A/A(Z`74XK.:3-PB4__4-8R
M-HH'BY>;50S]KK[H0UZ1:*E1WB,M(<Y31("[EJR!8=4F%1(W9NCV<O,C34P3
M87E0*[J99&_.@P\QIOM<*A8=I?D0.5<Q(D8-1CK0B*)BEGB8HPD>>L,G_K<P
MJE$P+6%;#P!U=?G\GHL0&YA40EOA`I49:)XO*DM($J(1.(),,4:X=D>]/?[0
MBQ#C8%HDR7?]5NWS10.-\#&&-F_V7#M]NYG7CIPJG)+4,;]%$Z2"3A88PC"N
M(^)H))09^.F[7([86_</O"8\':XE[>SF3>2'MQ#VL+$>7"I"G'4D)B0D<\AX
MK%'0X"H(2EE*U$MA]M^F^0/9US28%EJHN.D666`8^7^WRRSSYU=IF)T-XU@1
MHXT&?P'1A"&^25RAP,%5<3YJDHR.-AWUD:%2)E<,WH,,;0_NA=UE9'N02<6T
MI(:FA"#PR9<&88.X$!;1O&F+&>%8V']/Z8\XL(T)Z4$,Z\MYFWAU]?3:R[U^
M^VP7T]K"IN):T,!B?C231?`9L$+*:(\XB5(0)A7C`[TR\6,;U[B@'L2\UBXE
M`!=6?OWV6==-$/T85$[&H(A*B,;\RH;5!$DL"+3>)V*UDE:8O==D?D23&@O.
M`V8HGM=S._=[9B@V,*FL5-I3'/+=Z?G>`FF1QC@O?^?3AEB)H`=Z]V4\K4-G
M*,;!M+1W?RL67G>.W<QK1TX59@Y#U$R088PAX2RXF\X&Y+7"U%,JTG&_H#25
MZK=X\]/`6MK,7K3M*I\3>)76VRK:]_.0<RT^/SR[?A-T\VZ+[%>V-]?(KV^2
M>G61?^AKE*/76Z40$_..HN@)1E)YCCSV'L$D0J5.UO(T<)]5F43N`4SX&)10
MPN"?77IP5]_9R^M-'^M@?&/3=AME]^);F>"BPY@#3#;G+(D!IUDHI)WP+F%,
MP(T^YGF]D,&6!KGP4L2;>+%J_!FT!2*IKV^X]5M]>("XXIY&K:(`3SE@Y)AP
M2(8$KA2S3C@JF,(#XY##YDU&'PRG@++\6;]O3M;=?\#KP&?L[@OTY36QD5\M
M'KDF\-YTXA)39*SSB"2)(0RQ%,DD#</2*M7M%!?'=!@^E>18".4-,AI+)%U,
MR&"=WPKTRE##=5(#O:="9_$.J?O[-Z&.B'.Q[:;#WV#L]7)@5$1:[S0R0>7L
ML^3(YLL//.:&!,<I'KJ[_>`6MIM6-VTZ'1^\0YO-PVM;C\/_KMKE]84I^YC6
M_Y5W;4UNW,KY%W4%]TM57G0LRU&5Y55DG;CR-(6KQ`I%.B17COY]&D.NM+OB
M=3@`1\<O4NTN!I</'X#N1J/[DB8Z(X3-BAM(Q`I()@<4"9D"BS\[F1D-0P/7
MM*'?^#2Y@(>5D;XU5U^FU>RS*SKO^C_OW7R62S30%^O_2/%#NG;_.ZON3@O!
MO0FDQ$TW>-Q(!3H5_W*<41]]2'CH3-EX<5-VUH+XUK1\6W[1/X+;7H\LUYM5
MVLQ6O:B_TX9[6\QH.^H5+7;.9*=""8.I8@34K!GD<L6<#,N!.:(8&WB=RMOH
MG#?E<%OD;\UL/$9P0A?;`(OAR_L5#LR%W8O/_J<="<8B]O`&N^Q+1"[4_8D-
M#B$V";*-$K3.F7FGJ$L#!8<V[W=O2NNFN#>Z_/TVNN/WN]_*=4FQD`S"*P16
MR7!!@I'6`$]*""UDLG*@J;>1DWDEW>=:E%K,^)&QU[-7G66CD(K$'#P%DKT"
MF;,KZ34]&"9UBI9Q-_2A7B.WWQ_$:%-I,J9K)YY*E+@IF*]OM^%7N_R?2*B;
M9IXA0^?E1XMF\TCL0ABV&;CN<8_:/3+$1?:/E%$@>_06\,ULL2R^Z`_;&$IE
M3VO9)@9[DS8?B[-6\0+LU^81[C3L19=)<M27&%(V:\B"!5#&,!`AN.);D]/0
M^.1MR#F44M^_^IPPY$V4S8=WM&?MU7M*=V584M($5`D.,C&*0U(E+#.G.1KM
M4`.9,I4FRX'GVN(HV+?@U+OT.2WNCSH`/13IO).6*>(@E3#0J$,;D%Q+R#&5
MAV19VS#IC>CJ65F.!DR3B%UNGM:[/I90WNOCD4?W%>^"4T(YC\A0:4'KB*($
M<1FR)BGY0#+3<<I3/FR*GL?B&@>9XW-^("'2@$Q(QQ+[V*@9Y8DC#'CLRASB
MUOU\F]@G"*6&SF<;&\U5\UD!G68VYL<</+Z.]Q7O*!%.$Y,*1QGD%"P8CB(8
M\=DG+6(R8:"O7!LWS%'6\4C(M+''K?L,P[O07,=S.3\MVAEF*%+5@U%!`PXH
M0-`Y`->,:R(1038PXG@CB]G8Y_0("+6:\[O<'S"_+^?'7H`^*]D)[3-5Q1I(
M<=\RW#B0*N(V1J7(>!(A=)-V^[AN@O;,]G7@M)&[UPG;*6_&7N)F-%_V#Y=W
M`'S-I_/PXO3UHG_1L%Z7P1T5U0?7VJ7`$0M"P.+_0(7$?P(GQ704>,@V)'O]
MMO&CD*@MD$VT@=2;\G])"]Q<YR7F</PT6\S6FU7O5'(Z\N9Y%70ESBBGK#A&
M^?+`T7B(*BC(/%(7J`ANVI+&J#2JAED+QCP.2EVN*9ZF_3K"E.,?=LJPA%)V
M!"T2ZDM6*SS4LT-`K<K4!V/-0&-[&U^#41DR.E8MF/'*S59]'O$WR:WOM^X[
M?\PV'_^Y6/IU6O5)$%XO_KSODR(L%V$VWX8\?U<\*E>X(/[AUK/U0PC(+[^X
MV:((>=OKT+*=_NQ6"RQVC&3-^M"9:)GQL?C420DH>080J/M#\KT(X6.4`W7F
M1B$T1B7LE'$?9&$I/;A;%+7P+K\KDW'0L/)]R2YP5$%5TGC"BPA>&@W*8F^W
M%H-,B2,#N='FM!M+U1H/GR;^3<O%\NG`3XL_![_I+)6X36<-WH8`+*%NH8QD
M0+6)O;<$H0//LS:"\X]RJ3+F#+2[J;XD&\*A\/W>1%PKE@(Q185E)I;((1GW
MQ,BLLM[8/&T?J%&O@,?`I[VGPK4^!H=6E-?4&Y4-N.A)<0*C$+BS>)8GFI3V
M(@Z]TFUS`E7Q#A@/K.;NME>Z6UY<5Z=0P6`V1K"64G"2:[`2CWL3G`W*H#B8
MIFTN'L_YJ05X51TBOST2>KU8;U;W3[:8\7T;]S;W,FW<;-ZZU?=EFFHVN@Q]
M0T6-0@&IB#XH$VWY6:_5!UWH;5KUT4#:M71\%NONAW_TFT:*+SZCM/<A_7;_
MR:?577XYF]\7W]D^BL\=*I@;MRA6V".[X84U=;AJ/:J7`@31'+Q&U4=[+8$Z
M0HR2ED=Y\C!MBLEW0RC:=;@<D?WU=,:5A$!X(@N2&;A`!,1M5O%L58[X1SWI
MBZ6J\[]LBVP+263O&`ZA]>TYTZ5\.UUC";Q)\;2.$#WSP'.V*!"*",)S!$B)
MR,.D'Q/=G'E5,&ZD-FVMBFZ^"U'4#^&I./8M-M8NNM&+U<HM/J0S=*HK*^^(
M$!8ER0A,X/QXF308RQ*$%%4DC%DC!KYBO^&>.#9;]F7L:0U[54G[N;Q46_[<
M:K2UZZ\NNS]IYCW6?%_S[=6VM=I3L^]&I'5SMQ37'Z5R^]JWE[-UF"]+]XYL
MQL<_[*@E66>)(I(W`7QF&;0(!(+S,M.8/&$G[>IU1OS@,(I[F9\M^EG<FLUQ
MLC;EG1_.V&HWN;M[KB,P#*BM(SE)3K4''P/"XI@&RF@&*7,B7#+<CB<=R6S,
MJ5_>`LXFU^Q/XPJ44:Q<V'R[/+ULN0VIKM,LYF"M`H;0@).!@>#%1]9(KS@G
M67H_93F\(M$:X5E5C#EVF-#;G&'L-LU6%T;V-EY=-MG&DG7S)O;@?:W=4C(Y
M$M%MZW957N4?O4XYLX8N!QJ4,`Q\(`J"L!$RGAW`O4TJ<>UM.!D7JC4&@X;=
M.96T<EQ`=H)!5"4B$W,"I%$R),N$4`,/A#:21Y49?>[4-R9\35P]#X,2POVG
M,E<I_K):KM?_7*R2FQ>4BK?/UC'D>,2JJ^ONH@P^1<\1+A8@ER$X4:[W,]<Z
M"6X,'>A2W.B&\K:<JP?S5*E9KF]K4?-)W1V3)@CJ2F8Y8L$R[B%FJR%XHU(6
M)EL^,-YO&^^+J3+S6I3K"LV'Q9R:,O/A5@^)S&U7YLOD-P?XT_O\7K`03U75
M6:YH),07E<T`L:DX^\D$+)L@@XG<NC`U>:L,:I<6%7\J/M/%73;]=W*KZ\71
M<ROO2#`BA<2!(E2XH'"_5U%$2-HQ*I,($P_B4)<J9V]=%?&^[:GZ=&`O\B:M
M<%SO/ZZ6]Q\^OII][H<X@OXTH)V.X%SFA,*SQ],(9!8):$H)96G.38K&3SR`
M]"2Y6POZ08\Q+NKTV6P<J^K.4<$\M0Z,MAQ$2;24+4D/`2*20*GD1Q+WJA#P
MAFC?=NN\G4&EZNKZ:K@<=V5]K;;SF7)M6$1J,0$D"%0\N60/CX1D\N0'-2E=
M-KG7KY]K,/T1Q(YC5!R]C4YS3QB+#BR1.&6)>K!]\'F1.+><<B<&/JVXC;AQ
M)2^G`/"42/I$Z!^3F?LK[H22'N>M7!UR/`Y[\TO2'()D>$P+G@.?]$N?&]-Q
M-%1O95MZ=H'4R+94_UYT3]NG^U/SEGA/X[7O:1^]K6W2R"UO97_..87-UX#L
MV)]W;I/VO3L^LI>>7TE'N):VA,\(5D;05%D@F04@T?IL@Y)&WRA,^?Y!/(V;
M\%N)'Q_OL1@R</?N]67Z<Y7"]N\EJ,RC&"(70W95:YT-4F;&"%CF)43.&'BF
M!!BI9%39&F8&YD-J([K7HM'S],Z3@+Z%\#1TI'ULQ@KD[>OM<!O,>*I[,((0
MT-QIL%098%%%88CP3`RTV[21Y"=.TZ$@3X60+S:O4G$*G9>\'/<X[5^>%+Z2
MEB=J[QRJX['$)E0T:A1Y`X*7$48G`\DZ>$W4P`?8;>3Z"9%S?*BG0M$^8PP>
M`;_BU,_W2(L#N7FHVDYX[I,0&:0R&I(V'%Q`!2U('F3@F9(T\*JE39"V"9%R
M1(RGPL:=Z_.3$B]G^&%)J33[IBT.9.6IZCMMO63"<DA1>,A>,9#194@4Q1ZF
M98GE,8R=\N_&S@I83X6E^,N?5BG.CKX(O:RBSNL8I"Y><5KB)&CCL6<*%Z[#
MXP-7K)!#@P&JOQOSKD)U*ASK1=]OKV2O9=KSZCHMB>8ZBA(P34&,P8-FW(#W
MR207H^9VX#FL_VY\&P';03X-Y_3MC5O<9Q>*K7KQX>56O]IKS+FRQLXP;8C$
MX:K$'!B**RW0&+;W@I$[2^5`@XWY5^!3>WBKWB9\;_&M;LY_U&1]H_G3:,DH
M8Y>P_W_-YE7'=[#16QK57\T6N'!^1=+&YST\GB[F^(==I%EI)@PD%`,ABQ!`
M>Y)!$:DS=3Q2[6YC/'^-J.;#G?\:I/\Y)?9&!;FLJHXC)"PZ`<;'\G932!"9
M"!"1\Y0XBBUJX(N4-F;O,2?]NU`?U;%L\O;Z\!`>O5HX\^;E\LHZF5W4QCC@
MW!M0+B0(/`C0T=(045[ASQ/#3^S-4T6*-8'SQB3KW\,,HU3_:4>\4LY:"LH@
MP()'!CQX#B(Y_(UWS)^^];RE5?DV_!F*79O`6-_!<-DA=_KSSECA*#,9^Z`,
M1*8TT,1+[/=@>20IRG#RN#]YL-7<=L8?Y;_JYK.7^M<0:G\%G7=XC$L3P%%<
M1\13#]%X!RXE)Q.E+(A)1_*KSJAJ.`ZR5FSY/2_\GGWMF.L[EN]1W4WNN,QS
M>26=SH8JX12N#Z(A,\8A:_60=C,':>A)6:>]%/AH!+MK\'?IDYNA^+NZRZ]F
M:^1L\30<*!:>67L7F4N<8L^S%A9RCA*\+<3+1!.F">5NX.JJJXG4ILD%NW8]
MJ&^MJ'P_LM_2_VW>_Y7FG].;Y6+S<:"$>4;%'6/"IA`C4&(B\.*9E&CV8%@,
M+!NOLQUH:*R[[4^:F".@/#U.EL7U_J_E:%3<U=<1;J6SU`"W6D+,#(\[ES,$
M94ER-F?E)NE7,VD&#@=WHL3#YH\&S1M68R<9"UE:!L+&#$9P`E3@PD3AGWFB
M(S%#R5?7?V;ZY!L([S3I]VIY/YZ$^%!AEZWDRHL$LB@B*I6$-Y)8T,$08@PE
M60Z,2E/7/6;RY!N([D2YAV7'Y1Z6[:C@DA'I03J:P64?4%?E%E14W&AFA68#
M%9*Z#C+3Y]XP="O?+Y^Z#*T8$.E(X_5OGC^G17$O;M#$+6^5OW;B^!WRXV)=
M<DE;$1CHDLHM1$LA9<_!6L=RIIF)<*.PW5^[61;?^F/JZ5+L>7>YY'M??3[J
M3GW&URB6).*23^`(ST"LC^")P[XP$8,-0?DP\.!M<R\\?"*_LVG6`*N-67S7
M\S^6J_]YO7B[6H:TOIPDA[_N\-!@F00\-FQI7E!2<#4@G%`D>VNL.1F[[+8&
M\;%),BI834GRSOWUQFW2:N;FEW/DX,>=TE0:)S38DCO9EHO-H*(`DQ",LC10
MZYFBZ:(>1<;$JK)(M.OQ\P.\@>?=KL$6TL_.A_;UXK\<SDF?\WV;$K//CCB[
M>?/5,]G\BLU\>'()5K.-ZL/IG:-+=HSE?!;+#?;7*`C]\Z6"]K8/$^C"+27B
MZ:6.KW?";1?9ML=GI!X^]$F7!<TY:`;)NPA26PV)2FS26&YCY-KH22>K&6G^
M]AQM(\'5R%UDN\&>I/NSDIV)W#GA2N*XY,#BJ$!(;4!&[@WWCOLP\033E>;_
M6IA:3'L)$5^"<=\M2FRENWQ>ZOHC7W4.131B&`&M5`21+0=BD@>BG/+))I*&
M)I!H(]O68<.XB#4Q.#]-?_1^Y19KU[^">1C+.2'X+ZBET]%*0E0`EXA#A=`'
M\-XPL*@!<,&2=4.#S;1YDUZ'.741;,&D7O`;(E@=_["35!CE`@<><LD8D$7)
MM>6`1&X-T5HZ.O"M;IM7XG7X,CIHS2CR*)<;]C_TA#\FD![^J"LYWW3(N)LJ
M:4$P&X!+YX'A#JNT552PDU'PSWW^^>G/^?)+PK.^]PR>?^O/XM@@SOZVRQ87
MKL4IHJSX&)M<\F1HNKN&BB8J,NF$Q&--T[(^<"VH/B!_Y5FKX:IZ.ZMP4XB)
MH_C!-02;!##N,G#AI8Z*1G,Z&>LMC=8CD^Q6H#;;:U^$L+I/<="6>^S;+M`0
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M<(L-JJ)E'Y\M/KQ%92E4=>@YK_WS2DT$K/-*G0/MO_];^9/'I8`__#]02P,$
M%`````@`0(/X1J'?>P`E5P``WS0$`!4`'`!B:6EB+3(P,34P-C,P7V1E9BYX
M;6Q55`D``UB?LE58G[)5=7@+``$$)0X```0Y`0``[%U;<^,VEG[?JOT/WIYG
MQP!($$0JO5.X9CS5M[4[R;RQ:`FVN9%(#RFYW?OK%Y1,^=*2"%$D174G#VE9
M`@X/OO,!.#@X`'_Y^\-T<G)O\B+)TK=OX$_@S8E)1]DX26_>OOGM\I1=BO/S
M-W__[__\CU_^Z_3T7_SBW8G,1O.I26<G(C?QS(Q/OB2SVY,_QJ;X\^0ZSZ8G
M?V3YG\E]?'KZ6.MD^6F2I']>Q84Y>2B2GXO1K9G&[[)1/%L\^78VN_OY[.S+
MER\_/5SEDY^R_.8,`>"=K6IM+%'^=5H5.RV_.H7HU(,_/13C-R>V?6GA(/^Q
MY,_EK^/9JL+SPOAL^>.J:%GWA>@OWJ(LI)2>+7Y=%2V2=06M4'CVK_?O+A=H
MG"9I,8O3D7ECX3HY^27/)N;"7)^4__YV<?Y"P%62W9@T&9O13Z-L>E86.6,C
M:YCYI+3)Q]FMR44VO<O-K4F+Y-Z<6ZM.S;NL*!R+6=7+%OQ\FYOKMV^NDN3*
M8@LQ"#Q0(ONW;IXV^WIGWKXIDNG=Q)KD;`A`2#.+DTG/>+QZZ'!A@0?!!0X8
MF,_QU<3T3)>7SVP)E'_/DR(IA^?B^>?ZAFVOUZERSGW5J7H?JCKT'[?Z?2C[
MV3S,YO%D3Y5?2>E4<=?.Z%*[%45%-IG$5UEN_9Y[P])EK[XPDX4?5-PF=[7*
MNDOH2>'Z$LI".OOZWLQNL_%Y>F^*6>E`NO;6_C1H";#I-%F*MZJ(+)U99]HZ
MU<:]O8X".E4WJ>\V#E6[5G'+3ZX#;#O26VIH.K93NRD?56239%S.^SR>E(N"
MRUMC9L5O:3P?)_;;^E;M+*KO)GR*<XOLK9DEH_HY95^YW37N<F;_O^#(QVL1
M%[=ZDGW9TTYN(GMJTK<>9XN-<Q!^^&;N3]2]GM0/`&V;MDMK2I,G]XO)_CPM
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M?9[^'N=)^0A+8Y/;KQ=13(?-V)V$]*?V#KS<558KC7AG)=\X19:_+=FR`HY0
M;:S0BCJ/669/>SHK_W&UN;-\;)V:.POJ5WU'L)O*Z[<QS@5=1^+NG]PO0&YC
M?$-QK33EPA0FMV.@SG*9%*-LOLPY89-)]J7,<:A5WEE`/^HZ]J]=Y?2J?*UO
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MF;RIGNMDM*GDK965C^97YG0%24-5MTA:J[`E29(NSAN]LV4>2Y8Z'>C`[U))
MZ]V8=%SF[0Y,S;7#]$K;A:Y6VTDV6F>]A>6NX^)J8;YY<7H3QW=GY?!Y9B:S
MHOIF,:">`OAXBOQOCU]'CBI:@,SYS$Q72D[B*S-Y^\8J%345%0$18$D@U90!
M(B$2-&!2"<\'2B"/OMKZGY0GZ[.\LEYGB*P"(PN'<TM[7Q:,",:^AP#&@:\"
M@BGDU'ML#8>!9'6M>6(CRT<G63XV^=LWJZ7-8Z?>:0XJKR[HRT19B]C8IM@O
M%F/0SZ-)9M<`;]_,\KEY^C)+9[9_J,GB$7;X,3?EA_ZHL<S3+-'+TL51JH=D
M6\_86B_RA)*^9J'DR"<88ONIPIAS#Y*>B+-ED/^62$WMNXDF+0"S8$W'!'BE
MIGSA8*PQ_-KR42`%\P3&T!>4,>ACS_>K=C'ML6BMD]69X3<Z=UO,OI^]LNY0
M^GY8T+_U7[1CV,;OW^C/ILX/9O9;FIMXDOR?>7;T^E>K>#E[OG_AT6]WE)Q$
M14@)&C(/:Z1XH#!%/L(5&M2GL"^JK%NQ?,N3/2V:]0I6_]2IU-46.&F*Y"9=
MN&/Y_\QMPZZ_)NE-=3[V'V9\8W:E4S/Q$0L]'@H@PX!C#2#U/$^N4*-"-*(8
M.D:*]0)@S[23I77,F)O4?IA]FL1IP<;_.U_VGUT(YB`H8A`'6(G0$Y*),`PM
M!*):,V`>^(VHY!T=E=J'JF?2?,ZMRLL+1YJ198N`2$JF9=EL[4$E)?84":N6
M$ZF;>3_^T9&D/8AZ)L>V\($=1#]>?XX?]H\559(B&@:AI#Y`R,[A`@DJ:+#"
M`NB^ULB.=.DMS-(MC'U0:IO:W%QGN;DPHTE<%(L-G<7E1P[TVD-JY&OL^XA:
M*U#;FPDD4-`51AK)87E"O5&M/TC[H-UK74MGSP%*,<_+VTP^F3S)Q@X\;/,Q
MD48\Y!QB0;AO^ZK4(B05BKYL&"?LS*_JC9@'Q/C0`^2>(^&JU1Y0UKW@5"C%
M0<`!"A6J6LT""8;EC`UBR&N(W3/&_'+V<O]QD'N2KZ(E/6U*ON[23Z[QQ[F%
MW:4)#ON5+3XE8@(##K3T!?28[TDLX((%E&*.4%@;H1O65B;$@''J"18&`!&?
M4":?6A/Z:@A;F0>QWO9=SMU@^\%V.:FB,N!0*R\`=B@.F-9\!0Z`?7%JGUU.
M9_ONM,NY&S#'L[_%`ZBA)S!11&(HF?T/5.VRTZ5_K+N<SO9RVNAJAM+WPX(C
MV^7LU_B'WJKJ=Y<3VEE7(!`H#V.?`[OVTK!"`P*.^J+*/B%A9XONN\NY&UA_
M[7(N45,XE#"41`@9Z@`))IF_0DU[?%BQO2XIU@N`AXCDN7K_-<[L/F(C&=BU
MO\0!%Z'41!.L0E:AY&/5S-?=G6:'\'5[Q&W([*KUEO83'%$DH+4)UHR'E#)&
MRV#E(U(A\\%PG>M^"-(2*_="^R]^;D9L<&[_]TC+XZ%CK?>WG^#(#WS!<4@T
M8W;EYB&/!V)E(-)P@Z.SI45?M&B)C8TP[H.-'[(TLQY07![_7*JJ'N[*-SQL
M(=K&.A$63!"A@$`T`%KX".NP:I_GXV9KA]XX=(CP>%M8]L&5U460CRH^INUM
M8<J&&I%"H1=Z%&',/.4'!/E45FW#BC>+>'6VQAP"3]I!L@^67,834UR8>Y/.
M37D#8[D-O&U'9$WQB'!*@%(LP$`%%&`A@Y6S`+%NEE_461K'$/C1`HR]3#=F
M]NW1XW53S/-RD69*>P&S<Z=/0XL)0P0\#87!P!)AAT"'??`[FOR+=;?=M'J`
MW>65MCT\\)!GW_F\L&0LGNOCDC>RK5HD))$4>%HA&6K/.C:0<*D@H(QB1O6A
MSK2/;LUX/C$?K]<H7_"OS_ZJ3179452D,`BYL!W3IQZ4]C\8X@H1I(-:1/I(
M)FG'I*^GK6Z1&FS^R)K6U@3;-]2(`@@!HSZ`P/>`#C@D7E`!XGMDF#DCG5D]
MZP*T/ARC=9J6'W-3'X>LK1LA#2E`7`$<"*A"B7R!JO9Z4/#AAL+WMJ`#(]K`
MZOOGR.#"T<.CQBZ4^/8&M_*;2&3IO<D7[_W^=!OGTWADYHO7PF[>_7>J%^F0
M(!%009FG".0AI&6@8*E[&*)P6*&Y%FV1=8=2'YU^=;5G]@A`!8TI?LVW+Z+K
MJD8`RW(U*`%BO-RR#C2CCZT-?"R:A5GZY,3^#FC+&/7!B'7OR_LCF=W^EF97
MY=W.RW<HW,UGQ86Q_NTHF22+.(3]:Y[G27K#XR(IWB7QE?UE]O73/!_=QH79
MQJ2N'ADIK00+%4(:44ZD[<FP1!<JQ#T(O8$%@CMAX$"P[=.!$=GT*DD7K2CO
MW4_&BPT0Z^R7)[VO39Z;,73P95S$1)Z61"@HPS+U%):Q+^Y;%%!`".4@;+:T
M[BR4W`G#.L2KTUCAUFC884Y==1$.0U@!7U,..?0#8G$&U'HR0&BN/&W=CQ\O
M'&:1(-`/.9)"23OI*D54A0B!+!A\.,S9I/N&PW9#Z@<(AP&$`]]32@D.F)+0
MU_X*>4YP7UDLW8;#G*WN&`[;#;3C#W40P:1B2ED4,0^Q9I!Y57N9KX+C"X<Y
M6W#GF$<SK+Y_CAQ-..QPU!AR.(RH`+``LX`C7X6,A%;YE>ZR_C#ZP4,?36VQ
M4SAL-Y0.M(0LE\4WZ>(DV-@Z*\GUXBV2CV^!7:(T9NFX6B$GIK"_S:?EP;%'
M*YIWR7WYY\LWR.ZV`NU*BT@12'V"M">AM0;$(4*\LD'H*3IXIN[O%@\7[N.C
M?-7<_NB]>F+D"Q1(K@D(B(8"*"CD:I`*?-K7F:_OA\I-H>V#MJ]?Q;Z&9U61
M2",9$N+1P`>`<*9"*$2EO>\)?41!NJ;$:(C%L0U`TBP#C9_CAV<_?LC2T?*N
ML9Y&I3HU(@]XA"%J?2<-$`F#,EVVLD)ICF&EG`Y^J&H9[V-C_5-#>W4M7S\V
MHMSGB(8BE(Q"93UZ($B%,L2XV02,?UA6[XGOT;%XZT&.EI\4*00I!!0B:TSL
M0RW)DT<#@K`95X,?EZL[0WJXO;VU+]D]XAT^`"4+[>2&M`@YP40HP3@4S*,H
MI(S]@`GO`')@AT3&A"KOD14:*_&(2*"8;.;P][G#YVS2?7?X=D/J!]CALTCX
M*!1(DT``XBD+"GH$A&#0\.[QH>WP.5O=<8=O-]".?_?&%SXEDH:^AH&`.O2$
MX%5[;>_4Q[?#YVS!G;=QFF'U_7/D:';X#D>-(>_P*1U0GP<!Y5R3\LX97X)*
M=ZG]9F_K.N`.G[,M=MKAVPVE7A+>\VP\'\T^YI<FOT]&=9?0K2L>21J$+`P$
M#\KUMP^Y#BOOC"`$FR5]=GVY7%\^0@N(]<B#PJYF'Q4M:@?]C74B*:#G8PPD
M]9%@(?9@L.(Y\_P!I_SL9Z[UMF\-H.^/"(.;]0=B_S:F^@^_0P#]$*":J?U5
MN6CQMER*H81VTA,>%H"IU6+;%P-+UFD!XZP]-!I9ZH.9Y]E=/+M-1G=6\20=
M5^^KVFZYNGH1MNX&`B&G8:B%!4*I$%:Z:\6:;:MUE@'0LB5;1N?83Q_"D"*H
MM`\H4(%'&8$KAS;T,1C8A8.=1`-;QJA17_^4S<J-A'BBY[-Y;MXG$U/,LM14
MNHEL.DT6UQ=]SC[?)OGX4YS/OK*[NSQ[2*;QS$R^;AH.6A`=:2'*I6U`0D4I
M$R%65%8($(WPL$:,5EER(`S_.L.ZVSE+@!4@=H8F`GL>!![RV,JL/F]X<<)A
MDI>:CF,#P?9P9UC+ZSMMFU\<JV1Y'MMOE[WTMOQXGK)I-D]G'Z\W5%DAL/OQ
MU]8UB*22R!-*:S\`B@90AQQ7V*,`-TL\/DP*5%->#Q/J/K,WE^_^/$]'N>W9
M1IKEOPXYG>LK1I"$0)57==A%"Q.!=70Y6;FXD#>;S@^3@=245*TBU.MDO1S"
M95*,2F)?6.?"9;[]ME:D*<?4.K(@%+Y=QS(-2!6Z#)6/CBFW9^\I<V]XACOK
M792?/EY_G,_**SN+17/_D=S<MCZY;7I0I`,@B,\U02@`Y=E80H(*21C49]ZL
M)1HY*J(=%-%C2W$\CB-AE(HP1!IIJA`#"'`M5A%`3,)F=WF%Q\[J@<!]@+3)
MCB]"%MG$$CXK!XE[8Q%<W,E\82;+V.5M<G?(1]>76+XB[KV9W6;/WA5XT%N5
MG_9Z-RBWZB!.29=U0J+`%P%A&.`0(HP$]P($I*^DSV7(K7MYZ`34#0UP3SO=
M)B!2,E#(*U_W`A$/`P@55X^M)S[!?66";$TV[<*8&U-/6T1KL`FG=:W]]EMC
M/L2U[SS<1VS$H+`>O5(B`+XU&J88H0K:<B-IV*FK[;!F1U*VB&<?ON@F=1W?
M#+VI8J3L0A`0!31@NGR+LA8"5GV>"C;@=QGV8^"UKY)N&<WOF3^#RWHY1MJT
ML!E[&4^+>7K#DZQ(ILDDSME-;A8SY_;$B[IZ$96*!]@+0L^GG@<$Q)Y7Z>Y#
MU=L[YG=YJ_/^ALBZ@ZB1>9]-F_SKTV[M>?K/S"+UN_U^GMM5YR?SI-PFBS<0
M%2%`/.1S[&$%`QDRG]M_*MPP'E@>58<N<4\(-N+(\Z=__)*:_-(N8JT2(_M5
M?&.>J[J)&SN(B`"!4O+`TX$B'$A-*,=5BT*)F\62.LNOZ)H3W2%W&.]A@<E.
M;L.B1H0T85[H`Q%R"@/-&0M)U38A4+,LV<YR&GI8/+<#U.%(L"!S\8+,.]-B
MC8P(4NAQZU,Q'3!.<?EZGE4GP%[##9;.D@0.1I3]H3M(MN?N`XJKB$@R6+ZK
MM$QLAEQ`K;6OJ];;";'9,=[.$@%Z($Y'R#7R09Q)_#Y^2*;SZ29'9%<Y44@0
MHP`);%=O.N`,^8"MP/,(:<2*SA(#NO9&.H:OCR'EZ6V=VL*W^WCB5#\B'A4:
MX0`C.^M2$E*E5^@"))O1IK-M_AX&DRY@ZX,N%Z8P]CFW+!U+<V\FV=TBV+-\
MY[5Z&$WFXR2]J79SS]-/>39:[`(7VZXFVD-JF8Z%?1]0:AU]"16U@^\JUN"I
ML-F[ASO;:^^!6OV!V6CJ8N/Q`NUX\CI5?M,DM;E&!#U*M`B`\@11B@.ET&JY
MKT/9+&!"C]#X[0+5HD]2E,0;S<S8TNPZF5W>QOFZA<V.$B+B<QP(S:P;3I6/
M!$!D152%PH:7+H-CM7QGR/4QIRPR0BYCR]@+.UZE<[/]'KMUQ2/%(=!:^-37
M(`@PD)ZN=A1"!H*&;]D]QM!IBS!UF"GU="JJ/+RYRG<L#W`.ZV7J&\\&-+IR
MKDY:)!@FY56K5!."`!&8@7!I((Y#XM=.:%WG:M1>?;&AA2U>4+?M"9'PH%24
M$DMT*;"`$$A9X><3TM<.RJ[WUK7'B^;7V;6(:P=)1YNN+)A/YY-%:N%BJ'M7
M.KP;,H2VEH]$P+Q`^Y[2Q,?_S]Z5-K>M*]F?--B7CUCORU1NDDJ<>36?4(K%
M))KKB'F2G!O/KQ]0$BEO(BD*H&B_J52\B2#1IP^!;J#1K9CBQK!:0"U&JS>2
M*R--&N66Z9$<EJCBF6<?C<#H:!&LE%HJ;;'&2"MOHYMCZOYR9^WT0G<2X=^E
MS;/PF;Y>)Q-2,RUU)E"C+V]77Q8W-U'H]JB8)Q<&)I'7D#@#/$980NUC5_>]
M@Q!.)"E<,HS+A&`,4U7L?C]5/;XP8(R(@)1)P^/,P2V/?6R(R<&P](S)`Q/R
MJ.I,,(:MK\RNOQ]6>-XO"[WKP>>?5^75WW%FO]-]%'GB;0)V4CMA*971[HSB
M4>L:$@(R4,W)(PVRJ#DO5(-(<.A$NY8?7Q>T`C`2$525.Y"KQI+#-`(L'!8P
MDCP.((L:S\1BD)ZNXJ?]-/7TRL"ID<9S!I@RA*/XQ1_L<:2&Q8(FWWK/HJNS
MT1CS0.OYN=(9$AICJ+S`3E7UHP26M6R(D&&:GDX>U*1>9UHL+\63=.FQ;65O
M1(,#,^`M,-!:H6IY*9!N>GYK,@V>G"=[&%:OGR.3\8&G2XT43M;MC]G/*KNW
M^M;A9#V^,##M"&921#_0ZFI4!(@WZ[X*3S\'XU"TRX2PC!*:F2`K.HS,=@1A
M@02.LZ$WZ"!5="J'Q>J>[FJ]*&L@`9`CTB-1CFP:C6!`+4,4Q+?&"V;L03[L
MQ72G_O/4U3M9]C"`7A\1)C>_3T3_*3S\XOKK=@SK<.\?7A8<451;'874R'.C
M%.6@[ID<&JYX@53IO1$NDX%QD1,6*?-I4VLU1\YAJ)5GU")6VSX,"C#:RSK8
MELL6I9`8NC']MI>6<"^^6!)%3\I!+S@V3H`#DL:J88&38Z;KSD;"BP*=;+O\
ME(WR0`ED0BO,",#1)9/&`%KW42(RD;V=,<F0"JL+A$XNLF:8._K,EH_VH9SP
M2+?R#M!OR^6WJV+UH\Y5?NAGPXZ64;='ZX`9=UABXPV,I*HL5Z6BM4J`$@8:
MU[FE-K;<73&8'2U#M,N)EAK`2'[@97ROE-G+JPGC:"3[I36V,JG>RISX9(B1
M3!3LNYEMMH_\HRB_K68_OU?E"+NRKAUK4Z6C]0)S+#BB5'CB//(U*%K!8?G$
M,\=5)E/TXV#<1"B-8=]^VK'M?D\[URF.M@G40$1LM("4D@`(@(2`]2O'&3;3
M7;!*H+/'+$B,TNMCP^16K:9$@J'*7T=[[EOYZS^V6>Q7=Y7N<?U+I79\3^W[
M/P?SCV?T>_@P:,DUD-(ZPZ(1;*!VEM=]10H,V[#(=^CJ?,S+,R$8XUU].UO.
MVZR\^'$@)AI`",M(4<<8%!#RFK9&\/'6C?LI+JM1=SH<67V[Z!DMHRU8N;/E
MS6(>QYVYGMW,EM?%I^]%L5E_7LYNYXM-,7_8IZ2^7N\^?)BMHA*^%]N*U>-V
MJ!F2U^^_FMGZN[\I_[X4.`_Z4O[XN2J^5Q/+KV*7Y6'BO9J($L?"RA:KQ:_M
MXLZ;Y3HZ7`\2G(SSM$L><3UT:-U4N.FS(-+:+O!H_TBJG<#8<^Z-8'A_J)QJ
MKT3G69L\LC8=7=_K_?V1[&VYJ^^J[PX75"M8J]GUYBIV5=_]HYA_6RR_V6*]
M^+;L=9(UWT.#AAIY[`RB5@L=,0=T'P1%E:=\K+W#U@681#PY5HSITJ!.=M7&
MW*[B,'Y]U[%0<_^RX*C%A!A'J,""<JH1`;7H&K.Q2JV?M#8S!2:4R3`=X+[M
M'U8Q@S2_5:P@]QVX_=^#NKG9=V_1$FC2=GF`!CKDHWN#I=#20:(<;232FD]W
M[6:88LILF+P&;4]N;>9R2AY9N>[SQS9EQH\#PQJ[Z`<S@R#""D'J?-UC2LE$
MUF/2@/Y8@Z?+GUUC1MDVC<6/@P4*(TNYET8BS2@PLC:(5+4B,8UPC#P:.UW^
M[!K[0W]HTUC\.&!$O0/4>J3C6(,<HJSA&+9L6$1^\IB)/!H[7?[L&OO/#__=
MIK'X<3#`*PH0<81+(;5S"ME#C^$PMRGYT=<\&CM=_OQ&RN?643%^'#!756$8
M*I7DS"G'B?4'<<6P8TO)#\#FT=CI\H^QJ;!;G6O6ZVHGJ\/;;&D52!SU#83&
M,NT%BAX6,`TK@7?##,W,1U\GZ'RF@_B"-.K<2VYM%^)4)`D4@C&/..>>&.P:
MLP\S/%T/-8GV^C'B+*Q>+S<FY\].CQ(7"#>IPFZ/GJMYYJI@M$*,*@B`-\AB
M05@=YTL5)WXBGF]B?3R.*1F,QQ@ZW>:C?5<NRY_;(.WEMQT(^[SDG<KNTSQ`
M8)VG@GJM"-&0``F;230:4L-\LVR'&_*P(`-08]#CN8W2CXOU7QT69ENS(#Q2
M!B@"L*221@`I8PV$B@W+Z9GY//4$3<R$&(_+I/NP=)H1;<V"]$AR+*QG*KZ1
M%`!:'^:)+G2<CJ=K8:91WE%&),/JM3)C<O;E]`@Q/A%\N2KBV.A^7W^OCN_5
M?>XT0EK;!1K'54:=(]Q!KHWA4-=R:NO5Q(YVIU'9XSB-A`"-<HKWF8FU*Y7;
MD29!<R2,P=593V@IB-)Q7DOG%!AV/.KT9>:7;FTDPO=2[.E.VG6T4="&(J6]
M0IHY2QFPG)E:0L/PE#.ZG:VT'BPX"Z77R(?)V193HL&%5CAV&T$;M5X7F^XE
MK&--`M*6PSC7,H`(C),C=ZQ>O]&0R=',RIXG\Q.HZ;EEC/.1&4WO]VHW]=/Z
MDP;!:X^L!D8Q##20FF/4!,<RYO4@G>=+S9%)Y^?B,H;&U?7UZK:8OUW,OBQN
M(N(]%JN/-0G";!,<,^2(D:!*%F\:H]C#@15U\^7@2*_U1,B,N8:]VZS?G*+_
MKJ;!"B>P@`XA[AFE`$>VU])2A(;E8LE6J#W7VY\.H3'X\-3WZ7`>GV\0,$>$
M2&R,L$IXZ:*C)!O'&)&Q:JV_=-<Q";J7X4VGFW"L294>WWKHG"+26^V%B#+5
MTDF-)QS\<*ZZ.K5_%D*OC0>3<Q:GHOY+[$/L^EC,U7K?[<-:?*<ET:-U(`13
M3J/A9#F6G$JA50,B]'1B[N/YJGNR'9$:HC%H\:XZ(EUWO),&SUP="+3,",2I
M8)(+8QPVOI&)BXG%/R17^_F0C+L+N5W7:.RH=\5&?5EOS:->FY%'6P=C3+20
MK8SVMC3*$2QD(S/P<&)%`_*<&$Z/T[C<:#K\_NLC47J1XWCSX/TV-!T9!0F%
MT3O3PC6(RH$%W49@1P(]'N5(,K@F0)+:<;X;3I3F%H%ZQB'"4&O(",(HCK[U
MPKT!A`ZS*K/-*!<DRU#(V@ES)/'OLUE%KHK?F]O93<L<TKMML,)"ICQFB$A(
M!98.U4LMQG@VD=J>>6:07"B-.S2\+?\N5A^+"K]H8_TYV]RN(CFWV:IAKX&A
M[08!1;&UT]HI)../!%A06VBFJN4PC3DD@R:/#@H)X1J7*%6R\O.8TGJ'0#B0
M#CJH!:=*"DD<]`=H^;!4<WG*!(]$E91XG7Y:<['=7]NE?]S]_#C[X^ZO]SK\
MKJS@CQC\J/(>/L.)CA8!>V@0P5QQBR!6QGF%:YFXTL-"H_+4$,["@;3X##(9
M/B]7Q>QF\;_%_(^(P=NRJJWQ?KF/UZMS:-R;2*/)I(NO\>.KV>]CIL0Y]PS$
M<TB=\\X+3+4@B&/58.C$L,30>0H29^'$V`B.,:O\.?N]^''[X\G0]O[K<9':
MYIA!]PO"`\`IMT`2XQSF@+@Z0L108(;Y+'G*)V>=<<9`[U)'@];U^_*QN+Z9
MK=>+KXMB[B.XZOIZ5[VCF+\W;]XL-^7^_-/7K\5U=8\/Y:I2[;N>"REI'QD4
MAQ@[HQE`7D+D#/:-+CGQPT+ZV,OCYD0`G@)]RV_+:@)XL]P)]699/!)++><[
M.\']OKZYG>\P:62O*N)<1>LBON#G<3II/X)%3F**C"`*6B],Y$6S"A(_&Q;2
MP%\?T2^)^ACLKT5ML6KN`1/MXM:]N[;8FL1/JK#$4DL%L4=""J#88221:.!Q
M'O'R&'Q97.]Q-'6R]>=1JR*0,N:#+J^WSXEOM5MNHC'V9AG-^1_;W<]L#W6S
M567_K3\4JT_?9ZMBM`==,M&UBO#.%S>WVS)NQ75E^2Z*]?U!M$J*?KO90O_^
MZ^.NO^V1$SO5(P+%G%D+,=0\.O[:Q;&;6:<@T-+%[YTQP'D0/)3V/E/0KI39
M:1\4J&+$&!AQLP)9*R6'KD9343K6]G=KFNSQJ?,X6<@E,9]--8OVF5CHN^=O
MT!$5G/&I05E&)!90<NLH0TH(Y&O%&(/'VJDY*;3X4MQ\?#!A,FH9Y4S+LYU]
M-_O1G2"AJVF`"D;33A`*B,?<(^0(K*453('IQBA/@@.]>'DVW*^=9),+@'Z5
MW$JP5?5I4U[_]?YG)7554MC]^'E3WA7%]L]U";`/-[/ET1#9`7<)R"'K$/($
M,6:,0T+89I*@#D^L(EHZ-95C03:("E?Q9?JO8KTIYA_CU]7B>ELT*G;G<\3Z
M^*&[WFT#-50;A!"&QE<EX(SWIK$-N!^V"YDMT"F/VC,`-4C9?\Y6?Q6;ONI]
M_NI`G658PB@N<53`ZMQPXP\A((;9N]F.T^91:!)H!JE0S]:+ZSATV$JF8OYX
MRNJ*3>S9/%KTC@!)I<`*`.\)E;J9W9"!PZHFC#Q8C^#K9\1TE/,PQ6:W*5*M
M/O<X&O'L]4%S(@GSU'CL'4?.68NM,UQRQ80#$YG8\ZCJ\?F8!`"-KOB^"@^J
M.M%C#"+.<T.\<DKZO1Q2&CL112?219MF3T1B#(W^LUA\^UYM"/TJ5K-OQ;O;
M"ISW7[>T7K^_W:PWL^4\<KW'6W[JK4*<+TVT30W3AFOHE8A?XI\$$$ISRH=9
M!'D"4',/`)FQFQ*3ME`FH-'V/L$`@+1F\:5B'CCBA=1FAX/&T2:;V-B23\T#
M^30$Q%%"<YXNGO0X@7FT45!``$R@P7$`USPZ2XK86D)LS,3.WXY&DV2(C<&)
M.(^NMKM.LYNJSGRYW.&A-M$S_A*-]"\WQ56Y6X";K:OJV7?;_?S5J@K?[XI1
M.?_F`3B+$*41&R89HY1"S/:($6>(F=90E$+U3XM9C(OAQ::UO1GP](6<_\_M
M+D7:J1-<]QT#X9!("XFP.L)2G552M5J(-698A&J^HW_I^34.<!>TE8[)<KJU
M=.Q.`3#%#2386`RAU`@Z@&LLH@,R;)#*M@IW:7LI$8P90^6>W5C/%R7G_G5[
M[_QZIMNW!Z<E?LH^&#/SPS*KI3E<_6<Q6]^N'EH[XSSMDA&%38=V^6BCG_X@
M1^&VD_/WRX_55+2JAHOE_%VY7-6_5D[0^FV/L,*DSPE0>X>T(PI3)CW`C,A]
M20<N'>"=@?C3Q;(KK##9,P*U"E<+:M8X`#06"OC]^4S.$1Y8I3EQ1.&%6/.X
M`,2%,)]L1&$#B+YK?OS'(D[_J^OO=V^+7\5-1W!@OQN$:'`BH!AV4#%M*=1:
M^QJNZ-(,JW65.<[O`F0Y1M>4X(YAVC\[.3X5H3.JZJ3[!..C\`20"*]'1G+#
MU+[^)!<8^@G'\:56]#$>983QWY=6DXO<>U%LNB"+WBQ_1F]V"PCL+JYUO%4P
M'!O*4000.80L4=#!6D9EX6B54/JM)V32WS&6G(W7I3B!!G$"U3)Z*A4DELGJ
M'\=::%?+&'^?V$+EY3@Q#*]+<0(/XL2^5=#(2N>DT0Q1P,TV.K7!30Y,_9%M
MW?%RG!B&UZB<T'?W4/&KXE^WU9GC_L[2L=9!4>X$`]&)E=A"9CPFM:\@',;#
M"JZ</FZ\7$\I$;*7LF>;/@^R8A^U#AQQ28AW%C,0I=<><]'(K`U]$2[1^1KM
M8<&F0>[?@S53]G@F299ID&3=#,#]K9B6YH$`)B0P$DC)):?0`5^OP@K$P6@T
M&6[.#-9C'Y?X/+A&MF:V,[>I\EKUMV$>M@E*6^`81$Q3#U$EX>$%D]0-6R<Y
MW;I]N9;+67B.RI>ZY.43?+:`?%Z67];%ZE>%R]:JKQ))+:\CJON*6P=!^T]7
MB1\9F-16$4JHI09#33E7J'D;F6,OPC(:RICV;;%+@_S_5$Z+\I3-M9?.X/&9
M:\K5SW(UVQ2V^+(Y!!9VFG2M[0*$1F$*%%)$>0@TUT#7<FH!AR5$S&_+74S=
M93YPQR#1YT]7JRUH=]&B^:/\5:R6O:J[M;8+WGM./9/"2FNDI<I"4,L)$9E8
M78[)D2@EN&.0:"NXGEW_5<Q/&(=:6@7(D&&2"N`M]=:PZ"#5,DH/!FZDY5\@
MGPJ!TD%[`1.LT_?:@MGC!-19]PV<8@D!AM'_-P[)*G5]@Q/@4SF0_;+#ZLY!
M?+2![;#591?K*FCOMC5#1.^V@4I`F:%>(F8%CK8`U[6-*V4T>E\VPP;J]KF1
M+"&*HQCFL_7W"$_UK8IW_S6[>;!A>I"AS4CO>X\@D<*(85T-Y!1CJ@2I8RBD
MT5/+)Y!0GX\M[TR(C3+._)HM;BJSP)>K3['CATF[;8`YVB@HJ97TRB&BC67$
M>T-L,\?[@?LV^=)%9>-$,HC&.=%;55_Z<?I8T=XP"!-'6&D!0W![?AU$-&M)
M-?'#5H7RI9K*1H:D,(UB%S_,8V_*Y1:`AS5#>S'DQ#L%C9SEGD<#D!L"JN19
MZ.`C:#O,,DE>]"H_9?+BULZA(ZG+JL2&>X'+E2V^%K%K\RHQ5[%<;]W(?LP8
M?*_@O('6(EZ-F<Q'+U339O;4U@\KDI>\;%4^;HR%W$7]FR%^36`,`,F@4<0+
MIV!5!9+7\E6)7@<Q(WG1J!&LCD0(C<&`>S[<,#>WWPT"]\A*;JS17C%.I'&R
MD5S+@=P8:T5X)%\W"Y07-%363;'Q)-9*Z^V"4D`(5OUG$A'$!#?^'BK#PF6S
MN<&I5=W/;DF)X!B\TK?K154Y+$ZL7Q;+[;Q:B1)?N&C$QY_6BZBEV>[0_EZP
M%EH-N%OT$I%3!"&`O'>2&@A)@XF4`]-M9QNV,K,J/X"7G_$&SW2!`H@U4"2.
M^I!P;YDX+"@@@2:V9969*DFQNL>*U`ECVI)W/#HN/5+VCBINX%#G[6V//!Q'
M6@2,,0'8P^AL$,4LI<Z+7?9-'W_O/F0TAGQ=N3&>N3H0Z+"-G*D."$+I@7%"
M-G(!,=8AR]8L%V?KY$EYSG-QF$TU\\1#T3J"CI]>'*RMLLM"`I'#"'(N(:4U
M#%5L]4AT."G:^"QUME)C`"1C3+H/.]FKD,ZQ)L%"3[13R$E&*4>6:]*\0]7A
MP^D&[)ZCJE:MGXW.:^/`Y")=IZ#Z!*O/[\I-L?XPN]ME+_6Q!_/%]:R]`DI;
MF\"@%E`!+:Q5TBBOE+5UGS&`$W/;SX>^S`/,(&5^BM9PN=KVXM/B]X<R@N*J
MQ(^?BE_%TE>EO>.,%N6TM\75W_'[W?;3HNBJ:'7>;0-2QMC_8^_:FMO&D?5?
MPOWRB.N4JS(35S9[+D\HK4S;VI%%KR1G)_OK#RB+3)Q8(@41%.R<%T\\)D#T
MUTV@;^@64D#L@:($&LU=]UT@E19@R%?9=521F!:[*7;][X7\-'N[9V0`PE)D
M$8:><H<5%V377H8ZAAB'?JI28DER<KY%,"XZ4TO"0+8'2FS<[K3#G$HD/`26
MVST50FE;6-@@)X]/A&)ZA:X3PL'Z7#<BTN:$D-Z*I@(0EY93P_>T*0MLVJ63
M;+ZSO,9]*BH7\I+]<*1,Y"5K7=%J_J^GQ69QU!7=[T%+F"UHWY1+0\8B!S#4
M$D.U]XS*J,Y3?1GOVK>6U*_0M-%?^RGL\\B-](9`.6>-6",(B9!`.$Q4BY^!
M/*T$TLA>O*QR<;#1_92X%NL5S%]?"5"@M?``6X8Y,&K7;GT/%$.3%:U([#@_
MD9`D5%<Z#=?W42?'6*5(A-)0B`5HDCP8;6FV1/)R79*C<C2A8$X:<K^&U!3G
MQ"Q=6,H0DK&K*RF#,&->&<*DT2HJ%&UB>D14X+3+U!>MKC28CRG5E4Z#Z]=(
M8^)2.VNAQ4@BA+V6A)`6$XUY8:ZR*=7N_&A>:AOZ[\7V_J<;YYN75\X__7#_
M=T_A]=-Z?C_;'+U]ENN5@0LGL+#(:HRE5UQHM,^ZEI[S_D8PT[K\II350B!_
M@P+]6V1ETW+Z:O7<S/YJU78*FT["#Z\A*"V@L%`YBP4U4GHCV_/0&TK3LDRS
MN3_?L,B/QH,W^`W\K=INE[V=7_.]-&`*#3#64F&(-X0+S'V+L,0@;6//=JGP
M#4MY.N@7BB$<[SKXWB,)ABA$A5#<0T:I9UZ`9V><:N)'JC?&^:M'$@0!1"LF
M(/#.(H*!@&R/G].4IN6+%!!)&"P7F2()I^%:;"3A%1!ZH@<'1@3/A0*(:$>8
MA!8`IJEM`<$<%YEI/+DP'+"OS\-R2B_-]RMM_KFN^O-4>\<&(JB.-I:*VB4D
M3D<=@:/V8R;>^G(C!&=S<(!$C('5^Y>1XN(!Y8G&"%FQ<?/[4JWC-CBOKN]G
MZX?9O'K:+N:SY>&*EH/&!<<TT,#&I1/*C3)6X185C[Q/:S8_I1,VE1=U/I2F
M3W,[_8(2)":"(ZF4TBLFO9,0MA1QRM**Z61NY'1IM>%L&-_:A1;)`&7">,LC
M*M0CQH%KJ9/QC^7J!^>P:NC-EC1TWIL,%'?^E\#Z$4[\0N_!&*ZMQEPX)*T`
MVD)%OT&)>&'ZPOD,'/,>S&G8359JZ^KA<;98-P"9J/S<'2_O^>J``"C"D'#&
M!90$4(@0IRUE/AZV94G%E'ZO40"[6-)07&X$97.U:O[RK$%5\_O5XE]/)X?A
MC\X5K&>"$@"`Y9HI28Q$G8*M%$PK!UI4?#U5@')C.;T^<K7:5NMJL_TTVU9_
MV\8?-_M]<W8W_)K.L4D"=,Q+`2RDWNNHWSM&1(L`I#C-^5Y4Z#I5FK*!6&C*
MVA_U:KZK-W:L6N!9\P;-`*'([ZXR(FPY5J([U1W`[R""G"IL4^+Z!G,?+IK0
MQ@A`TN-&_[46<D\4-)V?C+NT[)YL!7,O?>!>`/(DH_$ZVB81EMG2/VWCTG]?
M+./N7J^JZ]G79[VA?GA8[*J-?ZX_WR_6-]>S]?:K>GQ<UW\M'N(!L'PMR7>L
MJ0.&\21A2A%+&'/`1-;(3C-A+"V6D*T6[Q1"=R%H)]TMGS^6I@I`_;3:Z1I#
M-KR?1P7:W#FF"GBK*=*,>\.^?4`ZL9HJ?\OB,SYJ%]+CFJWT;K7X3W5S==-\
M"[>+9IO=%SI^CO#<O"QX'/_6U*:Y6NVY6GU8?&E^W4;+:-&-/4WKR[6*H)1Q
MQ$.EH83,24H,WYMD'L0?:5XS\1XDMUPN3)UVN(M-;5ZNH4LW;!=RQCLCNE%9
MF2V_F7_3OFR?5GF1?,IOD</#S7<Z61Z4'3A@GJ`,Q=XU15$(400Q2:FR3@/I
M&7*$7CR'\C`-P[,D>^8(3#CG`<3(,X4=8THV%<-V&$"!F"HA#S(35P]F0(Z+
M6;$YCK_/_EFO/\<U;C[>-GZGN&<W/=":5/"6WIZ\A8$S!$XUT!H["7S3LE@I
MKG4+6$1QJIZ%B<D,HXE#/05Z4RB(`U;>&]`>/$>(-#J!G%"28$4<\Y1V]#>X
ME)OE,#J'3Y>@LS#\]62IN&R)MR-"HV11KA_K:+E4S4J^+>"Y(\GA]O*#QP8`
M:#0R."&:"(81AL:T6S62*/&:<+8X>`;>U'D1&Y/K?]2K<QC_X_`@""0:8XP$
MCS`AY0B#+24,RC3G9K80]F5X?R9H2>S_K?Y2K5>-QGOB%]\[,$AII$-2$VD]
MM]1(:$B[>BMX84U,,[-\;+A&8_;0#WW(V.`P!P1S3[UC$CEL(3?=?@5A6NW7
M;-'>"[#\3,22N/Y[O=[>S>ZJ2-['[7VUWOG[]&S^9W5SXC=_^DR!-GDV\00S
M$3MFI0$4XI8^`W2:;S=;)#6S1&3'+Y]\#-TFDB8+C$,)')'"8V<ET*YILMEZ
MC8!,,PRRA3Y+D)(S(9S"MOP1D][2:J\/"!!3)`2ACG(%X]FX*]'@-#34*2CZ
MFV)-&]C,)QRCPC1)_O1!U]V`)K7]@T,3E2+":R8IT!X@X6AG'1D^F6-SH&!,
MXT<?';;+"DJ2@(2H-PM+`8%2:(4TA@+0ED(.;6&U\\9DV6!I.!&C"V\7\_G3
MP].R2<'];5UO-G]?K:O9LHF!-]6A='5;KZO/L[_2=I-A<X>XKPK!)8AXR0@Y
M!]"WNS4BGJ5=XLCFP+B(3.6!LE31:XJ2Y1*]%W,'`0&@"#H*,%"0-/7..AM`
M:)/F.\OF2"E,],Z!\L*B]Q`-@88$4V\2-:7O9P@\?EW46R2,-DV_<"5$YTW4
M7J7IT=F<,Y<1HS,`RYD1=3AAZ#(=C\UL<Q\-F^8_C37R)8*XV@[*$>H9&:`Q
MG@O&G,;*<\BY5\W9@+$76I/^[E&YLX)>7__PC*`CXX-M$AB(XP8RR(%AC0W0
MTBZB'5!"-M!H_#N8_S,>0L7F_ERMOE2;YY3UN-">-)^?'PZ<,HRY5%QJP$W<
M];!4+0Q(DJG*YR5F](S"X'IDD*8XZE\NTD1EY:Y>+_ZS2^OM=8[U#P[8$X4-
MAEH@!`6$FB#34NP48.6FZIS#OJ.2,").OX*$%)>`4Y9@3"\0S>6FN,=&U>]Z
M%C?;7AEX]?D`$;2:8])<%]5.&NPT;^GB'$[6>GN8YC\FH^KQX9F"[9^JQ_W%
M2'6WKIYO0/3R_O"@`#"4T4*2\70US"+(J6(MA=;PPOHS9Q2`T3":)#FS7E5?
M?Y^M_ZRV_FEUTR\!KP\(R#.&!<#&0HR<YY((U(%E2^M5D)'[H^`S54F0$P*G
MKST>C!)<&0FE5U&N-0*&BY8J"D%AN3@9N3X".I,<]2_M(;4UL_7ZZV)UM[L+
M-R!B.FR"8(%CTC+)$.&`<FZ\!RWEAH+)6M@-DXM<_H8L8%U>3)+%(U#D%=><
M6*"9`/%[`,AWEC=!A14I&YM])TG'B5A=QC%\J,EWUNNK^!(O/=Z*),^K^Y=3
M3)/U(5[Y8\."I?%="&C1I*9ZYPWD2$-KG(+>F_[4_=PN^=YRQR-V-6E+)$=3
M`2!"&7&[<LG>Z3TBCDH[U3VF4]N7)+`TO4])"E+%.NRGNZQ+XE'E?(1,<6=`
MU$DA=2U@A)&I*LCFJCQ^HE0DWMD]#<3W=\_24LP0HHX8I2GAVF(CVL^;1;.I
MW$#`Z!Q.OG"9AN&O)TO%A0S>C@B=(CJ'ZJ!OFVN$=XOY-_])3\^3PR,"($)(
MP(!@("Y/((50BXC7GA56O3P#'^H<.(W%U^MZO;VMEXOZ!,YV8P*!CEEE'./(
M"*BL%PH_KQD!X=5D5^^3:VRE*Z]C@S.Q/9^Y\M75*OZSR8V<YAW'ZUSE>-4E
M.Y5VJ^DJQ,V_#K''CXX+WAFNG>><08,U,%%GYC9*/]A%*U'O/CT=K7V6]\$Q
M`5)IF'"6,XXI9<S+YC;T,XV(JR(J8XW$I9_R%,;!I%AC.I)V7:T7]4V/R?SB
MN1`/6TX8AQA3J)@'%,B.>,GQ5`)QDF$\`BOK\3"9PC;IUM=K@?SP9."&*TN$
M(M!PP^+A3I!N:=&$%YR\ELB30YP]"X^WS>/B;,G+L/8B+/W?:K9&`/#>9(.?
MGHWT."D$0<A8)*-.+A'N3CJ$<&%V8S(W?N;J63A,RU=Q`E]%2X^C%L)(!Y-6
M:RZ10)V\8Z73ZG5ERQH;GZ]I.$S+5WD"7_?/!L(U%=`(26`3MI;>.=718Q(S
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M93%_M<+*>1,&`1EU$3IOC"86"^1X>ZP*HUQ:@FG&Q.,Q)6%2Z#(&(KYSHV>/
M/[SL0Q*WS=_J^N;?BV6^C+XC[[QD'PY_N#O+D*#!D.$!"$804!8AI%14GXUW
M4:!EW)RHAKS_X\R=S'>$B.%I?'V3!(2CJH\X<!A*8;#07+,]"DK1Q/Y^(T<7
MQF7GP42^D;$J-NKP2DBY)_YP8$2P$0$*#+(`P*CW:^TX:@$!$!09B<C![P.]
MJLZ#:PJE][65/G?.JGI=VKUC`X6$`<R!-8X0*+A3RK?T1A6"E!O(.)N#`R1B
M#*S>OXP4%P@I3S1&L)FBQO^E6C<:?W5]/UL_S.;5TW8QGRU[4NCZQ@7H.+0"
M6HRPCL>P!+:Y=O2\=LI,85?L1N1%G0^E)`Y__KJ9_6.]B`;9S=.\IW+U:\^&
M:*H+10`W7@'AD4>D*0&V7Z,2H"PO5R9.CH#,-+[0HPTN]===QJA9SC9]ES5.
MG"E@IBT75'BOK;6`:HMEBX4`8"HI*4TCS`MC`2+U;?U_S![Z]8*$V0)S1G!*
M,5,`<8FM(:C[S(#1!6N3V;A_FI2-B.K_2UR#37&ZZ5L6M$L(6#S'YU%)^%1M
MJOC"IKJ"K;Y4R_KQX5AWCY/&AZA:"*8AIIH;IS2C\;=..W"VL&H"63G[DQ2-
MC]\D*2?KV4WU,%O_V7C+=[\T8/37ICDZ+KCF'@UC6C&`@**41"6TI1,:D[;9
M9(PB3R<G8^(VA7P<T2)/T+Q/F"4()B#&`B@7J3?04>TZM102F):>=GK$N32M
M.Q^$%Q:C$W6?$V<*'E`*FG!\5`X,!M(#0EHLB"2R7$T["\>'2]6(:/[:$E:<
M9OT6!6L$K^''I^V'Q3QB5-U<S[;]5ZH//1^,MUH(YT'4W@`4%`K3G?T,)19>
MS*8%9^-$/3Y64VP4>ZV\NOE<S>]7];*^^_II<7<_H!)KS\@`/'?.6$XDXIQ@
M!PQH:=4V'O9E:;VYY2(/:DE?_M7JI`__P.-!(PL\M$A&Y5P:PR`!K?6F-9"%
M=3Z>Y+L?!ZHI/OM]F.-CFY778[&\]GCP!$0SCWLM<=S'N-.(M6$6C96=*@6R
M---D!*PFE(#&\&XS,WMUP8-C@M.84,J1;HK,8(09Y[BE3PI4\,76\]CU.N]'
M`^C]"4)QZG\A_!_A7%?_]?$/]S_'#_/OGPE:.*DHM!HC2S%N[IFY=DTN'E=E
M:>XC8%N/@\047^6G>"+UG<K=,U'!D-89SJ2*Y!M,'?.B77^D)>TH/KT!?6E'
M<2I`DS&XO]W%MZ<"HUP)+1V7407%VDE!.R%EPA5\QB;PX35.GH7#V^1I<<?E
MM*R<GH6_1S@?GA[ZNY!\_US0)EKK`BOE%95-G-V0SFHWBA=6'"*)`S\6B#R#
M_DGX./MK&!^_?RY(`@20BF'"F*>8,V:ZFR8*Z;3[G=E\5J/P\0SZI\GD>*D0
M_%%MW5_SY=/-8G777F<;T#;DE&DB"B:J?9HS2B*J&C('V[BS%O(->;0_G'V%
M*B-NEPV#_7U3W3XM/RQNCUVV&S(\`*^U$-)"`;4C\8=E'=7>T\F.\*'9'3D8
M.CC<E8Q;HJ?[:"K+41DX;8)`%&004<^)9AQ!&7=?V_GM?6G1CJQ2D!6Y"P?/
M?UO7F\34GMW0(!BFR.P*<DM)H#*(H&XC5HGMKS-6D+CH;I&$60$)S#]A=%0S
M.6VJ$+=)0`BW`%I/4%3UC.V.<H1%FG:2L?+$!!*4&<-+Z+D[R3]-CH9,$""E
M+!))C;9"04"BH=!9:E#ZM%L\IWL*RY*>#,A=^)Q2\_G3P]-RMJUNU$.]WNZ;
M3*:=7`<F:]I+$L,%H((@+R0`H"GDLM?@`$C;B=B;EJ7L*%Y8KB)H:3(4!P8(
MM;8*(;US4ACM$>V^(*`3[6K^7N7E=,1*\<><Z8<)GD1U3SIB9238$>P]:#W+
M1C*>ED(JWK2<9,!M$FEY>)PMULV5GX^W/Y+P+/K+1O2/"<RP&8*R##5G,C#-
M;1$.$$3M?3>#D$B[)R'?MLQD@6X*L6FO^)OZX1_[BI.?NIJ#5S>1HL7M8O;=
MR;J[_G^C5C<?XO]>+)_[7VTV3P_-MGK4-C@B>A.N(C#N*;)0(^\X\P9Y9%HE
MP$`!$SL7@3<MO^7B_]TW,'Y-PKZJ?3\$828JV]<NXL.`&GT_/1LD)PP8J*EC
MF!D.N7+"$F>)CMHNT;T^\CPT?<M`:5<\O/K>BQ'!,V6E1=Q!*EA4XE53]:6A
M3WF/=:+W=^12>V=PY6!=O7-0F)5:1&^4W&A@)+1<:\(XD`V\RK901&MOJOH"
MB0E9B6P=E`A]$C!O+__5(&L%`88@AYTTJ+G5WM)GH,/E)FF=QZ[!B;!I`+T_
M02@NLZL0_H\0]OU<S6^C5K6>]=1">_E88!@*PJEB%GJ+A./4T79ED+'"TCY&
M0+@>#8PIC<+S:]MJ2[&1D3:*H[&K'#1"M[19CM,^S<DJF8US.(^#S:7X/EZ1
M4N84@(C$;0U@R1#F`KM6!Z;$%%QZ[&P.GERM-`VK]R\CQ1WEY8G&"*>Z?WJ8
M/38U5M7=\7/]IP<#)=90I*6DA`D3?]&4=:OS=JIBYJ,5.!V,=CTB+--$E[I>
M0X_-/>I]<YFC`:571P0,XEF(04.)(`13K"1I:1-*3U:&9!C+_X^]*VMN&\?6
M/^EB7QZQ=J4JT\XD[KXU3RRV3=N:D46/%D_[_OH+2*+L.))(420$I^<AE=@A
M0)SO'(!GQW"^F6'P2,'KG9]XZ[>UJ_ED=K^Y!:^#<W'?L$(#PZ1FB'(/$434
M>+9#S9%DFEURK@\(RF5\VZ/?O_-<S0*K7\9_P_&[=09\T?LW7H>7K,HQ[Q/:
MOB\!KQ;+Z.E=?)K]7L[7(9Y/VTOFW&RY#NM<]NV7O#]I[YI>NH1E6D86BB"I
M#?9"<"ZLP$QYN3DG,+)6MVI)8P=I#G&C>]#FZ`P%E4X@!@EG'*C8^L4HVM`/
MO$IU3^C1(,Y@/#P8TAD2HVQ#/(>(U"_K/D"3N\G-.MY\=;<!N,71U&>Z@FCH
ME0.0((&]=\HCHAHH)82IW(T]O5`#B4F=',@4JNW[Q>[?M:V>B5.F*8)2[R22
MA.JP]9WW@DJ[@]Q!GZ\C:URFU\DQ_:M*6'9NL(\K6`.XRWZM@@WX^+B:'6Y(
ML?>Y0D,D))12B7"$AQ^()+I9FS8F&9N[V=#CP%X/!U#/PM7&"CELA&SMO2/%
M[WVG*K3F%GCI%(9$^Y@ZK'>?;^]DOV3:T41@:)TX$6R]!.-K%2&)OITZ-IB<
ME-.WURI,@EV^K&?5]M+EZ&#Y6K]L;FJ_FIGZ\3&H>F',MS(\^%LP5N?7U?QQ
M<75GZFF0FWJ^WD3J?EY5&S5\OT@E742!&,5,`B\4(91&.#UH4#4:]TR-'5H8
MQQ>:^H-PH)=<1V_US;*Z?6S6_K19^UT]7S-OO:+ZKHSE4XME>5_=A#GC/7O+
M@/*^@I,!9BV<U5(!`"&@&@CDX\>BH1LKU"^&,+@W.:WD)84TA2:]_X::;?1D
ME]3>.-9W%]N8>G$L+'7&K(5R%&D`K#!:>XZ(L,8T&`GA^OFA!F\1D$SLTD-Z
MMLJF)^%8;MI[A_/VJ9Q%(![*I9I7M@KX/`;MY/:ZUM5OLYMZMJBGD]M8&-KF
M[CZFW`W^TD(R9PT+^%C,B`">.HQWJ#'2+ZM]\$X#:<^_G!`?,53W.8RZ_ZYD
M?/!(R^LK+AE.^5S'(R+@/XN7^`8>=(FD'!Y42!@[R!("+67$40LU9IP(:9%3
MQ+/6.^$24=D6,]D_H(A%Q]K[((GQAB_)M:%Z2YV4X8S-(40R!'/J$=#(-ACR
M;1G.I/BF7ZKZ?EX^/41UK27B<7!,@25RW#(03C%L+*#*6M2``C5(E6MU4ECC
M7/Z^#Z8-!$X*]??;1LC>KK35:WQP3$&XP3X0YV-*LH&.`^":#19_D6\08@">
MO9>"@5'Z^:0ANX!!3D+0E_F+H&/=U\__<U.O9LOY2^0];GZ(;,=OV+[]=?'I
M>@]_7_^S0+&;A(50RT"T!]`31)JU`LZ3U3)U\P</@'E])@0]?;N3QS]6\\5:
M`C]/'B?+M3P&4S:8OO5T=:"!4^>QA;$2.AG,"86]\M%S%U:^I<%YDQD;!]3C
MQH)H1`/L:OE0S<T;F]%/9N5L[;5M#JF-V32:?=9Y!9<TWW9+Z6*V_?APD"0A
ME<;<.LT%,D0A331'#EL.L<>M!LW(5+6FMGWW8.$](5183:3V$$,'$.,;:I@F
M'/=K[C>P>78.$P[IV7VHS]8<T^4T;+/JVT-5+3_7F[AV6Z'C@2&%ET8;%Q`0
MP$CO0/A4@082`5&6QEA?KKZO61H&DR35:WN6VEZV=G!04%8%U"9\OI@,A''#
MH^VZW4\,6I&O%78^TSI(P5DH_8SRD)T=EI,8I&?_1O%:S>?KC^2NDU7K529'
MQQ4>4B>QUA(P"H-^ZYT&#9V4Z\S2NH9@6#T>/&G:D51/Y>3VNOQS;_QOWV-%
MS$?S`C#NM9*.2,R0TAQCX3555K1&'Q(;ZL.I@F>@<*'Z]"X&R[%A!9$>&`4I
M#J2:F,D6^^EMH.+4"]K&ZY%,EUV%P)[%+_3+FY^ZU^UTFZJP&BN/A0:$.,(P
MD,ZK!A&"3"IM]ZCY,PQ+#U;OC()4OJ;28"UA)%&228REM\PAB1@,WX(M((*`
M5$F&/8MQAN9ZQUXQIX'V\?N`0&6L)]AKI*T'TC,)74.O1@ID;%>=R\&3&X+T
MP^KGEY'\;*WL1&.`4(JI9\_5/,8-JB^QY4EY4ZV6,1!TV(KJ-*XP!`EEK9>`
M.TP<M,;[9NW`XLS:B@S(BWH\E)(84]M4^.MZ"T`#3=5ZI5?;T`)"'O0V%RN(
ML+6:,P]V.T4!F-GEKZ,HH`-CE$(B?#F9_UY.5]7?JG*QFJ\UU_^=+!]^F]5_
M+*KY\R8_\VFU7,2FX[.;R732M"!?S6-W%5TN)HO&D?#R936_>2@71TWUL5Y9
MA*WJI=8PLHY"S#DFK$%7"MK/\!FM[<TH$I@)MBD5F#=]\6.8=MV]<ZWLS\O9
MXJZ:SZM;V$&7Z3)-(3'W""F[;DM$N%#8[-B"G>UWR>EHUQ:.(F$CXI5#'D'G
M!UL:#27IT;S;IZ\)(B]='&I=AA<.$J2T9EH3PS5F#@.\S@'!8>L'&;F,8^W(
MTML<:6U#"VL<0(%(S@V&%GG@X2;K!8>S3\E4WH^CCK-A6;>_7?50"&7K,!LV
MU1M:S8ASX=",5_=2P[B4#2BZ0\.H2SC-AN-TYZ3OTV#Z>&F^V!,*E=(0"^PD
M4=PQU6PZH-V'3/KNS+/.^;[]4/KYI"$[!UA.0M"7^6,D?0.+K`",*6L9(4@R
MK6BS5HC2=;T^-^F[,^8_)GV?!D&>2=\(4$JQ]A+&JF>%E/$[\K7Q>=YJ,:R6
M-Q9820[GV*/C:_5<S595;);;<@/OOL?#.>8HMYPJ+(,5:@#@PC=4$0[[M?,9
MS3TTJJ(_`#XIN/Y][<.+6RPGCT%8K^Z^A/^(#90_'_=9=QI?>.(@9X(;*C'%
M%@.-T8YNZ?L%,T9SZHPJ%V,`ED)0;+7Q.)GP9[+N]+/VX[S);]MFO!T1ELYS
M%$8KQ4@LOO&`QML[#7(-_4ZA?N7?@S>$2"(P8X&6@RMPY`;?L9'+_+E:^'IN
M)XNUNA7Q4]-I_9^8]'G!-U^VL?=TM<ETGMW^?55.)W<OZWXVFV7&]4[K&-GH
MXN<\>:Z"2:>,P%0%N73*41?^;<-I1ZVUFK;WNKHL)FT>T)/F*8*](*'R2#GD
MH0QJ7_A%@X7S/(O;7$?D\`\]F<?#+EM'Z2O1N[,A=M';GA_78?&M+<&[3!"]
MC>L[UIUFR#(:/CEJ!Q>R),LFX",)Q$&Q&Q#`%"K9\86W>M:Z#"\L,X)R:0BT
M"'HOE2)LMY<!U/FZ7(=FZTE2<Q9Z?Q79R<Y!^Q%$)KVH;!<85%E3+AX:=;:U
M2.S8L$)X!2`P`EF(J,=$$R8;*H&R/"]?X;",V]-M<B"<^F:PKKL4QH:%M_]<
M;:\D:LU>/3BF".8MQ@X`H+!@AL0=89LU6PW[9?",Y@0<A;=#@Y30_[M<S6??
MFZJM.[UE9&&QH,Y8!I&*]\Q):OV.5@][>H5'\_Z-NMF'A:K7?E>S<OJRF"RN
M[M1C/&G"W[-;\U#.[JMU*]OHR=KZK1NBVSK_GS%E0115%"-FJ67$>2*`-@W%
MV.5V"<3XQG!B0"^O:VX+L'LKF]OQ!8:,:.@P10%A*JTROMF2SFN4B2"E8^])
MRF<_$/OI&QMO=2#S>1*U\L5UO9_DK]6TC&[TZWI]:GZ:;4?^HRH/*R9#3%Y(
MH33U`'#+E''.0^)=@X)@.),P9G)1NAC"_;YSKSI7YR5^F4_J>5S@P3[HY\U:
M&"X"ZIISSA"+94].[^AVDO5S^([3<3^Y9"6%MI=(-<5'C0+W]#2=5+?J/F"Y
M6+:MN,/I-=3\!=9.`68`P-ABH[SWMC$;'6*XGPDV3C_]Y&)V(9#3"]QN;XPB
M;KO9"R0<%YA;+F*[)(N]%KK!03'6+[)`_RMLO2$>,;+?-:[]+K_T@_3H=((C
M$/:QA")\1@@''D?'KL#A<R(M;,TH'IFJ$WMTTBBMAFDMI41*.*B4:ZBAVF<1
M7#Z'"<=[=)Y&?;;AX2%[="KN8#BVA.)*($TDI(PUD#C*4EG(Y_3H[,S5KCTZ
M3\,D2='MP#T9"24.8N>%`4A*C[T%.\B"\67RC>">S[3NS1G[H?0SRD-V4=F<
MQ"`]^QO?\M?JIIJLFPNTQF,.#2D$`XI(PZP2%GJ"C92\H4Y!FHF+=$@VU:,@
MDX+OX_1FE0PC2@AD/O8=%<QQ3!HZ(>MY,<-X_3N&EX`AX>EETG];/3Z6\Y>K
MN_W6WZ=9O%XR%@N]S9]^"T1K-&ZX-Q3&`XF<<T8!:R"DT@?[LT%9H\P:#@U@
M3%P6P)\G&.<9DU;BL(>,-(H9@OGN//4RV?5]77Q"E^!VK]C<:9A>T@DT<EG'
MMX=R7NDR&.F->RWAJRY9N.$>GZ;U2U5]"_!/HO0UBXM7P@9M>B=#FT_EU5WL
M0'4_F_Q?6'XUG]2W\8KB3O>.#ORF`G'`B!):>HXEU)8[Q+?7S3++1&N)]TB>
MM5U?VV'H[=YG>L#W%89:JYD/BBM%PBOJ*)`[;)'(HAGUQ>3I8/_JRW$@6U]C
M^-35C]6K%M7-W7AD5!&[DG%EM86:2P<-L50WP'B9S-?0L]GU142D'@O=%,KE
M@=6VNJN.C@MJE2/$4(.U@%(`$FC;8>>HQ_EZ,`?A7C>).`NKGU<VLO-FYB<2
MZ44A&A#A/0_!:+#!VIK63W'9[L]XJ+:[-SN,+H""3'MK*?/(&Z\`1ZRA65J;
M64NA@?BWI[!D6)R2E"%4TS#G_2_5K)J7TVA6WCX&5D0+>SEYKK;+[U"4<,H\
M!2,(.R.8-$)`12'RTNUV'J']^E*.YA<=1U[&1"R%Y'PIHU.W53#>/E9(827@
MF"J(#%(<"X9\0P44IA_?1RM-&8?O9P"2Y$!H4;MC!M>T7"PF=Y/-+S[-?FPW
M<LQI/LZ+"JN)1I;RH.X+3"$SUK\B:7B_)/+1/D'9&.B79$*2>.Z&E.IV/Z7;
M4_98=+?3!`7R6#-F)>=2$<REX5YM*><8P,RZ\5V*[>_CPV-@FX]4_5HMK^ZN
MRS_/EJYFHB)>LP&0Y40IZH,RR6,=QQ8)(DV_$O_1]*8/)64],4XA;<-\+$SY
M-%F6T_C;33;VZ/&(']Y8:"I!V,?,"1U@ML!K31IL)2&M'?C3ZG^9R&\>S.B7
M?7%LQ[T-]2[6(<W&YCF8:M%ONH)XJGRPH`#1@#EGB%"-V<U%^)[T$KO1VAM>
M6.P2(IW-X1G.?1WL\+O)T@=VG*8@#O."P@I(+!52:F,HQ]9YV&CPW$+0KV?K
MX&4]F<CH1;$?,=7C8/[#90I\/FX"!"2,.`4,Q()8)P'&?"M0RAO)6\VQ_R9`
M'(ZM"A.OTW)22(2ETY8ZW6#K`.&I^HPE38#H+$])$B!.XT"V"1!?IN7LU_*Q
MK>/FV\<*S!D!@B**M3#4&X*4:!@AE4EU#6\&*0Z=A>"]_[D_G$G""MOEM0:J
MOW^P$!`)XP@R4"ON";60HX82!H'+-VNA'T,.</4L-#XR?[/+/+@$6P<PV?]6
MSO]5+;\MZYM__1;P:NE,N/_I`D%,J8&4J;`N[@6S<D>NLLE*7[O>)]`3Y'IH
M('HQ[#I(Y._58EG%#/;E?'(3/9T=V==E;($]5/%6`T!UL-!B_U6XHT%`W2^T
M,=XM,P,P<P18^O7N*A</WZKE<KK^_-_5\\=-%430&MHZAK:.+)#AQG*`F7,V
M@$.)`CN5EE+1;X^.=TG,`&P=')0DW\O.C&\944BH+.%442.@$YYXPV1#&^`N
MDRY%`S%\6#!Z[=Z=LA]/CN;>\4C6\:W;,JPP5``-;)!+#J304CH.FY7COC'`
MT1R%0^S;81$YKXSTJ&-<+1;US22&&N,-]79R=U=MF_?=S\O'[I6D0[RD())`
M3IFP&!D!@+7Q9JOF*#,LLYS,2SML+LZ`?-(6SD^&80!Y)Q$BC%*+++"Q^K=1
MC5S/6,;(Y:AI6=XO$>8T7/.1J.$380AQC'AD*,6$0>BYTCN@$5$YM8S]2!+6
M$]]LXK@?(@G&&!5T'RL$"RRSA&`B6(.MYR2GIK1YR&X>C/C("3"&$V$0\H9`
MB`E%``NWLW;Z7OD]3H/:RXI<0I0OD4;PKFE%JCZA^S?L?!X;P<;EZ9<?5JS^
M4\YONV0.G#]YH871VBBHB`7Q]E].S89OR@*M?6M%_]C)`JTD+@[1V#U!X,QW
M%%0P%FUZ"S@V,AR"!M`-AB:HICJ5Q_]X]].$HG(P#R`MT#]5[%]I")@C7&HG
M(8=(,X$:TB6R_;*'D\7^DS'^6+S_-`ASC@?'/#W)B0/8P4!"H$;`AA(.#/H@
M\?[.##D>&.Z'QD?F;][Q_D1LS27>K[T3QA+AN6;,4$2\$<TZ`="9./S.!;E#
MO/\T(/(+"EL8@]E>\;!P2Y`QDM%&O[%&9E9@-@0C!P?E8P6%C1:.6<4\<HHX
M;413Q1YH@Q;T"PJGR@(XE>'#@I%GMHY`VC+K"6;008FA0\8W-``D^R7(IHKR
M]]K!(\#2S]?WJNK'MU\]11!_">I]AQ["[4.+H/L'V51!DS`0.R!PL#@;"@)L
MJ3*?SRL0&M/6'@G)"S;=:$?+_7LU6;Y\F@7*5FL;<MUP^_JAG&TH7VQ(_S3;
M.,+'\*.=N(2">H&H$4"%`]8QBJ"3?(>^4,E:B'7Q10\I3-TZ;UP:[TMXI:^K
M/^.MW0=\TV-T%1Z[8_+JCT7U[U5L__4<7_?^YXN]^)+=E-^MI9-O_\"0`EE+
M#.%`46PPQ9@90#3'!"C!A=>MGL`D%+8ZW_<\7E!G'-$D[%+C@&$ZF)-P2QES
MP8+,PH]^-EO>GX7G(Y&OHWO3YOYJOHU>MSF\]SQ>\)C/2(##V'A@O(;<JP8*
M'W[(TO%]%D_?&VSGHY+$+-\L,P:%MPM=M+L]#XTI+,8<R5@Q!*`F6A/*;4,?
MX4)F[.$^BUW[>3\80#^?(.3G"L^#_P/8])^K\O9IFU1RW#GSXY,%Q,H&#1MQ
MP23S!E!@>+,^*W&JFP*ZNF+.Q[D>$H]>_%I?D/)<S5^Z,>W`XX7TT%",I)$&
M:TX84W@GJTKZW$K>AN7<,*"D.&:OPYNN[M[8S"W*U=[G"XP@]IA00:6E#`AB
MQ>O!Q&&J2]HNIUT-`4N29/,WN1)!UG^M9^7K;Z[#OQ;ES=H#TGYEXVDS%9I(
MJCV7RGOD'!1:.-!@89SQ^:IB9_+V?19Y$MS^VK*4G3:7MP@-H#2H7Z[-<3WA
M]8F">L:\%]Q`;I!G3EFV6P_@(+.RNM'0KH=`IU]9[6113EI*:%\?*1`DQE*H
MA5'(.\VLMS)H+\9I_?_=74N/FS`0_DFUC5](O=C8/FVU.?2.*&$WEI*0$M+N
M_OL.48FJ:"&1>83M,8H-YON&83P/CT6"+ZS5P"Q\A<,3%A?]7:S]<?-<'3;9
M7OOREV\B%_T,]LU)8<5<$^(HB0BA#/:2*H$U"T*1T9B%%7]-EK,P"Z4CXC5+
MO//*?(4;WS#=.V:D1"/J:!P;@ZE2RB0J<JW+V8K;D8"19.%QQOLXP#R(])M.
ML<XYJ70J(EHU9Q9C(R6F&D676`.*Y')-\L&,W9:`01C]?[*P.)-Z.2+P<.IO
M=Y;Z:'S*B>8BX:9IZP@Z$UL$W[B_SP7:<ZY:D'NSH8;ST\]X$"ISL-W;%<V^
M-;64?O^J\I\G7S5%E:NJS(OCL:FM[)&)`5=-P0"*I#!6&(H`\!B!N=5BQ%2@
M;W<NR1D>:Y\/NJ#-0GN\3_F2E[L=6,5-XE77+N'#P:F0TMDH@ETHK)%HQLC%
MZ2V$BA:6PSX:P:,A,D^`M#ADOBV=!ED\)[&IX[&H^[,CNJ>EPL6<8"ZU9K$2
M`B<@H.U3:AI8,31=<Y&Q7^P1L9E#`IY\WJSS7$3?P_B_P^#S%EFM.+)68X0E
M=YI>/F^QE&%O]G1]/,9F>``68;JXK&'=/MNZ4WVJBF]^6X`^V1=M%F4"*L;7
M9S=&^7WCJ_4JJ^IW=3A4Y9O?976Q?>_4W,,OG>K8$B(E1=9HKC&6#%]@),Z%
MN8&FZY@QKIZ?';^P:I>BVCV_/!79AZ>*70])$<4:*R.)!%/8,+`S+-:":A5S
M24%I!3'*/P>CX3B$Q3S6ZS-0V?9:=CIC()TS4B<02A!&S"K%J%%<RL:)S`1/
MB(D-#N)-?`[>1H-ERLS[RYDZ_G5_;LFSKU6>-X<@@:V_*K<^]Y.FP]]S^_M&
M]6>P+VNM]P#[]4OSUP]XZ^'''U!+`P04````"`!`@_A&.X>:5`KP```J+PP`
M%0`<`&)I:6(M,C`Q-3`V,S!?;&%B+GAM;%54"0`#6)^R55B?LE5U>`L``00E
M#@``!#D!``#476MOW#B6_;[`_@=NYL-V`W:L]Z/1/0.)DGJ\<.(@=G?/HK$H
MJ*IH6Y,JT2.IG'A^_9)Z5=FN!RF1DO(E\:.L>^ZYY.'EI4C^_+=OZQ5X0EF>
MX/27=^I[Y1U`Z0(OD_3^EW>_W9Q[-_#R\MW?_OJ?__'S?YV?_\/_?`4"O-BL
M45H`F*&X0$OP-2D>P!]+E'\!=QE>@S]P]B5YBL_/Z[\"U5>K)/WR$_UG'N<(
M?,N3G_+%`UK'5W@1%Z7YAZ)X_.GBXNO7K^^_S;/5>YS=7VB*HE^T?W7P$_2[
M\^9CY_1'YZIVKJOOO^7+=X`XF>:E;08CS<>_O?G\5[W\M.JZ[D7YV_:C>;+O
M@^2QZL4_/ES=E'Z>)VE>Q.D"O2-L`%#QD>$5^HSN`/W_M\^7!^&Y%_03%RFZ
MIY1_0EF"ES=%G!57\1RM"([R:0\9NMO_B%66O7@"I<BE%*D6I>@O)QY</#^B
M7][ER?IQ1?BYZ.-`!\3%6[32X)4T?.R"\ABOKQ\H&O`MZ<%(+.2WCQ0-NFIL
M8;J4T89?/U8T>+&8Y38.7,0KP8WCS2,/@U[1CUV1K^I/TL<?D>'2>BVN.T]&
MWPJ4+M&R$L\7SP;)\I=WY*O9)C^_C^/'6?BO35(\>_.\R.)%,;,"R](CSP@]
MWS452S5L3?=MS56]R#9T)YJ53YFA]/RWF\9H^:->3WW'X^Y;)C.4XTVVJ$8C
M`H>.QQ7"OU9`P)\-E/_[^6*+^24]>+$OXB6"NSB?ES!J_P@<U;Q`JR)O?G).
M?W*NJ/4P^I?]1+QF#"_Z,E81L*)I`<Z:MO0BXEZV`#A;HHRD+,U?Q=GB!-7U
M)RX6F`S"C\7Y"]9IYB(&/1;2;"H2".2]!+1-?IXD\]EG1%U*5DF91UW?U2:+
M(DOFFR*>K]`M_HA3B-."$$"><G^9%HBTL")O<7F!88>VHP:F'3BJ8^NN;M:X
M?"70U1E)$N>X'A$.]I7!X/#TKEWDS)WLI1,`WP%4=;MXQP]08)#B]'RQ=04D
MC2^'>^5($3PN<Y,,'9\POHK9]1VHI7+7`7"+`7$![/@`6B>81'6D\"WK>5=I
MX_L*XPOH`W;!]\PC(Z6M'.\42U?*T4X4D7O&Q\%C-/*(.KR_>*3.P#AJ-[G!
MAR3%&0'3&)RIKF&8KJ('BNU!Z#NNY=B-'>CX_NSQU03]9-;*;8*G7[]&P]RU
M/\++,S!']TF:T@Y+NG;U*$;1[<X?6ZHOE32^,>VFP(LO#WA%NF;^WWO'LZ(<
MSQ9[AK.!YP6O63LR,^A,\$3F!MWQ8T$MC5-I/J+BDK21-;K">?Y&^Q9OM6\&
M(T/Q`MN'EAM:BJW[3J`V0!QHF6P3`GGVI<\`"&2225#,X(<50?WCF[RC5+&4
M?(SH5Q%_XQ0O"2%A4[=Q8\$G?S0(EW40KLH@3%/[N#D](H[RXC,1]93H(!ZJ
MJ?/J[UYK!%N&XAQ%A")_DR<IRG.(U_,DK29Y3J!;MJJZ@>7ZJN]:!$X[&-!\
M=%:T1?K3O5X*`IZ>7QQ843C2_:,XR<!3O-H@JK%4:N,\1V2>'J=+0#+Z.4GK
MBP21[Q<D,\K0LOP%^4QRGY)O*HWFU64YH6+4YM&CQ*G/^]7W##20JR7A!C38
M03VT0G=A]IA*2XW45)1:KI.OU7H`2CO/S0.TA1$D>364$/OYH:'D[]6D;>;J
MKJ[[GFV%FA[:ON-$@=7@"WT/SMXLN'+/3Z5A8Q*.4TO1)T5D%W)=S]M7SNM9
M')`7P&Y%A7&#)E;M&U\JM7_AS9$<'=0>C5RGZ!H(COJ&]%A/9+P8WN\3]92!
MB&=;IWUIL9&UI![?EC547#R@;&:X9NAXID)@6$$$7<7WFW5B/]!4G27U%VY4
M<K9_F\5IOJI6>^+E/S=Y4;YG2%/Z$A_/DIQ0KAE63L>BN9>`)ZV`-T#!#PW4
M'T?FG&.Y<RSNNRUKBHP!VRHF!S^'5BME4#R%54DI?F');;/W*J,)R9CFV29T
MH>*JKAMZ1F/'5R.E7F5L7J'LL%QVP@#_&N/^USE/K3`B.G*<7EN<WFH8(W\3
MS?K8\9]<#>,B@KE'T&HP7>\G/1*E"V+N#F?K4L6].=X45TF1W)???H@+FL>T
M[P'H@:M`2W<MQ75U8C_R#=LV'#?00M>Q3)MQ*BC-OKS,@4(&.YAIA:]%#6(*
M&VQQ@QKX>"^I=J7X2#>5'K6)=&?Y?N*!NT,O>4A0?DN7C&:^XIM^%%D&A(:F
MNK8/3;^QYH:FQK,:T]&$Y`G8JTY.%U;^+(&QO@W9E\$N\BF%O%[BR,3;`*K7
M,,.L:=Q43E*Q^+TXJD<=26%6FQLR?T1T&ODKPO=9_/B0+.*5]RW)9[JKA79@
M*9;CZ#!03"\(M,:@ZBL>C^!TMR)9<W;QD'2!(.(5FQX$LNG-,-SQ20X7;5*T
MYB`K1^2F/Y,341P!CF#1C8Q7=]#]:W,!7L=).C-LJ$?$6D1,V%`-;44):X,>
M_0&7[G2V,JCN5)BXE:<[A8S*,PA[?93G)'%RM.<0+\>TIS>74]&>_HZ\UAY!
MU)S4G@7>I$7V/+N\G6E::.B!JOHN$;-(42-#,YHG*[;-M,#%\3C):G)9Q*MG
M1O7@(>&X3$CRGT\/+F^]J__MU/]SM'A_CY\N:C=H]]>;;VC/UW=Z_M;5/5V\
M`P\C]^4NB''GH/>M?UPE*;HDV4D^<U4M,'7#4`/3,D(S4'W=:BP:D<6ZP::'
MA6%G\107*(&-/I5O*>*9SO/S.I%!3H0GIZ;U7<EAW96?K.<;,I+0H?4J62=%
MF>(O+]//I`VNRM=09C!PU=`UPL#3(R^"OAXJ3073"R/(_IJ'$&N2!\D7&,&*
M@@1YB1(D*2@>$,A:K'S;KT4PS?"2Q^`D\PG82WY+?*`"""Y3\'E$;KGVK@_,
M<=?-Z>QM6<`V]-.<''IS0RB?4WAE0ZQ#6%;3ZUH%OKZ+DC0FXU.\^H3SI%H%
MJ]>['"N$(?2AXANFKNNN[_I10*`8OA,I(61=?A9B2YZ,M?#HNQLM0-`@'&]-
MF84WEN*G"-HGDJ:)]>E0250<8<S]\1-I-RC+T++<@/\ISJZS2@Q^I[O1/J'L
MYB'.T,RW+-N%NJ:JGFT%:JBIKM)8MZ#N\^V2%F24IVMVVAK=XB1#'@%Z!A[C
M>IL>9P%5%,MLNC<"O7S*M^7UIN*58"1]N$GB2IB`X`0ET('5CXV](_HGF/Z)
M**!HK[#4-LNI@A"OUS@];EHQ(\_7=,_2P\@.H!)%KMN8]M4@XI-`$1:EZU\%
MLJ_X"2&73?F&9I5/]FHZ)ZAY#+P=$3R1K$]$[82ZA.4U4DZ=^Q7CY==DM?)2
M,MDK2-M,YBODE4<-!$F^6.%\DZ$VY32(N!)5M2/?(O/TR#`BW:A`N'I@A0IC
MIQ1K5.*";XVSW(BU10HJJ&"+=;R9&1>51WJLG)!,I.]*<@X/T:IE].=;]*WP
M"4%?9JH=F*YB:+JMZ@0$]#W%;U#H@:GSI3""C4O/9MYV:=K1&R\XDQK1S`N4
M4CF42]-2"A>4>">IIBV;?>64/RS?DYYV\*Z+H'8ED5E1K[/[.$W^72Z20)SF
M>)4LJRT:Z9+,4?-F`66G5->6[[8;-GPE]%T8^H&CJZKF$%R*58&#2J@9K-.9
M8<#(4X%=_&?@A0>E,.SZ\+((OG5CO&1+"/M'5&/8Z$Y$3`9V&H_9H3BEQULN
MRY)_O&J-[VP1VZ>!MFOI)C&HZ+:BNKIFF=!H@&BFZ?+E<^+M2T_IKNE^\AUA
M0<M]&@("5,0);X8G(1QLJC]N'/@4?HMUA_C=';/3R/2X*3TBV_+",Q&)EN@@
M'JJE<TKOGO/VMG)OAV2V'OF1XD!5U5TUM&D-#GJZJYF!:@6,W;J7#7D]>-^1
ME2,F7<=8.M(IA9`[D?XGQA<LH?7QONNS>$#+S0I=WS76/7I\;?5B0^X_[WQ7
M[3Q55)):Z:KGP="$M@\C,X0U#BOT@HAK0Y9HXY)?&FWPTGE0VR=W(9^!^?/N
M#SIN61<?%,:7L<:,!^>+6>)#(><]+4Y*C[VS)2LZ$]%4>?Z]?I=++I'<&<V.
MO7*3+;%C:`[4(MN"BJV'Q*16F[--10MX)+:K#<E*NJ_+=MMQWYE$OHQ0)G\=
MDT$>ZJ3F@:^X84@!N[(Y$:7J[<:!Q*\?+;UTI[JS`#5;;:'AVH'K&)%J035R
M=`C]QK#GZ5Q)7G]K(VC1&6@P=MV/+X#D[@HEC]_^6L5%[6"Z]8(Q3@7KQO:$
MM:RC0PRJUH<JMJV.$*=/**.[*M&GASA;QPNT*>@I`OD'M)ZC;!9&EFOXEN7Z
M?F0[060;@=(8#2(#,F]S[&U)LJ[MX`.O`/+LNNM/Z'$=&YY+/@T[0B/XLT+'
M=4%O?SXY=C`.RFNWW8O]^&7;M'B*ACV"+Y:^*6Q6%.<,EM'"N#=%X>5F45QG
M-RA[2A:H3)@#UW(\QX*^!>T@-%0_<KS&EL9X4T$O`Y(EO<94O157X\J[S9N[
M\<>6DDJGCD_!N[$F:>/26V:.9)N]B)Q(@MG/AS=;D'H3PJLPN9<NFT93YZT!
M5'7#-)7`-33H.::N6JVD>;IA=9"9#E;&T9INL^$>7'))CF0:A>C..)/>@P2=
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M=8_1Q+<2S<_N1.;G8GPYO?[<E2#VFF'\7.Y#N\7U4G<#`N6_9CC/9ZKC:FH8
M&8JKA);N>K;:+GD[AJDPI:7"C,F>R\?Y`WC$6;-UE#2&/"$MJ1PT>`N(O8EE
MK",.R2EG.;&&1F^QK\&!+;HS4.(;NJIX@JYCQ4513$]$P\3Y\[K4*)8HMOGU
M)UP0FTF\BC;%)D,?DA7*"YRB!@P]("DI[T2_Q;</2;;\%&?%L_?XF.%OR3HN
MT.IY%D%(7UZT;"=T70\Z9N@&#2X[TDSF*?@08&2OIC0N@+O2![!NG"!SH<H+
MGKGE(.%AF,]/+3*<BMH&I8(/6OR@%=NM!^`6@]('4#H!7G@QN>!QU`ZF%L1N
MY06&'D8RD#:89!`MRF`^EL&,=[WI?4BZ`$8/%2J&#-84:AF#^HM'ZA6<LXPH
M3K+R+,(/**9[KRF(/Y+BX;<4SW.4/=%-2Y?IXZ;(/R/*<;)*RKY$OMMD69+>
M^W&>Y%=)/">_*9X_D1[U$)-T8J:8H6(KJF%#4]=51==TKYT5&3[T>68GHX&4
M_UIM=6U+T6M",UX,V29"WT7X^(9[ZE)UB.L9V/$*?"5N@5V_0.48>.G9&6A]
M`Z5S9Z!U[PRT#@X\`Y,5IR,SM]&;QD1F?./S@"?69_L?Z;%55[@KKEZ6D9Y<
MG?$$'^B7EZFWIK?/7=\=^)/6#746A(&FPS"*#$L)74N-'-]LX&N6Z799)!@;
ML^11[C)=9*01H>8&H?)0<5K$(W\`2")49CA+.@**&`RG0FKW8V(FWP8ZKI'L
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M5H-2M;J]P3@0-,FB]QFMR_=,[\$"Y^6*'<'WN$(%`MS;A,8*GLR"PB!Q&[!N
M4/I#BP6-1V=-M9YZ]5V4!PZ%1'@5H'?L)S(FC.6]D#F]H"#T&7EH(?\^3?Z-
MEI=+NEQ]E\3ME2SUZV)++UTV984$Y>1WFS6]2'R)[HBZ%N@J>4)OKG.9N2YT
M'"W2(C?4/$53_`BVF[9,VW%Z#DNCX99>5#A_S/""2B"]JX*$]J'<_KU$3VB%
M'\OU1OH]+F]%2+:W+L4E_/ZCV7@-HO-0]UVT!1'CX-91L.MI<^-6XVO90':\
M!;6[9V#K\'GI\=MKN\8?)65%DV\(';U-37=\'9^:TX/O^!CY1N8K=!^O/L0%
M'3$(KC9W6!!DVYLQ%%U5`]MU;=OW=",*@PC6-V,KIF$KG-=3B[')HX&=[O^Y
M(N&Y[[(H+(A3MF%I>#+Y!I02'Z@!E@/$"XAC7MS#1-T1]19+_41T5[!36&9K
MY;T#;;'8K#<K^OY'>;<7D>W'##T@,DEZ0I<IG0I=X3S_B(KKN]OX6WN#B1:X
MY1E=H>UYCA)"TS#-((1:&"C04SS6DYYDF9?7=W<0@^8VM!W,H`(-?J"P?SP#
M!#DM@A#LXUWQTY'D([U<=M@FTN^EN_GZ>JY!:.UPG1`CL/*"C:UDA;X10,.-
MZ.E9AF=HD:<8%2Q5CQR5:WNL;"R2*PF[-]S$.PI250X6+Q0DJ15D116D\V5#
MDD+&)NM3BA:?O.\&BDOJZRN)P'BI6T_2C\C]4.&<B.P/YN[!JXR&H)EY&"#3
M]U6<YV3:7IT0<[TIF!"^0N>Z3ACJGADXOA=Y:F2X9HL.AB[7=J2!($E?$GWI
M!<";@GV`X!P9AHHBVP`QP0#RC1.'8L<X9HP^6(@)P)$Q8^`(3V3H&-IK/&JW
MXAQ(]AC^B(L=NY;C14KD6J%CNKX)-27R?&K7=8-(BRRFVUR$&9,L_ES)):?6
M]R>:3<4'Y9A/GX]EZA3CF#764[0=455AC$]$+\7Y@R4US<XUD_!?FZ1X_H"*
M!_IR]1/*B^K@G_(2TC"P0DVW7<]4-=^Q5#7TPZJ:&]B&;7(IG2"3`U9`*IR@
M`@IVD/:^8KD?Z;S%C<'X[E[#Z$&UY"+%,?*8:A%"V)^(#HKVZF!E02!IPC3Q
M[4\1^ABOJ_M@/!4ZT`A#:"F&I2FF:VI:@XE>RB!2*7L!D:R?^SHR0F>`XNMV
M:93<L(C1TL$BPJ>P6X",`1A%2X^1UT-AA<3D.]%=,;YRJK%`@IDU^I#-^AZ<
M$!JJ8H=*I'B1Z9-D&4*UMNJXD.T"!D&F1M79;A=F]26734L'Y+6O6HYS:]9Q
M@HXHHB!F)Z)YHKS!4IH?S[FV-_$ZWZ3W?H+S9)VLXLR[SU"YFZ.^Q,`-0M\R
M=<O1#5?7%:B:NMX8-=308#ZTMK<EV;/K"A_8`@0MPD[WG?2G]KAH#<\JYQQZ
M>H1R'`([*+'=3GAM")XG^+QA.&Y0]CZS]10!>\1>+'%3.&U5G#-81ML275F]
M:N^#L`QHV9ZIF(ZJF1KT=9(H-PA\W^9ZU4"@V6E46*\Z7S,C,@*"2JURR)=2
M;F7B?9R::\MBG[HK?R@FD@_+\(RW_MJ5/+8\><>0_[P]WOHR_1^<I,7OY.>;
M#'GY)[35\IFFV+IF^*9NAJH5.)[AD_^:?-TT5;;M3=+,\W3G3CN=Z#:,+)EO
MRI=[:*,!3<92X&8#\!E8Q^GF+EZ41]33?3SK./N""IK4-#G-XT.<K>,%(@]:
MQ"NN>R&DA(TA+1\[7EVK"SGPGU]<ZG"9@A(RJ#$#+Z>'FVTS^2-YYD#AX$CJ
MQPY+MSQ_-SSSYQ?7-"0I^&<9GJ<Z/'$.'M'.-*#O+*`#8X<F!C+)G\)<0:I_
M>*!6S#,F[IJ[_IJB[.8A^7_VKFW);1S)_@H>W1%V!'@#B7T#0+#7&[Z-[>G=
MB7Y0T!*KBC,262-2;OOOER!%2G41"P`!BM[8B8F)*;>[\N1)XF0B<;MOK*[%
M%WZ;G6-;P=")8XJ\!/&0PC@),0UZ^U$<1`JYT*19ZSGPCW3?W6G08,Z:OU<#
M<7Q;7)#_[T.ZS842?&_*WKWX4?R#[N>\N"F;E-?=DE`*'ZO&1S&RCTZJB*[1
M,$GDOFO%1RWG/<QJ+4X@@((3TD>Y4"G3&25=(<-=BWR]S/9?#W)7^Z&#1U_Z
MHXPWN:VE0-"E1&:#XR4D,"M^E98_SLF+M&T>7;E)2+S(ARRBV$$))20*>W.,
MN4CM*@I=*U>8DM&\O,V*669DDV.@NXAKGGRU7'.QI77UU=L6A=*RK1J7"^E/
M37;CQ85:'5HFBM;'OBX\*>C*P8Y'L>^2!!&*`^PY\:":@4<\$S*F8]>ZL)U5
M;>4-J.KT7^T]]EVQ#79YD>\..R,ZI47[%.6RS;<9+7L-!IQG)?0B!.X9`I4E
M;TH0%BV"DQR3DL7IU.D_-W])J&/BN#Z.Q8W)#F5.DB1^TMMOY@OQI&?G=8U:
M7MPDFTTNZKYTVSY3-92!NW23B?KO;+]&=I^K%G7FJ)?3RJNPKB:5SSU0OY12
M4):^$:$T'H&%Z*1YOUYZP-X,<7)-6VF-?I_^$#73*@I=@J'+`I_S!%'B^I`,
MJZE>&"IT;HW;OG99V<%4Z0N:IU^B(WM5WLV4E\]6E^#]$@*@T)V]:B#T6K3'
M@.RZ@.2G@#RW+-&/B,E=6E6B+K5JK1&^A'ZM/>?*.;Y9Q=K^=&=3TM!P*66&
M'F:)&Z#`C2.&PPCS9-C[`]TX5"GLS5BT7-6?W:$N;KM3K-H-D2I7LL_/I^HV
MF/,K+MKN^%+*=2GJ1FIUL]0OI%`W[%1I\VM5OC"N>RN#%)OX]%(&_W&?%57&
M?ZRWATU>W/8WO[\M/G5O;+"RJL6K@X'O0XR1E\0.Q\TD8C@FY/&(J-T29P^'
M=6%\_KD1Y4O?+$9"3C>7$@0U-7W`_QEN<`0.7@W03R]]-'.K(WH@X,_]6NH$
MID?$=X[X+4229W'UR8UM<]$KUV$Y]5G?Y]LF491%=NSXK!P/APE#D'LLY)Q"
MSMUA%UX2Q8[T8<H)-N;K,N]Z:."^PZ8R3Y_"HD1+9"8"U23SC+L!%?@T+W<*
MW8R9.-3K6XQ]AY/;$Y<]O]2(,,#5$EH.)MPHS7Y"TYO?E<@5ZSK;-)GA)J^_
MW*7[;!7Z-$`L(1[Q,/==!MUPR`S<C;"T5!NT:5FZ>TC@OL4$*@$*_)77=YIK
M@\8YU^YU6Z?;3)>[>@V&('1(00OU6GQ/;FU;YWU24]L`_U/:V<^1H];(GD3O
M$O*)#;=>;EX;H$VZD]->3/PE;9+;YV9R4ARR#UF]XM2!2<)\["<0H0#&7M+?
M0!41B+A*BT;+@/7>2XL$[+/N=N:Z!'6VOBO$;N$G3[^V_Z3<EK<_0;U/B^I&
M'`+(]M_S9I:FV*S1(UNN"V.=9[44TEUX?832/I(U<Z_D.3Y&FB"3Z%M(=V.:
M#Z7![TEU`W&Z+_+B5AP);,5N>/8JY#0)"?980'P2AL)JW-G#D,1$]I()[=]O
ML<0Z0FI/*[>@KO=ZW"5ZQG:A3F5T(4-FNA^/]YB:(4;GSIQ'EFE:Y6O1=,RW
MAR;)/7Y)B*#$";W8@4[H1*[+7`H'.)'CJNW$MX7"^@:J%EZW!-,!!%D_,._;
MPW[RLQOK$9'3NB6$0DT*']RN\T067X-3C([(K_^VCB;)(X)J.VP+T5OK;EZ^
MEL<BK=)J'>?5>EM6XGSIC7B_(BNJX_OI[41$K/E4+;IO:=5,_XX;<4^O@"+8
M_)<$/DTX@Y%/(":A#QFE/L;4D[V2VS(*>TIQ`BZTXAPZ.&)OEV6KUYUTO&GQ
M@V&?^]4*K&F$CZC&3)%<B'C,Y6UYE>&BM%"PN]^6/S.Q(K'^UWTS6NX:T_?-
M6#EN<&WKEFK5Z);C0,AB3`CC?N`@QP]]SR=!\W_C1.I.;Y/V;"\0'%&"%B;H
M<0(!M-_ZVY5T:BL$ALB661V8GV?%:>NR*599$)B?:LW%`!.42ZX#2'%R<0W`
M+*.+Z/\;=JFT]P&J]@V$U;=5=<@V\6'?%,9-79R7FS:/53VT]B]].D+[U$"K
M5BBF;NBQ$'$8$\?W(Q;WV8R'-$9*%^]:PF`YS73X0-X"!X>B^0`!__+IDVJ?
MP%8$)/L$"R!?L4_0ZE\'&72800?Z6.^+Y=%>++N_W$,'+?:YFP1Z#(\U"2S'
M;"%UOG4W'S<)9J%56IJ3--__D6X/V6GB<9I-D-!%4>PY,6H20>C3*'"CKC$!
M$XJ1[$LRDVS8&^("%FAQ@3-@UYNXC]$T,DZ-L+N0P6C&E]+"YV=@6)T:?J&#
MH<-Q$D0<8Q0$T`WX8-2/)2\`-6/+^JK'V3![GZ4"W0N'QFP0JB]4=I@THU37
M6Y,894I1K-097K!::3@C(5>Z%$GK%2NWS8_EOKURE^SWS=?7#M,3AA.$@/D^
MC&+DHR3A4>(S#_6;PTB,D:)ZF;1L7<L>@&U7"?NM1]NVSR(.@:LJFU'JY73N
M6IRKJ=Y#LL]@GHG@-350@<411;01BX7HHQ772ON?LO)E#,->VCC[5I-BT^VT
M_9*MFPE>G9]5FYARA..`L!#[W`MY6VIRZI$@I`GV`^G+`XQ9M#=\'^PD%S!;
MO3SN-C\AO=Y\2Y[%D>%K(10+&;TV/'MRK8`E\J3'+OF>YENQ&R,IV_VG)\L"
MT/NT?HS#2:!+28Q(&#?_QP\BYK`CCM@+J>+=V,;-6Z^`OAQVNW3_L]L24;2@
M#N*(Y@#U/\#@U)N;<O]&N'4VW!6+(_/QD5/8JP9&36<?TET]I/NHO"?`UY-;
M54I'1-=:=!8BO?;\*V?ZS"W)\'_G]5U>?"RR?V3I?I@HKZ"#?18D.`DAA0'Q
M(7:C`15FOAU1U@1C7:+C0WLOHSCC_;-!)A[4V695(P5-KLUW[<:U&]%0^B[@
M6M)CW4"95><9(F13J\5)IF9R^_6O;-M,@-\WZ?:N^;-3,W"A`OX\ZP;D?&(X
M?S%QG^JMIM0;(=FN\)-=N:_%+7_MM34(>3P@H1=#Q#&E000CV".+$6<SB+\:
MH.LE@+3'"=8-T#FD7S%4%N7?7HSF3P&#+^T.]/;,RMS[3:;'P'1"T`OPKYP4
M-#TVD1BFD&V^.7-39_L&V->[?7FXO4OR[RW&ZBQ[$48=#BEU$7<B&/*DF<3T
MV<OU+4T0IN.:)56D`N8I6]0=6G`C5EW$GXB=;L/,0:;ZO'8P#;=X9HVBW60B
M@#?)I`1'9X#PYA>84KP8`Q/-(F-Q_L5RBD''==M+AJF?+<,\3(,X2CR.>!!X
M(2<,.C#VAN:8`T/%C1'S8EM*IGE8VLZ<8Q3#.4^>L1?'J^2:7VCN(A41BYE'
M+_+_1[*/IO.&,]"4$$C>D*R"\)G,&'*,G1A[V//"(`R"Q(V2'A/&C"L\264;
MRHPYYCRE3%CVF"="XWED<:'13!N@@0X>[09XLCK=XF\S19L_*O7YYCPA4[D9
M>D&ATSL4_/4NKT!>9SNPS^Z;O]>]XWB7G8TGL1]D(V)9G94$?]WEXLF#?0:R
M_B+1N@2[M'M,_=$X[=Z8$;_U6]I87V>@NLNR&FR:D=ON'#O]MB:S9;?EOBTB
MBBQO=^"F%;C+MILW=?EFUU'Z$Q3-!U?OT_95A1.NZ1=>3POH,P7#K-_)$HXZ
MS^9K>86!:#_[/ZQ*F@_4(Y!Z,0S<V`V:6+"PQX5\'UNO`-3@7*D*T%K[FB]&
MUFH`>\&9M0[0Z@O,%S[K]8"],!JL"9Y4`&G=CK;739JN18F0;OYY.&[X[9[:
MOFF^A72]WF?"^#!(T^ZG4F3V-_5=6KQI#-V7>['Q--_=-XI\W%8NZH*[;'/;
M9/C7(&]^?_'S_\N.R]^-V=)#[Y/\=<L/37^GER!3B#;0"E\ER/5@C(F#`N)'
M",'(I[W%(*+^JB[K=#NUJ_VB&151.R&25S3QKX#T:9?S7-`L+'^^3._4/K-1
M9@TVC1?3]M7JX4JSNOB&K+PGTMU517*T54K(YMEIH7.A;%<65LSQ&4<P]GP/
M,3]P"<)>CX/!.)ZB79.-+T'1C"ZX30^'GM;-&HG)"MA.=KY<C,$BUL1>8E1!
M,HT%9Z%":LZ_%^35,)$*U_<U,Q\QXVKOK5XU$Q-"L<=(A*`;^B$FL1MSYF$<
M4#?RE1[L4?S52H*I<=E>C^9XZ?O($3DC1,F)G46.U*1,@1Y+=]R=$S&B0)J,
M+41?=-$_N6AN`@GJVM"=W!975I=%>R7UCT:0,,<QHD["/00=G""2)'0P"AT]
MJ="R9%DYCM<:G$"!/P4L;0'18U-13ZP3J28OZAS:59GGZ)$1G4FT+DV#ICES
M29(,4"3_WM=#6W&Y2_-B19&3.!X+0M[,1YV8-/^!O3$J3J(J*).>A9D5"?S9
MX5*5)$WZY*3(/G/3)$B"-#N/I#W'RXCV3.-Q(9HST8G';Z,9H$2^+;5>'W:'
M]H6.#UG]]V*?I5LQ-3M=</-[8_U=657OL]VW;+]RF.,R%R+N!8%/89RPQ.EQ
M.)"Z*O)CW+AE93K#*Y[J!"?$9Z\/`X$9O!*H?U-M2AD/AF13ZIIQ4&Q*/0K!
M\[P#4M?[_-NA;I?MZQ)\2O>M*';X9[]`1I'?L1:5K5`M1$KM^?>X16672$T!
M[FTF#3%Q5N6WA?@''_=_.S3H;G[FQ2U+J[MD6_[UG]GF-NNQ\2"*G2@.&8NC
M!+F,Q,0?L"4>U1=E2X!F%NIS:6BW39Q<$7<,G)P!PAL@W`&=/Y,4W%8T=51]
M`8&<IO1/8O@X5(L6?3WZI1.!Y>@N,CG8]GDT8<Q"N'02^9RMMVE5Y3?YNMV!
M]O%0?[PY`]S>]2QF%/OL+BNJ_'OVMEB7NZSM7HA[#D@<(,JB.`F3,.`1Z3'Y
M`5=J=5H%8CEI/,8.RD.[]>]<B+I+LQ\X`#H/]-JF=@,GER<6$S.U_&`Y7%9R
MPA2J1W+!+!%<2`Z8Q]?R"D-D)LT_]I.PRYP0DR`A-,*8$`R3L$<5$5_JT=.9
MH"Q<]_6ZT[;#9U?[+41N7O6_3G=\&MT6,H!B''_Q'*#JK:$LH$6R]3QPG)'X
MR&<TB,*$$.XAS_4H8D-V"N-9\H`DE$7G@9GD7S9J=N7?0L#FE?_KM(2FT6U!
M_A7C^(O+OZJWAN1?BV1M^2?#0459?._R(GM;9[MJ15@`*4QBGSD>\;TX8,YI
MIYT;.5-R@4U<<R>&DR^JNB-\`JU34^<+5N.LESV6$N*)J<1R=&?)+!-"H9!F
MY@CX0G/.+*Z_D(#FHU\Z&WTHB_(^$V_:%;>=2?[COD&0K0)&6,@X9"Y&,&&^
M&R11;]#S`Z4E:GTKEC-%)PYY)P>OL@[4;^TE`HIR/X%(.?&>AT,U*3['U(OJ
MJR.LD;U45A3U(C\C^CB=TX6HG0%'2M.?F_+;EL+(U_3'T0[-BNPFKU?<C;S(
MPVX0$(_[*'1]'/?F`DZ5MD_KVK"L0L>14Z<_P+<.T4F+%&5(FT4Y$9J#0#4)
M.G+70`)'3.#5$=7<"G2!G!']F4KG0M1GLAM/'NLT08O\P;)TFU6?L^]9<<A^
M+\M-]2&K5R'%(>2<H`!RA&'`8C0L`CI!$J^*[%94;E\5CI7IV)$:.;@;.4\@
M28^B3_MR<UC7.H6/'GMR<F./,;U3J0(...)Y#5I$XMF<$<KLG!M[AI81E9G$
MXD(D9IH/CP^'32=$?H*5U<>I7%E5JX3PQ$/$9]3'43.)(VX(3[43(DJ3*J7?
M;+F$$1L^C].H]-&N3IJ7MUDAI@<C%Y.9X$YR'F6--L6Y4WL8HILRC9V!F'L:
M=4[/V-1)B\:%J(DF^,=3I`D4R!<GZ[ML<]AF'V^2O,CK[%W^79QYJ)M/*6^^
M$U)565UUY^Y=KY&OQBKW'!PQ+Z(A13''W'$"0@(>*1V!-V?6LO+T2$7?M\/Z
MI@4+3FA!!U?WJ@V#$9`L>ZY#OF(Q9)!W.U62-(MCM9/Y4"Q$`VUX]KC.LD6>
MW(W77W]6Z;=]?IS;'%=U71J)O3LA2PB,$C=Q_<CI#04DDMH^H__;+6OAUW]\
M(?3S6W#?@5*YNUB/K'$]FX<G-=EZ1)'$SA)37"E<W&R=,\V;F)6YD[MO^#EW
MG]'DZ=0LX4;@:0Z4IKX2Y>[\)KNY+.+TY_OTG^6>B>7.=@^]AV@<1D$D+E:)
M8QC0V,,]C`A"I5V*IFU;[^;W<-]L+Q1$WWZ"%C-H0>N=1#(>$=D5@.L%0W5E
MX,4X7.5,D2*#H\L'=F*QD`K5FGM/EAMLTFA*8D\@/J3#%G7$610&@8<(=$/L
MQ<QW![6'3'5QU+S]JTOMZP="*Y#KGO^Q$AXCFFL],J9U5RLHU]#BYYC5U^-)
M<?HU-'F:BVJZ;(!.!6UNJNQU5E6?LRIK_JT[4FSB['NV+>_%-*J_<28*(T0=
M+Z`AXX2BH/EIJ+UY3-5>939C4V6<:[V!];9X<]_A!/LCT/8UF\T)JK+2&B%;
M5EOG9EE53<$1(/A\3N\9QFN=CI&B;E0N35*_&($TZM03231/F;0(?MVGFVR7
M[O]5-5;;'X3P#C>E8(@@0I0@Z$(2!+Y'86_48<Q7$[]IMJR+W@E>.QC%&UP9
M*`1"1:V;R*F<QLU'IF(O]B&+[8]M.5A=2])&F1J1,C,,+T3"##E3VO@(%25K
M9-WIR;0^0I'C>1$DO#'.'!Y0/BQ!.;X3J\RE3=JU/(=^8>W61*O2:!3D).]:
M`5`30+/<6U%$!2)']-%&.!:BEE9<*^U_S>:4]-F)>`*#`'**<!Q&S(,X@;[?
MP_"QCPVIJ9;MJRJJN8ZD\9!,EE;KT3`IK\OI0BHRJJ>SDV*S?*V=YIZ\WAJ@
M46[WTL=#_2Y?B^,OFT]I+9XN.9;*+(EI%/$$-K-ZZ$2!$[&AQ8G<0&J;YS0+
MEO6SP?5F>P0&[CMD*MMS])D;%\#Y2%.3N082Z#&!(RBM?4WZQ"GL;9J%0+W]
M3<]]>),?4[_D[Z4-3I/Y6<(FI^E.E"8_&<5:]]A1%2?IUG=%N2UO?W[.;^\&
MLS`).6=QZ&,W#'V/0P9[LS3&$5.I;:?:LJS%`SQ0#_@4R]3);,J5I7,2J:;/
M)PY/T$"'[5I]SA?(&JDP3=&\D(K2F#NEG:]1I6)\6SRODM2-8>+$+H8NQ(PA
MQX?]<A"E$"/I@E'7@&6-(NM_'_)],[S$(D)>G%+XOAMCXH\URDAM.B6JR#F8
M5%YG-E)#:K.F4$+.P9Y>!?FV,%]`7O#V4OTXE9PEE(^3?2@-?BTJ$DS^^/B!
M_T]O(.*8!$Y,/3<./(^AY@]Z`[PQ+*V[2K_5MMBV6%0408T3"?&T1H>:8G8P
MM$12C1(%9;1&C9X<OO2QR`G@N5.75$_+\25(G1[P<FK,52^M;:+:/8Y!71QS
M%B),/-=C7L"1N/VK,]`8"Y6NG)7^K99%K06B^2"0/#-R\U@[I*A)FQP?=BY&
M[=T?F8.J4[20V:8&\,=7BFJZKC;2CV*"@I!$%/,0!\3W*,=1,(@)BKC4Q%'G
M]\XSVC6?@5'A1V'$6Z!&:\Q?Z9V5$P4OC7M%HI8T\E6A/S?VM=R7'OWO\R+?
M'79],<'<,(P\0A(28''$C?E#DXJ1D*EMZ57[W2H?NM86WB,<Q>&O2)"<`-AC
M1DT"CCBNU91^0,.(#.C1M1`AT`1?FOAB5,4@_7%F!/LP@I@@ST<H";P0(1;V
M1HA+'44Q4/K=]L6@@Z,J!FH$28J!-684Q:##<34Q.*=A3`RTZ%J*&.B!?RP&
M$R@PL?_SW?!(`8R0[T(2NZY+"$.4)7RP[81<J3E@Q*#EF<1+]YZ]TWX]Q@S=
M<HHS.]-J0F2$Y+GW;;Z3>)W%*.\+432S/LEOR]0E3.$$^$.#'[*:_UAO#YN\
MN!5W"/^5;[?D6U7OTW7=:#`+**<A"OQFGD8=Q)W^-!.-<!"I'@0W:-IZ*74V
M0M,6KO+I;Y-$RRG@U1A64\)GMK"+6X1?#5A!#_8W\&>/=_Y3X?)<CHBCE9`L
M1"3M^/;DJ+@U`@T4C7^OLIO#]EU^DZU@0FD4X=B)',K]YG]B--A.D@"IB:41
MD]9%DE=UOFN?I]LV>%Z#5WD!?F;IOE)][\4,PU/K1$O4&JP37X,.(Q`@%U,F
MGGC3*A,U:%^(`IKU2;I,U"9,=@/FZ(5%9]9]XB#'#9+0IRAT'1SP.!ZV?R9R
M.\@-F[0\53X!!=VM8/GC.A$<NA&Z'1VA5ED?U\$K$JY:)PY<7YHU2ZFA5:Z5
M]GM>@W/=':`JW[F!S:&2U%S:.&6>VR7LJK+@56GU@S37C?U]+UXCB9`7N(Q"
MEX08^PYAKN\.71#B*][&--F<]8*:E97J-7/3.9S<7C5/GLG6ZFO0XEM,M=S1
MI==056-Z\56RJC_RC50=HDQ=<?RD/[%JBG+H^V$,G3CQ78^*(U,]#M>+E!NI
MALW/(FOM^:711P9GXEJVE_J_W%UKD^,V=OTK_!:[JIV`X#O?\$PF9>]X/>U4
MI?Q!I5:SN[56B[VB-)[.KP]`D13[(34``B0FM;7E>=]SSR4.[L7%8T:23?/D
ML]VE]]96_;JC^`VA%Q=5'<7&$\%TYY_>U<1CB33N2C7J_=9ZF"2I,)003',4
M@I@5_:,@."RXYFL<5DPZ7FZXKO;+S=O:ZRJXOYS2.&79K!DU`<&CVU`-1C_$
M4H4\C;[32/:]$4:[7GW0:[)"FHUB&*U6A\?#1G9:T&.UVZ__][C<1%`>DRP'
M21Y#GA<`@`SUJ[\`Y-WKWJ/+8U,`2J/WY;/?>@(Y`!8,D=DKHHVY'UU6.R7=
M2:&M'XVI:^\SG)I5XV,#Y(FJNO10O6*W0Z8-M97/J(<AQA1!B)N3*01SF/0:
M#["\G4YF9J-U5<645HK9HU(>T_HE^5CJ1@NC;=;LBN!%0J?6.P'&3-MT./9?
MQ[2\4=<L?9*L;M1<\#B!I&`Q+819%D><@^[P+"G2K-!1*2L&'6O5FTV95\'6
M8$71!K-F1;!S4D>7P.=V8GJX_7+DMDMEWCV1-[L^&6RSU"1,7>H>GY;KG=RC
M\/GN-8ZC^#9;$!:(IE!6VX#(YS4R`$/8/5A)(,RU7K:P9=/U=J,>9E#=!=7;
MBUUUM<\6U8KR-P/+F@KX@N!W])`/GH"<6@/5V+LD@Y;Y]T4);;OU6@R=T#8F
M]?NT/;?EG7(<Q04D>4P!2$`,LI!3A@!C"8H@0*//Z)B;=MY6?MOGE#WF#F?P
MPW7Y;7]8*IXBF2`4QCGC-#&PDSOV6#T]Q7.62[UT<GQ(?!%3)[Y]G%[:(E!9
M5H>KBF]U?9%!$@(01PG`,0,DPE$!6JLLSE*@)Z0CC3F7SB$^F?DLN\N'W_2:
M-15S+,MJ&CDAO7JJ^)K7-RHYL0!>)NJ"Y%EBV!.1L^5-Y>0SU!2R3C"/:6IY
M.^B<G#+7G^7^1TH!%LEHD2<9+C)&L@1F'8`"$ZBG:?;LNI>W02-R?2KQ-@)<
M*1_X/O[.O@KN6Y\T5<YB"-0$;Q[N];2OPW@5="A?=H0'M?;/TV_(5F;P@BC:
MCX(G^NC`L<KU!VQQ>\U`QMFW)[F^]ELI[X\4K'^^X^MZM=S\3[G<+7)($0TI
MRJ,X3[#`1Y)40`MCG*:\R&R]K6L-C^/528EM)4?VW6%_V(F$<9C\E$?@5X$<
MC\$/N\8!61;6ZV_!8[7=/U@\)6XQA..W[<P1/<O[>(:!9%T@>R]D8GOT(Y".
M^-/M5J7><+N/[<!Z(OZ3NJRQ(<@-W8XFC+^5W_;7?Y6;K^4OC;8MD@(6,$OC
M!"+((I;1B/`650X4GRN:"(HOTT3J=#[0CY"+J<!I<*:8!:0#P=&#X.B"U_K_
MFF]KTF\<R.]2]<V]'27X(TEVI/5RUKG^JUJD),*R1HF3&"=QG#`*XA9,D1*<
M6#N=/@*#\Z46977/G*J[<DQ<B+J+8$RAY1*WT/+*:P5OR;4FW+K!^B[U6MO)
M43)M1JE+=1:?:[G($0,13?*$%1EC49K1$+=P,,QQX2X%5\?@2^Z=NU=GM9@X
MTV?KX9A.H25T_S5:HK2KTEHA^WYU6L_-\4IM0*M#K>9BQ"SB-$X9B&.8%SC+
M8<@`0RT:V3>-7*?22B#\R:4+YVJM%A578FT]')-IM43NO51+D%:56BM>WZU0
MZWDY6J<-2'4IT^+/+J(D%X#B.*)95`!6<(Y`BX;B&&&W&;42!$\2:@C<2[12
M1)Q)M.U@3"?1XN_X+]'BS]J5:)UX?;\2K>7E>(G6)U7M#N[!,9/3CMSCAMRC
M\`QU9Y$`QAG.`:4QA#"*`4E(BX!#$@.5<\`.S&I)L?YIX.9R+)UKGRV3>EE9
M9^;31$W?_?)Y@]/@;AT7E&O<MCT?]68W;EL*@=I]VUKDO#,-.638AWNW'7E6
M.?\\-:N`+\M-6=-UO:H.VWW]6RGL;FNTO46;3?774O!4RVV;=7\R)\0)S4'$
M8A01D*0)BA-(69@EE.:,*Z\'V#;K3A<;I$$/5>Z!:\`V!PU/<*^:LV[U?.?<
M-!F]D%BZBHTG&:4S]ZII/G'-`?[?R\VA41!A^N^'Y69]][S>WJ/5$9;$MZEJ
M(3;72Z$^BS@)BQ!QB!CD84%X'LNK;!H0E/%,Z3D7-Y8=%_4]V&9<G^`&'=[@
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M!$)`<DCE,WI1C..TZ&P"1#.]_4VC3#G?Q=0O>V@*VC@"U81L,N;T!*R%%=Q5
MNT`"ZY<<@S^.V*86KDL\71`L*_1Z(E1V?*D<?'\ZC612;9L51E$GH]M_'.J]
M[$S5K<&89%'$```HRE,2R]2/=@8I#A7?K!]OQ[DD#=`%`W@ZG<QQ1"KTBB=C
M4$^:SE"G($RV.=1H_D[&I5FO=\CI\H1O]#/*E]P^U\6U0I4/35L[CE2VOR*3
MENQ[_:+6+(WRA!&:AA"%&6)%0GEOEH<AU4LDQUIS+MPM-LU,<C2)&GWLB=@S
MZ5N_WZR>*Z7\@*V/>M(6>/8DL;3FSGL]9VLT6>\Q_[S>EI_VY6.]2`N&2!XE
MJ*`10RQAXL=]`9Y`K7.9]JU[U6N6L(,&MZN&LT98[#:=W43$9>-9*1BS=I][
M3BUTH/7CXXF^.G30L!-M2J5:B8^VR\USO:X_WZ%':5C\=WM+'L1W7G[:_KJK
M;@^K_6_EUW)[*+N5T'[?48P2E$0PI0E-8\;C'&#2X8D8X1HK`"YA.,\S._#R
M:KO]0W.LY]"\"7+5*,.J<2-8;Z^"78M=I^YU&B&%I05?0J,GSGU,/M\%1]S-
MCT0XCM"#3]N@!1^TZ`<-']TG']P'2F/]PI>`F2UOJ`ZFX*F-WJZ-7C>V1B^$
MC.#OW#K)%"'Q81EE$C^KB;]UJQL9\'(C?VD1A6F,0Q8E4$SB24$1X5T?D7$,
M^>*IW*VKVR_[Y6YO8S^#JEV=`?X:HO(8;\$$RV:4TW+5U)A!%#;W$\16]S(H
M$VYC,X,+EBWO9K@*6I!>[69H,1EO9]`EWKMJPXI36AL:S"A3;!P>=CLQ\PL!
M_KJN!8#ZNGI?C'^3KRF(LN>Z:A:@/FW;O]G<S5OD""<<@(RFB##&PYBS#EF>
M1HK+U1,"<M^*/(*1N4_KQ_$]"KGJL*^"NEFY%;G1JOUSSQ=OV)XM;BH-3>\"
MIMGY;"-P<B"XKLY7')T7\@\=U]]%?=+]&Y?O29\MBCHM5>^B:=A[?3O^Q+`[
M5XE\/#;'-VUM$'NVNSMIU'RH7R;VN)IMB&@M$9[:U\J8?A65P4XBJA<DRT6E
MA;,L2V&*(0(,]Y!8D9+%MKR7+[FHK!*Z1:*D'\51/X:@U=<V!EM@AMKP)#$V
M@J"W,N@X,"J+@QY$Q&Q]<!`*[8FY\:"9EKV*E\X:H3]Q,UPF',1/>PH>C+?Q
MJX6CF#R[8#A-?'R8<Z=RM9K^\]>997]=/C=XNCT83T^;=7F+[I?K;;W_".(P
M!8@P0R`E(@P1C0CBG--N(S"#:91JS+>387(^\W:>_-MJ5]ZN]Y;+YNEBIS`E
M^Q4TH\FY<Z'?A-8Z$;1>J$W7IN7S=-'4F+"]C*K9U-V/13$(VSV&;7B7;7B5
M9G.K=;0M>L_-YY.'SX>9?7JGJSE'S&2S?9^)+&#.LCS*:):SB.8TXCC''324
MIOE4<[TZ(D]F>L.*>ZJPN9[F+<=KQDG^5(K[&,>I)G@W\9QU>C^-T'DG]YY:
M)U.[?N"^^XG=P&5KT[HIW98W_Z0<<I2',"<)1E%$6!+R?OV`(-IN_F';#R9N
MNU;UM_YT``TW_OS785L&$3B^\OW_<CN**N7?U7849:>,MJ/H4:9^-'+U4-X>
M-N7GN\_[AW+WMVI;B6^XD85/VU7U6+87LS?WOEV7W_98$//G@J0Y8RE(2)S%
M+`(%YFE&8T9C)"2#HESSQ*0;$,ZWG31H1=HL(08_M`]5_'@5;,N][N%*1V%0
MV[SG`?]Z.7('6*KE,0A#S,&G-B(M[!_;ZRT#"3UHL$]^3M.(X0LZZSADG@BO
M:R]?'_:<@E0#:4:KU>X@"O[U\F:]6>_79?T*`4VC/(IQ3GB.\PP@!A/2(<`\
MU+P)R:)A]V>,C@B[5X*.>WHK&3UC!1[/MJ[J3DJSN=)V7`]P^J2L'[&HI*;6
M0N&=@MKS[*QJ6B9/62D[M6Y;'^?MDR1/<4*14.@B`3!#)"PZ^RR/M&X.MF94
M9_`:G(T_YD>;:GO_D_C;C\'F!%13(NW1K":0LS"L)X]]\MEUW;S21E4"+RBC
M]1AXHHOV_:H<?[R:FH@/]7I;UC6I'F_6VV9]@53;>GW;)+35]GJWW-9WI0!W
M&RY$FIH1%M)<?$CB/PF".*8LA&F6%1CDD<I;9TX,:VFCX6MGP9/XW8=E7<JU
M]4OGOR;@64T89Z-83QP[F,$`YU7P`FDP@#JQ..J0>$$@G<3"$Y%TXULUP<>L
M6VH?;NKRGP>AT^RK;*+T9Z%A4G`4L90R2@B*&4E1F,4Y`BD."YA]]%[AZ'_?
M86'70PJ.F&9\:.L,.Y<*MK&$>C+"QOOQNABS0XSQR!GD-:+,(W(_,"OR,.$T
MB1%K#::(AZE.K65NQ7%Q]684Z:XZF=-GICQNF!LM/3.N'YTC2$-]]$GU5'X,
M'/E`?TRI418@OESO9`>U>U-Z.UQ^^J5<RJO";C]O?RME(28O$MO>BJILU_T4
M+^OUL2);B!HL"@F!E#``<"20\:@IQ'"6P2C2ND%Q.E2.!4XZ$C2>7+7/P#<K
M[,-ECLZ=0*3SO4/-GQJZ%#0^&3[T-V&0U635S_CJR?`IM%T(FPU$5Y>".,\[
M@=;8OJ#ITT?4DSE@!L>KN0>3Z1R#G_L?_N=:U*>[U</SS^57$2GY`EC$8PA0
M&K$0I9@F(<:8=]89B4.C"62<R0EGAQZ=V3.$MCC6U._IZ#459QUFW:KO1:Y4
MI-4.V;[IIB6OSHFB3=+T%6^8&;S%T3[^140V'\8@%G++(2DRDB+:@LBCD`,C
MX;-B>4+]>YE##9*KP?`U>Y30<C`T%7+R.!AGL3I$NU5*%<Y4!-,J][[IIEWG
MSLFG`PKU5?33]NFPKQO5#MN'(T@6D22#0J\A@Y#&2/8S6I.(ADQOR]X82\[W
MZ/W]4.W+6WDD;74\98A6^_57474N=W^64BP;N$%H*HLF[&J*H&-:S7/#([">
MPKG>H;E`E(K.C:#7-U4;X\HY#1M-SRC%@IU)GA0HC&E:R/]E$<XQZTR*GUM0
M+%5+SA7KR_I^N[Y;KY;R>OQFB]?G&WD<I]G/=00<_'`<<O!'"[*E3+&Y;+G@
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MR7H"KVC3[`28DNZ;ZMEP26'5?QQ=XSJF_9:5[GU[D.8%(`4HBJS(DI`!GG:V
M8082PUITC$GG1>GY'FD/U48_5)OJ$6U0EQQ;D;T7F_CF+E0O,*?;`S4EWF/I
M,_=)I>,YCC"38K;9PT<VR[H^YIB8`I:&,,4)#Z$T><HQBX29;0W1MN(XO6O0
M!`V<T>6J+G_:1:I#ZO2T2X<UUP7I2U+4RE!#(GW3(G-'SI><HZ@Q/?KQSD[A
M9FOP<"6\6=\3ORTX6F_6S?G2(=HV14P+3%&<Q`E-2!3B),L0[%4R95I'UV8#
M.5E)&]P\!R_&\LA2=O)H:DJHSX$<H<`SE\>66561\+D"Z=L,,!L/E\^!S!48
MY?F'5+NG:K?<E[2\V7^1&-L3*TVJ'88$10E`$,6(AP!G&.#.*,Y#Q5=Z[=AR
M7N3W\();@2^H>X":D\!(2M64?#HN]>3X1*($%IR0S57"7R3J@L+:(=@3F;3D
M3.7B&]04K-^_7.\:47U&V]O_J,1(W\I5@M8HYSQ+>%KDM*"DH`FB(>B,AC#F
M>H(USI9SP3HA,A>KD72JB=5T/.J)U>]?@@Y8<TQX0.A,:G61J0MJ98=A3]3*
MDC.5BX]04ZV:-`XO5W^6MV\%,H4D+9(<<)IP2E*>TLYDP8'NZ8DQEIPKU2_5
M;G^_O"]/-QL'RZ9NNVD`F\O7*'[5Q&LJ8@W*WI]:^N;/LBZ0=$&U;%#KB699
M<:6R_^7-<!/-S^MM^6E?/M:+$',&,8M%'I@*5%$:%UVGIF`@HU/?1J..;,*]
M-%9NI)&>!8UK<UQ+HQ%QHW5*CX)MWMJ>+L[>WE_3AT1]97.BT'LRB\SDO(.[
M;$Q#X&RF:E#U-TEF252$(`I!Q@B#193@O)\^008TWWYRB\5Y=O[E\/BX%"5P
M=7?,RH\B-;AC/Q"QE=_^;;#<!W=2T[Y*;QW/-)H1<S.SN`O5V)GDZL4T(B/V
M95^M_GRH-D*DZG\)V#\/Z_WSF?FEG4[FNBUW5!0L3AYFT?U.)PM#9T=.#F,H
MUEMF.5V-0=?U:E-))+WAI`!)2A)>P)3F489!AKOM&T41PL)@L664/>>B?H3X
M[R;K*>.(U%A5F8Q!@[65E_<?G?#-)YH?4O;12HL5NCT1/XL.O;?J8I$J]5;\
MLGX0<BK_(^=ND6*]N._G!&110!3!-,)RU2>)H@3E<7=Q1D$PU<Q>[=EUWZ(7
M&(/R!%*W,V^/8<4N_2S4:G;L):<R?6Q^,(!Y1@"G[M^K4GBIEV\]#)ZHH`/'
M7O?X'5&GGMI]7:XW<IL4KW9?A/732O@"%1@5'#$88T+3F',2TWX-G.L=P!QA
MQO%:\?&&L>8*#.5]26[RC[,474H\QO/JR5BSX<GK5,,6.<JCZ=/V:UGO'\^-
MX9R(*JR@((5A!"'+@4AU.JLXYEJ;QD>:<CRJ!N@TDXBQ%*IE#A.RIY<N#(#Y
MD2!<9NJ"-%FBV!-YLN5-Y>0[U%W<KW;E^GY+FG<G5\^DVC:55U.:O0<#0T8S
MGK$8920&"4@C>.J&8ZJYNF/;NO.RB)8[D9DU]Y&N6K"ZJF:=<<7E^!FIUER`
M/R(-.JA!A[5=C_=###7YO+24[B@RGLBE,_=>+Y<[I?%#0;U9KV\6OXH/N5W5
MJG:T/+Y#2:K'IW);-\=-W@/".`DIA9G,/5,.4X:3OIS#E$,U275GW[FH2M1=
M/_2NVHGBZPA<2.P)N:+*.@S#99WU@W\]I6V(;W?+",!!AS@80M95VZG"<5NM
M#C);:OX%S\/R`JM>)[KI_]=B>,A-`_N',KA9BC^T*H/ZH2SWP:T\`"2W$VPV
MW1`2/WMW!`5/XB_6_ZH\3TKJFME/2"-HYCYC,M^9_=P'9N;Y;P('JZF^<5M-
MXD6:`E"D(4$QSQD*"<_RK#.(:!I;:@Y_:,?YG-:\%6^K)?PQ;2-;P5;YLM@"
M]J7O:]+O5>;4DSS=@B.J_5U-:I1U9[`_YE)7.>.0%AFA!'.49G%!6-%;QX6N
M"%DRZER1!CAU]ZK8XE5-I68@5$^R!@"]V[JB1MX%/;/,OB?B9MNKRNDG:V<-
MM^Y0/;\GP0B!/$_E_],"QC#-,\('6#(K"[GC('S'J[DCN1^UI#L=Z9;6=0<;
MK)_]2`1-F-5?X;43*$\4UJV/:FN]-@E55E]\J-?;LJY%K7VSWC:EML2SWMZ7
MV[WX4;T6S#>_W*-;H`(R%$,((.>L2$@8QCV4HHARG>Z_"_N.MP2<\$G=/0$,
MJIO-^K[YH:X..XF"F@S/'0`]%>[0!@.X5\$@(B\0#Y1Y8@DV8/6"`KN,D2<"
M[-3%:KI/WFK-OTA`&&&`8I"Q,,XX3?/3[BZ80[;8RX4Z&Y7^AZ:T1+5'Y73%
M<2QY-@IZJ[QI9J3BV]VNULM-=PK\KO^%CVM\KPI[XX)>F7U/5,Z6-UH%O"9)
MRMKU9?50WAXVY>>[\_M3K^6O+M*<,2Y`0)ZBB*4I*BBE#(."IV$.4Z23,-JS
MZCA-[(#*CF8/]:>[:O=3+<"^N(NGP:M[(8=%^M6$<![F]331(NE.=%"9PPN2
M:#\.GJBC`\<JUY^PIF;^LOQ'M;L6?Z?^?"=OPT3;V^/Y^Y/]YA;Y+,$`XX@5
M@,M;,!'*,.[,"TR%CF+:LNE8+QN808-3CM[F6EB9V+3W$PR'KLFS$]:85Q/+
M.4C7DTI[?#M12D4"+^BD[1!XHI+6W?H_ZJ[ON6T<2?\K?-B'I,JS1Q(@0=P]
MX0>Q.U>N22[CN9=Y4,DR[>A*%GV2G(GWKU]0(B79D6@T?E#,5NU.G/&RN[\&
MOFX`#70==N3Z9\CVI7,MI-39:\$H1@R7N<JRO0*-8IXYTE#J>%C2KC6%1_R]
M,64`Z(-QY65:2QB#Z,:70$?\/(P)-0S.F5;0F=7MGWE??7>^U#U<',<98X)@
MS'&1HQ0E0G0);4I38MBBP9^\X,?C9]LTM$>X&T@1N!^(^PGQ,MC"B/!\VX96
M0X.'A4.A"RBI'QQENQ+Z=X>P<SF\"1`G0H9_$,=0[N[7H#K4>/,0&GZKEZ]E
M%SC!'"&4%D1'II25.$\ZV7E"#?MA>!5YP0"A=?UEYBU(P,&VCQ-!4?85*K22
M(<(%'&?WB!$4;]>@T8-[J,#Q%@]@[+"&<\3AP]XF@PCB")A9$#DT03D7NB@5
MM$PIQU0J(C-!$X$[J;(@.2!\N`L+'CA.]E.R655X`-8@5`R+*"Q('$'I:2WA
M`5-`6!@66[N`T#M<G0/!NPB<"P'^H!L#^7NTI@XROEP)_X=(4R(28T14ILJ<
MIB62"1'[Y4J2&-Y#\R?O0K1ON5;P`[$E^P?%UD<`.`+56Q"`H^L8!X*B[!P*
M`JT+3("`1`1K$,<:%.P->B\N.$)E%AJZ#GUL>?>IZ<]WLO?8:S6R6!(N"!8%
MH[FD(LX2U*DA8BX`@2*`].!AP[RGH<T2(H0_#*+*A1T!/+WM/*"UC;;J[IX-
MBO@/;1%=5AXA7`$(01=VB5U`@D\.YP@%Q^E<O`J(^!BB5TCSZF$&KO?(]D.,
MS4E"XQ+30J%2TIB7S5L@K29E3`V;\P948$SQS7*M%,@SOL)<4)<$BW2NAS"!
MG.([X`5UCF/,`SEIF+AGNE0+B_U/$_WL+00'0$<PC>MOW]:M=7VD4986!<[*
MC+!$*H(2UDA+1%:RI!`(]N"*I9#PL>S00Z/:E79:=YRWQ;$_*@T(("SRG*B$
MO4R'^=/(])2].D(YDAI75RMJK^,KP$W2ZWVC8"8RI$J5Q!)CAM.<9AG;$Q_.
ML._;I.:2(=,K[(W2:^L^[YY]849GEW,#C.5\>^!B=TRO#3JLAW'*2/@RD'$6
M]TUM(?30&6W_M)_$3.!"<2TRYBI.BS+;EYX*HJ!=;]T%#IGIG;_-`WT!V0/0
M9GPY,,(PDGR'&"_6%O==S'JXT"/@(R%`GQ89MZNS!,M'$T@LRT)F,4YHP5G*
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M)R/^5[![)GX[E_[$Q&]IL`?B=X':!_$_UJM-HX>HUYL)T>$E4S(M!!?-\_.L
M*/:7"KEB"/(,L2^9H,0=_A[Q7IFHT<8?;\-P=6;G8)#ZY>!78$=\NI[WA,JA
MJ?880SM"M?+"^&G3SBQS<G2`S9@"1?WX.-_UK6?+N_TS\#,M_T0+))3Q(LEP
MK&A"TER++7*T>TF9:VHFID^>^14:;MH>Z;D]('FEZ2@:AH&0[)F\83PRDBD<
MR+AZB$%M74G2-7E@L_]_GJ_GVZXL_.7HIS,M'W;/_PJDR8524O)$BJ;;0RQE
MIQXF)+&K,0FKTX#5)_LV+,>61+<OQS^?;\OB_.!Y8-^:D?@8W0JC]R$]&KC2
MQ<D%1C4PPSAY)!%C<+//ULT,";OADVJ[%?O\6]6DJ^OKZIMV2O,@LL@9RA5&
MI2(X8SDC0N2=,*ZS59.8X28A<`0XZ!4U2[AUM&@T@SW'[@AA/S4/AQXPC[X\
M<)"GSH8`T/)M,SL@#9\T.V/WB?#@!Z<Q7'-Q-Z+V.71<B;A]95E2RBGC$G&4
M<J9D63#1B2.EE$Y4;"CC0F0,>_7=&4A+0@Z`H1]*'A@^1UH.`*,=,7>X1??U
M*AJ<I<\^;>\+N+$R-=2,][C:"A8SME9ZZ-S.%PL]JKH+C#15/,&EB!5*$4VX
MTB);*4F2"&.2AG\Z,#<W"D6M1A`FL<#(@'_#P@.CW6-DK*Z=6T`$X-BP4-E1
M*Q`R,Q;]P=!SY&F/R!@XTT'[VLNP`#&DIN+74A!*<9%D.16$E)Q(HF7MLV82
M*W.&!'\Z-$,VR8$-0\(Q,F'(H/``&?((&3N&A$,$8<B@4%DR)`PR0X9\:^A9
MAK1&9!0,::]][6580!BRG,Z^LKN[[;[O=/%I6?&=R#^>;NJ;O_2X>>&O=2@I
M;VY)9#2-B5:DN2"Q/V3$`/[T+3@PNS;J1M.]OE&]/,R/YZ=H4T>;K=(V#.S=
M!P;\?$GX8>P-1=Z*X;V[`,#_EW2%770(X!*S"`*$ZEQ\"87X&*)/,-OJ`88L
M)'(=I+9".(L3'0;C(D^RM&P6$(<-\5@FN7%H`G\Y<.SYM+1*[.$`&<2-H-C`
M`L,1+%:<#\<'0.I!<;)C;1A>9H3\ULQSC&L-QQ@HU5[YVL>(@)#BC?;6&S$D
M$U0HDL<Y$YBD^G_4H6`C949O.]E^.S`Q;C6RH48;F`S(,3!",'I\!8X50=J@
M!*#(P&C9D204-3.:_-'4<T3I`,H8J-)%_=K/V`#M#S\_3I^^3E>/[*';A>8E
M1CDM%$\D;^K9XI1T4@J&8O/]8?"G0^\/=PI%[!^@S4\X1B;[PT'A`>X/'R%C
MMS\,APBR/QP4*LO]81ADAOO#;PT]NS]LC<@8.-)!^]K+L``EE-7L?EL!W#7`
MP2SCDDLE>*J(8"PC<2>#E@4SSR:!'PZ=2I9"_2K++PR4($'!,<DA`^("3"`[
M2.R21R@VD,PQ($:6:2,`*\.4\;6-9_-%2RC&0(36NM<>Q@+P%MR)2Q-GKDE<
M[Q\?%5HVBA&ABI`T)B)C<;'G8X)!-]Y"R`],J:?N/_7==[JV?F`YB'/ZN7HL
M?H%1>A"7!+F'9H'K"8H<PDLCN5\6U,1ZN$%OR<NB?KR=+Z<]JK#52D^%:GN;
M^DOSIT_WGYXWL_JQ6F]?]OSG_.'K1,<(FB*4E(DJ"!)E$>>LU3(7D@%?;1Y8
M.0AO6+[P_'W^^/P8S0Z$,7M%&/-EM/E:-17KC\T-V+NF`+I^VC9';1X[F#X]
MK>IOTT7T.%]4ZTV]['N^*RBM^/&(`>,,[/J1D='0UI_AJ8LXP?[&U23#25YP
MAG(<(Z%7]$+$62>(IMB\R,KJZX'3PM-765QO![V/F<':.SA<L&SM4D@YWJ#R
MBIC/2ZTA[DF=6Y<[`3.&Q;F;`>_=B@)"89X.3O4XF%6_?ZVJS76#7\/MS6U9
M104798ED$0NJRIC%).:DZ>"=\R))C?8MG86$7G#O](JVBD6=9K`[\>Y`&JZ;
MA\`0N#BV@R],GGH&GKZ,TQ71L>2.SG:\S0+]`./$0>TM4$2+A`NF1$ZU(")(
M0LE.(DGR1!:N+&0HYD(\!+L([@-.>RX*@*0?-GH7Q,'XZ.P5<8^XCIB3H)88
ML)(5.,:\M&V$VS:\O9Y/;^>+XSZ4*LE*BCBG<9XEI62JY'$G-"/<:,WI1U+H
M]6?]^%0OFRVI^CZ:SF:KY^HNJKX_5<MUM3YT7`>RE".X9D0U'*XPKMIUW.Y:
MGQ]I=JF.M;U`]3"6'X!'0EJ>C*E#C$'H&Z1Z_;_=G#N<)]"DH(RCIE<N*5*!
M6<IQ)PDIE(*>$X5_/C!)[35RZCMK@9H9$04&#,8^4*S"O)OY`R(]-.,`WTBX
MQ<6"MP]3NH)AS"*?5]73='YW,_U>K2=ISA-5Q#E1G-$24Y2GC!.$"L4S)@M0
M3S70AP,S1ZM+M&F4`1(&#"`SJ@B&#8PD.EAN^F$)P@W'$/2P@A52(^$#.]UK
M#T,%VI]EE_`?92YM+K-_1KV(,Y(IHEDG9S'/,D%5VI&/9`P!NYHZRPM^JM^J
M&)7':Z!/%FL@#]B:<<JPH,*(ID/S2+FK_=+H<IV:WT.LAY?\H3T2LO)HT-O.
M*YZA"E`&U>GVTFHV22A7&*<I2O-"Q%J)/!>=1@)3&:KD":Q(<"+L9NE3TR2G
M7C;[0V<KG>K;Q?QA^T=HDA7258;[W>/P$7`_O"M=/=+Z?.GJU9Y_7_;L.]I2
ML[<H>RDKLW;=2$AZ"$NMR\4<P36F]:;V;'=>N5C4?S7G!4TCH"_5NEI]J];M
M$<*DQ$4LLDP6$B4YRA.68]4)9Y@1&(/[D1F<K+]4WZKE<_7+JMHU&EU5M_J?
M0R_MC,#JF<]^P1[)U/5L5!UR?`(G9/GXM*A?JNK+;M3]F.A->"89R?6D%U+D
M-$D5HWO!J1)&3S#[DQ9XLZE34"='C\WB<9<;->O'VVI9W<\WT.3(`[YF.="P
MT,)2G4ZW/;>=6DL.3'3OXM5#<OZP'@G!>32H#C4L[?;%OM0OT\4K<7I]*K(2
M<9IP5-`R1P1UXA*9<*O=,+"4\-E$I]&6O!;SF28SG?=%]Q6\P[PMDJ"]KZ`0
MVNUX[56Z%$>=@>;]K2UK,$?"1\YFG-[&<H3%F'MD=5]I`7=M2M])DX3D6<'3
MF,:J+'B2J+C<;Y6A.(51CZ60X,S3Z:47,%O%@&QCBYT9V0P`&HQK]FBU&EV*
M:DX#T\,TCDB.A&A<K:B]#B^;^L>S._23,I8XEJ5030<*1146=%^Z1+@J873C
M*"PX[=B<[[D":,8Y`R('XYY=E6/?^=XEJAS/(O5>F:,[Q",A)5_6G"IT]`42
MC*1.B%-)KM=WDI)495J"RD7).W&%Y!FX/-M"1N#-I)MZ,UUXKLBV01)`4X%!
MM.&GL?`2G)`<P!P3$[F8<8J"G&$QYIY?EWK65NO-K\OFX8.V'.BWZE"\P'%2
M)K%.QS"6!)>9*M!>;E(*X&:0L[AADJ1HIU_TH=7PXU6DE022D3NT9JPT**8P
M>NI4.XWGY4JCWH.LA[:\H3T2_O)G3QUH6((9[9N6VA27[R1W>DR:X\"X;)JP
M<EF07"4DZ[*W/,,$^,Z3M9C@#+:?=/.M8F#6LH7/E*T&P`W*4IU*+4]=19U6
M@_/2:7!Z^<@1S]'PD*L=/_"/%V#`F53+=).2(<PSI1C3$M(<"4Z[\B!2ICR=
M+*N'[7D?*,B;?MUHMM#=;#E6!,XR[:+-,CDR1@N6"WF%R2WU*=_#)VB&TTHW
M2&B@D(V&-RS5/Y.NV,%@S!+_F,Z7U_5Z_6G9/(STZ?[`4NL)R9%"!:5"X2R7
MB"1YVA$3H3C/80F*BZ3@.4JC7/1AH=7[&-7+]L&N^EZG+'LEKZ(E>,GEA*X9
MPPP%*XQM=GA>=W@VJC5P'BDW,/_TP-3#13[`'0DO>3&E]C_V@'REZE4U?UCN
M=J%F+S>KZ7*M%V_S>MDIPZM[_3LWT^\307+"TQAG!<](1J7":=ZI0#A-8/SE
M4W)P/FN5U<G0[&OSE&CTH'5<[QBN6G^TX3*OR)MQVZ4@AW%=AW6G9G2D9W1$
MA%?1[5;;YO[OP.P'`+*'#4.X8R3L&,2T.OQHMCG9^ZU>UD_;2R3+AU>;89-2
M_T=F1.24JEPDI10YZZ3*,B/@`SY[48'/^;;:V;"@*X*`@[UAP+,YWSO6[(>M
M]$L<])V%ZKWS/G>,1T)@OJPY=?KG"R3'F\2'JV];ZMR5;243BHA*4R9SE`N"
M2<&0R#H=4"F-6FX'$3Q(J<*3_K=?I^LJ>EK-9T-OZD#@ZIF)05`?R;P,8YO1
MI5$O`!K/V?,D(8J2E9@I@35!E!AE5-!.8*Z4F&R:D6PV0>VE@&;C7B%@8)RW
ML;#:'ROW9AA!)J5-+'2'=233S8,AM>\1!YQ(1[4V6O;LS=L=$K-4B;C$1":J
MR$A>BFX;6$A>@JYVNDD*'-Y>U9`=U`.FZXY@FF7KP^$(2];/0'BY,I=>H'KH
MR0_`(Z$H3\;4(<9@^!=_#LI-"!&E5`6F."="*1X7>7?%0B)!0*\]A]4D,-6)
M43SP`_&,&2^.QRDPWG1XYL<D4(WEI9^#KN"UF6\?CH2:!S+6_<D?:XC-&L)U
M+P"T;S\L#K%E>1"<XJQ0'*5)3-)"EE+RI#O@D[G@1GU$_$D+3-'[1T:ZYS".
MM(R6T.S4(\C]3'P9?&%L.UIH`2WH!H?8KB6=,]1F/>I,T#@1<OPC.88>=GX-
MJD,-.C_WF(_B4J$PHRF20HN1*A$2E]V20[*D!+69<I<VQ'&BGYO,$`@!AXF#
MH6=SGGCR/O/%4NEW\7KO4-$+UB-)B3T:9':WV1HJZ^O-1Q)SA7),,I%JT9@0
M@E'9G8U(FE(..:IP$!/XK&)W<KB]SQPMZN7#+YKQ'H]S`<=;SA!``106'DL;
M[AH19UF1E1NJ8V(I1TO>N?=L#0Z\P5132-L<-+'E7=,H;E5];5Z"^U:U?]MM
MZFH2I$*#A8C"1498F6R[4^"8\R+EN6D77-]BPTVX0Y.E^CYZI6)7A'2QDPT@
MB#V3,I0[1C)3@YEWKJ-3$!B!_2Y_E-M4>_Y6:>5NIM\_[Y[Z9YO-:G[[O)G>
M+JJ;^O/TU0%.SG+&D2A9GF<4"9SFDG;J44F9Q<-0`V@%H0*'QQ%FKZA@5X/Q
MGU:],P=P%"#A&9F';+*CDRS=E<,W3RYH)M>F7$6M,=&Q-=&FCG;V7([8/3GB
MO2QL0%>/)!`,;O;)'J)#P^XE<+!OT_FB44;5J^;BU>^5SDRW22J[^[_GW06L
MSH2)$)2PM(CSF)9-[S*""M'IQX@"7H(:3*W@H>./Y:J:+N;_JN[>W(W:WO_<
MJQY-.ZNB^WJUO1BZ+>IKB&LS_=[\XV\?$IQ]W+X1]K</^"I.Z<?M[VJH]']7
M514]ULO-UW54+>^TM/]^7E81BJ^BAG&V_R_]!WP5:5V?JME&0[IX^:_=U_(T
M:3^+KO0O'SZ[GG^'?]1C1/0[`MU#XL6&GO>8N+?D%^WK7YKA%AV,B0[6'$?/
M$85$B",L8V(07_\$03&,W8"H&!!X+V%15JOYMVG#=>O_>=;4?O\R7SZP]3^K
MNX=J'](G/!4495)E2HDDITT!+^X4:T['_,5#/_I<-A#>MW=;9]W=5OT7?TU7
M=]NF=$W^L_XQ&N(,=]$PS6-?L?`#3MNO9J,)@YY&G'O\&WZH>0]\1R9$!QNB
MZ3K:63'2@&>$O&6D\^O5GR#$>388$-M"0.TEJ'UN_D(O09=WV]_Z7.ME9[69
MK[9[FWS7X.JSGFNG8C!BC"59F<F"4H+S4F:H:-6EN"02]N+7I;0T8B67E\-Z
M`^#3SK*NE]A12;;'.!+4R>[1Y>+>]19S/NR,^A@U9EU%K6&'9N/1:]NBUKAH
M:]W5^)=?#IZRC%%#C(V?('(-`@,@G@WG%B]1[OS3*-J"[4^+7;O-$]H6B`HD
M,,)9GJ=8-M>;.VT5Y1Y/Q@(J&7R1MW^;:'/0,YKN%?48RT*ZTCV4C<2'WE=/
MO6]0->'MR+;QAS%[+UE&L0&&Q4\0Q(9``1##!G.*UVJ."28RI6E>L)+2N)0R
M%YAWLF.<PFM(704.6$UZJA*C?5;U>)\P0&W&^[#[*[SPBGC`JHH1,;HC/X.1
M_PG8%FZ3104#$#!C)CPA=B^2ZO6"TG3+1(9CQ9E2:D^^HI`40H`N<@+SGCC%
M==,WY4M\7C]4RV:*_AU(>DX(FW'=4.#"*,ZX9.QTJ=C`I->#80_7^4!^)!3G
MQ93:_\#T1VBOR[^:>P#-V6>]6&Q?A&J;>*2"IB*E!4\S4<HDC[=W`O8\BV![
M[:&U";ZG?I(<V_?UWW+D\I4-^I=W1JP=,L;@WG0FV.'<."P)O[;D4GV+'(&W
M8VZO+AT_N_LUUSP"!(#91Y30/RV>[[0.)XN&SZ@I42J:6";C(LEB28NLD)V:
MN4#*4ZH<1+<+I-?^HD`8;SE'A8L[*E"4V-MU]I['Z..&C6OLXDC003#^N!+6
M?/,X,X`;C./.H3SIU^5ZL]H^_;-FR[NF/JDI5&I*&[>5N'*^GNDL^WE5'5U0
M83%*6"&1)#$E>1EC)G$I,<^HD,2TDUU(%<(QU$'KZ$CM[8E8JWATT#PZJ'ZY
M"V<../?0S1#>&PFU#&)J/?SD@#;*FLY7_SM=/%?'M8U\JF?'K/K]:U5MKAM'
M:5[C+X=?$&U5]XV6Q5]:[66UGC_LWB6\:<AOPA.>*E2*-).\X*0@<49;C9G*
M"(,\[71!-4$)+/Q-J,:R:&?:<7'S5=1:%VW-BSK[KJ+;EZ/?BSH;H\;(Z,^M
M23U<-+HQ8!95?A+WPX+.L)X/TS`LF%]Z@M0(!L-(8M@8D'C;O6P$*@$W:]K"
M$?9]OIZ4F408BQ)G!2HRDO$4QYT,CG)0ER#0AP-'F7W!UY^--M```8/(<'LC
M%#K`O0E38,)L)!R!T+<+8(/52#C*3O>WZV][`-[E@>[.XH0M%JV<)@.O'Z?S
MY20129DJD7-$"T[+!#,MO9/%N5&K0R<!@7E!JQ0==(K^W&EER@]NT/7SQ&"H
MP?@"#%@/;ZRKV=\?ZF__T9G:\`;>_]1P!C[BC#Y`3G"'%_PNS"%^;*@]#B@H
MIY1_?)GDB*.2E"@7Z;_).[?F2'%DCW\5'J<C/+.``,$C$FBV]WC:'=T]N[%G
M'BIP%;:)+4-O4>[+?OHC<:MJNPHKA40Q>QZFIZ]DYE_HIU1*2(Z+8M?Q4]8_
MV_<])/?I`>B1QC\42)]V%1024EI(0D&W"#`(B.BMW_+'VV:3Y1-/7IMC/<=%
MT0\"+L)8QX=HM)2.#O+Y><>&!RS?D6F<K!([1F[B8Q;1R"6!;]/(Z9^-7!0!
M.[+,(XUW9)J5V:;(2BNIMMM,]G!RF"R2?5JW'L")@!`BN^IT&#G;6'\_YH&/
M]6.(+DOIQR"?G_=C>,#R_?A7\GZ%7)^EMI\PE_"9A)NZ?C`P`B6!#4KJ91YH
M.(DGXGB=^L%ZSX>BC?61/T$L-D*[LI0RDEU9MRBPKOQ[68A;2_Z'B["I'J]:
M76;MT3S^L1X-D6<I/1KD\_,>#0]8OD?_[?T_5]1FL6^[7NKA*(Q(FL9N<GBV
M([74!'J@X1[]M^QS5N9U;OTSESU``J:'9#_6+06L'S<J7(UKH+_O\IC'^BY$
MDJ7T79#/S_LN/&!`R>WW9(5P;'N!ZT>Q6-6.4^PE[##U#E-8B4WB@:9+:D]B
MQ7ZKGE-+B2);/-.L![!8UDMQD;2:QSY:%P-(LY2.#/+Y1=T+'+#T&EJ[)6XX
M3+]?XVO*]1[/XJGCT"0@+'3]F-ET8(?-4JD2N@X[AKM]MZWU</E$[YS:DMLD
M1>56X.82$\8,=1V-K-"-B#2R8*=#VH6LWVD)I=+_YNDA5%?^YW.2R'/",`B8
MBS%F'D7I4#5$`=+`*$E+EZ,4;.E/DZZ32&5`4FVLFK(NJ)U69Q<)]0J\;&)!
M@Y%CEI)$\G=]9=N\;A>:5I3$;N#'CFTSZB8H]`([[$U@CX$8!7FN82)]R+_D
MY1/TFRV0,'*0,:4)#"F-%]8?K1^S7T]VD&`$%BI"+00-2JX_OS),.7S8`5+O
MJK+ZG.\X9<2'0P(^Z3=QS&S>V7;L)&5^Z#,2>QYQ/#MRANV0XO,`\,W)4PT:
M!D5[IE%_1D#>NO9&Y8RHR<K*`65V46&D:?4\]F_X-+-S\<VE."2CW`B@M`J_
M$'+IC>G4$5%Z!9OTS>*'HOY7,QD,F1M3._9L%/F1SY,J/PB&M"H.'`CC)ADR
MS+:3WQ]:PCNUZM$T4>7P-IN>,*R=EO(BM:,QA4;PI478A6!+3RP2GU$J"J2`
MJ>./5;K97\3<"*,P84',IX"^;?M!_VUFC&@"^FIDDJ'Y,/7LZS.UXM$T4:&8
M,JRG,J8&*2]4-!I32`I3$X1='*:FQ'(64Y,%DO^<NST,.?VV?N!OVV"X2^%\
M/R&!GZ8>3AU,*,4.Z8V2A,7`0_"GV8)T+:6=K?U9Y[U_0S^#?AT]35(Y2LVG
M)0Q39T6\U-1P5*@16ND1>"&XTA3,\T]W-4H$/"N]V:*PC^LZW_>E-9<DV.$L
M#&S7<[@%G`9]:8TX003*J92-S%+2:C=H[*VL\4SIT',5_0!%+-/2J12N.I^L
MUJF+5JI.R/-:=6J*H@N!T/0X3AY4/ED8&'K>EE_R]E:(WAHCS$V(3>,`V<06
ME[2[_9<')`@8`8,';L+X)H#!H>:(J_92!G7\*&@(@(]9^530<ZS?);GS0IG7
MJ*,NY9*8,R&*4\29*HHT;^+U>O>4;ZZ+[+;8-L=\=?9"BGT:T<!-/1K9/L'<
M=&^/.1BT0U+9B&'F='Y9W;K=$7B`Q%%748XYLP@(HTZOW9%/E^+..75&R#-9
MT(6P9WH<E>8W37%703??>&DW"=,0A4[JNI@%OF\CSK_>KN^Z3&5'@;*Q6:9>
MVZJ\_YG_ZT=K>W!0<4N!NJRP[02S**JXE:"?RBZ`5*_));%_8++2"R&7OGC.
M[!O0))0TR5Z>$-<L_2'L>EZ$*`V3.&11&B5>-)2H7"^!\$O1A&%J]8<1'[FE
MMD%`54$Y5,T@'@Q0*KH9H=)I9498-%'*A1!H:A25UO=K,FVZ-3R>I27,2=/8
MBUA"6!AR*[V]B"#0CFQE(Y<@CMIJO[J.JM0Q(*$&[EQFE?^<.B#V``5=+'V@
M<;S*'R5A`)N/6D/Y)JX[VX>=3UVJY7G(QSZ?,B881=B/0A(/\'.8'\#6]G58
M-+["?W#2RFKKH>MKQ>`G>#>2!I7E4#6WO#!J_:AKS[#CW927F=))J#:Z7TF?
MY@L!F]:07NQ>TBV7-.[XC'(S6.]-.4E`0Q?[81#AD-(443:8PB'H:Q>5YQM.
ML]Y5>VNC%V=**LKAR[2`,%P)[9:*K!-*C2!JBJX+0=*D$"I]KYGR]NYZN,'@
MNBCSM_O\L5[A$+N13](0(88QHV&`A@5!%H>@PM(T2X8Q],,U)(?[2:P_A(=6
MXZ+Z'F\E967SJ;E$A6924_0TO-O[A%2CZ9,.B1="*4W!G-WP/5TB!7(U>Z8&
MP^_R_7!W&*44LR#AUFE$X]1#831`TV:.#9T;3K=H?&[X\>GQ,=M]%U>+'C7+
MLQSK99X`7?S3HCZ4<?/(KDJZ=D?F,>ZNK/A1G))NB4SMYNZ._[$5WV<BL[6H
M.!>.CU39=@EW*9Y55@J,T]ME<7C4$-)92.J22P&5@]6;NV?^K!AKKH)P:>QX
MOI/@@(3I@.G(!FV"T&)PMI2OW0%Z9=V)CONE[;AE#J^BZ1`9BL29]-7)Q%]W
M55VW?W`QWIV730IX&E1?'/%TQ'06>=H$T\6\?LO&]Y7/`NRXR"'$"3P7N00A
MW-FGMN>#%C.U&9V/??W^K^^&^0<07`L#S6BMS,'K@\PO63C\X;)X.+BESD1X
M*_PYN*@0%XR-JL*]RL?;HK@]?1_WI_S;_BG;#LEH$B9.$#,4N%[D^"&*4K??
MPT8I"YC<Y%F?O1F654^<H%);/W6.OI&:J)D2>QR*EU%9F8;+DW=3K9M_V6QJ
M6)C,/_@V4>Y?I(<8$6LS<-@!LIMA0SKZ$^.%?N4N/%`8"*@R]9(II\[7U==\
M]R$76WR*\OZW;/^TXT/2!_&5O+-RN6F2$I+&;L1_ZMF)W>_YH21-/=7BZB2C
MQ@>)QCMKUYP)4=U9FZ==TRUK\8N[[M"(_N8!\1M?L]W&6G='"JA76:>U!#2C
MGJT)5$>0*ZMMA\%'JW?2:KR\6"(]IIQ4&JU%^L4ET7JB.IM":Q1-@9)_+>X?
MSIOWL!VE3NJ0$/MQ%$9>ZK`#I'&HBLEI5HUSLG5O?E!.;`PH*>=K!754=DVQ
M.%:.:B<%2SWJ+XZ6FL(ZBTN=LKW*RZ(Y9N#(^KM*<("GL<W:Z`HQA[H>PC%.
M7`?%-&4QZLWAF+@R]=>I-@R76^/[^UU^G^USJ^S\LK+&,4G*399PG&ISJJ=.
ML=ZI;DU]TH5J;<2"6:C[N:`5.J+5*YJ<H),N%2],(VUA5'I?+DAY\_=REV?;
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M0*NY>S*PNO-;]JUX?'I\,4>ZN3OOE[,*F6UC'R=VY-$T1=CVTO[`1NK;%,%J
M/69\,)XWB-M3U@(3=;[?;]O[`?<%9P-OLD."<"6@\LA_]0"M]1AJ&KG*S^7;
M!)8C=/Z>*O[P@6,L2YBY+*0D[$B1R&Q#+:1D9#C(:LYW7\/U274_?O#$99O5
M=7%7Y!O&58L/R<L-??NVW%?=14]]RO&^VHGLC8\LJQ@["*64!+;+(L=-*6+#
MHBKV6#KUZJ59G#1<T.(N-'EJW2:J8L[!:?YY5VV>UGN>M38W6S:\%\G?T3C`
MF;/.=WN1X@[IWLOD4,-7*7._%-!U@P6_#SIV]5P=S4C?6,>168)BUE%L%@^.
M-SF?`[3A75E#@%8783-A7<`=5CJ:2FI=XT)OQT)&M<OK(''OU@4:1MO86-V7
M8K;UMFP]>UOFSWR+RTU;GTB_K;=/FS:P(8`RK^M/>2WN2Q1!)&X:(=^EH1<[
M"0MIZMK#!E7^9XGJ`O<2?#<^63H]DN;93B18]7&.?K[6:FV>FL)+/WKFQ\%J
M'D%G?G7T#*O+?6>,C+5=N.)%ZH?4HY#[0;4YB+RK0O9AMX/S#X%;7>1+'(.U
MMNN$@?DR[]>?9+2^D#C`(?R232@]KO?^CA1'CZ)[5^U'S[*JA9LH(E'L(.:&
M46C'P2']B%SHM7AS>W>)L9F/Q]7)Z]B/EVJT[VZ;O=WEAMTE-SAL8#T>0,<7
M3W_X=$7F`*ZYZZB:&V5D5+Q4\R]DW+M8^-4R>B'\$B`Q>G)C[ZMML2[R>OB,
M!6,;^2'!`6;,<\(D]B([26W'C9GC>.RU+1P:+)@CR\$IJ_?J<N>]G%=HI)MK
MD'4A/59')"^OLM$CCG0_^LC[;G%7K+-R_]*X^$",\)#_M:*>2Y(D#*F3$(\1
M%SD>Y=;=)')P%$6@TUPTF32\)G%T\%5]<%CL6^D[X.?.96#VI4MQ.8I=0&P8
MT8X<M$[233AI-5[.S3<Y[498IUG\A7!/=U25T3<6R$-QBV')Y?V>%/6:3].>
M=OF`8(>P,/9#/XS2P/9\%B5I^R5#G"0T\2+)+CG%A+E^.'AE'=RZ7&HQHM%(
M?].A[$(ZF990*OTOWO3N=-2%&>7YBYN0)*9NY$9>$OF]3>PF#JQ>-,F4\>+/
MX!TP6Y@FH#*0S"BG@TB72P?&9()!":[N<JFD$,OK6%(52)I+-*L?Q'_IOY^*
M+]E65"KB<O-;MOM7OL]NM_G'?"WVHOV8<?A)X,4I\2BV`Q2)4S5YQA$3/PY]
M)Z(8ABL3'ABG&"O*K%P7V7;"4;]&I)<#W:4UA_%/>'IEB1^M(X>OFH76@\_6
MP>E+PE%!VA%FFFRHA:#4:(C5?.\]M-[T=%OG_W[B+J2"^I^$^96?TM0CGNOP
M_]LT("F?U1&,/#L.@]2V":BZI&+`>"VI]\EJG.(=5;@%O0)"33O).I%IV8!5
M(;!B9BI`)U09J_=,$7$A7)H6P_-:SG1!Y#[1OLZSS>===;_+'OL[DQT4)SB,
M71P&4<"S2-^FN#>31"B6@8KJLPWS1'AD]2Y!OK95D6F<'W,H!$/'#^)(W%>E
M1R7`E\:&U5+[?ABJFMR7LR]#/4'/J:(LX2O7*>Y7>MX-T(&]?*9=\1G@]V>V
M(N90'[D1C2@BV`N"&,6]K3ABH30S50T8!N?@EA(]E5630.@<@L$X^E(K)9@J
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MMD9EE)N%Q[]^HMWC?18$C(68.IBZ+$CC)!@>;V/;DYYX`YYIFH[<$\A$$:*&
MQ(3:D!!`-G$GE&;-$#$`$V5#HB@>62@GCMQL^!#9N0FP0NQ+F/.JN%U-:W((
MP]*BSHKN^:[8@NL[)*2QRU(2)"R)^`R:BLL2;!Q('74$?JAABC6N0'HN2!`)
MCIG2`@:RQ@LEDH'T`*#,E"YJ+)/51PYF1[&=HYE*^$O`F9+?U<1VAP#MX]=\
M4]0/-[O/#UE)BNI+(?:Y=0:YN8"X+A,7)[J>3QF)*3>(7<].B.,GTH2;9,7T
M;I76-ZMUSAJ\@_3Z:2I*8'$V`6&</*>=$CJGB0A@Z6QBJL&U%[5J1;WM'9Q\
ML/-8W.?`JT6K)9!83R"5[M=HXGY"_J^;ZJA+;(]Y490DCA?'<4)CQ+I<%Z>8
M^%.V%,K:,,WIYWODFD4!I;43917EBHES"`CDM))VL^PQ[,09*0%.E7,AI;[)
M8;RRV5!-EBGD:6O+JY#%R"4Q(5[B)&'H>,1&O<'01E*[:*9;N0Q]U!8Y)FBI
M3"`#,FIAT&46*,X*!.,04-3ED@@:R.LL4I)&E49=TA6X),`T2.PH$?NMG=3F
M25AGC`:3LB!)"_-12)P2+GL#WD35E)AC0+")O`&7JXR@YM45SVDZ+A,QT"#&
M\:(DB2I:KHLR?[O/'WEBE20>];`=^X@B'Z&`VMZ`,C:)+O)&YDYS_A"N68UO
M$[,<@)!*P#&CX53F2,DW!W<&>>31`U=TF?11B&,<0*K"R)7DW_.7ZR&K\^IN
M73T^5F6]%Q^HXC!D*4*,/S=T7.+[+DYZ2SA&4A^-3GB\8>[T3C57G#1N68U?
MD/JQHFX2U7?SDL$P<T&U`&5V\ZJIU=?AZLF5UT_&>ZZN/DV<)134)T90:7M3
M@/G=^UW^.2LV:7OT=%QN;L21U'%=Y_MZA5D4N$X0$N)',<8.=:)^SP@F'I6Z
M3EV+(=.\;7VS^%_)N7(/S4[2#9]3;JO/C_")Y31-Y=*]V>0$LKA3LO.K$;+Q
MS&I=FSGK&U-I)//3(NY"LC\]L50&WCX@J:Z+M3!&JYK;"%R4DCBPTY0XMA,&
MC'C#;#<*0]"A(:`'&R;1IVJ?;:UMXY$X"57TG[L<?,PL3"LYXAB3"4:8S@VK
M\6-FG!Q+,((/):46@@LUWRL-KPID4O@IWSW>W%WG/$M:V9Y#G#@)W3`)P\1/
M<9(Z!'LDCH+0X_21G@I"'FH:`]P5D9!OA3.0>0Q(&(FYGBE-8'V^D>/FSKHV
M*@=@,F=*%K4IW`_R3-X7=13;N>F:2OA+F*0I^5U-;'=HFE.5]\),/PND?`Y8
M[!^'`Y08=3T2$=L)(FJS""-;;*5J<,K!BD%SLJFV#%-0N/?S7KS<0Y'BX*'B
M,6J3Y95,EF94%I@_31/53%XUKM98JJ5)YZ5D7[K">9Z0:97I598U!_?OOJ_H
M7U<DPL2.HB2E`>$/=TB:]`<843>VI<ZX`#S.](+@UV+_GWS'?V\CR1V(%.-H
M,:0"<$GO'V\__6_ZX3I^ER@QHL[7O]Q77_[2!2,0@?I?"#J@(SH<`CX!``4U
M+MS'53RNE)M>6]9Q6-U#`4Y1A"BCCATFR+&3N#]S@CHT#?1D'O+V+IM]7"OO
M!-"B]=0TQ(S,6E,1*85GSD>N)?8-Z!1]\7F)0DC2N8FJ7/+4X^/XRJ/\R2Z*
M2.RD0>"$CH/['>(TQ'+''H(>:)I;\LD)3`=)Y.B6`,B4T>C-T(*;',,!1)"E
M]'>0S\\[-#Q@Z1Y+GNI"W(_-(7%;E$V9C%;-)6&<%_QG=<&5:7[[NLANBVVQ
M_[["$4^2$B=!;N2ZB)'(\[SV$M(H)0@[J\_YKJ@V'_?9;B_7S4UX`>D2SQV6
M[ATL*W;6EVS[E%]9M_E]499BD:FZL]HGSMQQ%&0<Z6<F&V4AW=)HB-5\[SBP
MTXNW]N_BI?TMS\0%02(W^$>Q?_B]K&[K?/=%E##>EI^?]O6'7"C)G6D<^R!N
MMMAQCTE6%_7@9I]HU"L<IB$*$S<A"$4LQB%Q4><OPQ@GL$M]+N8F!!U*-__$
MFTW1G(<U,R!,*3I"D8LWXD)0<WD=JH7UKLM"J[^9_6VYWCYM\LW;,LUV8O2N
M5S$)G3!QXC1!H4^CB-'NEC0>`/7]<%7F]^*&]D_R\YCE."_%MJAEVXLXI0%'
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M;KA;"7^%OW"'ON3OJ[HMQS:;]PZW-KL1H2$+HI#P'VF$8XQIZQXF*8J`Y>RY
MO#)>O6;5+B_N2TN0/"_7WZV[:O<UV_T?=5>V&SF.97^%+XVI`EP#4;OFC2+%
MF02JTIY,=_=#/AARA&Q'EQWR2')FNK]^2&VQV!$F*5)B`86RT]L]]USR7/)R
M6P/6*ILJ7[%A3?.0LT%/415,+QKV@4_CFQ*P_Q@']P7_C6*5UVPT#"I^U9!T
M<6BV$(L-9FV,K>1&Q-X#+NZ##Z!W@G]MSPVP\P.,CO0[G0'W!;3.S'XCB9X8
MG,D8<T?9DBPRN]O'UZ,L0KM"MME!^+2M^6V]?#R[J]M\;=CTGW_M\HZR#,D&
MQ?GC55$Q+7QB_]@#ZF"?!"XE+HR3)$Q])R5.#Q1[+E+..W/A,YZ!OKX\/>75
M*]>EYH'EF+N[8M7P?ZU'#VOV><VR%*^X@+QN\P[7KLW.<U!NVU]GW6#-CU>V
M":PN'S?K]I?J@8Y6_S;;5?FDGJ5F:QJR^<K&-B&7N?:RT9X+AZL)%B4G380+
MI:FY@VM=PIJ=@).I:YE0Z$IB)P#VB78L!NU@9FD0>B0+"'2#!#I!BAC0'F8<
MNI[6%*8=W9P);+<^WEY.\<SOS.D/+!]E-+W)1W](M:2>16.I/F5Z/PGQQ>O1
M'?YCHT/CQ.D"[-8,K$]3LL%13U+&FL%?(T69<U\N01D.@T)Z&FUVER.A[7HH
M)VZ*NE^,6%\>K3,<3P3]V.'/C%(4!I@F<111GV0(.MB!.(Z4D],<V.9,37GK
M1IN6'G>.@*I8\?[!IE6-^NZNF2,JFYML"Z5Z9MI?DD:[@.ZY,ZQ4K_F$^&@!
MVJ:4I"$F0@EISMA;EXYF=?YD,IH_!`JI".=5]<J,MT`YQJQN-D^\=C3"KWE>
MO6WV,NH1R"Q""2)IB'W?"8.`D#3B(/T$(R<.G4`U%<V!;?99$M>M5>]8/V5J
M9TBWS7Y93SD1S1)/V41D6R#5$]'@29>,NBPT.K.7ININ/L6"NC^3LB@/:0B)
M4!Z:,_36Y:%9G3^9A^8/@?SN7(',^&97UN&FK!W6!`<$88_$3NIEU(O3R$V&
MG!GZ-%$\P#<G1//;'W8%N_:*]V&/2[MZ-&YR`>7MX^8^_^"4GT61E=RU:VM(
MU??K"LZ(+M[9QWNTC7?Y9&4B3");=9=H%9:DKF4Y.+4]=[F`B%T\C+;YXRL#
M<7G7[>E@'[?K[O3@I^U55:Y?5@Q/NT/L2\%1%L?I-76\!+EQD*9I$GM!ZCH9
M)AD,71\Z)`U2L90U$QCCR6EP8=@:L=H=Q*QZR#+W_<X0GO-YQ\*XR&68,2"7
M=_UVNO8S-O?I'&`)!/0N@-X',#@AE4<6"9[$%<]V!5'M8NC]WI5WP>2?\;)$
M%TS6S9[[8/;[6L=N-_D>Z<D$OI/`9XZ,#7=6S^AMN4CSETF_?87M\NY]!+NS
MIGAO9UR:/_(]*5\?BN+-9#?%!$+?I?Q`JD](X(<0#2`3WW4ELO'LV(PGY^XQ
MDD$0^);"\8C[B3V(MYT[H&[]D1'_^2,KD,BM#JED9;.O3;-D?C)]CW<8L!R_
M[Q'H70*=3Q/3_/R1ELCZ5D=<;1"PO_FX[="G,OYQ!S_5K2>/#'23?&J@L%@P
M;1@W+.=\:4-_DAE5?-HR*$V_@>@?>;7I2@O\(%C=9-NF+4>@V[H]+'8316X<
MHXS@P(UP%E/?B?LM0\CS\8=+9@8LFLL:>SBY*`Q(P0`5#%C!MP&M5"[0S+R$
MT"\7`345WX_$IW.1F*S.4LR<DEXS]-J@JX8\*XVW3<GUNG?MOI)-O7HL>5UV
M;XM_$B/"9GN>'X9I@!*^=W(`$"6>X!Q*OUWC\R-A=91<4--(O=@JV3*<RZ6B
M$^R^@AU,-C%9;`5+F,(SRU+ZPV#)6I,!QTK3+5A2+@_W5'2O*ODP\P@E(2(P
M@PEUF#IW"U`I]9$39S(O"ZC\?9G.J/(8TMYFJ=U3'B=V0LD^DJ+$IYC:F:92
M?<O9%!:-J-H[5)W1KRG$6J)4DUPH];6S2>J#?F[J&T(\Y#C0AV[FN3"*$A@$
M@Z4`9HZZ^`C]></:<]0_V/23@9JF,6*LJ4B,=L+D%$:6JQF4A",0%A(I^JS4
M$3D/SLJ(`AF**O(Y?RI(^91OMC<$4C_-D)LE81!$+HE2/Q[L84H"=2V1,#*O
MHEP`#@U\Z\!-4Q89)E7TQ1")DU1&F+\9U&;'C[#F*%!JI?*H^'%6?Y2)$2O%
M?RZ;HK[*7]NB?TF9R?5FE?]1/-T6U4T(TQ@B)XT)00E&%"%"!H.>`R.)Q?I)
M=HP7EEITH(?';Z$;`,K4UJ=1*;"(,1N'<D)T2-[UCCSPK<,FM4(QC46)!8G9
MV%1;?^A8?>[P35YC..?LJ24%+039L(*@QY%2=]N1VH=5;#=EU9K]NOEY56ZV
M3;:Y?VB^\N5=RN^T*U@SVC;DI;C^P3Z^MM\MBFV/R448DSB)H4<=%/@0IU$V
M#F!=)+7MRC`4XV(?_F<<!7\#G1^@ZV?KEP*P7A-+[:LQ'1.!E&!3,"3+</OT
M,^R@!0]:?*"%#VA[@6CG`&`>@,X%,/B@E%^,1TUF\Y-%T5/<ZS0]BM-W-TUC
M\>1FIIF"8T.&G,W7<H'6/ZDH\_ON26S/\QV/0DI#'X4D"#(ZSKY0B#WUFHRX
MC;F+O+^+O`BOET65>HP9`B<6?86XFZ$8,Y(C7(N1I]/*4HR"&V<K,:JT""O/
M_JQB/*"Y6U*_<6(2N,3U(`VBS$-1["=<\((L=,,(4BBW[V>JM9F*,OT,^$+]
M)K')M(I)TIQ\3BC0'-PGN8,WLT1]0-89J=)%LR62I<V=TDQKG"!A-X%/J.^E
MF1<%B1M3Z)"(]#9BE!)?7:\^_--SB]/AK5,3!.ICTN352"M;$Z1G08T1%!1A
MIBQ4#W'L9Z1"D@#%2=4H2,Q<%L<));&/8!8E)`IPU)M#Q"&2+UFH6C&N%N3H
M"KH)HQEE)E4F5F8HG+C.;</XY01-PE,L>6(M49S);IR=8JG2HG`Y)]HVF_7F
M\85?:/V5WW?3'AS(?G;GXRAS')=/SR]=/?3R;GA+^:JHOC[D5='M+@Q0Z&,,
M,Q21V"4D22+8EZ`2AC60VO,W,S3#I:3]7;;[_H"=0V#P"/!F!O9\XK\T>,5+
MQZ#U2W%C\]PA%]-9BZ,MN8ZS1*`-7^"I(R1G4L%"L;<D@RSE_<D[/!<(@G"^
MFH@M?7W_#[2;6A$)_<2+8<(2:\#2:AR[=(",L>?+)*\E<1K.9)I$[0+<OIX4
M2*7=](NV#;$L]U=I%G(I3S6*1K*608K/I#`;`FM)/K."BM*^?J<ET^WM?H8(
MXL2-_<#QJ1=1U\U\.-B-0R0UUYIL;)F<,^V,Q'2&IXB^(7*U*/>R9R<^XDM:
MAA6HMEI+5?P1$D1EH@0W[3;EZL_+Y_:*=_XTP-/S8_E:%.V7KU@+?<CKXHJU
MSV$_4^:2S'6I[X8AQID;QV2<0@29%\OLT=5KV7A]O`4&R@YP>U]JT4,&=?NM
MYQXT>&:_)[7=4W,,SDO@TN1+EFZD6%?;;:N9?IG-M<N%07$OK50XIF^;E>+G
MY"Y9,RQ;L2G6D&NE^48JDZ6N-T_%/XJZ*=9?V/^KS8I]UMK_^W;3U+WA``<I
M=EW7@Y@FGNMA2O%8WHJHX#-D^NP9ST@<Y6_?6YC\OLX>9]\17SA2&1G4P[%`
M[IF=7+F,P^&!#A_8`02=\K40E;*,'GHE<LOL-*MEE);NLXUX<A818>)4[M#*
MH@T90Z]#I:D&)Y,=_LBK/XOFK:F,A%X"V=S(SX(8DM3!X6#*=6+!K7U3+!C/
M`!TN5<57Y4U`XV<@3$[5>Z:FJK@J91*Z/0-U:DK]MK%-5N;W?3VEQ1.9L4%]
MI[I0ZFLH\Z[R_CX>3`F\*"0$>C"-D$?2#!(ZXF,?HQF7=,5!_376;Z<<AILO
MOK,LRYH)K9XU6#-1M7'E]G>!<WVS!]KJ=023?NM=@%4E7FQ,SU]U7*'MFG"`
MQ?K8^'C1>8`RWTF").:7WU'J!TDZKO2Z&`H^]JO5I/%1?PNT+;ZN.ZB@&$3C
MF8E&S='*#&JU<2TP,5B"9#G5[MCECQOV&-^59*67+;01+3&=6()PM?F%2+.>
M/.,0I./4%$0WFS;,2;3[5!IL?K)G/8OFTW95/A6_E_7N=8PT\A,_I`&F'LTB
M-\L(\4B&HR1"89PY@JO8TVP8SQ*?61>L>+/Z+]FCGFJ<B0WKS9,EI_8,#^@`
M@5\XI%\!:IIJ<\N&/?TUBU>LF;87)'^L^&:.B+['V)GQ]#2&+1D<3W3B^/2H
M!DK4).<&I4$*,7;]C$;8IRA#">V-)`DF4Z3FP[]M7F(*?F*T[3SY4:])-^5]
ML>5=:\GN(MI-A*FTL7N(@S_7+20I$.X._RS:&['6B+6P_+Y@6>FVJ"[OVNQ?
M7[XT=<-&?&Q(,'9+R(RZ<8S#%$<II"AF_V-?BIT8I5$02=[(H-V\\4XU(/XM
M[R!W`]\:O-3](YSYX^KED0VMM_>RF5U_+,22_J)!D!L/#%!!CQ5T8'EEKH,+
M]O!>C%/$Q48'LM2>441C4;)$-,WY5\[4W`U);SM'N\&.XZ9IR%)`2)W,IW&2
MX@Y$ZKEN%LNLR^BU;'CQ9>SR@^!NQR[/DN-3N1T4N-P!-R2\@I'0J[KZ@V!4
M<ENXEJILBTV#Q,J%Y"^FKY+.*8JK"H7B5P6]/78V:#ER8L?S(?;8O#*-7-=#
M/ADL>A@[DK<%J1LR/E#-[NZ*5<.[Z;C(68\P98>F4Q@5D\.9J)33/O)V>?@"
M#,1N.ZU377\P<ZG021;/R)X&ZBW1.!V>'-\NI(L<8?5BD_ZJ:-=G'G$[P.G$
M<[_P>5UVAVQS-NF\RE_;1\:JBK7<]O?J&R<CKAL$#$.8A&$0!-`+>V1^AGTL
MIW(S`#*NAE^E]V#.&0XQB;0L#G)2N@<>=.B'X>-Q17\4W5T&:W_RMUON%>C=
M`OM^S:RRTP-Q1HUGC+(EJCVGQ^5B74I'=:"O9[TM5:S_]=*]:G_C1]!/"/1C
MDC(DU'<(&I*23S#.;IJ2.3NA3J`!@U3%8(0K/VI[+AL&9\,4YZ!2H*,ZH",2
M$^H$,P=!3\5@J,:^+1N`'6X;2@<?LRM;1-`8+TM$V[B;(H4%[;1.+=Z>`G3C
MA"C"T/<P\2!,4A=FCC?`P"3&DV5Y@FW#<OSUY`+9]`V2QL(QJ88[2R3F6#BS
M08Q/TRE?R9T<&)O%5X=[8M5<330*;C5_J3?;HJXO&8;OF^+'5?FX6;U>%S^;
ME%'RYTU,$,(925V7,G.9@^(01K[C8QHY690(UCJTF#)>Q1B`2>UJGLK?>2F<
MG3@YW1N0@0$:^-:!`QP=:.');1*?2J?,YO`9:57;%$Z*>L5FR@6_;`:4`\4L
MJ30/!9]T/>?;UW;/.#_16S[S':_\GI+I^\3/,W-R?[@F0JW8%Z[+E])`BY,<
M3?.%E/KR#JU6Y<N6CPP[N\?6O00[*,51AER*80@]'+F#]=#S!:^0T6S4N.BW
M.'F?>F8_-/10R?&Q+H+%AL4+,"N9%09*=Q`O0)\7I/*#D6&P&'UG1K^:^;=D
MT*O;J])HHY540,RR(K.T;COWL<T4!BG%3&Z]*'$S2.*`6>MMDC03/$6IQ91Q
MM3M`)ZERTT@4T[;9V)-3M`-8%FG9.;K.*)@6EBW1+3V^E`::H:1&_;TN+N^R
MNMD\Y4U1WR"$$DP"&"1!G+'Y/0T],EBAB4?E5$GRCQO7(8:'#Q"*`9&D%,ER
M)28^!DF2DYN>G1&*18ISR-$9C5$DTQ)5445?:FE1DLKQI5@5F^]\-;T^UBI*
M:!1$#O0@(FZ8!)!]9!83'_L4LFFFS+[V"6:DUD`4;A#J1I4UJ$:(DH(RA4(Q
M<9F)/3FAV0-ED<:<INJ,WFC@UQ+MT>%)J;WQ26K25<7KD<TKOQNYX1<G_]_+
MYIE70(_M0QC$)/`B+W!#XB=I1A,\CJ8B*O5JB#:CAO5JP'G17A3>=%>)#U@E
ME4L?T6(ZM@C'<JJVH_=JI'>$:9'.B5)Y1O6T1\,2#=3O5VFX&4M?E/!CKQ96
ME5OVZ:K;\_A^92RF*4UH[#H1"7%"$70S;\"1IHG42$Z[<<-ZR?""?`0,G@\0
M2U_PHIMX,=U<E',Y_>1T[[""0[`6Z:<LI6=TU%AT+-%3<_Z]N5;#*)'B[XCS
M$RD/Y2/CM>;:WKQ^+IMB]QS]#@#Q/>)#Q_'3!*4TBR*?S=']C+!_,Q`>DBNT
MZ;-KO`;7P9-]K%L?KV*ZN0RA<H*YC_$_0(<2<)A@AQ-\6TXHA3D\HY#ZXV")
M-!IP[/@E:T/4"8OA9?-05/P^VZIX*+;UYGNQ=R/8]WSSR"L#M*R^YH][)S&O
M\Y\W,/73F"(&@<30AYZ3(M@!BD,G\%PY<32'P[A8,A"@&(\F;XL&O&RK(G_<
M_+M8@_M\LZW!+RR:=5'_RJN0Y?VV_0X_%;.[^SH??`1W907J7+I,:3"08FIL
M1P3EU+G%#`Y`']YZ>`%&Z+^QP/S&`W-P)IWAGUFQE7D^H^#F8V>)HL_@:#EW
MM]"H^*2H-M]S?H2O_M\7IF!WK_Q,3_T_Q?J^PQ3AB,08DS#VXP2&"?2S>,`4
M(5]R0XQ1*+/J_IV4[C,E*3;W6\"B715;-E%F7_B15VO`6G%[PX%LY<)L3*?K
M_ZS!U)X"]M"#'7R0UZ!SP+8L\!';BHE`6Q#_`KE`GZ\2Z4`SP6*G?+I9!Y]G
M,)/C#2N$9+%+_!AE(79"3"AU2!JY"424DA0+5CXF&)BIQ`%^Z8']JOAT@2)]
MYR5U)M[DA')9PB0.[Y@G3NW(3H=K\@F<=]U[1](U<&'#:9N)'I3:&L;D*O,5
MD_=RW5Y\DM<%*;J/-S2B*8I)1DF64M\),Q^AP7[@4\DKH[29G4N`-STPL&93
M'S:JXN?7GEO(D\O/JH2K5I]G8'IZ\?D"=##!@!/\,B#]=?':\_L,2I6>)P;!
MDK&I?K\^+#QK(4Y.'K\4SZSE/C`S5U5Y7^5/Z*5Y*"L^349/?*$0WK@I3B%.
M_""B,0U"A'V8#N8]CTCM;=!ET_"6AOZ2MNX]V>_YXTL!\A%C6QZN1A]4-%('
MZQ(2.3/A"@H)=A!!C_$"[%""#N82XO@Q=Q]IHT;V;9)&G6Z]IXS::9LHC%^*
MIWS#;^HYO-=YA^JZ3(O=;ZUOL.OZR$$XX^_*$QC0)!U'M90FDB>V9P)E?,QY
M(*W][?5[VEH-#@'](JL_@E,T>-'0Z9+HT8FW=RKMJ7=3@MMB[_?GOEM)3P"D
M==Y8A*U.`^:\%LH2ADD73B+7?.S^4KVV*'L,*S;*KYA)#Z9>`@,<(QHA)X2L
MU>+!),Q0*#.BGF)GSE%T+_65B`CH)U1,J.?B4DY]!U2@A771ZRL;'O?09A;3
M,R2=44@=U%HB>UI<*?6W/-DS8-U]SC4MJYT<7M[U5T$W[>D*ZJ"4&0DPCCWL
MA13%H^44IJ[4Z:_IY@S+U=4PNN%7>`U]KA4OV4-?&I@5$ZR92973K0%<6R_9
M&SPR>H=+\,^3:^98UX>4G5$QC7Q;(F8Z/3H^Q*6;+(E71+XSPV7U^KEHQD6F
M+`A]2*/80R%*O"#Q7,2K!Q1CA),H([+O@BB8F&-R_5QNVT['>MFFQ[B1OL%#
MC4`QS3+.G)Q*C7`N`'\S>+'7B]ZCY8P236+1$NV9YL.;URPF$R*O+U_R'W_D
M;*BQR1]K9O?R[DM1%]7WHK[QDRA.@M1%28*"U&'6"1PLXRQ451MU@\:UAT$#
M3P,V5;V90*BD^LS#I+(6<39'?)TT,44?,"ZE32=)$U&JZ8S;IEL:/#JE8KK(
MDM>T?Y;5GY^V5U6Y*NHCTXX39&D8A31Q'9*$A&0T'>441;&BJ$VP:%S5.#;^
M<L-SATY5UZ:0*BEL,[&IK&P#HSU":[3M-&\BXJ:!==O438=+I^1-&UWR^D8W
MVTW]4*S_NRS71Z8)"4A$@@0ZT$^Q%R&7DL$TP:'D`[DZ+!K7MP$;N.?@5.5M
M"J>2\C83F<KR-A+:`K1&W4[3)J)N&DBW3=UTN'1*W;31I53QNHEBWPL#B%V*
M(B^.*$*$#C;X;1XR[VU)_6&I`KW\8UK7_%?&JI;LW1AR%,G7LK2R,Z6&M6#A
M2K!@)4R5;:(AA?U,@4J2`+%C9%\*[L[F<=.>B;F\Z_84'S[G^IG]!#_@6CZR
MOW+_:<MFF$7=U-?M=\>++EQ$8!P'KA]G$(:(Q!%*NT-N89IDJ6#Q:F90Y@M<
M!ZZT%V1WYR?RHT><MP?^,,'J'9(YHS5C,,]+G<51E!/)H_!=W@U7`1V\P7U=
M@D-'P.@)^';=_8C:XUDS1E3BI)Z=D54[W3>Y@TX^&*B-S7<2Z4+ALN$`X@)>
MEXOV$>G1/S^_?IW_W-U:-2Z!44(HC#+7<U/H8410Z&7]@?4`DC02'NFJFS`Y
M\&UOB>#7@.S?Y;;<&NY)DLZ.C*=3:\U`68,K;\;-NNB9TI]V?3A+LR!"012$
M+K."8@)3=[!)TECR1LI)IHP/>7?]2V$+R10.E47)#'E:5&FY&R;/\20G3/+T
MVJM,"KY\+$VJ!`EK$RENFT];IG_M`/F/O.'7E;V2O"FZ]VB?VS%_Y,+$A]3W
M/.CX_\_=E2S'C2397XECEQEK#/LRMU@0-3)3E<HD35]TH*4R00K328"3BTKL
MK^\(+`EPR<SP0`0`U:&;5)%,?_X<>!ZK.\9>&#F8N(SA)`YHRH']J<S8M*Y6
M'W;%?5&NMO(82E?444P"1(P>\MVZ$#]X7#WFN[KCP/Y;M3O\*D9I#V@CO!O4
M@03JG*%XJ`G>](&`*9_$AWJ`-ZB#B"1&6<;KA')B"51B[H(6FF5^(:)HV*G*
MYL,*60F5'9S+XO[;89=_E_<`^DM'J_M=WM0[%T*PENNQ=_5&Q&J_SP_[6U],
MYWTW\&('9Y22E$11UH()*0T#E0L/=A&`MEC@=R!.N%$+?'!A"_70;U`+OKXK
M46_+-/@A"V+VHJ2PHKF(`,'$]>\1&\#:Y")BI+<4:2]6:@N1NM2=6W>T'HHE
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MV0`M:N&B%F_=1'./>L3`Y2O3,5!;QYJ1?F!B`C#__"")$-,_5SOYG[\T7DR]
MZ`_C^,+2EZ5@+60-S)9WU21/O+[B?MX)N]MZW/#*NE!VSJ1I[KN94'X_BY/.
M>LPXUE3:,28G5-@!3".Z.HIIL)Y.1;*^CO*V]0KM6J_\#!)Z@58UZ301E^5)
MIA&OSDNE.=)T)/)2HY#W0L+?'?*'_:U#HY#%;LI3[,3,]6@:X0Z'YZ>^IEB:
M,3ZA;%9U%Y_ULRX^17,2XHL$C&K$JD=F[84#K*C31T)?6Z^V4E*,A6TY5>)4
M35C-AF=Y$FO8O_-B:X-(T[);7Z:3?9C2)$I8&CB>)YNO"A0"QTG]'1Y;4%UE
MV\L0W;KQW2\W=5<\N;MTJ3_:-"$QJKQ6HF%1>$\W@:=O5`=D=+SL@F/S<ZDN
MW#T]T=6DT4@;4I++#ID?\[7<=2SNBG4]".\A!3P,`B\5"2`-6!:[L4O3$R3N
M,8C^VL1A^[S,>?V5\HN^UO!E[]'G^`TV%QT=*3597DJ0@&=FKLMR&Z)7Z&<4
M[!%<7Q#O*2*X$"&?Q%5`6U&S]"H+_$N#7!"ED'N:A;E#TXWJA)%[)"'$#6E,
M`I%S&*=)W&$,F`L:<4\*S/9PO&Y&LQ]HO&P1)1Q"*[6!NDP4P'PP;6#5$L1B
M8PK+&"_=:$*I-M2_:=>T#VV#OQE3B,EH7,@ILP1](4EF'M^K!;QU!N<9)]N^
MD['0)RG-,N)$Q/&2S.MLXX@YIB84R@8MIPVI#.M6+9IFJ_HY8O)!Z,C1)C@&
M"WGCS?H$&#]J$J;>\6[]+=\<M[(Z_VK_#9<;^466.?B^VLISR'49@UN&_2P*
MLIBZD1L[-,(T]%E&?)\G)&$!Z`"6&8N6W]$.9-VR0N"K;P[6WPR0MF5AH!M;
MABA7&YM-SS9LT&6(:#O-XU2XNR"$9KE?B!(:=NIE9S<+E(%**38'#3Z+/\0_
MBOUM'$:^'Z<X3HD3TRQD?HH[2V+&#NJ#I/'QEE6N1X0D)/1%@H+*F0YK:MIE
MF3"84$&YLE9Q\3DC%^1G!'T+T9HQ'KQ1@W$4&9HJ0L5<[%ZVGZSG:.T!)I\'
MV*>^2Q+/<Q/7)8%'.\L9=D!=(`V8FUAEGF-$7U@E[Z*,DQT]FG5DR#K#NK*T
M5V!R`E%ZBQ]ED1I%[B)%:YQ'%T7,`%G*HD9/E53^E(546F.N)TMM^0%/@I1D
M*?4S$G?&XM@%]CG7LP%YM;3;E@^+R`!U2I,Y-6FR3QE,C09<U8#F.K[])B\7
M5&@<CPL1GI%.5"8?+?!V97<#'I]NP+<6'=]-"7=2,>6C$?/<.,119Y'1V(-I
MS`A#UH5&L7($>,-0GUK5[;]).(5NYIVHZU'-)4?G&;JXP3::UH4(DPE/7FU^
M&2)'6:)^K\K\J;DCS8_EIK/F\2CR$\>GS/6]C,=ID'BG\18+$\A43M.$Y>E;
MC:HM"8#N)"Z@`NDRIZ8^$Y`&4YZ&KP81JB'-)3MO4W-!<D9RN1"Y&>M%9?0!
MTRCRV==?:&U1G,28IF[*L9`VXCE47GAK;(6N$\!K>H)-6!_]?#)9EA/.H)K8
M6*<.)C5UT<T>SUPZ\Q8K%U1F%(D+T9AQ/KQ1+G,D(>H+.6]NJ[T_7?)R*>5Q
M(NN*^9C';AQS3#JS)&"@G?ZQMBP/;"YL-[_7OK4ZFE_%A9\)J04N`8UDU<YZ
MT&6Z+JT,&2)Z(;IES)V7JT5&:0*IV<`>/M#5;O=4E/?_7&V/?;,(YF11RJ(T
M\H+8">.8<NYTUFGHQ,!U:C-&[8^HC@]BUE87=+LKRE59+\LVE2317\7AFWC:
MWJR:OLWW>W3XMBI1ZJ#-ZFDOCR)NCYM\4_]94:)U]X[7W^0]%QIB:2)\ZIHY
M<=PTI'.`\`:M#J@#B6J4\W6X46/OBI(:I']!@FK2JS=TU3AIAN3U-I0]+$D<
M,(=$B2-&J(['3\>P`H^8E-6KQNSO`]K4NNM<FM`XHR0:U[9%"9JVD"ES_%,(
MF+HW(.$"DJ1>2Z0K3LNKW:?5L))IWYV'AQA[<>R'H1]D)&1.X,0LPX3SD'/F
M`!ODF+!H7;I^?U'/5P[=V@:9VLML1JA6$[6I.88I&WY=$'FX)`?H'&NG!,AU
M\BYHG4GJ%R)X1EUZ6=[#.%UF+_+T*`).LX`QE[IA%M$P"8.8=2A8Y*<P%31L
M?/ZI\5PS8M-15!/8&<,'TUK(;:$9-1?&YP7YM128A2BQ+>]T[A3IDJAQ+6!/
M3]4BR!.5K:/%%/ZXV@[[I+W`Q%B08,RIZX>Q[V*'X91TF%P6`P_:6H4RI7:O
M>\0#Q?[ORSTJM.\9V(B;FCXO)F`PM1[>3>AQHZ]/:(#\>:/(^;5[#-<7E'R2
M$"Y$UZ?Q]>S=".L$`XXUK[;%O_/-;ZNBE)?Y/Y0#E"\@>%Y$O8`'F!,NOB:,
MDZ2#D#$?N$=ETK)U1?]S5ZWS?+-O"NZ<;SX$/OELD'TUH9Z+=I@N=RB1A-E5
MAZY*].PNV=PZ#*#RXB%J\P%9B,I:<>W5,6M;]*D?B#PU6!?C]^KA,2_W]7VW
MCWE=YHA6^\/^T[?5+B>K?;[Y<_748.MAD<3S4^Q3+PH)=H(H%8I>-V,G)(X]
M'WAVTC*:"8Y9"G"_?I7H4`</>L#2=D34M'9)H8#I;X^\7L<88$<M>%2COT%O
M14M(\VRB/)+S2X=")XKF0L1[,G=?'C6=E&9ED2?'?5'F^[V`]+4H6T3KZKZ4
MR>?=1F`0PWF9;G"]1HO7_W\L=OD&EYOWXC\7VWIX*'YV?!"_7A[$RU:(7][?
M!@(G(SQVHIB[U,E<RGR6.923S(^"-(.<9IT+H^53L$U-R^($"-8R?&YR%'/%
MSQ`[6`[I/$(#EVY0[Q0:>H4:MU#G5[UL/O`,M:[=(%Z4Q2'_]7WQ77Y$[^G$
M><92O"[DG[F?D(7DI=EIJ);UX@+SV&]5M?FKV&YON<>2./;3*'"<F.`L<2GM
M/C_P*8<D'N4/M9PI.AS`U*#.B9J66Z$#)K[7F;"BBIW9"S(&)F<AN@/'78U\
M*F8<H;+\+M^)'WY>_1C\\`_!5%,5^-9W_!A[J8\#[GAQ$KDA9YT/TIG;,K^O
MFR3.,WH=C5_IS4R;-_.5J^K3[!:F;("%MBW0IQD'MN/C/OUH=YI8+VD(?'IL
MA,O/?J-W^B<>#5^+YT1#9&./U4+RUS*YL3B8-AS`6?)PC[;YY=N4!,1+$YHP
MG+I9EF"'QAUF-PQG6RX"`YUBS:CN+SEC-H5';_KL:35PB\B6O8?MW_S$N?%E
MM";*A=H/R=\P]^ES83'7C0S0/+DM/]QFGINZ3NIZ*6-AX'(6]XM<3I2(=%8=
M5ML9TID"-E`&.[FAK(:?Y9^@4XG`QUVQOG#_<!G1FB%]&0[4,C+6I5'+\G-4
M/M44#1+\OV,F@KAO,_F`PZ!Q9:S?\A\>"L"[G7@?F^*:Y.G5L0#\UVJW:1JR
MA$D4N03'S(E]FCJ13YVP/A:`*4\R`MKNF`Z5Y5G2\++2\"#/LP,_0V_DR?@W
M3OR@VJ71S::LQU@M/RTSO+#,-'5D+5]2&QD(I?MK4P5[(9EH!L?/WGJ;EGKE
M[/.G>*7^6#TTO7@P<9TH"V)95-Z-78]$B=?92#T60A((Z(,MYP")!4DP>KVU
M8!RI";`U>F`:JLZ,%?4;LG!!P+3(6H@&Z6&O##PMFDK0M"^Z#6.?I7&0.7[F
MBH\7EA*WLQ([%-1S#_C1TZF!7M,K*%,P1;!`DK8FS-/*ZCD3"KH`I&QAR@!%
M?T8;M$BXJ@Y?B^)K74;J4WXX;,7`)-_=5;N'E?"P'JUTA9*92\)8EI,*.&6!
M1VD:M<,3YC":$A6Y,&7+LG[4E2[V#439.KS#B/8U2$4Q,4;L9769@U.8W%RA
M4Z&<NAU>-]7Z*,?@]3A]4?P^0S8ASR_$7KI>2[B8C#BU@"N2\8:BFZ9Q9HDW
M[DYEYVF##A'/F*,DR2*&(^YE.,@(35*:=N9<!NNDJFO#]J!Q\,(<RP)\-4>;
M.L7!XP2L`4>1`\(^:2J,H>&DL@J98G,I`\RQ;KP<:1JA17UCY-J*V;D%L_>G
M@O<DH810[.*`.:'/_#BD68>,$(Y!.R+VX=C>"E%8)+^R1OY>NR7'%-%4W/M8
M5B"!FQX3Q=#.9L=HYB_M<DP7UH7H^Y0>O]S7F)ILM86*P7;+H5K_Z\.C1/6;
M`'78GZKTNP2+9(5)E%#7SYS$%^8ZN['XAUHI$F/F(%*A5VMDL$VZES!15>-$
M]S50R+3:"+T*ZQ53\ZJY[_SA#M7X4`,0-0B5FH-8XA:P9C$UQWJ+%E<>WO\:
MNUBAP,*YU0J3!"YAN<*H/Y6E)VVJ*416U^5_5PIX]5.[KR];?/ZV*AOX^P;_
MNU+,B8IJ<QORQ`MIXF`Q_<FBT'.S-#[A3[`_R43#-&C;TY'Z?=993%D,0[9G
M''-&=.)YR0UJG$4#;U%3%J>N^=XZ?--EV:)$C=,_RQP&&$L;,QU;C]///A^R
MQHNI69/=P`':8N^*[P+S]WP`!9>;_\DW]T5YC]?B1_6IZ;[`65^T#+N^YP51
M$A+?]=TTS/RTF>\1)W$S3*'MLRU"L3XGZ]$/Y0[<8MMF--0RVV+"`,M6;_-?
MWU9ID:,>.AI4BIRSZN,(JB\DDTDBN)`$,8VOK_J*3T:PQIV3KF)/<\B81YBE
MS(LS-TPBGJ0XB]O#0YS[)*%Z-TA@-FS/.@8K"AVPT;<Z@"PJSAHF(%!SY0O$
MG>5[$\_(N31J'DGG0C1LM!MG;RB,H05<FZ_?!TCC('*H2\(L\B,:NS'.DE;B
MG#@@H,,C\$^WK#;]6Z*_<ZI!F9K`V&4+)BU`HJQ6]E/9;=3G;B$Z,L*!,T7_
M=*D`:T=W4Y<==V(`U4YYB4.CE$1>&'/7<\7LET<GFUG@@U9@1QFRK"CORO4N
ME]42#A6Z'U<+5(]'F+98IU!/9F[Z$@4-LGD6$R^QI"`^H\A=F`Z-\^6,)!D@
M"*Q.'ZOMEE<[N6QWR]S`2_R(N^+_0AQXG#NX,Y5@$L#6O'0LV#]>T#<"%!^R
M17<-,/GOP[<<K;_)M<UZN7ZD6H%XA8F4+4)UAT`2#VH!S34(&G"BH$0Z#"Y,
M@+1<.*,[^G3`BYQ'49)PH62.Z_IAYF4I3YSN\XG+^.UC+7N?#JO=`:8S5S\:
M\BZ\1*&1LK_F]T59RF0MQ.5QSGRM\$8HD[>PUT`=][G:WS#'P0]\O?5%F[1R
M&\84AXPF/`AQ&D2)Q^GIY:*^`SK@K67`\FB_QJ*9,&%$P3*F-8YTA_/-28$6
MT4RJ,"1%02&T.%R86NCY<$8Y1A`"3YL.8Q'!*75IEB4\RV+*P^[S`\>C;=K,
MR@TP:5[[8'C2[#!HO!9YN?DIDJ4J:0M[_-5QGTN6,,?53L'W+7::RG;9C_7V
MN!'CIF<K_(--QI!'/,&8,"^-?!J1,&,MA@S[S`6<B#=MVOKT]9UFRS4[1%].
MPK,S#$O.`VK;LJ`GK"]W#]4Z'$\0`,`!^CD#H7>8_M6SCO)30+K%F=$GZH&T
MO)$<K+*[A)/VUGRK)G@\-4^:5'=-4\.ZI^%+;/QX..YR_%#M#L6_ZV<Z^R&/
M1^:OFUOSE+L19R$-/9<$F-(.8^"DJ<[QE$F`69XE9OM#\5!W++ZK`:/5`+%<
MD46K;K=C;(O1:>.I-BE=;"AA^7)XNN9,!]`VD=Z@QALT=`>U_H!2JM6S.2;B
MH7"@9]*P+V0",H_O9XX.S1"`,2<=3R899L1+6.Q[D1.0E,<XC#N3*8V!NW-C
M+/W\NW2C>(;)O&V"]55;:U8SU?%(@**.87AA`CG*E>M')37I45['R<63=WA7
M?CI^W1>;0KS!MUG@^1RS,/%(S`CF,<<.==(H8X0(G22PQ1KXYT^Q(E.CDF*T
M/^%"_]C*)B3U5<![D6=*N::YEE/@^_P7X)*!!JEJ"S-VV02OOC0TOBM1#\@^
M4[`5%+N,:2^3O/$`FE@8>>7MA=4/?686LL0QPH'*U$,"'"S^<93US#[<?<P?
MQ7!5IO!/^7U]7^<VB5*,XS3QQ!<G9A$/`K>SF(;<A2P]C#!C>2&A05:/$D_8
MT+X%!QP1CB%3;4`X$8\PW>TI[&&A3U<IM#(*/$_0A4&@`587,@8TX4EE_)&#
MC`#;.^"?\]W#_L,=7J^KHS#U,5_GQ?>F*PBG\F!9AH,XHU%`7/&_SF@6<$@Q
MJ]&VK(\,NWH1!PE1OF&K%J10JPXE6NV*O=S0D(\#>MQ5F^/Z@/:K+:PP]WCB
M%4:,DS(.4[&.ZAJ;+'35H4,]O&GY!(PK)^55;XS9\7OQ61X]Y+Q&Q+GAIS$"
MES`4->=,9>,9@Z2#WXNR>#@^2*.\VKUA-&*^PT(_3/TLBAP:I#P..J->YD2`
M=##:EO5TT"*L7Z%VD^O5*P31J/'L*FC^I+3"-+_C4V*3MP_&:OYX/@&:/RFO
M>IJO\KR.EOQK/)R3?&/\+4'RS3E3V7C$0)*_^G'%*/%]DK*4R4;H2<")Q[S&
M*'6"$$-F`*-MV9?\!J$YR1_-KHKD3TDK4/);/HU)_F@^(9(_):^:DJ_PO(Z7
M_"L\G)5\4_PM0O*-.5/9>,2`"]'"TO'AN)5'NEC^*)Z5HG[NQ/?;O"X96&Z&
M)RK^W%6/^>[P)%O!'<3/9+G`1_FTWOHX8FD6IS3&#@FIG\9NW.'SLA!4%6$R
M4)87N0=^H,W`$>#Z]G0Q4EL-7V1X8.EH&)FA#S?HY$5=HV_HQPWJ/!'?25]N
MZE\YN3/QDKNI*%Q8H)\\T`M9SI_>[VKF-TS[K-L_5[M"YJ=N\S0K#W6)P;:5
M>)HE7N0&<13+"K%1*F_:U6=5?,_A&+27:<JF9<T?GM+J@*+31G\'=70=P)&\
MJPG]')3#=-P4VY:/QEVD3^F8G)D`+$1?C;MU]OB<2=J4U?&<4?)$MZO]OK@K
MUK5L?[BK?_)4]UH/B,MQYM0E/#C/,/<"W&%)73>!2*45`)9U\\+;^_4)/<<M
MW_8&.?HBL4-EU$Z`U#1U]MC`!/:2J%ZAWHJFZM!W06"M1F,A:FO7QVK"QQNH
MPR\MOHGMJ>UF'P1^EGII$)(DCC/.DS!EIUR0N1RBOT8-SZ.[8H[[0G._-'BA
M6FLV"&H:.QO_1K15AWHK6@NA\8+&6HG&0K35CF_5!(\S9&OPC_RX*QX>CF7>
M]F$FKI>D;IKB1(R?Q3^"-""=$4(I!VP%@C_;^M9?CPBR(07G2&%#SRHY,+'J
MH2AT5S=!#V!_SBI->OMQ/:31NVXOO3NWRZ;-PA)VU?3!5R8>!!,S_*?WI[+D
M./!20GV>"`U.6.)'F*>=6<8(J%C@6%LSC1_']"$83>^(J;@E9LV,#.?L67"%
M+>@D6X/GA8SYC+FC,G76IDGUXN]W84FFMW?EV;72_,?AN-J>.N@2$C.'IQGV
MW8#P-(I3<EHUY5G*0/>"S9NW/C[L0<M[FQ<6R/[10O]%LU&WE>`HC#KGC@I,
M*W_N<(`N,<\;%MT[SFKA,7#K&4S/N9&T3::7,-BVZE\UT2,+27,?<[DV(AMS
M5`<!IEAM6?X]WU;U(8G?BZV`4Y5Y>]-&MDS\6#VMMA+=AY)6#P_Y;BW^YI.\
MV_>_I8A,>QF'5EMAHMHUS77O=WG=6O?6BT(_2AV>X"`(0PF=.YT'E/@9($$N
M"[CUU'IR%SUV_J)-[S!ZZ#Q&CZW+]1&L7><TJDJT/KG=7,9$1^EX77SH=`5N
M/?0?K3H"(-E@69%12>O+0FQO0-`_1"='T<!3='*U:PN_1\)9=/(6?2A1[R^J
M'4:UQ_TEU6=.(_PW>(```Y%E(;<_A)%EY-;RI.BA.H@'XB0]1=G5M#T^B@PK
M'BTI1F]IU![]E6^W\JN4(>':ZM!4;EC)8Z:E2'](4BK87(GLC>[R7(P`T'&_
MNL]__2I;M+<2]]1_IKJJC1Y931KO<V.R93YT2QC-+929:O&*`1E!=AIP>KO;
M%_&NVLF*E,WYW.KN/^Q=6W/CN'+^*WR<K?*>(@E>DR>0`+<VM3MVYI*35!Y4
MM$39/$<C:D5I=IQ?'P"\2)8M"5<*FTKMP_HR%K[^FOC8:#0:):W9;6FKL#GY
MI'I.C"!1[VJ&499"U_4\-\S<Q"_HGMP`"4"?JY_P%#@,)XM')7TCDNS,TL$"
MIHT.-<)A5CB#&0ZS0^0]:]IS')&714X3"Z7^+_I+(-"QR&^*D8LQ__%%$&I$
MG@L))G*/#>_XJ4QMIG_Z9;<KLIK$$O/G=;-JGEY(D+`IUS2;]%SNX+9"%8V*
MZW6U^-)DU=<UX;AM5O6"GJ@YEXB:L6,Q49)@!*(@<8L0`S`@3J(@E]S8F![H
MQ%L@C\<&TOQ+9R%MH4J61-O*68Q&TKND'RNR>#FVT_D^9(7K(2M<]:;*YN=O
M\'`(;JS8_52H;,'\_^-`'P?)C1V['PL=6T`&'P^M>TC:/<&SVW0[]]L0Y5C"
MQ+D=K%L[1^IX[FI?]B>&_WU?KNKE2[U^&MI+H+J=KYIVOSVZ':.`,,U"#_HP
M0/3T<.&A"&$OI#WFXABELE=5Z$<RP6Y46VV)^]E::4$0=@U5:)*W7*V:/VFN
M5O96(R.NX2M[L\4G8C'&ZY.^/6[FBP/R0U.A`W;GOVVX&T.8Z0OE=%/XSY)2
MNTE,O7!XV"R]_&O>-?'""WV+-/OV8=L\;<MO[2_;IFUGOH?\#*<^O04]S5`8
MX0AE'OE_ED59RG=1G89A#.>-1W!W3@_/&?#=.0RAZ,I`@5'.A=XT9(HOU*SA
M47"%-`V?<BL<AH.L1WJ4]!WUO>=WTT-U_GRNY\_.<_F](FN::NW,RTV](Z+R
M/^RN1*=<?&=[O^Q&A"?:^X5^4+DA?_^]U'%9Z@4&+ZU,U&FW966AP9+3E8$N
M<B0B>[Q<5O-=_9TL*L@:NOI2_OA$EAJ?*LI&O>J2LR<7WR6%'X(\)2@*-XQ1
M%N4PZ6^.BKT\2&1#>P-0)HCMC]&1&;G[DTY*6D_Q]6^?_^8L*_(XTA(RH@1[
M-A5WY0]G2S=(:,Q9#2://Y9>!YAPI.A"X,8>E%\)C,"=#KE#H#L4NW/B8(ON
MR1,GFVLQ8-"'UJT&3-IZ=CE@G&#NMT`'X#.1)E;P,I9.IV'JN1F*`(A='P$O
M2?P<(1R@,'.#/+K60UCUXTW&K6QRCY"X3G`8F<9GN+DP0U79M&3R*9O1Z'W(
M!*?,IXI$:_NJ'<?!/LK<*`[\O,A3`(O`C;Q^',\->"^PD/[X"0*<#M&_"`8F
MXD3QB8I1AL349(!R.Q4Y)>."?$CS9HENR.-O-#U`HDLL6F7:#T9OWVT_5F2L
M",:!YT5>'/HI#F!&?C",%<(@%&ID*C.`X03;0W=]V9VSKJ;N8_P>'9<"7A7V
M+)D3:C:<!JCJA/`EHE_O:?Y;4Z]WV;ZMUU7;SB(7)(6;)R'VXH1,OR+*XWX\
M'_L!YP7WRL,8?ZN^!N?\@Z)S'GMX(KE3)3(Y,M!3L2CVYCVAC\%RLJGI$T@\
M3T6C7-IY#&38%93[2\^F0W]7MSMV4(A\GM,^TUH;\LUF6_U,DUCSYN<-^9B&
MI4O(5\N:'7$:4V+_ZFRK^MOCGKQ;V!*,_&E;K59TVY5FQ(Z/:58_-M6ZK5[_
M-3NHV0&FQS2[LYGT\MI?OWS]3_B1@-JU]:(:_^*NSYCWP(5QY^6Z7)3*B?,+
M3\"YM+F.A\:&I+D6.QK-LTDPFKLGC]/V^!5)WXY)E@$4ISD*(,HC/P["`@QC
M@<07K'&1&L+XFXJAFCB4>X^)"Z&<$G&6A')J-C0:GR3)A,BL2+P"IR[*80AB
M7)"9%P_+*!^%()BQ4Z]B:9"K'RJTG!G'YW[XO["#NOW;1K1$BY\9L<R'5E+D
M,AXW2G-PI#>XR;%DWHOC/I/.$#2<O_EUT[*3M+B+Q0YIDP2FR",C>4D"<9P!
MG&1HU!.O$'SY20]C_`5(D75[M3TTT4RH/(-\NC`)=6(ZP2!UMUKUH&Z7(SU'
MSP4Q46;4$G%1M^.T@[0>8H3$YW[)LE&?F]5BAM,P2U":I0"@S/<Q@IX_#)-Y
MH2>N.2*?/HW4T/4P#=WNB.`,?4'*HTNZV!';^1_[>LL*OG;D`VI:DE"V;;43
MC5&$">:7)%/,BBL198QA<2B8&\C/$1575$>&-(O$1@K^.QHC3X/`NJ6MR#]^
M)FIVU$.D%S8\S#S83[1?Z=UX\ZIM*;I9AC'T(DQ`)44:H2!W83!`BA+HB^[Y
MFD,RP?9P!_XT=S?Y"D&:PXN+"O.>L63V3F+JFZ7+5/3R;]IVF>A?JC6MVJ37
M8RZ^U>N:1CFT8JO'-O."#&5Q#-,$%7$>1AA'V;C6(I@$*V#U#&I\KO<X[YRG
M#FEW@NT55M'J54UT\T4E-^!9+%@9"?[EB.#7((<%U=2;ZUS47=INU\N]):JI
MVZK3+7D3I'%K85'66WITK?J]*NGQ-"K.?Z]WSU_7S2,]T-J=1-[LV?7R1[6K
MY+O]=DMP9V5;M[_5Y2/YS>[EE[)>_]:T[:^LVR'5<UQN:2^W=A86A8M]E\`/
M8[?P/0RAVQL`,IA&LW7U1'=Z^.34'MQ<2I%V2G%L(K=@?*#@?G)6]-0061DN
MB>7.=VJZ0\T>K>^:.JYW!#3]CNV$TF,)E^^0-R(DDSGG@A;9]X!8(F<6$M/8
M/K<5T^FS*`T2+RI@&D>Y7[@1P,$@W@!AA$2VS80_?)+ML_EI`ETQ?WZ=,KF\
MN5:V5//E-TZ2"R3'N6FS1.3D\5])A@L2P5<L217J?DWW\N^7G^JGYUT["_PD
M@'Z4Q2#`"/A9$`7#TA=X$/K<1_4E/MMP^3!%-!1UL1/,#)5(09\,7Y?E8@JJ
MQ-3B-BP)5#L:9DOR;/T):[0(<.B&3I6WH44S/9<D?%Z57:=V9[G?T?8O8YUA
MAC_^]E^?OT#R;^;-TWHX=T\_[E7=9#L>,B-_5+-32LI%A&^)/5<[J.`"&TH&
M5>`W>IY$T0+!#5M0K9^Z`VDTJIR!,`A`09N68L^%28QB;QS*)^\&D=A.YO,-
MAW?]:4I6--QL^O6D:'0GQ1M?@&>:,C'5'M$,1\P_4$`_35U:^9:32Y65"@Q:
M$NXIF7!:5ZE,![><?&S6S>O1AFQ?`&&>H2P`@1L%9%@0X80,F,<P2(E^"1XX
ME1_'^'8#JV+MWYS.AW[Q^-,MCI:=)>G"U%$GUI()I,&01O<S)]7G@$[7@IB7
MLTSHG@Q^/[ZTLFK9;`\-&:KV]WK=;.O=R]!JDZSS7G\*_F-/?OU[M7MN%H?F
MGD0//!"%/E$!/\P"`MY/X7#^``1>&(J\\VW"/4TL\<CL&28]/98SG`%B"22&
MG4;;7<9[R5IEM;NJ8JI`?T#^1#``L8EDH<8:=D`V%S"]"I.Z*/-@JG.P=7AH
M.@N<S@3GR(:[HZ8^M*X._]AM2Z*;];K<OG278-\Y1)3H%@G!N>IBM(ZGF[0%
MF<2S%]Y=-CY?EKP-K:3FW98HEF&4>6,3:'UDD%7K:EGO9K%+5NQ^CN,$`I=$
MW2C*QEV9,(ACL>!7=A3CH>^O;]Y_-]&A-\Q<U0QY+JV:WPIFO#L756F1C'3/
M3=JB\,CPJ8>C#.+,0[&+AZ-"H`BS1*S>0L^8QFLEL&+P.,'[7O5-K<J]57-0
MFU$7WXYZ*..>GP^LKP!+'`4)3B,O#8,L@C!)(8I!,HQ`QLU%%HH"'VMX'?>Q
MVO6K-\%EF`@S?*LD0Z2(+6(H'Z\6,FPQTA_K>:"G>NB]S[O=MG[<[UAKT5UC
MR5KDP-\%`9(@V1*5D4'>*#]AHFG@:G?0J^/'Y$OS^B$9GI$9#'TWC#*<@"`&
MKAOE43+T/00H"(%(AS']HQNN'SBHC_-AQ=(&Y<G46K^>6L/53^T-8P!AEB]E
MG8UYS))9:]#`TRRU82KE-&"6IDG@$9$)"H_VA,\#6(Q%1C[&GDC8(/;)DT4.
M;R9M5C=/U9J^./DK*`S,3=YYQ\VDC7.*'_RE^2)(`?=<&,IS'ZKM9]K`Z]#N
M-_%##X<IC&%2%($7%^ZX#0LR7_!.`NEAC&>&CF;)INJ[F%UH2&%D4IQCY\+\
M4";4DJFB;D>C^4E3G$"T'GX^"Q$*O=2/DQ"E?A&$>19&8[$[#EVUV<,WAO&I
MPV`X50_N,'WD7C<ZV>5;SYJG56QI.^!Q"""'(;IS&*8;RQ'#(*!%8CQ:*D2"
M1EQ1(1E*I"4(U:O]KEK,?!R&(8PR,D8:1K&?)\FXA,Z0#]5$B'<4XS+4`YE6
MB+@YEI,B$^2JBU&/ZL9RU*,0$"11-BV5)&$SKHB2'"W<LO3WBM:'5PM(9G7Y
M5'W<?WNLMO=+-G1[O]^UNW*]Z$\0SF?0S7&2A#D9,X<AROTH'4`$$?!",;'2
M._9?+)(R,@N%&+TP-\UXQI(9:\BX9HJ'6\_L[C7E#999CKTT2W/HYP7MIT`P
MP*&A7>!#7(BDT76/;3B)KCM`F7)^G^-4?(8K>\?N.:YN'M\LUT0C?P.GX=3=
M_3(OV^=BU?QYW*4R`Q&(D]Q-4P]%7E&D"3T'YF800#_@/5>D-(:Y$/CS\8%#
M"LQAR&[7>?423Q<FI!9Z+9E]>FPY;0NDCR"132@ZUL.V^5XOJD7V\K6E[3+&
M$U&0WFA9[^JCGK"1A]PPP)%+T'@1>:,7F3\@00`(UFH:`&`\3F:3<,DFX?$A
M2=K0=40KVDW:A"/X9._&'A"ONV'T#W"=QQ?G`T7LT(Y)A\.8!]2W$TIQ9B]O
M19IRDR6B:M+"MYN:9LF4J1P,70]&@5?D&$0!`@FM.QI&R`-/L`NVP`=/N+MI
M>:T;+U.6S!@9Y.=KW<2,YW["X>(?^[[\]DLSM.^J7I45?&F$9R,JBMA/BR!"
MGELD81)&^8`5N)E@I]:;0#0^ZXZLHHOZ[6`7*XD;CF(V[+NY@8CF-G[GBWFL
M=[A85'3BZ=$@YTV9,OWU7R9^,N&E"^^!FSX4EKQ1;LM!8]$L%7S+H6I#!+;K
M2DF^7E7T"]K:]^B*CYE;A&X<8Y!D41#[*"OB,!C&3GT@&.%I&=+\OO@1RJZS
M^!$\P5>*'I+Y7A&3LRLF^<?P[IP18-=:G(MA(Y+-P]H%"=9*NB62JM>FQN!3
M*IJ3[TN*JD7>?*.G8+O1L@3F;NQF252$`*2QY[GN,)I/_A.\1$%N$..RQG#]
M_$B!.?,C9*(W)4ARR+FC89X\P;V,(]9R+M;,[&"\R\NEO0LU(BU1(E4K3O<K
M=)`B$&`MJRV[+^;]D_?80WX.LB"$*$E1&!3^0>1`G`E>WJ0ZV@1A50?PJ*>2
M<`=N94IY(ZGIN!0-HGH2#XV$AD[=SH<>WM2='*^P=3%XTL.S)6JES9PW(9-.
MFL1NFJ<G#,EZ]75WO#R)\P(COW!A'H7((^O343!S/P!B;3ODQ^&:9RJM.J[<
M.:^;-CYU,LR77$]9UB*S!S4F\'I<D[>6/4?0!2E2)]42$=)@R&FS64W4B/0.
MVE8D2D-5]_^C]%A>;NI=N1IS8QDF8@?R),.XR+TT\#TT[``%>0P$EVX:!S9?
MTO%,OJM:UO']L/?!KMYE*955?[5,774M!40W0W0Z@4_7;L2^F-`-()T/`\R?
MJ`L.VQ`]U-OM0?#3>$$.#?C"$GTT8=G;QDYFR%-04#B?-_LUNXVJJMGM5#/7
MC0%*(Q]C$&8(@A@7@WH'81)GPLW7U(<T'M`-F.C><@]*61=EJ)551%.<ZM3"
MD>-/'!Q/)(%O>1,2/P7:K94]%9NN"IXR80I21[OGK0G9)/*9Q3B(`P"]R(59
M!A(<A"@8!XV+<-"X+_R':-0&E%"X+^(G9P9$+\KB)D2FK*II)U"GG!V!N[F,
M'6$1TB\9@JT5+BECKBJ6/$5J4=EV3V*8PUIMEB(7QT0G"^@5$?)R!,=JCR`-
M<ZY+];0.*#+A)`[Y]8C&.SF/KD"C-Z724T1'2UD=P9HPXPK!FDFR=05KC/[?
M>#B>+E@[X4TT6).EW5K-4[&))UA3(TQ=`8]N`'@H7[IX,4!D:1S#`+@)PFX4
M9@`.$%S?2[4(H<2XAO4P[T6/;8\ZFPZ4+MF3H5E1_0PSK"G$.]S*XCQ<HWQ:
M%7S+GXP8*GC!=DU4,8U7&I7I4]G[H+'0:0+Q8[6;D1@5)5D("Y0#%,0@1V",
M4@LW*53S=](#3[,MZ\P%=T#4-T"D/2&]`6+4!5HW0)A+CDYC'/SPV[$?/DY^
M9R(_JV+[(:JNL597U2V[OA^BASP#30-F+B;BG;G`"W"`HCA"<3BT+2"*7P#!
MMM:ZAA6*.N5Z7A\=J=L<G;5Z[V2=L58!U^GGD](;,2\FI1*M`:SM!W!!.PWX
MPA+M-&&9]+E_0?)4M;.[H^C]$VL!3G'F>1%P<^P7!!1.LC%[$!>"/=`-`#!?
MG7-R/+D>P.ION*+D""4UG<H#6E5U!&W%@6%Q9L6%5H>;[!9<+1;R":\^,D4:
MKLRK:L%NB?M<KBJX7OQ>[O;TEM3[)?Q>UBN:D"B:+?WEYVI.?\/>!R!Q0>@5
M>82`&V6%#R`:X'AQ+E@;:0J%<2D>@'="W!)TW;+T6X>>3O]F2;[;_K/JVDFV
M(WCQF^/,.(I/I6WPD)A4OW8-A<4\,Z"F?AEQ_[QLMC]3[SF?.?QCJC>/#,$7
M%-NTRRR1;>-FOFT1-`&M_`)>OO0M(>#\CWV]K2Y`*``F#U_AX["`*/1</T_&
MC3?HY:Y84E?GR,:SN@_DY\]EJU&/=?+.J<%3$RZGNSU*VENGQVF7T/*S>$E<
M#?C"%D$U8=JIB!JC3UXXLWU;KZN6:`0)S[NFL_UO%K,\"TD`'B1I#CR7MIOU
M@V),?Z`TDRCUU#K^-)6?#$Y;TW/M3$<?>\3CM:(LRUOVH%4%5<D?DHIJW`?:
M)/6`E.U[C=VPX57VIU'5"TR*R*H.A]BJJUILNR:L^@B45U82,F^J[>[E@3S5
M.Q(OT^OH-_2?S&`$<UK\E6#?BY,B+%`0C4%Q'N>*$:G\P-,&I)L>YYVSH4C9
M0K4:L*KJJ`+[DBIJF'9M&OHPTLZ0WC'>\77>IU'0LRR*Z*>Z*VQ53PV67=-.
M7>3)*R>K92`P%GN:$:ZZPI<9`%F&PC#&!23Q<)2EN,#CZ``#D>I534.:+EQM
MUC0O3FM7R?/2U@NV0]FLG6VUHMI+9W6Q_U9NGLOM-P?^T@6A7:BJJI^2/I#4
M3O/TJ^MF5X]U`-D79-U:,-^E3D0LU;BW52@5K;HFDCI($Q;(HMD>YV$9AG=V
MSV;T"D4`B]R/$P_E'E'J9"A;"+TT%SR&KGOT:6I9)?5/&\5B0C@IMVJ*N&RV
MSH=7VTP_]=+X7AW`C=21DT\.F=3M&<OT4KMY9X33#(T&*JYF.(YQ$H<!@A#E
M(4YS%X,!`:`WNJM7J\H,.VVUZKZK[7FWR,I8C=5UZOE$]4:LB^FI1$V5M854
M6@JHN'UAB8*:L$RZ8$J0/%7=+.IUN9Z_7[(50AR")(U!E((B*-PTS+T!"?FI
MJZ52507`Y)6JRP&L_DI5)4<HJ>E4'M"JJB-HFRM5+S`K+K0ZW&2WX&JQD$]X
M]9$IL_3_5&WZW9/[9=Y\^]:L/^^:^3]GA0>#(O:#T`-A%.4XQ%DZC%Q$*5;8
MI5<8=9J]^6$_B6XG[>A)N/WVQ6DIP-LM/,\PQK?65*7;DKFJTZ+S*TH]9$E5
MC?_:MGNB!63@[OKSK^L%7=#."3*:#EPOWK\8@>ZIM.2?K?;THG2&]G[#*DMF
M08:\H,`8%UG@Y7Y`(KJAU#UT"QC*UY9/CW7B"O2Z-Y"J`)O\+$G5GKF=Q2FW
M6WK,G3U%"O7H-W@$.).*?QG?"Z8@7SG]UR.G=[8Y>VJ<,UK'-K;/W3;#-K_;
M.V<TTF%6.KV9-ZR#U^XRSFKYVSTJMKRT["#C0N7]K5W$_:K$/^95VWXI?_07
M:K!C`^]B>R>FGH$P]5(?ICG(?$3[.(=@J'T-XSC)1';ZS2(Q7`#0@:>-JYS'
M#GY_Y(I)57--JF[A&KY7E#U>$7L%]0ZA=P1EQPXY]Y:Y>S?E,/'+18GL"R^/
M:9QHR<MA(F.;6\P3A770T6J,[>F]!P,&*')!YN$PRM,@C_P,1>-RK/`%>Q?H
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M$@TU8ULSP2,MFJQ=+JOY[GZ)?W3]GS^5N^I^_3ZR60'\T(\@P$6`@(NS-`G'
M0K,,AZG88E[KT,97\AU:NN%4]7B=+0$\MLUN],FK7I]P)F5OY0S!'.SHA0&H
M0Y%2]L\J[]095P$F+R5833C$$G4U8]MI^M0<@8I1*B3!\W;[0N+D_RA7^VKF
M(3_(P]1UH8?]U,U)K#R&R"B.\&S#7@F?=^5VIQ*DBHXK,HU/(8H'3*>B>><\
M5D_U>DV7FK3"Z[ERND&T!*O"/E")4DT2KRT\+>FROT/I,)A61*4GU`F'H[+4
M6Z*4FHWB"D#5*-.LC?]+W;4V-XYCU[_"JJ3RJ.J>@"!`$I5/>)`I)ST]WFY/
M)5OS025+M)N)+'HEN:>=7[\`15*R;$L`")#LK=VMGAZ;]]P#X`"X%[@0,`*"
M@Y1E`HF8AI"'61<^B**DT<9LK7FAU8U5<V5L`;K0Q4(]Z:>GB#_Q2-5M@Y]J
MI&H[9352S2C3'ZG5PT.YJ_,E"D-;F&)1%EM1;A>K:ONT*6Z*'SNV4B=PPPB%
M29RD!(,P$CR*\U3BD?^E&4`$"),3/(Y->SZR<X1V/\D>XPT.@$U7,([YUUS*
MC$>]X9I&D_7@#X4VJ.$.?=W'C,QSVNFG5:8BHIZ\.U53GR3JA][F&[6Y40&_
M^EC/P2"*,Y(G61KE22XR1D6<)K5!)M=>B"'#.)NU'?]!M0::6L?LS]&9ALKL
M.=2,BPU"GF$0K&7MNF5M3&E[EZ%SP:W>K$Y$L!PX<AJV<D3-11FZ+<O;F:@6
M3TH'5:DWJ8*[YZOU7;5YJ$\5=M<;XX1D.:8Y1V$>)2E%7+"]X32".+N4P7-G
MR-^0:N'MZR'6`(,CA%KWA'VQNVR^4O_:Q%A^@<T5V[]H*YARNM8E$$>@5B5M
M&MY0)_<4CJQ2'ARJ?/4V3=5:%N5L;^Q+<5\J&^O=Y_E#,2,H8@((AC,2@R3)
M(`*DM2/MAA=$ROJ['J?Y_<`XX`D4(*O9?5LL?KFOOO^;]%)-[$C]08T;=#2?
MO\?`&P.E-UDCCXO^^"M'O<:XUW,YWC;SU=5Z6?SXK^)YEI`(9(CG%$.&$<Y2
M^4^MH3#)+FWV[3_LO=\W@((:42`A#=#S3T@XV_5M"9M,W[=VX%7G[T>%5N_G
M3YN-M)++[?E\]==BOLG62S'?%3,N#24$YY%<`E"2AB`DO+6%^<4W&7M]VV-,
M:P\IV&,*%"BY4%H&"I;7<?`>%^\,A=[436`T]/>A<MB7C&>$O%P5&RY-W%<;
M.?1"!``)!80JZ!]CCEG4FN$9N+17L_VL]]F@AA.T>`:8"E[X?W8BL&-J`AV_
M%_Q7DT`?&K2Z>[O=N)&_,B,4)Y0P`=.08)SC3(CN^S')<XU^;O2]`4(/"H?7
MCGWL\#L]VHJ3"71E.]Q5S\Y@T7FOV],`]:2`"`%,)!&3.V0&8<[E9J$S!(2.
M6MM]>(#NW!QW'V35\B8)%[JX'6$3ZNN6#KS1Z?M08=3[#\NB7/[-=H8`#QF-
M,\&BG.=<I#GI@D.I7"89]'_33P\P`HX7[S6H0<;`"1$71H$M;1,:!]8NO#$2
M^M%A,1;V0V]O+`$P35&HM@>8Q2$AZC1R8RR_7%^EW\>'&P_-Q##TB#@B0VM,
MV)`WN5%AY<2[X\*>$JV10:6E96UM-;^?X23.".4P82G`D&,J1U]C`+'LXH.7
MYA_T-P(Z'($"XK7/OW#YG7YN1\L$^K8E\*IOCS"/TA\*DNZ+M?WVM-ONYFM5
M@FT6`DR@8`GF+(1"[H8%Q:U5&H8&(?L^5OS'[VMT^\J*']HJC4<(APCGGR'H
M?&S?!;,3&#`NO7D=]7='DO:9N;I8RZ=R?ENN7I;@YB*.0HHRC@6AC,HAG:$$
MI41$,,-)JGOHU?K[_H;3OJ#1$:;QBM:_Q\Z9DUZ]"9W(0:_^?E2.>YIYX3;U
M7EUK\?EPZO7Y1KU"/Q,\`Q!$29+P*!0P!WF8-'9S0DEF],1F7V,FP\GBH'Z#
MKQM5ST>'QI^#/VJ,NB>]W!&L)U&#<FLF53UI]56&[2Q=9[3+&=,3T3!W_KRN
MK.:2*!>:]JE<%U>[XF$[RT($*6,Q8X@G+(JS2`*I;4<H3A+L2-?T#8ZK;0IG
M4`-U*'`&;/<6.3]$.Q4Z+8Z'5KN.-SO%,Z=]^JIGX9.^\MD2IJU^GZKM]LA>
MMMV5#ZK&Q=VU_!>EE%WU`[,<96$2IPG'),*1B`"+8&L<D9R8R)\;B_[U[[%2
MU0JWQ6ZWJE_Z,!0Z1\3J*=WPG)I)G3)_K&X?@A:BNH/>@@S4CPVL=5K,G1$[
MM\Q/1.T<.U7Y[*R&>B>*NV*S*99<_J^L;VZ>[J&;PW<SSBB-40@%S@$.,4LY
MS%H`&8701//<6?6L>_2A>EKO`OD3Q>:[E#_U#-+N6[D-9`OMC(N0.R1;3P?'
MX=DPD]E@#!J0]?VE5_&Y#T&#=&`]U&;PC":Z;X6)Z*('QRK?'=A0'^E6KG@.
M<42*(QK%/`%9BE)!$0"L2=`B&%(JS"Z1&W[<9`Q:W1RG7[]F-U\-1<V4(3WE
M\DB-89JY!C)>>N`E$6=4QI*QB4B)+?K*2;>Q$H5&>3ICH8BC)"($)UB*#F`<
MI.!@+$YLM,'4AG>):._0S&MXIH]N6Q)G(AD^&;-1CF[A,K:$G!!S44ELB9R4
MH%@[\::N]*/$<1$_#`5$!##`*.<Y3[,<=,9!1JF9W+BQZ5]^S*M!_\35^G3I
MGLB0<^R45;4^,\KT9_SO\W*ELFYYM?DJ+7\M%D^;%_N/D*5I0E/(4,0R$;(H
MRV%K&"&6&<[^O>UY'XJ_SC?_5^P4QF#;H3-=#_2G57-M,"B?ANN$%MO'NVKS
M<2O1!0=X8\4]+A)V;OW@C.R)")M#AT[7%8ZITA>TQ4)%-K=?BD4AM50B4,\/
M-39!`BC-.<E`'N$8((RCK+69AIGATJ*7*?\QCP9=L.G@?0C6A6EZJQ^?FB(V
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MS0V7S%?K[[+;5)MG.>W-4,AH""B.PS0E$4D1Q[1;EH>1835IHT][GV4Z-`,O
MW(Y9.+-0LR)K(@LS.^R5@]YB<R?L1=1[EH81@4@5H<-I'D4I%J`;5CP&N5F7
MMS#@O>/O3YTL7J2X#/>!-KSI[?X\$V:V6MHS=9+A&N/BW`M"SHA&#_8F(AU]
M/'CKFEP?,NPRY3.81KG`<11S@"@G*8P1Z3:)/.0F3T:;?=GHF*#YF]`WZE?Z
M"8<A4Q8I<:<D]4J%CYG_ULU[:[,U$7FP!'\NSVU(@8-DVF?I:V.;A(QEC,,D
M3-(D)0E%,6YMBXB;GK1S8?(G3ZF9D-LWJ^:)5:>)M0/&R>36#I"LTFL6K$]%
MO9SZI)UDLR;,Y#;M8['9/5_+GEF_Z?"WI_)1A9_4WHV))(FS4"IIBF@4,XAI
MTMJ,*8_--*Z7*>_:UJ+[$#PJ?/4AGJ)%:)-QZ\>LGL`-1JF9L!VXO.ZXS`Y<
M?C['I:\;LN_R=$;)G-`[$05SX\OKF["N"#((<^YD7U/WSO:+06DJ^[%8/:D*
M1/]15<L_R]5J!J(P#4&2B@3&(20P2>/NF!67?V\:_G1@<H"P:(NRV>%=4"U/
M,=++5)V-G3ID>B(CSZU/KV*MS@G3'HG=]U-&Y=>(@)0G%+.8X+Q=FT00$L.;
M!=J?]3ZB6B0#CR&-<6+,T43&@CGNJF?GL,\K'"V^48I3P5(0LU0(!"%D[=LV
M*`(4,.O4@H&-0=)JVZ,GE:LZAMXWRV#"HG&BP1-]?7(-H^W:WZ1%+^-@0>-$
M]*2G$^_G':PI,4P]S%(!$@(83+,TST-*\PBTYV<CDF;8/.=P\9.#)!MZ)!DN
M<V*277!*ATU:891LPL4T@C8M$QGIIJC?3!P8.JU?E>FHI.=Z65?'_5:M)"-;
MM2/>/7<W\DB&(<(B80E,HCS,<9;23DMR$IHM))R9];ZV^'1%V=6GJYNK[&M`
M/XL@^\OO5S=_-2W1Y(QE/?T8A5XSA3FN$-Q&V7;/XUWEU:7LC#PY9WTB`N;>
MK],Z37Z(LQ'!TXO($1,8BHQ#2`D0G!)&PLZBH)&U[)D:\BYT[67ZU0&C:1&"
M/CP:"YM/`JVE;`(U"=ZG2$^Z;'F=GEA9>_*^//4CQZ!VW&UW_X>I%U@CS*(H
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MF(2`\XCEA,=)*##OED=19'/7S<+*$$*S>2J60?'CL5AOBZ.\],B/H&E>Z.K!
MZ41&3V\W+KR`9D=+CYCD+(]Y+F*:IW$:P90*@O/\,%)I9I)PM?C\(,G7]J;7
M412R=Q#R,G&VP4>GG/4/.HX>:32*,&J3-Q%!Z>/!Q8BB(1D&K^ZL[V^*S8.*
M4,QH#D'&&,`(Q""D44)X&YI`B7&\P.C3WB?<SST"AV8D:8J%+W8,94+"^+B3
M.`(%9/`G;PX<G),&&ZJF(@I6V%^]4V--@/%S-#?S'T?J<WQ8#*`LQ!AF5%#,
M&$Y8W*8R$,D3PVNAO<WY/]C1C8QE^TZ**G[4+CS.E&CQQ*]N1F)`8DW3%`V/
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M<4FFY$?OK]9R@5QL#P<X.>`12D).A,AH1/9%:1J4,.>&UUH&!N==!?<^F!X#
M'[J)]"1RPFUCIJK'COQS<V_F0]`Y$S3>!,?N!+LJ>.E0T'HTWDEUMRUR1L5'
M:OJ)"/]8WE>3&'^]IY?#FX0@03D*\S015*ZZ,YIFW8*;0VQ8F:>'(>^RS\I*
MSN+!U;)8*%WY9?],0"<Y10VW]Z2@3ZRMP'MAM+]8OU+FZ_FX5X:L;CLZH'NR
M`FGNR46QLR3'H!QB$X&O3>^?;$Q#F"9<I"&-6`1$CI/N=A*"#!J>Z;6QX%VJ
M.E#!5J'Z$#S.-\%WA2WX1_`+`&'P6#3/G!A70;0@5$^I?#-I)E$'"K_N*:P!
MR17E=OM4+`>O=_B*FC,:U(?(B8A/+Q=>%37L2X=1F+!:']G)809(S%*>0DIC
ME.<Q;Z]FHY`CTT>333\_2$!0;JK>5AF`K67&G$C]B*`W!LW#@)*Z":C+*2D7
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MI=C-RW6QS.:;=;F^WQ[!$L5=N2AW,Q&+!'-`$@Y9QCD%,8];RQ0!8#:8'1CT
M/GY;C$'1@#1<8+@@56^M,3";9LN.CL867?`OQ\K8`/S7@97P,F5GQ,\AWQ/1
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MLW5RZ*YL@`T=(#DEYLS(L.9P(N/"'G_EJ#.-<J)Y%D:$)2&+5:$X).3^`E/6
MHB,(@GX3MQ=(@TSVCB9S/VUBNP`8O3GZ+QIZ'%D>?6%A0[_18L1K^TY$J(?V
MVLMY9$/2G;W+,H,B%I0!SG$&0QKS&)#V%3F,$>"6-W/MC`TBY$?7=;LWCHV%
MO3^O>I(]**5F8OSVRRL3>V[EC%HZHW8B.NC.'\-G50R)TE_0+KX5RZ=5\=M=
M]O"XJIZ+XFNQ^5XNBJ\JUL+FVV*I\H'%>CNO9795-X'\TV]W7XI%=;\N_[]8
M7A>;LI(_)_=*-TJ`9RE/<)YF)"4P(AD3.&--@32:`92PF11D[<L7HR`T4LG.
M&?U%5N.4>D:A=2MH_`IJQS[>*L^"8]<^!`?GU"\>W`OV_@6U@\$?M8MG+B9,
MJ2=HKJHGWPD,%]FCMK^?E;>/)CJW$!^U2TQD/AJ9A--E^@2:Y.+,=UN6M[,.
MGYIHK^4@_2;!7<LA^FOQ<%ML9ARG0)U=RT4"2,H(R9+F)#[-(\(UGV)V8LI[
MV+/3GSI;&SPV$(-'^5.:<X@;3L]/!8.3::;H!Q6O66RQ!0I<\,<>GNZ4[(;.
M9;5X4N4>ZA$V'5I?P'+227_1GNF4L_7\!>((U+.7COMO3$).61MY+G'K2^6A
M6QGN:=Q,/I_*=7&U*QZVLQ#%**.`AU&*1$9`%"7M!)1SDJ0FNYFAL7G>Q[A?
MNRK7@MHWTPW,X,VNMW69<HL;;EK>:=N`;C;RYPJEZL'M\XL^<#U_KO^:_CG?
M+#^\_#7EF&:#>]FQ.&Z9,WN5L?K`1'8IH[E?36,HFNQ,OCX]/,PWS[_=O8TN
MV[]10[?;:E&JDYG_7>Z^B?+NKE"G>*XWU?UF_K#M"A@@@L($QZF(($\!$")J
M;^'0'/-8\T+>","\[WH:=]1<5!\K"_9ZM3@6J.9!H&#>.17\*;T*EJU;P6/C
ME\G"?N`6UMA53;=I#2<HIVVJ5>-E].8UV.5-MYGM]H2GS?VQ5W/WWD4ZI?>]
M/><X;3B%'>I(GE>C#R#3&[+[]4NQ/`MR%@.89P1"%&,LH``"4M):3S-@^%2Y
M(Z/^9_T+.F%Z?]\1UWH[R1%(-IM_.X#OA@&"[!+/?NX<:S%W9@/GF/J)[,M<
M>W5ZL=@':8YU\'"K&64QRB''.$)Q&.8)99T:0T0-GU1R;'R`W=!M?=;+B_[I
M<^Q2![V0ZTL/ZV>7U$)6`IZD-NJ48_#3+#^55II[9Z69EB0.G$%I2L&HOZ4/
MZCGK&>>4)KE(TU@N<05"$4KC%FZ>(-Y>?;X9.J%B#E5+-5Y>HKXQSZ\<X7I_
MCZON5IL6AABMA8=,FGAJU9[G`]QDRCX$QWUC[]Y/F3]YU4C>\RCVW6(B<]'H
M-'C)J_1M%LW\RKEY=7^KI%!ES!0BNEXV_V([XPE*.80Y1V$8(0Q!E&8M%@`Y
MTCD$X!6`[Q/+ER*L90-=U?3;[=^'KS/Z]?6/Q@FC.+JOAM))B$R@C2QR\P%[
M=X,1M*CE'YJC%E3=)YE2PYBD,B;00)9)BTN)J>-Q]'H$]<]2V#'W;C["<T-,
M(O/@V\=JP)YM&D7;;HO=U</CO-RHOLXENGMI#6`8A2B)DS0D".`0PF1_&XEF
M>0Z0T04?2Q.>Y[L:55!VL(+%'I=IA,R2/\U(F'_J#"->-6L'1`&_Q)J?F-:;
MO)R+7?4C<B+[@KY>G,:B7)"BK32Y-%,7T/JUKJA5GR;<2IMK:?-JK?Y-K80W
MQ>+;NOS;DP0B\CC%"``@$A93@CB!H@5":1B;B)![ZY[UJ<&F5@G?6W3!KH-G
M*%,>R-=3L'%Y-Q,WA75?GB\X1OLA.&J+#G%PH]$67L3/F-(SNNBO>28BF1X=
MK(;JZ89"*XK;W=5ZN]O4NY>V.,:7^:[XNE-AZNM"=G^YK;DO9F$6YR0%(L1Y
MSE`$LABE+8*_=W=MRVWC2/17\`&>*8)7\!$$P52J,I-4/+-56WE0T1)D<U<6
MO225B??K%^!-M,=2"!`@Z9V'*4>^X/1IXG0W"#2@Y]@R"JMQ6--+'34>4/#_
M`SZ1=QRXI)SJI'B<CB[$KIR`"I#@C/+F?*^I`'H#6N+/6&=6SO$D7I%,`YY8
MB5::L"PW_AA+JF-T*K,C*TM>?=]EQUJ2^[NR*_Y5F7&6ZX^[EAW/HMO0J1![
M_#:1;_':.T%N2&/;B0,'(]B!HI8CN8O$+!;CFTK.6,%V"!;D=X?LOOYR[MQH
M$J-7)OT\GEJ)#LQD;+[$9)#=*+'?LVW5WY/Q1_I#:%6#Z\2A?7YJ,97MM\2;
MK^.6HVO>B75[@</`2A**:&@G#HI@`B.G7;V#3F!12=V8"Y5Q!7F)"]RQZB_&
M>)G[P,"?O][^"O9,^/P`2AX<3GQ./(,J_=$D;O6B><=#_['L+HFYW#MR5\0*
M_2JY"Z+W2&."V.]6)W_@)=2;+@E<[J)E361?V\TPLSM7$CYF-_OU;H5%:)\8
M4EYAJ))&^6X[X7OQPQN$,(H2.PI"$EN.#7&$W0Y:E'B2G;KG0&1^AW,?(K3%
M`<T^F1(#EG.&*?U/*]`:`<ZN>_5+?91816B0\H%T6##CX56'!$,FCPH')NG6
M&@KJ=1%\W'WB/CST/\?*382=("(0>0ER(/0H#TE6B\GU"=%24FB",HOXUT6`
M](LQLR[0)_FS<&]*ZQOWB(JMAC_X>5:N6>,OD3Y1W"?[\AVI^G1;%>1<$\%:
M=3S)"Y;='U_\1']V/$L/&V0ET(>^9U.'.K[OHJ@[+LZQX<C6K^>3(1G7]=IK
MXAW=OH&J>DWJ/`[2I_:S>L:4ZK=&_.WGAH:L6?U_YH2)44";C]]1--!GLT)4
MT$RXUNC`/R0%VV55N;$2*_%=ST=6X,(@0+$/DPY%X-BNW/6QF@<?I2M3KI9M
M@=3)XE$<F6X6ZX[W]57VX%1QT/^M41L(`3)>T"?VNNDW+.OB&PW>-8OWF=2)
M,JW@G7<DR"K6*4BO,HE:1?;W_+ACNQ/_L;L#:P]6Q.RI8-MV%>@H#B8652LP
M&^AC%]L<8N39'O%B2G%?+21N3/1GY+H1&D_0NZ;/XC13Q;\A<(M>;$S^P/H2
M#M0GXDMZSI32O[#IW,ED:%8=IX>&K3DF2/IH8N`P]42\H^ABC`*%$&36'2-O
M)1F!\[?T>-JGV^I4\*0W;A`+.!;V_83P_ZA-O22P`Z^'XUF0CCZ>;A"#X6W;
M+U"!70=+ZLX-@PZX'DO6Q+UJO,B:>-%OP2I>[MYZ7+=_9*Y+68>?%&]2,>:O
MD9>M*)/W1L"=RQUK.(8^AYGYO$_Y3$7<Y^J!%9LXC''LQ[&7^)@&"8TA]OO*
M,G"<><JU<5C,%V:LX/-;;+#,Q%4&,Q5C(QUAMNS2[X&9"ZS:@/=62-6@#91,
M<MY\Y\61I+&:RB`5BK5J>@T`[_YU*JOZU.P&1A!9GD]]/Z:8$,^+4;](2&+7
MP-XF:0C&%;Q&9$"WY<G6)]=&63:ETC5H,$"]9FE^S?!$159VV#L28G4;%?1W
M(J$&#JYMB$TB"+'K>ES]J>,YA`>"%H$-2;RIN_U-D5JE8:56DWJ$"O._,GUV
M[.<,3U%8X^2:TM4UB>A;)$I+YR1/K%HPIUFF?#Y+DKS1XM@/W!\PWCXW=Y%#
M+R0^HG'@!X[G^7X2$I?K,K2B(+`#C&4:HJB/8G@A?3`Q!]#`MQJ<[*VL$[@<
MIWKST"@G<JH,&E&TBP1=$;#II*Y$KS08DNM^WB35B`_5=,G&/[)R@WPK</T`
M.H['"_#$\JRP'R0,'"D%DOO+AE5'3):VP?TW@4=6:"1I&B<NYAB2$Q0)<HQH
MR`L>KNB&&E\KT0I%\+F.1T95$^+\,<V.FX`$//%!V(4D('Z$>/H3=<-$;B#5
M"E/V;\^H"PTB96482Y:D-AC@25T=?DJ167UHAA^C$)*LK4TC9.%?4@DE&F1T
MXI\L+;BEP6_L\8X5?"`:(N3:-HGM,"!Q:#M!GZ38#I%4"LF_/H-6"$1`0))7
M"5FJ1NN$09;DE:(G"'QK\"P@%B\)N2X7BN2M1S!4#?B[9$RB0D$T4#<0]6((
M^0!^&$=1$-K([K,8!T>QFFB,_>LSB@92%HW15,F*A@F6U$4#+2\:2$(T9,E;
MG6A(&W!1--2H4!"-L!W(#2(/08)"%R8QC<*$4MP/1*Q1-V:I__4912-4%HW1
M5,F*A@F6U$4C7%XT0@G1D"5O=:(A;<!%T5"C8M*+ED_9D7T4>Q(W"25!1),@
M\"%Q(HM0+^S3&^C94J7*M)$6>N$B`((:H8ZW+A+$JK]Y,<.IGK<OH^B<[15,
MSY3D:QAYAE>B3YJ,&?$Z1I4B$[MG`NC$$9?(..9YEN\B,7*'@/];2RM.I8&-
M;U"4V4'S?[&58RSC*YF/)BQ3W\HA1YY\AD%_I(]MV_@O[)@>JHR)^Q.[*R;P
M=EN<V&Z#4.AY#A_>\8B7A)'%ZZ0.1H`23RGGT#2VX2SD][P2]Y+G^_J`?EG6
M]_?Q?VWSXBFO#XC]E54/#_EA)\Z#B3F=U==1BG\]=6;5![ZSUC#5I$67KR33
MF`7<I)S8#+"*G7)#]OM+=5K`2^4ZX^@<D_UH=LQ*]->8>9<R)",TCE;B/X]%
M?^L[!Q.Q(]N+AB]1''H^A=`-P\!R7#M"-(XIP;S4I)$?0AG%51W#M+*R"MPU
M6$2G0I""IX)]S_)3>7@&IP%F\)27F4+S*F5NQRGD'+3**>$04:V''::9Q>X"
M,U=$;2J7*Q&OR6;D>A\QF38;7XJ<SS.VB[,R/1SROU)N<?3,1\6GZB$O,J&+
M25Y\29]%"L2_NF7%=YX:E1L$?8_R6C(A)')C!]DTZ);!$,$T&%?,&09AO+#K
MH)][`H#=P`IPUUS#DYX-D>GQ8-`[U]5N16Z1$\/>'T/0('JNA7&`6W1<!2WR
M^NL.^TK<(]&!8QUN4FO`<9X^UR=-G2H\M>X27Y>M#;].;<&AS-X;<6TF=ZRA
M`<<,5N:S/N.2&?SM]H$+_H%]WM/'IT/^S%@[XNU#6K!(M/DC^:,X,MYTS#K4
M[A*'&O=?^^#>['HC>5F5?[`?5<1_YM\;Z/E1XE,GA!ZE40C=P`V;V_GBQ'=L
M2VZ1=#F<QD-O;<$O=W5'Q>W`!L":H_KMDDS=;U%<NKD3'^[JZS?S0[83_7;K
MR_*:VZ?%ZD[3!$BRWECP21A7L;R/1T`NS'<V":]U5G4A'`P?C*%E-^!LF_C%
MLW7=CN':OO9H$A!V@MK0N5^1&?/8E5IL^:=D)=7<"HC(US:!E8/C$)<86T3F
M'G0;K7%1\*G=J/`0^]O6U19$SU^X'-33]&R,'6'L.M3R+!<%CA4A%+N=,=A.
M?-7`N28;S`?5T^-C6CP+>2Q_%E_3LLQ%1U#^??$V!+!T^R!^D?_M"[\LWHX4
M^7V12G?96J<[I"/PFL#/$YV'6.OX6I=OPQ#=5>%#NU^'ZDLAO8W8O&`4!*PI
M<L_HZ5%1?8U/WNHB_BI)NI@-K!*MQ-KSV9*OK*R*;,LCR6W%1_OSF%4?.&Z>
MJKQ$X;@X\AP48C^A?NA'MN,Z'0J7>B/O_3(T^)RQF?WGE%7/X+[&":H<L#8S
MY,J9[_<\-RR:%^"[K&!;/KM*<.(%<%''YNVI$-?X\.*7FP6>^!A2JYX&W#9B
M,7I9?RG&O\^BR.S0@AHN$'A!`U@J7LWB"(EEYV4=HK;</$Q,BK-CFHEP$HYI
M9M3D565I<BZM)IMC>0VKR`:MRV=Y5"4+8SX\XS_\@(^[F'UGA_Q)/,-M:]'V
M>(&%(2_*X]CS$SLA";8"N^TMZOAA'+MR9:R.$8T'M@YD$['.,"5K1"WLCJOH
MYJ95+OZ\X'.`KVN;O-01I!&L7:EE='*^DLI#JTFYN4=4=OV/'?AW[S^PH[@G
M7MP6LWO,CAF7WE1L@&XQE"T(W[4=2I`?$H0@]J"=A+0#D;@>E5RWTSJV^9R^
M@7L#[AO`]91-7T"672G32_[(%:[%6)?,S#NZ/PSH?HFU$\ER*964XO+:VH\1
MGZQ$.0T9]WJMQ2"%H]7T2RJJ]7:,$,6A%3@>AC:Q<>`@WTZZ,2`BDF(I]:>-
M:^$?HC/Q3U\[W#1WW>[%%B%):91C<ISR&:-0<M];#6,IR1J2<$61E+A:B>"H
M8<\U/"RRR==/7@IS%2.'M"RS?=9\\/&89,?TN,W2PVV_'0;?"9';5ILX<B,[
M]@(;)<CQH$_BY(R2!)+72\P,;M8]2"_>2]&W]R#IW7DTLZ='IH+K=;%DKCAF
M&Y'('U^:(SS=&P3.%H%OG4VS)Y1:/7(MXUS&]2N)$$M9_SIG7=()HZ-4BX?M
MWH;;RN?OK/J\_R/]L;$M"BT[#ER,O<3",'"3+K4.W)!$,O=N:!Y:1H`4[MZX
M/=W5OS6S9LB1=$43#+&]DCEORKI\ED=6MM/'F-V'YP-K"6?K#92;&$$W]E`8
M1H1X@1/3!`8=NAA:X>;([H6MXV;S3*!&S?*PF>5#_*/G^<?S!;2L[A0A>\7.
M3,X9EP2NR2MJ5_.,WU0^.'(+A$*\60C,W>Y%"_]79'UF!Z]$[N>V^G4+F25(
M'Y_2;;?YB:>.7]F69=_%^_1VH0/Y%N9AQX\QBF'B.B04C:<@<B(;8^@E,ET-
ME`>12M/DVQI\[8__BIXQ+4AQBWB+4E+-U;D<I\^ST"BGN!TD<,:TU'+F)7:N
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MW8&T^H[WX4>=`K@NX85!XD=)X%F>18ACTPC&A&)(8VR-/7JK:31S^=<`3?UB
M&=08P>#CY5X<CR/ORMS4S/Y*)J=NJ_[6H]0`:2/K9[&QD=UGV\&`W59Q%Z'0
M\BU>MON1BVQL]\,E4>*/NH!BZAB&PV"/;#C[I"J9"?2-J3?G84ZR?GR+M!$+
M=WK9DZGKYF%1L4[KV<S.Z*977!=-OEA!32=I%161!C-RO<_.1#G^DA?5GM=.
M^<:%U(\QH7Y@$P1QG"#L-`/:%DKPR)W@T\<QO^3XQIP`3QV^B0HCP:>:0ILA
M<KI&@R_S,SA-I<TPJ4^GS\^D"<'NK9>0;'G&5BK:"H;\1+95J1E_:J?(MXSM
M2O$2_C8],%Y@_Y96IR*KGC_O\?<T.XAW8:)E"__F+=N>FB:FF]@FH1<2QPL1
M=5QLQ\AQ8AJY2>2@R*)(9O')%`;#>7@'N]E-\]@@[F[T*#G4N9>H%'F\4AB;
M]LQ**F7C9KX^7S,+K>-WQ%P<\4.1E^57EAY$:\8/:78L-R[%!&('N=""E%IN
MB%S48'`M*QB;SQD9VGB*U\$!]P*/[%X9K2R/6U9<C%ZYQ*^'^<L^+WX1T@G.
M2&]`C17TY'^X3KZ9K3821%[;?F/"'RL143.VO=ZF8XY`W7+Y*1=7LFVH[T*2
M^(X7!3AQ70=A0EH0#G1]7VX;N=ZQC>\6[^?LH09D1C''$JU5,G4R/(-F?OH)
M_TN*9H-MNFI*NN1]R::L<6JZJ42A0K_MZ%1F1U:6>/N?4]9<GU9&SX-_G5N<
MA;$;D]#Q/)I0F%B>:PD1MR+'LD-(/*E"TP@`TU4F__PA+1EX*L3YCK(U0;DO
MM4[JQRGJXJQ+KD(.FB]V@,$0\8WHXSSX8$WMG,<S?$5OC3IL);)KUL:+O9"-
M$:H@PN=+%S[NV+'*]AG;8:[_58.NX/\Z[CYEZ5UVJ",%_][I45SU]Z(%)826
M2ST/$9_".*;8MX.D@^G[)%#3YWFP&99N6E;98[TU=9]F!?B>'DZL;J-1/7`A
M9T^I6.X]/',7-2;6*I+65H*T-;->3#R<#17?%Y8JZ_],7I<-#>MSN'K4&%S8
M<S8&--8`/'3LP"#06K2F:*+%*:,"S;SN7UT,FMG\B^%I"3<H1"[Q?NS(7?=,
MFA;QK\:/;1^Z),#8]K!X:V:[%FH.COH>@;YLITY=PQI?GA:'://CN5=3BU8Y
M5$RE638&S,BONKCW(&]`"W--BGV=PE%2K,D+J]-8779=%$^MQ(U6Q=]8<<]3
MTV%!(5HI9V5W+WW)O]X>\O+$'_`SFB0*XMB*+-=.;-]"#@T3CVLT#BF&7ARY
M,FF[(0B&L_,A7$F)-,7Y.,%<`=UR\MD"OGFQBM(T?1^`!@/47%(7$U,U>J](
MJV%_K41H35N9SSH)_B;"PX?P$_^*?]A]Q/\G^NWP3_X'4$L#!!0````(`$"#
M^$8`CS&IRI$``+LJ!P`5`!P`8FEI8BTR,#$U,#8S,%]P<F4N>&UL550)``-8
MG[)56)^R575X"P`!!"4.```$.0$``.Q=6W/;.)9^WZK]#][,L]O$A030-;U3
MN,ZD*K=-TCWSQJ(EV.:V3+I)RDGVUR\HB6K'%Q&B2.J2>4DD&3@\^,Z'<PZN
M_.O?OM[.SNYM4:9Y]LLK\%/PZLQFDWR:9M>_O/KUTSG_)%^_?O6W__[/__CK
M?YV?_TM\?'.F\LG\UF;5F2QL4MGIV9>TNCG[Y]26OY]=%?GMV3_SXO?T/CD_
M7]4Z6WZ:I=GOETEIS[Z6Z<_EY,;>)F_R25(MGGQ357<_7UQ\^?+EIZ^7Q>RG
MO+B^@$&`+M:U7BQ1?SMOBIW7/YT#>([`3U_+Z:LSU[ZL])"_*OGSU_J'[\I_
M08O2@#%VL?CKNFB9/E?0B047_WK[YM.BB>=I5E9)-K&O'`9G9W\M\IG]:*_.
MZO]__?CZ.P&7:7YMLW1J)S]-\MN+NL@%GSBTY[,:Z/?5C2UD?GM7V!N;E>F]
M?>U,=6O?Y&7I6<RI7K?@YYO"7OWRZC)-+QU@(`PB%-1P_668IU7?[NPOK\KT
M]F[F<+XX!""4K9)T-C(>CQYZN+"`O>`"#AB8S\GES(Y,E^^?V1,H?\S3,JU]
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M?/_-W)VH.SUI'`#Z-NV0UE2V2.\7P?YU5E;%8HZI-5IMK#2<6IY!WZ?N<$KZ
MI<D>5?M1<35MZ&*N=B&W^O8ZN\J+VT4VUZJC1]U>E-1)D;ELH/Q@BT\WKMNV
M*?92^4&4\21=2[5!5/.CVN9:_2BV&!*T*O)=J1X?[&NBYPKWKX;GR'Y3G1Z5
M\N3(,V5[4<(D:?%;,IO;MS8IYX7U"B\;*PVGEB>-?.H.KF3K4,RK\N!JPEW4
MA*.IZ=EEMQ`QG,I^'=JC:C\JIID;-J;);(OL<5.=P93R[=SM58=6L;UK>]0=
M6LGVCNU1=V@ET0Y*HK&4]/4]WA(&4[A=A4ZLV$+L8$WS=*JM-7M1<#G<_YQ\
M;=?HF:)]J^#I.%^N,9!"GOVFM6+?ZOE1Z<4*/:E3)=EUZN3RLK2+&?>_Y_GT
M2SKSP*NUZM`J>C/.5\)("K<&[BU$#*VR+TL]!?2D[KWSJ'G1.I'PI&"_C_?F
MW_/E^U7F\5.\W9Y?_7Z5]675L\5[4V6U(/TZ^RTITOH1CL:V<#\O9C$]%F.W
M$C*>VEOP<EM9O33BC9-\[36S_+1DSPIX0O5BA5[46>TR^W--9YT_KA=WEH]M
M4W-K0>.J[PEV5WGC-L:[H*\G'O[)XP+DY^,[BNNE*1]M:0OG`TU>J+2<Y//E
MGA,^F^5?ZCT.K<I["QA'7<_^M:V<495OS8VW%C2.^GYLWU),+ZHOUO)$4M8[
M';YYS;N^7&,@A3R)VUIQ6/5:J=E><U@%6V?5VFL.JZ!G)/2M/Y"R?EVYK5X_
MRLTO2_O'W$G7]5"H?/R]54G/^J,HZ]O+MQ/3D^JWMTGQ[?W5I_0Z2Z_229)5
M?++PSVEV_<'E)CY[<[>3,J+B?J6\[3/8(P\.DGXMW^V96X/R\`0E6V*2V>LZ
MMWZ37-I'WO>Y>K.B^*Y:?6J3U:<V0;1H[7/2>M3RG:WZ5?2QP!YU_6"+-)_J
MK&=HGQ?;N]YNB%7TC/5+@GO4_;,M2MNOUD]%]JEO7B6SGO5](K(??3N0H7JJ
MHH?E[PHW$LJJQ93:&U=J5;:6N:<SUTLU78)ILZF=+H^#.T5G^>0Y-!9(7"7E
MY0*.>7E^G21W%W5,N+"SJFQ^642)\P"LSKO_9?5S[*F;<USOKSXG7_EE617)
MI&ITG=7X_O+*Z1;O*#$.9`1!!+0$4&L24((14EI"QA01H53?PS.K;P3(B\:,
M@^'SC/;O\LK6^;]P3_Q]`Q!M56."0B00,XP9+G!``6*NQ1P$@FM"H6EK\4/J
M\F)REA=36_SRRHWQW%^N;%&L(N.&6PT6-*Z>^)RDF#SI`-]77)6XN%N<63B?
MW*2S]2[_^G*'D3F1#PJ]:^S:7UP\=AB'YD:>S61_.&\"9,`0#RC35+,PY`!1
MXIB#<*`95YKLQYNL9Y(7(_0-S?Z^8$R(,((:'!FJD-:!-B%=T94C%<A_>PIO
M>^<]`OW`+PQ/F>6&]QJ//%N<2?V:ECX,>JY>C)!&1$B#.)-48!8!`IMV2A:B
MTR%45P._Q),>X!R#-H_45/EMDF8;Z/)L^5@:$Z%("<`U)]C@,`APTRY,T2G2
M9#?[YOVC.@9;'GA=YUE_S0J;S-+_LP\N2_B[4[QVO&_M[:4M_`*VEZA8.C@,
MY2$55(4TB)1+[QHT6!3`T^'8CFS(1P5Z?-HUZAH'G+)E>ITMLH#B?^:N85??
MTNRZ.0W_#SN]MMM2L9OX6`DW1(B@@3(43#I+4;8V#S4(=Z0G_+'H.0KX(U-6
MV:LTLU-A,_>A^C!+LI)/_W>^['O;D--#4,Q<7S5!H"-A`),<`XW#!@DH5.MX
MY@4:HA^(AOW#/#+A/A=.Y>6U1MV(MD%`C"$4.#0Z"CF%(@!4:-.TG(0*="08
M_H$(UA^\(Q-KTTC[C>LSKUUJO&FLN:VHF&H:0LQ#0@%6(=<2,[5"0T1<=)W/
M.,"@VM/P<V"$#XAOS<Q.?W.",9(P!(3H**#$A%!J)9N^)U3$N\;.`QQA#$>3
M;GSL:((QZ+A);6&O\L)^M)-94I:+[1&+JP0]J+F#U!AJSH`!G+$`,$8$%K+)
M/00'H.M`^`"=XF@T'<\<8U#VL:[U8,H#2CDO:J,L]T-X<+C/Q\1(8(UQ*#D"
MB.DHHI"N430T9*<S;AF-U'NTS[X=\XX>>-UJPY#+P95B&*"(&HHP)VOH->J:
M$1S@8.<@7&U'W(]QV?W10.Z'6W=7C"DCI-'$2,(<?2CE]3HL8R$BF-+C6G<W
M.-2,4!I*YQ>U0`&FT8JO$8R"'V_DT-W>F]?=MP/ZB-?=&7*Q5DMN3`2DXHR&
M3;B-0H%:N\?Q$*JK@;=;=]\*SN-9=Z>!BA0*`T`U@TPCB-=96>2^GY#?Z<F^
M7NONVZ%ZZNON]<;'B+C<#FL`0J$,XLU49"0HX:?#L1W9L.NZ^W9`_WO=?8E:
M2(E+(!13((B,(88`(E:H$11$72<.#G`V;$AZC@+^/N:^WL]=(NJ1M+9D:[N(
MC0775"(9<@)D@!""6C6;R`E@45</>H`4[2F9&Q'M0^9D:U*XF^!8&@X`@)A3
MHY%&,@"ZF64A5(D3&F2,0ZB>6-S).H?,X]9$8#?!L8*1`4`94R_`H%!CA=91
MB!O5-04X(1YO2ZF>F-S)/OM@\I_;<'R;YK/=I<>GQ,Y`VC`,=<@B)=T05U*Y
MQA""KCOL#W!];*`<8CSPQR#PNSS+[VS]*L/L>JFM_GI7OVEI`QU?K!,'6""#
MJ`@T"@R71AFU]@N1@-'I.M!16)$/8X<Q>+:^S'FEXFI3[`:6O5`C5CQB@0@E
M#X@2!AD5K4_2$J9,>#J#H$/@6#]6&&7]))G9\J.]M]G<UC<PUTM'FY9-GBD>
M<T,B(R@3('1=!H0.J*!I%:2BJ__R#XYMUWV<(L5ZL,0HD=)63Z_.>"XZ/BP7
MPX"$G(%ZLS=!1(6&0[7VQ%1V9=0!;OPX!"KM@OU1;?YX[L*]'V[K!U0LDB*2
MFG!.`RU#7"_62:A5X.(2;^U;`\6AR8V=SF?6C_*-+7WN=]E1<DP)#2#$&-<Y
M(!%(BK`Y5*Q<AS^A:;K!&?4XA(UJF4.>HO,F<S\/B#7C&`*HL`P#-XC'%*-F
MU4JYQ/2$1@-C<WHO!AH\"/\Q3\MTL>_^X>>]!%(Q+UW"4Y8.P\LT6QX&\(B6
MFZK%@($H,&Y81K'A&K$PT$SI@#/--!#!GD+B6UM<N_[Q'?K95*7E7;[Z6E\)
M/LOKMS"6/LZCF\"8&.Q&JHM+"$2D,`.$,:4,5334)&(G%`#[(4F^!]3WY`'V
M>8G9$(Y`"JA(%``#`9,0$"TB-WX&`>,,2P9;#[P.G1LWRC^T@?CVX%OKQNDM
M1<4*U9M,I$.$&!$*3BE0-2(H<-\1/J'%O7Z(\6**.PC>8^2TSRC>LEOGA1JQ
M03#B4NE(!Q$BD&C-3=,VYTQ/B$O#F3T?`NI]T:C^6-CVC3:M=6,"E:"`"1P*
M&49:*!A&R_;20'$J3H=:.UO<@T&[8+N92T]OPJ]_B66>W==I4C:Q'VZ2XC:9
MV'GE1E"SEW>Q>M6+18@"34(9A9!3$P98`[W4G2'AVG+:O.AHQWPXA/?D:7RV
MBVRJ%H<<8"Y<TZ3SS!P[%*.PP0X$INM)CP.<,-EGZ.J*]QBL6K^T)U]UJT9_
M6_Z]V+RVU58U1LC(0"J$!0J%YC#@&JQ:RRED)W2W8C]&SP?%=PPVF20M?DMF
M<_O6)O7`O];_GVEU\VN67]9O?%N^6?5N7I4?[23/)NDL75C7?9L719I=BZ1,
MRS=I<NG^4GW[,"\F-TEI-[%PJ$?&6@J)H$0ZPLB-C"C26#AT@88"N1!P0I/)
M@[#W0.PR9F1^,,2NW^293A?;L5Q`J6]F6UH<>$1J'S$Q1YKR@%`#E<.!$1[6
M,^D`1H10:<#PFU,:=CYY`\M1L'-`K/<[9[F?&R"&F+1D#&A-"#<8AA(I0I7&
M2@?2""45$*UCG!.<M#3:B$`I*`S45+APS\+5W'F]4MSUDLP#SJ=V(\;.DY9;
MX7U<DY9:`8VAU)@%*H2,$4A1TS8C6.O[CHZ'2\.9W7/2<CNHCW_24A$@"(T,
MQBYL2@FEU*9IK^NX)^BF.EM\ZTG+[;`]K$E+@Y4)#:4HQ$2'#%*CR5IW2/5I
M\Z*C';>:M-P.X6.=M!0@J._&1"@T]25/AF!,FU:J2)S0W0S[#%U=\=[3@+N>
M1+C.%C>A3!VRZ55:`\++TE;EJN]->39MYA-26[J_S6_KBU.F]<W\:67?I/?U
MURK)KM-UW>U&+T-I$3.D$"2(N^$G,\08A?3:L&XPVG4RZCA\9P<JM@_W#\14
MQ]==FN:.US763XQ=:$2!@,R8H#X(`HT6:H4M$9QVG?4Z0-=_!-V@JUG&H'Q]
M=.Q+.IMMX&A3)-:A,$@J87"DA080AKQ!DTC>^6V$!W@(?A!2=<3QV!R?6IGR
M<_+UP1_?Y=ED>;/U2-ZP38T8:Q5P+D+&(J9Q?8,R;D86!'<_$>U_QG#L4ZL'
M[RE[-MFQ=9P_&SIJ1OWXL3&B2H8B"C&#BA%J0J1P@W)(.K]--/Q!W/P!V>;H
M>L#&NP=Z?E*,J8`"<4TQ4<HYDA`:T&!)..@Z_1H=V<KP0?!\:W/L=_&X/J8S
M3V;?JW3$2\A$8X.,,`&5`"`&M',M`DB.&`P5B%H7N4YO"3D`]35`@'.I0UF_
M4SK4<H5(I+DRIS>/M!LQ=EU"W@[OXUI"=HW"D$IH2"0#@K1K'URUC80!_)&7
MD+W-[KF$O!W4Q[^$C"5F1#&*#8@D,!1)*9KV<HY.T$UUMOC62\C;87M82\C:
M1`R+*&)"&$*52^I4T.BN#.[ZYM8CX45'.VZUA+P=PJ.<4"CRZ7Q2O2\^V>(^
MG;3=J?Y<\5BQB'*ZN/F"*(V!,)0WK8+=[SD]P'6#T4)5#SB/R)[Z;H*5HF5K
M?'JQ3JPD0#@,`\4PE)R&"$3KWL$1/J$K37<S[_-<V1G0;L'HW6\@`)@&L"7X
M/"H70TQ"P$*@@'.M$H4RX'JE&V58GM`^MA[LD_>'9"<KO[/S(K]+JIMT<N<4
M3[-I\TK=S59OJQ>'+B#"@`I&J9$."*TI:'0WF@>G$SIZ9D'/R![K;K4`J/HP
M'H)&4D%"(K7D:^Z[/.UT5I?W.4KNBO>Q'[$%E$&@#0Y8H"/$ZI>)-(,`BL.@
MJW<ZP!C5C]&W/6*[';Z=(M>'O*H7%9*9F5?SPKY-9[:L\LPVNLG\]C9=7)W[
M.?]\DQ;3#TE1?>-W=T7^-;U-*CO[]E)PZT%T;*2LIR$B0C5C7-)0,]4@0`S\
M48[!;LNP/>'_[T/>VQTF#D(=$)>K$ADB!`($$5^;%0O9]2*5`XS.@_C/`['+
M_@YYUV_;<&W^[NPP+XK$_;KLX3?UQ]<9O\WG6?7^ZH4J:P2V/Q_>NP:QT@HB
MJ8W!4:!9!`P588,]C,*NYRL.\);Z0?K$89IIS$VW'VR1YM/7V:1P7L$JN_S?
M8RON\Q5C0&B@L80JX)K+R`T7!5D/%('HFH(<V\ZMKH3L%=U1$XQEZ*COD:T[
MQ4>7$/GD"$]KQ8:)D+G$/:`2`P6X"4@STJ0:PZY'#[??$W6<#.H/VL.-U!_K
M3^^OWL^K^M[R<M'<?Z37-[T'Y)<>%)LHD`0+0R",`D0`)R1JD`11YYDB\H.0
M=*_6.+8MJ4=RZI%)2J&!AFG(`Q@((]?K!B&A7:]HIS]NCS@04^UIF^L>7Y0T
MQ/96;9#&W&5L&D(`0@D,0$H'`CG\L42M6<W^M[=N]9XC?W$Q4(A1(1A&F`D<
MD%#BYD"BE"$XP>/2NQ%DAVVN'3$?(V#^V8RG;L^YN7:GU^%E7+T\*:[?34>8
MH%@J$H6T/D.@&RR1@+PC?P]XTGT@_N[#'`,'-YG/'`/S.I6]MT[[Q:N7/MK9
M$KN;]&X_`>Y]<9TXH-=7*>:S=+KD7S;]\*"Y[Z^,LW,V29/9^IW</I&P%_DQ
MBG3HC!=!S0*!C8JX#A36"@O%,6@_!#@,=M^;],_1R9]OT/%Q0EM(B9USQ@%5
M$8Z,T=2XSA2!!H=ZE]=8`?+>%I?YP"YF9.;D8UEE[WZFO81V/K;Z]M96-_7$
MX[U=O@)VK^]7.@X_Q7$$:11)QL(HU)Q$,!(K)A`H1>O5Z4,G5"\8UO^\VB8!
ML5:1AH@P'@(H:`2`%KII/7:)Y>FD[R.SY<4\J4=SC)O9/Z_XTU^M?9?<MIT=
MV$5LS(&D$FLMH\"9(PA9"&&#4KUO\G1(VS=MMF1ECU88@ZLOJ=MZ#&%SQ5A+
M#(+_)^]:N]O&D>Q/6KP?'_&<R9[NB4_BWJ\X:HFV->-(7LE.Q_OK%Y!-VK$M
MB81(D%'WG-.9=@@:N'59J"H4JK@#'B@?+1/@C:F-!2%-=F+R+\BW?@BQ'A#]
MK,3`K[-OVX?5M5ZNM\MOR]O91EUOJIWF/YS2?FQ<D-9I1C$3F$B,@8$4XWKN
M!#IR/LSI2XCKX>"=PG:Y;<X:3K'=7@XL&#&,*PJH@(A&`P3'#Z]&0&N>FU4W
MP?#5R%MA-N99"NG5[]6/+_FJGU;_O5ZN[O\G_CQZLVI[4;U\$OMT5,:K`@(<
M(Z(II@XR*Q31\8_Z:Z6TV'VL$C&+(02_+HI_%L->__;/?ZVJS=>;Y5V<Q#S)
M[;IZ/=5]S.KPB@`XM%8S[)GC&EC/I:;UBH2EN5&PSGKJ'!@U'.[C&.D[3#I9
MY[L1`7FNL"#`""TA\UHIP>NU&8.*-6;ZQ3G5+\SC46CW*6Q_^A0ZD^J#=P0H
M(=;1?U&>*2VIQ-`VGQ#%V<EBG9.TSYIFIP,_ROW"[LJL[2N"51`1:=/E;J@-
M]-X37Z\^;N6Y-9\FF(I=@'0#H9YE>;7^`'Z?_5A^>_BVS_SJ^IX@.%(2($.)
M<YYIA0A0#7B8Y[8@[IR:_8LKLA+@EU!FGU8I#_>W]7;K(WS=-5FK\8%C:3RB
MC*)H+4@NI/,-N@#97-)-,-6Z@!H;`O(25/L291A_SXU:+6SUO;I=W^V"R3_N
MJM6V<C_FMP^+Y>JZSA/ZM+K8K.>[3*7MH?/?$]Z:KN)00H"4T36RT,FH]IMX
M9.I!>C[YS@5H64X061NN6BQV"92SV[?7PO=MK?M'!(@E]X8!APUW3@/G4!.:
M\<+FAL;DWXHX_8+<HQ6V3:2=WU>+2-&KY?W7FXA4-_OKHS<$3C1EQJOHM,C4
MKA`@WI#<(9%[SQ>"OQ]K!D.]Q#ZX2]OZ.HML_Q+UY.JA.ERO_J/'@],0>&^(
M)!XP1H'%OCYE%0JP[-Z.$SQ3++!U]0#QX,F!=>625"ZLN6>72H:-F-NW;U;+
M:ON2;MDBAZ_3>P*F6D!*@)>0(Z:]$NSYO%=3@/GTK^'LN2;98_'Y0[\A&`RM
MDY)'@EM##83`VAH_PL^I7_!`O,J_O=.C7/)J<SY\>[C=I0_OM-UOR4[?DZ-W
M\/E@F,+,$^P\)U0QQ8UA]5RU$&?$H>+27?>/?V]<V9M#=V1$L%)JJ;3%&B.M
MO$U=F.OY<F?/H'=!3_(Z)OTL/+/D[]</FS^7M[<1\</Y;^\>#$PBKR%Q!GB,
ML(11E^IZ=A#",TC-[4T^ZQZ!S!-SG'X[,;]],&",2-PQF30\JC5N>9QC0VH.
M<KM&3"CM;!@QGPAD7J1C-K]YB;5\7E7Z:09_W%VN+_^*$#SJ-B3H^)J`G=1.
M6$HE`CPNCUK7$!B0;(I,J-[?(!09%N8L`KU,XC!#WCX7M`(PDA@(!BER28>]
M;'W`PMP$G0F5MQN$`B?BF"7CR_BW[:3\_LG`J9'&<P:8,H2C^"__8N`BE9OE
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M35?4ITAGW1N0(UFI>XO&9_6P.O:V8"((&&`N/><(<$,5$,WFRTGNH=N$(BE3
MV::&E\XH%U7Z;(1%K=4<.8>A5IY1BUAM3S(HP!GM:8-RH7-_K$ZPEU2+OUKU
M][B-2!2]8@>]X-@X`5Z0-%;E9F-.\BYR20J/*J;>$AVZI#@$2B`36F%&`(X.
MMC0&T'J.$I$S..0J2:2^<!XI(W,Y4L'S<7(QB?,FBE40![#T-O5J?"JTHAQP
ME(U4-['5&MJ5>.WRH@`Q@9QQ(2F`V$:*>M&@020X@RRG@5GRKI;K@/"/IQ\.
M+>LIFQO^C52(H<(S;Q`G&`&D29P<T!P3H(2&$A[]:(;!XK?UZOJRVGRK6R2^
M:AUZ)$W[R,@0ETJTU`#&#0QX&?=&9>KU$L:/JLQS51*M>;`>$N\2+E-34?8?
MU?IZ,[N[6<YG^]*PCXY)C9.\P!P+CFB$,.I:Y.OU:75.O3=ZD_3;!/Z>L"W"
MG>KZ[4R/GDSL'1.H@8C8Z%(I)0$0``D!G]=G.,-GD*C;HXS?LJ8G5-NS9AOM
MB^OU]__:-0/</";2X/H_$E_P*[X\_SB8?WY`C)>_#%IR#:2TSK#H1!FHG>7U
M7)$"N4>?4V3`Z?):GPA?"06Q7TFV.99H,3I@QAV6V'@#HR>?CO24JM<<#?O<
MA,X)IG`-M>'TCW(19LU6BT/4B7\=B(ES1EA&Q>D8@P)"7BM3(_@Y'77W*L.W
M_.@.Y>#>;/0_5]MJ\=(TH5KHV>UL-:^^WE35_?:/U>QAL8P_'<5U;;;W5XT;
M+M;/F5#'/=8VPP/R2/GHBCA-C>6(`:&?0]$$>G&\B-$P*W_NKG5\C3\_&%0J
MGL<,!TX0814!0)/GU2"H5+%859$Z8+V*=]TCKB7T]M,$S<,F0=6:*&^>#]"R
M:"1+23FU&`-MHJ'TLBZ66\)KDGS)%>F'S#@-R!($,;-MJMJ4_D@E-K[/;G<A
MFWLSVVP>EZOKW6G<H7A?F_&!(HN(!!IH9>*.*)P'S;J!4\52H\H1*%OR;\/@
M`^!;1/%\GRUODZ'LU[OJ*E^K^<-FU_;Q&9E#2NC8V`"U$%P)I`F.7A?4V-7U
M60@B1.?F]4_R`+]?/O6-;1$NS7=>]_9+-:_B%Q`G_Z_JO@6-#@P+@`.EO)$.
M>$P9()1B5Z]20)>KD299.KQG!O4':U;*AGVH4NW+/U;S5^[(KB)^G:&P+X'C
M^,@0:>^E=]0*%XU!R>._?*-(F<ZEQ21+??=#BV&0+:%64AFQ513?X^$:;*\?
M"P1&EQPH&GUR(;$4Q%#5*$>(BUUT_77XT0.,)<BP*P/WTXH/4.+]PT%`+!'!
MP!$J/,:"6M#0V[#L8@>3+*W=+S%.!K.X']W6?PY(8&\IB_XC(,I(@1B1S6YH
MLFOA="]]O;Z?W?Y"E#@%Q7&=FW^M5_,3_)N7X4%"K9TVB$,NN)!<$4;K55ML
M<F-T$W9Q3H^Y](]KH0N'=]7F_O'B=A:_G=4B^?F[^MF'[9)#PX*VG#,'X]<A
M2,12(ZIXO4JFS%EU1NJ)/3WB6<9ZO9^MKI>1[4_KC[-L"JW_8[U>_+6\_2B3
MO<OP`#`4$'"10N(02<0%:_2WB3\_/V_H9!8-@&L)-K5@3#-[H56<J[1(&:ZH
M9I+Z6H-BA&3N:<"$?:"369&)76''IY7Q\N'S@0@JK!;1D1?6$H20=C4P&"B0
MVX5VPN[/R9SH`\ARKL]1GR<("[@$&@DGO(\+]QC4<>/HX;O<7-3).CL]'1%V
MQ*U(LL]R]N?R=F<XIQO^]^OY?V[6MU$:VZ<J_"W.D=N^(DA'$:$I<0YQ[*&G
MKJY-$_GN9>Z]]DFZ.8.F(@R$>&&^M<]4V#\H8&TILLZ@U'#-&B6UA,T*;7:_
MSDF>-O<O]OV\.@WG$DRRU9\M#@9?/14T8%%[4XVQ$S;UGE(0UVMP@F8WYIDX
M5[)%N>X+RA)TN)S]J+87L\<4$SI.BP^>CGL[\"YNZ!8R1B5C!,`Z$HT-R<Y\
MFN3V-``]3H>T9'Y!:Z9\/"!PJ[C$CAO%#`1$488:2XXJDQONGV30;0"R]()J
M,9?Y/0#'G.;W(T(T]:B$P!BLO32,0TM-HS(QSCTUG&2`;0#&]`/K."9N)],V
M>&:\9<H+)C"*AINDWK]\!"HWX:U[@>W!G>L!:'(RGB7O;B6+ZA`W7CT6E$?`
M:0TH`0Q`A;DTM<5%^/E:)P,Y.OG(EG%MG@023:I74+0*V1X;&@@@#E**G+**
MIH+UFM4?%I&>YYXU3]UP&89'/:,]AD'3_B#@XQ4R2;CAB#J%#-32:$I,LT*"
M<O72U,V:8?C4&\Z%[9QV!D[`5J*H8*&RT0U4@B!/ZK-08I7.#0!/V[(9/%37
M$=8B-XV.%TWK5D\HH`@-2`6&L90<1V@HJ),RB"'ZK'(N!R=/?T"7*:/S%H!/
MJ^<LBXOU9B?0^_O-\L^'^Q1*N%PGI1F7%`&/4[G^M+JOHNS;'#/T^XN"`083
M#HVTUJG4B2-EG3TCB;S)U7:=#TG/@K*CRF8<EF<Q]B4?%W#BTS$BMRKN#$X)
MUVP*!M%B%1K*'+:.0XZC',V41IE,U&<I[F9][.KO!T\'`9'@QHIH>F@,K*>\
M"=$0I%&QHE+C,*R[:-_EH)X*:2E+;KUJQ9&WCP:/')!,"R.04HQXSTRMZPDT
M)/>"W21#5@,0Y$0\BYRF-;U++V;+Q:>5F=TMHVMUZ#CMXQ%!.2J9U\`"XRTR
MFEC:!.&PUKF7[289EAJ`*_W`6N@`]JGF=[7813LBRZ.$;JK5=OF]BMOV^EOU
MVWJ;<JD_7UW.?AP^F>WRID`4$]0(#9G5+.**H*PC*)0;D9NT.,E(U1`4&Q3N
M$M3[DHHNKZJ%FVU6T>[;OEJ1K:Z6\^4A4_OXX&"9Y=0`R0W2SA@%6-VYE]"4
M*GI.R?(#$*QWA(ND'6VJV?9A\]C*0GK_<%"$,ZBQ-!(;IZWE@MIZ1<#9X>-:
M\HDSJ^HZ`?VK<>9D1,=Q[3NY],%+P"4FVF,EB5:>(M&LR#B9>V0WP6S[`1AR
M,IXE&/+[<K7>[,(63Z&(`_QX^VA`//5%01`JSZR+_RA67YFF<0,^LZSZ201Z
M3I3!KQ,T'SQ8'B"6FD/-4FYH=$Y4W,=UC9PD*-=FZMY3:03=-I$@90&Y3>$F
M4[LSZ@^'!A0-3Z6!,=2E8A:&`5E?Y:24@-Q0IY@>2TL>7/>!]2MFC5P/^6*'
M[TUUGRK._SS),RJ.+)@SSF@#HC0PCDI`UJ6]A`?.C%0<^>=8>I3$Y\UN-8N=
M2W!1;;[>1.FT/M_8]X(0]5W*#DP;/6<61H)*4*^>&9Q[]7FB1QY]TN'@X4=/
M>!<^#\F@68O1`5"O-,**8>>Y-<![*>LU:Y@=$9BH/3\@Q_H'>XS-IH%H^_DJ
M50;VM^N_IE.$OYE1M_WEW;`@E,8,<V&`E-`R&`4A=ET0M,(*D9&ZPZ5JIW&J
M%YOU]RBJA7[\(TKGT^KSW:[[Z>I:S>^7WY]LF>/K[_ZRP*`%E#@&(C*044.]
M1C4J%N.S*L;>#SW6A3$O5#3L:GG_VY%.[LU#@8)H-Q/HC<.,6"P8E+1>@2$P
M-R(T2=8,*>#W1</R$"YS$O_OA^W]<U/Y+U5TV>?+7;7FEY.YRW5_NFR(7Q>8
M]9XCZ4DT]8`75%!F:E0QT+G6]20MGX*\G8"LRER:BE*.!F22?OS_M]6.!JN%
M^I;"6O^W^_D!1K<9'G;9T-QAH1GAR&K/*:E7+1$^*\TZ+FW>7;3J73I%HO#)
MR="SG4G_[2[:]L=8^/&`H(4R@`,MF(\ND.00`E"O#,7_G9-FG!3O>I%'R2NC
M3R!=SGZX'VFZE:Y6U=7!Q)8C(X.#%AF<$BRLD)82CUZ^*LQU;A_K26;F38I[
M_0JFV-W2=&`4$7J:]?.4#]!O[YA@!#?>6>2!,HS:Z//QYB,SB.0JO?;Y>@53
M8R9%O+Y$4H)R<7XI!:BRU=.?KQ!YSH%MX<VT?TG0+GYFV`CMG#=0$@1M[?D1
MPW$N*2>9XS<I4@XFHW%8^KZS4B=^OA\>`.#82H:<PU1;A;GS];=)J.##GTT5
M5)=#D.$HWT[&?!RFU<UX#M^]/C@N<$<XP0HRH+3&PA%J2;-.[G-3Y]O['S]S
MZW+PKL^C$"P?\=%TV.8A2JY5'8@VPX.TP/'X07D%?=P?C%7-YD`D-<5\C>';
MBH^EP4Y#?%2>-7Y04V8RAV[OWQ(`L1%@K@@&PCK`J,:JQB!=6REU,>B\67<R
M\".Y$\D9>HO2L2Z";5\2HI*W0E/E;:HYQK&QN%'S'HC<9(_V[L2Y&VT](5^"
M>^V/A'I),@@@I5-I@"%QQ#*>KE;59^KQN_2YKFSGDCH%FCA,R9$=3$(C<C19
MKMN^$F(.O"R0U%`60H:!<<A'<)S0C;G"?6Y5DTD>A)1,B.D/\T(),?.J6FQ3
M'^+4_$^M%K_/[E/_O\?/5_L[`Q[.GLEY8P!8`$RA-\QBP+1'6-D:&\C-6;6?
M&)(Z[U-M"HBC"%5GC\_[CIK_[\-R4^71L_U;@L<N3L4C1[VR%`)D1./1*6AR
M;U3EQFK.AI*#B6`4&M:]VJNG@@T)Q>>_673AX8'7A%2BU$DBI,$0I!T*$=]8
M+U;F!J3;!W-*!PW'9&-_@AB%CGL;LG8AX]Z7!)7ZML9/4$2#F@M/O26LV1<,
MS[V_-\FCY#%9V)<$1N'@+E005[!X2`A51WLAMGM!P%AK2REW7L6M@&GIO&M6
MCEVQ$^/AHXMC,J\/[$NR+AH-KXW<W?0_`*H%_5J^*5"J&%;>("Z@-3!^@Z+V
M&"F49OBVK>>M`X<1P[1B.KW$<H+CW`E.B57*&NJD`0[7"&!'<QV4"9:S*4C#
MP?`?D8'/5T+[B2H>>%F@RE$L),=,8D\\D-3`&I'XTV)%2,XMJM@?YH6WYB_5
MW<-F?C/;5A&EEVO$[7;C/8.#AXIXC@B%F#)F''5:UBOV3.;V]<I-T!K-'^Z%
M%?MWX7[@+QW&_K3=/J2B(I^O=E<.MG^L%LE^F,=%)7-VM?CX)D)RM+9-`9_=
M0C_?I;]H&^SN_?<&HBTDWCGG=?3L$(G;3;V#41#M\',ZHBG)\`D)K<3'X7[,
MJ^WV<O;C^;K#[BC@PV5]@/8!\I_TWH"IA!(I:;!&-F4G4%Q'=BGG8OB8YMC.
M_!#4+BF2TGK]U<:T<PF[D;7CFX(BE@&LH:/,2&(8TI8U>YQ'N<?CDRQQ/9+N
M[5\,T_*P>O&L4A%>`IF(WV4TNQB2RG#5(,`]*Q;T',O''X*&@^%?I'!6.I%:
M+=(?Z53@^^PV?447U6:Y7KQ-VSO`P2ZO"1(H9QGR/E4,9MP!W5S3I4::7!9V
M3^PM4%QT`*]^0*R+6)!75]4\`A+-BYO9ZKKZ$B'ZO/IX48<,Q@ZO"1XCBIC"
MSA.+0?0P!6UB:]K1W%3R25X/'(1S`Z(]GI9346]O-H]111_MH=1F?(#V_]F[
MMNZV<23]DQ;WRR.N/9[MQ-ETLG/F"4=MTPY/RU0?29Y-YM<O((FT8NM"021%
MJ^<E)[8)$O75!Z`*!50A8J@$0$&')#!QFF]F=\M9[D[2R2=W_UQ-!9$'\^7[
M8UH?4%\/Q2S"P!H@M+/1F%40&>@:`R(_\]S)09HUQ5S5=V6*BQ'L-*`OGH'R
M;=&?T>2B7'=G5=#V32=/2T_9YDV!6R5-I!KFG@C*E8-H,S-H@30[6MVN-T?O
MY5+#85_NY;F@#?:<14>!4H=E=!<X,;4L0@V7U[C_;:W>M/S65\O&=[!4+4=*
M>.VL![!.<]YB/'7TA1!ABQ.P<8HQ*K$AB%E98R>MO+(JDL.P\S*ZN32O]Y_8
M?KD@UJ+N8%>?",9(KI``#,BTY&..13,K*.ZO*IO@X(P[@?$]*NW2E+?1?/[7
M)$4%%__S/)F6#\GP5(N_%?>/19L:FV>_.VAD)*;64^\-9-(1Y4F-E[7ZJLI3
MC9GD?6CKTNS^E'ZQR@.Z/OX[B_@5RW*^6D(WP<15T+NS^?V,+P:LE(+442ND
MY(0Y2_'&C]22.)Y;QB_W/LQ?=B0,I\-+CX^XGA7E8V6>(S>JNQ]?YE&HB.I:
M^-5/TS6;NAH>^1\,6&!IHH8QH8PA8F6T:6MDO=2Y9OXH0]=C'AV#J?#2@^-,
MJK_4N>862<2$<E("9RTS1-=2`X)R]TY&&.H>,VTSU3'(AOW;'K?@WH%60<95
MQ\>AI0PEP&OEO6\&FA$V-\HXPLPMEZ9<=UJX,-/.K/9ZYIM#="N005)H1(VS
MD`'LZ-:HS+T$V3Z<]!>R?8?5U85YW7%5XXZ_%"Q&)DT1%@A(@96""EMCR0S.
MS>\VPL*Q(V;]`)H;<UQV5(5I!P[2(JH%$91`P1P&'#/(S*:^(^,<'AU_8PI2
M]!&52'8,U*G:I8JH6`$)Q$`K6&,$*,Y-NCO*,$1O_.DDW'"Z-B[M1!_<5>XI
MM)!0XH9;88QE43L2,@F)$XU>%,GU@$8951@#9SM6R*67RS&<7%KWH>E5NS(E
MNUI$1U1"H"W#F`-D,10"&6L=L50#8MC1Z^O]R/>Y^%=1/;>ZLO_ZT>"0U8!Q
M$DTP(['R!#"XD0B"^,,U+4EG:W76*9A#K"AIU5ML^OG+;':_.)Q/>]?CP3'%
M"80,<HI2G%+'7]12445RKQF/\,A:OD)?%[,['\?#[/B]+']?Z1PP#%8:3[\)
M7Y.#U<S#?Y^5U;).5[=#Z\>:!`:P\,`(ZB`746+/XMJS[C%RB)!K6OO/UGW'
M:`YF;VYS]?#LL.OQ(+3&ELMH]RAK&.*$>EQ+A07*M0]'F=&EL_FA`R2'X$<M
M;PN#(G@!O9/`&D53<:9(;UY#@2S%N7/%"&\`=L:"3.R&V0=>+!<IK>2Z'&$;
MTW)?DR"4M##*%>TJY;C&3FC;\!KZJ_(@NS8Q.P)U*,K</JRLG=]F+QCM8<K6
MD\')Z$=;J27&5B/DK(*HEB6:1E=U.O=\A>Y@2#Z8PZPBBR)^)]W0LG'&F\Y6
M>6HW`+COFXA!G4/YIEKE@%@LDF`'%Y[LMP;MG(+,192$E\P2`U)ZYC5&3*C<
M?=A1SDB=$VXXX`=QD(M5,.J7HBKFDVFJ<W__5%9EPBCMP1VOJMSN!0$2;37G
M2@KKN:',.::;)7Z(%.WOF7*]8#P$N]13BH/^>Z6UM!>ZG%2/Y>_3XQFO#S<,
MWBL%N%7<``V\)@2F*,9*4JQ%=H;A41[A[)Q-G6([!(O\I)ROKC!_*":+Y_7I
MZ7^4RV]?J]GOBV*^*I![4_WYO"J8NZJX5:Z$^YS"7?,X</1D42[J6I0_?IF4
M58HTK(/U:8IVDWD5'SM$R,'Z$*CWP"$0QS#EP"/HHCH:_)7L/Z'1@`>8.N?V
M6-5T"9_U!%\U,$D$9%Y)S@SR@&%'ZJ4#VSC\K^><9R\.R!E89NUS)U[>5FD#
M[?;A<_GX;>=:NN?)0)`@"JW2Q#F+D2:,U$8HABK;^A]A9LFN=B.Z07*0'>VZ
MMF.KU`P[G@Z8$H(]$,@[")3@EL-&)A2)?#W[F%WO59V/YA`,^3BK9C]W]+B/
MM[=-($J9Z'003``C44K,G(CRF700(XZ`P;(OOL>]S:Y0'8(U6[>V(BYF5L5.
M/\=^;S@_JQ:Z>)C-BZW2VQ_*:I;**-;G7.,2^?-;4JJBY8\/Q?);2O*7JD<\
M'4F0-V`O`H:8413'*Z*:1/13*I5ZY!)(<Z/^([2(NN;U>+4TW$B)4FT&\^::
M[U%6OVD1.(@F!3*."X5!7$,LTXV'00D?+#':>YQ;N\%T^)GUW#EQWSCQ'D;)
M)71,*Z>AY<#5$5;LJ<Y-U]W^=LB`FPK]SF?=(#P$LS[-9Y'R1UR`EX<"$4XR
M*"G13"DAE>58U!)$N7)+5\KK7_&R01S$X-_.#W?FI;63WQ4418`R[00F'`/`
M#!.FV0PA-+ML.;C>W8:AP!Z<?&V)%:04!,8!1#ST$`%#E&]VT)!SV0<B3C]R
M^^ZFHG.`'((0]?[YIV*^*KS2XF#5OB9!"D2AH]'D5\)[`KD'S>8*UMDU2.`H
MSS%T392.4+T$9U*,YNX$PJR>#]1:"B7B@EJ)/*%&4]8$;/*+@8[RE-7YRCW"
MEAQ(+T$56TZ?MZY=M2#+ID5`CJ8"NCH*)"GCR`C1&'+:HJM*!ML[7?)`'8(P
M_RA2**>X5Q'GR6/Q\?GI]V)>5[N[?5XNEI-J=9[K^#IUZJN"TEQZ9CQV!-.(
M+R8*-VB@;(K!41Z*ZGK]ZAGM,7'OV'IWTGN"`L8)04T4VRAJ#6*R'H.$83C8
M=;8A2-<?23+9F*.""U)Q,V^_$>-T,NY[4S`.2BV-0L:G`XL1"%4?NR!(N=R\
M-2>OL_WO#UR:C!VIH.<;]2_W_V^JB,/S3_O?@UZ;W]D35=VG5`0_U<"SY>)N
M.DO'S5I8"6>\-7!B#4LU2`D!V*3J#LJM4Q\`08R[4"&0#(F^1!7JZ>$ZY^>\
M-BB($2),I(,X&,I4"Z-!"CJ5NY<]RD5N$$;-+J:<2\PWMEA.RNE_IITZ49H"
M&"IAL>5`<N8`46M]46DL/WI@L.=3X=LI8_1DFLJ5__:M*):_IHY$1N@?+P^D
MTPA)IB^QJ_K'1GA;+,K':O7LE[2_WN88>.<?#1IJ%)=Z@ZC50G/!`94;E)6G
M/-L;')\A-`@7]QT,O[3B!CD)ODFIK;Z7!T^!;ST6'+68Q"F?4($%Y50C`FHI
M-&:#)<+IGWYCH,+K,^3YFFC/IT5<]AYG__JON\W'$I](\U/B$MGB4OW[H*;3
M3??2B)P]3<IJ!Z<./1Z@@0YYPS260DL'B8HRUA)IG7N2:83<RE/DK',,>V>%
M^_KY$`OBGP/#&CON,#,((JP0I,[7/::49(?^QV2#=Z.RU_H_';W>]6V4/:3O
M^.=@@<+(4NYE="0TH\!(6/<8(WP5>2[ZT??IZ/6N[U_TIT/ZCG\.&%'O`+4>
MZ3C/(8<H:QB*[?%D@.._1]2/MD_'KG=M__W3/P]I._XY&.`5!8@XPJ60*9$!
MLB\]AH-5S7EOVCX=N_XMNJ\'Y_+XYX"Y`H0A*M,M1J<<)]:_B"MRZ[Z?7FKF
MG6G[=.R&.V/>Q%YK_^:(>WB@52!QI3(0&LNT%R@Z-\`TC`;>Y5KT(XS:C-!;
M[$XQ%R3?7D^R5;L0%TY)H!",><0Y]\1@UYC'F`WF7`Q^K#A/V^T8E(7M(%F*
M4JK(#T6*8QY@S-93P6B%&%40`&^0Q8(P(&H9./'7SX]3=;DK@V\6EH-<<T_Y
M0_?>GSU*E#;-`P36>2JHUXH0#0F0L)F=T[[S]2QQ_3"H!Y"'H-:NX,3G<O''
M$6/I4+,@/%(IU1O`DDH:`:2,-1`JEGN?842>\HBMI0XU,RS_MF$Y:BT=:A:D
M1S+=0_-,Q7%,`:!,-?YG-!ZN9S'L1ME[&70VMH.D2UO7U77?[[Y-JL>FST=7
MQ8/M`HW#CE'G"'>0:V,XU+6<VGHU6'AZV!,UYRC\=02Z0WB'H-&N6?O((KBO
M2=`<"6,PQ\9!2T&4CO-:.J=`;LJI$6T>CG@![$@KE^+<T:5O?Z.@#45*>X4T
M<Y8R8'E=H(IJPW#N-N8(%[[SE=R"-5FH#N8/KG=QE^LTINU\P!U-`M*6PSB5
M,X`(C',O=ZSV=C5DV?DWWPEG3E7QSLIN9Z,Z&&>V,GBT8\R;!L%KG^I?&,4P
MT"!5D$5UX%9'GSDW%_$(]PGZXLNYF`[!%G5W-W^.FMADABU;;$?N:Q*$X=1(
MPY`C1@*J>12TEL[#[,1.(]P.Z($Q':$ZY"[E.CJX/(4[QYH&*YS``CJ$N&>4
M`AQ'2BTM12CWVM0(+>J^9IWNT!V"2V^=@B.^V.X&`7-$B,3&"*N$ERYZ$++Q
M,Q')3>\ZHL#^B#VQ3G1R&;8=]<+V-0EQ5K8>.J>(]%9[(:),M712XRN*Q)VK
MWJ-LR4)TF$WK=1^+^W6EYE6TI]Y_/;K8M6@=",&4T[BV6XXEIU)HU8`(/;VJ
M.KWG*_[-!G;7``^2.RS5UJX[?I1$.YX.!%IF!.)4,,F%,0X;W\C$Q16%<#NG
MS/EP#ALL6S3+_:]E5=PLBZ=VT=H=[4)<T)&D*8T>]IQ[(QANO$^OQ'#%,/Z*
M-E*7JAF6@JO]KJ;/'XOE2==R][8.QICHA=@H=G1OE2-8R&;8`0^O*G%91]K?
MRZFN4!Z664V';Q]>B=**6ON;!^]7)YV149!0&/UG+5R#J`2YVP@C-,X[Y<!>
M?G4&]0@(UE3!RB=9\XI`/>,08:@U9`1A%$V/.@QE0'X>X!&:8A<D6B[<A\FV
MIP;5SEO\*<G'\V1Z8.5KW39882%3'C-$)*0"2X?J33AC/!LL,]3[6_?ZPGC8
M2>G7V?\5\\]%<F.B@?EALGQ.)4(^I\,SL-64=.@%`46QM=/:*219JEEO0>T8
M&>T<N0:KJ@<>[)V0.@1[6)K]K7S\=A[/#KXA$`ZD@PYJP:F20A('_0NT/#=+
M]:BFL2&)UB7:IU^U+%>QZL0SO/E_8AC>8MCZMUL=_CA+JHL8/,V>JUU+XI$6
M`7MH$,%<<8L@5L9YA6N9N-)74+"Q/_YTBVV6H?2UFA>3:?GOXKXN)ULL;JO-
M<=`Z8<B6`1`-Q76!K"^3[_L,J'/>&8CGD#KGG1>8:D$0QZK!T(G<#+"CJI[=
M'Z.&QG^(U?##Y'OY]/ST9E*]?=@OTJ&U,>M]07@`..462&*<PQP05Y\1,Q28
M7!]Q5,4D^U\IA\#^4A>Q%O5H^US<32>+1?E0%O>I*I>ZNWM^>IZF8,6MN;FI
MEK/-;;.'AR*EDRL^I9KWL^ICRRVS;C\9%(<8.Z,90%Y"Y`SVC2XY\;GGD$<4
M41C2`KRH<L9`_=ECE9:>FVHMU$U5O!)+5?=K^\9]7Q>N7U6NJQ^JBD74RB+=
MR3QO/'3:CV"1DY@B(XB"U@L3>='L6<6_Y8;=1E7O\O+#Y)(Z&V+LU*(>L,:V
M@(G>P,'#$8>"R!U_*6&)I98*8H^$%$"QEWE(HNP;=NUK=%X%_R^KE2V&#Y:L
M>A5O_T^NZC5M-!6,:D:P%#S^PQRLM\JYUNQ2*?)_N_M6W#]/B]N'G[<?%K</
M6X487N3^-%N4JTK9*]VVR9;?T1<"DMH(SZ30\5\CN>+<U/C%@9"["(]J6WQ0
MGKW.JW(1/0V2HZ>1[*`)<E,UB4:B1UI6D^JNG$P_%?.'V?PIG3LZC>T=?2L`
M0RQ%WB(HI&2:`&TWTSPW&*E<WH]JEWX<O+^,QD8P`O;(MAG@3=BW`_Z?^J7@
M-&78.FHA2N78J%81S0V6@J'<G;=1%J(;(?M[UE??1NGL;B5&Q-!5RW+YXZ9:
MC=;TKA.MTGU'30Y\X>A1DQ9M`^/2>:J\(=!C+A0Q=H.GP(BZH[<+VD0.[XMR
MG9\U_N=U:M;XJ[#NW>?BL4R=JI8?)T^[*I'L>S1(@M,,J*F3#'#N$`&REB'*
ME%TTNQ\7L%.MS#J%YO2@<#O5FB*=FY[>Q!'P_;^+7:?J]CX;N,3`$>,519H2
MZD3\J98`\NR],?0>E7L>-MUK=Y/NP,?E8C+]9S&9N^K>QNE\CX+W/1Y,%()+
MZG&<_)04$$!I:CFH\;D'1?#[TG%'\/0UB'TY+>8F]N=Q-C\\A']Z,G!(`)#0
M(@2THFQ5^[/NO7$@]_X:>5_*/1^9[O5:"YNNL^Q1Z/8C02K*E=06"2@I]=19
MV_2729][+)6^+TV>`4E_*HQ^8CF[/SS][GPV$"FC!<VQCCAHE%*_UW&,*`'(
MSI#(WJ=2S\&F/^V^+`D^_F979.;`TX$``[5BSFKLC3=6>-G@(>*"DA]=?(\:
M/@^=OG6\YE][+6\]'SA`0A"83(3HJ4,9,6JL0<]%;CHF\9[UG(]/]YI6L5OW
MJZY-)[OJB+]Y)E#.G%0&<2T`18:J2,]-CXEV,E>C\GUI]!Q,>O-H9T]/L^JW
MY>SNCS8EXMLU#!!0B:SFU&B(;+0!K:*U;`K"[!`4>%\*[QRIGK<!W62>CALN
MXF2SZNE%`M*O.]$BVKRO23#IRA4C3"N+A4(N&3YK="42CAQ-TS:,A&W"!7O;
M!!*G$<]=FOJ]=5%2)G@MHR+Z*FY!=:?H63^P#CPP+UG<O,OQJ:B1W`.7$OVE
M,$R<8Z%U"@(MG7767&9\OH1Z5)S`[\OI<PKV_%;<I4/89;'8/E47)_<_G]=*
MO7UXPZ8CI<B[_5"@BA%CH%/<"F2ME!RZ&DU%Z6!9)OJ_H'T^H?9&]RZ@B2$"
MVV>*I7_L?L&1#(8]?C7$&9E(+*#DUE&&E!#(UQ@;@P=;]_IG^Z7(^3IMZVB4
M>;D!DV*11_,H'FL:H((FVB6$`A)]"8^0(\TL)9BZHHEZ%)QIQ>-L]61=*%UY
M@[=_KHX%)K?SZ<_I[$=1K'[]Z7E^]VVR*#Y-)]7>G'D9;PG((>L0\@0Q9HQ#
M0MAFX%.'<Z.3H_04NE/R;"C`LXCTI7PJ_K=8+(O[S_'?>7D7_[?JSM>J/)`0
MOW7;D()Y!B&$H?$2(VR\-\UJP7WN3>-1GJKLAS0]P)Q%E0^3^1_%LBTY=C\=
MJ+,,2QC%)8X*F#+\L[J?"(A<JVN4QPS[H4,GP+X#E^'7%DD\N_I$H)@S:R&&
MFBML=73Z/'OQ^]05%;.^#F<@5W-9$Y^>+,J[N%S;U-_B_H0-K%.:1R@=`9)*
M@14`WA,J=6./(@-SP]/OR+SJ4_VSWC4RQ)SZL5BN+^VFFQ(M=DYW/A\T)Y(P
M3XW'WG'D5H=UG.&2*R8<N`I#OA]%OTZ1W0&\_\_>E2VWC6/M5\*^7&+M256V
MZF1J+E&*S=B:=L2T).<?S]/_@"S*JR02(D%:F>KJ=-(Q0)SO?``.@+,4ITU;
MN@1I-+%84FL)9$!Z:,C.II2,G57"_1,U>8@7'7$LP8=_5?.KZQ3N'*&=754?
M;Y,)^>G[B^?E%BM,UZY"M'!-/,D:I@W7T"L1?XG_2P"A-*<\]P0PJ0-AD<5G
M8.2GQ,,-E#V0<--/`"B*#(%75#*,E012[FR&5-'@?*Y/AZ-()A=S%%`DW<[+
M*^(620KV-DJYM#"WU"JNA7=,$0MW$K(([SDL<L5)UAO>)1@5]__E)IQS=K-U
MX-K@H=;KY?Q;/-BD4/[Z_I%BMJHN/\_N-BYDRV5*8GHL[\SIG0?GD546.NB)
M0=(`;^@.,0CM69P!^B1./;(&1MN.M^;+R^E\^>_;^Y*M73?FXSV&:%\C&K<'
M1)Q6&@J.46,R>^Q8;K[;[O=Q=53P6^-F&=!'M`_WR=+=0MS74T":2:HL%\JG
M\J)`";7#`@&<&^+5/>'RX`0<VT;L206%/2A'S+C5IP,E=]IS);&ABBC.B0?,
M;KU4@;+J:&#%T`Z4+QPZGIZI,W)C=>HQ.,4\Y-A"`#D4"!FDP0X?`7/WH4E:
M2:>39*]3Y)"@#SWQ_[Y]5/^H[$3??+K-]'[R@P$*(2GWVCNH*-=1>V8;WR6)
MQNBH:3_0I$XOUM?U39P`J_L!?ZS7U4.&G5;3N&T?P1)L"00@RAPW#Q=9VZ0*
MD,1XG)M)<YH3-U/]SZ?K0.`6F:"C1C1DSE-F&<->$:>TI(!!PA'6'$FH/"=8
M'+4Q6SY?IXR_BXOYS;QY3+T?Q9.3ZL=ZL:GI6=_<;)*?KJNHD?6A2["^N@[*
M$NZX@)9R*]*A0V*Z12$N^_B$I$63GZFM"5"/BGF)D]Z'^:)>;D(G[\=Z8!8]
M_]$`)2%4`FP!5\9H(9G@C31&Z-SHX,X,^KF)L?ZRGBW7P[TJ%57_\[H2IR%?
MWD'B.2H7+U%I[3S1HJ]@/(D6,=>&2<<`QUI8V.`1#\QGX>PZ.@N'5DL1FKXZ
MT,VE\FQ5)?\G?;N:ITS[IO[Q;;YXDDGQ-:KF]!>$Q8Q#*"V3&FK)(C*[Z9M4
M4^R2:]B:)*.2M8!BQMB?;?4@@4V)%A.4FR35>R;A/^X/%AWV]=Q/!!F5@[7B
MS"'LN!;"6]:@Y[3*?=]O7]Q,WM-Z45VEF@)?SY?=(ZDLRXOWZ0#FVP',MS/Q
M<COR>GV]/Z:A0Q>!2.J$HB`*QJPW$FC=V/8ZU1G,)&'G2F9GN+8.K(O)'W>H
MB7-$<6JD`3*E;U*DD49#GQO]V;F2V,\F1=QYL:LGW$O>>FT+Y[RIRR]A-<!(
M:"4(%E8`9YG;HNDEX$=?5EJN^O=?;5F3_M4?#M8Z@2P1RC$#F+'>`]N,U&IS
MSE?)K954]XQBB37XY7WW?9*\QCAOC)E.[Q&O=Q$\]Q%$ZU(JH'@898XHU4A/
MB2_F<CKXQ<")RC_Z)-$+OL78]6?ULXGJ7M97R]D/=;N^CKO*?ZMM@;U#%71;
M]A"0-AH:22CWPE.F#(&ZD1UCF^NJ,J'8Q:&8U3NXXQ%K5^OWJ?_.@T!?:UT]
MM+KLS+NN'P@&(:*`,BY%IEM(4SK9!KFX>^3>A4XJTKL8,0=&OP1OOZ:5^G9Y
M]RB1I;J(T"T/DO%`JX"AQC):Y4)YK@"#\;NFD1$Z=4)"_3->^/H#M`1IMG[3
M*U\O']C]Z?NCE*@'N'.\<8C'-J6C<-08@0UF7HF=Q!KJ7/^NJ=W2]$NAWG$M
M<E8>TV,S\XRL$$$"82*(\,@9`'SC9\.TXKRP@\@KU[?'BY/V^X&`E(5"4$2$
M@Y`I*[C2#2+2Z;.J39I+A@QGD=Z1'WA&[^KA?=AL9D_CI8I.[=U('OSDVH0.
M'FH6%$=,6`PM@PQRHB/JV\SNP&O)CE[PEI.TC<_FP7:!0PF@DYX*)R6C%"#J
M=K*2\PI#ZT?I]7#PCC%KQW3<'&+R1L.)IACF"+;6R#A$]=;[EG/CCA][!Y94
MK5;5IM;I^_GL6]P74L#95AV7GQ9_IB"T90KV65S&;6'9_#'YZZ^.9:/N[1N!
M6H6A,<@:!X#&0@&/&PP1QL4R(0T?H-\/E?8M"8454>)`N)--W^U^^X]YM8S?
MOKY[7_VJ;HZDE&[70<">(*`8=E`Q;2G46OM&<F=(,:_D@A0LQY9]?.U3)47)
M^'A#>RG"T83/G?H)QD?A"2`17H^,Y"9:XUL<!,Y__Y\R-7LBQC[>#0![4?J]
M6_R\7:\V@,"]65E;M`J&8T,YB@`BAY`E"KJFN+E(J0K.TAKO5_O[.'8RVF,Q
M"F4Q"C4R>BH5));)]$]RO=:ND3'^.9=1D_*('Y]1>6B/Q2B<Q:AMJZ"1E<Y)
MHQFB(-K!*3_Z#C=I<ATK)_6N.#ZC\M`N?`)XA(I?5G_?5HN+N_;F_[[605'N
M!`.`6XDM9,9CTMBQPF%\1LF@)V7[]Z2/L0S_W9BSS/UGK0-'7!+BG<4,1.EU
MJAFYDUF;7.^):1OYIS.@A85_&M*C'2MW<[#]YGF@>2"`"0E,2KW():?0`<\:
MJ1$'Q?@UUBZ:S8(V9\C3P"Z\B6Z6?G,S6QTKQK:W35#:`L<@8IIZB)*$#]-3
M4I=[(S&A.,));I@G::$HR^[1>@6?#2#_7-3?5M7R5\)E8X(^?;5^+&C[O;7G
M3P8FM56$$FJIP5!3SA7:S6'FBB5#+[HAYS+L\(/$6$HI07E3+W_6R]FZLM6W
M]4-.QZ.;]L%V`4*C,`4**:(\!)IKH!LYM<BOAS[IW7HTLM3#J:8$!?_YI?'Q
MC+O/'W74V2)9)4<I>+!=\-YSZID45EHC+546@D9.B$BQ*(/?DH)]JJ8$!3>"
MZ]G%7]5EAS7P0*L`&3),4@&\I=X:%@WH1D;I0?;+Q+1O_:9"O_X4,X+5F66C
MOV]1?*[7[P2HO4/:D;B9L`@<9D0V9T3I`,_=XB<4S##!,]0(FIOB#-@(U,7Q
M+:??P"F6$&`(N#,.I2A\L5LI`#^/JF,C,^Q$GI^BKV)FQ</[UX//7`ON'FT;
MJ`24&>HE8E;@:,=SW:PF4L;C[N_,STQFO&9']*B#(@?ZV>HZPI/^DX(G?LUN
MGKS!/LAPZ'#?MH\@D<*(89W,*(HQ58(T+B'2Z/-RA^^1#<]/[`/A762-^S6;
MWR3KQM?++W'@#P;WH<5M;Z.@I%;2*X>(-I81GY)![^QSG_V0.,''[.'XU!N\
M)0CT;O&KNB_HTG&5.MPP"!/7=FD!0Q`CY`2(:#:2:N)S+\`G^,@S')%ZA;C(
M2:)>5O.KA8E60'HLW23:B@!L$.K&KHX]!8V<Y9Y'HY<;`E+$*GJX5]`VUQKK
M?!Y^VSOAL*@?9N">:.//-[/%5N!Z:;>J2-6^J\5JHZUVO,KN*SAOH+6(I]6:
M><2<IKL]7UM?+.;_;3*K%.ZCGB=SSI&!,0`D@T81+YR"QG/!&_E4M`TR>=4Y
M+^/;Y%7?^);@SZ,S<]ZE1+L.`O?(2FZLT5ZQ5&S%R9WD6F8SZRV\O16ZF1A$
M$2,::*M&H+M>K+2#W06E@!`L_<LD(H@);OPC5'+]I2=Y:=$W4=K9:WWB7X*5
MK^2T3Z+$Z1HACK];S:.&MSD$MH(=(&5&;_%<CIPB"`'DO9/40$AVF$B)<R_2
M)GCM,3`CAP=__)TZ>X<.%$"L@2)QOX&$>\O$P_4/$JB86\+P96('IEFO.(^8
MQ^19%/H;3F3",>'6"^\PX!XBQ:T4]^5W/1%2'$U9/(RDR0?OW2(.\3:A?BPE
MR2L_'0ATV$8&;4JO2P^,$[*1*VZDQ6*<1TXNTEJ]==^0EECOGX[R2&##RQ\.
MUF(%`"00.8P@YQ)2VDB4XC?.AR0GZ?,@-S*`+$^-C[,?U=&@@GU-@H6>:*>0
M2[FU.+)<D]TD2M&XYTJ3;JH]R))L-+,NGU-%V]7GV=U]YD,?1W`YOYCM]4P]
MVB8PJ`540`MKE33**V5M,V8,X%F=?4]77#T,K%E4^!+-NGJY&<67^7\^U_/%
MVLVOKM=?JE_5PL]_59^KY464T]Y67_\O_O=N\[=5M3C,EA.[#4@98^,&#+$'
MBA)H-'>[6854[NO$)._Z^B546>3+;U7O6_@D[VD1,,8$8`^]9T0Q2ZGS.T`5
MRTZ:,<'KD.'LF5PT2S#E\6+:[8+C2,O@A(/"8V.1C9L\UCC^TLCJ`3\KK\B3
M]?VB^&>?V);F44O2!.VY4]Q0Q[3@&E,A-6RD<%"=5638D`SI"&3Y#6A'X=8;
MT*Y%$$QXX!$"%A@"`<5>@(?K!ETL1<!;)$D_F(YX*?K,='K#EZ(17Z&!%0"S
MJ,A-5NVM5X-TR*&C:6&'D?3+Q75U>7M3??K>O-9L2KJLYIO:N_KNT9_VO-T<
MNTCMZ0N!<LX4=!Q!&"D:32],5(.?B;O?^5R8]$.CY\6A1E'#>61U`Q1H'1=,
M;!GFP"C)H6MD9JA<QJ/AJ5><)1DYW;IIXSQRNAFK%(E0&@JQ`,D?B=%&9DMD
ML;O":>1T:\V`C)QNW9`^EYQNRB#,F%>&,&FTPE`UX0,148%S#V*3/*KWRH*<
MG&[=P"[I='5\>6]SDYC16SS`IA3LR%CD`(9:1E!X@PE&5)_/+>/86^SPVOD]
MW`2YU,Y::#&2"&&O)2&DP41C7JS,Q\]-6>LOZ]ER/2AO!^5-#YZ#W?0QUL;]
MK_GZ^D7VG=73]#M_/LOEL)7P\[9<9JO33,^?#%PX@85%5F,LO>)"H^;8Z3G/
MSC$SR9O:DDR?B,+>X'3X(]II[^O5ZMWBXN;VLKI\MW"S9:IS77!^[!]#4%I`
M8:%R%@MJI/1&-A:D-Y3F>I&WO[66]Q-F45W-UM7EU\'MFC<\:WI3XQN<1E^J
M]?KF:174X>?-HX\&3*$!QEHJ#/&&<(&Y;Q"6&`R?O>SI1/G?'.E;9;_'<2#:
MF)YN$GD(Z82)>ZT2#29`9^>XZ!P:?G\<<(OS(?+PVACQ?3/5V[V=W3P=SQM^
MY102&L.EH)(PR4WZXWVTC7*.(G[4!_%W?^44!!"MF(#`.XL(!@*R!C]-::X/
MYY0O^D^BT4"OG-W4,-(5[9&7S3TM@N="`42TB]!""P#3=(<MYOB,`E2*L^'X
M56N&!L9B5_KMLCH>XG*T;2"":H&%BF<H2)R.)@!'6WD]\;;8Z]+PC#M9XRT8
M=`JV6>$.<4;\JI9Q;EQ4GZ]GRQ^SB^IV/;^8W>S/R]ZJ77!,`PUL'#JAW"AC
M%6Y0\<C[HW&B;YL7F7JLAT/X+8170F(B.))**;UBTCL)82,1IRS7J?R,'PIS
M=Z^3P7]K(9F2`<J$\99'5*A'C`/72"?C7Y[/<G2*:MN&9'9#\YSB\`S75F,N
M'))6`&VAH@]0(EYL6QLU#J^U^ON,P^N&_._A66.(0E0(Q3UDE'KF!5`-)L*J
MW`QP^%RWO>$Q+I:?\MV/G[/Y,DU,$ZW#J\-YP%]M$`!%&!+.N("2``H1XK21
MS$>`SV=/'%3OKV6J/!7LT7Q/XW`C**MWB_0W]S.NNKA>S/^^[>R;<K"O8#T3
ME```+-=,26(DVIU>E(*Y;RH3M/5+DF]H/90W^]\MHH:JU?K/V;KZLDZON%L[
M87;5/N#P4"<!.N:E`!92[W7<2QPCHD$`4IQ[+3_!#/8EF3B8`B;ZY/RQ7EQL
MTG,>>EX[J=^@&2`4>4%D-'JPY5B)G07L`"Y6"VZJ?GJY5"VIE3?H132J;RHC
M`$F/TTG36L@]4=#LKDZYRW6UZ^QZ<5Z+\T34E74Q]+E>Q]'.9S?^=AV'_F%^
M$_>5>E%]GMW=6SOUCQ_S33&5K_77Z_GR\O-LN;Y3/W\NZ__,?\2MY^8U]Z"^
MN@X8QCV,*44L8<P!$U4C=_848[GO89W3_9\'84=22]%5^GZB)4^)^G:QL9#:
M++0O6P4JXG2C"GBK*=*,>\,>)I_.3KC.?T_J]8_X2)9K6L*O%O/_5I?O+M,\
M^CY/R_NVCL+]0^7ETWH*\>]2WKUWB\OJ^WPQ7U?OY[_2']?Q'#G?M>UFYPXU
MBJ"4<<1#I:&$S$E*#-\>8#V(O^3>R(O?F_73U>`8#IV;6^?5TW&\84=.!Y1"
M/.Z%6B$(M*$6F4V&(`-`/(,?S74]M"-G5K&7C8Z2RZV.P_NKE3MG#]\)B`A@
MG/'1BJ#&2\&CT;O%$AI1+G5-T>CZDTBUUZVSO#I*[,@/\IG9<GD7Q[V1,8GG
M5NN-?7JYDWSUZ?O3B[,<6O?PG>"XDLIJ9@@!+!WF-$\X$FD4$"P[+<XD8T('
MIG5Y=10]OK28HR^N%9[>*K1A]Q"?"S)J4QF<W`FP\UAHCF2S6##B<_W-)IE]
M<!"23T`K0YN#T?B-@YS=/)J;H]B!CVH$IZ4B+2/1Y$ZQ>TW1Z1968?M.@C-"
M:2JA@@Y)!@@W+&61U%0)+"@\>H\U#`JI=ONS^NU1B`^SY5_5.A'K09`VBTI&
M;P%(KKF@5DC*L$G960RZSZ[I**4J]]UZDO;>$'2I2ZM@A`5B&__W6ZP3RGO,
M-*120$.<`SKE:W,:2$\]1N;H?!C:Z%:_HBHVF;;KY9?9$T*U#OL[TD?@G"C`
MG8I,!-9K&)$P6T+&S52>40S,$,38:SCW"WL)H_C#[-_U\FO\W-:@?PV?PU$1
M+7L(7,((+;7>"LJ1HE#KG>Q4ZV+;4,E0B=[X4)?`?")\.QHRT;J/X$W<RSD6
M0`&-G/62*=[(KR#,]3^9(.=Z9T1WQF5AGAD"N/Q9+V?K*HWD80#WQ8;7Q\(`
MC[<-,.6W)YI9I>(T5,9JXAH9."E76K&$R3R`9NMA\>Z3,Q_KQ2FT>=X\(.2<
M<!RF[T//$%9\-[\4]\7*-9\O<TZ$/(L\?]01ST4R(CNN-D<;!DXL58Y39`DC
M"KMTH;4;O9&Y6]0D;_0&)DS?8/=&E;:+3)NVP5@?4:$<.Z:($))ZX+<RP'A2
MR;T"GJ1/[0B$.1'O+,Y\J)?KJ]E5%<7[M+ZNEIO71#V[^*NZ[+C>=.\I&`B=
MCD==3"$7G!*"1;-\0D*S8ZHZ^ZN>`9\&1W\X=K5=HK(Z"SB><@5WV"D+$*36
MQ%\;*3TUN9M<9Q?3WX5C)RJ@Q$7`<TR.5HYXO4'0"!%D(91<.F,\1RC5(M/0
M4"?3C7XI%]*W3:U>02[KH[+_CNU]BQCV3OT$BI@`D"-C#+12``#\;AH!;L^H
M^NSP=YA#(E\DIGWOJ/^?O6MK<MO&TG\)]\LCKJE4.;'+XVSM/J$4-;NM6;7H
M4K<2>W_]`FJ1[JM(023(5F8>,K%#0,1W/AX<X-QZN*NZ!P>JF)8F'E@P(]X*
M9CB4S8H=L\4Z.I10;"-QX7F>^]"@3TNS+'H%(;B03@H/HPJ'4AFF5+-"9$VQ
MDIXE:#6DP'MSZ42$)U95R^7N=K=.H7V_;.N[NS\VVVJQ3A'SJ0J]KJ[K;?5E
M\3U/D_6;.R@'!=?,>Z4A\9A!@T%[P";9!]`9;JJ3\'$<,<R5MJEQPEBT?3)W
M4)9J++7&&FC)"=22B/9(Y8T:_>*V8*>`F1'W'$%,3-S;>'Q/2S#U7:9]^'B&
M@"7"VFC,B29"6QW/9(WC#%K`BUT&W]?WB_4%4O`,L*>+XGMFI5YH&!\T7F*.
M*3(I05`)BZVW3F/LA1"2=5[\C)\[<_<UOO^S4-'^(7Q'Q@=*%3':QZ]($&")
M9;C9JZU05%Q07,L8A#B2]S(4Y"5VF9_0I"O!CBB]EP_'8S3RDA(>]TNE*`/"
MF(-CRTHI:&XIQAF2:&`)UP-#6YXL)AI5-_5V]7][X75>O7</#AZ95)*-6,@9
M<:D!$Q3-BI5@%Q3=>8ZXCS)G`%Q+,"G5+JFVR?+XM/A6;3O)\^KS`6K*-*8.
M>RBA0D(K;]MU*5-,^91-2CE?S,^3408`MP1I/E??#A67U,VV>BA1T,F<MP<%
MIIB!$#J$N7'*I]O@%B^I>>[A>Y9A=B/29S"$BX2.UYOJQT.>E=]MKKKY\_J`
MX+'B#&D(K%+)9G2>P&9E3IK<X-X95L\<D3F#8%NJ-NL)40:O/1X``8I:D(X2
MUCA#*(/M_NZ8S\V6FF7(W8B<&0#;(@;.JV>$/L$$'2,#ME`P::,F)0@#(@'A
MH%VKRN;1##T=XYZXAL6Y%*<>)PS?/RFQT>-BK-\$`3G`N*!.6HLQY)A;)YN5
M4\ISBZ#,TJP>C`6OL&MPJ*<G63:Y`E:>84,]A=(PKR`U"#4K1:#<;6,I4@TI
M_).X=2+2TWD8GL4P7*B'06H7]0=5ADOB,'?[$N].8T6Y]I)T*M/2SL6TGM\6
M]T-$H;T^59`6<\@054@9`C4'$!P\8)8"RG/KM<Y2$XQ!E-Z.QT'PG];5_70)
MJ5;W:O-Q4_U/M=BV19@&X.;K$P>,D8":<&.5Y09JY&AS!48)%;F.\5DR=3P:
M9?)U$)G,EKWGQW#TG3Q$.P`I1)1&0"-I)?-6-8A9:"XJFWC>+#Y'+G-BLKJ.
MA_^XIB]?M_7NYFOJ8IB6=S>D2N[\C2``<1P0*QR!QNR[4;,&/PUH;@7L628]
MSX[70XOG/=![:)W=ZW>"9=ARA(W5@!F"`/6PQ5%2ENNEFN6]\;NA^3DBRLJ_
M/>F%>RGD(:8-PJ5"9T@BB84S"GMH\&'E$9/L_*)9YGV/3LX))%*0BUW:<ZBI
M@\7"<PV\$%@(@#T#G#8(,*ES[Q=FF2<^9TZ>(Y7WF!0G+8),@VC12^JP$]C@
MQ@G)@.?%DLBG#*,OMDV?B/84?'KJJ7[R->PK@Y_`LJZI`J8>.R28$-`+I*"`
MM@&8&4-R<\I/[P9TN=P;6`;3^5V>O<BE^ET<)1Z`%`^B@"=48!CW&TVDTM8Y
MV7EW.PX*G[;ULJJN[GSD=2+5ONCWGK(_CJ6M'X$D<\9@K(R:TTIHJ-+22X7<
M(?[&>"T0N,18Z^%(4T\AA&F-HGWZY.='6;]Y9M++:0(2/L$+`?1`2"@I-Z!!
M@7)\41?4!<@X(O8S8F!*W\VTU%^9)P#D$,;QU$P\M!9;8IHK'.,=(KD7&;-,
MQ)X/![/`G\YR2KTX=HOU/\)^(@IZJ9$1R@G@*'6*&QVEHP0GR+")XE:>M@MK
M]EB[K^][M]RNOB6)=T1F=XX/'$%)H"<80T"40I0!U:S=R.P0VUGZ_<>@Q"LA
MVT.#GG5Q^3%5:EW=?+W?5G\ELW/;9JXLVLR5;]5V&?^_OMX?91=OM?P]:[Z`
MXWMA2!`'RAFCI6;,'=9*C<G.FIUA#/>(]"HI@LQ[\FJ[N*E^G@1>Z^_T]DUX
MC\&!<VHMY0K%]S9.(FY0@QE%3.5JJEGZP,>FTAB(3V"K=-LODP?>JO5Z7W;V
M\5^=9+P<F2`08I2PGFG/*:#`&(S2AQT-6.BL`I-WYGJEG?F=_O'H3_VK>_2;
M*@@"9;HIIXPX00#1WND&$2IML48D17>;02CR9I&/49`ODO]:K%4788@X'U>O
MN#.`"PMI"S)A)#<\:X:L&X\6F1V[3H-^)K0;L&-7*MZ%$'7Q,]>IHH;%1AS6
M'S]Z4JP\Z7PZ=O5F1';'KM,PS[*G_W6?&OG<K):/=/KQ1@-OCP@@M>$`++41
MCZ\GD$+M'N"U9Q>DGD:083T&QB7TT"L*^D./G.QCPR)J\;<0T`)R8[WS!G+4
MK-+GMT&=X6&^V$8W(-Y#:9I/]?;^NEZOZA-T33LFD%0[4AG'>#R40F6]4/CA
MG1$07EU4+\!AA->A8G*AG>!`OO\4_AE=L8U*VX?!V%.C&$00H11\JKVG3OFI
MNF(?:3[1-%?/\B/^;,TN$J$C[0A$&$.I4HK:H:@K@0)>5*+@&'3H[3W,A;R$
M;=&K7$D?QITV42#8,2FQPIA20IW@V#1M>@@SY4K?7PCY1D6_;)7..Y.\':OK
M576E?YAZLP=FMU@_=L'U9N4YTP;&B`76IMA<0K'$C+(6):#M/]5/D<O1@K(H
M4]CQ9TA2"@GYN'FTP-X$/6&68%"T0[552E#'O<!.&MM@0)3*C7Z<95)=`3Z.
M!_W(]OJOF_BOJ0'$9`;ZX??MZFZYKN]VVSYUO(Z,"MY:#[E#.!ZKL%%6,>Q2
M)1&B!86V._NIV#K[[3EO#PM..\H5Y92AN#8E+-2H6:G5(C<Q=J9&]P`2?[&)
M#`9NN:_TX,F^D(]5`(8PU<)0B;CR2`-W0#E*TL-.TWV<=;KKZVIYO_JK:E_]
M<[0BDG&QVNQ6FYN/WZKM7HYWA__TN5K6F^5JO7KXEKHQ&>@7@N3`>R><1!X+
M#2-B#?4AYL!=5%&Y07CTO%/K)'(H85*^OK)GKW_OJRCOQ?I?D0&[R(P?3QX^
MF;\GS1Z$4$)'4?%H_P",H-**-)AI3R^J-6=QGO7B^9CRF@O'TV)2.M*'R)_U
M*]9N)KG?FC9HA;DV4-!HV4,8+7S@P`$EPDQVD_997D:]!U8/)*BYT-G7VVIU
MLWGRA%W%@4E>JY^I&9FT[IH^;K0>,L@H<MAAQHC0%+>H*9T;63++>ZSW0.^!
M!387FL>_-)$*JU=3#_(F"L`#SPAE`G`".1<VU<@_(,$QRLTYZ'_E53##[3U0
M-ULT<R'I[W4Z<^_B8W^N*_?]6[6YJVP5R;`\H+BY.E1)6'1D98WP:P$R112*
M6&J*J*'6.=7N;Y[8W/BN65:F>@]T'U=^65$^?5[[M\5F=YU<*MN(HWU8P*M<
M/G/&`(%BS)OX/X<<]1QQVJZ7`I@;(71RU:KQH\BF8FM9"<U92^\3(T;0Q_MY
M@Y56668M]4PY[IV%BK6[&<>YM8A.KH/U'\T[K*3FPNC]NZNK?^\._L4SB?Q\
MN@`U%(`RQU(-`F,HM:*UQHPEN5<8)]?2^@]_!Q'0=+1]#<9!G")AGW,*%8EG
M!FL=ICA5PS\@@&#V+9N<7[FW>1)T`*$4=YE.6[QD:,\ITT)18SC2)(HVY14X
M\Q!%PCF$8J)(X_:-'P@2I;+\T97.^^:8`*DT3#C+&<>41MM3&M*L$7%5+,"A
M1-[N`))^*[SA3%Q+[!_Q+3]5VU5]U9%[^^2Y(!C@A'&(,8V&FP<4R'8=DN-+
MY$>^+.OAD"S*B,ZTV&=/!FYXW':$(M!P$S^>N/GH9BV:\$[-^'Y8D2G#MYB0
MA5\A+J2"VA$AWMEZ^,6S<3U."D$0,A9);JQ$F+=?",(7E.B:+<F7C#@+P[*<
M$"=P0C3K<=3":))*)JW67"*!VF\%*UW,2_\>.9&'85E.R!,X<7@V$*ZI@$:D
M(FS6:>F=4^UZ#,CU#\ZPH_WPG,C#L$PRT$O+Z4./C/>CXX)WAFOG.6?08`V,
MH[+5AY"BW#UEAOIC>,MS2&0O\6XK6G!6QX_%VJA0&1%IY0T"\<\7%1<Y$!?R
M[ZQ.`[NHPG+?%[>KS?X]/U6;Q7J?J+2Y^G43/_KJ[EXME]M===5'A?6;*0@A
M*<41`TP-]5*#N+4W6'#A<]O>OQ.E=C[MQL6[!/?^V&RK97VS2:EL<1VZVE37
MQV.PWA@14@=WYB`D4G*`HST1-PKKC(J&@=-,CE]._)US:1A<LZ)"/FWK;U'O
M7]G5W6*]KO]>;):5CGO^=[6[_UH_)$SZ>OMI\2-YHU*%@FK[UVKY=B77[`F#
M@(RZ")TW1A.+!7*\,2>%42ZWD]E,LU2'Y%%1X,NY<B8M)3.X"P=1P*GG/G6'
M]=8;(0[1!R`:(5-5F/]9_J%?$.?)-3U.GS8(CR@V$EKJ`>56LU2^](`4-"2W
M0<J\3>)S&/-F28_1P1]=%]PO-C<ID$?MRYA'L^J7NK[Z>[6>QK';_/B#>??D
MU4[2$R?-$PB4P#/#O69Q[_:$>'Q(Q9+8,M=9O6%"+/KHBM,F"I!;*@%!./D^
M/#%:`=V@@2W-C;>;I788B2=U00%,IR&FS)V?1E%`B12*_X"0.0N-(U10ZV0\
M0%#)2'>.[=@FAE]M5O?5A[@?O5A-_RKP79,$A)U3B`.'H10&"\TU.Z"@%'7%
MS(?Q#Z,CL>--<V)@Z">J@-L1=/+&B&#C8B@PR`(`.2=:.XZ:M0$(+BC\9`R!
M=U>\S0!Y*@*E?]U656>L2N?80"%A`'-@X^=(H.!.*=^L-Q[\<[V0,R35V1+O
MP:!SL,VZ/#/U)IJ!Z?*F^O1UL;U=+*O=_6JY6'<4:N\:%Z#CT`IH,<):0RZ!
M]:!Y=QI-O,OF1:8<Z_$0SF+'EQ]WBS^WJT_;.J6C'&?$:\\&I(50!'#C%8CG
M<H](:K)]>$<E<LOVS=!%,Q(+!D"UC!/PJKI^>ZO5/_8]#?:E+SN,EQ-G"IAI
MRP45WFMK+:#:8ME@(0"X((85,&K&!7\&1/SY_K\O;KO-GXS9`G-&<$HQ4P!Q
MB:TAJ/TX@=$79!"-QI;36#F`%,HP<]]T/O52OJOB#Z9*U;;ZJUK7W_9=5KL"
M`'N-#W%?$4Q#3#4W3FE&XY_:K<'9W-KBL[Q;')47+S@X//I%0DRWBZOJ=K']
MWW2ON/]#`N-MX[[7N.!2DR#&M&(``44IB?9+LTYH3+%VN)?&LB%1+\&N(X;(
M"2;?";,$P03$6`#EXNH-=%2[UK*!!.8&PL\P3J>`N3<>\!.3[T0S[\29@@>4
M@A2^%,T9@X'T@)`&"R))L>XQXY-P%(;T9^$`Z&?=>WS<W7]8+5/=C:M/B_NJ
MLVWA6\\'XVT\JSL/HB$`H*!0F'8C8(A>D"=G-"G6P^-<0CL=C,/JZDNU_+JI
MU_7-C\^I[7VWZ=4Q,@#/G3.6$XDX)]@!`YJU:AOU_^7<>(S-J7$0S](XOVY.
M4CAO/!XTLL!#BV2T$*4Q#*8&,8<WU4#FYA+/T#PJHF^&@;F$NCE<$']L0F([
M3.[7'@^>@'A.X5Y+'/4G=QJQYH):8V6+12]?A&T]`,(%>9/.FTTP=:>Y_.:8
MX#0FE'*D4\MJC##C'#?KDP)=4"F#\\3[.E?.!C1KYU'_]?%W]]_'MYO'SP0M
MG%2I40U&EF*<$G!=\TXN*L6+$_(Y<JF'0;&$*O@<M5_7OM$^$[=`:9WA3*JX
M?(.I8UXT[Q_7DKM9G%RN]R(VBUQ8B]&B\]#RZ*G`*%="2\=E-*VP=E+0EMI,
MN`O:!3+D]IKDLW`K(?O?(N%O=[>=TG_R7-`F'I,$5LHK*I.'SY#VN&04+U;`
MIH1W($M^]7#H%6'!XGL_%CQ^+D@"!)"*8<*8IY@SEOKL/JQ#(9V;43M+']$@
M+#@#O8FOVS_TJ$_29W@`@A$$E$4(*15-(N-=NVK(L_-G9UA3?5KO3B[B9>(D
MGK[K[]6]^[Y<[ZY6FYLV7:!/(FO_:>+79J+5K3FC)'Z]&C('&\^J%K+<-7T)
M734L+5Z$28R&^K0Z[H^[ZGJW_K"Z/I;BTV=X`%YK(:2%`FI'XC\L:U?M/2UF
M'9>)G1B##KWU7#;JF5?X1P-%CC+HM`D"49!!1#TGFG$$9;0P;.N0\)?D`AJ5
M0:.B/K%-]LNVOLNTQ_9#@V"8(J,!4EQ*`I5!!+5;@"+%R@O^`_14%N(SB*9^
M@5%^*/6+J4)4T(`0;@&TGB"<BHBW)@C"(M<FFVDMG0+\&UD"4YP-]M_-:2SL
M,T&`E+*X2&JT%0H"$@_Q[1T,E#XWJ62&E]N%F#<"ZA/OKVJYW-WNUJDS9L^F
MB:=/%HP2Q'`!J"#("PD`2&6M#E8K`+DZL/]]2,$6H%/OP</(8&)61M#R&!@'
M!@BUM@JECNE4$:,]HNWW!W3V+<C)?>#&;U(T-==.1WLN-V]GWK@%3Z*)*QVQ
M,B[8$>P]:/QD1C*>&SI]<J^V"^'8")@78=KMM\5JFQ*G/EX_7\+#9[-.G\TQ
MLO6;(2C+4+(D@$E9,QP@B)J<0X.0*-=X[4(LN5%@+UD%Q=2W?QYJ'7]N*];^
M>A57M+I>+1Y9`_O<_2NUN?H0_WJUWA<?C?]M=YO4^=&3U!':%GR+P+BGR$*-
MO./,&^21:0P7`T5V@V((_J'<GZ_L)C(.?MT,XI9[<YI@O<9$(B.(!8`"`GCJ
MTJ&`<U1AE%VP:I8A!&4JH8T(?PD2/CZ8O=R`CM#N^,``.<..J+@PYP7AF"/<
MN-@-("BWD\![\<D-0(%Z1+Q+,*M9^8.!$[7VS]N`GS;/A^,NE=YS!`ZB-60U
M0PX+3*!G1#:?KTG=RBY)L17AVUC03WW)^.@S.C2"_URE`/0H[A0Y=+=<K%-'
MJ\Q;QYZS!V`\L$!01..!D4KN5.N8,H"I7+K.,*NLS"Y<7B;SX_'OU??[+W]7
MZ[^JW^K-_==,5W6/B8.&EG"N!-$I<I(JJ61[%M5,YP9+S#"M;8[L/5,<\R-N
M^OJ^_%T/QM?#?"&YOJ!.C5*L4(0XXFQ[2X=A]G']9)_CY1QV2LAAIOR,/Y\7
MJ'ATQH!QW&<B/``S):1-?>A\:SQ1DIOZ-\/X[-DR-$,.\^2HKW?#V:W-A$%2
M`Y&5_\_>E2TW;F/M1_JQ+Y=84UW52?=TG'\N48Q,NU4CBUU:DOCM!Y!$>95(
M420DLR=56=PA8)SO?``.@+.8B`R@&`E-T-XL,J!SPMF3WS!_YE6T@R*NE*+Q
MVWXI&K\-V*4H08NU!8Y+B$4\@NXW&`*[WFJ>_@3ZTRZB'=30R2/\V8O8=#^R
M8C.RN_4JREX<]QPZO9-@B!54,0ZHQ%!YC86KTYP8ZUX7OA_PO7/P]_5AR34X
M],\(=9FJ0J]""$==5H@8YS#ER'JNXGS'GF"Y*?BDO,?&-U;<&@:+IQC`6IKV
M-81>M`B>*2LMX@Y2P;R0*I4&J.73G>-!KC#B?B"]'RP8=`[.'R;O$TC5$KG6
M)"Y>DF%FE*VE(H:/*&/YV7IME>3I)#@_7I(G@ZP5!!B"'';2H)3FNI;/0)>M
M?.&EDCRU56_K)$^G`=K)$KTI)W?10%@4#35<7GX6&(:"\&C46.@M$HY31^N1
M0<9&E+ZT!^U4O0&9TQ_N_+)RVJ9RNU$VB@&"RD$C="V;Y;CK>G"%P:A];Q_]
M('HIMO170XXY!2`B<2$%6#*$N<!N5[$94-*YG,`5+C-G:_SD&G*G8=OMFF/]
M4/Q()<K4_?'MY<V'@1)K*-)24L)$/$`;3=E^=-Z.J"1ECYJJ>H0TIV_5YQ9I
M@MY\&R0G#!BHJ4NV%H=<N;J<.TB1^.-Q/NE[>SD7RSQNQ9/JH;PI_ME=S^IR
M7MY-CWL0O]LB8!"1P2"Q7!""*5:2U+()I4=4E.$,O;YQ!^X#RYQK2.U5;]>+
MZ?S^:[F85L?"A(XU"QH8)C5#E'N((*+&LSUJCHS)<.V/,3T"FI,VWZK9S%>+
MOXM%&[8\^SI82)#`S,/X#ZH(\AZH9U-A5*6N\ERNGH]R3N:TH$N(!W@1S_&Q
M)XBI0TYZ`>K1:VA]KJWGQV8:_KXJ%JLL/.FDP0-L.!'$G!3XLOI>+LSWE..S
MC>GZ_/-`N5'4&N$)C7LH$\B;/2P&YPMARK?']$F*,Z"\MC4"6,NTD@;&55-X
MY[CQM!X]`:CK$]W)QYCM&N'FPR;S&&2%.`W"RSVP;TYMRY>C&?7S>ERW$>%2
M:8,Q,H1BI.HK!\<Y;PRR;WG/U)BQ:@/\381:QQ[_<^@6ZL1N@J(^GKI5M'&0
M9*E00\K[MY-.8=LUD?55!@<.I/<J&_PYEOWZGJ8ZEKO9;QR$WG%`:R3I$+\F
M(,2\])!Y2PU%4!-E3(TB`3);Q.&U>8B<2N$K4$Y.BC^[BCR!L>^T"E99C83E
M&#%`M(QG1LIK&65W)Y.K3">:EX+GHSVXJ?17;%HM'B]B$NU_^TD&T)%6`>JX
M'U%!A7017>JE=7Y[\6%MG+>-:VDV.=O,V6/-@O$&0(2LMLH@B22QDM:2<C0N
MTZ<7C;^Y7^\-W%QS=.<=/)*I:B7T!%G`(/88>X,)YQI&Y(W27OE+3]7?RM4I
M`C[[/#C*"/2I4!!3$E,9=PVSD\Q([KHF-OMP4[.UA@]-S>Z@YGD?W0WS6_'W
MKT6TGJ?%+*70^'+W+>IO\=?1&\GFQH%(+B352$FIJ`91:@MKB8UCXZ11)Y4?
MXD]?V&9ET[^KQ7\^S;\NJDFY/)U.AUL'`*C3C,?S#`)6,ALW2KV'4_&N'J-7
M^5PV#)]Z`S<KH=(I>!G/(^DH<CJA#K<.UE+++9400!)/2%PA;VN9K6%=`WJO
M\MPX#*%Z`S<KH8YGLG[^6>""8$:A05YQ++A7ROI:"B]]MDH1.7(*#T&0TS',
M=1AY?2I)AZ=U,7LYF(][.-$.0N(0T4`80@4GA*7L."8:KIBBQHPOK9]-=D/X
M_V(QK=;+N+7<+XJ'@Q6"FAL%!"W23J+T7"^UI2Q:,W'DE&G-M.Q\FWR%OG:]
MZ*\:"-A<T_""#YK]SSI!$.5""R:(=<X@2O#N%9E%F$FCL\[0%^[[L9OU(C'T
MY/>BIBZ"10P2PY5"5,%(,$2`J!$PD'5.#'W5)M4Y3#AX\=XKT!EF\W*5\F`N
M/\W3XI/&^FD>E]#XQVZ^VJ2G/G&.']EQ&G_5D6E\>B>!<R2$<BGT@1LG?$1Z
M&T"C%28&-&;P'696OSOL$R_H6_<1@!3*:H!3S>B46(]H;FH,>#0+QS"OAZ1&
ME0?X:YCGW6[YKVBZ0T8,X9)@P"SP`'NU6UDQC/_1^)H\]"9^2(#V"3Z.]A"H
M=")M+IQQH)QF,KE&;N5'P*ML#W/#&>!#DN+@?MXGZ#EN2PZ-5S^:6;%<3N^F
MDUT*]NWBU1#AW:6[0#3TRH&-<Z?W3GE$5(V*A'!$.0)ZYTF;#:=?^'.0\O5@
M#^RC36'CIW03",$N/:%3+3AWW@LJ[1YR![-%8`Q/PF%)4F730:=(\]_*]6+Z
M\+">E\<#S5]_%S1$0D(IE8@S,_Y`HHU6CTT;DXT?.8Z\PRBMZ@_>B^V,CY];
M1*`WM`R*(*D-]B(")JS`3'E9RVJM'E%$ST7VN\Y(=UI0G@S,P_;E[M&A_0&F
M=5=!:QX-5>D4AD3[5(M1[Y'S3H[*^Z(W;;^^31\6]$ZTVI;L2('153Q2KZ;%
MS)9_E;/J1QKIK]-9'%TU+[\6CYNCC9K??JL>BUD:[)>YJ1X>RL4DMOF]B!_^
MD2I_W)2+A^67.U/-(NNJQ5;?]XNR3.T/$3+K(`)B%#,)?,J93VF"TX,:5:/Q
M*"Z5AZ=<]4'TUVE6I."'R:J\?:C'_F,[]KMJD6(HIIL157=%*MNT7!7WY23V
M&<V8V2HY5QVB^7F]!F>U5`!`"*@&`OED_M1R8X5&$!B3E[59U9'#DDS.,O'W
M?(\3[-G\VP7R[(/7ZGP8>\\M4RV/O5">T6M0CB(-@!5&:\\1$;8.%\)("-?U
M\N^*,B)EHVQ^=9QMINIIW`XFW^?5K+I_C.O\CV*>@/A>K-2BM&7$YR':5+<W
ME2[_F$^J^;*:36]3(;RF-[]C!FWOOS1(YJQA$1^+&1'`4X?Q'C5&LE7E&H^]
M<$WZ&OB-ZW,<T_V+J@E9G5)2(4E3163F<623QT_SN+D];)GX9[5>/8WNUV*5
M%LD6'BM=NPS..TR]8Q!!!V&TV939'9L`==Q?R)WE<WE?S.JASF^?)-N1O>G1
MNU7[`#"$EDO)>7K*]<YZ4Z>,H82#4=WJ#4^0:G@59%L6+AG%=DVK`[82&(8E
M`U+BJ'RO">=$2(N<%(SR"ZT.+\1I\2S^?H.@@:;:^[C[&(*@Y-I074LGHU4V
MGE>?X0GP>O;W@7B63`51?9L;C%_*Y$C[XWLZ2S:\<Q]L$[!$CEL&HJ&#C054
M68MJ^:#NG*[KZAEUNH)?^U#T!&D6RI3WKT?:^!I]L$T@W&"?<M>E%+T&.@Z`
MV\FGTA^,AS(]Z/@U:WI"M3UKEM%>N*_^^K])M9ZO%H^)-+C^(?$%/^/+[H_#
MIYMWB/'T/P-"CF`+H991:`]2/#*IQPHX'U%!E![T59T)7XX%XLW:V.;=^'"C
M("&R%!.2`CF(HQ9JS&H)B6>Z^QWSA]@;>D.FXUO<].'/=9P9B;F?IP_3U68=
MN_TT_U8NJ]GZ6.W%-FV#L1(Z&<\\"GOETUL)J$TLY;P9T?3O0Y'5L/`.?,+<
M)B1]=E_FI_-BOGEGJS?'[='S(B?/+XO[8K[+-/8TR$2K^>W79U)_N7L[[#;'
MT%[ZC\N(T](X;06&$"4/7;#+=V6`0Y<*P%*WMYNB',5L/_9GIZS30C9.[BMP
MR3"-L@/,`908,6I(C0FB-%M`98Z;K,PLJO+JYEH6H$O>@'V,=<A8RI&@0DD8
MB<0$HXYICARV3%NC&JVR@>\S&D-%7GP8O">$"JN)U!YBZ`!BO):&<-PU3\85
M6B&9M7_HHJ,+[#D.+[J81:'+W[^7Y>ISM74";JKL=Z!)\-+H5.7!"F"D=R">
MQT`MG8!H1-=A7=7ZNAY;/TA>BB?-M?P.-@I8"JA-M-"9C()QP],)<2,AAPS:
M$<4!G:_D%JSIA&H.WFPMD&V\^^=I\>=TMG$0.!B0T:I=\)`ZB;66@%$8SWK>
M:5#+2;D>40!/'\JNAH,VZYM-FWNUMQ\'"854&G/K-!?($(4TJ27"OG.@^Q7Y
M;/:\+9V-80Y61-OM1S&]O2G^.9HT[OEG(44;>0$8]UI)1R1F2&F.L?":*BNZ
MWJQ>X;)QC@K?5"+OC&`.'JC)9+&.N#\M9+NEK<7)L+%M$(!RZGE$BRF@*8T;
M-:I!LTIE*_KW<6Y:NIZ4^M9%%J-X5Z775`]_1DAVP&TOO%<)PDU1]^W%S5:L
M.O7/,:.Y<Z<!QH6>$(0P8L*`"`ICID;(D'$%B/7(EP-5L@=70)[(UMEZJ\_9
MK/H[F9*;V)]=2L^==7F$C:W:!T?B&892*RR&##.H&/&UW(JH1L>QC[1,#D>\
M(;#.P3'W\&-6/9;EMS*%Z;R#S!%^-;8-FEK%69P^*<>LA,@KN9<7>9.M%-[P
M1MMPS.H;Y8R&W3Y,L9E+!UH$'5$RU&$MH<:I*`?FN)8-6MC5[+^JX)'A.=0/
MNCF88W=*^5;^5<[793-QWF\0+.>,"HV`!-X)G=SAW1XI#+I>'-"?BS>]@)OM
MJO(@#DUWE0<;!@<L`=89[PSP7GIBY/Y&C6O?-=:=_5PTZA7D;'0ZG4?OR.8A
MBYNPE1QY&L7QS#A=RR:L;LQ6>H!`_&>R@/K!-@=OZEC*3_-)]5#N@HK;EGXZ
MWC1H`AT$<:DEQ'+BJ!=X+RUTIJLE=)7E,2Y[G=6S*O(0[RDB.`VZ%N$HX=YO
M$M*A%#@GE-%6<.8AI_5RS"CAH_)0ZT_5[Y3<Z`'=G(O63OH6:]3NR^`4)IIZ
MKU04`S%LM*ROS+A#>OC7.;EERKR\WQR-/RA3S@$U!T%^*:;SY!#^99Y2#&US
MX>]R]1XARY%6@3/LXWE3&D\HLYA#ANI)P"5A;$Q[V6#$Z0_@'"3RU:*<WL^W
MMMOD\691S)=1^JC`6@Y=WL5O;HI_CI#JA%Z"X8S',RJ))]5H=TKK"6(U!ES+
MKN%Z5WEU-!C)A@,\VSGNMVI>_=B\^LSO7^#3=)P[V#"X^%<T+@V3,IXZ8,J7
MHFI)K6L.MN_K=BE'5:2!B-4KPA=Z,&[CP7ZL69":0X7BT00""0''V.U/L%Q`
MW=65FWTX-O2(4A:WMGV^W'K@FX1ARTV\R5(_/ONI?1V(=ET%J[&*>[N.$#O"
M,)#.[V<&069$GMK]D.)@"8A!\,ZY$CT;:I/;__LM@B1*,HFQ])8Y)!&#^`E$
M`K*E<LV9X;IOM1]8R<Z#^E(TVJ8]+)NC`YK:!JA,-`"QUTA;#^(F+F']1A2-
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MM^DF2,P]0LHRS`PG7"AL]FK!SF9[_/F@[!P0ZQR,ZW(;?_B:V`BG'%'>$.BL
M(YA*(VOYF/==]^G3W:NJ53'[F!?Q?8&;@SS/G,#BL">M@P6/M@N6*.0-<(1;
M&"<>9\[4+^[&:I>M0,'8$ZKTJ84K#1%\DNODW;)EOX%SXZP71!+&T\D>"%9?
M&EAL^(CR)_3$E_-#!#NCW^GJK0[X66P#?F9/*,R/L:MUVX`(%5YC!$&<QM;%
M\Q>LG4,L,[IK_I8K/![TRZ"A$+Y@@$2K]:JQ;1">*(FP-5$ZZV$JBE0C:15T
M71EUA2;],&M2WPA?(D:B/97>EY!YS`BG!D51">><8%<?5:Q$,ENDW_"F_(`<
MZ@/:9^2Y:%[+UA_61;5>BI$K`^8KV-LDM3S0)!K6#$,59S:U4FF%N';;_.@8
M.<I%8PZ(@>[9%]7M>K)/-_7XK#I)DW-+4]-@C0,(X,A)@Z%%'GC(=Q)[J>2(
M'!#.5_J;W#Z]8ILU&U@O%5R@U8RX=-%!-(NK&TO%J7;RZ>[EV:^0._VING4M
ME]/`S4*>7FNY8$\H5$I#++"31'''U%8^3(#N7%GU"LG3@XY;UW(Y#=7VK!FB
ME@NPR`K`F+*6$8(DTXK68X7(D!$QX'Q]O:WE<AI\6?P!#J^2;;Q-VC0/#A*D
MM&9:$\,U9@['57<G->-\1%XG@^TY`^#<Z9IM\&HQ"%!*L?82ID+1"BGC]Y-+
M&S^B-,G]JO3DNC&G`9W%5BEFY7*7-.67JKI=_E8>.Q"^]WG<G:/Y;SE56!JJ
M#0!<^%HJPF'7A(`?:ZGI3I\>L<WRLOFR[*=;KJ8/D>A?[K[&_S&-Z^WGXQYM
MK=H'3QSD3'!#):;88J`QVLLM?5?GVRN\IQV44T.`G3.YEHE_3U<I0>'IB6Y:
M]Q&,5HJ15"W,`PJI%@:Y6GZG4-?L`%?XK#XHV88"_%JN>3?6Y/^J%QUVMV!:
M$$*`B#)H3[&QS&\+KRN+)16-!]6A0R"/1_)NU-NFE%JW#H-APCD&J"&<Q"DE
MM6>\1L=;E<W*_CAID5KSZ6#DY(`*RAN]^_;)M0-=FSH)EF$13R(B'D6TX$`Y
M1$V-@(ZGYER6_,]$T9Z5DC-9Q>1->9?6I&S;13!4L)0V.$Y&20'BRD!92^\$
M'I'#QF4).9!"!K;=ZK3EOEJD,IGITC?9G4^IS2]BK6U.\OOQ?"M7Z\7\Y;`V
MY_L6=MF)/04=-RJ4?.@A<M0[K@VFUD%JXCKA'&^,6!AZ&WM*/C^__=>ZF$WO
M'N.F')?`C7RG5;0]H]=`.2"*<LRQL`QAS04CUGIA!<&*L&PQWSDVNL$X='!+
M&UH?EUY4+EG']G)K"XRKO@#8$84-H(PJ0E'D!:?6"N=Q8Y6B8?!HS;4&!Z"3
M^@E60..(Y$"G?RE(M*1;OF)/X>L"\!_YQ60PEAPL2](__CELXN-E56[B.!K<
MA]IU$#CRG!J'#"8LKHQ8"^UKR6W$?#S,&X@1)Y7#Z0C[Y0G7Z'#4IGE01%"*
MA(YS&E/DL#>`[Z4VK.O%^%63K1\:G,2R3FCGX-AN@-$0,L7RO^U=V7(;.;+]
MI(M]B9@7K!V.<+<<MN;>F"<$1RI9-2.QU%S<[?GZ"Y`L2I9%5A&L3>R)7F0K
M"E5`Y@&0F3C(O*]W@<:RNL>:!42`EE@9!;C0Q"M+U5Z$PM+<2]63-+V[57O5
MFY1S$R]MMORX-*O;?ZUW"7T;DRX=;!,GE\*<*88A\))P@R0#=9\!&RX9Q+M%
M1M<B'I"`\K-9V;C*-+0,%#H<'5F.)([_`2R$V$\!HN1@)=W>+9SZ$?2PMM%Q
MT_%C"[;ER>\*V"JM/:$:&H*E$5YIL9]D,AMX$^1##6VB]Z.!K-U/S6</WY?E
M\NI./:9^Q)_S6W,_FW\M/LQW-(L=F:N>AD=B,N>^,B"N@8766`JMH`0ABME^
M;G,[&$=\V,6N<SQ4HZAC?'>QJQ*]B+N4)RTE\O$2"N4`?/:/:':YC)-A^%0L
MRNKVRVJV6/4"Q>$`DE6]]S0UY%G_VW/".,QOY3*E=[RNWA[RIAILG)_7U<:.
M^+"KT+#Z1S$[["9T\?(`M5:4$`",(MIH#8C;VSNIL-LE^!.#`W$T_>3MTL\>
M4.LN?HI+QR)U\"VKL(.WAF@?"Y+HVXP(9)%A&KAZW`SZW+VZO6,R0#&J<7`Y
MJ&*R`%GG&ZW=J:>GA[*X55^C?[9<-?6XQ<K9U?L#B_:YXEYCKQV7D'%$]L:Z
M%;Q_3O3%@G0D%0T/U_W,Z@6L^[<'JX"B2%%N19RT7$IF\(X\`*SCN7'#]C6.
M_@O5+A5T0=X0LD0:"3B,SJ<FT#@-ZW%3(G+IM"?7Y-YZ0VY^(=#L4PD3H1:]
MRC]P\=PBI1SCA%EIO1,*6V80LPX*K.-/31I3:O4DCYI>VU@:ZX<'`V#>2!*-
M1PJE\@K$MZ,=H#6%^()R!?6FYT/I7W($/$@&UNUJ\^6^*%8?DT++YE)7!YH$
M:3R4`#OF("!,,BD\?!X=R\TO-T7X9*KU=:+4;B0Y%DZ::U@=;!0T=-!0K)RT
M,FZ;AL@](45#GUV7<8)8.5_)+5"3)=4A<%.?;GPN;HIR4]>A\7S\4),0Y8.B
M.233Y6ZNO?%<UW$WK0BX<,R<JN*J%ZD.=DW+_'2?IQ$X1]L%1B3CPAND=;HM
M":EALAZG93`WJ_<$3[=[0$^7HATT#V(;IL3/#P<F02H7IP!6C`$ME.!N/R(K
M<I/731`L'9DR9\LP*\SW9?WX.%M\O[I[VU/_,+]Y6-^F7$8OTR2\G!Z-W(;N
MOA!TG'`.``F5U8)+AI#?RR/.F\&\JT'N;IT!AVH*XK^<8)[D7!&?LC`A1RPT
M!@%3CQN)[&)0$[*:1D-*5ESO-'V,'=<;,7?,>%$]R@V!GDH&842"Q%((8QUD
MB`#G.6X\0^R/BM>8IZ";%P=A`%-8*@.DD!YK;/!N"A#$`,\]`9CF7M47.LXD
MY9VEDI',J7;X[/H[P1F1+HUXP83%3$LOC-S+1N+!DL9>#%Q'UE#/N]Z7^RAI
M/5L6M_5!\2@;W#/C]^K.5(\IM=-F.)^WA8],M5PM-UW]Y\NNMMCOSGMQ(!$D
MS!".-"3`(B8\U)M,*3J:/[HY-CNRM'Y0;)N$'&>^.2`M4%R8L4&,:I5BN1[6
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MH"!+YZN4>>2-5X`C5H\Y>K\7=;FU(^V_D2ND6RD/<OI</,1W?OVEF!>+V4.*
MS=P^EO,RV12K\EN=Q;E%IHA3WA,80=@9P:01`BH*D9?NV5:AN>>+DPR"]8.V
M/N4]!.X^;637"*N7CP4IK`0<4P6108ICP9"O1P&%R47-)+.-](.:,\0Y!"BZ
M,2[;\&@Z_E)`'#"BA):>8PFUY0[QO2G+FLLRO",2SJ1<@7'U.,@&W3"D=#;W
M,%LNR[MR^XL/\[SZ)-U^**2K!LA2'M4I,(6I4/WSZF)X;L6R21J4HZ'PM5$P
MI@H'H6AOAU+<OCW2G=5SC+#=Z@4!>:P9LY)SJ0CFTG"O=B/G&,"+JB,S%FA>
MD[[[T,QT,/E;L;JZNY[]>38VZQ<%!!P$R'*B%/71L>3$US8])]+D7F$ZW>2H
M5K.'_R+T3/V\'_/:S)[*J/'TVRT_J'<S^Z<O!DTEB&L`<T)',5O@M2:U;"4A
MN22:W/0NU_U;W=.8`M/09QYA[-BD?4D26FYHI74`Y2`O+.]U@7BJ/",($`V8
M<X8(54<`N>#9B2LG6`=S9,@.J*7)K-UQV]'%O+@K5SZJXS3+N)L/I`2DQ%(A
MI3:&<FR=A[7KPBT$N46%)Y4H9B(('U5S8_&.QLG:,57BD0/4J93(16M#)`(V
M9:#?Z$PY0?WHM<C>,_%(&$Z]<%)(A*73ECKM:]D"PB\H1<10(!R$>'2:V@8Y
MZGJ8S7^;/385)WKY6,"<$2`HHE@+0[TA2(G=*'RZ5W$YX!L9!:\/R/*5,"24
M&LE#/SX8!$3".((,U(I[0BWDJ!X)@^""LB7E*?``"K*DE^6=_CI;_+M8?5E5
M-__^^[QL*O'R]M,!04RI@92IV"_N!;-R/UQE66[:B$E&K7-55'4MQBQU7Y>/
MQ?\6R[BY?H[_7Y0W*:K84OEMV@;LH1+28D!U="@H81SNQR"@SCW`F"3!I@LH
M]"#4+&"D,E-?BM7J8;.GW56+Q^TUM2B(IK)/C2T#,MQ8#C!SSL*4%UR!>E/T
ME(K<]6&"=;Z[@$3G`AW$0&@-FH86(:44()PJ:@1TPA.?$N7LQ@:XR\W%,,%`
MY9E@Z5:06:O&WG).*]:G]>+F/IK-:5C'EXR&9JD,/=#`1DQS((66TG%8]QSG
MGS"VC^6]LTVD6WE.)JH\2<(=)(PX!0S$@E@G`<9\O_0:R0<S</YJ#O*X>CPO
M5<31TR"U7%8W98IW_5^YNK?E701!L:F_\G4Q>VR??*N+CP0B">0TY1]`1@!@
M+:9X;U@8=E&W,49#U)M))$90WW1(2N<3YQA`WDF$"*/4(@LL4GMC1[CLX[])
M`7=,P.21YD[3RG3PV#UICA#'B$>&4DP8A)XKO1<T(BJ7E3RIN,B[PV>F=MZ/
M@3P%RIPQ*GHR5@@6568)P42P6K:>D_Y+-0]%F9L0_*>AR_=,ES.<"(.0-P1"
M3"@"6+A]\`297$-X0E&H"<!U0`V-11MZE0?S+TX;,H1A9#%'0DA`H,78;ZE>
MRGA/?>-Q<-^TH0,+Y6*1<E!NAJ*__Z1J]<=L<=N>*G3F-P(5C*7@H`4<&QD7
M3P-H+4/A]&"'K9.G![4&VT%ZT+"JFBHE2&D(F"-<:B<AAT@S@>I12&1S[SQ,
M$'`C:/X8#>@TP4^9!I1HO9(3!["#J60?Y`+6(^'`Y!:<G2"$\A1XG`9TFO3&
MHP%I[X2Q1'BN&3,4$6]$W4\`]$7$X,Y540L:T&EBG![;P\+$4O&*QXY;@HR1
M;+?V66"-'.Y^Z-`'^%D@Z%R@[XOM8;1PS"KFD5/$:2/JA#)Q;-""7+;']*E!
MIX*E6T%.DSPHD+;,>H(9=%!BZ)#Q]1@`DKGD\Y.#+N]E`^E!J"-FEGDVK@_9
MUFWX'N>_/&AAM#8**F(!Q=&#I,;5$M/:YV;^G>`&-K[#,[BZ\H+2SW)*T^OJ
M*77RE]C'%L71FIN&*+BX=*OH'AB('1`X=KP>05P7!KMT,V+6EUX47O6JATDO
ME>[W=;GZ_F$>1[;>3-]-=<KK^]E\._+E=N@?YMOSGCX6U!.[$*@7B!H!5+1>
M'*,(.LGWTA?J`C(+=P_$KE;3?G4UUN%+JFVQGCW\V)F_^!$,8B#^JRC1WAD@
MB`(R.I8@KJA$2HT;C^-/9(8O$\:?=I3DIVCS/L[^+!_7C\N-[])$$#_>.B!D
M(`3`6*F4<81"!@DGF"@:_VC]!5U6'4KI;['*.U7"()MFZO"'Y7)=W-KUHIQ_
MW2Y:6W?Y(%?^>/7CK#<&9C6*]C!G#E@%"1'&UG)W7&?7%9V@)S$P0(=5S.#[
MUX@51:>Z;Q&@`(P*\HY9BI'CUM4FD0>.-SKE?5,'.KHCT:(46V_?#)`R[9G#
M$E+GM$SK>!U#]`RCB_)#AX)CW[E',I4WR#Z\'^O+(:5N^VKQLQ_R(M;T<MAO
M"V8S>/T]K>:-]51'[4]`6BD2G3@*B.`8:"$LJ?6B4'.JI/?`_)[,I)JN8L^,
M.[X1X-^ZY"VK"9_ZHA`->$VQD(I%;4BF$2:X'AUQ-)>R,<F:%P/#=A"-]&VS
MKO^Y+'Y?Q^;N6Q+&Z[^/8KN^[D2;X@,'F@1$I5<X:M198Q1QAJ5,RD(!IJ%$
M?*0"OZ^[VVK;.]0FG1D;$YTMZJ2`U%M*E-N-D2D/<[>F"<9/SE?SZRVG(Z&.
M/$W'+*K;Y6S%WBANM*,82P*5),P#S7%<F454I!N+6/YC=QLYXF\\'J@SCFB"
M8/P)#--.&%B/S`%P0=D@SU?N\3F:(\]!R%2+ZG9]L[I:[#S!)F[V&X\'GA)Z
M$.`P-AX8KR'WJAZ5CW^Y6)2<J-379*KS93D@0M+UIUU'E\T,[$-M@L68(YE2
M$P*HB=:$<EN/CW`Q&$UW`,K=6>I]&RMG"S3+$?Q8S&Z?=M?MCA/M?GXR0*PL
M%PIQ$=T&;Z+#:GC=/ROQ!54R[T!'59>RS-)U\D:KZ/9^;Z?P`X\'Z:&)WJ@T
MTF#-"6,*[W&NI+^@1$4=:[T;@0ZQ+US'+UW=O8AG-9@.;SX?,(+88T(%E98R
M((@5SPLBA[F\FPD"I5/;H0MA#I+QY&6X<W[[6S6?/?_F.OYI&6WL1/%IY/"?
M^*:@B:3:<ZF\1\Y!H87;V^W&F0LR2L_$PNOD);W*.6M/4K]<F^/;T/,3@7K&
MO!?<0&Z09TY9MN\/X&"P)&+]Z[TW355=2#8OI6>YG)4-Z3N?'PD($F,IU,(H
MY)UFUEL9-T?CM':`L\$*JE^(KO-%FW>^]$=Q6R[OKQ9/][.Y+JMO9>)_'M?^
ML38A]IAIA#Q!&"%"HWNE3.PS1P18#6ENFJL)7N<:!`X=RGJ0`_]7]E7\<(-%
M>J!%0!H03Z2T%A*EE#4*^YVTN..Z_SJ+[],F[4:<(T&E,:1UL$T07F&D52K>
M"*T0D&B`Z_$)@`<KFSP\7$[6<#-BLF0Z`F8:_94WGP\,:<8-LT#:-,&@`W$9
MW8TK3K5+2F=ROFZ/HR5+HB,@Y6.;>Z,'F@1D+3&$`T6QP11C9@#9R\IGXV5"
MF>"&V(IRY3D$6CY'!<7OW$<SSA;?BH?J*=EPNT1S[L^4@:Z<?U4WOZ_+14I%
M]VE1W13+9:(%'0'4&6\-T9K#@EO'+0%Q>DH0;<=:1E1EQVZGOT9EP*0:2^Q9
M'E=]#:&ZNZD>'Z-[L#K"VGOSX<"%\`YC'^4@(-*4HGU0FW.%+RB_2F?@Z$R:
MPYSV%D^SLDYT&7&\N8NIELMB=9P7<+A9X%XR!)G0FDK%.301W/4H-<E.P#5]
M?^K\!:5#N0Z!GH_E3>KGAK-Z!"TO'XL&''9:,>"<A@`*YC79&W!2B-P59?HF
MSOGH.$..>?M'M8K]+F</?KU:+XI?RX=T/W->U*1D$Y>V<K6)0577]^7B]M-L
ML?JNGIX6U9_EXVQ5/'P_N-N<_^J@I4-("`*<U4Q#*"C<BQ%YGQO_.[ERTSM"
MTDBRS\L`52P>K^X^%K,W2W:\?B0``C545B`1G4Q+$S$^^@Y$*\D$B8ME)AK8
MI:,A7X9YAWNWMV42\>SA->X.'O8=;!$\!\``F$IS*TJL8D*D4PO*F4%66IBI
M<W[I.N],I+TSRNN,\>77>7E7WLSF*W5SD\H#I.O7U4-Y4XYT=?GG;K2@E!]N
M%#@'F`K-&?>>0&$5D<`Z`)'R$!+?&/GI*;9U3.ZM[H.T>D$P!&D;UQP#K29>
M(YR.(QV(B(-<2GE![(TN(/`Z^M6'C"<QL]L]->:]DJZ7`4B=4#[^@P15T=$#
M6E`#)(MFEI*ZF1_7<A?^,(](CPO_AWG:6,K;,DKYT/[[UK/!$82]LE0@S6/7
M//<*[/JI"<C.NSO)V_M=J*OJ5J!#./>_K=.!2[HR^E0M5BD^_Z7XNG$0CD#[
M<*,@F%0JNJ8H_@#<,D\(K$<HJ<\UUB882NP0,)W+-2\0L#4.DZNPO+K;#6_Y
MN;@IRF\'[IFU:A>H-QX*[!3ASC"B8?RO[KLCV4FU)GGQN^MEI&/A9@'CUW*>
MLG.E/OAJT1X83>T"LQA8BJG$CC%@B$P5OW9]1RX[5?<DLS-W#8R.A9L'C&W:
MMM.!T=`N,(VQEM$3%498D>Q8B[9]CXXO5;DKQB3+M7<.C&Z%.\B%@IN;]>-Z
MDQG#%E%#J3)<U%S\\T.Q4>$\E0M<K,K_;'[_:5$]%8O5)H/**A5P^WU=/AT(
M+G7]B8`5L])Q:;@"FAHL.>2U])"CN7=;)AB![,'`&4D+[\C-O:AP%V5.&,81
MYXQ)H&PJ/,,)(,8S*1EIO!?<<AO2ZV4Y+Y;+JV_IKE[QQZ8?WQLS&#4T"\*F
M]*,V$:*A`R[1D^"V]QPDZ/U%O-_62JQZD^T0>Y">+<MG"[L6Q/=F+)WV@H"E
M`4H;[A3R!C*(313M;N0,DUSRWR23MW6(JEZE/`2^3#5?QD[>;C>VUJ@ZUBQH
M2+4W<?I@+I&#-F["OAZEU2XW[\)[<ZQSL=2A;(=`T-^7*<?G<K4YG3\6GOOQ
MP:"4DNG:%Y54.)VD@FT]$B]Q[K'+>_.R<U%REC2'(1O7KMVR_;IRN%'PUG/*
M`<0P"HE)"N//.$))#/$P;MB7P[CI`2V=R76@+$!O^U?M<=3V%0%"*BS%'%/$
M+)':>6GVZRG/#@*_+[\Y%U4]27F0`Z;BCQ<"653S^,>;[2774RWL4U\5A-=>
M>H'2@8F17D'D<"T-K;,)!Q-D#O6`N9ZEW123^=O_I(=3>MSXE_\'4$L#!!0`
M```(`$"#^$99S!$R-Q0``$CV```1`!P`8FEI8BTR,#$U,#8S,"YX<V155`D`
M`UB?LE58G[)5=7@+``$$)0X```0Y`0``[5U;<]NXDG[?JO,?N'J:?5`LV4YF
MXAK/*?F6\I8=NRPG,^?I%$1"$C8DH`%`V]I?OP!X%0D2!*5$S%)/EDETL[N_
M!KH;`,'?__D6^,X+I`P1?#X8OQL-'(A=XB&\.!]\F0XGT\O;V\$___C'?_S^
MG\/A7Q=/=\X5<<,`8NY<4@@X])Q7Q)?.GQYDWYPY)8'S)Z'?T`L8#F,J)_KU
MQKPSYBYA`!S`.46SD,,;0H,K.`>AS\\'(?X[!#Z:(^@)*7PH'[+1('>;`[J`
M_#,((%L!%YX/EIROSHZ.7E]?W\T064",/.B^<TEP=#P:OQ]].!&:"5TQ.YLA
M-+-I[R/\;:/]VXSZ[PA=B):CDR-Y>P883)IC@G$8Z`D\3H_X>@6/1*.A:`4I
M<E,Z,]$F0<B&\C)+J>:`S11%<D>I,AR-AR?CA$AR]7A*DE?E_5%T,]\4U2B.
M,.,`NZGB;R5#O9ZHUN./'S\>J;MI4^;I&@JVXZ._[N^FRDL&PFD<1[D-"E:$
M<@>7X,ZKO`!@M:%QY&QWQ`5<>7=>9RWA$?0Y2ZX,,U;OA`P#Y\A2'DK\`@3M
M!5*\MI:H[!3M)5*\6DE4YTD5\I1)Y'_#A&XH+PW'QUN*D?5D.S$2NIV(\?$(
M4%?"+9!S^1"^K7R``2=T?2/^;R::3^D&E^N,B93QHY1Q_&$;&15K#!=R_&\N
M4YYJMX)8&":AV%X`_6C>1(X\Y>>(<)?BM!-E"SGT8:1A+TH(Y)/?6SZ3B9B]
M("]'+@DQIVLY1)TT&=MT=,D_PXQ)6VE"2D46I=B>6HF3)TS_&V9L6@KD060M
M2T(C?VPO`7QSEXTC3XE(_6H5;#;X(?P"&;=VDAQ9_'M[%\$`N2H4CVTDR:BB
MG\.,04LY&'*MI4AHY(\=2,!7U%Z$A$C]JA,"8$RXXJ2N)5=7*X3G)+XD+LH8
M?I8$\B<X=U2^>A9'T?JL]FA%R0I2CD1RE:L&%(,EA?/S@2PYADE=\6\7^.]$
M'IPT*3U@,\50\4J0N*&OU+C+A$PXR/'[?,"$O7V8*/_#M?+@W%8K08(PZK)2
M/IC9*B5(H-]5?584VNHC2)@HQ-OYGN3P+%HX2!1\$]<-`^G%T'O@2T@O22"8
M+R%FZ`7>8E%[PSO"6,-F`T<R__)T6U?+*PUV_-Q4Q43)S(W_.!Z/WX]'(V?H
M7"'F^H2%%(I_<JP=Q=O98.Y$W)U?)/__LFO]^U%1AJ)X(1,*X3_4[R*8,77<
MI(ZR,`(U)]SLY'JZ^&KB+3_.B:X@!\C?FR\ECZ]UJ=/Q^]/1\0]T*>>76*Z#
M<^T"W?&>O6O<P+U.]N%>SOC@8%L!_`QF/MS;X!4_O=:Y3L;O3T;C'^I<D5@]
M]*R_0\04/Y;_;>,=%1SJ$Y[1J3;AR>@W_CG`$OUND7C4,ZH?XT>GVA0B!]+F
M?SW.`&K-;!7+#9S,B&FB<D6WZG=,K37T,WSC(?!W!ES"SPS?:0OX8NX'$./?
M]BE.+9_Z9&5TJDU6*D'K::IQ27P?S`@5DKS`"8Z2Q"<82<:6:&6!5P->]>G'
M\5B3?FQP=0!.$L<-Q@?8BJ8VM[@6[L_7]Y`OB7>KED+D)AW[;.8'R%(_/A^/
M3\M=O9';-&PU="+YG$A`)R=A?[,K4;@%*#*"@/228(ZP\`T7MO$@$RN#`YQH
M'2!EJH#-LSV@5C0UL@G,=4P,(_R)=H2O0DHP/`"4FJ+FEGU)L^5SS!VR5*+6
MPFRXV^.22!C"@UB0BQ^,^,B3DV<7P)>;Y:9+"#G[@D'H(;5[JSGZS9G602UZ
M\\E(]>BIL+':Y:N0CKD[>?9.S-^)'N#\DC[B@&FU^1\!%;HN(4>N3>';^@DF
MM-^K2+L5VLXO&X\\H"_ME5J4/<PO`5O>^.1U9SW;P-R`^6GC'IX]QR%S1S[)
M48\Z]/4Z0,I+,M\%][K'&#S@N*T':!=W#K[0"J1=1H)VSS1Y2>/88.<EAWAA
M0/#[#1J6X\2XY3AQ&!FN($4O:A;J%C-.U4MY%A6YGMRPN^U84XMGC)P<IP,:
M;29&:[D8]O$<:PIH/3;]G<O2VM=VD:F.B6$[S+%FA:D*HYXN+R7O%T^P=XTY
MXNM;/"<T4()98%3'I0ZD41J2TA>=<S_E-%/$S\DQ[!M$UX!BA!?L$=+I4N19
MS6$I41KBS0=-O$EX."M('<6E[_:W#C-5#`P1YH,FPI31Z&]T*9K5-K!4T!MB
MR@=-3-&ATM-X$JW#6H`0M3<,3+I=CQ%E/^UK/P1MD!D&'MWVQ7A]O;^#3=Z`
MUKO<M-1F%$I;$@LH]'8#6V0'ZP$_3V48YG6;TQ+K]W1HOP&(?@5^".\AD!:Q
MG`'1D]</_*./FH%?,G(4)R?/Z@!'FRF06B[U(]3HHR9.5(#3W\!19V"+W2#U
M;,Q`E4*)":@>;N2HL_'Q;J`Z;@!5:2>[$:KC`U0Y&UMG9TV8F6%[;PU;7[,W
MK;UMD[DZ)O6YW>BC)K>K!*NOR1["`+L(^*U6N[34AAI_I$OU$CY]7NO2&=,^
MSZMA8BA$1[HT3P=,CY.\:NO:Y'AU7,P@E5.\6I#ZF.!5&]@FOZOC8H:IG-[5
MP]3#Y*[:P"<[@>FD`4SE=*X>II,#3-NDX&9>9L@^6$+6V_Q;8VPS`%N.D$T>
M8(;XUV80-P/^,+2VJ[RJ>1@FU4>ZPDL/54_+KFB?Y3-XLP$D3V0HLG[3%%GQ
MWDY%WV-[6Y=4&EK#`/:;II+*6[^_!539EM8I1#4+,RJETDF+2F\3AIQI;8-%
MF=00(W[3Q(A--'H;&CC`"R1TGS`&U9N_GPCQ7I%OU4FJF1B68O6A(V'G1/S4
MELV$XP&AU+@M@HN1EV%)0A]LZO#J<_@Q6=MB&J\),S-VFI#4"+L>3NO5&-P^
M7)E8&=:6].&K'KG>!K07H0"A%KM%,Q)#L/I5&ZQBXMX:ND44*E`:QJU?M3$G
MYM'G\!*;H&C/%D6.@9,9($U@20`J0]7CDB<VA7T$V20TQ(M?M?$BA:''H2$^
MO^T6?P4423.(,`J%9ER]$69U'%8S=O4AY5BW/R%_SAS"3L+:27@["?,#@!J+
MMPI'C;G6CX3'(\V)=(WA[&\HNQ.L%I9OA^9H#'U,]\)[1MU?6UOWE#*IH3L<
M:[I#QJ2__AY_DR$[&"-=KTH/R(A,TQR;YBP-BSFZER.2;S;D3O+(5MBR8S^B
M!QS`K+"\=7^SYFQ8D]"]6F$%[:''&J%HW-"^3/N.,I@=IU3@V3E.P]:]KQ`;
M0V=;0=HR-BRHZ7:[6PXE/:U"GX0"5%0$-X1*Z\D/%LL)X8GODU=Y<J8%IF96
MA@E-W=$<"5-G3JB3LE63RQGC`V@%2UO']L8<#7-ONO,\&D'8WUC>U/06JW/-
M69KA+$5:.SA[N%37V/J70F"+':>6?`_0[@%:VSRH*4/##+ONP)Z&8/8T[U$G
M&%T`)D^775N^^:>A-<QBZ)9J%9>A_/BUYR1\#BA89R[5+`Q5I&X=-\+D8@.3
M_F8FE::U2$5J>)CQ*06H6GQZ&(\JK6N15M3P,"-4>M&O'J'^O8Q2:5WK^38C
M)S-:I??]ZM'JZZQ7V=*V:5TE!\,\EFZGA!ZCOJ9MX8S!OT.AQ+7</\**_UM`
M9.)D6,;5'=>8\7`B)N4K!\`V_[?/]QHR-*P%GVK6@AO`U^-D,`P"0-</\RE:
M8#1'+L!\XJJB$N'%(_&1W>?[&O(S3!GKOM4:<Y:?=,CQ=C+F3L+]@*'.YLU:
MM>BXNW^X88YKK"OQ&GN'3=/#L+`#5+_7(&+Y]%JG.A[)79(_R*F27_^?O>KW
MHS?FG8'5"N$Y4=?B*QB32(7HHKP&_6C-%LP8I\#EYP-.0SA0CCA#:/;OR:?G
MRWL8S"`=.!@$\'RP<07)[RS[,"%C(KISQ$/YD$^4A*OSP=N,^N@,<1@,'"Z$
M/!]@@G$8G'DD``C?BAM2]H$3-5Q!BHCWK!IZ(8WW#![92/SUX?/U7P69-Z_M
M3^I,2L]3X`+_'HFR@Q,,XU(DE;FN11L-HBN!X,-%=RFJ,(N^ZW@^<"D4#]9I
MAC#C0#Z^7K'_">/=L,_DD1(O=/D3%*E>")/Y\^@KW'CQ3*9`:':+'\4SZ+\@
MH"Q3?DLNW]%`'ISI[=/27P7":X;8PWP2R`%+_,7>Y1+@!90ZZ52?Q+Q2:VW%
MHKVI!`L!P`XZ@[W\JEJ7TRD7/G&_;6&($J,M!@>>L-F!25Y$\B/EN"%4^O<4
MNB&-=ZK/^#W@\7^3.8?T!KU`Y?A":\K1_\H/O[',.W;":A\=JMF`TTJ]]"#0
M[:R49]-A"T$*%C#6061M]X!^$P^<Y;7,[-"L<7MMDPZP^]!_`1AR18^_0G[(
MH5?\5$MQV&S>?/]#Y$7($(:,/0AX7A!\58GLNC0`FIOM=7BK1.[R\]>Q*"Y_
M&QUO)FZ:ZQU,.>47D:>0<Q]ZPGG4)\?4][B%$[&"/DU:=E%#@M6-$/BYU*R@
M6WV;;FHE^HFH@5WX*"`(@`M#]2W:LF:F=IW4CJZ(((0R@&5C]V5(Y5=WBQHV
M:OOS:/F98!M%-<T[4"1>AH&:.WB!JL2Y$YFKGRJBO]>YPK`:.(T"DS?$ZA2,
M[S=3TN-G'@KDYZ>C7&.G@=E*K2OE#W6*I2TZX76J(XARZ05)VS6OP&-*F1EG
MRNZ&V5[\NIT'Z#\]&ZW\%U/0AFWWEG]6*RFW/XJ@N%Y1LJ`@*$3,ZML=#"%U
MWZ$M`=:L[?X+AJL0WE`2?,%N[GV=_R8(\Z1&2%5JTK)KQ6TEF-?`7693IP\8
M7@C1Q>\OJV?R_"I(U_&%38>U)^O`2'T]GT,W&CSB\Q*?!'9/4`#I(A\I#O<`
MAW.9E4NWNH)RY%5\8[6WX=#*`D)]H:@K]-A]1[Y&#*`"KAN7.CCX7`<KGZPA
MG')16#^&U%T"!A]%URCH86S6!7^,A:0RED-/^,],.)',K\6#W"B>%Q4RM.U<
M/EM2EDE$5C$B*\$[`&\H"`.FBOJBNL;66T0.Q:(.Q69ZJ>]5WD.^)%YVM,G#
M*X:4+='J,>J\:HI029YJ:$^WKP'$H"N[?EN)41%Z(E.=(QY_/KU.RPJ*[@V0
MT;=,];EHU<W]YS*)=8-D(705+82*S$NMD2L69`[D2,*DB[F^N.X"7SP?I!7S
MUEPZMZ:8&NA&*@!]$<<]E!X;"=2ID?-0!&X(HM4<D(_]MD0_30HH5V=FNB1/
M=Z.#*<$-":E>?LV-+LH?!F`EYTDGBX+\FAL=2%L^"2X/6$X[/,R?T&+)TZBM
MO?,3345\DC4XEFT,\[]-&G;0TW1B5\W\-FS;02UO\1T2^8!Z]X&7UUVJ;W>@
M;]WB>",;O).!IGA2\A<&YZ%_A^8PTZ8Y01O]0C:4/UBZ##W=49)2E/3ZS?5#
M$5D7&T=!EU9L[<FZL4$E.=WP%LLM_<A#0![)G.JDN[?W=#\](E6>T4A"]AA/
M3HJG9]-AID9=2X,VM(O*D5M\@0B'[A(3GRS6ER18`2R&N^<EX!,*KZ"`)T`8
M>L_D`F[.^U4?FYI9YWL^I&O6K1F4,T-4Z5-1:+4CW7\9EJMW+];/2T1%P*%R
M!EQ-%G\5UT71,)'[9R8+"F%^,VL[TI_0&6J.F*UV@V9$^W>`/%AJ8F>Z,;&3
M1S91THZD<Q,F=Q!X^A4N[9T.)H_1]CTU;?Q%9%4%+2KO=B!UC.<)GT48N2$T
M?IV#/4$7HA<I6Z:#L=T>-RMFZHBDMI$ZYG9=W'MY3RA?B!X]P9XZ)U!ELQ?`
M_08]0^W9BK*+/:V)'E75:5OB#MKA,Q3B!D&(X::*FNL=E9ZL`%\B=R4>@+"'
M7,6&E;4QM.O`&"H\QI7;,HGOBPP`Q<D%PBZ%\O@#&/TETN-2Q:Q(?J+)L,^B
M6F&/8*WJ:7(3!E!"5D"UODT'_37;JK"IB>9Z%Z4/>>W<5LW]#O0NN<L>RVEA
M"L4O)CI*LK(+DBJ&Q:DIF7/"A6>K.9Y4N_;TWS%3;C39$+^**+,4^;9593;3
MH%VG9O&2\V">H*A8,)NL5CZ"WF0!I%5,.Q<U^Q]WR*^[RX];*9F^MKD3D^6Y
M==A@@DTTW2N/J81S*'#VY`R:&.D4>?I>6?92?&J>=K1=FTO);$'DN(Z`?Z,6
MG8LO.S.A6H#4-,DSR28+A%=0(NH^$13\=+)A-ZRZN^5(./^*B%`H@`7)@:,7
MZV?P-@GYDD0U@G"*6%WY(J-\"\S-9F^W8=#AWA0'33)W!<`B`^>Y]96JFS]1
MXKJY'?-A'FW4F7`1\F8ACU)561IF67LRBUB:<]P-J_W/1#;4P]7HH5^&VR7#
M;BS0/4$4S$*15<K+=T@,?.H3#=XM%E&3^&%^*U##MEV81GN"@2JW%^E@?R5?
MH"$KV:PTXD^P]T36P)<#VP.6X[_(?^4W,>0[)E^P!VF<F5X2J1N))"@M7_SH
MA_Y$@],4!"S$BPM$F/`;'V0+.)N57(-V':CHINX2>J':[@/E6"7W"Z:SXY\H
MP%7C1QO";KZ*G6FBY']81?)(#8K1I%G3[KV\-(585`EJKF>*WA[E$M6U+,.G
MLJJ0FP3C!:JK$$;O?JB[$!:F6+9GTP6/3P]6S=<0<J\L9O*M$#_T9!R0IX#(
M@2V^D6:4[<D[ET]6NTOFW$J'9F]L6%-UP1FX?#5Z@=QL;?J14#XG/B*97K5M
MNE9GUJ!:TH,5$:QIT<')U/14/OTD2;XW9GMQ+B+K3I<0:@;X77+<?]6PO3H5
MP7_W?#N:&Z3G/M8-^Q/&B,AWA8Y_(KZ\0O,YC-\!5[LE*IUL1TP[F&^\BIR;
M+1_H:@GDKKD7)%_U+@PV]6TZ.-P\0W>.1#%36$(K7^Y`8),%U\/\3JY<9G+F
M+W5Q2\7S4E1(VL4][9TNN@@*X%<1.J&GJ8H*T;9AVRYJN69@1E$\^!>TTM_K
M0)=H<#+`WHX$:#E)D=.-0N#+TPOE&SQWA#$Y$W-#*$2+>`N-N\[.WF"?(;^`
M<W'[&;QERF_%8_^K"-&IOTS4Z`$0__X?4$L!`AX#%`````@`0(/X1F=&O7-[
MR@$``0PC`!$`&````````0```*2!`````&)I:6(M,C`Q-3`V,S`N>&UL550%
M``-8G[)5=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`0(/X1AV_'I>*)@``
M]JD!`!4`&````````0```*2!QLH!`&)I:6(M,C`Q-3`V,S!?8V%L+GAM;%54
M!0`#6)^R575X"P`!!"4.```$.0$``%!+`0(>`Q0````(`$"#^$:AWWL`)5<`
M`-\T!``5`!@```````$```"D@9_Q`0!B:6EB+3(P,34P-C,P7V1E9BYX;6Q5
M5`4``UB?LE5U>`L``00E#@``!#D!``!02P$"'@,4````"`!`@_A&.X>:5`KP
M```J+PP`%0`8```````!````I($320(`8FEI8BTR,#$U,#8S,%]L86(N>&UL
M550%``-8G[)5=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`0(/X1@"/,:G*
MD0``NRH'`!4`&````````0```*2!;#D#`&)I:6(M,C`Q-3`V,S!?<')E+GAM
M;%54!0`#6)^R575X"P`!!"4.```$.0$``%!+`0(>`Q0````(`$"#^$99S!$R
M-Q0``$CV```1`!@```````$```"D@87+`P!B:6EB+3(P,34P-C,P+GAS9%54
L!0`#6)^R575X"P`!!"4.```$.0$``%!+!08`````!@`&`!H"```'X`,`````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426947120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions Acquisitions (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Feb. 12, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,154,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,760,249<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember', window );">Convergence Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">In-process research and development and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 424,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(84,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 474,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4845-128472<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4845-128472<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 37<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35744172&amp;loc=d3e2207-128464<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4845-128472<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 37<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35744172&amp;loc=d3e2207-128464<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4845-128472<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4845-128472<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978499774000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reserves for Discounts and Allowances (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract', window );"><strong>Sales Discounts, Returns and Allowances, Goods [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock', window );">Analysis of the changes in reserves</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">An analysis of the change in reserves for discounts and allowances is summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Discounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Contractual</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Returns</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">47.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">387.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">49.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">483.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current provisions relating to sales in current year</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">209.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">854.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">19.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,082.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adjustments relating to prior years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(19.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(8.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(27.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments/credits relating to sales in current year</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(158.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(483.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(642.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments/credits relating to sales in prior years</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(43.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(254.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(7.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(305.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">55.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">483.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">51.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">590.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock', window );">Total reserves included in condensed consolidated balance sheets</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The total reserves above, included in our condensed consolidated balance sheets, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Reduction of accounts receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">143.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">124.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Component of accrued expenses and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">446.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">359.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total reserves</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">590.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">483.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Analysis of amount of and change in product revenue reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of total product revenue reserves included in consolidated balance sheets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_SummaryOfProductRevenueReservesIncludedInConsolidatedBalanceSheetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426632160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Purchase price schedule</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">he purchase price, as adjusted, consisted of the following:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash portion of consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">200.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">274.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase price</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">474.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Estimated fair values of the separately identifiable assets acquired and liabilities assumed</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">he following table summarizes the estimated fair values of the separately identifiable assets acquired and liabilities assumed as of February&#160;12, 2015, as adjusted:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In-process research and development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">424.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">128.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(84.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase price</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">474.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56956515&amp;loc=d3e1486-128463<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56956515&amp;loc=d3e1392-128463<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4845-128472<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426017376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Details 1) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValueAbstract', window );"><strong>Summary of financial assets with original maturities of less than 90 days included within cash and cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 974.0<span></span>
</td>
<td class="nump">$ 716.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValueAbstract', window );"><strong>Summary of financial assets with original maturities of less than 90 days included within cash and cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">38.8<span></span>
</td>
<td class="nump">54.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_RepurchaseAgreementsMember', window );">Overnight reverse repurchase agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValueAbstract', window );"><strong>Summary of financial assets with original maturities of less than 90 days included within cash and cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">185.0<span></span>
</td>
<td class="nump">305.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValueAbstract', window );"><strong>Summary of financial assets with original maturities of less than 90 days included within cash and cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">740.2<span></span>
</td>
<td class="nump">321.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember', window );">Short-term debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValueAbstract', window );"><strong>Summary of financial assets with original maturities of less than 90 days included within cash and cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="nump">$ 35.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_RepurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_RepurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978425271264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions Acquisitions (Details Textual) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2015</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Feb. 12, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 274.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember', window );">Convergence Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash portion of consideration</a></td>
<td class="nump">$ 200.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately', window );">Potential future milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration</a></td>
<td class="nump">$ 274.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Increase in the value of our estimated contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Increase in goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">In-process research and development and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">424.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember', window );">Convergence Pharmaceuticals | CNV1014802</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately', window );">Potential future milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Discount rate</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Remaining cost to complete CNV1014802</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">In-process research and development and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember', window );">Convergence Pharmaceuticals | Neuropathic pain indications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Remaining cost to complete CNV1014802</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">415.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">In-process research and development and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential future milestone payments commitment to third party approximately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)(3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4845-128472<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value.  For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (bbb)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductOrServiceAxis=biib_CNV1014802Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductOrServiceAxis=biib_CNV1014802Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductOrServiceAxis=biib_NeuropathicpainindicationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductOrServiceAxis=biib_NeuropathicpainindicationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978493942272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Components of inventory</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The components of inventory are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">173.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">128.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">516.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">511.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">175.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">164.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total inventory</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">865.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">804.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 2<br><br><br><br> -Paragraph 6<br><br><br><br> -Subparagraph a,b,c<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978499793600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_IntangibleAssetsExcludingGoodwillTableTextBlock', window );">Intangible assets</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Intangible assets, net of accumulated amortization, impairment charges and adjustments, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26" rowspan="1"></td></tr><tr><td width="21%" rowspan="1" colspan="1"></td><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Life</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Out-licensed patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">13-23 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">543.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(493.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">49.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">543.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(481.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">61.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Developed&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">15-23&#160;years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,005.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2,492.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">513.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,005.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2,396.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">608.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In-process research and development</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Indefinite until commercialization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">752.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">752.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">314.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">314.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Trademarks&#160;and&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">tradenames</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Indefinite</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">64.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">64.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">64.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">64.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired and in-licensed&#160;rights&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">and&#160;patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3-17 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,296.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(380.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,916.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,280.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(300.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,980.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7,661.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(3,366.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,294.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7,207.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3,178.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,028.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Estimated future amortization for acquired intangible assets</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Based upon this recent analysis, the estimated future amortization for acquired intangible assets is expected to be as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015 (remaining six months)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">185.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">312.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">285.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">281.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">270.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">263.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,599.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Summary of roll forward of the changes in goodwill</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table provides a roll forward of the changes in our goodwill balance:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,760.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increase to goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">390.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,154.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_IntangibleAssetsExcludingGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible assets excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_IntangibleAssetsExcludingGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978693272032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of significant accounting policies</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Summary of Significant Accounting Policies</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Business Overview</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Biogen is a global biopharmaceutical company focused on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. Our principal marketed products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI, and FAMPYRA for multiple sclerosis (MS), ALPROLIX for hemophilia B and ELOCTATE for hemophilia A. We also collaborate with Genentech, Inc., a wholly-owned member of the Roche Group, on the development and commercialization of RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and other conditions and share profits and losses for GAZYVA, which is approved for the treatment of chronic lymphocytic leukemia.  </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of our financial statements for interim periods in accordance with accounting principles generally accepted in the United States (U.S.&#160;GAAP). The information included in this quarterly report on Form&#160;10-Q should be read in conjunction with our consolidated financial statements and the accompanying notes included in our Annual Report on Form&#160;10-K for the year ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> (</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form&#160;10-K). Our accounting policies are described in the &#8220;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Notes to Consolidated Financial Statements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8221; in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form&#160;10-K and updated, as necessary, in this Form&#160;10-Q. The year-end condensed consolidated balance sheet data presented for comparative purposes was derived from our audited financial statements, but does not include all disclosures required by U.S.&#160;GAAP. The results of operations for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, are not necessarily indicative of the operating results for the full year or for any other subsequent interim period. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Consolidation</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our condensed consolidated financial statements reflect our financial statements, those of our wholly-owned subsidiaries and those of certain variable interest entities where we are the primary beneficiary. For consolidated entities where we own or are exposed to less than </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">100%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of the economics, we record net income (loss) attributable to noncontrolling interests in our condensed consolidated statements of income equal to the percentage of the economic or ownership interest retained in such entities by the respective noncontrolling parties. Intercompany balances and transactions are eliminated in consolidation. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In determining whether we are the primary beneficiary of an entity and therefore required to consolidate, we apply a qualitative approach that determines whether we have both (1) the power to direct the economically significant activities of the entity and (2) the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to that entity. These considerations impact the way we account for our existing collaborative relationships and other arrangements. We continuously assess whether we are the primary beneficiary of a variable interest entity as changes to existing relationships or future transactions may result in us consolidating or deconsolidating one or more of our collaborators or partners.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We operate as </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">one</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> operating segment, which is focused on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The preparation of our condensed consolidated financial statements requires us to make estimates, judgments, and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and judgments and methodologies. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Accounts Receivable</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our accounts receivable primarily arise from product sales in the U.S.&#160;and Europe and mainly represent amounts due from our wholesale distributors, public hospitals and other government entities. Concentrations of credit risk with respect to our accounts receivable, which are typically unsecured, are limited due to the wide variety of customers and markets using our products, as well as their dispersion across many different geographic areas. The majority of our accounts receivable require payment within </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">30 to 90 days</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. We monitor the financial performance and credit worthiness of our customers so that we can properly assess and respond to changes in their credit profile. We provide reserves against trade receivables for estimated losses that may result from a customer&#8217;s inability to pay. Amounts determined to be uncollectible are charged or written-off against the reserve. To date, our historical reserves and write-offs of accounts receivable have not been significant.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In countries where we have experienced a pattern of payments extending beyond our contractual payment term and we expect to collect receivables greater than one year after the time of sale, we have discounted our receivables and reduced related revenues over the period of time that we estimate those amounts will be paid using the country&#8217;s market-based borrowing rate for such period. The related receivables are classified at the time of sale as non-current assets. We accrete interest income on these receivables, which is recognized as a component of other income (expense), net within our condensed consolidated statement of income.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Property, Plant and Equipment</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Property, plant and equipment are recorded at cost, net of accumulated depreciation. Accumulated depreciation on property, plant and equipment was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1,274.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1,186.4 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">New Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard setting bodies that we adopt as of the specified effective date. Unless otherwise discussed, we do not believe that the impact of recently issued standards that are not yet effective will have a material impact on our financial position or results of operations upon adoption.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes all existing revenue recognition requirements, including most industry-specific guidance. The new standard requires a company to recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. In July 2015, the FASB decided to delay the effective date of the new revenue standard by one year. The new standard will be effective for us on January 1, 2018. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. We are currently evaluating the method of adoption and the potential impact that Topic 606 may have on our financial position and results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In June 2014, the FASB issued ASU No. 2014-11, Transfers and Servicing (Topic 860): Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosure. The new standard expanded secured borrowing accounting to include repurchase-to-maturity transactions and repurchase financings and set forth new disclosure requirements for repurchase agreements, securities lending transactions, and repurchase-to-maturity transactions that are accounted for as secured borrowings. We adopted this standard on April 1, 2015 and expanded our disclosures presented within Note 7, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Financial Instruments</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to these condensed consolidated financial statements. The adoption of this standard did not have an impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In April 2015, the FASB issued ASU No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The new standard requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The new standard will be effective for us on January 1, 2016. The adoption of this standard is not expected to have an impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In April 2015, the FASB issued ASU No. 2015-05, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Fees Paid in a Cloud Computing Arrangement. Under this standard, if a cloud computing arrangement includes a software license, the software license element of the arrangement should be accounted for consistent with the acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the arrangement should be accounted for as a service contract. The new standard will be effective for us on January 1, 2016. The adoption of this standard is not expected to have an impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2015, the FASB issued ASU No. 2015-07, Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent). The new standard removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient. The new standard will be effective for us on January 1, 2016. Early application is permitted. We maintain investments in certain venture capital funds which primarily invest in small, privately-owned, venture-backed biotechnology companies. The value of our investments in these venture capital funds is estimated using the net asset value of the fund and has been included in the fair value hierarchy disclosure as a Level 3 measurement. These venture capital investments are not material to our financial position or results of operations. We have elected to apply this standard as of June 30, 2015 and our investments in venture capital funds will no longer be included in our disclosures reflected within Note 6, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Fair Value Measurements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to these condensed consolidated financial statements.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18861-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18726-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18743-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18854-107790<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978499833488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of assets and liabilities recorded at fair value</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The tables below present information about our assets and liabilities that are regularly measured and carried at fair value and indicate the level within the fair value hierarchy of the valuation techniques we utilized to determine such fair value:</font></div><div style="line-height:120%;padding-top:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of June 30, 2015 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Quoted&#160;Prices</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">in Active</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant&#160;Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Observable&#160;Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">974.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">974.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable debt securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,198.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,198.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,700.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,700.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">290.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">290.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">100.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">100.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Plan assets for deferred compensation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,310.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,303.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">27.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">27.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">523.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">27.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2014 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Quoted&#160;Prices</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">in Active</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">716.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">716.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable debt securities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,063.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,063.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">849.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">849.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">198.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">198.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">72.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">72.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Plan assets for deferred compensation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,943.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,937.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">215.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">215.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">220.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">215.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Summary of fair and carrying value of debt instruments</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The fair and carrying values of our debt instruments, which are Level&#160;2 liabilities, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Notes payable to Fumedica</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">10.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">9.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">11.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.875% Senior Notes due March&#160;1, 2018</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">621.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">570.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">634.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">573.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">631.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">579.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">647.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">585.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair value of contingent consideration obligations</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table provides a roll forward of the fair values of our contingent consideration obligations which includes Level 3 measurements:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value, beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">461.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">275.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">215.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">280.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Additions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">36.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">274.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Changes in fair value</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">279.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">279.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19279-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19190-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978493935264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Consolidated Financial Statement Detail (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Other income (expense), net</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Components of other income (expense), net, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(7.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(12.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(14.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gain (loss) on investments, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">13.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">16.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Foreign exchange gains (losses), net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(14.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(4.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(8.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total other income (expense), net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(10.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(25.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued expenses and other</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other consists of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current portion of contingent consideration obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">493.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">265.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue-related rebates</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">446.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">359.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee compensation and benefits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">214.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">393.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Royalties and licensing fees</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">161.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">172.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">62.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">120.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">433.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">507.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total accrued expenses and other</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,812.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,819.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other long-term liabilities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other long-term liabilities consist of the following:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">302.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">200.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee compensation and benefits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">224.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">200.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">389.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">249.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total other long-term liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">915.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">650.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978494049008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details 2) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="nump">$ 36,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 274,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Changes in fair value</a></td>
<td class="num">(2,201)<span></span>
</td>
<td class="nump">4,019<span></span>
</td>
<td class="nump">5,643<span></span>
</td>
<td class="nump">3,220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value, beginning of period</a></td>
<td class="nump">461,800<span></span>
</td>
<td class="nump">275,100<span></span>
</td>
<td class="nump">215,500<span></span>
</td>
<td class="nump">280,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value, end of period</a></td>
<td class="nump">$ 495,600<span></span>
</td>
<td class="nump">$ 279,100<span></span>
</td>
<td class="nump">$ 495,600<span></span>
</td>
<td class="nump">$ 279,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionContingentConsiderationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph b<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978504144752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Textual) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2011</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.90%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">24.70%<span></span>
</td>
<td class="nump">26.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Notice of assessment of corporate withholding tax including penalties and interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Net benefit for a previously unrecognized position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2007Member', window );">Tax Year 2007</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices', window );">Proposed deduction disallowance by tax authorities</a></td>
<td class="nump">$ 130.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2008Member', window );">Tax Year 2008</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices', window );">Proposed deduction disallowance by tax authorities</a></td>
<td class="nump">130.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2009Member', window );">Tax Year 2009</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices', window );">Proposed deduction disallowance by tax authorities</a></td>
<td class="nump">$ 130.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proposed disallowance by tax authorities for payment for services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_ProposedDisallowanceByTaxAuthoritiesForPaymentForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 13<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h)(2))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 15<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 15A<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=SL6600010-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Unrecognized Tax Benefit<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6527854<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2007Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_TaxYear2007Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2008Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_TaxYear2008Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2009Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_TaxYear2009Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426028608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Income (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product, net</a></td>
<td class="nump">$ 2,198,566<span></span>
</td>
<td class="nump">$ 2,056,292<span></span>
</td>
<td class="nump">$ 4,370,888<span></span>
</td>
<td class="nump">$ 3,799,057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_UnconsolidatedJointBusiness', window );">Unconsolidated joint business</a></td>
<td class="nump">337,510<span></span>
</td>
<td class="nump">303,296<span></span>
</td>
<td class="nump">668,121<span></span>
</td>
<td class="nump">600,181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSalesRevenueNet', window );">Other</a></td>
<td class="nump">55,566<span></span>
</td>
<td class="nump">61,864<span></span>
</td>
<td class="nump">107,596<span></span>
</td>
<td class="nump">151,965<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,591,642<span></span>
</td>
<td class="nump">2,421,452<span></span>
</td>
<td class="nump">5,146,605<span></span>
</td>
<td class="nump">4,551,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Cost and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSold', window );">Cost of sales, excluding amortization of acquired intangible assets</a></td>
<td class="nump">286,120<span></span>
</td>
<td class="nump">291,887<span></span>
</td>
<td class="nump">598,551<span></span>
</td>
<td class="nump">571,132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">490,728<span></span>
</td>
<td class="nump">447,273<span></span>
</td>
<td class="nump">951,277<span></span>
</td>
<td class="nump">976,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">491,895<span></span>
</td>
<td class="nump">576,622<span></span>
</td>
<td class="nump">1,052,256<span></span>
</td>
<td class="nump">1,088,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">92,004<span></span>
</td>
<td class="nump">116,826<span></span>
</td>
<td class="nump">187,907<span></span>
</td>
<td class="nump">260,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">(Gain) loss on fair value remeasurement of contingent consideration</a></td>
<td class="num">(2,201)<span></span>
</td>
<td class="nump">4,019<span></span>
</td>
<td class="nump">5,643<span></span>
</td>
<td class="nump">3,220<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total cost and expenses</a></td>
<td class="nump">1,358,546<span></span>
</td>
<td class="nump">1,436,627<span></span>
</td>
<td class="nump">2,795,634<span></span>
</td>
<td class="nump">2,898,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_GainOnSaleOfRights', window );">Gain on sale of rights</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,759<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">1,233,096<span></span>
</td>
<td class="nump">988,725<span></span>
</td>
<td class="nump">2,350,971<span></span>
</td>
<td class="nump">1,660,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(10,889)<span></span>
</td>
<td class="nump">4,861<span></span>
</td>
<td class="num">(25,875)<span></span>
</td>
<td class="num">(740)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income tax expense and equity in loss of investee, net of tax</a></td>
<td class="nump">1,222,207<span></span>
</td>
<td class="nump">993,586<span></span>
</td>
<td class="nump">2,325,096<span></span>
</td>
<td class="nump">1,659,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">292,501<span></span>
</td>
<td class="nump">268,521<span></span>
</td>
<td class="nump">574,382<span></span>
</td>
<td class="nump">446,935<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in loss of investee, net of tax</a></td>
<td class="nump">4,881<span></span>
</td>
<td class="nump">1,933<span></span>
</td>
<td class="nump">5,715<span></span>
</td>
<td class="nump">9,538<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">924,825<span></span>
</td>
<td class="nump">723,132<span></span>
</td>
<td class="nump">1,744,999<span></span>
</td>
<td class="nump">1,202,860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income (loss) attributable to noncontrolling interests, net of tax</a></td>
<td class="num">(2,451)<span></span>
</td>
<td class="nump">8,626<span></span>
</td>
<td class="num">(4,818)<span></span>
</td>
<td class="nump">8,398<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Biogen Inc.</a></td>
<td class="nump">$ 927,276<span></span>
</td>
<td class="nump">$ 714,506<span></span>
</td>
<td class="nump">$ 1,749,817<span></span>
</td>
<td class="nump">$ 1,194,462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share attributable to Biogen Inc.</a></td>
<td class="nump">$ 3.94<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="nump">$ 7.44<span></span>
</td>
<td class="nump">$ 5.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share attributable to Biogen Inc.</a></td>
<td class="nump">$ 3.93<span></span>
</td>
<td class="nump">$ 3.01<span></span>
</td>
<td class="nump">$ 7.42<span></span>
</td>
<td class="nump">$ 5.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares used in calculating:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic earnings per share attributable to Biogen Inc.</a></td>
<td class="nump">235,286<span></span>
</td>
<td class="nump">236,661<span></span>
</td>
<td class="nump">235,122<span></span>
</td>
<td class="nump">236,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted earnings per share attributable to Biogen Inc.</a></td>
<td class="nump">235,718<span></span>
</td>
<td class="nump">237,401<span></span>
</td>
<td class="nump">235,671<span></span>
</td>
<td class="nump">237,634<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_GainOnSaleOfRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain on sale of our royalty and other rights related to future sales of BENLYSTA recognized in our consolidated statement of income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_GainOnSaleOfRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_UnconsolidatedJointBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenues from unconsolidated joint business consists of our share of pre-tax co-promotion profits in the U.S.; reimbursement of selling and development expense in the U.S.; and revenue on sales of RITUXAN outside the U.S., which consist of our share of pre-tax co-promotion profits in Canada.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_UnconsolidatedJointBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to goods produced and sold during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.2(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 52<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=32703322&amp;loc=d3e4984-109258<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-04.23)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 7<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 7<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 323<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35755396&amp;loc=d3e33749-111570<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.12)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 11<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -Subparagraph (a),(b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Income Tax Expense (or Benefit)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 4J<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35736750&amp;loc=SL4591551-111686<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=SL4573702-111684<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.7)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenues from the sale of other goods or rendering of other services, not elsewhere specified in the taxonomy; net of (reduced by) sales adjustments, returns, allowances, and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1(a),(d))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 19<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51664549&amp;loc=SL4569616-111683<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 4K<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35736750&amp;loc=SL4591552-111686<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1A<br><br><br><br> -Subparagraph (a),(c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=SL4573702-111684<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 4J<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35736750&amp;loc=SL4591551-111686<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 730<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Research and Development<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueGoodsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 330<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 30<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51677171&amp;loc=d3e3636-108311<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 16<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1505-109256<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 10<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1448-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Weighted-Average Number of Common Shares Outstanding<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978425906736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reserves for Discounts and Allowances (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract', window );"><strong>Analysis of the amount of, and change in, reserves</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance as of December 31, 2014</a></td>
<td class="nump">$ 483.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear', window );">Current provisions relating to sales in current year</a></td>
<td class="nump">1,082.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears', window );">Adjustments relating to prior years</a></td>
<td class="num">(27.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear', window );">Payments/credits relating to sales in current year</a></td>
<td class="num">(642.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear', window );">Payments/credits relating to sales in prior years</a></td>
<td class="num">(305.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance as of June 30, 2015</a></td>
<td class="nump">590.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ReserveForCashDiscountMember', window );">Discounts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract', window );"><strong>Analysis of the amount of, and change in, reserves</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance as of December 31, 2014</a></td>
<td class="nump">47.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear', window );">Current provisions relating to sales in current year</a></td>
<td class="nump">209.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears', window );">Adjustments relating to prior years</a></td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear', window );">Payments/credits relating to sales in current year</a></td>
<td class="num">(158.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear', window );">Payments/credits relating to sales in prior years</a></td>
<td class="num">(43.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance as of June 30, 2015</a></td>
<td class="nump">55.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=biib_ContractualAdjustmentsMember', window );">Contractual Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract', window );"><strong>Analysis of the amount of, and change in, reserves</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance as of December 31, 2014</a></td>
<td class="nump">387.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear', window );">Current provisions relating to sales in current year</a></td>
<td class="nump">854.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears', window );">Adjustments relating to prior years</a></td>
<td class="num">(19.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear', window );">Payments/credits relating to sales in current year</a></td>
<td class="num">(483.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear', window );">Payments/credits relating to sales in prior years</a></td>
<td class="num">(254.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance as of June 30, 2015</a></td>
<td class="nump">483.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember', window );">Returns</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract', window );"><strong>Analysis of the amount of, and change in, reserves</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance as of December 31, 2014</a></td>
<td class="nump">49.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear', window );">Current provisions relating to sales in current year</a></td>
<td class="nump">19.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears', window );">Adjustments relating to prior years</a></td>
<td class="num">(8.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear', window );">Payments/credits relating to sales in current year</a></td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear', window );">Payments/credits relating to sales in prior years</a></td>
<td class="num">(7.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance as of June 30, 2015</a></td>
<td class="nump">$ 51.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to product revenue reserves relating to sales in prior years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Analysis of the amount of, and change in product revenue reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_AnalysisOfAmountOfAndChangeInProductRevenueReservesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current provisions to product revenue reserves relating to sales in current year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments/ returns applied against product revenue reserves relating to current year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments/ returns applied against product revenue reserves relating to prior year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of allowances and reserves, the valuation and qualifying accounts that are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 09<br><br><br><br> -Article 12<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ReserveForCashDiscountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ReserveForCashDiscountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=biib_ContractualAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=biib_ContractualAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426071248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0005<span></span>
</td>
<td class="nump">$ 0.0005<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978503565408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Details Textual)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Original maturities of commercial paper and short-term debt securities</a></td>
<td class="text">less than 90&#160;days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_Overnightreverserepurchaseagreementspercentoftotalassets', window );">Overnight reverse repurchase agreements, percent of total assets</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_AverageMaturityOfMarketableSecurities', window );">Average maturity of marketable securities, months</a></td>
<td class="text">17 months<span></span>
</td>
<td class="text">15 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_AverageMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average remaining time to maturity of marketable debt securities, available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_AverageMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_Overnightreverserepurchaseagreementspercentoftotalassets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Overnight reverse repurchase agreements, percent of total assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_Overnightreverserepurchaseagreementspercentoftotalassets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.22(a)(2))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978499776560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock', window );">Reconciliation of equity attributable to noncontrolling interests</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table reconciles equity attributable to noncontrolling interests (NCI):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">NCI, beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) attributable to NCI, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of net assets and liabilities acquired and assigned to NCI</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Distribution to NCI</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(9.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(9.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Translation adjustment and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">NCI, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of equity attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_ReconciliationOfEquityAttributableToNoncontrollingInterestsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978495784064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">$ (10,889)<span></span>
</td>
<td class="nump">$ 4,861<span></span>
</td>
<td class="num">$ (25,875)<span></span>
</td>
<td class="num">$ (740)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="nump">292,501<span></span>
</td>
<td class="nump">268,521<span></span>
</td>
<td class="nump">574,382<span></span>
</td>
<td class="nump">446,935<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product, net</a></td>
<td class="num">(2,198,566)<span></span>
</td>
<td class="num">(2,056,292)<span></span>
</td>
<td class="num">(4,370,888)<span></span>
</td>
<td class="num">(3,799,057)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Biogen Inc.</a></td>
<td class="nump">927,276<span></span>
</td>
<td class="nump">714,506<span></span>
</td>
<td class="nump">1,749,817<span></span>
</td>
<td class="nump">1,194,462<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Biogen Inc.</a></td>
<td class="nump">40,100<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="nump">74,800<span></span>
</td>
<td class="num">(3,500)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Accumulated Net Unrealized Investment Gain (Loss) | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(200)<span></span>
</td>
<td class="nump">10,100<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="nump">10,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="nump">100<span></span>
</td>
<td class="num">(3,600)<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="num">(3,600)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(200)<span></span>
</td>
<td class="num">(500)<span></span>
</td>
<td class="num">(400)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product, net</a></td>
<td class="num">$ (40,400)<span></span>
</td>
<td class="num">$ (5,300)<span></span>
</td>
<td class="num">$ (75,400)<span></span>
</td>
<td class="num">$ (10,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -Subparagraph (a),(b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Income Tax Expense (or Benefit)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.7)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueGoodsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978503515168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Variable Interest Entities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_InvestmentsInVariableInterestEntitiesAbstract', window );"><strong>Investments in Variable Interest Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Investments in Variable Interest Entities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Investments in Variable Interest Entities</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Consolidated Variable Interest Entities</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our condensed consolidated financial statements include the financial results of variable interest entities in which we are the primary beneficiary.</font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Neurimmune SubOne AG</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In 2007, we entered into a collaboration agreement with Neurimmune SubOne AG (Neurimmune), a subsidiary of Neurimmune AG, for the development and commercialization of antibodies for the treatment of Alzheimer&#8217;s disease. Neurimmune conducts research to identify potential therapeutic antibodies and we are responsible for the development, manufacturing and commercialization of all products. Our anti-amyloid beta antibody, aducanumab (BIIB037), for the treatment of Alzheimer&#8217;s disease resulted from this collaboration. In December 2014, we reported positive interim data from the Phase 1b trial of aducanumab. Based upon our current development plans, we may pay Neurimmune up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$335.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in remaining milestone payments, of which </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$60.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> is payable upon dosing of the first patient in a Phase 3 trial for aducanumab. We may also pay royalties in the low-to-mid-teens on sales of any resulting commercial products.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts that are incurred by Neurimmune for research and development expenses in support of the collaboration that we reimburse are reflected in research and development expense in our condensed consolidated statements of income. Future milestone payments, if any, will be reflected within our condensed consolidated statements of income as a charge to noncontrolling interest, net of tax, when such milestones are achieved.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the collaboration incurred expenses totaling </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$35.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$47.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, which is included in total costs and expenses within our condensed consolidated statements of income, as compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$10.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$21.7 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in the prior year comparative periods. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The assets and liabilities of Neurimmune are not significant to our financial position or results of operations as it is a research and development organization. We have provided no financing to Neurimmune other than contractually required amounts.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Unconsolidated Variable Interest Entities</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have relationships with other variable interest entities that we do not consolidate as we lack the power to direct the activities that significantly impact the economic success of these entities. These relationships include investments in certain biotechnology companies and research collaboration agreements. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the total carrying value of our investments in biotechnology companies totaled </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$8.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$7.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. Our maximum exposure to losses related to these variable interest entities is limited to the carrying value of our investments.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have entered into research collaboration agreements with certain variable interest entities where we are required to fund certain development activities. These development activities are included in research and development expense within our condensed consolidated statements of income, as they are incurred. We have provided no financing to these variable interest entities other than previously contractually required amounts. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For additional information related to our investments in variable interest entities, please read Note 19, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Investments in Variable Interest Entities</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_InvestmentsInVariableInterestEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In Variable Interest Entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_InvestmentsInVariableInterestEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=52262685&amp;loc=SL6759159-111685<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=52262685&amp;loc=d3e5728-111685<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=52262685&amp;loc=d3e5710-111685<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978494704784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of accumulated other comprehensive income (loss)</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the changes in accumulated other comprehensive income (loss), net of tax by component:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="31%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Securities Available for Sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Foreign Currency Forward Contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unfunded Status of Postretirement Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Translation Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">71.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(31.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(99.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(59.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">66.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(37.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">33.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(75.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(74.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net current period other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(8.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(37.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(41.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">62.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(27.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(137.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(101.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="31%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Securities Available for Sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Foreign Currency Forward Contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unfunded Status of Postretirement Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Translation Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(23.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(19.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(27.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(11.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(6.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net current period other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">16.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(11.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(7.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(19.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(26.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Reclassification out of accumulated other comprehensive income</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the amounts reclassified from accumulated other comprehensive income:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="24%" rowspan="1" colspan="1"></td><td width="21%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Income Statement Location</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amounts Reclassified from Accumulated Other Comprehensive Income</font></div></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gains (losses) on securities available for sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax benefit (expense)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gains (losses) on foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenues</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">75.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(10.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax benefit (expense)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total reclassifications, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">74.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669686-108580<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978503445168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Litigation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyInformationAboutLitigationMattersAbstract', window );"><strong>Loss Contingency, Information about Litigation Matters [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Litigation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Litigation</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"> &#8217;755 Patent Litigation</font></div><div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On May&#160;28, 2010, Biogen MA Inc. (formerly Biogen Idec MA Inc.) filed a complaint in the U.S.&#160;District Court for the District of New Jersey alleging infringement by Bayer Healthcare Pharmaceuticals Inc. (Bayer) (manufacturer, marketer and seller of BETASERON and manufacturer of EXTAVIA), EMD Serono, Inc. (manufacturer, marketer and seller of REBIF), Pfizer Inc. (co-marketer of REBIF), and Novartis Pharmaceuticals Corp. (marketer and seller of EXTAVIA) of our U.S. Patent No. 7,588,755 (&#8217;755 Patent), which claims the use of interferon beta for immunomodulation or treating a viral condition, viral disease, cancers or tumors. The complaint seeks monetary damages, including lost profits and royalties. Bayer had previously filed a complaint against us in the same court, on May 27, 2010, seeking a declaratory judgment that it does not infringe the &#8217;755 Patent and that the patent is invalid, and seeking monetary relief in the form of attorneys' fees, costs and expenses. The court has consolidated the two lawsuits, and we refer to the two actions as the &#8220;Consolidated &#8217;755 Patent Actions.&#8221;</font></div><div style="line-height:120%;padding-top:12px;text-align:left;padding-left:12px;text-indent:17px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Bayer, Pfizer, Novartis and EMD Serono have all filed counterclaims in the Consolidated &#8217;755 Patent Actions seeking declaratory judgments of patent invalidity and non-infringement, and seeking monetary relief in the form of costs and attorneys' fees, and EMD Serono and Bayer have each filed a counterclaim seeking a declaratory judgment that the &#8217;755 Patent is unenforceable based on alleged inequitable conduct. Bayer has also amended its complaint to seek such a declaration. No trial date has been set.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Italian National Medicines Agency</font></div><div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the fourth quarter of 2011, Biogen Italia SRL&#160;received notice from the Italian National Medicines Agency (Agenzia Italiana del Farmaco or AIFA) that sales of TYSABRI after mid-February 2009 exceeded a reimbursement limit established pursuant to a Price Determination Resolution (Price Resolution) granted by AIFA in December 2006. On December&#160;23, 2011, we filed an appeal in the Regional Administrative Tribunal of Lazio (Il Tribunale Amministrativo Regionale per il Lazio) in Rome, Italy seeking a ruling that the reimbursement limit in the Price Resolution should apply as written to only &#8220;the first </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months&#8221; of TYSABRI sales, which ended in mid-February 2009. The appeal is still pending. In June 2014, AIFA approved a resolution affirming that there is no reimbursement limit from and after February 2013. AIFA and Biogen Italia SRL are discussing a possible resolution for the period from mid-February 2009 through January 2013.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Government Matters</font></div><div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have learned that state and federal governmental authorities are investigating our sales and promotional practices and have received related subpoenas. We have also received a subpoena from the federal government for documents relating to our relationship with certain pharmacy benefit managers. We are cooperating with the government in these matters.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Qui Tam Litigation</font></div><div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On July 6, 2015, four qui tam actions filed against us by relators suing on behalf of the United States and certain states were unsealed by the U.S. District Court for the District of Massachusetts. The actions, which have been administratively consolidated, allege sales and promotional activities in violation of the federal False Claims Act and state law counterparts, and seek single and treble damages, civil penalties, interest, attorneys&#8217; fees and costs. The United States has declined to intervene in two of the actions and has not made an intervention decision in the other two actions. We have not been served with any of the complaints. We have not formed an opinion that an unfavorable outcome in any of the actions is either &#8220;probable&#8221; or &#8220;remote&#8221; and are unable to estimate the magnitude or range of any potential loss.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Forward Pharma Litigation</font></div><div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On November 18, 2014 Forward Pharma A/S (Forward Pharma) filed suit against us in the Regional Court of Dusseldorf, Germany alleging that TECFIDERA infringes German Utility Model DE&#160;20 2005 022 112&#160;U1, which was issued in April 2014 and expires in October 2015. Forward Pharma subsequently&#160;extended its allegations&#160;to assert that TECFIDERA infringes Forward Pharma's European Patent No. 2,801,355, which was issued in May 2015 and expires in October 2025. Forward Pharma seeks declarations of infringement and damages. A hearing has been scheduled for early 2016.&#160;We have not formed an opinion that an unfavorable outcome is either &#8220;probable&#8221; or &#8220;remote&#8221; and are unable to estimate the magnitude or range of any potential loss.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160; </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Product Liability and Other Legal Proceedings</font></div><div style="line-height:120%;padding-top:6px;text-align:left;padding-left:5px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We are also involved in product liability claims and other legal proceedings generally incidental to our normal business activities. While the outcome of any of these proceedings cannot be accurately predicted, we do not believe the ultimate resolution of any of these existing matters would have a material adverse effect on our business or financial condition.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyInformationAboutLitigationMattersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyInformationAboutLitigationMattersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978500109904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments (Details 1) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract', window );"><strong>Summary of share based compensation expense associated with different programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Subtotal</a></td>
<td class="nump">$ 48.3<span></span>
</td>
<td class="nump">$ 58.1<span></span>
</td>
<td class="nump">$ 139.3<span></span>
</td>
<td class="nump">$ 134.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Capitalized share-based compensation costs</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="num">(5.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses', window );">Share-based compensation expense included in total costs and expenses</a></td>
<td class="nump">46.1<span></span>
</td>
<td class="nump">55.5<span></span>
</td>
<td class="nump">133.7<span></span>
</td>
<td class="nump">129.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=biib_MarketStockUnitsMember', window );">Market stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract', window );"><strong>Summary of share based compensation expense associated with different programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">26.1<span></span>
</td>
<td class="nump">23.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=biib_TimeVestedRestrictedStockUnitsMember', window );">Time-vested restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract', window );"><strong>Summary of share based compensation expense associated with different programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">31.8<span></span>
</td>
<td class="nump">29.2<span></span>
</td>
<td class="nump">63.7<span></span>
</td>
<td class="nump">58.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=biib_CashSettledPerformanceSharesMember', window );">Cash settled performance shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract', window );"><strong>Summary of share based compensation expense associated with different programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">27.0<span></span>
</td>
<td class="nump">35.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=us-gaap_PerformanceSharesMember', window );">Performance units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract', window );"><strong>Summary of share based compensation expense associated with different programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">14.4<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=biib_EmployeeStockPurchasePlanMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract', window );"><strong>Summary of share based compensation expense associated with different programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 2.7<span></span>
</td>
<td class="nump">$ 8.1<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation expense included in costs and expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_ShareBasedCompensationExpenseIncludedInCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of share-based compensation expense associated with different programs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_SummaryOfShareBasedCompensationExpenseAssociatedWithDifferentProgramsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 14.F)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (h)(1)(i)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 14<br><br><br><br> -Section F<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense, net of income tax, recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the compensation cost capitalized during the period arising from equity-based compensation arrangements (for example, shares of stock, units, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (h)(1)(ii)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=biib_MarketStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=biib_MarketStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=biib_TimeVestedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=biib_TimeVestedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=biib_CashSettledPerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=biib_CashSettledPerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=biib_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=biib_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978425966240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,744,999<span></span>
</td>
<td class="nump">$ 1,202,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">292,523<span></span>
</td>
<td class="nump">355,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">93,677<span></span>
</td>
<td class="nump">83,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(90,647)<span></span>
</td>
<td class="num">(146,506)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="num">(5,808)<span></span>
</td>
<td class="num">(64,213)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(38,907)<span></span>
</td>
<td class="num">(188,961)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(81,294)<span></span>
</td>
<td class="num">(72,689)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="num">(169,929)<span></span>
</td>
<td class="num">(30,299)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Current taxes payable</a></td>
<td class="nump">102,017<span></span>
</td>
<td class="nump">31,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other changes in operating assets and liabilities, net</a></td>
<td class="num">(66,374)<span></span>
</td>
<td class="num">(75,044)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash flows provided by operating activities</a></td>
<td class="nump">1,780,257<span></span>
</td>
<td class="nump">1,095,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from sales and maturities of marketable securities</a></td>
<td class="nump">975,517<span></span>
</td>
<td class="nump">1,317,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(2,045,046)<span></span>
</td>
<td class="num">(1,787,606)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions of business, net of cash acquired</a></td>
<td class="num">(198,798)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(227,688)<span></span>
</td>
<td class="num">(118,308)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherProductiveAssets', window );">Contingent consideration related to Fumapharm AG acquisition</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(10,119)<span></span>
</td>
<td class="num">(10,745)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash flows used in investing activities</a></td>
<td class="num">(1,756,134)<span></span>
</td>
<td class="num">(624,134)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury stock</a></td>
<td class="num">(42,193)<span></span>
</td>
<td class="num">(336,905)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of stock for share-based compensation arrangements</a></td>
<td class="nump">34,727<span></span>
</td>
<td class="nump">33,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities', window );">Excess tax benefit from stock options</a></td>
<td class="nump">69,690<span></span>
</td>
<td class="nump">83,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="nump">14,995<span></span>
</td>
<td class="nump">12,003<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash flows provided by (used in) financing activities</a></td>
<td class="nump">77,219<span></span>
</td>
<td class="num">(207,485)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">101,342<span></span>
</td>
<td class="nump">263,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(24,188)<span></span>
</td>
<td class="num">(2,965)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, beginning of the period</a></td>
<td class="nump">1,204,924<span></span>
</td>
<td class="nump">602,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, end of the period</a></td>
<td class="nump">$ 1,282,078<span></span>
</td>
<td class="nump">$ 863,197<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 230<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Deferred Tax Expense (or Benefit)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510177<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 6.I.7)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 6<br><br><br><br> -Section I<br><br><br><br> -Subsection 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 230<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=32706628&amp;loc=d3e11374-113907<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other assets used in operating activities less other operating liabilities used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets and liabilities, other noncurrent assets and liabilities, or a combination of other current and noncurrent assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 26<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3574-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 26<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3574-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other income (expense) included in net income that results in no cash inflows or outflows in the period. Includes noncash adjustments to reconcile net income (loss) to cash provided by (used in) operating activities that are not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from other investing activities. This element is used when there is not a more specific and appropriate element in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3098-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3095-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 15<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph (a),(b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49167202&amp;loc=d3e26853-111562<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of or capital improvements on other tangible or intangible assets not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total cash inflow associated with the amount received from holders to acquire the entity's shares under incentive and share awards, including stock option exercises. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow from other financing activities. This element is used when there is not a more specific and appropriate element in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3095-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3098-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale or maturity (principal being due) of securities not classified as either held-to-maturity securities or trading securities which are classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 12<br><br><br><br> -Subparagraph (a),(b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3179-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49167202&amp;loc=d3e26853-111562<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 19<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51664549&amp;loc=SL4569616-111683<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 4K<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35736750&amp;loc=SL4591552-111686<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1A<br><br><br><br> -Subparagraph (a),(c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=SL4573702-111684<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 4J<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35736750&amp;loc=SL4591551-111686<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426941888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Biogen Inc.</a></td>
<td class="nump">$ 927,276<span></span>
</td>
<td class="nump">$ 714,506<span></span>
</td>
<td class="nump">$ 1,749,817<span></span>
</td>
<td class="nump">$ 1,194,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gains (losses) on securities available for sale, net of tax of $(145) and $(4,029) for the three months ended June 30, 2015 and 2014, respectively; and $621 and $(3,015) for the six months ended June 30, 2015 and 2014, respectively</a></td>
<td class="num">(214)<span></span>
</td>
<td class="num">(6,865)<span></span>
</td>
<td class="nump">1,085<span></span>
</td>
<td class="num">(5,140)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax', window );">Unrealized gains (losses) on foreign currency forward contracts, net of tax of $(454) and $(260) for the three months ended June 30, 2015 and 2014, respectively; and $(42) and $5 for the six months ended June 30, 2015 and 2014, respectively</a></td>
<td class="num">(96,159)<span></span>
</td>
<td class="nump">10,760<span></span>
</td>
<td class="num">(8,913)<span></span>
</td>
<td class="nump">16,551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Unrealized gains (losses) on pension benefit obligation</a></td>
<td class="nump">2,851<span></span>
</td>
<td class="num">(170)<span></span>
</td>
<td class="nump">4,109<span></span>
</td>
<td class="nump">646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="nump">63,035<span></span>
</td>
<td class="num">(8,047)<span></span>
</td>
<td class="num">(37,818)<span></span>
</td>
<td class="num">(10,991)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(30,487)<span></span>
</td>
<td class="num">(4,322)<span></span>
</td>
<td class="num">(41,537)<span></span>
</td>
<td class="nump">1,066<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Biogen Inc.</a></td>
<td class="nump">896,789<span></span>
</td>
<td class="nump">710,184<span></span>
</td>
<td class="nump">1,708,280<span></span>
</td>
<td class="nump">1,195,528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income (loss) attributable to noncontrolling interests, net of tax</a></td>
<td class="num">(2,266)<span></span>
</td>
<td class="nump">8,626<span></span>
</td>
<td class="num">(4,533)<span></span>
</td>
<td class="nump">8,398<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">$ 894,523<span></span>
</td>
<td class="nump">$ 718,810<span></span>
</td>
<td class="nump">$ 1,703,747<span></span>
</td>
<td class="nump">$ 1,203,926<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831223<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e557-108580<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 21<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51664549&amp;loc=SL4613674-111683<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 20<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51664549&amp;loc=SL4569643-111683<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 4K<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35736750&amp;loc=SL4591552-111686<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 19<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51664549&amp;loc=SL4569616-111683<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 4K<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35736750&amp;loc=SL4591552-111686<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 10A<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 10A<br><br><br><br> -Subparagraph (d)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 20<br><br><br><br> -Subparagraph (b,c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32211-110900<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 10A<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669619-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1B<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669625-108580<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51821188&amp;loc=d3e1436-108581<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of (increase) decrease in accumulated other comprehensive (income) loss related to pension and other postretirement defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 10A<br><br><br><br> -Subparagraph (i-k)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426243872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Accumulated Other Comprehensive Income (Loss)</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the changes in accumulated other comprehensive income (loss), net of tax by component:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="31%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Securities Available for Sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Foreign Currency Forward Contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unfunded Status of Postretirement Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Translation Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">71.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(31.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(99.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(59.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">66.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(37.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">33.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(75.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(74.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net current period other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(8.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(37.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(41.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">62.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(27.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(137.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(101.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="31%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Securities Available for Sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Foreign Currency Forward Contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unfunded Status of Postretirement Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Translation Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(23.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(19.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(27.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(11.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(6.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net current period other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">16.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(11.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(7.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(19.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(26.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the amounts reclassified from accumulated other comprehensive income:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="24%" rowspan="1" colspan="1"></td><td width="21%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Income Statement Location</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amounts Reclassified from Accumulated Other Comprehensive Income</font></div></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gains (losses) on securities available for sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax benefit (expense)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gains (losses) on foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenues</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">75.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(10.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax benefit (expense)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total reclassifications, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">74.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e689-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669619-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e640-108580<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 17<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e716-108580<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 16<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e709-108580<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e681-108580<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Reclassification Adjustments<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6522872<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426842800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jul. 17, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BIOGEN INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000875045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,169,225<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document and Entity Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation 12B<br><br><br><br> -Number 240<br><br><br><br> -Section 12b<br><br><br><br> -Subsection 1<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation 12B<br><br><br><br> -Number 240<br><br><br><br> -Section 12b<br><br><br><br> -Subsection 1<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978628625264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings per Share</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Earnings&#160;per Share</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Basic and diluted earnings per share are calculated as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income attributable to Biogen Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">927.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">714.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,749.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,194.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted average number of common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">236.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">236.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Effect of dilutive securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Stock options and employee stock purchase plan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Time-vested restricted stock units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market stock units</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Dilutive potential common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Shares used in calculating diluted earnings per share</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">237.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">237.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts excluded from the calculation of net income per diluted share because their effects were anti-dilutive were not significant.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1278-109256<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 52<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=32703322&amp;loc=d3e4984-109258<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978425219520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events Subsequent Events (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 15, 2015</div></th>
<th class="th"><div>Jul. 31, 2015</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jul. 16, 2015</div></th>
<th class="th"><div>Jul. 02, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 490,728<span></span>
</td>
<td class="nump">$ 447,273<span></span>
</td>
<td class="nump">$ 951,277<span></span>
</td>
<td class="nump">$ 976,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=biib_AGTCMember', window );">AGTC | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_Purchaseofcommonstock', window );">Purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LicenseCosts', window );">Total licensing and fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately', window );">Potential future milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=biib_EisaiMember', window );">Eisai | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_TermOfLease', window );">Term of lease</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=biib_SwedishOrphanBiovitrumMember', window );">Swedish Orphan Biovitrum | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_AdditionalMilestonePayment', window );">Additional milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductOrServiceAxis=biib_LeadprogramsMember', window );">Lead programs | AGTC | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately', window );">Potential future milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">472,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductOrServiceAxis=biib_DiscoveryprogramsMember', window );">Discovery programs | AGTC | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately', window );">Potential future milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 592,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_AdditionalMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional milestone payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_AdditionalMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential future milestone payments commitment to third party approximately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_Purchaseofcommonstock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_Purchaseofcommonstock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_TermOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Of Lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_TermOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LicenseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.2(e))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LicenseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 730<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Research and Development<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=biib_AGTCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=biib_AGTCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=biib_EisaiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=biib_EisaiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=biib_SwedishOrphanBiovitrumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=biib_SwedishOrphanBiovitrumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductOrServiceAxis=biib_LeadprogramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductOrServiceAxis=biib_LeadprogramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductOrServiceAxis=biib_DiscoveryprogramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductOrServiceAxis=biib_DiscoveryprogramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978494127968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax', window );">Tax effect on net unrealized gains (losses) recognized on securities available for sale</a></td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 4,029<span></span>
</td>
<td class="nump">$ 621<span></span>
</td>
<td class="nump">$ 3,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax', window );">Tax effect of net unrealized gains (losses) recognized on foreign currency forward contracts</a></td>
<td class="nump">$ 454<span></span>
</td>
<td class="nump">$ 260<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 10A<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e640-108580<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 10A<br><br><br><br> -Subparagraph (d)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e640-108580<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978679379472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Intangible Assets and Goodwill</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Intangible Assets</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Intangible assets, net of accumulated amortization, impairment charges and adjustments, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26" rowspan="1"></td></tr><tr><td width="21%" rowspan="1" colspan="1"></td><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Life</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Out-licensed patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">13-23 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">543.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(493.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">49.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">543.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(481.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">61.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Developed&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">15-23&#160;years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,005.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2,492.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">513.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,005.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2,396.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">608.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In-process research and development</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Indefinite until commercialization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">752.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">752.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">314.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">314.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Trademarks&#160;and&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">tradenames</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Indefinite</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">64.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">64.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">64.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">64.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired and in-licensed&#160;rights&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">and&#160;patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3-17 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,296.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(380.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,916.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,280.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(300.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,980.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7,661.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(3,366.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,294.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7,207.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3,178.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,028.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, amortization of acquired intangible assets totaled </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$92.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$187.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, as compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$116.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$260.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in the prior year comparative periods. For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same periods in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in amortization of acquired intangible assets was primarily driven by a decrease in AVONEX and TYSABRI revenues during the comparative periods and higher expected lifetime revenues of TYSABRI as discussed below. Amortization of acquired intangible assets during the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> also includes a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$34.7 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> impairment charge related to one of our out-licensed patents. </font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Developed Technology</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Developed technology primarily relates to our AVONEX product, which was recorded in connection with the merger of Biogen, Inc. and IDEC Pharmaceuticals Corporation in 2003. The net book value of this asset as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$504.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">In-process Research and Development (IPR&amp;D)</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">IPR&amp;D represents the fair value assigned to research and development assets that we acquire that have not reached technological feasibility at the date of acquisition. Upon commercialization, we will determine the estimated useful life. In connection with our acquisition of Convergence in February 2015, we acquired IPR&amp;D programs with an estimated fair value of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$424.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. This amount will be adjusted for foreign exchange rate fluctuations. For a more detailed description of this transaction, please read Note 2, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Acquisitions</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to these condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Acquired and In-licensed Rights and Patents</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired and in-licensed rights and patents primarily relate to our acquisition of the TYSABRI rights from Elan Corporation plc (Elan). Elan was acquired by Perrigo Company plc (Perrigo) in December 2013. The net book value of this asset as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$2,851.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Estimated Future Amortization of Intangible Assets </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our amortization expense is based on the economic consumption of intangible assets. Our most significant intangible assets are related to our AVONEX and TYSABRI products. Annually, during our long-range planning cycle, we perform an analysis of anticipated lifetime revenues of AVONEX and TYSABRI. This analysis is also updated whenever events or changes in circumstances would significantly affect the anticipated lifetime revenues of either product.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our most recent long range planning cycle was updated in the third quarter of 2014. Our analysis included an increase in the expected future product revenues of TYSABRI, resulting in a decrease in the rate of amortization expense as compared to prior quarters. Our analysis also included a decrease in the expected future product revenues of AVONEX. The results of our TYSABRI and AVONEX analyses were impacted by changes in the estimated impact of TECFIDERA, as well as other existing and potential oral and alternative MS formulations, including PLEGRIDY, that may compete with TYSABRI and AVONEX. Based upon this recent analysis, the estimated future amortization for acquired intangible assets is expected to be as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015 (remaining six months)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">185.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">312.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">285.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">281.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">270.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">263.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,599.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table provides a roll forward of the changes in our goodwill balance:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,760.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increase to goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">390.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,154.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The increase in goodwill during the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> was related to a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$300.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> contingent payment achieved (exclusive of a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$38.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> tax benefit) and to be paid to former shareholders of Fumapharm AG or holders of their rights and our acquisition of Convergence. Other includes changes related to foreign exchange. For additional information related to future contingent payments to the former shareholders of Fumapharm AG or holders of their rights, please read Note 18, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Commitments and Contingencies</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to these condensed consolidated financial statements. For additional information related to our acquisition of Convergence, please read Note 2, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Acquisitions</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to these condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we had </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">no</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> accumulated impairment losses related to goodwill.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final.  May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16373-109275<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16265-109275<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978626915440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Inventory</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The components of inventory are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">173.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">128.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">516.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">511.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">175.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">164.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total inventory</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">865.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">804.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, our inventory included </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$35.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> associated with our ZINBRYTA and biosimilar programs, which have been capitalized in advance of regulatory approval. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, our inventory included </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$6.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> associated with our ZINBRYTA program, which had been capitalized in advance of regulatory approval.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.6)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 6<br><br><br><br> -Subparagraph a, b, c<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978503453984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborative and Other Relationships<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaborative and Other Relationships</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Collaborative and Other Relationships</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Samsung Bioepis</font></div><div style="line-height:120%;padding-top:6px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Joint Venture Agreement</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In February 2012, we entered into a joint venture agreement with Samsung BioLogics Co. Ltd. (Samsung Biologics), establishing an entity, Samsung Bioepis, to develop, manufacture and market biosimilar pharmaceuticals.&#160;Samsung Biologics contributed </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">280.5 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> South Korean won (approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$250.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">) for an </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">85%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> stake in Samsung Bioepis and we contributed approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">49.5 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> South Korean won (approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$45.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">) for the remaining </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">15%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> ownership interest.&#160;Under the joint venture agreement, we have no obligation to provide any additional funding and our ownership interest may be diluted due to financings in which we do not participate. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, our ownership interest is approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, which reflects our additional contribution of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.3 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> South Korean won (approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$5.7 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">) in the first quarter of 2015 and the effect of additional equity financings in which we did not participate. We maintain an option to purchase additional stock in Samsung Bioepis that would allow us to increase our ownership percentage up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">49.9%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">.&#160;The exercise of this option is within our control and is based on paying for </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">49.9%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of the total investment made by Samsung Biologics into Samsung Bioepis in excess of what we have already contributed under the agreement plus interest.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the carrying value of our investment in Samsung Bioepis totaled </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7.5 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9.1 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> South Korean won (approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$6.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$8.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">), respectively, which is classified as a component of investments and other assets within our condensed consolidated balance sheets. Based on our level of influence over Samsung Bioepis, we account for this investment under the equity method of accounting and we recognize our share of the results of operations related to our investment in Samsung Bioepis one quarter in arrears when the results of the entity become available, which is reflected as equity in loss of investee, net of tax within our condensed consolidated statements of income. During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we recognized a loss on our investment of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$4.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$5.7 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, as compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$9.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in the prior year comparative periods.</font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Commercial Agreement</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On December 17, 2013, pursuant to our rights under the joint venture agreement with Samsung Biologics, we entered into an agreement with Samsung Bioepis to commercialize anti-tumor necrosis factor (TNF) biosimilar product candidates in Europe and, in the case of one anti-TNF biosimilar candidate, Japan.&#160;Under the terms of this agreement, we have paid </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$46.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, which has been recorded as a research and development expense within our condensed consolidated statements of income as the programs they relate to have not achieved regulatory approval. Samsung Bioepis is eligible to receive an additional </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$75.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in additional milestones related to clinical development and regulatory approval of the product candidates. Upon commercialization, there will be a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">50%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> profit share with Samsung Bioepis.</font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Other Services</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Simultaneous with the formation of Samsung Bioepis, we also entered into a license agreement, a technical development services agreement and a manufacturing agreement with Samsung Bioepis. For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we recognized </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$17.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$36.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in other revenues in relation to these services, as compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$12.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$36.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in the prior year comparative periods. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For additional information related to our other significant collaboration arrangements, please read Note 20, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Collaborative and Other Relationships</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 808<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978503491872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-based Payments</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Share-based Payments</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Share-based Compensation Expense</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes share-based compensation expense included within our condensed consolidated statements of income:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">22.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">57.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">53.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">26.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">33.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">81.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">80.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Subtotal</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">48.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">58.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">139.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">134.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Capitalized share-based compensation costs </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation expense included in total cost and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">46.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">55.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">133.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">129.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax effect</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(12.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(16.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(39.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(38.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation expense included in net income attributable to Biogen Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">33.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">39.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">94.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">90.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">9.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">26.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">23.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Time-vested restricted stock units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">31.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">29.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">63.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">58.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash settled performance units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">14.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">27.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Performance units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">14.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee stock purchase plan</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">8.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Subtotal</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">48.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">58.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">139.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">134.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Capitalized share-based compensation costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation expense included in total cost and expenses</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">46.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">55.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">133.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">129.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Grants Under Share-based Compensation Plans</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes our equity grants to employees, officers and directors under our current stock plans:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market stock units</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">179,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">222,000</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash settled performance shares</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">115,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">180,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Performance units</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">89,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">50,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Time-vested restricted stock units</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">375,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">418,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Employee Stock Purchase Plan (ESPP)</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In June 2015, our stockholders approved the Biogen Inc. 2015 Employee Stock Purchase Plan (ESPP). The ESPP, which became effective on July 1, 2015, replaced the Biogen Idec Inc. 1995 ESPP (1995 ESPP), which expired on June&#160;30, 2015. The maximum aggregate number of shares of our common stock that may be purchased under the ESPP is </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6,200,000</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">98,000</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> shares were issued under our 1995 ESPP compared to approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">112,000</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;shares issued in the prior year comparative period.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 40<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6418621&amp;loc=d3e17540-113929<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 50<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51659978&amp;loc=d3e25284-112666<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 14<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426807680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Derivative Instruments</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Foreign Currency Forward Contracts - Hedging Instruments</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due to the global nature of our operations, portions of our revenues are earned in currencies other than the U.S.&#160;dollar. The value of revenues measured in U.S.&#160;dollars is therefore subject to changes in foreign currency exchange rates. In order to mitigate these changes we use foreign currency forward contracts to lock in exchange rates associated with a portion of our forecasted international revenues.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Foreign currency forward contracts in effect as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> had durations of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">18 months</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">15 months</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. These contracts have been designated as cash flow hedges and accordingly, to the extent effective, any unrealized gains or losses on these foreign currency forward contracts are reported in accumulated other comprehensive income (loss) (referred to as AOCI in the tables below). Realized gains and losses for the effective portion of such contracts are recognized in revenue when the sale of product in the currency being hedged is recognized. To the extent ineffective, hedge transaction gains and losses are reported in other income (expense), net.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The notional value of foreign currency forward contracts that were entered into to hedge forecasted revenues is summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="69%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Notional Amount</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Foreign Currency: (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Euro</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,437.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,174.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Canadian dollar</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">32.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">56.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">British pound sterling</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">21.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">34.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Japanese yen</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">15.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">16.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Australian dollar</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">10.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">19.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,517.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,302.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The portion of the fair value of these foreign currency forward contracts that was included in accumulated other comprehensive income (loss) within total equity reflected gains of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$63.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$72.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. We expect all contracts to be settled over the next </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">18</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months and any amounts in accumulated other comprehensive income (loss) to be reported as an adjustment to revenue. We consider the impact of our and our counterparties&#8217; credit risk on the fair value of the contracts as well as the ability of each party to execute its contractual obligations. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, credit risk did not change the fair value of our foreign currency forward contracts.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the effect of derivatives designated as hedging instruments on our condensed consolidated statements of income:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td width="20%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="19%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months Ended June 30,</font></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Reclassified from AOCI into Operating Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Recognized into Net Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Ineffective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td width="20%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="19%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months Ended June 30,</font></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Reclassified from AOCI into Operating Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Recognized into Net Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Ineffective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">75.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(10.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Foreign Currency Forward Contracts - Other Derivatives</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We also enter into other foreign currency forward contracts, usually with one month durations, to mitigate the foreign currency risk related to certain balance sheet positions. We have not elected hedge accounting for these transactions.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The aggregate notional amount of these outstanding foreign currency contracts was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$472.4 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$365.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. Net gains of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$13.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$3.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> related to these contracts were recognized as a component of other income (expense), net, for </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, as compared to net losses of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$2.4 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$3.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in the prior year comparative periods.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Summary of Derivatives</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">While certain of our derivatives are subject to netting arrangements with our counterparties, we do not offset derivative assets and liabilities within our condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the fair value and presentation in our condensed consolidated balance sheets of our outstanding derivatives including those designated as hedging instruments:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="43%" rowspan="1" colspan="1"></td><td width="42%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Balance Sheet Location</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">Fair Value As of June 30, 2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Hedging Instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">92.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">17.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Other Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Balance Sheet Location</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair Value As of December 31, 2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Hedging Instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">69.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Investments and other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Other Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6441202&amp;loc=d3e80720-113993<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4C<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624171-113959<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=d3e41620-113959<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4B<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624163-113959<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5579240-113959<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4D<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624177-113959<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35736893&amp;loc=d3e80784-113994<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=d3e41641-113959<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5579245-113959<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4H<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624258-113959<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35736893&amp;loc=d3e80748-113994<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4K<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5708775-113959<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4J<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5708773-113959<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5618551-113959<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1B<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5580258-113959<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4E<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624181-113959<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 25<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6886632&amp;loc=d3e76258-113986<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=d3e41638-113959<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(n))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978490071280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments Financial Instruments (Details Textual 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_StrategicInvestmentsMember', window );">Strategic Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_StrategicInvestmentPortfolio', window );">Strategic investment portfolio</a></td>
<td class="nump">$ 45.3<span></span>
</td>
<td class="nump">$ 47.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_StrategicInvestmentPortfolio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Strategic investment portfolio.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_StrategicInvestmentPortfolio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_StrategicInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=biib_StrategicInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978503472192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The tables below present information about our assets and liabilities that are regularly measured and carried at fair value and indicate the level within the fair value hierarchy of the valuation techniques we utilized to determine such fair value:</font></div><div style="line-height:120%;padding-top:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of June 30, 2015 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Quoted&#160;Prices</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">in Active</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant&#160;Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Observable&#160;Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">974.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">974.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable debt securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,198.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,198.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,700.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,700.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">290.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">290.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">100.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">100.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Plan assets for deferred compensation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,310.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4,303.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">27.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">27.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">523.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">27.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2014 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Quoted&#160;Prices</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">in Active</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">716.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">716.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable debt securities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,063.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,063.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">849.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">849.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">198.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">198.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">72.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">72.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Plan assets for deferred compensation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,943.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,937.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">215.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">215.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">220.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">215.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">There have been </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">no</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> material impairments of our assets measured and carried at fair value during the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. In addition, there were </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">no</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> changes in valuation techniques or inputs utilized or transfers between fair value measurement levels during the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. The fair value of Level 2 instruments classified as cash equivalents and marketable debt securities was determined through third party pricing services. For a description of our validation procedures related to prices provided by third party pricing services, refer to Note 1, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Summary of Significant Accounting Policies: Fair Value Measurements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K. For additional information related to our decision to no longer reflect our investments in venture capital funds within the fair value hierarchy, refer to Note 1, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Summary of Significant Accounting Policies: New Accounting Pronouncements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, to these condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Debt Instruments</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The fair and carrying values of our debt instruments, which are Level&#160;2 liabilities, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Notes payable to Fumedica</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">10.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">9.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">11.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.875% Senior Notes due March&#160;1, 2018</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">621.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">570.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">634.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">573.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">631.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">579.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">647.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">585.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The fair value of our notes payable to Fumedica was estimated using market observable inputs, including current interest and foreign currency exchange rates. The fair value of our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.875%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Senior Notes was determined through market, observable, and corroborated sources. For additional information related to our debt instruments, please read Note 12, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Indebtedness</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Contingent Consideration Obligations</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table provides a roll forward of the fair values of our contingent consideration obligations which includes Level 3 measurements:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value, beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">461.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">275.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">215.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">280.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Additions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">36.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">274.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Changes in fair value</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">279.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">279.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$302.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$200.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, of the fair value of our total contingent consideration obligations were reflected as components of other long-term liabilities within our condensed consolidated balance sheets with the remaining balances reflected as a component of accrued expenses and other. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In connection with our acquisition of Convergence, we recorded a liability of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$274.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, representing the fair value of the contingent consideration. This valuation was based on probability weighted net cash outflow projections of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$450.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, discounted using a rate of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, which is the estimated cost of debt financing for market participants. This liability reflects the revised estimate from the date of acquisition for our initial clinical development plans, resulting probabilities of success and the timing of certain milestone payments. For a more detailed description of this transaction, please read Note 2, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Acquisitions</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to these condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Acquired IPR&amp;D</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In connection with our acquisition of Convergence, we also allocated </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$424.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of the total purchase price to acquired IPR&amp;D, which was capitalized as an intangible asset. The amount allocated to acquired IPR&amp;D was based on significant inputs not observable in the market and thus represented a Level 3 fair value measurement. This estimate was also adjusted from our preliminary estimate as of the date of acquisition to reflect revised estimates to our initial clinical development plans, resulting probabilities of success and the timing of certain milestone payments. These assets will be tested for impairment annually until commercialization, after which time the IPR&amp;D will be amortized over its estimated useful life. For a more detailed description of this transaction, please read Note 2, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Acquisitions</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to these condensed consolidated financial statements.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 30<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 21<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13537-108611<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 16<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13504-108611<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 10<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13433-108611<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978639357296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Financial Instruments</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Financial Instruments</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Marketable Securities</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following tables summarize our marketable debt and equity securities:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of June 30, 2015 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Available-for-sale:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">375.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">375.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">822.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">823.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">710.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">710.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">989.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">989.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">289.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">289.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total marketable debt securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,188.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,188.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities, non-current</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2014 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Available-for-sale:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">370.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">370.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">692.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">693.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">269.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">270.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">579.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">580.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">198.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">198.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total marketable debt securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,111.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,112.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities, non-current</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes our financial assets with maturities of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">less than 90&#160;days</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> from the date of purchase included within cash and cash equivalents on the accompanying condensed consolidated balance sheet:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Commercial paper</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">38.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">54.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Overnight reverse repurchase agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">185.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">305.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Money market funds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">740.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">321.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Short-term debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">10.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">974.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">716.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The carrying values of our commercial paper, including accrued interest, overnight reverse repurchase agreements, money market funds and our short-term debt securities approximate fair value due to their short term maturities. Our overnight reverse repurchase agreements are collateralized with agency-guaranteed mortgage securities and represent approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.1%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of total assets as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Summary of Contractual Maturities: Available-for-Sale Securities</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The estimated fair value and amortized cost of our marketable debt securities available-for-sale by contractual maturity are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due in one year or less</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,086.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,086.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">640.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">640.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due after one year through five years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,954.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,954.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,343.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,345.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due after five years</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">147.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">147.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">126.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">126.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,188.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,188.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,111.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,112.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The average maturity of our marketable debt securities available-for-sale as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> was approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">17 months</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">15 months</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Proceeds from Marketable Debt Securities</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The proceeds from maturities and sales of marketable debt securities and resulting realized gains and losses are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Proceeds from maturities and sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">601.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">560.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">975.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,317.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Realized gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Realized losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Strategic Investments</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, our strategic investment portfolio was comprised of investments totaling </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$45.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$47.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, which are included in investments and other assets in our accompanying condensed consolidated balance sheets. Our strategic investment portfolio includes investments in equity securities of certain biotechnology companies and investments in venture capital funds where the underlying investments are in equity securities of biotechnology companies.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426953024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Equity</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total equity as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> increased </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1,759.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. This increase was driven by net income attributable to Biogen Inc. and an increase in additional paid in capital resulting from our share-based compensation arrangements, partially offset by other comprehensive losses and a reduction in additional paid-in-capital resulting from the repurchase and retirement of common stock as described below. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Share Repurchases</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2015, our Board of Directors authorized a program to repurchase up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$5.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of our common stock (2015 Share Repurchase Program). This authorization does not have an expiration date. We expect that purchases will be executed within a period of up to five years and that repurchased shares will be retired. The 2015 Share Repurchase Program is in addition to the approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> shares remaining under our February 2011 Share Repurchase Program (2011 Share Repurchase Program), which has been used principally to offset common stock issuances under our share-based compensation plans.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we repurchased and retired approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> shares of common stock at a cost of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$42.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> under our 2015 Share Repurchase Program and did not repurchase any shares of common stock under our 2011 Share Repurchase Program. During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we purchased approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> shares of common stock at a cost of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$336.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> under our 2011 Share Repurchase Program. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Noncontrolling Interests</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table reconciles equity attributable to noncontrolling interests (NCI):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">NCI, beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) attributable to NCI, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of net assets and liabilities acquired and assigned to NCI</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Distribution to NCI</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(9.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(9.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Translation adjustment and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">NCI, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 4<br><br><br><br> -Subparagraph (SAB TOPIC 4.C)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Preferred Stock<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section C<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978423269856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated other comprehensive income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="num">$ (101,025)<span></span>
</td>
<td class="num">$ (26,700)<span></span>
</td>
<td class="num">$ (101,025)<span></span>
</td>
<td class="num">$ (26,700)<span></span>
</td>
<td class="num">$ (59,488)<span></span>
</td>
<td class="num">$ (27,700)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income loss before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,300<span></span>
</td>
<td class="num">(2,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74,800)<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income loss</a></td>
<td class="num">(30,487)<span></span>
</td>
<td class="num">(4,322)<span></span>
</td>
<td class="num">(41,537)<span></span>
</td>
<td class="nump">1,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Accumulated Net Unrealized Investment Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated other comprehensive income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="num">(400)<span></span>
</td>
<td class="nump">5,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income loss before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="num">(6,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="num">(5,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated other comprehensive income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="nump">62,800<span></span>
</td>
<td class="num">(7,100)<span></span>
</td>
<td class="nump">62,800<span></span>
</td>
<td class="num">(7,100)<span></span>
</td>
<td class="nump">71,700<span></span>
</td>
<td class="num">(23,700)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income loss before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,100<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75,000)<span></span>
</td>
<td class="nump">10,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,900)<span></span>
</td>
<td class="nump">16,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Accumulated Defined Benefit Plans Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated other comprehensive income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="num">(27,500)<span></span>
</td>
<td class="num">(19,000)<span></span>
</td>
<td class="num">(27,500)<span></span>
</td>
<td class="num">(19,000)<span></span>
</td>
<td class="num">(31,600)<span></span>
</td>
<td class="num">(19,600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income loss before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated other comprehensive income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="num">$ (137,000)<span></span>
</td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="num">(137,000)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">$ (99,200)<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income loss before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,800)<span></span>
</td>
<td class="num">(11,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (37,800)<span></span>
</td>
<td class="num">$ (11,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e681-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669686-108580<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51821188&amp;loc=d3e1436-108581<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669686-108580<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669619-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1B<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669625-108580<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51821188&amp;loc=d3e1436-108581<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669686-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51821188&amp;loc=d3e1436-108581<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426695648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share (Details) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Biogen Inc</a></td>
<td class="nump">$ 927,276<span></span>
</td>
<td class="nump">$ 714,506<span></span>
</td>
<td class="nump">$ 1,749,817<span></span>
</td>
<td class="nump">$ 1,194,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares used in calculating:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding</a></td>
<td class="nump">235,286<span></span>
</td>
<td class="nump">236,661<span></span>
</td>
<td class="nump">235,122<span></span>
</td>
<td class="nump">236,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive potential common shares</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in calculating diluted earnings per share</a></td>
<td class="nump">235,718<span></span>
</td>
<td class="nump">237,401<span></span>
</td>
<td class="nump">235,671<span></span>
</td>
<td class="nump">237,634<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=biib_StockOptionsAndEmployeeStockPurchasePlanMember', window );">Stock options and employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock units</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=biib_TimeVestedRestrictedStockUnitsMember', window );">Time-vested restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock units</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=biib_MarketStockUnitsMember', window );">Market stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock units</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1500-109256<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 16<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1505-109256<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 10<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1448-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Weighted-Average Number of Common Shares Outstanding<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=biib_StockOptionsAndEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=biib_StockOptionsAndEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=biib_TimeVestedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=biib_TimeVestedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=biib_MarketStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=biib_MarketStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978507245952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details Textual) - USD ($)<br> $ in Thousands, shares in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_EquityTextualAbstract', window );"><strong>Equity (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Equity increase during the period</a></td>
<td class="nump">$ 1,759,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Common stock value authorized for repurchase</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased', window );">Common stock shares authorized remaining or repurchase</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock shares repurchased</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury stock</a></td>
<td class="nump">$ 42,193<span></span>
</td>
<td class="nump">$ 336,905<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_EquityTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_EquityTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 15<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in stockholders' equity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30<br><br><br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426394992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Foreign currency forward contracts that were entered into to hedge forecasted revenue</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The notional value of foreign currency forward contracts that were entered into to hedge forecasted revenues is summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="69%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Notional Amount</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Foreign Currency: (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Euro</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,437.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,174.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Canadian dollar</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">32.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">56.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">British pound sterling</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">21.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">34.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Japanese yen</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">15.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">16.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Australian dollar</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">10.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">19.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,517.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,302.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Summary of the effect of derivatives designated as hedging instruments on the condensed consolidated statements of income</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the effect of derivatives designated as hedging instruments on our condensed consolidated statements of income:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td width="20%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="19%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months Ended June 30,</font></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Reclassified from AOCI into Operating Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Recognized into Net Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Ineffective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">40.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td width="20%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="19%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months Ended June 30,</font></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Reclassified from AOCI into Operating Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Recognized into Net Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Ineffective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">75.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(10.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"></font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Summary of fair value and presentation of derivatives</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the fair value and presentation in our condensed consolidated balance sheets of our outstanding derivatives including those designated as hedging instruments:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="43%" rowspan="1" colspan="1"></td><td width="42%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Balance Sheet Location</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">Fair Value As of June 30, 2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Hedging Instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">92.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">17.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Other Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Balance Sheet Location</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair Value As of December 31, 2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Hedging Instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">69.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Investments and other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Other Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4C<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624171-113959<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4A<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5618551-113959<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4B<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624163-113959<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1A<br><br><br><br> -Subparagraph (d)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5579245-113959<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978423461472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Mar. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable debt securities</a></td>
<td class="nump">$ 3,188.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,111.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">974.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">716.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Derivative contracts</a></td>
<td class="nump">100.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PlanAssetsForDeferredCompensationFairValueDisclosure', window );">Plan assets for deferred compensation</a></td>
<td class="nump">40.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">4,310.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,943.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Derivative contracts</a></td>
<td class="nump">27.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration obligations</a></td>
<td class="nump">495.6<span></span>
</td>
<td class="nump">$ 461.8<span></span>
</td>
<td class="nump">215.5<span></span>
</td>
<td class="nump">$ 279.1<span></span>
</td>
<td class="nump">$ 275.1<span></span>
</td>
<td class="nump">$ 280.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">523.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable debt securities</a></td>
<td class="nump">1,198.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,063.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable debt securities</a></td>
<td class="nump">1,700.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">849.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Mortgage and other asset backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable debt securities</a></td>
<td class="nump">290.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets, Level 1 | Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Derivative contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PlanAssetsForDeferredCompensationFairValueDisclosure', window );">Plan assets for deferred compensation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Derivative contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration obligations</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets, Level 1 | Fair Value, Measurements, Recurring | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets, Level 1 | Fair Value, Measurements, Recurring | Government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets, Level 1 | Fair Value, Measurements, Recurring | Mortgage and other asset backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">974.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">716.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Derivative contracts</a></td>
<td class="nump">100.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PlanAssetsForDeferredCompensationFairValueDisclosure', window );">Plan assets for deferred compensation</a></td>
<td class="nump">40.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">4,303.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,937.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Derivative contracts</a></td>
<td class="nump">27.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration obligations</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">27.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable debt securities</a></td>
<td class="nump">1,198.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,063.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring | Government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable debt securities</a></td>
<td class="nump">1,700.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">849.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring | Mortgage and other asset backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable debt securities</a></td>
<td class="nump">290.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Derivative contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PlanAssetsForDeferredCompensationFairValueDisclosure', window );">Plan assets for deferred compensation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Derivative contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration obligations</a></td>
<td class="nump">495.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">495.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring | Government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring | Mortgage and other asset backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable debt securities</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_PlanAssetsForDeferredCompensationFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of all assets of deferred compensation plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_PlanAssetsForDeferredCompensationFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51813488&amp;loc=d3e22054-111558<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -Subparagraph (aa)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27232-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49167202&amp;loc=d3e26610-111562<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph b<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Trading Securities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6526789<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27723805&amp;loc=d3e24584-111560<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51813488&amp;loc=d3e22054-111558<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Available-for-Sale Securities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505594<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph a, f, g<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978503550144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Consolidated Financial Statement Detail<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Other Consolidated Financial Statement Detail</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Other Consolidated Financial Statement Detail</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Other Income (Expense), Net</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Components of other income (expense), net, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(7.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(12.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(14.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gain (loss) on investments, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">13.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">16.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Foreign exchange gains (losses), net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(14.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(4.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(8.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total other income (expense), net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(10.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(25.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Other Current Assets</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets includes prepaid taxes totaling approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$280.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$57.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Accrued Expenses and Other</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other consists of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current portion of contingent consideration obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">493.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">265.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue-related rebates</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">446.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">359.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee compensation and benefits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">214.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">393.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Royalties and licensing fees</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">161.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">172.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">62.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">120.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">433.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">507.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total accrued expenses and other</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,812.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,819.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Other Long-Term Liabilities</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other long-term liabilities consist of the following:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">302.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">200.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee compensation and benefits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">224.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">200.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">389.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">249.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total other long-term liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">915.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">650.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Pricing of TYSABRI in Italy - AIFA</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the fourth quarter of 2011, Biogen Italia SRL (formerly Biogen Idec Italia SRL), our Italian subsidiary,&#160;received notice from the Italian National Medicines Agency (Agenzia Italiana del Farmaco or AIFA) that sales of TYSABRI after mid-February 2009 exceeded a reimbursement limit established pursuant to a Price Determination Resolution granted by AIFA in December 2006. In December 2011, we filed an appeal against AIFA in administrative court in Rome, Italy seeking a ruling that the reimbursement limit is unenforceable. That appeal is pending. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In June 2014, AIFA approved a resolution, effective for a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> month term, setting the price for TYSABRI in Italy.&#160;This resolution also eliminated the reimbursement limit from February 2013 going forward. As a result, in June 2014, we recognized </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$53.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of TYSABRI revenues related to the periods beginning February 2013 that were previously deferred. In October 2014, we proposed a settlement to resolve all of AIFA's claims relating to sales of TYSABRI in excess of the reimbursement limit for the period from mid-February 2009 through January 2013 for an aggregate lump sum repayment of EUR</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. The settlement agreement was sent to the Avvocatura Generale dello Stata (Attorney General) for its opinion. In June 2015, the Attorney General chose not to approve the settlement. AIFA and Biogen Italia SRL continue to discuss a possible resolution for this period. We have approximately EUR</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">75 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> recorded as accrued expenses and deferred revenue included within our long-term liabilities within our condensed consolidated balance sheets for this matter.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For additional information relating to our agreement with AIFA relating to sales of TYSABRI in Italy, please read Note 4, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Accounts Receivable</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978623086320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Subsequent Events</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Applied Genetic Technologies Corporation</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On July 2, 2015, we announced a collaboration and license agreement to develop gene-based therapies for multiple ophthalmic diseases with Applied Genetic Technologies Corporation (AGTC). The collaboration will focus on the development of a portfolio of AGTC&#8217;s therapeutic programs, including both a clinical stage candidate for X-linked Retinoschisis (XLRS) and a pre-clinical candidate for the treatment of X-Linked Retinitis Pigmentosa (XLRP). The agreement also includes options for early stage discovery programs in two ophthalmic diseases and one non-ophthalmic condition, as well as an equity investment in AGTC by Biogen and a license agreement for manufacturing rights.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Upon closing, we will make an upfront payment in the amount of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$124.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to AGTC, which includes a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$30.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> equity investment in AGTC, prepaid research and development expenditures of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$58.4 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and total licensing and other fees of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$35.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. We will be granted a license to the XLRS and XLRP programs and the option to license discovery programs for three additional indications at the time of clinical candidate selection.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Under the collaboration, AGTC is eligible to receive upfront and milestone payments aggregating in excess of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. This includes up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$472.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> collectively for the two lead programs, which also will carry royalties in the high single digit to mid-teen percentages of annual net sales. In addition, we will make payments up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$592.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> across the discovery programs, along with royalties in the mid-single digits to low-teen percentages of annual net sales.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We will be granted worldwide commercialization rights for the XLRS and XLRP programs. AGTC has an option to share development costs and profits after the initial clinical trial data are available, and an option to co-promote the second of these products to be approved in the U.S. AGTC will lead the clinical development programs of XLRS through product approval and of XLRP through the completion of first-in-human trials. We will support the clinical development costs, subject to certain conditions, following the first-in-human study for XLRS and IND-enabling studies for XLRP. Under the manufacturing license, we will receive an exclusive license to use AGTC&#8217;s proprietary technology platform to make AAV vectors for up to six genes, three of which are in AGTC&#8217;s discretion, in exchange for payment of milestones and royalties.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The transaction is subject to customary closing conditions, including the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in the U.S., and is expected to close in the third quarter of 2015.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Research Triangle Park Facility Purchase</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On July 15, 2015, we entered into an arrangement with Eisai, Inc. (Eisai) to purchase their manufacturing facility in Research Triangle Park, North Carolina, including a drug product facility and supporting infrastructure.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Currently, we are leasing a portion of this facility in order to manufacture our and Eisai's oral solid dose products under a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> year lease. We have committed to buy that portion of the facility upon Eisai&#8217;s completion of certain transition activities.&#160; </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The transaction is subject to customary closing conditions, including the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in the U.S., and is expected to close in the third quarter of 2015.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Swedish Orphan Biovitrum AB</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On July 16, 2015, Swedish Orphan Biovitrum AB (Sobi) exercised its option to assume development and commercialization of ALPROLIX in Europe, Russia, Turkey and certain markets in the Middle East and paid us </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$10.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, which will be held in escrow pending E.U. regulatory approval.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We collaborate with Sobi to jointly develop and commercialize Factor VIII and Factor IX hemophilia products, including ELOCTATE and ALPROLIX. For more information about our agreement with Sobi, please read Note 20, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Collaborative and Other Relationships</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to our consolidated financial statements included within our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978423753792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Feb. 12, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Total intangible assets, gross</a></td>
<td class="nump">$ 7,661,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,661,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,207,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(3,366,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,366,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,178,600)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">4,294,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,294,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,028,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Intangible Assets and Goodwill (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">92,004<span></span>
</td>
<td class="nump">$ 116,826<span></span>
</td>
<td class="nump">187,907<span></span>
</td>
<td class="nump">$ 260,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses related to goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Expected future amortization expense, 2015 (remaining six months)</a></td>
<td class="nump">185,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Expected future amortization expense, 2016</a></td>
<td class="nump">312,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Expected future amortization expense, 2017</a></td>
<td class="nump">285,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Expected future amortization expense, 2018</a></td>
<td class="nump">281,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Expected future amortization expense, 2019</a></td>
<td class="nump">270,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Expected future amortization expense, 2020</a></td>
<td class="nump">263,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_Finitelivedintangibleassetsfutureamortization', window );">Total</a></td>
<td class="nump">1,599,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,599,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=biib_OutLicensedPatentsMember', window );">Out-licensed patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">543,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">543,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">543,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(493,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(493,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(481,700)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">49,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of out-licensed patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=biib_OutLicensedPatentsMember', window );">Out-licensed patents | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated life, (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=biib_OutLicensedPatentsMember', window );">Out-licensed patents | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated life, (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">23 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">3,005,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,005,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,005,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,492,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,492,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,396,800)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">513,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 513,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">608,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated life, (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated life, (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">23 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology | AVONEX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">504,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 504,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=biib_InLicensedPatentsMember', window );">Acquired and in-licensed rights and patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">3,296,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,296,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,280,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(380,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(380,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300,100)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">2,916,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,916,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,980,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=biib_InLicensedPatentsMember', window );">Acquired and in-licensed rights and patents | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated life, (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=biib_InLicensedPatentsMember', window );">Acquired and in-licensed rights and patents | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated life, (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_IndefiniteLivedIntangibleAssetsUsefulLife', window );">Indefinite lived intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Cost and Net</a></td>
<td class="nump">752,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 752,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">314,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_IndefiniteLivedIntangibleAssetsUsefulLife', window );">Indefinite lived intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Cost and Net</a></td>
<td class="nump">64,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember', window );">Convergence Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">In-process research and development and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 424,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=biib_TysabriProductMember', window );">TYSABRI product | Acquired and in-licensed rights and patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 2,851,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,851,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_Finitelivedintangibleassetsfutureamortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>FiniteLivedIntangibleAssetsFutureAmortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_Finitelivedintangibleassetsfutureamortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_IndefiniteLivedIntangibleAssetsUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indefinite lived intangible assets useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_IndefiniteLivedIntangibleAssetsUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:durationStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4845-128472<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a,h)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16373-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph ((a)(1),(b))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=biib_OutLicensedPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=biib_OutLicensedPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductOrServiceAxis=biib_AVONEXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductOrServiceAxis=biib_AVONEXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=biib_InLicensedPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=biib_InLicensedPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=biib_ConvergencePharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=biib_TysabriProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=biib_TysabriProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426090576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_InterestInSubsidiary', window );">Interest in subsidiary (less than given percentage)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_PaymentTermsOfAccountsReceivable', window );">Payment terms of accounts receivable arising from product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_MinimumTermForAccountsReceivable', window );">Minimum term for accounts receivable</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_MaximumTermForAccountsReceivable', window );">Maximum term for accounts receivable</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">$ 1,274.2<span></span>
</td>
<td class="nump">$ 1,186.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_InterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest in subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_InterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_MaximumTermForAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum term for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_MaximumTermForAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_MinimumTermForAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum term for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_MinimumTermForAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_PaymentTermsOfAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment  terms of accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_PaymentTermsOfAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:durationStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.14)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978426147120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,282,078<span></span>
</td>
<td class="nump">$ 1,204,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">1,086,595<span></span>
</td>
<td class="nump">640,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">1,310,821<span></span>
</td>
<td class="nump">1,292,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_DueFromUnconsolidatedJointBusiness', window );">Due from unconsolidated joint business, net</a></td>
<td class="nump">323,714<span></span>
</td>
<td class="nump">283,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">865,738<span></span>
</td>
<td class="nump">804,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">750,039<span></span>
</td>
<td class="nump">447,462<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">5,618,985<span></span>
</td>
<td class="nump">4,672,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesNoncurrent', window );">Marketable securities</a></td>
<td class="nump">2,101,796<span></span>
</td>
<td class="nump">1,470,652<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,837,670<span></span>
</td>
<td class="nump">1,765,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">4,294,791<span></span>
</td>
<td class="nump">4,028,507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,154,341<span></span>
</td>
<td class="nump">1,760,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Investments and other assets</a></td>
<td class="nump">751,588<span></span>
</td>
<td class="nump">618,795<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">16,759,171<span></span>
</td>
<td class="nump">14,316,559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current portion of notes payable</a></td>
<td class="nump">3,262<span></span>
</td>
<td class="nump">3,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Taxes payable</a></td>
<td class="nump">457,769<span></span>
</td>
<td class="nump">168,058<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">282,702<span></span>
</td>
<td class="nump">229,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Accrued expenses and other</a></td>
<td class="nump">1,812,099<span></span>
</td>
<td class="nump">1,819,334<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,555,832<span></span>
</td>
<td class="nump">2,219,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes payable</a></td>
<td class="nump">576,207<span></span>
</td>
<td class="nump">582,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Long-term deferred tax liability</a></td>
<td class="nump">138,403<span></span>
</td>
<td class="nump">50,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">915,731<span></span>
</td>
<td class="nump">650,096<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">$ 4,186,173<span></span>
</td>
<td class="nump">$ 3,502,519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Biogen Idec Inc. shareholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.001 per share</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.0005 per share</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">4,251,443<span></span>
</td>
<td class="nump">4,196,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(101,025)<span></span>
</td>
<td class="num">(59,488)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">11,033,736<span></span>
</td>
<td class="nump">9,283,919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost</a></td>
<td class="num">(2,611,706)<span></span>
</td>
<td class="num">(2,611,706)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Biogen Inc. shareholders&#8217; equity</a></td>
<td class="nump">12,572,577<span></span>
</td>
<td class="nump">10,809,010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">5,030<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">12,572,998<span></span>
</td>
<td class="nump">10,814,040<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 16,759,171<span></span>
</td>
<td class="nump">$ 14,316,559<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_DueFromUnconsolidatedJointBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivable from unconsolidated joint business for our share of the pre-tax co-promotion profits generated from our co-promotion arrangement for sales of RITUXAN.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_DueFromUnconsolidatedJointBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.3-4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph a(1)<br><br><br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 4<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e681-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669686-108580<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt and equity securities categorized neither as trading securities nor held-to-maturity securities and intended be sold or mature one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51813488&amp;loc=d3e22054-111558<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49167202&amp;loc=d3e26626-111562<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments in debt and equity securities which are categorized neither as held-to-maturity nor trading and which are intended to be sold or mature more than one year from the balance sheet date or operating cycle, if longer. Such securities are reported at fair value; unrealized gains (losses) related to Available-for-sale Securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income), unless the Available-for-sale security is designated as a hedge or is determined to have had an other than temporary decline in fair value below its amortized cost basis. All or a portion of the unrealized holding gain (loss) of an Available-for-sale security that is designated as being hedged in a fair value hedge is recognized in earnings during the period of the hedge, as are other than temporary declines in fair value below the cost basis for investments in equity securities and debt securities that an entity intends to sell or it is more likely than not that it will be required to sell before the recovery of its amortized cost basis. Other than temporary declines in fair value below the cost basis for debt securities categorized as Available-for-sale that an entity does not intend to sell and for which it is not more likely than not that the entity will be required to sell before the recovery of its amortized cost basis are bifurcated into credit losses and losses related to all other factors. Other than temporary declines in fair value below cost basis related to credit losses are recognized in earnings, and losses related to all other factors are recognized in other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Available-for-Sale Securities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505594<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49167202&amp;loc=d3e26626-111562<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.(a),19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19,20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, netted by jurisdiction and classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e31931-109318<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e31958-109318<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e31917-109318<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph ((a)(1),(b))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.6(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 330<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655945&amp;loc=d3e3927-108312<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19-26)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term debt, net of unamortized discount or premium, including current and noncurrent amounts. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.16)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.16)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20, 22<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 27<br><br><br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount, as of the balance sheet date, of current assets not separately disclosed in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.8)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.24)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 4I<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35736750&amp;loc=SL4590271-111686<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 16<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51664549&amp;loc=SL4568740-111683<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51664549&amp;loc=SL4568447-111683<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19,20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978503455888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reserves for Discounts and Allowances<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract', window );"><strong>Sales Discounts, Returns and Allowances, Goods [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Reserves for discounts and allowances</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Reserves for Discounts and Allowances</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">An analysis of the change in reserves for discounts and allowances is summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Discounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Contractual</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Returns</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">47.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">387.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">49.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">483.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current provisions relating to sales in current year</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">209.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">854.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">19.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,082.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adjustments relating to prior years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(19.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(8.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(27.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments/credits relating to sales in current year</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(158.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(483.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(642.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments/credits relating to sales in prior years</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(43.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(254.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(7.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(305.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">55.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">483.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">51.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">590.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The total reserves above, included in our condensed consolidated balance sheets, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Reduction of accounts receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">143.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">124.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Component of accrued expenses and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">446.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">359.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total reserves</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">590.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">483.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesDiscountsReturnsAndAllowancesGoodsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any allowance and reserve accounts (their beginning and ending balances, as well as a reconciliation by type of activity during the period). Alternatively, disclosure of the required information may be within the footnotes to the financial statements or a supplemental schedule to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 09<br><br><br><br> -Article 12<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978628590288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Details 3) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from maturities and sales</a></td>
<td class="nump">$ 601,900<span></span>
</td>
<td class="nump">$ 560,100<span></span>
</td>
<td class="nump">$ 975,517<span></span>
</td>
<td class="nump">$ 1,317,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGains', window );">Realized gains</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses', window );">Realized losses</a></td>
<td class="num">$ (500)<span></span>
</td>
<td class="num">$ (100)<span></span>
</td>
<td class="num">$ (800)<span></span>
</td>
<td class="num">$ (200)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the gross profit realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossRealizedGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the gross loss realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale or maturity (principal being due) of securities not classified as either held-to-maturity securities or trading securities which are classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 12<br><br><br><br> -Subparagraph (a),(b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3179-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49167202&amp;loc=d3e26853-111562<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978503080352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments (Details 2) - shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=biib_MarketStockUnitsMember', window );">Market stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_ScheduleOfStockOptionGrantsAbstract', window );"><strong>Schedule of stock option grants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Stock units</a></td>
<td class="nump">179,000<span></span>
</td>
<td class="nump">222,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=biib_CashSettledPerformanceSharesMember', window );">Cash settled performance shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_ScheduleOfStockOptionGrantsAbstract', window );"><strong>Schedule of stock option grants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Stock units</a></td>
<td class="nump">115,000<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=us-gaap_PerformanceSharesMember', window );">Performance units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_ScheduleOfStockOptionGrantsAbstract', window );"><strong>Schedule of stock option grants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Stock units</a></td>
<td class="nump">89,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=biib_TimeVestedRestrictedStockUnitsMember', window );">Time-vested restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_ScheduleOfStockOptionGrantsAbstract', window );"><strong>Schedule of stock option grants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Stock units</a></td>
<td class="nump">375,000<span></span>
</td>
<td class="nump">418,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_ScheduleOfStockOptionGrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of stock option grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_ScheduleOfStockOptionGrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(2)(iii)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=biib_MarketStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=biib_MarketStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=biib_CashSettledPerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=biib_CashSettledPerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=biib_TimeVestedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=biib_TimeVestedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978497422912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_BusinessOverviewPolicyTextBlock', window );">Overview</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Biogen is a global biopharmaceutical company focused on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. Our principal marketed products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI, and FAMPYRA for multiple sclerosis (MS), ALPROLIX for hemophilia B and ELOCTATE for hemophilia A. We also collaborate with Genentech, Inc., a wholly-owned member of the Roche Group, on the development and commercialization of RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and other conditions and share profits and losses for GAZYVA, which is approved for the treatment of chronic lymphocytic leukemia.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of our financial statements for interim periods in accordance with accounting principles generally accepted in the United States (U.S.&#160;GAAP). The information included in this quarterly report on Form&#160;10-Q should be read in conjunction with our consolidated financial statements and the accompanying notes included in our Annual Report on Form&#160;10-K for the year ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> (</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form&#160;10-K). Our accounting policies are described in the &#8220;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Notes to Consolidated Financial Statements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8221; in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form&#160;10-K and updated, as necessary, in this Form&#160;10-Q. The year-end condensed consolidated balance sheet data presented for comparative purposes was derived from our audited financial statements, but does not include all disclosures required by U.S.&#160;GAAP. The results of operations for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, are not necessarily indicative of the operating results for the full year or for any other subsequent interim period. </font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our condensed consolidated financial statements reflect our financial statements, those of our wholly-owned subsidiaries and those of certain variable interest entities where we are the primary beneficiary. For consolidated entities where we own or are exposed to less than </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">100%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of the economics, we record net income (loss) attributable to noncontrolling interests in our condensed consolidated statements of income equal to the percentage of the economic or ownership interest retained in such entities by the respective noncontrolling parties. Intercompany balances and transactions are eliminated in consolidation. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In determining whether we are the primary beneficiary of an entity and therefore required to consolidate, we apply a qualitative approach that determines whether we have both (1) the power to direct the economically significant activities of the entity and (2) the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to that entity. These considerations impact the way we account for our existing collaborative relationships and other arrangements. We continuously assess whether we are the primary beneficiary of a variable interest entity as changes to existing relationships or future transactions may result in us consolidating or deconsolidating one or more of our collaborators or partners.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We operate as </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">one</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> operating segment, which is focused on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The preparation of our condensed consolidated financial statements requires us to make estimates, judgments, and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and judgments and methodologies. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts receivable</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our accounts receivable primarily arise from product sales in the U.S.&#160;and Europe and mainly represent amounts due from our wholesale distributors, public hospitals and other government entities. Concentrations of credit risk with respect to our accounts receivable, which are typically unsecured, are limited due to the wide variety of customers and markets using our products, as well as their dispersion across many different geographic areas. The majority of our accounts receivable require payment within </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">30 to 90 days</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. We monitor the financial performance and credit worthiness of our customers so that we can properly assess and respond to changes in their credit profile. We provide reserves against trade receivables for estimated losses that may result from a customer&#8217;s inability to pay. Amounts determined to be uncollectible are charged or written-off against the reserve. To date, our historical reserves and write-offs of accounts receivable have not been significant.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In countries where we have experienced a pattern of payments extending beyond our contractual payment term and we expect to collect receivables greater than one year after the time of sale, we have discounted our receivables and reduced related revenues over the period of time that we estimate those amounts will be paid using the country&#8217;s market-based borrowing rate for such period. The related receivables are classified at the time of sale as non-current assets. We accrete interest income on these receivables, which is recognized as a component of other income (expense), net within our condensed consolidated statement of income.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, plant and equipment</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Property, plant and equipment are recorded at cost, net of accumulated depreciation. Accumulated depreciation on property, plant and equipment was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1,274.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1,186.4 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New accounting pronouncements</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard setting bodies that we adopt as of the specified effective date. Unless otherwise discussed, we do not believe that the impact of recently issued standards that are not yet effective will have a material impact on our financial position or results of operations upon adoption.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes all existing revenue recognition requirements, including most industry-specific guidance. The new standard requires a company to recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. In July 2015, the FASB decided to delay the effective date of the new revenue standard by one year. The new standard will be effective for us on January 1, 2018. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. We are currently evaluating the method of adoption and the potential impact that Topic 606 may have on our financial position and results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In June 2014, the FASB issued ASU No. 2014-11, Transfers and Servicing (Topic 860): Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosure. The new standard expanded secured borrowing accounting to include repurchase-to-maturity transactions and repurchase financings and set forth new disclosure requirements for repurchase agreements, securities lending transactions, and repurchase-to-maturity transactions that are accounted for as secured borrowings. We adopted this standard on April 1, 2015 and expanded our disclosures presented within Note 7, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Financial Instruments</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to these condensed consolidated financial statements. The adoption of this standard did not have an impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In April 2015, the FASB issued ASU No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The new standard requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The new standard will be effective for us on January 1, 2016. The adoption of this standard is not expected to have an impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In April 2015, the FASB issued ASU No. 2015-05, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Fees Paid in a Cloud Computing Arrangement. Under this standard, if a cloud computing arrangement includes a software license, the software license element of the arrangement should be accounted for consistent with the acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the arrangement should be accounted for as a service contract. The new standard will be effective for us on January 1, 2016. The adoption of this standard is not expected to have an impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2015, the FASB issued ASU No. 2015-07, Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent). The new standard removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient. The new standard will be effective for us on January 1, 2016. Early application is permitted. We maintain investments in certain venture capital funds which primarily invest in small, privately-owned, venture-backed biotechnology companies. The value of our investments in these venture capital funds is estimated using the net asset value of the fund and has been included in the fair value hierarchy disclosure as a Level 3 measurement. These venture capital investments are not material to our financial position or results of operations. We have elected to apply this standard as of June 30, 2015 and our investments in venture capital funds will no longer be included in our disclosures reflected within Note 6, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Fair Value Measurements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to these condensed consolidated financial statements.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_BusinessOverviewPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes an overview of the company and its operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_BusinessOverviewPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=d3e5614-111684<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.3A-02)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph k<br><br><br><br> -Article 1<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02, 03<br><br><br><br> -Article 3A<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for trade and other accounts receivable, and finance, loan and lease receivables, including those classified as held for investment and held for sale. This disclosure may include (1) the basis at which such receivables are carried in the entity's statements of financial position (2) how the level of the valuation allowance for receivables is determined (3) when impairments, charge-offs or recoveries are recognized for such receivables (4) the treatment of origination fees and costs, including the amortization method for net deferred fees or costs (5) the treatment of any premiums or discounts or unearned income (6) the entity's income recognition policies for such receivables, including those that are impaired, past due or placed on nonaccrual status and (7) the treatment of foreclosures or repossessions (8) the nature and amount of any guarantees to repurchase receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6378556&amp;loc=d3e10133-111534<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49124121&amp;loc=d3e4975-111524<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 3-5<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6061-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6143-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6132-108592<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.2.0.727</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>264</ContextCount>
  <ElementCount>311</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>88</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001000 - Statement - Condensed Consolidated Statements of Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002501 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003000 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1003501 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1004000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101100 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2104100 - Disclosure - Acquisitions Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/AcquisitionsAcquisitions</Role>
      <ShortName>Acquisitions Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2106100 - Disclosure - Reserves for Discounts and Allowances</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/ReservesForDiscountsAndAllowances</Role>
      <ShortName>Reserves for Discounts and Allowances</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2107100 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2108100 - Disclosure - Intangible Assets and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/IntangibleAssetsAndGoodwill</Role>
      <ShortName>Intangible Assets and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2109100 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2110100 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2112100 - Disclosure - Derivative Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/DerivativeInstruments</Role>
      <ShortName>Derivative Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2114100 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2115100 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLoss</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2116100 - Disclosure - Earnings per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/EarningsPerShare</Role>
      <ShortName>Earnings per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2117100 - Disclosure - Share-based Payments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/ShareBasedPayments</Role>
      <ShortName>Share-based Payments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2118100 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2119100 - Disclosure - Other Consolidated Financial Statement Detail</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetail</Role>
      <ShortName>Other Consolidated Financial Statement Detail</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2120100 - Disclosure - Investments in Variable Interest Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/InvestmentsInVariableInterestEntities</Role>
      <ShortName>Investments in Variable Interest Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2121100 - Disclosure - Collaborative and Other Relationships</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/CollaborativeAndOtherRelationships</Role>
      <ShortName>Collaborative and Other Relationships</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2122100 - Disclosure - Litigation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/Litigation</Role>
      <ShortName>Litigation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2123100 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2124100 - Disclosure - Subsequent Events Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/SubsequentEventsSubsequentEvents</Role>
      <ShortName>Subsequent Events Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2201201 - Disclosure - Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Acquisitions Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/AcquisitionsAcquisitionsTables</Role>
      <ShortName>Acquisitions Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/AcquisitionsAcquisitions</ParentRole>
      <Position>28</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2306301 - Disclosure - Reserves for Discounts and Allowances (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesTables</Role>
      <ShortName>Reserves for Discounts and Allowances (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/ReservesForDiscountsAndAllowances</ParentRole>
      <Position>29</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/Inventory</ParentRole>
      <Position>30</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2308301 - Disclosure - Intangible Assets and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillTables</Role>
      <ShortName>Intangible Assets and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/IntangibleAssetsAndGoodwill</ParentRole>
      <Position>31</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2309301 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/FairValueMeasurements</ParentRole>
      <Position>32</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2310301 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/FinancialInstruments</ParentRole>
      <Position>33</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2312301 - Disclosure - Derivative Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/DerivativeInstrumentsTables</Role>
      <ShortName>Derivative Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/DerivativeInstruments</ParentRole>
      <Position>34</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2314301 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/Equity</ParentRole>
      <Position>35</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2315301 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLoss</ParentRole>
      <Position>36</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2316301 - Disclosure - Earnings per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/EarningsPerShare</ParentRole>
      <Position>37</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2317301 - Disclosure - Share-Based Payments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/ShareBasedPaymentsTables</Role>
      <ShortName>Share-Based Payments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2318301 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/IncomeTaxes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2319301 - Disclosure - Other Consolidated Financial Statement Detail (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailTables</Role>
      <ShortName>Other Consolidated Financial Statement Detail (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetail</ParentRole>
      <Position>40</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2401402 - Disclosure - Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>41</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2404402 - Disclosure - Acquisitions  Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails</Role>
      <ShortName>Acquisitions Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/AcquisitionsAcquisitionsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2404403 - Disclosure - Acquisitions Acquisitions (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetails1</Role>
      <ShortName>Acquisitions Acquisitions (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/AcquisitionsAcquisitionsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2404404 - Disclosure - Acquisitions Acquisitions (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/AcquisitionsAcquisitionsDetailsTextual</Role>
      <ShortName>Acquisitions Acquisitions (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/AcquisitionsAcquisitionsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Reserves for Discounts and Allowances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails</Role>
      <ShortName>Reserves for Discounts and Allowances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Reserves for Discounts and Allowances (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails1</Role>
      <ShortName>Reserves for Discounts and Allowances (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/InventoryDetails</Role>
      <ShortName>Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/InventoryTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Inventory Inventory (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/InventoryInventoryDetailsTextual</Role>
      <ShortName>Inventory Inventory (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - Intangible Assets and Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails</Role>
      <ShortName>Intangible Assets and Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Intangible Assets and Goodwill (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails1</Role>
      <ShortName>Intangible Assets and Goodwill (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2409402 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2409403 - Disclosure - Fair Value Measurements (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/FairValueMeasurementsDetails1</Role>
      <ShortName>Fair Value Measurements (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Fair Value Measurements (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/FairValueMeasurementsDetails2</Role>
      <ShortName>Fair Value Measurements (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - Fair Value Measurements (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/FairValueMeasurementsDetailsTextual</Role>
      <ShortName>Fair Value Measurements (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2410402 - Disclosure - Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/FinancialInstrumentsDetails</Role>
      <ShortName>Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - Financial Instruments (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/FinancialInstrumentsDetails1</Role>
      <ShortName>Financial Instruments (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Financial Instruments (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/FinancialInstrumentsDetails2</Role>
      <ShortName>Financial Instruments (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2410405 - Disclosure - Financial Instruments (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/FinancialInstrumentsDetails3</Role>
      <ShortName>Financial Instruments (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2410406 - Disclosure - Financial Instruments (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/FinancialInstrumentsDetailsTextual</Role>
      <ShortName>Financial Instruments (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2410407 - Disclosure - Financial Instruments Financial Instruments (Details Textual 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/FinancialInstrumentsFinancialInstrumentsDetailsTextual2</Role>
      <ShortName>Financial Instruments Financial Instruments (Details Textual 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2412402 - Disclosure - Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/DerivativeInstrumentsDetails</Role>
      <ShortName>Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/DerivativeInstrumentsTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2414402 - Disclosure - Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/EquityDetails</Role>
      <ShortName>Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/EquityTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2414403 - Disclosure - Equity (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/EquityDetailsTextual</Role>
      <ShortName>Equity (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/EquityTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2415402 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2415403 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails1</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2416402 - Disclosure - Earnings per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/EarningsPerShareTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2417402 - Disclosure - Share-Based Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/ShareBasedPaymentsDetails</Role>
      <ShortName>Share-Based Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/ShareBasedPaymentsTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2417403 - Disclosure - Share-Based Payments (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/ShareBasedPaymentsDetails1</Role>
      <ShortName>Share-Based Payments (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/ShareBasedPaymentsTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2417404 - Disclosure - Share-Based Payments (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/ShareBasedPaymentsDetails2</Role>
      <ShortName>Share-Based Payments (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/ShareBasedPaymentsTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2417405 - Disclosure - Share-Based Payments (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/ShareBasedPaymentsDetailsTextual</Role>
      <ShortName>Share-Based Payments (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/ShareBasedPaymentsTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2418402 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/IncomeTaxesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2418403 - Disclosure - Income Taxes (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/IncomeTaxesDetailsTextual</Role>
      <ShortName>Income Taxes (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/IncomeTaxesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2419402 - Disclosure - Other Consolidated Financial Statement Detail (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailDetails</Role>
      <ShortName>Other Consolidated Financial Statement Detail (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2419403 - Disclosure - Other Consolidated Financial Statement Detail Other Consolidated Financial Statement (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailOtherConsolidatedFinancialStatementDetailsTextual</Role>
      <ShortName>Other Consolidated Financial Statement Detail Other Consolidated Financial Statement (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2420401 - Disclosure - Investments in Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/InvestmentsInVariableInterestEntitiesDetails</Role>
      <ShortName>Investments in Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/InvestmentsInVariableInterestEntities</ParentRole>
      <Position>75</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2421401 - Disclosure - Collaborative and Other Relationships Collaborative and Other Relationships - Equity Method Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsEquityMethodInvestmentsDetails</Role>
      <ShortName>Collaborative and Other Relationships Collaborative and Other Relationships - Equity Method Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2422401 - Disclosure - Litigation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/LitigationDetails</Role>
      <ShortName>Litigation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/Litigation</ParentRole>
      <Position>77</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2423401 - Disclosure - Commitments and Contingences (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/CommitmentsAndContingencesDetails</Role>
      <ShortName>Commitments and Contingences (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>78</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2423402 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/CommitmentsAndContingenciesCommitmentsAndContingenciesDetails1</Role>
      <ShortName>Commitments and Contingencies Commitments and Contingencies (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2424401 - Disclosure - Subsequent Events Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biogenidec.com/role/SubsequentEventsSubsequentEventsDetails</Role>
      <ShortName>Subsequent Events Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biogenidec.com/role/SubsequentEventsSubsequentEvents</ParentRole>
      <Position>80</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">In ''Condensed Consolidated Balance Sheets (Unaudited)'', column(s) 2, 4, 5, 6 are contained in other reports, so were removed by flow through suppression.</Log>
    <Log type="Info">In ''Condensed Consolidated Statements of Cash Flows (Unaudited)'', column(s) 1, 2 are contained in other reports, so were removed by flow through suppression.</Log>
  </Logs>
  <InputFiles>
    <File>biib-20150630.xml</File>
    <File>biib-20150630_cal.xml</File>
    <File>biib-20150630_def.xml</File>
    <File>biib-20150630_lab.xml</File>
    <File>biib-20150630_pre.xml</File>
    <File>biib-20150630.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978503207024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Consolidated Financial Statement Detail Other Consolidated Financial Statement (Details Textual)<br> $ in Thousands, &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityContingencyLineItems', window );"><strong>Product Liability Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product, net</a></td>
<td class="nump">$ 2,198,566<span></span>
</td>
<td class="nump">$ 2,056,292<span></span>
</td>
<td class="nump">$ 4,370,888<span></span>
</td>
<td class="nump">$ 3,799,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=country_IT', window );">Italy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityContingencyLineItems', window );"><strong>Product Liability Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_ReimbursementLimitStatedInResolution', window );">Reimbursement limit stated in the resolution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Proposed settlement | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 35.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent', window );">Amount reserved for this matter | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 75.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_ReimbursementLimitStatedInResolution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reimbursement limit stated in the resolution.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_ReimbursementLimitStatedInResolution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of unearned revenue or income, not otherwise specified in the taxonomy, which is expected to be taken into income during the current period and current obligations not separately disclosed in the balance sheet (other liabilities, current).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14557-108349<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueGoodsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=country_IT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=country_IT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978507184176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Share-based compensation expense included in condensed consolidated statements of income</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes share-based compensation expense included within our condensed consolidated statements of income:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">22.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">57.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">53.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">26.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">33.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">81.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">80.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Subtotal</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">48.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">58.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">139.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">134.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Capitalized share-based compensation costs </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation expense included in total cost and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">46.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">55.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">133.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">129.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax effect</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(12.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(16.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(39.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(38.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation expense included in net income attributable to Biogen Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">33.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">39.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">94.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">90.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Summary of share-based compensation expense associated with each of our share-based compensating programs</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">9.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">26.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">23.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Time-vested restricted stock units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">31.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">29.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">63.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">58.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash settled performance units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">14.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">27.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Performance units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">14.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee stock purchase plan</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">8.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Subtotal</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">48.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">58.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">139.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">134.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Capitalized share-based compensation costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation expense included in total cost and expenses</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">46.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">55.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">133.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">129.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock', window );">Summary of equity grants to employees, officers and directors under our current stock plans</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes our equity grants to employees, officers and directors under our current stock plans:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market stock units</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">179,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">222,000</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash settled performance shares</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">115,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">180,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Performance units</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">89,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">50,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Time-vested restricted stock units</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">375,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">418,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of restricted stock unit grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">biib_ScheduleOfRestrictedStockUnitGrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>biib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of total share-based compensation cost, including the amounts attributable to each share-based compensation plan and any related tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (h)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (h)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 14.F)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 14<br><br><br><br> -Section F<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm139978503506736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;padding-top:6px;text-indent:24px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, our effective tax rate was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">23.9%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24.7%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, as compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">27.0%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">26.9%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in the prior year comparative periods.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">A reconciliation between the U.S.&#160;federal statutory tax rate and our effective tax rate is summarized as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Statutory rate</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State taxes</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Taxes on foreign earnings</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(11.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(8.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(9.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(8.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Credits and net operating loss utilization</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Purchased intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Manufacturing deduction</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other permanent items</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Effective tax rate</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">23.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">27.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">24.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">26.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in our effective income tax rate is due to lower anticipated taxes on foreign earnings.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2014</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the decrease in our income tax rate was due to a benefit resulting from the remeasurement of one of our uncertain tax positions, described below, and lower anticipated taxes on foreign earnings.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Accounting for Uncertainty in Income Taxes</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We and our subsidiaries are routinely examined by various taxing authorities. We file income tax returns in the U.S.&#160;federal jurisdiction, various U.S. states, and foreign jurisdictions. With few exceptions, including the proposed disallowance we discuss below, we are no longer subject to U.S.&#160;federal tax examination for years before 2013 or state, local, or non-U.S.&#160;income tax examinations for years before 2004. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In March 2015, we received a final assessment from the Danish Tax Authority (SKAT) for fiscal 2009, regarding withholding taxes and the treatment of certain intercompany transactions involving our Danish affiliate and another of our affiliates.&#160;The audits of our tax filings for 2010 through 2013 are not completed but have been prepared in a manner consistent with prior filings, with similar transactions, which may result in an assessment for those years.&#160;The total amount assessed for 2009 is </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$48.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, including interest.&#160;For all periods potentially under dispute, we believe that positions taken in our tax filings are valid and we are contesting the assessment vigorously.  </font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;">Federal Uncertain Tax Positions</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the net effect of adjustments to our uncertain tax positions was a net benefit of approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$24.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> primarily related to the state impact of a federal uncertain tax item. It is reasonably possible that we will adjust the value of our uncertain tax positions related to our unconsolidated joint business and certain transfer pricing issues as we receive additional information from various taxing authorities, including reaching settlements with the authorities. In addition, the Internal Revenue Service (IRS) and other national tax authorities routinely examine our intercompany transfer pricing with respect to intellectual property related transactions and it is possible that they may disagree with one or more positions we have taken with respect to such valuations.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In October 2011, in conjunction with our examination, the IRS proposed a disallowance of approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$130.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in deductions for tax years 2007, 2008 and 2009 related to payments for services provided by our wholly owned Danish subsidiary located in Hiller&#248;d, Denmark. We believe that these items represent valid deductible business expenses and are vigorously defending our position. We have initiated a mutual agreement procedure between the IRS and SKAT for the years 2001 through 2009, in an attempt to reach agreement on the issue. In addition, we have applied for a bilateral advanced pricing agreement for the years 2010 through 2014 to resolve similar issues for the subsequent years.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
